key: cord-281410-y558a5jf authors: akashi, h.; inaba, y.; miura, y.; sato, k.; tokuhisa, s.; asagi, m.; hayashi, y. title: propagation of the kakegawa strain of bovine coronavirus in suckling mice, rats and hamsters date: 1981 journal: arch virol doi: 10.1007/bf01314841 sha: doc_id: 281410 cord_uid: y558a5jf the kakegawa strain of bovine coronavirus was easily propagated in suckling mice. infected animals died with nervous symptoms, and serial passage was readily accomplished by intracerebral inoculation with brain emulsions. the 3rd passage viral material from infected mice evoked the same disease in suckling mice, rats and hamsters inoculated by the intracerebral or by the subcutaneous route. viruses recovered from mice, rats and hamsters could be clearly differentiated from mouse hepatitis virus strain 2 by the neutralization test. w'ith 1 figure accepted november 5, 1980 summary the kakegawa strain of bovine coronavirus was easily propagated in suckling mice. infected animals died with nervous symptoms, and serial passage was readily accomplished by intraeerebral inoculation with brain emulsions. the 3rd passage viral material from infected mice evoked the same disease in suckling mice, rats and hamsters inoculated by the intracerebral or by the subcutaneous route. viruses recovered from mice, rats and hamsters could be clearly differentiated from mouse hepatitis virus strain 2 by the neutralization test. a bovine coronavirus (bcv) has been recognized as one of the causative agents of diarrhea in calves (8) . l~ecently the kakagawa strain isolated from the feces of a cow with cpizootic diarrhea has been identified as bcv (1, 9) . however, the study of bovine diarrheal disease produced by coronavirus has been greatly hampered by difficulty in isolating virus in cell cultures and the lack of experimental hosts other than cattle. recently many members of the eorona~drus family" have been found to grow in suckling mice (5--7). the present paper describes briefly our recent observation that the kakegawa strain of bcv readily propagates in suckling mice, rats and hamsters. the kakegawa strain of bcv used for mouse inoculation was at, the 10th passage level in primary bovine kidney cell cultures. conventionally reared oneday-old mice (strain ddy), rats and syrian hamsters were each inoculated with 0.01-ml of the viral materials by the intracerebral (ic) route and with 0.02-ml by the subcutaneous (s.c.) route. virus recovery and infectivity assay were carried out. by inoculation into cell cultures of bek-1 ecll, derived from bovine embryonic kidney (3). the a:nti-kakegawa strain immune serum having a homologous neutralizing antibody titer of 4096 was prepared in specific germ-free rabbits with virus grown in bek-1 cells as described previously (1), and the anti-mouse hepatitis virus (mhv) strain 2 rabbit immune serum having a neutralizing antibody titer of about 10,000 by 50 per cent plaque reduction neutralization test was kindly supplied by dr. k. fujiwara, university of tokyo, japan. neutralization (nt) test was carried out by the method described previously (1) . viruses recovered from the brains of affected animals containing 200 tcids0 were mixed with an equal volume of two-fold serum dilutions. each mixture was assayed for infectivity by using two tubes of bek-1 cell cultures per dilution. the antibody titer was expressed as the reciprocal of the highest serum dilution that showed no cytopathic changes in at least, one of the two tubes. fig. 1 . four-day-old mouse 3 days after intraeerebral inoculation with the 3rd mouse brain passaged kakegawa strain (left) and an uninoeulated 4-day-old mouse (right) four litters (10 to 12/litter) of suckling mice were inoculated intracerebrally with infected tissue culture fluid containing 106-5 tcid50/ml. at daily intervals, four animals were sacrificed and their brains taken. the inoculated animals developed an illness 4 days post-inoculation (p. i.) and began to die at 5 days p. i. the affected animals became anemic and showed mild neural symptoms such as weak limbs and sluggish staggering gait. the virus titers of infected brains rose at 2 days p. i. with a subsequent gradual rise to a maximum of 10 s.~ tcids0/g at 5 days p. i. serial passage in suckling mice was readily accomplished by the i. c. route with 10 per cent, (w/v) brain emulsions (fig. 1) . the incubation period fell to 2 to 3 days by the 3rd passage. uninoculated mice and mice inoculated with normal brain emulsions remained healthy. virus at the 3rd passage level in suckling mice containing 105.2 tcids0/ml also produced a clinical illness with the same symptoms described above. it caused death in all animals when ineoulated into one litter of suckling mice (10/litter) by the s.c. route, and into rats (9 or 12/litter) and hamsters (7 or 8/litter) by the i.e. or s.c. route. table 1 neutralizing antibody titer the results of one way cross nt test are summarized in table 1 . the homologous nt titers were much higher than the heterologous liters. these findings showed that the viruses recovered from the brains of affected animals were antigenieally the same as the cell culture passaged virus and could be clearly differentiated from the mttv strain 2. a histological study of affected animals showed inflammation in the brains and vacuolar degeneration of the intestinal villi only in the case of s.c. inoculation. however, there was no evidence of inflammation in the liver and other organs (dr. 3/[. kubo, personal communiea, tion). kaye et al. (4) reported that they had adapted the american strain of calf diarrhea coronavirus to suckling mouse brain. on ~he other hand, dea et al. (2) reported that the american strain and their new isolates of calf diarrhea coronavirus were not virulent for suckling mice, hamsters and guinea pigs. our present results support kaye's findings. nt tests and histological studies have ruled out contamination with mhv. further studies, however, wil] be necessary to investigate the immunological and pa~thological differences between bcv and mi-iv. properties of a coronavirus isolated from a cow with epizootic diarrhea physicochemical and biological properties of neonatal calf diarrhea eoronaviruses isolated in quebec and comparison with the nebraska calf eoronavirus replication of bovine coronavirus in cell line ben-i culture calf diarrhoea coronavirus antigenic relationship between human eoronavirus strain oc 43 and hemagglutinating encephalomyelitis virus strain 67n of swine: antibody responses in human and animal sera coronaviruses: a comparative review feline infectious peritonitis virus. ii. propagation in suckling mouse brain neonatal calf diarrhea: purification and electron microscopy of a coronavirus-iike agent epizootic diarrhoea of adult cattle associated with a coronavirus-like agent authors' address: dr. h. akas~i, national institute o~' animal ttealth a-1011 wien. fiir den text~eil verantwortlieh: dr. wilhelm schwabl, m61kerbastei 5, a-1011 wish. fiir den anzeigenteil verantwortlieh: niag. bruno schweder, m61kerbastei 5, a-1011 wien key: cord-000249-hkc4vbmj authors: schughart, klaus title: sysgenet: a meeting report from a new european network for systems genetics date: 2010-07-11 journal: mamm genome doi: 10.1007/s00335-010-9273-7 sha: doc_id: 249 cord_uid: hkc4vbmj the first scientific meeting of the newly established european sysgenet network took place at the helmholtz centre for infection research (hzi) in braunschweig, april 7-9, 2010. about 50 researchers working in the field of systems genetics using mouse genetic reference populations (grp) participated in the meeting and exchanged their results, phenotyping approaches, and data analysis tools for studying systems genetics. in addition, the future of grp resources and phenotyping in europe was discussed. sysgenet is funded through the cost framework (http://www.cost.eu/about_cost). cost is an intergovernmental framework for european cooperation in science and technology that promotes and coordinates nationally funded research in europe, through funding of research networks. sysgenet is coordinated by klaus schughart (helmholtz center for infection research, braunschweig, germany) . more detailed information about sysgenet can be obtained from the website http://www.helmholtzhzi.de/sysgenet/. infectious diseases continue to represent a threat to human health. due to global warming and travel, newly emerging diseases are spreading at an unprecedented rate around the world. examples are the dissemination of antibioticsresistant mycobacteria, the new swine influenza virus variant, sars, and west nile virus (wnv). several research groups are using mouse grps to identify complex genetic influences on the host susceptibility to infections. grps have been and will continue to be an important basis for understanding infectious diseases in humans. a very good example for translational research was presented by pascal rihet, who identified genomic susceptibility regions to malaria in human populations in africa (delahaye et al. 2007 ) and then continued to compare these results with studies in mouse grps. in this way, a region on human chromosome 5 and its homologous regions on mouse chromosomes 11 and 18 were identified. subsequent expression studies in mice will now help to determine the molecular networks and genes involved. paul denny described the mapping of genetic susceptibility to streptococcus pneumonia infections in mouse inbred strains to chromosomes 7 (denny et al. 2003) and 4 (unpublished) . infection susceptibility to influenza was described by klaus schughart, who also pointed out that high susceptibility includes a hyperreactive immune response in the host (srivastava et al. 2009 ). xavier montagutelli generated a unique resource of mus spretus 9 c57bl/6 j interspecific recombinant congenic strains that carry different genomic fragments of mus spretus on a c57bl/6 j background (burgio et al. 2007 ). this grp was used to identify resistance and susceptibility regions to various pathogens, including rift valley fever, west nile virus, yersinia pestis, and influenza. the first lines of the collaborative cross strains have been screened by fuad iraqi for a number of susceptibility loci to various pathogens (unpublished). it was remarkable to see that several quantitative trait loci (qtl) showed high significance and that the genomic intervals for several loci were very narrow, which should make it possible to identify quickly the underlying quantitative trait genes. metabolic diseases in humans are dramatically on the rise; obesity and related diseases in particular represent a serious challenge to future health systems. several groups addressed the complex genetics of metabolic functions and disorders using different mouse grps. gudrun brockmann reported on the mapping of qtls for obesity in a specific mouse strain isolated in berlin and the bxd congenic strain set (neuschl et al. 2010) . the future goal is to relate these qtls to genetic polymorphisms that influence the immune system. joan campbell-tofte presented the use of herbal extracts for the treatment of type 2 diabetes in humans. she nicely illustrated the use of mouse models: from human to mouse to humans and back to the mouse. pénélope andreux reported on the setting up of a mouse clinic in lausanne for a systematic analysis of mouse grps for a large number of metabolic phenotypes, including mitochondrial functions (koutnikova et al. 2009 ). juan m. falcon-perez described the genomic, proteomic, and metabolic phenotyping capabilities of their technological platform and introduced extracellular microvesicles and metabolomic profiles as two new biological sources for identifying biomarkers for the detection and monitoring of hepatic diseases (hackenberg et al. 2009 ). abnormalities and diseases of the liver are also the subject of studies presented by karl kashofer (kashofer et al. 2009 ). several loci for (nonalcoholic) steatohepatitis have been mapped in chromosome substitution strains, and a more detailed mapping in subcongenic strains is ongoing. although rats in general were the species of choice for use by experimental psychologists to study behavior, mice have been the preferred animal for behavior geneticists since at least the 1940 s. in addition, the adaptation of behavioral assays and the development of new methods have confirmed the mouse as one of the most preferred experimental systems to learn more about the genetic underpinnings of behavior and associated phenotypes. martien kas described the currently underlying scientific rationale. precise measurement of a well-described behavioral trait across a grp will lead to the identification of associated genes and genomic regions. in the next step these genes can be used to find homologous genes and pathways that contribute to the development of neuropsychiatric disorders in humans. the translational value of this interspecies genetic approach was nicely exemplified in a study in which a qtl for avoidance behavior in mice was related to bipolar disorders in humans (de mooij-van malsen et al. 2009 ). in a similar approach, iris hovatta used a cross-species neurogenomics comparison to correlate brain region-specific gene expression patterns and anxiety-like behavior in mouse grps to polymorphisms in the finnish population for anxiety disorders (hovatta et al. 2005) . the mouse genes allowed identification of potential candidate genes in humans who predispose to anxiety disorders. paul franken presented studies on the identification of genetic traits that influence homeostatic and circadian aspects of sleep, and the electroencephalogram in the bxd grp and in inter-and backcross panels of mice (shaw and franken 2003) . several genes that play a decisive role were identified, and further phenotyping of the extended bxd grp is planned. eero vasar and sulev kõks described the role of the wfs1 gene in knockout mice for anxiety behavior, an altered response to morphine and the release of striatal dopamine (koks et al. 2009; luuk et al. 2009 ). ewelina knapska reported the use of a highly sophisticated cage system, intellicage, to automatically record a number of different complex behavioral traits in mice (jaholkowski et al. 2009 ). mice can be housed in social groups but nevertheless tested individually. ryszard przewlocki reported on a systematic study on various inbred mouse strains to identify genetic determinants of alcohol and drug addiction (piechota et al. 2010) . combining these studies with comprehensive gene expression analyses revealed that glucocorticoid receptor-activated gene expression pathways play an important role. wim crusio studied behavioral traits in learning and related them to brain anatomy (crusio and schwegler 2005) . thereby, the extent of neuron projections in the hippocampus could be correlated to more efficient learning capabilities and these two phenotypes are very strongly correlated genetically. guus smit gave an overview on a collaborative effort in the netherlands in which several research groups have determined various behavioral phenotypic traits and qtls in a commonly used bxd population (loos et al. 2009 ). also, they established a mouse facility in which they are using automated screening cages with sophisticated video recording and analysis. cancer is still one of the most frequent causes of death in western countries, and understanding its molecular causes as well as establishing appropriate animal model systems for the development of new treatment strategies is very important. fragiskos kolisis reported on the setting up of an infrastructure for a systems biology approach to carcinogenesis and aging (chatziioannou et al. 2009 ). understanding proteasome function and dysfunction as well as studying the alterations of the genome and proteome that account for different cancer phenotypes in a mouse skin carcinogenesis model are among the research goals. javier santos used grps to identify genetic traits for the susceptibility to radiation-induced thymic lymphomas in interspecific recombinant congenic and consomic mouse strains (santos et al. 2009 ). frank lammert developed assay systems to determine genetic causes of liver fibrosis and inflammatory liver carcinogens in the bxd mouse recombinant congenic grp (weber et al. 2008) . leonard schalkwyk studied allele-specific methylation in humans (schalkwyk et al. 2010) . he estimated that potentially more than 35,000 sites in the genome exhibit allele-specific modifications, and of these 10% are not in cis, a number that largely exceeds the number of known imprinted loci. these findings suggest that individual genetic heterogeneity may be much larger than estimated thus far and may contribute to individual phenotypic differences. jiri forejt used inter-subspecific consomic strains (gregorova et al. 2008) to investigate male sterility and its consequences for interspecies hybrid sterility (mihola et al. 2009 ). furthermore, in the livers of inter-subspecific hybrid strains he discovered new patterns of gene expression that were absent from both parental strains. the capture, storage, handling, and analysis of large data sets will present a specific challenge for future systems genetics projects. ritsert jansen and pjotr prins presented their approaches to integrate data from various phenotypic studies, encompassing gene expression, metabolome, and classical traits, and to develop new tools for advanced and improved mapping of qtls (jansen et al. 2009; li et al. 2008; swertz and jansen 2007) . these tools will be provided to the scientific community. andreas beyer gave a report on how to integrate data obtained at the post-transcriptional level with rna expression data. several loci that influence the post-transcriptional regulation of gene products could be identified in yeast. steffen möller presented his suite for the analysis of expression qtl (http://eqtl.berlios.de), which is being applied to the analysis of experimental autoimmune encephalomyelitis in mouse and rat. anastasios bezerianos presented a platform and developments for the identification of gene regulatory networks integrating protein-protein interactions and microarray data (bezerianos and maraziotis 2008). they started with yeast data and will soon expand to mouse, concentrating on time-varying gene regulatory networks. morris swertz presented xgap, a software platform developed for data management and integration of large data sets from phenotyping and genotyping studies (swertz et al. 2010) . grant morahan described the development of an extended tool for webqtl that allows a genome-centric analysis of qtl interactions (unpublished). the collaborative cross (cc) is currently being generated as a community resource for more sensitive and refined mapping of qtls. the goal is to breed a large population of recombinant inbred strains starting from eight founder strains. the eight founder strains were selected to capture a large portion of the genetic variation in the mouse genome. in fact, the genetic variation represented in the cc will be twice the genetic variation present in the human population (reviewed in valdar et al. 2006) . the three sites where the resource is being generated reported the present status of their breeding colonies; the final goal is to generate a total of 700 lines (chesler et al. 2008; iraqi et al. 2008; morahan et al. 2008a) . grant morahan gave an update on the ''southern cross'' being established in perth, australia. an inbreeding depression was observed at generations 7-9. at present, about 200 strains have been bred beyond generation 10. the first 40 strains are expected to be inbred by the end of the year. david threadgill reported the status of the breeding colony at the university of north carolina, chapel hill, nc, usa. about 300 lines are currently breeding at unc. the first 50 recombinant inbred lines will be available by the end of this year and 200 lines by the end of 2011. to speed up the inbreeding process, markerassisted breeding will be used to create homozygous lines beyond generation 12. genome analysis demonstrated that all parental genomes are well represented in the advanced generations. the first phenotyping analysis showed a large variation in body weight, exercise propensity, and susceptibility to pathogens. richard mott described the genome structure of a smaller cc colony, funded by the wellcome trust, which was developed by fuad iraqi and is presently housed in tel aviv, israel. a first phenotyping analysis for the qtls that affect recombination frequencies was performed. a full-genome sequencing project to complete the parental strains with high coverage is underway at the sanger institute. the two-day meeting in braunschweig has clearly demonstrated the great value of mouse grps in identifying genetic determinants of complex genetic traits for various phenotypic traits related to diseases in humans. the partners of the network collectively have great expertise in disease phenotyping and analysis of genetic reference populations. several examples that illustrated the translation of the knowledge gained in the mouse experimental systems to humans were presented. links to clinical researchers already exist at several places but will have to be further expanded in the future. furthermore, mouse grps can be ideally combined with mouse mutant lines carrying a gene-knockout mutation to determine the effect of a strong genetic defect in combination with modifier genes. it also became clear that a strong and sustained financial investment in mouse breeding and phenotyping facilities as well as in bioinformatic infrastructure is urgently needed to further advance a systems genetics approach in europe. open access this article is distributed under the terms of the creative commons attribution noncommercial license which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. greece; sulev kõks, university of tartu, estonia; frank wfs1-deficient mice display impaired behavioural adaptation in stressful environment detection and interpretation of expression quantitative trait loci (eqtl) a mouse speciation gene encodes a meiotic histone h3 methyltransferase establishment of ''the gene mine'': a resource for rapid identification of complex trait genes systems genetics can provide new insights into immune regulation and autoimmunity a unique genetic defect on chromosome 3 is responsible for juvenile obesity in the berlin fat mouse a new set of bxd recombinant inbred lines from advanced intercross populations in mice the mouse as a model for human biology: a resource guide for complex trait analysis the dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum the polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for qtl discovery and systems genetics a role for stroma-derived annexin a1 as mediator in the control of genetic susceptibility to t-cell lymphoblastic malignancies through prostaglandin e2 secretion allelic skewing of dna methylation is widespread across the genome perchance to dream: solving the mystery of sleep through genetic analysis host genetic background strongly influences the response to influenza a virus infections beyond standardization: dynamic software infrastructures for systems biology xgap: a uniform and extensible data model and software platform for genotype and phenotype experiments simulating the collaborative cross: power of quantitative trait loci detection and mapping resolution in large sets of recombinant inbred strains of mice genetic determinants in hepatic fibrosis: from experimental models to fibrogenic gene signatures in humans bao l, wei l, peirce jl, homayouni r, li h et al (2006) combining gene expression qtl mapping and phenotypic spectrum analysis to uncover gene regulatory relationships. key: cord-288133-h3wmo0xj authors: hickman, debra l title: evaluation of the neutrophil:lymphocyte ratio as an indicator of chronic distress in the laboratory mouse date: 2017-06-23 journal: lab anim (ny) doi: 10.1038/laban.1298 sha: doc_id: 288133 cord_uid: h3wmo0xj when evaluating the effect of husbandry and biomethodologies on the well-being of laboratory mice, it is critical to utilize measurements that allow the distinguishing of acute stress from chronic stress. one of the most common measurements of stress in laboratory animals is the corticosterone assessment. however, while this measurement provides a highly accurate reflection of the animal's response to acute stressors, its interpretation is more prone to error when evaluating the effect of chronic stress. this study evaluated the use of the neutrophil:lymphocyte (ne:ly) ratio as an assessment of chronic stress in male and female c57bl/6n mice as compared to serum corticosterone. one group of mice was exposed to mild daily stressors for 7 days, while the control group was handled with normal husbandry. the ne:ly ratio and serum corticosterone levels were significantly elevated in the chronically stressed mice, though a significant increase in corticosterone was only significant in males when compared by sex. the chronically stressed mice also demonstrated significantly fewer entries into the open arms and less time spent in the open arms of the elevated plus maze, suggesting that the mild daily stressors had induced a state of distress. the findings of this study confirm that the ne:ly ratio is a valid measurement for chronic stress in the laboratory mouse. however, these assays do not distinguish between distress or eustress, so behavioral and physiological assessments should always be included to determine a complete assessment of the well-being of the mouse. supplementary information: the online version of this article (doi:10.1038/laban.1298) contains supplementary material, which is available to authorized users. when designing studies that use animal models, it has been recognized that the results are more translatable to human disease when the subjects are healthy with minimal stressors [1] [2] [3] [4] [5] [6] . but, not all stress is bad, so it is critical that evaluations of animal well-being differentiate between distress (that which results in decreases in animal well-being as the animal is unable to cope or adapt) and eustress (stressors which enhance the functioning of the animal) 7, 8 . appropriate selection of assessments of animal well-being can assist laboratory animal professionals as they seek to evaluate and improve current practices 9 , especially with mice. generally, the most common method to assess laboratory mouse well-being has been focused on assessment of the response to acute stressors (i.e. an injection, brief restraint, a cage change) 10 . these stress events have consistently been associated with elevations in mouse serum and fecal corticosterone 6, 11, 12 and neuropeptides 13 . mice that have been exposed to acute stressors also have shown increased anxiety when assessed by the elevated plus maze and other behavioral assessments [14] [15] [16] [17] , in addition to elevations of heart rate and blood pressure [18] [19] [20] . it has been more challenging to measure states of chronic stress, where an animal was exposed to the stressors for hours or days instead of seconds or minutes. corticosteroids are commonly used in these assessments, but interpretation is complicated because corticosterone levels are influenced by factors that include the method of sample collection, sex, immune status, circadian rhythm, and nutritional status 10 . they also increase when an animal experiences extreme fear (distress) or extreme pleasure (eustress) 21 , requiring the addition of behavioral assessment to accurately determine the state of the animal. changes in body weight and organ weights relative to body weight have been among the more reliable measures of chronic stress as these measure change more slowly, making them a stronger reflection of the effects of exposure to chronic stressors 22-24 . work by this laboratory and others have noted that chronic stressors that induce increase glucocorticoid responses also induce when evaluating the effect of husbandry and biomethodologies on the well-being of laboratory mice, it is critical to utilize measurements that allow the distinguishing of acute stress from chronic stress. one of the most common measurements of stress in laboratory animals is the corticosterone assessment. however, while this measurement provides a highly accurate reflection of the animal's response to acute stressors, its interpretation is more prone to error when evaluating the effect of chronic stress. this study evaluated the use of the neutrophil:lymphocyte (ne:ly) ratio as an assessment of chronic stress in male and female c57bl/6n mice as compared to serum corticosterone. one group of mice was exposed to mild daily stressors for 7 days, while the control group was handled with normal husbandry. the ne:ly ratio and serum corticosterone levels were significantly elevated in the chronically stressed mice, though a significant increase in corticosterone was only significant in males when compared by sex. the chronically stressed mice also demonstrated significantly fewer entries into the open arms and less time spent in the open arms of the elevated plus maze, suggesting that the mild daily stressors had induced a state of distress. the findings of this study confirm that the ne:ly ratio is a valid measurement for chronic stress in the laboratory mouse. however, these assays do not distinguish between distress or eustress, so behavioral and physiological assessments should always be included to determine a complete assessment of the well-being of the mouse. an apparent immunosuppression that presents within a couple of hours of elevated corticosterone exposure as a neutrophilia that may include a concurrent lymphopenia [25] [26] [27] [28] . these immunologic changes are also seen in disorders which are associated with elevated glucocorticoids 29, 30 and other chronic illnesses, supporting the role of glucocorticoids in the apparent immunosuppression. the high correlation coupled with the relatively low cost to obtain a complete blood count has resulted in use of the neutrophil:lymphocyte (ne:ly) ratio to assess stress in multiple species 25, 27 . the objective of this study was to determine if the ne:ly ratio was consistent with serum corticosterone as a measurement of chronic stress in the laboratory mouse. additionally, we included the elevated plus maze to determine if the ne:ly ratio accurately measured distress in the chronically stressed mice, as compared to the behavior of the non-manipulated, non-stressed mice. the indiana university school of medicine (iusm) animal care and use program was in compliance with federal regulations and accredited by aaalac, international. all procedures were approved by the iusm iacuc prior to initiation of the study. the study was structured with a between-subjects design where subjects were randomly assigned to the independent variable of "stress exposure" which had two groups. the first group ("chronically stressed") was exposed to random, mild daily stressors for 7 consecutive days. the second group ("non-stressed") was housed and handled as per usual in the animal facility. each group consisted of 6 males and 6 females which were randomly assigned to their treatment group upon arrival at the animal facility. random assignment was accomplished by assigning each animal a number, then using a random number generator to assign animals to treatment groups. twelve male and twelve female c657bl/6ncrl mice (charles river laboratories, wilmington, ma) were used for this study. the mice were approximately 10 weeks of age. as social housing in mice has been demonstrated to prevent stress-associated responses 31, 32 , the mice in the chronically stressed group were housed individually, while the non-stressed animals were group housed. they were allowed to acclimate for 7 days prior to initiating the experimental manipulations. all animals were housed in shoebox caging with filter tops (alternative design, siloam springs, ar) on corncob bedding (bed o' cob, andersons, maumee, oh) under static conditions. all mice were provided with tissue material for nesting. both males and females were housed in the same room, but the mice in each treatment group were housed in different rooms as described below. the cages measured 18.5 cm w x 30 cm d x 12 cm h. feed (labdiet 2018, st. louis, mo) and water were provided ad libitium. standard operating procedures for the animal facilities required that all cages be changed at least once weekly. soiled cages were sanitized in a mechanical cage washer with a final rinse temperature of 180° f (82° c) and autoclaved prior to reuse. the macroenvironment was kept on a 12:12-h light:dark cycle (lights on at 0:700, off at 19:00) with temperature and humidity maintained at 72°f (22°c) and at least 30%, respectively. indirect sentinels were utilized to assess colony health. at the time of this study, the colony was free of mouse parvovirus, mouse coronavirus, mouse theliovirus, pneumonia virus of mice, sendai virus, reovirus 3, mouse rotavirus, lymphocytic choriomeningitis virus, mycoplasma pulmois, and ectoparasite and endoparasites. half of the mice were exposed to a daily stressor for 7 consecutive days. these stressors were presented in a random order and included: (1) forced swim, (2) heat stress, (3) shaker stress, and (4) restraint stress modified from previously published work 33 . for the forced swim, the mouse was gently placed in a 13 cm diameter x 30 cm tall clear plexiglass cylinder filled with water at 70° to 75° f (21° to 24° c). they remained in the water until they began floating with positional adjustments or 2 minutes, whichever was longer. they were removed, dried and allowed to warm. after 10 minutes of rest, the swim stress was repeated for a maximum of 4 sessions per mouse. for the heat stress, the mouse was placed in a clean cage with no bedding and a wire mesh to prevent escape. an incandescent light was positioned above the cage to create heat in the cage. the temperature was monitored and the target temperature was 85° f (29° c). the mouse was removed if the intracage temperature exceeded 90° f (32° c). they stayed in the cage for 2 hours and were continuously monitored during this stressor. for the shaker stress, the mouse remained in its home cage which was placed on a plate shaker that provided gentle, continuous shaking at no more than 160 rpm for 2 hours. mice were assessed every 30 minutes during this stressor. for the restraint stress, mice were restrained in a 50ml centrifuge tube with air-holes for a maximum of 3 hours. mice were continuously monitored through this stressor. the actual times and stressor assignments are provided as supplemental data. these mice were individually housed and held in a room isolated from other mice and outside of the main animal facility to minimize the potential effect of pheromones on other ongoing studies, including the non-stressed controls for this study. the cages for mice in this group were situated so that they were at average human eye level. these mice were tested and euthanized on day 8 of the study. the non-stressed mice were housed in groups of 3 mice of the same sex per cage. they were handled normally, with no additional interactions with the research staff. the cages for mice in this group were situated so that they were at average human thigh to knee level. the non-stressed mice were tested and euthanized on day 7 of the study to avoid release of pheromones from the stressed mice influencing the response of the non-stressed mice. all mice were assessed on an elevated plus maze at the end of the 7 consecutive days of daily stressors for the chronically stressed mice. the maze measured 25 cm l x 5 cm w open arms, 25 cm l x 5 cm w x 16 cm h closed arms, center platform of 5 cm x 5 cm. the closed arms were opaque. mice were brought to the testing room and allowed a minimum of 30 minutes to acclimate to the training room before being tested. each mouse was placed on the center platform to start the epm and digitally recorded for 10 minutes. at the end of 10 minutes, the mouse was removed from the maze and the maze was cleaned with 70% isopropyl alcohol before the next mouse. the proportion of entries into the open arms relative to the total number of arm entries was compared between treatment groups. the proportion of time each mouse spent in the open or closed arms relative to the total time in the maze was also compared between treatment groups. each mouse was tested once. all trials were between 8:00 and 12:00. all non-stressed mice were tested separately from the chronically stressed mice. data from two non-stressed and one chronically stressed mouse were not collected due to complications with the digital recording. after being tested on the elevated plus maze, each mouse was anesthetized with pentobarbital (390 mg/ml, fatal plus, vortech pharmaceuticals, dearborn, mi) administered ip. once anesthetized, a terminal blood collection was collected from the heart. half of the sample was placed in an edta treated tube and the remainder was placed in a serum separator tube and subsequently centrifuged to allow collection of the serum. the serum samples were stored at −80° f (−62° c) until processed. all samples were collected between 8:00 and 12:00 to control for alterations due to circadian rhythm. the edta sample was placed in a hemavet (drew scientific, waterbury, ct) and a complete blood count was performed. the mean of the white blood count, total number of neutrophils, total number of lymphocytes, and ne:ly ratio were compared between treatment groups. the serum corticosterone levels were assessed using a commercially available elisa kit (corticosterone rat/mouse, mp biomedicals, llp, solon, oh). the mean serum corticosterone levels were compared between treatment groups. we were unable to collect enough blood for serum from 2 of the non-stressed mice. to determine the appropriate animal numbers to be used prior to the initiation of the study, we performed a power analysis using our previous work with the neutrophil:lymphocyte ratio in our laboratory as the basis for the analysis. an online calculator was utilized 34 with µ a set at 0.4, µ b set at 0.25, σ set at 0.09, a sampling ratio (ê) of 1, power at 0.80 and α at 5%. this calculated a sample size of 6 animals per sex per group. data analyses were performed using a generalized linear model (jmp 10, cary, nc). the animal was the experimental unit. a single observation was made for each animal and this data was averaged per animal for analysis using a simple model of treatment, sex, and their interaction. if interactions were found to be non-significant, the models were updated by removing the interactions terms to retest the main effects and these values were reported. a full-factorial glm was completed for each observational unit. if interactions were found to be significant, these results were reported. all summary data are presented as box-and-whisker plots with whiskers representing min and max values, boxes first and third quartiles, and middle line the median value. there were no significant differences between the treatment groups in the total white blood cell count (f[1,23] = 2.0245, p=0.1682) ( fig. 2a; see supplementary figs. 6-9 for raw data plots), the total number of neutrophils (f[1,23] = 0.5778, p=0.4549) (fig. 2b; see supplementary figs. 6-9 for raw data plots), or the total number of lymphocytes (f[1,23] = 3.4353, p=0.0767) ( fig. 2c ; see supplementary figs. 6-9 for raw data plots). the ne:ly ratio of the chronically stressed mice was significantly increased as compared to the non-stressed mice (f[1,23] = 7.4200, p=0.0121) ( fig. 2d ; see supplementary figs. 6-9 for raw data plots). there was no interaction of sex with treatment for the total white blood cell count (p=0.8018), total number of neutrophils (p=0.6877), total number of lymphocytes (p=0.8665), and the ne:ly ratio (p=0.5542). the chronically stressed mice exhibited a significant increase in their levels of serum corticosterone as compared to the non-stressed mice (f[1,21 = 5.3431, p=0.0310). there was a significant interaction of sex and treatment (p=0.0389). chronically stressed male mice expressed significantly higher levels of serum corticosterone as compared to the non-stressed male mice (f[1,8] = 9.0825, p=0.0167), but females expressed no significant differences between non-stressed and chronically stressed mice (f [1, 11] = 0.1282, p=0.7270) ( fig. 3 ; see supplementary figs. 10 and 11 for raw data plots). the mice that had been exposed to 7 days of mild stressors mice demonstrated a significant increase in their serum corticosterone levels, suggesting that these mice were more stressed as compared to the mice that were handled routinely. not unexpectedly, the study also documented a sex difference in serum corticosterone levels, with the chronically stressed male mice exhibiting a significantly higher corticosterone level as compared to the chronically stressed female mice. additionally, the behavioral assessment of the chronically stressed mice demonstrated that they were less likely to spend time on the open arms and less likely to enter the open arms of the elevated plus maze. as demonstrated by previous studies, these findings suggest that the mice were more anxious and distressed 35 as compared to the mice that were handled routinely. these behavioral findings suggest that the daily stressors were adequately disturbing to create a situation of distress for these mice. the finding that the ne:ly ratio was also increased in the chronically stressed mice suggests that this assessment can be a reliable tool for the measurement of stress in the laboratory mouse. there was also a non-significant neutrophilia and lymphopenia in the chronically stressed mice, but all values were within published normal for c57bl/6ncrl mice 36 . these findings are consistent with other published studies that chronic exposure to elevated corticosterone causes a shift of neutrophilia with or without a concurrent lymphopenia 10, 25, 27 , and can be measured successfully by evaluating the ne:ly ratio of experimental treatment groups as compared to control groups 25, 27 . because the differences were robust and reflective of the behavioral changes, this suggests that the ne:ly ratio is an appropriate measurement to use when assessing chronic distress in a clinically healthy mouse. the measurement of the ne:ly ratio also has significant advantages over the measurement of serum corticosterone. although this study utilized an automated hemocytology machine, the ne:ly ratio can be calculated from a blood smear by manually performing a differential 25, 27 . measurement of serum corticosterone requires the use of specialized kits and additional machinery, such as elisa readers, for accurate calculation of the concentrations. as previously reported in the laboratory rat, the ne:ly ratio also is not influenced by the response to acute stressors, such as handling to obtain the blood collection 27 . it is also less sensitive to potentially confounding variables such as time of day, sex (which was seen in the serum corticosterone results of this study) and appetence, though it can be affected by chronic pathogen exposure 25, 27 . in this study, we conclude that the ne:ly ratio is an acceptable immunological measurement of exposure to chronic stress in the clinically healthy laboratory mouse. it can be run inexpensively without specialized equipment and is reliably robust in the face of individual and environmental factors. however, as should be considered for all assessments of stress in animals, this method should not be used alone, but as part of a multi-faceted panel of assessments that include physiologic and behavioral assessments to determine if changes are due to distress, eustress, or disease status 9,10 . note: any supplementary information and source data files are available in the online version of the paper. reducing mouse anxiety during handling: effect of experience with handling tunnels aspen shaving versus chip bedding: effects on breeding and behavior the effect of handling method on the mouse grimace scale in two strains of laboratory mice cage enrichment with paper tissue, but not plastic tunnels, increases variability in mouse model of asthma happy animals make good science effects of cage-change frequency and bedding volume on mice and their microenvironment stress and distress corticotropin-releasing factor in the hippocampus: eustress or distress? defining, measuring, and interpreting stress in laboratory animals domestic animal behaviour and welfare a robust and reliable non-invasive test for stress responsivity in mice glucocorticoids in the nonobese diabetic (nod) mouse: basal serum levels, effect of endocrine manipulation and immobilization stress stress and welfare: two complimentary concepts that are intrinsically related to the animal's point of view antidepressant action of agomelatine (s 20098) in a transgenic mouse model unaltered hormonal response to stress in a mouse model of fragile x syndrome marble burying as a test of the delayed anxiogenic effects of acute immobilisation stress in mice feeding, exploratory, anxiety-and depression-related behaviors are not altered in interleukin-6-deficient male mice hypertensive response to acute stress is attenuated in interleukin-6 knockout mice sympathetic and angiotensindependent hypertension during cage-switch stress in mice mouse strain differences in autonomic responses to stress causes and consequences of stress body condition scoring: a rapid and accurate method for assessing health status in mice effects of chronic social stress on neuroendocrine responsiveness to challenge with ethanol, dexamethasone and corticotropin-releasing hormone the context specificity of anxiety responses induced by chronic psychosocial stress in rats: a shift from anxiety to social phobia? the use of leukocyte profiles to measure stress in vertebrates: a review for ecologists corticosteroid-induced modulation of immunoglobulin secretion by human b lymphocytes: potentiation of background mitogenic signals evaluation of the neutrophil-lymphocyte ratio as a measure of distress in rats endogenous corticosteroids mediate the neutrophilia caused by platelet-activating factor in the mouse diseases of the adrenal cortex of dogs and cats pergolide treatment for cushing's syndrome in a horse activation of the mouse odorant receptor 37 subsystem coincides with a reduction of novel environment-induced activity within the paraventricular nucleus of the hypothalamus social modeling of conditioned fear in mice by nonfearful conspecifics dynamics and correlation of serum cortisol and corticosterone under different physiological or stressful conditions in mice a review of the validity and variability of the elevated plus-maze as an animal model of anxiety c57bl/6 mouse clinical pathology data this study was funded from internal sources. the author thanks melissa swan, jessica peveler, and brittany baker for their assistance with the data collection for this study. the author declares no competing financial interests. key: cord-306516-5t3ix35e authors: li, minghui; su, yangang; yu, yong; yu, ying; wang, xinggang; zou, yunzeng; ge, junbo; chen, ruizhen title: dual roles of calpain in facilitating coxsackievirus b3 replication and prompting inflammation in acute myocarditis date: 2016-10-15 journal: int j cardiol doi: 10.1016/j.ijcard.2016.07.121 sha: doc_id: 306516 cord_uid: 5t3ix35e background: viral myocarditis (vmc) treatment has long been lacking of effective methods. our former studies indicated roles of calpain in vmc pathogenesis. this study aimed at verifying the potential of calpain in coxsackievirus b3 (cvb3)-induced myocarditis treatment. methods: a transgenic mouse overexpressing the endogenous calpain inhibitor, calpastatin, was introduced in the study. vmc mouse model was established via intraperitoneal injection of cvb3 in transgenic and wild mouse respectively. myocardial injury was assayed histologically (he staining and pathology grading) and serologically (myocardial damage markers of ck-mb and ctni). cvb3 replication was observed in vivo and in vitro via the capsid protein vp1 detection or virus titration. inflammation/fibrotic factors of mpo, perforin, ifnγ, il17, smad3 and mmp2 were evaluated using western blot or immunohistology stain. role of calpain in regulating fibroblast migration was studied in scratch assays. results: calpastatin overexpression ameliorated myocardial injury induced by cvb3 infection significantly in transgenic mouse indicated by reduced peripheral ck-mb and ctni levels and improved histology injury. comparing with cvb3-infected wild type mouse, the transgenic mouse heart tissue carried lower virus load. the inflammation factors of mpo, perforin, ifnγ and il17 were down-regulated accompanied with fibrotic agents of smad3 and mmp2 inhibition. and calpain participated in the migration of fibroblasts in vitro, which further proves its role in regulating fibrosis. conclusion: calpain plays dual roles of facilitating cvb3 replication and inflammation promotion. calpain inhibition in cvb3-induced myocarditis showed significant treatment effect. calpain might be a novel target for vmc treatment in clinical practices. viral myocarditis (vmc) is a common cardiovascular disease in clinical practice [1] . while many vmc cases showed a self-limited regression, there are still approximately 30% cases progressing into dilated cardiomyopathy (dcm) and heart failure that might require mechanical circulatory support or heart transplant at the end stage despite of the optimal pharmacotherapy [1, 2] . so an effective treatment of vmc in the early stage is meaningful. vmc treatment has always been a challenge, especially with regard to the immunosuppressive treatment [2] . many researchers considered vmc an autoimmune disease [3] , which made immunosuppression treatment reasonable. however, virus persistence in the myocardium [1, 4] holds back the intended host immune suppression because this might enhance virus replication. clinical observations of myocarditis immunosuppression therapy also returned controversial results [1] . as such, guidelines also weight the words on this issue [2] . this ambiguity might be attributed to several reasons. 1) the core concern might be that it is a risk to prescribe immunosuppressant agents considering the role of host immune responses in virus clearance. 2) besides, we haven't completely clarified the life cycle of the intruded-viruses. so we don't know the timing to interfere the disease course. 3) the patterns that viruses interact with hosts were basically vague. so we don't know the appropriate methods to interfere. 4) last but not least, myocarditis-causing viruses' spectrum has always been shifting temporally and regionally [5] , which adds another variable for clinical specialists when facing a unique patient suffering from vmc. thus, logically speaking, a candidate compromising these two factors, virus replication and host inflammation response, might be an optimal choice. we found in our former study that calpain, a family of neutral cysteine proteases, could facilitate coxsackievirus b3 (cvb3, a common causing virus of vmc) replication in vitro [6] . besides, many studies demonstrated that calpain mediates systemic inflammation response in vivo [1] . so, calpain might participate both in the virus life cycle and the host inflammation response simultaneously. if it is the case, calpain would be an optical choice of myocarditis treatment. calpain activity is regulated by the endogenous inhibitor, calpastatin. calpastatin is an intracellular 110-kda protein that inhibits calpain activity specifically. binding of calpastatin across the calpain active site would block its access to substrates in vivo. however, calpastatin could not penetrate across the cell membrane for the large molecular weight and cannot be used as an inhibitor in vitro. thus, we introduced here a transgenic mouse overexpressing calpastatin in vivo to discuss this hypothesis in the mouse model of cvb3induced viral myocarditis. coxsackievirus b3 (nancy strain) was preserved in key laboratory of viral heart diseases, zhongshan hospital, fudan university. calpain inhibitor i (n-acetyl-leu-leu-norleucinal, alln), an inhibitor of neutral cysteine proteases, was purchased commercially (biomol research laboratories inc. usa, catalog no.: p-120) and dissolved in dimethyl sulfoxide (dmso, amresco llc., usa, product code: n182) with a final concentration of less than 0.1% in cell culture studies. alln was further diluted using culture medium into target concentrations during the research. the calpastatin transgenic mouse strain (tg-cast) was introduced from the laboratory of tianqing peng (lawson health research institute, canada) and was bred in the department of laboratory animal science, fudan university in a standard specific pathogen free (spf) environment. male inbred c57bl/6 mice aging3-6 weeks were used for the experiment and were grouped as: wild type control group (con. n = 10), transgenic mouse control group (tg-cast, n = 10), cvb3-infected group (virus n = 15) and cvb3-infencted transgenic mouse group (virus + tg-cast, n = 15). all littermates were genotyped following the protocol of peng's lab. we give assurance that all animals received humane care and that study protocols was approved by the ethical committee of fudan university. the cvb3-induced viral myocarditis model was established following the protocol sd previous [7] . in short, 100,000 tcid 50 /ml × 0.3 ml cvb3 was injected intraperitoneally with the same amount of pbs for the controls. then, all mice were kept in spf environment for 7 days before sacrifice. occasional dead mouse were excluded from the study. blood samples were collected via picking the eye balls and serum were separated via centrifuge (3000 r/min for 5 min). methods and grading standards were prescribed elsewhere [7] . level of peripheral ctni and ck-mb were measured by elisa assays following the protocol in former study [6] . heart tissue were grinned using homogenizer in lysis buffer (50 mm tris-hcl, ph 7.2, 250 mm nacl, 0.1% np-40, 2 mm edta, 10% glycerol) containing protease inhibitor cocktail on ice. tissue homogenate were centrifuged at 12,000 g for 10 min at 4°c. the protein concentration was determined by the bradford assay (bio-rad). detailed western blot protocol was described elsewhere in our former study [6] . in brief, equal amounts of protein were loaded for sds gel electrophoresis and then transferred to nitrocellulose membranes. after block, the blots were incubated overnight at 4°c with the primary antibody of α-fodrin no.: sc-101154, 1:1000) or mmp2 (bioworld technology, inc., usa, catalog no.: bs1236, 1:500) respectively followed by incubation for another hour with the corresponding secondary antibody (1:4000). bands were visualized by ecl (super signal west pico kit; pierce) and quantified by densitometry using quantity one software (bio-rad). gapdh was used as internal reference. virus titer was measured using tcid 50 assay in hela cells. heart tissue homogenates were prepared at 4°c using ice cold homogenizer followed by centrifugation to harvest virus-containing supernatant. decimal serial dilutions of cell culture supernatant or tissue homogenate supernatant were added to the cultured hela cells and incubated for 1 h at 37°c. then the infected hela cells were cultured at 37°c. cytopathic effect was observed daily for 7 days. and tcid 50 were calculated using reed-muench method. mmp activity was detected according to the instruction of the commercial assay kit (anaspec, inc., ca, catalog no.: 71151). tissues homogenate in assay buffer were centrifuged for 15 min at 10,000 g at 4°c followed by incubation with apma at a final concentration of 1 mm in the assay buffer for 1 h at 37°c. activate mmp immediately before the experiment. dilute mmp-2 substrate 1:100 in assay buffer. add 50 μl per well of sample and mmp2 substrate solution in 96-well plate. mix the reagents by shaking the plate gently for 30 s. incubate the reaction at 37°c for 50 min. keep plate away from direct light. add 50 μl pe well of stop solution. mix the reagents and measure fluorescence intensity at ex/em = 490/520 nm. plot data as rfu fold change comparing with the control. immunohistochemistry staining of vp1 (leica biosystems newcastle ltd., united kingdom, catalog no.: ncl-entero, 1:200), ifnγ (bio legend inc. usa, catalog no.: 505811, 1:500) and il17 (abcam inc. usa, catalog no.: ab79056, 1:500) were carried out according to the method prescribed elsewhere [7] . mpo activity was assayed using commercial kit (sigma-aldrich co. llc, usa, catalog no.: mak069). standard curve was prepared according to the instruction. then tissue samples (10 mg heart tissue + 5 volume mpo assay buffer) were prepared using mpo assay buffer followed by making master reaction mix. at room temperature, the fluorescence intensity was read and mpo activity was calculated according to the instruction. primary cardiomyocytes were separated from neonatal rat heart. in short, neonatal rat (1-3 days old, supplied by department of laboratory animal science, fudan university) were fertilized and hearts were taken out quickly, sliced into pieces and digested in 0.1% trypsin at 37°c for 10 min and centrifuged at 3000 r/min to collect the digested cells and suspended the cells in dmem. repeat the digest-centrifuge cycles until the left tissue become apparent. the collected cells were suspended in dmem containing 10% fbs and cultured in 37°c for 2 h. the adherent cells are fibroblast and the still suspending cells are primary cardiomyocytes. then the cardiomyocytes were counted and seeded for research. the fibroblasts were passaged as routine and the third generation of cells was used for the study. prepared cardiomyocytes were fasted in dmem overnight followed by inoculation with cvb3 for 1 h in 37°c. then the supernatant were changed into dmem containing 10% fbs and cultured in 37°c for the designed time course. fibroblasts were seeded into 6-well plate at the density of 1 * 10 5 cells/well and cultured for 48 h. then the cells were synchronized by fasting in dmem without fbs for 24 h. scratch injury were made using the tips of 200 μl pipets. then dmem containing 10% fbs were changed with or without 5 μg/ml of calpain inhibitor alln (biomol research laboratories inc., usa, catalog no.: p-12) and cultured for another 24 h. then pictures of the scratch trace were taken and the distance were measured and analyzed. data were specified as mean values ± sd and analyzed using spss software (version 16.0; spss, inc., chicago, il, usa). 2-group comparison was performed using student t test. p b 0.05 was considered statistically significant. transgenic mouse had lower mortality post cvb3 challenge (fig. 1a) . calpain inhibition decreased the hw/bw ratio significantly (fig. 1b) . and myocardial damage markers of ck-mb and ctni were also decreased (fig. 1c, d) in the peripheral blood indicating the protective effect of calpastatin overexpression. to make certain the calpain activity in the transgenic mouse, the degradation product of calpain-specific substrate, α-fodrin, was blotted and as expected, the calpain activity was down-regulated in the transgenic mouse heart tissue (fig. 1e ). to observe the role of calpain activity in cvb3 replication, cvb3 capsid protein vp1 was blotted. it showed that comparing with wild type mouse cvb3-infected transgenic mouse had a lower level of vp1 expression in the myocardium (fig. 2a) . vp1 detection with immune histology method also showed that virus capsid protein decreased significantly (fig. 2b) . virus load in heart tissue were titrated and it demonstrated that virus titer were lower in the heart of transgenic mouse (fig. 2c) . in further, we verify this finding in vitro. neonate rat cardiomyocytes were separated accordingly. post virus infection, the cells were inoculated with culture medium containing calpain inhibitor alln of various dilutions (5 μg/ml, 2.5 μg/ml and 1 μg/ml) respectively. cardiomyocytes inoculated with culture medium without alln were set as normal control. and 12 h later, virus load in the supernatant were titrated. we found that comparing with the normal control 2.5 and 5 μg/ml of alln hindered virus replication significantly (fig. 2d ). to observe the effect of calpastatin over-expression on cvb3-induced myocardial inflammation, tissue sections were he stained. comparing with wild littermates, inflammation infiltration in transgenic mouse heart tissues was ameliorated significantly (fig. 3a) . mpo, the marker of neutrophils infiltration, was also decreased in transgenic mouse hearts (fig. 3b) . perforin is the effective protein of cytotoxic lymphocytes and natural killers. in the transgenic mouse's heart, calpain inhibition was accompanied with significant perforin down-regulation post virus infection (fig. 3b) . this was also the case for the inflammation factors of ifnγ (fig. 4ab) and il17 (fig. 4cd) , which demonstrated the role of calpain in mediating inflammation infiltration in virus-induced myocarditis. fibrosis is the key pathophysiology course in myocarditis progression. thus, we observed here whether calpain participated in fibrosis in cvb3-induced myocarditis. the classic fibrotic agents of smad3 (fig. 5a) and mmp2 (fig. 5b) were blotted and it demonstrated that calpain inhibition resulted in the downregulation of the two factors as well as the total mmps activity (fig. 5c) . to observe if calpain could regulate myocardial fibroblasts function, we proceed scratch assays with fibroblast. cultured fibroblasts were incubated with the calpain inhibitor alln (5 μg/ml) for 24 h with a this study, utilizing a calpastatin-overexpression transgenic mouse model of viral myocarditis, demonstrated that endogenous calpain inhibition ameliorated myocardial injury significantly. simultaneously, calpain inhibition was associated with decreased cvb3 replication and ameliorated inflammation/fibrosis formation. these data indicated the dual involvements of calpain in both virus replication and host inflammation. this might be an answer for the ambiguous problem of immunosuppressive therapy in viral myocarditis treatment [1] . calpain is a family of proteinases that cleave substrates into peptide segments. its activity was regulated by the endogenous inhibitor of calpastatin [8] . as we have demonstrated, transgenic mouse 5 . calpain was involved in myocardium fibrosis. a, b: western blot of smad3 and mmp2 respectively. n = 6 for each group. *p b 0.05 vs. con. group; # p b 0.05 vs. virus group. c: heart tissue total mmp activity assay. con. group mmp activity was set 1 arbitrarily. *p b 0.05 vs. con. group; # p b 0.05 vs. virus group. n = 4 for each group. d: represented scratch assay picture of cultured fibroblasts with or without calpain inhibitor alln. longer distance indicated weaker migration ability of the cells. *p b 0.05 vs. con. group. the experiment was repeated for 3 times. overexpressing calpastatin have a lower level of calpain activity in vivo (fig. 1d ). many researchers have reported the involvement of calpain in viruses' life cycles. for examples, calpain participated in the replication of influenza a virus [9] , severe acute respiratory syndrome coronavirus [10] , echovirus 1 [11] and human immunodeficiency virus [12] . in our former study, we found that cvb3-induced calpain activation facilitates the progeny virus replication in the early phase of infection in vitro [6] . bozym et al. [14, 13] reported the roles of calpain in mediating cvb both the entry into and the release from endothelial cells. yoon et al. [15] demonstrated that cvb4 uses autophagy for replication after calpain activation in rat primary neurons. as we presented in this paper, calpain inhibition reduced cvb3 loads both in vivo and in vitro (fig. 2) , which further proves the calpain involvement in facilitating cvb3 replication. role of calpain in regulating inflammation has been observed in different animal models, such as allergic encephalomyelitis [16] , sepsis [17] , abdominal aortic atherosclerosis [18] , ventilatorinduced lung injury [19] and hypercholesterolemic nephropathy [20] . in the realm of viral myocarditis, debiasi et al. [21] found in a mice model of reovirus strain 8b-induced myocarditis that calpain inhibition protects against virus-induced apoptotic myocardial injury, which presented the role of calpain in treating myocarditis. but few evidence of inflammation was mentioned as we presented here in a transgenic mouse. mechanisms of calpain involvement in inflammation might be associated with its regulation on inflammation cell behaviors. this point is supported by evidences from several studies focusing on different inflammation cells. in neutrophil, calpain participated in cell migration, adhesion, arrest and oxidative burst [22] . calpain1 also contributes to ige-mediated mast cell activation [23] . calpastatin overexpression can impair post infarct scar healing in mice by compromising reparative immune cell recruitment and activation [24] . and in leukocytes, calpain deficiency reduces angiotensin ii-induced inflammation and atherosclerosis [25] . we presented here in cvb3-induced myocarditis model that myocardium inflammation infiltration was significantly ameliorated in transgenic mouse, as well as the inflammation factors of mpo activity, il17, perforin and ifnγ. although there might be some background levels of expression of the above factors, it is reasonable considering the wide spread of inflammatory cells even in physiology conditions without virus infection. actually, a variety of inflammation factors whose production or secretion were regulated by calpain have been reported elsewhere including il5 [26] , il6 [27] , il16 [28] and il33 [29] . combined what we have reported in this paper, we could conclude that calpain participates in the regulation of a wide spectrum of inflammation factor production. researches from peng's lab [30, 31] in the animal models of sepsis and myocardial infarction have demonstrated respectively that calpain induces myocardial nf-κb activation, which might explain the mechanism that calpain regulates inflammation factors production. data from another group of our lab also found the role of calpain in regulating nf-κb activity in cvb3-induced myocarditis mice (unpublished data). inflammation factors are always fibrotic agents. the most solid evidence of calpain involvement of tissue fibrosis might be from cystic fibrosis patients [32] . and jiang et al. [33] reported that calpain1 regulates mmp2 activity in vascular smooth muscle cells to facilitate ageassociated aortic wall fibrosis. so we further observed the effect of calpain on myocardium fibrosis. as we have mentioned here that smad3/mmp2 pathway was inhibited in the transgenic mouse indicating role of calpain in regulating this classic fibrosis pathway. this was coincided with what peng's lab have demonstrates that calpain inhibition ameliorates myocardial remodeling after myocardial infarction [31] and myocardial fibrosis in diabetic cardiomyopathy [34] . what's more, we also observed the role of calpain in regulating fibroblasts migration in vitro and found calpain inhibition hinders fibroblast migration in scratch assays. this might explain in a novel angle the mechanisms of calpain in mediating fibrosis. this study also has some drawbacks.1) this is an animal study, and the results should be interpreted in caution in clinical practices. data from vmc patients should be collected in future clinical studies. 2) the data were mainly observational. mechanisms studies including roles of calpain in cvb3 replication and mediating inflammation in vivo should be performed in further studies respectively. in summary, in cvb3-induced myocarditis model, we presented here that calpain plays a dual role of both facilitating cvb3 replication and mediating inflammation/fibrosis. endogenous inhibition of calpain activity showed significant treatment effect for cvb3induced myocarditis. this might provide a novel target for viral myocarditis treatment in the future. we declare no conflicts of interests. viral myocarditis-diagnosis, treatment options, and current controversies current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the european society of cardiology working group on myocardial and pericardial diseases autoimmunity in viral myocarditis viral myocarditis: from experimental models to molecular diagnosis in patients parvovirus b19 is a bystander in adult myocarditis coxsackievirus b3-induced calpain activation facilitates the progeny virus replication via a likely mechanism related with both autophagy enhancement and apoptosis inhibition in the early phase of infection: an in vitro study in h9c2 cells initial weight and virus dose: two factors affecting the onset of acute coxsackievirus b3 myocarditis in c57bl/6 mouse-a histopathologybased study the calpain system and diabetes targeting host calpain proteases decreases influenza a virus infection severe acute respiratory syndrome coronavirus replication is severely impaired by mg132 due to proteasomeindependent inhibition of m-calpain calpain 1 and 2 are required for rna replication of echovirus 1 human immunodeficiency virus-1 tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and vmax calcium signals and calpain-dependent necrosis are essential for release of coxsackievirus b from polarized intestinal epithelial cells release of intracellular calcium stores facilitates coxsackievirus entry into polarized endothelial cells coxsackievirus b4 uses autophagy for replication after calpain activation in rat primary neurons calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats muscle-specific calpastatin overexpression prevents diaphragm weakness in cecal ligation puncture-induced sepsis calpain inhibition attenuates angiotensin ii-induced abdominal aortic aneurysms and atherosclerosis in low-density lipoprotein receptor-deficient mice activation of calpains mediates early lung neutrophilic inflammation in ventilator-induced lung injury nicotinic acetylcholine receptor α1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy calpain inhibition protects against virus-induced apoptotic myocardial injury calpain inhibition impairs tnf-alpha-mediated neutrophil adhesion, arrest and oxidative burst calpain-1 contributes to ige-mediated mast cell activation calpastatin overexpression impairs postinfarct scar healing in mice by compromising reparative immune cell recruitment and activation leukocyte calpain deficiency reduces angiotensin ii-induced inflammation and atherosclerosis but not abdominal aortic aneurysms in mice parp-1 deficiency blocks il-5 expression through calpain-dependent degradation of stat-6 in a murine asthma model overexpression of a minimal domain of calpastatin suppresses il-6 production and th17 development via reduced nf-κb and increased stat5 signals secretion of il-16 through tnfr1 and calpain-caspase signaling contributes to mrsa pneumonia caspase-1, caspase-8, and calpain are dispensable for il-33 release by macrophages cleavage of iκbα by calpain induces myocardial nf-κb activation, tnf-α expression, and cardiac dysfunction in septic mice deficiency of capn4 gene inhibits nuclear factor-κb (nf-κb) protein signaling/inflammation and reduces remodeling after myocardial infarction evidence for alteration of calpain/calpastatin system in pbmc of cystic fibrosis patients calpain-1 regulation of matrix metalloproteinase 2 activity in vascular smooth muscle cells facilitates age-associated aortic wall calcification and fibrosis targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes funding for this study were provided by the national science key: cord-303662-ro9879dl authors: wang, fun-in; stohlman, stephen a.; fleming, john o. title: demyelination induced by murine hepatitis virus jhm strain (mhv-4) is immunologically mediated date: 1990-11-30 journal: journal of neuroimmunology doi: 10.1016/0165-5728(90)90050-w sha: doc_id: 303662 cord_uid: ro9879dl abstract the neurotropic mouse hepatitis viruses (mhv), in particular strain jhm (jhmv or mhv-4), cause experimental central nervous system demyelination that pathologically resembles multiple sclerosis, an important human demyelinating disease. the mechanism of jhmv-induced demyelination remains unclear, though its tropism for oligodendrocytes had led to the belief that jhmv causes demyelination by direct lysis of these myelin-producing cells. however, several studies have also implicated the involvement of immune responses in the demyelinating process. in this communication, we present evidence that generalized immunosuppression with gamma irradiation prevents jhmv-induced demyelination, a finding that was not limited to a particular strain of jhmv or to one strain of mouse. in addition, significant paralytic-demyelinating disease was restored to infected, irradiated mice after the adoptive transfer of nylon wool nonadherent splenic cells and appeared to be restricted by the major histocompatibility complex (mhc). these observations indicate that the principal mechanisms of jhmv-induced demyelination are most likely immunopathological. has been used to study demyelination experimentally. these models include experimental allergic the murine coronavirus jhmv, also desig-encephalomyelitis (eae) and infection by theiler's hated mhv-4, was originally isolated from mice virus, canine distemper virus, semliki forest virus, which spontaneously developed hindlimb paralysis a59 coronavirus, visna virus, and others (reviewed and demyelination (bailey et al, 1949; cheever et by raine, 1984; martin and nathanson, 1979; dal al., 1949) . subsequently, jhmv infection of ro-canto and rabinowitz, 1982; stohlman and dents has been one of several model diseases which kyuwa, 1990) . for the viral models of experimental demyelination, rodriguez (1988) has outlined a use-gory of direct viral cytopathic effect on oligo-representative mice bled and tested by enzymedendrocytes, the cells which produce and maintain linked immunosorbent assay (elisa; fleming and myelin; in this mechanism, the immune system pen, 1988) for antibodies to murine coronaviruses plays no role or merely has a scavenging function, were seronegative. this hypothesis is supported by findings that the isolation and characterization of jhmv jhmv replicates and causes acute cytopathology antigenic variant 2.2-v-1 in oligodendrocytes (lampert et al., 1973; and a small plaque variant jhmv-ds (stohlman 1973; powell and lampert, 1975; fleury et al., et al., 1982) have been described previously. 1980), as well as by several reports that animals viruses were propagated under serum-free condiwhich are either immunosuppressed or im-tions and quantitated by plaque assay on dbt munodeficient nonetheless develop jhmv-in-cells (stohlman and weiner, 1978) . prior to inocduced demyelination to a variable degree (soren-ulation, viruses were diluted in dulbecco's minimal sen et al., 1982, 1987) . on the other hand, studies essential medium. mice were injected either i.c. have shown that mhv may elicit a variety of with 30 /xl containing 103 plaque-forming units potentially immunopathological responses, includ-(pfu) of virus or i.p. with 0.5 ml containing 106 ing alteration in major histocompatibility complex pfu of virus. infectious virus titers in brain ho-(mhc) antigen expression (massa et al., 1986; mogenates were measured on l2 cells and by suzumura et al., 1986) , reactivity to myelin basic infectious center assays as previously described protein (watanabe et al., 1983) , anti-viral antibod(stohlman and weiner, 1978) . ies (fleming et al., 1983 ) and anti-viral t cells (sussman et al., 1989) . despite the evidence show-gammdirradiation ing that jhmv is capable of causing (1) direct mice were irradiated with a ~3vcs gamma verticytopathology and (2) potentially immunopatho-cal beam source at 150 rad/min (gamma cell 40, logical responses, controversy remains about the atomic energy of canada) under the experimenextent to which either of these processes actually tal conditions noted below. in experiments conpredominates in vivo. ducted to compare the effects of irradiation of the two approaches were taken to directly study central nervous system (cns) with those of systhe role of the immune system in the jhmv-in-temic compartments, mice were anesthetized using duced demyelination. first, infected animals were pentobarbital (75 mg/kg; i.p.), placed in a plastic immunosuppressed by gamma irradiation early in restrainer, and protected by 25 mm thick lead the disease course. second, immunosuppressed shields introduced above and below the mice mice were reconstituted by the adoptive transfer longitudinally to either cover the cns (systemic of spleen cells from immune donors. these experi-exposure; 4 mm dorsal shield) or the non-cns, ments revealed that jhmv-induced demyelination systemic areas (cns exposure; ventral shield to is prevented by gamma irradiation and partially within 4 mm of the back). mock experiments and restored by the transfer of immune splenocytes, dissections confirmed that differential irradiation providing direct evidence for a central role of the of the cns (brain and spinal cord) or systemic immune system during jhmv-induced demyelina-compartments (including spleen, lymph nodes, and tion. bone marrow) was achieved under these shielding conditions. donor mice were either not immunized (naive donors) or immunized i.p. with approximately 106 six-week-old male c57bl/6j and balb/cj pfu of virus (immune donors) at 6 days prior to mice were obtained from jackson laboratories adoptive transfer. single-cell suspensions were (bar harbor, me, u.s.a.). mice were held for prepared from spleens of donor mice, and 5 x 10 v 48-72 h before intracerebral (i.c.) infection or cells were injected intravenously (i.v.) into recipiintraperitoneal (i.p.) immunization with virus. all ent mice which had received 850 rad of irradiation immediately prior to transfer. in some experi-statistical analyses ments, donor cells were fractionated into nylon both clinical and histological scores were comwool adherent (nwa) and nylon wool non-adher-pared for statistical significance using the mannent (nwna) populations (sussman et al., 1989) whitney test for nonparametric samples (statsoft prior to transfer, statistical programs, tulsa, ok, u.s.a.). a probability (p) < 0.05 by this test was considered sig-clinical evaluation nificant. in instances where observers disagreed, mice were evaluated for clinical signs of de-the histological score assigned was~either the lower myelination using a scale modified from brown et grade (one-step disagreement, n = 31/90 observaal. (1982) . numerical values were assigned as fol-tions) or intermediate grade (two-step disagreelows: 0, normal; 1, minimal gait abnormality; 2; ment, n = 2/90 observations). moderate paraparesis; 3, severe paraparesis; and 4, paraplegic. evaluations were scored at day 12 postinfection (p.i.), as almost all mice that will results develop subacute or chronic disease after 2.2-v-1 infection show some abnormal clinical signs at or whole body irradiation before day 12 p.i. . to study the immunosuppressive effects of irradiation, different amounts of whole body histological evaluation gamma irradiation were administered daily mice were sacrificed at day 12 p.i. and tissues throughout the disease course in c57bl/6j mice were fixed in clarke's solution (75% absolute al-after i.c. infection with jhmv variant 2.2-v-1. cohol and 25% glacial acetic acid), embedded in irradiation dramatically reduced paralytic-deparaffin, and stained with hematoxylin and eosin myelinating disease if 850 rad were administered (h&e) or luxol fast blue (lfb) counterstained at day 6 p.i. or earlier. at day 7 p.i. or later, with eosin . for quantitative however, disease was unaffected by as much as assessments, a single longitudinal section of h& 1250 rad. based on these data, we chose to admin-e-stained spinal cord was reviewed independently ister 850 rad on day 6 p.i. in subsequent experiby two observers without knowledge of the ments in which clinical and histological diseases animal's experimental group. evaluation focused were monitored quantitatively. on the degree of inflammation, edema, and dis-severe paralysis and demyelination were eviruption of tissue architecture in the white matter, dent by day 12 p.i. in infected, untreated mice pathology was graded as follows: 0, normal; i, (table 1 , group 1) as reported previously (fleming slight (mild, focal) ; 2, moderate (mild, diffuse); 3, et al. , 1986) . fig. 1 shows several histological marked (intense, focal) and 4, severe (intense, features of the demyelinating lesions observed in confluent). grade 3 and 4 lesions correspond to group 1, including inflammatory hypercellularity the fully developed plaques of acute, primary (a, b, c, e), scanty viral antigen and the presence jhmv-induced demyelination first described by of naked axons (d). in contrast, infected mice bailey et al. (1949) and weiner (1973) . using irradiated at day 6 p.i. had a marked reduction in myelin staining and electron microscopy, we have both paralysis and demyelination (table 1 , group previously shown that jhmv antigenic variant 2; fig. 2b ). irradiation given to uninfected, naive 2.2-v-1 produces lesions identical to those initially mice had no demonstrable clinical or histological described, in which the principal changes are effect (data not shown). to determine if the dimyelin loss and axonal preservation (fleming et minution in disease could be attributed to the al., 1986, 1987) . viral antigen was detected by inhibition of virus replication by irradiation, the immunoperoxidase staining , virus titer in brains of irradiated (850 rad) and using monoclonal antibody (designated j.3.3) control mice were compared. fig. 3 shows that the specific for the jhmv nucleocapsid protein as virus titer in the irradiated mice exceeded that of primary antibody, and counterstained with hema-the unirradiated controls. these data indicate that toxylin, the absence of disease was not due to an inhibisix-week-old male c57bl/6j mice were given 103 pfu of jhmv 2.2-v-1 i.c. on day 0, as indicated by ' +' sign. 850 tad of whole body irradiation were given at day 6 p.i., as indicated by ' +' sign. c clinical observations and blinded histological evaluations were performed as indicated in materials and methods (0-4 scales, with grade 4 being maximal disease). the mean, standard deviation, and number (n) of mice tested are shown. underlined values indicate a statistically significant difference (p < 0.05) between groups 1 and 2 as determined by the mann-whitney test for nonparametric samples. tion of virus replication. in addition, immunohis-infected with 103 pfu of 2.2-v-1 also developed tochemical studies showed that following 2.2-v-1 severe paralytic-demyelinating disease by day 12 challenge, viral antigen was scanty or absent in p.i. disease was also prevented in these mice by unirradiated mice (fig. 1d ) but was very abun-850 rad of whole body irradiation at day 6 p.i. dant in irradiated mice ( fig. 2a) . many of the (data not shown). these findings are essentially antigen-positive cells in irradiated, infected mice identical to those obtained in c57bl/6j mice appeared to be oligodendrocytes ( fig. 2a) ; infected with 2.2-v-1, suggesting that abrogation surprisingly, these cells showed few or no morpho-of demyelination by irradiation is not dependent logical abnormalities, on an unusual characteristic of a particular jhmv in control experiments paralleling those shown strain or mouse strain. in table 1 , mice were infected with a second jhmv strain, jhmv-ds (stohlman et al., 1982) , and were either irradiated or not irradiated. un-in view of the finding that whole body irradiairradiated mice demonstrated intense disease at tion at day 6 p.i. prevents jhmv-induced paraday 9 p.i. by contrast, mice given 850 rad at day 6 lytic-demyelinating disease, differential irradiation p.i. had few histological changes at day 9 p.i. in studies were conducted to determine whether critiaddition, a second mouse strain, balb/cj mice cal radiosensitive targets reside in the systemic or a immune donor mice were 6-week-old c57bl/6j males given 106 pfu of jhmv 2.2-v-1 i.p. 6 days prior to transfer. naive donors were identical mice not given virus. in each group, 5 x 10 v spleen cells were transferred i.v. into recipient mice on day 6 p.i. b recipient mice were 6-week-old c57bl/6j male inoculated (virus) or not (naive) with 103 pfu of jhmv 2.2-v-1 i.c. on day 0. all recipient mice were given 850 rad prior to adoptive transfer on day 6 p.i. scoring was performed as indicated in table 1 . underlined values are clinical or histological scores which are significantly greater than respective scores of jhmv-infected, irradiated mice not given splenocytes ( cns compartments. when 850 rad were delivered at day 6 p.i. to systemic regions (including spleen, to the cns only (brain and spinal cord) at day 6 lymph nodes, and bone marrow) but not to the after 2.2-v-1 infection, marked white matter pa-cns, white matter appeared normal (fig. 4c, d) . thology was observed (fig. 4a, b) . in the con-these findings are essentially identical to those verse experiment in which 850 rad were delivered found in eae (hickey and kimura, 1988) and im m k ,,. ~'l_m suggest that radiosensitive cells residing in the formed, using balb/cj (h-2 d) donor and systemic compartment at day 6 p.i. are essential c57bl/6j (h-2 h) recipient mice. as shown in for subsequent lesion development. table 3 (groups 6 and 7), allogeneic transfers did not restore disease, suggesting that mhc restriction is, in fact, required. to further define the characteristics of cells to jhmv-induced disease, spleen cells from donor which are active in the adoptive transfer of dismice were transferred into irradiated recipient mice ease, syngeneic immune spleen cells were sep-( table 2 ). when 2.2-v-l-infected, irradiated mice arated by nylon wool to yield t cell-enriched received immune spleen cells (group 3, table 2 ), (nylon wool nonadherent) and t cell-depleted significant disease was restored (clinical score, p (nylon wool adherent) fractions. as shown in ta-= 0.0023; histological score, p = 0.0587). while this effect was often quite dramatic in individual 60 mice (fig. 5a) , the mean clinical and histological scores in these animals were not as high as those of virally infected, unirradiated mice (group 1, oe ,0 table 1) . surprisingly, adoptive transfer of naive ~ spleen cells into infected, irradiated recipients ~ /,~/~p je3 (group 4, table 2 ; fig. 5b ) also produced mod-~o ,0 ~ .... crate disease. on the other hand, following trans-g / fer of immune splenocytes to naive, uninfected j 2° / mice (group 5, table 2 ) recipients were completely // normal (fig. 5c) the ability of spleen cells from naive mice to fig. 3 . viral replication in the brains of c57bl/6j mice induce disease in infected, irradiated mice (group inoculated with jhmv 2.2-v-1 on day 0 and sacrificed at the indicated time points, each of which represents the mean titer 4, table 2) raised the possibility that a nonfrom a group of 4-6 mice. mice were either not irradiated (i~), mhc-restricted cell, such as a macrophage, might or subjected to 850 rad of whole body irradiation at either day be responsible for mediating this effect. to test -1 (o) or at day + 6 (o) relative to the day of viral inoculathis hypothesis, allogeneic transfers were per-tion. a allogeneic (balb/cj, h-2 d) or syngeneic (c57bl/6j, h-2 b) donor mice were given 106 pfu of jhmv 2.2-v-1 i.p. 6 days prior to transfer (immune) or not (naive), as noted in table 2 . in groups 6 and 7, 5 x 107 spleen cells were transferred i.v. into each recipient at day 6 p.i. nwna indicates nylon wool nonadherent ceils, and nwa indicates nylon wool adherent cells (selected from a total of 5 x 107 spleen cells) transferred i.v. to recipients at day 6 p.i. b in all groups, recipient mice were 6-week-old c57bl/6j males given 103 pfu of jhmv 2.2-v-1 i.c. on day 0 and irradiated on day 6 p.i. prior to transfer. c scoring was also performed as in table 1 . underlined values are those which are significantly greater than respective scores of jhmv-infected, irradiated mice not given splenocytes ( ble 3, the ability to transfer clinical disease was vestigation cannot exclude some contribution of contained in the t cell-enriched population (group direct viral cytolysis of oligodendrocytes (lampert 8) . although histological scores were elevated in et al., 1973) to the jhmv pathogenesis. clearly, these mice relative to irradiated, infected mice not however, the role of this mechanism, if present, given spleen cells (group 2, table 1 ), this value did must be minor, since it should be unaffected or not achieve statistical significance, possibly due to even enhanced by an immunosuppressive dose of the relatively small number of animals in the irradiation. in fact, infected irradiated mice show experiment. taken together, the characteristics of little or no evidence of demyelination or cell de-mhc restriction and nylon wool nonadherent struction (fig. 2) , despite marked increases in suggest that spleen cells which are most active in both viral antigen-positive oligodendrocytes (fig. adoptive transfers are likely to be t lymphocytes. 2a) and brain viral titers (fig. 3) . prior studies in athymic (sorensen et al., 1982 ), immunosuppressed (sorensen et al., 1982 zimmer and dales, discussion 1989) , or lethally challenged sussman et al., 1989) rodents have established a the major finding of this study is that ira-protective role for cellular immunity early in the munosuppression of jhmv-infected mice by jhmv pathogenesis by limiting virus infection in means of gamma irradiation abrogates viral-in-susceptible cells, such as oligodendrocytes and duced demyelination. this result strongly argues neurons. again, these studies have limited relethat jhmv causes demyelination through ira-vance to the study of jhmv-induced demyelinamunopathological mechanisms. however, our in-tion, since early challenge of animals with severe immunodeficiency or with large amounts of viru-the two jhmv strains, 2.2-v-1 and jhmv-ds, lent virus primarily results in an acute, fulminant used in the present study are essentially identical panencephalitis, with little or no demyelination, to most jhmv strains in all respects except neu-further support for an immunopathological rovirulence (weiner, 1973; stohlman et al., 1982 ; mechanism of jhmv-induced demyelination . in terms of neurovirulence, comes from the adoptive transfer studies. these they resemble the original jhmv isolates, which experiments indicate that populations of murine in early passages primarily caused a nonfatal paradonor spleen cells, which are enriched for t lytic disease (bailey et al., 1949; cheever et al., lymphocytes and appear to be mhc-restricted, 1949) ; only after many i.c. passages did the virus restore demyelination to infected, irradiated re-acquire marked neurovirulence. most importantly, cipient mice (tables 2 and 3 ). two features of the the minimal neurovirulence of jhmv 2.2-v-1, adoptive transfers were unexpected, however, and jhmv-ds, and similar jhmv strains (hirano et indicate that these experiments must be interpret-al., 1981; knobler et al., 1982; dalziel et al., 1986 ) ed cautiously. first, cells from naive donors (ta-allows virus-induced demyelination to be studied ble 2, group 4) were nearly as effective as cells directly, by minimizing the confounding fatal enfrom immune donors ( the only previous study of irradiation during p.i. this result may reflect the fact that in an jhmv infection was that of love et al. (1987), established cellular immune response within the who applied regional irradiation to the spinal cords cns, the majority of lymphocytes present locally of mice which had been infected with jhmv, may not be antigen-specific (ceredig et al., 1987; strain ts8 (knobler et al., 1982 ) 2 months previ-fallis et al., 1987 . second, although the degree to ously. under these circumstances, irradiation had which adoptive transfers reconstituted disease was no effect on the clinical or histological course of clearly significant in the aggregate (table 2) and jhmv pathogenesis. we have confirmed the reoften dramatic in individual animals (fig. 5a, b) , suit of love et al. (1987) , that irradiation applied the mean clinical and histological scores of recon-to the cns alone or applied after disease has stituted mice were considerably lower than those become firmly established has no effect on of the infected unirradiated mice (table 1, group jhmv-induced demyelination. the suggestion of 1). thus, the disease was, on average, only parlove et al. (1987) , that irradiation administered at tially restored by adoptive transfer of spleen cells, an earlier time in the course of disease might have this result may reflect technical factors, such as an effect on demyelination was shown to be corthe quantity or quality of transferred cells or the rect in the present study (table 1) . ability of transferred cells to reach specific targets. in conclusion, we have shown that jhmv-in-alternatively, it is possible that irradiation at day duced paralytic-demyelinating disease may be pre-6 p.i. irreversibly damages critical elements in the vented by immunosuppressive dose of gamma cascade leading to demyelination. in order to ad-irradiation and partially restored by the adoptive dress these questions, further experiments in which transfer of spleen cells, which are most likely t adoptive transfers performed during the early, in-lymphocytes. taken together, these findings indiductive phase of disease are in progress, cate that the primary mechanism of jhmv-in-an immunopathological mechanism has not duced demyelination is immunopathological, been established previously for jhmv-induced rather than being due to direct viral lysis of demyelination, possibly due to the use of a rela-oligodendrocytes. tively virulent virus strain coupled with cyclophosphamide-mediated immunosuppression applied simultaneously with virus infection (lampert et a murine virus (jhm) causing disseminated 279-280. encephalomyelitis with extensive destruction of myelin myelinating disease caused by theiler's virus, mouse (1987) phenotypic analysis of the inflammatory exudate in hepatitis virus or experimental allergic encephalomyelitis. j. murine lymphocytic choriomeningitis animal models of new encephalomyelitis with extensive destruction of myelin viral med~ 90, 181-194. particles induce la antigen expression on astrocytes analysis of autoimmune demyelination: its 4 peplomer glycoprotein e2 results in reduced neuroviruimpact upon multiple sclerosis mechanisms of virus-induced demyelina-fallis in vivo and in bridoma supernatants and ascites in absolute units by vitro models of demyelinating disease. xvii. the infectious sensitive and reliable enzyme-linked immunosorbent assays process in athymic rats inoculated with jhm virus. microb. (elisa) pathogenesis of a murine (1983) improvements in obtaining and characterizing mouse coronavirus, strain jhm in the central nervous system of cerebrospinal fluid. application to mouse hepatitis virus-inmice 53-61. variant of murine coronavirus jhm selected with mono-stohlman in vivo effects of coronavirus-specific t cell pathog. 3, 9-20. clones: dth inducer cells prevent a lethal infection but do fleury further ultrastructural observations of virus t-cell-mediated clearance of mouse hepatitis virus duced demyelinating encephalomyelitis pathogenesis of demyelination induced by suzumura, a in vivo and in vitro models 993. of demyelinating diseases. xxiv. the infectious process in adoptive cyclosporin a treated wistar lewis rats inoculated with transfer of eae-like lesions from rats with coronavirus-in-jhm virus acknowledgements al., 1973; weiner, 1973) . in this setting, the majority of mice died of fulminant acute encephalitiswe are very grateful to thomas bohlmann, and did not manifest typical jhmv-induced sub-cindy fabricius-segal, wen-quiang wei and acute or chronic paralysis and demyelination.ligaya key: cord-329061-1xut73dq authors: bhatt, pravin n.; percy, dean h.; jonas, albert m. title: characterization of the virus of sialodacryoadenitis of rats: a member of the coronavirus group date: 1972-08-17 journal: j infect dis doi: 10.1093/infdis/126.2.123 sha: doc_id: 329061 cord_uid: 1xut73dq the virus that causes sialodacryoadenitis in rats has been isolated in mice and in primary cultures of rat-kidney cells and has been characterized as a heat-labile rna virus that is sensitive to lipid solvents and is relatively stable at ph 3.0. this virus is antigenically related to the virus of hepatitis in mice and to coronavirus of rats. the range of hosts of this agent appears to be narrow. on the basis of available biologic characteristics, it has been placed in the coronavirus group. cated that neither source had detectable serum antibodies to sda virus and that both were susceptible to infection with this agent. rats were inoculated intranasally with 0.1 ml of virus-infected salivary-gland suspension, observed daily for evidence of overt illness, and sacrificed at various intervals. all rats were maintained in rigid plastic isolators with high-efficiency air filters. tissue culture. three cell lines, baby-hamster kidney (bhk-21), vera, and hep-2, and primary monolayer cultures of rat embryo, rabbit kidney, rhesus-monkey kidney, guinea-pig-embryo skin, muscle, and kidney were used as previously described [l ] . monolayers obtained from explant cultures of submaxillary, parotid, harderian, and exorbital glands of germfree rats, monolayers of trypsin-dispersed brain cells of infant mice, and a line of polyoma-transformed mouse cells (py-al/n) [6j were also tested. at a later stage in the study, primary rat-kidney (prk) cultures prepared from kidneys of weanling charles river cd germfree or conventional inbred dark agouti fda) rats were used. inoculated tubes were kept in a roller drum at 37 c and observed for cytopathic effect (cpe) at intervals of two to four days for at least 21 days. the fluid medium was changed when necessary. in the absence of cpe, a blind passage was made between the eighth and 16th day after inoculation. cultures for passage were observed for one to two weeks for development of cpe, and, in the absence of cpe, vera, bhk-21, and pmk cultures were challenged on the 12th day after inoculation with chandipura [8j virus, an arbovirus of the vesicular stomatitis viral group, for determination of interference. in addition, the fluid from each of the second-passage cultures was inoculated ic into infant mice, and the mice were observed for 21 days. in some instances tissueculture fluid from inoculated tubes was passaged into infant mice without further passages in tissue culture. monolayer cultures of prk, infant-mouse brain, and py-al/n cells were also examined by indirect immunofluorescence for the presence of viral antigen [5] . characterization of the virus. for determination of the effect of 5-bromodeoxyuridine (5-budr), lipid solvent, low ph, and various temperatures, methods described by bhatt et al. [9j were used. the hemagglutination method will be bhatt, percy, and jonas described under results. staining with acridine orange was done according to the method of hsiung [10] . preparation of immune sera. hyperimmune sera were prepared in rats and mice by repeated inoculation of a suspension of salivary glands from infected rats and of brains from infected mice, respectively. complement-fixation test. complement-fixing antigen was prepared by sucrose-acetone extraction from infected brains of two-to four-day-old mice. polyvalent mouse-hepatitis cf antigen prepared in tissue culture was obtained from microbiological associates. the cf test was performed by the micromethod [l l ] using two units of complement and four to eight units of antigen. serum of mice immune to sda strain 681 was tested against 118 viral antigens by the cf test. neutralization test. the neutralization (n) test with sera immune to murine viruses was performed in infant mice, and these animals were observed for 14 days after inoculation. prk cultures were used for cross-n tests, using sda strain 681 and parker's rcv. sera were inactivated at 56 c for 30 min. cultures were examined on the third and fifth days after inoculation. the titers of antibody and virus were calculated by the method of reed and muench [12j. fluorescent-antibody method. pieces of mouse brain 2-4 mm thick were quick-frozen in a dry ice-alcohol bath and stored at -83 c. sections 6-8f!m thick were cut in a cryostat, two sections were mounted per slide, and then the slides were fixed in acetone at 25 c for 15-20 min and dried at 37 c for 15 min. sections were stained immediately or stored at -25 c for 1-30 days before use. tissue-culture cover slips were similarly prepared but at times were kept in chilled acetone at -25 c for 18 hr. the section and cover-slip preparations were reacted with sera immune to virus for 20 min at 25 c and then exposed to mouse or rat antiglobulin conjugate for 20 min. phosphate-buffered saline (pbs) was used for washing. preparations were examined with a carl zeiss microscope fitted with an hbo 200 w/4 supermercury lamp, a ug-5 exciter filter, and a 47/65 barrier filter. histopathology. histologic examination of tissue from inoculated rats included harderian, exorbital, parotid, and submaxillary glands. in suckling mice, coronal sections of brain and serial transverse sections of the thoracic and abdominal regions were examined. attempts to induce disease in weanling mice. sixty female mice, three-to four-weeks old, were given 2.5 mg of cortisone im twice a week beginning a week before inoculation and continuing until the end of the experiment. twenty mice each were inoculated ic and ip with 0.03 ml and 0.1 ml of viral suspension containing 2 x 1()3·9 and 6.3 x 10 3 . 9 infant mouse ld50 (imld50), respectively. twenty control mice were inoculated with diluent, 10 by the ic route and 10 by the ip route. another group of controls was neither inoculated nor given cortisone. six mice from each group were killed for histologic studies on the seventh day after inoculation and two were killed on the 14th day after inoculation. remaining mice were observed until the 21st day after inoculation, when the experiment was terminated. a complete necropsy was done on each mouse. induction of sialodacryoadenitis in susceptible rats by mouse-brain-adapted virus. eleven rats, weighing 250 g and from a colony known to be susceptible to sda virus, were inoculated by the intranasal route with fourth passage, infectedmouse-brain material. the inoculum contained approximately 6.6 x 10 3 . 8 imld 50 of virus. rats were sacrificed on the fifth, sixth, and eighth days after inoculation. harderian and submaxillary glands were processed for isolation of virus and histologic examination, whereas parotid gland was collected for histologic examination only. adaptation to mice and related observations. a 10% suspension of infected salivary glands was inoculated ic into one-day-old mice. one mouse was sick on the fifth day after inoculation, eight more were sick on the seventh day after inoculation, and six on the eighth day after inoculation. some of these animals were killed, and tissues were harvested for passages and histologic study, but mice that were sick but not killed died on the 10th day after inoculation. one mouse was unaffected and survived until the 21st day, when it was discarded. the disease was characterized by ataxia and uncoordination, followed by paresis, paralysis, and death. the same pattern of illness was observed on further passages. by the fifth mouse-brain passage, the incubation period was 125 shortened to two to three days. there was usually a random pattern of illness and death from two to eight days and occasionally up to 10 days after inoculation. the pattern has remained unchanged for 29 passages with this strain of virus. one other observation made during the first passage in mice and amply confirmed during subsequent work was emaciation of sick mice as compared to uninoculated control mice of the same age. these differences were more marked in mice that were two to four days old or older when inoculated. other significant observations can be summarized as follows: (l) the agent of sda does not cause detectable illness in weanling (three-to four-week-old) mice when inoculated ic or ip or in infant mice inoculated ip. (2) a comparative titration was done in mice two days old, 13 days old, and 22 days old that were inoculated ic with viral stock passaged 12 times in mouse brain. titers were 10 4 . 00, 10 4 . 25 , and <10 2 . 0 imld50/0.015 mi, respectively. (3) virus has undergone 29 serial ic passages in zero-to six-day-old mice, the cumulative dilution of which exceeds 10-100. (4) the titer of virus between the fifth and 29th passage in mouse brain has remained relatively stable at 10 3 . 5_105.0 imld50/0.015 ml (usually around 1q3·7 imld50/0.015 ml). (5) the original salivary-gland suspension was titrated in one-day-old mice and had a titer of 1()3·6 imld 50/o.015 ml. (6) when inoculated intranasally into susceptible rats, mouse-brain-adapted virus produced sialodacryoadenitis. (7) brains from two uninoculated mice (two days old) were harvested as controls; seven serial ic passages of this material were made at intervals of six to seven days in mice three to four days old. no agent pathogenic for mice was isolated from these control animals. histopathologic and immunofluorescent observations in inoculated mice. in general, histologic changes observed in the central nervous system of inoculated mice were characterized by diffuse and focal neuronal degeneration with minimal inflammatory cell response. regions of brain most frequently involved were the cortices of the occipital and parietal lobes. other foci of neuronal destruction were scattered elsewhere in the central nervous system; there was relatively little destruction 0 some important observations are summarized as follows. (l) cultures were most sensitive when used within a week after seeding; then sensitivity decreased. the cpe was delayed and less extensive in older cultures. (2) development of virus in prk cells was monitored by cpe, detection of viral antigen by indirect immunofluorescence, and quantitation of infectious virus in prk tubes. results are presented in table 1. significantly, detectable viral antigen developed by 12 hr and was followed by release of infectious virus into the medium. cpe was detected at 24 hr. beyond 24 hr, quantitation of viral antigen was difficult due to lysis of cell sheets, and after 36 hr, titer of infectious virus decreased. (3) the sensitivity of inoculation of mice ic with strain 681 virus was compared with that of inoculation of prk cultures. titers obtained with a mouse-brain-adapted virus were 2.5 x 10 4 imld50 in mice and lox 10 4 . 3 tcid50 in prk cultures. similar differences were also noted in other experiments. characterization of the agent. the effect of 5-budr on viral multiplication was determined by the method of bhatt et al. [9] . chandipura virus was used as rna control (p. n. bhatt, unpub-hour in the cerebellum. affected neurons were pyknotic and densely eosinophilic. in addition, there was a scattering of shrunken, densely staining astrocytes in these areas. occasionally there was hypertrophy and hyperplasia of capillary endothelial cells and minimal perivascular cuffing with mononuclear cells. sometimes a few polymorphonuclear leukocytes were scattered in areas of destruction. spinal cord, salivary glands, lung, heart, liver, kidney, spleen, and intestine were histologically normal. immunofluorescence procedures detected viral antigen in regions where frank cellular necrosis was seen by standard histologic techniques. in addition, intense staining was observed in neuronal cytoplasm of scattered cells that were intact and not associated with frank necrosis. serial coronal sections had immunofluorescence staining in dorsal cortical areas, the ventral portion of ammon's horn, the hypothalamus, and the brain stem, but fluorescence was rarely found in cerebellar folia and white matter. a ttempts to adapt the agent to monolayer cell cultures. the original salivary-gland suspension inoculated onto various monolayer cell cultures produced no detectable cpe up to 21 days after inoculation. when blind passages were made and cultures were challenged with chandipura virus [8] , interference was not observed. fluid from the second passage in tissue culture was inoculated ic into infant mice; the results were negative. attempts were made to propagate mouse-brainadapted virus to cell-culture systems, such as monolayers obtained from explant cultures of parotid, harderian, exorbital, and submaxillary glands of germfree rats and monolayers of trypsindispersed infant-mouse-brain cultures. there was no detectable cpe. similar results were obtained with the py-al/n cell line. infectious virus or viral antigen was not detected when tissue-culture fluids from infected-mouse-brain and py-al/n cultures were inoculated ic into infant mice or when monolayers were examined by indirect immunofluorescence. however, prk cultures showed cpe characterized by formation of multinucleated giant cells, which were seen as highly reflective masses. these cells fell off the glass wall a few hours later and were seen floating in medium. tissue-culture fluids of these cultures contained virus as detected in infant mice, and cultures were positive for viral antigen by indirect immunofluorescence. sensitivity of sda virus to a lipid solvent was also tested. the titer of virus was 10 3 . 8 and < 10 2 . 0 imld50/0.015 ml for controls and chloroformtreated samples, respectively. the test was repeated with similar results, and it was concluded that the agent is sensitive to lipid solvents. effect of low ph on infectivity. the test was performed as described by leibhaber [13] . tenfold serial dilutions of infected-mouse-brain suspension kept at different ph values were made in eagle's minimal essential medium in earle's base with 3% fetal bovine serum (fbs). the ph of each dilution was adjusted to approximately 7.0 by addition of tris, and this solution was inoculated into mice. end points of infectivity were calculated by the method of reed and muench [12] . the titers of infectious virus detected in pbs after incubation for 3.0 hr at 25 c was 103. 6 imld50/0.015 ml, whereas at ph 7.0 and ph 3.0 it was 10 3 . 9 imld50/0.015 m1 and lq2·8 1mld50/ 0.015 ml, respectively. thus infectious virus was relatively stable at low ph. effect of temperature on infectivity. the effect of a temperature of 37 c on infectious virus was determined as outlined by bhatt et al. [9] . to determine the effect of a temperature of 56 c, infectivity was determined at intervals of 0, 5, and 10 min. an aliquot of viral stock was kept at 4 c, and infectivity was determined on days 0, 7, and 28. infectivity of viral strain 681 was stable in pbs plus 3% fbs at 37 c for 3 hr; the titer then decreased by 1.1 log., by 5 hr. at 56 c the infectivity decreased from 10 3 . 8 1mld50 at zero time to trace levels by 5 the size of infectious viral particles. the approximate size of infectious viral particles was determined by the method of atoynatan and hsiung [14] and casals [15] as modified by bhatt et al. [9] . a fresh, 10% suspension of mouse brain was made in pbs plus fbs, clarified by centrifugation at 1,000 g for 20 min, and filtered through miliipore filters (millipore corp., bedford, mass.) of various pore sizes. viral titers obtained were 103. 5, 104.2, 103. 8 , 10 3 . 0, and < lq2 1mld50/0.015 m1 for unfiltered virus and after filtration through pore sizes 1,200 urn, 450/lm, 220/lm, and 100 urn, respectively. results indicate that the size of the virus is less than 220 urn but greater than 100 urn. the particles without membranes measured by electron microscopy were previously reported to be 6 1 were identified as differentially expressed genes (degs). degs were used as query to search for enriched biological processes (gene ontology bp) using metascape. heatmaps of gene expression levels were constructed using heatmap package in r (https://cran.rstudio.com/web/packages/pheatmap/index.html). dot plots and volcano plots were constructed using ggplot2 (https://ggplot2.tidyverse.org/) package in r. production of fab fragment. the b8 and d14 fab fragments (43) were generated using a pierce fab preparation kit (thermo scientific). briefly, the antibody was mixed with immobilized-papain and then digested at 37 ˚c for 3-4 h. the fab was separated from the fc fragment and undigested iggs by protein a affinity column and then concentrated for analysis. surface plasmon resonance. mace2 was immobilized onto a cm5 sensor chip surface using the nhs/edc method to a level of ~600 response units (rus) using biacore® 3000 (ge healthcare) and pbs as running buffer (supplemented with 0.05% tween-20). wtrbd, rbdmascp25 and rbdmascp36, which were purified and diluted, were injected in concentration from high to low. the binding responses were measured, and chip surfaces were regenerated with 10 mm glycine, ph 1.5 (ge healthcare). the apparent binding affinity (kd) for individual antibody was calculated using biacore® 3000 evaluation software (ge healthcare). for the competitive binding assays, the first sample flew over the chip at a rate of 20 ul/min for 120 s, after which the second sample was injected at the same rate for another 120s. all antibodies were evaluated at a saturation concentration of 500 nm, while mace2 was applied at 1000 nm concentration. all surfaces of chips were regenerated with 10 mm glycine, ph 1.5 (ge healthcare). the response units were recorded at room temperature and analyzed using the same software as mentioned above. for cryo-em sample preparation, the quaternary complex (rbdmascp25/rbdmascp36-fabb8-fabd14-mace2) was diluted to 0.8 mg/ml. holy-carbon gold grid (quantifoil r0.6/1.0 mesh 300) were freshly glow-discharged with a solarus 950 plasma cleaner (gatan) for 60s. a 3 μl aliquot of the mixture complex was transferred onto the grids, blotted with filter paper at 22℃ and 100% humidity, and plunged into the ethane using a vitrobot mark iv (fei). for rbdmascp25/rbdmascp36-fabb8-fabd14-mace2 complex, micrographs were collected at 300 kv using a titan krios microscope (thermo fisher), equipped with a k2 detector (gatan, pleasanton, ca), using serialem automated data collection software (43) movies (32 frames, each 0.2 s, total dose 60 e − å −2 ) were recorded at final pixel size of 1.04 å with a defocus of between -1.25 and -2.7 μm. image processing. for rbdmascp25-fabb8-fabd14-mace2 complex, a total of 2,109 micrographs were recorded. for rbdmascp36-fabb8-fabd14-mace2 complex, a total of 2,982 micrographs were recorded. both sets of the data were processed in the same way. firstly, the raw data were processed by motioncor2, which were aligned and averaged into motion-corrected summed images. then, the defocus value for each micrograph was determined using gctf. next, particles were picked and extracted for two-dimensional alignment. the partial well-defined particles were selected for initial model reconstruction in relion. the initial model was used as a reference for three-dimensional classification. after the refinement and postprocessing, the overall resolution of rbdmascp36-fabb8-fabd14-mace2 complex was up to 3.69å, on the basis of the gold-standard fourier shell correlation (threshold = 0.143) (44) . for rbdmascp25-fabb8-fabd14-mace2 complex, the class i complex the resolution achieved was 7.89 å, classii complex had a resolution of 8.17 å, while class iii complex was reconstructed to a resolution of 4.4 å. the quality of the local resolution was evaluated by resmap (45) . model building and refinement. the wtrbd-hace2 (pdb id: 6m0j) structures were manually docked into the refined maps of rbdmascp36-fabb8-fabd14-mace2 complex using ucsf chimera (46) and further corrected manually by real-space refinement in coot (47) . the atomic models were further refined by positional and b-factor refinement in real space using phenix (48) . validation of the final model was performed with molprobity (49) . the data sets and refinement statistics are shown in table s1. statistical analyses were carried out using prism software (graphpad). all data are presented as means ± standard error of the means (sem). statistical significance among different groups was calculated using the student's t test, fisher's exact test, two-way anova or mann-whitney test *, **, and *** indicate p < 0.05, p < 0.01, and p < 0.001, respectively. dying with sars-cov-2 infection-an autopsy study of the first consecutive autopsy in suspected covid-19 cases the pathological autopsy of coronavirus disease 2019 (covid-2019) in china: a review. pathogens and disease considering how biological sex impacts immune responses and covid-19 outcomes clinical features of covid-19 in elderly patients: a comparison with young and middle-aged patients structure of the sars-cov-2 spike receptor-binding domain bound to the ace2 receptor characteristics of sars-cov-2 and covid-19 comparative analysis reveals the species-specific genetic determinants of ace2 required for sars-cov-2 entry the pathogenicity of sars-cov-2 in hace2 transgenic mice mouse model of sars-cov-2 reveals inflammatory role of type i interferon signaling. biorxiv a sars-cov-2 infection model in mice demonstrates protection by neutralizing antibodies a mouse-adapted model of sars-cov-2 to test covid-19 countermeasures adaptation of sars-cov-2 in balb/c mice for testing vaccine efficacy a mouse-adapted sars-cov-2 induces acute lung injury and mortality in standard laboratory mice adaptation of sars-cov-2 in balb/c mice for testing vaccine efficacy an official american thoracic society workshop report: features and measurements of experimental acute lung injury in animals covid-19 makes b cells forget, but t cells remember the novel severe acute respiratory syndrome coronavirus 2 (sars-cov-2) directly decimates human spleens and lymph nodes. medrxiv human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (sars-cov-2) infection. medrxiv structural basis for neutralization of sars-cov-2 and sars-cov by a potent therapeutic antibody mouse-adapted sars-cov-2 replicates efficiently in the upper and lower respiratory tract of balb/c and c57bl/6j mice a mouse-adapted model of sars-cov-2 to test covid-19 countermeasures histopathology and ultrastructural findings of fatal covid-19 infections in washington state: a case series pathological study of the 2019 novel coronavirus disease (covid-19) through postmortem core biopsies. modern pathology : an official journal of the united states and canadian academy of pathology clinical features of covid-19 and factors associated with severe clinical course: a systematic review and meta-analysis. ssrn pathological findings of covid-19 associated with acute respiratory distress syndrome. the lancet identification of a potential mechanism of acute kidney injury during the covid-19 outbreak: a study based on singlecell transcriptome analysis neurological associations of covid-19 lung pathology of fatal severe acute respiratory syndrome a new coronavirus associated with human respiratory disease in china pandemic preparedness and response--lessons from the h1n1 influenza of report of the who-china joint mission on coronavirus disease 2019 (covid-19) sars-cov-2: virus dynamics and host response chronic inflammation in the etiology of disease across the life span disparities in age-specific morbidity and mortality from sars-cov-2 in china and the republic of korea characteristics of covid-19 patients dying in italy report based on available data on the lethal sex gap: covid-19 sex differences in immune responses spike mutation d614g alters sars-cov-2 fitness acknowledgements: this work was in memory of prof this work was supported by the national key plan for scientific research and development of china quantifying the local resolution of cryo-em density maps visualization system for exploratory research and analysis tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions towards automated crystallographic structure refinement with phenix.refine molprobity: all-atom structure validation for macromolecular crystallography relion: implementation of a bayesian approach to cryo-em structure determination automated electron microscope tomography using robust prediction of specimen movements chadox1 ncov-19 vaccine prevents sars-cov-2 pneumonia in rhesus macaques data and materials availability: all requests for resources and reagents should be directed to c.-f.q. (qincf@bmi.ac.cn and qinlab313@163.com) and will be fulfilled after completion of a materials transfer agreement. key: cord-000261-ip32y0j5 authors: becker, pablo d.; legrand, nicolas; van geelen, caroline m. m.; noerder, miriam; huntington, nicholas d.; lim, annick; yasuda, etsuko; diehl, sean a.; scheeren, ferenc a.; ott, michael; weijer, kees; wedemeyer, heiner; di santo, james p.; beaumont, tim; guzman, carlos a.; spits, hergen title: generation of human antigen-specific monoclonal igm antibodies using vaccinated “human immune system” mice date: 2010-10-04 journal: plos one doi: 10.1371/journal.pone.0013137 sha: doc_id: 261 cord_uid: ip32y0j5 background: passive transfer of antibodies not only provides immediate short-term protection against disease, but also can be exploited as a therapeutic tool. however, the ‘humanization’ of murine monoclonal antibodies (mabs) is a time-consuming and expensive process that has the inherent drawback of potentially altering antigenic specificity and/or affinity. the immortalization of human b cells represents an alternative for obtaining human mabs, but relies on the availability of biological samples from vaccinated individuals or convalescent patients. in this work we describe a novel approach to generate fully human mabs by combining a humanized mouse model with a new b cell immortalization technique. methodology/principal findings: after transplantation with cd34(+)cd38(−) human hematopoietic progenitor cells, balb/c rag2(−/−)il-2rγc(−/−) mice acquire a human immune system and harbor b cells with a diverse igm repertoire. “human immune system” mice were then immunized with two commercial vaccine antigens, tetanus toxoid and hepatitis b surface antigen. sorted human cd19(+)cd27(+) b cells were retrovirally transduced with the human b cell lymphoma (bcl)-6 and bcl-xl genes, and subsequently cultured in the presence of cd40-ligand and il-21. this procedure allows generating stable b cell receptor-positive b cells that secrete immunoglobulins. we recovered stable b cell clones that produced igm specific for tetanus toxoid and the hepatitis b surface antigen, respectively. conclusion/significance: this work provides the proof-of-concept for the usefulness of this novel method based on the immunization of humanized mice for the rapid generation of human mabs against a wide range of antigens. hyper-immune sera containing polyclonal immunoglobulins (igs) have been widely used in both therapeutic and prophylactic clinical settings [1] . however, the use of polyclonal sera was associated with several problems, such as the stimulation of allergic reactions, low reproducibility between clinical batches and high off-label use, which finally caused a decline in their use [2] . the advent of technologies to make monoclonal antibodies (mabs) derived from animals, especially mice, has overcome many of the problems associated with the use of polyclonal sera. the technology to make monoclonal cell lines of antibody-producing cells by fusing antibody producing plasma cells with myeloma cells was described for the first time in 1975 by milstein and kohler [3] . the therapeutic potential of mabs was immediately recognized and in 1980 the first mab, okt3, was approved for therapeutic applications. this antibody inactivates t cells, thereby preventing rejections of organ transplants [4] . however, because of the animal origin of the first generation of mabs that were used in clinical trials, human subjects treated with these antibodies developed vigorous immune reactions against the animal proteins, which were thereby eliminated preventing their therapeutic actions [5] . to overcome these problems technologies were developed to diminish the immunogenicity of mouse antibodies by replacing part or the complete mouse antibody backbone by its human equivalent, first generating chimeric, and subsequently fully humanized antibodies [6] . in a parallel approach transgenic mice bearing the human ig region were created to obtain fully human antibodies following immunization. the use of these mice obviates the elaborate molecular engineering of antibodies that is needed to humanize antibodies generated in wild-type mice, however, the maturation process of the mouse b cells expressing human igs is different from that of fully human b cells [7] . immortalization of b cells from immune humans seems to be the logical strategy to avoid these problems. however, the methods to achieve this goal have showed low efficiencies, although some progress has recently been reported [8, 9] . nevertheless, the major disadvantage of human b cells immortalization is the need for cells from either vaccinated individuals or patients who had recovered from an infection. thus, to fully exploit the ig repertoire of human b cells in an in vivo setting, we explored the possibility to raise mabs following de novo induction of human b cell responses in mice carrying elements of the human immune system (his). his mice are generated by engrafting immunodeficient mice with human hematopoietic stem cells (hsc) with or without human lymphoid tissues from fetal origin [10, 11, 12] . in particular, mice deficient for the recombinase activating gene-2 (rag2) and the common gamma chain of the il-2 receptor (il2rg) on a balb/c or a non-obese diabetic (nod) background are permissive for human hsc xenografts. inoculation of newborn mice from these strains with human hsc of fetal or umbilical cord blood origin gives rise to robust engraftment of a number of immune cells, including t, b, nk and dendritic cells. in this work, we describe a convenient approach to generate fully human mabs based on the immunization of balb/c rag2 2/2 il-2rcc 2/2 engrafted with human cd34 + cd38 2 hsc [13, 14] . to this end, his mice were immunized with commercial vaccines against hepatitis b virus (hbv) and tetanus. following immunization, human cd19 + b cells were sorted based on surface cd27 expression, as a marker of memory phenotype, and the isotype of surface igs. the sorted b cell populations were immortalized in vitro by retroviral transduction with human b cell lymphoma (bcl)-6 and bcl-xl genes and antigen-specific b cell clones were established and characterized. the obtained results provided the proof-of-concept for the usefulness of this generic approach based on his mice combined with immortalization of human b cells for the rapid and inexpensive development of human mabs against a wide range of antigens. the use of fetal liver tissue obtained from elective abortions with gestational age ranging from 14 to 20 weeks was approved by the medical ethical committee of the amc-uva and was contingent on informed written consent. balb/c rag2 2/2 il-2rcc 2/2 mice were bred and maintained in individual ventilated cages, and fed with autoclaved food and water. his mice were generated as previously described [13, 14, 15, 16] , with the approval of the animal ethical committee of the amc-uva (permit number dhl-100970). in brief, human fetal livers were obtained from elective abortions with gestational age ranging from 14 to 20 weeks. magnetic enrichment of cd34 + cells (.98% pure) was performed by using the cd34 progenitor cell isolation kit (miltenyi biotech), after preparation of single cell suspensions and isolation of mononuclear cells by density gradient centrifugation over lymphoprep (axis shield). finally, newborn (,5 days old) sub-lethally irradiated (3.5 gy) balb/c rag2 2/2 il-2rcc 2/2 mice were injected via intra-hepatic route with 5-10610 4 sorted cd34 + cd38 2 human fetal liver hematopoietic stem cells in 30 ml. all manipulations of his mice were performed under laminar flow. cell suspensions were prepared in rpmi medium supplemented with 2% fetal calf serum (fcs). twelve to sixteen weeks after cd34 + cd38 2 hsc engraftment, his mice were killed and single cell suspensions of splenocytes were prepared. red cells lysis was performed in 1 ml of red cell lysis buffer (sigma) for 10 min. splenocytes were washed, resuspended in 600 ml of rlt lysis buffer (qiagen) and homogenized by passing through a 21-gauge needle several times using rnase free syringes. rna was prepared using rneasy mini kits (qiagen) according to manufactures instructions. bcr v h immunoscope was performed as previously described [17] . briefly, cdna was prepared and real-time pcr performed by combining primers for the different v h chains (v h 1-7) and specific fluorochrome-labeled probes against the different constant regions (c h m, c h a and c h c). an additional four pcr cycles 'run-off reactions' were then performed on the pcr products using fluorescent primers specific for the constant regions (fcm, fca and fcc). products were gel separated to determine cdr3 lengths. analysis of six individual his-mice containing greater than 30% human chimerism in the spleen was performed. the number of human cd19 + b cells in chimeric spleens ranged from 5-12610 6 . eight weeks after hsc transplantation, blood was taken from his mice to verify the level of engraftment by flow cytometry, as described elsewhere [18] . his mice with a good level of human reconstitution (.20% hcd45 + cells) were immunized by intramuscular route (biceps femoris) using a 29g needle, three times on weeks 14, 16 and 18 with either 100 ml of the hbv vaccine (engerix-b, glaxosmithkline) or 50 ml of tetanus toxoid (tt) containing vaccine (tetanus vaccine, the netherlands vaccine institute). these amounts correspond to 1/10 of the normal human dose. negative controls received the same volume of pbs buffer. two weeks after the last immunization, his mice were exsanguinated under isofluran/oxygen narcosis. spleens and mln were removed aseptically and cellular suspensions were prepared. the bm cells were isolated from the femur and tibia. from beckman coulter; cd3 (sk7), cd4 (sk3), cd8 (sk1), cd19 (hib19), cd38 (hit2), cd45 (2d1 and hi30), cd45ra (hi100), cd138 (mi15), igm (g20-127), igd (ia6-2), igg (g18-145) and ccr7 (3d12) from bd biosciences; cd27 (lt27) from abd-serotec; cd27 (lg.7f9) from ebioscience. tt-specific b cells were also occasionally stained with pe-coupled tt, kindly provided by dr. andreas radbruch (german rheumatism research center, berlin, germany). dead cells were excluded based on dapi incorporation. all washings and reagent dilutions were done with pbs containing 2% fcs and 0.02% nan 3 . stained cells were analyzed with an lsr-ii interfaced to a facs-diva software system (bd biosciences). cell sorting of b cell subsets were performed on his mouse bm and spleens using a facs-aria cell sorter interfaced to a facs-diva software system (bd biosciences). for these experiments, all washings and reagent dilutions were done with 2% fcs supplemented pbs without nan 3 . the human bcl6 [19, 20] and bcl-xl [21] encoding cdnas were further cloned in a lzrs retroviral expression vector, around a t2a cleavage-promoting peptide sequence and upstream a cassette containing an internal ribosome entry site (ires) and the gene encoding gfp. we therefore obtained a lzrs vector in the following configuration: bcl6-t2a-bclxl-ires-gfp [9] . transfection of phoenix-galv packaging cells and virus production were performed as previously described [22] . before retroviral transduction, memory b cells were activated on c-irradiated (50 gy) mouse l cell fibroblasts stably expressing cd40l (cd40l-l cells) in the presence of 25-50 ng/ml recombinant mouse interleukin-21 (rmil-21, r&d systems) for 36 h [19] . the b cells were washed, mixed with retroviral supernatants in retronectin-coated plates (takara), centrifuged at room temperature for 60 min at 360 g, and subsequently incubated with the retroviruses at 37uc, 5% co 2 for 6-8 h. transduced b cells were maintained in co-cultures using cd40l-l cells (10 5 cells/ml) and in standard imdm (gibco) culture medium supplemented with 8% fetal bovine serum (fbs; hyclone), penicillin/streptomycin (roche) and 25 ng/ml rmil-21. the analysis of human ig-v h sequences was performed as follows. total rna was isolated from approximately 5610 5 monoclonal b cells with trizol (invitrogen). the cdna was generated and subjected to pcr with primers specific to the different v h family members. pcr products were sequenced to determine the cdr3 region of the different clones. sequence analysis was performed using bigdye terminator chemistry (applied biosystems inc.) and codoncode aligner software. the plasma harvested from his mice (7 days after the first and second immunization; 10 days after the third immunization) and b cell clone culture supernatants were screened by elisa for the presence of total human igm, total human igg and antigenspecific antibodies. measurement of total igm and igg was performed by coating 96-well plates either with affinipure f(ab') 2 fragment goat anti-human igm (fc5m-specific, jackson immu-noresearch) or affinipure goat anti-human igg (fcc fragmentspecific; jackson immunoresearch). control human serum protein calibrator (dako) with known igm (0.8 mg/ml) and igg (10.4 mg/ml) concentrations was used as a standard to be compared to the samples. for the detection of antigen-specific antibodies, 96-well plates were coated either with tetanus vaccine (nederlands vaccin instituut) or engerix b (glaxosmithkline) (106 diluted in pbs) for 1 h at 37uc or overnight at 4uc. alternatively, ridascreen tetanus igg elisa plates (biopharm) were also used to screen for tt-specific antibodies. after coating, the plates were washed in elisa wash buffer (pbs, 0.5% tween-20). a pbs solution containing 4% of milk was used as a blocking agent, before adding serial dilution of his mouse plasma (starting at a dilution of 1:5) or cell culture supernatants (starting at a dilution of 1:2). enzyme-conjugated detection antibodies were added at a dilution of 1:2500 for hrp-conjugated anti-igg and a dilution of 1:5000 for hrp-conjugated anti-igm (both from jackson immunoresearch). then, tmb substrate/stop solution (biosource) was used for the development of the elisa assay. statistical analyses were performed using graphpad prism version 5.02 for windows (graphpad software). data were subjected to two-tailed unpaired student t test analysis. the obtained p values were considered significant when p,0.05. we have generated his mice by transplanting human hsc into alymphoid balb/c rag2 2/2 il-2rcc 2/2 newborn mice ( figure 1a ). as reported previously, multilineage human hematopoietic reconstitution is observed in his mice, which demonstrate human thymopoiesis, b cell differentiation, nk cell and plasmacytoid dendritic cell development, and myelopoiesis [10, 13, 14, 15, 16] . human immune cells accumulate in lymphoid tissues, and several b cell subsets are observed in his mice ( figure 1b) . we analyzed the human b cell repertoire present in naive his mice by using b cell receptor (bcr) immunoscope analysis based on quantitative pcr of ig variable (v h ) and constant (c h ) region gene segments [17] . due to the lack of human spleen samples, the cells isolated from his mouse spleens, which contained sufficient numbers of human b cells to perform the immunoscope analysis, were compared to control human peripheral blood mononuclear cells (pbmc) samples, which were considered acceptable for the purpose of the performed comparison. we observed that igm-expressing b cells as well as ig isotype-switched b cells are found in naive his mice ( figure 1c) . the vast majority of b cells of his mice expressed an igm (97.961.0%), whereas igg (1.861.0%) and iga (0.0760.04%) expressing b cells represented minor populations. only the frequency of iga-expressing b cells was found significantly higher in control human pbmc samples (p,0.0001). at 10-14 weeks post-transplantation (i.e. in steady state conditions), the human ig concentrations in the blood were 12268 mg/ml (igm) and 143612 mg/ml (igg) ( figure 1d ), as previously reported [8, 16] . in comparison, the normal range for ig concentration in healthy humans is 400-3100 mg igm/ml and 7200-14700 mg igg/ml. in brief, despite a low frequency of igg-expressing cells, both human igm and igg accumulated in the plasma of ,3 month-old his mice to levels representing around 10% and 1% of adult human igm and igg concentrations, respectively. we further examined the antigen receptor repertoire diversity in his mice, by determining the length of cdr3 hypervariable regions for each ig-v h gene family. the analysis of cdr3 length distribution of individual his mouse splenocytes showed that igm repertoires are undistinguishable from normal human pbmc igm repertoires, as measured by the bcr immunoscope analysis ( figure 1e ). this observation suggests that his mice contain a broad variety of naive igm + b cell clones. the v h -family usage was large and similar to control human pbmc ( table 1) . the bcr immunoscope analysis was also performed for igg and iga repertoires and we observed more restricted repertoires, as expected from b cells undergoing clonal selection and ig class switch recombination ( figure s1 ). immunization of his mice with hbv and tetanus vaccines results in the generation of antigen-specific antibody responses since his mice contained broad naïve b cell repertoires, we analyzed the induction of human antigen-specific b cell responses after immunization with commercially available human vaccines. we designed a vaccination protocol based on repeated intramuscular immunizations (3 injections with 2-week intervals) of 10-14-week old his mice with vaccines containing hepatitis b surface antigen (hbsag) or tt. seven days after the last immunization mice were sacrificed, the blood and the lymphoid organs were harvested, and the phenotype and function of human cells was analyzed. all his mice showed human reconstitution (.20% hcd45 + cells) in the blood before starting the immunization protocol, which correlated with human engraftment in lymphoid organs. overall, 42% of hbsag-vaccinated (8 out of 19 vaccinated animals) and 40% of tt-vaccinated (6 out of 15) his mice showed significant production of antigen-specific igm antibodies, as detected by elisa (figure 2a) . we performed a kinetic monitoring of antigen-specific plasma ig levels in individual hbsag-vaccinated responder his mice and we observed that after the first immunization antigen-specific igs were rarely detected. in contrast, after the second immunization antigen-specific igm was detected, which steadily increased after the third immunization with approximately 25-40% of responder mice also showing an antigen-specific igg response (figure 2a) . this suggests that repeated vaccination leads to enhanced antigen-specific antibody production. the responder mice exhibited higher total igm (173641 mg/ml) and total igg (4596140 mg/ml) concentrations in their plasma, as compared to pbs-injected (igm: 37612 mg/ml; igg: 191658 mg/ml) and non-responder vaccinated (igm: 44611 mg/ml; igg: 192667 mg/ml) animals ( figure 2b) . at the end of the immunization protocol, vaccinated animals showed significantly higher numbers of hcd45 + cells in all organs (i.e. spleen, bone marrow (bm) and mesenteric lymph nodes (mln)) in comparison to mock-injected control mice. responder his mice exhibited higher numbers of human t and b cells in the spleen, as well as t cells in the bm ( table 2; table s1 ), suggesting that the vaccination protocol had a positive impact on the accumulation of human b and t cells. moreover, the mln isolated from vaccinated his mice contained 4 to 5-fold more hcd45 + cells than those of control animals ( figure 2c ), suggesting that the mln structure might play a role in eliciting an immune response in the his mice. in humans, the cd27 + memory b cell population contains the majority of antigen-experienced b cells [23, 24] , and we reasoned that the same should be true in vaccinated his mice. we therefore cell sorted several different cd19 + cd27 + b cell subsets from individual his mice. we used two strategies to isolate the following human b cell (cd45 + cd19 + ) subsets from bm and spleens of vaccinated his mice: (i) cd27 hi cd38 hi , (ii) cd27 + cd38 lo/int igd + , and (iii) cd27 + cd38 lo/int igd 2 on the one hand ( figure 3 , although the number of cells was increased for each of these subpopulations in the vaccinated animals, as expected from the enhanced number of total b cells ( table 2) . we only observed a significant increase in the frequency of igg + b cells within the cd27 hi cd38 hi plasmablast population of vaccinated responder his mice, as compared to pbs-injected animals (13.262.7% and 4.361.8% of cd27 hi cd38 hi b cells, respectively; p = 0.0311). in order to identify, isolate and immortalize the antigen-specific antibody-producing b cells, the aforementioned b cell subsets were transduced immediately after cell sorting with a retroviral vector encoding both human bcl6 and bcl-xl [9, 19] . by ectopically expressing bcl6 and bcl-xl in splenic or peripheral blood memory b cells and culturing them with factors produced by follicular helper t cells (cd40l and il-21), we generated highly proliferative, bcr positive b cell lines that secrete igs. since these cells express bcl6, the differentiation of memory b cells to terminal plasma cells is blocked [28, 29, 30] . therefore, the resulting b cells can expand extensively in vitro for long periods of time in presence of cd40l and il-21, and provide a tool to generate antigen-specific human bcr-positive, antibody-secreting b cell lines. the number of isolated cells from spleen and antigen-specific b cell clones that were generated with the bcl6/bcl-xl transduction approach is provided in the table s2 . since the frequency of antigen-specific b cell clones was unknown, we started with microcell cultures ranging from 0.6 to 640 cells per well. the wells containing antigen-specific b cells -as determined by hbsagspecific or tt-specific elisa -were subsequently cultured by limiting dilution to obtain monoclonal b cell lines. overall, we generated 15 anti-hbsag igm + b cell clones from 3 his mice vaccinated with hbsag, and 18 anti-tt igm + b cell clones from 3 his mice vaccinated with tt ( table s2 ). the estimated frequency of hbsag-specific b cells (clones) in the his mice after vaccination was 1/350. the igm secretion level of the b cell clones were in the range of 1 mg per 10 5 cells over 3 days in culture, which was in a similar range of secretion (0.6-5 mg/10 5 cells/3 days) to what was previously reported for b cell clones generated from human blood [9] . the igm v h regions of the bcr of the antigen-specific igm + b cell clones were sequenced. overall, the bcr of hbsag-specific and tt-specific b cell clones exhibited a v h sequence close to the germ-line sequence, although limited frequencies of somatic hyper-mutations were observed (table s3 and table s4 ). somatic hyper-mutations were occasionally detected in all framework regions (fr) and complementary determining regions (cdr), and most of the bcr diversity was the result of nadditions in the cdr3 region. based on the bcr sequence, we observed that 12 out the 15 anti-hbsag igm + b cell clones were unique, as well as 5 out the 18 anti-tt igm + b cell clones ( table s2, table s3 and table s4 ). the supernatants of tt-specific b cell clones were further tested for their capacity to recognize different antigens by elisa. we observed that igm mabs did not cross-react with unrelated antigens (i.e., hbsag and respiratory syncytial virus (rsv) antigens) ( figure 4a) . the tt-specific b cell clones were also screened by flow cytometry for direct binding of the tt antigen labeled with a fluorochrome ( figure 4b) . interestingly, three types of clones that produced antibodies that gave a similar signal in elisa were detected, with high, intermediate and low binding of the fluorescent tt antigen. in the present work we established a new approach to generate fully human mabs. we immortalized b cells from vaccinated his mice by transduction with bcl6 and bcl-xl followed by expansion in presence of il-21 and cd40l. antigen-specific b cell clones were obtained that expressed the bcr on their cell surface and secreted antigen-specific antibodies. similarly to methods based on the immortalization of human memory b cells from individuals that were either vaccinated or exposed to pathogens, our strategy exploits the antibody repertoire of human b cells which is likely to be different from that of b cells of mice expressing human ig gene segments. naïve his mice display an extensive human igm-expressing b cell repertoire. based on the analysis of the length of the cdr3 regions, this igm b cell repertoire is similar to the repertoire of healthy individuals. thus, his mice have no obvious limitations for the generation of human igm mabs against any possible antigen. upon intramuscular vaccinations with either tt or hbsag, approximately 40% of the his mice were able to mount an antigen-specific antibody response. human igm-producing b cell lines against both antigens were obtained after isolation of memory b cells followed by ex vivo differentiation into plasmablastlike cells. it is important to highlight that the selection of the antigen-specific human b cell clones relied on relevant bioassays (e.g., elisa or neutralization test). in contrast to ebv-based approaches, human b cell immortalization using transduction with bcl-6 and bcl-xl preserves the expression of the bcr at the surface and antigen-specific b cell clones can also be selected by binding of labeled antigen to the bcr of immortalized memory b cells (e.g. by using a labeled antigen). even when igg was used as a selection criterion, we were unable to establish antigen-specific igg + human b cell clones. the reason for this might be that t cell help in this system is suboptimal as indicated by the absence of antigen-specific t cell responses after vaccination (not shown). we also observed that the bcr of the b cell clones had a close to germ-line sequence, suggesting that also the induction of somatic hyper-mutation is sub-optimal in his mice. in our hands the great majority of the vaccinated his mice showed a defective formation of germinal centers [14, 16] , which further explains the absence of antigenspecific ig-class switched b cells. so far, humanized mouse models based on the transplantation of human hsc only -i.e. without additional human tissues -share these limitations, and immunization strategies result in the limited generation of class-switched antigen-specific b cell responses [14, 31, 32] . similar patterns are observed in human hsc-transplanted immunodeficient mice infected with lymphotropic pathogens, such as hiv [33] or ebv [34] , although dengue virus infection in his mice was reported to induce an igg response in a majority of the responder animals [35] . it is not clear why igg antigen-specific responses are limited while serum igg can accumulate efficiently, considering the low frequency of igg + b cells in his mice. it remains to be determined whether this apparent discrepancy might be explained by the conjunction of particularly effective igg production on a cell basis by igg + b cells (which might occur in a t cell independent manner, such as in the case of the igg3 subclass), long-term stability of human igg in the his mouse serum as compared to human igm, and/or defective survival of igg + b cells under specific conditions (e.g. after antigen-specific triggering of the bcr). although igm mabs might already be useful for some specific applications or could be modified by ig class swapping to obtain igg mabs [36] , optimized humanized mouse models with improved b cell function are highly desirable. one reason for the suboptimal interaction of t and b cells may be the poor survival resulting in a high turnover of human t cells (discussed in [10, 37] ), making it very likely that procedures leading to improved accumulation of human t cells may promote b cell responses and isotype switching. it was already shown that human b cells undergoing isotype switching can be obtained in humanized mice, provided that a human environment supporting this process is present, e.g. in scid mice transplanted with human fetal bones, thymus and lymph nodes [38] . consistent with this notion, enhanced human peripheral t cell accumulation was observed in nod/scid mice transplanted with human bone marrow hsc, fetal liver and fetal thymus tissues (referred to as blt mice), as compared to conventional humanized mouse systems [39] . interestingly, blt mice consistently generated an antigen-specific igg response after hiv-infection [40] . although it is yet unknown whether the isotype switch observed in blt mice is truly t cell dependent, those data might support the idea that improved t cell homeostasis has a positive impact on b cell responses. to obtain humanized mouse models with improved b and t cell homeostasis, alternative strategies not relying on the transplantation of human fetal tissues -which are not necessarily easy to access to, for ethical, legal or practical reasons -will likely be favored in the future. the replacement of mouse genes involved in the hematopoietic system by their human equivalent is a valuable strategy to improve development, maintenance and/or function of several hematopoietic cell subsets in humanized mouse models, as shown with cytokines, such as il-7 and il-15 [15, 21, 41, 42] , or mhc molecules (n.d.h and j.p.d., manuscript submitted) [43, 44] . the fact that the human cd47 was shown to be unable to properly interact with the mouse sirpa indicates that reintroducing a functional phagocyte inhibition mechanism via the cd47/sirpa signaling axis is another strategy of potential interest [45] . in conclusion, our results show using two standard vaccine antigens the general applicability of an innovative b cell immortalization method in combination with the his mouse model to generate human mabs. similarly to methods based on the immortalization of human memory b cells from vaccinated or convalescent individuals [9] , our approach exploits the broad antibody repertoire of human b cells, overcoming the potential limitations of conventional humanized murine mabs such as laboriousness or impaired biological properties, synthetic antibody libraries that require a known target antigen, and transgenic mice bearing the human ig locus that have limited b cell repertoires. in addition, our method enables to exploit experimental infection models and immunization regimes that would be unethical or untenable in humans. considering the upcoming advances in his mice models [37] , this new approach will provide a powerful tool to generate human mabs for either diagnostic or therapeutic purposes. figure s1 igg/iga b cell repertoire in naïve his mice. similarly to figure 1e , the naive igg (a) and iga (b) b cell repertoires of his (balb-rag/c) mice were evaluated on splenocytes by performing a bcr immunoscope for each v h family. the profiles obtained with control human pbmc are also shown. found at: doi:10.1371/journal.pone.0013137.s001 (1.61 mb tif) figure 3 . limited dilutions of b cells transduced with bcl-6 and bcl-xl were performed with 6.4 and 0.64 cells/well. after sub-cloning of the positive wells, we generated 15 igm + anti-hbsag mabs, of which 13 are unique (as determined by ig-v h sequence, see table s3 ), and 18 igm + anti-tt mabs, of which 5 are unique (see table s4 ). in the case of hbsag vaccination, the number of screened b cells was ((192*6.4)+(96*0.64))*3 = 3870, which eventually suggests that the frequency of hbsag-specific b cells is at least 1/350 b cells. found at: doi:10.1371/journal.pone.0013137.s003 (0.13 mb doc) igm v h amino-acid sequence of generated hbsagspecific b cell clones. the germ-line sequence is given for each v h family, with indication of framework regions (fr) and complementary determining regions (cdr). highlighted amino-acids correspond to n-additions (in the cdr3 region) and somatic hyper-mutation events, whether it results in a silent mutation (green) or not (red). clones with identical bcr sequences are grouped together. found at: doi:10.1371/journal.pone.0013137.s004 (0.02 mb pdf) the mechanism of diphtheria immunity and tetanus immunity in animals immunogenicity of therapeutic monoclonal antibodies continuous cultures of fused cells secreting antibody of predefined specificity upping the ante on antibodies mice with a human touch molecular engineering and design of therapeutic antibodies from xenomouse technology to panitumumab, the first fully human antibody product from transgenic mice an efficient method to make human monoclonal antibodies from memory b cells: potent neutralization of sars coronavirus generation of stable monoclonal antibody-producing b cell receptorpositive human memory b cells by genetic programming experimental models to study development and function of the human immune system in vivo human-hemato-lymphoid-system mice: opportunities and challenges humanized mice in translational biomedical research monitoring the effect of gene silencing by rna interference in human cd34+ cells injected into newborn rag2-/-gammac-/-mice: functional inactivation of p53 in developing t cells development of a human adaptive immune system in cord blood celltransplanted mice il-15 trans-presentation promotes human nk cell development and differentiation in vivo t cellindependent development and induction of somatic hypermutation in human igm+ igd+ cd27+ b cells many human peripheral vh5-expressing igm+ b cells display a unique heavy-chain rearrangement experimental model for the study of the human immune system: production and monitoring of ''human immune system'' rag2-/-gamma c-/-mice stat3-mediated up-regulation of blimp1 is coordinated with bcl6 down-regulation to control human plasma cell differentiation a senescence rescue screen identifies bcl6 as an inhibitor of anti-proliferative p19(arf)-p53 signaling il-7 enhances thymic human t cell development in ''human immune system'' rag22/2il-2rgammac2/2 mice without affecting peripheral t cell homeostasis stat5 regulates the self-renewal capacity and differentiation of human memory b cells and controls bcl-6 expression cd27: a memory bcell marker human b cell subsets rapid cloning of high-affinity human monoclonal antibodies against influenza virus human immunoglobulin m memory b cells controlling streptococcus pneumoniae infections are generated in the spleen human blood igm ''memory'' b cells are circulating splenic marginal zone b cells harboring a prediversified immunoglobulin repertoire control of inflammation, cytokine expression, and germinal center formation by bcl-6 bcl-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control the bcl-6 protooncogene controls germinal-centre formation and th2-type inflammation antigen-specific antibody production of human b cells in nog mice reconstituted with the human immune system antigen-specific human t-cell responses and t cell-dependent production of human antibodies in a humanized mouse model disseminated and sustained hiv infection in cd34+ cord blood cell-transplanted rag2-/-gamma c-/-mice a new humanized mouse model of epstein-barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses dengue virus infection and immune response in humanized rag2(2/2)gamma(c)(2/2) (rag-hu) mice potent antibody therapeutics by design humanized mice for modeling human infectious disease: challenges, progress, and outlook generation of primary antigen-specific human t-and b-cell responses in immunocompetent scid-hu mice humanized mice mount specific adaptive and innate immune responses to ebv and tsst-1 intrarectal transmission, systemic infection, and cd4+ t cell depletion in humanized mice infected with hiv-1 lentiviral vector delivery of human interleukin-7 (hil-7) to human immune system (his) mice expands t lymphocyte populations human lymphoid and myeloid cell development in nod/ltsz-scid il2r gamma null mice engrafted with mobilized human hemopoietic stem cells generation of functional human t-cell subsets with hla-restricted immune responses in hla class i expressing nod/scid/il2r gamma(null) humanized mice priming of protective t cell responses against virus-induced tumors in mice with human immune system components polymorphism in sirpa modulates engraftment of human hematopoietic stem cells we thank berend hooibrink for expert cell sorting and maintenance of the amc-uva flow cytometry facility. we acknowledge the bloemenhove clinic (heemstede, the netherlands) for providing fetal tissues and the staff of the animal research institute amsterdam for animal care. access to technologies available at the centre d'immunologie humaine of the institut pasteur was greatly appreciated. key: cord-292157-hrm69640 authors: stull-lane, annica r.; lokken-toyli, kristen l.; diaz-ochoa, vladimir e.; walker, gregory t.; cevallos, stephanie a.; winter, andromeda l. n.; muñoz, ariel del hoyo; yang, guiyan g.; velazquez, eric m.; wu, chun-yi; tsolis, renée m. title: vitamin a supplementation boosts control of antibiotic-resistant salmonella infection in malnourished mice date: 2020-10-02 journal: plos negl trop dis doi: 10.1371/journal.pntd.0008737 sha: doc_id: 292157 cord_uid: hrm69640 disseminated disease from non-typhoidal salmonella enterica strains results in >20% mortality globally. barriers to effective treatment include emerging multidrug resistance, antibiotic treatment failure, and risk factors such as malnutrition and related micronutrient deficiencies. individuals in sub-saharan africa are disproportionately affected by non-typhoidal s. enterica bloodstream infections. to inform a clinical trial in people, we investigated vitamin a as a treatment in the context of antibiotic treatment failure in a mouse model of vitamin a deficiency. vitamin a-deficient (vad) mice exhibited higher systemic bacterial levels with a multidrug-resistant clinical isolate in comparison to mice on a control diet. sex-specific differences in vitamin a deficiency and disseminated infection with s. enterica serotype typhimurium (s. typhimurium) were observed. vad male mice had decreased weight gain compared to control male mice. further, infected vad male mice had significant weight loss and decreased survival during the course of infection. these differences were not apparent in female mice. in a model of disseminated s. typhimurium infection and antibiotic treatment failure, we assessed the potential of two consecutive doses of vitamin a in alleviating infection in male and female mice on a vad or control diet. we found that subtherapeutic antibiotic treatment synergized with vitamin a treatment in infected vad male mice, significantly decreasing systemic bacterial levels, mitigating weight loss and improving survival. these results suggest that assessing vitamin a as a therapy during bacteremia in malnourished patients may lead to improved health outcomes in a subset of patients, especially in the context of antibiotic treatment failure. a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 in susceptible populations globally, there is a vicious cycle of infection and malnutrition [1] . malnutrition overlaps with deficiencies in micronutrients, such as iron, iodine, zinc and fatsoluble vitamins like vitamin a [2] . severe or recurrent infections can lead to vitamin a deficiency due to impaired nutrient absorption and decreased food intake, as well as direct nutrient loss through urine [3, 4] . in turn, vitamin a deficiency compromises the gastrointestinal mucosal epithelial barrier, increasing susceptibility to enteroinvasive bacteria and sepsis [4] . one of the most common enteric pathogens is salmonella enterica [5] . non-typhoidal serotypes of s. enterica cause significant morbidity and mortality worldwide, resulting in 93.8 million cases of gastroenteritis and 155,000 associated deaths annually [6] . invasive non-typhoidal salmonella (ints) infection, a severe febrile illness with bacteremia, disproportionately affects infants, older adults and immunosuppressed individuals. an estimated 3.4 million cases of invasive disease occur globally per year, resulting in 680,000 deaths [7] . malnutrition and concurrent malaria are key risk factors for systemic disease, and populations in sub-saharan africa are disproportionately affected [8] . barriers to effective treatment of ints illness include appropriate diagnostic tools, antibiotic treatment failure and antimicrobial resistance [9] . notably, the mortality rate due to ints in children reaches 20-25% [10] , indicating that more effective treatment is vital. vitamin a administration has been studied as treatment of infectious disease, such as for measles in children [11] . in addition, the who recommends vitamin a supplementation in the treatment of children that present with severe acute malnutrition [12] . given the importance of vitamin a in immune function [4, 13, 14] , these treatment recommendations suggest a role for vitamin a as a host-directed therapy [15] . however, vitamin a has not been studied as a treatment for nonspecific febrile illnesses like ints disease, especially in the context of antibiotic treatment failure. this study aimed to explore the therapeutic potential of vitamin a administered after onset of infection, simulating care of a sick patient presenting to clinic. our hypothesis was that vitamin a therapy could boost the effect of subtherapeutic antibiotic treatment and improve treatment outcomes for a drug-resistant ints infection. to address this question, we used mice to model antibiotic treatment failure of s. enterica serotype typhimurium in the setting of vitamin a deficiency. mouse experiments were carried out in compliance with the national institutes of health policies on animal welfare, the animal welfare act, and all other applicable federal, state and local laws. mice were cared for by research staff and university of california (uc) davis teaching and research animal care services (tracs) under a program accredited by the association for assessment and accreditation of laboratory animal care international (aaalac). tracs maintains a health monitoring program administered through the uc davis comparative pathology laboratory. when needed, campus veterinary services is available to provide interventional and supportive care. all mouse experiments were approved by the uc davis institutional animal care and use committee (iacuc) under protocol 19900. inbred c57bl/6j-slc11a1 +/+ mice are a c57bl/6j congenic strain containing a genomic segment with slc11a1 from s29s1 mice that was introgressed into chromosome 1 [16] . this mouse line was maintained at uc davis under specific pathogen-free conditions in cages with sterile alpha-dri bedding manufactured by shepherd specialty papers (watertown, tn). to generate vad and control mice, c57bl/6j-slc11a1 +/+ dams were given a vad diet at 2 weeks of gestation. pups were placed on either vad or control diets at weaning and were maintained as groups throughout each experiment. mouse weights were monitored weekly during growth. custom vad and control diets were obtained from envigo teklad diets (madison, wi). when the model was established, liver retinol concentration was confirmed by hplc. liver retinol concentration of control mice ranged from 120-300 nmol/g, whereas liver retinol concentration of vad mice ranged from 0-7 nmol/g. inbred c57bl/6j mice were purchased from the jackson laboratory (bar harbor, me) and were maintained on standard chow. d23580, a multidrug-resistant salmonella enterica serotype typhimurium clinical bloodstream isolate, was received from robert heyderman at the malawi-liverpool-wellcome trust clinical research centre [17] . inocula were cultured aerobically in luria-bertani (lb) media with 30 μg/ml chloramphenicol shaking for 16-18 hours at 37˚c, subcultured to a calculated optical density (od) of 0.001, and grown 16-18 hours rocking at 37˚c in a 96-well plate containing lb with serial dilutions of enrofloxacin ranging from 0 μg/ml to 2.56 μg/ml. enrofloxacin (baytril 100 by bayer) was obtained from the pharmaceutical service at the uc davis veterinary medical teaching hospital. the od was read at 595 nm on a biorad model 680 microplate reader (hercules, ca). the experiment was repeated six times, and the average minimum inhibitory concentration (mic) was recorded. a determination of susceptible (s), intermediate (i) or resistant (r) was made according to clsi guidelines [18] . inocula of s. typhimurium strains d23580, a multilocus sequence type (st) 313 strain isolated from blood, sl1344, an st19 isolate from a calf with salmonellosis [19] and sara16, an st19 human isolate and reference strain [20, 21] , were cultured in lb with shaking for 16-18 hours at 37˚c. the identity of each strain was confirmed by antibiotic resistance profiling. mice received 100 μl of sterile pbs or 100 μl of 1000 colony-forming units (cfu) diluted in sterile pbs by intraperitoneal (i.p.) injection. mouse weights were monitored daily during infection. mice were euthanized if they showed signs of lethal morbidity. systemic bacterial levels were characterized at day 1, 4 or 5 post-infection by determining tissue loads of s. typhimurium (cfu). liver and spleen were collected in pbs, weighed and homogenized using an ultra turrax t25 basic mixer from ika (staufen, germany). blood was collected in k2 edta microtainer tubes (becton, dickinson and company, franklin lakes, nj), kept on ice for one hour, and then incubated for 10 minutes with 100-200 μl of 1% triton x-100. liver, spleen and blood samples were serially diluted and plated on lb agar plates containing appropriate antibiotic selection. cfu/gram tissue or cfu/ml was calculated after overnight growth at 37˚c. mice were infected with s. typhimurium d23580 as previously described. for preliminary antibiotic treatment experiments, s. typhimurium systemic bacterial levels (cfu) were assessed for male (n = 5) and female (n = 5) mice on a standard diet 5 days post-infection for the following treatment groups: 0 mg/ml, 0.01 mg/ml, 0.05 mg/ml, and 0.10 mg/ml enrofloxacin delivered in the drinking water. water and mouse weights were collected daily, and the average antibiotic consumed (μg/kg/day) was determined. for co-treatment experiments with mice on special diets, 4-6 mice were assessed for control and vad male and female mice in the following groups: mock-treated, mock-treated and enrofloxacin, vitamin a only, and vitamin a and enrofloxacin co-treatment. mock-treated mice received 100 μl of sterile pbs administered by oral gavage on day 1 and day 2 post-infection. vitamin a-treated mice received 600 iu of retinyl palmitate (interplexus, inc., kent, wa) in 100 μl of sterile pbs administered by oral gavage on day 1 and day 2 post-infection and were changed to control diet at day 1 post-infection. enrofloxacin (0.05 mg/ml or 0.01 mg/ml) was administered at day 2 post-infection in the drinking water. enrofloxacin (baytril 100 by bayer) was obtained from the pharmaceutical service at the uc davis veterinary medical teaching hospital. water weights were monitored daily to determine average antibiotic consumption per mouse. cfu/ gram tissue or cfu/ml was calculated for liver, spleen and blood. for measurement of plasma enrofloxacin concentrations, blood was first centrifuged for 10 minutes at 1000 x g. plasma was stored at -80˚c for further analysis by liquid chromatography with tandem mass spectrometry (lc-ms/ms). the remaining blood sample was incubated at room temperature for 10 minutes with 100-200 μl of 1% triton x-100 and plated for cfu as previously described. lc-ms/ms was used to quantify enrofloxacin and ciprofloxacin concentrations in the mouse plasma. first, a mixed master stock solution of 10 μg/ml of enrofloxacin (milliporesigma, st. louis, mo) and ciprofloxacin (milliporesigma, st. louis, mo) was made in control cd-1 mouse plasma (bioreclamation ivt, westbury, ny) with k2 edta. this stock solution was then further diluted with the same control mouse plasma to establish a mouse plasma calibration curve. the following calibrator concentrations were used: 0, 1, 2.5, 5, 10, 50, 100, 500, 1000 and 5000 ng/ml. calibrators 10, 100 and 1000 ng/ml also served as quality control (qc) samples. moxifloxacin (milliporesigma, st. louis, mo) in acetonitrile (acn) (fisher scientific, hampton, nh) was used as an internal standard such that 160 μl of 200 ng/ml moxifloxacin in acn was added to 40 μl of the mouse plasma calibrators, qc samples and the experimental mouse plasma samples collected as previously described. all samples were vortexed for 10 seconds. samples were then centrifuged at room temperature for 5 minutes at 17,000 x g, and 25 μl of resulting supernatant was diluted with 175 μl of water. next, 2 μl of the final solution was injected into the acquity ultra performance liquid chromatography (uplc) system with a beh c18 column, 1.7 μm, 2.1 mm x 50 mm (waters corporation, milford, ma). the following mobile phases were used: a (h 2 o with 0.1% formic acid), and b (acn with 0.1% formic acid) (fisher scientific, hampton, nh). mobile phase a was also used for purging, and acn/h 2 o at 50/50 (v/v) was used for the needle washing between each injection. the flow rate was 0.2 ml/min, the column temperature was set at 50˚c and the autosampler temperature was set at 10˚c. the following uplc gradient program was used for the separation: 0-1 min, 10% b; 2.5 min, 72.5% b; 2.51-4.75 min, 95% b; 4.76-7 min, 10% b. the output of the uplc was fed to a xevo tq-s triple quadrupole mass spectrometry (ms/ms) system (waters corporation, milford, ma), which was used to ionize target molecules with electrospray ionization (esi+) and monitor the ion m/z fragmentation transitions from 360.1-245.2 for enrofloxacin quantification, 332.2-245.2 for ciprofloxacin quantification and 402.2-261.1 for moxifloxacin quantification in multiple reaction monitoring (mrm) mode. the retention times were 2.45, 2.38 and 2.58 minutes for enrofloxacin, ciprofloxacin and moxifloxacin, respectively. the calibration curve was fitted with a weighted (1/x 2 ) least-squares linear regression algorithm. the detection range was from 1 ng/ml to 5000 ng/ml for enrofloxacin and from 2.5 ng/ml to 5000 ng/ml for ciprofloxacin. the extraction yield was about 80-100% for all three antibiotics and the matrix effect enhanced both enrofloxacin and ciprofloxacin ms signals by 10% and 4%, respectively. the matrix effect enhanced moxifloxacin ms signals by 48%. both inter-and intra-batch accuracy were lower than 10% (% deviation) except that ciprofloxacin had 11% of inter-batch deviation at 2.5 ng/ml. both intra-and inter-batch precision were also lower than 10% coefficient of variation (cv), except that enrofloxacin and ciprofloxacin had 20-40% cv at 1 ng/ml and 2.5 ng/ml, respectively. the lower limit of quantification (lloq) for enrofloxacin was determined to be 1 ng/ml and the lloq for ciprofloxacin was determined to be 2.5 ng/ml. to assess survival in untreated mice, control and vad male and female mice were infected with s. typhimurium d23580 as previously described, and weights were monitored daily for up to 4 days post-infection. percent survival for each group (n = 8-9) was reported with a kaplan-meier survival curve. to assess male-specific survival with treatment conditions, control and vad male mice were infected with s. typhimurium as previously described. control mice and one group of vad mice were mock-treated with pbs. other vad groups received either enrofloxacin treatment alone (0.01 mg/ml) or co-treatment of enrofloxacin and vitamin a as previously described. percent survival of 6-16 mice/group at 8 days post-infection was assessed with a kaplan-meier survival curve. to assess treatment of vitamin a alone, control and vad male and female mice were infected with s. typhimurium as previously described. control mice were mock-treated with pbs, one group of vad mice was treated with vitamin a as previously described and a second group of vad mice received mock-treatment. percent survival of 12 mice/group at 13 days post-infection was assessed with a kaplan-meier survival curve. for all survival curve experiments, mice were weighed daily and humanely euthanized when they approached 20% weight loss or displayed signs of lethal morbidity, according to our institution's humane endpoints policy. statistical analyses were performed with graphpad prism 8 (graphpad, la jolla, ca). since data were found not to have a normal distribution, nonparametric analyses were utilized. significance of differences between two groups was determined with a mann-whitney test. significance of differences between multiple groups from a control group was determined with a kruskal-wallis test and a post-hoc dunn's multiple comparisons test. for the survival curves, statistical significance was determined using a log-rank (mantel-cox) test. data for weights, systemic bacterial levels, antibiotic consumed and plasma enrofloxacin concentration were reported as mean ± sem. a p<0.05 was considered significant. in order to model how malnutrition and associated vitamin a deficiency are risk factors for developing systemic s. typhimurium infection in people, we established a mouse model of vitamin a deficiency and disseminated disease (fig 1a) . mice were maintained on either a vad diet or a control diet containing adequate vitamin a. to model systemic infection, mice were infected with s. typhimurium d23580 via the intraperitoneal (i.p.) route. at 4d postinfection, systemic levels of s. typhimurium in liver, spleen and blood were significantly higher in vad mice compared to control (fig 1b) , and there was no sex difference observed in bacterial colonization (s1a fig). in a similar experiment with a necropsy at 5d post-infection, no sex differences in systemic bacterial burden was observed in control mice (s1b to generate vitamin a-deficient (vad) mice, c57bl/6 slc11a1 +/+ pregnant mice were put on a vad diet 2 weeks into gestation (a). at 3 weeks, pups were weaned onto either a vad or control diet. male (n = 7) and female (n = 7-8) mice on each diet were infected with s. typhimurium (stm) d23580 via the intraperitoneal (i.p.) route at 9 weeks of age and systemic bacterial burden was characterized by colony-forming units (cfu) in liver, spleen and blood collected at necropsy (nx) 4 days after infection (b). data represent mean ± sem. significance between control and vad mice was determined with a mann-whitney test of log-transformed values. a p<0.05 was considered significant. data demonstrated that our model of vitamin a deficiency could be utilized to study its effect on susceptibility to systemic s. typhimurium infection. it has been known for decades that vitamin a deficiency affects males and females differently [22] . to assess if this held true for our mouse model, both male and female mice were included. during maintenance on vad and control diets, mice were weighed weekly. while diet had no effect on weight gain of female mice, vad male mice gained significantly less weight than control mice starting at postnatal week 5 (fig 2a) . during the course of infection with s. typhimurium d23580, vad male mice had significant weight loss from day 0 to day 4 of infection, and 50% of mice in the vad male group exhibited lethal morbidity by day 4 ( fig 2b and 2c ). in contrast, vad females and control mice of both sexes maintained their weight over the course of the experiment (fig 2c) . while vitamin a deficiency had sex-specific effects on infection-induced morbidity ( fig 2b and 2c ), both male and female mice were similar in exhibiting significantly higher systemic burdens of s. typhimurium in vad compared to control mice (s1c fig). these results indicated that while vitamin a deficiency compromised control of systemic s. typhimurium infection in both sexes, male mice were affected more strongly, both by reduced growth while on the vad diet and by increased morbidity during infection. since there was no sex difference in systemic bacterial burden by day 4 post-infection (fig 1b) but vad males lost weight and had decreased survival compared to female mice (fig 2) , we investigated whether an earlier time point would yield sex differences in salmonella pathogenesis. further, we assessed if this trend would hold true for multiple strains of s. typhimurium, including d23580 (an st313 strain), and the st19 strains sl1344 and sara16. there was no sex difference in systemic bacterial burden for any of the s. typhimurium strains in mice fed a control diet (fig 3a) . however, at day 1 post-infection, male mice on a vad diet had significantly more or a trend towards a higher systemic burden of all three s. typhimurium strains than vad female mice (fig 3b) . these results suggest that vitamin a deficiency has a more marked effect in male mice on responses that control systemic replication of s. typhimurium in the early stages of infection. emerging multidrug-resistant s. typhimurium strains like d23580 are resistant to the firstline drugs for ints: ampicillin, chloramphenicol and trimethoprim/sulfamethoxazole. for this reason, the fluoroquinolone ciprofloxacin is one of the currently recommended treatments for ints [23] . however, emergence of fluoroquinolone resistance in salmonella strains and host factors like malnutrition can contribute to treatment failure [24, 25] . we chose to model antibiotic treatment failure with the fluoroquinolone enrofloxacin since it can be administered orally through the drinking water to mice and because we could measure it in the bloodstream. we first confirmed susceptibility of d23580 to enrofloxacin in vitro. the average mic was 0.04 μg/ml, which by clsi guidelines is susceptible [18] . we next sought to determine an in vivo mic. in order to assess the subtherapeutic concentration of enrofloxacin administered in the drinking water, systemic bacterial levels were assessed for male and female mice at a range of concentrations at day 5 post-infection. to model antibiotic treatment failure, enrofloxacin administration was delayed to day 2 post-infection. we used c57bl/6j mice fed a standard diet for titration experiments. no sex difference was observed in systemic bacterial levels (s2 fig) . a significant decrease in bacteria in liver, spleen and blood was seen at an enrofloxacin concentration of 0.10 mg/ml (fig 4a) . the concentration 0.01 mg/ml was subtherapeutic, as it failed to significantly decrease systemic s. typhimurium levels. the concentration 0.05 mg/ml was partly subtherapeutic, as it did not significantly decrease s. typhimurium levels in the liver. water weights and mouse weights were monitored daily during infection, and the vitamin a and antibiotics synergize against antibiotic resistant salmonella average amount of enrofloxacin consumed was calculated in μg/kg/day for days 2-3, 3-4 and 4-5. enrofloxacin consumption tracked with dosage, although 0.01 mg/ml and 0.05 mg/ml were not statistically significant from the untreated group (fig 4b) . taken together, these data demonstrated that 0.01 mg/ml and 0.05 mg/ml could model antibiotic treatment failure and thus were used for subsequent experiments with mice on special diets. to assess the therapeutic potential of vitamin a in the context of antibiotic treatment failure, systemic levels of s. typhimurium d23580 at day 4 post-infection were assessed for male and female mice on either control or vad diets with the following treatment groups: mocktreated, vitamin a only, enrofloxacin (0.05 mg/ml) only, and vitamin a and enrofloxacin cotreatment (fig 5a) . in vad male mice, co-treatment significantly decreased bacterial levels at all three systemic sites in comparison to mock treatment; however, individual treatments did not (fig 5b) . systemic colonization of vad male mice in all groups combined was significantly higher if the mouse had >10% weight loss than if the mouse had <10% weight loss (s3 fig). mock-treated vad male mice lost significant weight from day 0 to day 4, but none of the vitamin a and antibiotics synergize against antibiotic resistant salmonella treatment groups were significant (s4 fig). in contrast, vad female mice either showed no significant improvement with any treatment (spleen), or equal effectiveness with enrofloxacin alone and co-treatment (liver, blood) (fig 5c) . in male and female mice on a control diet, both enrofloxacin (0.05 mg/ml) and co-treatment yielded significant or trending decreases in systemic s. typhimurium (s5a and s5b fig). since 0.05 mg/ml enrofloxacin was successful, independent of vitamin a, at decreasing s. typhimurium in liver and blood in vad female mice and control mice for both sexes, a concentration of 0.01 mg/ml was also assessed for these groups. however, co-treatment of 0.01 mg/ml enrofloxacin and vitamin a yielded no benefit in vad female mice compared to mock-treated animals (s6 fig). for males on a control diet, co-treatment of 0.01 mg/ml enrofloxacin and vitamin a showed a slight decrease in splenic bacterial levels, but there was no difference in the liver and blood (s7a fig). there was no benefit of any therapy for females on a control diet (s7b fig). enrofloxacin is a common antibiotic used in veterinary medicine, and it is converted to ciprofloxacin by the liver [26] . no significant differences in plasma enrofloxacin or plasma ciprofloxacin levels were detected between enrofloxacin only and co-treated male (s8a fig) and as 0.01 mg/ml was subtherapeutic such that there was still lethal morbidity in vad male mice, these conditions were used to assess survival of vad male mice with treatments. mice were monitored for 8 days post-infection and euthanized upon showing signs of lethal morbidity, and a kaplan-meier survival curve was generated (fig 5d) . of the infected mice fed control diets, 100% of males survived. the percent survival of mock-treated vad males was only 25%, but this was improved with enrofloxacin only (41.7%) or co-treatment of vitamin a and enrofloxacin (66.7%). significance between each treatment group and survival of mice on a control diet was assessed with a log-rank (mantel-cox) test. further, for the 44 male mice 6-16 ). an enrofloxacin concentration of 0.01 mg/ml was used in drinking water treatment, and oral gavage treatments were given as previously described. significance was determined with pairwise comparisons between the control group and each other treatment group using a log-rank (mantel-cox) test ( � , p<0.05; ns, not significant). data from untreated controls are also included in fig 1. https://doi.org/10.1371/journal.pntd.0008737.g005 represented in the survival curve (fig 5d) , weight loss correlated with survival. over the course of the experiment, if a mouse lost less than 10% of its weight, it was more likely to have survived (16/21; 76% survival) than if a mouse had lost more than 10% of its weight (7/23; 30% survival). in a separate experiment with a longer time course grouping sexes, vitamin a treatment alone improved survival by 66.7% in vad mice (s9 fig). taken together, these data indicated that vitamin a synergized with subtherapeutic (0.05 mg/ml) enrofloxacin treatment to decrease systemic s. typhimurium levels and improve survival in vad male mice. epidemiologic studies have shown that vitamin a deficiency and disseminated non-typhoidal salmonella infections are co-endemic, disproportionately affecting sub-saharan africa [10, 27] . the high mortality rate of disseminated infection has been attributed to antimicrobial resistance of st313 strains that circulate regionally in sub-saharan africa, to genomic features of these strains associated with increased systemic dissemination, and to the high prevalence of co-morbidities that predispose to systemic disease [17, 23, 24] . the current study was designed as a preclinical trial in mice to assess the potential utility of vitamin a as an adjunct to antibiotic therapy. our results suggest a benefit of combined antibiotic treatment and vitamin a supplementation, with the effect being most apparent in male mice. it is well-appreciated that vitamin a supplementation can be a useful tool for disease prevention and treatment. in populations with a �1% prevalence of night blindness or a �20% prevalence of vitamin a deficiency, the who recommends vitamin a supplementation for children 12-59 months of age [28] . vitamin a supplementation was found to significantly reduce the risk of all-cause morbidity and mortality due to diarrhea [29] . in children 2 and under presenting with measles, the who-recommended treatment of two consecutive daily megadoses of vitamin a [30] reduces overall and pneumonia-specific mortality [11] and decreases duration of diarrhea and fever. however, the utility of vitamin a for bacterial bloodstream infections has not been assessed. s. typhimurium bloodstream infections typically present as a febrile illness; diarrhea is often absent or not a prominent symptom [10, 31, 32] . our results suggest that co-treatment with vitamin a and antibiotics may improve outcomes during bloodstream infections with drug-resistant s. typhimurium. despite who's recommendation for vitamin a supplementation, full coverage is still lacking in many countries. therefore, supplementing with vitamin a during episodes of febrile illness is a potential strategy to increase coverage and improve infection outcomes. a notable finding of our study was the sex-specific effect of vitamin a supplementation with antibiotics for treatment of s. typhimurium infection in mice. the picture emerging from recent studies of innate immunity is that multiple sex-specific differences impact resistance of males and females to infection. human males are more susceptible to many infectious diseases, whereas females are more at risk of developing an autoimmune condition [33] . in current events, males are at a higher risk of severe covid-19 infection [34] . males also have a higher risk of developing sepsis [35, 36] . a study on sepsis in children found that vitamin a deficiency was more common in the sepsis group as compared to control, and vitamin a deficiency rates were~80% in the subgroups of severe sepsis and septic shock [37] , indicating how a vad status can predispose to severe disease. the majority of patients with sepsis in this study were male. in addition, some genes encoding for innate immune molecules are located on the x chromosome [33] , suggesting a genetic basis for some of the differences observed. it is therefore possible that malnutrition and vitamin a deficiency may compromise the immune response to systemic salmonella infection in a sex-specific manner. we speculate that vitamin a may be playing the role of a host-directed therapy by boosting the immune response of vad male mice, synergizing with an initially subtherapeutic dose of antibiotic, and leading to better immunological control of infection. while the current study did not investigate the mechanisms underlying sex differences in the response to vitamin a supplementation, possible explanations include sex differences in innate immune cell function [33] , intestinal microbiota composition [38] , and hormone levels [39] . antibiotic treatment failure is the persistence of symptoms despite initiation of antibiotics. common causes include wrong diagnosis, infection with a resistant organism, or host failure such as malnutrition [25] . we modeled antibiotic treatment failure with a subtherapeutic enrofloxacin concentration that yielded no difference in systemic bacterial burden, but circulating antibiotic was still present in the mouse. it can be the joint action of antibiotics and host defense mechanisms that leads to clearance of bacteria and resolution of disease. while antibiotics are typically studied for their bactericidal or bacteriostatic activity against susceptible bacteria, they can also exist at subtherapeutic or subinhibitory concentrations, i.e. at concentrations below the mic. subinhibitory antibiotic concentrations can still affect both the host and the bacterium [40] . it has been proposed that some antibiotics may influence antiphagocytic cell-surface structures and lead to enhanced phagocytosis, modifying immune cell function [41] . for example, neutrophil phagocytosis and intracellular killing activity have been enhanced by pre-incubation with subinhibitory antimicrobial concentrations in some studies, although it depends on the antibiotic used and organism studied [42] . one study reported that subinhibitory levels of fluoroquinolone antibiotics like ciprofloxacin lead to enhanced binding of anti-lps antibodies to enterobacteriaceae like escherichia coli [43] . taken together, these findings suggest that vitamin a treatment may synergize with subtherapeutic antibiotics to enhance immune function in male mice. our study has limitations. we studied the effect of vitamin a co-treatment with only a single antibiotic, enrofloxacin, and a single clinical isolate, d23580. common treatments for ints have included first-line antibiotics of ampicillin, chloramphenicol and trimethoprim/sulfamethoxazole [23] . d23580 is resistant to all of these first-line drugs. it is sensitive to fluoroquinolones at certain concentrations in vitro and in vivo. however, future studies should incorporate s. typhimurium strains also resistant to fluoroquinolones, as this is an emerging issue [9] . in addition, it would be important to determine whether vitamin a supplementation can prevent treatment failure with other commonly used antibiotics. there are also limitations to using a mouse model of infection, including the low genetic variation of inbred mice used and the short infection time course permitted by the vad male mouse model. future studies could incorporate additional mouse lines, routes of infection and challenge doses. however, given the track record of using vitamin a as prevention and treatment for other infections, this information on whether vitamin a supplementation could be effective against disseminated infections with antibiotic-resistant salmonella might be best obtained in a clinical study. 1-7) . the same data is represented in two different ways. initially there were more vad male mice in the study but they reached lethal endpoint prior to day 5 and were likely to have a higher cfu than in the figure. c. levels of s. typhimurium in liver, spleen and blood at day 4 and 5 post-infection combined (n = 8-15). data shown in this figure are a re-analysis of data presented in s1a and s1b. data represent mean ± sem. significance between groups was determined with a mann-whitney test of logadditionally, vad mice treated with retinyl palmitate were placed on a control diet replete with vitamin a one-day after s. typhimurium infection. data represent percent survival of 12 mice per group from three independent experiments. pairwise comparisons between the control diet group and each other group was determined with a survival analysis log-rank (mantel-cox) test ( � , p<0.05). (tif) burden of infection on growth failure malnutrition and health in developing countries increased urinary retinol loss in children with severe infections vitamin a, infection, and immune function antimicrobial susceptibility testing of bacteria that cause gastroenteritis the global burden of nontyphoidal salmonella gastroenteritis global burden of invasive nontyphoidal salmonella disease the global burden and epidemiology of invasive non-typhoidal salmonella infections fluoroquinolone-resistant enteric bacteria in sub-saharan africa: clones, implications and research needs invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in africa vitamin a for treating measles in children guideline: updates on the management of severe acute malnutrition in infants and children. who guidelines approved by the guidelines review committee. geneva: world health organization vitamin a supplementation in infants and children vitamin a deficiency alters rat neutrophil function host-directed therapies for bacterial and viral infections tlr signaling is required for salmonella typhimurium virulence loss of multicellular behavior in epidemic african nontyphoidal salmonella enterica serovar typhimurium st313 strain d23580 m100: performance standards for antimicrobial susceptibility testing the estimation of doses of salmonella typhimurium suitable for the experimental production of disease in calves reference collection of strains of the salmonella typhimurium complex from natural populations defining the core genome of salmonella enterica serovar typhimurium for genomic surveillance and epidemiological typing the sex difference in vitamin-a metabolism fluoroquinolone resistance in salmonella: insights by whole-genome sequencing epidemic multiple drug resistant salmonella typhimurium causing invasive disease in sub-saharan africa have a distinct genotype recommendations for treatment of childhood non-severe pneumonia pharmacology of the fluoroquinolones: a perspective for the use in domestic animals global prevalence of vitamin a deficiency in populations at risk 1995-2005: who global database on vitamin a deficiency. geneva: world health organization guideline: vitamin a supplementation in infants and children 6-59 months of age. who guidelines approved by the guidelines review committee. geneva: world health organization vitamin a supplementation for preventing morbidity and mortality in children from six months to five years of age treating measles in children. department of immunization, vaccines and biologicals. geneva: world health organization non-typhoidal salmonella bacteraemia among hiv-infected malawian adults: high mortality and frequent recrudescence clinical presentation of non-typhoidal salmonella bacteraemia in malawian children sexual dimorphism in innate immunity sex differences in mortality from covid-19 pandemic: are men vulnerable and women protected? jacc case rep predictors of sepsis in moderately severely injured patients: an analysis of the national trauma data bank gender differences in human sepsis vitamin a deficiency in critically ill children with sepsis neonatal vitamin a supplementation and vitamin a status are associated with gut microbiome composition in bangladeshi infants in early infancy and at 2 years of age the early postnatal period, mini-puberty, provides a window on the role of testosterone in human neurobehavioural development role of antibodies and antibiotics in aerobic gram-negative septicemia-possible synergism between antimicrobial treatment and immunotherapy. reviews of infectious diseases subinhibitory antimicrobial concentrations: a review of in vitro and in vivo data influence of subinhibitory levels of antibiotics on expression of escherichia-coli lipopolysaccharide and binding of antilipopolysaccharide monoclonal-antibodies the authors thank greg barton for providing inbred c57bl/6-slc11a1 +/+ mice, robert hey key: cord-292596-ulu5y140 authors: lee, su hae; jee, seung wan; hwang, dae youn; kang, jong koo title: characterization of changes in global gene expression in the hearts and kidneys of transgenic mice overexpressing human angiotensin-converting enzyme 2 date: 2020-07-29 journal: lab anim res doi: 10.1186/s42826-020-00056-y sha: doc_id: 292596 cord_uid: ulu5y140 human angiotensin-converting enzyme 2 (hace2) has recently received a great attention due to it play a critical role as sars-cov receptor in the infection of human body. however, no further analysis for gene regulation has been performed in target tissues of model mice during hace2 overproduction. to characterize changes in global gene expression in the hearts and kidneys of rtta/hace2 double transgenic (dtg) mice in response to hace2 overexpression, total rna extracted from these tissues from dtg mice after doxycycline (dox) treatment was hybridized to oligonucleotide microarrays. briefly, dtg mice were generated by cross-mating pα-mhc/rtta tg mice with ptre/hace2 tg mice. the expression level of hace2 protein was determined to be high in hearts, kidneys, and brains of dtg mice, whereas lung, liver, and testis tissues expressed low levels. the level of hace2 was significantly enhanced in hearts and kidneys of the dox+dtg group compared to that in vehicle+dtg mice although consistent levels of mouse ace2 (mace2) remained in the same tissues. based on the microarray analysis of heart tissue, 385 genes were differentially expressed, including 168 upregulated and 217 downregulated, when comparing non-tg and vehicle+dtg mice, whereas 216 genes were differentially expressed, including 136 upregulated and 80 downregulated, between vehicle+dtg and dox+dtg mice. in the kidneys, 402 genes were differentially expressed, including 159 upregulated and 243 downregulated, between non-tg and vehicle+dtg mice. dox-treated dtg mice exhibited the differential expression of 4735 genes including 1636 upregulated and 3109 downregulated. taken together, these findings suggested that several functional groups and individual genes can be considered biomarkers that respond to hace2 overexpression in dtg mice. moreover, our results provided a lot of useful information to predict physiological responses when these dtg mice are applied as a susceptible model for novel coronavirus (sars-cov, covid-19) in both vaccine and drug development. angiotensin-converting enzyme 2 (ace2) is the first known human homolog of ace and was cloned from a human heart failure and human lymphoma cdna library [1, 2] . ace2 might play a pivotal role as a new element of the renin angiotensin system (ras) by reducing ang ii and increasing levels of ang1-7 [3] [4] [5] [6] and is distributed in a wide variety of tissues, including the brain, lung, heart, liver, kidney, and testis, as well as most cardiovascular-relevant tissues [7] [8] [9] [10] [11] . in the heart, myocardial infarction increases ace2 expression, which is localized to the vascular endothelium, smooth muscle, and cardiomyocytes of both rats and humans [12] . ace2 participates in the regulation of blood pressure and cardiac and renal functions and is associated with major cardiac and renal pathophysiological processes. especially, it has been reported that ace2 gene expression is upregulated in humans with heart failure [13] . it is also predominantly expressed in the proximal tubular brush border, distal tubules, and glomerular epithelial cells in the kidneys of humans, rats, and mice [14] [15] [16] [17] . the colocalization of ace2 with ang1-7 in renal tubules reveals the functional ability of ang1-7 to counteract the action of ang ii, and these vasodilator peptides might be a critical link, mediating regulatory feedback between ace and ace2 [18] [19] [20] . although the function of ace2 in the brain is poorly understood, there is considerable evidence of a role for ang1-7. previous studies have shown that ang1-7 is an important neuromodulator of cardiac baroreflex mechanisms [21] . the ace1/2 and neutral endopeptidase or neprilysin (nep) are zinc metallopeptidases [22] . however, more recently, ace2 has aroused considerable attention as a receptor for the coronavirus that causes severe acute respiratory syndrome and a protector against severe lung failure [23, 24] . in the past decade, functional studies on hace2 have continued using transgenic animals to clarify the mechanism related to heart and renal failures, as well as other pathophysiological conditions. first, in knockout mice, the genetic disruption of ace2 leads to severe cardiac contractile dysfunction, increases in ang ii levels, the upregulation of hypoxia-induced genes, and decreases in ace2 transcript and protein levels in the heart [25] . however, it is necessary to additionally study the effects related to hace2 expression levels to clarify whether increased levels can have a beneficial effect on cardiac and renal functions. myosin heavy chain (mhc), which is found in the contractile apparatus and is a major protein, is composed of two heavy chains and four light chains. in the cardiac muscle, two distinct mhc genes, which encode αand β-mhc isoforms, have been identified [26] . previously, the α-mhc gene promoter was used to direct tissue-and developmental-specific expression of the transgene in transgenic (tg) animals [27] . further, there are many transcriptional regulation systems, and tetracycline regulatory systems have been widely used for conditional gene expression. the tetracycline-controlled transactivator (tta) is generated by fusing the dnabinding domain of the tetracycline-resistance operon (tetr) encoded by tn10 of e. coli with the transcriptional activation domain of vp16 of herpes simplex virus [28] . there are two basic variants of this, tta and reverse tta (rtta) systems. to compensate for the tta system, which requires long-term administration of doxycycline (dox) for induction of the transgene, the other inducible system, namely rtta (tet-on system), has been developed. this system requires two dna constructs, a transcriptional regulatory unit and the responsive element teto sequences linked to a p cmv -derived target gene. in the presence of dox, rtta binds teto sequences and p cmv , which activates the target gene. in contrast, rtta does not bind teto and the target gene is not transcribed in the absence of dox [29, 30] . the doxinducible gene regulatory system allows for the tight and adjustable control of a transgene of interest to study organ development and disease pathogenesis. previously, tg rats expressing human ace under the control of the rat cardiac myosin light chain 2 (mlc2) promoter and tg mice expressing human ace2 under the control of the mouse cardiac α-mhc promoter have been generated [31, 32] . these tg mice had a high incidence of sudden death and rhythmic disturbances with sustained ventricular tachycardia including terminal ventricular fibrillation and heart block. however, in surviving older mice, spontaneous downregulation of the ace2 transgene was observed, which was associated with the restoration of nearly normal conduction, rhythm, and connexin expression. because sudden death occurs earlier in higher-expressing transgenic lines, a promoter that can be regulated, such as the tet-on or off system, might be useful to examine cardiac and renal pathophysiology at the basal level. the aim of this study was to characterize changes in global gene expression in the hearts and kidneys of dtg mice, created with pα-mhc/ rtta and ptre/hace2 vectors, in response to the overproduction of hace2 protein. first, pα-mhc/rtta was constructed by fusing the rtta-m2 gene with the α-mhc promoter (gene bank accession no. u71441). the puhrt62-1 was a gift from dr. wolfgang hillen at the university of heidelberg, germany [33] . this plasmid contains a mutagenized rtta-m2 fragment harboring the s12g, e19g, and a56p mutations. the α-mhc sequence was amplified by pcr, with the genomic dna as a template, which was isolated from the tail of bdf2 mice. the following primers were used for the amplification: the sense primer, 5′-ctcct tcctt gttgc atctt cc-3′ (corresponding to nucleotides 2,278-2,299 of α-mhc), and the antisense primer, 5′-cagga ggaag atgga gaaga cag-3′ (corresponding to nucleotides 4,578-4,600 of α-mhc). the amplified α-mhc product was cloned into pgem-t (pα-mhc-t). the α-mhc fragment obtained by the digestion of pα-mhc-t with saci and sacii was cloned into puhdrtta2s-m2-splice, in which the human cmv promoter has been eliminated via digestion with xhoi and sacii (pa-mhc/rtta). second, ptre/hace2 was constructed by inserting the hace2 gene into the noti site within the multiple cloning site of ptre2hyp (clontech laboratories inc., mountain view, ca, usa). the ptre2hyp gene contains a tet response element (tre), which consists of seven copies of the 19-bp tetracycline operator sequence (teto) and hygromycin resistance genes. the hace2 cdna was amplified by pcr, using a sense primer (5′-gacga tgtca agctc ttcct g-3′) with nucleotides 100-120 and an antisense primer (5′-gccta cagat cttct tcaga aataa gtttt tgttc aaagg tctga acatc atcag tg-3′; lowercase letter, c-myc tag) with nucleotides 2,494-2,521 based on hace2 (gene bank accession no. nm_021804). full-length rna was used as the template, which was isolated from hek-293 cells (atcc crl-1573). the amplified hace2 product was inserted into pgem-t (phace2-t; fig. 1a and b). the experimental protocol for dtg mice was carefully reviewed based on ethical and scientific care guidelines and approved by the national institute of food and drug safety evaluation-institutional animal care and use committee (nifds-iacuc; approval no. nitr0631). all c57bl/6nkorl and dba/2korl mice at 6 weeks of age were provided by the department of laboratory animals resources in nifds (cheongju, korea). all mice used in this study were provided with ad libitum access to water and an irradiated standard chow diet (purina mills inc., pyeongtaek, korea). mice were housed in cages under specified pathogen free (spf) condition under a strict light cycle (light on at 06: 00 h and off at 18:00 h). all mice were handled in an accredited nifds animal facility in accordance with the aaalac international animal care policies (accredited unit-the ministry of food and drug safety: unit number-001492). for the first lineage of tg mice, a linear 5.8-kb α-mhc/ rtta fragment was microinjected into the pronucleus of fertilized eggs of bdf1 mice, which had been obtained by mating c57bl/6nkorl (males) and dba2korl (females) mice. for the second lineage of tg mice, the linear 7.9-kb fragment of tre/hace2 was microinjected into the pronucleus of a fertilized embryo after dilution to a concentration of 4 ng/μl. microinjection was performed using microscopy (nikon, tokyo, japan) and a micromanipulator (narishge, tokyo, japan). each tg line was established by back crossing the founder mice with a parental strain of c57bl/6nkorl mice. the dtg mice were obtained by crossing the first lineage of α-mhc/rtta tg mice with the second lineage of tre/ hace2 tg mice. the single and double tg founder mice were back crossed onto the parental strain of the c57bl/6nkorl background to establish homogenous tg lines. the transgene was identified by dna-pcr analysis of the genomic dna isolated from the tail of 4-week-old founder mice. the precipitated dna was separated by centrifugation at 15,000 rpm for 10 min. after washing in 700 μl 70% et-oh, dna was dried for 15 min and dissolved in 200 μl of distilled water. the α-mhc/rtta gene was amplified as a template using the sense primer (5′-ctgtc ttctc catct tcctc ctg-3′) with a complementary α-mhc promoter ranging from 4578 to 4600 nucleotides and an antisense primer (5′-caggg taggc tgctc aactc-3′) with a complementary rtta gene ranging from 888 to 908 nucleotides. the tre/hace2 gene was also synthesized as a template using a sense primer (5′-gacga tgtca agctc ttcct g-3′) and antisense primer (5′-catat aatgg cctca gctgc-3′) with a complementary hace2 gene ranging from 100 to 120 and from 625 to 644 nucleotides, respectively. pcr amplification was carried out in a thermal cycler (perkin elmer, norwalk, ct, usa) using the following cycling conditions: one cycle: 94°c, 4 min; 27 cycles: 30 s at 94°c, 1 min at 62°c, and 45 s at 72°c; one elongation step of 7 min at 72°c. the dtg mice were distributed into two groups (3-5 mice per group), namely vehicle and dox treatment. drinking water containing 2 mg/ml dox (sigma-aldrich co., st. louis, mo, usa) was administered to mice of the dox-treated group for 4 weeks, whereas tap water was administrated to mice of the vehicle group for the same period. the brain, heart, lung, liver, kidney, and testis tissues were collected from mice of subset groups and homogenized with 1% nnonidet p-40 in 15 mm nacl, 10 mm tris hcl, and 1 mm edta supplemented with a protein inhibitor mixture (roche, basel, switzerland), which was followed by centrifugation at 4°c for 15 min. for western blot analysis, the proteins were separated by electrophoresis using a 4-20% gradient sds-polyacrylamide gel for 2 h and then transferred to a nitrocellulose membrane with transfer buffer containing 25 mm tris-base, 192 mm glycine, and 20% methanol at 45 v for 2 h. membranes were blocked with 3% (w/v) non-fat dried milk in pbs (137 mm nacl, 2.7 mm kcl, 10 mm na 2 hpo and 2 mm kh 2 po 4 ) solution containing 0.05% tween-20 (sigma-aldrich co.). the membrane was washed with pbs and incubated overnight 4°c with primary antibodies as follows: anti-human ace2 (santa cruz fig. 1 reverse tet promoter-controlled transactivator (rtta) and hace2 vectors and identification of α-mhc/rtta and tre/hace2 transgenes. a construction of the pα-mhc/rtta and ptre/hace2 expression vectors. rtta and hace2 (human ace2) were placed under the control of the α-mhc and tre promoter, respectively. two independent lineages of transgenic (tg) mice were produced and mated together to obtain the double tg (dtg) mice. in the dtg mice, the expression of the hace2 is induced by rtta in the presence of doxycycline (dox). the arrow (--->) indicates transcription. b features of the tet response element (tre) promoter sequence. the tre promoter is contained with seven copies of the teto sequence, a tata box, and an hcmv promoter. c the genomic dna was isolated from the tail of the founder mouse, and the 174-bp and 545bp products were shown in the dual transgenic mice carrying the α-mhc/rtta and tre/hace2 transgenes, respectively biotechnology inc., santa cruz, ca, usa), anti-human ace (santa cruz biotechnology inc.), and anti-α-tubulin (sigma-aldrich co.). after washing, each antigen-antibody complex was visualized with biotinylated secondary antibodies as follows: goat anti-mouse igg (h+l) hrpconjugated antibody, rabbit anti-goat igg (h+l) hrpconjugated antibody, and goat anti-rabbit igg (h+l) hrp-conjugated antibody (zymed laboratories inc., san francisco, ca, usa) at a 1:1000 dilution in pbs buffer containing 3% non-fat dried milk/pbs buffer at room temperature for 1 h. immunoreactive proteins were detected by an enhanced chemiluminescent substrate (ecl, amersham pharmacia biotech, inc., amersham, england) reaction, which was followed by exposing the membranes to hyperfilm ecl. the hearts and kidneys from non-tg, vehicle+dtg, and dox+dtg mice were used for the isolation of total rna using rnazol (tel-test inc., friendswood, texas, usa) according to the manufacturer's instructions. the frozen tissues were minced with scissors and homogenized in rnazol b solution using a teflon glass homogenizer. the rna pellet was suspended in depc-treated dh 2 o and purified using a qiaquick purification kit (qiagen inc., chatsworth, ca, usa). the integrity of the 18s/ 28s rrna was analyzed using a bioanalyzer 2100 (quality agilent technology inc., santa clara, ca, usa), with the rna quality checked based on the ratio of absorbance at 260 nm to that at 280 nm using a biophotometer (hamburg-eppendorf, hamburg, germany). the integrity of each rna sample was confirmed by 1% agarose gel electrophoresis, which showed the presence of intact 18s and 28s ribosomal bands. crna synthesis and labeling were performed using a chemiluminescent rt-ivt labeling kit (applied biosystems, foster city, ca, usa) according to the manufacturer's instruction. individual samples were submitted in randomly assigned pairs representing tissues from non-tg and tg mice. three micrograms of total rna was used to synthesize cdna. double stranded cdna was synthesized for 2 h at 16°c in a reaction mixture containing nuclease free water, 5× 2 nd strand buffer, and 2 nd strand enzyme and then purified using a purification column. finally, the biotinylated crna was generated from the cdna using a bioarray crna high yield rna transcript kit containing purified double stranded cdna, 5× ivt buffer mix, dig-utp and ivt enzyme mix. changes in global gene expression in the hearts and kidneys of mice overexpressing human ace2 were analyzed using the mouse genome survey microarray (applied biosystems) containing oligonucleotide probes for 44, 000 genes. the crna was fragmented in fragmentation buffer for 30 min at 60°c prior to chip hybridization. fifteen micrograms of fragmented crna was then added to the hybridization cocktail. each sample was hybridized to a separate oligonucleotide array for 16 h at 55°c in the genechip hybridization oven 640. after hybridization, the solution was removed and the slides were washed twice with 2× ssc containing 0.1% sds for 5 min at 42°c. the slides were incubated for 20 min with anti-dig-ap in cl blocking buffer and then developed using the chemiluminescence substrate. thereafter, the hybridized arrays were scanned using an abi700 analyzer. scanning and basic analyses were performed using geneplex software release 1.0 (istech inc., seoul, korea). logged gene expression ratios from the fluorescent intensity of each spot were normalized based on regression. tests for significance were performed using a one-way anova test of variance (spss for windows, release 10.01, standard version, and chicago, il, usa). all values are reported as the mean ± standard deviation (sd). microarray data and the statistical significance of differential expression were assessed by hypergeometric distribution analysis. p values less than 0.05 were considered significant. first, we produced one male founder mouse carrying the pα-mhc/rtta construct and one female founder mouse carrying the tre/hace2 construct using microinjection techniques. these showed different rates of transgene insertion into the chromosome at 18 and 7%, respectively. moreover, α-mhc/rtta and tre/hace2 single tg mice with a bdf2 background were backcrossed with c57bl/6nkorl mice to change their background. during this process, α-mhc/rtta and tre/hace2 constructs were transmitted into the genomes of their offspring of both sexes at a rate of approximately 50% hemizygous animals based on mendelian inheritance. furthermore, both construct genes were transmitted into the genomes of dtg mice at a 16.3% efficiency. to test whether the hace2 transgene was expressed under the control of rtta in a tissue-specific manner, its expression level was detected in various tissues including the brain, heart, lung, liver, kidney, and testis of dtg mice treated with 2 mg/ml dox for 4 weeks. the expression level of hace2 was higher in the heart, kidney, and brain than in other organs, although the highest level was detected in the heart. a low level of hace2 protein expression was observed in the lung, liver, and testis (fig. 2) . however, any significant expression of hace2 protein was not detected in heart and kidney of non-tg and c57bl/6 mice (data not shown). therefore, these results indicate that the hace2 protein might be successfully expressed in various tissues of dtg mice through regulation of the dox-controlled rtta system. to compare the expression level of mace and hace2 proteins in the heart and kidney with or without dox treatment, both proteins were detected with specific antibodies in these tissues of non-tg, ve-hicle+dtg, and dox+dtg mice at the age of 10 weeks. a similar expression pattern for both proteins was observed in the heart and kidney. the hace2 gene was highly expressed in only dox+dtg mice, whereas in non-tg and vehicle+dtg groups, expression was maintained at low level. however, the expression level of mace protein remained constant regardless of hace2 expression and dox treatment ( fig. 3a and b) . thus, these results suggest that hace2 protein can be successfully overexpressed in the hearts and kidneys of dtg mice after dox treatment. further, it was suggested that these organs would have great potential for microarray analysis to characterize the changes in global genes during overexpression of the hace2 protein. to analyze the differential expression of global genes during hace2 overproduction in the heart and kidney, microarray data were normalized based on the lowest values obtained from the experiments repeated in triplicate. the normalized log ratios of various genes in each experiment were used to compare relative expression between two independent experiments. based on these arbitrary differences, a substantial number of genes were expressed at elevated or reduced levels in the tg group before and after dox treatment. in the heart, 385 transcripts were selected as differentially expressed genes between non-tg and vehicle+dtg groups based on a 2-fold change in expression, whereas 216 differential transcripts were identified between vehicle+dtg and dox+dtg groups. among the former 385 genes, 168 were upregulated and 217 were downregulated in the heart tissue of the dtg group as compared to levels in the non-tg group before dox treatment. moreover, 216 genes, including 136 upregulated and 80 downregulated, were differentially expressed in the dtg group after dox treatment (table 1 ). in the kidney, a total of 402 genes, including 159 upregulated and 243 downregulated genes, were changed in the vehicle+dtg mice compared to levels in non-tg mice. furthermore, after dox treatment for 4 weeks, 4735 genes, comprising 1636 upregulated and 3109 downregulated, were altered in the dtg group based on a 3-fold change in (table 1) . overall, these results suggest that hace2 overproduction is more closely related to differentially expressed genes in the kidney than in the heart. to analyze the kegg pathways associated with hace2regulated gene expression in the heart and kidney of non-tg and dtg mice based on dox treatment, genplex software release 1.0 was used. the results are presented in tables 2 and 3 . genplex identified 15 pathways that were associated with significant changes in the heart ( table 2 ). as presented in table 2 , the largest numbers of genes in the heart were mainly associated with cytokine-cytokine receptor interaction, the calcium signaling pathway, apoptosis, and ecm-receptor interaction. in the kidney, 17 pathways were identified (table 3) . especially, genes involved in wnt signaling were highly changed, followed by those related to oxidative phosphorylation, prostate and colorectal cancer, the tgf-beta signaling pathway, and apoptosis. furthermore, we characterized the genes that were downregulated and upregulated by hace2 overproduction in the hearts and kidneys of dox+dtg mice. of the 136 upregulated genes in the heart, the highest difference was detected for cap1, followed by pik3c2g, syt16, hecw1, and tmod2, whereas downregulated genes included calgranulin a, calgranulin b, paip1, ptx3, and hspa1a. in the kidney, gabrg1 was associated with the highest increase, followed by wdr66, ppp1r14c, bin1, and mef2c among 1636 upregulated genes, but slc16a4, fgfr3, slc16a10, stam2, and mrps2 were significantly decreased after hace2 overproduction. taken together, this showed that hace2 overexpression is mainly associated with cellular pathways related to cytokine-cytokine receptor interactions, the calcium signaling pathway, apoptosis, ecm-receptor interactions, wnt and tgfbeta signaling, cancer, and oxidative phosphorylation in the hearts and kidneys of dtg mice. recently, advances in molecular biology have enabled functional analyses of interesting genes by using transgenic animals and stable cell lines with constant gene expression. however, if the transgene is related to the embryogenesis, the animal might be genetically predisposed to tolerate the effects of the transgene products [34] . to overcome this problem, it is necessary to develop transgenic animals in which transgene expression can be induced at selected time points but kept silent for an extended period. conditional gene expression has been achieved using a variety of model systems [35, 36] . non-regulatable promoters in tg animals cannot direct the genetic switches to upregulate or downregulate expression from the promoter-linked target gene, and therefore, it is impossible to know how the target gene interacts and regulates the pathophysiological processes at both the basal and inducible level. the tet-on and tet-off expression systems are the most widely used inducible regulatory systems. in the tet-on system, the reverse tetracycline-controlled transactivator (rtta) acts as an activator of gene transcription [29, 37] . dox binds the dox-binding site of the rtta protein, which represents random mutagenesis of the tta fusion protein between the tet repressor dna-binding domain (207 amino acids) and the vp-16 transcriptional activation domain (130 amino acids) of the herpes simplex virus. the dox-rtta complex then binds the tet sequence, which brings the vp-16 activation domain in close proximity to the minimal human cmv promoter, thereby activating the target gene in the presence of dox. indeed, rtta under the control of the cmv promoter was previously shown to activate the expression of a target gene in various organs [38, 39] . in this study, the inducible tg mice expressing α-mhc-controlled, rtta-regulated hace2 were generated to address the hypothesis that unregulated expression of the hace2 transgene leads to the generation of defects including cardiac contractile dysfunction, rhythmic disorders, and sudden death. first, single tg mice expressing α-mhc-controlled rtta and hace2 were successfully developed by directly introducing each gene into fertilized eggs. tg mice were mated to induce rtta-regulated hace2 expression, which generated founder mice in which hace2 expression could be increased by dox. in the established tg line, neither the location of the transgenes in the genome nor the locus was impacted by gestation or neonatal imprinting. because of this, all offspring in this experiment exhibited the transmission of α-mhc/rtta and tre/hace2 genes into their genomes in approximately 50% of hemizygotes. ace is considered the central enzyme in the ras, converting ang i to ang ii. however, the identification of novel ras components such as ace2 and collectrin, a homologue of ace, capable of degrading ang ii and forming ang1-7, has emphasized the increasing complexity and multiplicity of biochemical pathways forming the ras. in a previous study, non-regulatable promoters have been used to create transgenic rats or mice expressing ace or ace2 genes under control of the rat cardiac mlc2 or mouse cardiac α-mhc promoter [7, 32] . unexpectedly, the loss of ace2 in mice results in profound contractile dysfunction. however, the complete rescue of the heart phenotype in ace/ace2double mutant mice indicates that ace expression has a causative role in the onset of heart dysfunction [25] . because ace2 is expressed in the vascular endothelium and not in cardiac myocytes, local increases in ang ii might lead to vasoconstriction, resulting in hyperperfusion and hypoxia in the myocardium. it has been established that ang ii can induce oxidative stress in endothelial cells, and thus, its increase could result in dysfunction of the vascular endothelium via the induction of oxidative stress in the heart [25, 40, 41] . in this study, a heart-specific promoter system was employed to induce rtta-regulated hace2 expression at a physiologically relevant site. hace2 protein was abundantly expressed in heart and kidney tissue of dox+dtg mice, although this protein was also detected in several other tissues. these results suggest that the binding of dox to the rtta protein might successfully induce hace2 expression in the heart, kidney, and other organs of dtg mice. however, any significant histopathological changes was not observed in heart and kidney of dox+dtg mice after induction of hace2 expression for only 4 weeks (supplement fig. 1) . interestingly, the ras can be seen as a dual function system in which vasoconstrictor or vasodilator actions are primarily driven by the ace/ace2 balance [42] [43] [44] . elevated ace2 activity concomitant with reduced ace activity leads to a decrease in ang ii levels by converting it into ang1-7, which in turn promotes vasodilatation [45] . according to this concept, dox-driven hace2 expression resulted in a decrease in ace levels in both hearts and kidneys of dox-inducible tg mice compared to that in non-tg mice. these results imply that the effects of hace2 expression, via the formation of ang1-7, have a counter regulatory role in ace activity in heart and kidney functions. the present study also investigated gene profiles to offer critical insight into complexity of the ras, as well as heart and renal failure related to hace2 overexpression. inducible tg mice overexpressing hace2 and non-tg mice were used to address the hypothesis that genes many genes involved in cardiovascular and renal disorders are modulated as compared to levels in dox+dtg and non-tg mice. the results identified 136 genes from the hearts of dox+dtg mice that were significantly upregulated and 80 genes that were downregulated compared to levels in the hearts of vehicle+dtg mice. a total of 216 genes associated with cellular pathways comprising 15 categories mainly related to ecmreceptor interaction, cytokine-cytokine receptor interaction, apoptosis, the calcium signaling pathway, and the tgf-beta signaling pathway were identified. of these genes, s100a8 and s100a9, encoding s100 calciumbinding proteins that bind several types of proinflammatory cytokines, such as tnf-alpha, il-6, and il1beta, to form the proinflammatory cytokine complex in acute inflammation, play a role in calcium-mediated signaling [46, 47] . ptx3, a pentraxin-related gene, is induced in vascular smooth muscle cells via atherogenic modified low density [48] and acts as a nonredundant regulator of tissue damage in acute myocardial ischemia and reperfusion [49] . thus, these results suggest that the overexpression of hace2 might be involved in acute myocardial infarction and ischemia in the hearts of inducible rtta-regulated tg mice. in the kidney, 1636 genes in dox-treated tg mice were upregulated and 3109 genes were downregulated. these genes were also associated with cellular pathways comprising 17 categories related to apoptosis, the calcium and wnt signaling pathway, oxidative phosphorylation, cancer, and the tgf-beta signaling pathway. especially, hace2 expression was mainly associated with the cellular pathway related to cytokine-cytokine receptor interactions, the calcium signaling pathway, apoptosis, ecm-receptor interactions, wnt and tgf-beta signaling, cancer, and oxidative phosphorylation, and rtta-controlled hace2 expression regulates the expression of genes related to binding, receptor, transferase, oxidoreductase, and hydrolase activities in the hearts and kidneys of dtg mice. however, our study provides limited information since only mrna level were analyzed to characterize global gene expression in response to hace2 overexpression. furthermore, protein expression analyses and molecular mechanism studies are necessary to conform the effects of identified genes in future study. taken together, we produced rtta/hace2 dtg mice that overexpress the hace2 gene based on a doxinducible system and analyzed the changes in global gene expression in heart and kidney tissue using a microarray. the results of the present study suggest that hace2 protein was successfully expressed in the heart, kidney, and brain of dtg mice after dox treatment. moreover, our microarray analysis was able to identify several functional groups of genes and individual genes that respond to hace2 overexpression in the hearts and kidneys of tg mice. however, additional work should address the extent to which these changes are correlated with hace2 expression levels to determine whether beneficial effects can be obtained by reducing expression levels or if the increased expression of ace2 at any level is deleterious with respect to cardiac and renal disease. furthermore, it will be necessary to study the functions of differentially expressed genes, which could represent targets for the development of novel drugs, using pharmacoproteomics. supplementary information accompanies this paper at https://doi.org/10. 1186/s42826-020-00056-y. additional file 1. additional file 3. abbreviations ace2: angiotensin-converting enzyme 2; mhc: myosin heavy chain; rtta: reverse tetracycline-controlled transactivator; tetr: tetracyclineresistance operon; tre: tet response element a novel angiotensin-converting enzyme-related carboxypeptidase (ace2) converts angiotensin i to angiotensin 1-9 a human homolog of angiotensin-converting enzyme. cloning and functional expression as a captopril-insensitive carboxypeptidase counter regulatory actions of angiotensin-(1-7) angiotension-(1-7) and antihypertensive mechanisms the renin-angiotensin system and diabetes: an update. vasc health risk manag prevention of angiotensin ii-induced cardiac remodeling by angiotensin differential expression of neuronal ace2 in transgenic mice with overexpression of the brain renin-angiotensin system angiotensin ii at1 receptors regulate ace2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats tissue distribution of ace2 protein, the functional receptor for sars coronavirus. a first step in understanding sars pathogenesis distribution of angiotensin-(1-7) and ace2 in human placentas of normal and pathological pregnancies age-and gender-related difference of ace2 expression in rat lung myocardial infarction increases ace2 expression in rat and humans ace2 gene expression is upregulated in the human failing heart organ-specific distribution of ace2 mrna and correlating peptidase activity in rodents characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensinconverting enzyme: implications for albuminuria in diabetes angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ace2-dependent processing of angiotensin ii ace and ace2: their role to balance the expression of angiotensin ii and angiotensin temporal-spatial expression of ang-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats the role of ace2 in pulmonary diseases--relevance for the nephrologist pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveries a crucial role of angiotensin converting enzyme 2 (ace2) in sars coronavirus-induced lung injury angiotensinconverting enzyme 2 is a functional receptor for the sars coronavirus angiotensin-converting enzyme 2 is an essential regulator of heart function molecular characterization of two myosin heavy chain genes expressed in the adult heart tissuespecific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice tight control of gene expression in mammalian cells by tetracycline-responsive promoters transcriptional activation by tetracyclines in mammalian cells tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling over-expression of angiotensin converting enzyme-1 augments cardiac hypertrophy in transgenic rats heart block, ventricular tachycardia, and sudden death in ace2 transgenic mice with downregulated connexins exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity conditional control of gene expression in the mouse tools for targeted manipulation of the mouse genome tetracycline-inducible expression systems: new strategies and practices in the transgenic mouse modeling generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtta2s-m2 doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice generation of the regulatory protein rtta transgenic mice vascular protective effects of angiotensin converting enzyme inhibitors and their relation to clinical events endothelial dysfunction in cardiovascular diseases: the role of oxidant stress liver fibrosis: a balance of aces? emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-mas receptor axis: more than regulation of blood pressure? angiotensin-(1-7) and the renin-angiotensin system the therapeutic potential of angiotensin-(1-7) as a novel renin-angiotensin system mediator possibility of formation of the s100a8/a9-proinflammatory cytokine complexes in vivo in acute inflammation and their functional roles molecular basis of the complex formation between the two calcium-binding proteins s100a8 (mrp8) and s100a9 (mrp14) modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells cardioprotective function of the long pentraxin ptx3 in acute myocardial infarction publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations we thank the animal technician, seon m. choi, and mee k. jang for directing the animal care and use at the division of laboratory animal resources, njfds at korea. availability of data and materials available. the authors declare that there are no financial conflicts of interest with respect to the publication of these results. key: cord-003315-r1wkx0ml authors: jacobs, sophie; wavreil, fanny; schepens, bert; gad, hans henrik; hartmann, rune; rocha-pereira, joana; neyts, johan; saelens, xavier; michiels, thomas title: species specificity of type iii interferon activity and development of a sensitive luciferase-based bioassay for quantitation of mouse interferon-λ date: 2018-11-01 journal: j interferon cytokine res doi: 10.1089/jir.2018.0066 sha: doc_id: 3315 cord_uid: r1wkx0ml the type iii interferon (ifn-λ) family includes 4 ifn-λ subtypes in man. in the mouse, only the genes coding for ifn-λ2 and -λ3 are present. unlike mouse and human type i ifns (ifn-α/β), which exhibit strong species specificity, type iii ifns were reported to act in a cross-specific manner. we reexamined the cross-specificity and observed that mouse and human ifn-λ exhibit some species specificity, although much less than type i ifns. mouse ifn-λ3 displayed clear species specificity, being 25-fold less active in human cells than the closely related mouse ifn-λ2. this specificity likely depends on amino acids in α helices a and f that diverged from other ifn-λ sequences. human ifn-λ4, in contrast, retained high activity in mouse cells. we next developed a firefly luciferase-based reporter cell line, named fawa-λ-luc, to detect ifn-λ in biological fluids with high specificity and sensitivity. fawa-λ-luc cells, derived from mouse epithelial cells that are responsive to ifn-λ, were made nonresponsive to type i ifns by inactivation of the ifnar2 gene and strongly responsive to ifn-λ by overexpression of the mouse ifnlr1. this bioassay was as sensitive as a commercially available enzyme-linked immunosorbent assay in detecting mouse ifn-λ in cell culture supernatant, as well as in serum and bronchoalveolar lavage samples of virus-infected mice. the assay also enabled the sensitive detection of human ifn-λ activity, including that of the divergent ifn-λ4 with a bias, however, due to variable activity of ifn-λ subtypes. t ype i and iii interferons (ifns) are typically produced in response to viral infection, and these cytokines induce an antiviral state in target cells (isaacs and lindenmann 1957; kotenko and others 2003; sheppard and others 2003) . type i ifns consist of 13 ifn-a subtypes and ifn-b, -o (human) , and -z (mouse) -e and -k. the type iii family of ifns in humans comprises 3 functional genes that express ifn-l1 (il-29), ifn-l2 (il-28a), and ifn-l3 (il-28b) (kotenko and others 2003; sheppard and others 2003) . a fourth ifn-l subtype (ifn-l4) is present in a part of the human population, depending on a dinucleotide frameshift polymorphism upstream of the ifnl3 gene, which creates or disrupts the open reading frame (orf) encoding ifn-l4 (prokunina-olsson and others 2013) . in the mouse, ifnl1 is a pseudogene, and only ifn-l2 and ifn-l3 are expressed. unlike mouse and human type i ifns that exhibit strongly species-specific activity (veomett and veomett 1979) , type iii ifns were reported to act on cell types from both origins (lasfar and others 2006; hermant and others 2014) . the type i ifn family members signal through a unique heterodimeric receptor (ifnar), composed of the ifnar1 and ifnar2 subunits. type iii ifns engage a distinct receptor (ifnlr), composed of 2 chains: the ifn-l-specific ifnlr1, and il10rb which is shared by other il10-related cytokines (kotenko and others 2003; sheppard and others 2003) . while ifnar is ubiquitously expressed, ifnlr is expressed by a restricted range of cell types and mostly acts at mucosal surfaces. epithelial cells are well-established targets of ifn-l in vivo (sommereyns and others 2008) , although some immune cells such as neutrophils and dendritic cells have been characterized as ifn-l responders (koltsida and others 2011; blazek and others 2015; broggi and others 2017; espinosa and others 2017) . although type i and type iii ifns act on distinct receptors, they activate a similar jak-stat transduction pathway, leading to the phosphorylation of stat1 and stat2 that associate with irf9 to form the isgf3 complex. type i and type iii ifn signaling leads to the transcription of an overlapping set of ifn-stimulated genes (isgs) (dumoutier and others 2004; ank and others 2006) . type i ifn in biological samples can be measured by a variety of bioassays, but efficient techniques for type iii ifn quantification are largely lacking. enzyme-linked immunosorbent assay (elisa) for ifn-l detection is time and cost intensive and fails to detect ifn-l4. conventional cytopathic effect reduction bioassays to quantify antiviral activity as a proxy for the presence of ifn require the manipulation of infectious virus. luciferase reporter cells that have previously been used for recombinant human ifn-l detection were still responsive to type i ifn and would not allow specific ifn-l detection from biological samples (uze and monneron 2007) . in this work, we reexamined the species specificity of ifn-l activity, and we developed a very sensitive luciferase-based bioassay specific for type iii ifn detection. the lkr10 cell line (kind gift from guido bommer, de duve institute, brussels, belgium) is derived from lung adenocarcinoma tissues from a k-rasla1 mouse ( johnson and others 2001) . a549 cells (atcc) were kindly provided by pierre coulie, balb/3t3 fibroblasts (aaronson and todaro 1968) those cells, and derivatives, were maintained in dulbecco's modified eagle's medium (dmem) (lonza, vervier, belgium) containing 4.5 g/l glucose, supplemented with 10% fetal calf serum (fcs) (sigma-aldrich, overijse, belgium). african green monkey kidney (vero) cells (atcc) were cultured in dmem supplemented with 10% fcs, nonessential amino-acid, l-glutamine, and sodium pyruvate. bhk-21 cells (atcc) were cultured in glasgow's minimum essential medium (gibco; thermo fisher scientific, asse, belgium) supplemented with 10% newborn calf serum and 2.95 g/l tryptose phosphate broth. all media were supplemented with 50 u/ml penicillin and 50 mg/ml streptomycin (lonza). expression vectors used in this study are listed in table 1 . plasmids psj1 and psj7 are pcdna3 derivatives (invitrogen; thermo fisher scientific) used for mouse ifn-l2 and ifn-l3 expression in 293t cells. these plasmids were constructed by cloning the orf encoding ifn-l2 (psj1) and between the bamhi and xbai sites of the vector. coding sequences were polymerase chain reaction (pcr)-amplified from liver cdna samples of a c57bl/6 mouse infected with influenza turh (h7/n1) strain (hermant and others 2014) , using the following primers: forward (fw): bamhi-agei-kozak-mifn-l2/3, 5¢-aaa agg atc cac cgg tgc cac cat gct cct cct gct gtt gcc tct g-3¢; reverse (rev): mifn-l2/3-stop-xbai, 5¢-aaa atc tag att atc aga cac act ggt ctc cay tgg c-3¢. the sequence of psj7 matches the genomic ifnl3 sequence but diverges from a few nucleotides from that of the previously constructed pcs59 plasmid (sommereyns and others 2008) . both plasmids encode functional ifn-l3. pph23 was obtained by pcr-cloning the ifna2 orf from hela-m cell cdna, between the ecori and noti sites of pcdna3 (fw: ecori-kozak-ifna2, 5¢-aaa aga att cac cat ggc ctt gac ctt tgc ttt-3¢; rev: ifna2noti, 5¢-aaa agc ggc cgc tca ttc ctt act tct taa act tt-3¢). pmk03 is a lentiviral vector, derived from ptm897, that carries the mouse mx1 gene promoter driving the expression of the firefly luciferase gene. it is derived from pcclsin. cppt.hpgk.gfp.pre (follenzi and others 2000) in which a cloning polysite was first inserted to replace the coding sequences, yielding ptm897. the firefly luciferase gene from pgl4.16 (promega) was inserted between the xhoi and xbai sites of the vector, and the mx1 promoter was then cloned from pbsk-mx1, a gift from peter staeheli (freiburg university, freiburg, germany), as a bamhi/bsabi fragment. the lentiviral vector psj12, used for expression of the mouse ifn-l receptor, was obtained by cloning the ifnlr1 orf between the bamhi and xbai sites of ptm945, a lentiviral vector allowing the coexpression of the cloned gene and of mcherry (hermant and others 2013) . the ifnlr1 orf sequence was subcloned in this plasmid from pcr2.1-licr2, kindly provided by laure dumoutier (de duve institute, brussels, belgium). gene inactivation was done with px461 plasmid (pspcas9n-2a-gfp) coding for the cas9 nickase and green fluorescent protein (gfp) (ran and others 2013a). the 2 single guide rnas (sgrnas) were designed using the mit clustered regularly interspaced short palindromic repeats (crispr) design tool website (http://crispr.mit.edu). the selected sgrna pair (sgrna1-fw: 5¢-cac cgt caa att ctg gcg gct caa g-3¢; rev: 5¢-aaa cct tga gcc gcc aga att tga c-3¢; sgrna2-fw: 5¢-cac cga gac cac ata aac gtg acg a-3¢; rev: 5¢-aaa ctc gtc acg ttt atg tgg tct c-3¢) was targeting exon 6 of the mouse ifnar2 gene (genbank: y09865.1) and exhibited no expected off-target cleavage site. the sgrnas were cloned into px461 to form the plasmids psj37 and psj38. these constructs were cotransfected in lkr10 cells, using transit ò -lt1 transfection reagent (mirus bio llc, madison), according to the manufacturer's instructions. after 48 h, gfp-positive cells were sorted by fluorescence activated cell sorting (facs aria iii; bd biosciences) and cloned in 96-well plates. clones were screened for loss of type i ifn response with an antiviral assay. genome editing of the targeted exon was further confirmed by sequencing (genewiz). isg expression was measured by reverse transcriptionquantitative pcr. ifnar2-knockout (ko) and wild-type (wt) lkr10 cells were treated with 100 u/ml mouse ifn-aa, 700 pg/ml mouse ifn-l3, or control supernatant (mock) for 8 h before rna extraction. total rna extraction, reverse transcription, and sybr green quantitative pcr for mrna encoding mouse b-actin, oasl2, and usp18 were performed as previously described (paul and michiels 2006) . for infection analysis, cells were dissociated with trypsin-edta and suspended in phosphate-buffered saline (pbs) containing 5% of filtered fcs and 0.5% of paraformalde-hyde. data acquisition was done with an lsrfortessa flow cytometer (bd biosciences) using facsdiva software. data were analyzed using flowjo 9.6.4. the rate of infection was defined as the percentage of mcherry-positive cells 24 h postinfection with 0.5 pfu/cell tm967. for cell sorting, transduced cells were suspended in pbs containing 1% fcs and 1 mm edta. mcherry-or gfppositive cells were cloned at 1 cell per well in 96-well plates using the facs aria iii (bd biosciences). immunoblotting stat1, p-stat1, and b-actin were detected by western blot using sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels containing 10% acrylamide and run in a tris-glycine buffer. blots were probed with anti-stat1 polyclonal (sc-346; santa cruz biotechnology, heidelberg, germany), p-stat1 monoclonal (#9167; cell signaling technology, leiden, the netherlands), and anti-b-actin monoclonal (a5441; sigma-aldrich) antibodies. mouse ifn-aa, ifn-b, ifn-l2, ifn-l3, and human ifn-a2 were produced as described previously from 293t cells transfected with pcdna3-ifn-aa, pcdna3-ifn-b (van pesch and others 2004), pcdna3-ifn-l2 (psj1), and pcdna3-ifn-l3 (psj7). human ifn-a2 was produced similarly, using pcdna3-ifn-a2 (pph23). supernatant collected from 293t cells transfected in parallel with the empty pcdna3 vector was used for control treatment (mock) of cells and diluted as for ifns. recombinant mouse ifn-l3 (1789-ml-025) and human ifn-l1 (1598-il-025), ifn-l2 (1587-il-025), and ifn-l3 (5259-il-025) were purchased from r&d (r&d systems, minneapolis). recombinant human ifn-l4 was produced as described (hamming and others 2013) . mouse (ref 315-05) and human (ref 300-02) ifn-g were purchased from pe-protech (london, united kingdom). genbank accession numbers for mouse and human ifn-l are listed in table 2 . ifns were diluted in culture medium for cell treatment or in reagent diluent for elisa. mouse ifn-l2 and ifn-l3 were quantified by elisa. mouse ifn-aa and human ifn-a2 antiviral activities were quantified, as described previously, by a cytopathic effect reduction assay in mouse balb-3t3 and human hela-m cells, respectively, using mengovirus (van pesch and michiels 2003) . similar assays were conducted in human a549 cells and mouse lkr10 cells for quantification of ifn-l cross-species activity. ifnl4 was quantified by a cytopathic effect reduction assay in a549 cells, using recombinant human ifn-l3 as a standard, which was reported to have a similar specific activity (hamming and others 2013). mouse ifn-l2/3 measurement by elisa was performed using the mouse ifn-l2/3 duoset (r&d systems), according to the manufacturer's protocol. mouse sera were diluted 5-to 10-fold, and bronchoalveolar lavage fluids (balfs) were diluted 5-fold. when required (in case of samples derived from infected cells or mice), infectious virus present in biological samples was ultraviolet light (uv)-inactivated. for uv inactivation, 2.5 mm thick fluid samples were exposed at fixed uv dose (0.25-0.5-1-2 j/cm 2 ) with the uv irradiation system biolink 254 (vilber lourmat, eberhardzell, germany), either in 24-(470 ml) or in 96-well (80 ml) plate. uv-exposed samples were titrated on bhk-21 cells by a standard plaque assay to confirm virus inactivation. to confirm that the uv irradiation procedure that was established for picornaviruses effectively inactivates respiratory syncytial virus (rsv), 3 samples of 470 ml containing 1.5 · 10 6 pfu of rsv were exposed to 2 j/cm 2 with the uv irradiation system bio-link 254 at room temperature in a 24-well plate (uv irradiated samples). as controls 3 similar samples of 470 ml containing 1.5 · 10 6 pfu of rsv were incubated at room temperature in a 24-well plate (untreated samples). the titers of replicating rsv in the uv irradiated and untreated samples were determined by plaque assay using vero cells. cells were seeded at 160,000 cells per well in 24-well plates for cell supernatant and recombinant ifn analysis or at 32,000 cells per well in 96-well plates for mouse serum and bal analysis. forty-eight hours after seeding, cells were treated with ifn-l2/3 or mock-treated or incubated with uv-treated mouse serum (50-and 100-fold dilutions) or bal (5-fold dilutions). samples were diluted in culture medium. recombinant mouse ifn-l3 provided in the elisa kit was used as a standard. firefly luciferase activity was measured 6 h after treatment using the luciferase assay system (promega). twenty microliters and 100-ml lysis buffer were used in 96-and 24-well plates, respectively; 10 ml of the lysate was mixed with 25 ml of substrate for detection. luminescence was measured with a glomax 20/20 luminometer (promega). the limit of detection (lod) for each test was established based on the mean of mock-treated samples, plus 3 standard deviations, in all assays. tm967 is a theiler's murine encephalomyelitis virus (tmev) (strain da) derivative that carries a capsid adapted to infect l929 cells and the orf encoding the mcherry fluorescent protein cloned as a xbai/bsiwi fragment to replace codons 5-67 of the leader protein coding region, in the pkj6 vector ( jnaoui and michiels 1998) . mengovirus (a strain of encephalomyocarditis virus) used for ifn bio-assay is an attenuated variant that has been described previously (hermant and others 2013) . those viruses were quantified by plaque assay on bhk21 cells. rsv propagation and enrichment were performed as described in schepens and others (schepens and others 2014) . mouse experiments were conducted according to the national (belgian law 14/08/1986 and 22/12/2003, belgian royal decree 06/04/2010) and european (eu directives 2010/ 63/eu, 86/609/eeg) animal regulations. animal protocols were approved by the ethics committee of ghent university (permit no. la1400091, approval id 2013-030). all efforts were made to avoid or ameliorate suffering of animals. specific pathogen-free female balb/c mice at the age of 7-8 weeks were purchased from charles river. the mice were housed in a specific-pathogen-free temperature controlled environment with 12-h light/12-h dark cycles and given water and food ad libitum. mice were used at 9 weeks of age after adaptation in the animal room for 1 week. for challenge, the mice were sedated with isoflurane and infected intranasally with 4 · 10 6 pfu of human rsv. mock infection of the control group was performed with hank's balanced salt solution. five days postinfection, bal was isolated under anesthesia with an intraperitoneal injection of avertin (2.5% in pbs). a 23gauge cannula was inserted into the trachea, and cells were collected by washing the airway lumen twice with 0.5 ml pbs containing 0.05 mm edta. after removing the cells by centrifugation (5 min at 400g), the balf was stored at -80°c. serum samples from norovirus-infected and plasmidelectroinjected mice were reused from a previously published experiment (rocha-pereira and others 2018) to minimize animal experimentation. statistical analysis was performed using prism 7 software (graphpad software, san diego, ca). [***p < 0.001, **p < 0.01, *p < 0.05, and ns no statistically significant difference (p ‡ 0.05)]. unlike mouse and human type i ifns (ifn-a/b) that exhibit strong species specificity, type iii ifns were reported to act in a cross-species manner. to confirm whether a mouse cellbased bioassay would permit the detection of ifn-l subtypes from 2 different mammalian species, the species specificity of mouse and human type iii ifns was reexamined. crossreactive antiviral activity was systematically compared in a cytopathic effect reduction assay, using epithelial cell lines from mouse (lkr10) and human (a549) origin. as expected, type i human (ifn-a2) and mouse (ifn-aa) ifns were extremely species-specific in the antiviral assay, with an activity difference higher than 10,000-fold when applied to mouse and human cells. ifn-l exhibited some level of species specificity although much less than type i ifns (fig. 1a) . mouse ifn-l3 displayed the most pronounced species specificity. for a quantity that yielded the same antiviral activity in mouse cells, ifn-l3 was 25 times less active in human cells than the closely related mouse ifn-l2. human ifn-l1, ifnl-2 and, to a lesser extent, ifnl-3 exhibited significant antiviral effect on mouse epithelial cells. as ifn-l4 has been shown to have a specific activity similar to that of human ifn-l3 in human cells, it was quantified accordingly using the antiviral assay (hamming and others 2013) . remarkably, human ifn-l4 displayed much more antiviral activity on mouse cells than equivalent amounts of human ifn-l3. accordingly, treatment of lkr10 cells with concentrations of human ifn-l3 and ifn-l4 that yielded equivalent antiviral activities in human cells resulted in clear stat1 phosphorylation after ifn-l4 but not after ifn-l3 treatment (fig. 1b) . in line with their epithelial origin, mouse lkr10 cells respond to ifn-l. to ensure a selective detection of type iii ifns, the gene coding for the ifnar2 subunit of the type i ifn receptor was inactivated using the double nickase crispr/crispr-associated (cas) 9 technology (ran and others 2013b). an lkr10-ifnar2-ko clone was selected for the absence of response to type i ifn and intact response to type iii ifn. sequencing of the targeted exon revealed frameshift mutations in both ifnar2 alleles, resulting in premature stop codon appearance. in contrast to ifn-l treatment, ifn-a treatment of this clone failed to induce the expression of the ifn-stimulated genes, oasl2 ( fig. 2a) and usp18 (fig. 2b) , and to protect against infection with tm967, a tmev derivative expressing mcherry (fig. 2c) . to develop ifn-l reporter cells, the lkr10-ifnar2-ko clone was transduced with a lentiviral vector encoding the firefly luciferase gene under the control of the mx1 pro-moter. among the clones tested for luciferase activity induction after ifn-l treatment, the best one displayed not more than 10-fold luciferase activity induction. to try to boost the reporter gene responsiveness to ifn-l, this clone was transduced with sj12, a lentiviral vector that coexpresses the mouse ifnlr1 and mcherry. transduced cells were sorted, based on mcherry expression, and cloned. a selected clone, named ''fawa-l-luc,'' responded vigorously to ifn-l3. this clone displayed increased constitutive stat1 expression and strong stat1 phosphorylation after ifn-l3 but not after ifn-a treatment (fig. 2d) . a significant luciferase activity increase was measured in fawa-lluc cells as soon as 1 h after treatment with 700 pg/ml (quantified by elisa) of mouse ifn-l3. maximal induction was reached within 6 h and lasted up to 16 h posttreatment (fig. 3a) . the sensitivity of the fawa-l-luc assay was compared to that of an available elisa test for mouse ifn-l. mouse ifn-l2 and -3 produced by transfected 293t cells and recombinant mouse ifn-l3 were quantified in parallel by elisa and the fawa-l-luc assay. in the elisa, responses were linear between 1,000 and 16.25 pg/ml, the experimental lod of this test (fig. 3b ). in the fawa-l-luc assay, linearity was reached in a narrower concentration range (1.95-62.5 pg/ml for mouse ifn-l2; 3.9-125 pg/ml for mouse ifn-l3), but a higher sensitivity was observed with the detection limit being below 1.95 pg/ml and 3.9 pg/ml, for ifn-l2 and -3, respectively (fig. 3c, d) . based on elisa quantification, mouse ifn-l2 bioactivity in this assay was 2-fold higher than that of mouse ifn-l3. importantly, after up to 29 passages, the intensity of the luciferase signal in the fawa-l-luc cells tended to decrease, but the sensitivity of the bioassay was preserved because table showing the relative antiviral activity of mouse and human ifn-l on mouse lkr10 and human a549 cells. species specificity index was calculated as the ratio between the relative antiviral activity on cells of homologous to nonhomologous species (eg, for mouse ifn: relative activity in mouse cells/relative activity in human cells). relative activities in a given cell line were calculated as the ifn dilutions (starting from 1 ng/ml) that yielded similar antiviral activities. *due to the low amount of ifn-l4 available, the initial concentration of this ifn was estimated by comparison with human ifn-l3 antiviral activity that was reported to have a similar specific activity. (b) western blot showing stat1 phosphorylation in mouse lkr10 cells 30 min after treatment with control medium (mock) or ifn-l. concentrations of human (hu) ifn-l3 (615 pg/ml) and ifn-l4 that yielded the same antiviral activity on human a549 cells were used. as a control, mouse ifn-l3 was used at a concentration (2.5 ng/ml) showing equivalent antiviral activity as human ifn-l4 on mouse cells. results are representative of 3 experiments. the background activity also decreased with high passage numbers. to confirm the specificity of fawa-l-luc cells for ifn-l, we also evaluated any possible luciferase induction after treatment with type i and type ii (ie, ifn-g) ifns. as expected, no signal was observed after treatment with up to 2,500 iu/ml of either mouse ifn-aa or ifn-b. human ifn-g also failed to induce a detectable luminescent signal in the fawa-l-luc cells in the tested concentration range (0-25 ng/ml). the lod for mouse ifn-g was 12.55 ng/ml, a concentration at least 10-fold higher than what is observed in mouse fluids in infectious contexts (pomeroy and others 1998; claser and others 2017) . ifn-g is thus not expected to interfere with ifn-l detection in biological samples. we tested the sensitivity of our bioassay for human ifn-l detection. responses were analyzed individually for all 4 human ifn-l subtypes (fig. 4a-d) . as their cross-species activity differed, different detection sensitivities were reached with our mouse cell-based reporter assay: 15.125 pg/ml for ifn-l1, 500 pg/ml for ifn-l2, 31.25 pg/ml for ifn-l3, and 1.95 pg/ml for ifn-l4. the bioassay turned out to be extremely sensitive for human ifn-l4 detection. it is, however, worth noting that the recombinant ifn-l4 stock concentration was determined by comparison of its activity with that of a human ifn-l3 standard. when testing biological samples, potential occurrence of infectious virus may interfere with the viability of reporter cells. it is therefore important to inactivate infectious viruses in such samples. as ifn-l had previously been shown to be acid labile (kugel and others 2011) , uv inactivation of the virus was preferred. we thus tested whether virucidal uv doses would affect ifn-l activity. to this end, tm967 virus, mouse ifn-l2, and mouse ifn-l3 were irradiated with increasing uv doses. mock-and uv-exposed samples were then analyzed with the bioassay for mouse ifn-l2 and ifn-l3 detection and by plaque assay to determine viral titers. a 2 j/cm 2 uv exposure was sufficient to ensure a virus titer reduction of more than 100,000-fold (5.5 · 10 5 pfu to <1 pfu). at this uv dose, mouse ifn-l2 activity was not significantly reduced and mouse ifn-l3 showed a bioactivity reduction of less than 25% (fig. 5a) . similarly, ifn-l1 and ifn-l4 bioactivities were reduced by 25%, while human ifn-l2 and ifnl-3 were slightly more sensitive to irradiation, with about 2-fold activity decrease (fig. 5b) . we then compared the sensitivities of the fawa-l-luc and of the elisa assays to detect ifn-l in mouse serum and bal samples. ifn-l was first quantified in the serum of mice that were either injected intramuscularly with an ifn-l3 expressing plasmid (pcs59), thus expected to produce circulating ifn-l, or infected with mouse norovirus (rocha-pereira and others 2018). a preliminary test revealed that the minimal serum dilution that did not interfere with spiked-in ifn-l detection was 16fold for the bioassay and 5-fold for the elisa (fig. 5c, d) with both the fawa-l-luc and elisa assays. ifn-l was clearly detected at day 2 and 4 in the serum of mice that were electroinjected with the ifn-l3 expressing plasmid, as well as at day 3 postnorovirus infection (fig. 6a, b) . at day 2 after a single ifn-l3 injection, the cytokine was detectable in 1 out of 4 mice by elisa and in 3 out of 4 mice by the bioassay. the detection limit was higher for the elisa (194 pg/ml) than for the bioassay (9.29 pg/ml), showing the higher sensitivity of the luciferase-based bioassay (fig. 6a, b) . next, we compared ifn-l detection by the fawa-l-luc assay and by elisa in balf of balb/c mice that were mock infected or infected with rsv. balf and lungs were collected 5 days postinfection. plaque assay revealed that balf of all infected mice contained between 1.8 · 10 2 and 7.33 · 10 2 pfu/ ml of live replicating virus. the used uv irradiation procedure proved to readily inactivate rsv (rsv titer reduction of more than 46,000-fold; 4.6 · 10 4 pfu to <1 pfu). five-fold diluted control balf did not modify ifn-l2/3 detection in any of the 2 assays. using 5-fold dilutions of the balf as in the bioassay, we failed to detect any ifn-l by elisa (fig. 6c ). in contrast (fig. 6d) , ifn-l was detected by fawal-luc assay at a very low concentration in the balf of the rsv infected mice (5/6) and not detected in the control group. percentage of ifn-l activity (mean and sd) remaining after uv treatment (n = 3) at 2 j/cm 2 . ifn activity was measured in fawa-l-luc cells for ifn concentrations that yielded equivalent luciferase activities (20,000 rlu) before uv treatment (250 pg/ml mifn-l2 and mifn-l3, 125 pg/ml human ifn-l1, 10 ng/ml huifn-l2, 500 pg/ml huifn-l3, and 62.5 pg/ml huifn-l4). (c, d) influence of serum dilution on ifn-l detection by fawa-l-luc cells (c) and elisa (d). (c) fawa-l-luc cells were treated in triplicate with fixed doses of 15 and 250 pg/ml mifn-l2 supernatant and with 2-fold serial dilutions (2-128-fold) of control mouse serum. (d) 125 pg/ml recombinant mifn-l3 was mixed with 2-fold serial dilutions of control mouse serum (2.5-10-fold) before detection by elisa. (a-c) reporter cells were exposed to ifn for 6 h before luciferase assay. student's t-test: */**/***denotes a significant difference in signal compared to no uv exposure (a) or the absence of serum (c). uv, ultraviolet light. we conclude that the fawa-l-luc-based assay described in this study allows to quantify ifn-l from biological samples in a highly sensitive way. we reexamined the species specificity of ifn-l and highlighted a previously overlooked difference in bioactivity between mouse and human type iii ifns. mouse ifn-l3 displayed a surprising species specificity, with a 50-fold difference in relative antiviral activity when applied to lkr10 (mouse) and a549 (human) cells. this contrasted strongly with the closely related mouse ifn-l2 (93% amino acid sequence identity), which displayed little species specificity and was 25 times more active in human cells than mouse ifn-l3. in contrast, human ifn-l4 displayed a strikingly strong activity on mouse cells compared to human ifn-l3. although ifn-l4 is not expressed in mouse and rat, it is highly conserved in many mammalian species (key and others 2014) where it was shown to be cross-reactive. the nonhuman ifn-l4 orthologs were reported to activate ifnlr1 in human cells, sometimes with a higher efficacy than human ifn-l4 (eg, dog ifn-l4) (paquin and others 2016). the mouse cell response to human ifn-l4 is thus in line with the ability of ifn-l4 to be cross-reactive among mammalian species, although we do not have any physiological explanation for this phenomenon. ifn-l proteins follow the typical class ii cytokine structure, consisting of 6 secondary structure elements (a-f) (pestka and others 2004) . helix a is involved in both ifnlr1 and il10rb binding, while helix d binds il10rb and helix f binds ifnlr1 (gad and others 2010). among amino acid residues that have been characterized as crucial for ifnlr1 binding and activation (gad and others 2010), a few divergences are observed between sequences from mouse and human ifn-l (fig. 7) . notably, the more species-specific mouse ifn-l3 has 4 amino acid residues in a helices a and f that diverge from the 5 other ifn-l sequences, including the related mouse ifn-l2. in helix a, gly37 uniquely replaces the asp residue present in the other sequences. in helix f, 3 residues are unique to mouse ifn-l3: asp 150 (ala / asp), gln158 and bioassay (b) in the serum of ag129 mice 2 or 4 days after electroinjection of mouse ifn-l3 (mifn-l3) expressing (pcs59) or empty (pcdna3) plasmids, 2 days after injection of pcs59, or 3 days after infection with mouse norovirus. ifnl detection in the serum by elisa was performed without uv exposure to keep maximal sensitivity. (c, d) ifn-l2/3 detection by elisa (c) and bioassay (d) in the bronchoalveolar lavage of balb/c mice, 5 days postinfection with rsv, compared to control mice (mock). balf were uv-exposed before testing. (a-d) the horizontal dotted line represents the lod. mann-whitney: */**indicates a significant difference compared to pcdna3 group at days 2 or 4 (a, b) or compared to mock (d). balf, bronchoalveolar lavage fluid; rsv, respiratory syncytial virus. (arg / gln), and leu161 (thr / leu). future site-directed mutagenesis studies could help defining the key residues involved in the species specificity. we designed a highly sensitive bioassay named ''fawa-lluc'' based on luciferase reporter cells, specific for ifn-l detection and quantification. the bioassay is based on a cell line that is naturally responsive to ifn-l in which the type i ifn receptor gene was inactivated. overexpression of the mouse ifnlr1 receptor in those cells led to increased induction of the reporter gene after ifn-l treatment. unlike previously described bioassays, such as hl-116 fibroblasts stably transfected with the human ifnlr1 (uze and monneron 2007), fawa-l-luc cells permit the selective detection of type iii ifn because they lack the type i ifn receptor. they also fail to respond to ifn-g concentrations that are reached in infected mouse serum. this novel bioassay is efficient in measuring ifn-l from mouse bal and serum. ifn-l activity was hardly affected by uv exposure at virucidal doses, thus allowing detection in infected biological fluids. the high sensitivity of the assay permits sparing biological material as 10-fold more diluted serum samples could be used for bioassay detection (50-100-fold dilution) compared to the elisa (5-10-fold). when cell toxicity of the tested samples is suspected, cell viability may independently be confirmed with nonlytic viability assays such as resazurin-based tests, which are compatible with luciferase detection. importantly, our bioassay offers a physiologic analysis, attesting of the functionality of the ifn-l present in the samples, irrespective of specific activity. the bioassay also allows to detect human ifn-l. given the divergent cross-species activity and the higher uv lability of the human type iii ifns, the bioassay might be used for individual subtype analysis, but would not fit for their detection in complex biological samples. finally, it offers a sensitive detection of the divergent ifn-l4, for which no efficient commercial test is available. development of 3t3-like lines from balb-c mouse embryo cultures: transformation susceptibility to sv40 lambda interferon (ifn-lambda), a type iii ifn, is induced by viruses and ifns and displays potent antiviral activity against select virus infections in vivo ifn-lambda resolves inflammation via suppression of neutrophil infiltration and il-1beta production ifn-lambda suppresses intestinal inflammation by non-translational regulation of neutrophil function host resistance to plasmodiuminduced acute immune pathology is regulated by interleukin-10 receptor signaling basis for regulated rna cleavage by functional analysis of rnase l and ire1p role of the interleukin (il)-28 receptor tyrosine residues for antiviral and antiproliferative activity of il-29/interferon-lambda 1: similarities with type i interferon signaling type iii interferon is a critical regulator of innate antifungal immunity gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by hiv-1 pol sequences the structure of human interferon lambda and what it has taught us interferon lambda 4 signals via the ifnlambda receptor to regulate antiviral activity against hcv and coronaviruses ifn-l sequence alignments. sequences of human and mouse ifn-l regions implicated in receptor binding were aligned. key amino acid residues involved in receptor activation that differs between mouse and human ifn-l2 and ifn-l3 sequences are indicated in bold in mouse sequences. residues unique to mouse ifn-l3 in helices a and f are indicated in bold red. *indicates identical amino acids between human ifn-l3 and ifn-l4 human but not mouse hepatocytes respond to interferon-lambda in vivo ifnepsilon is constitutively expressed by cells of the reproductive tract and is inefficiently secreted by fibroblasts and cell lines virus interference. i. the interferon adaptation of theiler's virus to l929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence somatic activation of the k-ras oncogene causes early onset lung cancer in mice selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (ifnl4) il-28a (ifn-lambda2) modulates lung dc function to promote th1 immune skewing and suppress allergic airway disease ifn-lambdas mediate antiviral protection through a distinct class ii cytokine receptor complex novel nonviral bioassays for mouse type i and type iii interferon characterization of the mouse ifn-lambda ligand-receptor system: ifn-lambdas exhibit antitumor activity against b16 melanoma comparative functional analysis of 12 mammalian ifn-lambda4 orthologs cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness interferons, interferonlike cytokines, and their receptors role of interferon-gamma in murine cytomegalovirus infection a variant upstream of ifnl3 (il28b) creating a new interferon gene ifnl4 is associated with impaired clearance of hepatitis c virus double nicking by rna-guided crispr cas9 for enhanced genome editing specificity genome engineering using the crispr-cas9 system interferon lambda (ifn-lambda) efficiently blocks norovirus transmission in a mouse model protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein il-28, il-29 and their class ii cytokine receptor il-28r ifnlambda (ifn-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo il-28 and il-29: newcomers to the interferon family characterization of the murine alpha interferon gene family characterization of interferonalpha 13, a novel constitutive murine interferon-alpha subtype species specificity of interferon action: maintenance and establishment of the antiviral state in the presence of a heterospecific nucleus the authors are grateful to nicolas dauguet for his help in flow cytometry (ludwig institute for cancer research). work was supported by the eos joint programme of fonds de la recherche scientifique-fnrs and fonds wetenschapellijk onderzoek-vlaanderen-fwo (eos id: 30981113), by interuniversitary attraction poles program initiated by the belgian science policy office (iap-p7/45 belvir), by actions de recherche concertées (arc), and by a pdr grant (t.0185.14) of fnrs to t.m., and b.s. is a doctoral assistant at the department of biomedical molecular biology of ghent university. no competing financial interests exist. key: cord-299605-j1ewxk4q authors: lin, jing-wen; sodenkamp, jan; cunningham, deirdre; deroost, katrien; tshitenge, tshibuayi christine; mclaughlin, sarah; lamb, tracey j.; spencer-dene, bradley; hosking, caroline; ramesar, jai; janse, chris j.; graham, christine; o’garra, anne; langhorne, jean title: signatures of malaria-associated pathology revealed by high-resolution whole-blood transcriptomics in a rodent model of malaria date: 2017-02-03 journal: sci rep doi: 10.1038/srep41722 sha: doc_id: 299605 cord_uid: j1ewxk4q the influence of parasite genetic factors on immune responses and development of severe pathology of malaria is largely unknown. in this study, we performed genome-wide transcriptomic profiling of mouse whole blood during blood-stage infections of two strains of the rodent malaria parasite plasmodium chabaudi that differ in virulence. we identified several transcriptomic signatures associated with the virulent infection, including signatures for platelet aggregation, stronger and prolonged anemia and lung inflammation. the first two signatures were detected prior to pathology. the anemia signature indicated deregulation of host erythropoiesis, and the lung inflammation signature was linked to increased neutrophil infiltration, more cell death and greater parasite sequestration in the lungs. this comparative whole-blood transcriptomics profiling of virulent and avirulent malaria shows the validity of this approach to inform severity of the infection and provide insight into pathogenic mechanisms. scientific reports | 7:41722 | doi: 10.1038/srep41722 offers a feasible alternative as it is one of the "highways" of the immune system via which naïve, and activated or primed immune cells travel between lymphoid organs and the tissues affected by the infection. by profiling global transcriptomes of whole blood, insights can be obtained into the complex changes in systemic or even local host responses brought about by an infection, and thus inform more targeted mechanistic studies. to investigate the use of genome-wide transcriptomic profiling of the whole blood in identifying pathology signatures in malarial infection, and to gain insights into the mechanisms underlying pathology, we used the well-establised p. chabaudi chabaudi rodent malaria model to study malarial immunology and pathology 2,3 . using two strains of p. c. chabaudi, as and cb, that differ in virulence in c57bl/6 mice, we performed high-resolution comparative whole-blood transcriptomic analysis throughout the acute phase of the blood-stage infection, and identified several transcriptomic signatures associated with severe malarial pathology before the onset of pathology or disease. the virulent cb strain of p. c. chabaudi induces more severe pathology in the acute phase of a blood-stage infection compared with the avirulent as strain. infection of c57bl/6 mice was initiated by intraperitoneal inoculation of 10 5 infected red blood cells (irbc) of p. c. chabaudi as or cb. infection with the cb strain gave rise to a more severe infection, resulting in 40% (range 20-60%) of mice reaching the humane end points (more than 25% weight loss, persistent laboured breathing and severe hypothermia), while all as infected mice survived the infection without showing severe pathologies (fig. 1a) . as and cb infected mice showed comparable irbc loads (parasitemia multiplied by total rbc numbers), despite the fact that higher peak the total numbers of infected red blood cells (irbc) per ml of blood (b) and the parasitemia (percentage of infected irbc) (c) in the mice infected with as or cb parasites. (d,e) the change in rbc numbers during the infection in as or cb infected mice (d) and the hemoglobin (hgb) concentration in the blood of the infected mice (e). (f,g) the percentage change in temperature (f) and weight (g) during the infection in as or cb infected mice. data were pooled from 21 mice in 3 independent experiments. graphs show mean with sem, mann-whitney u test was performed (* p < 0.05, **p < 0.005, ***p < 0.0005). scientific reports | 7:41722 | doi: 10 .1038/srep41722 parasitemias were observed in the acute cb infection (fig. 1b,c) . a more severe rbc loss with a significantly lower hemoglobin concentration was observed in cb infection at 10 days post infection (dpi) compared to that in as infected mice, agreeing with previous observations, which showed more severe anemia in cb infected balb/c mice 4 . moreover, the rbc loss in cb infected mice is longer lasting, even after the peak of infection at 12 dpi (fig. 1d,e) . in addition, at 10 dpi, cb infected mice showed greater temperature and weight loss (fig. 1f,g) . virulent cb and avirulent as strains of p. c. chabaudi induce distinct responses in host whole blood transcriptome. to investigate whether as and cb parasites induce different host responses that might contribute to the differences in severity of the blood-stage infection we carried out genome-wide transcriptomic analyses of whole blood during the acute phase of infection. peripheral blood was collected into tempus tubes via cardiac puncture from c57bl/6 mice infected with as or cb at 2, 4, 6, 8, 10, and 12 dpi. blood samples collected from age-matched uninfected animals at day 0 and day 12 were used as naïve controls to exclude transcriptional changes due to time. the total rna was extracted, depleted of globin mrna and analysed using illumina mouse wg-6 v2.0 beadarrays. spearman's rank correlation coefficient (r s ) analysis of unfiltered transcripts normalised across the median of all samples, revealed high levels of similarity amongst naïve and 2, 4 dpi samples in both as and cb infections (fig. 2ai ,ii, r s ranging from 0.73 to 0.88), while from 6 dpi onwards the whole blood transcriptomes diverge significantly from the earlier time points (r s ranging from 0.08 to − 0.59 compared to naïve controls). when comparing as and cb infections at each of the time points, lower correlation values were observed between 6-10 dpi (fig. 2aiii , r s = 0.37, 0.67, 0.44, respectively). this indicates that as and cb infections induce different host responses at these times of infection. as infected mice and those cb infected mice that survived this phase of infection showed similar profiles at 12 dpi (fig. 2aiii , r s = 0.82). differential expression analysis (anova unequal variance with post-hoc hsd test, fdr < 0.01) was performed on transcripts normalised to the median of their respective naïve controls (supplementary table 1 ). at any of the post-infection time points examined, there were 6226 differentially expressed transcripts with a greater than 2-fold change in the infected mice compared to the naïve mice (fig. 2b, supplementary fig. 1a) . consistent with correlation analyses of unfiltered transcripts (fig. 2a) , only a few transcripts were differentially expressed at 2 and 4 dpi (fig. 2b) . strikingly, at 6 dpi, a large majority of transcripts were down-regulated compared to naïve controls in both as and cb infections. however, the number was greater in cb infected mice compared to as (as 1856 out of 2265 transcripts, cb 4306 out of 4471 transcripts) (fig. 2b) . the number of down-regulated transcripts increased steadily from 6 to 12 dpi in as infection (fig. 2b) . while down-regulation of transcripts was also observed at 6-8 dpi in the cb infection, the level of down-regulation was significantly lower at 10 dpi and there was a sudden up-regulation of transcripts occurred only in cb infected mice at this time point (fig. 2b , supplementary fig. 1a ), a critical time point when infected animals were either recovering from acute infection or suffering from severe pathologies leading to death (fig. 1) , indicating that these up-regulated transcripts may relate to the manifestation of severe pathology in the cb infection. indeed this higher level of transcriptional up-regulation was further confirmed in 4 cb infected mice that had reached humane end points at 9 dpi ( supplementary fig. 1b ). this up-or down-regulation of gene expression in whole blood are due to both the leukocyte population changes and transcript regulation during the infection ( supplementary fig. 1c ). in the blood associated with severe pathology. a hierarchical clustering of the 6226 differentially expressed transcripts of whole blood revealed 2 clusters of transcripts comprised of 22 genes that were significantly more up-regulated in cb infected mice between 8 and 10 dpi than in the blood of as infected mice ( supplementary fig. 2 , 22 genes in fig. 3a) , during which severe clinical signs were manifested (severe hypothermia, weight loss and host death) (fig. 1 ). ingenuity pathway analysis (ipa) diseases and function analysis showed that some of these genes were significantly enriched in 'functions' of inflammation and myeloid cell movement (fig. 3b) . interestingly, 5 genes (fig. 3a , indicated in red) were enriched in 'disease' of severe acute respiratory syndrome (sars) (fig. 3b) . these 5 genes have been shown to be amongst the top 10 up-regulated genes in transcriptomic analysis of pbmcs (peripheral blood mononuclear cells) isolated from sars patients suffering from severe lung inflammation 5 (fig. 3c) . importantly, in 4 of the cb infected mice that had reached humane end points at 9 dpi, these 5 genes showed an even higher level of up-regulation compared to naïve controls (fig. 3c) , indicating possible lung pathology in these 4 cb infected mice. to identify further pathology-related blood transcriptomic signatures, we included the microarray data of blood isolated from the 4 cb-infected mice that had reached the humane end points, and followed the same differential expression analysis as described above, yielding a total of 6321 differentially expressed transcripts (supplementary table 2 ). a self-organising map (som) clustering method was used to generate clusters of co-expressing transcripts ( supplementary fig. 3 , supplementary table 3) 6 . the cluster expression level was defined as the average fold-change of all transcripts within each module compared to that of naïve controls (fig. 3d) . the clusters were annotated with ipa diseases and function analysis and manually curated. several clusters, c8, c10, c13, c15, c16 and c20 showed greater up-regulation in cb infection during 9-10 dpi, indicating their association with lethality/severe pathology in cb infection (fig. 3d , indicated in red). modular analysis identified an early platelet aggregation signature only associated with the virulent p. c. chabaudi cb infection. clusters c15 and c20, were exclusively up-regulated in the cb infection, especially in the mice that had reached humane end points at 9 dpi (fig. 3d ). c15 showed a maximum average of 2.3-fold up-regulation and c20 showed a maximum average of 1.4-fold up-regulation in cb infected mice that were dying from the infection. twenty-seven genes within these 2 clusters are associated with platelet aggregation/pro-coagulation, a common feature of severe malaria infection 7 (fig. 4a) . they are significantly enriched in canonical pathways integrin signalling (−log(p value) 4.3, z score 2) and actin cytoskeleton signalling (−log (p value) 4.2, z score 2). importantly, this set of genes was significantly up-regulated in all cb infected mice as early as 2 dpi (fig. 4b) , at the time of which very few genes were differentially expressed compared to naïve controls (fig. 2b) . modular analysis identified a more pronounced and longer-lasting anemia signature in the virulent p. c. chabaudi cb infection. two clusters, c16 and c17 contained 21 genes related to anemia (fig. 5a ). for most of these genes, their down-regulation is associated with anemia, and up-regulation is associated with alleviation of anemia ( supplementary fig. 4 ). the anemia signature was already present at 6 dpi in both infections ( fig. 5a ), prior to clinical observation of rbc and hemoglobin loss at 8 dpi (fig. 1 ). the mean normalised intensity of these 21 genes was significantly down-regulated compared to naïve controls, and cb infected mice had even significantly lower values (fig. 5b) . the peak activation z scores calculated by ipa for this anemia signature of cb infection was 1.6-fold higher compared with that of as (fig. 5c , 3.6 vs 2.2, 6 dpi), agreeing with the more severe rbc loss (area under the curve analysis) in cb than as infection (1.5-fold, 36.0 vs 23.5) (fig. 1d) . interestingly, at 8 dpi, 13 out of the 21 genes within this signature were already up-regulated in as infections compared to naïve controls; by contrast, the majority (15) of these genes were still down-regulated in the blood of cb infected mice (fig. 5a, supplementary fig. 4 ). the activation z score was − 2.0 in as infected mice indicating anemia alleviation at this time point, compared to that of 2.0 in cb infected mice (fig. 5c ), which indicates a longer-lasting anemia. this is consistent with the more severe rbc and hemoglobin loss in cb infection at 10 dpi compared to as (fig. 1d,e) . moreover, in support of this data, ipa canonical pathway analysis of heme biosynthesis ii pathway also showed that genes in this pathway were more down-regulated or less up-regulated in cb than in as infected mice at 8 dpi compared to naïve controls (fig. 5d ). together, these data suggest a deregulated or stressed erythropoietic response in cb infected mice, leading to a stronger and prolonged severe anemia (fig. 1d ,e). the lungs of p. c. chabaudi cb infected mice. in addition to the 5 genes we identified from hierarchical clustering, the som analysis revealed a further 18 genes in clusters c8 and c20 related to sars, and the majority of these 18 genes were up-regulated only in cb infected mice that reached human end point at 9 dpi ( supplementary fig. 5a ). we therefore investigated whether this lung inflammation signature was reflected by more severe lung pathology in cb infected animals. lungs isolated from systemically perfused cb infected animals were of a darker coloration than lungs of uninfected or as infected mice (fig. 6a) . examination of bronchoalveolar lavage fluid showed significantly higher levels of igm in the lungs of mice infected with as or cb parasites compared to naïve mice (fig. 6b) . the hematoxylin and eosin (h&e) stained sections of perfused lungs a) were even more highly up-regulated compared to naïve controls in the blood extracted from 4 cb infected mice that had reached humane end points at 9 dpi compared to randomly selected mice infected with as or cb parasites at 10 dpi. fold changes in sars patients were from ref. 13 . (d) the twenty-four modules identified by using self-organising map (som) method were presented with the average fold change of all differentially expressed transcripts within each module compared to naïve controls. red represents positive mean fold change above zero (white) and blue indicates negative mean fold change. the clusters were annotated with ipa diseases and function analysis with manual curation. clusters indicated in red showed greater up-regulation in cb infection during 9-10 dpi. from both as and cb infected mice showed signs of leukocyte infiltration. in the lungs of some cb infected mice, patches of dense leukocyte accumulation between epithelial walls were observed in close proximity to hemozoin (hz) crystals ( supplementary fig. 5b) . we also observed more cell death in the lung tissues of cb infected mice (greater than two fold) compared to as infected mice by tunel staining (fig. 6c) . flow cytometry analysis confirmed leukocyte infiltration in the lungs of both as and cb infected mice compared to that in naïve mice (fig. 6d , gating strategy in supplementary fig. 6 ). we further characterised the cell populations within the infiltrating leukocytes in the lungs of infected animals. although cd3 + t cells, cd19 + b cells and cd3 − cd19 − innate cell numbers all increased in both infections, they did not significantly differ between as and cb infections; however, there was a trend towards higher t cell numbers in the as infection, and more innate cells in the cb infection ( supplementary fig. 6b,c) . within the innate cell populations, both the percentage and the cell numbers of ly6g + cd11b + neutrophils were significantly increased in lungs of cb infected mice compared to as infected mice (fig. 6e) , whereas other myeloid cell populations did not significantly differ between the two infections ( supplementary fig. 6d ). this observation of neutrophil infiltration is consistent with the ipa 'disease and function' analysis on the sars signature, which was up-regulated more in cb infection compared to as infection, indicating myeloid cell movement (fig. 3b) , especially neutrophils (z score 2.182). one of the top up-regulated genes, s100a9 (mrp14, myeloid-related protein 14) , indicates that neutrophils may be involved in the lung pathology of the cb infection. we therefore investigated whether the up-regulation of mrp14 transcript in the blood is associated with higher protein level and neutrophil infiltration in the lungs. we analysed the concentration of mrp14 protein in the serum at 9 dpi. while high level of mrp14 protein was also detected in sera of all (12) cb infected mice, it was below detection limit by elisa in the sera from 5 out of 12 as infected mice and all (12) from naïve mice . 6f) . we next measured the amount of mrp14 in the whole lung lysates, and found that cb infected mice contained more than twice the amount of mrp14 protein compared to that of lungs of as infected mice at 9 dpi; moreover, this upregulation was observed as early as 6 dpi (fig. 6g) . ifng, il6, kc (cxcl1) and lix (cxcl5) were higher in the lungs of cb infected mice, indicating a heightened proinflammatory response in the cb infection ( supplementary fig. 7a ). immunohistochemical staining of mrp14 on lung sections showed more mrp14 + cells present in the lungs of cb infected mice compared to naïve and as infected mice ( supplementary fig. 7b) , and flow cytometry analysis confirmed a greater than two fold increase of mrp14 hi ly6g + neutrophils in cb compared to as infected mice (fig. 6h) . together, these data show that the blood transcriptomic signature of lung inflammation is linked to an mrp14-associated neutrophil response in the lungs of mice infected with the more virulent cb strain of p. c. chabaudi compared with the avirulent as strain. amount of hz accumulated in the lungs of cb infected mice compared to as infected mice (fig. 7a) . this observation suggested a higher level of sequestration/accumulation of irbc in the lungs of cb infected mice. to investigate the level of sequestration of irbcs in p. c. chabaudi as and cb infected mice, we generated transgenic parasites, pccasluc 230p and pcccbluc 230p , expressing luciferase constitutively throughout the plasmodium life cycle under the control of eef1a promoter (supplementary fig. 8 ). at day 4, 6 and 9 dpi, the total parasite load was determined by measuring luciferase activity from 2 μ l tail blood when the parasites were at late trophozoite stage 8 , and the level of sequestration in different organs was investigated during schizogony. consistent with the peripheral load of irbc (fig. 1b) , there were no significant differences in luciferase activity between pccasluc 230p and pcccbluc 230p infected mice at 6 dpi either in peripheral blood or by whole body imaging (fig. 7b) . after intensive systemic perfusion, the luciferase activities in isolated organs were measured and relative ratio of sequestration was calculated as the level of luciferase activity per organ (total flux per second) relative to the total parasite load measured in peripheral blood before schizogony (relative light unit, rlu) (fig. 7c) . consistent with previous findings 8 , both as and cb irbc, sequester/accumulate mainly in the spleen, liver and lungs, with no significant signals observed in the kidney or brain. the relative levels of sequestration/accumulation in the spleen and liver were similar between as and cb infections. by contrast, a significantly higher level of sequestration in the lungs occurred in the cb infection at 6 dpi, and the trend was still maintained at 9 dpi (fig. 7c) . the higher level of sequestration/accumulation of schizonts in the lungs is consistent with the observation of greater amounts of hz in the lungs of cb infected mice compared to as infected mice (fig. 7a ). host genetics and immune status play important parts in the outcome of an infection with plasmodium 9,10 . however, there is an increasing amount of evidence showing that genetic diversity of the parasite also contributes to the varying severity of malarial disease. in this study we used a top-down systems analysis of peripheral blood to investigate whether transcriptomic signatures could be identified that would indicate or predict severity of acute blood-stage malaria caused by 2 strains of p. c. chabaudi of differing virulence. using high-resolution (c) bar charts showing the relative ratio of sequestration in different organs, which was quantified as the level of luciferase activities in the perfused ex vivo organs relative to the total parasite load measured in peripheral blood at late trophozoite stage (b, left). all data in (b,c) were pooled from 2 independent experiments (n = 9-12 in total). in all bar charts, median values are shown and each dot represents an individual mouse. mann-whitney u test was performed, p values are provided when significant difference was observed. profiling of the whole blood transcriptomics over multiple time points during the acute phase of infection, and data-driven modular analysis, we investigated the involvement of biological processes rather than specific genes, and uncovered several transcriptomic signatures related to severe pathologies in the virulent cb infection. these include distinct signatures for platelet aggregation, anemia and lung inflammation, which can be seen at different time points and distinguished the two infections. this analysis also revealed several signatures common between avirulent as and virulent cb infections, but they occurred at different time points or were of different magnitude. this highlights the value of studying pathological factors in the host induced by parasites over the course of the infection and not at a single time point. the platelet aggregation signature was highly up-regulated in all cb infected mice that had reached humane end points. this was the earliest pathology signature identified in this study and similar to the anemia signature was detected before the onset of severe disease. this set of genes was up-regulated as early as 2 days post infection in all cb infected mice regardless of eventual survival. it has been shown that in severe p. falciparum infections, platelets mediate irbc clumping and adhesion 11, 12 . these observations of association between infection severity and platelets aggregation suggest that similar mechanisms underlie pathology in both the p. c. chabaudi model of malaria and in human infections, and the experimental model may be useful to explore the underlying mechanisms. it would be of great interest to analyse the platelet aggregation signature in human malarial infections and investigate whether this transcriptomic signature could be used as an early marker to predict development of severe pathology. the anemia signature identified was present in the whole blood transcriptome ahead of the clinical onset of rbc loss in both avirulent as and virulent cb infections, but it was stronger and lasted longer in the cb infection. this transcriptomic signature predicted the more severe and longer-lasting anemia we have observed in cb infections 4 . both the anemia signature and the heme biosynthesis ii pathway analysis indicate a deregulated or stressed host erythropoietic response in the more severe cb infection. in addition to the platelet aggregation and anemia signatures, we identified a lung inflammatory signature in cb infected mice. although sequestration of p. c. chabaudi as parasites in lungs has been documented 8 , lung damage has not been previously reported for this experimental model. we confirmed that this sars-related lung inflammation signature in the blood was indeed associated with a more severe pulmonary neutrophilic infiltration and more cell death in the lungs in cb infections. furthermore, it was linked to a higher level of sequestration of cb irbc in this organ. both p. falciparum and p. vivax can sequester within the pulmonary microvasculature and cause lethal malaria-associated acute respiratory distress syndrome (ma-ards) 13 . members of the pfemp1 family (p. falciparum erythocyte membrane protein-1) of variant surface-expressed parasite proteins have been shown as parasite ligands mediating parasite cytoadherence 14 . although pfemp1 is lacking in other plasmodium parasites, another multigene family pir (plasmodium interspersed repeat) is present in most, if not all, species of plasmodium; and there is evidence that some pirs in p. vivax bind to icam-1 endothelial receptor in vitro 15 . it is possible that differential pirs expression between p. c. chabaudi as and cb is responsible for this differential pulmonary sequestration ability. however, it is also possible that as parasite is removed more effectively from the lung than cb due to the higher inflammation caused by cb infection. the higher level of cb pulmonary sequestration leaves greater amounts of hemozoin compared with the as parasite. there is evidence that hz can directly induce pulmonary proinflammatory responses 16 . in addition it has been shown that parasite-derived microparticles can induce macrophage activation in a tlr4 (toll-like receptor 4)-myd88 dependent manner 17 . in our study, cb infection induced higher level of inflammation (ifng, il-6 and mrp14) in the lungs of infected mice. mrp14 (s100a9) is one of the top up-regulated genes identified in the lung inflammation signagure. together with s100a8 (mrp8), mrp8/14 forms a heterodimer complex that has previously been shown to be a potent chemotactic factor for myeloid cells, especially neutrophils 18 . mrp8/14 are tlr4 ligands and are recognized as damage-associated molecular pattern molecules (damp) involved in many inflammatory diseases and infections 19 . for example, in tuberculosis and influenza infection, mrp8/14 is shown to exacerbate pro-inflammatory responses, cell-death and pathogenesis 20, 21 . of relevance here, mrp14 protein is significantly increased in p. falciparum and p. vivax infected patients 22, 23 . interestingly, in our p. c. chabaudi mouse model, mrp14 was detectable in all mice infected with the virulent cb strain; by contrast, it was detectable in only 40% of mice infected with the avirulent as strain. moreover, when mrp14 was detected in as infected mice, it was present at significantly lower level than that in cb infected mice. this coincided with a significantly higher number of mrp14 hi ly6g + neutrophils in the lungs of cb infected mice. it is possible that mrp14 + cells respond to the microparticles upon rupture of sequestered cb schizonts, leading to proinflammatory response and recruiting more mrp14 + neutrophils. our analysis offers evidence that different parasite strains, exhibiting different sequestration tendencies, can lead to different levels of lung inflammation and damage. deciphering the complex host immune responses during acute malaria is extremely challenging. here we demonstrate that whole blood transcriptomic signatures can help to reveal severe malaria-associated pathologies, often preceding clinical observations. our data demonstrate the potential in searching further transcriptomic signatures in human malaria for severity diagnosis and prognosis. furthermore, these blood signatures can also provide crucial information about the pathogenic processes taking place in organs or tissues during infection, as demonstrated here with the neutrophil-related lung inflammation signature. this unbiased modular analysis of blood transcriptomic data also offers a promising method to search for protective mechanisms in mouse and human malarial infections. this is particularly important for p. vivax infections of humans, because of its greater genetic diversity 24 , and the recent surge in reports of severe and fatal p. vivax malaria 25, 26 . mice. female c57bl/6 aged 6-8 weeks from the spf unit at the francis crick institute mill hill laboratory were housed under reverse light conditions (light 19.00-07.00, dark 07.00-19.00 gmt) at 20-22 °c, and had continuous access to mouse breeder diet and water. core body temperature was measured with an infrared surface thermometer (fluke); body weight was calculated relative to a baseline measurement taken before infection; and erythrocyte density was determined on a vetscan hm5 haematology system (abaxis). this study was carried out in accordance with the uk animals (scientific procedures) act 1986 (home office licence 80/2538 and 70/8326), and was approved by the francis crick institute ethical committee. walliker, university of edinburgh, uk and subsequently passaged through mice by injection of infected red blood cells (irbc) at the mrc national institute for medical research, uk and cryopreserved as described 27 . for experimental work, infections were initiated by intraperitoneal (i.p.) injection of 10 5 irbc derived from cryopreserved stocks. the course of infection was monitored on giemsa-stained thin blood films by enumerating the percentage of rbc infected with asexual parasites (parasitemia). the limit of detection for patent parasitemia was 0.01% infected erythrocytes. mice were culled upon reaching humane end points by showing the following signs: emaciation (more than 25% weight loss), persistent labored breathing, severe hypothermia (body temperature below 28 °c), inability to remain upright when conscious or lack of natural functions, or continuous convulsions lasting more than 5 min. p. c. chabaudi as and cb expressing luciferase under the control of the constitutive promoter eef1a were generated by transfection with the construct ppc-luc230p, targeting the neutral p230p locus (pchas_0308200 or pchcb_0308200). transfection and cloning of transgenic p. chabaudi parasites were performed as described previously 28 , and integration was verified by southern blot analysis of chromosomes separated by pulsed field gel (pfg) as described 29 . the construct ppc-luc230p was modified from ppc-luccam 8 by replacing the p. chabaudi ssu targeting region with 230p targeting region, chab03 277001-278950, generated by gene synthesis (genewiz llc, nj, usa). female c57bl/6 mice aged between 6-8 weeks were intraperitoneally infected with 10 5 irbc of p. c. chabaudi as or cb. at 2, 4, 6, 8, 10 and 12 days post infection, 0.5 ml of blood was collected via cardiac puncture into 1 ml tempus rna stabilising solution (applied biosystems). naïve samples were also collected at day 0 (the day of infection) and day 12 (the end of the experiment) and used as controls. samples were snap frozen on dry ice and stored at − 80 °c until rna isolation. total blood rna was extracted using perfectpure rna blood kit (5 prime) and globinclear kit (ambion) was used to remove globin mrna according to the manufacturer's instructions. crna samples were prepared from 300 μ g globin reduced blood rna using illumina totalprep rna amplification kit (ambion) and hybridized to illumina mouse wg-6 v2.0 beadarrays according to the manufacturer's protocols. at each step, the quantity and quality of the rna samples was verified using nanodrop 1000 spectrophotometer (thermo fisher scientific) and caliper labchip gx (caliper life sciences). microarray data analysis. illumina beadstudio/genomestudio software was used to subtract background and scale average samples' signal intensity and genespring gx 13.1 software (aigent technologies) was used to perform further normalization and analyses as described previously 30 . first, all signal intensity values less than ten fluorescent units were set to equal ten, log 2 transformed and per chip normalised using 75 th percentile shift algorithm. transcripts were further normalized to the median across all samples or to the median of control samples. transcripts were first selected if they were present (cut off 0.99) in ≥ 10% of all samples, and further filtered with a minimum of 2-fold expression up-or down-change compared with the median intensity across all samples. all microarray data are deposited in geo under accession number gse93631. genespring software was used to perform statistical tests, anova unequal variance with post-hoc tukey's hsd (honest significant difference) test, followed by benjamini-hochberg multiple test correction (fdr < 0.01); fold change was further performed on the combined list of transcripts differentially expressed either in as or cb infection, with 2-fold cut off compared to naïve controls. the set of transcripts was defined as differentially expressed transcripts and was used for further analyses. hierarchical clustering of samples at different infected time points compared to naïve were performed using pearson uncentred correlation with an average-linkage-clustering algorithm that organizes all transcripts according to their trend of expression across all samples. the hierarchical clustering on the 6226 transcripts differentiall expressed in as or cb (supplementray table 1 ) across the acute phase of infection was performed using euclidean distance metric with ward's linkage rule. for the pathological modules (in fig. 4) , prediction was performed on the 6321 transcripts differentially expressed in as or cb infection including the samples collected at 9 dpi (supplementray table 2 ) using the self-organising map algorithm in genespring. euclidean distance was used for similarity measurement and the maximum number of iterations was set at 10e5. the initial learning rate was set at 0.03 and initial neighbourhood radius 5, the number of grids was tested from 10 × 10, till less than 15% of clusters have similarities above 90%, at a final grid of 4 × 6 (24 clusters). ingenuity pathways analysis (ipa) (qiagen) was used to identify enriched disease and functions and networks. the significance of the association between the dataset and each analysis was measured using fisher's exact test, z score cut-off 2 and/or p value cut-off 0.01. this program was also used to map the canonical pathways and overlay it with expression data from the dataset. module annotation was determined using disease and function analysis in ipa. to obtain bronchoalveolar lavage fluid (balf), mice were terminally anaethetised, and lungs were cannulated and inflated with 500 μ l pbs. the liquid was retrieved and spun at 300 g for 10 min at 4 °c. supernatants were obtained and kept at − 80 °c till further analysis. igm levels in balf were quantified using a sandwich elisa. (southern biotech). detection of mrp14 and cytokines in sera and lung lysate. mouse serum was collected via cardiac puncture, clotted in room temperature for 30 min and collected by centrifuging twice at 10,000 g for 10 min at 4 °c. lung proteins were extracted in ripa lysis buffer with protease inhibitor cocktails (sigma) and homogenized with polytron homogenizer (kinematica) on ice. protein levels were quantified by pierce bca protein assay (thermo scientific) as per the manufacturer's instructions. all plates were read on a safire ii plate reader (tecan). mouse s100a9 elisa kit (r&d systems) was used to determine the level of s100a9/mrp14 in serum and lung lysate samples following manufacturer's instructions. cytokine concentrations were determined using cytometric bead array (biolegend) following the manufacturer's manual. histology and immunohistochemical analyses. the lungs were extensively perfused with 10 ml pbs and then inflated by injection of 3 ml of 10% neutral buffered formalin (nbf) through the tracheal cannula. tissue was then fixed overnight in 10% nbf, and transferred into 70% ethanol until embedded in paraffin and sectioned. each lung specimen was stained with haematoxylin and eosin (h&e). for each mouse, the number of hemozoin crystals were quantified from 10 randomly selected fields on h&e stained slides under leica light microscopy (400× ). immunohistochemical staining was performed to examine the expression of mrp14 on paraffin-embedded lung sections with anti-mrp14 antibody (clone 2b10). tunel staining was performed using apoptag ® fluorescein in situ apoptosis detection kit (merck millipore) following the manufacturer's protocol. imaging of slides was performed on a vs120 slide scanner (olympus) with a vc50 camera, a uplsapo lens, at a magnification of 20× or 40× . images were processed and analysed using olyvia image viewer 2.6 (olympus) and fiji 31 . and tunel positive cell numbers were quantified in an area of 1nm 2 using olyvia image viewer 2.6. in vivo imaging and luciferase assay. mice were infected intraperitoneally with 10 5 rbc infected with pccasluc 230p or pcccbluc 230p parasites; and at each time point 2 μ l of heparinized tail blood was collected before sequestration 8 . bioluminescence was assessed with the luciferase assay system (promega) according to the manufacturer's protocol and quantified with the tecan safire2 plate reader and magellan software (tecan). under these conditions, bioluminescence intensity is proportional to the amount of parasites in this blood volume 8 , which reflects the total parasite load before sequestration. at the time of maximum sequestration (12.00-14.00 h gmt, reverse light) 8 , d-luciferin (150 mg/kg, caliper life sciences) was injected subcutaneously 5 min before whole-body and organ imaging. mice were terminally anaesthetized and systemically perfused by intracardiac injection of 10 ml pbs 8 . the brain, lungs, liver, spleen, left kidney and gut were removed immediately and luciferase assessed using in vivo imaging system ivis lumina (xenogen), with a 10 cm field of view, a binning factor of 4, and an exposure time of 10 s. bioluminescence (total flux per second) was quantified with the software living image (xenogen) by adjusting a region of interest to the shape of each organ. to account for the influence of total parasite load on the number of parasites sequestered in the organs, bioluminescence in the organs was normalized to total parasite load. luciferase activities measured in the organs were divided by parasite load in 2 μ l blood (see above), allowing comparison between mice with different parasite burdens. quantifying genetic and nongenetic contributions to malarial infection in a sri lankan population malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen-specific t cells disruption of il-21 signaling affects t cell-b cell interactions and abrogates protective humoral immunity to malaria the severity of malarial anaemia in plasmodium chabaudi infections of balb/c mice is determined independently of the number of circulating parasites expression profile of immune response genes in patients with severe acute respiratory syndrome an unsupervised hierarchical dynamic self-organizing approach to cancer class discovery and marker gene identification in microarray data complement driven innate immune response to malaria: fuelling severe malarial diseases sequestration and histopathology in plasmodium chabaudi malaria are influenced by the immune response in an organ-specific manner genome-wide association study indicates two novel resistance loci for severe malaria evidence for additive and interaction effects of host genotype and infection in malaria platelet-mediated clumping of plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria platelet-induced clumping of plasmodium falciparum-infected erythrocytes from malawian patients with cerebral malaria-possible modulation in vivo by thrombocytopenia pathogenesis of malaria-associated acute respiratory distress syndrome malaria's deadly grip: cytoadhesion of plasmodium falciparum-infected erythrocytes functional analysis of plasmodium vivax vir proteins reveals different subcellular localizations and cytoadherence to the icam-1 endothelial receptor hemozoin induces lung inflammation and correlates with malaria-associated acute respiratory distress syndrome parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation proinflammatory activities of s100: proteins s100a8, s100a9, and s100a8/a9 induce neutrophil chemotaxis and adhesion the endogenous toll-like receptor 4 agonist s100a8/s100a9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer s100a8/a9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis damp molecule s100a9 acts as a molecular pattern to enhance inflammation during influenza a virus infection: role of ddx21-trif-tlr4-myd88 pathway mrp 8/14 as marker for plasmodium falciparum-induced malaria episodes in individuals in a holoendemic area up-regulated s100 calcium binding protein a8 in plasmodium-infected patients correlates with cd4(+ )cd25(+ ) foxp3 regulatory t cell generation the malaria parasite plasmodium vivax exhibits greater genetic diversity than plasmodium falciparum is plasmodium vivax malaria a severe malaria?: a systematic review and meta-analysis evidence and implications of mortality associated with acute plasmodium vivax malaria vector transmission regulates immune control of plasmodium virulence transformation of the rodent malaria parasite plasmodium chabaudi high-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite plasmodium berghei detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy fiji: an open-source platform for biological-image analysis were made in graphpad prism, each dot represents an individual biological replicate and p-values were derived from mann whitney u test or multiple t-test. we would like to thank thibaut brugat, audrey vandomme and barbara capuccini for critical reading of the manuscript. we are grateful to the brf at mill hill for animal husbandry, to the high-throughput screening (hts), flow cytometry, experimental histopathology and microscopy facilities at mill hill for excellent technical support. this work is supported by the francis crick institute, which receives its funding from the uk medical research council (grant u117584248), cancer research uk, and the wellcome trust (grant wt104777ma). key: cord-292402-u3sfc1yz authors: watanabe, rihito; kakizaki, masatoshi; ikehara, yuzuru; togayachi, akira title: formation of fibroblastic reticular network in the brain after infection with neurovirulent murine coronavirus date: 2016-04-28 journal: neuropathology doi: 10.1111/neup.12302 sha: doc_id: 292402 cord_uid: u3sfc1yz cl‐2 virus is an extremely neurovirulent murine coronavirus. however, during the initial phase of infection between 12 and 24 h post‐inoculation (hpi), the viral antigens are detected only in the meninges, followed by viral spread into the ventricular wall before invasion into the brain parenchyma, indicating that the viruses employ a passage between the meninges and ventricular wall as an entry route into the brain parenchyma. at 48 hpi, the passage was found to be constructed by er‐tr7 antigen (erag)‐positive fibers (erfibs) associated with laminin and collagen iii between the fourth ventricle and meninges at the cerebellopontine angle. the construct of the fibers mimics the reticular fibers of the fibroblastic reticular network, which comprises a conduit system in the lymphoid organs. in the meninges, erfibs together with collagen fibers, lining in a striped pattern, made up a pile of thin sheets. in the brain parenchyma, mature erfibs associated with laminin were found around blood vessels. besides mature erfibs, immature erfibs without associations with other extracellular matrix components like laminin and collagen appeared after infection, suggesting that the cns creates a unique conduit system for immune communication triggered by viral invasion. coronaviruses have relatively high mutation and rna recombination rates and rapidly undergo cross-species transmission events in vitro and in vivo. [1] [2] [3] in humans, viruses newly emerging out of members of coronaviridae cause serious diseases, such as severe acute respiratory syndrome (sars) 4 and middle east respiratory syndrome (mers). 5 interest in the pathogenicity of murine coronaviruses, particularly, mouse hepatitis virus (mhv), has grown because of the high incidences of mutation rates with consequences of different pathogeneses 6-10 as well as their ability, especially in jhm strains of mhv (jhmv), to cause both acute and chronic cns diseases , 10, 11 because neuropathogenic viruses can induce significant neuronal dysfunction and degeneration of specific neuronal populations, sometimes leading to devastating, life-threatening consequences in infected humans. 12, 13 among jhmvs, cl-2 exhibits extremely high neurovirulence. 10, 14, 15 a less virulent viral clone, srr7, has been isolated from cl-2, as a soluble receptor-resistant mutant. 16, 15 all mice infected with cl-2 die within 3 days post-inoculation (dpi), whereas mice infected with srr7 exhibit no clinical sign before 5 dpi and some of them survive after 10 dpi. however, there is no difference in the viral growth rate during the initial phase of infection between these two strains. 15, [17] [18] [19] the different virulence of these viruses is attributed to their capability to infect neurons, 15, 20 or their infectivity being independent or dependent upon a major mhv-receptor, carcinoembryonic cell adhesion molecule 1. 21, 22 in agreement with their similar viral proliferation rates during the early phase of infection, the two viruses exhibit almost the same patterns of viral spread in the brain during the initial phase of infection. the viral antigens are first detected in the infiltrating cells, namely cd11b-positive (cd11b + ) cells of monocyte lineage, in the meninges at 12 h post-inoculation (hpi), and not at the site of the inoculation in the frontal lobe. 17, 19, 23 during 24 to 48 hpi, infected cd11b + cells appear in the ventricular cavity followed by infection of cell components of the ventricular wall, before viral spread into the brain parenchymal cells. 17, 18 the ventricular wall is also the target site during th einitial phase of infection with other species of viruses, including herpes simplex virus 24 and lymphocytic choriomeningitis virus. 25 the manner of the viral spread after infection with cl-2 or srr7 indicated that there could be some other routes of viral entry into the brain parenchyma than crossing over the blood brain barrier (bbb), which has been almost exclusively studied or hypothesized as the mechanism of neuropathogenic viral entry into the brain parenchyma, [26] [27] [28] [29] [30] including a pioneering study of poliovirus using genemanipulated mice introduced by the human-type polioviral receptor-gene. 31 however, the mechanism of viral distribution of a neurovirulent strain of polioviruses, the mahoney strain, infecting motor neurons in the cns, was not elucidated through studies of its ability to circumvent the bbb in comparison with that of an attenuated viral strain, sabin strain. 32 our investigation to identify the viral entry route focused on the area between the fourth ventricle (ivv) and meninges in the cerebellopontine angle, because viral antigens are often found in the area during the early phase of infection between 24 to 48 hpi, 17, 18 and there is a conduit, the foramen of luschka, for csf to flow from the ventricle into the subarachnoid space. another intriguing feature of viral antigen localization after infection with cl-2 or srr7 is that the viral antigens were found in fibrous structures, which appeared to be the extracellular matrix (ecm), in the brain and spleen. 17, 18 viruses proliferate and produce viral antigens in living cells, and it is unusual to find them in the ecm area through a light-microscopical observation. however, such colocalization of viral antigen or viral particles with the ecm has been reported to occur in the lymphoid organs. after infection with lymphocytic choriomeningitis virus (lcmv), viral antigens are colocalized with the components of reticular fibers, including collagen iii and laminin, in the spleen. 33 similar phenomena have been reported in infection with extremely virulent viruses, such as ebola, 34 marburg and lassa viruses. 35 these viruses infect fibroblastic reticular cells (frcs) in the lymphoid organs, followed by immune dysfunction leading to viral persistence 33 or tissue destruction. 35 frcs are considered to maintain reticular fibers, which compose fibroblastic reticular network (frn) in the lymph nodes [36] [37] [38] and spleen. 39, 40 erasmus university rotterdam thymic reticulum antibody 7 (er-tr7) has been used to define frcs, 41, 42, 33 although the antigen of er-tr7 has yet to be determined. furthermore, there have been no reports on the size or determinant of the antigen using immune reactions, including western blotting or immunoprecipitation. each reticular fiber comprising the frn is around 1 μm in diameter, and contains collagen fibers as a core surrounded by an er-tr7 antigen-positive (erag + ) microfibrillar layer, and is further enclosed with a basement lamina at the outer surface. the entire fiber is largely ensheathed by frcs. 43 the frn functions as a conduit system for immunocompetent cells and inflammation-associated molecules such as cytokines and ligands or foreign antigens to reach appropriate sites in order to cause immune reactions in the lymph nodes 44 and spleen, 39 or to guide homing of the cells. 42, 40 subsequently, frcs, which are podoplanin (gp38)-positive (pod + ) and cd31-negative (cd31 à ), have been reported to co-operate with other stromal cells in the lymph nodes, such as pod + cd31 + lymphatic endothelial cells, pod à cd31 + blood endothelial cells, and pod à cd31 à myofibroblastic pericytes, to play a key role in the frn function, 45, 46 indicating that there should be organ-specific specialization of the fibroblastic stroma. in this report, we show the virus antigens detected in the brain as fibrous structures colocalized with erag and laminin as the same images, as previously reported in the spleen infected with lcmv. 33 this finding encouraged us to prove the expression of erag along the reticular system in the brain, which could function as a scaffold for viral entry and inflammatory cell invasion into the brain. the highly neurotropic mhv strain mhv-jhm cl-2 (cl-2) 14 was used. this virus was propagated and titrated using dbt cells maintained in dulbecco's modified eagle's minimal essential medium (dmem) (gibco, grand island, ny) supplemented with 5% fetal bovine serum (fbs) (sigma, tokyo japan), as previously described. 14 specific pathogen-free inbred balb/c mice purchased from charles river (tokyo, japan) were maintained according to the guidelines set by the committee of our university. for the experiment with infectious agents, mice were transferred to a biosafety level 3 (bsl-3) laboratory after permission from the committee. at 7-8 weeks old, each mouse was inoculated with 1 × 10 2 of cl-2 virus into the right frontal lobe under deep anesthesia. as described previously, 17 the scar caused by the needle tip was found in the right frontal lobe after post mortem examination. between 12 and 72 hpi, organs including the brains and spleens were removed from treated or untreated mice after exsanguination under deep anesthesia. parts of the organs were embedded in tissue tek oct (sakura, tokyo, japan) and frozen to prepare frozen sections. remaining portions were processed for viral titration, or fixed in 4% paraformaldehyde buffered with 0.12 mol/l phosphate (pfa) for pathological examination using paraffin-embedded sections to check that each experiment had been appropriately performed as we previously reported using cl-2 for infection, 17, 15 and no contradiction was found (data not shown). some mice were perfused with pfa from the aorta via the left ventricle under deep anesthesia using diethyl ether and 0.2 mg of chlorar hydrate (mylan seiyaku, tokyo, japan) per mouse to obtain sections for the detection of dexran labeled with texas red, for the three-dimensional construct, or for double or triple immunostaining that includes podoplanin detection. ten-micrometer cryostat sections prepared from unfixed frozen tissues were fixed in ice-cold acetone for 10 min. pfa-fixed tissues were rinsed with graded concentrations of sucrose overnight, and processed to prepare cryosections as previously described, 18 which were used without further fixation. chamber slides with mixed primary culture were fixed either in cold ethanol for 1 min followed by fixation in cold acetone for 5 min, or in pfa for 5 min to perform double or triple immunostaining that includes podoplaninstaining. immunostaining was carried out using the antibodies and reagents listed in table 1 , as previously described. 18 fluorescence was visualized with a confocal laser scanning microscope (leica microsystems, heidelberg, germany) to obtain images of double or triple immunostaining and three-dimensional constructs. a fluorescence microscope (keyence, osaka, japan) equipped with a bz analyzer (keyence) was used for statistical study. one mg of 10 kilodalton lysine fixable dextran labeled with texas red (invitrogen corp., carlsbad, ca, usa) was injected intravenously in 400 μl of pbs through the tail vein. ten minutes after the injection, mice were perfused with pfa, the brains and spleens were immersion-fixed overnight in pfa, and then processed for cryosections as described earlier. the pfa-fixed brains were processed either for 40-μm cryosections, or thick sections of 90-150 μm thick, which were prepared by slicing the brain with sharp stainless blades under a dissecting microscope. the cryosections were stained in the same way as the other cryosections described earlier. all procedures to stain the thick sections were performed in a floating state. after rinsing in 0.12 mol/l tris-hcl (ph 7.4) for 1 h, thick sections were incubated with blocking solutions for 1 h, 18 followed by incubation with primary antibodies overnight. each of the second and third steps of staining were conducted for 30 min. three-dimensional images were generated with leica software (leica microsystems, heidelberg, germany). twenty-four-bit color images with a 1360 × 1024 pixel resolution were acquired with a fluorescence microscope (keyence). three independent approaches were performed to quantify the observed immunofluorescence signal using the bz analyzer. the background fluorescence intensity (fi) in areas of the field of view was subtracted from total measurements of fi. the average fluorescence intensity (afi) within the unit area was obtained by dividing its integrated fi by its area. an increased level of erfibs in the restricted area of the brain was already detectable at 12 hpi with cl-2 ( fig. 1a -c), with an increased and intense staining for erfib compared with that of an uninfected mouse (fig. 1b ) or sham infected mouse ( fig. 1c ) in the root of the trigeminal nerve, especially in the area where gfap-positive activated astrocytes were observed near the border with the peripheral nervous system (fig. 1a3) . a more extended distribution of erfibs was observed during the later phase of infection (fig. 1d , e). furthermore, virus antigens in fibrous structures reported in our previous study 17, 18 were found to colocalize with laminin and erag ( fig. 1f ) with almost the same image observed in the spleen of mice infected with lcmv, 33 which indicated that viruses are concentrated in the narrow space of reticular fibers 33, 43 and are recognized by immunofluorescence, and they use the reticular conduit system as a scaffold. 33, 35 in order to quantify the increase and association of erfibs with laminin, the average fluorescence intensity (afi) of divided areas (0.9-2.4 × 10 4 μm 2 ) was measured in sections which included the pons ( fig. 2a) . there was a high positive correlation of the distribution and intensity between laminin and erag expression in an untreated mouse (r 2 = 0.82) and virally infected mouse at 48 hpi (r 2 = 0.78, fig. 2a) , as well as an increase of the expression at 48 hpi with cl-2 compared with that at 12 hpi ( table 2 ). the laminin expression of the mouse at 12 hpi with cl-2 was more rapid compared with the erag expression, and was more extensive at 48 hpi than those of medium or untreated mice (table 2) . next, a detailed study of afi in the area around the foramen of luschka, which provides a conduit for csf between the fourth ventricle and subarachnoid space at the cerebellopontine angle, was performed, because the viral antigens are initially detected in inflammatory cells that have infiltrated the meninges, followed by inflammatory cells in the ventricular cavity and cell components of the ventricular wall. 17, 18 afis in the dotted areas in figure 3e were compared among those of cl-2-, sham-infected and untreated mice (fig. 2b) . because of variable afi levels in individual mice, especially in infected mice showing high sds, a significant increase of afi in the area of cl-2-infected mice compared with that of sham-infected mice at 48 hpi was obtained in the deeper area of the fourth ventricle, 300-500 μm inside from the outermost portion of the lateral recess of the fourth ventricle (ov) (fig. 2b) . at 72 hpi, the expression of erfib remained at high levels in cl-2-infected mice, whereas the relatively high levels in the outer areas of the lateral recess of sham-infected mice at 48 hpi decreased at 72 hpi to the levels of untreated mice (fig. 2b ). the expression of erag was either colocalized with that of components of the extracellular matrix (ecm) such as laminin (fig. 1d ) and collagen (fig. 1e ) in the same way as reticular fibers reported in lymphoid organs, 33 or found without such colocalization as shown in the brain parenchyma ( fig. 1d2 and d3) and trigeminal root (supplemental figure s1a ). in the ventricle, we also found erag without an association with other ecm (figs 1e and 4d ), which indicated that there could be immature erfibs formed during initial events of the host reaction, compared with the mature form of erag + reticular fibers associated with several kinds of ecms observed in lymphoid organs. 33, 45, 47 therefore, we compared the length of erfibs colocalized with laminin in the ventricle between those of infected and sham infected mice, and found a greater difference between those in the two groups (fig. 2c ) than on comparison of erfibs alone. erag + structure as a conduit in the brain in order to examine whether the expression of erfib plays a role as a conduit system in the ventricle as reported in the spleen and lymph node, 39,44 fluorescence-labeled dextran was intravenously injected. mice infected with the virus showed the infiltration of many particles of dextran along with erfibs into a deep area in the ventricle ( fig. 3a and supplemental figure s1b ). a few dextran particles were detected in the hilum of the ventricle near the border with the meninx of sham-infected mice (fig. 3b) , and no trace of the particles was seen in the ventricles of mice with no treatment (fig. 3c) . the dextran particles were appropriately introduced into the recipients, because a high level of the particles was seen in the spleen of mice with no treatment along with erfbs, especially in the marginal zone around the follicle (fig. 3d) , and partially in the follicle (insert in fig. 3d ), as previously reported. 39 the viral antigens were detected in the ventricle of cl-2-infected mice in a similar way as dextran particles. in the deeper area of the ventricle at the positions corresponding to b and c in figure 3e , viral antigen-positive cells closely associated with erfibs were observed ( fig. 3g and h, respectively) . however, in the area near the junction between the meninges and ventricle at position a in figure 3e , the viral antigens did not always distribute along with erfibs (fig. 3f) , possibly because viruses brought into the ventricle earlier than in the deeper area had time to induce the antigens in the infiltrated and domestic cells after infection. because viral antigens are already detectable in cells of the monocyte lineage (mocs) that have infiltrated the meninges during the initial phase of infection at 12 hpi, 17 cd11b-positive (cd11b + ) cells as a carrier to transport viruses into the ventricle were examined. double staining for cd11b and erag revealed a close association of mocs and erfibs in the ventricle (fig. 3i) . as expected, many of the cd11b + cells in the ventricle were infected (fig. 3j ). in order to study stereostructures of erfbs, we threedimensionally reconstructed consecutive confocal images with prominent astrocytic activation (a3)), the expression of er-tr7 antigen (erag) was detected. the dotted area in a1 is shown at higher magnifications (a2 and a3). the orientation of this area is shown at a lower magnification in supplemental figure s1a2 . b: a low level of erag was detected (b1) especially in the area of the peripheral nerve (gfap-negative lower area). the area of the peripheral nerve is shown as a laminin-positive area in the serial section (b2). c: moderately more intensive staining of erag was observed in the sham-infected mouse than in the uninfected mouse. the boxed area is shown at a higher magnification (c2 and c3). in the area of the peripheral nerve (lower area), erag was not colocalized with laminin (supplemental fig. s1a ), although, in the peripheral nervous system, there were abundant amounts of laminin (b2) comprising the basement lamina around schwann cells. d: at 48 hpi with cl-2, erag colocalized with laminin around the blood vessels (arrows) and meninx (triangles) became prominent. away from the blood vessels and meninx, erag + areas without such colocalization were distributed. higher magnifications (d2 and d3) of boxed areas in d1 show that some areas of the erag + laminin arrangement exhibit cellular structures, and some fibrous configurations (arrowhead). e: erag and collagen iii, in the fourth ventricle. f: colocalization of laminin, collagen iii and the viral antigens in the meninx around the pons is shown in white. single and double bars indicate 50 and 20 μm, respectively. of 40 μm-thick sections of the brains. the integrated intensity of immunofluorescence of 35 slices of a 1.5 μm thickness showed robustly stained fibrous structures with a more than 5 μm thickness in the meninx (fig. 4a) and ventricle (fig. 4e) , which were double-stained for erag and collagen or laminin, respectively. in the meninx, most of the erfbs seemed to localize together with collagen based on the view of the integrated image (fig. 4a) . however, rotation of the image revealed a sheet composed of erfbs and collagen fibers in a fine striped pattern ( fig. 4c and supplemental movie s1). at the meninx with inflammation, many cells were observed, after triple staining for the nucleus, erfibs and collagen, in the narrow space between the sheets composed of an association of erfibs and collagen (fig. 4b) . another finding obtained from three-dimensional analysis was that a hammock-like structure composed of fine erfbs table 2 . b: the area in the fourth ventricle (ivv) including the space and ependymal cell layers was divided into five areas between the outermost portion of the lateral recess of the ivv (ov) and 500 μm distant from ov. afi of erag is shown as fi of each area per pixel obtained from three independently treated mice for each group. vertical lines indicate sd. c: the average length per μm 2 of erag-positive fibers associated with laminin expression in ivv obtained from three independently treated mice for each group. vertical lines indicate sd. * and ** indicate the p-value (p) examined by student's t-test <0.05 and <0.005, respectively. hanging on bold lines of laminin, which were partially colocalized with erfibs, was formed in the ventricle (fig. 4e and supplemental movie s2), which could have been ignored on non-specific staining based on typical confocal images of two dimensions because of their overly faint staining. in the meninges, arachnoid cells with the expression of cytokeratin or zic2 showed colocalization with erag (fig. 5c, d) . arachnoid cells are reportedly podoplaninpositive (pod + ), 48 just as with frcs in the lymphoid organs. [45] [46] [47] however, in our analysis, only part of zic2 + cells in the meninges was pod + (supplemental fig. s1c) . a thick pod + layer in the meninges was colocalized with erag ( fig. 5b) , most of which could be produced by fibroblasts, which are located in the meninges. 49 some podoplaninnegative (pod à ) cells (arrowheads in fig. 5b ) as well as structures making up the basal area (arrows in fig. 5b ) of meninges were also found to be erag + . in the ventricle, some of the ependymal cells with cytokeratin expression were found to produce erag. in the brain parenchyma, many gfap-positive astrocytes, especially those comprising glia limitans at the brain surface (fig. 5f) , or near the border with the peripheral nerve (fig. 1c) , were found to be erag + . deep in the parenchyma, erag + astrocytes were observed around the blood vessel (fig. 5g) . however, in the brain parenchyma, many erag + cells without colocalization with laminin (fig. 1d3) , which were not located around the blood vessels, were seen. furthermore, astrocytes situated away from blood vessels deep in the brain parenchyma, even though they had contact with erag + cells, did not produce erag (supplemental fig. s1d) . therefore, we examined other cell types which produce erag in the brain parenchyma, and found erag + neurons and oligodendrocytes (fig. 5h, i) , in addition to endothelial cells (fig. 5j) and pericytes (fig. 5k ) of blood vessels (bv) in the brain parenchymal area (pabv). however, brain parenchymal cd11b low cells (arrowheads in supplemental fig. s1e ), possibly microglia, 50 as well as infiltrating cd11b high cells in the meninges (arrows in supplemental fig. s1e ) and ventricle ( fig 3i) were erag à . in addition, erag + cells distributed in the area away from the viral antigen-positive site (fig. 5l) indicated that the signal of viral entry reached these erag + cells via an undetermined pathway. a classical neuropathology states that, in the brain in the presence of infectious diseases, there is an increase in reticular fibers, detected by silver staining, and these fibers are associated with inflammatory cells. 51 a recent study also detected an increase of reticular fibers as second harmonic generation structures in toxoplasmic encephalitis (te). 52 although the modern sophisticated technique revealed a three-dimensional structure of the reticular network, which may be used as a scaffold for antigen-specific t cells to fig. 2a, respectively) , where 2% of the population measured in (v-) mouse were found. when afis are higher than the highest afi measured in the (v-) mouse, which corresponds to an afi of >15.4 or 6.8 in laminin or erag staining, respectively, that was defined as highly positive (high). hps, hours post-infection; n, no matched areas. figures in the parentheses are mean ± sd, and the figures without ± show that one area was counted under the term. the significance of the difference was analyzed by student's t-test, with p-value shown. migrate into the infected sites in the brain, questions that were raised half a century ago 51 (what are the components of the reticular fibers, and which cells in the cns produce the components?), still remain to be answered. 52 in this report, we showed erfibs as one of such components, which increase during infection and comprise a reticular network unique to the brain (brrn) but in part analogous to frn in the lymphoid organs, detected as erag + fibrous structures and forming a conduit system . 39, 44, 45 erag + structures have been detected in the brains after infection 52, 53 or physical treatment, 49 and in the retina of gene-manipulated mice, 54 as well as in normal mice at low basal levels in the meninges 49, 52 and basement membrane of blood vessels. 52 in these reports, erag was used as a marker of reticular fibroblasts, although the figures in the papers show the co-localization of erag and gfap , 49, 54 and the contribution of erfibs to immune-mediating communication or a scaffold is not mentioned. one of the reasons that such an important role of erfibs to operate a conduit system in other organs was not described could be that the authors might have been obliged to limit the character of erag + structures, because an increase of these structures in injured regions, which were examined at around 1 week or more after the treatment of the mice, might not be large enough to trace and prove that they function as a conduit system. for example, erag + structures in the meninges have been reported to be found only in the sulcus 52 where the arachnoid membrane does not exist. in contrast, our results showed high expression of erag + structures in the arachnoid membrane. the reason why we could trace the erfibs could be that the virus cl-2 is an extremely neurovirulent strain, leading infected mice to a morbid state in 48 hpi. 8, 9, 14 the more vigorous the insult is, the more extended the host reaction would be. actually, the increased thickness of the arachnoid membrane formed during concentrated time periods after the infection enabled us to observe the architecture of a striped pattern consisting of erfibs and collagen fibers, forming the sheet of a thin membrane. each of the sheets was approximately 0.7-1.0 μm thick, which corresponds to the diameter of each reticular fiber serving as a unit of the conduit system in the lymphoid organs, 43, 45 and the sheets had been considered to be meningeal fibers on the two-dimensional observation of thin sections. furthermore, between the sheets, many cells were detected, many of which should be infected cd11b + cells. 17, 18 a classic neuropathological understanding of the sites of infiltrating cells observed in meningitis has theoretically assumed a subarachnoid space between the arachnoid membrane and pia mater. the erfib-embedded sheets may guide inflammatory cells after extravasation to migrate into the meningeal region, but on the other hand, the sheets might restrict the inflammatory lesion in the meninx blocking the direct spread of inflammatory cells and viral particles from the meninx into the brain parenchyma. at least at 48 hpi, the prevention of direct invasion of the inflammatory cells and viruses from the meninx to the brain parenchyma seemed to be successful, as has also been observed in meningitis induced by other infectious agents. [55] [56] [57] before our findings, such prevention was thought to be operated by the pia mater and astrocytes comprising glia limitans at the brain surface, 58 because inflammatory cells and infectious agents have been considered to be able to freely move around the presumed subarachnoid space. the increase in erfibs after infection had already occurred at 12 hpi. however, the possibility that all of the newly formed erfibs function analogous to frn in the lymph nodes and spleen is not conceivable, because invasions of cd11b + cells and viruses into erag-upregulated areas were not prominent at 12 hpi. in addition, although erfibs in the fourth ventricle, especially near the area of fig. 4 three-dimensional images were constructed after staining er-tr7 antigen (erag) (er) and collagen iii (col) in the meninges of the cerebellopontine angle (a d), or laminin (la) in the fourth ventricle (e) of a mouse infected with cl-2 at 48 hours post-infection (hpi). nuclear counter-staining was performed using hoechst 33342 (hoe). the letters in parenthesis in b,c indicate the areas of images corresponding to the boxed areas in a. between the sheets, many cells were found to be packed (b1). the thickness of the sheet was estimated at around 0.5 1.0 μm after viewing the sheet from a different angle (b2 and supplemental figure s2 ). the rotation of images around the y axis disclosed sheet structures (supplemental movie s1) composed of erag-positive fibers (erfibs) and collagen fibers (c and d at a higher magnification of the dotted area in c3). the ventricle contained a fine erag + structure without colocalization with laminin (arrows in e) after the rotation of images (supplemental movie s2). the double bar in a indicates 20 μm. single bars indicate 2 μm (b2 d) and 10 μm (b1 and e). the junction of the ventricle and meninx, were increased in sham-infected mice compared with non-treated mice, fluorescence-labeled dextran particles, which have been used as tracers to show the function of frns in the spleen, 39 were not detected in the fourth ventricle. in contrast, in cl-2infected mice, labeled dextran particles were found in the ventricle showing a close association with erfibs. this and subsequent findings indicated that erfibs need to be allied with some other substances including ecm components detected in frn to function as a scaffold. the erfibs in the ventricle of infected mice were co-localized with laminin at a higher level compared with those of sham-infected mice. in addition, erfibs that appeared at 12 hpi were not colocalized with laminin, although in the area of peripheral nerves there were high levels of pre-existing laminin as a component of the basement membrane around schwann cells. another immature form of erfibs appeared after the three-dimensional construction of images. in the fourth ventricle, an erag + net-like structure was found hanging on two pole-like structures of laminin, without forming firm fibers. the findings were supported by a study using a primary brain mix culture, where several stages of erag + expression with various types of association with ecm were observed (data not shown). besides collagen and components of the basement lamina including laminin, 43 several kinds of molecules, such as decorin, biglycan and fibromodulin, which are surrounded by the erag + matrix and localized to the conduit core, 45 are supposed to be engaged in the maturation , oligodendrocyte lineage transcription factor 2 (oli), cd31 and cd13 antigens, and nuclear counter-staining (nuc) by immunofluorescence. a e: arachnoid cells shown as ck-positive (ck + ) and zic-2 + and ependymal cells shown as ck + cells produced erag. pod is reportedly expressed in arachnoid cells, 48 but only a part of zic2 + cells were pod + (supplemental fig. s1c, respectively) . f and g: astrocytes producing erag at the brain surface making up glia limitans (f), and those deep in the brain parenchyma, where astrocytes around the blood vessels (pabvs) produce erag (g), but not those distant from pabvs, even in the area with many erag-producing parenchymal cells (supplemental fig. s1d ). the dotted area in f1 is shown at a higher magnification in f2 and f3. h k: cns components other than astrocytes produced erag, such as neurons (h), oligodendrocytes (i), endothelial cells (j), and pericytes (k). however, neither cd11b high nor cd11b low cells produced erag (supplemental fig. s1e ). triangles and ivv indicate the meninges and fourth ventricle, respectively. single and double bars indicate 50 and 20 μm, respectively. of frn with the erag + matrix to function as a conduit in the lymph nodes. in addition, frcs, a core cell population to maintain the ecm and conduit system in the lymph nodes, produce large amounts of other molecules involved in the matrix and elastic fiber assembly, including lysyl oxidase (lox), lox-like 1, microfibril-associated glycoprotein 2 (mfap-2), mfap-5 and fibulin-1. 45 future studies should elucidate the roles of these factors in regulating the reticular network in the brain. frcs are thought to be highly specialized to the lymphoid microenvironment. 45, 59 in order to study the corresponding cell population in the brain, we investigated cells that produce erag, which is one of the whole markers of frcs and frn . 33, 40, 41 besides expected cell populations such as pod + erag + cells in the meninges, various types of cells in the brain showed erag expression, including arachnoid cells, ependymal cells, endothelial cells and pericytes, which were judged through the expression of representative cell marker proteins, their localization in the tissue and their shape. in addition, to our surprise, all kinds of the brain parenchymal cells except for cd11b low cells, provbably microglia, showed erag expression. in spite of these findings, it is not plausible that the erag produced by brain parenchymal cells was directly employed in the conduit system to guide the invasions of the virus or inflammatory cells, as indicated in the meninges and ventricle, because the viral antigens and inflammatory cell invasions were not observed at 48 hpi in the large area where they were produced by brain parenchymal cells. furthermore, most of them were not colocalized with laminin fibers, except for the close association of gfap + and laminin + fibers around the blood vessels, where the basement membrane is formed facing astrocytes at the side of blood vessels even under normal conditions. 26 however, the colocalization of erag and laminin + fibers around the blood vessels was detected. the results indicate that a conduit system could be created around the pabv, because information that virus-bearing cd11b + cells had invaded the meninges and ventricle must reach to the area with erag expression in the brain parenchyma. the conduits in the lymphoid organs are able to transfer such information through micro-and macromolecules, including cytokines and ligands. 36, 39 in the brain, foot processes of astrocytes, neurons and microglia adhere to the basement lamina around the blood vessels. 26, 60 when the information reaches the cells around the blood vessels, cell-to-cell-mediated immune cross-talk through an immune synapse reported in lymphoid cells, 61 and /or the use of not only immune-related molecules but also several neurotransmitters as a tool, 62 could possibly trigger an immune reaction in the brain parenchymal cells distant from blood vessels. astrocytes might play such a role in cellular communication because of their ability to produce high levels of erag and their localization around the blood vessels, ventricles and brain surface. therefore, local immune reactions relevant to brain pathology should be further examined, especially on cross-talk between brain parenchymal cells, 63 possibly after receiving information from the conduit around the pabv. cns region in the trigeminal root (trigr), fourth ventricle (ivv), meninx (mx), inferior cerebellar peduncle (icp), and pons (po). figure (fig.) numbers in parenthesis indicate the figures where the legend of each image is described. long arrows and arrowheads in e indicate cd11b high and cd11b low cells, respectively. j: the area of the trigeminal root in figure 1a , which is indicated by the boxed area, is indicated by closed lines. the border between the cns area (upper right) and peripheral nerve (lower left) is indicated by a dotted line. single and double bars indicate 50 and 20 μm, respectively. supplemental figure s2 . infiltrating cells indicated by nuclear staining (blue) between thin sheets with collagen iii (red) and erag (green), illustrated in figure 4b , are viewed from different angles. bar indicates 10 μm. supplemental movie s1. supporting info item supplemental movie s2. supporting info item episodic evolution mediates interspecies transfer of a murine coronavirus persistent infection promotes cross-species transmissibility of mouse hepatitis virus feline aminopeptidase n serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup i simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry announcement of the coronavirus study group structural and biological basis of ctl escape in coronavirus-infected mice isolation and characterization of murine coronavirus mutants resistant to neutralization by soluble receptors receptor-independent infection by mutant viruses newly isolated from the neuropathogenic mouse hepatitis virus srr7 detected through a combination of spinoculation and ultraviolet radiation mutant murine hepatitis virus-induced apoptosis in the hippocampus murine coronavirus receptors are differentially expressed in the central nervous system and play virus strain-dependent roles in neuronal spread coronavirus-induced encephalomyelitis: balance between protection and immune pathology depends on the immunization schedule with spike protein s inflammation in neurodegenerative diseases poliovirus induces apoptosis in the mouse central nervous system characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus jhm neurovirulence in mice of soluble receptor-resistant (srr) mutants of mouse hepatitis virus: intensive apoptosis caused by less virulent srr mutant identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptorresistant mutants cytopathy of an infiltrating monocyte lineage during the early phase of infection with murinecoronavirus in the brain spongiform degeneration induced by neuropathogenic murine coronavirus infection mice lacking alpha1,3-fucosyltransferase 9 exhibit modulation of in vivo immune responses against pathogens receptor-independent spread of a highly neurotropic murine coronavirus jhmv strain from initially infected microglial cells in mixed neural cultures receptor-independent infection of murine coronavirus: analysis by spinoculation receptor-induced conformational changes of murine coronavirus spike protein contribution of lewis x carbohydrate structure to neuropathogenic murine coronaviral spreads infection of neurons and encephalitis after intracranial inoculation of herpes simplex virus requires the entry receptor nectin-1 type i interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system acquired immunodeficiency syndrome and the blood-brain barrier molecular and cellular mechanisms for microbial entry into the cns replication strategies of rabies virus loss of active neuroinvasiveness in attenuated strains of west nile virus: pathogenicity in immunocompetent and scid mice viral neuroinvasion and encephalitis induced by lipopolysaccharide and its mediators transgenic mice susceptible to poliovirus efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor regulation of homeostatic chemokine expression and cell trafficking during immune responses pathology of experimental ebola virus infection in african green monkeys. involvement of fibroblastic reticular cells fibroblastic reticular cells and their role in viral hemorrhagic fevers sophisticated strategies for information encounter in the lymph node: the reticular network as a conduit of soluble information and a highway for cell traffic cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex the conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the t cell area of the lymph node a conduit system distributes chemokines and small bloodborne molecules through the splenic white pulp fibroblastic reticular cells guide t lymphocyte entry into and migration within the splenic t cell zone reticular fibroblasts in peripheral lymphoid organs identified by a monoclonal antibody stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes the extracellular matrix of the spleen as a potential organizer of immune cell compartments lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks association of t-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes the histopathological spectrum of cutaneous meningeal heterotopias: clues and pitfalls alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice murine coronavirus mouse hepatitis virus is recognized by mda5 and induces type i interferon in brain macrophages/microglia vascular tissues in the central nervous system behavior of parasite-specific effector cd8+ t cells in the brain and visualization of a kinesis-associated system of reticular fibers myelomonocytic cell recruitment causes fatal cns vascular injury during acute viral meningitis reactive gliosis of astrocytes and muller glial cells in retina of pomgnt1-deficient mice enterovirus meningitis in adults choriomeningitis and myocarditis in an adolescent with isolation of coxsackie b-5 virus aseptic meningitis and viral myelitis evidence for distinct leptomeningeal cell-dependent paracrine and egf-linked autocrine regulatory pathways for suppression of fibrillar collagens in astrocytes human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor b-cell growth: role of stromal cells in follicular lymphoma pathogenesis the cns microvascular pericyte: pericyte-astrocyte crosstalk in the regulation of tissue survival the immunological synapse: a focal point for endocytosis and exocytosis chemokines: a new class of neuromodulator? neuronal 'on' and 'off' signals control microglia this work was supported in part by grants from the ministry of education, culture, sports, science and technology grant number: 22 590 368). additional supporting information may be found in the online version of this article at the publisher's web site: supplemental figure s1 . immunofluorescence to detect erag (er), laminin (la), jhmv (v), zic2, podoplanin (pod), gfap (gf), cd11b, neun and nucleus (nuc). images were taken in areas of the peripheral nerve (pn) or key: cord-327568-5vo4nmei authors: tosini, fabio; ludovisi, alessandra; tonanzi, daniele; amati, marco; cherchi, simona; pozio, edoardo; gómez-morales, maria angeles title: delivery of sa35 and sa40 peptides in mice enhances humoral and cellular immune responses and confers protection against cryptosporidium parvum infection date: 2019-05-15 journal: parasit vectors doi: 10.1186/s13071-019-3486-8 sha: doc_id: 327568 cord_uid: 5vo4nmei background: cryptosporidium parvum is a major cause of diarrhea in children and ruminants at the earliest stages of life. maternal antibodies represent the main shield of neonate mammals for most of the infections. two recombinant antigens (sa35 and sa40), portions of two c. parvum proteins, were tested for their ability to induce immune responses in adult mice and for protection on neonate balb/c mice born from females immunised by mucosal delivery of both peptides. methods: adult balb/c mice were intraperitoneally immunised with sa35 and sa40, separately or mixed, and their immune response was characterised. furthermore, balb/c pregnant mice were immunised by mucosal delivery with an sa35/40 mix, before and during pregnancy. soon after birth, their offspring were infected with two doses (1 × 10(5) and 5 × 10(3)) of c. parvum oocysts and the parasitic burden was determined at 5 and 9 days post-infection. results: intraperitoneal immunisation with sa35 and sa40 induced specific igg and igg1 in serum, specific iga in the intestinal mucosa, increase of cd3+/cd4+ and cd30+ cells in splenocytes, which produced ifn-γ. neonates born from immunised mice and infected with 1 × 10(5) oocysts showed a significant reduction of oocysts and intestinal forms (23 and 42%, respectively). a reduction of all parasitic forms (96%; p < 0.05) was observed when neonates were infected with 5 × 10(3) oocysts. conclusions: sa35 and sa40 peptides induce specific humoral and cell-mediated immune responses to c. parvum in adult mice. moreover, mucosal administration of the sa35/40 mix in pregnant mice reduces c. parvum burden in their litters. the cryptosporidium genus includes 38 species that infect a wide range of vertebrates, including many mammals. humans are also susceptible to these parasites, and domesticated and wild ruminants, particularly livestock, represent important sources of zoonotic transmission [1] . in mammals, cryptosporidium spp. mainly affect the gut, causing gastrointestinal symptoms and diarrhoea. approximately 90% of human infections are caused by cryptosporidium parvum and cryptosporidium hominis, although over 20 species can infect humans [2] . in immunocompetent patients, cryptosporidiosis is a self-limiting infection of the small intestine that causes watery diarrhoea and can last up to ten days, whereas the infection can become a chronic and life-threatening disease in immunocompromised individuals such as aids subjects [3] . parasites & vectors *correspondence: fabio.tosini@iss.it; mariaangeles.gomezmorales@iss.it european union reference laboratory for parasites, istituto superiore di sanità, rome, italy transmission occurs via the faecal-oral route through the ingestion of oocysts contaminating food or water. oocysts are highly resistant to environmental conditions, chlorination and other sterilisation treatments, and contamination of water plants can therefore cause massive outbreaks [4] . it follows that the food and agriculture organisation and the world health organisation consider protozoa of the genus cryptosporidium to be one of the most significant food-borne parasites [5] . in livestock husbandry, c. parvum is a major cause of severe diarrhoea among neonate calves and lambs, resulting in substantial costs for farmers. a recent study on diarrhoea conducted on calves younger than one month reported that c. parvum is responsible, as the sole agent, for 37% of diarrhoeal infections and for 20% of coinfections with other intestinal pathogens [6] . in recent years, infections by c. parvum and c. hominis have emerged as significant causes of infantile diarrhoea. an extended case-control study, referred to as the global enteric multicenter study (gems) [7] , has shown a high prevalence of cryptosporidium spp. among children in developing countries, ranking these protozoa among the four pathogens responsible for the majority of diarrhoea cases in children younger than five years [8] . the prevalence of these parasites is higher in infants aged less than 11 months and, in this age range, cryptosporidium spp. is the second most common cause of death associated with diarrhoea, after rotavirus [9] . the susceptibility of neonates and children to cryptosporidium spp. is not completely understood. in the nursing period, the innate immune response of enterocytes, which is usually triggered by the stimulation of toll-like receptor 4 (tlr4), is almost completely inhibited so as to favour the establishment of commensal flora in the gut [10] . given that the immune response to cryptosporidium spp. begins with tlr4 stimulation and the consequent activation of the nf-kappa b pathway [11] , the temporary inhibition of the innate enterocyte response could promote the proliferation and dissemination of cryptosporidium spp. in the neonatal intestine. at present, nitazoxanide is the only drug approved for cryptosporidiosis by the us food and drug administration (us-fda), but this drug cannot be used in children younger than one year and is ineffective in immunodeficient patients [12] . a vaccine for cryptosporidiosis is not yet available, and immune protection of neonates is difficult to achieve because of their early-age immune status. however, various cryptosporidium spp. proteins, particularly those considered to be virulence factors, have been proposed as possible vaccine candidates [13, 14] . in this context, the passive immunisation of neonates might be an alternative to a conventional vaccine. indeed, passive immunity provided through hyperimmune bovine colostrum has been shown to establish an appreciable level of protection in human patients with aidsassociated cryptosporidiosis [15, 16] . more recently, the protective role of maternal anti-cryptosporidium antibodies has been demonstrated in two natural contexts. a survey of a child cohort in bangladesh reported that the presence of anti-cryptosporidium iga in breast milk protects neonates from cryptosporidiosis [17] . a second study, conducted in an endemic area of tanzania on a cohort of breastfeeding mothers and their infants (0 to 6 months), has shown that the infection rate increases with a reduction in maternal milk ingestion [18] . this study investigates the feasibility of an immunological preventive treatment to impede or reduce cryptosporidiosis in newborn mammals. as a preliminary step, two recombinant antigens, sa35 and sa40 [19] , were inoculated in adult mice to achieve the onset of a specific immune response. a group of female mice were then immunised by mucosal delivery of the same antigens prior to and during their pregnancies in parallel with a control group treated only with the adjuvant. the offspring of these mice were then infected with two different doses of c. parvum oocysts (1 × 10 5 and 5 × 10 3 ) and the parasite burden was measured by flow cytometry, microscopic count and a quantitative pcr assay. our results indicated that neonates born from immunised mothers had a reduced parasitic load compared to the neonates born from the control mice. cryptosporidium parvum oocysts (isolate code issc6) were collected from faeces of experimentally infected calves and purified by centrifuging with sucrose and percoll ® (sigma-aldrich, saint louis, mo, usa) densitygradients [20] . cryptosporidium parvum-crude extract (cce) was obtained as previously described [21] . heatlabile enterotoxin (lt) was obtained from chiron spa (siena, italy), and ketavet and xylazine solutions were provided by the animal care unit of the istituto superiore di sanità in rome, italy. a rabbit anti-c. parvum igg polyclonal antibody, which recognises all stages of c. parvum [22] , was used for ifa assays. the recombinant peptides sa35 (mw, 35 kda) and sa40 (mw, 40 kda) represent antigenic portions of two microneme proteins of c. parvum named cpa135 (cgd7_1730) and gp900 (cgd7_4020), respectively [23, 24] . protein id codes refer to sequences in the cryptodb database, release 37 [25] . the two peptides were purified as previously described [26] , dialysed in phosphate buffered saline (pbs) plus 50% glycerol and stored in aliquots at −20 °c. both peptides were used as a sole immunising agent or as a 1:1 mixture of the two antigens (referred to hereafter as the sa35/40 mix). eight-to ten-week-old balb/c female mice (charles river laboratories, milan, italy) were housed in the animal care unit of the istituto superiore di sanità in accordance with european directive 63/2010. the in vivo protocol was approved by the italian ministry of health (approval no. 8/2014-b, 15 january 2014). three groups of five female mice each were immunised intraperitoneally: one group with 5 μg of sa35, a second group with 5 μg of sa40, and a third group with the sa35/40 mix (5 μg plus 5 μg of sa35 and sa40, respectively). a control group (n = 5) was injected with an equal volume of pbs instead of antigens, according to the same immunisation schedule, which was as follows: day 0, peptides or pbs were administered in freund's complete adjuvant (sigma-aldrich); day 14, the same amount of peptides or pbs were inoculated using freund's incomplete adjuvant (sigma-aldrich); day 28, the last booster was provided using the same quantity of peptides or pbs without adjuvant. the mice were bled on days 0, 7, 14, 21, 28 and 35 following initial immunisation. individual sera were stored at −20 °c. faecal samples for an iga assay were collected weekly from each mouse separately, weighed and dissolved in 1.0 ml of pbs with 0.1% sodium azide per 100 mg of faecal material, and a cocktail of protease inhibitors (sigma-aldrich) was added at a ratio of 1:20 to each sample. the samples were then vortexed for 5-10 min and centrifuged to remove debris; supernatants were collected and stored at −70 °c. levels of igg, igg1 and iga in serum samples and iga in faecal samples specific to c. parvum were determined by elisa. levels of igg and iga specific to sa35 and sa40 peptides were also determined by elisa. microtiter plates (nunc-immuno plate polysorp ™ , sigma-aldrich, roskilde, denmark) were blocked using 200 μl per well of 1% w/v bsa in pbs, at room temperature (rt) for 90 min and coated with 1 µg/ml of recombinant peptides (sa35 or sa40) or 5 µg/ml of cce in a 50 mm carbonate/bicarbonate buffer with a ph of 9.6, and incubated at 37 °c for 90 min. serum samples were diluted in pbs with 0.5% w/v bsa and 0.05% v/v tween-20. supernatants of faecal samples were diluted as described above. plates were washed three times with 0.05%-tween-20 in pbs after incubation with sera, and washes were repeated after incubation using conjugated antibodies. dilutions of 1:50 for sera and 1:10 for faecal supernatants were established to be the optimal working conditions. these dilutions were then added in duplicate to wells and incubated overnight at 4 °c. as negative controls, the corresponding pre-immune faecal and serum samples from each mouse were used at the same dilution in elisa. bound antibodies were detected by incubation with 1:500 dilutions of biotin-conjugated rat monoclonal anti-mouse igg, igg1, and iga antibodies (bd pharmingen tm , san diego, ca, usa) at rt for 5 h followed by 2.5 mg/ml avidin-peroxidase (sigma-aldrich) for 30 min. the peroxidase substrate tmb (3,3′,5,5′-tetramethylbenzidine, kierkegaard and perry laboratories, gaithersburg, md, usa) was added to each well and the optical density was measured by a multiskan spectrum elisa reader (thermo scientific, vantaa, finland) at 450 nm. elisa was performed for each isotype using the same protocol. at the end of the immunisation schedule, the mice were sacrificed and their spleens were harvested under sterile conditions and disrupted using a syringe. the erythrocytes were lysed, and the splenocytes were then suspended in complete medium [rpmi-1640 containing 10% foetal bovine serum, 25 mm hepes, 2 mm l-glutamine, 100 u/ml penicillin, 100 µg/ml streptomycin, 1 mm sodium pyruvate, 5.5 × 10 −5 m 2-mercaptoethanol and 0.1 mm non-essential amino acids, all from hyclone laboratories (logan, ut, usa)]. the final cell concentration for proliferation analysis was 1 × 10 6 cells/ml and cells were settled in flat-bottom 96-well plates (costar corporation, cambridge, ma, usa). for cytokine and phenotypic analysis, cells were suspended at 2 × 10 6 cell/ ml in 5 ml tubes (becton dickinson, franklin lakes, nj, usa). cell cultures were stimulated with 5 μg/ml of cce, 1 μg/ml of sa35 or 2.5 μg/ml of sa40 and incubated in 5% co 2 at 37 °c for five days. cell cultures for negative controls were grown without any stimulants, whereas positive control cells were stimulated with 1.0 μg/ml of concanavalin a. lymphocyte proliferation was measured after 12 h of culture by 3 h-thymidine incorporation in the presence of 0.5 µci/well [ 3 h]-thymidine (amersham life science, buckinghamshire, uk) sampled in triplicate. proliferation was expressed as a stimulation index (si) (i.e. counts per minute of cce-stimulated cells divided by counts per minute of unstimulated cells). an si above 3.0 was considered positive. for the cytokine analysis, culture supernatants were harvested after five days of culture and stored at −70 °c until assayed. cytokine levels (ifn-γ, il-4, il12) were measured in culture supernatants by elisa. essentially, 96-well plates (nunc-immuno tm plate maxisorp tm surface, sigma-aldrich, roskilde, denmark) were coated with a solution of 1 μg/ml (in 0.1 m na 2 hpo 4 , ph 9.0) of monoclonal rat anti-mouse cytokine antibody (bd pharmingen). after overnight incubation at 4 °c, the plates were washed with pbs-t and blocked with 1% bsa (sigma-aldrich) in pbs for 2 h at 37 °c. after washing, serial dilutions of culture supernatants and standards, i.e. recombinant mouse cytokines, were added to the wells and incubated overnight at 4 °c. the plates were then washed and the appropriate biotin-conjugated rat antimouse cytokine antibody (bd pharmingen) was added to the well and incubated for 2 h at 37 °c. after washing and the addition of hrp-conjugated streptavidin (bd pharmingen) for 2 h at 37 °c, the tmb (kirkegaard & perry laboratories) substrate was added to the wells and absorbance was measured at 450 nm after 10-20 min. standard curves were generated for each cytokine using the corresponding murine recombinant standard. the minimum detection level for each cytokine by elisa was < 15 pg/ml for ifn-γ, < 4 pg/ml for il-4, and < 15 pg/ ml for il-12. to analyse the lymphocyte subsets after incubation with cce, the splenocyte suspension from each mouse was washed with pbs containing 2% bsa, and further re-suspended in 100 µl of the same buffer. the cells were then incubated with 5 µl of the following fluorescein isothiocyanate (fitc) or phycoerythrin (pe) conjugated monoclonal antibodies to murine leukocyte differentiation molecules: anti-cd3, anti-cd4, anti-cd8, anti-cd25, and cd30 (bd pharmingen). the cells were analysed for single and dual fluorescence assay in a fluorescence-activated cell-sorter (facscalibur; becton dickinson, franklin lakes, nj, usa) and data were acquired by cell-quest software (becton dickinson). the instrument was set to measure the fluorescence intensities of forward-angle light scatter (fsc), side-angle light scatter (ssc-h), fitc (fl1), pe (fl2) and fitc (fl1). cells incubated with fitc-and pe-conjugated mouse igg1/igg2a served as isotype control. the proportion (%) of cells expressing a given molecule was determined as the average of three replicas. two groups (experimental and control groups) of five mice each were anaesthetised with ketavet (100 mg/ml) and xylazine (20 mg/ml) at 50 mg/kg and 3 mg/kg, respectively. the mice from the experimental group were then immunised intranasally with 15-20 μl of pbs containing 1 μg of lt with 5 μg of sa35/40 mix, whereas the mice from the control group were inoculated intranasally with 15-20 μl of pbs containing 1 μg of lt. after seven days, the same immunisation protocol was repeated. then, bedding from cages housing male mice was transferred to the cages housing females for 48 h to induce oestrus. subsequently, one male and two females were kept in the same cage for 72 h and the females were examined daily for the presence of copulatory plugs. the day of plug detection was assumed to be day 0 of pregnancy [27] . immunisations were repeated at days 7, 14, and 21 of pregnancy ( fig. 1 ). blood samples were taken by tail bleeding on days 0, 7, 14, 21, 28, 35 and 230 after initial immunisation. individual sera were stored at −20 °c until analysis. faecal samples were collected at the same times and treated and stored as described above. specific igg and iga to c. parvum were measured in serum and faecal samples by elisa. proliferation assays and phenotypic analysis of spleen cells were performed as described above. to study the protection induced by mucosal immunisation, six litters of three-day-old balb/c mice (39 mice) were used. two litters, which were born from mothers immunised intranasally with sa35/40 with lt, were infected with 10 5 oocysts and then sacrificed five [28] and nine days post-infection (p.i.), respectively [29] . another litter born from an intranasally immunised mother was infected with 5 × 10 3 oocysts and sacrificed at nine days p.i. the remaining three litters were the respective control groups. all suckling mice were experimentally infected by the oral route using oocysts suspended in 20 µl of pbs with a 24-gauge gavage needle and kept with their mothers. suckling mice were anaesthetised before euthanasia and the whole intestine was collected. lymphocytic phenotypic analysis was performed on spleens from mice born from intranasally immunised mothers, infected with 10 5 oocysts and sacrificed five days later. the entire intestinal content was collected after washing of the intestinal tract with pbs. samples were vortexed for 30 s with a 1-min pause. the supernatant was centrifuged at 2500×g for 10 min at 4 °c. the pellet containing oocysts and free forms of the parasite was then suspended in 1 ml of pbs and vortexed for 30 s. each sample was divided in two aliquots: one aliquot was tested by an immunofluorescence assay, i.e. flow cytometry or indirect immunofluorescence assay (ifa), whereas the second aliquot was used to extract dna for qpcr (see below). using flow cytometry, the number of oocysts in the faecal sample was evaluated using an acquisition gate based on the forward-angle light scatter (fsc-h) characteristic and the fluorescence intensities of fitc (on fl1 detector) of a positive control [30, 31] . the positive control consisted of an oocyst suspension in pbs incubated with the anti-c. parvum igg. flow cytometry analysis was performed three times for each mouse and the number of oocysts was expressed as the mean ± sd for each mouse group. intracellular parasites were counted in the ileum homogenate from each mouse [28, 32] . homogenisation was carried out individually in 1 ml of pbs for 1 min at 20×g using a potter homogeniser and further diluted 1:5 in pbs. the suspension was then filtered using a 30-µm filcon syringe (beckton dickinson) and incubated with the anti-c. parvum igg and an anti-rabbit fitc antibody for 30 min at rt. intracellular parasites were counted using flow cytometry as above. the number of intracellular stages was expressed as the mean ± sd for each mouse group. when significant differences between the experimental and control groups were not found, the number of oocysts was also evaluated using ifa (see below). for ifa, the oocyst suspension was mixed with 20 µl of a solution of 0.5 µg/ml anti-c. parvum igg in pbs. the mixture was kept in the dark at 4 °c for 30 min and then centrifuged for ten min at 2500×g. the pellet was resuspended in 1 ml of pbs, and 20 µl of an anti-rabbit fitc antibody was added. the samples were kept in the dark at 4 °c for 30 min and then centrifuged at 2500×g for 10 min. the pellet was suspended in 1 ml of pbs and transferred to a polystyrene tube and kept at 4 °c. all samples were analysed on the day of oocyst collection. the number of oocysts was evaluated by fluorescence microscopy (zeiss axioplan 2; carl zeiss, jena, germany) at 400× magnification [31] . after washing (see above), the intestines from mice infected with 5 × 10 3 oocysts were fixed in 4% formaldehyde in pbs for 4 h for histological examination, which was performed using the following procedure. the ileum portion was cut and washed in tap water overnight, dehydrated in increasing concentrations of ethanol from 50 to 100%, placed in 100% xylol and finally included in paraffin. the paraffinated tissue was cut using a leica rm2125 rts microtome (leica biosystems, nussloch, germany) into microscopic slices of 4-6 μm, distributed on microscopic slides and dried overnight at 37 °c. the slices were then deparaffinated by immersion in 100% xylol for 5 min and re-hydrated with decreasing concentrations of ethanol from 100 to 50% and a final wash in distilled water for 2 min. antigen retrieval from fixed tissue was performed using the following "pressure cooking protocol": the microscopic slides were placed in a stainless steel slide rack in the boiling citrate buffer (10 mm sodium citrate, 0.05% tween 20, ph 6.0) in a pressure cooker heated by a hot plate; the lid was then closed for steaming at high pressure for 90 s, and the pan was then rapidly cooled using running tap water on the lid. immediately after the slides were prepared for indirect immunofluorescence assay (ifa), blocked using 2% foetal calf serum (fcs) in pbs for 1 h at room temperature, incubated for 1 h with anti-c. parvum rabbit serum [26] diluted 1:500 in 2% fcs in pbs, and washed three times (5-min wash) with pbs to remove unbound antibodies. secondary incubation was conducted for 1 h at room temperature using goat anti-rabbit antibody conjugate with fluorescein (fitc) (biorad, hercules, ca, usa) diluted 1:1000 in 2% fcs in pbs, and the slides were then washed as above and sealed using prolong antifade (thermo fisher scientific, waltham, ma, usa). microscopic inspection of the tissue slices was conducted using a fluorescence microscope (zeiss axioplan 2) at 1000× magnification and digital images were obtained using axiovision software (carl zeiss). for qpcr, aliquots of whole intestinal content from mice infected with 5 × 10 3 oocysts (see above) were centrifuged, suspended in 1 ml of 50% ethanol in pbs and stored at −20 °c until dna extraction. each aliquot was centrifuged, washed once with pbs and resuspended in 100 µl of lysis buffer (10 mm dtt, 1.8 mg/ml proteinase k in pbs), transferred to a 96-well plate and incubated for 1 h at 55 °c. for automated extraction, the plates were transferred to a biosprint 96 apparatus (qiagen, hilden, germany) using the protocol for blood samples and one-for-all vet kit reagents (qiagen), and dna was eluted in a final volume of 50 µl. dna was also extracted in the same way from referenced dilutions of purified oocysts in triplicate to obtain samples with 10 5 , 10 4 , 10 3 , 100, 10, 1 and a theoretical 0.1 oocysts, and used for a standard curve based on the median crossing threshold (ct) in qpcr experiments. dna samples from infected mice and referenced dilutions were analysed using real-time pcr assay (qpcr) based on the cowp gene [33] . this assay was tested for sensitivity using reference samples, obtaining positive curves with a single oocyst (ct = 36 in three out of three replicas) and up to a theoretical 0.1 oocysts (ct = 39 in one out of three replicas), and samples producing less than 40 ct were considered positive. cowp primers were synthesised by primm (milan, italy), and taqman probe and cowp probe labelled with 5′-hexachlorofluorescein (hex; λ em = 553 nm) were from tib molbiol (berlin, germany). each pcr reaction was completed in a final volume of 25 μl, comprising 12.5 μl of lightcycler 480 probes master mix containing fast-start taq dna polymerase, a proprietary buffer including deoxynucleotide triphosphates (dntps), mgcl 2 at a final concentration of 3.2 mm, 300 nm of each primer, 500 nm of taqman probe, and 5 µl (1/20 of whole intestinal content) as dna sample. all reactions were performed on a 96-well plate in a lightcycler 480 pcr system (roche diagnostics, mannheim, germany) in triplicate and three negative controls were included in each plate. the pcr conditions were: 10 min of incubation at 95 °c followed by 40 cycles of 95 °c for 15 s and 60 °c for 1 min. fluorescence data (three data real-time points) were collected at the end of each cycle. to compare each experimental group with the relevant control group, the mann-whitney u-test was used. a p-value < 0.05 was considered significant. the ip immunisation of adult balb/c mice to a single antigen (sa35 or sa40) or to a mixture of the two antigens (sa35/40 mix) induced specific anti-cryptosporidium igg in serum after day 14 following initial administration. later, the level of specific igg progressively increased over time, reaching the highest response 35 days after initial immunisation (sa35, u ( fig. 2c ). as expected, sera from mice immunised with sa35, sa40 or sa35/40 mix reacted with their respective homologous antigens by elisa (data not shown). specific anti-cryptosporidium iga were detected in faeces from day 7 after initial immunisation until the last sampling (day 35) with all the three antigen formulations (u (0) = 2, z = −2.50672, p = 0.0079 for sa35, sa40 and sa35/40 mix; fig. 2d ). no specific iga response was detected in faeces at day 0 in the control mice. cce induced proliferation in splenocytes from sa35, sa40 and sa35/40 mix in ip immunised mice. the highest responses to cce were obtained in splenocytes from mice immunised with sa35 alone or the sa35/40 mix. splenocytes from immunised and control mice responded to concanavalin a. single peptides also induced proliferation in splenocytes from mice immunised with homologous peptides (fig. 3) . cce induced ifn-γ production in the splenocytes from all groups of immunised mice. splenocytes from mice immunised with sa35 or sa40 produced higher levels of ifn-γ after stimulation with homologous peptides than mice immunised with the sa35/40 mix and stimulated with the same mix. il-12 production was observed in all mouse groups; the highest level of il-12 production was observed in splenocytes from mice immunised with sa35. minimal basal production of il-4 was detected in spleen cells from some groups of immunised mice (table 1) . induced cell populations in splenocytes were analysed at day 35 after initial immunisation. the percentages of cd3+ and cd4+ t cells were similar in mice immunised with sa35, sa40 and the sa35/40 mix and were significantly higher than in non-immunised control mice. however, the percentage of cd8+ t cells was similar among all groups, including the controls. moreover, the percentage of activated cd4+ lymphocytes co-expressing the high affinity interleukin-2 receptor (cd25) was decreased in all immunised groups, particularly in the sa35 immunised group (u (0) = 5, z =, 2.80224, p = 0.0022; fig. 4 ). the mucosal delivery of sa35/40 mix in female balb/c mice induced specific anti-cryptosporidium igg (mainly igg1) in serum 21 days after initial immunisation. the igg level increased over time from day 28 until day 35. high igg levels were detected until the last observation on day 230 (versus control group u (0) = 2, z = −2.50672, p = 0.01208 for igg and igg1; fig. 5a , b). a low specific iga level was detectable in serum until the end of the experiment (230 days after initial immunisation; fig. 5c ). in faeces, specific anti-cryptosporidium igg and iga began to increase on the day 28 following the first delivery and then over time (versus control group u (0) = 3, z = 2.64733, p = 0.0022 and u (0) = 5, z = −2.80224, p = 0.00512 for igg and iga, respectively). no specific igg or iga responses were detected in faeces at day 0 or in the control mice (fig. 5d, e) . cce and cona induced proliferation in splenocytes from mice immunised intranasally with the sa35/40 mix. splenocytes from control mice responded only to concanavalin a (fig. 6) . the cytometric analysis was performed in cce-stimulated splenocytes from both adult mice immunised intranasally and their litters. spleens were harvested from adult mice at day 236 following initial immunisation. the percentages of cd3+/cd4+ and cd30+ t cells were increased in adult mice treated with the sa35/40 mix. the same results were obtained with the cce-stimulated splenocytes from passively immunised litters infected with 10 5 oocysts (table 2) . when infected with 10 5 oocysts, passively immunised suckling mice showed similar levels of reduction at day 5 and day 9 following infection. in particular, a significant reduction of 23% of excreted oocysts (u (20) = 38, z = −2.76956, p = 0.0028) and 42% of intracellular forms (u (14) = 23, z = −2.43588, p = 0.00734) in the ileum was observed using flow cytometry (fig. 7a) . infection of neonates was also undertaken with a lower dose of oocysts in order to get closer to a natural infective dose using 5 × 10 3 oocysts. the histological examination of the ileums of infected mice did not show any evidence of the infection (i.e. parasitophorous vacuoles) in the analysed sections from neonates born from immunised females (fig. 8c, d) . by contrast, newborns from non-immunised females had numerous parasitophorous vacuoles disseminated along the epithelial lining of the intestinal lumen (fig. 8c, d) . indeed, a quantitative analysis of the entire intestinal content at day 9 p.i. showed a striking 96% reduction in parasites in newborns from immunised females (u (4) = 12, z = 2.65165, p = 0.00402), as evaluated by microscopic counting after ifa (fig. 7b) . to confirm the overall reduction in parasitic forms in passively immunised newborn mice infected with the lower infective dose (i.e. 5 × 10 3 oocysts), the intestinal contents of these newborns were evaluated using a realtime qpcr assay. as shown in fig. 9 , ct values in faecal samples from suckling mice born from immunised mothers ranged between 34 and 40, i.e. equivalent to 5-0.1 oocysts. four out of 6 samples showed a ct value higher than 37, thus with less than one oocyst equivalent in their content. ct values for the control mice ranged between 27 and 33, i.e. equivalent to 10-100 oocysts. therefore, qpcr analysis confirmed that the parasitic load in the intestinal contents of newborns from immunised mothers was extremely low when newborns were infected with the lower dose of 4.5 × 10 3 oocysts. control of neonatal cryptosporidiosis is a challenging task because of the lack of appropriate drugs and the difficulties in providing effective immunisation in the early phase of life. here, we explored the protective effect of anti-c. parvum maternal antibodies transferred to newborns through the placenta during gestation and through the colostrum in the first days of life. to this end, two recombinant peptides (sa35 and sa40) were first immunologically characterised by ip injection in adult mice to evaluate their potential as immunogens. both peptides, separately and in a mixed formulation, induced specific igg and iga responses. sa35 and sa40 peptides have been previously described as immunodominant antigens involved in the maintenance of t-cell response in healthy c. parvum-sensitised individuals [20] . it is important to note that the amino acid sequences of sa35 and sa40 peptides do not show similarities with mammalian proteins, but, by contrast, are also highly conserved in other cryptosporidium species and particularly in other human pathogens (data not shown). therefore, it is most likely that antibodies for sa35 and sa40 also react with the strictly related proteins of c. hominis and c. ubiquitum. in this study, it has been demonstrated that ip immunisation with these recombinant peptides is able to support an effective cell-mediated immunity in response to specific stimuli: cce-, sa35-and sa40-induced specific proliferation in splenocytes from all immunised adult mice. however, maximum proliferative responses to cce were obtained in splenocytes from mice following ip immunisation with sa35 or the sa35/40 mix (fig. 3) . the induced cell populations showed a higher percentage of cells expressing cd3+ and cd4+. moreover, splenocytes from mice immunised with sa35 showed a significant reduction in the percentage of regulatory cells (cd4+/cd25+) compared to the control group, whereas the others did not (fig. 4) . overall, the three antigen formulations (sa35, sa40 or sa35/40 mix) induced ifnγ, il-12 and, to a lesser extent, il-4 in immunised mice (table 1) . what is noteworthy is that stimulation with the homologous antigen resulted in the highest level of production of these cytokines even when the splenocytes also responded to stimulation with cce (table 1) . experimental studies and clinical cases have demonstrated that activation of cd4+ lymphocytes and production of ifn-γ are crucial for parasite clearance [34] [35] [36] [37] . indeed, ifn-γ production is one of the essential functions of cd4+ cells in response to cryptosporidium antigens [38, 39] . with regard to humoral response, all three antigenic formulations (sa35, sa40 or sa35/40 mix) induced specific igg, igg1 and secretory iga (fig. 2) . the production of these transferable antibodies is a fundamental requirement in conferring protective immunity for neonates. therefore, the antigenic sa35/40 mix was used for mucosal immunisation of female mice in order to evaluate the protective effect on their offspring. the notes: adult female balb/c mice were mucosally immunised with sa35/40 mix. cells were stimulated with c. parvum crude extract and were gated for 90-95% cd45 + . analysis of splenocytes from adult mice was carried out on the last day of the experiments. the number of mice is shown in fig. 1 . newborn mice born from intranasally immunised mothers were infected with 10 5 oocysts and sacrificed five days later the comparison between c. parvum-infected littermates born from immunised mothers and their respective controls, i.e. c. parvum-infected littermates born from mothers immunised only using a mucosal adjuvant, showed that maternal protection is highly effective with the lower infective dose (5 × 10 3 ), since there was a 96% reduction in parasitic burden (fig. 7) . in adult females, mucosal immunisation with the sa35/40 mix leads to a long-lasting (33 weeks) humoral response at systemic and intestinal level (fig. 5) . moreover, splenocytes from balb/c mothers specifically proliferated in response to cce and the resulting population showed an increase in the percentages of cd3+/cd4+ and cd30+ cells ( table 2) . the experimental infection of neonate mice born from immunised mothers showed that when neonates were infected with a massive dose of oocysts (1 × 10 5 ), the protective effect on the progeny is measurable but ineffective (−23% of excreted oocysts). conversely, a drastic reduction (96%) in oocyst emission was observed when neonates were infected with a lower dose (5 × 10 3 oocysts), which still represents a huge amount given the small weight (about 1 g) of newborn mice (fig. 7) ; in fact, this dose is comparable to a dose of 30 × 10 7 oocysts in a 60 kg human. these oocyst numbers were tested in the first instance to allow a quantitative analysis of excreted oocysts and of all parasitic forms using flow cytometry, although the 5 × 10 3 dose yielded parasite amounts below the sensitivity threshold for the instrument. to overcome this technical limitation, ifa/microscopic counting and qpcr were used to evaluate the minimal quantity of parasites in infected mice. moreover, dna samples for qpcr were prepared using an ad-hoc automated method in order to reduce handling errors. cell-mediated immunity showed unexpected signs of activity in splenocytes harvested from litters from immunised mothers, as there was an increase in the percentage of cd3+-cd4+ cells as well as cd30+ cells (table 2) . similarly, t-cell responses were identified after maternal vaccination in newborn mice of a plasmodium yoelii model, although there was no parallel increase in antibody response [40] . recent studies indicate that during pregnancy, maternal molecules such as inflammatory cytokines, as well as microbial products, are transferred in utero to the foetus and this influences the foetal immune system [41] . thus, neonatal hosts may compensate for an insufficiency in adaptive immune responses by having a heightened capacity to mount certain types of innate immune responses [42] . attempts at passive immunisation through administration of hyperimmune colostrum have been performed in humans and in other mammals. indeed, hyperimmune bovine colostrum was given to aids patients with prolonged cryptosporidiosis, resulting in a reduction in diarrhoea and an improvement in symptoms [15, 16] . in livestock, passive immunisation with recombinant antigens has shown a certain efficacy in protecting passively immunised calves and kids [43, 44] . more recently, heterologous protection was also successfully tested through administration of hyperimmune ovine colostrum in neonate mice [45] . unlike previous studies, this study combined the use of a mixture of two defined antigens extensively characterised as immunogens. a further peculiarity of this study is the mucosal immunisation of females to confer protection for their progeny. maternal immunisation protocols for other pathogens have been applied successfully to prevent neonatal infectious diseases in various contexts. with regard to livestock, a vaccine for rotavirus, coronavirus and escherichia coli (rotavec-corona ® , msd) is commonly used to immunise heifers and preparturient cows. this treatment induces a higher titre of specific antibodies for these pathogens in colostrum and milk [46] and has significant efficacy in reducing diarrhoea in neonate calves [47] . in humans, maternal immunisation with tetanus toxoid has fig. 9 quantification of cowp gene dna copies by qpcr in the intestinal content of neonate mice infected with 5 × 10 3 cryptosporidium parvum oocysts. values are expressed as the mean of cycles for crossing thresholds (ct), and each sample was tested in triplicate. standard curve (black dots) was obtained from dna extracted from the following oocysts dilutions: 1 × 10 5 (1), 1 × 10 4 (2), 1 × 10 3 (3), 100 (4), 10 (5), 1 (6) and 0.1 (7) . blue dots represent ct values from control mice. red dots represent ct values from immunised mice. values from control mice are between 33 and 29 cycles, equivalent to dna amounts from 6 to 100 oocysts, whereas values from immunised mice are between 39 to 35 cycles, equivalent to dna amounts from 0.1 to 5 oocysts been the first example of effective prevention for neonates [48] and it has been extensively applied as part of the who maternal and neonatal tetanus elimination (mnte) program. successful immunisations have been also achieved with influenza virus [49] and with the acellular pertussis antigen vaccine that protects infants from clinical pertussis [50] . therefore, maternal immunisation can be an effective strategy to limit neonatal cryptosporidiosis before the development of a mature immune system. the sa35 and sa40 peptides enhance humoral and cellmediated immune responses to c. parvum in adult mice. mucosal immunisation of pregnant mice with a mixture of sa35 and sa40 antigens (sa35/40 mix) resulted in a remarkable reduction in parasite load in the gut of their infected offspring. overall, this result represents the proof of concept that maternal immunisation can effectively prevent neonatal cryptosporidiosis. genetic diversity and population structure of cryptosporidium molecular epidemiologic tools for waterborne pathogens cryptosporidium spp. and giardia duodenalis a review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium a massive outbreak in milwaukee of cryptosporidium infection transmitted through the public water supply world health organization. who estimates of the global burden of foodborne diseases bovine cryptosporidiosis: impact, host-parasite interaction and control strategies the global enteric multicenter study (gems): impetus, rationale, and genesis burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the global enteric multicenter study, gems): a prospective, case-control study use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the gems case-control study the impact of perinatal immune development on mucosal homeostasis and chronic inflammation innate immune responses against cryptosporidium parvum infection cryptosporidiosis drug discovery: opportunities and challenges cryptosporidium pathogenicity and virulence cryptosporidium hominis gene catalog: a resource for the selection of novel cryptosporidium vaccine candidates. database (oxford) cessation of cryptosporidiumassociated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in aids patients breast milk parasite-specific antibodies and protection from amebiasis and cryptosporidiosis in bangladeshi infants: a prospective cohort study cryptosporidium prevalence and risk factors among mothers and infants 0 to 6 months in rural and semi-rural northwest tanzania: a prospective cohort study identification and characterisation of three antigenic proteins from cryptosporidium parvum sporozoites using a dna library expressing poly-histidine tagged peptides convenient online submission • thorough peer review by experienced researchers in your field • rapid publication on acceptance • support for research data, including large and complex data types • gold open access which fosters wider collaboration and increased citations maximum visibility for your research: over 100m website views per year • at bmc experimental cryptosporidiosis in hamsters cryptosporidium parvum-specific cd4 th1 cells from sensitized donors responding to both fractionated and recombinant antigenic proteins characterization and immunolocalization of a cryptosporidium protein containing repeated amino acid motifs a new modular protein of cryptosporidium parvum, with ricin b and lccl domains, expressed in the sporozoite invasive stage a novel multi-domain mucin-like glycoprotein of cryptosporidium parvum mediates invasion the immunological selection of recombinant peptides from cryptosporidium parvum reveals 14 proteins expressed at the sporozoite stage, 7 of which are conserved in other apicomplexa immunization with native surface protein ncsrs2 induces a th2 immune response and reduces congenital neospora caninum transmission in mice long-term survival of cryptosporidium parvum oocysts in seawater and in experimentally infected mussels (mytilus galloprovincialis) a newborn mouse cryptosporidium parvum infection model: its application to the study of therapeutic and prophylactic measures for controlling cryptosporidiosis in ruminants quantitative flow cytometric evaluation of maximal cryptosporidium parvum oocyst infectivity in a neonate mouse model detection and counting of cryptosporidium parvum in hct-8 cells by flowcytometry indinavir reduces cryptosporidium parvum infection in both in vitro and in vivo models real-time pcr for quantification of giardia and cryptosporidium in environmental water samples and sewage cryptosporidium infection in an adult mouse model. independent roles for ifn-gamma and cd4+ t lymphocytes in protective immunity cryptosporidium parvum: the contribution of th1-inducing pathways to the resolution of infection in mice severe, protracted intestinal cryptosporidiosis associated with interferon gamma deficiency: pediatric case report susceptibility differences to cryptosporidium parvum infection in two strains of gamma interferon knockout mice seropositive human subjects produce interferon gamma after stimulation with recombinant cryptosporidium hominis gp15 adoptive transfer of protective immunity from cryptosporidium parvum-infected interferon-gamma and interleukin-12-deficient mice to naive recipients successful induction of cd8 t cell-dependent protection against malaria by sequential immunization with dna and recombinant poxvirus of neonatal mice born to immune mothers dynamics of immunoglobulins at the feto-maternal interface transfer of maternal immunity and programming of the newborn immune system protection of calves against cryptosporidiosis with immune bovine colostrum induced by a cryptosporidium parvum recombinant protein protection of kids against cryptosporidium parvum infection after immunization of dams with cp15-dna oral administration of hyperimmune anti-cryptosporidium parvum ovine colostral whey confers a high level of protection against cryptosporidiosis in newborn nmri mice serological, colostral and milk responses of cows vaccinated with a single dose of a combined vaccine against rotavirus, coronavirus and escherichia coli f5 (k99) evaluation of a protocol to reduce the incidence of neonatal calf diarrhoea on dairy herds neonatal tetanus in new guinea. effect of active immunization in pregnancy maternal immunization with inactivated influenza vaccine: rationale and experience effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations we are very grateful to dr silvia vendetti for her helpful suggestions on the mucosal delivery mouse model. we would like to thank simone m. cacciò for the critical reading of the manuscript. all data presented in this manuscript are available at the istituto superiore di sanità. not applicable. the authors declare that they have no competing interests.received: 28 november 2018 accepted: 6 may 2019 key: cord-002341-v4r5d26a authors: chan, jasper fuk-woo; zhang, anna jinxia; chan, chris chung-sing; yip, cyril chik-yan; mak, winger wing-nga; zhu, houshun; poon, vincent kwok-man; tee, kah-meng; zhu, zheng; cai, jian-piao; tsang, jessica oi-ling; chik, kenn ka-heng; yin, feifei; chan, kwok-hung; kok, kin-hang; jin, dong-yan; au-yeung, rex kwok-him; yuen, kwok-yung title: zika virus infection in dexamethasone-immunosuppressed mice demonstrating disseminated infection with multi-organ involvement including orchitis effectively treated by recombinant type i interferons date: 2016-11-12 journal: ebiomedicine doi: 10.1016/j.ebiom.2016.11.017 sha: doc_id: 2341 cord_uid: v4r5d26a background: disseminated or fatal zika virus (zikv) infections were reported in immunosuppressed patients. existing interferon-signaling/receptor-deficient mouse models may not be suitable for evaluating treatment effects of recombinant interferons. methods: we developed a novel mouse model for zikv infection by immunosuppressing balb/c mice with dexamethasone. results: dexamethasone-immunosuppressed male mice (6–8 weeks) developed disseminated infection as evidenced by the detection of zikv-ns1 protein expression and high viral loads in multiple organs. they had ≥ 10% weight loss and high clinical scores soon after dexamethasone withdrawal (10 dpi), which warranted euthanasia at 12 dpi. viral loads in blood and most tissues at 5 dpi were significantly higher than those at 12 dpi (p < 0.05). histological examination revealed prominent inflammatory infiltrates in multiple organs, and cd45 + and cd8 + inflammatory cells were seen in the testis. these findings suggested that clinical deterioration occurred during viral clearance by host immune response. type i interferon treatments improved clinical outcome of mice (100% vs 0% survival). conclusions: besides virus dissemination, inflammation of various tissues, especially orchitis, may be potential complications of zikv infection with significant implications on disease transmission and male fertility. interferon treatment should be considered in patients at high risks for zikv-associated complications when the potential benefits outweigh the side effects of treatment. zika virus (zikv) is an emerging flavivirus that has been largely neglected for n 60 years after its discovery due to its restricted geographical distribution and its presumed low clinical significance (chan et al., 2016a) . since 2007, large-scale outbreaks of zikv infection have occurred in the pacific islands, latin america, and most recently, usa and southeast asia (duffy et al., 2009; musso and gubler, 2016; zhu et al., 2016) . as of 27 october 2016, n 70 countries/territories have ebiomedicine 14 (2016) 112-122 reported continuing mosquito-borne transmission of zikv (world health organization. zika situation report. october 27, 2016) . in addition to mosquito-borne transmission, sexual and transplacental transmissions of zikv have also been reported (chan et al., 2016a; musso et al., 2015a; foy et al., 2011; calvet et al., 2016) . these non-vectorborne transmission routes render the control of the continuing epidemic more complicated. zikv was not considered as an important human pathogen in the past as most infected adult patients were asymptomatic or developed a self-limiting acute febrile illness which resolved within 1-2 weeks (chan et al., 2016a; duffy et al., 2009 ). however, it has been recently recognized that infected mothers may transmit the virus transplacentally to developing fetuses, leading to congenital malformations, including microcephaly, cerebral malformations, ophthalmological and hearing defects, and arthrogryposis (chan et al., 2016a; mlakar et al., 2016; de paula et al., 2016; leal et al., 2016) . some infected adults may also develop severe neurological complications, such as guillain-barré syndrome, meningoencephalitis, and myelitis (cao-lormeau et al., 2016; carteaux et al., 2016; mecharles et al., 2016) . moreover, zikv-related fatalities have been increasingly recognized. most of the patients with fatal infection had underlying medical conditions and some were markedly immunosuppressed, including a patient with systemic lupus erythematosus and rheumatoid arthritis who was on corticosteroid therapy and died of disseminated infection with detectable zikv rna in blood, brain, spleen, liver, kidney, lung, and heart obtained at postmortem examination (pan american health organization/world health oganization (paho/who), 2015; sarmiento-ospina et al., 2016; arzuza-ortega et al., 2016) . a number of animal models have been developed for studying the pathogenesis and evaluating countermeasures for zikv infection. rhesus macaques with subcutaneous zikv inoculation develop mild clinical signs that resemble the self-limiting illness in most infected immunocompetent adults (dudley et al., 2016) . this non-human primate model provides a robust platform for the evaluation of vaccines and host immune response (abbink et al., 2016) . however, the mild clinical disease in these primates is suboptimal for antiviral treatment evaluation. moreover, expertise and facilities for working with non-human primates are not available in most research laboratories. wild-type adult balb/c mice are not susceptible to intraperitoneal zikv inoculation (dick, 1952) . suckling and young mice with intracerebral zikv inoculation develop disease that is localized to the central nervous system (dick, 1952; way et al., 1976; weinbren and williams, 1958; bell et al., 1971) . pregnant mice and fetal mice with partially intact type i interferon signaling response (fetuses of female mice deficienct in type i interferon signaling response crossed to wild-type male mice) were used to study pathogenesis in pregnancy and maternalfetal transmission, but these models are technically more demanding (miner et al., 2016; cugola et al., 2016) . type i/ii interferon-signaling-/ receptor-deficient mice with intraperitoneal or subcutaneous zikv inoculation develop fatal, disseminated infection (lazear et al., 2016; dowall et al., 2016; aliota et al., 2016; rossi et al., 2016) . these models are useful for the evaluation of countermeasures for zikv infection as the protective effects of antivirals drugs and vaccines are more easily observed in treated mice. however, such models have complete/nearcomplete deficiency in interferon response and do not resemble the real clinical situation in immunosuppressed humans. moreover, these mice are suboptimal for the study of host immune response and may be too expensive for laboratories in resource-limited areas. because of these limitations and knowledge gaps, we developed and characterized a more readily available mouse model which resembles immunosuppressed hosts with disseminated infection. we showed that these mice developed inflammation in multiple organs, including the testes, which may have important implications on zikv's longterm outcome and effects on fertility. we also utilized this novel animal model to show that early treatment with clinically approved recombinant type i interferons improved the clinical outcome of these mice. a clinical isolate of zikv (puerto rico strain prvabc59) was kindly provided by brandy russell and barbara johnson, centers for disease control and prevention, usa. the virus was amplified by three additional passages in vero cells (atcc) in minimum essential medium (mem) supplemented with 1% fetal calf serum and 100 units/ml penicillin plus 100 μg/ml streptomycin to make working stocks of the virus. for virus titration, aliquots of zikv were applied on confluent vero cells in 96well plates for 50% tissue culture infectious dose (tcid 50 ) assay as we previously described with slight modifications (zhou et al., 2014) . briefly, serial 10-fold dilutions of zikv were inoculated in a vero cell monolayer in quadruplicate and cultured in penicillin/streptomycinsupplemented mem. the plates were observed for cytopathic effect for 5 days. viral titer was calculated with the reed and münch endpoint method. one tcid 50 was interpreted as the amount of virus that causes cytopathic effect in 50% of inoculated wells. approval was obtained from the committee on the use of live animals in teaching and research of the university of hong kong. male and female balb/c mice, 6-8 weeks old, were obtained from the laboratory animal unit of the university of hong kong. the mice were kept in biosafety level-2 housing and given access to standard pellet feed and water ad libitum. virus inoculation experiments were performed in a biosafety level-2 animal facility according to the standard operating procedures approved by the committee on the use of live animals in teaching and research of the university of hong kong as we described previously (zhang et al., 2014) . the mice were randomly divided into 11 groups and given different regimens of virus inoculation, dexamethasone, and recombinant interferon treatment (table 1) . phosphate-buffered saline (pbs) was used to dilute the virus stocks to the desired concentration, and inocula were back-titrated to verify the dose given. on the day of virus inoculation, a dose of the virus equivalent to 6 × 10 6 tcid 50 (3.24 × 10 6 plaque forming units) in 200 μl of pbs was inoculated via the intraperitoneal route into mice under ketamine (100 mg/kg) and xylazine (10 mg/kg) anesthesia. mice in the negative-control groups (groups 5 to 8) were injected with the same volume of pbs. mice were monitored three times each day for clinical signs of disease and a numerical score was assigned at each observation as previously described (dowall et al., 2016; graham et al., 2015) . their body weight and survival were monitored for 14 days post-inoculation (dpi) or until euthanasia. three mice in each group (except groups 7 and 8 which included mock-infected control mice without dexamethasone immunosuppression and group 9 which included zikv-inoculated, dexamethasone-immunosuppressed mice without dexamethasone withdrawal) were sacrificed at 5 dpi for virological, histological, and immunohistochemistry analyses. the remaining mice were sacrificed at 14 dpi or euthanized when there was a 20% weight loss or 10% weight loss with ≥1 clinical sign (dowall et al., 2016) . samples of brain, testis/ epididymis (male), prostate (male), ovary/uterus (female), kidney, urinary bladder, spleen, liver, pancreas, intestine, heart, lung, and salivary gland were collected at necropsy. the specimens were separated into two parts, one immediately fixed in 10% pbs-buffered formalin, the other immediately frozen at −80°c until further experiments. blood samples were also collected for rna extraction and real-time pcr analysis. paraffin-embedded tissues were cut into 4-6 μm sections, mounted on slides, and stained with hematoxylin and eosin (h&e) for light microscopy examination as we previously described (zheng et al., 2008) . for immunohistochemical staining of zikv-ns1 antigen, mouse antiserum against zikv-ns1 protein prepared as we previously described was used as primary antibody (chan et al., 2016b) . de-paraffinized and rehydrated tissue sections were treated with antigen unmasking solution according to manufacturer's instructions (vector laboratories inc., burlingame, ca, usa) and then stained with mouse on mouse polymer ihc kit (abcam, cambridge, united kingdom). the primary antibody mouse anti-zikv-ns1 antiserum (1:1000 dilution with 1% bsa/pbs) was incubated at 4°c overnight. this was followed by mouse on mouse hrp polymer kit (abcam) with horseradish peroxidase-conjugated secondary antibody for 15 min. color development was performed using 3,3′-diaminobenzidine (dab) (vector laboratories, burlingame, ca, usa). for immunohistochemical staining of cd45 and cd8, the sections were incubated at 4°c for overnight with primary antibody (rabbit anti-mouse cd45, or rat anti-mouse cd8α (abcam) after antigen unmasking and blocking. this was then followed by incubation with biotin-conjugated goat anti-rabbit igg or goat anti-rat igg (calbiochem, darmstadt, germany) for 30 min at room temperature. streptavidin/peroxidase complex reagent (vector laboratories) was then added and incubated at room temperature for 30 min. color development was done with dab (vector laboratories). all tissue sections were examined microscopically by two pathologists in an operatorblinded manner. images were captured with nikon80i imaging system equipped with spot-advance computer software. total nucleic acid (tna) was extracted from the blood and necropsied tissues using ez1 virus mini kit v2.0 and qiasymphony dsp virus/pathogen mini kit (qiagen, hilden, germany), respectively, as we previously described (zheng et al., 2008; chan et al., 2016b; chan et al., 2015a) . zikv envelope gene was measured by using quantinova probe rt-pcr kit (qiagen) in lightcycler 96 real-time pcr system (roche diagnostics, basel, switzerland). 5 μl of purified tna was amplified in a 20 μl-reaction containing 10 μl of 2× quantinova probe rt-pcr master mix, 0.2 μl qn probe rt-mix, 0.8 μm forward primer, 0.8 μm reverse primer, and 200 nm probe. forward primer (5′-cgytgcccaacacaagg-3′), reverse primer (5′-ccacyaaygttcttttgcabaca-3′), and probe (5′-hex-agcctaccttgayaagcartcagacactc-iabkfq-3′) targeting the zikv envelope gene as we previously described were used (chan et al., 2016b) . reactions were incubated at 45°c for 10 min, followed by 95°c for 5 min, and then thermal cycled for 50 cycles (95°c for 5 s, 55°c for 30 s). internal control β-actin gene was measured by using quantinova sybr green rt-pcr kit (qiagen) in lightcycler 96 real-time pcr system. 5 μl of purified tna was amplified in a 20 μl-reaction containing 10 μl of 2× quantinova sybr green rt-pcr master mix, 0.2 μl qn sybr green rt-mix, 0.5 μm forward primer (5′-acggccaggtcatcactattg-3′) and 0.5 μm reverse primer (5′-caagaaggaaggctggaaaag-3′) for the β-actin gene. reactions were incubated at 50°c for 10 min, followed by 95°c for 2 min, and then thermal cycled for 50 cycles (95°c for 5 s, 60°c for 10 s). a series of 10-fold dilutions equivalent to 1 × 10 2 to 1 × 10 6 copies/reaction mixture were prepared to generate standard curves and run in parallel with the test samples. all data were analyzed with graphpad prism software (graphpad software, inc). kaplan-meier survival curves were analyzed by the log rank test, and weight losses were compared using two-way anova. student's t-test was used to determine significant differences in virus titers, and tukey-kramer post hoc tests were used to discern differences among individual treatment groups as previously reported rossi et al., 2016) . p-values b0.05 were considered statistically significant. to establish a novel mouse model for zikv infection, we compared the clinical, histological, and virological findings of male (group 1) and female (group 2) mice with dexamethasone immunosuppression and zikv inoculation with those of the appropriate controls (groups 3 to 8) (table 1 ). in terms of the clinical parameters, the dexamethasone-immunosuppressed mice developed mild (~5%) weight loss (fig. 1a) and no mortality at 5 dpi ( fig. 1b and c) . the weight losses of the dexamethasone-immunosuppressed mice with zikv inoculation (groups 1 and 2) table 1 eleven groups of mice receiving different regimens of virus inoculation, dexamethasone, and antiviral treatment in this study a . group gender routes and inoculum of zikv (0 dpi) dexamethasone antiviral treatment b date of sacrifice/euthanasia 1 m ip 6 × 10 6 tcid 50 50 mg/kg q24h ip, from 3 days before to 9 dpi inclusively no 5 (n = 3) and 12 (n = 6) dpi c 2 f ip 6 × 10 6 tcid 50 50 mg/kg q24h ip, from 3 days before to 9 dpi inclusively no 5 (n = 3) and 14 (n = 6) dpi 3 m ip 6 × 10 6 tcid 50 no no 5 (n = 3) and 14 (n = 6) dpi 4 f ip 6 × 10 6 tcid 50 no no 5 (n = 3) and 14 (n = 6) dpi 5 m no 50 mg/kg q24h ip, from 3 days before to 9 dpi inclusively no 5 (n = 3) and 14 (n = 6) dpi 6 f no 50 mg/kg q24h ip, from 3 days before to 9dpi inclusively no 5 (n = 3) and 14 (n = 6) dpi 7 no 14 (n = 6) dpi 9 m ip 6 × 10 6 tcid 50 50 mg/kg q24h ip, from 3 days before to 13 dpi inclusively no 14 (n = 6) dpi 10 m ip 6 × 10 6 tcid 50 50 mg/kg q24h ip, from 3 days before to 9 dpi inclusively pegylated ifn-α2b 1920 iu/dose q96h sc at 1, 5, and 9 dpi 5 (n = 3) and 14 (n = 8) dpi 11 m ip 6 × 10 6 tcid 50 50 mg/kg q24h ip, from 3 days before to 9 dpi inclusively ifn-β1b 160,000 iu/dose q48h ip at 1, 3, 5, 7, and 9 dpi 5 (n = 3) and 14 (n = 8) dpi abbreviations: dpi, days post-inoculation; f, female; ifn, interferon; ip, intraperitoneal; m, male; sc, subcutaneous. a 6-8 week-old balb/c mice were used in all the groups. b the preparations of pegylated ifn-α2b and ifn-β1b used in this study were pegintron (merck & co., inc., whitehouse station, nj, usa) and betaferon (bayer schering pharma ag, berlin, germany), respectively. c the mice in group 1 were euthanized at 12 dpi as they had ≥10% weight loss and ≥1 clinical symptom. were consistently more significant than those of their comparators, including the zikv-inoculated mice without dexamethasone immunosuppression (groups 3 and 4) and mock-infected mice without dexamethasone immunosuppression (groups 7 and 8) starting at 1 dpi (p b 0.05). minimal histological changes and inflammatory infiltrates were seen in the tissues of the male and female mice with dexamethasone immunosuppression and zikv inoculation (groups 1 and 2). on the other hand, zikv-ns1 protein expression was detected by immunohistochemical staining in most tissues of these mice, but not in dexamethasone-immunosuppressed mice with mock infection (groups 5 and 6), suggesting that the viral protein expression was specific and not related to dexamethasone effects (fig. 2) . the dexamethasone-immunosuppressed mice with zikv inoculation (groups 1 and 2) also had high mean viral loads in blood and most tissues at 5 dpi, especially in the testis/epididymis, ovary/uterus, prostate, spleen, and pancreas (figs. 3a and b and s1a and b). these findings at 5 dpi were suggestive of disseminated but non-lethal zikv infection involving different organs with minimal inflammatory response due to dexamethasone immunosuppression. to investigate the possible effects of immune reconstitution in the dexamethasone-immunosuppressed mice, dexamethasone was stopped after 9 dpi. this led to prominent weight loss and increased symptoms in the dexamethasone-immunosuppressed mice (groups 1 and 2). the most prominent body weight loss was observed in the male mice with dexamethasone immunosuppression and zikv inoculation (group 1), with all 6 mice having weight loss of ≥ 10% at 12 dpi (fig. 1a) . all of the female mice with dexamethasone immunosuppression and zikv inoculation (group 2) also had progressive weight loss and 4/6 (66.7%) of them had ≥ 10% weight loss at 14 dpi. in contrast, none of the mice with dexamethasone immunosuppression from 3 days before to 13 days post-infection (group 9) developed abrupt weight loss between 10 dpi and 14 dpi (fig. 1a) . the weight loss of mice in groups 1 and 2 became consistently more than those of their comparators in the other control groups (groups 3 to 8), including those in the dexamethasone-immunosuppressed mice with mock infection (groups 5 and 6) since 10 dpi (p b 0.05). together, these findings suggested that the combination of immune reconstitution after dexamethasone withdrawal and disseminated virus infection were responsible for the abrupt clinical deterioration. all of the mice in groups 1 and 2 developed rapid breathing, lethargy, and/or ruffled fur since 11 dpi (group 1) or 12 dpi (group 2), shortly after dexamethasone was stopped (fig. 1b) . the reasons for the earlier onset of weight loss and symptoms in the male mice were not fully understood, but might be related to the higher cumulative dose of dexamethasone because of their higher baseline body weights and/or possible effects of androgen on virus replication (tian et al., 2012) . based on the predefined criteria, all 6 (100%) male and 4/6 (66.7%) female mice were euthanized at 12 dpi and 14 dpi, respectively (fig. 1c) . comparatively, all the mice in the other control groups (groups 3 to 9) had either gained weight or had b 5% weight loss with spontaneous recovery at 14 dpi (fig. 1a) , remained asymptomatic (fig. 1b) , and survived through the study period (fig. 1c) . at euthanasia (12-14 dpi), h&e staining of the necropsied tissues of these mice showed prominent acute inflammatory reactions with predominantly lymphocytic infiltrates. the most prominent inflammatory changes were seen in the brain (cortical parenchymal and perivascular lymphocytic infiltrates) (fig. 4a to c), kidney (acute tubulitis and interstitial inflammation) (fig. 4d to f), and testis (necrotic and hemorrhagic seminiferous tubules with marked lymphocytic infiltration in the perimeter of the tubules and the interstitium) (fig. 5a to d) . zikv-ns1 protein expression was still visible, but to a lesser degree, in the immunohistochemical staining of the testis/epididymis, ovary/uterus, kidney, spleen, small intestine, pancreas, and salivary gland of the dexamethasone-immunosuppressed mice with zikv inoculation at 12-14 dpi compared with 5 dpi. in contrast, no inflammatory reaction and viral protein expression were seen in any organ of the control mice with zikv inoculation alone (groups 3 and 4) or dexamethasone immunosuppression alone (groups 5 and 6) ( fig. 5c and d) . these findings confirmed that mice with zikv inoculation but no dexamethasone immunosuppression were not susceptible to infection as previously reported, and that the histological changes in the model mice (groups 1 and 2) were unrelated to dexamethasone-induced effects such as drug-induced testicular toxicity (lazear et al., 2016; dowall et al., 2016; aliota et al., 2016; rossi et al., 2016; khorsandi et al., 2013) . the absence of inflammatory infiltrates in zikv-inoculated, dexamethasone-immunosuppressed mice without dexamethasone withdrawal (group 9) supported the role of the host immune response in eliciting the clinical and histological changes in the zikv-inoculated mice with dexamethasone withdrawal (groups 1 and 2). to further confirm the presence of inflammatory infiltrates and characterize the cell types involved in the host immune response, we stained the necropsied testis of the dexamethasone-immunosuppressed mice with zikv inoculation and those of the dexamethasoneimmunosuppressed mock-infected control mice with cd45 (pan-leukocyte) and cd8 (cytotoxic t lymphocyte) antibodies. corroborative to the histological findings, only the testis of the dexamethasone-immunosuppressed mice with zikv inoculation, but not those of the control mice, stained positive for cd45 ( fig. 5e and f) and cd8 antibodies ( fig. 5g and h). these findings confirmed the presence of inflammatory infiltrates and especially cd8+ t lymphocytes in the testis of the zikv-infected mice. the dexamethasone-immunosuppressed mice with zikv inoculation (groups 1 and 2) also had significantly lower mean viral loads in blood and most tissues at euthanasia at 12-14 dpi as compared with those collected at 5 dpi (↓ 1-4 log 10 copies/10 6 β-actin at 12-14 dpi) (figs. 3a and b and s1a and b). at euthanasia (12-14 dpi), viral rna was still detectable in most tissues of the male mice (up to 3 log 10 copies/10 6 β-actin), but viremia was absent. the control mice with zikv inoculation but no dexamethasone immunosuppression had undetectable viral rna in blood and most tissues, which was consistent with previous reports (lazear et al., 2016; dowall et al., 2016; aliota et al., 2016; rossi et al., 2016) . overall, these findings were suggestive of multi-organ inflammation upon immune reconstitution with partial viral clearance in the mice after withdrawal of dexamethasone immunosuppression. we next evaluated the effects of recombinant type i interferon treatment in our mouse model. we used male mice as they had earlier onset of weight loss and clinical symptoms requiring necropsy at 12 dpi. the mice were treated with pegylated interferon-α2b (pegintron®, merck & co., inc., whitehouse station, nj, usa) 1920 iu/dose every 96 h subcutaneously at 1 dpi, 5 dpi, and 9 dpi (group 10) or interferon-β1b (betaferon®, bayer schering pharma ag, berlin, germany) 160,000 iu/dose every 48 h intraperitoneally at 1 dpi, 3 dpi, 5 dpi, 7 dpi, and 9 dpi (group 11). as shown in fig. 6a , the mice treated with pegylated interferon-α2b (group 10) or interferon-β1b (group 11) had b10% weight loss with spontaneous recovery at 14 dpi. the weight loss of the untreated group became significantly more than those of the mice treated with either interferon-α2 or interferon-β1b starting at 10 dpi (p b 0.05). all of these mice remained asymptomatic and survived through the study period ( fig. 6b and c) . none of their tissues showed prominent inflammatory reactions in h&e staining at 5 dpi or 14 dpi. zikv-ns1 protein expression was only rarely seen in the immunohistochemical staining of the testis/epididymis, kidney, spleen, small intestine, lung, and pancreas collected at 5 dpi, and testis, epididymis, kidney, and spleen at 14 dpi. they had reduced mean viral loads in blood and all the tissues (↓2-4 log 10 copies/10 6 β-actin) as compared with those of the untreated mice at 5 dpi and 14 dpi ( fig. 7a and b) . the reductions were most significant in the tissues with high viral loads, such as the spleen, testis, pancreas, and prostate (p b 0.05). overall, these findings suggested that early use of systemic recombinant type i interferons improved the clinical, histological, and virological parameters of mice with disseminated zikv infection. the full spectrum of clinical manifestations and complications of zikv infection remains incompletely understood as of today. the previous assumption that zikv infection is an entirely self-limiting disease without severe or long-lasting sequelae has been overturned by the increasing recognition of congenital malformations, neurological complications, immune-mediated thrombocytopenia, and even fatality in some immunosuppressed patients (pan american health organization/ a b fig. 3 . viral loads in the blood and major organs of dexamethasone-immunosuppressed balb/c male and female mice with zikv inoculation. mice ((a) male (5 dpi, n = 3 from two independent experiments; 14 dpi, n = 6 from two independent experiments) and (b) female (5 dpi, n = 3 from two independent experiments; 14 dpi, n = 6 from two independent experiments)) with dexamethasone immunosuppression had higher blood and tissue viral loads at 5 dpi while they were on dexamethasone than at euthanasia (12 dpi for male mice and 14 dpi for female mice) after dexamethasone was stopped (10 dpi). zikv rna copies in the blood and tissues of the mice were determined by real-time rt-pcr and normalized by β-actin as described in the text. * denotes p-values of b0.05. *** denotes p-values b0.001. error bars represent standard error of the mean. world health oganization (paho/who), 2015; sarmiento-ospina et al., 2016; arzuza-ortega et al., 2016; duijster et al., 2016) . notably, patients with severe non-pregnancy-related complications of zikv often deteriorated suddenly after an initially mild disease phase as the viral load began to decrease (cao-lormeau et al., 2016; mecharles et al., 2016; sarmiento-ospina et al., 2016) . this has led us to hypothesize that, like many other flavivirus infections, including yellow fever, dengue, and west nile virus infection, the host immune response may also play a role in these zikv-associated complications, especially during the viral clearance phase by the host immune system (quaresma et al., 2013; screaton et al., 2015; wang et al., 2003) . in this study, we characterized a novel and readily available mouse model for severe zikv infection which attempts to provide an alternative venue for studying the host immune response of and evaluating countermeasures for zikv infection. the findings in our study have important implications on the pathogenesis, potential complications, and treatment of zikv infection. the dexamethasone-immunosuppressed mice with zikv inoculation in our study developed disseminated infection with viremia and multi-organ involvement, including the brain, urogenital tract, intestine, liver, spleen, pancreas, heart, lung, and salivary gland as evident by zikv-ns1 protein expression on immunohistochemical staining and/or detectable viral load in these tissues. immunohistochemistry staining of the testis confirmed the presence of inflammatory cell infiltrate (pan-leukocyte marker cd45 +) with predominantly cd8 + t lymphocytes. clinically, the male mice developed earlier onset of disease than the female mice, with ≥10% weight loss and ≥1 clinical sign, which warranted euthanasia at 12 dpi. their weight loss, clinical scores, and histological evidence of inflammatory reactions were most severe soon after dexamethasone withdrawal, when viral loads had already decreased by about 2-5 log 10 copies/10 6 β-actin. overall, these findings suggested that, like the other related flaviviruses, the host immune response might have led to marked clinical deterioration in the face of disseminated zikv infection at the time when immune-mediated clearance of the virus began. our findings provided an additional explanation for the pathogenesis of fatal zikv infection, which has been proposed to be related to uncontrolled virus dissemination in previously described mouse models utilizing types i/ii interferon-signaling-/receptor-deficient mice that were unable to mount a robust host innate immune response. our mouse model is also useful for studying zikv's tissue tropism and potential complications of severe zikv infection. in addition to the reported findings of detectable virus particles and/or rna in the brain, spinal cord, kidney, spleen, liver, testis, ovary, heart, lung, muscle, and blood of types i/ii interferon-signaling-/receptor-deficient mice with zikv infection, our study identified intestine, pancreas, and salivary gland as other possible tissues and anatomical sites for virus infection (dick, 1952; lazear et al., 2016; dowall et al., 2016; aliota et al., 2016; rossi et al., 2016) . this tissue tropism of zikv in our mouse model concurs with the in-vitro observation that zikv efficiently replicates in diverse cell types of neuronal, testicular, prostatic, renal, intestinal, hepatic, and placental origin (chan et al., 2016b; brault et al., 2016; hughes et al., 2016) . such degree of virus dissemination and multiorgan involvement is also compatible with the clinical findings in patients with severe and/or fatal zikv infection, in whom viral particles and/or rna were detected in multiple organs at post-mortem examination (pan american health organization/world health oganization (paho/who), 2015; sarmiento-ospina et al., 2016; arzuza-ortega et al., 2016) . while inflammatory neurological complications, such as guillain-barré syndrome, meningoencephalitis, and myelitis, have been recently reported in patients with zikv infection, inflammatory disorders of the other non-neuronal tissues were not well recognized (cao-lormeau et al., 2016; carteaux et al., 2016; mecharles et al., 2016) . our findings showed that inflammation could be observed in multiple organs including the testis, kidney, spleen, liver, intestine, pancreas, lung, and salivary gland outside the nervous system. among these non-neuronal tissues, the inflammatory reactions were most prominent in the testis of our model mice. some patients with zikv infection reported hematospermia, pelvic pain, and dysuria with detectable viral particles and/or rna in their semen (chan et al., 2016a; musso et al., 2015a; foy et al., 2011) . histological evidence of orchitis has not been reported due to the difficulty in obtaining the patients' testicular tissues for histological examination. previous mouse fig. 4 . representative histological findings in the brain and kidney of dexamethasone-immunosuppressed balb/c mice with zikv inoculation and dexamethasone-immunosuppressed mock-infected control mice. the brain and kidneys of all sacrificed mice were examined. each organ was entirely embedded in one paraffin block, and one full-face paraffin section at the maximum diameter of each organ was examined per block. sections of the brain (12 dpi) of a dexamethasone-immunosuppressed mouse with zikv inoculation showing (a) moderate degree of perivascular lymphocytic infiltrate and (b) marked lymphocytic infiltration in the cortical parenchyma (h&e, original magnification ×400). section of the brain (12 dpi) of dexamethasone-immunosuppressed mock-infected mouse showing normal architecture in the parenchyma (c) (h&e, original magnification ×400). sections of the kidney (12 dpi) showing (d) acute tubulitis with a large amount of inflammatory exudation in tubular lumens and (e) moderate degree of interstitial inflammation (h&e, original magnification ×400). (f) section of the kidney (12 dpi) of a dexamethasone-immunosuppressed mock-infected mouse showing normal architecture (h&e, original magnification ×400). models for zikv infection utilizing types i/ii interferon-signaling-/receptor-deficient mice have also showed that viral particles and rna could be detected in the mice's testes, but histological analysis were not reported (lazear et al., 2016) . the markedly necrotic and hemorrhagic seminiferous tubules observed in our mice are highly alarming as orchitis may have long-term effects on fertility. these changes were not accountable by dexamethasone-induced testicular toxicity, as they were morphologically different from the latter, and were not present in any of the testes of the control mice with dexamethasone treatment and mock infection (khorsandi et al., 2013) . during revision of this work, similar findings were reported in the testes of c57bl/6 mice treated with anti-ifna1 blocking monoclonal antibody and inoculated with zikv . clinical studies to confirm the presence of orchitis and to assess the fertility of convalescent male patients should be conducted to ascertain the long-term consequences of zikv infection regarding reproductive and hormonal derangements. inflammation of other organs, such as acute tubulitis, interstitial nephritis, sialadenitis, hepatitis, enteritis, and acute pancreatitis have been reported in patients with zikv or other flavivirus infections (chan et al., 2016a; sarmiento-ospina et al., 2016; arzuza-ortega et al., 2016; duijster et al., 2016; bonaldo et al., 2016; gourinat et al., 2015; musso et al., 2015b; mercado et al., 2016; bhagat et al., 2012; torres et al., 2000; macnamara, 1954; chatterjee et al., 2014) . these potential complications may be increasingly recognized as the zikv epidemic continues to expand into developed countries with a large ageing and immunosuppressed population. finally, our mouse model also provided a novel avenue for the evaluation of anti-zikv treatment. type i interferons have broad-spectrum antiviral activities including those against zikv, but type i interferonsignaling-/receptor-deficient mice were not suitable for evaluation of the effects of recombinant type i interferons. we therefore evaluated the antiviral effects of two commercially available preparations of recombinant type i interferons in this new mouse model (hamel et al., 2015; zumla et al., 2016; chan et al., 2013; chan et al., 2015b) . we showed that the early use of either drug was associated with improved clinical outcome with no fatality (100% fatality in untreated mice), markedly decreased inflammatory response after dexamethasone withdrawal, and reduced viral loads in various tissues of the mice as compared to those of the untreated mice. the viral load reductions were especially significant in the early phase of the disease (5 dpi), when the mice were on dexamethasone. these findings suggested that the early use of recombinant interferons might help to control viral replication during the initial phase of infection, and prevent the subsequent development of severe complications related to an exaggerated immune response in the presence of high viral loads as seen in the untreated mice. it is important to further confirm these results in our mouse model using different zikv strains and in clinical trials because zikv antagonizes mouse stat2 less efficiently than human stat2, and thus may be more susceptible to type i interferons in mice (grant et al., 2016) . while most patients with mild zikv infection may not require systemic interferon treatment, clinical trials should be considered to evaluate the benefits of the early use of interferon treatment in patients at risk of developing severe zikv-associated complications, such as those with underlying comorbidities (sarmiento-ospina et al., 2016) . the increased risk of fetal loss and low birth weight associated with interferon therapy in the first trimester of pregnancy may be outweighed by the risk of congenital malformations due to zikv infection. the optimal timing of treatment commencement should be further investigated as late commencement of interferon treatment may be useless or deleterious and should be avoided (solomon et al., 2003) . in summary, this novel mouse model is useful for investigating host immune response-associated damage of and evaluating countermeasures for zikv infection. inflammation of different visceral organs may be important complications of zikv that should be further studied in infected humans. long-term monitoring of the testicular function of zikvinfected male patients should be considered. clinical trials should be , inc., whitehouse station, nj, usa) 1920 iu/dose every 96 h subcutaneously at 1 dpi, 5 dpi, and 9 dpi or interferon-β1b (betaferon®, bayer schering pharma ag, berlin, germany) 160,000 iu/dose every 48 h intraperitoneally at 1 dpi, 3 dpi, 5 dpi, 7 dpi, and 9 dpi. no interferon treatment group (n = 6), interferon-α2b treatment group (n = 8), and interferon-β1b treatment group (n = 8). results were combined from two independent experiments. p-values b0.05 are indicated by (no interferon treatment versus interferon-α2b treatment) and * (no interferon treatment versus interferon-β1b treatment). abbreviation: ifn, interferon. clinical scores: normal = 0; ruffled fur = 2; lethargy, pinched, hunched, wasp waisted = 3; labored breathing, rapid breathing, inactive, neurological = 5; and immobile = 10. considered for evaluating the effects of recombinant interferon treatments in patients at high risk for zikv-associated complications when the potential benefits may outweight the side effects of treatment. supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.ebiom.2016.11.017. jfwc, ajz, ccsc, and kyy designed the study. ajz, ccsc, hz, and vkmp performed infections. ccyy, jolt, kkhc, and khc prepared virus stocks and viral titrations. ajz, wwnm, vkmp, and rkhay prepared histology and immunohistochemistry slides. ccyy, kmt, zz, and jpc performed viral load studies. jfwc, ajz, rkhay, vkmp, and kyy acquired images at the microscope, analyzed, and quantified the data. fy, khk, dyj provided technical assistance and edited the manuscript. jfw, ajz, and kyy wrote the manuscript. jasper f.w. chan has received travel grants from pfizer corporation hong kong and astellas pharma hong kong corporation limited, and was an invited speaker for gilead sciences hong kong limited. the other authors declared no conflict of interests. the funding sources had no role in study design, data collection, analysis or interpretation or writing of the report. the corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. we are grateful to can li, andrew chak-yiu lee, and shuofeng yuan for their facilitation of the study. this work was partly supported by the donations of larry chi-kin yung, and hui hoy and chow sin lan charity fund limited; and funding from the consultancy service for enhancing α β α β a b fig. 7 . viral loads in the blood and major organs of dexamethasone-immunosuppressed balb/c mice with zikv inoculation with or without recombinant type i interferon treatment. male mice with interferon-α2b or -β1b treatment had reduced zikv blood and tissue viral loads as compared to untreated mice at (a) 5 dpi (n = 3 per group from two independent experiments) and (b) 14 dpi (n = 6-8 per group from two independent experiments). zikv rna copies in the blood and tissues of the mice were determined by real-time rt-pcr and normalized by β-actin as described in the text. * denotes p-values of b0.05. error bars represent standard error of the mean. protective efficacy of multiple vaccine platforms against zika virus challenge in rhesus monkeys characterization of lethal zika virus infection in ag129 mice fatal sickle cell disease and zika virus infection in girl from colombia zika virus infection of the central nervous system of mice acute glomerulonephritis in dengue haemorrhagic fever in the absence of shock, sepsis, haemolysis or rhabdomyolysis isolation of infective zika virus from urine and saliva of patients in brazil comparative analysis between flaviviruses reveals specific neural stem cell tropism for zika virus in the mouse developing neocortex detection and sequencing of zika virus from amniotic fluid of fetuses with microcephaly in brazil: a case study guillain-barre syndrome outbreak associated with zika virus infection in french polynesia: a case-control study zika virus associated with meningoencephalitis broad-spectrum antivirals for the emerging middle east respiratory syndrome coronavirus development and evaluation of novel realtime reverse transcription-pcr assays with locked nucleic acid probes targeting leader sequences of human-pathogenic coronaviruses treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of mers-cov infection in a nonhuman primate model of common marmoset zika fever and congenital zika syndrome: an unexpected emerging arboviral disease differential cell line susceptibility to the emerging zika virus: implications for disease pathogenesis, non-vector-borne human transmission and animal reservoirs an observational study of dengue fever in a tertiary care hospital of eastern india the brazilian zika virus strain causes birth defects in experimental models ocular findings in infants with microcephaly associated with presumed zika virus congenital infection in salvador, brazil zika virus. ii. pathogenicity and physical properties a susceptible mouse model for zika virus infection a rhesus macaque model of asian-lineage zika virus infection zika virus outbreak on yap island, federated states of micronesia zika virus infection in 18 travellers returning from surinam and the dominican republic probable non-vector-borne transmission of zika virus detection of zika virus in urine zika virus infection damages the testes in mice genetic diversity in the collaborative cross model recapitulates human west nile virus disease outcomes zika virus targets human stat2 to inhibit type i interferon signaling biology of zika virus infection in human skin cells infectivity of immature neurons to zika virus: a link to congenital zika syndrome effect of curcumin on dexamethasone-induced testicular toxicity in mice a mouse model of zika virus pathogenesis hearing loss in infants with microcephaly and evidence of congenital zika virus infection -brazil zika virus: a report on three cases of human infection during an epidemic of jaundice in nigeria acute myelitis due to zika virus infection clinical and histopathological features of fatal cases with dengue and chikungunya virus co-infection in colombia zika virus infection during pregnancy in mice causes placental damage and fetal demise zika virus associated with microcephaly zika virus potential sexual transmission of zika virus detection of zika virus in saliva epidemiological alert -neurological syndrome, congenital malformations, and zika virus infeciton. implications for public health in the americas immunity and immune response, pathology and pathologic changes: progress and challenges in the immunopathology of yellow fever characterization of a novel murine model to study zika virus zika virus associated deaths in colombia new insights into the immunopathology and control of dengue virus infection interferon alfa-2a in japanese encephalitis: a randomised double-blind placebo-controlled trial enhancement of hepatitis b virus replication by androgen and its receptor in mice acute parotitis due to dengue virus cd8+ t cells mediate recovery and immunopathology in west nile virus encephalitis comparative studies of some african arboviruses in cell culture and in mice zika virus: further isolations in the zika area, and some studies on the strains isolated zika situation report toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza a(h1n1)pdm09 virus infection in balb/c mice delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza a/ h5n1 virus active replication of middle east respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis comparative genomic analysis of pre-epidemic and epidemic zika virus strains for virological factors potentially associated with the rapidly expanding epidemic coronaviruses -drug discovery and therapeutic options key: cord-001958-2gt3fwpy authors: meseda, clement a.; atukorale, vajini; kuhn, jordan; schmeisser, falko; weir, jerry p. title: percutaneous vaccination as an effective method of delivery of mva and mva-vectored vaccines date: 2016-02-19 journal: plos one doi: 10.1371/journal.pone.0149364 sha: doc_id: 1958 cord_uid: 2gt3fwpy the robustness of immune responses to an antigen could be dictated by the route of vaccine inoculation. traditional smallpox vaccines, essentially vaccinia virus strains, that were used in the eradication of smallpox were administered by percutaneous inoculation (skin scarification). the modified vaccinia virus ankara is licensed as a smallpox vaccine in europe and canada and currently undergoing clinical development in the united states. mva is also being investigated as a vector for the delivery of heterologous genes for prophylactic or therapeutic immunization. since mva is replication-deficient, mva and mva-vectored vaccines are often inoculated through the intramuscular, intradermal or subcutaneous routes. vaccine inoculation via the intramuscular, intradermal or subcutaneous routes requires the use of injection needles, and an estimated 10 to 20% of the population of the united states has needle phobia. following an observation in our laboratory that a replication-deficient recombinant vaccinia virus derived from the new york city board of health strain elicited protective immune responses in a mouse model upon inoculation by tail scarification, we investigated whether mva and mva recombinants can elicit protective responses following percutaneous administration in mouse models. our data suggest that mva administered by percutaneous inoculation, elicited vaccinia-specific antibody responses, and protected mice from lethal vaccinia virus challenge, at levels comparable to or better than subcutaneous or intramuscular inoculation. high titers of specific neutralizing antibodies were elicited in mice inoculated with a recombinant mva expressing the herpes simplex type 2 glycoprotein d after scarification. similarly, a recombinant mva expressing the hemagglutinin of attenuated influenza virus rga/viet nam/1203/2004 (h5n1) elicited protective immune responses when administered at low doses by scarification. taken together, our data suggest that mva and mva-vectored vaccines inoculated by scarification can elicit protective immune responses that are comparable to subcutaneous vaccination, and may allow for antigen sparing when vaccine supply is limited. the eradication of smallpox, a disease that caused the death of hundreds of millions of people over many centuries, was accomplished primarily by the use of replication-competent vaccinia virus strains as vaccines. traditional (first-generation) smallpox vaccines, as well as more recently developed cell culture-derived second-generation smallpox vaccines such as acam2000 [1, 2] , the currently licensed smallpox vaccine in the united states, are inoculated into vaccine recipients by scarification of the skin surface, also known as percutaneous, skin or cutaneous vaccination [3] . rare but severe adverse reactions caused by these vaccines, including generalized vaccinia, eczema vaccinatum, and the more recently recognized cases of myopericarditis [4, 5, 6, 7] , limit the use of these vaccines for routine preventative vaccination of the general populace in the absence of any immediate risk of exposure to variola virus (the etiologic agent for smallpox) or other pathogenic orthopoxviruses such as monkeypox virus. thus, as early as the 1930s, efforts were made to develop safer smallpox vaccines by attenuating existing strains of vaccinia virus [8, 9] . as part of this effort, the modified vaccinia virus ankara (mva) was developed in the early 1970s. mva was derived from the chorioallantois vaccinia virus ankara (cva) strain of vaccinia virus, by more than 570 passages in chick embryo fibroblast (cef) cells [10] . during the course of passage of cva in cef cells, several genes (mainly host-range and immunomodulatory genes) were lost, resulting in the severely attenuated mva. about 15% of the viral genome was lost during passage in cef cells, and mva does not replicate productively in most mammalian cells [11, 12, 13] . mva has been extensively evaluated in different animal models [14, 15, 16, 17] and in clinical trials, and found to be less reactogenic when compared with replication-competent first and second generation smallpox vaccines [18, 19] . mva is licensed as a smallpox vaccine in europe and canada, and currently undergoing clinical development in the united states. the severe attenuation of mva and its consequent loss of the capacity to replicate efficiently in mammalian cells is evident in its inability to produce a "vaccine take", a pustular lesion that develops at the inoculation site, when vaccinia virus is inoculated on the skin surface. apart from its potential use as a smallpox vaccine in immunocompromised individuals, mva has the capacity to accommodate heterologous dna, and express encoded proteins, thus serving as a useful viral vector in vaccine development against different types of pathogens. several recombinant mva vectors expressing heterologous proteins of different human pathogens are at various phases of clinical development [20, 21] some of the mva-vectored vaccines in clinical trials include those expressing human immunodeficiency virus antigens [22, 23, 24] , mycobacterium tuberculosis 85a antigen [25, 26, 27] , malaria antigens [28, 29, 30] , human papilloma virus antigen [31] , hepatitis c antigens [32, 33] , respiratory syncytial virus antigens [34] , influenza virus antigens [35, 36, 37] , epstein-barr virus antigen [38, 39] and more recently, ebola virus antigens [40] . several other mva-vectored vaccines have also been evaluated in preclinical studies [41, 42, 43] . in most preclinical and clinical studies, mva or recombinant mva vectors, unlike replication-competent vaccinia virus strains, are inoculated into subjects via the intramuscular, intradermal or subcutaneous routes. although mva has been demonstrated to have a better safety profile than replication-competent vaccinia virus, a relatively large inoculum volume of 0.05 to 0.10ml and 0.5 to 1ml of mva or recombinant mva is typically used in small animal models and in non-human primates/humans, respectively. this often results in local reactions at the site of inoculation, including muscle ache, pain, and tenderness [44, 36] . in addition, the inoculation of prophylactic or therapeutic regimens with needles and syringes can be problematic for some people, a global problem commonly called needle phobia or fear of the needle in common phraseology. although the use of needle-free injection devices such as the jet injector [45] has become increasingly popular, hypodermic syringes and needles remain in wide use for the delivery of prophylactic and therapeutic remedies. previously, we [46] described a recombinant vaccinia virus, a33r/b5rko, that was severely attenuated for plaque formation in permissive cell lines due to deletions of the a33r and b5r genes, encoding the a33 and b5 proteins, respectively, of the extracellular virion form of vaccinia virus. the severe attenuation and growth characteristics of the a33/b5rko virus is reminiscent of the properties of mva. a33r/b5rko elicited vaccinia-specific igg and neutralizing antibodies when balb/c mice were inoculated by scarification at the base of the tail. in an intranasal challenge model, using the western reserve strain of vaccinia virus, the a33r/ b5rko virus conferred comparable levels of protection on mice as those vaccinated with a clonal isolate of dryvax, dv-3. during the course of the work above [46] , antibody [47] and robust cell-mediated immune responses after the inoculation of recombinant mva vectors through the skin, were also reported [48, 49, 50] , suggesting that percutaneous inoculation of mva may elicit equivalent or higher immune responses than subcutaneous injection. in the work described here, we demonstrate in mouse models that percutaneous inoculation of mva elicited protective immune responses against lethal intranasal challenge with the western reserve (wr) strain of vaccinia virus, and at low doses of mva, lower morbidity was recorded in mice that were vaccinated via the percutaneous route than in those immunized via the intramuscular or subcutaneous routes. in addition, we show in two models that percutaneous inoculation of recombinant mva expressing heterologous antigens elicited specific immune responses, including neutralizing antibodies, at levels that are comparable to subcutaneous inoculation. a recombinant mva expressing herpes simplex virus 2 (hsv-2) glycoprotein d elicited gd2-specific igg and hsv-2 neutralizing antibodies, and a recombinant mva expressing the hemagglutinin of influenza rga/vietnam/1203/04, h5n1, elicited protective immune responses when inoculated by the percutaneous route. our data suggest that vaccination via the percutaneous route is efficient in stimulating protective immune responses, and may find clinical relevance in immunizations with mva and mva-vectored vaccines. the modified vaccinia virus ankara (mva; atcc # vr-1508) was provided by drs. linda wyatt and bernard moss (niaid/nih) and vaccinia virus strain western reserve (vv-wr; atcc # vr-1354) was provided by dr. bernard moss. we have previously described the construction of a recombinant mva expressing the herpes simplex virus type 2 glycoprotein d (mva-gd2), in which the us6 gene of hsv-2 (strain ms) was inserted into the deletion ii region in mva by homologous recombination [51] . expression of glycoprotein d is driven by the synthetic vaccinia early/late promoter [52] . recombinant mva expressing the hemagglutinin (h5) of influenza virus rga/viet nam/1203/2004 (h5n1) (mva-ha) was constructed by homologous recombination of the h5 gene into the deletion iii region of mva [53] . expression of the influenza h5 is driven by the vaccinia h5r promoter. mva and recombinant mva vectors were prepared from primary chick embryo fibroblast cells (cef) or df-1 cells (atcc # crl-12203) that had been infected with the appropriate virus as previously described [54] , and partially purified viruses were obtained by passing infected cell lysates through a 36% sucrose cushion. mva and mva recombinants were titered on df-1 cell monolayers. vv-wr was prepared from infected bsc-1 cells (atcc # ccl26) , and was also partially purified through a 36% sucrose cushion, and titered on bsc-40 cell monolayers (atcc # crl-2761). the attenuated influenza virus rga/viet nam/1203/2004 (h5n1) was grown in the allantoic cavity of embryonated eggs and titrated on mdck cells. cells were cultivated and regularly maintained in dmem containing 10% fetal bovine serum (5% for mdck cells) and 5μg/ml gentamicin. balb/c mice (4-5 weeks old) were obtained from the jackson laboratories, bar harbor, maine. mice received feed and water freely. the animal study protocol for the work described in this manuscript was approved by the institutional animal care and use committee (iacuc) of the center for biologics evaluation and research, usfda (cber/fda). intramuscular inoculation into the muscles of the hind legs and subcutaneous inoculation at the base of the tail using 1ml tuberculin syringes affixed with 25-gauge needles, were performed as previously described [17] . tail scarification of anesthetized animals was also performed as previously described [17] . briefly, the inoculum was diluted in sterile endotoxin-free phosphate-buffered saline (pbs) such that the desired unit dose is contained per 2μl. mice were anesthetized by intraperitoneal injection of 1x avertin (2,2,2,-tribromoethanol in tert-amyl alcohol (sigma-aldrich, st. louis, missouri)) diluted in pbs at 20 μl per gram body weight. using a 25-gauge needle, 15 to 20 needle scratches/puncture were made at the base of the tail and 2μl of the inoculum was applied to the scarified surface. vaccinia virus (strain wr) and attenuated influenza a virus (rga/viet nam/1203/2004 (h5n1)), a 6+2 reassortant vaccine strain bases on influenza a/puerto rico/8/34, were used in challenge experiments. for intranasal mouse challenge, a dose of ten 50% lethal dose (10 ld 50 ) (equivalent to 1.5 x 10 5 pfu) of vv-wr was used. for challenge with rga/viet nam/1203/2004 (h5n1)), a dose of 10 6 pfu was used. we previously determined this dose to be lethal in our influenza virus challenge model. mice were anesthetized by intraperitoneal injection of 1x avertin (20 μl per gram body weight), followed by inoculation of the challenge virus in a total of 20 μl suspension into the nares (10μl per naris) as previously described [17] . mice were monitored and weighed daily for two weeks post challenge. mice that lost 25% of their initial body weight were considered to have reached the study endpoint, and were humanely euthanized per the iacuc-approved animal study protocol. testing of antisera for antigen-specific antibodies (igg) was performed by standard enzymelinked immunosorbent assay (elisa). elisa for vaccinia-specific antibodies was performed using psoralen/uv-inactivated vaccinia virus (dryvax) as the antigen, as previously described [17] . hsv-2 gd-specific igg elisa using partially-purified hsv-2 glycoproteins (50 ng/well) as the antigen, and hsv-2 neutralization assay were performed in 96-well immulon 2 hb plates (fisher scientific) and 96-well tissue culture plates (corning), respectively, as previously described [51] . influenza virus h5-specific igg was quantified using sanofi pasteur's inactivated rga/viet nam/1203/2004 vaccine (cber reference antigen #50) as the coating antigen. immulon 2 hb plates were coated with cber reference antigen at 1 μg/well, and plates were stored at 4°c overnight. plates were washed with phosphate-buffered saline containing 0.5% tween-20 (pbst), and then blocked with pbst containing 10% fetal bovine serum for 2 hours. subsequent incubation of the antigen with the test serum samples and completion of the assay followed standard elisa protocol as previously described [51] . testing of antisera for the neutralization of influenza a virus rga/viet nam/1203/2004 (h5n1), an attenuated vaccine strain generated by reverse genetics, was performed using a microneutralization assay as previously described [55] . the presence of virus was detected using biotin-conjugated antibody to influenza np (clone a; milipore, billerica, ma, usa) followed by hrp-labeled streptavidin (kpl, gaithersburg, md, usa). mice were vaccinated with 10 7 pfu of mva-gd2 via the subcutaneous or percutaneous route. a control group was vaccinated with 10 7 pfu of mva. seven (7) days after vaccination, mice were euthanized, spleens were collected from dissected mice, and lymphocytes were isolated from spleen homogenates as previously described [51] . spleen cells were cultured in 24-well tissue culture plates and re-stimulated with live hsv-2 (strain ms) at a multiplicity of infection of 1.0. culture supernatants were harvested after 48 hours, clarified of cells by centrifugation, and tested for il-2 and ifn-γ by capture elisa as described [51] , and reagents obtained from bd pharmingen. unpaired, two-tailed student's t-test for statistical comparison of antibody titers was performed using graphpad prism 6.02 software (graphpad software, inc.). the kaplan-meier survival logrank test was performed using the sigmaplot 13.0 software (systat software, inc.), and was used to compare differences in the number of surviving animals in the various treatment groups after virus challenge. in all cases, a p value <0.05 indicates statistically significant differences between treatment groups. in a preliminary experiment to investigate the utility of the percutaneous route for the delivery of mva, we observed that mva delivered by tail scarification, while statistically insignificant (p = 0.298), elicited a higher vaccinia-specific igg response and protection in mice than the same dose (10 6 pfu) delivered by the intramuscular route (s1 fig) . the experiment using 10 6 pfu of mva did not allow us to observe any differences in antibody response, disease progression and protection between the two immunization routes. thus in subsequent experiments, lower doses of mva were evaluated. groups of mice were vaccinated with 10 5 pfu of mva via the intramuscular, subcutaneous, or percutaneous routes. for comparison, a set of three groups of mice were similarly vaccinated with 10 5 pfu of the licensed acam2000 smallpox vaccine, via the same three routes. an untreated group was included as a control. three weeks after vaccination, serum samples were obtained from all mice and tested for vaccinia-specific antibodies by elisa, using inactivated dryvax as the antigen. among mice in the mva treatment cohort, an igg response was detectable in 2/5 mice in the subcutaneous group, and 1/5 in the percutaneous group. the untreated mice and all mice in the mva intramuscular group had no detectable igg at this time point. by contrast, all but three mice (2/5 and 1/5 in the intramuscular and subcutaneous groups, respectively) in the acam2000 cohort had detectable levels of igg (fig 1a) . at 4 weeks postimmunization, all mice were challenged intranasally, with a lethal dose (10 ld 50 ) of vv-wr. all mice in the untreated group showed severe symptoms of infection, reaching the study endpoint of 25% weight loss by day 7 post-challenge, and had to be euthanized (fig 1b & 1c) . except for a mouse in the mva-intramuscular group, all other mice vaccinated with mva or acam2000, survived. among the mva vaccinated animals, mice in the intramuscular group lost the most weight (fig 1b) , with a mean peak loss of about 16% on day 9 post-challenge. weight loss among the mva subcutaneous and percutaneous groups were similar, with peak losses of 9.6% (day 6) and 8.9% (day 7), respectively. however, mice in the mva percutaneous group recovered more quickly (98.4% of original mean body weight on day 14) than the subcutaneous group (94.4% mean weight on day-14). among the acam2000 treatment groups ( fig 1c) , the average peak weight loss was 8.8% (day-5), 7.7% (day-6), and 6.2% (day-6), for the intramuscular, subcutaneous, and percutaneous groups, respectively. in another experiment, mice in groups of five were vaccinated with 10 3 pfu or 10 5 pfu of mva by scarification. two other groups were similarly vaccinated with 10 3 pfu or 10 5 pfu of acam2000, and a control group was scarified with pbs. antisera were collected after three weeks and mice were challenged with 10 ld 50 of vv-wr. none of the mice in the pbs group had detectable igg and all succumbed to vv-wr infection ( table 1 ). all mice in the 10 3 pfu mva group had no detectable igg and 2/5 in the 10 5 mva group had detectable igg. however, 1/5 and 5/5 of mice survived in the 10 3 pfu and 10 5 pfu mva, respectively. in the acam2000 cohort, 2/5 and 5/5 of mice in the 10 3 pfu and 10 5 pfu groups, respectively, were seropositive. three of five (3/5) and . morbidity, as measured by mean weight changes post-challenge, is shown for the mva treatment groups (b), and for the acam2000 treatment groups (c). the "untreated" control group was the same for both the mva and acam2000 groups. a "+" sign represents a mouse that succumbed to infection. 5/5 of mice in the acam2000 cohort survived vv-wr challenge (table 1) . these sets of data suggest that in this mouse model, mva inoculation by the percutaneous route elicits equivalent or greater protective immune responses than inoculation via the intramuscular or subcutaneous routes. percutaneous vaccination with recombinant mva-gd2 elicits hsv-2-specific immune responses mva is an attractive vector being used for the expression of transgenes and has been used in the expression of antigens of a variety of pathogens. similar to studies investigating mva as a smallpox vaccine, preclinical and clinical evaluation of mva-vectored vaccines in development has relied predominantly on the use of intramuscular, intradermal or subcutaneous routes of mva delivery. in order to determine whether the percutaneous route will be useful for the evaluation of mva-vectored recombinant vaccines, a recombinant mva (mva-gd2) expressing the glycoprotein d of herpes simplex virus type-2 (hsv-2, strain ms) was evaluated for immunogenicity in the balb/c mouse model. in this recombinant mva, the hsv-2 us6 gene encoding glycoprotein d was inserted into the deletion ii site in mva by homologous recombination [51] . groups of mice were vaccinated with mva-gd2 at three dose levels: 10 5 pfu, 10 6 pfu, and 10 7 pfu; with each dose level administered subcutaneously or percutaneously. the control group received 10 7 pfu of mva subcutaneously. all treatment groups were vaccinated using a prime/boost immunization strategy as previously described [51] . antisera were collected 3 weeks after the priming vaccination, as well as at 3 weeks after the boost, and were tested for hsv-2-specific igg at both time points, using partially-purified hsv-2 glycoproteins as the antigen (fig 2a) . antisera collected at the 6-week time point were also tested for hsv-2 neutralizing antibodies (fig 2b) . antisera obtained from mice vaccinated with the mva vector had no detectable hsv-2 specific antibodies at both time points. hsv-2 specific antibodies were detected in antisera obtained from mice vaccinated with mva-gd2 at both time points (fig 2a) . the mean igg titers (log 10 the serum samples obtained at the 6-week time point were tested for the ability to neutralize hsv-2 infectivity in vero cells. similar to the igg elisa result, antisera from the mva control group did not neutralize hsv-2 (mean serum neutralization (sn) titer was below the level of quantitation of 0.30 log 10 ). low to modest neutralizing antibody titers were detected in mva-gd2 vaccinated mice (table 2 ). in the subcutaneous vaccination sub-groups, mean sn titers (log 10 ) of 0.96 (±0.13), 1.08 (±0.46), and 2.41 (±0.43), were obtained for the 10 5 pfu, 10 6 pfu, and 10 7 pfu groups, in another experiment, cellular immune response to mva-gd2 was evaluated. mice were vaccinated with 10 7 pfu of mva subcutaneously, or with 10 7 pfu of mva-gd2 either subcutaneously or percutaneously. spleen cells were harvested from mice 7 days after vaccination and tested for cytokine (il-2 and ifn-γ) secretion as previously described (meseda et al., 2002) . spleen cells were re-stimulated in vitro by live infection with hsv-2 (strain ms) at a multiplicity of infection of 1.0. supernatants were collected from the cultured spleen cells and tested for levels of il-2 and ifn-γ. whereas the levels of il-2 and ifn-γ in the supernatants from the spleen of mva-infected mice were below detection, all mice in both mva-gd2 groups had detectable levels of il-2 and ifn-γ, ( table 2 ). mean il-2 levels of 40.3 ± 21 pg/ml and 52.3 ± 40.1 pg/ml were obtained for the mva-gd2 subcutaneous and percutaneous groups, respectively. similarly, ifn-γ levels were 28.5 ± 17.4 pg/ml, and 82.3 ± 114.3 pg/ml, for the subcutaneous and percutaneous mva-gd2 groups, respectively. taken together, this set of data suggests that the inoculation of recombinant mva-gd2 by scarification is capable of eliciting antigen-specific immune responses that are comparable or higher than delivery by subcutaneous inoculation. mva is used as a vector for the expression of heterologous antigens. the deletion sites in mva, including the deletion ii and deletion iii sites, are commonly used for the insertion of transgenes. in order to broaden our understanding of the utility of the percutaneous route for the delivery of mva-vectored vaccines, we further evaluated a recombinant mva, mva-ha, in which the hemagglutinin gene of influenza a virus rga/viet nam/1203/2004 (h5n1), was inserted in the deletion iii site of mva. in a series of experiments, the antibody response following vaccination via the subcutaneous or percutaneous routes was characterized, and the protective effectiveness of vaccination via these routes was evaluated in a mouse intranasal challenge model. in the first experiment, groups of mice (five per group) were vaccinated with 10 5 , 10 6 , or 10 7 pfu of mva-ha on a prime-boost schedule at an interval of 3 weeks between vaccinations. each dose of mva-ha was administered via the subcutaneous or percutaneous routes. a control group was vaccinated with 10 7 pfu of mva via the subcutaneous route. three weeks after vaccination, serum samples were obtained from mice and tested for h5-specific igg, and all mice were challenged with 10 6 pfu of attenuated influenza rga/viet nam/1203/2004 (h5n1) via the intranasal route. except for a mouse in the mva control group that had a low level of non-specific igg, all other mice in the control group had no h5-specific igg, and 4/5 (including the one with detectable igg) succumbed to influenza virus challenge. all mice that were vaccinated with mva-ha, irrespective of the route, had high levels of h5-specific igg titers in the second experiment, mice in groups of mice (five per group) were vaccinated with 10 4 , 10 5 , or 10 6 pfu of mva-ha via the subcutaneous or percutaneous route on a prime-boost schedule at an interval of 3 weeks between vaccinations. a control group was vaccinated with 10 6 pfu of mva, subcutaneously. antisera were obtained from mice three weeks after the booster vaccination, and all mice were challenged with 10 6 pfu of influenza rga/viet nam/ 1203/2004. all mice in the mva group had no detectable h5-specific igg. by contrast, all mice inoculated with mva-ha, irrespective of the dose, had high titers of h5-specific igg (fig 3a) . the differences in igg levels between the subcutaneous and percutaneous cohorts at each dose level of mva-ha were not statistically significant, although mean igg titers were slightly higher in the subcutaneous cohort. following intranasal challenge with influenza rga/viet nam/1203/2004, all mice in the mva group succumbed to infection, and all mice vaccinated with mva-ha, irrespective of the dose, survived with varying degrees of morbidity. among mva-ha vaccinated mice, the 10 4 pfu/subcutaneous group recorded the severest weight loss (fig 3b) , and the difference in weight changes between the subcutaneous and percutaneous groups vaccinated with 10 4 pfu was statistically significant (two-tailed p-value = <0.001). a summary of the neutralizing antibody titers of pooled antisera for each treatment group from the two mva-ha experiments described above is presented in table 3 . the mva control group had no detectable neutralizing antibody in the serum samples obtained at any time point. among the groups vaccinated with mva-ha, neutralizing antibody was below detection in post-prime antisera, except in the 10 7 pfu subcutaneous group where a titer of 10 was obtained. however, following the administration of booster inoculations, all mva-ha treatment groups had detectable levels of neutralizing antibody that increased with increase in vaccine dose. neutralizing antibody titers in mice in the subcutaneous cohort were 15, 40, and 80, for the 10 4 , 10 5 , and 10 6 pfu, respectively. similarly, neutralizing antibody titers among the percutaneous cohort were 15, 60, and 80, for the 10 4 , 10 5 , and 10 6 pfu, respectively. interestingly, the levels of neutralizing antibody for the percutaneous treatment groups were similar to the subcutaneous group at the same mva-ha dosage, in spite of slightly higher total h5-specific igg levels in the subcutaneous cohort (difference is not statistically significant). this set of data suggests that the antibody response, both total igg and neutralizing antibodies, elicited by mva-ha was comparable between mice that were inoculated via the subcutaneous route and those inoculated via the percutaneous route. further, we observed that all mice inoculated with 10 4 pfu of mva-ha by prime-boost, were protected from influenza virus challenge. in the experiments with mva-ha described above, all mice that were vaccinated on a primeboost schedule with 10 4 pfu of mva-ha elicited antibody responses and protection that were indistinguishable between subcutaneous and percutaneous treatment cohorts. in order to further scrutinize the differences between the two inoculation routes, lower doses of mva-ha were used in experiments. in one experiment, groups of mice (five per group) were vaccinated with mva-ha at doses of 10 2 , 10 3 or 10 4 pfu, each dose administered via the subcutaneous or percutaneous route. a control group was inoculated subcutaneously with 10 4 pfu of mva. booster inoculations in the same amount of mva-ha or mva were administered three weeks after mice were primed. at three weeks after the booster doses, mice were challenged with attenuated rga/viet nam/1203/2004, at 10 6 pfu per mouse, and were evaluated daily for two weeks as described above. none of the animals vaccinated with mva survived. all mice vaccinated with 10 3 pfu mva-ha in this prime/boost schedule survived. in the 10 2 pfu mva-ha group, 2/5 and 1/5 survived in the subcutaneous and percutaneous groups, respectively. influenza virus pathogenesis in these mice, as measured by weight loss (fig 4) shows a doseresponse with respect to mva-ha, with weight loss being inversely proportional to the dose of mva-ha. there were no major differences in survival rates between mice in the subcutaneous and percutaneous groups inoculated with the same dose of mva-ha. at 10 2 pfu of mva-ha, the mean weight loss was higher in the percutaneous group than the subcutaneous group, but the difference was not statistically significant (two-tailed p-value = 0.084). finally, in two independent experiments, mice in groups of five in each experiment were vaccinated with low doses of mva-ha that were administered once, and were challenged three weeks after vaccination. groups of mice were inoculated at doses of 10 2 , 10 3 , or 10 4 pfu of mva-ha subcutaneously or percutaneously. control groups received 10 4 pfu of mva subcutaneously. a summary of the number of surviving mice is presented in table 4 . none of the mice vaccinated with mva survived. among mice in the mva-ha subcutaneous vaccination cohort, 3/10, 5/10, and 8/10 survived in the 10 2 pfu, 10 3 pfu, and 10 4 pfu vaccination groups, respectively. similarly, among mice in the percutaneous vaccination cohort, 5/10, 6/10, and 8/ 10 survived viral challenge. the mean weight loss among mice in these experiments are shown in fig 5. statistical comparisons of the number of surviving mice show that differences in survival between mice that were vaccinated with 10 4 pfu of mva-ha (irrespective of vaccination route) and the mva control group, were statistically significant (table 4 ). however, a comparison of the observed differences in survival between the percutaneous and subcutaneous groups at the 10 2 pfu dose level indicates the difference is not statistically significant. this set of data suggests that even at low vaccination doses, differences between mouse groups vaccinated via the subcutaneous and percutaneous routes are not apparent in this challenge model. the modified vaccinia virus ankara (mva) is licensed in europe and canada as a third generation smallpox vaccine, and currently in clinical development for licensure in the united states. the relatively better safety record of mva compared to first and second generation smallpox vaccines is well documented. this, in addition to its large capacity to accommodate heterologous genes, express encoded proteins, and elicit both humoral and cell-mediated immune responses also makes mva an attractive vector for the delivery of several candidate vaccines for a variety of infectious and non-infectious human and veterinary diseases [56, 57, 58, 59, 60] . evidence for the delivery of antigens through the skin in asia dates back to the 1500s with the practice of variolation and continued with the advent of the smallpox vaccine in the late 18 th century [3] . thus replication-competent smallpox vaccines, including those that were used in the successful eradication of smallpox, such as dryvax, lister, livp, temple of heaven, and em-63, were mostly administered by skin scarification [61] . the current us-licensed secondgeneration smallpox vaccine, acam2000, is also administered by skin scarification, a procedure that is believed to be partly responsible for the success of the global eradication of smallpox by provoking robust innate and adaptive immune responses [62] . due to the severe attenuation of mva, as epitomized by its inability to replicate productively in many mammalian cells [11, 12, 13] , mva and mva-vectored vaccines are usually administered via routes other than percutaneous in preclinical studies. clinical investigations of mva-vectored vaccines have mostly used intramuscular [23, 34, 35, 36] and intradermal routes [38, 39] , and to a lesser extent, the subcutaneous injection route [63] . local reactogenicity following vaccination with mva or mva-vectored vaccines is believed to be more severe with subcutaneous and intradermal inoculations than via intramuscular route [57, 63, 64] . in a comparison of the safety and immunogenicity of an mva-vectored hiv vaccine, individuals vaccinated with mva.hiva by the subcutaneous and intradermal routes were found to develop more severe local reactions than those vaccinated via the intramuscular route [63] . however, intramuscular and subcutaneous tissues have relatively fewer antigen presenting cells than the skin tissue and may not be adequate for optimal immune responses [65] . administering vaccines against infectious diseases through the skin has generated significant interest in recent years, including its use in the delivery of the bcg tuberculosis vaccine [66] , and has been further boosted by the development of the microneedle patch technology, which delivers vaccines intradermally. microneedle inoculation of vaccines has been used in preclinical evaluation of several vaccines, including inactivated polio vaccine [67] , influenza vaccine [68, 69, 70] , and measles vaccine [71] . clinical application of vaccines to the skin has also been documented for a number of vaccines, including influenza vaccine [72, 73] , and rabies vaccine [74] . recent studies have suggested that vaccine delivery through the skin takes advantage of the abundant presence of skin-resident antigen-presenting cells, including different subsets of dendritic cells and langerhans cells, as well as infiltrating antigen presenting cells, to provoke robust immune responses that include both humoral and cell-mediated immune responses [65] , and induce long-lived cd8 + t cell memory [75, 76] . moreover, data on the delivery of different types of vaccines through the skin suggest that both live vaccines and subunit vaccines can be administered through the skin, with successful immunization outcomes [67-71, 73,74] . earlier data from our laboratory [17] as well as from clinical trials [57, 77] suggest that delivery of the modified vaccinia virus ankara into the intradermal layer of the skin elicited robust immune responses that were higher than intramuscular or subcutaneous inoculations, and protected mice from intranasal challenge with vaccinia virus [17] . we further showed that a severely attenuated recombinant vaccinia virus that fails to form visible plaques in several mammalian cell lines, reminiscent of mva, elicited protective immune responses when used to vaccinate mice by scarification [46] . in the work described here, we expanded our investigation on the delivery of mva as well as mva-vectored antigens through the skin. in a preliminary experiment, we observed that igg titers were higher in mice that received 10 6 pfu of mva by skin scarification than in mice that received the same dose of mva by intramuscular inoculation. in subsequent experiments, antibody responses and protection of mice that were vaccinated with mva subcutaneously or by tail scarification were higher than in those vaccinated via the intramuscular route. melamed et al. [47] compared the antibody response elicited in response to mva and two recombinant mvas that had been genetically modified to replicate in vero and bsc-1 cells, after inoculating mice by intramuscular injection or tail scarification. their data indicate that tail scarification was efficient at inducing an antibody response, although the intramuscular route elicited higher geometric mean titers of antibody and conferred higher survival rates. the difference between their observation and the one reported here may be due to differences in experimental procedures and/or assay methods. for instance, in our work, mva for tail scarification is typically in 2 μl volume per dose, making it easier to handle than the 10μl used by melamed et al [47] . in subsequent experiments, the route comparison was limited to subcutaneous versus percutaneous routes, since the subcutaneous route is more commonly used in vaccination studies of mva vectors. as the utility of mva as a viral vector for the expression of heterologous antigens is expanding [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] 78] , we also compared the antibody responses and protection conferred by vaccination with two mva recombinants, one expressing the hsv-2 glycoprotein d, and the other expressing the h5 hemagglutinin of influenza virus rg/a viet nam/1203/2004 (h5n1). mice that were vaccinated with mva-gd2 by tail scarification, elicited higher than or similar titers of hsv-2 gd2-specific igg and neutralizing antibodies to those vaccinated by subcutaneous inoculation. the observed differences in igg titers were not statistically significant between the two routes at 10 6 or 10 7 pfu, but were statistically significant at 10 5 pfu, suggesting that the percutaneous delivery of mva-gd2 may be more effective than subcutaneous inoculation in eliciting hsv-2 neutralizing antibodies at lower vaccine doses. consistent with previous reports [48, 49] , percutaneous inoculation of mva-gd2 also elicited cell-mediated immune responses, as evident in the secretion of ifn-γ and il-2 by re-stimulated immune splenocytes. mva vectors expressing influenza antigens have been shown to elicit protective immune responses in animal models [79] , including mice [80] [81] [82] [83] , ferrets [84] and macaques [85, 86] . in the second recombinant mva vaccine model, mva-ha, expressing influenza virus h5, was used to vaccinate mice by subcutaneous injection or by tail scarification, and the h5-specific antibody response and protective effectiveness against intranasal challenge with the homologous attenuated influenza virus rga/viet nam/1203/2004, were assessed. the data indicate that comparable levels of antibody titers and protection were conferred by the two immunization routes. interestingly, higher survival rates among mice vaccinated by tail scarification were recorded at low vaccine doses. among the advantages attributed to skin delivery of vaccines is the possibility of antigen dose sparing [70, 72] . the data described in this manuscript support these earlier reports as lower doses of mva or mva-gd2 or mva-ha were found to elicits full or partial protection of mice. in summary, we showed that mva, and recombinant mva vectors expressing hsv-2 gd2 or influenza virus h5 elicited protective immune responses in the mouse model. taken together, the data presented in this work suggest that mva and mva-vectored vaccines can be effective when delivered through the skin. with the advantage that antigen delivery to the skin requires a volume that is at least 25 times (in murine models) to 200 times (in humans) less than the volume used in subcutaneous vaccination, a more comprehensive investigation of the clinical benefit of delivering mva and mva-vectored vaccines through the skin is necessary. apart from its efficiency in provoking robust immune responses, it may also help to ameliorate or obliterate some of the commonly reported volume-related local reactions associated with subcutaneous or intramuscular vaccine delivery, such as pain at the site of injection, and may be more acceptable in people with needle phobia, thus enhancing compliance with scheduled immunization programs. although the preclinical evaluation of vaccines by skin scarification, as described in our study, involves the use of improvised needles for the scarification process prior to the application of vaccines, advances in the development of the microneedle patch [87, 88, 89] should facilitate painless application of vaccines to the skin without the use of hypodermic injection needles or the bifurcated needle used in administering smallpox vaccines. in preclinical studies, microneedle delivery of mva-vectored vaccines has been shown to be effective in eliciting robust immune responses against malaria [90] that are comparable to the levels attained by intradermal vaccination. thus with further refinement, the use of microneedle delivery appears to hold a promising future for the application of viral-vectored vaccines through the skin. were vaccinated subcutaneously or percutaneously with 10 5 , 10 6 , or 10 7 pfu of mva-ha by prime-boost at an interval of 3 weeks between vaccinations. a control group received 10 7 pfu of mva prime-boost, subcutaneously. serum samples obtained 3 weeks after priming (week-3) and 3 weeks after boosting (week-6) were tested for h5-specific igg (a). error bars represent standard deviation. mice were subsequently challenged with 10 6 pfu of influenza rga/viet nam/1203/2004, and weighed daily for two weeks (b). a "+" sign represents a mouse that succumbed to infection. (tif) acam2000 clonal vero cell culture vaccinia virus (new york city board of health strain)-a second-generation smallpox vaccine for biological defense acam2000: a newly licensed cell culture-based live vaccinia smallpox vaccine cutaneous vaccination: antigen delivery into or onto the skin cardiac adverse events following smallpox vaccination-united states myopericarditis following smallpox vaccination among vaccinia-naive us military personnel incidence and followup of inflammatory cardiac complications after smallpox vaccination smallpox vaccination-associated myopericarditis is more common with the newest smallpox vaccine jennerian prophylaxis by means of intradermal injections of culture vaccine virus smallpox vaccination and its consequences: first experiences with the highly attenuated smallpox vaccine mva the smallpox vaccination strain mva: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debili modified vaccinia virus ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine host range and cytopathogenicity of the highly attenuated mva strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line highly attenuated modified vaccinia virus ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge immunogenicity of a highly attenuated mva smallpox vaccine and protection against monkeypox modified vaccinia virus ankara protects macaques against respiratory challenge with monkeypox virus enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus ankara and licensed smallpox vaccine dryvax in a mouse model safety and immunogenicity of modified vaccinia ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial safety and immunogenicity of modified vaccinia ankara-bavarian nordic smallpox vaccine in vaccinia-naive and experienced human immunodeficiency virus-infected individuals: an open-label, controlled clinical phase ii trial therapeutic vaccination to treat chronic infectious diseases: current clinical developments using mva-based vaccines biosafety aspects of modified vaccinia virus ankara (mva)-based vectors used for gene therapy or vaccination safety and immunogenicity of a modified pox vector-based hiv/aids vaccine candidate expressing env, gag, pol and nef proteins of hiv-1 subtype b (mva-b) in healthy hiv-1-uninfected volunteers: a phase i clinical trial (risvac02) safety and immunogenicity of dna and mva hiv-1 subtype c vaccine prime-boost regimens: a phase i randomised trial in hiv-uninfected indian volunteers pedvacc 002: a phase i/ii randomized clinical trial of mva.hiva vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in nairobi safety and efficacy of mva85a, a new tuberculosis vaccine, in infants previously vaccinated with bcg: a randomised, placebo-controlled phase 2b trial safety and immunogenicity of a candidate tuberculosis vaccine mva85a delivered by aerosol in bcg-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine mva85a in healthy adults infected with hiv-1: a randomised, placebo-controlled, phase 2 trial a phase ia study to assess the safety and immunogenicity of new malaria vaccine candidates chad63 cs administered alone and with mva cs a human phase i/ iia malaria challenge trial of a polyprotein malaria vaccine evaluation of the efficacy of chad63-mva vectored vaccines expressing circumsporozoite protein and me-trap against controlled human malaria infection in malaria-naive individuals immune therapy for human papillomaviruses-related cancers a human vaccine strategy based on chimpanzee adenoviral and mva vectors that primes, boosts, and sustains functional hcv-specific t cell memory efficacy of immunotherapy with tg4040, peg-interferon, and ribavirin in a phase 2 study of patients with chronic hcv infection safety and immunogenicity of novel respiratory syncytial virus (rsv) vaccines based on the rsv viral proteins f, n and m2-1 encoded by simian adenovirus (panad3-rsv) and mva (mva-rsv); protocol for an open-label, doseescalation, single-centre, phase 1 clinical trial in healthy adults a t cell-inducing influenza vaccine for the elderly: safety and immunogenicity of mva-np+m1 in adults aged over 50 years safety and immunogenicity of a modified-vaccinia-virus-ankara-based influenza a h5n1 vaccine: a randomised, double-blind phase 1/2a clinical trial induction of influenza (h5n8) antibodies by modified vaccinia virus ankara h5n1 vaccine a recombinant modified vaccinia ankara vaccine encoding epstein-barr virus (ebv) target antigens: a phase i trial in uk patients with ebv-positive cancer phase i trial of recombinant modified vaccinia ankara encoding epstein-barr viral tumor antigens in nasopharyngeal carcinoma patients use of chad3-ebo-z ebola virus vaccine in malian and us adults, and boosting of malian adults with mva-bn-filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial high, broad, polyfunctional, and durable t cell immune responses induced in mice by a novel hepatitis c virus (hcv) vaccine candidate (mva-hcv) based on modified vaccinia virus ankara expressing the nearly full-length hcv genome a novel poxvirus-based vaccine, mva-chikv, is highly immunogenic and protects mice against chikungunya infection comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates safety and immunogenicity of imvamune, a promising candidate as a third generation smallpox vaccine needle-free vaccine delivery effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model attenuation and immunogenicity of host-range extended modified vaccinia virus ankara recombinants epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective t cell-mediated immunity microneedle array design determines the induction of protective memory cd8+ t cell responses induced by a recombinant live malaria vaccine in mice dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific t cell responses in mice prime-boost immunization with dna and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein d elicits greater specific antibody and cytokine responses than dna vaccine alone compact, synthetic, vaccinia virus early/late promoter for protein expression production and characterization of mammalian virus-like particles from modified vaccinia virus ankara vectors expressing influenza h5n1 hemagglutinin and neuraminidase preparation of cell cultures and vaccinia virus stocks detection of antibody to avian influenza a (h5n1) virus in human serum by using a combination of serologic assays protective efficacy of recombinant modified vaccinia virus ankara delivering middle east respiratory syndrome coronavirus spike glycoprotein safety and immunogenicity of modified vaccinia ankara (acam3000): effect of dose and route of administration cardiac safety of modified vaccinia ankara for vaccination against smallpox in a young, healthy study population efficacy assessment of an mva vectored rift valley fever vaccine in lambs evaluation of mva-5t4 as a novel immunotherapeutic vaccine in colorectal, renal and prostate cancer smallpox vaccines for biodefense protective properties of vaccinia virus-based vaccines: skin scarification promotes a nonspecific immune response that protects against orthopoxvirus disease studies of a prophylactic hiv-1 vaccine candidate based on modified vaccinia virus ankara (mva) with and without dna priming: effects of dosage and route on safety and immunogenicity comparing the safety and immunogenicity of a candidate tb vaccine mva85a administered by intramuscular and intradermal delivery microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy efficacy of percutaneous versus intradermal bcg in the prevention of tuberculosis in south african infants: randomised trial inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles measles vaccination using a microneedle patch dose sparing with intradermal injection of influenza vaccine comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults long-term anti-rabies antibody persistence following intramuscular or lowdose intradermal vaccination of young vietnamese children skin infection generates non-migratory memory cd8+ t(rm) cells providing global skin immunity skin vaccination with live virus vectored microneedle arrays induce long lived cd8(+) t cell memory comparison of lyophilized versus liquid modified vaccinia ankara (mva) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naive subjects modified vaccinia virus ankara as antigen delivery system: how can we best use its potential? candidate influenza vaccines based on recombinant modified vaccinia virus ankara recombinant modified vaccinia virus ankara-based vaccine induces protective immunity in mice against infection with influenza virus h5n1 vaccinia virus-based multivalent h5n1 avian influenza vaccines adjuvanted with il-15 confer sterile cross-clade protection in mice vectors based on modified vaccinia ankara expressing influenza h5n1 hemagglutinin induce substantial cross-clade protective immunity broad protection against avian influenza virus by using a modified vaccinia ankara virus expressing a mosaic hemagglutinin gene evaluation of a modified vaccinia virus ankara (mva)-based candidate pandemic influenza a/h1n1 vaccine in the ferret model preclinical evaluation of a modified vaccinia virus ankara (mva)-based vaccine against influenza a/h5n1 viruses modified vaccinia virus ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques coated microneedles for transdermal delivery microneedle-based vaccines coated microneedle arrays for transcutaneous delivery of live virus vaccines microneedle array design determines the induction of protective memory cd8+ t cell responses induced by a recombinant live malaria vaccine in mice the authors wish to thank drs. bernard moss and linda wyatt, niaid/nih, for the mva and vv-wr viruses. we also thank dr. maryna eichelberger and dr. alonzo garcia, cber/ fda, for reviewing this manuscript. this work was supported by intramural research funds key: cord-304855-7v0cncid authors: raaben, matthijs; prins, henk‐jan; martens, anton c.; rottier, peter j. m.; de haan, cornelis a. m. title: non‐invasive imaging of mouse hepatitis coronavirus infection reveals determinants of viral replication and spread in vivo date: 2009-02-10 journal: cell microbiol doi: 10.1111/j.1462-5822.2009.01298.x sha: doc_id: 304855 cord_uid: 7v0cncid bioluminescence imaging (bli) is a powerful new method to study virus dissemination in the live animal. here we used this method to monitor the spatial and temporal progression of mouse hepatitis coronavirus (mhv) infection in mice using luciferase‐expressing viruses. upon intranasal inoculation, virus replication could initially be observed in the nasal cavity and the cervical lymph nodes, after which the infection spread to the brain and frequently to the eyes. the kinetics of virus spread to and clearance from the brain appeared to depend on the inoculation dose. after intraperitoneal inoculation, virus replication was predominantly observed in the liver and occasionally in the intestines, but interestingly also in the tail and paws. bli thus elucidated new anatomic locations of virus replication. furthermore, mhv dissemination was shown to be critically depended on the viral spike protein, but also on the mouse strain used. widespread dissemination was observed in mice lacking a functional type i interferon response. the importance of the type i interferon system in limiting viral spread was also demonstrated by the administration of type i interferons to mice. our results provide new insights in coronavirus pathogenesis and demonstrate the potential of bli to study coronavirus–host interactions in vivo. current insights into infection processes of pathogens in their hosts and into the dynamics of their spread are largely based on studies using conventional methodologies. these methods have, however, many limitations. they require the experimental animals to be sacrificed in order to identify the sites of infection and to quantify the replication of the pathogens. they hence require large numbers of animals and are costly. they do not allow the real-time monitoring of spatial and temporal progression of infection in the same animal. important variations in host-pathogen interactions might therefore be overlooked, while dissemination of a pathogen to unexpected anatomical locations might be missed, simply because the infected tissue is not harvested and analysed (hutchens and luker, 2007; luker and luker, 2008a) . as of recently many of these limitations of the conventional techniques can be overcome by powerful new methods that involve non-invasive imaging of pathogen replication and spread in infected live animals. as a member of the coronavirus (cov) family, the mouse hepatitis virus (mhv) provides a practical model system for studying cov-induced pathogenesis in mice. depending on the inoculation route, the virus strain and the genetic background of the host, mhv infection can result in a variety of pathological disorders (compton et al., 1993) . the most commonly used laboratory strains primarily infect the liver and the brain, thereby providing animal models for studying encephalitis and hepatitis as well as for immune-mediated demyelinating disease that sometimes develop during a later stage of infection (perlman, 1998) . inoculation of susceptible mice, either intracranially or intranasally, with neurotropic mhv strains can result in a number of different outcomes, ranging from acute encephalomyelitis to chronic demyelinating disease (houtman and fleming, 1996) . besides a mild encephalitis, mhv strain a59 also causes enteric disease and moderate hepatitis (lavi et al., 1986) . the differences in pathogenesis between various mhv strains have been linked mainly to the spike protein which mediates viruscell attachment and subsequent membrane fusion (phillips et al., 1999) . however, other viral genes have been shown to also significantly contribute to pathogenesis (de haan et al., 2002; sperry et al., 2005; iacono et al., 2006) . the role of the immune system in response to mhv infection has been extensively studied. both humoral and cellular immune reactions are essential to guard against mhv infections marten et al., 2001; morales et al., 2001) . clearance of virus during acute infection is predominantly regulated by a typical expression pattern of proinflammatory chemokines that attract cd8 + and cd4 + t lymphocytes to sites of infection (glass et al., 2002; lane et al., 2006; stiles et al., 2006) . also interferon (ifn)-and perforin-mediated mechanisms are involved in the clearance of mhv from different cell types (weiss and navas-martin, 2005) . the kinetics and the extent of the host immune response, which aims to limit the production of infectious virus and viral spread without inducing extensive deleterious effects, is important in determining survival of the host. infectious virus is usually cleared from mhv-infected mice within 2 weeks. most animals, however, do not appear to obtain complete sterile immunity, since viral rna is often found to persist within the central nervous system (cns). recent biotechnological advances now allow the realtime imaging of pathogen replication and spread in living animals by making use of bioluminescence imaging (bli). to this end, light emitted by luciferase reporter proteins is detected by a cooled charge-coupled device (ccd) camera (contag et al., 1997; wu et al., 2001) . important advantages of bli are an intrinsically low background combined with a very high sensitivity for monitoring light emission in vivo (contag and bachmann, 2002; hutchens and luker, 2007) . furthermore, the substrate for firefly luciferase (fl), d-luciferin, is able to cross cellular membranes as well as the intact blood-brain barrier, thereby allowing the imaging of any anatomic location. in addition, d-luciferin is non-toxic, allowing the monitoring of individual mice over time through consecutive imaging. thus, fewer animals are typically needed to acquire statistically meaningful data at multiple time points as compared with conventional approaches (hutchens and luker, 2007) . initially, bli was used to identify sites of bacterial replication in intact animals (contag et al., 1995) . nowadays, this technique is widely used to study the formation and spread of cancer metastases and to visualize the effect of chemotherapy (shah et al., 2004) . bli has also been used to study the dissemination of herpes simplex virus, sindbis virus, vaccinia virus, and infectious hematopoietic necrosis virus (rodriguez et al., 1988; luker et al., 2002; cook and griffin, 2003; harmache et al., 2006) . all previous studies describing mhv infections and pathogenesis in mouse models have been relying on the sacrifice of infected mice in order to determine virus distribution and titres in various organs over time. although these conventional approaches have defined important factors that dictate replication and virulence of mhv in vivo as described above, non-invasive whole-body imaging of mhv infection in living mice is likely to offer new insights into virus replication, dissemination and pathogenesis. here, we have taken advantage of bli to study the replication and spread of fl-expressing mhv (de haan et al., 2003; 2005a) in mice in real-time. we were also able to demonstrate differences in virus replication and spread, resulting either from differences in virus doses, mutations in the spike gene, differences in host susceptibility or from the administration of antiviral compounds. in addition, we identified new anatomic sites of virus replication. our results provide new insights in cov pathogenesis and demonstrate the potential of bli to study cov-host interactions in vivo. in our previous studies we extensively characterized various recombinant mhvs expressing luciferase reporter genes. the insertion of an fl expression cassette at different positions in the viral rna genome was shown not to appreciably affect virus multiplication in vitro, while the fl expression levels were demonstrated to be a reliable measure for virus replication (de haan et al., 2003; verheije et al., 2008) . to verify the feasibility of detecting mhv infection in vivo with bli, we compared two recombinant mhvs containing the luciferase gene at different positions in the viral genome with a recombinant wildtype mhv-a59 with respect to virus replication. therefore, we prepared new stocks of mhv-eflm (containing the fl gene as an additional expression cassette between the e and m gene), mhv-2afls (containing the fl expression cassette at the position of the haemagglutinin esterase pseudo-gene) and wild-type mhv-a59 (fig. 1a ). in agreement with the previous studies we observed that the growth characteristics of the luciferaseexpressing viruses in tissue culture were highly similar to that of the parental mhv-a59 (fig. 1b) , with the fl reporter gene being expressed at high levels for both mhv-eflm and mhv-2afls. for the characterization of the fl-expressing viruses in vivo we used balb/c mice, which have been shown to be susceptible to mhv infection (ohtsuka and taguchi, 1997) . as the inoculation route largely determines the dissemination of virus infection in an animal, we made use of both intranasal and intraperitoneal injection. the 6-to 8-week-old mice were inoculated with 10 6 tissue culture 50% infectious dose (tcid50) of virus or with phosphate-buffered saline (pbs) (control) and sacrificed at 5 days post inoculation, at which day virus titres peak (macnamara et al., 2005) . as mhv-a59 mainly targets the liver and brain (lavi et al., 1984; haring and perlman, 2001) , these organs were taken for analyses. tissue homogenates were prepared and subsequently tested for virus titres, rna levels and fl activity. in intranasally inoculated animals, we detected high virus titres in the brains of all infected mice, with no disparity between the wild-type and fl-expressing viruses ( fig. 2a) . infectious virus could not be recovered from the liver homogenates. also the viral rna levels in the brains of the animals, as determined by quantitative reverse transcriptase polymerase chain reaction (rt-pcr), were indistinguishable between groups. however, viral rna in the liver could only be detected in wild-type mhv-infected mice (fig. 2b ). all mice infected with the fl-expressing recombinants showed high fl activity in the brain, as well as some fl activity in the liver (fig. 2c ). although not statistically significant, the fl expression levels of mhv-2afls were somewhat lower than those of mhv-eflm, which is consistent with the relative expression levels observed in vitro (de haan et al., 2003) . after intraperitoneal inoculation, infectious virus could only be recovered from the livers of wild-type mhv-a59-infected animals ( fig. 2a) . although viral rna was detected in the livers of all groups, the levels were approximately a 1000-fold lower for the fl-expressing mhv recombinants (fig. 2b) . furthermore, only in some livers of mhv-eflm-and mhv-2afls-infected mice could fl activity above background level be detected. overall, these data show that the introduction of the fl expression cassette into the genome of mhv-a59 affected virus multiplication in the liver but, importantly, not in the brain of 6-to 8-week-old balb/c mice. high levels of fl activity were measured in the brains of mhv-eflm-and mhv-2afls-infected mice at 5 days post infection, indicating that these viruses are attractive candidates to be used for bli after intranasal inoculation. in vivo imaging of mhv infection 827 thus, we applied whole-body bli to study the replication and spread of the two fl-expressing mhvs. to this end, balb/c mice were inoculated intranasally with 10 6 tcid50 of virus after which virus replication was followed over time in individual mice. in general, very similar patterns of virus dissemination were observed for both viruses. at 2 days post inoculation, a strong signal was observed, apparently emanating from the nasal cavity, when the mice were imaged at their dorsal side (fig. 3a ). when imaged from the ventral side, replication additionally could be observed in two distinct spots, probably representing the cervical lymph nodes of the animal. at this time point, no signal coming from the brain could yet be detected. three days later, dissemination of virus replication to the brain was apparent, while replication in the cervical lymph nodes was no longer observed. at 7 days post inoculation, the signal coming from the brain appeared more dispersed, while its intensity was clearly declining. at 9 days post inoculation, signal from the brain was the 6-to 8-week-old female balb/c mice were inoculated either intranasally or intraperitoneally with pbs or with 10 6 tcid50 of wild-type mhv-a59, mhv-eflm or mhv-2afls. at 5 days post inoculation, all mice were sacrificed and brains and livers were collected. homogenates were prepared as described in the experimental procedures. a. viral infectivity in the homogenates was determined by performing a plaque assay on lr7 cells. the viral titres are expressed as plaque-forming units per gram (pfu g -1 ) tissue. b. the amounts of viral genomic rna relative to total rna, isolated from the liver and brain homogenates, were determined by quantitative taqman rt-pcr. c. luciferase activities (in rlu) in each of the homogenates were determined by using a luminometer as described above. standard deviations (n = 4) are indicated in all graphs. scarcely detectable in most mice, while it could no longer be detected at day 12 (data not shown). with bli, it is important to note that the measurable photon flux decreases with increasing depth of the target tissue (luker and luker, 2008b) . thus, the signal coming from the brain is significantly attenuated when compared with the signal from the olfactory epithelium, because photons emitted from brain cells must penetrate considerably more tissue to be detected (fig. 3b) . as a consequence, signal intensities should only be compared when photons emanate from the same tissue. photon quantification of the head regions demonstrated that mice infected with mhv-eflm showed significantly higher signal intensities than mice infected with mhv-2afls at 2 days post inoculation (fig. 3b ). in conclusion, with bli the temporal and spatial spread of mhv replication could be readily visualized in living mice. while mice infected with different luciferase-expressing viruses displayed very similar patterns of virus dissemination, bli allowed the quantitative detection of relatively small differences in fl-expression levels between mhv-eflm and mhv-2afls, which is consistent with our earlier observations (de haan et al., 2003) . we next analysed whether we could visualize virus inoculation dose-dependent effects. to this end, balb/c mice were infected with two different doses of mhv-eflm, a high dose of 5 ¥ 10 6 and a low dose of 2 ¥ 10 3 tcid50, and progression of infection was subsequently monitored by bli at different time points post inoculation (fig. 4a ). as expected, photon quantification of the head regions at 2 days post inoculation demonstrated a clear correlation between the virus inoculation dose and the total signal produced from the olfactory epithelium ( fig. 4b ). in addition, spread of virus replication from the nasal cavity into the cns was more rapidly observed for the mice inoculated with the higher dose. this effect was quantified by dividing the head region into two sections (i.e. anterior versus posterior) after which the relative amount of photons emitted from these sections was determined (fig. 4c ). with a high virus inoculation dose, approximately 50% of the total amount of photons was coming from the posterior part at day 5, while with the low virus dose this degree of dissemination was delayed until around day 7. consistently, while mice that received the high dose showed virus replication in the cervical lymph nodes after 2 days, this was apparent in the mice inoculated with the low dose only after 5 days (table s1a) . interestingly, mice infected with the higher dose appeared to clear the virus infection faster than animals infected with the low dose. mhv replication was easily detectable at day 9 in mice inoculated with the low dose, whereas the luciferase signal of the high dose-inoculated group was almost undetectable at this time point. in some mice infected with a high virus dose, we could additionally visualize infection of the liver and lungs after 2 days, whereas at later time points (9 days), strong signals from the eyes were occasionally detectable. for a summary of the results see table s1a . in conclusion, virus dissemination was shown to differ in mice infected with a low or a high dose. in mice that received the low dose virus replication was initially restricted to the nasal cavity, while much faster dissemination of virus infection was observed after inoculation with a high dose. strikingly, and counter intuitively, this rapid dissemination appeared to come at a cost, as these mice were able to clear the infection faster than the mice that received the low dose. we next analysed the essential contribution of the s protein to virus dissemination by using bli. the s protein of mhv is a major determinant of pathogenesis and tropism (phillips et al., 1999) . it mediates virus-cell attachment and fusion via binding of the mhv receptor ceacam1a both in vitro and in vivo hemmila et al., 2004) . schickli et al. (1997) have described a limited set of mutations in the s protein of an mhv-a59 variant that had been acquired after extensive passaging in cell culture. we have recently shown that fig. 4 . the inoculation dose affects virus dissemination. balb/c mice were inoculated intranasally with 5 ¥ 10 6 or 2 ¥ 10 3 tcid50 of mhv-eflm. at the indicated times post inoculation (days p.i.), mice were processed for bli. a. dorsal images of a representative mouse are portrayed. the emitted photons were measured at the indicated time points and are displayed as a heat map in an overlay representation. scaling [in arbitrary units (au)] is similar in all depicted images. the vertical line in all panels represents the arbitrary border between the anterior (nose) and posterior (brain) regions of the head, which were selected for photon quantification. b. the total amounts of emitted photons from the complete head regions at the different time points were quantified and are expressed as integrated intensities on a log 2 scale with standard deviations (n = 4). c. the relative amounts of emitted photons from the anterior and posterior regions of the head (i.e. brain versus nasal epithelium) at the different time points were quantified and are expressed as percentage of the total signal, with standard deviations for both virus doses (n = 4). d. interesting phenotypes of mice at early (i.e. 2 days; ventral images portrayed) or late (i.e. 9 days; dorsal images portrayed) times post inoculation with 5 ¥ 10 6 tcid50 of mhv-eflm are shown: (a) liver, (b) paw, (c) lung, (d) eye and (e) cervical lymph nodes. note that the scaling [in arbitrary units (au)] differs between the ventral and dorsal images. these mutations enable the virus to use heparan sulfate as an additional attachment/entry factor. as a result, viruses carrying these mutations appeared to have acquired an extended host range as they were capable of entering cells also in a ceacam1a-independent manner (schickli et al., 1997; de haan et al., 2005b) . the physiological consequences of this adaptation in vivo, however, remain to be elucidated. here, we examined the infection of mice by an mhv with such an extended host range. therefore, we made use of a previously described recombinant virus (de haan et al., 2005b) , which contains the mutant spike gene (srec) and the fl reporter gene. thus, this recombinant virus mhv-2aflsrec only differs from its control virus mhv-2afls in its spike protein. both viruses replicated to comparable titres in murine lr7 cells as demonstrated by the one-step growth curve shown in fig. 1b and displayed similar fl expression kinetics ( fig. 1c) . next, balb/c mice were inoculated via the intranasal route with these viruses. clearly, mhv-2aflsrec replicated to a lower extent than the parental virus mhv-2afls at all time points measured ( fig. 5a and b) . although the luciferase signal exhibited by the virus with the extended host range increased until 5 days post infection, the infection did not progress towards the cns as was observed for the control virus. apparently, the acquisition of a heparan sulfate-dependent tropism significantly attenuated the ability of the virus to replicate and spread in vivo. replication of viruses in vivo is not only dependent on the genetic make-up of the virus, but also that of its host. it has been observed that the susceptibility of inbred mouse strains to different virus infections can vary significantly (parker et al., 1978; jubelt et al., 1991; thach et al., 2000) . in order to comparatively evaluate the mhv infection process in mice, we infected three commonly used mouse strains with mhv-eflm. to this end, balb/c, c57bl/6 and 129svev mice were inoculated in parallel each with 10 6 tcid50 via the intranasal route after which virus replication was monitored over time. clearly, at 5 days post inoculation balb/c mice displayed the highest signal in the brain, followed by c57bl/6 mice ( fig. 6a and b) . interestingly, 129svev mice were significantly less susceptible to mhv-eflm infection. in contrast to balb/c and c57bl/6 mice, virus replication was no longer detectable from 7 days post inoculation in these animals (data not shown). to confirm these observations, we inoculated mice also with mhv-a59 wild-type virus and determined the viral rna load in the brain by quantitative rt-pcr at 5 days post inoculation. in agreement with the bli results, balb/c mice showed the highest viral rna levels, while the brains from c57bl/6 and 129svev mice contained considerably less viral rna (fig. 6b ). next we studied virus replication and spread of the fl-expressing virus after intraperitoneal inoculation of balb/c and c57bl/6 mice. to this end 4-week-old mice were inoculated intraperitoneally with 10 6 tcid50 of mhv-eflm (fig. 5c ). at 2 days post inoculation we could visualize virus replication of the liver, with no apparent fig. 6 . replication of mhv-eflm in mice of different genetic background. the 6-to 8-week-old female balb/c, c57bl/6 and 129svev mice were inoculated intranasally with 10 6 tcid50 of mhv-eflm. a. bli was performed at 5 days post inoculation as described in the experimental procedures. here, the biospace photon imager was used as detector for reporter gene expression. the emitted photon counts were measured and are displayed as a heat map in an overlay image. a representative dorsal image is shown for the different mouse strains. b. the emitted photons from the head regions of each individual mouse were quantified and are expressed as the total number of counts measured within the 10 min imaging period. data are corrected for the background values (signal from uninfected mice). c. mice infected with wild-type mhv-a59 were sacrificed at day 5 post infection, after which the individual brains were collected. total rna was isolated and taqman rt-pcr was performed targeting mhv genomic rna sequences. the relative viral rna (vrna) levels and standard deviations are depicted (n = 4). d. the 4-week-old balb/c and c57bl/6 mice were inoculated intraperitoneally with 10 6 tcid50 of mhv-eflm. bli was performed at 2 days post inoculation. also here, the biospace photon imager was used. the emitted photons were measured and are displayed as a heat map in an overlay image. two representative ventral images are shown for the two different mouse strains. the anatomic locations displaying virus replication are indicated and include: (a) liver and (b) intestine. the arrows point to sites of virus replication in the tail and paws of the mice. difference between the two mouse strains. in some mice, infection of the intestine was also observed. interestingly, in all mice we could observe infection of the tail and paws, hitherto unidentified sites of infection. the signal rapidly decreased in time, with infection no longer being visible at 5-7 days post inoculation (data not shown). these results show that although replication of fl gene-containing viruses is decreased in 6-to 8-week-old mice (fig. 2) , which hardly enabled the detection of mhv replication by bli (data not shown), the infection could easily be monitored in younger mice, which are known to be more susceptible to infection. in addition, the technology allowed the identification of new anatomic sites of mhv replication that had been missed with the conventional techniques (table s1b) . next, bli was used to investigate the importance of the antiviral type i ifn system in controlling acute mhv infection. to this end, the effect of ifn alpha receptor knock-out (ifnar-/-) was studied using 129svev mice. wild-type and knock-out mice were inoculated via the intranasal route with 10 6 tcid50 of mhv-eflm and the infection process was monitored as before. already at 2 days post infection a significant difference between the ifnar-/-and wild-type mice was apparent when the animals were examined from the ventral side (fig. 7a) . a much higher signal was emitted from the nasal cavity in the ifnar-/-mice compared with the wild-type mice while, in addition, infection of the cervical lymph nodes was only detected in the knock-out mice. at later time points, infection was rapidly cleared from the wild-type mice, whereas dissemination to other organs, including liver and intestine, was manifest in the ifnar-/-mice. virus dissemination was accompanied by severe clinical signs, which included a significant decrease in body weight (fig. 7b) . mice had to be euthanized at 7 days post infection. interestingly, virus replication in the tail and paws could again be detected in the ifnar-/-mice, similar to what we had observed after inoculation of balb/c and c57bl/6 mice via the intraperitoneal route ( fig. 5c) . ex vivo imaging of the abdominal region of the ifnar-/-mice clearly identified the liver as the major site of mhv-eflm replication (fig. 7c) , the organ showing a focal pattern of luciferase expression. this observation was confirmed by the histological analysis of liver sections, as focal lesions were only observed in ifnar-/mice, but not in the control mice (fig. 7d) . overall, these results indicate that mice lacking a functional type i ifn response exhibit disseminated infection after intranasal inoculation with mhv-a59, which could be readily visualized using bli. in view of the increasing availability of all kinds of mutant mice, bli is an attractive approach to investigate the role of a particular host protein or pathway in virus replication and dissemination in vivo. as apparently uncontrolled virus dissemination was observed in mice lacking a functional type i ifn response, we next evaluated the anti-coronaviral effect of exogenous administration of type i ifn. thus, a cocktail of ifna/b was applied to balb/c mice intranasally. it has been established before that ifn can bypass the bloodbrain barrier after intranasal delivery (ross et al., 2004) . following subsequent intranasal inoculation with 2 ¥ 10 3 tcid50 of mhv-eflm, mice were processed for bli at the indicated time points as described above (fig. 8a) . at day 2, replication of mhv was not significantly affected by the application of ifn. however, while virus replication spread to the brains of the mock-treated animals, this was not observed in the ifn-treated mice. rather, the luciferase signal was lost by day 7. these observations were confirmed by the photon quantification of the head regions of the individual mice (fig. 8b) . thus, exogenous delivery of type i ifn did not prevent the initial replication in the nose, but prevented dissemination of virus infection to the cns. the results also indicate that bli is a promising technique for the non-invasive screening of antiviral compounds, the major advantage being that this system allows the detection of virus replication and spread after application of an antiviral compound over time within the same animal. b. the average body weight of both groups of mice is shown as the percentage relative to the initial weight at the beginning of the experiment. standard deviations are indicated (n = 4). c. in vivo versus ex vivo imaging of an ifnar-/-mouse infected with mhv-eflm at 7 days post inoculation. after the standard bli procedure, this mouse was sacrificed and immediately processed for imaging of the internal organs. note that the scaling [in arbitrary units (au)] in both images is different in order to visualize the focal infection pattern in the liver after ex vivo imaging. d. the liver of the ifnar-/-mouse in c was subsequently processed for histology as described in the experimental procedures. as a control, a liver section of a mhv-eflm-infected 129svev wild-type mouse is shown. typical focal lesions resulting from infection with mhv are indicated by the black arrows. mouse models are essential for defining factors that regulate replication and virulence of viruses. however, the conventional approaches for studying viral infections in mouse models are frequently limited by the need to sacrifice large numbers of animals to quantify viral titres, and establish the complete pattern of virus dissemination. the in vivo imaging of mhv infection 835 application of non-invasive imaging methods for the monitoring of virus infections in living animals can significantly facilitate studies on determinants of viral spread and pathogenesis (hutchens and luker, 2007) . we used bli for the real-time monitoring of mhv infection by using recombinant mhv viruses that express fl reporter proteins. we confirm and extend previous observations by demonstrating that mhv dissemination is critically dependent on the virus inoculation route and dose, the viral spike protein, the genetic background of the host, and the type i ifn system. in addition, the technology provided insights into the kinetics and dynamics of the infection process under these different conditions. furthermore, bli revealed an animal-to-animal variation in viral spread and elucidated new anatomic locations of virus replication. despite its many attractive features for studying mhv replication and spread, the bli technology has also some inherent limitations. first of all, photon transmission is affected by hair and organ pigmentation. thus, photon flux from the surface of an animal will be superior to that from an internal organ, because light is attenuated about 10-fold for every centimetre of tissue through which it has to pass (contag and bachmann, 2002) . as a consequence it is impossible to quantitatively compare bioluminescent signals derived from different anatomic locations. this phenomenon also explains why the photon flux from the head region at 2 days post infection is much higher than at later time points as the signal initially originates from the nasal cavity but thereafter increasingly derives from the cns, where it is much more shielded by surrounding tissue. to partly overcome this limitation, we routinely imaged the mice from both the ventral and the dorsal side. second, the introduction of a foreign gene into the viral genome may affect virus replication in vivo. interestingly, no significant differences could be observed between the replication of wild-type and fl-expressing viruses in the brain of intranasally infected mice, indicating that introduction of the foreign gene did not affect replication in vivo per se. however, after intraperitoneal application the replication of reporter gene expressing viruses in the liver was clearly much lower. the cause of this apparent discrepancy is currently unknown. importantly, however, fl expression was found at all the known sites of mhv replication (robbins et al., 1990; holmes and lai, 1996; komurasaki et al., 1996; mcintosh, 1996; perlman et al., 1999; macnamara et al., 2008) . the mhv spike protein is an important determinant of pathogenesis (phillips et al., 1999) . using bli, we monitored virus replication and spread of a recombinant virus that carried mutations in the spike gene shown to result in an extended host range in vitro due to the virus' ability to enter cells in a ceacam1a-independent but heparan sulfate-dependent manner (schickli et al., 1997; de haan et al., 2005b; . although it has been suggested that host range variants might arise in vivo during persistent infection of tissues that express low levels of the native mhv receptor (schickli et al., 1997; , this particular host range extension was obtained after serial passaging in vitro. clearly, the mutant virus replicated to a much lower extent in vivo and was not able to spread to the brain. many viruses adapt to heparan sulfate as an entry receptor upon propagation of the virus in cell culture (olmsted et al., 1984; mandl et al., 2001; lee et al., 2004) . often, but not always (liu and thorp, 2002; de haan et al., 2008) , this adaptation results in a reduction of virulence in living animals, consistent with our results. inbred mouse strains are known to differ in their susceptibility to many virus infections (parker et al., 1978; jubelt et al., 1991; compton et al., 1993; thach et al., 2000) . in our experiments we monitored the replication of mhv in three different mouse strains. c57bl/6 and 129svev mice appeared to be less susceptible to infection compared with balb/c mice after intranasal inoculation. similar results were obtained when mice were infected with wild-type mhv-a59 and viral rna load monitored using quantitative rt-pcr. strikingly, mhv replicated to approximately the same extent in balb/c and c57bl/6 mice after intraperitoneal inoculation. previously, mouse susceptibility to mhv infection was found to be linked to the viral receptor genotype (ohtsuka and taguchi, 1997) . however, quantitative rt-pcr analysis of the ceacam1a expression levels in brain and liver revealed only relatively small differences in the mhv receptor levels between the different mice strains, which did not correlate with the observed differences in viral replication (data not shown). apparently, other yet unknown host factors contribute to or limit the dissemination of mhv. the resistance of 129svev mice to infection is not restricted to mhv, because also vesicular stomatitis virus replicated much more efficiently in balb/c than in 129svev mice after intranasal inoculation (durbin et al., 2002) . the difference in mhv replication between balb/c and c57bl/6 mice might be associated with the mouse strain variation in immune responses which have been described for other virus infections (scalzo et al., 1992; brenner et al., 1994; thach et al., 2000; leipner et al., 2004; weinberg et al., 2004) . in general, c57bl/6 mice have a propensity to elicit a predominant t helper cell 1 response, while balb/c mice have a tendency to elicit a predominant t helper cell 2 response. our results confirm and extend previous observations that dissemination of mhv infection is determined both by the route and by the dose of inoculation. interestingly, clear differences in the spatio-temporal dissemination of the infection could be observed after intranasal inoculation with different virus doses. as expected, the virus inoculation dose correlated with the luminescent signal at 2 days post infection. however, inoculation with a low virus dose resulted in delayed spreading of the infection to the cns and subsequent delayed clearance. this result suggests that a certain level of replication in the nasal epithelium is required for subsequent dissemination. strikingly, at 9 days post infection higher levels of virus replication could be observed after inoculation with the low dose compared with the high dose. thus after inoculation with the high dose, virus was cleared faster from the brain. apparently, clearance of the virus is triggered by the extent of virus replication in the brain. probably high levels of virus replication more effectively induce an antiviral innate immune response. these results are corroborated by the observation that the expression levels of type i ifn and other cytokines positively correlate with the viral load in the brain of mhvinfected mice (m. raaben, unpublished results). type i ifn is a fundamental component of the innate immune response, which upon induction elicits an important antiviral signalling cascade that controls and orchestrates the outcome of numerous virus infections (zuniga et al., 2007) . here, we analysed the full extent of mhv dissemination in mice lacking a functional type i ifn response. these mice appeared to be highly susceptible to mhv and showed severe spread of the infection throughout the body when analysed with bli after intranasal inoculation. in contrast, the parental 129svev animals only showed some low levels of viral replication in the nasal cavity. these results confirm and extend recent studies in which mhv-a59-infected ifnar-/-mice were also shown to be highly susceptible to infection, both after intraperitoneal (cervantes-barragan et al., 2007) and after intracranial inoculation (roth-cross et al., 2008) . we additionally demonstrated the importance of the type i ifn system in controlling mhv dissemination by administration of type i ifns. intranasal delivery of recombinant type in vivo imaging of mhv infection 837 i ifns inhibited the spread of the infection to the brain, consistent with a previous study using the mhv strain jhm (minagawa et al., 1987) . it was interesting to observe that, while the spread to the brain was affected, the initial replication in the nasal epithelium was not decreased by the intranasally administered ifns. the experiments demonstrate the power of the bli technology for studying the effects of antiviral agents on virus replication and dissemination in animal models as was also illustrated earlier (luker et al., 2002; . our observations show that virus dissemination in an organism is a multifactorial process in which the genetic make-up of pathogen and host, the inoculation dose and route, and the status of the immune system play important roles. in addition, through the application of bli it has now become evident that, besides the typical, reproducible dissemination characteristics of mhv in mice, clear animal-to-animal variation also occurs. thus, while the infection invariably targets organs like brain, cervical lymph nodes and liver, depending on the inoculation route/dose, other anatomical sites of replication are less frequently detected (see table s1 for an overview). occasionally, mhv replication was measured in the lungs, in the intestine or in the eyes. quite frequently infection was also detected in the tail and paws, body parts not described earlier as sites of mhv replication. these results suggest that mhv can spread to and replicate in bone marrow in vivo, consistent with earlier in vitro studies demonstrating infection of bone marrow-derived macrophages and dendritic cells (zhou and perlman, 2006; roth-cross et al., 2008) . strikingly, mhv replication in tail and paws was never observed throughout the entire length of these extremities, but occurred only in distinct sites that differed between animals. in this respect, the dissemination of mhv is reminiscent of cancer metastases, which often also occur at distinct anatomical locations (molloy and van't veer, 2008) . similar to the importance of micro-environmental host factors in determining the non-random pattern of tumour localization, replication of mhv may also be enabled by local conditions in a specific micro-environment. lr7 mouse fibroblast cells (kuo et al., 2000) were maintained in dulbecco's modified eagle's medium (cambrex bio science) containing 10% (v/v) fetal calf serum (bodinco b.v), 100 u ml -1 penicillin, and 100 mg ml -1 streptomycin, supplemented with geneticin g418 (250 mg ml -1 ). mhv strain a59 and the derivates expressing the fl reporter gene (mhv-eflm, mhv-2afls and mhv-2aflsrec) have been described previously (de haan et al., 2003; 2005b) . all viruses were grown in lr7 cells. virus stocks were concentrated by pelleting through sucrose-cushion centrifugation, and subsequently resuspended in pbs. balb/c and c57bl/6 mice at different ages were obtained from charles river, while type i ifn receptor knock-out mice (ifnar-/-) (muller et al., 1994) and the parental 129svev mice were obtained from b&k universal ltd. mice were inoculated either intraperitoneally or intranasally with various doses of the different viruses. infected mice were either processed for bli, or sacrificed at the indicated time points for organ dissection. when indicated, mice were (pre-)treated with 1000 u of a cocktail of recombinant mouse ifn alpha/beta (ifn-a/b; sigma-aldrich). the cytokines were applied intranasally on each of days -2, -1, 0, 1 and 2 relative to the inoculation with mhv-eflm. control animals were treated with pbs. whole brains and livers were dissected from the mhv-infected and control mice. the tissues were added to lysing matrix d tubes (mp biomedical), containing 1 ml of pbs, and processed using a fastprep instrument (mp biomedical). the tissues were homogenized at 6000 r.p.m. for 40 s and immediately placed on ice. subsequently, the homogenates were centrifuged at 14 000 r.p.m. for 10 min at 4°c and supernatants were harvested, aliquoted and stored at -80°c. the aliquots were processed for the different assays as described below. when indicated, whole livers from mhv-infected mice were harvested, fixed in phosphate-buffered formalin, embedded in paraffin, sectioned and stained with haematoxylin. total rna was isolated from brain and liver homogenates using the trizol reagent (invitrogen) according to the manufacturer's protocol. rna was further purified using the rneasy mini-kit with subsequent dnasei treatment on the column (qiagen). the relative amounts of viral genomic rna were determined by quantitative taqman rt-pcr as described before (de haan et al., 2004) . titration of virus stocks was performed by determination of the tcid50 in lr7 cells (verheije et al., 2006) . the viral titres in tissue homogenates were determined by plaque assays. briefly, lr7 cells in 6 well microplates were inoculated with fourfold serial dilutions of the homogenates. at 1 h post inoculation, medium was replaced with an agar overlay. at approximately 48 h post inoculation, the lr7 cell monolayers were fixed and stained with crystal violet, after which the total amount of plaques was counted. the viral titres are expressed as plaque-forming units per gram (pfu g -1 ) tissue. monolayers of mhv-infected lr7 cells were lysed with 1¥ passive lysis buffer (promega). luciferase expression was measured according to the manufacturer's instructions, and relative light units (rlu) were determined in a turner designs td-20/20 luminometer. in case of the tissue homogenates, 40 ml was mixed with 40 ml 2¥ passive lysis buffer and incubated for 5 min at room temperature after which the luciferase expression was measured as described above. when indicated, mhv replication in mice was assessed by in vivo bli with a highly sensitive, ccd camera (versarray 1300b, roper scientific inc.) mounted in a light-tight imaging chamber (roper scientific inc.). imaging and quantification of signals was controlled by the acquisition software metavue (universal imaging corporation). prior to imaging, mice were anaesthetized by intraperitoneal injection of kxa: ketamine hydrochloride (100 mg kg -1 ; vétoquinol bv) plus xylazine (10 mg kg -1 ; eurovet animal health bv) and atropine (0.05 mg kg -1 ; pharmachemie bv). the substrate d-luciferin sodium salt (synchem laborgemeinschaft ohg) dissolved in pbs was injected intraperitoneal at a dose of~125 mg kg -1 . mice were positioned in a specially designed box and placed onto the stage inside the light-tight camera box. four mice were imaged simultaneously exactly 5 min after the injection of d-luciferin. the integrated light intensity of a stack of sequential 1 min exposures (10 from the dorsal side and 10 from the ventral side) was used to calculate the amount of emitted light from the animals. a low-intensity visible light image was made and used to create overlay images. images were further analysed with metamorph imaging software (universal imaging corporation). in some bli experiments, the detection of emitted photons was performed by the equally sensitive photon imager from biospace laboratory. bli images obtained with the biospace ccd camera were analysed by photovision software (biospace laboratory). table s1a . anatomical sites of mhv-eflm infection in balb/c mice inoculated with different doses (i.e. 2 ¥ 10 3 and 5 ¥ 10 6 tcid50). the numbers of mice from a group of four which showed infection at the indicated anatomical sites are indicated at the different time points post infection (days p.i.). table s1b . anatomical sites of infection in mhv-eflm infected mice of different genetic background (i.e. balb/c, c57bl/6, 129svev and ifnar-/-). note that mice were inoculated intranasally (i.n.) or intraperitoneally (i.p.) with 10 6 tcid50 of mhv-eflm and subsequently imaged at different time points post inoculation. the numbers of mice from a group of eight or four animals which showed infection at the indicated anatomical sites at any time point post inoculation are indicated. please note: wiley-blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. any queries (other than missing material) should be directed to the corresponding author for the article. in vivo imaging of mhv infection 841 cd8 t cell mediated immunity to neurotropic mhv infection targeted disruption of the ceacam1 (mhvr) gene leads to reduced susceptibility of mice to mouse hepatitis virus infection similar immune response to nonlethal infection with herpes simplex virus-1 in sensitive (balb/c) and resistant (c57bl/6) strains of mice control of coronavirus infection through plasmacytoid dendritic-cell-derived type i interferon the cellular and molecular pathogenesis of coronaviruses advances in in vivo bioluminescence imaging of gene expression photonic detection of bacterial pathogens in living hosts visualizing gene expression in living mammals using a bioluminescent reporter luciferase imaging of a neurotropic viral infection in intact animals pkr protection against intranasal vesicular stomatitis virus infection is mouse strain dependent mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease the group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host coronaviruses as vectors: position dependence of foreign gene expression cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion coronaviruses as vectors: stability of foreign gene expression murine coronavirus with an extended host range uses heparan sulfate as an entry receptor cooperative involvement of the s1 and s2 subunits of the murine coronavirus spike protein in receptor binding and extended host range cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation mouse hepatitis virus bioluminescence imaging of live infected salmonids reveals that the fin bases are the major portal of entry for novirhabdovirus ceacam1a-/-mice are completely resistant to infection by murine coronavirus mouse hepatitis virus a59 coronaviruses. in fields virology pathogenesis of mouse hepatitis virus-induced demyelination applications of bioluminescence imaging to the study of infectious diseases both spike and background genes contribute to murine coronavirus neurovirulence susceptibility and resistance to poliovirus-induced paralysis of inbred mouse strains virus rna persists within the retina in coronavirusinduced retinopathy retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier functional diversity of chemokines and chemokine receptors in response to viral infection of the central nervous system persistence of mouse hepatitis virus a59 rna in a slow virus demyelinating infection in mice as detected by in situ hybridization the organ tropism of mouse hepatitis virus a59 in mice is dependent on dose and route of inoculation common e protein determinants for attenuation of glycosaminoglycan-binding variants of japanese encephalitis and west nile viruses coxsackievirus b3-induced myocarditis: differences in the immune response of c57bl/6 and balb/c mice cell surface heparan sulfate and its roles in assisting viral infections optical imaging: current applications and future directions noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation bioluminescence imaging of vaccinia virus: effects of interferon on viral replication and spread coronaviruses. in fields virology contributions of the viral genetic background and a single amino acid substitution in an immunodominant cd8+ t-cell epitope to murine coronavirus neurovirulence priming of cd8+ t cells during central nervous system infection with a murine coronavirus is strain dependent adaptation of tick-borne encephalitis virus to bhk-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo mhv infection of the cns: mechanisms of immunemediated control protective effect of recombinant murine interferon beta against mouse hepatitis virus infection recent advances in metastasis research b-cell-mediated lysis of cells infected with the neurotropic jhm strain of mouse hepatitis virus functional role of type i and type ii interferons in antiviral defense mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype sindbis virus mutants selected for rapid growth in cell culture display attenuated virulence in animals susceptibility of inbred and outbred mouse strains to sendai virus and prevalence of infection in laboratory rodents pathogenesis of coronavirus-induced infections. review of pathological and immunological aspects coronaviruses: hepatitis, hepatitis, and central nervous system disease pathogenesis of chimeric mhv4/mhv-a59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence retinopathy following intravitreal injection of mice with mhv strain jhm expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis murine coronavirus mouse hepatitis virus is recognized by mda5 and induces type i interferon in brain macrophages/ microglia the effect of the cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells the murine coronavirus mouse hepatitis virus strain a59 from persistently infected murine cells exhibits an extended host range the n-terminal region of the murine coronavirus spike glycoprotein is associated with the extended host range of viruses from persistently infected murine cells molecular imaging of gene therapy for cancer single-amino-acid substitutions in open reading frame (orf) 1b-nsp14 and orf 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice t cell antiviral effector function is not dependent on cxcl10 following murine coronavirus infection differences between c57bl/6 and balb/cby mice in mortality and virus replication after intranasal infection with neuroadapted sindbis virus redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapter mouse hepatitis coronavirus rna replication depends on gbf1-mediated arf1 activation mouse strain differences in the chemokine response to acute lung infection with a murine gammaherpesvirus coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice preferential infection of mature dendritic cells by mouse hepatitis virus strain jhm type i interferon during viral infections: multiple triggers for a multifunctional mediator additional supporting information may be found in the online version of this article this work was supported by grants from the m.w. beijerinck virology fund, royal netherlands academy of arts and sciences, and the netherlands organization for scientific research (nwo-vidi-700.54.421) to c.a.m. de haan. we thank monique oostra, marne hagemeijer and mijke vogels for stimulating discussions. key: cord-324326-q014b5ym authors: murakami, makoto title: lipoquality control by phospholipase a(2) enzymes date: 2017-11-10 journal: proc jpn acad ser b phys biol sci doi: 10.2183/pjab.93.043 sha: doc_id: 324326 cord_uid: q014b5ym the phospholipase a(2) (pla(2)) family comprises a group of lipolytic enzymes that typically hydrolyze the sn-2 position of glycerophospholipids to give rise to fatty acids and lysophospholipids. the mammalian genome encodes more than 50 pla(2)s or related enzymes, which are classified into several subfamilies on the basis of their structures and functions. from a general viewpoint, the pla(2) family has mainly been implicated in signal transduction, producing bioactive lipid mediators derived from fatty acids and lysophospholipids. recent evidence indicates that pla(2)s also contribute to phospholipid remodeling for membrane homeostasis or energy production for fatty acid β-oxidation. accordingly, pla(2) enzymes can be regarded as one of the key regulators of the quality of lipids, which i herein refer to as lipoquality. disturbance of pla(2)-regulated lipoquality hampers tissue and cellular homeostasis and can be linked to various diseases. here i overview the current state of understanding of the classification, enzymatic properties, and physiological functions of the pla(2) family. in terms of signal transduction, the phospholipase a 2 (pla 2 ) reaction, which hydrolyzes the sn-2 position of phospholipids to yield fatty acids and lysophospholipids, has been considered to be of particular importance, since arachidonic acid (aa, c20:4), one of the polyunsaturated fatty acids (pufas) released from membrane phospholipids by pla 2 , is metabolized by cyclooxygenases (coxs) and lipoxygenases (loxs) to lipid mediators including prostaglandins (pgs) and leukotrienes (lts), which are often referred to as eicosanoids (fig. 1) . lysophospholipids or their metabolites, such as lysophosphatidic acid (lpa) and platelet-activating factor (paf), are categorized into another class of pla 2 -driven lipid mediators ( fig. 2a, b) . more recently, a novel class of anti-inflammatory lipid mediators derived from b3 pufas, such as eicosapentaenoic acid (epa, c20:5) and docosahexaenoic acid (dha, c22:6), has also been attracting much attention (fig. 2c ). these lipid mediators exert numerous biological actions on target cells mainly by acting on their cognate g protein-coupled receptors. the pathophysiological roles of individual lipid mediators have been summarized in recent reviews. 1)-4) however, this principal concept appears to be insufficient to fully explain the biological aspects and physiological roles of the pla 2 family. phospholipids comprise numerous molecular species that contain various combinations of fatty acids esterified at the sn-1 and sn-2 positions and several polar head groups at the sn-3 position. many, if not all, pla 2 enzymes recognize such differences in the fatty acyl and/or head group moieties in their substrate phospholipids. moreover, several enzymes in the pla 2 family also catalyze the phospholipase a 1 (pla 1 ), lysophospholipase, neutral lipid lipase, or even transacylase/ acyltransferase reaction rather than or in addition to the genuine pla 2 reaction. therefore, the fatty acids and lysophospholipids released by different pla 2 s are not always identical; rather, in many situations, specific fatty acids and lysophosholipids can be released by a particular pla 2 in the presence of a given microenvironmental cue. in this context, pla 2 enzymes act as one of the critical regulators of spatiotemporal lipid profiles, namely the quality of lipids (lipoquality). to comprehensively understand the lipoquality regulation by individual pla 2 s in various pathophysiological contexts, their precise enzymatic, biochemical and cell biological properties, tissue and cellular distributions, and availability of phospholipid substrates in various pathophysiological settings should be taken into consideration. herein, i overview current understanding of the biological aspects of various pla 2 enzymes in the context of lipoquality. obviously, the substrate specificity of individual pla 2 s is the critical determinant of lipoquality. the in vitro enzymatic activity of pla 2 s may be influenced by the assay conditions employed, such as the composition of the substrate phospholipids, concentrations of pla 2 s and substrates, presence of detergents, and ph. hence, the enzymatic properties of individual pla 2 s determined in different studies may not be entirely identical. since natural membranes contain numerous phospholipid molecular species, the results obtained using artificial phospholipid vesicles comprising only one or a few phospholipid species may not always reflect the true enzymatic properties of a given pla 2 . addition of an excess amount of recombinant or purified pla 2 to an enzyme assay often results in hydrolysis of bulk phospholipids, which makes precise evaluation of its substrate specificity difficult. the results obtained using a commercially available pla 2 assay kit, in which a synthetic, chromophoric phospholipid is used as a substrate, should be interpreted carefully, since some pla 2 s are unable to hydrolyze it efficiently. in this regard, mass spectrometric examination of the in vitro hydrolysis of natural membrane phospholipids extracted from the affected tissues or cells by pla 2 , particularly at a low (physiologically relevant) concentration of the enzyme, could provide a valuable clue to the in vivo substrates and products of this enzyme. 5)-7) the overall tendency in this in vitro assay using natural membranes is recapitulated in several in vivo systems, often with even more selective patterns of hydrolysis that are relevant to the results of studies using pla 2 knockout and/or transgenic mice (see below). importantly, the mobilization of distinct lipids by pla 2 s in vivo relies not only on their intrinsic enzymatic properties, but also on tissue-or disease-specific contexts such as the lipid composition of target membranes, the spatiotemporal availability of downstream lipid-metabolizing enzymes, or the presence of cofactor(s) that can modulate the enzymatic function, which may account for why distinct pla 2 enzymes even in the same subfamily exert specific functions with different lipid profiles in distinct settings. hereafter, i describe the current understanding of various pla 2 s in the context of lipoquality. the classification, distributions, properties and functions of individual pla 2 s, whose pathophysiological functions have currently been studied using their gene-manipulated mice, are summarized in table 1 enzymes whose in vivo functions have been analyzed using knockout mice are summarized. the cpla 2 family. the cytosolic pla 2 (cpla 2 ) family comprises 6 isoforms (,-1), among which cpla 2 o, /, c and 1 map to the same chromosomal locus (fig. 3a) . 8) cpla 2 , (also known as group iva pla 2 ) is undoubtedly the best known pla 2 and its biological roles in association with lipoquality have been well documented. 9) cpla 2 , is the only pla 2 that shows a striking substrate specificity for aa-containing phospholipids. strictly speaking, cpla 2 , can also hydrolyze phospholipids containing epa, yet the low abundance of this b3 pufa relative to other fatty acids including b6 aa in cell membranes allows cpla 2 , to release aa rather specifically in most situations. upon cell activation, cpla 2 , translocates from the cytosol to the phosphatidylcholine (pc)-rich perinuclear, endoplasmic reticulum (er) and golgi membranes (particularly golgi) in response to an increase in the µm range of cytosolic ca 2d concentration, and is maximally activated by phosphorylation through mitogen-activated protein kinases (mapks) and other kinases. 10),11) in addition, the phosphoinositide pip 2 and ceramide-1-phosphate modulate the subcellular localization and activation of cpla 2 ,. 12),13) the aa released by cpla 2 , is converted by the sequential action of constitutive cox-1 or inducible cox-2 and terminal pg synthases to pgs or by the sequential action of 5-lox and terminal lt synthases to lts (fig. 3b ). mice deficient in cpla 2 , display a number of phenotypes that can be explained by reductions of pgs and/or lts. under physiological conditions, cpla 2 ,-deficient mice display a hemorrhagic tendency, impaired female reproduction, gastrointestinal ulcer, and renal malfunction, among others. 14)18) under pathological conditions, cpla 2 ,-deficient mice are protected against bronchial asthma, pulmonary fibrosis, cerebral infarction, alzheimer's disease, experimental autoimmune encephalomyelitis, collagen-induced arthritis, metabolic diseases, intestinal cancer and so on, whereas they suffer from more severe colitis and spinal cord injury. 15),19)-24) most of these phenotypes are recapitulated in mice lacking one or more of the biosynthetic enzymes or receptors for pgs and lts, lending strong support to the notion that cpla 2 , lies upstream of eicosanoid biosynthesis in many situations. for instance, as is the case for cpla 2 ,-deficient mice, mice lacking ltc 4 synthase (ltc 4 s), ltd 4 receptor (cyslt1), ltb 4 receptor (blt1), or pgd 2 receptor (dp1) are protected from asthma, 25)-27) revealing the critical role of the cpla 2 ,-ltb 4 /ltc 4 /pgd 2 axis in this allergic disease. likewise, the decrease of pge 2 in cpla 2 ,-deficient mice can account largely, even if not solely, for the mitigation of arthritis, autoimmune encephalomyelitis, cancer and neurodegeneration as well as the exacerbation of colitis, since these phenotypes are mimicked by mice lacking pge 2 synthase (mpges-1) or either of the four pge 2 receptors (ep194). 28)-32) furthermore, cpla 2 ,-triggered release of aa by platelets is coupled not only with biosynthesis of the pro-thrombotic eicosanoid thromboxane a 2 (txa 2 ), but also with o-oxidationmediated bioenergetics for blood clotting. 33) importantly, inherited human cpla 2 , mutations are associated with reduced eicosanoid biosynthesis, platelet dysfunction, and intestinal ulceration, 34) , 35) thus mimicking cpla 2 , deletion in mice. on the other hand, the enzymatic activities and biological functions of cpla 2 isoforms other than cpla 2 , have remained largely unknown. reportedly, cpla 2 o (group ivb pla 2 ), which has a unique jimc domain in the n-terminal region, display pla 1 , pla 2 and lysophospholipase activities. 36) cpla 2 . (group ivc pla 2 ), which uniquely lacks the c2 domain characteristic of the cpla 2 family, is cterminally farnesylated and possesses lysophospholipase and transacylase activities in addition to pla 2 activity. 37) cpla 2 / (group ivd pla 2 ), whose expression is elevated in human psoriatic skin, 38) shows pla 1 activity in preference to pla 2 activity. 36) cpla 2 c (group ive pla 2 ) exhibits a unique transacylase activity that transfers sn-1 fatty acid of pc to an amino residue of phosphatidylethanolamine (pe) to form n-acyl-pe, a precursor of the endocannabinoid lipid mediator n-acylethanolamine. 39) cpla 2 1 (group ivf pla 2 ) displays both pla 1 and pla 2 activities without fatty acid selectivity. 40) however, these enzymatic properties of cpla 2 o-1 vary according to the in vitro assays employed, implying that analyses using gene-manipulated mice for these enzymes will be necessary for clarifying their biological roles in the context of lipoquality. the ipla 2 /pnpla family. the human genome encodes 9 ca 2d -independent pla 2 (ipla 2 ) enzymes (fig. 4) . these enzymes are now more generally referred to as patatin-like phospholipase domain-containing lipases (pnpla199), as all members in this family share a patatin domain, which was initially discovered in patatin (ipla 2 ,), a potato protein. 41 ),42) mammalian ipla 2 /pnpla isoforms include lipid hydrolases or transacylases with specificities for diverse lipids such as phospholipids, neutral lipids, sphingolipids, and retinol esters. generally speaking, enzymes bearing a large and unique n-terminal region (pnpla699) act mainly on phospholipids (phospholipase type), whereas those lacking the n-terminal domain (pnpla195) act on neutral lipids (lipase type). analysis of mutant mouse models and clinical symptoms of patients with mutations for these enzymes have provided valuable insights into the physiological roles of the ipla 2 / pnpla family in various forms of homeostatic lipid metabolism that are fundamental for life. among the ipla 2 /pnpla family, pnpla9 (ipla 2 o, also known as group via pla 2 ) is the only isoform that acts primarily as a pla 2 with poor fatty acid selectivity. 43),44) although pnpla8 (ipla 2 . or group vib pla 2 ) displays pla 2 activity, it acts as a pla 1 toward phospholipids bearing sn-2 pufa. 45), 46) accordingly, hydrolysis of pufa-bearing phospholipids by pnpla8/ipla 2 . typically gives rise to 2-lysophospholipids (having a pufa at the sn-2 position) rather than 1-lysophospholipids (having a saturated or monounsaturated fatty acid at the sn-1 position). pnpla6 (ipla 2 /) and its closest paralog pnpla7 (ipla 2 3) have lysophospholipase activity that cleaves lysophosphatidylcholine to yield fatty acid and glycerophosphocholine. 47),48) genetic mutations or deletions of these phospholipid-targeting pnplas cause various forms of metabolic dysfunction and neurodegeneration. 49)-53) in particular, pnpla9/ipla 2 o is also referred to as the parkinsonism-associated protein park14, whose mutations impair ca 2d signaling in dopaminergic neurons. 54) apart from the metabolic and neurodegenerative phenotypes, the lack of pnpla9/ipla 2 o leads to male infertility through an unknown mechanism. 55) pnpla2 (ipla 2 1), more generally known as adipose triglyceride lipase (atgl), is a major lipase that hydrolyzes triglycerides in lipid droplets to release fatty acids as a fuel for o-oxidation-coupled energy production, a process known as lipolysis. 56) genetic deletion or mutation of pnpla2 leads to massive accumulation of triglycerides in multiple tissues leading to multi-organ failures, 57) while protecting from cancer-associated cachexia by preventing fat loss. 58) the activity of pnpla2 is regulated positively by abhd5 (see below) and negatively by perilipin and g0s2, which modulate the accessibility of pnpla2 to lipid droplets. 59) the fatty acids released from lipid droplets by pnpla2 act as endogenous ligands for the nuclear receptor ppar, or ppar/, which accelerates energy consumption. 59), 60) the regulatory mechanisms and metabolic roles of pnpla2 have been detailed in other elegant reviews. 61),62) mutations of pnpla3 (ipla 2 c) are highly associated with non-alcoholic fatty liver disease. 63) although the catalytic activity of pnpla3 is controversial, it may serve as a triglyceride lipase, since its loss-of function mutation increases cellular triglyceride levels. 64) furthermore, recent evidence suggests that pnpla3 acts as a retinyl-palmitate lipase in hepatic stellate cells to fine-tune the plasma levels of retinoids. the expressions of pnpla2 and pnpla3 are nutritionally regulated in a reciprocal way; pnpla2 is upregulated, while pnpla3 is downregulated, upon starvation, and vice versa upon feeding. 65) biochemical and cell biological studies have suggested that pnpla4 (ipla 2 2, which is absent in mice) might be involved in retinol ester metabolism 66) and that pnpla5 might participate in triglyceride lipolysis coupled with autophagosome formation, 67) although the in vivo relevance of these in vitro observations is unclear. unlike most pnpla isoforms that are ubiquitously expressed in many tissues, pnpla1 is localized predominantly in the upper layer of the epidermis. pnpla1 acts as a unique transacylase, catalyzing the transfer of linoleic acid (la; c18:2) in triglyceride to the b-hydroxy residue of ultra-longchain fatty acid in ceramide to form b-o-acylceramide, a lipid component essential for skin barrier function. 68),69) accordingly, genetic deletion or mutation of pnpla1 hampers epidermal b-o-acylceramide formation, thereby severely impairing skin barrier function and causing ichthyosis. the unique role of pnpla1 in the acylceramide-metabolic pathway in the epidermis is depicted in fig. 5 . the pafah family. the paf-acetylhydrolase (pafah) family comprises one extracellular and three intracellular pla 2 s that were originally found to have the capacity to deacetylate and thereby inactivate the lysophospholipid-derived lipid mediator paf. 70),71) type-i pafah is a heterotrimer composed of two catalytic subunits, group xiiia and xiiib pla 2 s, and a regulatory subunit lis-1, the causative gene for a type of miller diecker syndrome. 72) deficiency of type-i pafah leads to male infertility through an unknown mechanism. 73) type-ii pafah (group viib pla 2 ) preferentially hydrolyzes oxidized phospholipids (i.e., phospholipids having an oxygenated fatty acid at the sn-2 position) in cellular membranes, thereby protecting cells from oxidative damage. 74) although plasma-type pafah (group viia pla 2 ) is a secreted protein, it is described here as its structure is close to type-ii pafah. plasma-type pafah is now more generally called lipoprotein-associated pla 2 (lp-pla 2 ), existing as a low-density lipoprotein (ldl)-bound form in human plasma. 75) a series of studies have revealed the correlation of lp-pla 2 with atherosclerosis, likely because this enzyme liberates toxic oxidized fatty acids from modified ldl with pro-atherogenic potential. 76),77) furthermore, deficiency of lp-pla 2 decreases intestinal polyposis and colon tumorigenesis in apc min/d mice, 78) suggesting an anti-tumorigenic role for paf in this setting. lysosomal pla 2 . lysosomal pla 2 (lpla 2 ), also known as group xv pla 2 , is homologous with lecithin cholesterol acyltransferase (lcat) and catalytically active under mildly acidic conditions. 79) lpla 2 hydrolyzes both sn-1 and sn-2 fatty acids in phospholipids and contributes to phospholipid degradation in lysosomes. genetic deletion of lpla 2 results in unusual accumulation of non-degraded lung surfactant phospholipids in lysosomes of alveolar macrophages, leading to phospholipidosis, 80) perturbed presentation of endogenous lysophospholipid antigens to cd1d by invariant natural killer t (inkt) cells, 81) and impairment of adaptive t cell immunity against mycobacterium. 82) the plaat family. the pla-acyltransferase (plaat) family (3 enzymes in humans and 5 enzymes in mice) is structurally similar to lecithin retinol acyltransferase (lrat). members of this family, including group xvi pla 2 (pla2g16), display pla 1 and pla 2 activities, as well as acyltransferase activity that synthesizes n-acyl-pe, to various degrees. 83) pla2g16 is highly expressed in adipocytes, and pla2g16-deficient mice are resistant to diet-induced obesity. 84) pla2g16 and its paralogs in this family have also been implicated in tumor invasion and metastasis, 85) vitamin a metabolism, 86) peroxisome biogenesis, 87) and cellular entry and clearance of picornaviruses. 88) the abhd family. the ,/o hydrolase (abhd) family is a newly recognized group of lipolytic enzymes, comprising at least 19 enzymes in humans. 89) enzymes in this family typically possess both hydrolase and acyltransferase motifs. although the functions of many of the abhd isoforms still remain uncertain, some of them have been demonstrated to act on neutral lipids or phospholipids as lipid hydrolases. abhd3 selectively hydrolyzes phospholipids with medium-chain fatty acids. 90 lipoquality control by phospholipase a 2 enzymes no. 9] abhd4 releases fatty acids from multiple classes of n-acyl-phospholipids to produce n-acyl-lysophospholipids. 91) abhd6 acts as lysophospholipase or monoacylglycerol lipase, the latter being possibly related to the regulation of 2-arachidonoyl glycerol (2-ag) signaling. 92),93) 2-ag is an endocannabinoid lipid mediator that plays a role in the retrograde neurotransmission and is considered to be produced mainly by diacylglycerol lipase ,. 94) interestingly, in the brain, the aa released from 2-ag by monoacylglycerol lipase, rather than that released from phospholipids by cpla 2 , (see above), is linked to the production of a pool of pge 2 that promotes fever. 2),95) abhd12 hydrolyzes lysophosphatidylserine (lysops), and is therefore referred to as lysops lipase. 96) mutations in the human abhd12 gene result in accumulation of lysops in the brain and cause a disease called pharc, which is characterized by polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract. 97) abhd16a acts as a phosphatidylserine (ps)-selective pla 2 (referred to as ps lipase), being located upstream of abhd12 in the ps-catabolic pathway. 96) although abhd5 (also called cgi-58) does not have a catalytic activity because of the absence of a serine residue in the catalytic center, it greatly enhances pnpla2directed hydrolysis of triglycerides in lipid droplets by acting as an essential lipolytic cofactor. 98) 4. lipoquality control by secreted pla 2 s general aspects. the secreted pla 2 (spla 2 ) family contains 10 catalytically active isoforms and one inactive isoform in mammals. 42),99) based on the structural and evolutional relationships, these enzymes are categorized into classical (ib, iia, iic, iid, iie, iif, v and x) and atypical (iii and xii) classes (fig. 6) . the spla 2 family strictly hydrolyzes the sn-2 position of phospholipids, a feature that differs from intracellular pla 2 s that often display pla 1 , lysophospholipase, lipase, or transacylase/acyltransferase activity (see above). individual spla 2 s exhibit unique tissue and cellular distributions, suggesting their distinct biological roles. as spla 2 s are secreted and require ca 2d in the mm range for their catalytic action, their principal targets are phospholipids in the extracellular space, such as microparticles, surfactant, lipoproteins, and foreign phospholipids in microbe membranes or dietary components. the biochemical properties and pathophysiological functions of spla 2 s have been detailed in several recent reviews. 5), 100) here, i describe several key features of lipoquality regulation by the spla 2 family. in terms of the lipoquality, spla 2 s have long been considered to display no apparent selectivity for sn-2 fatty acid species in the substrate phospholipids. this view was based on the fact that spla 2 -ib and -iia, two prototypic spla 2 s that were initially identified through classical protein purification from the pancreas and sites of inflammation, respectively, 101),102) as well as a number of snake venom pla 2 s that belong to group i and ii spla 2 s, are capable of releasing fatty acids non-selectively. however, recent lipidomics-based evaluation of the substrate specificity of spla 2 s toward natural membranes (see above) has revealed that several spla 2 s can distinguish sn-2 fatty acyl moieties in phospholipids under physiologically relevant conditions. in general terms, spla 2 -ib, -iia and -iie do not discriminate fatty acid species, spla 2 -v tends to prefer those with a lower degree of unsaturation such as oleic acid (oa; c18:1), and spla 2 -iid, -iif, -iii and -x tend to prefer pufas including aa and dha. several spla 2 s can also distinguish differences in the polar head groups of phospholipids. for instance, spla 2 -x is very active on pc, while spla 2 -iia has much higher affinity for pe than for pc, and this substrate selectivity has been partly ascribed to their crystal structures. 103),104) therefore, in order to comprehensively understand the specific biological roles of this enzyme family, it is important to consider when and where different spla 2 s are expressed, which isoforms are involved in what types of pathophysiology, why they are needed, and how they exhibit their unique functions by driving specific types of lipid metabolism. classical spla 2 s. spla 2 -ib, also known as "pancreatic spla 2 ", is synthesized as an inactive zymogen in the pancreas, and its n-terminal propeptide is cleaved by trypsin to yield an active enzyme in the duodenum. 101) the main role of spla 2 -ib is to digest dietary and biliary phospholipids in the intestinal lumen. perturbation of this process by gene disruption or pharmacological inhibition of spla 2 -ib leads to resistance to diet-induced obesity, insulin resistance, and atherosclerosis due to decreased phospholipid digestion and absorption in the gastrointestinal tract. 105)-108) the human pla2g1b gene maps to an obesity-susceptible locus. 109) spla 2 -iia is often referred to as "inflammatory spla 2 ", since its expression is induced by proinflammatory cytokines such as tnf, and il-1o or by bacterial products such as lipopolysaccharide. 110) in mice, however, spla 2 -iia in mice is distributed only in intestinal paneth cells (in balb/c, c3h, nzb and dba, etc.) or not expressed at all due to a natural frameshift mutation (in c57bl/6, a/j, c58/ j, p/j, 129/sv and b10.riii, etc.). 111),112) the bestknown physiological function of spla 2 -iia is the degradation of bacterial membranes, thereby providing the first line of antimicrobial defense in the host. 113),114) consistent with this, spla 2 -iia preferentially hydrolyzes pe and phosphatidylglycerol, which are enriched in bacterial membranes. under sterile conditions, spla 2 -iia attacks phospholipids in microparticles, particularly those in extracellular mitochondria (an organelle that evolutionally originated from bacteria), which are released from activated platelets or leukocytes at inflamed sites. 115) hydrolysis of microparticular phospholipids by spla 2 -iia results in production of pro-inflammatory eicosanoids and lysophospholipids as well as in release of mitochondrial dna as a danger-associated molecular pattern (damp). thus, spla 2 -iia is primarily involved in host defense by killing bacteria and triggering innate immunity, while over-amplification of the response leads to exacerbation of inflammation. spla 2 -iia, -iic, -iid, -iie and -iif are often classified into the group ii subfamily (spla 2 -iic is a pseudogene in human), since they share structural characteristics and map to the same chromosome locus. spla 2 -iid is constitutively expressed in dendritic cells (dcs) in lymphoid organs. spla 2 -iid is an "immunosuppressive spla 2 " that attenuates dc-mediated adaptive immunity by hydrolyzing pe probably in microparticles to mobilize antiinflammatory b3 pufas and their metabolites such as resolvin d1 (rvd1). 7) as such, spla 2 -iid-null mice exhibit more severe contact hypersensitivity and psoriasis, whereas they are protected against infection and cancer because of enhanced anti-viral and anti-tumor immunity. 7),116),117) unlike spla 2 -iia, which is stimulus-inducible (see above), spla 2 -iid is downregulated by pro-inflammatory stimuli, consistent with its anti-inflammatory role. in mice, spla 2 -iie instead of spla 2 -iia is upregulated in several tissues under inflammatory or other conditions. spla 2 -iie is expressed in hair follicles in association with the growth phase of the hair cycle 118) and induced in adipose tissue in association with obesity in mice. 119) spla 2 -iie hydrolyzes pe without apparent fatty acid selectivity in hair follicles and lipoproteins, and accordingly, spla 2 -iie-deficient mice display subtle abnormalities in hair follicles 118) and are modestly protected from diet-induced obesity and hyperlipidemia. 119) spla 2 -iif has a long c-terminal extension containing a free cysteine, which might contribute to formation of a homodimer, and is more hydrophobic than other spla 2 s. 120) physiologically, spla 2 -iif is an "epidermal spla 2 " that is expressed predominantly in the upper epidermis and induced by il-22, a th17 cytokine, in psoriatic skin. 6) spla 2 -iif preferentially hydrolyzes pufa-containing plasmalogen-type pe in keratinocyte-secreted phospholipids to produce plasmalogen-type lysophosphatidylethanolamine (p-lpe; lysoplasmalogen), which in turn promotes epidermal hyperplasia (fig. 7a-c) . accordingly, spla 2 -iif-null mice are protected against epidermal-hyperplasic diseases such as psoriasis and skin cancer, while spla 2 -iif-transgenic mice spontaneously develop psoriasis-like skin. 6) although spla 2 -v was previously thought to be a regulator of aa metabolism, 121), 122) it is now becoming obvious that this spla 2 has a preference for phospholipids having fatty acids with a lower degree of unsaturation. spla 2 -v is markedly induced in adipocytes during obesity as a "metabolic spla 2 " and hydrolyzes pc in hyperlipidemic ldl to release oa and to a lesser extent la, which counteract adipose tissue inflammation and thereby ameliorates obesity-associated metabolic disorders. 119) transgenic overexpression of spla 2 -v, but not other spla 2 s, results in neonatal death due to a respiratory defect, which is attributable to the ability of spla 2 -v to potently hydrolyze pc with palmitic acid (pa, c16:0), a major component of lung surfactant. 123) this unique substrate preference of spla 2 -v has also been supported by a recent lipidomics analysis of the spleen (a tissue where spla 2 -v is abundantly expressed), in which the levels of fatty acids with a lower degree of unsaturation (e.g. pa, oa and la), rather than pufas (aa, epa and dha), are significantly reduced in spla 2 -v-deficient mice relative to wild-type mice (fig. 8) . this is in contrast to the spleen of spla 2 -iid-deficient mice, in which b3 pufas and their metabolites are selectively diminished, 7) revealing distinct lipoquality regulation 0.0e+00 2.0e+08 4.0e+08 6.0e+08 8.0e+08 , were significantly reduced in spla 2 -v-deficient mice relative to control mice. accordingly, la metabolites, including 9-and 13-hydroxyoctadecadienoic acids (hodes) among others, were substantially decreased in mutant mice relative to control mice, whereas none of the aa, epa and dha metabolites differed significantly between the genotypes. these results are consistent with the view that spla 2 -v has a propensity to preferentially hydrolyze phospholipids having sn-2 fatty acids with a lower degree of unsaturation, as illustrated at right bottom. by different spla 2 s. another intriguing feature of spla 2 -v is that it is the only "th2-prone spla 2 " induced in m2 macrophages by the th2 cytokines il-4 and il-13 and promotes th2-driven pathology such as asthma. gene ablation of spla 2 -v perturbs proper polarization and function of m2 macrophages in association with decreased th2 immunity, 124) although the underlying lipid metabolism responsible for this event remains obscure. probably because of this alteration in the macrophage phenotype, spla 2 -v-null macrophages have a reduced ability to phagocytose extracellular materials. accordingly, spla 2 -v-null mice are more susceptible to fungal infection and arthritis due to defective clearance of hazardous fungi and immune complexes, respectively. 125),126) likewise, spla 2 -v-null mice suffer from more severe lung inflammation caused by bacterial or viral infection, 127) which could also be explained by poor clearance of these microbes by alveolar macrophages. among the mammalian spla 2 s, spla 2 -x has the highest affinity for pc leading to release of fatty acids, with an apparent tendency for pufa preference. spla 2 -x is activated by cleavage of the nterminal propeptide by furin-type convertases. 128) spla 2 -x is expressed abundantly in colorectal epithelial and goblet cells and has a protective role in colitis by mobilizing anti-inflammatory b3 pufas. 24) consistently, spla 2 -x-transgenic mice exhibit global anti-inflammatory phenotypes in association with elevation of systemic b3 pufa levels. 24) in the process of reproduction, spla 2 -x secreted from the acrosomes of activated spermatozoa hydrolyzes sperm membrane phospholipids to release dha and docosapentaenioc acid (dpa, c22:5), the latter facilitating fertilization. 24),129) additionally, spla 2 -x-null mice are protected from asthma, accompanied by decreased levels of pulmonary b6 aa-derived eicosanoids. 130) unlike the situation in spla 2 -v-null mice (see above), however, the th2 response per se is not affected in the asthma model 131) and the lung damage is milder following influenza infection 132) in spla 2 -x-null mice, illustrating the distinct actions of different spla 2 s in the same tissue. atypical spla 2 s. spla 2 -iii is unusual in that it consists of three domains, in which the central spla 2 domain similar to bee venom group iii spla 2 is flanked by large and unique n-and cterminal domains. 133) the enzyme is processed to the spla 2 domain-only form that retains full enzymatic activity. 134) although spla 2 -iii does not discriminate the polar head groups, it tends to prefer sn-2 pufas in the substrate phospholipids. spla 2 -iii is expressed in the epididymal epithelium and acts on immature sperm cells passing through the epididymal duct in a paracrine manner to allow sperm membrane phospholipid remodeling, a process that is prerequisite for sperm motility. 135) spla 2 -iii is also secreted from mast cells and acts on microenvironmental fibroblasts to produce pgd 2 , which in turn promotes proper maturation of mast cells. 136) accordingly, mice lacking spla 2 -iii exhibit male hypofertility and reduced anaphylactic responses. spla 2 -xiia is evolutionally far distant from other spla 2 s. 137) spla 2 -xiia is expressed in many tissues at relatively high levels, yet its enzymatic activity is weaker than that of other spla 2 s. the properties and physiological roles of spla 2 -xiia are currently unclear and await future studies using spla 2 -xiia-deficient mice. apart from lipoquality regulation, spla 2 -xiib is a catalytically inactive protein due to substitution of the catalytic center histidine by leucine. 138) spla 2 -xiib deficiency impairs hepatic lipoprotein secretion, 139) although the mechanism is unclear. beyond the lipoquality control by spla 2 s, several spla 2 s binds to spla 2 receptor (pla2r1, also known as the c-type lectin clec13c) with different affinities. 140) in mice, pla2r1 binds to spla 2 -ib, -iia, -iie, -iif and -x with high affinity, spla 2 -v with moderate affinity, and spla 2 -iid, -iii and -xiia with low or no affinity. 138) pla2r1 is homologous to spla 2 -inhibitory proteins present in snake plasma and exists as an integral membrane protein or as a soluble protein resulting from shedding or alternative splicing. pla2r1 may act as a clearance receptor or endogenous inhibitor that inactivates spla 2 s, as a signaling receptor that transduces spla 2 -dependent signals in a catalytic activity-independent manner, or as a pleiotropic receptor that binds to non-spla 2 ligands. in support of its clearance role, pla2r1 !/! mice show more severe asthma, likely due to defective clearance of pro-asthmatic spla 2 -x. 141) in support of its signaling role, pla2r1, probably through binding to myocardial spla 2 s or other ways, promotes the migration and growth of myofibroblasts and thereby protects against cardiac rupture in a model of myocardial infarction. 142) pla2r1 has recently attracted attention as a major autoantigen in membranous nephropathy, a severe autoimmune disease leading to podocyte injury and proteinuria, 143) although it is not clear whether this role of pla2r1 is spla 2dependent or -independent. by applying lipidomics approaches to knockout or transgenic mice for various pla 2 s, it has become evident that individual enzymes regulate specific forms of lipid metabolism, perturbation of which can be eventually linked to distinct pathophysiological outcomes. knowledge of lipoquality control by individual pla 2 s acquired from studies using animal models should be translated to humans. current knowledges on the relationship between pla 2 gene mutations and human diseases are summarized in table 2 . nonetheless, future development of more comprehensive and highly sensitive lipidomics techniques will contribute to the discovery of novel pla 2driven lipid pathways that could be biomarkers or druggable targets for particular diseases. nakanishi, h., ikeda, k., taguchi, r., kabashima deletion of cytosolic phospholipase a 2 promotes striated muscle growth lipid signaling in cytosolic phospholipase a 2 ,-cyclooxygenase-2 cascade mediates cerebellar longterm depression and motor learning acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase a 2 cytosolic phospholipase a 2 ,-deficient mice are resistant to collagen-induced arthritis an essential role of cytosolic phospholipase a 2 , in prostaglandin e 2 -mediated bone resorption associated with inflammation cytosolic phospholipase a 2 ,-deficient mice are resistant to experimental autoimmune encephalomyelitis phospholipase a 2 reduction ameliorates cognitive deficits in a mouse model of alzheimer's disease group x secreted phospholipase a 2 releases b3 polyunsaturated fatty acids, suppresses colitis, and promotes sperm fertility cysteinyl leukotrienes regulate th2 celldependent pulmonary inflammation leukotriene b 4 receptor blt1 mediates early effector t cell recruitment prostaglandin d 2 as a mediator of allergic asthma dual roles of pge 2 -ep4 prostaglandin e 2 -ep4 signaling promotes immune inflammation through th1 cell differentiation and th17 cell expansion acceleration of intestinal polyposis through prostaglandin receptor ep2 in apc "716 knockout mice involvement of prostaglandin e 2 in production of amyloid-o peptides both in vitro and in vivo the prostaglandin receptor ep4 suppresses colitis, mucosal damage and cd4 cell activation in the gut mapping the human platelet lipidome reveals cytosolic phospholipase a 2 as a regulator of mitochondrial bioenergetics during activation the enteropathy of prostaglandin deficiency inherited human cpla 2 , deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction interfacial kinetic and binding properties of mammalian group ivb phospholipase a 2 (cpla 2 o) and comparison with the other cpla 2 isoforms a novel calcium-independent phospholipase a 2 , cpla 2 ., that is prenylated and contains homology to cpla 2 cloning of a gene for a novel epithelium-specific cytosolic phospholipase a 2 , cpla 2 /, induced in psoriatic skin a calcium-dependent acyltransferase that produces n-acyl phosphatidylethanolamines function, activity, and membrane targeting of cytosolic phospholipase a 2 1 in mouse lung fibroblasts mammalian patatin domain containing proteins: a family with diverse lipolytic activities involved in multiple biological functions recent progress in phospholipase a 2 research: from cells to animals to humans a novel cytosolic calcium-independent phospholipase a 2 contains eight ankyrin motifs multiple splice variants of the human calcium-independent phospholipase a 2 and their effect on enzyme activity cyclooxygenase-2 mediated oxidation of 2-arachidonoyl-lysophospholipids identifies unknown lipid signaling pathways activation of mitochondrial calcium-independent phospholipase a 2 . (ipla 2 .) by divalent cations mediating arachidonate release and production of downstream eicosanoids identification of an insulin-regulated lysophospholipase with homology to neuropathy target esterase evidence that mouse brain neuropathy target esterase is a lysophospholipase genetic ablation of calcium-independent phospholipase a 2 . prevents obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and increased adipocyte fatty acid oxidation loss of function variants in human pnpla8 encoding calcium-independent phospholipase a 2 . recapitulate the mitochondriopathy of the homologous null mouse loss-offunction mutations in pnpla6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in gordon holmes syndrome mutations in pnpla6 are linked to photoreceptor degeneration and various forms of childhood blindness impairment of park14-dependent ca 2d signalling is a novel determinant of parkinson's disease male mice that do not express group via phospholipase a 2 produce spermatozoa with impaired motility and have greatly reduced fertility fat mobilization in adipose tissue is promoted by adipose triglyceride lipase defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase adipose triglyceride lipase contributes to cancer-associated cachexia the g 0 /g 1 switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase atgl-mediated fat catabolism regulates cardiac mitochondrial function via ppar-, and pgc-1 lipolysis -a highly regulated multienzyme complex mediates the catabolism of cellular fat stores biochemistry and pathophysiology of intravascular and intracellular lipolysis genetic variation in pnpla3 confers susceptibility to nonalcoholic fatty liver disease chronic overexpression of pnpla3 i148m in mouse liver causes hepatic steatosis a feedforward loop amplifies nutritional regulation of pnpla3 identification of a novel keratinocyte retinyl ester hydrolase as a transacylase and lipase neutral lipid stores and lipase pnpla5 contribute to autophagosome biogenesis has a crucial role in skin barrier function by directing acylceramide biosynthesis pnpla1 is a transacylase essential for the generation of the skin barrier lipid b-o-acylceramide intracellular pafacetylhydrolase type i intracellular plateletactivating factor acetylhydrolase, type ii: a unique cellular phospholipase a 2 that hydrolyzes oxidatively modified phospholipids brain acetylhydrolase that inactivates plateletactivating factor is a g-protein-like trimer targeted disruption of intracellular type i platelet activating factor-acetylhydrolase catalytic subunits causes severe impairment in spermatogenesis protection against oxidative stress-induced hepatic injury by intracellular type ii platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo antiinflammatory properties of a platelet-activating factor acetylhydrolase inhibition of lipoprotein-associated phospholipase a 2 reduces complex coronary atherosclerotic plaque development phospholipase a 2 inhibitors in atherosclerosis: the race is on deficiency of phospholipase a 2 group 7 decreases intestinal polyposis and colon tumorigenesis in apc min/d mice lysosomal phospholipase a 2 is selectively expressed in alveolar macrophages lysosomal phospholipase a 2 and phospholipidosis role for lysosomal phospholipase a 2 in inkt cell-mediated cd1d recognition lysosomal phospholipase a 2 : a novel player in host immunity to mycobacterium tuberculosis generation of n-acylphosphatidylethanolamine by members of the phospholipase a/acyltransferase adpla ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency pla2g16 phospholipase mediates gain-of-function activities of mutant p53 lrat-specific domain facilitates vitamin a metabolism by domain swapping in hrasls3 interaction of phospholipase a/ acyltransferase-3 with pex19p: a possible involvement in the down-regulation of peroxisomes represents a switch between entry and clearance of picornaviridae in vivo metabolite profiling as a means to identify uncharacterized lipase function: recent success stories within the alpha beta hydrolase domain (abhd) enzyme family metabolomics annotates abhd3 as a physiologic regulator of mediumchain phospholipids abhd4 regulates multiple classes of n-acyl phospholipids in the mammalian central nervous system the serine hydrolase abhd6 controls the accumulation and efficacy of 2-ag at cannabinoid receptors the serine hydrolase abhd6 is a critical regulator of the metabolic syndrome the endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase , mediates retrograde suppression of synaptic transmission fever is mediated by conversion of endocannabinoid 2-arachidonoylglycerol to prostaglandin e 2 immunomodulatory lysophosphatidylserines are regulated by abhd16a and abhd12 interplay abhd12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease pharc adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by cgi-58 and defective in chanarin-dorfman syndrome a new era of secreted phospholipase a 2 the roles of the secreted phospholipase a 2 gene family in immunology pancreatic phospholipase a 2 : isolation of the human gene and cdnas from porcine pancreas and human lung cloning and recombinant expression of phospholipase a 2 present in rheumatoid arthritic synovial fluid crystal structure of human group x secreted phospholipase a 2 . electrostatically neutral interfacial surface targets zwitterionic membranes structures of free and inhibited human secretory phospholipase a 2 from inflammatory exudate protection against diet-induced obesity and obesity-related insulin resistance in group 1b pla 2 -deficient mice group 1b phospholipase a 2 -mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia the phospholipase a 2 inhibitor methyl indoxam suppresses diet-induced obesity and glucose intolerance in mice group 1b phospholipase a 2 inactivation suppresses atherosclerosis and metabolic diseases in ldl receptor-deficient mice linkage and potential association of obesity-related phenotypes with two genes on chromosome 12q24 in a female dizygous twin cohort phospholipase a 2 -a mediator between proximal and distal effectors of inflammation a natural disruption of the secretory group ii phospholipase a 2 gene in inbred mouse strains the secretory phospholipase a 2 gene is a candidate for the mom1 locus, a major modifier of apc min -induced intestinal neoplasia mobilization of potent plasma bactericidal activity during systemic bacterial challenge. role of group iia phospholipase a 2 staphylococcus aureus adenosine inhibits spla 2 -iia-mediated host killing in the airways platelets release mitochondria serving as substrate for bactericidal group iia-secreted phospholipase a 2 to promote inflammation dual roles of group iid phospholipase a 2 in inflammation and cancer critical role of phospholipase a 2 group iid in age-related susceptibility to severe acute respiratory syndrome-cov infection expression and function of group iie phospholipase a 2 in mouse skin the adipocyte-inducible secreted phospholipases pla2g5 and pla2g2e play distinct roles in obesity on the diversity of secreted phospholipases a 2 . cloning, tissue distribution, and functional expression of two novel mouse group ii enzymes the functions of five distinct mammalian phospholipase a 2 s in regulating arachidonic acid release. type iia and type v secretory phospholipase a 2 s are functionally redundant and act in concert with cytosolic phospholipase a 2 regulation of delayed prostaglandin production in activated p388d1 macrophages by group iv cytosolic and group v secretory phospholipase a 2 s transgenic expression of group v, but not group x, secreted phospholipase a 2 in mice leads to neonatal lethality because of lung dysfunction group v secretory phospholipase a 2 is involved in macrophage activation and is sufficient for macrophage effector functions in allergic pulmonary inflammation group v secretory phospholipase a 2 modulates phagosome maturation and regulates the innate immune response against candida albicans a novel anti-inflammatory role for secretory phospholipase a 2 in immune complexmediated arthritis group v phospholipase a 2 in bone marrowderived myeloid cells and bronchial epithelial cells promotes bacterial clearance after escherichia coli pneumonia group x secreted phospholipase a 2 proenzyme is matured by a furin-like proprotein convertase and releases arachidonic acid inside of human hek293 cells group x phospholipase a 2 is released during sperm acrosome reaction and controls fertility outcome in mice importance of group x-secreted phospholipase a 2 in allergen-induced airway inflammation and remodeling in a mouse asthma model key role of group v secreted phospholipase a 2 in th2 cytokine and dendritic celldriven airway hyperresponsiveness and remodeling lack of group x secreted phospholipase a 2 increases survival following pandemic h1n1 influenza infection novel human secreted phospholipase a 2 with homology to the group iii bee venom enzyme cellular arachidonate-releasing function of novel classes of secretory phospholipase a 2 s (groups iii and xii) group iii secreted phospholipase a 2 regulates epididymal sperm maturation and fertility in mice mast cell maturation is driven via a group cloning and recombinant expression of a structurally novel human secreted phospholipase a 2 novel mammalian group xii secreted phospholipase a 2 lacking enzymatic activity hepatocyte nuclear factor-4, regulates liver triglyceride metabolism in part through secreted phospholipase a 2 gxiib biochemistry and physiology of mammalian secreted phospholipases a 2 deficiency of phospholipase a 2 receptor exacerbates ovalbumin-induced lung inflammation circulating levels of secretory type ii phospholipase a 2 predict coronary events in patients with coronary artery disease thrombospondin type-1 domain-containing 7a in idiopathic membranous nephropathy efficient phagocytosis requires triacylglycerol hydrolysis by adipose triglyceride lipase desnutrin/ atgl activates ppar/ to promote mitochondrial function for insulin secretion in islet o cells patatin-like phospholipase domain-containing protein 3 is involved in hepatic fatty acid and triglyceride metabolism through x-box binding protein 1 and modulation of endoplasmic reticulum stress in mice patatin-like phospholipase domain-containing 3/ adiponutrin deficiency in mice is not associated with fatty liver disease brainspecific deletion of neuropathy target esterase/ swisscheese results in neurodegeneration group vib calcium-independent phospholipase a 2 (ipla 2 .) regulates platelet activation, hemostasis and thrombosis in mice mitochondrial dysfunction and reduced prostaglandin synthesis in skeletal muscle of group vib ca 2d -independent phospholipase a 2 .-deficient mice mice deficient in group vib phospholipase a 2 (ipla 2 .) exhibit relative resistance to obesity and metabolic abnormalities induced by a western diet genetic ablation of calcium-independent phospholipase a 2 . leads to alterations in hippocampal cardiolipin content and molecular species distribution, mitochondrial degeneration, autophagy, and cognitive dysfunction genetic ablation of calcium-independent phospholipase a 2 . leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype smooth muscle cell arachidonic acid release, migration, and proliferation are markedly attenuated in mice null for calcium-independent phospholipase a 2 o age-related changes in bone morphology are accelerated in group via phospholipase a 2 (ipla 2 o)-null mice neuroaxonal dystrophy caused by group via phospholipase a 2 deficiency in mice: a model of human neurodegenerative disease group via phospholipase a 2 in both host and tumor cells is involved in ovarian cancer development platelet-activating factor and metastasis: calciumindependent phospholipase a 2 o deficiency protects against breast cancer metastasis to the lung loss of pafah1b2 reduces amyloid-o generation by promoting the degradation of amyloid precursor protein c-terminal fragments paf-ah catalytic subunits modulate the wnt pathway in developing gabaergic neurons increase of smooth muscle cell migration and of intimal hyperplasia in mice lacking the ,/o hydrolase domain containing 2 gene age-related pulmonary emphysema in mice lacking ,/o hydrolase domain containing 2 gene skin barrier development depends on cgi-58 protein expression during late-stage keratinocyte differentiation growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (cgi-58) /o-hydrolase domain 6 deletion induces adipose browning and prevents obesity and type 2 diabetes platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase a 2 -iia secreted phospholipases a 2 are intestinal stem cell niche factors with distinct roles in homeostasis, inflammation, and cancer secretory group v phospholipase a 2 regulates acute lung injury and neutrophilic inflammation caused by lps in mice group v secretory phospholipase a 2 promotes atherosclerosis: evidence from genetically altered mice group v secretory phospholipase a 2 plays a pathogenic role in myocardial ischaemia-reperfusion injury group v secretory phospholipase a 2 enhances the progression of angiotensin ii-induced abdominal aortic aneurysms but confers protection against angiotensin ii-induced cardiac fibrosis in apoe-deficient mice group x secretory phospholipase a 2 regulates insulin secretion through a cyclooxygenase-2-dependent mechanism group x secretory phospholipase a 2 enhances tlr4 signaling in macrophages group x secreted phospholipase a 2 limits the development of atherosclerosis in ldl receptor-null mice group x secretory phospholipase a 2 augments angiotensin ii-induced inflammatory responses and abdominal aortic aneurysm formation in apoe-deficient mice group x secretory pla 2 in neutrophils plays a pathogenic role in abdominal aortic aneurysms in mice mutations cause autosomal recessive congenital ichthyosis in golden retriever dogs and humans the gene encoding adipose triglyceride lipase (pnpla2) is mutated in neutral lipid storage disease with myopathy neuropathy target esterase gene mutations cause motor neuron disease genetic associations of nonsynonymous exonic variants with psychophysiological endophenotypes genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi lipoprotein-associated phospholipase a 2 adds to risk prediction of incident coronary events by c-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern germany tagging-snp haplotype analysis of the secretory pla 2 iia gene pla2g2a shows strong association with serum levels of spla 2 iia: results from the udacs study phospholipase a 2 group iia expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis a novel polymorphism in secretory phospholipase a 2 -iid is associated with body weight loss in chronic obstructive pulmonary disease phospholipase a 2 group iii and group x have opposing associations with prognosis in colorectal cancer a gene involved in oxidative stress induced death, is associated with alzheimer's disease tagging snp haplotype analysis of the secretory pla 2 -v gene, pla2g5, shows strong association with ldl and oxldl levels, suggesting functional distinction from spla 2 -iia: results from the udacs study biallelic mutations in pla2g5, encoding group v phospholipase a 2 , cause benign fleck retina key: cord-287670-z6ckhkgg authors: magrini, elena; mantovani, alberto; garlanda, cecilia title: the dual complexity of ptx3 in health and disease: a balancing act? date: 2016-06-30 journal: trends in molecular medicine doi: 10.1016/j.molmed.2016.04.007 sha: doc_id: 287670 cord_uid: z6ckhkgg the humoral arm of innate immunity is complex and includes various molecules that serve as markers of inflammation with complementary characteristics, such as the short pentraxins c-reactive protein (crp) and serum amyloid p (sap) and the long pentraxin ptx3. there is a growing amount of evidence – including mouse and human genetics – that suggests that ptx3 is essential in conferring host resistance against selected pathogens and, moreover, that it plays a dual antagonistic role in the regulation of inflammation. dissection of such a yin-and-yang role of pentraxins in immunity and inflammation is timely and significant as it may pave the way for better clinical exploitation against various diseases. the dual complexity of ptx3 in health and disease: a balancing act? elena magrini, 1 alberto mantovani, 1,2, * and cecilia garlanda 1 the humoral arm of innate immunity is complex and includes various molecules that serve as markers of inflammation with complementary characteristics, such as the short pentraxins c-reactive protein (crp) and serum amyloid p (sap) and the long pentraxin ptx3. there is a growing amount of evidenceincluding mouse and human geneticsthat suggests that ptx3 is essential in conferring host resistance against selected pathogens and, moreover, that it plays a dual antagonistic role in the regulation of inflammation. dissection of such a yin-andyang role of pentraxins in immunity and inflammation is timely and significant as it may pave the way for better clinical exploitation against various diseases. the innate immune response is the first line of defense against invading microbes and tissue damage and comprises both a cellular and a humoral arm. sensing of microbes and tissue injury through pattern recognition molecules (prms) (see glossary) triggers a complex response in the organism that includes the production of inflammatory cytokines, the activation of the acute phase response, and leukocyte recruitment and polarization [1, 2] . this response has general significance in defense and orchestration of tissue repair; however, it is potentially part of the pathogenic mechanisms associated with the original cause of a particular diseasefor instance, in sepsis or in chronic inflammatory diseases such as arthritis. the cellular arm of innate immunity comprises cell-associated prms located in different cellular compartments (plasma membrane, endosomes, cytoplasm) belonging to different molecular classes, such as the toll-like receptors (tlrs), the nucleotide-binding oligomerization domain (nod), and rig-like receptors, as well as the scavenger receptors. the humoral arm of innate immunity includes biochemically heterogeneous molecules such as the classic short pentraxins crp) and sap, the long pentraxin ptx3, complement recognition molecules such as c1q and ficolins, and the collectins. the activation of such molecules represents an important component of the host response against invading microbes or tissue injury [3] . these fluid-phase prms harbor antibody-like properties, recognizing microbial moieties, exhibiting opsonic activity, and activating and regulating the complement cascade [4] , as well as interacting with extracellular matrix (ecm) components [5] . the expression of humoral prms is induced following infection or injury in various cell types and with different kinetics, thus providing a continuous presence of these molecules both in the circulation and in tissues [3] . the liver supports the expression and production of short pentraxins systemically. other cell types, particularly macrophages, dendritic cells (dcs), and endothelial cells (ecs), produce ptx3 in a gene expression-dependent fashion [4] . finally, neutrophils act as a reservoir of ready-made ptx3, rapidly released within minutes to sites where tissue damage or microbial stimulation are occurring, thus representing a primary source of soluble prms [6] . the long pentraxin ptx3 is an essential component of humoral innate immunity and plays a role in the regulation of inflammation. ptx3 has complex effects on the vasculature, including an interaction with the angiogenic growth factor fgf2 and the regulation of vessel wall tone. by modulating complement-driven inflammation, ptx3 acts as an oncosuppressor gene in mice and selected human tumors. by interacting with provisional matrix components, ptx3 contributes to the orchestration of wound healing and tissue repair/remodeling. ptx3 and the related pentraxins creactive protein (crp) and serum amyloid p (sap) can exert dual roles in inflammation and antimicrobial resistance, by either exerting a protective function or amplifying tissue damage. dissection of the yin-yang role of pentraxins in immunopathology may pave the way towards better exploitation of these molecules as envisaged disease markers and candidate therapeutic agents. the rapid production of pentraxins at the systemic level or within tissues has been shown to correlate with the severity of various clinical conditions, such as cardiovascular diseases [7] [8] [9] . this in turn appears to sustain their high levels of expression and consequently has often raised the question of their precise role in a given disease: are they simple markers, innocent bystanders, or players in disease pathogenesis [7] [8] [9] ? in particular, crp is a widely used biomarker of inflammation in humans; however, lack of strict evolutionary conservation between mouse and human has precluded the use of straightforward genetic approaches to explore its functions in vivo [10, 11] . by contrast, gene-targeted mice have allowed us to define the role of ptx3 in innate immunity and inflammation as a predecessor to antibody functions and an active player in tissue remodeling [5, [12] [13] [14] . even if most animal studies on the long pentraxin ptx3 are supported by human genetic findings suggesting that ptx3 is important in conferring host resistance to infection [15, 16] , a prevalent concept has surfaced: depending on the disease context, the cellular source, or the levels of protein released, ptx3 may contribute to disease pathogenesis [12, [17] [18] [19] . consequently, this review focuses on the multifaceted and yin-yang role of ptx3 in humoral innate immunity, microbial defense, and regulation of inflammation as well as in tissue remodeling and repair. this concept is presented at an exciting moment, when key players in innate immunity, the pentraxins, have emerged as being capable of exerting potential contradictory roles in health and disease. this is an opportune time to begin making a greater effort to elucidate the exact roles of ptx3 in disease pathogenesis and to better dissect its precise mechanisms of action in a context-specific manner. pentraxins are conserved multimeric proteins characterized by the presence of a conserved eight-amino-acid sequence, the 'pentraxin domain', in their carboxy terminus [4] . based on the primary structure of the protomer, pentraxins have been divided into short pentraxins, including crp and sap, and long pentraxins, such as the prototype long pentraxin ptx3 [4] . crp and sap are approximately 25-kda proteins organized in five identical subunits arranged with pentameric radial symmetry [3, 4] . crp and sap are the main acute phase proteins produced by human and murine liver, respectively [3] . they act as players in the innate immune response by regulating the complement system, recognizing pathogens, and interacting with fcg receptors (fcgrs), thus favoring cytokine secretion and phagocytosis of microorganisms by immune cells [20] . ptx3 was the first long pentraxin identified [4] , followed by other long pentraxins including guinea pig apexin, neuronal pentraxin (np) 1, np2, neuronal pentraxin receptor (npr), and ptx4 [21] . the gene encoding ptx3 is localized to chromosome 3 in humans and mice and comprises three exons encoding the leader signal peptide, the n-terminal domain, and the c-terminal pentraxin domain [4] . the expression of ptx3 is mainly induced by inflammatory stimuli such as inflammatory cytokines [tumor necrosis factor alpha (tnf/) and il-1b] and damage-associated molecular patterns (damps) or microbial moieties. in particular, il-1 is a major inducer of local ptx3 production in sterile tissue damage, such as in mouse models of acute myocardial infarction and in 3-methylcholanthrene (3-mca)-induced carcinogenesis [12, 22] . in skin-wound healing, tlr sensing and il-1 amplification are involved in the expression and production of ptx3 [5] . in urinary tract infections (utis) mediated by uropathogenic escherichia coli (upec), ptx3 production by human and murine uroepithelial cells has been shown to be under the control of the tlr4/myd88 signaling pathway [14] . accordingly, the human and murine ptx3 gene promoters have potential binding sites for many inflammatory transcription factors, including pu.1, ap-1, nf-kb, sp-1, and nf-il-6 [23, 24] . the pi3k/akt axis and jnk have also been shown to activate ptx3 transcription [14] . in addition, epigenetic mechanisms have been implicated in the regulation of human ptx3 expression, since methylation of a ptx3 glossary arthritogenic alphaviruses: include viruses such as chikv and rrv. they are enveloped, positive-sense, single-stranded rna viruses that are usually transmitted by mosquitoes and cause rheumatic disease. c1q: subcomponent of complement c1. c1q has binding sites for antibodies and initiates the complement cascade via the classical pathway. collectins: oligomeric proteins containing a c-terminal carbohydrate recognition domain linked to a collagen-like region through an alphahelical hydrophobic neck region and an n-terminal region. they have the capacity to interact with carbohydrates and lipids exposed on pathogen surfaces. they also bear opsonic activity and can activate the lectin pathway of the complement system. complement cascade: a multimolecular biologic process sustained by more than 20 proteins. these molecules act in concert and in a specific sequence called the complement cascade. three different pathways (i.e., the classical pathway, alternative pathway, and lectin pathway) can be activated. the terminal pathway of the complement cascade leads to the formation of a membrane-attack complex on target surfaces, which induces cell lysis. conidia: also called chlamidospores or mitospores; asexual, nonmotile spores of a fungus. they develop at the tip of specialized hyphae in fungi called conidiophores and are formed by the abstriction at the top of a hyphal branch. this process induces the separation and release of a mature spore by the formation of a septum. cumulus cells: a cluster of cells forming the cumulus oophorus, which is a follicular mass surrounding the oocyte in the ovarian follicle. damage-associated molecular patterns (damps): also known as danger-associated molecular patterns or endogenous alarmins; host cellderived molecules released by stressed cells and necrotic cells (e.g., hmgb1, il-1/). damps can engage receptors (e.g., tlrs) to induce and sustain the inflammatory response. fcg receptors (fcgrs): receptors for the fc (tail) region of igg. based on their structure, they comprise fcgri (cd64), fcgrii (cd32), and fcgriii (cd16). fcgrs participate in the regulation of the immune response. besides their capacity to recognize igg, fcgrs can act as receptors for opsonins (e.g., pentraxins). m2-like polarization: in response to external signals, macrophages can undergo m1 activation (also called classical activation) on stimulation by tlr ligands and ifng or m2 activation (also called alternative activation) on stimulation by il-4/il-13. the m2 or m2-like polarization state has been associated with high production of il-10, low production of il-12, and resolution or smoldering of chronic inflammation. neutrophil extracellular traps (nets): extracellular fibrillary networks formed and released by activated neutrophils. nets comprise dna and histones and contain a set of proteins from neutrophil granules (e.g., mpo, neutrophil elastase, ptx3). nets have the capacity to trap microbes and favor their elimination. nucleotide-binding oligomerization domain (nod) and rig-like receptors: intracellular sensors of microbial moieties and damps associated with cell stress or viruses, respectively. opsonic activity: opsonization is a process by which a molecule (i.e., opsonin) interacts with microbes leading to facilitated microbial recognition and elimination by phagocytosis. pattern recognition molecules (prms): a set of germline-encoded receptors used to discriminate selfversus non-self and modified-self antigens. based on their localization, prms have been divided into cellassociated receptors (e.g., tlrs) and soluble molecules (e.g., collectins, pentraxins). restenosis: common adverse event in endovascular procedures; involves the recurrence of narrowing of a blood vessel, usually an artery. toll-like receptors (tlrs): a family of prms characterized by an extracellular leucine-rich domain and a cytoplasmic domain sharing homology with the receptor for il-1 and the toll protein of drosophila. tlrs are cell-associated molecules located in cytoplasmic membranes or in the membranes of endosomal vesicles. they sense molecules in extracellular compartments and in the lumen of endosomal vesicles. enhancer and a ptx3 promoter has been deemed responsible of ptx3 gene silencing in human colorectal and esophageal cancer cell lines [12] . the protein is a multimer with a complex quaternary structure comprising two tetramers linked by interchain bridges to form an octamer of 340 kda. the protomer comprises 381 amino acids including a 17-amino-acid signal peptide, an n-terminal domain unrelated to any known protein, and a c-terminal pentraxin domain homologous to the short pentraxins crp and sap [25] . a single n-glycosylation site localized in the c-terminal domain at asn220 is occupied by corefucosylated and sialylated complex-type oligosaccharides [26] , which have been shown to modulate the interaction of human ptx3 with complement components such as human c1q [26] , factor h [27] , and ficolin-1 [28] and to be required for influenza virus recognition [29] and binding to the human and murine adhesion molecule p-selectin in vitro and in vivo [30] . various cell types, including dcs, monocytes, macrophages, epithelial cells, ecs, fibroblasts, and adipocytes, produce ptx3 on stimulation with inflammatory cytokines (e.g., tnf/, il-1b), tlr agonists and microbial moieties [e.g., lipopolysaccharide (lps), klebsiella pneumoniae outer membrane protein a (kpompa), other pathogens such as upec and fungal aspergillus fumigatus] [14] ( figure 1 ). neutrophils store ptx3 in specific granules and rapidly release it on encounter with microorganisms or on cell stimulation due to infection, such as in aspergillosis, or with sterile tissue damage, as in the case of human acute myocardial infarction [6, 31] . ptx3 ɵssue damage tlr agonists, inflammatory cytokines (il-1, tnf) ... mrna is transcribed only in myeloid precursors (promyelocytes and myelocytes/metamyelocytes) and not in resting mature cells in mice and humans [6] . the binding of ptx3 to select microorganisms, including bacteria, fungi, and viruses, leads to the activation of various antimicrobial effector mechanisms [3] (figures 1 and 2 ). in addition, ptx3 behaves as an immunoregulatory molecule; it can interact with p-selectin, which results in the modulation of neutrophil recruitment, but it can also interact with components of the complement cascade and tune complement activation [30, 32] . during infection, such as in the case of human sepsis, ptx3 blood levels rapidly increase from approximately 2 ng/ml to 200-800 ng/ml, correlating with both infection and disease severity and predicting patient survival [16, [33] [34] [35] [36] ( figure 1 ). importantly, although ptx3 has long been demonstrated to exert a protective role during microbial infections, it has now emerged as a potential player in contributing to immunopathology under specific circumstances. for instance, in vitro specific binding of ptx3 to fungal components has been observed for a. fumigatus [37] , paracoccidioides brasiliensis, and zymosan [38] . in particular, in vivo studies have revealed that global ptx3-deficient mice are more susceptible to a. fumigatus infection due to defective recognition of conidia by alveolar macrophages and dcs and to the induction of an impaired t helper (th) 1 lymphocyte response [37] . intravenous (i.v.) or intraperitoneal (i.p.) treatment with recombinant ptx3 alone or in combination with antifungal agents such as amphotericin b or voriconazole has resulted in therapeutic outcomes such as the reduction of fungal burden in murine and rat models of pulmonary aspergillosis [6, 37, 39, 40] and by favoring phagocytosis. ptx3 is stored in neutrophil granules and in response to microbial recognition has been found in human neutrophil extracellular traps (nets), suggesting that ptx3 is involved in the antimicrobial activity of nets [6] . in this same study, the recognition and elimination of a. fumigatus conidia by ptx3-deficient neutrophils was poorly efficient, but opsonization of conidia by ptx3 reversed this phenotype [6, 39] . furthermore, neutrophil adoptive transfer protected ptx3-deficient mice from aspergillosis and reduced fungal burden, revealing that neutrophil-associated ptx3 exerted major control of a. fumigatus infection [6] . ptx3 has also been reported to increase recognition and phagocytosis of microbes in an fcgriiand complement-dependent manner, as evidenced from studies with c1q-, c3-, and fcgrdeficient mice that displayed impaired phagocytosis of conidia [39] . in particular, the binding of ptx3-opsonized conidia to fcgrii (which acts as a pentraxin receptor) [20] induced inside-out activation of cd11b, resulting in facilitated phagocytosis of c3b-opsonized conidia by human neutrophils [39] . in addition, other in vitro studies have also shown that the interaction and heterocomplex formation of ptx3 with ficolin-2, and, of ptx3 with mannose-binding lectin (mbl) on fungal surfaces, could increase complement deposition on the same surfaces of a. fumigatus and candida albicans, respectively [41, 42] . zymosan has also been shown to induce the expression of ptx3 in mouse peritoneal macrophages in vitro [38] . ptx3, in turn, by binding to zymosan particles as well as to the yeast form of p. brasiliensis, was found to induce their aggregation and phagocytosis by macrophages (in high numbers) through a dectin-1-dependent mechanism, as demonstrated using blocking anti-dectin-1 antibodies [38] . moreover, snps and haplotypes in the human ptx3 gene have been associated with high susceptibility to invasive aspergillosis following allogeneic hematopoietic stem-cell transplantation [43] . since then, a link between ptx3 genetic variants and susceptibility to mold infections has been confirmed for more than 1000 patients in the swiss organ transplantation cohort [44] as well as in a small cohort of lung transplantation patients [45] . this indicates that the results obtained with ptx3 in mouse models of fungal infections can be translated to human scenarios. ptx3 can also bind various bacteria, including pseudomonas aeruginosa, klebsiella pneumoniae, neisseria meningitidis, and upec [13, 14, 37, 39, 46] . in particular, ptx3 has been reported to behave as an opsonin of p. aeruginosa and upec, facilitating their recognition and ingestion by human and mouse phagocytes [14, 39] (figure 2 ). accordingly, in acute and chronic models of p. aeruginosa lung infection in mice ptx3 has exhibited therapeutic outcomes such as reduced bacterial burden and inflammation [47, 48] . in addition, in utis, uroepithelial cells have been found to rapidly express ptx3 in response to upec infection in mice and humans, with ptx3 augmenting phagocytosis by, and phagosome maturation in, peripheral blood neutrophils [14] . in agreement with these findings, global ptx3-deficient mice displayed a defective capacity to clear bacteria concomitant with an exacerbated inflammatory response, as evidenced by increased production of inflammatory mediators and leukocyte recruitment in the urinary tract [14] . ptx3 binds to outer membrane vesicles (omvs) from n. meningitidis and to three selected meningococcal molecules (gna0667, gna1030, and gna2091) [13] . moreover, global ptx3deficient mice have shown a defective antibody response in vaccination protocols using n. meningitidis omv, while coadministration of ptx3 was found to increase antibody responses relative to controls. importantly, administration of ptx3 reversed the defective humoral responses to vaccination with omv of ptx3-deficient mice but also protected infant rats from infection when they were challenged with n. meningitidis [13] . these results indicate that even if a direct effect of ptx3 in adaptive immune responses has not been described so far, the ptx3dependent facilitated recognition of microbial components by antigen-presenting cells results in improved adaptive immune responses. the relevance in humans of the results obtained in bacterial infection animal models has been confirmed by several genetic studies showing a clear association between specific ptx3 genetic variants and augmented susceptibility to mycobacterium tuberculosis pulmonary infection [49] , acute pyelonephritis and cystitis [14] , or p. aeruginosa lung infection in cystic fibrosis patients [50] . regarding viral infections, ptx3 has been proposed to play a protective role in defense against viruses such as human and murine cytomegalovirus (cmv) and influenza virus type a (iva) [29, 51] (figure 2 ). increased susceptibility to cmv infection and to specific strains of influenza virus infections have been observed in global ptx3 à/à mice [29, 51] . in these cases, ptx3 was found to exert a protective role in the host by binding human and murine cmv, which reduced viral entry into permissive cells and dcs and induced interferon regulatory factor 3 (irf3) activation in in vitro experiments [51] . accordingly, intraperitoneal injection of ptx3 resulted in therapeutic efficacy against primary cmv infection and cmv reactivation in hematopoietic stem-cell transplantation experiments in mice, as indicated by the observed reduced viral load and tissue damage and increased animal survival [51] . ptx3 also recognizes specific strains of h3n2-subtype iav by interacting with viral envelope hemagglutinin and neuraminidase glycoproteins through a sialic acid residue on its glycosidic moiety [29] . in this manner, human and murine ptx3 were shown to act as 'receptor decoys' for the virus, preventing viral spread and infection by specific iav strains [29] . in line with these data, ptx3 à/à animals were more susceptible to h3n2 infection than wild-type mice and administration of ptx3 resulted in a protective effect, as evidenced by increased survival and reduced viral burden [29] . by contrast, ptx3 did not result in antiviral effects against seasonal or pandemic h1n1 and other h3n2 iav strains because specific amino acid residues of individual viral ha sequences led to a lack of interacting ability with the sialylated residue of ptx3 [52,53]. hence, these data suggested selective pressures on ha leading to viral escape from the neutralizing activity of ptx3. another study has reported that ptx3 exerts a protective role in defense against coronavirus murine hepatitis virus strain 1 (mhv-1) in vitro and in vivo [54] . ptx3 was shown to bind to mhv-1 with resulting reduced infectivity of cells in culture. in the same study, global ptx3-deficient mice were more susceptible than their wild-type counterparts to mhv-1 infection [54]. administration of ptx3 led to protection against mhv-1, because reduced lung injury and inflammation and accelerated viral clearance were observed [54]. although collectively these results have demonstrated a protective role of ptx3 during microbial invasion, there are other studies where ptx3 has been found to promote immunopathology in a context-specific manner (figure 2 ). in a model of k. pneumoniae infection in mice, ptx3 overexpression was reported to play antagonistic roles depending on the bacterial concentrations used to infect animals [17] . with high bacterial loads, transgenic mice expressing multiple copies of ptx3 under the control of its own promoter displayed faster lethality, reduced lung infiltration of neutrophils, and increased bacterial dissemination in blood compared with wild-type animals [17] . by contrast, with lower k. pneumonia pulmonary inocula ptx3 overexpression conferred protection on mice by increasing the expression of proinflammatory cytokines and the recruitment of neutrophils into lung tissues and by promoting bacterial phagocytosis [17] . kpompa, a conserved major component of the outer membrane of enterobacteriaceae, is one of the few characterized microbial ptx3 ligands [46] . in the mouse air pouch and footpad swelling model, kpompa has been found to induce ptx3 production and ptx3, in turn, can amplify tlr2-dependent inflammatory responses such as leukocyte recruitment induced following kpompa recognition of the scavenger receptors lectin-like oxidized lowdensity lipoprotein receptor-1 (lox-1) and scavenger receptor expressed by ecs i (srec-i) [46] . these results suggest that k. pneumoniae-induced, amplified ptx3-dependent inflammatory responses either play protective roles for the host or might contribute to immunopathology, depending on microbial load. this underlies the relevance of balanced and finely tuned inflammatory responses and innate resistance to this type of bacterial infection (figure 2 ). although future research might further clarify whether these type of findings could be influenced by particular experimental conditions, or whether the results hold true for different pathogen infections, the fact remains that ptx3 plays a complex role in immunoregulation. furthermore, a pathogenic role of ptx3 has been demonstrated in arthritogenic alphavirus infections induced by chikungunya virus (chikv) and ross river virus (rrv) [55] (figure 2 ). for instance, the expression of ptx3 mrna in peripheral blood leukocytes and ptx3 levels in serum have been found to be increased during the acute phase of alphavirus infection both in patients and in animal models [55] . increased ptx3 expression was associated not only with enhanced viral load but also with disease severity based on temperature, pulse rate, and platelet counts [55] . a murine model of acute rrv infection revealed a delay in disease progression, as shown by increased animal strength and hind-leg paralysis as well as fast recovery in global ptx3 à/à mice compared with wild-type controls. in addition, reduced leukocyte recruitment, expression of inflammatory mediators, and viral replication were reported with ptx3 deficiency. it was proposed that this phenotype could be explained by early rrv and chikv viral entry and replication, which were promoted by the binding of ptx3 to alphavirus, through still undefined mechanisms [55] . interestingly, this suggested that ptx3 might potentially be exploited by viruses to facilitate an increase in viral entrance and replication in host cells [55] (figure 2 ). in addition to its involvement in immunoregulation, ptx3 has been implicated in various other biological processes. for instance, it has been postulated that ptx3 also contributes to tissue remodeling under physiological and inflammatory conditions ( figure 1 ). the involvement of ptx3 in physiological tissue remodeling was first identified in ptx3-deficient infertile female mice [56]. this phenotype was reported to be due to defective assembly of the hyaluronan (ha)-rich matrix that forms around oocytes in preovulatory follicles, a process that is absolutely required for fertilization in vivo [56]. ptx3 produced by cumulus cells during the preovulatory phase was found to interact through its n-terminal domain with two ha-binding proteins, tnf/-induced protein 6 (tnfaip6 or tsg-6) and the serum proteoglycan inter-/-trypsin inhibitor (i/i), which are major functional proteins of the cumulus ecm, thus providing structural integrity to the cumulus matrix [56, 57] . ptx3 is thus required to facilitate murine female fertility. ptx3 has also been found to bind various fibroblast growth factors (fgfs) via its n-terminal extension, including fgf2, fgf6, fgf8b, fgf10, and fgf17 [58] [59] [60] , inhibiting fgf-dependent ec proliferation in vitro and angiogenesis in vivo in an animal model using chick embryo chorioallantoic membranes [61] . in addition, ptx3 has been demonstrated to inhibit fgf2dependent smooth muscle cell (smc) proliferation and suppressed the mitogenic and chemotactic activity exerted by fgf2 on these cells [62] . it has been therefore suggested that ptx3 produced by ecs and inflammatory cells, which are a major source of ptx3, may affect the autocrine and paracrine activity of fgfs on endothelium and smcs, providing, in turn, a mechanism for finely tuning the neovascularization processes and restenosis of carotid arteries in rodent models of arterial balloon injury [63, 64] . additional evidence has indicated that ptx3 is involved in modulating inflammation and tissue damage in animal models of sterile injury [22, 65] . for example, in a murine model of cardiac ischemia/reperfusion injury, global ptx3 deficiency was associated with increased tissue damage and neutrophil infiltration in the myocardium [22] . since higher deposition of complement c3 was observed in the infarct area of ptx3-deficient mice relative to controls [22] , it was hypothesized that this phenotype could be attributed to the potential defective regulation of complement activation via factor h [27] . surface-bound ptx3 was found to enhance the recruitment of factor h, which retained its cofactor activity leading to c3b cleavage [27] . this indicated that ptx3 participates in the localization of functionally active factor h in sites of tissue damage [27] . moreover, ptx3-deficiency in apolipoprotein e knockout mice (apoe mice) was associated with increased atherosclerosis and macrophage accumulation within atherosclerotic plaques as well as with more pronounced inflammatory profiles in vascular walls, as revealed by the increased expression of inflammatory mediators and macrophage recruitment within plaques [65] . in addition to regulating complement, ptx3 has been reported to selectively bind p-selectin via its n-linked glycosidic moiety, thus inhibiting leukocyte rolling on endothelium and providing a negative feedback loop that prevents excessive p-selectin-dependent recruitment of neutrophils and tissue damage in murine models of acute lung injury, pleurisy, and mesenteric inflammation [30] as well as in post-ischemic acute kidney injury [66] . recently ptx3 was demonstrated to play a nonredundant role in tissue repair, through a novel mechanism [5] . in various murine models of tissue damage, including skin-wound healing, chemically induced sterile liver and lung injury and arterial thrombosis, global ptx3 deficiency was associated with increased clot formation as well as with fibrin and collagen deposition/ persistence in sites of tissue damage. under these conditions, macrophages and mesenchymal cells produced ptx3 in response to tlr activation and amplification by il-1, localizing to the pericellular matrix of macrophages and mesenchymal remodeling cells [5] . moreover, ptx3deficient mesenchymal remodeling cells exhibited defective pericellular fibrinolysis in vitro and impaired directional collective migration in the provisional fibrin-rich inflammatory matrix in mice in vivo. it was proposed that this phenotype resulted from the interaction of the ptx3 n-terminal domain with fibrin and plasminogen proteins at an acidic ph and that this occurred in vivo as a consequence of cell metabolic adaptation under conditions of tissue damage-associated hypoperfusion and hypoxia [5] . furthermore, this work argued that the tripartite interaction between ptx3, fibrin, and plasminogen at sites of tissue repair facilitated plasminogen-dependent fibrinolysis [5] . deposited fibrin in damaged tissues acts as a provisional matrix component and its timely remodeling is essential for normal tissue repair [67] . consequently, the phenotype of ptx3 à/à mice described by doni et al. [5] demonstrates that the ptx3-dependent promotion of fibrin-rich inflammatory matrix remodeling contributes to tissue repair. along the same lines, in another murine study ptx3-deficient mesenchymal stromal cells were found to be impaired in their ability to promote skin-wound healing and were also associated with defective pericellular fibrinolysis and cell migration through fibrin [68] . these studies provide further evidence of the interaction between humoral pattern recognition molecules and ecm components and underscore the evolutionary link that exists between microbial and ecm recognition in the humoral arm of innate immunity [3, 69] . regarding the involvement of ptx3 in inflammatory processes, other studies have provided interesting data. for example, in a model of mouse cardiomyocyte death resulting from coxsackievirus b3 (cvb3) viral infection, global ptx3 deficiency increased heart injury, as evidenced by increased serum creatinine kinase activity and cardiomyocyte apoptosis, albeit without affecting viral titers [70] and through a poorly defined mechanism. in this context, it was proposed that the catalytic activity of the immunoproteasome that prevents exacerbation of cvb3-induced myocardial destruction regulated the timely availability of certain factors (erk1/2 and p38) for controlling ptx3 mrna expression and protein production during the infection [70] . this suggested that the cardioprotective function of immunoproteasome-dependent ptx3 expression was a crucial mechanism of stress-induced damage response in myocardial inflammation during cvb3 viral infection [70] . from a different perspective, ptx3 has also been shown to play a protective role in various brain disorders. for example, in a murine model of limbic seizure ptx3 synthesis was induced in the brain, exerting a protective role in seizure-induced neurodegeneration as evidenced by a lower number of degenerating neurons in wild-type mice compared with ptx3-deficient mice [71] . in cerebral ischemia mouse models, ptx3 production was induced in neurons and glia, and although ptx3 deficiency did not affect acute ischemic brain injury it did, however, compromise blood-brain barrier integrity and resolution of brain edema during recovery as well as impairing glial scar formation and neurogenesis [72, 73] . thus, ptx3 has been proposed to support bloodbrain barrier integrity [74] . ptx3 induction in association with tissue damage has also been identified in other pathological contexts [70] (figure 3 , key figure) . for instance, in a mouse model of superior mesenteric artery ischemia and reperfusion, ptx3 deficiency was associated with inhibition of local and remote inflammation and tissue injury, whereas genetic ptx3 overexpression or i.v. ptx3 administration worsened tissue injury and lethality [75, 76] . accordingly, in another murine study, ptx3 overexpression resulted in increased inflammatory responses and a faster decline in a model of ventilator-induced lung injury [77] . ptx3 overexpression also led to increased hypertrophic responses and ventricular dysfunction following increased pressure overload in a murine cardiac injury model [78] . more recently, ptx3 has been found to induce mouse ec dysfunction by inhibiting acetylcholine-evoked vasorelaxation in an in vitro model of the vascular reactivity of resistance vessels and by inducing morphological changes in ecs [79] . these effects were the yin-yang of ptx3 in innate immunity, inflammation, tissue damage, and cancer reported to be mediated by a p-selectin/matrix metalloproteinase-1-dependent pathway leading to impaired phosphorylation of enos and nitric oxide production in vitro [79] . in agreement, i.v. ptx3 administration caused hypertension in wild-type animals but not in p-selectin-deficient mice [79] . these results suggest that ptx3 may have a possible direct role on blood pressure homeostasis and endothelial function. inflammation is an essential component of tumor microenvironments in cancer, sustaining tumor development and growth [80] . however, the role of the humoral arm of the innate immune system in cancer is poorly understood. various reports have associated increased plasma levels of crp with cancer risk [81] [82] [83] . furthermore, elevated local or systemic ptx3 levels have been observed for several cancers, including glioma, liposarcoma, lung cancer, prostate carcinoma, pancreatic carcinoma, and breast cancer bone metastases, that correlate with either grade of malignancy or a poor prognosis [18, [84] [85] [86] [87] [88] . gene expression profiling has identified ptx3 as one of the expressed genes associated with the stromal response/ecm signature and poor prognosis in human ovarian cancer [89] . in addition, ptx3 genetic variants have been associated with increased ptx3 plasma levels and a risk of developing hepatocellular carcinoma in hepatitis c virus-infected subjects [90] . to investigate the role of ptx3 as a marker of cancer-related inflammation and malignant transformation and/or an active player in pathogenesis, our group addressed the susceptibility of ptx3-deficient mice to mesenchymal and epithelial carcinogenesis in models of 3-mca-induced carcinogenesis and 7,12-dimethylbenz [/] anthracene/terephthalic acid (dmba/tpa)-induced skin carcinogenesis [12] . in these models global ptx3 deficiency was associated with more pronounced cancer-related inflammation relative to controls, displayed a higher number of tumor-infiltrating macrophages that showed upregulated expression of genes associated with macrophage m2-like polarization, as well as increased angiogenesis, secretion of proinflammatory cytokines, and complement activation (with increased c3 and lower factor h localization in tumor tissues in addition to higher c5a levels in tumor homogenates) [12] (figure 4) . moreover, ptx3-deficient tumors were also characterized by enhanced genetic damage as indicated by increased trp53 mutations, oxidative dna damage, and expression of dna damage markers, in line with the hypothesis that inflammation contributes to genetic events that can lead to cancer and to the genetic instability observed in tumors [91] . importantly, c3 deficiency in mice or inhibition through a blocking antibody of the chemokine ccl2 led to a reduction in tumor macrophages, an outcome that was sufficient to revert the increased susceptibility to chemically induced carcinogenesis of ptx3-deficient mice. these results indicate that, at least in mice, ptx3 exerts a protective role in carcinogenesis and that this effect is based on the regulation of complement activation [12] (figure 3 ). the potential protumoral role of the complement system has also been suggested by a recent study showing that deficiency in key components of the complement pathway (e.g., c3, c5, c5a receptor) can be linked to colitis-associated colon cancer resistance in mice [92] . however, in specific mouse models, cancer-related inflammation was found to be complement independent [93, 94] , indicating that complement activation may contribute to cancer-related inflammation depending on the tissue context and driving molecular pathways. the functional relevance of ptx3 in human cancer has been further strengthened by results showing that the ptx3 promoter and regulatory regions of the locus are highly methylated in human mesenchymal and epithelial tumors, in contrast to normal healthy tissue, and, furthermore, that such ptx3 methylation can result in silencing of ptx3 protein expression [12] . ptx3 promoter hypermethylation and reduced ptx3 expression have also been reported in human esophageal squamous cell carcinomas [95] . taken together, these studies indicate that ptx3, which is an essential component of humoral innate immunity and a regulator of complement activation, also acts as an extrinsic oncosuppressor gene in mouse and man. moreover, its oncosuppressive role appears to act at the level of complement-mediated, macrophagesustained, tumor-promoting inflammation inhibition [95] . of note, since ptx3 binds certain fgfs (i.e., fgf2, fgf8), impairing the interaction with their cognate receptors [60, 61] , ptx3 plays a protective role in inhibiting tumor growth by regulating fgf-dependent effects as well [60, 96] (figure 4 ). ptx3 overexpression, under the control of the endothelium-specific tie2/tek transcription regulatory sequences, has been associated with reduced malignant growth of fgf2-dependent mouse tramp-c2 prostate cancer and b16 melanoma as well as reduced melanoma metastasis and cancer-associated angiogenesis [96] . furthermore, ptx3 has also been shown to impair cell proliferation and epithelial-mesenchymal transition (emt) in human melanoma cells in vitro [60] . however, contrary to the reports describing a protective role of ptx3 against cancer, other studies have suggested a protumorigenic effect (figure 3 ). ptx3 has been reported to promote in vitro migration and invasion of human pancreatic tumor cells, breast carcinoma, and head and neck squamous cell carcinoma, as well as macrophage chemotaxis, by still poorly defined molecular mechanisms [82, 84, 97, 98] . in another study, ptx3 silencing was found to promote the gastric cancer cell migratory potential, the recruitment of macrophages, and their subsequent binding to gastric cancer cells [98] . in addition, the transcription factor ccaat/enhancerbinding protein delta (cebpd) was shown to activate ptx3 transcription by directly binding to its promoter region in response to cisplatin or 5-fluorouracil treatment in human and murine m2 figure 4 . ptx3 as an extrinsic oncosuppressor in cancer. in cancer, ptx3 gene and protein expression is controlled by the presence of inflammatory mediators (e.g., il-1) and/or by genetic and epigenetic mechanisms. ptx3 regulates complement-dependent tumor-promoting inflammation in a host, including macrophage infiltration and cytokine production, as well as fibroblast growth factor (fgf)-dependent angiogenesis, which can lead to genetic instability and tumor promotion. macrophages and cancer-associated fibroblasts. as a result, ptx3 was found to promote the growth, metastasis, and invasion of drug-resistant human breast cancer cells in immunodeficient mice [19] . these murine studies and the reports showing a positive correlation between ptx3 expression and poor prognosis in specific human cancers suggest that the tumor-promoting or tumorsuppressing role of ptx3 might very likely depend on tissue, cancer type, and cellular source (e.g., cancer cells versus tumor-associated macrophages or fibroblasts) and contradict the assumption that ptx3 plays a unique role in cancer (figures 3 and 4) . however, it should be emphasized that hard genetic data in mice and humans demonstrate that this molecule is a bona fide cancer gene acting as an extrinsic oncosuppressor. further research should help clarify these collective context-dependent findings. pentraxins are a phylogenetically conserved superfamily of humoral prms exerting common essential functions in innate responses to pathogens and in tissue repair. crp is a widely used biomarker of inflammation in humans. however, the lack of strict evolutionary conservation between mouse and human has precluded the use of straightforward genetic approaches to explore its functions in vivo. by contrast, gene-targeting mouse studies have allowed better definition of the functional role of ptx3 in innate immunity, inflammation, and tissue remodeling. in addition, genetic and epigenetic data are consistent with the hypothesis that ptx3 exerts similar functions in humans. from the results described here it has been inferred that, on selective binding of conserved microbial molecules, ptx3 generally exhibits protective antibodylike functions such as complement activation, opsonization of microbes, and glycosylationdependent regulation of inflammation. furthermore, studies in tissue repair models have shown that ptx3-dependent promotion of fibrin-rich inflammatory matrix remodeling contributes to tissue repair and underline the evolutionary link that exists between microbial and ecm recognition in the humoral arm of innate immunity. thus, genetic evidence in mouse and human indicates that ptx3 is essential for resistance against selected pathogens and that it also promotes tissue repair. the described findings strongly support the promising potential of ptx3 in prophylaxis and therapy against infectious diseases in specific clinical settings. of note, the regulation of complement activation also appears to be an essential mechanism of action for the oncosuppressive role of ptx3 that has been recently described, suggesting that novel therapeutic approaches could be envisioned. however, several issues remain (see outstanding questions). for example, it is important to take into account that ptx3 could potentially lead to harmful consequences in an organism under certain circumstances. consequently, when considering the exploitation of ptx3 by viruses (such as alphaviruses) to facilitate viral entry into host cells [55] (figures 2 and 3) , the interaction of ptx3 with collectins and ficolins, which can lead to potent synergic complement activation [32] , as well as its potential to induce endothelial dysfunction [79] and inflammation [19, 76] ( figure 3 ), future clinical trials involving ptx3 administration (or blockade) should carefully assess the possibility of generating unbalanced inflammatory responses and other adverse clinical outcomes. finally, a call is made to strive to achieve a better understanding of the multiple mechanistic pathways in which ptx3 is involved. deciphering more clearly the multifaceted functional roles of ptx3 in physiology may facilitate the development of targeted therapeutic approaches in various clinical conditions. the . what is the impact of ptx3 as a genetic or circulating protein marker on disease management for specific clinical conditions? in what immediate conditions can ptx3 be assessed? what is the mechanistic basis of the oncosuppressive role of ptx3 in various forms of cancer? does ptx3 play differential or redundant roles in diverse forms of cancer? what is the role of complement in carcinogenesis and human cancer? what is the role of ptx3 in antiviral resistance? what impact does it have in mediating antiviral defense versus facilitating viral entry? for which different types of virus does ptx3 facilitate viral entry? what is the therapeutic potential of ptx3 in specific microbial infections (e.g., aspergillus fumigatus, pseudomonas aeruginosa)? what is the mechanistic basis for the observed antagonistic effects of ptx3 in response to varying bacterial burdens during an infection and is there a threshold? would this phenomenon apply to different pathogens? is there an underlying functional advantage in response to these different scenarios for the host? acute-phase proteins and other systemic responses to inflammation negative regulatory receptors of the il-1 family an integrated view of humoral innate immunity: pentraxins as a paradigm pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility an acidic microenvironment sets the humoral pattern recognition molecule ptx3 in a tissue repair mode the humoral pattern recognition receptor ptx3 is stored in neutrophil granules and localizes in extracellular traps c-reactive protein and coronary heart disease: a critical review association between c reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data the long pentraxin ptx3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases targeting c-reactive protein for the treatment of cardiovascular disease transgenic human c-reactive protein is not proatherogenic in apolipoprotein e-deficient mice ptx3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer recognition of neisseria meningitidis by the long pentraxin ptx3 and its role as an endogenous adjuvant the humoral pattern recognition molecule ptx3 is a key component of innate immunity against urinary tract infection ptx3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition the long pentraxin ptx3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases dual function of the long pentraxin ptx3 in resistance against pulmonary infection with klebsiella pneumoniae in transgenic mice prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients targeting chemotherapy-induced ptx3 in tumor stroma to prevent the progression of drug-resistant cancers structural recognition and functional activation of fcgr by innate pentraxins evolution of the pentraxin family: the new entry ptx4 cardioprotective function of the long pentraxin ptx3 in acute myocardial infarction promoter structure and transcriptional activation of the murine tsg-14 gene encoding a tumor necrosis factor/interleukin-1-inducible pentraxin protein characterization of the promoter for the human long pentraxin ptx3. role of nf-kb in tumor necrosis factor-/ and interleukin-1b regulation structural characterization of ptx3 disulfide bond network and its multimeric status in cumulus matrix organization structure and function of the long pentraxin ptx3 glycosidic moiety: fine-tuning of the interaction with c1q and complement activation binding of the long pentraxin ptx3 to factor h: interacting domains and function in the regulation of complement activation m-ficolin interacts with the long pentraxin ptx3: a novel case of cross-talk between soluble pattern-recognition molecules antiviral activity of the long chain pentraxin ptx3 against influenza viruses regulation of leukocyte recruitment by the long pentraxin ptx3 early and transient release of leukocyte pentraxin 3 during acute myocardial infarction ptx3 as a paradigm for the interaction of pentraxins with the complement system pentraxins in innate immunity: from creactive protein to the long pentraxin ptx3 circulating levels of the long pentraxin ptx3 correlate with severity of infection in critically ill patients long pentraxin ptx3 is associated with mortality and disease severity in severe leptospirosis persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality non-redundant role of the long pentraxin ptx3 in anti-fungal innate immune response ptx3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages role of complement and fcg receptors in the protective activity of the long pentraxin ptx3 against aspergillus fumigatus anti-aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition ficolin-1-ptx3 complex formation promotes clearance of altered self-cells and modulates il-8 production genetic ptx3 deficiency and aspergillosis in stem-cell transplantation polymorphisms and invasive mold infections after solid organ transplant ptx3-based genetic testing for risk of aspergillosis after lung transplant complexity and complementarity of outer membrane protein a recognition by cellular and humoral innate immunity receptors the therapeutic potential of the humoral pattern recognition molecule ptx3 in chronic lung infection caused by pseudomonas aeruginosa prototypic long pentraxin ptx3 is present in breast milk, spreads in tissues, and protects neonate mice from pseudomonas aeruginosa lung infection dc-sign (cd209), pentraxin 3 and vitamin d receptor gene variants associate with pulmonary tuberculosis risk in west africans ptx3 interacts with inter-/-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion identification of an antiangiogenic fgf2-binding site in the n terminus of the soluble pattern recognition receptor ptx3 role of the soluble pattern recognition receptor ptx3 in vascular biology long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer selective recognition of fibroblast growth factor-2 by the long pentraxin ptx3 inhibits angiogenesis pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo fibroblast growth factor-2 antagonist and antiangiogenic activity of long-pentraxin 3-derived synthetic peptides anti-fgf2 approaches as a strategy to compensate resistance to anti-vegf therapy: long-pentraxin 3 as a novel antiangiogenic fgf2-antagonist deficiency of the long pentraxin ptx3 promotes vascular inflammation and atherosclerosis endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency mesenchymal stromal cell-derived ptx3 promotes wound healing via fibrin remodeling the primary role of fibrinogen-related proteins in invertebrates is defense, not coagulation the immunoproteasome controls the availability of the cardioprotective pattern recognition molecule pentraxin3 dynamic induction of the long pentraxin ptx3 in the cns after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration the acute-phase protein ptx3 is an essential mediator of glial scar formation and resolution of brain edema after ischemic injury pentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia astrocyte-derived pentraxin 3 supports blood-brain barrier integrity under acute phase of stroke the long pentraxin ptx3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury pentraxin 3 accelerates lung injury in high tidal volume ventilation in mice long pentraxin ptx3 exacerbates pressure overload-induced left ventricular dysfunction pentraxin 3 induces vascular endothelial dysfunction through a p-selectin/matrix metalloproteinase-1 pathway cancer-related inflammation c-reactive protein and risk of breast cancer: a systematic review and meta-analysis clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinoma elevated pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function pentraxin-3 is a novel biomarker of lung carcinoma antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells the long pentraxin ptx3 as a correlate of cancer-related inflammation and prognosis of malignancy in gliomas pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome genetic variation in ptx3 and plasma levels associated with hepatocellular carcinoma in patients with hcv cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability complement activation promotes colitisassociated carcinogenesis through activating intestinal il-1b/il-17a axis fcrg activation regulates inflammationassociated squamous carcinogenesis early neoplastic progression is complement independent aberrant methylation of the 3q25 tumor suppressor gene ptx3 in human esophageal squamous cell carcinoma long-pentraxin 3 derivative as a smallmolecule fgf trap for cancer therapy ptx3 gene activation in egf-induced head and neck cancer cell metastasis pentraxin-3 silencing suppresses gastric cancer-related inflammation by inhibiting chemotactic migration of macrophages key: cord-001569-jd028cyg authors: dos santos, gimena; rogel, micah r.; baker, margaret a.; troken, james r.; urich, daniela; morales-nebreda, luisa; sennello, joseph a.; kutuzov, mikhail a.; sitikov, albert; davis, jennifer m.; lam, anna p.; cheresh, paul; kamp, david; shumaker, dale k.; budinger, g. r. scott; ridge, karen m. title: vimentin regulates activation of the nlrp3 inflammasome date: 2015-03-12 journal: nat commun doi: 10.1038/ncomms7574 sha: doc_id: 1569 cord_uid: jd028cyg activation of the nlrp3 inflammasome and subsequent maturation of il-1β have been implicated in acute lung injury (ali), resulting in inflammation and fibrosis. we investigated the role of vimentin, a type iii intermediate filament, in this process using three well-characterized murine models of ali known to require nlrp3 inflammasome activation. we demonstrate that central pathophysiologic events in ali (inflammation, il-1β levels, endothelial and alveolar epithelial barrier permeability, remodelling and fibrosis) are attenuated in the lungs of vim(−/−) mice challenged with lps, bleomycin and asbestos. bone marrow chimeric mice lacking vimentin have reduced il-1β levels and attenuated lung injury and fibrosis following bleomycin exposure. furthermore, decreased active caspase-1 and il-1β levels are observed in vitro in vim(−/−) and vimentin-knockdown macrophages. importantly, we show direct protein–protein interaction between nlrp3 and vimentin. this study provides insights into lung inflammation and fibrosis and suggests that vimentin may be a key regulator of the nlrp3 inflammasome. supplementary information: the online version of this article (doi:10.1038/ncomms7574) contains supplementary material, which is available to authorized users. t he cytoskeleton comprises microfilaments, microtubules and intermediate filaments (ifs) 1 . vimentin is the most abundant if protein and has a critical role in stabilizing intracellular architecture 2 . until recently, the importance of vimentin remained elusive because vimentin knockout (vim à / à ) mice displayed a relatively normal phenotype 3 . however, a thorough characterization of vim à / à mice under stress conditions revealed prominent abnormalities [4] [5] [6] , complementing the metabolic, signalling and regulatory abnormalities displayed by patients with if-related diseases and mice expressing functional mutations in ifs 2, [7] [8] [9] [10] . recently, evidence to support a role for ifs as scaffolds for macromolecular complexes involved in critical cell signalling functions was reported 11, 12 . in this study, we demonstrate that vimentin is required for the activation of the nlrp3 (nacht, lrr and pyd domains-containing protein 3) inflammasome, a macromolecular complex that orchestrates early inflammatory responses of the innate immune system. the nlrp3 inflammasome is activated in response to a broad spectrum of infectious agents known to cause acute lung injury (ali), including the bacterial pathogens staphylococcus aureus, pseudomonas aeruginosa and mycobacterim tuberculosis [13] [14] [15] and viral pathogens such as influenza a virus 16 . the wide range of pathogens known to activate the nlrp3 inflammasome suggests that nlrp3 indirectly senses microbes by probing for hostderived danger-associated molecular patterns that are produced or released after cellular or tissue injury 17, 18 . for example, uric acid released from cells exposed to bleomycin triggers the nlrp3 inflammasome, leading to maturation of interleukin 1b (il-1b) and inflammation 19 . in both human patients and animals treated with bleomycin, il-1b released from injured cells results in production of the pro-fibrotic cytokine transforming growth factor b (tgf-b), which contributes to the development of pulmonary fibrosis 20 . in addition, exposure to crystalline particles such as asbestos and silica also cause pulmonary fibrosis 21 that is regulated by the nlrp3 inflammasome 22, 23 . the nlrp3 inflammasome must be tightly regulated to avoid deleterious effects from the wide array of pathogens, pathogenassociated molecular patterns, danger-associated molecular patterns and environmental irritants, which are known to trigger its activation. unlike other inflammasome-associated nod-like receptor (nlr) proteins, nlrp3 is expressed at very low levels in naive macrophages. activation of the nlrp3 inflammasome requires two distinct pro-inflammatory stimuli. in the first step, toll-like receptor (tlr) signalling activates nf-kb and upregulates nlrp3 and pro-il-1b 24 . the second step involves the assembly of the multiprotein complex, which induces selfcleavage of caspase-1, which in turn mediates the cleavage of pro-il-1b into its biologically active form 25 . the mechanism by which the inflammasome is ultimately activated is still a subject of intensive research. we postulate that vimentin is required for nlrp3 inflammasome assembly and activation. the experiments described below use three well-established rodent models of nlrp3 inflammasome activation and result in increased levels of biologically active il-1b that contribute to lung injury. our data suggest that the if protein vimentin may act as an additional checkpoint to control the nlrp3 inflammasome. vimentin deficiency suppresses inflammation and injury. lipopolysaccharide (lps) is a potent inducer of inflammation and a known nlrp3 inflammasome activator [26] [27] [28] . to determine whether vimentin is important in the inflammatory response, wild-type (wt) and vimentin knockout (vim à / à ) mice were subjected to a lethal dose of lps, which induces both proinflammatory cytokine expression and a systemic inflammatory response that is associated with significant mortality. wild-type mice displayed about a threefold increase in mortality compared with vim à / à mice. vim à / à mice had a median survival of 138 h, whereas wt animals had a median survival of b40 h (fig. 1a) . surviving vim à / à mice exhibited mild lethargy, coat ruffling, febrile shaking and eye watering but recovered by day 7. to study whether vimentin affects lps-induced inflammation and ali, we used a sublethal dose of lps, as previously described 29, 30 . histopathological examination showed that lungs of lps-treated wt mice had more severe alveolar damage characterized by interstitial oedema and more fluid and debris in the airspace than in lps-treated vim à / à mice (fig. 1b) . wild-type mice exposed to lps exhibited an increase in wet-todry lung weight ratio and total protein concentration in the bronchoalveolar lavage fluid (balf), whereas vim à / à mice failed to exhibit such an increase (fig. 1c,d) . exposure to lps is followed by large increases in immune cells in the airspace 29, 30 . therefore, to further characterize the nature of immune cell recruitment into the lungs, we performed a systematic flow cytometric analysis of whole-lung lysates 31 . no differences were observed in the myeloid cell population between wt and vim à / à mice treated with saline ( supplementary fig. 1a ). as expected, both wt and vim à / à mice challenged with lps had significant increases in neutrophils and moderate increases in macrophages compared with saline-treated animals ( supplementary fig. 1a ); no differences were observed between wt and vim à / à mice challenged with lps ( supplementary fig. 1a) . these data suggest that the protection from the lpsinduced increase in alveolar capillary barrier permeability observed in vim à / à mice was not associated with impaired recruitment of inflammatory cells to the lung. lps induces rapid production and release of pro-inflammatory cytokines and chemokines, which are sufficient to induce lung inflammation and ali in mice and humans 32 . when we exposed wt and vim à / à mice to lps for 24 h, significantly more caspase-1 and mature il-1b were found in balf from wt mice than in vim à / à mice (fig. 1e,f) . furthermore, whole-lung homogenates prepared from wt and vim à / à mice exposed to lps had increased levels of il-1b messenger rna (mrna, supplementary fig. 1b) . these data suggest that vimentin is not involved in the tlr-mediated nf-kb activation and upregulation of pro-il-1b and nlrp3 (refs 26-28) . rather, vimentin must be required for the second step in lps-induced caspase-1 activation and il-1b maturation via the nlrp3 inflammasome. vimentin required for asbestos-induced injury and fibrosis. the nlrp3 inflammasome has been implicated in the pathological increase of il-1b production in a variety of pulmonary inflammatory diseases that lead to fibrosis, including asbestosis [21] [22] [23] . in a model of asbestosis, we sought to determine whether vim à / à mice showed diminished cytokine production and whether these animals were protected from lung injury and pulmonary fibrosis. wild-type and vim à / à mice were exposed to crocidolite asbestos or an inert particle, titanium dioxide (tio 2 ); markers of injury, inflammation, cytokine production and fibrosis were assessed. confirming previous reports 22, 23 , asbestosexposed mice had increased total cell numbers in balf compared with tio 2 -exposed animals. however, significantly fewer cells were recruited to the lungs of vim à / à mice after asbestos exposure (fig. 2a) . additional analysis of immune cell recruitment into the lungs of wt and vim à / à mice was performed by fluorescence-activated cell sorting analysis of whole-lung lysates ( supplementary fig. 2a) . wild-type mice had profound inflammatory cell infiltrates following exposure to asbestos as observed by haematoxylin and eosin (h&e) staining; in contrast vim à / à mice showed reduced inflammation ( supplementary fig. 2b ). wild-type mice exhibited an increase in total protein concentration in balf, whereas vim à / à mice failed to exhibit such an increase (fig. 2b) . the reduction in inflammation in vim à / à mice exposed to asbestos was associated with reduced levels of caspase-1 and il-1b in balf compared with wt mice (fig. 2c,d) . these data suggest that vimentin is required for asbestos-mediated activation of the nlrp3 inflammasome (step 2), but not for nf-kb activation and upregulation of pro-il-1b and nlrp3 (step 1). furthermore, we observed that wt mice exposed to asbestos develop pulmonary fibrosis, as assessed by masson trichrome and picrosirius red stain (a dye that binds specifically to collagen fibrils, fig. 2e ) and sircol assay (fig. 2f) . vimentin deficiency prevented pulmonary fibrosis, as no significant increase in collagen deposition was observed in vim à / à mice (fig. 2e,f) . collectively, these results demonstrate that loss of vimentin prevents asbestos-induced collagen deposition and fibrosis. vimentin required for bleomycin-induced injury and fibrosis. bleomycin is one of the best characterized rodent models of pulmonary fibrosis 33 ; intratracheal delivery of the drug causes severe ali, which is followed by clearance of alveolar inflammatory cells, fibroblast proliferation and increased collagen deposition 34 . moreover, bleomycin-induced fibrosis has been shown to be dependent on the nlrp3 inflammasome 35 . wt and vim à / à mice were exposed to bleomycin for 5 days. wt mice displayed intense lung inflammation as assessed by h&e staining (fig. 3a) , increased wet-to-dry lung weight ratio (fig. 3b) , and increased protein concentration in balf (fig. 3c) . all of these end points were significantly attenuated in vim à / à mice (fig. 3a-c) . exposure to bleomycin resulted in a large increase in immune cells in the airspace of both wt and vim à / à mice as assessed by flow cytometric analysis of whole-lung lysates ( supplementary fig. 3a ). vim à / à mice failed to exhibit an increase in caspase-1 (fig. 3d ) and il-1b (fig. 3e) in balf following the exposure to bleomycin; in contrast, wt mice showed a robust activation of caspase-1 and production of mature il-1b (fig. 3d,e) . as a proinflammatory cytokine, macrophage-produced il-1b is known to induce production of interleukin 6 (il-6). we observed that wt mice, but not vim à / à mice, had increased levels of il-6 following the exposure to bleomycin (fig. 3f ). tgf-b1 is a critical mediator of remodelling and fibrotic responses in the lung. total tgf-b1 was detected after activation in balf from wt mice 5 days following the exposure to bleomycin, but remained at the baseline level in balf from vim à / à mice (fig. 3g ). no significant difference was observed between wt and vim à / à mice in nlrp3 inflammasome-independent cytokines tnf-a and mcp-1 (fig. 3h,i) . interestingly, il-1b mrna levels were increased in the lungs of both wt and vim à / à mice following the exposure to bleomycin ( supplementary fig. 3b ). bleomycin exposure results in chronic inflammation and progressive pulmonary fibrosis 19, 35 . the role of vimentin in pulmonary fibrosis was examined 21 days following the administration of bleomycin. the lung architecture was similar for saline-treated wt and vim à / à mice, but in wt mice bleomycin induced extensive fibrotic areas with abundant collagen production, as assessed by masson trichrome stain ( fig. 4a and supplementary fig. 4a ). cellular infiltrates, alveolar wall destruction and collagen deposition were significantly reduced in vim à / à mice. similarly, we observed increases in collagen deposition in bleomycin-treated wt mice by staining with picrosirius red (fig. 4b) . in contrast, there was virtually no collagen deposition in the lungs of vim à / à mice (fig. 4b) . lung collagen concentrations, as assessed by sircol assay, were (a) survival of wt and vim à / à mice subjected to a lethal dose of lps (80 mg kg à 1 , intraperitoneally) was measured and compared. the survival curves were analysed using the log rank test, which calculates the chi-square (w 2 ) for each event time for each group and sums the results. the summed results for each group were added to derive the ultimate chi-square to compare the full curves of each group. the log rank test for the entire data set was p ¼ 0.001. (b-f) wt and vim à / à mice were challenged with a sublethal dose of lps and markers of ali were measured after 48 h, as assessed by h&e staining (scale bar, 200 mm) (b); by wet-to-dry lung weight ratio (c); and by protein content in the balf (d). inflammasome activation was measured by elisa for caspase-1 (e) or il-1b (f) in balf from vim à / à and wt mice. data in b-e are from three independent experiments of n ¼ 6-8 animals per group and presented as mean±s.d. **po0.001, ***po0.0001 relative to wt versus vim à / à , by one-way analysis of variance with a correction provided by the bonferroni multiple comparisons test. nature communications | doi: 10.1038/ncomms7574 article 0.57 ± 0.09 and 0.31 ± 0.03 mg per lung in bleomycin-treated wt and vim à / à mice, respectively (fig. 4d ). in patients with pulmonary fibrosis, pulmonary function tests typically reveal a parenchymal-restrictive ventilatory defect due to decreased lung compliance 36 . lung compliance is influenced by the underlying connective tissue, which is rich in extracellular matrix components such as collagen 37 . because vim à / à mice exhibited less collagen deposition following treatment with either bleomycin or asbestos, we reasoned that lungs of these mice would maintain normal compliance. to test this hypothesis, we measured the lung mechanics of wt and vim à / à mice using a scireq ventilator 21 days following the bleomycin administration. in comparison with saline treatments, lungs of wt mice exhibited a 2.5-fold decrease in quasi-static compliance following the bleomycin administration, whereas the compliance of lungs from vim à / à mice decreased only 1.3-fold (fig. 4e) . bleomycin administration creates heterogeneous regions of lung fibrosis in mice (fig. 4a) , which is a pathologic feature of the human disease as well 38 . to assess focal changes in lung tissue stiffness, we performed regional nano-indentations on lung sections (200-400 mm thick) using atomic force microscopy (afm). the micro-indentations provide a measure of the stiffness or elastic modulus (e) of lung tissue, which is inversely related to lung compliance. elasticity maps from afm micro-indentation from bleomycin-treated wt lungs clearly displayed the wide ranges of tissue stiffness (fig. 4c) , which corresponded to the heterogeneity of collagen deposition (fig. 4a) . the median elastic modulus of lung parenchymal tissue from wt mice increased 2.4-fold in response to bleomycin compared with control lung tissue (27 to 7.5 kpa, respectively), whereas the elastic modulus of lung tissue from bleomycin-treated vim à / à mice was significantly decreased (po0.0001) compared with wt bleomycin-treated lung tissue (fig. 4f) . the wide range of e-values is reflected in the frequency of occurrence and in the median and interquartile ranges for each condition ( supplementary fig. 4b ). in addition, there was a strong correlation (pearson r ¼ à 0.99) between the mean compliance values for each condition and the mean e-values for each condition (for example, wt-bleomycin-afm versus wtbleomycin-scireq). thus, the mechanical properties of the lung were preserved in vim à / à mice following the bleomycin treatment, which is evident at both the global tissue scale and in focal regions of lung. injury and fibrosis reduced in vim à / à bone marrow chimeras. because multiple cell types contribute to the inflammatory and fibrotic responses, we next addressed the respective roles of bone marrow-derived cells in bleomycin-induced lung injury and fibrosis by generating bone marrow chimeras (fig. 5a) . reconstitution of bone marrow from wt donor mice into irradiated recipient mice (wt) resulted in protein accumulation in balf in response to bleomycin, whereas in recipient mice reconstituted with bone marrow from vim à / à donor mice (vim à / à ), the balf protein was unchanged from saline controls (fig. 5b) . secretion of il-1b (fig. 5c ), il-6 ( fig. 5d ) and tgf-b (fig. 5e ) in the balf of wt mice significantly increased in response to bleomycin; the response in vim à / à mice was significantly attenuated. finally, wt mice displayed a significant degree of collagen deposition and fibrosis, as shown by masson trichrome wt and vim à / à mice were treated with pbs containing either 200 mg of asbestos crocidolite or the control particle titanium dioxide (tio 2 ), intratracheally. markers of inflammation and fibrosis were assessed 3 and 6 weeks after instillation, respectively. (a) total cell count (macrophages, neutrophils, eosinophils, erythrocytes and lymphocytes ) and (b) protein levels were assessed in balf collected from vim à / à mice 3 weeks after asbestos administration. inflammasome activation in wt and vim à / à mice was measured by elisa for caspase-1 (c) and il-1b (d) levels in balf at the same time point. collagen deposition was evaluated in asbestos-treated vim à / à and wt mice by masson's trichrome and picrosirius red staining of lung slices (e; scale bar, 200 mm) and by measuring total collagen content by sircol assay (f). data are from two independent experiments n ¼ 6-8 animals per group, and presented as mean ± s.d. *po0.05, **po0.001, relative to wt versus vim à / à , by one-way analysis of variance with a correction provided by the bonferroni multiple comparisons test. sircol assay ( fig. 5f ), whereas this response was severely attenuated in vim à / à mice ( fig. 5f ,g and supplementary fig. 5c ). all together, these results suggest that vimentin-expressing bone marrow-derived cells are important for bleomycin-induced activation of the nlrp3 inflammasome and pulmonary fibrosis. loss of vimentin prevents nlrp3 activation. as stated above, nlrp3 inflammasome activation requires two distinct stimuli. an inflammatory stimulus, such as lps, primes cells to transcribe and synthesize pro-il-1b (signal 1) and then another stimulus such as extracellular adenosine triphosphate (atp), monosodium urate (msu) or asbestos (signal 2) is necessary for inflammasome complex formation, caspase-1 activation and il-1b maturation 19, 22, 39 . to further investigate the possibility that nlrp3 inflammasome activation requires vimentin, we isolated primary alveolar macrophages from wt and vim à / à mice. macrophages were primed with lps and stimulated with atp as previously described 39 . levels of mature caspase-1 and il-1b were significantly increased in the supernatants collected from wt macrophages following lsp and atp treatment compared with saline treatment, but in the supernatant collected from vim à / à macrophages there was only a slight increase (fig. 6a,b) . there was no difference in pro-il-1b levels in total cell lysates between activated wt and vim à / à alveolar macrophages ( fig. 6c ; full blots are presented in supplementary fig. 7) . as an independent approach, we expressed a small hairpin rna (shrna) targeted to vimentin (vim kd ) or a scrambled shrna (ctrl) in j774a.1 macrophages and treated the cells with atp. caspase-1 is required to cleave pro-il-1b into its biologically active form and like other caspases is proteolytically activated from a pro-enzyme to produce a tetramer of its two active subunits, p20 and p10 (ref. 28 ). the levels of mature caspase-1 p20, but not pro-caspase-1, were considerably reduced in vim kd cells (fig. 6d ,e; full blots are presented in supplementary fig. 7 ) compared with ctrl cells treated with atp, further supporting the hypothesis that vimentin deficiency prevents nlrp3 inflammasome activation. uric acid released from cells exposed to bleomycin triggers nlrp3 inflammasome assembly leading to il-1b maturation and inflammation in the lungs 19, 40 . in an in vitro model, we examined whether silencing vimentin would impair nlrp3 inflammasome activation in response to msu. a human macrophage-like cell line was treated with silencing rna (sirna) targeted to vimentin (vim kd ) or a scrambled sirna (ct; fig. 7a ; full blots are presented in supplementary fig. 8 ) and subsequently activated with msu. no differences were observed in the levels of pro-il-1b between ct and vim kd cells (fig. 7a) , suggesting that vimentin deficiency does not impair signal 1. nlrp3 inflammasome activation was repressed in vim kd cells as assessed by il-1b and caspase-1 levels in cell supernatants (fig. 7b,c) . similar results were obtained when ct and vim kd cells were activated with asbestos (fig. 7b,c) . in addition, bone marrow-derived macrophages (bmdms) were isolated from wt and vim à / à mice, primed with lps and activated with msu. caspase-1 activation was assessed using a specific fluorescent probe, fam-yvad-fmk 41 . wt bmdms showed robust caspase-1 activation following treatment with msu, with caspase-1 forming aggregates throughout the cytoplasm. however, caspase-1 activation was severely reduced in bmdms isolated from vim à / à mice (fig. 7d) . no caspase-1 activation was observed in untreated bmdms isolated from either wt or vim à / à mice. vimentin interacts with inflammasome components. inflammasome activation involves the physical interaction of nlrp3, asc (apoptosis-associated speck-like protein containing a card) and caspase-1 (ref. 28 ), but the mechanism by which the inflammasome assembles is not clear. if the vimentin network serves as a protein scaffold upon which the nlrp3 inflammasome components are assembled, then vimentin should interact with inflammasome proteins. immunoprecipitation of caspase-1 and nlrp3 from human macrophage lysates resulted in a robust co-precipitation of vimentin, which was enhanced following activation of cells with atp ( fig. 8a ; full blots are presented in supplementary fig. 9 ). these interactions were specific for vimentin, as no actin was detectable in immunoprecipitates. we also used solution-binding assays to demonstrate a direct protein-protein interaction between vimentin and nlrp3. bacterially expressed and purified s-tag his-vimentin was incubated with extracts prepared from either control or msutreated human macrophage cells. the s-tag vimentin was precipitated using s-protein agarose. the precipitated proteins (c) representative elastographs from afm micro-indentation of lung tissue from wt and vim à / à animals. the colour bar indicates elastic modulus, e. the darkest red corresponds to elastic modulus values of 50 kpa and above. the data represent 256 indentations per region, with at least two regions per tissue section from at least three mice per group. (d) collagen content in lungs from wt and vim à / à mice assessed by sircol assay. (e) mice were ventilated 21 days after intratracheal instillation of bleomycin or pbs. shown are quasistatic compliance measurements of wt and vim à / à lungs. (f) elastic modulus frequency plot obtained from live, unfixed lung tissue of saline and bleomycin-treated wt and vim à / à animals. microindentation data were fit using the hertz model to acquire the elastic modulus of regions of lung tissue. images in a-b represent data obtained from at least three animals per group; data shown in d-e are mean ± s.d. of at least five animals. **po0.001, ***po0.0001 relative to wt versus vim à / à , by one-way analysis of variance with a correction provided by the bonferroni multiple comparisons test. were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (sds-page), transferred to nitrocellulose and then immunoprobed with antibodies directed against nlrp3. we observed a 3.0 ± 0.8-fold increase in binding between vimentin and nlrp3 in extracts prepared from msu-treated cells, as compared with untreated control cells (supplementary fig. 6 ). article a complementary method, bio-layer interferometry (bli), was also used to investigate the interaction between nlrp3 and vimentin. bli is an optical technique that analyses the interference pattern of white light reflected from two surfaces: a layer of immobilized protein on the biosensor tip and an internal reference layer 42 . any change in the number of molecules bound to the biosensor tip causes a shift in the interference pattern that can be measured in real time, providing detailed information on the kinetics of association and dissociation between the two molecules (k a , k d and k d ). commercially available nlrp3 was bound to the biosensor tip, then various concentrations (55 mm, 18 mm, 6 mm, 1.8 mm, 180 nm, 18 nm and 1.8 nm) of full-length vimentin were added to determine the association kinetics with nlrp3. in agreement with other methods (fig. 8a ,b,d and supplementary fig. 6 ), the assay demonstrated that nlrp3 binds to vimentin with a measureable affinity; a global dissociation constant (k d ) of 640 nm was determined using blitz pro. consistent with the co-immunoprecipitation and solutionbinding results, we observed co-localization of nlrp3 and vimentin in stimulated alveolar macrophages by confocal immunofluorescence microscopy (fig. 8d) . following activation, the wt cells, but not the vim kd cells, were spread and displayed lamellipodia. furthermore, the vimentin network spanned the cytoplasm in the wt activated cells, whereas in unstimulated cells, the network appeared to be collapsed around the nucleus and lamellipodia were not observed (fig. 8d) . vimentin filaments (red) strongly co-localized with nlrp3 (green) in both perinuclear and distal regions of the cells. co-localization studies were performed using fiji 1.48r (64-bit, win) and the coloc 2 test 43 . co-localization analyses were calculated on rois drawn around the lamellipodia, determined by the vimentin image. the thresholded manders co-localization scores were 0.89 ± 0.15 for vimentin and 0.86 ± 0.18 for nlrp3. nlrp3 and asc also colocalized in stimulated macrophages ( supplementary fig. 5 ); the score for nlrp3 co-localization with asc in untreated cells was 0.20 ± 0.11, indicating weak co-localization. in contrast, the score for nlrp3 co-localization with asc in cells treated with atp was 0.85 ± 0.21, indicating strong co-localization. however, knockdown of vimentin resulted in a lack of co-localization between nlrp3 and asc, even in activated macrophages ( supplementary fig. 5 ). taken together, these results demonstrate that vimentin associates with components of the inflammasome and is required for inflammasome activation. inflammation, the process aimed at restoring homeostasis after an insult, can be more damaging than the insult itself if uncontrolled, excessive or prolonged. growing evidence indicates that il-1b is a critical mediator of acute inflammation, remodelling and fibrosis in the lung. using three well-characterized murine models of ali and pulmonary fibrosis, which were previously shown to be dependent on the nlrp3 inflammasome 19, 22, 23, 35 , we show that nlrp3 inflammasome activation, which leads to il-1b maturation, is dependent on the type iii if protein vimentin. our data obtained in vimentin knockout mice and vimentin-null cells suggest that vimentin is required for nlrp3 inflammasome activation. dysregulated inflammation, excessive leukocyte accumulation and increased permeability of endothelial and alveolar epithelial barriers are the central pathophysiologic events in ali and its most severe form, the acute respiratory distress syndrome (ards) 44 . all these end points were observed in wt mice challenged with lps, bleomycin and asbestos. in contrast, vim à / à mice exposed to the same treatments experienced mild increases in protein levels in balf and limited alterations in lung histopathology, suggesting that they were protected from lps-, bleomycin-and asbestos-induced ali. inflammasome-regulated cytokines have a key role in the initiation and propagation of the aforementioned features of ali 45 . in fact, alveolar macrophages from patients with ards produce excessive amounts of il-1b 46 , and il-18 was elevated in the plasma of patients with ards, which correlated with increased morbidity and mortality 45 . since vimentin-deficient mice were protected from ali, we speculated that failure to produce inflammasome-mediated cytokines (for example, il-1b) caused this protection. in fact, vimentin-deficient mice failed to increase mature il-1b levels following exposure to lps, asbestos or bleomycin. moreover, we demonstrated that caspase-1 activation and mature il-1b production in vitro requires vimentin, as no increase was observed in activated macrophages either isolated from vim à / à mice or in which vimentin was silenced using rna interference. resolution of ali/ards depends on a precise balance of inflammatory and molecular signalling 44 ; an imbalance in that process caused by il-1b overproduction might prevent cellular restoration and lead to pulmonary fibrosis. in fact, il-1b produced by the inflammasome has been recently identified as an initiator of fibrosis in response to bleomycin 35 , and administration of il-1b alone recapitulates much of the lung pathology caused by bleomycin 47 . because vimentin-deficient mice did not produce the same amount of il-1b as wt mice, we reasoned that vim à / à mice would be protected from bleomycin-and asbestos-induced pulmonary fibrosis. indeed, lung pathology was significantly reduced in vimentin-deficient mice, pointing to the essential role of vimentin in pulmonary fibrosis. we found substantially less collagen deposition in vim à / à mice compared with wt mice. the excessive collagen deposition in lungs of wt mice led to loss of mechanical compliance, whereas the lungs of vim à / à mice maintained compliance similar to that of saline-treated mice. these results are consistent with previous reports demonstrating decreases in the compliance of fibrotic lungs 33 . the elastic modulus measurements strongly suggest that increased tissue stiffness at the microscale corresponds to areas of increased collagen deposition. importantly, macroscale measurements of lung compliance were highly correlated with the microscale elastic modulus measurements obtained by afm. a number of studies have demonstrated that il-1b can induce ali and contribute to the progression of pulmonary fibrosis 19, 23, 35, 48 . il-1b-induced fibrosis is associated with an increase in tgf-1b, demonstrating that ali initiated by proinflammatory cytokines can result in progressive fibrosis 35, 48 . vim à / à mice were treated with recombinant mouse il-1b (rmil-1b 0.05 mg kg à 1 body weight, intranasal (i.n.)), but we were unable to detect latent tgf-b1 in balf from vim à / à mice after i.n. rmil-1b at days 1, 7 and 14 (data not shown), whereas latent tgf-b1 was detected 5 days after bleomycin administration in wt mice (fig. 3) . gasse et al. 19 reported that collagen deposition was increased by rmil-1b in wild-type mice; vim à / à mice treated with rmil-1b had no increase in collagen deposition. we reason that the incomplete suppression of mil-1b in vim à / à mice is a reflection of incomplete chimera, with only b90% engraftment. studies with il-1r1 à / à , myd88 à / à , asc à / à , caspase-1 à / à and nlrp3 à / à mice have suggested that uric acid (induced by bleomycin), asbestos and silica are detected by the nlrp3 inflammasome in macrophages, likely leading to il-1r1/myd88 signalling in pulmonary epithelial cells, then to inflammation, neutrophil and lymphocyte recruitment and fibroblast activation 35 . lung fibroblast activation results in collagen deposition and pulmonary fibrosis. importantly, it was reported that vimentin is required for the stabilization of collagen mrnas 49 . we reason that the vim à / à mice treated with either rmil-1b or wt bone marrow failed to increase collagen deposition because vimentin knockout fibroblasts fail to produce type i collagen due to decreased stability of collagen a1(i) and a2(i) mrnas 49 . protection from injury, inflammation and fibrosis has been observed in mice lacking any components of the nlrp3 inflammasome, similar to our observations of vim à / à mice following injury 19, 22, 23, 35, 50 . these phenotypes led us to investigate whether vimentin might serve as a scaffold for the inflammasome by binding to one or more proteins in the inflammasome complex. several studies have suggested that ifs, including vimentin, act as scaffolds for signalling molecules 2,11,12 . in fact, vimentin interacts with and is involved in the translocation of perk1/2 to the nucleus 51 , limits the ability of 14-3-3 to interact with raf and cdk1, and regulates the release and translocation of roka following rhoa activation. these findings exemplify how vimentin ifs can act as scaffolds for signalling molecules. recently, vimentin was reported to bind to nod2 (nucleotide-binding oligomerization domain-containing protein 2), a member of the nlr family, via the leucin-richrepeat (lrr) 52 . the lrr is a protein-binding domain shared by 19 other nlr family members, including nlrp3. therefore, we sought to determine whether vimentin interacts with nlrp3. in our experiments, immunoprecipitation of both nlrp3 and caspase-1 in lysates from wt alveolar macrophages resulted in a robust co-precipitation of vimentin, which was enhanced following activation of the nlrp3 inflammasome. these data were confirmed by immunofluorescent confocal microscopy of human and murine macrophages. the co-localization score for vimentin with nlrp3 was 0.89±0.15, indicating strong colocalization 43 . moreover, we were able to demonstrate a direct protein-protein interaction between vimentin and nlrp3 by bli assays, further establishing a role for vimentin in assembly of the nlrp3 inflammasome. intermediate filaments, including vimentin, have been shown to provide a scaffold whereby active subunits of caspase-9 can activate caspase-3, which, in turn, can activate more caspase-9 resulting in an amplification loop 53, 54 . caspase-3, caspase-6 and caspase-7 have also been shown to interact with vimentin 54 ; to our knowledge, we are the first to report an interaction between caspase-1 and vimentin. we can only speculate about where and how vimentin associates with nlrp3 and caspase-1 during inflammasome assembly, since the crystal structures of the vimentin dimer and all components of the inflammasome except for pyd are unknown [13] [14] [15] . nlrp3 proteins have been shown to form inactive preassembled complexes in unstimulated cells [13] [14] [15] . under stimulation, these proteins undergo conformational changes whereby the inflammasome is activated. the vimentin if network could potentially associate with the nlrp3 inflammasome through one or more domains of nlrp3 and mediate the conformation change or stabilization of nlrp3 that leads to activation. we reason that vimentin may interact with nlrp3 in two distinct regions: the nacht domain and the lrr; vimentin has been previously shown to interact with nod2 in the lrr domain 52 . because asc is localized to the nucleus in unactivated cells, no interaction with vimentin is anticipated in nonactivated cells. furthermore, on the basis of the structure of asc, a pyd and card domain with a short linker, we do not anticipate a direct interaction with vimentin as vimentin lacks either of the asc domains, therefore, any asc signal following cell activation is anticipated to be due to vimentin interaction with other proteins in the inflammasome protein complex. an unresolved issue is how vimentin mediates inflammasome activation. mitochondrial-derived reactive oxygen species (ros) have been linked to inflammasome activation 55 . vimentin if are known to modulate mitochondrial motility 56 , and lack of vimentin results in increased ros production 57 . this suggests that vimentin-deficient cells should have more robust inflammasome signalling, the exact opposite of what we have demonstrated. in a very provocative paper, however, bauernfeind et al. 24 demonstrated that mitochondrial-derived ros is required for priming, not activation, of the inflammasome, as ros inhibitors blocked the priming step required for nlrp3 expression, but activation was not affected. this correlates with our findings that signal 1 is unaffected by the lack of vimentin. further studies on the relationship between vimentin, mitochondria and ros will likely provide insights into the regulation behind both signals 1 and 2 during inflammation, but currently they are beyond the scope of this paper. in summary, this study demonstrates a novel function for the type iii if, vimentin, in innate immunity and inflammation leading to ali and pulmonary fibrosis. in our experiments, vimentin deficiency resulted in a blunted inflammatory response in the early stages of injury, which was consistent among the different animal models of lung injury used: lps, bleomycin and asbestos. we further demonstrate that vimentin is required for il-1b maturation through its interaction with the nlrp3 inflammasome. vimentin may act as a scaffold for assembly of the inflammasome protein complex and thus regulate its function. overall, this study provides new insights into lung inflammation and fibrosis, and importantly, suggests that vimentin may be a key regulator of the nlrp3 inflammasome. mice and induction of acute lung injury. age-and sex-matched 8-to 10-weekold mice were used in all the experiments. the 129/sv6 vimentin-deficient (vim à / à ) mice were a gift from albee messing (madison, wi). bleomycin (0.07 units in 50 ml of pbs; hospira) and asbestos (200 mg in pbs; us epa) were administered intratracheally via two 25-ml aliquots. lps (80 mg kg à 1 , lethal dose; 24 mg kg à 1 , sublethal dose; sigma-aldrich) was administered via intraperitoneal injection. wt and vim à / à mice were treated with a single intratracheal injection of 50 ml of phosphate-buffered saline (pbs) or bleomycin (0.07 units in 50 ml of pbs; hospira). all mice were bred in our animal facility and the experiments were approved by the northwestern university animal care and use committee. histology. a 20-gauge angiocath was sutured into the trachea, heart and lungs were removed en bloc and inflated with 0.8 ml of 4% paraformaldehyde. the heart and lungs were fixed and embedded in paraffin; 5-mm sections were stained with h&e, picrosirius red or masson trichrome 58 by the mouse histology phenotyping laboratory (northwestern university, chicago, il). sections were visualized using the tissuegnostics tissue/cell high throughput imaging analysis system (vienna, austria) and captured using tissuefaxs software (tissuegnostics, los angeles, ca) at the northwestern university cell imaging facility. specific regions of interest were visualized using a zeiss axioskop microscope and captured using the cri nuance spectral camera software suite. wet-to-dry weight ratios. mice were anaesthetised and lungs were surgically removed en bloc. the left lung was ligated, excised and weighed in a tared container. the left lung was then dried at 70°c in a speed-vac sc100 evaporator (thermo scientific, waltham, ma) until a constant weight was obtained, and the wet-to-dry weight ratio was calculated. bronchoalveolar lavage. to perform bronchoalveolar lavage (bal), a 20-gauge angiocath ligated into the trachea and 1 ml of sterile pbs was instilled, then removed through the angiocath; the process was repeated three times. the samples were pooled and a 200 ml aliquot of the bal fluid was placed in a cytospin and centrifuged at 500 g for 10 min. the pellet was re-suspended in 1 ml of pbs, plated on glass slides, stained with crystal violet and subjected to a blinded manual cell count and differential. cytokine and chemokine levels in the supernatant were measured using the bd cytometric bead array (bd biosciences). samples were analysed in triplicate using the mouse inflammation kit (bd biosciences) according to the instructions provided. this kit detects interleukin (il)-6, mcp-1 and tumour necrosis factor (tnf)-a. total transforming growth factor (tgf)-b1 was measured using the tgf-b1 rii duoset enzyme-linked immunosorbent assay (elisa, r&d systems, minneapolis, mn) according to the manufacturer's instructions. total interleukin (il)-1b was measured using the il-b1 ready-set-go elisa (ebioscience, san diego, ca) according to the manufacturer's instructions. caspase-1 activity was measured using the caspase-1 fluorometric assay (r&d systems), according to the manufacturer's instructions. sircol assay. total collagen content was determined by harvesting lungs from mice 21 d after treatment with bleomycin or pbs, or 12 weeks after treatment with asbestos or tio 2 . exsanguination was accomplished by a left nephrectomy, followed by perfusion of the right ventricle with 2 ml of cold pbs. both lungs were removed and homogenized (1 min with a tissue homogenizer followed by 12 strokes in a dounce homogenizer) in 1 ml of 0.5 n acetic acid supplemented with roche edta protease inhibitor. aliquots of lung homogenate were then assayed for total lung collagen levels and compared with a standard curve prepared from rat tail collagen by using the sircol collagen dye binding assay (biocolor ltd, newtownabbey, uk), according to the manufacturer's directions. compliance measurements. wt and vim à / à mice were anaesthetised with ketamine and xylazine (45 mg per 100 g of body weight) and a tracheotomy was performed. pancuronium was administered intraperitoneally (0.08 mg kg à 1 of body weight). the mouse was mechanically ventilated on a computer-controlled piston ventilator (flexivent; scireq, montréal, québec, canada) with a tidal volume of 10 ml kg à 1 at a frequency of 150 breaths per minute against 2-3 cm h 2 o positive end-expiratory pressure. following two total lung capacity manoeuvres to standardize volume history, pressure and flow data (reflective of airway and tissue dynamics) were collected during a series of standardized volume perturbation manoeuvres. these data were used to calculate both total lung resistance (r) and elastance (e) using the single-compartment model and used to derive further parameters of respiratory function. the flexivent calibration procedure removes cannula impedance from the reported data. residual impedence (i) is therefore negligible and is not reported herein. atomic force microscopy measurements. lungs were used at 17-21 days following bleomycin challenge. following instillation of 2.5% low-gel point agar (50 ml kg à 1 ), lungs were sectioned using a vibratome (leica vt1000 s) into 200mm or 400-mm thick slices. these slices were used within 24 h of harvest; microindentations were performed using a bruker bioscope catalyst located at the northwestern university nuance facility. modified probes with 5-mm spheres (novascan, ames, ia) were used to indent 80 mm â 80 mm areas on the lung slices. force and indentation depth were converted to elastic modulus using the hertz spherical indentation model 21, 59 and a custom matlab program (generated by dr esra roan, university of memphis). a poisson ratio of m ¼ 0.4 was assumed for the tissue 60-62 . cell culture. to isolate bone marrow-derived macrophages (bmdm), bone marrow was extracted from mice femurs and tibia then purified through a ficoll-paque gradient. upon purification, cells were differentiated on charge-free plates in dmem containing 20% endotoxin-reduced fetal bovine serum and 30% l929 cell supernatant for 5 days 63 . peritoneal macrophages were obtained from untreated mice. briefly, the abdomen of anaesthetised mice was exposed and 5 ml of sterile pbs was instilled intraperitoneally using a 20-gauge syringe. following agitation, the fluid was removed and centrifuged. the cells were plated in dulbecco modified eagle medium containing 10% fetal bovine serum and used for western blotting. alveolar macrophages were obtained from balf of untreated mice. briefly, 1 ml of sterile pbs was instilled through a 20-gauge angiocath ligated into the trachea and the fluid then removed; this process was repeated three times. the fluid was centrifuged and cells were used for elisa. the second-generation lentiviral pgipz expression vectors encoding shrnas against mouse vimentin (clones v2lmm_14765, v2lhs_171946 and v2lhs_171949) and scrambled shrna control (catalogue no. rhs4346) originated from the thermo fisher scientific shrna library (waltham, ma) and were provided by rnai/throughput robotics core of northwestern university (evanston, il). lentiviral stocks (with titres of 10 7 -10 8 tu ml à 1 ) encoding shrnas against mouse vimentin were produced by the dna/rna delivery core (skin disease research center, northwestern university, chicago, il). western blotting. primary murine macrophages were cultured overnight in 1% serum and treated or not with lps (100 ng ml à 1 ) for 7 h. atp (50 mm) was added to lps-stimulated cells during the last 45 min. cells were lysed in sample buffer and equal volumes loaded in 10% sds-page gels transferred to nitrocellulose membranes. the presence of indicated proteins in cell lysates and medium was assessed by western blotting using the following antibodies: mouse monoclonal anti-vimentin (clone v9; 1:500; sigma-aldrich no. treated according to manufacturer's instructions. bound proteins were prepared for western blotting. protein-protein interaction. the interaction between nlrp3 and vimentin was analysed using a bli, blitz (fortebio, menlo park, ca). antibodies directed against nlrp3 (adipogen) were diluted 1:4 then attached to a protein a biosensor. next, commercially available, purified nlrp3 (abnova) was attached to the biosensor for 3 min. finally, each labelled biosensor was placed into a specific concentration of purified vimentin 66 and binding was measured for 120 s followed by dissociation in pbs for 120 s. at the start of each binding experiment, vimentin was diluted into pbs to assemble filaments 67 real-time reverse transcriptase polymerase chain reaction. total rna extraction and quantitative pcr were performed as previously described (). briefly, total rna was isolated using the aurum total rna mini kit (qiagen). cdna was synthesized using the qscript cdna supermix (quanta biosciences) and amplified using 40-cycle two-step pcr with sequence-specific primer pairs (idt). sybr green fluorescence was quantified with a cfx96 real-time system thermal cycler (bio-rad) using ddct analysis. relative il-1b mrna expression was determined via normalizing to b-actin mrna expression. statistical analysis. data are expressed as means ± s.d. or means ± s.e.m. differences between two groups were assessed by using a student's t-test. differences between three or more groups were assessed using one-way analysis of variance with a bonferroni multiple comparisons test. values of po0.05 were considered to be significant. the log rank test, which calculates the chi-square (w 2 ) for each event time for each group and sums the results, was used in the analysis of the kaplan-meier curve was used. all analyses were performed using graphpad prism software version 4.00 for windows (graphpad software, san diego, ca). wild-type j774.1 cells and j774.1 cells expressing shrna against vimentin were fixed in methanol ( à 20°c) for 7 min and processed for indirect immunofluorescence as described previously 64,65 using the following antibodies: mouse monoclonal anti-nlrp3 (adipogen international no. ag-20b-0014 images of fixed, stained preparations were taken with either a zeiss lsm 510 microscope or a nikon a1r microscope immunoprecipitated caspase-1 in the right panel could not be detected due to masking by the signal from the heavy chain of the antibody. protein a/g agarose was incubated with cell lysates in the absence of an antibody to control for non-specific binding. to enable caspase-1 detection in immunoprecipitates, caspase-1 antibodies were crosslinked to protein a/g agarose using crosslink ip kit (thermo) cell mechanics and the cytoskeleton introducing intermediate filaments: from discovery to disease mice lacking vimentin develop and reproduce without an obvious phenotype impaired wound healing in embryonic and adult mice lacking vimentin a role for vimentin in crohn disease functions of the intermediate filament cytoskeleton in the eye lens if-pathies": a broad spectrum of intermediate filamentassociated diseases intermediate filaments: primary determinants of cell architecture and plasticity dysfunctions of neuronal and glial intermediate filaments in disease novel functions of vimentin in cell adhesion, migration, and signaling intermediate filaments as signaling platforms inflammasome-mediated production of il-1beta is required for neutrophil recruitment against staphylococcus aureus in vivo activation of inflammasome signaling mediates pathology of acute p. aeruginosa pneumonia mycobacterium tuberculosis protein esat-6 is a potent activator of the nlrp3/asc inflammasome the nlrp3 inflammasome mediates in vivo innate immunity to influenza a virus through recognition of viral rna the inflammasomes inflammasomes: guardians of cytosolic sanctity uric acid is a danger signal activating nalp3 inflammasome in lung injury inflammation and fibrosis integrating mechanisms of pulmonary fibrosis molecular basis of asbestos-induced lung disease innate immune activation through nalp3 inflammasome sensing of asbestos and silica the nalp3 inflammasome is essential for the development of silicosis cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the nlrp3 inflammasome the inflammasomes regulation of inflammasome signaling inflammasomes in health and disease the inflammasome in lung diseases suppression of inflammation and acute lung injury by miz1 via repression of c/ebp-d the intrinsic apoptotic pathway is required for lipopolysaccharide-induced lung endothelial cell death flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung cytokine storm in a phase 1 trial of the anti-cd28 monoclonal antibody murine models of pulmonary fibrosis an official american thoracic society workshop report: features and measurements of experimental acute lung injury in animals il-1r1/myd88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice idiopathic pulmonary fibrosis lung parenchymal mechanics in health and disease mechanisms of pulmonary fibrosis cutting edge: nitric oxide inhibits the nlrp3 inflammasome gout-associated uric acid crystals activate the nalp3 inflammasome cell volume regulation modulates nlrp3 inflammasome activation bio-layer interferometry for measuring kinetics of protein-protein interactions and allosteric ligand effects briding the gap between qualitative and quantitative colocalization results in fluorescence microscopy studies the acute respiratory distress syndrome inflammasome-regulated cytokines are critical mediators of acute lung injury elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome bleomycin and il-1 beta-mediated pulmonary fibrosis is il-17a dependent transient expression of il-1b induces acute lung injury and chronic repair leading to pulmonary fibrosis a novel role of vimentin filaments: binding and stabilization of collagen mrnas the highly conserved nuclear lamin ig-fold binds to pcna: its role in dna replication vimentin binding to phosphorylated erk sterically hinders enzymatic dephosphorylation of the kinase the intermediate filament protein, vimentin, is a regulator of nod2 activity intermediate filaments control the intracellular distribution of capases during apopptosis caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis a role for mitochondria in nlrp3 inflammasome activation vimentin intermediate filaments modulate the motility of mitochondria vimentin is secreted by activated macrophages proapoptotic bid is required for pulmonary fibrosis norepinephrine increases alveolar fluid reabsorption and na,k-atpase activity poissons' ratio of lung parenchyma and parenchymal interaction with bronchi feedback amplification of fibrosis through matrix stiffening and cox-2 suppression oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis a nuclear receptor atlas: macrophage activation shear stress induced reorganization of the keratin intermediate filament network requires phosphorylation by protein kinase c zeta vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells structure and assembly properties of the intermediate filament protein vimentin: the role of its head, rod and tail domains vimentin intermediate filament formation: in vitro measurement and mathematical modeling of the filament length distribution during assembly dr esra roan (university of memphis, tn) generously assisted with the afm microindentation matlab code and analysis of results. we thank mr luke skertich for assistance with immunofluorescence confocal microscopy. histological staining was performed by the mouse histology phenotyping laboratory. imaging work was performed at the northwestern university cell imaging facility generously supported by nci ccsg p30 ca060553 awarded to the robert h. lurie comprehensive cancer center. afm measurements were produced in the nifti facility (nuance center, northwestern university), which has received support from the nsf-nsec, nsf-mrsec, keck foundation, the state of illinois and northwestern university. key: cord-312692-jv3425w1 authors: iwata-yoshikawa, naoko; okamura, tadashi; shimizu, yukiko; kotani, osamu; sato, hironori; sekimukai, hanako; fukushi, shuetsu; suzuki, tadaki; sato, yuko; takeda, makoto; tashiro, masato; hasegawa, hideki; nagata, noriyo title: acute respiratory infection in human dipeptidyl peptidase 4-transgenic mice infected with middle east respiratory syndrome coronavirus date: 2019-01-09 journal: journal of virology doi: 10.1128/jvi.01818-18 sha: doc_id: 312692 cord_uid: jv3425w1 middle east respiratory syndrome coronavirus (mers-cov) infection can manifest as a mild illness, acute respiratory distress, organ failure, or death. several animal models have been established to study disease pathogenesis and to develop vaccines and therapeutic agents. here, we developed transgenic (tg) mice on a c57bl/6 background; these mice expressed human cd26/dipeptidyl peptidase 4 (hdpp4), a functional receptor for mers-cov, under the control of an endogenous hdpp4 promoter. we then characterized this mouse model of mers-cov. the expression profile of hdpp4 in these mice was almost equivalent to that in human tissues, including kidney and lung; however, hdpp4 was overexpressed in murine cd3-positive cells within peripheral blood and lymphoid tissues. intranasal inoculation of young and adult tg mice with mers-cov led to infection of the lower respiratory tract and pathological evidence of acute multifocal interstitial pneumonia within 7 days, with only transient loss of body weight. however, the immunopathology in young and adult tg mice was different. on day 5 or 7 postinoculation, lungs of adult tg mice contained higher levels of proinflammatory cytokines and chemokines associated with migration of macrophages. these results suggest that the immunopathology of mers-cov infection in the tg mouse is age dependent. the mouse model described here will increase our understanding of disease pathogenesis and host mediators that protect against mers-cov infection. importance middle east respiratory syndrome coronavirus (mers-cov) infections are endemic in the middle east and a threat to public health worldwide. rodents are not susceptible to the virus because they do not express functional receptors; therefore, we generated a new animal model of mers-cov infection based on transgenic mice expressing human dpp4 (hdpp4). the pattern of hdpp4 expression in this model was similar to that in human tissues (except lymphoid tissue). in addition, mers-cov was limited to the respiratory tract. here, we focused on host factors involved in immunopathology in mers-cov infection and clarified differences in antiviral immune responses between young and adult transgenic mice. this new small-animal model could contribute to more in-depth study of the pathology of mers-cov infection and aid development of suitable treatments. m iddle east respiratory syndrome coronavirus (mers-cov) was originally isolated as a novel coronavirus from a fatal case of acute respiratory distress syndrome and renal failure in 2012 (1). a human receptor for the virus, called human cd26/dipeptidyl peptidase 4 (hdpp4), was identified subsequently (2) . many epidemiological and virological investigations have been undertaken since then; however, information about the pathogenesis of mers-cov is limited. in addition, because mers-cov is endemic in the middle east, the development of effective prophylactic and therapeutic treatment strategies remains a high priority. therefore, appropriate animal models are needed to better understand the pathogenesis of mers-cov and facilitate development of effective vaccines and drugs. some research groups experimentally infected nonhuman primates and small experimental animals with mers-cov (3) (4) (5) (6) (7) . rhesus macaques appear to develop a transient lower respiratory tract infection after a combination of intratracheal, ocular, oral, and intranasal inoculation with mers-cov (3), whereas the common marmoset develops progressive and severe pneumonia, which can be lethal (4) . however, animal models based on nonhuman primates present both ethical and economic problems. thus, establishing a small-animal model of mers-cov infection is desirable. unfortunately, mers-cov does not infect or replicate in small rodents such as syrian hamsters (8) , mice (9) , or rats (10) because they lack a functional mers-cov receptor. zhao et al. described lung infection in a mouse model transduced with an adenovirus expressing hdpp4 (11) ; thus, a transgenic (tg) mouse carrying hdpp4 should be suitable for mers-cov studies (5) . some research groups developed tg mice overexpressing the hdpp4 receptor under the control of cag or cytokeratin 18 promoters (5) (6) (7) . these mice developed severe lung disease, along with infection of the brain. autopsy data are available from only one mers patient; therefore, it is unclear whether mers-cov causes a systemic infection although there is no evidence that mers-cov infects the human brain. other studies describe development of an hdpp4 knock-in mouse (12) (13) (14) . although the tissue distribution and expression levels of hdpp4 in these models are largely equivalent to those of dpp4 in wild-type mice, the phenotype that determines mers-cov susceptibility varies from model to model. the hdpp4 knock-in mouse model described by coleman et al. (12) succumbed to infection with wild-type mers-cov. in contrast, model mice described by cockrell et al. (14) and li et al. (13) are susceptible to infection by serially passaged mers-cov, which induces severe lung pathology and diffuse alveolar damage (dad). these mice would be good models for studying pathogenesis of mers. here, we developed a new tg mouse model expressing hdpp4 under the control of its endogenous promoter to better mimic physiological expression of hdpp4. these tg mice were then backcrossed onto th1prone c57bl/6 mice. after evaluating susceptibility to mers-cov infection, we investigated age-dependent differences in disease pathogenesis because older age is one of the common factors related to mers severity and mortality (15) (16) (17) (18) (19) (20) . both young and adult tg mice infected with mers-cov showed transient weight loss along with moderate pneumonia and mers-cov replication in the lung; however, they did not recapitulate the severe disease and lethal infection seen in humans. young and adult tg mice infected with mers-cov did, however, show different immunopathologies. adult tg mice showed higher levels of proinflammatory cytokine-and chemokinemediated macrophage infiltration of the lungs than young tg mice. taken together, these results suggest that age affects the immunopathology of mers-cov infection in tg mice. the data suggest that other factors are required to recapitulate severe human disease in these tg mice; however, this mouse model will be useful for identifying host mediators that protect against mers-cov infection. this animal model will provide new insight into factors that cause severe mers-cov infection. expression of hdpp4 in tg mouse tissues. to generate tg mice showing tissueor cell-type-specific hdpp4 expression mimicking that in humans, we first looked at research involving tg mice harboring human enterovirus receptors (such as the human poliovirus receptor) and scarb2 receptor-driven endogenous promoters (21, 22) . promoter sequences, which normally include a transcriptional start site, are usually isolated from the upstream regions of endogenous mammalian genes (23) . therefore, we used a bacterial artificial chromosome (bac) clone (rp11-345j9) containing the complete hdpp4 gene and an endogenous promoter to generate tg mice harboring hdpp4 (fig. 1a) . to screen the tg mice generated, we confirmed presence of the transgene by pcr genotyping using two primers sets specific for hdpp4 (table 1, exons 3 and 10) . hdpp4 is a protease expressed on the surface of cells in various organs, including t cells (24, 25) . the enzyme is expressed by approximately 60% of resting t cells isolated from blood (26) . since handling of peripheral blood in a laboratory is relatively simple, we conducted flow cytometry analysis using a fluorescein isothiocyanate (fitc)-conjugated anti-human cd26/hdpp4 monoclonal antibody that does no react with murine dpp4 to detect expression of hdpp4 in mice. cd3-positive lymphocytes from 2/15 tested pups were positive for hdpp4. these mice were then crossed with c57bl/6 mice to establish two independent tg lines (tg1 and tg2), which were maintained as hemizygotes carrying the hdpp4 gene. the tg animals were born at the the open and filled circles denote the centromere (cen) and telomere (tel) of human chromosome 2, respectively. the gray arrows indicate the genes located downstream of the hdpp4 gene (white arrow). the cloned region in the bac construct is denoted by a black line. gcg, glucagon gene; fap, fibroblast activation protein; ifih1, interferon induced with helicase c domain 1. (b) expression of hdpp4 on peripheral blood cd3-positive t lymphocytes from the transgenic (tg) mice. tg1 and tg2, hdpp4 ϩ/ϫ transgenic mouse lines 1 and 2; non-tg, hdpp4 ϫ/ϫ mouse. (c) genomic dna was extracted from tg2 mice, and human dpp4 exons 1 to 26 were subjected to pcr using specific primers. expected mendelian ratio and were outwardly indistinguishable from control littermates. because cd3-positive lymphocytes from peripheral blood of line tg2 showed higher hdpp4 expression than those from line tg1 (fig. 1b) , tg2 was used for further analyses. pcr genotyping using primer sets specific for hdpp4 revealed that the complete hdpp4 gene had integrated into the genome of tg2 mice ( fig. 1c and table 1) . to examine hdpp4 expression in human and tg2 tissues, we first performed western blot analysis with a goat anti-cd26/hdpp4 polyclonal antibody (af1180; r&d systems), which detected hdpp4 but cross-reacted weakly with mouse dpp4. bands of about 110 kda (hdpp4) were detected in all tested human tissues (liver, spleen, kidney, heart, lung, stomach, small intestine, large intestine, pancreas, brain, spinal cord, and skeletal muscle), except brain ( fig. 2a) . all of the tissues from hdpp4 tg mice expressed hdpp4, including liver, spleen, kidney, heart, lung, stomach, small intestine, large intestine, pancreas, brain, spinal cord, and skeletal muscle ( fig. 2a) . these results suggest that the human transgene was expressed in the majority of organs/tissues in tg2 mice. to further determine hdpp4 distribution in tissues, immunohistochemistry (ihc) was performed (fig. 2b ). ihc using a goat anti-cd26/hdpp4 antibody detected hdpp4 antigens in pneumocytes in the lung, in bile capillaries in the liver, in renal tubular epithelium, on the surface of epithelial cells lining the small intestine, in pancreatic islets, in lymphocytes in the lymph nodes, and in several types of endothelial cell and serous membranes (fig. 2b , left column). while hdpp4 expression was undetectable in brain tissue by western blot analysis, ihc revealed that endothelial cells lining blood vessels and leptomeninges of the human brain were positive for hdpp4 although neurons and glia were negative. in tg2 mice, pneumocytes and bronchial epithelial cells in the lungs, bile capillaries in the liver, the renal tubular epithelium, and the surface of epithelial cells in the small intestine were positive for hdpp4 (fig. 2b ). in addition, several types of endothelial cells and serous membranes in all tested tissues, including the central nervous system, from tg2 mice were positive for hdpp4. notably, most lymphocytes in the t cell zones of the spleen and lymph nodes from tg2 mice were positive for hdpp4. staining of tissues from non-tg mice was very weak or absent (except for the small intestine) (fig. 2b) . these data suggest that the pattern of hdpp4 expression in tg2 mice is similar to that in humans (except for pancreas and lymphoid tissues). expression of hdpp4 was higher in lymphocytes from tg2 mice than in those from humans ( fig. 1c and fig. 2b ). therefore, we investigated the immune response profile in tg2 mice. to assess innate immune responses in the lungs of tg2, non-tg, and c57bl/6 mice, all animals received intranasal administration of pbs with or without (b) immunohistochemical analysis of hdpp4 expression in human, tg2, and non-tg mouse tissues stained with an anti-hdpp4 polyclonal antibody. sections were counterstained with hematoxylin. scale bars, 50 m (large images of liver, kidney, small intestine, pancreas, spleen, and lymph node), 20 m (large images of lung and brain), and 25 m (insets). poly(i·c), a synthetic analog of double-stranded rna (fig. 3) . there was no statistically significant difference in cytokine expression levels between tg2, non-tg, and c57bl/6 mice at 24 h after inoculation with poly(i·c) or phosphate-buffered saline (pbs) (fig. 3) . however, when we set expression levels after pbs treatment as 1, we noted that expression of macrophage inflammatory protein 1␣ (mip-1␣), granulocyte-macrophage colony-stimulating factor (gm-csf), interleukin-1␤ (il-1␤), il-12, and il-2 in poly(i·c)treated tg2 mice was 0.8-to 2-fold higher than in the other two strains. these results suggest that hdpp4 expression in mice does not have a marked effect on basal innate immune responses in the three mouse strains; however, tg2 mice show slightly stronger or earlier innate immune responses than c57bl/6 mice and non-tg mice. thus, when we investigated immune responses in this animal model, we made comparisons between mers-cov-infected and noninfected tg mice. susceptibility of hdpp4-tg mice to mers-cov infection. in this experiment, c57bl/6 mice were used instead of non-tg mice because we were unable to prepare a sufficient number of non-tg mice from littermate mice for this experiment. after intranasal inoculation of 10-week-old tg2 and c57bl/6 mice with 10 5 50% tissue culture infectious doses (tcid 50 ) of mers-cov, neither group was lethargic; however, tg2 mice showed mild but transient weight loss from days 6 to 7 postinoculation (p.i.) (tg2 mice, n ϭ 8 [four females and four males]; c57bl/6 mice, n ϭ 10 [five females and five males]) (fig. 4a ). tg2 mice showed seroconversion at 35 days p.i., whereas c57bl/6 mice did not (tg2 mice, n ϭ 5 [three females and two males]; c57bl/6 mice, n ϭ 6 [three females and three males]) (fig. 4b ), suggesting that tg2 mice are susceptible to infection by mers-cov. we next examined viral replication kinetics and sites of viral replication in 10-weekold tg2 and c57bl/6 mice (n ϭ 3-4 [2 females and 1 to 2 males per time point]). tg2 mice and c57bl/6 mice were inoculated intranasally with 10 5 tcid 50 of mers-cov, and tissue specimens (the maxilla [including the nostril], nasal wash fluid, lung, and lung wash fluid) were collected at 6 h p.i. and on days 1, 3, 5, and 7 p.i. the nasal wash fluid from three out of four tg2 mice contained barely detectable levels of infectious virus at days 1 and 5 p.i. (fig. 4c ). supernatants from maxilla tissue homogenates (20%) from tg2 mice contained 10 2.8 tcid 50 /g at day 1 p.i. although the titer fell by 5 days p.i. the viral titers in lung wash fluid and supernatants of lung tissue homogenates (20%) from tg2 mice contained 10 2.3 tcid 50 /ml and 10 4.6 tcid 50 /g, respectively, at 1 day p.i.; these values were significantly higher than those at 6 h p.i. (p ͻ 0.05 and p ͻ 0.01, respectively; one-way analysis of variance [anova]). the virus titers in the lungs were detectable up until 5 days p.i. virus was undetectable in the respiratory tract at 7 days p.i. although ihc revealed that various organs from tg2 mice were positive for the hdpp4 antigen (fig. 2b ), no infectious virus was detected in the liver, spleen, kidney, heart, intestines, and brain up to 7 days p.i. (table 2 ). in contrast, virus was detected in the respiratory tract of c57bl/6 mice at 6 h p.i. only. these observations suggest that mers-cov infects and replicates mainly in the lower respiratory tract of tg2 mice and is eliminated within 7 days of infection. several research groups have developed tg mouse models of mers-cov infection; however, in these models, viral replication and mers-cov rna were detected in the brain (5-7, 27). thus, we next measured the amount of viral rna in the brain of tg2 mice at 6 h and at 1, 3, 5, and 7 days p.i. by real-time reverse transcription-pcr (rt-pcr) using primers specific for mers-cov; however, no mers-cov rna was detected in the brain of tg2 mice. furthermore, another study showed that experimental infection of common marmosets with mers-cov resulted in viremia (4) . quantitative examination of viral rna levels in tg2 mice revealed very low copy numbers of viral rna in the blood at 3 and 5 days p.i., while sera from tg2 mice were negative for the virus ( table 2 ). these results suggest that although intranasal inoculation of tg2 mice with mers-cov causes no neuroinvasion, it may induce viremia. several animal studies have identified mers-cov rna in the lymphoid organs of infected animals (3, 4, 28) , but no infectious virus was detected in the spleen from tg2 mice up to 7 days p.i. (table 2 ). to investigate whether lymphoid organs in tg2 mice are susceptible to mers-cov infection, we harvested splenocytes from tg2 and c57bl/6 mice and estimated infectivity and mers-cov rna levels (fig. 4d) . although the amount of infectious mers-cov in splenocytes was below the detection limit, viral rna was detected in splenocytes from tg2 mice (peaking at 2 days p.i.). thus, lymphoid organs of tg2 mice were as susceptible to mers-cov infection as those reported in other animal studies although lymphoid organs were not a major site of mers-cov replication in tg2 mice after intranasal inoculation. acute inflammatory changes in the lungs of hdpp4-tg mice after mers-cov inoculation. mers-cov infection of the nasal cavity, lungs, brain, spinal cord, liver, spleen, kidney, heart, and gastrointestinal tract of tg2 mice was examined histopathologically on days 1, 3, 5, 7, 14, and 35 p.i (n ϭ 3; one or two females and one or two males per time point). histopathological investigations revealed that tg2 mice showed progressive pulmonary inflammation associated with acute virus infection, from which they recovered (fig. 5 ). on day 1 p.i., there was no obvious infiltration of the lungs in tg2 mice; however, mild cellular degeneration and viral antigen-positive cells were seen in the bronchioles and a few alveolar areas ( fig. 5a to c). double-immunofluorescence staining revealed that mers-cov antigen colocalized with hdpp4-positive bronchioles and alveolar cells on day 1 p.i. (fig. 6 ). on days 3 and 5 p.i., inflammatory reactions, including partial and/or mild perivascular and peribronchiolar infiltration by mononuclear cells and eosinophils in response to viral antigens, were observed in alveolar areas of lung tissue from tg2 mice (fig. 5d to i). from day 3 p.i. onwards, the alveolar area was the main site of inflammatory responses to viral replication (fig. 5f , i, and l). on day 7 p.i., the point at which tg2 mice showed weight loss, there was evidence of severe lung inflammation, including perivascular and alveolar septal thickening, caused by infiltrating mononuclear cells; some alveoli were positive for viral antigens (fig. 5k ). at day 14 p.i., focal cellular infiltration was still evident in the peribronchioles and alveolar septa although viral antigens and inflammatory responses had cleared from the lungs by day 35 p.i. (fig. 5m to p). there was no evidence of diffuse alveolar damage in the lungs up to day 35 p.i. these findings suggest that progressive immunopathology occurred uniformly throughout the lungs but resolved within 14 days after infection. neither histopathology nor ihc detected inflammatory infiltration or viral antigens in the nasal cavity through 35 days p.i. in addition, there was no inflammation or viral antigen expression in the brain through 35 days p.i. i a g i a g i a g i a g i a g i a g i a (fig. 7) . in contrast, c57bl/6 mice showed no histopathological changes or viral antigen in any organ, including the lung. these results indicate that tg2 mice suffer acute pneumonia after infection of the lungs with mers-cov, which is related to expression of hdpp4 in the bronchiolar epithelium and pneumocytes. splenocytes from tg2 mice (fig. 4d) ; however, the spleen and other lymphoid tissues did not harbor viral antigens. furthermore, mers-cov induced t cell apoptosis upon infection in vitro (28) , whereas immunohistochemical staining detected no evidence of apoptosis in lymphoid tissues, including spleen and lymph nodes, of mers-cov-infected tg2 mice. similar to findings in the other mouse models in which mouse dpp4 was replaced with hdpp4 (12), mers-cov replication and pathology were localized in the lungs in tg2 mice. differences in the immunopathology of mers-cov infection between young and adult hdpp4-tg mice. according to an epidemiological study (29) , age (ͼ45 years) is considered to be one of the risk factors for mers-cov infection in humans. therefore, we infected 25-week-old mice with mers-cov. tg2 mice showed significant weight loss from days 7 and 8 p.i. before recovering by day 14 p.i. (tg2 mice, n ϭ 6 [one female and five males]; non-tg mice, n ϭ 7 [three females and four males]) (fig. 8a) . however, 25-week-old tg2 mice showed no obvious clinical signs (such as respiratory illness and mortality). the 25-week-old tg2 mice had seroconverted by 35 days p.i., whereas the c57bl/6 mice had not (fig. 8b) . next, we examined viral replication kinetics and sites of viral replication in 25-week-old tg2 and non-tg mice (n ϭ 4; two females and two males per time point). the nasal wash fluid from one out of four tg2 mice contained barely detectable levels of infectious virus at 1, 3, and 5 days p.i. (fig. 8c) . supernatants from maxilla tissue homogenates (20%) from tg2 mice contained 10 1.7 and 10 2.0 tcid 50 /g at 1 and 3 days p.i., respectively, although the titer was undetectable at 5 days p.i. the viral titers in lung wash fluid from tg2 mice were detectable up until 3 days p.i., while the supernatants from lung tissue homogenates (20%) from tg2 mice showed a high viral load from 1 to 5 days p.i.; infectious virus was detectable up until 7 days p.i. viral loads in the respiratory tract peaked at 3 days p.i. although no virus was detectable in the respiratory tract of 10-week-old tg mice at 7 days p.i., infectious virus was detected in the lungs of 25-week-old tg mice up until 5 days p.i. in addition, infectious virus was detected in the lungs of one of four 25-week-old tg mice (10 2.5 tcid 50 /g) even at 7 days p.i. we also found that viral titers in the nasal wash fluid, maxilla (including nostril), lung wash fluid, and lungs of 25-week-old tg2 mice on day 3 p.i. (10 2.6 tcid 50 /ml, 10 3.3 tcid 50 /ml, 10 2.3 tcid 50 /ml, and 10 4.9 tcid 50 /ml, respectively) were slightly higher than those in 10-week-old tg2 mice (10 1.6 tcid 50 /ml, 10 2.9 tcid 50 / ml, 10 1.8 tcid 50 /ml, and 10 4.5 tcid 50 /ml, respectively) (p ϭ 0.04, student's t test with welch's correction). histopathological analysis revealed that 25-week-old tg2 mice showed delayed and prolonged inflammatory responses in the lung compared with those in 10-week-old tg2 mice (fig. 9) . interestingly, viral antigen-positive cells were seen in the alveolar area on day 1 p.i. and then in the bronchi on day 3 p.i., along with a sparse cellular infiltrate (fig. 9a to f) . cellular infiltration (which included mononuclear cells and polynuclear cells) was observed in the alveoli from 5 days p.i.; this expanded on day 7 p.i. (fig. 9g to l). focal cell infiltration was seen in the alveoli on day 14 p.i., and lymphoid cell aggregates were seen around bronchioles and blood vessels on day 35 p.i. (fig. 9m to r). next, we compared inflammation of the alveoli in 10-week-old tg mice and 25week-old tg mice on day 7 p.i. ionized calcium binding adaptor molecule 1 (iba-1) is expressed specifically by monocytes/macrophages and is upregulated when these cells are activated. the predominant inflammatory infiltrate within the lungs of both 10week-old and 25-week-old tg mice comprised iba-1-positive large cells and cd3positive mononuclear cells (fig. 10) . phagocytic vacuoles were prominent in large iba-1-positive cells from 25-week-old tg mice. (30) . therefore, we measured the levels of 20 cytokines and chemokines in lung samples from both 10-week-old and 25-week-old tg2 mice inoculated with either mers-cov or minimal essential medium (mem). measurements were made at 6 h and at 1, 3, 5, and 7 days p.i. (n ϭ 3 to 4 [2 females and 1 to 2 males per time point] and n ϭ 4 [2 females and 2 males per time point]) ( fig. 11a and b, for 10-week-old and 25-week-old mice, respectively). on day 3 p.i., we observed early expression of gamma interferon (ifn-␥)-induced protein 10 (ip-10) in the lungs of both 10-and 25-week-old tg2 mice, a level which was significantly higher than that in control mice; this increase lasted through day 7. this was followed by a transient increase in expression of interleukin-6 (il-6), il-13, and monocyte chemotactic protein-1 (mcp-1) in lungs from both 10-and 25-week-old tg2 mice at day 5 p.i. high levels of macrophage inflammatory protein 1␣ (mip-1␣) and monokine induced by ifn-␥ (mig) were detected in the lungs of both groups of tg2 mice from days 3 or 5 to 7 p.i., whereas il-12 levels increased at day 7 p.i. ifn-␥ production in the lungs of 10-week-old tg2 mice peaked significantly on day 5 p.i. while high values were seen in both infected and noninfected 25-week-old mice during the observation period. in contrast, expression of ip-10, il-12, and il-1␤ in 25-week-old tg mice was higher than that in 10-week-old tg2 mice. interestingly, il-1␣ and il-17 were detected only in 25-week-old tg2 mice infected with mers-cov. il-1␣, a potent proinflammatory cytokine associated with inflammation and fever, was detected from 3 days p.i. and remained significantly elevated until 7 days p.i.; il-17 (a proinflammatory cytokine that recruits monocytes and neutrophils) was detected from 3 days p.i. and peaked at 5 days p.i. before falling at 7 days p.i. these results indicate that mers-cov infection induces production of acute inflammatory chemokines and cytokines in the lungs. in addition, aging causes more severe immunopathology; this means that young and adult tg mice show different pathologies in the lung after mers-cov infection. furthermore, we measured expression of mrna encoding ifn-␣4 and ifn-␤ (type i ifn with antiviral activity) in the lungs of 10-and 25-week-old mice at 6 h and at 1, 3, 5, and 7 days p.i. by real-time reverse transcription-pcr (rt-pcr) (31). we did not find any evidence of ifn-␣4 or ifn-␤ in the lungs from 10-week-old tg2 mice at early times postinfection; however, we observed a transient increase in ifn-␣4 expression in the lungs of two out of four tg2 mice at 5 days p.i.; this level fell by 7 days p.i. (fig. 11c) . day 5 p.i. was the time point at which the amount of virus in the lungs of tg2 mice began to fall. no ifn-␤ mrna was detectable in lung samples from either group. on the other hand, the lungs of 25-week-old tg2 mice showed a transient increase in ifn-␣4 and ifn-␤ mrna expression at 3 days p.i. (fig. 11c ). in addition, ifn-␣4 and ifn-␤ mrna expression was higher than that in 10-week-old tg2 mice. taken together, these results indicate that both type i and type ii ifn contribute to the immunopathology of the lungs of 25-week-old tg2 mice infected with mers-cov. here, we describe a new hdpp4-tg mouse expressing the human gene under the control of an endogenous human promoter. this mouse model shows a pattern of hdpp4 expression that closely mimics that in human tissues and is similar to that in other recent models (5) (6) (7) . this mouse model also shows susceptibility to infection by mers-cov; this mimics the nonlethal observations in other mouse models (13, 14) . after intranasal inoculation with a human isolate of mers-cov, the tg mice developed acute and mild interstitial pneumonia; however, the infection was nonlethal and so did not mimic severe cases seen in human mers-cov patients. mers-cov infection can cause severe illness, resulting in acute respiratory distress syndrome, although a large number of mers-cov infections follow a mild or asymptomatic course in healthy individuals (32) (33) (34) (35) . thus, this tg mouse model reflects the natural course of a mild mers-cov infection. the majority of severe mers-cov cases occur in middle-aged and older males (36, 37) . therefore, we infected tg2 mice aged 25 weeks with mers-cov. the mice showed prominent proinflammatory responses and prolonged pulmonary inflammation compared with responses in tg2 mice aged 10 weeks. however, none of the infected tg2 mice had a severe outcome, such as respiratory distress, that led to death. epidemiologically, patients with diabetes, kidney failure, or chronic lung disease, all of which might weaken the immune system, tend to have a poor outcome after infection by mers-cov (http://www.who.int/csr/don/23-september-2015-mers-kuwait/en/). thus, it is presumed that a combination of older age and underlying disease might also increase mortality in this animal model. this hdpp4-tg mouse model, which lacks the clinical signs and mortality associated with severe mers-cov infection, is likely to be less advantageous than other lethal mouse models with respect to development of novel vaccines or antiviral agents (12) (13) (14) . when we asked why the tg2 mice showed nonlethal responses to infection, we could not ignore the fact that virus levels in lungs were lower than those reported for other mers mouse models (5, 12, 13, 38, 39) . one reason for this is that the transgene used in this study is a hemizygote, meaning that the copy number or expression level may be lower than that in mice homozygous for hdpp4. in addition, the dpp4 protein is active as a dimer (40) , but the tg2 mice harbor both murine and hdpp4. we presume that the viral yield in the lungs of tg2 mice was low because of heterodimers formed by hdpp4 and murine dpp4. to address this, we constructed structural models of homo-and heterodimers comprising human and mouse dpp4. notably, the estimated interaction energy of the dpp4 heterodimers was greater than that of murine and hdpp4 homodimers (ϫ358.2, ϫ347.6, and ϫ344.6 kcal/mol, respectively). these results suggest that dpp4 heterodimers are as stable as dpp4 homodimers. cockrell et al. reported that mouse dpp4 does not support mers-cov entry (38) . thus, the presence of stable dpp4 heterodimers may be a reason for the lower levels of infection in our mouse model. further study is necessary to clarify this. some research groups generated a mouse-adapted mers-cov for use in severe/ lethal mers-cov infection mouse models (13, 14) . this may be one way to establish severe mers infection in our tg2 mice. while the tg2 mice expressed hdpp4 protein in the liver, spleen, kidney, heart, lung, gastrointestinal tract, pancreas, and brain, viral infection and replication were limited (mainly) to the lower respiratory tract, with little upper respiratory tract involvement, after intranasal inoculation of mers-cov. tg2 mice developed interstitial pneumonia, and mers-cov antigens were detected in the lungs. virus yields in the lung were up to 100-fold higher than those in the upper respiratory tract. most mers patients exhibit a severe lower respiratory tract infection, with little involvement of the upper respiratory tract (36) . this suggests that mers-cov infection in tg2 mice mimics mild infection in humans. in vitro analysis of mers-cov suggests that the virus also infects human t cells and macrophages (28, 41, 42) . we detected mers-cov rna in serum and spleen cells from tg2 mice. these data are similar to those generated from another tg mouse model in which mouse dpp4 was replaced with hdpp4 under the control of the endogenous mouse dpp4 promoter (12) . mers-cov infection of t cells might affect immunopathology or induction of apoptosis in tg mice, but we found no clear evidence of this. although tg2 mice showed systemic viremia, infection of organs (except lung) did not lead to secondary complications. the disease phenotype (including clinical symptoms, viral titer in the lung, and acute pneumonia) appeared to be driven by infiltration by macrophages and lymphocytes; this is similar to the phenotype observed in another tg mouse model harboring hdpp4 under the control of the endogenous mouse dpp4 promoter (12) . the tg2 mice described herein did not show any brain or renal lesions after mers-cov infection. other tg mouse models in which hdpp4 is expressed under a strong ubiquitous promoter show high levels of viral rna and inflammation in the lungs, which are accompanied by brain lesions (5, 7, 11) . a fatal case of human mers-cov infection published by ng et al. showed no sign of mers-cov infection in the brain (43) . to date, no reports suggest that mers-cov shows tropism for brain tissue. the primary target of mers-cov is the lower respiratory tract; however, patients with mers often show signs of acute kidney failure (1, 43). in addition, mers-cov was identified in the urine of mers patients (44, 45) . data from the first autopsy case did find pathological signs in the patient's kidneys although ihc revealed no evidence of mers-cov replication in the kidneys (43) . in addition, acute renal failure in this patient was not caused by mers-cov directly; rather, it was caused by hypotension (43) and/or acute respiratory distress syndrome (46) . histopathological analysis identified cd3-positive t cells and iba-1-positive macrophages in the lungs of tg2 mice on day 7 p.i., which correlated with expression of inflammatory cytokines and inflammatory infiltrates in the lung. tg2 mice aged 10 and 25 weeks showed increased expression of cytokines and chemokines associated with migration of t cells and activation of macrophages, including ip-10, il-6, il-13, mcp-1, ifn-␥, mip-1␣, mig, and il-12, in the lungs at day 5 and/or 7 p.i. this result is the same as that observed in a hdpp4 knock-in mouse model reported by coleman et al. (12) . in this hdpp4 knock-in mouse model, cd8 ϩ t cells and macrophages affected the course of mers-cov-induced disease (12) . in addition, tg2 mice expressed mrna encoding the type i ifn, ifn-␣4, during the early phase of the mers-cov infection. importantly, the pathogenic and immune response data from the knock-in mouse model and our own model are similar. thus, an acute inflammatory reaction (including production of type i and type ii ifns) and infiltration by macrophages might clear the virus from the lung, thereby preventing progression to mers. interestingly, we detected il-1␣ and il-17 in the lungs of 25-week-old tg2 mice, but not those of 10-week-old tg2 mice, after mers-cov infection. both il-1␣ and il-17 are proinflammatory cytokines that attract monocytes and neutrophils; therefore, they may exacerbate immunopathology after infection. these findings support the notion that the severity of mers-cov infection is age dependent. age is one of the most common factors related to severity and mortality of mers infection; however, the underlying pathology is unclear (47) . many studies have examined immune responses of mers patients (30, (48) (49) (50) (51) (52) . indeed, elevated serum levels of il-6, il-12, ip-10, and ifn-␥ are observed in patients during the early period after severe infection (48) (49) (50) (51) . in addition, a prominent proinflammatory th1 and th17 response, including production of ifn-␥, tumor necrosis factor alpha (tnf-␣), il-15, and il-17, is seen in patients during the acute phase of mers-cov infection (52) . in contrast, we found that administration of poly(i·c) to tg2 mice induced a mild increase (or earlier induction) in innate immune responses compared with those in c57bl/6 mice and non-tg mice. this suggests that overexpression of hdpp4 might influence immune responses in tg2 mice. thus, we must exercise caution when assessing the relationship between immunopathology and outcome in patients and animal models of mers-cov; however, proinflammatory responses seem to contribute to immunopathology during the acute phase of mers-cov infection in both patients and mouse models. in summary, we generated an hdpp4-tg mouse model showing mild respiratory infection by mers-cov. while this tg mouse has limitations as a model for human mers (i.e., lower virus titer in the lungs and mild disease), the immunopathology seems to resemble a mild and early stage of infection in humans. even though it has limitations, this tg mouse model will increase our understanding of the mechanisms underlying mers-cov infection. indeed, we recently used this mouse model to confirm a role for transmembrane protease serine type 2 (tmprss2) during mers-cov infection (53) . this animal model may provide new insight into disease pathogenesis and guide development of therapeutic interventions that mitigate mers. ethics statements. experiments using recombinant dna and pathogens were approved by the committee for experiments using recombinant dna and pathogens at the national institute of infectious diseases, tokyo, japan. all animal experiments were approved by the animal care and use committee of the national institute of infectious diseases and the national center for global health and medicine (ncgm) research institute and were conducted in accordance with institutional guidelines for the care and use of animals. all animals were housed in a japan health sciences foundation-certified facility. all human samples used in this study were obtained from us biomax, inc., genetex, inc., alpha diagnostics international, or protein biotechnologies. the protocols were approved by the health insurance portability and accountability act (hipaa) or institutional review board (irb). cells and viruses. mers-cov, hcov-emc 2012 strain, was kindly provided by bart haagmans and ron fochier (erasmus medical center, rotterdam, the netherlands) and was used throughout the study. vero e6 cells, purchased from the american type cell collection (manassas, va), were cultured in eagle's mem containing 5% fetal bovine serum (fbs), 50 iu/ml penicillin g, and 50 g/ml streptomycin (5% fbs-mem). stocks of mers-cov were propagated and titrated on vero e6 cells and cryopreserved at ϫ80°c. viral infectivity titers are expressed as the tcid 50 /milliliter on vero e6 cells and were calculated according to the behrens-kärber method. work with infectious mers-cov was performed under biosafety level 3 conditions. virus isolation and titration. lung wash fluids and liver, kidney, heart, spleen, intestine, and brain tissue samples from tg2, non-tg, and c57bl/6 mice were collected at the time of postmortem examination and stored at ϫ80°c. tissue homogenates (20%, wt/vol) were prepared in 2% fbs-mem, and samples were inoculated onto vero e6 cell cultures, which were then examined for cytopathic effects (cpe) for 5 days. blind passage was performed after freezing and thawing cells from the first-or second-round passages. if mers-cov-specific cpe were not observed in the first-, second-, or third-round cultures, the samples were deemed negative for infectious virus. viral infectivity titers were determined in vero e6 cell cultures using the microtitration assay described above. mers-cov neutralizing assay. blood was obtained from each mouse and allowed to clot. sera were then obtained by centrifugation and inactivated by incubation at 56°c for 30 min. one hundred tcid 50 aliquots of mers-cov were incubated for 1 h in the presence or absence of mouse serum (serially diluted 2-fold) and then added to confluent vero e6 cell cultures in 96-well microtiter plates. the presence of viral cpe was determined on day 5, and the titers of neutralizing antibody were determined as the reciprocal of the highest dilution at which no cpe were observed. the lowest and highest serum dilutions tested were 1:2 and 1:512, respectively. generation of hdpp4-tg mice. to generate tg mice expressing hdpp4, a bac vector carrying the hdpp4 gene (clone rp11-345j9) was purchased from advanced genotechs co., japan. the bac dna was purified using a large-construct kit (qiagen) according to the manufacturer's instructions and suspended in te buffer (10 mm tris-hcl and 0.1 mm edta, ph 7.5) at a concentration of 4 ng/l. tg mice were generated using standard procedures (23). the purified bac clones were microinjected into the pronuclei of fertilized eggs from bdf1ϫc57bl/6ncr mice (slc, inc., hamamatsu, japan) and then transplanted into pseudopregnant icr mice (slc inc.). expression of the transgene was assessed by fluorescence-activated cell sorter (facs) analysis as described below. the tg mice were then backcrossed onto c57bl/6ncr for five generations. after weaning, the mice were tested for tg integration by pcr and facs analysis. briefly, genomic dna isolated from ear punch tissues was subjected to pcr using hdpp4-specific primers ( table 2) , and lymphocytes were isolated from blood taken from the tail vein. lymphocytes were screened for hdpp4 protein expression by flow cytometry analysis. tg mice and their non-tg littermates were used for the mers-cov infection study. flow cytometry analysis. blood was collected from the retro-orbital venous plexus under isoflurane anesthesia using heparinized capillary tubes. the samples were then treated with red blood cell lysis buffer (sigma-aldrich, st. louis, mo) to remove erythroid cells. for immunofluorescence staining, cells kit (thermo fisher scientific). a panel of inflammatory cytokines and chemokines (basic fibroblast growth factor [bfgf], granulocyte-macrophage colony-stimulating factor [gm-csf], ifn-␥, il-1␣, il-1␤, il-2, il-4, il-5, il-6, il-10, il-12p40/p70, il-13, il-17, ip-10, keratinocyte chemoattractant [kc] , mcp-1, mig, mip-1␣, tnf-␣, and vascular endothelial growth factor) was measured according to the manufacturer's protocols. isolation of splenocytes and infection with mers-cov. spleens were removed aseptically from tg2 and c57bl/6 mice (n ϭ 3 each), dissociated in rpmi 1640 medium, and pressed gently through a 40-m-pore-size nylon mesh filter. the cell suspension was centrifuged at 400 ϫ g for 10 min, and red blood cells were lysed with blood cell lysis buffer (final concentrations of 155 mm nh 4 cl, 10 mm khco 3 , and 0.1 mm edta, ph 7.3) at room temperature for 5 min. the cells were washed twice with rpmi 1640 medium and centrifuged at 1,000 ϫ g for 10 min. hdpp4-expressing cd3 ϩ t cells within the splenocyte population were detected by flow cytometry analysis. the percentage of cd3 ϩ t cells was 39.11% ϯ 3.8%, and that of hdpp4-expressing cd3 ϩ t cells was 26.46% ϯ 1.9%. the cells were resuspended in the medium and infected with mers-cov (multiplicity of infection [moi] of 1). viral replication was determined after 1 and 2 days of culture. viral infectivity titers were measured in vero e6 cell cultures using a microtitration assay. to detect the mers-cov genome in splenocytes, rna from splenocytes infected with mers-cov was extracted at 1 and 2 days p.i. and subjected to quantitative real-time rt-pcr (10) . molecular modeling of dpp4 homo-and heterodimers. dpp4 dimer models were constructed using the molecular operating environment (moe) (chemical computing group, inc., montreal, qc, canada) based on the crystal structure of hdpp4 at a resolution of 2.55 å (pdb accession number 2onc). stereochemical quality was assessed using the ramachandran plot and atom clashes applications in moe. interaction energy, which is an indicator of the affinity of the dimer, was calculated using the potential energy application in moe. statistical analysis. data are expressed as the means and standard errors of the means. statistical analyses were performed using graphpad prism, version 5, software (graphpad software, inc., la jolla, ca). intergroup comparisons were performed using one-way and two-way anova or student's t test with welch's correction. a p value of ͻ0.05 was considered statistically significant. 05% nan 3 ), and fc receptors were blocked by incubation for 20 min on ice with an unlabeled anti-mouse cd16/cd32 monoclonal antibody (clone 2.4g2; bay bioscience co., ltd ca) and an allophycocyanin (apc)-labeled anti-human cd3 antibody human skeletal muscle lysates were purchased from protein biotechnologies (ramona, ca) and used under irb-approved protocols. to prepare protein samples from the tg and non-tg mouse organs, tissues were homogenized in 0.5 ml of radioimmunoprecipitation assay (ripa) buffer (50 mm tris/hcl and the protein concentrations were measured using a pierce bicinchoninic acid (bca) protein assay kit after being blocked, the membranes were incubated for 1 h with a goat anti-hdpp4 antibody (0.1 g/ml) (af1180 followed by incubation with a donkey anti-goat horseradish peroxidase (hrp)-conjugated antibody (abcam) and an anti-rabbit hrp-conjugated antibody (abcam). the bands were detected by an immobilon western chemiluminescent hrp substrate (millipore) and an las-3000 apparatus inflammatory cytokine profiles in 20% (wt/vol) lung homogenates were detected using a commercial mouse cytokine 20-plex antibody bead kit (thermo fisher scientific), as described by the manufacturer. inoculation of mice with mers-cov. tg2 and non-tg mice (9 to 10 weeks or 25 weeks old) and tg2-balb mice (12 to 22 weeks old) were anesthetized and inoculated intranasally with 1 ϫ 10 5 tcid 50 (30 l) of mers-cov. body weight was measured daily for 14 days (n ϭ 4 to 8 per group), and animals were sacrificed at 6 h and at 1, 3, 5, 7, 14, and 35 days p.i. to analyze virus replication, hematological parameters, cytokine expression, and disease pathology (n ϭ 3 to 6 per group) for double staining of cd3 (t cells) and iba-1 (macrophages) antigen, we used a rabbit anti-human cd3 antibody tucson, az) and a rabbit anti-human iba-1 antibody diaminobenzidine (dab 0) for 10 min at 121°c. the second staining was performed for iba-1 with vina green. nuclei were counterstained with hematoxylin for 10 s. to detect apoptosis, terminal deoxynucleotidyltransferase-mediated dutp-biotin nick end labeling (tunel) was performed using an in situ cell death detection kit (roche) dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-emc middle east respiratory syndrome coronavirus (mers-cov) causes transient lower respiratory tract infection in rhesus macaques infection with mers-cov causes lethal pneumonia in the common marmoset generation of a transgenic mouse model of middle east respiratory syndrome coronavirus infection and disease multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with middle east respiratory syndrome-coronavirus middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4 the middle east respiratory syndrome coronavirus (mers-cov) does not replicate in syrian hamsters wild type and innate immune deficient mice are not susceptible to the middle east respiratory syndrome coronavirus no susceptibility of neonatal and adult rats against the middle east respiratory syndrome coronavirus rapid generation of a mouse model for middle east respiratory syndrome cd8 ϩ t cells and macrophages regulate pathogenesis in a mouse model of middle east respiratory syndrome mouse-adapted mers coronavirus causes lethal lung disease in human dpp4 knockin mice a mouse model for mers coronavirus-induced acute respiratory distress syndrome middle east respiratory syndrome coronavirus outbreak in the republic of korea clinical aspects and outcomes of 70 patients with middle east respiratory syndrome coronavirus infection: a single-center experience in saudi arabia the predictors of 3-and 30-day mortality in 660 mers-cov patients the epidemiology of middle east respiratory syndrome coronavirus in the kingdom of saudi arabia mortality risk factors for middle east respiratory syndrome outbreak clinical presentation and outcomes of middle east respiratory syndrome in the republic of korea transgenic mice susceptible to poliovirus transgenic mouse model for the study of enterovirus 71 neuropathogenesis overview: engineering transgenic constructs and mice accessory cell signals involved in t-cell activation cd26: a surface protease involved in t-cell activation the t cell triggering molecule tp103 is associated with dipeptidyl aminopeptidase iv activity a human dpp4-knockin mouse's susceptibility to infection by authentic and pseudotyped mers-cov middle east respiratory syndrome coronavirus efficiently infects human primary t lymphocytes and activates the extrinsic and intrinsic apoptosis pathways the pattern of middle east respiratory syndrome coronavirus in saudi arabia: a descriptive epidemiological analysis of data from the saudi ministry of health pathogenesis of middle east respiratory syndrome coronavirus effects of toll-like receptor stimulation on eosinophilic infiltration in lungs of balb/c mice immunized with uv-inactivated severe acute respiratory syndrome-related coronavirus vaccine middle east respiratory syndrome coronavirus infections in health care workers state of knowledge and data gaps of middle east respiratory syndrome coronavirus (mers-cov) in humans estimation of severe middle east respiratory syndrome cases in the middle east a family cluster of middle east respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case update: severe respiratory illness associated with middle east respiratory syndrome coronavirus (mers-cov)-worldwide multifacility outbreak of middle east respiratory syndrome in taif, saudi arabia mouse dipeptidyl peptidase 4 is not a functional receptor for middle east respiratory syndrome coronavirus infection pre-and postexposure efficacy of fully human antibodies against spike protein in a novel humanized mouse model of mers-cov infection one site mutation disrupts dimer formation in human dpp-iv proteins middle east respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells active replication of middle east respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of middle east respiratory syndrome coronavirus infection in the united arab emirates kinetics and pattern of viral excretion in biological specimens of two mers-cov cases clinical features and virological analysis of a case of middle east respiratory syndrome coronavirus infection updates in the management of acute lung injury: a focus on the overlap between aki and ards mers transmission and risk factors: a systematic review distinct immune response in two mers-cov-infected patients: can we go from bench to bedside? characteristics of traveler with middle east respiratory syndrome comparative and kinetic analysis of viral shedding and immunological responses in mers patients representing a broad spectrum of disease severity immune responses to mers coronavirus during the acute and convalescent phases of human infection mers-cov infection in humans is associated with a pro-inflammatory th1 and th17 cytokine profile tmprss2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection synthetic double-stranded rna poly(i:c) combined with mucosal vaccine protects against influenza virus infection we thank bart haagmans and ron fouchier for providing mers-cov (isolate hcov-emc/2012) and satoshi koike, ken fujii (tokyo metropolitan institute of medical science), and shutoku matsuyama (national institute of infectious diseases) for helpful discussions. we also thank ayako harashima and midori ozaki for technical assistance.this work was supported by the following: a grant-in-aid for research (h25-shinko-wakate-004) from the ministry of health, labor, and welfare, japan; the research program on emerging and reemerging infectious diseases (grants jp17fk0108313, jp18fk0108058, and jp18fk0108072) from the japan agency for medical research and development; grants-in-aid for scientific research from the ministry of education, culture, sports, science and technology, japan (16k09951 and 18h02665), and a grant from the national center for global health and medicine (27a1102). key: cord-267482-afqfymbq authors: ryu, seungjin; shchukina, irina; youm, yun-hee; qing, hua; hilliard, brandon k.; dlugos, tamara; zhang, xinbo; yasumoto, yuki; booth, carmen j.; fernández-hernando, carlos; suárez, yajaira; khanna, kamal m.; horvath, tamas l.; dietrich, marcelo o.; artyomov, maxim n.; wang, andrew; dixit, vishwa deep title: ketogenesis restrains aging-induced exacerbation of covid in a mouse model date: 2020-09-12 journal: biorxiv doi: 10.1101/2020.09.11.294363 sha: doc_id: 267482 cord_uid: afqfymbq increasing age is the strongest predictor of risk of covid-19 severity. unregulated cytokine storm together with impaired immunometabolic response leads to highest mortality in elderly infected with sars-cov-2. to investigate how aging compromises defense against covid-19, we developed a model of natural murine beta coronavirus (mcov) infection with mouse hepatitis virus strain mhv-a59 (mcov-a59) that recapitulated majority of clinical hallmarks of covid-19. aged mcov-a59-infected mice have increased mortality and higher systemic inflammation in the heart, adipose tissue and hypothalamus, including neutrophilia and loss of γδ t cells in lungs. ketogenic diet increases beta-hydroxybutyrate, expands tissue protective γδ t cells, deactivates the inflammasome and decreases pathogenic monocytes in lungs of infected aged mice. these data underscore the value of mcov-a59 model to test mechanism and establishes harnessing of the ketogenic immunometabolic checkpoint as a potential treatment against covid-19 in the elderly. highlights natural mhv-a59 mouse coronavirus infection mimics covid-19 in elderly. aged infected mice have systemic inflammation and inflammasome activation murine beta coronavirus (mcov) infection results in loss of pulmonary γδ t cells. ketones protect aged mice from infection by reducing inflammation. etoc blurb elderly have the greatest risk of death from covid-19. here, ryu et al report an aging mouse model of coronavirus infection that recapitulates clinical hallmarks of covid-19 seen in elderly. the increased severity of infection in aged animals involved increased inflammasome activation and loss of γδ t cells that was corrected by ketogenic diet. aging-driven reduced resilience to infections is dependent in part on the restricted t cell repertoire diversity together with impaired t and b cell activation as well as inflammasomedriven low-grade systemic inflammation that compromises innate immune function (akbar and gilroy, 2020; camell et al., 2017; youm et al., 2013) . consequently, 80 percent of deaths due to in us are in adults > 65 years old (https://www.cdc.gov/) and aging is the strongest factor to increase infection fatality (pastor-barriuso et al., 2020; perez-saez et al., 2020; ward et al., 2020) . lack of an aging animal model that mimics sars-cov-2 immunopathology has been a major limitation in the effort to determine the mechanism of disease and to develop effective therapeutics for the elderly. inability of mouse ace2 to bind sars-cov-2 is a significant hurdle in understanding the basic mechanism of covid-19. accordingly, several approaches have been employed to develop models including introduction of human-ace2 in mice and transient induction of hace2 through adenoviral-associated vectors. these models have begun to yield important information on the mechanism of disease development. for example, epithelial cell specific induction of hace2 (k18-hace2) as a model of sars-cov-2 infection demonstrated that post intranasal inoculation, animals develop lung inflammation and pneumonia driven by infiltration of monocytes, neutrophils and t cells . also, initial studies that employ lung ciliated epithelial cell-specific hfh4/foxj1 promoter driven hace2 transgenic mice show sars-cov-2 infection induces weight loss, lung inflammation and approximately 50% mortality rate, suggesting the usefulness of this model to understand the mechanism of immune dysregulation (jiang et al., 2020) . however, significant hurdles remain to understand the mechanism and test therapeutic interventions that are relevant to disease severity in elderly, as complicated breeding and specific mutations need to be introduced in hace2 transgenic strains in addition to the time required to age these models. the mouse model of sars-cov-2 based on adeno-associated virus (aav)-mediated expression of hace2 may allow circumvention of the above constrains. the delivery of hace2 into the respiratory tract of c57bl/6 mice with aav9 causes a productive infection as revealed by >200 fold increase in sars-cov-2 rna and show similar interferon gene expression signatures as covid-19 patients . however, in young wild-type mice, this model induces mild acute respiratory distress syndrome (ards) and does not cause neutrophilia, weight loss or lethality . other studies using replication deficient adenovirus-mediated transduction of hace in mice and infection with sars-cov-2 produced 20% weight-loss including lung inflammation (hassan et al., 2020; sun et al., 2020) . furthermore, genetic remodeling of the sars-cov-2 spike receptor binding domain that allow interaction with mace demonstrated peribronchiolar lymphocytic inflammatory infiltrates and epithelial damage but no weight-loss in infected mice (dinnon et al., 2020) . moreover, middle aged female mice (one year old, analogous to approx. 43 year old human), display greater lung pathology and loss of function post infection with 10% weight-loss followed by spontaneous recovery 7 days post infection (dinnon et al., 2020) . however, it remains unclear if this model replicates the clinical, systemic inflammation and immunological response and mortality observed in covid-19. the mouse hepatitis virus (mhv) and sars-cov-2 are both ards-related beta coronaviruses with a high degree of homology (gorbalenya et al., 2020) . until the emergence of sars-cov-2, the natural infection with mhv mouse coronavirus-a59 (mcov-a59) has traditionally been thought to be of minor relevance to human disease and largely been a primary veterinary concern to maintain the specific-pathogen free status of mouse research facilities (hickman and thompson, 2004) . however, lack of an aging mouse model of necessitates re-evaluation of mcov-a59 to investigate the mechanism of multi-organ inflammation, morbidity and mortality caused by the disease. importantly, the mcov-a59 utilizes the entry receptor ceacam1, which is expressed on respiratory epithelium, but also on enterocytes, endothelial cells, and neurons, much like ace2 (godfraind et al., 1995) thus allowing the study of wide-ranging systemic impacts of infection. moreover, natural infection with mcov-a59 causes ards in c57bl/6j animals, while all other mhv strains require the a/j or type-i interferon-deficient background, for the development of severe disease (de albuquerque et al., 2006; khanolkar et al., 2009; yang et al., 2014) limiting their use. lastly, another major practical advantage of natural infection with mcov-a59 mouse model is that it does not require limited bsl3 facilities, thus allowing the allocation of precious world-wide bsl3 specialized laboratory space to be prioritized for human sars-cov-2 virus studies in primates and other models, which cannot be achieved by using mouse-adapted sars-cov-2 models. aging-induced chronic inflammation in the absence of overt infections is predominantly driven by the nlrp3 inflammasome (bauernfeind et al., 2016; camell et al., 2017; youm et al., 2013) , a myeloid cell-expressed multiprotein complex that senses pathogen associated molecular patterns (pamps) and danger associated molecular patterns (damps) to cause the processing and secretion of il-1β and il-18. there is increasing evidence that sars-cov-2 infection activates the nlrp3 inflammasome (siu et al., 2019) with increased levels of il-18 and lactate dehydrogenase (ldh) levels due to inflammasome mediated pyroptotic cell death (lucas et al., 2020; zhou et al., 2020) . it is now known that increased glycolysis, which activates inflammasome is associated with worsened covid-19 outcome (codo et al., 2020) . this raises the question whether the substrate switch from glycolysis-to-ketogenesis, can be employed to stave off covid-19 in high risk elderly population. here, we establish that intranasal infection with mcov-a59 recapitulates clinical features of covid-19 seen in elderly and demonstrate that ketone metabolites protect against disease through inhibition of nlrp3 inflammasome and expansion of protective γδ t cells in lungs. to determine the underlying deficits in immune and inflammatory response in aging, we investigated the impact of mcov-a59 intranasal inoculation on adult (2-6 month) and old male mice (20-24 month) ( figure 1a ). the ld-0 infectious dose of mcov-a59 in adult (pfu 7e3) caused 100 percent lethality in aged mice ( figure 1b ). compared to adults, the old infected mice displayed greater weight-loss ( figure 1c ), hypoxemia ( figure 1d ), and anorexia ( figure 1e ) without a significant difference in viral load in lungs ( figure s1a ). interestingly, aging led to a significant reduction in cd4, cd4:cd8 ratio ( figure 1f and figure s1b ) and ϒδ t cells ( figure 1g and figure s1c ) in lungs and spleen ( figure s1d ) with increased neutrophils ( figure 1h ), ly6c hi monocytes ( figure 1i and s1e) and no change in eosinophils ( figure s1f ). in addition, the lungs of old infected mice displayed increased frequency of cd64 + mertk + cells ( figure 1j and s1e) with no significant differences in the total population of alveolar or interstitial macrophages ( figure s1g and s1h). transmission electron microscopy confirmed the dissemination of the viral particles in pneumocytes in lungs ( figure 2a ). following mcov-a59 inoculation, ihc analyses by he and msb staining, in both 6 month and 20-24-month old mice, there is perivascular inflammation (arrows, arrowhead) as well as perivascular edema (*) and increased perivascular collagen/fibrosis (msb, blue) that is more severe in the 20-24-month mcov-a59 infected mice ( figure 2b ). further, 20-24 month old mice inoculated with mcov-a59 have dense foci visible at low power (box) and amphophilic material (fibrosis) with few scattered brightly eosinophilic erythrocytes (grey arrowhead) admixed with lymphocytes and plasma cells. by msb stain, at higher power this same focus (***) in the 20-24 month infected mice revealed that the end of a small blood vessel (bv) terminates in to a mass of collapsed alveoli, without obvious septa admixed with inflammatory cells, disorganized fibrin/collagen fibers (blue) suggestive of ante mortem pulmonary thrombosis in contrast to post mortem blood clots where erythrocytes are yellow (** msb, yellow) ( figure 2b ). taken together, consistent with ards, the lungs of aged mice infected with mcov-a59 had increased foci of inflammation, immune cell infiltration, perivascular edema, hyaline membrane formation and type ii pneumocyte hyperplasia, organizing pneumonia, interstitial pneumonitis, and occasional hemorrhage and microthrombi, affecting approximately 75% of the lungs ( figure 2b ). we next investigated whether mcov-a59 infection in aged mice mimics the hyperinflammatory systemic response seen in elderly patients infected with covid-19. compared to young animals, old mice infected with equivalent doses of mcov-a59 displayed significant increase in circulating il-1β, tnfα, il-6 ( figure 3a -c) and mcp-1 without affecting mip-1β ( figure s2a and s2b). similar to covid-19, the infection with mcov-a59 caused increased cardiac inflammation in old mice as evaluated by greater number of infiltrating cd68 + myeloid cells ( figure 3d ). given that increased visceral adiposity is a risk factor for covid-19 severity and expression of ace2 is upregulated in adipocytes of obese and diabetic patients infected with sars-cov-2 (kruglikov and scherer, 2020) , we next studied whether mcov-a59 infection affects adipose tissue. given the prevalence of obesity is 10% among younger adults aged 20-39, 45% among adults aged 40-59 years and 43% among older adults aged 60 and over (hales et al., 2020) we investigated adipose tissue inflammation as a potential mechanism that contributes to infection severity in the aged. interestingly, consistent with the prior findings that adipose tissue can harbor several viruses (damouche et al., 2015) , the mcov-a59 rna was detectable in vat ( figure 3e ). despite similar viral loads, vat of aged infected mice had significantly higher levels of the pro-inflammatory cytokines il-1β, tnfα and il-6 ( figure 3f -h). moreover, compared to young mice, old animals infected with mcov-a59 had increased caspase-1 cleavage (p20 active heterodimer), a marker of inflammasome activation ( figure 3i and s2c). in addition, similar to sars-cov-2 invasiveness in cns, the mcov-a59 was detectable in the hypothalamus ( figure 3j ). compared to adults, the hypothalamus of aged infected mice showed increased expression of tnfα and caspase-1 ( figure 3k and l) with no significant differences in il-1β, il-6 ( figure 3m and n) and nlrp3 ( figure s2d ). infection in both young and aged mice caused significant increases in markers of astrogliosis and microglia activation ( figure s2e and f). interestingly, mcov-a59 reduced the mrna expression of orexigenic neuropeptide-y (npy) ( figure s2e and f), consistent with the fact that infected mice display anorexia ( figure 1c and e). however, mcov-a59 infection completely abolished the expression of preopiomelanocortin (pomc) in the hypothalamus, a transcript expressed by pomc neurons, which is involved in the control of the autonomic nervous system and integrative physiology. therefore, further investigation will be necessary to test the involvement of the hypothalamus in the pathogenesis of covid-19 and organ failure due to alterations in autonomic nervous system. given the switch from glycolysis to fatty acid oxidation reprograms the myeloid cell from proinflammatory to tissue reparative phenotype during infections (ayres, 2020; buck et al., 2017; galván-peña and o'neill, 2014) , we next investigated whether mcov-a59-driven hyperinflammatory response in aging can be targeted through immunometabolic approaches. hepatic ketogenesis, a process downstream of lipolysis that converts long-chain fatty acids into short chain β-hydroxybutyrate (bhb) as a preferential fatty acid fuel during starvation or glucoprivic states, inhibits the nlrp3 inflammasome activation (youm et al., 2015) and protects against influenza infection induced mortality in mice (goldberg et al., 2019) . moreover, given our recent findings that ketogenesis inhibits inflammation and expands tissue resident ϒδ t cells (goldberg et al., 2019) while sars-cov-2 infection in patients is associated with depletion of ϒδ t cells (lei et al., 2020; rijkers et al., 2020) , we next tested whether elevating bhb by feeding a ketogenic diet (kd) protects against mcov-a59-driven inflammatory damage in aged mice. we infected bone marrow derived macrophages (bmdms) with mcov-a59 in vitro in tlr4 ( figure 4a and s3a) and tlr1/2 primed cells ( figure 4b and s3b). infection with mcov-a59 caused robust activation of inflammasome as measured by cleavage of active il-1β (p17) in bmdm supernatants ( figure 4a and b) as well as in cell lysates ( figure s3a and b). given our prior findings that ketone metabolites specifically inhibits the nlrp3 inflammasome in response to sterile damps such as atp, ceramides, silica and urate crystals (youm et al., 2015) , we next tested whether bhb impacts inflammasome activation caused by mcov-a59. interestingly, bhb treatment reduced pro and active cleaved il-1β (p17) in both conditions when protein level was measured in the supernatant ( figure 4a and b) and cell lysate ( figure s3a and b). mechanistically, post mcov-a59 infection, the bhb reduced the oligomerization of asc, which is an adaptor protein required for the assembly of the inflammasome complex ( figure 4c and d). this data provides evidence that the ketone metabolite bhb can lower inflammation in response to coronavirus infection and deactivate the inflammasome. however, inflammasome activation is also required for mounting adequate immune response against pathogens including certain viruses. therefore, we next investigated if induction of ketogenesis and ketolysis in vivo by feeding a diet rich in fat and low in carbohydrates that elevates bhb level impacts inflammasome and host defense against mcov-a59 infection in aged mice. ketogenesis is dependent on hydrolysis of triglycerides and conversion of long chain fatty acids in liver into short chain fatty acid bhb that serves as primary source of atp for heart and brain when glucose is limiting. aging is associated with impaired lipid metabolism which includes reduced lipolysis that generates free fatty acids that are essential substrates for bhb production. thus, it is unclear whether in context of severe infection and aging, if sufficient ketogenesis can be induced. to test this, the aged male mice (20-21 months old) were fed a kd or control diet for 5 days and then intranasally infected with mcov-a59 ( figure 4e ). despite mcov-a59's known effects in causing hepatic inflammation (navas et al., 2001) , we observed that compared to chow fed animals, old kd fed mice achieved mild physiological ketosis between 0.6 to 1mm over the course of infection for one week ( figure s3c ). compared to chow fed animals, the mcov-a59 infected mice fed kd displayed similar levels of food intake, blood glucose, core-body temperature, heart rate, and respiration ( figure s3d -i). interestingly, mcov-a59 infected kd fed mice were protected from infection-induced weight-loss and hypoxemia ( figure 4f and g). importantly, consistent with in vitro data, kd feeding caused significant reduction in inflammasome activation in the vat ( figure 4h ), a major source of inflammation in aging. together, these data show that kd lowers exuberant inflammasome activation in old mice and can potentially be therapeutically employed. the elderly covid-19 patients exhibit multi-organ failure with systemic viremia and inflammation. therefore, we next investigated the impact of kd on the inflammatory response in lungs, adipose tissue and hypothalamus in old mice post mcov-a59 infection. consistent with the improved clinical outcome and protection afforded by ketone bodies in infected mice, we found that kd-fed mice inoculated with mcov-a59 had significantly reduced expression of pro-inflammatory cytokines il-1β, tnfα and il-6 in lung, vat and hypothalamus ( figure 5a -c). aging and mcov-a59 increases inflammasome activation which is increasingly implicated in the pathogenesis of covid-19 (vijay et al., 2017; youm et al., 2013) . the sars-cov open reading frame 3a (orf3a) and orf8b activates the nlrp3 inflammasome (siu et al., 2019) by inducing er stress and lysosomal damage (shi et al., 2019) . moreover, ability of bats to harbor multiple viruses including coronaviruses is due to splicevariants in the lrr domain of nlrp3 which prevents inflammasome mediated inflammatory damage (ahn et al., 2019) . interestingly, in the aging mouse model of mcov-a59 infection, kd significantly lowered nlrp3 and caspase-1 mrna in lung, vat and hypothalamus ( figure 5d and e) and decreased myeloid cell infiltration in heart ( figure 5f ). the ketogenesis in infected old mice did not affect the frequency of cd4, cd8 effector memory or macrophage subsets in lungs suggesting that reduction in pro-inflammatory cytokines was not a reflection of reduced infiltration of these cell types ( figure s4 ). interestingly, we found that kd feeding rescued mcov-a59-induced depletion of ϒδ t cell in lungs of aged mice ( figure 5g and s4a). to determine the mechanism of ketogenesis-induced protection from mcov-a59 driven inflammatory damage in aging, we next investigated the transcriptional changes in lung at the single-cell level. the scrna sequencing of whole lung tissues ( figure 6a ) found that kd feeding in old infected mice caused significant increase in goblet cells ( figure 6b ), expansion of ϒδ t cells ( figure 6b ) and significant decrease in proliferative cell subsets and monocyte populations ( figure 6b ). comparison with scrna-seq of the lungs from young and old noninfected animals highlighted that only loss of proliferative myeloid cells was associated with the baseline aging process ( figure s5 ), while other age-specific changes in cellular subpopulations emerged as a result of interaction between virus and host. moreover, the old mice showed reduced interferon responses, suggesting increased vulnerability to the viral infection ( figure s5 ). interestingly, some of the most striking changes occurred in t cells, where ketogenesis led to a substantial increase in ϒδ but not αβ t cells ( figure 6c and figure s6b ). to understand whether expansion of ϒδ t cells was also accompanied by the changes in their regulatory programs, we sorted the lung ϒδ t cells from aged mice fed chow diet and kd and conducted bulk rna sequencing to determine the mechanism of potential tissue protective effects of these cells in mcov-a59 infection. we found that kd in aging significantly increased the genes associated with reduced inflammation ( figure 6d ), increased lipoprotein remodeling and downregulation of tlr signaling, plk1 and aurora b signaling pathways in ϒδ t cells ( figure 6e ). furthermore, rna sequencing revealed that lung ϒδ t cells from ketogenic mcov-a59 infected old mice displayed elevated respiratory electron transport and complex i biogenesis ( figure 6e ). in addition, golgi to er retrograde transport and cell cycle are downregulated, suggesting the reduced activation status of ϒδ t cell ( figure 6e ). this may indicate that ϒδ t cells expanded with kd are functionally more homeostatic and immune protective against mcov-a59 infection. zooming in into monocyte subpopulation we observed three distinct monocyte clusters ( figure 6f ), characterized by ifi44, lmna, and cd300e respectively ( figure 6g ). strikingly, ketogenesis-induced change in the monocyte compartment was driven by a loss of cluster 1 (characterized by high levels of chil3, lmna, il1r2, lcn2, cd33, cd24a, figure 6h and figure s6d and e). in addition, the loss of monocyte subpopulation was observed in cells with low interferon-response further suggesting the immune protective response induction post ketogenesis in infected mice. this is an intriguing finding that is consistent with recent observations that dietary interventions can impact plasticity of the monocyte pool in both mouse and human (collins et al., 2019; jordan et al., 2019) . immune-senescence exemplified by inflammasome-mediated basal activation of myeloid cells, expansion of pro-inflammatory aged b cells, impaired germinal center and antibody responses together with thymic demise and restriction of t cell repertoire diversity all contribute to increased risk of infections and vaccination failures in elderly (akbar and gilroy, 2020; frasca et al., 2020; goldberg and dixit, 2015; goronzy and weyand, 2019) . it is likely that multiple mechanisms partake in aging-induced mortality and morbidity to sars-cov-2. however, study of immunometabolic mechanisms that control aberrant inflammatory response in elderly covid-19 patients are hindered due to lack of availability of an aging mouse model of disease that recapitulates the key features of sars-cov-2 immunopathology and multi-organ inflammation. despite the severity of this viral infection, it is currently unclear what underlies the symptom diversity and the mortality of this pandemic. epidemiological data strongly support that elderly and aged individuals with late-onset chronic diseases-including diabetes, obesity, heart conditions, pulmonary dysfunctions and cancer-present a much higher disease severity compared to young healthy adults (cai et al., 2020; chen et al., 2020) . these observations suggest that it is the vulnerability of the various tissues that occur in these chronic conditions that predispose elderly to develop severe forms of covid-19. rodent covs are natural, highly contagious pathogens of mice and rats (compton et al., 2003; compton et al., 1993) . they are efficient and safe platforms for recapitulating and examining factors and interventions that impact disease. these models enable basic and translational covid-19 studies by minimizing studies requiring sars-cov-2 infection, thereby conserving and reserving limited bsl-3 space for studies using the most promising candidates in a homologous sars-cov-2 model. among the diverse rodent covs, mouse hepatitis virus (mhv) is a collection of mouse cov strains which have clinical diseases ranging from clinically silent (enterotropic) to mortality (polytropic/respiratory tropic). of particular interest for covid-19 are the strains of mhv that are respiratory tropic (yang et al., 2014) . given, these advantages, mhv mcov-a59 infection in c57bl/6 mice can be a powerful tool to rapidly study the disease as well as test therapeutic interventions. we demonstrate that compared to all reported models (dinnon et al., 2020; hassan et al., 2020; israelow et al., 2020; jiang et al., 2020; sun et al., 2020; winkler et al., 2020) , mhv mcov-a59 infection recapitulates severe features of covid-19 that includes, up to 30% weight-loss, sickness behavior exemplified by anorexia, loss of oxygen saturation, lung pathology including neutrophilia, monocytosis, loss of γδ t cells, lymphopenia, increase in circulating pro-inflammatory cytokines, hypothalamic, adipose and cardiac inflammation and inflammasome activation. importantly, ld0 dose of mhv mcov-a59 induces 100% lethality in 2 year old male mice, suggesting that this model allows investigation of covid-19 relevant immunometabolic mechanisms that control disease development and severity with aging. mechanistically, nlrp3 inflammasome has been demonstrated to be an important driver of aging-induced chronic inflammation and organ damage (bauernfeind et al., 2016; camell et al., 2017; youm et al., 2013) . covid-19 patients have inflammasome dependent pyroptosis and increase in il-18 (lucas et al., 2020; zhou et al., 2020) . consistent with the hypothesis that aging may exacerbate inflammasome activation in sars-cov-2 infection, our data demonstrates that in vivo, mcov infection increases nlrp3 inflammasome mediated inflammation. emerging evidence demonstrates that ability of bats to harbor multiple viruses including coronaviruses is due to splice-variants in the lrr domain of nlrp3 which prevents inflammasome mediated inflammatory damage (ahn et al., 2019) . furthermore, recent study shows that mhv-a59 also activates the nlrp3 inflammasome in vitro bone marrow derived macrophages . in addition severe cases of covid-19 are accompanied with dyregulation of monocyte populations with increased level of s100a8/a9 or calprotectin (schulte-schrepping et al., 2020; silvin et al., 2020) , which can prime and induce the inflammasome activation . these data underscore that enhanced innate immune tolerance mediated by inflammasome deactivation maybe an important strategy against covid-19. the integrated immunometabolic response (iimr) is critical in regulating the setpoint of protective versus pathogenic inflammatory response (lee and dixit, 2020). the iimr involves sensing of nutrient balance by neuronal (sympathetic and sensory innervation) and humoral signals (e.g. hormones and cytokines) between the cns and peripheral tissues that allow the host to prioritize storage and/or utilize substrates for tissue growth, maintenance and protective inflammatory responses. peripheral immune cells, both in circulation and those residing within tissues, are subject to regulation by the metabolic status of the host. ketone bodies, bhb and acetoacetate are produced during starvation to support the survival of host by serving as an alternative energy substrate when glycogen reserves are depleted (newman and verdin, 2017) . classically, ketone bodies are considered essential metabolic fuels for key tissues such as the brain and heart (puchalska and crawford, 2017; veech et al., 2017) . however, there is increasing evidence that immune cells can also be profoundly regulated by ketone bodies (youm et al, 2015 , goldberg et al 2020 . for example, stable isotope tracing revealed that macrophage oxidation of liver-derived acac was essential for protection against liver fibrosis (puchalska et al., 2019) . given our past findings that ketone bodies inhibit nlrp3 inflammasome activation induced by sterile damps, we next hypothesized that coronavirus mediated inflammasome activation and disease severity in aging could be improved by bhb driven improved metabolic efficiency and nlrp3 deactivation. in support of this hypothesis, we found that bhb inhibits the mcov-a59 induced nlrp3 inflammasome assembly and kd reduces caspase-1 cleavage as well as decreases gene expression of inflammasome components. we next investigated the mechanism of protection elicited by kd that is relevant to aging. interestingly, scrna sequencing analyses of lung homogenates of old mice fed kd revealed robust expansion of immunoprotective γδ t cells, which are reported to decline in covid-19 patients (lei et al., 2020; rijkers et al., 2020) . the kd activated the mitochondrial function as evidenced by enhanced complex-1 biogenesis and upregulation of etc in immunoprotective γδ t cells. moreover, the kd feeding blocked infiltration of pathogenic monocyte subset in lungs that has high s100a8/9 and low interferon expression. our data shows that the mcov-a59 murine model offers an efficient and biosafety level-2 platform for recapitulating covid-19 to test mechanism of age-related immune decline and can thereby fast-track testing of interventions that impact disease outcome. our findings assumes strong clinical significance as recent studies, demonstrate that γδ t cells were severely depleted in covid-19 patients in two highly variable cohorts and disease progression was correlated with near ablation of vγ9vδ2 cells that are dominant subtype of circulating γδ t cells (laing et al., 2020) . taken together these data demonstrate that a ketogenic immunometabolic switch protects against mcov-a59 driven covid in mice and this anti-inflammatory response in lung is coupled with reduction of inflammasome activation, restoration of protective ϒδ t cells and remodeling of the pool of the inflammatory monocytes. finally, our results suggest that acutely switching infected or at-risk elderly patients to a kd may ameliorate covid-19 and, therefore, is a relatively accessible and affordable intervention that can be promptly applied in most clinical settings. mouse remains imperfect to model human biology and disease. instead of following the current approaches to make human sars-cov-2 amenable to infecting an unnatural murine host with unknown biological compatibility, we focused on natural mouse hepatitis virus (mhv)-a59 because like sars-cov-2, it belongs to the family of ards-related beta coronaviruses that are highly homologous. however, the obvious limitation of the model is that mhv-a59 is not sars-cov-2 virus. although, both these beta coronaviruses display high degree of homology, mhv-a59 uses ceacam1 instead of ace2 for binding and infectivity. however, cellular expression of ceacam1 is similar to ace2 in humans and similarity of viral orfs offer significant advantages in studying tissue responses. like most models of disease, this study shows that not all features of sars-cov-2 infection seen in humans are seen in mice. this includes lack of development of fever instead mice become hypothermic. also, despite monocyte infiltration in heart, the aged mice did not die due to cardiac failure and displayed normal heart rate. mcov-a59 virus induced hypothalamic inflammation and led to anorexia that included reduction in orexigenic npy but almost complete loss of pomc gene expression. it remains unclear, if this alters pomc derived peptides including melanocortins and endogenous opioids peptides, in addition these data suggest potential dysregulation of autonomic nervous system which can play a role in organ failure post infection. in terms of mechanism, our data shows that the inflammasome is activated in infection and kd-induced protection is associated with nlrp3 inflammasome deactivation. future studies are required to test if aged nlrp3 deficient mice are protected from mcov-a59 or if absence of γδ t cell increases mortality. aw and vdd conceived the project and helped with data interpretation and manuscript preparation. the authors declare they have no competing interests. fed chow (old-chow, n=6) or ketogenic diet (old-kd, n=5). the mice were provided with diet from 5 days before infection. after infection, the phenotype was evaluated until 7 days post infection. weight change (%) (f), and % o2 saturation (g) in old mice fed chow or kd. (g) western blot analysis of caspase-1 inflammasome activation in vat of infected old-chow and old-kd mice. error bars represent the mean ± s.e.m. two-tailed unpaired t-tests were performed for statistical analysis. * p < 0.05; ** p < 0.01. further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, vishwa deep dixit (vishwa.dixit@yale.edu). this study did not generate new unique reagents. the single cell rna-sequencing and bulk rna-sequencing data has been uploaded to gene expression omnibus (gse155346 and gse155347) respectively. all mice used in this study were c57bl/6 mice. old mice (20-24 month old) were received from nia, maintained in our laboratory. young mice (2-6 month old) were from nia or purchased from jackson laboratories or bred in our laboratory. the mice were housed in specific pathogenfree facilities with free access to sterile water through yale animal resources center. mice were fed a standard vivarium chow (harlan 2018s) or a ketogenic diet (envigo, td.190049) for indicated time. the mice were housed under 12 h light/dark cycles. all experiments and animal use were conducted in compliance with the national institute of health guide for the care and use of laboratory animals and were approved by the institutional animal care and use committee (iacuc) at yale university. mhv-a59 was purchased from bei resources (nr-43000) and grown in bv2 cells. mice were anesthetized by intraperitoneal injection of ketamine/xylazine. 700 or 7000 pfu of mhv-a59 was delivered in 40ul pbs via intranasal inoculation. vital signs were measured before and after infection. arterial oxygen saturation, breath rate, heart rate, and pulse distention were measured in conscious, unrestrained mice via pulse oximetry using the mouseox plus (starr life sciences corp.). lungs were fixed in 10% formaldehyde, osmicated in 1% osmium tetroxide, and dehydrated in ethanol. during dehydration, 1% uranyl acetate was added to the 70% ethanol to enhance ultrastructural membrane contrast. after dehydration, the lungs were embedded in durcupan and ultrathin sections were cut on a leica ultra-microtome, collected on formvar-coated single-slot grids, and analyzed with a tecnai 12 biotwin electron microscope (fei). h&e and msb staining of lung tissues were performed on sections of formalin-fixed paraffinembedded at the comparative pathology research core at yale school of medicine. for immunohistochemistry, the hearts were harvested from mhv-a59 infected mice, fixed in 4% pfa overnight and embedded in oct after dehydration with 30% sucrose and serial sections of aortic root were cut at 6 μm thickness using a cryostat. sections were incubated at 4°c overnight with cd68 (serotec; #mca1957) and alexa fluor™ 594 phalloidin (thermofisher, a12381) after blocking with blocker buffer (5% donkey serum, 0.5% bsa, 0.3% triton x-100 in pbs) for 1 hour at rt, followed by incubation with alexa fluor secondary antibody (invitrogen, carlsbad, ca) for 1 hour at rt. the stained sections were captured using a carl zeiss scanning microscope axiovert 200m imaging system and images were digitized under constant exposure time, gain, and offset. results are expressed as the percent of the total plaque area stained measured with the image j software (imagej version 1.51). plaque assay l2 cell (1.5 ml of 6x10 5 cells/ml) were seeded on 6 well plates (corning, 3516) in supplemented dmem and allowed to adhere overnight. tissue samples were homogenized in unsupplemented dmem, and spun down at 2000 rpm for 5 min. supernatant was serially diluted and 200 μl of each sample was added to aspirated l2 cells in 6 well plates. plates were agitated regularly for 1 hour before adding overlay media consisting of 1 part 1.2% avicel and 1 part 2x dmem (thermo fisher, 12800) supplemented with 4% fbs (thermo fisher, a3840301), penicillin-streptomycin (gibco, 15140122), mem non-essential amino acids solution (gibco, 11140050), and hepes (gibco, 15630080). after a four-day incubation, cells were fixed in 10% formaldehyde (sigma aldrich, 8187081000) diluted with pbs for 1 hour. cells were then stained in 1% (w/v) crystal violet (sigma aldrich, c0775) for 1 hour, washed once in distilled water, and then quantified for plaque formations. serum cytokine and chemokine level was measured by procartaplex multiplex assay (thermo fisher scientific). assay was prepared following manufacture's instruction. 25 µl of collected serum from each mice in this study was used. customized assay including il-1β, tnf , il-6, mcp-1, and mip-1β was used. luminex xponent system was used to perform the assay. to extract and purify rna from tissues, rneasy plus micro kit (qiagen) and direct-zol™ rna miniprep plus kit (zymo research) were used according to manufacturer's instructions. cdna was synthesized with isolated rna using iscript cdna synthesis kit (bio-rad). to quantify amount of mrna, real time quantitative pcr (qpcr) was done with the synthesized cdna, gene specific primers, and power sybr green detection reagent (thermo fischer scientific) using the lightcycler 480 ii (roche). analysis was done by ddct method with measured values from specific genes, the values were normalized with gaphd gene as an endogenous control. bone marrow derived macrophage was cultured by collecting mouse femurs and tibias in complete collecting media containing rpmi (thermo fischer scientific), 10% fbs (omega scientific), and 1% antibiotics/antimycotic (thermo fischer scientific). using needle and syringe, bone marrow was flushed into new complete media, followed by red blood cells lysis by ack lyses buffer (quality biological). in 6 well plate, the collected cells were seeded to be differentiated into macrophages incubated with 10 ng/ml m-csf (r&d) and l929 (atcc) conditioned media. cells were harvested on day 7, and seeded as 1x10 6 cell/well in 24 well plate for experiments. to infect bmdm, mhv-a59 was incubated with bmdm as a moi 1 (1:1) for 24 hour. for inflammasome activation, lps (1ug/ml) or pam3csk4 (1ug/ml) were pre-treated with or without bhb (1, 5, 10 mm) for 4 hour before mhv-a59 infection for 24 hour or atp (5mm) treatment for 1 hour. to prepare samples for western blotting, tissues were snap frozen in liquid nitrogen. ripa buffer with protease inhibitors were used to homogenize the tissues. after cell supernatant was collected, cells were harvested by directly adding ripa buffer on cell culture plate. after quantification of protein amount by the dc protein assay (bio-rad), same amount of protein was run on sds-page gel followed by transferring to nitrocellulose membrane. specific primary antibodies and appropriate secondary antibodies (thermo fisher scientific) were used to probe blots and bands were detected by ecl western blotting substrate (pierce). the following primary antibodies were used for experiments. antibodies to caspase-1 (1:250, genentech), βactin (1:1,000, 4967l; cell signaling), il-1β (1:1000, gtx74034, genetex), and asc (1:1000, ag-25b-0006, adipogen) were used. to detect asc oligomers, cells were harvested in np-40 lysis buffer which contains 20mm hepes-koh (ph 7.5), 150 mm kcl, 1% np-40, 0.1 mm pmsf, and protease inhibitors. the cells in lysis buffer were incubated on ice for 15 min, and centrifuged at 6,000 rpm at 4°c for 10 min. supernatant was collected and kept for cell lysate western blotting. the pellet was vortexed with 1 ml of np-40 lysis buffer, and centrifuged at 6,000 rpm at 4°c for 10 min. the pellet was incubated with 50ul of np-40 lysis buffer and 1 ul of 200 mm dss (disuccinimidyl suberate) for 30 min at room temperature, then centrifuged at 6,000 rpm at 4°c for 10 min. the pellet with sds sample buffer and reducing reagent was loaded for western blotting. lung was digested in rpmi (thermo fisher) with 0.5mg/ml collagenase i (worthington) and 0.2mg/ml dnase i (roche) for 1 hour. digested lung tissues were minced through 100 μm strainer. spleen was directly minced through 100 μm strainer. minced tissues were additionally filtered with 40 μm strainer after red blood cell lysis by ack lysing buffer (quality biological). after incubation with fc block cd16/32 antibodies (thermo fisher scientific), the cells from lung and spleen were further incubated with surface antibodies for 30 min on ice in the dark. washed cells were stained with live/dead™ fixable aqua dead cell stain kit (thermo fisher scientific). bd lsrii was used for flow cytometry and results were analyzed by flowjo software. the following antibodies were used for flow cytometry analysis to detect cd4 t cell, cd8 t cell, γδ t cell, neutrophil, eosinophil, and macrophage: cd45-bv711, mertk-fitc, cd64-bv605, f4/80-efluor450, ly6c-percp-cy5.5, cd11c-apc, cd169-pe, cd86-pe-cy7, cd3-bv605, cd4-pe-cy7, cd8-efluor450, tcr γ/δ-pe, ly6g-apc, siglecf-percp-cy5.5, cd62l-percp-cy5.5, cd44-apc-cy7. lung cells were prepared as mentioned above for flow cytometry and equal amount of cells were pooled as indicted in the experiments. single-cell rna sequencing libraries were prepared at yale center for genome analysis following manufacturer's instruction (10x genomics). novaseq6000 was used for sequencing library read. the cell ranger single-cell software suite (v3.0.2) (available at https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-iscell-ranger) was used to perform sample demultiplexing, barcode processing, and single-cell 3' counting. cellranger mkfastq was used to demultiplex raw base call files from the novaseq6000 sequencer into sample-specific fastq files. subsequently, fastq files for each sample were processed with cellranger counts to align reads to the mouse reference (version mm10-3.0.0) with default parameters. for the analysis, the r (v3.5.0) package seurat (v3.1.1) (butler et al., 2018) was used. cell ranger filtered genes by barcode expression matrices were used as analysis inputs. samples were pooled together using the merge function. the fraction of mitochondrial genes was calculated for every cell, and cells with high (>5%) mitochondrial fraction were filtered out. expression measurements for each cell were normalized by total expression and then scaled to 10,000, after that log normalization was performed (normalizedata function). two sources of unwanted variation: umi counts and fraction of mitochondrial reads -were removed with scaledata function. for both datasets platelet clusters as well as a cluster of degraded cells (no specific signature and low umi count) were removed and data was re-normalized without them. in case of old-keto and old-chow dataset we additionally removed neutrophils, doublets, and red blood cells. the most variable genes were detected using the findvariablegenes function. pca was run only using these genes. cells are represented with umap (uniform manifold approximation and projection) plots. we applied runumap function to normalized data, using first 15 pca components. for clustering, we used functions findneighbors and findclusters that implement snn (shared nearest neighbor) modularity optimization-based clustering algorithm on top 20 pca components using resolution of 0.3 for both datasets. to identify marker genes, findallmarkers function was used with likelihood-ratio test for single cell gene expression. for each cluster, only genes that were expressed in more than 10% of cells with at least 0.1-fold difference (log-scale) were considered. for heatmap representation, mean expression of markers inside each cluster calculated by averageexpression function was used. single cell rna-seq differential expression to obtain differential expression between clusters, mast test was performed via findmarkers function on genes expressed in at least 1% of cells in both sets of cells, and p-value adjustment was done using a bonferroni correction (finak et al., 2015) . pathway analysis was performed using clusterprofiler package (v3.12.0) (yu et al., 2012) with hallmark gene sets from msigdb. significantly different genes were used (padj < 0.05) if percent difference between conditions (|pct.1 -pct.2|) was over 1%. to visualize pathway expression for each cell z-scores of all pathway genes were averaged. to separate ab t cells and gs t cells we subset raw values of t cell (cluster 2), normalized and clustered corresponding data separately as described above with clustering resolution 0.2. obtained subclusters were projected on the original umap, splitting cluster 2 in 2_1 (ab t cells) and 2_2 (gs t cells). monocyte clusters 0 and 1 were subset and re-analyzed in the same manner with clustering resolution 0.3. umap was recalculated for monocytes only as shown in figure 6f . bulk rna sequencing of sorted gδ t cells cells from lung were prepared as mentioned above for flow cytometry and γδ t cell was sorted by flow cytometry (live cd45+ cd3+ cd4-cd8-tcr γ/δ+). rna was isolated from sorted cells using rneasy plus micro kit (qiagen). quality checked rna was used for rna sequencing library preparation at yale center for genome analysis following manufacturer's instruction (illumina). novaseq6000 was used for sequencing library read. fastq files for each sample were aligned to the mm10 genome (gencode, release m25) using star (v2.7.3a) with the following parameters: star --genomedir $genome_dir --readfilesin $work_dir/$file_1 $work_dir/$file_2 --runthreadn 12 --readfilescommand zcat --outfiltermultimapnmax 15 --outfiltermismatchnmax 6 --outreadsunmapped fastx --outsamstrandfield intronmotif --outsamtype bam sortedbycoordinate --outfilenameprefix ./$ (dobin et al., 2013) . quality control was performed by fastqc (v0.11.8), multiqc (v1.9) (ewels et al., 2016) , and picard tools (v2.21.6). quantification was done using htseq-count function from htseq framework (v0.11.2): htseqcount -f bam -r pos -s no -t exon $bam $annotation > $output . differential expression analysis was done using deseq function from deseq2 package (love et al., 2014) (v1.24 .0) with default settings. significance threshold was set to adjusted p-value < 0.05. gene set enrichment analysis via fgsea r package (sergushichev, 2016) (v1.10 .0) was used to identify enriched pathways and plot enrichment curves. to calculate statistical significance, two-tailed student's t test was used. level of significance was indicated as follow. *p < 0.05; **p < 0.005; ***p < 0.001; ****p < 0.0001 respectively. all statistical tests used 95% confidence interval and normal distribution of data was assumed. biological replication numbers for each experiment were indicated in each figure and figure legend. data were shown as mean ± s.e.m. graphpad prism software was used for all statistical tests to analyze experimental results. expression analysis in hypothalamus of young uninfected and young infected mice (e), and old uninfected and old infected mice (f). error bars represent the mean ± s.e.m. two-tailed unpaired t-tests were performed for statistical analysis. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. figure s5a split by sample. color represents expression of mki67. (e) summary of cluster-by-cluster differential expression comparison of young and old samples. each dot represents a gene, significant genes are shown in red. (f) gene set enrichment analysis of significantly up-and down-regulated genes described in figure s5e. (g, h) umap as in figure s5a split by sample. color shows average z-scores of genes in selected pathways. figure 6c . color represents expression of trac. (c) summary of cluster-by-cluster differential expression comparison of old-kd and old-chow. each dot represents a gene, significant genes are shown in red. (d) percentage of each monocyte subset as identified in figure 6f relative to total number of monocytes in the corresponding sample. (e) umap plot as in figure 6f showing average zscores of genes in ifn-alpha and ifn-gamma pathways. dampened nlrp3-mediated inflammation in bats and implications for a special viral reservoir host aging immunity may exacerbate covid-19 htseq-a python framework to work with high-throughput sequencing data immunometabolism of infections aging-associated tnf production primes inflammasome activation and nlrp3-related metabolic disturbances integrating single-cell transcriptomic data across different conditions, technologies, and species obesity and covid-19 severity in a designated hospital inflammasome-driven catecholamine catabolism in macrophages blunts lipolysis during ageing clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study elevated glucose levels favor sars-cov-2 infection and monocyte response through a hif-1alpha/glycolysis-dependent axis the bone marrow protects and optimizes immunological memory during dietary restriction pathogenesis of mouse hepatitis virus infection in gamma interferon-deficient mice is modulated by coinfection with helicobacter hepaticus the cellular and molecular pathogenesis of coronaviruses adipose tissue is a neglected viral reservoir and an inflammatory site during chronic hiv and siv infection murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in a/j mice a mouse-adapted model of sars-cov-2 to test covid-19 countermeasures star: ultrafast universal rna-seq aligner multiqc: summarize analysis results for multiple tools and samples in a single report mast: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell rna sequencing data age-related factors that affect b cell responses to vaccination in mice and humans metabolic reprograming in macrophage polarization tissue and cellular distribution of an adhesion molecule in the carcinoembryonic antigen family that serves as a receptor for mouse hepatitis virus hydroxybutyrate deactivates neutrophil nlrp3 inflammasome to relieve gout flares drivers of age-related inflammation and strategies for healthspan extension the species severe acute respiratory syndrome-related coronavirus: classifying 2019-ncov and naming it sars-cov-2 mechanisms underlying t cell ageing prevalence of obesity and severe obesity among adults: united states a sars-cov-2 infection model in mice demonstrates protection by neutralizing antibodies multi-phase approach to eradicate enzootic mouse coronavirus infection mouse model of sars-cov-2 reveals inflammatory role of type i interferon signaling pathogenesis of sars-cov-2 in transgenic mice expressing human angiotensin-converting enzyme 2 dietary intake regulates the circulating inflammatory monocyte pool the role of adipocytes and adipocyte-like cells in the severity of covid-19 infections a consensus covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis. medrxiv the phenotypic changes of γδ t cells in covid-19 patients. medrxiv moderated estimation of fold change and dispersion for rna-seq data with deseq2 longitudinal analyses reveal immunological misfiring in severe covid-19 murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis hydroxybutyrate: a signaling metabolite. annual review of nutrition sars-cov-2 infection fatality risk in a nationwide seroepidemiological study. medrxiv serology-informed estimates of sars-cov-2 infection fatality risk in multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics hepatocyte-macrophage acetoacetate shuttle protects against tissue fibrosis more bricks in the wall against sars-cov-2 infection: involvement of γ9δ2 t cells severe covid-19 is marked by a dysregulated myeloid cell compartment an algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation. biorxiv sars-coronavirus open reading frame-8b triggers intracellular stress pathways and activates nlrp3 inflammasomes elevated calprotectin and abnormal myeloid cell severe acute respiratory syndrome coronavirus orf3a protein activates the nlrp3 inflammasome by promoting traf3-dependent ubiquitination of asc generation of a broadly useful model for covid-19 pathogenesis, vaccination, and treatment virus-induced inflammasome activation is suppressed by prostaglandin d2/dp1 signaling antibody prevalence for sars-cov-2 in england following first peak of the pandemic: react2 study in 100,000 adults. medrxiv sars-cov-2 infection of human ace2-transgenic mice causes severe lung inflammation and impaired function coronavirus mhv-a59 infects the lung and causes severe pneumonia in c57bl/6 mice the ketone metabolite β-hydroxybutyrate blocks nlrp3 inflammasome-mediated inflammatory disease canonical nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging clusterprofiler: an r package for comparing biological themes among gene clusters impaired nlrp3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/ripk3 during coronavirus infection clinical course and risk factors for mortality of adult inpatients with covid-19 in wuhan, china: a retrospective cohort study key: cord-298117-9ycl7mn6 authors: monk, caroline title: ocular surface disease in rodents (guinea pigs, mice, rats, chinchillas) date: 2018-11-17 journal: vet clin north am exot anim pract doi: 10.1016/j.cvex.2018.08.001 sha: doc_id: 298117 cord_uid: 9ycl7mn6 this article discusses the clinical appearance, differential diagnoses, and treatment considerations of corneal disease in the most common domesticated species of rodent: mouse, rat, chinchilla, and guinea pig. many corneal diseases are related to inbred strains of either research or pet rodents. diseases are complicated by husbandry and treatment-related challenges in this small, social species. this article is broken down by species, first discussing normal anatomy, then discussing commonly encountered diseases, and concluding with treatment considerations. attending veterinarian. mice, rats, and chinchillas are thought to be predominantly nocturnal to crepuscular, while guinea pigs are diurnal. their eye anatomy reflects their origins. all rodents have a cornea divided into stratified epithelium, a bowman layer (epithelial basement membrane), stroma, descemet membrane, and the endothelium. guinea pigs are the largest of the rodents covered in this section. they live an average of 4 to 5 years, but can live as long as 8 years. they are not found in the wild, but are a domesticated relative of other species of cavies. once used frequently for research studies, they are now primarily a household pet. fine superficial corneal neovascularization (usually extending from limbus axially to the first or second third of the cornea) has been reported as a normal finding in fetal, newborn, and adult guinea pigs. 1 however, a later confocal microscopy study did not confirm this. 2 small palpebral conjunctival outpouchings were noted in the upper and lower fornices in almost all examined animals according to dwyer and colleagues (1983) , and were determined via histology to be masses of lymphoid tissue. their prevalence across individuals resulted in researchers concluding these foci to be a normal finding. guinea pigs have a remarkably low corneal sensitivity (or a high pressure threshold is needed to elicit a blink), replicated in 3 studies. 1, 3, 4 in these studies, the guinea pig was observed to have limited to no reflex tearing, which may be a component of the lack of corneal sensitivity ( fig. 1, table 1 ). this plays an important clinical role. staphylococcus epidermidis, a-hemolytic streptococcus, and corynebacterium were the top 3 aerobic commensal isolates from normal healthy guinea pigs. 4 trichiasis, or hair from the skin contacting the cornea, occurs in a wire-haired breed of guinea pigs, texel cavies; 0.8% of surveyed animals had this congenital abnormality. 11 after birth the wiry hair can curl inwards into the eye, causing corneal ulcers and epiphora. lubricating the eyes and hair around frequently immediately after birth until the hair grows in a more controlled manner can help. entropion, either primary or cicatrial after an eyelid trauma, is reported in guinea pigs. entropion is typically treated via a variety of blepharoplasties. to the author's knowledge, blepharoplasty in a guinea pig has not been reported. because of their small adnexal structures, they may be more suited to a hyaluronate injection that can evert the lids semipermanently or to frequent lubrication of the cornea to mitigate pathology. to the author's knowledge, guinea pigs are the only species discussed in this article formally reported to exhibit periocular dermoids. 12 large corneal dermoids can compromise vision by their opacification of the visual axis. haired dermoids may contaminate the conjunctival sac by harboring foreign material and debris. the treatment of choice for dermoids is surgical removal via keratectomy, but given the thinness of the guinea pig cornea ( table 2) , this treatment should be undertaken with great care. corneal lipidosis (bilateral stromal lipid dystrophy) is also reported. 11 this has been described as a bilateral paracentral lipid deposition with varying degrees of density and coverage. this appears to be less common than the corneal dystrophy reported in mice and rats. as previously discussed, guinea pigs have been found to have a low corneal sensitivity and a negligible ability to produce reflex tears, thereby placing them at an unusual risk for ocular foreign bodies. they have also been noted to have an unusually low blink rate. 2, 5 this is compounded by their typical housing, in a bedded enclosure with straw and hay at eye level. in a survey of 1000 guinea pigs, 4.7% had conjunctivitis, which was frequently secondary to a traumatic injury from a foreign body. 11 this had also been seen in a previous survey of guinea pigs. 1 it has been theorized that the corneal vessels and lymphoid tissue unique to guinea pigs eyes were an evolved strategy over increased blinking and discomfort seen in other animals. that being said, foreign bodies should still be taken seriously and treated promptly. per williams and sullivan (2010), these foreign bodies, along with congenital trichiasis, seemed to be the most irritating for the animals. guinea pigs have lost their ability to endogenously form ascorbic acid, like people and capybaras, and are therefore at greater risk for scurvy relative to other species of rodent. scurvy often starts with mucous membrane disease including petechiation and ulceration. dry eye has also been reported as a sequela. vitamin c is used in other species as an anticollagenase. 18 therefore, supplementation during times of ulceration, especially a melting ulcer (fig. 2) , is likely to be beneficial regardless of nutritional status. many foods are rich in vitamin c, and there are also nutritional supplements available. because guinea pigs are the largest of the species discussed here, topical treatment is more feasible in terms of administration. systemic absorption is still a risk, and so prolonged treatment, especially with topical steroids and nonsteroidal antiinflammatory drugs, should be approached cautiously. guinea pigs are typically docile and amenable to handling. given their common place as a household pet, individualized treatment including frequent topical medication is more achievable. mice are the smallest rodent discussed in this section. they are one of the most successful mammals on earth today and are viewed as pets, research subjects, vermin, and vectors. they are the most common experimental laboratory animal in recent decades because of their homology with people, small size, and rapid reproduction. breeding onset is about 50 days, and the life span is typically 1 to 2 years when kept as pet. a detailed comparative study was performed using confocal microscopy of normal 4-month-old swiss mice. 15 bowman layer was observed between basal epithelial cells and the anterior stroma. similar to rats, the anterior and posterior stroma had numerous anuclear reflective stellate structures. endothelial cell density was also determined (see table 2 ). just like guinea pigs, corneal vascularization has been reported to be a normal finding in 2 mouse strains -athymic and euthymic nude mice. 19 schirmer tear test with traditional whatman filter paper is not possible in the species based on size, but normal tear volume can be assessed via phenol red thread testing (see table 1 ). 6 no article on mice would be complete without touching on their significance as a research model. mice are models for certain ocular surface diseases, most notably sjö gren syndrome (ss), a common autoimmune dry eye syndrome in people. mice exhibiting ss-like characteristics have a mononuclear cell infiltration into exocrine glands, loss of acinar tissue, and secretory dysfunction. corneal pathology includes corneal vascularization, keratinization, and the propensity for bacterial corneal ulcers (fig. 3) . numerous murine strains have been used for their ss-like disease manifestations, and an excellent review article summarizing the various models has been published. 20 initially these characteristics were spontaneously arising, but later the alterations were associated with gene knockout, resulting in transgenic mice that model aspects of the disease. mice have helped make a breakthrough in the link between primary open-angle glaucoma and the thickness of the central cornea. mice were recently used to identify a transcription factor, pou6f2, that is associated with central corneal thickness and susceptibility of retinal ganglion cells to injury. 21 corneal deposits are a common finding in laboratory mice (fig. 4) . deposition of calcium in bowman layer with or without accompanying vascularization has been reported in both normal and ss-model mice (mrl/mp strain). 22 it is speculated that these deposits are genetically linked, but excess ammonia in cage bedding may also contribute. 23 after investigating husbandry, treatment of the deposits is not performed. peter anomaly, a form of anterior segment dysgenesis, has been documented spontaneously mice and is being used as a model for the disease. 24, 25 the keratolenticular adhesion results in the presence of a leukoma (corneal opacity) of varying size. corneal transplant is the treatment in people, but even then overall visual prognosis is poor. 26 this treatment has not been reported in veterinary patients. additionally, intraocular pressure should be assessed, as aggressive glaucoma often accompanies these changes. 24 fig. 4 . severe example of corneal dystrophy in a laboratory mouse. this individual was considered comfortable (no blepharospasm) and clinically acceptable as a research subject. the primary limiting factor in treatment of mice is their small size. corneal transplants have been performed successfully, but the success rate of these surgeries has not been published, as most studies focus on graft rejection, excluding those leaking or infected grafts from statistical analysis. 27, 28 in veterinary medicine, conjunctival grafts are more commonly performed relative to clear corneal transplants, but to the author's knowledge, this surgical technique has not been reported in any the species covered in this article. the small size of the mouse also means many topical treatments have the potential for significant systemic absorption. even the application of a topical sodium channel blocker to facilitate examination should be applied with judiciousness given its potential for systemic toxicity. 29 rats and mice are closely related and only differentiated by their size, not specific taxonomic criteria. this section focuses on the most common rat species, rattus norvegicus (brown rat and laboratory rat), rattus rattus (black rat), and fancy rat (rattus norvegicus). life span is typically 2 years when kept as a pet, but they can live up to 3 years. rats and mice have 3 tear-producing glands, the intraorbital, the extraorbital, and the harderian. the harderian is a well-studied exocrine gland associated with the third eyelid. this is what produces the porphyrin and lipid-laden tears in rats and is of clinical significance because of the vivid, visible tears it produces in several diseases. 30 tear staining or chromodacryorrhea refers to a dark stain below the inner corner of the eye, caused by porphyrin-pigmented secretion from the harderian gland. it indicates stress in rats but can have other indirect causes. chromodacryorrhea was produced within 15 minutes in young rats following intravenous injection of acetylcholine or acute stress induced by limb restraint. 31 by a similar mechanism, the presence of chromodacryorrhea was even identified as a welfare indicator on commercial pig farms. 32 this finding may gain more attention in the laboratory animal sphere, where welfare is paramount. the presence of chromodacryorrhea should not be ignored, as it is not a normal finding. as discussed, it may be caused by environmental stress, physical illness, or underlying disease. furthermore, even when not hypersecreted, porphyrins are labile until photic energy. exposure to high-intensity light induced necrosis of the glandular cells in a study on a research population of wistar rats. 33 the injury appeared to be caused by the creation of free radicals within glandular cells, probably as a result of photodynamic action on the porphyrins in the gland. proper husbandry with a day-night cycle is essential for rat health and welfare. certain strains of rat are reported to have a high rate of subepithelial mineralization (corneal dystrophy), just like mice. clinically, these opacities are subepithelial (associated with abnormal epithelial basement membrane, bowman layer). they vary from a few punctate opacities only visible with a slit lamp to marked dense opacities covering a majority of the corneal surface (fig. 5) . a thorough ophthalmologic and histopathological study was performed on fischer-344 (f344) rats that demonstrated a high incidence of corneal basement membrane dystrophy. 34 in the most severely affected ocular surface disease in rodents strains, this correlated to a systemic basement membrane disorder. it was speculated that these opacities are relatively under-reported for several reasons, and in this study anywhere from 50% to 100% of rats examined from various breeders had corneal dystrophy. thankfully, these opacifications did not appear to cause the animals discomfort or have an adverse effect on normal physiologic function. however, in people, epithelial basement membrane dystrophy is associated with recurrent corneal erosions. 35 f344 rat strains are also unusually prone to intraocular tumor, which may manifest as a pigmented opacity in the cornea. orbital malignant schwannomas and amelanotic melanoma are reported. 36 sialodacryoadenitis (sda) is a highly contagious common viral infection in rats. sda is caused by rat coronavirus and can spread rapidly, especially through laboratory colonies. anorexia occurs during these viral infections. the virus has a tropism for epithelial cells and can infect the harderian and extraorbital glands, causing ocular disease. 37 often, lacrimal gland involvement leads to reduced tear production. young rats are especially susceptible to sda, and the infection can occur in the lower respiratory tract, resulting in pneumonia. thankfully, the primary disease is usually selflimiting and resolves within a week; however, secondary signs may take up to a month to fully resolve. diagnosis is confirmed by detecting coronavirus antigen with reverse transcriptase polymerase chain reaction (rt-pcr) 38 or serologic testing. 39 treatment limitations are similar between rats and mice. their small size and colony habitat often preclude topical treatment. of the species covered, chinchillas are the most recently domesticated and the least studied. they are also the longest lived in this group of rodents, living on average 10 years in captivity, although chinchillas living into their 20s have been reported. 10 chinchillas were originally bred for fur but since have become pets and are used in scientific research. of the species discussed here, chinchillas have the most recent literature regarding presentation as a pet for ocular examination, and less research-based publications relating to their ocular biology. in a recent retrospective study over the course of 10 years, 7.8% of chinchillas presenting to a tertiary clinic had primary ophthalmic complaints. 10 chinchillas are characterized as having a shallow orbit, and proptosis can easily be induced with pressure on the eyelids; therefore, care must be taken when examining them. 40 chinchilla endothelial cell density has been determined via specular microscopy (see table 2 ). 17 like in other species, cell density decreases and pleomorphism increases with age. of the available publications and consensus among zoo veterinarians, ocular discharge appears to be the most common condition. the discharge/epiphora is suspected to be secondary to dental disease, as in all rodents, chinchillas are hypsodonts with continually growing teeth. this continual growth is compounded by their longevity and potential for inappropriate husbandry. 41 root extension into the nasolacrimal duct and subsequent epiphora is the most common clinical sign. chinchillas with only clear epiphora are typically considered primary dental disease patients. 10 bacteria normally populate the conjunctival fornix. in chinchillas, 9 lima and colleagues (2010) found that streptococcus species (27.45%) was most commonly isolated, followed by staphylococcus aureus (23.52%), and finally coagulase-negative staphylococcus (19.60%). this is in comparison to 42 ozawa and colleagues (2017), who studied chinchillas affected by bacterial conjunctivitis. in diseased individuals, 61.5% yielded a gram-negative isolate (50% being pseudomonas aeruginosa). the remainder yielded gram-positive isolates, staphylococcus species being most common (26.9%). chinchillas with acute conjunctivitis (1-3 days) were much more commonly affected by gram-negative organisms, and most cases were unilateral; 36.7% had concurrent dental disease. as chinchillas often experience conjunctivitis secondary to other disease, a thorough dental examination addressing the underlying cause is essential. however, despite this clinical paradigm, most chinchillas with bacterial conjunctivitis are reported to fully resolved with topical with or without oral antimicrobial therapy within 3 weeks. 42 being larger in size than rats and mice and more typically housed in a pet environment, chinchillas may be more amenable to topical medication, similar to guinea pigs. most diseases specific to rodents are either congenital or related to husbandry. unfortunately, their small size limits many of the typical surgical treatments routinely performed in other veterinary species. once husbandry is addressed, treatment may be limited to mitigation of the disease process but not complete resolution. unusual features in the conjunctiva and cornea of the normal guinea-pig: clinical and histological studies the cornea of guinea pig: structural and functional studies correlation between corneal sensitivity and quantity of reflex tearing in cows, horses, goats, sheep, dogs, cats, rabbits, and guinea pigs results of diagnostic ophthalmic testing in healthy guinea pigs schirmer tear test, phenol red thread tear test, eye blink frequency and corneal sensitivity in the guinea pig a mouse dry eye model induced by topical administration of benzalkonium chloride degeneration and regeneration of corneal nerves in response to hsv-1 infection effect of topical anesthesia on evaluation of corneal sensitivity and intraocular pressure in rats and dogs the chinchilla eye: morphologic observations, echobiometric findings and reference values for selected ophthalmic diagnostic tests reference values for selected ophthalmic diagnostic tests and clinical characteristics of chinchilla eyes (chinchilla lanigera) ocular disease in the guinea pig (cavia porcellus): a survey of 1000 animals conjunctival dermoid in two guinea pigs: a case report central corneal thickness does not correlate with tonolab-measured iop in several mouse strains with single transgenic mutations of matricellular proteins in vivo pachymetry in normal eyes of rats, mice and rabbits with the optical low coherence reflectometer comparative anatomy of laboratory animal corneas with a new-generation high-resolution in vivo confocal microscope regeneration of corneal endothelial cells following keratoplasty in rats with bullous keratopathy specular microscopy to determine corneal endothelial cell morphology and morphometry in chinchillas (chinchilla lanigera) in vivo efficacy of systemic vitamin c supplementation in reducing corneal opacity resulting from infectious keratitis vascularization of corneas of hairless mutant mice sjö gren's syndrome: studying the disease in mice genomic locus modulating corneal thickness in the mouse identifies pou6f2 as a potential risk of developing glaucoma spontaneous development of corneal crystalline deposits in mrl/mp mice effects of cage-change frequency and bedding volume on mice and their microenvironment genetic dissection of anterior segment dysgenesis caused by a col4a1 mutation in mouse a novel mouse model of anterior segment dysgenesis (asd): conditional deletion of tsc1 disrupts ciliary body and iris development outcome of penetrating keratoplasty for peters anomaly dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice the balance of th1/th2 and lap1tregs/th17 cells is crucial for graft survival in allogeneic corneal transplantation systemic toxicity and resuscitation in bupivacaine-, levobupivacaine-, or ropivacaine-infused rats the eye and harderian gland chromodacryorrhea in laboratory rats (rattus norvegicus): etiologic considerations tear staining in pigs: a potential tool for welfare assessment on commercial farms sequential changes in the harderian gland of rats exposed to high intensity light spontaneous corneal dystrophy and generalized basement membrane changes in fischer-344 rats recurrent corneal erosions and epithelial basement membrane dystrophy intraocular and orbital malignant schwannomas in f344 rats comparison of the pathogenicity in rats of rat coronaviruses of different neutralization groups reverse transcriptase polymerase chain reaction-based diagnosis and molecular characterization of a new rat coronavirus strain coronavirus infection in the laboratory rat: immunization trials using attenuated virus replicated in l-2 cells clinical ocular findings in a colony of chinchillas (chinchilla laniger) skull size and cheek-tooth length in wild-caught and captive-bred chinchillas epidemiology of bacterial conjunctivitis in chinchillas key: cord-267965-84sotgds authors: noll, kelsey e.; ferris, martin t.; heise, mark t. title: the collaborative cross: a systems genetics resource for studying host-pathogen interactions date: 2019-04-10 journal: cell host & microbe doi: 10.1016/j.chom.2019.03.009 sha: doc_id: 267965 cord_uid: 84sotgds host genetic variation has a major impact on infectious disease susceptibility. the study of pathogen resistance genes, largely aided by mouse models, has significantly advanced our understanding of infectious disease pathogenesis. the collaborative cross (cc), a newly developed multi-parental mouse genetic reference population, serves as a tractable model system to study how pathogens interact with genetically diverse populations. in this review, we summarize progress utilizing the cc as a platform to develop improved models of pathogen-induced disease and to map polymorphic host response loci associated with variation in susceptibility to pathogens. pathogens often cause variable disease outcomes across infected individuals, ranging from asymptomatic infection to severe or fatal disease. multiple factors influence an individual's susceptibility to a pathogen, including variation in pathogen dose or virulence as well as host age, prior immune experience, microbiome/coinfection, and genetics. a role for host genetics in pathogen susceptibility is supported both by twin studies (kallmann and reisner, 1943) and by evidence of pathogen-driven selective pressure on the evolution of the human immune system (cagliani and sironi, 2013) . human genetic studies have demonstrated a role for host genetics in pathogen susceptibility and identified polymorphic genetic loci and genes associated with variation in susceptibility to specific pathogens (e.g., hiv) (mclaren et al., 2015) , classes of pathogens (e.g., mycobacteria) (bustamante et al., 2014) , and more generalized primary immunodeficiencies (pids) that result in severe immune defects (chapman and hill, 2012) . this information has enhanced our understanding of how host genetic variation affects pathogen susceptibility and how specific genes regulate human immunity and host-pathogen interactions. while advances in human genetic analysis have led to the identification of several host genes that regulate pathogen susceptibility in humans (newport and finan, 2011) , much of our understanding of how specific genes affect infectious disease pathogenesis in mammals has come from studies using mouse models (masopust et al., 2017) . this is in large part due to the existence of inbred mouse strains as well as the vast amount of immunological and molecular genetic tools available for the mouse, including the early generation of the mouse reference genome. inbred strains, in which each mouse is essentially genetically identical, allow control of host genetics as well as other factors that can confound human studies, such as pathogen dose, nutrition, and prior immune exposure. additionally, targeted knockout technology has been used in the mouse genome for almost 30 years (bouabe and okkenhaug, 2013) . while advances in gene editing techniques (e.g., crispr) have recently extended these approaches to other species, genetically modified mice have been an unparalleled resource for studying the role of specific genes in the response to a variety of pathogens (masopust et al., 2017) . furthermore, the use of classical genetic crossing approaches (e.g., intercrosses), as well as reproducible mouse genetic reference populations (grps), has facilitated the discovery of key regulators of host immunity and pathogen susceptibility such as the innate immune receptor tlr4, oligoadenylate-synthetase oas1b, and divalent metal transporter nramp1 (perelygin et al., 2002; qureshi et al., 1999; vidal et al., 1993) . the recent development of multiparental grps, such as the collaborative cross (cc), promises to further extend genetic mapping capabilities, while also leading to the development of mouse models that more accurately reproduce the genetic diversity and phenotypic range seen in human populations (churchill et al., 2004) . this review will summarize recent advances in the use of mouse grps, with an emphasis on the use of the cc for studying infectious diseases and immunity. the impact of host genetics on pathogen susceptibility can be illustrated by genes exhibiting large effects such as the chemokine receptor ccr5 and fucosyltransferase 2 (fut2), for which specific variants have a major impact on resistance to viral infection (hiv and norovirus, respectively) (quillent et al., 1998; thorven et al., 2005) . likewise, deleterious mutations in immune genes can result in pids, which cause enhanced susceptibility to specific or entire classes of pathogens (carneiro-sampaio and coutinho, 2007) . to date, over 350 genetically driven pids have been identified in humans (picard et al., 2018) . the identification of these monogenic resistance and susceptibility genes has enhanced our understanding of human immunity and hostpathogen interactions while contributing to the development of antiviral therapies, such as hiv entry inhibitors, as well as gene therapy and immune replacement therapies (collins and thrasher, 2015; lenardo et al., 2016) . though genes of large effect can impact human health, inheritance patterns suggest that susceptibility to infectious disease is largely polygenic (driven by tens to thousands of variants of smaller effect) (hill, 2012) . this is supported by results from genome-wide association studies (gwas) designed to map loci associated with variation in pathogen susceptibility and vaccine response. for example, gwas of hiv viral load have shown that mutations in the hiv co-receptor ccr5 and variants in human leukocyte antigen (hla) explain approximately 15% of the total variance, with an additional 5% of heritable variance explained by additive effects of other genes (mclaren et al., 2015) . gwas on malaria susceptibility have identified variants in multiple genes including the calcium atpase atp2b4, the glucose phosphate dehydrogenase gp6d, and hlas, as well as confirming previously identified variants in hemoglobin genes (sickle cell and thalassemia) (hedrick, 2011; timmann et al., 2012) . multiple loci have been associated with clearance of hepatitis c virus, including the cytokine il-28b and hla genes (duggal et al., 2013) , and over 20 loci have been associated with leprosy susceptibility (wang et al., 2016) . while gwas have been applied to and enhanced our understanding of infectious diseases, these studies explain only a fraction of the heritable variation in pathogen susceptibility (hill, 2012) . this is partly attributable to factors such as small cohort sizes, ethnic striations, and lack of replicates, which limit detection and interpretation of results (du et al., 2012) . rare genetic variants are unlikely to be detected by gwas, due to both lack of power and lack of tagging on conventional genotyping arrays (auer and lettre, 2015) . a specific concern for gwas in infectious diseases is that studies can be confounded by pathogen genetics, pathogen dose, and other environmental factors. furthermore, validation and mechanistic analysis can be difficult in humans due to factors such as lack of replicates and inability to routinely access many affected tissue types. for these reasons, the use of appropriate animal models has been a critical resource for identifying and studying pathogen susceptibility genes. while a variety of model genetic systems have been used to analyze host-pathogen interactions (e.g., caenorhabditis elegans, danio rerio, and drosophila melanogaster) (allen and neely, 2010; dionne and schneider, 2008; marsh and may, 2012) , the laboratory mouse (mus musculus) provides the most robust mammalian system for dissecting genetic regulation of immune responses in human-relevant diseases. mice are relatively inexpensive, can be easily controlled in diet and environment, and reproduce quickly. a wide variety of well-characterized mouse immunological reagents are available, as well as genetic tools such as reproducible inbred strains, gene-specific knockouts, genome-wide mutagenesis strategies (e.g., n-ethyl-n-nitrosourea [enu] and crispr/cas9), and transgenic technologies. these systems facilitate the identification and mechanistic characterization of specific host genes that affect disease pathogenesis and/or immunity (pelletier et al., 2015; takaki et al., 2017) . though over 450 commercially available inbred mouse strains and outbred stocks are available (beck et al., 2000) , the majority of research in infectious disease and immunology is conducted in a limited set of strains. one of the major reasons for the focus on specific strains is the need to control for genetic background when analyzing gene-specific knockouts or performing largescale mutagenesis screens. large-scale initiatives such as the international mouse phenotyping consortium (impc) depend upon the ability to control background strain to analyze the impact of specific gene deletions or mutations on a wide range of developmental and immune phenotypes (muñ oz-fuentes et al., 2018) , and have thus generated these mutants on common backgrounds using largely identical procedures. c57bl/6j is the most commonly used inbred mouse strain; it is the source of the mouse reference genome and the genetic background for the majority of knockout mice. other strains, such as the balb/c substrains, also have a rich history of use in immunology and infectious disease research (watanabe et al., 2004) . while the ongoing use of such strains is driven by the need to compare results across studies, it is important to note that every inbred strain has a unique set of genetic features, and thus no one strain is representative of all mice, let alone of a genetically complex population such as humans. although genetically modified mice have been an essential resource for gene discovery and mechanistic analysis, there has been a growing acknowledgment in the field that knockout approaches have limitations. approximately 15% of genes cannot be knocked out because they are developmentally essential (nih, 2015) . similarly, other knockouts have no observable phenotype, due to genetic redundancy and/or lack of robustness in the phenotyping pipeline (barbaric et al., 2007) . in other cases, knockouts have disparate phenotypes on different genetic backgrounds due to gene-gene interactions (doetschman, 2009) . furthermore, gene knockouts result in null alleles (complete loss of gene function), whereas naturally occurring genetic variants are most likely to be hypomorphic or hypermorphic alleles (partial loss or gain of gene function; alterations in timing and magnitude of expression). lastly, while single-gene approaches are straightforward, they are isolated systems that do not model the simultaneous contribution of variants in multiple pathways, as would most likely be observed in a natural system. thus, to better model and understand the role of genes in complex phenotypes such as immunity and infectious disease, it is pertinent to consider complex genetic interactions across diverse genetic backgrounds. in contrast to the approaches discussed above, researchers have also studied the role of natural genetic variants by leveraging differential phenotypes across inbred strains, using classical genetic breeding strategies to identify pathogen susceptibility genes such as oas1b, immune cell activating receptor ly49h, and large interferon-induced gtpase mx1 (casanova et al., 2002) . in contrast to mapping crosses between stocks (e.g., f2 crosses), where each mouse is unique and therefore ephemeral, grps serve as reproducible models to study the role of genetic diversity. grps consist of anywhere from a few to hundreds of inbred lines derived and split from a common ancestral population, and each line has a fixed and known genome that can be replicated indefinitely. the existence of reproducible yet genetically diverse individual mouse strains facilitates study designs that involve case versus control, genotype by environment interactions (gxe), and phenotypic penetrance or threshold traits. these populations further facilitate the integration of phenotypic, genotypic, and molecular data for systems-level data analysis while also allowing retrospective integration of new layers of data. the first recombinant inbred panel, the cxb (balb/cj 3 c57bl/6j), was created by donald bailey to facilitate mapping of the mhc locus (bailey, 1971) . subsequent biparental recombinant inbred panels include the axb/bxa (a/j 3 c57bl/6j, c57bl/6j 3 a/j), the bxh (c57bl/6j 3 c3h/hej), and the bxd (c57bl/6j 3 dba/2j), which is the largest and most extensively used of these panels (peirce et al., 2004) . though originally developed to study monogenic traits, use of these panels has been extended to study genetically complex traits such as susceptibility to murine plasmodia (hoffmann et al., 1984) , murine leukemia virus (panoutsakopoulou et al., 1998) , group a streptococcus (chella krishnan et al., 2016) , and influenza a virus (iav) (nedelko et al., 2012) . as results from these panels accumulated, there was a community-wide recognition that larger and more genetically diverse grps would improve the ability to genetically dissect more complex traits (threadgill et al., 2002) . based on results from the early grps as well as genetic mapping studies, the complex trait consortium proposed to create a second-generation, multi-parent advanced intercross grp to promote complex trait genetic mapping and systems genetics research (threadgill et al., 2002) . in contrast to single-gene approaches, systems genetics considers phenotypes in the context of global genetic variation as well as intermediate molecular factors such as gene expression, protein abundance, and environmental interactions. the resource ultimately derived from this proposal was the cc, a large panel of recombinant inbred strains derived from eight genetically diverse founder strains. the cc was designed to facilitate systems genetics approaches with improved resolution and higher statistical power compared to traditional grps, to expand the pool of genetic variation segregating in the population, and to bridge the analysis of genetic and molecular networks across diverse phenotypes (churchill et al., 2004) . of the eight cc founder strains, five are classical laboratory strains chosen for their rich history of use in mouse genetics (c57bl/6j and 129s1/svimj) or their relevance as models of common diseases including cancer, type 1 diabetes, metabolic syndrome, and obesity (a/j, nod/shiltj, and nzo/hiltj). the other three cc founders are wild-derived inbred strains, which represent the three major subspecies of mus musculus: casteneus (cast/eij), musculus (pwk/phj), and domesticus (wsb/eij), and introduce much of the genetic diversity into the cc. these eight founder strains were interbred in a funnel breeding scheme to produce recombinant mice with genomic contributions from each founder, which were then bred to homozygosity to produce recombinant inbred (ri) cc strains (figure 1 ). although the initial goal was to produce 1,000 cc strains, only around 100 cc strains survived the inbreeding process due to high rates of infertility and breeding issues, largely caused by genomic incompatibility introduced by the wild-derived strains. extinction of cc strains during the inbreeding process inspired the creation of the diversity outbred (do) panel, an outbred population derived from a set of incipient cc strains (churchill et al., 2012) . the do now serves as its own important genetic resource that has proven useful for high-resolution genetic mapping as well as exploration of phenotypic diversity ( while the do has only been used in a limited number of infectious disease studies (mchugh et al., 2013; niazi et al., 2015) , the do and cc should be viewed as complementary resources for studying how genetic variation affects pathogen susceptibility and immunity. while classical mouse grps remain actively used, and in some ways provide a more straightforward analytical path than the cc due to reduced complexity, several aspects of the cc make it more attractive for discovery-based research. the cc captures approximately 90% of common genetic variants described within laboratory mice, with up to eight distinct haplotypes at any region of the genome (roberts et al., 2007) . due to higher genetic diversity with novel allele combinations and epistatic interactions, the cc yields more phenotypic variation and extreme phenotypes than classical grps. the selection of founder strains and the breeding design, as well as higher levels of recombination, result in lower levels of long-range disequilibrium and population structure than classical grps, allowing for higher resolution quantitative trait locus (qtl) mapping (iraqi et al., 2012; threadgill et al., 2002) . genetic variation is also more uniformly distributed across the genome, removing several genomic ''blind spots'' that interfere with mapping in classical inbred strains and grps (roberts et al., 2007) . although the cc has only been available for a relatively short period of time, it has been utilized across a number of disciplines, including response to environmental toxins (venkatratnam et al., 2017) , nutrition (schoenrock et al., 2018) , body composition (mathes et al., 2011) , and immunity and pathogenesis (discussed further here). importantly, these studies have highlighted previously uncharacterized phenotypic diversity, including expansion of the phenotypic range, disassociation of traits previously thought to be connected, and identification of completely novel phenotypes (srivastava et al., 2017) . the cc is an especially useful resource for studying the role of host genetics in hostpathogen interactions because it allows for control of many of the factors described above that confound infectious disease studies in humans. over the past decade, a variety of studies utilizing the cc, including non-fully inbred incipient cc lines (commonly termed the pre-cc) and derived cc populations (such as cc-f1s), have been used to probe the role of host genetics in the response to infectious disease. here we will discuss the current work in this field, including studies focusing on phenotypic characterization (e.g., model development and molecular signatures of disease response) and genetic mapping of disease trait-associated qtl. there is an ongoing debate over the validity of mouse models in recapitulating human disease (seok et al., 2013; takao and miyakawa, 2015) . while the utility of the mouse is undeniable in the infectious disease field, it is equally true that individual classical inbred strains do not fully recapitulate human disease and most models recapitulate only a portion of the disease phenotypes observed in humans. in an effort to improve model fidelity to human disease, a number of researchers have turned to the cc to develop new mouse models. genetically diverse cc strains show a range of responses to pathogens, from variation in disease severity to completely novel disease phenotypes. this phenotypic variability better mimics the diversity of disease presentation across the human population, thus providing a more comprehensive platform to develop newer, more representative mouse models. ebola virus ebola virus (ebov) causes severe, and often lethal, hemorrhagic fever in humans. while classical inbred strains are susceptible to mouse-adapted ebov (ma-ebov), they do not display many of the characteristic symptoms observed in severe human cases such as coagulopathy, hemorrhagic manifestations, and rash (st claire et al., 2017) . rasmussen et al. infected a panel of f1 crosses between cc strains (cc-f1s) following an initial assessment in founder strains (rasmussen et al., 2014) . they observed significant phenotypic variation following ma-ebov infection, from high resistance to complete lethality, and covering a spectrum of different pathologies similar to the range of clinical disease observed in humans. importantly, some strains presented with severe hemorrhagic disease and liver damage, consistent with human ebov disease. follow-up studies with representative susceptible and resistant strains found differential transcriptional responses, highlighting the central transcriptional regulatory gene tek, for which haplotypes across these cc-f1s correlated with weight loss and mortality following ma-ebov infection. west nile virus (wnv), a neuroinvasive flavivirus, induces a diverse spectrum of immune responses and clinical outcomes in humans that classical mouse models do not fully recapitulate (graham et al., 2015) . graham et al. assessed wnv susceptibility in a panel of cc-f1 crosses that were heterozygous for the h-2b mhc haplotype, which allowed quantification of wnv-specific t cells with the same mhc tetramer. wnv outcome ranged from highly resistant to highly susceptible, including a novel outcome group in which mice were outwardly asymptomatic despite higher viral titers and immunopathology in the brain. graham et al. followed up on one unique cc-f1 ((cc032/ geniunc 3 cc013/geniunc)-f1), in which half of the mice that survived infection displayed sustained weight loss and persistent viral loads in the cns. they found that these mice exhibited a rapid early innate inflammatory response characterized by increased early expression of ifn-b and the interferonstimulated gene ifn1, as well as high early viral titers and the ability to control, but not clear, viral replication in the cns figure 1 . representative cc funnels cc founders were bred in funnel breeding schemes to produce progeny with genetic contributions from each of the eight founders, at which point they were inbred for generations until reaching near homozygosity. many different funnels were set up, each to produce a unique cc ri line. (graham et al., 2016) . additionally, (cc032/geniunc 3 cc013/ geniunc)-f1 mice had a unique immunoregulatory signature, with a high number of t regulatory cells in both infected and uninfected animals and a distinctive post-infection gene expression profile that indicated reduced cytolytic ability. the initial graham et al. study (graham et al., 2015) found that wnv response largely tracked with the haplotype of oas1b, a known flavivirus resistance gene, although there was still considerable disease variation within oas1b haplotype groups. green et al. continued to dissect the impact of oas1b on the innate immune transcriptional landscape following wnv infection (green et al., 2017) by performing genome-wide micro-array analysis across multiple time points post-infection in seven cc-f1s carrying different combinations of functional (wild-derived) or nonfunctional (classical inbred strain-derived) oas1b haplotypes. transcriptional correlation analysis of differentially expressed immune genes across cc-f1s yielded three gene clusters, and pathway analysis led to the construction of innate immune regulatory networks associated with wnv infection between oas1b haplotype groups. mycobacterium tuberculosis (mtb) infection varies broadly in disease presentation and pathology in humans. likewise, the efficacy of the standard tb vaccine, the live-attenuated bcg, is variable across individuals (mangtani et al., 2014) . smith et al. studied mtb pathogenesis and bcg vaccine efficacy in the cc founders and three ri strains that were selected based on a pilot study assessing mtb susceptibility (smith et al., 2016) . the authors observed a wide range of susceptibility to mtb and dissociation of previously associated phenotypes such as bacterial burden, immune cell recruitment, and tissue damage. when the bcg vaccine was administered prior to mtb challenge, vaccine efficacy was low overall and not correlated with susceptibility to primary infection. while bcg vaccination reduced mtb burden in four strains, there was an increased bacterial burden in nzo/hlltj mice, a model for obesity and type 2 diabetes. in addition to highlighting the importance of host genetics on mtb susceptibility and bcg-induced vaccine responses, the study illustrates the potential impact of comorbidities, such as type 2 diabetes in nzo/hlltj mice, on vaccine responses in genetically diverse populations. maurizio et al. analyzed the heritability of iav-induced disease using cc-f1s as well as f1 crosses between founder strains (maurizio et al., 2018) . these studies determined that iavinduced weight loss was 57% heritable at day 4 post-infection, and that this heritability was mostly composed of additive effects largely attributable to the haplotype of mx1, a polymorphic largeeffect anti-iav gene. the genetic dominance of the protective mx1 haplotype varied depending on subspecies origin, with the m. musculus musculus allele acting dominantly and the cast/eij allele, identified by ferris et al. (2013) , acting additively. consistent with ferris et al. (discussed below) , these authors determined that when controlling for mx1, non-mx1 heritable effects still accounted for 34% of the phenotypic variation, and this effect was consistent across founder diallel, pre-cc, and cc-f1 populations. human studies have identified blood transcriptomic and proteomic signatures associated with iav infection that could be used to predict patient outcome. elbahesh and schughart observed that gene signatures from iav-infected humans were reproduced in the peripheral blood of cc founders (elbahesh and schughart, 2016) . in a follow-up study, kollmus et al. characterized the transcriptional response to iav in the peripheral blood of eleven cc strains (kollmus et al., 2018) . though both human and mouse datasets were globally heterogeneous, the cc dataset showed that genetic background strongly influenced gene expression, highlighting the importance of genetics in driving the immune response. for the most differentially expressed genes, the transcriptional responses in mice and humans were largely similar, demonstrating the utility of the cc in recapitulating iav-induced host response in humans. xiong et al. characterized transcriptomic variation in response to severe acute respiratory syndrome coronavirus (sars-cov) and iav across the eight cc founder strains (xiong et al., 2014) . differential gene expression analysis at days 2 and 4 post sars-cov or iav infection showed significant differences driven by mouse strain, infection status, and time point. genes with strain-specific differential expression patterns were largely enriched for immune pathways, while more generic differential expression patterns were enriched for basic biological functions. the study also noted the presence of strain-specific isoforms and novel transcripts not present in the c57bl/6j reference annotation. pseudomonas aeruginosa is an opportunistic bacterial pathogen with variable clinical outcomes across susceptible individuals. human studies, including twin studies as well as association studies, have identified multiple genes associated with susceptibility to p. aeruginosa. lorè et al. studied p. aeruginosa infection in 17 pre-cc lines, focusing on survival time and early body weight change, and observed a large amount of variation in these phenotypes (lorè et al., 2015) . genetic mapping of disease response in the cc as described above, the cc was initially envisioned as a genetic mapping population with approximately 1,000 strains (threadgill et al., 2002) . while the number of available cc ri strains is closer to 100, this population has proven to be sufficient for successful qtl mapping. mapping studies have identified qtls spanning the genome that are driven by variants from all eight cc founders and show very little overlap across pathogens (figure 2 ; table 1 ; discussed below). overall, infectious disease phenotypes mapped in the cc show a broad range in overall heritability (the proportion of population-wide variation explained by differences between strains) as well as effect sizes (the proportion of population-wide variation explained by specific loci). across the studies described in table 1 , reported estimates for heritability range from 12% to over 80%, while reported estimates for effect size range from 5% (for a qtl of small effect influencing sars-cov viral titer) to over 40% (for a large effect qtl containing the gene mx1 on influenza-induced weight loss). authors have narrowed many of these qtls to lists of candidate genes, and a small number of these candidates have been subsequently validated. to date, most publications have highlighted qtls mapped by phenotyping large panels of cc strains; however, this is not the only successful strategy. as mentioned above, some cc strains present with unique disease phenotypes, which may be driven by complex genetic regulatory networks involving multiple loci with epistatic interactions. when one or a few cc strains possess the combination of genetic variants needed to manifest the novel phenotype, population-wide studies may not possess sufficient mapping power. in these cases, researchers have successfully used more traditional f2 or backcross approaches to identify causal genes (rogala et al., 2014) . in this section, we will highlight results of both population-wide and intercrossmediated cc studies of relevance to infectious disease research. the first host-pathogen study in the cc examined susceptibility to the fungus aspergillus fumigatus, which is pathogenic in immunocompromised individuals. durrant et al. found that survival time varied between 4 days and over 28 days post-infection in 66 pre-cc lines (durrant et al., 2011) . the authors mapped multiple genome-wide significant qtls for survival time that were largely driven by wild-derived founder haplotypes. candidate genes were identified using merge analysis, a procedure that compares the pattern of sequence variants (e.g., snps or indels) to the pattern of haplotype effects (impact of each founder strain haplotype on the phenotype) observed under the qtl (yalcin et al., 2005) . the application of merge analysis to the cc enables more effective gene refinement compared to studies in classic biparental grps, where the presence of only two haplotypes means that every genetic variant in a locus is a putative candidate causal variant. merge analysis supported the candidate gene irf2, an interferon regulatory transcriptional factor gene, under the most significant qtl; however, for the remaining qtls there was no strong concordance between a priori and merge-supported candidates. klebsiella pneumoniae vered et al. challenged 73 pre-cc lines with k. pneuomonia, which causes severe pneumonia and sepsis in immunocompromised individuals (vered et al., 2014) . the pre-cc mice displayed broad and heritable variation in survival time exceeding that observed in classic inbred strains, as well as dissociation of survival time from temperature or body weight changes. the study identified one qtl at day 2 post-infection and two at day 8 post-infection. the authors used merge analysis to refine candidate genes; however, they found that the best merge candidates showed simpler allele effect patterns than the more complex haplotype effects observed under the qtl. the strongest candidate genes identified were ikbkap, a transcriptional elongation factor complex component, and actl7a, actl7b, and ctnnal1, which are involved in cell adhesion and cytoskeletal structure. bottomly et al. analyzed a set of 99 pre-cc lines infected with mouse-adapted influenza a/pr/8/34 and assessed weight loss, clinical score, and mortality through 4 days post-infection (bottomly et al., 2012) . a subset of pre-cc lines, classified as high and low responders based on a composite metric of weight loss and histopathological scoring, were selected for transcriptomic profiling. over 2,000 transcripts were differentially expressed between susceptible and resistant classes, and mapping identified 21 significant expression qtls (eqtls). twelve of the eqtls were validated in cc founder strains, and structural equation modeling was applied to these candidates to infer reactive expression networks underlying the transcriptional differences. in a companion study, ferris et al. further characterized variation in response to influenza a/pr/8/34 in 155 pre-cc lines (ferris et al., 2013) . while disease-associated phenotypes (weight loss, viral titer, and inflammation) were largely correlated, subsets of these pre-cc mice showed breakdowns in these relationships, resulting in novel phenotypic combinations not observed in classical mouse strains (e.g., high weight loss with minimal inflammation). this study identified four significant qtls, including one strong qtl that explained approximately 42% of iav-induced weight loss, over the iav resistance gene mx1. importantly, while mx1 is well studied, the authors identified a novel allelic variant derived from cast/eij that protects from weight loss but less efficiently inhibits viral replication compared to the functional m. musculus musculus-derived allele carried by nzo/hiltj and pwk/phj. consistent with ferris et al.'s finding of a uniquely functional cast/eij mx1 variant, leist et al. found that cast/eij mice have a unique response to an h3n2 strain of iav (leist et al., 2016) . while the mx1 locus had a dominating effect in the ferris et al. study, large phenotypic variation occurred within mx1 classes, suggesting the presence of modifier alleles. three additional qtls were mapped when controlling for mx1 haplotype, corresponding to variation in weight loss, pulmonary edema, and airway neutrophils. notably, aside from the mx1 locus, none of the qtls identified by ferris et al. matched influenza susceptibility loci found in mapping studies conducted in the bxd population. (boon et al., 2009; nedelko et al., 2012) . these differences may reflect the more complex genetics of the cc compared to the bxd and/or differences in the strain of influenza or other experimental variables across studies. salmonella enterica salmonella enterica serovar typhimurium (s. typhimurium) causes typhoid fever, and previous mouse mapping studies have identified multiple loci associated with susceptibility (roy significance threshold levels: *<0.1, **0.1, ***0.05. genome coordinates marked with 0 refer to genome assembly gscv38/mm10; otherwise, coordinates refer to mgscv37/mm9. et al., 2006; sebastiani et al., 1998) . to identify novel loci associated with s. typhimurium susceptibility, zhang et al. infected 35 cc ri strains and measured bacterial load in the liver and spleen at 4 days post-infection (zhang et al., 2018) . qtl scans for bacterial load mapped multiple significant or suggestive qtl (figure 2 ; table 1 ), which differed from those identified in studies conducted in other mapping populations (roy et al., 2006; sebastiani et al., 1998) . zhang et al. used merge analysis in combination with immune cell gene expression, gene ontology, and analysis of known protein functions to narrow the list of candidate genes under the two significant loci. they identified candidate genes cul4a (ubiquitin ligase), lamp1 (lysosomal membrane protein), mcf2l (guanine nucleotide exchange factor), pcid2 (trex-2 complex component involved in mrna nuclear export), and a high-priority candidate slc35f1, which has lactate dehydrogenase activity that may be important in the s. typhimurium pyruvate metabolism pathway. the study also noted that one strain, cc042/geniunc, had extremely high bacterial loads, suggesting that it may be uniquely susceptible to s. typhimurium. sars-cov causes severe acute respiratory syndrome in humans, but the genes regulating these processes are poorly understood. gralinski et al. infected the cc founder strains and 147 pre-cc lines with mouse-adapted sars-cov and studied disease through day 4 post-infection (gralinski et al., 2015) . variation in weight loss and viral titer was significant in the cc founders and even broader in the pre-cc mice. similar to iav, phenotypic dissociation was observed in some pre-cc lines, with viral titer not correlated with weight loss. qtl mapping identified a significant main effect qtl, as well as a modifier qtl for vascular cuffing in the lungs, explaining 26% and 21% of the variation, respectively. suggestive qtls were identified for eosinophilia (26% of variation) and viral titer (22% of variation) (figure 2 ; table 1 ). the candidate region for the main effect vascular cuffing qtl was narrowed to a small 450 kb region of shared ancestry between the high-response haplotypes. this region contained only one functional gene, trim55, a ring zinc-finger-containing protein expressed in smooth muscle, which had not previously been implicated in any immune phenotypes. follow-up validation studies using trim55 knockout mice, which showed altered chemokine and tight junction gene expression as well as altered inflammatory cell recruitment, confirmed a role for this gene in sars-covinduced vascular cuffing. the authors also noted a high-priority candidate under the modifier qtl, the cadherin family member cdhr2, which may be involved in migration of inflammatory cell from the blood into the lung. in a subsequent study, gralinksi et al. used an f2 cross between two cc-ri strains with highly divergent sars-cov susceptibilities to map five significant loci affecting weight loss, viral titer, and other disease phenotypes, including one main effect qtl that explained between 6% and 12% of the variation in every phenotype (gralinski et al., 2017) . ticam2, a tlr4 adaptor protein, was identified as a high-priority candidate gene under the main effect qtl given the known importance of tlr4 in sars-cov pathogenesis (totura et al., 2015) . ticam2 knockout mice had increased sars-cov-induced weight loss, early viral titers, and pulmonary hemorrhage. in addition to exhibiting high levels of variation in pathogeninduced responses, the cc also exhibits variation in baseline (homeostatic) immunity. variation in immune homeostasis has been associated with variation in vaccine responses in humans (tsang et al., 2014) , and the cc provides a novel resource to study how variation in pre-existing immunity affects the host response to infection or vaccination. phillippi et al. analyzed subsets of lymphocytes and antigen-presenting cells in the cc founders, cc founder f1s, and 66 pre-cc strains (phillippi et al., 2014) . they observed variation in the pre-cc exceeding that in the founders, as well as novel extreme phenotypes such as lymphopenia and inverted cd4/cd8 ratios. while some immune phenotypes were highly correlated, others showed little or no correlation to other immune populations. mapping identified 10 significant qtls across 8 phenotypes, including b/t cell ratio and mean fluorescence intensity for cd23, also known as fc epsilon rii. the cd23 qtl contains the gene fcer2a, which codes for cd23 itself, and a combination of merge analysis, conditional association, and residue conservation was used to identify specific coding polymorphisms within fcer2a driving the qtl. graham et al. also performed an extensive examination of homeostatic immunity in over 100 cc-f1 crosses, with a focus on t cell populations, expression of activation markers, and production of inflammatory cytokines (graham et al., 2017) . cc strains exhibited high levels of phenotypic variation that extended well beyond the variation observed between c57bl/6j and balb/c, the most common laboratory strains in immunological studies. mapping identified two highly significant qtls driving the frequency of specific t regulatory subsets, and candidates were chosen based on concordance of haplotype effects with founder polymorphisms that were coding or splice variants. similar to the cis-qtl for cd23 expression identified by phillippi et al., the qtl mapped by graham et al. for cxcr3+ t regulatory cells contains the cxcr3 gene itself. kri sti c et al. studied variation in igg glycosylation, which is important for antibody structure and function, in 95 cc strains and observed nearly double the variation observed in humans (kri sti c et al., 2018) . glycosylation patterns were up to 80% heritable, and multiple qtls associated with variation in different glycans were identified. variation in 5 different glycans all mapped to the immunoglobulin heavy chain locus. variation in 2 other glycans mapped to a locus containing the glycosyltransferaseencoding gene mgat3, which was identified as a strong candidate. commensals and the microbiome in the cc while the focus of this review is on genetic control of immune populations and response to infectious agents, there is a growing appreciation for the role commensals play in shaping health and modulating immune responses. two studies have addressed these responses in the cc (snijders et al., 2016) and do (carmody et al., 2015) populations. both found that there were significant contributions of host genetic backgrounds. further, the cc study found strong genomic signals for many bacterial groups (otus) around the genome. given the increasing appreciation and awareness of the microbiome in modulating a variety of biomedically relevant traits, as well as the impact of commensals and the virome (virgin, 2014) on directly modulating immune responses (masopust et al., 2017) , future work within the cc will allow for the disentangling of direct roles on host genetic variants on disease responses, as well as indirect roles mediated through effects on commensals or prior immune exposure. the cc is a powerful resource for model development, extreme phenotype discovery, population-based qtl mapping, intercross mapping, validation of candidate genes across genetic backgrounds, and a variety of other approaches. here, we provide an overview of different study designs that can be implemented to study the impact of host genetic variation on pathogen outcomes or immunity using the cc (figure 3) . many of the genetic mapping studies described above utilized large panels of cc strains and were able to identify loci of moderate to large effects on pathogen outcomes. however, these types of studies are extremely resource intensive and may not always be the optimal approach. rather, we suggest a tiered approach to study design within the cc, starting with a small-scale analysis in a set of strains (e.g., 12-16) that sample most of the haplotypes present across the cc genomes, and expanding as necessary. the efficacy of this type of approach is demonstrated by the success of small cc screens that have identified strains with unique phenotypes and proceeded with further targeted studies such as f2 crosses to reveal complex polygenic networks driving the outlier phenotype (gralinski et al., 2017; rogala et al., 2014) . furthermore, even when investigators opt for large mapping studies, they may still identify strains with unique outlier phenotypes that cannot be explained by qtls identified in the initial screen. this missing heritability may be driven by complex genetic interactions such as epistasis, which are difficult to study in complex populations and are more effectively studied in targeted crosses (rogala et al., 2014) . initially screening small sets of cc strains (e.g., 12-16) allows the investigator to obtain insight into the distribution of trait variation (e.g., continuous, bimodal), while testing whether any strains show unique or strong outlier phenotypes (gralinski et al., 2015; rasmussen et al., 2014; rogala et al., 2014) . these small screens also facilitate estimation of the proportion of phenotypic variation explained by genetics within the test population (heritability), identification of potential confounding factors (e.g., mouse size and activity levels), and performance of power calculations before embarking on a large-scale screen. in contrast to conducting the initial screen in the cc founders, cc strains exhibit more phenotypic diversity due to re-assortment of allelic variants throughout the genome. furthermore, a specific set of cc strains can be chosen to avoid the presence of large effect resistance genes such as mx1 or oas1b that may dominate the response to some pathogens. likewise, strains can be selected that carry specific gene haplotypes to facilitate specific assays (e.g., mhc haplotypes for antigen-specific t cell analysis) (graham et al., 2015 (graham et al., , 2017 . following an initial screen, researchers interested in developing new models can pursue the strains with the most relevant phenotypes, while those interested in genetic mapping may either perform a more extensive population-wide study (e.g., across the entire cc) or conduct a focused analysis of one or more strains with extreme or novel phenotypes via classical intercrosses. unlike cc mice, which are fully inbred and genotyped, each mouse in an f2 or other intercross mapping population will need to be genotyped. in both cases, genetic mapping should identify a subset of the variants impacting the phenotype of interest (e.g., disease). while an in-depth discussion of mapping methods is beyond the scope of this review, several robust mapping strategies have been successfully applied to the cc, including doqtl, bagpipe, and r/qtl (arends et al., 2010; gatti et al., 2014; valdar et al., 2009 ). once qtls have been mapped, investigators can confirm the underlying haplotype effects by screening additional cc strains with high or low responder haplotypes under the qtls that were not included in the initial screen, or by screening a set of mice from the related do population. while not essential, this step confirms the initial mapping studies and provides confidence in the qtl effects prior to embarking on candidate gene investigation. the identification and validation of candidate genes can be a challenging and intensive process. qtls are often large, containing tens to hundreds of genes. in contrast to mapping in biparental grps or intercross populations, where there are only two haplotypes and every variant is a putative candidate, in the cc, merge analysis (yalcin et al., 2005) can be used to narrow candidates based on how the pattern of variants (e.g., snps or indels) for each founder matches the distribution of phenotypic responses associated with each founder haplotype. as described above, merge analysis has been a useful tool in the cc; however, a drawback of merge analysis is that it assumes a single snp variant driving the locus. in multi-parental populations, different snps or other mutations within the same gene may phenocopy one another (e.g., different mx1 null alleles; ferris et al., 2013) . furthermore, other genetic variants (e.g., copy number variants and transposable elements) are often missed by traditional merge databases. other in silico tools, including baseline tissue and/or haplotype-specific gene expression (e.g., immgen and gecco) (shay and kang, 2013 ; http://csbio.unc.edu/gecco) and protein functional consequence prediction (e.g., sift; sim et al., 2012) , can help narrow candidates to a single high-priority candidate gene or small set of candidates (ferris et al., 2013; gralinski et al., 2015) . alternatively, if causal variants are suspected of altering transcript levels, de novo gene expression analysis can be used to further refine candidate genes under the locus. following candidate gene identification, there are several options for testing whether the candidate is actually causal. when the phenotype is driven by an individual cellular factor, such as an antiviral molecule or receptor, gene function can be validated in vitro using techniques such as crispr or ectopic expression of different variants. when the phenotype has a more systemic cause, in vivo validation is generally necessary. this can be facilitated by the wide availability of knockout mouse lines (gralinski et al., 2015 (gralinski et al., , 2017 . however, in vivo validation studies should take into account factors such as genetic background of the knockout, the effect of the variant, and the distribution of haplotypes (e.g., a knockout on a c57bl/6j background may not provide an interpretable phenotype if, in the cc, the c57bl/6j haplotype is an extreme response haplotype, or if the c57bl/6j allele is hypomorphic or amorphic). more recent advances in crispr technology open up the possibility of knocking out or performing allele swaps in genes directly in cc founders or ri strains, enhancing the utility of the cc as a resource for both identifying and studying polymorphic genes affecting pathogen susceptibility or other phenotypes of interest. in less than two decades since the cc was conceptualized (churchill et al., 2004) , the cc has proven to be a fruitful resource across many fields, including infectious disease and immunology. expanding use of the cc has highlighted certain challenges and considerations that should be recognized to drive future development in both experimental design and resource expansion. (1) small screen in a subset of cc strains (12-16), selected based on availability or a genotype of interest (e.g., mhc haplotype). (2) assess variation across strains, identify outliers, measure heritability, perform power calculations, and identify confounding variables and reassess experimental design if necessary. (3) perform a larger screen either in the full cc population or a targeted intercross. following mapping, this can be repeated to follow-up on modifier alleles or other unexplained loci. (4) reassess variation, outliers, and heritability across mapping population. (5) map qtls driving phenotype of interest; analyze founder haplotype effects if mapping is done in the cc. (6) rationally select candidate genes using different tools as applicable. (7) perform validation studies in vitro and/or in vivo to confirm effect of candidate gene on phenotype. genetic mapping studies in the cc have successfully identified loci underlying infectious disease and immune phenotypes; however, relatively few have subsequently validated the initially identified candidate genes. even more challenging than candidate gene validation is the identification of specific causal variants within a gene. while strategies such as merge analysis can help refine candidates and variants, these tools are not always informative. there is a need for more refinement methodologies that can be applied in combination with experimental validation to narrow and identify causal variants. the wide array of genomic, molecular, and immunological reagents available is a valuable asset for mouse research; however, these do not necessarily uniformly work across the cc and should be validated before use. existing cc-specific resources, such as gecco, are not necessarily informative for infectious disease research since lymphoid organs, such as the spleen, thymus, and bone marrow, are not profiled. furthermore, the development of new cc-specific tools, such as cc-derived cell lines (e.g., mefs and ipscs), will expand the utility of the cc across fields, including the infectious diseases and immunology fields. one of the largest challenges across all of model organism research is connecting back to human relevancy. the cc has already proven useful in providing improved models of humanlike disease, as highlighted above. a number of genes that have been highlighted in the cc, such as mx1 and oas1b, have human paralogs relevant in infectious disease susceptibility (lin and brass, 2013; simon-loriere et al., 2015) , demonstrating the overlap between important genetically diverse infectious disease pathways in mouse and humans. however, the majority of studies have not yet made direct connections back to human datasets. as cc research develops, it will be increasingly important to continue to extend analysis from the cc to human genetics and vice versa. this will require more crosstalk between mouse and human geneticists to bridge gaps in research and communication. host immunity and susceptibility to infectious disease is a complex response driven by a multitude of factors, from environment and immune experience to the genetics of both the pathogen and the host. studying the role of host genetics in infectious disease directly in humans is challenging because of this complexity, and therefore much of the research in the field leans heavily on the mouse as a model organism. while the role of traditional laboratory strains and genetically modified mice in driving advances in the field cannot be understated, these models do not capture the genetic diversity and phenotypic complexity observed in the natural population. building on the success of classical intercrosses and biparental grps, the cc is a highly diverse and reproducible resource for studying and mapping complex traits, including infectious disease susceptibility. the reproducibility of cc strains will allow the community to cross-compare genes and genetic networks that regulate response across pathogens (e.g., iav and sars-cov; xiong et al., 2014) , while also exploring the impact of factors such as the microbiome, co-infections, and genetic variation of the pathogen in the context of a controlled, genetically diverse model population. the cc also holds promise for the development of new models and testing platforms that will better reproduce specific human disease outcomes or host responses to pathogens and vaccines. trolling for the ideal model host: zebrafish take the bait r/qtl: highthroughput multiple qtl mapping rare variant association studies: considerations, challenges and opportunities recombinant-inbred strains. an aid to finding identity, linkage, and function of histocompatibility and other genes appearances can be deceiving: phenotypes of knockout mice genealogies of mouse inbred strains host genetic variation affects resistance to infection with a highly pathogenic h5n1 influenza a virus in mice expression quantitative trait loci for extreme host response to influenza a in pre-collaborative cross mice gene targeting in mice: a review mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of ifn-g immunity pathogen-driven selection in the human genome diet dominates host genotype in shaping the murine gut microbiota immunity to microbes: lessons from primary immunodeficiencies forward genetics of infectious diseases: immunological impact human genetic susceptibility to infectious disease genetic architecture of group a streptococcal necrotizing soft tissue infections in the mouse defining the consequences of genetic variation on a proteome-wide scale the collaborative cross, a community resource for the genetic analysis of complex traits the diversity outbred mouse population gene therapy: progress and predictions models of infectious diseases in the fruit fly drosophila melanogaster influence of genetic background on genetically engineered mouse phenotypes genome-wide association studies: inherent limitations and future challenges genomewide association study of spontaneous resolution of hepatitis c virus infection: data from multiple cohorts collaborative cross mice and their power to map host susceptibility to aspergillus fumigatus infection genetically diverse cc-founder mouse strains replicate the human influenza gene expression signature modeling host genetic regulation of influenza pathogenesis in the collaborative cross quantitative trait locus mapping methods for diversity outbred mice. g3 (bethesda) karyoploter: an r/bioconductor package to plot customizable genomes displaying arbitrary data genetic diversity in the collaborative cross model recapitulates human west nile virus disease outcomes a mouse model of chronic west nile virus disease extensive homeostatic t cell phenotypic variation within the collaborative cross genome wide identification of sars-cov susceptibility loci using the collaborative cross allelic variation in the toll-like receptor adaptor protein ticam2 contributes to sars-coronavirus pathogenesis in mice oas1b-dependent immune transcriptional profiles of west nile virus infection in the collaborative cross. g3 (bethesda) population genetics of malaria resistance in humans evolution, revolution and heresy in the genetics of infectious disease susceptibility susceptibility of cxb recombinant inbred mice to murine plasmodia the genome architecture of the collaborative cross mouse genetic reference population twin studies on genetic variations in resistance to tuberculosis of mice and men: the host response to influenza virus infection profiling and genetic control of the murine immunoglobulin g glycome influenza h3n2 infection of the collaborative cross founder strains reveals highly divergent host responses and identifies a unique phenotype in cast/eij mice genomics of immune diseases and new therapies host genetic determinants of influenza pathogenicity host genetic diversity influences the severity of pseudomonas aeruginosa pneumonia in the collaborative cross mice protection by bcg vaccine against tuberculosis: a systematic review of randomized controlled trials caenorhabditis elegans, a model organism for investigating immunity of mice, dirty mice, and men: using mice to understand human immunology architecture of energy balance traits in emerging lines of the collaborative cross bayesian diallel analysis reveals mx1-dependent and mx1-independent effects on response to influenza a virus in mice a novel outbred mouse model of 2009 pandemic influenza and bacterial coinfection severity polymorphisms of large effect explain the majority of the host genetic contribution to variation of hiv-1 virus load the international mouse phenotyping consortium (impc): a functional catalogue of the mammalian genome that informs conservation distinct gene loci control the host response to influenza h1n1 virus infection in a time-dependent manner genome-wide association studies and susceptibility to infectious diseases lung necrosis and neutrophils reflect common pathways of susceptibility to mycobacterium tuberculosis in genetically diverse, immune-competent mice knockout mouse fact sheet differences in the immune response during the acute phase of e-55+ murine leukemia virus infection in progressor balb and long term nonprogressor c57bl mice a new set of bxd recombinant inbred lines from advanced intercross populations in mice mouse genome engineering via crispr-cas9 for study of immune function positional cloning of the murine flavivirus resistance gene using the emerging collaborative cross to probe the immune system international union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity hiv-1-resistance phenotype conferred by combination of two separate inherited mutations of ccr5 gene endotoxin-tolerant mice have mutations in toll-like receptor 4 (tlr4) host genetic diversity enables ebola hemorrhagic fever pathogenesis and resistance the polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for qtl discovery and systems genetics the collaborative cross as a resource for modeling human disease: cc011/unc, a new mouse model for spontaneous colitis complexity in the host response to salmonella typhimurium infection in acb and bca recombinant congenic strains perinatal nutrition interacts with genetic background to alter behavior in a parentof-origin-dependent manner in adult collaborative cross mice mapping of genetic modulators of natural resistance to infection with salmonella typhimurium in wild-derived mice genomic responses in mouse models poorly mimic human inflammatory diseases immunological genome project and systems immunology quantitative trait mapping in diversity outbred mice identifies two genomic regions associated with heart size sift web server: predicting effects of amino acid substitutions on proteins high anti-dengue virus activity of the oas gene family is associated with increased severity of dengue high-resolution genetic mapping in the diversity outbred mouse population identifies apobec1 as a candidate gene for atherosclerosis tuberculosis susceptibility and vaccine protection are independently controlled by host genotype influence of early life exposure, host genetics and diet on the mouse gut microbiome and metabolome genomes of the mouse collaborative cross animal models of ebolavirus infection development of mouse models for analysis of human virus infections genomic responses in mouse models greatly mimic human inflammatory diseases a homozygous nonsense mutation (428g->a) in the human secretor (fut2) gene provides resistance to symptomatic norovirus (ggii) infections genetic dissection of complex and quantitative traits: from fantasy to reality via a community effort genome-wide association study indicates two novel resistance loci for severe malaria toll-like receptor 3 signaling via trif contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection global analyses of human immune variation reveal baseline predictors of postvaccination responses mapping in structured populations by resample model averaging editor's highlight: collaborative cross mouse population enables refinements to characterization of the variability in toxicokinetics of trichloroethylene and provides genetic evidence for the role of ppar pathway in its oxidative metabolism susceptibility to klebsiella pneumonaie infection in collaborative cross mice is a complex trait controlled by at least three loci acting at different time points natural resistance to infection with intracellular parasites: isolation of a candidate for bcg the virome in mammalian physiology and disease a large-scale genome-wide association and metaanalysis identified four novel susceptibility loci for leprosy innate immune response in th1-and th2-dominant mouse strains genomic profiling of collaborative cross founder mice infected with respiratory viruses reveals novel transcripts and infectionrelated strain-specific gene and isoform expression using progenitor strain information to identify quantitative trait nucleotides in outbred mice identification of new loci involved in the host susceptibility to salmonella typhimurium in collaborative cross mice we would like to thank sharon taft-benz, sanjay sarkar, emily madden, and brea hampton for critical reading of the manuscript. chromosome ideograms shown in figure 2 were generated using the karyoploter package for r (gel and serra, 2017) . this work was supported by u19 ai100625 and p01ai132130. k.e.n. received support from t32ai007419. key: cord-335424-h84jtx94 authors: kirkland, j. l.; tchkonia, t. title: senolytic drugs: from discovery to translation date: 2020-08-04 journal: j intern med doi: 10.1111/joim.13141 sha: doc_id: 335424 cord_uid: h84jtx94 senolytics are a class of drugs that selectively clear senescent cells (sc). the first senolytic drugs dasatinib, quercetin, fisetin and navitoclax were discovered using a hypothesis‐driven approach. sc accumulate with ageing and at causal sites of multiple chronic disorders, including diseases accounting for the bulk of morbidity, mortality and health expenditures. the most deleterious sc are resistant to apoptosis and have up‐regulation of anti‐apoptotic pathways which defend sc against their own inflammatory senescence‐associated secretory phenotype (sasp), allowing them to survive, despite killing neighbouring cells. senolytics transiently disable these scaps, causing apoptosis of those sc with a tissue‐destructive sasp. because sc take weeks to reaccumulate, senolytics can be administered intermittently – a ‘hit‐and‐run’ approach. in preclinical models, senolytics delay, prevent or alleviate frailty, cancers and cardiovascular, neuropsychiatric, liver, kidney, musculoskeletal, lung, eye, haematological, metabolic and skin disorders as well as complications of organ transplantation, radiation and cancer treatment. as anticipated for agents targeting the fundamental ageing mechanisms that are ‘root cause’ contributors to multiple disorders, potential uses of senolytics are protean, potentially alleviating over 40 conditions in preclinical studies, opening a new route for treating age‐related dysfunction and diseases. early pilot trials of senolytics suggest they decrease senescent cells, reduce inflammation and alleviate frailty in humans. clinical trials for diabetes, idiopathic pulmonary fibrosis, alzheimer’s disease, covid‐19, osteoarthritis, osteoporosis, eye diseases and bone marrow transplant and childhood cancer survivors are underway or beginning. until such studies are done, it is too early for senolytics to be used outside of clinical trials. ageing is associated with increasing risk for developing multiple chronic diseases, the geriatric syndromes, impaired physical resilience and mortality [1] [2] [3] [4] . these risks increase exponentially in the last 25% of the lifespan [5] . amongst the diseases for which chronological age is a leading risk factor are congestive heart failure, myocardial infarction, dementias, strokes, most cancers, diabetes and metabolic diseases, renal dysfunction, chronic lung diseases, osteoporosis, arthritis, blindness and many others [6] [7] [8] . the geriatric syndromes include frailty, sarcopenia, falls, incontinence and mild cognitive impairment amongst others. decreased resilience can be manifested as delayed recovery following myocardial infarction, strokes, injuries or surgery, increased severity of infections such as influenza and coronaviruses and impaired development of antibodies after immunization [3] . combinations of several of these diseases, geriatric syndromes and resiliency impairments frequently occur in older people. indeed, the incidence of multi-morbidity, with 3 or more conditions being present simultaneously, increases exponentially beginning in adulthood [5] . analogous increases in disease burden occur with increasing age across multiple species. the geroscience hypothesis posits that fundamental ageing mechanisms are 'root cause' contributors to the increasing burden of disorders and diseases with advancing age that are responsible for the bulk of morbidity, mortality and health costs in the developed and developing worlds [9] . these fundamental ageing processes include: (1) chronic low grade 'sterile' (absence of bacteria, fungi, etc.) inflammation often accompanied by fibrosis, 2) macromolecular dysfunction (e.g. dna damage, telomere uncapping, protein misfolding and aggregation, decreased autophagy, increased advanced glycation end-products [ages], lipotoxicity and accumulation of bioactive lipids) and organelle dysfunction (altered nuclear membranes related to deficient lamin b, mitochondrial dysfunction leading to reduced fatty acid metabolism, higher glucose utilization, depletion of nad + and increased reactive oxygen species [ros] generation, etc.), 3) stem, progenitor and immune cell dysfunction (including altered proliferative capacity and dysdifferentiation with failure to develop into functional mature cells, declines in 'geroprotective' factors [e.g. a-klotho], contributing to stem and progenitor cell dysfunction) and 4) cellular senescence. our unitary theory of fundamental aging processes hypothesizes that these fundamental ageing processes may be interlinked. if this unitary theory is correct, then accelerating or targeting any one fundamental ageing process (e.g. cellular senescence) genetically or with drugs should affect many or perhaps all of the rest. indeed, consistent with the unitary theory, senescent cells contribute to inflammation, fibrosis, dna damage, development of protein aggregates, failed autophagy, lipotoxicity, mitochondrial dysfunction, depletion of nad + , ros generation and stem, progenitor and immune cell dysfunction [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . cellular senescence, first reported in 1961 by hayflick and moorehead, is a cell fate that entails essentially irreversible replicative arrest, sustained viability with resistance to apoptosis, and frequently, increased metabolic activity [6, 8, [25] [26] [27] (fig. 1 ). intra and extracellular signals that can contribute to cells' entering the senescent cell fate mainly include signals related to tissue or cellular damage and/or cancer development. these include dna damage, telomeric uncapping or dysfunction, exposure to extracellular dna, oncogene activation, replicative stress or inducers of proliferation (such as growth hormone/igf-1), protein aggregates, misfolded proteins, failed protein removal fig. 1 cellular senescence: causes, mechanisms and consequences. a number of factors can combine to cause a cell to enter the senescent cell fate, as opposed to apoptosis or necrosis, through transcription factor cascades that can involve p16 ink4a , rb, p53, p21 cip1 or others. note that not every senescent cell exhibits increased p16 ink4a , rb, p53 or p21 cip1 . it can take up to 6 weeks for a cell to become a fully senescent, nondividing cell. this indicates that senescent cells can be removed intermittently, rather than having to treat with agents continuously to remove these cells. some, but not all senescent cells can develop a sasp. this sasp is a 'root cause contributor' to the stem cell, progenitor, tissue and systemic dysfunction that predispose to multiple disorders, which account for the bulk of morbidity, mortality and health costs. through decreased autophagy, presence of ages due to the reaction of reducing sugars with amino groups in proteins (e.g. haemoglobin a1c is an age), saturated lipids and other bioactive lipids (bradykines, certain prostaglandins, etc.), reactive metabolites (e.g. ros, hypoxia or hyperoxia), mechanical stress (e.g. bone-on-bone stress in osteoarthritis or shear stress such as occurs on the venous side of av fistulae for haemodialysis or around atherosclerotic plaques), inflammatory cytokines (e.g. tnfa), damage-associated molecular patterns (damps, e.g. released intracellular contents signalling breakage of neighbouring cells), and pathogen-associated molecular patterns (pamps, e.g. bacterial endotoxins). these inducers active one or more senescence-promoting transcription factor cascades, in some cases involving p16 ink4a -retinoblastoma protein (rb), in others, p53 and p21 cip1 , both of these pathways, or other pathways. these transcription factor cascades enforce replicative arrest and cause altered expression of hundreds of genes as well as epigenetic changes in dna. cellular senescence takes longer to become established than other cell fates, such as replication, differentiation, apoptosis or necrosis. from initiation to the attainment of a completed state of cellular senescence takes from 10 days to 6 weeks, at least in cell culture, depending on the cell type and the inducers driving the cell into the senescent fate. some, but not all senescent cells can acquire a senescence-associated secretory phenotype (sasp) [28, 29] , which we term here as deleterious (d-) senescent cells (fig. 2) . the sasp can include: 1) inflammatory, pro-apoptotic, insulin resistanceinducing cytokines, such as tnfa [30] , interleukin-(il-) 6, il-8 and others, 2) chemokines that attract, activate and anchor immune cells, 3) matrix metalloproteinases (mmps), such as mmp-3, à9 and à12 that cause tissue destruction, 4) tgfb family members that can contribute to fibrosis and stem cell and progenitor dysfunction, 5) activins and inhibins that also induce stem cell and progenitor dysfunction and dysdifferentiation [12] , 6) factors such as the serpines (e.g. plasminogen activator inhibitor [pai] à1 and à2) that can cause blood clotting and fibrosis [31, 32] , 7) growth factors that can exacerbate tumour spread [33] , 8) bioactive lipids that also contribute to inflammation and tissue dysfunction (e.g. bradykines, ceramides or prostaglandins) [34] , 9) micro-rnas (mirnas) that contribute to stem and progenitor cell dysfunction, inflammation and insulin resistance [35] and 10) exosomes that can carry cytotoxic and senescenceinducing cargos locally and systemically [36] . d-senescent cells can comprise 30 to 70 % of the senescent cell population. sasp components produced by d-senescent cells depend on the cell type that became senescent and the cause of senescence (e.g. mechanical stress, repeated replication, radiation, chemotherapy, pamps, etc.). the sasp can be modulated by hormones, drugs, pathogens and other factors. for example, endogenous or pharmacological glucocorticoids [37] can attenuate release of a subset of sasp factors, as can rapamycin and metformin [38, 39] . bacterial toxins such as lipopolysaccharide can exacerbate the sasp, as can tnfa [40] (unpublished observations). the sasp can vary over time due to factors inside or outside of senescent cells. for example, after a few months, transpositional events can begin to occur in senescent cells involving line-1 or other elements [41, 42] . this can lead to rearrangement of chromosomes and activation of cgas/sting, cellular pathways that recognize dna damage and exacerbate production of inflammatory sasp factors through interferon-1. thus, the sasp varies considerably depending on the tissue where d-senescent cells are located, the originating cell type, senescence inducers, hormonal milieu, drugs, pathogens and passage of time. other senescent cells, termed here helper-(h-) senescent cells, do not appear to release inflammatory and pro-apoptotic factors substantially and may be involved in promoting stem and progenitor cell determination into appropriate lineages and functions [43, 44] (unpublished observations). hsenescent cells might account for 30 to 70% of senescent cells. we speculate there could be mechanisms through which d-and h-senescent cells can interconvert, but this remains to be fully explored. d-and h-senescent cells may both have beneficial functions, including remodelling of tissues during development, release of factors by placental senescent cells during childbirth that promote passage of the infant through the birth canal, removal of damaged tissue during initial phases of wound repair, and cancer defence [44] [45] [46] [47] . cellular senescence can protect against cancer: senescence is induced by oncogenic insults, leading to replicative arrest of cancerous cells, as well as a pro-apoptotic sasp that can eliminate surrounding tumour cells. additionally, interfering with mechanisms involved in ability of cells to become senescent by decreasing capacity to express p16 ink4a , rb, p53 or p21 cip1 promotes cancer development [48, 49] . however, clearing already formed senescent cells, many of which harbour oncogenic mutations or cause cancer-promoting inflammation due to their sasp, prevents or delays cancer development [46] . indeed, senolytic drugs, agents that selectively eliminate senescent cells [50] , delay development of multiple forms of cancer in old mice as well as cancer-prone, dna repair-deficient ercc1 -/d mice [51, 52] . furthermore, although capacity for cells to become senescent is a cancer defence mechanism, already formed, chronically persisting senescent cells can accelerate cancer growth because of suppression of immune responses, growth factors in the sasp, production of proteases that can interfere with encapsulation of tumours and therefore can enhance spread of cancer, and promotion of mesenchymal transition of cells [10, 53] . thus, targeting transcription factor cascades that allow cells to become senescent can exacerbate cancer development, whilst clearing already formed senescent cells with senolytics can prevent cancer development, growth and spread. there are no completely sensitive or specific markers of senescent cells. most senescent cells are larger than nonsenescent cells. they generally have multiple dna damage foci identifiable by immunostaining for c-histone-2ax (ch2ax), but cancer cells and other cell types, including normal cells, can also have ch2ax-positive foci [54] . in senescent cells, frequently 2 or more ch2ax foci can be located within telomeric dna (telomereassociated foci [tafs]), one of the more sensitive and specific indicators of senescent cells [55] . senescent cells can develop peri-centromeric distended satellite dna (senescence-associated distension of satellites [sads]), which can be detected with antibodies to cenp-b, another marker for detecting senescent cells [56] . senescent cells can have increased lysosomal b-galactosidase activity (senescence-associated b-galactosidase [sa-b-gal]), but so can macrophages and other cell types [57, 58] . some, but not all senescent cells may have high expression of p16 ink4a , but p16 ink4a expression can be high in activated macrophages and many other cell types [59] . like p16 ink4a , p21 cip1 is not fully sensitive or specific for detecting senescent cells [60] . a subset of senescent cells can express sasp factors or damage signals, such as cytosolic hmgb1 [61] , but again, these indicators are not fully sensitive or specific. because of the less than perfect specificity and sensitivity of markers for cellular senescence, generally several need to be tested. this will especially be the case for the initial clinical trials of senolytics for different diseases that are already underway. some senescent cells have enlarged, fused mitochondria and changes in mitochondrial function, including a shift from utilizing fatty acids for energy generation towards utilizing glucose, much like the 'warburg shift' in cancer cells [62, 63] . this shift to dependence on glycolysis can be associated with lipid accumulation, resulting in lipid droplet accumulation and lipotoxicity, contributing to an adipocyte-like appearance of senescent mesenchymal cells or 'mad cells' (mesenchymal adipocytelike default cells) that are insulin-insensitive [15] . an example is the accumulation of pro-inflammatory, perilipin-expressing, lipid-laden senescent ependymal mad cells around the third ventricle in obesity [24] . these cells contribute to neuroinflammation, failed brain microcirculation, impaired neurogenesis and neuropsychiatric dysfunction in obese, insulin-resistant mice. although senescent cells can appear at any point during life in vertebrates, even in 32 cell stage human blastocysts [45] , senescent cells accumulate in multiple tissues during the latter part of the lifespan. for example, skin senescent cells increase sharply in otherwise healthy humans at a point usually between ages 60 and 80 (although there has been debate about this) [64] [65] [66] [67] [68] . the same is true for human adipose tissue biopsied from healthy subjects donating a kidney as well as adipose depots of ageing mice [22, 69] . senescent cells can accumulate at aetiological sites of multiple diseases throughout the lifespan. for example, in humans, senescent cells accumulate in adipose tissue in diabetes and obesity, in the hippocampi and frontal cortex in alzheimer's disease (ad), the substantia nigra in parkinson's disease (pd), bone and marrow in age-related osteoporosis, lungs in idiopathic pulmonary fibrosis, liver in cirrhosis, retinae in macular degeneration, plaques in psoriasis, kidneys in diabetic kidney disease, endothelium in pre-eclampsia, and the heart and major arteries in cardiovascular disease, amongst many other conditions [6, 7, 13, 19, 23, [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] . consistent with a causal contribution of senescent cells to chronic diseases, transplanting small numbers of autologous or syngeneic senescent cells near the knee joints of younger mice causes an osteoarthritis-like state, with radiographic findings similar to those of human spontaneous osteoarthritis, as well as knee pain and impaired mobility, whilst transplanting nonsenescent cells does not [81] . transplanting 10 6 syngeneic adipose cell progenitors or autologous ear fibroblasts made senescent by irradiation, doxorubicin exposure or repeated replication is sufficient to cause frailty and accelerate death from all causes, not just one or a few, in middle-aged mice, whilst transplanting nonsenescent cells does not [51] . transplanting 10 6 senescent human cells into immunodeficient mice also causes frailty. additionally, transplanting senescent porcine renal scattered tubular-like cells into the aorta of young mice causes kidney fibrosis and inflammation in the recipients, whilst transplanting nonsenescent cells does not [82] . there is a lag between senescent cell accumulation and development of functional effects. frailty was evident a month after transplanting senescent cells into middle-aged mice and increased mortality became apparent 3 months later [51] . this study demonstrated that if only 1/10,000 cells in recipient mice is a transplanted senescent cell, an accelerated ageing-like state ensues. transplanting 500 000 senescent cells did not do this, suggesting a senescent cell 'threshold effect'. consistent with this, transplanting 500 000 senescent cells into old mice, as opposed to middle-aged recipients, did cause frailty. furthermore, transplanting 500 000 senescent cells into middle-aged but diet-induced obese (dio) mice caused frailty, whilst 10 6 senescent cells had to be transplanted into age-matched, lean mice for frailty to occur. thus, pre-existing senescent cell burden, together with acute acquisition of yet more senescent cells, can surpass a threshold and cause clinical effects. a potential reason for this 'threshold effect' is that d-senescent cells can spread senescence to normal cells, even at a distance [51] . if senescent cells are labelled with luciferase, so transplanted senescent cells can be distinguished from the recipients' own cells, and the labelled senescent cells are transplanted into the abdominal cavity where they remain, senescent cells originating from the recipient's own cells appear throughout the recipient, including in the limbs. since senescent cells resist cell death and are normally removed by the immune system [10] , the threshold effect may be a result of the rate of spread of senescence exceeding the capacity of the immune system to clear them. this'threshold theory of cellular senescence' may explain the rapid increase in senescent cell abundance in skin and adipose tissue of otherwise healthy people at a point after age 60 [22, [64] [65] [66] [67] , as well as the lag between the first histological evidence for increased senescent cell abundance and subsequent development of symptoms. an article by the sharpless group in 2004 led us to start searching for interventions that remove senescent cells [83] . they reported delayed accumulation of p16 ink4a -, sa-b-gal-positive cells in mice in which healthspan had been extended by caloric restriction or a mutation that decreases growth hormone signalling. this indicates there is an inverse association between senescent cell burden and healthspan. beginning in 2005, we attempted to develop fusion proteins with a senescent cell recognition site and a toxin to kill senescent cells. we then attempted to find chemicals that would kill senescent but not nonsenescent cells using high-throughput screens of human senescent vs. nonsenescent cells. neither approach was successful. the high-throughput screening approach suffered from difficulties in selecting the right controls. parallel nondividing, nonsenescent cells had to be serum-starved or confluent in order to prevent replication. however, serum starvation or confluence both cause artefactual effects. alternatively, dividing nonsenescent cells could be used as controls. however, these dividing control cells have to be compared to senescent cells that, by definition, cannot divide, introducing a confounder that interferes with interpretation of the results. thus, rather than random high-throughput drug library screening or other traditional drug development strategies, we turned to a hypothesisdriven, mechanism-based drug discovery paradigm to develop the first senolytic drugs. our strategy was based on the 1995 observation by e. wang that senescent cells resist apoptosis [84] . this apoptosis resistance occurs despite senescent cell production of pro-apoptotic sasp factors. the existence of the sasp had been discussed within the field for a couple of years before it was published [28, 29, 85] . our hypotheses upon which senolytic drug discovery was based were: 1) senescent cells can resist apoptotic stimuli, implying increased pro-survivalanti-apoptotic defences and 2) in some respects, senescent cells are like cancer cells that do not divide, including apoptosis resistance and metabolic shifts. we speculated that senescent cells might prevent their own removal through protective senescent cell anti-apoptotic pathway (scap) networks [86] . from proteomic and transcriptomic databases, we found that scap pathways were more highly expressed by senescent than nonsenescent cells [86] . we interrogated the scap network using rna interference and demonstrated that senescent cells with a pro-apoptotic sasp do indeed depend on this network to evade self-destruction. the small interfering rna's (sirna's) against antiapoptotic regulators that were effective in selectively decreasing senescent cell viability depended on the senescent cell type. for example, we found that sirna's that decrease bcl-xl or other bcl-2 family members were effective in selectively causing apoptosis of senescent vs. nonsenescent human umbilical vein endothelial primary cells (huvec's) [86] , as was confirmed by others [87] . however, the same sirna's were ineffective in selectively inducing apoptosis of senescent vs. nonsenescent human primary adipocyte progenitor cells. furthermore, more than one scap pathway had to be targeted to kill some types of senescent cells, indicating that senescent cell defences against apoptosis are in some cases redundant. next, we used bioinformatics approaches to find compounds whose mechanisms of action involve targeting the scap network nodes that we had identified as being critical for protecting senescent cells from apoptosis. we identified 46 potentially senolytic compounds. to accelerate translation into clinical application, the compounds that we focused on initially were drugs and natural products already in use for other indications in humans, many as anti-cancer agents. these included the tyrosine kinase inhibitor, dasatinib (d), which has been approved for clinical use in the united states since 2006, and quercetin (q), the naturally occurring flavonoid that makes apple peels taste bitter. unlike other tyrosine kinase inhibitors such as imatinib, which are not senolytic, d promotes apoptosis caused by dependence receptors, such as the ephrins, in part by inhibiting src kinase [88, 89] . fisetin (f) is another naturally occurring flavonoid that is senolytic [52, 90] . the senolytic flavonoids act in part by inhibiting bcl-2 family members such as bcl-xl as well as hif-1a and other scap network components. based on their known targets, we predicted that d would target senescent human cultured primary adipocyte progenitor cells, whilst q would target senescent cultured huvec's. these predictions proved to be correct. the combination of d + q caused apoptosis of both senescent human primary adipocyte progenitor cells and senescent huvec's, but not nonsenescent adipocyte progenitor cells or huvec's. furthermore, likely because of redundancy of scap pathways, in some cell types, for example, mouse embryonic fibroblasts, neither d nor q are senolytic on their own, whilst the combination of d + q is senolytic [86] . the target of true senolytics is senescent cells, not a single receptor, enzyme or biochemical pathway. efforts to discover senolytics by finding agents that act on multiple scap network nodes effectively increases specificity for senescent cells, reduces off-target effects on nonsenescent cells compared with candidates that act on a single molecule, such as a receptor or an enzyme, and likely flatten sideeffect profiles. consistent with this prediction, candidates that do act upon single or limited targets, for example, navitoclax (n) [91, 92] or nutlin3a [93] , have substantial off-target apoptotic effects on nonsenescent cell types, such as platelets and immune cells [94, 95] , making them potentially 'panolytic'. also, nutlins can actually cause senescence [96] and drugs like n, which act on a single or few scap nodes, eliminate only a restricted range of senescent cells. for example, n and other bcl-2 family member inhibitors such as a1331852 or a1155463, are not senolytic against human adipocyte progenitors, one of the most abundant senescent cell types in the elderly as well as patients with diabetes and obesity [90, 91] . thus, candidates that act on only one or a limited range of scap-related molecules are generally less specifically senolytic and are more 'panolytic', causing apoptosis or dysfunction of multiple cell types other than senescent cells, than agents or combinations of agents that act on multiple nodes across the scap network. the first senolytics were discovered using bioinformatics approaches to identify agents that transiently disable the scap networks that allow dsenescent cells to survive the hostile microenvironment they create that kills the nonsenescent cells around them (table 1 ). in this respect, the development of senolytics has been distinct from the conventional approaches for developing drugs usually followed in other fields. approaches for developing senolytics has held more in common with those used to develop antibiotics than the traditional one target-one drug-one disease approach. a second generation of senolytic agents is now being identified using more traditional drug discovery methods, including random highthroughput drug library screens, such as one in which both senescent and nonsenescent cells are within the same wells, overcoming the control cell problem [97] . several other strategies have recently been used to develop potentially senolytic interventions. these include the development of galacto-oligosaccharide-coated nanoparticles with toxic cargos that are engulfed by senescent cells and opened by sa-b-gal, vaccines and immunomodulators [10, [98] [99] [100] . perhaps some of these will make it through preclinical studies and into clinical trials within the next few years. d + q and f have been shown to reduce senescent cell abundance in vivo whilst not destroying nonsenescent cells [51, 52] . after intraperitoneal transplantation of 10 5 radiation-induced syngeneic senescent adipocyte progenitors, which could be detected due to constitutive sffv promoter-driven luciferase expression, into middle-aged mice, treatment with oral d + q for 3 days substantially decreased luminescence 2 days after the last dose [51] . no decrease in luminescence was evident after treating senescent cell-transplanted mice with vehicle, nor was decreased luminescence found after treating mice transplanted with nonsenescent luciferase-expressing cells with either d + q or vehicle. oral treatment with f of progeroid ercc -/d mice expressing luciferase driven by a p16 ink4a promoter element also resulted in decreased luminescence, whilst treating these mice with vehicle had no effect. thus, d + q and f are senolytic in mice, each eliminating 30 to 70% of transplanted or endogenous senescent cells, respectively. to test if d + q is senolytic in human tissue, abdominal subcutaneous adipose tissue fragments that were freshly isolated during surgery from patients with diabetes and obesity, who have extensive adipose tissue senescent cell accumulation [108] [109] [110] [111] [112] , were immediately placed in organ culture and exposed to d + q or vehicle [51] . within 2 days, abundance of senescent cells detected by tafs had decreased by 70%. this was accompanied by increases in cleaved caspase-3, confirming that the decrease was caused by apoptosis. furthermore, the sasp factors, il-6, il-8, mcp-1, pai-1 and gm-csf, decreased journal of internal medicine significantly in conditioned medium from the organ cultures treated with d + q compared to vehicle. also, f reduced senescent cell number in adipose tissue organ cultures [52] . thus, d + q and f cause decreased senescent cell abundance by apoptosis in human tissue within 2 days. senolytic drugs alleviate a number of disorders in mouse disease models [6] [7] [8] 108] (table 2) . intermittent oral administration of d + q enhances cardiac and vascular function in 24-month-old mice (equivalent to roughly 80 years in humans), with partial reversal of age-related declines in cardiac ejection fraction, reduction in conduit vessel calcification and restoration of conduit vessel reactivity to nitroprusside and acetylcholine [113] . d + q decreases cardiac senescent cell burden, as manifested by lowering of p16 ink4a , and partly reverses age-related cardiomyocyte hypertrophy and left ventricular fibrosis [13] . senescent cells can develop in the venous arm of arterialvenous (av) fistulae of the type surgically fashioned for haemodialysis, potentially contributing to clotting and failure of the av fistulae [114] . in mice, d + q decreases senescent cell abundance in av fistulae. furthermore, d + q reduces senescent cell burden and calcification in the aortic media of high fat-fed apoe -/mice, a mouse model of atherosclerosis [113] . n is also senolytic in the hearts of old mice [18] . following 1 month of n, there was decreased cardiac fibrosis and a 40% decrease in taf + cardiomyocytes (it appears nondividing cells such as cardiomyocytes can develop a senescent-like state). thus, senolytics alleviate age-and lipid-related cardiovascular dysfunction in mice. intermittent oral d + q administration enhances insulin sensitivity in dio as well as genetically obese mice, as manifested by improvements in glucose and insulin tolerance [111] . d + q does so mainly by reducing peripheral insulin resistance. this is in part due to restoring adipose tissue akt responses to insulin and in part to restoration of the capacity of adipocyte progenitors to differentiate into insulin-responsive adipocytes. furthermore, intermittent d + q reduces the adipose tissue inflammation that is a causal contributor to the pathogenesis of type 2 diabetes. d + q does so in part by reducing homing of monocytes to adipose tissue: there is decreased trafficking of luciferase-expressing monocytes injected into the tail vain into adipose tissue of genetically obese mice treated with d + q, but not in mice treated with vehicle. d + q does not kill the activated macrophages that can accumulate in adipose tissue in diabetes [51] . these macrophages have increased p16 ink4a expression but are not senescent [59] . consistent with this, senolytic drugs also do not target atherosclerotic foam cells, which are essentially activated macrophages, as opposed to the truly senescent cells that are deeper within plaques or the media of atherosclerotic blood vessels that are ablated by d + q [113] . n, which is not effective in targeting senescent adipocyte progenitors [91] , does decrease senescent high-throughput compound library screens [98] vaccines [100, 108] toxin-loaded nanoparticles preferentially lysed by senescent cells [99] immunomodulators [101] pancreatic b cells, enhancing pancreatic function in dio mice [115] . thus, senolytics can alleviate diabetes by decreasing sasp-expressing adipose tissue senescent cells, leading to increased peripheral insulin sensitivity, reducing chemo-attraction and activation of pro-inflammatory macrophages that further contribute to insulin resistance, and/ or enhancing pancreatic insulin production. senolytics decrease several complications of diabetes in mouse models. liver fat accumulation and consequent cirrhosis and liver failure are increasingly common complications of diabetes and obesity [108, 109] . d + q reduces liver senescent cell accumulation related to hepatic steatosis in genetically obese mice [136] . additionally, proteinuria and renal dysfunction are frequent complications of diabetes. dio mice develop increased kidney senescent cell burden manifested by p16 ink4a and p53 expression and sasp factors in renal tubular cells along with glomerulomegaly, decreased renal function and impaired cortical oxygenation compared to lean mice [128] . proteinuria is reduced in dio mice treated with d + q [110] . dio mice with renal dysfunction that were treated with oral q for 5 days every 2 weeks for 10 weeks had decreased kidney senescent cells, decreased sasp factors, decreased renal fibrosis, increased renal cortical oxygenation and decreased plasma creatinine levels compared to mice treated with vehicle [128] . another complication of diabetes/obesity is neuropsychiatric dysfunction, particularly anxiety and its complications [24] . in genetically obese mice, senescent adipocyte-like ependymal mad cells can accumulate near the third ventricles near the limbic system, which regulates emotions. d + q reduces the burden of these senescent adipocytelike periventricular ependymal cells. administering d + q also increases neuronal markers, indicating improved neurogenesis and reduces neuro-inflammation in obese mice. importantly, intermittent table 2 . conditions with emerging evidence for a causal contribution of cellular senescence or benefits of senolytics diabetes/ obesity [109, 110, 112, [116] [117] [118] cardiac dysfunction [13, 18, 114] vascular hyporeactivity/ calcification [114] av fistulae [115] frailty [21, 51, 52, 87] age-related muscle loss (sarcopenia) [119] chemotherapy complications [21, 51, 93, 120, 121] radiation complications [122] cancers [51] bone marrow transplant complications [120] organ transplantation complications [123, 124] myeloma/ mgus [125] age-related cognitive dysfunction [126] alzheimer's disease [23, 127] parkinson's disease [76] amyotrophic lateral sclerosis [128] ataxia [87] obesity-related neuropsychiatric dysfunction [24] renal dysfunction [111, 129] urinary incontinence [87] osteoporosis [14, 71, 130] osteoarthritis [131] age-related intervertebral disc disease [87, 132] idiopathic pulmonary fibrosis [21, 133] hyperoxic lung damage [134] chronic obstructive pulmonary disease [135] tobacco [136] hepatic steatosis [137] cirrhosis [78] primary biliary cirrhosis [138] progerias [52, 87] pre-eclampsia [72] macular degeneration [75, 139] glaucoma [140] [141] [142] cataracts [143] prostatic hypertrophy [144] [145] [146] psoriasis [81] healthspan [51, 52, 87] lifespan [51, 52, 87] d + q alleviates anxiety in these obese mice, as manifest by reduced fear in open-field testing. thus, senolytics not only restore peripheral insulin responsiveness in diabetic/obese mice, they alleviate complications of diabetes for which no effective mechanism-based treatments currently exist. in addition to diabetic/obesity-related neuropsychiatric dysfunction, senolytics alleviate alzheimer's-like changes in tau + as well as b-amyloid + (ab) mouse models of alzheimer's disease [23, 126] . accumulation of tau protein aggregates is a common pathology across multiple degenerative brain diseases, including ad, progressive supranuclear palsy, traumatic brain injury and over twenty others. furthermore, tau-containing neurofibrillary tangles correlate with cognitive decline and brain cell loss. neurofibrillary tangle-containing neurons from postmortem human ad brains have expression profiles that are consistent with cellular senescence. also, in both mice and humans, p16 ink4a expression correlates directly with brain atrophy and neurofibrillary tangles. in 23-monthold tau nft -mapt 0/0 mice that overexpress tau, d + q every 2 weeks for 3 months reduced total neurofibrillary tangle density, neuronal loss, neuro-inflammation, gliosis, small vessel hypoperfusion and ventricular enlargement and increased cortical volume and neurogenesis, despite the advanced age of these mice. administering d + q to ab + mice was also effective, with selective removal of senescent cells from the ad-associated plaque environment, reduced neuro-inflammation, decreased ab load and alleviation of deficits in cognitive function, with improved memory and executive function [126] . thus, senolytic drugs may potentially prove to be effective, mechanismbased interventions for alleviating ad and other chronic brain diseases, depending on results of the clinical trials that are underway. senolytics alleviate dysfunction in mouse models of chronic lung diseases. idiopathic pulmonary fibrosis (ipf) is a progressive, fatal, senescence-driven lung disease for which there are no highly effective interventions apart from lung transplantation [21] . it affects older patients, leading to respiratory failure, pronounced frailty and weight loss. targeting senescent cells with d + q was effective in alleviating frailty as shown by improved treadmill endurance, reducing extent of weight loss, and enhancing lung compliance in a mouse bleomycin inhalation-induced pulmonary fibrosis model of ipf. another lung condition that might be alleviated by senolytics is hyperoxia-induced damage to airway structure and function [133] . supplemental o 2 can be a necessary intervention in premature infants, but appears to contribute to development of neonatal and paediatric asthma. at least in cell culture, d + q shows promise for alleviating complications of supplemental o 2 . foetal airway smooth muscle (asm) exposed for 7 days to 40% o 2 developed markers of senescence, including sa-bgal and increased p16 ink4a , p21 cip1 , p-p53, ch2a.x and pro-fibrotic and inflammatory sasp factors. treating na€ ıve asm cells with media from hyperoxia-exposed senescent asm cells increased collagen, fibronectin and contractility. d + q selectively reduced the number of hyperoxia-induced senescent asm cells. hence, senolytic drugs may become interventions for multiple lung diseases. indeed, in the first clinical trial of senolytics, d + q alleviated physical dysfunction in a preliminary study in patients with ipf [70] (see below). additionally, the senolytic, f, reduces mortality in mice infected with mouse bcoronavirus and covid-19 viral antigens exacerbate the sasp in human senescent cells (unpublished observations). based on these discoveries, a clinical trial of f for older hospitalized covid-19 patients to prevent progression to cytokine storm and acute respiratory distress syndrome has been approved by the us food and drug administration (fda) and is about to start. age-related, as opposed to hormone-deficiencyrelated, osteoporosis appears to be associated with senescent cell accumulation, particularly senescent-like osteocytes and bone marrow cells [71, 129] . osteoclasts cause bone resorption. conditioned medium from senescent cells increases early monocyte osteoclast progenitors due to enhanced survival of these cells [14] . the sasp factors, il-6, il-8 and pai-1, contribute to this increased survival of osteoclast progenitors. in old (20 months) mice with osteoporosis, d + q treatment once monthly for 4 months led to significant reductions in bone p16 ink4a mrna and sads + senescent osteocytes [14] . in d + q-treated mice, trabecular bone histomorphometry demonstrated reduced osteoclasts vs. in vehicle-treated mice. d + q treatment increased femoral cortical thickness and bone strength. this was associated with reduced endocortical surface osteoclast numbers and increases in endocortical numbers of osteoblasts, the cells that form new bone, mineral apposition rate and bone formation rate. these beneficial effects of targeting senescent cells resulted in suppression of bone resorption accompanied by either maintenance (trabecular) or increased (cortical) bone formation. thus, unlike the coupled decreases in bone resorption and formation that results from currently available antiresorptive treatments for osteoporosis, d + q causes decreased bone resorption whilst not causing a coupled decrease in bone formation. these beneficial effects result from a decrease in development of bone-resorbing osteoclasts and an increase in development of bone-forming osteoblasts from their respective stem cells/progenitors. furthermore, intermittent d + q was as effective as continuous d + q, consistent with our contention that a 'hit-and-run' approach of senolytic administration is effective and could decrease adverse effects. a clinical trial of d + q for agerelated osteoporosis is currently underway (see below). n also decreases bone senescent cells in old mice but, unlike d + q, does not alleviate agerelated osteoporosis because, consistent with its 'panolytic' side-effect profile, n is directly cytotoxic to bone-forming osteoblasts [146] . in addition to age-related osteoporosis [129] and osteoarthritis [130] , senescent cells contribute to another skeletal disorder, age-related intervertebral disc disease. glycosaminoglycan content of the nucleus pulposus of intervertebral discs declines with ageing in progeroid mice [86] . d + q increases spinal glycosaminoglycan levels in progeroid mice compared to animals receiving vehicle only. since senolytics increase vertebral proteoglycans in preclinical models, they might prove to be an effective treatment for intervertebral disc disease. d + q or f alleviate physical dysfunction across a range of mouse models in which senescent cells are linked to frailty: naturally aged mice, progeroid ercc -/d mice, senescent cell-transplanted younger mice and mice with bleomycin-induced pulmonary fibrosis [21, 51, 52, 86] . in these mouse models, senolytics prevented frailty or restored physical function as assessed by daily activity (movement detected by laser measurement), distance run on a treadmill, treadmill speed, grip strength, time able to hang on a suspended wire, and/or ability to remain on a rotating spindle (rotarod test). d + q as well as f alone both extended remaining lifespan in old mice by up to 35% [52, 86] . consistent with the geroscience hypothesis, d + q delayed death in old mice not due to any single age-related disease, but from multiple disorders that cause death in naturally aged, untreated mice [86] . as would be expected from their use as anticancer drugs, the senolytics d + q and f delay death from cancers in mice [51, 52] . over 50% of deaths in most mouse strains are caused by cancers, and d + q and f delay deaths of old mice by up to 35 and 17%, respectively. furthermore, even though f might cause aneuploidy in cultured nonsenescent cells [147] , f delays cancers in cancer-prone erc-c1 -/d mice that have a dna repair enzyme mutation [52] . in these preclinical studies, it would be desirable to prove that a candidate agent alleviates a phenotype because it is actually a senolytic drug. an approach for proving senolytic effects is to use a modified set of koch's postulates. if an agent is truly senolytic, then: 1) senescent cells should be present in association with the phenotype, 2) individuals without senescent cells should not have the phenotype, 3) inducing accumulation of senescent cells should cause the phenotype, 4) clearing these induced senescent cells should alleviate the phenotype, 5) clearing naturally occurring senescent cells should alleviate the phenotype, 6) the drug should induce few or no effects related to the phenotype in young individuals without senescent cells, 7) administering the senolytic candidate intermittently should be effective and 8) the senolytic candidate should alleviate multiple agerelated conditions. in the case of d + q, these modified koch's postulates have been met in mice for age-and cellular senescence-related physical dysfunction, insulin resistance, cognitive dysfunction, osteoporosis, osteoarthritis and cancers in the published studies cited above and in unpublished studies. evidence consistent for a true senolytic effect of f is mounting. to our knowledge, there is not yet comprehensive evidence for a true senolytic effect of n or nutlin3a that meets this modified set of koch's postulates. since clearing senescent cells with senolytic drugs is a completely new therapeutic paradigm, a novel strategy for translating senolytics into interventions for humans is needed (fig. 3) . in particular, ethical risk/benefit concerns have to be addressed: situations in which senolytic drugs enter the first clinical trials should ideally be serious and be those for which currently available treatments are ineffective (fig. 3) , such as ipf, complications of advanced diabetes, diastolic heart failure, advanced osteoporosis, dementias or covid-19 infections in hospitalized elderly patients. to accelerate progress, our approach has been to start multiple small, parallel trials for such conditions instead of conducting trials one after the other in series. if these trials in serious disorders show acceptable side-effect profiles, if the agents are well tolerated, if target engagement (i.e. killing senescent cells) can be demonstrated, and if the candidate senolytic drugs are effective in treating serious diseases, then use of senolytics could go on to be tested for less serious conditions related to cellular senescence. depending on results of such trials, the step after that would be to test effectiveness of the candidate senolytic drugs in delaying or preventing clinically manifest disease in subjects in whom presence of senescent cells can be demonstrated by blood, imaging, saliva or urine tests or biopsies. this could be feasible, since we discovered that there is a lag between accumulation of senescent cells and appearance of clinically apparent disease: after transplanting senescent cells into middle-aged mice, it took time for frailty to develop [51] . as this progression from: 1) administration of senolytics in clinical trials for serious diseases, 2) to less serious conditions, 3) to prevention in at-risk individuals proceeds, clinical trials will need to become progressively larger, longer and more expensive. ideally, the first clinical trials should be with agents that have, insofar as possible, an established clinical safety profile, with strong preclinical data available about the drugs and indications to be tested. intermittent administration, as opposed to continuous dosing, could reduce off-target sideeffects. the clinical trials should be carefully monitored for safety, tolerability, target engagement (removal of senescent cells) and effectiveness. to speed translation, ideally several of these trials would be conducted in parallel across several diseases, rather than conducting one trial after the other in series. if safe and effective in initial trials for serious diseases, moving a senolytic drug towards less serious conditions and, eventually, to prevention in humans with an increased senescent cell burden and who are at risk for subsequently developing cell senescence-associated diseases, could be a translational strategy. it is currently too early for practicing physicians to prescribe senolytic agents outside the context of carefully monitored clinical trials. a consideration is whether systemic or local administration of candidate senolytic drugs is the best approach for initial clinical trials. for agents with an unknown or poor safety profile, local administration for senescence-related conditions could be an option, but the following points run counter to this: 1) senescence spreads from cell to cell [51] , meaning that apparently local accumulations of senescent cells could be the 'tip of the iceberg', with an increased systemic senescent cell burden being a possible consequence. this could be the case even if effects of this systemic senescent cell burden are not yet apparentas discussed above, there is a lag between senescent cell accrual and appearance of clinically apparent symptoms. 2) also consistent with the concern that local injection of senolytics would be less beneficial than systemic administration is the geroscience hypothesis: multiple age-and figure 3 early clinical studies of senolytics: balancing benefit and risk. since senolytic drugs are at the forefront of a completely new potential therapeutic paradigmtargeting fundamental ageing processes to delay, prevent or alleviate age-related phenotypes, multiple diseases, geriatric syndromes and reductions in physical resiliencea careful risk-benefit balance must be struck within firstin-human senolytic drug clinical trials, since potential short-and long-term side-effects from clearing senescent cells are not yet fully known. senescence-related diseases cluster within individuals, reducing the possible benefits from local injection. 3) locally injected drugs generally do not stay local, particularly if the injection is into, for example, an osteoarthritic knee joint in which the synovial cavity is damaged. in the absence of an intact synovial membrane, local injection into the damaged knee joint could be effectively systemic, more like an intramuscular injection than a truly intra-articular injection into a patient with an intact knee joint. 4) the previous points notwithstanding, local skin application, particularly of poorly absorbed senolytics, might be a viable strategy for treating senescence-related skin disorders, such a melanotic naevi or psoriasis. therefore, in general, systemic senolytic administration in initial clinical trials appears to be a reasonable approach, especially in the cases of candidates with an established safety profile, such as d, which has been approved for clinical prescription in the united states since 2006, or the natural product, q. this would be less true for n or a1331852, which are not yet approved for general use as prescription drugs in the united states. in a preliminary report from an early, open-label clinical trial of 3 days of d + q administration orally in patients with diabetes complicated by renal dysfunction, evidence for target engagement was found. compared to biopsies before d + q administration, 11 days after the last dose of d + q (which has an 11 hour elimination half-life), p16 ink4a+ and sa-bgal + senescent cells had decreased in the diabetic subjects' adipose tissue [116, 117] . furthermore, d + q decreased adipose tissue inflammation as evident by reduced macrophages and immune infiltration-related crown-like structures. a composite score of blood sasp factors was also decreased by d + q in these patients. thus, as in mice, d + q can successfully decease senescent cell burden in humans. the first-in-human trial of senolytics was of d + q for patients with ipf [70] (n = 14 patients with stable ipf) in an open-label study of intermittent d + q (3 days/week over 3 weeks). physical function was evaluated by testing 6-minute walk distance, 4-metre gait speed and chair-stands time. these assessments were significantly and clinically meaningfully improved by d + q (p < 0.05). furthermore, correlations were found between change in function and change in sasp-related pro-inflammatory cytokines, matrix-remodelling proteases and micro-rnas (23/48 markers; r ≥ 0.50). this pilot study supports the feasibility of further clinical trials using senolytics. it provided initial evidence that senolytics can alleviate physical dysfunction in ipf, supporting evaluation of d + q in larger randomized, controlled trials for senescence-associated diseases. several clinical trials of senolytics are currently underway or planned ( it should be understood that the target of senolytics is senescent cells, not a single molecule or pathway, since targeting networks might yield more truly senolytic, less panolytic, drugs. additionally, consistent with true senolytic activity, intermittent treatment with d + q or f appears to be as effective as continuous administration, despite their short elimination half-lives. d + q already satisfies a modified set of koch's postulates for certain disorders and mounting evidence indicates that these postulates could also be satisfied for a number of other conditions in the cases of d + q and f. true senolytic effects remain to be established for n or nutlin3a. consistent with the unitary theory, senolytics appear to restore progenitor dysfunction, attenuate tissue inflammation and alleviate age-and disease-related metabolic dysfunction across cell types and tissues. senolytics appear to delay, prevent or alleviate multiple age-related conditions and chronic diseases and enhance healthspan and lifespan in experimental animals. therefore, these agents could lead to interventions for humans that delay, prevent or treat senescence-and age-related conditionsif clinical trials continue to demonstrate effectiveness and low toxicity. however, unless and until such clinical trials are completed and demonstrate safety, tolerability, target engagement and effectiveness, candidate senolytics should not be prescribed or used by general patient populations. they should only be administered in the course of carefully monitored clinical trials. translating the science of aging into therapeu-ticiinterventions translating advances from the basic biology of aging into clinical application resilience in aging mice life expectancy and education: the author replies risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity cellular senescence: a translational perspective the clinical potential of senolytic drugs aging, cell senescence, and chronic disease: emerging therapeutic strategies geroscience: linking aging to chronic disease senescent cell clearance by the immune system: emerging therapeutic opportunities the nadase cd38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular nad(+) decline targeting senescent cells enhances adipogenesis and metabolic function in old age aged-senescent cells contribute to impaired heart regeneration targeting cellular senescence prevents age-related bone loss in mice karagiannides i. adipogenesis and aging: does aging make fat go mad? mitochondrial dysfunction and cell senescence: deciphering a complex relationship measuring reactive oxygen species in senescent cells length-independent telomere damage drives post-mitotic cardiomyocyte senescence inflammation and cellular senescence: potential contribution to chronic diseases and disabilities with aging nad(+) metabolism governs the proinflammatory senescence-associated secretome cellular senescence mediates fibrotic pulmonary disease jak inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age tau protein aggregation is associated with cellular senescence in the brain obesity-induced cellular senescence drives anxiety and impairs neurogenesis the serial cultivation of human diploid strains fat tissue, aging, and cellular senescence the biochemistry of mammalian senescence senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic ras and the p53 tumor suppressor senescence-messaging secretome: sms-ing cellular stress increased tnfa and ccaat/enhancer binding protein homologous protein (chop) with aging predispose preadipocytes to resist adipogenesis serpine 1 induces alveolar type ii cell senescence through activating p53-p21-rb pathway in fibrotic lung disease plasminogen activator inhibitor-1 in aging tumor cell senescence response produces aggressive variants role of sphingolipids in senescence: implication in aging and age-related diseases micrornas and the metabolic hallmarks of aging kirkland & t. tchkonia ª 2020 the authors the role of exosomes and micrornas in senescence and aging glucocorticoids suppress selected components of the senescence-associated secretory phenotype p53 and rapamycin are additive metformin inhibits the senescence-associated secretory phenotype by interfering with ikk/nf-kappab activation tnfalpha-senescence initiates a stat-dependent positive feedback loop, leading to a sustained interferon signature, dna damage, and cytokine secretion author correction: l1 drives ifn in senescent cells and promotes age-associated inflammation l1 drives ifn in senescent cells and promotes age-associated inflammation exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors an essential role for senescent cells in optimal wound healing through secretion of pdgf-aa markers of cellular senescence are elevated in murine blastocysts cultured in vitro: molecular consequences of culture in atmospheric oxygen aging, cellular senescence, and cancer placental membrane aging and hmgb1 signaling associated with human parturition intrinsic cooperation between p16ink4a and p21waf1/cip1 in the onset of cellular senescence and tumor suppression in vivo p53, p16ink4a, senescence and malignant transformation clinical strategies and animal models for developing senolytic agents senolytics improve physical function and increase lifespan in old age fisetin is a senotherapeutic that extends health and lifespan new insights into the role of epithelial-mesenchymal transition during aging gammah2ax in cancer cells: a potential biomarker for cancer diagnostics, prediction and recurrence telomeres are favoured targets of a persistent dna damage response in ageing and stress-induced senescence integrity of the human centromere dna repeats is protected by a biomarker that identifies senescent human cells in culture and in aging skin in vivo p16(ink4a) and senescence-associated beta-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli murine mesenchymal cells that express elevated levels of the cdk inhibitor p16(ink4a) in vivo are not necessarily senescent patterns of early p21 dynamics determine proliferation-senescence cell fate after p53-dependent release of alarmin hmgb1 is a central mediator of senescent phenotypes from ancient pathways to aging cellsconnecting metabolism and cellular senescence mitochondria, telomeres and cell senescence: implications for lung ageing and disease aging and cultured human skin fibroblasts cell replication and aging: in vitro and in vivo studies the relationship between in vitro cellular aging and in vivo human age cellular replication and aging p16ink4a is a robust in vivo biomarker of cellular aging in human skin age, anatomic site, and the replication and differentiation of adipocyte precursors senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study independent roles of estrogen deficiency and cellular senescence in the pathogenesis of osteoporosis: evidence in young adult mice and older humans targeting senescence improves angiogenic potential of adipose-derived mesenchymal stem cells in patients with preeclampsia tchkonia 16 ª 2020 the authors senescence marker activin a is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy hmgb1 and caveolin-1 related to rpe cell senescence in age-related macular degeneration cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to parkinson's disease cell senescence and fibrotic lung diseases targeting senescent cholangiocytes and activated fibroblasts with bcl-xl inhibitors ameliorates fibrosis in mdr2-/-mice cellular senescence in age-related macular degeneration: can autophagy and dna damage response play a role the emerging role of cellular senescence in renal diseases circulating senescent t cells are linked to systemic inflammation and lesion size during human cutaneous leishmaniasis transplanted senescent cells induce an osteoarthritis-like condition in mice transplanted senescent renal scattered tubular-like cells induce injury in the mouse kidney ink4a/arf expression is a biomarker of aging senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved oncogeneinduced senescence relayed by an interleukin-dependent inflammatory network the achilles' heel of senescent cells: from transcriptome to senolytic drugs directed elimination of senescent cells by inhibition of bcl-w and bcl-xl activity and safety of dasatinib as second-line treatment or in newly diagnosed chronic phase chronic myeloid leukemia patients targeted inhibition of src kinase with dasatinib blocks thyroid cancer growth and metastasis new agents that target senescent cells: the flavone, fisetin, and the bcl-xl inhibitors, a1331852 and a1155463 identification of a novel senolytic agent, navitoclax, targeting the bcl-2 family of anti-apoptotic factors clearance of senescent cells by abt263 rejuvenates aged hematopoietic stem cells in mice mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells navitoclax, a targeted high-affinity inhibitor of bcl-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity p53 activation inhibits all types of hematopoietic progenitors and all stages of megakaryopoiesis inhibition of dyrk1a-egfr axis by p53-mdm2 cascade mediates the induction of cellular senescence sa-beta-galactosidase-based screening assay for the identification of senotherapeutic drugs a versatile drug delivery system targeting senescent cells senescent cells re-engineered to express soluble programmed death receptor-1 for inhibiting programmed death receptor-1/programmed death ligand-1 as a vaccination approach against breast cancer cellular senescence and senescence-associated t cells as a potential therapeutic target the curcumin analog ef24 is a novel senolytic agent identification of hsp90 inhibitors as a novel class of senolytics senolytic activity of piperlongumine analogues: synthesis and biological evaluation targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging identification and characterization of cardiac glycosides as senolytic compounds cardiac glycosides are broad-spectrum senolytics enhanced killing of therapy-induced senescent tumor cells by oncolytic measles vaccine viruses cellular senescence: at the nexus between ageing and diabetes aging and adipose tissue: potential interventions for diabetes and regenerative medicine kirkland & t. tchkonia ª 2020 the authors cellular senescence in type 2 diabetes: a therapeutic opportunity targeting senescent cells alleviates obesity-induced metabolic dysfunction a crucial role for adipose tissue p53 in the regulation of insulin resistance chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice the murine dialysis fistula model exhibits a senescence phenotype: pathobiologic mechanisms and therapeutic potential acceleration of beta cell aging determines diabetes and senolysis improves disease outcomes senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease corrigendum to 'senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease sarcopenia: aging-related loss of muscle mass and function biology of premature ageing in survivors of cancer frailty in childhood cancer survivors inhibition of bcl-2/xl with abt-263 selectively kills senescent type ii pneumocytes and reverses persistent pulmonary fibrosis induced by ionizing radiation in mice cellular senescence as a therapeutic target to improve renal transplantation outcome mixing old and young: enhancing rejuvenation and accelerating aging evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells senescence of the brain: focus on cognitive kinases senolytic therapy alleviates abeta-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an alzheimer's disease model expression of p16 and p21 in the frontal association cortex of als/mnd brains suggests neuronal cell cycle dysregulation and astrocyte senescence in early stages of the disease increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin identification of senescent cells in the bone microenvironment transplanted senescent cells induce an osteoarthritis-like condition in mice systemic clearance of p16 (ink4a) -positive senescent cells mitigates age-associated intervertebral disc degeneration cellular senescence biomarker p16ink4a+ cell burden in thigh adipose is associated with poor physical function in older women hyperoxia-induced cellular senescence in fetal airway smooth muscle cells cellular senescence as a mechanism and target in chronic lung diseases cigarette smoke induces cellular senescence cellular senescence drives age-dependent hepatic steatosis cholangiocyte senescence by way of n-ras activation is a characteristic of primary sclerosing cholangitis senescence in the pathogenesis of age-related macular degeneration cellular senescence in the glaucomatous outflow pathway bcl-2, bcl-xl, and p-akt are involved in neuroprotective effects of transcription factor brn3b in an ocular hypertension rat model of glaucoma glaucoma: a disease of early cellular senescence effects of senescent lens epithelial cells on the severity of age-related cortical cataract in humans: a case-control study cellular senescence in the pathogenesis of benign prostatic hyperplasia tchkonia 18 ª 2020 the authors expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia the senescenceassociated secretory phenotype promotes benign prostatic hyperplasia the senolytic drug navitoclax (abt-263) causes trabecular bone loss and impaired osteoprogenitor function in aged mice a comparative study of the aneugenic and polyploidy-inducing effects of fisetin and two model aurora kinase inhibitors dr. yi zhu worked with the authors in 2013 to discover the first senolytic drugs as reported in march, 2015 [87] . the authors acknowledge support from the journal of internal medicine, us nih grants r37 ag013925, p01 ag062413 and r33 ag061456 (translational geroscience network), the connor fund, robert j. and theresa w. ryan and the noaber foundation. the authors have a financial interest related to this research. patents on senolytic drugs are held by mayo clinic. this research has been reviewed by key: cord-300372-h5g4z8ts authors: kelvin, alyson a.; degousee, norbert; banner, david; stefanski, eva; leon, alberto j.; angoulvant, denis; paquette, stéphane g.; huang, stephen s. h.; danesh, ali; robbins, clinton s.; noyan, hossein; husain, mansoor; lambeau, gerard; gelb, michael h.; kelvin, david j.; rubin, barry b. title: lack of group x secreted phospholipase a(2) increases survival following pandemic h1n1 influenza infection date: 2014-04-01 journal: virology doi: 10.1016/j.virol.2014.01.030 sha: doc_id: 300372 cord_uid: h5g4z8ts the role of group x secreted phospholipase a(2) (gx-spla(2)) during influenza infection has not been previously investigated. we examined the role of (reviewer 2 minor comment 2) gx-spla(2) during h1n1 pandemic influenza infection in a gx-spla(2) gene targeted mouse (gx(−/−)) model and found that survival after infection was significantly greater in gx(−/−) mice than in gx(+/+) mice. downstream products of gx-spla(2) activity, pgd(2), pge(2), ltb(4), cysteinyl leukotrienes and lipoxin a(4) were significantly lower in gx(−/−) mice bal fluid. lung microarray analysis identified an earlier and more robust induction of t and b cell associated genes in gx(−/−) mice. based on the central role of spla(2) enzymes as key initiators of inflammatory processes, we propose that activation of gx-spla(2) during h1n1pdm infection is an early step of pulmonary inflammation and its (reviewer 2 minor comment 2) inhibition increases adaptive immunity and improves survival. our findings suggest that gx-spla(2) may be a potential therapeutic target during influenza. influenza is a leading source of morbidity and mortality worldwide that is caused by ever changing and newly emerging influenza viruses including the introduction of the 2009 a/h1n1/2009 (h1n1pdm) and novel avian h7n9 viruses (fisher et al., 2005; groom and luster, 2011; widegren et al., 2011) . while effective vaccines and antiviral drugs have been developed for circulating strains of human influenza (santone et al., 2008) , continued antigenic drift and shift generate novel virus strains that pose a threat to immunologically naïve populations. the emergence of pandemic influenza h1n1pdm in the spring of 2009 led to hundreds of thousands of hospitalizations with significant numbers of fatalities in north america (update: influenza activity -united states, 2009-10). severe cases were characterized by viral pneumonia and uncontrollable pulmonary inflammation, and were similar to the inflammation observed in severe cases of sars, h5n1 and spanish influenza patients (baillie and digard, 2013; bermejo-martin et al., 2010; cameron et al., 2012; curfs et al., 2008) importantly there is little understood regarding the pathways driving the pulmonary inflammatory process for these diseases. host-defenses against influenza include anatomic barriers, mucociliary clearance, anti-microbial secretions and innate and adaptive immune responses. early host responses are characterized by the mobilization of leukocytes, such as alveolar and circulating macrophages, polymorphonuclear leukocytes (pmn) (world health organization, 2012) and nk cells which continues into the activation of adaptive immune cells such as t-cells, b-cells and dendritic cells. importantly, factors that lead to the activation of these cells and cell networks are increased after h1n1pdm infection (influenza activity -united states and worldwide, 2010; ohtsuki et al., 2006; ohtsuki et al., 2006; paquette et al., 2014) . these include inflammatory mediators such as chemokines, cytokines and lipid mediators like eicosanoids. the first step in the generation of eicosanoids, inflammatory mediators that participate in the regulation of the inflammatory response, is catalyzed by pla 2 enzymes, which release arachidonic acid (aa) from phospholipids (del et al., 2007) . to date, 11 secreted pla 2 enzymes (spla 2 ; ib, iia, iic, iid, iie, iif, iii, v, x, xiia and xiib) , six cytosolic pla 2 enzymes (cpla 2 s; α, β, γ, δ, ε, and ξ) (kim et al., 2007) , nine ca 2 þ -independent pla 2 enzymes (ipla 2 s; α, β, γ, δ 2 , δ, ε, ε2 ξ, θ, and η) , and two lysosomal pla 2 enzymes (femling et al., 2005) have been described. the spla 2 enzymes are structurally related, ca 2 þ -dependent proteins with unique biological properties, enzymatic activities against membrane phospholipids and tissue and cellular locations, suggest distinct roles for these enzymes in various pathophysiological events. spla 2 enzymes are implicated in lipid mediator release, degranulation, cellular proliferation, destruction of invading bacteria , viruses (kennedy et al., 1995; mazur et al., 2007) and activation of intracellular signaling cascades (kim et al., 2007) . gx-spla 2 is expressed in alveolar macrophages and epithelial cells in the lungs of patients with pneumonia (marshall et al., 2000) , neuronal cells (gaudreault and gosselin, 2008) , male reproductive organs (dennis, 1994) and atherosclerotic plaques , and is cleaved to its active form in inflamed tissues (lu et al., 2006) . arachidonic acid (aa) is the precursor of prostaglandins, thromboxanes, leukotrienes and lipoxins, eicosanoids that regulate pulmonary vascular and bronchial responses, leukocyte activation, adhesion and emigration (guan et al., 2013; henderson et al., 1995) . eicosanoids also regulate antigen presenting cell [apc] function (degousee et al., 2001; murakami et al., 2011; truchetet et al., 2012) , t cell maturation (myers et al., 2012) and th17 expansion (stephenson et al., 1988; zhao et al., 2011) . we found that il-17 and th17 cells are dysregulated during human h1n1pdm infection (baillie and digard, 2013; bermejo-martin et al., 2010; ohtsuki et al., 2006) . therefore, spla 2 enzymes and eicosanoids may play a central role in determining the outcome of pulmonary viral infection. the role of spla 2 enzymes in the immune responses to h1n1pdm infection in vivo has not been evaluated. gx-spla 2 has been highly implicated in the inflammatory response including pattern recognition receptor function, and displays the highest activity among all mammalian spla 2 s on phosphatidylcholine-rich liposomes in vitro (crooks and stockley, 1998; henderson et al., 1995) . recently, gx-spla 2 has been suggested as a signal amplifier in tlr4 stimulation which further suggests a role for gx-spla 2 in the regulation of the inflammatory response (schultz-cherry and jones, 2010) . considering the potential of gx-spla 2 in the inflammatory response, spla 2 enzymes may play a central role in determining the outcome of pulmonary viral infections, which cause uncontrolled inflammatory destruction of the respiratory tract (henderson et al., 1995) . we have developed a robust lethal mouse model of h1n1pdm infection to study innate host defense mechanisms and antiviral compound activity . we have shown that h1n1pdm infection in this mouse model leads to pulmonary inflammation, a histopathological picture similar to what is observed in fatal human cases, and over 90% lethality within 5-8 days . in this study, we document a marked increase in gx-spla 2 expression in lung following infection in gx þ / þ mice. to specifically evaluate the pathophysiological role of gx-spla 2 in our lethal influenza mouse model, we subjected gx þ / þ and gx à / à mice (henderson et al., 1995) to h1n1pdm infection in vivo. our results showed that, in two distinct mouse strains, targeted deletion of gx significantly increased survival following h1n1pdm infection in comparison with gx þ / þ mice. in addition, eicosanoid accumulation in bal fluid was attenuated and induction of t cell and b cell associated genes was higher in gx à / à than gx þ / þ mice after h1n1pdm infection. taken together, our data suggests a negative role for gx-spla 2 in the immune response to pulmonary infection with h1n1pdm influenza in vivo. furthermore, these findings implicate gx-spla 2 as a potential therapeutic target during severe influenza infection. airway epithelial cells and myeloid cells can both express gx-spla 2 (marshall et al., 2000) . previously, we have investigated the host immune responses to pulmonary viral infections, including infection with the influenza viruses h5n1 and h1n1pdm (baillie and digard, 2013; bermejo-martin et al., 2010; bhavsar et al., 2010; cameron et al., 2008; cameron et al., 2012; escoffier et al., 2010; huang et al., 2009; huang et al., 2012; kudo and murakami, 1999) . furthermore, we have also delineated the biology and molecular regulation of many of the enzymes that catalyze eicosanoid biosynthesis in vitro and in vivo degousee et al., 2006; degousee et al., 2008; degousee et al., 2002; degousee et al., 2003; leon et al., 2012; lu et al., 2006; saez de et al., 2011) . to begin to investigate the role of gx-spla 2 during h1n1pdm infection, we evaluated the pulmonary expression of gx-spla 2 in our h1n1 pandemic influenza mouse model. gx þ / þ mice were infected intranasally with a/mexico/4108/ 2009 (h1n1pdm) and lung tissues were harvested at baseline and on day 3, 6 and 14 post infection (pi). real-time pcr was performed on the extracted rna and identified a significant increase in the ratio of gx-spla 2 to gapdh mrna on day 3 and day 14, but not day 6 pi (fig. 1ai) . gx-spla 2 /gapdh mrna increased approximately four fold on day 3 and three fold on day 14 compared to baseline. furthermore, we also determined the regulation of cytosolic pla 2 (cpla 2 ) (fig. 1aii ) and the spla 2 family member gv-pla 2 (fig. 1aiii ) in both gx þ / þ and gx à / à mice. there was negligible total protein upregulation of cpla 2 and gv-pla 2 was not regulated throughout the infection time course. the absence of the change of total protein of cpla 2 was also confirmed by immunohistochemistry (data not shown). no statistical differences in mrna transcripts for cpla 2 and gv-pla 2 were noted between the gx þ / þ or gx à / à mice. these results demonstrated that h1n1pdm influenza infection stimulated a bimodal increase in pulmonary gx-spla 2 mrna expression which was /4108/2009) and the lungs were assessed for the mrna and protein expression and localization of plas during a 14 day time course. gx-spla 2 mrna (ai), cpla 2 mrna (aii) and gv-spla 2 mrna (aiii) expression quantified by real-time rt-pcr was normalized to gapdh, gx þ / þ (open bars) and gx à / à (filled bars) mice (c3h/hen background mice). gx þ / þ and gx à / à mouse lungs were perfusion fixed in situ with 4% paraformaldehyde, sectioned and subject to immunohistochemical analysis with the igg fraction of rabbit anti-mouse gx-spla 2 antiserum (1/100 dilution) (b). giia and gx-spla 2 protein expression determined by immunoblot analysis of lung tissue homogenates of wild type gx þ / þ (lane 1) and knockout gx à / à (lane 2) mice (c). for each blot, the corresponding recombinant spla 2 enzyme (rec spla 2 ) was run alone (lane 3) as a control. representative results for five separate experiments are shown. all the mice used in these experiments were genotyped littermates and grouped and analyzed by their genotype. a, p o 0.05 gx þ / þ or gx à / à vs. base; b, p o 0.05 gx þ / þ vs. gx à / à at any time point, anova followed by paired t-test, two tailed, assuming unequal variance. nz 8 per group; 400 â ; scale bar: 50 μm for immunohistochemistry. specific for this spla 2 since neither cpla 2 nor gv-spla 2 was upregulated. since gx-spla 2 mrna levels increased in response to h1n1pdm infection, we investigated the spatial and temporal expression of gx-spla 2 protein in mouse lungs after influenza infection. lungs from gx þ / þ and gx à / à mice infected with h1n1pdm were harvested at baseline, 3, 6 and 14 days pi and subjected to immunohistochemical analysis with anti-mouse gx-spla 2 antiserum. visualization by light microscopy revealed gx-spla 2 protein accumulation in the lungs of infected mice compared to baseline (fig. 1b) . gx-spla 2 protein was identified in inflammatory cells that had infiltrated in the alveolar space on day 3 and 6 in gx þ / þ mice infected with h1n1pdm (shown by arrows). gx-spla 2 protein was also clearly identified in epithelial cells lining the bronchioles on day 3, 6 and 14 in gx þ / þ mice infected with h1n1pdm (fig. 1b , upper right panels). no staining for gx-spla 2 protein was observed in gx à / à mice at baseline or at any time point after infection with h1n1pdm (fig. 1b , lower panel rows). similarly, no proteins cross reacting with the secondary antibody alone was identified in gx þ / þ or gx à / à mice (fig. 1b , left hand panels). we confirmed the loss of gx-spla 2 in the gx à / à mice by immunoblot analysis. we indeed observed a specific depletion of gx-spla 2 but no change in the expression of giia-spla 2 in the gx à / à mice compared to gx þ / þ mice (fig. 1c ). taken together, these results show that intranasal infection with h1n1pdm increases gx-spla 2 rna and protein expression in the lung that corresponds to the increase in lung inflammation associated with influenza infection. this suggests a possible role for gx-spla 2 in the pathogenesis of pulmonary h1n1pdm influenza infection. since gx-spla 2 was upregulated in the lung during h1n1pdm infection, we explored its role in the host response to pulmonary infection with h1n1pdm influenza. we first examined the clinical outcome of gx-spla 2 deletion by assessing weight loss and survival of g þ / þ and gx-spla 2 gene targeted mice à / à mice on two different genetic backgrounds following infection and assessed weight loss and survival. in the first series of infections, gx þ / þ (n¼25), gx þ /-(n¼32), and gx à /à (n¼24) mice on a c57bl/6j background were infected intranasally with h1n1pdm influenza a/mexico/4108/2009 ( fig. 2a ). mice on this background lack the giia-spla 2 gene (karabina et al., 2006) . animals were euthanized if their body weight decreased to less than 80% of baseline weight, or if the 14-day duration of the study was completed. survival 14 days after h1n1pdm influenza infection was 70% in gx à /à mice (blue line), 48% in gx þ /mice (green line) and 15% in gx þ / þ mice (red line). the difference in survival between gx à /à and gx þ /mice, and between gx à /à and gx þ / þ mice after h1n1pdm infection was statistically significant, pr0.01. to independently confirm these findings, we evaluated the survival of gx þ / þ (n¼ 71) and gx à / à (n ¼ 57) mice on a c3h/hen background (fig. 2b) which have a functional giia-spla 2 gene (karabina et al., 2006) . as with the studies with the c57bl/6j mice, animals were infected intranasally with a/mexico/4108/2009 and euthanized if their body weight decreased to less than 80% of baseline weight, or at the end of the study. survival of gx à / à mice on the c3h/hen background was again significantly higher (62%, blue line) following h1n1pdm infection than survival of gx þ / þ mice on a c3h/hen background (36%, red line). together, these studies showed that targeted deletion of gx-spla 2 in two different mouse models led to increased survival following h1n1pdm infection in vivo. furthermore, since the c3h/hen mice expressed endogenous giia-spla 2 , these results demonstrate that the ability to express giia-spla 2 does not compensate for the loss of gx-spla 2 during host immune responses to pulmonary h1n1pdm influenza infection. depletion of gx-spla 2 during h1n1pdm infection leads to a decrease in downstream phospholipid catalysis (aa) products but no difference in innate cell recruitment gx þ / þ and gx-spla 2 gene targeted mice à / à on a c3h/hen background were infected with a/mexico/4108/2009, and bal fluid was harvested 3 or 6 days post h1n1pdm infection. to assess the general inflammatory response and lung tissue destruction that typically occurs during h1n1pdm infection (ohtsuki et al., 2006; paquette et al., 2012) , we investigated the histopathology by h&e staining of lungs isolated from both gx à / à and gx þ / þ mice at baseline, day 3, 6 and 14 pi (fig. 3a) . the pulmonary pathology peaked quickly by day 3 pi in infected gx þ / þ and gx à / à animals. bronchiolitis and alveolitis with mononuclear cell and neutrophil infiltration were observed in several loci of the infected lungs of both groups. hemorrhage, edema, and necrotizing respiratory epithelia were also observed with similar severity among both groups. pathology persisted until day 7 pi where mononuclear cell and neutrophil infiltration were still profound and caused patches of consolidation in the lung tissue in both groups. it seemed by day 14 pi that the pulmonary pathology was slightly more minimal in the gx à / à mice with reduced level of leukocyte infiltration. in contrast, multi foci cell infiltration and tissue consolidation was still prominent in the gx þ / þ lungs by day 14 pi. to further examine the inflammatory cell types that may be recruited to the lung during h1n1pdm infection we analyzed lung homogenates from day 0, 3, 6 and 14 pi from both gx þ / þ and gx à / à mice by immunoblot for neutrophil and leukocyte cell markers, mpo and cd45 respectively. mpo was induced on day 3 and day 6 pi in both the mouse genotypes and returned to baseline on day 14 and cd45 was induced from baseline for all time points measured. neither mpo nor cd45 showed any variation in the lungs between gx à / à or gx þ / þ throughout the infection time course (fig. 3bi) ; densitometry did not reveal any statistical differences (fig. 3bii) . furthermore, we also analyzed gx à / à and gx þ / þ lungs for the presence and activation of macrophages by immunohistochemistry and real-time rt-pcr ( fig. 3ci , cii and d). here we found that the macrophage marker mac-3 was significantly increased and peaked at day 6 following infection as determined by immunohistochemistry staining which was further confirmed by quantifying the staining and quantification of the signal ( fig. 3ci and cii). furthermore the mrna for the inflammatory chemokine ccl2 was also significantly increased following infection (days 3 and 6) and decreased by day 14 (fig. 3d) . no difference was determined for mac-3 or ccl2 expression between gx à / à or gx þ / þ mice. taken together, these results suggest a similar inflammatory and innate response in both the gx þ / þ and gx à / à mice. to assess the role of gx-spla 2 in leukocyte infiltration into the bronchoalveolar space after h1n1pdm infection, we measured total leukocyte cell counts and the levels of different leukocyte cell types in the bal fluid of h1n1pdm infected in gx þ / þ and gx à / à mice (fig. 4a ). no significant difference in total cell counts ( fig. 4ai ) or the percentage of cd4 þ , cd8 þ , b or natural killer cells, or granulocytes were identified in the bal fluid of gx þ / þ and gx à / à mice 6 days after h1n1pdm infection (fig. 4aii ). in addition, targeted deletion of gx-spla 2 had no effect on lung viral titers 3 or 6 days pi (fig. 4b ). we next determined by elisa the levels of diferent aa metabolites including pgd 2 , ltb 4 , cysteinyl leukotrienes, pge 2 , a stable pge metabolite, and lipoxin a 4 which are known to regulate bronchiolar reactivity and inflammatory cell adhesion, migration and activation (henderson et al., 1995) were determined by elisa. levels of pgd 2 ( 5g ) were all significantly lower in the bal fluid from gx à / à mice (solid bars) on day 3 pi compared to gx þ / þ mice. conversely, on day 6 pi, the levels of these metabolites were similar in gx þ / þ and gx à / à mice ( fig. 5a-f) . in summary, these results show that deletion of gx-spla 2 in mice led to a transient but significant decrease in the levels of a panel of aa metabolites when mice were infected with a lethal h1n1pdm influenza virus that was not associated with alterations in inflammatory cell infiltration or viral clearance. increased expression of immunoglobulin chain, lymphocyte differentiation, antigen processing genes and presence of cd3 þ t cells in the lungs of mice lacking gx-spla 2 after h1n1pdm infection to increase our understanding of the molecular events leading to increased survival following h1n1pdm infection in gx à / à mice, we conducted microarray analysis of rna extracted from the lungs of gx þ / þ and gx à / à influenza infected animals. as previously reported by our group paquette et al., 2014; , influenza infection caused a progressive increase in the total number of upregulated genes in the lung tissue of gx þ / þ mice (1246 genes at 3 days pi and 2469 genes at 6 days pi). genes that belonged to different functional groups, such as immune response, inflammatory response and prostaglandin signaling pathways (figs. 6 and 7) showed a progressive increase that was parallel to the global evolution of gene expression. conversely, the expression of cytokine-related genes reached maximal levels 3 days pi and were maintained thereafter (fig. 6a) . at first sight, lack of gx-spla 2 did not modify the global evolution of gene expression in the lungs. similarly to gx þ / þ mice, gx à / à mice showed a progressive increase in the number of upregulated genes (1578 at 3 days pi and 2469 at 6 days pi). further analysis demonstrated that on day 3 pi, gx à / à mice showed significantly higher levels of the cytokines lta and ltb, the chemokines ccl19, cxcl9 and cxcl13 and the chemokine receptors cxcr3 and cxcr5 ( fig. 6b and c). in contrast, the expression pattern of cytokines and chemokines showed no differences between gx þ / þ and gx à / à mice 6 days pi (data not shown). interestingly, expression of 21 immunoglobulin chains, including heavy and light chains, was identified in gx à / à mice 3 days pi, while no expression of immunoglobulin chain genes was identified in gx þ / þ mice at this time point. in addition, the number of immunoglobulin chain related genes was higher in gx à / à than gx þ / þ mice 6 days after h1n1pdm infection (fig. 6b ). no differences were observed in the patterns of interferon regulated genes between gx þ / þ and gx à / à mice after h1n1pdm infection (data not shown). to determine which functional pathways are differentially enriched between gx þ / þ and gx à / à mice after h1n1pdm infection, we performed intersect analysis of the respective sets of upregulated genes (fig. 7) . at 3 days pi, expression of interferon regulated, inflammatory response and innate immune response genes were common to both gx þ / þ and gx à / à mice. a number of genes related with eicosanoid synthesis and their receptors were found to be regulated during influenza infection; however, gx-spla 2 deficiency did not cause any major alterations in their expression profiles (fig. s1) . the set of genes specifically enriched in the gx à / à mice at 3 day pi were those related to adaptive immune responses, such as immunoglobulin chains, lymphocyte differentiation and antigen processing and presentation. on the other hand, the set of genes more enriched in the gx þ / þ mice were genes involved in the tissue development category at 3 days pi (fig. 7a ). at 6 days pi (fig. 7b) , the enrichment profiles of upregulated genes in gx þ / þ and gx à / à mice were nearly identical. while immunoglobulin chain gene expression was identified in both gx þ / þ and gx à / à mice, expression of immunoglobulin chain genes remained elevated only in the gx à / à set of genes 6 days pi, while the gx þ / þ set of genes continued to show enrichment in the tissue development category at day 6 pi. to further evaluate the adaptive immune system of the gx à / à mice infected with h1n1pdm we investigated the t and b cell responses within the lung during infection. here we stained lung sections with anti-cd3 to assess infiltration of t cells using immunocytochemistry ( fig. 8a and b) . we found a significant increase of cd3 positive t cells in the lung on day 3 pi in the gx à / à mice compared to gx þ / þ mice (fig. 8a , upper right panels) by approximately 2 fold (fig. 8b) . interestingly, cd3 staining of the gx þ / þ animals had increased to similar levels seen in the gx à / à mice by day 6 and both genotypes had sustained levels of cd3 on day 14. moreover, we also investigated cd8a and igg (ighg) mrna levels in the lungs of the gx à / à mice throughout the time course and there was a slight trend for increase cd8a levels. taken together, the results from the cd3 and igg analysis supported the microarray studies where the adaptive immune system of the gx à / à had a faster and more robust initiation. gx-spla 2 has been highly implicated in various inflammatory diseases of the respiratory tract, including th2 cytokine-driven asthma (de jong et al., 2006; henderson et al., 2007) and lung injury (napolitani et al., 2009 ), but its role during influenza infection has not been previously investigated. here we evaluated the pathophysiological role of gx-spla 2 during severe influenza a h1n1pdm infection in the mouse. we found that gx-spla 2 expression was increased following infection, and that targeted deletion of gx-spla 2 led to increased survival in mice. lack of gx-spla 2 resulted in decreased levels of pgd 2 , ltb 4 , cysteinyl leukotrienes, pge 2 and lipoxin a 4 and increased adaptive immune responses at 3 but not 6 days following h1n1pdm infection. this demonstrates that gx-spla 2 plays an important role in the production of several biologically active inflammatory lipid mediators during the early phase of the inflammatory response that follows h1n1pdm influenza infection. human patients with a severe respiratory disease caused by influenza infection have a dysregulated inflammatory response that leads to lung pathogenesis associated with hypercytokinemia in most cases (bermejo-martin et al., 2010; curfs et al., 2008) . taken together with the previous findings showing a role of gx-spla 2 in inflammatory lung diseases, our work supports the further investigation of the therapeutic potential of attenuating gx-spla 2 during severe influenza infection as well as the interplay between eicosanoids and adaptive immunity. spla 2 has previously been implicated in pulmonary disease onset and progression putting it forth as a potential biomarker for severe respiratory diseases (henderson et al., 1995; henderson et al., 2007) . we show that gx-spla 2 protein and mrna expression increased in the lungs of gx þ / þ mice following h1n1pdm infection, suggesting that gx-spla 2 may be used as a possible biomarker of severe influenza infection. this is the first report of increased gx-spla 2 expression following influenza virus infection. both epithelial cells and leukocytes were found to be sources of gx-spla 2 during infection, and gx-spla 2 expression was detected in epithelial cells 3 days prior to the infiltration of leukocytes. in will be interesting to determine in future experiments whether the specific deletion of gx-spla 2 expression in epithelial cells vs. infiltrating leukocytes or both is responsible for the increased survival. here we observed a bimodal expression pattern of gx-spla 2 during the 14 day time course of infection. it is possible that this occurred due to the protein stability as it is used to regulate bioactive lipid mediator synthesis. if the protein does not remain stable throughout the course of infection and recovery, it may be important to have a second increase in gx-spla 2 in the later stages of infection to compensate for the loss of protein. it is in fact possible that the protein exerts distinct roles in the clearance of the virus and tissue remodeling in addition to the regulation of immune cells. such a scenario would require inductions at specific time points during infection. it will be important to further explore the local expression in the virus niche and the stability of protein gx-spla 2 during influenza infection to better understand how gx-spla 2 stability may influence influenza severity in the initiation of the innate immune response, adaptive maintenance, and recovery. furthermore, it would also be of value to investigate the source of gx-spla 2 by expression analysis of each cell type and also by investigating the role of hematopoietic gx-spla 2 compared to epithelial gx-spla 2 . the latter could be studied by employing bone marrow transplantation experiments from gx à / à mice into gx þ / þ and the reverse. while the association between gx-spla 2 and influenza related complications has not previously been investigated, ltb 4 , a downstream product of gx-spla 2 has been suggested to be a biomarker for pulmonary disease and respiratory complications following trauma (influenza activity -united states and worldwide, 2010; henderson et al., 2011; shridas et al., 2011) . multiple studies have implicated gx-spla 2 in the pathophysiology of pulmonary diseases onset and progression, suggesting gx-spla 2 might be a suitable therapeutic target in lung (henderson et al., 1995; morita et al., 2013) . deletion of gx-spla 2 in a th2 cytokine-driven mouse asthma model significantly impairs development of asthma (henderson et al., 1995) and accordingly, administration of a human gx-spla 2 selective inhibitor in a human gx-spla 2 knock-in mouse model led to a significant reduction in airway inflammation, mucus hypersecretion and airway hyperresponsiveness (henderson et al., 2007) . furthermore, although not specific for human gx-spla 2 , the indole-based spla 2 inhibitor varespladib has been shown to significantly inhibit spla 2 activity in the bal fluid of infants with post-neonatal ards (de jong et al., 2006) during induced asthma, suggesting the involvement of spla 2 among other spla 2 s. our results showing increased survival of the gx à / à mice after infection with h1n1pdm further support the notion that gx-spla 2 is a therapeutic target in pulmonary diseases due to viral infection and that infection with h1n1 might be better controlled by inhibiting this spla 2 . one of the main functions of gx-spla 2 is likely the generation of bioactive lipid mediators which play important roles in lung inflammatory diseases (gao et al., 2013; gaudreault and gosselin, 2007; van elssen et al., 2011) . although we did not see any major differences in the mrna analysis of the eicosanoid pathways between the gx à / à and gx þ / þ mice, measuring the mrna levels of these genes may have limited value to determine the level of activation of their signaling pathways. conversely, we observed decreased levels of pgd 2 , ltb 4 , cysteinyl leukotrienes, pge 2 and lipoxin a 4 in bal fluid 3 day pi in the gx à / à mice, indicating that gx-spla 2 acts upstream of these bioactive lipid mediators during influenza infection and thereby suggests a possible role of these bioactive mediators in pulmonary pathogenesis after influenza infection. in agreement with our findings, pgd 2 has been implicated during influenza a infection as pgd 2 expression in the lungs of older animals inhibits regulatory dendritic cells activity and t cell responses (zhang et al., 2000) . other eicosanoids have been implicated in different lung diseases, and the dysregulation of leukotrienes and lipoxins have been reported as contributing factors to the pathogenesis and severity of other respiratory diseases (bermejo-martin et al., 2009) . ltb 4 has been suggested to play a destructive inflammatory role in the lung by priming neutrophils for adhesion, chemotaxis and stimulation of granule release (cameron et al., 2007) . as well pgd 2 , pgd receptor, lipocalin-type pgd synthase and ltb 4 have been implicated in asthma pathogenesis (arima and fukuda, 2011; masuda et al., 2005; rusinova et al., 2012) . although asthma and pulmonary disease due to influenza infection differ in derivation, both are characterized by hyper-inflammation of the respiratory tract. taken together, our data supports a role of gx-spla 2 signaling and bioactive mediator production in the regulation of the pulmonary response to h1n1pdm infection. in the future it would be important to specifically determine whether pgd 2 , ltb 4 , cysteinly leukotrienes, pge 2 , lipoxin a 4 or another aa metabolite specifically modulates the response to h1n1pdm infection. the inflammatory response may be simultaneously beneficial and destructive during lung infection (baillie and digard, 2013; fig. 2 . increased survival of gx à / à vs. gx þ / à or gx þ / þ mice following a/mexico/ 4108/2009 infection. gx þ / þ (n¼ 25), gx þ / à (n ¼32), and gx à / à (n¼24) mice (c57bl/6j background, lacks giia-spla 2 ) were infected intranasally with a/mexico/ 4108/2009 and survival was assessed for a 14 day period (a). gx þ / þ (n¼71) and gx à / à (n¼ 57) mice (c3h/hen background, expresses giia-spla 2 ) were infected intranasally with a/mexico/4108/2009 and survival was assessed for a 14 day period (b). animals were sacrificed if their body weight decreased to less than 80% of baseline weight, or if the 14-day duration of the study was completed. log rank test, p o0.05 gx à / à vs. gx þ / þ and gx þ / à mice or po 0.05, gx à / à vs. gx þ / þ mice. all the mice used in these experiments were genotyped littermates and grouped and analyzed by their genotype. bermejo-martin et al., 2010) . although destructive killing of foreign pathogens is imperative for eradication and microbe clearing, the over production of inflammatory mediators leading to an overt inflammatory response may accentuate disease pathology, as is the case during severe influenza h5n1 and h1n1 infection (bermejo-martin et al., 2010; curfs et al., 2008; huang et al., 2009) . this illustrates the dual role of proinflammatory mediators, which has also been suggested for some gx-spla 2 downstream lipid mediators. for instance, ltb 4 has been shown to increase the activity of nasal neutrophil killing of human coronavirus, rsv, and influenza b virus (van elssen et al., 2011) and to induce the release of antimicrobial peptides in vivo in the lungs of fig. 3 . infection with h1n1pdm influenza induces similar pulmonary inflammation and recruitment of inflammatory cells in gx þ / þ and gx à / à mice. gx þ / þ and gx à / à mice (c3h/hen background mice) were infected with h1n1pdm (a/mexico/4108/2009) influenza and the lungs were perfusion fixed in situ with 4% paraformaldehyde on specific time points following infection, sectioned and subject to hematoxylin and eosin staining (a). mpo protein (neutrophil marker), cd45 protein (leukocyte marker) and gapdh protein (loading control) expression levels were determined by immunoblot analysis from lung tissue homogenates of gx þ / þ and gx à / à mice over a 14 day time course of h1n1pdm influenza infection (bi). densitometric analysis of mpo (bii) and cd45 (biii) protein levels normalized to gapdh levels in lung tissue of gx þ / þ (open bars) and gx à / à (filled bars) mice after h1n1pdm influenza infection, are presented. immunohistochemical analysis with specific rabbit primary antibody against mouse mac-3 antigen (marker for macrophages) is shown (ci). assessment of mac-3 positive cells (indicated by -) per high power field before, 3, 6 or 14 days after infection with h1n1pdm influenza is shown (cii). ccl2 mrna expression normalized to gapdh was determined by quantitative real-time pcr in lung tissue of gx þ / þ and gx à / à mice after h1n1pdm influenza infection (d). representative images ( â 200) from five independent experiments are shown. scale bar: 100 μm (a) or 50 μm (c). a, p o 0.05 gx þ / þ or gx à / à vs. base; b, p o0.05 gx þ / þ vs. gx à / à at any time point, anova followed by paired t-test, two tailed, assuming unequal variance. nz 8 per group. mice infected with viruses (gao et al., 2013; gaudreault and gosselin, 2007) . the lipid product protectin d1 has been implicated in influenza therapeutics (arima and fukuda, 2011; mitsuishi et al., 2006) . although these previous reports seem to suggest a conflicting role for gx-spla 2 in consideration of our data, it may be possible that ltb 4 and gx-spla 2 promote antiviral activity and are significant during a viral response but only at moderate levels. alternatively, it is possible that gx-spla 2 prevents h1n1 infection but also triggers excessive inflammation that is associated with lipid surfactant destruction. more work is needed to understand how the function of gx-spla 2 mediates both beneficial and deleterious roles during influenza infection. our survival data from gx gene targeted mice indicated that the loss of gx-spla 2 was beneficial to the host during influenza infection. the microarray mrna data from lungs of gx þ / þ infected mice were in agreement with our previously published data on pandemic h1n1 2009 virus infection, in mice including the progressive increase of immune and inflammatory responses and of the prostaglandin signaling pathway (paquette et al., 2014) . together, the results of microarray analysis, gene expression by real-time rt pcr and immunocytochemistry of the lungs suggested that gx à / à mice exhibited a more robust adaptive immune response than gx þ / þ mice. indeed, we observed significant differences in lymphocyte gene profiles at day 3 pi, associated with differences in the levels of lymphotoxin alpha and beta, b cell chemokines, t cell chemokine receptors and b cell immunoglobulin chains as measured which by immunofluorescence and rt-pcr. expression of b cell immunoglobulin chain genes were substantially increased on day 3 pi in the gx à / à mice but not in the gx þ / þ . b cell immunoglobulin gene expression was significantly greater on day 6 pi. and the expression of the t cell, b cell and dendritic cell chemokines and chemokine receptors, i.e., ccl19, cxcr3, etc., were significantly higher in the gx à / à samples than gx þ / þ . these results suggest that the downstream products of gx-spla 2 , such as pgd 2 , pge 2 , ltb 4 may inhibit the early adaptive immune responses of t and b cells during viral infection and this fits with the fact that aspirin, which attenuates eicosanoid production, can be an effective therapy for patients with influenza infection (matsuoka et al., 2000) . it would be of value in future studies to further investigate the effect of gx-spla 2 on the proliferation, activation and differentiation of t and b lymphocytes. consistent with this notion, the chemokines and chemokine receptors found to be upregulated in the h1n1pdm infected gx à /à mice are known to play significant roles in t and b cell migration and localization to the lymph nodes (goracci et al., 2010; muthuswamy et al., 2010) . cxcl13/cxcr5 signaling has been shown to activate b cells (sadik and luster, 2012) , which may explain the increased immunoglobulin chain gene expression observed in gx à /à mice. our data supports previous findings implicating pgd 2 in the inhibition of cell migration to lymph nodes (zhang et al., 2000) , and pge 2 in the inhibition of adaptive immune cellular events such as chemokine production by dcs and the attraction of naïve t cells (murakami et al., 2011; truchetet et al., 2012) . in conclusion, our findings provide new insights into the molecular pathophysiology of lethal influenza infection, highlighting a new role for gx-spla 2 during h1n1pdm infection. overall, the spla 2 appears as a negative effector but it may act at several steps during infection. we found that gx-spla 2 and its downstream products may have a role in the inhibition of adaptive immunity during viral infection in mice thereby contributing to pathogenesis. within this mechanism, it is in fact possible that t and b cell maturation and activation are initiated in mice lacking gx-spla 2 prior to virus infection, and that a more robust and earlier adaptive fig. 4 . lung viral titers and cell counts in bal fluid show similar cell numbers and cell population distributions following infection in gx þ / þ and gx à / à mice. gx à / à and gx þ / þ mice infected with a/mexico/4108/2009 were investigated for lung cell numbers, populations and viral load. bal fluid was harvested from infected gx þ / þ (open bars) and gx à / à (filled bars) mice (c3h/hen background mice) on day 0 and 6 and the cell numbers (ai) and cell population distributions (aii) were assessed by facs. viral load was determined on day 0, 3 and 6 pi of gx þ / þ (open bars) and gx à / à (filled bars) mice by real-time rt-pcr vrna quantification (b). all the mice used in these experiments were genotyped littermates and grouped and analyzed by their genotype. a, p o0.05 gx þ / þ vs. base, anova followed by paired t-test, two tailed, assuming unequal variance. nz 7 per group. immune response increased the survival of gx à / à mice after h1n1pdm infection. since gx-spla 2 may contribute to inflammatory response dysregulation during influenza infection and contribute to the morbidity and mortality associated with hospitalized influenza patients, this work may shed important insight into the molecular mechanisms of severe influenza infection. our findings further support the notion that gx-spla 2 is an interesting therapeutic target in lung inflammatory diseases. whether inhibition or attenuation of gx-spla 2 activity during severe influenza infection has a therapeutic effect remains to be demonstrated. to dissect the role of gx-spla 2 in the molecular regulation of pulmonary infection with h1n1pdm influenza, mice that lack gx-spla 2 (gx à / à mice) on the c57bl/6j background previously described were used (matsuoka et al., 2000) . this mixed background strain has a naturally occurring mutation in the gene encoding giia-spla 2 (karabina et al., 2006) , which has been fig. 5 . decreased eicosanoid levels in the bal fluid 3 but not 6 days after infection with a/mexico/4108/2009 in gx à / à vs. gx þ / þ mice. the eicosanoid levels in the bal fluid of gx à / à and gx þ / þ mice (c3h/hen background) were investigated at baseline and following infection with a/mexico/4108/2009. gx þ / þ (open bars) and gx à / à (filled bars) mice (c3h/hen background mice) bal fluid was harvested by instilling ice cold nacl (1 ml) five times and pooled. levels of pgd 2 mox (a), ltb 4 (b), cysteinyl leukotrienes (c), pge 2 (d), stable pge metabolite (e), pge 2 plus pge metabolite (f) and lipoxin a 4 (g) were assessed by elisa. these results are the mean of 5 independent studies. all the mice used in these experiments were genotyped littermates and grouped and analyzed by their genotype. gx þ / þ (open bars) and gx à / à (filled bars). results are expressed in pg/ml. a, p o0.05 gx þ / þ or gx à / à vs. base; b, p o0.05 gx þ / þ vs. gx à / à at any time point, anova followed by paired t-test, two tailed, assuming unequal variance. n z7 per group. implicated in bacterial phospholipid hydrolysis . furthermore, we generated gx à / à mice on the c3h/hen background (fig. 1c ) by backcrossing the c57bl/6j gx à / à mice for 10 generations which had functional giia-spla 2 . mice were maintained on standard animal feed and water ad libitum in the conventional environmental conditions and controlled temperature and humidity with a 12 h light and dark cycle. for infection studies, animals were housed in hepa-filtered cage racks adherent to absl2 þ conditions (toronto general hospital, animal resource centre, toronto, canada). all animal procedures were performed in a certified class ii biosafety cabinet (baker company, sanford, nc, usa). housing and experimental procedures were approved by the animal care committee of the university health network, and were in accordance with the guide for the care and use of laboratory animals research statutes, ontario (1980) . all infection experiments were conducted with h1n1pdm strain, a/mexico/4108/2009 (h1n1pdm), provided by the centers for disease control and prevention (atlanta, ga, usa). virus was propagated and titrated in embryonated eggs and titrated prior to animal challenge. viral stocks were stored in liquid nitrogen and thawed prior to use. mice were weighed and randomly assigned for sample collection, and were infected through intranasal instillation with 50 ml phosphate-buffered saline (mock infection) or 50 ml a/mexico/4108/2009 (h1n1pdm) at 1 â 10 5 or 1 â 10 4 50% egg infectious dose (eid) 50 . virus dosage were 1 â 10 4 eid 50 and â 10 5 eid 50 for host response profiling in c57bl/6j mice and 1 â 10 4 eid 50 for comparing disease severity between gx þ / þ and gx à / à mice. throughout infection experiments, animal survival, clinical signs, and weights were recorded daily. in accordance with animal care committee recommendation, mice were euthanized when recorded body weight fell below 80% of original body weight. at day 0, 3 and 6 pi, 3 gx þ / þ and 3 gx à / à mice were euthanized and lung homogenates collected for viral load determination by either madin-darby canin kidney (mdck) cell growth determination or real-time rt-pcr (rna analysis methods and table s1 ). for mdck determination lungs were homogenized (10% w/v) in high glucose (4.5 g/l) dulbecco's modified eagle medium (dmem), supplemented with 1% bovine serum albumin, 50 mg/ml gentamycin, 100 u/ml penicillin, 100 mg/ml streptomycin, and 1 mg/ml tpck-trypsin (vdmem). homogenates were then serially diluted (0.5 log 10 ) in quadruplicate over madin-darby canine kidney cells, cultured at 2.0 â 10 4 cells/well in 96-well plates. cells were incubated for 2 h at 37 1c and 5% co 2 . homogenates were then removed and replaced with fresh vdmem. cells infected were incubated for 6 days at 37 1c and 5% fig. 6 . effect of gx-spla 2 deficiency in the mrna expression levels of cytokines, chemokines and their receptors and immunoglobulin chains in the lung tissue of mice during influenza infection. gx þ / þ and gx à / à mice (c3h/hen background mice) were infected with influenza a/mexico/4108/2009 and the gene expression profiles were analyzed in the lung tissue at day 0, 3, and 6 days after infection by microarray analysis (n¼ 4 per group). evolution of gene enrichment (fisher's exact test) of the kegg category "cytokine-cytokine receptor interaction" (a). differences in the expression levels of cytokines (b) and chemokines (c) and their receptors at 3 days pi. the heatmaps show the genes that are significantly upregulated with respect to the control group and the blue boxes indicate that the expression levels of those genes are significantly higher in the gx à / à than in the wild type mice at the same time-point. evolution in the expression levels of immunoglobulin genes: total number of regulated genes (d) and overview of different experimental groups and time-points (e). all the mice used in these experiments were genotyped littermates and grouped and analyzed by their genotype. fig. 7 . intersect analysis of the genes up-regulated in the lung tissue of gx à / à and gx þ / þ mice during influenza infection and functional classification of the resulting gene subsets. venn diagrams are representative of the total number of genes that are significantly up-regulated with respected to the uninfected mice. david annotation tool was used to classify the genes of each subset, and the fold enrichment is shown for each category. all the mice used in these experiments were genotyped littermates and grouped and analyzed by their genotype. * the "immunoglobulin chains" category was manually curated and contains 84 genes. nn the "interferon responses category". fig. 8 . gx-spla 2 deficiency increases t cell recruitment and immunoglobulin heavy chain mrna expression in the lung tissue of mice during influenza infection. day 0 and 3 pi with h1n1pdm (a/mexico/4108/2009) influenza the lungs from gx þ / þ and gx à / à mice (c3h/hen background mice) were perfusion fixed in situ with 4% paraformaldehyde, sectioned and subject to immunofluorescence analysis with specific rabbit primary antibody against mouse cd3 antigen (marker for t-cell) (ai). representative images (at â 400 with 3.4 zoom factor) from five independent experiments are shown. assessment of cd3 positive cells per high power field for day 0, 3, 6 and 14 days following infection with h1n1pdm influenza is shown (aii). igg (b) and cd8a (c) mrna expression normalized to gapdh were determined by quantitative real-time pcr in lung tissue of gx þ / þ and gx à / à mice after h1n1pdm influenza infection. scale bar: 10 μm. a, po 0.05 gx þ / þ or gx à / à vs. base; b, p o 0.05 gx þ / þ vs. gx à / à at any time point, anova followed by paired t-test, two tailed, assuming unequal variance. nz 8 per group. all the mice used in these experiments were genotyped littermates and grouped and analyzed by their genotype. co 2 , after which cell culture supernatants were tested for the presence of virus by hemagglutination assay using 0.5% (v/v) turkey red blood cells (lampire biological laboratories, pipersville, pa, usa). viral loads were determined as the reciprocal of the dilution at which 50% of wells were positive for viral infection. viral loads were reported as tcid 50 per gram of lung tissue. limit of detection of 10 1 tcid 50 /g. lung tissues from both gx à / à and gx þ / þ mice were collected at 3 and 6 days post infection (pi) and from uninfected controls (four mice per group). rna was purified from lung tissue using tripure (roche, indianapolis, in, usa). purified rna was then reverse transcribed using improm-ii reverse transcription system (promega, madison, wi, usa). real time rt-pcr was performed using the abi-prism 7900ht sequence detection systems (applied biosystems, foster city, ca, usa). data was collected with applied biosystems sequence detection systems version 2.3 software. each reaction well contained 4 μl of 0.625 ng/μl cdna, 0.5 μl each of forward and reverse primers (final concentration of 200 nm), and 5 μl sybr green master mix, for a total reaction volume of 10 μl and run in quadruplicate. host gene expression was normalized to the glyceraldehyde-3-phosphate dehydrogenase (gapdh) housekeeping gene, and quantified by relative standard curve method. viral load was quantified by the absolute standard curve method, normalized to gapdh housekeeping. primer sequences are listed in table s1 . histology, immunohistochemistry, immunofluorescence and immunoblotting gx þ / þ and gx à / à mice were euthanized at baseline, day 3, day 6 and day 14 pi (n 45 mice) and the mouse whole body was vascular perfused by cardiac puncture in situ with a fixative solution of 10% buffered formalin by a continuous release pump under pressure and volume-controlled conditions. fixed lung tissues were paraffin wax embedded for histology and immunohistochemistry. for h&e, tissue slides were then stained with hematoxylin-eosin for histopathology assessment. rabbit antimurine gx-spla 2 (degousee et al., 2008) was used to assess the tissue distribution of the gx-spla 2 protein. sections were counterstained with hematoxylin and eosin and observed under light microscope (accu-scope s , commack, ny, usa). images were captured using a digital camera and se premium software (micrometrics tm , londonderry, nh, usa) . for mac-3 tissue expression, rat anti-mouse mac-3 was used (bd biosciences, mississauga, on). for cd3 immunofluorescence, following heat-induced antigen retrieval, lung tissue sections were blocked with donkey serum and stained with primary antibodies rabbit anti-cd3 (dako, burlington, on). donkey anti-rabbit cy3 was used as secondary antibodies (millipore, billerica, ma) and dapi (sigma) for nuclear counterstain. images were recorded with an olympus fluo view 1000 confocal laser scanning microscope (olympus, tokoyo, japan). immunoblots for gx-spla 2 were carried out as described by our group (degousee et al., 2008) . for immunoblotting detection antibodies against mpo (upstate, lake placid), cd45 (bd biosciences, mississauga, on), and gapdh (santa cruz biotechnology, dallas, tx). lungs were lavaged at 0 and 6 days post h1n1 infection with 5 ml of normal saline. the bal fluid was centrifuged at 250g for 10 min and the supernatant was used for estimation of pgd 2 , pge 2 , ltb 4 , cysteinyl leukotriens and lipoxin a 4 content. analysis of pgd 2 in bal fluid 0.5 ml of bal fluid was mixed with 0.5 ml of ice-cold acetone, incubated on ice for 5 min and centrifuged for 10 min at 3000g at 4 1c. after supernatant aspiration, the pellet was extracted with 1 ml of ice-cold acetone and centrifuged again. the acetone extracts were combined and the acetone evaporated under nitrogen. all the samples were then methoximated (pgd 2 -mox eia kit (cayman chemical), and purified on oasis hlb columns (waters corporation) equilibrated with methanol/0.2% formic acid. methanol eluants were evaporated in a savant speed vac concentrator and samples dissolved in cayman eia buffer before eia analysis, according to the manufacturer's instructions. analysis of pge 2 , ltb 4 and cysteinyl leukotriens in bal fluid 1.2 ml of bal fluid was mixed with 2.4 ml of methanol containing 0.2% formic acid, incubated on ice for 5 min and centrifuged at 3000g for 10 min at 4 1c. after adjustment of methanol to 15%, supernatants were loaded on oasis hlb column equilibrated with methanol/0.2% formic acid (waters corporation). columns were processed in a vacuum manifold (waters corporation). after wash with water/0.03% formic acid, the samples were eluted with methanol/0.2% formic acid, methanol eluants were evaporated in a savant speed vac concentrator and samples dissolved in cayman eia buffer before eia analysis for pge 2 , ltb 4 and cysteinyl leukotrienes (eia kits, cayman chemical) according to the manufacturer's instructions. 0.6 ml of bal fluid was extracted with 1.2 ml of ice-cold methanol, incubated on ice for 5 min and centrifuged at 3000g for 10 min at 4 1c. the supernatants were diluted with water to achieve 11% methanol concentration and adjusted to ph 3.5 with 1n hcl. samples were purified on c18 sep-pak columns (waters corporation) preconditioned with methanol. after column wash with water followed by hexane, samples were eluted with methyl formate. the eluants were evaporated under nitrogen and the samples reconstituted in eia buffer and assayed for lipoxin a 4 content (neogen corporation) according to the manufacturer's protocol. lung tissues from both gx à / à and gx þ / þ mice were collected at 3 and 6 days pi and from uninfected controls (four mice per group) as with the real time rt-pcr. rna was purified from lung tissue using tripure (roche, indianapolis, in, usa) and amplified with illumina totalprep rna amplification kit (ambion, austin, tx, usa). 1.5 mg of crna was labeled and hybridized to mouse wg-6 v2.0 expression beadchip (illumina, san diego, ca, usa) and scanned on illumina beadstation 500gx. raw data was processed with illumina genomestudio v2010.3 software. the data sets were subjected to quantile normalization, variance stabilization and log 2 transformation. genes were considered significantly regulated if the expression levels with respect to the uninfected controls were z1.5fold different and the student t-test's p value was o0.05. david bioinformatics resource v6.7 (http://david.abcc.ncifcrf.gov/home.jsp) (hicks et al., 2007) was used to perform functional classification of differentially expressed genes. additionally, interferon regulated genes were selected by using the interferome (v2) database (http://interfer ome.its.monash.edu.au/interferome/home.jspx) (rubin et al., 2005) . immunoglobulin chains and prostaglandin-related gene categories were defined by searching for relevant keywords in the annotated microarray datasets. multiexperiment viewer v4.7.2 (http://www.tm4. org/mev/) was used to perform complete hierarchical clustering and generate heatmap representations of selected genes. data are presented as mean 7sem. analyses of data recorded at one time point were performed by 2-tailed, unpaired, student t-tests. analyses of data recorded at several time points for two groups (gx þ / þ and gx à / à mice) were performed by 2-way anova (to evaluate the effect of group, time and group-time interactions); if significant, a bonferroni correction for multiple comparisons was applied for post-hoc analysis between different time points or between different groups at the same time point. survival after h1n1pdm influenza infection was assessed by a logrank test. a value of p o0.05 was accepted as statistically significant. the authors had full access to and take full responsibility for the integrity of the data. all authors have read and agree to the manuscript as written. prostaglandin d(2) and t(h)2 inflammation in the pathogenesis of bronchial asthma influenza -time to target the host? th1 and th17 hypercytokinemia as early host response signature in severe pandemic influenza host adaptive immunity deficiency in severe pandemic influenza corticosteroid suppression of lipoxin a4 and leukotriene b4 from alveolar macrophages in severe asthma 12 gene expression analysis of host innate immune responses during lethal h5n1 infection in ferrets interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome lack of innate interferon responses during sars coronavirus infection in a vaccination and reinfection ferret model2 leukotriene b42 macrophage secretory phospholipase a 2 group x enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology ex vivo effect of varespladib on secretory phospholipase a 2 alveolar activity in infants with ards p38 mapk regulates group iia phospholipase a 2 expression in interleukin-1b stimulated rat neonatal cardiomyocytes groups iv, v, and x phospholipases a 2 s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis map kinase kinase 6-p38 map kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo c-jun n-terminal kinase-mediated stabilization of microsomal prostaglandin e 2 synthase-1 mrna regulates delayed microsomal prostaglandin e 2 synthase-1 expression and prostaglandin e 2 biosynthesis by cardiomyocytes microsomal prostaglandin e2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction regulation of dendritic cell migration and adaptive immune response by leukotriene b4 receptors: a role for ltb4 in up-regulation of ccr7 expression and function1 diversity of group types, regulation, and function of phospholipase a 2 fatal outcome of human influenza a (h5n1) is associated with high viral load and hypercytokinemia group x phospholipase a 2 is released during sperm acrosome reaction and controls fertility outcome in mice seasonal h1n1 infection induces cross protective pandemic h1n1 immunity through a cd8 independent, b cell dependent mechanism synergy between extracellular group iia phospholipase a 2 and phagocyte nadph oxidase in digestion of phospholipids of staphylococcus aureus ingested by human neutrophils altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase a 2 human infection with a novel avian-origin influenza a (h7n9) virus leukotriene b4-mediated release of antimicrobial peptides against cytomegalovirus is blt1 dependent leukotriene b4 induces release of antimicrobial peptides in lungs of virally infected mice low molecular weight phospholipases a 2 in mammalian brain and neural cells: roles in functions and dysfunctions4 cxcr3 ligands: redundant, collaborative and antagonistic functions4 h7n9 incident, immune status, the elderly and a warning of an influenza pandemic the arachidonate-activable, nadph oxidase-associated h þ channel. evidence that gp91-phox functions as an essential part of the channel importance of group x-secreted phospholipase a 2 in allergen-induced airway inflammation and remodeling in a mouse asthma model blockade of human group x secreted phospholipase a 2 (gx-spla 2 )-induced airway inflammation and hyperresponsiveness in a mouse asthma model by a selective gx-spla 2 inhibitor leukotriene b4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developments comparative analyses of pandemic h1n1 and seasonal h1n1, h3n2, and influenza b infections depict distinct clinical pictures in ferrets differential pathological and immune responses in newly weaned ferrets are associated with mild clinical outcome of pandemic 2009 h1n1 infection1 systematic and integrative analysis of large gene lists using david bioinformatics resources atherogenic properties of ldl particles modified by human group x secreted phospholipase a 2 on human endothelial cell function a natural disruption of the secretory group ii phospholipase a 2 gene in inbred mouse strains lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase a 2 diverse functional coupling of prostanoid biosynthetic enzymes in various cell types sequencing, annotation and characterization of the influenza ferret infectome1 disruption of jnk2 decreases the cytokine response to plasmodium falciparum glycosylphosphatidylinositol in vitro and confers protection in a cerebral malaria model involvement of cytosolic phospholipase a 2 and secretory phospholipase a 2 in arachidonic acid release from human neutrophils expression of secretory phospholipase a 2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lungderived cells prostaglandin d2 as a mediator of allergic asthma5 acetylsalicylic acid (asa) blocks influenza virus propagation via its nf-kappab-inhibiting activity group v and x secretory phospholipase a 2 prevents adenoviral infection in mammalian cells the lipid mediator protectin d1 inhibits influenza virus replication and improves severe influenza different functional aspects of the group ii subfamily (types iia and v) and type x secretory phospholipase a(2)s in regulating arachidonic acid release and prostaglandin generation. implications of cyclooxygenase-2 induction and phospholipid scramblase-mediated cellular membrane perturbation57 recent progress in phospholipase a(2) research: from cells to animals to humans pge(2) transiently enhances dc expression of ccr7 but inhibits the ability of dcs to produce ccl19 and attract naive t cells11 lymphotoxin alpha(1) beta (2) expression on b cells is required for follicular dendritic cell activation during the germinal center response1 prostaglandin e2 enhances th17 responses via modulation of il-17 and ifn-gamma production by memory cd4þ t cells3 transgenic expression of group v, but not group x, secreted phospholipase a 2 in mice leads to neonatal lethality because of lung dysfunction interleukin-6 is a potential biomarker for severe pandemic h1n1 influenza a infection2 pandemic h1n1 influenza a directly induces a robust and acute inflammatory gene signature in primary human bronchial epithelial cells downstream of membrane fusion in vivo ribavirin activity against severe pandemic h1n1 influenza a/mexico/4108/2009 modeling host responses in ferrets during a/california/07/2009 influenza infection cytosolic phospholipase a 2 -a is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cpla 2 -a does not regulate neutrophil nadph oxidase activity interferome v2.0: an updated database of annotated interferon-regulated genes1 lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation2 cxcl13/cxcr5 signaling enhances bcr-triggered b-cell activation by shaping cell dynamics1 mast cell stabilization improves cardiac contractile function following hemorrhagic shock and resuscitation influenza vaccines: the good, the bad, and the eggs group x secretory phospholipase a 2 enhances tlr4 signaling in macrophages1 increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ards or at risk for ards prostaglandin i(2) analogues enhance already exuberant th17 cell responses in systemic sclerosis3 update: influenza activity -united states, 2009-10 season inflammation-restraining effects of prostaglandin e2 on natural killer-dendritic cell (nk-dc) interaction are imprinted during dc maturation1 ltb4 increases nasal neutrophil activity and conditions neutrophils to exert antiviral effects2 global influenza programme. (ref type: online source) innate immunity and pulmonary host defense age-related increases in pgd (2) expression impair respiratory dc migration, resulting in diminished t cell responses upon respiratory virus infection in mice1 supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.virol.2014.01.030. key: cord-326223-q6e60nf8 authors: gembardt, florian; sterner-kock, anja; imboden, hans; spalteholz, matthias; reibitz, franziska; schultheiss, heinz-peter; siems, wolf-eberhard; walther, thomas title: organ-specific distribution of ace2 mrna and correlating peptidase activity in rodents date: 2005-02-16 journal: peptides doi: 10.1016/j.peptides.2005.01.009 sha: doc_id: 326223 cord_uid: q6e60nf8 biochemical analysis revealed that angiotensin-converting enzyme related carboxy-peptidase (ace2) cleaves angiotensin (ang) ii to ang-(1–7), a heptapeptide identified as an endogenous ligand for the g protein-coupled receptor mas. no data are currently available that systematically describe ace2 distribution and activity in rodents. therefore, we analyzed the ace2 expression in different tissues of mice and rats on mrna (rnase protection assay) and protein levels (immunohistochemistry, ace2 activity, western blot). although ace2 mrna in both investigated species showed the highest expression in the ileum, the mouse organ exceeded rat ace2, as also demonstrated in the kidney and colon. corresponding to mrna, ace2 activity was highest in the ileum and mouse kidney but weak in the rat kidney, which was also confirmed by immunohistochemistry. contrary to mrna, we found weak activity in the lung of both species. our data demonstrate a tissueand species-specific pattern for ace2 under physiological conditions. in the regulation of heart function and blood pressure, different peptide systems are involved, e.g. the renin-angiotensin system (ras), the kallikrein-kinin system, and the natriuretic peptide system. in these systems, proteases like angiotensin-converting enzyme (ace) or neutral endopeptidase (nep) have the distinction of generating or catabolizing biologically active peptides [10, 39, 42] . the newly discovered angiotensin-converting enzyme-related carboxypeptidase (ace2) has considerable sequence homology to ace (40% identity and 61% similarity), contains a hexxh zinc-binding domain, and conserves other critical residues typical of the ace family [12, 37] . the first step in generating angiotensin peptides is the cleavage of angiotensinogen to angiotensin (ang) i by renin. ang i is hydrolyzed by either ace or chymase to ang ii, which mediates its biological actions via the at1 and at2 receptors [15, 21] . ang i is also metabolized by nep to ang-(1-7) [15] , which mediates distinct effects through its receptor mas [35] . importantly, ang-(1-7) can also be directly metabolized from ang ii by ace2, whereas aminopeptidase a converts ang ii to ang iii [18] . ace2 also hydrolyzes ang i to ang-(1-9), although there is no hydrolysis of ang-(1-9), ang-(1-7), and ang(1) (2) (3) (4) (5) . moreover, ace2 hydrolysis is also specific for des-arg [9] bradykinin and its shorter fragments, although it cleaves neither bradykinin nor bradykinin-(1-7) [40] . ace2 mrna is expressed in many tissues but shows a less ubiquitous profile than ace. first studies in mice detected the highest expression in the ileum by quantitative reverse transcriptase polymerase chain reaction (qrt-pcr) [23] . ace2 is an important part of the ras, which counteracts the function of ace. it was also shown that ace2 expression can be upregulated by blockade of at 1 -receptors [27] . the importance of ace2 in cardiovascular regulation was confirmed by targeted disruption of ace2 in mice. the absence of ace2 in mice leads to a severe cardiac contractility defect, increased ang ii levels, and upregulation of hypoxia-induced genes in the heart [11] . in addition to its peptidolytic function, recent investigations have discovered that ace2 is a functional receptor for the coronavirus, which causes the severe acute respiratory syndrome (sars) [30] . in this investigation, we (i) measured the mrna distribution of ace2 through different tissues in both species. moreover, we (ii) quantified ace2 protein by western blot using a commercial polyclonal antibody to ace2. we (iii) measured ace2 activity in different tissues of mice and rats. we (iv) established a monoclonal antibody against ace2 to complete the investigation of tissue distribution by immunohistochemistry. finally, we compared (v) the distribution of ace2 in both species on the mrna and protein level. all experiments were done according to the guidelines of the federal law on the use of experimental animals in germany and were approved by the local authorities. for this investigation we used c57bl/6 mice and sprague-dawley (sd) rats in an age of 3-5 months. animals were killed by cervical dislocation. for rnase protection assay (rpa), ace2 activity assay and western blot, the tissues were snap frozen in liquid nitrogen. the samples were stored at −80 • c until further processing (all organs in total, heart divided into atria and ventricles). the tissues for immunohistochemistry were put in 4% formalin. after 24 h they were embedded and processed to paraffin sections. the polymerase chain reaction (pcr) amplified a 358 bp fragment (probe: mmace2) from mouse kidney cdna using the 5 -primer ctc agt gga tgg gat ctt gg (mmace25) and the 3 -primer tgt agc cat ctg ctc cct ct (mmace23), respectively a 342 bp fragment (probe: rnace2) from rat lung cdna using the 5 -primer cgg gga aag atg tca agc tcc tgc (rnace25) and the 3 -primer ctt gtc tgg tga cag cgc (rnace23), which were subcloned in a t-vector (promega gmbh, mannheim, germany). a sp6 polymerase transcribed a radioactive probe complementary to mmace2 (resp. rnace2) mrna, and a rna complementary to 127 nucleotides of the rl32 mrna was used as positive control [2] . ace2-specific mrna for mouse and rat were identified by rnase protection assay (rpa) using the ambion rpa ii kit (ambion (europe) ltd., huntingdon, uk). total rna was isolated from tissues using the trizol reagent (invitrogen gmbh, karlsruhe, germany) with subsequent chloroform-isopropanol extraction according to the manufacturer's instructions. a 15 g total rna fraction of each sample was hybridized with approximately 50 000 cpm for ace2 and 50 000 cpm for rl32 of the radiolabeled antisense probes in the same assay. equal loading has been insured by mrna measurements and mrna gel electrophoresis using 1 g of each sample (not shown). the hybridized fragments protected from rnase a + t1 digestion were separated by electrophoresis on a denaturing gel (5%, w/v polyacrylamide, 8 m urea) and analyzed using a fujix bas 2000 phospho-imager system (raytest gmbh, straubenhardt, germany) to perform quantitative analysis by measuring the intensity of the ace2 bands. the blots of each species were calculated to ace2 mrna expression in kidney, which was present on both blots of each species. the expression level in the lung was set to 100%. ace2 activity was measured similar to the method by vickers et al. [40] . tissue was homogenized in assay buffer (50 mm 2-morpholinoethanesulfonic acid, 300 mm nacl, 10 m zncl 2 , 0.01% brij-35, ph 6.5). protein concentration was determined using roti-quant (carl roth gmbh and co. kg, karlsruhe, germany) by the manufacturers instruction. we used mca-apk(dnp) (biosynthan gmbh, berlin, germany) dissolved in dmso (50 m, final concentration) as the ace2 substrate. the assay was performed in assay buffer and was started by adding 10 l of tissue homogenate. after 2 h incubation at ambient temperature (24 • c), the reaction was suppressed by adding 100 m o-phenanthrolin (final concentration). parallel control tests were performed in the presence of 1 m dx 600 (data not shown) [25] . after centrifugation (10 min, 10 000 × g) the fluorescence was measured at 320 nm (excitation) and 405 nm (emission) with the perkin-elmer fluorescence reader lambda 5 (perkin-elmer las gmbh, rodgau, germany). the molecular standardization was performed with mca-ap (biosynthan gmbh, berlin, germany) and calculated per mg protein. the functionality of the assay was proven by a standardized solution with defined, recombinant ace2 activity (r&d systems gmbh, wiesbaden, germany). tissue was homogenized in phosphate-buffered solution (pbs) containing protease inhibitor mixture (complete, roche diagnostics gmbh, mannheim, germany). protein concentration was determined with bca protein assay kit (perbio science gmbh, bonn, germany). sample proteins (10 g/lane) and a prestained protein-weight marker (amersham biosciences gmbh, freiburg, germany) were size fractionated by sds-polyacrylamide gels (10%) and transferred to pvdf membranes with a pegasus semidry-blotter (phase gmbh, lübeck, germany). equal loading has been insured by staining control gels with simply-blue safe stain (invitrogen gmbh, karlsruhe, germany) using 10 g of each sample (not shown). the membranes were blocked at room temperature in 5% dry milk powder (blotting grade, non-fat dry milk, bio-rad laboratories gmbh, munich, germany) prepared with tris-buffered saline containing 0.1% tween 20 (ttbs) for 1 h, incubated with goat polyclonal antibody against ace2 (santa cruz biotechnology inc., heidelberg, germany, 1:250 diluted in 5% dry milk powder ttbs, 1 h), and then washed three times with ttbs (15 min each). subsequently, the membranes were incubated with horseradish peroxidase-conjugated antigoat igg (dakocytomation a/s, glostrup, denmark, 1:1000, 1 h) and washed three times. specific immunoreactive proteins were detected by enhanced chemiluminescence (amersham biosciences gmbh, freiburg, germany). the bands on the x-ray film were quantified by densitometry scanning and expressed as percentage of the kidney protein signal. monoclonal antibodies against the synthetic peptide avgeimslsaat (aa 403-414 of murine ace2) have been raised. for immunization of the mice peptide was cross-linked with glutaraldehyde to albumin fraction v from bovine serum. balb/cj female mice were injected with the conjugate. following four booster injections the spleen lymphocytes were fused with fo myeloma cells by using polyethylene glycol 1500 (roche diagnostics gmbh, mannheim, germany) following the manufacturers instructions. the different hybridoma supernatants were screened for specific antibodies by using the synthetic peptide in the nctest [26] . for production of monoclonal antibodies, positive hybridoma cells were grown in celline incubators (integra biosciences gmbh, fernwald, germany). the mouse monoclonal antibodies were affinity purified on a mabtrap g ii column (amersham-pharmacia gmbh, otelfingen, switzerland) from cell culture supernatants. immunoglobulin class and subclasses were determined with the immuno type kit (sigma-aldrich chemie gmbh, taufkirchen, germany). paraffin sections of mouse tissues were prepared and stained using standard histology procedures. for immunostainings, deparaffinized and rehydrated tissue slides were first treated for 30 min with 30% h 2 o 2 to block the endogenous peroxidase. after rinsing in ddh 2 o and soaking in pbs for 5-10 min, slides were treated with 10% (w/v) bsa in pbs to eliminate non-specific protein binding sites. the slides were then exposed (overnight, 4 • c) to the monoclonal ace 2 antibodies (clone 7e7, 1d3) at concentrations of 1 and 4 g/ml, respectively. after removing excess antibody, slides were treated with biotin-labeled anti-mouse (dianova gmbh, hamburg, germany) antibody for 30 min at 37 • c and finally with horse-radish peroxidase (hrp) labeled streptavidine (zymed laboratories inc., san francisco, usa) for 20 min at 37 • c. after washing, slides were incubated in aminoethylcarbazol (sigma-aldrich co., st. louis, usa) for 10 min at room temperature. slides were counterstained with hematoxylin, and cover slipped according to conventional procedures. slides were examined under a conventional microscope after removing the excess substrate in ddh 2 o. negative controls were performed without the primary antibody, just applying dilution buffer of the primary antibody. data were analyzed by t-test using spss11 software (spss benelux bv, gorinchem, the netherlands). each value was expressed as the mean ± s.e.m., and statistical significance was accepted for p < 0.05. ace2 mrna could be detected in all investigated organs, but with profound distinction between different organs. in both species, only a low amount was found in ventricle, liver, testis, forebrain, and spleen ( figs. 1 and 2) , whereas in the lungs a moderate and comparable expression of ace2 mrna was found and set to 100%. the highest levels were found in the ileum of both species (fig. 3) . between the species several differences in tissue specific expression of ace2 mrna were found. the expression in mouse was most pronounced higher than in rat in kidney (∼31.9-fold), colon (∼18.6-fold), and ileum (∼12.0-fold) (fig. 3) , whereas in bladder (∼2.5-fold) and ventricle (∼2.1-fold) ace2 expression in rat exceeded the mouse. in accordance with the rna expression data, highest activity for ace2 was found in the ileum of mouse and rat (table 1) , whereas the activity in the mouse was 3.2fold higher. lowest ace2 activity was found for both species in spleen. low activity was also found for liver of mice and thymus of rats. corresponding to the differences on mrna levels in the kidney the ace2 activity fig. 3 . quantification of the rpas of mice (white columns) and rats (black columns). the mrna amount of the lungs is set to 100% (n ≤ 4) . the values are shown as mean + s.e.m. 1. ventricle, 2. kidney, 3. lung, 4. liver, 5. testis, 6. bladder, 7. forebrain, 8. spleen, 9. thymus, 10. stomach, 11. ileum, 12. colon, 13. brainstem, 14. atrium, 15. adipose tissue. * p < 0.05, ** p < 0.01, *** p < 0.0001 compared mouse vs. rat. was much higher in mice than in rats (∼13.9-fold). the activity of ace2 in the lung was different to mrna and 2.6-fold higher in rats than in mice. in contrast to rpa data the activity in colon was comparable between both species. using a commercial polyclonal antibody in western blot for the quantification of protein levels in mouse and rat tissues (fig. 4) a pattern completely different from rna expression and ace2 activity was found. a moderate and comparable expression could be detected in the kidney of both species and was set to 100%. thus, the highest amount of protein could be detected in atrium of both species (mouse: 124.5%; rat: 131.5%) and ventricle (mouse: 131.7%; rat: 143.3%). for the mouse less ace2 protein was found in lung (19.7%) and testis (28.7%), whereas no protein was detectable in these two tissues in rat. in thymus (mouse: 44.4%; rat: 50.6%) and forebrain (mouse: 87.9%; rat: 80.7%) of both species a moderate expression was detectable, whereas no ace2 protein was found in spleen of mouse and rat. to further clarify the discrepancy between rpa and activity on one side and western blot on the other, immunohistochemistry was performed in lung, kidney (fig. 5) , and testis (data not shown) of mice and rat with new monoclonal ace2 antibodies (clones 7e7 and 1d3), we generated. the antibodies were determined to belong to the igg1 subclass. in the lungs of both species alveolar macrophages and type 2 cells (fig. 5 , upper row) were stained with both monoclonal ace2 antibodies (data for clone 1d3 not shown). the epithelium of the renal tubuli was strongly stained (fig. 5 , lower row, left) in the kidney of mice. in rats only a weak signal, but the same pattern as in mouse, was detected, what aligned with mrna and ace2 activity (fig. 5, lower row, right) . in recent investigations it was shown that peptidases like ace and nep are important regulators of cardiovascular and endothelial function as well as myocardial remodelling [1, 7, 36, 41] . consequently, after its discovery in 2000, ace2 became an enzyme of interest for scientific investigation of its impact in cardiovascular physiology and pathophysiology [11, 12, 37] . to elucidate some of its physiological functions we investigated the tissue distribution of mrna and protein in a variety of tissues of c57bl/6 mice and sprague-dawley rats. while we could see correlating patterns of mrna and ace2 activity in most of the examined tissues, we also found significant divergences between the investigated species. the huge difference between mrna and protein levels in the lung may be due to shedding as demonstrated for ace [4, 12, 32] . this shedding leads to an increased secretion of ace2 and lowered its protein content in the lung by even high mrna expression. the significant differences that we found between the species on ace2 protein and mrna levels in kidney could be explained by the varying interspecies regulation and expression of peptidases, as shown in the literature for nep activity in rat and rabbit kidneys [14] . comparing our mrna and activity data with the western blot pattern, we have to conclude that the commercial polyclonal antibody is not detecting ace2 protein in organ homogenates and is not suitable for ace2 staining. in contrast, using immunohistochemistry our new monoclonal ace2 antibodies produce staining patterns comparable to our mrna and activity data. we have shown that ace2 expression in rodents is highest in ileum among the examined organs. it was shown for other peptidases of ras like ace and nep that they are also present at high levels in the intestine [29] . however, the distinct function of these peptidases in the ileum is not yet known. further investigations have to clarify the physiological and pathophysiological functions of the peptidases in the gastrointestinal tract. beside its physiological function as a peptidase, ace2 is used by coronavirus as a co-receptor in severe acute respiratory syndrome (sars) [30] . it was shown that the sars coronavirus only can enter cells which express ace2 [24] . ace2 distribution in the small intestine, lung and vascular endothelium may offer a point of entry for the sars coronavirus, but does not reflect its basic function [22, 30, 38] . interestingly, the distribution patterns we found for mrna and ace2 activity contradict investigations using a commercial northern blot for detecting mrna [12, 37] but have been confirmed by recent papers using rt-pcr [23] . this discrepancy may be a species-specific alteration of tissue distribution, since they used human tissue for northern blot, or it may be due to technique differences (commercial northern versus rpa and activity assay). the first possibility is at least supported by our finding that significant differences in ace2 expression patterns exist between the close relatives mouse and rat. recent investigations revealed biological activity for angiotensin peptides other than angii, like ang-(1-7) [16, 33, 34] . ace2 can generate ang-(1-7) by cleaving the cterminal amino acid from angii [40] . ace2 is also involved in another pathway leading to the generation of ang-(1-7). it cleaves angi to ang-(1-9) [12] . ang-(1-9) is then hydrolyzed by ace to ang-(1-7) . we demonstrated that ang-(1-7) is an endogenous ligand for the g protein-coupled receptor (gpcr) mas [35] . mrna of the gpcr mas was found at high levels in testis and certain brain regions and at fig. 5 . immunohistochemical visualization of ace2 positive cells. sections of lungs (upper row) and kidneys (lower row) from mouse (left panel) and rat (right panel). in the lungs of both species alveolar macrophages and type 2 cells were stained positive. the tubulus epithelium in mouse kidney was stained positive, whereas in the rat kidney only weak staining was seen. moderate levels in kidney and heart [2, 3, 31] . it was shown that high concentrations of ang-(1-7) were present in heart, kidney, and brain [5, 6, 8, 28] . in recent investigations, it was demonstrated that ace2, mas, and its endogenous ligand ang-(1-7) are present in the same cells of the kidney [9] . as we recently postulated, this indicates a relevant impact of the ace2/ang-(1-7)/mas axis on blood pressure regulation and cardioprotection. actual investigations indicate an upregulation of ace2 in heart failure, pointing to the relevance of ace2 in cardiac function [20, 32, 43] . however, there was a high incidence of sudden death in animals overexpressing ace2. electrophysiology revealed severe, progressive conduction and rhythm disturbances with sustained ventricular tachycardia that progressed to fibrillation and death [13] . while anti-arrhythmic actions were demonstrated for ang-(1-7) in low concentra-tions (0.22 nm) by stimulating its own receptor, 100-fold higher concentrations of ang-(1-7) lead to arrhythmias by stimulating the at1 receptor [17, 19] . therefore, the overexpression of ace2 may lead to a high increase in the production of ang-(1-7), turning its cardioprotective actions into effects causing arrhythmias by unspecific at1 stimulation. in future studies, the actions of ang-(1-7) and its concentrationdependency on ace2 expression on heart rhythm have to be proven in in vivo experiments with at1-and mas-deficient animals. our data on tissue and species-specific ace2 expression point to the fact that the ras becomes increasingly complex. since we identified an expression pattern markedly different from ace, we conclude that the expression levels of the involved peptidases like ace, ace2, and nep that generate and/or degrade the bioactive peptides of the ras are predic-tive of either the occurrence of vasoconstriction or dilatation or the dominance of pathophysiological stimuli over beneficial conditions. the acute infarction ramipril efficacy (aire) study investigators, effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure imprinting of the murine mas protooncogene is restricted to its antisense rna cell type-specific expression of the mas proto-oncogene in testis a point mutation in the juxtamembrane stalk of human angiotensin i-converting enzyme invokes the action of a distinct secretase cardiac angiotensin-(1-7) in ischemic cardiomyopathy immunocytochemical localization of angiotensin-(1-7) in the rat forebrain vasopeptidase inhibitors: an emerging class of cardiovascular drugs enhanced renal immunocytochemical expression of ang-(1-7) and ace2 during pregnancy novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ace2 and blood pressure regulation vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? angiotensin-converting enzyme 2 is an essential regulator of heart function a novel angiotensin-converting enzyme-related carboxypeptidase (ace2) converts angiotensin i to angiotensin 1-9 heart block, ventricular tachycardia, and sudden death in ace2 transgenic mice with downregulated connexins distribution of neutral endopeptidase activity along the rat and rabbit nephron novel angiotensin peptides counterregulatory actions of angiotensin-(1-7) angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion brain renin-angiotensin system blockade by systemically active aminopeptidase a inhibitors: a potential treatment of salt-dependent hypertension effects of angiotensin ii and angiotensin-(1-7) on the release of [3h]norepinephrine from rat atria ace2 gene expression is up-regulated in the human failing heart insights into angiotensin ii receptor function through at2 receptor knockout mice tissue distribution of ace2 protein, the functional receptor for sars coronavirus. a first step in understanding sars pathogenesis quantitative mrna expression profiling of ace 2, a novel homologue of angiotensin converting enzyme susceptibility to sars coronavirus s protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor novel peptide inhibitors of angiotensin-converting enzyme 2 immunocytochemistry in brain tissue upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin ii receptors angiotensin-(1-7) immunoreactivity in the hypothalamus of the (mren-2d)27 transgenic rat burrell lm. differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the rat angiotensin-converting enzyme 2 is a functional receptor for the sars coronavirus expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues the role of ace2 in cardiovascular physiology vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles angiotensin-(1-7): an update angiotensin-(1-7) is an endogenous ligand for the g protein-coupled receptor mas remodeling of myocardium and arteries by chronic angiotensin converting enzyme inhibition in hypertensive patients a human homolog of angiotensin-converting enzyme. cloning and functional expression as a captopril-insensitive carboxypeptidase exploring the pathogenesis of severe acute respiratory syndrome (sars): the tissue distribution of the coronavirus (sars-cov) and its putative receptor, angiotensin-converting enzyme 2 (ace2) the angiotensin-converting enzyme gene family: genomics and pharmacology hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase at1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats vasopeptidase inhibitors: will they have a role in clinical practice? increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ace2 florian gembardt is paid by a grant from the "deutsche forschungsgemeinschaft" (german research foundation)[grk865]. this study was also supported by the "stiftung zur förderung der wissenschaftlichen forschung an der universität bern". we thank helmut würdemann and susanne gygax for their technical assistance. key: cord-333043-fe24ezt6 authors: traavik, t.; mehl, r.; kjeldsberg, elisabeth title: “runde“ virus, a coronavirus-like agent associated with seabirds and ticks date: 1977 journal: arch virol doi: 10.1007/bf01314476 sha: doc_id: 333043 cord_uid: fe24ezt6 from 206i. uriae collected in the seabird colonies at runde, norway, two identical virus strains demonstrating no antigenic relationships to major arbovirus groups were isolated. the new strains demonstrated a corona-virus like morphology, haemagglutinated chicken red cells and were sensitive to sodium desoxycholate. multiplication with cpe was demonstrated in bhk 21/c13 and bsc-1 cells, and without cpe in vero and gmk cell cultures. the mouse pathogenicity was relatively low. in gel precipitation three to five specific lines were seen. precipitating antibodies have been found in seabird species commonly infested byi. uriae. the ecological circumstances of the isolates indicate an earlier unrecognized arbovirus circulating between seabirds andi. uriae. this corona-like virus has been tentatively termed runde virus. in 1973 investigations were undertaken to evaluate the extent, distribution and ecological circumstances of arbovirus loci in norway. until then., no arbovirus isolates had been reported from this country, although ecological and cli-nicai/epidemiological considerations (3, 24, 26) and a limited serological survey on bovine sera (28) indicated the existence of central-european tick-borne encephalitis virus fool. the early phase of the project concerns the study of the importance of ticks as vectors; later, mosquito-borne agents will be investigated. in norway five ixodes species are abundant: _[. ricinus (23) , i. tria.nguticeps (24) , i. hexagonus (17) , i. tividus (16) and 1. uriae (15, 23) . the latter species is present at great numbers in the vast norwegian seabird colonies. its ability to attack man and mammms has been questionable, but this has been recently documented (18) . this paper describes studies with ixodes uriae as a possible vector. these studies were undertaken since: a) the tick is part of rather confined ecosystem which might be suitable for studies on virus-vector-host interrelationships. b) virus-transmission by this tick might have mainly zoonoticm but also some public health importance. c) reports of arbovirus isolates from seabird colonies have been presented earlier (9, 10, 12, 32, 33) . the seabird colonies at runde were chosen from a great number of possibilities due to relative ease of access, and because an unusually high and unexplainable chick mortality had recently been reported. from 206 i. uriae ticks collected at runde in late september 1973, three virus strains have been isolated. one of these isolates belongs to the uukuniemi group (30, 31) . the additional two strains are serologically closely related or identical. some characteristics and ecological circumstances of the latter viruses are reported in the present article. description o/ the biotope the island runde is situated at 62°25'n ' 5°38'e, approx. 30 kin from the city alesund (fig. 1) . the total area is about 6.4 km 2 and the circumference 20 kin. there are two small settlements on the island, l~unde in southeast and goksoyr in northeast : most of the island consists of an uneven mountain platea.u, and has altitudes varying between 100 and 330 metres above sea level. in the southwest part, the plateau is terminated by cliffs bordering the sea. most seabird colonies are situated in this area. approaching sea-level there is naked stone with niches and clefts inhabited mainly by rissa tridactyla, sula bassana, alca torda and uria aalge. further up towards the plateau there are rockfalls covered by thin layers of soil supporting various gramnivor plants. these parts are inhabited by the common puffin (fratercula arctica). we visited the island between september 25--27, 1973 , and collected ixodes uriae in the puffin rockfalls. according to local ornithologists, the puffins had migrated south about 3 weeks earlier. we found the ticks under and between the rocks. signs of engorgement were never seen, and they seemed to have entered into diapause. most of the ticks were to varying degrees surrounded by desiccated skinflaps indicating that they had newly emerged to their present stage. some had not completed their development from nymph to adult, and were totally surrounded by nymph cutis. the ticks were kept on dram-vials with moist plaster of paris, and transported alive to the laboratory. we collected a totm of 257 i. uriae, 206 of which were processed for virus-isolation (table 1) . isolation procedures the ticks were divided according to stage and sex, pools of imagos consisting of 5 and nymph pools of 20 individuals. after rinsing in saline, the ticks were ground in a mortar in 0.4 per cent bovine albumin in pbs pi-i 7.4 (apbs) with mycostatin, streptomycin and penicillin. suspensions were clarified by centrifugation at 1500 × g and inoculated i.c. into baby mouse litters, born: nmri (spe), aged one to three days. suspensions not inoculated the same day as processed were kept at --70°c (l~evco ultrmow). mice were observed during 3 weeks for signs of illness. diseased mice were killed, brains removed aseptically and homogenated in apbs with antibiotics, centrifuged and passed into new baby mice. litters which remained healthy were killed after 3 weeks, brains processed and passed as described. two blind passages were performed routinely. calculations of 50 per cent end point, titers, lds0 baby mice (bmlda0) were performed according to ir,~d and mu~nci4 (20) , based on ten-fold titrations in mice. virus-multiplication has been tested in bhk21/c t3, itela bristol, bsc-1, rk-13 and vero celt lines and also in primary gmk cells. bi-ik21/c i3 cells were grown in the medium described by maephe~asos" and sto~e~ (it). all other cultures were grown in eagle's medium with 2 per cent inactivated calf serum. tubes were seeded with 105 cells in 1 ml medium. cultures were used when confluent monolayers were present. cells were washed with saline, virus was diluted ~enfold from 10 -1 to t0 -6 in the medium, a volume of 0.2 ml of each dilution was inoculated into three tubes and allowed to adsorb for 1 hour at room temperature before washing with saline and addition, of new medium, culture tubes were incubated for 8 days at 37 ° c and inspected daily for a cytopathie effect (cpe). after 8 days culture fluids were inoculated i.c. in baby mice litters, 0.0t ml per mouse. cell controls were treated in parallel. bhk21/e 13 cultures in roux bottles were established by seeding 6 × 10a cells/ml. efforts to plaque the isolates were performed in bitk 21/c 13 cells under carboxymethylcellulose overlay by a method recently described (22) . one to three hundred times concentration of cell culture fluids were performed by precipitation with polyethylene glycol (peg) 6000 and nac1 as described by mcs~arry and benzingee (14) . in some instances the precipitates were sonicated at 100w for 3 × 15 seconds in a branson b 12 sonifier, sensitivity to sodium-desoxycholate (si)c) was determined in baby mouse litters by the method of t~ei~a (25) . for haemagglutination (ha), immunoelectroosmophoresis (ieop) and closed hexagon immundiffusion (chi) experiments, the following antigen preparations have been employed : a) crude suckling mouse brain (smb) preparations: a 20 per cent infected suspension in apbs which has been centrifuged for 15 minutes at 10,000 rpm. b) sucrose-aceton (sa) extracted infected mouse brains: prepared according to c~ar~:e and casals (4), but omitting the final lyophilization step. c) cell culture antigens: culture fluids from infected bhk21/c13 roux bottle cultures were precipitated with 6 per cent peg 6000 (macrogolum, norsk medisinaldepot) and 2.2 per cent naci (14) . the 100--300 times concentrated virus-precipitates were sonieated. antibodies were produced in adult, white mice inoculated with infectious suckling mouse brain preparations. initially each mouse received a virus dose of approximately 2.5 x 104-5 bmld~0 in 0.25 ml brain suspension mixed thoroughly with 0.25 mi freund's complete adjuvant (difco). subsequently 3 weekly injections with approximately 5× 104-5 bmld~0 in 0.5 ml suspension were given. the last injection, identical to the initial one, was performed one week thereafter. another 7--8 days later paraeentesis and bleeding from the retro-orbital sinus were performed. arltibody preparations for tahyna virus were produced in the same way. a fowl antiserum to avian infectious bronchitis virus (aib) with a ni of 6.1, was kindly provided by the institute of veterinary medicine, oslo. reference mouse antibody preparations to tbe, tribec, eee, wee and uukuniemi (s 23) were supplied by the yale arbovirus research urlit. an ornithological expedition to tternyken, rost (approx. 67 ° 28°n, 12°e (fig. 1) , collected 19 seabird sera in early may 1975. the composition of this material is cited in table 6 . serological methods tiaemagglutination (ha) and haemagglutination inhibition (hai) tests were performed according to clarke and casals (4), modified for microtitration equipment (cooke eng. co.). ha activity was tested within the ph range 5.6--7.2 at 4 °, 22 ° and 37 ° c. erythrocytes from a variety of species have been investigated. these results will be reported separately, and all ha and hai titers in the present paper refer to the employment of 0.5 per cent chicken erythrocytes. (ieop) twelve ml gel was poured onto precoated 8 × 8 cm lantern slides. for antigen detection i per cent agarose (l'industr. biol. franc.) and for antibody detection a mixture of 0.6 per cent agarose and 0.4~ per cent difco baeto agar was used (29) . three rows of paired wells with 3 mm diameter were punched out. the well interdistance was 3 ram. in the i-lepascreen eleetrophoresis apparatus (spectra biologicals, oxnard, calif., 9303) 2 slides were run simultaneously for i--2 hours. in screenings, this allows testing of 58 unknown samples in one run. gel precipitation this was performed by a sensitive modification of the micro ouehterlony technique termed closed hexagon immunodiffusion (chi) (27) , and also with varying patterns on lantern slides. to obtain the maximum number and intensity of the precipitation lines, the antigens were applieated several times (2--5) during the 16 24 hours prior to antiserum application. due to the lower diffusion rate of antigens, an interval of 2--4 hours between the last antigen and the antiserum application was adopted. the first lines then could be seen 4--5 hours after antiserum application. the gels were incubated at room temperature overnight, and then several days at -~4 ° c before staining and final reading. ieop and chi gels were stained by 4 per cent tannic acid as previously described (8) . negative contrast eiv[ infected culture fluids from bgk21/cl3 cells grown in roux bottles were concentrated 300 times by peg6000/nac1 precipitation (14) , resuspended in borate saline pit 9 or pbs pti 7.4 and sonicated. then 0.3 ml suspension was diluted 1/10 in pbs and centrifuged for 1 hour in a sorvm1 rc 2-b with rotor 55--34 at 20,000 rpm. the pellet was suspended in a few drops of distilled water and negatively stained with 2 per cent phosphotungstie acid pi-i 7.0 or 0.5 per cent uranyloxalate pi-i 6.0. one drop virus-stain mixture was placed on a formvar-earbon coated grid and excess fluid was withdrawn with filterpaper. the grid was examined in a jem 100b electron miscroseope at a magnification of 50,000 ×. thin section em infected and control bhk 21/c 13 cultures were harvested 4 days p.i. by means of a rubber policeman. the ceils were fixed in 3 per cent glutaraldehyde for 1 hour at -~ 4 ° c, washed three times in eacodylate buffer, postfixed in 1 per cent osmiumtetroxyde for 1 hour at room temperature and centrifuged for 3 minutes at 2500 rpm. the cell pellet was resuspended in a few drops of caeodylate buffer and centrifuged in micro capillary tubes in a hematocrit eentrifuge for 3 minutes at 12,500 rpm. the pellets were removed from the capillary tubes, dehydrated in acetone and embedded in spurt by a rapid procedure (6) . ultrathin sections (silver) were cut on a u 2-reichert ultramierotome and doubly stained by saturated uranylacetate in 50 per cent ethanol and reynolds lead citrate (21) . electron microscopy was carried out in a jem 100b at a magnification of 50,000 ×. two pools, both processed from 5 unengorged female i. urine, termed e81 and e85 were inoculated into mouse litters 2 and 3 days old respectively. the mice seemed unaffected during the 3 weeks observation period. however, in the first passage (m1) the mice were moribund after 1.4 days for e81 and 13 days for e85. in the second passage (m2), incubation periods were reduced to i0 and 9 days respectively and in the subsequent passages to 5--7 days for both strains. the viruses were reisolated twice from the original tick pools during the following year. these results are summarized in table 2 . the original tick pools were diluted 1/10 in bhk-medimn and inoculated on five bhk21/c 13 tube cultures. the tubes were harvested after five days. no cpe was recorded. the culture fluids were incubated into three baby mouse litters each. the mice were moribund after 8--10 days. the viruses were shown to be serologically identical to the strains isolated in mice by hai, chi and ieop. the ru e8t tick pool was diluted 1/100 in bhk-medium, and three bhk cultures in roux bottles were infected. tile cultures were harvested after four days. infected culture fluid was inoculated i.c. into 5 baby mouse litters, which were paralysed at day 10 p.i. the rest of the culture fluids were concentrated 100 times by peg 6000/naci, and used as antigen. the isolates were shown to be serologiealty identical, and also identical to the mouse-passaged strains by hai, chi and ieop. a 20 per cent brain suspension from the third suckling mouse brain passage (m3) titered 105-s bmlds0/ml in 1 day old mice. the virus suspension was titrated in parallel in 7 and 1.4 days old mice. as shown in table 3, 1 week old mice were nearly as sensitive as the newborn, while there was a drop in infectivity of 1.2 logs and a prolongation of average survival time from 6.3 to 10.5 days for 2 week old mice. during production of antibody preparations it was demon-strafed that adult mice were refractary to intraperitoneally injections with both e81 and e85. in hela bristol and rk-13 cultures no signs of virus multiplication were detected during primary inoculation and 3 consecutive blind passages. no cpe was present, and culture media concentrated 1--300 times by peg 6000/nac1 precipitation did not affect 1--3 days old suckling mice. as mentioned before, virus multiplication but no cpe was recorded after infection of bhk 21/c13 cultures with the original tick pools. plaquing in bhk 21/e 13 cells was not successful by the method used. both i~unde es1 and e85 virus demonstrated a very marked sensitivity to treatment with sodiumdesoxycholate. the titers were reduced from 5.5 to 3.4 in the case of ru e81 and 5.8 to 3.6 in the case of l~u e36. l~unde virus produces antigens in suckling mouse brains as well as in bhk 21 l c 13. the antigens demonstrate specific reactions with mouse antisera and immune aseitie fluids in hai, chi and ieop. the antigenic preparations have been kept at, --20 ° c for 11 months without loss in reactivity, itaemagglutinating (ha) antigens can be produced ~om infected smb by the sa extraction method of cl~r~:e and casals (4), hut mso suspensions of crude infected smb and peg 6000/nac1 precipitated cell culture fluids contain haemagglutinating activity. the ability to agglutinate chicken erythrocytes is relatively independent of pit and temperature. the highest titers and most clearcut endpoints have however been attained by pit 6.4--6.8 at 4 ° c. in hai no serologic differences between rue81 and e85 could be demonstrated. the mouse antisera and immune ascitie fluids were inhibitory to 4i-ia units of antigen to dilutions of 1/80--640. normal mouse sera were not inhibitory, neither was a fowl antiserum to aib virus or antisera to tbe, tribec, eee, wee and tahyna. precipitating antigens, as revealed by chi and i e o p , also were present in the same preparations as cited above. i n citi 3 --5 specific lines have been noted (fig. 2) , while in i e o p double lines were seen. no antigenic difference between the two strains was detected. virus from mouse brains and cell culture demonstrated total i d e n t i t y b y these methods. no reaction was observed with a n antiserum aga, inst avian infectious bronchitis virus. the 19 seabird sera were screened by i e o p , and the specificity secured by chi. foul" out of 19 birds had precipitating antibodies to r u e 8 t . the composition of the material and the results are sho~nt in table 4 . negative contrast em a series of electron micrographs of negatively stained preparations are presented in figs. 3, 4. fig. 3 shows corona-virus-like structures in a preparation from l~u e 81 infected cell culture supernate. similar structures were never seen in uninfected controls. most of the particles have an approximate total diameter of 170 nm, but in other preparations particles with diameters varying from l l 0 to 220 n m have been seen. fig. 4 a demonstrates an intuct particle at a greater magnification. i t seems to contain an inner structure 80 nm in diameter. fig. 4 b and 4c demonstrate partly and completely disrupted particles with loss of knobs and release of inner helical material. staining with 0.5 per cent uranyloxalate (fig. 4d ) produces a sort of 3-dimensional picture of the virus-like particle. thin section em thin sections of r u es1 infected b h k 21/e13 cultures 4 days p.i., demonstrate virus-like particles in the cytoplasm and extraeellularly between broken and intact cells (fig. 5) . the particles have a diameter of 100--110 nm. some of them look empty, while others are penetrated by stain and expose inner structures. the particles seem to have a double outer membrane, but no knobs are visible by thin sections and positive staining. when the runde virus strairts were first isolated, it had to be kept in mind that they might originate from the staff handling the tick pools, or from the baby mice used for isolation. the reisolations from the original tick suspensions (table 2) , a~d the properties differing from known human, rodent and also avian eoronaviruses (2, 19) , could not entirely rule out these possibilities. but the fact that antibodies to the virus were demonstrated irt seabirds and the isolation of virus also in cell cultures seem to settle this question. circumstances of tickcollection strongly support that runde virus is an arbovirus in the ecological sense, and not a mechanical pick-up : 1. i t is highly unlike that a relatively labile virus should survive for 3 weeks in i. uriae without active multiplication. 2. the lack of engorgement or pregnancy of the female i. uriae, and the fact that they were in diapause and surrounded by desiccated skinlaps, strongly indicate that t~unde virus m a y have passed interstadially in the virus-carrying ticks. still, the final inclusion of t~unde virus amortg the arboviruses must await the demonstratiorl of true biological transmission by .i. uriae. although the morphology of gunde virus strikingly resembles that of the eoronavirus group, some characteristics of the virus differ considerably from 3* those of known coronaviruses. this holds true for the pathogenicity to mice (2, 13) , the ability to grow in cell cultures (1, 2, 5) and the haemagglutinating properties (2, 7) . besides, the size of the virion seems larger than for other members of the coronavirus group (19) . the discrepancy in size between negative contrast and thin sections may be partly due to shrinkage during fixation and dehydration prior to embedding and thin sectioning, and partly to collapse of the particles by negative staining adding to their actual size. the most reliable staining procedure for size calculations probably is negative staining by uranyloxalate which also stabilizes the structure of the particles. detailed taxonomic considerations for runde virus must await further characterization of biological, serological and molecular properties. but runde virus is probably a "new" coronavirus on the grounds of: its morphology, the lack of cross reaction with avian infectious bronchitis virus and the lack of serological reactions with control mouse sera probably eliminating the possibility of mi-iv isolates. also, our department of experimental animals have no indications of mouse hepatitis in the mouse colony which have been used in these studies. the demonstration of this hitherto unrecognized virus associated with seabirds and ticks also necessitates further efforts to clarify-the ecological and possible epizootologieal implications. as alre~ody mentioned, an unusually high chick mortality ill the seabird colonies at runde has been reported during the ias~ few years. bacteriological and toxocological research has not been able to reveal any definite etiological factor, although pesticide residues have been demonstrated to some extent. this must of course bring viruses into consideration. a synergistic action between pesticides and virus seems one possible working hypothesis in this connection. since norwegian seabird colonies in general are rather frequently visited by scientists, students, holiday travellers and the local public, the recent documentation of the ability of i. uriae to attack man (18) raises the question of public health implications. isolations from i. urine of uukuniemi viruses (30, 31, 33) orbiviruses (12, 32) and flaviviruses (9, 33) ill addition to runde virus further stresses this point. at present nothing is known concerning the distribution and general infection rates of runde virus. some indications that it might be widespread in norwegian seabird eolonies can be given, however. firstly, the isolation of two virus strains from only 206 i. urine collected at runde indicates a rather high infection rate of the vectors in this location. secondly, the demonstration of a high rate of seropositive birds at tlernyken, rest, proves that virus-circulation is not restricted to runde. further field work and experiments which may throw more light upon th(~ ecological interrelationships of runde virus as well as upon the characteristics of the virion are in progress. we are indebted to eva mood petterson, einar brunvold and hatlgrim sog£rd for their skilfui technical assistance, and to tone lea for her valuable help with the preparation of figures. the propagation of "eoronaviruses" in tissue-culture coronaviruses of mart meningoeneephalomyeloradieulitis in sunnhordland. tidsskr. for den norske l~egeforening 11 techniques for haemagglutination inhibition with arthropod-borne viruses replication of avian infectious bronchitis virus in african green monkey kidney cell line veto two-hour embedding procedure for intracellular detection of viruses by electron microscopy some characteristics of haemagglutination of certain strains of "ibv-like" virus a serological tool for the diagnostics of virus b hepatitis. aeta path. microbiol, scand tuleniy virus--a new group b arbovirus isolated from ixodes (ceratixodes) putus pick.--camb. 1878 collected on tuleniy island sakhalin v i r u s --a new arbovirus isolated from ixodes (ceratixodes) put~ts p i c k . --c a m b . 1878 collected on tuleniy island, sea of 0khotsk polyoma transformation of hamster cell c l o n e s --a n investigation of genetic factors affecting cell competence great island and bauline : two new kemorovo group orbiviruses from ixodes uriae in eastern canada growth in suckling mouse brain of "ibv-like" viruses from patients with upper respiratory tract disease concentration and purification of vesicular stomatitis virus by polyethylen glycol "precipitation lopper og lundelus p£ sjofugl p& t~ost 1968. fauna (oslo) 21 records of eetoparasitic insects and mites on birds and mammals in norway lopper, f~tt og midd p~ piggsvin i norge. fauna (oslo) 25 ultrastructure of animm viruses and bacteriophages: an atlas a simple method of estimating fifty percent endpoints the use of lead citrate at high p i t as an electron opaque stain in electron:microscopy arboviruses in finland. ii. isolation and characterization of uukuniemi virus, a virus associated with ticks and birds notes on norwegian ticks ixodes ricinus som mulig vektor for sykdommer hos mennesker i norge action of sodium desoxycholate on arthropod-borne viruses arbovirusencephalitt overfort av ixodes ricinus a sensitive modification of the ouehterlony technique. detection of hepatitis associated antigen by immunodiffusion in a closed hexagonal system. acta path. mierobiol, seand serological investigations indicating the existence of tick-borne encephalitis virus loci along the norwegian coast. aeta path. microbiol, seand development of a modified immunoelecgroosmophoresis method for uukmfiemi and i~unde virus serology tickborne viruses in norway uukuniemi group viruses isolated ill norway tickborne viruses in western north america. ii. yaquina head, a new arbovirus of the kemorovo group isolated from ixoedes uriae tick-borne viruses from seabird nesting sites in oregon and alaska authors' address: dr. t. t~aavik, institute of medical biology, university of tromso, 9001 tromso, norway.received august 24, 1976 key: cord-332233-01rdlf8l authors: tully, thomas n. title: chapter 12 mice and rats date: 2009-12-31 journal: manual of exotic pet practice doi: 10.1016/b978-141600119-5.50015-9 sha: doc_id: 332233 cord_uid: 01rdlf8l publisher summary this chapter focuses on mice and rats, and provides detailed information that may be useful for veterinarians treating these animals. mice are continuous, polyestrous rodents that should be bred in polygamous or monogamous setups because of the males' aggressive territoriality behavior. when breeding mice that have been housed in a polygamous ratio, there may be one male with two to six females. females are removed from a polygamous cage before parturition, whereas the monogamous pair is maintained together with the young until weaning. mice are maintained in environments that are similar to other small rodents but require a thorough cleaning of their cage more often because of their malodorous urine. ventilation is essential for small rodent housing to prevent irritation of the respiratory tract from ammonia vapors generated by urine. quarantining is important when a new animal is being introduced into a setting in which there is an established group. as with other animals, a 30-day quarantine period is recommended, along with a physical examination and fecal parasite check. to maintain oversight of breeding animals' health and reduce the exposure of young animals to infectious disease and parasites, routine screening of representative animals within the colony is recommended. in very large colonies, special caging, food, and water may be necessary to prevent exposure to disease organisms. c h a p t e r 1 2 thomas n. tully, jr. this chapter, on mice and rats, contains information on the companion species that is useful for veterinarians treating the animals or providing information to the owners. although similarities exist for mice and rats-in care, husbandry, diagnostic testing, and treatment-emphasis will be on the differences between the species. mice may be maintained as pets because of their size and playful nature. although playful, mice can be aggressive to cagemates and owners. the aggressive nature often manifests as barbering and/or fi ghting with cagemates and biting their owners. any potential owner should be educated on the aggressive nature of these small dynamos. domestic mice (mus musculus) and the african pygmy mouse (baiomys spp.) are commonly sold for pets and are available in several varieties. the mice varieties sold in pet stores include white, black, or tan colored, satin hair coat (shiny), pied or spotted, and longhaired 1,2 (figure 12-1) . the size and ability of mice to escape quickly from the grasp of a human handler make these animals, as pets, better suited for older individuals. the timid nature of mice predispose these animals to biting if handled roughly, which commonly occurs with a young owner. mice are nocturnal animals and may be a disturbance at night if maintained in a bedroom. female mice produce less odor than males and therefore may be more desirable as pets. as mentioned earlier, male mice are territorial, and if placed with other male mice, may fi ght. advantages of having mice as pets include their size, ability to be a good companion animal for the educated (regarding mouse behavior) owner, and adorable appearance. mice also rarely become infected with bacterial diseases, and their life span is approximately 2 years (box 12-1). the integument of mice is commonly associated with a number of disease presentations. a hair coat that has not been adequately maintained is often the fi rst clinical sign associated with disease. mice are fastidious with their grooming and, when healthy, maintain a very tidy hair coat. common problems associated with a hair coat that is not maintained include general illness, parasitism (internal and external), aggression by cagemates as a result of psychological trauma, and infectious dermatitis. neoplasia is a disease condition that affects mice. there are some mouse strains in which mouse mammary tumor viruses have been identifi ed that have a neoplasia incidence as high as 70%. 3 tumor viruses, as well as a very short life span (up to 2 years), predispose these animals to cancer. mammary adenocarcinomas and fi brosarcomas are the most common tumors that affect mouse mammary tissue. 4 unfortunately, by the time many of these tumors are diagnosed, the malignant masses are large and ulcerated. 4 fibrosarcomas may be hormonally induced, and the incidence of this disease process can be reduced through an ovariectomy at an early age. the small size of the female mouse often makes the ovariectomy surgery challenging for the veterinary surgeon. although relatively uncommon, urethral obstruction can occur in male mice as a result of preputial and/or bulbourethral gland infections. 4 male mice suffering from an urethral obstruction may have a mutilated penis, a sign often associated with the disease process. mice are continuous, polyestrous rodents that should be bred in polygamous or monogamous setups because of the males' aggressive territoriality behavior. 2 when breeding mice that have been housed in a polygamous ratio, there may be one male with two to six females. 2 females are removed from a polygamous cage before parturition, whereas the monogamous pair is maintained together with the young until weaning. 2 mice can chew out of enclosures; therefore, it is important that the housing be "mouse proof." if an animal escapes, the best way to capture the pet is to place food in the center of the room. once it has been determined in which room the animal is staying, then it should be sealed and measures taken to look for the pet. because mice are nocturnal animals, capture at night in a dark room with a fl ashlight may work best. this technique will work for capture of other small rodents and pocket pets too. mice are maintained in environments that are similar to other small rodents but require a thorough cleaning of their cage more often because of their malodorous urine. ventilation is essential for small rodent housing to prevent irritation of the respiratory tract from ammonia vapors generated by urine. the recommended housing unit for mice is 12-15″ × 12-15″ × 6″ (length × width × height) for each adult mouse; females and young require 2 to 3 times the space listed. 2 the major considerations for selecting an enclosure for mice is that it be resistant to their escape and easy to clean. an open screen top of the enclosure is recommended for proper ventilation. available rodent cages that fi t this criterion are wire or metal mesh, plastic, and plexiglas. if the plastic tube housing systems are used, there should be routine cleaning of the sections using hot water and a mild detergent. owners should be informed of the small distance required for a mouse to escape and their ability to chew through plastic. an owner must always monitor the cage for possible escape avenues, especially if the animal has a predilection for modifying the cage opening through chewing. it is very important to provide cage toys and exercise opportunities for mice. the enclosure should be large enough to house not only food and water containers but also cage toys and an exercise wheel (figure 12-2 ). although not a cage toy, a hide box, in some form, should also be included for the psychological well-being of the animal. this hide box can be manufactured or a small cardboard container that has one end cut out. mice like to hide and also sleep during the day. this piece of cage furniture will enable the mouse to sleep undisturbed during the daylight hours. mice, especially males, have odiferous urine. to prevent the buildup of urine and fecal material in the cage, commercially available paper rodent bedding or hardwood shavings should be used as a cage substrate. although softwood (pine) and cedar shavings are available, the volatile oils that radiate from these substrates are irritating to small animals. these irritating compounds can cause dermal and respiratory infl ammation, often leading to secondary bacterial infections. cardboard tissue tubes can be placed in a mouse enclosure; mice like to chew and run through these items. because many fabrics have strong thread and elastic, it is not recommended to put clothes items in enclosures with animals that chew. often mice will shred the clothing items, exposing thread and elastic that can become entangled around an extremity; this can lead to necrosis distal to the stricture. it is recommended to change the substrate within the enclosure at least twice a week-more often if there is a problem with odor or excessive excreta. temperature, humidity, and lighting within the enclosure should follow what is commonly maintained with the ambient conditions within the house. if the animals are housed outside or in an outbuilding, the temperature range should be 65° f to 85° f and humidity 30% to 70%, although the recommended humidity is on the higher end of the range provided. 2 mice, especially males, are extremely territorial animals. if mice are housed alone, it is better to keep them separate, as introduction of new animals will often lead to aggression and fi ghting. to prevent aggression, fi ghting, and psychologically induced adverse behavior (e.g., barbering), a single mouse is recommended as a companion animal. for those who intend to breed the animals, enclosures with a single pair is necessary for reproductive success. because mice are commonly used as laboratory animals in investigations of human disease processes, much research literature is available on the recommended nutritional requirements of these animals. the benefi t of these dietary studies is the availability of commercially produced diets that provide the recommended daily nutritional requirements of the mouse. the problem that most owners face is the multitude of dietary products available for mice and the lack of knowledge regarding which food to buy. most new mouse owners think that rodents eat seed-based diets. although mice will happily eat seed, seed-based diets are lacking in a number of the nutritional requirements needed to maintain long-term health. commercial rodent biscuits or pellets with more than 14% protein are the recommended diets for mice. 2 the commercial rodent biscuits or pellets are the only food mice need to obtain their required nutrients (figure 12-3) . again, seed-based diets are not recommended, nor is a signifi cant supplementation of fruits, nuts, vegetables, cheese, or other human foods (e.g., peanut butter). if a treat is to be given, yogurt or dried fruit treats manufactured specifi cally for rodents and/or mice should be provided 2 to 3 times a week. for younger mice, less than 3 weeks old, softer pellets are needed because babies start eating pellets and drinking water at 2 to 3 weeks of age. 2 a sipper bottle, placed on the outside of the cage, is easy to maintain and does not take any space within the enclosure. if the cage is plastic or plexiglas, modifi cations will be needed to attach the sipper bottle on the outside of the cage. most sipper bottles come with attachment hardware to attach to wire cages ( figure 12 -4). fresh bottled water is recommended for mice, although chlorinated tap water is acceptable. the water should be checked on a daily basis and clean water supplied at least every 2 days, if not every day. quarantining an animal is important when a new animal is being introduced into a setting in which there is an established group. as with other animals, a 30-day quarantine period is recommended, along with a physical examination and fecal parasite check. unfortunately, there is no time period that will screen 100% against potential infectious agents, and with mice, time is critical because their life span and reproductive time frame are so short. the animals should be quarantined in conditions similar to those in which they will be permanently maintained. providing adequate food and water will make for a smooth transition. it is imperative that the owner screen the new animal for diseases and watch for any signs of illness. the most common sign of clinical illness is a rough hair coat. the lack of grooming is most often related to the animal feeling depressed or sick, thereby not having the energy to perform routine behaviors. if a number of animals are being quarantined, sacrifi cing an apparently diseased animal is the most effi cient way to determine a rapid defi nitive diagnosis. if it is a single or an expensive animal, routine diagnostic testing will be required. to maintain oversight of breeding animals' health and reduce the exposure of young animals to infectious disease and parasites, routine screening of representative animals within the colony is recommended. in very large colonies, special caging (e.g., fi lter), food, and water may be necessary to prevent exposure to disease organisms. 2 before a veterinarian examines a mouse, the examination table should be disinfected with either a dilute sodium hypochlorite or chlorhexidine solution. the examiner should always wash his or her hands and, if necessary, wear examination gloves to capture and restrain the patient. the diffi culty with using latex gloves when examining a mouse is the small size of the patient and its ability to twist and turn. the only way to restrain some mouse patients is without gloves. if gloves are not worn, the examiner's hands must be washed thoroughly after the examination is completed. to catch a mouse, the tail should be grabbed with the thumb and forefi nger, allowing the mouse to hold on to an object with their front feet (figure 12-5 ). when the mouse securely attaches itself to an object, the opposite hand then grabs the dorsal skin in the cervical region while keeping the tail in a fi rm grasp. if one is unable to adequately restrain a mouse while the animal is conscious, inhalant anesthesia may be used for sedation purposes. the animal should be placed in a small induction chamber and isofl urane gas permeated into the closed space. once the animal has stopped moving, the enclosure top is removed and a nose cone placed on the anesthesia tube and placed on the patient's face. a syringe case can be modifi ed as a nose cone for small rodents, including mice. once the physical examination is complete, the nose cone is removed, allowing the patient to breath oxygen from the anesthesia unit. obtaining a detailed history of the mouse patient is very important, as it is with other animal patients that are brought to a veterinarian's offi ce. it is important to get as much information from the owner as possible, even if it is a routine health examination. typical background information required includes how long the mouse been owned, where it was acquired, how often it is handled, and what the character of the feces and urine is. husbandry questions should focus on the animal's housing and whether it is allowed to roam unobserved; cage location; type, size, and material of the cage; cage substrate, furniture, and toys; and the frequency with which the cage is cleaned and what disinfectant is used. when investigating the diet, the veterinarian should ask not only if pellets are fed and in what quantity, but also what the animal is eating and what the primary diet is. supplemental offerings and frequency of feeding are important data for the case work-up. the veterinarian should fi nd out about the water supply, how often the water is changed, and how much the animal drinks on a daily basis. because there are transmissible diseases among animals, the fi nal questions should center on the other pets in the household, if new animals have been added to the family, and if the animals are housed together. a description of any previous problems and a complete chronological description of the presenting problem are needed to complete the history form. before the animal is restrained, an observation should be made on the attitude, activity, and posture of the animal. the next step is to weigh the mouse in a basket on a digital gram scale. if possible, temperature, respiration, and pulse should be measured and any abnormalities in rate and/or character noted. the veterinarian should start the physical examination at the head, looking for any abnormalities. eyes, ears, and nares are observed, looking for discharge or infl ammation. the oral cavity is diffi cult to examine in mice because of the small opening and tendency for the buccal mucosa to encroach toward the middle of the mouth. a small speculum (e.g., modifi ed paper clip) or an otoscope may be used to examine the oral cavity and cheek teeth. mucous membranes help determine hydration status using capillary refi ll time and moisture. body condition and abdominal palpation are important information that should be obtained. lymph nodes and limbs are palpated before checking the nails and plantar surface of each foot. the patient should have a normal posture, be aware of its surroundings, and move properly. any problems should be noted in the record. finally, a dermatologic exam considers hair coat quality, alopecia, external parasites, and any skin abnormalities. all abnormal fi ndings are written in the record for case review, differential diagnoses determination, diagnostic testing, and treatment considerations. most of the common problems noted during the physical examination of mice involve the skin and hair coat. as mentioned previously, an unkempt hair coat may point toward generalized illness or external parasitism. abrasive lesions or pustules on the skin can be signs of external parasites or infectious dermatitis. if external parasites are a problem, the mouse may be uncontrollably scratching. hair loss may be associated with barbering, either cagemate or self-induced, or with infection (e.g., ringworm). although not common, trichophyton mentagrophytes will cause hair loss in mice, from the face, head, and neck. 4 mice will commonly present with tumors and abscesses. the entire body of the mouse should be palpated for any evidence of masses. if a mass is identifi ed, a fi ne needle aspirate is recommended for basic diagnostic evaluation. with most fi ne needle aspirate samples, the clinical pathology results are not very rewarding. if a diagnosis cannot be obtained through cytologic examination, a biopsy of the lesion is required, and if possible, an excisional biopsy is the procedure of choice. as with many rodents, respiratory disease is commonly identifi ed in mice. mice may have presenting symptoms of dyspnea, sneezing, coughing, chattering, and sniffl ing if they have a respiratory infection. in cases where respiratory signs are observed, anesthetizing the animal to perform the physical examination is not recommended, and handling should be kept to a minimum. the two most common respiratory disease conditions in mice are sendai virus and mycoplasma pulmonis. 4 these two organisms are very diffi cult to identify through routine diagnostic measures, and obtaining samples significantly stresses the patient. if the animal is being examined for placement into a colony or breeding environment, sacrifi ce to identify the disease condition is recommended. if the animal is an individual companion animal, doxycycline treatment should be initiated. although treatment with doxycycline will not clear the organism from the animal, it will reduce clinical disease and improve the quality of life. the treated animal should always be considered a carrier of these respiratory diseases if a defi nitive diagnosis cannot be obtained. male mice that are licking and/or mutilating their penis may be suffering from a urethral obstruction. infection of accessory sex glands, young males with aggressive breeding activity, urolithiasis, and trauma may initiate this self-induced trauma to the penis. 4 pasteurella pneumotropica is often isolated from accessory sex gland infections as well as subdermal abscesses. 4 treatment for this organism may aid in the recovery of a mouse affected by urethral obstruction. diarrhea in mice is rare, but endoparasite examinations should be performed if the animal has diarrhea. although pinworms are considered nonpathogenic in mice, syphacia obvelata and aspiculuris tetraptera may cause rectal prolapse due to straining in immunosuppressed individuals. 5 as with other animals, a tape test is the best way to identify these parasites. a tape test follows a procedure of pressing the sticky side of the tape against the rectum and perianal area and then examining the tape under a microscope for eggs and parasites. 5 as with other pocket pets, blood collection from mice can be quite diffi cult. approximately 0.5 to 0.7 ml/100 g body weight can be safely removed from a nonanemic healthy mouse. 2 the mouse patient should always be anesthetized for blood collection procedures. usually inducing the animals in a closed chamber and maintaining the patients in a mask will allow the technician plenty of time to collect the blood sample. a small, 25-, 26-, or 30-gauge needle, usually placed on a 1-ml syringe, is recommended for collecting the blood. recommended blood collection sites in a mouse are a warmed ventral tail vein or the tip of the tail. 2 box 12-2 describes the technique used for retroorbital bleeding in mice. the retroorbital bleeding technique is commonly used in laboratory animal settings and is easily performed by an experienced veterinarian or veterinary technician. 5 on smaller rodents, the saphenous vein or lateral vein of the tarsus may be used for multiple blood collections without the use of anesthesia. the patient must be properly immobilized in a restraint tube (35-ml syringe) with the leg extended and the skin held tight on the medial aspect of the thigh using the thumb and forefi nger. 2 the taut skin on the lateral aspect of the thigh allows exposure of the saphenous vein. a 23-gauge needle is used to puncture the vein, and blood is collected in a microhematocrit tube as it fl ows from the vessel. 5 blood samples obtained from nail and ear clips are not considered appropriate diagnostic samples. cardiac puncture is recommended only in terminal cases and when the animal is maintained under general anesthesia because of possible complications involving the lungs and heart vessels. reference ranges for complete blood counts and serum biochemistry panels for mice are listed in boxes 12-3 and 12-4. 1,2 marrow samples may be obtained from the ilium, tibia, sternum, femur, or the bones of the proximal one third of the tail. 5 preparation of the samples is consistent with that of other mammalian patients. standard rodent cages can be used without substrate to collect urine and feces when the patient is hospitalized. after placing a rodent in a zip-lock bag, urination frequently occurs and the sample can be collected. 4 in a similar manner, urine can be collected over a disinfected stainless steel examination table. the urine is voided while the animal is restrained and can be collected in a capillary tube for evaluation on urine reagent strips. 1 urinalysis reference values for mice are listed in box 12-5. under most practice settings, the size of a mouse patient limits imaging capabilities to radiographs. restraint is essential for quality diagnostic images and is even more important when patients weigh as little as 40 g. to obtain adequate restraint and prevent movement of the mouse patient during radiographic evaluation, sedation is required. as with all diagnostic box 12-2 retroorbital blood collection for mice from procedures involving avian and exotic animals, an evaluation of the patient is required to determine its ability to withstand the stress associated with the assessment. if it is determined that the patient cannot withstand sedation, then it should be stabilized until it is deemed healthy enough for diagnostic imaging evaluation. sedating the mouse using an induction chamber and isofl urane anesthetic, as described for restraint, is necessary to obtain diagnostic fi lms. high-speed, 300-ma machines with fi ne or detail-intensifying screens should be adequate for most small exotic mammal images. with mice, dental x-ray units that can focus at short distances may be advantageous for both isolation of focal anatomy and full body radiographs in extremely small patients. for extreme detail in small exotic mammal medicine, using a traditional radiography unit, the min r mammography system (eastman kodak) with min r single-intensifying screen cassettes, in conjunction with min r single-emulsion fi lm, has been recommended. 1 digital radiography is bringing a new dimension to radiograph evaluations and detail. the secret to success in either traditional or digital radiographic imaging is to restrict patient movement during exposure. two views, ventrodorsal and lateral, are recommend for mice patients. again, because of a mouse patient's size, whole body radiographs are commonly obtained during the radiographic evaluation, even using dental radiographic equipment. for the mouse patient in which microbiological testing is recommended, standard collection techniques used for other animals is appropriate. the diffi culty when culturing mice is acquiring a representative sample of the suspect area that will provide diagnostic information. sick mice often are extremely stressed when being examined or when diagnostic samples are being collected. it is also important to know what the common disease conditions are and the common etiologies associated with those clinical signs. with the most common respiratory conditions in mice, one is sendai virus and the other a mycoplasma sp. both sendai virus and mycoplasma spp. will not be isolated using standard aerobic or anaerobic culture techniques. if in doubt on collecting, preserving, and/or shipping a microbiological sample, the diagnostic laboratory must be contacted for full instructions as they relate to mouse submissions. routine fecal parasite evaluations should be performed on small rodents when they are brought to the veterinary clinic for a health examination or an abnormal stool. common protozoal organisms can be detected using a direct fecal examination, and mouse pinworms are commonly diagnosed using the sticky side of clear cellophane tape to make an impression of the perianal area. the anal tape test will aid in diagnosing syphacia spp. the sticky surface will pick up any of the banana-shaped pinworm eggs that can be observed under a microscope. diagnosis of ectoparasites in small rodents is similar to that in other species listed in this text. the pelage tape test is performed by pressing clear cellophane tape against the pelt of a mouse, dorsally and ventrally, from the nose to the base of the tail. myobia spp. and myocoptes spp. can be diagnosed using the pelage tape test. a skin scraping of the affected area may also help in identifying ectoparasites. diagnosis of intestinal parasites can be made by fi nding individual eggs during fecal examination or whole worms within the lumen of the small intestine during necropsy. 6 even though most of the diagnostic testing is performed through pathologic examination for mice, there are serologic tests available that can be run on a minimum of 50 μl of undiluted serum. sound diagnostics, inc. (woodinville, washington) provides serologic testing on a number of common mouse diseases, including ectromelia virus, mouse hepatitis virus, mouse parvovirus, mouse minute virus, rotavirus, theiler's murine encephalomyelitis virus, pneumonia virus of mice, reovirus 3, sendai virus, mycoplasma pulmonis, lymphocytic choriomeningitis virus, and mouse adenovirus. the serologic tests are done using enzyme-linked immunosorbent assay (elisa) and, when indicated, are confi rmed by indirect fl uorescent antibody testing. many of the diseases for which there are available serologic tests are benefi cial in maintaining disease-free animals in laboratory settings or large breeding facilities. in cases of unknown disease conditions for the individual pet mouse, there are panels available that test for multiple diseases from a single serum sample. it is very important for the veterinary clinician to understand both the signifi cance of any test that is being promoted for mice and how the results are interpreted. bacterial infections associated with dermatitis lesions and subcutaneous abscesses in mice are commonly caused by staphylococcus aureus, pasteurella pneumotropica, and streptococcus pyogens. 4 acute and chronic respiratory infections may be caused by sendai virus or mycoplasma pulmonis. 4 acute respiratory infections usually are associated with sendai virus; adults live while neonates often die. chronic respiratory infection, with clinical signs being pneumonia, suppurative rhinitis, and occasionally otitis media, may be the result of a mycoplasma pulmonis infection. 4 both infections should be treated using supportive care, whereas mycoplasmosis can be treated with enrofl oxacin in combination with doxycycline hyclate for 7 days. 7 p. pneumotropica has been associated with urethral obstruction caused by infl ammation and swelling related to infection of accessory sex glands. 4 although uncommon, trichophyton mentagrophytes (ringworm) can cause alopecia of the face, head, and neck of mice. 4 in addition to the disease organisms mentioned in this chapter (which are the most common disease organisms identifi ed in pet mice), there are other bacterial, fungal, and viral organisms that can cause disease in mice. proper diagnostic protocol should always be followed to identify the causal agent. once the cause is identifi ed, the proper treatment can be initiated and control measures implemented to prevent other animals' exposure to the disease. numerous parasites have been identifi ed in mice. hymenolepis nana (dwarf tapeworm) and cysticercus fasciolaris (the larval stage of the cat tapeworm) can be isolated from these small rodents. 5 the dwarf tapeworm is often found in young mice that are dead or have severe gastroenteritis resulting in diarrhea. diagnosis of the dwarf tapeworm can be made following either a fecal fl otation exam or necropsy, when the adults may be found in the small intestine. treatment for the dwarf tapeworm is with praziquantel. the mouse pinworm (syphacia obvelata) is a commensal oxyurid nematode that feeds on bacteria that inhabit the intestinal tract of mice. 6 although these nematodes are nonpathogenic in most cases, an overwhelming number of them can cause severe irritation of the terminal gastrointestinal tract. these nematode parasites can be diagnosed using transparent tape and applying it to the rectal area. after removing the tape from the affected rectal area, it is placed on a slide and the ova may be viewed under a microscope. ivermectin and fenbendazole have been used effectively in treating this parasite in mice. 6 giardia muris is a common protozoal parasite affecting mice. 5 this organism can be seen using a direct fecal examination of an affected patient's fecal material. metronidazole is the treatment of choice for giardia spp. infections in small rodents. myobia musculi, myocoptes musculinis, radfordia affi nis, and psorergates simplex are fur mites that can cause severe selfmutilation and hair loss in mice. 6 polyplax serrata (house mouse louse) can cause anemia, pruritus, dermatitis, and death in severely infested mice. 6 diagnosis of ectoparasites in mice is similar to that in other companion animal species (e.g., skin scraping, examining hair samples for nits). treatment of ectoparasites can be accomplished with ivermectin and a topical miticide. as with other rodent species, there has been an increasing ectoparasite resistance to ivermectin treatment. because most rodent diets are manufactured in the form of pellets or small biscuits that provide all recommended nutrients, there are few nutritional disease problems diagnosed in pet mice. if mice are fed an all-seed diet, there could be nutritionally related consequences. a lack of vitamin a could result in roughened hair coat or skin lesions. a breakdown of the protective epithelial lining of the gastrointestinal and/or respiratory tract could predispose the mouse to secondary bacterial infections affecting those body systems. nutritional defi ciencies may also result in poor reproductive activity. it is important to provide an adequate supply of fresh water and appropriate rodent food on a daily basis. following these basic nutritional instructions should provide a nutritional basis for mice to live healthy lives. the average life span of a mouse is 2 years old. this short life span and aging process increase the prevalence of tumors in these small rodents. if an animal is over 18 months of age, neoplastic disease should be considered as a differential diagnosis, especially if an asymmetrical mass is present. the most common tumors diagnosed in mice are mammary adenocarcinomas and fi broadenomas. 4 other tumor types are identifi ed in mice, and if possible, the suspect tissue should be completely excised. representative tissue sections should be submitted for histopathological evaluation. although there are treatment options available for mice that have been diagnosed with neoplasia (e.g., radiation, chemotherapy), its small size does not allow it to withstand the stress and negative side effects of these healing modalities. in mice, the recommended treatment for neoplasia is removal of the affected tissue, if possible, to increase its quality of life. the most common disease in mice colonies is barbering. barbering is defi ned as the dominant mouse nibbling off the whiskers and hair around the face of the subservient cagemates. 5 the hair clipping is very close to the skin without causing skin lesions. this behavior is noted often among female mice, whereas male mice are more likely to fi ght. mice may injure themselves on cage furniture or poorly designed cages and sustain abrasions on the face or nose. individual animals may show stereotypic behavior that results in abrasions and/or alopecia. enrichment furniture and toys may help alleviate this initial cause of dermatologic abnormality. the size of mice contributes to the diffi culty in properly administering therapeutic medications. the scruff of the neck or caudal fl ank are the subcutaneous sites that may be utilized to administer medication, fl uids, or both. 2 the semitendinosus, triceps, and epaxial muscles are commonly used for intramuscular injections, whereas intraperitoneal injections are used in extremely small animal species, including mice. 2 intraosseous catheters are much easier to place in mice than are intravenous catheters. the tibial plateau and the greater trochanter are the sites of choice for intraosseous catheter placement in mice. 5 although there are many methods that may be used to administer medication in small mammals, oral treatment using a dropper or tuberculin syringe is the easiest to administer and the least stressful for the patient. medication can be added to the food or water, but often the patient is anorexic or the medicated food or water is not palatable, in which case, the patient does not receive the treatment. although a relatively diffi cult procedure in mice, gastric gavage can be performed using a bulbed stainless steel feeding needle or fl exible red rubber feeding tube. the length of the tube is premeasured, externally from the nares to the last rib, and marked. a water-based lubricant is applied to the feeding tube before it is inserted through the intradermal space toward the back of the oral cavity. 2 the tube should advance without diffi culty until the premeasured mark is reached. restraint of mice for this procedure is accomplished by pinching the dorsal neck skin fold and holding the body with the remaining free fi ngers. both oral medication and nutritional supplementation can be administered through an oral gastric feeding tube. medication dosages for mice can be found in a number of formularies. before administration of any therapeutic agent, the dosage should be checked twice and calculations thoroughly evaluated to make sure they are correct. because mice are very small patients, any overdose of medication can have adverse consequences on the patient's recovery. inducing and maintaining mouse patients under anesthesia can be very challenging. with the widespread use of isofl urane anesthesia in small animal practices, the previous problems associated with methoxyfl urane and halothane anesthetic agents has been overcome. there are still concerns and differences in anesthetic protocol because of these animals' small size, but in general, isofl urane is a safe agent when used on a relatively healthy surgical candidate. although there are doses of injectable agents for sedation, the small size of the mouse makes it diffi cult to respond to anesthetic crises that may appear during a diagnostic or surgical procedure. therefore, inhalant anesthetic agents (e.g., isofl urane, sevofl urane) are recommended for anesthetizing mouse patients. an induction chamber is used to induce the patients, and then they are maintained under gas anesthesia using a face mask. it may be possible to intubate a larger rodent, but it is very diffi cult in mice; under most conditions, a modifi ed syringe case face mask is used. 5 to guard against aspiration of stomach contents in a patient that is not intubated, the veterinary surgeon should place the head and neck in a position slightly higher than the body. box 12-6 provides basic guidelines for proper techniques used in surgical preparation and surgical assistance in small mammals, including mice. 9 premedication and sedation doses for mice and rats are listed in surgical procedures that are performed on mouse patients require similar techniques to those used with larger animals. veterinarians should follow the same protocol but remember that the surgical fi eld is smaller and patient manipulation more delicate with patients that weigh less than 50 g. zoonotic diseases associated with mice maintained as pets are rare. possibly the most commonly reported zoonotic condition associated with mice is an allergic reaction to their dander and urine. as with all animals, it is important that a handler wash his or her hands after interacting with a mouse. salmonella spp. may colonize the intestinal tract of small mammals, including mice. 7 contact with the feces or anus of a mouse may expose the handler to this enteric pathogen. washing hands after handling a mouse will help prevent exposure to possible pathogenic organisms a mouse may carry. one can monitor the individual mouse and mice colonies for subclinical carriers of zoonotic organisms by culturing the terminal intestinal tract. mice are carriers of two potentially deadly viruses: the hantaan disease virus and an arenavirus that causes lymphocytic choriomeningitis (lcm) in humans. 7 mice that are propagated for sale in the pet trade are rarely if ever exposed to the hantaan disease virus. 7 lymphocytic choriomeningitisinfected mice generally show no clinical signs, although weight loss, photophobia, tremors, and convulsions may occur. 7 humans are exposed to lcm through contaminated feces, urine, or a bite wound. disease signs in humans infected with lcm are fl u-like (e.g., malaise, headaches, fever, myalgia, arthritis). 7 fatal aseptic meningitis or meningoencephalitis in humans infected with lcm is rare. hymenolepis spp. are cestodes found in mice that can infect humans if contaminated feces are ingested. 7 rarely identifi ed in pet mice, giardia spp. are protozoan parasites that can cause severe gastroenteritis in humans. because feces have to be ingested for someone to be exposed, it is more common for children to become infected with zoonotic intestinal parasites than for adults. using proper sanitary practices after handling mice helps reduce exposure to zoonotic intestinal parasites and other potentially transmissible diseases. although there are diseases listed in this zoonotic section that can be transmitted from mice to humans, the occurrence of this happening is extremely rare when commercially bred mice are purchased at reputable pet stores. rats, like mice, are common laboratory animals and are propagated for commercial sale in the pet trade and for use as reptile food. the life expectancy of a rat is 2 to 3 years. unlike mice, rats have excellent pet characteristics that include a charming personable disposition and extreme intelligence (figure 12-6 ). the common rat species maintained as a companion animal is rattus norvegicus, with the white rat and hooded rat being the most common variations. although rats have an excellent temperament for companionship, they can infl ict a serious bite if provoked. also, as with other animal species, humans can be allergic to their hair, skin dander, and urine and salivary proteins. 2 rats are not as territorial as other rodent species and are very social. the integument of rats is commonly associated with a number of presenting symptoms of disease. as with mice, a rat's hair coat that has not been adequately maintained is often the fi rst clinical sign associated with disease. rats are fastidious with their grooming and, when healthy, maintain a very tidy hair coat. common problems associated with a hair coat that is not maintained include general illness, parasitism (internal and external), aggression by cagemates as a result of psychological trauma, and infectious dermatitis. staphylococcus aureus infections initiated by self-trauma due to a fur mite infestation will manifest as ulcerative dermatitis. 4 the most common tumor in rats is a mammary-associated fi broadenoma. 4 fibroadenomas rarely metastasize but are locally invasive and can grow to a large size. a coronavirus is the etiologic agent behind sialodacryoadenitis which results in infl ammation and swelling of the cervical salivary glands. 4 the most common disease presentations in rats involve the respiratory system. the three major pathogens that infect rat respiratory systems are mycoplasma pulmonis, streptococcus pneumoniae, and corynebacterium kutcheri. 5 respiratory disease in rats often produces "red tears" and a red nasal discharge. this red staining around the eyes and nose is not blood but porphyrins produced by an irritated harderian gland located behind each eye. the red staining at the nasal opening is due to the drainage of the porphyrins via the nasolacrimal duct. renal disease may present in older males in the form of chronic progressive nephrosis. 4 on necropsy, kidneys in affected animals are enlarged, appear pale, and have a pitted mottled surface. 4 rats are continuous, polyestrous rodents that should be bred in polygamous or monogamous systems. 2 when breeding rats that are housed in a polygamous ratio, it is recommended to have one male with two to six females. 2 females are removed from a polygamous cage on day 16 of gestation, whereas the monogamous pair is maintained together with the young until weaning. 2 baseline rat physical information is listed in box 12-7. rats, like mice, can chew out of enclosures; therefore, it is important that the housing be "rat proof" regarding the animal's ability to chew through the substance and escape into the house. rats are maintained in environments that are similar to those of other small rodents, but rats do not produce the quantities of odiferous urine associated with other rodents. for rats, large wire cages with easy-to-remove plastic bottoms are the optimal enclosure (figure 12-7) . the recommended housing unit size for rats is 15-20″ × 15-20″ × 7-10″ (length × width × height) for each adult rat, with females and young requiring 2 to 3 times the space listed. 2 rats like to climb ramps and rope for exercise, so a cage that is taller than the listed requirements would be better suited for most singly housed animals. the major considerations for selecting an enclosure for rats, as with mice, are that it is resistant to their escape and easy to clean. an open screen top on the enclosure is recommended for proper ventilation. available rodent cages that fi t this criterion are wire or metal mesh, plastic, and plexiglas. if the plastic tube housing systems are used, there should be routine cleaning of the sections using hot water and a mild detergent. an owner must always monitor the cage for possible escape avenues, especially if the animal adult male 450-520 g adult female 250-320 g birth weight 5-6 g rectal body temperature 99°-101° f normal heart rate 250-450 beats/min normal respiratory rate 70-115 breaths/min daily food consumption 10 g/100 g body weight daily water consumption 10-12 ml/100 g body weight has a predilection for modifying the cage opening through chewing. it is very important to provide cage toys and exercise opportunities for rats; therefore, the enclosure should be large enough to house not only food and water containers but also cage toys and an exercise wheel. although not a cage toy, a hide box, in some form, should also be included, for the psychological well-being of the animal. this hide box can be a manufactured one or a small cardboard container that has one end cut out. rats like to hide and also sleep during the day. by providing this piece of cage furniture or deep enough substrate for the rat to burrow, it will be able to sleep undisturbed during the daylight hours. to prevent the buildup of urine and fecal material in the cage, commercially available paper rodent bedding or hardwood shavings should be used as a cage substrate (figure 12-8) . although softwood (pine) and cedar shavings are available, the volatile oils that radiate from these substrates are irritating to small animals, especially because they are in very close contact with the material. these irritating compounds can cause dermal and respiratory infl ammation, often leading to secondary bacterial infections. cardboard tissue tubes can be placed in a rat enclosure for chewing and play. clothes items are not recommended in cages with animals that chew. rats will shred the clothing items, exposing thread and elastic material that can become entangled around a rat's extremity, leading to necrosis distal to the stricture. it is recommended to change the substrate within the enclosure at least twice a week and more often if there is a problem with odor or excessive excreta. temperature, humidity, and lighting within the enclosure should follow what is commonly maintained with the ambient conditions within the house. for animals housed outside or in an outbuilding, the temperature range should be 65° f to 85° f. 2 the preferred light cycle for rats is 12 hours of light alternating with 12 hours of darkness. 2 there have been a number of studies investigating the recommended nutritional requirements of rats. these studies have taken place because of the fact that rats are one of the most commonly used laboratory animals when investigating human disease processes. the benefi t of these dietary studies is the availability of commercially produced diets that provide the recommended daily nutritional requirements of the rat. the problem that most owners face is the multitude of dietary products available for rats, and owners often buy seed-based diets. like mice, rats will happily eat seed although seed-based diets are lacking in a number of the nutritional requirements needed to maintain long-term health. commercial rodent biscuits or pellets with 20% to 27% protein are the recommended diets for rats. the commercial rodent biscuits or pellets are the only food rats need to obtain their required nutrients. again, seed-based diets are not recommended, nor is a signifi cant supplementation of fruits, nuts, vegetables, cheese, or other human foods (e.g., peanut butter). if a treat is to be given, yogurt or dried fruit treats manufactured specifi cally for rodents and/or rats should be provided 2 to 3 times a week (figure 12-9) . for younger rats, less than 3 weeks old, softer pellets are needed because babies start eating pellets and drinking water at 2 to 3 weeks of age. 2 a sipper bottle, placed on the outside of the cage is easy to maintain and does not take up space within the enclosure. if the cage is plastic or plexiglas, modifi cations will be needed to attach the sipper bottle on the outside of the cage. most sipper bottles come with attachment hardware to attach to wire cages. fresh bottled water is recommended for rats, although chlorinated tap water can also be used. the water should be checked on a daily basis and clean water supplied at least every 2 days, if not every day. quarantining an animal is important for the pet owner who is introducing a new animal into a setting in which there is an established group. as with other animals a 30-day quarantine period is recommended, along with a physical examination and fecal parasite check. unfortunately, there is no time period that will screen 100% against potential infectious agents, and with rats, time is critical because their life span and repro ductive time frame is so short. quarantining the introduced animals in conditions similar to those in which they will be maintained permanently, reduction of handling, and providing adequate food and water will make for a smooth transition. it is imperative that the owner screen the new animal for diseases and watch for any signs of illness. all rats that are captive, either as pets or in a breeding setup, should have no access to insects, wild rodents, or other animals. the most common sign of clinical illness is an unkempt hair coat. the lack of grooming is most often related to the animal feeling depressed or sick and thereby not having the energy to perform routine behaviors. if a number of animals are being quarantined, sacrifi cing an apparently diseased animal is the most effi cient way to determine a rapid defi nitive diagnosis. if it is a single or an expensive animal, routine diagnostic testing will be required. to maintain oversight of a breeding animal's health and reduce the exposure of young animals to infectious disease and parasites, routine screening of representative animals within the colony is recommended. in very large colonies, special caging (e.g., fi lter), food, and water may be necessary to maintain disease control. 1 before examining a rat, the examination table should be disinfected with either a dilute sodium hypochlorite or chlorhexidine solution. the examiner should always wash his or her hands and, if necessary, put on gloves before the capture and restraint of the patient. the diffi culty with using latex gloves when examining a rat is the small size of the patient and its ability to twist and turn. some rat patients can be restrained only if the examiner is not wearing gloves. if gloves are not worn, the examiner must thoroughly wash his or her hands, as with all cases, after the examination is completed. to restrain a rat, the animal should be picked up with one hand being placed over the back and rib cage, restraining the head with the thumb and forefi nger directly behind the jaws. the other hand is grasping the tail, stabilizing the animal (figure 12-10) . the skin on the dorsal cervical region may also be used, as with other rodents, to pick up the rat. a plastic sandwich bag can be modifi ed as a restraint device for rats and small rodents. the rat's head is placed toward a bottom corner and the sides folded over the animal's back to limit movement. if one is unable to adequately restrain a rat while the animal is conscious, an inhalant anesthetic may be used for sedation purposes. the animal should be placed in a small induction chamber and isofl urane gas permeated into the closed space (figure 12-11) . once the animal has stopped moving, the enclosure top is removed and a nose cone placed on the anesthesia tube and placed on the patient's face. a syringe case can be modifi ed as a nose cone for small rodents. after the physical examination is completed, the nose cone is removed and the patient is allowed to recover, breathing oxygen from the anesthesia unit. injectable agents are another form of sedation used with rats for examination and diagnostic sample collection purposes (see table 12 -2). a thorough assessment of the patient is necessary before using injectable drugs for sedation and anesthesia because of the inability of veterinarians or technicians to rapidly manipulate the effects of these treatments. obtaining a detailed history for the rat patient is very important. it is imperative to get as much information from the owner as possible as it relates to the patient's presenting problem, even if it is routine health examination. typical background information required for the rat patient includes how long the owner has had the animal, where it was acquired, how often it is handled, and the appearance of the feces and urine. husbandry questions should focus on where the animal is housed, whether it is allowed to roam unobserved, where its cage is located; type, size, and material of the cage; cage substrate, furniture, and toys; how often the cage is cleaned and what disinfectant is used. when investigating the diet it is important to ask not only if pellets are fed and in what quantity, but also what the animal is eating and what its primary diet is. supplemental offerings and frequency of feeding are very important data for the case work-up. the technician should fi nd out about the water supply, how often the water is changed, and how much the animal drinks on a daily basis. because there are transmissible diseases among animals, the fi nal questions should center on other pets in the household, if new animals have been added to the family, or if the animals are housed together. a description of any previous problems and a complete chronological description of the presenting problem are needed to complete the history form. before restraining the animal, an observation should be made on its attitude, activity, and posture. the next step is to weigh the rat in a basket on a digital gram scale. if possible, temperature, respiration, and pulse should be measured and any abnormalities in rate and/or character noted. the physical examination starts at the head where the veterinarian should look for any abnormalities. eyes, ears, and nares are observed for signs of discharge or infl ammation. the oral cavity is diffi cult to examine in rats because of the small opening and tendency for the buccal mucosa to encroach toward the middle of the mouth. rat incisors have a tendency to overgrow, so examination of the front teeth for normal occlusion and length is essential. a small speculum (e.g., modifi ed paper clip) or an otoscope may be used to examine the oral cavity and cheek teeth. mucous membranes help determine hydration status using capillary refi ll time and moisture. body condition should be examined and abdominal palpation performed. lymph nodes and limbs are palpated before checking the nails and plantar surface of each foot. the patient should have a normal posture, be aware of its surroundings, and move properly. any problems should be noted in the record. finally, a dermatologic exam considers hair coat quality, alopecia, external parasites, or any skin abnormalities. all abnormal fi ndings are written in the record for case review, differential diagnoses determination, diagnostic testing, and treatment considerations. respiratory disease is often the primary complaint offered by owners when presenting a sick rat to the veterinary hospital. bacterial and viral pathogens can infect rats and are easily spread within breeding colonies because most of the organisms are transmitted by subclinical carriers. ocular and nasal discharge is often observed in combination with dark red pigment. this pigment may be mistaken for blood by owners but actually is porphyrins produced by the harderian glands located behind the eyes. the irritation of the harderian glands causes the excessive production of porphyrins, which are secreted around the eye and down the nasolacrimal duct to the nose. rats have incisors that grow continuously. the continuous growth is not a problem for animals with normal occlusion. if the incisors do not line up, then there is a condition that leads to overgrowth of these teeth. the upper incisors will curve around, and if they are not cut, they will lodge in the dorsal aspect of the oral cavity. the ventral incisors will fl are out from the oral cavity. a common tumor found in older intact female rats is the mammary tumor. mammary tumors can be large and extensive. rat mammary tissue extends, on their ventrum, from the inguinal area to the thoracic inlet and up to their dorsal lateral body wall. the most common subcutaneous mammary tumor in the rat is a fi broadenoma (figure 12-12) . 4 removing the ovaries at an early age reduces the incidence of the hormonally infl uenced tumor later in a female rat's life. swelling of the cervical salivary gland is caused by a virus. the etiologic agent of this condition is a coronavirus, sialodacryoadenitis virus, resulting in upper respiratory infl ammation and the previously mentioned swelling of the cervical salivary and lacrimal gland. 4 there is no treatment for this highly contagious viral disease. external and internal parasites may affect rats in the form of a rough hair coat or dermal lesions. rats that are pruritic may cause abrasions or scratches that become infected with staphylococcus aureus bacteria, leading to secondary ulcerative dermatitis. 4 routine parasite examinations are necessary so that the veterinarian can identify parasitic infestations and administer treatment. rats can also present with neurologic, gastrointestinal, and urinary disease signs. a detailed history and examination will help direct the clinician toward a differential diagnosis list in which the appropriate diagnostic tests can be submitted to obtain a defi nitive diagnosis. as with other pocket pets, blood collection from rats can be quite diffi cult. approximately 0.5 to 0.7 ml/100 g body weight can be safely removed from a nonanemic healthy rat. 2 a rat patient should always be anesthetized for blood collection procedures, to reduce patient stress and movement. usually inducing the animals in a closed chamber and maintaining the patients in a mask will allow the technician plenty of time to collect the blood sample. using a warmed ventral tail vein, 0.5 ml can be collected through a 23-gauge butterfl y needle. 2 to collect from the tail vein, warm the distal two-thirds of the ventral aspect of the tail in a container of warm water for approximately 15 minutes. 2 the tail vein can be observed more clearly in the distal aspect of the tail. a 22-to 25-gauge butterfl y needle is used, and free fl owing blood can be collected directly into the microtainer tubes. 2 a tape bandage should be placed on the injection site to aid in hemostasis. the easiest way to collect blood from many small mammals, including rats, is from the anterior vena cava. with the rat under general anesthesia, a 25-gauge, 1-inch needle attached to a 3-ml syringe is directed toward the umbilicus from the right side of the manubrium. 2 box 12-8 describes the technique used for retroorbital bleeding in rats and is not recommended for companion animals. the retroorbital bleeding technique is commonly used in laboratory animal settings and is easily performed by an experienced veterinarian or veterinary technician. as with smaller rodents, the saphenous vein or lateral vein of the tarsus may be used for multiple blood collections without the use of an anesthetic. the patient must be properly immobilized in a restraint tube (35-ml syringe) with the leg extended and the skin on the medial aspect of the thigh held tightly between the handler's thumb and forefi nger. the taut skin on the lateral aspect of the thigh allows exposure of the saphenous vein. a 23-gauge needle is used to puncture the vein, and blood is collected in a microhematocrit tube as it fl ows from the vessel. 2 blood samples obtained from nail and ear clips are not considered appropriate diagnostic samples. cardiac puncture is recommended only in terminal cases and when the animal is maintained under general anesthesia because of possible complications involving the lungs and heart vessels. the collection of samples for diagnostic testing in rats is similar to that in other rodents. the reference ranges for complete blood counts and serum biochemistry panels are listed in boxes 12-9 and 12-10. marrow samples may be obtained from the ilium, tibia, sternum, femur, or the bones of the proximal one third of the tail. 5 preparation of the samples is consistent with that of other mammalian patients. standard rodent cages can be used without substrate to collect urine and feces when the patient is hospitalized. by placing a rodent in a ziplock bag, urination frequently occurs and the sample can be collected. in a similar manner the urine in a rat can be collected over a disinfected stainless steel examination table. 1 the urine is voided while the animal is restrained and can be collected in a capillary tube for evaluation on urine reagent strips. 1 urinalysis reference values for rats are listed in box 12-11. under most practice settings, the size of a rat patient limits imaging capabilities to radiographs. restraint is essential for quality diagnostic images. to obtain adequate restraint and prevent movement of the patient during radiographic evaluation, sedation is required. as with all diagnostic procedures involving avian and exotic animals, an evaluation of the patient is required to determine its ability to withstand the stress associated with the assessment. if it is determined that the patient cannot withstand sedation, then it should be stabilized until it is deemed healthy enough for diagnostic imaging evaluation. a rat can be sedated in an induction chamber following a technique similar to that described for mice. because rats are larger than mice, they are easier to intubate. using a special otoscope adapter, exposure is enhanced for endotracheal tube placement. high-speed, 300-ma machines with fi ne or detail-intensifying screens should be adequate for most small exotic mammal images. dental x-ray units that can focus at short distances may be advantageous for both isolation of focal anatomy and full body radiographs in extremely small patients, including rats. for extreme detail in small exotic mammal medicine, using a traditional radiography unit, the min r mammography system (eastman kodak) with min r singleintensifying screen cassettes in conjunction with min r singleemulsion fi lm has been recommended. 1 digital radiography is bringing a new dimension to radiograph evaluations and detail. the secret to success with either traditional or digital radiographic imaging is to restrict patient movement during exposure. 2 two views, ventrodorsal and lateral, are recommend for rat patients. if there are rotational problems with the rat patient, a dorsoventral view may provide better imaging quality. 2 the patient should be taped to the cassette or positioning board with white cloth tape or masking tape. taping the rat to the cassette or positioning board will aid in image consistency with that particular patient and among similar animals. in the lateral views, the dependent legs should be positioned cranial to the contralateral limbs. 1 again, as with mice, whole body radiographs are commonly obtained for rat patients during the radiographic evaluation. normal radiographic appearance of the rat patient is described in box 12-12. for the rat patient in which microbiological testing is recommended, standard collection techniques used for other animals are appropriate. with the most common respiratory conditions in rats being viral and bacterial organisms, it is important to try and aid the diagnostic laboratory in organism isolation through listing the potential pathogens. as always, if in doubt on collecting, preserving, and/or shipping a microbiological sample, the diagnostic laboratory should be contacted for full instructions regarding rat submissions. parasitology routine fecal parasite evaluations should be performed on small rodents when they are brought to the veterinary clinic for a health examination or an abnormal stool. common protozoal organisms can be detected using a direct fecal examination. an anal tape test is useful for identifying syphacia spp. in rats. diagnosis of ectoparasites in small rodents is similar to that in other species listed in this text. a skin scraping of the affected area or a pelage tape test (to identify radfordia spp.) will usually yield the parasite. diagnosis of intestinal parasites can be made by fi nding individual eggs in a fecal fl otation of a macerated fecal pellet and in the lumen of the small intestine during necropsy. staphylococcus aureus is the most common cause of ulcerative dermatitis in rats. 4 this organism is ubiquitous in most rat colonies and survives on the animals' skin. unless there is a break in the skin, there is no infection or disease caused by the organism. in cases where there is a fur mite (radfordia ensifera) infestation, rats become pruritic, developing lesions that seed the s. aureus organism. 4 the ulcerative dermatitis can be treated with an appropriate antibiotic through both systemic and topical application, cleaning the affected areas, and clipping the toe nails of the rear feet. mycoplasma pulmonis, streptococcus pneumoniae, corynebacterium kutscheri, sendai virus, and cilia-associated respiratory bacillus have been isolated and identifi ed as infectious agents causing rat respiratory disease. 4 with the respiratory pathogens, clinical signs can vary from mild dyspnea to severe pneumonia and death. rats with mycoplasmosis are treated in much the same way as infected mice. sialodacryoadenitis virus is a highly contagious disease that causes rhinitis and infl ammation of the cervical salivary and lacrimal glands. 4 there is no treatment for this viral disease, and supportive care is recommended for the affected patient. there are other infectious diseases that can infect rats, as evidenced by the available serologic tests (e.g., kilham's rat virus, pneumonia virus of mice, rat parvovirus, rat coronavirus, toolan's h-1 virus, theiler's murine encephalomyelitis virus, mouse adenovirus, reovirus 3). these infectious diseases are diagnosed less commonly than those previously identifi ed. even so, veterinarians should be aware of the infectious disease organisms to which rat patients may be exposed and aware that tests are available for antemortem diagnosis. specifi c intestinal parasites identifi ed in rats include the dwarf tapeworm (hymenolepis nana), pinworms (syphacia muris), nematodes (specifi cally trichosomoides crassicauda), and giardia muris. 5 diagnosis of intestinal parasites is important for the implementation of the appropriate treatment plan. pinworms are diagnosed through the anal tape test, protozoan parasites (e.g., giardia muris) through a direct fecal exam, and cestodes and nematodes from fecal fl otation on macerated fecal pellets. 5 once the parasite has been identifi ed, proper treatment can be initiated and environmental recommendations applied to prevent exposure of other animals and reexposure of the patient being treated. rats do not appear as susceptible to ectoparasites as mice, but the following have been identifi ed: ornithonyssus bacoti (tropical rat mite), radfordia ensifera (rat fur mite), demodex nanus (demodex), polyplax spinulosa (the spined rat louse), and fl eas. 5 diagnosis and treatments are similar to those recommended for mice although the dosages and duration differ. treatment of ectoparasites can be accomplished with ivermectin and a topical miticide. as with other rodent species, there has been an increasing ectoparasite resistance to ivermectin treatment. because most rodent diets are manufactured in the form of pellets or small biscuits that provide all recommended nutrients, there are few nutritional disease problems diagnosed in pet rats. it is also important to provide an adequate supply of fresh water and appropriate rodent food on a daily basis. if rats are fed an all-seed diet, there could be nutrition-related consequences. a lack of vitamin a could result in roughened hair coat or skin lesions. a breakdown of the protective epithelial lining of the gastrointestinal and/or respiratory tract could predispose the rat to secondary bacterial infections affecting those body systems. 2 nutritional defi ciencies may also result in poor reproductive activity. vitamins b complex, c, and e plus selenium are recommended for treatment of female rats diagnosed with pregnancy toxemia. 2 rats, if fed a high quantity of human food, will develop dental plaque on the cheek teeth. 8 proper diet, primarily rodent biscuits or pellets, will reduce the formation and buildup of dental plaque. 8 if left unattended, the excess plaque may lead to gum disease and dental caries. if caries develop within cheek teeth, the recommended treatment is removal of the affected teeth. 8 rats are susceptible to tumors, most likely because of their short life span and physiologic predisposition. the most common subcutaneous tumor in rats is the fi broadenoma of the mammary tissue. 4 the mammary tumors can reach very large sizes and affect both males and females. to reduce the incidence of fi broadenomas, ovariohysterectomies are advocated at an early age in female animals. whereas mammary tumors in mice are almost always malignant, rat mammary tumors are usually localized and respond to surgical resection. 4 rats have continuously growing incisors. under normal anatomic conditions, the incisors maintain their length by grinding on their occlusive surface. if the position of the incisors is compromised, malocclusion will occur, causing overgrowth of their front teeth. the teeth, if left untrimmed, can cause trauma to the dorsal surface of the oral cavity (upper incisors) and the lower teeth extending outside of the mouth. in severe cases the teeth may adversely affect the animal's ability to eat. the teeth can be trimmed with a high-speed motor tool (e.g., dremel ® ) with a cutting disk attachment. a common disease in older male rats is chronic progressive nephrosis; the disease can also affect females. 4 the protein level in the urine commonly exceeds 10 mg/day and progressively increases as the animal ages. 4 the pathophysiology of chronic progressive nephrosis involves glomerulosclerosis with tubulointerstitial disease primarily affecting the convoluted proximal tubule. 4 the progression of the disease process may be slowed through a low-protein diet and anabolic steroid therapy. 4 therapeutics fluid therapy can be given to rats through intramuscular, subcutaneous, intraperitoneal, and intravenous routes. using a 25-gauge needle, a volume of up to 0.2 ml of fl uid can be injected into the quadriceps muscle. 2 up to 5 ml of fl uid can be injected under the loose skin covering the neck or lateral body wall. 2 intraperitoneal fl uids should be administered while the rat is properly restrained to restrict movement. with one of the rat's hindlimbs extended, a 25-gauge needle is inserted into the center of the caudal quadrant of the abdomen, following the line of the extended leg. 2 up to 5 ml of fl uids can be given via the intraperitoneal route. 2 the most diffi cult method of providing fl uids is intravenously to the lateral tail vein. to access the tail vein, warming the tail to dilate the vessel in warm water for approximately 15 minutes is required to aid in visualization. 2 the older the animal is, the more diffi cult it is to see the vessel through the tail skin. although there are many methods that may be used to administer medication in small mammals, oral treatment with a dropper or tuberculin syringe is the easiest for the veterinarian and least stressful to the patient. medication can be added to the food or water, but often the patient is anorexic or the medicated food/water is not palatable, in which case, the patient does not receive treatment. both oral medication and nutritional supplementation can be administered through an oral gastric feeding tube to rat patients. the techniques described earlier for mice can also be applied to rats. medication dosages for rats can be found in a number of formularies. before administration of any therapeutic agent, the dosage should be checked twice and calculations thoroughly evaluated to make sure they are correct. the same surgical and anesthetic techniques described for mice can be used for rats (see box 12-6). dosages for rat injectable anesthetic and sedative agents and analgesic treatment can be found in tables 12-1 and 12-2. rats are larger than mice and can be intubated using a modifi ed otoscope head (figure 12-13) . when using inhalant anesthesia, an intubated animal can be ventilated and there is less risk of aspiration from fl uid that enters the oral cavity. surgical procedures that are performed on rat patients use similar techniques utilized on larger animals. veterinary surgeons should follow the same protocols but remember that the surgical fi eld is small and patient manipulation is delicate. the most common surgical procedures performed on rats are castration, ovariohysterectomy, and tumor (especially mammary tumor) removal. occurrences of humans becoming infected with zoonotic diseases associated with pet rats are uncommon. as with mice, an basic anatomy, physiology, husbandry, and clinical techniques small rodents: exotic companion medicine handbook for veterinarians box 12-12 normal radiographic appearance of the rat from johnson-delaney ca, harrison lr: small rodents: exotic companion medicine handbook for veterinarians basic anatomy, physiology, husbandry, and clinical techniques small rodents: exotic companion medicine handbook for veterinarians tumours of the mammary gland disease problems of small rodents a technician's guide to exotic animal care parasites of ferrets, rabbits, and rodents zoonotic diseases small mammal dentistry allergic reaction to rat dander and urine may be the most commonly reported zoonotic condition. as with all animals it is important that a handler always wash his or her hands after interacting with a rat. salmonella spp. may colonize the intestinal tract of rats. 7 there has been a human case of chorioamnionitis in which corynebacterium kutscheri has been isolated. 7 this grampositive bacillus is routinely isolated from the nasopharynx of rats and therefore can be considered a zoonotic agent.streptobacillus moniliformis and spirillum minus are organisms that initiate the disease called rat-bite fever. 7 a rat bite is required to seed the bacteria in a human, and after a 6-to 10day incubation cycle, the human begins to show clinical signs associated with the disease (e.g., relapsing fever, chills, vomiting, myalgia, regional lymphadenopathy). 7 rats appear to be one of the primary rodent carriers of streptococcus pneumoniae. the rodent develops respiratory disease through which the organism is shed and humans are exposed. infected humans have respiratory and meningeal disease signs associated with s. pneumoniae illness. 7 it should be mentioned that the rodent fl ea (xenopsylla cheopis) transmits the plague organism yersinia pestis. 7 it is wild rodents in which the plague organism is of most concern, but the disease is found worldwide, especially in the american southwest. this is a very good reason why rats under the care of humans should have no access to wild animals.leptospira interrogans is transmitted from the infected urine of rats. 7 again, restricting contact with wild rodents will reduce the risk of pet exposure. humans infected with l. interrogans have chills and fever and often develop septicemic conditions that can lead to organ dysfunction. 7 hymenolepis sp. is a cestode found in rats, which can infect humans if contaminated feces are ingested. 7 giardia sp. is a protozoan parasite, rarely identifi ed in pet rats, that can cause severe gastroenteritis in humans. 7 because feces have to be ingested for exposure, it is more common for children to become infected with zoonotic intestinal parasites than for adults. proper sanitary practices after handling rats will help reduce humans' exposure to zoonotic intestinal parasites and other potentially transmissible diseases. all potential rat owners and current rat owners should know that the occurrence of zoonotic disease transmission is extremely rare when commercially bred rats are purchased from reputable pet stores. key: cord-266745-jit1xeqc authors: liou, jenn-fa; chang, chih-wei; tailiu, jui-jane; yu, chun-keung; lei, huan-yao; chen, lih-ren; tai, chein title: passive protection effect of chicken egg yolk immunoglobulins on enterovirus 71 infected mice date: 2010-11-29 journal: vaccine doi: 10.1016/j.vaccine.2010.09.089 sha: doc_id: 266745 cord_uid: jit1xeqc the objective of this study is to evaluate the passive protective efficiency of immunoglobulin in yolk (igy) specific against human enterovirus type 71 (ev71). the antibody was raised by intramuscular immunization to 10 white leghorn hens, with inactivated human ev71 serving as the antigen. the titer and specificity of the antibody were analyzed from purified igy in the egg yolks of immunized hens. results indicate that the titer of igy specific against ev71 increased from the third week after the first immunization. the content of total igy was 190 ± 26 mg/yolk, with an average concentration of specific igy of 6.34 ± 3.38 mg/yolk in the eggs from 3 to 18 wk after immunization. the results of the neutralization effect of specific igy in ev71-challenged mice demonstrate that the ev71-specific igy, either by intraperitoneal injection or oral administration, was able to significantly reduce the morbidity and mortality in ev71 infected mice pups. researchers have extensively studied passive immunization in both humans and animals using specific antibodies to protect against pathogens. an increase in antibiotic-resistant bacteria and the desire to treat pathogens that do not respond to antibiotics, such as viral pathogens, has prompted many researches to use antibodies as alternative to antibiotics [1] . igy (immunoglobulin in yolk) antibodies are the predominant serum immunoglobulin in birds, reptiles, and amphibians, and are transferred from serum to egg yolk in the females to confer passive immunity to their embryos and neonates [2] . the potential of orally administered igy for the prevention and treatment of many pathogens has been studied for many years, for escherichia coli [3] , helicobacter pylori [4] , salmonella [5] , rotavirus [6] , staphylococcus [7] , streptococcus mutans [8] , yersinia [9] , coronavirus [10] , and the porcine epidemic diarrhea virus [11] . this paper evaluates the efficiency of igy against enterovirus 71 (ev71). enterovirus 71 belongs to the human enterovirus a family of picornaviridae. these virions consist of a non-enveloped capsid surrounding a core of single-stranded, positive-polarity rna approximately 7.5 kb in size [12] . since the initial description of ev71 in 1974 [13] , outbreaks of this virus have been identi-fied periodically in countries throughout the world, including the usa, australia, sweden, japan, bulgaria, hungary, hong kong, and malaysia [14] . in 1998, an outbreak of ev71 infections occurred in taiwan, in which 405 children were hospitalized and 78 died [15] . ev71 infections are generally mild, like hand-foot-and-mouth disease (hfmd) and herpangina, but occasionally lead to severe diseases such as aseptic meningitis, poliomyelitis-like paralysis, and even fatal encephalitis in neonates [16] [17] [18] . in recent years, some efforts have been made to control ev71 infections. the most promising antiviral agents for ev71 are win-group compounds, which have undergone clinical trials [19, 20] . in addition, a research group from taiwan has developed two candidate ev71 vaccines, including a formalin-inactivated whole virus vaccine and a vp1 expressing dna vaccine [21] . the efficacy of both vaccine constructs is currently being tested in animal models. several approaches have been attempted in the treatment of viral diseases. researchers tried to block the replication of virus through binding the capsid of virus with some chemicals, such as pyridazinamines [22] , phenoxyl imidazoles [23] , or pleconaril [24, 25] . however, the treatment of ev71 with pleconaril was not significant, the binding of pleconaril with capsid was limited under higher viral concentration in vitro [26] . a specific antibody which could bind with the virus and hence reduce the contact of virus with host cells is an alternative choice. human's immunoglobulin has been applied in the treatment of ev71 infections in babies whose immune system are not well-developed [27, 28] . there is no routine therapy for the treatment of ev71 infection with human's immunoglobulin so far. however, some animal model of ev71 challenged mouse has been developed, and provided some information about the protective effects of the neutralizing antibody on ev71 infection [29] . compared to traditional antibody production, chicken as bio-factory can produce higher yield of igy antibodies than mammals' igg. a chicken can lay 280 eggs in a year and an egg yolk contains 100-200 mg of igy antibodies. this study was subjected to produce igy against enterovirus 71 (anti-ev71 igy) and evaluated the inhibition effects of specific igy on ev71, including in vitro virus neutralization test and in vivo icr mice model. this study also provided an animal model for the application of igy in the cure or prevention of ev71. the ev71 strains 4643 and mp4. strain 4643 was originally derived from a patient with ev71 encephalitis [30] , while strain mp4 was a mouse-adapted enterovirus 71 with increased virulence in mice, and it was generated after four serial passages of the 4643 strain [31] . ev71 stock virus of strains 4643 and mp4 were grown in rd (rhabdomyosarcoma) cells, which were maintained in dulbecco's modified eagle's medium (dmem, invitrogen, u.s.a.) containing 10% fetal bovine serum (fbs, invitrogen, u.s.a.), 2 mm of l-glutamine (invitrogen, u.s.a.), 100 iu/ml of penicillin (invitrogen, u.s.a.), and 100 g/ml of streptomycin (invitrogen, u.s.a.). all animals received humane care as outlined in the guide for the care and use of experimental animals and viral challenge (institutional animal care and use committee; iacuc approval no. 940020). four 6-month-old white leghorn laying hens, obtained from livestock research institute, council of agriculture, executive yuan, taiwan, were utilized for the production of anti-ev71 igy. a formalin-inactivated ev71 of strain 4643 was utilized as the antigen. one milliliter of ev71 antigen (400 g/ml, 5.4 × 10 6 pfu) was emulsified with an equal volume of freund complete adjuvant and immunized intramuscularly to chickens at 4 sites in the breast muscle. four booster injections with freund's incomplete adjuvant were given at weeks 2, 4, 6, and 13 after the first immunization. the eggs were collected daily from the first day to 3 weeks after the last immunization, and stored at 4 • c. the egg yolk was separated, pooled, and kept at −20 • c prior to igy purification, and all egg yolks from each chicken for each week were pooled into one analysis sample. the isolation of igy was carried out as described by akita and nakai [32, 33] , with some modifications. the egg yolk was first mixed with one of nine volumes of cold distilled water (acidified with 0.1 n hcl to ph 5.0) and stored overnight at 4 • c. the mixture was then centrifuged at 3125 × g at 4 • c for 40 min to obtain the water soluble fraction (wsf). the wsf was collected and filtered to remove solids. the resulting igy-containing wsf was further purified by ultra filtration using amicon ultra-15 filter (pl-100, millipore), condensing the sample to 1/30 to 1/40 of its original volume. these wsf concentrates were then subjected to the virus neutralization test and mice challenge experiments. the antibody activity of anti-ev71 igy was determined using the elisa method described by lee et al. [34] , with some modifications. briefly, microtiter plates were coated with 100 l of inactivated ev71 4643 antigen (10 g/well), while control wells were coated with rabbit anti-chicken igy antibody (10 g/ml, sigma c2288). the plate was then incubated overnight at 4 • c. after washing with pbs-tween 20 buffer, 2% bsa blocking was conducted overnight at 4 • c. the wells were then washed with pbs-tween 20 buffer. next, 100-fold diluted wsf was added to the sample wells (100 l/well) for testing. wsf from the same chicken before immunization was used as a control. to generate the standard curve, wells were filled with 100 l serial-diluted pure chicken igy at a concentration from 0.015 g/ml to 1 g/ml (promega, g116a) and incubated at 4 • c for overnight. after washing with pbs-tween 20 buffer, 100 l of alkaline phosphate-conjugated goat anti-chicken igy (promega, g115a) was added to the wells and incubated at 37 • c for 2 h. after washing with pbs-tween 20 buffer, 100 l of disodium p-nitrophenyl phosphate was added to each well as a substrate (sigma, n9389) and allowed to react at 37 • c for 10 min. the absorbance was then measured at 405 nm using a microplate reader (multiskan ms: thermo labsystems). the resulting absorbance of standard curves provided a relative measurement of anti-ev71 igy concentration. for the total igy determination, each well on the microtiter plate was first coated with 100 l of rabbit anti-chicken igy antibody (10 g/ml, sigma c2288), to which 100 l of 10,000-fold diluted wsf was then added. the following experiments were performed following the same protocol described above. the ev71 was run on sds-polyacrylamide gel electrophoresis (sds-page) and transferred electrically onto a nitrocellulose membrane. the membrane was divided into 3 parts and soaked in blocking buffer (5% nonfat dry milk in tbst) for 30 min at room temperature, then incubated with anti-ev71 or non-specific igy for 1 h. after washing 4 times with tbs-t, the membranes were incubated with peroxidase-conjugate goat anti-chicken igy (1000fold dilution in blocking buffer for each) at room temperature for 1 h. immunoreactivity was detected by incubating the membranes with 0.02% (w/v) 4-methoxy-1-naphthol in tbs and 0.02% (v/v) h 2 o 2 . the tcid 50 of mp4 virus and the neutralization titer of anti-ev71 igy were determined using the method described by yu et al. [35] . in the tcid 50 tests, each 96-well 8 × 10 3 rd cell was added to a microplate well, followed by the 10-fold serial diluted virus. the 50% tissue culture infective dose was determined after incubation under 5% co 2 at 37 • c for 7 days. in the neutralization tests, each 50 l sample of serial diluted anti-ev71 igy concentrate solution was mixed with 50 l of 100 tcid 50 ev71 in a microplate well. two hours later, the rd cell suspensions (8 × 10 3 cell/well) were added and further incubated under 37 • c and 5% co 2 for 7 days. neutralization antibody titers were then identified as the highest dilution of purified igy solution that completely inhibited virus growth. the challenge test of ev71 of the mouse model in this study was modified from wang et al. [30] . trials 1-4 were designed to test the effect of igy with different neutralization titers on mortality in suckling mice. each one-day-old icr strain mouse was intraperitoneally (ip) inoculated with 1 × 10 5 pfu of mp4 virus, which is a mouse-adapted 4643 strain of ev71. thereafter, igy with different neutralization titers (64, 128, 256, and 512) was injected ip into the challenged mice 1-3 days after inoculation (dpi). the dosage of igy week after immunization mg anti-ev71 igy was 100 l per mouse. in trials 5 and 6, the igy treatment dates were 2-4 dpi and 4-6 dpi, respectively. trials 7-8 were used to evaluate the protection effect of anti-ev71 igy by oral treatment. specifically, trials 7 and 8 used a 24-gauge feeding tube to orally inoculate mice of 4-5 d (2.5-3.0 g) and 5-6 d old (3.0-3.5 g), respectively. the mice were given 100 l of mp4 virus (3 × 10 6 pfu/mouse) after 12-h of fasting. for each pup, 100 l of anti-ev71 igy with a titer of 512 was orally administered either 1 h before or 1 h after viral challenge. all mice were checked daily for their body weight and the syndromes of ev71 infection, including limb paralysis and abnormal hair coat until 2 weeks after viral infection. morbidity and mortality data was collected for two weeks after the viral challenge. the concentration of total igy and specific anti-ev71 igy was analyzed by elisa. the content of igy in the wsf of egg yolk was investigated for a period of 18 weeks, from the first week of immunization until 6 weeks after the last booster injection. the average content of total igy in each yolk was 190 ± 26 mg (table 1) , which was 32% of the egg yolk's total protein. after condensation by ultrafiltration, the total protein per egg was 231 ± 25 mg on average, and the purity of total igy increased to 65%. the content of specific anti-ev71 igy increased gradually from the third week after the first immunization, as fig. 1 indicates. a variation in immune response among individual hens was noticed from the large standard deviation. the average anti-ev71 igy concentration reached 6.34 ± 3.38 mg per yolk between the third to eighteenth weeks, equivalent to 3.33% of the total igy. the neutralization titer of specific anti-ev71 igy was determined by the cytopathic effect (cpe) of ev71 on rd cells (fig. 2) . the resulting neutralization titers of specific igy obtained from eggs of all immunized chickens ranged from 0 to 2048 (data not shown). comparing the neutralization titers to the contents of specific igy in the respective yolks showed no significant corb the igy-containing wsf was further purified by ultra filtration using amicon ultra-15 filter (pl-100, millipore), condensing the sample to 1/40 of its original volume. these wsf concentrates were then subjected to the virus neutralization test. relation between these two sets of data (r = −0.396, data not shown). western blotting analysis of the immunoreactivity of anti-ev71 igy. the ev71 was run sds-page and transferred onto nitrocellulose filter and probe with ev71 immunized and non-immunized igy. the ev71 was detected of ∼52 kda molecular mass (fig. 3a) and anti-ev71 igy was specifically bound to the proteins witch molecular weight corresponding of ev71 virus (fig. 3b ). in the first part of the animal tests, icr mice showed both limb paralysis and abnormal hair growth after ev71 challenge in the ip model (fig. 4) . in trials 1-6 was conducted to investigate the effect of ip injected specific igy on curing ip ev71-challenged mice (table 3) . when one-day-old icr mice were challenged with ev71 of strain mp4 with a dose of 10 5 pfu per mouse, the average morbidity was 96.5 ± 6.1% in the control group. the resulting mortality was 88.0 ± 8.4% based on the challenged mice, or 91.2 ± 7.6% when based on illness in mice injected with only non-immunized igy (table 3) . we ip administrated the purified specific igy derived from condensation of the immunized yolk wsf to ev71-challenged mice. this administrated was applied continuously for 3 days, from the day after viral infection (1 dpi) to the third day post infection (3 dpi). the therapeutic effects of igy varied according to the neutralization titers of the specific igy administered. the infection rate was 100% when the titer of specific igy was 64, which is same infection rate as in the control group (table 3 ). the treatment of igy with a titer of 64 did not significantly reduce mortality in trial 1. however, when the igy titers were 128 or higher, the morbidities reduced to 20%, 7%, and 0%, respectively for igy treated groups with titers of 128, 256 or 512. only the group of titer 128 (trial 2) had some deaths after viral infection and igy injections, with a mortality rate of 10%. without the treatment of specific igy, the challenged mice showed high morbidities and mortality. in trials 5 and 6, if the treatment between 64 and 512) . c non-immunized igy. # differences in proportions morbidity and mortality were tested with the use of the x 2 statistic (p < 0.05). time of specific igy began at 2 or 3 dpi, the morbidities increased to 43% and 89%, respectively. this reduction in cure effects increased mortalities by 21% and 63%, respectively. the mortalities of mice showing illness were 50% and 71% in trials 5 and 6, respectively, indicating a decrease in cure effects of specific igy following the delay of igy administration for one or 2 days. the second part of the animal tests involved oral administration of specific igy to ev71 orally challenged mice. in trial 7, a dosage of 3 × 10 6 pfu mp4 strain ev71 was orally fed to pups 4 or 5 days old with a body weight of 2.5-3.0 g. the results indicated that if 100 l of specific igy was orally fed 1 h before the viral challenge, the morbidity and mortality of challenged mice was 24% and 20%, respectively. both morbidity and mortality were significantly reduced compared to those of the control group, at 69% and 62%, respectively (table 4 ). when the specific igy was given to the pups 1 h after the viral challenge, the infection rate was 38% with a final mortality rate of 31%. the morbidity and mortality rates of the specific igy treatment groups were lower than those of the control group. regardless of whether the igy was fed 1 h before or after the viral challenge, virus neutralization by specific igy was effective. comparing the mortality of mice exhibiting infection symptoms, the igy treated groups showed a similar rate to the control groups, which all exceeded 80%. the igy application in trial 8 was similar to that in trial 7, changing only the age of challenged pups from 5-to 6-days old, with their body weight ranging from 3.0 to 3.5 g. under this situation, the average infection rate decreased to 13% in the igy treated group and 29% in the control group. also, the mortality in the igy treated group among ill pups was lower than that in the control groups. although the average mortality of igy treated groups was as low as 8%, the control groups also exhibited a lower mortality (26.5%) than the control groups in trial 7. in recent years, pathogen-specific igy has also been demonstrated to be effective in the passive protection of human's diseases, such as staphylococcus for holotoxin [7] , rotavirus for diarrhea [36] , dental caries caused by s. mutans [37] , and h. pylori for gastric ulcers [4] . in this study, we tried to produce the specific igy against human ev71. this enterovirus was first reported in the united states in 1974 [13] and has subsequently been reported worldwide [38, 39] . in taiwan, some severe cases of human ev71 are reported every year after the devastating ev71 outbreak of 1998 [15] . the seriousness of ev71 infection lies in its complications, which include hand-foot-and-mouth disease, herpangina, aseptic meningitis, poliomyelitis-like paralysis, and fatal encephalitis [40] . most fatal cases occur in children under 3 years old, and high mortality is correlated with brainstem encephalitis [41] . the specific igy against ev71 in the egg yolk increased after the third week after the first immunization, though there were obvious differences among individual hens. this variation in antibody pro-duction, based on the specific igy production, might be the result of differences in individual immune responses [3] . the origin of antigen also plays an important role in the immune response, as different outer membrane proteins or fimbrial adhesions from the bacteria affected the rate of igy production [5, 9] . when the protein antigen contained whole bacteria, or when the virus achieved better specific antibody production, the in vivo neutralization effect of the resultant antibody was also better [7] . this study used the whole virus as the antigen source to obtain a better igy titer. the total protein obtained from an egg yolk by the water dilution method is around 595 mg per egg. this protein contains few lipids and lipoproteins, and accounts for one-sixth of the total protein of a yolk [42] . in this study, the purity of igy in wsf was approximately 30-40% (table 1 ). this demonstrates that the water dilution method can easily separate the igy from other egg yolk components, as described previously [4, 34] . for the production of igy in trials 1-8, the immunization dosage of antigen used was doubled and the immunization schedule was modified. a longer interval of 7 weeks was applied after the fourth immunization, and the last boost was given on week thirteen. thereafter, the average specific-igy against ev71 between 3 and 18 weeks increased to 3.33% of the total igy, which is significantly higher than that of the pre-test which is only 1% of the total igy (p < 0.5). however, whether or not this modified protocol is beneficial to the production of specific igy remains to be clarified. an analysis of the relationship between the concentration of specific igy with the neutralization titer of the same sample revealed no significant correlation (table 2 ). this indicated that the amount of specific igy estimated by the elisa method was not a good indicator of the neutralization titer of ev71 virus in this study. previous studies on the effect of antibodies against bacillus spores, botulinum pentavalent (abcde) toxoid and anthrax vaccine also suggest that elisa is not a reliable indicator for the neutralization titers [43, 44] . the neutralization titer itself is a better indicator of antibody functionality. we determined the concentration of specific igy by elisa method using the cell lysate from the whole virus particle as the coating antigen. the binding between all viral proteins and specific igy would be counted as part of the igy concentration, whether or not the specific antibody was effective in virus neutralization. kovacs-nolan et al. [45] studied the epitopes of human rotavirus (hrv) by igy and found that only three out of the five sequential neutralization epitopes on the wa strain subunit protein vp8 were directly involved in hrv neutralization [46, 47] . our results indicate that the therapeutic function was significant when neutralization titer of the anti-ev71 igy was 128 or higher (table 2) . however, further research is necessary to identify the antibodies directly involved in the neutralization of ev71. this study includes two panels of animal tests for the ev71 challenge and igy treatment. in trial 1, we challenged 1-day-old mice with a mouse-adapted ev71 strain mp4 by intraperitoneally administering a dosage of 10 5 pfu per mouse, and treated with specific igy of neutralization titer 64. the results revealed no therapeutic effect. on the contrary, if the neutralization titer value of specific igy was 128 or higher, the protective effects were significant (table 2 ). previous studies also show that this level of neutralization titer is effective for the serum igg of mice [31, 35] . compared to the control group, the mice in specific igy treated group not only had a lower mortality, but also had normal weight gains. most of the mice in control group showed a weight loss 5 days after the viral challenge, and continued to lose body weight until they died. less than 10% of the sick mice in the control group survived the artificial infection of ev71 at a dose of 10 5 pfu per mouse. the surviving mice gained some weight despite showing signs of illness. after reaching a body weight of 4.5-5.0 g, they recovered from the infection and returned to healthy status. however, their subsequent weight gains were only 60-70% of the mice in the specific igy treated group (data not shown). some surviving mice also exhibited persistent paralysis of the hind limb and remained paralyzed for the rest of their lives, just like some children infected by ev71 [47] . in trials 1-4, the ip injection time of specific igy began from the second day after viral infection and lasted for three consecutive days, before the ev71 syndrome appeared. in practical situations, children infected by ev71 will probably only receive the igg treatment after they exhibit the typical symptoms. to determine the critical timing of effective treatment, trials 5 and 6 applied specific igy treatment one and two days later, respectively. clearly, the starting time of specific igy injection was essential in reducing the mortality of infected mice. if igy was given on 4-6 dpi, at which point most mice exhibited the symptoms of hind limb paralysis, only 37% of infected mice survived. it has been reported that on the first day of ev71 infection, the virus is kept in the small intestine, and then spreads to other organs on 2 dpi. the virus attacks most organs on 3 dpi, including the brain stem, lung, spinal cord, and muscle [31, 48] . if we started the specific igy treatment on 2 dpi, which corresponds to the onset of clinical symptoms in children, then the therapeutic outcome was improved. in this case, the survival rate of the ev71-infected mice could be increased to 79%, highlighting the importance of the timing of specific igy treatment. before the on-set of clinical symptoms, specific igy treatment has a better chance of achieving effective therapy. some animal studies use oral feeding of egg yolk powder directly, without any purification of specific antibodies from the yolk [10, 49] . these studies prove the possibility of passive protection from the de novo form of yolk powder. in this study, 4 to 5 day-old mice were orally challenged with a viral dosage of 3 × 10 6 pfu per mouse. challenged mice in the specific igy-treated group showed a lower morbidity rate of 29% (12/41) than the control group, which showed a morbidity rate of 79% (38/48) . this indicates that the orally fed specific igy effectively neutralized the viral attack in the gastroenteric duct, thereby blocking the infection of virus in challenged mice. the neutralization function appeared to be effective no matter if it was given 1 h before or after the viral challenge. the mortality among specific igy treated mice was 24% (10/41), which was significantly lower than that of the control group, at 69% (33/48). however, the effect of specific igy declined for pups aged 5 to 6 days old with a body weight ranging from 3.0 to 3.5 g. previous research also shows that the age of mice affects the infection results [50] . mice more than 6 days old would not be infected by ev71 after artificial challenge, indicating that the immune system of mice at this age could provide suitable protection. when mice are challenged orally or received the igy through an oral passage, the virus and igy pass through gastroenteric duct and be digested by gastric juice, reducing the viral infectivity of the igy function. this was noticed by the lower morbidity after oral challenge with the same strain of ev71 and a less protective function of igy among infected mice, compared to the results in trials 1-6, where an infection rate near 100% and a curing function more than 90% was obtained. the igy specific to human rotavirus exhibits a passive protection against diarrhea in mice [51] . although gastric juice had some influence on igy, was still protective when a sufficient amount of igy was provided. oral administration of spray dried yolk antibodies specific against salmonella typhimurium or salmonella dublin is effective in preventing salmonella infections in calves [5] . igy raised against etec antigen has also been proven effective in controlling the diarrhea of piglets by oral administration [49] . nevertheless, because the 4 to 6 day-old mice pups in this study could not consume egg yolk, we applied a purified antibody from igy instead. this purified igy, derived from the water soluble fraction of egg yolk, was more accessible to the gastric juice and easily exposed to digestive enzymes. the activity of might be influenced by the change of structure and loss of bioactivity [5, 7] . based on the limitations of oral administration in suckling pups, a higher titer of igy or a continuous treatment of igy after viral challenge might achieve greater protection. this possibility is worthy of further research. the results of this study, however, indicate the potential of igy in the prevention of ev71 infection in young children. several studies have been conducted to evaluate the stability of these antibodies. the igy is not degraded during pasteurization at 60 • c [52] igy was stable after 30 min in 60-65 • c, but was no longer active after 20 min in 80 • c [53] . so igy technology being new potential market applications in medicine, public health, veterinary medicine and food safety. a broader use of igy technology could be applied as biological or diagnostic tool, nutraceutical or functional food development, oral-supplementation for prophylaxis, and as pathogen-specific antimicrobial agents for infectious disease control. in conclusion, the icr mice ip challenged with mouse-adapted strain mp4 of ev71 at a dose of 10 5 pfu per mouse induced an ev71 infection resulting in a high mortality rate. however, a survival rate of 98.3% (60/61) was achieved if the challenged mice were ip injected, 1-3 dpi for 3 consecutive days, with a purified igy antibody with a neutralization titer of 128 or more. when the challenge was carried out orally with a dose of 3 × 10 6 pfu per mouse, the lower morbidity in igy treated group proved that the protection could be achieved by the neutralization of virus in the gastroenteric duct, thereby reducing the mortality of challenged mice. this is the first study to evaluate the effect of igy treatment on ev71 infection, and our positive results indicate that further application in the prevention of ev71 is possible. in the form of an egg-yolk-added drink, yolk powder tablet, or capsule, it is can potentially be used to prevent the early infection of ev71. efficient production of chicken egg yolk antibodies against a conserved mammalian protein phylogen of immunoglobulin structure and function. immunoglobulins of the chicken antienteropathogenic escherichia coli immunoglobulin y isolated from eggs laid by immunised leghorn chickens use of egg yolkderived immunoglobulin as an alternative to antibiotic treatment for control of helicobacter pylori infection oral passive immunization against experimental salmonellosis in mice using chicken egg yolk antibodies specific for salmonella enteritidis and s. typhimurium oral passive immunization effect of anti-human rotavirus igy and its behavior against proteolytic enzymes protection against bacterial superantigen staphylococcal enterotoxin b by passive vaccination passive immunization against dental plaque formation in humans: effect of a mouth rinse containing egg yolk antibodies (igy) specific to streptococcus mutans effects of hen egg yolk immunoglobulin in passive protection of rainbow trout against yersinia ruckeri passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder immunoprophylactic effect of chicken egg yolk immunoglobulin (igy) against porcine epidemic diarrhea virus (pedv) in piglets picornaviridae in virus taxonomy. seventh report of the international committee for the taxonomy of viruses an apparently new enterovirus isolated from patients with disease of the central nervous system enterovirus infections with special reference to enterovirus 71 an epidemic of enterovirus 71 infection in taiwan. taiwan enterovirus epidemic working group fatal enterovirus 71 encephalomyelitis outbreak of severe neurologic involvement associated with enterovirus 71 infection pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema treatment of potentially life-threatening enterovirus infections with pleconaril sch 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating characterization of a vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate safety and efficacy of intranasal pirodavir (r77975) in experimental rhinovirus infection sch 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating treatment of potentially life-threatening enterovirus infections with pleconaril acute flaccid paralysis syndrome associated with echovirus 19, managed with pleconaril and intravenous immunoglobulin activity of pleconaril against enteroviruses neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin neurological complications of enterovirus 71 infection in children: lessons from this taiwan epidemic neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice complete genome analysis of enterovirus 71 isolated from an outbreak in taiwan and rapid identification of enterovirus 71 and coxsackievirus a16 by rt-pcr a mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection comparison of four purification methods for the production of immunoglobulins from eggs laid by hens immunized with an enterotoxigenic e. coli strain immunoglobulins from egg yolk: isolation and purification in vitro studies of chicken egg yolk antibody (igy) against salmonella enteritidis and salmonella typhimurium neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea passive transfer of immunoglobulin yantibody to streptococcus mutans glucan binding protein b can confer protection against experimental dental caries enterovirus 71 infections and neurologic disease-united states, 1977-1991 monoplegia caused by enterovirus 71: an outbreak in hong kong enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis clinical spectrum of enterovirus 71 infection in children in southern taiwan, with an emphasis on neurological complications general chemical composition of hen eggs search for correlates of protective immunity conferred by anthrax vaccine immunological correlates for protection against intranasal challenge of bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits fine mapping of sequential neutralization epitopes on the subunit protein vp8 of human rotavirus identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (sars) coronavirus: implication for developing sars diagnostics and vaccines outbreak of poliomyelitis-like paralysis associated with enterovirus 71 a murine oral enterovirus 71 infection model with central nervous system involvement passive protective effect of egg-yolk antibodies against enterotoxigenic escherichia coli k88+ infection in neonatal and early-weaned piglets outbreaks of hand, foot and mouth diease by enterovirus 71. high incidence of complication disorders of central nervous system antibodies to rotaviruses in chickens' eggs: a potential source of antiviral immunoglobulins suitable for human consumption productivity and some properties of egg yolk antibody (igy) against human rotavirus compared withr abbit igg suppressive effect of functional drinking yogurt containing specific egg yolk immunoglobulin on helicobacter pylori in humans key: cord-337464-otwps68u authors: parray, hilal ahmed; shukla, shivangi; samal, sweety; shrivastava, tripti; ahmed, shubbir; sharma, chandresh; kumar, rajesh title: hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives date: 2020-05-27 journal: int immunopharmacol doi: 10.1016/j.intimp.2020.106639 sha: doc_id: 337464 cord_uid: otwps68u the advancements in technology and manufacturing processes have allowed the development of new derivatives, biosimilar or advanced improved versions for approved antibodies each year for treatment regimen. there are more than 700 antibody-based molecules that are in different stages of phase i/ii/ iii clinical trials targeting new unique targets. to date, approximately more than 80 monoclonal antibodies (mabs) have been approved. a total of 7 novel antibody therapeutics had been granted the first approval either in the united states or european union in the year 2019, representing approximately 20% of the total number of approved drugs. most of these licenced mabs or their derivatives are either of hybridoma origin or their improvised engineered versions. even with the recent development of high throughput mab generation technologies, hybridoma is the most favoured method due to its indigenous nature to preserve natural cognate antibody pairing information and preserves innate functions of immune cells. the recent advent of antibody engineering technology has superseded the species level barriers and has shown success in isolation of hybridoma across phylogenetically distinct species. this has led to the isolation of monoclonal antibodies against human targets that are conserved and non-immunogenic in the rodent. in this review, we have discussed in detail about hybridoma technology, its expansion towards different animal species, the importance of antibodies isolated from different animal sources that are useful in biological applications, advantages, and limitations. this review also summarizes the challenges and recent progress associated with hybridoma development, and how it has been overcome in these years to provide new insights for the isolation of mabs. antibodies are the glycoproteins produced by the b-cells also known as immunoglobulins, which are present in higher eukaryotes. immunoglobulins are present in either as a soluble form (blood or plasma) or as membrane-bound form (b cell receptors). antibodies are the major component of the humoral immune system that provides protection against the invading pathogens i.e. viruses and bacteria [1] . an antibody is made up of two structural unit's i.e. heavy and light chain. generally, each heavy chain has one variable and three constant regions whereas the light chain has one variable and one constant region. the variable region of antibodies is mainly responsible for its interactions with the invading pathogen and antigen recognition. the antigen-antibody recognition mechanism works like a lock and key fashion. each antibody has a particular paratope (i.e. lock) that binds to a particular antigen (i.e. key). one type of b cell produces one type of antibody against a particular antigen. there are five different types of heavy chains based on the structure of crystallizable fragments (fc) that is attached to the antigen-binding fragments. on the basis of different fc region, antibodies are grouped into five different isotypes i.e; igm, igg, iga, igd, and ige. among all the isotypes igg is the smallest and the most common isotype with the highest therapeutic potential. it makes 70-80% of the total antibodies. iggs have a longer half-life and are permeable to extravascular spaces [2, 3] . https://doi.org/10.1016/j.intimp.2020.106639 received 11 april 2020; received in revised form 6 may 2020; accepted 22 may 2020 antibodies are potentially used for various applications as extraordinary tools in biomedical research for many years. high specificity and selective binding have expanded the scope of antibodies to various applications such as flow cytometry, magnetic cell sorting, immunoassays, therapeutic approaches etc. [4] . antibodies have developed about 40 years ago and have expanded the scope of antibodies to various applications due to their specificity and selective binding ability. these antibodies are classified into two primary subtypes, monoclonal and polyclonal on the means they are basis of their origin from the lymphocytes [5, 6] . both polyclonal and mabs have their advantages and limitations which make them equally suitable for different applications. polyclonal antibodies (pabs) are a pool of immunoglobulin molecules that are secreted by different b cell lineages and react against multiple epitopes of a specific antigen. the pabs are generated by injecting an immunogen into an animal using a prime-boost immunization strategy to produce high titres of antibodies against the particular antigen. after immunization, pabs can be used directly or in the purified form (through affinity column chromatography to remove other serum protein components). polyclonal sera display multiple epitope binding properties which make them an attractive reagent for various purposes, like its use as research or therapeutic reagent either directly or in purified form. the polyclonal serum is widely used for several decades for the treatment of toxin-mediated bacterial and viral diseases [7] . emil adolf von behring was awarded nobel prize in physiology and medicine in 1901 for his work on serum therapy, especially its application against diphtheria, through which he opened doors for new ways of treatment in medical sciences [8, 9] . animal serum-derived therapy has been successfully applied for different medical aspects like overdosing of medication, viral disease (like rabies) and as antitoxins in snakebite envenoming [10] . the beneficial effects of pabs come from its polyclonal nature and biophysical diversity. the poly clonality nature allows targeting multiple sites in a single window of the application and biophysical diversity provides greater stability in environmental changes [11, 12] . despite having beneficial effects of serumderived pabs therapy has several limitations, which need to be evaluated before introducing new interventions. as blood-derived products, intravenous polyclonal immunoglobulins (ivig) have limited availability, batch-to-batch variability; carry the risk of blood-borne disease transmission and only a small fraction of antibodies from the pool of antibodies binds to the target of interest to exert the desired effect. this sometimes results in low specific activity and relatively needs high doses to observe a desired beneficial clinical effect [13, 14] . the other limitation of polyclonal serum is that it cannot be used for the treatment of chronic diseases [15] . due to some of these potential drawbacks of pabs, the way for mab isolation, need, and urgency comes into the light. however, mabs are most suitable and frequently used because of their high sensitivity, specificity, affinity and homogenous nature [16] . monoclonal antibodies are monospecific in nature and produced by identical b cells having high affinity and specificity towards a single epitope of an antigen. in 1975 hybridoma based technology was used to generate the mabs showing very minimal and acceptable batch to batch variation, produced in an indefinite amount continuously. the mabs can be produced against any given epitope present on an antigen or immunogen. moreover, they can be used to detect, purify and characterize the substance of interest. since the development of mab, the scope of antibodies has expanded to various further applications due to their target specificity [17] . this has made mabs a powerful tool in the fields of biochemistry, molecular biology, and medicine. antibody-based biologics are one of the best-selling classes of biomolecules in today's market. advancement in mab generation technologies in recent years has made ease in identification of new target antigens to be explored in diagnostic and therapeutic approaches [18, 19] . several mab generation technologies had been developed over the years, to isolate mabs from immune and non-immune sources using hybridoma, display methods, and more advanced novel mab development technologies like single b cell amplification and culturing methods. unlike the hybridoma method, other methods rely mostly on recombinant production of mabs. each of these technology platforms has their respective advantage, limitations, and applicability [18, 20, 21] . hybridoma technology is the primitive, most fundamental and successful methodology in the field of mab isolation [19] . this technology is quite robust and useful in discovering thousands of antibodies for different applications [22] . the basic practical advantage associated with hybridoma technology is, once the hybridoma clones are established, the production of mab becomes simple and efficient. the antibodies isolated through hybridoma methodology preserves the native pairing of variable and constant regions gene combination, which further supports studies on both direct and indirect functions of a mab. hybridoma technology relies on b cells that are matured in secondary lymphatic organs in response to an antigen. these b cells undergo natural antibody maturation process where the variable region of antibodies diversified by accumulating somatic hypermutations which further results in the selection of high-affinity tight binders [18, 20] . resulting antibodies possess the natural pairing of variable heavy and light chain genes with naturally class-switched matured constant region gene through class switch recombination (csr). such freedom of natural csr is not possible in other mab isolation method that makes hybridoma a unique way to produce naturally matured in vivo antibodies in the laboratory [19] . nevertheless, hybridoma technology is the most preferred technology for mab discovery for in vivo applications. presently there are more than 90% of the antibodies approved by the united states food and drug administration (us fda) are generated by traditional hybridoma technology and are used either directly or in chimeric or humanized versions [19, 23, 24] . a list of these fda approved antibodies has been listed in table 1 . the dominance of this technology has been continued with the recent development of transgenic humanized animals that has opened new avenues for more effective generation of high-quality human antibodies in the modern biotherapeutic era. in this review, we have discussed in detail about hybridoma technology, how it has been expanded to different animal species and their associated biological applications which determine their usage for certain intends. we have also discussed the advancement and challenges associated with hybridoma development, and how it has been overcome in years. georges kohler and cesar milstein in 1975 invented the hybridoma technology, for which they received the nobel prize in 1984 in physiology and medicine [25] . during the same period, herve bazin in louvain-la-nerve belgium created a rat myeloma cell line ir983, allowing the generation of first rat mabs (https://www.synabs.be/2019/ 11/25/hybridoma-vs-display-the-fight-of-the-century/). hybridoma cells are generated via fusion between a short-lived antibody-producing b cell and an immortal myeloma cell. each hybridoma cell constitutively expresses a large amount of one purely specific mab, and favoured hybridoma clones can be cryopreserved for continuous mab production for a long period. hybridoma generation process takes advantage of a host animal's natural ability to generate functional, highly specific and high-affinity mabs [19] . to date, several mabs are developed using this technology and are presently used for diagnosis, prevention, and treatment of different diseases tables 1, 2 and 3. initially, hybridoma technology was limited to murine antigens but with advancement in this field, it is a well-established technology to develop mabs against a vast range of antigens and from different species like rabbits [26] , humans [27, 28] , chickens [29] , goats, sheep [30] , cows [31] , mice [32] , guinea pigs, and rats [33] . choice of animal species especially for mab isolation depends on several factors such as the presence of a homologous protein in the immunized species, table 3 a list of fda approved rabbit mabs that are used in diagnostics. device name availability of suitable fusion partner, the amount of protein or antigen available for immunization, the time required to obtain an antibody response and finally, a purpose for which these mabs are needed. most commonly used hosts for mab production are the mice followed by rabbits. the inbred balb/c strain of mice is usually the right choice and preferably suited for mab isolation [34] . chickens are also considered as a preferred host of choice due to its distinct phylogenetic relationship between the antigen donor and the antibody producer [16, 35] . hybridoma technology has not gained much attention because its success mainly depends on the availability of a suitable fusion partner. in the initial years of hybridoma discovery, technology was limited to mice but in progressive years researchers used this platform for human and rabbit hybridoma development. however major limitation associated with the production of mabs from other species is the instability of hybridoma clones produced with fusion partners from heterologousspecies [18] . this instability resulted in the hybridoma clones are due to the fusion of two cells from different species which leads to chromosomal instability. to overcome this, in the past few years many different strategies have been used to increase the fusion efficiency. generally, there are two types of hybridomas one is homo-hybridomas and second is hetero-hybridomas. in homo-hybridomas both, the igg secreting b cells and fusion partners are from the same species. in hetero-hybridomas the antibody-secreting b cells and fusion partners are from two different species. homo hybridomas are genetically more stable and secrete stable igg as compared to hetero-hybridomas as it gradually lost the chromosomal recombinants during the clonal selection step due to their genetic instability. 3. animal species used for hybridoma development over the years: mouse polyclonal and mabs held the largest market in 2019 as they are more specific and easier to produce in nature. the structural similarities between human and mice antibodies are the prime reason for their high acceptability rate. upgradation and simplicity of mice hybridoma process have made it a more prime reason for their high adoption rate in research and therapeutics [36] . the mice hybridoma technology is a multi-step process that takes advantage of a host animal's natural ability to produce highly specific, high-affinity and fully functional mabs. it involves the development and optimization of specific immunogenic antigen (ag). following the optimization, a host animal is immunized with the ag along with adjuvant for several weeks. the sera from immunized animals are tested for their reactivity and specificity to the immunizing antigen while the animals with high titres of binding antibodies are selected further for splenocytes isolation [32] . the spleen cells are fused with the immortalised myeloma cells in the presence of fusogenic agents like viruses, chemicals and electric pulses. the most common myeloma fusion cell lines are x63-ag 8.6539 [37] and sp2/0-ag 1410 [38] , with the origin from balb/c mouse. the fused cells are then selected on hypoxanthine-aminopterin-thymidine (hat) medium. the myeloma cells are sensitive to hat medium as they lack hypoxanthine-guanine phosphoribosyltransferase (hgprt) gene required for nucleotide synthesis by the de novo or salvage pathways while the unfused b cells die as of short life span. in this process, only the hybrid (b cell-myeloma) survives, as they harbour the functional hgprt gene from the b cells. however, hybrid cells retain the dual properties, antibody secreting property of b cells and continuously growing property (immortality) from myeloma cells. fused or hybrid cells are then screened by "limited dilution cloning" method or with semi solid selective medium to select only those hybridoma that produce antibodies of appropriate specificity. a detailed schematic representation of steps involved in hybridoma production is shown in fig. 1 . production of antibodies by mouse hybridoma technology is quite robust and has been useful to discover thousands of antibodies for different applications. academic and industrial research groups with expertise in the field of antibody isolation, hybridoma methodology continues being the methodology of the first choice, particularly if the goal is to obtain antibodies for analytical purposes. the main associated advantage is that, once the hybridoma clone is isolated, mab production in mouse ascites is simple, efficient and reproducible. these hybridomas can be stored in liquid nitrogen for several years making them virtually immortal [39] . the mouse mabs can be potentially used for diagnostic, therapeutic as well as for other research applications. the first therapeutic antibody that was approved by the food and drug administration (fda) in 1985, developed by murine hybridoma technology was potentially used to reduce the graft rejection in transplant patients [18] . okt3, the first mab to be used in organ transplantation and during the past one decade there has been an extensive experience of its use both for prevention and treatment of organ transplantation rejection. okt3 blocks t cell function by modulating cd3 and the t cell receptor from the t cell surface, functions as an immunosuppressant [40] . since its discovery, okt3 was further improvised in progressive years from chimeric to humanized version, to further reduce adverse effects and to increase immunologic efficiency [41] . the use of murine derived mabs has less therapeutic value as they are entirely from mouse origin and can cause immunogenic reactions in the target host. such limitations have been addressed by chimerization and humanization of antibodies, potentially removing the mouse immunogenic content [42] . several murine mabs has been approved by the fda for use in diagnostic and therapeutic purposes over the years as listed in table 2 . since the discovery of mouse mabs, rabbit hybridoma has been potentially used as a dominant tool in the field of research, diagnostics and therapeutics from several decades [4] . however, a new technology for generating mabs with improved affinity, specificity and having the ability to recognize non-immunogenic rodent's epitopes, are in need as an alternative for the scientific community. the rabbit immune system has been documented as a vehicle for developing antibodies with higher affinity and more diverse recognition of many molecules including phospho-peptides, carbohydrates and immunogens that are not otherwise immunogenic in mouse [24] . antibodies produced in rabbits usually have about 10 to 100 fold greater affinity than those produced by mice. rabbits generate more diverse and complex immune response towards target antigen as compared to human and mice because of gene conversion and somatic hypermutations phenomenon leads towards more mutations in rabbit antibody repertoire [43, 44] . the gene conversion is responsible for introducing mutations and affinity maturation of variable antibody fragments which takes place in double-stranded rearranged v(d)j dna segment of antibody gene via homologous recombination [19, 45] . the rabbit iggs are somewhat simpler than the mouse and human antibodies. rabbit igg has only one subclass i.e. cî³ gene and the majority (90-95%) of light chains are derived from isotype cîº1. only 5% to 10% of the total igg light chains are isotype l. fig. 2 . several efforts were made to generate rabbit mabs after the development of mouse hybridoma technology in the 1970s. due to the favourable properties of rabbit antibodies, many scientific groups tried to develop methods for the generation of rabbit hybridomas. this endeavour was significantly complicated by the absence of rabbit myeloma cell lines. viral transformation of rabbit b cells to generate myeloma-like cell lines also proved to be difficult and rather inefficient [46] . for these reasons, substantial efforts are focused on generating rabbit-mouse hetero-hybridomas. unfortunately, all hetero-hybridomas generated in the early days of hybridoma technology revealed poor fusion efficiency, genetic instability and impaired functional rabbit heavy-and light-chain pairings. in 1988, raybould et al. generated the first stable rabbit-mouse hetero-hybridoma by polyethylene glycol-mediated fusion of rabbit spleen b cells with the mouse myeloma cell line sp2/0-ag14. even though they observed stable rabbit igg expression for several months, other groups observed genetic instability and concomitant decrease of mab secretion [47] . these shortcomings could be partially addressed by extensive efforts to regularly subclone the rabbit-mouse hetero-hybridoma in 1996, weimin zhu and robert pytela, at the university of california, developed an improved rabbit hybridoma fusion partner by repeatedly subcloning. after multiple rounds of subcloning, they selected high fusion efficiency clones based on characteristics like robust growth, morphological characteristics and named it as a new cell line 240e-w, with better fusion efficiency and stability. since then this cell line 240e-w has been further developed and optimized to eliminate endogenous igg and has been used for the production of rabbit mabs for research and commercial applications [48] . the cell line 240e-w was further modified to a superior version 240e-w2. abcam patented this technology to develop highly specific mabs, under the name of ranmab, which has been potentially explored for the production of diagnostic and research antibodies. a large number of rabbit mabs are used in basic laboratory research. rabbit mabs are preferred over the mouse and human mabs in diagnostics and pharmaceuticals applications because of their high specificity and affinity. various rabbit mabs have been approved by the fda to use as in vitro tumour diagnostic tool [49] . a list of fda approved rabbit mabs for diagnostics are listed in table 3 . recently, wei et al. developed an ultrasensitive test for ebola virus diagnostics using carbon nanoparticle-labelled pad with rabbit anti-ebola virus (ebov)-vp40 igg for rapid detection lateral flow test strip for ebola virus [50] . limited success has been gained in the development of rabbit mabs as therapeutic agents but the potential use of rabbit pabs for the prophylaxis and treatment of acute rejection against t cells in organ transplant opened venture to explore the use of humanized rabbit mabs as a therapeutic agent [46] . a company name epitomics has developed a humanized rabbit monoclonal drug candidate and demonstrated in vitro and in vivo efficacies [51] . recent fda approval of humanized rabbit monoclonal single-chain antibody fragment, brolucizumab in 2019 for the treatment of wet age-related macular degeneration (amd) has increased hope and venture of other humanized rabbit monoclonal for therapeutics in near future [52] . a detailed description of these antibodies has been reviewed by mage et al. 2018 [53] . human hybridoma technology which allows the direct generation of human antibodies in a native form, is the most direct effective approach for the production of natural therapeutic and diagnostic antibodies with no additional modifications require [54] . it is believed to be the most promising and convenient technological platform for the isolation of therapeutic mabs. however, success of human hybridoma technology for the therapeutic purposes has been limited since years due to several technical challenges like unavailability of human fusion partners, as most of the fusion partners available are from rodent origin or heteromyelomas. a fusion of human b cells with different fusion partners limits the use of these mabs for therapeutic applications. several hetero-myelomas fusion has been successfully employed for the generation of mabs of human origin for different diseases like hiv [28, 55] , chikungunya [56, 57] , dengue [58] etc. however, such hybridomas are unstable, leads to a loss in the ability of antibody secretion hence there is a challenge in achieving desired pharmacokinetic characteristics of natural human antibodies in terms of distribution, metabolism and excretion [54] . several scientific groups have attempted to develop natural human fusion partner cell lines but limited success stories are reported using these fully human fusion partners. one such example of fusion cell is human karyochi cells which were successfully used to develop complete human stable hybridomas with igg secreting properties for several months. the fusion efficiency of these human karyochi cells was in the range of 10 -5 to 10 -3 with no reports on the endogenous generation of immunoglobulin or chains that can interfere with subsequent synthesis, assembly and purification of mabs. the other major limiting step in the development of human hybridomas is low fusion efficiency of human b cells with the myeloma partner (0.001%) and secondly, the low percentage of circulating antigen-specific b cells in the peripheral blood (0.01%) also limits the use of this technology [59] . frequency of antigen-specific b cells is very rare in circulation therefore, selection of a proper blood donor is critical for the success of this method. acutely infected patients have a higher number of circulating b cells as compared to the convalescent patients. donors showing a high titre of serum binding/neutralizing antibodies may have a higher frequency of peripheral b cells, and an indication of the greater chance of successful production of hybridomas. to overcome these challenges different groups have tried ebv(epstein-barr virus) transformation approach to enrich the population of b cells [60] . the most commonly used cell line b95-8 is a continuous cell line releases high titres of transforming ebv in supernatants [61] . the b95-8 cell line was initiated by exposing marmoset blood leukocytes to ebv fig. 2 . schematic drawing of natural rabbit, mouse, chicken and human igg. generally 150-kda igg comprises of two identical îº or î» light chains paired with two identical heavy chains. the light chain consists of an n-terminal variable domain (vl), followed by one constant domain (cl). the heavy chain consists of an nterminal variable domain (vh), followed by three constant domains (ch1, ch2 and ch3) generally, however, the heavy chain of avian igy contains four constant regions (ch1, ch2, ch3 and ch4). schematic drawing of natural rabbit antibodies in igg format. the~150-kda rabbit igg molecule contains two identical îº (white) or î» (light grey) light chains paired with two identical heavy chains (dark grey). the light chain consists of an n-terminal variable domain (vl), shown with its three cdrs, followed by one constant domain (cl). the heavy chain consists of an n-terminal variable domain (vh), also shown with its three cdrs, followed by three constant domains (ch1, ch2 and ch3). ch1 and ch2 are linked through a flexible hinge region that has the amino-acid sequence apstcskptcp (or apstcskpmcp in an allotypic variant) and anchors three disulphide bridges (orange) of the igg molecule, one for each of the two light-and heavy-chain pairs, and one for the heavychain pair. notably, rabbits have two îº light chains, k1 and k2. the more frequent îº light chain, k1, contains an additional disulfide bridge that links vl and cl. rabbits of the commonly used new zealand white strain have~90% igg-îº (k1),~10% igg-îº (k2) and < 1% igg-î» antibodies. (for interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) extracted from a human leukocyte cell line. b95-8 provides a source for ebv to establish continuous lymphocytic cell lines from human donors. ebv mainly binds with the cells in peripheral blood that contains cd21 receptor and b cells in peripheral blood express these antigens on their surface and activates latent membrane protein (lmp) 2a and lmp1 [62, 63] . due to low antibody-secreting and chromosomal instability characteristics transformed b cells cannot be cultured for a long period. the transformation efficiency of ebv to b cells is low, ranges from 0.1 to 1%, however, the transformation efficiency of b cells in presence of ebv can be increased by the addition of cpg, which acts as toll-like receptor (tlr) 9 agonist [27] . cpg oligo-deoxynucleotides (or cpg odn) are defined as short single-stranded synthetic dna molecules where c refers for a cytosine triphosphate deoxynucleotide ("c") followed by a guanine triphosphate deoxynucleotide ("g"). the "p" denotes to the phosphodiester bond between consecutive nucleotides [64] . in unmethylated form, these cpg motifs act as immune stimulants and are recognized by the pattern recognition receptor (prr) toll-like receptor 9 (tlr9), which is constitutively expressed on immune system cells like b cells. these b cells undergo polyclonal response to cpg dna stimulation by proliferation and differentiation to antibody-producing cells [65] . these transformed b cells are grown for a specific time for the emergence of immortalized cells, which further fused with the fusion partner to establish hybridomas. this cpg activation method has been successfully used to produce mabs against severe acute respiratory syndrome coronavirus (sars-cov) [66] and hiv [27] . the main concern of developing hybridoma for therapeutic purpose is that the final hybrid cells should be free of ebv and other human viruses [67] . the two most common cell lines used for fusion are shm-d3327 and hmma 2.5. the shm-d33; produced by fusing the human myeloma cell line fu-266, clone e-1 (hat sensitive, 8-azaguanine resistant and resistant to g-418 -an antibiotic similar to gentamicin) with the murine myeloma p3x63ag8.653 [68] . this cell line has been used as a fusion partner to stabilize the lymphoblastoid cell lines (lcl's) secreting immunoglobulins to produce mabs against envelope proteins of hiv-1 and parvovirus b19 [55, 69] . hmma 2.5 is a human ã� mouse cell line that was generated by fusing mouse myeloma cell line p3x6ag8.653 with bone marrow mononuclear cells of a patient with iga myeloma [70] . several mabs have been produced using this cell line as a myeloma fusion partner [71] . the other limiting steps in human hybridoma development are fusion efficiency. fusion is mainly performed by three methods (i) chemical agents like polyethylene glycol (peg) (ii) viral agent mediated methods and (iii) electric fusion methods. peg mediated fusion is the most common and traditional method of fusion due to its simplicity and most commonly convenient fusing agent of choice for hybridoma production. peg fuses the plasma membranes of two adjacent mammalian cells by dehydrating the lipid head groups, leading to the asymmetry of the membrane bilayer, favouring fusion of two cells leading to a single cell with two or more nuclei. one major drawback of peg mediated fusion is a generation of non-specific fusion between different kinds of cells [72] . over the year's viral agents have also been used as a successful agent to perform fusion among two different cells. sendai and vesicular stomatitis virus are the two most commonly viruses used as fusion partners. the most efficient and innovative method for cell fusion is electrical cytofusion. this mainly works on the principle of fusion of cells in the presence of high-intensity electric field pulse that causes transient membrane permeabilization. this method has higher fusion efficiency over chemical or viral-based fusion methods. however, electrofusion yields in low fusion efficiency when fusion partner cells are different in size [73] . hmma 2.5 myeloma cell line is found to be the most preferred cell line for electrofusion showing maximum fusion efficiency as compared to other myeloma cells [71] . rems et al., developed a numerical calculation method to fuse cells with shorter, nanosecond (ns) pulses. the performance of this method works on the principle of contact areas between two fusion cells, regardless of their cell size [73] . use of cephalin as fugenic reagent along with emetine and actinomycin d, golestani as selection method dramatically increased the fusion efficiency and recovery (19-34%) [74] . the major advantage of human hybridoma technology is that antibodies produced by this technology are derived from human origin have more therapeutic applications than rodent derived counterparts due to attributable differences between the human and rodent immune systems. due to evolutionary differences between mammalian (e.g. human, mice) and avian species (chickens), the avian/chicken immune system recognizes more epitopes on mammalian proteins as foreign and generates a more vigorous and diverse immune antibody repertoire [35] . phytogenic differences among different species have been illustrated in fig. 3 . as the phylogenetic difference between the immunizing antigen and the immunized animal increases, the immune response increases accordingly. it is, therefore, possible to produce antibodies in chicken that are difficult or impossible to produce in mammals such as g-protein-coupled receptors (gpcrs) against which producing antibodies in rodents is a challenge as of high sequence conservation (> 70%) at the protein level. chickens are emerging as valuable immunization hosts specifically for therapeutic antibody discovery for difficult targets having sequence conservation in mammals. the use of chicken egg yolk for antibody production represents a reduction in animal use (ethical issues) as chicken produces a larger amount of antibodies than laboratory rodents [75] . the advantages of chicken (gallus domesticus) antibodies as diagnostic and therapeutic biomolecules are less characterized than their mammalian counterparts [16] . initially, in 1989 a successful attempt was made to generate chicken hybridomas against newcastle disease virus (ndv) by fusing the peripheral blood lymphocytes (pbl) and thymidine-kinase deficient (tk-) chicken myeloma cells [76] . surprisingly, the secreted antibody hybridomas were initially obtained, but they lose the ability to produce antibody in the culture immediately [77] . to overcome this issue nishinaka s et al., in 1991 developed a new improved fusion cell line r27h4, for the production of chicken mabs [29] . the new cell line was efficient in the development of antibody-producing hybridomas with highly reactive igg secretion ability of 6 months. these cell lines were further improved and several chicken hybridomas were successfully developed [29, 78] . however, chicken hybridoma technology has been explored in limits and most of the investigators prefer to use phage display method over hybridoma for the development of chicken mabs [79] . the main avian antibody isotype igy shares structural and functional homology to mammalian igg and ige isotype counterparts but the difference in a constant region of antibodies, igy has 4 constant regions whereas igg has 3 constant regions [80] [81] [82] fig. 2 . igy present in chicken sera gets passed to the embryo through the egg yolk [83] . egg igy antibodies have been used previously against bacterial and viral infections [84, 85] . humanization of these antibodies can have great potential for biopharmaceutical development [86, 87] . the recent development of transgenic chicken with human immunoglobulin loci has expedited the use of transgenic chicken derived mabs directly for human therapeutic use [88, 89] . these engineered transgenic chickens express antibodies from immunoglobulin heavy and light chain loci containing human variable regions and exhibit normal b cell development raising immune responses to conserved human targets that are non-immunogenic in mice [90] . these transgenic chickens can be potentially used for the development of hybridoma secreting antibodies of human origin. however, like others, the unavailability of robust hybridoma fusion partner limits its potential utility [88] . in recent years different research groups have extensively explored the display method to overcome the limitations of chicken hybridoma. antibodies isolated through hybridoma methodologies have the advantage of being used directly and could be cryopreserved for future uses till an indefinite time, as the fusion partners are myelomas possessing remodelled transcriptional machinery to secrete a continuously large amount of antibodies [91] . advancement in recombinant technology has overcome the challenges by cloning of variable heavy (vh) and variable light (vl) from unstable hybridoma; cloning in transient transfection vectors to produce antibodies in mammalian expression system [92] . currently the development of stable cell lines has advanced the antibody production system by developing stable cell lines from unstable hybridomas to produce consistent antibody production. chinese hamster ovary cell line (cho) is the most preferred cells used for large scale production of mabs. however, the development of stable cell lines is a tedious process that sometimes takes a month to year time where the success of this process depends on random genome integration of transgenes [93] . development of crispr-cas9 in recent years has overcome by immunogenomics reprogramming using plug and play technology, where crispr-cas9 was used to engineer immunogenomics by homology-directed repair to replace endogenous immunoglobulin region by exogenous donor counterpart with the help of guide rna. this technology platform has enabled the rapid generation of full-length antibody-secreting cell lines [94] . a major limitation of hybridoma technology is the lack of suitable fusion partners which limits the use of this technology and limits its applicability to other species. to overcome the problem of suitable fusion partners, the transgenic mice model h-2k b -tsa58 has been developed. h-2k b -tsa58 transgenic mice express the simian virus 40 (sv40) antigens (tag) under the control of mouse major histocompatibility complex h-2k b promotor. this promotor allows differential expression of sv40 antigen in different tissues at various levels. expression of this antigen can be increased by simply increasing the levels of interferons (ifns) [95] . the higher expression level of this antigen is responsible for tumorigenesis and aberrant development. in this approach transgenic mice h-2k b -tsa58 were specifically used to isolate monoclonal against the filamentous phage. transgenic mice were immunized with filamentous phage suspension. splenocytes were recovered from the immunized animals and spleen cells were limited diluted from 6, 24-, 96-well plates. cells from the positive wells were selected to develop monoclonal lines. the main advantage of this technology is that it eliminates the use of fusion partners and can parallelly be used for the development of monoclonal and polyclonal based therapies [96] . the other major challenge associated with hybridoma development is the requirement of purified antigen to generate a specific immune response. in some of the cases, it's a challenging task to purify the antigen. the lack of specific immune reagents for characterization and monitoring of these numerous proteins limits the overall time process for the production of hybridoma. expression and purification of recombinant protein are time-consuming and sometimes not cost-effective. additionally, immunization of animals with these purified recombinant proteins in formulation with adjuvants sometimes leads to alteration of native conformation of these proteins which finally leads to an undesired immune response in animals. in recent years, different approaches have been successfully implemented to overcome these challenges; a novel strategy has been developed to isolate mabs against the native proteins [55] . in this strategy, animals were directly immunized with transiently transfected hek cells that express desire protein on the surface of these cells in a proper folded and glycosylated form. this modified technology is mainly useful for the isolation of mabs against native antigens. the advantage of this technology is that expressed protein on transfected cells closely mimics as it expresses in naturally infected cells. a similar type of strategy was developed by hazen m et al; where they had attempted to isolate monoclonal against the native conformation of extracellular loops & multi transmembrane proteins using dna based immunization strategy in combination with immunomodulatory agents [97] . use of immunomodulators in dna immunization has positively enhanced the immune response and proved to be a successful approach to isolate desired specificity binding mabs to native conformations. kato et al., in 2019 developed a cell-based immunization and screening (cbis) method for isolation of mabs for podoplanin (pdpn) [98] . in this strategy, they immunized the mice with transfected cells overexpressing pdpn and screened the fused hybridoma cells using flow cytometry. these cell-based immunization methods are useful in the isolation of mabs against various membrane proteins which is still difficult to achieve otherwise [56, 57] . the other challenge in hybridoma technology is animal immunization. the overall efficiency of hybridoma depends upon the efficiency of immunization. some factors that affect the efficiency of immunization are; route of administration of antigen, dose, choice of adjuvant, number of boosts and immunization protocol. dna based immunizations are generally more preferred where it is difficult to express fulllength proteins and immune response are mainly targeted towards native or conformational epitopes because the structural integrity of protein is critical for induction of functional mabs. the major routes of dna based delivery are intramuscular, intravenous and intrasplenic. intrasplenic routes are considered to be the most efficient route. a single dose of dna delivery is sufficient to induce antibody responses. antibodies against different proteins can be produced at the same time by immunizing with several nucleic acids encoding for different proteins or single plasmid encoding different subunits of the protein. in such cases multiple booster doses are usually avoided, to reduce immune-dominance amongst antigens. another major challenge in the field of human hybridomas is the requirement of lymphocytes from actively infected patients or who have been exposed to antigen. if the active immune response is absent or not sufficient then the probability of circulating b cells in such cases is very poor or negligible. due to ethical issues and considerations, it is generally not possible to immunize humans. to overcome these limitations li et al., in 2006 have developed a novel and rapid combined ex-vivo immunization strategy with morphogenics platform process for the isolation of therapeutic human mabs. in this strategy, the group has purified b cells (cd19+) and cd4 positive t cells from healthy volunteer blood samples using magnetic bead-based sorting. these b/t cells were cultured in the presence of growth factor and antigen to activate b cells. the pool of these b and t cells were then fused with myeloma fusion partner using electric cyto plus. the fused cells were screened for antigen-specific antibody secreting properties by limited dilution method. the isolated mabs had shown high specificity, biological activity and high affinity. this method avoids the collection and screening of a large number of patient samples which are normally the basic requirement for the generation of therapeutic human hybridomas. it also avoids the risk of potential viral transmission associated with conventional methods where pbmcs are sometimes used from viral infected patients. screening of volunteers and blood cells can be performed before ex vivo immunization and after hybridoma development. this platform technology offers a rapid and cost-effective way for therapeutic human mabs having natural pairing of immunoglobulin genes [99] . after cell fusions between b cells and myeloma cells, protocols of hybridoma technology include multistep screening and cloning processes to identify antigen-specific hybridomas, which is labour-intensive and time-consuming. however, recent advances in robotic screening methods have alleviated this to some extent [88] . the screening process on semi-solid selective medium has made it easy and reduces the overall time in hybridoma production by repeated selection and cloning steps. this screening technology has been used by companies to sale ready to use kit based systems for the development of murine hybridoma. it has also facilitated the use of murine hybridoma technology in a less cumbersome and user friendly. methylcellulosebased semi-solid selective medium is preferentially used in hybridoma selection [56] . technically it avoids the loss of rare clones from an overgrowth of faster-growing cells, which can occur during selection in a liquid medium. the selected clones are further dispersed into a liquid growth medium for screening and expansion. similarly, paul et al recently developed microarray-based screening technology for direct identification of high-affinity clones which avoids the loss of slowgrowing clones. additionally, this approach eliminates the enrichment, isolation, and purification of igg for the characterization process. the crude culture supernatants can be directly used and thus avoids expensive and lengthy screening steps [100] . the screening process has advanced through flow cytometry-based methodology where single cells could be sorted from a bulk mixture of fused hybridoma cells. it has advanced by saving time and labour instead of the traditional multimicro well plate seeding and limiting dilution sub-cloning [101] . in recent years tedious hybridoma screening and cloning processes are replaced with flow cytometry-based sorting methods. these methods avoid effort and time of tedious repeated screening processes. this method could also differentiate igm and igg secreting hybridoma. facs based screening methodology can be applied in any laboratory easily setup as it doesn't require any special reagents [102] [103] [104] . the other alternative approach that some groups had used is the screening of hybridoma supernatant directly by bio-layer interferometry based on disassociation rates to select clones containing high-affinity antibodies for further expansion and subsequent characterization. the main drawback of the elisa based screening method is that clones that express high levels of a low-affinity antibody can give an equivalent signal to clones that express low levels of a high-affinity antibody. as a consequence, superior clones can be overshadowed by inferior clones because elisa method score antibodies based on the binding signal strength and do not provide accurate affinities or dissociation rate constants [105, 106] . current drug approval rates underline the revolutionary effect of fully human mab therapeutics on drug development. antibodies isolated for therapeutic applications from different species excluding human needs a multistep process of humanization and developability through rational sequence optimization [107] . mouse is the most common and preferred progenitor used in mab isolation. to avoid the multistep process of humanization, the concept of transgenic mice harbouring the human antibody repertoire has gain attention, where large human immunoglobulin loci are transferred into the mice germline using yeast artificial chromosome approach [108] . the xenomouse and humab mouse are the first engineered transgenic mice that carry the majority of human vh & vl antibody repertoire [109] . xenomouse transgenic technology was developed by cell-genesya a biotech company (now a part of bristol myers squibb, new york, usa). the first therapeutic antibody developed by this transgenic technology was approved by the fda in 2006 for the treatment of advanced colorectal cancer. the strength of transgenic technology can be evaluated by the recent data on approved mabs. more than 18 fully human mabs developed by transgenic animal-based technology are used for human therapy. a list of fda approved mabs developed by transgenic technology is listed in table 4 . initially, this technology was limited to mice but over the years this technology has been established for other animal models like rabbits, rats, and cows. the success of this technology table 4 a list of fda approved mabs derived from transgenic technology. treatment of colorectal cancer mainly depends on the proper representation of the target antigen to the immune system. in addition, designing a proper immunogen is very critical for success. to avoid the ambiguity of immunogen design in soluble form, genetic immunizations are more preferred over the traditional methods. in contrast to human, mouse possesses very less antibody diversity represents the main limiting step in xenomouse transgenic technology. human antibody repertoire shows diversity more than 10 11 , however, the number of b cells in a mouse is~10 8 only. a single mouse can harbour the only fraction of the antibody repertoire from human antibody [110, 111] . moreover, immunization of a large cohort of mice to increase the diverse response against antigens could be used to overcome the limited antibody diversity. the other transgenic mice technologies, where kymouse & trianni mouse models were developed to represent a more diverse human antibody repertoire that allows the selection of diverse human antibodies and overcomes the limitations of xenomouse [112] . fig. 4 represents an illustration of transgenic antibody technology showing the antibody production route. besides, the other limitation of this technology platform is immune tolerance when attempting to raise an immune response against human targets. a large number of human targets possesses a very high degree of sequence and structural homology, because of this homology the transgenic immune system recognizes these antigens as self-antigen. different groups have tried to overcome the immune tolerance mechanism by adding t cell epitopes to the antigen [89, 113] . the other similar approach tried by different groups to abolish the expression of murine orthologues gene [114] . but the major limitation with these defected mice models is that sometimes these mice suffer from health issues and some of these knockdown genes are necessary for the development of a foetus. recent developments of transgenic rat and fig. 4 . illustration of transgenic antibody technology shows the antibody production route: mouse immunoglobulin gene loci were functionally inactivated in embryonic stem (es) cells by targeted gene deletion used to generate mice homozygous for the necessary deletions. crossbreeding between the transgenic mice (containing both human and mouse antibodies) with mice incapable of producing mouse immunoglobin, resulting in the xenomouse strain which expresses human antibodies but not the mouse antibodies. b cells, isolated from immunized xenomouse, are fused with myeloma cells to produce hybridomas producing human mabs. chicken (omnichicken) models have partially overcome these limitations. the transgenic model-based technology harbours some advantages over the phage display derived antibodies. the antibody developed by transgenic technology requires less development or optimization and thus require a shorter time to reach the product development stage. production of stereo-specific mabs is still a very big challenge. there are hardly any practical technologies available for the generation of stereospecific antibodies, because of hurdles like how to immunize a mouse maintaining the antigen structure intact in the presence of adjuvant. in addition, adjuvants allow more effective sensitization, disrupting the native structure of proteins. however, if an adjuvant is not used, immunization efficiency could be very low. another difficulty is strict selection of stereospecific mab producing sensitized b lymphocytes. although, if the immunization is successful with a native intact antigen, the number of desired sensitized b lymphocytes is extremely small, accounting for very less population of total spleen cells after repeated immunization [72] . most of the established therapeutic mabs have specificity for the antigen targets having primary structures. generally mabs can recognize two types of antigen epitopes which includes linear in the primary structures of proteins and the conformational, dependent on secondary and tertiary structures [115] . stereo-specific mabs recognizing conformational structures of target antigens may thus offer a markedly more versatile approach. besides primary, secondary and tertiary structures, proteins may also exhibit quarterly structures. which are formed by hetero or homo-subunits, providing unique interfacial geometric structures on their complexes. native or conformation-specific mabs are quite reasonable and attractive for future therapeutic purpose. there is need to replace the conventional mabs with stereospecific mabs in the near future for therapeutic medicine as they recognize the 3 dimensional conformation, which intrinsically determine their fundamental biological functions [116] . stereospecific mabs that recognize 3d molecular configuration has advantages over linear epitope-specific mabs that consider only 2d configuration. in general, mabs against primary structures, in target therapeutic antigens with the dominant secondary and tertiary folding are having affinity only with full antigens in restricted areas, as their linear epitope may be masked due to conformational folding. alternatively, target antigens in the immune system can be identified by assuring indigenous structures via immunizing dna of the target antigens expressed on the surface of the cell, allowing healthy and intact structural conformation. this can be linked to membranes, which mimics membrane protein, with a soluble protein harbouring sufficient signal peptides and membrane-penetrating areas that are genetically linked to the 5â�² and/or 3â�² terminals of genes of the desired soluble proteins as nucleic acid sequences to express as a fusion protein [117] . in the emerging diseases like human immunodeficiency viruses-1 (hiv-1), coronavirus -19 (sars-cov2), dengue, and chikungunya, the immunogenic proteins of pathogens harbour complex structural glycoproteins, needs an urgent high-quality stereospecific mabs to control their spread. development of therapeutic antibodies against these pathogenic diseases is aimed to the structural antigens. the complex native structures of envelope proteins on viral surface facilitate the attachment of virus to the host cell, and subsequently entry inside the cell [118] . these native structural proteins induce predominantly cross reactive neutralizing antibodies. the neutralizing antibodies have shown promising results in the protection against pathogens however nonneutralizing antibodies help the virus in evading immune system [119] . in hiv-1, researchers are working to develop broadly neutralizing antibodies targeting conformational epitopes [120] . similar approaches have been taken for other viral antigenic targets [121] . in many of these viral infections "conventional abs" are generated in response to virus infection, but the virus adopts numerous evasion strategies like conformational masking of antigenic targets by glycosylation, high mutation rate etc. [122] . generation of stereospecific mabs are required to display impressive breadth and potency against the conformational proteins. these stereospecific mab productions with promising therapeutic potential can be achieved by inclusion of critical steps like i. dna or soluble protein immunization with native like targets or structural proteins ii. selection of antigen specific myeloma cells and iii. selective fusion of myeloma and b cells to generate hybridoma cells secreting stereospecific mabs. different novel approaches and attempts are being taken to produce the soluble trimers which can display native-like conformational stable structure mimicking with virus surface. these conformational protein structures are promising targets for protein or dna immunization and could subsequently require for the production of stereospecific mabs. one major challenge associated with the use of native like antigens for the development of stereospecific antibodies is use of adjuvants in immunization process. most of the adjuvants usually disrupts the original protein native structure and hence impede its ability to present relevant epitopes or occludes the trimer conformational epitope [115] . in recent years' studies using iscom class of adjuvants in animal preceded by in vitro analyses showed that it has no adverse effect on native trimer conformation or antigenicity [123] . the other way to generate stereospecific antibodies is the direct immunization of mammalian cells expressing cell surface antigens in its native conformation [124] . a number of stereospecific antibodies has been generated against several targets like receptors [125] , ligands [126] , antagonist and chemical compounds [127] . a detailed schematic representation of different approaches used for isolation of stereospecific mab is shown in fig. 5 . the production of stereo-specific mabs could be achieved by tweaking the conventional hybridoma fusion through stereo-specific targeting (sst) technique invented for the first time by tsumoto et al [115] . crucially, it involves a strict selection of the required sensitized b lymphocytes by intact antigens, expressed on myeloma cells, through b-cell receptors (bcrs) and their selective electrofusion (only attached cells can be fused among themselves) to generate a specific hybridoma [128] . sst technology offers selective production, against different protein types, of monoclonal stereospecific antibodies not only for membranous but also for soluble non-membranous antigens. morshed et al recently showed efficiency in activation of the g-protein coupled receptor which holds seven-transmembrane domains by a stereo-specific mab [117] . furthermore, the new promising class of therapeutic mabs, catalytic antibodies are capable of identifying and degrading antigens, has fundamentally demonstrated. hifumi et al. have developed a catalytic antibody to degrade the active site for urease o helicobacter pylori and eliminates the bacterial infection in the mouse [129] . moreover, the catalytic antibodies have proven their utility in suppressing infection of the rabies virus [130] and the influenza virus [131] in vitro and in vivo using human antibody light chains. in addition, they have recently been noted in their ability to effectively reduce the accumulated ã�-amyloid in the mice's brain [132, 133] . medi9447 is a mab that inhibits cd73 (ecto-5â�²nucleotidase) activity on a non-competitive basis and is considered a promising immuno-oncology target [134] . this mab is antagonistic to cd73 employing dual inter-cd73 dimer cross-linking and/or steric blockage mechanisms that prevent the adoption of the cd73 catalytic active conformation [135] . bispecific mabs with stereo-detection may be especially effective for cancer cell detection of membranous antigens which have not been easily detected by conventional linear mabs. in a nutshell, as proteins retain their native conformation in nature, development of stereospecific, alternate forms of bispecific and catalytic mabs, for selective therapy is the founding factor in therapeutic future drugs. the mab has come a long way since the days when unmodified murine mab was explored against the cancer-causing agents. from the last two decades, mabs have been a standard element of cancer therapy, however, with still much room for further improvement in future [64] . the mabs are always preferred over the chemical compound based therapies because of their high specific reactivity and affinity towards the target antigen recognition. they show minimal side effects with favourable pharmacotoxicity and pharmacokinetics properties. the high specificity of mabs towards their targets presents an attractive and successful option for the development of medical treatment and molecular drug targets. [136] . early clinical attempts exploring mab-based therapeutics were very primitive and disappointing 20 years ago, some clinical experts considered the antibody-based therapy treatment for cancer as a failed hypothesis [137] . the first mab which was clinically evaluated against cancer was the murine mab. although there were some fascinating hints that mab therapy could be successful, however, the problems related to the administration of murine mab to humans limited their clinical utility and applications [138] . rise in immune response against the therapeutic mab, very rapid clearance of the mab from the system and suboptimal ability of the murine mab to interact with the human immune system in a manner that led to immune destruction were the challenging tasks. however, some investigators tried continuously to explore the use of mab as a possible cancer treatment. they also evaluated other strategies such as using; igg to target cancer directly, alter the host immune response to cancer, provide cytotoxic substances to cancer, and retarget the cellular immune response towards cancer [64] . over the last twenty years, the effectiveness of antibodies in the treatment of patients with cancer and other deadly diseases has been increasingly recognized, as mentioned in tables 1 and 4. many of these antibodies are specific for antigens expressed by the disease-causing agents itself [139] . in the case of viral targets, mab-based therapeutics have shown limited success. however neutralizing antibodies play an essential part in antiviral immunity and human protection against viral diseases is primarily mediated by the humoral immune response [120, 122] . it is well documented that early administration of mabs in the treatment regimen reduces mortality rate significantly up to 95% [140] . to date, only two mab is licensed for viral infection i.e. respiratory syncytial virus (rsv) and the other one is ibalizumab, which has been recently approved in 2018 for the treatment of hiv positive people with multidrug resistance towards anti-retroviral therapy (art) [18, 141] . several other candidates are at the different stages of clinical trials e.g. leronlimab, an anti-ccr5 igg4 for hiv infection and regn-eb3: a mixture of 3 igg1 mabs for ebola virus infection (https://www. antibodysociety.org/antibodies-to-watch-in-2020-at-pegs-europe/). lack of vaccines against various deadly viral diseases necessitates the development of antibody therapeutics to save the loss of lives and control deadly diseases [142] . however, it is always easy to generate monoclonal to protect the population at the time of the outbreak in a much shorter time as compared to vaccine production. though vaccines are one of the most cost-effective ways to manage infections, vaccines also require time to elicit protective immunity and depend on the host's ability to mount an immune response. a number of a prophylactic vaccine against pathogens such as; herpes simplex virus type-1 (hsv-1) and human immunodeficiency type-1 (hiv-1) have shown protection in animal immunization studies, but, so far, no effective human vaccine against these diseases are available [58, 59] . antigenic drift and high diversity among the emerging pathogens; such as influenza virus and hiv have been reported [60, 61] which further add to the complexity and may lead to vaccine mismatch drop in vaccine effectiveness against circulating serotypes and strains. in developing countries, it is not economically feasible to make a vaccine of every disease because of a lack of awareness of disease burden [62] . the mabs are widely used in the fields of diagnostic, therapeutic and biological applications due to their high specificity and affinity. at present, the majority of mabs approved for therapeutics are humanized or the chimeric versions of mouse mabs and were generated using hybridoma technology. in recent years, these engineered humanize and chimeric antibodies are potentially used to generate different forms of antibody fragments such as scfvs [143, 144] , diabodies [145] , tandom abs [146] , and domain antibodies [147] , pegylated fabs [148] to target novel antigenic sites. technical advancement in the applicability of hybridoma technology to other animal species (other than mice) of different phytogenic origin has led to the development of novel mabs to conserve human antigens. it has opened a new path for therapeutic and diagnostic mabs with high specificity and affinity to poorly immunogenic targets. with the recent development of high throughput mab generation technologies, hybridoma technology is the most favoured method due to its indigenous nature to preserve natural cognate pairing information of antibodies that is lost in other methodologies, reduces the specific diversity of antibodies [149] . advancement in recombinant dna technology methods like chimerization and humanization has increased the potential of hybridoma technology to a great extent. an antibody that undergoes the process of humanization preserves the natural specificity and limits risk of cdrs causing an immune response. the unnatural pairing of antibodies in terms of affinity maturation and recombination pairing in display methods sometimes results in high immunogenic response [19] . all these features have make hybridoma platform as first and most preferred mab isolation technology. recent advances in development of hybridoma cells secreting stereo-specific mabs have opened new avenues of future therapeutics. in comparison with other anti-viral drug treatments, a stereospecific antibody-based therapy could offer potent anti-viral actions by more comprehensive target and potent neutralizing effect. the mab market has shown tremendous increase in the last five years as a diagnostic and therapeutic reagent. the commercial development of therapeutic mabs commenced in the early 1980s, and by 1986 the first therapeutic mab was fda approved for the prevention of kidney transplant rejection. over the years mab market has changed rapidly as a major class of therapeutic agents for the treatment of many human diseases, in terms of global sales revenue for all mab products was~$115.2 billion in 2018. a graphical representation of the global antibody-based therapeutic market trend is represented in figs. 6 and 7 . the global mab therapeutics market is expected to grow at a compound annual growth rate (cagr) of 12.80% and is expected to reach market revenue of around usd 218.97 billion by the end of 2023 [150] . humanized mab accounts for the largest revenue-generating share among antibody-based therapeutics, showing to its widespread acceptance for numerous diseases including cancer, autoimmune diseases, inflammatory diseases, infectious diseases, haematological diseases, and others. the other potential area where mab has shown great success is diagnostics. the mab -based diagnostic reagents potentially identify abnormal cell targets, infectious agents, or elements of the body's this article does not contain any studies with animals performed by any of the authors. this work was supported by translational health science and technology institute core grant. the authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. the structure of natural and recombinant antibodies glycans in the immune system and the altered glycan theory of autoimmunity: a critical review pr: human physiology why recombinant antibodies -benefits and applications antibodies against alpha-synuclein: tools and therapies the pharmacology and therapeutic applications of monoclonal antibodies polyclonal and monoclonal antibodies in clinic blood is a very special juice"-introduction of serum therapy for diphtheria in norway, tidsskrift for den norske laegeforening : tidsskrift for praktisk medicin emil adolf von behring and serum therapy for diphtheria history of envenoming therapy and current perspectives benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens overlooked benefits of using polyclonal antibodies preparation and use of therapeutic antibodies primarily of human origin back to the future: recombinant polyclonal antibody therapeutics recombinant therapeutic antibodies insights into the chicken igy with emphasis on the generation and applications of chicken recombinant monoclonal antibodies monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources phage display antibody libraries: a robust approach for generation of recombinant human monoclonal antibodies hybridoma technology: the preferred method for monoclonal antibody generation for in vivo applications a novel strategy for efficient production of anti-v3 human scfvs against hiv-1 clade c isolation and characterization of cross-neutralizing human anti-v3 single-chain variable fragments (scfvs) against hiv-1 from an antigen preselected phage library use of human hybridoma technology to isolate human monoclonal antibodies hybridoma technology for the generation of monoclonal antibodies advances in the isolation of specific monoclonal rabbit antibodies continuous cultures of fused cells secreting antibody of predefined specificity rabbit-mouse hybridomas secreting intact rabbit immunoglobulin production and characterization of human anti-v3 monoclonal antibodies from the cells of hiv-1 infected indian donors cross-neutralizing activity of human anti-v3 monoclonal antibodies derived from non-b clade hiv-1 infected individuals a new cell line for the production of chicken monoclonal antibody by hybridoma technology generation of a sheep x mouse heterohybridoma cell line (1c6.3a6t.1d7) and evaluation of its use in the production of ovine monoclonal antibodies specific bovine monoclonal antibody produced by a re-fused mouse/calf hybridoma a repertoire of high-affinity monoclonal antibodies specific to s. typhi: as potential candidate for improved typhoid diagnostic study on rat-rat hybridoma technique and production of rat monoclonal antibodies against hiv and hbsag majority of the antibody therapeutics entering clinical study during 2018-19 were against cancer patients. percentage of antibody therapeutics entering the clinical trials were bispecific 32%, adcs 17%, t cell engagers 11% and immune check point modulators a high sensitivity zenk monoclonal antibody to map neuronal activity in aves assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms by end use, by product, by technology, by source, by application (oncology, stem cells), and segment forecasts a new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines a better cell line for making hybridomas secreting specific antibodies human monoclonal antibodies: the emperor's new clothes? mechanisms of action and overview of okt3 release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of okt3 monoclonal antibody in kidney transplant recipients humanized okt3 antibodies: successful transfer of immune modulating properties and idiotype expression gene-conversion in rabbit bcell ontogeny and during immune responses in splenic germinal centers diversification of the primary antibody repertoire by aid-mediated gene conversion the biochemistry of somatic hypermutation from rabbit antibody repertoires to rabbit monoclonal antibodies production of stable rabbit-mouse hybridomas that secrete rabbit mab of defined specificity rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas current status of companion and complementary diagnostics: strategic considerations for development and launch a novel carbon nanoparticle probe-based ultrasensitive lateral flow assay for rapid detection of ebola virus a humanized anti-vegf rabbit monoclonal antibody inhibits angiogenesis and blocks tumor growth in xenograft models brolucizumab-dbll) dapb: u.s. food and drug administration (fda) rabbit models of human diseases for diagnostics and therapeutics development updates on the production of therapeutic antibodies using human hybridoma technique repertoire of neutralizing human monoclonal antibodies specific for the v3 domain of hiv-1 gp120 generation of mouse monoclonal antibodies specific to chikungunya virus using clonacell-hy hybridoma cloning kit broadspectrum monoclonal antibodies against chikungunya virus structural proteins: promising candidates for antibody-based rapid diagnostic test development identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies expansion of igg+ bcells during mitogen stimulation for memory b-cell elispot analysis is influenced by size and composition of the b-cell pool eb virus-induced b lymphocyte cell lines producing specific antibody epstein-barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes immortalization of immunologically committed epstein-barr virustransformed human b-lymphoblastoid cell lines accompanied by a strong telomerase activity clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human b-lymphoblastoid cell lines transformed by epstein-barr virus building better monoclonal antibody-based therapeutics plasmacytoid dendritic cells: the key to cpg an efficient method to make human monoclonal antibodies from memory b cells: potent neutralization of sars coronavirus points to consider in the manufacture and testing of monoclonal antibody products for human use (1997). u.s. food and drug administration center for biologics evaluation and research construction and testing of mouse-human heteromyelomas for human monoclonal antibody production generation of neutralizing human monoclonal antibodies against parvovirus b19 proteins the construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies an optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies monoclonal antibodies based on hybridoma technology cell electrofusion using nanosecond electric pulses an extreme strategy for the production of hybridoma generation and characterization of chicken egg yolk antibodies (igy) against tnfr1 development and characterization of chickenchicken b cell hybridomas secreting monoclonal antibodies that detect sporozoite and merozoite antigens of eimeria establishment of a chicken x chicken hybridoma secreting specific antibody production of chicken monoclonal antibody two chicken b cell lines resistant to ouabain for the production of chicken monoclonal antibodies chicken immunoglobulin gamma-heavy chains: limited vh gene repertoire, combinatorial diversification by d gene segments and evolution of the heavy chain locus avian igy binds to a monocyte receptor with igg-like kinetics despite an ige-like structure the crystal structure of an avian igy-fc fragment reveals conservation with both mammalian igg and ige chicken antibodies: a clinical chemistry perspective anti-pseudomonas aeruginosa igy antibodies augment bacterial clearance in a murine pneumonia model prophylactic and therapeutic efficacy of avian antibodies against influenza virus h5n1 and h1n1 in mice humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif augmented binary substitution: single-pass cdr germ-lining and stabilization of therapeutic antibodies chickens with humanized immunoglobulin genes generate antibodies with high affinity and broad epitope coverage to conserved targets strategies for generating diverse antibody repertoires using transgenic animals expressing human antibodies the transgenic chicken derived anti-cd20 monoclonal antibodies exhibits greater anti-cancer therapeutic potential with enhanced fc effector functions transcriptional profiling of mouse b cell terminal differentiation defines a signature for antibody-secreting plasma cells transient expression technologies: past, present, and future cho cells in biotechnology for production of recombinant proteins: current state and further potential immunogenomic engineering of a plug-and-(dis)play hybridoma platform direct derivation of conditionally immortal cell lines from an h-2kb-tsa58 transgenic mouse hybridoma-free generation of monoclonal antibodies an improved and robust dna immunization method to develop antibodies against extracellular loops of multi-transmembrane proteins establishment of a monoclonal antibody pmab-225 against alpaca podoplanin for immunohistochemical analyses human antibodies for immunotherapy development generated via a human b cell hybridoma technology antibody screening by microarray technology-direct identification of selective high-affinity clones a rapid method to characterize mouse igg antibodies and isolate native antigen binding igg b cell hybridomas antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter flow cytometry-based method for rapid and high-throughput screening of hybridoma cells secreting monoclonal antibody a rapid method for antigen-specific hybridoma clone isolation highthroughput kinetic screening of hybridomas to identify high-affinity antibodies using bio-layer interferometry comparison of techniques to screen and characterize bacteria-specific hybridomas for high-quality monoclonal antibodies selection boosting antibody developability through rational sequence optimization production of transgenic mice with yeast artificial chromosomes discovery and bio-optimization of human antibody therapeutics using the xenomouse(r) transgenic mouse platform b-cell homeostasis, competition, resources, and positive selection by self-antigens precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire progress and challenges in the design and clinical development of antibodies for cancer therapy tolerance in t-cell-receptor transgenic mice involves deletion of nonmature cd4+8+ thymocytes the construction of transgenic and gene knockout/knockin mouse models of human disease future perspectives of therapeutic monoclonal antibodies therapeutic antibodies: successes, limitations and hopes for the future biased signaling by thyroid-stimulating hormone receptor-specific antibodies determines thyrocyte survival in autoimmunity overexpression of ebola virus envelope gp1 protein antibody responses to viral infections: a structural perspective across three different enveloped viruses conformational epitope-specific broadly neutralizing plasma antibodies obtained from an hiv-1 clade c-infected elite neutralizer mediate autologous virus escape through mutations in the v1 loop antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection broadly neutralizing antibodies in hiv-1 treatment and prevention, therapeutic ad envelope glycoprotein sosip trimers in vitro an efficient system to generate monoclonal antibodies against membrane-associated proteins by immunisation with antigen-expressing mammalian cells mouse monoclonal antibody to a latent epitope of leucocyte receptors for leukotriene b4 monoclonal antibodies specific for betaadrenergic ligands stereospecific antibodies to propranolol culture of animal cells: a manual of basic technique and specialized applications catalytic features and eradication ability of antibody light-chain ua15-l against helicobacter pylori highly efficient method of preparing human catalytic antibody light chains and their biological characteristics biochemical features and antiviral activity of a monomeric catalytic antibody light-chain 23d4 against influenza a virus catalytic immunoglobulin gene delivery in a mouse model of alzheimer's disease: prophylactic and therapeutic applications specific amyloid beta clearance by a catalytic antibody construct anti-cd73 in cancer immunotherapy: awakening new opportunities inhibition of cd73 amp hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action beyond peptides and mabs-current status and future perspectives for biotherapeutics with novel constructs overview of monoclonal antibodies in the diagnosis and therapy of cancer a clinical trial of anti-idiotype therapy for b cell malignancy congenital prostato-urethral fistula caused by persistence of the mesonephric (wolffian) duct antibody therapies for the prevention and treatment of viral infections broadly neutralizing anti-hiv-1 monoclonal antibodies in the clinic the contribution of vaccination to global health: past, present and future single-chain antigen-binding proteins protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain fv analogue produced in escherichia coli diabodies: small bispecific antibody fragments bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics binding activities of a repertoire of single immunoglobulin variable domains secreted from escherichia coli efficacy of a novel pegylated humanized anti-tnf fragment (cdp870) in patients with rheumatoid arthritis: a phase ii doubleblinded, randomized, dose-escalating trial veterinary sources of nonrodent monoclonal antibodies: interspecific and intraspecific hybridomas storyid=1096715878&title= global-monoclonal-antibody-therapeutics-market-to-be-worth-usd-21897-billion-by-2023: global monoclonal antibody therapeutics market to be worth usd 218.97 billion by 2023 supplementary data to this article can be found online at https:// doi.org/10.1016/j.intimp.2020.106639. key: cord-295194-xbla6tu7 authors: stripecke, renata; münz, christian; schuringa, jan jacob; bissig, karl‐dimiter; soper, brian; meeham, terrence; yao, li‐chin; di santo, james p; brehm, michael; rodriguez, estefania; wege, anja kathrin; bonnet, dominique; guionaud, silvia; howard, kristina e; kitchen, scott; klein, florian; saeb‐parsy, kourosh; sam, johannes; sharma, amar deep; trumpp, andreas; trusolino, livio; bult, carol; shultz, leonard title: innovations, challenges, and minimal information for standardization of humanized mice date: 2020-06-24 journal: embo mol med doi: 10.15252/emmm.201708662 sha: doc_id: 295194 cord_uid: xbla6tu7 mice xenotransplanted with human cells and/or expressing human gene products (also known as “humanized mice”) recapitulate the human evolutionary specialization and diversity of genotypic and phenotypic traits. these models can provide a relevant in vivo context for understanding of human‐specific physiology and pathologies. humanized mice have advanced toward mainstream preclinical models and are now at the forefront of biomedical research. here, we considered innovations and challenges regarding the reconstitution of human immunity and human tissues, modeling of human infections and cancer, and the use of humanized mice for testing drugs or regenerative therapy products. as the number of publications exploring different facets of humanized mouse models has steadily increased in past years, it is becoming evident that standardized reporting is needed in the field. therefore, an international community‐driven resource called “minimal information for standardization of humanized mice” (mishum) has been created for the purpose of enhancing rigor and reproducibility of studies in the field. within mishum, we propose comprehensive guidelines for reporting critical information generated using humanized mice. antibody-dependent cellular cytotoxicity, is an immune defense mechanism whereby effector cells such as nk cells lyses target cells that have been bound by specific antibodies aml acute myeloid leukemia art anti-retroviral therapy bdbv bundibugyo ebolavirus bite bispecific t-cell engagers is a registered trademark for a class of recombinant bispecific monoclonal antibodies which bind to the cd3 receptor and to a tumor-specific antigen blt bone marrow-liver-thymus bm bone marrow bnabs broadly neutralizing antibodies are antibodies capable of neutralizing different types of viral strains brgf balb/c rag2 à/à il2rg à/à flt3 à/à mouse strain expressing macrophage colonystimulating factors (m-csf), il-3, il-6, gm-csf, and thrombopoietin (tpo) mscs mesenchymal stromal cells myelo-ablated mice are mice treated with irradiation or chemotherapy in order to decrease the bone marrow activity in order to improve the engraftment of transplanted stem cells myelodysplasia is an abnormal accumulation of immature blood cells in the bone marrow myelofibrosis is the replacement of the bone marrow with scar tissue due to proliferation of immature blood cells nash non-alcoholic steatohepatitis nih national institutes of health nk natural killer nod non-obese diabetic nog nod.cg-prkdc scid il2rg tm1sug /jic nrgf nod-rag1 à/à il2rg à/à flk2 à/à nrg nod-rag1 tm1mom il2rg tm1wjl /szj nsg nod.cg-prkdc scid il2rg tm1wjl /szj pbmcs peripheral blood mononuclear cells pd-1 programmed death receptor 1 pd-l1 pd-1 ligand 1 pdx-mi pdx model minimal information standard pdx patient-derived xenograft pirf por à/à /il2rg à/à /rag2 à/à /fah à/à rag1 recombination activating gene studies of human stem cell engraftment, hematopoiesis, and immunity studies using immunocompetent mice have provided critical insights into the development and regulation of hematopoiesis and immunity. however, such studies do not always reflect responses in humans because of multiple species-specific differences. therefore, mice developing components of the human immune system (his) mice were created. these models have provided tools for the understanding of human hematopoiesis and immunity in vivo and to test new therapies or vaccines without incurring risks to patients. the simplest engraftment method is the adoptive administration of human peripheral blood mononuclear cells (pbmcs) into severely immunodeficient mice ( fig 1a, table 1 ). since the adoptive human t cells react forcefully against the xenogeneic major histocompatibility complex (mhc) class i and ii expressed by mouse tissues, this so-called "hupbl" model faces the hardship of fulminant xenograft graft-versus-host disease (gvhd) occurring 2-4 weeks after pbmc transfer. these models have limited applicability to follow specific antigenic responses, but can be used to test human immunosuppressive agents. improvement of the hupbl model has been described with novel mouse strains lacking mouse mhc class i and ii, resulting in lower occurrences of gvhd (yaguchi et al, 2018; brehm et al, 2019) . a more complex approach covered here in detail is the hematopoietic stem cell transplantation (hct) of preconditioned immunodeficient mice with human hematopoietic stem cells (hscs). despite the full mismatch between the human leukocyte antigens (hla) expressed on the human hematopoietic cells and the mouse mhc expressed on tissues, hct leads to "fully" humanized his models ( fig 1a, table 1 ). human hscs can differentiate into multiple human hematopoietic lineages, giving rise to mature leukocytes, including several lineages of the human immune system. robust engraftment with human hematopoietic and lymphoid cells was pioneered back in 1988 with the description of the cb17-prkdc scid severely compromised immunodeficient (scid) strain engrafted with human fetal liver hematopoietic cells and autologous thymic tissues (mccune et al, 1988) . this scid-humanized (scidhu) system showed initially only a transient presence of human t cells and human immunoglobulin g (igg) in the circulation. the critical relevance of the strain background for engraftment success of human cells was later appreciated when it was observed that non-obese diabetic (nod)-scid mice had a much higher capacity to support human hsc engraftment. this was elucidated to be due to the expression of a human-like signal regulatory protein alpha (sirpa) allele in the nod strain, popularly known as the "don't eat me signal", bypassing phagocytosis of human cells by mouse macrophages (takenaka et al, 2007; shultz et al, 2012) . targeting the interleukin 2 (il-2) receptor common gamma chain (il2rg) resulted in the absence of mouse natural killer (nk) cell activity as well as ablation of t and b lymphocyte lineages. in addition, the development of mice lacking the expression of recombination activating gene 1 (rag1) à/à and rag2 à/à provided radioresistant mouse models lacking mature host t cells as well as b cells (shultz et al, 2007) . currently, there are approximately 50 diverse humanized mouse models available from biorepositories. most of these models are homozygous for the scid, il2rg, rag1, or rag2 mutations and express the nod or human sirpa allele. the nod-scid il2rg (à/à) (nsg), the nod-rag1 à/à il2rg à/à (nrg), and the nod/shi-scid il2rg (à/à) (nog) are broadly used strains for xenografting a large variety of human cells, but several other strains are prospering (for recent reviews, see shultz et al, 2019; allen et al, 2019) . it is important to be thoughtful also about the nature of the human hscs. although humans and mice differ greatly in their biological characteristics, human hscs can essentially engraft in myelo-ablated or irradiated mice and reside in the mouse bone marrow (bm) niche. this hct approach opened several doors for the understanding of the basic properties for long-term durable repopulation of human hscs. as sources of human hscs, cord blood (cb) or fetal liver are mostly used, as they have high frequencies of hscs. generally, a range of 1 × 10 4 -10 5 isolated hscs is administered per mouse in order to enable efficient human hematopoietic engraftment and long-term reconstitution. several laboratories have opted to use fetal tissues due to the higher abundance in the numbers of hscs, which can be explored to generate larger cohorts of humanized mice (n = 30-40) compared with cord blood (n = 10-20). some groups have tried to overcome this limitation by pooling hscs from several donors, but upon development of immune systems that are not hla-matched, once the t cells develop, allograft reactions among donors can complicate the analyses of the immune responses. additionally, it is important to take into consideration that hscs in fetal and neonatal tissues may be intrinsically different regarding the stage of the hematopoietic development. further, it is important to consider ethical constraints and difficulties in procurement of human fetal tissues. in fact, the us national institutes of health (nih) is currently supporting investigators to seek and develop humanized mouse models that do not rely on human fetal tissues (allen et al, 2019) . human hsc cell surface markers have been used to allow their identification, purification, and analyses, in order to define the hsc populations with highest engraftment and/or repopulation capacity. xenotransplantation of human cd34 + hscs into preconditioned immunodeficient mice is the most broadly used procedure to generate his mice, and this approach is corroborated by the clinical evidence that transplantation with human-enriched cd34 + hematopoietic/stem/progenitor cells (hspcs) is a salvage procedure when the hla is not optimally matched between patients and donors. remarkably, a defined cd93 hi sub-fraction within the lineage negative (lin à ) cd34 à cd38 à cell present in cb has high repopulating capacity in nod-scid mice (danet et al, 2002) . cd49f is an adhesion molecule serving as a hsc marker and intra-femoral injection of single cd49f + cells into female nsg mice can generate long-term (20 weeks) multilineage grafts (notta et al, 2011) . thus, the quest for the archetypical human hsc population and whether other defined cd34 à hscs subpopulations should also be considered for the generation of his mice and how to eventually expand these cells ex vivo without compromising their self-renewal potential remains to be clarified. another aspect to be taken in account is that the ability of human hspcs to engraft and differentiate into different hematopoietic lineages may largely depend on their interactions with the mouse bm microenvironment constituents. as some human factors may be absent in the mouse bm niche, sponge scaffolds seeded with human bm-derived mesenchymal stromal cells (mscs) have been implanted subcutaneously into nsg mice to allow the formation of niches for human hscs to differentiate (antonelli et al, 2016; reinisch et al, 2016; abarrategi et al, 2017) . using two-photon microscopy for high-resolution non-invasive in vivo analyses, these implants are currently enabling the clarification of the human bm microenvironment requirements in regulating human normal and malignant hematopoiesis in vivo . another limitation in his models is the lack or low levels of human factors and cytokines in mouse tissues or circulating in the plasma and needed for human hsc self-renewal or differentiation. transgenic expression of human interleukin 3 (il-3)/granulocyte macrophage-colony-stimulating factors (gm-csf)/stem cell factor (scf) in nsg mice resulted in enhanced levels of human myeloid cells and regulatory t cells (t reg ) (billerbeck et al, 2011) . very promising models are his mice generated with a mouse strain expressing several human cytokines such as macrophage colonystimulating factors (m-csf), il-3, il-6, gm-csf, and thrombopoietin (tpo), the "mistrg-6", and showing improved human t, b, and nk cell development (das et al, 2016; yu et al, 2017) . this is a valid approach, and expression of several different human growth factors and cytokines to support differentiation of early or mature lymphoid or myeloid cells has been performed (rongvaux et al, 2014; bryce et al, 2016; jangalwe et al, 2016) . some recent development was also exemplified by transgenic expression of human thymic-stromalcell-derived lymphopoietin (tslp) that supported lymph node development in immunodeficient mice (li et al, 2018) . dendritic cells (dcs) are main orchestrators of the adaptive immune system presenting processed peptide antigens to t cells through mhc classes i/ii and expressing key costimulatory molecules such as cd40 ligand (cd40l) required for b-cell activation and class switching (steinman, 2012) . different types of dcs exist in mice but they are not homologous to human dcs. further, in his mice, the human dc development and maturation are not optimal. novel his models based on the balb/c rag2 (à/à) il2rg (à/à) flt3 (à/à) (brgf) and nod.cg-rag1 tm1mom il2rg tm1wjl/szj flk2/flt3 à/à (nrgf) mice with a mutated receptor tyrosine kinase flk2/flt3 were created. human dc development is increased in brgf and nrgf mice with exogenous administration of human flt3 ligand (flt3l) after hct, leading to a major increase also in the numbers of human nk and t cells (li et al, 2016; douam et al, 2018) . a factor to be taken into account for the generation of his is the gender of the mice. females show better hsc engraftment and faster human t-cell immune development and maturation (volk et al, 2017) . when setting up these models, it is important to keep in mind that the kinetics of human immune reconstitution is not linear and the time of analyses after hct has to be longitudinally established for different strains and methods. for example, human t cells show maturation, activation, and functionality at 15-20 weeks after cb-hct in nrg-his mice (volk et al, 2017; theobald et al, 2018) , but this varies considerably for other his models. future improvements are seeking a better development of human t cells in his mice so that they will be equipped with functional t-cell receptors (tcrs) able to interact with the matched hla complexes on antigen-presenting cells. this critical advance relies essentially on the substitution of the mouse mhc class i and ii by different hla haplotypes. to solve this mismatch problem, a transgenic nrg mouse strain called "drag" was developed that expresses hla-dr4 . drag mice transplanted with hla-dr4 + hscs developed more cd4 + t cells and higher levels of human immunoglobulins g and m (igm and igg; kim et al, 2017) . hsc-humanized mice expressing class ii hla-dr4 and class i hla-a2 transgenes ("draga" mice) generated cd8 + -specific t cells and influenza-specific antibody responses (mendoza et al, 2018a) . similarly humanized brgs mice expressing human hla-a2 and dr2 transgenes (brgsa2dr2) showed faster development of cd4 + and cd8 + t cells and higher concentration of iggs in plasma (masse-ranson et al, 2019). the practical limitation of these hla-transgenic strains is that it is difficult to find hscs that express a particular combination of hlas. another method to improve and accelerate the regeneration of human t and b cells in his mice is the adoptive transfer of geneengineered human dcs from the hsc donor that are long-lived in vivo (salguero et al, 2014; daenthanasanmak et al, 2015; volk et al, 2017) . this approach significantly enhanced the regeneration of lymph nodes in his-nrg mice promoting maturation of functional human t cells, b cell class switching, and development of antigenspecific iggs (salguero et al, 2014; daenthanasanmak et al, 2015) . as a take-home message, development of human immunity in his mice depends on several variables ( fig 1a, table 1 ). different approaches are being taken concurrently to accelerate and optimize human immune responses in mice. a structured approach to converge the reporting in scientific publications of the materials and methods (such as specific mouse strains, sex of the mice, methods used for hct, time-points of analyses) will facilitate the interactions in the community to boost these promising preclinical models (table 1 ). the liver is a vital organ responsible for key metabolic functions of the body and the site for several human-specific viral infections. for efficient generation of mice xenografted with human liver tissues, a combination of a growth disadvantage of the murine liver and a regeneration stimulus for the human cells is required. several approaches resulted in high human liver chimerism in mice (dandri et al, 2001; mercer et al, 2001; bissig et al, 2007; hasegawa et al, 2011) and the resulting models have pros and cons (reviewed in ref. bissig et al, 2018) . for example, the transgenic upa (urokinase-type plasminogen activator expressed under the albumin promoter) mouse has a profound dysfunction and triggers apoptosis of murine hepatocytes (heckel et al, 1990; dandri et al, 2001; mercer et al, 2001) . therefore, salvage human hepatocyte transplantation is required within 2-4 weeks after birth. nevertheless, humanized upa mice maintain considerable health problems. transgenic upa mice are difficult to breed, which is also a limitation of another utilized mouse strain based on nog mice expressing transgenic herpes simplex virus type 1 thymidine kinase (hsvtk) under the albumin promoter (tk-nog; hasegawa et al, 2011) . conversely, the metabolic dysfunction of the il2rg à/à rag2 à/à mice with a knock-out for the fumarylacetoacetate hydrolase gene (fah à/à ) can be regulated by a small drug and bred efficiently but the mice frequently develop murine hepatocellular cancer (azuma et al, 2007; bissig et al, 2007) . all these models show some remaining mouse liver tissue that can blur human-specific liver metabolism ( fig 1b, table 1 ). therefore, next-generation models seek to eliminate the interfering mouse metabolism. one such model is the por à/à il2rg à/à rag2 à/à fah à/à (pirf) mouse (barzi et al, 2017) , lacking murine p450 cytochrome function and allowing a human-only cytochrome metabolism in mice. human liver chimeric mice have also been used to model metabolic disorders. the first xenograft model for metabolic liver disease was established using human hepatocytes from a patient with familial hypercholesterolemia with a low-density lipoprotein (ldl) receptor deficiency; bissig-choisat et al, 2015) . it would be desirable to extend metabolic disease models also to more prevalent disorders such as non-alcoholic steatohepatitis (nash). a nash model would also require a functional immune system in addition to the liver chimerism. such dual humanizations have been achieved previously (gutti et al, 2014; strick-marchand et al, 2015; billerbeck et al, 2016; dagur et al, 2018) . the combined human liver and immune system models can show formation of fibrosis upon hepatitis c virus (hcv) or hepatitis b virus (hbv) infections (washburn et al, 2011; bility et al, 2014) . another promising approach to study human liver function is the combination of organoid technology with humanized mouse models to examine the immune response to regenerative cellular therapies and cancer. organoid technology allows the generation of unlimited numbers of non-malignant (sampaziotis et al, 2017) or cancer cells (broutier et al, 2017 ; fig 1b, table 1 ). if derived from the same hsc donor used to humanize the mice, this approach can potentially be used to compare the immunogenicity of autologous and allogeneic cellular therapies or investigation of safety and efficacy of autologous cancer immunotherapies. studies of type 1 diabetes (t1d) are also prospering with the use of humanized mice. backcrossing the insulin 2 (akita) mutation into nrg mice (nrg-akita) followed by human hct into newborn mice resulted in > 50% of the nrg-akita mice rejecting human islet allografts (brehm et al, 2010 ; fig 1b, table 1 ). the akita model was also used to demonstrate the efficacy of stem cell-derived human beta cells (sc-beta) to regulate blood glucose levels in vivo. the effect of viral infections was also established for studies of t1d, showing that coxsackievirus b accelerated the destruction of insulinproducing beta cells of pancreatic islets (gallagher et al, 2015) . his models are currently being developed to recapitulate the course of disease in human t1d, including the interactions between human immune system and beta cells (tan et al, 2017; walsh et al, 2017) . recent studies have included engraftment of mice with diverse hematopoietic and non-hematopoietic human tissues and cell populations, human-induced pluripotent (ips) stem cells and embryonic stem (es) cell-derived tissues (shultz et al, 2014) . exciting advances on the development and use of emerging humanized mouse models in multiple disciplines are ongoing (fig 1b, table 1 ). technical and analytical annotation and standardization strategies to harmonize the use of human tissues implanted into humanized mice will be needed (table 1) . infections with human-specific pathogens his mice offer a unique possibility to study infectious disease agents with a tropism toward human leukocytes, hepatocytes, and lung ª 2020 the authors embo molecular medicine 12: e8662 | 2020 epithelia, to characterize the induced immune responses and to develop therapeutic interventions against associated pathologies ( fig 1c, table 1 ). one such pathogen is the epstein-barr virus (ebv), a common c-herpesvirus that persistently infects more than 95% of the human adult population and was the first oncogenic virus identified in man (mü nz, 2019). accordingly, it is associated with around 2% of all malignancies in humans (cohen et al, 2011) . despite the threat of primarily b and epithelial cell transformation in infected individuals, ebv remains asymptomatic in most carriers, presumably due to a near perfect immune control of the virus by cytotoxic lymphocytes (taylor et al, 2015) . his mice can model this cell-mediated immune control by primarily cd8 + t lymphocytes (mchugh et al, 2019) . ebv infection resulted in dramatic cd8 + t-cell expansion in humanized mice with a peculiar phenotype (chatterjee et al, 2019; danisch et al, 2019) . the expanding cd8 + t cells carried the programmed death receptor (pd)-1 and t-cell immunoglobulin and mucin domain-containing protein 3 (tim-3) but retained cytokine production and were even superior in cytotoxicity to pd-1 negative cd8 + t-cell populations. nonetheless, pd-1 blockade with antibodies did not improve ebvspecific immune control in his mice (chatterjee et al, 2019) . in contrast, pd-1 inhibition led to elevated ebv titers, increased il-10 production, and associated lymphomagenesis. long-term infection of his mice with another herpes virus, the human cytomegalovirus (hcmv) is also possible as human cd34 + cell serves as a latent reservoir, whereas lytic reactivation in monocytes and macrophages can be stimulated with granulocyte-colony-stimulating factor (g-csf) (for a review, see koenig et al, 2020) . hcmv infection and reactivation result in different immunological responses and reactivation is associated with a higher pd-1 expression on t cells (theobald et al, 2018) . other pathogens that challenge immune compromised humans, especially pediatric patients after hct, are human adenoviruses. human adenovirus 2 (hadv2) infection of his mice resulted in liver pathology in one-third of mice, while two-thirds of infected mice remained asymptomatic (rodriguez et al, 2017) . his mice with asymptomatic hadv2 infection developed virus-specific igm and interferon (ifn)-c-producing t-cell responses. in blood and bm of mice not showing pathology, only early viral rna transcripts could be detected, which suggested the establishment of a persistent infection. in contrast, severely affected mice showed both early and late transcripts in many tissues as well as virus production in the liver (rodriguez et al, 2017) , all signs of disseminated disease, similar to what is observed in hct patients that suffer severe hadv infections (lion, 2014) . viruses for which dichotomous outcomes of infection can be modeled in his mice are the filoviruses of the genus ebolavirus his mice also offer platforms to explore new therapeutic avenues. this has primarily been investigated for human immunodeficiency virus (hiv; marsden & zack, 2017) . for example, treatment of hiv infection with broadly neutralizing antibodies (bnabs) was established in his mice (klein et al, 2012) . these studies primarily explored antibodies against four regions of the hiv envelope protein that consists of three heterodimers of glycoprotein (gp)41 and gp120 (caskey et al, 2019) . these four regions are the cd4 binding site, the v3 loop, the membrane proximal region, and the v1/v2 region. in these bnab treatment studies, mutational escape from single bnab treatment of viremic his mice was observed, while mixtures of several bnabs were able to suppress hiv viral titers for several weeks (klein et al, 2012) . based on these successful treatments in his mice and control of hybrid simian and human immunodeficiency virus (shiv) in macaques (nishimura et al, 2017) , hiv-specific bnabs were also tested in patients with and without prior anti-retroviral therapy (art; caskey et al, 2015 caskey et al, , 2017 . similar to his mice, individual bnab treatment suppressed hiv viremia only transiently with escape mutation development. even transfer of two bnabs only achieved suppression in hivinfected individuals after prior art treatment (bar-on et al, 2018; mendoza et al, 2018b) . thus, multiple bnabs probably need to be maintained at sufficient plasma levels to suppress hiv long term in his mice and patients. improving t cell-mediated immune control of hiv through gene therapy is another avenue that is explored in his mice. studies fall into two main categories, either improving t-cell reactivity by hivspecific tcr and chimeric antigen receptor (car) expression or rendering t cells resistant to hiv infection . for improving t-cell function, hiv-specific tcrs were introduced in hscs and could suppress hiv infection (kitchen et al, 2012) . as another strategy, in order to target cells replicating hiv and with gp120 surface expression, an extracellular domain of cd4 fused to the cd3f signaling domain was expressed in t cells (zhen et al, 2015 . downregulation of the hiv co-receptor, a chemokine receptor targeted by r5 tropic hiv strains (ccr5), has primarily been explored. hiv infection in his mice could be significantly compromised by ccr5 deletion or downregulation by zinc finger nuclease-mediated gene editing or rna silencing, respectively (holt et al, 2010; myburgh et al, 2015; shimizu et al, 2015) . the longterm survival of such engineered t cells might potentiate a functional cure of hiv, but also raises concerns with respect to toxicities and adverse effects of the respective cellular products, which can be assessed in his mice. engraftment of additional human tissues, like liver, bone, lung, and thymus, has been reported, but mainly hepatocytes and human lung tissue have been explored for infections with human pathogens. for example, humanized liver mouse models have been used to study infections by different hepatitis viruses (dandri et al, 2001; mercer et al, 2001; bissig et al, 2010; lutgehetmann et al, 2012; allweiss et al, 2016) . however, simultaneous reconstitution of human tissues with autologous human immune cells remains a challenge. nevertheless, hbv and hcv infections have been explored in his mice with allogeneic or autologous hepatocyte engraftment (washburn et al, 2011; billerbeck et al, 2016; dusseaux et al, 2017) . more recently, bone marrow, liver, and thymus (blt) engrafted mice have also been combined with ectopic human lung transplants (wahl et al, 2019) . intra-organ infection of these 8 of 16 embo molecular medicine 12: e8662 | 2020 ª 2020 the authors animals with different human-specific viruses (middle east respiratory syndrome-related coronavirus (mers), zika virus, respiratory syncytial virus (rsv), and hcmv) showed virus replication within lung implants, as well as antigen-specific humoral and t-cell responses. further studies in this direction are necessary to widen the application of humanized mice to additional human pathogens and immune responses against them. these examples of the use of humanized mice to recapitulate human infections and associated immune responses illustrate the vigor and translational value of these models. standardization of the reporting will improve the interpretation of results for single infections and for cross-reference among the different pathogens studied (table 1) . over the past decades, mouse xenograft models have significantly contributed to a better understanding of human malignancies. cancer-derived immortalized cell lines can adapt to in vitro growth and do not replicate the original malignant physiology seen in patients, potentially leading to artifacts in oncology studies. thus, patient-derived xenograft (pdx) models are currently the state-ofthe-art approach. development of liquid and solid pdx models relies on the availability of material obtained from patients with defined types of cancer, which after minimal manipulation is transferred by several routes into immunodeficient mice (fig 1d, table 1 ). nevertheless, whereas cell line-based xenografts allow an easier standardization of models, pdx samples are highly variable, can adapt to the murine environment and the human tumor stroma can be eventually replaced by murine cells. for leukemia research, while the generation of immunodeficient mouse strains like nsg has enabled functional in vivo studies on human hematopoiesis, engraftment of (in particular) myeloid malignant cells has remained challenging. the absence of a human bone marrow niche and species-specific growth factors underlies these challenges, and most notably, it has been difficult to maintain selfrenewal properties of malignant stem cells. since these populations are thought to be the therapy-resistant cells that frequently cause relapse of disease, it is of critical importance to use xenograft models in which specifically these cells can be propagated and stemness maintained. in order to further humanize xenograft models, transgenic and knock-in strains have been generated that (over)express growth factors like il-3, gm-csf, scf, tpo, and/or m-csf, as well as others (wunderlich et al, 2010; rongvaux et al, 2014 ). an alternative approach has been to develop a human microenvironment in the mouse initiated by mesenchymal stem cells coated on 3d scaffolds (antonelli et al, 2016; abarrategi et al, 2017; carretta et al, 2017) or embedded in matrigel (reinisch et al, 2016) . these models have allowed the engraftment of various hematological malignancies, including those that are notoriously difficult to engraft in regular nsg models such as low-risk acute myeloid leukemia (aml), myelodysplastic syndrome (mds), and myelofibrosis. importantly, self-renewal was better maintained in these models as shown by serial transplantation experiments and transcriptome studies. as such, these models more faithfully capture the disease phenotypes as seen in human patients and therefore are likely to produce more clinically relevant and translatable results when used in drug screens. a challenge that remains is that myeloid malignancies, in particular aml, display a complex clonal heterogeneity. multiple genetically distinct subclones can co-exist within an individual patient, each driven by a similar founder mutation but with different secondary driver mutations. these clones are not only genetically distinct; they also differ remarkably at the transcriptome, epigenome, and cell biological level (de boer et al, 2018) . to develop curative therapies, this clonal heterogeneity needs to be taken into account. it has become clear that not all clones of an individual patient might engraft equally efficiently in mice, and also the level of humanization of the model used might impact on whether the true clonal heterogeneity is preserved in vivo (klco et al, 2014; antonelli et al, 2016; carretta et al, 2017; wang et al, 2017; de boer et al, 2018) . both (deep) sequencing technologies and flow cytometry-based approaches are useful tools to dissect clonal heterogeneity, in vitro as well as in mouse models. for instance, an "infinicyt"based approach, which combines expression profiles of multiple aberrant aml-specific plasma membrane proteins, can provide subclone-specific insights into the clonal complexity of the malignancy under study (de boer et al, 2018) . implementation of such technologies is warranted in any conducted in vivo xenograft experiment to link drug responses to specific genetic features of malignant clones. in the case of solid tumors, the use of pdxs for preclinical drug development holds potential to improve our knowledge of the principles underlying responsiveness to individualized treatment regimens (hidalgo et al, 2014; byrne et al, 2017 ). yet, many questions are still open, in particular concerning the ability of the pdx approach to directly influence clinical decision making (aparicio et al, 2015) . not all cells that compose the parental tumor successfully engraft in the mouse, which introduces a selective pressure for genetic variants conferring better survival fitness (ben-david et al, 2017) . the subsequent propagation steps may also affect clonal dynamics, with further deviation of serially passaged samples from the primary tumor from which they were derived (eirew et al, 2015) . the lack of a fully functional immune system in the host and the fact that human stromal components -such as cancer-associated fibroblasts, endothelial cells, and inflammatory cells-are replaced by murine counterparts add extra layers of divergence over native tumors (hidalgo et al, 2014; aparicio et al, 2015; byrne et al, 2017) . these limitations notwithstanding pdx models of solid tumors offer considerable opportunities for biomarker and target nomination. first, although serially passaged pdxs are likely to be genetically different from the matched tumor of their donor patients, they are expected to display genomic makeups and polyclonality patterns that, on a probabilistic basis, may be similar to those of tumors that spontaneously develop in unrelated individuals (eirew et al, 2015; byrne et al, 2017) . these factors make pdxs critical tools in the translational oncology domain, whereby predictive biomarkers discovered in pdxs may be leveraged for the prospective identification of patients with tumors exhibiting the same biomarker repertoire. second, responses to therapies that target driver oncoproteins are thought to be only partly influenced by microenvironmental parameters and more directly dependent on cancer cell-intrinsic features, which affords results in pdxs with adequate predictive power for cancer cell-directed treatments (byrne et al, 2017) . finally, vast pdx collections are poised to capture inter-patient tumor diversity on a population scale, thus representing powerful platforms for large-scale genotype-response associations (gao et al, 2015) . the above examples illustrated the importance of pdx models in understanding the evolution of tumor growth, investigating the mechanisms of drug resistance, and developing personalized treatments. critical to these studies is ensuring researchers have access to high-quality pdx models and molecular datasets that give sufficient power to perform informative analyses. however, the complex nature of pdx models and the heterogeneous resources that generate them often lead to crucial information about tumors, host strains, transplant, and quality assurance processes being inconsistently presented. to address this challenge, the pdx research community developed the pdx model minimal information standard (pdx-mi) that defines the critical metadata needed to exchange knowledge about pdx models (meehan et al, 2017) . pdx-mi describes the clinical attributes of a patient's tumor, the processes of implantation and passaging of tumors in a host mouse strain, quality assurance methods, and the use of pdx models in cancer research. since its inception, pdx-mi has been adopted by producers of pdx models including the international pdxnet and europdx consortia as well as the pdx finder catalog that captures, harmonizes, and disseminates data about pdx models and associated omic datasets (conte et al, 2019) . pdx-mi promotes reuse of models and data, maximizing the impact of these models on oncology research and facilitating the development of new treatments. therapeutic modulation of the human immune system to improve recognition and response to tumors is a clinically accepted revolution in oncology treatment for multiple tumor types (pardoll, 2012) . immuno-oncology (io) is considered a breakthrough due to significant and durable tumor regression coupled with increased long-term survival. however, these clinical responses only occur in a subset of patients. therefore, considerable investment in preclinical research is still necessary to identify new and improved approaches to cancer cell-specific immune response as well as testing of combinatorial strategies. these and other approaches are typically developed in syngeneic mouse models of oncology to work out mechanisms of action. nonetheless, human-specific immune modulators require in vivo models with human-specific targets on both human immune cells and human tumors to validate preclinical responses, accelerate development, and improve translation to the clinic. ideally, io in vivo studies will rely on the combination of his and pdx models. as described in the following sections, his mice co-engrafted with human tumors are proving to be a valuable tool in the development of new strategies for human-specific immuno-oncology therapies. nonetheless, as these models are per se complex and the matching of the tumor and immune system from the same patient is currently a difficult task, several studies explore cell line derived xenograft (cdx) implanted after humanization in his mice or administration of human peripheral blood lymphocytes (pbl; fig 1e, table 1 ). these io studies have been used, for example, to test immune modulation caused by engineered agonistic or antagonistic monoclonal antibodies (mab; scott et al, 2012) , bispecific t-cell engagers (bite; baeuerle & reinhardt, 2009) , or t-cell bispecific antibodies (tcb; bacac et al, 2018) . a very important and commonly asked question regarding human tumor cell engraftment in his mice is whether the cdx or pdx tumor and hematopoietic donor must be 100% hla-matched to allow co-engraftment. neonatal irradiated nsg mice co-injected into the liver with cd34 + cord blood-derived hsc and hlamismatched human breast cdx, resulted in the development of a human immune system together with human tumor growth, including metastases in the lung and brain (wege et al, 2011 (wege et al, , 2014 . tumors were partially infiltrated with t cells, b cells, and myeloid cells. more detailed analyses of the spleen revealed not only a t-cell specific activation pattern but also b-cell maturation and the production of tumor-specific antibodies (wege et al, 2014) . moreover, the tumor engrafted his mice were used for a preclinical trial to test the potential of il-15 in combination with trastuzumab (anti-her2 mab) therapy with the intention to enhance antibody-dependent cellular cytotoxicity (adcc; wege et al, 2017) . il-15 treatment triggered immune activation and promoted tumor depletion but also induced systemic inflammation, resulting in death of the treated mice (wege et al, 2017) . in another study, 3-week-old nsg mice were engrafted with cord blood-derived cd34 + hsc first to establish mature multilineage immune engraftment and then injected subcutaneously 12-16 weeks later with partially hla-matched pdx tumors (wang et al, 2017) . despite the presence of a wide range of functional immune cells, the his mice were capable of engrafting the tumors and in many cases the growth kinetics of these tumors did not vary significantly from immunodeficient controls not engrafted with hsc. however, not all partially hla-matched tumor/hsc donor combinations escape immune-mediated changes in growth kinetics and some tumors are rejected, highlighting the importance of empirically testing tumor growth against multiple hsc donors. subcutaneously engrafted tumors were infiltrated with a wide range of human innate and adaptive immune cells and both the frequency and distribution of immune cell types varied across different tumor types (wang et al, 2017) . one mechanism known to prevent t cells from responding to tumors is the pd-1 and its ligand (pd-l1) checkpoint pathway. the clinically approved checkpoint inhibitor pembrolizumab (anti-pd-1 mab) has been tested in tumor-bearing his mice and suppression of tumor growth was observed using both cdx and pdx tumors (wang et al, 2017) . suppression of tumor growth with pembrolizumab only occurred in mice co-engrafted with human immune cells and the response was abrogated when mice were pretreated with anti-human cd8 mab to deplete human cd8 + t cells, demonstrating human cd8 + t cells mediated the effector response following release from checkpoint inhibition. efficacy studies with pembrolizumab were run with multiple hsc donors distributed among both control and treatment arms of each tumor tested for response. multiple hsc donors allowed the observation that not all tumor/hsc combinations show a response to pembrolizumab, and the frequency of donor-related response (~25-30%) is similar to what is observed in the clinic (topalian et al, 2012) . regulatory t cells (tregs) infiltrate a wide range of tumor types and mechanism of action studies performed in syngeneic mouse tumor models revealed that depletion of these cells from the tumor could release t effector cells from treg suppression (smyth et al, 2014) . preclinical efficacy for this approach was demonstrated when his mice were engrafted with sk-mel-5 human melanoma cdx and treated with an anti-human mab targeting the glucocorticoidinduced tnfr family-related (gitr) protein, highly expressed on tregs. tumor growth was significantly suppressed, the percentage of tregs was reduced in tumor and spleen, and tumor-infiltrating lymphocytes showed increased secretion of the effector cytokines il-2 and ifn-c (mahne et al, 2017) . as more io treatments move through clinical trials, clinicians are seeing an association between strong immune-mediated tumor killing responses and cytokine release syndrome (crs). given these observations, preclinical studies able to recapitulate crs in his mice are becoming highly relevant. in a recent report, his mice were co-engrafted with a diffuse large b-cell lymphoma (wsu-dlcl2) and treated with either obinutuzumab (anti-cd20 mab) or a novel cd20-t-cell bispecific antibody (tcb) containing two cd20 binding domains and one cd3e domain in a head-to-tail orientation to one of the cd20 regions (bacac et al, 2018) . cd20-tcb promoted a more extensive killing response than obinutuzumab. further, cd20-tcb administration was associated with increased expression of multiple human inflammatory cytokines indicating a crs response that was not observed with obinutuzumab treatment. an alternate strategy was tested where treatment was initiated with a single dose of obinutuzumab followed by multiple high doses of cd20-tcb. the pretreatment with obinutuzumab strategy enabled rapid and extensive tumor killing with minimal crs response. these types of preclinical experiments with his mice demonstrate their value in working out protocols designed to maximize both efficacy and safety. the question of immuno-therapy-mediated toxicity, particularly in the context of crs, is a key component of preclinical evaluation and a reliable assay is needed. neither in vitro assays nor nonhuman primates have proven reliable for assessment of crs (stebbings et al, 2007) . a team at the us food and drug administration recently published two reports testing crs using mab therapies known to have a strong cytotoxic response in the blt-his mice (yan et al, 2019a,b) . blt mice were injected with adalimumab (anti-tnf-a mab) as a negative control because it is used clinically without evidence of crs. the test article was tgn1412 (anti-cd28 mab), a reagent known to be associated with clinical crs. tgn1412-treated blt mice released multiple cytokines into peripheral blood within 2-4 hours of treatment, indicating a strong crs response that was not observed in the adalimumab-treated group (yan et al, 2019a) . the mice also showed a decrease in human cd45 + , cd3 + , cd4 + , cd8 + , and cd19 + cells in peripheral blood similar to human patients and showed an increase in murine serum amyloid a, indicating severe liver inflammation. a second study compared muromonab (anti-cd3 mab, okt3) to adalimumab in blt mice. the muromonab-treated mice released multiple proinflammatory cytokines associated with crs into peripheral blood within 2-4 h, and pretreatment of mice with methylprednisolone prior to muromonab blunted or delayed development of crs (yan et al, 2019b) . together, these studies show that blt-his mice are capable of recapitulating multiple aspects of a strong crs response when dosed with mab therapies designed to stimulate strong t-cell activation. to our knowledge, no direct comparisons between pbmc-his and blt-his model mice have been made to date. there are several published studies using pbmc-his mice demonstrating crs (brady et al, 2014; weissmuller et al, 2016) with the mice being used between 6 and 16 days of pbmc injection. in both reports, the authors state there were no signs of gvhd present when used. in yan et al (2019a) , a limited comparison of cd34-his mice and blt-his mice was undertaken and blt-his mice showed clear evidence of crs and no gvhd, whereas cd34-his mice did not show any difference as compared to control treatment, suggesting that the cd34-his mouse does not show a clear signal for crs and may not be an appropriate model. as previously published for the blt-his mouse (weaver et al, 2019) , when present, gvhd is clearly evident and can be differentiated from other processes, such as crs. gvhd occurs rapidly and for all pbmc-his mice, but does not occur with high frequency in blt-his mice. with respect to crs, pbmc-his mice would potentially demonstrate crs for drugs specifically impacting t cells, but not other tissues or cell types. blt-his mice have much broader engraftment in terms of cell types and presence in non-lymphoid organs, suggesting that a wider range of targets could demonstrate crs if present. for preclinical use, the stebbings in vitro assay (stebbings et al, 2007) should be initially undertaken. studies with his mice would be adjunctive and informed by both the target of the therapeutic and what organ system(s) were targeted. additional circumstances in which in vivo testing could be helpful include higher risk drug targets and non-t-cell targets. in conclusion, his mice are a powerful tool for io research. his mice do not recapitulate every aspect of human immunity, but they are capable of answering a wide range of important scientific questions that form a critical guide for preclinical io discovery. future challenges will include the understanding of the donor-to-donor immune variability observed in some of these treatment strategies. this will provide opportunities to identify predictive markers and clinical diagnostics assays helpful in assisting patient enrollment for improved treatment outcomes. tumor populations that escape response in subsets of mice can be further analyzed for understanding mechanism of resistance. humanized mouse models result from the sum of several components: choice and availability of human donors, human cells or tissues, mouse recipient, types of manipulations, human infections, and human tumor types. furthermore, the materials available for analyses and methods of analyses provide another level of complexity. it is quite clear that humanized mouse models are customized by the different laboratories around the globe and it would be unrealistic to standardize how the models should be built. nevertheless, reporting of minimal information provided by specific guidelines can facilitate independent validation of published data, which is a fundamental cornerstone for scientific advancements. the list of variables provided in table 1 is an initial attempt brought up by the faculty participating in the 2017 and 2019 embo practical courses created for training young investigators on the development of humanized mouse models. this initiative called "minimal information for standardization of humanized mouse models" (mishum) is built on the experience of the authors of this manuscript in developing similar reporting standards for non-humanized pdx models (meehan et al, 2017) . the main aim of this workgroup is, similar to pdx-mi, to promote material and protocol exchange, transparency in reporting of assays and analyses performed. the standards described here represent a starting point. the longer term intention is to extend this initiative beyond the embo courses to include input from multiple stakeholders from both academia and industry. further, in order to enable a standardized interpretation of already published results, the collection of technical information and quantifiable data can in the future be procured within mishum for the creation of a digitalized database. once these standards and database are evolving, a parallel data mining activity will provide the opportunity to explore and discover convergent signatures and patterns of human immunology, infections, and oncology in vivo in humanized mice. our long-term goal is that, in the future, these models will become largely reproducible and predictive models for the understanding of human physiology, immunology, and oncology, which require a living experimental system. beyond the gain of scientific information, we hope to make humanized mouse models more environmentally sustainable by optimizing the methods and reducing the number of humanized mice used for experimentation. ultimately, we seek to support the "3r" principles: (i) replace the use of humanized mice if alternative in vitro techniques (such by the use of organoids or chips), metadata or data mining eventually prove to be as solid as the in vivo results; (ii) reduce the number of humanized mice to a minimum within each experimental cohort; and (iii) refine the experimental setup using the best and ethically available human material and analyses, also making sure that invasive approaches can be minimized to mitigate the suffering of the animals. only with a consensus checklist and with a coherent reporting policy, we will be able to identify the best material, methods, and analyses that will ultimately lead to optimized humanized mouse models. below is a summary of main topics identified by our community that remain to be solved on a case-by-case basis depending on the use of the humanized mouse model: human hematopoiesis and immunity: methods to expand human hscs will enable larger experimental cohorts. novel methods for matching the hla between human hematopoietic cells and mouse epithelial cells will improve human t-cell development in a hlarestricted manner. better development of lymph nodes and germinal centers within the spleen that would improve innate and adaptive immune responses. novel mouse strains or methods allowing regeneration of lymph nodes will allow b cell class switch and production of human high-affinity igg and iga antibodies. human metabolism: mice and human display different rates and pathways of metabolism, and particularly for liver metabolism, it is essential to address this limitation of humanized mice. since many metabolites are diffusible, new models are needed that can eliminate or temporarily block murine metabolism while using chimeric mice. human infections: engraftment of human peripheral tissues (i.e., liver, lung, skin, and brain) will allow infections with human pathogens targeting other tissues than immune cells, and the possibility of combining them with hlas matched human hematopoietic stem cells will create a more complete model of human infection. better engraftment of the human erythrocyte lineage will allow further studies of erythrocyte-infecting pathogens (i.e., plasmodium). human oncology: further humanization of xenograft mouse models such as implantation of human msc-coated 3d scaffolds or nsg mice (over) expressing human cytokines has improved engraftment rates of primary tumor cells. however, for each individual cancer patient case, it will have to be established which (sub)clones preferably grow out. also, it will need to be carefully evaluated how the transcriptome and epigenome of the original patient samples are preserved in the pdx models. human immuno-oncology: the hla matching of the human immune system and tumor will be required. a functional enhancement of the cd4 + and cd8 + t cells will be needed to allow higher tumor infiltration and anti-tumor responses. an improved and faster development of "avatar" pdx models will allow decisions about personalized therapeutic options. (iii) https://www.mdpi.com/journal/vaccines/special_issues/humanized_mice in this special issue "humanized mice in vaccinology: opportunities and challenges", aspects related to the use of humanized mice in vaccinology, opportunities, and the challenges ahead are discussed. (iv) http://www.pdxfinder.org/pdx-standard/ the pdx minimal information document represents the results of a broad community effort to develop a standard regarding the essential information needed to describe a pdx model. versatile humanized niche model enables study of normal and malignant human hematopoiesis humanized immune system mouse models: progress, challenges and opportunities human liver chimeric mice as a new model of chronic hepatitis e virus infection and preclinical drug evaluation establishing human leukemia xenograft mouse models by implanting human bone marrow-like scaffold-based niches examining the utility of patientderived xenograft mouse models robust expansion of human hepatocytes in fah à/à /rag2 à/à /il2rg à/à mice cd20-tcb with obinutuzumab pretreatment as next-generation treatment of hematologic malignancies bispecific t-cell engaging antibodies for cancer therapy safety and antiviral activity of combination hiv-1 broadly neutralizing antibodies in viremic individuals a novel humanized mouse lacking murine p450 oxidoreductase for studying human drug metabolism patient-derived xenografts undergo mouse-specific tumor evolution hepatitis b virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and m2-like macrophages development of human cd4+ foxp3+ regulatory t cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing nod-scid il2rgamma(null) humanized mice humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and nk cells repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model human liver chimeric mice provide a model for hepatitis b and c virus infection and treatment p450-humanized and human liver chimeric mouse models for studying xenobiotic metabolism and toxicity development and rescue of human familial hypercholesterolaemia in a xenograft mouse model prospective isolation and characterization of genetically and functionally distinct aml subclones preclinical screening for acute toxicity of therapeutic monoclonal antibodies in a hu-scid model human immune system development and rejection of human islet allografts in spontaneously diabetic nod-rag1null il2rgammanull ins2akita mice lack of acute xenogeneic graft-versus-host disease, but retention of t-cell function following engraftment of human peripheral blood mononuclear cells in nsg mice deficient in mhc class i and ii expression human primary liver cancer-derived organoid cultures for disease modeling and drug screening humanized mouse model of mast cell-mediated passive cutaneous anaphylaxis and passive systemic anaphylaxis interrogating open issues in cancer precision medicine with patient-derived xenografts genetically engineered mesenchymal stromal cells produce il-3 and tpo to further improve human scaffold-based xenograft models new approaches for the enhancement of chimeric antigen receptors for the treatment of hiv viraemia suppressed in hiv-1-infected humans by broadly neutralizing antibody 3bnc117 antibody 10-1074 suppresses viremia in hiv-1-infected individuals broadly neutralizing anti-hiv-1 monoclonal antibodies in the clinic cd8 + t cells retain protective functions despite sustained inhibitory receptor expression during epstein-barr virus infection in vivo epstein-barr virus: an important vaccine target for cancer prevention pdx finder: a portal for patient-derived tumor xenograft model discovery engineered dendritic cells from cord blood and adult blood accelerate effector t cell immune reconstitution against hcmv human hepatocyte depletion in the presence of hiv-1 infection in dual reconstituted humanized mice repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis b virus c1qrp defines a new human stem cell population with hematopoietic and hepatic potential spatiotemporally skewed activation of programmed cell death receptor 1-positive t cells after epstein-barr virus infection and tumor development in long-term fully humanized mice microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice selective expansion of myeloid and nk cells in humanized mice yields human-like vaccine responses viral load affects the immune response to hbv in mice with humanized immune system and liver dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution comparative pathogenesis of ebola virus and reston virus infection in humanized mice viral infection of engrafted human islets leads to diabetes high-throughput screening using patientderived tumor xenografts to predict clinical trial drug response human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned upa-nog mice the reconstituted 'humanized liver' in tk-nog mice is mature and functional neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator patient-derived xenograft models: an emerging platform for translational cancer research human hematopoietic stem/ progenitor cells modified by zinc-finger nucleases targeted to ccr5 control hiv-1 in vivo improved b cell development in humanized nod-scid il2rgamma(null) mice transgenically expressing human stem cell factor, granulocytemacrophage colony-stimulating factor and interleukin-3 tracking human immunodeficiency virus-1 infection in the humanized drag mouse model in vivo suppression of hiv by antigen specific t cells derived from engineered hematopoietic stem cells functional heterogeneity of genetically defined subclones in acute myeloid leukemia hiv therapy by a combination of broadly neutralizing antibodies in humanized mice modeling human cytomegalovirus in humanized mice for vaccine testing a novel flt3-deficient his mouse model with selective enhancement of human dc development a human immune system mouse model with robust lymph node development adenovirus infections in immunocompetent and immunocompromised patients ebola virus disease in mice with transplanted human hematopoietic stem cells humanized chimeric upa mouse model for the study of hepatitis b and d virus interactions and preclinical drug evaluation dual roles for regulatory t-cell depletion and costimulatory signaling in agonistic gitr targeting for tumor immunotherapy humanized mouse models for human immunodeficiency virus infection accelerated thymopoiesis and improved t-cell responses in hla-a2/-dr2 transgenic brgs-based human immune system mice the scid-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function infection and immune control of human oncogenic gamma-herpesviruses in humanized mice pdx-mi: minimal information for patient-derived tumor xenograft models generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model combination therapy with anti-hiv-1 antibodies maintains viral suppression hepatitis c virus replication in mice with chimeric human livers latency and lytic replication in the oncogenesis of the epstein barr virus lentivector knockdown of ccr5 in hematopoietic stem and progenitor cells confers functional and persistent hiv-1 resistance in humanized mice early antibody therapy can induce long-lasting immunity to shiv isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment the blockade of immune checkpoints in cancer immunotherapy bioengineering of humanized bone marrow microenvironments in mouse and their visualization by live imaging a humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells humanized mice reproduce acute and persistent human adenovirus infection development and function of human innate immune cells in a humanized mouse model dendritic cellmediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids antibody therapy of cancer rnai-mediated ccr5 knockdown provides hiv-1 resistance to memory t cells in humanized blt mice humanized mice in translational biomedical research humanized mice for immune system investigation: progress, promise and challenges human cancer growth and therapy in immunodeficient mouse models humanized mouse models of immunological diseases and precision medicine targeting regulatory t cells in tumor immunotherapy cytokine storm" in the phase i trial of monoclonal antibody tgn1412: better understanding the causes to improve preclinical testing of immunotherapeutics decisions about dendritic cells: past, present, and future e8662 | 2020 human hepatocytes polymorphism in sirpa modulates engraftment of human hematopoietic stem cells type 1 diabetes induction in humanized mice the immunology of epstein-barr virus-induced disease signatures of t and b cell development, functional responses and pd-1 upregulation after hcmv latent infections and reactivations in nod.rag.gamma mice humanized with cord blood cd34(+) cells safety, activity, and immune correlates of anti-pd-1 antibody in cancer multidimensional analysis integrating human t-cell signatures in lymphatic tissues with sex of humanized mice for prediction of responses after dendritic cell immunization precision mouse models with expanded tropism for human pathogens humanized mouse models of clinical disease patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias a humanized mouse model to study hepatitis c virus infection, immune response, and liver disease blt-immune humanized mice as a model for nivolumab-induced immune-mediated adverse events: comparison of the nog and nog-exl strains humanized tumor mice-a new model to study and manipulate the immune response in advanced cancer therapy co-transplantation of human hematopoietic stem cells and human breast cancer cells in nsg mice: a novel approach to generate tumor cell specific human antibodies il-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (htm) tgn1412 induces lymphopenia and human cytokine release in a humanized mouse model aml xenograft efficiency is significantly improved in nod/ scid-il2rg mice constitutively expressing human scf, gm-csf and il-3 human pbmc-transferred murine mhc class i/ii-deficient nog mice enable long-term evaluation of human immune responses evaluation of a tgn1412 analogue using in vitro assays and two immune humanized mouse models bone marrow-liverthymus (blt) immune humanized mice as a model to predict cytokine release syndrome a novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production hiv-specific immunity derived from chimeric antigen receptor-engineered stem cells long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor t cells in a nonhuman primate model of hiv/aids license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited we thank the european molecular biology organization (embo) and the jackson laboratory (jax) for funding, and we thank the staff of the euro key: cord-308461-4lhh3du0 authors: ueki, hiroshi; wang, i-hsuan; zhao, dongming; gunzer, matthias; kawaoka, yoshihiro title: multicolor two-photon imaging of in vivo cellular pathophysiology upon influenza virus infection using the two-photon impress date: 2020-01-29 journal: nat protoc doi: 10.1038/s41596-019-0275-y sha: doc_id: 308461 cord_uid: 4lhh3du0 in vivo two-photon imaging is a valuable technique for studies of viral pathogenesis and host responses to infection in vivo. in this protocol, we describe a methodology for analyzing influenza virus–infected lung in vivo by two-photon imaging microscopy. we describe the surgical procedure, how to stabilize the lung, and an approach to analyzing the data. further, we provide a database of fluorescent dyes, antibodies, and reporter mouse lines that can be used in combination with a reporter influenza virus (color-flu) for multicolor analysis. setup of this model typically takes ~30 min and enables the observation of influenza virus–infected lungs for >4 h during the acute phase of the inflammation and at least 1 h in the lethal phase. this imaging system, which we termed two-photon impress (imaging pathophysiology research system), is broadly applicable to analyses of other respiratory pathogens and reveals disease progression at the cellular level in vivo. in vivo two-photon imaging is an analytical approach that can be used to visualize cell dynamics and hemodynamics in organs or tissues of live animals. information in real time obtained by using this approach, such as changes in cell behavior and morphology, tissue localization, and blood flow, has revealed highly sophisticated and dynamic systems of living organisms. during in vivo imaging, the blood circulation in the tissue being observed is maintained; therefore, this technique is also effective for analyzing the migration and invasion of immune cells in the inflammatory environment. observations in physiological environments deepen our understanding of host response mechanisms under both steady-state and disease conditions. computed tomography, x-ray, and ivis spectrum (an in vivo imaging system) imaging methods have been used as non-invasive approaches; however, these techniques have low spatiotemporal resolution and have been able to estimate only the site of inflammation in an organ 1, 2 . therefore, it is impossible to observe cellular responses of the immune system using these approaches. by contrast, a two-photon excitation laser microscope, the light source of which is a near-infrared laser that produces low damage to cells but has long-reaching depth in tissue, enables us to capture the movement of cells in living animals at high resolution. two-photon imaging has been in use in biological science since the 1990s; it has progressed at a remarkable rate, and observation methods for various organs, including brain, liver, and lymph nodes, have been reported 3, 4 . in this protocol, we describe how to use it to image virus-infected lungs. we have previously demonstrated that this protocol works by using mice infected with mouse-adapted seasonal influenza virus (h1n1) or highly pathogenic avian influenza virus (h5n1) 5 . the lung, which is a respiratory organ, has contact with the outside environment and is an important organ for research on immunity to infectious diseases. in the seventeenth century, marcello malpighi discovered pulmonary capillaries and alveoli in the frog lung by using optical microscopy 6 ; now fluorescent reporter mice facilitate the study of disease models in conjunction with two-photon excitation microscopy (table 1) . however, a challenge encountered when imaging the lung is that it is constantly moving during respiration. the lung has been stabilized in several ways during in vivo observation by microscopy, including bronchus clamping, prolonged apnea, gluing, and suction 7, 8 ; however, it is difficult to reduce motion artifacts due to lung respiratory movement under physiological conditions and hence to obtain high-quality images. bronchus clamping can suppress respiratory motion artifacts of the lung lobe 9, 10 ; however, it is not suitable for long-term observation because it causes severe hypoxia. although prolonging apnea is less invasive [11] [12] [13] , it does not allow researchers sufficient time to observe the lung for image acquisition by two-photon excitation microscopy, and the quality of the images tends to deteriorate over time. gluing addresses the above limitations 14, 15 ; however, it can induce shear force injury and inflammation, which affect the interpretation of results. a suction window, which is currently the most commonly used stabilizing system during lung imaging, achieves moderate immobilization of the lung and high-quality images [16] [17] [18] [19] ; however, the observation period is limited to ≤12 h. ex vivo imaging of lungs and in vivo imaging of trachea have also been performed as complementary methods 8 . each of these methods has its advantages and disadvantages, and it is important to select and optimize the method best suited to the goal of the experiments and disease model. in vivo observation of lungs has been performed using various lung disease and experimental models, including bacterial infection, allergen inoculation, tumor metastasis, and lipopolysaccharide (lps)-induced sepsis (table 1) . however, for viral respiratory diseases, such as influenza, other than an observation in a methodology report 20 , only analyses of the trachea in vivo [21] [22] [23] and isolated lungs had been performed 24 , with no analysis of the lung in vivo, until our recent publication 5 (table 1) . unlike ex vivo methods, which involve isolated or sliced lungs, in vivo imaging using two-photon excitation microscopy of live animals enables researchers to observe hemodynamics, migration and extravasation of immune cells, as well as interactions among immune cells during influenza virus infection. however, it is technically demanding to perform two-photon excitation microscopy of live influenza virus-infected lung, which exhibits severe inflammation, requiring the development of highly sophisticated, less invasive instruments and surgical techniques. in addition, when observing animals infected with pathogenic viruses, specialized facilities and instruments are frequently required to avoid the spread of the virus. furthermore, because many types of immune cells infiltrate the infected lung in an inflammatory environment, it is necessary to distinguish the target immune cells from the infected cells by using fluorescent labels in the infected microenvironment. to detect multiple fluorescent signals excited simultaneously by a two-photon excitation laser, fluorochromes with different spectra and equal brightness must be selected; however, there is currently no comprehensive database of fluorescent reagents, fluorescent reporter viruses, and reporter mouse lines available for lung in vivo imaging. we therefore also provide a database of fluorescent dyes, antibodies, and reporter mouse lines that can be used in combination with a reporter influenza virus (color-flu) [25] [26] [27] for multicolor analysis under pathological conditions in this protocol. our system uses suction-based lung stabilization 16, 28 to improve an existing in vivo two-photon imaging system for influenza virus-infected lung as a model of an acute inflammatory respiratory disease 5 . we have successfully used c57bl/6 mice and transgenic mice of the c57bl/6 background (6-to 10-week-old males and females). by using our method, described in detail here, it is possible to visualize and analyze the behavior of immune cells and their interactions with infected cells during an influenza virus infection, which creates an acute inflammatory environment. a limitation of two-photon excitation microscopy is that the observation depth that can be achieved is a maximum of~70 μm. therefore, we cannot observe the bronchial region. this limitation is linked to the wavelength of the infrared laser and detector capability of the microscope. however, as laser technology develops, the observation depth achievable using this method will improve. in this protocol, we describe the application of this methodology to influenza virus infection of the lungs because this is what we have used it for previously. this protocol could be applied not only to studies of the early stages of inflammation due to infection or other causes, but also to analyses of tissue regeneration mechanisms in lungs that are in the process of recovering from infection or other protocol nature protocols injuries. the information provided will also be useful to those using two-photon imaging analysis for the evaluation of the effects of drugs and vaccines, as well as biological events in the lungs and other organs (e.g., liver, spleen) 5 . moreover, with minor modifications, the approach could be applied to analyses of other respiratory diseases, including other infectious models (e.g., severe acute respiratory syndrome (sars) and middle east respiratory syndrome (mers)), pulmonary fibrosis, and tumor metastasis. . dna fingerprinting showed that this cell line has the same origin as one obtained from atcc (cat. no. ccl-34, rrid:cvcl_0422) ! caution all viruses and infected animals should be handled in accordance with your institution's biosafety regulations. all work on highly pathogenic avian influenza viruses must be performed under biosafety level 3 (bsl3) regulations. accordingly, all our in vivo imaging studies were performed in the bsl3 facility at the university of tokyo (tokyo, japan), which is approved for such use by the ministry of agriculture, forestry, and fisheries of japan c critical the cells should be regularly checked to ensure that they are not contaminated with mycoplasma. • isoflurane (msd animal health) ! caution isoflurane is an anesthetic gas associated with adverse health outcomes. it should be used in a well-ventilated room or with another appropriate removal system. store it in a locked drawer at room temperature (18-25°c). • sevoflurane (maruishi pharmaceutical) ! caution sevoflurane is an anesthetic gas associated with adverse health outcomes. it should be used in a well-ventilated room or with another appropriate removal system. store it in a locked drawer at room temperature. c critical all reagents should be prepared under sterile conditions. fluorescent reagents should be protecting from light during the setup procedure because they are light sensitive. to prepare 10 mg/ml of tamoxifen solution in sunflower seed oil, dissolve 100 mg of tamoxifen in 1 ml of ethanol (99.5%) and add 9 ml of sunflower seed oil. after adding the ethanol and sunflower seed oil, mix well by vortexing and sonication. this solution can be stored in a refrigerator (2-8°c) for a week. ! caution tamoxifen powder should be handled in a hood. to avoid inhalation and contact with skin, wear rubber gloves and a surgical mask. prepare a solution at a concentration of 2 mg/ml in sterile 1× pbs or saline, make aliquots in 1.5-ml microtubes, and store them in a refrigerator (2-8°c) for up to 2 weeks. inject 50 μl (100 μg) of fluorescent dextran i.v. per mouse. qtracker 655 vascular labels immediately before use, add 5 μl of the stock solution to 95 μl of sterile 1× pbs or saline to make 100 μl total and inject 50 μl i.v. at a concentration of 0.1 μm. prepare a solution at a concentration of 1 × 10 8 beads/ml in sterile 1× pbs or saline, make aliquots of the solution in dark 1.5-ml microtubes, and store them in a refrigerator (2-8°c) for long periods (~3 months). immediately before use, mix well and inject 50 μl i.v. per mouse. qdot 655 wga immediately before use, add 5 μl of the stock solution to 95 μl of sterile 1× pbs or saline to make 100 μl total and i.v. inject 50 μl. prepare a solution at a concentration of 100 μm in sterile 1× pbs or saline, dispense the solution into dark 1.5-ml microtubes, and store them in a refrigerator (2-8°c) for up to 2 weeks. inject 50 μl of fluorescent dextran i.v. per mouse. divide the 5 mm dmso stock solution into dark 1.5-ml microtubes and store them at −20°c for up to 3 months. immediately before use, prepare a solution at a concentration of 50 μm in sterile 1× pbs or saline and i.v. inject 50 μl per mouse. prepare a solution at a concentration of 100 mm in sterile 1× pbs or saline, dispense the solution in dark 1.5-ml microtubes, and store them at −20°c for up to 3 months. immediately before use, prepare a solution at a concentration of 1 mm in sterile 1× pbs or saline and inject 50 μl i.v. per mouse. prepare a solution at a concentration of 10 mm in sterile 1× pbs or saline, make aliquots of the solution in dark 1.5-ml microtubes, and store them in a refrigerator (2-8°c) for up to 2 weeks. inject 50 μl of the solution i.v. per mouse. prepare a working solution according to the vendor's manual, dissolve pan caspase in vivo probe in 5 μl of dmso, and add 55 μl of 1× injection buffer (from the kit). inject 60 μl of the solution i.v. per mouse within 1 h of preparation. prepare a working solution according to the vendor's manual, dissolve 100 μl of pkh26pcl in 900 μl of ethanol and store at room temperature for up to 3 months. immediately before use, prepare a solution at a concentration of 10 μm in sterile dilution buffer (from the kit) and inject 50 μl intranasally per mouse. cellrox green, orange, and deep red immediately before use, add 50 μl of the stock solution to 450 μl of sterile 1× pbs or saline to make 500 μl total and inject 50 μl i.v. at a concentration of 250 μm. lysotracker blue, green, red, and deep red immediately before use, add 50 μl of the stock solution to 450 μl of sterile 1× pbs or saline to make 500 μl total and inject 50 μl i.v. at a concentration of 100 μm. mitotracker orange cmtmros, red cm-h2xros, and red fm immediately before use, dilute 50 μg of mitotracker in 1 ml of dmso and inject 50 μl i.v. at a concentration of 100 μm. c critical the mitotracker solution should be prepared fresh each time immediately before use. prepare the solution at a concentration of 10 mm in sterile 1× pbs or saline, make aliquots in dark 1.5-ml microtubes, and store them in a refrigerator (2-8°c) for up to 2 weeks. immediately before use, prepare a solution at a concentration of 10 μm in sterile 1× pbs or saline and inject 50 μl i.v. per mouse. prepare the solution at a concentration of 10 mm in dmso, make aliquots in dark 1.5-ml microtubes, and store them in a refrigerator (2-8°c) for up to 2 weeks. immediately before use, prepare a working solution at a concentration of 1 mm in sterile 1× pbs or saline and inject 50 μl i.v. per mouse. prepare each solution at a concentration of 1 mm in dmso, make aliquots in dark 1.5-ml microtubes, and store them in a refrigerator (2-8°c) for up to 1 week. immediately before use, prepare solutions at a concentration of 100 μm in sterile 1× pbs or saline and inject 50 μl i.v. per mouse. dilute fluorescent antibodies to a concentration of 1 µg per 10 μl with sterile 1× pbs or saline and inject 50 μl i.v. per mouse. ! caution it should be noted that antibody staining may affect the target cell behavior; for example, at a high dose (~200 μg), antibodies may neutralize cell activities and/or cause antibody-dependent cytotoxic activity [35] [36] [37] . in our studies, we use 5 µg of antibody for brightness screening because inoculation of fluorochrome-conjugated anti-ly-6g antibody at low doses (1-40 µg) into mice does not affect neutrophil recruitment 38 . the contribution of ly-6g, which is expressed predominantly on murine neutrophils, to recruitment during inflammation remains a matter of debate. it has been reported that low-dose antibody treatment inhibited ly-6g ligation and the recruitment of neutrophils to the site of inflammation 39 ; however, a more recent study indicated that ly-6g knockout did not affect either neutrophil differentiation or recruitment to the site of inflammation in catchup mice 32 . therefore, a low dose of anti-ly-6g antibody is used in our protocol. laser path adjustment system an overview of the laser path adjustment system is shown in fig. 1 . our two-photon excitation laser (chameleon vision ii) unit is placed on an anti-vibration table outside the bsl3 facility. the laser beam enters the bsl3 room, where the two-photon excitation scanning microscope is located, through a window (composed of a small glass window (wg12012-b) and a planar window (rs seal)) connecting the inside and the outside of the bsl3 facility (fig. 1c,d) . the laser path connecting the laser source unit and the two-photon excitation microscope is adjusted by automated laser beam alignment and the aligna 4d stabilization system is adjusted with two active mirrors. ! caution this system adjusts the laser path passing from the outside to the inside of the bsl3 facility for maintenance purposes, so there is no need for this setup unless you are using pathogens that require bsl3 containment. heat is generated when the laser source unit is running, so keep the temperature and humidity constant by using air conditioning equipment. ! caution the system should be operated only by users trained to deal with unenclosed high-power invisible beams and should be placed in an appropriate enclosure with interlocking doors. two-photon excitation laser scanning microscopy system for in vivo imaging of virus-infected mouse lungs in a bsl3 facility a schematic of the arrangement of the in vivo lung imaging system for virus-infected mouse is shown in fig. 2a, and layout examples are shown in fig. 2b -g. this in vivo lung imaging system is based on the upright microscope lsm 780 nlo system, which is equipped with four different lasers (excitation at 405, 488, 543, and 633 nm) for confocal imaging and a two-photon excitation laser (excitation at 630-1,050 nm). to be able to perform the surgical procedure on the mouse, we replaced the sample stage with a large, flat one (microscope stage for in vivo experiment) as shown in fig. 2b ,c. to efficiently excite multiple fluorescent proteins and fluorescent dyes simultaneously, the wavelength of the infrared laser should be set at 910 nm. all fluorescent spectra between the 410-and 695-nm wavelengths can be detected using a 20× water immersion lens, and we record signals in lambda image stacks (0.13 frames per s, 1,024 × 1,024 pixels) and acquire z-stack images with z-depths of 5 μm (total of 10-μm z-depth). we perform spectral separation of the acquired lambda stacks by using the linear unmixing function of the zen software. although the lsm 780 microscope system is controlled by a primary personal computer, we recommended adding >64 gb of ram for appropriate imaging analysis. we keep the mice on a heated stage on the sample stage and record their vital signs using a labox-1 pulse oximeter. to observe the lungs of the mice with a thoracotomy, we place the ventilator with an airway pressure monitor and anesthesia machine for rodents in appropriate positions on the stage. we installed high-efficiency particulate air (hepa) filters in the exhalation duct of the ventilation system (fig. 2b,d) , and the operator wore a positive pressure mask (versaflo faceshields) and a tyvek suit (fig. 2e-g) to avoid exposure to the viruses. ! caution the wavelength and power of the excitation laser should be adjusted appropriately according to the experimental conditions. increasing the laser power enhances target signals and enables detection of second-harmonic generation (shg), in which structures with repeating patterns lead to the formation of a signal. shg is a useful phenomenon for visualizing collagen fibers in the lung without staining; however, it should be noted that the autofluorescence of lung tissue is also enhanced under excessive excitation conditions ( supplementary fig. 1 ). when using this protocol, we did not perform experiments under which shg occurs, in order to minimize autofluorescence; it is better to adjust the laser power according to the experimental purpose. when the wavelength of the excitation laser is too short, the autofluorescence signal becomes very strong and it is difficult to observe properly. by contrast, when the laser wavelength is too long, it becomes difficult to obtain a signal because of the short excitation energy (supplementary fig. 2 ). ! caution although color separation of emission using a conventional optical band-pass filter is also available for this protocol, multispectral imaging is a useful approach for simultaneously analyzing multiple targets by eliminating tissue autofluorescence and identifying fluorescent labels with overlapping spectra 40, 41 . in vivo two-photon imaging is performed under conditions of single stimulation with a two-photon excitation laser; limitations exist regarding available fluorescent reagents/proteins for multiple labeling of target cells and lung architecture. therefore, we recommend using a multispectral approach to produce crosstalk-free images of fluorescence with overlapping spectra that cannot be separated by using band-pass filters. before starting experiments, it is necessary to collect spectral signatures of the emission signal of each fluorescent reagent and protein as reference spectra under the same excitation condition as will be used in the experiment. to observe the mouse lung using an upright microscope, it is necessary to prepare a thoracic suction window to immobilize the lung. in the bsl3 facility, animal experiments must be performed while wearing two or three layers of latex gloves; therefore, the thoracic suction window was designed for easy handling, even in the bsl3 facility, and to be minimally invasive for the infected animals (fig. 3a-c and supplementary fig. 3 ). to position a cover glass for each observation, flatten the upper surface of the thoracic suction window so that a commercially available cover glass will fit. this device is also designed to reduce concavity and convexity as much as possible so that blood containing virus cannot accumulate. connect the thoracic suction window to an aspirator through a waste tank and a suction regulator. to prevent the spread of virus-containing aerosols, install hepa filters between the waste tank and the suction regulator as shown in fig. 3d . starting up the imaging system equipment • timing 20-30 min 2 on the day of analysis, turn on the two-photon excitation laser and the aligna 4d control unit placed outside the bsl3 facility, and verify that they are working. c critical the aligna 4d control unit needs to be kept on. 3 wearing a tyvek suit, positive pressure mask, and gloves according to the guidelines for the bsl3 facility, enter the bsl3 facility where the imaging system is housed. ? troubleshooting 4 turn on the microscope controllers, confocal lasers, and the computer for the two-photon excitation microscope and the aligna 4d system. 5 launch the microscope control software zen and turn on the lasers, including the two-photon excitation laser. 6 launch the aligna 4d control software kangoo and adjust the laser path connecting the laser source unit and the microscope (supplementary fig. 4) . ? troubleshooting 7 wrap the hot plate with aluminum foil, turn it on, and keep it at 35°c. sterilize the surgical area and tools with 70% ethanol and place all instruments within easy reach. animal anesthesia • timing 2-3 min 8 turn on the gas anesthesia vaporizer and supply 5% isoflurane to a mouse anesthesia induction chamber. 9 anesthetize the influenza virus-infected mouse with 5% isoflurane in a mouse anesthesia induction chamber. subsequently, transfer the mouse to the hot plate while supplying 2% isoflurane via an anesthetic mask. ? troubleshooting 10 inject the chosen fluorescent dyes and antibodies via the retro-orbital plexus (as shown in supplementary video 1) using an insulin syringe. tables 4 and 5 show the brightness levels of antibodies and fluorescence of dyes, respectively, in vivo. ! caution when working with viruses in a bsl3 containment, it is not safe to use needles, so we avoid them as much as possible, which is a standard precaution in high-containment laboratories. in addition, in the bsl3 facility, animal experiments must be performed wearing two or three layers of latex gloves. tail-vein administration is a common method; however, it is not easy to perform these procedures with so many layers of gloves. use tweezers to hold down the mouse to make the administration route. when an infected animal is not used, an administration route can be created via the tail vein or the jugular vein. ? troubleshooting surgical procedure • timing 10-15 min c critical before experimenting with infected animals, practice the surgical procedures with euthanized animals. 11 place the mouse on its back and tape the anterior limbs with adhesive tape (fig. 4a) . 12 using straight scissors, cut the skin beneath the chin in the middle and expose the trachea (fig. 4b) . insert a tracheal cannula and intubate the mouse to facilitate mechanical ventilation with a ventilator (fig. 4c) . turn on the ventilator, ventilate the mouse at a respiratory rate of 120 breaths per min, and apply positive-end expiratory pressure (peep;~6 cm h 2 o) and a tidal volume of 0.5 ml. deliver isoflurane continuously at 2% to maintain anesthesia. ! caution perform the surgery with care so as not to cut the blood vessels. if bleeding occurs, stop the bleeding with fine bulldog forceps for microsurgery. 13 place the mouse in the right lateral decubitus position and re-fix its anterior limbs with the tape (fig. 4d) . make an incision in the skin at the left axilla using straight scissors, straight iris scissors, and hooked forceps (fig. 4e) . ! caution carefully change the mouse's position in order to avoid cannula drop off. 14 expose the left lung lobe by surgical intercostal incision between ribs 3 and 4, and keep it exposed by using retractors (fig. 4f) . the brightness of each fluorescent protein during in vivo lung imaging was scored as relative fluorescence intensity compared with fluospheres fluorescent microspheres as an internal standard. for relative intensities of 0-0.2, 0.2-0.6, 0.6-0.9, and >0.9, the brightness scores are represented as +, ++, +++, and ++++, respectively. the brightness of each fluorochrome during in vivo lung imaging was scored as relative fluorescence intensity compared with fluospheres fluorescent microspheres as an internal standard. for relative intensities of 0-0.2, 0.2-0.6, 0.6-0.9, and >0.9, the brightness scores are represented as +, ++, +++, and ++++, respectively. af, alexa fluor; nd, not detected. ! caution perform the surgery with care so as not to cut the blood vessels. if bleeding occurs, stop the bleeding with fine bulldog forceps for microsurgery. c critical because lungs infected with viruses often shrink, secure a large field of surgical view so that the suction window can reach it. 15 place the mouse beneath the objective lens and connect a device to monitor the heart rate of the mouse (we use a labox-1 pulse oximeter). starting up the thoracic vacuum window system • timing 2-3 min 16 turn on the aspirator connected to the thoracic suction window. 17 fix the thoracic suction window to the holding block at a 90°angle and put a round cover glass on the tip of the suction device. ? troubleshooting 18 turn on the suction pressure regulator and adjust the suction pressure to 25-30 mmhg. 19 lower the thoracic suction window gently to immobilize the mouse lungs (fig. 4g,h) . the thoracic suction window should cause the lung to stick to the cover glass because of negative pressure. ! caution carefully move the suction window so as not to scratch the objective. 20 position the objective lens above the thoracic window. 21 put water drops on the cover glass by using a pasteur pipette and lower the objective lens to the thoracic suction window (fig. 4i) . unmixing of spectrum data and analyzing the images • timing 1-2 h per sample 24 to unmix the spectrum data, prepare a reference image of each spectrum in advance. to make a reference image, acquire each fluorescent dye or protein separately without any co-staining and analyze the single fluorescent spectrum. we use the linear unmixing module of the zen software for separating spectrum data; however, other commercial or open-source software is available (table 6 ). 25 subject unmixed time-series stacks to image registration to correct for tissue drifts and respiratory artifacts. this step is critical to certain analyses, such as long-term tracking of individual cells or subcellular structures. in some cases, a reference channel is required for determining the shift and distortion of the objects. in our studies, we use time-series stacks of blood vessels or collagens for such use, because their localizations are constant over time without substantial changes in shape or structure during the observation. ! caution some image registration algorithms may cause spatial distortion. choose algorithms that generate corrected data suitable for your subsequent analyses, especially when examination of the shape and structure of cells and tissues is required. 26 analyze the movies as required for your experiment. troubleshooting advice can be found in table 7 . step 1, infection: 10-20 min anticipated results the imaging system described in this protocol enables the observation of the behavior of virusinfected cells and immune cells in infected lungs in real time. typical images of influenza virus-infected lung are shown in fig. 5a and supplementary video 2. when observing while using a multicolor fluorescent label, it is easier to analyze the detected images if the brightness level of each fluorophore is adjusted to make them similar. it is better to choose fluorescent dyes or proteins that possess high fluorescence stability for long-term observations (tables 2, 4 and 5). we have found that use of ma-cerulean-viruses or ma-venus-viruses for infection produces influenza virus-infected cells with sufficient brightness (table 3) . for labeling immune cells and alveolar cells, we have achieved good results by using the fluorochrome phycoerythrin (pe) for antibody staining and rosa-tdtomato 42 or -mtfp1 33 mice that were crossed with cell-specific cre-expressing mice. if using reporter mice expressing a fluorescent protein such as gfp, which is regulated by an endogenous promoter, the expression level of the fluorescent protein should be confirmed. to visualize the lung structure, we use texas-red dextran or qtracker 655 vascular labels for the red to far-infrared channel. mice die during anesthesia the level of anesthesia is too high decrease the concentration of anesthesia as soon as the mouse shows loss of righting reflex 10 mice regain consciousness during anesthesia the level of anesthesia is too low confirm the concentration of anesthesia; administer the reagents again after a brief pause 15 no heart rate is measured the monitoring probe is mispositioned make sure that the monitoring probe is in the appropriate place 17 the cover glass falls off the cover glass does not hold on the suction device put water droplets on the tip of the suction device and then place the cover glass on it influenza virus-infected lungs are infiltrated by numerous immune cells, including neutrophils and monocytes [43] [44] [45] . an immune cell-specific reporter mouse line can be used to visualize cells infiltrating the alveoli and cells in blood vessels, whereas it is preferable to label intravascular cells by intravenous administration of fluorochrome-conjugated antibodies 5, 46, 47 . consistent with previous reports, intravenously injected antibodies will label only the cells in contact with the blood flow and not those in extravascular regions under our experimental conditions 5 . by administering a fluorescently labeled antibody against neutrophils into neutrophil reporter mice, we can observe the behavior of both the neutrophils infiltrating the influenza-infected lungs and the neutrophils in blood vessels separately (fig. 5b) . to observe the interaction between different kinds of infiltrating immune cells, such as neutrophils and monocytes, double-reporter mice expressing fluorescent proteins with different spectra but similar brightness have a major advantage (fig. 5c and supplementary video 3) . co-infection of the host with different strains of influenza virus can lead to the emergence of reassortant viruses. by infecting mice with color-flu viruses that produce different fluorescence spectra, we detected alveolar epithelial cells that simultaneously expressed two fluorescent proteins in vivo (fig. 6) . visualization of co-infected cells might enable us to better understand the reassortment process of influenza viruses in vivo. in summary, the use of this in vivo imaging system for infected animal and multicolor imaging enables us to analyze pathology and immune cell dynamics at the cellular level, which would not be possible by using conventional histopathology methods. this imaging system thus provides a novel and useful approach for investigating viral pathogenicity. further information on research design is available in the nature research reporting summary linked to this article. the data that support this study are available from the corresponding author upon reasonable request. the matlab scripts are available at https://github.com/kawaokalab/ueki_pnas_2018. for all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or methods section. the exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement a statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly the statistical test(s) used and whether they are one-or two-sided only common tests should be described solely by name; describe more complex techniques in the methods section. a description of all covariates tested a description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons a full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) and variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals) for null hypothesis testing, the test statistic (e.g. f, t, r) with confidence intervals, effect sizes, degrees of freedom and p value noted give p values as exact values whenever suitable. for hierarchical and complex designs, identification of the appropriate level for tests and full reporting of outcomes estimates of effect sizes (e.g. cohen's d, pearson's r), indicating how they were calculated our web collection on statistics for biologists contains articles on many of the points above. policy information about availability of computer code to efficiently excite multiple fluorescent proteins and fluorescent dyes simultaneously, the wavelength of the infrared laser was set at 910 nm. all fluorescent spectra between 410 and 695 nm wavelengths were detected using a 20x water immersion lens (carl zeiss ag, germany) and the signals were recorded in lambda image stacks. we use the linear unmixing module of zen software for separating spectrum data. unmixed time-series stacks are subjected to image registration to correct for tissue drifts and respiratory artefacts. a reference channel is required for determining the shift and distortion of the objects. in our studies, we employ time-series stacks of blood vessels or collagens for such use, as their localizations are constant over time without significant changes in shapes or structures during the observation. for manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. we strongly encourage code deposition in a community repository (e.g. github). see the nature research guidelines for submitting code & software for further information. policy information about availability of data all manuscripts must include a data availability statement. this statement should provide the following information, where applicable: -accession codes, unique identifiers, or web links for publicly available datasets -a list of figures that have associated raw data -a description of any restrictions on data availability the data that support this study are available from the corresponding author upon reasonable request. october 2018 field-specific reporting please select the one below that is the best fit for your research. if you are not sure, read the appropriate sections before making your selection. for a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf all studies must disclose on these points even when the disclosure is negative. only one sample was shown as a representative example that can be obtained by using the imaging protocol. data exclusions no data was excluded since one representative image was shown. no repeated measurements were performed in this paper since one image has been shown as a representative image by using the imaging protocol. • microsurgery straight scissors (13.5 cm • microsurgery bulldog forceps (brc, cat. no. 70052-30cii/r) • insulin syringes (0.5 ml, 100 u, 30 gauge × 10 mm; nipro, cat. no. 08277) • pasteur pipettes (bd falcon, cat. no. 357575) • customized surgical retractor • thoracic suction window (sakura seiki, custom made) stage for mounting a thoracic suction window (sakura seiki, custom made) • suction regulator (iwaki, cat. no. 1450050) • cover glass (matsunami glass, cat. no. c013001) • hot plate (hipet, cat • confocal microscope system (zeiss, model no. lsm 780 nlo) • infrared laser (coherent, model no. chameleon vision ii) • 20× water immersion lens (zeiss, plan-apochromat model) • beam-pointing stabilizer (tem messtechnik, model no. aligna 4d system high-efficiency particulate air (hepa) filters (vacushield; pall, cat. no. 4402) • artificial ventilator (shinano, cat • airway pressure monitor (shinano) • gas anesthesia vaporizer • mouse anesthesia induction chamber • mouse anesthesia mask • positive pressure mask (versaflo faceshields softwear iii) • surgical gloves rs seal (roxtec, cat labox-1) highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread consecutive ct in vivo lung imaging as quantitative parameter of influenza vaccine efficacy in the ferret model calcium imaging of single stereocilia in hair cells: localization of transduction channels at both ends of tip links in vivo fluorescence microscopy: lessons from observing cell behavior in their native environment in vivo imaging of the pathophysiological changes and neutrophil dynamics in influenza virus-infected mouse lungs marcello malpighi and the discovery of the pulmonary capillaries and alveoli live imaging of the lung live imaging of the pulmonary immune environment examination of the pulmonary circulation with the microscope color-coded real-time cellular imaging of lung t-lymphocyte accumulation and focus formation in a mouse asthma model pathophysiological role of endothelins in pulmonary microcirculatory disorders due to intestinal ischemia and reperfusion intravital microscopy of the murine pulmonary microcirculation surfactant protein a mediates pulmonary clearance of staphylococcus aureus in vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation dap12 expression in lung macrophages mediates ischemia/reperfusion injury by promoting neutrophil extravasation stabilized imaging of immune surveillance in the mouse lung two-photon imaging within the murine thorax without respiratory and cardiac motion artifact visualization of immediate immune responses to pioneer metastatic cells in the lung the lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors t cell response in the lung following influenza virus infection neutrophil trails guide influenza-specific cd8 + t cells in the airways live imaging of influenza infection of the trachea reveals dynamic regulation of cd8 + t cell motility by antigen imaging cell interaction in tracheal mucosa during influenza virus infection using two-photon intravital microscopy three phases of cd8 t cell response in the lung following h1n1 influenza infection and sphingosine 1 phosphate agonist therapy multi-spectral fluorescent reporter influenza viruses (color-flu) as powerful tools for in vivo studies molecular determinants of virulence and stability of a reporter-expressing h5n1 influenza a virus amino acid changes in pb2 and ha affect the growth of a recombinant influenza virus expressing a fluorescent reporter protein live imaging of the lung a transgenic mouse line that retains cre recombinase activity in mature oocytes irrespective of the cre ransgene transmission insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes a multifunctional teal-fluorescent rosa26 reporter mouse line for cre-and flp-mediated recombination trackmate: an open and extensible platform for single-particle tracking the role of neutrophils during mild and severe influenza virus infections of mice excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis the effects of acute neutrophil depletion on resolution of acute influenza infection, establishment of tissue resident memory (trm), and heterosubtypic immunity antibodies against neutrophil ly6g do not inhibit leukocyte recruitment in mice in vivo ly6g ligation blocks recruitment of neutrophils via a β2-integrin-dependent mechanism spectral imaging: principles and applications multispectral imaging in biology and medicine: slices of life a robust and high-throughput cre reporting and characterization system for the whole mouse brain regulating the adaptive immune response to respiratory virus infection a systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection innate immunity to influenza virus infection intravascular staining for discrimination of vascular and tissue leukocytes in vivo compartmental analysis of leukocytes in mouse lungs a study of the pulmonary circulation by the transillumination method pulmonary capillary recruitment during airway hypoxia in the dog the behavior of the arterioles and capillaries of the lung capillary recruitment during airway hypoxia: role of pulmonary artery pressure capillaroscopic appearance of the pulmonary alveoli in the living dog diffusing capacity of the lung during hypoxia: role of capillary recruitment intrapulmonary blood flow redistribution during hypoxia increases gas exchange surface area the normal behavior of the pulmonary blood vessels with observations on the intermittence of the flow of blood in the arterioles and capillaries an experimental model for simultaneous quantitative analysis of pulmonary micro-and macrocirculation during unilateral hypoxia in vivo a thoracic window for observation of the lung in a living animal microscopic observation of the lung in vivo precapillary oxygenation contributes relevantly to gas exchange in the intact lung pulmonary microcirculatory observations in vivo under physiological conditions direct measurement of pulmonary capillary transit times intravital laser confocal microscopy of pulmonary edema resulting from intestinal ischemia-reperfusion injury in the rat physiological neutrophil sequestration in the lung: visual evidence for localization in capillaries measurement of lung microvascular pressure in the intact anesthetized rabbit by the micropuncture technique emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance capillary perfusion patterns in single alveolar walls measurement of microhemodynamics in the ventilated rabbit lung by intravital fluorescence microscopy donor pulmonary intravascular nonclassical monocytes recruit recipient neutrophils and mediate primary lung allograft dysfunction leukocyte kinetics in pulmonary microcirculation: intravital fluorescence microscopic study the pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis temporal capillary perfusion patterns in single alveolar walls of intact dogs aspirin-triggered 15-epi-lipoxin a4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice sites of leukocyte sequestration in the pulmonary microcirculation cxcr4 identifies transitional bone marrow premonocytes that replenish the mature monocyte pool for peripheral responses contribution of selectins to leucocyte sequestration in pulmonary microvessels by intravital microscopy in rabbits lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli leukocyte margination in alveolar capillaries: interrelationship with functional capillary geometry and microhemodynamics neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury platelet kinetics in the pulmonary microcirculation in vivo assessed by intravital microscopy pulmonary microvascular changes during sepsis: evaluation using intravital videomicroscopy intravital microscopic observations of 15-microm microspheres lodging in the pulmonary microcirculation intravital imaging of a pulmonary endothelial surface layer in a murine sepsis model in vivo measurement of the mouse pulmonary endothelial surface layer real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation direct visualisation of microparticles in the living lung spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to t cells in the lung two-photon intravital imaging of lungs during anthrax infection reveals long-lasting macrophage-dendritic cell contacts intravital imaging allows real-time characterization of tissue resident eosinophils quantitative intravital two-photon excitation microscopy reveals absence of pulmonary vaso-occlusion in unchallenged sickle cell disease mice initial host response to bacteria in the murine lung differs between pseudomonas aeruginosa, staphylococcus aureus and streptococcus pneumoniae inkt cell emigration out of the lung vasculature requires neutrophils and monocyte-derived dendritic cells in inflammation a new model for the study of pulmonary microcirculation: determination of pulmonary edema in rats the lung is a host defense niche for immediate neutrophil-mediated vascular protection an experimental rat model for studying pulmonary microcirculation by in vivo videomicroscopy bispecific antibody targets multiple pseudomonas aeruginosa evasion mechanisms in the lung vasculature alveolar dynamics in acute lung injury: heterogeneous distension rather than cyclic opening and collapse maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury leukotriene b4-mediated neutrophil recruitment causes pulmonary capillaritis during lethal fungal sepsis α-toxin induces platelet aggregation and liver injury during staphylococcus aureus sepsis neutrophil mobilization via plerixafor-mediated cxcr4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow transfusion of human platelets treated with mirasol pathogen reduction technology does not induce acute lung injury in mice a new model of lung metastasis for intravital studies visualizing the function and fate of neutrophils in sterile injury and repair in vivo subcellular resolution optical imaging in the lung reveals early metastatic proliferation and motility two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches patrolling monocytes control tumor metastasis to the lung pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans long-term high-resolution intravital microscopy in the lung with a vacuum stabilized imaging window cancer cells induce metastasis-supporting neutrophil extracellular dna traps a permanent window for the murine lung enables high-resolution imaging of cancer metastasis embryonic stem cells and mice expressing different gfp variants for multiple non-invasive reporter usage within a single animal cre reporter strains produced by targeted insertion of eyfp and ecfp into the rosa26 locus a global double-fluorescent cre reporter mouse in vivo depletion of cd11c + dendritic cells abrogates priming of cd8 + t cells by exogenous cell-associated antigens notch-rbp-j signaling controls the homeostasis of cd8 -dendritic cells in the spleen zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages absence of mhc class ii on cdcs results in microbial-dependent intestinal inflammation identification of a dendritic cell receptor that couples sensing of necrosis to immunity a macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse analysis of fractalkine receptor cx(3)cr1 function by targeted deletion and green fluorescent protein reporter gene insertion fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis generation of cd4creer(t(2)) transgenic mice to study development of peripheral cd4-t-cells notch2 integrates signaling by the transcription factors rbp-j and creb1 to promote t cell cytotoxicity b lymphocyte-specific, cre-mediated mutagenesis in mice genetic analysis of basophil function in vivo lethal influenza infection in the absence of the natural killer cell receptor gene ncr1 high-efficiency type ii cell-enhanced green fluorescent protein expression facilitates cellular identification, tracking, and isolation hyperspectral phasor analysis enables multiplexed 5d in vivo imaging the orfeo toolbox remote sensing image processing software optimizing imaging parameters for the separation of multiple labels in a fluorescence image spectral imaging and linear un-mixing enables improved fret efficiency with a novel gfp2-yfp fret pair blind source separation techniques for the decomposition of multiply labeled fluorescence images image matching as a diffusion process: an analogy with maxwell's demons diffeomorphic demons: efficient non-parametric image registration automated motion artifact removal for intravital microscopy, without a priori information nonrigid registration using free-form deformations: application to breast mr images imart software for correction of motion artifacts in images collected in intravital microscopy automated filtering of intrinsic movement artifacts during twophoton intravital microscopy removing physiological motion from intravital and clinical functional imaging data software tools for single-cell tracking and quantification of cellular and molecular properties cellprofiler: image analysis software for identifying and quantifying cell phenotypes icy: an open bioimage informatics platform for extended reproducible research additional information supplementary information is available for this peer review information nature protocols thanks megan macleod and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. reprints and permissions information is available at www.nature.com/reprints. publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations we thank s. watson for editing the manuscript. we thank k. iwatsuki-horimoto, l. wu, s. fukuyama, y. matsuzawa, and k. miyake randomization no randomization is included in this paper since one image has been shown as a representative image by using the imaging protocol. blinding was not relevant to this study which is describing a imaging protocol and anticipated results. we require information from authors about some types of materials, experimental systems and methods used in many studies. here, indicate whether each material, system or method listed is relevant to your study. if you are not sure if a list item applies to your research, read the appropriate section before selecting a response. all antibodies used are commercialized and the fluorescence has been tested in this study. the information is included in table 4 . animals and other organisms policy information about studies involving animals; arrive guidelines recommended for reporting animal research laboratory animals six-ten-week-old c57bl/6 mice (japan slc, inc.) and transgenic mouse lines were used in this study. all animal care and experiments conformed to the guidelines for animal experiments of the university of tokyo, and were approved by the animal research committee of the university of tokyo (pa17-31 and pa17-17). all in vivo imaging studies were performed in the biosafety level 3 facility at the university of tokyo (tokyo, japan), which is approved for such use by the ministry of agriculture, forestry, and fisheries of japan. field-collected samples not applicable. all experiments with mice were performed in accordance with the university of tokyo's regulations for animal care and use and were approved by the animal experiment committee of the institute of medical science, the university of tokyo.note that full information on the approval of the study protocol must also be provided in the manuscript. key: cord-324617-yok7mh70 authors: andreata-santos, robert; alves, rúbens prince dos santos; pereira, sara araujo; pereira, lennon ramos; de freitas, carla longo; pereira, samuel santos; venceslau-carvalho, alexia adrianne; castro-amarante, maria fernanda; favaro, marianna teixeira pinho; mathias-santos, camila; amorim, jaime henrique; ferreira, luís carlos de souza title: transcutaneous administration of dengue vaccines date: 2020-05-06 journal: viruses doi: 10.3390/v12050514 sha: doc_id: 324617 cord_uid: yok7mh70 in the present study, we evaluated the immunological responses induced by dengue vaccines under experimental conditions after delivery via a transcutaneous (tc) route. vaccines against type 2 dengue virus particles (denv2 new guinea c (ngc) strain) combined with enterotoxigenic escherichia coli (etec) heat-labile toxin (lt) were administered to balb/c mice in a three-dose immunization regimen via the tc route. as a control for the parenteral administration route, other mouse groups were immunized with the same vaccine formulation via the intradermic (id) route. our results showed that mice vaccinated either via the tc or id routes developed similar protective immunity, as measured after lethal challenges with the denv2 ngc strain. notably, the vaccine delivered through the tc route induced lower serum antibody (igg) responses with regard to id-immunized mice, particularly after the third dose. the protective immunity elicited in tc-immunized mice was attributed to different antigen-specific antibody properties, such as epitope specificity and igg subclass responses, and cellular immune responses, as determined by cytokine secretion profiles. altogether, the results of the present study demonstrate the immunogenicity and protective properties of a dengue vaccine delivered through the tc route and offer perspectives for future clinical applications. infection with one of the four dengue virus serotypes (denv1-4) may cause a spectrum of diseases ranging from an acute, self-limiting febrile illness (df) characterized mainly by fever, retro-orbital headache, rash, arthralgia, and to more severe, life-threatening, conditions that may include hemorrhagic manifestations, increased vascular permeability, thrombocytopenia, and shock [1] [2] [3] . in fact, it is estimated that 3.9 billion people in 128 countries are at risk of infection [2, 4] . denv causes approximately 390 million infections, of which 500,000 cases develop into severe forms, making denv infection one of the most economically and epidemiologically relevant arthropod-borne diseases the murine model elected for this study was based on the balb/c mouse line. male mice from 6 to 8 weeks old were supplied by the parasitology department animal house at the university of são paulo. the animals were considered free of pathogens and routinely subjected to standard monitoring. aedes albopictus cells of the c6/36 strain were used for viral propagation, while cercopithecus aethiops kidney epithelial cells (vero) were used for plaque assays. briefly, vero cells (1 × 10 5 /well) were plated in 24-well culture plates and incubated at 37 • c in a co 2 incubator overnight. denv supernatant aliquots (100 µl) were 10-fold serially diluted in medium, added to the vero cells, and incubated at 37 • c for 1 h. the viral supernatant was aspirated, and a prewarmed solution of 1% carboxymethyl cellulose medium (synth, diadema, brazil) was added to each well. after 7 days incubation, the cells were fixed with 4% paraformaldehyde solution for 15 min at room temperature (rt), washed with water and stained with a 1% crystal violet solution for 10 min. the staining solution was removed and the plates washed to remove residual staining. finally, after drying on the bench, plaque forming units (pfu) were counted to obtain the virus titers, which were expressed in pfu/ml. the denv2 new guinea c (ngc) strain was previously isolated and adapted to infect and kill immunocompetent mice after intracranial (i.c.) administration [20] . the lt was purified from a recombinant e. coli k12 strain transformed with a bspks (-) vector carrying the sequence encoding the toxin originally expressed by enterotoxigenic e. coli [21] . the recombinant lt1 was purified by affinity chromatography with immobilized d-galactose, as previously described [22] . c6/36 cells were grown in leibovitz-15 (l-15) medium (vitrocell, campinas, brazil) supplemented with 10% fetal bovine serum (fbs) (vitrocell, campinas, brazil) until they reached approximately 50% confluence in plastic culture bottles (corning, new york, ny, usa). then, the cells were washed and infected with the denv2 ngc at a standard moi equal to 1, and when the cells displayed syncytial characteristics, the supernatant was harvested. the cells were centrifuged (eppendorf, hamburg, ger) at 3200× g for 15 min and then lysed by freezing at −80 • c for 5 min and melting through the liquid state three times. after being lysed, the cells were centrifuged one more time, and the supernatant containing the released virus was added to the cell culture supernatant. the whole supernatant was mixed with polyethylene glycol (peg-6000) (synth, diadema, brazil) in a proportion of 2.5 ml of peg to 10 ml of supernatant and incubated overnight at −4 • c. after incubation, the supernatants were centrifuged at 3200× g for 30 min, the supernatant was discarded, and the precipitate viruses were suspended in mem supplemented with hepes buffer. the concentrated viruses (up to 100-fold) were titrated, and the content of total protein was also determined using an epoch take3 spectrophotometer (biotek, winooski, vt, usa) and maintained at −80 • c until being used for immunization assays. the purification of denv2 virus particles was performed by ion exchange chromatography using the akta fplc chromatograph (amersham pharmacia biotech, little chalfont, uk) associated with a 1 ml hitraptm anx (high sub) (gelifesciences, boston, ma, usa) anion exchange column previously loaded with 60 mm sodium phosphate buffer (ph 7.2). a total of 10 ml of infected cell culture supernatant (vero cell previously infected for 7 days with denv2, moi of 0.1) was used for purification. the elution procedure was carried out by applying a linear gradient from 60 to 600 mm of sodium phosphate (ph 7.2) in 15 column volumes (cv). the virus-containing fractions were combined, added with 5% sterile glycerol and stored at −80 • c for later use. for the id immunizations, balb/c mice (n = 5) were immunized with different vaccine formulations containing 40 µg/ml of polymyxin b, 10 or 50 µg of denv2 ngc virus particles administered alone or with 10 µg of purified lt1. the vaccination regimen consisted of three doses given at two-week intervals (14 days). serum samples were collected through the submandibular plexus before each immunization (days −1, 13, 27, 41). the administration was performed in the dorsal region on the back of the mice with a 25 mm gauge needle loaded with 25 µl of the vaccine formulation. the same vaccine formulations were used in the tc immunizations. the dorsum of balb/c mice (n = 5/group) was shaved with an electric clipper and depilatory cream. before the administration of the vaccine patches, a slight abrasion with fine-grained sandpaper was applied to the shaved skin to disrupt the stratum corneum (sc). the patches were prepared with a double-sided waterproof adhesive film (smith&nephew, london, uk) cut in squares of approximately 2.5 cm 2 . an absorbent sterile gauze piece (approximately 1 cm 2 ) was placed in the center of the adhesive film to form a pad that received the vaccine. the vaccines were placed on the back of the animals for 24 h, and bandages were applied to prevent their removal by the animals ( figure s1 ). mouse sera were individually tested for the presence of the virus-specific abs by elisas. maxisorp plates (nunc, roskilde, dk) were coated with pbs containing 200 ng of denv2 ngc virus particles and incubated overnight at 4 • c. the plates were blocked with 3% gelatin in pbs at 37 • c for 2 h. serum samples were then serially diluted in 1% gelatin diluted in 0.05% pbs-tween (pbst) and incubated at 37 • c for 1.5 h. after three washes with pbst, the plates were treated with goat anti-mouse igg (1:6000), igg1 (1:3000) or igg2a (1:2000) conjugated with horseradish peroxidase (sigma-aldrich, san luis, mo, usa) at 37 • c for 1.5 h. after a new wash cycle with pbst, a solution containing orthophenylenediamine dihydrochloride (opd) (sigma-aldrich, san luis, mo, usa) and h 2 o 2 was added for a final volume of 100 µl per well. the plates containing the developer solution were maintained in the dark for 15 min, at which time, the reaction was stopped by the addition of 50 µl of 2 n h 2 so 4 . the od 492nm was measured by an epoch take3 spectrophotometer (biotek, winooski, vt, usa), and the ab concentration values were calculated by comparison with a reference igg preparation at defined concentrations that had been added to each plate. antigen avidity with serum abs was determined with serum pools collected after the last vaccine dose was administered and carried out as previously reported [23] . after incubation with normalized concentrations of antivirus sera, plates were washed and exposed to phosphate-buffered saline (pbs)-diluted ammonium thiocyanate sigma-aldrich, san luis, mo, usa ranging from 0 to 8 m. the plates were allowed to stand for 15 min at room temperature before being washed. the concentrations of the ammonium thiocyanate required to dissociate 50% of the bound abs were determined. the percentage of binding was calculated as follows: od 492nm in the presence of ammonium thiocyanate x 100/od 492nm in the absence of ammonium thiocyanate. the values are expressed as percentages compared with those of the sample not subjected to the ammonium thiocyanate treatment. mice were sacrificed, and the spleens were aseptically harvested. splenocytes were counted after red blood cell lysis and suspended in 10% fbs/rpmi medium. splenocytes were plated (2.5 × 10 5 cells/well) and stimulated with 2 µg of thermally inactivated denv2 for 96 h. the levels of secreted il-10, tnf-α, ifn-γ, il-4, and il-2 were determined with a cytometric bead array (cba) mouse th1/th2/th17 cytokine kit (bd, franklin lakes, nj, usa) according to the manufacturer's protocol. the measurements were performed using bd lsrfortessa (bd, franklin lakes, nj, usa), and the results were processed with system software. three technical repeats were carried out for each animal, and the results were statistically evaluated using one-way anova with bonferroni's post-test. two weeks after receiving the last vaccine dose, the immunized mice were first anesthetized with a mixture of ketamine and xylazine and subsequently challenged with 1 × 10 6 plaque forming units (pfus) of the ngc strain to a final volume of 50 µl administered through the intracranial (i.c.) route, as previously described [24] . these inoculated mice were monitored for 21 days for survival. all statistical analyses were calculated using prism 5 and 6 software (graphpad software inc, la jolla, ca, usa), and differences with p ≤ 0.05 were considered significant. to compare results generated in several groups, a two-way anova test was applied in association with bonferroni's post-test. a comparison of the results generated in three groups was performed using one-way anova in association with bonferroni's post-test. statistical significance based on the mortality curves was determined by mantel-cox tests. male balb/c mice received three vaccine doses via the tc or id route with either 10 or 50 µg of concentrated denv2 particles (ngc strain) with or without purified lt1 ( figure s1e ). as shown in figure 1 , the mice inoculated with denv2 mounted a low antigen-specific igg response following the tc and id immunizations ( figure 1a ,b). the addition of lt1 to the vaccines significantly enhanced the denv2-specific serum igg responses elicited in the mice immunized via the tc or id route, with the maximal values reached two weeks after the third vaccine dose ( figure 1a ,b). similar serum antibody responses were also measured in mice immunized virus particles purified from cell culture supernatants by anionic chromatography ( figure s2 ). male balb/c mice received three vaccine doses via the tc or id route with either 10 or 50 μg of concentrated denv2 particles (ngc strain) with or without purified lt1 ( figure s1e ). as shown in figure 1 , the mice inoculated with denv2 mounted a low antigen-specific igg response following the tc and id immunizations ( figure 1a ,b). the addition of lt1 to the vaccines significantly enhanced the denv2-specific serum igg responses elicited in the mice immunized via the tc or id route, with the maximal values reached two weeks after the third vaccine dose ( figure 1a ,b). similar serum antibody responses were also measured in mice immunized virus particles purified from cell culture supernatants by anionic chromatography ( figure s2 ). the results also demonstrated that the serum denv2-specific igg responses increased according to the amount of inoculated antigen in the id-immunized mice but not in the mice immunized via the tc route ( figure 1a ,b). the tc-immunized mice that received the higher antigen dose (50 μg) combined with lt1 showed an increased serum igg response two weeks after the third dose ( figure 1c ). the id-immunized mice showed significant differences in denv2-specific serum igg responses in the presence of lt1, particularly in the group immunized with 50 μg of the tested antigen ( figure 1d ). in conclusion, tc administration of the anti-denv vaccine induced serum antigen-specific antibody responses but at lower levels than those elicited by the id administered vaccine. the results also demonstrated that the serum denv2-specific igg responses increased according to the amount of inoculated antigen in the id-immunized mice but not in the mice immunized via the tc route ( figure 1a,b) . the tc-immunized mice that received the higher antigen dose (50 µg) combined with lt1 showed an increased serum igg response two weeks after the third dose ( figure 1c ). the id-immunized mice showed significant differences in denv2-specific serum igg responses in the presence of lt1, particularly in the group immunized with 50 µg of the tested antigen ( figure 1d ). in conclusion, tc administration of the anti-denv vaccine induced serum antigen-specific antibody responses but at lower levels than those elicited by the id administered vaccine. the vaccinated mice were also monitored for different physiological aspects in a search of possible vaccine-induced adverse effects ( figure s3 ). in general, there was no indication of significant hematological alterations or tissue damage, such as in a tissue damage marker like ldh, in mice immunized via the tc or id route, with the exception of decreased hematocrit values and increased platelet numbers in the id-immunized mice receiving lt1 and 50 µg of the vaccine antigen ( figure s3b ). no other adverse reactions, such as weight loss or altered animal behavior, were observed in the mice in which the vaccine regimens were tested [25] . collectively, these results indicate that the anti-denv vaccines were safe under the experimental test conditions. we first measured the igg-specific subclass responses in the mice subjected to different immunization regimens. the serum igg1 subclass response prevailed in the mice immunized without adjuvant two weeks after they received the third dose. a higher igg1/igg2a ratio was observed among the mice immunized via the tc route compared with that of the mice immunized via the id route (figure 2a,b) . the mice immunized with lt1 also developed a predominant igg1 response, but those immunized with the higher antigen dose developed a more balanced igg1/igg2a ratio, particularly the animals immunized via the id route (figure 2a,b) . aiming for an initial characterization of the antibodies capable of binding conformational epitopes in the mice immunized with the tested vaccine formulations, we measured the specificity of denv2-specific antibodies against intact viral epitopes. for this experiment, we used heat-denatured and intact virus particles in the solid phase. as shown in figure 2c ,d, igg was increased in the mice immunized via the tc or id route, but significantly fewer igg molecules were bound to the denv particles after heat-denaturation treatment. the reduction in the anti-denv titers for groups inoculated with lt1 adjuvant and was greater in the tc-immunized mice (55% to 58%) than it was in the id-immunized mice (25% to 34%) ( figure s4a ,b). these results suggest that a significant fraction of antibodies generated in mice immunized with intact virus particles target conformational epitopes on the virus surface. in addition, the results indicate that the proportion of antibodies targeting conformational epitopes was higher (p = 0.0321) in the mice immunized via the tc route than it was in the mice immunized via the parenteral route. finally, we measured the avidity of the denv-specific antibodies in the mice subjected to different vaccine regimens tested. for this experiment, we followed a previously described elisa protocol with an additional dissociation step performed with ammonium thiocyanate. taken together, the results presented in figure 2e ,f demonstrate that the addition of lt1 steadily promoted an increase in the avidity of the antibodies to virus particles administered through both routes. however, in accordance with the measurements of the antibody titers, the amount of antigen had an impact only in the id-immunized mice, which presented enhanced avidity after the mice received higher antigen doses ( figure 2e ,f and figure s4c ,d). finally, we measured the avidity of the denv-specific antibodies in the mice subjected to different vaccine regimens tested. for this experiment, we followed a previously described elisa protocol with an additional dissociation step performed with ammonium thiocyanate. taken together, the results presented in figure 2e ,f demonstrate that the addition of lt1 steadily promoted an increase in the avidity of the antibodies to virus particles administered through both routes. however, in accordance with the measurements of the antibody titers, the amount of antigen had an impact only in the id-immunized mice, which presented enhanced avidity after the mice received higher antigen doses ( figure 2e ,f and figure s4c ,d). to analyze the immune responses elicited in the vaccinated mice, we assessed the cytokine secretion profile of spleen cells collected two weeks following the administration of the last vaccine dose. as indicated in figure 3 , different cytokine secretion patterns were observed according to the tested administration route. mice immunized via the tc route showed higher tumor necrosis factor alpha (tnf-α) and interleukin 4 (il-4) levels than shown by those immunized via the id route ( figure 3b,d) . in contrast, id-immunized mice mounted higher il-10 and il-2 responses than shown by those immunized via the tc route ( figure 3c,e) . nonetheless, an increase in interferon gamma (ifn-γ) was found following immunization via both routes. flow-cytometry assays were also performed with spleen cells after the immunization protocols prior to challenge, but no significant difference among immunized versus nonimmunized mice was observed [26] . alpha (tnf-α) and interleukin 4 (il-4) levels than shown by those immunized via the id route ( figure 3b,d) . in contrast, id-immunized mice mounted higher il-10 and il-2 responses than shown by those immunized via the tc route ( figure 3c,e) . nonetheless, an increase in interferon gamma (ifn-γ) was found following immunization via both routes. flow-cytometry assays were also performed with spleen cells after the immunization protocols prior to challenge, but no significant difference among immunized versus nonimmunized mice was observed [26] . mice immunized via the tc or id route were subjected to a lethal i.c. challenge with the denv2 ngc strain. as shown in figure 4 , the immunized mice developed partial or complete protective immunity to a lethal challenge with the denv2 strain. in the tc-immunized mice, the conferred protection was dependent on the addition of lt1 and the antigen amount, with maximal survival values observed in the mice immunized with 50 μg of denv2 combined with lt1 (100% survival in comparison with 20% survival in the sham-treated group) ( figure 4a ). among the id-immunized mice, the group immunized with the higher antigen dose and lt1 were fully protected against the lethal challenge ( figure 4b ). we also looked for signs of morbidity in the mice challenged with the denv2 ngc strain ( figure 4c,d) . among the immunized mice, only those immunized with the higher antigen dose combined with lt1 displayed the maximal protection compared to that shown by the sham-treated animals ( figure 4d ). at the end of the observation period, all the mice immunized via the id route and 80% of the mice immunized via the tc route showed no signs of mice immunized via the tc or id route were subjected to a lethal i.c. challenge with the denv2 ngc strain. as shown in figure 4 , the immunized mice developed partial or complete protective immunity to a lethal challenge with the denv2 strain. in the tc-immunized mice, the conferred protection was dependent on the addition of lt1 and the antigen amount, with maximal survival values observed in the mice immunized with 50 µg of denv2 combined with lt1 (100% survival in comparison with 20% survival in the sham-treated group) ( figure 4a ). among the id-immunized mice, the group immunized with the higher antigen dose and lt1 were fully protected against the lethal challenge ( figure 4b ). we also looked for signs of morbidity in the mice challenged with the denv2 ngc strain ( figure 4c,d) . among the immunized mice, only those immunized with the higher antigen dose combined with lt1 displayed the maximal protection compared to that shown by the sham-treated animals ( figure 4d ). at the end of the observation period, all the mice immunized via the id route and 80% of the mice immunized via the tc route showed no signs of morbidity. altogether, these results indicated that the administration of the tested vaccine formulation administered via either the tc or id route induced protective immunity against denv2. viruses 2020, 12, 514 9 of 16 viruses 2020, 12, x for peer review 9 of 15 morbidity. altogether, these results indicated that the administration of the tested vaccine formulation administered via either the tc or id route induced protective immunity against denv2. despite a number of reports describing the use of tc for the delivery of different antibacterial and antivirus vaccines [5] [6] [7] [8] [14] [15] [16] [17] [18] [19] [27] [28] [29] [30] , thus far, only two studies addressed the performance of denv vaccines, delivered with microneedle pads, that were tested under experimental conditions [31, 32] . here, we showed mice immunized with whole denv2 particles through the use of adhesive patches applied on the surface of the skin and compared the results with regard to mice immunized via a parenteral route (id). the results demonstrated that induction of dose-dependent serum virus-specific antibody responses required the incorporation of an adjuvant (lt1). in addition, although mice immunized via the tc route developed lower serum igg responses, the protective immunity elicited in both mouse groups was similar. such results indicate that differences in the properties of antigen-specific antibodies or activation of differential cellular immune responses contribute to the protective immunity induced in tc-immunized animals. there are several ways to perform tc immunizations that include the use of different technologies to break the skin barrier. microneedle devices represent an alternative to deliver the antigens right below the sc [32] . on the other hand, tc immunization may be performed with adhesive patches soaked with the antigen and applied directly on the surface skin after a gentle superficial abrasion [33] . the use of adhesive patches has several inherent advantages over parenteral routes, such as the lack of needles and pain and reduced risks of contamination, but precise determination of the amount of antigen actually delivered into the host is not possible. a precise definition of the efficiency of the tc administration route would, therefore, require comparison of immune responses and protective immunity induced after immunization with the same vaccine delivered via a parenteral route. in the present study, we performed, for the first time, such a comparison with denv antigens and demonstrated that antigen delivered via the tc route induced similar immune responses and, more relevantly, protective immunity to denv, thus representing an alternative for the administration of denv vaccines. the recent report of microneedle-based tc immunization with a live-attenuated denv vaccine further supported the use of this delivery route for the administration of live virus vaccines [32] . previous reports demonstrated that the tc route is a safe and efficient immunization method [15] [16] [17] [18] [27] [28] [29] 34, 35] . in particular, the tc administration route prevents the toxicity of certain adjuvants, such as lt1, which may induce local and systemic side effects when delivered via parenteral routes [23, 36] . indeed, our results demonstrate that administration of denv2 particles admixed with lt1 and delivered through the tc route led to the generation of specific antibody and cellular responses without any significant deleterious effects or local inflammatory reactions. studies describing the use of viral antigens administered via the tc route usually exhibit a wide range of antigen doses [7, 14, 19, 27, 37] . the antigen loads tested in the present study were designed to permit comparisons with mice immunized under the same conditions via a parenteral (id) route. interestingly, similar amounts of denv envelope (e) protein were shown to be immunogenic and protect against challenge after skin application of the microneedle device [31] . immunization of mice with the same vaccine via two different administration routes allowed for comparisons of the impact on the antigen-specific immune responses and the induction of protective immunity. under the test conditions, the induction of anti-denv serum igg responses was lower in the mice subjected to tc immunization than it was in the mice immunized via the id route. this difference was clear after the third immunization dose and may be ascribed to the natural limitations of the naked ablated skin to efficiently deliver antigens compared with that delivered via parenteral inoculations. despite such differences, mice immunized via the tc or id route developed similar protective immunity after challenge with the denv2 ngc strain. the immune responses elicited in the mice immunized via the tc route, therefore, confer a more efficient protective immunity against denv. antibodies increased in the mice immunized via the tc route displayed a different reactivity toward conformation-dependent epitopes presented on the virus particles. heat denaturation of the virus particles is expected to disrupt conformational epitopes present on structural proteins, while linear epitopes would not be affected to the same extent after similar exposure to the protein denaturation step. indeed, results from previous studies based on human monoclonal abs (hmabs) generated from patients infected with denv demonstrated that protective antibodies react preferentially to tertiary and quaternary conformational epitopes of the e protein [38] . thus, the lower reactivity of the antibodies to the heat-denatured viruses in the tc-immunized mice may reflect differences in epitope specificity. antigen avidity has been reported to affect the capacity of antibodies to neutralize viruses [39] . although mice immunized via the id route developed antibodies with higher antigen avidity than those immunized via the tc route, particularly the mice immunized with the higher antigen concentration (50 µg/dose), the protective immunity to denv2 was similar in both groups. thus, antigen avidity did not seem to play a relevant role in the immune protection against denv observed under the test conditions. the classic protection correlate for denv infection consists of the induction of neutralizing antibodies, but several results generated under experimental and clinical conditions indicated that the cellular arm of the immune system also plays a relevant role in the development of antiviral immunity [40, 41] . modulation of immune responses, particularly the production of th1-related cytokines, such as ifn-γ and tnf-α, enables the activation of immune cells and control of the intracellular replication of viruses through both direct destruction of infected host cells and noncytotoxic pathways [42] . the abundant presence of intraepithelial antigen-present cells (apcs), such as langerhans cells (lcs), capable of processing exogenous antigens and priming naïve t cells, is expected to improve the performance of vaccines delivered via this route [13] . furthermore, a previous report showed that, in contrast to other antigen-presenting cells, few lcs are infected by denv [43] , indicating the more efficient activation of b and t lymphocytes. in this study, the mice immunized via the tc route secreted high amounts of ifn-γ and, particularly, tnf-α. on the other hand, spleen cells collected from the id-immunized mice secreted ifn-γ and il-2. the production of ifn-γ and tnf as associated with the expression of cd107a was previously correlated with protection mediated by cd8 + t cell responses [44, 45] . moreover, ifn-γ, tnf-α and il-2 production was correlated with subclinical denv secondary infections [46] and may contribute to protection through multifunctional cd4 + t cells after vaccination [47] . the same pattern was observed in hiv patients with lower viral loads, indicating that proinflammatory responses are relevant for viral control [48] . spleen cells collected from the mice immunized via the tc route also secreted higher amounts of il-4 and had lower production of il-10 in comparison with the mice immunized via the id route. both il-4 and il-10 were previously correlated with severity increases in denv diseases [49] [50] [51] . il-4 is associated with the upregulation of denv-targeted receptors, leading to an increase in denv infectivity in dermal apcs [52] . the production of il-4 is modulated by denv during infection, which explains the crescent levels after the increase in viral particle administration or adjuvant-mediated inflammation. il-4 also induces the transformation of b cells in plasma cells [52] , increasing the amount of specific antibodies produced, as observed at a level of significance in the group that received 50 µg of denv2. il-10 is usually associated with the suppression of pathogen-mediated inflammation and is found in high amounts in the sera of denv-infected mice and humans [53, 54] . the presence of il-10 + monocytes after yellow fever (yfv) vaccination was associated with a reduction in immune responses and immune system adverse reactions [55, 56] . accordingly, higher levels of il-10 were expected to be observed after id inoculation with lt1. furthermore, il-10 + cd8 + t cells showed higher cytolytic activity than did the il-10 -cd8 + t cells during the control of coronavirus-induced acute encephalitis [57] , suggesting possible enhancement of the survival and activation of cd8 + t cells during acute inflammation. collectively, these results demonstrated that the same vaccine formulation delivered by either the id or tc routes triggered different cellular immune responses, as indicated by the cytokine secretion pattern of total spleen cells collected from the vaccinated animals. the experimental virus challenge model used in the present study depended on the i.c. inoculation of a mouse-adapted denv2 strain (ngc). although this infection route did not correspond to the infection process observed under natural conditions, the mouse-adapted virus strain represents a classic tool for the determination of protective immunity elicited in immunocompetent mice [58] [59] [60] . it has been demonstrated that serum antibody responses are only partial contributions to the encephalitis developed in i.c. challenge with denv viruses [43] . furthermore, the depletion of cd4 + or cd8 + t lymphocytes drastically reduced the vaccine-based protection observed in the encephalitis model [43, 61] . thus, the high protective status induced by the tested vaccine administered via both inoculation routes suggests the relevant role of cellular immune responses. this study adds further experimental evidence that, similar to other virus vaccines, the tc route represents a promising route for vaccine administration capable of inducing protective immunity without the concerns associated with needle-delivered vaccines. despite difficulties in standardizing the amount of antigen effectively delivered into the host tissues, this vaccine administration route is safer and a similarly effective alternative to parenterally administered denv vaccines. further studies based on preclinical models should contribute to the translation of the present results into an alternative for the clinical testing of denv vaccines in humans. the following are available online at http://www.mdpi.com/1999-4915/12/5/514/s1, figure s1 : antigens and transcutaneous immunization procedures adopted in the study. figure s2 : serum igg responses in mice immunized with purified denv2 particles. figure s3 : hematological analyses of mice submitted to tc or id immunizations with concentrated denv2 particles. figure s4 : binding of anti-denv antibodies to viral particles following antigen heat denaturation or treatment with ammonium thiocyanate. cost of dengue outbreaks: literature review and country case studies the global distribution and burden of dengue assessing the economics of dengue: results from a systematic review of the literature and expert survey world health organization (who) dengue and severe dengue transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge transcutaneous immunization: a human vaccine delivery strategy using a patch a low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens topical application of escherichia coli-vectored vaccine as a simple method for eliciting protective immunity skin-resident t cells: the ups and downs of on site immunity transcutaneous and intradermal vaccination transcutaneous antigen delivery system needle-free vaccine delivery advances in transcutaneous vaccine delivery: do all ways lead to rome? effective transcutaneous immunization against hepatitis b virus by a combined approach of hydrogel patch formulation and microneedle arrays simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective hiv-1 vaccines particle-based transcutaneous administration of hiv-1 p24 protein to human skin explants and targeting of epidermal antigen presenting cells transcutaneous immunization by lipoplex-patch based dna vaccines is effective vaccination against japanese encephalitis virus infection transcutaneous immunisation with herpes simplex virus stimulates immunity in mice a combined approach of vesicle formulations and microneedle arrays for transcutaneous immunization against hepatitis b virus new mouse model for dengue virus vaccine testing functional diversity of heat-labile toxins (lt) produced by enterotoxigenic escherichia coli: differential enzymatic and immunological activities of lt1 (hlt) and lt4 (plt) production and release of heat-labile toxin by wild-type human-derived enterotoxigenic escherichia coli functional and immunological characterization of a natural polymorphic variant of a heat-labile toxin (lt-i) produced by enterotoxigenic escherichia coli (etec): research article a genetic and pathologic study of a denv2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge other adverse reactions, such as weight loss or altered animal behavior, were observed in the mice in which the vaccine regimens were tested preferential amplification of cd8 effector-t cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase i trial transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis coated microneedle arrays for transcutaneous delivery of live virus vaccines transcutaneous anti-influenza vaccination promotes both cd4 and cd8 t cell immune responses in humans efficient delivery of dengue virus subunit vaccines to the skin by microprojection arrays microneedle-based intradermal delivery of stabilized dengue virus transcutaneous immunization with bacterial adp-ribosylating exotoxins, subunits, and unrelated adjuvants transcutaneous delivery and thermostability of a dry trivalent inactivated influenza vaccine patch successful induction of protective antibody responses against haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine genetic diversity of heat-labile toxin expressed by enterotoxigenic escherichia coli strains isolated from humans microneedle arrays for the transcutaneous immunization of diphtheria and influenza in balb/c mice mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop high-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection protective role of cross-reactive cd8 t cells against dengue virus infection cells can mediate short-term protection against heterotypic dengue virus reinfection in mice gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model a protective role for dengue virus-specific cd8 + t cells cells are not required for the induction of dengue virus-specific cd8 + t cell or antibody responses but contribute to protection after vaccination intracellular cytokine production by dengue virus-specific t cells correlates with subclinical secondary infection primary vaccination with low dose live dengue 1 virus generates a proinflammatory, multifunctional t cell response in humans presence of hiv-1 gag-specific ifn-γ + il-2 + and cd28 + il-2 + cd4 t cell responses is associated with nonprogression in hiv-1 infection vascular endothelium: the battlefield of dengue viruses differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections thrombocytopenia in dengue fever dermal cd14 + dendritic cell and macrophage infection by dengue virus is stimulated by interleukin-4 il-10 levels in dengue patients: some findings from the exceptional epidemiological conditions in cuba vascular endothelial growth factor kdr receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17dd live attenuated yellow fever first-time vaccination characterization of main cytokine sources from the innate and adaptive immune responses following primary 17dd yellow fever vaccination in adults highly activated cytotoxic cd8 t cells express protective il-10 at the peak of coronavirus-induced encephalitis protection against dengue type 2 virus induced in mice immunized with a dna plasmid encoding the non-structural 1 (ns1) gene fused to the tissue plasminogen activator signal sequence production of a recombinant dengue virus 2 ns5 protein and potential use as a vaccine antigen immunogenic and protective response in mice immunized with a purified, inactivated, dengue-2 virus vaccine prototype made in fetal rhesus lung cells flow-cytometry assays were also performed with spleen cells after the immunization protocols prior to challenge we thank mariana cintra and pietro pisani for technical support in tc immunizations and eduardo gimenes martins for the administrative and technical support. the authors declare no conflict of interest. the funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. key: cord-353600-5wo74ms4 authors: tyrrell, daniel j.; goldstein, daniel r. title: ageing and atherosclerosis: vascular intrinsic and extrinsic factors and potential role of il-6 date: 2020-09-11 journal: nat rev cardiol doi: 10.1038/s41569-020-0431-7 sha: doc_id: 353600 cord_uid: 5wo74ms4 the number of old people is rising worldwide, and advancing age is a major risk factor for atherosclerotic cardiovascular disease. however, the mechanisms underlying this phenomenon remain unclear. in this review, we discuss vascular intrinsic and extrinsic mechanisms of how ageing influences the pathology of atherosclerosis. first, we focus on factors that are extrinsic to the vasculature. we discuss how ageing affects the development of myeloid cells leading to the expansion of certain myeloid cell clones and induces changes in myeloid cell functions that promote atherosclerosis via inflammation, including a potential role for il-6. next, we describe vascular intrinsic factors by which ageing promotes atherogenesis — in particular, the effects on mitochondrial function. studies in mice and humans have shown that ageing leads to a decline in vascular mitochondrial function and impaired mitophagy. in mice, ageing is associated with an elevation in the levels of the inflammatory cytokine il-6 in the aorta, which participates in a positive feedback loop with the impaired vascular mitochondrial function to accelerate atherogenesis. we speculate that vascular and myeloid cell ageing synergize, via il-6 signalling, to accelerate atherosclerosis. finally, we propose future avenues of clinical investigation and potential therapeutic approaches to reduce the burden of atherosclerosis in old people. the number of old people (aged >65 years) is rising worldwide, and cardiovascular diseases are the largest contributor to morbidity and mortality in this popu lation 1, 2 . changes in diet and lifestyle contribute to the high cardiovascular morbidity and mortality in old indi viduals, but many biological processes that are altered with ageing also contribute to this increased cardio vascular risk. as a result, therapies for cardiovascular disease that are effective in young and middle aged peo ple might be less effective in older people. additionally, novel therapies might be required to improve disease management specifically in old people. deciphering the mechanisms by which ageing promotes atheroscle rotic cardiovascular disease will be fundamental for the development of novel therapies to reduce the burden of atherosclerosis with ageing. the development of new therapies is especially relevant with the coronavirus dis ease 2019 (covid19) pandemic, because old people and particularly those with cardiovascular diseases are at a substantially higher risk of morbidity and death 3, 4 . in this review, we describe two major areas by which ageing promotes atherosclerosis. first, we dis cuss age related factors that are extrinsic to the vascula ture, focusing on the effects of ageing on myeloid cells of the immune system. age related effects in the bone marrow skew the differentiation of haematopoietic cells towards the myeloid cell lineage. ageing also promotes the generation of clones of haematopoietic cells with out clear development of haematopoietic malignancy or other known clonal disorder, a phenomenon known as clonal haematopoiesis of indeterminate potential (chip) [5] [6] [7] [8] . clinical studies from the past decade have revealed that the presence of chip increases the risk of cardiovascular diseases 6, 7 . intriguingly, the increased risk of cardiovas cular disease associated with the presence of chip is abrogated in patients with a loss of function mutation in il6 (ref. 9 ). however, the precise mechanisms by which chip promotes the development of cardiovascular diseases are yet to be fully clarified. we next address vascular intrinsic factors, discussing how ageing impairs vascular bioenergetics by compro mising mitochondrial function and how this alteration connects with inflammatory pathways within the vascu lature to promote atherosclerosis 10, 11 . we describe studies in mice and humans showing that, in the aorta, ageing impairs both mitochondrial function and the removal of damaged mitochondria (mitophagy) 10, 11 . we describe experimental evidence reported in 2020 demonstrating that the age mediated increase in the levels of the plei otropic cytokine il6 in the aorta occurs in a positive clonal haematopoiesis of indeterminate potential (chip) . clonal expansion of haematopoietic stem cells that carry certain somatic mutations that confer a cell proliferation advantage. feedback loop with vascular mitochondrial dysfunction and that these alterations promote atherosclerosis 11 . the cantos study 12 demonstrated that il1β block ade reduces the risk of recurrent cardiovascular events in patients aged >60 years. importantly, the greatest bene fit of il1β blockade was seen in patients who had low plasma il6 levels 13 . this pivotal clinical study indicates that chronic inflammation, potentially via il6 signal ling, is a major contributor to age related atherosclerosis. given this observation, we speculate that increased ath erosclerosis with ageing could result from a synergy between myeloid cells of the immune system and the vasculature via il6 signalling (fig. 1 ). this mechanism is especially important because clinically approved agents targeting this pathway (such as anti il6 therapies) are already available and could reduce the risk of cardio vascular disease in old people. finally, we propose that future experimental and clinical investigation will be required to determine the contribution of this inflamma tory pathway in age related atherosclerosis. we acknowl edge that other inflammatory pathways and cytokines could contribute to age related atherosclerosis, and the source of these cytokines (including il6) could be senescent adipocytes. a detailed discussion of the con tribution of ageing to senescence and atherosclerosis has been published previously 14 . ageing affects the immune system in complex ways (as reviewed previously [15] [16] [17] , and various components of the immune system contribute to atherosclerosis 18, 19 . this review focuses on clones of myeloid cells that increase with ageing and how these clones contribute to athero sclerosis. we do not describe how ageing affects other cells of the immune system, which has been reviewed previously (for example, b cells 20 , t cells 21 , eosinophils or dendritic cells 22 ). in addition, we focus on vascular mito chondrial function and how mitochondrial dysfunction could influence inflammatory pathways within the vasculature. however, given that most of the available evidence indicates that oxidative stress is not a major driver of biological ageing [23] [24] [25] , and given the complex roles that oxidative stress has in atherosclerosis 26 , we do not describe in detail the contributions of oxidative stress in age related atherosclerosis. neither do we describe in detail how ageing affects other processes within the arte rial wall, such as extracellular matrix remodelling or pro duction of pro fibrotic and pro calcific factors, which can promote atherosclerosis indirectly via increasing arterial stiffness and hypertension 27, 28 , and which have been previously reviewed 29, 30 . effects of ageing on myeloid cell production. numerous subpopulations of immune cells of various lineages have been implicated in atherosclerosis, including macrophages 31 , dendritic cells 32 , t helper 1 (t h 1) cells 33 and b cells 34 (reviewed previously 18, 35 ), all of which are affected by ageing. immune cells are generated in the bone marrow via haematopoiesis from regenerative haematopoietic stem cells (hscs) 36, 37 . monocytes, mac rophages and neutrophils are derived from myeloid biased hscs. with ageing, although the absolute number of hscs increases 38 , hscs lose their regener ative capacity 39, 40 . this loss of regenerative potential is accompanied by an expansion of the number of hscs that are committed to the platelet (megakaryocytes) and myeloid lineages 38, 41 . competitive bone marrow transplantation studies in mice have demonstrated that aged hscs have a reduced repopulation capacity, with an imbalance towards myeloid cell differentiation, compared with young hscs 38, 42 . several major biological pathways contribute to ageing, including dna damage, mitochondrial dysfunction, cell senescence, impaired autophagy, epigenetic alterations and gene transcrip tion dysregulation 25 . transcriptomic studies in mice have shown that with ageing, hscs upregulate stress responses and inflammatory pathways and downregu late the expression of genes related to genetic stability 43 . with ageing, hscs exhibit an increase in epigenetic dysregulation, specifically downregulation in chroma tin remodelling and transcriptional silencing 43 , and increases in dna methylation (as reviewed previously 44 ). these epigenetic alterations are accompanied by func tional defects in hscs, including a reduction in hsc homing to the bone marrow and hsc proliferation 43, 45 . importantly, mutations in genes such as idh2, which alter epigenetic regulation, lead to impairments in hae matopoietic progenitors in mice 46 and are associated with t cell lymphomas in humans 47 , a malignancy that increases with ageing. although whether hscs, or stem cells in general, undergo senescence is questionable 48 , the clearance of senescent cells improves hsc engraft ment in bone marrow transplantation mouse models and reduces myeloid skewing 49 . autophagy deficient young mice have increased mitochondrial content and metabolism that lead to mitochondrial stress in hscs compared with wild type young mice 50 . these features are also observed in aged wild type mice and are asso ciated with a skewing towards the myeloid lineage and a reduced proliferative capacity of hscs 50, 51 . loss of microrna146a (mir146a) in hscs with ageing also promotes a myeloid bias 52 . furthermore, myeloid cells derived from mir146a deficient hscs have elevated levels of both il6 and tumour necrosis factor (tnf) 52 , which connects altered regulation of transcription in hscs to inflammation. overall, these studies indicate that ageing has effects on hscs via several complex pathways that lead to reduced hsc function. ageing also alters haematopoiesis by influencing the bone marrow niche independently of the direct effects • ageing-related alterations in the bone marrow increase the phenomenon of clonal haematopoiesis of indeterminate potential (chip) and promote a skewing towards myeloid cell differentiation, both of which can accelerate atherosclerosis. • the increased risk of atherosclerotic cardiovascular diseases associated with the presence of chip might be mediated by il-6 signalling and/or inflammasome activation. • ageing is associated with a decline in mitochondrial function and an increase in il-6 levels in the vasculature, and both effects probably accelerate atherosclerosis independently of chronic hyperlipidaemia. • the role of the vasculature and myeloid cells of the immune system in promoting age-related atherosclerosis might be mediated by shared inflammatory pathways, in particular il-6 signalling. senescence a state of permanent replicative arrest in normally proliferative cells. www.nature.com/nrcardio on hscs. the bone marrow niche provides a support ing environment for hsc function and includes mesen chymal cells and endothelial cells 53 . how ageing affects the bone marrow niche is not clear, but the presence of chronic systemic inflammation might contribute. ageing leads to a chronic systemic low grade inflammatory state 54, 55 , which might be mediated by cellular senescence that leads to the production of inflammatory mediators (termed the senescence-associated secretory phenotype (sasp)) 56,57 . one source of senescent inflammatory cells is the adipose tissue, which typically increases in size with ageing 58, 59 . the number of adipocytes also increases in the bone marrow with ageing, accompanied by an elevation in the levels of pro inflammatory cytokines, including il6 (refs 60,61 ). these cytokines promote a skewing towards myeloid cell differentiation and an increase in platelet production, the latter of which could contribute to thrombosis 60, 61 . importantly, adipocytes arising from leptin receptor positive progenitors in the bone marrow, but not within other fat depots, synthesize stem cell factor, which promotes hsc regeneration 62, 63 . senescent stromal cells in the bone marrow are another potential source of inflammation 64 . these cells can dif ferentiate into adipocytes in the ageing bone marrow 65 and further promote an inflammatory environment. the function of bone marrow endothelial cells also declines with ageing 66 . furthermore, the number of vascular niches in the bone marrow that support hsc regenera tion decreases with ageing, but can be restored in aged mice by activating notch signalling in endothelial cells 53 . activation of the innate immune receptor toll like receptor 4 (tlr4) induces myeloid differentiation in hscs in mice 67 . ageing is associated with alterations in gut microbiota 68 , which could act as a microbial source for tlr4 stimulation (for example, lipopolysaccharide (lps) from gram negative bacteria activates tlr4). tlr4 activation could then increase the imbalance of hsc differentiation towards the myeloid lineage. in a 2019 study in mice, β 2 adrenergic receptor signalling in the bone marrow niche was found to increase with ageing in association with increased generation of myeloid cells and platelets through an il6 dependent mechanism 60 . this study also demonstrated that the bone marrow niche switches from an endosteal to a non endosteal mutation show an increased production of il-6 and il-1β, which can contribute to accelerated atherosclerosis. ageing can also have pro-atherogenic effects directly on the vasculature. ageing is associated with an increase in the levels of il-6, possibly mediated by increased production by vascular smooth muscle cells (vsmcs), and mitochondrial genomic instability and with a decline in mitochondrial function in the vasculature. the reduced mitochondrial function alters mitophagy and increases il-6 levels, creating a positive feedback loop that accelerates atherogenesis. vascular ageing also leads to the production of chemoattractants that increase myeloid cell recruitment into the arterial wall, further promoting atherosclerosis. impaired mitochondrial function combined with reduced mitophagy might lead to increased levels of reactive oxygen species (ros). senescence-associated secretory phenotype (sasp). secretion of cytokines, chemokines, growth factors and proteases by senescent cells. nature reviews | cardiology niche with ageing, indicating that ageing shifts myeloid cell production away from the bone tissue to further within the bone marrow 60 . this study also found that a mouse model of hutchinson-gilford progeria syn drome, which is associated with accelerated ageing 69 , had an imbalance favouring myeloid cells over lymphoid cells in the peripheral blood 60 . this effect was mitigated by administration of a β 3 adrenergic receptor agonist 60 . overall, clear evidence indicates that ageing alters the bone marrow niche via multiple mechanisms to impair hsc function and promote myeloid cell differentiation. clonal haematopoiesis and cardiovascular disease: clinical correlation. the positive selection and expansion of clones of hscs carrying certain somatic mutations, known as clonal haematopoiesis, occurs commonly with ageing. approximately 10% of individuals aged >70 years carry mutations associated with clonal haemato poiesis, whereas these mutations are rare in individu als aged <40 years 7, 70, 71 . these clones of haematopoietic cells harbour single somatic mutations most commonly in genes associated with haematological malignan cies, such as dnmt3a, tet2 and asxl1. individuals with mutations in these genes have an increased risk of developing haematological malignancies (hr 11-12, depending on the study) 7, 70, 71 . all cause mortality is increased in individuals with any somatic mutation asso ciated with clonal haematopoiesis (hr 1-2) compared with those with no mutations 7 . interestingly, the cause of the increased mortality in these individuals is not only the higher rate of haematological malignancies but also a higher rate of adverse cardiovascular events 7,70-72 . the association between clonal haematopoiesis and the risk of adverse cardiovascular events remained even after adjustment for traditional cardiovascular risk fac tors, such as diabetes mellitus, hypertension, smoking and bmi, in multivariate analyses 6 . as a result of these studies, the term chip was coined to distinguish the phenomenon of clonal haematopoiesis without clear development of haematopoietic malignancy or other known clonal disorder from the pre malignant clonal haematopoiesis of clinical importance 73 . a follow up clinical study provided further evidence of the association between cardiovascular disease and chip 6 . in particular, old individuals (aged 60-70 years) with chip had an approximately twofold higher risk of incident coronary artery disease, a fourfold higher risk of early onset myocardial infarction and a three fold higher coronary artery calcium score than similarly aged individuals without chip 6 . importantly, the size of the chip clone, defined as the variant allele frequency (vaf), correlates with the risk of cardiovascular dis ease. specifically, individuals with a chip clone with a vaf of >10% have a 12 fold increased risk of cardi ovascular disease compared with individuals with no mutations, whereas the risk of cardiovascular disease is not significantly increased in chip carriers with a vaf of <10% 6 . this study has established that chip is associated with the risk of cardiovascular diseases and has developed a potential new paradigm that certain clones of haematopoietic cells accelerate atherogenesis 6 . however, to date, the presence of chip can be used only as a biomarker of atherosclerosis and is not therapeutically actionable. mutations in tet2 are the second most prevalent somatic mutations associated with chip after those in dnmt3a. mouse models have been used to elucidate the mechanistic contributions of tet2 mutations to ath erogenesis. in irradiated, atheroprone ldlr −/− mice, those reconstituted with either tet2 −/− or tet2 +/− bone marrow had increased atherosclerotic lesion size compared with mice receiving wild type bone marrow 6, 74 . these data imply that deletion of one copy of the tet2 gene is sufficient to increase atherosclerosis in mice. further studies in mice showed that myeloid cell specific tet2 deficiency increases atherosclerotic plaque size 74 . interestingly, tet2 deficiency in bone marrow derived macrophages leads to an elevated secretion of il6 and il1β (a signature cytokine produced by inflammasome activation) 75 in response to various stimuli (such as ldl, lps and ifnγ) in vitro 74 . furthermore, the increased atherogenic potential of tet2 −/− bone marrow cells is reduced when bone marrow transplantation recipients are treated with a small molecule inhibitor of the nlrp3 inflammasome 74 . the effect of tet2 deficiency might not be limited to vascular diseases, because experimen tal studies have demonstrated that transfer of tet2 −/− bone marrow cells into non irradiated mice accelerates the development of age related cardiac hypertrophy and fibrosis 76 , and tet2 deficiency in myeloid cells worsens the development of heart failure in mice after acute injury 77 . the contribution of il6 to the cardiovascular risk in individuals with large chip clones (vaf >10%) was evaluated in 35,416 individuals without prevalent cardi ovascular disease enrolled in the uk biobank registry 9 . the investigators examined whether an il6r coding mutation that leads to reduced il6 signalling alters the association between chip and the risk of adverse cardiovascular events (myocardial infarction, coronary artery disease revascularization, stroke or death). the study revealed that the presence of the il6r mutation mitigated the increased risk of adverse cardiovascular events in individuals with large chip clones but not in individuals without chip 9 . these data indicate that il6 signalling is causally linked to the increased risk of cardiovascular disease associated with chip. il6 is released following inflammasome activation 78 ; therefore, the observed link between il6 and chip suggests that inflammasome activation is a mecha nism by which chip promotes the development of cardiovascular diseases. this concept is compatible with the study in mice discussed above, showing that the nlrp3 inflammasome contributes to the increased atherosclerotic burden induced by tet2 −/− bone marrow transplantation 74 . the contribution of il1β to cardio vascular disease in humans was demonstrated in the cantos study 12, 13 , which showed that a monoclonal antibody against il1β reduces the risk of recurrent car diovascular events in patients with previous myocardial infarction. the effects of il1β blockade in the cantos trial were greater in patients who had lower circulating variant allele frequency (vaf) . the proportion of sequences that match a gene mutation divided by the overall coverage at that gene locus. www.nature.com/nrcardio il6 levels after il1β blockade than in those with higher circulating il6 levels 13 . however, the role of il1β and il6 in experimental models of atherosclerosis is not completely clear because data indicating that each of these cytokines has atheroprotective effects have been reported 79, 80 . however, these studies were performed in young mice, so these cytokines might have increasingly pathogenic roles with ageing. monocytes and macrophages contribute to both the initiation of the chronic inflammatory process of ath erosclerosis and the resolution of the chronic vascular inflammation 81 . ageing directly influences the function of monocytes and macrophages 16 . human monocytes have lower levels of tlrs and a reduction in tlr dependent pro inflammatory cytokine production with ageing 16 . a study comparing bone marrow derived monocytes from young and aged atheroprone ldlr −/− mice showed that ageing leads to a downregulation in the expression of tnf and il1b but monocyte chemotaxis is preserved 82 . aged (6 month old) atherosclerotic apoe −/− mice have a reduction in the number of vascular progenitor cells in the bone marrow compared with 1 month old atheroscle rotic apoe −/− mice 83 . furthermore, administration of bone marrow derived hscs from young non atherosclerotic mice to non irradiated 6 month old apoe −/− mice reduced atherogenesis after feeding a high fat diet 83 . this finding suggests that ageing is accompanied by a reduc tion in the number of atheroprotective progenitor cells in the bone marrow. aged (18-21 month old) mice with chronic or induced acute hyperlipidaemia have more macrophage infiltration into atherosclerotic lesions than young mice 11, 82 . furthermore, the aortas of aged athero sclerotic mice (12 months old) and rats (30 months old) have higher levels of macrophage attracting chemokines and il6 than the aortas of young atherosclerotic mice (2 months old) and rats(10 months old) 82, 84 . although macrophages and monocytes can have an increased basal secretion of inflammatory cytokines, such as il1β, il6 and il8, with ageing 85 (possibly owing to senescence) 57 , whether these cells are the major contributors to the increased vascular production of il6 with ageing during atherogenesis is unclear. vascular cells such as vascular smooth muscle cells (vsmcs) have been shown in animal models to have an elevated il6 production with ageing before any signs of atherosclerosis development 86, 87 . efferocytosis is a crucial mechanism for resolving plaque inflammation and reducing atherosclerosis progression 88 . in vivo and in vitro assays have indi cated that the phagocytic function of tissue alveolar macrophages to take up apoptotic neutrophils declines with ageing 89 and is associated with reduced expres sion of scavenger receptor cd204 (ref. 90 ). in a mouse model of peritonitis, ageing led to reduced resolution of acute inflammation and was associated with reduced levels of pro resolution lipid mediators, specifically resolvins 91 . resolution of inflammation was also delayed with ageing in a human model of skin blistering 92 . this phenotype is related to reduced expression of the effe rocytotic receptor tim4 in macrophages. reduced tim4 expression with ageing was caused by elevations in p38 mitogen activated protein kinase activity in macrophages, and treatment with an oral p38 inhibitor increased the resolution of blister inflammation in old individuals 92 . overall, macrophages show impaired inflammation resolution properties with ageing; how ever, whether this impaired macrophage function contributes to increased atherosclerosis is not yet clear. vascular mitochondrial dysfunction with ageing before atherogenesis initiation. ageing affects the vasculature before the development of atherosclerosis. generally, ageing is associated with remodelling of the arterial wall, with evidence of reduced endothelial cell function, increased collagen deposition, fibrosis and functionally stiffer vessels 28, 93, 94 . in addition, vsmcs acquire a more proliferative and synthetic function with ageing 86 . vsmcs also show an increased generation of reactive oxygen spe cies (ros) and high oxidative damage 95 . endothelial cells also have a dysregulated antioxidant capacity with ageing (mediated by the disruption of nuclear factor erythroid 2 related factor 2 signalling), thereby contributing to vas cular ageing 96, 97 . all these effects of ageing can contribute to the development of hypertension, a major risk factor for cardiovascular disease. most studies on vascular ageing in rodent models have been performed in normolipidaemic animals. these studies provide evidence that mitochondrial dysfunction, a known hallmark of ageing 25 , contrib utes to vascular ageing before the initiation of athero genesis. disease free, normolipidaemic mice develop mitochondrial dysfunction in the aorta as they age, first detected at 11 months of age (measured as a decline in oxygen consumption rate (ocr)) and becoming more evident as the mice reach 18 months of age 98 . the reduction in ocr is accompanied by an increase in mitochondrial dna (mtdna) damage 98 , a sign of mito chondrial genomic instability, which is another hallmark of ageing 25 . furthermore, reduced vascular mitochon drial function with ageing is accompanied by a decrease in the expression of the mtdna helicase twinkle 98 , an enzyme involved in preserving mtdna integrity. aged transgenic mice expressing high levels of twinkle show delayed vascular ageing; in particular, the decrease in aortic compliance and the increase in aortic stiffness are delayed in these mice compared with aged wild type mice 98 . overall, experimental evidence indicates that mitochondrial dysfunction and mitochondrial genomic instability contribute to vascular ageing. in humans, atherosclerotic plaques show evidence of damage to mtdna, which is associated with reduced mitochondrial function, specifically lower ocr in the fibrous cap and core regions of the atherosclerotic plaque than in the shoulder region of the plaque or in non overtly diseased regions of the aorta 10 . these findings are compatible with those of previous experimental work indicating that apoe −/− mice fed a low fat, standard chow diet have increased vascular mtdna damage but not nuclear dna damage as the mice age 99, 100 . furthermore, human atherosclerotic plaques have lower levels of mitochondrial complex i and complex ii than non diseased aortic regions 10 . similar findings are noted in efferocytosis phagocytosis of apoptotic cells by phagocytic cells. atherosclerotic apoe −/− mice fed a high fat diet 10 . apoe −/− mice overexpressing twinkle have a reduced necrotic core area in atherosclerotic plaques compared with con trol apoe −/− mice 10 . mitochondrial dysfunction probably has a central role in ros generation but the interaction between these two factors is complex. for example, low levels of ros might improve cell fitness and pro mote survival, a concept known as mitohormesis 25, 101 . however, higher levels of ros might contribute to age related chronic vascular diseases. the complex inter action between mitochondrial dysfunction and ros might explain why disruption of some mitochondrial enzymatic pathways (such as nadph oxidase 1 (nox1) and nox2 signalling) in atherosclerotic mice has no effect on age related atherosclerosis 102 , whereas partial deficiency of ros scavenging enzymes (such as super oxide dismutase) 103 in atherosclerotic mice contributes to atherosclerosis 99 . however, one study found that mtdna damage occurs in both vsmcs and monocytes and cor relates with atherosclerotic burden in humans but with out evidence of alterations in ros levels 100 . furthermore, clinical trials on antioxidants have yet to reveal a benefi cial effect in patients with atherosclerotic cardiovascular disease 104, 105 . overall, mitochondrial dysfunction occurs during chronic hyperlipidaemia and atherogenesis, and this mitochondrial dysfunction promotes atherosclero sis. however, the precise role of ros in this context is complex and requires further investigation. part of the challenge of using stand ard mouse models of atherosclerosis (such as ldlr −/− or apoe −/− mice) to understand the role of ageing on atherogenesis is that even when fed a standard low fat diet, these mice age with chronic hyperlipidaemia. therefore, the effects of ageing cannot be dissected from the effects of chronic hyperlipidaemia. a study in mice published in 2020 circumvented this issue by first examining mitochondrial function in the aortas of young and aged wild type mice without hyperlipidaemia or vascular diseases 11 . consistent with previous studies, aged mice had evidence of reduced ocr in the aortas compared with young mice 11 . this ocr reduction in the vasculature from aged mice was accompanied by increased expression of the mitophagy protein parkin and increased basal mitophagy (box 1), a macroau tophagy process to remove damaged mitochondria. altered mitochondrial quality control in the ageing vas culature without hyperlipidaemia is linked to arterial stiffening in mice 106 . the mitochondrial dysfunction and elevated parkin levels with ageing in the mouse aorta are accompanied by an increase in tlr9, myd88 and il6 levels 11 . importantly, blocking il6 in aged mouse aortas in vitro increased the ocr and reduced parkin levels. this study identified a positive feedback loop in which mitochondrial dysfunction and elevated il6 levels coexist and positively influence each other 11 . however, the exact identity of the il6 producing and il6 responsive cell(s) has yet to be identified, although evidence suggests that vsmcs secrete more il6 with ageing 87 . to study the link between the changes occurring with normolipidaemia in the aged aorta and atherogen esis, young and aged wild type mice were made acutely hyperlipidaemic by inducing a decrease in ldl recep tor levels with adeno associated virus vector mediated during homeostasis, damaged mitochondria are recycled via mitophagy, which is a specialized subset of macroautophagy (see the figure) . mitophagy reduces the production of mitochondrial damage-associated molecular patterns (mtdamps) and limits inflammation. mitochondrial depolarization results in the accumulation of the serine/threonine protein kinase pink1 at the outer mitochondrial membrane, leading to the recruitment of parkin, an e3 ubiquitin ligase that ubiquitylates mitochondrial membrane proteins including mitofusin 1 (mfn1), mfn2 and voltage-dependent anion-selective channel protein 1 (vdac1). this ubiquitylation primes the mitochondria for targeting by the autophagy machinery, including sequestosome 1 (p62) and microtubule-associated protein 1 light chain 3 (lc3), to package mitochondria in autophagosomes and deliver them to lysosomes for degradation. other mitophagy mechanisms involve the apoptotic bcl-2 family proteins bcl-2/ adenovirus e1b 19 kda protein-interacting protein 3 (bnip3) and nip3-like protein (nix; also known as bnip3l), which dimerize and bind directly to lc3 and function as adaptors between mitochondria and autophagosomes. bnip3 and nix can also facilitate apoptosis and cell death by participating in the release of mitochondrial cytochrome c and opening of the mitochondrial permeability transition pore. pgc1α, proliferator-activated receptorγ co-activator 1α; tf, transcription factor. release of mtdamps www.nature.com/nrcardio delivery of pcsk9 and by feeding the mice a high fat diet for 10 weeks 11 , which is an established technique 107 . with this protocol, young and aged mice had similar and durable levels of hyperlipidaemia; however, aged hyperlipidaemic mice had larger atherosclerotic lesions with larger necrotic cores than young hyperlipidaemic mice 11 . importantly, administering spermidine, an agent that increases macroautophagy and mitophagy, to aged hyperlipidaemic mice reduced the levels of both il6 and parkin in the aorta and reduced the size of ather osclerotic plaques 11 . this finding is consistent with pre vious studies showing that treatment with spermidine or trehalose, an agent that increases mitophagy, reduces stiffness in the aged vasculature in normolipidaemic, non atherosclerotic aged mice 106, 108 . the cantos study 12 showed that in old patients (aged >60 years) with cardiovascular disease, il1β blockade reduces the risk of recurrent cardiovascular events, indi cating that chronic inflammation is a major contribu tor to age related atherosclerosis. as described above, mitochondrial dysfunction might coexist in a positive feedback loop with il6 signalling 11 to increase chronic inflammation in vascular ageing. furthermore, mito chondrial components that are released to the cyto sol after mitochondrial damage can stimulate innate immune responses 109 . mitochondrial injury in turn can be induced by tlr stimulation leading to the activa tion of caspase 4 and caspase 5 in humans or caspase 11 in mice 110 . these inflammatory caspases cleave gasder min d, which enables gasdermin d to form pores in the outer mitochondrial membrane, leading to impaired mitochondrial membrane potential and further increas ing mitochondrial injury 110 . whether this pathway is activated during ageing and in particular vascular age ing is unclear. nevertheless, the involvement of such a pathway could explain why chronic tlr activation, via either microbial products or sterile inflammatory medi ators, could lead to a chronic basal inflammatory state and mitochondrial dysfunction in the vasculature with ageing. mitochondrial injury leads to the release of mito chondrial components, known a s m it oc ho nd rial damageassociated molecular patterns (mtdamps), including mtdna, that when in the cytosol, can activate intracel lular innate immune signalling pathways, such as the dna sensing receptor cyclic gmp-amp synthase and the inflammasome 75, [110] [111] [112] . transfer of mitochondrial components into endosomes also activates the tlr9 inflammatory pathway 111 , but the detailed mechanisms are not fully elucidated. mitochondria also contain n formylated peptides that induce inflammation via engaging the n formyl peptide receptor 1 to increase neutrophil chemoattraction 113 , arterial injury and ros release 114 . cardiolipin, a component of mitochondrial membranes, can directly bind to nlrp3 and activate the nlrp3 inflammasome 115 . if chronically activated, all these pathways could promote vascular ageing and also diminish mitochondrial function, although ascertain ing the definitive contributions of each pathway requires future investigation. age related atherosclerosis might be mediated by alterations in the vasculature and mye loid cells via a shared inflammatory pathway. a potential candidate pathway is il6 signalling because available evidence indicates that the level of il6 is elevated with ageing in both the immune system and the vasculature. in the bone marrow niche in mice, il6 levels increase with ageing, which is probably mediated by increased β 2 adrenergic receptor signalling and increased num bers of adipocytes 60 (fig. 1) . il6 directly acts on hscs to promote a bias towards myeloid cell differentiation 60 . in mouse macrophages, tet2 deficiency, which is one of the most common genetic alterations found in the age related condition chip, increases il6 secretion in vitro 74 . importantly, the atherosclerosis promoting effects of chip seem to be abrogated in individuals with a loss of function il6 genetic polymorphism 9 . in the vasculature, the level of il6 increases with ageing, which is at least in part mediated by il6 production by vsmcs 87 . il6 is associated with ageing in general and is part of the 'inflammageing' phenotype 15, 16, 116 . why ageing leads to elevated basal secretion of inflammatory cytokines (not solely il6 but also other inflammatory mediators such as tnf) is not clear but might be caused by alter ations in the microbiota 117 , increased adiposity 118 , and changes in the immune system 17 and the vasculature 29, 30 . elevated cytokine levels with ageing could also be a manifestation of chronic, latent infections such as with herpesviruses 119 , of cellular senescence 57, 86, 87 or, potentially, of mitochondrial dysfunction. the role of il6 in young animal models of ath erosclerosis remains unclear and might relate to the complexities of il6 signalling (box 2). specifically, signalling via the classic il6 pathway occurs in a restricted number of cells (such as hepatocytes and some immune cells) and involves il6 binding to the membrane bound il6 receptor (il6r), with subse quent association with the signal transducing il6r subunit β (also known as gp130). evidence indicates that classic il6 signalling is important for tissue home ostasis, regeneration and host defence (as reviewed previously 120 ). soluble il6r can also engage il6 in the circulation and activate a broader range of cells than the classic pathway, via membrane activation of gp130. this pathway is termed il6 trans signalling (box 2) and can result in chronic inflammation 120 . these different il6 signalling pathways might explain the pleiotropic effects of il6 in different tissues and cellular compartments and also the divergent role of il6 in experimental atherosclerotic models. for instance, one study in apoe −/− mice showed that admin istration of exogenous il6 worsens atherosclerosis 121 . by contrast, another study in apoe +/− mice showed that il6 deficiency worsens atherosclerosis 80 nature reviews | cardiology atherosclerotic ldlr −/− mice 122 . the study found that inhib iting il6 trans signalling reduced atherosclerosis 122 , indicating that il6 trans signalling might have a path ogenic role in atherosclerosis. therefore, clinical ther apeutics to reduce atherosclerosis should focus on this il6 pathway. whether il6 has a causal role in age related ather osclerosis is not known yet. the contribution of il6 to age related atherosclerosis should be investigated in the future and should determine the main il6 producing and il6 responding cells. furthermore, the iden tification of the major il6 producing cells (fig. 2) and whether il6 activation occurs via the classic or trans signalling pathway with ageing could lead to more targeted therapeutics for atherosclerosis, especially given the availability of clinically approved agents to target il6 (refs 123,124 ). importantly, the risk-benefit balance of targeting il6 in atherosclerosis will need to be deter mined, given that anti il6 therapies in human studies increased the risk of infections 120 , similar to other bio logical agents (such as anti il1β antibodies) that have been used to reduce atherosclerosis 12, 13 . however, other biological agents such as tnf inhibitors 125 might be ben eficial for the treatment of atherosclerotic cardiovascular disease and should be investigated in age related ather osclerosis. finally, other inflammatory cytokines (such as tnf, c c motif chemokine 2 and il18, which are all part of the sasp) 56 might have a pathogenic role in age related atherosclerosis and should be assessed in future studies. therapies that can mitigate some of the detrimental biological effects of ageing, such as removing senescent cells (including senescent adipocytes) 126, 127 , improving mitochondrial function (for example, with metformin therapy) 128 , or augmenting macroautophagy (for exam ple, with rapamycin therapy) 129 or mitophagy, might reduce the burden of atherosclerosis in old people and should be investigated in future clinical studies. agents that increase mitophagy, such as spermidine, have been shown in experimental studies to reduce atherosclero sis in both young 130 and aged 11 mice. some or all these agents might have pleiotropic effects, which could reduce inflammation. furthermore, these agents might synergize with specific anti inflammatory therapies to reduce atherosclerosis with ageing, which will require future clinical investigation. ageing influences atherogenesis via multiple complex pathways, and one sole factor is unlikely to be a domi nant pathophysiological mechanism. in this review, we provide an overview of how ageing affects two systems, myeloid cell haematopoiesis and the vasculature, to pro mote atherosclerosis. we lay a framework of a poten tial shared inflammatory pathway, mediated by il6 signalling, that connects the role of the two systems in box 2 | il-6 signalling il-6 can signal via a classic signalling pathway and a trans-signalling pathway (see the figure) . in the classic il-6 signalling pathway, il-6 engages the membrane-bound il-6 receptor (il-6r) and subsequently interacts with the il-6r subunitβ (also known as gp130). intracellular signalling mainly involves activation of the janus kinase (jak) and the signal transducer and activator of transcription 3 (stat3). the classic pathway is generally restricted to hepatocytes and immune cells such as myeloid cells and lymphocytes. the trans-signalling pathway is activated by il-6 binding to soluble il-6r (sil-6r) in the circulation and then binding of the il-6-sil-6r complex to membrane-bound gp130 on a broad range of cells. sil-6r is released by enzymatic cleavage of membrane-bound il-6r by disintegrin and metalloproteinase domain-containing protein 17 (adam17). activation of the il-6 trans-signalling pathway generally leads to chronic inflammation, whereas the il-6 classic signalling pathway is involved in cell growth, regeneration and host defence. age related atherosclerosis and propose future avenues of investigation to determine whether il6 and/or other inflammatory pathways are feasible and effective ther apeutic targets to reduce the burden of atherosclerosis in old people. anti inflammatory strategies should be considered in the context of other therapies that aim to reduce many of the detrimental biological effects of ageing. overall, we hope that with the pursuit of further clinical investigation and trials, therapeutic options will be available in the future to reduce the burden of ath erosclerosis in the increasing number of old people in our society. fig. 2 | il-6 as a potential therapeutic target in age-related atherosclerosis. il-6 is upregulated in multiple tissues that have important roles in the increase in atherogenesis with ageing. therefore, blockade of il-6 might be an effective therapeutic strategy to reduce atherosclerosis development and progression during ageing. blocking il-6 might interfere with the increased il-6 signalling in bone marrow adipocytes that occurs with ageing (which promotes a skewing towards myeloid cell differentiation), thereby reducing the risk of clonal haematopoiesis of indeterminate potential (chip). il-6 blockade might also reduce the inflammatory potential of clones of myeloid cells associated with chip. il-6 blockade might reduce atherosclerosis burden, although direct comparisons of efficacy and safety with il-1β inhibition requires future investigation. il-6 blockade might increase mitochondrial function and reduce the expression of parkin, a mitochondrial stress protein, which might also contribute to reducing atherogenesis during ageing. hsc, haematopoietic stem cell; vsmc, vascular smooth muscle cell. prevalence and determinants of carotid plaque in the cross-sectional refine-reykjavik study heart disease and stroke statistics-2019 update: a report from the clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in wuhan, china association of cardiac injury with mortality in hospitalized patients with covid-19 in wuhan somatic mutations and clonal hematopoiesis: unexpected potential new drivers of age-related cardiovascular disease clonal hematopoiesis and risk of atherosclerotic cardiovascular disease age-related clonal hematopoiesis associated with adverse outcomes clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis mitochondrial respiration is reduced in atherosclerosis, promoting necrotic core formation and reducing relative fibrous cap thickness age-associated mitochondrial dysfunction accelerates atherogenesis antiinflammatory therapy with canakinumab for atherosclerotic disease modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the canakinumab anti-inflammatory thrombosis outcomes study (cantos) killing the old: cell senescence in atherosclerosis t-cell immunity to influenza in older adults: a pathophysiological framework for development of more effective vaccines age-dependent dysregulation of innate immunity the twilight of immunity: emerging concepts in aging of the immune system the immune response in atherosclerosis: a double-edged sword immunity and inflammation in atherosclerosis b cell dysfunction associated with aging and autoimmune diseases aging of the immune system. mechanisms and therapeutic targets immunosenescence in aging: between immune cells depletion and cytokines up-regulation is the oxidative stress theory of aging dead? overexpression of mn superoxide dismutase does not increase life span in mice the hallmarks of aging oxidative stress in atherosclerosis is pulse pressure useful in predicting risk for coronary heart disease? the framingham heart study endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period mechanisms of dysfunction in the aging vasculature and role in age-related disease mechanisms of vascular aging ly-6chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata s-100 positive cells in human arterial intima and in atherosclerotic lesions in vivo downregulation of t helper cell 1 immune responses reduces atherogenesis in apolipoprotein e-knockout mice detection of b cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein e knockout mice inflammation and atherosclerosis causes and mechanisms of hematopoietic stem cell aging inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion cell intrinsic alterations underlie hematopoietic stem cell aging age-associated characteristics of murine hematopoietic stem cells human and murine hematopoietic stem cell aging is associated with functional impairments and intrinsic megakaryocytic/ erythroid bias genetic regulation of primitive hematopoietic stem cell senescence aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation the epigenetic basis of hematopoietic stem cell aging clonal analysis reveals multiple functional defects of aged murine hematopoietic stem cells idh1(r132h) mutation increases murine haematopoietic progenitors and alters epigenetics idh2r172 mutations define a unique subgroup of patients with angioimmunoblastic t-cell lymphoma hematopoietic stem cell ageing is uncoupled from p16 ink4a-mediated senescence clearance of senescent cells by abt263 rejuvenates aged hematopoietic stem cells in mice autophagy maintains the metabolism and function of young and old stem cells stem cell aging. a mitochondrial upr-mediated metabolic checkpoint regulates hematopoietic stem cell aging altered microrna expression links il6 and tnf-induced inflammaging with myeloid malignancy age-dependent modulation of vascular niches for haematopoietic stem cells inflamm-aging. an evolutionary perspective on immunosenescence associations of elevated interleukin-6 and c-reactive protein levels with mortality in the elderly cellular senescence: a translational perspective cellular senescence and the senescent secretory phenotype: therapeutic opportunities clearance of p16ink4a-positive senescent cells delays ageing-associated disorders sarcopenia, obesity, and inflammationresults from the trial of angiotensin converting enzyme inhibition and novel cardiovascular risk factors study remodeling of bone marrow hematopoietic stem cell niches promotes myeloid cell expansion during premature or physiological aging changes in human bone marrow fat content associated with changes in hematopoietic stem cell numbers and cytokine levels with aging bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting scf leptin receptor promotes adipogenesis and reduces osteogenesis by regulating mesenchymal stromal cells in adult bone marrow an early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program age-related marrow adipogenesis is linked to increased expression of rankl endothelial transplantation rejuvenates aged hematopoietic stem cell function chronic exposure to a tlr ligand injures hematopoietic stem cells gut microbiota composition correlates with diet and health in the elderly defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of hutchinson-gilford progeria syndrome that is ameliorated on pyrophosphate treatment clonal hematopoiesis and blood-cancer risk inferred from blood dna sequence age-related mutations associated with clonal hematopoietic expansion and malignancies age-related clonal hematopoiesis clonal hematopoiesis in human aging and disease clonal hematopoiesis associated with tet2 deficiency accelerates atherosclerosis development in mice inflammasomes: mechanism of action, role in disease, and therapeutics tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the il-1β/nlrp3 inflammasome il-6 biology: implications for clinical targeting in rheumatic disease interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice atheroprotective role of interleukin-6 in diet-and/or pathogen-associated atherosclerosis using an apoe heterozygote murine model macrophages in atherosclerosis: a dynamic balance age-associated vascular inflammation promotes monocytosis during atherogenesis aging, progenitor cell exhaustion, and atherosclerosis increased production of tumor necrosis factor and interleukin-6 by arterial wall of aged rats age-associated elevation in tlr5 leads to increased inflammatory responses in the elderly age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate macaca mulatta: reversal by resveratrol treatment aging enhances the basal production of il-6 and ccl2 in vascular smooth muscle cells the role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis age-related defects in tlr2 signaling diminish the cytokine response by alveolar macrophages during murine pneumococcal pneumonia aging impairs alveolar macrophage phagocytosis and increases influenza-induced mortality in mice aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines blocking elevated p38 mapk restores efferocytosis and inflammatory resolution in the elderly origin of matrix-producing cells that contribute to aortic fibrosis in hypertension vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis aging, oxidative responses, and proliferative capacity in cultured mouse aortic smooth muscle cells disruption of nrf2 signaling impairs angiogenic capacity of endothelial cells: implications for microvascular aging vascular oxidative stress in aging: a homeostatic failure due to dysregulation of nrf2-mediated antioxidant response restoring mitochondrial dna copy number preserves mitochondrial function and delays vascular aging in mice mitochondrial integrity and function in atherogenesis mitochondrial dna damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans nox4 nadph oxidase-dependent mitochondrial oxidative stress in aging-associated cardiovascular disease attenuated superoxide dismutase 2 activity induces atherosclerotic plaque instability during aging in hyperlipidemic mice antioxidants in cardiovascular therapy: panacea or false hope? front role of antioxidants in atherosclerosis: epidemiological and clinical update mitochondrial quality control and age-associated arterial stiffening induction of atherosclerosis in mice and hamsters without germline genetic engineering the autophagy enhancer spermidine reverses arterial aging mitochondria in innate immune responses mtdna activates cgas signaling and suppresses the yap-mediated endothelial cell proliferation program to promote inflammatory injury inhibition of x-box binding protein 1 reduces tunicamycininduced apoptosis in aged murine macrophages pan-viral specificity of ifninduced genes reveals new roles for cgas in innate immunity f2l, a peptide derived from hemebinding protein, chemoattracts mouse neutrophils by specifically activating fpr2, the low-affinity n-formylpeptide receptor mitochondrial n-formyl peptides induce cardiovascular collapse and sepsislike syndrome mitochondrial cardiolipin is required for nlrp3 inflammasome activation understanding how we age: insights into inflammaging age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction inflammation, aging, and adiposity: implications for physical therapists immunologic changes in frail older adults the role of il-6 in host defence against infections: immunobiology and clinical implications interleukin-6 exacerbates early atherosclerosis in mice transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice tocilizumab: a review in rheumatoid arthritis targeting interleukin-6 signaling in clinic risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study senolytics improve physical function and increase lifespan in old age chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice metformin as antiaging therapy: is it for everyone? rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice spermidine reduces lipid accumulation and necrotic core formation in atherosclerotic plaques via induction of autophagy acknowledgements d.j.t. is supported by nih award f32-hl1400728, and d.r.g. is supported by nih awards r01-hl127687, r01-ai138347 and k07-ag050096. both authors researched data for the article, discussed its content, wrote the manuscript, and reviewed and edited it before submission. the authors declare no competing interests. nature reviews cardiology thanks c. leeuwenburgh, h. oliveira, a. tedgui and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. key: cord-004774-fvf671jn authors: kjeldsberg, elisabeth; hem, annelise title: detection of astroviruses in gut contents of nude and normal mice date: 1985 journal: arch virol doi: 10.1007/bf01310560 sha: doc_id: 4774 cord_uid: fvf671jn gut contents of nude and normal mice were examined by electron microscopy in association with an outbreak of diarrhea in a colony of nude mice. virus-like particles with a morphology consistent with previous descriptions of astroviruses of other species were demonstrated in a high percentage of the animals. gut contents of nude and normal mice were examined by electron microscopy in association with an outbreak of diarrhea in a colony of nude mice. virus-like particles with a morphology consistent with previous descriptions of astroviruses of other species were demonstrated in a high percentage of the animals. various viruses have been detected in recent years by electron microscopy (em) of stools and contents of the intestinal tract from both man and animals (15) . the relationship of some of these viruses to gastroenteritis has been established or postulated. different viruses are causative agents of diarrhea in mice. the epizootic diarrhea of infant mice (edi~[) virus was demonstrated in 1947 by cheeve~ and muell~ (3) . the morphology of this virus was described in 1972 by muck and zajac (12) and it was later classified as a rotavirus. lethal intestinal virus of infant mice (livim) was first described by k~aft in 1962 (8) . this virus could be distinguished from edim by its pathology and clinical signs, and by serological tests (9) and it was later shown to belong to the coronavirus group (1, 2). recently another coronavirus was isolated from an infant mouse in association with diarrhea and designated as diarrhea virus of infant mice (dvim) (14) . astroviruses were first detected in human faeces in association wit, h gastroenteritis (10) , and morphologically indistinguishable particles have been reported in diarrheal faeces of lambs (13) , calves (16) , birds (11) and cats (6) . astrovirus has not been demonstrated in mice so far. in this note we report the detection of astrovirus-like partieles in gut contents from nude mice, with and without clinical signs of illness, and from normal symptomless mice in association with an outbreak of diarrhea. gut contents of mice from different sources and of different strains and stocks were examined: 1. han:nmri nu/nu bred in isolators in the animal unit. 2. balb/e/nu/nu bom. 3. nih:bg/nu/nu bred in isolators in the animal unit. 4. nih:nihs/nu/nu bred in isolators in the animal unit. 5. bom:nml~i (normal controls). all the animals were caesarean derived and barrier maintained and of specified pathogen free quality when delivered from the breeder. the nude and thymus deficient mice were kept in a barrier unit. they were given irradiated altromin 1410 pelleted diet ad libitum. the water was acidified to ph 2.5 with hydrochloric acid. autoclaved woodshavings (hahnflock 3) were used as bedding. the diarrhea episode started during a heat wave in the summer when the temperature in the anim m room varied between 22--32 ° c and the relative humidity between 25--70 per cent. the duration of the disease in the individual animal was generally protracted. when it was obvious that 'the animal was ill with diarrhea or wasting it was killed. the mice with normal haircoat were kept in a conventional animal room for 2--3 days after arrival from the breeder before they were submitted to examination. only animals received from the same breeder were kept in this room. the age of the animals varied between 4 weeks and 9 months. both sexes were represented about evenly in nude and normal animals. the gut contents of the mice were scraped off and suspended to 10 per cent v/v in phosphate buffered saline (pbs) ph 7. the suspension was shaken with a vortex mixer for one minute to disperse the material, left on the bench for 30 minutes at room temperature and shaken by hand from time to time. the extract was centrifuged at 640 g for five minutes and the supernatant was kept at --20 ° c until required for use. in a few experiments gut contents were suspended to 20 per cent v/v in pbs containing 1 per cent w/v triton x-100 (pbs/tx-100) and disrupted with ten strokes of a glass homogenizer. the mixture was cleared at i040 × g for 10 minutes, the pellet washed with a small volume of pbs/tx-i00 and the supernatants pooled. for electron microscopy the extracts from gut contents were treated as earlier described (7). 2.5 ml extract was centrifuged for 30 minutes at 6000 r.p.m, and the supernatant reeentrifuged for 90 minutes at 20,000 r.p.m. in a sorvall rc2-b centrifuge ss-34 rotor. the deposit was suspended in a few drops of distilled water and treated in a branson 220 ultrasonic bath for 3 minutes to disperse the virus particles. negative staining was performed by mixing equal volumes of virus suspension and 2 per cent potassium phosphotungstate pit 7 and layering the mixture on a formvar carbon coated 400 mesh copper grid. after one minute excess fluid was removed with filtering paper, and the grid was air-dried. the specimen was examined in a jem 100b electron microscope at a magnification of 50,000 x using 80 kv accelerating voltage. the magnification had been calibrated with a diffraction grating specimen. a sample was considered negative if no virus particles were observed within 15 minutes examination. intestinal scrapings from 72 nude mice with and without clinical signs of illnes and from 10 normal symptomless mice were treated and examined symptomless or with symptoms other than diarrhea in the electron microscope as described above. particles resembling astrovirus were demonstrated in 50 of the nude mice. the particles were roughly spherical in outline and had a diameter of about 30 nm. the 5--6 pointed star configuration, characteristic of astroviruses, was seen on some of the particles, which mostly appeared in aggregates (fig. 1 a--c) . on some of the micrographs the virus particles showed a smooth outer edge (fig. 1 a) . often, however, fiber-like structures which seemed to form bridges between the virus particles were seen (fig. 1 b) . electron microscopy of pbs/tx-100 extracts of gut contents occasionally showed astrovirus particles penetrated with stain revealing an inner core structure 13--14 nm in diameter (fig. 1 c) . virus particles were demonstrated in both apparently healthy and diseased animals. the results of the examination of 72 nude and 10 normal mice are summarized in table 1 . seventeen of the nude mice examined suffered from diarrhea while 55 animals were killed for various reasons; i.e. abcesses, bite wounds, termination of experiments. astrovirus was demonstrated in 16 (94 per cent) of the animals with diarrhea and in 34 (62 per cent) from the control group. no attempt was made to quantify the amount of virus in the samples, but there appeared to be a higher number of virus particles in the samples from animals with diarrhea than from those without. small amounts of astrovirns-like particles were also demonstrated in 4 of l0 normal mice showing no sign of illness. the morphology of the virus-like particles detected in gut contents of nude and normal mice corresponds to the previous description of astroviruses. the occurrence of the virus in association with diarrhea is consistent with the demonstration of astrovirnses in humans and other animal species in association with gastroenteritis. the failure to demonstrate virus in one of the animals with diarrhea may be due to low sensitivity of the technique. as the majority of astrovirns particles are usually aggregated (5) a great deal is probably lost in the low speed centrifugation. demonstration of aggregates of virus-like structures in deposits after low speed centrifugation confirms this assumption. the presence of large aggregates of virus-like particles in the intestinal scraping suggests a multiplication of the astrovirus in epithelial cells of the intestinm tract, which would be in agreement with earlier findings in infected lambs (4). demonstration of astrovirus in a high percentage of nude and normal mice without diarrheal symptoms might suggest that the animals are symptomless carriers of the virus and that the pathogenicity in the nude mice is enhanced by break-down of the climatic control or heavy experimental stress. this hypothesis needs further support. studies on the pathogenicity and characteristics of the mouse astrovirus and the relationship of the virus to diarrhea in these animals are in progress. lethal enteritis in infant mice caused by mouse hepatitis virus lethal intestinal virus of infant mice is mouse hepatitis virus epidemic diarrheal disease of suckling mice. i. manifestations, epidemiology and attempts to transmit the disease ultrastructure of the small intestine in astrovirusdnfeeted lambs purification and characterization of ovine astrovirus detection of astroviruses in feces of a eat with diarrhea comparison of solid-phase (immune electron microscopy, direct electron microscopy and enzyme-linked immunosorbent assay for detection of rotavirus in faecal samples an apparently new lethal virus disease of infant, mice epizootic diarrhea of infant mice and lethal intestinal virus infection of infant mice viruses in infantile gastroenteritis detection of astroviruses in turkey faeces by direct electron microcopy purification and characterization of epizootic diarrhea of infant mice virus detection and transmission of 30 nm virus particles (astroviruses) in faeces of lambs with diarrhea morphnogicat and biological properties of a new eoronavirus associated with diarrhea in infant miee virus infections of the gastrointestinal tract isolation of small viruses resembling astroviruses and caliciviruses from acute enteritis of calves authors' address : dr. elisabeth kjeldsberg, national institute of public health key: cord-352480-1ay8y7li authors: wang, ting; yin, huiquan; li, yan; zhao, lingxiao; sun, xiahui; cong, hua title: vaccination with recombinant adenovirus expressing multi-stage antigens of toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes date: 2017-04-03 journal: parasite doi: 10.1051/parasite/2017013 sha: doc_id: 352480 cord_uid: 1ay8y7li toxoplasmosis caused by toxoplasma gondii, an obligate intracellular protozoan, is a cause of congenital disease and abortion in humans and animals. various vaccination strategies against toxoplasmosis in rodent models have been used in the past few decades; however, effective vaccines remain a challenge. a recombinant adenovirus vaccine expressing ubiquitin-conjugated multi-stage antigen segments (ad-umas) derived from different life-cycle stages of t. gondii was constructed previously. here, we compared the immune responses and protection effects in vaccination of mice with ad-umas by five vaccination routes including intramuscular (i.m.), intravenous (i.v.), subcutaneous (s.c.), intraoral (i.o.), and intranasal (i.n.). much higher levels of t. gondii-specific igg and iga antibodies were detected in the sera of the intraoral and intranasal vaccination groups on day 49 compared with controls (p < 0.05). the percentages of cd8(+) t-cells in mice immunized intranasally and intraorally were larger than in mice immunized intramuscularly (p < 0.05). the highest level of il-2 and ifn-γ was detected in the group with nasal immunization, and splenocyte proliferation activity was significantly enhanced in mice immunized via the oral and nasal routes. furthermore, the higher survival rate (50%) and lower cyst numbers observed in the intraoral and intranasal groups all indicate that ad-umas is far more effective in protecting mice against t. gondii infection via the mucosal route. ad-umas could be an effective and safe mucosal candidate vaccine to protect animals and humans against t. gondii infection. toxoplasma gondii is a single-cell obligate intracellular protozoan with an infection rate of approximately 25%-30% in the worldwide population [6, 13, 29] . in pregnant women, this parasite may threaten health or even be fatal concerning congenitally infected fetuses [30] . it is also a major opportunistic infection in immunodeficient individuals, causing toxoplasmic encephalitis and retinochoroiditis [7, 17, 33] . as a result, an effective vaccine against t. gondii is urgently needed to prevent this disease. various vaccination strategies against toxoplasmosis in rodent models have been used in the last few decades. however, effective vaccines remain a challenge as tested vaccines have not been able to confer sterile immunity against infection [19] . current research on t. gondii vaccines only focuses on antigens expressed in the tachyzoite stage, which only induce partial protective immunity [20, 28, 38, 44] . the development of a variety of epitope combinations from different stages of the life cycle, including tachyzoites, bradyzoites (in tissue cysts), and sporozoites (in oocysts), are likely to induce full protection [2, 3, 4, 43] . with the development of bioinformatics, epitope vaccines are considered a novel immunization approach to prevent t. gondii infection. in addition, an appropriate delivery system of vaccines could increase the transfection efficiency of immune cells. adenovirus, which can penetrate host cells delivering vaccine antigen to antigen-presenting cells (apcs) and elicit vigorous and sustained t-cell responses, is a promising t. gondii vaccine vector and can be used effectively to transport immunogens [27] . recent studies have also found that recombinant canine adenovirus type-2 expressing tgrop16 and tgrop18 provides partial protection against acute t. gondii infection in mice, and indicate that adenovirus vectors may be potentially useful in the development of an effective vaccine against t. gondii infection [21, 22] . the mucosal immune system consisting of specialized epithelial cells can trigger both humoral and cell immune responses when antigens are administered with appropriate adjuvants or attenuated live vaccines via mucosal routes (oral, nasal, sublingual, ocular, genital, or rectal) [18, 23] . furthermore, local mucosal immunization can lead to antigen-specific t-and b-cell responses not only in mucosal sites but also systemically [5, 24] . hence, there is a greater need for effective vaccines that exert protective effects at mucosal surfaces, especially for intracellular parasites such as t. gondii. in this research, we utilize a recombinant adenovirus vaccine expressing ubiquitin-conjugated multi-stage antigen segments (ad-umas) derived from different life-cycle stages of t. gondii to evaluate the immune responses obtained with the different intramuscular vaccination routes described in our earlier study [41] . to further explore the optimal immune pathway for this recombinant adenovirus t. gondii vaccine, we plan to determine the immune responses and protection efficacy by vaccinating balb/c mice via five routes (intramuscular (i.m.), intravenous (i.v.), subcutaneous (s.c.), intraoral (i.o.), and intranasal (i.n.)). all the experimental procedures with animals used in the present study were granted prior approval by the institutional animal care and use committee of shandong university under contract ll201602044. humane endpoints are chosen to terminate the pain or distress of the experimental animals via euthanasia. mice were monitored daily over 11 weeks for signs of toxoplasmosis including food and water intake difficulties, fatigue, severe ascites, and any test animals that showed signs of illness were euthanized immediately with co 2 gas. tissue cysts of the low-virulence prugniaud (pru) strain (type ii) and tachyzoites of the high-virulence rh strain (type i) of t. gondii, which were a kindly provided by professor xingquan zhu at lanzhou veterinary research institute, were propagated and harvested as described in our previous studies [41] , and then used for the in vivo challenge of mice. ad-umas vaccine was constructed as previously described [40] . briefly, ad-umas was constructed using the admax system (hanbio, shanghai, china). the ubiquitinconjugated multi-stage antigen segments (umas) were cloned into a shuttle plasmid, phbad-mcmv-gfp. ad-umas was generated by homologous recombination of phbad-mcmv-gfp-umas with phbad-bhg in hek-293 cells. ad-umas particles, with a titer of 10 11 plaque-forming units (pfu)/ml, were purified by cesium chloride gradient centrifugation and then stored in storage buffer (10 mm tris, 2 mm mgcl 2 , and 5% sucrose, ph 8.0) at à80°c. specific-pathogen-free female balb/c mice aged 6-8 weeks were purchased from shandong university laboratory animal centre (jinan, china). the animals for vaccination included intramuscular, intravenous, subcutaneous, intraoral, and intranasal immunization groups (15 mice per group). for the intramuscular group, the mice were injected 100 ll (3 · 10 8 pfu) ad-umas in the quadriceps muscle. for the intravenous group, the mice were injected 50 ll (3 · 10 8 pfu) ad-umas in the caudal vein. the subcutaneous and oral groups were administered 200 ll (3 · 10 8 pfu) ad-umas by subcutaneous injection and intragastric administration. for intranasal vaccinations, mice were anesthetized with 3% isoflurane in oxygen and were given a nasal drip of 10 ll (3 · 10 8 pfu) ad-umas with the head canted 45°for 10 min. each group also had 15 mice that were treated with phosphate-buffered saline (pbs) as the control. mice were vaccinated twice at 3-week intervals. table 1 summarizes the treatments given to the mice. figure 1 shows the study flowchart for vaccinated mice. serum samples were collected by retro-orbital bleeding on days 0, 14, 35, and 49. standard elisas were used to determine the levels of t. gondii-specific antibodies, igg, igg1, igg2a, and iga, in the serum samples from the inoculated mice. this was done with some changes to the method previously described [3, 5] . briefly, a flat-bottom 96-well plate was pre-coated with the umas peptide pool at a concentration of 10 lg/ml in a 50 mm carbonate-bicarbonate buffer (ph 9.6) overnight at 4°c. the mouse sera were diluted in pbs (1:100) and incubated at 37°c for 1 h. after washing the plates, bound antibodies were then reacted with horseradish peroxidase (hrp)-conjugated goat anti-mouse igg, igg1, igg2a, or iga (sigma-aldrich, usa) at 37°c for 1 h. peroxidase activity was revealed by 3, 3 0 , 5, 5 0 -tetramethylbenzidine (tmb, 10 mg/ml) and stopped by adding 50 ll of 2 m h 2 so 4 . the optical density (od) at 450 nm was measured by a thermo scientific multiskan fc microplate photometer (thermo scientific, usa). spleens were removed from three immunized mice per group four weeks after the last immunization. single-cell splenocytes were harvested following the method described in a previous study [5, 42] . isolated splenocytes were plated in 96-well plates, at a density of 1 · 10 6 per well, in 100 ll rpmi-1640 medium (sigma-aldrich, usa) supplemented with 10% fetal calf serum and cultured with concanavalin a (cona, 2 lg/ml, sigma-aldrich) or the umas peptide pool (10 lg/ml). cell proliferative activity was measured according to the manufacturer's instructions on a dojindo cell counting kit-8 (dojindo, japan). the results were expressed as absorbance at 450 nm. the level of cytokine production was determined using splenocytes from three mice per group 4 weeks after the last immunization. commercial elisa kits (r&d systems, usa) were used following the manufacturer's instructions to assay il-2 at 24 h, il-10 at 72 h, and ifn-c at 96 h in culture supernatants obtained as previously described [40] . this was done by collecting the cell supernatant of three wells from the 96-well plates and centrifuging to discard cell debris. the supernatant was tested for cytokines. the detection was replicated three times for each spleen. cells were stained with fluorescein isothiocyanate (fitc)labeled anti-mouse cd8 + monoclonal antibody and phycoerythrin (pe)-labeled anti-mouse cd4 + monoclonal antibody; tlymphocyte subsets were measured by a beckman coulter fc500 flow cytometer (beckman coulter, usa). four weeks after the last immunization, mice were challenged with the type 1 or type 2 parasites to evaluate the protective effect. six mice per group were infected intraperitoneally with 1 · 10 3 tachyzoites of t. gondii rh strain (type 1 parasite) after the last immunization, and the survival time of the mice was observed and recorded. another six immunized mice per group were infected via the gastric route with 20 cysts of the t. gondii pru (type 2 parasite) strain. the challenged mice were sacrificed 4 weeks later and the brains were removed and homogenized in 1 ml pbs. the mean number of cysts per brain was determined by counting three samples of 10 ll aliquots from each homogenized brain under an optical microscope [20] . statistical significances between the groups were calculated by one-way analysis of variance (anova) using spss 19.0 software. the survival rate was compared by the kaplan-meier method. a p-value of less than 0.05 (p < 0.05) was considered to be significant. to assess the systemic humoral immune responses obtained with the five immunization routes of ad-umas, we collected sera at different times after the immunization, and anti-t. gondii igg and igg subtypes were detected by elisa. as shown in figure 2a , the levels of antibody titers all increased in the five ad-umas immunization routes. compared to the control, levels of t. gondii-specific igg antibodies increased dramatically in the sera of all vaccination mice from day 14 to day 35 and achieved the highest on day 49 (p < 0.05). among different immunization routes, the intramuscular group achieved the highest titer of igg antibodies, then the subcutaneous, nasal, and oral groups, in decreasing order (fig. 2b) . in the intravenous vaccination group, the titer of igg increased rapidly at 2 weeks and gradually more slowly thereafter, making the final titer relatively low. further evaluation of serum igg subtype antibody revealed that t. gondii-specific igg1 and igg2a antibody levels were both significantly increased in five ad-umas vaccination groups as compared with the control (p < 0.05), while their differences were substantial in igg2a but not in igg1. the values of igg2a antibody were relatively higher in the intramuscular and subcutaneous vaccination groups than with other vaccination routes (figs. 2c and 2d ). to evaluate the ability of ad-umas to induce local mucosal immune responses via the five pathways, mucosal iga antibody response was detected in the collected mouse sera. as shown in figure 2e , vaccination in the intraoral and intranasal groups elicited strong t. gondii-specific iga antibody levels that were significantly higher than other vaccination routes (p < 0.05) (fig. 2e) . however, there were no statistically significant differences of iga titer in the intramuscular, intravenous, and subcutaneous vaccination groups compared to control groups (p > 0.05). cellular immune responses were first evaluated by analysis of the t-cell subset. the cd4 + and cd8 + t lymphocyte subsets in immunized mice were assayed by flow cytometry. table 2 shows the percentage of cd4 + and cd8 + t-cells, in comparison with control groups; the percentage of cd8 + t-cells in all vaccination groups with ad-umas increased significantly (p < 0.05). the percentages of cd8 + t-cells in mice immunized intranasally (36.5 ± 1.8%), intraorally (29.7 ± 0.2%), and intramuscularly (27.6 ± 1.3%) were higher than in mice immunized by the subcutaneous and intranasal routes (p < 0.05). the cell-mediated immunity induced in the immunized mice was further evaluated by measuring the amount of cytokines il-2, il-10, and ifn-c. table 3 shows the values of il-2, ifn-c, and il-10 in all vaccination groups. the highest levels of il-2 and ifn-c were detected in the nasal immunization group at 638.7 ± 17.6 pg/ml and 1429.8 ± 37.6 pg/ml, respectively. furthermore, the lymphocyte proliferation ability was also higher in the mice inoculated nasally with ad-umas than the controls (p < 0.05). however, there were no statistically significant differences in the amount of il-10 between all the immunization group and control groups (p > 0.05) ( table 3) . to evaluate the protective immunity, six mice of each group were given an intraperitoneal injection of 1 · 10 3 tachyzoites of t. gondii rh strain at 4 weeks after vaccination. the survival rates of mice immunized via different routes are shown in figure 3 . the mice immunized with ad-umas via i.m., i.o., and i.n. showed an almost 50% survival rate and lower survival rates of 40% were found in the i.v. and s.c. immunization groups 28 days after challenge. all the control mice died within 8 days. the level of protective effect against chronic infection was evaluated by counting cysts in the brains of mice challenged with 20 cysts of the pru strain of t. gondii (fig. 3 ). an obvious reduction in the burden of brain cyst was detected in all the immunized mice compared with the control mice (p < 0.05). the brain cyst numbers in the oral and nasal immunization groups were significantly reduced to 459 ± 34 and 398 ± 61, respectively, which is much lower than the other immunization groups with injection in muscle (569 ± 23), via the venous route (892 ± 51), and via the subcutaneous route (675 ± 65) (p < 0.05). the antigen delivery pathway is a key parameter for the induction of protective immune responses by vaccines against intracellular pathogens [10] . as a novel inoculation, the splenocyte culture supernatants taken from mice (n = 3, each group) 2 weeks after the last immunization were stained with fitclabeled anti-mouse cd8 + monoclonal antibody and pe-labeled anti-mouse cd4 + monoclonal antibody; t lymphocyte subsets were measured using flow cytometry. asterisks mark the significant difference: * p < 0.05; ** p < 0.01. each bar represents the mean od (± sd). there is general agreement that effective mucosal vaccines (oral, nasal, sublingual, and genital tract vaccines) could dramatically stimulate protective immune responses not only against mucosal infections but also against hiv, mycobacterium tuberculosis, and many other pathogens [8, 37] . in this study, we compared the capability of ad-umas to induce systemic humoral and cellular immune responses, and local mucosal immune responses via five vaccination pathways (i.m., i.v., s.c., i.o., and i.n.). mucosal vaccines are advantageous compared with systemic vaccines from a production and regulatory perspective [18, 23] . previous studies have revealed that a middle east respiratory syndrome (mers) vaccine greatly enhances local mucosal immune responses in immunized balb/c mice with the intranasal inoculation method [24] . ideal attenuated vaccines could be engineered to have a limited capacity for replication and to deliver an effective antigen, while avoiding unwanted inflammatory responses [35, 39, 41] . recombinant adenoviruses are some of the most intensively investigated vaccine carriers in many pathogenic infections, such as ebola virus, hiv, and the malaria parasite [1, 11, 16, 32] . several clinical trials have shown that vaccines based on adenoviruses could elicit vigorous and sustained t-cell responses, with the advantage of safety and high immunogenicity [25] . our results showed that the ad-umas vaccine could effectively improve the humoral response intramuscular pathway. systemic humoral igg antibody responses induced by the intraoral and intranasal vaccination pathway were comparable to those induced by the other pathway in the collected mouse sera. interestingly, we found that igg antibody in the intravenous vaccination group increased very sharply at first but slowly later on, even after the boost immunization. it should be considered that antigens that are transmitted to the bloodstream directly can induce strong immune responses in the early stage, but can also cause immune tolerance, explaining why antibody levels increase slowly in the following time [25] . moreover, evaluation of serum igg subtype antibody responses revealed that all vaccination pathways induced a relatively higher level of th1-associated igg2a than th2associated igg1 in this study. it should be noted that ad-umas induced a slightly biased th1-associated antibody (a) (b) figure 3 . evaluation of the protective ability against t. gondii infection. (a) six immunized mice per group were infected intraperitoneally with 1 · 10 3 tachyzoites of t. gondii rh strain 4 weeks after the last immunization. survival was monitored daily for 28 days after challenge. (b) another six immunized mice per group were infected intragastrically with 20 cysts of t. gondii pru strain and the cyst burden in the brain of vaccinated mice was counted 4 weeks later. the mean number of cysts in every mouse group was based on each mouse brain cyst in the group. asterisks mark the significant difference: *p < 0.05; **p < 0.05. each bar represents the mean od (± sd). response. it is known that production of igg subtype is driven by cytokines secreted during cellular immune responses. therefore, the presence of igg1 and igg2a indirectly suggests that the vaccination protocol also promoted activation of a cellmediated response [12, 31] . these data suggest that ad-umas immunization by the mucosal vaccination route was capable of eliciting similar systemic humoral antibody responses compared with those elicited by the intramuscular pathway in vaccinated mice. mucosal vaccines against toxoplasma infection require the induction of protective responses at mucosal surfaces and also the induction of systemic protective immune responses in the systemic compartment [18] . as the first line of defense in protecting mucous membranes, specific siga plays a protective role against many pathogens. therefore, vaccines capable of inducing strong local mucosal immunity represented by secretory iga would be helpful in preventing t. gondii infection [9] . our data indicated that t. gondii-specific iga antibody responses in vaccinated mouse sera were elicited by i.n. and i.o vaccination of ad-umas, which were significantly higher than those induced by other vaccination routes, confirming the ability of ad-umas to induce strong mucosal immunity via the mucosal route. the memory t-cell consists of cd4 + and cd8 + t-cells, which play a vital role in the establishment of protective immunity in hosts [31] . cd8 + t-cells can control the spreading and development of t. gondii infection in synergy with cd4 + t-cells [12] . in our study, cd4 + and cd8 + t lymphocyte subsets from immunized mice were assayed by flow cytometry. there was a marked increase in the percentage of cd8 + t-cells in mice immunized with the ad-umas vaccine via mucosal routes. cytokines play a critical role in the activities of th cells. as we know, th1 cells are responsible for limiting tissue extension of the parasite through the production of il-2 and ifn-c [15] . our results show that in contrast with the blank control, high levels of il-2 and ifn-c were induced in mice immunization with ad-umas especially treated intraorally and intranasally. however, there is no difference in il-10 production between vaccinated and control groups. additionally, splenocyte proliferation activity was significantly enhanced in mice immunized via oral and nasal routes. these results clearly suggest that mucosal vaccination with ad-umas can significantly augment th1-mediated cellular immune responses in which cd8 + t lymphocytes are considered as major effectors responsible for controlling parasite infection and secreting ifn-c during the cellular response against toxoplasmosis. in our study, a highly virulent rh strain and a mild virulent pru strain of t. gondii were used for the challenge study. with the rh strain, it is easy to induce acute infection in mice through intraperitoneal injection with tachyzoites. the pru strain is more likely to induce chronic infection in mice following intragastric administration with cysts [36] . in order to simulate acute and chronic infection in the host, mice were infected with the rh strain and pru strain by different challenge routes. when challenged with lethal doses of t. gondii (1 · 10 3 ), all five groups immunized with ad-umas had a prolonged survival time as compared with control mice. in particular, mice immunized intranasally and intraorally showed higher survival rates than with the other immunization routes. since protection via vaccination was not 100% because the strain of the parasite has high mortality and the dose of rh parasites for immunized mice was larger, the optimal challenge dose should be determined in the future. furthermore, the higher mucosal immune responses that were induced by intraoral and intranasal vaccination of ad-umas may explain the significant reduction in the cyst burden in the mice immunized with ad-umas intraorally and intranasally, which exhibited reductions of 75.3% and 78.6% of brain cysts, respectively. earlier studies [14, 26, 34] have determined mortality, cytokine production, and parasite burden after challenge infection in susceptible and resistant strains of mice with the same or similar doses of t. gondii parasites. these studies found that different inbred strains of mice have markedly different susceptibility to t. gondii infection. these susceptibility differences may be due to differences in the virulence of the parasite itself or differences in the genetic make-up of the mice in terms of their immune response. in our study, only one inbred strain of mice was used for the experiment. it is therefore necessary to assess the different immunizations in different strains of mice in future research. in summary, mucosal immunization with recombinant adenovirus vaccine expressing ubiquitin-conjugated multistage antigen segments (ad-umas) is a potential vaccination route to elicit protective immune responses. compared to other immunization routes, oral and nasal immunizations with ad-umas elicit both robust systemic and mucosal immune responses, accompanied by a significant increase in survival rates after challenge with highly virulent parasites and a dramatic reduction in brain cyst burdens in vaccinated mice after challenge with mild strains of t. gondii. therefore, the results of this study should contribute to the development of an effective and safe mucosal vaccine for preventing t. gondii infection. the authors declare that they have no competing interests. a single dose respiratory recombinant adenovirus-based vaccine provides long-term protection for non-human primates from lethal ebola infection toxoplasma gondii hla-b*0702-restricted gra7 human immunome, bioinformatic analyses using hla supermotifs and the parasite genome, binding assays, studies of human t cell responses, and immunization of hla-a*1101 transgenic mice including novel adjuvants provide a foundation for hla-a03 restricted cd8 + t cell epitope based, adjuvanted vaccine protective against toxoplasma gondii towards an immunosense vaccine to prevent toxoplasmosis: protective toxoplasma gondii epitopes restricted by hla-a*0201 comparative efficacy of a multi-epitope dna vaccine via intranasal, peroral, and intramuscular delivery against lethal toxoplasma gondii infection in mice isoenzyme analysis of 35 toxoplasma gondii isolates and the biological and epidemiological implications prevention of toxoplasmosis in transplant patients efficiency of dendritic cell vaccination against b16 melanoma depends on the immunization route prime-boost strategies in mucosal immunization affect local iga production and the type of th response dna vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations recombinant adenovirus type 5 hiv gag/pol/nef vaccine in south africa: unblinded, long-term follow-up of the phase 2b hvtn 503/phambili study immunogenetics of toxoplasma gondii informs vaccine design a brief history and overview of toxoplasma gondii genetic analysis of influences on survival following toxoplasma gondii infection functional characterization of in vivo effector cd4(+) and cd8(+) t cell responses in acute toxoplasmosis: an interplay of ifn-gamma and cytolytic t cells a replicating adenovirus capsid display recombinant elicits antibodies against plasmodium falciparum sporozoites in aotus nancymaae monkeys epidemiology, pathophysiology, and the future of ocular toxoplasmosis recent progress in mucosal immunology and vaccine development recent advances in toxoplasma gondii immunotherapeutics toxoplasma gondii: immune response and protective efficacy induced by rop16/gra7 multicomponent dna vaccine with a genetic adjuvant b7-2 recombinant canine adenovirus type-2 expressing tgrop16 provides partial protection against acute toxoplasma gondii infection in mice protective efficacy of recombinant canine adenovirus type-2 expressing tgrop18 (cav-2-rop18) against acute and chronic toxoplasma gondii infection in mice recent progress in mucosal vaccine development: potential and limitations intranasal vaccination with recombinant receptor-binding domain of mers-cov spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: implication for designing novel mucosal mers vaccines peripheral immune tolerance blocks clonal expansion but fails to prevent the differentiation of th1 cells immune responses associated with early survival after peroral infection with toxoplasma gondii myd88-dependent protective immunity elicited by adenovirus 5 expressing the surface antigen 1 from toxoplasma gondii is mediated by cd8 (+) t lymphocytes evaluation of protective immune responses induced by dna vaccines encoding toxoplasma gondii surface antigen 1 (sag1) and 14-3-3 protein in balb/c mice toxoplasmosis in pregnancy: prevention, screening, and treatment innate responses to toxoplasma gondii in mice and humans a recombinant adenovirus encoding multiple hiv-1 epitopes induces stronger cd4 t cell responses than a dna vaccine in mice toxoplasmic encephalitis in children inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in toxoplasma gondii-susceptible c57bl/6 mice but does not reactivate the latent disease in t. gondii-resistant balb/c mice recombinant adenoviral vector expressing hcv ns4 induces protective immune responses in a mouse model of vaccinia-hcv virus infection: a dose and route conundrum mechanisms of toxoplasma gondii persistence and latency effect of immunization route on mucosal and systemic immune response in atlantic salmon (salmo salar) development of toxoplasma gondii vaccine: a global challenge induction of mucosal immunity with a replication-defective adenoviral recombinant a toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to balb/c mice against parasite infection protective effect of a prime-boost strategy with plasmid dna followed by recombinant adenovirus expressing tgama1 as vaccines against toxoplasma gondii infection in mice dna vaccine encoding the toxoplasma gondii bradyzoitespecific surface antigens sag2cdx protect balb/c mice against type ii parasite infection advances in the study of hla-restricted epitope vaccines protective immune response against toxoplasma gondii elicited by a recombinant dna vaccine with a novel genetic adjuvant vaccination with recombinant adenovirus expressing multi-stage antigens of toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes reviews, articles and short notes may be submitted. fields include, but are not limited to: general, medical and veterinary parasitology including entomology, acarology, helminthology and protistology, and molecular analyses; molecular biology and biochemistry; immunology of parasitic diseases; host-parasite relationships; ecology and life history of parasites all papers in parasite are published in english. manuscripts should have a broad interest and must not have been published or submitted elsewhere. no limit is imposed on the length of manuscripts parasite (open-access) continues parasite (print and online editions, 1994-2012) and annales de parasitologie humaine et comparée (1923-1993) and is the official journal of the société franc¸aise de parasitologie. editor-in-chief acknowledgements. this study was supported by grants from the national natural science foundation project of china (grant no. 81171604) and the development project of shandong province (grant no. 2016gsf201201). key: cord-351011-v4zmksio authors: golden, joseph w.; cline, curtis r.; zeng, xiankun; garrison, aura r.; carey, brian d.; mucker, eric m.; white, lauren e.; shamblin, joshua d.; brocato, rebecca l.; liu, jun; babka, april m.; rauch, hypaitia b.; smith, jeffrey m.; hollidge, bradley s.; fitzpatrick, collin; badger, catherine v.; hooper, jay w. title: human angiotensin-converting enzyme 2 transgenic mice infected with sars-cov-2 develop severe and fatal respiratory disease date: 2020-07-09 journal: biorxiv doi: 10.1101/2020.07.09.195230 sha: doc_id: 351011 cord_uid: v4zmksio the emergence of sars-cov-2 has created an international health crisis. small animal models mirroring sars-cov-2 human disease are essential for medical countermeasure (mcm) development. mice are refractory to sars-cov-2 infection due to low affinity binding to the murine angiotensin-converting enzyme 2 (ace2) protein. here we evaluated the pathogenesis of sars-cov-2 in male and female mice expressing the human ace2 gene under the control of the keratin 18 promotor. in contrast to non-transgenic mice, intranasal exposure of k18-hace2 animals to two different doses of sars-cov-2 resulted in acute disease including weight loss, lung injury, brain infection and lethality. vasculitis was the most prominent finding in the lungs of infected mice. transcriptomic analysis from lungs of infected animals revealed increases in transcripts involved in lung injury and inflammatory cytokines. in the lower dose challenge groups, there was a survival advantage in the female mice with 60% surviving infection whereas all male mice succumbed to disease. male mice that succumbed to disease had higher levels of inflammatory transcripts compared to female mice. this is the first highly lethal murine infection model for sars-cov-2. the k18-hace2 murine model will be valuable for the study of sars-cov-2 pathogenesis and the assessment of mcms. sars-cov-2 is a betacoronavirus and the causative agent of covid-19, a febrile 55 respiratory human disease that emerged in late 2019 in china and subsequently spread throughout the world (1, 2). covid-19 is primarily a respiratory disease with a wide spectrum of severity ranging from a mild cough, to the development of hypoxia, and in some cases resulting in a lifethreatening acute respiratory distress syndrome (ards) requiring mechanical ventilation (3, 4). the most severe cases are generally skewed towards the aged population (>50) and those with 60 underlying health conditions such as hypertension or cardiovascular disorders (5, 6) . sars-cov-2 human infections can also cause vasculature damage and coagulopathies, leading to infarction (7-9). acute disease often presents with elevated levels of inflammatory cytokines, including il-6, and these host molecules may play a role in the pathogenic process (10, 11) . additionally, ~30% of cases include signs of neurological disease such as headache, anosmia (loss of smell), ataxia, 65 meningitis, seizures and impaired consciousness (12) (13) (14) . to-date, sars-cov-2 has infected over eight million people world-wide and resulted in the death of more than 400,000. there is an urgent need for medical countermeasures to prevent this disease or limit disease severity in a post exposure setting. similar to sars-cov (15) , sars-cov-2 binds to target cells via an interaction between the 70 139 kda viral spike protein and the host angiotensin-converting enzyme 2 (ace2) protein (16) (17) (18) (19) ). an important factor in host tropism of the virus is this receptor interaction and reduced affinity between these two molecules greatly impacts host susceptibility to infection. both sars-cov and possibly to a greater extent sars-cov-2 bind to murine ace2 (mace) poorly compared human ace2 (hace2) (20) . accordingly, mice are inherently refractory to infection by ace2 utilizing 75 golden jw, et al sars-cov-2 pathogenesis in k18-hace2 mice human coronaviruses (21) (22) (23) . in these animals, infection by sars-cov (22) and sars-cov-2 (23) is rapidly controlled, although older mice are more permissive to lung replication, but nevertheless lung injury is limited and mortality is generally low. indeed, even infection in mice lacking adaptive immunity due to rag deficiencies (no t-cells or b-cells) are protected against severe sars-cov disease, whereas mice genetically devoid of stat-1, an important molecule 80 involved in innate immunity, are sensitive to infection by sars-cov(24-26). however, disease in stat-1 mice is protracted and not highly representative of human infections (25, 26) . in response to the need for small animal models to study sars-cov, several laboratories 32) . k18 limits expression to airway epithelial cells, colon and to a lesser extent kidney, liver, spleen and small intestine. a minor level 90 of hace2 expression was also detected in the brain. these mice are susceptible to sars-cov strain urbani and develop severe respiratory disease subsequent to intranasal exposure characterized by lung inflammation, serum cytokine and chemokine production as well as high lethality (30). as with several mouse strains transgenic for hace2, sars-cov infects the brains of k18-hace2 mice (30, 32) . cns localization is speculated to play a major role in host mortality 95 due to neuronal cell death, particular cell loss in cardiorespiratory control center (32) . some of these previous hace2 transgenic mice are being used for sars-cov-2 research and newer golden jw, et al sars-cov-2 pathogenesis in k18-hace2 mice systems have been developed using crsipr-cas9 (23, 33, 34). however, none were shown to produce a consistent lethal disease and in models where lung injury occurred, it was most pronounced in aged animals (23, 34). here, we evaluated susceptibility of k18-hace2 mice to 100 sars-cov-2. we found that mice developed severe disease that included respiratory distress with weight loss and mortality, as well as brain infection. sars-cov-2 produces severe and fatal infection of k18-hace2 mice. two groups of 9-week old k18-hace2 mice (n=14 per group) were intranasally infected with 2x10 4 or 2x10 3 pfu of 105 sars-cov-2. these groups equally divided by sex (n=7 per group/sex). on day 3, two mice per group were euthanized to assess disease severity. the remaining 5 mice per group were monitored up to 28 days. we also infected c57bl/6, balb/c and rag2 deficient mice with a challenge dose of 2x10 4 pfu. on day 4, all groups of infected k18-hace2 mice began to lose weight, which was more pronounced in the female mice compared to the male mice in either challenge dose group 110 ( fig. 1a & fig. s1a ). non-transgenic mice did not lose any weight and no animal succumbed to disease. starting on day 5, several k18-hace2 animals began to show signs of respiratory disease, included labored breathing and conjunctivitis. on day 5 through day 7 the majority of mice (15/20 mice) began to meet euthanasia criteria (n=13) or died (n=2). an additional animal in the low dose male group succumbed to disease on day 11, after a period of weight loss. the highest mean weight 115 loss was in the female groups (>20%), although male mice lost >12% weight (fig s1a,b) . of the k18-hace2 mice in the high dose challenge groups, all females and 80% of the male mice succumbed to disease. most female mice survived in the low dose group with 40% mortality, but all male mice succumbed to disease. the difference in survival between low dose male and female golden jw, et al sars-cov-2 pathogenesis in k18-hace2 mice mice was significant (log-rank; p=0.040), as was mortality between the high and low dose female 120 groups (log-rank; p=0.037). there was no statistical significance in survival between the other groups. lung homogenates taken on day 3 showed high levels of virus in k18-hace2, in contrast to c57bl/6 or rag2-deficient mice which had low levels of virus (fig. 1b,c) . the virus rna levels were nearly identical between all the infected k18-hace2 groups and remained high in most of the euthanized mice, with the exception of the mouse that died on day 11. that animal had 125 markedly lower levels of detectable genomic rna (fig. 1c) . compared to non-transgenic mice and uninfected k18-hace2 mice, infected k18-hace2 mice had comparatively higher serum levels of tnf-α, il-6 and il-10 as well as the monocyte chemoattractants mcp-1 (ccl2) and mcp-3 (ccl7) (fig. 1d) . levels of cytokines observed in mice that succumbed to disease were generally higher compared to those sampled on day 3. overall, these findings indicated that 130 sars-cov-2 causes a severe disease in k18-hace2 mice following intranasal exposure. lungs of k18-hace2 mice exposed to sars-cov-2 show signs of acute disease. lungs were collected from k18-hace2 on day 3 or at the time of euthanasia due to disease severity. in k18-hace2, viral rna was detected by in situ hybridization (ish) in all mice on day 3 and in most 135 mice succumbing to disease on days 5-7, but these levels diminished as disease progressed (fig 2a, fig s2, table s1 ). additionally, ish labeling was patchy (fig. s2) and most severe at the day 3 time point. ish labeling was present in both inflamed and normal appearing alveolar septa. positive ish labeling for sars-cov-2 was identified multifocally in alveolar septa in the lung, suggesting infection of pneumocytes and macrophages. this was confirmed by the detection of 140 golden jw, et al sars-cov-2 pathogenesis in k18-hace2 mice sars-cov-2 protein in e-cadherin positive cells (pneumocytes) and cd68 positive (alveolar and infiltrating macrophages) using immunofluorescence assay (ifa, fig. 2b ,c). in comparison with the normal lung architecture in uninfected control animals, infected mice necropsied on day 3, and those succumbing to disease on days 5-11, had varying levels of lung injury including area of lung consolidation characterized by inflammation/expansion of 145 alveolar septa with fibrin, edema and mononuclear leukocytes and infiltration of vessel walls by numerous mononuclear leukocytes (fig 3a, fig s4, and table s1 ). type ii pneumocyte hyperplasia was identified in less than half of infected animals. this lesion had a relatively patchy distribution except in the most severely affected animals where it is more abundant. in areas of septal inflammation, exudation of fibrin and edema into alveolar lumina from damaged septal 150 capillaries was observed in most animals. vasculitis was the most common finding and was present in ~95% percent of all mice (fig. 3a,b) . the lesion encompassed small and intermediate caliber vessels, and was often characterized by near circumferential infiltration of the vessel wall by numerous mononuclear inflammatory cells. this lesion also contained small amounts of fibrin and occasional necrotic debris, affecting all tunics and obscuring the vessel wall architecture. however, 155 the endothelial cells surrounding lung vasculature were largely free of viral rna (fig. 3b) . in one low dose male mouse that died on day 11, evidence of numerous fibrin thrombi were identified in the small and intermediate vessels, suggestive of a hypercoagulable state within the lung. this same animal had marginally detectable virus in the lung (fig. 1c) , and fibrin thrombi were not identified in other organs including liver and kidney. infected k18-hace2 mice had elevated 160 numbers of tunel positive cells, suggesting increased cell death (fig. 3c) . we also detected increased expression of ki-67, a marker for cellular proliferation, likely expressed by proliferating golden jw, et al sars-cov-2 pathogenesis in k18-hace2 mice pneumocytes and potentially by replicating alveolar macrophages (fig. 3d) . neutrophilia was detected by h&e staining, consistent with an increase in myeloperoxidase (mpo)-positive cells (neutrophils, basophil and eosinophil) detected by ifa (fig. s3a) . however, the mpo positive 165 cells were devoid of viral antigen (fig. s3a) . there was also an increase in the presence of cd68 positive macrophages (fig. s3b) and a pronounced increase in cd45 and cd3 positive cells in infected lungs, indicative of infiltrating leukocytes including t-cells, which is consistent with histologic findings (fig. s3c) . these data indicate that k18-hace2 mice develop a pronounced lung injury upon exposure to sars-cov-2. transcriptional profiles of host immunological and inflammatory genes in lung homogenates from sars-cov-2 infected k18-hace2 and c57bl/6 mice were examined by nanostring-based gene barcoding on day 3 (k18-hace2 and c57bl/6) or in k18-hace2 mice at the time euthanasia. 478 transcripts were increased in k18-hace2 mice and 430 decreased at a log2 fold cutoff of 1 and a p value <0.05. many of the increased transcripts in the k18-hace2 175 mice were inflammatory genes including il-6, interferon gamma and chemokines (ccl2, ccl5, ccl9 and cxcl10) (fig. 4a) . the type i interferon transcripts ifna1 and ifnb1 along with the cytokines il-9 and il-2 were decreased. consistent with the increased presence of cd68 macrophages, cd68 transcripts were also significantly increased in k18-hace2 mice. viral sensing pathways were elevated in infected mice with severe disease, indicated by high transcript was observed in the nasal turbinates in the majority of mice and rarely within the eyes of infected mice (fig. 5a, fig. s5 and table s1 ). viral rna in the eye was localized to the retina, suggesting 195 viral infection of neurons in the inner nuclear layer and ganglion cell layer (fig. s5) . despite infection, evidence of inflammation or other damage in the retina or elsewhere in the eye was not present. viral rna and spike protein were also detected to some degree in the nasal turbinate epithelium (predominantly olfactory epithelium) as early as day 3 post-infection (fig. 5b) , as indicated by co-staining with cytokeratin ( fig 5c) . pathology was minimal, predominantly 200 isolated to few areas of olfactory epithelium atrophy, with degeneration or erosion present in the epithelium lining the dorsal and lateral nasal meatuses (fig. 5d) . some cellular sloughing was also detected and these sloughed cells contained viral rna (fig. s5) . in mice succumbing to disease on days 5-7, virus was present in the olfactory bulb and most animals showed asymmetrical staining, with one bulb more positive than the other. viral rna was detected throughout the 205 olfactory bulb, including in the olfactory nerve layer (onl), glomerular layer (gl), external golden jw, et al sars-cov-2 pathogenesis in k18-hace2 mice plexiform layer (epl), and mitral cell layer (mcl) of olfactory bulbs in most of animals. viral protein co-localized with the neuronal marker neun, suggesting virus was present within neurons in the olfactory bulb (fig. s6) . virus was not detected in the olfactory bulb of animals taken on day 3, suggesting that virus trafficked to this region on day 4 or 5. these data indicated that sars-210 cov-2 infects cells within the nasal turbinates, eyes and olfactory system and that infection was observed in epithelial cells and neurons. brain infection was not observed in the majority of animals examined on day 3, but was prevalent in mice necropsied on days 5-11 (table 215 s1 ). evidence of sars-cov-2 was found throughout the brain including strong but variably diffuse signal in regions of the thalamus, hypothalamus, amygdala, cerebral cortex, medulla, pons and midbrain (fig. 6a, table s1 ). similar intense but less diffuse signal was present within the hippocampus. ish positive cells included neurons of thalamic nuclei. in contrast, cells within the vessel walls and perivascular spaces infiltrated by mononuclear inflammatory cells were negative 220 for viral genomic rna (fig. 6a) . histopathological changes were detected in the brains of several infected k18-hace2 mice euthanized on day 5-11, but not in most mice taken on day 3 (fig. 6b , table s1 and fig. s7 ). in the thalamus/hypothalamus, vasculitis was the most common lesion characterized by endothelial hypertrophy and increases in mononuclear leukocytes within the vessel wall and/or filling the perivascular space. small amounts of necrotic debris were also 225 identified. in the majority of these cases, the vascular lesion was characterized by the presence of increased numbers of microglia within the adjacent neuropil. occlusive fibrin thrombi were also detected within the thalamus in a few mice. meningitis was observed in a subset of animals and golden jw, et al sars-cov-2 pathogenesis in k18-hace2 mice was associated with infiltration of mononuclear leukocytes (majority lymphocytes) and is most prominent adjacent to vessels. in the mouse that died late on day 11 with massive pulmonary 230 clotting, the rostral cerebral cortex brain lesions included small to intermediate size vessel walls multifocally expanded by mononuclear inflammatory cells and perivascular hemorrhage extending into the adjacent neuropil (fig. 6b) . increased numbers of microglia were readily detected on h&e stained sections, expanding outward from the perivascular neuropil. an increase in numbers of microglia were found in the neuropil surrounding affected vessels. additionally, brains also 235 showed signs of neuroinflammation indicated by increased staining of iba-1 and gfap indicating microgliosis and astrocytosis, respectively (fig. 6c) . necrosis was identified in at least five animals, and was most prominent within the periventricular region of the hypothalamus as well as in the amygdala. the lesion was characterized by moderate numbers of shrunken, angular cells with hypereosinophilic cytoplasm, pyknotic nuclei and surrounded by a clear halo (fig. s7) . the 240 morphology and location of individual cells was suggestive of neuronal necrosis, but further investigation will be required to confirm this finding. viral spike protein was detected in neun positive cells, indicating viral infection of neurons (fig. 6d) . viral antigen was absent in gfap positive cells suggesting virus does not productively infect astrocytes. these data indicate that similar to sars-cov, sars-cov-2 also targets the brain of k18-hace2 mice, causing brain 245 injury. as indicated by duplex ish labeling of brain, neurons are positive for both hace2 transgene expression and viral genomic rna (fig. s8) . no animal showed outward signs of neurological deficient, such as hind limb paralysis, head tilting or tremors. 250 golden jw, et al sars-cov-2 pathogenesis in k18-hace2 mice other murine infection models for sars-cov-2 involving transgene expression of the human ace2 protein have been reported (23, 33, 34) . however in these models, sars-cov-2 only produces a transient weight loss with some lung injury, but the animals generally recover. additionally, several of these models required mice aged >30 weeks for the most severe disease to occur, diminishing the practicality of these systems given the urgent need for medical 255 countermeasures (mcms) (23, 34). one system tested sars-cov-2 infection in mice in which hace2 was expressed under the control of the hfh4 promoter (33) . infection in these mice was only ~40% lethal (2/5 mice) and lung injury (assessed by plethysmography) and weight loss were absent. lethality in this system was exclusive to animals where virus was detected in the brain. other recently reported sars-cov-2 murine models involved transduction of mouse lungs with 260 a replication-incompetent adenovirus virus or an adeno associated virus (aav) encoding the hace2 gene (35, 36) . transduced lung cells expressing hace2 supported sars-cov-2 replication and lung pathology ensued along with weight loss. however, disease was generally mild with no lethality. blockade of the type i interferon system using pharmacological intervention was needed to produce the most severe disease 26 . murine systems faithfully producing the major 265 elements of severe disease observed in humans will be more useful for identifying the most promising mcms. the k18-hace2 mice lost considerable weight >12% in males and >20% in females and lethality in the high dose exceeded 90%. acute lung injury was detected in all animals succumbing to disease, with vascular damage the most common lesion. similar to findings with sars-cov, sars-cov-2 infected the brains of k18-hace2 mice. brain infection resulted in 270 vasculitis and inflammation, with sars-cov-2 antigen detected in neurons. it is possible virus enters the brain via the olfactory bulb, as has been reported for sars-cov, although more studies golden jw, et al sars-cov-2 pathogenesis in k18-hace2 mice will be required as virus may also have entered the brain via inflamed vessels. whether mortality results directly from brain infection is not clear, but this has been speculated as the major cause of mortality in sars-cov infected mice (32) . infection in the brain was delayed by at least four 275 days, as it was an uncommon finding in day 3 animals. thus, early during infection lung appears to be the primary target. we have not yet evaluated the protective efficacy of mcms in this model, but it has been reported that antibodies protect against sars-cov, demonstrating the k18-hace2 system is useful for evaluating countermeasures against ace2-targeting human coronaviruses. importantly, in our study some animals at the lower dose survived infection despite significant infection of k18-hace2 mice by sars-cov-2 produces a disease similar to that observed in acute human cases, with development of an acute lung injury associated with edema, production 285 of inflammatory cytokines and the accumulation of mononuclear cells in the lung. impacted lungs had elevated levels of transcripts consistent with respiratory damage such as increased expression of himf, which is involved in activation of lung endothelial cells in response to lung inflammation (37) . we also found increased levels of sgpl1, a molecule associated with lung injury (38) and known to be increased in mechanically ventilated mice (39) . a prominent finding in infected k18-290 hace2 mice system was vasculitis. endotheliitis/vasculitis has been observed in human covid-19 patients and a role for the endothelium in acute disease is becoming more apparent (7, 8, 40) . direct viral infection in human endothelial cells has also been reported (7). curiously in the mice, virus was absent in these areas suggesting vasculitis was due to host inflammatory processes, but golden jw, et al sars-cov-2 pathogenesis in k18-hace2 mice further study will be required to determine if vascular damage is incurred by direct or indirect viral 295 effects. it has been speculated that during human acute disease, inflammatory cytokines (il-6 in particular) are major drivers of tissue damage and this is supported by data from humans showing il-6 receptor targeting with pharmacological antagonists (tocilizumab) can reduce morbidity (41). we found il-6 transcripts, as well chemokines, are elevated in mouse lungs. during human disease, pulmonary inflammation is associated with increases in lung granulocytes and an increase 300 in macrophages (4, 42, 43) . some have speculated that these macrophages play an important role in host injury (44) . it is still unclear if human macrophages are directly infected by sars-cov-2, though we found virus antigen in cd68 macrophages and others report infection in murine mac2-positive macrophages (23). further study will be required to determine the role macrophages play in sars-cov-2 lung injury and given the regents available, murine systems 305 may be highly suited for these studies. in addition to vascular issues, coagulopathies are a common findings in humans (9), with pulmonary embolism having been reported, along with clotting abnormities leading to loss of limbs (45) . at least some mice produced evidence of these clotting issues, with one mouse presenting with fibrin thrombi in the lungs. during human infections, males have been reported to have more severe outcomes despite 310 a similar infection rate (46). in our experiments, we observed a statistically significant difference in survival of female and male mice infected at the lower dose of virus, with 60% of females but no males surviving infection. despite surviving, the female mice challenged with the low dose still lost a significant amount of weight (>20%). transcriptomic profiling in mouse lungs indicated that female mice that succumbed to disease had modestly lower levels of il-6, cxcl-2 and il-1ra 315 suggesting a less intense inflammatory response. our work only involved a small number of golden jw, et al sars-cov-2 pathogenesis in k18-hace2 mice animals, and more work will be required to determine if the k18-hace2 system recapitulates this sex difference in disease severity. the neuroinvasive aspects of covid-19 are becoming more appreciated (12) . indeed, sars-cov-2 causes neurological sequela in at least a third of human cases including headache, infection of these cells may help explain the loss of smell associated with some covid-19 cases. however, the virus may also gain access via disruption of the blood brain barrier, as these were inflamed in most animals and neurovasculitis has been found in humans (48). overall, the k18were then heated in kit-provided antigen retrieval buffer and digested by kit-provided proteinase. 405 sections were exposed to ish target probe pairs and incubated at 40°c in a hybridization oven for 2 h. after rinsing, ish signal was amplified using kit-provided pre-amplifier and amplifier conjugated to alkaline phosphatase and incubated with a fast red substrate solution for 10 min at room temperature. sections were then stained with hematoxylin, air-dried, and coverslipped. epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, china: a descriptive study a pneumonia outbreak associated with a new coronavirus of probable bat origin clinical course and outcomes of critically ill patients with sars-cov-2 pneumonia in wuhan, china: a single-centered, retrospective, observational study targeting potential drivers of covid-19: neutrophil extracellular traps covid-19 and crosstalk with the hallmarks of aging the hallmarks of covid-19 disease pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19 covid-19: the vasculature unleashed covid-19 and its implications for thrombosis and anticoagulation the pathogenesis and treatment of the `cytokine storm' in covid-19 the many faces of the anti-covid immune response neuromechanisms of sars-cov-2: a review early recovery following new onset anosmia during the covid-19 pandemic -an observational cohort study does sars-cov-2 invade the brain? translational lessons from animal models angiotensin-converting enzyme 2 is a functional receptor for the sars coronavirus structural basis of receptor recognition by sars-cov-2 sars-cov-2 cell entry depends on ace2 and tmprss2 and is blocked by a clinically proven 520 cryo-em structure of the 2019-ncov spike in the prefusion conformation structure of the sars-cov-2 spike 525 receptor-binding domain bound to the ace2 receptor receptor recognition by the novel coronavirus from wuhan: an analysis based on decade-long structural studies of sars coronavirus animal models for sars and mers coronaviruses prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice sars-like wiv1-cov poised for human emergence severe acute respiratory 560 syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ace2 a mouse-adapted sars-cov-2 model for the evaluation of covid-19 medical countermeasures a mouse model of sars-cov-2 infection and pathogenesis a sars-cov-2 infection model in mice demonstrates protection by neutralizing antibodies mouse model of sars-cov-2 reveals inflammatory role of type i interferon signaling hypoxiainduced mitogenic factor (himf/fizz1/relmalpha) increases lung inflammation and activates pulmonary microvascular endothelial cells via an il-4-dependent mechanism protection of lps-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression sphingolipids in ventilator induced lung injury: role of sphingosine-1-phosphate lyase endothelial cell infection and endotheliitis in covid-19 effective treatment of severe covid-19 patients with tocilizumab macrophages: a trojan horse in covid-19? the use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (covid-19): the 590 perspectives of clinical immunologists from china severe covid-19 and aging: are monocytes the key? geroscience acute pulmonary embolism associated with covid-19 pneumonia detected by pulmonary ct angiography gender differences in patients with covid-19: focus on severity and mortality 465 this project was funded by a grant awarded to j.w.g. and j.w.h. from the military infectious disease program. we thank the usamriid histology lab and comparative medicine division for their assistance. we also express gratitude to the jackson laboratory for providing early access to duplex in situ hybridization. duplex in situ hybridization was performed using the rnascope 2.5 hd duplex assay kit (advanced cell diagnostics) according to the manufacturer's instructions with minor modifications. in addition to sars-cov-2 genomic rna probe mentioned above (#854841, green), another probe with c2 channel (#848031-c2, red) specifically targeting human ace2 (nm_021804.3) was designed and synthesized by advanced cell diagnostics. ish signal was amplified using kit-provided pre-amplifiers and amplifiers conjugated to either alkaline phosphatase or horseradish peroxidase, and incubated sequentially with a fast red and green chromogenic substrate solution for 10 min at room temperature. sections were then stained with hematoxylin, air-dried, and coverslipped. key: cord-314333-hkyiy1gm authors: nagata, noriyo; iwata, naoko; hasegawa, hideki; fukushi, shuetsu; harashima, ayako; sato, yuko; saijo, masayuki; taguchi, fumihiro; morikawa, shigeru; sata, tetsutaro title: mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice date: 2008-06-30 journal: the american journal of pathology doi: 10.2353/ajpath.2008.071060 sha: doc_id: 314333 cord_uid: hkyiy1gm advanced age is a risk factor of severe acute respiratory syndrome (sars) in humans. to understand its pathogenesis, we developed an animal model using balb/c mice and the mouse-passaged frankfurt 1 isolate of sars coronavirus (sars-cov). we examined the immune responses to sars-cov in both young and adult mice. sars-cov induced severe respiratory illness in all adult, but not young, mice on day 2 after inoculation with a mortality rate of 30 to 50%. moribund adult mice showed severe pulmonary edema and diffuse alveolar damage accompanied by virus replication. adult murine lungs, which had significantly higher interleukin (il)-4 and lower il-10 and il-13 levels before infection than young murine lungs, rapidly produced high levels of proinflammatory chemokines and cytokines known to induce macrophage and neutrophil infiltration and activation (eg, tumor necrosis factor-α). on day 2 after inoculation, young murine lungs produced not only proinflammatory cytokines but also il-2, interferon-γ, il-10, and il-13. adult mice showed early and acute excessive proinflammatory responses (ie, cytokine storm) in the lungs after sars-cov infection, which led to severe pulmonary edema and diffuse alveolar damage. intravenous injection with anti-tumor necrosis factor-α antibody 3 hours after infection had no effect on sars-cov infection. however, intraperitoneal interferon-γ injection protected adult mice from the lethal respiratory illness. the experimental model described here may be useful for elucidating the pathophysiology of sars and for evaluating therapies to treat sars-cov infection. in the severe acute respiratory syndrome-associated coronavirus (sars-cov) epidemic of winter 2002 to 2003, ϳ800 people (10% of the ͼ8000 sars patients) suffered progressive respiratory failure and died. [1] [2] [3] [4] [5] common symptoms of sars include fever, nonproductive cough, myalgia, and dyspnea. an age of 60 years or older, co-morbid disease, male sex, high neutrophil counts, and several biochemical abnormalities are associated with poor outcomes. 6 -10 the sars-cov spike (s) protein mediates the infection of cells bearing an appropriate receptor. 11 one such receptor is angiotensin-converting enzyme 2 (ace2), which binds sars-cov s protein with high affinity. [11] [12] [13] [14] that the binding of sars-cov to ace2 may contribute to sars-cov-associated pathology is suggested by several reports showing that angiotensin ii expression promotes severe lung failure on acute lung injury whereas ace2 expression protects from lung injury. 15, 16 however, it is likely that the acute lung injury caused by sars-cov infection is also attributable to a complex pathophysiological process in which inflammatory cytokines released by activated alveoli macrophages induce immune system dysregulation. [17] [18] [19] [20] to understand the pathogenesis of sars-cov, the sars-cov susceptibility of experimental animals such as monkeys, cats, ferrets, mice, pigs, guinea pigs, ham-sters, chickens, and rats has been investigated. 2, 4, [21] [22] [23] [24] [25] [26] [27] [28] all of these animals are susceptible to sars-cov after intrarespiratory inoculation and exhibit virus excretion in pharyngeal or nasal swabs, histopathological pulmonary lesions, and seroconversion. however, the course of infection in these animals is shorter than that in humans. as in humans, an advanced age correlates positively and independently with adverse outcomes and is a predictor of mortality in animal models. 6 -10 moreover, sars-cov isolates replicate better in aged balb/c mice than in younger mice. 29 it is likely that the correlation between poor outcome and advanced age reflects the weakened immune responses of the elderly, in particular their impaired cytokine responses. this is significant because cytokines regulate the immune response to infection. indeed, analysis of the cytokine responses of elderly individuals to respiratory infections that lead to severe pulmonary diseases (eg, listeria monocytogenes, respiratory syncytial virus, influenza virus) 30 -33 have revealed unbalanced th1-type and th2-type responses. we recently succeeded in establishing a rat model of sars using rat-passaged sars-cov. 34 although the ratpassaged sars-cov was not lethal, it induced more severe pathological lesions in adult f344 rats than in young rats. we found that the severe inflammation in the adult rats was associated with high levels of inflammatory cytokines in the serum and lung homogenates, especially interleukin (il)-6, along with low levels of the immunosuppressive cytokine il-10. il-6 is an inflammatory cytokine that is produced by monocytes, leukocytes, endothelial cells, fibroblasts, and alveolar epithelial cells. sars patients have significantly elevated serum il-6 levels. 19 il-10 is produced by macrophages, th2 lymphocytes, and b cells and inhibits tumor necrosis factor (tnf)-␣ production and neutrophil activation in lipopolysaccharide-induced acute lung injury, thereby suppressing lung tissue injury. 35 it has been reported that serum il-10 levels increase in sars patients during the convalescence phase. 19 in this study, we established a new and more useful experimental small animal model for sars by using balb/c mice and mouse-passaged sars-cov. this model allows us to better characterize the virus-host relationship and determine which immune responses are antiviral and which are pathogenic. here, we sought to determine why sars-cov infection is more frequently lethal in elderly patients by comparing sars-cov-infected adult and young mice in terms of their pulmonary pathology and immune responses. the frankfurt 1 isolate of sars-cov used in this study was kindly supplied by dr. john ziebuhr, institute of virology and immunology, university of wü rzburg, wü rzburg, germany. the virus was propagated twice in vero e6 cells purchased from american type cell collection (manassas, va) that were cultured in eagle's minimal essential medium (mem) containing 5% fetal bovine serum, 50 iu of penicillin g, and 50 g of streptomycin per ml. titers of this stock virus were expressed as 50% of the tissue culture infectious dose (tcid 50 )/ml on vero e6 cells, which was calculated according to the behrens-kä rber method. work with infectious sars-cov was performed under biosafety level 3 conditions. compared to the original virus, the frankfurt 1 isolate used in our laboratory has one amino acid change at position 641 (his to tyr) in the s protein and another in open reading frame (orf) 1a 429 (ala to ser). these changes presumably arose during the passage through vero e6 cells. female 4-week-old or 6-month-old balb/c mice were purchased from japan slc (shizuoka, japan) and maintained in specific pathogen-free facilities. on experimental infection, these animals were housed in biosafety level 3 animal facilities. these animal experiments were approved by the animal care and use committee of the national institute of infectious diseases, tokyo, japan. the frankfurt 1 isolate of sars-cov was serially passaged 10 times in 4-week-old female balb/c mice, as follows. after intranasal inoculation, three mice were sacrificed on day 3 after inoculation and their bronchoalveolar wash fluids were collected. these bronchoalveolar fluids were then used to inoculate three additional balb/c mice, whose bronchoalveolar fluids on day 3 after inoculation were used to inoculate fresh mice. after 10 such passages in mice, the lungs were removed under sterile conditions, washed three times, and homogenized in 1 ml of phosphate buffer containing 0.1% bovine serum albumin, 20 iu of penicillin g, 20 l of streptomycin, and 1 g of amphotericin b per ml. the lung homogenates were centrifuged at 1000 ϫ g for 20 minutes, and 1 ml of the supernatants in 10 ml of mem containing 2% fetal bovine serum were used to infect vero e6 cells. after 1 hour of adsorption, the inoculum was removed and mem containing 2% fetal bovine serum was added. the cell cultures were incubated at 37°c with 5% co 2 for 2 days and then treated once with freezethawing. after centrifugation at 1000 ϫ g for 20 minutes, the supernatants (referred to here as f-musx-veroe6) were used as the virus inoculum. compared to the original virus, f-musx-veroe6 has amino acid mutations in the s protein at positions 480 (asp to glu) and 641 (his to tyr); the latter change is identical to one of the mutations found in the frankfurt 1 isolate. in the completely sequenced genome, f-musx-veroe6 also has two additional mutations in orf1a 3534 (phe to leu) and orf1ab 5172 (thr to ile). the mutation in orf1a 429 found in the frankfurt 1 isolate was not present. mice were anesthetized by intraperitoneal injection with a 0.1 ml/10 g body weight mixture of 1.0 mg ketamine and 0.02 mg xylazine. the animals were then inoculated intranasally in the left nostril with the frankfurt 1 isolate or f-musx-veroe6 (2 ϫ 10 6 tcid 50 in 20 l) and observed for clinical signs. body weight was measured daily for 10 or 21 days. infected animals were also sacrificed at various time points after inoculation to analyze virus replication, hematology, cytokine expression, and pathology (n ϭ 3 in each group). twenty percent (w/v) tissue homogenates of the lung, maxilla (including the nasal cavity), cervical lymph node, spleen, liver, and kidney were prepared in mem containing 2% fetal bovine serum, 50 iu penicillin g, 50 g streptomycin, and 2.5 g amphotericin b per ml (mem-2fbs). bronchoalveolar and nasal wash fluids were also collected for analysis of virus replication. viral infectivity titers of respiratory tract and wash fluids were determined as described above. virus isolation from other tissues was performed by blind passage after freezing and thawing the first-round passage using vero e6 cells. total blood cell counts in peripheral blood collected in sodium-heparinized tubes were measured by an autoanalyzer (cell tuck; nihon koden, tokyo, japan). neutrophil, lymphocyte, monocyte, eosinophil, and basophil counts were determined by microscopic analysis. antibodies used for flow cytometry were anti-cd4-phycoerythrin-cy5 (ebioscience, san diego, ca), anti-cd8␤phycoerythrin (santa cruz biotechnology, santa cruz, ca), and anti-pan-nk cells-fluorescein isothiocyanate (ebioscience). cells incubated with these surface-binding antibodies were fixed in 2% paraformaldehyde in phosphate-buffered saline (pbs) and subjected to flow cytometry (epics elite; beckman coulter, fullerton, ca) using expo cytometer software (beckman coulter). homogenized lung tissue samples were diluted 1:1 with cell extraction buffer [10 mmol/l tris, ph 7.4, 100 mmol/l nacl, 1 mmol/l edta, 1 mmol/l egta, 1 mmol/l naf, 20 mmol/l na 4 p 2 o 7 , 2 mmol/l na 3 vo 4 , 1% triton x-100, 10% glycerol, 0.1% sodium dodecyl sulfate, and 0.5% deoxycholate (biosource international, inc., camarillo, ca)], incubated for 30 minutes on ice with vortexing at 10 minute intervals, and then centrifuged at 15,000 ϫ g for 10 minutes at 4°c. supernatants were diluted 1:5 in assay diluent of the mouse cytokine 20-plex antibody bead kit (biosource international). sera and the 20% lung homogenate supernatants were subjected to ultraviolet irradiation for 10 minutes to inactivated virus infectivity and stored at ϫ80°c until they were used to determine the presence of mouse cytokines, namely, basic fibroblast growth factor, gm-csf, interferon (ifn)-␥, il-1␣, il-1␤, il-2, il-4, il-5, il-6, il-10, il-12p40/p70, il-13, il-17, ip-10, keratinocyte chemoattractant (kc), monocyte chemoattractant protein 1 (mcp-1), mig, mip-1␣, tnf-␣, and vascular endothelial growth factor (vegf), by using the mouse cytokine 20-plex antibody bead kit and luminex 100tm (luminex co., austin, tx). animals (n ϭ 3 in each group) were anesthetized and perfused with 2 ml of 10% phosphate-buffered formalin. fixed lung, heart, kidney, liver, spleen, small and large intestine, brain, spinal cord, and maxilla (including nasal cavity) tissues were routinely embedded in paraffin, sectioned, and stained with hematoxylin and eosin. maxilla samples were decalcified in phosphate-buffered saline (ph 7.4) plus 10% edta before being embedded. immunohistochemical detection of the sars-cov antigens was performed on paraffin-embedded sections, as follows. after deparaffinizing with xylene, sections were rehydrated in ethanol and immersed in pbs. antigens were retrieved by hydrolytic autoclaving for 20 minutes at 121°c in 10 mmol/l sodium citrate-sodium chloride buffer (ph 6.0). after cooling, the sections were immersed in pbs. endogenous peroxidase was blocked by incubation in 1% hydrogen peroxide in methanol for 30 minutes. after washing in pbs, the sections were incubated with normal rabbit serum for 5 minutes, and then with rabbit antibody against sars-cov 32,36 overnight at 4°c. after three washes in pbs, the sections were incubated with biotin-conjugated anti-rabbit igg for 30 minutes at 37°c, followed by reaction with streptavidin-peroxidase for 30 minutes at room temperature. peroxidase activity was detected by development with diaminobenzidine containing hydrogen peroxide. nuclei were counterstained by hematoxylin. sars-cov-and mock-infected adult and young mice were euthanized 1, 3, and 5 days after inoculation by exsanguination under excess ether anesthesia, after which the lungs were harvested for pathological examination (three mice per group). mock infection was performed by using mem containing 2% fetal bovine serum. for staining with anti-mac-3 and anti-surfactant d (sp-d) antibodies and to detect sars-cov antigens, the lungs were fixed with 4% paraformaldehyde in pbs at 4°c for 15 to 18 hours and embedded in paraffin according to the manufacturer's instructions (bd biosciences pharmingen, san diego, ca). the paraffin-embedded sections were then subjected to a double-immunofluorescence staining method 37 using a polyclonal rabbit antibody against sars-cov 36 and the skot9 monoclonal mouse antibody against nucleocapsid protein 38 or a monoclonal rat anti-mac-3 antibody against mouse mononuclear phagocytes (bd biosciences pharmingen), and a poly-clonal rabbit anti-sp-d antibody (chemicon international, inc., billerica, ma). briefly, after deparaffinization with xylene, the sections were rehydrated in ethanol and immersed in pbs. antigens were retrieved by hydrolytic autoclaving for 10 minutes at 121°c in 10 mmol/l sodium citrate-sodium chloride buffer (ph 6.0). after cooling, the sections were immersed in pbs, and then incubated with primary antibodies overnight at 4°c. to block background staining, normal donkey serum or the m.o.m. immunodetection kit for primary mouse monoclonal antibody (vector laboratories, burlingame, ca) were used according to the manufacturer's instructions. after three washes in pbs, the sections were incubated for 30 minutes at 37°c with biotin-conjugated secondary antibodies, ie, a donkey anti-rat serum (jackson immunoresearch, west grove, pa) to detect the mac-3 antibody or a goat anti-rabbit serum (jackson immunoresearch) to detect the sp-d antibody. after three washes in pbs, the sections were incubated with streptavidin-alexa fluor 488 (molecular probes, eugene, or) for 60 minutes at room temperature. after three washes in pbs, to detect the sars-cov antibodies (the skot9 or the rabbit antibody), the sections were incubated with anti-rabbit or anti-mouse alexa fluor 568 (molecular probes) for 60 minutes at room temperature. the sections were counterstained with to-pro-3 nucleic acid staining (molecular probes) and images were captured and analyzed by confocal laser microscopy (fluoview, fv1000; olympus, tokyo, japan). three hours after intranasal inoculation of f-musx-veroe6 (2 ϫ 10 6 tcid 50 in 20 l), adult (6-month-old) balb/c females mice were injected intravenously with 100 l of anti-mouse tnf-␣ rat monoclonal antibody (1 g/l, biosource), or isotype-matched control rat antibody (1 g/l; mp biomedicals, solon, oh) in pbs, or injected intraperitoneally with 100 l of recombinant mouse ifn-␥ (0.05 g/l; r&d systems, minneapolis, mn) or intraperitoneal injection with 100 l of pbs/0.1% bovine serum albumin was used as control. at least two independent experiments were performed (n ϭ 5 or 8 per group). sars-cov-and mock-infected mice were injected intravenously with 100 l of 1% evans blue dye (tokyo kasei, tokyo, japan) 1 hour before sacrifice (n ϭ 3 in each group). mock infection was performed by using mem containing 2% fetal bovine serum. after perfusion with isotonic saline, the whole lung was removed and immersed in 10% phosphate-buffered formalin. the fixed lungs were immediately frozen in cold acetone with dry ice in 100% o.c.t. compound (sakura finetechnical co. ltd., tokyo, japan). cryosections (5 m) (cm1900; leica, wetzlar, germany) were mounted on mas-coated slides (matsunami, osaka, japan), air-dried, and examined with a fluorescence microscope. statistical significance was determined by student's ttest. p values ͻ0.05 were considered significant. the frankfurt 1 isolate was passaged twice on veroe6 cells and then serially passaged 10 times in young balb/c mice (4-week-old females) by intranasal inoculation of bronchoalveolar fluids from infected mice. the f-musx-veroe6 strain showed higher replication and pathogenicity in the respiratory tract of young balb/c mice than the original frankfurt 1 isolate, as follows (figure 1 , a-e). on day 3 after inoculation, f-musx-veroe6 replication in the lung washes was higher than that of the original frankfurt 1 isolate (p ϭ 0.055) but lower in the nasal washes (p ͻ 0.01) ( figure 1a ). compared to frankfurt 1 isolate-inoculated young mice, the f-musx-veroe6inoculated young mice also evinced more lung inflammation, as shown by neutrophil, macrophage, and lymphocyte infiltration and virus antigen-positive cells in the alveolar spaces ( figure 1 , b-e). however, the f-musx-veroe6-inoculated young mice did not develop any obvious respiratory illnesses, although they did show transient weight loss for a few days after inoculation (data not shown). because advanced age is associated with higher mortality in human sars patients and sars-cov replicates better in aged mice, 6 -10,29 we experimentally infected 6-month-old (adult) female balb/c mice with f-musx-veroe6 or the frankfurt 1 isolate. although none of the mice showed clinical signs of illness after intranasal inoculation with frankfurt 1 isolate, all f-musx-veroe6-inoculated mice became severely ill, as revealed by significant weight loss (ϳ20% of their initial body weight), hunching, ruffled fur, and dyspnea on day 2 after inoculation ( figure 1f ). three of the ten mice became moribund and died of severe respiratory illness on days 3, 6, and 10 after inoculation (30% mortality rate). the surviving animals recovered their body weight during days 4 to 6 after inoculation. these results demonstrated that serial in vivo passage of sars-cov in mice increased the virulence of the virus, especially in adult mice. thus, we characterized the clinical and pathological features of f-musx-veroe6-infected young and adult mice up until day 5 after inoculation in more detail. the young mice again showed transient weight loss of up to 8.2% (sd ϭ 3.7%) during days 2 to 4 after inoculation but had recovered their weight by day 5 after inoculation ( figure 2a ). in contrast, the adult mice showed continuous weight loss of up to 23.0% (sd ϭ 4.5%) of their initial body weight that continued until day 5 after inoculation. all adult mice showed virtually identical clinical manifestations during days 1 to 2 after inoc-ulation (such as hunching and ruffled fur) that were not observed in the young mice. severe respiratory symptoms such as dyspnea were also observed in the adult mice from 2 days after inoculation onwards. in this experiment, 50% of the adult mice had died by day 5 after inoculation. the lungs of infected young and adult mice were weighed on days 0 to 5 after inoculation. the progressive increase in lung weight of the adult mice suggested the development of pulmonary edema (figure 2 , b and c). by day 5 after inoculation, the adults showed significantly greater lung weight changes than the young mice (p ͻ 0.01). the lungs of infected young and adult mice were also subjected to histopathological analysis on days 1 to 5 after inoculation (figure 3, a-h) . on day 1 after inoculation, both young and adult mice had antigen-positive epithelial cells in the bronchi and alveoli. the antigenpositive cells in the alveoli were considered on the bases of morphology and immunohistochemistry to be mainly type ii pneumocytes (figure 3 , a and e; see supplemental figure s1 at http://ajp.amjpathol.org). on day 2 after inoculation, antigen-positive atrophic and necrotic cells were seen in the alveolar area of both mice ( figure 3b ). in addition, antigen-positive activated alveolar macrophages associated with inflammatory infiltrations were seen in the alveolar area of adult mice ( figure 3f ). no antigen-positive cells were seen in the bronchi on day 2 after inoculation or afterward in either young or adult mice. on day 3 after inoculation, the young mice had diffuse inflammatory infiltrates consisting mainly of mononuclear cells (figure 3 , c and d), and virus antigenpositive cells were seen in the alveolar area. activated macrophages, lymphocytes, and neutrophils were seen in the alveoli on days 4 and 5 after inoculation. in contrast, the adult mice evinced severe pulmonary edema, and congestion on day 3 after inoculation ( figure 3 , g and h). in these mice, the main inflammatory cells around the adult blood vessels and alveolar area on days 3 to 5 after inoculation were neutrophils and activated macrophages. fibrin deposition and hyaline membrane formation in the alveolar duct and alveoli were also observed ( figure 3h ), and microhemorrhages was seen in the alveolar area. the adult mice also had high virus titers in the lung and maxilla (including nasal cavity) and their fluid (figure 2, d and e) . after the infection, virus continued to be isolated from the cervical lymph nodes, spleen, liver, and kidneys of adult mice after day 2 after inoculation whereas virus could no longer be isolated from any young mouse tissue (apart from the lung) after this time point (table 1) . to analyze the immune responses of young and adult mice after infection with f-musx-veroe6, we examined their peripheral blood white blood cell counts (figure 4) , and measured the levels of 20 different chemokines and cytokine levels in their plasma and lung homogenates (figures 5 and 6 ). before infection (day 0), the adult mice had significantly lower white blood cells counts, especially with regard to lymphocytes (including cd4 ϩ and cd8␤ ϩ t cells), than the , lung wash fluid, and lung homogenates of young mice on days 3, 5, and 7 after inoculation (n ϭ 3 per group). the detection limit was 10 1.5 tcid 50 /g of tissue. asterisks indicate statistically significant differences between f-musx-veroe6 and the frankfurt isolate (p ͻ 0.05). b-e: histopathological features of the lungs of young mice on day 3 after inoculation. b: after infection with the frankfurt 1 isolate, inflammatory infiltrates in the lung were not detected. moreover, very few alveolar pneumocytes and alveolar duct and alveolus epithelial cells were sars-cov antigen-positive (c, arrowheads). in contrast, extensive cellular infiltration (d) and many virus antigen-positive cells (e) were seen in the alveolar area after f-musx-veroe6 infection. f: clinical illness in individual 6-month-old adult balb/c mice after frankfurt isolate or f-musx-veroe6 infection (n ϭ 10 per group). shown are the changes in body weight (expressed as percentages of the body weight on day 0). the mean initial body weight of the two mouse groups (on day 0) were 24.72 ϯ 1.04 g and 25.44 ϯ 1.55 g, respectively. significant differences in body weight change were detected on days 2 to 8 after inoculation. for example, the average body weight f-musx-veroe6-infected adult mice on day 5 after inoculation was 83.4 ϯ 9.88% of the mean day 0 body weight. this was significantly lower than the average body weight change of frankfurt 1 isolate-infected adult mice on day 5 after inoculation (102.4 ϯ 2.99%). three f-musx-veroe6-infected adult mice died (crosses) of severe pulmonary edema on days 3, 6, and 10 after inoculation. young mice (figure 4 ). after infection, the neutrophil counts in the adult mice increased; however, this change was not observed in the young mice. in young mice, relative to counts on day 0, lymphocyte counts decreased signifi-cantly (p ͻ 0.05) on days 2, 3, and 4 after inoculation but then recovered, cd8␤ ϩ t-cell counts decreased significantly on day 2 and then recovered, and cd4 ϩ t-cell counts decreased slightly and then showed a significant to assess the lungs for pulmonary edema, the lungs were weighed after mice were sacrificed on days 1 to 5 after inoculation by exsanguination under anesthesia (n ϭ 3 per group). c: lungs from virus-and mock-infected young and adult mice obtained at the indicated time points after inoculation. arrowheads indicate focal congestion. on day increase on day 5. in contrast, although the lymphocyte counts of adult mice also dropped and were significantly lower than day 0 counts on days 3 and 4, they did not evidence an improvement on day 5 after inoculation. moreover, the cd8␤ ϩ t-and cd4 ϩ t-cell counts of the adult mice also showed significant drops on days 1, 3, and 4 after inoculation (p ͻ 0.05) but had recovered poorly on day 5 after inoculation, unlike the counts in young mice. with regard to the pannk ϩ cells counts, both the young and adult mice showed a marked drop on day 1 after inoculation that was followed by a brief recovery and then another loss on day 4 after inoculation cell count loss at day 1 and 5 days after inoculation compared with 0 days after inoculation in adult mice (p ͻ 0.05). with regard to the cytokine responses of the mice, the lung homogenates of adult mice on day 1 after inoculation had significantly higher levels of monocyterelated chemokines [ie, mcp-1, macrophage inflammatory protein 1 (mip-1), and ifn-␥-inducible protein 10 (ip-10)] than those from young mice ( figure 5 ). in contrast, on day 2 after inoculation, the lung homogenates of young mice exhibited elevated levels of these three cytokines as well as kc, monokine induced by ifn-␥ (mig), and vascular endothelial growth factor (vegf) ( figure 5 ). compared to young mice, the lung homogenates of adult mice on day 1 after inoculation also had higher levels of il-1␣, il-1␤, and tnf-␣, and on day 3 after inoculation, higher levels of il-6 were 0 0 0 0 0 0 0 0 0 1d a y 3 3 3 1 0 3 3 3 3 0 2 days 3 3 2 2 0 3 3 2 2 1 3 days 3 0 0 0 0 3 2 1 1 1 4 observed ( figure 6 ). in contrast, the lung homogenates of young mice had significantly higher levels of ifn-␥ (on day 2 after inoculation), il-2 (on days 2 to 5 after inoculation), il-10 (on days 0, and 2 to 5 after inoculation), and il-13 (on days 0 to 2, and 4 and 5 after inoculation). notably, the lung homogenates of preinfected adult mice (day 0) had higher il-4 and lower il-10 and il-13 levels than young murine lungs. these observations indicate that the patterns of cytokine/chemokines responses are different between young and adult mice after sars-cov infection. adult mice showed early and acutely excessive proinflammatory responses in the lung after sars-cov infection. to determine whether the tnf-␣ response of the adult mice and the ifn-␥ produced by the young but not adult mice played significant roles in the development of sars-like illness by the f-musx-veroe6-infected adult mice, we treated adult mice with an anti-tnf-␣ antibody or ifn-␥ 3 hours after infection (figure 7 , a and b). although the intravenous injection with anti-tnf-␣ antibody delayed the onset of this weight loss in the infected adult mice, as well as the onset of respiratory illness, both the anti-tnf-␣ antibody-treated and control adult mice showed significant body weight loss up until 6 days after inoculation and there were no significant differences in mortality rates between treated and control adult mice (treated adult mice: 62.5%, 50% mortality rate; control adult mice: 37.5%, 37.5% mortality rate in two separate experiments) ( figure 7a ). in contrast, the ifn-␥-treated mice rapidly recovered from the illness as evidenced by their body weight loss and severe acute respiratory symptoms and all animals survived after onset 3 days after inoculation ( figure 7b ). in contrast, 50% of the control adult mice died. . asterisks indicate statistically significant higher or lower chemokine levels in adult mice (p ͻ 0.05) compared to young balb/c mice. adult mice showed earlier induction of mcp-1, mip-1, and ip-10 in the lungs than young mice but these three chemokines and mig and vegf were at significantly higher levels in the lungs of young mice on day 2 after inoculation. to determine whether the protective effect of ifn-␥ treatment is attributable to suppression of viral replication, the virus titers on the day 3 after inoculation of nasal washes, maxilla homogenates, lung washes, and lung homogenates of ifn-␥-treated and pbs-treated adult mice after the infection were compared. however, the two groups did not differ significantly in terms of virus titers in the respiratory tracts ( figure 7c ). the ifn-␥-treated mice showed much milder histopathological changes than the untreated mice because only very mild edema with slight mononuclear cell infiltration was observed around the blood vessels after the infection ( figure 7d ). in contrast, the pbs-treated mice exhibited severe edema and infiltration of inflammatory cells, mainly neutrophils, around blood vessels ( figure 7e ). by examining evans blue dye extravasation, we found the ifn-␥treated mice also had lower blood vessel permeability than the pbs-treated mice (figure 8, a-g) . together, these results suggest that ifn-␥ treatment 3 hours after inoculation protected the mice from severe sars-covinduced pulmonary edema that was responsible for the death of the untreated adult mice. to understand better the pathogenesis of sars after sars-cov infection, we developed a useful experimental mouse model of sars. when the frankfurt 1 isolate of sars-cov was serially passaged in vivo in young balb/c mice, the passaged virus (f-musx-veroe6) exhibited in-creased infectivity in the murine lung. f-musx-veroe6 was also able to induce severe sars-like illness in adult (6-month-old) balb/c mice and several animals died of severe pulmonary edema and acute alveolar damage. however, young (4-week-old) mice were relatively resistant to f-musx-veroe6 and did not evince any obvious respiratory illness. when the immune responses of infected young and adult mice were compared, the adult animals had significantly lower pre-existing lymphocyte and cd4 ϩ and cd8 ϩ t-cell counts, their lungs expressed significantly higher il-4 and lower il-10 and il-13 levels before infection, and their lungs did not show the strong up-regulation of il-2 (a t-cell cytokine), il-10, il-13, and ifn-␥ that was exhibited by the young murine lungs after infection. during the infection, the lungs of adult mice also produced inflammatory chemokine-/cytokine-related macrophages (ie, mcp-1, mip-1 and ip-10, il-1␣, il-1␤, and tnf-␣) earlier than young mice (day 1 after inoculation) and at higher levels. they also had higher il-6 levels on day 3 after inoculation. in contrast, the young mice produced high levels of inflammatory chemokines and cytokines (ie, mcp-1, mip-1, ip-10, kc, mig, vegf, and il-1␣) on day 2 after inoculation and produced very little il-6 at any time point. these observations suggest that advanced-age balb/c mice have an early and acutely excessive proinflammatory cytokine reactions (ie, a cytokine storm) in response to f-musx-veroe6. this cytokine storm results in severe pulmonary edema with macrophage and neutrophil infiltration, which causes severe acute lung injury and is likely to be the cause of death in infected adult mice. supporting this scenario are reports of age-related differences in pulmonary cytokine and chemokine responses to other pathogens, especially th1 and th2 cytokine imbalances. [31] [32] [33] moreover, recent reports showed that unregulated ifn responses during acute sars prevented sars-cov-infected patients from switching from innate to adaptive immunity, 39, 40 and some reports described that ifn-␥ may be responsible for lung immunopathology in sars patients. 41, 42 interestingly, in our model, injection of ifn-␥ 3 hours after inoculation significantly reduced the acute pulmonary edema induced by infection. notably, these protective effects of ifn-␥ injection were not associated with reductions in viral titers in the lung. this animal model and human results seem not to be consistent. however, these observations together suggest that the failure of the adult animals to produce ifn-␥, which is a prominent immunomodulator that plays a key role in host defense against intracellular pathogens, 43,44 was responsible for their inability to control the excessive and pathogenic innate immune response to the virus in the lung. supporting this is our previous study on the rat sars model, which showed that although adult rats developed severe inflammatory reactions that led to pulmonary edema, all of the infected animals survived; significantly, the infected adult rats had similar cytokine profiles as infected adult mice except that they also produced ifn-␥. 34 thus, a strong and timely ifn-␥ response may be needed to prevent the immunopathology induced by sars-cov infection. with regard to the inflammatory reactions in the f-musx-veroe6-infected adult lung, our histopathological and chemokine/cytokine analyses suggested that on day 1 after inoculation, the affected respiratory epithelial cells and pulmonary macrophages released acute inflammatory chemokines (mcp-1, mip-1, ip-10) and cytokines (il-1, tnf-␣, il-12). thus, pulmonary macrophage activation associated with the release of tnf-␣ and il-1 appears to predominate in the early phase of the inflammatory reaction in adults. tnf-␣ and il-1 are classic acute inflammatory cytokines that recruit neutrophils and monocytes to the area of infection along with increasing vascular permeability, where they activate these cells so that they can eradicate the pathogens. however, when tnf-␣ is overexpressed, it can induce systemic clinical and pathological abnormalities such as depressing cardiac dysfunction and cardiomyocyte death. 45, 46 this double-edged aspect of tnf-␣ function may be why there were no effects of neutralizing tnf-␣ antibodies on sars-cov infection in this model. supporting the key role of tnf-␣ in f-musx-veroe6-induced immunopathology is that the lungs of the adult mice on days 3 and 5 after inoculation were infiltrated with predominantly neutrophils; these mice also exhibited neutrophilia. young mice did not evince these changes. this suggested that infected adult mice produce tnf-␣, which then induces neutrophil-mediated inflammation in their lungs. although the significance of this is not clear, high neutrophil infiltration in the lung is known to be the cause or the result of lung injury characterized by hyaline membrane formation and pulmonary edema. 47 high neutrophil counts in human sars cases have also been associated with poor outcomes. 8, 10 we observed in the anti-tnf-␣ antibody and ifn-␥injection experiments that the control groups, which were injected 3 hours after infection with rat igg serum intravenously or pbs intraperitoneally, showed body weight loss starting on day 1 after inoculation. in contrast, untreated mice (such as those shown in figures 1f and 2a) only started to lose weight on day 2 after inoculation. it may be that the injection with serum or pbs after the infection enhanced the pulmonary edema by hyperpermeability in the lung. we previously reported that serial in vivo passage of sars-cov in f344 rats increased the infectivity of the virus in rats, and that this correlated with a single amino acid change in the virus receptor-binding domain of the s protein. 34 we detected the similar change in f-musx-veroe6 along with another amino acid change in the receptor-binding domain of the s protein in f-musx-veroe6. the amino acid change may be responsible, at least in part, for the increased replication of f-musx-veroe6 in the pulmonary tissue of balb/c mice. [12] [13] [14] [15] 34, 48 using another sars-cov isolate (urbani), roberts and colleagues 48 have described the development and characterization of the mouse-adapted strain ma15, which is lethal for young (6-to 8-week-old) female balb/c mice after intranasal inoculation. compared with the original urbani isolate, the ma15 strain had six coding mutations that may have been responsible for the mouse adaptation and increased virulence of this strain. the fewer amino acid mutations in our mouse-adapted f-musx-veroe6 strain may be responsible for the fact that it is less virulent than ma15. in conclusion, we developed an experimental mouse animal model of sars by using in vivo-passaged sars-cov and balb/c mice. we found that the virus was lethal in adult mice because they generated an excessive innate immune response that induced lethal pulmonary edema and diffuse alveolar damage with infiltration of macrophages and neutrophils. ifn-␥ appears to play an important role in modulating the innate immune response because ifn-␥ treatment protected the animals from the lethal respiratory illness. this study, along with our previous study 34 and studies of humans infected with sars-cov during the sars epidemic of winter of 2002 to 2003, 6 -10 improve our understanding of sars pathogenesis because they indicate that both advanced age and virus adaptation to a particular animal species may dictate the pathogenic capacity of sars-cov. the new experimental model described here may also be useful for elucidating the pathophysiology of sars and for evaluating anti-sars-cov vaccine candidates and antiviral agents. identification of a novel coronavirus in patients with severe acute respiratory syndrome koch's postulates fulfilled for sars virus anderson lj, the sars working group: a novel coronavirus associated with severe acute respiratory syndrome osterhaus adme: newly discovered coronavirus as the primary cause of severe acute respiratory syndrome yuen ky, members of the sars study group: coronavirus as a possible cause of severe acute respiratory syndrome clinical features and short-term outcomes of 144 patients with sars in the greater toronto area epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in hong kong a major outbreak of severe acute respiratory syndrome in hong kong clinical progression and viral load in a community outbreak of coronavirusassociated sars pneumonia: a prospective study severe acute respiratory syndrome: clinical outcome and prognostic correlates angiotensin-converting enzyme 2 is a functional receptor for the sars coronavirus receptor and viral determinants of sars-coronavirus adaptation to human ace2 structure of sars coronavirus spike receptor-binding domain complexed with receptor efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2 angiotensin-converting enzyme 2 protects from severe acute lung failure penninger jm: a crucial role of angiotensin converting enzyme 2 (ace2) in sars coronavirus-induced lung injury pathology and pathogenesis of severe acute respiratory syndrome lung pathology of fatal severe acute respiratory syndrome analysis of serum cytokines in patients with severe acute respiratory syndrome cytokine regulation in sars coronavirus infection compared to other respiratory virus infections effects of a sars-associated coronavirus vaccine in monkeys replication of sars coronavirus administered into the respiratory tract of african green, rhesus and cynomolgus monkeys an animal model of sars produced by infection of macaca mulatta with sars coronavirus macaque model for severe acute respiratory syndrome pathology of guinea pigs experimentally infected with a novel reovirus and coronavirus isolated from sars patients susceptibility of pigs and chickens to sars coronavirus severe acute respiratory syndrome coronavirus infection of golden syrian hamsters osterhaus ad: sars virus infection of cats and ferrets aged balb/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans is ageing associated with a shift in the balance between type 1 and type 2 cytokines in humans? effect of aging on cytokine production in response to respiratory syncytial virus infection effect of age on respiratory defense mechanisms: pulmonary bacterial clearance in fischer 344 rats after intratracheal instillation of listeria monocytogenes age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by antiinflammatory and antiviral treatment participation of both host and virus factors in induction of severe acute respiratory syndrome (sars) in f344 rats infected with sars coronavirus effect of interleukin-10 (il-10) on experimental lps-induced acute lung injury vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein h5n1-infected cells in lung with diffuse alveolar damage in exudative phase from a fatal case in vietnam immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies human immunopathogenesis of severe acute respiratory syndrome (sars) interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in severe acute respiratory syndrome (sars) patients a probable role for ifn-gamma in the development of a lung immunopathology in sars an interferon-gamma-related cytokine storm in sars patients functional identity between murine gamma interferon and macrophage activating factor ifn-gamma and il-4 regulate the growth and differentiation of cd8ϩ t cells into subpopulations with distinct cytokine profiles endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock tumor necrosis factor in the heart the acute respiratory distress syndrome a mouse-adapted sars-coronavirus causes disease and mortality in balb/c mice key: cord-004663-a47pkh8q authors: tardieu, m.; goffinet, a.; harmant-van rijckevorsel, g.; lyon, g. title: ependymitis, leukoencephalitis, hydrocephalus, and thrombotic vasculitis following chronic infection by mouse hepatitis virus 3 (mhv 3) date: 1982 journal: acta neuropathol doi: 10.1007/bf00690797 sha: doc_id: 4663 cord_uid: a47pkh8q mouse hepatitis virus 3 (mhv 3) is either avirulent (resistant mice), hepatotropic (susceptible mice). or neurotropic (semisusceptible mice), depending on the strain of mice infected. in semisusceptible mice, infection led first to a transient meningitis, ependymitis, and leukoencephalitis, followed by a permanent communicating hydrocephalus and, later on, to a chronic thrombotic vasculitis affecting meningeal and parenchymal vessels at the brain stem level. small foci of ischemic necrosis related to vascular occlusions were seen in the dorsal brain stem. cyclophosphamide treatment of semisusceptible mice significantly reduced the meningeal infiltrates but did not prevent the development of hydrocephalus and other neuropathologic changes. identical lesions occurred in fully susceptible mice infected with a low dose of virus, but no neurologic disorder could be induced in genetically resistant mice even following immunosuppression or intracranial inoculation. the leukoencephalitis differed from the demyelinating lesions observed with mhv4. vascular lesions were of particular interest. more attention should be given to the possibifity of virus induced chronic cerebral vasculitis in man. differences in susceptibility to virus infection depend on characteristics of injected virus (weiner et al. 1977 wolinsky and stroop 1978) , the route of infection (johnson 1964) , and on host genetic factors and immune function (allison 1965; hirsch et al. 1970; levy-leblond et al. 1979 ). mouse hepatitis virus 3 (mhv 3), a member of the corona virus group, is either avirulent, hepatotropic, or neurotropic, depending on the strain of mice infected. adult a/j mice are fully resistant to the virus. susceptible strains (e.g., dba/2 or balb/c) develop an acute hepatic necrosis leading to death within a few days. some mouse strains (e.g., c3h/he) as well as f 1 hybrids between resistant and susceptible strains exhibit a "semisusceptibility" resulting either in early death or, in surviving animals, in the development of a chronic disease with neurologic manifestations and virus persistence (dupuy et al. 1975; le prevost et al. 1975a, b) . ependymitis and vasculitis have been reported . susceptibility or resistance to mhv 3 infection has been shown to be under the influence of at least two major gene complexes, one for the acute disease and the other, h-2 linked, for the chronic disease (levy-leblond et al. 1979 ). in addition to genetic factors, one of us has observed that host defense against mhv 3 infection requires at least three types of immunocompetent cells: t-lymphocytes, splenic macrophages, and nk-like lymphoid cells (tardieu et al. 1980) . the aim of the present neuropathologic study was to better delineate the interaction of mhv 3 with the different cells of the central nervous system (cns), as influenced by the genetic background and immunologic status of the host. of particular interest were an early transient leukoencephalitis and a chronic thrombotic vasculitis in the later stage of the disease. x a/j) fi hybrids (thereafter designed as baf 1 mice) were bred in our mouse colony as previously described (le prevost et al. 1975 a) . passage, assay, and recovery of mhv 3 were performed in susceptible dba/2 mice as reported previously (le prevost et al. 1975 a) . virus titer was expressed in ld 50/g of tissue. the virus was injected intraperitoneally (i.p.) at a dose of 103 ld 50 in 0.1 ml of saline buffer unless otherwise specified. in a group of a/j strain mice, 103 ld 50 of viral suspension were injected intracerebrally through a burhole in the parietal bone (total injected volume: i gl). a total of 158 mice were injected. ninety-one survived and were available for study. at various times after infection [on days 2, 4, 7, 9, 14, 21, 28, 35, 43, 60, 78, 90, 100, and 130 post infection (p.i.) ], mice were anesthetized with ether and perfused through the left ventricle with either formaldehyde (4 % w/v in phosphate buffer) for opto-microscopic studies, or formaldehyde (2 % w/v in phosphate buffer) plus glutaraldehyde (2.5% v/v) for electron-microscopic studies. the whole cranium was fixed overnight. the brain was then removed, embedded in paraffin, and sliced coronally on a serial basis for the preparation of paraffin sections which were processed by conventional techniques. in a series of mice prepared for electron-microscopic studies, selected fragments of ependyma, white matter, cortex and brain stem were obtained, postfixed in 1% oso 4, and embedded in epoxy resin. semithin sections were stained with toluidine blue or with the pas method. thin sections were stained with uranyl acetate and lead citrate and examined using a philips em 300 electron microscope. cyclophosphamide treatment. cyclophosphamide was reconstituted with saline buffer and a freshly prepared solution was injected i.p. at a dose of 150 mg/kg. cyclophosphamide treatment, in semisusceptible baf 1 mice, given either before or just after mhv 3 infection, leads to 100 % mortality (willenborg et al. 1973) . to avoid acute mortality, cyclophosphamide was injected on days 7, 10, 14 p.i. or 10 and 14 p.i. in some experiments, a/j strain mice were injected with cyclophosphamide 9, 13, and/or 17 days before infection. a9strontium treatment. 100 cu of 89strontium (89sr) were injected i.p. in baf 1 mice on two separate occasions, 5 weeks apart. six weeks after the last injection, animals were considered "898rtreated", as described previously (tardieu et al. 1980) . mhv 3 was injected 5 weeks after the second injection. after infection, 54 (62 %) of the semisusceptible mice (baf 1, ch 3) survived and developed a progressive neurologic disease characterized by incoordination, paresis of the hind limbs, enlargement of the head, and progressive neurologic deterioration leading to death within 3-5 months. in this group of animals, no neuropathologic changes could be detected when examined on days 2 and 4 p.i. the first abnormalities, at 7 days p.i., consisted of an important meningeal in-filtration of polymorphonuclear and mononuclear cells. at 14days p.i., the infiltrate consisted of small lymphocytes, plasmocytes, and macrophages. after 21 days p.i., the diffuse meningeal infiltrate diminished progressively and was minimal after 60 days p.i. during the same period inflammatory cuffing of meningeal vessels became progressively more marked. perivascular inflammatory cells consisted of small lymphocytes, plasmocytes, and macrophages. between 7 and 14 days p.i. perivascular infiltrations of mononuclear cells and microglial nodules appeared in the hemispheric white matter (fig. l a) . in rare instances, a microglial nodule was observed in the adjacent cortex. at 21 days the inflammatory lesions in the white matter had disappeared, leaving widespread destruction and cavitation (fig. i b) . at 10 days p.i., the first signs of an ependymitis appeared. between 21 and 35 days p.i. the granular ependymitis was particularly marked. inflammatory lesions predominated in the fourth ventricle and aqueduct ( fig. 2a) . focal aggregates of inflammatory cells consisting of mononuclear cells were formed beneath the ependyma and the ependymal cell line was focally disrupted. some of these granulomas bulged into the ventricular lumen and became even detached to form rosettes which were found free in the csf or were attached to the cilia of the ependymal cells. under the electron microscope, these granulomatous buds were seen to consist of lymphocytes and histio-monocytes together with ependymocytes. no viral particles could be seen within the affected ependymal cells. the cells of the subependymal aggregates did not stain with an antiserum against gfap, suggesting that they did not contain proliferating astrocytes. no changes were detected in the chroid plexus. after 35 days p.i., the ependymal lesions became progressively less active and demonstrated residual scarring. the ependymal cell line was focally disrupted, and in the posterior part of the fourth ventricle it was completely destroyed. proliferation of subependymal atrocytes was not conspicuous (fig. 2b) . the first evidence of ventricle enlargement was noted at 21days p.i. hydrocephalus progressed thoughout the life span of the animals. on serial sectioning of the aqueduct no stenosis was observed at 100 and 130days p.i. in mice killed after 45 days p.i. vascular lesions were observed. numerous meningeal arterioles showed severe alterations : hyaline necrosis of the media, fragmentation of the elastic lamina and intimal proliferation (fig. 3) . some arterioles and capillaries were occluded by an inflammatory thrombus (figs. 3, 4) consisting of plasmocytes, a few polymorphonuclear leukocytes, and necrotic cells of uncertain origin (fig. 5) . between 60-130 days p.i. vasculitis and thrombosis were seen to affect intraparenchymal yesfig. 1a , b. inflammatory nodules in hemispheric white matter. neocortex is situated below and subiculum above the central white matter. fragments of ependyma are seen amidst the inflammatory cells. a9 days p.i. nissl, x 108. b widespread destruction of cerebral white matter, no inflammation; 21 days p.i. he, x 94 sels beneath the iv ventricle and in the dorsolateral part of the brain stem (fig. 6) . a t some points, the nervous tissue surrounding these vessels showed distinct signs of ischemic necrosis, characterized by the presence of macrophages and proliferating astrocytes. aggregates of inflammatory cells were seen around vessels and in the surrounding parenchyma. n o microglial nodules and no intranuclear inclusions were observed. the infected semisusceptible mice which died acutely during week 1 showed lesions similar to those observed in fully susceptible mice, i.e., acute hepatitis with a normal appearance of the cns. cyclophosphamide treatment. a group of 14 baf 1 mice were injected i.p. with mhv 3 (103 ld 50). two died acutely and the 12 others were treated with cyclophosphamide as described in material and methods. among the 12 infected and cyclophosphamide-treated mice, 10 survived and two died at 23 and 27 days p.i. pathologically, the ependymal lesions and ventricular dilatation were identical to non-treated mice. hyaline necrosis of the walls of meningeal arteries and thrombosis existed as in controls. in contrast, there was a marked diminution of the meningeal and perivascular inflammatory cell infiltration as compared to control mice which were infected by mhv 3 but were not treated with cyclophosphamide. there was no evidence of leukoencephalitis. 89 strontium treatment. treatment with 89 sr resulted in acute liver necrosis with death between day 5 and 9 p.i. in the five semisusceptible mice tested. these mice showed a pattern of lesions similar to that observed in susceptible mice. when six susceptible balb/c mice were injected i.p. with mhv 3 (103ld50), they died of an acute hepatic necrosis 5 -8 d a y s after m h v 3 infection, and no neuropatholigic lesion was observed except a slight degree of meningeal infiltration. a group of 10 balb/c mice was then infected with a low dose of virus (10 ld50). eight of these animals died acutely with in 5 -8 days, the other two survived. the neuropathologic lesions were identical to those observed in semisusceptible mice, i.e., meningitis, leukoencephalitis, ependymitis, ventricular dilatation, and vasculitis. if the dose of inoculated virus was further lowered (1 ld 50), neither acute nor chronic lesions developed in five injected animals. to determine whether resistant mice could develop a chronic disease, three experiments were performed. first, three resistant a/j mice were injected in the same way as the semisusceptible animals. no clinical manifestations or neuropathologic abnormalities were observed. secondly, 5 a/j strain mice were immunosuppressed with cyclophosphamide. after infection with mhv 3, the most profoundly immunosuppressed animals (two or three cyclophosphamide injections before mhv 3 infection) died acutely as previously shown (willenborg et al. 1973) ; in the two surviving animals a slight meningeal infiltration and a perivascular infiltrate were observed on day21 p.i. without any ependymal damage, in a third experimental group mhv 3 was injected directly into the brain of nine mice. only minimal neuropathologic lesions were observed (a light microglial infiltration at the point of injection) without any ependymal or vascular change. systemic infection of semisusceptible strains of mice with mhv 3 leads to a remarkable sequence of brain lesions, such as meningitis and leukoencephalitis to mention those appearing first. the diffuse meningeal infiltrate tends to disappear progressively within a few weeks without fibrotic changes. however, perivascular infiltrates remain, especially at the level of the brain stem. the acute leukoencephalitis (fig. 1 a) , which is more marked in c3h, is restricted to the central white matter of the cerebral hemisphere and is visible only during a limited period of time between days 7 and 14 p.i., leaving behind severe destructive lesions (fig. 1 b) . this type of leukoencephalitis is different from white matter lesions produced by mhv 4, which consist of noninflammatory patchy demyelination (waksman and adams 1962; lampert et al. 1973; weiner 1973; herndon et al. 1975; haspel et al. 1978; weiner and stohlman 1978; stohlman and weiner 1981) . the presence of glial nodules in the white matter and occasionally in the adjacent cortex, may be considered as an indication of a direct action of the virus on glial cells. inflammatory changes in the ependyma appeared approximately at day 14 and persisted for about 1 month (fig. 2a) . they resulted in widespread destruction of the ependymal lining (fig. 2b) . viral particles were not detected with the electron microscope in the ependymal cells, in contrast with the findings in other viral ependymitis (nielsen and baringer 1972; wolinsky 1977) . progressive hydrocephalus starting at about 3 weeks p.i. was probably a major factor in the death of the animals. virus-induced experimental hydrocephalus has been attributed either to stenosis of the aqueduct produced by an ependymitis (johnson et al. 1967; johnson and johnson 1968; johnson 1975) or to a post infectious fibrosis of the meninges (masters et al. 1977) . in our animals aqueductal stenosis was not observed (at least until the 130th day p.i.), and there was no meningeal fibrosis (arachnoid villi were not examined). immunosuppression of semisusceptible animals with cyclophosphamide did not prevent the appearance of hydrocephalus; its most remarkable effect was the nearly complete suppression of the meningeal infiltrate. fibrosis of the meninges can, therefore, probably be discounted as the cause of intraventricutar hypertension and the mechanism of hydrocephalus remains unsettled. however, the parallelism between the intensity of ependymitis and hydrocephalus should be noted: both abnormalities were more important in baf 1 mice than in c3h mice. in contrast to the early, self-limiting, inflammatory lesions observed in the cerebral white matter and ependyma, vasculitis appeared late, after ependymitis had subsided, and increased progressively thoughout the life of the animals. these remarkable lesions consisted in hyaline necrosis of vessel walls and thromboses (figs. 3, 4) . plasmocytes were remarkably numerous in the inflammatory thrombi (fig. 5 ). perivascular cuffings with lymphocytes and plasmocytes were even more abundant than in the early phases of the disease. arterioles, capillaries, and venules were affected, essentially in the meninges surrounding the pons and medulla, deep in the subependymal region of the ivth ventricle, and within the dorsolateral parts of the brain stem, where small loci of ischemic necrosis related to vascular occlusions were observed (fig. 6) . it is not impossible that some of the parenchymal lesions could be ascribed to an encephalitic process; however, the presence of vascular occlusions and ischemic necrosis in these areas is unquestionable. in man, particularly in the fetus, the possibility for a chronic viral infection to induce ischemic brain lesions after a long delay, through a slowly progressive thrombotic vasculitis, has not been sufficiently considered. such a sequence of events is known, however, in congenital rubella, where degeneration of vessel walls leads to multifocal ischemic necrosis of the brain (rorke and spiro 1967; singer et al. 1967; rorke 1973 ) and similar lesions have been shown in experimental animals (rorke et al. 1968) . a rare condition, granulomatous angiitis has been related to varicella-zoster infection (kolodny et al. 1968; rosenblum and hodfield 1972; linnemann and alvira 1980) and to other viral infections (reyes et al. 1976 ) in man. also, it is known that inflammatory perivascular infiltrates perist for many months in human poliomyelitis (esiri 1980) . at the time vascular lesions develop, a low titer of virus can still be detected in the brain, as late as 6 months p.i. (le prevost et al. 1975b), and dupuy et al. (1973) have demonstrated at that stage a severe non specific immunodepression (dupuy et al. 1973) . to investigate possible immune mediation in the generation of vascular lesions, we studied the effects of two immunomodulating regimen in semisusceptible mice: cyclophosphamide, which depresses t-and b-cell activities (stockman et al. 1973) and s9sr, which abolishes selectively nk cell activity (kumar et al. 1976; tardieu et al. 1980 ). cyclophosphamide did not prevent necrosis of vessel walls and thrombosis. 89 sr treatment changed the pattern from semisusceptible to susceptible mice, dying of acute hepatic necrosis. to study further the effect of 898r, preliminary experiments were performed in which mice were injected with mhv 3 1 day after the second injection of 89sr, to avoid acute hepatic necrosis. the intensity of vasculitis in these mice and in controls was identical. these experiments suggest that t, b, and nk-cells do not play a prominent role in the induction of vascular lesions. however, there is as yet no clear evidence in favor of a direct action of the virus on the vessels, and further research is needed into the pathogenesis of the thrombotic vasculitis following mhv 3 infection. the same neurologic disease can occur in fully susceptible mice infected with a low dose of virus, but attempts to induce this disease in genetically resistant mice have been unsuccessful, even following immunosuppression or intracranial inoculation. these findings suggest that host cells in the brain from fully susceptible and semisusceptible strains are equally able to support viral replication and are equally susceptible to give rise to destructive lesions. the absence of disease in resistant mice may be related to an inability of host cells to either bind or replicate mhv 3. it is also possible that other means of immunosuppression may alter this genetic resistance. genetic factors in resistance against virus infection persistent virus infection with neurological involvement in mice infected with mhv 3 c (1975) hnmunopathology of mouse hepatitis virus type 3 infection. ii. effect of immunosuppression in resistant mice poliomyelitis: immunoglobulin-containing cells in the central nervous system in acute and convalescent phases of the human disease temperaturesensitive mutants of mouse hepatitis virus produce a high incidence of demyelination mhvinduced recurrent demyelination. a preliminary report allison ac (t970) macrophages and agedependent resistance to herpes simplex virus in mice the pathogenesis of herpes virus encephalitis. i. virus pathways to the nervous system of suckling mice demonstrated by fluorescent antibody staining virus induced hydrocephalus: development of aqueductal stenosis in hamster after mumps infection hydrocephalus following viral infections: the pathology of aqueductai stenosis developing after experimental mumps virus infection hydrocephalus and viral infections granulomatous angiitis of the central nervous system mechanism of genetic resistance to friend leukemia virus in mice. i. role of 89sr-sensitive effector cells responsible for rejection of bone marrow allografts mechanism of demyelination in jhm virus encephalomyelitis. electronmicroscopic studies immunopathology of mouse hepatitis virus type 3 infection role of humoral and cell-mediated immunity in resistance mechanisms b) immunopathology of mouse hepatitis virus type 3 infection. iii. clinical and virologic observations of a !aeristent viral infection genetic study of mouse sensitivity to hmv 3 infection: influence of the h-2 complex pathogenesis of varicella-zoster angiitis in the cns pathogenesis ofreovirus type i hydrocephalus in mice. significance of aqueductal change reovirus-induced aqueductal stenosis in hamsters. phase contrast and electron-microscopic studies virus-like particles in granulomatous angiitis of the central nervous system cerebral lesions in congenital rubella syndrome experimental cerebrovascular lesions in congenital and neonatal rubella-virus infections of ferrets nervous system lesions in the congenital rubella syndrome granulomatous angiitis of the nervous system in cases of herpes zoster and lymphosarcoma pathology of the congenital rubella syndrome differential effects of cyclophosphamide on the b-and t-cell compartments of adult mice chronic central nervous system demyelination in mice after jhm virus infection neonatal susceptibility to mhv 3 infection in mice. ii. role of natural effector marrow cells in transfer of resistance neuropathological effects of persistent infection of mice by mouse hepatitis virus infectious leukoencephalitis. a critical comparison of certain experimental and naturallyoccuring viral leukoencephalitis with experimental allergic encephalomyelitis pathogenesis of demyelination induced by a mouse hepatitis virus (jhm virus) molecular basis of reovirus virulence: role of the s 1 gene viral models of demyelination effect of cyclophosphamide on the genetic resistance of c3h mice to mouse hepatitis virus mumps virus-induced hydrocephalus in hamsters. ultrastructure of the chronic infection virulence and persistence of three prototype strains of mumps virus in newborn hamster key: cord-288253-wqrhiq08 authors: park, jung-eun; park, eui-soon; yu, jung-eun; rho, jaerang; paudel, sarita; hyun, bang-hun; yang, dong-kun; shin, hyun-jin title: development of transgenic mouse model expressing porcine aminopeptidase n and its susceptibility to porcine epidemic diarrhea virus date: 2015-02-02 journal: virus res doi: 10.1016/j.virusres.2014.12.024 sha: doc_id: 288253 cord_uid: wqrhiq08 porcine coronavirus infections have known as they are specific to pigs with predominantly enteric or respiratory diseases. no laboratory animal model is yet been developed in porcine coronaviruses study. here, we report that development of a transgenic mouse model expressing porcine apn which is susceptible to porcine coronavirus infection. the porcine apn transgene was constructed by fusing with mouse proximal apn promoter at 5′ terminus and bovine growth hormone polyadenylation site at its 3′ terminus. after screen on pubs from the microinjected mice, we confirmed two transgenic lines expressing porcine apn in various organs. we confirmed the susceptibility to porcine epidemic diarrhea virus, one of the porcine coronaviruses. these transgenic mice will be an important tool for research into the porcine coronaviruses. the coronaviruses belong to the family coronaviridae within the order nidovirales. they are classified into four genera, alphacoronavirus, betacoronavirus, gammacoronavirus, and deltacoronavirus, based on genetic similarities (adams et al., 2014) . the primary replication of the coronaviruses is often confined to respiratory-or gastrointestinal-tract epithelial cells, so they usually induce respiratory or enteric diseases, but also hepatic, renal and neuronal infections (lednicky et al., 2013; masters, 2006; weiss and navas-martin, 2005) . the pathogenesis of several porcine coronaviruses, including transmissible gastroenteritis virus (tgev) and porcine respiratory coronavirus (prcov), has been broadly studied (enjuanes et al., 1995; saif, 2004a,b; saif, 2004a,b; weiss and navas-martin, 2005) . tgev is a major cause of viral enteritis and fetal diarrhea in swine, most severely in neonates and with a high mortality rate, which causes significant economic losses worldwide (enjuanes et al., 1995) . prcov is reported to be an attenuated variant of tgev. prcov infects lung epithelial cells, and prcov antigen has been found in type i and type ii pneumocytes and alveolar macrophages, and infection is followed by interstitial pneumonia (halbur et al., 1993; saif, 2004a,b) . porcine epidemic diarrhea virus (pedv) is the causative agent of porcine epidemic diarrhea, which is characterized by watery diarrhea, as is tgev infection (chasey and cartwright, 1978; pensaert and de bouck, 1978; turgeon et al., 1980) . pedv-infected piglets usually show typical enteric signs, including profuse watery diarrhea, weight loss, and loss of milk uptake, entailing high mortality. pedv has been reported in europe and asia, and also recently in the united states (hess et al., 1980; huang et al., 2013; pan et al., 2012; park et al., 2013; wang et al., 2014) . all these porcine coronaviruses belong to the genus alphacoronavirus. a hemagglutinating enteric coronavirus, a member of the genus betacoronavirus, is antigenically unrelated to the other porcine coronaviruses and uses a 5-nacetyl-9-o-acetylneuraminic-acid-containing moiety as its cellular receptor. coronavirus infections are mediated by the spike (s) glycoprotein, a large surface glycoprotein on the viral envelope (delmas and laude, 1990; masters, 2006) . coronavirus s glycoproteins recognize cellular receptors and mediate virus-cell fusion (masters, 2006; peng et al., 2011) . most alphacoronavirus, including tgev, pedv, and prcov, use aminopeptidase n (apn/cd13) as their cellular receptor (delmas et al., 1992; li et al., 2007; ren et al., 2010; tresnan and holmes, 1998; yeager et al., 1992) . apn/cd13 is a 150-kda, zinc-dependent metalloprotease consisting of 967 amino acids (rawlings and barrett, 1995) . mammalian apn is ubiquitously expressed as a glycosylated homodimer on the surfaces of epithelial cells in the liver, intestine, kidney, and respiratory tract, and in fibroblasts and leukocytes, and plays multiple roles in many physiological processes, including coronavirus entry (barnes et al., 1994; luan and xu, 2007; mina-osorio et al., 2008; miura et al., 1983) . the natural hosts of porcine coronaviruses are young piglets, and clinical illness has only been observed in sucking piglets. however, in vivo studies using suckling piglets have many disadvantages, including their high cost, difficulty in handling the piglets, limited reagents, etc. because the use of laboratory animal models (e.g., mouse models) can circumvent these limitations, several transgenic animal models have been generated to study porcine viruses (benbacer et al., 1998; ono et al., 2006) . here, we generated transgenic mice expressing porcine apn under the control of the mouse proximal apn promoter. we tested their susceptibility to pedv with reverse transcription-polymerase chain reaction (rt-pcr) and immunochemical analyses, and found that the porcine apn transgenic mice were susceptible to pedv infection. vero monkey kidney cells were maintained in minimal essential medium containing 10% fetal bovine serum (fbs), 100 u/ml penicillin g, 100 g/ml streptomycin, and 250 g/ml amphotericin b in a 5% co 2 atmosphere at 37 • c. 293t human embryonic kidney cells were maintained in dulbecco's modified eagle's medium containing 10% fbs, 100 u/ml penicillin g, 100 g/ml streptomycin, and 250 g/ml amphotericin b. all tissue culture reagents were purchased from gibco (carlsbad, ca, usa). kpedv-9, a cell-adapted vaccine strain of pedv, was grown and titrated in the vero cells, as described previously, and stored at −80 • c until use (cruz and shin, 2007; hofmann and wyler, 1988) . the polyclonal antibodies specific for pedv and porcine apn were generated in balb/c mice immunized with kpedv-9 and purified porcine apn, respectively, as described previously (cruz et al., 2008) . the antibody specificities were confirmed with enzyme-linked immunosorbent assays. the anti-flag m2 monoclonal antibody (anti-flag) and anti-flag m2 affinity gels (gel beads) were purchased from sigma-aldrich (st. louis, mo, usa). fluorescein isothiocyanate (fitc)-conjugated anti-mouse igg antibody was purchased from santa cruz biotechnology (santa cruz, ca, usa). the mouse proximal apn promoter region (starting at nucleotide-1044) was amplified from c57bl/6j genomic dna by pcr with primers 5 -cccgcggccgcaagatttgaaacagtgga-3 and 5 -cccaagcttgatgccggtggacaggga-3 , containing flanking noti and hindiii restriction endonuclease sites, respectively. the pcr product was cloned into the pbluescript ks (+) vector and the pgl3-basic vector (promega, madison, wi, usa), which contains a promoterless luciferase reporter gene. the porcine apn gene was amplified from the total rna isolated from porcine enterocytes with rt-pcr using specific primers and cloned into the pbluescript ks (+) vector. a sequence encoding the flag epitope (dykddddk) was fused to the 3 terminus of porcine apn with pcr with primers 5 -cccaagcttaccatggccaagggattctac-3 and 5 -cccctcgagtcacttgtcgtcatcgtctttgtagtcgctgtgctctat-gaacca-3 , which contain flanking hindiii and xhoi restriction endonuclease sites, respectively. the bgh-polya sequence was amplified from the pcdna3.1 vector (invitrogen, carlsbad, ca, usa) with pcr using primers 5 -cccctcgagcgactgtgccttctagtt-3 and 5 -cccggtaccccatagagcccaccgcat-3 , which contain flanking xhoi and kpni restriction endonuclease sites, respectively. the pcr product was cloned into the pbluescript ks (+) vector. all pcr products were confirmed with automated sequencing. to generate the porcine apn transgene, porcine apn-flag and the mouse proximal apn promoter were ligated into pbluescript ks-bgh-polya after they were digested with hindiii/xhoi and noti/hindiii, respectively. 293t cells (2.5 × 10 5 cells/ml) were plated in 24-well plates. after 24 h, the cells were transfected with pgl3-basic-mouse proximal apn promoter (mapn-luc) (0.2 g or 1 g). the cells were transfected in triplicate using lipofectamine 2000 (invitrogen), according to the manufacturer's instructions. after 24 h, the cells were lysed for assay with the luciferase assay system (promega), according to the manufacture's protocol. all luciferase activities were normalized to ␤-galactosidase activity. the porcine apn transgene was linearized by restriction with noti and purified with gel extraction (qiagen, valencia, ca, usa). gain-of-function gene transfer was performed by microinjecting the purified dna into the pronuclei of icr mouse zygotes, which were then transferred into the oviducts of female recipient mice. the transgenic mice were identified with pcr analysis of tail genomic dna with primers: pcr1-f: 5 -cccaagcttaccatggccaagggattctac-3 and pcr1-r: 5 -gaagttggagagcatcct-3 ; and pcr2-f: 5 -ggcgtcctacttgcatgc-3 and pcr2-r: 5 -cccctc-gagtcacttgtcgtcatcgtctttgtagtcgctgtgctctatgaacca-3 . the founder mice were backcrossed to the c57bl/6j background for five generations. all the mice used in this study were maintained in a specific-pathogen-free facility at the biomedical research center at the korea advanced institute of science and technology, daejeon, korea. all animals were cared for and the experiments were performed at the animal facility at chungnam national university (cnu), korea, with the permission of and according to protocols approved by the institutional animal care and ethics committee of cnu (permission number 20110825). the porcine apn transgenic and nontransgenic wild-type mice were orally inoculated with 5 × 10 6 tcid 50 of kpedv-9 or phosphate-buffered saline (pbs, ph 7.2) as the negative control. their clinical signs were monitored and their feces collected for 5 days. two mice from each group were killed on the indicated days after viral infection. the tissues were aseptically collected and prepared for rt-pcr and immunohistopathological analysis. total rnas were extracted from the feces and tissue samples using trizol ® reagent (invitrogen) and transcribed to cdna using power cdna synthesis kit (intron biotechnology, korea), according to the manufacturer's protocol. the porcine apn-flag cdna was pcr amplified with the specific primers used for the genotyping pcr. as a control, specific primers were used to amplify ␤-actin (mouse ␤-actin-f: 5 -cggttccgatgccctgaggctctt-3 and mouse ␤-actin-r: 5 -cgtcacacttcatgatggaattga-3 ). the cycling parameters were initial denaturation at 94 • c for 2 min, followed by 30 cycles of denaturation at 94 • c for 15 s, annealing at 60 • c for 40 s, and extension at 72 • c for 90 s, with a final extension step at 72 • c for 5 min. to detect the viral genome, viral rna was extracted from tissue homogenates using the viral gene-spin viral dna/rna extraction kit (intron biotechnology), according to the manufacturer's instructions. m-mlv reverse transcriptase (intron biotechnology) was used for first-strand cdna synthesis, together with 10 l of extracted viral rna in a 50 l randomly primed reaction. the specific primers used for the detection of the n gene were pedv-n forward (5 -ggtaccatggcatctgtcagcttt-3 ) and pedv-n reverse (5 -ggatccttaatttcctgt tcgaa-3 ). rt-pcr was performed at 94 • c for 2 min, followed by 30 cycles of 94 • c for 20 s, 54 • c for 10 s, and 72 • c for 2 min, with a final extension at 72 • c for 10 min. the pcr products were analyzed by gel electrophoresis and visualized with ethidium bromide staining and uv transillumination. 293t cells were lysed with cell lysis buffer (25 mm tris-cl [ph 7.5], 150 mm nacl, 1 mm edta, 1 mm naf, 1 mm sodium orthovanadate, 1 mm pmsf, 5% glycerol, 0.5% triton x-100, and protease inhibitors [roche, indianapolis, in, usa]). the small intestines were rinsed with pbs and homogenized in lysis buffer (1% np40, 150 mm tris-cl, 50 mm nacl, 1 mm edta). the cell or tissue lysates were separated with 8-15% gradient sds-page and transferred into pvdf membrane (amersham-pharmacia biotech, piscataway, nj, usa). the proteins were probed with an anti-flag monoclonal antibody diluted 1:4000 and an anti-␤-actin antibody diluted 1:10,000. the immune complexes were detected with peroxidase-conjugated goat anti-mouse igg antibody (santa cruz biotechnology) and visualized with amersham ecl western blotting detection reagent (amersham-pharmacia biotech). 293t cells were transfected with the porcine apn transgene. after 24 h, the cells were rinsed with pbs and detached with non-enzymatic cell dissociation solution (sigma-aldrich) for 2 min. the detached cells were harvested and resuspended in fluorescenceactivated cell sorting (facs) staining buffer (pbs containing 2% fbs). the cells were stained with the anti-flag m2 monoclonal antibody (1:200) for 15 min at 4 • c and then with fitc-conjugated anti-mouse igg secondary antibody (1:500) for 15 min at 4 • c. the antibody-stained cells were analyzed with flow cytometry (fac-scalibur, becton-dickinson biosciences, franklin lakes, nj, usa). kidney and liver tissues collected from mice were rinsed with pbs, and the renal or hepatic cells were isolated from the tissues with a 70 m mesh filter (becton-dickinson biosciences), resuspended in facs staining buffer, and analyzed as described above. small intestine samples were fixed in 10% buffered formalin and embedded in paraffin. serial 5 m sections were mounted on silane-coated slides. the sections were deparaffinized for immunohistochemical analysis, and the endogenous peroxidases were blocked with 0.6% h 2 o 2 in methanol for 30 min. antigens were retrieved with microwave heating in citrate buffer for 10 min, and the slides were incubated with 1.5% horse serum for 30 min at room temperature. polyclonal anti-porcine apn antiserum, monoclonal anti-flag antibody, or polyclonal anti-pedv antiserum were applied overnight at 4 • c. the biotinylated anti-mouse igg secondary antibody was detected with an avidin-biotin-peroxidase kit (vectastain abc kit, vector laboratories, burlingame, ca, usa). antibody binding was detected with the chromogen diaminobenzidine (vector laboratories), and the cells were counterstained with hematoxylin and eosin. 2.11. pedv replication in the small intestines of porcine apn transgenic mice both wild type and porcine apn transgenic mice were infected with pedv orally on day 0. viral titer in inoculum was 5x tcid 50 10 6 . two mice from each group were killed daily up to 5 days, and small intestine samples from all mice were collected in mem and homogenized. samples were centrifuged and supernatants were kept in −80 • c until processed for titration. titration was performed using vero cells. the pedv titer was measured and described in log value. the transcription of mouse apn is regulated by two different promoters, as shown in fig. 1a (bhagwat et al., 2001) . the distal promoter is located 8 kb upstream from the transcription -1 (3 and 4) , and cnupedm-3 mice (5 and 6). porcine apn rnas were amplified using specific primers targeting porcine apn, as described in section 2. ␤-actin was detected as the loading control. (b) expression of porcine apn protein in the small intestines. small intestine samples were collected from cnupedm-1 and cnupedm-3 mice. porcine apn protein was detected in small intestine homogenates with immunoblotting using an anti-flag monoclonal antibody (2 and 4). no recombinant protein was detected in the small intestine samples derived from nontransgenic wild-type mice (1 and 3). ␤-actin was used as the loading control. (c) immunohistochemical analysis of porcine apn transgenic mice. small intestine sections were prepared from porcine apn transgenic mice (a-c: cnupedm-1; d-f: cnupedm-3) and incubated with anti-flag monoclonal antibody (anti-flag) (a and d), mouse anti-porcine apn polyclonal antiserum (anti-papn) (b and e), or normal mouse serum (c and f). the immune complexes were visualized with avidin-biotin-peroxidase and the cells were counterstained with hematoxylin and eosin. magnification, ×40. start site and controls apn expression in myeloid and fibroblast cells, whereas the proximal promoter regulates apn expression in epithelial cells (olsen et al., 1991; shapiro et al., 1991) . following references and preliminary studies, we choose the mouse proximal apn promoter to express porcine apn in mouse epithelial cells. to test the promoter's activity, the sequence encoding the promoter region was amplified and cloned into the pgl3-basic promoterless vector (fig. 1b) , and the promoter activity was measured by luciferase assay. as shown in fig. 1b , the luciferase activity was about eight-fold higher in 293t human embryonic kidney cells transfected with the vector containing the mouse proximal apn promoter (mapn-luc) than in cells transfected with the empty vector. we constructed a vector encoding porcine apn, which was regulated by the mouse proximal apn promoter (porcine apn transgene) (fig. 2a) . the porcine apn cdna was amplified from porcine enterocytes and tagged at the c-terminus with the flag epitope to distinguish exogenously expressed porcine apn from endogenously expressed murine apn. the 2.9-kb flag-epitopetagged porcine apn cdna was cloned into the pbluescript ks (+) vector under the control of a 1.1-kb genomic sequence containing the mouse proximal apn promoter. the splice sites and polyadenylation signal for the cdna were provided by a 0.2-kb bovine growth hormone polyadenylation signal (bgh-polya). the expression of the porcine apn protein was detected with immunoprecipitation and immunoblotting in 293t cells transfected with the porcine apn transgene. the flag-tagged recombinant protein, with a molecularweight of about 150 kda (the expected molecular mass for porcine apn), was confirmed with immunoprecipitation (fig. 2b) . we also measured the surface expression of porcine apn with flow cytometry using an anti-flag antibody, and found that 21.3% of cells were flag-positive (fig. 2c ). our data demonstrate that the mouse proximal apn promoter efficiently induced porcine apn expression from our construct. the porcine apn transgene was linearized with noti restriction and the dna microinjected into mouse zygotes. to screen for porcine apn expression, we designed two genomic pcr primers, as indicated in fig. 3a (arrowheads) . the presence of the porcine apn transgene in mouse litters was monitored with pcr analysis on tail genomic dna (fig. 3b) . microinjection of the porcine apn transgene produced two transgenic founders, designated cnupedm-1 and cnupedm-3. the transgenic mice were healthy and showed no negative effects of transgene expression. because the major pathological changes of the porcine coronaviruses (e.g., tgev and pedv) involves enteric diseases, we measured porcine apn expression in the small intestine by rt-pcr, immunoblotting, and ihc. all the tested litters descended from cnupedm-1 or cnupedm-3 expressed porcine apn mrna in their small intestines (fig. 4a ). the small intestines expressed a recombinant protein with the molecular mass expected for porcine apn (fig. 4b ). an immunohistochemical analysis, with both anti-flag and anti-porcine apn antibodies, clearly confirmed porcine apn expression in the brush borders of the absorptive cells in the small intestines of the mouse model (fig. 4c) . these results demonstrate that the porcine apn transgenic mice expressed porcine apn in their small intestines. we also screened for porcine apn expression in various other tissues with rt-pcr. porcine apn mrna was strongly expressed in the lung, kidney, and the intestine, and was slightly expressed in the liver (fig. 5a) . the extracellular expression of porcine apn was examined in the kidney and liver by facs analysis (fig. 5b) . consistent with the rt-pcr results, the number of flag-positive renal cells was significantly higher (2-4.3-fold) in the porcine apn transgenic mice than in the nontransgenic wild-type mice, whereas the number of flag-positive hepatic cells was also slightly higher (1.6-3-fold) in summary, we confirmed the expression of porcine apn in the small intestines, lungs, livers, and kidneys of the porcine apn transgenic mice. we examined the susceptibility of the porcine apn transgenic mice to pedv, one of the enteropathogenic porcine coronaviruses. porcine apn transgenic or nontransgenic wild-type mice were inoculated orally with kpedv-9, a vero-cell-adapted korean strain of pedv. in infected transgenic mice, other than slightly watery feces observed at 3 days after inoculation (fig. 6a) , whereas no clinical signs (e.g., watery diarrhea, vomiting, fever, weight loss, or death) were observed for 5 days. viral replication was detected in various tissue extracts with rt-pcr. viral rna was confirmed in the small intestines (for at least 5 days), kidneys (for at least 2 days), and spleen (for at least 3 days) only in the porcine apn transgenic mice (table 1) , and not in the nontransgenic mice. an immunohistochemical analysis detected pedv antigen in the brush borders of the small intestines, at the same location at which porcine apn is expressed (fig. 6b) , which has been demonstrated in pedvinfected piglets (debouck and pensaert, 1980; pensaert et al., 1981) . however, no histopathological changes were observed in the small intestines that shown in pedv infected piglets. overall, these data indicate that porcine apn transgenic mice are susceptible to pedv infection, although they showed none of the enteric disease symptoms typical of pedv-infected piglets (fig. 7) . 3.6. pedv replication in the small intestines of porcine apn transgenic mice pedv replication in both wild type and porcine apn transgenic mice were confirmed and compared by viral load in the small intestines. there were no detectable pedv in any of wild type mice samples. in porcine apn transgenic mice, the mean value of pedv was tcid 50-10 3.1 on day 1. it increased to tcid 50-10 3.8 , tcid 50-10 4.8 , tcid 50-10 5.0 , tcid 50-10 5.1 , on day 2, 3, 4, and 5, respectively. there was no big change in titer between 3 and 5 days pi. we could confirm clear pedv replication in the small intestines of porcine apn transgenic mice. laboratory animal models are crucial tools for the study of viral pathogenesis in vivo, especially for highly pathogenic human viruses or viruses with restricted host ranges (calvert et al., 2014; chiu et al., 2014; deruaz and luster, 2013) . unlike in vitro cell culture systems, laboratory animal models offer researchers invaluable opportunities to study the biological, pathological, and histological characteristics of human and animal diseases. for these purposes, many transgenic mouse models have been developed to study viral pathogenesis, immune responses, and vaccines (darling et both wild type and porcine apn transgenic mice were infected with pedv (5x tcid5010 6 ) orally on day 0. two mice from each group were killed daily up to 5 days, and intestine samples were collected and prepared for titration. titration was done using vero cells. y value is pedv titer in tcid50 in log value. reynaud et al., 2014) . in the field of coronavirus research, studies of severe acute respiratory syndrome coronavirus (sars-cov) and human coronavirus 229e (hcov-229e) have been conducted with transgenic mouse models (lassnig et al., 2005; tseng et al., 2007) . the host range of the porcine coronaviruses is strongly limited to pigs, so pigs are the only animals available in which to study viral pathogenesis. however, in vivo experiments using pigs are relatively challenging because they require special treatments, reagents, and facilities. because most porcine coronaviruses use porcine apn as their receptor, we generated porcine apn transgenic mice, which are susceptible to porcine coronaviruses. we constructed the porcine apn transgene by attaching the mouse proximal apn promoter to the 5 terminus of the porcine apn gene and the bgh-polya signal at its 3 terminus. we thus generated porcine apn transgenic mice expressing porcine apn in the brush borders of their small intestines and various tissues (lungs and kidneys). previous attempts to generate apn transgenic mice susceptible to tgev or hcov-229e have been documented (benbacer et al., 1998; lassnig et al., 2005) . benbacer et al. generated an rt-pcrpositive lineage, but failed to confirm either the expression of the porcine apn protein in the intestine or tgev replication in their porcine apn transgenic mouse model (benbacer et al., 1998) . a susceptible mouse model for hcov-229e infection was successfully developed using comprehensive apn regulatory elements to generate human apn +/+ stat1 −/− double transgenic mice, and a virus was adapted to grow in primary embryonic fibroblasts from these mice (lassnig et al., 2005) . a transgenic mouse model of sars was generated by expressing human angiotensin-converting enzyme 2, a functional receptor for the virus, under the regulation of a global promoter (tseng et al., 2007) . the significance of our study is that we successfully generated transgenic mice expressing porcine apn with minimal modifications, by using the mouse apn proximal promoter and the bgh-polya signal to ensure the strong expression and correct splicing of the gene (pfarr et al., 1986) . therefore, we could express porcine apn in the brush borders of the mouse small intestines and on the surfaces of their renal cells (figs. 4 and 5) . among the porcine coronaviruses, pedv is relatively poorly studied, and many questions and controversies remain regarding its outbreaks and pathogenesis. outbreaks of porcine epidemic diarrhea have been limited to few countries in east asia in the cold season, whereas it has spread to most swine farms in the asian region (mole, 2013; pan et al., 2012; park et al., 2013; song and park, 2012; stevenson et al., 2013) . recently, pedv has also spread rapidly among swine farms in the united states, causing high piglet mortality in more than 17 states (huang et al., 2013; mole, 2013; stevenson et al., 2013; wang et al., 2014) . more importantly, although vaccination is practiced on most swine farms in korea, reported outbreaks are still increasing. moreover, a method for isolating wild-type pedv is not well established. for these reasons, we tested the susceptibility of porcine apn transgenic mice to pedv. although significant clinical illness was not observed when the transgenic mice were infected with pedv, their susceptibility to the virus was confirmed by the detection of viral rna in various organs with rt-pcr and viral proteins in the small intestines with ihc. more clearly, pedv replication was confirmed by increase in viral titer up to 5 days pi compared to those in wild type mice. we could found clear increase in viral titer in the small intestines of papn transgenic mice but not from wild type mice. these results also confirmed that porcine apn plays a role as the cellular receptor for pedv. however, similar experiments using other porcine coronaviruses are required. although we have presented evidence of pedv infection in the small intestines of porcine apn transgenic mice, no clinical signs were observed, apart from moderately soft feces. it has previously been shown that pedv can infect cells lacking extracellular trypsin, although trypsin is essential for the generation of a cytopathic effect (cpe) in infected cells (park et al., 2011) . therefore, we assume that cellular cofactors (e.g., trypsin) other than the primary receptor might be involved in and required for pedv pathogenesis in vivo. however, these factors are probably present at insufficient levels in mice. proteases are generally required for efficient viral entry and the cpes of coronaviruses (matsuyama et al., 2005; simmons et al., 2004 simmons et al., , 2013 . although the viral receptors are usually expressed in various organs, the diseases caused by coronavirus infections are limited to the small intestines and/or lungs, which are enriched cellular proteases. this suggests that proteases play a role in the pathogenesis of the coronaviruses in vivo, as is already well established for influenza virus infections (hatesuer et al., 2013; sakai et al., 2014; tarnow et al., 2014) . the porcine apn transgenic mouse model should extend our understanding of the pathogenesis of and other studies to porcine coronavirus infections. this laboratory animal model should also circumvent all the disadvantages and difficulties related to the study of porcine coronaviruses in suckling piglets. with the strategy described here, transgenic mouse models expressing the apn genes of other animals could be developed and used for the study of other coronaviruses. ratification vote on taxonomic proposals to the international committee on taxonomy of viruses localization of aminopeptidase n and dipeptidyl peptidase iv in pig striatum and in neuronal and glial cell cultures obtention of porcine aminopeptidase-n transgenic mice and analysis of their susceptibility to transmissible gastroenteritis virus cd13/apn is activated by angiogenic signals and is essential for capillary tube formation development of a small animal peripheral challenge model of japanese encephalitis virus using interferon deficient ag129 mice and the sa14-14-2 vaccine virus strain virus-like particles associated with porcine epidemic diarrhoea multiple models of porcine teschovirus pathogenesis in endemically infected pigs the gprlqpy motif located at the carboxyterminal of the spike protein induces antibodies that neutralize porcine epidemic diarrhea virus application of a focus formation assay for detection and titration of porcine epidemic diarrhea virus il-10 suppresses il-17-mediated dermal inflammation and reduces the systemic burden of vaccinia virus in a mouse model of eczema vaccinatum experimental infection of pigs with a new porcine enteric coronavirus, cv 777 aminopeptidase n is a major receptor for the entero-pathogenic coronavirus tgev assembly of coronavirus spike protein into trimers and its role in epitope expression blt humanized mice as model to study hiv vaginal transmission development of protection against coronavirus induced diseases: a review experimental reproduction of pneumonia in gnotobiotic pigs with porcine respiratory coronavirus isolate ar310 tmprss2 is essential for influenza h1n1 virus pathogenesis in mice current aspects in the etiology of viral diarrheas of swine: occurrence of infections with the epizootic viral diarrhea (evd) virus propagation of the virus of porcine epidemic diarrhea in cell culture origin, evolution, and genotyping of emergent porcine epidemic diarrhea virus strains in the united states development of a transgenic mouse model susceptible to human coronavirus 229e isolation and genetic characterization of human coronavirus nl63 in primary human renal proximal tubular epithelial cells obtained from a commercial supplier, and confirmation of its replication in two different types of human primary kidney cells porcine aminopeptidase n is a functional receptor for the pedv coronavirus the structure and main functions of aminopeptidase n the molecular biology of coronaviruses proteasemediated enhancement of severe acute respiratory syndrome coronavirus infection cd13 is a novel mediator of monocytic/endothelial cell adhesion distribution and biosynthesis of aminopeptidase n and dipeptidyl aminopeptidase iv in rat small intestine vaccination with recombinant adenoviruses expressing ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse use of irf-3 and/or irf-7 knockout mice to study viral pathogenesis: lessons from a murine retrovirus-induced aids model tissue-specific interactions between nuclear proteins and the aminopeptidase n promoter the first immunoglobulin-like domain of porcine nectin-1 is sufficient to confer resistance to pseudorabies virus infection in transgenic mice isolation and characterization of a variant porcine epidemic diarrhea virus in china receptor-bound porcine epidemic diarrhea virus spike protein cleaved by trypsin induces membrane fusion molecular epidemiology and phylogenetic analysis of porcine epidemic diarrhea virus (pedv) field isolates in korea crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor a new coronavirus-like particle associated with diarrhea in swine an immunoelectron microscopic and immunofluorescent study on the antigenic relationship between the coronavirus-like agent, cv 777, and several coronaviruses differential effects of polyadenylation regions on gene expression in mammalian cells families of aspartic peptidases, and those of unknown catalytic mechanism binding characterization of determinants in porcine aminopeptidase n, the cellular receptor for transmissible gastroenteritis virus human herpesvirus 6a infection in cd46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via toll-like receptor 9 animal coronavirus vaccines: lessons for sars animal coronaviruses: what can they teach us about the severe acute respiratory syndrome? the host protease tmprss2 plays a major role in in vivo replication of emerging h7n9 and seasonal influenza viruses separate promoters control transcription of the human aminopeptidase n gene in myeloid and intestinal epithelial cells characterization of severe acute respiratory syndrome-associated coronavirus (sars-cov) spike glycoprotein-mediated viral entry proteolytic activation of the sars-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research porcine epidemic diarrhoea virus: a comprehensive review of molecular epidemiology, diagnosis, and vaccines emergence of porcine epidemic diarrhea virus in the united states: clinical signs, lesions, and viral genomic sequences tmprss2 is a host factor that is essential for pneumotropism and pathogenicity of h7n9 influenza a virus in mice feline aminopeptidase n is a receptor for all group i coronaviruses severe acute respiratory syndrome coronavirus infection of mice transgenic for the human angiotensinconverting enzyme 2 virus receptor coronavirus-like particles associated with diarrhea in baby pigs in quebec new variant of porcine epidemic diarrhea virus coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. microbiol human aminopeptidase n is a receptor for human coronavirus 229e this work was supported by a grant from animal and plant quarantine agency of korea (grant no. z-ad-14-2009-10-02), and a grant from the technology development program for agriculture and forestry, ministry for food, agriculture, forestry and fisheries, the korean research foundation grants (grants no. 20120008358, 2011grants (grants no. 20120008358, -0023942, 211-2006. key: cord-345359-okmkgsbr authors: ohno, marumi; sekiya, toshiki; nomura, naoki; daito, taku ji; shingai, masashi; kida, hiroshi title: influenza virus infection affects insulin signaling, fatty acid-metabolizing enzyme expressions, and the tricarboxylic acid cycle in mice date: 2020-07-02 journal: sci rep doi: 10.1038/s41598-020-67879-6 sha: doc_id: 345359 cord_uid: okmkgsbr although the severity of influenza virus infections has been associated with host energy metabolism, the related mechanisms have not yet been clarified. here we examined the effects of influenza virus infection on host energy metabolism in mice. after infecting mice with intranasal applications of 500 plaque-forming units of a/puerto rico/8/34 (h1n1; pr8) virus, the serum levels of most intermediates in the tricarboxylic acid (tca) cycle and related metabolic pathways were significantly reduced. these data suggest that substrate supply to the tca cycle is reduced under these conditions, rather than specific metabolic reactions being inhibited. then, we focused on glucose and fatty acid metabolism that supply substrates to the tca cycle. akt phosphorylation following insulin injections was attenuated in the livers of pr8 virus-infected mice. furthermore, glucose tolerance tests revealed that the pr8 virus-infected mice showed higher blood glucose levels than the vehicle-inoculated control mice. these results suggest that influenza virus infection impairs insulin signaling, which regulates glucose uptake. however, increases in the hepatic expressions of fatty acid-metabolizing enzymes suggest that fatty acids accumulate in liver cells of infected mice. collectively, our data indicate that influenza virus infection dysregulates host energy metabolism. this line of investigation provides novel insights into the pathogenesis of influenza. www.nature.com/scientificreports/ investigated metabolic changes by determining the serum levels of metabolites, insulin sensitivity in the liver, glucose availability, and hepatic gene expressions in the early stages of symptom onset as well as the lethal phase of influenza in a mouse model. the results of this study indicate that influenza virus infection dysregulates glucose and fatty acid metabolism and decreases tricarboxylic acid (tca) cycle activity, leading to enhanced degradation of adenosine triphosphate (atp) and guanosine triphosphate (gtp). we believe that this research provides novel insights into the pathogenesis of influenza and contributes to the development of novel influenza drugs. metabolome analysis indicated reduced tca cycle activity and enhanced purine degradation in mice with severe influenza. upon infection of 500 plaque-forming units of pr8 virus, the mice showed significant body weight loss starting at 3 day post infection (1 dpi, 98.3% ± 2.1% in control mice, 99.5% ± 0.9% in pr8 virus-infected mice; 3 dpi, 100.2% ± 2.2% in control, 85.9% ± 0.7% in pr8 virus-infected mice; 6 dpi, 100.2% ± 2.4% in control mice, 75.5% ± 2.2% in pr8 virus-infected mice). mice were sacrificed when weight loss reached a humane endpoint (25% at 6 dpi). to investigate the systemic effect of influenza virus infection on the host metabolic system, metabolome analyses were performed with serum samples collected at 1, 3, and 6 dpi for samples at very early-stage, onset of symptoms, and lethal phase during influenza, respectively. metabolome analyses identified 74 metabolites in the serum samples of the control and pr8 virus-infected mice at all time points. peak areas and relative ratios of all metabolites are provided in supplemental tables s1 and s2. samples collected at 6 dpi showed the greatest effect of pr8 virus infection on serum metabolomes, as indicated by principle component analyses with high contribution rates of principle component 1 (pc1; 51.4%; supplemental fig. s1 ). moreover, pc1 scores for the control and pr8 virus-infected mice were negative and positive, respectively, suggesting that the pc1 score was positively related to the effects of pr8 virus infection. accordingly, metabolites with high positive and negative factor loading in pc1 tended to increase and decrease with pr8 virus infection, respectively (table 1) . relative increases in the serum levels of hypoxanthine, xanthine, and inosine were 4.56-, 2.90-, and 2.68-fold, respectively, in the pr8 virus-infected mice. these molecules are intermediates of purine degradation, and their increased serum levels are considered indicative of enhanced adenosine triphosphate (atp) and guanosine triphosphate (gtp) catabolism. in agreement, the relative serum levels of the upstream purine metabolites adenosine monophosphate (amp), adenosine, guanosine monophosphate (gmp), and guanosine, were decreased by 0.033-, 0.010-, 0.0075-, and 0.25-fold, respectively, at 6 dpi. among them, the serum levels of amp and adenosine did not differ significantly between the control and infected groups at any time point owing to large individual differences in the control groups (fig. 1) . thus, the lethal phase of influenza is considered to be characterized by increased degradation of atp and gtp. metabolites that were present at reduced levels in the sera of pr8 virus-infected mice were mainly related to the tca cycle, urea cycle, and amino acid metabolism, as indicated by the serum levels of metabolite in these pathways at 1, 3, and 6 dpi (fig. 2) . the effects of 6-day pr8 virus infections on the serum levels of metabolite are summarized in fig. 3 . the levels of tca cycle metabolites pyruvic acid, 2-ketoglutaric acid, fumaric acid, and malic acid were significantly reduced in pr8 virus-infected mice at 6 dpi (0.60-, 0.54-, 0.24-, and 0.27-fold, respectively). succinic acid levels were significantly increased by 1.62-fold at 1 dpi but decreased by 0.26-fold at 6 dpi in pr8 virus-infected mice. in addition, 4-aminobutyric acid, which is synthesized from glutamic acid and converted to succinic acid, was present at reduced in pr8 virus-infected mice at 3 and 6 dpi (0.61-and 0.55-fold, respectively). the levels of urea cycle metabolites argininosuccinic acid, ornithine, and citrulline were decreased by 0.35-, 0.57-, and 0.61-fold, respectively, in pr8 virus-infected mice at 6 dpi, whereas the level of arginine was not altered significantly at any time point. given that the levels of most metabolites were significantly reduced in the tca cycle and related pathways, we suggest that pr8 virus infection reduces flux through these pathways, particularly through the tca cycle. as for amino acids, while the serum levels of ketogenic amino acids did not show any apparent decreases, those of glucogenic amino acids were significantly reduced in pr8 virus-infected mice at 6 dpi. specifically, the serum levels of asparagine, glycine, proline, serine, and tyrosine were significantly decreased by 0.49-, 0.50-, 0.62-, 0.52-, and 0.58-fold, respectively. furthermore, to estimate the effect of pr8 virus infection on glutaminolysis in which glutamine is converted to 2-ketoglutaric acid via glutamic acid and enters the tca cycle, we compared the ratio of the peak areas of glutamic acid to those of glutamine and the ratio of the peak areas of ketoglutaric acid to those of glutamic acid. while the ratio of glutamic acid to glutamine was not changed by the infection, the ratio of 2-ketoglutaric acid to glutamic acid was significantly decreased by 0.48-and 0.65-fold, respectively, at 3 and 6 dpi (supplemental table s3 ). therefore, it was indicated that glutaminolysis contribution to the tca cycle was attenuated by influenza virus infection. pathway analysis using metaboanalyst further confirmed that the tca cycle and related pathways were significantly affected by pr8 virus infection at 6 dpi. the top 10 pathways are listed in table 2 . given that the tca cycle generates gtp and contributes electrons to mitochondrial oxidative phosphorylation to generate a substantial amount of atp, suppression of the tca cycle in pr8 virus-infected mice is considered to cause imbalanced synthesis and degradation of atp and gtp. moreover, these data suggest that suppression of the tca cycle was due to reduced substrate supply to the pathway due to pr8 virus infection, rather than inhibition of specific metabolic reactions. tca cycle flux is associated with glucose and fatty acid metabolism because both these energy sources are eventually converted to acetyl-coa, which enters the tca cycle. because the liver plays a predominant role in whole-body energy metabolism, we further investigated the effect of pr8 virus infection on liver function in terms of glucose and fatty acid metabolism. www.nature.com/scientificreports/ insulin regulates cellular glucose uptake from the blood and intracellular glycolysis 9,10 , which supplies substrates to the tca cycle. upon insulin binding to the insulin receptor on the cell surface, the signal is transduced to downstream molecules and phosphorylates akt. phosphorylated akt activates glucose transporters to increase glucose uptake. therefore, phosphorylation of akt is a good indicator of activation of insulin signaling. here we examined the effect of influenza virus infection on insulin sensitivity in the livers according to ratios of insulin-induced phosphorylatable 1 . increased or decreased serum levels of metabolites in pr8 virus-infected mice at 6 dpi. metabolites with high factor loading (> 0.7) and significant differences (p < 0.05, t-test) were selected as significant metabolites and are listed here. the relative serum levels of each metabolite from pr8 virus-infected mice are presented as fold changes relative to those from control mice. factor loading was defined for each metabolite as correlation coefficients between pc1 scores and metabolite levels that were normalized by autoscaling in each sample. www.nature.com/scientificreports/ tion of akt. western blotting analyses ( fig. 4a ) of phosphorylated and total akt in whole liver lysates of control and pr8 virus-infected mice at 6 dpi revealed that the ratios of phosphorylated akt to total akt were increased by 13.0-fold after insulin treatments in control mice, but this ratio was increased by only 4.6-fold in pr8 virusinfected mice (fig. 4b) . similar experiments were performed with the livers collected at other time points. at 3 dpi, akt phosphorylation was clearly inhibited by pr8 virus infection, but no clear differences were observed in samples collected at 1 dpi (supplemental fig. s2 ). taken together, these results demonstrated that influenza virus infection impairs insulin actions in the liver. we also performed glucose tolerance tests (gtt) in control and pr8 virus-infected mice at 6 dpi to investigate whether pr8 virus infection affected glucose uptake in response to high doses of glucose (fig. 4c) . we found no significant differences in fasting blood glucose levels between the groups. moreover, at 30 min after glucose injections, the control and pr8 virus-infected mice showed similar blood glucose levels (394.4 ± 18.2 mg/dl vs. 363.2 ± 29.7 mg/dl). subsequently, blood glucose levels were rapidly decreased in control mice (60 min, 274.2 ± 13.7 mg/dl; 90 min, 193.4 ± 8.5 mg/dl; 120 min, 165.4 ± 9.0 mg/dl). conversely, decreases in blood glucose levels were delayed and higher blood glucose levels were observed in pr8 virus-infected mice, compared with the control mice, at all time points (60 min, 387.0 ± 35.4 mg/dl; 90 min, 258.6 ± 11.1 mg/dl; 120 min, 184.2 ± 4.4 mg/dl). significant differences in blood glucose levels were identified at 60 and 90 min between the groups (p < 0.05, two-way anova). these results indicate that pr8 virus infection impairs insulin signaling in the liver and induces a tendency toward glucose intolerance, potentially reflecting reduced glucose uptake. fatty acid accumulation in the liver of infected mice was suggested by gene expression assays. we also investigated the effects of pr8 virus infection on the hepatic expressions of genes that are transcriptionally regulated by insulin signaling (fig. 5) . pck2, which encodes a gluconeogenic enzyme, was expressed dpi. mice were intranasally inoculated with pbs alone or pbs comprising pr8 virus, and serum samples were collected for metabolome analysis at 1, 3, and 6 dpi. the serum levels of purine metabolites in pr8 virusinfected mice were expressed relative to those in control mice at each time point. bars represent mean ± sem of 3 or 4 animals. in each panel, white, gray, and black bars indicate data from pr8 virus-infecetd mice at 1, 3, and 6 dpi, respectively; *p < 0.05, unpaired t-test using the holm-sidak correction method with an alpha value of 0.05, control vs. pr8 virus-infected mice at each time point. the right panel shows a schematic of the effects of pr8 virus infection on purine metabolism at 6 dpi. upward and downward black arrows indicate significant increases and decreases, respectively. downward gray arrows indicate observed but not significant decreases. www.nature.com/scientificreports/ at slightly but significantly increased (1.3-fold) levels in the liver of infected mice at 3 and 6 dpi (fig. 5a ). this gene is negatively regulated by insulin signaling through inactivation of a transcriptional factor forkhead boxcontaining protein o sub-family 1 (foxo1) which reduces glycolysis and activates gluconeogenesis 11 . therefore, the increase in pck2 expression in the present study also suggests reduced insulin activity or sensitivity in pr8 virus-infected mice. in addition to glucose, fatty acids are important sources of acetyl-coa for the tca cycle. fatty acid metabolism was previously reported to be inhibited by influenza virus infection 12, 13 . therefore, we investigated whether pr8 virus infection altered the hepatic expressions of genes encoding fatty acid-metabolizing enzymes (fig. 5b) . cd36 and pnpla2 play important roles in fatty acid transport and lipolysis, respectively, and their gene expressions are downregulated by insulin signaling 14, 15 . here, cd36 was expressed at significantly increased levels in the livers of pr8 virus-infected mice, with 2.44-and 2.38-fold increases at 3 and 6 dpi, respectively. in addition, pnpla was significantly induced by 2.06-and 2.57-fold at 3 and 6 dpi, respectively. significant increases in the expressions of figure 2 . relative serum levels of intermediates of the tca cycle and related pathways in control vs. pr8 virusinfected mice at 1, 3, and 6 dpi. mice were intranasally inoculated with pbs alone or pbs comprising pr8 virus, and serum samples were collected for metabolome analysis at 1, 3, and 6 dpi. the serum levels of tca cycle metabolites in pr8 virus-infected mice are presented relative to those in control mice at each time point. each panels show metabolites of the tca cycle, urea cycle, and amino acid metabolism, respectively. bars represent mean ± sem of 3 or 4 animals. in each panel, white, gray, and black bars indicate data from pr8 virus-infected mice at 1, 3, and 6 dpi, respectively; *p < 0.05, unpaired t test using the holm-sidak correction method with an alpha value of 0.05, control vs. pr8 virus-infected mice at each time point. www.nature.com/scientificreports/ cd36 and pnpla2 as well as of pck2 suggested the attenuation of insulin signaling in the liver of pr8 virus-infected mice. conversely, we observed no changes in the expressions of acox1 and cpt1β, which encode key enzymes of fatty acid β-oxidation. in addition, the serum levels of carnitine were significantly decreased by 0.52-fold at 6 dpi (fig. 2) . because carnitine is involved in fatty acid transport into mitochondria, the observed decrease would possibly reduce fatty acid β-oxidation in mitochondria. these changes suggest fatty acid accumulation in the liver cells of pr8 virus-infected mice, although further analyses on protein expressions and enzymatic activities are warranted in the future. in the present study, metabolome analyses demonstrated that pr8 virus infection decreases the serum levels of most tca cycle intermediates and metabolites in the related metabolic pathways, suggesting reduced flux through the tca cycle. because the tca cycle greatly contributes electrons for mitochondrial oxidative phosphorylation, suppression of the tca cycle leads to reduced atp synthesis. hence, the rates of atp and gtp degradation were possibly greater than the respective rates of their synthesis in pr8 virus-infected mice, leading to significant increases in the serum levels of metabolites, such as xanthine, hypoxanthine, and inosine. energy depletion indicated by the reduced levels of atp and gtp has been described in several studies on infectious diseases and endotoxemia [16] [17] [18] . reduced atp levels in blood and various organs, including the liver, have been previously associated with influenza virus infection in a mouse model 16 . decreased gtp levels have been shown www.nature.com/scientificreports/ in the lung tissues of rabbits treated with bacterial endotoxin lipopolysaccharide 17 . increases in the serum levels of hypoxanthine and inosine have also been reported in patients with primary dengue virus infection at the febrile stage, suggesting an imbalance of atp and/or gtp synthesis and degradation during the acute stage of the dengue fever 18 . these studies and ours indicate that regulatory energy depletion is a common symptom of infectious diseases. tca cycle flux is associated with glucose and fatty acid metabolism because these energy sources are eventually converted to acetyl-coa for entry into the tca cycle. if either pathway is inhibited, the other pathway becomes activated to compensate for the reduced substrate supply to the tca cycle. in the case of hfd-induced obese mice with insulin resistance, fatty acid oxidation is increased in a leptin-dependent manner, and tca cycle activity is enhanced 19, 20 . conversely, db/db mice, a well-known mouse model of type 2 diabetes, reportedly developed insulin resistance without activation of fatty acid oxidation due to lack of leptin receptor and showed reduced serum levels of the tca cycle intermediates citric acid, 2-ketoglutaric acid, malic acid, and fumaric acid with disease progression 21 . in the present study, no changes in the expression of cpt1 or acox1 in the liver suggest that fatty acid oxidation was not enhanced in pr8 virus-infected mice despite insulin resistance. although the effect of pr8 virus infection on fatty acid oxidation was not evaluated in the present study, reduced fatty acid oxidation during influenza has been demonstrated previously 12, 13 . if both insulin signaling and fatty acid oxidation are inhibited during influenza, it might result in suppression of the tca cycle due to reduced substrate supply. given significant body weight loss in pr8 virus-infected mice, however, decrease in food intake during influenza could affect the serum levels of the tca cycle and related pathways. further investigations, such as studies with pair-fed control and lower titer of virus, will provide helpful information to confirm the underlying association. here we demonstrated for the first time that influenza virus infection impairs insulin signaling in liver tissues, which critically regulates glucose metabolism 9,10 , and induces a tendency toward glucose intolerance. importantly, nagao et al., reported a high blood glucose level (over 150 mg/dl) as one of the worst prognostic factors in pediatric patients with influenza-associated encephalopathy 22 . in addition to the elevated glucocorticoid levels, as speculated by nagao et al., our study suggests the impairment of insulin signaling as a mechanism of elevated blood glucose levels in children with severe influenza. conversely, another study reported that glucose uptake was activated in the lungs of patients with respiratory viral infections, including influenza virus infection 23 . this discrepancy may be associated with tissue-specific metabolic changes in response to influenza virus infection. however, given the direct activating effect of influenza virus proliferation on glucose metabolism in cultured mice were intranasally inoculated with pbs alone or pbs comprising pr8 virus. at 6 dpi, the mice were intraperitoneally injected with pbs or insulin after overnight fasting, and liver samples were collected after 15 min for whole lysate preparation. western blotting was performed to quantitate phosphorylated and total akt protein levels in lysates. (a) a representative western blotting analysis shows total akt and akt phosphorylated at ser473 on the same membrane that was sequentially immunoblotted with corresponding antibodies. (b) relative akt phosphorylation levels were calculated from band densities and expressed relative to data from pbs-treated control mice. bars represent mean ± sem of 3 animals. white and black bars indicate data from pbs-and insulin-treated mice, respectively; p < 0.05, two-way anova, pbs vs. insulin (*), control vs. pr8 virus-infected mice (#). (c) mice were intranasally inoculated with pbs alone or pbs comprising pr8 virus. at 6 dpi, gtt was performed after overnight fasting. to this end, mice were intraperitoneally injected with glucose, and their blood glucose levels were sequentially measured at 0, 30, 60, and 90 min post injection. dots represents mean ± sem of 5 animals; *p < 0.05, unpaired t test using the holm-sidak correction method with an alpha value of 0.05, control vs. pr8 virus-infected mice at each time point. www.nature.com/scientificreports/ madin-darby canine kidney cells 24 , the hepatic insulin resistance demonstrated here could have been induced by host factors and not the virus itself. upon intranasal infection of pr8 virus, proliferation of the virus occurs mainly in the lung and not in the liver of mice 25 . hence, the hepatic insulin resistance observed herein is possibly induced by host factors, such as systemically secreted cytokines. the direct roles of cytokines on insulin signaling have been demonstrated in a study showing that the proinflammatory cytokine interleukin-6 (il-6) inhibited insulin-dependent phosphorylation of akt in hepg2 cells and human primary hepatocytes 26 . furthermore, il-6 treatments reportedly impaired insulin signaling and inhibited insulin-induced decreases in blood glucose levels in mice 27 ; in this previous experiment, the serum levels of il-6 reached approximately 125 pg/ml, which was comparable to that observed herein in pr8 virus-infected mice at 3 and 6 dpi when reduced insulin-induced phosphorylation of akt was observed (supplemental fig. s3, 109.3 and 137.1 pg/ml at 3 and 6 dpi, respectively). thus, we suggest that this cytokine is one of host factor candidates that affect insulin resistance, particularly in the liver. in addition to il-6, interferon-gamma (ifn-γ) was reportedly induced by murine cytomegalovirus infections and was recently shown to induce insulin resistance in skeletal muscle 28 . besides il-6, the serum levels of ifn-γ were elevated in pr8 virus-infected mice at 6 dpi but were very low at 3 dpi in our study (supplemental fig. s3; 1 .391 and 313.4 pg/ml at 3 and 6 dpi, respectively). therefore, we propose that influenza virus infection induces hepatic insulin resistance through systemic cytokine secretion. as stated above, in addition to glucose, fatty acids are important sources of the tca cycle substrate acetyl-coa. reduced fatty acid metabolism during influenza has been reported in previous reports showing mitochondrial abnormalities, decreases in the expressions of relevant enzymes, and hepatic steatosis in mice 12, 13 . consistently, our gene expression data indicate altered fatty acid metabolism in the livers of pr8 virus-infected mice. in particular, the transcription levels of the fatty acid transporter cd36 and the lipolytic enzyme pnpla2 were upregulated at 3 and 6 dpi, possibly elevating extracellular fatty acid delivery and stored triglyceride lysis in liver cells. however, no changes were observed in the mrna expressions of acox1 and cpt1b. these encoded enzymes are rate limiting factors for fatty acid β-oxidation in peroxisomes and mitochondria, respectively. taken together, our data suggest that fatty acids are accumulated in the cytoplasm of liver cells in influenza virus-infected mice. although anorexia due to influenza virus infection may induce similar alterations in gene expressions and subsequent hepatic steatosis, the findings of pair-fed studies on influenza eliminated the possibility that starvation www.nature.com/scientificreports/ is solely responsible for these changes 12, 13 . moreover, fasting generally increases the mrna expressions of acox1 and cpt1b, thereby discriminating the effects of influenza virus infection on fatty acid metabolism from those of starvation 29, 30 . fatty acid accumulation can induce mitochondrial dysfunction, as reported previously in cultured hepatocytes 31 . mitochondrial dysfunction increases oxidative stress via reactive oxygen species production. reactive oxygen species and diacylglycerol, converted from triacylglycerol by adipose triglyceride lipase (encoded by pnpla2), inhibit insulin signaling 32 . it is suggested that accumulation of intracellular fatty acids triggers and complicates insulin resistance in the liver of infected mice. given the higher influenza-associated mortality and morbidity rates in patients and mice with energy metabolism disorders 2-6 , energy metabolism dysregulation induced by influenza virus infection is possibly associated with pathogenicity. increased mortality rates with influenza have been reported in diet-induced obese mice which probably had insulin resistance as well as in long-chain acyl-coa dehydrogenase-knockout mice, which had reduced mitochondrial fatty acid oxidation 2,5 . interestingly, both these mouse models presented with subdued immune responses to virus infection and similar or lower lung virus titers compared with the control mice. hence, increased influenza severity in animals and patients with energy metabolism disorders can be explained neither by the increased levels of inflammatory cytokines nor by the reduced clearance of pathogens 2,5 . as described above, dysregulation of energy metabolism appears to be a downstream response to cytokine and inflammatory signaling and thus could be more directly associated with the pathogenesis and severity of influenza. previous cohort studies have demonstrated that antiinflammatory corticosteroids have no beneficial effects and that these corticosteroids can exacerbate outcomes in patients with severe influenza 33 . given that glucocorticoids inhibit insulin signaling as well as cytokine-dependent pathogen clearance 34, 35 , corticosteroid treatments could confound pathogenicity. thus, improvements in host energy metabolism would be a novel therapeutic target for severe influenza rather than immune suppression. moreover, this concept could be expanded to other infectious diseases because energy metabolism dysregulation is possibly induced by host factors, such as proinflammatory cytokines, and not by the viruses themselves. given the recent emerging infectious diseases such as the pandemic influenza in 2009 and severe pneumonia by the novel corona virus in 2019, the importance of developing novel therapeutic drugs that target host factors against common symptoms of various diseases is important. infants and children younger than 5 years of age are generally at high risks of mortality and morbidity due to influenza compared with middle-aged adults 36 . previously, a negative correlation of nasal lavage and plasma inflammatory cytokine levels with age has been reported and thought to be a reason for the high mortality and severe illness caused by influenza virus infection in young children 37, 38 . in addition to cytokine responses, age-specific features of energy metabolism could provide insights into the pathogenesis of influenza at different ages. in pediatric patients with type i diabetes, the youngest population (0-5 years of age) reportedly showed the highest prevalence of diabetic ketoacidosis, which has an impact on morbidity and mortality 39 , indicating that attenuation of insulin signaling by virus infection could result in more severe symptoms in such populations. the present study provides novel insights into host responses during influenza. based on the findings of the present and previous studies, we conclude that influenza virus infection induces dysregulation of both insulinregulating glucose metabolism and fatty acid oxidation, leading to decreased tca activity. in future studies, we aim to investigate the effect of influenza virus infection at lethal and sublethal doses of various virus strains for further understanding of influenza pathogenesis and examine the therapeutic effects of interventions that improve host energy metabolism. materials. phosphate-buffered saline (pbs) was purchased from gibco/life technologies (carlsbad, ca). tris-buffered saline (tbs) tablets were purchased from takara bio (otsu, japan). urea, tween 20, and glucose were purchased from sigma-aldrich (st louis, mo). sodium dodecyl sulfate (sds) was purchased from wako (tokyo, japan). mouse. male c57bl/6 mice were purchased from hokudo (sapporo, japan) and were kept at a bsl-2 laboratory at the research center for zoonosis control, hokkaido university, under standard laboratory conditions (room temperature 22 °c ± 2 °c, relative humidity 50% ± 10%) and a 12/12-h light/dark cycle. the mice were administered a standard ce-2 chow diet purchased from clea japan (sapporo, japan) with water ad libtum. experiments were performed on 9-14 week-old mice. virus infection and sample collection. pr8 virus particles at 500 plaque-forming units in 50 µl of pbs or pbs only (control) were intranasally inoculated into the mice under inhalation anesthesia with isoflurane. at 1, 3, or 6 dpi, the mice were euthanized, and their liver and blood samples were collected. blood samples were incubated at room temperature for 1 h to clot and were then centrifuged at 1,000g for 20 min. supernatants were collected as serum and were stored at − 20 °c until further analysis. tissue samples were stored at − 80 °c until further analysis. to evaluate insulin sensitivity, the mice were administered insulin (humulin r, eli lilly, indianapolis, in) at 2 u/kg body weight intraperitoneally at 6 dpi after overnight fasting. after 15 min, the mice were euthanized, and their liver samples were collected and frozen immediately in liquid nitrogen. liver samples were stored at − 80 °c until further analysis. research (kyoto, japan) using liquid chromatography-tandem mass spectrometry (lc-ms/ms). briefly, after the addition of an internal standard (2-isopropylmalic acid) to the serum samples, sample preparation was conducted using a series of hydrochloride and acetonitrile extractions. after centrifugation at 10,000 rpm for 5 min at room temperature, the supernatants were divided into two tubes: one was used for analyses of amp, gmp, aconitic acid, citric acid, and fumaric acid, whereas in the other one, the supernatant was mixed with hydrochloride and used for analysis of other compounds. chromatographic separations were performed on a 2 discovery hs f5-3 column (2.1 mm × 150 mm, 3 μm, sigma-aldrich). the oven temperature for the column was maintained at 40 °c. mobile phases a and b were 0.1% formic acid-water solution and 0.1% formic acid-acetonitrile, respectively. separation was performed using gradient elution at a flow rate of 0.25 ml/min with a nexera uhplc system (shimadzu). compounds were eluted by changing proportions of mobile phase b as follows: 0% (0-2 min), 0%-25% b (2-5 min), 25%-35% b (5-11 min), 35%-95% (11-15 min), 95% (15-20 min), 95%-0% (20-20.1 min), and 0% (20.1-25 min). compounds were detected using an lcms-8050 (shimadzu) instrument with electrospray ionization. the peak areas of each compound were measured using labsolutions (shimadzu) and were normalized to that of an internal standard. the metabolome analyses identified 74 molecules in our sample sets. among them, cysteine, cytosine, and methionine sulfoxide were not detected in some samples from pr8 virus-infected mice at 3 and 6 dpi (supplemental table s1 ). to examine the effects of pr8 virus infection on the serum levels of various compounds, the relative peak areas for pr8 virus-infected mice were expressed as fold changes relative to the average peak areas for the control mice at corresponding time points. the peak areas and relative ratios are provided in supplemental table s1 and s2. serum metabolome data analysis using metaboanalyst. utilizing peak areas of 74 molecules, principal component analysis and pathway analysis were performed with metaboanalyst (https ://www.metab oanal yst.ca). the values were normalized by autoscaling function. missing values in cysteine, cytosine, and methionine sulfoxide were replaced by small values (a half of the minimum positive values in the original data). factor loading was defined for each metabolite as the correlation coefficient between the pc1 score and the level of the metabolite after normalizing by autoscaling for each sample. metabolites with high factor loading (> 0.7) and significant differences (p < 0.05, t-test) were selected as significant metabolites and are listed in table 1 . pathway analyses were performed based on the kyoto encyclopedia of genes and genomes (https ://www.genom e.jp/ kegg/), and the most significantly altered metabolic pathways in pr8 virus-infected mice were identified. the top 10 pathways identified are listed in table 2 . evaluation of phosphorylated akt by western blotting. liver samples were homogenized in tbs comprising 8 m urea and 1% sds using an ultrasonic homogenizer (q125 sonicator, qsonica, newtown, ct) and centrifuged at 15,000g for 10 min at 10 °c to obtain supernatants as whole liver lysates. protein levels were measured using pierce bca protein assay kits (thermo fisher scientific, waltham, ma). samples for western blotting were prepared by mixing whole liver lysates with the nupage lds sample buffer (thermo fisher scientific) and heating at 70 °c for 10 min. subsequently, 10 μg aliquots of total protein were separated using 10% sds-polyacrylamide gel electrophoresis (sds-page) and were transferred to polyvinylidene difluoride membranes. after blocking with 5% nonfat dry milk in tbs buffer comprising 0.1% tween 20 (tbst), the membranes were probed with an anti-akt phosphorylated at ser473 antibody (1:1,000, #9271, cell signaling technology, beverly, ma) or an anti-akt antibody (1:1,000, cell signaling technology) in tbst buffer comprising 5% bovine serum albumin overnight at 4 °c. the membranes were then treated with secondary horseradish peroxidase-conjugated antirabbit antibody (1:5,000, sc-2357, santa cruz) for 1 h at room temperature. protein bands on membranes were detected using supersignal west femto maximum sensitivity substrate (thermo fisher scientific) and an imagequant las4000 system (ge, buckinghamshire, uk). the bands were quantified using the imagequant tl analysis system (ge). full-length images are provided in supplemental fig. s4 . pbs at 2 g/kg body weight after overnight fasting. blood was collected from tail veins at 0, 30, 60, and 90 min after injections, and plasma glucose concentrations were measured using an accu-chek glucose meter (roche diagnostic, mannheim, germany). www.nature.com/scientificreports/ amount of assay buffer for serum samples or serum matrix for standards and controls. magnetic beads coated with antibodies against the target cytokines were added to each well, and the plates were incubated on a plate shaker overnight at 4 °c. after washing with washing buffer in the kit, the samples were reacted with biotinylated detection antibodies for 1 h and then with streptavidin-phycoerythrin for 30 min. after washing and addition of loading buffer from the kit, the samples were analyzed by the magpix system (luminex, austin, tx, usa). the results are presented in supplemental fig. s3 . statistical analysis. statistical analyses were performed using prism 7 (graphpad software, san diego, ca, usa). differences were identified using unpaired t-tests or two-way anova and were considered significant when p < 0.05. data are presented as mean ± standard error of the mean (sem). all experiments were performed at least twice to confirm the reproducibility. ethical statement. all mouse experiments were performed with approval from the animal care and use committee of hokkaido university following the fundamental guidelines for proper conduct of animal experiment and related activities in academic research institutions under the jurisdiction of the ministry of education, culture, sports, science and technology in japan. body weight losses were monitored daily after infection, and mice were humanely euthanized when weight loss reached 25%. all data generated or analyzed during this study are included in this published article and its supplementary information files. received: 28 december 2019; accepted: 8 june 2020 influenza-who cares diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-hispanic black and white us adults preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with a(h1n1)2009 influenza virus increased mortality from influenza infection in long-chain acyl-coa dehydrogenase knockout mice thermolabile cpt ii variants and low blood atp levels are closely related to severity of acute encephalopathy in japanese children ikk-beta links inflammation to obesity-induced insulin resistance chronic inflammation aggravates metabolic disorders of hepatic fatty acids in high-fat diet-induced obese mice stimulation of glycolysis by insulin regulation of glucose uptake in muscle. i. the effects of insulin and anoxia on glucose transport and phosphorylation in the isolated, perfused heart of normal rats foxo1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression role of influenza b virus in hepatic steatosis and mitochondrial abnormalities in a mouse model of reye syndrome kupffer cells modulate hepatic fatty acid oxidation during infection with pr8 influenza increased cd36 protein as a response to defective insulin signaling in macrophages the adipose tissue triglyceride lipase atgl/pnpla2 is downregulated by insulin and tnf-alpha in 3t3-l1 adipocytes and is a target for transactivation by ppargamma diisopropylamine dichloroacetate, a novel pyruvate dehydrogenase kinase 4 inhibitor, as a potential therapeutic agent for metabolic disorders and multiorgan failure in severe influenza adenosine a1 and a2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung serum metabolome and lipidome changes in adult patients with primary dengue infection elevated tca cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver leptin stimulates fatty-acid oxidation by activating amp-activated protein kinase gc/tofms analysis of metabolites in serum and urine reveals metabolic perturbation of tca cycle in db/db mice involved in diabetic nephropathy prognostic factors in influenza-associated encephalopathy targeting metabolic reprogramming by influenza infection for therapeutic intervention metabolic effects of influenza virus infection in cultured animal cells: intra-and extracellular metabolite profiling multiorgan distribution of human influenza a virus strains observed in a mouse model interleukin-6 induces cellular insulin resistance in hepatocytes chronic exposure to interleukin-6 causes hepatic insulin resistance in mice virus-induced interferon-γ causes insulin resistance in skeletal muscle and derails glycemic control in obesity nutrient-sensing nuclear receptors coordinate autophagy extrahepatic pparα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction inflammation and lipid signaling in the etiology of insulin resistance corticosteroids for severe influenza pneumonia: a critical appraisal glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin-and non-insulin-related stimuli interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology age-specific mortality risk from pandemic influenza mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load cytokine and chemokine response in children with the 2009 pandemic influenza a (h1n1) virus infection ketoacidosis at diagnosis of type 1 diabetes in french children and adolescents we thank the national institute of infectious disease in japan for kindly providing influenza virus a/puerto rico/8/34 (h1n1). this work was supported by japan science and technology agency basic research programs, jsps kakenhi (grant number 17k15367), and northern advancement center for science and technology, hokkaido japan (grant number 786k001018). the authors declare no competing interests. supplementary information is available for this paper at https ://doi.org/10.1038/s4159 8-020-67879 -6.correspondence and requests for materials should be addressed to h.k. publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.open access this article is licensed under a creative commons attribution 4.0 international license, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the creative commons license, and indicate if changes were made. the images or other third party material in this article are included in the article's creative commons license, unless indicated otherwise in a credit line to the material. if material is not included in the article's creative commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. to view a copy of this license, visit http://creat iveco mmons .org/licen ses/by/4.0/. key: cord-350593-bvmg7f15 authors: mcdonald, r.s.; sambol, a.r.; heimbuch, b.k.; brown, t.l.; hinrichs, s.h.; wander, j.d. title: proportional mouse model for aerosol infection by influenza date: 2012-08-21 journal: j appl microbiol doi: 10.1111/j.1365-2672.2012.05402.x sha: doc_id: 350593 cord_uid: bvmg7f15 aims: the aim of this study was to demonstrate a prototype tool for measuring infectivity of an aerosolized human pathogen – influenza a/pr/8/34 (h1n1) virus – using a small‐animal model in the controlled aerosol test system (cats). methods and results: intranasal inoculation of nonadapted h1n1 virus into c57bl, balb/c and cd‐1 mice caused infection in all three species. respiratory exposure of cd‐1 mice to the aerosolized virus at graduated doses was accomplished in a modified rodent exposure apparatus. weight change was recorded for 7 days postexposure, and viral populations in lung tissue homogenates were measured post mortem by dna amplification (qrt‐pcr), direct fluorescence and microscopic evaluation of cytopathic effect. plots of weight change and of pcr cycle threshold vs delivered dose were linear to threshold doses of ~40 tcid (50) and ~12 tcid (50), respectively. conclusions: mid (50) for inspired h1n1 aerosols in cd‐1 mice is between 12 and 40 tcid (50); proportionality to dose of weight loss and viral populations makes the cd‐1 mouse a useful model for measuring infectivity by inhalation. significance and impact of the study: in the cats, this mouse–virus model provides the first quantitative method to evaluate the ability of respiratory protective technologies to attenuate the infectivity of an inspired pathogenic aerosol. whereas aerosols and contact are accepted as modes of transmitting many disease-causing organisms, including legionella pneumophila, smallpox, severe acute respiratory syndrome (sars), coronaviruses, rhinovirus (fiegel et al. 2006 ) and tuberculosis (wells 1934; riley et al. 1959; mcclement and christianson 1980) , the role of bioaerosols as a transmission mechanism for influenza is less clearly understood (tellier 2006; tellier 2007a,b; lemieux and brankston, 2007; brankston et al. 2007; tang and li, 2007; lee 2007) . although a few publications have documented the transmissibility of influenza a through inhalation routes (tellier 2006 (tellier , 2009 , few studies to date have utilized a mouse model to investigate susceptibility to and pathogenicity of measured aerosol exposures. the lack of aerobiology studies results from several factors, including the need for specialized equipment to generate and monitor bioaerosols, the technical difficulty involved, inconsistency among reported techniques (lore et al. 2011 ) and the considerable cost of conducting this research (sherwood et al. 1988) . therefore, the most commonly described method of infecting mice with influenza virus is through the installation of fluid into the nasal passages (lu et al. 1999; govorkova et al. 2007; gillim-ross et al. 2008; chen et al. 2011) . for more than 75 years, laboratory mice have served as models for susceptibility to and pathogenesis of influenza disease (andrewes et al. 1934) . their low cost, small size, relative susceptibility to the virus and ease of handling make mice a favourable platform for studying influenza virus infections. the mouse is currently considered the primary model for the evaluation of influenza antiviral agents because it is a predictive indicator of the efficacy of such treatments in humans (sidwell and smee 2004) . the use of a well-characterized mouse model is especially important in studying the infectious pathways of new pandemic (pdm) subtypes of influenza a. indeed, the latest emergence of influenza has reignited interest in the use of mouse models (beigel and bray 2008) . although mathematical models have been used for decades (findeisen 1935; yeh et al. 1976 ; international commission on radiological protection (icrp) 1994; asgharian and anjilvel 1998; heyder 2004) to calculate particle deposition within the respiratory tract, such calculations of particle placement are able to rationalize but not to predict the resulting clinical effect. animal models allow closer approximation to a human response (schulman 1968; lowen et al. 2006; gustin et al. 2011) , and therefore, it is important to continue to further develop these models kawaoka 2012) . experimental inhalation exposure systems are an established tool and the subject of several reviews (drew and laskin 1973; macfarland 1983; cheng and moss 1995; jaeger et al. 2006; wong 2007) . the purpose of this study was to identify and evaluate a mouse model as a complement to a measured-dose bioaerosol delivery apparatus termed cats (controlled aerosol test system) for testing the clinical effectiveness of media used in respiratory protective equipment (rpe). this validation, which includes complementary data measured postmortem, renders the mice available to serve as a detector to evaluate the clinical significance of articles of rpe by directly measuring the change in infectivity the protective article causes. exposure to influenza virus often leads to a disease presenting as an acute and temporarily incapacitating infection of the upper respiratory tract that can be fatal. influenza illness is often associated with occurrences of annual or near-annual epidemics in temperate climate zones. within the last 100 years, influenza pandemics have occurred four times [1918 (h1n1), 1957 (h2n2), 1968 (h3n2) and 2009 (h1n1)] (oxford 2000) . pandemics are infrequent but often severe events because of the emergence of novel, unpredictable strains of influenza a virus caused by recombination of genetic material from two or more circulating virus subtypes. this antigenic shift can often lead to a new virus subtype with the ability to jump from one species into another, potentially naive species (e.g. avian influenza), and cause a large proportion of influenza-related deaths. a number of animal models have been studied to evaluate new vaccines and other approaches for preventing influenza-related disease (gubareva et al. 1998; ng et al. 2010) . green and kass (1964) conducted studies on the clearance of inhaled microbial aerosols from the murine respiratory tract. schulman and kilbourne (1963) studied mouse-to-mouse transmissibility of influenza virus. a factor complicating viral research in animal models is that a virus may be present in a host without causing disease. this may be due to restrictions such as the absence of appropriate receptors on certain cell types (e.g. tissue tropism) and the lack of intracellular processes required to generate infectious progeny viruses or induce cytolytic effects. differences in viral receptors have been documented for respiratory epithelial cells based on location in either the pharynx or peripheral lung (van riel et al. 2007 (van riel et al. , 2010 . in addition, either the organism or host cell may mount an immune response or generate intracellular molecules that disrupt the viral effects. therefore, differences may appear at either the cellular or tissue level or among susceptible hosts depending upon the method of infection, especially in regard to aerosol exposures (phalen et al. 2008) . this study examined these parameters related to efficient (near threshold) infection versus overwhelming infection of mice by exposure to aerosolized influenza virus. the cats is an apparatus that was designed, constructed and validated (stone 2010; stone et al., 2012) to deliver a precisely measured aerosol concentration, either directly or after passage through a filter medium, through a nose-only directed-flow inhalation exposure system (noies; ch technologies, westwood, nj, usa, jaeger et al. 2006) to individual mice (figs 1 and 2) . this low-flow, singlepass design consists of an aerosol generator, diffusion drier, charge neutralizer, filter holder, sampling points and noies unit (stone 2010; stone et al., 2012) . the cats generates a biological aerosol over a range of constant concentrations andafter conditioning and treatment, if any is applieddelivers the particles to the nose of a mouse constrained in a polycarbonate tube (cht-247; ch technologies) as a pure respiratory exposure. the main system components were connected using 0á5-inch (12á7-mm) stainless steel tubing with a minimum number of gradual bends. in operation, a single-jet collison nebulizer (bgi inc., waltham, ma, usa), regulated to 25-30 psi was used to atomize the viral suspensions. the aerosol, which acquires surface charges during atomization, passes through a 9á5-inch (23-cm) diffusion drier and then through a 2-mci 85 kr charge neutralizer (tsi inc., shoreview, mn, usa) to restore the 'normal' boltzmann equilibrium charge distribution. after passage through the filter holder and any filter medium mounted in it, the aerosol enters the 12-port noies, from which it exits the test system through the hepa-filtered exhaust. total flow rate through the system was regulated at the nebulizer to deliver 2á0 ± 0á1 l min à1 measured on exit by a mass flow metre (tsi model 4043e). the entire system was designed to fit inside a biological safety cabinet (baker company, sanford, me, usa; sg603-ats) for additional protection from generated aerosols. the unique feature of the system is an optional filter holder (triosyn corp, williston, vt, usa), which is capable of holding filter media samples 47 mm in diameter. smaller discs of filter media can be accommodated with the use of reducers. correlation of sampling ports stone et al. (2012 , stone 2010 ) demonstrated uniform distribution of aerosol to several ports of the cats. following transport and installation of the cats in an animal biosafety level 3 (abl3) facility at the university of nebraska medical center, the exposure system was retested to verify consistency of particle counts among all 12 ports, using tap water to generate test aerosol particles. from each of the 12 exposure ports, samples of particles delivered by a single-jet collison nebulizer were measured in triplicate using a scanning mobility particle sizer (smps) system (tsi inc., minneapolis, mn, usa). the aerosol particle size and concentration were determined using 6á0 l min à1 sheath air and 0á6 l min à1 sample air. data outputs from the smps were collected by the aerosol instrument manager ® software (ver. 8.1.0.0; tsi inc., minneapolis, mn, usa). influenza a/pr/8/34 (h1n1) virus was obtained from american type culture collection (rockville, md, usa) as frozen stock (atcc vr-1469). virus was propagated using cdc unit 15g.1 protocol (szretter et al. 2006) . titres were performed and calculated using the spearman-kärber method (armitage and allen 1950; finney 1964) . to assess the psd of aerosols containing influenza virus, samples were taken in triplicate from the sampling port located downstream from the cats, diluted with filtered air and routed to the smps. results indicated a single-mode, polydisperse aerosol in the size range 10-400 nm. three strains of female mice (c57bl, balb/c and cd-1) were purchased from charles river laboratories (portage facility, mi, usa). the mice were 6-8 weeks old and ranged in weight from 18 to 30 g. mice were randomly divided into groups assigned to specific exposure time points, and no more than five (all in a given exposure group) were housed per cage. animals were provided rodent chow (harlan teklad, usa) and water ad libitum and maintained on a 12-h light/dark cycle. all animal work was carried out in an abl3 facility following institutional and regulatory procedures. to minimize artefacts caused by stress during respiratory exposure sessions, mice were preconditioned daily during the week preceding their exposure sessions (nrc 2003 (nrc , 2011 ) by insertion into a mouse restraint device (ch247; ch technologies) for a period that did not exceed the maximum exposure time for that experiment. to select a suitable mouse strain for infection with the influenza a/pr/8/34 (h1n1) (not mouse-adapted) strain used in this study, two inbred (balb/c and c57bl) and one semi-outbred strain (cd-1) of 20-25 g female mice were tested for susceptibility to infection by the virus. individual base weights were determined prior to exposure, and all mice were weighed daily at a uniform, scheduled time throughout the study. the average weights from surviving exposed mice at day 7 were compared to the averages of control mice. all mice were euthanized by day 7 postinoculation. the inoculum, consisting of 30 ll of virus at a concentration of 4á74 9 10 7 median tissue culture infectious dose (tcid 50 ) ml à1 , was placed intranasally into each mouse. the dose was divided equally and placed dropletby-droplet by pipette into each naris of the anesthetized (ketamine/xylazine) mouse. following the same procedure, a 1 : 10 dilution of virus stock in 19 phosphatebuffered saline (pbs) medium was used to inoculate a second set of mice of the same three strains. in all, five mice per strain per dilution were used to determine susceptibility to the virus. three mice per strain were used as controls. each control mouse was intranasally inoculated with 30 ll total 1 9 pbs medium as previously described (jerrells et al. 2007) . in a preliminary study conducted to establish a baseline dose of virus capable of causing infection following aerosolization, the working stock of influenza virus was diluted 1 : 30 in endotoxin-free water (sigma, st. louis, mo, usa) and delivered into the collison nebulizer at 1á58 9 10 6 tcid 50 ml à1 . four sets of three cd-1 mice were emplaced in polycarbonate restraints, installed into the noies with the filter holder empty, and exposed to aerosolized virus at exposure times of 2, 6, 20 and 60 min. aliquots of the influenza working stock (4á74 9 10 7 tcid 50 ml à1 titre) were subsequently diluted to 1 : 300 and 1 : 1000 (v/v) in endotoxin-free water to prepare concentrations aerosolized during three successive mouse exposure series described below. the single-jet collison nebulizer was charged and allowed to run for 5 min to stabilize the system. the bypass valve directly upstream of the cats directed the aerosol through two hepa filters connected in series until exposure was initiated. nonanesthetized mice were carefully immobilized in the polycarbonate tubes so that the tip of the nose projected out of an opening in the front of the holder. the tubes were then inserted securely into a port on the cats. once the animals were emplaced, the test aerosol was directed through the system. vents inside the cavity of the cats directed an airstream containing the filtered aerosol at the nares of the mouse as her only source of breathing air. excess aerosol flow and exhaled air were continuously swept away to preclude inhalation of previously exhaled air. a spread of delivered doses (proportional to concentration, c, 9 time, t) around each dilution was achieved by varying the time of exposure. the bioaerosol dose received is calculated as follows: where vsf is the ratio of viable airborne counts, in tcid 50 ml à1 , to viable counts, in tcid 50 ml à1 , in the collison reservoir, and r a is the respiration rate per minute, and v a is the tidal volume in ml a (ml of air), respectively, of the cd-1 mouse. r a and v a are reported (fairchild 1972) to be 261 respirations/min and 0á16 ml a , respectively. thus, a mouse exposed for 2 min to a 300 : 1 dilution of a suspension containing 4á74 9 10 7 tcid 50 ml à1 of virus inhales a dose of d p ¼ 4á74 â 10 7 tcid 50 ml à1 â 1=300 â 9 â 10 à7 ml ml à1 a â 261 resp min à1 â 0á16 ml a resp à1 â 2 min ¼ 12 tcid 50 mice were exposed in groups for each preselected time (tables 2-4 ). at the end of the exposure period, the polycarbonate tubes holding the mice were removed, and the next group was inserted, until all mice for that series of experiments were exposed. when time points allowed, the mice were inserted in overlapping groups. unused ports were sealed with the supplier's standard plugs. all exposures were carried out within a biological safety cabinet. control mice for 1 : 30 (1á58 9 10 6 tcid 50 ml à1 ) and 1 : 300 (1á58 9 10 5 tcid 50 ml à1 ) exposure groups were placed in polycarbonate tubes during the testing equal to the maximum exposure time and exposed to aerosols generated from endotoxin-free water (sigma) containing no virus. for the 1 : 1000 (4á74 9 10 4 tcid 50 ) exposure group, two sets of controls were used. one mouse group was exposed as earlier, while a second group was exposed to uninfected allantoic fluid processed in the same manner as from influenza-infected eggs. mice were observed and weighed each of 7 days postexposure. severely distressed mice were euthanized after the day's weighing and, following the final weighing, all surviving mice were euthanized by administration of an overdose of ketamine/xylazine by intraperitoneal injection. a necropsy was conducted and selected portions of the lungs were selected for molecular, histological or virus culture assessment. lung tissues aseptically placed into 2á7 ml of cold bd universal virus transport medium (becton, dickinson and co., franklin lakes, nj, usa) were homogenized by hand using a closed ultra tissue grinder system (fisher scientific, pittsburgh, pa, usa) and then stored at à80°c. cell culture and molecular assays tcid 50 /cpe and dfa assays starting viral titres were quantified by cell culture endpoint-dilution assays performed using madin-darby canine kidney (mdck) cells and calculated using the spearman-kärber method in units of log 10 tcid 50 ml à1 . cell culture plates containing mdck cells were grown and maintained using standard cell culture techniques. presence of viable virus in homogenates of murine lung tissue was qualitatively assessed by two-concentration cell culture endpoint assays performed using mdck cells. cell culture plates containing mdck cells were grown and maintained using standard cell culture techniques. aliquots (1á0 ml) of lung homogenates were plated in serial 1 : 10 dilutions (in serum-free eagle's minimal essential medium (emem)) from 10 à1 to 10 à4 in quadruplicate on confluent cell monolayers. the samples remained in contact with the monolayer for a 1-h incubation before 1% bsa-serumfree emem with trypsin was added (bovine serum albumin). the plates were incubated for 5-6 days under 5% co 2 at 37°c prior to visualization under the microscope for cytopathic effect (cpe) or fluorescent-labelled antibody evaluation. test plates were read using a +/à system, in which + showed disruption of the monolayer and à showed that the monolayer remained confluent. direct fluorescent antibody assay (dfa) was used to qualitatively determine influenza infection of the mdck cell line using the d 3 ultra dfa respiratory virus screening and id kit (diagnostic hybrids inc., athens, oh, usa) per manufacturer's instructions. rna extraction and qrt-pcr ribonucleic acid (rna) was extracted from samples using the qiaamp ® minelute ® virus spin kit following the manufacturer's protocol (qiagen, valencia, ca, usa). rna amplification was performed using invitrogen's superscript iii platinum one-step quantitative real-time polymerase chain reaction (qrt-pcr) kit (invitrogen, grand island, ny, usa). the qrt-pcr assay was run on the roche lightcycler ® 480 real-time pcr system (roche diagnostics, indianapolis, in). assay conditions and reaction volumes were used from protocols previously described by the cdc (who 2009 ). the cycle threshold (ct) values from replicate runs were averaged for each time point and rounded to two decimal places. the recommended cut-off ct value of 30 was used as the criterion for infection. following fixation and routine processing, tissue sections were stained with hematoxylin and eosin and reviewed under standard light microscopy. compared to normal tissue, influenza-infected lungs showed lobular pneumonia with interbronchial inflammation. infected lungs also showed focal chronic inflammatory cell infiltration with a few neutrophils and some interstitial thickening. figure 3 shows the infiltrates in the infected tissue compared to uninfected tissue. after installation in the abl3 cabinet, a reverification of cats performance was conducted with water. the par-ticle counts at each port were averaged and again seen to be uniform within 10% (data not shown). a subsequent delivery of 100 mg l à1 sodium chloride in water showed number mean diameter (d 50,n ) = 74 nm and mass mean diameter (d 50,m ) = 208 nm over the range of particle diameters from 10 to 407 nm. figure 4 plots the coefficient of variation (cov) as a function of particle size at the 12 ports for the nacl aerosol measurements. groups of five mice were inoculated intranasally with one of two doses of virus and weighed daily for a week. per cent changes in average weights of exposed and control groups are indicated in table 1 . the nonmouse-adapted influenza virus produced obvious infection in all three strains of mice used. as no difference in gross infectivity was indicated by weight loss (table 1) , the less-expensive cd-1 mice were selected for further study. aerosol exposure (1á58 9 10 6 tcid 50 ml à1 ) two mice were used as unexposed controls. all of the mice survived to day 7, when they were euthanized and necropsied, and their lung tissue was examined by three different assays. at all four exposure time points, mouse lung tissues gave positive results from the qrt-pcr assay, for which a positive value was defined to be 31 ct. dfa and cpe assays on the lung tissue were also all positive ( table 2 ). there was a direct correlation between dose received (for convenience reckoned as ct values (product of concentration and exposure time)), with lower pcr ct values resulting from prolonged exposure. the mean ct value for control mice was 37, which was defined to be a negative response. values of 37 > ct > 31 were considered indeterminate. weight losses again showed proportionality to dose delivered. the results demonstrated that the influenza virus remained viable and capable of causing infection in cd-1 mice when aerosolized under test conditions. aerosol exposure (1á58 9 10 5 tcid 50 ml à1 ) because exposure to the 1 : 30 dilution of aerosolized virus resulted in massive but graduated infection of all tested mice, a greater dilution of the working stock was delivered in an effort to identify a threshold infective dose. the dilution was increased tenfold (to 1 : 300, resulting in delivery of a 1á58 9 10 5 tcid 50 ml à1 dispersion from the nebulizer and an overlap (as ct products) of the two smaller doses from the 1 : 30 dilutions), and the initial aerosol exposure sequence was repeated. three mice per time point were assayed by qrt-pcr. variation in ct values was observed in the 2-min exposure group, one mouse being clearly positive as reflected by ct values, and the other two mice falling within the indeterminate range (table 3 ). all mice in the 6-, 20-and 60-min time points were positive (<31 ct) with minimal variation in ct values. all control mice were negative (ct values ! 37). tcid 50 assays were performed on mice from group 1 at each time point. one mouse lung homogenate in group 1 that was indeterminate by qrt-pcr (36 ct) was negative by tcid 50 assay. all other lung homogenates tested positive by both methods. aerosol exposure (4á7 9 10 4 tcid 50 ml à1 ) although weight loss by the mice appeared to have reached baseline at the dose delivered in 6 min at 1 : 300 dilution, ct results from the aerosol challenge at 1 : 300 dilution show that all the mice exposed for 6 min or more received an infectious dosethat is, weight loss is an indicator of dose but ct measurements provide better sensitivity to detect an endpoint. in an effort to better define the threshold at which viral infection occurs, the stock suspension was further diluted to 4á7 9 10 4 tcid 50 ml à1 (1 : 1000), the exposure times were reduced, the number of mice per time group was increased to five, and two additional time points were added to increase the range and dose of aerosol exposure. results of this test are shown in table 4 . 4á74 9 10 7 tcid 50 ml à1 4á74 9 10 6 tcid 50 ml à1 controls sd, standard deviation. *one mouse died before day 7. table 2 results of three assays [pcr, direct fluorescent antibody assay (dfa) and cpe] from the homogenates of cd-1 murine lung tissue exposed to an aerosol generated from 1á58 9 10 6 tcid 50 ml à1 at the 3-min exposure time, no mice were positive for influenza virus as determined by ct value. in all four of the longer-exposure groups, a single mouse displayed a positive ct value. a trend may be suggested by the pattern of indeterminate values, but the quantitative ct values show an equally unconvincing opposite trend. all of the lung homogenates were tested by virus cell culture assay for tcid 50 and dfa. for homogenates whose ct value is <31, both tcid 50 and dfa were positive. it is accepted that influenza may be contracted through a variety of methods including large droplet and contact transmission. the only route of infection examined during this study was inhalation of droplet nuclei through nasal passageways. results should be expected to be different if other mucosal surfaces had been dosed with the same viral aerosols. this study sought only to determine the existence and scale of a measurable threshold aerosol infective dose in this animal model and to set parameters such as the mouse restraints in the experimentthat limit other exposure. although this study demonstrated infectivity of the aerosol, its residence time as dispersed fine particles was shorthundreds of milliseconds from nozzle to noseand viruses are known to spontaneously lose viability, so the importance of such bioaerosols as an environmental component remains uncertain. however, the experiment accurately simulates direct exposure to droplet nuclei generated by a cough, which can accordingly be concluded to be a mechanism for immediate transmission of this virus. the range of states resulting from influenza virus spans from asymptomatic infection to mild symptoms to pneumonia, which is often fatal. factors such as the strain of influenza virus that caused the illness, immune status of the host and/or age of the affected individual play an important role in recovery or progression of disease. this was evident in the 2009 outbreak of influenza with the influenza a virus h1n1 pandemic (pdm) strain, during which a disproportionately high percentage of morbidity occurred in children and young adults as well as in individuals with underlying conditions such as obesity and or diabetes (jhung et al. 2011) . influenza a (h1n1) virus selected for this study was chosen based on reports of its infectivity in mice (smee et al. 2008 )although it had not been mouse adaptedand its known hardiness in culture systems as a starting point for development of a mouse model for aerosolized influenza. our results showed a significant variability in morbidity and mortality among the mice exposed to aerosolized influenza virus. this appears to have been owing to individual susceptibility of the mice, because variability in the uniformity of the aerosol delivered was found not to be significant when each of the ports was analysed. in addition, significant differences were noted when mice were exposed over times ranging from 6 to 18 min with minimal or no morbidity when a low quantity of virus was sprayed over an extended period of time. our preferred explanation is that some of the mice were able to process and clear virus, while in others, it caused clinical infection and disease. additionally, the hardiness of immune response to influenza varies among the mice, resulting in different levels of susceptibility. for example, in table 3 at the lowest exposure time, one of the three mice was positive for infection, whereas in the lowest dose experiment (table 4) , one mouse was positive following only 6 min of exposure. as with many viruses, influenza produces a significant number of defective particles incapable of causing infection (huang 1973; pathak and nagy 2009) . this is further demonstrated by the wide variationranging from hundreds to thousandsin reported gene copy (total virions)-to-tcid 50 (infectious virion fraction) ratio (yang et al. 2011 ). sidorenko and reichl (2004) table 4 pcr ct values from homogenates of cd-1 murine lung tissue exposed to aerosol generated from a 4á74 9 10 4 tcid 50 ml à1 dilution of influenza virus over five different exposure times are indicated in parentheses: x = mouse death; pos = positive, ct < 31; ind = indeterminate, 37 > ct ! 31; and neg = negative, ct ! 37 level for influenza a (h1n1) to be 1 tcid 50 for using qrt-pcr and 0á1 tcid 50 using nested qrt-pcr. recognizing that a direct correlation may not always exist between a method that detects viable organisms and one based on viral genomes, our system showed excellent correlation between classical virology methods, morphology based on histological examination, clinical features and molecular quantification by qrt-pcr. influenza infection in mice has been monitored by several different parameters including mean time to death, lung weight and change in body weight (sidwell and smee 2000) . however, these indicators are difficult to interpret when the infectivity and challenge dose of the virus does not clinically manifest an illness (morbidity or mortality). therefore, we utilized qrt-pcr in comparison with tcid 50 to minimize the variability. virus replication in lung tissue is considered the most informative endpoint for efficacy studies because even modest changes in virus load can have a large impact on survivability (haga and horimoto 2010) . assays of postsacrifice tissue samples from the mice were uniformly positive in the 1 : 30 dilution series. in contrast with the data shown in fig. 4 , in the 1 : 300 dilution series only, the 2-min exposure (12 tcid 50 dose) group contained subjects that were not unequivocally positive for infection, both by ct (2 of 3) and by cpe (1 of 3). one-way anova and a two-tailed t-test did not find any statistical differences between the change in the mouse's weight and the pcr data; however, a more precise threshold value and statistical significance of this difference can be expected when the number of mice (n) in each exposure group is increased. likewise, the two sets of subjects that shared ct products (2 min 9 1 : 30 and 20 min 9 1 : 300, and 6 min 9 1 : 30 and 60 min 9 1 : 300) appear to show increased sensitivity with increasing aerosol concentration, which could be taken to imply that an acute exposure leads to greater infectivity than the same dose experienced more gradually. although this interpretation is intuitively reasonable, the volume of data supporting it is too limited to justify such a conclusion. owing to logistical constraints in the abl-3 facility, the psd was not measured during the exposures. however, stone et al. (2012; stone 2010 ) measured bioaerosol particles in the range 100~500 nm for a slightly smaller virus (ms2 coli phage) in the same apparatus. the absorbed dose was likely slightly smaller than the presented dose because deposition of inspired particles in this size range is incomplete and size dependent (stuart 1973; clay and clarke 1987; heyder 2004) . a plot of weight loss vs calculated inhaled dose (fig. 5 ) was fitted to a straight line, which intersects the mean weight change of the control group at approximately 40 tcid 50 . a third series of exposures was performed to a 1 : 1000 dilution, intended to improve definition of the threshold dose for weight loss; however, the results were equivocal, likely because the delivery was gradual enough that the mice developed an immune response that was able to manage the challenge, and/or the n of five was too small to average out what we presume to have been idiosyncrasies among the subjects. our results showed that qrt-pcr was more sensitive or that an excess of genome was present in comparison with the number of infectious virions as determined by tcid 50 and dfa assays. as the gold standard (schrauwen et al. 2011) for determining the moi has been tcid 50 and quantification of virus in mice exposed to influenza aerosols by qrt-pcr has not been previously reported, additional confirmatory studies were needed. we chose seven days as the terminal point for our study based on symptomatology in humans where virus production peaks approximately 48 h postinfection, and few virus particles are shed after day 6 (taubenberger and morens 2008). our results showed the delivered aerosol mid 50 to be at least 12 tcid 50 as determined by qrt-pcr ct value and significantly <40 tcid 50 as determined by obvious clinical response. however, the sample size must be expanded in the future to achieve greater resolution and statistical significance. in addition, future studies will utilize the influenza virus a (h1n1) pdm strain to determine variation in mid 50 between the two strains. the data and methods presented here contribute to a fundamental basis for refining studies of aerosol delivery of particles into animal models for study of a variety of clinical subjects, such as infectious doses and vaccine delivery. further work will be needed to more precisely define the median infective dose (mid 50 ) of the current influenza strain in the cd-1 mouse, and to better understand the effect of bioaerosol ageing and dose rate on infectivity. work presented herein validates aerosolization of one organism and delivery by a pure respiratory pathway into one murine host as a technique for assaying infectivity in the challenging bioaerosol. this work can serve as a starting point for a continuation of work using other microbial organisms and other animal hosts. the intended application of the aerosol influenza animal model described here is the assessment of the clinical effect of respiratory protection devices incorporating antimicrobial treatments. various approaches have been proposed to increase the effectiveness of respiratory filtering media including the addition of bioactive media. although materials such as silver nanoparticles (lala et al. 2007) , copper oxide (borkow et al. 2010) , iodinated compounds (heimbuch and wander 2006) and others (cecchini et al. 2004) have shown biocidal potential, only the iodine vector has been proposed (lee et al. 2009 ) to operate by a noncontact mechanism. additional studies will focus on evaluating such new technologies and, after replacement of the filter holder with a larger enclosure able to collect aerosols behind a filtering facepiece respirator (ffr) worn by an articulated headform, on quantifying the effect on protectivity of seal leakage and on optimizing the particle removal efficiency of ffrs and other rpe to maximize net protectivity. the susceptibility of mice to the viruses of human and swine influenza methods of estimating the ld 50 in quantal response data multiple-path model of fiber deposition in the rat lung current and future antiviral therapy of severe seasonal and avian influenza a novel anti-influenza copper oxide containing respiratory face mask transmission of influenza a in human beings effects of antimicrobial treatment on fiberglass-acrylic filters comparison of a live attenuated 2009 h1n1 vaccine with seasonal influenza vaccines against 2009 pandemic h1n1 virus infection in mice and ferrets inhalation exposure systems effect of nebulised aerosol size on lung deposition in patients with mild asthma environmental inhalation chambers measurement of respiratory volume for virus retention studies in mice airborne infectious disease and the suppression of pulmonary bioaerosols ü ber das absetzen kleiner statistical methods in biological assay avian influenza h6 viruses productively infect and cause illness in mice and ferrets efficacy of oseltamivir therapy in ferrets inoculated with different clades of h5n1 influenza virus factors influencing the clearance of bacteria by the lung characterization of influenza a/hongkong/156/ 97 (h5n1) virus in a mouse model and protective effect of zanamivir on h5n1 infection in mice influenza virus aerosol exposure and analytical system for ferrets animal models to study influenza virus pathogenesis and control bioaerosol challenges to antimicrobial surface treatments: enchanced efficacy against ms2 coli phage of air filter media coated with polystyrene-4-methyltrimethylammonium triiodide deposition of inhaled in the human respiratory tract and consequences for regional targeting in respiratory drug delivery international commission on radiological protection (icrp). (1994) human respiratory tract models for radiological protection directed-flow aerosol inhalation exposure systems: applications to pathogens and highly toxic agents association of chronic alcohol consumption and increased susceptibility to and pathogenic effects of pulmonary infection with respiratory syncytial virus in mice epidemiology of 2009 pandemic influenza a (h1n1) in the united states h5n1: flu transmission work is urgent fabrication of nanofibers with antimicrobial functionality used as filters: protection against bacterial contaminants reflection and reaction-transmission of influenza a in human beings assessment of iodine-treated filter media for removal and inactivation of ms2 bacteriophage aerosols questioning aerosol transmission of influenza inter-laboratory performance between two nanoparticle air filtration systems using scanning mobility particle analyzers the guinea pig as a transmission model for human influenza viruses a mouse model for the evaluation of pathogenesis and immunity to influenza a (h5n1) viruses isolated from humans designs and operational characteristics of inhalation exposure equipment -a review clinical forms of tb prevention and treatment of influenza with hyperimmune bovine colostrum antibody guidelines for the care and use of mammals in neuroscience and behavioral research guide for the care and use of laboratory animals influenza a pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology defective interfering rnas: foes of viruses and friends of virologists nested real-time pcr assay has an increased sensitivity suitable for detection of viruses in aerosol studies the relevance of animal models for aerosol studies human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses aerial dissemination of pulmonary tuberculosis. a two-year study of contagion in a tuberculosis ward possible increased pathogenicity of pandemic (h1n1) 2009 influenza virus upon reassortment the use of an animal model to study transmission of influenza virus infection experimental transmission of influenza virus infection in mice. i. the period of transmissibility comparison of streptococcus zooepidemicus and influenza virus pathogenicity in mice by three pulmonary exposure routes structured model of influenza virus replication in mdck cells in vitro and in vivo assay systems for study of influenza virus inhibitors experimental disease models of influenza virus infections: recent developments treatment of influenza a (h1n1) virus infections in mice and ferrets with cyanovirin-n consistency and reproducibility of bioaerosol delivery for infectivity studies on mice design, construction and validation of a nose-only inhalation exposure system to measure infectivity of filtered bioaerosols in mice deposition of inhaled aerosols current protocols in microbiology; unit 15g.1 influenza: propagation, quantification, and storage reflection and reactiontransmission of influenza a in human beings review of aerosol transmission of influenza a virus questioning aerosol transmission of influenza: in response reflection and reaction-transmission of influenza a in human beings aerosol transmission of influenza a virus: a review of new studies on air-borne infection. study ii. droplets and droplet nuclei cdc protocol of realtime rtpcr for influenza a(h1n1) revision 2 inhalation exposure systems: design, methods, and operation concentrations and size distributions of airborne influenza a viruses measured indoors at a health centre, a day-care centre and on aeroplanes factors influencing the deposition of inhaled particles pilgrim's pride farms (live oak, fl) donated 100 embryonic eggs from stock-breeding hens, of which 80 were used for virus propagation and 20 served as controls. this work was supported in part by contract no. fa8650-07-c-5911, funded by the defense threat reduction agency. protocols for animal use were approved by the university of nebraska medical center institutional animal care and use committee and all active participants received all required training prior to the acquisition of mice. disclaimerpublication of this work does not indicate endorsement or approval of this work by the department of defence. key: cord-347039-eap592i7 authors: lee, seung-hwan; dimock, ken; gray, douglas a; beauchemin, nicole; holmes, kathryn v.; belouchi, majid; realson, john; vidal, silvia m. title: maneuvering for advantage: the genetics of mouse susceptibility to virus infection date: 2003-08-31 journal: trends in genetics doi: 10.1016/s0168-9525(03)00172-0 sha: doc_id: 347039 cord_uid: eap592i7 abstract genetic studies of host susceptibility to infection contribute to our understanding of an organism's response to pathogens at the immunological, cellular, and molecular levels. in this review we describe how the study of host genetics in mouse models has helped our understanding of host defense mechanisms against viral infection, and how this knowledge can be extended to human infections. we focus especially on the innate mechanisms that function as the host's first line of defense against infection. we also discuss the main issues that confront this field, as well as its future. genetic studies of host susceptibility to infection contribute to our understanding of an organism's response to pathogens at the immunological, cellular, and molecular levels. in this review we describe how the study of host genetics in mouse models has helped our understanding of host defense mechanisms against viral infection, and how this knowledge can be extended to human infections. we focus especially on the innate mechanisms that function as the host's first line of defense against infection. we also discuss the main issues that confront this field, as well as its future. viral infections in humans are notable for the diversity of host responses, rates of progression, and disease outcomes. a large body of evidence indicates that these differential responses depend not only on viral factors but also on inherited components affecting host susceptibility. significant advances in our understanding of the host response to infection in humans and other animal species have recently been achieved through the use of mouse models of infection. in laboratory mice, years of inbreeding have fixed deleterious alleles, which can be detected as susceptibility phenotypes. two major breakthroughs advanced this field. one was our ability to manipulate the mouse genome using transgenic and gene knockout technologies. this 'reverse genetics' approach allows direct testing of specific genes for their role in host resistance or susceptibility to infection. the other was our ability to clone genes responsible for natural variation in susceptibility to infection among inbred strains of mice, through molecular genetics. this 'forward genetics' approach can uncover novel mechanisms of host defense that are crucial to effective and protective responses to infection. to date more than 30 mouse loci (table 1 ) and many fewer human genes ( table 2 ) have been associated with the outcome of virus infection [1, 2] . each locus controls infection by a single virus family or strain. this is probably related to the vast diversity of virus life cycles and the likelihood that the product of each host resistance gene interacts with unique molecules encoded by individual viruses (fig. 1) . in this review we illustrate the contribution of mouse genetics to our understanding of mechanisms of host resistance to virus infection. these mechanisms might manifest themselves as: (1) barriers to infection at the host cell membrane; (2) intracellular host responses to infection; or (3) recognition or destruction of infected cells. viruses used as examples are described in table 3 . barriers to infection at the host cell membrane the first step in the life cycle of a virus is attachment to a receptor on the cell surface and delivery of the viral genome into the interior. usually the virus takes advantage of a host molecule with an unrelated function, such as an adhesion molecule or complement regulator, for its own benefit. receptors are recognized as important determinants of virus host range and tissue tropism; and some host resistance/susceptibility loci encode molecules that are expressed on the cell surface. for example, sjl mice are 10 000 times more resistant to a lethal dose of mouse hepatitis virus (mhv) -a murine coronavirus -than c57bl/6 or balb/c mice [3] . resistance is due to allelic variation in the gene encoding carcinoembryonic antigen-related cell adhesion molecule 1 (ceacam1) [4] . susceptible strains carry the ceacam1a allele, which encodes the principal mhv receptor, cea-cam1a. resistant strains, such as sjl, are homozygous for the ceacam1b allele, which encodes a 27-amino-acid substitution in the n-terminal virus-binding domain of ceacam1a [4] . an immunoreceptor tyrosine-based inhibitory motif (itim) (see glossary) is present in the cytoplasmic domain of ceacam1, also suggesting a potential immunomodulatory function for this molecule during mhv infection. although no role for human ceacam1a has been described during viral infection of humans [5] , a possible immunomodulatory function is consistent with the observation of a ceacam1-mediated suppression of cd4 þ t-cell activation during infection by the pathogenic bacteria neisseria gonorrhoeae, neisseria meningitidis and haemophilus influenzae. these human pathogens bind to domain 1 of ceacam1, very close to the site recognized by mhv [6] . another example of natural host resistance is the restriction of ecotropic murine leukemia virus (mulv) infection by the mouse fv4 gene. binding of retroviral env glycoproteins to cellular receptors triggers fusion of viral and cellular membranes, and allows the virus nucleocapsid to enter the cell. the fv4 (or akvr) locus is a defective endogenous ecotropic provirus that encodes an env protein, which also has a fusion defect [7, 8] . it has been proposed that the env protein encoded by fv4 blocks mulv infection by interacting with the cellular receptor and restricting the amount of receptor available for exogenous retrovirus attachment (box 1) [9] . in humans, resistance to human immunodeficiency virus (hiv) is also mediated by a barrier at the cell surface. cd4 is the primary or 'attachment' receptor for hiv, but cd4 is necessary but not sufficient for the productive entry of hiv into target cells. the identification of ccr5 as a coreceptor for hiv prompted genetic screening of individuals that escape hiv disease despite high-risk behavior [10] . individuals carrying a homozygous 32 bp deletion in the coding sequence of ccr5 (ccr5d32) are extremely resistant to the 'r5'strain of hiv because the deletion results in a frame shift and generates a nonfunctional receptor [10] . the ccr5d32 mutation is found predominantly in the caucasian population and is absent in africans, american indians and east asians [11] . it has been speculated that this distribution is consistent with resistance to an agent that predates hivand caused enormous mortality. one candidate is yersinia pestis, the causative agent of bubonic plague, although other pathogens targeting the macrophage/monocyte lineage cannot be excluded [12] . delivery of a viral genome to the interior of an infected host cell does not guarantee that an infection will be glossary advanced intercross lines : mouse lines generated by producing an f2 generation between two inbred strains and then intercrossing in each subsequent generation, but avoiding sibling matings. this provides increasing probability of tightly linked genes recombining. congenic strain : a mouse strain that has been bred to be identical to an inbred strain, except for a selected differential chromosomal segment. congenic strains are derived by backcrossing to a parental inbred strain for at least ten generations while selecting for heterozygosity at a particular locus. consomic strain : a variation on a congenic strain in which recombinants between two inbred strains are backcrossed to produce a strain that carries a single chromosome from one strain on the genetic background of the other. epistasis : the interaction between alleles at different loci that allows an allele at one locus to alter the effects of alleles at a different locus. immunoreceptor tyrosine-based activation motif (itam) : a cytoplasmic tyrosine-containing motif that is the site of tyrosine phosphorylation. these motifs are associated with tyrosine kinases and other phosphotyrosinebinding proteins involved in cellular activation. immunoreceptor tyrosine-based inhibitory motif (itim) : a cytoplasmic tyrosine-containing motif. in contrast to itams, phosphorylation of the tyrosine residues within itims recruits the src-homology-2-domain-containing tyrosine phosphatase shp-1 and/or shp-2, transducing a negative signal that inhibits cellular activation. interferons (ifns) : a group of immunoregulatory proteins that are produced by cells infected with a virus and have the ability to inhibit viral growth. ifns are classified as type i (ifn-a/b), which have antiviral properties, and as type ii (ifn-g), which is known as immune interferon. despite the use of different receptors, certain ifn-a/b and ifn-g functions are shared because the signal transduction pathways activated through these receptors partly overlap. murine leukemia virus (mulv) : there are four subgroups of naturally occurring mulvs based on receptor usage on mouse cells: ecotropic mulvs, which are able to infect only mouse cells utilizing the cationic amino acid transporter as a receptor; amphotropic mulvs, which are able to infect mouse cells as well as those of other species (including human) by binding to an inorganic phosphate transporter protein; polytropic mulvs, which can infect cells from mouse as well as nonmurine species using yet another cellular receptor protein, thought to be a g-protein-coupled receptor; and xenotropic mulvs, which use receptors from cells of most species except mice. quantitative trait loci (qtls) : the locations of genes that affect a trait that is measured on a quantitative (linear) scale, such as body weight or blood pressure in animals, as identified by statistical analysis. these traits are typically affected by more than one gene, and also by the environment. recombinant congenic strain : a variation on recombinant inbred strains in which the initial outcross is followed by several generations of backcrossing before inbreeding. retroviral interference : the phenomenon by which prior infection of cells with a retrovirus confers strong resistance to infection of the same cells by a retrovirus that utilizes the same receptor; however, cells remain susceptible to viruses that use a different receptor. this process results from masking or downregulation of the receptor due to interaction with the glycoprotein of the established virus. an important element of resistance to retroviral infection is provided by endogenous retroviral elements. some retroviral elements in the mammalian genome are transcriptionally active but carry deletions and point mutations that render them unable to replicate. some of their gene products, such as the fv4 and fv1 proteins, interfere with infection by their exogenous relatives thus providing a selective advantage to their hosts. for example, fv4 encodes an env protein that interferes with ecotropic murine leukemia virus (mulv) infection (see main text) at the level of viral entry. examples of this phenomenon can be found in mice, chickens and cats, suggesting that env-mediated retroviral interference is commonly used for limiting virus spread [76] . gene therapy based on the principle of receptor interference has demonstrated that introduction of fv4-envtransduced bone marrow cells into a thymectomized host confers resistance to friend leukemia virus-induced leukemogenesis [77] . these findings suggest that a similar approach could be used as a therapeutic strategy to inhibit infections by other retroviruses in vivo, including immunodeficiency virus. for example, transfer of a gene encoding a normally processed but fusion-defective retroviral env protein into susceptible cells would interfere with viral entry and potentially reduce the infectiousness of viruses emerging from the cell. the fv1 locus [78, 79] encodes a retrovirus capsid-like protein [80] that restricts mulv infection at a post-entry stage, before integration of the provirus [81] . because all retroviruses replicate in very similar ways, it is conceivable that similar restriction mechanisms could be found in humans. interestingly, although an fv1 ortholog was not detected in nonmurine species, a mechanism of preintegration interference, resistance factor 1 (ref1), has been demonstrated in human cell lines [82] . at the time of writing, the ref1 gene has not been cloned, but there is speculation that, like fv1, ref1 might consist of endogenous retroviral sequences. a recent study suggests the existence of a ref1-like restriction in humans and nonhuman primates that determines lentivirus tropism [83] . consistent with this proposal, the target for this restriction is within the capsid protein of hiv [83] . an example of an alternative mechanism of resistance to retroviral infection is provided by fv2, which determines the progression of friend virus complex-induced erythroleukemia. fv2 is identical to ron, which encodes stk, a member of the met family of receptor tyrosine kinases. susceptible mice express a positive-acting truncated version of stk lacking most of the extracellular domain, which is associated with proliferation of sffv-infected erythroblasts [84] . successful, because potent defense mechanisms act at the intracellular level. one of the initial cellular responses to viral infection is the production of type i interferons (ifns). ifns, in turn, stimulate the expression of several gene products, including the double-stranded rna-activated protein kinase (pkr) and rnase l, which leads to the establishment of an antiviral state in cells, characterized by a general inhibition of protein synthesis. the ifn-induced mx1 protein is one of the best-studied determinants of innate immune responses to viral infection. the inbred mouse strain a2g is resistant to doses of mouse-adapted influenza virus (an orthomyxovirus) that are lethal for other inbred strains [13] . resistance in these mice is determined by a single dominant locus, mx1, whose gene product, mx1, rapidly accumulates in the nuclei of cells following influenza virus infection, and blocks virus spread [14] . susceptible mice produce no functional mx protein due to either a nonsense mutation (cba/j) or gene deletion (balb/c) [15] . the mx1 product belongs to the dynamin superfamily of large gtpases conserved in all vertebrates. in mice there are actually two mx gene products, mx1 and mx2. mx1 protein blocks transcription of influenza virus, probably via interaction with the pb2 subunit of the influenza virus polymerase [16] . by contrast, the mx2 protein is cytoplasmic and has been shown to inhibit viruses that replicate in the cytoplasm, such as vesicular stomatitis virus (vsv) and members of the family bunyaviridae [14] . mx proteins inhibit virus replication by interfering with the transport of viral nucleocapsids, and by sorting them to locations where they become unavailable for the generation of new virus particles [14] , possibly to promyelocytic leukemia protein nuclear bodies (pml nbs) [17] , which are known to be a site of proteasome-mediated degradation. humans also possess mx genes, mxa and mxb, but only the mxa gene product has antiviral properties. however, in contrast to its mouse mx1 ortholog, the mxa gtpase accumulates in the cytoplasm of ifn-treated cells, where it inhibits not only the replication of orthomyxoviruses, vsv and bunyaviruses but also the replication of other rna viruses such as measles virus, coxsackievirus b4 and semliki forest virus [14] . a mechanism of resistance to flaviviruses, which also appears to be ifn-mediated, was recently revealed by the cloning of flv, which confers resistance (flv r ) or susceptibility (flv s ) to flavivirus infection. virus titers in the brains of resistant mice infected with murray valley encephalitis virus, yellow fever virus or west nile virus are orders of magnitude lower than in susceptible animals. viral yields in tissue cultured from resistant or susceptible animals are also dramatically different, indicating that the flv gene product acts intracellularly on flavivirus replication [18] . genetic mapping localized flv1 to chromosome 5 [19] and, more recently, it was demonstrated that flv susceptibility is associated with a nonsense mutation in a member of the 2 0 ,5 0 -oligoadenylate synthetase (oas) family, oas1b [20, 21] . oas proteins are induced by ifns and play a central role in producing the antiviral state by binding double-stranded rna and catalyzing the synthesis of 2 0 ,5 0 -oligoadenylates (2-5a), which, in turn, interact with and activate rnase l to degrade singlestranded viral and cellular rnas. whereas oas1b genes from resistant mice encode full-length proteins, those from susceptible mice encode proteins truncated at the c-terminus that might not form active synthetases. in contrast to the single oas1 gene found in humans, there are eight closely linked oas1 genes in the murine genome [20, 22] , but only oas1b is associated with resistance to flaviviruses. in addition to resistance imparted by barriers to virus entry or by intracellular antiviral defense mechanisms, cytotoxic cells can control the level of viral replication in an animal (box 2). host recognition of virus-infected cells is mediated by two players: natural killer (nk) cells and cytotoxic t cells. herpesviruses avoid recognition and activation of the adaptive immune system by downregulating major [24] . strains of the c57bl background carry a dominant resistance allele, cmv1 r , that restricts viral replication in target organs, whereas other mouse strains carry a recessive susceptibility allele, cmv1 s , that allows rapid proliferation of the virus [25] . cmv1 r encodes an activating nk-cell receptor, ly49h [26 -28] , which is absent in susceptible strains. mouse strains express different repertoires of ly49 molecules, which are part of a large family of polymorphic receptors expressed on overlapping populations of nk cells. upon binding of mhc class i ligands, different ly49 molecules deliver either activating or inhibitory signals that modulate nk-cell function [29] . recent studies have revealed that ly49h recognizes mcmv-infected cells via direct interaction with the viral antigen, m157, which shares structural homology with mhc class i molecules and is expressed on the surface of infected cells [30, 31] . m157 also binds to an inhibitory receptor, ly49i, expressed in susceptible strain 129 mice, suggesting that m157 could have evolved as a mechanism to escape nk-cell killing by targeting inhibitory receptors [30] . in resistant mice, ly49h might have evolved as a countermeasure against virus-encoded mhc class i homologs, providing an overriding activating signal to the nk cell, and promoting the elimination of mcmv-infected cells (fig. 2a) . considering the prevalence of human cytomegalovirus (hcmv) in the human population, we expect that there are likely to be hcmv-specific activating receptors present on human leukocytes that might function in a manner analogous to ly49h. the mhc (box 2) is a set of genes, present in all vertebrates, with immunological and nonimmunological functions. mhc class i genes play a crucial role in in vertebrates, host defense against virus infection is mediated by innate and adaptive immunity. innate immunity constitutes the first line of defense, providing a rapid response through germ-line encoded proteins that pre-exist or are induced within hours of infection. adaptive immunity is a slower, yet highly specific response mediated by b cells and t cells that confers effective and long-lasting protection against infection, and is characterized by immunological memory. major histocompatibility complex (mhc) molecules are highly polymorphic glycoproteins encoded by mhc class i and ii genes, which are mainly involved in the presentation of peptide antigens to t cells. mhc class i molecules bind peptides derived from proteins synthesized in the cytosol, such as viral proteins, and present them to cytotoxic cd8 þ t cells. by contrast, mhc class ii molecules are loaded with peptides derived from exogenous antigens engulfed within intracellular vesicles, for presentation to cd4 þ t cells. mhc class i molecules also play an important role in modulating the cytotoxic activity of natural killer (nk) cells. nk cells are a component of the innate system, so named because of their propensity to kill certain neoplastic and virus-infected cells without prior sensitization. the cytotoxic activity of nk cells is regulated by signals elicited by inhibitory receptors containing immunoreceptor tyrosine-based inhibitory motifs (itims), or stimulatory receptors associated with immunoreceptor tyrosine-based activation motifs (itam)-bearing adaptor molecules. inhibitory receptors interact with mhc class i molecules and prevent cell killing of healthy cells by autologous nk cells. in situations where mhc class i is downregulated, such as during tumorigenesis or viral infection, reduced inhibitory signals result in nk-cell-mediated lysis [85] . activating nk-cell receptors recognize stress-induced or pathogenencoded mhc class i-like proteins and stimulate killing of cells expressing these molecules [85] . review trends in genetics vol. 19 no.8 august 2003 combating viral infection in mice (fig. 3a) . congenic mice with intra-mhc recombinations provide an important tool for dissecting the contribution of mhc class i subregions to virus infection. for example, comparisons of t-cell responses in h2 congenic mice that differ in their recovery from friend leukemia virus infection were used to localize friend leukemia virus resistance loci rfv1 and rfv2. rfv1 mapped to the h2d subregion and determined t-cell activation. rfv2 mapped to the ia subregion and determined unresponsiveness of t cells in a proliferation assay [35] . resistance to acute lethal infection of mcmv is also controlled by genes linked to h2, with the k haplotype being more resistant than b or d. resistance was associated with genes of subregions k/ia and d. interestingly in this model, transfection of macrophages with sequences encoding mhc molecules such as h2-k d , d d or k b renders these cells, which are major reservoirs for mcmv, sensitive to mcmv infection [37] , consistent with a role for mhc molecules as mcmv receptors. in humans, association analysis between mhc and specific viral infections has also suggested a differential role of specific alleles in susceptibility to hiv, hepatitis b virus (hbv) and hepatitis c virus (hcv) (fig. 3b) . for example, hla-drb1*1302 is associated with resistance to chronic hbv infection in both african and european populations [42, 43] whereas hla-b*35-cw*04 is associated with the rapid progression of aids in caucasian populations [38] . although polymorphisms in the classical mhc class i and class ii genes are known to be related to antigen presentation, it is important to note that there are other genes within the mhc class iii region, such as components of the complement cascade (c2, c4), cytokines -tumor necrosis factor (tnf)-a and -b -and proteins involved in antigen processing (lmp2, tap1), which also have an important function in immunity [51] . therefore, disease resistance or susceptibility that maps to the mhc must be interpreted with caution, to differentiate the role of antigen presentation from the other roles of mhcassociated genes. although advances in genomic analysis have paralleled the discovery of host susceptibility traits that are determined by single alleles, most differences in host susceptibility to viral infection are the result of interactions among different genes with multiple alleles. the study of infectious disease under complex genetic control in humans is complicated by a variety of factors including genetic heterogeneity, low penetrance and environmental factors. the tools currently available to the mouse geneticist make the identification and isolation of disease susceptibility genes much more attainable. an example is the response to theiler's murine encephalomyelitis virus (tmev), a rodent model for multiple sclerosis [52] . in genetically susceptible mice, certain tmev strains cause persistent infection, inflammation, and a chronic demyelinating disease. one of the loci determining theiler's murine encephalomyelitis virus persistence (tmevp1), maps to the mhc region and corresponds to the h2d gene [52] . mice transgenic for the h2d b allele acquired resistance to persistent virus infection, suggesting that the gene effect was at the level of peptide presentation by h2d b [53] . using the amount of viral rna in the spinal cords of persistently infected mice as a phenotype, and a genetic dissection strategy based on genome scans, a second locus, tmevp2, was localized near the type ii interferon (ifn-g) gene on distal chromosome 10 [54] . analysis of a panel of congenic mice that inherited different portions of mouse chromosome 10 revealed that tmevp2 was actually two distinct loci, now termed tmevp2 and tmevp3, and excluded the ifn-g gene from the candidate region [55] . recently, a strong candidate for tmevp3, named tmevpg1, has been identified as a noncoding rna expressed in immune cells infiltrating the central nervous system of resistant mice, where an inverse relationship with ifn-g mrna levels has been observed [56] , suggesting a role for this rna in regulating ifn-g synthesis. consistent with this observation, the same reciprocal pattern of rna expression was observed for tmevpg1, the human counterpart, and ifn-g in human nk cells and t cells. several complementary avenues promise significant acceleration in the identification of genes that determine resistance or susceptibility in complex models of virus infection. the well-defined sets of recombinant congenic strains (rcs) [57] , consomic (chromosome substitution) strains [58] and advanced intercrossed lines [59] that are now available can be used to map a locus of interest and to characterize the specific phenotypic component of disease susceptibility under genetic control. also, traditional genetic mapping techniques are now complemented by high-throughput methods for studying gene function and regulation. for example, high-density oligonucleotide arrays [60] or cdna arrays [61] allow for gene expression monitoring on a genome-wide scale and offer an opportunity to establish functional links between genotype and phenotype. a strategy that combines congenic mapping with microarray expression profiling would aid in the identification of novel susceptibility genes and biochemical pathways not previously known to be involved in disease etiology. furthermore, the availability of the human and mouse genome sequences represents the ultimate breakthrough in quantitative trait loci (qtl) studies by placing the identification of candidate genes within a defined genetic interval only a (computer) mouse click away. one of the current limitations of using inbred strains of mice to study susceptibility to viral infection is the limited extent of genetic variation, mainly due to a small number of original progenitor strains [62] . therefore, although these resources are valuable, they do not permit the identification of all possible resistance or susceptibility loci. wild-derived inbred strains of mice are an important source of additional resistance alleles [63] that is just beginning to be exploited, as demonstrated by the characterization of flv. chemical mutagenesis, a method that has been successfully applied to the study of other model organisms, from bacteria to drosophila, is another promising strategy for creating novel susceptibility alleles in the mouse. the alkylating agent n-ethyl-n-nitrosourea (enu) introduces point mutations and creates random variation throughout the genome [64] . this is highly advantageous for defining host susceptibility phenotypes because it represents an unbiased method for identifying previously unrecognized physiological pathways because no assumptions are made about the relevant genes. enu mutagenesis yields models of simple inheritance that are readily accessible to analysis by positional cloning [64] . the effort to understand the genetic basis of susceptibility to viral disease is driven by three considerations: (1) the increased public awareness of the toll imposed by viruses on the host; (2) the increase in susceptible human populations because of longer life expectancy, frequently accompanied by chronic illness, and the consequences of advances in medical technology, including immunosuppressive therapies for organ transplantation or treatment of malignancy; and (3) the need to develop new therapies for infections caused by multidrug-resistant human killer-cell immunoglobulin-type receptor (kir) is considered to be a functional homolog of mouse ly49. an epistatic interaction between kir3ds1 and hla-b delays progression to aids, suggesting that hla-b behaves as a ligand for kir3ds1 [32] . the peptide presented on hla-b that is responsible for this interaction remains to be identified. because kir3ds1 receptor is also associated with the adaptor molecule dap12, the intracellular signaling cascade leading to cellular activation and killing of virus-infected cells seems to be similar to that triggered by mouse ly49h. by using inhibitory small molecules, represent promising approaches to antiviral therapy. therapies based on the principle of receptor interference for viruses other than retroviruses (box 1) could be explored. type i ifn induces an intracellular antiviral response against many different rna and dna viruses. mouse genetics has provided a starting point for dissecting intracellular mechanisms of host defense, and has revealed that several ifn-inducible gene products have inhibitory effects on a much more restricted number of viruses than expected. the precise nature (sequence or structural) of determinants recognized by effector proteins such as mx or oas1b remain to be characterized. the identification of additional effector molecules and viral targets must continue to be an important area of active research, particularly in view of the existence of orthologous human genes. mouse genetics has also demonstrated that recognition and destruction of virus-infected cells by nk cells is mediated by specific interactions between activating nkcell receptors and viral target molecules. viruses pose a particular problem for specific recognition because all the components of the virus are synthesized and assembled in the host cell. important questions to be answered include: (1) do other activating nk-cell receptors have specialized functions in virus recognition? (2) is the mhc class i fold a recognition-associated structure? (3) what is the extent of the repertoire of target molecules for nk-cell-activating receptors? in addition, studies of mouse nk-cell receptors, such as the ly49 family, have provided a conceptual framework for understanding human nk-cell biology. because no functional human ly49 counterpart has been identified, prime candidates for the recognition of viral pathogens by human nk cells are members of the killercell immunoglobulin-like receptor (kir) family [65] . although the ligands of activating kir receptors remain to be identified, it has been proposed that activating kir molecules have evolved to recognize infectious agents (fig. 2b) [32] . it is suspected that several common and/or chronic human diseases under complex genetic control are triggered by a viral infection. this idea is supported by experimental evidence derived from mouse models for initiation and exacerbation of atherosclerosis following mcmv infection [66] , for diabetes [67] or dilated cardiomyopathy [68] following coxsackievirus infection, and for multiple sclerosis-like disease following tmev [33] or mhv [69] infection. identifying genes that control susceptibility to acute and chronic viral infection in these models is a crucial step in understanding the development of these complex pathologies. comparisons between mouse and human mechanisms of host resistance or susceptibility to viral infection have increased our awareness not only of their differences but also, more importantly, of their similarities. in the future, the use of comparative genomic approaches in animal model systems will provide more comprehensive knowledge of the impact of viruses on human health. forward genetics of infectious diseases: immunological impact genetics of susceptibility to human infectious disease resistance to fatal central nervous system disease by mouse hepatitis virus strain jhm. i. genetic analysis specificity of coronavirus/ receptor interactions human aminopeptidase n is a receptor for human coronavirus 229e crystal structure of murine sceacam1a[1,4]: a coronavirus receptor in the cea family molecular characterization of the akvr-1 restriction gene: a defective endogenous retrovirus-borne gene identical to fv-4r fv-4 resistance gene: a truncated endogenous murine leukemia virus with ecotropic interference properties fv-4: identification of the defect in env and the mechanism of resistance to ecotropic murine leukemia virus chemokine receptors as hiv-1 coreceptors: roles in viral entry, tropism, and disease global distribution of the ccr5 gene 32-basepair deletion dating the origin of the ccr5-delta32 aids-resistance allele by the coalescence of haplotypes resistance of mice to mouse adapted influenza a virus interferon-induced mx proteins: dynamin-like gtpases with antiviral activity influenza virus-susceptible mice carry mx genes with a large deletion or a nonsense mutation function of the mouse mx1 protein is inhibited by overexpression of the pb2 protein of influenza virus interferon-induced antiviral mx1 gtpase is associated with components of the sumo-1 system and promyelocytic leukemia protein nuclear bodies genetically determined resistance to infection with group b arboviruses. ii. increased production of interfering particles in cell cultures from resistant mice development and characterization of new flavivirus-resistant mouse strains bearing flv(r)-like and flv(mr) alleles from wild or wild-derived mice positional cloning of the murine flavivirus resistance gene a nonsense mutation in the gene encoding 2 0 -5 0 -oligoadenylate synthetase/l1 isoform is associated with west nile virus susceptibility in laboratory mice gene structure of the murine 2 0 -5 0 -oligoadenylate synthetase family selective rejection of h-2-deficient lymphoma variants suggests alternative immune defence strategy inhibition of natural killer cells by a cytomegalovirus mhc class i homologue in vivo cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the c-type lectin superfamily vital involvement of a natural killer cell activation receptor in resistance to viral infection murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to ly49h the ever-expanding ly49 gene family: repertoire and signaling direct recognition of cytomegalovirus by activating and inhibitory nk cell receptors recognition of a virus-encoded ligand by a natural killer cell activation receptor epistatic interaction between kir3ds1 and hla-b delays the progression to aids genetics of susceptibility to theiler's virus infection serial backcross analysis of genetic resistance to mousepox, using marker loci for rmp-2 and rmp-3 h-2d control of recovery from friend virus leukemia: h-2d region influences the kinetics of the t lymphocyte response to friend virus genetic control of sensitivity to moloney leukemia virus in mice. iii. the three h-2 linked rmv genes are immune response genes controlling the antiviral antibody response are mhc proteins cellular receptors for cmv? hla and hiv-1: heterozygote advantage and b*35-cw*04 disadvantage influence of combinations of human major histocompatibility complex genes on the course of hiv-1 infection hla alleles determine human t-lymphotropic virus-i (htlv-i) proviral load and the risk of htlv-i-associated myelopathy a tumor necrosis factor-alpha (tnf-alpha) promoter polymorphism is associated with chronic hepatitis b infection hla-drb1*1301 and *1302 protect against chronic hepatitis b association between an mhc class ii allele and clearance of hepatitis b virus in the gambia class ii hla alleles and hepatitis b virus persistence in african americans influence of mhc class ii genotype on outcome of infection with hepatitis c virus. the hencore group. hepatitis c european network for cooperative research association between mhc class ii alleles and clearance of circulating hepatitis c virus. members of the trent hepatitis c virus study group genes of the major histocompatibility complex class ii influence the outcome of hepatitis c virus infection association between hla class ii genotype and spontaneous clearance of hepatitis c viraemia influence of hla haplotypes on the clinical courses of individuals infected with hepatitis c virus hla drb1 and dqb1 alleles and haplotypes influencing the progression of hepatitis c complete sequencing and gene map of a human major histocompatibility complex (mhc) the infection of mouse by theiler's virus: from genetics to immunology fvb mice transgenic for the h-2db gene become resistant to persistent infection by theiler's virus mapping loci influencing the persistence of theiler's virus in the murine central nervous system two loci, tmevp2 and tmevp3, located on the telomeric region of chromosome 10, control the persistence of theiler's virus in the central nervous system of mice tmevpg1, a candidate gene for the control of theiler's virus persistence, could be implicated in the regulation of gamma interferon recombinant congenic strains derived from a/j and c57bl/6j: a tool for genetic dissection of complex traits analysing complex genetic traits with chromosome substitution strains simultaneous detection and fine mapping of quantitative trait loci in mice using heterogeneous stocks high density synthetic oligonucleotide arrays quantitative monitoring of gene expression patterns with a complementary dna microarray the mosaic structure of variation in the laboratory mouse genome wild mice: an ever-increasing contribution to a popular mammalian model enu mutagenesis: analyzing gene function in mice divergent and convergent evolution of nk-cell receptors does cytomegalovirus play a role in atherosclerosis coxsackieviruses and diabetes the transition from viral to autoimmune myocarditis mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease susceptibility to hiv infection and progression of aids in relation to variant alleles of mannose-binding lectin genetic restriction of hiv-1 pathogenesis to aids by promoter alleles of il10 mutation of gene of mannose-binding protein associated with chronic hepatitis b viral infection tuberculosis and chronic hepatitis b virus infection in africans and variation in the vitamin d receptor gene host response to ebv infection in x-linked lymphoproliferative disease results from mutations in an sh2-domain encoding gene the x-linked lymphoproliferative-disease gene product sap regulates signals induced through the co-receptor slam endogenous retroviruses and the evolution of resistance to retroviral infection a gene therapy model for retrovirus-induced disease with a viral env gene: expression-dependent resistance in immunosuppressed hosts susceptibility to two strains of friend leukemia virus in mice inheritance of susceptibility to friend mouse leukemia virus. 11. spleen foci method applied to test the susceptibility of crossbred progeny between a sensitive and a resistant strain positional cloning of the mouse retrovirus restriction gene fv1 physical mapping of the fv-1 tropism host range determinant of balb/c murine leukemia viruses a conserved mechanism of retrovirus restriction in mammals cellular inhibitors with fv1-like activity restrict human and simian immunodeficiency virus tropism fv2 encodes a truncated form of the stk receptor tyrosine kinase natural killer cells, viruses and cancer we are grateful to christine di donato for critical reading of the manuscript. our laboratories are supported by grants from the canadian institutes of health research (cihr) and natural sciences and engineering research council of canada (nserc). seung-hwan lee is supported by a cihr doctoral scholarship and silvia m. vidal is a junior scientist of cihr. key: cord-003389-0yh5k6jk authors: patton, john b.; bennuru, sasisekhar; eberhard, mark l.; hess, jessica a.; torigian, april; lustigman, sara; nutman, thomas b.; abraham, david title: development of onchocerca volvulus in humanized nsg mice and detection of parasite biomarkers in urine and serum date: 2018-12-12 journal: plos negl trop dis doi: 10.1371/journal.pntd.0006977 sha: doc_id: 3389 cord_uid: 0yh5k6jk background: the study of onchocerca volvulus has been limited by its host range, with only humans and non-human primates shown to be susceptible to the full life cycle infection. small animal models that support the development of adult parasites have not been identified. methodology/principal findings: we hypothesized that highly immunodeficient nsg mice would support the survival and maturation of o. volvulus and alteration of the host microenvironment through the addition of various human cells and tissues would further enhance the level of parasite maturation. nsg mice were humanized with: (1) umbilical cord derived cd34(+) stem cells, (2) fetal derived liver, thymus and cd34(+) stem cells or (3) primary human skeletal muscle cells. nsg and humanized nsg mice were infected with 100 o. volvulus infective larvae (l3) for 4 to 12 weeks. when necropsies of infected animals were performed, it was observed that parasites survived and developed throughout the infection time course. in each of the different humanized mouse models, worms matured from l3 to advanced fourth stage larvae, with both male and female organ development. in addition, worms increased in length by up to 4-fold. serum and urine, collected from humanized mice for identification of potential biomarkers of infection, allowed for the identification of 10 o. volvulus-derived proteins found specifically in either the urine or the serum of the humanized o. volvulus-infected nsg mice. conclusions/significance: the newly identified mouse models for onchocerciasis will enable the development of o. volvulus specific biomarkers, screening for new therapeutic approaches and potentially studying the human immune response to infection with o. volvulus. a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 onchocerciasis, caused by the parasitic filarial nematode onchocerca volvulus, remains a significant source of morbidity throughout sub-saharan africa [1] . o. volvulus infection is commonly diagnosed through the presence of microfilariae in skin snips, but skin samples can be further analyzed by qpcr for enhanced sensitivity [2] . antibody tests (e.g. ov16 [3, 4] ) are available but do not have the ability to differentiate between past and present infections which is problematic in areas where the infection is endemic [5] . recently, a limited number of biomarkers have been identified in the urine that can distinguish between o. volvulus-infected and non-infected individuals [6] [7] [8] . a significant obstacle for studying the biology of o. volvulus and for the development of new therapeutics and diagnostics has been the absence of small animal models. the only susceptible animal hosts for o. volvulus are chimpanzees [9, 10] and mangabey monkeys [11] . chimpanzees infected with o. volvulus had patent infections that lasted between 6 to 9 years with adult-worm bundles located in deep tissues with microfilariae in skin snips being detected 12-18 months post infection [12, 13] . while immunologically intact mice are resistant to infection with the infective larvae (l3) of o. volvulus [14] , adult worms within nodules have been successfully transplanted into scid mice (nod.cb17-prkdc scid /j) with the worms surviving greater than 20 weeks [15] . this observation was confirmed by the successful transplantation of adult onchocerca ochengi into scid mice [16] . as an alternative approach, o. volvulus l3 were implanted in primates and rodents within diffusion chambers that consist of a lucite ring enclosed with permeable membranes, allowing for migration of cells and other humoral factors into the diffusion chamber with simultaneous containment of the parasites. o. volvulus in diffusion chambers implanted in multiple species of rodents and primates showed limited growth of larvae in all host species [17] . several strategies have been employed to overcome murine resistance to infection with various human pathogens. the collaborative cross (cc) is a large group of inbred mouse strains that were developed to address many of the different shortcomings found within the existing experimental mouse populations, including small numbers of homozygous strains, limited genetic diversity, and non-ideal population structures. based on the hypothesis that there is a genetic basis for mouse susceptibility and resistance to infection, novel strains of cc mice have been identified that are susceptible to specific bacteria, viruses, and parasites of humans [18] [19] [20] [21] [22] [23] . as an alternative approach to overcome murine resistance to infection, mice have been developed with greatly diminished immune responses. scid mice were shown to be susceptible to infection with brugia malayi while immunocompetent mice were resistant to the infection [24] . nod.cg-prkdc scid il2rg tm1wjl /szj (nsg) mice are a highly immune-compromised strain of mice that have profound defects in the adaptive and innate immune responses [25] . the most notable defects include those in: 1) macrophages, dendritic cells and in the complement cascade [26] [27] [28] ; 2) maturation of t and b cells [29] ; 3) nk cells; 4) signaling of 6 different cytokines [30] and 5) the presence of eosinophils in the peripheral circulation and in tissue [31] . nod-rag1 tm1mom il2rg tm1wjl mice (nrg) are phenotypically similar to nsg mice with disruption in the b and t-cell production [32] . interestingly, nsg mice can support the complete lifecycle of the human nematode strongyloides stercoralis, whereas immunologically intact mice cannot [31] . a third strategy to enhance pathogen survival in mice has been to add human-derived cells required for survival and growth [33] . nsg mice have the unique ability to support several different xenografts including human hematopoietic stem cells (cd34 + stem cells) that allow for the development of an immature partially-functional human immune system [25, 27, 30, 34] . nod.cg-prkdc scid il2rg tm1wjl tg (cmv-il3, csf2, kitlg)1eav/mloyszj (sgm) mice have an additional three human genes il3, csf2, and kitlg under the cmv promoter to enhance the overall microenvironment for the development of human xenografts. this results in increased numbers of cd33 + myeloid cells, b-cells, t-cells, and hematopoietic stem cells [35] . humanized blt mice are nsg mice that received a xenograft of human cd34 + stem cells and a transplant of human fetal thymus and liver implanted under the kidney capsule, which results in the formation of a "human immune organ" [36] . control and potential elimination of onchocerciasis has been significantly impeded by the limited number of available drugs and the development of resistance to those therapies [37, 38] . in addition, biomarkers to assess the infection status of treated individuals or macrofilaricidal activity are sorely lacking [6] [7] [8] . one of the critical barriers blocking drug and biomarker development has been the absence of suitable small animal hosts for experimentation. hence, this study was focused on the development of a small animal model that would support the growth and maturation of o. volvulus and could serve to identify parasite specific biomarkers. to this end we tested multiple genetically defined mouse strains and xenografted (with human cells) immunodeficient mice to identify those microenvironments suitable for o. volvulus development. in so doing, we were able to develop convenient and tractable murine models that support the development of o. volvulus l3 into advanced larval stages. moreover, we were able to use these o. volvulus-infected animals to identify parasite-derived biomarkers measurable in both urine and serum. the parasite material was collected during the years 1994-1999 in the research facility at the tropical medicine research station, kumba, cameroon. the procedures used for the production of o. volvulus forest strain third-stage-larvae (l3) were approved by an nih accredited institutional review board of the medical research council kumba, cameroon (protocol 001). the protocol was reviewed and approved annually. l3 were collected from black flies (simulium damnosum) that were fed on consenting infected donors. after seven days the flies were dissected and the developed l3 were collected, cleaned and cryopreserved. the cryopreserved l3 were shipped to the new york blood center in liquid nitrogen and upon arrival in new york were stored in liquid nitrogen. all protocols using the l3 cryopreserved samples in this study were approved by the new york blood center's irb (protocol 321 and protocol 603-09). all l3 samples were anonymized. all experimental procedures in mice were performed in compliance with the ethical and regulatory standards set by the nih for animal experimentation. the animal use protocol (01469) was approved by the thomas jefferson university institutional animal care and use committee. the animal care and use protocol adhered to the "guide for the care and use of laboratory animals" published by the national research council, usa. cryopreserved l3 were prepared as previously described [39] [40] [41] . briefly, black flies (simulium damnosum) were fed on consenting donors infected with o. volvulus, and after 7 days the developed l3 were collected from dissected flies, cleaned, and cryopreserved in dimethyl sulfoxide and sucrose using biocool ii computerized freezing equipment (fts systems inc., stone ridge, ny) [42] . cryopreserved l3 were removed from liquid nitrogen storage and placed on dry ice for 15 minutes followed immediately by a 37˚water bath. the l3 were then washed 5 times in a 1:1 mixture of nctc-135 and iscove's modified dulbecco's medium (sigma, st. louis mo) supplemented with 100 u penicillin, 100 μg streptomycin (corning, tewksbury ma) 100 μg gentamicin and 30 μg chloramphenicol per ml (sigma). l3 isolated from different collection days were tested first for viability in diffusion chambers implanted in balb/byj for 21 days, as previously described [17] . batches of l3 with viabilities greater than 50% at 21 days post implantation were used in these studies. one hundred worms (except where noted) were then counted and loaded into 1 ml tuberculin syringes with 21 g needle for subcutaneous injection of the larvae into the nape of the neck. all mice were housed in micro-isolator boxes in a pathogen-free room at the laboratory animal science facility at thomas jefferson university (philadelphia, pa). collaborative cross (cc) mouse strains, cast/eij, il16680 (cc055/tauunc), au8052 (cc052/geniunc), au8049 (cc038/geniunc) and or13067 (cc003/unc), were purchased and imported from the systems genetics core facility of university of north carolina (unc-chapel hill). information about the cc strains can be found on the unc systems genetics website at http:// csbio.unc.edu/ccstatus/index.py. the mice were kept under temperature, humidity and light cycle-controlled conditions and fed autoclavable rodent chow and given water ad libitum. nod-scid il2rg null (nsg), nod-rag1 null il2rg null (nrg), and nod-scid il2rg null -3/ gm/sf (sgm) mice were obtained from the jackson laboratories (bar harbor, me). an nsg, nrg, and sgm mouse breeding colony was maintained in the laboratory animal science facility, at thomas jefferson university with breeding trios given acidified water and low fat 5k52 animal chow (labdiet, st. louis, mo). the following human cell types were individually transferred into nsg mice: (1) human keratinocytes (hacat) (atcc, manassas, va), (2) bovine embryo skeletal muscle cells (besm) in the initial experiments, mice were injected with 5×10 6 besm, hacat, lec, or huskmc cells subcutaneously weekly throughout the experiment. the frequency of injection was subsequently determined by in vivo imaging experiments. genes encoding green fluorescent protein (gfp) and luciferase were inserted into huskmc cells using lentiviral vectors following the manufacturer's recommendations (cell biolabs, inc, san diego, ca). cells expressing gfp were isolated using the gfp marker by fluorescence-activated cell sorting using a bd facs aria (bd biosciences, franklin lakes, nj). the isolated cells were grown in huskmc media as described above and 5×10 6 cells were injected subcutaneously into nsg mice. mice were injected with vivoglo (promega, madison, wi) and imaged following manufacturer's recommendations on an ivis lumina xr (promega). two approaches were used to create humanized mice containing multiple human-cell types [25, 36] . human umbilical cord blood was obtained through collaboration with thomas jefferson university hospital department of obstetrics and gynecology from full term natural deliveries. cd34 + stem cells were isolated from cord blood using magnetic assisted cell sorting (macs) and cryopreserved until use. sgm, nrg and nsg mice were humanized with cd34 + umbilical cord derived stem cells by intrahepatic injection of 5x10 5 cd34 + stem cells into 48-hour old pups that were irradiated with 1.5 gray. six weeks following injection of the stem cells, peripheral blood from the mice was screened for the presence of human cells and mice with counts greater than 600 human cd45 + hematopoietic cells per μl of whole blood were used for experimentation, following previously published protocols [31] . blt mice were purchased from the jackson laboratories or were prepared following previously established protocols [27] . briefly, nsg mice (4-to 6-week old) were implanted with 1 mm 3 sections of fetal thymus and liver (advanced biomedical resources, alameda, ca) under the kidney capsule. two weeks post-implantation the mice were treated with busulfan (sigma) (20 mg/kg ip) and were injected retro-orbitally with 5x10 5 cd34 + stem cells, isolated from the donor fetal liver using macs, (miltenyi biotec inc. auburn, ca). eight weeks following the stem cell xenograft the peripheral blood from the blt mice was screened for the presence of human cells. blt mice were screened and selected using the same protocol described above for the cd34 + cord blood mice. pcr screening for o. volvulus dna was performed on all the infected mouse tissues to identify the presence of current or past o. volvulus larvae in that location. mice were anesthetized and exsanguinated, and the internal organs were removed, and the skin was removed from the muscle. the muscle and skin were then divided into 100 different sections and individually frozen in 1.7 ml eppendorf tubes. dna was extracted from the tissue sections using the promega genomic dna kit a1125 following the manufacturer's directions. realtime pcr was performed using custom taqman probes (integrated dna technologies, coralville, ia) against the ov-150 [44] [45] [46] repeats and an abi onestep-plus (thermofisher). mice were necropsied following previously established protocols for the isolation of filarial worms from tissues [47, 48] . briefly, mice were anesthetized using isoflurane gas and exsanguinated. the head was removed from the body of the mouse and discarded. the remaining internal organs and skin were removed from the muscles, and the muscle was divided into upper and lower sections at the bottom of the rib cage. all portions of the mouse (muscle, skin, and all internal organs with the exception of the head) were soaked overnight in rpmi containing 10% fbs and with 100 u penicillin, 100 μg streptomycin (corning), and emerging parasites were then collected and enumerated. infected mice were evaluated using two criteria: 1) percent established, measured the proportion of mice in a group of infected animals from which live parasites were recovered; and 2) the geometric mean number of live worms recovered per mouse within the group. recovered worms were placed in boiling fixative consisting of 95% ethanol (deacon labs, king of prussia, pa) and 5% glycerol (fisher, fair lawn, nj). after allowing the alcohol to evaporate, glycerol was added, and the worms were transferred to glycerin jelly (gelatin 10 g, ddh 2 o 60.0 ml, glycerine 70.0 ml, phenol 1.0 ml). fixed worms were measured using an olympus szx16 dissecting scope connected to a dp26 camera (olympus, center valley, pa). cellsens dimensions software (olympus) was used to measure the length of the recovered worms. serum and urine were collected and frozen as terminal procedures during necropsy. serum was thawed on ice and 25 μl removed for processing from each mouse. sera from 4 mice from each group/strain were pooled for maximizing the protein identifications. abundant proteins were depleted using an affinity chromatography (mars-ms-3, agilent) according to the manufacturer's directions. urine was thawed on ice, centrifuged and then filtered through a 0.22 μm filter (corning). serum and urine samples were prepared for mass spectrometry by digestion using the filter-assisted sample preparation (fasp) method [49] . briefly, the samples brought to 1% sodium deoxycholate (sdc), 50 mm tris-hcl, ph 7.6, 3 mm dithiothreitol, sonicated briefly, and incubated in a thermo-mixer at 90 o c, 1,000 rpm for 20 min. samples were centrifuged to clarify and the supernatant was transferred to a passivated 30 kd mwco device (millipore, merck kgaa, darmstadt, germany) and centrifuged at 13,000g for 30 min. the remaining sample was buffer exchanged with 1% sdc, 100 mm tris-hcl, ph 7.6, then alkylated with 15 mm iodoacetamide. the sdc concentration was reduced to 0.1%. samples were digested using trypsin at an enzyme to substrate ratio of 1:100, overnight, at 37 o c in a thermo-mixer at 1,000 rpm. digested peptides were collected by centrifugation and the filter washed with 0.5 nacl to elute electrostatically bound peptides. digested peptides were desalted using reversed phase stop-and-go extraction tips [50] . peptides were eluted with 80% acetonitrile, 0.5% formic acid and lyophilized in a speedvac (thermo savant, holbrook, ny) to near dryness, approximately 1 h. each digestion mixture was analyzed by ultra-high performance liquid chromatography tandem mass spectrometry (uhplc-ms/ms). lc was performed using an easy-nlc 1000 uhplc system (thermo fisher scientific, waltham, ma). mobile phase a was 97.5% milliq water, 2% acetonitrile, 0.5% formic acid. mobile phase b was 99.5% acetonitrile, 0.5% formic acid. the 240 min lc gradient ran from 0% b to 35% b over 210 min, then to 80% b for the remaining 30 min. samples were loaded directly to the column. the column was 50 cm x 75 um i.d. and packed with 2 μm c18 media (thermo easy spray pepmap). the lc was interfaced to a quadrupole-orbitrap mass spectrometer (q-exactive, thermo fisher scientific, waltham, ma) via nano-electrospray ionization using a source with an integrated column heater (thermo easy spray, thermo fisher scientific, waltham, ma). the column was heated to 50˚c. an electrospray voltage of 2.2 kv was applied. the mass spectrometer was programmed to acquire, by data-dependent acquisition, tandem mass spectra from the top 10 ions in the full scan from 400-1200 m/z. dynamic exclusion was set to 15 s, singly-charged ions were excluded, isolation width was set to 1.6 da, full ms resolution to 70,000 and ms/ms resolution to 17,500. normalized collision energy was set to 25, automatic gain control to 2e5, max fill ms to 20 ms, max fill ms/ms to 60 ms and the underfill ratio to 0.1%. mass spectrometer raw data files were converted to mzml format using msconvert [51] . mgf files were generated from mzml using the peak picker hires tool, part of the openms framework [52] . all searches were performed on amazon web services-based cluster compute instances using the proteome cluster interface. detailed search parameters are printed in the search output xml files. briefly, all searches required 10 ppm precursor mass tolerance, 0.02 da fragment mass tolerance, strict tryptic cleavage, up to 2 missed cleavages, fixed modification of cysteine alkylation, variable modification of methionine oxidation and protein-level expectation value scores of 0.0001 or lower. proteome cluster builds species-and genus-specific protein sequence libraries from the most current uniprotkb distribution [53] . mgf files were searched using the most recent protein sequence libraries available from uniprotkb using x!tandem [54] and omssa [55] . xml output files were parsed and non-redundant protein sets determined using proteome cluster based on previously published rules [56] . ms1-based isotopoic features were detected and peptide peak areas were calculated using the featurefindercentroid tool, part of the openms framework [52] . proteins were required to have 1 or more unique peptides across the analyzed samples with e-value scores of 0.0001 or less. geometric means (gm) were used as measures of central tendency. data were analyzed for larval growth by multifactorial analysis of variance anova with post-hoc fisher's least significant difference (lsd) testing in systat v.11 (systat inc., evanstown, il, usa). probability values less than 0.05 were considered statistically significant. all experiments were performed a minimum of 2 times. to determine if there was an underlying genetic basis for the resistance of mice to infection with o. volvulus [14] , 5 mouse strains having a wide range of genetic diversity from the cc (cast/eij, il16680, au8052, au8049 and or13067) [57] were screened for their susceptibility to o. volvulus. five mice from each of the different strains were infected with 100 o. volvulus l3 and necropsied at 4-weeks post infection. none of the 5 strains of cc mice tested was susceptible to infection with o. volvulus l3. to assess the role of the mouse immune system in mediating resistance to o. volvulus, immunodeficient mouse strains were assessed for their susceptibility to infection with o. volvulus. in a preliminary set of studies, 250 o. volvulus l3 were injected into 2 nsg mice. after 4-weeks the skin and muscle from the mice was divided into 100 anatomically distinct sections and qpcr for o-150 was performed on extracted dna from each section. twenty-three of the sections were positive from, spatially widespread regions of the body. it was concluded that parasites survived in nsg mice and had the ability to migrate extensively. this indicated that all regions of the mice had to be inspected for the presence of parasites following infection. nsg mice were infected with 100 o. volvulus l3 and necropsied at 4-and 8-weeks following infection. infected mice had an established infection rate of 63% with a gm worm recovery of 2.0 (range 1 to 4) worms recovered at 4-weeks following infection. at 8-weeks, 75% of mice had an established infection, with a gm recovery of 1.4 (range 1 to 3) worms per mouse ( fig 1a) . the recovered worms were measured and found to be significantly increased in size (p<0.0001; min: 677 μm, max 843 μm, gm: 717 μm) at 4-weeks compared to l3. they also significantly increased in size between 4 and 8 weeks (p<0.0001) reaching a maximum of 1,085 μm (min: 700 μm, gm: 1034 μm) (fig 2) . table) . mice engrafted with lec had 20% established infection and gm of 4 worms recovered per mouse with a range of 1 to 4 worms per mouse (s1 table) . hacat cell engrafted mice had a 60% established infection and gm recovery 1.7 worms recovered per mouse with between 1 and 2 worms per mouse (s1 table) . huskmc cell engrafted mice had an 81% estab(fig 1b) . at each time point tested the parasites in huskmc-engrafted mice demonstrated continued parasite growth. at 4-weeks recovered parasites had gm lengths of 713 μm (min: 592 μm, max: 788 μm), at 8-weeks lengths of 751 μm (min: 642 μm, max: 1,081 μm), and at 12-weeks the gm length was 1,121 μm with a maximum length of 2,086 μm observed (min: 748 μm), representing a 4-fold increase in length over l3 (fig 2) . these growth rates represented significant changes between l3 and 4-week worms (p = 0.0010) and between 8-and 12-week worms (p<0.0001). sgm, nrg and nsg (hunsg) mice humanized with cd34 + umbilical cord derived stem cells were infected with 100 o. volvulus l3. each of these humanized mice had human hematopoietic lineage cells at a concentration greater than 600 cells per μl of blood. while a complete picture of the cell populations in these specific mice was not determined, based upon flow analysis during the screening process all humanized mice had both human b and t-cells present in their blood. at 4-weeks post-infection humanized sgm mice contained a gm of 2.4 (range 1-7) worms/mouse, humanized nrg mice had a gm of 1.7 (range 1 to 4) worms/ table) . hunsg at 4-weeks post-infection had a 69% established infection rate with a gm of 3.4 (range 1-14) worms/mouse, and at 8-weeks post infection hunsg mice had a 46% established infection rate and a gm of 2.6 (range 1-18) worms/mouse (fig 1c) . larval growth in hunsg mice was comparable to that seen in nsg and in nsg mice engrafted with huskmc (fig 2) . a significant increase in length was seen between the l3 and 4-week recovery 12 ). after 4-, 8-or 12-weeks the percent established (the proportion of mice in a group of infected animals from which live parasites were recovered) (fig 1a-1d ) and the geometric mean number of live worms recovered per mouse within the group was determined (fig 1e-1h) . https://doi.org/10.1371/journal.pntd.0006977.g001 humanized nsg (hunsg) mice: nsg mice that had received a human cd34 + stem cell transfer, (4) blt: nsg mice that had been engrafted with human fetal liver derived cd34 + stem cells and engrafted with fetal thymus and liver tissues. after 4, 8 or 12-weeks, animals were necropsied and worms were recovered and measured. solid colored bar is the geometric mean of the lengths of larvae recovered. solid black line is the geometric mean of the length of l3 recovered from black flies and dotted line is the 95 th confidence interval. � asterisk represents statistical difference, p value � 0.05, in length of larvae recovered from mice. complete statistical analyses for all groups are included on s2 blt mice humanized with fetal thymus, liver and cd34 + stem cells, which display an enhanced repertoire of the developing human cells [58] , were infected with 100 o. volvulus l3 and then necropsied at 4-and 8-weeks post infection. at 4-weeks post infection blt mice had an established infection rate of 77% with a gm of 4.8 (range 2-10) worms/mouse. at 8-weeks post infection blt mice had an established infection rate of 60% with a gm of 2.3 (range 2-3) worms/mouse (fig 1d) . growth of the parasites was equivalent to that seen in the nsg mice and the other humanized models with the maximum length reaching 1,080 μm at 4-weeks (min: 391 μm, gm: 623 μm) and 1,448 μm at 8-weeks (min: 730 μm, gm: 949 μm) (fig 2) . the overall growth was significant between the l3 and worms 4-weeks post infection (p<0.0001) and between worms recovered at the 4-and 8-week time points (p<0.0001). during necropsy, mice were sectioned into 4 groupings: upper muscles, lower muscles, skin, and the complete set of internal organs. no nodules were found in any of these tissues upon necropsy. worms were recovered from all four of the different tissue groupings with no apparent preference for any region of the animal in all of the mice tested. detailed morphological analyses focused on worms recovered from blt mice infected for 8-weeks and huskmc humanized mice infected for 12-weeks. although there were clear differences in lengths of these worms, their morphological characteristics were similar. no differences in the ratio of males and female worms recovered from the mice was observed, however it was noted that most of the longer worms were females. both the anterior and posterior ends in both sexes were bluntly rounded and only slightly tapered (fig 3a, 3b and 3f ). other than growth in length, the major change from l3 was development of the reproductive systems. in the l3, both the female and male systems are rudimentary genital primordia consisting of only several cells. in the 8-12-week old worms, the female ovejector had formed and had attached to the body wall. the ovejector was ovoid in shape, relatively large and filled the body cavity, and had a distinct lumen (fig 3c and 3d) . rudimentary cellular growth of the reproductive tubes was also evident (fig 3d) . in males, the testis, located at approximately mid-body, had become elongate in shape and had looped posteriorly to form a classic shepherd's crook (fig 3e) . in addition, the spicule pads were well developed and demarcated (fig 3f) but were still oval in shape and had not yet started to take on the shape of the spicules nor was there any evidence of cuticularization. these observations are consistent with parasite development into advanced fourth stage larvae (l4). global proteomic analyses were performed with serum and urine collected from blt mice infected for 8-weeks and huskmc humanized mice infected for 12-weeks. a total of 7,430 proteins were identified based on the spectral matching to a combined protein database of human, mouse, o. volvulus and its wolbachia (wov) endosymbiont. because of the ambiguity in distinguishing certain spectral matches for proteins commonly found in both humans and mice, these proteins were grouped as non-o. volvulus proteins (4,743 in serum, 2,836 in urine, s1 development of onchocerca volvulus in nsg mice serum and urine of the infected mice, the blt and huskmc mice had 5 proteins (ovoc115 56, ovoc835, ovoc10244, ovoc4009 and ovoc9087) in common in the serum and 5 (ovoc7220, ovoc4139, ovoc224, ovoc8249 and ovoc9267) in the urine (fig 4b) . almost all the proteins identified have been shown through rnaseq to be transcribed by various stages of the o. volvulus parasite (fig 4b) . the objective of this project was to identify small animal models that would support the development of black-fly derived o. volvulus l3 into advanced mammalian-adapted stages of the parasite. these small animal models are critically needed for identifying biomarkers released from the early stages of the infection and for screening potential new anthelmintics. published findings on the susceptibility of mice to infection with the l3 of o. volvulus suggest that mice are resistant to infection when the larvae were injected subcutaneously [14] . however, o. volvulus l3 have been shown to survive and develop in mice when implanted within diffusion chambers at rates comparable to those seen in susceptible primates [17] . genetic traits can play a significant role in the susceptibility of animals to infection as has been clearly demonstrated by the diversity of susceptibility of different mouse strains to infection with litomosoides sigmodontis [59] . the cc mouse project was developed to produce an extremely diverse set of inbred animals that could be used for mapping different genetic traits [57] . five different cc mouse strains, selected based on their diverse genetic backgrounds, were tested for susceptibility to o. volvulus and were completely resistant to the infection. this observation suggests that either mice are missing some integral factors required for parasite growth or the immune responses in mice are effective at eliminating the infection. the question remains as to why parasites are recovered live from diffusion chambers implanted in mice but not when injected into the tissues. there are several possible explanations including: (1) the diffusion chamber acts as a barrier from the immune response creating an immune privileged site, (2) the larvae within the diffusion chamber are blocked from migrating through the tissue releasing excretory and secretory products and thereby eliciting an immune reaction, or (3) the diffusion chamber attracts host components to the parasite microenvironment that are beneficial for parasite development. to test the hypothesis that mouse-intrinsic immune responses control o. volvulus infections, nsg mice that lack both functional innate and adaptive immune systems were infected with o. volvulus l3. advanced stages of the parasites were consistently recovered from the infected nsg mice, and parasites survived and developed over the 8-week time course into advanced l4. these findings demonstrate that the mouse immune response was capable of controlling infection with o. volvulus, with elements of the mouse immune response eliminating the infection in immunologically intact mice. many mechanisms have been described for innate immune control of nematode infections in mice [39, [60] [61] [62] [63] [64] [65] [66] [67] all or some of which may be effective against o. volvulus. interestingly, tissues and cells in nsg mice provide required factors for parasite development and based on pcr analyses, the larvae actively migrated far from the infection site. the present study did not identify the point at which o. volvulus ceased surviving and developing in nsg mice. studies with the human parasite s. stercoralis have demonstrated that the entire parasite life cycle will develop in nsg mice within 4-weeks [31] . given the significant difference in time that it takes for o. volvulus adults to develop (12-15 months in chimpanzees [9, 10] ) and their size as mature adults (females are 50 cm [68] ) it is unlikely that the entire o. volvulus life cycle, including mating and development of microfilariae, will occur in nsg mice. in vitro studies on the development of filarial worms including o. volvulus [69, 70] and brugia malayi [71] have demonstrated that host cells are needed in the culture wells to optimize parasite growth and development. furthermore, optimal development and survival of larval t. spiralis in mice requires the presence of mouse eosinophils [33] . it was thus hypothesized that adding human cells to the nsg mice, from the tissues that the parasites are normally found juxtaposed in humans, might provide additional required nutritional or developmental elements found in humans required for parasite development and survival. four different single cell xenografts were screened: huskmc, lec, hacat and besm. of these four cell lines, huskmc was found to support the highest average percent survival of the implanted worms and consistent infection rates over a 12-week time period (figs 1 and 2) as an alternative to adding single cell populations to the nsg mice, multipotential umbilical cord stem cells were transferred to the immunodeficient mice. nsg, nsg-sgm, and nrg mice, all of which lack functional immune responses, were humanized with cd34 + umbilical cord stem cells. the humanization of the various immunocompromised mouse strains resulted in the development of an immature human immune system. the developing immune system in these mice displays a t-independent response, limited antigen-specific igm responses, and the presence of multiple innate immune cells has been noted [25] . when humanized nsg, nsg-sgm, and nrg mice were infected with o. volvulus l3, higher gm parasite recoveries were observed when compared to nsg mice without any human cells but these enhancements were not significant. although nsg-sgm did have consistent infection rates with o. volvulus we had significant difficulties establishing reliable engraftment of human cells in this strain of mice. extending this concept further, blt mice which contain cd34 + stem cells in addition to fetal tissue were used. blt mice are known to develop a more mature version of a human immune system. limited t-dependent recognition is seen within these mice and better overall functionality of both the b and t-cells has been documented [36] . blt mice supported the highest average parasite recoveries of any mouse model tested at 4-weeks, although the average fell to be in line with the hunsg and huskmc models by 8-weeks post infection. the mean lengths of the parasites recovered from 4-and 8-week time points from the nsg mice were comparable to those recovered from blt mice. this suggests a link between the enhanced survival, may be related to the presence of the human immune cells, but the growth of the parasites that survive may not be related to the human cell byproducts. although cellular engraftments levels in blt and hunsg mice were not rechecked at the end of the experiment previously published data have shown that these animals reliably hold their engraftments for extended periods of time [72, 73] . the mouse models developed in this study offer a number of advantages over the models that currently exist. l3 implanted within diffusion chambers in both non-human primates and mice successfully molt into l4 but the lengths of the recovered parasites were significantly shorter than those recovered at 8 and 12 weeks post infection from the mice tested in this study [17] . while non-human primates can support the development of the parasites from l3 to microfilariae producing adults, cost and ethical considerations limit the utility of primates for drug discovery and antigen identification [10, 14] . nodules containing adult worms recovered from humans have been implanted into scid mice and the female worms survived and released microfilariae [15] . this method allows for identification of adult antigens and biomarkers, but lacks the intermediate l3 and l4 stages of development. finally, an alternative model using adult male o. ochengi implanted into scid mice has been developed for the identifying filaricides [16] , which may also be effective against o. volvulus. the nsg models developed in this study have the critical advantage of working with o. volvulus, thereby allowing species-specific screening of filaricides and identification of biomarkers. it was of interest to note that the immune response found in normal mice was highly efficient at eliminating the l3 of o. volvulus, but the human immune cells in nsg mice were supportive rather than destructive of the parasites. it is possible that the mouse immune cells were evolutionally adapted to eliminate the parasites, whereas the human cells were evolutionally adapted to support the parasites as observed in nature. a comparison between mouse and human immune reactions to the worms might yield important new insights into the etiology of resistance and susceptibility to infection with o. volvulus. the source of the l3 used in these studies was from parasites cryopreserved in liquid nitrogen. after defrosting, 100 individual parasites were selected, attempting to identify only the viable/undamaged l3. it is reasonable to predict that a percentage of larvae exiting from the mouth parts of a black fly have the potential to resume development in the human host and that the cryopreservation process damaged some of those worms. approximately 50 percent of the larvae recovered after cryopreservation survived in diffusion chambers implanted in mice, which may explain the overall number of worms recovered from the different mouse models in this study. while minor differences in the overall larval recovery levels were observed between individual batches of cryopreserved larvae, multiple batches were combined before implantation to help ensure a consistent viability level going into the animal hosts. even with the combination of multiple batches of larvae it cannot be ruled out that the overall viability of the injected larvae played a role in the observed recovery rates. the recovery rates of o. volvulus larvae after developing in nsg mice with or without human cells was in the same order of magnitude as that reported for the recovery of adult filarial worms, where infections were initiated by larvae recovered directly from the insect vector. these infections included brugia pahangi in cats [74] , brugia malayi in leaf-monkey [75] , and onchocerca ochengi in cattle [76] . in the final analysis, optimal parasite recovery was observed in mice humanized with huskmc (maximum of 10 worms), hunsg (maximum of 18 worms) and blt mice (maximum of 10 worms). it was clear that worms increased in size during the infection period with individual worms achieving up to 4 times the size of the original l3. growth of worms within a single mouse was not consistent and suggests that there is significant variability within the infecting larval population. it does verify, however, that humanized mice have the potential to support extended development of o. volvulus. both male and female worms grew in length and resumed their sexual development. although no cast cuticles were observed, it was evident from organ development that the parasites had molted into fourth-stage larvae. urine and serum was collected from humanized mice infected for 8-12-weeks with o. volvulus for the identification of biomarkers. infected huskmc mice or blt mice were selected for this analysis so the biomarkers identified would develop in the presence of human cells thereby potentially enhancing their specificity. several o. volvulus-specific peptides were identified in the serum and urine of blt and huskmc mice (s3 table) , however, no o. volvulusspecific proteins were found in both urine and serum from either mouse source. the most likely useful biomarkers were the proteins listed in fig 4b. though most of the proteins were identified by one or more unique peptide(s), among the proteins with unknown function (ovoc9087, ovoc835, ovoc224), ovoc9087 does not have orthologues in other filarial species and hence would likely be able to distinguish o. volvulus from other filarial infections. because of the expected low number and abundance of o. volvulus-specific protein identification in the serum and urine from any given mouse in the current system, mass spectrometry was carried out with pooled serum and urine samples from each group of mice. in conclusion, novel small-animal hosts, nsg mice, have been identified that support the survival and development of o. volvulus l3 into advanced l4 mammalian stages. humanized mice have also been shown to be effective at identifying biomarkers for early o. volvulus infections. it is anticipated that these small-animal hosts for o. volvulus will also be useful as part of the effort to identify new anthelminthic drugs. finally, the fact that o. volvulus survives and develops in nsg mice humanized with human immune cells may provide the opportunity to study the human immune response to early infection with o. volvulus in a small animal model. global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study detection of onchocerca volvulus in skin snips by microscopy and real-time polymerase chain reaction: implications for monitoring and evaluation activities an immunogenic onchocerca volvulus antigen: a specific and early marker of infection a rapid-format antibody card test for diagnosis of onchocerciasis a comparison of newer tests for the diagnosis of onchocerciasis onchocerca volvulus-neurotransmitter tyramine is a biomarker for river blindness validation of onchocerciasis biomarker n-acetyltyramine-o-glucuronide (natog) evaluation of the diagnostic potential of urinary n-acetyltyramine-o,beta-glucuronide (natog) as diagnostic biomarker for onchocerca volvulus infection observations on onchocerca volvulus in experimentally infected chimpanzees primate model for onchocerciasis research experimental onchocerca volvulus infections in mangabey monkeys (cercocebus atys) compared to infections in humans and chimpanzees (pan troglodytes) experimental onchocerciasis in chimpanzees. antibody response and antigen recognition after primary infection with onchocerca volvulus experimental onchocerciasis in chimpanzees. cell-mediated immune responses, and production and effects of il-1 and il-2 with onchocerca volvulus infection attempts to establish onchocerca volvulus infection in primates and small laboratory animals survival of onchocerca volvulus in nodules implanted in immunodeficient rodents a murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis survival and development of larval onchocerca volvulus in diffusion chambers implanted in primate and rodent hosts translational rodent models for research on parasitic protozoa-a review of confounders and possibilities host genetic diversity influences the severity of pseudomonas aeruginosa pneumonia in the collaborative cross mice susceptibility to klebsiella pneumonaie infection in collaborative cross mice is a complex trait controlled by at least three loci acting at different time points modeling host genetic regulation of influenza pathogenesis in the collaborative cross genome wide identification of sars-cov susceptibility loci using the collaborative cross genetic diversity in the collaborative cross model recapitulates human west nile virus disease outcomes the immunodeficient scid mouse as a model for human lymphatic filariasis human lymphoid and myeloid cell development in nod/ltsz-scid il2r gamma null mice engrafted with mobilized human hemopoietic stem cells defects in the differentiation and function of antigen presenting cells in nod/lt mice multiple defects in innate and adaptive immunologic function in nod/ltsz-scid mice daf-12 regulates developmental age and the dauer alternative in caenorhabditis elegans the scid mouse mutant: definition, characterization, and potential uses expanded cd34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in nod-scid il2rgamma(null) mice methylprednisolone acetate induces, and delta7-dafachronic acid suppresses, strongyloides stercoralis hyperinfection in nsg mice non-obese diabetic-recombination activating gene-1 (nod-rag1 null) interleukin (il)-2 receptor common gamma chain (il2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment eosinophils and il-4 support nematode growth coincident with an innate response to tissue injury humoral immunity in humanized mice: a work in progress aml xenograft efficiency is significantly improved in nod/scid-il2rg mice constitutively expressing human scf, gm-csf and il-3 blt humanized mice as a small animal model of hiv infection ivermectin resistance in onchocerca volvulus: toward a genetic basis genome-wide analysis of ivermectin response by onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity protective immunity to the larval stages of onchocerca volvulus is dependent on toll-like receptor 4 immunoglobulin e and eosinophil-dependent protective immunity to larval onchocerca volvulus in mice immunized with irradiated larvae differential cytokine and antibody responses to adult and larval stages of onchocerca volvulus consistent with the development of concomitant immunity cryopreservation of infective larvae of onchocerca volvulus (filarioidea: onchocercidae) infection of tissue culture cells with bloodstream trypomastigotes of trypanosoma cruzi detection of onchocerca volvulus infection by o-150 polymerase chain reaction analysis of skin scratches polymerase chain reactionbased diagnosis of onchocerca volvulus infection: improved detection of patients with onchocerciasis dna-based detection of onchocerca volvulus effects of presensitization on the development of lymphatic lesions in brugia pahangi-infected jirds removal of wolbachia from brugia pahangi is closely linked to worm death and fecundity but does not result in altered lymphatic lesion formation in mongolian gerbils (meriones unguiculatus) universal sample preparation method for proteome analysis protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using stagetips a cross-platform toolkit for mass spectrometry and proteomics openms-an open-source software framework for mass spectrometry uniprot: a hub for protein information tandem: matching proteins with tandem mass spectra open mass spectrometry search algorithm masssieve: panning ms/ms peptide data for proteins the collaborative cross, a community resource for the genetic analysis of complex traits the utility of the new generation of humanized mice to study hiv-1 infection: transmission, prevention, pathogenesis, and treatment resistance and susceptibility to filarial infection with litomosoides sigmodontis are associated with early differences in parasite development and in localized immune reactions complement component c3 is required for protective innate and adaptive immunity to larval strongyloides stercoralis in mice role of eosinophils and neutrophils in innate and adaptive protective immunity to larval strongyloides stercoralis in mice strongyloides infection in rodents: immune response and immune regulation extracellular traps are associated with human and mouse neutrophil and macrophage mediated killing of larval strongyloides stercoralis human and mouse macrophages collaborate with neutrophils to kill larval strongyloides stercoralis innate and adaptive immunity to the nematode strongyloides stercoralis in a mouse model strongyloides stercoralis: protective immunity to third-stage larvae inbalb/cbyj mice immunity to onchocerca spp. in animal hosts morphology of onchocerca volvulus the use of cell-conditioned medium for the in vitro culture of onchocerca spp. larvae (nematoda: filarioidea) onchocerca volvulus: biochemical and morphological characteristics of the surface of third-and fourth-stage larvae in vitro cultivation of third-stage larvae of brugia malayi to the young adult stage sustained engraftment of cryopreserved human bone marrow cd34(+) cells in young adult nsg mice long-term human cd34+ stem cell-engrafted nonobese diabetic/scid/il-2r gamma(null) mice show impaired cd8+ t cell maintenance and a functional arrest of immature nk cells repeated infection of cats with brugia pahangi: parasitological observations experimental infection of the leaf-monkeys, presbytis cristata and presbytis melalophos with subperiodic brugia malayi onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments we thank the consenting infected donors from the villages around kumba, cameroon (marumba i, marumba ii, boa bakundu, bombanda, and bombele) who participated in the study. we also thank dr. peter enyong and the staff at the tropical medicine research station for their technical support in the production and cryopreservation of the o. volvulus l3s.we thank dr. timothy manser, thomas jefferson university, for his support and encouragement for using human-stem cell engrafted humanized mice; dr. judy sakanari, university of california san francisco for her gift of bovine embryo skeletal muscle cells and dr. fernando pardo manuel de villena, ms. darla r. miller, and dr. linda d. siracusa for guidance with collaborative cross strain import and husbandry. key: cord-006588-aavpj5r3 authors: schwarte, l.a.; zuurbier, c.j.; ince, c. title: mechanical ventilation of mice date: 2000 journal: basic res cardiol doi: 10.1007/s003950070029 sha: doc_id: 6588 cord_uid: aavpj5r3 due to growing interest in murine functional genomics research, there is an increasing need for physiological stable in vivo murine models. of special importance is support and control of ventilation by artificial respiration, which is difficult to execute as a consequence of the small size of the animal and the technically demanding breathing pattern. in addition, numerous genetically altered mice show depressed spontaneous ventilation or impaired respiratory responses. after an introduction in murine respiratory physiology we describe options for ventilatory support, its monitoring and the potential side effects. this review will provide an overview on current possibilities in the field of airway support in mouse research. rate (rr) of 79 min ð1 , a ventilatory tidal volume (vt) of 25µl, an inspiratory fraction (inspiratory to total time of the respiratory cycle, ti/tt) of 0.44 and a resulting ventilatory minute volume (ve) of 1.98 mlámin ð1 was found. similar values are found for wild type and endothelin-1 knock-out mice (et (ð/ð) ) when birth was achieved by cesarean section (30) . rather low respiratory values were found in a study comparing wild type neonates with littermates deþcient for the ret-protooncogene: rr ranged from 28ð40 min ð1 , vt from 7ð10 µl and ve from 0.26ð0.32 mlámin ð1 , with no significant differences between the groups. the authors suggest that a reduced body temperature in their setting contributed to their þndings (4) . with respect to control of breathing, newborn wild type mice (1 g bodyweight) show similar ventilatory responses to hypercapnia compared to other newborn mammals (34) . neonates deþcient in endothelin-1 (129sv/j x icr, et-1 (ð/ð) ) have an attenuated ventilatory response to hypoxia and hypercapnia, compared to their wild type littermates (30) . a signiþcantly reduced ventilatory response to hypercapnia was also found in neonate mice deþcient in the ret-protooncogene, compared to wild type littermates, whereas no consistent differences were obtained during hypoxic challenge (4) . parameters for the spontaneous ventilation of adult mice are given in table 1 , where the following characteristics of mice ventilation are given: rr = 180ð270 mlámin ð1 , vt = 0.1ð0.2 ml and ti/tt = 0.30ð0. 35 . little information is currently available on the lung mechanics of mice (37) . murine lung-thorax compliance was measured in pancuronium-relaxed, mechanically ventilated mice (balb/c, no weight stated) in the range of 31ð38 µl (cmh 2 o) ð1 under control conditions, and 12 µl (cmh 2 o) ð1 after experimental surfactant inactivation (50) . respiratory system resistance was measured in age matched a/j-and c3h/hejmice, revealing signiþcant strain differences under baseline conditions (1 vs. 2 cmh 2 oám/ ð1 ás ð1 ) and especially after i.v. acetylcholine treatment (3 vs. 15 cmh 2 oám/ ð1 ás ð1 ) (11) . in the same study, signiþcant differences were also found for the respiratory system elastance under both conditions (25 vs. 30 cm h 2 oáml ð1 at baseline and 28 vs. 95 cm h 2 oáml ð1 after i.v. acetylcholine). again, one has to realize that marked differences exist between mouse strains in respect to respiratory physiology and pathophysiology. divergent data is available on physiologic values for murine arterial blood gasses, regarded as the gold standard for the evaluation of adequacy of ventilation. information on tissue pco 2 of the mouse indicates that it þts within the normal mammalian range (53) . later it was suggested that mice have considerably lower alveolar and arterial pco 2 than other mammals, as low as 20 mmhg (at ph 7.4) (31) . indeed, recent data support these lower pco 2 (24 mmhg in chronically instrumented 129sv/j x icr mice (30) , 34 mmhg in chronically instrumented c57bl/6 mice (39)). although effects of (30, 39) or restrainment cannot completely be excluded in these studies, the data does indicate a lower paco 2 for the mouse, e.g., compared to mammals ranging from rats to humans (paco 2 33ð41 and 35ð45 mmhg respectively). mechanical mouse ventilation is indicated unter the following circumstances. first, the òanesthesiologicaló indication: one of the major goals of anesthesia is achievement of more (39, 52) , mice lacking the brain derived neurotropic factor bdnf (1), ret-protooncogene deþcient mice with depressed ventilatory response (4), and endothelin-1 deficient mice with altered blood gas-values (e.g., signiþcantly lower po 2 than wild type littermates) and impaired respiratory response to hypoxia and hypercapnia (30) . however, it is often unknown when during development and under which conditions alterations occur in the respiratory system or the control of breathing (27) . also among inbred wild type strains the control of respiration differs substantially, e.g., the c57bl/6-strain was classiþed as highly responsive to hypercapnia, whereas the dba/2-strain was highly responsive to hypoxia (51) . therefore, in these animals mechanical ventilation offers the possibility to study effect of differences in genetic background independent of changes in ventilation. second, the òsurgicaló indication: certain surgical procedures have an improved outcome or can only be performed with support of mechanical ventilation. examples are the bilateral ligation of the carotid artery (36) , where non-ventilated mice often die from respiratory disturbances, or the growing þeld of cardiac research that needs an open-chest murine model (15, 18, 29, 44) . hereby opening of the thorax and the adherent interpleural space induces lung collapse with respiratory insufficiency, whereas with support of a mechanical respirator the lungs can be inßated and ventilated. there are several possibilities of accessing and maintaining the airway in mice. in early studies using a mechanical ventilator with active in-and expiration for mice (28) , the airway was accessed by advancing a tube through the mouth into the pharynx, but not further into the trachea. although technically less demanding than endotracheal intubation, this attempt risked gastric gas-insufflation (including aspiration of stomach content) and did not provide peep capability. a different, nontraumatizing mode to access the airways is performed with the brady-newsom apparatus (3): it consists of a gas-chamber around the murine head, sealed at the thorax by a tight neoprenecollar. elevating the pressure in this chamber leads to increased airway pressures, with respect to ambient air. thus this concept provides continuous positive airway pressure (cpap) if the mouse ventilates spontaneously, or mechanical ventilation, if periodic pressure changes in the chamber are generated. although this apparatus has advantages, e.g., the technically less demanding airway access, it is also hampered with the disadvantage of gastic gas insufflation and aspiration of gastric content. to circumvent this problem, mechanical ventilation of mice today is usually performed after securing the airways by orotracheal intubation or via tracheotomy and consecutive endotracheal intubation. tracheotomy has been performed in preterm neonate mice (1.15 g bodyweight) with insertion of polyethylene tubes (sp8, natsume, tokyo, japan; tapered 0.4 mm outer diameter (od)) (30), whereas for adult mice the od of the endotracheal tube ranges from 0.9 mm (25ð38 g mice) (29) to 1.1 mm (20ð35 g mice) (15) . for experiments requiring recovery after surgery, temporary orotracheal intubation is performed, ideally via direct laryngoscopy with a purpose-made laryngoscope (13) . the visualization of relevant airway structures requires a strong small-focus light-source, allowing transillumination of the laryngeal cavity (with vocal cords and tracheal oriþce), when put on the ventral cervical region from the outside (2). orotracheal intubation is performed with or without visual conþrmation of the tubeõs tip-position (tube position judged by respiratory excursions). visualization of the trachea (after surgical access to the deeper cervical structures) and controlled advancement of the endotracheal tube allows more accurate positioning of the tube, but is more invasive and has therefore an increased morbidity and mortality. for animals sacriþced at the end of the experiment, direct surgical access to the airways is an alternative option. since most of our mouse surgeries require preparation of deeper cervical structures (e.g., catherization of a carotid artery and jugular vein) performing tracheotomies is convenient, with the additional advantage of minimized dead space (vd). a reliable surgical procedure for this airway access is brießy described: after induction of anesthesia the mouse is put into the supine position and the head is reclined (silk or rubber band around the upper incision teeth and attached to the operating surface) to allow easy access to the ventral neck. a median cerival skin incision (upper thorax aperture to lower jaw) is performed and layerwise skin, fascia, fat and connective tissue covering the thyroid gland are removed. the thyroid lobes are divided bluntly at their isthmus, pulled aside and kept retracted by bulldogclamps. the pretracheal muscles are spread bluntly and pulled aside to allow access to larynx and trachea. tracheotomy is performed by a transversal cut between two tracheal rings, usually in the lower third of the trachea. for the endotracheal intubation vascular pe-catheters (abbocath-t¨, abbott-venisystems) are used, cut to a length of about 5 mm with an angled tip (45¡) to allow smooth introduction. the correct position of the endotracheal tube is conþrmed by judging chest excursions, e.g., if respiration is still visible and symmetric. the tube is secured by ligation (silk 6-0, davis & geck¨) around the trachea. if maintenance of spontaneous ventilation is desired, the endotracheal tube is shortened to minimize vd and airway resistance. for mechanical ventilation, initially applied rr and/or vt should be sufficiently higher than spontaneous rr and vt of the anesthetized mouse to decrease respiratory drive (e.g., òbreathing against the ven-tilatoró) by moderate hyperventilation. after connecting the endotracheal tube, anesthesia can be safely deepened for an additional depression of ventilatory drive and facilitation of mechanical ventilation. alternatively, this goal can be achieved (avoiding additional cardiocirculatory depression) by a non-depolarizing muscle relaxant (vecuronium-bromid 0.25 mgákg ð1 bodyweight i.p., norcuron¨, organon). using this option it should be realized however that anesthesia depth cannot be judged from parameters like spontaneous movement or limb-withdrawal to paw pinch, but instead on changes in hemodynamics. a side aspect of murine airway access is the preparation of a ventilated (and perfused) isolated lung. this model has been described for the investigation of cytokines released from a hyperventilated mouse lung (57) . the physiological lung variables obtained from this murine model (female balb/c, 22ð30 g body weight) after 60 min of npv (negative pressure ventilation) are a vt = 187 µl, dynamic compliance (cdyn) of 0.022 ml/cmh 2 o and an airway resistance of 0.45 cm h 2 oás/ml. there are two basic modes of respiration, spontaneous ventilation and controlled mechanical ventilation (cmv), where work of breathing is taken over by the ventilator. between these there are a variety of mixed forms, like respiratory assistance, augmenting inspiration if shallow or labored (rsp1002, kent-scientiþc¨, us) or supported spontaneous ventilation with continuous positive airway pressure (cpap), adopted for mice by brady and colleagues (3) . however, these mixed modes are not largely established for mice yet, and will therefore not discussed in detail. although mechanical ventilation of mice has major advantages, it is confounded by difficulties: obviously, the small size of the animals makes airway access more challenging than in other laboratory animals. for example, in 25ð30 g mice, the trachea has an accessible length of only 3ð5 mm and a circumference of about 2.5 mm (49) . appropriate endotracheal tubes have an outher diameter ranging from 0.4 mm for neonate mice (30) to 1.0 mm for adult mice (13) . the actual mechanical ventilation of the mouse is complicated by the technically demanding respiratory pattern of this species, e.g., the high rr, the low ti/tt ratio and the small vt, with the latter also demanding a minimized deadspace (vd) to prevent rebreathing. in commercially available rodent ventilators, the relatively large system-vd allows substantial gas compression, thereby minimizing the vt delivered to the mouse. ewart et al. (11) reported that 2 ml of added vd (compliancẽ 0.002 ml/cmh 2 o) and a peak inspiratory pressure of 40 cm h 2 o reduce the delivered vt by about 50 %. thus, mouse ventilators (see table 2 ) should have a range of technical modalities to enable proper murine ventilation. since some authors did not report on the type of ventilator used (see table 3 ) the list might be incomplete. the most obvious difference between spontaneous respiration and usual modes of mechanical ventilation (mv) are inverted pressure relations, with respect to ambient pressure, during the respiratory cycle: during spontaneous inspiration the expansion of the intrathoracic volume (mainly caused by contraction of the diaphragm and extension of the rib cage) generates a negative intrathoracic pressure and allows gas ßow into the lungs. during expiration mainly passive elastic forces of lung and rib cage generate a positive intrathoracic pressure, leading to exhalation of air. applying usual mv, the air is pushed during inspiration into the miceõs lungs, leading to a positive intrathoracic pressure. during expiration intrathoracic pressure equilibrates with ambient pressure (intermittent positive pressure ventilation, ippv) or remains positive (continuous positive pressure ventilation, cppv). therefore it is important to notice that mean airway pressure during mechanical ventilation is higher than during spontaneous ventilation. these higher pressures contribute to side effects induced by mechanical ventilation. mechanical ventilators are classified according to their method of cycling between the inspiratory and expiratory phases. small animal ventilators are usually time-cycled: the ventilator switches between the respiratory phases after a certain time has elapsed, depending on the preset respiratory rate. although other methods of cycling might be favorable under certain experimental conditions (e.g., volume-cycled to prevent pulmonary volutrauma in murine open chest preparations), they are not established yet. however, although the method of cycling is classiþed according to a single parameter (e.g., time), some mouse respirators allow a more sophisticated control of the ventilation by limiting relevant parameters: to prevent high inspiratory peak airway pressures, for example, most mouse ventilators allow the limitation of the ventilatory system pressure. most commercial mouse ventilators are time cycled and pressure limited. the primary goal of mechanical ventilation is delivery of an adequate respiratory minute-volume (ve) to the murine 514 basic research in cardiology, vol. 95, no. 6 (2000) © steinkopff verlag 2000 lung. to achieve this, the rr and vt have to be adjusted to supply the actual ventilatory requirements. rr in most mouse ventilators is the preset cycling parameter, but vt-lung may vary, depending on the compliance of lungs and tubing and whether respiration is pressure limited. a decrease in compliance of the respiratory system, for example in murine models of interstitial pulmonary diseases (ards, pneumonia), increases the airway pressure for a given vt ventilator . if ventilation is pressure limited, then vt lung will be considerably less than vt ventilator . in contrast, if higher peak pressures are accepted to maintain vt lung , the risk to traumatize the delicate murine lung will increase (17) . to prevent the occurrence of these high pressures, inspiration time relative to expiration can be increased for a given vt (up to inverse ratio ventilation (irv), with inspiration longer than expiration). disadvantages of a higher inspiratory fraction during mechanical ventilation are possibly insufficient times for complete exhalation (òair trappingó) and the prolonged phases of elevated intrathoracic pressure, which may cause a decreased cardiac preload and consequently lowered blood pressures (7). a feature provided by some mouse-ventilators is the possible application of external positive end-expiratory airway pressure (peep): during expiration, airway pressure is not allowed to equilibrate with ambient pressure (0 cmh 2 o), but kept at a higher level (usually 2ð10 cmh 2 o). mechanical ventilation with peep prevents the endexpiratory collapse of small airways and possibly recruits atelectatic pulmonary areas for gas exchange by increase of functional residual capacity (frc). since pulmonary compliance increases (up to a certain degree) with increased frc, ventilation with peep supports pulmonary inßation. whether this holds true for mice has not been shown yet. additionally, ventilation with peep might mimic the physiologic end-expiratory tonus of inspiratory muscles and glottis of spontaneous ventilating mice (56) . typical side effects, demonstrated in a murine model of peep, are discussed below. a list of ventilator settings is given in table 3 . most experiments have mechanical ventilation set at rr = 100ð 150ámin ð1 , vt = 0.2ð0.7 ml, ti/tt 0.2ð0.4. when these values are compared to values of spontaneous ventilating mice (table 1) , it becomes obvious that lower rr and higher vt are commonly used to mechanically ventilate mice. a more rare feature provided by some mouse ventilators is the intermittent sigh-ventilation. here an inspiration with higher tidal volume (hyperinßation-or sigh-cycle) is administered after a certain number of respiratory cycles (for example every 50 ventilatory cycles) or triggered manually (rsp-1002, kent-scientific¨corporation, litchfield, ct, usa or 60ð 1100/1099, harvard instruments¨, us). although not proven, this imitation of physiological sighing is thought to result in recruitment of atelectatic pulmonary areas, without the need for a continuous peep, circumventing constant elevation of airway pressures. intermittent positive pressure ventilation (ippv) and continuous positive pressure ventilation (cppv) are the two common modes in murine mechanical ventilation, as provided by commercial ventilators. however, for the ventilation of newborn mice (1.0ð1.5 g bodyweight, vt 5ð20 µl) the concept of the òiron lungó, based on the principle of body surface negative pressure ventilation has been adopted (27) to prolong survival time of nmda-receptor mutant mice (32) , usually dying within 20 h after birth. only a few studies using mechanical ventilation in mice report on additional ventilatory parameters, like inspiratory gas ßow or pressures in the ventilatory system. using a rr of 140ámin ð1 , a vt of 0.7 ml and an inspiratory time of 0.2 s (resulting in a inspiratory fraction (ti/tt) of 0.41, table 3 data are also available on ventilation regimen for murine open-chest preparations: guo et al. (18) compared respiratory rates of 95, 105 and 121ámin ð1 (harvard rodent ventilator, room air with oxygen (21ámin ð1 ), vt = 2.2 ml with endotracheal tube loosely connected) in male icr mice (8ð12 weeks old, mean body weight 33.3 g) with respect to the resulting arterial blood gases. adequate ventilation was obtained with a rr of 105ámin ð1 , resulting in an arterial pao 2 of 327 mmhg (177 and 321 mmhg for 95ámin ð1 and 121ámin ð1 respectively), an arterial paco 2 of 31 mmhg (43 and 18 mmhg for 95ámin ð1 and 121ámin ð1 respectively) and an arterial ph of 7.4 (7.3 and 7.5 for 95ámin ð1 and 121ámin ð1 respectively). other regimens for the ventilation of open chest mice are listed in table 3 . during controlled mechanical ventilation (cmv), the most frequent applied mode of artiþcial respiration in mice, the work of breathing is taken over by the respirator. to facilitate this controlled mechanical ventilation (e.g., prevention of òbreathing against the ventilatoró) it is usually performed under deep anesthesia. this ensures that relevant compensatory mechanisms (e.g., onset of spontaneous ventilation induced by hypercapnia or hypoxia) are impaired and underline the importance of monitoring mechanical ventilation. attempts to monitor mechanical mouse ventilation are complicated by the fact that even standard variables for ventilation are not established yet or show conßicting results (see table 1 ). several possibilities are applicable to monitor adequacy of ventilation. a highly subjective way, requiring experience, is to observe the thorax-excursions with respect to rate, amplitude, symmetry and regularity as indicators of ventilatory rate, tidal volume, endotracheal tube position and attempt to spontaneous ventilatory effort. dalkara et al. (7) suggest for a physiological mouse ventilation (mean paco 2 = 35 mmhg) keeping òthe volume at a level at which thoracic movements þrst become noticeably observedó. information on the oxygenation can be obtained from the ear and tailskin color, e.g., with cyanosis indicating poor oxygenation (desoxy-hemoglobin 5 gá100 ml ð1 ). these measures might serve as a þrst orientation in the evaluation of the adequacy of mechanical ventilation. more objective and in-depth measures are gas ßows, airway pressures and partial pressures (see below). the measurement of respiratory gas ßow in mice has been a technical challenge, mainly because pneumotachographs attached to the endotracheal tube increase the ventilatory dead space (vd). recently pneumotachographs have been developed for mice that allow both direct airway gas ßow measurement and plethysmography (kent-scientiþc¨small animal pneumotachs, trn3100, kent scientiþc corporation). but even modern devices in this setting are suspected to increase dead space to a crucial extent, leading to partial rebreathing and consequently to hypercapnia and eventually hypoxia. the direct, non-invasive measurement of murine airway pressures is technically difficult; therefore, substitutes have been established to obtain estimates. in commercially available mouse ventilators, the airway pressures are measured inside the ventilator. the advantage of this construction is that it circumvents the need for an additional pressure transducing line, ideally originating from the endotracheal tube itself, to a pressure transducer. a major disadvantage however is that pressures measured in the ventilator need to be extrapolated to airway pressures within the endotracheal tube. this extrapolation is determined by the compliance of the respiratory gases and the tubing system (òsignal dampingó). it is therefore desirable to measure airway pressures as close as possible to the endotracheal tube. with respect to this, we have developed an integrated endotracheal tube within a small aluminum frame (10 x 5 x 2 mm, 5 g), consisting of temperature controlled adapters for in-and expiratory tubing, an inline-capnography cell (vd = 25 µl) and a liquid-filled airway-pressure transducer. although airway pressures are usually monitored to maintain safe values for mean-and peak-airway pressure, this measure can also serve to titrate damage in murine models of respirator-induced lung impairment, such as baro-or volutrauma (17) , where tidal volumes (vt) have been adjusted to achieve traumatizing target airway pressures. fresh-gas inßow composition to the mechanical ventilator can be monitored with respect to the concentrations of the different respiratory gases, e.g., oxygen (o 2 ), nitrogen (n 2 ), nitrous oxide (n 2 o) and volatile anesthetics. when rebreathing of exhaled air is excluded in the ventilatory circuit, analysis of fresh gas streaming to the respirator should accurately reßect the composition of inspiratory gases. this attempt is advantageous, compared to sample lines attached to the inspiratory tubing-limb of the system, because it circumvents the need for gas extraction from the inspiratory tubing with the consequence of decreased inspiratory airways-pressures and ventilatory tidal volumes. the actual measurement can be performed online with commercially available multi-gas analyzers (datex¨, hp¨). it has been argued that ventilation with room air may not be ideal in mice (24) , based on observed high murine p 50 values (po 2 corresponding to 50 % hemoglobin saturation) of 65 mmhg (46) or even 71 mmhg (48) . however, most studies have found a p 50~ 40 mmhg for the mouse, when measured under standard conditions (ph = 7.4, pco 2 = 40 mmhg, 37 ¡c) (25, 31, 35, 42, 47) . a p 50 of ~ 40 mmhg is still rightshifted, when compared to humans (p 50 = 28 mmhg). nevertheless, although even with a high p 50~ 65 mmhg blood is virtually 100 % saturated at room air (46) , increased fio 2 may be helpful in the mouse when uncertainty exists whether mechanical ventilation optimally expands the lungs. if volatile anesthetics (halothane, enßurane, isoßurane or more recent ones such as sevoßurane and desßurane) are used, additional considerations have to be taken into account: clinically used vaporizers for volatile anesthetics (draeger¨, series 19) are usually precalibrated for gas ßows higher than that required for mice and will therefore give unreliable results when used with low gas ßows. although recalibration of the vaporizer for low air-ßow is the best option, a more common approach is to use an appropriate high gasßow (several hundred mlámin ð1 ) with the abundant air released via a t-type adapter or valve. disadvantages of the latter approach are higher costs and the generation of relatively large amounts of waste gas giving environmental contamination and increased toxicity for exposed personnel. in contrast to maintenance of sufficient arterial oxygenation, which even under conditions of poor ventilatory support can be achieved by an increased fraction of inspiratory oxygen (fio 2 ), adequate pulmonary elimination of co 2 is the more challenging aspect of mechanical ventilation. although the arterial blood gas analysis is regarded as the gold standard for evaluation of proper ventilation, the drawbacks are that it is a discontinuous and invasive method requiring a substantial vol-ume of arterial blood (0.1ð0.2 ml for a single measurement, 5ð10 % of the total blood volume of a 25 g mouse (58)), the latter aspect adding new sources of instability to the model. though often neglected, measurement of respiratory carbon dioxide concentration (capnography) is therefore recommended in mouse research. especially the determination of the end-tidal co 2 (etco 2 ), as a measure for alveolar co 2 -concentration, is described as essential to maintain stable physiological parameters during mechanical mouse ventilation (7) . however, capnography has rarely been performed in mice due to technical difficulties, like gas dilution artifacts occurring in side stream systems, which prevent accurate detection of endtidal co 2 -peaks or-plateaus. therefore, to use the potential of capnography to its full extent, fast responding mainstreamcapnography is required. to this end we have developed an integrated mouse endotracheal tube with an implemented capnography-cell with minimal gas-mixing artifacts. since this cell is located in the endotracheal tube it allows real-time in-and expiratory mainstream breath-by-breath capnography. a typical capnography curve using this device is shown in fig. 1 , showing several single breath capnography curves (inner section with high chart speed, rr ~ 100 min ð1 ). capnography is not only a measure for the adequacy of mechanical ventilation, but can also serve to detect changes in hemodynamics. an example for this is given in fig. 2 : during steady-state anesthesia 0.2 ml blood was withdrawn from an arterial line (black arrow). the end-tidal carbon dioxide concentration drops immediately, likely due to a decrease in pulmonary perfusion (decreased cardiac output). resuscitation is performed by rapid infusion of 0.2 ml albumin solution (white arrow), which increased capnography values back to baseline, probably by restoring pulmonary perfusion. since time resolution is enhanced by our breath-by-breath capnography, the relation between expiratory co 2 and speciþc events can be described precisely. additionally, the capnography curves can be analyzed with respect to irregularity (e.g., due to intermittent spontaneous breathing) and shape alterations (e.g., airway obstruction). a few mouse capnographs are commercially available, mostly using side stream sampling (e.g., kent scientiþc corporation sc-210 respiratory co 2 monitor). the only main stream capnograph commercially available for mice to our knowledge is the sc-300 (kent-scientiþc corporation) with an external co 2 -probe to be placed in the ventilation tubing. however, we were unable to þnd studies reporting on this device. a disadvantage of this device, as reported by the manufacturer, is that rr is limited to 150 min ð1 , which might not meet the demands of all experimental designs (table 3) . the enhanced stability of the murine homeostasis is a major goal of mechanical ventilation, but typical side effects have to be considered, possibly adding new sources of instability to the murine model. these side effects can be classiþed as regional (airways and lungs affected) or systemic (distant organs affected). a typical example for a ventilator-induced regional side effect is the mechanical hyperinßation of the murine lung, e.g., when large tidal volumes or high airway pressures are applied. this induces histological damage of the delicate murine pulmonary structures. this volutrauma has been shown in mice to trigger the onset of inßammation, including expression of cytokines (57) . the systemic side effects of mechanical ventilation are (at least partly) due to a compromised hemodynamic situation. mechanical ventilation per se results in larger intrapulmonary pressures as compared to spontaneous ventilation, possibly inhibiting venous return to the heart. in addition, prolonged phases of positive airway pressures, e.g., when the inspiratory fraction (ti/tt) is increased or when external peep is applied, depresses the circulation by several mechanisms, also via an impaired venous return to the heart. as an example for a global hemodynamic variable, arterial blood pressure decreases immediately after application of higher levels of peep: fig. 3 shows a typical blood pressure trace of a deeply anesthetized mouse (c57bl/6, 25 g bodyweight, anesthesia with ketamine (35 mgákg ð1 áh ð1 ) and medetomidine (35 µgákg ð1 áh ð1 ) indicating the immediate hypotensive reaction after application of 10 cmh 2 o peep. the extent of hypotension induced by mechanical ventilation is further related to the respiratory phase, as demonstrated in fig. 1 , a simultaneous recording of capnography and arterial blood pressure in a c57bl/6mouse (anesthetized with fentanyl (0.8 mgákgá ð1 áh ð1 ), ßuanison (25 mgákgá ð1 áh ð1 ) and midazlam (3 mgákgá ð1 áh ð1 ), a more hypotensive anesthesia than used in fig. 3 , explaining the different baseline blood pressures). at end-expiration (white arrow), where intrathoracic pressure is minimal, arterial blood pressure reaches its peak value and vice versa (black arrow). a second example for side effects of the mechanical ventilation with peep distant to the lung is the impairment of the intestinal microcirculation. in anesthetized c57bl/6-mice (terminal ileum exposed) we were able to visualize a marked reduction of perfused capillaries and a decrease in capillary blood flow velocity, using orthogonal polarized spectral (ops-) imaging (16) . figure 4 a/b shows a typical example for peep-induced microcirculatory impairment. both images show the same intestinal region, before (4a) and 15 minutes after (4b) onset of 5 cmh 2 o external peep, with white arrowheads marking corresponding capillaries (black) in both images. in contrast to fig. 4a the capillaries in 4b are markedly less numerous and appear dashed, indicating erythrocyte aggregations formed at low capillary blood flow velocities. respiratory control of mice is a field of growing interest. although spontaneous ventilation is the more physiological mode of breathing, only mechanical ventilation maintains physiological values (blood gases, acid-base status) in situations with impaired spontaneous breathing, as occurring during anesthesia, surgery or constitutively in murine strains with impaired spontaneous ventilation. there are currently several commercially available small rodent ventilators feasible for use in mice. if mechanical ventilation is performed, then monitoring of this intervention is required, ideally by means of capnography. research still has to be performed on how the most physiological ventilation can be achieved in mice, which ventilatory patterns are appropriate and how ventilation related side effects can be limited. 518 basic research in cardiology, vol. 95, no. 6 (2000) © steinkopff verlag 2000 brain derived neurotropic factor is required for normal development of the central respiratory rhythm in mice in vivo electrophysiologic studies in mice effect of positive pressure breathing on the vibration tolerance of mice ret-protooncogene is important for the development of respiratory co2 sensitivity physiological characteristics of the chest and lungs and the work of breathing in different mammalian species breathing and pulmonary surfactant function in mice 24 h after ozone exposure cerebrovascular responses under controlled and monitored physiological conditions in the anesthetized mouse the effect of restraint on ventilatory response to hypercapnia and hypoxia in adult mice contribution of type i nos to expired gas no and bronchial responsiveness in mice whole body plethysmography, does it measure tidal volumes of small animals? respiratory system mechanics in mice measured by end-inflation occlusion measurement of respiratory volume for virus retention studies in mice hemodynamic response to anesthesia in pregnant and nonpregnant icr mice in vivo left ventricular pressurevolume relations by miniaturized conductance micromanometry orthogonal polarization imaging: a new method for study of the microcirculation a murine model of volutrauma: potential contribution of inßammatory cell proteases to lung injury demonstration of an early and a late phase of ischemic preconditioning in mice measurement of respiratory volumes of laboratory animals various immunological phenotypes are associated with increased airway responsiveness invasive hemodynamic studies in open and closed chest mice (eds) cardiovascular physiology in the genetically engineered mouse murine cardiac function ð a cautionary tail enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation altered respiratory responses to hypoxia in mutant mice deþcient in neuronal nitric oxide synthase a miniature mechanical ventilator for newborn mice method of artiþcial respiration in curarized mice end-systolic pressure-dimension relationship of in situ mouse left ventricle impaired ventilatory responses to hypoxia and hypercapnia in mutant mice deþcient in endothelin-1 blood oxygen affinity and alveolar ventilation in relation to body weight in mammals whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of nmdar1 knockout mice cardiovascular physiology in mice the ventilatory and metabolic response to hypercapnia in newborn mammalian species stable rightward shifts of the oxyhemoglobin dissociation curve induced by encapsulation of inositol hexaphosphate in red blood cells using electrophoration the development of a new mouse model of global ischemia lung tissue behavior in the mouse during constriction induced by methacholine and endothelin-1 ventilation, co2-production, and co2-exposure effects in conscious, restrained cf-1 mice leptin prevents respiratory depression in obesity determination of ventilatory volume in mice by whole body plethysmography cardiovascular reßexes in mice regulation of oxygen affinity in blood of fetal, newborn and adult mouse a computer-controlled research ventilator for small animals: design and evaluation reperfusion arrhythmias in the murine heart: their characteristics and alteration after ischemic preconditioning scaling: why is animal size so important oxygen dissociation curves of mammalian blood in relation to body size temporal change of plasma erythropoetin level in hypobaric hypoxic mice and the influence of an altered blood oxygen affinity near simultaneous hemoglobin saturation and oxygen tension maps in the mouse cortex during amphetamine stimulation mouse smooth muscle studies using gene-altered mouse models lung protein leakage in respiratory failure induced by a hybridoma making monoclonal antibody to the hydrophobic surfactant-associated polypeptide sp-b differential control of ventilation among inbred strains of mice leptin attenuates respiratory complications associated with the obese phenotype tissue gas tension in small wild mammals comparative quantitative morphology of the mammalian lung: diffusing area depressed heart rate variability and arterial baroreßex in conscious transgenic mice with overexpression of cardiac gs-alpha dynamic mechanisms determine functional residual capacity in mice, mus musculus hyperventilation induces release of cytokines from perfused mouse lung direct determination of plasma, cell, and organ blood volumes in normal and hypervolemic mice comparison of sensitization to scrude and purified house dust mite allergens key: cord-004416-qw6tusd2 authors: krishna, smriti m.; omer, safraz mohamed; li, jiaze; morton, susan k.; jose, roby j.; golledge, jonathan title: development of a two-stage limb ischemia model to better simulate human peripheral artery disease date: 2020-02-26 journal: sci rep doi: 10.1038/s41598-020-60352-4 sha: doc_id: 4416 cord_uid: qw6tusd2 peripheral arterial disease (pad) develops due to the narrowing or blockage of arteries supplying blood to the lower limbs. surgical and endovascular interventions are the main treatments for advanced pad but alternative and adjunctive medical therapies are needed. currently the main preclinical experimental model employed in pad research is based on induction of acute hind limb ischemia (hli) by a 1-stage procedure. since there are concerns regarding the ability to translate findings from this animal model to patients, we aimed to develop a novel clinically relevant animal model of pad. hli was induced in male apolipoprotein e (apoe(−/−)) deficient mice by a 2-stage procedure of initial gradual femoral artery occlusion by ameroid constrictors for 14 days and subsequent excision of the femoral artery. this 2-stage hli model was compared to the classical 1-stage hli model and sham controls. ischemia severity was assessed using laser doppler perfusion imaging (ldpi). ambulatory ability was assessed using an open field test, a treadmill test and using established scoring scales. molecular markers of angiogenesis and shear stress were assessed within gastrocnemius muscle tissue samples using quantitative polymerase chain reaction. hli was more severe in mice receiving the 2-stage compared to the 1-stage ischemia induction procedure as assessed by ldpi (p = 0.014), and reflected in a higher ischemic score (p = 0.004) and lower average distance travelled on a treadmill test (p = 0.045). mice undergoing the 2-stage hli also had lower expression of angiogenesis markers (vascular endothelial growth factor, p = 0.004; vascular endothelial growth factorreceptor 2, p = 0.008) and shear stress response mechano-transducer transient receptor potential vanilloid 4 (p = 0.041) within gastrocnemius muscle samples, compared to animals having the 1-stage hli procedure. mice subjected to the 2-stage hli receiving an exercise program showed significantly greater improvement in their ambulatory ability on a treadmill test than a sedentary control group. this study describes a novel model of hli which leads to more severe and sustained ischemia than the conventionally used model. exercise therapy, which has established efficacy in pad patients, was also effective in this new model. this new model maybe useful in the evaluation of potential novel pad therapies. major amputation, renal failure and death) and poor long-term durability [5] [6] [7] [8] . there is great interest in developing novel medical therapies for the leg symptoms of pad. recent efforts have focused on stimulating development of new blood vessels within the leg through angiogenesis or by encouraging the remodelling of existing small vessels into improved collateral channels (arteriogenesis). promising results for novel treatments, such as viral vectors carrying angiogenesis promoting agents and stem cells, in pre-clinical models of pad have not been consistently replicated in large clinical trials 9-12 . in patients that have pad, atherosclerosis-associated arterial narrowing develops gradually over many years allowing the legs to adjust to the gradual decrease in blood flow through compensatory mechanisms within the blood vessels and muscle fibres 13 . in contrast, the most commonly used animal model for initial testing of novel therapies for pad is a model of acute blood supply interruption through ligation or excision of the femoral artery (referred to here as the 1-stage hind limb ischemia (hli) model) 14, 15 . previous studies report that the ligation and excision of the femoral artery in the 1-stage model leads to increased fluid shear stress within the limb collateral arteries resulting in altered gene expression patterns through shear stress responsive elements which promote arterio-and angio-genesis [16] [17] [18] . hind limb blood supply in this 1-stage model therefore usually naturally recovers over a period of approximately 4 weeks 15 . this model does not therefore simulate the clinical presentation of pad. patients typically present with a history of acute exacerbation of chronic symptoms of leg pain on walking and have ongoing ischemic symptoms. the 1-stage hli model may therefore not be an ideal model to study therapeutic angiogenesis and arteriogenesis 14, 19 . another approach to inducing hli is the placement of an ameroid constrictor around the femoral artery to induce gradual occlusion 16, 20, 21 . previous studies suggest that this approach leads to mild ischemia 20 and that blood flow recovery occurs within 2-3 weeks 16, 21 . furthermore, previous pre-clinical pad research has mainly focused on assessing hind limb blood supply with limited assessment of ambulatory ability 14, 15 . on the other hand, the assessment of novel treatments in pad patients usually involves measures of walking ability using treadmill or corridor walking tests 22, 23 . there is therefore a need for an increased focus on functional tests of the limb within clinically-relevant rodent models. we hypothesised that the limb ischemia produced by the current 1-stage hli model would be more severe and sustained if the model was modified to include an initial more slowly progressive arterial narrowing over 14 days prior to the induction of acute ischemia (i.e. a 2-stage model). our overall aim was to develop a more clinically relevant rodent model that could incorporates stable on-going limb ischemia in order to test therapeutic interventions. mice. male apolipoprotein e deficient (apoe −/− ) mice (n = 118, obtained from animal resources centre, western australia) were used for the experiments. mice were housed in a temperature-controlled room (21 ± 1 °c) with an automatic 12:12-h light/dark cycle (07:00 to 19:00 hours). mice were singly housed in a clear individually-ventilated, temperature and humidity-controlled cage system (aero ivc green line; tecniplast) with enrichment. all experiments were performed during the light phase (10:00-18:00 hours) and mice were fed with standard rodent chow and water ad libitum during the course of these experiments. approval for the animal studies was obtained from the institutional ethics committee (animal ethics committee, james cook university) and experimental work performed in accordance with the institutional and ethical guidelines of james cook university, australia, and conforming to the guide for the care and use of laboratory animals (national institutes of health, usa). hli models. the first phase of the study utilised two hli models: the most commonly used unilateral acute hli model (1-stage hli) 16, 24, 25 and the newly developed 2-stage hli model. male apoe −/− mice aged 20 months were randomly divided into 4 groups as follows: group 1 = 1-stage hli model (n = 25), group 2 = 1-stage sham (n = 19), group 3 = 2-stage hli model (n = 25) and group 4 = 2-stage sham (n = 19). body weight and primary outcome measures were recorded at regular intervals as illustrated in fig. 1a . all functional assessments were performed in a subset of mice randomly selected from each experimental group (n = 5-7). the creation of the 1-stage hli model involved exposure of the left femoral artery through a vertical 0.5-1 cm skin incision under a stereotactic microscope (leica). the femoral artery and its side branches were then ligated with 6-0 silk sutures (ethicon) immediately distal to the inguinal ligament and proximal to the popliteal bifurcation before being excised ( supplementary fig. s1a,b) . femoral nerves were carefully preserved. the wound was irrigated with sterile saline and then the overlying skin was closed using 4-0 vicryl sutures (ethicon). post-operative pain was reduced using lignocaine (troy laboratories). a similar surgery without ligation or excision of the femoral artery was performed on the 1-stage sham controls. the 2-stage hli model was performed using a 2-stage surgical procedure. the left femoral artery was exposed as described above and 2 custom made miniature ameroid constrictors of 0.25 mm internal diameter (research instruments sw) were positioned on the artery. one was placed on the femoral artery immediately distal to the inguinal ligament and one was positioned proximal to the sapheno-popliteal bifurcation ( supplementary fig. s1c ). after 14 days, a new incision was made and the femoral artery ligated and excised, as described for the 1-stage hli model. a similar two-stage surgery was performed without placement of ameroids, nor ligation and excision of the femoral artery for the 2-stage sham controls. assessment of the effect of exercise training in the 2-stage hli model. during the second phase of the study, the effect of an exercise program on male apoe −/− mice aged 6 months undergoing the 2-stage hli model (male apoe −/− mice, n = 30) was tested. mice subjected to 2-stage hli were randomly allocated to an exercise training or control group (n = 15 per group). mice in the exercise group received 180 to 200 m (between 30-45 mins of running wheel access) of exercise each day on a running wheel (8 station home cage running the movement of animals were monitored and functional scores of the various groups were assessed according to the scoring criteria detailed in the materials and methods section. the 2-stage hli model showed reduced function throughout the experimental period compared to the 1-stage hli model. data shown as mean ± sem and analysed by repeated measures 2-way anova, and p value significant at ≤0.05. (e) graph showing modified ischemia scores. the animals were monitored and scored for signs of ischemia according to previously published criteria detailed in the materials and methods. the 2-stage hli model showed a higher level of ischemia compared to the 1-stage hli depicted by a lower scoring throughout the study period. data shown as median ±sem and analysed by repeated measures 2-way anova, and p value significance set at ≤0.05. suggested that the hli typically resolved over the course of 28 days, with hind limb blood supply reaching a plateau between 21 and 28 days after surgery 28 . the ldpi measurements were therefore performed at the following time points for 1-stage hli model: day 0 prior to surgery, immediately after surgery, days 3, 7, 14, 21 and 28 after surgery. for the 2-stage hli model, the ldpi measurements were performed at the following time points: day 0 prior to the first operation (ameroid placement), immediately after the first operation, days 3, 7, and 14 after the first operation, immediately after the second operation (femoral artery excision), and 7, 14, 21 and 28 days after the second operation (i.e. 14, 21, 28, 35 and 42 days after the first operation). a schematic illustration of the experimental design is shown in fig. 1a . body mass was also measured on the same day as the ldpi measurements. in clinical practice pad patients are treated to improve pain free walking capacity and resolve rest pain and tissue loss (critical limb ischemia, cli). in clinical trials, these are usually investigated by walking tests and assessment of pain. similar to clinical trials, in the current study ambulatory ability was assessed with a treadmill test, voluntary physical activity examined through an open field test and foot pain estimated through a mechanical allodynia test. all outcomes were assessed by an assessor blinded to mice group. semi-quantitative assessments of limb function and ischemia were performed at the same time points as the blood flow measurements ( fig. 1a ; supplementary tables s1, s2). limb function was assessed using the clinical use score (tarlov scale) as: 0 = no movement; 1 = barely perceptible movement, no weight bearing; 2 = frequent and vigorous movement, no weight bearing; 3 = supports weight, may take 1 or 2 steps; 4 = walks with only mild deficit; 5 = normal but slow walking and 6 = full and fast walking 29, 30 . limb ischemia was scored using the ischemia scoring scale as previously reported: 0 = auto-amputation of leg; 1 = leg necrosis; 2 = foot necrosis; 3 = two or more toe discoloration; 4 = one toe discoloration; 5 = two or more nail discolorations; 6 = one nail discoloration and 7 = no necrosis 30 . all scoring was performed by two independent observers and found to be identical. treadmill test. mice were run on a six lane excer3/6 treadmill (columbus instruments) without incline. mice were acclimatised to the treadmill by ambulating on it at 5 m/min for 5 min once daily on three consecutive days prior to any testing. before each treadmill test, mice were fasted for 1 h. the speed of the treadmill was controlled using the software and calibrated using an inbuilt speedometer mounted on the treadmill platform. a treadmill test involved an initial warm up at 5 m/min for 5 min followed by a progressive speed increase from 5 to 10 m/min, accelerated at 1 m/min. following this the treadmill speed remained at 10 m/min for up to a total running time of 20 min. during the test a stimulus grid of 3 hz was kept on until mouse exhaustion as previously reported 31 . exhaustion of the mouse was defined if the mouse returned to the stimulus grid 10 times despite a 3 hz electrical stimulus to encourage walking on the belt. the treadmill software recorded the total distance walked by a mouse until exhaustion. a blinded observer supervised the experiment to assess outcomes. the treadmill belt and lanes were cleaned with water and 70% alcohol and dried with paper towel after each test to remove any body scent. treadmill testing was carried out before ameroid placement, 10 days after ameroid placement, and 1 and 3 weeks after completion of the 2-stage hli (fig. 1a) . for the 1-stage hli model, treadmill testing was performed before ligation and excision of the femoral artery and 1 and 3 weeks after ischemia induction. voluntary physical activity test. the open field test is a common measure of voluntary physical activity in rodents suggested to be similar to a 6-min walk test used in humans 32 . to ensure consistency prior to the test, mice were brought to the testing room in their home cages at least 1 hr prior to the start of behavioural testing. the mice were fasted during the acclimatisation period and given free access to water under normal lighting. the open field box was made of opaque plastic (40 × 40 × 40 cm), divided into an outer field (periphery) and a central field (20 × 20 cm) which was primarily used for analysis. mice were individually placed in the centre of the arena and movements of the mice were recorded using a video camera (logitech) supported with acquisition software (capture star ver. 1; cleversys inc) and analysed by the topscan lite software (high throughput version 2.0; cleversys inc). the test protocol used was identical for each mouse assessed. after each test the open field box was cleaned with water and 70% alcohol and dried with a paper towel to remove the body scent, which could be a cue to movement of the mice. room lighting, temperature, and noise levels were kept consistent for all tests. the mouse movements were recorded for 20 min, to mimic the short timed nature of the 6-min walk test. rest time was recorded as motion measure score <0.05 in the software and average speed was calculated only for motion measure score >0.05. total distance travelled (m), frequency of movement, time spent in the arena (s) and average velocity in the arena (mm/s) were measured. mechanical allodynia test. the paw pressure transducer and the pressure application measurement device (pam; ugo basile) is a non-invasive tool for measuring mechanical allodynia threshold and hypersensitivity in rodents. the pam device allows an accurate measurement of primary mechanical hypersensitivity in rodents 33, 34 . a gradually increasing squeeze force is applied across the joint at a rate of approximately 300 gms/sec until a behavioural response (paw withdrawal, freezing of whisker movement, wriggling or vocalization) is observed with a cut-off of 5 sec. the peak gram force (gf) applied immediately prior to limb withdrawal was recorded by the base unit, and this value was designated the limb withdrawal threshold (lwt). lwt was measured twice in both the ipsilateral and contralateral limbs by two independent observers. the measurements were averaged and presented as a ratio of operated left limb to the un-operated right limb. blood tests. blood was collected by cardiac puncture at the completion of the experiments. platelet poor plasma was separated as described previously 35, 36 . the plasma concentrations of interleukin (il)-6, interferon (ifn)-γ, monocyte chemoattractant protein-1 (mcp-1) and tumour necrosis factor (tnf)-α were determined scientific reports | (2020) 10:3449 | https://doi.org/10.1038/s41598-020-60352-4 www.nature.com/scientificreports www.nature.com/scientificreports/ using a cytometric bead array kit (cba, bd biosciences). the inflammatory markers were assessed in samples (n = 10/group) selected from each group using a random number generator. briefly, 50 μl of mixed capture beads and 50 μl of serially diluted standard or plasma sample and 50 μl of phycoerythrin (pe) detection reagent, were incubated in the dark for 2 h in sample assay tubes. samples were then washed twice with 1 ml of the wash buffer, resuspended, and acquired on the cyan adp flow cytometer (beckman coulter). results were analysed and quantified by fcap array ™ software (v3, bd biosciences). we previously reported this method to have good reproducibility with an inter-assay coefficient of variation of 6-9% (n = 8-10) 36 . total nitrate was measured in plasma samples by a nitrate/nitrite colorimetric assay kit following the manufacturer's protocol (inter-assay coefficient of variation 2.7%; cayman chemicals) as reported previously 37 . briefly, nitrate was converted to nitrite using nitrate reductase. subsequently, addition of the griess reagents converted nitrite into a deep purple azo compound and the absorbance was measured at 540 nm using an omega plate reader. histological assessments. low capillary density has been reported in the gastrocnemius muscle of pad patients and animal hli models and associated with functional impairment 38, 39 . hence at the end of experiments gastrocnemius muscle samples were collected from the mice and stored in optimal cutting compound (oct, proscitech) which was progressively frozen in isopentane (sigma) suspended in liquid nitrogen. sections (5 µm-thick) were obtained on poly l-lysine coated slides (proscitech) from each sample with muscle fibres oriented in the transverse direction. all histological assessments were performed on sections that were examined in a blinded fashion at 40x magnification. muscle fibre structure. fixed cryostat sections were stained with hematoxylin and eosin (h&e, proscitech), examined at magnifications of 100x or 400x to assess the integrity of the tissues. degenerating muscle fibres were identified in the h&e stained sections by morphological assessment. assessors looked for the presence of mature skeletal muscle fibres (small peripheral nuclei) versus immature skeletal muscle myoblasts (large lobulated central nuclei) 40 . muscle fibre number and size were examined in 5 separate fields in 4 distinct areas in each specimen. muscle fibrosis. the extent of skeletal muscle fibrosis was assessed by staining the cryostat sections (5µm-thick) with picrosirius (proscitech). briefly, tissue sections were stained and examined under 40x power light microscope and skeletal muscle fibrosis was analysed using the image analysis software (zeiss axio imager z1). quantification of fibrosis was expressed as the percentage of fibrotic tissue present within the section (1 mm 2 tissue area) using a previously published protocol 40 . immunohistochemistry and morphometric analysis of capillary and arteriolar density. these were performed as previously reported 41, 42 . the gastrocnemius muscles from ischaemic and non-ischaemic hind-limbs were collected and embedded in oct compound (proscitech), frozen, and cut into 5 µm-thick sections. the slides were fixed at −20 °c in 95% ethanol for 1 hr. slides were washed three times in cold pbs with 1% horse serum (5 min/ wash) and blocked overnight with 5% horse serum in pbs at 4 °c. immunohistochemistry was performed using primary antibodies against cd31 (1:100 dilution; abcam) and smooth muscle α-actin (α-sma, 1:200 dilution; abcam). bound primary antibodies were detected by using appropriate secondary antibodies (biotinylated anti-goat igg and biotinylated anti-rat igg, all at 1:100 dilutions, vector labs) using avidin-biotin-peroxidase (vector labs) as described previously 43 . pictures from four random areas of each section and three sections per mouse were taken by using a digital camera (nikon eclipse sci epifluorescence microscope, nikon corporation) at 40× magnification. capillary density were quantified by measuring the percentage of cd31 and α-sma staining out of the total area as previously described. western blotting. gastrocnemius muscles were mainly harvested at the end of studies (i.e. 4 weeks after full ischemia induction). gastrocnemius muscles were also harvested from a subset of mice (n = 15) subjected to the 2-stage hli (n = 5/time-point) prior to and days 3 and 7 after ameroid placement. samples were frozen in liquid nitrogen, and stored in oct compound (proscitech) at −80 °c. tissues were pulverised in ripa buffer (150 mm sodium chloride, 1.0% np-40 or triton x-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 50 mm tris, ph 8.0) with protease inhibitors (roche diagnostics, australia) and phostop (roche diagnostics, australia) to extract proteins and quantitated using the bradford protein assay kit (biorad, usa). samples (25 μg of protein/lane) were loaded onto a 10% sds-polyacrylamide electrophoresis gel. after electrophoresis (110 v, 90 min), the separated proteins were transferred (15 ma, 60 min) to a polyvinylidene difluoride membrane (biorad, usa). non-specific sites were blocked with 5% non-fat dry milk for 60 min, and the blots were then incubated with following antibodies: anti-vascular endothelial growth factor (anti-vegf www.nature.com/scientificreports www.nature.com/scientificreports/ mrna analysis by quantitative real-time pcr. at the end of the study gastrocnemius muscle samples were harvested, placed in rna later (qiagen) and stored at −80 °c. samples (n = 10/group) were selected from each group using a random number generator and were processed for gene expression analysis. total rna was isolated using an rneasy mini kit (qiagen) according to manufacturer's instructions and quantified spectrophotometrically using nanodrop 2000. rna samples (20 ng) were subjected to quantitative real time pcr (qrt-pcr) analysis of genes of interest using the quantitect sybr green one-step rt-pcr assay (qiagen). qrt-pcr was performed using primers for mouse vegf-r1 (ppm03066f), vegf-r2 (ppm03057a), trpv4 (ppm36070a), klf4 (ppm25088b) and gapdh (qt01658692). the relative expression of these genes were calculated by using the concentration-ct-standard curve method and normalized using the average expression of mouse gapdh for each sample using the rotor-gene q operating software (version 2.0.24) as previously reported 44,45 . statistical analyses. all data were tested for normality using the d' agostino-pearson normality test. data with normal distribution were expressed as mean ± standard error of mean (sem) and analysed using parametric tests. non-normally distributed data were expressed as median and interquartile ranges (iqr) and analysed using non-parametric tests. statistical significance was determined using the unpaired student t test for comparison between two groups or analysis of variance followed by student-newman-keuls post-hoc analysis for comparison between multiple groups. comparison of the time course of ldpi indices, clinical scores, open field tests and treadmill exercise tests were done by 2-way anova for repeated measures, followed by bonferroni post hoc analysis or by linear mixed effect method using r studio software. difference in the clinical ischemia score were determined by fisher's exact test. analyses were performed using prism (graphpad software, san diego, ca) or r software. a p value of ≤0.05 was considered to be statistically significant. mice undergoing 2-stage hli had more severe ischemia than those undergoing 1-stage hli. immediately after femoral artery excision, limb perfusion assessed by ldpi was similarly reduced in both hli models by approximately 70%. mice subjected to the 1-stage hli had more rapid recovery of hind limb perfusion than those subjected to the 2-stage procedure (p = 0.014, fig. 1b,c, supplementary fig. s2 ). by 28 days after ischemia induction limb perfusion was similar in mice subjected to the 1-stage procedure and sham controls (p = 0.510) but still reduced in mice subjected to the 2-stage procedure by comparison to sham controls (p < 0.001). there was no change in overall body mass after ischemia induction (supplementary fig. s3 ). mice subjected to 2-stage hli showed more severely impaired hind limb use than those undergoing 1-stage hli. after ischemia induction, mice subjected to both methods of hli developed limb oedema, paleness of skin and occasional muscle necrosis. mice in all experimental groups exhibited a severe functional deficit after surgery (fig. 1d) . functional score was significantly worse in mice subjected to the 2-stage hli than those subjected to the 1-stage hli (p = 0.014). both the hli models showed increased ischemia compared to the respective shams. there were no cases of auto-amputation or foot or limb necrosis (supplementary fig. s4 ). mice subjected to the 2-stage hli showed a significantly worse ischemic score compared to those subjected to the 1-stage hli (repeated measures 2 way anova, p = 0.004, fig. 1e ). mice subjected to 2-stage hli had reduced treadmill performance. mice subjected to the 1-stage hli showed no significant difference in total distance travelled during the study period on a treadmill test when compared to shams (repeated measures 2 way anova, p = 0.818; fig. 2a ). after the first procedure of the 2-stage model (ameroid placement) the treadmill ambulatory performance of mice was not significantly affected ( supplementary fig. s5a ). in contrast mice subjected to 2-stage hli had a significant reduction in total distance travelled on the treadmill compared to their sham controls (p = 0.050) and mice subjected to 1-stage hli (p = 0.045; fig. 2a ). supplementary fig. s5b-d) . this reduction in physical activity was maintained after completing the 2-stage hli by comparison to sham controls and also mice subjected to 1-stage hli (fig. 2b) . the reduction in physical activity of mice subjected to 2-stage hli was reflected in less distance travelled, less total time in motion and lower velocity of the movement compared to sham controls (fig. 2c-e) . when compared to the 1-stage hli, the 2 stage-hli model showed a reduction in the total distance travelled in the open field arena (linear mixed effect model, p = 0.036). mice subjected to hli had enhanced mechanical allodynia. mice subjected to both 1-stage and 2-stage hli showed significantly increased sensitivity to pressure compared their respective sham controls and there was no significant difference in pressure sensitivity between the two models (fig. 2f ). hli induces systemic inflammation. the plasma concentrations of the cytokines assessed were below the detectable ranges in both the sham control groups (table 1) . mice subjected to hli, irrespective of model, had plasma cytokine concentration significantly higher than the sham controls although levels were not significantly different between models ( table 1 ). the plasma concentrations of nitric oxide (no) metabolites were higher in mice undergoing 1-stage hli than the sham control group (p < 0.001) and mice undergoing 2-stage hli (p = 0.031, table 1 ). myofibers which are healthy and functionally active are characterised by peripheral nuclei, while myofibrils with central nuclei are immature and do not show optimal contraction 46 . in gastrocnemius muscle samples removed from sham controls, myocytes were angular with peripheral nucleus (fig. 3a) . at day 28 after ischemia induction, mice subjected to 2-stage hli showed microscopic changes such as cellular swelling, focal necrosis and interstitial oedema. there were also numerous infiltrating inflammatory cells. gastrocnemius muscle samples from mice subjected to 1-stage hli showed more homogenous appearance with all myocytes showing peripheral nuclei and limited inflammatory cell infiltration (fig. 3a) . histological evaluation revealed that tissues of mice subjected to 1-stage hli had fewer immature myofibers cells than the tissues from 2-stage hli model. furthermore, muscle samples from mice subjected to 2-stage had prominent oedema, myofibre separation and multifocal neutrophilic infiltration. neutrophils were observed throughout the tissue sections. necrotic muscle fibres were prominent and formed confluent areas (fig. 3a) . muscle fibrosis was assessed by picrosirius red staining which suggested that 2-stage hli led to increased skeletal muscle fibrosis compared to 1-stage hli (p = 0.007) or sham controls (p = 0.001; fig. 3b ,e). mice subjected to 2-stage hli had fewer hind limb collaterals. consistent with the reduced perfusion as assessed by ldpi, both arteriogenesis and angiogenesis was inhibited in the ischemic gastrocnemius muscles of the 2-stage hli model (fig. 3c,d) . measurement of angiogenesis by cd31 immunostaining showed that the presence of arterioles was significantly reduced in samples from the 2-stage hli compared to the 1-stage hli (p = 0.002) or sham controls (p = 0.004; fig. 3 ). the arteriolar density was also significantly less in samples from the 2-stage hli model compared to the 1-stage hli (p = 0.001) or sham control (p = 0.004; fig. 3 ). protein concentrations of angiogenesis and shear stress response markers were downregulated in the gastrocnemius muscles of mice undergoing 2-stage hli. the relative total vegf and vegfr-2 (but not vegfr-1, p-enos/enos and hif-α) protein levels in gastrocnemius tissue collected from mice 4 weeks after 2-stage hli were significantly less than in sham controls and mice undergoing 1-stage hli (fig. 4a-d, supplementary fig. s6 ). analysis of tissues from the 2-stage hli model prior to ameroid placement and day 3 and day 7 after ameroid placement suggested no significant changes in concentrations of trpv4 or vegf in response to ameroid constriction ( supplementary fig. s7 ). at the end of the experiment, protein concentrations of trpv4 and klf4 were significantly less in the gastrocnemius muscle samples from mice undergoing 2-stage hli compared to sham controls and mice undergoing 1-stage hli (fig. 4e,f) . qrt-pcr showed that the relative expressions of vegf-r2, trpv4 and klf4 in gastrocnemius muscle of mice subjected to 2-stage hli were significantly lower than within the gastrocnemius muscle of mice undergoing 1-stage hli or in sham controls (fig. 4g-j) . exercise training improved functional capacity but not limb perfusion in mice subjected to 2-stage hli. supervised exercise training is an established method to improve functional capacity in pad patients 47, 48 and previous studies show that mice respond positively to exercise training 49, 50 . in order to examine whether an established clinically effective therapy was effective in the novel animal model, the effect of exercise training (using a running wheel) on functional capacity of mice subjected to 2-stage hli was assessed. exercise training was commenced 5 days after ischemia induction. exercise training did not affect limb perfusion as shows the data from the ischemic limbs from the 1-stage and 2-stage hli models and the respective sham controls (n = 8/group, scale bars in all images = 25 µm). (e-g) quantitative bar graphs showing the effect of hli on (e) skeletal muscle fibrosis by picrosirius red staining, (f) angiogenesis by immunohistochemical staining against cd31 and (g) arteriogenesis by immunohistochemical staining against α-sma. all values are median and interquartile ranges (n = 8/group) and p value significance set at ≤0.05. (2020) 10:3449 | https://doi.org/10.1038/s41598-020-60352-4 www.nature.com/scientificreports www.nature.com/scientificreports/ www.nature.com/scientificreports www.nature.com/scientificreports/ assessed by ldpi (linear mixed effect test, p = 0.700; fig. 5b ,c). mice subjected to exercise training showed a significant increase in average treadmill walking capacity compared to sedentary controls (p = 0.003; fig. 5d ). exercise training upregulated gastrocnemius muscle vegf and trpv4 levels. since improvement in ambulatory performance as a result of exercise training could be due to enhanced angiogenesis, the expression of angiogenesis and shear stress responsive proteins vegf, vegf-r1, vegf-r2, trpv4 and klf4 were assessed in the gastrocnemius muscles (fig. 6). vegf (p = 0.001, fig. 6b ) and trpv4 (p = 0.027, fig. 6e ) but not vegf-r1, vegf-r2 and klf4, were highly upregulated following exercise training (fig. 6c,d,f ). this report describes the development of a novel model of hli which results in more severe and prolonged ischemia than the traditional model. mice subjected to the 2-stage hli had functional and ambulatory impairment and a positive response to exercise training as has been reported for pad patients 51 . previous rodent studies suggest that placing of ameroid constrictors alone without manipulating the femoral artery results in mild ischemia 20 and blood flow recovers within 2 weeks 16 . hence, the novel hli model was based on placement of two ameroid constrictors on the femoral artery to promote gradual occlusion followed by excision of intervening segment after 14 days to induce severe ischemia. a previous report suggests that recovery of hind limb blood flow is reduced in apoe −/− compared to c57bl/6 j mice due to their limited collateral arteries and hence apoe −/− mice were used in the current study 24 . pad patients are generally older and exhibit metabolic derangements that limit angio-and arterio-genesis and previous studies suggest that apoe −/− mice have delayed skeletal muscle healing 52 , reduced angiogenesis responses and impaired functional recovery after hli further supporting the rationale for choosing this mice species 26, 28, 53 . mice subjected to 1-stage hli had rapid recovery of limb blood flow and reached a perfusion level similar to the sham controls within 28 days as has been reported by other investigators 28, 54, 55 . ligation and sudden excision of the femoral artery is believed to generate a pressure gradient between the proximal and distal ends of the occluded vessel, resulting in increased shear stress and a redirection of blood flow towards the collaterals and through numerous branches arising from the internal iliac artery, resulting in rapid improvement in blood flow 14, 56 . ameroid constrictors have been shown to cause luminal occlusion within 14 days, however, the blood flow slowly increases in the next 2-3 weeks 16, 21 . hence, in the new model, we superimposed a secondary acute event by excising the intervening femoral artery segment along with the ameroid constrictors. in contrast to the 1-stage hli, mice subjected to 2-stage hli had on-going limb ischemia and a prolonged functional deficit on both forced and voluntary ambulation tests. these findings support the value of the novel model for the testing of interventions aimed at achieving clinical improvements in pad patients. since angiogenesis is an inflammation-driven process 57 , the concentrations of circulating cytokines were measured. these markers of systemic inflammation increased in response to hli in both models examined. twenty eight days after hli induction, the concentrations of circulating cytokines were similar in the two models studied. gastrocnemius muscle samples obtained from the 2-stage hli model had marked neutrophilic infiltration. it has been previously reported that inflammatory cells accumulate in hypoxic tissues and promote angiogenesis 58 . it is possible that the systemic concentrations of cytokines were not reflective of the level of inflammation within the hind limb. markers of angiogenesis and arteriogenesis in gastrocnemius tissue, such as cd31 and α-smc, were found to be less evident in the 2-stage than the 1-stage hli model. furthermore, gastrocnemius vegf and vegf-r2 protein levels and amount of total plasma no metabolites were significantly lower in the 2-stage than 1-stage hli model. vegf promotes angiogenesis 59 through binding to vegf-r2 60 expressed on endothelial cells 61 . vegf induces the release of no 62 thereby promoting microvascular perfusion and endothelial progenitor cell mobilization [63] [64] [65] . endothelial cell derived microrna, such as mir-16, have also been implicated in controlling angiogenesis through inhibiting rho gdp dissociation inhibitor (rhogdi)-α, an important regulator of enos phosphorylation 66 . it appears likely that the low levels of pro-angiogenic markers in the 2-stage hli model reflect less activation of endothelium-dependent pro-angiogenesis signalling pathways which were stimulated by collateral flow within the 1-stage model. shear stress promotes arteriogenesis by stimulating remodelling of collaterals 67, 68 . endothelial cells transduce changes in shear stress into intracellular signals which promote expression of a distinct set of genes which can control the response to ischemia [69] [70] [71] . previous studies suggest that increased shear stress promotes phosphorylation and upregulation of mechano-sensors, such as trpv4 [72] [73] [74] [75] . it was postulated that the distinct ways of inducing hli in the two models studied might be reflected in different trpv4 expression. mice subjected to 2-stage hli had lower expression of trpv4 compared to those undergoing 1-stage hli. furthermore, in the 2-stage hli model, there was no change in trpv4 protein levels after ameroid placement, suggesting that ameroid constriction is a gradual process that does not lead to shear stress changes capable of stimulating mechano-sensors like trpv4. these findings also suggest that 2-stage hli results in more limited collateral flow than the 1-stage approach. the acute reduction in arterial pressure gradient following femoral artery excision in the 1-stage hli model it thought to be registered by endothelial shear stress response elements resulting in upregulation of angiogenesis and arteriogenesis promoting genes 21 . simulation of trpv4, for example by 4α-phorbol 12, of vegf-r1 (g), vegf-r2 (h), trpv4 (i) and klf4 (j) assessed in the gastrocnemius muscles of mice undergoing hli. quantitative real time pcr (qrt pcr) was performed on extracted total mrna using specific primers and normalised to glyceraldehyde 3 phosphate dehydrogenase (gapdh) expression. data analysed by mann-whitney u test (n = 10 samples/group). (2020) 10:3449 | https://doi.org/10.1038/s41598-020-60352-4 www.nature.com/scientificreports www.nature.com/scientificreports/ 13-didecanoate, has been reported to promote increase no release and increased hind limb blood flow 73 . trpv4 deficient rodents have impaired vasodilatation [76] [77] [78] [79] . this supports the important role of trpv4 in promoting adaptation to acute limb ischemia. four weeks of exercise training led to an approximate 2-fold increase in treadmill ambulatory distance in the mice subjected to 2-stage hli, paralleling findings from pad patients [80] [81] [82] [83] . these findings suggest the novel 2-stage hli mouse model simulates the walking impairment experienced by patients. in support of the relevance of this model to patients, we found that exercise therapy improved treadmill performance without improving limb perfusion, a finding similar to that described in pad patients 47, 48, 84 . since exercise training increases shear stress in pre-existing collaterals we examined the expression of trpv4 and angiogenesis markers 85 . compared to sedentary controls, mice undergoing exercise training showed increased total protein levels of vegf and trpv4, which was in accordance with previous reports showing enhanced expression of pro-angiogenesis markers after exercise training [86] [87] [88] . overall these findings suggest flow-mediated upregulation of shear stress responsive genes is important in stimulating angiogenesis responses in the new model. this study have several strengths and weaknesses. the 1-stage hli model which is usually utilised for pad research has many limitations including its disparate pathophysiological mechanisms compared to patient presentations, the temporary nature of the ischemia and its relative responsiveness to a variety of therapies which are not effective in patients 14 . this study suggests the novel 2-stage model has clear advantages over the 1-stage model since ischemia is more severe and prolonged and does not naturally recover making it suitable to access the longer term effects of potential therapies. the study also has some limitations. these include the absence of a detailed time course of the genes and proteins assessed and the absence of a definitive test of the role of shear stress response elements in the differences in the models found. the importance of shear stress response elements in the response to hli has however been previously reported in prior studies 85 . it is therefore logical to assume similar mechanisms were involved in the current study given the gene expression differences demonstrated. the study also lacked the use of new high resolution imaging systems, such as fluorescent microsphere angiography. lower-limb arterial disease comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis the global pandemic of peripheral artery disease global and regional burden of death and disability from peripheral artery disease: 21 world regions endovascular versus open revascularization for peripheral arterial disease outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions trial of a paclitaxel-coated balloon for femoropopliteal artery disease drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the in.pact sfa randomized trial autologous cell therapy for peripheral arterial disease: systematic review and meta-analysis of randomized, nonrandomized, and noncontrolled studies growth factors for angiogenesis in peripheral arterial disease trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft the australian national workplace health project: design and baseline findings muscle fiber characteristics in patients with peripheral arterial disease evaluation of the clinical relevance and limitations of current pre-clinical models of peripheral artery disease the efficacy of extraembryonic stem cells in improving blood flow within animal models of lower limb ischaemia the effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype biomechanical activation of vascular endothelium as a determinant of its functional phenotype a review of the pathophysiology and potential biomarkers for peripheral artery disease subacute limb ischemia induces skeletal muscle injury in genetically susceptible mice independent of vascular density cellular and molecular mechanism regulating blood flow recovery in acute versus gradual femoral artery occlusion are distinct in the mouse physical activity during daily life and mortality in patients with peripheral arterial disease skeletal muscle perfusion in peripheral arterial disease a novel end point for cardiovascular imaging impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in apoe −/− mice murine model of hindlimb ischemia delayed arteriogenesis in hypercholesterolemic mice vascular growth factor expression in a rat model of severe limb ischemia mouse model of angiogenesis critical function of bmx/etk in ischemia-mediated arteriogenesis and angiogenesis limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis exercise performance and peripheral vascular insufficiency improve with ampk activation in high-fat diet-fed mice altered behavioural adaptation in mice with neural corticotrophin-releasing factor overexpression amitriptyline reverses hyperalgesia and improves associated mood-like disorders in a model of experimental monoarthritis validation of the digital pressure application measurement (pam) device for detection of primary mechanical hyperalgesia in rat and mouse antigen-induced knee joint arthritis a peptide antagonist of thrombospondin-1 promotes abdominal aortic aneurysm progression in the angiotensin ii-infused apolipoprotein-e-deficient mouse influence of apolipoprotein e, age and aortic site on calcium phosphate induced abdominal aortic aneurysm in mice impaired acetylcholine-induced endothelium-dependent aortic relaxation by caveolin-1 in angiotensin ii-infused apolipoprotein-e (apoe −/− ) knockout mice relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis sildenafil promotes ischemia-induced angiogenesis through a pkg-dependent pathway fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model osteoprotegerin deficiency limits angiotensin ii-induced aortic dilatation and rupture in the apolipoprotein e-knockout mouse wnt signaling pathway inhibitor sclerostin inhibits angiotensin ii-induced aortic aneurysm and atherosclerosis nuclear positioning in muscle development and disease the effect of exercise on haemodynamics in intermittent claudication: a systematic review of randomized controlled trials exercise for intermittent claudication impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training hypercholesterolemia impairs exercise capacity in mice exercise for intermittent claudication apolipoprotein e −/− mice have delayed skeletal muscle healing after hind limb ischemia-reperfusion peripheral nerve ischemia: apolipoprotein e deficiency results in impaired functional recovery and reduction of associated intraneural angiogenic response differential necrosis despite similar perfusion in mouse strains after ischemia time course of skeletal muscle repair and gene expression following acute hind limb ischemia in mice promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success inflammation and wound healing: the role of the macrophage post-ischaemic neovascularization and inflammation vegf receptor signalling -in control of vascular function glycaemic control improves perfusion recovery and vegfr2 protein expression in diabetic mice following experimental pad high affinity vegf binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor nitric oxide synthase modulates angiogenesis in response to tissue ischemia essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells hindlimb ischemia impairs endothelial recovery and increases neointimal proliferation in the carotid artery hemodynamic stresses and structural remodeling of anastomosing arteriolar networks: design principles of collateral arterioles wall remodeling during luminal expansion of mesenteric arterial collaterals in the rat shear-induced force transmission in a multicomponent, multicell model of the endothelium oscillatory shear stress and hydrostatic pressure modulate cell-matrix attachment proteins in cultured endothelial cells effects of biaxial oscillatory shear stress on endothelial cell proliferation and morphology ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis) trpv4 induces collateral vessel growth during regeneration of the arterial circulation calcium-dependent signalling is essential during collateral growth in the pig hind limb-ischemia model effects of endogenous nitric oxide and of deta nonoate in arteriogenesis trpv4-dependent dilation of peripheral resistance arteries influences arterial pressure transient receptor potential vanilloid type 4-deficient mice exhibit impaired endothelium-dependent relaxation induced by acetylcholine in vitro and in vivo activation mediates flow-induced nitric oxide production in the rat thick ascending limb trpv4-mediated endothelial ca2+ influx and vasodilation in response to shear stress esc guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (esvs): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesendorsed by: the european stroke organization (eso)the task force for the diagnosis and treatment of peripheral arterial diseases of the european society of cardiology (esc) and of the european society for vascular surgery (esvs) cilostazol for intermittent claudication a systematic review of the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication exercise for intermittent claudication a systematic review of treatment of intermittent claudication in the lower extremities cardiovascular effects of exercise: role of endothelial shear stress exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle the influence of physical training on the angiopoietin and vegf-a systems in human skeletal muscle exercise linked to transient increase in expression and activity of cation channels in newly formed hind-limb collaterals this research was funded by a faculty administered grant and a research infrastructure block grant from james cook university and funding from the queensland government. jg holds a practitioner fellowship from the national health and medical research council, australia (1117061) and a senior clinical research fellowship from the queensland government. smo was supported by funding from the graduate research school and college of medicine, james cook university. we would like to acknowledge with thanks the help of prof. zoltan sarnyai (james cook university) who provided access to open field test assessment facility, dr. joseph moxon (james cook university) who assisted with the lme used to analyse data from the exercise study and dr. pacific huynh (james cook university) who provided the mouse images in figs. 1a and 5a. s.m.k. lead the design of the research, undertaking of experiments, and interpretation of data and writing of the manuscript. s.m.o., j.l., s.m. and r.j.j. performed parts of the experiments, contributed to interpretation of the data and gave critical comments on the manuscript. j.g. contributed rationales for the studies, led funding applications, co-wrote the manuscript and contributed to project supervision and data interpretation. the authors declare no competing interests. supplementary information is available for this paper at https://doi.org/10.1038/s41598-020-60352-4.correspondence and requests for materials should be addressed to j.g.reprints and permissions information is available at www.nature.com/reprints.publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. license, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the creative commons license, and indicate if changes were made. the images or other third party material in this article are included in the article's creative commons license, unless indicated otherwise in a credit line to the material. if material is not included in the article's creative commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. to view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. key: cord-010278-loey5xq9 authors: huh, changgoo; nagle, james w.; kozak, christine a.; abrahamson, magnus; karlsson, stefan title: structural organization, expression and chromosomal mapping of the mouse cystatin-c-encoding gene (cst3) date: 1995-01-23 journal: gene doi: 10.1016/0378-1119(94)00728-b sha: doc_id: 10278 cord_uid: loey5xq9 cystatin c (cstc) is a potent cysteine-proteinase inhibitor. the structure of the mouse cstc-encoding gene (cst3) was examined by sequencing a 6.1-kb genomic dna containing the entire gene, as well as 0.9 kb of 5′ flanking and 1.7 kb of its 3′ flanking region. the sequence revealed that the overall organization of the gene is very similar to those of the genes encoding human cstc and other type-2 cst, with two introns at positions identical to those in the human gene. the promoter area does not contain typical tata or caat ☐es. two copies of a spl-binding motif, gggcgg, are present in the 5′ flanking region within 300 bp upstream from the initiation codon. a hexa-nucleotide, tgttct, which is a core sequence of the androgen-responsive element (are), is found in the promoter region. this region also contains a 21-nucleotide sequence, 5′-agactagcagctgactgaagc, which contains two potential binding sites for the transcription factor, ap-1. the mouse cst3 mrna was detected in all of thirteen tissues examined by northern blot analysis. cst3 was mapped in the mouse to a position on distal chromosome 2. the cystatins (cst) are a group of potent cysteineproteinase inhibitors. there are at least five distinct types in the cst superfamily, each type consisting of several proteins (rawlings and barrett, 1990; devos et al., 1993) . cstc belongs to the family of type-2 cst and consists of 120 aa, with two intrachain disulfide bonds (barrett et al., 1986) . although the proteinase-inhibiting function of the cstc has been thoroughly investigated, less is known about its broader biological role. recent reports indicate that cstc may play a role in cancer progression (sloane, 1990) , bone resorption (lerner and grubb, 1992) , modulation of neutrophil chemotactic activity and inflammation (leung-tack et al., 1990a,b) , and resistance to viral infection (collins and grubb, 1991) . furthermore, a point mutation in the cst3 gene, resulting in a leu~gln substitution, is the primary cause of autosomal dominant hereditary disorder, hereditary cstc amyloid angiopathy (hccaa) (grubb et al., 1984) . as young adults, carriers of this mutation suffer from repeated and massive brain hemorrhages due to deposition of the mutant protein in the walls of the cerebral arteries. the gene structures for several type-2 cst have been determined. the human cst1 and cst2 genes (saitoh et al., 1987) , and the human cst3 (abrahamson et al., 1990) and cst4 (freije et al., 1991) genes show very similar structural organization with respect to the number and position of the introns. structural analysis of the genes for these proteins will be necessary to understand the function and evolution of the members in the cystatin multigene superfamily. in this paper, we report the structural organization and expression of the mouse cst3 gene, compare its regulatory elements with that of other cst genes and map the cst3 gene in the mouse. using two primers mcyc3: (5'-atg gcc agc ccg ctg cgc tcc ttg-3') and mcyc4: (5'-ggc att ttt gca gct gaa ttt tgt cag-3'), a 420-bp dna fragment within the coding region was generated from mouse cst3 cdna, labeled with 32p by random primer extension, and used as a probe to screen a ~,fixli genomic dna library from 129/sv mice (purchased from stratagene, la jolla, ca, usa). among several hybridizing clones, one clone, ~,cygl3, was chosen for characterization. southern blot and pcr analysis indicated the presence of the mouse cst3 gene in a 15-kb dna insert. southern blot analysis of the genomic dna did not show any evidence for the presence of a cst3 pseudogene. a 6.1-kb genomic dna fragment containing the entire gene, as well as 0.9 kb of 5' flanking and 1.7 kb of 3' flanking region, was subjected to nt sequencing. the 6125-nt sequence covering the entire mouse cst3 gene is shown in fig. 1 . comparison of the mouse cst3 gene sequence with that of the corresponding cdna (solem et al., 1990) revealed that the gene contains two intron sequences located between the nt triplets encoding aa 55-56 and 93-94 of the proposed mature polypeptide chain, exactly as in the human cst3 gene. the presence of two introns, at homologous positions, has also been reported in the other type-2 cst genes fully characterized to date: the human csti, cst2 and cst4 genes. the intron-exon junctions in the mouse cst3 gene are all close matches to the consensus sequences for the donor and acceptor splice sites of introns (mount, 1982) . some differences were observed between the exons of the genomic dna sequence and the published cdna, the five differences are summarized in table 1 . two of these positions, 994 and 3421, are in the coding region. the nt 994 in exon 1 results in a gcc codon (coding for ala) towards the c-terminal part of the leader sequence. however, a ggc codon (coding for gly) was reported at this position in the published cdna. this gcc codon found in the genomic dna exists in the corresponding site of the rat and human cst3 cdnas. the nt 342~ in exon 2 forms a ttg codon for leu (ttt coding for phe in cdna). the differences between genomic and cdna sequence may be due to an error during cdna synthesis or due to polymorphism between the mouse strains 129/sv and balb/c. the sequence of the 0.9-kb segment flanking exon 1 of the mouse cst3 gene at the 5' end, did not reveal a typical tata or caat box in the suggested promoter area. however, a tata-box-like taaaa sequence is present at 78-82 nt upstream from the start codon. a similar slightly atypical tata-box is found at the homologous position in the human cst3 gene (ataaaa), the human cst4 gene (ataaat), the human csti and cst2 genes (ataaa). the tata-box is preceded by a spl-binding gc-box sequence (pugh and tjian, 1990) with the core consensus sequence, gggcgg, ending 23 nt upstream from the at-sequence. a corresponding sequence in the human cst3 gene is located slightly closer to the tatabox (distance 16 nt). in the human cst4 gene, a gc-box is also found in the immediate 5'-flanking region (upstream distance from the at-sequence 41 nt). by contrast, in the human csti and cst2 genes, a segment similar to the caat consensus is found instead of the gc box. a core sequence of the are, tgttct, is found 22 nt downstream from the taaaa sequence. this hexanucleotide is located in a partial palindromic setting. some naturally occurring sequences and synthetic constructs containing this core sequence in a partial palindromic structure were shown to be inducible with androgens (ham et al., 1988) . this are is not found in the promoters of any other type-2 cst genes published. however, it is present in cst-related protein-encoding genes whose expression is regulated by androgen in the ventral prostate and lachrymal gland (chamberlain et al., 1983 ). an exact match of nine nt with the pituitary transcription factor (pit-l) recognition element is centered around nt -795 from the start codon, but is probably of low significance for the expression of the gene because multiple recognition elements have been shown to be needed for markedly increased expression of the rat prolactin gene by pit-1 (ingraham et al., 1988 recognized by the leader binding protein (lbp-1), 5'-wctgg-3' or its inverse, that is present in several copies in the hiv-1 promoter and contribute to its basal function (jones et al., 1988) , is strikingly abundant in the 5'-flanking region of the mouse cst3 gene. another five lbp-i motifs are found within a 300-bp segment in the first part of the first intron. transcription factor ap-l-binding sites that bind the jun-fos protooncogene complexes contain the consensus sequence 5'-tgactcagc. the mouse cst3 promoter contains two ap-l-like binding sequences within the sequence 5'-agactagcagctgactgaagc, immediately upstream from the first spl-binding site. this 21-mer sequence contains direct repeats of two adjacent potential ap-l-binding sites, each slightly deviating from the consensus sequence. it has been shown that two adjacent ap-l-like binding sites act synergistically to confer inducibility beyond that observed for a single ap-1 consensus sequence (friling et al., 1992) . the presence of the two ap-l-like binding sites in the promoter indicates that differences between the mouse cst3 gene sequence and that of the published edna (solem et al., 1990) position" genomic dna b cdna c aa a (genomic/cdna) 994 c (11) g ala/gly 3421 g(5) t leu/phe 4393 c 15) t 4564-5 gc (3) at a the nt positions refer to fig. 1 . b the nt refers to the genomic dna sequence. sequence was determined on both strands (number of independent sequencing runs in parentheses). c the nt refers to the cdna sequence. d the aa encoded by nt in columns genomic dna and cdna. transcription factor ap-1 may play a role in the cst3 gene expression. there is evidence that induction of gene expression by tgf-13 is mediated by transcription factor ap-1. autoregulation of tgf-131 expression is mediated by the binding of ap-1 to a loose consensus binding site, tgagaca, in the tgf-131 promoter (kim et al., 1990) . a strong positive regulation of the cst3 gene by tgf-13 in serum free mouse embryo cells has also been reported (solem et al., 1990) . the presence of ap-l-like binding sites in the mouse cst3 promoter suggests that cystatin c induction by tgf-[3 may be mediated by the ap-i complex, the y-flanking region of the human cst3 gene has a notably high g+c content, with >70% g+c in the 400 bp sequence upstream from the start codon. the g+c-rich region also includes the coding part of exon 1 and the 5' part of the first intron, which together represents a 900-bp segment with a g+c content of 73%, and contains cpg/gpc dinucleotides in a ratio close to unity (abrahamson et al., 1990) . the immediate 5'-flanking region of the mouse cst3 gene does not have such a strikingly high g + c content, but is more similar to the human cst1, cst2 and cst4 genes in having a gc content of approx. 60%. however, the cpg/gpc ratio is 1/1.3 in the 300 bp region upstream from the start codon (as compared to 1/4.1 over the entire 6. l-kb sequenced region), differing markedly from ratios of 1/6, 1/9 and 1/16 for the human cst4, csti and cst2 genes, respectively. thus, the mouse cst3 gene y-flanking region is not a typical housekeeping gene promoter having extremely high g + c content. rather it is similar to these promoters and the human cst3 promoter because it displays several spl-binding sites and contains a high number of cpg dinucleotides. this may indicate a low degree of methylation due to constant transcription of the gene (bird, 1986) . proposed promoter regions of several type-2 cst are compared in fig. 2 (saitoh et al., 1987 : abrahamson et al., 1990 : freije et al., 1991 . sequence determination of the mouse cst3 gene 1.7-kb 3'-flanking segment revealed no alternative polyadenylation signals in addition to the one present in the corresponding edna, 213bp downstream from the stop codon. analysis of short tandem repeats within the entire gene sequence revealed the presence of(gt)zl and (ga)26 in the region immediately 3'-flanking the polyadenylation signal and three stretches of perfect ct repeats, (ct)13, (ct)14 and (ct)25, 1300 bp further downstream. analysis of two multilocus crosses .was used to define the chr location for the mouse cst3 gene: (nfs/n or c58/j × m. m. musculus) × m. m. musculus ) and (nfs/n ×m. spretus)×m, spretus or c58/j (adamson et al., 1991) . dnas extracted from parental mice and progeny of the crosses were typed by southern blotting analysis for rflps of cst3 using the mouse cst3 cdna as probe. ssti digestion produced fragments of 8.6 and 6.0 kb in m. spretus and 6.0 and 2.8 kb in nfs/n and c58/j mice, and bamhi fragments of 22.0 and 18.8 kb were detected in m. m. musculus and nfs/n, respectively. inheritance of the parental fragments was followed in both crosses and compared with inheritance of almost 650 markers previously typed and mapped to all 19 autosomes and the x chromosome. as shown in fig. 3 the numbers given between adjacent loci represent percent recombination±the standard error calculated according to green (1981) . (b) chr 2 linkage maps. the map on the right was generated from the two crosses described here and indicates the position of cst3 relative to the other markers typed in this cross. distances between adjacent markers (in centimorgans) are indicated to the immediate left of the map. the map on the left is an abbreviated version of the composite genetic map (siracusa and abbott, 1993) . numbers to the left of the map are centimorgan distances from the centromere. human map locations for homologs of the underlined mouse genes are indicated to the far left of this map. and distal to snap (encoding synaptosomal associated protein), markers which were typed in these crosses as previously described (joseph et al., 1990; grimaldi et al., 1992) . it has recently been shown that the human homolog of this gene maps to 20pll (schnittger et al., 1993) . this is consistent with our results, since the distal end of mouse chr 2 contains a substantial region of linkage conservation with human chr 20 (siracusa and abbot, 1993; fig. 3b ). the human cst3 is part of a cluster which includes up to eight members of the cst gene family (schnittger et al., 1993) further suggesting that the mouse homologs of these genes are likely to map to the same site on chr 2. we examined the expression of the mouse cst3 gene in 13 different tissues by northern blot analysis using the mouse cst3 cdna probe. as expected, cst3 mrna was detected in all tissues examined, including stomach, brain, intestines, liver, muscle, spleen, heart, kidney, lung, pancreas, testis, uterus and ovary (data not shown). the pattern of the mouse cst3 gene expression is similar to that of its human counterpart. both species show expression of the gene in all tissues examined with high level of cst3 messenger rna in brain and testis, and lowest level in pancreas. this overall similarity between the two species indicates that mouse may be suitable for generating an animal model for the human genetic disease hccaa. structure and expression of the human cystatin c gene the mouse homolog of the gibbon ape leukemia virus receptor: genetic mapping and a possible receptor function in rodents nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin cpg-rich islands and the function of dna methylation isolation, properties, and androgen regulation of a 20-kilodalton protein from rat ventral prostate inhibitory effects of recombinant human cystafin c on human coronaviruses structure of rat genes encoding androgen-regulated cystatin-related proteins (crps): a new member of the cystatin superfamily structure and expression of the gene encoding cystatin d, a novel human cysteine proteinase inhibitor two adjacent ap-l-like binding sites form the electrophile-responsive element of the murine glutathione s-transferase ya subunit gene genetics and probability in animal breeding experiments genomic structure and chromosomal mapping of the murine cd40 gene abnormal metabolism of 7-trace alkaline microprotein characterization of response elements for androgens, glucocorticolds and progestins in mouse mammary tumour virus a tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype structural arrangements of transcription control domains within the 5'-untranslated leader regions of the hiv-i and hiv-2 promoters characterization and expression of the complementary dna encoding rat histidine decarboxylase autoinduction of transforming growth factor 131 is mediated by the ap-1 complex molecular genetic markers spanning mouse chromosome 10 neutrophil chemotactic activity is modulated by human cystatin c, an inhibitor of cysteine proteases modulation of phagocytosis-associated respiratory burst by human cystatin c: role of the n-terminal tetrapeptide lys-pro-pro-arg human cystatin c, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy a catalogue of splice junction sequences mechanism of transcriptional activation by sp 1; evidence for coactivators evolution of proteins of the cystatin superfamily human cysteineproteinase inhibitors: nucleotide sequence analysis of three members of the cystatin gene family cystatin c (cst3), the candidate gene for heretary cystatin c amyloid angiopathy (hccaa), and other members of the cystatin gene family are clustered on chromosome 20pl 1.2 mouse chromosome 2. mammal cathepsin b and cystatins: evidence for a role in cancer progression transforming growth factor beta regulates cystatin c in serum-free mouse embryo (sfme) cells we thank dr. jakob reiser for critical reading of the manuscript. key: cord-010187-ymhcfyxx authors: gromeier, matthias; lu, hui-hua; wimmer, eckard title: mouse neuropathogenic poliovirus strains cause damage in the central nervous system distinct from poliomyelitis date: 2005-03-25 journal: microb pathog doi: 10.1016/s0882-4010(05)80002-6 sha: doc_id: 10187 cord_uid: ymhcfyxx poliomyelitis as a consequence of poliovirus infection is observed only in primates. despitea host range restricted to primates, experimental infection of rodents with certain genetically well defined poliovirus strains produces neurological disease. the outcome of infection of mice with mouse-adapted poliovirus strains has been described previously mainly in terms of paralysis and death, and it was generally assumed that these strains produce the same disease syndromes in normal mice and in mice transgenic for the human poliovirus receptor (hpvr-tg mice). we report a comparison of the clinical course and the histopathological features of neurological disease resulting from intracerebral virus inoculation in normal micewith those of murine poliomyelitis in hpvr-tg mice. the consistent pattern of clinical deficits in poliomyelitic transgenic mice contrasted with highly variable neurologic disease that developed in mice infected with different mouse-adapted polioviruses. histopathological analysis showed a diffuse encephalomyelitis induced by specific poliovirus serotype 2 isolates in normal mice, that affected neuronal cell populations without discrimination, whereas in hpvr-tg animals, damage was restricted to spinal motor neurons. mouse neurovirulent strains of poliovirus type 2 differed from mouse neurovirulent poliovirus type 1 derivatives in their ability to induce cns lesions. our findings indicate that the characteristic clinical appearance and highly specific histopathological features of poliomyelitis are mediated by the hpvr. our data lead us to conclude that the tissue tropism of mouse-adapted poliovirus strains in normal mice is fundamentally different from that of poliovirus in hpvr-tg mice and primates, and that this is indicative of an as yet unknown mechanism of adsorption and uptake of the virus into cells of the murine cns. poliomyelitis is a rare neurological complication of primate infection with poliovirus (pv), a member of the picornavirus family, genus enterovirus. ingestion of virulent particles results in intestinal uptake, presumably through m-cells, 1 initial viral replication in subjacent lymphatic tissue, spread to deeper cervical and mesenteric *author to whom correspondence should be addressed. 0882-4010/95/040253+15 $08.00/0 o 1995 academic press limited lymph nodes (lymphatic phase), and ultimately entry of the virus into the bloodstream (viremic phase). 2 the latter is a prerequisite for passage of the blood brain barrier 3 and subsequent lytic infection of motor neurons. only a small proportion of pv infections lead to a distinctive neurological syndrome that ranges in severity from transient flaccid monoparesis to progressive flaccid paraplegia with respirato.ry impairment and sometimes bulbar involvement. 4 the hallmark of poliomyelitis histopathology is selective damage to anterior horn motor neurons along the entire spinal cord. spinal neurons outside the motor neuron system are characteristically spared, 5 in spite of their close anatomical relationship to the target of polioviral attack. the predominant molecular determinant of pv tropism is the hpvry the nucleotide sequence of hpvr identified it to be a member of the immunoglobulin superfamily, whose four mrna isoforms are the result of alternative splicing events, and give rise to different receptor molecules. 6'8 hpvrc~ and hpvr& are integral membrane proteins with divergent cytoplasmatic domains, whereas hpvr/~ and hpvr7 are secreted molecules lacking the putative transmembrane domain. 6 the hpvr is a highly glycosylated protein with an apparent molecular weight of 80kda2 the animal model for poliomyelitis in hpvr-tg mice showed pv-induced damage of comparable anatomical distribution as in primates, 1°'11 an observation confirming views of the hpvr as the critical determinant conferring pv susceptibility. unexpectedly, hpvr mrna and hpvr-related proteins were shown to be present in a wide variety of tissue homogenates not known to be sites of pv replication, ~'1° an observation suggesting additional limiting factors of pv susceptibility, mrnas specifying the simian 12 and murine ~3 homologues to hpvr have been isolated, but only the monkey-specific pvr can promote pv infection. ~2 attempts to use rodents as possible models of pv-induced disease resulted in the isolation of mouse-neurovirulent (ran) strains. a 1937 pv serotype 2 field isolate from lansing, michigan, [pv2(l)], which caused a syndrome described as 'polioencephalitis' upon intracerebral injection in the cotton rat, tm provided the first system of pv encephalitogenesis in the wild type (wt) mouse. ~s histopathological analyses of murine infection with the rodent-passaged pv2(l) isolate described a pattern of damage in accordance with concepts of primate poliomyelitis. ~6 a structural element conferring mouse neurovirulence to pv2(l) was determined to map in the capsid region. ~7 sufficient in causing this effect was a segment within the bc-ioop of vp1 since mouse avirulent pv type 1 (mahoney) [pvi(m)], after transposition of the lansing bc-ioop, caused neurological disease in mice. 18' 19 surprisingly, point mutations in distant regions of vp1 and vp2 could be shown to exert a mn phenotype. 2°.2~ the histopathological features of neurological disease caused by these genetically well defined mn pv strains have not been reported thus far. in addition to the selection of wt pv strains expressing a mn phenotype in mice, attenuated pv strains with a mouse host range phenotype but reduced neurovirulence have also been described [pv type 2, strain w222]. the attenuated (att) phenotype of pv2(w2) is reminiscent of the sabin strains of pv that express an att phenotype for primates. 23 the genetic determinants of viral neurotropism have been studied in several viral systems. most frequently, these determinants mapped to the envelope gene; examples are the alphaviruses sindbis virus 24 we have infected swiss-webster-, and icr-mice with a variety of mn virus isolates of different serotypical origin. type 2 strains pv2(l), pv2(mef-1), a recent pv2 isolate from india (ind), and pv2(w2) caused a fatal diffuse encephalomyelitis in these mice with considerable differences in intensity between individual viral strains. pvl(lsa), a mouse-adapted derivative of pvl(m), 37 caused a characteristic non-progressive panmyelitic syndrome. we have also studied the histopathology of murine infection with pvi(m), carrying a single mutation in position 54 of capsid protein vp1 that we constructed according to a published report. 2~ infections with each of these strains did not follow the stereotypic course of predictable progression seen in pv-induced poliomyelitis in hpvr-tg icr-mice. syndromes with distinct and consistent features followed intracerebral infection with each group of strains. these syndromes could be separately characterized and distinguished from hpvr-mediated poliomyelitis, on both clinical and histopathological grounds. poliovirus isolates and experimental animals. pv transgenic icr-mice expressing the hpvr ~° were a generous gift from a. nomoto (the university of tokyo, japan). swiss-webster-and normal icr-mice were obtained from taconic (germantown, ny, u.s.a). ultraviolet (uv) irradiation conditions. uv irradiation was performed in a uv-stratalinker (stratagene, lajolla, ca, u.s.a) a suspension of pv was irradiated at a distance of ca. 10 cm with an intensity of ca. 3.5 j/m z. virus was exposed to the irradiation source in ice-cooled plastic dishes at a solution depth of ca. 1ram. the loss of infectivity was confirmed in a plaque assay. poliovirus intracerebral infections. virus preparations were used to infect tg or normal mice with the desired input titer by intracerebral inoculation. mice were anesthetized, and a 25 gauge hypodermic needle was used to inject maximally 30 pl of virus suspension in dulbecco's minimal essential medium (dmem). the point of injection was the middle on the median between the ear pinnacle and the eye. infected mice were regularly observed for symptoms. none of the treated animals showed any external signs of damage or neurological disturbances in 24 h following injection. tissue processing, sectioning, and staining. affected animals in the final stage of their disease were sacrificed according to approved protocols, and their bodies were immediately perfused with 15 ml of phosphate buffered saline (pbs), followed by 15 ml of 4% neutral buffered paraformaldehyde. the brain and spinal cord were removed and fixed for 2 h at room temperature in the fixative used for perfusion. tissue specimens were rinsed for 30 rain in icecold pbs, then placed in 70% ethanol over night. dehydration was achieved through a scheme of gradually increasing ethanol concentration, followed by clearing in toluene for 2 h and infiltration with paraffin at 57.5°c for 2 h. neural tissues were embedded and cut on a rotary microtome at a thickness of 10/~m. tissue sections were placed on microscopic slides treated transgenic mice expressing the pv receptor tm were infected intracerebrally with pvi(m) with an amount of virus ranging from 10 4 to 5x 10 6 plaque forming units (pfu). all infected mice developed a characteristic neurological syndrome displaying stereotypic clinical features irrespective of input titer of virus and differing only with regard to onset of symptoms (table 1) . once visible signs of functional impairment were apparent, the progression of disease followed a predictable course. two to five days after intracerebral injection, initial signs were invariably a flaccid paralysis of the lower extremities and tail (fig. 1a) . the condition was rapidly progressive leading to complete immobilization and respiratory difficulty within 48 h. respiratory distress caused visible signs of bobbing of the head, strenuous respiratory effort, insufficient thoracic excursions, and nasal flaring. animals in the final stage of the disease were killed and their cns tissues processed according to standard procedures. histopathological analysis of the cns of pvl(m)-infected hpvr-tg mice revealed the spinal pathology of poliomyelitis described in earlier reports. 1°' 11 selective loss of anterior horn motor neurons along the entire spinal cord was invariably present (fig. 2b) . foci of virally-induced damage in the higher cervical cord extended into the brain stem and were accompanied by minor signs of inflammation in a predominantly perivascular distribution. characteristically, apart from a clearly defined lesion in the pyramidal cell layer of the hippocampal formation, lesions above the brain stem were absent in all cases analyzed. the appearance of initial lesions in the lumbar spine, distant from the injection site without evidence of damage to cortical motor neurons or descending tracts, indicated that virus had been disseminated via the hematogenous or cerebrospinal fluid route. twenty eight day old swiss-webster-and icr-mice were injected intracerebrally with pvi(m), pv2(l), pv2(mef-1), pv2(ind), or pv2(w2), with amounts of virus ranging from 104 to 5x 106. three groups of four animals each with different genetic backgrounds, swiss-webster and icr, were injected with the same viral strain. it is important to note that we were unableto detect clinical or histological evidence for differences in susceptibility towards pv infection between both outbred mouse strains used. therefore, in the following text, the term 'normal mouse' will refer to swiss-webster mice. all mn pv strains assayed caused poliomyelitis when injected into hpvr-tg mice (clinical and histopathological details are described later). none of the normal mice injected with pvi(m) showed clinical signs of neurological damage, whereas inoculation of type 2 pv strains produced signs of cns infection ( table 2) . mice infected with pv2(mef-1) and pv2(ind) were most severely affected. initial symptoms appeared 2-5 days post infection (p.i.) in all animals but they were inconsistent regarding the sites of manifestation and quality of functional impairment. motor symptoms consisted predominantly of spastic weakness involving the lower or upper extremities in a random fashion ( table 2) . paraplegic animals had a characteristic posture marked by kyphoscoliotic deformity (fig. 1b) . the progression of motor symptoms did not follow any apparent topographical scheme. pareses frequently were accompanied by gait ataxia or motor incoordination. clinical signs of respiratory involvement as described above usually did not appear during the course of the disease ( table 2 ). the clinical course proceeded to a terminal stage within 4 days after onset of symptoms. preterminal animals were severely emaciated once functional impairment supervened, and refused intake of fluid and food offered within their reach. compared to pv2(mef-1) and pv2(ind) a proportionally lower number of pv2(l)infected animals died (table 1) . their clinical syndrome was less variable, but also diverged from the regular pattern of disease localization and progression seen in poliomyelitic hpvr-tg mice. motor symptoms similar to those in pv2(mef-1) infected littermates dominated the clinical picture. progression of motor involvement did not follow any recognizable pattern and it only rarely included respiratory function ( table 2 ). eventually immobilization led to quick deterioration of the starving animals. pv2(w2) was previously reported to be of attenuated neuropathogenicity with respect to pv2(l) in mice. 44 accordingly, the proportion of infected animals that developed disease, and the severity and pace of progression of symptoms, were less than in animals infected with other pv type 2 isolates (table 1 ). this observation confirms the attenuated nature of the strain." the spectrum of functional deficits observed was identical to pv2(l)-induced disease. likewise, there was considerable variability in the sites involved in production of symptoms, course of progression, the clinical discrepancies between wt pv-induced poliomyelitis in hpvr-tg mice, and mouse-adapted pv2 infections in normal mice, were confirmed by histopathological differences. the severity and variability of clinical signs secondary to infection with the pv2 strains in normal mice was consistent with the histopathological findings. extent, morphology and localization of viral lesions in swiss-webster-and icr-mice were comparable. the range of vitally-induced damage encompassed a variety of lesions indiscriminately affecting structures within the cerebral hemispheres and the entire spinal cord. characteristically, spinal pathology was patchy and irregular, and it did not follow the consistent pattern of damage to the entire cord seen in pvinfected hpvr-tg mice. unexpectedly, anterior horn motor neurons remained frequently unaffected in normal mice infected with mn pv2, although severe pathological changes within the spinal cord were apparent (fig. 2c,d) . in contrast, routine poliomyelitis in hpvr-tg mice invariably led to complete and exclusive elimination of the motor neuron population in the spinal cord with only minor infiltrative changes ( fig. 2b) . unlike the limitation of vitally-induced lesions in pv infections of hpvr-tg mice to the spinal cord, pv2-induced disease involved the entire cns. microglial nodules accompanied by mixed lymphocytic and neutrophilic infiltrates were scattered throughout the brain and were found within the insular, piriform and temporal cortex (fig. 2f) , and the basal ganglia and thalamus (fig. 2h) . these structures were never affected in infected hpvr-tg mice (fig. 2e,g) . perivascular cuffing and dense infiltration of perivascular and periventricular parenchyma were distributed ubiquitously in the cns. the cerebral white matter was a frequent site of viral lesions. lymphocytic infiltrates within the cerebral or cerebellar peduncles, the internal capsule, or the long descending tracts and posterior columns within the upper cervical cord, occasionally caused rarefaction necrosis with secondary demyelination (fig. 21) . immunohistochemical staining for viral proteins with a polyclonal anti-pv2 antiserum revealed positive signals in those structures frequently involved by virallyfig. 3 . signs of widespread lesions and diffuse encephalomyelitis were most commonly associated with the isolates pv2(mef-1) and pv2(ind), whereas in pv2(l) cases a myelitic pattern of disease predominated over encephalitis. parallel to the clinical findings, overall cns damage induced by pv2(w2) was moderate in comparison with the other serotype 2 isolates. neurological damage focused on the spinal cord with rare cerebral involvement. spinal pathology qualitatively resembled the pv2 panmyelitis described above but the extent and number of lesions were reduced (data not shown). to analyze the clinical course of murine infection with pv2 in mice expressing the hpvr, tg mice were inoculated intracerebrally with pv2(mef-1) or pv2(l). the resulting clinical picture featured signs typically seen in murine poliomyelitis. the onset of disease was marked by a flaccid paraparesis, followed by ascending progressive symptoms as in poliomyelitis. all affected animals developed a preterminal dyspneic stage before they were killed. associated histopathology showed elements characteristic of hpvr-mediated poliomyelitis, as well as pv2-induced encephalomyelitis. anterior horn motor neurons had changes typical for poliomyelitis. in addition, there was almost always severe hemispheric involvement, never associated with hpvr-tg murine poliomyelitis resulting from infection with pvi(m). lesions equivalent to those seen in pv2-induced encephalomyelitis were distributed in the same widespread indiscriminate manner throughout the cns. gray matter structures were affected as well as cerebral white matter (data not shown). two groups of ten 28-day-old swiss-webster-and icr-mice were each infected intracerebrally with pvi(ls-a) at a range of 105 to 5 x 106pfu. as in previous assays, there was no notable difference in clinical signs and histopathological features in mice with different genetic background. all infected animals developed a specific neurological syndrome with stereotypical onset, clinical course, functional deficits, and pattern of progression. four days p.i., mice showed the first signs of an insidious spastic paraparesis (fig. 1c) . no ascending motor deficits occurred, respiratory function remained unaffected, and there were no fatalities. intracerebral inoculation of pvl(ls-a) was required to produce symptoms, since intravenous injection of virus with concomitant intracerebral needle puncture produced no neurological impairment. intracerebral inoculation of equal particle numbers of pvi(ls-a) virus, inactivated by uv-irradiation, also caused no neurological signs of cns damage. this finding indicated viral replication to be a prerequisite for pvi(ls-a) neuropathogenicity. histopathology of the neurological syndrome caused by this variant centered exclusively on the spinal cord. extensive infiltrates, originating from spinal blood vessels, invaded both the gray and white matter. pathologic changes involved the entire spinal cord, but did increase in extent of damage caudally (fig. 4a,b) . there was no apparent predilection for any cell subtype. motor neuron damage was seen within areas of destructive necrotic tissue change secondary to the inflammation. at no time during the infection could damage to motor neurons within the thoracic or cervical cord be distinguished (fig. 4b) , despite prominent inflammation affecting these regions. spinal sections taken from animals which underwent partial reversal of neurological defects, 4 weeks p.i., revealed complete regression of infiltrative changes and preservation of motor neuron populations (fig. 4c ). a mutant pvi(m) virus, which had previously been reported to exert neuropathogenic potential in normal mice 21 was tested in a similar manner as the above mentioned strains. pvl(vp1-54) carried a point mutation at position 54 (p1054s) within capsid protein vp1. intracerebral inoculation of each four swiss-webster-and icr-mice with at least i x 109pfu resulted in visible signs of neurological damage in 50% of affected animals in both groups. with the genetic variant constructed in this laboratory, this large inoculum was required to induce clinical signs. the nature of the neurological syndrome was partly obfuscated by the vigorous host response to the application of excess viral antigen, and the resulting clinical deterioration. sick mice showed prominent systemic signs of disease such as ruffled fur, reduced activity, and emaciation. symptoms of minor motor impairment were present in half of the diseased mice, but the limb pareses were difficult to assess in quality due to the general weakened state of the animal. mild limb weakness did not progress with any apparent disease pattern. severely weakened, emaciated animals succumbed to the effects of infection, without the clear causal relationship of neurological disease and fatal outcome seen in poliomyelitis, hpvr-tg mice injected with pv1(vp1-54) developed a neurological condition indistinguishable from pvi(m) related poliomyelitis (data not shown). similar to clinical findings, the histopathologic features induced by pvl(vp1-54) were less defined than in the other described infections. there was no supraspinal involvement, and spinal cord sections at all levels displayed widespread parenchymal invasion and reactive migroglial proliferation. no targeted attack against specific cell populations was apparent (fig. 4d) . histopathologic evidence for a primary thoracic and cervical cord affection was not present. with the rare exception of certain serotype 2 pv strains, e.g. pv2(mef-1) and pv2(l), naturally occurring pv strains can only infect primates, and even pv2(mef-1) and pv2(l) are mouse neurovirulent only when artificially inoculated by intracerebral injection. the narrow host range of pv results from its stringent dependence on the express exactly the same cell tropism in the murine cns as they do in the primate cns unlikely and, hence, that mn pvs would cause the same specific disease syndrome (poliomyelitis) in normal mice as they do in primates. to shed some light on these complex problems we have compared the disease syndromes caused by a variety of different pv strains in hpvr-tg and normal mice. we have come to the conclusion that mn pv strains do not produce poliomyelitis in normal mice. the occurrence of poliomyelitis in hpvr-tg mice corroborates the function of the hpvr as a major determining factor in the pathogenesis of the peculiar histopathological and clinical features of this disease. 1°'11 poliomyelitis in tg mice followed a stereotypic course: initial flaccid pareses of the lower limbs, followed by cranial progression, involving respiratory function, and fatal outcome. in contrast, the clinical symptoms resulting from mn pv infections in normal swiss-webster-and icr-mice could not be explained by classical terms of the syndrome poliomyelitis. infection of normal mice with mn pv strains caused a diffuse encephalomyelitis with highly variable neurological symptoms appearing in random order, at topographically unrelated sites. mouse neuropathogenicity was shared by several serotype 2 field isolates, the mouse adapted attenuated strain pv2(w2), the pvi(m) derivative pvi(ls-a), and pvi(m) with a mutation in residue 54 of capsid protein vpi. interestingly, the type 2 pv field isolates pv2(mef-1) and pv2(ind), have been reported to be mn without a lengthy process of adaptation, whereas other type 2 [pv2(l)] and type 1 strains [pvi(ls-a)] were passaged in the rodent cns before they acquired the mn phenotype. mn type 1 or type 3 pv field isolates have not been described. the molecular basis underlying this peculiar property of type 2 pv strains is not understood. earlier reports stressed the similarity between primate poliomyelitis and encephalomyelitis caused by pv2(l) in normal mice. 16 comparative studies at that time were impeded by the lack of a murine model of hpvr-mediated poliomyelitis. viral antigen was shown to be expressed in spinal anterior horn motor neurons, ~8 but in situ hybridization revealed the presence of viral rna in cells in posterior portions of the spinal cord as well as the white matter. "s previous analyses of pv neurovirulence using mn strains were based on the assumption of a similar pathogenesis of mn pv infections in wt mice and in primates. one parameter to assess the potential of viral neurovirulence is the ldso value, and in earlier studies, animals showing evidence of neurological functional impairment were generally killed without further histopathological analysis (see for example, ref. 17) . our results suggest that the expression of the mn phenotype of pv strains in mice should not be compared to the expression of pv neurovirulence in primates, the normal host. indeed, it appears that the expression of a mn phenotype in wt mice can result from very different genetic changes in pv strains, and that each genetic change can produce different syndromes. this is apparent not only from various type 2 mn strains, but also from the type 1 mn strain pvi(ls-a) [a derivative of pvi(m) whose genotype has been recently elucidated38]. histopathological changes within the cns should therefore be monitored when murine infections with mn pv strains are studied. a major determinant for the mn phenotype of pv2(l) is the bc-ioop of vp1 ~7 a surface protrusion of about 10 amino acids located at the apex of the poliovirion 46 that functions as a neutralization antigenic site. 47 exchange of the vp1 bc-ioop of the mouse-inert pvi(m) with the bc-ioop of pv2(l) produces the mn phenotype, ~8' 19 an observation that prompted speculation that the vp1 bc-ioop is involved in the recognition of a putative mouse receptor. no evidence for this hypothesis has been obtained as yet. strain pvi(ls-a), a mn derivative of pvi(m), accumulated 54 point mutations during passage in non-human tissue, of which 10 mutations led to amino acid exchanges in the capsid region28 these capsid mutations, however, were insufficient to produce the mn phenotype. instead, the mutations in capsid protein vp1 plus, surprisingly, five mutations in the coding region of the non-structural protein 2a "r°, a proteinase, produced mouse neurovirulence. the syndrome pv1 (ls-a) ir~duced in normal mice, however is distinct from the encephalomyelitis caused by type 2 pv strains. a pathological entity different from those observed with all other mn poliovirus strains, wes seen with pv1(vp1-54), a virus that we constructed according to a previous report. 21 pv1(vp1-54) is a mn derivative of pvi(m) that carries only a single amino acid exchange in capsid protein vp1 (p1054s). the mutation, located at an interpentameric interface inside the capsid, was suggested to destabilize the virion in the mouse cns, but the neurological syndrome caused by infection with pv1(vp1-54) was not histopathologically characterized. 21 infection of mice with pv1(vp1-54) led to neurological damage only after intracerebral inoculation of excess viral antigen. the poorly defined histopathological features of cns involvement lacked characteristics of specificity observed in hpvr-mediated poliomyelitis. the genotypic differences between mn pv strains and the clinical syndromes they cause, which differ from hpvr-mediated poliomyelitis, challenge the hypothesis of common determinants of a mn phenotype. rather, it appears that a multitude of non-related genetic elements affect this phenotypic marker in various ways. as indicated before, the nature of the receptor(s) used by the mn pv strains in the mouse cns remains to be determined. available data suggest that the mouse homologue to the hpvr does not serve as surrogate for the mn pv strains. 13 it is more likely that the mn pv strains enter neuronal tissue via cell-surface protein(s) unrelated to hpvr. if so, it is not surprising that the syndromes produced by these viral strains are distinct from poliomyelitis. in recent years picornaviruses other than poliovirus have been implicated as causative agents of neurological disease. these include enterovirus (ev) 70, 48 the etiologic agent of acute hemorrhagic conjunctivitis, or ev 71. 49 however, it has also been reported that the encephalomyelitis caused by the newly emerging human pathogen ev 71 did not always resemble poliomyelitis. s° the evolution of enterovirus strains with new neuropathogenic properties distinct from previously non-neuropathogenic ancestors might be due to adaptation to new receptor entities. the mouse-neurotropic pv variants with altered cell tropism constitute a precedent for the emergence of non-poliomyelitic picornaviral cns disease. we thank a. nomoto for the generous gift of the hpvr-tg mouse strain used in this study and b. jubelt and o. kew for kindly providing pv type 2 strains. we are grateful to p. coyle for critical review of this manuscript. we thank n. peress for helpful discussion and d. colflesh for help with microscopic imaging. this work was supported in part by nci grant ca28146, and nih grants ai15122 and ai32100. m.g. is a recipient of a grant from the stipendienprogramm infektionsforschung, heidelberg, germany. poliovirus type 1 enters the human host through intestinal m cells emerging concept of poliomyelitis infection poliovirus crystals within the endoplasmic reticulum of endothelial and mononuclear cells in the monkey spinal cord onuf's motoneuron is resistant to poiiovirus the poliovirus receptor protein is produced both as membrane-bound and secreted forms cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily the poliovirus receptors molecular characterization of the cellular receptor for poliovirus transgenic mice susceptible to poliovirus transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis a second gene for the african green monkey poliovirus receptor that has no putative n-glycosylation site in the functional n-terminal immunoglobulin-like domain molecular cloning and expression of a murine homolog of the human poliovirus receptor gene the experimental transmission of poliomyelitis to the eastern cotton rat, sigmodon hispidus hispidus successful transfer of the lansing strain of poliomyelitis virus from the cotton rat to the white mouse pathogenesis of human poliovirus infection in mice. i. clinical and pathological studies mapping of sequences required for mouse neurovirulence of poliovirus type 2 lansing engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site i molecular characterization of mouse-virulent poliovirus type 1 mahoney mutants: involvement of residues of polypeptides vp1 and vp2 located on the inner surface of the capsid protein shell host range determinants located on the interior of the poliovirus capsid localization of genomic regions specific for the attenuated, mouse-adapted poliovirus type 2 strain w-2 genetics of poliovirus molecular basis of sindbis virus neurovirulence in mice sindbis virus mutations which coordinately affect glycoprotein processing, penetration, and virulence in mice two mutations in the envelope glycoprotein e2 of semliki forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice genetic determinants of dengue type 4 virus neurovirulence for mice glycosylation of neuraminidase determines the neurovirulence of influenza a/wsn/33 virus rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site iii of the glycoprotein physical mapping of the paralysis-inducing determinant of a wild mouse ecotropic neurotropic virus the v5a13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type 4 is neuroattenuated by its reduced rate of spread in the central nervous system hemagglutinin variants of reovirus type 3 have altered central nervous system tropism pathogenesis of early and late disease in mice infected with theiler's virus, using intratypic recombinant gdvii/da viruses retrovirus-induced murine motor neuron disease: mapping the determinant of spongiform degeneration within the envelope gene molecular basis of viral neurotropism isolation of a non-neurotropic variant of type 1 poliomyelitis virus mouse-neurovirulence determinants of poliovirus type 1 strain ls-a map to the coding regions of capsid protein vp1 and proteinase 2~ pr° studies on rodent adapted poliomyelitis virus. io cerebral resistance induced in the rhesus monkey transmission to rodents of lansing type poliomyelitis virus originating in the middle east van der ploeg m. in situ hybridization of dna sequences in human metaphase chromosomes visualized by an indirect fluorescent immunocytochemical procedure manual of histological staining methods ofthe american armed forces institute of pathology poliovirus antigenic hybrids simultaneously expressing antigenic determinants from all three serotypes poliovirus infection of cyclophosphamide-treated mice results in persistence and late paralysis: i. clinical, pathologic, and immunologic studies molecular pathogenesis of type 2 poliovirus in mice the three-dimensional structure of poliovirus at 2.9 ,a, resolution antigenic structure of picornaviruses radiculomyelitis following acute haemorrhagic conjunctivitis an apparently new enterovirus isolated from patients with disease of the central nervous system enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis key: cord-007094-ur9sz21s authors: mahabir, esther; bauer, beth; schmidt, jörg title: rodent and germplasm trafficking: risks of microbial contamination in a high-tech biomedical world date: 2008-01-01 journal: ilar j doi: 10.1093/ilar.49.3.347 sha: doc_id: 7094 cord_uid: ur9sz21s high-tech biomedical advances have led to increases both in the number of mice used for research and in exchanges of mice and/or their tissues between institutions. the latter are associated with the risk of dissemination of infectious agents. because of the lack of international standardization of health surveillance programs, health certificates for imported rodents may be informative but may not address the needs of the importing facility. preservation of mouse germ-plasm is achieved by cryopreservation of spermatozoa, embryos, or ovaries, and embryonic stem cells are used for the production of genetically engineered mice. after embryo transfer, recipients and rederived pups that test negative in microbiological screening for relevant microorganisms are released into full barrier holding areas. however, current research shows that embryos may also transmit microorganisms, especially viruses, to the recipient mice. in this article, we discuss regulations and practical issues in the shipping of live mice and mouse tissues, including spermatozoa, embryos, ovaries, and embryonic stem cells, and review work on microbial contamination of these biological materials. in addition, we present ways to reduce the risk of transmission of pathogens to mice under routine conditions. k nowledge of the prevalence, replication, and persistence of pathogens in a mouse facility aids both in assessments of the risk of transmission to other mice and mouse facilities and in the development of suitable management strategies to eliminate such risks. but there is a lack of current, comprehensive information on the prevalence of bacteria and parasites in mice in europe (for detailed information on us prevalence of these and murine viruses see carty 2008) . with respect to murine viruses, a summary of data from the past decade shows that the most prevalent in the united states (carty 2008; livingston and riley 2003) and europe (schoondermark-van de ven et al. 2006 ) are mouse hepatitis virus (mhv 1 ), parvoviruses, mouse rotavirus, theiler's murine encephalomyelitis virus (tmev 1 ), reovirus type 3 (reo 3), sendai virus, and mouse adenovirus (madv) (fl + k87). the report on european prevalence (schoondermark-van de ven et al. 2006) showed that the main viruses of concern there are mhv (12%), parvoviruses (8.8%), mouse rotavirus (3.7%), tmev (2.2%), reo 3 (0.6%), pneumonia virus of mice (pvm, 0.2%), sendai virus (0.2%), and polyoma (0.1%). the same report noted that viruses such as lymphocytic choriomeningitis virus (lcmv), mouse k virus, ectromelia virus, madv, and mouse thymic virus (mtv) have not been detected in europe in the last decade. these data are based on serological analysis of 80% of samples obtained between 2000 and 2003 from more than 100 different institutions including universities, research centers, breeding companies, and industry in the netherlands (45%), france (35%), belgium (7%), and other european countries (13%, mainly germany and switzerland). since the discovery of murine norovirus (mnv 1 ) in 2003 (karst et al. 2003) , its prevalence is reported to be 22.1% from 12,639 mouse serum samples collected in the united states and canada in 2003 (hsu et al. 2005) . perdue and colleagues (2007) reported a prevalence ranging from 2% to 83% in sentinel mice from five us mouse facilities. in some german mouse facilities, mnv had a prevalence of 60% (nicklas et al. 2006) , 64.3% (müller et al. 2007) , and 0% to 69%, depending on the type of mouse holding area (mahabir et al. 2007b) . some viruses, such as mhv, mouse rotavirus, and sendai virus, are shed for only a short period of time, whereas ectromelia virus and pvm are shed for a moderate length of time, and other viruses such as lcmv, lactate dehydroge-nase-elevating virus (ldhv), murine cytomegalovirus (mcmv), minute virus of mice (mvm 1 ), mouse parvovirus (mpv 1 ), tmev, and mtv persist for longer periods of time (compton and riley 2001) . a comprehensive list of viruses and their target tissues is available in compton and riley (2001) . transportation of live mice and mouse cells and tissues from one institution to another is crucial to biomedical research in the international community. for the benefit of the mice, it is important to thoroughly plan such transportation before making shipping decisions. major proactive points of consideration include the observance of national legislation of all aspects of genetic technology and biosafety, international shipping regulations, packaging requirements, and consultations with and requirements of the exporting and importing institutions. us guidelines have recently been published for the transportation of laboratory animals (nrc 2006) , and european guidelines are summarized in appendix a of the european convention for the protection of vertebrate animals used for experimental and other scientific purposes (ets no. 123 ; http://conventions.coe.int). the uk laboratory animal science association (lasa) also has published guidance on the transport of laboratory animals (swallow et al. 2005) . for shipments of live mice, specialized courier companies provide professional and comprehensive services. they are experienced in global logistics as well as country-and species-specific requirements and regulatory documents and concerns. in addition to importing/exporting country requirements, the international air transport association (iata) regulations should be followed when packing and preparing live animals for air transport (iata 2007) . packages for any kind of animal transport should be designed to prevent the animals' escape, exclude the entry of microorganisms, allow visual inspection of the animals without compromising their microbiological status, and allow external disinfection of the package on arrival at the receiving facility (lee et al. 2007 ). in addition, the following measures are indispensable to ensure minimal transit time and facilitate the animals' arrival in good health at their final destination: • a recent health report by a veterinarian of the exporting institution's animal colony including a 1 1 ⁄2-year history of the colony's health status, • packaging in adequate transport boxes, with bedding, food, and water, • safety and stress reduction measures for the animals, and • early contact with the shipping corporation or carrier. for regional shipping, ground transport may pose the least stress as it entails minimal handling of the shipping container and a single environment during transportation. ground transportation should be carried out by licensed personnel in climate-controlled vehicles using the shortest routes. regional shipments by ground transportation normally involve one licensed carrier, whereas long distance or transcontinental shipping generally requires coordination of both ground transport and air freight and may be performed by multiple subcontractors, resulting in longer transit times and more handling, both of which may be more stressful for the mice (nrc 2006) . for the animals' comfort, it is particularly important to ensure suitable environmental conditions throughout the shipping. further to the stress involved in any shipment, longer journeys (particularly international or transcontinental journeys) also affect their diurnal rhythm. mice that experience shifts in light/dark cycles require up to 2 weeks to normalize (weinert et al. 1994 ) and thus require a longer period of overall adaptation and restoration, ranging from 1 to 7 days to several weeks or even months, depending on the stress to which they were exposed during shipment (obernier and baldwin 2006) . the us department of agriculture (usda) guidelines for the importation of live laboratory animals set forth regulations on international transport of laboratory mice and their tissue to the united states (http://www.aphis.usda.gov/ vs/ncie/ilive-mam.html). other us regulatory agencies that may have oversight of research animal importation or shipment are the centers for disease control and prevention (cdc), the department of transportation (dot), and the us fish and wildlife service. in general, research mice are exempt from these regulations provided that they are not carrying infectious diseases and are from the genus mus musculus. imports to countries of the european union (eu) require the permission of the local government. to ensure us customs clearance, the following documentation should accompany the shipment: a pro forma invoice stating that the shipment contains "live laboratory mice" and listing the species (mus musculus), number, gender, age, type of package, and names and addresses of the exporting and importing institutions. the invoice should also include a statement that the animals do not meet the criteria for an endangered species nor pose a risk to human health. in addition, a health certificate is required with, if appropriate, a veterinarian's statement that "animals are healthy and have not been exposed to or inoculated with any livestock or poultry disease agents exotic to the united states" and that "the animals have not originated from a facility where work with exotic disease agents affecting livestock or poultry is conducted." some countries may have additional exportation documents that must be completed before the animals leave the country of origin, and commercial airlines also may ask for additional documents, which should be applied for and prepared well ahead of the time of shipment. for live mice and the cells and tissues derived from them some institutions require material transfer agreements (mtas) or, if the material is transferred on a collaborative basis, a short plan of the research project before shipment. exportation of live mice from the united states or the european union is not regulated but the shipment must conform to iata regulations and the destination country's regulations. because each country has its own regulations and requirements it is highly advisable to use a customs broker and/or a courier company knowledgeable in live animal shipping for international shipments of live mice. cryopreservation of embryos (glenister et al. 1990; shaw and nagakata 2002) and spermatozoa has become a routine mechanism to preserve mouse models and to transfer single mice or colonies without the welfare concerns that arise in the shipping of live animals. additional advantages to shipping cryopreserved germplasm (spermatozoa, oocytes, and resulting embryos) are the suitability of cryopreserved materials for storage and use when needed and for preliminary testing of sample aliquots to determine microbiological status before use. many institutions (including both of ours) have established transgenic animal cores that can assist in the recovery of cryopreserved materials. but if this expertise is not available at an investigator's institution there are established regional repositories in countries around the world that can assist in the recovery of cryopreserved materials; a number of these repositories have joined together to form the federation of international mouse resources (fimre; table 1 ). many members are working together to assist the transfer of models across continents from one repository to another to facilitate their use by individual investigators (davisson 2006 ). these cooperative agreements will enable investigators to obtain recovered live mouse models from their local regional repository even if the model is cryopreserved and held in another country. cryopreserved oocytes, embryos, spermatozoa, and ovaries are typically shipped in a "dry shipper" in which the liquid nitrogen is absorbed in the shipper liner. these containers usually maintain an ultralow temperature for 7 to 21 days, depending on the model of shipper. in compliance with iata regulations, documentation of an inversion test should be included to demonstrate that no free liquid nitrogen is present in the shipper. cell lines, including murine embryonic stem (es 1 ) cells, and tissues are usually shipped on dry ice, which is considered a hazardous material and has special packaging and labeling requirements (set forth in the iata regulations). alternatively, for short-term (less than 24 hours) shipping, embryos can be transported in holding medium in cryopreservation straws at room temperature. likewise, murine es cells can be sent directly in the culture flask at room temperature. the importation paperwork for cryopreserved laboratory mouse tissues and cell lines is similar to that required for live animal importation to the united states (i.e., a pro forma invoice and declaration statements). in addition, any cells or tissues grown in vitro before shipment must be declared free of animal cell culture-derived products of livestock origin, particularly fetal or adult bovine serum. shipments of cell lines or tissues that contain a material of livestock origin such as fetal bovine serum require a usda importation permit. above all, proactive communication between the exporting institution, carrier, veterinary and legal authorities, regulatory agencies, and importing institution is of paramount importance for safe and successful deliveries. the oocyte and preimplantation embryo are surrounded by a zona pellucida (zp 1 ), essentially a sulphated glycoprotein gel of the order of 2% to 6% (weight/volume) (green 1997) that protects the embryo from its environment (epifano and dean 1994; wasserman et al. 1996) . after removal of the surrounding cumulus cells, the zp is composed of a complex fibrous network interspersed with numerous pores that are largest at the outer surface and decrease in size centripetally. in viremic mice the reproductive tract may be susceptible to infectious pathogens either locally or systemically and viruses can spread from there to various tissues and organs. in mouse germplasm cells, pathogens may (1) be present in the oocyte at fertilization and replicate in the embryo, fetus, or pups; (2) be present in or attached to the spermatozoa and carried into the oocyte at fertilization; (3) traverse, become embedded in, or adhere to the zp; or (4) be present in the embryo after damage to the zp during handling or manipulation such as assisted reproductive technologies (arts). oocytes and embryos with an intact zp subjected to vigorous pipetting may rupture, and are further at risk when the zp is partially disrupted from arts such as intracytoplasmic sperm injection (icsi), subzonal injection (suzi), microinjection of oocytes, and blastocyst injection. there are typically four main experimental designs to determine the risk of pathogen transmission by in vivoderived embryos (hare 1990 ): • in vitro-in vitro: embryos from clean donors are exposed to the pathogen in vitro and assayed in vitro • in vitro-in vivo: embryos from clean donors are exposed to the pathogen in vitro and transferred to seronegative recipients, which are screened for the development of antibodies to the pathogen • in vivo-in vitro: embryos are collected from infected and/or seropositive donors and assayed in vitro • in vivo-in vivo: embryos are collected from infected and/or seropositive donors and transferred to seronegative recipients, which are screened for the development of antibodies to the pathogen. in efforts to gain more knowledge about the epidemiological potential of current and emerging arts, the main difficulty of working with an in vivo system is the selection of mice that are carrying the virus as they may be seropositive but not necessarily virus positive. many of the wellknown murine pathogens are shed for a short period of time and diagnosis of virus-positive mice depends heavily on environmental monitoring. in some cases, fecal samples are adequate for antemortem determination of the microbiological status (e.g., for parvoviruses, mnv, mhv, mouse rotavirus, reo 3, and tmev). in order to gain as much information as possible about the biological interaction of the germplasm with pathogens it is generally speedier to perform experimental work that more or less simulates in vivo conditions. however, experimental designs often include infections with high viral doses to demonstrate the "worst case" scenario. in the in vitro system, pathogens may be present either in the collecting media or in or on the gametes or embryos themselves. in vitro fertilization (ivf 1 ) with infected spermatozoa and/or oocytes is an effective method to determine the risks posed by gametes or in vitro-derived embryos. the resulting embryos are analyzed in vitro by polymerase chain reaction (pcr) and/or are transferred to seronegative recipients that are monitored for seroconversion. it is also useful to screen their pups for the presence of the virus by pcr or serological analysis. a further step in determining the epidemiological potential of such germplasm is to monitor the collecting and washing fluids for the presence of the infectious agent, usually by pcr and virus isolation in cell culture. embryos are usually kept in short-term culture (e.g., for 1 day) to prevent low levels of viruses from replicating to such an extent that they pose a real threat. ivf with fresh samples of mouse spermatozoa resulted in live offspring as early as 1969 (mukherjee and cohen 1970) , and cryopreservation of sperm with subsequent ivf and recovery of live mice started in the early 1990s (yokoyama et al. 1990 ). advances in cryopreservation of spermatozoa, ivf, icsi, and embryo culture techniques make sperm cryopreservation a reliable means for preserving mouse strains and lines. few studies have examined the possibility of transmission of murine pathogens by spermatozoa. dutko and oldstone (1979) found that murine cytomegalovirus (mcmv) replicated in germ cells of the testes. baskar and colleagues (1986) confirmed this observation and found viral particles in spermatids; however, they did not detect any decreased fertility in these male mice and embryos developed normally to the blastocyst stage. tebourbi and colleagues (2002) examined whether mcmv microinjected directly into zygote-stage embryos (simulating icsi conditions) would result in infected live pups; they were able to infect the embryos, and the virus was present up until the blastocyst stage but disappeared in fetuses and pups. retroviruses have been demonstrated to replicate in epididymal sperm epithelium and associate with spermatozoa as they move through the epididymis, suggesting that venereal transmission is possible (kiessling et al. 1989) . recent studies have focused on murine pathogens that are prevalent in mouse colonies. raspa (2004, 2006) examined testes and epididymis for the presence of helicobacter typhlonius and mhv, both of which were present transiently. in these two studies, spermatozoa collected from males with testes that tested positive for either h. typhlonius or mhv failed to produce positive live pups after ivf and embryo transfer (et 1 ). peters and colleagues (2006) demonstrated that standard washing procedures in the ivf and embryo culture system are sufficient to eliminate mhv transmission when spermatozoa and oocytes are incubated with high levels of virus. mpv was recently found in spermatozoal samples (agca et al. 2007 ), but it remains to be determined if embryos generated using mpvcontaminated sperm result in infected offspring. in a recent study (mahabir et al. 2007a) we demonstrated that mvmexposed in vivo-derived embryos washed ten times are still capable of transmitting the virus to recipient female mice. however, we also demonstrated that the ivf-et procedure with mvm-contaminated spermatozoa resulted in the production of virus-free seronegative pups (mahabir et al. 2008) . additional studies are needed to determine whether other prevalent viruses such as mnv, rotavirus, or tmev can be transmitted by spermatozoa. methods to remove pathogens from mouse spermatozoa have not been widely explored but one study did demonstrate that percoll separation of spermatozoa was not sufficient to remove mpv (agca et al. 2007 ). pathogens can be transmitted by et to recipients by contaminated personnel, instruments, or equipment, and transport or wash medium, as well as in or on the embryo itself, although an intact zp is usually regarded as a mechanism for preventing pathogen transmission during et. agents that infect embryos could be viruses, bacteria, fungi, mycoplasmas, or parasites, but because of their size viruses are the most likely pathogens to be transmitted during et. oocytes are typically collected and immediately used in icsi or ivf with cryopreserved sperm, although cryopreservation of oocytes is possible and becoming more common (endoh et al. 2007) . females are superovulated and the cumulus oocyte complexes (cocs) can either be used as intact clutches for ivf or treated with hyaluronidase to remove the cumulus cells for icsi. wild-type oocytes are usually collected from female donors held in known pathogen-free colonies and are coincubated with spermatozoa containing the mutation or gene of interest. however, in rare instances, oocytes or ovarian tissue (gunasena et al. 1997; hani et al. 2006 ) may be used as the primary means to recover mutant or transgenic mouse lines and the risk posed by pathogens may be higher in these cases. ovarian tissue cryopreservation is particularly useful for mouse models in which male infertility occurs (such as the x-autosome translocation mouse lines) or for rescue of lines in which only female animals are available (disteche et al. 1979; takahashi et al. 2001) . ovarian tissue transplantation carries an increased risk compared to gametes and embryos because it is a complex organ with multiple cell types, and tissue from viremic donors is likely to transfer infectious organisms. retroviral contamination of donor tissue by a recipient female has occurred with transmission to recovered offspring (lock et al. 1988) , demonstrating that genetic alteration via retroviruses can occur in offspring as a consequence of either the donor or recipient female. ovarian tissue from mice naturally infected with mhv has been shown to transmit mhv to the recipient females and offspring (scavizzi and raspa 2004) . in contrast, h. typhlonius-infected ovarian tissue transplantation did not result in infection of the recipient female or offspring (scavizzi and raspa 2006) . researchers have found mpv in both ovarian tissue and oocytes (agca et al. 2007 ), but it is unknown whether transplantation of infected ovarian tissue results in infection of recipient females and their offspring. very small viruses belonging to the picornaviridae family-for example, mengo virus, which is 27 to 28 nm (gwatkin 1963 (gwatkin , 1966 (gwatkin , 1967 , and the coxsackie b-4 virus, which is 30 nm (heggie and gaddis 1979)-have been shown to traverse the zp of murine embryos. investigators have documented lcmv in mouse oocytes and embryos, providing evidence of transmission via the oocyte (mims 1966) , and sendai virus (100 to 200 nm) in the murine zp (lavilla-apelo et al. 1991 , 1992 tuffrey et al. 1972) . one study reported infection with polyoma in the trophectoderm but not in the inner cell mass of murine embryos (abramczuck et al. 1978 ). we include es cells in this overview as they are fundamental to the production of genetically engineered mice. during blastocyst injection, besides feeder cells and the blastocysts themselves, the es cells may harbor infectious pathogens. the exchange of es cells between laboratories worldwide may increase the risk of transmitting mouse infectious agents as es cells are often not screened for viruses, and viral contamination and infection are not readily detectable by cell morphology. although a survey of 46 es cell lines did not show the presence of murine infectious agents (nicklas and weiss 2000) , two studies showed that murine es cells infected with mhv-2 (kyuwa 1997; okumura et al. 1996) and mhv-a59 (kyuwa 1997) grew in vitro without showing either cytopathic effects or signs of differentiation okumura et al. 1996) . in addition to mhv, parvovirus and mycoplasma contamination has been found in es cells submitted to diagnostic laboratories for pcr testing (bb personal communication with lela riley, university of kansas, august 2007). the risk of es cell contamination by feeder cells and embryos can be reduced by obtaining them from mice that are free of relevant pathogens. washing protocols for embryos remove the viruses from the germplasm to a level below an infectious and/or immunogenic dose. although there are well-established washing protocols for the embryos of some domestic animals such as cattle and pigs (stringfellow and seidel 1998), none exist for murine embryos. some major contributing factors to reducing the risk of pathogen transmission during washing of the embryos include working under sterile conditions, repeated testing and use of pathogen-free reagents, use of a new pipette between washing drops, dilution of the washing fluids in a 1:100 range, and removal of zp-less or damaged embryos before transfer to suitable recipient mice. because of the zp's porous nature and depending on the virus size, even after washing there may be a risk of viruses nesting in the zp micropores. for example, reports show that trysin treatment of embryos has not been successful in removing sendai virus even after 12 washings (lavilla-apelo et al. 1991) . experimental infection with mvm and washing of embryos 10 times with medium revealed transmission of the virus by in vivo-derived embryos (mahabir et al. 2007a) but not by embryos produced by ivf of oocytes with mvm-coincubated spermatozoa (mahabir et al. 2008) . this was an unexpected result that may be due to differences in the characteristics of the embryos themselves. with respect to in vitro-derived embryos, the cumulus cells surrounding the oocytes may have adsorbed some of the virus thereby reducing the quantity left for entrapment in the micropores. furthermore, the cumulus cells block entry of the virus as micropores are present only after removal of these cells. removal of the cumulus cells and washing of oocytes have been shown to eliminate mpv contamination in mouse oocytes (agca et al. 2007) , and this approach should be sufficient to remove the majority of viral contaminants when they are not present in the oocyte itself. embryo transfer recipients in rederivation programs should be held in individually ventilated cages (ivcs 1 ) until testing shows that they are free of all unwanted microorganisms, including those listed in appendix 3 of the federation of laboratory animal science associations (felasa) recommendations (nicklas et al. 2002) . there should be a minimum of 6 weeks between the et and microbiological examination of the recipients, coinciding with weaning of the offspring at 3 or 4 weeks of age (wild-type littermate pups should not undergo health monitoring until they are at least 6 weeks old). some mouse facilities screen recipients before releasing pups into full barrier areas and, for subsequent screening of the pups themselves, use sentinel mice or random samples from the colony. other mouse facilities screen the recipient mother and at least one pup from each litter (usually a wild-type pup) before releasing rederived pups into full barrier areas. if wild-type pups are not available for screening, it may be preferable to use cohoused wild-type sentinels placed at the time of weaning rather than relying on test results of genetically altered mice whose immune status is usually unknown. a number of reports have shown that in vitro-derived 2-cell embryos (peters et al. 2006 ) and in vivo-derived 1-cell (van keuren and saunders 2004) and 2-cell embryos (carthew et al. 1983 (carthew et al. , 1985 mahabir et al. 2007a; reetz et al. 1988; suzuki et al. 1996) did not pose a risk of transferring mhv during embryo transfer. in addition, embryos from mice from holding areas that were positive for madv, mouse rotavirus, mpv, or tmev led to rederivation of the mouse lines (van keuren and saunders 2004) . the efficacy of embryo transfer for rederiving mice is reported to be high. due to short periods of virus shedding, donor mice may be seropositive but may not be virus carriers, thus leading to the production of virus-free seronegative pups. laboratories that deal with frequent imports of mice and biological materials should establish and implement effective measures to reduce the risk of transmitting infectious agents to staff or existing animal colonies at the importing institution. even collection of germplasm under sterile conditions does not prevent dissemination of infectious agents from colonies where they are prevalent. although health certificates that precede or accompany an import colony provide information on the animals' health status and a 1-to 1 1 ⁄2-year history of health data, because of the interval between collection and analysis of the samples and preparation of the health report, both mice and biological materials should be considered carriers of microorganisms unless analyses prove the absence of contaminants. imported mice should therefore be kept in quarantine pending reevaluation of their health status and biological materials should be carefully screened before use. to enable facility management to obtain sound information on imported animals' current health status at any given time, each facility should design and implement health monitoring programs based on its needs. these programs use randomly sampled mice, contact sentinels, or sentinels exposed to soiled bedding. some protocols also include monitoring of exhaust air for pathogens not transferred by soiled bedding (brielmeier et al. 2006; compton et al. 2004) . in recent years, there has been an increase in the use of ivc rack systems in laboratory rodent facilities. recent data (brielmeier et al. 2006) show that ivcs provide complete biocontainment when infected and noninfected mice are kept in separate cages in the same ivc rack provided that cage bedding is changed in class ii laminar flow hoods or cage changing cabinets (cccs) and appropriate standard operating procedures (sops) are strictly observed. in a typical ivc rack, each cage receives high-efficiency particulate air (hepa)-filtered air. mice are kept under positive pressure to protect them from airborne infectious or other noxious particulate agents in the environment (clough et al. 1995; cunliffe-beamer and les 1983; lipman et al. 1993; lipman 1999) . similarly, the exhaust air from the cages is hepa-filtered before being returned to the room environment or to the heating, ventilation, and air conditioning (hvac) system. maintaining mice under negative pressure prevents dissemination of pathogens into the environment and minimizes (gordon et al. 2001; lipman 1999) or prevents transfer of infectious agents from cage to cage in an ivc rack or room, depending on the ivc rack model. for biocontainment purposes, ivcs are optimal for holding imported mouse colonies under quarantine pending the completion of adequate microbiological analyses. irrespective of the health report from the exporting institution, some facilities conduct routine prophylactic treatments of all imported and quarantined mice for pinworm and ectoparasites. others refuse import applications for mice infected with parasites and authorize such imports only if the mice have been successfully treated at the exporting institution before shipment. once the health status of an imported mouse colony is found compatible with that of the importing institution mice may be transferred from the quarantine area to an experimental unit and released for investigators' use. although ivcs meet a number of requirements for breeding and holding mice under specific pathogen-free (spf) conditions in experimental units, filter-top cages are an economical and suitable alternative. for core breeding units and long-term holding of laboratory mice under spf conditions, full barrier areas with a wet entry system or air shower and the use of ivcs have become an international standard. in general, these units do not allow access to investigators and mice are imported into the barrier only by et. trafficking of biological materials, including germplasm and es cells, should meet the same hygienic standards as those required for importing laboratory mice. care should be taken to ensure that collection and/or processing of cells and tissues of the germplasm are performed under sterile conditions. to determine microbiological status-for example, if investigators suspect the presence of a particular agent or wish to screen for a limited number of agents-it may be useful to test aliquots of biological materials, collection media, or washing drops by molecular biological analysis. well-established sensitive pcr techniques are available for determining the microbiological status of murine biological materials in-house or by commercial laboratories. in addition, the mouse antibody production (map) test blank et al. 2004; bootz et al. 2003; livingston et al. 2004; mahabir et al. 2004 ) is also performed as antibodies to several viruses are detectable by standard serological analyses. for such tests, mice should be free of all felasa-listed microorganisms (as well as mnv) and held under conditions that prevent dissemination of infectious agents. taken together, health monitoring, evaluation of the risk of pathogen transmission by mouse and germplasm trafficking, and appropriate managerial strategies are fundamental components of a facility's quality assurance program. last but not least, the establishment and implementation of suitable quality assurance programs are based on the expertise of the facility's supervisory staff, who must have sufficient knowledge of and experience in laboratory animal science (nevalainen et al. 1999) . infection of mouse preimplantation embryos with simian virus 40 and polyoma virus detection of mouse parvovirus in mus musculus gametes, embryos, and ovarian tissues by polymerase chain reaction assay murine cytomegalovirus infection of mouse testes comparison of the mouse antibody production (map) assay and polymerase chain reaction (pcr) assays for the detection of viral contaminants virus pcr assay panels: an alternative to the mouse antibody production test comparison of the sensitivity of in vivo antibody production tests with in vitro pcr-based methods to detect infectious contamination of biological materials microbiological monitoring of laboratory mice and biocontainment in individually ventilated cages: a field study elimination of sendai (parainfluenza type 1) virus infection from mice by embryo transfer pathogenicity of mouse hepatitis virus for preimplantation mouse embryos opportunistic infections of mice and rats: jacoby and lindsey revisited a positive, individually ventilated caging system: a local barrier system to protect both animals and personnel detection of infectious agents in laboratory rodents: traditional and molecular techniques efficacy of three microbiological monitoring methods in a ventilated cage rack effectiveness of pressurized individually ventilated (piv) cages in reducing transmission of pneumonia virus of mice (pvm) (abstr) federation of international mouse resources: global networking of resource centers late replication in an xautosome translocation in the mouse: correlation with genetic inactivation and evidence for selective effects during embryogenesis murine cytomegalovirus infects spermatogenic cells the developmental ability of vitrified oocytes from different mouse strains assessed by parthenogenetic activation and intracytoplasmic sperm injection biology and structure of the zona pellucida: a target for immunocontraception genome cryopreservation: a valuable contribution to mammalian genetic research elimination of mouse allergens in the working environment: assessment of individually ventilated cage systems and ventilated cabinets in the containment of mouse allergens three-dimensional structure of the zona pellucida live births after autologous transplant of cryopreserved mouse ovaries effect of viruses on early mammalian development. i. action of mengo encephalitis virus on mouse ova cultivated in vitro effect of viruses on early mammalian development. iii. further studies concerning the interaction of mengo encephalitis virus with mouse ova passage of mengovirus through the zona pellucida of the mouse morula fertility of mice receiving vitrified adult mouse ovaries design and analysis of research on infectious disease transmission by embryos effects of viral exposure of the two-cell mouse embryo on cleavage and blastocyst formation in vitro development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase pcr assay to detect murine norovirus 1 infection in mice live animal regulations stat1-dependent innate immunity to a norwalk-like virus epididymis is a principal site of retrovirus expression in the mouse replication of murine coronaviruses in mouse embryonic stem cell lines in vitro characterization of embryonic stem-like cell lines derived from embryoid bodies the effectiveness of trypsin treatment to remove sendai virus adhering to the zona pellucida of mouse preimplantation embryos the effect of experimental infection of mouse preimplantation embryos with paramyxovirus sendai efficacy of disinfectants against mvm-and mnv-contaminated surfaces isolator rodent caging systems (state of the art): a critical view evaluation of isolator caging systems for protection of mice against challenge with mouse hepatitis virus diagnostic testing of mouse and rat colonies for infectious agents polymerase chain reaction (pcr) testing of biological materials for rodent pathogens as an alternative to the mouse antibody production (map) test. (abstract) 9th felasa symposium studies of the mechanism of spontaneous germline ecotropic provirus acquisition in mice mouse antibody production test: can we do without it? transmission of mouse minute virus (mvm) but not mouse hepatitis virus (mhv) following embryo transfer with experimentally exposed in vivo-derived embryos prevalence of mouse norovirus (mnv) in a large breeding and experimental mouse facility. (abstract) 10th felasa symposium production of virus-free seronegative pups from murine embryos arising from in vitro fertilization with mice minute virus-exposed spermatozoa immunofluorescence study of the carrier state and mechanism of vertical transmission in lymphocytic choriomeningitis virus infection in mice development of normal mice by in vitro fertilization genetic diversity and recombination of murine noroviruses in immunocompromised mice felasa guidelines for education of specialists in laboratory animal science (category d): report of the federation of laboratory animal science association's working group on education of specialists (category d) accepted by the felasa board of management survey of embryonic stem cells for murine infective agents recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units mouse norovirus (mnv): erste untersuchungsergebnisse (abstract) 44. gv-solas annual meeting guidelines for the humane transportation of research animals establishing an appropriate period of acclimatization following transportation of laboratory animals maintenance of pluripotency in mouse embryonic stem cells persistently infected with murine coronavirus naturally occurring murine norovirus infection in a large research institution risk assessment of mouse hepatitis virus infection via in vitro fertilization and embryo transfer by the use of zona-intact and laser-microdissected oocytes rederivation of inbred strains of mice by means of embryo transfer tissue distribution and duration of mouse hepatitis virus in naturally infected immunocompetent icr (cd-1) and immunodeficient athymic nude-nu mouse strains used for ovarian transplantation and in vitro fertilization helicobacter typhlonius was detected in the sex organs of three mouse strains but did not transmit vertically prevalence of naturally occurring viral infections, mycoplasma pulmonis and clostridium piliforme in laboratory rodents in western europe screened from cryopreservation of transgenic mouse lines manual of the international embryo transfer society rederivation of mice by means of in vitro fertilization and embryo transfer guidance on the transport of laboratory animals rescue of a transgenic mouse line by transplantation of a frozen-thawed ovary obtained postmortem failure to infect embryos after virus injection in mouse zygotes sendai (parainfluenza 1) infection of mouse eggs rederivation of transgenic and genetargeted mice by embryo transfer constructing the mammalian egg zona pellucida: some new pieces of an old puzzle resynchronization of the circadian corticosterone rhythm after a light/dark shift in juvenile and adult mice production of normal young following transfer of mouse embryos obtained by in vitro fertilization using cryopreserved spermatozoa key: cord-354325-r73datur authors: berger, mitchell; shankar, vidya; vafai, abbas title: therapeutic applications of monoclonal antibodies date: 2002-07-31 journal: the american journal of the medical sciences doi: 10.1097/00000441-200207000-00004 sha: doc_id: 354325 cord_uid: r73datur abstract researchers have sought therapeutic applications for monoclonal antibodies since their development in 1975. however, murine-derived monoclonal antibodies may cause an immunogenic response in human patients, reducing their therapeutic efficacy. chimeric and humanized antibodies have been developed that are less likely to provoke an immune reaction in human patients than are murine-derived antibodies. antibody fragments, bispecific antibodies, and antibodies produced through the use of phage display systems and genetically modified plants and animals may aid researchers in developing new uses for monoclonal antibodies in the treatment of disease. monoclonal antibodies may have a number of promising potential therapeutic applications in the treatment of asthma, autoimmune diseases, cancer, poisoning, septicemia, substance abuse, viral infections, and other diseases. i n 1975, kohler and milstein revolutionized the field of immunology by developing monoclonal antibodies (mabs). since that time, many mabs have been developed for use in diagnostic procedures and in immunotherapy. ever since it was observed that the therapeutic use of heterologous mabs elicited immunogenic responses in humans, significant research efforts have been devoted toward creating chimeric and humanized antibodies for use in human patients. major achievements have been in the production of mabs in transgenic plants and animals. the use of phage display libraries has created customized antibodies with defined affinity and specificity. this review describes how rodent, chimeric, and humanized antibodies have each been used, with varying degrees of success to treat cancer, septicemia, autoimmune disorders, and infectious diseases. we also describe here recent applications of antibody engineering, such as the use of bispecific antibodies and antibody fragments in immunotherapy. von behring and kitasato discovered in 1890 that the serum of vaccinated persons contained certain substances, which they termed "antibodies." in 1895, they treated diphtheria with an antiserum raised against the toxin. on the basis of research on tetanus toxin and trypanosome parasites, ehrlich proposed in 1900 the "side-chain theory" of antibody formation, which hypothesized that physiologically active substances, including toxins, attach to cell surface receptors that are produced in response to toxin-cell interactions and then ejected from the cells into the bloodstream, leading to circulating antibodies. 1, 2 not until the 1950s, however, did scientists' understanding of antibodies become sufficient to lay the foundation for the development of mabs. jerne 3 postulated in 1955 a theory of natural selection for antibody formation. animals vaccinated with an antigen were expected to produce several distinct antibodies against several epitopes of the antigen. frank macfarlane burnet subsequently refined and expanded jerne's theory. 4 burnet's "clonal selection theory," as it is generally known, postulates that cells specific for synthesizing 1 type of antibody are spontaneously generated due to random somatic mutations during the maturation of the immune system and that these cells proliferate when exposed to an antigen. at about the same time, porter isolated fragment antigen binding (fab) and fragment crystalline (fc) from proteolytically cleaved rabbit ␥-globulin. 5 until the 1960s, antibody-producing cells were difficult to maintain in culture, because they died after a few days. in addition, only polyclonal antibodies could be obtained. in 1964, littlefield 6 developed a way to isolate hybrid cells from 2 parent cell lines using the hypoxanthine-aminopterin-thymi-dine (hat) selection media. in 1975, khler and milstein 7 provided the most outstanding proof of the clonal selection theory from results of heterokaryons-cell hybrids formed by the fusion of normal and malignant cells. twenty-five years after kohler and milstein produced the first monoclonal antibodies, dramatic progress has been made in using antibodies for diagnostic purposes, but the uses of mabs to treat disease have-until recently-remained somewhat limited. 8, 9 however, as this review indicates, the potential of mabs to aid in the treatment of a wide range of diseases is now beginning to be realized. antibodies are y-shaped proteins composed of peptides called heavy and light chains, the ends of which vary from antibody to antibody. each combination of heavy and light chains binds to a particular antigenic site. these glycoprotein chains are folded into domains of about 110 amino acids that become twisted into the immunoglobulin (ig) fold and are stabilized by disulfide bonds. structurally, each ig molecule consists of 2 50-kd heavy chains and 2 25-kd light chains, linked by disulfide bonds. human immunoglobulins are divided into 5 classes or isotypes based on the amino acid composition of their heavy chains: ␣, ␦, ⑀, ␥, and , denoted iga, igd, ige, igg, and igm, respectively. there are 2 kinds of light chains, (k) and (l), which are common to all 5 classes. four subclasses of igg (igg1, igg2, igg3, and igg4) and 2 subclasses of iga (iga1 and iga2) exist, each with a distinct function. secretory iga exists in dimeric form held together by a j chain and is associated with a secretory component that helps it pass through the cell membrane. 10, 11 each chain has a constant domain to bind host effector molecule and a variable domain to bind to the target antigen. light chains have 1 variable (v l ) and 1 constant domain (c l ), whereas heavy chains have 1 variable (v h ) and either 3 (␣, ␦, and ␥ chains) or 4 constant domains (⑀ and heavy chains) depending upon the isotype class. each variable domain contains 3 regions known as "hypervariable loops," also known as complementarity-determining regions (cdrs), that identify the antigen. the other amino acids in the variable (fv) domain are known as framework residues and act as a scaffold to support the loops. the v l and the v h , the c h 1 and the c l , and the 2 c h 3 domains are paired; the 2 c h 2 domains have carbohydrate side chains attached to them and are not paired. the folded constant domains may be homologous among different species, allowing hybrid domains (eg, mouse-human) to be produced. the variable domain confers specificity and affinity. the cdr amino acid sequences are extremely variable and play a large role in interac-tion with the targeted antigen. the chain type, region, and distance from the amino terminus characterize the domains. thus, c h 2 domain refers to the second constant domain of the heavy chain. upon digestion with papain, the antibody molecule is cleaved on the amino-terminal side of the disulfide bridges into 2 identical fabs and an fc fragment, whereas pepsin cleaves the antibody on the carboxy-terminal side of the disulfide bridges into 1 f(ab') 2 fragment containing both the arms of the antibody, and many small pieces of the fc fragment. currently, the following are available: whole antibodies, enzymatically produced 50-kd fab fragments, engineered 25-kd single-chain fv (scfv) antibodies consisting of the v h and v l connected by a flexible peptide linker, diabodies (noncovalent dimers of scfv), minibodies (scfv-c h 3 dimers), and heavy chain iggs found in species of the camelidae family, which are devoid of light chains and are referred to as v hh . the first mab described by kohler and milstein was created by the fusion of murine myeloma cells with murine-antibody-secreting lymphocytes. 7, 8 myeloma cells are immortalized b lymphocytes capable of secreting homogeneous antibodies. the immortal myeloma cell lacks the enzyme hypoxanthine guanosine phosphoribosyl transferase (hgprt) and is sensitive to the hat media. however, a hybrid cell known as a hybridoma, generated by the fusion of myeloma cell and an antibody-producing b cell, can survive in the hat media. the spleen b lymphocytes contribute the hgprt gene to the hybrid cell and, hence, unfused myeloma cells and spleen cells die in the hat media. the conventional method of generating mabs is the hybridoma technology in which spleen cells from immunized mice are fused with murine myeloma cells. whereas the myeloma cell imparts immortality to the hybridoma allowing cells to be cultivated indefinitely, the immune spleen b-cell confers antigen specificity. because each hybridoma is derived from a single cell, the cells within a hybridoma cell line are identical and make the same antibody molecule with same antigen-binding site and isotype, hence it is called a mab. among several excellent reviews that detail mab production with hybridomas is a recent review by dean and shepherd. 12 initial attempts to bypass the mouse to make human mabs involved fusion of human immune spleen lymphocytes with nonsecreting human myeloma partners to obtain hybrid cells that continually secrete a specific antibody. however, poor fusion of human myelomas, unsatisfactory performance of the hybrid cells, and the difficulty in accessing immune lymphocytes have prevented success. although heteromyelomas-which are fusions of hu-man and mouse myelomas-work better, these hybrids are usually unstable. attempts to use mouse myeloma cells to create hybrids and derive human mabs led to the loss of human chromosomes and the inability to make human igs. 13 unfortunately, in vitro immunization is limited by its inability to produce a secondary response and by the absence of the affinity maturation process that occurs in vivo. 13 affinity maturation process is a complex phenomenon, a consequence of intense bcell proliferation, somatic hypermutation of ig variable domain genes, and selection for b cells with high-affinity antigen binding, all occurring in the specialized microenvironment of the germinal center within the lymphoid tissue. thus, the search for an ideal fusion partner for generating human mabs has been difficult, which is why the epstein-barr virus (ebv) technique for immortalization of b lymphocytes is preferred. but immortalized b cells do not always replicate exactly the in vivo antibody response, because the tissues from which these cells were selected and the manipulations to which they are subjected to in the laboratory may alter the antibody specificity. 14, 15 protocols for the preparation of ebv virus, b cells, and cell fusion have been described elsewhere. 14, 16, 17 methods used for large-scale production of mabs may include the generation of ascites tumors in mice or in vitro mammalian cell culture fermentation by using bioreactors and continuous perfusion culture systems. 18, 19 the key issues in scale-up productions are the growth media, fermenter size, fermentation time, and purification procedures. 19 purification or downstream processing is accomplished by chromatography, fragmentation, conjugation with chelating agents, ultrafiltration, and controlled precipitation. 18 a more recent technique for producing antibodylike molecules uses what is known as the phage display library. it involves the construction of v h and v l gene libraries and their expression on the surface of a filamentous bacteriophage. developed in the 1990s, the phage display method requires repeated "panning" or screening of different antibodies based on their affinity for a specific antigen. antibody genes are linked to bacteriophage coat protein genes and the bacteriophages with the fusion genes are used to infect bacteria to create the phage display library. the resulting bacteriophages express the fusion proteins and display them on their surface, and the phage display library comprises recombinant phages, each displaying a different antigenbinding site on its surface. the phage expressing an antigen-binding domain specific for a particular antigen can be detected and isolated by binding to the surface coated with that antigen. libraries of v h and v l genes may be generated from nonimmunized donors, immunized donors who have an immune response against a particular antigen or from a synthetic library consisting of antibody fragments. 20, 21 one promising way to increase antibody yield or develop new antibodies may be by using genetically altered animals and plants. abgenix, a company in fremont, ca, has developed the transgenic "xeno-mouse," in which the mouse antibody-producing genes have been inactivated and functionally replaced by approximately 90% of the human ig gene loci in germline configuration, coding for the heavy and light chains. 22, 23 upon immunization with any specific human or nonhuman antigens, the "xeno-mouse" generates mabs, which are fully human igs, with high affinities and antigen-binding specificities. "xenomouse" strains producing specifically igg1, igg2, or igg4 isotypes have also been created to generate panels of diverse and highly specific mabs. kirin brewery company, japan, has developed another transgenic mouse known as the "trans-chromo" mouse. the endogenous igh and igg loci of the "trans-chromo" mouse were inactivated, but it harbors 2 individual human chromosome fragments, derived from human chromosomes 2 and 14, that contain whole human ig light-and heavy-chain loci, respectively. 24 these mice are capable of producing every subtype of fully human ig, including iga and igm. in these transgenic mouse models, human antibodies with high affinity to an immunized antigen are naturally selected by the murine immune system via an affinity maturation process, and thereby show increased diversity of the mabs. transgenic mice may be a suitable alternative to chimeric or humanized antibody production or the use of phage display systems to create less immunogenic or novel antibodies. 25 for instance, transgenic mice that express mabs to coronavirus in their milk have been developed. 26, 27 because ruminant animals, such as cows, goats, and sheep, produce relatively large amounts of milk, genetically-modified members of these species could also be used to produce large quantities of therapeutic proteins, including mabs. 28 plants may be a potential source of recombinant proteins, including mabs. 29 -31 plant virus vectors, such as the tobacco mosaic virus, may be used to make mabs. transgenic tobacco plants may also be used for large-scale production of recombinant iga, which is used in passive mucosal immunotherapy. 30, 31 this mab could be added to toothpaste to effectively protect against bacteria that cause tooth decay. 31, 32 recombinant antigens obtained from plants may also have therapeutic applications. for instance, attempts to immunize mice with escherichia coli heat labile enterotoxin b produced in transgenic tobacco and potato plants have proved promising. 33 hepatitis b viral surface protein produced in transgenic tobacco plants has been shown to be immunogenic in mice. 32 the genes coding for murine malignant b-cell specific markers are inserted into tobacco mosaic virus to cultivate an immunogenic protein in tobacco plants that may eventually be used in developing a vaccine against non-hodgkin lymphoma. 34, 35 other immunotherapeutic proteins under development include norwalk virus capsid proteins produced in tobacco and potatoes, cholera toxin and ct-b produced in potatoes, hepatitis b antigen produced in tobacco, anti-human igg used to detect nonagglutinating antibodies produced in alfalfa, and humanized anti-herpes simplex virus (hsv)-2 grown in soybeans. 36 -39 the food and drug administration (fda) considers antibodies to be "biopharmaceuticals"; as such, mab applications are regulated by the agency's center for biologics evaluation and research (cber) and the center for drug evaluation and research. 40, 41 the fda has created a "points to consider" document advising manufacturers of factors to consider in the production and testing of mabs intended for human use and identified information that should appear in investigational new drug or biologics license applications. 40 the "points to consider" document serves to "indicate the agency's current thinking on mab products for human use." 40 the agency's recommendations are aimed at protecting human health because viruses and cellular dna from antibody-producing cells with malignant phenotypes may be integrated into host cells after transformation. accordingly, among the points to consider are several steps-such as taking care to ensure purity of immunoconjugates and demonstrating the ability of any purification scheme to remove adventitious agents-designed to prevent contamination of the final product by human pathogens. 40 manufacturers must also adhere to animal care standards and detail steps to prevent contamination of cell culture. the points to consider document includes a list of normal human tissues used in cross-reactivity testing, tests for murine viruses, and organs to be considered in dosimetry estimates. the fda recognizes that because of species differences, animal models expressing the antigen of interest or cross-reactive epitopes are not always available. the agency has also published a guidance entitled s6 preclinical safety evaluation of biotechnology derived pharmaceuticals based on international conference of harmonization technical requirements. 41 before beginning phase 1 clinical studiesconducted to assess the safety of the drug and its mechanism of action-the fda recommends that researchers conduct in vivo and in vitro testing of the mab to assess cross-reactivity with human tissues or non-target-tissue binding. preclinical safety testing aims to evaluate the immunogenicity, crossreactivity, stability and effector functions of mabs. the metabolism, carcinogenicity, and genotoxicity of the product should also be evaluated. 41 guidance has also been published for mabs used as reagents in drug manufacturing. 42 the guidance emphasizes biological safety, performance characteristics of the reagent, and potential presence of residual amounts of the reagent in the final product. the fda general principles for testing and manufacturing are broadly applicable to many classes of antibodies, including those produced by phage display systems or transgenic plants and animals. depending on the expression system being used, other fda guidance documents, such as cber's points to produce biologicals should also be referenced. [43] [44] [45] humanizing monoclonal antibodies rodent mabs with excellent affinities and specificities have been generated using conventional hybridoma technology, but their use in clinical medicine is limited due to the immune responses they elicit in humans. for instance, the human antimouse antibody (hama) response can compromise the clinical effectiveness of murine mabs. although hama responses are directed against the murine constant regions, which represent the major antigenic features of the mouse ig, significant responses are also directed toward the murine variable regions. as a result, patients may mount an immune response against the injected murine antibodies, leading to allergic or immune complex hypersensitivities, rapid clearance of the antibody, and reduced clinical efficacy. 13,46 -51 initially, morrison and colleagues 48,52 introduced chimeric mabs in 1984, which showed several advantages over unmodified rodent antibodies. generally, chimeras combine the human constant regions with the intact rodent variable regions, replicating the rodent antibody variable regions by pcr and then cloning them into eukaryotic expression vectors containing human constant regions. 49 ideally, this allows better interaction with human effector cells and the complement system. because the fc region has little influence on the structure of the fv region, the chimeric constructs' affinity and specificity are virtually unchanged, and both rodent and chimeric antibodies cause apoptosis at a similar rate and intensity against target cells in vitro. 50, 51, 55 although chimeric antibodies have helped solve some of the problems associated with the use of rodent mabs, they still show significant immunogenicity in humans; because of their approximately 30% mouse sequence, they cause an human-antichimeric antibody response. humanized antibodies containing only the cdrs of the rodent variable region grafted onto the human variable region framework have been introduced to overcome these deficiencies. 53 the early work on recombinant, chimeric, and rodent/human antibodies happened during the mid 1980s and, by the late 1980s, greg winters and his colleagues demonstrated that a functional human-like antibody could be created by grafting the antigen-binding cdrs from variable domains of rodent antibodies onto human variable domains. numerous humanized antibodies have now been designed and constructed, and many are currently being evaluated in clinical trials. 13, 14, 39, 47, 54 efficient procedures for constructing humanized antibodies have been developed. 13, 14, 47, 55 the first step is to clone and sequence the complementary dnas (cdnas), coding for the variable domains of the mouse antibody to be humanized. the mouse hybridoma cell line is grown in an appropriate culture medium, and cells are harvested for rna isolation. polymerase chain reaction (pcr) primers that hybridize to the 5' ends of the mouse leader sequences and to the 5' ends of the mouse constant regions are designed for cloning light chain variable regions and heavy chain variable regions. cdna is synthesized from total rna, followed by pcr amplification with light and heavy chain specific primers. positive bacterial colonies containing mouse variable regions are then screened. construction of a chimeric antibody involves modifying the cloned mouse leader-variable regions at the 5'-and 3'-ends, using pcr primers to create restriction enzyme sites for convenient insertion into expression vectors, to incorporate sequences for efficient eukaryotic translation, and to incorporate splice-donor sites for rna splicing of the variable and constant regions. the adapted mouse light and heavy chain leader-variable regions are inserted into vectors containing, for example, human cytomegalovirus enhancer and promoter for transcription, a human light or heavy chain constant region, a neomycin gene for selection of transformed cells, and the simian virus 40 origin of replication in cos cells. these vectors are designed to express chimeric or reshaped human light and heavy chains in mammalian cells. the design and construction of an engineered human antibody require an analysis of the primary amino acid sequences of the mouse variable regions to identify the residues most critical in forming the antigen-binding site. a structural model of the mouse variable region is built on the basis of homology to known antibody variable regions. the framework regions (frs) of the new variable regions are modeled on frs from structurally similar immunoglobulin variable regions. the design process involves selecting human light and heavy chain variable regions that will serve as templates for the construction of a reshaped human antibody. the mouse cdrs are then joined to the frs from selected human variable regions. the primary amino acid sequences are then carefully analyzed to ascertain whether they would recreate an antigen-binding site that mimics the original mouse antibody. within the frs, the amino acid differences between the mouse and the human sequences are examined, and the relative importance of each amino acid in the formation of antigen-binding site is evaluated. minimum changes in the frs are desirable and should closely match the sequences from natural human antibodies. any potential glycosylation site in the frs of either mouse or human sequence needs to be identified and its influence on antigen binding considered. the dna sequences coding for the reshaped human variable regions, either made synthetically or based on an existing sequence that is very similar to the newly designed reshaped human variable region, are modified by pcr with specially designed oligonucleotide primers. the human variable regions together with their leader sequences are then cloned into a mammalian expression vector that already contains human constant regions. each human variable region is linked to the desired constant region via an intron. preliminary expression and analysis of the reshaped human antibodies are done by cotransfection of mammalian cell-expression vectors, 1 coding for human light chain and 1 coding for human heavy chain. the vectors will replicate in the cos cells and transiently express and secrete reshaped human antibodies. the concentration of the antibody produced can be analyzed by using an enzyme-linked immunosorbent assay. specific changes in the amino acids of the framework region may also be required to preserve the orientation and structure of the rodent cdr required for binding. computer modeling using databases containing human variable genes will identify sequences homologous to the rodent v regions. 13, 47 a computer model of the rodent fv can identify the non-cdr residues that interact with the cdr sequences, and choices can be made regarding which residues need to be included in the variable region. antibodies humanized in this way may have binding affinities up to one-third greater than the corresponding murine antibodies. 49 allergenicity is also significantly reduced. about 20 to 40% of patients exhibit a hama reaction to murine antibodies, whereas only about 7% have a similar reaction to humanized antibodies. 47,53,56 -58 humanization of mabs still has several practical difficulties. first, a detailed knowledge of the antibody structure and function is required. second, methods for efficient construction of humanized mabs are limited. third, unpredictable immunogenicity may result when a new amino acid sequence is introduced to balance affinity retention. fourth, the antibody repertoire is limited to the animal in which the progenitor mab originated. fifth, the rodent mab producing hybridoma must be isolated and thoroughly characterized. however, obstacles to humanization are gradually being surmounted. karpas et al 15 reported creating a hat-sensitive and ouabain-resistant human myeloma cell line that can fuse with human lymphoblast cells. a hat-sensitive subline of the myeloma cells that secreted only light chains was fused with ebv-transformed white blood cells that produced igg mabs to hiv-1 gp41. eventually, a clone was isolated that was polyethylene glycol-resistant and would not revert when placed in hat medium. standard polyethylene glycol fusion protocol was followed to fuse the myeloma cells with both ebvtransformed white cells and fresh white cells obtained from the peripheral blood of adults and tonsil cells from 2 children. the authors reported promising rates of hybridoma formation, stable ig production, and high yield of secreted antibodies compared with antibody-producing cell lines from mouse myeloma cells. the authors have now developed 40 hybridomas that have been secreting cells for more than 5 months. a human myeloma cell line may eventually prove useful in creating mabs against certain autoimmune diseases and cancers. this technique may also make it easier for other researchers to generate human mabs for use in therapy. antibodies may act directly when binding to a target molecule by inducing apoptosis, inhibiting cell growth, mimicking or blocking a ligand, or interfering with a key function. 53, 59 in addition, antibodies may modulate or potentiate drugs or other therapies. the antibody may itself act as an effector-as in antibody-dependent cellular cytotoxicity (adcc) or antibody-dependent complement-mediated cascade-or it may involve effector elements such as cytotoxins, enzymes, radioactive isotopes, signals for other parts of the immune system, and/or cytotoxic drugs. 49,50,60 -62 adcc occurs if fc regions on the antibodies are recognized by receptors present on cytotoxic cells, such as natural killer cells, macrophages, granulocytes, and monocytes. complement-mediated cytotoxicity ensues if the antibody binding prompts a complement cascade to occur. active immunotherapy can be accomplished if the antigen can provoke a long-lasting t-cell response, which may be achieved by administering whole cancer cell extracts or by using small antigenic peptides isolated from tumors in experimental patients or animals. 58 for instance, mabs mimicking breast cancer-specific antigens elicit anti-idiotype antibodies; this is another way of creating active immunity, which can lead to a humoral auto antibody-like immune response. 58 the use of bispecific molecules that recognize antigens on both the target cell and effector cell can increase adcc. the most effective mechanisms are blockade of a crucial ligand or growth factor or adcc in which tumor cells are killed by fc receptorbearing cytotoxic effectors. cell killing by adcc is proportional to the amount of antibody bound to a cell, whereas the blockade of an essential growth factor may not show effects until most of its receptor is saturated. a higher antigen expression by the target cell will increase antibody binding and subsequent adcc. but high receptor expression will also make it difficult to prevent the binding of a cytokine or ligand at minimum threshold. 53, 59, 63 with a bispecific antibody, the specificity of mab is combined with the cytotoxicity of immune effector cells, for instance, to neutralize a tumor. 9, 45, 63, 64 bispecific antibodies link the tumor cell directly to the killer cell via cytotoxic trigger molecules, such as t-cell receptors or fc receptors, leading to lysis and/or phagocytosis by the effector cells. although bispecific antibodies can enrich effectors at the tumor site and activate tumor bound effector cells by enabling cross-linking between effector and target cells, they can cause system-wide immune activation because of t-cell receptor cross-linking. bispecific antibodies can also mediate cellular cytotoxicity via various effector cells, including phagocytes, natural killer cells, and t-lymphocytes. another way to use the binding properties of antibodies is by conjugating antibodies to cytotoxic drugs, radioisotopes, or toxins. 49, 58, 63, 65, 66 techniques for conjugation have been described in several recent reviews and articles. 49, 58, 67, 70 mabs can be conjugated to chemotherapeutic drugs such as doxorubicin, mitomycin, and methotrexate. chemotherapeutic agents constitute cytotoxic or cytostatic drugs that can be conjugated to antibodies; thus far, however, these drugs have shown poor specificity for target cells and frequently lead to toxicity. 55, 62, 65 often, antibodies may lose reactivity upon conjugation with such agents. immunotoxins used in cancer therapy are conjugated antibodies that combine plant (ricin, gelonin, saponin, abrin, pokeweed antiviral protein) or bacterial (diphtheria toxin and pseudomonas toxin a) toxins with antibody specificity. 52, 59, 62, 63, 65, 66, 68, 69 toxins may inhibit protein synthesis even at picomolar concentrations. natural toxins, such as diphtheria toxin, can act at low concentrations, enter cells, and disrupt key cellular processes. 69 enzymes may also be conjugated to antibodies in antibody-directed enzyme-prodrug therapy. 55, 61, 62, 66, 71 an enzyme that can convert a prodrug to an active form may be conjugated to an antibody and targeted to a desired location using the antibody-binding region. they may more effectively localize tumors than chemical conjugates, and a prodrug is converted to an active drug by the enzyme at the target cells. another therapeutic technique relies on using antibody fragments, which may be produced by the traditional method (proteolytic digestion with papain) or with newer methods that may reduce damage to the binding sites. 66, 71 some newer methods attempt to construct mimetics that combine multiple cdrs from several antibodies into single molecules with molecular weights substantially lower than single chain fragments. because of their smaller size, antibody fragments may be able to penetrate tissues and tumors more readily and be less immunogenic than whole mabs. however, although antibody fragments may have better penetration than whole antibodies, their shorter half-lives may compromise clinical usefulness. 68 heteropolymerized antibodies have recently been developed by chemically linking a mouse igg mab, specific to a complement receptor site (cr1) on the human or nonhuman primate erythrocyte, to a second mouse igg mab that is specific to the targeted antigen. 72 the heteropolymer technique is based on immune adherence, in which antibody-antigen immune complexes bind to a complement receptor on the red blood cell, facilitating the phagocytosis of these complexes. 72 once introduced into the patient, the heteropolymers will bind to both the red blood cells and the targeted antigen. the antigen-antibody heteropolymer complexes are then transported to the liver and spleen, where the complexes are destroyed by macrophages, whereas the red blood cells return to the circulation unharmed. [72] [73] [74] [75] a wide variety of conditions, of both autoimmune and foreign origin, may potentially be treated with this method, including hiv infection, systemic lupus erythematosus, marburg virus infection, and myasthenia gravis. 76 -78 although mouse antibodies are currently being used with this technique, chimeric mousehuman antibodies could also be constructed. 72 it may also be possible to use the heteropolymers as "sentinels" by injecting them before antigen exposure. in 1 recent study, multiple infusions of heteropolymers provided nonimmunized monkeys with protection against an antigen (⌽174) for as long as 2 weeks. 79 when milstein and kohler announced their isolation of a mab in 1975, many thought mabs would provide an effective cancer treatment. however, early clinical trials were disappointing. 80 -81 producing mabs to tumor antigens is a complex process. first, proteins peculiar to human cancer cells are identified; then, mice are injected with human tumor cells (antigen) to stimulate an immune response. after about 30 days, the mouse lymphocytes are removed and fused with myeloma cells to isolate and reproduce hybrid cells specific to a predetermined antigen. rodent antibodies alone have been used in several trials, but the clinical effects are often minimal because of poor activation of human effector or complement cells by the fc region of the murine antibody and the accompanying hama responses. 55, 57 substituting the rodent fc region with a human fc fragment may help overcome these effects. 81 with the discovery of proto-oncogenes, secondgeneration trials in the 1990s turned to more specific tumor antigens that could be potential targets. 58 in 1994, mab 17-1a, an antibody to epithelial cell surface antigen expressed on human colorectal carcinomas, was approved for the identification of adenocarcinomas; mab17-1a may reduce the mortality and occurrence rate of colorectal cancer. 82, 83 in 1997, rituximab, a mouse-human chimeric anti-cd20 antibody, was approved for the treatment of non-hodgkin b cell lymphoma. 53, 83 rituximab binds to cd20 antigen on b cells and b cell tumors and then elicits a natural immune response that can kill malignant cells. recent animal trials have shown the potential of mab therapy in cancer. 52 increases in epidermal growth factor (egf) receptor expression have been found on many human cancers, and a fully human anti-egf receptor igg2 mab has been shown to inhibit human cancer growth in vitro and in vivo. 22 other efforts are focusing on antibody to her2 antigen in breast cancer. patients with cancer often mount an immunologic response to tumor-associated antigens with increases in cytotoxic lymphocytes and antibodies. 14 several tumor-reactive antibodies have been cloned against melanomas, colon carcinomas, ovarian, breast, and lung tumors. often, these antibodies cross-react with other malignant tissues or cell lines. 14 recently, trastuzumab (herceptin), a humanized mab that binds directly to the c-erb2 protein (her2), has been approved by the fda for the treatment of breast cancer. 52,84 -89 herceptin can be used to treat metastatic breast cancer in patients whose tumors overexpress the her2 protein (about 30% of breast cancer patients) and may be used in conjunction with other therapies such as paclitaxel (taxol). 89 antibody was developed by humanizing murine mab 4d5 by inserting antigen-binding regions of mab 4d5 into the framework of a consensus human igg1, resulting in rhumab-her2 or trastuzumab. 85 cancer cells have antigens that are specific to the tumor (tumor-specific antigens) or are present in greater concentration than normal (tumor-associated antigens). antibodies may eliminate target cells by complement action or through adcc. the variable region of the antibody recognizes and attaches to a specific antigen and the constant region, then joins with an effector cell capable of killing the targeted cancer cell. when the antigen and antibody bind, precipitation and agglutination may isolate the complex. anti-idiotype mabs that mimic-tumor associated antigens also may be used in cancer therapy. 82 the idiotype network hypothesis, formulated by lindemann and jerne, suggests that because each mature b cell secretes an antibody with unique antigenbinding specificity in the variable domain (referred to as the idiotype), anti-idiotype mabs can be generated and used as surrogate antigens or vaccines for immunization against the tumor. 82, 90 a murine anti-idiotype mab, aca125, which mimics the tumor-associated antigen ca125, was recently found to induce a specific anti-anti-idiotypic immune response in 28 of 42 patients with platinum-pretreated recurrent ovarian cancer enrolled in a phase i/ii clinical trial. 90,91 a positive immune response was associated with statistically significant (p ͻ 0.0001) prolonged survival times (19.9 ϯ 3.1 months in patients shown to have an anti-antiidiotypic response compared with 5.3 ϯ 4.3 months in patients who were anti-anti-idiotypic negative). 90, 91 in addition, peripheral blood lymphocyte mediated lysis of ca-125 expressing tumor cells increased in 9 of 18 patients after vaccination with the mab. 91 despite the use of a murine antibody, both this study and a previous phase i study involving patients with ovarian cancer found minimal side effects. 90, 91 promising early results have also been demonstrated in patients with advanced colorectal carcinoma who received a murine anti-idiotype mab that mimics an epitope of carcinoembryonic antigen (ceavac) 82, 90 and in patients with malignant melanoma who received an anti-idiotype mab (trigem) that mimics disialoganglioside gd2 92 despite promising developments, however, there are still several obstacles to effective cancer therapy with mabs. problems with the tumor, the mab, or conjugate characteristics all continue to challenge researchers. 52, 63, 84 thus far, chemotherapeutic mab therapies have faced obstacles due to the poor ability of agents to affect tumor cells preferentially over healthy cells, the intrinsic insensitivity of many tumors to these drugs, and the rapid development of resistance in tumor cells. 65, 66, 93, 94 mabs often decrease the size of tumors, but rarely lead to complete remission of solid tumors. 59 at the cellular level, mabs at low doses ideally should bind with excellent affinities. because no antigens have been identified that are expressed exclusively on tumor cells, cross-reactivity of mabs must be examined with histochemical tests on tissue sections or in animal models. careful testing must also be done to ensure that the effector molecules such as drugs, toxins, or isotopes in the conjugates do not inadvertently target healthy cells. although humanized antibodies have greater affinity than murine antibodies, this potential has yet to be translated into improved clinical outcomes against cancer. 52 however, recent success using the xenomouse technology to develop a fully human igg2 mab specific to epidermal growth factor receptor indicates the potential for future advances in this area. 22 recombinant immunotoxins, fusion proteins containing the fv of a mab and a bacterial toxin, are under development for cancer therapy. because immunotoxins exploit only the variable region-binding function of the mab, in theory just a fragment of the binding region, such as the bivalent f(ab')2 fragment, monovalent fab, scfv, or disulfide-stabilized fv fragments may be used as opposed to the larger and probably more immunogenic whole antibody. disulfide-stabilized fragments may be more stable or have higher affinity for the antigen than scfv, in which the linker may interfere with binding or fail to stabilize the fragment. 66 recombinant immunotoxins derived from pseudomonas enterotoxin have been shown to be active against lymphomas, solid tumors, and leukemias. 66 because binding specificity and affinity are the key elements, it is not known which form of the immunoconjugate is usually more effective in treating human tumors; some animal tests suggest that the whole antibody, with its longer half-life and bivalent binding, is more effective than the antibody fragments with decreased binding affinity. bispecific antibodies and single chain fvs are being developed that may be more effective because they clear faster from nontumor tissues and more deeply penetrate tumors than whole antibodies. 49, 64, 70 bispecific antibodies may be used to target tumor vascular endothelial cells, thereby limiting the tumor's blood supply and possibly inhibiting its spread. 70 advances in radiolabeling have allowed immunoconjugates to be delivered to cells and showed promise in clinical trials. 14, 63, 80, 95, 96 radioimmunotherapy uses a radiolabeled mab to deliver radioactive isotopes to targeted cells. radioisotopes such as iodine-131 and yttrium-90, which are ␤ emitters, can cause damage not only to the bound cell but also to cells adjacent to tumor cells that antibodies may not be able to reach within the tumors. lack of knowledge about the appropriate dose, biodistribution, and shedding of antigen hinders use of radioisotopes. radiolabeled mabs may also affect normal cells, depending on the extent to which reticuloendothelial cells expressing fc receptors bind to the constant regions of intact antibody molecules. using antibody fragments or constructs may modify this nonspecific uptake. 63, 68, 82, 93 radiotherapy exerts most of its effect by emitting a low dose, which exponentially decreases continuous radiation, but the antibody per se may have a cytotoxic effect. the duration of radiotherapy is determined by the half-lives of the antibody and the isotope used. the success of radioimmunotherapy is affected by the specificity, affinity, dose, and immunoreactivity of the antibody, heterogeneity of antigen expression, diffusion rate, tumor volume, blood supply and tumor location, dose rate effects, and variability in dose deposition. the choice of radionuclide, selection of the chelate used to link the mab to the radionuclide, and the mab selected are critical in development of radiolabeled mabs. 80 suitable radio nuclides include yttrium-90, iodine-131, and copper-67. iodine-131 was the first radioisotope to be used in treatment of hodgkin disease and other lymphomas. 68 yttrium-90 is potentially useful for lymphoma therapy because it decays with ␤, but not ␥, emissions that may kill other tumor cells in a cross-fire effect. 68 the energy released by yttrium is 5 times higher than that of iodine-131, which degrades rapidly after uptake into a tumor cell, causing toxicity. 80 in addition to their uses in radiotherapy, radiolabeled mabs can also be used to diagnose cancer. 18, 56, 57, 82, 94 radioactive isotopes linked with mabs may help localize tumors in a form of diagnostic imaging called immunoscintigraphy. for instance, oncoscint, a mab coupled to indium-111, may be used to detect an antigen (tag-72) found on colorectal adenocarcinomas. 56 mabs may potentially be used to suppress the immune system after transplant or to induce tolerance to transplanted organs or tissues. thus far, however, only antibodies to cd3 and cd25 are licensed for clinical use. 97 okt3, a murine igg2a antibody to human cd3, and antibodies to cd25 (il-2 receptor) have been used to reduce allograft rejection. 97 graft-versus-host disease (gvhd) is a complication of allogeneic stem cell transplant that occurs despite histocompatibility testing and use of cyclosporine and its analogs. 98 gvhd is a frequent cause of illness or death in allogeneic transplant patients and occurs when alloselective donor t cells recognize and interact with major and minor histocompatibility antiigens in the host, leading to cytokine release. mab therapy against gvhd is most effective when it is administered after a bone marrow transplant but before gvhd development by targeting t-cells before their activation. 99 for instance, 1 target is the interleukin-2 receptor ␣-chain (il-2r␣ tac protein or cd25), whose expression is a crucial step in the activation of alloreactive t cells. 97, 100 recently, it was reported that daclizumab, a humanized anti-il-2a antibody, was an effective complement to dual immunosuppression therapy in renal transplant patients. 101 because only activated cells express il-2, antibodies to this cytokine might inhibit t cells during allograft rejection and prevent generation of cytotoxic t cells. the development of hama response in patients and the decreased effectiveness of murine mab relative to human mab have thus far compromised the effectiveness of this approach. however, humanized anti-tac mabs, with better human effector functions, may survive longer in vivo and may prove less immunogenic than its murine counterpart. short-term cd4 antibody therapy may also contribute to long-term acceptance of skin and islet allografts, even after gaining immunocompetence. 102 more generally, the ability of mabs to induce tolerance to transplanted tissues and self-antigens may hold great therapeutic potential. 97, 102 mabs to cd4 and cd8 have been studied, although thus far these have not resulted in clinical success. 97 depletion or blockade of t cells by antibodies may facilitate tolerance by preventing t cells from attacking the graft, and recent t cell depletion studies in primates have proven promising. 97 mab treatments for other complications after transplants are also under study, including potential treatment of posttransplant lymphoproliferative disorder with the anti-cd20 mab rituximab and the use of anti-lfa-1 mab (odulimomab) to protect against ischemia-reperfusion injury after kidney transplants. [103] [104] [105] daclizumab, a humanized antibody that targets the anti il-2 receptor, may reduce the risk of acute rejection of a renal transplant and also lower cytomegalovirus infection rates among transplant recipients. 106 the inflammatory bowel disorder known as crohn disease has also been treated with mab therapy. 107 a chimeric igg1k antibody, infliximab (remicade), acts by binding to soluble and transmembrane tumor necrosis factor ␣ (tnf␣), preventing it from binding to its receptors on activated macrophages. the anti-tnf␣ antibody may provide relief to patients with moderately to severely active crohn's disease. in addition, the fda recently approved infliximab for the treatment of rheumatoid arthritis in combination with methotrexate. 108 -111 high levels of ige may cause bronchial hyperresponsiveness, a risk factor for asthma. [112] [113] [114] im-therapeutic applications of monoclonal antibodies mune responses mediated by ige are important in the pathogenesis of allergic asthma. in 1 recent study with subjects reporting moderate to severe allergic asthma, twice-weekly injections of recombinant humanized anti-ige antibody (rhumab-e25), which forms complexes with free ige and blocks its interaction with mast cells and basophils led to a fall in serum ige levels and slightly decreased asthma symptom scores relative to the placebo group. 112 patients receiving anti-ige were able to reduce reliance on corticosteroids. although the study must be interpreted cautiously, it is nonetheless a promising step in finding more effective asthma therapies. 112, 114, 116 approximately 400,000 cases of sepsis in the us and about 25,000 cases in the uk are reported each year. 116, 117 the mortality rate could be as high as 40 to 70%, depending on the population studied. 117, 118 mabs have been targeted to tnf␣ and tnf␣ receptors, which are key elements of the inflammatory response. unfortunately, this may inhibit many cytokines, which can impair the patients' ability to fight infection and increase the risk of secondary sepsis; also inhibiting a few cytokines may not be sufficient. although mabs targeted toward components of the host immune system, such as individual receptors or mediator cells, help in the treatment of septic shock, targeting the bacterial endotoxin or lipid a of gram-negative bacteria with mabs may be more efficacious. lipopolysaccharide endotoxin, a component of the outer cell membrane of gramnegative bacteria, consisting of a highly variable o-linked polysaccharide chain, an r core region, and lipid a, which in turn is composed of a glucosamine disaccharide backbone substituted with amide-and ester-linked long-chain fatty acids, is believed to be important in many cases of septic shock and septicemia, and can trigger an inflammatory cascade that can cause serious injury and even death. 119, 120 lipid a is linked by the core region to the o-linked side chain, and variations in the o-linked side chains result in an enormous diversity among gram-negative bacteria, making adoptive immunotherapy against the o-linked antigenic determinants difficult. 114 directing antibodies to the core region or lipid a, which tend to be more conserved, would allow for therapy against a diverse array of gram-negative bacteria. favorable results with polyclonal j5 antibody have spurred attempts to develop a mab. 116, 117 a murine igm mab, e5 (xoma, berkeley, ca) binds to an epitope on lipid a of e coli j5. a human igm, ha-1a (centoxin) is derived from a heterohybridoma fused from spleen cells of a patient vaccinated with e coli j5 before splenectomy. 116, 117, 119, 121 both the antibodies have thus far shown mixed success in patients with sepsis and neither is currently cleared by the fda for therapeutic use. because patients with bacteremia often have endotoxemia, ha-1a, an igm antibody to endotoxin may be effective against endotoxin in the bloodstream as well. unfortunately, the high cost of antibody ($3500/dose in europe) combined with the uncertainty that the sepsis is caused by gram-negative bacteria has hindered the widespread use of ha-1a. 112, 115, 117 although it is less efficacious, the only other option may be to target tnf␣, but 1 recent study reported a high (54.1%) rate of adverse reactions in patients receiving an anti-tnf␣ antibody. 118 the antibody was no more effective than the placebo given to control subjects. however, research on a mab for the treatment of septicemia continues. cytomegalovirus (cmv) causes serious illness affecting the immunocompromised, such as patients with aids and those undergoing organ transplants. infection rates may be up to 75% in those negative for cmv who receive kidneys from seropositive patients. 122 cmv infection can result in retinitis and gastroenteritis in hiv-infected patients and may also cause chronic intrauterine infection. 122, 123 up to 40,000 cases of congenital cmv infection are reported each year; mental retardation and hearing loss may occur in about 25% of these cases. 122 currently, there is no vaccine against cmv. ganciclovir, foscarnet, and (s)-1-[3-hydroxy-(2 phosphonylmethoxy)propyl]cytosine are some of the potential treatments for cmv infection. 122 another mode of treatment is via administration of anti-cmv hyperimmunoglobulin, derived from pooled sera of cmvseropositive persons. passive immunization has been shown to reduce the severity of cmv and prevent mother-to-infant transmissions. 122 moreover, antibodies may be able to clear the virus from infected tissues, a function previously thought to be exclusive to cytotoxic t lymphocytes. many physicians use a combination of antiviral agents and immunoglobulins in patients at risk for cmv infection. mabs may also decrease the amount of antiviral agents required for treatment. mabs against murine cmv polypeptides have been shown to be protective in animal models. 124 although mabs may act synergistically with foscarnet or ganciclovir in vitro, it is unclear whether this advantage could be extrapolated to in vivo conditions. experiments in which murine cmv is used as a model system suggest that high concentrations of antibody, along with ganciclovir or (s)-1-[3-hydroxy-(2 phosphonylmethoxy)propyl]cytosine, synergistically inhibit the growth of murine cmv in cell culture, whereas lower antibody concentrations produce only an additive effect. however, antibody ad-ministered along with ganciclovir in severe combined immunodeficient mice also produced only an additive effect. 123 the extent to which a mab can protect the host from cmv infection cannot reliably be predicted from its immunoreactivity, neutralizing titers in vitro, or from its antigen-binding data, because the mechanism of action of a mab in vitro and in vivo may be entirely different. 124 if an antibody is used along with drugs, not only is the treatment efficacy improved but also the side effects of a high drug concentration may be avoided. for instance, 25 mg of ganciclovir/kg of body weight, along with an antibody, was almost as effective as 50 mg/kg ganciclovir administered alone in cmv-infected severe combined immunodeficient mice. 124 the msl109 antibody, a human igg1 directed against human cmv glycoprotein, is marginally synergistic in inhibiting cmv in vitro when conjugated to ganciclovir or foscarnet. in a recent trial involving 209 aids patients with active cmv retinitis, the rate of retinitis progression was similar in the group receiving the antibody (60 mg, intravenous) for 2 weeks and the placebo control group. 125 surprisingly, mortality increased in the msl-109 group, and the poor performance of msl-109 in this trial may have been due to the inability of the antibody to neutralize the established cmv infection in aids patients or its failure to cross the blood-ocular barrier in sufficient quantities. liver transplant patients are also at risk of cmv infection and may require treatment with the murine mab okt3, an anti-t cell antibody that is directed to cd3 antigen, along with ganciclovir to mitigate transplant rejection. 126 human mabs neutralizing cmv were tested for their safety and pharmacokinetics over a period of 3 to 73 days in bone marrow transplant recipients and were found to be safe and efficacious, as evidenced by a steady increase in the neutralizing activity. 127 also, a human anti-cmv mab designated c23 that was purified from hybridomas generated by the fusion of human lymphocytes with mouse myeloma cells has virus neutralization titers about 1000-fold higher than those produced after conventional human ␥ globulin used in humans. 128 a humanized mab has been developed that binds to the 86-kd glycoprotein, gpul75 (gh), of cmv, recognizes a variety of virus strains, and neutralizes clinical isolates of cmv; it could be used as a potential agent for the prevention or treatment of cmv infections in humans. 129 respiratory syncytial virus (rsv) causes serious lower respiratory tract disease requiring considerable supportive care, administration of humidified oxygen, and respiratory assistance. the fda approved the use of a humanized mab against rsv, which afflicts mostly infants and children younger than 24 months of age. 130, 131 known as palivizumab, the antibody (produced by synagis and medimmune, inc.) treatment showed a 55% reduction in rsv infection in hospitalized patients. 130, 131 the american academy of pediatrics' committee on infectious diseases has published recommendations on the use of this antibody in children at risk for rsv infection. 130, 131 mabs have also been used in the therapy of hsv infections. the incidence of neonatal herpes is 30 to 50% in babies born vaginally to mothers with primary infection but only 1 to 3% in babies born to mothers with recurrent infections. 132 this difference is attributed to the passive transfer of protective antibodies to the fetus. antibodies to hsv-1 may also confer partial protection against type 2 strains. based on this observation, the potential of mab therapy against herpes has been studied for more than a decade. experiments in mice, for instance, indicate that microgram quantities of antibodies may promote healing of corneal opacity and blepharitis caused by herpes simplex. 133 however, attempts to confer immunity in humans and other higher animals by passive immunization alone have been disappointing, because antibodies to hsv are restricted to only a few specific epitopes. 133 among the 11 glycoproteins expressed by the herpes virus on its surface, 5 glycoproteins (gb, gd, gh, gk, and gl) are thought to be crucial to infection. the initial step in hsv infection seems to be the binding of gc to heparan sulfate proteoglycans followed by the binding of gb, and the binding of gb and gc is stabilized by gd. gh is involved in initiation of viral fusion and other glycoproteins may help in expanding the fusion process. evidence that neutralizing antibodies to gh, gd, and gb prevent membrane fusion but not viral attachment is consistent with this model. 133 most human antibodies are directed against gd and gb epitopes. mabs can target at least 7 different antigenic sites on hsv glycoprotein d in the murine model. 133, 134 glycoprotein d is necessary for virus replication in tissue culture. yamamoto et al 135 reported the antibody-dependent cellular cytotoxicity effect of hs1, a neutralizing mab to glycoprotein b of hsv, in athymic nude mice inoculated with hsv intracutaneously. when hs1 is administered, the skin lesions healed in 50% of the mice given the antibody. also, latent infection in the ganglia was prevented in mice that survived, as evidenced by the failure to detect hsv upon co-cultivation with vero cells. administration of hs1 after development of zosteriform lesions (5 to 9 days after infection) reduced the virus in the ganglia and prolonged survival time; however, the disease was not totally avoided and eventually the mice succumbed to the disease. the antibody therapy could prevent or decrease the severity of herpetic keratitis, iritis, and blepharitis after corneal infection by hsv. 136, 137 thus, mabs could potentially be used to prevent congenital herpes and sexual transmission of the herpes virus. 47, 133, 138, 139 currently, no treatments exist for the hemorrhagic fever caused by the filovirus ebola. recently, a team of researchers at the us army's medical research institute identified protective antibodies directed against epitopes on ebola virus membraneanchored glycoprotein. some of the antibodies protected mice as long as 2 days after exposure; doses were equivalent to acceptable (3 to 5 mg/kg) human levels. antibody specificity is important, because some mabs studied bound to ebola zaire but not to the ivory coast or sudan serotypes. much research remains to be done before the potential of antibodies in the treatment of ebola will become realized. 140 toxins are poisonous proteinaceous substances. antibodies were first clinically used in the 1970s for protection against the toxin digitalis. 48, 102 today, antidigitalis immunotoxicotherapy is a standard therapy. digoxin is produced from sheep immunized with digoxin-serum albumin conjugate. igg antibody specific for digoxin is purified and cleaved into fabs, because the smaller molecular mass of the fragments allows faster renal clearance and more rapid action than the whole antibody. the fab fragments bind to circulating digitalis molecules and generate a complex that is unable to bind to receptors. adverse effects are rare, and the immunotherapy is generally effective against digoxin and digitoxin within 1 hour. 120, 141 however, because polyclonal antibodies may be difficult to produce and may cause hypersensitive reactions, researchers have attempted to develop humanized mabs against digoxin and other toxins. 141 for example, 1 group has used a transgenic mouse to produce hybridomasecreted human mabs against digoxin. 141 more recently, the effect of goat anti-colchicine igg antibodies has been studied in mice exposed to a lethal intraperitoneal dose of anti-inflammatory colchicines, and preliminary studies in a 25-yearold woman with colchicine poisoning showed promise. 102, 141 attempts have also been made to use drug-specific goat antibody fragments to treat anti-tricyclic antidepressant (tca) overdose. 120, 141 antidepressant overdose is the most common cause of intentional drug overdose in the us. however, lethal doses of tricyclics are 10-to 100-fold higher than those of colchicine, digoxin, and snake venom, which require higher antibody doses (up to several g/kg) to reverse the toxicity. 120, 142 high-affinity tricyclic antidepressant-specific mabs have been shown to reverse the cardiovascular toxicity of antidepressant desipramine in rats and prolong their survival, and tricyclic antidepressant-specific fab fragments, along with sodium bicarbonate, a standard treatment for tricyclic overdose, also minimizes the required dose of antibody. 142 the use of smaller antibody fragments, such as single chain fv fragments, half the size of a fab, may also be a promising approach because the single chain fragment retains affinity and has shorter half-life in the body. monoclonal antibodies may also help to alleviate poisoning due to environmental contamination. hexachlorobiphenyl, paraquat, atrazine, 3,5,6-trichloro-2-pyridinol, the chief degradation byproduct of the insecticides chloropyrifos, triclopyr, and chloroprifosmethyl, and other chemicals may soon be detected and remediated with the help of antibodies. 139, [143] [144] [145] antibodies may also be used in the treatment of poisoning due to paraquat, hexachlorobiphenyl, domoic acid [amnesic shellfish poisoning], and other contaminants that are otherwise difficult to remove from the body or surrounding environment. [145] [146] [147] [148] the primary target of many abused drugs is the central nervous system (cns), and immunotherapy against such chemicals must be able to penetrate the cns. 149 pcp or phencyclidine (angel dust) is a type of arylcyclohexamine that affects multiple sites in the brain. 150, 151 it is linked to violent psychotic episodes that are similar to schizophrenia. 149 treatment is difficult because there is no known antagonist identified, pcp has a high volume of distribution, and about 95% of it is cleared after being metabolized. 151 recently, mabs have been described that could bind to cocaine or pcp and act like sponges in the bloodstream to prevent them from reaching the brain. 152 it has been shown that a single dose of antibody reduced pcp effects for up to 2 weeks in animals, which might be equivalent to a several months in humans. high-affinity antibody 6b5 fragments against pcp function better in that the fragments with bound pcp are more quickly cleared from the body than the whole antibodybound pcp. 153 the crystal structure of the antibody fragment complexed with pcp has been studied in detail. 154 antibody fragments are also preferable to whole antibodies in the treatment of pcp addiction because of their lower antigenicity and improved pharmacokinetics. 149, 151 anti-idiotype antibodies could potentially be produced against the drug-mab binding site and mimic drug structural features, although these antibodies do not cross the bloodbrain barrier. 151 by increasing protein binding in the vascular compartment and lowering the drug's volume of distribution, the antibody acts like a pharmacokinetic antagonist. 150 evidence that the antibody can also reverse effects of other potent arylcyclohexylamine drugs suggests that antibody medications can be used to treat different classes of drugs. 150, 151 an anti-pcp igg has been produced from a hybridoma cell line using both ascites and bioreactor methods, and the pharmacological and immune specificity of the antibody has been confirmed by administering the anti-pcp fragment to rats in three different studies without producing observable effects in behavior. 155 active immunotherapy against methamphetamine addiction is also being contemplated. 156 antibody therapy for cocaine addiction is also a possibility, especially with the development of catalytic antibodies having enzyme-like characteristics that can be used to inactivate drugs. 151, [157] [158] [159] antibodies with esterase activity have been successfully mimicked, and because cocaine is believed to be metabolized by in vivo esterases, such antibodies would be useful in the treatment of cocaine addiction. 151 catalytic antibodies probably would not be as useful as high-affinity anti-cocaine antibodies, but could be used in medical emergencies or as part of a withdrawal therapy. 151 potential antibody applications against cocaine addiction have been tested in rats with a vaccine approach by (1) attaching cocaine molecules to a carrier protein for immunizing rats to produce antibodies against cocaine and (2) humanizing anticocaine antibodies derived from rats and producing them in bacteria. 152, 160 a catalytic mab (15a10) has recently been reported to attenuate cocaine's cardiovascular effects in mice. 155, 159 conclusion about 200 years have elapsed since edward jenner vaccinated a young child against smallpox. since that time, the field of immunology has evolved at a rapid pace and has yielded many critical developments. although vaccination has thus far proven to be the most cost-effective method of preventing diseases worldwide, the development of mabs that use the specificity of immunological responses is one of the most successful applications of immunology to date. chimeric and humanized antibodies have reduced the risk of allergenicity from exposure to nonself antibodies and heightened the clinical effectiveness of mab treatments. developments in radiology and pharmacology have allowed radiolabeled and immunoconjugated antibodies to be produced. antibody fragments, heteropolymers, and bispecific antibodies are now available in addition to whole mabs. these promising developments may soon allow mabs to be used to treat afflictions as varied as substance abuse, cancer, asthma, viral infection, septicemia, and poisoning. as heddy zola observed in 1995, "the therapeutic application of mabs, whilst still limited in scope, promises to break its substantial shackles and realize the potential forecast by its proponents." 46 on immunity: with special reference to cell life ehrlich's passion: the origins of his receptor immunology the natural selection theory of antibody formation a modification of jerne's theory of antibody production using the concept of clonal selection the hydrolysis of rabbit gamma globulin and antibodies with crystalline papain selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants continuous cultures of fused cells secreting antibody of predefined specificity with the benefit of hindsight antibodies in diagnostics-from immunoassays to protein chips igg subclasses-a review biological activities of immunoglobulins of different classes and subclasses preparation of rodent monoclonal antibodies by in vitro somatic hybridization monoclonal antibodies in clinical applications monoclonal antibodies: the second generation. herndon (va): bios scientific a human myeloma cell line suitable for the generation of human monoclonal antibodies the optimal technological approach to the development of human hybridomas continuous production of monoclonal rheumatoid factor by ebv-transformed lymphocytes clinical use of monoclonal antibodies production of clinical grade monoclonal antibodies. presentation at international business communications fifth annual antibody production & downstream processing conference introduction to antibody engineering and phage display natural and designer binding sites made by phage display technology development of abx-egf, a fully human anti-egf receptor monoclonal antibody, for cancer therapy antibody engineering via genetic engineering of the mouse: xenomouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing ig heavy and loci and expression of fully human antibodies the trimera mouse: generating human monoclonal antibodies and an animal model for human diseases lactogenic immunity in transgenic mice producing recombinant antibodies neutralizing coronavirus transgenic mice secreting coronavirus neutralizing antibodies into the milk the future of transgenics. regulatory affairs focus expression and assembly of a full-length monoclonal antibody in plants using a plant virus vector characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans generation and assembly of secretory antibodies in plants exploring transgenic plants as a new vaccine source oral immunization with a recombinant bacterial antigen produced in transgenic plants tobacco can be good for you. the new york times rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain fv epitopes in tobacco plants production of antibodies in transgenic plants a humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes production of a diagnostic monoclonal antibody in perennial alfalfa plants using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases points to consider in the manufacture and testing of monoclonal antibody products for human use guidance for industry. s6 preclinical safety evaluation of biotechnology-derived pharmaceuticals center for biologics evaluation and research and center for drug evaluation and research, us food & drug administration points to consider in the production and testing of therapeutic products for human use derived from transgenic animals points to consider in the production and testing of new drugs and biologicals produced by recombinant dna technology points to consider in the characterization of cell lines used to produce biologicals. center for biologics evaluation and research, us food & drug administration monoclonal antibodies: the second generation human antibodies by design genetically engineered antibody molecules engineering antibodies for therapy recombinant antibodies: alternative strategies for developing and manipulating murine-derived monoclonal antibodies monoclonal antibody-based therapy for solid tumors: an overview monoclonal antibodies: innovations in diagnosis and therapy unconjugated monoclonal antibody therapy of lymphoma monoclonal antibodies: the second generation. herndon (va): bios scientific preparation of recombinant antibodies from immune rodent spleens and the design of their humanization by cdr grafting the promise and pitfalls of monoclonal antibody therapeutics radiolabeled monoclonal antibodies monoclonal antibody-based therapy of breast cancer monoclonal antibodies in cancer therapy antibody-based therapies for hodgkin's disease principles of antibody therapy reconstruction of monoclonal antibodies by genetic engineering genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents immunotherapeutic perspective for bispecific antibodies monoclonal antibodybased therapy of cancer recombinant fv immunotoxins and fv fragments as novel agents for cancer therapy and diagnosis photoreduction of monoclonal antibodies for conjugation and fragmentation monoclonal antibody-based therapies of leukemia and lymphoma immunotoxin therapy of lymphoma: studies with anti-b4-blocked ricin the use of bispecific antibodies in tumor cell and tumor vasculature directed immunotherapy production of fab fragments of monoclonal antibodies using polyelectrolyte complexes use of heteropolymeric monoclonal antibodies to attach antigens to the c3b receptor of human erythrocytes: a potential therapeutic treatment bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model the primate erythrocyte complement receptor (cr1) as a privileged site: binding of immunoglobulin g to erythrocyte cr1 does not target erythrocytes for phagocytosis antigenbased heteropolymers facilitate, via primate erythrocyte complement receptor type 1, rapid erythrocyte binding of an autoantibody and its clearance from the circulation in rhesus monkeys quantitative studies of heteropolymer-mediated binding of inactivated marburg virus to the complement receptor on primate erythrocytes antigen-based heteropolymers, a potential therapy for binding and clearing autoantibodies via erythrocyte cr1 infusion of bispecific monoclonal antibody complexes into monkeys provides immunologic protection against later challenge with a model pathogen radioimmunotherapy of interleukin-2r alpha-expressing adult t-cell leukemia with yttrium-90-labeled anti-tac monoclonal antibody therapy of cancer colorectal cancer as a model for immunotherapy advances in cancer immunotherapy antibody-targeted immunotherapy for treatment of malignancy first mab approved for treatment of metastatic breast cancer breast cancer biology blossoms in the clinic response of metastatic breast cancer to trastuzumab anti-her2 antibody and heregulin suppress growth of her2-overexpressing human breast cancer cells through different mechanisms tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents are solid tumor anti-idiotype vaccines ready for prime time? immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody aca125: immune responses and survival in palliative treatment clinical and immune responses in advanced melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside gd2 delivery of monoclonal antibodies to the tumor cells monoclonal antibody-based therapy of melanoma radioimmunoconjugate therapy of non-hodgkin's lymphoma tumor markers as targets for selective diagnostic and therapeutic procedures monoclonal antibody therapy in organ transplantation immunotoxin therapy of graft-versus-host disease immunotoxins: an update anti-tac-h, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival reduction of acute renal allograft rejection by daclizumab. daclizumab double therapy study group how do monoclonal antibodies induce tolerance? a role for infectious tolerance? treatment of posttransplant lymphoproliferative disorder with the anti-cd20 monoclonal antibody rituximab alone in an adult after liver transplantation: a new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid organ transplantation rituximab (anti-cd20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases protective effect of an anti-lfa 1 monoclonal antibody (odulimomab) on renal damage due to ischemia and kidney autotransplantation cytomegalovirus infections after treatment with daclizumab, an anti il-2 receptor antibody, for prevention of renal allograft rejection infliximab for the treatment of fistulas in patients with crohn's disease therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with lowdose weekly methotrexate in rheumatoid arthritis antibodies to tumour necrosis factor alpha as treatment for crohn's disease tumor necrosis factor blockers in rheumatoid arthritis monoclonal antibody therapy in rheumatoid arthritis treatment of allergic asthma with monoclonal anti-ige antibody. rhu mab-e25 study group treatment of allergic asthma with monoclonal anti-ige antibody anti-ige therapy for asthma treatment of allergic asthma with monoclonal anti-ige antibody monoclonal antibodies in sepsis and septic shock treatment of gram-negative bacteremia and septic shock with ha-1a human monoclonal antibody against endotoxin. a randomized, double-blind, placebo-controlled trial double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. norasept ii study group adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide antibodies proposed as therapeutic agents anti-endotoxin monoclonal antibodies human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries effects of monoclonal antibody combined with ganciclovir or (s)-1-[3-hydroxy-(2-phosphonylmethoxy)-propyl]cytosine against murine cytomegalovirus infections in cell culture and in severe combined immunodeficient mice protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies msl-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the monoclonal antibody cytomegalovirus retinitis trial. the studies of ocular complications of aids research group ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with okt3 monoclonal antibodies human monoclonal antibodies neutralizing cytomegalovirus (cmv) for prophylaxis of cmv disease: report of a phase i trial in bone marrow recipients characterization of human anti-cytomegalovirus monoclonal antibody as biologics a humanized antibody against human cytomegalovirus (cmv) gp ul75 (gh) for prophylaxis or treatment of cmv infections american academy of pediatrics committee on infectious diseases and committee of fetus and newborn. prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of rsv-igiv respiratory syncytial virus (rsv) immune globulin and palivizumab for prevention of rsv infection directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries effective antibody therapy in herpes simplex virus ocular infection: characterization of recipient immune response use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease ability of monoclonal antibody to herpes simplex virus glycoprotein gb to promote healing of herpetic skin lesions in nude mice protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoprotein passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential topically applied human recombinant monoclonal igg 1 antibody and its fab and f(ab')2 fragments protect mice from vaginal transmission of hsv-2 epitopes involved in antibody-mediated protection from ebola virus isolation and characterization of human monoclonal antibodies to digoxin drug-specific antibodies as antidotes for tricyclic antidepressant overdose automated immunosensing system for 3,5,6-trichloro-2-pyridinol application to surface water samples exploiting antibody-based technologies to manage environmental pollution pharmacokinetic mechanisms for obtaining high renal coelimination of phencyclidine and a monoclonal antiphencyclidine antigen-binding fragment of immunoglobulin g in the rat prevention of paraquat toxicity in suspensions of alveolar type ii cells by paraquatspecific antibodies production and characterization of a monoclonal antibody against domoic acid and its application to enzyme immunoassay antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats pharmacodynamics of a monoclonal antiphencyclidine fab with broad selectivity for phencyclidine-like drugs antibodies as pharmacokinetic and metabolic modifiers of neurotoxicity antibodies may treat overdoses, addiction phencyclidine-specific fab fragments alter phencyclidine disposition in dogs crystal structure of monoclonal 6b5 fab complexed with phencyclidine disposition of a monoclonal anti-phencyclidine fab fragment of immunoglobulin g in rats drug-fighting drugs reactive immunization a catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis natural and artificial enzymes against cocaine. i. monoclonal antibody 15a10 and the reinforcing effects of cocaine in rats evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat selfadministration model we thank carolyn m. black and the national center for infectious diseases editorial office for the critical review of this manuscript. key: cord-007726-bqlf72fe authors: rydell-törmänen, kristina; johnson, jill r. title: the applicability of mouse models to the study of human disease date: 2018-11-09 journal: mouse cell culture doi: 10.1007/978-1-4939-9086-3_1 sha: doc_id: 7726 cord_uid: bqlf72fe the laboratory mouse mus musculus has long been used as a model organism to test hypotheses and treatments related to understanding the mechanisms of disease in humans; however, for these experiments to be relevant, it is important to know the complex ways in which mice are similar to humans and, crucially, the ways in which they differ. in this chapter, an in-depth analysis of these similarities and differences is provided to allow researchers to use mouse models of human disease and primary cells derived from these animal models under the most appropriate and meaningful conditions. although there are considerable differences between mice and humans, particularly regarding genetics, physiology, and immunology, a more thorough understanding of these differences and their effects on the function of the whole organism will provide deeper insights into relevant disease mechanisms and potential drug targets for further clinical investigation. using specific examples of mouse models of human lung disease, i.e., asthma, chronic obstructive pulmonary disease, and pulmonary fibrosis, this chapter explores the most salient features of mouse models of human disease and provides a full assessment of the advantages and limitations of these models, focusing on the relevance of disease induction and their ability to replicate critical features of human disease pathophysiology and response to treatment. the chapter concludes with a discussion on the future of using mice in medical research with regard to ethical and technological considerations. although the genetic lineages of mice and humans diverged around 75 million years ago, these two species have evolved to live together, particularly since the development of agriculture. for millennia, mice (mus musculus) were considered to be pests due to their propensity to ravenously consume stored foodstuff (mush in ancient sanskrit means "to steal" [1] ) and their ability to adapt to a wide range of environmental conditions. since the 1700s, domesticated mice have been bred and kept as companion animals, and in victorian england, "fancy" mice were prized for their variations in coat color and comportment; these mouse strains were the forerunners to the strains used in the laboratory today. robert hooke performed the first recorded inquiry-driven experiments on mice in 1664, when he investigated the effects of changes in air pressure on respiratory function [2] . more recently, with data from the human genome project and sequencing of the mus musculus genome showing remarkable genetic homology between these species, as well as the advent of biotechnology and the development of myriad knockout and transgenic mouse strains, it is clear why the mouse has become the most ubiquitous model organism used to study human disease. in addition, their small size, rapid breeding, and ease of handling are all important advantages to scientists for practical and financial reasons. however, keeping in mind that mice are fellow vertebrates and mammals, there are ethical issues inherent to using these animals in medical research. this chapter will provide an overview of the important similarities and differences between mus musculus and homo sapiens and their relevance to the use of the mouse as a model organism and provide specific examples of the quality of mouse models used to investigate the mechanisms, pathology, and treatment of human lung diseases. we will then conclude with an assessment of the future of mice in medical research considering ethical and technological advances. as a model organism used to test hypotheses and treatments related to human disease, it is important to understand the complex ways in which mice are similar to humans, and crucially, the ways in which they differ. a clear understanding of these aspects will allow researchers to use mouse models of human disease and primary cells derived from mice under the most appropriate and meaningful conditions. in 2014, the encyclopedia of dna elements (encode) program published a comparative analysis of the genomes of homo sapiens and mus musculus [3] , as well as an in-depth analysis of the differences in the regulatory landscape of the genomes of these species [4] . encode, a follow-up to the human genome project, was implemented by the national human genome research institute (nhgri) at the national institutes of health in order to develop a comprehensive catalog of protein-encoding and nonproteincoding genes and the regulatory elements that control gene expression in a number of species. this was achieved using a number of genomic approaches (e.g., rna-seq, dnase-seq, and chip-seq) to assess gene expression in over 100 mouse cell types and tissues; the data were then compared with the human genome. overall, these studies showed that although gene expression is fairly similar between mice and humans, considerable differences were observed in the regulatory networks controlling the activity of the immune system, metabolic functions, and responses to stress, all of which have important implications when using mice to model human disease. in essence, mice and humans demonstrate genetic similarity with regulatory divergence. specifically, there is a high degree of similarity in transcription factor networks but a great deal of divergence in the cis-regulatory elements that control gene transcription in the mouse and human genomes. moreover, the chromatin landscape in cell types of similar lineages in mouse and human is both developmentally stable and evolutionarily conserved [3] . of particular relevance regarding modeling human diseases involving the immune system, in its assessment of transcription factor networks, the mouse encode consortium revealed potentially important differences in the activity of ets1 in the mouse and human genome. although conserved between the two species, divergence in ets1 regulation may be responsible for discrepancies in the function of the immune system in mouse and human [4] . certainly, the biological consequences of these differences in gene expression and regulation between human and mouse invite further investigation. the anatomical and physiological differences between model organisms and humans can have profound impacts on interpreting experimental results. virtually every biological process under investigation in experimental studies involves at least one anatomical structure. to aid in interpretation, many anatomy compendia have been developed for model organisms; the most useful organize anatomical entities into hierarchies representing the structure of the human body, e.g., the foundational model of anatomy developed by the structural informatics group at the university of washington [5] . although an analysis of the myriad differences between mouse and human anatomy is beyond the scope of this chapter, a few of the most critical issues that have an impact on the interpretation of data from mouse experiments should be mentioned. the most obvious difference between mice and humans is size; the human body is about 2500 times larger than that of the mouse. size influences many aspects of biology, particularly the metabolic rate, which is correlated to body size in placental mammals through the relationship bmr ¼ 70 â mass (0.75), where bmr is the basal metabolic rate (in kcal/day). thus, the mouse bmr is roughly seven times faster than that of an average-sized human [6] . this higher bmr has effects on thermoregulation, nutrient demand, and nutrient supply. as such, mice have greater amounts of metabolically active tissues (e.g., liver and kidney) and more extensive deposits of brown fat [6] . furthermore, mice more readily produce reactive oxygen species than do humans, which is an important consideration when modeling human diseases involving the induction of oxidative stress (i.e., aging, inflammation, and neurodegeneration) [6] . the lung provides an excellent example of the similarities and differences between human and mouse anatomy. similar to the human organ, the mouse lung is subdivided into lobes of lung parenchyma containing a branching bronchial tree and is vascularized by the pulmonary circulation originating from the right ventricle. there are a number of subtle variations in this general structure between species, i.e., the number of lobes on the right and left, the branching pattern, and the distribution of cartilage rings around the large airways, but the most important differences between the mouse and human lung are related to the organism's size (airway diameter and alveolar size are naturally much smaller in the mouse) and respiratory rate. moreover, there are important differences in the blood supply of the large airways in humans versus mice [7] . specifically, the bronchial circulation (a branch of the high-pressure systemic circulation that arises from the aorta and intercostal arteries) supplies a miniscule proportion of the pulmonary tissue in mice (the trachea and bronchi) compared to humans; the majority of the lung parenchyma is supplied by the low-pressure, high-flow pulmonary circulation. in the mouse, these systemic blood vessels do not penetrate into the intraparenchymal airways, as they do in larger species [8] . this difference, although subtle, has important ramifications regarding the vascular supply of lung tumors which, in humans, is primarily derived from the systemic circulation [9] . these differences may also have profound consequences when modeling human diseases involving the lung vasculature. the adaptive immune system evolved in jawed fish about 500 million years ago, well before the evolution of mammals and the divergence of mouse and human ancestral species [10] . many features of the adaptive immune system, including antigen recognition, clonal selection, antibody production, and immunological tolerance, have been maintained since they first arose in early vertebrates. however, the finer details of the mouse and human immune systems differ considerably, which is not surprising since these species diverged 75 million years ago [6] . while some have claimed that these differences mean that research into immunological phenomena in mice is not transferable to humans, as long as these differences are understood and acknowledged, the study of mouse immune responses can continue to be relevant. research on mice has been vital to the discovery of key features of both innate and adaptive immune responses; for example, the first descriptions of the major histocompatibility complex, the t cell receptor, and antibody synthesis were derived from experiments performed on mice [6] . the general structure of the immune system is similar in mice and humans, with similar mediators and cell types involved in rapid, innate immune responses (complement, macrophages, neutrophils, and natural killer cells) as well as adaptive immune responses informed by antigen-presenting dendritic cells and executed by b and t cells. however, due to the anatomical and physiological differences between these species as described above, divergence in key features of the immune system, such as the maintenance of memory t cells (related to the life span of the organism) and the commensal microbiota (related to the lifestyle of the organism), has arisen [11] . similar to what has been discovered regarding the genetics of mice and humans, i.e., broad similarities in structure but considerable differences in regulation, there are a number of known discrepancies in the regulation of innate and adaptive immunity in mouse models of human disease mice versus humans, including the balance of leukocyte subsets, t cell activation and costimulation, antibody subtypes and cellular responses to antibody, th1/th2 differentiation, and responses to pathogens (described in detail in table 1 ). in addition to these differences in immune cell functions, the expression of specific genes involved in immune responses also differs, particularly those for toll-like receptors, defensins, nk inhibitory receptors, thy-1, and many components of chemokine and cytokine signaling; additionally, differences between mouse strains are known to exist for many of these mediators [12] . another important consideration when using mice to perform immunological research (with a view to translating these findings to human medicine) is the availability of hundreds of strains of genetically modified mice that have enabled exquisitely detailed studies on immune cell function, regulation, and trafficking. many of these strains involve the expression of inducible cre or cas9 that allow for targeted knockdown or overexpression of key immune function-related genes in specific cell types at specific moments in time. however, it is important to note that drift between mouse colonies has long been known to occur. in fact, a recent report described the fortuitous discovery of a point mutation in the natural cytotoxicity receptor 1 (ncr1) gene in the c57/bl6 cd45.1 mouse strain, resulting in absent ncr1 expression. this mutation was found to have profound effects on the response of mice to viral infection, i.e., the mice were resistant to cytomegalovirus infection but more susceptible to influenza virus [23] . this cautionary tale highlights the importance of understanding the genetic evolution of laboratory strains of mice, the effect of these genetic and immunological changes on mouse biology, and the impact on the translation of these results to human medicine. in addition to the differences between mouse and human genetics, physiology, and immunology highlighted above, several factors must also be taken into account when performing in vitro assays using isolated mouse cells and applying these findings to our understanding of human disease. particularly with regard to stem cell research, it should be noted that the telomeres of mouse cells are five-to tenfold longer than human telomeres, resulting in greater replicative capacity [24] . there are also important differences in the regulation of pluripotency and stem cell differentiation pathways in humans and mice [25] . moreover, there are considerable species differences in the longevity of cultured cells; for example, mouse fibroblasts are capable of spontaneous immortalization in vitro, whereas human fibroblasts become senescent and ultimately fail to thrive in culture [26] . in summary, although there are considerable differences between mice and humans, constant improvement in the analytical techniques used to delineate these differences and their effects on whole organism and cell function have provided vital information and contributed to our understanding of both murine and human biology. experimentation employing mouse models of human disease will continue to provide key insights into relevant disease mechanisms and potential drug targets for further clinical investigation. however, several important considerations must be taken into account when selecting a mouse model of human disease, as described in the following section, using mouse models of human lung disease to illustrate this point. the two most salient features of a mouse model of human disease are the accuracy of its etiology (it employs a physiologically relevant method of disease induction) and its presentation (its ability to recapitulate the features of human disease). the relevance of any given mouse model can be judged on the basis of these two criteria, and there is considerable variation within mouse models of human disease in this regard. as a full assessment of the advantages and limitations of all currently available mouse models of human disease would be prohibitively long and complex, here we have elected to assess the accuracy of currently available models of human lung diseases, i.e., asthma, chronic obstructive pulmonary disease, and pulmonary fibrosis, focusing on the relevance of disease induction in these models and their ability to replicate critical features of human disease pathophysiology and response to treatment. the first and foremost notion when modeling human disease in mice is to acknowledge the species differences, which are significant [27] . as described above, genetics, anatomy, physiology, and immunology differ between mice and humans, but despite these differences, mouse models of human disease are useful and necessary, as long as data interpretation is performed appropriately. an elegant example of differences between mice and humans that must be considered when designing a mouse model of human inflammatory lung disease is the key effector cell type in human asthma, i.e., mast cells. these leukocytes differ in granule composition as well as localization in the mouse and human airways [28] . mice mostly lack mast cells in the peripheral lung [29] , whereas humans have numerous mast cells of multiple subpopulations in the alveolar parenchyma [30] . another example is anatomy: in contrast to humans, mice lack an extensive pulmonary circulation, which may have significant effects on leukocyte adhesion and migration, and subsequently inflammation [31] . still, as long as these differences are taken into consideration, mouse models can be powerful tools in the discovery and exploitation of new targets for the treatment of human disease. the world health organization (who) defines asthma as a chronic disease characterized by recurrent attacks of breathlessness and wheezing, which may vary in severity and frequency from person to person. the disease is characterized by airway hyperresponsiveness, airway smooth muscle thickening, increased mucus secretion and collagen deposition, as well as prominent inflammation affecting both large and small airways [32] . nowadays, it is recognized that asthma is not a single homogenous disease but rather several different phenotypes united by similar clinical symptoms [32, 33] . only a few animal species develop asthma naturally, including cats and horses [34, 35] , whereas mice do not [31] . however, mice can be manipulated to develop a type of allergic airway inflammation, which is similar in many ways to the human disease, in response to different aeroallergens [36] . importantly, these models are capable of recapitulating only the allergic type of human asthma and have less relevance for other types of asthma (i.e., endotypes induced by medication, obesity, and air pollution). as with many human diseases, asthma has a complex and multifaceted etiology, where environmental factors, genetic susceptibility, and microbial colonization all contribute; thus, it is important to take strain differences into consideration. generations of inbreeding have created mouse strains that differ not only in coat color and disposition but also from a physiological, immunological, and genetic perspective. different strains may be more susceptible to allergic airway inflammation or pulmonary fibrosis, whereas others are more or less resistant. choosing the right strain to model a specific disease or pathologic event is thus essential. the most widely used strains for models of allergic airway inflammation are balb/c and c57bl/6. these strains differ regarding the type of immune response mounted to an inhaled allergen: c57bl/6 is generally considered a t h 1-skewed strain, whereas balb/c is regarded as a t h 2-skewed strain [36] . due to their strong t h 2response, and subsequent development of robust asthmatic responses, balb/c has been commonly used to model asthma [37] . however, most humans do not express such a strongly t h 2-skewed immune system, suggesting this strain may not be the best model of human disease; instead, c57bl/6 may be more suitable as immune responses in this strain are more similar to those of atopic human subjects [37] . furthermore, as c57bl/6 is the most commonly used strain for the development of genetically manipulated mice, using these mice allows for very specific investigations into disease pathology; thus, this strain is increasingly used in models of human lung disease. besides the genetic differences in the mouse strains used in these models, the etiology (the method of disease induction) of commonly used models of asthma is highly variable. in humans with allergic asthma, environmental allergen exposure occurs at the airway mucosa; the immune response is coordinated in the bronchopulmonary lymph nodes, and the t cells, macrophages, and eosinophils recruited as part of this response travel to the lung where they mediate the cardinal features of asthma: airway inflammation, structural remodeling of the airway wall, and airway hyperreactivity [38] . ideally, these features should be found in a physiologically relevant mouse model of asthma. however, for the sake of cost and convenience, early mouse models of asthma used the surrogate protein ovalbumin (ova) [31] rather than an environmental allergen to induce an immune response, which also requires the use of a powerful t h 2-polarizing adjuvant such as alum delivered via the intraperitoneal route, followed by ova nebulization-a clear divergence from the etiology of human asthma [36] . in terms of disease presentation, mice develop some hallmarks of asthma, including airway eosinophilic inflammation, goblet cell metaplasia, and increased airway smooth muscle density [31] . after the cessation of ova exposure, most of the remodeling resolves, although some structural alterations remain up to 1 month after the last challenge [39] . based on these attributes, the ova model is primarily a model to investigate the initiation of inflammation, rather than the chronic progression and maintenance of inflammation [31] . a clear advantage with the ova model is the number of studies where it is used; both the pros and cons are familiar. it is easy to find a suitable protocol, and the model is readily accessible and flexible regarding the number of sensitizations and allergen doses. the model is relatively easy to reproduce, as ova and different adjuvants are easily obtained. however, the resolution of remodeling following the cessation of allergen provocations is a disadvantage, as is the practical problem with the nebulization of an allergen-it ends up in the mouse's coat and is ingested during grooming, potentially resulting in systemic exposure (this is particularly relevant in models employing systemic, intraperitoneal sensitization). in addition, concerns have been raised against the use of adjuvants to induce the immunological response, as well as the clinical relevance of ova as an allergen, which have driven the development of more clinically relevant allergens and models [31] . the common environmental aeroallergen house dust mite (hdm) extract is increasingly used to initiate disease in mouse models of allergic airway inflammation, as it is a common human allergen (around 50% of asthmatics are sensitized to hdm [40] ) that evokes asthma attacks and other allergic responses in susceptible individuals. in addition, hdm has inherent allergenic properties, likely due to components with protease activity [40] , so there is no need to use an adjuvant, thus improving the etiological similarity of these models with the clinical situation [41] . in contrast to ova, prolonged exposure of hdm (up to 7 weeks) induces asthma-like severe airway inflammation with prominent eosinophilia, severe hyperreactivity to methacholine, and robust remodeling of the airway wall [41] , i.e., the presentation of chronic respiratory hdm exposure in mice effectively recapitulates the key features of human allergic asthma. importantly, the airway structural changes induced by chronic hdm exposure, such as increased collagen deposition, airway smooth muscle thickening, and microvascular alterations, persist for at least 4 weeks after the cessation of hdm exposure [42] , another commonality with human asthma in which airway remodeling is currently considered to be irreversible. thus, the advantages of using hdm as the allergen in mouse models of asthma are the clinical relevance of the allergen [43] and the route of delivery via the respiratory tract. moreover, studies have shown that the type of inflammation and characteristics of tissue remodeling are relatively similar to those seen in human asthmatics [35, 41, 43] . one disadvantage is the complexity of hdm extract; as a consequence of this complexity, variations exist in some components between batches, particularly regarding the content of lipopolysaccharide, so reproducibility in these studies may be problematic. with similarity to hdm, these models were developed to be as clinically relevant as possible, as many patients suffer from allergy toward cockroach allergen, molds, and other environmental irritants. a common feature of these allergens is their complex nature, as they commonly consist of a mix of different allergic epitopes and fragments. this complexity is most likely why the immunological reaction in mice is relatively similar to that seen in asthmatics [44] . cockroach allergen (cra) is a common allergen, known to induce asthma in susceptible individuals; thus, it shares with hdm the advantage of being highly clinically relevant [45] . cra induces peribronchial inflammation with significant eosinophilic inflammation and transient airway hyperresponsiveness, both of which can be increased by repeated administrations of the allergen [45] . colonization of the airways with aspergillus fumigatus is the cause of allergic bronchopulmonary aspergillosis (abpa), a disease where the lungs are colonized by the fungus, but allergens from aspergillus fumigatus can also induce asthma similar to other allergens [46] . the reaction to aspergillus allergens is robust, and often no adjuvants are needed to elicit inflammation [46] . in addition to aspergillus, other fungi such as penicillium and alternaria can also induce asthma in humans and have been used to model disease in mice [47] . a common difficulty with these allergens is the method of administration, as the physiological route is believed to be the inhalation of dry allergens; mimicking this route with a nebulizer introduces the risk of the animals ingesting the allergen and thus causing systemic responses [47] . exacerbations of asthma are defined as the worsening of symptoms, prompting an adjustment in treatment, and are believed to be associated with increased inflammation in the distal airways. clinically, exacerbations are believed to be induced by infections (most common), allergen exposure, or pollutants, which can be modeled in different ways [48, 49] : 1. infections with viruses and bacteria or exposure to proteins/ dna/rna derived from these microbes. 2. administration of a high dose of allergen in a previously sensitized animal. 3. exposure to environmental pollutants, such as diesel exhaust or ozone. modeling exacerbations adds a layer of complexity, as robust ongoing allergic airway inflammation needs to be established first, before challenge with the exacerbating agent. both the ova and hdm models are used in this respect, and in both cases chronic protocols extending for several weeks before triggering an exacerbation have been used [48] . chronic obstructive pulmonary disease (copd) is characterized by chronic airway obstruction, in contrast to asthma where the obstruction is reversible (particularly in response to bronchodilator treatment). clinically, in copd, chronic bronchitis and emphysema can occur either separately or in combination. copd is almost always associated with either first-or secondhand tobacco smoking or in rare cases with a deficiency in the production of α1antitrypsin (a serpin that prevents elastin breakdown as a result of neutrophil degranulation) [50] . the etiology of copd is highly complex and is believed to develop after many years of smoking in combination with other known factors such as genetic susceptibility or environmental factors [51] . in similarity to asthma, inflammation is a major component in copd, but the leukocyte profile is very different: the most prominent players in copd-related inflammation are neutrophils and, to some degree, macrophages [51] . due to the complex etiology of copd, it is difficult to recapitulate all aspects of this disease in a single model, so in most cases, the aim is to induce copd-like lesions by exposing mice to tissue-damaging substances (usually cigarette smoke) or to mimic emphysema by the administration of tissue-degrading enzymes [27, 51] . clearly, mice do not smoke cigarettes on their own, so to model copd by cigarette smoke (cs) inhalation, the mice need to be exposed to unfiltered cs in an induction chamber; moreover, in an attempt to better model the chronic aspects of copd, this needs to be performed for a prolonged period of time. mice are very tolerant to cs, but eventually (over a period of several weeks), cs induces pulmonary neutrophilic inflammation that is associated with some degree of tissue degradation and destruction [51] . an important advantage of this model is the fact that cs is the actual irritant responsible for disease in humans, and mice develop several features similar to the clinical disease, making this model highly clinically relevant [27] . a significant drawback is the self-limitation of the model-the pathological changes do not progress after the cessation of cs exposure [51] . furthermore, the exposure time needed for mice to develop copd-like pathology is extensive, i.e., studies have shown that an exposure protocol of 5 days per week for a minimum of 3 months is needed to generate robust structural changes to the lung [52]. the pathological image in copd is complex and varies greatly between patients, commonly encompassing chronic bronchitis and bronchiolitis, emphysema, fibrosis, and airway obstruction. although mice develop some of these symptoms when exposed to cs, they do not develop all the symptoms of human disease; thus, cs has advantages as a model but fails to mimic the complexity of the clinical situation and disease presentation [27] . other models of copd rely on the administration of proteases (protein-degrading enzymes) that are believed to be involved in the pathology of this disease in a subset of patients, such as elastindegrading elastase. this approach mimics the emphysematous changes seen in copd, but the pathological process underlying tissue destruction is likely very different compared to the clinical situation [51] , as very few patients show evidence of elastase dysregulation [27] . however, if the aim of the study is to investigate the general effect of protease-induced tissue destruction and regeneration, then this is a highly relevant method [51] . some studies on copd have also used genetically modified animals, such as mice overexpressing collagenase, which results in tissue destruction without inflammation or fibrosis with an end result fairly similar to the type of emphysema observed in copd [53] . pulmonary fibrosis, the accumulation of fibrotic tissue within the alveolar parenchyma, is merely a symptom of disease, and the etiology of this pathology in humans varies greatly [54] . the most enigmatic class is perhaps the idiopathic interstitial pneumonias, especially idiopathic pulmonary fibrosis (ipf). ipf is a debilitating and progressive disease with a grave prognosis, characterized by progressive fibrosis believed to reflect aberrant tissue regeneration [55] . as the reason behind this defective repair is unknown, although a combination of immunological, genetic, and environmental factors are suspected, it is very difficult to model disease in a clinically relevant fashion [56] . the most common method used to model pulmonary fibrosis in mice is administration of the chemotherapeutic agent bleomycin; this agent is known to cause pulmonary fibrosis in humans as well, but this may not accurately reflect the true etiology of most cases of human disease. the strain of choice is c57bl/6, as it is prone to developing pulmonary fibrosis, whereas balb/c is relatively resistant, a feature believed to reflect the cytokine response following cellular stress and damage [57] . bleomycin administration can be performed locally or systemically, producing very different results. the most common model of pulmonary fibrosis is a single intranasal or intratracheal administration of bleomycin, with analysis 3 to 4 weeks later. during this time, the drug causes acute tissue damage in a restricted area of the lung (where the solution ends up during administration), followed by intense inflammation in this area and subsequent fibrosis, which gradually resolves within weeks. however, if older mice are used, the fibrosis will persist longer than in younger mice, which is in accordance with clinical ipf, where the majority of the patients are 65 years of age or older [56, 58] . a great advantage of this model is how well-characterized it is. in addition, local administration is labor-effective, as only one administration is required and the result is highly reproducible. the fibrosis is robust, only affects the lungs, and the accumulation of extracellular matrix can be easily measured using standard techniques [58] . furthermore, as it is used throughout the world, studies performed in different labs and by different groups can be compared relatively easily. unfortunately, the intense pulmonary inflammation may be lethal, and fatalities are to be expected with this model [59] , representing an important ethical limitation. furthermore, fibrosis is heterogeneous-it develops where the bleomycin solution is deposited. the solution usually deposits within the central lung, a localization that is not in agreement with the clinical situation where fibrosis is located in the more distal regions of the lung parenchyma. in addition, the fibrosis that develops as a result of severe tissue damage is self-limiting and reversible, unlike what is observed clinically [58] . the severe degree of tissue damage induced by bleomycin may in fact be more relevant for modeling acute lung injury (ali) or acute respiratory distress syndrome (ards). bleomycin can also be administered systemically, through intravenous or subcutaneous injection. in contrast to local administration, this route requires multiple administrations and is thus more laborintensive [58] . some studies have described the usage of osmotic mini-pumps, where bleomycin is slowly administered over a short period of time, and then fibrosis continues to develop over subsequent weeks [60] . irrespective of the route of delivery, systemic administration results in more homogenous fibrosis, affecting the entire lung through the pulmonary endothelium and persisting much longer than following local administration [61] . the main advantages of systemic administration are that inflammation is limited, while the fibrosis is more apparent and displays a more distal pattern, all of which mimics the clinical situation relatively well. the multiple administrations allow for lower doses with each injection; this is less stressful to the animals and results in little to no mortality [61] and is thus more ethically acceptable. a major disadvantage with this model is that it takes time for fibrosis to develop [58] , which may be the reason it is used relatively scarcely, and thus the pathological development is less well-understood. in addition, as ipf is a local disease, local administration of the etiologic agent may better mimic the clinical reality [56] . the administration of fluorescein isothiocyanate (fitc) induces focal inflammation, primarily involving mononuclear cells and neutrophils, and localizes in areas where the fitc solution is deposited [58] . antibodies against fitc can be detected after 1 week, and the fibrosis persists for up to 5 months after instillation [58] . the benefits of this model are mainly related to the persistent fibrosis that does not appear to be self-limiting, thus reflecting the clinical situation, and it is also very easy to determine which part of the lung has been exposed to fitc, as the molecule is fluorescent [58] . it is also an advantage that both c57bl/6 and balb/c mice are susceptible and develop fibrosis following fitc administration [56] . the disadvantages of this model include profound variability due to differences between batches of fitc, as well as in the method used to prepare the solution before instillation. importantly, given the characteristics of the etiologic agent used to induce this model of ipf, this model is considered a very artificial system with limited clinical relevance [56] . adenovirus vectors have been used to overexpress the pro-fibrotic cytokine transforming growth factor (tgf)-β, which results in pulmonary fibrosis. as tgf-β overexpression in the lungs is known to be crucial in the development of fibrosis in humans [62] , this model mimics an important feature of disease etiology. however, the delivery system has some drawbacks, as the virus itself initiates an immune response. moreover, adenoviruses display significant tropism for epithelial cells and rarely infect other cell types such as fibroblasts [58] , which are the cells meant to be targeted in this model. as tgf-β has major effects on fibroblast biology, the main feature of this model is the effect of epitheliumderived tgf-β on fibroblasts and myofibroblasts, resulting in the deposition of ecm proteins and areas of dense fibrosis [63] . an advantage of this model is the relatively low degree of inflammation, as well as what appears to be a direct effect on fibroblasts/ myofibroblasts [63] , which is in accordance with the clinical situation (as we understand it today). silica administration induces a similar pathology in mouse lungs as in humans exposed to silica, and as is also observed in human silicainduced fibrosis, structural remodeling persists when administration is halted [56] . following the administration of silica particles, fibrotic nodules develop in mouse lungs, with considerable resemblance to the human lesions that develop after exposure to mineral fibers [56] . the fibrotic response is accompanied by a limited inflammatory response, and different pro-fibrotic cytokines such as tgf-β, platelet-derived growth factor, and il-10 are involved in disease development, which is in accordance with the clinical situation [56] . another advantage is that nodules develop around silica fibers, and these fibers are easy to identify by light microscopy. the response in this model is strain-dependent, with c57bl/6 mice being the most susceptible. the main drawbacks are the time required to establish disease, i.e., 30-60 days, and the need for special equipment to aerosolize the silica particles. however, since the route of administration, the driving etiologic agent, and the resulting pathobiology are all similar to the characteristics of this subtype of pulmonary fibrosis [56, 58] , the silica exposure model can be considered to have very good clinical relevance. 7 what does the future hold for mouse models of human disease? medical research using experimental animals (not only mice but other animals including rats, guinea pigs, zebrafish, and fruit flies) has greatly contributed to many important scientific and medical advances in the past century and will continue to do so into the near future. these advances have contributed to the development of new medicines and treatments for human disease and have therefore played a vital role in increasing the human life span and improving quality of life. despite the acknowledged benefits of performing research using experimental animals, a number of considerations must be made before embarking on this type of research. of course, the financial aspects of conducting this type of work are an important limitation, as the costs of purchasing and housing mice can be prohibitive, especially when genetically modified mice and colony maintenance are required for the study. the practicalities of working with animals such as mice may also be an issue, as this type of work requires specialized facilities, equipment, and staff to ensure studies are carried out in a manner that is safe for both the researchers and the animals. moreover, as discussed in detail in this chapter, the relevance of the selected animal model to human disease must be carefully evaluated to ensure that these experiments provide robust results that are translatable to human health and disease. another important and demanding aspect of biomedical research using animals is the ethics of imposing pain and suffering on live animals. although there has been a considerable reduction in the numbers of animals used in research in the last 30 years, animal research remains a vital part of biomedical research. however, no responsible scientist wants to cause unnecessary suffering in experimental animals if it can be avoided, so scientists have accepted controls on the use of animals for medical research. in the uk, this ethical framework has been enshrined in law, i.e., the animals (scientific procedures) act 1986. this legislation requires that applications for a project license to perform research involving the use of "protected" animals (including all vertebrates and cephalopods) must be fully assessed with regard to any harm imposed on the animals. this involves a detailed examination of the proposed procedures and experiments, and the numbers and types of animal used, with robust statistical calculations to support these numbers. the planned studies are then considered in light of the potential benefits of the project. both within and outside the uk, approval for a study involving protected animals also requires an internal ethical review process, usually conducted by the research institution where the work is taking place, with the aim of promoting animal welfare by ensuring the work will be carried out in an ethical manner and that the use of animals is justified. additionally, the uk has a national animal use reduction strategy supported by the national centre for the replacement, refinement and reduction of animals in research (nc3rs; london, uk). this consortium was established in 2004 to promote and develop high-quality research that takes the principles of replacement, refinement, and reduction (the 3rs) into account. replacement strategies often involve the use of alternative, non-protected species (e.g., zebrafish, fruit flies, flatworms) and in vitro correlates (two-dimensional cell culture or threedimensional organoids containing multiple cell types) to test hypotheses and assess the effects of therapeutic interventions. the main obstacle with studies on non-protected animals is the difficulty of accurately mimicking the complex physiological systems involved in human health and disease, as described in detail above. for example, the fruit fly drosophila melanogaster is an excellent model organism for studies on genetic diseases, aging, and pathogen-borne illnesses but may be less relevant for studies on complex lung diseases. importantly, model organisms such as fruit flies, zebrafish, and flatworms do not possess lungs, which somewhat limits the translatability of research on these animals in the field of respiratory disease. as such, it is likely that rodents will remain the model organism of choice for studies into lung disease for some time to come. there has been considerable progress recently in imitating single organs such as the liver, lung, and brain in vitro using multiple cell types and a physical scaffold. as an important advantage, these in vitro tests have replaced a large number of rodents in initial drug discovery experiments, while also speeding up the process [64] . these studies still require further refinement and validation to establish them as suitable models for an entire organ; importantly, these in vitro organoids cannot take into account interactions between organ systems in complex, multisystem diseases such as copd. refinement involves selecting the most clinically relevant model for the disease available, informed by the discussion above on closely recapitulating the etiologic agent and disease pathobiology associated with clinical cases. another important factor is refining the management of pain. an assessment of the procedures used and the effects of the substance on the animal, as well as the degree of handling, restraint, and analgesia, are other important aspects of refinement. this standard of animal care is achieved through strict regulations and controls on how personnel are trained to carry out experiments on live animals. adequate training is an important aspect of refinement and should be reviewed and improved on an ongoing basis. moreover, refinement can be achieved by improving animal housing by environmental enrichment, e.g., providing a place for mice to hide in the cage and housing social animals such as mice in appropriate-sized groups. these simple changes can improve the physiological and behavioral status of research animals; this not only increases animal well-being but also contributes to the quality of the experimental results by reducing stress levels. the 3rs aspect of reduction focuses on the statistical power of experiments and by following the animal research: reporting of in vivo experiments (arrive) guidelines, originally published in plos biology in 2010. these guidelines provide a framework to improve the reporting of research performed on live animals by maximizing the quality of the scientific data and by minimizing unnecessary studies. the arrive guidelines provide a checklist of aspects that must be considered in good quality research using live animals. the guidelines are most appropriate for comparative studies involving two or more groups of experimental animals with at least one control group, but they also apply to studies involving drug dosing in which a single animal is used as its own control (within-subject experiments). the guidelines provide recommendations on what should be considered when preparing to report on the results of experiments involving live animals, i.e., by providing a concise but thorough background on the scientific theory and why and how animals were used to test a hypothesis, a statement on ethical approvals and study design including power and sample size calculations, a clear description of the methods used to ensure repeatability, objective measurements of outcomes and adverse effects, and interpretation of the results in light of the available literature and the limitations of the study. in addition to the positive impact of the arrive guidelines on reducing the number of animals used in experiments, this checklist provides an easy-tofollow roadmap on what is required for good quality reporting of experimental results. in conclusion, the use of animals in research will continue to be an important aspect of medical research, and these procedures can be ethically justified provided the proper controls are in place. the benefits of animal research have been vital to the progress of medical science; abandoning these studies would have severe negative consequences on human health. by considering aspects such as the 3rs and the arrive guidelines in planning experiments involving live animals, the number of animals used and suffering of these animals for the benefit of human health can be minimized. this requires a strong regulatory framework such as that found in the uk and many other countries, as well an ongoing public debate on the advantages and limitations of animal experimentation. use of house mice in biomedical research the laboratory mouse a comparative encyclopedia of dna elements in the mouse genome principles of regulatory information conservation between mouse and human of mice and men: aligning mouse and human anatomies mouse models of human disease: an evolutionary perspective structure and composition of pulmonary arteries, capillaries, and veins angiogenesis in the mouse lung lung cancer perfusion: can we measure pulmonary and bronchial circulation simultaneously? origin and evolution of the adaptive immune system: genetic events and selective pressures the evolutionary basis for differences between the immune systems of man, mouse, pig and ruminants of mice and not men: differences between mouse and human immunology gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods species differences in the expression of major histocompatibility complex class ii antigens on coronary artery endothelium: implications for cellmediated xenoreactivity icos is critical for cd40-mediated antibody class switching homozygous loss of icos is associated with adultonset common variable immunodeficiency b7-h3: a costimulatory molecule for t cell activation and ifn-gamma production global gene regulation during activation of immunoglobulin class switching in human b cells selective loss of type i interferon-induced stat4 activation caused by a minisatellite insertion in mouse stat2 regulation of human helper t cell subset differentiation by cytokines functional dichotomy in the cd4+ t cell response to schistosoma mansoni what animal models teach humans about tuberculosis cutting edge: check your mice-a point mutation in the ncr1 locus identified in cd45.1 congenic mice with consequences in mouse susceptibility to infection comparative computational analysis of pluripotency in human and mouse stem cells the transition from primary culture to spontaneous immortalization in mouse fibroblast populations studying human respiratory disease in animals -role of induced and naturally occurring models role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data allergic airway inflammation induces migration of mast cell populations into the mouse airway novel site-specific mast cell subpopulations in the human lung animal models of asthma: reprise or reboot? emerging molecular phenotypes of asthma allergens in veterinary medicine immunologic responses following respiratory sensitization to house dust mite allergens in mice understanding asthma using animal models use of the cockroach antigen model of acute asthma to determine the immunomodulatory role of early exposure to gastrointestinal infection t cell homing to epithelial barriers in allergic disease allergic airway inflammation initiates long-term vascular remodeling of the pulmonary circulation respiratory allergy caused by house dust mites: what do we really know? continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling induction of vascular remodeling in the lung by chronic house dust mite exposure lung responses in murine models of experimental asthma: value of house dust mite over ovalbumin sensitization a novel mouse model of experimental asthma temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia animal models of allergic bronchopulmonary aspergillosis murine models of airway fungal exposure and allergic sensitization mouse models of acute exacerbations of allergic asthma mouse models of severe asthma: understanding the mechanisms of steroid resistance, tissue remodelling and disease exacerbation novel variants of ser-pin1a gene: interplay between alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease different lung responses to cigarette smoke in two strains of mice sensitive to oxidants collagenase expression in the lungs of transgenic mice causes pulmonary emphysema tissue remodelling in pulmonary fibrosis idiopathic pulmonary fibrosis exploring animal models that resemble idiopathic pulmonary fibrosis the role of mouse strain differences in the susceptibility to fibrosis: a systematic review murine models of pulmonary fibrosis highly selective endothelin-1 receptor a inhibition prevents bleomycin-induced pulmonary inflammation and fibrosis in mice (r)-resolvin d1 ameliorates bleomycin-induced pulmonary fibrosis in mice extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis smad3 signaling involved in pulmonary fibrosis and emphysema adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung the ethics of animal research. talking point on the use of animals in scientific research key: cord-003634-iq0e1qp1 authors: otxoa-de-amezaga, amaia; miró-mur, francesc; pedragosa, jordi; gallizioli, mattia; justicia, carles; gaja-capdevila, núria; ruíz-jaen, francisca; salas-perdomo, angélica; bosch, anna; calvo, maria; márquez-kisinousky, leonardo; denes, adam; gunzer, matthias; planas, anna m. title: microglial cell loss after ischemic stroke favors brain neutrophil accumulation date: 2018-12-22 journal: acta neuropathol doi: 10.1007/s00401-018-1954-4 sha: doc_id: 3634 cord_uid: iq0e1qp1 stroke attracts neutrophils to the injured brain tissue where they can damage the integrity of the blood–brain barrier and exacerbate the lesion. however, the mechanisms involved in neutrophil transmigration, location and accumulation in the ischemic brain are not fully elucidated. neutrophils can reach the perivascular spaces of brain vessels after crossing the endothelial cell layer and endothelial basal lamina of post-capillary venules, or migrating from the leptomeninges following pial vessel extravasation and/or a suggested translocation from the skull bone marrow. based on previous observations of microglia phagocytosing neutrophils recruited to the ischemic brain lesion, we hypothesized that microglial cells might control neutrophil accumulation in the injured brain. we studied a model of permanent occlusion of the middle cerebral artery in mice, including microgliaand neutrophil-reporter mice. using various in vitro and in vivo strategies to impair microglial function or to eliminate microglia by targeting colony stimulating factor 1 receptor (csf1r), this study demonstrates that microglial phagocytosis of neutrophils has fundamental consequences for the ischemic tissue. we found that reactive microglia engulf neutrophils at the periphery of the ischemic lesion, whereas local microglial cell loss and dystrophy occurring in the ischemic core are associated with the accumulation of neutrophils first in perivascular spaces and later in the parenchyma. accordingly, microglia depletion by long-term treatment with a csf1r inhibitor increased the numbers of neutrophils and enlarged the ischemic lesion. hence, microglial phagocytic function sets a critical line of defense against the vascular and tissue damaging capacity of neutrophils in brain ischemia. electronic supplementary material: the online version of this article (10.1007/s00401-018-1954-4) contains supplementary material, which is available to authorized users. neutrophil infiltration under conditions of sterile inflammation can contribute to tissue injury. neutrophils are transiently detected in the brain after stroke since they are rapidly attracted to the injured brain peaking between 1 and 3 days post-ischemia [10, 23, 24, 51] . compelling evidence suggests that neutrophils are contributors to tissue damage after ischemic stroke [35, 44, 51, 61, 64] , in spite of the fact that diverse experimental strategies inhibiting neutrophil activation or depleting neutrophils provided conflicting results [16, 61] . likely, the differences between experimental studies depend on the efficacy and potential side effects of the diverse neutrophil depleting or inhibiting strategies, status of capillary reperfusion, lesion severity, and integrity of the blood-brain barrier (bbb). moreover, several aspects of neutrophil infiltration after acute ischemic brain damage remain controversial. neutrophils accumulate in perivascular spaces in murine and human strokes [17, 55] . the presence of neutrophils in the brain parenchyma has been reported in rodent models of permanent ischemia [23, 51, 55] , but it is more controversial in experimental models of transient ischemia [17, 64] . several studies reported the presence of neutrophils in the brain parenchyma in postmortem samples of patients deceased between day 1 and 5 [55] , or 3 days after stroke onset but not at other time points [56, 76] . in other studies, neutrophils were not detected in the brain parenchyma of stroke patients [17] . therefore, the molecular determinants underlying perivascular neutrophil accumulation and the conditions facilitating the potential access of neutrophils to the brain parenchyma need further clarification. the observation that microglia phagocytose neutrophils in the ischemic brain [50] [51] [52] led us to hypothesize that microglia function may be critical to explain neutrophil accumulation in the injured brain tissue. microglial cells react to brain ischemia in different ways depending on the regional location and temporal course of the lesion. microglial cells are vulnerable to ischemia and previous reports showed death of microglia after oxygen and glucose deprivation in tissue slices [18] and cell cultures [41, 73] . in addition, microglial reduction has been reported after transient mcao [43] , and microglial dysfunction and loss was detected in classical neuropathological studies of brain ischemia in rodents and primates [3, 4] . classical histopathological studies have shown long-lasting microgliosis surrounding the infarction several days after ischemic stroke onset. however, the progression of this reaction from the very acute phase of stroke is less precisely determined mainly due to the fact that microglia and infiltrating macrophages show many common features and markers leading to the frequent terminology of microglia/macrophages to describe the mononuclear myeloid cell reaction that follows stroke. microglia have a unique transcriptomic signature distinguishable from that of macrophages or monocytes [7, 32] . therefore, reactive microglia and infiltrating macrophages likely play different functions in the injured brain tissue. current developments allow the distinction between these cells with antibodies against more specific microglia markers [1, 7] , availability of fluorescent reporter mice [74] , or transfer of fluorescent reporter leukocytes [46] . by exploiting some of these novel experimental possibilities, we investigated the neutrophil-microglia crosstalk after brain ischemia. the results show that microglial cells effectively remove brain-infiltrating neutrophils, hence microglia dysfunction or death is associated with neutrophil accumulation into the injured brain tissue. we used adult male mice on the c57bl/6 background. mice expressing tamoxifen-inducible cre recombinase under the direction of the cx3cr1 promoter in the mononuclear phagocyte system (cx3cr1 cre/ert2 ) [74] (#020940 jax ® mice) were crossed with either ai 9 mice harboring a loxp-flanked stop cassette that prevents transcription of the red fluorescent protein tdtomato (tdt) (b6.cg-gt(rosa) 26sortm9 (cag-tdtomato)hze/j (#007909 jax ® mice) [42] , or colony stimulating factor 1 receptor (csf1r) +/flox mice (b6.cg-csf1r tm1jwp /j, #021212 jax ® mice). we used heterozygous catchup ivm mice expressing tdt in ly6g +/− neutrophils [26] . homozygous catchup ivm (ly6g −/− ) mice were crossed with cx3cr1 gfp/gfp mice to obtain double heterozygous mice with red fluorescent neutrophils and green fluorescent microglia [50, 75] . we also obtained cells from dsred mice constitutively expressing the red fluorescent protein dsred under the control of the actin promoter [8] . wildtype mice were obtained from a commercial source (janvier, france). mice were maintained in the animal house of the school of medicine of the university of barcelona under controlled spf conditions. animal work was conducted with the approval of the ethical committee of the university of barcelona (ceea) and the direcció general de polítiques ambientals i medi natural, departament de territori i sostenibilitat de la generalitat de catalunya. studies complied with the "principles of laboratory animal care" (nih publication no. 86-23, revised 1985), and the spanish national law (real decreto 53/2013). the brains of six patients suffering from acute ischemic stroke who died between 1 and 6 days after stroke onset at the stroke unit of the hospital clinic of barcelona were used after obtaining written consent from their relatives or legal representatives for tissue removal after death at the neurological tissue bank of the biobank-hospital clinic-institut d'investigacions biomèdiques august pi i sunyer (idibaps). the ethics committee of this hospital approved the study. online resource 1 shows a summary of patient characteristics. the elapsed time from death to autopsy was 2-8 h. an expert neuropathologist dissected the ischemic core, periphery, and a portion of non-ischemic tissue (control) obtained from a region distant to infarction, as described [55] . samples were embedded in oct and immediately frozen in liquid nitrogen for sectioning at 5 µm in a cryostat. the bone marrow of transgenic dsred mice [46] was used to generate chimeric mice, as reported [37] . in brief, recipient adult (2-month old) wild-type mice received three intraperitoneal injections of the chemotherapeutic agent busulfan (30 mg/g body weight) 7, 5 and 3 days prior to transfer via the tail vein of five million bone marrow cells from dsred donor mice. mice were used 8 weeks after grafting and reconstitution was assessed by flow cytometry analysis. to impair microglial function, mice received a daily oral administration by gavage of the csf1r inhibitor gw2580 [12] (75 mg/kg body weight in a volume of 0.2 ml) (#s8042, selleckchem) for 4 days, which is a dosing regimen that does not challenge microglial survival [54] . treatment controls received the same volume of the vehicle (0.5% hydroxypropylcellulose, 0.1% tween-80). treatment started 2 h prior to induction of ischemia, it was randomly allocated, and was administered in a blinded fashion. for microglia depletion, mice received the csf1r inhibitor plx5622 (plexxikon) following previously reported protocols [15, 33, 69] . the inhibitor was mixed into ain-76a standard chow at 1200 ppm (brogaarden, denmark). mice (8-week-old) received the diet ad libitum for 3 weeks prior to induction of ischemia and the diet was maintained until the mice were killed. treatment controls received ain-76a diet for the same period of time. both diets were given in parallel in groups of five animals per cage. surgery was carried out under isoflurane anaesthesia and mice received analgesia (buprenorphine, 140 µl of a 0.015 mg/ml solution, via s.c.). permanent occlusion of the middle cerebral artery (mcao) was induced by coagulation of the distal portion of the right mca together with ligation of the ipsilateral common carotid artery. this experimental model induces a focal cortical lesion in the ipsilateral hemisphere. a subset of mice receiving the above diets (control or plx5622) was used to study the volume of the lesion 1 day after induction of ischemia by t2w mri in a 7.0 t biospec 70/30 horizontal animal scanner (bruker biospin, ettlingen, germany), as reported [13] . sample size was calculated using g*power 3.1 software (university of dusseldorf) with an alpha level of 0.05, statistical power of 0.95, and estimating a size effect of 1.8 based on sd of previous results from our laboratory and published data on the effect of microglia depletion on infarct volume in other stroke models [65] . one mouse died (control diet), and one mouse was excluded (plx5622 diet) due to surgical problems. bromodeoxyuridine (brdu) (10 mg/ml) (#550891, bs pharmingen) was daily injected (150 μl) via i.p. into mice starting 1 day after mcao until day 4. one-hour after the last brdu administration mice were killed and processed for immunofluorescence. brdu was detected in brain tissue sections using a rat monoclonal fitc-anti-brdu antibody (1:50, #ab74545, abcam, cambridge, uk) [46] . mouse blood and brain tissue were processed for flow cytometry as described [46] . fc receptors were blocked by previous incubation for 10 min with cd16/cd32 (clone 2.4g2, bd pharmingen) in facs buffer (pbs, 2 mm edta, 2% fbs) at 4 °c. live/dead aqua cell stain (molecular probe, invitrogen) was used to determine the viability of cells. cells were incubated with the following mix of microglia cells from adult mice (9-14 weeks old) were isolated and cultured using immunomagnetic separation (miltenyi biotec, germany). mice were perfused via the left ventricle with 60 ml of cold saline and collected in hanks' balanced salt solution (hbss) buffer without calcium/magnesium (#14175-05; life technologies). the brain tissue was enzymatically dissociated using the neural tissue dissociation kit-p (#130-092-628; miltenyi biotec). the gentlemacs™ dissociator with heaters (#130-096-427; miltenyi biotec) was used for mechanical dissociation steps during 30 min at 37 °c. the digested tissue was filtered (70 µm) with hbss buffer with calcium and magnesium (#14025-050; life technologies) and prepared for myelin removal process (myelin removal beads ii, #130-096-733; miltenyi biotec). then, cells were magnetically labeled with cd11b microbeads (#130-093-634; miltenyi biotec) diluted in pbs supplemented with 0.5% bsa for 15 min in the dark in the refrigerator (2-8 °c) . cd11b + cells were collected using magnetic field columns (miltenyi biotec). cell suspensions (35 μl) were then plated in complete medium consisting of dmem medium (#10569010; gibco-brl) supplemented with 10% fetal bovine serum (fbs; gibco-brl) containing 40 u/ml penicillin and 40 μg/ml streptomycin (#15140122; gibco-brl) added as a drop in the middle of each well of a poly-l-lysine (#p4832; sigma) pre-coated 8-well plate (µ-slide 8 well, ibidi #80826). cells were incubated for 30 min at 37 °c and then 250 µl of complete medium were carefully added to each well. twenty-four hours later, we replaced 50% of complete medium, and we did a full medium change at day 5. the cells were maintained at 37 °c in a humidified atmosphere of 5% co 2 for 7 div. we obtained human microglial cells from the ischemic tissue of one patient deceased 5 days after fatal stroke. fresh brain tissue (about 500 mg) was harvested at autopsy (8 h after death) and was placed in a falcon tube with sterile cold rpmi 1640 medium (#21875-034, gibco). visible meninges were removed, the tissue was cut in small pieces using a scalpel and incubated in a 0.25% trypsin-edta solution in pbs at rt for 30 min. then, dmem/f12 (#11330032; gibco-brl) with 20% fbs and dnase i (200 units/ml) was added (1:1), the tissue was disaggregated, centrifuged for 7 min at 250×g and the pellet was re-suspended in 30 ml dmem/f12 supplemented with 10% fbs, 10% l-cell conditioned medium obtained from the l929 cell line, and 100 u/ml penicillin/100 μg/ml streptomycin (#15140122; gibco-brl). cells were seeded in poly-l-lysine coated t25 flasks, incubated in 5% co 2 at 37 °c and allowed to adhere. culture medium was changed twice a week and at 7div the cells were scrapped and seeded in a 8-well plate (µ-slide 8 well, ibidi #80826) previously coated o/n with poly-l-lysine. a time-lapse microscopy study was initiated 6 h later after addition of fresh bone marrow neutrophils. afterwards, we fixed the cells for an immunofluorescence study with antibodies against the purinergic receptor p2y, g-protein coupled, 12 (p2ry12) (1:200, #as55042a, anaspec). neutrophils were obtained from the bone marrow of adult (10-14 weeks old) mice. the bone marrow was flushed using a 25-gauge needle with rpmi 1640 (#21875-034, gibco) supplemented with 10% fbs onto a 50 ml falcon tube through a 70-μm cell strainer. cells were centrifuged at 300×g for 5 min. the supernatant was discarded and cells were then incubated for 2 min with an erythrocyte lysis solution (150 mm nh 4 cl, 1 mm khco 3 , 0.1 mm edta). after washing with cold pbs supplemented with 2% fbs, cells were incubated at 4 °c for 15 min with a mix of fcblock (1/200; clone 2.4g2; bd pharmingen; bd bioscience), and the antibody ly6g (clone 1a8, fitc; bd pharmingen) with 10 µl/10 7 cells. cells were washed with pbs-0.5% bsa, and were then incubated with anti-fitc microbeads (#130-048-701, miltenyi biotec) for 15 min at 4 °c with 10 µl microbeads/10 7 cells. after washing, the fraction of positive ly6g cells was magnetically collected and prepared for immediate use or cells were frozen in fbs serum with 10% of dmso until the day of the experiment. human neutrophils were isolated from the blood by density gradient centrifugation. human and mouse neutrophils were stained with celltracker™ green cmfda (#c2925; ther-mofisher scientific). fig. 1 localization of microglia and infiltrating leukocytes. we generated chimeric mice by administering dsred fluorescent bone marrow cells to 2-month old wild-type receptor mice (n = 10). after 2 months, we induced ischemia and 4 days later we studied the brain by immunofluorescence (n = 5) (a, b) and flow cytometry (n = 5) (c, e). a cd45 hi cd11b hi cells infiltrating the ipsilateral hemisphere are mostly dsred + whereas cd45 dim cd11b dim microglial cells are dsred − . b flow cytometry shows an increase in infiltrating dsred leukocytes (cd11b hi cd45 hi ) (mann-whitney test, **p = 0.008). c immunostaining of astrocytes (gfap, green) showed the presence of dsred cells at the border and core of the lesion separated from the peripheral area that shows a prominent astroglial reaction. d microglial cells were stained with an antibody against p2ry12 (green), which did not co-localize with dsred + leukocytes. the morphology of the microglia in the different regions is illustrated with representative images. cell nuclei were stained with to-pro3 (blue). e p2ry12 + microglial cell at the border of the lesion nearby dsred + infiltrating leukocytes. f schematic representation of the distribution of microglia (green) and infiltrating leukocytes (red) in the different regions of the ischemic hemisphere. scale bar c 50 µm; d, e 10 µm . c-f analysis of microglial morphology in the core and periphery of the ipsilateral cortex and the contralateral cortex (contral.) (n = 25-49 cells per region of 5 different mice represented by the different colors) using imagej tools. g, h imaris analysis of 3d-reconstructions of the above cells (b). i counting the number of microglial cells per area showed an increased microglial density in the periphery and a decrease in the core (n = 17-27 fields in 5 different mice). statistical analyses in c-i were carried out with the kruskal-wallis test followed by the dunn's test. **p < 0.01 and ***p < 0.001 vs. contralateral microglia; && p < 0.01 and &&& p < 0.001 vs. peripheral microglia. j flow cytometry after dissecting out the core and periphery regions of the ipsilateral hemisphere and mirror regions of the contralateral hemisphere 1 and 4 days after mcao in an independent group of mice (n = 5 mice per time point). for comparative purposes the number of microglial cells (cd45 low cd11b + ) is expressed by mg of brain tissue. data analysis was conducted with two-way anova by region (p < 0.0001) and time point (p = 0.039) followed by the bonferroni test. the number of microglia was higher in the periphery than the core of infarction 1 day ( && p < 0.01) and 4 days ( &&& p < 0.001) after mcao. furthermore, the number of microglia decreased in the core of infarction versus the corresponding contralateral region 1 day (**p < 0.01) and 4 days (*p < 0.05) postischemia. in the periphery, the number of microglia cells increased in the ipsilateral versus the corresponding contralateral hemisphere at day 4 ( # p < 0.05). scale bar 10 μm isolated and stained neutrophils (75,000 cells/ml) were added to the adult microglia cultures at 7div. automated multiposition live cell imaging was carried out using a leica tcs sp5 confocal microscope (leica microsystems, heidelberg, germany) equipped with adaptive focus control to keep the specimen in focus and an incubation system with temperature and co 2 control. cells were subjected to a timelapse study while maintained at 37 °c in a humidified atmosphere of 5% co 2 . all images (3-4 z sections) were acquired using a apo 63 × (numerical aperture 1.3) glycerol immersion objective lens, pinhole set at 1.5 airy units. images of cmfda and dsred were acquired sequentially line by line using 488 and 561 laser lines and detection ranges at 500-550 and 570-650, respectively. simultaneously, bright field images were acquired. multiposition confocal images were acquired every 4 min during 12-14 h, with an image matrix of 512 × 512 pixel; 600 hz; 2 × line average and autofocus control. manual analysis was performed using fiji software (version 2.0.0-rc-67/1.52d). we recorded 3-4 timelapse videos per well and analysed 180-210 frames in each video. in every frame, manual tracking of neutrophils was performed using the mtrackj plugin [45] to identify phagocytosis of neutrophils by microglial cells. we studied in parallel four wells per genotype (csf1r +/+ or csf1r +/− microglial cells) in each independent experiment and conducted five independent experiments. the analysis was performed in a blinded fashion by assigning a code to each video that did not reveal the identity of the genotype. we used green fluorescent zymosan a bioparticles (#z-23373; thermo fisher scientific) in the phagocytosis assay. at 7 div, microglial cells were exposed to zymosan fluorescent beads (75,000 particles/ml) for 1 h. following 3-4 washes to remove all the non-phagocyted particles, cells were fixed with cold 4% paraformaldehyde for 20 min, permeabilized with 0.2% triton x-100 (sigma) in pbs 0.1 m for 15 min, blocked with 3% goat serum in pbs for 1 h, and incubated overnight at 4 °c with the primary rabbit antibody against the p2ry12 receptor (1:200, #as55042a, anaspec). the next day, cells were washed and incubated with red fluorescence alexa fluor ® 546 dye-labelled goat anti-rabbit igg antibody (#a10036, life technologies) for 1 h at room temperature. dapi (#d3571, life technologies) stained was performed to visualize the cell nuclei. cells were then covered using fluoromount-g ® (southern biotech, birmingham, al, usa). images were obtained with a fluorescence inverted microscope (leica ctr 40000). mice were perfused via the left heart ventricle with 40 ml of cold saline (0.9%) followed by 20 ml of cold 4% paraformaldehyde (pfa) diluted in phosphate buffer (pb) ph 7.4. the brain was removed, fixed overnight with the same fixative, and immersed in 30% sucrose in pb for cryoprotection for at least 48 h until the brains were completely sunk to the bottom of the tube. after that, brains were frozen in isopentane at − 40 °c. cryostat brain sections (14-μm thick) were fixed in ethanol 70%, blocked with 3% normal serum, and incubated overnight at 4 °c with primary antibodies: rat monoclonal antibodies against ly6g cell nuclei were stained with dapi or to-pro3 (invitrogen). cryostat sections from human brain tissue were processed for immunofluorescence as described above with a rabbit polyclonal antibody against p2ry12 (1:200, #5042a, anaspec) and a mouse monoclonal antibody against ki67 (1:400, #9449, cell signaling tech). consecutive sections were stained with thionine for examination of the lesion at the light microscope. confocal images were obtained (tcs-spe-ii or sp5 microscopes from leica microsystems; or a zeiss lsm880 microscope) and were not further processed except for enhancing global signal intensity in the entire images for image presentation purposes using las software (leica), imagej, or adobe photoshop. for estimation of the density of p2ry12 + cells and ki67 + cells in human brain sections, images were obtained (40 × objective), the number of immunostained cells and cell nuclei per image were counted in ten different fields per brain region of each subject, and average values per region and time group were calculated. for cell counting in mouse brain sections, we obtained 5-6 confocal images of the immunostaining (63 × objective) in three different brain sections per mouse. microglia morphology was assessed using fiji software (version 2.0.0-rc-67/1.52d) and imaris software (ima-ris bitplane v.9.0). basic shape descriptors such 1 3 as the circularity index (ci) or the area were performed with the plugin shape descriptors [68] ; other parameters, such us the ramification index (ri), were obtained using the sholl analysis plugin [21] . parameters such as volume or sphericity index were measured using imaris software after creating a 3d surface in the maximum intensity projection image. then, microglial cells were thresholded by the huang method [34] to generate a binary mask (with a 1.5 mean filter). the ci parameter was calculated by the shape descriptors plugin (4p[area]/[perimeter] 2 ). the highest count of intersections (max inters) reflects the highest number of processes in the cell. two-group comparisons were carried out with the mann-whitney u test. for multiple group comparisons we used the kruskal-wallis test followed by the dunn's test. comparisons were two-sided. comparisons of groups by brain region and time were carried out with two-way anova followed by the bonferroni post-hoc analysis. twoway anova by genotype and experiment, with an experiment-matched design, was used to analyze quantification of in vitro studies. statistical analyses were performed with graphpad software. the specific test used in each experiment and n values are reported in the figure legends. to unequivocally distinguish microglia from infiltrating leukocytes we generated chimeric mice with the hematopoietic system derived from fluorescent (dsred) donor mice where microglia remained non-fluorescent, whereas a high proportion of peripheral myeloid cells were dsred + (fig. 1a; online resource 2). most myeloid cells infiltrating the ipsilateral brain hemisphere were dsred + 4 days after mcao, as assessed by flow cytometry (fig. 1a, b) , and they were preferentially located in the lesion core where the expression of gfap is lost (fig. 1c) . we stained microglia with anti-p2ry12 antibodies [7, 28, 59] and verified that the infiltrating dsred + cells were not p2ry12 + . microglia and infiltrating dsred + leukocytes co-existed at the border of infarction, whereas microglia were abundant at the infarct periphery but scarce in the core of the lesion (fig. 1d-f ). microglia acquired a reactive phenotype at the periphery and border of infarction with thicker ramifications compared to microglia of the contralateral hemisphere. in contrast, microglial cells in the infarcted core showed a dystrophic morphology since the cell body became smaller and there were only a few long ramifications showing an appearance of discontinuity as if they were broken or beaded, and the density appeared to be reduced (fig. 1d) . to ensure that in wild-type mice we did not miss microglial cells in the infarcted core due to downregulation of the markers used to label microglia, i.e. iba1 and p2ry12, we studied the cx3cr1 cre/ert2 mice [74] crossed with floxed rosa26:tdt reporter mice [42] , which express the red fluorescent protein in microglia (fig. 2a, b; online resource 3) obtaining the same findings as in wild-type mice. next, we analysed microglia morphology (online resource 4) in the contralateral hemisphere, and in different zones of the ipsilateral hemisphere, i.e. periphery and infarcted core, 4 days after mcao (fig. 2c-h) . shape descriptors showed increased circularity and reduced area of microglia in the ipsilateral hemisphere that was more marked in cells located in the core region (fig. 2c, d) . a sholl analysis showed that ischemia reduced the number of ramifications, and maximal intersections per microglial cell, and again the changes were greater in the core (fig. 2e, f) . analysis of 3d-reconstructions of the cells showed a reduced volume and higher sphericity index after ischemia, particularly in the core (fig. 2g, h) . furthermore, the quantification of cells per area showed that while microglial cell density increased in the periphery, it was reduced in the core of the lesion (fig. 2i) . this result was confirmed by flow cytometry after excising the core and periphery of the ipsilateral hemisphere and mirror regions of the contralateral hemisphere 1 and 4 days after mcao. microglia cell number was severely reduced in the core of the lesion at 1 and 4 days post-ischemia (fig. 2j) . altogether, these findings show that microglial cells are sensitive to persistent ischemic conditions and are lost in the infarcted core. fig. 3 microglial proliferation after ischemic stroke in mouse and human brain. immunofluorescence in mouse (a-c) and human (d-g) brain tissue. a-c brdu incorporation (green) in dsred − ramified microglial cells expressing p2ry12 (blue). d human tissue of stroke patients deceased at different time points after stroke onset. the brains were grouped according to the day of death after stroke in '1-3 days' (n = 3) and '4-6 days' (n = 3) groups. the number of p2ry12 + cells per area tended to decrease in the core of the lesion in both groups and to increase at the periphery of infarction in the '4-6 days' group. **p < 0.01 vs. periphery. the percentage of ki67 + cells among the p2ry12 + cell population increased at the periphery of infarction in the '4-6 days' group (***p < 0.001 vs. control and vs. core). e-g representative images of double-immunopositive p2ry12 (green) and ki67 (red) microglial cells (arrowheads) at the periphery of infarction from different stroke patients deceased 5 (e-f) or 6 (g) days after stroke. nuclei are stained with to-pro3 (blue). scale bar 10 µm in contrast to the lesion core, the microglial cell number increased at the periphery of infarction 4 days post-ischemia (fig. 2i, j) . this effect was attributable to microglial proliferation as shown in dsred chimeric mice that received injections of the cell proliferation marker brdu after mcao (fig. 3a-c) . by cell counting, we calculated that 26.8 ± 8.8% (mean ± sd, n = 3 mice) of the microglial cells at the periphery of infarction incorporated brdu suggesting microglial proliferation, in agreement with previous reports [14, 40] . in contrast, microglial cells were brdu − in the contralateral non-ischemic hemisphere. notably, brdu was found in ramified microglial cells suggesting that microglia could undergo cell division without regression of their differentiation status. we extended the results to the human brain by showing an increased number of microglial cells and proliferating ki67 + microglia at the periphery of infarction in post-mortem human brain tissue of stroke patients (fig. 3d-g) . we also found reduced microglial cell numbers in the lesion core of stroked human brains (fig. 3d) thus supporting that the findings in mice might be relevant to human stroke. our data identified the edge of the lesion as a site for possible interactions between microglia and leukocytes since both cell types were abundant in this zone. indeed, we observed numerous microglial cell processes surrounding the blood vessels and getting into contact with infiltrating dsred + leukocytes by sampling the dsred + cells adjacent to the vascular endothelium (online resource 5). furthermore, we detected microglial processes surrounding dsred + cells suggestive of engulfment of leukocytes (fig. 4a-c; online resource 6). 3d-reconstructions of confocal images showed phagosomes completely wrapping dsred + leukocytes (fig. 4b, c) . the csf1r signaling pathway is critical for survival of microglia and maintenance of their functions [2] , including endocytic processes [60] . consequently, by interfering with microglial function after oral administration of the csf1r inhibitor gw2580 [12] for 4 days, we found more dsred + cells at the periphery of infarction not surrounded by microglia or in apparent contact with microglia, suggesting that microglia dysfunction impaired the process of phagocytosis of leukocytes (fig. 4d) . neutrophils showed bright dsred fluorescence in the dsred chimeric mice, as assessed by flow cytometry and immunofluorescence 4 days post-ischemia (fig. 5a) . we detected ly6g + dsred + neutrophils shrouded by microglia at the periphery of infarction (fig. 5b, c) . furthermore, processes of microglial cells located nearby the surface of the cortex seemed to traverse the external cortical basement membrane and surround neutrophils located in the subpial space (fig. 5d) . catchup ivm mice crossed with transgenic cx3cr1 gfp/gfp mice allowed obtaining heterozygous double reporter mice with red fluorescent neutrophils and green fluorescent microglia [50, 75] . in these mice, we observed microglia (green) adjacent to the basal lamina of blood vessels and surrounding extravasated neutrophils (red) after mcao (fig. 5e to further investigate the phagocytosis of neutrophils by microglia, we carried out an in vitro study using time-lapse confocal microscopy. we isolated microglia from adult mouse brains, cultured the cells in vitro for 7 days, and exposed them to freshly isolated bone marrow neutrophils (stained with cmfda) to study phagocytosis. microglial cells phagocytosed neutrophils in vitro (fig. 6a, b , and timelapse microscopy movie in online resource 8). by following neutrophil trajectories along time (time-lapse microscopy movie in online resource 9), we counted the number of neutrophils phagocytosed by microglia. we validated that allogenicity in the phagocytosis experimental design was not interfering with the assay by comparing phagocytosis of neutrophils obtained from different mice with the phagocytosis of neutrophils from the same mouse. we found no differences, ruling out prime effects of allogenicity in the fig. 4 microglia cells phagocytose infiltrating dsred leukocytes. a-c chimeric mice were generated by bone marrow transfer from donor dsred mice to recipient wild type mice and were subjected to ischemia (n = 5). immunofluorescence showing iba1 + dsred − microglial cells engulfing dsred leukocytes at the periphery of infarction at day 4 after mcao. a confocal images of an iba1 + (green) dsred − microglial cell engulfing a dsred leukocyte. the images correspond to different z planes. b 3d-reconstructions of iba1 + dsred − microglial cells (blue) engulfing dsred + leukocytes (red). c microglial cell (iba1 + , blue) with engulfed red cells in several prolongations. nuclei are stained with dapi (white). magnified details of engulfed dsred cells are shown on the right hand side. f dsred chimeric mice received oral administration of either the csf1r inhibitor gw2580 or the vehicle (n = 5 per group) starting 2 h prior to mcao and then daily for 3 days. the brain was studied 4 days post-ischemia by immunofluorescence using anti-p2ry12 antibody to label microglia (green), dsred for infiltrating leukocytes, and to-pro-3 for staining the cell nuclei (blue). the image shows a microglial cell at the periphery of infarction engulfing dsred leukocytes. schematic representation of this cell illustrating: (a) a dsred cell completely surrounded by a microglial process; (b) a microglial process making apparent contact with a dsred leukocyte (touching); and (c) a dsred leukocyte separated from microglia (free). counting the number of dsred cells in the above status (a-c) in relation to microglia showed that the csf1r inhibitor increased (***p < 0.001) the number of free dsred cells. two-way anova by treatment and condition followed by the bonferroni test. scale bar corresponds to a, b 5 µm; c 10 µm for left image and 5 µm for the magnifications on the right; d 10 µm ◂ phagocytosis of neutrophils by microglia (online resource 10). given that we observed signs of impaired phagocytosis of neutrophils in vivo after ischemia in mice after shortterm treatment with a csf1r inhibitor (fig. 4d) , we investigated in vitro the role of csf1r in this process. to this end, we obtained microglia from adult mice with heterozygous csf1r +/− microglia (obtained by crossing cx3cr1 cre/ ert2 with csf1r flox/+ mice). less neutrophils were phagocytosed by csf1r +/− microglia compared to csf1r +/+ microglia, as assessed by time-lapse microscopy where we counted the neutrophils phagocytosed by microglia during the 14-h duration of the experiment (fig. 6c ). in addition, csf1r +/− microglia showed reduced phagocytic activity in a phagocytosis assay with fluorescent beads (fig. 6d-f ). we then studied the potential relevance of these findings for human cells by obtaining human microglia from the post-mortem brain of an ischemic stroke patient deceased 5 days after stroke onset. after maintaining the human cells in culture for 7 days, we exposed the cells to neutrophils obtained from blood of a donor control subject. we observed very active phagocytosis of neutrophils (fig. 6g, h and timelapse microscopy movie in online resource 11). by immunofluorescence after the ex vivo assay, we detected p2ry12 expression in the cells and observed that they contained material from neutrophils (fig. 6i) . neutrophil numbers were higher in the core of infarction than the periphery 1 and 4 days after mcao, as assessed by flow cytometry after dissection of these brain regions (fig. 7a) . neutrophils were seen in perivascular spaces of venules (fig. 7b) but also in the parenchyma outside the basement membrane in the core of the lesion (fig. 7c, d) . strikingly, neutrophils were found in the brain parenchyma in zones of the core where microglia was absent or showed signs of dystrophy, as assessed in immunostained brain sections of wild-type mice and reporter mice, including the cx3cr1 cre/ert2 -rosa26:tdt mice (fig. 7e ) and the catchup ivm -cx3cr1 +/− double reporter mice (fig. 7f-h) . at the periphery of infarction neutrophils were surrounded by reactive microglia, suggesting that microglia phagocytosed neutrophils thereby preventing their accumulation in this region. in contrast, in the core of infarction, dysfunction or loss of microglia might facilitate the accumulation of neutrophils. to obtain further evidence that microglia remove neutrophils after ischemia, we depleted microglia by feeding the mice for 3 weeks with a diet containing a csf1r antagonist (plx5622) [15, 33, 69] . plx5622 diet caused a strong reduction (90%) of the microglia population (fig. 8a ) but did not affect blood leukocyte counts (online resource 12 shows the gating strategy and cell quantifications are shown in online resource 13), in agreement with previous reports [20, 70] . however, we detected a reduction of a minor subset of blood ly6c − monocytes (online resource 13), which is dependent on csf1r [39] . in brain tissue, plx5622 diet reduced the numbers of infiltrating monocytes (40%) and f4/80 + macrophages (60%) versus the control diet 4 days post-ischemia (online resource 14), in agreement with previous findings suggesting a role for microglia in the recruitment of monocytes into the brain [20] . in contrast, the plx5622 diet increased the numbers of neutrophils in the brain tissue after ischemia, as assessed by flow cytometry at day 4 (fig. 8b) . immunofluorescence in cx3cr1 cre/ert2 :r26-tdt mice showed extravasated neutrophils that seemed more abundant in the absence of microglia (fig. 8c, d) . by counting the number of neutrophils located either in the parenchyma or associated with blood vessels (hence not crossing the parenchymal basal lamina) we found an increase in the percentage of parenchymal neutrophils in the absence of microglia 1 and 4 days post-ischemia (fig. 8e) . of note, neutrophils were often observed on the fig. 5 microglia engulf neutrophils. a-c chimeric mice generated by transfer of dsred bone marrow cells to wild type recipients. a flow cytometry shows cd11b + ly6g + dsred neutrophils in the ipsilateral but not the contralateral hemisphere (mann-whitney test, **p = 0.008, n = 5) 4 days post-ischemia. infiltrating neutrophils (nimp-r14 + , ly6g + ) are dsred + . b, c p2ry12 + microglial cells (blue) engulf neutrophils at the periphery of infarction. images obtained 4 days after mcao representative of n = 5 chimeric mice. d image of a cx3cr1 cre/ert2 :rosa26-tdt mouse 4 days after mcao showing a microglial cell (red) sending a process across the external basal lamina of the cortex (α4-laminin, blue) to trap a neutrophil (ly6g + , green) in the subpial space. e-i images obtained from cx3cr1 gfp/+ /catchup mice, which have gfp + microglia (green) and tdt + neutrophils (red) 1 day after mcao. sequence of confocal z-images showing the basal lamina (pan-laminin, blue) of a capillary with a neutrophil in the lumen and an extravasated neutrophil, surrounded by a microglial cell (e). z projections of one plane and confocal projection illustrating interaction of microglia with basal lamina and neutrophils (f-g). 3d-reconstructions showing the microglial cell (green) attached to the capillary (blue) and intraluminal (h) and extravasated (i) neutrophils (red). nuclei are stained with dapi (white). images were obtained from superficial cortical layers (a-c, e-i) and the brain surface (d) in zones corresponding to the core of the lesion (a), border of the lesion (d-i), and periphery (b, c). scale bar 10 μm ◂ 1 3 basement membrane of capillaries (fig. 8d) and venules (fig. 8f) suggesting a possible interaction of these cells with basal lamina components. in line with this, microglia depletion increased the size of the ischemic lesion (fig. 8g) , further supporting a beneficial effect of microglia at the periphery of the infarction. this study supports the concept that microglia phagocytose and remove neutrophils after brain ischemia [14, [50] [51] [52] and demonstrates that neutrophil accumulation in the brain parenchyma is associated with reduced microglial phagocytic activity, attributable to ischemia-induced microglial cell dysfunction due to loss or dystrophy. morphometric analysis of microglia showed changes in the periphery of the lesion compatible with microglial reactivity and similar to those reported [27] . overall, morphological changes of microglia within the lesion core were larger than in the periphery, for instance regarding the notable loss of ramifications and reduced cell size. such profound morphological changes of microglia in the lesion core might indicate a further process of transformation from reactive microglia to dystrophic microglia, potentially associated with cell dysfunction. furthermore, we found reduced microglial cell numbers in the core of infarction. while our results support microglial degeneration in the infarcted core, microglial cells proliferated and accumulated at the periphery of infarction in mouse and human brain, in agreement with previous findings in the mouse brain [14, 40] . these reactive microglial cells at the periphery of infarction phagocytosed neutrophils, suggesting that the phagocytic activity of microglia prevented neutrophil accumulation in this region. accordingly, the numbers of neutrophils were higher in the core than the periphery of the lesion. microglial activity and survival are critically dependent on csf1r [12] . consequently, drug-induced inhibition of csf1r or genetic reduction of csf1r expression in microglia impaired their phagocytic capacity in vivo and in vitro. previous studies reported that csf-1 promotes phagocytosis of ab1-42 peptide by primary human microglia in vitro [62] , and it regulates cell motility in macrophages [58] . csf1r is a tyrosine kinase that upon activation shows phosphorylation of several intracellular tyrosine residues [77] . upon activation, csf1r associates with several signaling molecules, notably phosphoinositide 3-kinase (pi3k) [58] . csf1r also activates akt [11] , and it induces erk1/2-mediated signaling in microglia [9] . akt [22, 67] and erk1/2 [19] are involved in the phagocytic process. however, the specific signaling molecules downstream of csf1r participating in phagocytosis in microglia after brain ischemia, and the precise step(s) of the phagocytic process affected by csfr1 remain to be identified. microglia depletion induced by long-term inhibition of csf1r in vivo [15, 33, 65, 69] increased the numbers of neutrophils in the ischemic brain tissue, further supporting the view that microglial cells contribute to neutrophil removal. neutrophils are attracted to the injured brain after acute stroke [10, 23, 30, 31, 50, 51] . thereby, neutrophils adhere to venules and migrate through the vessel wall to reach perivascular spaces [17] . in addition, neutrophils access perivascular spaces of penetrating cortical vessels from the leptomeninges [55] . accumulation of neutrophils in the leptomeninges might be due to extravasation from pial vessels. in addition, neutrophil migration from the skull bone marrow through direct anatomic connections [29] might explain the presence of neutrophils in the subarachnoid space, although migration of neutrophils from there to perivascular spaces of cortical vessels still needs further investigation. subpial neutrophils are separated from the brain parenchyma by the basement membrane and glia limitans. likewise, the parenchymal basal lamina and surrounding astrocyte end-feet separate perivascular cells from the brain parenchyma. interestingly, we observed ramifications of microglial cells apparently crossing the basal lamina suggesting the possibility that reactive microglia might sample the perivascular space and also the subpial space after brain ischemia. using intravital fig. 6 microglia phagocytose neutrophils in vitro under the control of microglial csf1r expression. microglial cells were obtained from adult mice (a-f) or a human stroke patient deceased 5 days after ischemic stroke (g-i). after 7 days in culture, the cells were exposed to corresponding control mouse or human neutrophils and studied by time-lapse confocal microscopy for 14 h. a, b microglia were obtained from dsred mice (red) and neutrophils were stained with cmfda (green). 3d-reconstructions of image sequences (1) (2) (3) (4) (5) of the time-lapse video (see supplementary video 3 and 4) illustrating the phagocytosis of neutrophils by mouse microglia (a). the time point of each image is indicated (hours:minutes). an original confocal image is shown b for illustrative purposes. c microglia cultures were obtained from csf1r +/+ (wt) and csf1r +/− littermate mice (n = 5 mice per genotype) and the cell cultures were exposed to neutrophils and studied by time-lapse microscopy, where microglial cells were seen by phase contrast and neutrophils were stained with cmfda and detected by green fluorescence. we studied four wells per mouse in each independent experiment (n = 5), recorded 3-4 videos of different fields per well, and analysed 180-210 frames per time-lapse video. quantification of the number of neutrophils phagocytosed by microglia (normalized by the number of microglia in each well) shows that heterozygous csf1r +/− microglia phagocytose less neutrophils than wt microglia. two-way anova by genotype and experiment, with an experiment-matched design, show a genotype effect ***p < 0.0001. d-f cultures of wt and csf1r +/− microglia were exposed to green fluorescent zymosan beads (n = 3 independent experiments). at the end of the experiment cells were fixed and immunostained with anti-p2ry12 antibodies (red) and the number of cells containing fluorescent beads was counted. compared to wt microglia (d), csf1r +/− microglia (e) also shows a reduced capacity to phagocytose zymosan beads (green) (f). two-way anova by genotype and experiment, as above, shows a significant genotype effect **p < 0.01. g sequential snapshot images (1-6) of human microglia obtained during the 12 h time-lapse microscopy study in which 720 frames were studied. the images illustrate neutrophil phagocytosis by human microglia at the indicated times (hours:minutes). h magnification of the indicated part of sequence 6 in g is shown to illustrate the engulfment of a neutrophil by a human microglial cell. i after the time lapse-experiment, human cells were fixed and stained with anti-p2ry12 antibodies (red). nuclei are shown in blue (dapi). the microglial cells contain material (green fluorescence) derived from digested neutrophils. scale bar 20 μm ◂ 1 3 microscopy, we previously found evidence that microglia phagocytosed neutrophils before they extravasated to the brain parenchyma [50, 51] . however, further studies are required to demonstrate whether microglia can really cross the external cortical basement membrane after brain ischemia. although we detected engulfment of complete cells by microglia, some of the images suggest that microglia may take portions of the neutrophils while they are located in the perivascular or subpial spaces, potentially through a process of trogocytosis [71] . the blood vessel glycocalyx and basement membrane composition varies between organs and inflammatory conditions suggesting that leukocytes may have to use diverse strategies to access different inflamed tissues [53] . in the brain, neutrophils cross the endothelial cell layer and the endothelial basal lamina of venules to reach the perivascular spaces after ischemia [17] . then, they accumulate in the perivascular spaces because they do not seem to readily cross the parenchymal basal lamina [17] , at least not at the same pace as they transmigrate through the former layers. however, the precise molecular determinants of this process remain to be identified. the different molecular composition of the two layers of basal lamina surrounding the perivascular spaces, local molecular diversity, and the finding that certain basal lamina components inhibit leukocyte transmigration [63] , might explain why neutrophils have more difficulty to cross the parenchymal than the endothelial basal lamina after brain ischemia. in a model of transient ischemia, there is evidence suggesting that neutrophils are kept in the perivascular spaces without infiltrating the brain parenchyma [17] , whereas other studies suggested that neutrophils reach the brain parenchyma [64] . it is plausible that stroke severity, status of microglia function, and time point of the study are critical determinants of the presence of neutrophils in the brain parenchyma. neutrophils located in the perivascular spaces might damage the basement membrane by releasing proteolytic enzymes and/or undergoing netosis [55] . however, at this stage we cannot exclude the possibility that neutrophils gained access to the brain parenchyma in a passive fashion after loss of vessel integrity in the ischemic core. several lines of evidence support that after brain ischemia neutrophils release proteolytic enzymes, promote matrix metalloproteinase (mmp) activation, and cause bbb breakdown [25, 35, 36, 57, 66, 72] . accordingly, blocking neutrophils or neutrophil-derived mmp-9 is markedly protective in models of systemic inflammation and stroke, e.g. [35, 44] . furthermore, pharmacological inhibition of neutrophil elastase or genetic deficiency of this enzyme reduced bbb disruption and vasogenic edema after transient mcao [64] suggesting that neutrophils contributed to vascular damage following stroke. in this study we showed that, after permanent ischemia, neutrophils gained access to the brain parenchyma of the lesion core when it was already severely damaged and microglia was lost due to persistent ischemia. under these conditions, parenchymal neutrophils might be bystanders of severe tissue damage. therefore, it is likely that preventing the access of neutrophils to the brain parenchyma in this model would not have a major impact on the size of the brain lesion since the damage is already established by the time the cells reach the parenchyma and the core of infarction will not recover. this possibility agrees with the finding that inhibition or deficiency of neutrophil elastase was not protective in models of permanent mcao [64] . in contrast, inhibiting microglial phagocytic activity in this model might bear negative effects by favoring neutrophil accumulation in the ischemic periphery. accordingly, detrimental effects of neutrophils became apparent in our study after microglia depletion causing an abnormal increase in neutrophils and larger ischemic lesions. a limitation of our study is that we did not assess stroke outcome in the long term. future work should investigate how microglia depletion affects the progression of the ischemic brain lesion and the neurological deficits. the results highlight an aspect of microglia phagocytic function that may be beneficial for the ischemic tissue. nonetheless, several mechanisms can contribute to the detrimental effect of microglia depletion and csf1r deficiency. for instance, pioneer studies demonstrated increased ischemic lesions related to reduced production of neurotrophic factors after depleting proliferating microglia [38] , and neuroprotective functions mediated by csf1r [47] . moreover, we previously identified that absence of microglia significantly augmented infarct size in a model of transient ischemia, in part mediated by dysregulation of fig. 7 the presence of neutrophils in the brain parenchyma is associated with dystrophy and loss of microglia. a flow cytometry analysis of cd11b + ly6g + neutrophils in the core and periphery of infarction and in mirror regions of the contralateral hemisphere 1 and 4 days after mcao (n = 5 mice per time point) shows that ischemia increases the number of neutrophils in the core of infarction more than the periphery (two-way anova, bonferroni test, ***p < 0.001). b-d brain confocal images 1 day after mcao (n = 8) show ly6g + neutrophils (green) in the perivascular space of a venule (b) and the parenchymal side of capillaries (c, d). the basal lamina is stained with pan-laminin (red) and nuclei are stained with to-pro3 (blue). e neutrophil (ly6g + , green) accumulation is higher at the border (dotted line) of the infarcted core than the periphery, whereas microglia (red cells, cx3cr1 cre/ert2 :rosa26-tdt mice) accumulate in the infarct periphery and are scarce in the core. the vascular basal lamina is shown in blue (pan-laminin). f-h images obtained from catchup mice crossed with cx3cr1 gfp/gfp mice at day 1 (f, g) and day 4 (h) postischemia. extravasated neutrophils (red) away from the vascular basal lamina (pan-laminin, blue) are seen in the core of the lesion where microglia (green) is absent or dystrophic, whereas neutrophils are surrounded by reactive microglial cells in the periphery (f). g examples (1-5) of microglial cells sending prolongations towards neutrophils 1 day after pmcao. neutrophils located in perivascular spaces extend protuberances crossing the basal lamina (1). extravasated neutrophils are seen near vessels with discontinuous basal lamina (2). they are surrounded by reactive microglia at the border of the lesion (2-4), but dystrophic microglia seem to be unable to fully reach the extravasated neutrophils (5) . h at day 4, microglial cells sending prolongations towards neutrophils are seen at the border of the lesion (1). extravasated neutrophils are seen in zones where microglia is dystrophic (1-2) or absent (3) (4) (5) . the vascular basal lamina is hardly detected at places where the neutrophils are located (3) . arrowheads indicate neutrophils, whereas arrows indicate microglia. the cell nuclei (dapi, white) are shown in g (4) (5) and h (1-3). scale bar 10 μm ◂ neuronal activity [65] . the latter model caused moderate leukocyte infiltration and we failed to observe a significant impact of microglia depletion on bbb injury and leukocyte recruitment, at least at the times examined [65] . in contrast to the findings suggesting beneficial effects of microglia in brain ischemia, several lines of evidence support that the phagocytic activity of microglia could exert negative effects by removing viable neurons through phagoptosis [5, 6, 48, 49] . it is possible that any negative consequences of phagoptosis of neurons might predominate under mild ischemic conditions where the inflammatory response is low, vascular integrity is preserved, and neutrophil attraction to the brain is negligible. collectively, our results support a model where microglia removes neutrophils from the parenchyma and perivascular and subpial spaces after brain ischemia. severe ischemic conditions induce local microglia loss/dystrophy facilitating the presence of neutrophils in perivascular spaces first and in the brain parenchyma later. overall, this study shows that reactive microglial cells phagocytose and remove neutrophils, whereas microglial loss or dysfunction enhances neutrophil accumulation in the ischemic lesion. our results, hence, suggest that microglia function is critical to prevent neutrophil infiltration to the brain parenchyma and to minimize the negative impact of neutrophils in the vascular bed after ischemic stroke. fig. 8 microglia depletion increases the number of neutrophils in the brain parenchyma. a schematic representation of the experimental design. eight-week old mice received a control or plx5622-containing diet for 21 days. then mcao was induced and the animals continued with the corresponding diet one or four more days until the end of the study. b flow cytometry (n = 7 mice per group) showed the microglia (cd45 low cd11b + cells) depleting effect of the plx5622 diet, and an increased number of neutrophils (cd11b + ly6g + ) in the ipsilateral hemisphere of mice with depleted microglia. two-way anova by treatment and brain hemisphere, and bonferroni posthoc test, **p < 0.01. c control or plx5622-containing diet was given to cx3cr1 cre/ert2 :rosa26-tdt mice with the same dosing regimen. microglia is shown in red, neutrophils in green (ly6g + ), the vascular basal lamina is stained with pan-laminin (blue), and nuclei (dapi) are shown in white. the absence of microglia is associated with an increased presence of extravasated neutrophils (arrowheads). d is a magnified image showing extravasated neutrophils after a plx5622containing diet. e, f distribution of neutrophils in parenchymal versus perivascular or intravascular locations, as assessed by cell counting in brain sections immunostained with ly6g, pan-laminin and to-pro3. mice treated with the plx5622 diet show a higher (mann-whitney test) percentage of parenchymal neutrophils 1 day (**p = 0.004) and 4 days (**p = 0.006) post-ischemia (n = 5-7 mice per group). f illustrates the previous staining after plx5622 diet. g brain lesion volume was measured with t2w mri 24 h post-ischemia in both diet groups (n = 9 per group). the brain lesion was larger in mice depleted of microglia (mann-whitney test, *p = 0.031). scale bar 20 μm (c); 10 μm (e, f) ◂ new tools for studying microglia in the mouse and human cns diverse requirements for microglial survival, specification, and function revealed by defined-medium cultures the origin of lipid phagocytes in the central nervous system i. the intrinsic microglia the origin of lipid phagocytes in the central nervous system ii. the adventitia of blood vessels eaten alive! cell death by primary phagocytosis: 'phagoptosis' microglial phagocytosis of live neurons identification of a unique tgf-βdependent molecular and functional signature in microglia rhythmic modulation of the hematopoietic niche through neutrophil clearance neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated erk1/2 signals immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia autocrine csf-1r signaling drives mesothelioma chemoresistance via akt activation inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cfms kinase inhibitor gw2580 mannose-binding lectin promotes local microvascular thrombosis after transient brain ischemia in mice proliferating resident microglia after focal cerebral ischaemia in mice colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain the role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct? the neurovascular unit as a selective barrier to polymorphonuclear granulocyte (pmn) infiltration into the brain after ischemic injury p2x7 receptor activation regulates microglial cell death during oxygenglucose deprivation differential regulation of adhesion and phagocytosis of resting and activated microglia by dopamine microglia control the spread of neurotropic virus infection via p2y12 signalling and recruit monocytes through p2y12-independent mechanisms neuronal morphometry directly from bitmap images the serine/threonine kinase akt promotes fc gamma receptor-mediated phagocytosis in murine macrophages through the activation of p70s6 kinase influx of leukocytes and platelets in an evolving brain infarct (wistar rat) temporal and spatial dynamics of cerebral immune cell accumulation in stroke leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes automated morphological analysis of microglia after stroke the p2y12 receptor regulates microglial activation by extracellular nucleotides direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration implications of polymorphonuclear neutrophils for ischemic stroke and intracerebral hemorrhage: predictive value, pathophysiological consequences and utility as therapeutic target role of polymorphonuclear neutrophils in the reperfused ischemic brain: insights from cell-type-specific immunodepletion and fluorescence microscopy studies the microglial sensome revealed by direct rna sequencing microglia are irrelevant for neuronal degeneration and axon regeneration after acute injury image thresholding by minimizing the measure of fuzziness targeting neutrophils in ischemic stroke: translational insights from experimental studies neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats bone marrow cell recruitment to the brain in the absence of irradiation or parabiosis bias selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain specific contributions of csf-1 and gm-csf to the dynamics of the mononuclear phagocyte system proliferation of parenchymal microglia is the main source of microgliosis after ischaemic stroke oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglycemia injury in vitro a robust and high-throughput cre reporting and characterization system for the whole mouse brain antibodies to cd11b, cd68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions systemic inflammatory stimulus potentiates the acute phase and cxc chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1-and neutrophil-dependent mechanisms methods for cell and particle tracking immature monocytes recruited to the ischemic mouse brain differentiate into macrophages with features of alternative activation microglia overexpressing the macrophage colony-stimulating factor receptor are neuroprotective in a microglial-hippocampal organotypic coculture system phagocytosis executes delayed neuronal death after focal brain ischemia inhibition of microglial phagocytosis is sufficient to prevent inflammatory neuronal death beware the intruder: real time observation of infiltrated neutrophils and neutrophil-microglia interaction during stroke in vivo very-late-antigen-4 (vla-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of cns immune privilege leukocyte migration into inflamed tissues pharmacological targeting of csf1r inhibits microglial proliferation and prevents the progression of alzheimer's-like pathology neutrophil recruitment to the brain in mouse and human ischemic stroke cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study mmp-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type iv collagen degradation during hemorrhagic transformation after human ischemic stroke phosphorylation of csf-1r y721 mediates its association with pi3k to regulate macrophage motility and enhancement of tumor cell invasion selective expression of gi/o-coupled atp receptor p2y12 in microglia in rat brain a comprehensive profile of chip-seq-based pu.1/spi1 target genes in microglia the paradox of the neutrophil's role in tissue injury m-csf increases proliferation and phagocytosis while modulating receptor and transcription factor expression in adult human microglia endothelial basement membrane laminin 511 contributes to endothelial junctional tightness and thereby inhibits leukocyte transmigration neutrophil elastase and neurovascular injury following focal stroke and reperfusion microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after stroke implications of mmp9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke akt signaling pathway in macrophage activation and m1/ m2 polarization ijblob: an imagej library for connected component analysis and shape analysis homeostasis of microglia in the adult brain: review of novel microglia depletion systems microglia are required for protection against lethal coronavirus encephalitis in mice microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction blood-brain barrier breakdown in acute and chronic cerebrovascular disease ischemic vulnerability of primary murine microglial cultures fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis neutrophil migration into the infected uroepithelium is regulated by the crosstalk between resident and helper macrophages dominant role of microglial and macrophage innate immune responses in human ischemic infarcts csf-1 receptor structure/function in maccsf1r −/− macrophages: regulation of proliferation, differentiation, and morphology acknowledgements aoda had a predoctoral fellowship from the mineco-fpi program and fmm had a peris award by the health department of generalitat de catalunya. part of this work was performed at the centre de recerca biomèdica cellex, barcelona. the cerca programme of generalitat de catalunya supports the institut d'investigacions biomèdiques august pi i sunyer (idibaps). plx5622 was provided by plexxikon under materials transfer agreement. we acknowledge the cytomics and image platforms of idibaps for access to equipment. we would like to thank elisenda coll (advanced optical microscopy-ccitub) for excellent technical assistance. we thank the neurological tissue bank of the biobank-hospital clinic-idibaps for sample and data procurement, and to patient's relatives for giving consent to sample use for research purposes. key: cord-009388-k3exf8a4 authors: agarwal, yash; beatty, cole; biradar, shivkumar; castronova, isabella; ho, sara; melody, kevin; bility, moses turkle title: moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against hiv infection and associated pathologies date: 2020-04-10 journal: retrovirology doi: 10.1186/s12977-020-00515-3 sha: doc_id: 9388 cord_uid: k3exf8a4 the development of safe and effective combination antiretroviral therapies for human immunodeficiency virus (hiv) infection over the past several decades has significantly reduced hiv-associated morbidity and mortality. additionally, antiretroviral drugs have provided an effective means of protection against hiv transmission. despite these advances, significant limitations exist; namely, the inability to eliminate hiv reservoirs, the inability to reverse lymphoid tissues damage, and the lack of an effective vaccine for preventing hiv transmission. evaluation of the safety and efficacy of therapeutics and vaccines for eliminating hiv reservoirs and preventing hiv transmission requires robust in vivo models. since hiv is a human-specific pathogen, that targets hematopoietic lineage cells and lymphoid tissues, in vivo animal models for hiv-host interactions require incorporation of human hematopoietic lineage cells and lymphoid tissues. in this review, we will discuss the construction of mouse models with human lymphoid tissues and/or hematopoietic lineage cells, termed, human immune system (his)-humanized mice. these his-humanized mouse models can support the development of functional human innate and adaptive immune cells, along with primary (thymus) and secondary (spleen) lymphoid tissues. we will discuss applications of his-humanized mouse models in evaluating the safety and efficacy of therapeutics against hiv reservoirs and associated immunopathology, and delineate the human immune response elicited by candidate hiv vaccines. in addition to focusing on how these his-humanized mouse models have already furthered our understanding of hiv and contributed to hiv therapeutics development, we discuss how emerging his-humanized rat models could address the limitations of his-mouse models. despite combination antiretroviral therapy (cart)mediated suppression of human immunodeficiency virus (hiv) replication and promotion of immune reconstitution in patients, hiv-associated morbidity persists and is associated with the latent reservoir, unresolved immune abnormalities, and fibrosis in lymphoid organs [1] . additionally, hiv transmission remains endemic across the globe, and development of a functional cure and/or an effective vaccine will be required to end this epidemic [2] . hiv is a human specific pathogen; thus, animal models for evaluating the safety and efficacy of therapeutics and vaccines directly against hiv requires the incorporation of human lymphoid tissues and/or hematopoietic lineage cells. such mouse models exist, and are termed, human immune system (his)-humanized mice [3, 4] . to construct his-humanized mice, immunodeficient mice are myoablated to eradicate residual mouse bone marrow stem cells, and then engrafted with human peripheral blood mononuclear cells (pbmcs) or human hematopoietic stem cells (hsc) with or without transplantation of lymphoid tissues, such as thymus and/or spleen [5] . over a period of a few weeks to months, transplanted mice develop human immune cells, and reconstitution is confirmed by flow cytometry [5] (fig. 1) . his-humanized mice can then be employed in studies investigating hiv prevention or cure strategies [5] . in this review, we will discuss the myriad of approaches for developing hishumanized mouse models, and their applications in hiv therapeutics and vaccine development studies, along with their limitations. finally, we will discuss the potential of an emerging his-humanized rat model, which has a longer lifespan and greater physiological similarity to humans compared to mice, designed to enable longitudinal studies in evaluating therapeutics against hiv reservoirs and vaccine-induced immunity [6, 7] . human cd4 + t cells are the major target for hiv infection; thus, a mouse model with human cd4 + t cells provides a platform for modeling hiv/aids. various immunodeficient mouse models lacking mature t, b, [8] and nk cells, along with defects in macrophage phagocytic function [9] support robust reconstitution of human cd4+ t cells and other lymphocytes (e.g. cd8 + t cells) following transplantation of human pbmcs or cd4+ t cells. such cells can be transplanted via intravenous (iv) or intraperitoneal (ip) injection into myoablated, immunodeficient juvenile mice (6-8 weeks old) at a dose of 5-10 × 10^6 cell per mouse, to generate peripheral blood lymphocyte (pbl)-humanized mice. human cd4 + t cells are readily detectable in the blood fig. 1 construction of the human immune system-humanized mouse models. (i) immunodeficient mice are myoablated via irradiation or busulfan, followed by the administration of antibiotics and analgesics. general anesthesia is induced prior to surgery. (ii) to generate human lymphoid tissue xenografts along with autologous immune cell reconstitution, human fetal lymphoid tissue(s) and liver are processed into 1 mm 2 pieces, and autologous cd34 + hscs are isolated from the fetal liver via immunomagnetic selection. cd34 + hscs are then transplanted via retro-orbital injection following renal capsule transplantation of the lymphoid tissues. alternatively, to generate human immune cell only, pbmcs, cd4+ t cells, or cd34 + hscs are transplanted via iv or ip injection. (iii) transplanted mice are maintained under specific pathogen-free conditions and the human lymphoid tissue(s), and/or immune cell reconstitution in the peripheral blood and murine lymphoid tissues (humanized-murine tissues) are allowed to develop over a period of 2-10 weeks (or more), resulting in the his-humanized mouse model at 4 weeks post-transplantation [9, 10] , hence providing a humanized mouse model that can be generated in a relatively short period. the pbl-humanized mouse model supports hiv replication and provides a means of evaluating the efficacy of direct-acting therapeutics (e.g. antivirals drugs, antibodies) geared towards preventing hiv transmission [11] and controlling hiv replication [9] . additionally, pbl-humanized mouse models constructed using pbmcs from hiv-infected individuals with undetectable viral load can be employed as an in vivo assay (mouse-quantitative viral outgrowth assay) for evaluating the eradication of the hiv reservoir in said individuals [12, 13] . a major limitation of this model is the rapid development of graft-versus-host (gvhd) disease within 6-7 weeks following transplantation of lymphocytes, thus significantly restricting the experimental window [14] . additionally, the pbl-humanized mouse model does not incorporate human macrophages, which are a major hiv reservoir in various organs, including the brain [9, 15] . however, modification of the pbl-humanized mouse model via transplantation of hiv-infected monocyte-derived macrophages in the brain supports hiv infection and pathogenesis in the brain [15] . in order to generate a de novo human immune system and reconstitute a broader spectrum of human immune cells in his-humanized mice, myoablated, immunodeficient mice are transplanted with human cd34 + hscs via intrahepatic or intracardiac injection in neonatal mice [10, 16] or iv injection in juvenile/adult mice [16, 17] . these hscs can be obtained from a myriad of sources, including fetal liver tissue [17, 18] and neonatal cord blood cells [4, 16, 19] . human immune reconstitution in the hsc-humanized mouse model requires 10-12 weeks to develop [20] . various hematopoietic lineages, including t cells, monocytes/macrophages, b cells and dendritic cells are developed in the blood and other tissues (e.g., spleen, liver, brain) [20] . moreover, the hsc-humanized mouse model generates a naïve human immune system, which negates confounding factors associated with prior pathogen exposure [16, 21] . the hsc-humanized mouse model supports hiv infection, cd4+ t cell depletion, chronic immune activation and limited anti-hiv t and b cell immune responses [4] . a major advantage of the hsc-humanized mouse model over the pbl-humanized mouse model is the delayed and reduced incidence of gvhd, which provides the opportunity for long-term modeling of hiv infection and replication [9] . the hsc-humanized mouse model provides a means of evaluating the efficacy and safety of directacting therapeutics (e.g. antivirals drugs, antibodies) and immune-modulatory agents (e.g. pdc modulators [22] ) geared towards preventing hiv transmission, controlling hiv replication, and ameliorating cd4+ t cell depletion and chronic immune activation [4] . the hschumanized mouse model supports hiv transmission via the iv (along with ip) route [18] ; however, conflicting reports exist for the mucosal route of transmission [23, 24] . additionally, the reconstituted human t cells are educated in the mouse thymic epithelium, thus limiting antigen-specific responses [25] . this limitation of t cell education in the murine thymic epithelium has been partially overcome by the construction human leukocyte antigen (hla) class i transgenic-immunodeficient mice to support robust t cell development of hla-matched hsc transplants [26] . moreover, lymph nodes and spleen are poorly reconstituted, including a limited development of human b and myeloid cells in the white and red pulps of the spleen [27] . several modifications have been made to the hsc model to address these limitations. li et al. constructed an immunodeficient mouse model that incorporated a lymphoid tissue-stromal cytokine transgene (i.e. thymic-stromal-cell-derived lymphopoietin) and demonstrated improved lymph node development in hsc-humanized mice [27] . additionally, studies have demonstrated enhanced human b and myeloid cell development in murine secondary lymphoid tissues via transgenic expression of critical cytokines (i.e. il6; il3, gm-csf and scf) for b and myeloid cell maturation [28] [29] [30] . although incorporation of requisite human transgenes in his-humanized mice has been successful in demonstrating improved development of immune cells, often the resultant lineage is skewed, as the transgene expression is not synchronized for physiological expression and supporting stromal cells and other essential cytokines are absent [28] [29] [30] . another strategy for improving human immune cell development in his-humanized mouse models is to implant human lymphoid tissues containing the requisite microenvironment for supporting robust immune cell development. to facilitate human t cell education and associated function, human thymic tissues are incorporated in his-humanized mice, and termed, bone marrow-liver-thymus (blt)-humanized mice [31, 32] (fig. 2) . blt-humanized mice have served as a key animal model for hiv research for over a decade and are a cost-effective alternative to the surrogate, simian immunodeficiency virus (siv)-non-human primate (nhp) models. the blt-humanized mouse model is generated by surgically transplanting myoablated, immunodeficient mice with fetal human liver and thymus tissues, followed by iv injection of autologous cd34 + hscs [31, 33, 34] . transplanted mice require 10-12 weeks for systemic reconstitution of human cells post-transplantation [31, 33, 34] . the most widely utilized strain for constructing blt mice is the nod-prkdc scid il2rg tm1wjl (nsg) [21, 32] , which is readily available from jackson laboratory. blt-humanized mice can also be constructed using comparable immunodeficient mouse strains, such as, c57bl/6 rag2−/−γc−/−cd47−/− (tko) [21, 35] . the key benefit of the blt-humanized mouse model over pbl-and hsc-humanized mouse models is the presence of human thymic microenvironment, which facilitates t cell education in an autologous human tissue that contains the requisite stromal cells (as well as cytokines and factors, presumably at physiological levels) [21] . blt-humanized mice have systemic tissue reconstitution with human immune cells, including in mucosal tissues, which enables mucosal transmission [36] [37] [38] [39] [40] [41] [42] [43] and recapitulates the main route of hiv transmission in humans [36] [37] [38] [39] [40] [41] [42] [43] [44] . other hallmarks of hiv infection and replication in blt-humanized mice include robust t cell depletion [36, 42] , central nervous system infiltration [45, 46] , immune response [35, [47] [48] [49] [50] , and latency [51] [52] [53] . the blt-humanized mouse model is a robust platform for evaluating hiv prevention and cure strategies, including antiretroviral therapy, pre-exposure prophylaxis (prep), latency reversing agents (lra), vaccination, proviral excision, and t cell engineering (table 1) . despite significant advances gained from the blthumanized mouse model, the system does have some disadvantages. construction of blt-humanized mice requires advanced surgical expertise and extensive experience; therefore, these animals are constructed predominantly by specialized core facilities. additionally, blt-humanized mice are prone to gvhd, which limits the experimental window these animals can be utilized to approximately 6 months post-engraftment [54, 55] . however, blt-humanized mice constructed with a c57bl/6 immunodeficient background are resistant to gvhd [35, 53] . another disadvantage involves the use of human fetal tissues in constructing the model; these tissues are not readily available. furthermore, a typical human fetal thymus and autologous fetal liver-derived hscs can only support the construction of 15-25 blt-humanized mice. the limited availability of said human fetal tissues creates logistical and operational constraints. recently, a novel blt-like humanized mouse model has been developed using non-autologous human cord blood-derived hscs and human neonatal/pediatric thymus, which enable investigators to construct > 1000 blt-like humanized mice using cryopreserved thymus tissues and readily available cord blood-derived hscs [96] . recent studies demonstrate that these blt-like humanized mice develop human immune cells, support hiv infection and replication, and exhibit anti-hiv immune response (unpublished data from elie haddad, chloé colas, et al., at the cancure 5th annual general meeting-2019, poster session, in montreal, canada). despite systemic immune cell reconstitution and hiv-specific immune responses, both neonatal/pediatric tissue-and fetal tissue-derived blt-humanized mouse models blt mice do not develop a complete human immune system. the current widely used immunodeficient mouse models possess an il-2 receptor γ chain deletion [97] [98] [99] [100] . as a result, mouse lymphoid organs do not fully develop in such models, [21] and the loss of lymphoid tissue microenvironment impairs the ability of blt-humanized mice to develop a robust humoral immune response, as immunoglobulins are skewed towards igm or weak igg response [35, 49, 99, [101] [102] [103] . constructing blt-humanized mice using immunodeficient mouse models with requisite human transgenic factors/cytokines, may optimize human b cell development and overcome the limitations of humoral immune response in the model [28, 104, 105 ]. an alternative strategy, which is consistent with the blt-model to construct his-humanized mice and rats, immunodeficient mice and rats are myoablated, followed by engraftment of human lymphoid tissues (thymus with or without human spleen) under the kidney capsule, along with injection of autologous human cd34+ hematopoietic stem cells. in representative images, we show the engrafted human lymphoid tissues (human thymus xenograft-thymus, white tissue; human spleen xenograft-spleen, dark brown tissue and the reconstituted rodent-spleen (humanized spleen-hspleen). note: mouse and rat organs are not at the same scale pre-exposure prophylaxis (prep) c5a peptide [66] cc-griffithsin [67] cd4 asics [68] cd4-expressing lactobacillus acidophilus [69] cd4mc p-iii-48 [70] dtg-ultra la [71] efda [72] g2-s16 pcd [73] iga [74] mvc [75] ral-la [76] rpv-la [39, 77] siccr5 lfa-1 i-tsnp [78] tnv gel [79] [80] [81] vrc01 bnab [82] ftc, taf [83] ftc, tdf [36, 43, 84, 85] taf, evg [86] b12, vrc01, vrc07 g54w bnabs [87] latency-reversing agents (lras) azd5582 [88] panobinostat [89] suw133 (bryostatin analog) [90] vaccines plga-gag microparticles [49, 91] recombinant gp140∆683 [49, 91] proviral excision sacas9/sgrna [92] t cell engineering ccr5 shrna [93, 94] cd4 car [95] 3tc, lamivudine; asics, aptamer-sirna chimeras; azt, zidovudine; bnab, broadly neutralizing antibody; ccr5, c-c chemokine receptor type 5; car, chimeric antigen receptor; cd4, cluster of differentiation 4; cd4mc, cd4 mimetic compound; cc, caulobacter crescentus recombinant expressing; dca, didehydro-cortistatin a; ddi, didanosine; dtg, dolutegravir; dtg-ultra la, long acting dolutegravir; efda, 4′-ethynyl-2-fluoro-2′-deoxyadenosine; evg, elvitegravir; ftc, emtricitabine; idv, indinavir; ifnα14, interferon α suptype 14; iga, immunoglobulin a; lfa-1 i-tsnp, lymphocyte function-associated antigen-1 integrin-targeted and stabilized nanoparticle; mab, monoclonal antibody; mvc, maraviroc; pcd, polyanionic carbosilane dendrimers; pd-1, programmed cell death protein 1; plga, poly(lactic-co-glycolic) acid; ral, raltegravir; ral-la, long-acting raltegravir; rpv, rilpivirine; rpv-la, long acting rilpivirine; sacas9/sgrna, staphylococcus aureus crispr-associated protein 9/single-guide rna; shrna, short hairpin rna; siccr5, small interfering rna ccr5; taf, tenofovir alafenamide; tdf, tenofovir disoproxil fumarate; tnv; tenofovir strategy, is to incorporate the requisite human secondary lymphoid tissue (i.e. spleen) microenvironment for robust human immune cell (e.g. b cells, macrophages) development and response [5] . to address the limitations of the blt-humanized mouse model, namely, poor development of secondary lymphoid tissue and modest macrophage reconstitution, we incorporated human spleen into the blt-humanized mouse model, and termed these animals, bone marrow-liverthymus-spleen (blts)-humanized mice [5] (fig. 2) . blts-humanized mice exhibit significant improvement over the blt-humanized mice by addressing several limitations [5] . successful spleen growth dramatically lowers the incidence of gvhd in blts-humanized mice, thus allowing for experimental studies that extend up to 9 months post-transplantation [5] . we speculate that the decreased gvhd in blts-humanized mice results from appropriate modulation of t cell activation by the human antigen-presenting cells in the human spleen xenograft. the human spleen in the blts-humanized mouse model recapitulates human adult spleen architecture and facilitates better reconstitution of immune cells, including human red pulp macrophages, which are poorly reconstituted in the blt-humanized mouse model [5] . it is well established that macrophages can serve as a reservoir for hiv [106] [107] [108] ; thus, the blts-humanized mouse model provides a system for investigating human splenic macrophage-hiv interactions [5] . additionally, the spleen is a major lymphoid tissue reservoir, with b cell follicles in the white-pulp serving as an immune privilege site for anti-hiv t-cells [109] . the human spleen in bltshumanized mice provides a model for investigating anti-hiv immune response within the white-pulp and the role of b cell follicle in mediating hiv persistence. the blts-humanized mouse model supports cart-mediated hiv load suppression, and replication competent hiv reservoirs can be detected in human spleen tissues [5] . lymphoid tissue fibrosis is an immuno-pathogenic feature associated with hiv infection and plays a major role in mediating chronic inflammation and abrogating the development of a robust immune response [110] . a major advantage of the blts-humanized mouse model is that hiv infection results in lymphoid tissue fibrosis; this disease manifestation is absent in hiv-infected blt-humanized mice [5] . although the blts-humanized mouse model exhibits more robust immune reconstitution compared to its blt counterpart, the two models share some limitations. the transplantation of the human tissues under the renal capsule requires an individual with advanced surgical skills. the blts-humanized mouse model uses human fetal tissues, which introduces logistical and operational constraints. the use of frozen fetal tissues and hscs can alleviate some of those constraints (unpublished data). demonstrating robust anti-hiv immunity in his-humanized mouse models has been a long-term goal in the field because said system would allow robust evaluation of hiv vaccine candidates against circulating viral strains. the incorporation of human primary and secondary lymphoid tissues in hishumanized mice brings us closer to this goal. at present, we are actively investigating the anti-hiv human immunity in the blts-humanized mouse model to determine if this system provides a means for evaluating hiv vaccines. prior to the development of genetic engineering technologies for creating transgenic and knockout mice, rats were the predominant specie of rodents employed in biomedical research [6] . advantages of using rats include their longer lifespans (~ 3.5 years) and larger size (~ 350 grams), which facilitates longer experimental window and larger sampling volumes compared to the short lifespan (< 1 year) and small size (< 25 g) of mice [6] . rats provide a more ideal platform for in vivo imaging of diseases, as the larger size of rats provides better resolution [111] . additionally, rat models exhibit advanced cognitive skills and critical physiological parameters (e.g. heart rate, drug metabolism) that more closely mimic humans [112] [113] [114] [115] . recent advances in genetic engineering, such as the crispr/cas 9 technology has enabled the development of several immunodeficient rat models for transplanting and regenerating human tissues and cells [7, [116] [117] [118] . similar to currently used immunodeficient mouse models, immunodeficient rat models carry mutations in rag1/2 and il2rγ genes, with or without sirp1α transgene [7, [116] [117] [118] . a recent study demonstrated that these immunodeficient rats can be reconstituted with a myriad of human immune cells following transplantation with human-fetal liver-derived hscs and autologous thymus tissues [7] (fig. 2) . these his-humanized rat models could provide a means for robust longitudinal studies on the safety and efficacy of therapeutic agents targeting the hiv reservoir. additionally, his-humanized rats could provide a means for modeling hiv-associated end organ diseases, such as cardiovascular, neurocognitive and lung diseases. despite successful prevention of hiv transmission with antiviral drugs, it is likely that an effective vaccine provides the only means of ending the hiv epidemic [2] . over the past decades, several promising vaccine candidates have failed in large-scale safety and efficacy clinical trials [2] . the failure of those clinical trials suggests that improved "gate keeper" animal modeling systems are needed for better prediction of vaccine candidate outcomes in human clinical trials [119] . currently, the surrogate siv-nhp model is the sole "gate keeper" animal model for determining potential of vaccine candidates [119] . candidate hiv vaccines selected using this gatekeeper system have been unsuccessful in human clinical trials [119] ; suggesting, major improvements in animal modeling are needed. although significant advancements are still needed in improving his-humanized models, several recent advances, such as improved human-secondary lymphoid tissue development, along with the previously developed, robust primary lymphoid tissue development has made it possible to evaluate human immune responses to vaccines [5, 27] . ideally, these "improved" his-humanized mouse models will complement nhp models in addressing critical gaps, such as vaccine-induced immune responses against circulating hiv strains, vaccine safety in the context of hiv transmission, and human-correlates of immunity. although cart has significantly reduced the morbidity and mortality associated with chronic hiv infection, the hiv reservoir persists in people living with hiv (plhiv) and is associated with chronic inflammation, lymphoid tissue damage, and a myriad of end-organ diseases [1] . therefore, eradicating the hiv reservoir and associated chronic inflammation and end organ diseases remains a major challenge. the mechanisms of hiv persistence in plhiv, despite robust cart-mediated suppression of the virus, are thought to be multifactorial. these factors include persistence in transcriptionally quiescent resting memory cd4+ t cells in the peripheral blood and lymphoid tissues, infection of long-lived resident tissue macrophages in lymphoid tissues and immune privilege organs (e.g. brain, testes, b cell follicle, etc.), and dysregulation in anti-hiv immunity. by virtue of the multitude of factors that play a role in hiv persistence, in vivo models that recapitulate human host-hiv interactions are necessary for determining the safety and efficacy of therapeutic agents for eradicating hiv reservoirs. improved his-humanized mouse models with systemic reconstitution of human immune cells and robust lymphoid tissues development provide a means of evaluating both directacting and immune-modulatory hiv-cure therapeutics. further advances in improving the human-immune system in his-humanized mouse and rat models will provide better in vivo systems for evaluating the safety and efficacy of therapeutics and vaccines for hiv prevention and cure. not applicable. moses turkle bility is the senior author authors' contributions mtb conceived this review and contributed to the preparation of the manuscript. ya, cb, sb, ic, sh and km contributed equally to the preparation of the manuscript. all authors read and approved the final manuscript. this work was supported by the following nih grants (r21od024789, (national institute of allergy and infectious diseases) r21ai135412). not applicable. the human fetal liver, spleen and thymus (gestational age of 18-20 weeks) used in the transplantations were obtained from medically or elective indicated termination of pregnancy through magee-women' ). the use of human hematopoietic stem cells was reviewed and approved by the human stem cell research oversight (hscro) at the university of pittsburgh. the use of biological agents (e.g., hiv), recombinant dna, and transgenic animals was reviewed and approved by the institutional biosafety committee (ibc) at the university of pittsburgh. all animal studies were approved by the iacuc at the university of pittsburgh and were conducted following nih guidelines for housing and care of laboratory animals. why and where an hiv cure is needed and how it might be achieved the complex challenges of hiv vaccine development require renewed and expanded global commitment small animal models for human immunodeficiency virus (hiv), hepatitis b, and tuberculosis: proceedings of an niaid workshop humanized immune system mouse models: progress, challenges and opportunities human immunodeficiency virus infection induces lymphoid fibrosis in the bm-liver-thymus-spleen humanized mouse model rats! disease models & mechanisms an immune system-modified rat model for human stem cell transplantation research hu-pbl-scid mice: a model for human immune function, aids, and lymphomagenesis a simple mouse model for the study of human immunodeficiency virus chronic, acute, and reactivated hiv infection in humanized immunodeficient mouse models hu-pbl-scid mice can be protected from hiv-1 infection by passive transfer of monoclonal-antibody to the principal neutralizing determinant of envelope gp120 the mouse viral outgrowth assay: avatars for the detection of hiv-1 reservoirs high activation and skewed t cell differentiation are associated with low il-17a levels in a hu-pbl-nsg-sgm3 mouse model of hiv infection xenogeneic graft-versus-host-disease in nod-scid il-2rgammanull mice display a t-effector memory phenotype generation of cytotoxic t cells against virus-infected human brain macrophages in a murine model of hiv-1 encephalitis parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the il2rgamma(null) mutation hiv-1 infection and pathogenesis in a novel humanized mouse model humanized mice engrafted with human hsc only or hsc and thymus support comparable hiv-1 replication, immunopathology, and responses to art and immune therapy comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in nod-scid/gammac-/-, balb/c-rag1-/-gammac-/-, and cb-17-scid/bg immunodeficient mice generation of immunodeficient mice bearing human immune systems by the engraftment of hematopoietic stem cells humanized mice for immune system investigation: progress, promise and challenges flt3l-mediated expansion of plasmacytoid dendritic cells suppresses hiv infection in humanized mice rag2(-/-)gamma(-/-)(c) mice transplanted with cd34(+) cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus mucosal transmission of r5 and x4 tropic hiv-1 via vaginal and rectal routes in humanized rag2-/-gammac -/-(rag-hu) mice the analysis of the functions of human b and t cells in humanized nod/shi-scid/gammac(null) (nog) mice (hu-hsc nog mice) generation of functional human t-cell subsets with hla-restricted immune responses in hla class i expressing nod/scid/il2r gamma(null) humanized mice a human immune system mouse model with robust lymph node development a novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production development and function of human innate immune cells in a humanized mouse model development of human cd4 + foxp3 + regulatory t cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing nod-scid il2rgamma(null) humanized mice reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and cd34(+) cell transplantation antiretroviral pre-exposure prophylaxis prevents vaginal transmission of hiv-1 in humanized blt mice humanized mice mount specific adaptive and innate immune responses to ebv and tsst-1 immunodeficient mouse model for human hematopoietic stem cell engraftment and immune system development blt-humanized c57bl/6 rag2-/-gammac-/-cd47-/-mice are resistant to gvhd and develop b-and t-cell immunity to hiv infection antiretroviral pre-exposure prophylaxis prevents vaginal transmission of hiv-1 in humanized blt mice art influences hiv persistence in the female reproductive tract and cervicovaginal secretions animal models for hiv/aids research long-acting rilpivirine (rpv) preexposure prophylaxis does not inhibit vaginal transmission of rpvresistant hiv-1 or select for high-frequency drug resistance in humanized mice immune reconstitution of the female reproductive tract of humanized blt mice and their susceptibility to human immunodeficiency virus infection superior human leukocyte reconstitution and susceptibility to vaginal hiv transmission in humanized nod-scid il-2rgamma(-/-) (nsg) blt mice intrarectal transmission, systemic infection, and cd4 + t cell depletion in humanized mice infected with hiv-1 human breast milk and antiretrovirals dramatically reduce oral hiv-1 transmission in blt humanized mice setting the stage: host invasion by hiv reduced antiretroviral drug efficacy and concentration in hiv-infected microglia contributes to viral persistence in brain t cells establish and maintain cns viral infection in hiv-infected humanized mice induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized blt mice alpha interferon and hiv infection cause activation of human t cells in nsg-blt mice humoral immune responses in humanized blt mice immunized with west nile virus and hiv-1 envelope proteins are largely mediated via human cd5 + b cells rapid evolution of hiv-1 to functional cd8 + t cell responses in humanized blt mice generation of hiv latency in humanized blt mice hiv latency in the humanized blt mouse an advanced blt-humanized mouse model for extended hiv-1 cure studies graft versus host disease in the bone marrow, liver and thymus humanized mouse model human immune system development and survival of nonobese diabetic (nod)-scid il2rgamma(null) (nsg) mice engrafted with human thymus and autologous haematopoietic stem cells in vivo suppression of hiv rebound by didehydro-cortistatin a, a "block-and-lock" strategy for hiv-1 treatment efficient inhibition of hiv replication in the gastrointestinal and female reproductive tracts of humanized blt mice by efda pd-1 blockade in chronically hiv-1-infected humanized mice suppresses viral loads efficacy of broadly neutralizing monoclonal antibody pg16 in hiv-infected humanized mice therapeutic efficacy of vectored pgt121 gene delivery in hiv-1-infected humanized mice early initiation of antiretroviral therapy can functionally control productive hiv-1 infection in humanized-blt mice long-acting parenteral combination antiretroviral loaded nano-drug delivery system to treat chronic hiv-1 infection: a humanized mouse model study elite suppressor and chronic progressor hiv-1 isolates replicate vigorously and cause cd4 + t cell depletion in humanized blt mice targeted cytotoxic therapy kills persisting hiv infected cells during art concurrent administration of ifnα14 and cart in tko-blt mice enhances suppression of hiv-1 viremia but does not eliminate the latent reservoir protection efficacy of c5a against vaginal and rectal hiv challenges in humanized mice a caulobacter crescentus microbicide protects from vaginal infection with hiv-1jr-csf in humanized bone marrow-liver-thymus mice inhibition of hiv transmission in human cervicovaginal explants and humanized mice using cd4 aptamer-sirna chimeras blocking hiv-1 infection by chromosomal integrative expression of human cd4 on the surface of lactobacillus acidophilus atcc 4356 a small-molecule cd4-mimetic compound protects bone marrow-liver-thymus humanized mice from hiv-1 infection ultra-longacting removable drug delivery system for hiv treatment and prevention hiv pre-exposure prophylaxis for women and infants prevents vaginal and oral hiv transmission in a preclinical model of hiv infection prevention vaginally of hiv-1 transmission in humanized blt mice and mode of antiviral action of polyanionic carbosilane dendrimer inhibitory effect of hiv-specific neutralizing iga on mucosal transmission of hiv in humanized mice role of semen on vaginal hiv-1 transmission and maraviroc protection a long-acting formulation of the integrase inhibitor raltegravir protects humanized blt mice from repeated high-dose vaginal hiv challenges nanoformulations of rilpivirine for topical pericoital and systemic coitus-independent administration efficiently prevent hiv transmission rnai-mediated ccr5 silencing by lfa-1-targeted nanoparticles prevents hiv infection in blt mice rectal transmission of transmitted/founder hiv-1 is efficiently prevented by topical 1% tenofovir in blt humanized mice one percent tenofovir applied topically to humanized blt mice and used according to the caprisa 004 experimental design demonstrates partial protection from vaginal hiv infection, validating the blt model for evaluation of new microbicide candidates topical tenofovir disoproxil fumarate nanoparticles prevent hiv-1 vaginal transmission in a humanized mouse model vrc01 antibody protects against vaginal and rectal transmission of human immunodeficiency virus 1 in hu-blt mice nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: a comparative preexposure prophylaxis efficacy study against hiv-1 vaginal transmission prevention of vaginal and rectal hiv transmission by antiretroviral combinations in humanized mice systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous hiv-1 transmission in humanized blt mice tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of hiv-1 vaginal transmission vectored immunoprophylaxis protects humanized mice from mucosal hiv transmission systemic hiv and siv latency reversal via non-canonical nf-kappab signalling in vivo in vivo analysis of the effect of panobinostat on cell-associated hiv rna and dna levels and latent hiv infection in vivo activation of latent hiv with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication immunization of blt humanized mice redirects t cell responses to gag and reduces acute hiv-1 viremia in vivo excision of hiv-1 provirus by sacas9 and multiplex single-guide rnas in animal models a highly efficient short hairpin rna potently down-regulates ccr5 expression in systemic lymphoid organs in the hu-blt mouse model engineering hiv-1-resistant t-cells from short-hairpin rna-expressing hematopoietic stem/progenitor cells in humanized blt mice stem-cell based engineered immunity against hiv infection in the humanized mouse model a humanized mouse model generated using surplus neonatal tissue cryptopatches are essential for the development of human galt generation of improved humanized mouse models for human infectious diseases human immune system mice: current potential and limitations for translational research on human antibody responses defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain th1 and th17 immunocompetence in humanized nod/scid/il2rγnull mice the analysis of the functions of human b and t cells in humanized nod/shi-scid/ cnull (nog) mice (hu-hsc nog mice) hypogammaglobulinemia in blt humanized mice-an animal model of primary antibody deficiency improved b cell development in humanized nod-scid il2rgamma(null) mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3 enhanced antibody responses in a novel nog transgenic mouse with restored lymph node organogenesis the hiv reservoir in monocytes and macrophages hiv-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy macrophages sustain hiv replication in vivo independently of t cells the b-cell follicle in hiv infection: barrier to a cure lymphoid tissue fibrosis is associated with impaired vaccine responses technical and conceptual considerations for performing and interpreting functional mri studies in awake rats rodent models in neuroscience research: is it a rat race? rat models of cardiovascular diseases autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology 2011:497841. research data, including large and complex data types • gold open access which fosters wider collaboration and increased citations maximum visibility for your research: over 100m website views per year • at bmc a novel immunodeficient rat model supports human lung cancer xenografts severe-combined immunodeficient rats can be used to generate a model of perinatal hypoxic-ischemic brain injury to facilitate studies of engrafted human neural stem cells sprague dawley rag2-null rats created from engineered spermatogonial stem cells are immunodeficient and permissive to human xenografts monkeying around with hiv vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations key: cord-022324-tcltmhi7 authors: barthold, stephen w. title: mouse hepatitis virus biology and epizootiology date: 2012-12-02 journal: viral and mycoplasmal of laboratory rodents doi: 10.1016/b978-0-12-095785-9.50032-9 sha: doc_id: 22324 cord_uid: tcltmhi7 nan mouse hepatitis virus (mhv) is a highly contagious and ubiquitous coronavirus of laboratory mice. it is present among mice in many commercial breeding colonies and most biomédical research institutions and has been documented in laboratory mice throughout the world. recognition of the ubiquity of mhv is often not realized because of unfamiliarity with its biology, reliance on insensitive diagnostic methods and the subtle effects of the virus. its subtle effects should not be underestimated, however, since mhv has been associated with a panoply of effects on mice and research data derived from them. considering the large financial investment in biomédical research and that mice represent the majority of animals used in such research, the potential scientific and economic impact of this single virus is enormous. since the original isolation of mhv in 1949 (1), a body of literature representing nearly 350 citations has been developed on the subject of mhv. the voluminous literature on mhv would not have been generated if mhv were simply a pathogen of mice. interest in mhv has evolved from a number of different perspectives, including emphasis on mhv as a model of viral hepatitis, viral encephalitis and demyelinating disease, genetic mechanisms of host resistance to viral infection, and the molecular biology of coronaviruses, using mhv as a prototype. these have been the subjects of several reviews (2-11). on the one hand, the literature clearly illustrates the complexity of mhv pathogenesis. virus strain, passage history, dose, route of inoculation, host genotype, age, immune function and co-infection with other agents all interact to determine the ultimate expression of mhv disease. on the other hand, this complexity interferes with a clear view of the biology of mhv as a natural pathogen of mice. many of these studies have emphasized different aspects of mhv-host interactions, using artificial routes of inoculation and analysis of only one or a few target organs or effects. as a result, still relatively little is known about the natural pathobiology of mhv in mice. without such information, the true significance of this agent cannot be assessed and its effect under diverse experimental conditions cannot be predicted. this review will discuss recent updates in mhv pathobiology and incorporate past literature in that discussion wherever possible. coronaviruses, including mhv, are enveloped viruses containing single-stranded, non-segmented, infectious rna with positive (messenger) polarity. the molecular biology of mhv will be discussed in dr. holmes' chapter and has been reviewed elsewhere (3,10). physical resistance properties have also been reviewed (4). coronaviruses infect many species of birds and mammals, causing respiratory or enteric infections in their hosts (table 1 ). the relationship among viruses of this family is complex. they do not share a common group antigen, yet many are antigenically and genetically related (8,10,12). although "mhv" is a singular term, it refers to many named and unnamed strains of mouse coronavirus (table 2) . certain prototype strains have served as standards for study of the mhv group, including mhv-l,-2,-3,-a59,-jhm and -s. these strains have been used in most experimental studies and as antigenic or genetic standards for mhv serodiagnosis and comparison to new mhv all mhv strains or isolates share cross-reacting antigens, but each strain also possesses strain-specific antigenicity, with considerable overlap (6,12-15)· similarly, while there is rna and polypeptide homology between mhv strains, there is also strain-related heterogeneity (16,17). this suggests ongoing "drift" or mutation as a factor in the biology of mhv. relatedness of one mhv strain to another is not a useful means of predicting biological behavior. for example, mhv-s and mhv-jhm are relatively unrelated genetically, yet induce similar patterns of disease. related strains such as mhv-s and mhv-s/cdc produce different patterns of disease (14, 16-20). furthermore, the behavior of a defined or named mhv strain depends on its passage history and thus varies from laboratory to laboratory. mhv also cross-reacts antigenically with coronaviruses of the rat and some strains of coronavirus of other species, including man (12,21-23). the biological significance of these relationships has not been thoroughly explored. mhv produces disease in mice by lytic infection of cells, although viral replication and exocytosis can take place in the absence of cytolysis. in addition to cytolysis, cell fusion is a hallmark of mhv, both in vivo and in vitro, although it is not necessary for viral replication (3,7 in contrast to respiratory mhv strains, very little is known about host resistance factors to enteric mhv. most of the mhv strains listed in table 2 have not been characterized as to their primary pattern of infection, but it is clear that both respiratory and enteric strains exist in contempory mouse populations (19). selective organotropisra is often stressed as an mhv strain-related phenomenon, such as neurotropism of mhv-jhm (37), hepatotropism of mhv-a59 (38), lymphocytotropism and bone marrow tropism of mhv-3 (39,40). such differences are only relative, with considerable overlap between mhv strains (19). many of these differences are simply a reflection of the emphasis an author places on a particular target organ. nevertheless, recent work is suggesting that selective cell tropism can take place with specific mhv strains and that host cell type can influence the outcome of mhv infection. in primary central nervous system cell cultures, mhv strains exhibit different cell tropism, cytopathic effects and viral assembly, which may account for different patterns of disease (10,41-48). understanding the pathogenesis of mhv is best approached by catagorizing infections into the respiratory and enteric patterns, which are determined by virus strain. relative differences in órgano-and cell tropism exist between virus strains in each of these catagories. furthermore, host factors play a significant role in severity of infection within these basic themes. the following discussion will detail what is known about the pathogenesis of respiratory and enteric patterns of mhv infection with supporting references for each pattern. these mhv strains rely on upper respiratory mucosa as a site of primary replication and excretion. in weanling or adult outbred mice infected with low-virulence mhv (mhv-s), infection is largely restricted to upper respiratory mucosa (18,20 since brain is often infected with several strains of mhv in susceptible hosts, neurotropism is not a particularly unique feature of any single mhv strain. however, some mhv strains (s and jhm) seem to possess the relatively unique ability to extend directly from the nasal lining into the olfactory tracts of the brain, even in older, resistant mice (18-20,37,53). within 48 hours after intranasal inoculation, mhv-jhm causes meningitis and necrosis of mitral cells in the olfactory bulbs, with extension into the olfactory tracts, meninges, piriform cortex, septum pelucidum, anterior commissure, and hippocampus within 120 hours. during this phase, both neurons and glia are infected. at 144 hours, virus is present in the pons, medulla and spinal cord and by 168 hours, severe demyelination is present. at this time, titers are diminishing (53). a similar course of events probably occurs with mhv-s (18,20). the demyelinating component has been shown to be due to selective destruction of oligodendroglia (54-57) and reportedly does not seem to occur with other encephalitogenic strains of mhv, such as mhv-3 (41,47,58). virus strain tropism for different nervous system cell types in vitro correlates with disease phenotype (41-48). the pattern of nervous system disease that occurs is also dependent on host age, genotype as well as dose and route of virus inoculation (45,57-59). duration of mhv infection is a subject of considerable contention. the behavior of the virus under natural conditions has created the impression that infections are chronic and latent, since many experimental manipulations such as immunosuppression, tumor transplantation or co-infection with other agents will precipitate acute disease (3). it appears, however, that this impression is created by the generally subclinical (but not latent) nature of mhv infection and that experimental manipulations that exacerbate disease are coincidentally applied during active infection. an overwhelming body of literature with a number of mhv strains clearly supports the concept of short-term infection, from which the host fully recovers within 2-3 weeks of infection (18,19,40,48,57,60-66). aggressive immunosuppression after the acute phase of mhv infection will not reactivate the virus, even when residual mhv antigen and lesions remain in the brain (66,67). a smaller number of reports exist, however, that uphold the hypothesis of persistence. mice of the semisusceptible c3h genotype that survive intraperitoneal inoculation of virulent mhv-3 can have persistent infections, in which virus can be recovered in low titer from liver, brain and lymphoid organs for up to 42 days (68). chronic brain infections have also been established in mice following intracerebral inoculation of mhv-3, intracerebral or intranasal inoculation of brainpassaged mhv-jhm and selected temperature sensitive jhm mutants (58, 69-71). however, others have shown neurotropic mhv is eventually cleared from the brain (18,19,48,57,67). these studies suggest that mhv can potentially cause chronic persistent infections, particularly under artificial experimental conditions, but limited infections, without a chronic carrier state, are the norm. an obvious exception is the athymic nude mouse, which suffers from a wasting syndrome due to chronic, persistent mhv infections. in contrast to their heterozygous euthymic counterparts, which recover within 2-3 weeks, homozygous athymic mice develop increasingly high titers of virus in multiple organs, ultimately dying from hepatitis or encephalitis. during the early acute phase of infection, euthymic and athymic mice have parallel titers and distribution of virus (28,60, 72,73). persistent mhv infections incontestably take place in vitro in cultured cells in the absence of immune surveillance in the live mouse. this has been demonstrated repeatedly with a variety of mouse and rat cell types (47, [74] [75] [76] [77] [78] [79] . the addition of a low concentration of antiviral antibody to the culture medium was found to modulate infection, producing a carrier state with intracytoplasmic antigen, but no virus production or expression of viral antigens on the cell surface. the carrier state continued in the absence of antibody, and virus could not be rescued by co-cultivation with susceptible cells. virus could only be recovered following fusion of persistently infected cells to permissive cells with polyethylene glycol (78,79). the significance of these observations for the mouse remain to be determined. host-related factors in mhv pathogenesis have been elucidated using several respiratory prototype mhv strains. mice less than 2-3 weeks of age are susceptible, regardless of genotype (2,26,80-82). other workers have suggested that resistance to intracerebral jhm infection further evolves at 6-12 weeks of age (83,84 mhv-jhm productively infects both neuronal and non-neuronal cells in vitro, while laboratory-created temperature-sensitive mutants of jhm cause non-productive infection of non-neuronal cells only, with expression of antigen without virus replication. on the other hand, mhv-a59 selectively infects non-neuronal cells in a productive fashion (41). differences among various mhv strains have been observed in their ability to productively infect adherent cells (macrophages) from liver expiant cultures (88). intrinsic susceptibility of cells in vitro can be modified with lymphokines (90,91) and interferon (82,96,97). lymphoreticular function in the whole animal also influences the course of mhv infection. agents that interfere with or stimulate macrophage activity alter the course of mhv infections (65,90,95,98-100). interferon (if) plays a disputed role in mhv pathogenesis. serum if levels are low in mhv-infected immature mice and elevated in adults (82), but others have found that resistant mouse genotypes may produce lower levels of if than susceptible genotypes in response to mhv infection (88,101). others have found the same degree of if levels (93). tissue if levels have also been variably correlated with resistance (88,102). it is apparent that if plays a role in the initial response of mice to mhv (97), and becomes elevated in adult, susceptible genotypes because of permissive infections, also resulting in increased natural killer (nk) cell activity in some mice. in resistant adults, virus titers, if and nk cells may all remain low (101). immunosuppression by a variety of means, including x-irradiation, neonatal thymectomy, antilymphocyte serum, graft vs host reaction, cyclophosphamide and corticosteroid treatments, renders resistant mice susceptible to mhv. immunosuppression, however, does not modify intrinsic genetically determined resistance of cells cultured ±n_ vitro or abrogate a secondary immune response to virus challenge (62,64,94,103,104). cell-mediated immunity is crucial in recovery from mhv infections. this fact is most evident in t cell deficient, athymic nude mice, in which mhv titers initially parallel their heterozygous euthymic counterparts, but continue to rise as hétérozygotes recover (73) only a single study has demonstrated delayed-type hypersensitivity in mhv immunized mice (62). it becomes apparent from this overview that mhv strains interact at different levels with mice of different ages and genotypes. expression of susceptibility or resistance is mediated first through the intrinsic ability of the target cell to support or restrict mhv replication. this can be further modified by if and nk cells, among other factors. secondly, infection is restricted by a specific immune response to the virus, resulting in susceptibility, attenuated disease or recovery. this is influenced by immunosuppressive regimens or impaired immune responsiveness. both intrinsic resistance and development of an effective immune response are age and genotype dependent (29,62,64,84, 97,101,103,109). this is why susceptibility to mhv can be predicted in genotypes that allow high-titer virus replication early in infection, prior to mounting an immune response (62,64,97,109). it also explains the confusion over whether genetic susceptibility or resistance are inherited as one or two genes, recessive or dominant, h-2 haplotype linked or unlinked with different mhv strains, different routes of inoculation and different mouse genotypes (2,45, 46,59,80,109). the course of mhv infection is notoriously sensitive to modification of lymphoreticular function. normally resistant mice are rendered susceptible by x-irradiâtion, cyclophosphamide, cortisone, neonatal thymectomy, antilymphocyte serum and graft vs host reaction, among other manipulations (3). co-infection with other infectious agents also potentiates mhv disease. eperythrozoon coccoides and k virus are normally minimally pathogenic, but they exacerbate mhv in resistant hosts (104,110). leukoviruses and even schistosoma mansoni also enhance mhv disease. these diversely related infectious agents have been suggested to have a common mechanism by blocking if responsiveness of the host to mhv (111-113). several enterotropic strains of mhv have been identified. like other mhv strains, they can be differentiated antigenically, but also share antigenic and genetic homology with other members of the mhv group (13,14,17,34-36). the upper respiratory mucosa is often a target of enterotropic mhv (19), but intestinal mucosa is the major target for virus replication and excretion. unlike respiratory mhv strains that infect intestine only in highly susceptible hosts, enterotropic mhv universally infects intestine, regardless of host age. in neonatal mice, epithelial degeneration, necrosis and syncytia predominate, resulting in erosions, ulcération and villus attenuation. virusinduced syncytia, or "balloon cells," are diagnostic. intracytoplasmic inclusions have also been described. lesions can be fully developed within 24-48 hours (32), but are usually most severe at three to five days (14,19,33). in surviving mice or mice exposed at older ages, there tends to be less necrosis and more compensatory mucosal proliferation, or hyperplasia. adult mice are also susceptible, but usually have mild infections with only minor lesions (3,13, 14,31,32,34). lesions can be found anywhere from pylorus to anus, but stomach is not involved. distal small intestine, cecum and ascending colon are preferential sites (3,13,14, 19,31-33). dissemination beyond the intestine can also occur. some mhv strains are highly restricted to intestinal mucosa and mesenteric lymph nodes, while others spread to liver and other organs (3,13,14,19,31,32). mhv-d, like mhv-jhm and -s, appears to share the ability of infecting the olfactory bulbs of the brain (33). these differences in behavior have not been carefully examined and may be either virus strain or host related. the influence of host genotype and immune response have not been well studied with enterotropic mhv. however, clinical symptoms and lesions associated with intestinal protozoal infestations are exacerbated by enterotropic mhv (3,31) and x-irradiation exacerbates enterotropic mhv infection. duration of intestinal mhv infections is limited, with no known carrier state beyond two weeks after exposure (3,13,19,31,32 ). an exception is the athymic nude mouse, which develops persistent infections of the intestinal and nasal mucosa. enteric mucosa tends to be segmentally hyperplastic with syncytia. involvement of other organs is minimal or absent. these mice suffer from progressive emaciation, but lesions and distribution of lesions differ markedly from the typical wasting syndrome caused by respiratory mhv strains (3,31,114). clinical disease is usually absent or mild and lesions are often restricted to the primary target organ (nose or intestine), except in highly susceptible hosts. disease and lesions are most apt to be seen in naive mouse populations experiencing an initial epizootic. suckling, genetically susceptible or immunologically compromised mice are the best candidates for diagnostic evaluation. suckling mice naturally infected with respiratory mhv suffer moderate to high mortality between 4-10 days of age. they may have signs of encephalitis, but more often signs are nonspecific. gross necropsy findings include multiple white spots on the liver (30,51). flaccid paralysis was described in adult swiss mice naturally infected with mhv-jhm (1), but this is uncommon. a variety of experimental manipulations will exacerbate otherwise mild infections in resistant mice (3). enterotropic mhv strains tend to produce explosive epizootics of diarrhea and high mortality among infants but these signs may be absent in enzootically-infected colonies. necropsy findings include enteritis, usually in the absence of liver lesions. surviviors are often runted and pot-bellied (3,14,19,31-34) . histopathology is a useful means of confirming a diagnosis of mhv, but only in susceptible mice during the active phase of infection. in susceptible hosts, particularly neonates and athymic nude mice, mhv induces multinucleate syncytia in multiple tissues, which are pathognomonic for mhv. syncytia are especially obvious in enteric mucosa of mice infected with enterotropic mhv. histopathology details are given elsewhere (3,30,31) . a more definitive diagnosis can be made with the use of immunohistochemical techniques such as immunofluorescence and immunoperoxidase. formalin-fixed, paraffin-embedded tissues can be ultilized for this purpose if subjected to prior trypsinization. antigen is very stable in formalin-fixed tissue, allowing retrospective analysis of archival cases (13,18,19,115) . electron microscopy can also be utilized. mhv has characteristic coronavirus morphology and buds into cisternae of endoplasmic reticulum. it can also produce intracytoplasmic aggregates of viral products (3,13,31) . virus recovery from actively infected tissues is difficult but can be accomplished using a variety of effective cell lines, such as nctc 1469, dbt, 17c1-1 or l929 cells. these cell lines, however, may not be successful substrates for some enterotropic mhv strains. syncytium formation is the hallmark mhv cytopathic effect. identification of a suspect agent as an mhv strain can be accomplished by immunocytochemistry. reciprocal serum neutralization is used as a means of characterizing the antigenic relatedness of a new isolate to prototype mhv strains. however, because of extensive and complex antigenic inter-relationships, this method is not definitive for strain classification (13-15, 19,116) . several serological assays can be used for detection of antibody in mhv-recovered mice. the complement fixation test was used extensively at one time, but is usually too insensitive to detect seroconversion following natural exposure (13,117-120). as mentioned above, serum neutralization against prototype mhv strains grown ±n_ vitro can be used, but it tends to be highly strain-specific. the neutralizing profiles of sera from different mouse populations or from different mhv outbreaks within a population can be compared to determine if the same or unrelated mhv strains are involved (13-15). hemagglutination inhibition is used for detecting antibody to coronaviruses of other species, but only one mhv isolate (dvim) has been found to possess a hemagglutinin (35,36). two very sensitive and specific assays for mhv antibody are an indirect immunofluorescence assay (ifa), using mhv-infected cells and an enzyme-linked immunosorbent assay (elisa) (118-120). both offer the advantage of using multiple mhv strains simultaneously as antigens in order to cover a broad range of reactivity to mhv serotypes. under experimental conditions, these two tests are nearly equally sensitive and both are more sensitive than serum neutralization (120). nude mice are not good candidates for serology. although they can produce neutralizing antibody to mhv, titers are widely variable and sometimes absent (60,141). morphological, immunohistochemical, virus recovery and serological methods can be embellished with the use of susceptible mhv hosts. for example, if mhv is suspected but cannot be confirmed in a mouse population, athymic nude mice can be placed in the animal room as sentinels. when these mice become infected, lesions and antigen are easily confirmed and virus is easier to isolate. infant mouse brain inoculation will amplify virus titers from suspect tissues, allowing easier antigen detection or virus recovery. similarly, inoculation of cortisonized mice will serve the same purpose. the mouse antibody production test can also be effectively utilized. inoculation of adult, virus antibody free mice with suspect material will result in seroconversion if mhv is present. under natural conditions, mhv is highly contagious and is transmitted by the respiratory or oro-fecal routes. expression of overt disease requires immature, immunocompromised or genetically susceptible mice. under experimental conditions, mice seroconvert by ifa or elisa between 7 to 14 days after inoculation (120) . under natural conditions, seroconversion occurs in 100% of mice within two weeks after introduction to an mhv-infected population, underscoring the rapidity of exposure that takes place (unpublished observations). outbreaks of clinical disease among susceptible neonatal mice are also very rapid with high morbidity (13,14). as already discussed, infections last less than two weeks with seroconversion at the time of recovery (18,120). maintenance of infection in a mouse population (enzootic infection) requires continual exposure of new, susceptible mice, either through newly introduced mice or breeding populations. in the absence of susceptible mice, mhv will die out of a population. frequently, mhv-free mice are received into enzootically infected mouse rooms. if they are neonatal mice, they suffer high mortality (51). however, extramural mice are usually weanlings or older, developing only subclinical infections upon exposure, but perpetuating the infectious cycle. use of these newly acquired exposed mice within the first one to two weeks after arrival creates a high potential for exacerbation of overt disease from subclinical infection when experimentally immunosuppressed or otherwise stressed. in enzootically infected populations, disease or lesions are most apt to be encountered in weanlings, rather than neonates, because neonates are protected by passive immunity. colostral igg from immune dams is partially protective under experimental conditions and seems to occur naturally (14,122). therefore, when mhv initially infects a naive mouse population, neonatal mice suffer high mortality, particularly with enterotropic mhv strains (13,14). once infection is enzootic, adult mice confer protection to neonates, so the infection cycle is perpetuated among older mice, when their passive immunity wanes. vertical transmission of mhv is possible, but unlikely in the short time span of an acute infection relative to the breeding life of a female mouse. transplacental transmission to fetuses has been shown in mice inoculated with mhv-jhm intravenously, but depended upon stage of gestation at the time of inoculation (123) . neither transplacental transmission to fetuses nor vaginal transmission to newborns could be demonstrated in dams inoculated intraperitoneally with mhv-3 (124) . thus, the potential is there, but it is not a likely consideration. one aspect of mhv epizootiology that is not well understood is whether repeated infections can occur with the same mhv strain or different mhv strains. challenge resistence to mhv has been accomplished by vaccination of mice with denatured virus or surface peplomers, but not with virus membrane or ribonucleoprotein subcomponents, suggesting that the most immunogenic components of the virion are virus-strain specific (60,108). the host range of mhv has not been defined. under natural conditions, rats and mice develop serum antibody to coronaviruses of the heterologous species but this is not surprising because of the antigenic cross-activity of rat and mouse coronaviruses (21,23). mice are experimentally susceptible to rat sialodacryoadenitits virus (sdav) (21). suckling mice infected with sdav develop encephalitis, but not hepatitis or enteritis. weanling mice develop interstitial pneumonia, with antigen in alveolar lining cells (type 1 pneumocytes). in contrast, mhv infects alveolar septal cells, but not lining cells in the mouse (19). suckling rats are susceptible to mhv by intranasal inoculation. lesions are restricted to the nasal mucosa and antigen is present for only 2-3 days (125) . intracereberal inoculation of rats with mhv-jhm causes encephalitis and demyelination (9). ιτ± vitro growth characteristics of viruses from these two species also differ. sdav will grow in primary rat kidney but not mouse cells and mhv will grow in mouse but not rat cells (23,126). sdav passaged through infant mouse brain remains unable to grow in mouse cells in vitro (126) . it therefore appears that cross-species infections are laboratory, rather than natural, phenomena. the antigenic relatedness of mhv to coronaviruses of other species, including man, has unexplored biological significance. mhv has a long history of interference with research. most mhv strains were isolated and identified as inadvertant contaminants that were exacerbated by experimental protocol. subclinical mhv infections are potentiated by a variety of experimental manipulations that modify immune or observed (38,127,131-133) . the ubiquity of mhv among laboratory mice creates a high potential for contamination of other agents by mhv or confusion with mhv when passed in mice. examples are not hard to find. tettnang virus was an unclassified virus isolated from ticks and man in germany, egypt and czechoslovakia. the agent was unrelated to a variety of other tick-born arboviruses, and was eventually found to be mhv. retrospective study revealed that there was a relationship among other examples include isolation of mhv when human encephalitis brain biopsy material was passed in infant mice (142), confusion over the human or mouse origin of coronaviruses isolated from multiple sclerosis material passed in mice or mouse tissue (143) and confusion over avian or mouse origin of coronavirus isolated from manx shearwaters suffering from puffinosis (144). mhv has a number of effects on immunologie and nonspecific host responses to antigens. following intraperitoneal injection of mhv-3, mice had a modified immune response to sheep red blood cells. during acute infections, if mice were infected prior to antigen exposure, immunodepression occurred, while simultaneous injection with mhv and antigen resulted in immunostimulation. mice inoculated oronasally with mhv-jhm and an enterotropic mhv isolate display transient but significant functional disturbances in t and b lymphocyte populations, in mitogenesis assays with splenocytes from susceptible (balb/cbyj) but not resistant (sjl) genotypes (146). it remains to be determined if these effects are due to direct or indirect action of the virus on lymphoid tissue. mhv certainly has the potential of direct action on lymphoid organs (19,39) . pre-infection of mice with mhv, either naturally or experimentally, alters the ability of normally permissive respiratory tract tissues to support replication of pneumonia virus of mice and also reduces susceptibility of dba/2j mice to sendai virus (147). regardless of the mechanisms involved, these observations have broad implications for experimental virology and laboratory animal science, since mhv-infected mice respond abnormally to respiratory and possibly other viruses. mhv has been shown to activate nk cells and alter the if responsiveness of infected mice (101,145) . -recovered mice (100,117,148, 149) . athymic nude mice infected with mhv develop a number of immunological peculiarities. responses to sheep red blood cells, including a secondary immune response (121, 151) . in addition, they are able to reject tumor xenografts (131, 134) . since mhv causes acute infections and because its contagiousness results in almost simultaneous infection of an entire population, it can be controlled like coronaviruses of the rat by simply breaking the infectious cycle (3). cessation of breeding or quarantine without introduction of new mice will achieve this objective. selection of seropositive breeding stock for re-establishment of a breeding colony will ensure that mice are recovered from infection. judgement on the success of this approach must be made only under conditions that prevent re-infection of the population. prevention of infection is extremely difficult in facilities receiving mice from outside sources at various intervals. such conditions can allow introduction of subclinically infected animals that can infect resident stock or, conversely, perpetuation of the infectious cycle by introduction of naive mice following exposure to infected populations. furthermore, mhv is so highly contagious that it is very likely to re-contaminate mouse populations that have become rid of the agent by re-derivation, re-population or quarantine, particularly if identical husbandry practices prevail. the best means of mhv control is preventing its entry into a facility. this can be achieved by purchase of mice from mhv-free sources and shipment in filtered boxes. also, transplantable tumors and other mouse biological products must be mhv-free. since most institutions are unable to achieve this goal, mhv-free mice can be maintained in properly controlled barrier facilities, plastic film isolators or filtered cage systems. filter-top cages offer a relatively inexpensive means of preventing mhv infections, but handling and service of the cages must be strictly aseptic (13,18,19,120) . vaccination has been shown to effectively reduce severity of challenge mhv infection, but not totally prevent it (60,108). since vaccination immunity is produced against virus peplomeric antigens, it is likely to be strainspecific (108). the number of antigenic mhv biotypes therefore makes vaccination impractical. furthermore, mhv usually causes subclinical infections, particularly when the virus is enzootic in a colony. it is likely that vaccination will cause greater effects on the host than natural infection· if exacerbation of mhv disease is a problem in an experimental protocol, newly arrived mice can be allowed to become infected and recover prior to use, or virus-free mice under appropriate preventive husbandry conditions can be used. a number of aspects of mhv biology are worthy of future research pursuit. rather than generating a list of such topics, the author has attempted to indicate throughout the text where deficiencies in knowledge exist. since scientific knowledge evolves best from a multi-disciplinary approach, it is hoped that scientists in various fields will seek ways to better understand this agent from their own perspectives. effect of corticosteroids on mouse hepatitis virus infection chronic central nervous system demyelination in mice after jhm infection immunopathology of mouse hepatitis virus type 3 infection. iii. clinical and virologie observation of a persistent viral infection mouse hepatitis virus-induced recurrent demyelination. a preliminary report virus persistence and recurrent demyelination produced by a temperature-sensitive mutant of mouse hepatitis virus selected mutants of mouse hepatitis virus type 4 (jhm strain) induce different cns diseases. pathobiology of disease induced by wild type and mutants ts 8 and ts 15 in balb/c and sjl/j mice hepatosplenic myelosis in the nude mouse naturally infected with mouse hepatitis virus persistent infection with mouse hepatitis virus of low virulence in nude mice persistent infection with mouse hepatitis virus in vivo and ±n_ vitro models of demyelinating diseases. ii. persistence and host-regulated thermosensitivity in cells of neural derivation infected with mouse hepatitis and measles viruses fusion resistance and decreased infectability as major host cell determinants of coronaviruses persistence enterotropic mouse hepatitis virus infection in nude mice mouse hepatitis immunofluorescence in formalin-or bouin'sfixed tissues using trypsin digestion complications of viral and mycoplasmal infections in rodents to toxicology research and testing peritoneal and macrophage alterations caused by naturally occurring mouse hepatitis virus the enzyme-linked immunosorbent assay for mouse hepatitis and rat coronaviruses enzyme-linked immunosorbent assay for detection of antibodies to murine hepatitis virus an immunofluoresence test for detection of serum antibody to rodent coronaviruses igm and igg response to sheep red blood cells in mouse hepatitis virusinfected nude mice maternally derived immune resistance to fatal diarrhea in infant mice due to mouse hepatitis virus vertical transmission of mouse hepatitis virus infection in mice lack of transplacental transmissibility of mhv-3 virus. archiv, ges virusforsch asymptomatic infection of mouse hepatitis virus in the rat pathogenicity of sialodacryoadenitis virus for rats after brain passages in suckling mice viral hepatitis associated with transplantable mouse leukemia. i acute hepatic manifestations following treatment with urethane or methylformamide influence of halothane on mortality from murine hepatitis virus (mhv3) enzymatic activities of the first two steps of liver heme biosynthesis in experimental mhv-3 viral hepatitis effect of a necrogenic yeast diet on viral hepatitis (mhv-3) in mice influence of mouse hepatitis virus on the growth of human melanoma in the peritoneal cavity of the athymic mouse adverse effects of mouse hepatitis virus on ascites myeloma passage in the balb/cj mouse emergence of hepatitis virus in mice infected with ascites tumor influence of the mouse hepatitis virus (mhv) infection on the growth of human tumors in the athymic mouse enhanced growth of a murine coronavirus in transformed mouse cells mouse hepatitis virus strain mhv-s: formation of pseudotypes with a murine leukemia virus envelope detection of alpha fetoprotein in mice infected with mouse hepatitis virus effect of mouse hepatitis virus infection on iron retention in the mouse liver inhibition of the mitotic response in regenerating mouse liver during viral hepatitis · hematological changes in viral (mhv-3) murine hepatitis ιηάμ^ίοη of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice western equine encephalitis mimicking herpes simplex encephalitis coronavirus isolates sk and sd from multiple sclerosis isolation of a latent murine hepatitis virus from cultured mouse liver cells. am. j. gastroenterol. 58: 259-74. 78. stohlman, s.a., sakaguchi, a.y., weiner, l.p. (1979) .characterization of the cold-sensitive murine hepatitis virus mutants rescued from latently infected cells by cell fusion. virol key: cord-017521-z9l9c83i authors: kubota, tetsuya; kubota, naoto title: cuff-induced neointimal formation in mouse models date: 2015-11-05 journal: mouse models of vascular diseases doi: 10.1007/978-4-431-55813-2_2 sha: doc_id: 17521 cord_uid: z9l9c83i ischemic heart failure caused by atherosclerosis is a major cause of death worldwide. although remarkable technological advances have been made in the treatment of coronary heart disease, there is as yet no treatment that can sufficiently suppress the progression of atherosclerosis, including neointimal thickening. therefore, a precise understanding of the mechanism of neointimal hyperplasia will provide the development of new technologies. both apoe-ko and ldlr-ko mice have been employed to generate other relevant mouse models of cardiovascular disease through breeding strategies. although these mice are effective tools for the investigation of atherosclerosis, development of a progressive atherosclerotic lesion takes a long time, resulting in increase of both the costs and the space needed for the research. thus, it is necessary to develop simpler tools that would allow easy evaluation of atherosclerosis in mouse models. in this review, we discuss our experience in generating mouse models of cuff-induced injury of the femoral artery and attempt to provide a better understanding of cuff-induced neointimal formation. epidemiological studies reveal that coronary heart diseases caused by atherosclerosis, including myocardial infarction and other forms of ischemic heart disease, are major causes of death worldwide [1] . if coronary blood flow is impaired by the development of atherosclerosis, interventions such as balloon angioplasty and endovascular stent placement are employed to overcome the vascular occlusion. these interventions can produce mechanical damage to the vasculature, including endothelial cells, smooth muscle cells (smcs), and the adventitia [2] [3] [4] . destruction of the endothelial cell layer is observed in the early phase after these interventions, with the formation of a thin thrombus layer covering the vascular surface [5] . within several weeks, the vascular endothelial cells completely cover the neointima. endothelial injury causes recruitment and adherence of circulating leucocytes, which results in the progression of neointimal formation [6] . the extent of neointimal formation has been reported to be correlated with the number of macrophages in the neointima [7] . macrophages and neutrophils enhance the inflammatory response through the release of growth factors such as fibroblast growth factor (fgf), transforming growth factor-beta (tgf-β), platelet-derived growth factor (pdgf), and vascular endothelial growth factor (vegf) [5] . human studies have shown the existence of a correlation between chronic inflammation after stent placement and intimal thickening [7] . the release of the aforementioned growth factors and cytokines by the injured endothelium and infiltrating inflammatory cells leads to smc migration and proliferation, which is preceded by transition of the smcs from a contractile to a synthetic phenotype with excessive extracellular matrix (ecm) deposition in the intima [8, 9] . although remarkable technological advances have been made in the treatment of coronary heart disease, none of the available treatments up to date can sufficiently suppress atherosclerosis or entirely prevent restenosis after angioplasty [10] [11] [12] . although in-stent restenosis can be alleviated by the use of drug-eluting stents, a number of cases treated with drug-eluting stents are still reported to develop restenosis [13, 14] . there also remains the question of the safety of drug-eluting stents, including in relation to the higher frequency of occurrence of thrombotic events observed with the use of drug-eluting stents as compared to bare-metal stents [15, 16] . moreover, cases with neointimal hyperplasia occurring after bypass surgery or allograft cardiac transplantation cannot be treated with drug-eluting stents [17, 18] . thus, a more precise understanding of the mechanism of neointimal hyperplasia will provide the development of new technologies. in this review, we discuss our experience in generating mouse models of cuff-induced injury of the femoral artery and attempt to provide a better understanding of cuff-induced neointimal formation. many previous studies have reported rabbit models of cuff-induced injury. two types of materials have been used for the generation of these rabbit models, a polyethylene tube and a silastic tube. in 1969, mizukawa et al. have reported neointimal formation induced by the insertion of a polyethylene tube in the rabbit carotid artery [19] . histological analysis revealed that the neointima was composed of smcs, but had no other characteristics of atherosclerosis, e.g., foam cells [20] [21] [22] . importantly, the polyethylene tube produced only mild, not severe, injury of the endothelial cells. hirosumi et al. carried out an in-depth investigation of the morphometric changes induced in an artery by the insertion of a polyethylene tube by scanning electron microscopy and light microscopy (1.5 cm long pe-280; inner diameter, 2.15 mm; outer diameter, 3.25 mm; becton, dickinson and company) [23] . at 30 min after cuff placement, small endothelial defects and adherence of a small number of platelets were observed in the subendothelium. at 2 h, a number of leukocytes were recruited to this cuff-injured area. the endothelial defects increased for 24 h, and leukocytic infiltration of the internal elastic lamina and endothelial cells was observed. after the 3rd day, regeneration of spindle-shaped endothelial cells occurred and covered the exposed subendothelium. however, the leukocytic infiltration persisted. the internal elastic laminae were irregular, swollen, and wavy. the smcs under these laminae were markedly deformed and edematous. although the endothelial cells became flat after 1 week, gaps were often observed at the cell junctions. light microscopy revealed regression of the edematous media and smc-like intimal cell proliferation. after 2 weeks, the endothelial cells completely covered the subendothelium, and the gaps between the cells acquired normal tightness. leukocytes were no longer seen at the endothelial surface. on the other hand, booth et al. were the first to use a biologically inert soft and flexible silastic cuff, 2.1 cm length with an internal volume of 0.3 cm 3 in the carotid artery of a new zealand white male rabbit [24] . neointimal formation consisted largely of smc-like cells, similar to the case in the polyethylene cuff-induced injury. no foam cells were detected in any of the sections obtained from the carotid arteries of the new zealand white rabbits at 7 days after the placement of the silastic cuff. moreover, an intact endothelial layer was observed after 7 days. the endothelial cells remained in contact with each other, and no denudation or exposure of the subendothelium was seen at 24 h after placement of the silastic cuff [25] . kockx et al. revealed that silicone cuff-induced neointimal formation can be distinguished into three phases [26] . the first phase begins within 2 h, with polymorphonuclear leukocyte (pmn) infiltration from the luminal surface toward the intima and the inner media. in the second phase, which starts within 12 h, the replication rate of the smcs in the media increases by about 20-fold as compared with that in unmanipulated arteries. the third phase, beginning from day 3, is characterized by the appearance of subendothelial smcs that are immunoreactive for α-sm actin (α-sma). although the neointima formed in response to both injury caused by a polyethylene and that caused by a silastic cuff consists of smcs, the injury caused by the polyethylene cuff was associated with injury of the endothelial cells, whereas that caused by the silastic cuff was devoid of injury to the endothelium. mouse models have been used popularly as experimental animal models due to their well-defined genetic background and the possibility of manipulating the mouse genome. mouse models are useful for evaluating the roles of specific molecules in vascular remodeling, such as in the case of post-percutaneous coronary intervention (pci) restenosis. apolipoprotein (apo) e-knockout (ko) mice have been used extensively because they develop spontaneous atherosclerosis [27, 28] . furthermore, the atherosclerotic lesions in this mouse model closely resemble the atherosclerotic lesions, both stable and unstable, in humans. low-density lipoprotein (ldl) r-ko mice also serve as good models to evaluate human atherosclerotic lesions [29] . however, unlike the apoe-ko mice, the ldlr-ko mice do not develop spontaneous atherosclerosis [28] . both apoe-ko and ldlr-ko mice have also been utilized to generate other relevant mouse models of cardiovascular disease through a variety of breeding strategies. although these mice are effective tools for the investigation of atherosclerosis, development of a progressive atherosclerotic lesion takes a long time, resulting in an increase of both the costs and the space for the research. mouse arteries, unlike the arteries of larger animals, are too small for transluminal injury to be induced with a balloon. thus, it is necessary to develop tools for easier evaluation of atherosclerosis in mouse models. three methods for the induction of neointimal formation in mice have been mainly reported [10] . in the arterial ligation model, blood flow through the common carotid artery is disrupted by ligation near the distal bifurcation [30] . the decrease in the blood flow resulting from the dramatic reduction of the vessel diameter results in the formation of an extensive smc-rich neointima within 2-4 weeks. this model has the advantage of reproducibility due to the ease of use of the method for inducing neointimal hyperplasia. lindner and colleagues were the first to report mechanically induced endothelial denudation model, which involves passage of a flexible guidewire three times in the carotid artery [31] . this procedure completely removes the endothelial cell layer, which results in the recruitment of platelets to the denuded surface and activation of the medial smcs. neointimal hyperplasia is typically observed within 2 weeks after the injury. this procedure is the most similar to angioplasty. however, this procedure is a relatively challenging procedure, which leads to difficulty in achieving reproducible results. subsequently, sata et al. modified the wire injury method to develop a more convenient and reproducible results [32] . since the wire injury model shows complete denudation of the endothelial cell layer, it may not be suitable for investigation of the involvement of endothelial cell-specific molecules in the development of atherosclerosis. use of a polyethylene cuff also causes damage to the endothelial cell layer as described above, but it produces milder injury as compared to wire injury. the endothelium itself is not directly injured by a polyethylene cuff. in fact, endothelial cells have reported to remain relatively intact after perivascular cuff placement [33] . moroi et al. first adapted an external vascular cuff model used in rabbits to mice deleted with endothelial cell-specific enos gene [34] . since the virus-mediated vector and drug can be injected easily between the cuff and the vessel, this cuff-induced injury model is also excellent for the observation of changes in the adventitia associated with arteriosclerosis [35] . thus, the use of mouse models of cuff-induced injury has increased in recent years. dr. moroi kindly taught us the procedure for the cuff placement [34] . before the operation, the cuff (intramedic polyethylene tubing (pe-50, inner diameter ¼ 0.58 mm), becton dickinson) needs to be prepared. polyethylene tube was cut for each length 2 mm and cut in longitudinal direction. we tied polyethylene tube directly to 8-0 nylon suture with needle (bear medic corporation) in two places on both side and made stringlike. the mice were anesthetized by an intraperitoneal (ip) injection of sodium pentobarbital at the dose of 40-50 mg/kg. then, the mice were fixed in the supine position and their skin was shaved from the inguinal region to the medial aspect of the thigh above the knee and disinfected with 70 % ethanol. the skin was next lifted with tweezers under stereomicroscopic observation, and an incision about 7-10 mm length was placed in the inguinal region. the subcutaneous connective tissue was carefully removed to expose both the femoral artery and the femoral vein. the femoral artery is separated from the femoral vein by blunt dissection with micro tweezers. a stringlike nylon suture with polyethylene tube is sent under a separating femoral artery. the break of the polyethylene tube is expanded by pulling stringlike nylon suture of polyethylene tube. the polyethylene tube is placed around the femoral artery. finally, the surrounding tissue is straightened and the skin is sutured ( fig. 2.1) . a sham operation is performed without polyethylene tube placement in the other femoral artery, as control. the mice are anesthetized by ip injection of pentobarbital 14 days after the operation and fix in the supine position. after laparotomy, the diaphragm is incised to expose the heart. ice-cold 4 % paraformaldehyde is injected into the systemic circulation via the cardiac apex at a pressure of 100 cm h 2 o, followed by incision of the right auricular appendage. both the cuffed-femoral artery and the sham-operated artery of the opposite sides are removed and immersed in oct compound. for the immunohistochemical staining, 5-to 6-μm-thick sections are prepared from each sample. paraffin sections are more suitable for the measurement of intimal thickness than frozen sections. femoral artery samples embedded in paraffin were cut from one edge to the other edge of the cuffed portion. the areas of the lumen, intima, and media were measured in 10 cross sections using the image analyzer. images are digitized and captured with a ccd camera connected to a personal computer ( fig. 2 the medial thickness for each vessel cross section, the linear distance between the internal elastic lamina and external elastic lamina is measured independently in 10 places, separated by 90 each and then averaged. the ratio of the intimal to the medial area and the percent luminal stenosis are calculated based on these measurements [10, 34] . since cuff-induced neointimal formation showed positive staining with an α-smc antibody (fig. 2.2b) , the neointima appears to be almost entirely composed of smcs. neointimal formation induced by cuff placement can be considered as a consequence of migration and/or proliferation of the smcs induced by some factors such as pdgf-bb or inflammatory cytokines ( fig. 2.3 ). although the exact mechanisms underlying the neointimal formation in cuff-induced injury models are still uncertain, i would like to refer to reports from the literature of studies carried out using genetically manipulated mouse models to discuss the mechanisms of neointimal formation ( cuff replacement around the femoral artery induced neointimal hyperplasia, which was exclusively composed of smcs, as mentioned above. platelet-derived growth factor (pdgf)-bb, which is mainly secreted from platelets, is one of the most the expression levels of pdgf-bb mrna in the cuffed artery were significantly increased as compared to those in the sham-operated artery (fig. 2.3 ). an antagonist of the pdgf-bb receptor was shown to suppress the proliferation of vascular smcs after balloon-induced injury in a rat model [36] . pdgf-bb induces vascular smc proliferation via, at least in part, regulation of the cell cycle. schwaiberger et al. demonstrated that local treatment with a cyclin-dependent kinase inhibitor inhibited cuff-induced neointimal formation, accompanied by reduction of the phosphorylation level of signal transducer and activator of transcription 3 (stat3), but not of akt, erk1/2, or p38mapk activation [35] . these data suggest that pdgf-bb-stat3 signaling is involved in cuffinduced neointimal formation. in addition to pdgf-bb-stat3 signaling, pdgf-bb has been reported to augment the migration of smcs through the lr11, a member of the ldl receptor family/urokinase-type plasminogen activator receptor (upar) pathway [37] . ohwaki et al. found that balloon-injured intimal smcs showed strong expression of lr11 in rat arteries. high-fat diet-fed lr11-ko mice showed a decrease of cuff-induced neointimal formation [38] . in in vitro experiments, the secreted soluble form of lr11 (soilr11) promoted the migration of thp-1 induced by pdgf-bb, an effect that was completely canceled by the anti-upar antibody [38] . these data suggest that pdgf-bb induced by cuff-induced injury is one of strongest regulators of neointimal formation. the ecm has been reported to be a key player in arterial remodeling after vascular injury [4] . hyaluronan 2 (has2), which is a primary component of the ecm, is expressed in neointimal lesions in humans with atherosclerosis and at sites of wire-induced injury of the arteries in mice. mice overexpressing the murine has2 gene specifically in the vascular smcs (chas2/cresm22a mice) showed markedly enhanced cuff-induced neointimal formation, with augmentation of smc migration and proliferation, and production of inflammatory cytokines and ros [39] . consistent with these data, in a wire-induced injury model, a ha synthesis inhibitor markedly suppressed neointimal formation. the ecm induced by arterial cuff-induced injury promotes migration of smcs into the intima, leading to neointimal formation. the roles of bone marrow (bm)-derived cells in the pathogenesis of atherosclerosis have been extensively studied [40] . fluorescence in situ hybridization (fish) analysis has revealed that female-derived bm cells transplanted into male mice were detected in the neointima of male mice (fig. 2.4) . following bmt from green fluorescent protein (gfp)-transgenic mice to apoe-ko mice, gfp-positive cells were confirmed in the vascular neointima (4-10 %) and media (5-32 %) in the latter mice. following bone marrow transplantation (bmt) from lacz mice to wild-type (wt) mice, a number of lacz-positive macrophages were found in the neointima (25.7 %), media (7.3 %), and adventitia (73.7 %) of the arteries of the wt mice at 4 weeks after cuff placement [33] . it was worthy of note that more marked infiltration of the adventitia by macrophages was observed after injury induced by cuff placement than after wire injury or ligation injury. xu et al. transplanted the bm of gfp-transgenic mice into ldlr-ko mice to identify the cell lineage in the lesion [41] . two weeks after cuff placement following a high-fat diet for 4 weeks, atherosclerotic lesions developing in the intima predominantly consisted of a massive accumulation of foam cells with a number of α-smaand gfp-positive cells. in addition to macrophages, adventitial small vessels also showed positive staining for both the endothelium-specific marker cd31 and gfp in mice transplanted with bm obtained from gfp-transgenic mice [41] . most of the macrophages are gfp-positive, and some of the smcs and ecs are also gfp-positive. in a cuff-induced vascular injury model, bm-derived cells are recruited to the adventitia and differentiate into macrophages, smcs, and endothelial cells. treatment with a blocker of m-csf, which guides differentiation into macrophages, caused a prominent decrease of macrophages, and inhibition of the pdgf receptor suppressed the recruitment of smcs to the adventitia after cuff placement [42] . these data suggest that the adventitia plays a pivotal role in neointimal formation induced by cuff placement. scott et al. demonstrated that the adventitia is important in the first wave of growth after angioplasty following occurrence of neointimal hyperplasia [43] . the importance of t and b lymphocytes in the process of restenosis after pci has been pointed out [44] . rag-1-ko mice, which lack mature b and t cells, have been demonstrated to show increased thickness of cuff-induced neointima in the carotid artery. reconstitution of the rag-1-ko mice with b cells from wt mice reduced the neointimal formation. moreover, both igg and igm were detected in the cuffinjured carotid arteries of reconstituted rag-1-ko mice with b cells [45] . these data suggest that an increase of immunoglobulin by activation of b cells exerts a protective action against intimal thickening. the neointimal area and intima/media ratio were significantly reduced in mice treated with immunoglobulin administered intraperitoneally for 5 consecutive days starting 1 day prior to cuff placement. on the other hand, immunoglobulin could not suppress cuff-induced neointimal formation, when the treatment was commenced 3 days after cuff placement [46] . when pooled mouse igg or igm was given to rag-1-ko mice by intravenous injection, a significant reduction of intimal thickening was observed as compared with that in the untreated rag-1-ko mice. immunoglobulin treatments modify the serum complement c3 profile, and the amount of complement c3 was decreased in the injured arteries. depletion of complement c3 in the rag-1-ko mice significantly decreased the degree of intimal thickening [47] . these data suggest that igg, igm, and complement c3 are involved in the modulation of the neointimal hyperplasia response to cuff-induced injury. moreover, treatment with immunoglobulin significantly enhanced the secretion of interleukin (il)-10, suggesting activation of t cells by immunoglobulin [46] . rag-1-ko mice reconstituted with t cells from wt mice showed a reduction of neointimal formation after cuff placement [48] . dimayuga et al. carried out a detailed examination of the t-cell fraction. splenic cd8 + cd25 + t cells and cd8 + cd28 + t cells, but not cd4 + cd25 + and cd4 + cd28 + t cells, were also significantly increased after arterial injury in the wt mice. rag-1-ko mice given cd8 + t cells showed a significant decrease of neointimal formation as compared to rag-1-ko mice not given the cells. on the other hand, transfer of cd4 + t cells was not associated with inhibition of the neointimal formation [49] . neointimal formation induced by cuff placement was significantly reduced in cd4-ko mice as compared with that in the wt mice, because of the higher percentage of cd8 + t cells. moreover, adoptive transfer of cd8 + cd28 hi t cells into recipient rag-1-ko mice significantly reduced neointimal formation as compared to that of cd8 + cd28 + t cells [50] . although both cd8 + t cells and cd4 + t cells are activated in response to arterial injury, cd8 + t cells, which constitute at least a fraction of the cd8 + cd28 hi , are mainly involved in the inhibition of cuff-induced neointimal formation. nitric oxide (no) is an important vascular regulatory factor that is generated by the enzyme nitric oxide synthase (nos) [51] . three different isoforms of nos are recognized: among these is endothelial nos (enos), which is constitutively expressed mainly in the vascular endothelial cells [52] . enos can be an important factor modulating vascular endothelial function and is activated by acetylcholine (ach) and insulin. enos-ko mice exhibit impaired ach-induced vascular relaxation [53] . the second isoform is inducible nos (inos), which cannot be detected in normal tissue, but is expressed in several cell types, including macrophages and vascular smcs, after cytokine stimulation [54] , and the third isoform is neuronal nos (nnos), which is constitutively expressed mainly in the nervous tissues and skeletal muscle type ii. enos-ko mice exhibit increased neointimal formation following cuff placement [34] . consistent with these data, the neointimal formation induced by ligation is also significantly more pronounced in the enos-ko mice than in the wt mice [55] . since antiplatelet and antihypertensive treatments cannot attenuate the progression of neointimal formation, the neointimal hyperplasia observed in enos-ko mice is produced by the direct action of enos and not mediated by thrombus formation or high blood pressure [33] . when adenovirus-mediated human endothelial constitutive nos cdna (adcmvcenos) was transduced into the rat carotid artery after balloon injury, the intima/media ratio decreased significantly because of inhibition of smc proliferation [56] . these data suggest that no mediated by enos inhibits neointimal hyperplasia induced by vascular injury. inos has been shown to be expressed in the smcs after cuff-induced vascular injury in rabbits [57, 58] , and inos-ko mice showed a significant reduction of neointimal thickening induced by cuff placement [59] . unlike enos-deficient mice, inos-ko mice showed no reduction of the neointimal hyperplasia associated with mechanically induced endothelial denudation. both the medial area and medial thickness were increased in the inos-ko mice after mechanically induced endothelial denudation [60] . consistent with these data, yogo et al. demonstrated that vascular remodeling, but not neointimal hyperplasia, after carotid artery ligation was increased in the inos-ko mice [55] . the differences in the procedure used to induce vascular injury may be related to the degree of neointimal hyperplasia and vascular remodeling in the inos-ko mice. cuff placement evokes significant participation of inflammatory cells, including macrophages, in the adventitia as compared to the ligation model, as mentioned above. increase of inflammation in the adventitia may be associated with increased inos expression levels, which may promote neointimal formation induced by cuff placement. mechanically induced endothelial denudation and ligation may mainly induce migration of the smcs from the media to the intima, resulting in increased neointimal hyperplasia. similar results were also observed in soluble epoxide hydrolase (seh)/apoe double-ko mice and inhibition of seh by 12-(3-adamantan-1-yl-ureido) dodecanoic acid, which suppress metabolism of epoxyeicosatrienoic acids (eets). seh/apoe double-ko mice or mice with inhibition of seh showed significant reduction of the neointimal formation in the femoral artery cuff model, but not in the carotid artery ligation model. the expressions of proinflammatory genes were significantly reduced in the femoral arteries of the seh/apoe double-ko mice [61] . inflammation is considered as an important factor in human atherogenesis [8] . an inflammatory response to vascular injury, mediated by proinflammatory cytokines, influences the progression of neointimal formation and development of atherosclerotic lesions. it has been demonstrated that the expressions of toll-like receptors (tlrs) 2 and 4 are markedly enhanced in human atherosclerotic plaques and vascular adventitia [62] . tlr4 serves as the receptor for bacterial lipopolysaccharides (lps) and also recognizes cellular fibronectin, heat shock protein 60, and endogenous peptides that are produced in response to tissue injury [63] . in the adventitia, not all tlr4-positive cells are colocalized with macrophages. although application of lps between the cuff and artery augmented the neointimal formation induced by cuff-induced injury in the wt mice, no such finding was observed in the tlr4-ko mice [64] . application of pam3cys-sk4, a synthetic tlr2 ligand, significantly enhanced the neointimal formation induced by cuff placement in the femoral arteries of the wt mice. no such increase of the neointimal formation was observed in the tlr2-ko mice. in apoe-ko mice, application of pam3cys-sk4 led to a significant increase in the formation of atherosclerotic plaques [65] . tlr2 stimulation produced significant induction of inflammatory cytokines in human adventitial fibroblasts in vitro. treatment with cathepsin k (catk), which is one of the most potent of mammalian collagenases, increased the mrna levels of inflammatory cytokines, including tlr2 and tlr4. catk-ko mice showed significantly reduced neointimal formation following cuff placement and ligation, accompanied by a decrease in the expression levels of tlr2 and tlr4 mrna [66] . these findings provide evidence for a link between inflammatory cytokines in the adventitia and intimal lesion formation. although tlr2/4 are expressed on the cell surface, tlr7/9 are expressed on the endosomes. tlr7/9 were detected at sites of post-interventional remodeling and accelerated atherosclerosis [67] . in hypercholesterolemic apolipoprotein e*3-leiden mice, femoral artery cuff placement led to a strong increase of the tlr7/9 expressions [68] . blockade of tlr7/9 with a dual antagonist reduced neointimal thickening and foam cell accumulation; the intima/media ratio was reduced by 64.5 % and luminal stenosis by 62.8 %. application of the tlr7/9 dual antagonist also reduced arterial wall inflammation, with reduced macrophage infiltration and altered serum il-10 levels. stimulation of cultured macrophages with tlr7/9 ligands enhanced tnfα expression, which was decreased by coadministration of the tlr7/9 antagonist. furthermore, the antagonist abolished the tlr7/9-enhanced ldl uptake. the antagonist also reduced oxidized ldl-induced foam cell formation, most likely not via decreased influx, but via increased efflux induced by increased il-10 levels. the renin-angiotensin-aldosterone system (raas) has various physiological actions such as vasoconstriction and is known to be involved in the development of hypertension and atherosclerosis [69, 70] . specifically, modulation of the local raas may play a key role, just like that of the systemic ras, in the development of cardiovascular diseases. angiotensin (ang) ii is a peptide that exerts potent vasoconstrictive action via the at1 receptor-mapk pathway. although human renin (hrn)/human angiotensinogen (hang)-transgenic (tg) mice showed increased blood pressure and medial thickening even in the absence of cuff placement, the hrn/hang-tg mice showed even more pronounced inflammatory vascular remodeling after cuff placement. treatment with an at1 blocker inhibited cuff-induced neointimal formation associated with reduced inflammation, but independently of the blood pressure change [71] . when the direct renin inhibitor aliskiren was administered to c57bl/6 mice via an osmotic pump, it inhibited cuff-induced vascular remodeling. the number of adherent leukocytes was increased in the cuff-injured mice not treated with aliskiren, where it was significantly reduced in the aliskiren-treated mice without any change of the blood pressure. aliskiren decreased the adhesion of thp-1 cells to tnfα-stimulated human umbilical vein endothelial cells [72] . these data indicate that ras activation augments neointimal hyperplasia induced by cuff placement via increased release of inflammatory cytokines. moreover, the ace expression level increased in a time-dependent manner after cuff placement and was observed in the medial and neointimal layers and the adventitia of the cuffed arteries in fvb/n mice. the intima/media ratio after cuff placement was significantly decreased by ace inhibitor treatment [73] . ang ii appears to be one of the factors exacerbating cuff-induced neointimal formation. in fact, at1 receptor-ko mice showed decreased neointimal formation following cuff placement, accompanied by an increase of apoptotic cells among the smcs [74] . consistent with these data, the at1-selective receptor blocker olmesartan suppressed cuff-induced neointimal formation via reducing erk phosphorylation [75] . on the other hand, neointimal formation induced by cuff placement was increased in at2 receptor-ko mice. the expressions of bcl-2 and bcl-xl mrna, which are regulators of apoptosis, were enhanced in the at2 receptor-ko mice showing enhanced neointimal formation [74] . recently, in addition to the ang ii-at1 receptor pathway, ang-(1-7), which is synthesized from ang i and ang ii mainly via ace2 activity, has been reported to play a crucial role in vascular remodeling via mas receptor activation [76, 77] . mas-ko mice showed markedly increased neointimal formation after cuff placement, independently of the at1 receptor. treatment with ang-(1-7) also suppressed neointimal formation, associated with suppression of vascular smc proliferation, release of inflammatory cytokines and superoxide anion production in the injured artery. on the other hand, these inhibitory effects of ang-(1-7) were less marked in the mas-ko [78] . interestingly, treatment with an at1 receptor blocker inhibited neointimal formation induced by cuff placement, accompanied by a decrease in the expression levels of ace2 and mas mrna and an increase in the expression of at2 receptor mrna. at2 receptor-ko mice showed no reduction of the neointimal formation by treatment with ang(1-7) . these results suggest that in addition to the activities of the ace2/ang-(1-7)/mas axis, blockade of the at1 receptor could enhance the activities of the ace2/ang-(1-7)/at2 receptor axis and thereby inhibit neointimal formation induced by cuff placement. atherosclerosis is associated with increased production of reactive oxygen species (ros) in the vessel [79] . the superoxide dismutases (sods) are enzymes that catalyze the dismutation of superoxide anions to hydrogen peroxide; three isoenzymes of the sods have been identified, namely, manganese sod (mnsod), which is localized in the mitochondria; copper/zinc sod (cu/znsod), which is localized in the cytosol; and extracellular sod (ec-sod). the antioxidant enzyme cu/znsod metabolizes superoxide anions (o2-) in the vascular endothelial cells [80] . although there was no difference in the degree of cuff-induced neointimal formation between the cu/znsod-ko and wt mice, the former showed a significant decrease in the intima/media ratio after cuff placement [81] . this increased medial smcs in the cu/znsod-ko mice showed positive staining for smemb/ mhc-b, which is a useful molecular marker of embryonic-type smcs. moreover, the expression levels of tnfα, icam1, vcam1, and inos in the media were higher in the cu/znsod-ko mice than in the wt mice, suggesting that cu/ znsod-ko mice showed enhanced inflammation, expression of adhesion molecules, and altered structure of the media post-injury. when an adenovirus vector expressing ec-sod (axcaec-sod) was injected between the cuff and the adventitia of the femoral arteries in rat models, neointimal formation was significantly reduced in the axcaec-sod-transfected arteries [82] . furthermore, proliferation of smcs in the neointima and media was inhibited by ec-sod treatment. augmented inos expression, apoptosis, collagen content, and ros generation in the vascular wall were also reduced by ec-sod treatment. the amount of generation of ros may have influence on the degree of medial thickening as well as neointimal formation induced by cuff placement. insulin resistance has been reported to be associated with atherosclerosis; however, the underlying mechanism is still unknown [83] . insulin resistance is caused by impaired insulin signaling induced by some factors. insulin activates insulin receptor substrates (irs) 1 and 2, which are expressed ubiquitously in various tissues, including the endothelial cells and smcs, through the insulin receptor and the downstream signaling [84] . both irs1-and irs2-ko mice show features of the metabolic syndrome, including insulin resistance, dyslipidemia, and hypertension. although both genotypes of mice show a similar degree of insulin resistance, the irs2-ko mice show more pronounced cuff-induced neointimal formation than the irs1-ko mice, which in turn show more pronounced cuff-induced neointimal formation than the wt mice. irs2 expression, but not irs1 expression, is detected in the blood vessels [85] . insulin resistance in the blood vessels is considered to exacerbate cuff-induced neointimal formation. on the other hand, mice with phosphatase and tensin homology deleted on chromosome 10 (pten), which is an antagonist of phosphatidylinositol 3-kinase (pi3k), exhibited significant reduction of neointimal formation when adenovirusmediated human pten (adpten) type 1 was injected between the cuff and the adventitia. adpten reduced smc proliferation and release of inflammatory cytokines [86] . since insulin activates pi3k via the irs, the overexpression of pten in response to cuff-induced injury appears to be a seemingly contradictory finding to that observed in the irs-ko mice. however, as pi3k has known to be activated by some factors independently of insulin signaling, activated pi3k may enhance neointimal hyperplasia induced by cuff placement under some conditions. cuff placement causes mild endothelial cell damage, smc proliferation and migration, and inflammation of the adventitia. this is a convenient and reproducible tool and is relatively less expensive and time-consuming. this tool is effective for analyzing the mechanism of vascular remodeling using mice, including genetically engineered mice. further experiments to identify the precise mechanisms of neointimal hyperplasia by using this tool will provide the development of new technologies in the future. global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study in stent restenosis: bane of the stent era the importance of the endothelium in atherothrombosis and coronary stenting mechanisms of post-intervention arterial remodelling biological responses in stented arteries acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen morphological predictors of arterial remodeling in coronary atherosclerosis atherosclerosis -an inflammatory disease smooth muscle phenotypic modulation -a personal experience intimal hyperplasia in murine models pathology of in-stent restenosis coronary in-stent restenosis: current status and future strategies sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery a polymerbased, paclitaxel-eluting stent in patients with coronary artery disease safety and efficacy of sirolimus-and paclitaxel-eluting coronary stents pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk the prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts experimental studies on the morphogenesis of arteriosclerosis aortic alterations in rabbits following sheathing with silastic and polyethylene tubes experimental diffuse intimal thickening of the femoral arteries in the rabbit an electron microscopic study on the early change of intimal thickening in arteriosclerosis inflammatory responses in cuff-induced atherosclerosis in rabbits rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation the endothelium during cuff-induced neointima formation in the rabbit carotid artery triphasic sequence of neointimal formation in the cuffed carotid artery of the rabbit spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein e animal models of atherosclerosis low density lipoprotein receptor-negative mice expressing human apolipoprotein b-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a) remodeling with neointima formation in the mouse carotid artery after cessation of blood flow mouse model of arterial injury a mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice indirubin-3 0 -monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo targeting endogenous platelet-derived growth factor b-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury ang ii-stimulated migration of vascular smooth muscle cells is dependent on lr11 in mice a secreted soluble form of lr11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipidladen macrophages crucial role of hyaluronan in neointimal formation after vascular injury hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis hypercholesterolemia contributes to the development of atherosclerosis and vascular remodeling by recruiting bone marrow-derived cells in cuff-induced vascular injury role of bone marrowderived progenitor cells in cuff-induced vascular injury in mice identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries th2-dependent cytokine release in patients treated with coronary angioplasty inhibitory effect on arterial injury-induced neointimal formation by adoptive b-cell transfer in rag-1 knockout mice the effect of intravenous immunoglobulins on intimal thickening in a mouse model of arterial injury natural antibodies and complement modulate intimal thickening after arterial injury t cell modulation of intimal thickening after vascular injury: the bimodal role of ifn-gamma in immune deficiency enhanced neointima formation following arterial injury in immune deficient rag-1à/à mice is attenuated by adoptive transfer of cd8 t cells reduced neointima formation after arterial injury in cd4à/à mice is mediated by cd8+cd28hi t cells cellular and molecular mechanisms of endothelial cell dysfunction primary endothelial dysfunction: atherosclerosis hypertension in mice lacking the gene for endothelial nitric oxide synthase isoforms of nitric oxide synthase. characterization and purification from different cell types different vasculoprotective roles of no synthase isoforms in vascular lesion formation in mice human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury induction of nitric oxide synthase in the neointima induced by a periarterial collar in rabbits decreased neointimal thickening after arterial wall injury in inducible nitric oxide synthase knockout mice apolipoprotein e inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction in vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development cathepsin k activity controls injuryrelated vascular repair in mice vessel-specific toll-like receptor profiles in human medium and large arteries blocking toll-like receptors 7 and 9 reduces postinterventional remodeling via reduced macrophage activation, foam cell formation, and migration angiotensin ii promotes atherosclerotic lesions and aneurysms in apolipoprotein e-deficient mice angiotensin ii-induced hypertension accelerates the development of atherosclerosis in apoe-deficient mice temporary treatment with at1 receptor blocker, valsartan, from early stage of hypertension prevented vascular remodeling dynamic observation of mechanically-injured mouse femoral artery reveals an antiinflammatory effect of renin inhibitor angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice role of angiotensin ii-regulated apoptosis through distinct at1 and at2 receptors in neointimal formation effect of estrogen and at1 receptor blocker on neointima formation angiotensin-(1-7): beyond the cardio-renal actions possible involvement of angiotensin-converting enzyme 2 and mas activation in inhibitory effects of angiotensin ii type 1 receptor blockade on vascular remodeling possible role of angiotensin-converting enzyme 2 and activation of angiotensin ii type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin ii type 1 receptor blockade role of oxidative modifications in atherosclerosis vascular expression of extracellular superoxide dismutase in atherosclerosis deficiency of cuzn superoxide dismutase promotes inflammation and alters medial structure following vascular injury extracellular superoxide dismutase overexpression reduces cuff-induced arterial neointimal formation insulin sensitivity and atherosclerosis. the insulin resistance atherosclerosis study (iras) investigators snapshot: physiology of insulin signaling lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury pten reduces cuffinduced neointima formation and proinflammatory cytokines key: cord-032975-7hugs419 authors: sun, j. d.; dahl, a. r.; gillett, n. a.; barr, e. b.; crews, m. l.; eidson, a. f.; bechtold, w. e.; burt, d. g.; dieter, m. p.; hobbs, c. h. title: two-week, repeated inhalation exposure of f344/n rats and b6c3f mice to ferrocene(1) date: 1991-07-17 journal: fundam appl toxicol doi: 10.1093/toxsci/17.1.150 sha: doc_id: 32975 cord_uid: 7hugs419 two-week, repeated inhalation exposure of f344/n rats and b6c3f(1) mice to ferrocene. sun, j. d., dahl, a. r., gillett, n. a., barr, e. b., crews, m. l., eidson, a. f., bechtold, w. e., burt, d. g., dieter, m. p., and hobbs, c. h. (1991). fundam. appltoxicol. 17, 150-158. ferrocene (dicyclopentadienyl iron; cas no. 102-54-5) is a relatively volatile, organometallic compound used as a chemical intermediate, a catalyst, and as an antiknock additive in gasoline. it is of particular interest because of its structural similarities to other metallocenes that have been shown to be carcinogenic. f344/n rats and b6c3f, mice were exposed to 0, 2.5, 5.0, 10, 20, and 40 mg ferrocene vapor/m3, 6 hr/day for 2 weeks. during these exposures, there were no mortality and no observable clinical signs of ferrocene-related toxicity in any of the animals. at the end of the exposures, male rats exposed to the highest level of ferrocene had decreased body-weight gains relative to the weight gained by filtered air-exposed control rats, while body-weight gains for all groups of both ferroceneand filtered air-exposed female rats were similar. male mice exposed to the highest level of ferrocene also had decreased body-weight gains, relative to controls, while female mice had relative decreases in body-weight gains at the three highest exposure levels. male rats had a slight decrease in relative liver weight at the highest level of exposure, whereas no relative differences in organ weights were seen in female rats. male mice had exposure-relative decreases in liver and spleen weights, and an increase in thymus weights, relative to controls. for female mice, relative decreases in organ weights were seen for brain, liver, and spleen. no exposure-related gross lesions were seen in any of the rats or mice at necropsy. histopathological examination was done only on the nasal turbinates, lungs, liver, and spleen. the only exposure-related finding was histopathologic lesions in the nasal turbinates of both species. these lesions were primarily centered in the olfactory epithelium and were morphologically diagnosed as subacute, necrotizing inflammation. nasal lesions were observed in all ferrocene-exposed animals and differed only in severity, which was dependent on the exposure concentration. in vitro metabolism studies of ferrocene showed that nasal tissue, particularly the olfactory epithelium, had 10 times higher “ferrocene hydroxylating” activity than did liver tissue from the same animals. these results suggest that the mechanism of ferrocene toxicity may be the intracellular release of ferrous ion through ferrocene metabolism, followed by iron-catalyzed lipid peroxidalion of cellular membranes. lizer, a smoke suppressant for polymers, and a polymerization catalyst, as well as in lubricant additives, and rocket propellants. the annual production of ferrocene is reported to be less than 1000 pounds per year (usepa, 1982) . ferrocene was selected for study by the national toxicology program because of its structural similarities to other metallocenes, some of which are carcinogenic, and because of the increasing potential for human exposure to ferrocene. the current tlv for ferrocene is 10 mg/m 3 (acgih, 1986) . at temperatures of 20°c or higher and concentrations in air of less than 40 mg/m 3 , ferrocene exists mostly as a vapor (jacobs et al, 1983) . therefore, ferrocene vapor, as opposed to droplets or particles, is the most likely chemical form to be inhaled by people. despite the increasing use of ferrocene and similar organometallic compounds, there is virtually no information available regarding the effects of long-term inhalation of vapors or aerosols of such compounds. inhalation exposures to inorganic forms of iron have been shown to be relatively nontoxic (committee on medical and biological effects of environmental pollutants, subcommittee on iron, 1979) . however, because of the lipophilicity imparted by its organometallic structure, ferrocene is able to deliver iron to lipophilic, intracellular sites in tissues which neither insoluble or water-soluble iron can reach (dahl and briner, 1980) . as a result, there may be ironinduced toxic effects that are not elicited by inorganic forms of iron, because of the differences in microdosimetry at specific sites. dahl and briner (1980) studied the toxicokinetics of inhaled ferrocene vapor. for these studies, they used ferrocene that was labeled with both iron-59 and tritium. inhalation exposure to ferrocene vapor resulted in an initial deposition of 37% of the inhaled vapor. of this amount, approximately 60% was deposited in the nasopharyngeal region and 25% in the lung. over 75% of the tritium label was excreted within the first day, but the 59 fe label remained, largely in the bronchopul-monary and nasopharyngeal regions, over the 117-day duration of the study. this suggested that the ferrocene was being metabolized in the respiratory tract, probably to hydroxyferrocene, which then decomposed in the lipidcontaining environment of the cellular endoplasmic reticulum. these investigators hypothesized that, because of the tendency of iron ions to catalyze the production of hydroxy radicals, inhaling ferrocene created the potential for cellular injury in the respiratory tract, particularly at the sites where ferrocene could deliver its iron moiety. by using an estimated half-time of 200 days for clearance of iron introduced into rat lungs by inhaled ferrocene, dahl and briner calculated that a human breathing ferrocene at the tlv concentration of 10 mg/m 3 would have acquired 1.7 g of ferrocene-derived iron in the pulmonary region at equilibrium. the purpose of our study was to characterize the toxic effects of inhaled ferrocene vapor after 2-weeks of inhalation exposure. we also investigated the in vitro metabolism of ferrocene in selected tissues to gain further insight into the importance of metabolism of this compound as a mechanism of ferrocene-induced toxicity. chemicals. the ferrocene used for this study was obtained from midwest research institute and was >99% pure, as determined by high-performance liquid chromatography (hplq. we studied the potential for ferrocene degradation that might be caused by the generation of exposure atmospheres. hplc analyses and graphite furnace atomic absorption of the exposure atmosphere showed that ferrocene was degraded by less than 1%. "fe-labeled ferrocene was prepared by treating a mixture of anhydrous ferrous chloride and w fe-labeled ferric chloride with sodium cydopentadienide. the labeled ferrocene was purified by sublimation and then was dissolved in ether. the concentration of ferrocene in the ethereal solution was determined by measuring the visible absorbance at 440 nm and calculating the concentration, using the molar absorptivity (0.95 m"'cm"'). the m fe activity was determined by scintillation counting. from the concentration and activity of the w fe, we were able to determine the specific activity of the synthesized material, which was then corrected for loss of activity due to radiodecay, the half-life of w fe is 45 days. exposure atmosphere generation and exposure system. wright dust feeders (wdf) (bgi, inc., waltham, ma) were used to generate the ferrocene aerosols. the aerosol generated by each wdf was heated to 200°c to vaporize the ferrocene particles. a separate wdf generator/vapor system was used for each of the five exposure chambers. six hazleton h-2000 whole-body exposure chambers were used to house animals being exposed to each of the five levels of ferrocene (2.5, 5.0, 10, 20, and 40 mg ferrocene vapor/m 3 ) or to filtered air (control). the highest ferrocene exposure level represented the highest concentration of ferrocene vapor that could be generated without producing condensation aerosols of the vapor in the chamber. the method used to determine aerosol concentrations in the chambers was a bubbler sampling train. the hexane solution from each bubbler system was analyzed on a hewlett-packard model hp589oa gas chromatograph to determine the chamber vapor concentration. a real-time aerosol monitor (ram-s; gca corp., bedford, ma) was used to determine whether significant levels of particles were present in the chambers during exposures. during the exposures, we measured the homogeneity of the ferrocene vapor within each exposure chamber by injecting heated line samples directly into the gas chromatograph. animals. thirty male and 30 female f344/n rats and 30 male and 30 female b6c3f, mice (4 weeks old) were received from the simonsen laboratories, inc. (gilroy, ca). the animals were quarantined in cage units within a hazleton h-2000 chamber prior to exposure, 2 per cage, for the first 4 days and then 1 per cage for 11 (rats) or 12 (mice) days. animals were exposed for 5 days/week, starting on a monday, for 2 weeks, with 2 or 3 additional exposure days before terminal euthanization, for a total of 12 or 13 exposure days for both rats and mice. this exposure schedule was necessitated to accomplish day-before-euthanization exposure and to facilitate timely necropsy of euthanized animals. most animals (67%) were exposed for 12 days. prior to the start of exposures, we used a computerbased randomization system (path/tox, xybion corp.) to randomly assign the rats and mice. individual animals assigned to the study were identified by tail tatoos for rats and tail tatoos and ear tags for mice. serum was obtained from two males and two females of each rodent species prior to the first day of exposure and was analyzed for antibody liters to specific rat viruses (kilham rat virus, toolan h-1 virus, pneumonia virus of mice, sendai virus, rat coronavirus/sialodacryoadenitis virus) and mouse viruses (k. virus, polyoma virus, mouse hepatitis virus, ectromelia, mouse encephalomyelitis (theiler's gd vii), mouse adenovirus, lymphocytic choriomeningitis virus, minute virus of mice, sendai virus, pneumonia virus of mice, epizootic diarrhea of infant mice, and reovirus 3). titers were negative for all of these agents. the animals were fed zeigler nih-07 open formula rat or mouse ration (zeigler brothers, inc., gardners, pa). food was withheld during the 6-hr-exposure period. water was available at all times, provided by an automatic watering system. temperature and relative humidity in the inhalation chambers were monitored once every 5 min and averaged 22.8 ± 1.1 °c and 55 ± 6% (mean + sd), respectively. the light cycle was automatically controlled to provide 12 hr of fluorescent light and 12 hr of darkness each 24 hr (on at 6 am and off at 6 pm). experimental design. rats and mice were weighed prior to starting the study, after 1 week of exposure, and at terminal euthanization. detailed clinical examinations were also made at these times. morbidity/mortality checks were made twice daily on all animals. rats and mice were killed at terminal euthanization by cardiac puncture exsanguination while under halothane anesthesia, and each animal was given a complete gross necropsy examination. the liver, thymus, right kidney, right testicle, brain, heart, and lungs were weighed and then fixed in 10% neutral-buffered formalin. tissues for microscopic examination (nasal turbinates, lungs, liver, and spleen) were embedded in paraffin, sectioned at 5 nm, and stained with hematoxylin and eosin. in vitro metabolism of ferrocene. microsomes for in vitro studies of ferrocene metabolism were obtained from the cells of 14-20 week old unexposed male f344/n rats. the rats were killed by co 2 asphyxiation. nasal ethmo-and maxilloturbinates and the liver were removed and homogenized. mictosomes were separated and stored as described previously (hadley and dahl, 1982) . suspensions of microsomes, appropriate cofactors (hadley and dahl, 1982) , and the radiolabeled ferrocene were incubated for 20 min at 37°c. metabolism was stopped by adding 1 m k.oh to raise the ph to ~ 11; adding the koh not only stopped the reaction, but also ionized phenolic metabolites to keep this species water soluble. after exhaustive hexane extractions of unmetabolized ferrocene, the aqueous portion of the reaction mixture was evaporated to dryness to remove, by sublimation, any small amounts of ferrocene that had not been extracted into the hexane. the residue was analyzed for radioactivity by liquid scintillation spectroscopy, and the protein content was determined with lowry protein assay (lowry et a!.. 1951) . statistics. the data from male and female animals were analyzed separately, using bartlett's test for data homogeneity and dunnett's test for the equality of mean values. the criterion for significance was set at p < 0.05. the overall mean ferrocene concentrations in each exposure chamber (2.5, 5, 10, 20, and 40 mg vapor/m 3 ) during the 2-week, repeated study were within ± 10% of the target concentrations (table 1 ). the relative standard deviation of the daily means was within 45%. the homogeneity (i.e., the variation among " mean ± sd (n =• 78). each ferrocene exposure concentration was shown to be statistically different from all other exposure concentrations at p < 0.05. six position samples within each chamber) of the ferrocene vapor concentrations ranged from 5.7 to 17.6% among all exposure chambers. no rats or mice died during the study, nor were any clinical signs of toxicity found during either the daily or the detailed observation times. group mean body weights at the end of the study (day 17) and mean weight gain over the exposure period are given in tables 2 and 3 for rats and mice, respectively. relative to control mice, male rats exposed to the highest concentration of ferrocene (40 mg/m 3 ) had statistically significant decreases in terminal body weight and rate of weight gain during the exposures. no significant body-weight differences were seen among the groups of exposed and control female rats at the end of the study. male mice exposed to the two highest concentrations of ferrocene (20 and 40 mg/m 3 ) had significant decreases in terminal body weight and/or in the rate of weight gain, while female mice had decreases in terminal body weight and rate of weight gain at the three highest exposure levels (10, 20, and 40 mg/m 3 ). no exposure-related gross lesions were found at necropsy in either rats or mice from any exposure group. the only measured organ weight affected by ferrocene exposure in rats was that of the liver. group mean liver weights for male and female rats are given in table 4 . male rats exposed to the highest concentration of ferrocene vapor had a statistically significant, although small, decrease in liver weights, compared to control animals. statistically significant decreases in liver weight were not seen in female rats at any exposure concentration. postexposure, group mean organ weights for male and female mice are given in table 5 . male mice had a statistically significant decrease in liver and spleen weights after exposures to the two highest concentrations of ferrocene vapor, and a statistically significant increase in thymus weight after exposure to the highest concentration of ferrocene, when compared to control animals. female mice had exposurerelated decreases in brain, liver, spleen, and right kidney weights, relative to control female mice. the measured weights for other organs were not affected by ferrocene exposure (data not shown). because of the absence of any gross lesions in other organs, only lung, nasal turbinates, and high level, ferrocene-exposed mice (b) (x135). note the marked attenuation, necrosis and accompanying inflammation of the nasal epithelium from the ferrocene-exposed animal (b). similar nasal lesions were found in rats exposed to ferrocene vapor. epithelium present at the entry to the nasal cavity. the respiratory epithelium was minimally affected; occasional necrosis of individual cells and occasional cells containing a granular, light-brown pigment within the cytoplasm were observed in this epithelium. these alterations were primarily centered in the nasal septum. the transitional epithelium that extends between the squamous and respiratory epithelial regions exhibited minimal necrosis and epithelial hyperplasia. brown, cytoplasmic pigment, as described above, was also present within individual cells of this region. the severity of the lesions in the nonolfactory epithelium was exposure concentration-related, and both sexes and species were equally affected. however, the lesions were minimal in degree, even in the group exposed to the highest concentration of ferrocene (40 mg/m 3 ). the primary histopathological lesion for both rats and mice for both sexes and at all exposure levels was located in the olfactory epithelium (fig. 1) and was most severe in the dorsal meatus. this lesion was classified as subacute, necrotizing inflammation and encompassed the features described below. the olfactory epithelium was characterized by patchy areas of degeneration and by necrosis of neuroepithelial and sustentacular cells. many areas were markedly atrophic. inflammatory cells, predominantly neutrophils, were present; however, they were not a prominent component of the reaction. the relative pau-city of inflammatory cells that we observed is a common finding in lesions of the olfactory epithelium. the majority of the remaining epithelium was characterized by the presence of mitotic figures, rosette formation, and loss of basement membrane orientation of epithelial cells, all of which are indicative of marked regenerative attempts by the olfactory epithelium. many epithelial cells contained cytoplasmic, light-brown, granular pigment. bowman's glands were also characterized by patchy necrosis and atrophy. lesions were graded based on severity and distribution on a 1 to 5 scale, with 1 being minimal and 5 being severe. none of the animals had lesions that were considered to be more than moderate (grade 3) in degree. "minimal" lesions were those having rare individual cell necrosis and degeneration with subtle atrophy of the olfactory epithelium. "mild" lesions were characterized by patchy areas of degeneration and necrosis that involved less than 10% of the epithelium. "moderate" lesions were more extensive, involving up to approximately 25% of the epithelium; an inflammatory response was more prominent in lesions of this severity. the severity of the lesion in the olfactory epithelium was directly related to exposure dose. lesions were most severe in the groups exposed to the highest ferrocene concentration (40 mg/m 3 ) and were scored as moderate in degree. lesions of a similar magnitude were also observed in the groups exposed to 20 mg/ m 3 ferrocene. lesions, minimal to mild in degree, were seen in the groups exposed to 5 and 10 mg/m 3 ferrocene. lesions, minimal in degree, were seen in the group exposed to the lowest concentration of ferrocene, 2.5 mg/m 3 . we did not observe sex-related differences, and the severity of the lesion occurring after exposure to a given ferrocene concentration was about the same in rats and mice. no exposurerelated microscopic lesions were found in either livers or spleens. the in vitro studies of ferrocene metabolism showed that microsomes from the ethmoturbinates metabolized ferrocene more rapidly " values for v^ and k m and estimated 95% confidence intervals were taken from a plot of rate and concentrations of ferrocene derived by using 10 data points representing a range of ferrocene concentrations of 2 to 300 ^m. protein concentration was 0.5-1 mg microsomal protein, which was then normalized to a per gram tissue basis. than did those from the maxilloturbinates. also, microsomes from both nasal tissues had up to 10 times higher activities towards the ferrocene than did the liver microsomes (table 6). the localization of lesions in the olfactory mucosa is probably related to the high retention of ferrocene-derived iron in the nose (dahl and briner, 1980) , which, in turn, is probably a result of the high metabolic capacity in the nose, particularly in the olfactory mucosa. metabolism of ferrocene by cytochrome p450 probably proceeds according to the reactions shown in fig. 2 ; ferrocene is metabolized to unstable hydroxyferrocene (hanzlikeza/., 1978) , which then decomposes, releasing free ferrous ion intracellularly. the ferrous ion can then catalyze lipid peroxidation (dumelin and tappel, 1977) . this scenario could account for the lesions we observed. in addition to the high metabolic capacity of the olfactory epithelium, the greater sensitivity of this tissue to ferrocene toxicity as opposed to respiratory tract epithelium may also be due to a higher tissue dose and a lower rate of chemical clearance than respiratory epithelium. the olfactory epithelium lacks the ciliary clearance mechanism that is present in the respiratory epithelium. the olfactory epithelium also has fewer mucus-secreting cells and thus lacks the protective mucus layer that covers the respiratory epithelium. other inhalants that are metabolized to toxic products in the olfactory mucosa include dimethylnitrosamine (reznik-schiiller, 1983) , hexamethylphosphoramide (lee and trochimowicz, 1982) , and 3-trifluoromethylpyridine (gaskell el ai., 1988) . the feature that is unique for ferrocene is the suggestion that metabolism leads to free intracellular ferrous ion, which produces toxicity by catalytic peroxidation. experimental evidence for such a mechanism of toxicity for ferrocene has been provided by eidson et al. (1989) . other metabolically active sites, including the lung bronchioles, in which clara cells are located, and the liver, were not affected by inhaled ferrocene. this may reflect either less rapid ferrocene metabolism (as is the case for rat liver) or less penetration of ferrocene into those regions (dahl and briner, 1980) . exposure-related decreases in organ weights were seen for liver in rats, and in mice, liver, spleen, kidney, and brain weights also decreased, while thymus weights increased. while these results suggest that the named tissues may be target organs for toxicity resulting from long-term exposures to ferrocene, it is more likely that these changes were secondary effects brought on by the nasal lesions. however, in the case of liver, which, like olfactory epithelium, is highly active in xenobiotic metabolism, it is possible that primary toxic effects may result if ferrocene reaches this organ. also, the differences between the two species in the effects of ferrocene exposure on body and organ weights indicate that mice may be more susceptible to ferrocene toxicity than are rats, and that in longer-term exposure, female mice may be more sensitive to the toxic effects of ferrocene than are male mice. the results from these studies were used to select the exposure concentrations for a 13-week subchronic inhalation exposure study. these 13week subchronic inhalation exposures, using concentrations of 3.0, 10, and 30 mg/m 3 ferrocene, are currently in progress to determine the cumulative toxicity of ferrocene. threshold limit values and biological exposure indices for 1986-1987 biological fate of a representative lipophilic metal compound (ferrocene) deposited by inhalation in the respiratory tract of rats hydrocarbon gases produced during in vitro peroxidation of polyunsaturated fatty acids and decomposition of preformed hydroperoxides toxicity of ferrocene and vinylferrocene to rat nasal epithelium olfactory and hepatic changes following inhalation of 3-trifluoromethylpyridine in rats cytochrome p450 dependent monooxygenase activity in rat nasal epithelial membranes biological activity and disposition of the amphetamine analog 2-aminopropylferrocene the vapor pressure and enthalpy of sublimation of ferrocene metaplastic changes of nasal respiratory epithelium in rats exposed to hexamethylphosphoramide (hmpa) by inhalation protein measurement with folin phenol reagent nitrosamine-induced nasal cavity carcinogenesis chemicals in commerce information system (cicis), office of pesticides and toxic substances. chemical information division the authors are indebted to a number of individuals on the technical staff for their assistance on this project. this research was conducted in facilities fully accredited by the american association for accreditation of laboratory animal care. this research was sponsored by the national institute of environmental health sciences/national toxicology program under interagcncy agreement y01 -es-70157 and the office of health and environmental research of the u.s. department of energy under contract de-aco4-76ev01013. key: cord-104251-cq8ojfit authors: nan title: in vitro macrophage manifestation of cortisone-induced decrease in resistance to mouse hepatitis virus date: 1981-03-01 journal: j exp med doi: nan sha: doc_id: 104251 cord_uid: cq8ojfit genetically resistant g3h mice routinely yielded macrophages that were resistant when grown in 90% horse serum. these mice also routinely yielded macrophages that were susceptible to the same virus, mhv (pri), in vitro after the mice had been treated with three intraperitoneal doses, of hydrocortisone. dexamethasone and prednisolone when similarly administered also increased the susceptibility of c3h macrophages taken from the treated animal, but progesterone and testosterone did not. in addition, spleen cells from mice treated with cortisone made the resistant c3h macrophages 100 times more susceptible in vitro. increased in vitro susceptibility induced in this way by hydrocortisone was reversed by exposure to supernatant fluid removed from cultures of concanavalin a-treated spleen cells. effect of adding spleen cells from cortisone-treated mice. previous work from our laboratory has suggested that susceptibility of macrophages may be regulated by various lymphokines. therefore, cells from cortisone-treated mice were combined in vitro with normally resistant call macrophages and the susceptibility of these was tested. c3h mice were given 2.5 mg cortisone on day 0, and the spleens were removed 3 d later. 0.5 × 106 spleen cells were then added to each culture of normal c3h macrophages. control macrophage cultures received equal numbers of untreated spleen cells from syngeneic mice. various dilutions of virus [mhv(pri)] were inoculated into both groups of cultures. all cultures were kept for 6 d at 37°c. the results are summarized in table i . genetically resistant macrophages were destroyed by day 3 at 100-fold greater dilutions when they were cocultivated with spleen cells from cortisone-treated spleen cells but not the normal spleen cells. spleen cells that had been killed by heating to 56°c for 30 min or by freezing and thawing did not alter the resistance of call macrophages. direct addition of hc to peritoneal adherent cell populations. 10 table ii , however, shows that macrophages from hc-treated resistant mice (which had been treated three times) were 400-1,000 times more susceptible to the virus than those from untreated mice. when the mice were given only one injection of hc, the macrophages were not susceptible. viral growth was demonstrated primarily by cell destruction, which occurred as early as 2 d, but giant-cell formation also occurred which eventually ended in loss of contact with the culture tube. virus yield was determined in critical cases. the 1,000-fold increase in susceptibility of the macrophages was routinely observed if three doses of hc ranging from 50 #g to 5 mg were given to the mice, but when 10 mg was used, the cells were only 10-fold more susceptible. shif and bang (3) demonstrated that when high multiplicities of mhv(pri) were each group of csh mice (six per group) received three intraperitoneal doses (1 mg each) of the steroid after thioglycollate stimulation, and pec were harvested 24 h after the last dose. * all macrophages in the experiment were seeded in 16-mm 24-well tissue culture cluster plates and incubated at 37°c with 5% cc.~z and humidified air, given to c3h macrophages, a mutant virus, mhv(c3h), emerged that grew to high titer in both resistant and susceptible macrophages. following the above findings, macrophage cultures from hc-treated mice receiving 104 lds0 of mhv(pri), and which were destroyed by the virus, were assayed for virus yield on czh and c3hss macrophages on days 5 and 7 postinfection. virus harvested from macrophages of hc-treated mice on day 5 postinfection titered 10,000 times higher in cahss macrophages than in cnh macrophages. by day 7 postinfection, the difference had decreased to 2 logs, presumably because of late growth of the mutant. because of this, most of the subsequent experiments were limited to observations within 5 d of inoculation. the effect of cortisone is apparently glucoeorticoid-specific. prednisolone and dexamethasone were administered in the same way as hc: three successive injections, intraperitoneally, in vivo. two steroids (progesterone and testosterone) were similarly administered. the results showed that the active glucocorticoids increased susceptibility of the c3h macrophages, whereas the other steroids did not (table iii) . growth curve of mhv(pri) in macrophages from csi-iss, call, and hc-treated mice. virus (1.5 × 104 tissue culture infective doses/2 × 106 cells) was adsorbed for 60 min at 37°c in a roller drum. the fluid was then replaced by culture medium. at various intervals, individual tubes were harvested, frozen, then titered for total cellular and supernatant virus. as can be seen from fig. 1 , there was a sharp increase in virus titer in czhss macrophages during the first 10 h. there was no rapid initial rise in virus titer in either normal or hc-treated c3h macrophages. however, after about 11 h, the growth rate in the macrophages from hc-treated mice increased rapidly. at 21 h postinfection, virus replication in czh resistant macrophages started to decelerate, whereas in macrophages from hc-treated czh mice, it continued to increase. although virus growth in the latter attained almost the same final yield as in c~hss, it required ~20 h longer for this to occur. in vivo, however, c3h mice challenged with virus 3 d after cortisone (2.5 mg s.c.) die in just as short, or shorter, time period than susceptible czhss mice (mean survival time: 1.9 d for c3h; 2.5 d for c3hss). earlier, willenborg (7) had found that c3h mice challenged with virus 1 h after cortisone administration take longer to die than genetically susceptible pri mice. evidently, the time of cortisone administration may be a factor in the induction of susceptibility to the virus. it has been previously shown in our laboratory that genetically susceptible mice, as well as their macrophages, gain resistance when the mice are treated with con a, or when the macrophages are treated with the supernate from con a-treated spleen cells (4) . it was therefore of interest to determine whether con a would be antagonistic to cortisone. therefore, 0.1 ml of supernate fluid from con a-treated spleen cells (4) and also from normal spleen cells was added to macrophages from hc-treated mice and incubated for 14 h before inoculation of virus. table iv shows the complete reversal of the hc effect by supernatant fluid from con a-treated spleen cells but only a partial reversal by supernate fluid from normal spleen ceils. the addition of normal spleen cells did not make the macrophages from cortisonetreated mice resistant again. 0.5 × 106 spleen cells/ml, harvested from normal call mice, were added to macrophages from hc-treated mice and incubated for 24 h before viral infection. there was no significant difference between macrophages that received the spleen cells and those that did not (table iv) . although it has been known almost from the start of research on cortisone that this powerful anti-inflammatory drug depresses various immunologic mechanisms (1), the way in which it alters susceptibility to specific agents is not clear. the correspondence between in vivo and in vitro susceptibility of macrophages to mouse hepatitis made this model an attractive one to study. cortisone-induced increase in susceptibility of mice to mouse hepatitis virus has also been observed by a number of other investigators as summarized by vella and starr (8) . administration of cortisone to the genetically resistant czi-i mice (9) , as well as to outbred mice, rendered them susceptible to viral [mhv(pri)] infection. the lds0 of mhv(pri) virus was 108.5 in pri mice, 106.5 in cortisone-treated call mice, and <101'° in untreated call mice (9) . the slight or equivocal change in macrophage resistance, which had been demonstrated in vitro (7, 9) , was in no way comparable to the marked effects on the intact animal. gallily et al. (9) , using a 1:100 dilution of stock virus (106 lds0), had found that 85-100% of taylor et al. brief definitive report cortisone-treated cultures were killed by virus as compared to -20% of cultures given virus alone. willenborg (7), using a single dose of 2.5 mg cortisone, had found that the lds0 of mhv(pri) virus in macrophage cultures from cortisone-treated call mice was 103.4 , and in cultures from untreated mice, it was 103.2 . in our studies, it was apparently crucial to administer three doses of hc to the mice to achieve sufficient suppression of viral resistance for in vitro expression of the effect. presumably, a 1,000fold increase of susceptibility of macrophages may explain most, if not all, of the 105.5 difference in titer in normal and cortisone-treated mice. the mechanism whereby hc or cortisone changes the resistance of the all-important macrophage remains unclear. addition of spleen cells from cortisone-treated mice enhanced the susceptibility of call macrophages 100-fold. furthermore, cultures from hc-treated mice remained susceptible up to 72 h in culture, but fully regained resistance by 1 wk. the implication is that resistance of c3h macrophages is altered by some product of lymphoid cell activity induced by the steroid. that two other steroids, testosterone and progesterone, failed to cause the development of susceptible macrophages, whereas dexamethasone and prednisolone did, again suggests a correspondence of the in vitro results with the susceptibility of the whole animal. the addition of whole spleen cells from normal resistant mice to macrophages from hc-treated mice for a period of 24 h before viral infection did not restore resistance. however, adding 0.1 ml ofsupernate fluid from con a-stimulated spleen cells reversed the hc effect. this suggests that resistance is dependent, in part at least, upon a lymphokine released from t cells. because con a stimulates a variety of lymphokines, such as migration-inhibitory factor, interferon, soluble immune response suppressor, and t cell growth factor, it will be necessary to identify which specific lymphokine is responsible for the effect. the growth-curve experiment reveals that during the first 12 h of observation, virus replication was equal in both sets of czh macrophages, but that after this period, virus growth started to decelerate in the call control macrophages, although it continued to increase in macrophages from hc-treated mice. this suggests that resistance might be a result of the capacity of the call macrophage to produce an anti-viral substance during early growth which restricts viral growth. the work of gillis et al. (10) on how cortisone is able to suppress immune responses begins to explain the well known ability of cortisone to suppress antibody and t cell response. suppression of the production of a t cell growth factor by this corticosteroid is then followed by a failure of the t cell compartment to expand after either specific antigenic stimulus or administration of con a. that con a and cortisone act antagonistically in their studies (10) is very relevant to the similar blocking effect of one by the other in our system. however, because our studies seem to demonstrate that the cortisone-treated cells cause a change in the macrophage rather than prevent the release of a factor from lymphocytes, the analogy needs to be explored further. genetically resistant call mice routinely yielded macrophages that were resistant when grown in 90% horse serum. these mice also routinely yielded macrophages that were susceptible to the same virus, mhv(pri), in vitro after the mice had been treated with three intraperitoneal doses of hydrocortisone. dexamethasone and prednisolone when similarly administered also increased the susceptibility of csh macrophages taken from the treated animal, hut progesterone and testosterone did not. in addition, spleen cells from mice treated with cortisone made the resistant call macrophages 100 times more susceptible in vitro. increased in vitro susceptibility induced in this way by hydrocortisone was reversed by exposure to supernatant fluid removed from cultures of concanavalin a-treated spleen cells. received for publication 10 november 1980. mechanisms of glucocorticoid action on immune processes congenic strains of mice susceptible and resistant to mouse hepatitis virus in vitro interaction of mouse hepatitis virus and macrophages from genetically resistant mice. ii. biological characterization of a variant virus mhv(c3h) isolated from stocks of mhv(pri) blocking of in vitro and in vivo susceptibility to mouse hepatitis virus biochemical actions of glucocorticoids on macrophages in culture. specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions a simple method of estimating fifty percent end-points the effect of chemical and physical agents on the genetic resistance of mice to mouse hepatitis virus mhv(pri) effect of x-irradiation and cortisone on mouse hepatitis virus infection in germ-free mice effect of cortisone on genetic resistance to mouse hepatitis virus in vivo and in vitro glucocorticoid-induced inhibition of t cell growth factor production. i. the effect on mitogen-induced lymphocyte proliferation key: cord-306535-j26eqmxt authors: robertson, matthew j.; kent, katarzyna; tharp, nathan; nozawa, kaori; dean, laura; mathew, michelle; grimm, sandra l.; yu, zhifeng; légaré, christine; fujihara, yoshitaka; ikawa, masahito; sullivan, robert; coarfa, cristian; matzuk, martin m.; garcia, thomas x. title: large-scale discovery of male reproductive tract-specific genes through analysis of rna-seq datasets date: 2020-08-19 journal: bmc biol doi: 10.1186/s12915-020-00826-z sha: doc_id: 306535 cord_uid: j26eqmxt background: the development of a safe, effective, reversible, non-hormonal contraceptive method for men has been an ongoing effort for the past few decades. however, despite significant progress on elucidating the function of key proteins involved in reproduction, understanding male reproductive physiology is limited by incomplete information on the genes expressed in reproductive tissues, and no contraceptive targets have so far reached clinical trials. to advance product development, further identification of novel reproductive tract-specific genes leading to potentially druggable protein targets is imperative. results: in this study, we expand on previous single tissue, single species studies by integrating analysis of publicly available human and mouse rna-seq datasets whose initial published purpose was not focused on identifying male reproductive tract-specific targets. we also incorporate analysis of additional newly acquired human and mouse testis and epididymis samples to increase the number of targets identified. we detected a combined total of 1178 genes for which no previous evidence of male reproductive tract-specific expression was annotated, many of which are potentially druggable targets. through rt-pcr, we confirmed the reproductive tract-specific expression of 51 novel orthologous human and mouse genes without a reported mouse model. of these, we ablated four epididymis-specific genes (spint3, spint4, spint5, and ces5a) and two testis-specific genes (pp2d1 and saxo1) in individual or double knockout mice generated through the crispr/cas9 system. our results validate a functional requirement for spint4/5 and ces5a in male mouse fertility, while demonstrating that spint3, pp2d1, and saxo1 are each individually dispensable for male mouse fertility. conclusions: our work provides a plethora of novel testisand epididymis-specific genes and elucidates the functional requirement of several of these genes, which is essential towards understanding the etiology of male infertility and the development of male contraceptives. the world human population reached nearly eight billion people in august 2019. this number continues to rise and is predicted to reach nearly ten billion by the year 2050 [1] . the increasing need to promote family planning through the development of reliable contraceptive options available to both men and women is widely recognized. currently there are numerous contraceptive options available to women; however, identification of a safe, non-hormonal contraceptive option for men is still an ongoing challenge. although several different fertility control alternatives for men have been investigated, none are currently clinically approved for use. our understanding of the mechanisms underlying male reproductive physiology is still at an early stage as the identification and elucidation of the function of key reproductive proteins is still an ongoing effort. identifying druggable protein targets expressed in the male reproductive tract has been the focus of numerous studies dedicated to the development of male contraception. the mammalian epididymis is a segmented organ comprised of a single, highly coiled tubule with functionally and morphologically distinct regions that can be subdivided most simplistically into a proximal, central, and distal region, conventionally named the caput, corpus, and cauda regions, respectively [2] . as mammalian spermatozoa transit through the epididymis, they acquire the ability to recognize and fertilize an egg, properties that they did not possess upon exiting the testis [3] . considering its essential role, the epididymis-in addition to maturing germ cells of the testis and spermatozoa-is a prime target for the development of a male contraceptive. to advance progress towards the development of a non-hormonal male contraceptive, several previous high-throughput studies have been published that identified a number of human, mouse, and rat genes as testis-specific or epididymis-specific [2, [4] [5] [6] [7] [8] [9] . in 2003, schultz et al. conducted the first study to identify male reproductive tract-specific genes using microarrays. through affymetrix-based genome-wide geneexpression analysis of meiotic-and post-meiotic spermatogenic cells, together with parallel analysis of available data from the ncbi unigene database, the authors identified 271 mouse genes as testis-specific, which included genes with both known and unknown function at the time [4] . in the following 5 years, through two additional microarray-based studies of rat testes and purified rat testicular cells, johnston et al. identified 58 [5] and 398 [8] additional or overlapping genes as testisspecific. in 2014, as part of the continued effort to identify novel contraceptive targets, the newer rna-seqbased transcriptomics methodology was utilized identifying 364 human genes as testis-specific [9] . together with antibody-based protein profiling, many of these genes were characterized in terms of the spermatogenic cell populations showing expression [9] . the first high-throughput transcriptomics study to identify epididymis-specific genes was a 2005 mouse epididymal transcriptome study, in which rna isolated from each of the 10 epididymal segments was analyzed by microarray analysis, identifying 75 epididymis-specific genes with distinct patterns of segmental gene regulation [2] . later in 2007, additional transcriptome profiling utilizing whole genome microarrays resulted in identification of 77 previously unreported epididymis-specific transcripts in the mouse [6] and 110 epididymis-specific transcripts in the rat [7] . a significant number of the identified mouse and rat genes in these studies were not known at the time, and only the probe identification numbers were presented. when evaluating potential druggability in a targetbased drug discovery process, one must consider the protein properties that are required for safe and effective inhibition. among the most significant is tissue expression specificity to minimize potential adverse effects, protein function and whether protein activity or interaction with other proteins is potentially druggable, sequence similarity to closely related paralogs that may be ubiquitously expressed, and whether genetically manipulated animal models demonstrate a functional requirement for the target of interest [10] . several noteworthy review publications have mentioned numerous genes whose critical functions, high expression, and specificity to the testes or epididymides make them viable nonhormonal male contraceptive targets [11] [12] [13] [14] [15] [16] [17] [18] . however, among the identified genes, a significant number either (1) are required for fertility, but are expressed in nonreproductive tissues, or (2) are reproductive tractspecific, but, when disrupted, lead to subfertility [10] . in either case, both are ineffective and highly undesirable outcomes for a potential male contraceptive target. therefore, the identification of additional novel male reproductive tract-specific genes would allow for further advances to be made in the quest to develop an effective and safe non-hormonal male contraceptive. in this study, 21 newly acquired and 243 previously published human and mouse rna-seq datasets [9, [19] [20] [21] [22] [23] [24] [25] [26] were processed in parallel through a custom bioinformatics pipeline designed to identify novel reproductive tractspecific and reproductive tract-enriched transcripts. additional databases obtained from illuminating the druggable genome [27] , mouse genome informatics [28] , and ensembl biomart [29] were utilized to stratify the results into subgroups based on protein druggability and on the availability of a mouse model. numerous reproductive tract-specific and reproductive tract-enriched, potentially druggable targets for which no published mouse model exists, congruent in expression across both mouse and human datasets were identified through our analysis and verified through conventional polymerase chain reaction (pcr). we present the data in a manner that should be most relevant and of substantial interest to the male contraceptive development field since identification of new targets worthy of consideration for further functional analysis in a knockout animal model and potential drug targeting continues to be of vast importance. through our results, we identified four novel epididymis-specific genes (spint3, spint4, spint5, and ces5a) and two novel testis-specific genes (pp2d1 and saxo1) worthy of functional validation in an animal model. through the crispr/cas9 system, we generated four individual gene knockouts (spint3, ces5a, pp2d1, and saxo1) and one double knockout mouse model (spint4/5) revealing an essential requirement for spint4 and spint5 in male mouse fertility, and the potential utility of pursuing spint4 in humans as a non-hormonal contraceptive target. despite significant advances in our understanding of the human and rodent testis and epididymis transcriptome, mostly through microarray-based studies, no prior studies have utilized purified human testis cells for the identification of human testis-specific transcripts, no prior studies have utilized the more state-of-the-art rna-seqbased transcriptomics methodology for analysis of human epididymis-specific transcripts, and no prior studies have utilized rna-seq analysis of rodent reproductive tissues or cells to identify rodent reproductive tractspecific transcripts. to address these gaps in knowledge, and to increase the number of identified reproductive tract-specific genes in both species using the most relevant high-throughput transcriptomics methodology, we analyzed in parallel on a custom bioinformatics pipeline a large number of published and newly acquired human and mouse rna-seq datasets. one hundred and sixtytwo previously published human and 81 previously published mouse rna-seq datasets were retrieved from the sequence read archive (sra). the sra value for each sample is listed in additional file 1: table s1 and additional file 1: table s2 . we also generated 12 new human and 9 new mouse reproductive tissue rna-seq samples (geo accession gse150854). the final dataset is comprised of 3 new and 5 previously published human testis datasets [9] , 27 previously published purified human germ cell datasets [23, 24] , 6 previously published purified human sertoli cell datasets [23, 26] , 9 new and 6 previously published human epididymis segment datasets [21] , 6 previously published mouse testis datasets [19] , 9 new mouse epididymis datasets, 10 previously published purified mouse germ cell datasets [22, 25] , and 3 previously published purified mouse sertoli cell datasets [20] . an additional 118 previously published datasets contributed to the 26 non-reproductive human tissues [30] and 62 previously published datasets contributed to the 14 non-reproductive mouse tissues [19] . figure 1a , b summarizes all the samples acquired for the study. we performed a principal component analysis to visualize the variation in the samples after correcting for batch effects. human reproductive and non-reproductive tissues grouped according to sample type. the reproductive tissue samples clustered by tissue type whether or not they were newly generated or acquired from the sra (fig. 1c) . mouse data showed a similar variation in the samples based on the tissue type (fig. 1d) . for both human and mouse reproductive tissues, samples separated by whether or not the rna-seq was performed on isolated cells or the whole tissue. epididymal tissue was distinct from testis tissue in both human and mouse (fig. 1c, d) . to identify potential male reproductive tract-specific drug candidates, we analyzed the aggregated rna-seq data to find genes that were statistically significant in expression when compared to the non-reproductive tissue that had the maximum expression for that gene. this gene list was then further refined by filtering for genes that were lowly expressed in the non-reproductive tissue that had the maximum expression for that gene (tpm less than or equal to 1.0 for human; tpm less than or equal to 2.0 for mouse). finally, this tpm filtered list was then filtered for the genes that had a reproductive tissue or cell expression value greater than or equal to 10.0 tpm for human, or 8.0 tpm for mouse (fig. 2a) . across all the reproductive tissues, 720 candidate genes were identified in the human and 1304 candidate genes were identified in the mouse samples (fig. 2b , additional file 2: fig. s1 ). additional file 3: table s3 and additional file 4: table s4 summarize the differential fold change, identity of the non-reproductive tissue with maximal gene expression based on the differential gene analysis, fdr, average and standard deviation tpm expression values, and log2 cpm gene expression value for the human and mouse samples, respectively. the results from the fdr and tpm expression value filtering for the human and mouse samples are summarized in additional file 5: table s5 and additional file 6: table s6 , respectively. additional file 5: table s5 and additional file 6: table s6 report the log2 fold change for the reproductive tissue or cell of interest compared to the tissue with maximal gene expression. the genes identified in additional file 5: table s5 and additional file 6: table s6 pass the filters in at least one of the reproductive tissues or cells of interest. in additional file 5: table s5 and additional file 6: table s6 , a value of zero for a given gene and fold expression comparison indicates that for that comparison, the gene did not pass the filters. the majority of genes were downregulated in the reproductive tissue of interest compared to the maximal gene expressing nonreproductive tissue (additional file 7: fig. s2 ). from the analysis, the majority of the candidate genes that passed the fdr and tpm filters were identified in the testis-or sperm-related cells in both human and mouse samples (additional file 7: fig. s2 ). the majority of candidate genes identified in our screen that were testis-specific were already identified by the human protein atlas [9] and/or our reanalysis of (see figure on previous page.) fig. 1 summary of the human and mouse rna-seq samples used in the identification of novel male reproductive tract-specific drug targets. the rna-seq samples used in the human (a) and mouse (b) analyses are schematically shown. principal component analysis was performed on the human (c) and mouse (d) non-reproductive and reproductive samples separately. the colors of the circles next to the tissues listed in a and b correspond to the colors used in the circles for the pca in c and d. sample size (n) values in red and/or black denote the number of new (red) and previously published (black) samples included in our analysis. fig. 2 identification of candidate drug male reproductive gene targets. a diagrammatic representation of overall methodology used to identify reproductive tract-specific candidate genes in humans (720 genes) and in mice (1062 genes). the maximum gene expression was determined across all the non-reproductive tissue samples for each gene for a reproductive tissue or cell sample of interest. genes were then filtered for significance using a false discovery rate (fdr) of less than or equal to 0.05 based on the differential gene expression analysis for the nonreproductive tissue with maximum gene expression and reproductive tissue or cell sample of interest. genes that passed the fdr filter were filtered such that the average tpm expression value of the maximum expressing non-reproductive tissue was less than or equal to 1.0 tpm and the average tpm expression value of the reproductive tissue or cell of interest was greater than or equal to 10.0 tpm. b diagrammatic representation of the number of human and mouse candidate genes in terms of (1) the number of orthologs in the opposite species, (2) the number of genes previously or not previously identified in a prior transcriptomics-based drug target report, (3) the availability and phenotypic outcome of any reported mouse models, and (4) the number of novel genes without a reported mouse model congruent across both species. the main value in each bubble represents the total number of candidate genes identified regardless of tissue or cell identified in. the numbers in parentheses comprise the total number of candidate genes that are either epididymis-specific or specific to testis and epididymis, but not testis and/or testis cell-specific only. the hpa testis datasets (additional file 8: fig. s3 and additional file 9: table s7 ). thirty-six out of the 91 genes that were identified across all the human epididymis tissue were also identified by the human combined (newly acquired and previously published datasets) testis candidate gene list. finally, the majority of the candidate genes, 300, identified from the combined newly generated and previously published human testis datasets were shared with genes identified from the various testis cell datasets. we identified more candidate genes in the newly generated human epididymis tissues compared to previously published data: 19 out of 54 genes were unique to the newly generated caput samples compared to only 1 out of 36 genes which was unique to the previously published samples, 19 out of 75 genes were unique in the newly generated corpus samples compared to 12 out of 68 genes which were unique to the previously published corpus samples, and 33 genes were unique to the newly generated cauda samples compared to 2 genes in the previously published cauda data with no overlap between the two cauda gene lists (additional file 8: fig. s3 and additional file 9: table s7 ). there were 117 candidate genes that overlapped between the newly generated human testis samples and mouse testis sample gene lists, while there were 134 candidate genes that overlapped between the previously published human testis sample and mouse testis sample gene lists (additional file 8: fig. s3 and additional file 9: table s7 ). across all human epididymis tissue samples, including the newly generated and previously published samples, there were 16 genes in common with the combined list of candidate genes across all the mouse epididymis tissue samples. there was a small overlap between the human and mouse samples when the newly generated human caput, corpus, and cauda tissues were individually compared to the mouse caput, corpus, and cauda tissues; there was an overlap of 10, 12, and 4 for the caput, corpus, and cauda, respectively (additional file 8: fig. s3 and additional file 9: table s7 ). this trend was continued for the candidate gene lists derived from the previously published human caput, corpus, and cauda samples when compared to the candidate gene list from the mouse caput, corpus, and cauda, with 7, 10, and 4 genes in common for the caput, corpus, and cauda comparisons, respectively (additional file 8: fig. s3 and additional file 9: table s7 ). additional file 9: table s7 details the genes that are unique and in common for each of the comparisons. to assess the potential usefulness of the candidate genes identified in each human reproductive tissue as drug targets, we assigned the genes to a protein family (i.e., gpcr or ion channel). the majority of identified genes were not from a traditional drug target family like kinases or enzymes. the testis and germ cell datasets provided the most potential targets while the epididymis datasets provided the fewest (additional file 10: fig. s4a ). the protein family classification for each candidate gene identified in each reproductive tissue is detailed in additional file 11: table s8 . the majority of the candidate genes do not have a reported mouse model (additional file 10: fig. s4b ). additional file 12: table s9 summarizes mouse model availability for each candidate gene identified from human reproductive tissues or cells. figure 3 shows the complete list of novel human genes without a reported mouse model as identified in each of the respective cell and/or tissue datasets. digital pcrs (heatmap) and conventional pcrs demonstrating expression of a subset of the novel human reproductive tract-specific genes without a reported mouse model that we identified are shown in figs. 4 and 5, respectively. additional file 13: fig. s5 shows the complete list of previously identified human genes that remain without a reported mouse model as identified in each of the respective cell and/or tissue datasets. additional file 14: fig. s6 shows the complete list of male reproductive tract-specific human genes for which a previously generated mouse model shows male infertility phenotype, as identified in each of the respective cell and/or tissue datasets. through our bioinformatics analysis of previously published and newly acquired rna-seq datasets, we identified a total of 720 genes as reproductive tract-specific in humans (fig. 2 ). of these genes, 122 genes do not have a mouse gene ortholog, while 598 genes have a mouse gene ortholog (fig. 2) . of those with a mouse gene ortholog, 477 have a single gene ortholog (324 have the same symbol in mouse, while 153 have a different symbol in mouse), while 121 have two or more orthologous mouse genes. seventy-six human genes had 2-3 orthologous mouse symbols, 36 genes had 4-10 orthologous mouse symbols, and 9 genes (fam205a, krta p10-6, magea10, or2ag1, pramef11, pramef2, ssx2, ssx3, and ssx4b) had greater than 10 orthologous mouse symbols (11-93 symbols) (additional file 5: table s5 ). of the 720 human genes that we identified as male reproductive tract-specific, 435 have not been previously identified in a transcriptomics-based male reproductive tract-specific study [2, [4] [5] [6] [7] [8] [9] . the sum of our human data confirms the findings of 232 out of 364 genes from djureinovic et al. [9] . after re-identification of gene symbols from reported affymetrix ids and consideration of orthologous genes (mouse to human and rat to human), our human data confirm the findings of 19 out of 39 genes from johnston et al. [5] , 77 out of 176 genes from schultz et al. [4] , 5 out of 32 genes from johnston et al. [6] , 36 out of 253 genes from johnston et al. [2] , 4 out of 58 genes from johnston et al. [8] , and 3 out of 19 genes from jelinsky et al. [7] . of the 598 genes that have a mouse gene ortholog, 346 have not been previously identified as male reproductive tractspecific, and of these, 233 human genes currently lack mouse phenotype information based on data obtained from ensembl biomart, mgi, impc, and ncbi. three hundred and eighty-six genes were identified as testis-specific through either the reanalysis of djureinovic et al. testis datasets (377 genes identified), analysis of our de novo testis datasets (322 genes identified), or both (additional file 5: table s5 ). three hundred and thirteen genes were congruent across both datasets, while 64 genes were uniquely identified through our reanalysis of djureinovic et al.'s datasets and only 9 genes [ac136352.4, ankrd20a1, ankrd62, fam230a, ggtlc2, iqcm, potec, prnt, and utf1] were uniquely identified through our de novo datasets (additional file 5: table s5 ). interestingly, of the 377 genes we identified through djureinovic et al.'s reanalyzed datasets, 143 were not previously identified in their report [9] or any of the other previous reports [2, [4] [5] [6] [7] [8] . of these 143 genes, we randomly verified 21 of these genes as testis-specific in humans through conventional pcr (fig. 5) . we also verified through rt-pcr an additional 15 genes-such as allc, cdkl3, cox7b2, or2h1, and sppl2c-that had been identified through previous studies (additional file 15: fig. s7 ). of the 386 genes identified through either testis datasets, 150 have not been previously identified; of these, 117 genes have one or more mouse orthologs; and of these, 76 genes are lacking reported phenotype information. of the 76 novel genes lacking a reported mouse model, 7 genes encode enzymes (adam20, cpa5, dusp21, naa11, plscr2, prss38, and triml1), 6 encode transcription factors (bhmg1, foxr2, prdm9, tgif2ly, znf560, znf729), 2 encode transporters (slc22a14, slc25a52), and 61 encode proteins of unknown drug target type two hundred and thirty-three novel human reproductive tract-specific genes that each have mouse orthologous genes but with no reported knockout mouse models. the listed genes were identified in one or more datasets as indicated in the venn diagram. underlined genes were also identified in our studies as reproductive tract-specific in mouse (109 genes). genes written in blue encode either enzymes, kinases, gpcrs, ogpcrs, transporters, transcription factors, or proteins involved in epigenetic regulation (74 genes) . genes written in dark red were identified in both testis (testis and/or testis cell) and epididymis (10 genes). (such as etdb, smim36, bend2, btg4, cnbd1, dppa2, efcab5, erich6, fthl17, iqcm, mroh2b, ms4a5, oosp2, pnma6e, ppp4r3c, rbmxl3, rtl9, spdye4, spem2). all of these genes are listed in fig. 3 , and many of these genes are listed in figs. 4, 5, and/or 6. to the best of our knowledge, no prior studies have utilized purified human testis cells for the identification of human testis-specific transcripts. through our analysis, we identified 291 genes as human testis-specific through one or more of the human germ cell datasets, but not through either of the human testis datasets (additional file 5: table s5 ). seventy-six genes were identified exclusively through one or more of the five human spermatogonia datasets (genes such as anp32d, c13orf42, dscr4, or13g1, or2d2, or52e4, ssx2, tle7), while 18 genes were identified exclusively through the human spermatocyte datasets (genes such as h2bfm, mageb17, mageb18, or2b6, tcp10, and znf709) and 79 genes were identified exclusively through the human spermatid datasets (genes such as ac013269.1, clec20a, or7e24, pramef2, spat a31a3, tmem191c, znf679). thirty-four genes were identified through all three cell types' datasets (genes such as ccdc166, eloa2, fam47a, heat r9, and spata31a1). many of these genes are listed in figs. 3, 4, 5, and/or 6. of the 291 genes identified as human testis-specific through one or more of the human germ cell datasets, 252 genes have not been previously identified, 201 of which have one or more equivalent mouse orthologs with 139 of these genes having not been knocked out in mouse. of these 139 novel genes with no mouse model, 8 encode enzymes (glt6d1, prss48, satl1, sult6b1, tmprss7, tpte2, triml2, and ttll8), 1 encodes an epigenetic protein (taf1l), 6 encode gpcrs (gpr156, tas2r13, tas2r30, tas2r46, tas2r50, vn1r2), 1 encodes a kinase (cdkl4), 33 encode ogpcrs (such as or2d3, or3a2, or52e5, or8g5, or10j1, and ) and obp2b met candidate threshold through our analysis of human testes datasets but did not meet candidate threshold from any of the germ cell or sertoli cell datasets, indicating potential expression in peritubular myoid cells, leydig cells, or other cell outside of the seminiferous epithelium. fam36a has not been previously identified, and neither mouse orthologs (1700011m02rik, gm9112) have been knocked out. obp2b was previously identified through djureinovic et al. [9] and johnston et al. [6] ; however, of the equivalent mouse orthologs (lcn4, obp2a, obp2b), only obp2a has been knocked out revealing abnormal coat/hair pigmentation [31] . ism2 and magec2 were identified through both human sertoli cell datasets, while also identified through testis and/or germ cell datasets. both genes have been previously identified (ism2 [8] , magec2 [9] ). ism2 knockout mice display non-reproductive phenotypes [9] . consistent with this finding, our mouse data do not identify ism2 as reproductive tract-specific in mice. magec2 lacks a mouse ortholog for functional analysis in mice. human sertoli cell-specific krtap2-3, krtap4-12, lhx9, and psg5 were identified through one or both human sertoli cell datasets but were not identified through any of the testis or germ cell three hundred and two novel mouse genes with human orthologs without a reported mouse model. the listed genes were identified in one or more mouse datasets as indicated in the venn diagram. underlined genes were also identified through our studies as reproductive tractspecific in human (111 genes). genes written in blue encode either enzymes, kinases, gpcrs, ogpcrs, transporters, transcription factors, or proteins involved in epigenetic regulation (60 genes). genes written in dark red were identified in both testis (testis and/or testis cell) and epididymis (14 genes). datasets indicating sertoli cell-specific expression in the testes (additional file 5: table s5 ). none of these genes have been previously identified as reproductive tractspecific in humans although lhx9 and psg5 have mouse orthologs that have been knocked out [32] [33] [34] [35] [36] [37] . human krtap2-3 has mouse orthologs krtap5-2, gm4559, gm40460, and gm45618, and human krta p4-12 has mouse orthologs krtap4-7 and gm11555; none of these mouse orthologs have been knocked out ( fig. 3 and additional file 5: table s5 ). psg5 knockout mice display non-reproductive phenotypes [32] [33] [34] [35] [36] ; however, lhx9 knockout mice display absent testes and sterility due to an essential requirement for lhx9 during mouse gonad formation [37] . a lhx9-gfpcreer knock-in mouse line-generated by knocking-in gfpcreer at the endogenous lhx9 locuscrossed with the rosa26-tdtomato reporter mouse line revealed cre recombinase activity in retinal amacrine cells, developing limbs, testis, hippocampal neurons, thalamic neurons, and cerebellar neurons [38] . thus, lhx9 is not reproductive tract-specific in mice. our mouse data confirm this finding. to the best of our knowledge, no prior studies have utilized rna-seq for analysis of human epididymis-specific transcripts. through our studies, we identified 39 genes as human epididymis-specific through one or more of the human epididymis segment datasets that were not identified through any of the other human male reproductive tissue or cell datasets, indicating true epididymis specificity (additional file 5: table s5 ). of these 39 genes identified as human epididymis-specific, 29 genes have not been previously identified, 24 of which have equivalent mouse orthologs with 16 of these genes having not been knocked out in mouse. of these 16 novel human epididymis-specific genes with no mouse model, 1 encodes an enzyme-related gene (spint3) and the remaining 15 encode proteins of unknown drug target type (such as actbl2, bsph1, mslnl, spag11a, spag11b, wfdc10a, and wfdc9) (fig. 3) . seven genes were identified through our de novo sequenced human epididymis segment datasets that were not identified through our reanalysis of the human epididymis segment datasets by browne et al.; two of these genes are considered novel without mouse models: defb104a and defb104b (fig. 3 , additional file 5: table s5 , and additional file 9: table s7 ). meanwhile, five genes were identified through our reanalysis of the human epididymis segment datasets by browne et al. that were not identified through our de novo-sequenced human epididymis segment datasets; two of these genes are considered novel without mouse models: actbl2 and mslnl (fig. 3 , additional file 5: table s5 , and additional file 9: table s7 ). fifty-two genes met the criteria for identification as epididymis-specific through one or more of the human epididymis segment datasets, while also being identified as reproductive tract-specific through one or more of the testes, germ cell, and/or sertoli cell datasets (additional file 5: table s5 ). thus, these targets are not epididymis-specific per se, but may be desirable potential male contraceptive targets considering their broader target availability. of these 52 genes identified as human male reproductive tract-specific and epididymisexpressed, 20 genes have not been previously identified, 15 of which have one or more equivalent mouse orthologs with 11 of these genes having not been knocked out in mouse. all 11 of these novel genes with no mouse model encode proteins of unknown drug target type (al163195.3, ccdc168, ccnb3, defb121, defb134, eppin-wfdc6, krtap2-3, magea11, pnma6e, spem2, tex44) ( fig. 3 and additional file 5: table s5 ). since model organisms other than mice may be of interest for the future functional study of human genes-especially those for which no known mouse ortholog exists-we list novel reproductive tract-specific human genes without a mouse ortholog in additional file 16: fig. s8 , which may be of interest for generating null rat or marmoset models [39] . digital pcr (heatmap) demonstrating expression of a subset of these novel human reproductive tract-specific genes without mouse orthologs is shown in additional file 17: fig. s9 . through our bioinformatics analysis of previously published and newly acquired mouse rna-seq datasets, we identified a total of 1062 genes as reproductive tractspecific in mice. of these genes, 303 genes do not have a human gene ortholog, while 759 genes do (fig. 2) . of those with a human gene ortholog, 632 have a single ortholog (451 with the same gene symbol in human; 181 with a different symbol), while 127 mouse genes have two or more ortholog human genes (fig. 2 ). ninety-two mouse genes have 2-3 orthologous human symbols, 16 genes have 4-10 orthologous human symbols, and 19 genes (such as 1700080o16rik, ankrd36, fam90a1b, gm15319, magea10, pramel1, spdye4a, spdye4b, and zfy1) have greater than 10 orthologous human symbols ranging anywhere from twelve to twenty-six symbols (additional file 6: table s6 ). of the 1062 mouse genes that we identified as male reproductive tract-specific in mouse, 743 have not been identified in a previous transcriptomics-based study [2, [4] [5] [6] [7] [8] [9] . the sum of our mouse data confirms the findings of 150 out of 271 mouse genes from schultz et al. [4] , 7 out of 54 mouse genes from johnston et al. [2] , and 6 out of 23 mouse genes from johnston et al. [6] (additional file 18: table s10 ). of the 759 mouse genes that have a human ortholog equivalent, 482 have not been previously identified as male reproductive tract-specific, and of these, 302 genes currently lack mouse phenotype information based on data obtained from ensembl biomart, mgi, impc, and ncbi (fig. 6 ). digital pcr (heatmap) demonstrating expression of a subset of the novel mouse reproductive tract-specific genes with human orthologs and no reported mouse model, and with human reproductive tract enrichment, is shown in fig. 7 . seventeen novel genes without mouse models (8030474k03rik, fthl17b, fthl17c, fthl17d, fthl17e, fthl17f, gm15262, gm18336, magea3, magea4, magea5, magea6, magea8, mageb2, xlr5a, xlr5b, and xlr5c) were identified through the mouse id4+ spermatogonia datasets that were also identified as spermatogonia-specific through the human datasets (bend2, bx276092.9, fam9a, fthl17, magea3, magea4, magea6, mageb6, and pnma6e) and were not identified through either mouse or human testis datasets, indicating restricted expression in spermatogonia, spermatogonial stem cells, or both (additional file 5: table s5 and additional file 6: table s6 ). eight genes (1700080o16rik, ccnb3, gm21964, gm4779, pet2, prr23a1, prr23a2, and prr23a3) were identified through the mouse id4+ spermatogonia datasets, genes whose human orthologs-ccnb3, dcaf8l1, magea10, magea11, magea12, magea9, magea9b, prr23a, prr23b, prr23c, and tle7-were also identified through the human spermatogonia datasets. since these genes were also identified through mouse, human, or both species' respective testis datasets, this indicates either strong expression in the spermatogonia compartment or expression outside of and in addition to the spermatogonia compartment. twenty-two genes were identified as mouse sertoli cellspecific as they were not otherwise identified as reproductive tract-specific through our analysis of mouse testes or germ cell datasets (encode project consortium testes and helsel et al.'s id4+ germ cell datasets) (additional file 6: table s6 ). of these 22 genes, 18 have human orthologs; of these 18 genes, 17 are novel and not previously identified as male reproductive tractspecific; of these 17 genes, 7 have not been previously knocked out in the mouse (c1ql2, gm45015, mageb18, mycs, shc4, sowahd, and tmsb15b2); and of these 7 genes, 2 genes (gm45015 and mageb18) were identified with human orthologs (pnma6e and mageb18) that were also identified through our human analysis as human reproductive tract-specific (additional file 5: table s5 and additional file 6: table s6 ). unlike the limited number of reproductive tract-specific genes we identified through human sertoli cell-specific datasets, a considerable number of genes-202 mouse genes-were identified as reproductive tract-specific through analysis of zimmermann et al.'s mouse postnatal day 35 sertoli cell datasets that were also identified through either the mouse testis datasets, mouse id4+ germ cell datasets, or both (additional file 6: table s6 ). of these 202 genes, 160 have one or more human orthologs; of these 160 genes, 54 are novel and not previously identified as male reproductive tract-specific; of these 54 genes, 36 have not been previously knocked out in the mouse; and of these 36 genes, 16 (1700011l22rik, 1700011m02rik, 1700018b08rik, 1700042g07rik, ankrd36, ankrd60, etd, gm39566, gm6657, gm9112, magea10, spata31d1b, tcp10c, tex44, tex48, and wfdc9) were identified with human orthologs that were also identified through our analyses as human reproductive tractspecific (fig. 6 , additional file 5: table s5 , and additional file 6: table s6 ). to the best of our knowledge, published rna-seq data of mouse whole epididymis or epididymis segments does not exist, for the identification of epididymis-specific transcripts or otherwise. therefore, we isolated caput, corpus, and cauda segments from adult (postnatal day 60) b6/129 mice and subjected the rna to sequencing. sixty-six genes were identified as mouse epididymisspecific as they were not identified as mouse male reproductive tract-specific through our reanalysis of the entable s6 ). of these 66 genes, 48 have human orthologs; of these 48 genes, 34 are novel and not previously identified as male reproductive tract-specific; of these 34 genes, 17 have not been previously knocked out in the mouse (ascl4, bsph1, c1s2, clec18a, cyp2j13, cyp4a30b, defb42, gm45826, lce6a, lcn6, muc15, odam, spag11a, spag11b, spink13, svs1, tchhl1); and of these 17 genes, 5 genes (bsph1, defb42, gm45826, spag11a, and spag11b) were identified with human orthologs (bsph1, defb136, spag11a, and spag11b) that are also human epididymis-specific (fig. 6 , additional file 5: table s5 , and additional file 6: table s6 ). sixty-five genes were identified as reproductive tractspecific in mouse with expression in both epididymis and testis and/or testis cell. of these 65 genes, 48 have human orthologs; of these 48 genes, 24 are novel and not previously identified as male reproductive tract-specific; of these 24 genes, 14 have not been previously knocked out in the mouse (1700009n14rik, 4922502d21rik, 4930563d23rik, d330045a20rik, defb28, dgkk, fam90a1b, gm6871, hrasls5, nxf3, shc4, spint3, trpc5os, wfdc9); and of these 14 genes, 3 genes (spint3, trpc5os, and wfdc9) were identified with human orthologs (spint3, trpc5os, and wfdc9) that are also human epididymis-specific (fig. 6 , additional file 5: table s5 , and additional file 6: table s6 ). through the aforementioned studies, we identified spint3, spint4, ces5a, pp2d1, and saxo1 as congruent in expression across both mouse and human datasets with expression restricted to either the epididymis (spint3, spint4, ces5a) or the testis (pp2d1 and saxo1) (figs. 3, 4, 5, and 6; additional file 5: table s5 ; additional file 6: table s6 ). spint5 was also identified as epididymisspecific in mouse (fig. 5 , additional file 6: table s6 ); however, in humans, spint5p is a pseudogene that is not processed into protein. conventional rt-pcr of a panel of mouse and human tissue cdnas confirmed epididymis-or testis-restricted expression of spint3, spint4, ces5a, pp2d1, and saxo1 in both species and spint5 in mouse (fig. 5) . to glean insight into the onset of expression for the epididymis-specific genes, spint3, spint4, spint5, and ces5a; whole epididymides from postnatal days (p) 3, p6, p10, and p14; and epididymis segments (caput, corpus, and cauda) from p21, p28, p35, and p60 aged mice were collected and analyzed through rt-pcr (additional file 19: fig. s10 ). spint3 expression begins as early as p3 (low) and gradually increases through p10 and p14 reaching steady levels throughout p21 to p60 in all three segments of the epididymis (additional file 19: fig. s10 ). in contrast, spint4 and spint5 display near identical expression levels with no expression at p3, p6, or p10, and expression apparent at p14 and later time points, with expression restricted to corpus only at p21 and p28, and caput and corpus, but not cauda at p35 and p60 (additional file 19: fig. s10 ). rnascope-based fluorescence in situ hybridization revealed a distinct segment-specific pattern of expression for spint4 that was identical to spint5, with both showing expression in most of the epithelial cells restricted to a brief region of distal caput/proximal corpus (additional file 20: fig. s11) . spint3, on the other hand, displayed a pattern of expression in a majority of epithelial cells that begins just a bit further downstream along the corpus, but persisting for much further along the corpus, throughout the corpus and into the cauda (additional file 20: fig. s11 ). these results indicate that spint3 shares a role that is distinct from spint4 and spint5 and indicates a potential redundancy between spint4 and spint5 and how humans may have lost the evolutionary pressure to keep spint5p as a protein-coding gene. to glean insight into the potential spermatogenic cell population(s) expressing pp2d1 and saxo1, we performed rt-pcr of mouse testes isolated at postnatal day (p) 3, a time point enriched for gonocytes; p6 (onset of expression of type a spermatogonia); p10 (early spermatocytes); p14 (late spermatocytes); p21 (spermatids); and p35 and p60, which display complete spermatogenesis [40] (additional file 19: fig. s10 ). expression of pp2d1 and saxo1 is detected at similar levels at p28 and later, but not at p21 or before indicating expression during spermiogenesis and spermiation (additional file 19: fig. s10 ). to determine the male reproductive requirement and potential functional role of the identified novel male reproductive tract-specific genes, spint3, ces5a, pp2d1, and saxo1 were individually ablated by crispr/cas9mediated zygote approach. since in humans spint5p is a pseudogene, and in mice, spint5 protein is most similar in sequence to mouse spint4, we simultaneously ablated both mouse spint4 and spint5 genes, which on mouse chromosome 2 are only separated by 12.9 kilobases. the efficiency of generating each mutant is summarized in additional file 1: table s11 . each of the genes contained deletions of differing sizes and genomic targets. the genomic sequences flanking the deletion in each mutant are presented in additional file 1: table s12 , and representative sanger sequencing results for each mutant are presented in fig. 8 . using the forward and reverse primer pairs presented in fig. 8a -e and listed in additional file 1: table s13 , offspring carrying the mutant alleles were identified through routine genotyping (fig. 8k-o) . spint3, spint4/5, ces5a, pp2d1, and saxo1 knockout mouse lines were examined in parallel with littermate controls of equivalent age to determine the effect of gene ablation on spermatogenesis, sperm maturation, and fertility in male mice. none of the knockout strains generated in this study displayed any overtly abnormal appearance, difference in body weight (fig. 9 ) or composition, or difference in behavior when compared to the controls. to determine the male reproductive requirement of each of the genes of interest, spint3, spint4/5, ces5a, pp2d1, and saxo1 knockout and control adult male mice were housed continuously with two females for 3 months and the size and number of litters were recorded. although spint3, pp2d1, and saxo1 knockout males sired a number and size of litters during the test mating period that was not significantly different from controls (fig. 9a-c) , spint4/5 and ces5a knockout males sired significantly fewer litters and pups over the test mating period (fig. 9a-c) . spint4/5 null males displayed a statistically significant 95% reduction in the number of litters and pups sired per male and statistically significant 64% reduction in litter size, over the 3-month mating period (n = 9 controls, n = 9 kos) (fig. 9 ). seven out of 9 males displayed complete infertility, and the two remaining males, who sired pups, sired pups at a significantly reduced number of litters and pups per month with litters of reduced litter size (fig. 9a-c) . this fertility defect in spint4/5 double ko males was not associated with any significant changes in epididymis and testis histology (additional file 21: fig. s12 ) or sperm numbers, motility, and morphology ( fig. 9g-i) . ces5a null males displayed a variegated phenotype with an overall statistically significant 50% reduction in the number of litters and pups sired per male, but no significant difference in litter size, over a 3-month mating period (n = 9 controls, n = 9 kos). the fertility defect in ces5a ko males was associated with significant changes in epididymis histology (additional file 22: fig. s13 ) and significant reductions in sperm motility and progressive motility (fig. 9h, i) . ces5a null males displayed a 50% reduction in sperm motility and progressive cells, a 50% increase in static cells, and a 25% decrease in average path velocity and progressive velocity after hyperactivation. no changes in testis histology were found (additional file 22: fig. s13) , and despite the sperm motility defect, scanning electron microscopy failed to identify a morphological defect in ces5a null sperm in comparison to controls (additional file 23: fig. s14) . the epididymides and testes weights of spint3, spint4/5, ces5a, pp2d1, and saxo1 knockout mice were not significantly different from littermate control mice (fig. 9e, f) . histological analyses of testes from spint3, spint4/5, ces5a, pp2d1, and saxo1 knockout mice revealed all had seminiferous tubules with intact epithelia and the presence of all germ cell subtypes and all stages of spermatogenesis (additional file 21: fig. s12 and additional file 24: fig. s15 ). histological analyses of caput, corpus, and cauda from spint3, spint4/5, pp2d1, and saxo1 ko mice revealed spermatozoa in tubule lumens of all knockouts with no significant differences in epididymal histology in comparison to controls (additional file 21: fig. s12 and additional file 24: fig. s15 ). however, ces5a knockout mice displayed significant histological abnormalities including lumen dilation (possibly from occlusion), inflammation, and the appearance of abnormal epithelia (additional file 22: fig. s13 ). computer-assisted sperm analysis of spint3, spint4/5, pp2d1, and saxo1 knockouts 9 phenotype analysis of crispr/cas9 generated null mice for determining the contraceptive potential of the selected genes. spint4/5 and ces5a null mice show significant fertility defects; meanwhile, spint3, pp2d1, and saxo1 null mice appear normal. fertility (a-c), body and reproductive organ weights (d-f), and sperm parameters (g-i) were all measured between knockout (−/−) and littermate control [wild-type (+/+) and heterozygous (+/−)] mice as indicated. bars represent mean ± sem. *p < 0.05, **p < 0.01, ***p < 0.005. ns, not significant. showed no statistically significant differences across all measured parameters including sperm concentration, sperm motility, and progressive motility (fig. 9g-i) . ces5a knockouts displayed significant decreases in sperm number and sperm motility (fig. 9h, i) ; however, cauda epididymal sperm isolated from a variety of ces5a null animals looked morphologically indistinguishable to controls (additional file 23: fig. s14 ). to date, the etiology of idiopathic male infertility is not fully understood, and hormonal male contraceptives have not been effective. therefore, identification of novel reproductive tract-specific genes, and elucidating the functional requirement or lack thereof of these genes, is essential towards understanding the etiology of male infertility and the development of male contraceptives. despite significant advances in our understanding of the human and rodent testis and epididymis transcriptome, mostly through microarray-based studies, no prior studies have utilized purified human testis cells for the identification of human testis-specific transcripts, no prior studies have utilized the more state-of-the-art rna-seq-based transcriptomics methodology for analysis of human epididymis-specific transcripts, and no prior studies have utilized rna-seq analysis of rodent reproductive tissues or cells to identify rodent reproductive tract-specific transcripts. to address these gaps in knowledge, and to increase the number of identified reproductive tract-specific genes using the most relevant high-throughput transcriptomics methodology, we analyzed in parallel on a custom bioinformatics pipeline a large number of published and newly acquired human and mouse rna-seq datasets. through our studies, we identified and verified many novel male reproductive tract-specific transcripts in both species, and through the crispr/cas9 system, we interrogated the reproductive requirement of a subset of these genes. we found that spint4 (together with spint5) in mice is required for normal male mouse fertility, and although not required for male fertility, we identified ces5a as playing a major biological role in the epididymis. we report the remaining genes that we knocked out-spint3, pp2d1, and saxo1as dispensable for male reproductive function, which is essential information to disseminate to the scientific community. our study also verified the male reproductive tract-specific expression of many previously identified genes (additional file 13: fig. s5 , additional file 15: fig. s7) , and genes for which previously published mouse models display male infertility phenotypes (additional file 14: fig. s6 ). this later group of already functionally validated genes serves as potential male contraceptive targets worth underscoring to the research community. prior to massively parallel microarray-based and rnaseq-based transcriptomics analyses for the identification of reproductive tract-specific genes, the ncbi unigene database was a valuable resource for many in the male reproductive biology field for identifying testis-specific transcripts [4, [41] [42] [43] . although in our study we only considered prior microarray-based and rna-seq-based studies when considering the novelty of the genes that we identified, it is worth noting that several genes that we identified-not previously identified in microarray-based and rna-seq-based transcriptomics studies-were previously identified through studies that solely utilized the unigene database [41, 42] . nineteen human genes that we identified-c16orf82, ccdc27, cpa5, fam217a, fam46d, fam47c, fbxo24, fbxw10, fkbp6, galn tl5, kcnu1, mageb3, mroh2b, nutm1, prdm9, rbmxl3, spata31e1, triml1, and trpc5os-were previously identified by liu et al. [42] , and seven mouse genes that we identified-1700013d24rik, akap3, ankrd36, hrasls5, spesp1, tex22, and ubqlnl-were previously identified by choi et al. [41] and liu et al. [42] . thus, our results confirm the findings of these previous studies. since more than half of all human protein-coding genes are categorized as unknown in terms of drug target potential (additional file 11 table s8 ), and only 30% encode for classically druggable enzymes, gpcrs, ion channels, nuclear receptors, and transporters (additional file 10 fig. s4) , the potential to find new undiscovered drug targets that can be drugged using classical approaches is somewhat limited. indeed, in our study, we found one hundred and nine genes to be novel in terms of previously published high-throughput transcriptomics studies, without a current reported mouse model, and reproductive tract-specific in both humans and mice (figs. 2, 3, and 6 ). many of these genes (93 genes; 85%) fall into the category of unknown and may otherwise be considered "undruggable" due to various challenges with existing targeting approaches [10] . however, the contraceptive potential of these genes should not be overseen, but rather investigated for potential identification of a high-affinity small molecule that can either interfere with protein-protein interaction (ppi) or target the protein specifically for degradation using a new technology called proteolysis targeting chimeras (protacs). protein-protein interaction targets are not deemed undruggable, based on the discovery of small molecules capable of deeper and higher affinity binding within the contact surfaces of the target protein [44] . additionally, once a high-affinity small molecule against a specific target protein is identified, an engineered protac molecule can mark a target protein for proteasomal degradation by linking the target protein to the polypeptide co-factor, ubiquitin [45] [46] [47] . there are currently various combinations of protacs developed to overcome the limitations of cell permeability, stability, solubility, selectivity, and tissue distribution [48] [49] [50] [51] . therefore, disrupting ppis or utilizing protacs provides the potential to greatly promote the development of contraceptive drugs against the "undruggable" nonenzymatic target protein space. if gene knockouts for closely related and ubiquitously expressed paralogs display no abnormal phenotype, then unintended drug targeting of these proteins may result in no side effects in humans. however, the burden of safety for a male contraceptive is extremely high, and if it can be avoided, targeting non-reproductive tractexpressed proteins in humans should be avoided since the functional requirements for these proteins may not be fully understood. further, although mice are one of the best models for human disease, they are unable to communicate when they are unwell, a phenomenon that may occur independent of any measurable phenotypic traits. thus, potential reported side effects in humans during clinical trials may have been present, but missed, during animal studies, or in fact be present in humans and not in mice because of the vast biological differences across these two species. thus, with drug safety in mind, reproductive tract-specific candidates should be prioritized based on somatic cell-expressed protein sequence similarity, especially in the drug binding pocket. according to ensembl, several novel reproductive tract-specific genes without mouse models that we identified and verified-ac022167.5, al672043.1, bhmg1, c1orf105, c2orf92, c4orf51, ccdc196, spint3, tex44, tex48, tex51, and trpc5os (figs. 3, 4, and 5; additional file 5: table s5 )-have no known associated paralogs, indicating reproductive tract-specific drug targeting is highly likely. additionally, spag11a and spag11b are epididymis-specific paralogs (figs. 3, 4 , and 5; additional file 5: table s5 ) with no other known paralogs according to ensembl. efcab5 (figs. 3 and 5, additional file 5: table s5 ) has a ubiquitously expressed paralog, nsrp1, with only 7% amino acid sequence similarity, indicating specific drug targeting potential for this candidate. likewise, erich6 and mroh2b (figs. 3 and 5, additional file 5: table s5 ) have ubiquitously expressed paralogs erich6b and mroh2a, respectively, with 20% and 30% amino acid sequence similarity, indicating reasonable potential for specific drug targeting. prr23a, prr23b, and prr23c are testis-specific paralogs (figs. 3 and 5, additional file 5: table s5 ) with prr23d2 as the next closest paralog according to ensembl. since prr23d2 has less than 26% amino acid sequence similarity to prr23a, prr23b, and prr23c, but appears to be epididymis-specific according to the human protein atlas [52] , all four proteins of unknown function make suitable drug candidates. likewise, spat a31d1, spata31d3, and spata31d4 are testis-specific paralogs (figs. 3 and 5, additional file 5: table s5 ) with spata31a5 as the next closest paralog according to ensembl. since spata31a5 has less than 26% sequence similarity to spata31d1, spata31d3, and spat a31d4, but also appears to be reproductive tractspecific according to hpa [52] , all four proteins with unknown function also appear to be worthy of consideration for potential drug targeting. tpte and tpte2 are testis-specific paralogs (figs. 3 and 5, additional file 5: table s5 ) with ubiquitously expressed pten as the next closest paralog according to ensembl. since pten has less than 25% sequence similarity to tpte and tpte2, off-target effects appear to be unlikely. likewise, wfdc10a, wfdc10b, and wfdc13 are all epididymis-specific paralogs with the closest nonreproductive tract-expressed paralog, wfdc5, having less than 26% sequence similarity to any of the rts paralogs, also indicating high drug specificity potential. several additional novel reproductive tract-specific enzyme and gpcr genes without mouse models that we identified-gpr156, prss38, prss48, sult6b1, tmpr ss7, triml2, and ttll8 (fig. 3, 4 , and 5; additional file 5: table s5 )-have non-reproductive tract-expressed paralogs with less than 35% sequence similarity indicating good drug specificity potential. a novel testis-specific transporter gene without a reported mouse model that we identified, slc25a52, would make a poor drug candidate since its closest paralog, slc25a51, is 93% similar in amino acid sequence and ubiquitously expressed. cpa5, iqca1l, and ppp4r3c have ubiquitously expressed paralogs, cpa1, iqca1, and ppp4r3b, respectively, with 50-60% protein sequence similarity indicating careful consideration must be made for potential drug targeting without off-target effects. of the seventy-three genes that our study identifies as reproductive tract-specific in humans and for which a published mouse model shows male infertility phenotype (additional file 14: fig. s6) [28, 29, 31] , it is worth noting that 21 genes-cnbd2, defb110, fam170a, fbxo47, meig1, meiob, meioc, odf1, odf4, rec114, rnf17, spaca1, spata22, spem1, spo11, sycp1, terb1, tex19, tex38, tnp2, and topaz-do not have any associated paralogs and, thereby, may be considered most suitable for further drug development. however, it is also worth noting that it may be possible that genes required for male fertility in mice may not necessarily be required for male fertility in humans. of the seventy-three human reproductive tract-specific genes our study identified with male mouse infertility phenotypes, twenty-seven genes-actl7b [53] , akap4 [54] , boll [55] , brdt [55] [56] [57] [58] [59] [60] , catsper4 [54] , ccdc155 [61] , fkbp6 [55, [61] [62] [63] , meig1 [64] , meiob [55] [56] [57] 65] , nanos2 [55, 61] , odf1 [55] , prdm9 [61, 66, 67] , prss37 [55] , rad21l1 [68] , rbmxl2 [55, 62] , rnf17 [69] , sohlh2 [61, 70] , spaca1 [55] , spata16 [55, 56] , spem1 [55] , spo11 [55, 58, 61] , sun5 [55] [56] [57] , sycp1 [55] , tex38 [55] , tnp2 [55] , tssk1b [62] , and zpbp [55] -are currently associated with mutations underlying human male infertility, confirming a similar functional requirement for these genes in humans may exist. for the remaining 45 genes, however, either these genes are not required for human male fertility as they are required in mice, or associated mutations in male infertile patients have not yet been reported. although many reproductive tract-specific genes have been studied through functional genetics approaches, many remain to be solved. elucidating the function of these novel genes is necessary to build a better understanding of the factors underlying spermatogenesis and sperm maturation, which has implications in understanding the etiology of male infertility and the development of male contraceptives. in this study, four epididymis-specific genes (spint3, spint4, spint5, and ces5a) and two testis-specific genes (pp2d1 and saxo1) were deleted in mice to determine their functional requirement in male fertility and potential utility as male contraceptive target. we chose to study these genes because all but saxo1 encode enzymes or enzyme-related protein products and are thus considered druggable in the classical sense. saxo1, a cilia-related gene, was chosen because prior literature demonstrated expression in sperm [71] . although not druggable in the classical sense, if targeted through non-canonical approaches, one could obtain a fast-acting drug with greater reversibility potential and a decreased likelihood of affecting testicular function and size. the epididymis-specific genes we chose to target for functional analysis, by the very nature of their tissue's expression, also fit this potential drug profile of modulating only the latest stages of sperm development. analyses of testis and epididymis organ weights and histology, sperm parameters and morphology, and fertility revealed no significant differences in spint3, pp2d1, and saxo1 knockout mice in comparison to littermate controls demonstrating that, individually, spint3, pp2d1, and saxo1 are not required for male mouse fertility and are not suitable targets for the development of a male contraceptive. however, we found partial effects on male fertility in ces5a knockout mice and profound effects on male fertility in spint4/5 double knockout mice. ces5a is a member of a multigene family of mammalian carboxylesterases that can hydrolyze ester, thioester, amide, and carbamate linkages in a wide variety of endogenous and exogenous molecular substrates, including triglycerides, thus playing key roles in both metabolism and detoxification [72] [73] [74] [75] . ces5a shares roughly similar percent homology (~40% homology) to all four of its related paralogs, ces1, ces2, ces3, and ces4a. human carboxylesterase 1 (ces1) is predominantly expressed in the liver and has been shown to have triglyceride hydrolase activity as overexpression of human ces1 in cells leads to an increase in cholesteryl ester hydrolysis and free cholesterol efflux [76] . further, mouse ces1g-a protein expressed by one of a cluster of eight syntenic genes (ces1a through ces1h) orthologous to the human ces1 gene-has been shown to have triglyceride hydrolase activity as ces1g null mice display hyperlipidemia and abnormal lipid homeostasis including increased liver and circulating cholesterol and triglycerides, and altered saturated and unsaturated fatty acid levels [77, 78] . therefore, it is likely that ces5a exhibits similar carboxylesterase activity in the epididymis hydrolyzing cholesteryl ester and affecting free cholesterol efflux. indeed, recombinant ces5a protein has been previously shown to have carboxylesterase activity hydrolyzing cholesterol ester and choline ester [79] . since sperm cholesterol content is significantly decreased during epididymal maturation [80, 81] and a proper cholesterol/phospholipid (c/pl) ratio of the sperm plasma membrane is required for sperm capacitation [82, 83] , ces5a may be pivotal in regulating sperm membrane cholesterol and lipid levels to ensure the normal function of male gametes in the last steps of the fertilization process. the most closely related paralog to spint4 is eppin, which, as reviewed in o'rand et al., has at least three physiological functions [16] . eppin inhibits sperm motility when it binds the semen coagulation protein semenogelin 1 (semg1) on the sperm surface [84] ; it modulates the proteolytic activity of prostate-specific antigen (psa), a serine protease, against its seminal plasma substrate, semg1 [85] ; and it exhibits strong antibacterial activity [86] . these functions are postulated to prevent premature hyperactivation and capacitation of sperm in the female reproductive tract [16] , and to protect spermatozoa from proteolytic and bacterial attack during transit in the female reproductive tract [11, 16] . thus, it is possible that the physiological function of spin t4 is similar. however, unlike spint1 and spint2, which have been shown to act as protease inhibitors against a wide variety of prss and tmprss proteases [87] [88] [89] [90] , when tested against a panel of eight proteases (including psa, trypsin, chymotrypsin, plasmin, urokinase, thrombin, factor xa, and elastase), spint3 and spint4 were shown to lack protease inhibiting capability [91] . this indicates that either the protease inhibiting properties of spint3 and spint4 were lost in favor of yet unknown functions or their protease activity has a narrower spectrum of inhibition against unknown targets. since spint4/5 null male mice are severely subfertile, without an apparent difference in epididymis histology, sperm number, sperm morphology, and sperm motility parameters in comparison to the wild-type (wt) mice, this phenocopies the reproductive phenotype of several null mice of testis-, epididymis-, or prostate-specific genes (sof1, tmem95, and spaca6; pate8, and pate10), which reveal a requirement in regulating sperm migration through the oviduct and sperm-oocyte fusion in mice [92, 93] . a severe fertility defect associated with normal sperm number, morphology, and motility is also shared among mice lacking the sperm membrane protein adam3, thought to be crucial in sperm-zp binding and sperm migration through the uterotubular junction (utj) [94, 95] . more than 10 proteins including 2 proteases (ace, adam1a, adam2, calr3, clgn, cmtm2a/b, pdilt, pmis2, prss37, rnase10, tex101, and tpst2) have been described that affect the processing and/or localization of adam3 protein in spermatozoa [96, 97] . further studies with spint4/5 null mice are required to determine whether sperm behavior in the female reproductive tract, specifically the sperm migration through the utj, is adversely affected. since a large 16,797-bp genomic region-including the intergenic region between the spint4 and spint5 genes-was deleted ( fig. 8 ; additional file 1: table s12 ), based on the evidence presented in this manuscript, we cannot exclude the possibility that cis-acting elements and/or trans-acting factors affecting the expression of other genes may have contributed to the phenotype of these mice. lack of protein-coding ability of human spint5p does not necessarily indicate that this pseudogene is functionally obsolete. pseudogenes have been shown to play roles in gene expression and gene regulation [98] . for example, pseudogene transcripts can act as competitive endogenous rnas (cerna) through competitive binding of mirna, which results in regulation of gene expression [99] . to this end, studying the functional requirement of spint5 in male mice is necessary to further our knowledge of evolutionarily conserved genes between species. since humans are genetically diverse, a limitation to phenotype characterization of genetically manipulated mice is the reliance of a single mouse background to the examination of complex genetic outcomes, such as fertility, that is under the control of many genes with different levels of contribution to the phenotype [100] . it is possible that a gene that causes complete infertility in an inbred mouse background may only cause partial infertility or subfertility in a different inbred line or more robust outbred background. since the mice used in our study were a cross between c57bl/6 (b6) mice and dba/2 (d2) mice, and thus, these b6d2f1 mice are heterozygous for b6 and d2 alleles at all loci in their genome, we can eliminate infertility susceptibility of either the b6 or the d2 background as the cause for fertility defects in ces5a and spint4/5 mice. it does remain to be determined, however, whether the phenotype of the genes we knocked out would be more or less severe on a different mouse background, and if required for male fertility in humans, the level of contribution to male fertility of these genes across genetically diverse men. a limitation to this study is the reliance on mrna abundance positively correlating with protein abundance. future studies are necessary to elucidate the relationship between mrna and protein expression levels of the candidate genes identified in our study. furthermore, despite batch corrections that were made, technical differences in sample preparation and integrity across the various published rna-seq datasets can influence the results of our findings. one of the major advantages to our study design is the use of rna-seq datasets from purified human and mouse germ cells and sertoli cells to identify reproductive tract-specific targets since the use of whole testes for the identification of cell typespecific transcripts in past studies is subject to dilution effects. however, this advantage could also be considered a disadvantage since purified cells from nonreproductive tissues were not used for comparison but, if analyzed, purified cells from non-reproductive tissues may have revealed significant levels of expression in non-reproductive tissues. ultimately, functional studies in animals and humans will help to confirm whether genes identified in our study are essential for male fertility and not any other physiological process. through the integration of hundreds of published and newly acquired human and mouse reproductive and non-reproductive tissue and cell rna-seq datasets, we have generated a list of novel genes expressed predominantly or exclusively in the male reproductive tract that are worthy of consideration for functional validation in an animal model and potential targeting for a male contraceptive. our results further validate a functional requirement for spint4/5 and ces5a in male mouse fertility, while demonstrating that spint3, pp2d1, and saxo1 are each individually dispensable for male mouse fertility. identifying novel reproductive tract-specific genes congruent across species adds insight into organismal biology and valuable information that can be used to identify potential male contraceptive drug target candidates. furthermore, elucidating the individual functional requirement or lack thereof of these novel genes builds a better understanding of the factors underlying spermatogenesis and sperm maturation, which has implications in understanding the etiology of male infertility and further validation of the utility of a potential male contraceptive target. the de novo isolated human testes and epididymides included in this study were obtained from three donors through a local organ transplant program in quebec, canada, called transplant quebec. all procedures were approved by the local ethics committee, and written consent was obtained from each respective donor's family. the donors were of 40, 52, and 65 years of age with no preexisting medical condition that could affect reproductive function. donor testes and epididymides were removed under artificial circulation to preserve other organs that were assigned for transplantation. each testis and epididymis were dissected in the laboratory of robert sullivan at université laval. each epididymis was dissected into three segments corresponding to the caput, corpus, and cauda regions and minced into small tissue pieces. testes and epididymides tissue fragments were immediately snap frozen in liquid nitrogen, stored at − 80°c, and shipped frozen to baylor college of medicine for further processing. eight non-reproductive tissue types (kidney, liver, lung, skin, spleen, and stomach) and 2 female reproductive tissues (ovary and uterus) were obtained from the baylor college of medicine tissue acquisition and pathology core. thirteen nonreproductive tissue types (adipose, adrenal gland, brain, colon, heart, leukocytes, pancreas, prostate, salivary gland, skeletal muscle, small intestine, smooth muscle, thyroid) were obtained as purified rnas from takara bio (kusatsu, japan). human testes and epididymis segments were used for de novo rna-seq analysis; all human tissues and/or resulting rnas were used for rt-pcr verification. mouse tissues [testis, caput, corpus, cauda, ovary, uterus, and 17 non-reproductive tissue types (adipose, bladder, brain, colon, eye, heart, kidney, liver, lung, prostate, skeletal muscle, skin, small intestine, spleen, stomach)] were obtained from dissection of b6/129 mice; the remaining 2 non-reproductive tissues (smooth muscle and thyroid) were obtained as purified rnas from takara bio. mouse epididymis segments were used for de novo rna-seq analysis; all mouse tissues and/or resulting rnas were used for rt-pcr verification. rna for both rna-seq and/or rt-pcr verification was isolated from human and mouse tissues using trizol/ chloroform extraction method followed by rneasy mini kit from qiagen with on-column dnase (qiagen) treatment using the manufacturer's protocol. rnas used for rna-seq were assessed by bioanalyzer for rna integrity. for rt-pcr, rna was reverse-transcribed to cdna using superscript iii reverse transcriptase from thermo fisher according to the manufacturer's protocol. cdna was then pcr amplified using gene-specific primers designed using ncbi primer design tool. primer sequences are listed in additional file 1: table s14 . library generation for rna-seq rna-seq libraries were made using kapa stranded mrna-seq kit (kk8420). briefly, poly-a rna was purified from total rna using oligo-dt beads; subsequently, it was fragmented to small size; and first strand cdna was synthesized. second strand cdna was synthesized and marked with dutp. resultant cdna was used for end repair, a-tailing, and adaptor ligation. finally, the library was amplified for sequencing on an illumina novaseq 6000 platform. the strand marked with dutp was not amplified, allowing strand-specific sequencing. sequence alignment, quantification, and differential gene expression human testes, human epididymis segments, and mouse epididymis segments were sequenced by the department of molecular and human genetics functional genomics core at baylor college of medicine (additional file 1: table s1 and additional file 1: table s2 ). previously published reproductive and non-reproductive tissue and cell sequences were downloaded from the sequence read archive (sra) [101] (additional file 1: table s1 and additional file 1: table s2 ). all sequences were trimmed using trim galore! and aligned against the human genome (grch38) or mouse genome (grcm38) using hisat2 [102, 103] . gene expression in each tissue was quantified using featurecounts, filtered for only protein-coding genes, and batch corrected by removing unwanted variation using the ruvr method from ruvseq [104, 105] . differential gene expression was determined for each reproductive tissue against each nonreproductive tissue using the r package edger [106] . principal component analysis (pca) was performed in the r statistical environment using the log2 counts per million (cpm) for each gene in the corresponding tissue after using the ruvr method to correct for batch variation as described above. our procedure for identifying a reproductive-specific gene was repeated for each reproductive tissue or cell sample independently. the following selection criteria were applied to each reproductive tissue or cell sample. first, the non-reproductive tissue with the maximum expression, expressed as the log2 fold change between the non-reproductive tissue and the reproductive tissue or cell of interest, was identified for each gene using the results from the differential gene expression analysis. second, we identified reproductive-specific gene drug candidates using three filters: a false discovery rate (fdr) filter, a maximum transcript per million (tpm) expression value filter on the non-reproductive sample with the maximum expression identified as described above, and a minimum tpm expression value filter on the reproductive tissue or cell sample of interest. a gene was kept if the fdr from the differential gene expression analysis was less than or equal to 0.05 for the comparison of the reproductive tissue or cell sample of interest to the non-reproductive tissue with the maximum expression. a gene was considered to be a male reproductive tissue-specific drug target if the average tpm expression value in the non-reproductive tissue with the maximum expression from the differential analysis was less than or equal to 1.0 for human (2.0 for mice), and if the average tpm expression value for that gene was greater than or equal to 10.0 for human (8.0 for mice) in the reproductive tissue or cell sample of interest. the average and standard deviation of the tpm expression value for each gene was calculated from the ruvr batch corrected counts per million expression value for each tissue or cell sample. we consolidated data from ensembl biomart [29] and mouse genome informatics (mgi) [28] to create a comprehensive database of mouse gene symbols orthologous to human genes and vice versa. each respective species' stable ensemble gene id was used for each conversion, with gene symbol as the final output. as mentioned, several notable high-throughput gene expression studies using microarrays or rna-seq, focused on identifying male reproductive tract-specific genes, have been previously published [2, [4] [5] [6] [7] [8] [9] . tables and supplementary tables from these studies were gathered to collect the lists of genes previously identified. for microarray-based studies, affymetrix ids were used to confirm the identity of a listed gene, based on current sequence mappings, or in many cases to identify de novo the identity of a gene only known at the time of the study by its affymetrix id and not gene symbol. for mouse and rat studies, gene symbols were converted to orthologous human symbols, to systematically catalog both the rodent and corresponding human symbols as previously identified. for example, 399 affymetrix probe ids were listed as reproductive tract-specific in johnston et al. [8] . after re-identification of gene symbols based on current ensembl sequence mappings, 42 identified gene symbols remained the same, 160 received an updated/replacement gene symbol identification, 103 genes that were previously unidentified received a new gene symbol identification, 26 affymetrix ids lost mapping to any gene symbol, and 67 remain unidentified. out of the total of 305 affymetrix ids that mapped to 301 current rat gene symbols, 257 rat gene symbols converted to at least one human ortholog gene symbol that was either the same symbol or different. both rat and human symbols, based on new mappings, were considered previously identified. for the complete list of previously identified genes, see additional file 18: table s10 . genes were classified as encoding either enzymes, epigenetic-related proteins, g protein-coupled receptors (gpcrs), ion channels, kinases, nuclear receptors, orphan gpcrs (ogpcrs), transcription factors, transporters, or unknown proteins based on data obtained from illuminating the druggable genome [27] (additional file 11: table s8 ). we used data obtained from ensembl biomart [29] , mgi [28] , the international mouse phenotyping consortium (impc) [31] , and pubmed searches to generate a comprehensive database identifying the existence of a mouse model for all mouse genes (additional file 12: table s9 ). we then queried our identified candidate human and mouse genes against this list. for a given human gene, we queried the equivalent mouse ortholog gene symbol(s). spint3, spint4/5, ces5a, pp2d1, and saxo1 knockout mice were produced at baylor college of medicine. b6d2f1 (c57bl/6 × dba2) mice were used as embryo donors, and cd1 mice were used as foster mothers. mice were purchased from charles river (wilmington, ma). all mice were housed in a temperature-controlled environment with 12-h light cycles and free access to food and water. mice were housed in accordance with nih guidelines, and all animal experiments were approved by the institutional animal care and use committee (iacuc) at baylor college of medicine. generation of spint3, spint4/5, ces5a, pp2d1, and saxo1 knockout mice to generate spint3, spint4/5, ces5a, pp2d1, and saxo1 knockout mice, grna/cas9 ribonucleoprotein complex was electroporated into fertilized eggs and transplanted into surrogate mothers as previously described [107] . briefly, to harvest fertilized eggs, card hyperova (0.1 ml, cosmo bio) was injected into the abdominal cavity of b6d2f1 females (charles river), followed by human chorionic gonadotropin (hcg) (5 units, emd chemicals). forty-eight hours after card hyperova, b6d2f1 males were allowed to mate naturally. twenty hours after mating, fertilized eggs with 2 pronuclei were collected for electroporation. custom crrnas targeting each gene were purchased from millipore-sigma. the sequences for all guide rnas used for crispr/cas9mediated gene editing are listed in additional file 1: table s11 . crrna and tracrrna (millipore-sigma) were diluted with nuclease-free water. the mixture was denatured at 95°c for 5 min and allowed to anneal by cooling gradually to room temperature (1 h). each grna was mixed with cas9 protein solution (thermo fisher scientific) and opti-mem media (thermo fisher scientific), and then incubated at 37°c for 5 min to prepare the grna/cas9 rnps [final concentration, 300 ng/μl cas9 for 250 ng/μl of each grna]. the grna/cas9 rnp solution was placed between electrodes with a 1mm gap in the ecm 830 electroporation system (btx). fertilized eggs were arranged between the electrodes, and then, the electroporation was performed with the following conditions: 30 v, 1-ms pulse duration, and 2 pulses separated by 100-ms pulse interval. for egg transfer, electroporated embryos were transplanted into the oviduct of pseudo-pregnant icr recipients. after 19 days, offspring were obtained by natural birth or cesarean section. the f0 mice with sequence-predicted heterozygous mutations were used for the mating with additional b6d2f1 mice to generate homozygous mutants. the f2 or later generations were used for the phenotypic analyses. for sanger sequence analysis of mutant mice, genomic dna was isolated by incubating tail tips in lysis buffer [20 mm tris-hcl (ph 8.0), 5 mm edta, 400 mm nacl, 0.3% sds, and 200 μg/ml actinase e solution] at 60°c overnight. polymerase chain reactions (pcrs) amplifying the genomic region containing the insertion/deletion events were performed using kod xtreme enzyme (toyobo, osaka, japan); pcr products were purified using the qiaquick pcr purification kit (qiagen, carlsbad, ca, usa) and sent for sanger sequencing on an abi 3130xl genetic analyzer (thermo fisher scientific, waltham, ma, usa) using the forward primer. for routine genotyping of mutant mice, genomic dna was isolated by separately incubating ear snips and tail tips in 50 mm naoh solution at 95°c overnight and inactivating with 1 m tris ph = 8.0. pcrs amplifying wild-type and mutant-specific amplicons were performed using 2x amfisure pcr master mix (gendepot, barker, tx). primer sequences are listed in additional file 1: table s13 . upon sexual maturation (6-7 weeks of age), knockout and littermate control male mice (n = 6-9 mice per genotype) were continuously housed with two 7-8week-old wild-type b6d2f1/j female mice per male for 12 weeks. during the fertility test, the number of pups was counted shortly after birth. the total number of litters and pups per male over the mating trial was calculated and divided by the number of months to generate averages and statistics per genotype. the average number of pups per litter is based on the average litter size per male where a litter is considered one or more pups. knockout and littermate control male mice (n = 5-13 mice per genotype) that were 12 weeks of age were used to examine body and reproductive organ weights, and testicular and epididymal histology. testes and epididymides were fixed in bouin's fixative, embedded in paraffin, sectioned at 5 μm thickness, and stained with 1% periodic acid-schiff (pas) stain followed by counterstaining with hematoxylin 2 solution. histological images were acquired with an aperio at2 slide scanner (leica microsystems). knockout and littermate control male mice (n = 5-13 mice per genotype) that were 12 weeks of age were used to examine sperm numbers and motility parameters using computer-assisted sperm analysis (casa). cauda of both epididymides was isolated, transferred into human tubule fluid (htf) (irvine scientific, santa ana, ca) containing 5 mg/ml of bsa, minced, and placed in a humidified incubator for 15 min at 37°c with 5% co 2 . following incubation, the sperm were diluted 1:50 in htf, added to a pre-warmed slide, and analyzed using a hamilton-thorne bioscience's ceros ii instrument. several fields of view were illuminated and captured until at least 200 cells were counted. rnascope 2.5 hd reagent kit (red) (cat. 322350, advanced cell diagnostics, newark, ca, usa) was used to detect spint3, spint4, and spint5 mrna transcripts on pfa-fixed, paraffin-embedded sections from 3-monthold wild-type epididymis. the probes against mm-spint3, mm-spint4, and mm-spint5 were custom-made, and the standard positive control (mm-ppib, cat. 313911) and negative control (dapb, cat. 310043) probes were used. the assay was performed according to the manufacturer's instructions. slides were counterstained using dapi and mounted using prolong glass antifade mountant (thermo fisher scientific inc.). multi-channel fluorescent images were acquired with an aperio versa (leica microsystems). all measurements are expressed as mean ± standard error of the mean. statistical differences were determined using student's t test. differences were considered statistically significant if the p value was less than 0.05. supplementary information accompanies this paper at https://doi.org/10. 1186/s12915-020-00826-z. additional file 1: tables s1, s2, s11, s12, s13, and s14. table s1 . summary of human rna-seq datasets. this table contains the sra value for each previously published human rna-seq dataset that was reanalyzed as part of this study. the geo accession number for each new human rna-seq dataset generated and subsequently analyzed in this study is also included. table s2 . summary of mouse rna-seq datasets. this table contains the sra value for each previously published mouse rna-seq dataset that was reanalyzed as part of this study. the geo accession number for each new mouse sample generated and subsequently analyzed in this study is also included. table s11 . single-guide rnas targeting the genes' upstream (u) and downstream (d) regions used for generating knockout mice. efficiency of embryo transplantation was presented using the number of total pups delivered by pseudopregnant mice divided by the number of total embryos used for oviduct transplantation (total pups/embryos transplanted). efficiency of genome editing was determined by the number of pups carrying enzymatic mutations divided by the number of pups subjected to genotyping (gm pups/pups genotyped). table s12 . sanger sequencing of detailed genotype of mutant dna sequences in all the five mouse lines. table s13 . primers and pcr conditions used for genotyping the mutant alleles of the knockout mouse lines. table s14 . human and mouse rt-pcr primer sequences used for verification of reproductive tract-specificity. additional file 2: fig. s1 . genes that passed the tpm and fdr filters in at least one of the measured reproductive tissues or cells were visualized using a heatmap of the ruvr batch corrected log2 cpm gene expression values for the human (a) and mouse (b) samples. additional file 3: table s3 . human expression summary. contains differential fold change, identity of the non-reproductive tissue with maximal gene expression based on the differential gene analysis, false detection rate (fdr) value, average and standard deviation tpm expression values, and log2 cpm gene expression value for the human samples. all protein-coding genes (18,305 genes) that had expression in at least one reproductive tissue or cell is listed. additional file 4: table s4 . mouse expression summary. contains differential fold change, identity of the non-reproductive tissue with maximal gene expression based on the differential gene analysis, false detection rate (fdr) value, average and standard deviation tpm expression values, and log2 cpm gene expression value for the mouse samples. all protein-coding genes (16,891 genes) that had expression in at least one reproductive tissue or cell is listed. additional file 5: table s5 . all human male reproductive tract-specific genes that met the criteria of identification as reproductive tract-specific in at least one male reproductive tissue or purified cell type, with the level of fold change listed under the tissue or cell if all criteria were met. the criteria of selection are as follows: fdr < 0.05; tpm repro > 10; tpm non-repro , max < 1. a fold change value of 0 indicates the criteria were not met for that that tissue or cell. additional columns indicating 1.) the equivalent mouse ortholog gene symbols (single or multiple symbols) that exist, and 2.) if our studies identified any of these mouse orthologs as reproductive tract-specific in mouse, are included. additional file 6: table s6 . all mouse male reproductive tract-specific genes that met the criteria of identification as reproductive tract-specific in at least one male reproductive tissue or purified cell type, with the level of fold change listed under the tissue or cell if all criteria were met. the criteria of selection are as follows: fdr < 0.05; tpm repro > 8; tpm non-repro , max < 2. a fold change value of 0 indicates the criteria were not met for that that tissue or cell. additional columns indicating 1.) the equivalent human ortholog gene symbols (single or multiple symbols) that exist, and 2.) if our studies identified any of these human orthologs as reproductive tract-specific in human, are included. received: 17 april 2020 accepted: 8 july 2020 population division: un the mouse epididymal transcriptome: transcriptional profiling of segmental gene expression in the epididymis1 the human epididymis: its function in sperm maturation a multitude of genes expressed solely in meiotic or postmeiotic spermatogenic cells offers a myriad of contraceptive targets identification of testis-specific male contraceptive targets: insights from transcriptional profiling of the cycle of the rat seminiferous epithelium and purified testicular cells identification of epididymis-specific transcripts in the mouse and rat by transcriptional profiling the rat epididymal transcriptome: comparison of segmental gene expression in the rat and mouse epididymides1 stage-specific gene expression is a fundamental characteristic of rat spermatogenic cells and sertoli cells the human testis-specific proteome defined by transcriptomics and antibody-based profiling toward development of the male pill: a decade of potential non-hormonal contraceptive targets epididymal protein targets: a brief history of the development of epididymal protease inhibitor as a contraceptive disrupting the male germ line to find infertility and contraception targets male contraception: another holy grail male contraception: past, present and future metabolic cooperation in testis as a pharmacological target: from disease to contraception non-hormonal male contraception: a review and development of an eppin based contraceptive the control of male fertility by spermatid-specific factors: searching for contraceptive targets from spermatozoon's head to tail epididymal approaches to male contraception an integrated encyclopedia of dna elements in the human genome research resource: the dynamic transcriptional profile of sertoli cells during the progression of spermatogenesis expression profiles of human epididymis epithelial cells reveal the functional diversity of caput, corpus and cauda regions transcriptome analysis of highly purified mouse spermatogenic cell populations: gene expression signatures switch from meiotic-to postmeiotic-related processes at pachytene stage dynamics of the transcriptome during human spermatogenesis: predicting the potential key genes regulating male gametes generation chromatin and single-cell rna-seq profiling reveal dynamic signaling and metabolic transitions during human spermatogonial stem cell development id4 levels dictate the stem cell state in mouse spermatogonia human sertoli cells support high levels of zika virus replication and persistence pharos: collating protein information to shed light on the druggable genome 2018: knowledgebase for the laboratory mouse analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics high-throughput discovery of novel developmental phenotypes carcinoembryonic antigen-related cell adhesion molecule 2 controls energy balance and peripheral insulin action in mice shp1 phosphatase-dependent t cell inhibition by ceacam1 adhesion molecule isoforms deletion of the carcinoembryonic antigen-related cell adhesion molecule 1 (ceacam1) gene contributes to colon tumor progression in a murine model of carcinogenesis ceacam1a-/-mice are completely resistant to infection by murine coronavirus mouse hepatitis virus a59 carcinoembryonic antigen-related cell adhesion molecule 10 expressed specifically early in pregnancy in the decidua is dispensable for normal murine development the lim homeobox gene lhx9 is essential for mouse gonad formation generation and characterization oflhx9-gfpcreert2knock-in mouse line targeted germline modifications in rats using crispr/cas9 and spermatogonial stem cells spermatogenic cells of the prepuberal mouse. isolation and morphological characterization integrative characterization of germ cell-specific genes from mouse spermatocyte unigene library comparative and functional analysis of testis-specific genes genome engineering uncovers 54 evolutionarily conserved and testis-enriched genes that are not required for male fertility in mice reaching for high-hanging fruit in drug discovery at protein-protein interfaces pharmacological perturbation of cdk9 using selective cdk9 inhibition or degradation catalytic in vivo protein knockdown by small-molecule protacs hijacking the e3 ubiquitin ligase cereblon to efficiently target brd4 lessons in protac design from selective degradation with a promiscuous warhead assessing different e3 ligases for small molecule induced protein ubiquitination and degradation cell-penetrating peptides: 20 years later, where do we stand? tat peptide-mediated cellular delivery: back to basics proteomics. tissue-based map of the human proteome single nucleotide polymorphisms: discovery of the genetic causes of male infertility a comprehensive gene mutation screen in men with asthenozoospermia malacards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search genetic evaluation of patients with non-syndromic male infertility a systematic review on the genetics of male infertility in the era of nextgeneration sequencing genetics of male infertility: from research to clinic association study of single-nucleotide polymorphisms in faslg, jmjdia, loc203413, tex15, brdt, or2w3, insr, and tas2r38 genes with male infertility evaluation of 172 candidate polymorphisms for association with oligozoospermia or azoospermia in a large cohort of men of european descent point-of-care whole-exome sequencing of idiopathic male infertility the biology of infertility: research advances and clinical challenges mutation screening of the fkbp6 gene and its association study with spermatogenic impairment in idiopathic infertile men efficient typing of copy number variations in a segmental duplication-mediated rearrangement hotspot using multiplex competitive amplification genetic defects in human azoospermia single-nucleotide polymorphisms of the prdm9 (meisetz) gene in patients with nonobstructive azoospermia two single nucleotide polymorphisms in prdm9 (meisetz) gene may be a genetic risk factor for japanese patients with azoospermia by meiotic arrest single-nucleotide polymorphisms in the human rad21l gene may be a genetic risk factor for japanese patients with azoospermia caused by meiotic arrest and sertoli cell-only syndrome excess of rare variants in genes that are key epigenetic regulators of spermatogenesis in the patients with non-obstructive azoospermia mutations in sohlh1 gene associate with nonobstructive azoospermia human fam154a (saxo1) is a microtubule-stabilizing protein specific to cilia and related structures human carboxylesterases: a comprehensive review structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs human carboxylesterases and their role in xenobiotic and endobiotic metabolism the mammalian carboxylesterases: from molecules to functions heterologous expression, purification, and characterization of human triacylglycerol hydrolase hepatic carboxylesterase 1 is essential for both normal and farnesoid x receptorcontrolled lipid homeostasis deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia baculo-expression and enzymatic characterization of ces7 esterase lipid remodeling of murine epididymosomes and spermatozoa during epididymal maturation development changes occurring in the lipids of ram epididymal spermatozoa plasma membrane regionalization and redistribution of membrane phospholipids and cholesterol in mouse spermatozoa during in vitro capacitation variation in the cholesterol/phospholipid ratio in human spermatozoa and its relationship with capacitation analysis of recombinant human semenogelin as an inhibitor of human sperm motility characterization of an eppin protein complex from human semen and spermatozoa antimicrobial activity of human eppin, an androgen-regulated, sperm-bound protein with a whey acidic protein motif the role of type ii transmembrane serine proteasemediated signaling in cancer delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin mechanisms of hepatocyte growth factor activation in cancer tissues regulation of cell surface protease matriptase by hai2 is essential for placental development, neural tube closure and embryonic survival in mice three genes expressing kunitz domains in the epididymis are related to genes of wfdc-type protease inhibitors and semen coagulum proteins in spite of lacking similarity between their protein products sperm proteins sof1, tmem95, and spaca6 are required for spermoocyte fusion in mice identification of multiple male reproductive tract-specific proteins that regulate sperm migration through the oviduct in mice disruption of adam3 impairs the migration of sperm into oviduct in mouse male mice deficient for germ-cell cyritestin are infertile co-expression of sperm membrane proteins cmtm2a and cmtm2b is essential for adam3 localization and male fertility in mice factors controlling sperm migration through the oviduct revealed by gene-modified mouse models pseudogenes regulate parental gene expression via cerna network interspecific recombinant congenic strains between c57bl/6 and mice of the mus spretus species: a powerful tool to dissect genetic control of complex traits the sequence read archive cutadapt removes adapter sequences from high-throughput sequencing reads transcript-level expression analysis of rna-seq experiments with hisat, stringtie and ballgown systematic selection of reference genes for the normalization of circulating rna transcripts in pregnant women based on rna-seq data featurecounts: an efficient general purpose program for assigning sequence reads to genomic features edger: a bioconductor package for differential expression analysis of digital gene expression data crispr/cas9 mediated genome editing in es cells and its application for chimeric analysis in mice publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations we thank drs. yumei li all data generated or analyzed during this study are included in this published article, its supplementary information files, and publicly available repositories. the sra values for each of the 162 previously published reproductive and non-reproductive human rna-seq datasets [9, 21, 23, 24, 26, 30] and 81 previously published reproductive and non-reproductive mouse rna-seq datasets [19, 22, 25] are listed in additional file 1: table s1 and additional file 1: table s2 . all raw and processed data for the 12 new human and 9 new mouse samples generated in this study is deposited in ncbi geo (accession gse150854). all mice generated in this study, and any additional information about this study, are available from the corresponding authors upon request.ethics approval and consent to participate human tissue acquisition was approved by the ethics committee at université laval with written consent obtained from each respective donor's family. all animal experiments were approved by the institutional animal care and use committee (iacuc) at baylor college of medicine. additional file 7: fig. s2 . summary of number of statistically significant up and down-regulated genes, and quantification of candidate genes with respect to the individual reproductive tissue or cell of interest. the plots in panels (a) and (b) summarizes the number of statistically significant human or mouse genes respectively, that are up-regulated or downregulated in each reproductive tissue or cell of interest compared to the non-reproductive tissue with maximal gene expression. red columns depict the number genes that are up-regulated and blue columns depict the number genes that are down-regulated. changes in gene expression were considered statistically significant for an fdr of less than or equal to 0.05. the total number of candidate genes are designated by the black columns. candidate genes are genes that passed the fdr and tpm expression value filters.additional file 8: fig. s3 . venn diagrams comparing the overlap between the candidate male reproductive genes identified by the indicated reproductive tissues. the human testis combined gene list is the list of genes from both new samples we isolated and from previously published testis samples. the human epididymis combined gene list is the list of genes identified in either previously published samples or the newly generated samples across all sections of the epididymis. lastly, the mouse epididymis combined gene list is the list combined list of genes identified across all three sections of the mouse epididymis.additional file 9: table s7 . complete cross-sample comparison identifying human and mouse reproductive tract specific genes common to two or more samples and unique to each as identified through our studies.additional file 10: fig. s4 . classification of genes into different protein families and identification of the existence of an experimental mouse model. each candidate human gene was classified as an enzyme (enzyme), chromosome and histone modifiers (epigenetic), g-proteincoupled receptor (gpcr), orphan g-protein-couple receptor (ogpcr), kinase (kinase), transcription factor (tf), nuclear receptor (nr), ion channel (ic), chromosome and histone modifying transcript factor (tf; epigenetic), transporter (transporter) and unknown (a). the total number of candidate genes identified in our search for mouse models were plotted. orange columns designate the number of candidate genes where a model was identified while yellow designates candidate genes where a model was not identified (b).additional file 11: table s8 . drug target type classification for human genes. genes are listed according to the tissue and/or cell that they were identified as reproductive tract-specific in.additional file 12: table s9 . availability of a mouse model for human genes with a mouse ortholog. genes are listed according to the tissue and/or cell that they were identified as reproductive tract-specific in.additional file 13: fig. s5 . one-hundred and forty-two previously identified human male reproductive tract-specific genes that remain without a reported mouse model. the listed genes were identified in one or more datasets as indicated in the venn diagram. underlined genes were also identified in our studies as reproductive tract-specific in mouse. genes written in blue encode either enzymes, kinases, gpcrs, ogpcrs, transporters, transcription factors, or proteins involved in epigenetic regulation. genes written in dark red were identified in both testis (testis and/or testis cell) and in epididymis.additional file 14: fig. s6 . seventy-three human male reproductive tract-specific genes that each have a reported mouse model with male infertility phenotype. the listed genes were identified in one or more datasets as indicated in the venn diagram. underlined genes were also identified in our studies as reproductive tract-specific in mouse. genes written in blue encode either enzymes, kinases, gpcrs, ogpcrs, transporters, transcription factors, or proteins involved in epigenetic regulation. genes written in dark red were identified in both testis (testis and/or testis cell) and in epididymis.additional file 15: fig. s7 . rt-pcr confirmation of reproductive tractspecificity in both humans (a) and mice (b). the genes listed in this figure were identified through our studies and previous studies, but currently remain without a reported mouse model. gapdh and hprt are included as housekeeping genes.additional file 16: fig. s8 . eighty-nine novel human genes without a mouse ortholog. the listed genes were identified in one or more datasets as indicated in the venn diagram. genes written in blue encode either enzymes, kinases, gpcrs, ogpcrs, transporters, transcription factors, or proteins involved in epigenetic regulation. genes written in dark red were identified in both testis (testis and/or testis cell) and in epididymis.additional file 17: fig. s9 . novel reproductive tract-specific human genes that do not have any equivalent mouse orthologs. these genes may serve as potential contraceptive targets, however functional validation would need to be carried out in another model organism than mouse, such as rat or marmoset, which do have orthologs to these genes. the digital pcr (heatmap) depicts the average transcripts per million (tpm) value per tissue per gene from the indicated human rna-seq datasets as processed in parallel through our bioinformatics pipeline. white = 0 tpm, black ≥30 tpm. the expression profile of the human housekeeping gene, gapdh, is included as reference. for data obtained from published datasets, superscript values reference the dataset publication as previously mentioned.additional file 18: table s10 . 1064 previously identified genes. genes previously identified as male reproductive tract-specific through high throughput gene expression studies using either microarrays or rna-seq [2] [3] [4] [5] [6] [7] [8] . the human ortholog to genes identified in mouse and rat studies is included.additional file 19: fig. s10 . developmental expression pattern of spint3, spint4, spint5, pp2d1, and saxo1 in epididymis and testis of postnatal and adult mice. whole epididymides were used at postnatal days 3, 6, 10, and 14 and epididymis segments (caput, corpus, and cauda) were used at postnatal days 21, 28, 35, and 60. whole testes were used at all time points. the housekeeping gene, hprt, was used as reference.additional file 20: fig. s11 . multi-channel fluorescence images of bilateral epididymis serial sections stained with custom rnascope probes targeting either spint3, spint4, or spint5 mrna (red) and dapi (blue). the position of caput (cap), corpus (cor), and cauda (cau) is labeled in the overview image (left column). the position of the magnification over the epididymis is the same for all three sections (right column).additional file 21: fig. s12 . representative periodic acid-schiff staining of spint3 and spint4/5 knockout and littermate control (wild-type) testes and epididymis segments (caput, corpus, and cauda) at 3 months of age.additional file 22: fig. s13 . representative periodic acid-schiff staining of ces5a knockout and littermate control (wild-type) testes and epididymis segments (caput, corpus, and cauda) at 3 months of age.additional file 23: fig. s14 . representative scanning electron microscopy images of spint4/5 and ces5a ko and littermate control mouse sperm.additional file 24: fig. s15 . representative periodic acid-schiff staining of pp2d1 and saxo1 knockout and littermate control (wild-type) testes and epididymis segments (caput, corpus, and cauda) at 3 months of age. all authors have no competing interests. key: cord-104092-yau3r79c authors: tamming, renee j.; dumeaux, vanessa; langlois, luana; ellegood, jacob; qiu, lily r.; jiang, yan; lerch, jason p.; bérubé, nathalie g. title: atrx deletion in neurons leads to sexually-dimorphic dysregulation of mir-137 and spatial learning and memory deficits date: 2019-04-13 journal: biorxiv doi: 10.1101/606442 sha: doc_id: 104092 cord_uid: yau3r79c mutations in the atrx chromatin remodeler are associated with syndromic and non-syndromic intellectual disability. emerging evidence points to key roles for atrx in preserving neuroprogenitor cell genomic stability, whereas atrx function in differentiated neurons and memory processes are still unresolved. here, we show that atrx deletion in mouse forebrain glutamatergic neurons causes distinct hippocampal structural defects identified by magnetic resonance imaging. ultrastructural analysis revealed fewer presynaptic vesicles and an enlarged postsynaptic area at ca1 apical dendrite-axon junctions. these synaptic defects are associated with impaired long-term contextual memory in male, but not female mice. mechanistically, we identify atrx-dependent and sex-specific alterations in synaptic gene expression linked to mir137 levels, a known regulator of presynaptic processes and spatial memory. we conclude that ablation of atrx in excitatory forebrain neurons leads to sexually dimorphic outcomes on mir-137 and on spatial memory, identifying a promising therapeutic target for neurological disorders caused by atrx dysfunction. summary statement ablation of the atrx chromatin remodeler specifically in forebrain excitatory neurons of mice causes male-specific deficits in long-term spatial memory associated with mir-137 overexpression, transcriptional changes and structural alterations corresponding to preand post-synaptic abnormalities. alpha-thalassemia x-linked intellectual disability syndrome, or atr-x syndrome, is a rare congenital x-linked disorder resulting in moderate to severe intellectual disability (id), developmental delay, microcephaly, hypomyelination, and a mild form of alphathalassemia [omim: 301040] 1 . in a recent study of approximately 1000 individuals with id, atrx mutations were identified as one of the most frequent cause of non-syndromic id 2 , emphasizing a key requirement for this gene in cognitive processes. atrx-related id arises from hypomorphic mutations in the atrx gene, most commonly in the highly conserved atrx/dnmt3/dnmt3l (add) and switch/sucrose non-fermenting (swi/snf) domains 3, 4 . the former targets atrx to chromatin by means of a histone reader domain that recognizes specific histone tail modifications 5 , and the latter confers atpase activity and is critical for its chromatin remodeling activity 6,7 . atrx, in a complex with the histone chaperone daxx, promotes the deposition of the histone variant h3.3 at heterochromatic domains including telomeres and pericentromeres 8, 9 . however, atrx is also required for h3.3 deposition within the gene body of a subset of g-rich genes, presumably to reduce g-quadruplex formation and promote transcriptional elongation 10 . atrx is also required for the postnatal suppression of a network of imprinted genes in the neonatal brain by promoting long range chromatin interactions via ctcf and cohesin 11 . in mice, germline deletion of atrx results in embryonic lethality 12 while conditional deletion of atrx in neuroprogenitors leads to excessive dna damage caused by dna replication stress and subsequent tp53-dependent apoptosis 13, 14 . mice with deletion of exon 2 of atrx (atrx δe2 ) were generated that result in global reduction of atrx expression. these mice are viable and exhibit impaired novel object recognition memory, spatial memory in the barnes maze, and contextual fear memory 15 . some of the molecular defects identified in these mice included decreased activation of camkii and the ampa receptor in the hippocampus as well as decreased spine density in the medial prefrontal cortex, and altered dna methylation and increased expression of xlr3b in neurons 16 . our group also reported similar behavioural impairments in female mice exhibiting mosaic expression of atrx in the central nervous system 17 . however, the contribution of different cell types and sex difference to behavioural abnormalities have not yet been resolved. to start addressing these questions, we deleted atrx specifically in glutamatergic forebrain neurons in male and female mice. this approach bypasses deleterious effects of atrx loss of function that we previously observed during brain development caused by replication stress in proliferating neuroprogenitors 12, 13 . a comprehensive analysis of these mice reveals that atrx promotes long-term spatial learning and memory associated with morphological and synaptic ultrastructural changes in the hippocampus. we show that female mice lacking atrx in neurons are protected from spatial learning and memory defects and identify sex-specific effects of atrx loss on the expression of synaptic genes and mir-137. overall, we identify a novel sex-specific function for atrx in neurons in the regulation of long-term spatial memory associated with abnormal synapse ultrastructure. animal care and husbandry. mice were exposed to a 12-hour-light/12-hour-dark cycle and with water and chow ad libitum. the atrx loxp mice have been described previously 18 . atrx loxp mice were mated with c57bl/6 mice expressing cre recombinase under the control of the αcamkii gene promoter 19 . the progeny includes hemizygous male mice that produce no atrx protein in forebrain excitatory neurons (atrx-cko). the atrx-cko males were mated to atrx loxp females to yield homozygous deletion of atrx in female mice (atrx-cko fem ). male and female littermate floxed mice lacking the cre allele were used as controls (ctrl; ctrl fem ). genotyping of tail biopsies for the presence of the floxed and cre alleles was performed as described previously 18 arrive guidelines were followed: mouse groups were randomized, experimenters were blind to the genotypes, and software-based analysis was used to score mouse performance in all the tasks. all behavioural experiments were performed between 9:00 am and 4:00 pm. immunofluorescence staining. mice were perfused with 25ml phosphate buffered saline (pbs) followed by 25ml 4% paraformaldehyde (pfa) in pbs and the brain fixed for 24 hours in 4% pfa in pbs and cryopreserved in 30% sucrose/pbs. brains were flash frozen in cryomatrix (thermo scientific) and sectioned at 8µm thickness as described previously 13 . for immunostaining, antigen retrieval was performed by incubating slides in 10 mm sodium citrate at 95°c for 10 min. cooled sections were washed and blocked with 10% normal goat serum (sigma). the slides were incubated overnight in primary antibody sections were washed again three times for 5 min, counterstained with dapi and mounted with slowfade gold (invitrogen). all images were captured using an inverted microscope (leica dmi 6000b) with a digital camera (hamamatsu orca-er). openlab image software was used for manual image capture, and images were processed using the volocity software (demo version 6.0.1; perkinelmer) and adobe photoshop cs6 (version 13.0). cell counts of dapi, gfap, and iba1 were performed in adobe photoshop. dapi was counted per mm 2 and gfap and iba1 were counted as percentages of dapi + cells. one section from five pairs of ctrl/atrx-cko was counted. reverse transcriptase real-time pcr (qrt-pcr). total rna was isolated from control and atrx-cko frontal cortex and hippocampus using the mirvana total rna isolation kit (thermofisher) and reverse transcribed to cdna using 1 μg rna and superscript ii reverse transcriptase (invitrogen). real-time pcr was performed in duplicate using gene-specific primers under the following conditions: 95°c for 10 s, 58°c for 20 s, 72°c for 30 s for 35 cycles. all data were normalized against β-actin expression levels. primers used were as follows: β-actin (forward ctgtcgagtcgcgtccaccc, reverse acatgccggagccgttgtcg); atrx (forward agaaattgaggatgcttcacc, reverse tgaacctggggacttctttg). total rna was also used for reverse transcription of mirna using the taqman advanced microrna reverse transcription kit (thermofisher). qrt-pcr was performed using the short-term memory, mice were exposed to the original object (a) and a novel object (b; a blue plastic pyramid attached on top of a green prism base) 1.5 hours after training. to test long-term memory, mice were exposed to (a) and (b) 24 hours after training. novel object recognition was expressed as the percentage of time spent with the novel object as a fraction of the total time spent interacting. interaction was defined as sniffing or touching the object, but not leaning against or climbing on the object. morris water maze. the morris water maze was conducted as described previously 36 touchscreen assays. the paired associate learning (dpal) and visual paired discrimination (vpd) and reversal tasks were performed as previously described 37-39 . animals were food-restricted to 85% starting body weight. animals were separated into two counter-balanced subgroups to control for time of day of testing, and equipment variation. mice were tested in bussey-saksida mouse touch screen chambers (lafayette neuroscience) with strawberry milkshake given as a reward. for the dpal acquisition phase, animals were tested for their ability to associate objects with locations. mice were presented with two images in two of three windows; one image was in its correct location (s+) and one was in one of its two incorrect locations (s-). the third window was blank. a correct response triggered reward presentation and start of an inter-trial period. the pre-training was repeated until mice reached criterion (completion of 36 trials within 60 minutes). the dpal evaluation phase was performed for 45 sessions over 9 weeks. a correct response triggered reward presentation, whereas an incorrect response caused a 5 s time out and the house lights to turn on. an incorrect response also resulted in a correction trial, where the same s+/s-images were presented in the same two locations until the mouse responded correctly. the mouse was given 36 trials over 60 minutes per day. percent correct, number of correction trials, latency to a correct or incorrect response, and latency to retrieve reward were recorded for each week. vpd acquisition required the animal to touch the same image (s+) no matter which window it appeared in. the other screen had an incorrect image (s-). a correct response triggered reward presentation, whereas an incorrect response triggered the house lights to turn on, a time out of 5 s, and a correction trial to begin (previous trial repeated until a correct choice is made). this was repeated until mice reached criterion of 24/30 trials correct within 60 minutes over 2 consecutive days, after which baseline measurements were done for two sessions. parameters for baseline were identical to the acquisition steps. immediately following baseline measurements, the vpd task reversal began, where most parameters were the same as the acquisition, but the correct image associated with the reward was s-, and the incorrect response that triggers house lights was s+. this also determined total number of vesicles per synapse. vesicle cluster size was measured to calculate vesicle density. the area of the post-synaptic density was also quantified. statistics were calculated by two-way repeated measures anova with sidak's multiple comparison test or unpaired student's t-tests where applicable. statistical analyses. all data were analyzed using graphpad prism software with student's t test (unpaired, two-tailed) or one or two-way repeated measures anova with sidak's post-test where applicable. all results are depicted as mean +/-sem unless indicated otherwise. p values of less than 0.05 were considered to indicate significance. we generated mice lacking atrx in postnatal forebrain excitatory neurons by cre/loxp mediated recombination of the mouse atrx gene with the camkii-cre driver line of mice 49 . to confirm loss of atrx, we performed immunofluorescence staining of control and conditional knockout (atrx-cko) brain cryosections obtained from 3-month-old mice (figure 1a,b) . atrx is highly expressed in excitatory neurons of the hippocampus of control mice, including the cortex and hippocampal ca1, ca2/3, and dentate gyrus neurons, but is absent in these cells in the atrx-cko mice. additional validation of atrx inactivation in atrx-cko mice was achieved by qrt-pcr (figure 1c) , showing that atrx expression is decreased by 78% (+/-9.4%) and 81% (+/-1.7%) in the cortex and the hippocampus, respectively, which is expected from a neuron-specific deletion. the brain sub-region specificity of atrx loss was demonstrated by western blot analysis, showing reduced protein levels in the rostral and caudal cortices and hippocampus, but not in the cerebellum (figure 1d ). the mice survived to adulthood and had normal general appearance and behaviour. however, body weight measurements revealed a small but significant reduction in atrx-cko compared to control mice (figure 1e ). these findings demonstrate that we achieved specific deletion of atrx in excitatory neurons and while the mice were slightly smaller, they survived to adulthood, allowing further analyses in the adult brain. we first examined control and atrx-cko mouse brains for neuroanatomical anomalies by magnetic resonance imaging (mri). using a t2-weighted mri sequence, we were able to analyze and compare the entire brain as well as independent brain regions from 16 control and 13 atrx-cko male animals. the data obtained showed that the overall volume of the atrx-cko brain is significantly smaller compared to controls (92.8% of control volume, p<0.0001), as indicated by whole volume in mm 3 and cumulative serial slices of control and atrx-cko brains (figure 2a,b) , which correlates with the smaller body size of the mice. due to the reduction in body size and absolute total brain and hippocampal volumes of the atrx-cko mice, we next examined hippocampal neuroanatomy relative to total brain volume ( we postulated that the increase in relative volume of the ca1 sr/slm may be due to increased length or branching of ca1 apical dendrites. to investigate this possibility, golgi staining was used to sporadically label neurons (figure 3a ) and sholl analysis was performed on confocal microscopy images to evaluate apical dendrite branching of ca1 hippocampal neurons. however, no significant difference in dendritic branching or length was observed between control and atrx-cko mice, whether analyzed separately for apical or basal dendrites (figure 3b-g) . increased relative volume might also be caused by an increased number of cells, but immunofluorescence staining and quantification of astrocytes (gfap+) and microglia (iba1+) and total number of cells (inferred from dapi+ staining) revealed no differences in atrx-cko hippocampi (figure 3h-j) . overall, the increased relative volume of the ca1 sr/slm cannot be explained by increased length or complexity of dendritic trees or by an increased number of glial cells. based on the hippocampal structural alterations we detected by mri, we looked more closely at potential ultrastructural changes in the ca1 sr/slm area using transmission electron microscopy (tem) (figure 4a) . the presynaptic boutons were divided in 50nm bins from the active zone, and the number of vesicles in each bin was counted. the spatial distribution of vesicles in relation to the cleft was unchanged between the atrx-cko mice and controls (figure 4b) . however, we found that the total number of vesicles, the density of the vesicles, and the number of docked vesicles was significantly decreased at atrx-cko compared to control synapses (figure 4c-e) . we also analysed other structural aspects of synapses and found that the size of the postsynaptic density and the width of the synaptic cleft were both increased in atrx-cko compared to controls (figure 4f,g) . the length of the active zone, cluster size, or diameter of the vesicles did not vary significantly between control and atrx-cko samples ( figure 4h -j). these results suggest that atrx is required for structural integrity of the pre-and post-synapse, including maintenance of the synaptic vesicle pool at pre-synaptic termini and potential defects in postsynaptic protein clustering. we to investigate the effects of neuronal-specific atrx ablation on spatial learning and memory, we tested the mice in the morris water maze task. the atrx-cko mice showed a significant delay in latency to find the platform on day 3 of the learning portion of the task; however, by day 4 they were able to find the platform as quickly as the control mice (f=4.622, p=0.0404; figure 5a ). this finding was reflected in the distance traveled p=0.0251; figure 5f , g). these behavioural analyses suggest that atrx in required in excitatory neurons for long-term hippocampal-dependent spatial learning and memory. to determine whether loss of atrx in female mice would exhibit similar behavioural defects as seen in male mice, we generated atrx-cko female mice (atrx given the observed male-specific defects in spatial memory, we performed additional translational cognitive tasks on the atrx-cko male mice. the dpal touchscreen task in mice is analogous to cognitive testing done in humans by the cambridge neuropsychological test automated battery (cantab) 50,51 and normal performance in this task is thought to partly depend on the hippocampus 39,52 . control and atrx-cko mice were trained to identify the position of three images as depicted in figure 6a , undergoing 36 trials per day for 10 weeks. the results demonstrate that the atrx-cko mice exhibit a profound deficit in this task, indicated by both the percent correct (f=10.53, p=0.0031; figure 6b ) and the number of correction trials required (f=30.64, p<0.0001; figure 6c ) (supplementary video 1, 2) . these defects were not due to an inability to perform within the chamber or to attentional deficits, as latency to a correct answer (f=0.4802, p=0.4943), to an incorrect answer (f=0.1259, p=0.7255), and to retrieve the reward (f=0.9840, p=0.3300) was not significantly different between control and atrx-cko mice (figure 6d-f) . to determine if the impairment in the dpal task is caused by a vision problem rather than a learning defect, the mice were also tested in the visual paired discrimination (vpd) touchscreen task which requires the mice to discriminate between two images regardless of position on the screen. while the atrx-cko mice took significantly longer to reach the criterion pre-testing (t=2.945, p=0.0067; to identify the molecular mechanism(s) leading to spatial memory impairment, we performed rna-sequencing in both male and female hippocampi obtained from three pairs of littermate-matched ctrl/atrx-cko and ctrl fem /atrx-cko fem mice. there were 1520 transcripts differentially expressed in the atrx-cko males compared to control counterparts and 9068 transcripts in atrx-cko fem compared to the female controls (fdr < 0.20). to isolate transcripts that were likely to be causative to the impaired learning and memory phenotype in the male mice which was not found in the female mice, we focused on transcripts whose changes in expression with the atrx-cko were differential between male and female mice (n = 1054 transcripts, interaction term fdr < 0.05). the expression heat map of these transcripts illustrates that their expression levels are similar in control males and females but are differentially expressed when atrx is lost depending on sex (figure 7a) . we then utilized panther 53 , a tool for gene enrichment analysis based on functional annotations to examine gene ontology biological processes for which our list of transcripts was enriched (figure 7b) . the top five pathways included neurotransmitter receptor transport to postsynaptic membrane, protein localization to postsynaptic membrane, non-motile cilium assembly, and vesicle-mediated transport to the membrane. therefore, the rna sequencing revealed many transcripts related to synapses, supporting the tem data. certain mirna are enriched within presynaptic terminals and have been figure 5a ) as well as an enrichment for targets of mir-137 (supp. figure 5b) . we compared the list of genes downregulated in the atrx-cko male hippocampi to those predicted to be regulated by mir-137 through mirna.org (supp. table 1) . we found shank2, cadps2, glrb, and sgip1 expression to be inversely 64 . this data provides additional evidence that loss of atrx in the cortex and hippocampus of male mice leads to increased mir-137 expression and consequent downregulation of its target genes, starting at early stages of forebrain development. this study presents evidence that atrx is required in a sex-specific manner in excitatory forebrain neurons for normal spatial learning and memory (figure 8) [75] [76] [77] . in humans, neurological disorders such as autismspectrum disorders tend to preferentially affect males rather than females, possibly due to combinatorial contributions of hormonal and genetic factors in a phenomenon known as the female protective effect [78] [79] [80] , and this is regularly supported with mouse models [81] [82] [83] . the presence of estrogen and estrogen receptor in the female brain has been shown to be neuroprotective and leads to enhanced schaffer-collateral ltp 84 . in addition, certain x-linked genes involved in chromatin regulation (e.g. utx, a histone demethylase) are able to escape x-inactivation and so are expressed two-fold in females compared to males 85 in conclusion, our study presents strong evidence that atrx is required in forebrain excitatory neurons for spatial learning and long-term memory and regulation of genes required for efficient synaptic transmission. vpd touchscreen assays were performed at the robarts research institute neurobehavioural core facility, tem imaging at the biotron at western university and the rna sequencing at the london regional genomics centre. mutations in a putative global transcriptional regulator cause x-linked mental retardation with alpha-thalassemia (atr-x syndrome) targeted next-generation sequencing analysis of 1,000 individuals with intellectual disability mutations in transcriptional regulator atrx establish the functional significance of a phd-like domain microrna-34a regulates neurite outgrowth, spinal morphology, and function mir-27b shapes the presynaptic transcriptome and influences neurotransmission by silencing the polycomb group protein bmi1 the schizophrenia risk gene product mir-137 alters presynaptic plasticity the swi/snf protein atrx co-regulates pseudoautosomal genes that have translocated to autosomes in the mouse genome toppgene suite for gene list enrichment analysis and candidate gene prioritization the shank family of scaffold proteins the glycine receptor cloning and characterization of human cadps and cadps2, new members of the ca2+-dependent activator for secretion protein family intersectin 1 forms complexes with sgip1 and reps1 in clathrin-coated pits disruption of the direct perforant path input to the ca1 subregion of the dorsal hippocampus interferes with spatial working memory and novelty detection a macromolecular synthesis-dependent late phase of long-term potentiation requiring camp in the medial perforant pathway of rat hippocampal slices abnormal microglia and enhanced inflammation-related gene transcription in mice with conditional deletion of ctcf in camk2a-cre-expressing neurons lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats learning, memory, and glial cell changes following recovery from chronic unpredictable stress disruption of the perineuronal net in the hippocampus or medial prefrontal cortex impairs fear conditioning modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-r differentially affects several forms of synaptic plasticity in the hippocampus new translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and rats synaptic scaffold evolution generated components of vertebrate cognitive complexity x-linked alphathalassemia/mental retardation (atr-x) syndrome: localization to xq12-q21.31 by x inactivation and linkage analysis sexually dimorphic behavior, neuronal activity, and gene expression in chd8-mutant mice mecp2 organizes juvenile social behavior in a sex-specific manner mecp2 modulates sex differences in the postsynaptic development of the valproate animal model of autism epidemiology of pervasive developmental disorders a higher mutational burden in females supports a "female protective model" in neurodevelopmental disorders transcriptomic analysis of autistic brain reveals convergent molecular pathology human crmp4 mutation and disrupted crmp4 expression in mice are associated with asd characteristics and sexual dimorphism shank1 deletions in males with investigation of sex differences in the expression of rora and its transcriptional targets in the brain as a potential contributor to the sex bias in autism memory-related synaptic plasticity is sexually dimorphic in rodent hippocampus sex-specific differences in expression of histone demethylases utx and uty in mouse brain and neurons mirna expression profile after status epilepticus and hippocampal neuroprotection by targeting mir-132 microarray based analysis of microrna expression in rat cerebral cortex after traumatic brain injury the brain-specific microrna mir-128b regulates the formation of fear-extinction memory supplementary figure 5: transcriptional profiling reveals dysregulation of presynaptic genes in atrx-foxg1 mice. (a) differentially expressed genes between control and atrx-foxg1 p0.5 forebrain were used for gene ontology analysis and top 25 biological processes were listed by p-value. (b) top mirna predicted to regulate differentially expressed genes from control and atrx-foxg1 mice we are grateful to doug higgs and richard gibbons for the atrx floxed mice, vania prado and marco prado for the camkii-cre mice, michael miller for advice on statistical analyses, and tim bussey for discussions on the touchscreen assays. the dpal and the authors declare no competing or financial interests. 0 key: cord-103703-t03r6ny8 authors: nguyen-tu, marie-sophie; martinez-sanchez, aida; leclerc, isabelle; rutter, guy a.; da silva xavier, gabriela title: reduced expression of tcf7l2 in adipocyte impairs glucose tolerance associated with decreased insulin secretion, incretins levels and lipid metabolism dysregulation in male mice date: 2020-05-20 journal: biorxiv doi: 10.1101/2020.05.18.102384 sha: doc_id: 103703 cord_uid: t03r6ny8 transcription factor 7-like 2 (tcf7l2) is a downstream effector of the wnt/beta-catenin signalling pathway and its expression is critical for adipocyte development. the precise role of tcf7l2 in glucose and lipid metabolism in adult adipocytes remains to be defined. here, we aim to investigate how changes in tcf7l2 expression in mature adipocytes affect glucose homeostasis. tcf7l2 was selectively ablated from mature adipocytes in c57bl/6j mice using an adiponectin promoter-driven cre recombinase to recombine alleles floxed at exon 1 of the tcf7l2 gene. mice lacking tcf7l2 in mature adipocytes displayed normal body weight. male mice exhibited normal glucose homeostasis at eight weeks of age. male heterozygote knockout mice (atcf7l2het) exhibited impaired glucose tolerance (auc increased 1.14 ± 0.04 -fold, p=0.03), as assessed by intraperitoneal glucose tolerance test, and changes in fat mass at 16 weeks (increased by 1.4 ± 0.09-fold, p=0.007). homozygote knockout mice exhibited impaired oral glucose tolerance at 16 weeks of age (auc increased 2.15 ± 0.15-fold, p=0.0001). islets of langerhans exhibited impaired glucose-stimulated insulin secretion in vitro (decreased 0.54 ± 0.13-fold atcf7l2ko vs control, p=0.02), but no changes in in vivo glucose-stimulated insulin secretion. female mice in which one or two alleles of the tcf7l2 gene was knocked out in adipocytes displayed no changes in glucose tolerance, insulin sensitivity or insulin secretion. plasma levels of glucagon-like peptide-1 and gastric inhibitory polypeptide were lowered in knockout mice (decreased 0.57 ± 0.03-fold and 0.41 ± 0.12-fold, p=0.04 and p=0.002, respectively), whilst plasma free fatty acids and fatty acid binding protein 4 circulating levels were increased by 1.27 ± 0.07 and 1.78 ± 0.32-fold, respectively (p=0.05 and p=0.03). mice with biallelic tcf7l2 deletion exposed to high fat diet for 9 weeks exhibited impaired glucose tolerance (p=0.003 at 15 min after glucose injection) which was associated with reduced in vivo glucose-stimulated insulin secretion (decreased 0.51 ± 0.03-fold, p=0.02). thus, our data indicate that loss of tcf7l2 gene expression in adipocytes leads to impairments on metabolic responses which are dependent on gender, age and nutritional status. our findings further illuminate the role of tcf7l2 in the maintenance of glucose homeostasis. transcription factor 7-like 2 (tcf7l2) is a member of the high mobility group box family of transcription factors, a downstream effector of the wnt/beta-catenin signalling pathway, and a key regulator of development and cell growth [1] . tcf7l2 function is important for the proper function of tissues involved in the regulation of energy homeostasis. for example, tcf7l2 is required for the maintenance of functional pancreatic beta cell mass and insulin release from the endocrine pancreas [2, 3] . in the liver, ablation of tcf7l2 expression from hepatocytes has variously been shown to lead to reduced hepatic glucose production and improved glucose homeostasis [4] , or hyperglycemia [5] . studies by macdougald and colleagues [6] [7] [8] have demonstrated that tcf7l2 is involved in the regulation of the expression of proadipogenic genes during adipocyte development. additionally, insulin/insulin receptor substrate-1 and insulin growth factor 1 have been shown to cross-talk with the wnt signalling pathway to regulate insulin sensitivity in preadipocytes [9, 10] . the presence of tcf7l2 binding sites on the promoter of the insulin receptor gene also suggests a role of tcf7l2/wnt signalling pathway in regulating insulin action in adipocytes [11] . genome-wide association studies (gwas) have identified single nucleotide polymorphisms (snps; rs12255372 and rs7903146) in the tcf7l2 gene as being amongst the most strongly associated with an increased risk of type 2 diabetes [12] . humans carrying the t risk allele at rs7903146 have elevated proinsulin levels, lowered first-phase insulin secretion and impaired responses to the incretin hormone glucagon-like peptide 1 (glp-1) [13] [14] [15] [16] [17] . whilst tcf7l2 variants appear chiefly to affect pancreatic beta cell function in man, the mechanisms driving impaired insulin secretion are still poorly defined [18, 19] . although rs7903146 in tcf7l2 is not associated with changes in overall tcf7l2 transcription (i.e. of all isoforms), with conflicting data regarding the association of rs7903146 with specific tcf7l2 variant expression in subcutaneous fat [20] [21] [22] , tcf7l2 expression has been shown to be reduced in adipose tissue from type 2 diabetes subjects [23] and in obese mice [24] . additionally, surgery-induced weight loss has been shown to regulate alternative splicing of tcf7l2 in adipose tissue [25] . tcf7l2 splice variant expression is regulated by plasma triglycerides and free fatty acids [25, 26] , with evidence indicating that acute intake of fat leads to reduced expression of tcf7l2 in human adipocytes [27] . thus, overall these data suggest that changes in tcf7l2 expression may be linked to adaptation to changes in fuel intake. efforts to understand the causal relationship between tcf7l2 and diabetes led to studies on several metabolic tissues, with the data suggesting that the combined effects of loss of tcf7l2 in multiple tissues may account for the diabetes phenotype [28] . for example, previous reports have described the impact of loss of tcf7l2 expression on adipocyte development and insulin sensitivity [24, 29] . in the present study, we used a genetic model of ablation of tcf7l2 gene expression in mature adipocytes to determine whether tcf7l2 plays a role in adipocyte function, independent of its role in adipogenesis. we have focused on whether loss of tcf7l2 expression in the adipocyte impacts the release of hormones involved in glucose homeostasis, notably insulin and incretins. in this way, we sought to explore the possibility that altered tcf7l2 expression in the adipocyte may contribute to type 2 diabetes risk through downstream effects on multiple effector organs [28, 30] . to generate tissue-specific knockout of tcf7l2 alleles, we crossed mice in which exon 1 (encoding for the beta-catenin-binding domain) was flanked by loxp sites [2] with mice expressing cre recombinase under the control of the adiponectin promoter [31] (a kind gift from d. withers, imperial college london) to produce deletion of one tcf7l2 allele (atcf7l2het) or two alleles (atcf7l2ko). littermates used as controls did not express cre recombinase but were homozygous or heterozygous for the floxed tcf7l2 allele. adiponectin-cre [31] or mice with tcf7l2 gene flanked by loxp sites (tcf7l2-floxed) [2] did not display phenotypes that deviate from wild-type littermate control mice, consequently we used tcf7l2-floxed mice as controls in our test cohorts. mice were born at the expected mendelian ratios with no apparent abnormalities. animals were housed 2-5 per individuallyventilated cage in a pathogen-free facility with 12:12 light:dark cycle with free access to standard mouse chow (rm-1; special diet services) diet and water. high fat diet (hfd) cohort were put under a high sucrose high fat diet (d12331; research diets) for 12 weeks from 7-week-old. for the chow diet cohort, metabolic exploration was performed on each animal within a 2-week window at 2 stages (8-week-old and 16-week-old). all in vivo procedures described were performed at the imperial college central biomedical service and approved by the uk home office animals scientific procedures act, 1986 (ho licence ppl 70/7971 to gdsx). glucose tolerance was performed on 15 h-fasted mice after an oral gavage of glucose (ogtt, 2 g/kg of body weight) or intraperitoneal injection of glucose (ipgtt, 1g/kg body weight. ipgtt and ogtt were performed at two stages (at 8-week-old and at 16-week-old) for each individual mouse. insulin tolerance was performed after a 5 h-fast with an intraperitoneal injection of insulin (ipitt, 0.5 u/kg in females, 0.75 u/kg in males under chow diet, 1.5u/kg in males under hfd). in vivo glucosestimulated insulin secretion was assessed after oral or intraperitoneal administration of glucose and blood was collected at 0-and 15-minutes post-injection to assess plasma insulin levels using an ultrasensitive mouse insulin elisa kit (crystal chem, netherlands) or using a homogeneous time resolved fluorescence (htrf) insulin kit (cisbio, france) in a pherastar reader (bmg labtech, uk). to assess insulin sensitivity, male mice were starved for four hours and following an intraperitoneal injection of insulin (1ui/kg body weight) adipose tissues were collected and frozen in liquid nitrogen. adipose tissue proteins were extracted in lysis buffer (150 mmol/l nacl, 50 mmol/l tris-hcl ph 8.0, 1% np-40) supplemented with protease inhibitors (roche, germany) and phosphatase inhibitors (sigma-aldrich, uk) and analysed by western blotting using antibodies for tcf4/tcf7l2 (c48h11) (#2569, 1:500, cell signalling, neb, uk), phospho-akt (#9271, 1:1000, cell signalling, neb, uk), total-akt (#9272, 1:1000, cell signalling, neb, uk), gapdh (#2118, 1:10000, cell signalling, neb, uk), alpha-tubulin (t5168, 1:10 000, sigma-aldrich, uk). fiji software was used for densitometry quantification. uncut versions of all western blot images are presented in supplemental figure s1. islets were isolated by digestion with collagenase as described [32] . in brief, pancreata were inflated with a solution of collagenase from clostridium histolyticum (1 mg/ml; nordmark, germany) and placed in a water bath at 37 ⁰c for 12 min. islets were washed and purified on a histopaque gradient (sigma-aldrich, uk). isolated islets were cultured for 24 h in rpmi 1640 containing 11.1 mmol/l glucose, 10% foetal bovine serum and l-glutamine (sigma-aldrich, uk) and allowed to recover overnight. insulin secretion assays on isolated mouse islets were performed as previously described [32] . in measurement of intracellular calcium dynamics was performed as previously described [33] . in brief, whole isolated islets were incubated with fura-8am (invitrogen, uk) [34] for 45 min at 37⁰c in khb containing 3 mmol/l glucose. fluorescence imaging was performed using a nipkow spinning disk head, allowing rapid scanning of islet areas for prolonged periods of time with minimal phototoxicity. volocity software (perkinelmer life sciences, uk) provided interface while islets were kept at 37⁰c and constantly perifused with khb containing 3 mmol/l or 17 mmol/l glucose or 30 mmol/l kcl. epididymal adipose tissue were removed from euthanized mice, fixed overnight in 10% formalin and subsequently embedded in paraffin wax. adipose tissue slices (5 μm) were stained with hematoxylin and eosin (sigma-aldrich, uk) for morphological analysis. blood in the fed state was obtained by tail bleeding, and circulating factor concentrations were measured using the following kits according to the respective manufacturer's protocols: bio-plex protein array system (biorad, uk) with one multiplex panel was used to measure total glucagon-like peptide-1 (glp-1), glucose-dependent insulinotropic polypeptide (gip), leptin, adiponectin and plasminogen activator inhibitor-1 (pai-1); one multiplex panel was used to measure fatty acid binding protein 4 (fabp4) and resistin (r&d systems, uk); non-esterified fatty acid (nefa) serum levels were measured by colorimetric assay (randox, uk) and dipeptidyl peptidase 4 (dpp4; r&d systems, uk) levels were measured by elisa. rna was isolated from epididymal and subcutaneous adipose tissue, liver and pancreatic islets with trizol following manufacturer's instructions (invitrogen, uk). rna purity and concentration were measured by spectrophotometry (nanodrop, thermo scientific, uk). only rna with absorption ratios between 1.8-2.0 for 260/280 and 260/230nm were used. rna integrity was checked on an agarose gel. rna was reversed transcribed using high-capacity cdna reverse transcription kit (applied biosystems, uk). qpcr was performed with fast sybr green master mix (applied biosystems, uk). the comparative ct method (2 -ct ) was used to calculate relative gene expression levels using gapdh, βactin or ppia as an internal control. the primers sequences are listed in supplemental table s1. data are shown as means ± sem. graphpad prism 8.4 was used for statistical analysis. statistical significance was evaluated by the two-tailed unpaired student t-test and one-or two-way anova, with tukey or bonferroni multiple comparisons post-hoc test as indicated in the figure legends. p values of <0.05 were considered statistically significant. to determine the role of tcf7l2 in the mature adipocyte, we generated a mouse line in which tcf7l2 is deleted specifically in these cells through the expression of cre recombinase under the control of the adiponectin promoter [31] . cre recombinase mediated the excision of exon 1 of tcf7l2 generating one single tcf7l2 allele deletion (atcf7l2het) or a biallelic tcf7l2 deletion (atcf7l2ko). tcf7l2 mrna levels were decreased in inguinal adipose tissue (iwat) by 39.8 ± 13.3% (p=0.008) while in epididymal adipose tissue (ewat), a reduction by 46.3 ± 20.1% did not reach any statistical significance (p=0.09) in atcf7l2het mice compared to controls. in atcf7l2ko mice, expression was reduced by 77.3 ± 11.2 % and 57.8 ± 20.2%, respectively in ewat and iwat compared to controls. conversely, no changes in tcf7l2 expression were apparent in liver and pancreatic islets from atcf7l2het and atcf7l2ko mice vs islets from littermate controls (fig.1a) . correspondingly, the content of the two tcf7l2 protein isoforms (79kda and 58kda) in ewat was significantly reduced by 41 ± 11 % and 35 ± 7 % respectively in atcf7l2het mice and reduced by 77 ± 17 % and 80 ± 14 % in atcf7l2ko mice ( fig.1b and c) . body weight was unchanged in male ( likewise, we found no change in fat or lean mass in 8 weeks old male or female mice, as assessed by echomri ( fig.1g , i, k and m). however, fat mass was significantly increased, and lean mass was decreased, in male atcf7l2het mice on normal chow diet ( fig.1h and j) . female mice showed no change in body composition with age ( fig.1l and n) . to explore the effects of adipocyte-specific tcf7l2 ablation on whole body metabolism, we measured glucose tolerance, and found an age-dependent impairment in the response to glucose administration. glucose challenge was assessed in male and female mice at a young stage (8 weeks of age) and at an older stage (16 weeks of age). in younger mice, blood glucose levels after intraperitoneal injection of glucose were similar in atcf7l2het and atcf7l2ko compared to sex-matched littermate controls regardless of the gender ( fig.2a and fig.3a ). in older mice, glucose levels were impaired in male atcf7l2het mice rising to 17.7 ± 1.0 mmol/l at 15 minutes after intraperitoneal injection of glucose compared to littermate controls rising to 13.4 ± 0.8 mmol/l (fig.2b) . likewise, atcf7l2het and young atcf7l2ko mice had similar increases in glucose levels 15 minutes after oral administration of glucose (17.4 ± 1.1 mmol/l and 15.8 ± 0.7 mmol/l respectively) compared to littermate controls (16.7 ± 0.7 mmol/l; fig.2c) . surprisingly, glucose tolerance (as assessed by oral glucose tolerance test) was impaired in older atcf7l2ko mice (17 weeks) compared to littermate controls (fig.2d) . female mice exhibited no change in glucose tolerance regardless of age and genotype (fig.3a, fig.3b and fig.3c ). whole body insulin sensitivity was unaffected in both genders across all genotypes ( fig.2e and fig.3d ). in order to assess whether ablation of tcf7l2 in mature adipocyte affects organs involved in glycaemic control, beta cell secretory capacity was measured during glucose challenge. we sought first to examine whether impaired intraperitoneal and oral glucose challenge in older male atcf7l2het and atcf7l2ko mice was due to an impact on insulin secretion. fasting plasma insulin levels and in vivo glucose-stimulated insulin release were similar in atcf7l2het and atcf7l2ko mice vs littermate controls after intraperitoneal injection of glucose (fig.2f) or after oral administration of glucose (fig.2g) . glucose stimulated insulin secretion in isolated islets was decreased after high (17 mm) glucose incubation (0.32 ± 0.08% in atcf7l2ko vs 0.59 ± 0.13% in controls) while responses to kcl (30 mm) were not different in islets from atcf7l2ko compared to islets from littermate controls (fig.2h) . when exploring after tcf7l2 loss expression of key genes associated with normal beta cell function, we observed no significant changes in gene expression. indeed, no difference was observed for the expression of the insulin (ins1, ins2), or glucagon (gcg) genes in islets from all genotypes, however a reduction in the expression of the glucose transporter 2 (glut2/slc2a2) gene was observed in atcf7l2ko mice (0.73 ± 0.06 in atcf7l2ko vs 1.00 ± 0.03 in controls; fig.2i ). to further evaluate the origins of the secretory defects observed in isolated islets (fig. 2h) , we measured the changes in cytosolic calcium in response to incubation with varying concentrations of glucose (3 mm, 17 mm) in the presence or absence of kcl (30 mm) on isolated islets (fig.2j) . islets from atcf7l2ko male mice showed a diminished response to high glucose incubation compared to atcf7l2het animals, while differences compared to control mice did not reach any statistical significance. islets from atcf7l2het male mice showed an increase response to kcl compared to controls (fig.2j) . in vivo after intraperitoneal injection and in vitro glucose stimulated insulin secretion was unchanged in female atcf7l2kohet and atcf7l2ko mice ( fig.3e and f) . therefore, alterations in pancreatic beta cell function observed ex vivo in the absence of tcf7l2 in adipocyte have no impact on whole body glucose-stimulated insulin secretion. to investigate the causes of impaired oral glucose tolerance in male atcf7l2ko mice, we measured the circulating levels of other hormones regulating glucose metabolism. circulating glp-1 and gip levels in plasma were decreased in older male atcf7l2ko mice compared to age-and sex-matched littermate control mice (glp-1: 23.7 ± 6.8 vs 57.6 ± 11.6 ng/ml; gip: 335.1 ± 21.4 vs 583.8 ± 39.5 ng/ml respectively; fig.4a and fig.4b ). we observed a significant decrease in gip levels (421.8 ± 24.6 vs 583.8 ± 39.5 ng/ml in controls), but no robust or statistical differences in glp-1 levels in atcf7l2het mice ( fig.4a and b) . plasma dpp4 levels in male atcf7l2ko mice were not different compared to controls (fig.4c ). evidence suggests a role of wnt/tcf7l2 signalling in the control of lipid metabolism [24, 35] . we, therefore, sought to determine whether tcf7l2 could play a role as a regulator of fatty acid release from mature adipocyte. plasma levels of circulating nefa and the lipid carrier fabp4 were found to be increased respectively in atcf7l2ko mice compared to age-and sex-matched littermate controls (nefa: 0.79 ± 0.04 vs 0.62 ± 0.04 mmol/l, respectively; fabp4: 75.0 ± 13.5 ng/ml vs 42.1 ± 6.0 ng/ml, respectively; fig.3d and e) . finally, we investigated endocrine adipocyte function by measuring adipokines which are usually found to be affected in insulin resistance and metabolic diseases. plasma levels of adiponectin, leptin, resistin and pai-1 were found to be unchanged in male mice of all genotypes (fig.4f , g and supplemental fig.s2a and b) . we next explored whether loss of tcf7l2 expression may affect insulin signalling in adipocytes, since previous reports [24, 29] described hepatic insulin resistance in a mouse model of ablation of tcf7l2. pkb/akt ser473 phosphorylation was elevated at basal condition prior insulin stimulation in older (17 weeks) atcf7l2 male mice ( fig.4h and i) , but pkb/akt ser473 phosphorylation in response to insulin was similar adipocytes from atcf7l2ko mice and control littermates. however, relative expression of phosphorylated akt after insulin stimulation compared to basal appeared decreased in atcf7l2ko mice compared to controls but was not robust enough to reach statistical significance (p=0.07; fig.4j ). indicative of unaltered hepatic insulin sensitivity, liver levels of the gluconeogenic genes g6pase and pepck (pck1) did not differ between control and atcf7l2ko mice (fig.4j) . therefore, our results suggest that tcf7l2 could control lipolysis and lipid metabolism in adipocyte. in order to investigate whether nutritional status had an impact on glucose metabolism in the absence of tcf7l2 expression in adipocytes, we maintained atcf7l2ko male mice on high fat (60%) diet for 12 weeks. we focused on males as no change were observed in female mice on chow diet. body weight trajectory showed a similar increase in atcf7l2ko compared to control mice (fig.5a) . glucose tolerance was altered after intraperitoneal injection of a high concentration (2g/kg) of glucose by a delay of 15 minutes in the blood glucose peak after injection of glucose compared to controls (17.6 ± 1.5 vs 23.7 ± 2.2 mmol/l respectively; fig.5b and c) . no significant change in oral glucose tolerance ( fig.5d and e) , or insulin sensitivity (fig.5f) , was observed between mice of all genotypes. insulin secretion was impaired during in vivo oral glucose challenge in atcf7l2ko compared to littermate controls (at 15 minutes, 4.6 ± 0.2 vs 8.9 ± 1.0 ng/ml respectively; fig.5h ). we observed no robust changes following intraperitoneal injection of glucose to reach statistical significance (fig.5g) . ex vivo insulin release in response to high glucose (17 mm), glp-1 (20nm) and kcl (30 mm) was found to be no different between islets of langerhans isolated from atcf7l2ko mice and littermate control mice (fig.5i) . in the present study, we demonstrate that changes in the expression of tcf7l2 in murine adult adipose tissue may lead to alterations not only in adipocyte function but also in the function of other tissues involved in the regulation of energy homeostasis in a gender-, age-, and nutritional status-dependent manner. thus, we provide evidence that deletion of tcf7l2 in adipocytes leads to alterations in the function of adipocytes, pancreatic islet beta cells, and enteroendocrine cells, thereby highlighting a role for tcf7l2 in systemic glucose homeostasis. wnt signalling and its effectors beta-catenin and tcf7l2 are critical during adipogenesis [6, 8, 29] . the presence of this signalling module during adulthood suggests that it may also be important for the function of adult adipocytes. in the present study, we found that young mice presented no alteration of glucose tolerance or body composition, regardless of the gender, in the absence of tcf7l2 in adipocyte, whilst defects appear with age ( fig.1g and fig.2a) . recently, tian et al. revealed crosstalk between wnt signalling and females hormones through tcf7l2 to regulate lipid metabolism [35] . thus, gender differences observed when expressing a dominant-negative form of tcf7l2 in hepatocytes would suggest that sex hormones regulate glucose homeostasis via repressing hepatic gluconeogenesis and regulate lipid metabolism [35] . in our study, we also found that female mice were largely unaffected by the loss of tcf7l2 function in the adipocyte, suggesting a role for female hormones to maintain glucose homeostasis. the key effector of the wnt signalling pathway is the association of beta-catenin and a member of the tcf family which may include tcf7l2, tcf7, tcf7l1 and lef-1 [1] . the availability of free betacatenin entering the nucleus to bind tcf7l2 is crucial for activation of expression of downstream target genes. however, the regulation of tcf7l2 expression is also essential. high-fat feeding modulates tcf7l2 expression in pancreatic islets, in hepatocytes and in human adipocytes [27, 36, 37] . furthermore, studies have suggested that variation in tcf7l2 expression altered glucose metabolism and induces type 2 diabetes phenotype [38] . we found that deletion of a single tcf7l2 allele generates distinct features of obesity-induced glucose intolerance while biallelic tcf7l2 deletion reveals a disruption of endocrine signalling molecules. therefore, alterations induced by deletion of tcf7l2 in mature adipocytes could depend on age and on the dosage of tcf7l2 expression. we found that under chow diet fed mice lacking tcf7l2 selectively in adipocytes displayed an impaired response to oral glucose challenge (fig. 2d) but normal tolerance to intraperitoneal injection of the sugar (fig. 2b) . this suggests an impaired incretin effect, defined as the postprandial insulin response provoked by incretin hormones such as glp-1 and gip. however, insulin release in response to an oral glucose challenge was maintained (fig. 3d) , whilst glucose-stimulated insulin secretion ex vivo from isolated islets of langerhans is impaired (fig. 3e) . our data therefore suggest that a mechanism exists to maintain insulin release in vivo after deletion of tcf7l2 from adipocytes. however, when challenged with high fat feeding, impaired glucose tolerance is associated with impaired insulin secretion ( fig.5b and h) . future studies will need to assess further the effects of highfat diet feeding on beta cell function on a larger cohort, as exploration were suspended during the pandemic events of covid-19. a striking finding in the present study is that tcf7l2 is required in adipose tissue for normal incretin production and insulin secretion: we reveal that decreased tcf7l2 expression in mature adipocytes leads to lowered circulating levels of glp-1 and gip ( fig.4a and b) . this suggests that a compensatory effect is unmasked in atcf7l2ko mice to stimulate insulin secretion in pancreatic beta cells when the incretin effect is compromised. one possible explanation to reconcile our findings on in vivo and ex vivo glucose-stimulated insulin secretion is that elevated fatty levels compensate in part for the lowered levels of circulating incretins, acting to amplify insulin release through the action of fatty acid receptors. nefa and specifically long-chain fatty acids potentiate glucose-stimulated insulin secretion [39, 40] . moreover, a direct insulinotropic action of fabp4, a cytosolic lipid chaperone expressed and secreted by white and brown adipocytes may act directly on pancreatic beta cells as demonstrated in previous studies showing that recombinant fabp4 administration enhanced glucose-stimulated insulin secretion in vitro and in vivo [41, 42] . in a small type 2 diabetes cohort, increased serum fabp4 was correlated to enhanced insulin release [43] . taking these findings together, lowered circulating incretins may have provoked impaired glucose tolerance with no apparent change in beta cell function to release insulin in vivo-compensated by stimulation of glucose-stimulated insulin secretion by higher circulating fabp4 and nefa-in atcf7l2ko mice. nevertheless, there is a need to further investigate the mechanisms that may link impaired glucose tolerance with normal insulin secretion. these might include mechanisms such as reduced insulinindependent glucose disposal, or insulin resistance-induced altered glut2 trafficking in enterocytes [44] . by what mechanisms might depletion of tcf7l2 from adipocytes lead to a decrease in the circulating levels of glp-1 and gip? our data suggest that decreased incretin levels are unlikely to be due to an increase in the rate of degradation of these hormones in the bloodstream, as no change was found in circulating dpp4 in atcf7l2ko mice (fig.4c) . we observed elevated circulating plasma fatty acids and fabp4 levels ( fig.4d and e) , reflecting altered adipocyte metabolism in the absence of tcf7l2. wnt and tcf7l2 are regulators of lipid metabolism in hepatocytes [35] , consistent with elevated plasma triglycerides associated with tcf7l2 risk variant rs7903146 [45] . moreover, the genetic variant is localized near the regulatory region for acyl-coa synthetase long chain 5 (acsl5) which activates fatty acids to generate long chain fatty acyl coa [45] . consistent with our model, martchenko and colleagues [46] have recently reported fatty acid-induced lowering of circadian release of glp-1 from l-cells as a result of decreased bmal1 expression. similarly, filipello et al [47] reported decreased insulin-dependent glp-1 secretion from l-cell-derived glutag cells, and increased glucagon release, upon fatty acid treatment. similar findings on glp-1 secretion were reported by others [48, 49] , whist long chain saturated (palmitate) but not unsaturated (oleate) fatty acids lead to l-cell apoptosis [50] . on the other hand, activation of free fatty acid receptors with ffar1/gpr40 agonist tak-875 [51] or with short-chain fatty acids (ffar2/gpr43) [52] acutely increased glp-1 secretion from l-cells, indicating a balance between shorter term, and more chronic "lipotoxic" effects, is likely to govern overall glp-1 production, with the latter predominating after tcf7l2 deletion in adipocytes. to explore further the direct role of tcf7l2 in lipid metabolism, future studies will be necessary to assess lipolysis and insulin action in adipocyte lacking tcf7l2. in this study, high fat diet feeding altered glucose tolerance and insulin secretion. some discrepancies emerge from our report and the previous studies using the same genetic model. when examining the effects of conditional deletion tcf7l2 in mature adipocytes, chen et al. [29] found impairments in glucose tolerance after intraperitoneal injection of glucose in 3-month-old males and females under standard diet associated with hepatic insulin resistance. geoghegan et al. [24] also generated a conditional knockout of tcf7l2 in the adipocyte, reporting that knockout animals maintained on regular chow displayed no change in intraperitoneal glucose tolerance, whilst exaggerated insulin resistance and impaired glucose tolerance were apparent after high fat feeding [24] . the authors demonstrated a role for tcf7l2 in regulating lipid metabolism, finding a reduction in lipid accumulation and lipolysis during high fat feeding. we note that slightly different genetic strategies were used to create the mouse models in each case. thus, both our own and the earlier studies used a similar same loxp strategy with a cre recombinase under the control of the adiponectin promoter, but we have deleted exon 1, whereas chen et al. targeted exon 11 and geoghegan et al. targeted exon 5 [24, 29] . the tcf7l2 gene consists of 17 exons [53] and tissue-specific splicing variants could exert tissue-dependent distinct function and impact differently on specific cell type function such as the adipocyte or the beta cell [54] . alternative splicing of tcf7l2 potentially results in transcripts lacking exons 1 and 2 predicted to encode proteins lacking the β-catenin-binding domain [22] . might changes in tcf7l2 expression in adipose tissue contribute to the effects of type 2 diabetes-associated variants? whilst inspection of data in the gtex database [55] does not reveal any genotype-driven alteration in subcutaneous or breast adipose tissue tcf7l2 expression for rs7903146, we note that other intronic variants in this gene, such as rs6585195, reveal significant expression quantitative trait loci for tcf7l2, and may conceivably influence incretin and insulin levels through the mechanisms identified here. in summary, tcf7l2 could play a post-developmental role on metabolic tissues depending on its level of expression and the age of the mice. our findings provide an unexpected insight into the action of tcf7l2 and reveal a novel mechanism through which adipocytes may impact insulin and incretin secretion. in demonstrating an action on multiple tissues, we also reveal a new level of complexity in the effects of gene action at the systems level on disease risk. such findings may highlight the importance of early interventions with incretins when tcf7l2 expression is compromised and therefore the development of novel personalized therapies. m-sn-t co-designed the study, collected, analysed, interpreted the data and drafted the manuscript. gdsx conceived and co-designed the study, collected, interpreted the data and substantially critically revised the manuscript. gar conceived the study and co-wrote the manuscript. am-s contributed to the collection of data and critically revised the manuscript for important intellectual content. il contributed for resources. all authors gave final approval of the manuscript and gave consent to publication. gar is the guarantor of this work. awards, mrc programme grants (mr/r022259/1, mr/j0003042/1, mr/l020149/1) an mrc experimental challenge grant (diva, mr/l02036x/1), mrc (mr/n00275x/1), diabetes uk (bda/11/0004210 this project has received funding from the european association for the study of diabetes, and university of birmingham to gdsx, european union's horizon 2020 research and innovation programme via the innovative medicines initiative 2 joint undertaking under grant agreement no 115881 (rhapsody) to gar. this joint undertaking receives support from the european union's horizon 2020 research and innovation programme and efpia. duality of interest gar has received grant funding from the wnt signaling pathway effector tcf7l2 and type 2 diabetes mellitus abnormal glucose tolerance and insulin secretion in pancreas-specific tcf7l2-null mice selective disruption of tcf7l2 in the pancreatic beta cell impairs secretory function and lowers beta cell mass diabetes risk gene and wnt effector tcf7l2/tcf4 controls hepatic response to perinatal and adult metabolic demand tcf7l2 modulates glucose homeostasis by regulating creb-and foxo1-dependent transcriptional pathway in the liver inhibition of adipogenesis by wnt signaling wnt10b inhibits development of white and brown adipose tissues wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms cross-talk between insulin and wnt signaling in preadipocytes: role of wnt co-receptor low density lipoprotein receptor-related protein-5 (lrp5) wnt signaling regulates mitochondrial physiology and insulin sensitivity lrp6 enhances glucose metabolism by promoting tcf7l2-dependent insulin receptor expression and igf receptor stabilization in humans variant of transcription factor 7-like 2 (tcf7l2) gene confers risk of type 2 diabetes genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes tcf7l2 polymorphisms modulate proinsulin levels and beta-cell function in a british europid population mechanisms by which common variants in the tcf7l2 gene increase risk of type 2 diabetes tcf7l2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action the t allele of rs7903146 tcf7l2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men tcf7l2 rs7903146 impairs islet function and morphology in non-diabetic individuals human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in us participants of european and african descent genotype and tissue-specific effects on alternative splicing of the transcription factor 7-like 2 gene in humans tissue-specific alternative splicing of tcf7l2 transcription factor tcf7l2 genetic study in the french population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes targeted deletion of tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism adipose tissue tcf7l2 splicing is regulated by weight loss and associates with glucose and fatty acid metabolism tcf7l2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia tcf7l2 expression is regulated by cell differentiation and overfeeding in human adipose tissue tcf7l2 and glucose metabolism: time to look beyond the pancreas the diabetes gene and wnt pathway effector tcf7l2 regulates adipocyte development and function tcf7l2 and diabetes: a tale of two tissues, and of two species transcriptional control of adipose lipid handling by irf4 isolation and culture of mouse pancreatic islets for ex vivo imaging studies with trappable or recombinant fluorescent probes the transcription factor pax6 is required for pancreatic beta cell identity, glucose-regulated atp synthesis, and ca(2+) dynamics in adult mice lipotoxicity disrupts incretinregulated human beta cell connectivity the developmental wnt signaling pathway effector beta-catenin/tcf mediates hepatic functions of the sex hormone estradiol in regulating lipid metabolism insulin treatment and high-fat diet feeding reduces the expression of three tcf genes in rodent pancreas the wnt signaling pathway effector tcf7l2 is upregulated by insulin and represses hepatic gluconeogenesis alterations in tcf7l2 expression define its role as a key regulator of glucose metabolism gpr40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo endogenous fatty acids are essential signaling factors of pancreatic beta-cells and insulin secretion identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity circulating adipocyte fatty acid-binding protein induces insulin resistance in mice in vivo serum fatty acid-binding protein 4 (fabp4) concentration is associated with insulin resistance in peripheral tissues, a clinical study insulin internalizes glut2 in the enterocytes of healthy but not insulin-resistant mice the type 2 diabetes presumed causal variant within tcf7l2 resides in an element that controls the expression of acsl5 suppression of circadian secretion of glucagon-like peptide-1 by the saturated fatty acid, palmitate chronic exposure to palmitate impairs insulin signaling in an intestinal l-cell line: a possible shift from glp-1 to glucagon production differential molecular and cellular responses of glp-1 secreting l-cells and pancreatic alpha cells to glucotoxicity and lipotoxicity glucagon-like peptide-1 production in the glutag cell line is impaired by free fatty acids via endoplasmic reticulum stress mechanistic insights into the detection of free fatty and bile acids by ileal glucagon-like peptide-1 secreting cells vascular, but not luminal, activation of ffar1 (gpr40) stimulates glp-1 secretion from isolated perfused rat small intestine short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the g-protein-coupled receptor ffar2 the human t-cell factor-4 gene splicing isoforms, wnt signal pathway, and apoptosis in renal cell carcinoma tcf7l2 splice variants have distinct effects on beta-cell turnover and function the genotype-tissue expression (gtex) project blood glucose levels during ogtt in male mice after 12 weeks of hfd (n=4 control mice, n=3 atcf7l2ko mice). (f) blood glucose levels during ipitt in male mice after 12 weeks of hfd (n=3 mice/genotype). (g) insulin plasma levels after intraperitoneal injection of glucose (2g/kg) in male mice following 12 weeks of hfd (n=4 control mice, n=3 atcf7l2ko mice). (h) insulin plasma levels after oral administration of glucose (2g/kg) in male mice following 12 weeks of hfd (n=4 control mice, n=3 atcf7l2ko mice). data were analysed by unpaired student's t-test, p*<0.05 versus control. (i) insulin secretion on isolated islets from male mice after 12 weeks of hfd during static incubation of 3 mmol/l glucose (3g), 17 mmol/l glucose (17g), a combination of 17 mmol/l glucose and 20 nmol/l glp-1 (17g+glp-1) and 30 mol/l kcl, (n=3 mice/genotype). (j) proposed mechanism: decreased tcf7l2 expression in adipocyte provoked increased circulating levels of lipids and subsequently, decreased incretins and glucose-stimulated insulin secretion (gsis) were observed in vivo the authors would like to thank dominic withers (mrc london institute of medical sciences (lms) at imperial college london) for the adipoq-cre mouse, lorraine lawrence (research histology facility at imperial college london) and stephen rothery (facility for imaging by light microscopy film at imperial college london) for technical assistance. key: cord-022505-17khcmta authors: delaney, martha a.; treuting, piper m.; rothenburger, jamie l. title: rodentia date: 2018-10-26 journal: pathology of wildlife and zoo animals doi: 10.1016/b978-0-12-805306-5.00020-1 sha: doc_id: 22505 cord_uid: 17khcmta this chapter includes diseases of animals in the order rodentia, in which there are over 2000 species representing 40% of all mammals. this incredibly diverse order includes members inhabiting every continent, either naturally or in human-made environments. while rodents have been the cause or implicated in disease transmission that has lead to human pandemics, such as the black death, and the decimation of certain animal species, like island-dwelling birds; genetically modified rodents have contributed significantly to the advancement of biomedical research and human health. there are more than 50 species of endangered rats, mice, voles, squirrels, and marmots. the recent extinction of the bramble cay melomys represents the first human-induced rodent extinction linked to climate change. rodents are the reservoir host of several human and domestic pathogens of concern listed by oie. herein, we highlight those diseases of rodents that lead to clinically important gross and microscopic lesions. the order rodentia includes 29 families, 468 genera, and over 2052 species. two separate systems exist to classify rodents (carleton and musser, 2005) . the first classification scheme by j.f. brandt (1855) is based on morphology of the jaw and skull together with masticatory muscle position and has three suborders: sciuromorpha (squirrellike); myomorpha (mouse-like); and hystricomorpha (porcupine-like). the second separates rodents into two suborders, sciurognathi and hysticognathi, based on the position of incisors and the angle of the jaw (carleton and musser, 2005) . molecular studies yield seven clades containing three phylogenetic lineages: squirrel-related (sciuriodea and gliridae); mouse-related (anomaluromorpha, castoridae, geomyoidae, and myodonta); and ctenohystrica. with diverse ecologic strategies, rodents are found naturally in a variety of habitats globally except antarctica. the natural history and biology of members of this extensive order exhibit substantial variation. nevertheless, similarities exist among rodents including dentition, anatomy, and disease susceptibility. the unifying characteristic of all rodents is their dentition, which includes two pairs of continuously growing (elondont) incisors. brachydonts have elondont incisors with brachydont molars; in hystricomorphs, all of the teeth are elondont. dentition is important when considering the diet and husbandry needs of these groups. brachydonts, which include mice, rats, hamsters, and gerbils, need high calorie diets with low amounts of fiber, whereas the hystricomorphs (porcupine-like; guinea pigs, chinchillas, agoutis) are strictly herbivores and require ample abrasive roughage. dental formulae vary but in general, rodents have four incisors, no canines, 1-2 premolars, and numerous (up to 12) molars. as most rodents are omnivorous, their digestive system typically consists of a simple stomach (monogastric) and a variably adapted intestinal tract depending on the degree of hind gut fermentation (stevens and hume, 1998) . most practice coprophagy or cecotrophy to maintain normal microflora and absorb microbially derived amino acids and vitamins (e.g., b and k). as such, herbivorous, omnivorous, insectivorous, and carnivorous rodents have different gastric and large intestinal anatomy. some rodents lack gall bladders (e.g., rats and pocket gophers). rats and hamsters are unable to vomit due to a muscular sphincter at the esophageal-gastric junction. members of caviidae lack the enzyme l-gulonolactone oxidase, making vitamin c (ascorbic acid) a necessary dietary requirement for this group (see scurvy in section, nutritional diseases). rodents are typically small (as small as 10 g) and rotund with short legs, though the largest rodents are almost 70 kg (e.g., capybaras). rodents are nocturnal and though some species hibernate (e.g., woodchucks) but most of the species do not. there are numerous specializations among rodents including cheek pouches (food transport), extremity and claw development (e.g., burrowing, jumping, climbing, flying), sensory organ variations (e.g., vibrissae and large ears or eyes), special integument and pelage (e.g., porcupine quills and chinchilla fur), and tail adaptations (e.g., prehensile, fat storage). rodents have a strong sense of smell and a well-developed vomeronasal organ, which is important for reproduction and social behavior through the sensing of pheromones. since rodents lack sweat glands, they are susceptible to overheating. reproductive anatomy varies though most female rodents ovulate spontaneously and are polyestrous. like rabbits, chinchillas have two cervices that communicate with individual uterine horns. vaginas are imperforate prior to sexual maturing and during nonbreeding and/or postpartum intervals. placentation is discoid and hemochorial. mammary gland anatomy varies among species. the suborders 500 pathology of wildlife and zoo animals scuirognatha and stricognatha have altricial and precocial young, respectively. some male rodents have testes within a scrotum, though the testes of porcupines, agoutis, chinchillas, cavies, and capybaras are located within the inguinal canal, which remains open in most male rodents. male rodents also have well developed accessory sex glands and an os penis. prairie dogs have perianal sacs similar to canids and felids, which are important for sexual communication. male beavers have persistent paramesonephric ducts that resemble a uterus and are referred to as masculine uterus (doboszynska and zurowski, 1981; meier et al., 1998) . south american rodents including guinea pigs and related species have unique pulmonary anatomy as do burrow-dwelling, subterranean mole-rats that live in low oxygen tension environments, for example, large and dilated, primitive bronchi and bronchioles (ilgun et al., 2014; widmer et al., 1997) . lung morphology of 40 different rodent species representing 11 families is well described (wallau et al., 2000) . common microscopic findings in rodents that may be misinterpreted as lesions include: multinucleated, karyomegalic, and cytomegalic hepatocytes are common in several rodent species and can increase with age ( fig. 20 .1); hepatocellular intranuclear cytoplasmic invaginations (pseudoinclusions) (fig. 20 .1); eosinophilic cytoplasmic spherical inclusions in renal tubular epithelial cells and hepatocytes seen predominantly male mice, rats, and hamsters; splenic extramedullary hematopoiesis, which is very common in healthy rodents of all ages (fig. 20 .2); hemosiderin, lipofuscin, ceroid, and melanin (in dark or black coated animals) are commonly detected in various tissues, such as spleen, liver, kidney, and adrenal glands; cardiac muscle in the tunica of pulmonary veins in the lung is a normal finding in mice; male rodents may have refluxed seminal coagula in the urinary bladder and urethra that is thought to occur peri mortem; and adrenal x-zone vacuolation in female mice. furthermore, there are evident sexual dimorphisms of some organs and glands, such as the cuboidal parietal epithelium of the glomeruli in male rodents. hematological reference ranges have been established for some common domestic, zoo-housed, and ubiquitous free-ranging species. in general, the lifespan of rodent erythrocytes is shorter than other mammals, thus, higher levels of circulating reticulocytes (1%-6%), seen as polychromasia and anisocytosis, is considered normal. howell-jolly bodies may also be present. in all age groups, lymphocytes are more numerous than neutrophils. in fact, lymphocytes are the predominant white blood cells in guinea pigs (45%-80%). in addition, guinea pigs and capybaras have kurloff cells (fig. 20. 3), which are lymphocytes containing a single, large intracytoplasmic mucopolysaccharide inclusion body, known as a kurloff body (jara et al., 2005) . though the actual function of these cells is unknown, they are presumed to be natural killer cells. the number of kurloff cells in females fluctuate with the reproductive cycle stage, thus they are considered to be estrogen-dependent. pregnant females may have 2%-5% kurloff cells in circulation while males typically have fewer. guinea pigs have heterophils similar to rabbits. rats, mice, and hamsters commonly have neutrophils with ring-form nuclei. chinchillas and porcupines have welldefined and segmented neutrophil nuclei. band neutrophils may be a normal finding in some species including new world porcupines, coypu, and agoutis. serum biochemical parameters have been compiled for some rodent species (kurtz et al., 2017; . of note is that serum levels of alanine aminotransferase (alt) are not sensitive biomarkers of liver health in guinea pigs and figure 20.1 normal liver in an aged mouse. common findings inlcude anisocytosis, anisokaryosis, and eosinophilic intranuclear pseudoinclusions of invaginated cytoplasm. within the red pulp are hematopoietic elements including erythroid and myeloid lineages. note the large multinucleated megakaryocytes, which are readily visible at this magnification. some other rodents as they normally have low hepatic levels of this enzyme. in contrast, gamma glutamyl transferase is present in the liver of all rodents and can be evaluated to determine the hepatic injury or disease. hamsters and other desert species may have high levels of serum calcium. rodents like mice and rats, and specifically those evolved in arid regions, have a profound ability to concentrate their urine, thus it is often turbid and contain calcium crystals. the following list of diseases of rodents is not exhaustive but instead highlights the more common findings in species of which there is published literature or knowledge. a plethora of information exists regarding the anatomy, physiology, and diseases of rodents used as animal models in biomedical research (i.e., laboratory animals) and is a valuable resource when examining lesser-studied rodent species using a comparative approach greaves, 2011; suckow et al., 2012; treuting and dintzis, 2017) . as many rodents are important prey species, diseased or dead rodents are exceedingly difficult to detect in nature using the passive surveillance techniques of traditional wildlife disease monitoring. thus, less is known about the diseases and pathology of free-ranging rodents as compared to larger and charismatic mammals. one of the most well described nutritional diseases in rodents is hypovitaminosis c or scurvy. guinea pigs and a number of other species including capybaras and humans, lack the enzyme l-gulonolactone oxidase which is required for l-ascorbic acid (vitamin c) production therefore, these species require dietary vitamin c (cueto et al., 2000) . vitamin c is necessary for the formation of collagen via hydroxylation of proline/lysine for cross linking of fibrillar collagen. hypovitaminosis c results in decreased collagen fibril cross linking, leading to the increased fragility of blood vessels, cartilage, and osteoid. in affected individuals, gross and histologic lesions are characteristic and include capillary hemorrhage and lack of bone deposition and remodeling as a result of poorly formed and weak collagen. other gross lesions include evidence of anemia (e.g., pallor, reactive bone marrow), periarticular hemorrhage, and swollen joints, specifically at the costochondral junctions (scorbutic lattice). characteristic oral lesions include gingival swelling, erythema, hemorrhage, erosion, ulceration, and tooth loss. histological examination is necessary to confirm and define bone lesions, which include: dilation of metaphyseal blood vessels, irregular columnization and hypertrophy of physeal cartilage, calcification of metaphyseal cartilage with reduced or absent osteoid, microfractures with surrounding and subperiosteal hemorrhage, medullary fibrosis, and decreased osteoclastic activity and remodeling. tooth loss may result from a combination of abnormal odontoblasts, dentin resorption, pulp fibrosis, and a lack of/ abnormal alveolar bone remodeling. like lagomorphs, some hindgut-fermenting rodents are susceptible to gut stasis and related diseases if they are not able to obtain enough fiber from the diet. obesity can be common in rodent species if fed a high caloric diet and can predispose to diabetes mellitus, cardiac disease, pregnancy toxemia, and hepatic lipidosis in females. dystrophic mineralization occurs in guinea pigs, hamsters, and free-ranging rats (rothenburger et al., 2015a) . mineralization most often affects the myocardium but can also occur in other tissues, such as the diaphragm, tongue, liver, kidney, lungs, cornea, and aorta (see section congenital/ genetic). though the pathogenesis is not fully elucidated, mitochondria appear to be preferentially mineralized based on ultrastructural studies. gross lesions may include cardiomegaly with chalky to gritty white material and streaking within the myocardium of the atria and ventricles. histologically, affected cardiac myocytes are degenerative and/ or necrotic with rupture of the sarcolemma. damaged myocytes will have variable and progressive mineralization until the entire myofiber is densely mineralized. variably mature fibrosis surrounds individual and clusters of dead and mineralized myocytes. satellite cells are frequently hypertrophic. pregnancy toxemia occurs in overweight, pregnant, and lactating female guinea pigs and hamsters. there are two forms in guinea pigs, a fasting type that results from decreased carbohydrate intake and subsequent mobilization of fat stores and a circulatory type that occurs when the gravid uterus compresses the aorta and causes reduced blood flow to abdominal organs. characteristic gross and histologic lesions include hepatic lipidosis and fat deposition in renal tubular epithelial cells. similarly, hepatic lipidosis and associated metabolic effects occasionally affect overweight nongravid sows and boars. urolithiasis is common in guinea pigs, rats, and mice due to high urine ph and calcium concentrations. obstructive urolithiasis has also been reported in captive male agoutis resulting in bilateral hydronephrosis, urinary bladder rupture, and peritonitis (batista et al., 2010) . a number of other endocrine diseases have rarely been documented in various rodent species. they have typically been associated with hormone-producing neoplasms (adrenal, islet, thyroid, parathyroid, and pituitary tumors). fluorosis is well studied in rats as they are used as models in toxicology studies. guinea pigs and rabbits are also susceptible and fluorosis has occurred in free-ranging cotton rats in sites contaminated by petrochemical waste (rafferty et al., 2000) . pathognomonic lesions occur in teeth and bones. periosteal hyperostosis occurs first along the medial surface of the metatarsals, then progresses to affect the mandible, metacarpals, and ribs though all bones can be affected in severe, chronic disease. bones are brittle and chalkywhite. pathological fractures are common but joints are typically spared. although characteristic, enamel hypoplasia only occurs when fluorosis is present during tooth development. tooth lesions include dull, dry, and chalky hypomineralized or hypoplastic enamel with pitting, grooves, and discoloration (due to oxidation); excessive attrition affects the incisors first. irregular wear, malocclusion, and fractures may be present. histologically, ameloblasts are small while osteoblasts are vacuolated and disorganized. there is abundant globular dentin and hypomineralization of the outer enamel layer. a differential for enamel hypoplasia in young syrian hamsters is hamster parvovirus (hapv); concurrent testicular hypoplasia, and cerebral malacia is present with this viral infection. cholecalciferol (vitamin d) is used as a rodenticide. the deliberate poisoning of free-ranging rats and mice results in inadvertent toxicity of nontarget animals including other rodents, such as squirrels or carnivorous predators that consume affected carcasses. multisystemic mineralization occurs prior to death in affected individuals. unlike other rodents, naked mole-rats, beavers, and woodchucks do not require dietary vitamin d and toxicity can develop if they are fed rodent chow or diets supplemented with vitamin d. lesions consistent with calcinosis cutis and circumscripta can develop in naked mole-rats fed such diets. soft tis-sue calcification is not limited to pressure points and can be found throughout the body in severe cases. resolution occurs with correction of the diet (delaney et al., 2013) . anticoagulant rodenticides including warfarin and its derivatives are frequently used to control free-ranging mice and rat populations. these compounds antagonize vitamin k and thus inhibit production of vitamin k-dependent clotting factors (i, ii, vii, ix, x). gross lesions include multisystemic hemorrhage, particularly subcutaneous and periarticular hematomas. "bait," some of which are brightly colored (e.g., teal-green), may be present within the intestines. inadvertent consumption by nontarget wildlife may have fatal consequences. hindgut fermenting rodents are susceptible to similar antibiotic-related toxicities as rabbits (see chapter 19). nephrotoxicosis can be the result of exposure to numerous agents and has been extensively described in laboratory animals. for example, swainsonine toxicity occurs following the ingestion of plants from the genus swainsona and results in acquired alpha-mannosidosis in rats. histologically, renal tubular epithelial cells are severely and diffusely vacuolated. dystrophic mineralization, also known as dystrophic cardiac calcinosis is considered as a genetic disease in inbred mouse strains, particularly in aged individuals (eaton et al., 1978) . cardiac mineralization is detected grossly as pinpoint foci to larger irregular crusts composed of white, gritty material within and overlying the epicardium. histologic lesions vary depending on severity and chronicity with degeneration and necrosis of individual myocytes to extensive regions of myocyte loss and replacement by deeply basophilic granular material. in severe cases, mineralization extends into the myocardium resulting in scar formation and can also be seen in the kidneys and lungs. the prevalence of this disease in wild mice from which these strains originated is unknown. diabetes mellitus (dm) in chinese hamsters is a heritable, autosomal recessive disease (green et al., 1963) . symptomology and lesions are similar to those found in humans and include hydropic degeneration and degranulation of pancreatic islet î²-cells with secondary vascular lesions, such as arteriosclerosis and glomerulosclerosis. in addition, affected hamsters are predisposed to pancreatic adenocarcinomas. serum levels of î±-2 globulins are a useful indicator of risk for diabetes mellitus development in these populations. polycystic kidney disease has been diagnosed in captive populations of brazilian agoutis (mã¼ller et al., 2009) . most affected individuals have no clinical signs and are potentially related genetically. grossly, affected agoutis have a range of bilateral renal changes including atrophy, roughened granular cortical surfaces, and multiple cysts. histologically, there is cystic dilatation of renal tubules and bowman's capsules with mesangial and capsular thickening accompanied by mononuclear interstitial nephritis and fibrosis. many degenerative and age-related diseases are described in rodents used in toxicology studies pettan-brewer and treuting, 2011) . a significant disease confounding these studies is chronic progressive nephropathy, which is best described in rats though mice, naked mole-rats, and australian rodents, particularly the sticknest rat, are also affected (delaney et al., 2016a) . the exact pathogenesis is unknown; however genetic factors may play a role. grossly, kidneys are bilaterally pale and either enlarged or shrunken with numerous pinpoint to large, 1 mm cortical microcysts creating a nodular surface. histologically, renal tubules are markedly ectatic and tortuous and many contain brightly eosinophilic fluid (proteinosis) ( fig. 20.4 ). tubules have a range of degeneration, necrosis, and regeneration with occasional tubular hyperplasia and adenoma formation (predominantly in rats). glomeruli are variably affected by membranous and/or proliferative changes with thickened basement membranes, sclerosis, and obsolescence. synechiae, dilated bowman's capsules, and hypertrophied parietal epithelium are common. the interstitium is expanded by lymphoplasmacytic infiltrates with pigment-laden macrophages, mild hemorrhage, and edema. there is often substantial interstitial fibrosis and in severe cases, infarction. diagnosis is based on histologic evaluation though in some species, clinical pathology may be preferentially used to determine renal function. cardiomyopathy is common in aged mice, rats and hamsters; it is particularly common in syrian hamsters and is reported in woodchucks (chanut et al., 2013; rothenburger et al., 2015a; roth and king, 1986) . lesion severity varies though it appears to increase with age and is more common in males. though considered strain and thus possibly genetically related in laboratory rats, free-ranging rats develop similar disease (rothenburger et al., 2015a) . grossly, there may be cardiomegaly but macroscopic changes are not always apparent. histologically, myocardial lesions consist of multifocal and perivascular lymphoplasmacytic infiltrates accompanied by fibrosis, myocyte degeneration, and drop out ( fig. 20 .5a,b). trichrome, movat pentachrome, or other stains that highlight the fibrosis are useful to evaluate severity and chronicity. syrian hamsters develop cardiomyopathy associated spontaneous atrial thrombosis and subsequent coagulopathy that is often fatal (fig. 20.6 ). females appear to be affected earlier in the life than males. like other species, rodents are susceptible to skeletal degeneration and related diseases. guinea pigs, specifically the duncan-hartley breed and syrian hamsters, frequently develop degenerative joint disease. gross lesions include thickened joint capsules, variable osteophyte formation, roughened cartilage surfaces, eburnation, joint effusion, and synovial proliferation. depending on which joints are affected and chronicity, crepitus may be present when joints are manipulated. microscopic examination of joints reveals degeneration, necrosis, and ulceration of the articular cartilage with proliferation and fibrosis of the synovium and joint capsule, periarticular and periosteal bone formation, and remodeling. there may also be variable inflammation and hemorrhage within joint spaces. amyloidosis is typically seen in aged animals. amyloid is an extracellular accumulation of insoluble protein. excessive amyloid deposits can lead to tissue atrophy and dysfunction. amyloidosis is most common in myomorphs (mice, rats, hamsters, gerbils) and appears in the kidneys, spleen, adrenals, and liver as well as the gastrointestinal lamina propria (mouse) (fig. 20.7 ). there is a higher prevalence in females. of note is the eosinophilic substance within the nasal planum of aged mice that was once thought to be amyloid, through histochemical and ultrastructural studies, has instead been shown to consist of collagen and complex carbohydrates produced by the nasal gland epithelial cells (doi et al., 2007) . hemosiderosis is the accumulation of iron within various tissues, most commonly the liver. it is described in numerous species including primates, birds, rhinoceros, hyraces, and rodents. in one zoological institution, hemosiderosis was present in approximately 65% of adult naked mole rats (delaney et al., 2013) . grossly, livers appear bronze. iron accumulation appears histologically as zonal to diffuse hepatocellular accumulation of brown granular to figure 20.4 chronic progressive nephropathy in a naked molerat. renal tubules are variably ectatic, atrophied, degenerate, necrotic, and replaced by collagenous fibrous tissue. within the interstitium are accumulations of mononuclear cells (primarily lymphocytes and fewer macrophages). there is also sclerosis of glomeruli and periglomerular fibrosis. globular pigment. pigment is most intense in the periportal hepatocytes. the pigment stains positively with prussian blue and is not refractile with polarized light. aged mice can develop intrapulpal denticles, which are dysplastic tooth-like growths arising in the pulp of incisors. these may result in abnormal wear and or breakage of the incisors contributing to periodontitis and decreased ability to effectively gnaw (pettan-brewer and treuting, 2011). despite their protective quills, porcupines are particularly susceptible to cutaneous trauma and tears due to an exquisitely fragile integument. secondary infections resulting in pyoderma and persistent ulceration may occur. stress dermatosis (or dermatitis) is a condition of several south american rodents including, the agouti, acouchis, and capybaras. this syndrome is seen in captive and free-ranging individuals in densely populated groups. it presents as alopecic skin lesions and lacerations along the lumbosacral spine. stress is thought to increase skin fragility and overcrowding with intraspecific aggression contributes to lesion development. sun exposure, pruritus, and self-mutilation result in large patches of alopecia with erythema and excoriated skin with loss of the long hairs along the dorsum and tail. microscopic lesions correlate to severity and chronicity and include variable epidermal degeneration, necrosis, erosion/ulceration, and associated dermatitis with hemorrhage and edema. diagnosis is based on clinical history, demonstrated absence of a parasitic etiology in skin scrapings and histopathology. malocclusion is common especially in hysticomorphs, though it is also seen in brachydonts. it is a significant disease in captivity and may be related to genetics, nutrition and diet, and husbandry practices (losco, 1995) . ovarian cysts are common in rodents. cystic rete ovarii are prevalent in female guinea pigs (veiga-parga et al., 2016) and can be distinguished from other ovarian cysts as they arise from the rete and compress adjacent ovarian tissue ( fig. 20.8 ). other ovarian cystic structures reported in female rodents include: bursal cysts, epithelial cysts, follicular cysts, luteal cysts, and paraovarian cysts . the hemochorial placentation in rodents predisposes them to trophoblast emboli. this incidental lesion is best described in chinchillas and is not associated with clinical ramifications or gross lesions. histologically, intravascular trophoblasts are present in the lung, uterus, spleen, liver, and other sites, such as the adrenal glands with no associated inflammation. trophoblasts are large (>100 âµm) with abundant amphophilic granular cytoplasm and large nuclei with prominent nucleoli. many neoplasms of inbred mice and rats appear to be strain related. nevertheless, certain neoplasms occur more frequently among free-ranging and domesticated outbred rodents than in other mammalian orders. several of them are described below. a list of other common neoplasms in rodent species is listed in the supplemental materials (table e1) . naked mole-rats are a popular zoo species and are heralded as animal models for cancer and aging due to their extreme longevity and purported cancer resistance. rare cases of neoplasia have been reported in naked mole-rats and in the related damaraland mole-rat, which is also longlived and appears to be relatively resistant to cancer and agerelated diseases (delaney et al., 2016b; taylor et al., 2016,) . other subterranean rodents used as animal models for carcinogenesis research include some members of spalacidae (mole-rats, blind mole-rats, zokors, and bamboo rats). there are currently no reported spontaneous tumors in this group; however, subcutaneous tumors (fibromas and fibrosarcomas) may be induced with application of carcinogenic compounds. odontoma, or more aptly named odontogenic dysplasia, is described in several rodent species (rats, mice, guinea pig, prairie dogs, degus, chinchilla, chipmunk, squirrels; . most odontomas are not true neoplasms and instead represent dysplastic changes resulting from chronic inflammation or trauma and associated regional tissue response. as there is no demonstrated metastatic potential or criteria for malignancy, these lesions are increasingly identified as hamartomas versus neoplasms (and also referred to as pseudo-odontomas). nevertheless, these toothy masses are regionally destructive and almost exclusively affect the incisors. grossly, odontogenic dysplasia presents as nodular swellings around the maxillary or mandibular incisors. microscopically, these lesions are composed of disorganized and dysplastic proliferations of odontogenic epithelium, enamel matrix, and mineralized enamel, dentin, pulp, and cementum. in rodents, odontomas have been described as complex because they contain fully differentiated tooth elements but do not form the tooth-like structures grossly present in compound odontomas seen in other species (e.g., horse). histologically, rodent odontomas are composed of welldifferentiated odontogenic epithelium among an enamel organ with dental pulp mesenchyme and a variably mineralized enamel matrix. several important infectious and zoonotic diseases of rodents described are later with a focus on those that cause significant lesions in rodent species. additional pathogens, including zoonotic pathogens that occur in rodent species are listed in the supplemental materials (table e2 ). several references exist pertaining to rodent reservoirs of emerging and reemerging zoonotic pathogens ). poxviral diseases in rodents are caused by members of orthopoxviridae, which includes mousepox and cowpox (oie listed reportable zoonotic diseases). several species of rodents serve as the reservoir for cowpox virus, which results in cutaneous lesions in humans. in laboratory mice, mousepox, more commonly known as ectromelia, is an important disease. this infection can be acutely fatal with minimal lesions. in the chronic form, gross lesions include crusting lesions of face, legs, and tail, conjunctivitis, an enlarged, swollen and friable liver and spleen, and in cases of recovery, splenic fibrosis. necrosis of the kidney, thymus, and lymph nodes may also be grossly evident. the small intestine, urinary bladder, and vagina can have mucosal erosions and hemorrhage. histologically, skin and mucosal lesions include epithelial ballooning degeneration, hyperplasia, and erosions with characteristic intraepithelial, intracytoplasmic inclusion bodies. within the parenchymal organs, splenic and hepatocellular necrosis is typically coagulative and multifocal to coalescing. diagnosis is based on characteristic lesions with viral inclusions. electron microscopy, pcr, and virus isolation are useful for confirmation of the viral strain. in 2003, an outbreak of monkeypox (orthopoxviridae), a zoonotic virus, occurred in prairie dogs sold as companion animals in the united states (gaurner et al., 2004) . fatal infections in infected prairie dogs were characterized by necrotizing bronchopneumonia, conjunctivitis, and glossal ulcers. viruses and viral antigens were detected in multiple tissues and cell types via immunohistochemical staining, pcr, and electron microscopy. infected humans developed fever and vascular rashes. forty seven confirmed and probable cases of monkeypox were reported from six states. the prairie dogs contracted the virus following exposure to infected african rodents. other rodents that also developed disease and died included: rope squirrels, tree squirrels, gambian giant rats, brush-tailed porcupine, dormice, and striped mice. fibromas and fibromatosis of gray squirrels are potentially fatal conditions caused by squirrel fibroma virus (leporipoxviridae). disease is mainly reported in the eastern north america (terrell et al., 2002) but also occurs in red squirrels and has been reported in a fox squirrel (wilcoxen et al., 2015) . transmission is likely through biting arthropods (fleas, ticks, and mosquitoes). gross and histologic lesions are similar to shope fibromas in rabbits (both are leporipoxviruses). multifocal to coalescing tan, firm nodules may cover all parts of the body and begin as alopecic nodules with progression to plaque-like to pedunculated masses ( fig. 20.9a ). systemic disease manifests as renomegaly and multiple pulmonary nodules . histologically, the skin nodules exhibit marked epidermal hyperplasia with ballooning degeneration of keratinocytes, spongiosis, and intracytoplasmic eosinophilic viral inclusions (fig. 20.9b,c) . pulmonary nodules correlate histologically to adenomatous hyperplasia with similar viral inclusions. other microscopic lesions may include atypical mesencyhmal proliferation in the liver and seminal vesicles, and renal tubular epithelial hyperplasia with viral inclusions. diagnosis is based on characteristic lesions and detection of virus by pcr or isolation. parapoxvirus is an important cause of disease in red squirrels in the united kingdom and ireland where it is a suspected factor in severe population declines tompkins et al., 2002) . the causative agent is referred to as red squirrel parapoxvirus. grey squirrels are the likely maintenance hosts since a large percentage of healthy gray squirrels are positive for the virus and their range overlaps with that of red squirrels. lesions in red squirrels include exudative dermatitis with crusting that is similar to other poxviral diseases. viral inclusions can be detected histologically within the cytoplasm of infected cells. electron microscopy and pcr are used to detect the virus. woodchuck hepatitis virus (whv; hepadnaviridae) is a disease in captive and free-ranging animals . although not zoonotic, this disease is a valuable animal model for viral hepatitis and hepatocarcinogenicity associated with hepatitis b in humans. it affects both sexes and is typically found in animals greater than 4 years of age. activated t cells (cd8 +) cause cellular and dna damage leading to persistent hepatitis. simultaneously, viral dna integrates into the host genome at loci containing oncogenes, creating the potential for carcinogenic transformation. hepatocellular carcinomas are reported in 100% of experimentally infected woodchucks. grossly, most carcinomas are solitary and involve one hepatic lobe. histologically, neoplastic masses have differing growth patterns: trabecular, adenoid, or solid with and without cystic spaces, hemorrhage, and necrosis. an interesting feature of these tumors is the presence of atypical, bizarre, and giant neoplastic cells. adenomas may be present and are considered a precursor to carcinomas. mitotic index and cellular morphology are used to classify tumors as adenomas versus carcinomas. the remaining hepatic parenchyma often contains acute and/or chronic hepatitis with neutrophilic to mononuclear inflammation, variable hepatocellular degeneration, necrosis, fibrosis, and biliary changes. electron microscopic identification of the virus is definitive. beechey ground squirrels have a similar virus with variable hepatic lesions (cullen and marion, 1996) . hamster polyomavirus (hapyv), a papovavirus, causes cutaneous trichoepitheliomas in syrian hamsters . the virus is transmitted via urine and is highly contagious, with reported 50% morbidity in affected breeding colonies. early lesions consist of wartlike growths and alopecic nodules of the face and perineum with progression to severe, multifocal to coalescing nodules throughout the body. histologically, these characteristic skin tumors contain multiple islands of basilar to variably differentiated follicular epithelium and abrupt central keratinization with faded anuclear keratinocytes (ghost cells). rudimentary hairs may be present and follicular rupture may be associated with inflammation. other polyomaviruses-associated neoplasms include other cutaneous tumors, lymphomas and salivary gland tumors. in virally induced lymphomas, affected tissues are effaced by diffuse sheets of neoplastic lymphocytes among scant stroma. viral inclusions are not present. in a case of polyomavirus-induced, multicentric lymphoma in an 8-week old syrian hamster, the virus was detected in tumor cells, renal tubular epithelial cells, and enterocytes via in situ pcr indicating some degree of tissue tropism . diagnosis is based on clinical history, gross and histologic lesions, and detection of the virus via pcr and/or electron microscopy. mouse hepatitis caused by mhv (coronaviridae) is enzootic in some colonies of inbred laboratory mice . mouse hepatitis may also occur in nonlaboratory strains of mice in zoo settings. mhv causes polytropic and enterotropic disease syndromes, both of which occur following highly contagious viral infection by the oronasal route. grossly, there is hepatomegaly, splenomegaly, lymphadenomegaly, and lymphadenopathy with jaundice and ascites. there may be gross evidence of intestinal (ileal and cecal) disease with thickened and necrotic mucosa. within the liver, spleen, and lymph nodes, there are multiple coalescing and random white necrotic foci. histologically, polytropic disease includes necrotizing hepatitis with syncytial cells within necrotic foci, and demyelination in cns in immunodeficient mice. the enterotropic disease lesions are age-dependent and may include villous attenuation and syncytial cell formation with eosinophilic intracytoplasmic inclusion bodies in enterocytes, mesenteric lymph nodes, and endothelial cells; granulomatous serositis may also be present. diagnosis is based on histologic features and immunohistochemical demonstration of viral antigens within lesions. virus isolation, pcr, and serology are used to confirm infection and exposure, respectively. sendai virus infection (parainfluenza-1; paramyxoviridae) is common in wild and pet rodents and is actively excluded from laboratory populations of mice, rats, and gerbils (easterbrook et al., 2008) . disease manifestations occur quickly following the aerosol inhalation, direct contact, or in utero exposure. the virus targets respiratory epithelium and type ii pneumocytes, which may impair ciliary activity and predispose affected individuals to secondary mycoplasma pulmonis and other bacterial infections. gross lesions include dark purple discoloration, atelectasis, and consolidation of the cranioventral lung lobes and diffuse pulmonary edema. splenomegaly and lymphadenomegaly are common and if infection occurs in a gravid female, fetal death may occur. histologically, lesions include necrotizing rhinitis, laryngotracheitis, bronchitis, and bronchointerstitial pneumonia. in immunocompromised animals (e.g., athymic and scid mice), intracytoplasmic and intranuclear inclusion bodies may be present. diagnosis is based on supportive clinical history, histologic findings, and pcr detection of the virus. sialodacryoadenitis is a disease specific to rats and is caused by sialodacryoadenitis virus (sdav; coronaviridae). the virus may be enzootic in some research colonies and in pet and free-ranging rats (easterbrook et al., 2008) . virus is shed in nasal secretions and/or saliva. sdav infects and replicates in the respiratory tract and spreads to salivary and lacrimal glands resulting in secondary lesions of the nasopharynx, respiratory tract, and eyes. grossly, the parotid and submandibular salivary glands, harderian glands, exorbital glands, and cervical lymph nodes are enlarged, pale, and edematous. the harderian glands may exhibit brown pigmentation, which correlates to accumulations of porphyrin within acini. histologically, there is acute necrotizing adenitis. in chronic cases, there is fibrosis and extensive squamous metaplasia of glandular tissue. there may be rhinitis, tracheitis, bronchitis, and bronchiolitis in severe and chronic cases. histologic lesions are characteristic and supportive of the diagnosis. within this section are several zoonotic and notable nonzoonotic bacteria that infect rodents. several others that are notable but not associated with disease in their rodent host are listed in the supplemental materials (table e2 ). plague is an oie-listed and who-reportable zoonotic disease that is important to consider when working with rodents. fleas spread the causative agent, yersinia pestis, between hosts. cats and other rodent-eating predators can also contract infection through ingestion and rarely via inhalation. historically, plague has been implicated in the deaths of millions of humans, most notably in 14th century europe during the black death. there are two main host types: enzootic reservoirs (voles and deer mice) and epizootic amplifiers (prairie dogs, rats, and squirrels). with close to 100% mortality, plague outbreaks in prairie dog colonies are a devastating and significant threat not only this species but to endangered black-footed ferrets, who are susceptible to disease because prairie dogs are their primary food source (cully et al., 2010) . there are three disease forms: bubonic (lymphadenomegaly with abscessation); pneumonic ( necrotizing pneumonia with fibrinous pleuritis); and septicemic (multifocal necrosis of liver, lung, spleen, kidney, eye, brain). gross lesions include multifocal pulmonary hemorrhage (fig. 20.10) , hemorrhagic lymph nodes, erythema of axillary and inguinal skin, splenomegaly and localized hemorrhage and necrosis in the dermis and subutis (suspected site of flea bite). histologic lesions of bubonic disease include necrosuppurative lymphadenitis; in the pneumonic form, necrotizing pneumonia; and in the septicemic form, multifocal abscessation. all lesions contain gram and giemsa positive coccobacilli with characteristic bipolar morphology resembling a safety pin. bacterial culture must be completed at a certified, biosecure laboratory; identification using immunohistochemistry or immunofluorescence is a beneficial diagnostic aid. yersiniosis (pseudotuberculosis) is caused by y. pseudotuberculosis and y. entercolitica. rodents may serve as carriers of this zoonotic bacterial agent, though some species, including mice, voles, beavers, and muskrats may succumb to acutely fatal disease or develop more characteristic lesions and symptoms. gross and histologic lesions include multifocal necrotizing hepatitis and splenitis and/or fibrinonecrotizing and ulcerative enterocolitis (fig. 20.11 ). agoutis appear to be uniquely susceptible in zoo-settings (k. terio, personal communication). tularemia caused by francisella tularensis is an important zoonotic and oie listed reportable disease that is maintained by wild rodents and lagomorphs. disease occurs in many rodents including mice, beavers, and muskrats, while voles appear to be subclinical carriers and serve as a reservoir (nelson et al., 2014; rossow et al., 2014) . lesions of affected species are similar to those described in rabbits (see chapter 19). miliary to multifocal and coalescing hepatic necrosis with variable inflammation (depending on chronicity) characterize the disease (fig. 20.12) . unlike yersiniosis and similar to listeriosis, bacteria are not readily detected but can be better visualized with special stains. listeriosis is a common zoonotic bacterium in rodent species. it can cause variable, yet similar lesions as for rabbits (see chapter 19) . the systemic form is most common. during an outbreak in bushy-tailed jirds, death occurred without clinical signs (tappe et al., 1984) . salmonellosis is reported in guinea pigs, rats, and mice, though any rodent species can be infected and develop disease. salmonella enterica enteritidis or typhimurium are the most common zoonotic serovars. guinea pigs become septicemic and often die acutely. other rodents may develop gastrointestinal disease that includes diarrhea and abdominal pain prior to systemic spread. in hamsters, salmonellosis must be considered and ruled out in cases of "wet tail," which is typically associated with infection by lawsonia intracellularis. gross lesions of salmonellosis include cyanosis of mucous membranes and polyserositis with splenomegaly. hepatic, splenic, and lymph node necrosis are typical, as are multifocal necrosis and button ulcers in the colon with segmental intestinal infarction. histologic lesions correlate to gross findings and include small foci of hepatocellular necrosis containing necrotic cell debris and variable numbers of macrophages, lymphocytes, and fewer neutrophils (paratyphoid nodules) and kupffer cell hyperplasia; granulomatous hepatitis, splenitis, and lymphadenitis; and fibrinonecrotic ileotyphlocolitis. intestinal infarction can be attributed to vasculitis and thrombosis of the mesenteric or mesocolic vessels. culture of the causative agent and histologic lesions confirm the diagnosis. mycobacteriosis is a zoonotic disease that is rarely reported in rodents, though some species may serve as reservoirs. there are reports of mycobacteriosis (mycobacterium microti) in british voles and wood mice (cavanagh et al., 2002) , hamsters, and korean and richardson's ground squirrels in spain. chlamydophila caviae and less frequently c. psittaci cause disease in guinea pigs, primarily juveniles. conjunctivitis, bronchitis, and pneumonia may occur and result in debilitation and death. histologically, there is heterophilic keratoconjunctivitis and uveitis. pneumonia has a cranioventral pattern and is heterophilic. some animals may be asymptomatic. diagnosis is achieved through cytology of ocular discharge and/or pcr of affected tissues. immunohistochemistry of tissue sections is also available. bordetella bronchiseptica causes bordetellosis (epizootic pneumonia), a common respiratory disease in guinea pigs though is also reported in free-ranging squirrel populations . similar disease can occur in other rodents, particularly in the context of immunosuppression or coinfection. grossly, there is cranioventral pneumonia with multifocal to coalescing, discrete, reddish-gray consolidated regions affecting multiple lobes, and pleuritis. mucopurulent exudate may be present in the nares, nasal passages, trachea, and tympanic bullae. there is often crusting conjunctivitis. females may have metritis and pyosalpinx. histologically, lung lesions consist of necrotizing and heterophilic bronchopneumonia with obliteration of the airways. diagnosis is confirmed with bacterial culture or pcr. other predisposing pathogens (e.g., adenovirus, mycoplasma spp.) must be ruled out. ciliated associated respiratory (car) bacillus is an unclassified bacterium that colonizes the ciliated epithelium of the respiratory tract of rats, mice, rabbits, and a variety of other species. this agent acts synergistically with other respiratory pathogens including mycoplasma pulmonis, sendai virus, coronavirus, streptococcus pneumoniae, corynebacterium kutscheri, bordetella bronchiseptica, klebsiella pneumoniae, or pasteurella spp. lesions include suppurative to mucopurulent bronchopneumonia, perivascular and bronchiolar lymphoid hyperplasia, rhinitis and lymphoplasmacytic tracheitis in free-ranging, pet and laboratory rats rothenburger et al., 2015b) . coinfection of car bacillus and mycoplasmas has been reported in rats and spinifex hopping mice with pneumonia (mackie et al., 2001) . murine respiratory mycoplasmosis is caused by mycoplasma pulmonis . gross lesions include catarrhal exudate in the upper respiratory tract with cranioventral bronchopneumonia and mucopurulent exudate in airways with atelectasis. histologic lesions include peribronchial lymphoid cuffing with balt hyperplasia; neutrophilic bronchopneumonia; type ii pneumocyte hyperplasia of alveolar epithelium; and emphysema; bronchiectasis is a characteristic finding. histology alone cannot differentiate m. pulmonis and car bacillus respiratory infections (rothenburger et al., 2015b) . other lesions associated with m. pulmonis include endometritis, salpingitis, and perioophoritis. diagnosis is based on histologic features, culture or pcr detection, and elisa. pasteurellosis caused by p. multocida affects young and immunocompromised rodents, most frequently following direct transmission from the dam. strain virulence and species determine lesions, which in general, are similar to those reported in other species, including rabbits (see chapter 19) . prairie dogs develop upper respiratory disease and pneumonia, while conjunctivitis is more common in rats and mice. hamsters have variable susceptibility. cervical lymphadenitis, a disease classically described in guinea pigs, is caused by streptococcus equi subsp. zooepidemicus. infection is associated with coarse foods that cause traumatic lesions of the oral mucosa; bite wounds may serve as another route of entry. grossly, the cervical and submandibular lymph nodes are markedly enlarged and contain thick purulent yellow-white to red-gray exudate. lymph nodes in severely affected and chronic cases may rupture. histologically, affected lymph nodes are effaced by heterophilic lymphadenitis with central necrosis and peripheral fibrosis. thoracic lesions include fibrinous pleural adhesions, fibrinosuppurative bronchopneumonia, pleuritis, and pericarditis. chains of gram-positive cocci are present within lesions. diagnosis is based on gross and histologic lesions and culture of causative agent. tyzzer's disease, caused by clostridium piliforme, is a potentially fatal disease of many rodent species. it has been reported in captive gerbils, hamsters, and spinifex hopping mice (stannard et al., 2017) . infection results in a triad of gross lesions including icterus and hepatomegaly with military gray foci, congestion, and edema of the intestine, and lymphadenomegaly with edema and hemorrhage. sudden death without clinical disease or lesions is possible in peracute cases. histologically, multifocal random to coalescing hepatic necrosis is surrounded by hemorrhage, heterophils, and macrophages (fig. 20.13a ). at the necrotic margins, hepatocytes may accumulate characteristic criss-crossed bundles of faintly staining bacilli that are best visualized with silver stains (fig. 20.13b ). proliferative ileitis (wet tail) due to lawsonia intracellularis is most commonly reported in hamsters. similar to this infection in other species, there is segmental thickening of ileum with serosal nodules. histologically, there is marked crypt hyperplasia and herniation and villous elongation, hyperplasia, and fusion with variable necrosis and hemorrhage. silver stains and pcr are useful to confirm infection. a diverse array of pneumocystis spp. are carried without clinical signs by a variety of wild rodents; these organisms are thought to be highly host-specific. pneumocystis spp. are found within alveoli and alveolar macrophages and appear as small, eosinophilic round organisms with a small central body. in severe cases, organisms within alveolar spaces and alveolar macrophages can obliterate alveoli; in some cases they can be associated with interstitial pneumonia (fig. 20.14a,b) . this fungus can cause significant opportunistic infections in immunocomromised individuals. cryptococcosis (cryptococcus neoformans) can be a significant pathogen in some rodent species. for example, approximately 20% of slender-tailed cloud rats at one zoological institution died with or as a result of cryptococcal pneumonia over a 15-year period (berliner et al., 2007) . these large, arboreal rodents were likely infected by contaminated substrates and may be a highly susceptible species, similar to some species of nonhuman primates and felids. lesions included none or mild to severe, chronic granulomatous pneumonia with or without necrosis and regional lymphadenitis. disseminated disease can produce subcutaneous nodules ( cryptococcoma) and meningoencephalitis. microscopically, characteristic fungal yeasts with narrow-based budding are present in cytologic preparations and histologic sections. gms staining can enhance detection of fungal yeasts, which are 5-20 âµm diameter with a distinct, thick (5-10 âµm), nonstaining mucopolysaccharide capsule, the latter of which is best visualized using the pas reaction and mucin stains. culture can confirm infection ( fig. 20.15) adiaspiromycosis is a systemic fungal disease reported in several captive and free-ranging rodent species. it is caused by the saphrophytic fungi chrysosporium parum and c. crescens. once inhaled, these fungi cause pulmonary granulomas with fungal spherules and conidia. additional diagnostic tests may be useful, including immunodiffusion and complement fixation. these fungi are zoonotic. other systemic mycoses of rodents include infections caused by the endemic (and zoonotic) fungi blastomcyes dermatitides and histoplasma capsulatum. reported cases include juvenile mice and chinchillas. immunity to fungal pathogens appears limited in mice. dermatophytosis is a cutaneous fungal disease that can be found in any rodent species and is similar to that of other mammalian species. causative agents include trichophyton mentagrophytes, microsporum canis, m. gypseum, and epidermophyton. of note, these fungi are zoonotic and can cause skin lesions in other animals. additionally, sporothrix schneckii associated cutaneous disease is reported in several rodent species and can be zoonotic. dermatitis lesions vary from suppurative and necrotizing to granulomatous and fibrosing depending on chronicity. paspositive yeast are present within macrophages. character-istic organisms on cytologic preparations of skin scrapes prepared with potassium hydroxide support the diagnosis. capillaria hepatica (synonymn calodium hepaticum) affects a broad host range worldwide, including rodents and humans. it is a ubiquitous parasite of globally invasive norway and black rat populations . gross lesions consist of multifocal to coalescing, tortuous, white tracks in the liver parenchyma ( fig. 20.16a ). histologically, varying combinations of lymphoplasmocytic and granulomatous inflammatory infiltrates, fibrosis, and bioperculate eggs and occasionally adult parasites replace hepatic parenchyma (fig. 20.16b ). cross sections of viable or mineralized capillarid nematodes may be present. eggs are only released from the liver following carcass decomposition or ingestion by a predator/cannibalistic conspecific. therefore, diagnosis is based on the presence of the nematode and/or eggs in the liver and not fecal parasitology. many species of free-ranging rodents are susceptible to fatal visceral larval migrans associated with the raccoon nematode baylisascaris procyonis (fig. 20.17 ). significant clinical disease is often related to parasite migration in the brain, where they may be accompanied by low numbers of eosinophils, gliosis, spheroids, and rarefaction or necrosis of the neuropil. rodents, particularly squirrels are prone to notoedric mange cornish et al., 2001; . mites burrow into the stratum corneum inducing marked hypekeratosis, which results in patchy alopecia, and crusting and thickening of the skin (lichenification), which can appear yellow to gray. gross lesions are predominantly found on the ears, nose, tail, external genitalia, inguinal and perianal regions, and feet though they can cover the entire body in severe cases. peripheral lymphadenopathy may also be seen. skin scrapings and fecal floats are beneficial to best examine mite features and presence of eggs, respectively. histologically, there is marked epidermial hyperplasia with parakeratotic hyperkeratosis forming caps over tunnels containing mites with superficial, perivascular eosinophilic dermatitis ( fig. 20.18a,b) . secondary bacterial infections are common. additional notable parasites of rodents are listed in the supplemental materials (table e3) . chronic progressive nephropathy (cpn), naked mole-rat, kidney. in the kidney, there is marked ectasia of tubules and bowman's spaces forming numerous microcysts seen at low magnification. some ectatic tubules contain luminal proteinaceous material and there is multifocal tubular degeneration, necrosis, and regeneration. interstitium has areas of mixed inflammation, fibrosis and edema. glomeruli have segmental to global membranous change and multifocal sclerosis. (see fig. 20 .4). hepatic hemosiderosis is seen in sections of the liver. eslide: vm05054 20.e2 chronic progressive nephropathy (cpn), naked mole-rat, kidney. in the kidney, there is marked ectasia of tubules and bowman's spaces forming numerous microcysts seen at low magnification. some ectatic tubules contain luminal proteinaceous material and there is multifocal tubular degeneration, necrosis, and regeneration. interstitium has areas of mixed inflammation, fibrosis and edema. glomeruli have segmental to global membranous change and multifocal sclerosis. (see fig. 20 .4). hepatic hemosiderosis is seen in sections of the liver. eslide: vm05053 20.e3 chronic progressive nephropathy (cpn), naked mole-rat, kidney. there is mild to moderate ectasia of tubules and bowman's spaces forming numerous microcysts seen at low magnification. some ectatic tubules contain luminal proteinaceous material and there is multifocal tubular degeneration, necrosis, and regeneration. interstitium has areas of mixed inflammation, fibrosis and edema. glomeruli have segmental to global membranous change and multifocal sclerosis. (see fig. 20 .4). eslide: vm05057 20.e4 hepatic hemosiderosis, naked mole-rat, liver. prussian blue staining highlights bright blue granular intracytoplasmic (iron) pigments throughout the liver. the kidney has changes consistent with chronic progressive nephropathy. eslide: vm05058 20.e5 yersiniosis, beaver, liver and diaphragm. yersiniosis in the liver and diaphragm of a free-ranging north american beaver. bacterial infection causes multifocal random,necrosis throughout the hepatic parenchyma. large, central colonies of the causative agent, yersinia pseudotuberculosis are surrounded by mild neutrophilic inflammation. (see fig. 20 .11). eslide: vm04954 20.e6 tularemia, beaver, liver and spleen. tularemia in the liver and spleen of a free-ranging north american beaver. large, multifocal random areas of coagulative necrosis are present throughout the hepatic and splenic parenchyma. note the relative lack of inflammation. unlike yersiniosis, bacterial colonies are not readily detected with routine hematoxylin and eosin staining. (see fig. 20 .12). eslide: vm04952 20.e7 pneumocystis murina pneumonia, mouse, lung. multifocally, alveoli are partially to completely filled with large macrophages containing small round yeasts.(see fig. 20 .14). eslide: vm05178 20.e8 pneumocystis murina pneumonia, mouse, lung, gms. gomori methenamine silver (gms) staining highlights the intrahistiocytic yeasts within the alveoli. (see fig. 20 .14). eslide: vm05275 20.e9 pulmonary cryptococcosis, slender-tailed cloud rat, lung. the interstitium and air spaces are moderately to markedly expanded and distorted by myriad fungal yeasts that are associated with histiocytic to granulomatous inflammation. aggregates of lymphoplasmacytic inflammation are present but infrequent. (see fig. 20 .15). eslide: vm05089 20.e10 pulmonary cryptococcosis, slender-tailed cloud rat, lung. gms. intralesional yeasts are hhighlighed gray/ blue with silver staining. gms (see fig. 20 .15). eslide: vm05096 20.e11 pulmonary cryptococcosis, slender-tailed cloud rat, lung. mucicarmine. mucicarmine staining highlights the thick mucopolysaccharide capsule of the crytpococcal yeast and stains it bright pink. mucicarmine (see fig. 20 .15). eslide: vm05097 20.e12 capillaria hepatica (calodium hepaticum), norway rat, liver. capillaria hepatica in the liver of a freeranging norway rat. adult nematodes and eggs invade and efface the liver parenchyma. there are examples of viable and degenerative adults. the eggs are characteristically bioperculate with a thick shell. inflammation is lymphoplasmacytic to granulomatous and is associated with fibrosis indicating chronic infection. in some areas, there is multifocal mineralization adjacent to eggs. (see fig. 20 .16). eslide: vm04956 20.e13 baylisacaris visceral larval migrans, groundhog, brain. multifocally, multiple sections of larval nematodes with prominent lateral alae and lateral cords, a thick cuticle, and coelomyarian musculature, features consistent with larval ascarids, are present in the brain. inflammation, including eosinophils, gliosis, and spheroids and rarefaction of the neuropil due to parasite migration, are multifocal and occasionally associated with intralesional nematodes. (see fig. 20 .17). eslide: vm04961 (2012); krinke (1994) , krinke (1996) mice, rats mammary fibroadenoma rudman (2012); krinke (1994) , krinke (1996) gray squirrel mammary (mixed malignant) williams (1989) mice, rats zymbal gland adenoma/carcinoma rudman (2012); krinke (1994) , krinke (1996) mice, rats preputial/clitoral adenoma/carcinoma rudman (2012), , krinke (1994) , krinke (1996) female reproductive ovarian adenocarcinoma , krinke (1994) , krinke (1996) mice teratoma dixon (2014), mice, rats uterine decidual reaction/deciduoma dixon (2014) woodchuck, mice, rats uterine leiomyoma foley (1993) , mice, rats uterine leiomyosarcoma dixon (2014) woodchuck adenoma of the rete testis foley (1993) rat, woodchuck interstitial cells tumors foley (1993) , , creasy (2012) woodchuck sertoli cell tumors foley (1993) woodchuck seminoma foley (1993) woodchuck, mice teratoma foley (1993) , , creasy (2012) hepatobilliary foci of cellular alteration thoolen (2010) woodchuck, rat, mice hepatocellular adenoma roth (1991) , thoolen (2010) , krinke (1994) , krinke (1996) woodchuck, rat, mice hepatocellular carcinoma , thoolen (2010) , krinke (1994) , krinke (1996) hemolymphatic mice, rats histiocytic sarcoma krinke (1994) , krinke (1996) , kogan (2002) , guinea pig, rat lymphocytic leukemia yarto-jaramillo (2011), guinea pig, hamster, mice, woodchuck, rat lymphoma nagy (2002) , , yarto-jaramillo (2011), kogan (2002) , woodchuck, mice, rats myeloproliferative disease roth (1991) , kogan (2002) , (2008), , krinke (1994) , krinke (1996) ground squirrel integumentary gland adenocarcinoma carminato (2012) damaraland mole rat melanomas sura (2011) yellow cheeked vole sebacious gland adenoma williams (1989) capybara, tundra vole, arctic ground squirrel,woodchuck squamous cell carcinoma hamanno (2014) , takahisa (2014), anderson (1990) beaver, insular vole, porcupine squamous papilloma williams (1989) hamsters, red squirrels trichoepithelioma , guinea pig trichofolliculoma (2004) beaver rhabdomyoma williams (1989) red backed vole rhabdomyosarcoma williams (1989) tundra vole osteoma williams (1989) guinea pig alveologenic carcinoma yarto-jaramillo (2015) guinea pig bronchogenic carcinoma yarto-jaramillo (2015) guinea pig papillary adenoma yarto-jaramillo (2015) gray squirrels pulmonary adenomatosis red squirrels, mice pulmonary carcinoma , , renne mice, rats pulomnary adenoma , renne (2009) red and gray squirrels, mice, rats renal adenoma , williams (1989) , frazier spontaneous neoplastic and hyperplastic skin lesions of the woodchuck cutaneous and systemic poxviral disease in red (tamiasciurus hudsonicus) and gray (sciurus carolinensis) squirrels pathology of laboratory rodents and rabbits non-proliverative and proliferative lesions of the cardiovascular system of the rat and mouse endocrine system odontoma-like tumours of squirrel elodont incisors -elodontomas spontaneous hibernomas in sprague-dawley rats adenocarcinoma of the dorsal glands in 2 european ground squirrels (spermophilus citellus) synhimantus (nematoda) associated with gastric squamous tumors in muskrats proliferative and nonproliferative lesions of the rat and mouse male reproductive system nonproliferative and proliferative lesions of the rat and mouse female reproductive system neoplastic and nonneoplastic lesions of the reproductive tract of the woodchuck (marmota monax) polyomavirus infection in hamsters and trichoepitheliomas/ cutaneous adnexal tumors proliferative and nonproliferative lesions of the rat and mouse urinary system proliferative and non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle and mesothelium squamous cell carcinoma in a capybara (hydrochoerus hydrochaeris) malignant pleural mesothelioma in a woodchuck (marmota monax) oral leiomyosarcoma in a woodchuck (marmota monax) changes in the major ocular glands nonneoplastic and neoplastic changes in the harderian and lacrimal glands pulmonary lesions produced by fibromas viruses in squirrels and rabbits bethesda proposal for classification of nonlymphoind hematopoietic neoplasms in mice lymphosarcoma in the laboratory woodchuck obstructive respiratory disease in prairie dogs with odontomas proliferative and nonproliferative lesions of the rat and mouse respiratory tract harderian gland neoplasms in captive, wild-caught beechey ground squirrels (spermophilus beecheyi) chronic hepatitis and hepatocellular carcinoma associated with persistent woodchuck hepatitis virus infection hepatic lesions in woodchucks (marmota monax) serongative for woodchuck hepatitis virus lesions associated with eucoleus sp. in the non-glandular stomach of wild urban rats (rattus norvegicus) proliferative and nonproliferative lesions of the rat and mouse mammary, zymbal's preputial and clitoral glands hamster polyomavirus infection in a pet syrian hamster (mesocricetus auratus) causes of mortality and pathological lesions observed post-mortem in red squirrels (sciurus vulgaris) in great britain endocrine system. endocrine system neoplasia and granulomas surrounding microchip transponders in damaraland mole rats (cryptomys damarensis) squamous cell carcinoma in a capybara (hydrochoerus hydrochaeris) comparative histomorphological review of rat and human hepatocellular proliferative lesions spontaneous tumors of free-ranging terrestrial mammals of north america fowler's zoo and wild animal medicine leptospira and leptospirosis natural history of plague: perspectives from more than a century of research plague and yersiniosis bartonella infection in rodents and their flea ectoparasites: an overview. vector borne zoonotic dis rodent reservoirs of future zoonotic diseases a review of listeria monocytogenes and listeriosis yersiniosis in wildlife and its public health implications rodent-borne diseases and their risks for public health the ecology of tularaemia tularemia in deer mice (peromyscus maniculatus) during a population irruption in saskatchewan *this list includes the zoonotic pathogens carried by rodents that cause disease in wild animals and those deemed most relevent to wildlife and zoo animal specialists ear mange mites (notoedres muris) in black and norway rats (rattus rattus and rattus norvegicus) from inner-city vancouver ear mange mites (notoedres muris) in black and norway rats (rattus rattus and rattus norvegicus) from inner-city vancouver nathural pathogens of laboratory mice, rats, and rabbits and their effects on research toxoplasmosis in a woodchuck (marmota monax) and two american red squirrels (tamiasciurus hudsonicus) baylisascariosis-infections of animals and humans with 'unusual'roundworms echinococcus multilocularis detection in live eurasian beavers (castor fiber) using a combination of laparoscopy and abdominal ultrasound under field conditions synhimantus (nematoda) associated with gastric squamous tumors in muskrats besnoitia jellisoni (sporozoa: toxoplasmea) in rodents from utah and california a survey of hemoparasite infections in free-ranging mammals and reptiles in french guiana systemic toxoplasmosis in a five month old beaver, (castor canadensis) echinococcus vogeli rausch and bernstein, 1972, from the paca, cuniculus paca l.(rodentia: dasyproctidae), in the departamento de santa cruz pathomorphologic findings in short-tailed voles (microtus agrestis) experimentallyinfected with frenkelia microti pneumocystis carinii causes a distinctive interstitial pneumonia in immunocompetent laboratory rats that had been attributed to "rat respiratory virus more than a rabbit's tale-encephalitozoon spp. in wild mammals and birds studies on the nematode parasite, gongylonema neoplasticum (spiroptera neoplasticum) and avitaminosis a in the forestomach of rats: comparison with fibiger's results echinococcus multilocularis in a european beaver from switzerland frenkelia sp. from the brain of a porcupine (erethizon dorsatum) from alberta the role of wildlife rehabilitation as sentinels for one health issues at the wildlife and public health interface: reports of taenia crassiceps cysticercosis in woodchucks (marmota monax) and squirrels (sciurus carolinensis) in maryland and virginia cysticerci of taenia mustelae in the fox squirrel characteristics of natural infections of the stomach worm, obeliscoides cuniculi (graybill), in lagomorphs and woodchucks in canada first identification of echinococcus multilocularis in rodent intermediate hosts in sweden parasites of ferrets, rabbits, and rodents klossiella infection of the guinea pig the taxonomic status of echinococcus cruzi brumpt and joyeux, 1924 (cestoda: taeniidae) from an agouti (rodentia: dasyproctidae) in brazil capillaria hepatica in wild norway rats (rattus norvegicus) from vancouver lesions associated with eucoleus sp. in the non-glandular stomach of wild urban rats (rattus norvegicus) cutaneous leishmaniasis in the amazon: isolation of leishmania (v.) lainsoni rodent agouti paca (rodentia: dasyproctidae) in the state of para causes of mortality and pathological lesions observed post-mortem in red squirrels (sciurus vulgaris) in great britain pathologic findings in western gray squirrels (sciurus griseus) from a notoedric mange epidemic in san bernardino moutnains, california natural infection of the ground squirrel (spermophilus spp.) with echinococcus granulosus in china ear mange mites (notoedres muris) in black and norway rats (rattus rattus and rattus norvegicus) from inner-city vancouver. can nathural pathogens of laboratory mice, rats, and rabbits and their effects on research cutaneous and systemic poxviral disease in red (tamiasciurus hudsonicus) and gray (sciurus carolinensis) squirrels pathology of laboratory rodents and rabbits diseases of agouti (dasyprocta agouti) rained in captivity diagnosed by pathological examination cryptococcus neoformans pneumonia in slender tailed cloud rats (phloeomys pallidus): a review of seven cases odontoma-like tumors of squirrel elodont incisors -elondontomas order rodentia mycobacterium microti infection (vole tuberculosis) in wild rodent populations spontaneous cardiomyopathy in young sprague-dawley rats: evaluation of biological and environmental variability notoedric mange in western gray squirrels from washington scurvy in capybaras bred in captivity argentine non-neoplastic liver disease associated with chronic ground squirrel hepatitis virus infection disease limits populations: plague and black-tailed prairie dogs. vector-borne zoonotic dis spontaneous histologic lesions of the adult naked mole-rat (heterocephalus glaber): a retrospective survey of lesions in a zoo population renal pathology in a non-traditional aging model: the naked mole-rat (heterocephalus glaber) initial case reports of cancer in naked mole-rats (heterocephalus glaber) nonproliferative and proliferative lesions of the rat and mouse female reproductive system anatomical studies of the male genital organs of the european beaver eosinophilic substanceis "not amyloid" in the mouse nasal septum a survey of rodent-borne pathogens carried by wild-caught norway rats: a potential threat to laboratory rodent colonies dystrophic cardiac calcinosis in mice polyomavirus infection in hamsters and trichoepitheliomas/cutaneous adnexal tumors monkeypox transmission and pathogenesis in prairie dogs histopathology of preclinical toxicity studies prediction of spontaneous hereditary diabetes mellitus in chinese hamsters by means of elevated alpha-2 serum levels rodent reservoirs of future zoonotic diseases macroscopic anatomy of the lower respiratory system in mole rats (spalax leucodon) kurloff cells in peripheral blood and organs of wild capybaras pulmonary lesions produced by fibromas viruses in squirrels and rabbits the clinical chemistry of laboratory animals dental dysplasia in rats and mice concurrent infection with cilia-associated respiratory bacillus and mycoplasmas in spinifex hopping-mice (notomys alexis) with pneumonia rodent-borne diseases and their risks for public health persistent paramesonpehric ducts (masculine uterus) in the male north american beaver (castor candadensis) polycystic kidney disease in adult brazilian agoutis (dasyprocta leporina) francisella tularensis infection rodentia chapter | 20 515 without lesions in gray tree squirrels (sciurus griseus): a diagnostic challenge practical pathology of aging mice fluorosis risks to resident hispid cotton rats on land-treatment facilities for petrochemical wastes detection of francisella tularensis in voles in finland. vector borne zoonotic dis congestive cardiomyopathy in the woodchuck, marmota monax chronic hepatitis and hepatocellular carcinoma associated with persistent woodchuck hepatitis virus infection capillaria hepatica in wild norway rats (rattus norvegicus) from vancouver survey of cardiovascular pathology in wild urban rattus norvegicus and rattus rattus respiratory pathology and pathogens in wild urban rats (rattus norvegicus and rattus rattus) hamster polyomavirus infection in a pet syrian hamster (mesocricetus auratus) causes of mortality and pathological lesions observed postmortem in red squirrels (sciurus vulgaris) in great britain pathologic findings in western gray squirrels (sciurus griseus) from a notoedric mange epidemic in san bernardino moutnains, california contributions of microbes in vertebrate gastrointestinal tract to production and conservation of nutrients the laboratory rabbit, guinea pig, hamster, and other rodents neoplasia and granulomas surrounding microchip transponders in damaraland mole rats (cryptomys damarensis) four cases of spontaneous neoplasia in the naked mole-rat (heterocephalus glaber), a putative cancer-resistant species an epizootic of fibromatosis in gray squirrels (sciurus carolinensis) in florida parapoxvirus causes a deleterious disease in red squirrels associated with uk population declines listeriosis in seven bushy-tailed jirds spontaneous reproductive pathology in female guinea pigs lung morphology in rodents (mammalia rodentia) and its implication for systematics working underground: respiratory adaptations in the blind mole rat fibroma virus infection in an eastern fox squirrel (sciurus niger) from sangamon county illinois fowler's zoo and wild animal medicine chirodiscoides caviae skin none guinea pigs morrisey (1996) demodex skin alopecia, dermatitis, pruritis gerbil, hamster morrisey (1996) gliricola porcelli skin alopecia, crusting dermatitis, pruritis guinea pigs morrisey (1996) gyropus ovalis skin alopecia, crusting dermatitis, pruritis guinea pigs morrisey (1996) myobia musculi skin alopecia, pruritis, selfmutilation mice myocoptes musculinis skin alopecia, pruritis, selfmutilation mice morrisey (1996) notoedres sp. skin alopecia, crusting dermatitishamster, grey squirrel, ratsanholt (2014), , morrisey (1996) , ornithonyssus bacoti skin anemia rats morrisey (1996) polyplax serrata skin anemia, pruritis, dermatitis mice morrisey (1996) polyplax spinulosa skin anemia, pruritis rats morrisey (1996) psoregates simplex skin follicular nodules mice morrisey (1996) radfordia affinis skin alopecia, pruritis, selfmutilation mice morrisey (1996) trixacarus caviae skin alopecia, crusting dermatitis guinea pigs morrisey (1996) key: cord-254950-y6kayxie authors: morse, stephen s. title: mouse thymic virus (mtlv; murid herpesvirus 3) infection in athymic nude mice: evidence for a t lymphocyte requirement date: 1988-03-31 journal: virology doi: 10.1016/0042-6822(88)90262-0 sha: doc_id: 254950 cord_uid: y6kayxie abstract mouse thymic virus (mtlv; murid herpesvirus 3) is a lymphotropic herpesvirus that cytolytically infects developing t lineage lymphocytes in the thymus of neonatal mice. mtlv establishes a persistent infection and can be recovered indefinitely from infected mice, but nothing is known about requirements for this persistent infection. in order to determine whether t lineage lymphocytes are required for infection, young adult athymic nude (nulnu) mice and euthymic littermates were infected with mtlv and tested for virus shedding. although euthymic littermates regularly shed virus, in the nude mice only about 20% of isolation attempts up to 100 days postinfection were positive. blind passage yielded an additional three isolations out of 14 samples (21 %). in addition, unlike many other herpesviruses, the virus did not replicate in a number of epithelial and fibroblastic cell lines that were tested. these data confirm that the virus is preferentially t lymphotropic and suggest that infection may require t lineage lymphocytes. mouse iclymic virus (mtlv; murid herpesvirus 3) is a lymphotropic herpesvirus that infects and kills developing t lymphocytes in the thymus of neonatal mice (1) (2) (3) . the virus is also cytolytic for t lymphocytes in peripheral lymphoid tissues (4) . when adult mice are infected, the virus appears to bypass the thymus (2) but can be isolated indefinitely from salivary glands and on mouth swabs (1) (2) (3) . irrespective of virus dose and age at primary infection, regular lifetime virus shedding appears to be the rule (1, 2) . although thymus-derived lymphocytes appear to be the targets for primary infection in newborn mice, nothing is known about cells involved in persistent infection. the nude mouse is an ideal model for dissecting the effects of lymphotropic viruses. nude mice are athymic as a result of a genetic defect which prevents the development of the embryonic thymus (5) . because t lymphocytes mature in the thymus, this lymphocyte type is largely absent in nude mice (6). the nude gene is autosomal recessive; heterozygotes (+lnu) are phenotypically normal (5) and have essentially normal t lymphocyte function (6). in this study, experimentally infected nude mice and euthymic littermates were used to determine whether t lymphocytes are required for infection by mtlv. because there is no tissue culture system for assay of mtlv in vitro (2, 3) , the standard assay, and the most sensitive and reliable assay available at present is based on infectivity (thymic necrosis) in litters of newborn mice. the breeding stocks used to provide litters for our infectivity assay have been screened for thymic virus by infectivity testing of mouth swabs and salivary glands from retired breeders (i, 3) and are negative. in addition, the breeding stocks used were seronegative for all known murine pathogens. forvirus assay of mouth swabs, each swab was expressed into 1 ml dulbecco's modified eagle's medium supplemented with 10% fetal bovine serum and 50 pg gentamycin per milliliter (dme-1 0), and the liquid was inoculated intraperitoneally (0.05 ml per mouse; additional mice received up to 0.2 ml per newborn mouse) into litters of newborn (less than 24 hr old) balb/c mice (3). the pups were examined for thymic necrosis after 9-l 1 days (2, 3); any visible necrosis was considered positive. typically, these necrotic thymuses were ~20% of normal size. to determine whether mtlv infection requires thymus-derived lymphocytes, 4-week-old female icr swiss athymic nude (nulnu) and euthymic (+lnu) littermate controls (four each; memorial sloan-kettering cancer center nude mouse breeding colony) were inoculated intraperitoneally with either 40 or 200 ids0 of mtlv and virus shedding was tested by mouth swabs beginning 6 days after infection. all nude mice and littermate controls were negative for mtlv by virus isolation at the outset of the experiment (before inoculation). after inoculation, all the inoculated mice became infected with the virus. ability to recover virus was not correlated with input virus dose. virus could as readily be recovered from mice that had received 40 ids0 as from those that had received 200 idso. the infected mice remained healthy throughout the observation period (over 100 days), and no overt disease was attributable to mtlv infection in the nude mice. in the euthymic controls, all virus isolation attempts were positive through 100 days postinfection, with most of the inoculated pups developing macroscopic thymic necrosis (mean, 92%). in the athymic nude mice, by contrast, although virus was recovered at least once from each nude mouse (table l) , only 5 of 27 primary isolation attempts from day 6 through day 98 were positive, giving an isolation rate of 18.5%. in positive isolations, fewer inoculated pups showed thymic necrosis (mean, 14.2%) than pups that received swab fluids from controls (table 1) . for many viruses, virulence or tissue tropism can be altered by conditions of infection (7); introduction of mtlv into the nude mouse could therefore have altered virus infectivity. blind passage is a standard method for restoring virulence and increasing assay sensitivity (1, 2) . although limitations in the number of note. infected icr swiss athymic nude (nulnu) and euthymic (+/nu) littermate controls (total number of mice, eight) were tested forvirus shedding at the times shown. forvirus assay, mouth swabs were taken using cotton swabs moistened with dulbecco's modified eagle's medium + 10% fetal bovine serum and 50 pg gentamytin per milliliter (dme-1 0), and tested for mtlv by infectivity assay in newborn balb/c mice as described in the text. additional infectivity assays in normal newborn icr background swiss mice gave the same results. a values in parentheses represent number of nude mice yielding positive isolations on that day. infectivity assays from four nude mice through day 30, three on day 34, three on days 44/48 together, and two on day 98. litters available did not allow every negative sample to be tested, additional litters of normal newborn mice were inoculated with fresh homogenates (1 o-20%, w/v) of randomly selected negative thymuses and salivary glands, representing various test dates up to day 48, from 14 assay litters that had received swab fluids from nude mice. up to two blind passage cycles were performed. these passages yielded a total of three additional isolations (21%) ( table 2 ). in an additional biological passage, separate litters of normal neonatal mice were inoculated with swab fluids from each of the nude mice (day 50 postinfection) and these newborns were allowed to reach adulthood. homogenates of salivary glands and thymuses were prepared from these animals, and tested for mtlv by infectivity assay in fresh litters of newborn mice. one sample, from an animal that had received fluids from nude mouse 2, was positive on assay. this represented only the second isolation from this nude mouse, which was positive on primary isolation on day 6 and had been consistently negative thereafter. tissues from uninfected mice (as negative controls), or other negative samples, passaged at the same time as nude mouse samples were consistently negative. nude mice lack t lymphocyte function, but nonspecific immune functions, such as natural killer (nk) activity, are normal or even increased in the nude mouse (8). nk-deficient nude mice have recently been developed (9) . in order to determine whether reduced virus shedding in the nude mice could have been due to active suppression by nk cells or similar mechanisms, eight nk-deficient balb/c-c57 beige hybrid mice (life sciences, st. petersburg, fl) were infected with mtlv and tested at various times after infection. there were six positive or possibly positive isolations out of a total of 46 attempts (13%) from 1 to 14 weeks postinfection. virus was isolated consistently more than once from only one mouse, which was negative on day 6, positive on days 19, 26, and 41, positive with a lower level of virus shedding on day 33, and negative on day 48 and thereafter. one other nude mouse appeared to shed a low level of virus on day 19 and was possibly positive on day 34, but appeared negative on other isolation attempts including days 6, 41, and 48 postinfection. the other six nude mice were negative on all isolation attempts (e.g., days 6, 19, 26, 33-34, 41, 48 and thereafter through 14 weeks). thus, mtlv establishes a persistent infection in the nude mouse, but virus shedding may be reduced in comparison with euthymic mice. aside from thymusderived (t) lymphocytes, most other cell types appear to be normal in the nude mouse (5, 6) . therefore, if persistent mtlv infection were to involve mostly nonlymphoid cells, all isolations should have been positive after initial infection. that this did not appear to occur suggests that t lineage lymphocytes might well be the major target cells for persistent infection. this has been demonstrated in herpesvirus sylvilagus, a rabbit herpesvirus, which can be isolated from saliva and salivary glands of infected hosts, but the virus is associated with lymphocytes and not with epithelial cells (12) . mtlv similarly persists in salivary gland (1, 2), but electron microscopy of salivary gland epithelial cells of infected animals revealed no abnormalities (i), and no viral antigens could be detected in salivary gland epithelial cells (2) . there are two likely explanations for the apparently low level iof virus shedding in the nude mouse. although nude mice lack mature functional t lymphocytes, early t lineage precursors are present in the nude mouse (6, 8, 10); under certain conditions, these cells in the nude mouse can also differentiate extrathymically into mature t lymphocytes (7 1). in addition, several reports indicate that a small number of apparently matu"e (bearing the t lymphocyte marker thy 1) t lineage lymphocytes are present in nude mice throughout their lives (6, 10). a small population of this type could be persistently infected and responsible for the low level of virus shedding observed. this population reportedly increases with age or intercurrent infection (111. infection with the coronavirus mouse hepatitis virus (mhv), a common murine pathogen endemic in many nude mouse colonies, has also been reported to induce extrathymic t cell differentiation in nude mice (11) . some of our preliminary results (data not shown) suggest that nude mice older at primary infection, or nude mice that have been infected with mhv, appear more likely to shed mtlv. alternatively, there could be a secondary cell type (such as the macrophage) in which virus can persist at low levels even in the absence of t lymphocytes. macrophage infection by another t lymphocytolytic virus, human immunodeficiency virus (hiv-l), has been documented (13). our preliminary attempts to isolate mtlv from adherent peritoneal macrophages of persistently infected euthymic mice have been negative so far. however, low levels of infected cells might not be detected. specific molecular probes, such as genomic dna probes or monoclonal antibodies, are not presently available for this virus. we are in the process of producing specific high-titer antisera and other probes in order to test the presence of mtlv in various lymphoid and hematopoietic tissues and in nerve cells. as regards other susceptible cells, original attempts to grow the virus in mouse embryo cells or mouse embryo kidney cells, among others, were unsuccessful (1). our attempts to infect a variety of epithelial and fibroblastic cell cultures that support the replication of many other viruses have been uniformly negative. for infection, subconfluent monolayers of cells were incubated for 90 min with dme-10 containing 500-2000 ids0 mtlv and polybrene (30 pg/ml), then fed (dme supplemented with 5010 fetal bovine serum), incubated, and tested for mtlv by infectivity assay at 5-7 days and at 2 weeks. cells tested included ar42j rat glandular epithelium, balb cl.7 mouse fibroblast, balb 3t3 fibroblast, cl271 mouse mammary tumor, j774a.l mouse macrophage, nctc 1469 mouse liver, sc-l feral mouse embryo, tcmk-1 mouse kidney, 32 ill a rat hepatoma, a549 human lung carcinoma, hep-2 human epidermoid carcinoma, mdck canine kidney epithelium, vero african green monkey kidney, wish diploid human amniotic epithelium, 324k human kidney, and primary cultures of african green monkey kidney, cynomolgous monkey kidney, rabbit kidney, and rhesus monkey kidney. replicate cultures, observed up to a month for cytolysis or focus formation, remained negative throughout. additional cultures cocultivated with primary mtlv-infected thymocytes (5 x 105/ml, harvested day 5 postinfection) also remained uninfected. these results suggest that mtlv is unable to productively infect many cell lines that support the cytolytic replication of many viruses including other lymphotropic herpesviruses. taken together, these lines of evidence appear to implicate the t lineage lymphocyte as the primary target of both acute and persistent mtlv infection. co/d spring harbor conf. cell pro/if key: cord-013023-uanozm00 authors: crouse, richard b; kim, kristen; batchelor, hannah m; girardi, eric m; kamaletdinova, rufina; chan, justin; rajebhosale, prithviraj; pittenger, steven t; role, lorna w; talmage, david a; jing, miao; li, yulong; gao, xiao-bing; mineur, yann s; picciotto, marina r title: acetylcholine is released in the basolateral amygdala in response to predictors of reward and enhances the learning of cue-reward contingency date: 2020-09-18 journal: nan doi: 10.7554/elife.57335 sha: doc_id: 13023 cord_uid: uanozm00 the basolateral amygdala (bla) is critical for associating initially neutral cues with appetitive and aversive stimuli and receives dense neuromodulatory acetylcholine (ach) projections. we measured bla ach signaling and activity of neurons expressing camkiiα (a marker for glutamatergic principal cells) in mice during cue-reward learning using a fluorescent ach sensor and calcium indicators. we found that ach levels and nucleus basalis of meynert (nbm) cholinergic terminal activity in the bla (nbm-bla) increased sharply in response to reward-related events and shifted as mice learned the cue-reward contingency. bla camkiiα neuron activity followed reward retrieval and moved to the reward-predictive cue after task acquisition. optical stimulation of cholinergic nbm-bla terminal fibers led to a quicker acquisition of the cue-reward contingency. these results indicate bla ach signaling carries important information about salient events in cue-reward learning and provides a framework for understanding how ach signaling contributes to shaping bla responses to emotional stimuli. learning how environmental stimuli predict the availability of food and other natural rewards is critical for survival. the basolateral amygdala (bla) is a brain area necessary for associating cues with both positive and negative valence outcomes (baxter and murray, 2002; janak and tye, 2015; ledoux et al., 1990) . a recent study has shown that genetically distinct subsets of bla principal neurons encode the appetitive and aversive value of stimuli (kim et al., 2016b) . this encoding involves the interplay between principal neurons, interneurons, and incoming terminal fibers, all of which need to be tightly regulated to function efficiently. the neuromodulator acetylcholine (ach) is released throughout the brain and can control neuronal activity via a wide range of mechanisms. ach signals through two families of receptors (nicotinic, nachrs and muscarinic, machrs) that are differentially expressed on bla neurons as well as their afferents (picciotto et al., 2012) . ach signals through these receptors to increase signal-to-noise ratios and modify synaptic transmission and plasticity in circuits involved in learning new contingencies (picciotto et al., 2012) , especially in areas that receive dense cholinergic input, like the bla (woolf, 1991; zaborszky et al., 2012) . the effect of ach signaling can differ depending on the receptor, as metabotropic machrs work on a slower timescale than the rapid, ionotropic nachrs (gu and yakel, 2011; picciotto et al., 2012) . the overall impact of ach signaling on the bla is likely quite heterogeneous as machrs are coupled to both inhibitory and excitatory signaling cascades and nachrs are found on both glutamatergic and gabaergic bla neurons (picciotto et al., 2012) . the basal forebrain complex is a primary source of ach input to the bla. in particular, the nucleus basalis of meynert (nbm) sends dense cholinergic projections to the bla (woolf, 1991; zaborszky et al., 2012) . optical stimulation of bla-projecting cholinergic terminal fibers (nbm-bla) during fear conditioning is sufficient to strengthen fear memories (jiang et al., 2016) and may support appetitive behavior (aitta-aho et al., 2018) . cholinergic nbm neurons increase their firing in response to both rewarding and aversive unconditioned stimuli (hangya et al., 2015) . cholinergic signaling in the medial prefrontal cortex and visual cortex has been linked to cue detection (parikh et al., 2007) and reward timing (chubykin et al., 2013; liu et al., 2015) , respectively. a recent study has also demonstrated that nbm cells fire in response to a conditioned stimulus during trace fear conditioning, indicating that ach signaling may be involved in learning about cues that predict salient outcomes (guo et al., 2019) . we hypothesized that ach signaling in the bla is a critical neuromodulatory signal that responds to both unconditioned stimuli and cues that gain salience, thereby coordinating activity in circuits necessary for learning cue-reward contingencies. to test this hypothesis, we measured relative levels of bla ach (ach signaling), cholinergic nbm-bla terminal fiber activity (bla ach signal origin), and the activity of bla principal neurons (bla output) across all phases of learning in an appetitive operant learning task to evaluate how bla output and ach signaling are related to behavioral performance in this paradigm. we then optically stimulated cholinergic nbm fibers locally in the bla, while mice learned to nose poke in response to an auditory cue to receive a food reward to determine if accelerating the increase in ach signaling that occurs as mice learn the task would enhance performance. we also pharmacologically blocked different ach receptors during the learning task to determine the subtypes involved, and varied the timing of optical stimulation of cholinergic nbm-bla terminal fibers to determine whether ach release time-locked with the reward-predictive cue is necessary for the improvement of the task performance. these studies provide a novel framework for understanding how nbm ach signaling in the bla is recruited during the perception of novel stimuli and how it contributes to linking previously neutral cues to predictions about future salient outcomes. acetylcholine release in the bla occurs at salient points in the cuereward learning task and shifts as mice learn the cue-reward contingency the bla is critical for learning that previously neutral cues can predict future punishments or rewards and for assigning valence to those cues (baxter and murray, 2002; janak and tye, 2015) . the bla receives dense cholinergic input (woolf, 1991; zaborszky et al., 2012) and we speculated that, since ach signaling is involved in both attention and several types of learning (picciotto et al., 2012) , it could be essential for learning about cues that predict salient events, such as reward delivery. based on data showing that ach neurons fire in response to unexpected or salient events (hangya et al., 2015) , we also hypothesized that ach release might vary as mice learn a cue-reward contingency. therefore, we designed a cue-reward learning task in which food-restricted mice were trained to perform a nose poke when signaled by a cue (tone) to receive a palatable reward (ensure) on a 30 s variable intertrial interval (iti; figure 1a -d). we injected adeno-associated virus (aav) carrying an improved version of the fluorescent ach sensor grab ach3.0 (ach3.0; jing et al., 2018; jing et al., 2019) construct into the bla of mice and implanted an optical fiber above the bla to record ach signaling during the cue-reward learning task ( during the pre-training phase of the task, mice received reward and receptacle light presentation for performing a nose poke in the active port during tone presentation ( figure 1c , purple active nose poke coincident with tone) but there was no consequence for an incorrect nose poke ( figure 1c , red active nose poke not coincident with tone). animals quickly learned to make a high number of responses over the course of each pre-training session. in this paradigm, mice obtained most available rewards by day 5 of pre-training ( figure 2b , blue shaded region). however, this phase of training did not promote learning of the cue-reward contingency, (i.e. that they should only nose poke during tone presentation) seen by the high number of incorrect nose pokes (figure 2figure supplement 2a, blue shaded region). mice performed roughly eightfold more incorrect nose pokes than correct nose pokes, suggesting that mice were not attending to the task contingency. the training phase of the task was identical to pre-training except incorrect nose pokes resulted in a 5 s timeout, during which the house light was illuminated, that concluded with a restarting of the iti timer ( figure 1d , red active nose poke not coincident with tone). on day 1 of the training phase, all animals earned fewer rewards ( figure 2b , pink shading) and, while still high, incorrect nose pokes dropped (figure 2-figure supplement 2a, pink shading). animals that did not meet acquisition criterion by day 9 (defined as consistently earning 20 or more rewards per session, figure 2b , white horizontal line) were moved to a 20 s variable iti to promote responding ( figure 2b , pink shading day 10). following the change in iti, mice acquired the cue-reward behavior at different rates. after figure 1 . experimental timeline and cue-reward learning paradigm. (a) experimental timeline. mice began food restriction 7 d after surgery and were maintained at 85% free-feeding body weight for the duration of the experiment. after 7 d of handling, 5-6 d of operant familiarization prepared the mice for the cue-reward learning task (pre-training through extinction). (b) behavioral chamber setup. mice were placed in modular test chambers that included two nose poke ports on the left wall (active and inactive) and the reward receptacle on the right wall. a tone generator and timeout light were placed outside the modular test chamber. for fiber photometry (fp) and optical stimulation (laser) experiments, mice were tethered to a patch cord(s). (c-d) details of the cue-reward learning paradigm. (c) in pre-training, an auditory tone was presented on a variable interval 30 schedule (vi30), during which an active nose poke yielded ensure reward delivery but there was no consequence for incorrect nose pokes (active nose pokes not during tone). (d) training was identical to pre-training, except incorrect nose pokes resulted in a 5 s timeout, signaled by timeout light illumination, followed by a restarting of the intertrial interval (iti). during pre-training, when there were high numbers of both correct and incorrect nose pokes, there was a large increase in ach release following correct nose pokes, which were followed by reward delivery and receptacle light, but not incorrect nose pokes ( figure 2c + figure 2 -figure supplement 1b-c). we used bootstrapped confidence intervals (bcis) to determine when transients were statistically significant (bci did not contain the null of 0 [jeanrichard-dit-bressel et al., 2020] ). correct, but not incorrect, nose poke trials consistently showed a sustained, significant responses of mice expressing ach3.0 in bla. individual mice acquired the task at different rates as measured by rewards earned. horizontal white line: acquisition threshold, when a mouse began to earn 20 rewards consistently in training. incorrect nose pokes shown in figure 2 -figure supplement 2a. pre-training (pt): blue shaded area, training: pink shaded area, extinction (ext): orange shaded area. (c) fluorescence traces from bla of ach3.0expressing mouse. a significant increase in fluorescence representing bla ach release consistently coincided with correct (green line) but not incorrect (gray line) nose pokes on the last day of pt (data are shown from mouse 1). the mean z-scored precent df/f0 (z%df/f0) overlaid on bootstrapped 99% confidence intervals (99% bcis). shaded significance bars under traces represent time points where 99% bcis do not contain 0 for at least 0.5 s. correct: n = 24; downsampled incorrect: n = 24 of 58. traces of signal and reference channels (%df/f0) during nose pokes are shown in figure 2 figure supplement 1b-c. incorrect nose pokes on the last day of pt versus training day 1 shown in figure 2 -figure supplement 2b. (d) heatmap of bla ach signaling in mouse 1 across all training phases, aligned to tone onset (tone), correct nose poke (np), and receptacle entry (rec). each row is the average of rewarded trials across a training session. white dashed horizontal line: first training day earning 10 rewards. horizontal white line: acquisition threshold, when a mouse began to earn 20 rewards consistently in training. black horizontal lines: divisions between training phases. black vertical lines: divisions between breaks in time to allow for variable latencies in tone onset, correct nose poke, and receptacle entry (reward retrieval). the bci plot for mouse 1 is in figure 2 increase in fluorescence close to the time of nose poke onset ( figure 2c) . we also observed a significant decrease in fluorescence for most mice around 2-4 s after correct nose poke, which corresponds to the time of reward retrieval. ach release occurred in response to different events as mice learned the task (data for individual mice are shown in figure 2d + figure 2 -figure supplement 1d-g and averaged data across all mice at key time points in the task is shown in figure 2e + figure 2 -figure supplement 1h). during pre-training rewarded trials, the highest levels of ach release occurred close to the time of correct nose pokes (np), with a smaller peak at the time of reward retrieval (entry into the reward receptacle, rec). as training began, the ach release during reward trials shifted dramatically toward the time of reward retrieval, likely because the animals were learning that many nose pokes did not result in reward delivery. incorrect nose pokes that triggered a timeout were also followed by a modest but non-significant increase in bla ach levels ( ), ach level significantly increased at the time of the tone, suggesting that as animals learned the cue-reward contingency, the tone became a more salient event. at this time point, there was still a peak at the time of reward, but its magnitude was diminished. after task acquisition, the increase in ach following correct nose pokes remained but was diminished, and incorrect nose pokes did not elicit apparent ach release ( ) but met the acquisition criteria faster than initial mice because aspects of the behavioral setup were optimized (3d printed wall extensions) to allow the imaging apparatus to be used inside sound attenuating chambers (see materials and methods section). one difference observed in this group that learned the task more rapidly, was small magnitude, but significant, increases in bla ach release following tone onset late in pre-training (figure 2-figure supplement 3c-i). as behavioral performance during the training phase increased, ach release to tone onset became more pronounced, as in the initial cohort. in order to determine the source of the ach released in the bla during cue-reward learning, we recorded calcium dynamics as a measure of cell activity of chat + nbm terminal fibers in the bla (nbm-bla), since the nbm is a major source of cholinergic input to the bla (jiang et al., 2016; woolf, 1991; zaborszky et al., 2012) . we injected aav carrying a cre-recombinase-dependent, genetically-encoded calcium indicator (dio-gcamp7s) into the nbm of chat-ires-cre mice and implanted an optical fiber above the ipsilateral bla ( figure 2f . strikingly, nbm-bla cholinergic terminal activity most closely followed correct nose pokes in pre-training and shifted primarily to tone onset as mice learned the contingency during training. as in the replication cohort for the ach sensor, small magnitude, but significant, increases in terminal activity were observed following tone onset late in pre-training ( figure 2j in order to record nbm-bla cholinergic terminal activity and bla ach levels simultaneously in the same mouse, we injected aav carrying a construct for cre-recombinase dependent red-shifted genetically-encoded calcium indicator (dio-jrcamp1b) into the nbm of chat-ires-cre mice, ach3.0 sensor into the ipsilateral bla, and implanted a fiber above the bla (figure 2 -figure supplement 9a-e, mouse 1). dio-jrcamp1b was also injected into the nbm of a wild-type littermate so cre-mediated recombination would not occur to control for any crosstalk between the ach3.0 and jrcamp1b channels. while this was only a single animal and proof of principle for future studies, we found that nbm-bla cholinergic terminal activity coincided with ach levels (figure 2 -figure supplement 9f-g). importantly, this relationship between ach release and nbm-bla terminal fiber activity was not explained by signal crosstalk (figure 2 -figure supplement 9h-i), further indicating that the bla ach measured comes at least in part from the nbm. bla principal neurons respond to reward availability and follows cuereward learning glutamatergic principal cells are the primary output neurons of the bla (janak and tye, 2015) , and their firing is modulated by nbm-bla cholinergic signaling (jiang et al., 2016; unal et al., 2015) . bla principal neurons can increase their firing in response to cues as animals learn cue-reward contingencies (sanghera et al., 1979; schoenbaum et al., 1998; tye and janak, 2007) . calcium/calmodulin-dependent protein kinase (camkii) has been shown to be a marker for glutamatergic bla principal cells (butler et al., 2011; felix-ortiz and tye, 2014; mcdonald, 1992; tye et al., 2011) . to determine whether ach modulates principal neuron activity during cue-reward learning, we injected aav carrying a cre-recombinase dependent genetically encoded calcium indicator (dio-gcamp6s) into the bla of camkiia-cre mice to record bla principal cell activity during the learning task ( figure 3a + figure 3 -figure supplement 1a). as was seen for bla ach levels, there was a significant increase in bla camkiia cell activity following correct and a modest decrease in activity following incorrect nose pokes on the last day of pre-training ( figure 3b ). however, the activity peaked later after the correct nose poke response (~2.5 s) compared to the ach3.0 signal (~0.5 s) and appeared to align more tightly with reward retrieval ( during pre-training, the highest levels of bla camkiia cell activity followed reward retrieval. in addition, during the first few days of training, bla camkiia cell activity after reward retrieval was higher than it was during pre-training, and the magnitude of response decreased as mice learned the contingency and earned more rewards, ultimately reaching similar intensity to that observed during pre-training. concurrently, as mice approached acquisition of the task ( figure 3c , white horizontal line), bla camkiia cell activity significantly increased in response to tone onset ( figure 3d -e + figure 3 -figure supplement 1e-h, acq.), suggesting that the recruitment of bla camkiia cell activity likely reflects the association of the cue with a salient outcome (lutas et al., 2019; sengupta et al., 2018) . incorrect nose pokes that triggered a timeout did not elicit a different response in camkiia cell activity compared to before timeouts were incorporated (figure 3-figure supplement 2b-g). in an independent cohort of mice, those with more posterior fiber tip placements (mice 4 + 7) replicated the primary findings (figure 3-figure supplements 3-4). since ach released by nbm-bla terminals during training shifted to tone onset during acquisition of cue-reward learning ( figure 2e ,j), we hypothesized that ach may potentiate learning the cuereward contingency. we, therefore, tested whether increasing ach release in bla during learning could alter cue-reward learning by injecting aav carrying a cre-recombinase-dependent channelrhodopsin-eyfp (aav-dio-chr2-eyfp) construct bilaterally into the nbm of chat-ires-cre transgenic mice and placing fibers over the blas to optically stimulate cholinergic terminals originating from the nbm selectively ( figure 4a figure 4c ) and training ( figure 4d ). stimulation usually occurred during at least a portion of all three components of a during pre-training, auditory tones were presented on a variable interval 30 schedule (vi30), during which an active nose poke (correct) yielded ensure reward delivery and 2 s of optical stimulation but there was no consequence for incorrect nose pokes (active nose pokes not during tone). (d) training was identical to pre-training, except incorrect nose pokes resulted in a 5 s timeout, signaled by house light illumination, followed by a restarting of the iti. (e) behavioral performance in a cue-reward learning task improves with optical stimulation of chat + fibers in bla. eyfp-and chr2-expressing mice earn similar numbers of rewards during pt (blue shaded region). chr2-expressing mice more rapidly earn significantly more rewards than eyfpexpressing mice during training (pink shaded region). no significant differences were observed during extinction training (orange shaded region). horizontal white line: acquisition threshold, when a mouse began to earn~20 rewards consistently in training. mean ± sem, eyfp: n = 5, chr2: n = 6. figure 4 continued on next page rewarded trial: tone, correct nose poke, and reward retrieval, since these events were often separated by short latencies. as seen in previous experiments, during the pre-training phase animals made a high number of nose poke responses over the course of each session, obtained most available rewards by the last day ( figure 4e as the animals learned that a nose poke occurring outside of the cued period resulted in a timeout, both control eyfp and chr2 groups learned the contingency and improved their performance, resulting in acquisition of the cue-reward task (20 rewards earned). however, significant group differences emerged, such that chr2 mice earned significantly more rewards than eyfp controls ( figure 4e two-way repeated-measures anova, f (1, 9)=12.67, p=0.0061), suggesting that the chr2 group learned the tone-reward contingency more quickly than the eyfp group. eyfp mice were able to reach the same peak cue-reward performance as the chr2 group only after 4-6 additional days of training. once peak performance was achieved, there was no difference in extinction learning between the groups (main effect of group (eyfp versus chr2) in a two-way repeated-measures anova, f (1, 9)=2.293, p=0.1643). while sex differences in the behavior were not formally tested side by side, an independent cohort of male mice (eyfp n = 7, chr2 n = 7, figure 4 -figure supplement 4) was tested to determine whether both male and female mice would respond to ach stimulation, revealing similar trends during training for rewards earned ( in order to determine if optical stimulation of nbm-bla cholinergic terminals improved performance in the task by increasing the rewarding value of the outcome, rather than enhancing cuereward learning by some other means, we allowed mice to nose poke for optical stimulation rather than for ensure (figure 4-figure supplement 5a ). there were no differences between the eyfp control and chr2 groups (two-way repeated-measures anova, f (1, 9)=0.6653, p=0.4357). we also tested whether nbm-bla cholinergic terminal activation was reinforcing on its own by stimulating these terminals in a real-time place preference test. mice were allowed to explore two similar compartments to determine baseline preference, and nbm-bla cholinergic terminals were then stimulated in one of the two chambers to determine whether it increased time spent in the simulationpaired chamber. there was no difference between groups (figure 4-figure supplement 5b, main effect of group (eyfp versus chr2) in a two-way repeated-measures anova, f (1, 9)=0.1311, p=0.7257) in place preference, confirming that optical activation of nbm-bla cholinergic terminals is not innately rewarding. stimulation of nbm-bla cholinergic terminals also did not lead to changes in nose poke behavior in an uncued progressive ratio task ( muscarinic, but not nicotinic, receptors are required for acquisition of the cue-reward contingency ach signals through multiple receptor subtypes, with rapid, ionotropic signaling mediated through stimulation of nachrs, and metabotropic signaling mediated through stimulation of machrs (picciotto et al., 2012) . to determine which ach receptors were involved in this cue-reward learning task, mice were injected intraperitoneally with saline (n = 8), mecamylamine (non-competitive nicotinic antagonist, mec, n = 9), scopolamine (competitive muscarinic antagonist, scop, n = 8), or a combination of both antagonists (mec+scop, n = 9) 30 min prior to pre-training and training, during the same epochs of the task in which optical stimulation was administered ( figure 5a ). like optical stimulation, blockade of ach receptors during the pre-training phase of the task had no effect on rewards earned ( figure 5b we have shown that this dose of mecamylamine delivered i.p. has significant effects in tests of anxiety-like behavior and responses to inescapable stress. in addition, chronic treatment with mecamylamine at this dose is sufficient to decrease bla c-fos immunoreactivity (mineur et al., 2007) . consistent with the inability to acquire the cue-reward contingency, mice treated with scop or mec+scop also obtained very few rewards during extinction ( figure 5b ach-mediated accelerated cue-reward learning does not require contingent stimulation of chat + nbm terminals in the bla acetylcholine is often thought of as a neuromodulator (picciotto et al., 2012) , and the window for cholinergic effects on synaptic plasticity varies across ach receptor subtypes (gu and yakel, 2011) . it is therefore possible that ach signaling may result in intracellular signaling changes that outlast the cue presentation window. in order to determine if the effect of nbm-bla stimulation is there was no significant difference between saline controls and those receiving the nicotinic achr antagonist (mec) during training and mice extinguished responding at similar rates. figure 5 continued on next page dependent upon the timing of correct nose poke and laser stimulation contingency, we repeated the experiment in an independent cohort of mice with an additional non-contingent chr2 group that received the same number of stimulation trains as the contingent chr2 group, but in which light stimulation was explicitly unpaired with task events ( figure 6a + figure 6-figure supplement 1) . as in the previous experiment, there were no differences between the eyfp control (n = 6) and stimulation groups (contingent-chr2 n = 5 and non-contingent chr2 n = 5) during pre-training ( figure these results demonstrate that chr2-mediated ach release does not have to be time-locked to the cue, nose poke, or reward retrieval to improve performance of the task, suggesting that ach may alter the threshold for neuronal plasticity for cue-reward pairing over a much longer timescale than might be expected based on results from the ach3.0 recording and nbm-bla recordings, which could be consistent with the involvement of machr signaling in this effect. as in the previous experiment, once all groups reached criterion for acquisition of the cue-reward contingency, there were no differences between any of the groups during extinction ( figure it is increasingly recognized that the bla is involved in learning to predict both positive and negative outcomes from previously neutral cues (cador et al., 1989; janak and tye, 2015; ledoux et al., 1990) . cholinergic cells in the basal forebrain complex fire in response to both positive and negative reinforcement (hangya et al., 2015) . the results shown here indicate that ach signaling in the bla is intimately involved in cue-reward learning. endogenous ach is released in the bla in response to salient events in the task, and ach dynamics evolved as the subject formed associations between stimuli and reward. while the pattern of ach signaling in the bla may seem reminiscent of how dopamine neurons encode reward prediction errors as measured in other brain areas (schultz et al., 1997) , the current results suggest that ach release in the bla may instead be involved in signaling a combination of salience and novelty. ach release and nbm-bla activity increased following correct nose poke and, around the time that animals acquired the cue-reward task, following tone onset. however, earlier in training, incorrect nose pokes that resulted in a timeout were also followed by ach release, although this was smaller in magnitude. further, stimulating nbm-bla cholinergic terminals during learning enhanced behavioral performance, but was not intrinsically rewarding on its own and did not support responding for the tone alone. although ach was released in the bla at discrete points during the task, the effects of heightened bla ach signaling were relatively long lasting, since it was not necessary for stimulation to be time-locked to cue presentation or reward retrieval to enhance behavioral performance. thus, cholinergic inputs from the basal forebrain complex to the bla are a key component of the circuitry that links salient events to previously neutral stimuli in the environment and uses those neutral cues to predict future rewarded outcomes. we have shown that ach release in the bla is coincident with the stimulus that was most salient to the animal at each phase of the task. use of the fluorescent ach sensor was essential in determining these dynamics (jing et al., 2018; jing et al., 2019) . previous microdialysis studies have shown that ach is released in response to positive, negative, or surprising stimuli, but this technique is limited by relatively long timescales (min) and cannot be used to determine when cholinergic transients align to given events in an appetitive learning task and how they evolve over time (sarter and lustig, 2020) . in this cue-reward learning paradigm, when there was no consequence for incorrect nosepoking (pre-training phase), animals learned to perform a very high number of nose pokes and received a large number of rewards, and bla ach signaling peaked following correct nose pokes. both the behavioral response (nose poking that was not contingent with the tone) and the ach response (linked to the correct nose poke) suggest that the animals were not attending to the tone during most of the pre-training phase of the task, but rather were attending to the cues associated with reward delivery, such as the reward light or the sound of the pump that delivered the reward. consistent with this possibility, in the next phase of the task when mice received a timeout for responding if the tone was not presented, performance of all groups dropped dramatically. interestingly, in animals that had difficulty learning the cue-reward contingency, during early training sessions ach release shifted to reward retrieval, likely because this was the most salient aspect of the task when the majority of nose pokes performed did not result in reward. finally, as mice acquired the contingency between tone and reward availability, the tone also began to elicit ach release in the bla, suggesting that mice learned that the tone is a salient event predicting reward availability. since there are multiple sources of ach input to the bla, it was important to determine whether nbm cholinergic neurons were active during the periods when ach levels were high (woolf, 1991) . recordings from cholinergic nbm-bla terminal fibers showed similar dynamics to ach measurements, suggesting that the nbm is a primary source of ach across the phases of cue-reward learning. perhaps the most well-known example of dynamic responding related to learning cue-reward contingencies and encoding of reward prediction errors is the firing of dopaminergic neurons of the ventral tegmental area (vta; schultz, 1998) . after sufficient pairings, dopaminergic neurons will fire figure 6 . non-contingent stimulation of cholinergic nbm-bla terminals is sufficient to enhance cue-reward learning. (a) experimental details of laser stimulation in non-contingent-chr2 mice. non-contingent-chr2expressing mice received the same number of light stimulations as contingent-chr2-expressing mice, but stimulation was only given during the iti, when non-contingent mice had not made a response within 2 s. injection sites and fiber placements are shown in figure 6-figure supplement 1a-b. (b) non-contingent nbm-bla optical stimulation also improves behavioral performance in cue-reward learning task. there was no significant difference in the number of rewards earned between eyfp (n = 6), contingent-chr2 (n = 5), or non-contingent-chr2 (n = 5) mice during pre-training. contingent-and non-contingent-chr2-expressing mice more rapidly earned significantly more rewards during training than eyfp-expressing mice. no differences were observed between groups during extinction training. mean ± sem eyfp: n = 6, contingent-chr2: n = 5, non-contingent-chr2: n = 5. horizontal white line: acquisition threshold, when a mouse began to earn 20 rewards consistently in training. individual data are shown in figure 6 -figure supplement 2a. (c) incorrect nose pokes. there was no significant difference in the number of incorrect nose pokes between groups during pre-training. contingent-and non-contingent-chr2-expressing mice made significantly fewer incorrect nose pokes during training than eyfpexpressing mice. no differences between groups were observed during extinction training. mean ± sem eyfp: n = 6, contingent-chr2: n = 5, non-contingent: n = 5. individual data are shown in figure 6 in response to the cue that predicts the reward, and no longer to the rewarding outcome, which corresponds with behavioral changes that indicate an association has been formed between conditioned stimuli (cs) and unconditioned stimuli (us). it should be noted that dopamine signaling is not unique in this learning-related dynamic response profile. serotonergic neuronal responses also evolve during reward learning in a manner distinct from dopaminergic neurons (zhong et al., 2017) . plasticity related to learning has also been observed in cholinergic neurons in the basal forebrain complex during aversive trace conditioning, such that after several training days, neuronal activity spans the delay between cs and us (guo et al., 2019) . additionally, a recent study suggested that ach may signal a valence-free reinforcement prediction error (sturgill et al., 2020) . future studies on the selective inputs to nbm to bla cholinergic neurons would be of interest to identify the links between brain areas involved in prediction error coding. we found that bla camkiia cells were most reliably activated following reward retrieval before contingency acquisition (both when they were receiving several rewards but no timeouts in pre-training and few rewards early in training). similar to the recording of ach levels, after acquisition, the tone began to elicit an increase in bla camkiia cell population activity. however, activity of camkiia neurons differed from ach signaling in the bla in important ways. ach was released in response to the salient events in the task that were best able to predict reward delivery or availability. by contrast, the activity of bla camkiia neurons was not tightly time-locked to correct nose poking, and instead followed reward retrieval until acquisition, when activity increased in response to tone onset. the divergent dynamics of ach release and camkiia neuron activity underscores that ach's role in the bla is to modulate, rather than drive, the activity of camkiia neurons, and therefore may alter dynamics of the network through selective engagement of different populations of gaba interneurons (unal et al., 2015) . neuronal activity and plasticity in the bla is required for both acquisition of appetitive learning (conditioned reinforcement) and fear conditioning, however the inputs that increase activity in the structure during salient events likely come from many brain areas (mckernan and shinnick-gallagher, 1997; rogan et al., 1997; tye et al., 2008) . in particular, dopaminergic inputs to the bla are important for acquisition of conditioned reinforcement and for linking the rewarding properties of addictive drugs to cues that predict their availability (cador et al., 1989) . our results indicate that ach is a critical neuromodulator upstream of the bla that is responsive to salient events, such as reward availability, motor actions that elicit reward, and cues that predict reward. we show here that increasing endogenous ach signaling in the bla caused mice to perform significantly better than controls in an appetitive cued-learning task. heightened ach release during learning of a cueaction-reward contingency led to fewer incorrect responses and increased acquisition rate in both female and male mice. the optical stimulation was triggered by correct nose poke, thus the cholinergic nbm-bla terminal fiber stimulation overlapped with all three salient events: tone, nose poke, and reward retrieval, since the tone terminated 2 s after correct nose poke. we chose this stimulation pattern, as opposed to linking optical stimulation to tone onset, to ensure stimulation was dependent on behavioral responses. therefore, stimulation did not precisely recapitulate the ach release profile observed in mice that had already acquired the task (when ach increases following tone onset). this suggests that behaviorally-contingent increases in bla ach are sufficient to enhance task acquisition (but see below). it is also possible that optogenetic-mediated ach release may last longer than endogenous, tone-evoked release. a simultaneous stimulation and recording approach would be required to compare ach release under both conditions (pisansky et al., 2019) . it is important to note that basal forebrain neurons have been demonstrated to co-release ach and gaba (ma et al., 2018; saunders et al., 2015) , and cholinergic basal forebrain neurons that project to the bla have been shown to co-express a glutamate transporter (ma et al., 2018; nickerson poulin et al., 2006) . thus, it is possible that both fiber photometry and optogenetic results could be influenced, in part, by co-release of other neurotransmitters from chat-positive neurons. future studies employing additional fluorescent neurotransmitter sensors (marvin et al., 2013; marvin et al., 2018; marvin et al., 2019) could help understand the interaction between the different signals employed by basal forebrain neurons. it is possible that ach improved learning by increasing the intensity of the reward, potentiating the learned association, improving discrimination, or a combination of these phenomena. however, increasing ach release in the bla was not inherently rewarding, because it did not support self-stimulation or real-time place preference. this is at odds with a recent study that found stimulation of nbm-bla cholinergic terminals could induce a type of place-preference and modest self-stimulation (aitta-aho et al., 2018) . perhaps slight differences in targeting of chr2 infusion or differences in the behavioral paradigm could be responsible for the lack of direct rewarding effects of optical chat terminal stimulation in the current study. other recent work (jiang et al., 2016) has demonstrated that stimulating this nbm-bla cholinergic pathway is sufficient to strengthen cued aversive memory, suggesting that the effect of ach in the bla may not be inherently rewarding or punishing but instead potentiates plasticity in the bla, allowing learning of cue-outcome contingencies. similarly, it is possible that ach alters motor activity. however, there were no effects of optical stimulation on locomotion or responding in the inactive nose poke port. in addition, during the pre-training phase when there was no consequence for incorrect nose pokes, all groups earned the same number of rewards, regardless of optical stimulation or pharmacological blockade of ach receptors, suggesting that ach is not involved in the motor aspects of the task or the value of the reward. indeed, differences emerged only during the training phase, when attention to the tone was critical to earn rewards. further, incorrect nose poking remained high for mice administered scopolamine. this suggests that scopolamine-treated animals were seeking the reward, as in the operant familiarization and pre-training phases of training, but were unable to learn that they should only nose poke in response to the tone. cell-type-specific expression of achrs and activity-dependent effects place cholinergic signaling at a prime position to shape bla activity during learning. for instance, late-firing interneurons in the bla exhibit nachr-dependent epsp's when no effect is seen on fast-spiking interneurons, while principal neurons can be either excited or inhibited through machrs, depending on activity level of the neuron at the time of cholinergic stimulation (unal et al., 2015) . bla machrs can support persistent firing in principal neurons and can be important for the expression of conditioned place preference behavior, as well as trace fear conditioning (baysinger et al., 2012; egorov et al., 2006; mcintyre et al., 1998) . similar to studies of trace fear conditioning, in which activity of the network over a delay period must be maintained, we found that metabotropic (machrs) but not ionotropic (nachrs) ach receptors were required for learning the contingency of this cue-reward task. the timing of cholinergic signaling can be a critical factor in the induction of synaptic plasticity in other brain regions, so we hypothesized that the enhancement of cue-reward learning observed might be dependent upon when nbm-bla terminal fibers were stimulated with respect to tone presentation and/or behavioral responses (gu and yakel, 2011) . however, we found that heightened ach signaling in the bla improved behavioral performance even when stimulations were explicitly unpaired with the cue or correct nose poking. this suggests that the effect of increased cholinergic signaling in the bla is long lasting, and that stimulation during a learning session is sufficient to potentiate synaptic events linking the cue to a salient outcome-even if cs and/or reward delivery are presented tens of seconds later. given the findings from fiber photometry recordings, which showed endogenous ach release was time-locked to salient stimuli during the task and evolved with learning, it is surprising that time-locking of exogenous ach release was not necessary for enhancement of cue-reward learning. coupled with pharmacological evidence demonstrating that muscarinic signaling is necessary for reward learning in this task, these results suggest the involvement of metabotropic signaling downstream of muscarinic receptors that outlasts the initial cholinergic stimulation. to conclude, the abundant ach input to the bla results in ach release in response to stimuli that predict reward in a learned cue-reward task. increasing cholinergic signaling results in accelerated learning of the cue-reward contingency. these findings are consistent with the hypothesis that ach is a neuromodulator that is released in response to salient stimuli and suggests that ach signaling may enhance neuronal plasticity in the bla network, leading to accelerated cue-reward learning. key resources all procedures were approved by the yale university institutional animal care and use committee (protocol: 2019-07895) in compliance with the national institute of health's guide for the care and use of laboratory animals. experiments were performed in mice of both sexes, in keeping with the nih policy of including sex as a biological variable. sex of mice in behavioral graphs is indicated by circles for females and squares for males. female and male heterozygous mice with cre recombinase knocked into the choline acetyltransferase (chat) gene (chat-ires-cre, b6;129s6-chat tm2(cre)lowl/j , jackson laboratory, bar harbor, me) were bred in house by mating chat-ires-cre with c57bl6/j mice. camkiia-cre (tg(camk2acre)2gsc) mice obtained from ronald duman (casanova et al., 2001; wohleb et al., 2016) were bred in house as above. c57bl6/j mice were obtained from the jackson laboratory at 6-10 weeks of age, and tested at 5-7 months of age, following at least 1 week of acclimation. all mice were maintained in a temperature-controlled animal facility on a 12 hr light/dark cycle (lights on at 7:00 am). mice were group housed 3-5 per cage and provided with ad libitum food and water until undergoing behavioral testing. mice were single housed 1-3 weeks before surgery to facilitate food restriction and body weight maintenance. surgical procedures for behavior were performed in fully adult mice at 4-6 months of age, agematched across conditions. for viral infusion and fiber implantation, mice were anesthetized using isoflurane (induced at 4%, maintained at 1.5-2%) and secured in a stereotactic apparatus (david kopf instruments, tujunga, ca). the skull was exposed using a scalpel and bregma was determined using the syringe needle tip (2 ml hamilton neuros syringe, 30 gauge needle, flat tip; reno, nv). for fiber photometry surgeries, 0.4 ml of aav9 hsyn-ach3.0 (vigene biosciences inc) to measure bla ach levels ( figure 2a -e + figure 2 -figure supplements 1-2) was delivered unilaterally to the bla (a/p; à1.34 mm, m/l + or -2.65 mm, d/v à4.6 mm, relative to bregma) of chat-ires-cre or wild-type c57bl6/j mice at a rate of 0.1 ml/min. the needle was allowed to remain at the infusion site for 5 min before and 5 min after injection. a mono fiber-optic cannula (1.25 mm outer diameter metal ferrule; 6 mm long, 400 mm core diameter/430 mm outer diameter, 0.48 numerical aperture (na), hard polymer cladding outer layer cannula; doric lenses, quebec city, quebec, canada) was implanted above the bla (a/p; à1.34 mm, m/l + 2.65 mm, d/v à4.25 mm) and affixed to the skull using opaque dental cement (parkell inc, edgewood, ny). for bla camkiia cell calcium dynamic recordings (figure 3 + figure 3-figure supplements 1-2) , 0.5 ml of aav1 syn-flex-gcamp6s-wpre-sv40 (addgene, watertown, ma) was injected into the left bla using the same procedure and coordinates but was injected into camkiia-cre mice. cholinergic nbm-bla terminal fiber calcium dynamic recording ( figure dana et al., 2016; dana et al., 2019) . mice were allowed to recover in a cage without bedding with a microwavable heating pad underneath it until recovery before being returned to home cage. for 2 d following surgery, mice received 5 mg/kg rimadyl i.p (zoetis inc, kalamazoo, mi) as postoperative care. figure 6-figure supplements 1-2) , surgeries were performed as above except as follows: 0.5 ml of control vector (aav2 ef1a-dio-eyfp) or channelrhodopsin (aav2 ef1a-dio-hchr2(h134r)-eyfp; university of north carolina gene therapy center vector core, chapel hill, nc) was delivered bilaterally into the nbm (a/p: -0.7 mm, m/l ± 1.75 mm, d/v -4.5 mm) of chat-ires-cre mice. mono fiber-optic cannulas (1.25 mm outer diameter zirconia ferrule; 5 mm long, 200 mm core diameter/245 mm outer diameter, 0.37 na, polyimide buffer outer layer cannula; doric lenses) were inserted bilaterally above the basolateral amygdala (bla, a/p; à1.22 mm, m/l ± 2.75 mm, d/v à4.25 mm). mice were randomly assigned to eyfp or chr2 groups, controlling for average group age. for ex vivo local field potential electrophysiology experiments ( figure 4b) , the nbm was injected with dio-chr2-eyfp as described above, except mice were 8 weeks of age (see supplemental methods for current clamp recording methods). the coronal brain slices containing the nbm were prepared after 2-4 weeks of expression. briefly, mice were anesthetized with 1â fatal-plus (vortech pharmaceuticals, dearborn, mi) and were perfused through their circulatory systems to cool down the brain with an ice-cold (4˚c) and oxygenated cutting solution containing (mm): sucrose 220, kcl 2.5, nah 2 po 4 1.23, nahco 3 26, cacl 2 1, mgcl 2 6 and glucose 10 (ph 7.3 with naoh). mice were then decapitated with a guillotine immediately; the brain was removed and immersed in the ice-cold (4˚c) and oxygenated cutting solution to trim to a small tissue block containing the nbm. coronal slices (300 mm thick) were prepared with a leica vibratome (leica biosystems inc, buffalo grove, il) after the tissue block was glued on the vibratome stage with loctite 404 instant adhesive (henkel adhesive technologies, dü sseldorf, germany). after preparation, slices were maintained at room temperature (23-25˚c) in the storage chamber in the artificial cerebrospinal fluid (acsf; bubbled with 5% co 2 % and 95% o 2 ) containing (in mm): nacl 124, kcl 3, cacl 2 2, mgcl 2 2, nah 2 po 4 1.23, nahco 3 26, glucose 10 (ph 7.4 with naoh) for recovery and storage. slices were transferred to the recording chamber and constantly perfused with acsf with a perfusion rate of 2 ml/min at a temperature of 33˚c for electrophysiological experiments. cell-attached extracellular recording of action potentials was performed by attaching a glass micropipette filled with acsf on eyfp-expressing cholinergic neurons with an input resistance of 10-20 mw under current clamp. blue light (488 nm) pulse (60 ms) was applied to the recorded cells through an olympus bx51wi microscope (olympus, waltham, ma) under the control of the sutter filter wheel shutter controller (lambda 10-2, sutter instrument, novato, ca). all data were sampled at 3-10 khz, filtered at 3 khz and analyzed with an apple macintosh computer using axograph x (axograph). events of field action potentials were detected and analyzed with an algorithm in axograph x as reported previously (rao et al., 2008) . one week after surgery, mice were weighed daily and given sufficient food (2018s standard chow, envigo, madison, wi) to maintain 85% free-feeding body weight. all behavioral tests were performed during the light cycle. mice were allowed to acclimate to the behavioral room for 30 min before testing and were returned to the animal colony after behavioral sessions ended. two weeks after surgery, mice were handled 3 min per day for 7 d in the behavioral room. mice were given free access to the reward (ensureplus vanilla nutrition shake solution mixed with equal parts water (ensure); abbott laboratories, abbott park, il) in a 50 ml conical tube cap in their home cages on the last 3 d of handling to familiarize them to the novel solution. mice were also habituated to patch cord attachment during the last 3 d of handling for optical stimulation and fiber photometry experiments. immediately before training each day, a patch cord was connected to their optical fiber(s) via zirconia sleeve(s) (1.25 mm, doric lenses) before being placed in the behavioral chamber. all operant training was carried out using med associates modular test chambers and accessories (env-307a; med associates inc, georgia, vt). for optical stimulation experiments, test chambers were housed in sound attenuating chambers (env-022m). two nose poke ports (env-313-m) were placed on the left wall of the chamber and the reward receptacle (env-303lphd-rl3) was placed on the right wall. the receptacle cup spout was connected to a 5 ml syringe filled with ensure loaded in a single speed syringe pump (phm-100). nose pokes and receptacle entries were detected by infrared beam breaks. the tone generator (env-230) and speaker (env-224bm) were placed outside the test chamber, but within the sound attenuating chamber, to the left. the house light (used for timeout, env-315m) was placed on top of the tone generator to avoid snagging patch cords. each chamber had a fan (env-025f28) running throughout the session for ventilation and white noise. behavior chambers were connected to a computer running medpc iv to collect event frequency and timestamps. for optical stimulation experiments, a hole drilled in the top of the sound attenuating chambers allowed the patch cord to pass through. initial bla ach3.0 (figure 2a-e) and bla camkiia gcamp6s (figure 3 ) fiber photometry recordings occurred in a darkened behavioral room outside of sound attenuating chambers due to steric constraints with rigid fiber photometry patch cords. later behavioral chamber optimization (wall height was extended with 3d printed and laser cut acrylic panels to allow removing the test chamber lid while preventing escape) allowed all other fiber photometry cohorts to be tested inside sound attenuating chambers. for fiber photometry experiments, a custom receptacle was 3d printed that extended the cup beyond the chamber wall to allow mice to retrieve the reward with more rigid patch cords. each mouse was pseudo-randomly assigned to behavioral chamber when multiple chambers were used, counterbalancing for groups across boxes. three weeks after surgery, initial operant familiarization consisted of one 35 min session of free reward to demonstrate the location of reward delivery; all other sessions were 30 min. during free reward, only the reward receptacle was accessible. after 5 min of habituation, ensure (24 ml over 2 s) was delivered in the receptacle cup and a light was turned on above the receptacle. the receptacle light was turned off upon receptacle entry. the next phase of operant familiarization, mice learned to nose poke to receive reward on a fixed-ratio one (fr1) schedule of reinforcement. mice in experiments involving manipulations (optical stimulation and antagonist studies) were pseudo-randomly assigned to left or right active (reinforced) nose poke port. mice in fiber photometry experiments were all assigned to right active port to minimize potential across subject variability. the inactive (unreinforced) port served as a locomotor control. during fr1 operant familiarization, each nose poke response into the active port resulted in receptacle light and reward delivery. after the mice reached criterion on fr1 operant familiarization (group average of 30 rewards for 2 consecutive days, usually 4-5 d), mice were advanced to the pre-training phase. this phase incorporated an auditory tone (2.5-5 khz,~60 db) that lasted for at most 10 s and signaled when active nose pokes would be rewarded. only active nose pokes made during the 10 s auditory tone (correct nose pokes) resulted in reward and receptacle light delivery. the tone co-terminated with ensure delivery. during pre-training, there was no consequence for improper nose pokes, neither in the active port outside the tone (incorrect nose pokes) nor in the inactive port (inactive nose pokes). the number of inactive nose pokes were typically very low after operant familiarization and were not included in analysis. after reward retrieval (receptacle entry following reward delivery) the receptacle light was turned off and the tone was presented again on a variable intertrial interval schedule with an average interval of 30 s (vi 30), ranging from 10 to 50 s (ambroggi et al., 2008) . after 4-5 d of pre-training, mice progressed to the training phase, which had the same contingency as pre-training except incorrect nose pokes resulted in a 5 s timeout signaled by house light illumination, followed by a restarting of the previous intertrial interval. mice were considered to have acquired the task after earning 20 rewards during the training phase of the task. in order to promote task acquisition, mice that were not increasing number of rewards earned reliably were moved to a vi 20 schedule after 9 d of vi 30 training for bla ach3.0 or 6-7 d for bla camkiia cell mice. the vi 20 schedule was only needed for the two groups that were trained outside of the sound attenuating chambers. mice progressed to extinction after 12 d of training or, in the case of fiber photometry cohorts, once all mice met the acquisition criteria. extinction was identical to training except no ensure was delivered in response to correct nose pokes. the replicate cohorts of the bla camkiia gcamp6s and nbm-bla terminal fiber recording experiments were advanced to 1 d of extinction after only 7 d of training due to the covid-19 shutdown. between mice, excrement was removed from the chambers with a paper towel. at the end of the day chambers were cleaned with rescue disinfectant (virox animal health, oakville, ontario, canada) and ensure syringe lines were flushed with water then air. mice were excluded from analyses if a behavioral chamber malfunctioned (e.g. syringe pump failed) or they received the improper compound. fiber photometry mice were excluded from analyses if they did not meet the acquisition criterion by the last day of training. see supplementary file 1 for number of mice that acquired, were excluded, and further explanations for behavioral paradigm deviations. optical stimulation was generated by a 473 nm diode-pumped solid-state continuous wave laser (opto engine llc, midvale, ut) controlled by a ttl adapter (sg-231, med associates inc). the laser was connected to a fiber optic rotary joint (doric lenses) via a mono fiber optic patch cord (200 mm core, 220 mm cladding, 0.53 na, fc connectors; doric lenses). the rotary joint was suspended above the sound attenuating chamber with a connected branching fiber optic patch cord (200 mm core, 220 mm cladding, 0.53 na, fc connector with metal ferrule; doric lenses) fed into the behavioral box. laser power was adjusted to yield 10-12 mw of power at each fiber tip. the stimulation pattern was 25 ms pulses at 20 hz for 2 s modified from parameters in jiang et al., 2016. jiang et al. used a 20 hz pulse frequency, 5 ms pulses, and 10-12 mw power at the fiber tips. in this study, we used a 2 s stimulation duration because it matched the time of syringe pump activation for reward delivery and co-terminated with the pump and auditory tone. a 25 ms pulse width was used because our lasers were not able to generate sufficient power with 5 ms pulses. optical stimulation was only delivered during the pre-training and training phases of the operant task. both control (eyfp) and experimental (chr2) groups received identical light delivery, and stimulation was triggered by a correct nose poke and co-terminated with the auditory tone and ensure delivery. for the non-contingent experiment, the number of light stimulations was yoked to the concurrently running chr2 mouse. the timing of the non-contingent stimulation was explicitly unpaired with correct nose pokes or tones and was held in queue until the mouse had not made a response in the last 2 s, a tone was not going to be delivered within the next 2 s, or at least 5 s had passed since the mouse entered the receptacle after earning reward. fluorescent measurements of ach and calcium levels were recorded using two doric lenses 1-site fiber photometry systems: a standard 405/465 nm system and a 405/470/560 nm system. the standard 405/465 system was configured as follows: the fiber photometry console controlled the two connectorized leds (cleds, 405 nm modulated at 208.616 hz and 465 nm modulated at 572.205 hz) through the led module driver (cassidy et al., 2019) . each cled was connected via attenuating patch cord to the five-port fluorescence minicube (fmc5_ae(405)_af(420-450)_e1(460-490)_f1 (500-550)_s). a pigtailed fiber optic rotary joint was connected to the minicube and suspended above the behavioral chamber with a rotary joint holder in order to deliver and receive light through the implanted optical fiber. the other end of the rotary joint was connected to the mono fiber optic patch cord via m3 connector and attached with a zirconia sleeve to the implanted fiber optic as above. the f1 (500-550 nm) port of the minicube was connected to the photoreceiver (ac low mode, new focus 2151 visible femtowatt photoreceiver, new focus, san jose, ca) via a fiber optic adapter (doric lenses) that was finally connected back to the fiber photometry console through an analog port. the 405/470/560 nm system was set up similarly, except a 560 nm led was incorporated (modulated at 333.786 hz), a six-port minicube with two integrated photodetector heads was used (ifmc6_ie(400-410)_e1(460-490)_f1(500-540)_e2(555-570)_f2(580-680)_s), and doric fluorescence detector amplifiers were used (ac 1â or 10â mode, dfd_foa_fc). a ttl adapter (sg-231, med associates inc) was connected to the digital input/output port to allow for timestamping when events occurred in the behavioral chamber. signal was recorded using doric neuroscience studio (v 5.3.3.14) via the lock-in demodulation mode with a sampling rate of 12.0 ks/s. data were decimated by a factor of 100 and saved as a comma-separated file. pre-processing of raw data was performed using a modified version of a matlab (mathworks, natick, ma) script provided by doric. the baseline fluorescence (f0) was calculated using a firstorder least mean squares regression over the~30 min recording session. second-order least mean squares regressions were used when photobleaching of the sensor was more pronounced, as in the case of nbm-bla terminal fiber recordings. the change in fluorescence for a given time point (df) was calculated as the difference between it and f0, divided by f0, which was multiplied by 100 to yield %df/f0. the %df/f0 was calculated independently for both the signal (465 nm) and reference (405 nm) channels to assess the degree of movement artifact. since little movement artifact was observed in the recordings (figure 2-figure supplement 1b-c, figure 2 -figure supplement 5d-e, figure 3 -figure supplement 1c-d, tan lines), the signal %df/f0 was analyzed alone (the code provided allows for running the entire analysis pipeline with the reference channel %df/f0 if desired). the %df/f0 was z-scored to give the final z%df/f0 reported here. for the bla camkiia cell recordings (figure 3-figure supplement 1c-d) , the reference channel displayed some mirroring (moving in the opposite direction) compared to the signal. this is likely because 405 nm is not the 'true' isosbestic point for gcamp and we were instead measuring some changes in calciumunbound gcamp rather than calcium-insensitive gcamp signal alone (barnett et al., 2017; kim et al., 2016a; sych et al., 2019) . graphs and heatmaps for averaged traces aligned to actions were based on licking bout epoch filtering code from tdt (alachua, fl; link in code comments). combined action heatmaps were generated in matlab (2020a) by analyzing data 5 s preceding tone onset (rewarded trials only) to 5 s after receptacle entry. actions were aligned despite variable latencies by evenly splitting a maximum of 4 s post-tone onset/pre-correct nose poke and 1 s postcorrect nose poke/pre-receptacle entry for each trial within a day. the resulting aligned trials were averaged to generate daily averages that made up the rows of the individual animal heatmaps. blanks in the rows of heatmaps (black time bins) indicate time bins added for alignment, meaning that no trials for that day had a latency that stretched the entire window. only rewarded trials where the mouse entered the receptacle within 5 s after nose poke were analyzed. full or partial training days were excluded from analysis if there were acquisition issues such as the patch cord losing contact with the fiber or behavioral apparatus malfunction. lack of trials (fewer than three) for analysis or recording issues led to missing rows of fiber photometry data in the heatmap despite having behavioral data, in which case these rows were skipped rather than adding entire blank rows. due to individual differences in behavior, across-mouse average data was calculated by using a selection of days in which behavior was roughly similar or milestones such as the first and last day of pre-training, first day earning 10 rewards in training, first day crossing acquisition threshold (and maintaining afterward), last day of training, last day of extinction (with three or more rewarded trials that met analysis criteria). additional days were included in across-mouse average heatmaps when possible. incorrect nose poke heatmaps were generated by averaging signals for 5 s before and 5 s after incorrect nose pokes that were not preceded by an incorrect nose poke in the last 5 s. the incorrect nose poke heatmaps averaged across mice were generated using the same selection of days as the combined action heatmaps for a given experiment. bootstrapped confidence intervals (bcis) of the z-scored % df/f0 fiber photometry data within and across mice were generated using the methods described in jeanrichard-dit-bressel et al., 2020 for the following events: tone onset, correct nose poke, receptacle entry, and incorrect nose poke. for the within-mouse analysis by day, trials were aligned to event onset, and bcis were generated for events that had at least 3 trials from 5 s before to 10 s after each event. each series of data were bootstrapped 10,000 times and a two-sided 99% confidence interval was constructed. data were considered significantly different from baseline (z% df/f0 = 0) when their 99% bcis did not contain zero for an interval of time designated by a consecutive threshold of 0.5 s. to avoid comparing vastly different numbers of trials, in graphs where correct and incorrect nose pokes were plotted together, incorrect nose pokes were downsampled to match the number of correct nose poke trials. for incorrect nose pokes graphs where last pre-training day and training day 1 were plotted together, both days were downsampled to the number of correct nose pokes on the last pre-training day. for the combined action bci plots (tone onset, correct nose poke, and receptacle entry), the selection of days for each mouse matched that of the cohort-averaged combined action heatmaps. the three-event plots were combined by cropping to match the maximum latencies used in the combined action heatmaps. for the across-mouse averaged bci plots, analyses were carried out as above except the bootstrapping used mouse trial averages. the mean lines for across-mouse averaged bci plots were calculated by taking the mean of all individual trials together. the nbm-bla cholinergic terminal fiber experiment required combining the two independent cohorts to obtain n ! 3. for the incorrect nose poke bci plots, the number of trials used for each day was downsampled to 20 if a mouse performed more than 20. male wild-type c57bl/6j mice were injected i.p. 30 min before each pre-training and training session with a volume of 10 ml/kg with the following compounds: 1â dpbs (thermo fisher scientific, waltham, ma), 1 mg/kg mecamylamine hydrochloride (millipore sigma, st. louis, mo), 0.5 mg/kg (-) scopolamine hydrochloride (millipore sigma), or 1 mg/kg mecamylamine + 0.5 mg/kg scopolamine ( figure 5 + figure 5-figure supplement 1) . after completion of behavioral experiments, animals were anesthetized with 1â fatal-plus (vortech pharmaceuticals). once there was no response to toe-pinch, mice were transcardially perfused with 20 ml ice-cold 1â dpbs followed by 20 ml 4% paraformaldehyde (pfa, electron microscopy sciences, hatfield, pa). brains were extracted and post-fixed for at least 1 d in 4% pfa at 4˚c and transferred to 30% sucrose (millipore sigma) for at least 1 dy at 4˚c. brains were sliced 40 mm thick on a self-cooling microtome and stored in a 0.02% sodium azide (millipore sigma) pbs solution. brain slices were washed in pbs, blocked for 2-3 hr (0.3% triton x-100, american bioanalytical, canton, ma; 3% normal donkey serum, jackson immunoresearch, west grove, pa), then incubated overnight with primary antibodies (1:1000 + 1% normal donkey serum). slices were then washed in pbs and incubated with secondary antibodies (1:1000) for 2 hr, washed, stained with dapi for 5 min, washed, mounted, and coverslipped with fluoromount-g (electron microscopy sciences). all incubations were at room temperature. microscope slides were imaged using a fluoview fv10i confocal microscope (olympus). injection sites and fiber placements were designated on modified allen mouse brain atlas figures (lein et al., 2007) . mice were excluded from analyses if fluorescence was not observed at injection sites or if fiber tips were not identified at the intended site. operant behavioral data saved by medpc iv was transferred to excel using mpc2xl. data were organized in matlab and analyzed in prism (v8.3.0, graphpad software, san diego, ca). differences between groups and interactions across days for training were evaluated using two-way repeated measures anovas. we computed the required sample size for a 90% power level with an alpha of 0.05 by estimating the control (eyfp) group mean would be 10 rewards and the mean experimental (chr2) group would be 20 rewards with a standard deviation of 5. we utilized a power calculator for continuous outcomes of two independent samples, assuming a normal distribution. the result was six samples per group. each manipulation experiment started with at least six mice included in each group (sealed envelope, 2020) . in each experiment, each animal within a group served as a biological replicate. these studies did not include technical replicates. masking was not applied during data acquisition but data analyses were semi-automated in matlab and performed blind to condition. editing; miao jing, yulong li, resources, writing -review and editing; xiao-bing gao, data curation, formal analysis, investigation, writing -review and editing; yann s mineur, conceptualization, investigation, methodology, writing -review and editing; marina r picciotto, conceptualization, resources, supervision, funding acquisition, project administration, writing -review and editing supplementary files . supplementary file 1. number of mice that acquired the reward learning behavior, number that were excluded, and any training deviations. (a) mice in the initial bla ach3.0 group were trained outside of the sound attenuating chambers. these mice had 5 dof pre-training because they were trained concurrently with another cohort of mice (not shown) that required an extra day to reach two consecutive days of 20 rewards earned and were advanced to a vi 20 schedule of reinforcement during training after 9 d to promote responding. training was extended to allow all mice to acquire. due to time constraints during acquisition, mouse 3 in this cohort was moved to extinction after 20 d of training because it had acquired earlier, was earning the most rewards, and we wanted to record more extinction days. (b) mice in the bla ach3.0 and nbm-bla terminal fiber replicate experiments were advanced to 1 d of extinction after only 7 d of training due to the covid-19 shutdown. (c) bla ach3.0 and nbm-bla terminal fiber jrcamp1b mice were analyzed as dual channel mice just through pre-training and were instead used as replicates of the bla ach3.0 experiment. one of the mice had apparatus errors during training and had to be excluded. (d) mice in the initial bla camkiia gcamp6 were trained outside of the sound attenuating chambers. mouse 1 progressed from pre-training to training a day earlier than the rest of the group and was able to have an extra day of training before the 2 d of extinction. mice in this group were advanced to a vi 20 schedule of reinforcement during training after 6-7 d to promote responding. training was extended to allow more mice to acquire. . transparent reporting form data availability all data generated or analysed during this study are included in the manuscript and supporting files. source data files have been provided for all experiments on dryad digital repository: https://doi. org/10.5061/dryad.3xsj3txcf. the following dataset was generated: conceptualization, resources, data curation, software, formal analysis, validation, investigation, visualization, methodology, writing -original draft data curation, formal analysis, investigation, methodology, writing -review and editing conceptualization, data curation, investigation, methodology, writing -review and editing data curation, software, formal analysis, investigation, visualization, writing -review investigation, methodology, writing -review and editing basal forebrain and brainstem cholinergic neurons differentially impact amygdala circuits and learning-related behavior basolateral amygdala neurons facilitate reward-seeking behavior by exciting nucleus accumbens neurons deciphering the molecular mechanism responsible for gcamp6m's ca2+-dependent change in fluorescence the amygdala and reward muscarinic receptors in amygdala control trace fear conditioning activation of phenotypically-distinct neuronal subpopulations of the rat amygdala following exposure to predator odor involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum a camkiialpha icre bac allows brain-specific gene inactivation a lateral hypothalamus to basal forebrain neurocircuit promotes feeding by suppressing responses to anxiogenic environmental cues ultrasensitive fluorescent proteins for imaging neuronal activity a cholinergic mechanism for reward timing within primary visual cortex sensitive red protein calcium indicators for imaging neural activity. elife 5:e12727 high-performance calcium sensors for imaging activity in neuronal populations and microcompartments muscarinic control of graded persistent activity in lateral amygdala neurons amygdala inputs to the ventral hippocampus bidirectionally modulate social behavior timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity the cholinergic basal forebrain links auditory stimuli with delayed reinforcement to support learning central cholinergic neurons are rapidly recruited by reinforcement feedback from circuits to behaviour in the amygdala analyzing event-related transients: confidence intervals, permutation tests, and consecutive thresholds cholinergic signaling controls conditioned fear behaviors and enhances plasticity of cortical-amygdala circuits a genetically encoded fluorescent acetylcholine indicator for in vitro and in vivo studies an optimized acetylcholine sensor for monitoring in vivo cholinergic activity simultaneous fast measurement of circuit dynamics at multiple sites across the mammalian brain antagonistic negative and positive neurons of the basolateral amygdala the lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning genome-wide atlas of gene expression in the adult mouse brain selective activation of a putative reinforcement signal conditions cued interval timing in primary visual cortex state-specific gating of salient cues by midbrain dopaminergic input to basal amygdala dual-transmitter systems regulating arousal, attention, learning and memory an optimized fluorescent probe for visualizing glutamate neurotransmission stability, affinity, and chromatic variants of the glutamate sensor iglusnfr a genetically encoded fluorescent sensor for in vivo imaging of gaba projection neurons of the basolateral amygdala: a correlative golgi and retrograde tract tracing study intra-amygdala infusions of scopolamine impair performance on a conditioned place preference task but not a spatial radial maze task fear conditioning induces a lasting potentiation of synaptic currents in vitro cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male c57bl/6j mice vesicular glutamate transporter 3 immunoreactivity is present in cholinergic basal forebrain neurons projecting to the basolateral amygdala in rat prefrontal acetylcholine release controls cue detection on multiple timescales acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior nucleus accumbens fast-spiking interneurons constrain impulsive action regulation of synaptic efficacy in hypocretin/orexin-containing neurons by melanin concentrating hormone in the lateral hypothalamus fear conditioning induces associative long-term potentiation in the amygdala visual responses of neurons in the dorsolateral amygdala of the alert monkey forebrain cholinergic signaling: wired and phasic, not tonic, and causing behavior corelease of acetylcholine and gaba from cholinergic forebrain neurons orbitofrontal cortex and basolateral amygdala encode expected outcomes during learning a neural substrate of prediction and reward predictive reward signal of dopamine neurons power calculator for continuous outcome superiority trial basolateral amygdala neurons maintain aversive emotional salience basal forebrainderived acetylcholine encodes valence-free reinforcement prediction error high-density multi-fiber photometry for studying large-scale brain circuit dynamics rapid strengthening of thalamo-amygdala synapses mediates cue-reward learning amygdala circuitry mediating reversible and bidirectional control of anxiety amygdala neurons differentially encode motivation and reinforcement impact of basal forebrain cholinergic inputs on basolateral amygdala neurons gaba interneurons mediate the rapid antidepressant-like effects of scopolamine cholinergic systems in mammalian brain and spinal cord the basal forebrain cholinergic projection system in mice. the mouse nervous system was connected to a computer running ethovision xt (version 10.1.856, noldus, wageningen, netherlands) to track the position of the mouse and deliver optical stimulation when the mouse was on the laserpaired side (via ttl pulse to otpg_4 laser controller (doric lenses) connected to the laser; 20 hz, 25 ms pulses). optical stimulation on a progressive ratio schedule (escalations given below) these studies were supported by grants da14241, da037566, mh077681. lw, dt, and pr were supported by ns022061, mh109104 from the national institutes of health, and by the intramural programs of ninds and nimh. x-bg was supported by da046160. rbc was supported by t32-ns007224. this work was funded in part by the state of connecticut, department of mental health and addiction services but this publication does not express the views of the department of mental health and addiction services or the state of connecticut. the views and opinions expressed are those of the authors. we thank samantha sheppard for the use of her mouse illustration and animal care assistance and nadia jordan-spasov for genotyping and laboratory help. li jiang performed the ex vivo current-clamp recordings. angela lee and wenliang zhou provided helpful input into experimental planning. colin bond, marcelo dietrich, usman farooq, onur iyilikci, sharif kronemer, matthew pettus, and zach saltzman provided insightful discussion and assistance with analysis and figure design. ralph dileone, stephanie groman, hyojung seo, and jane taylor offered helpful discussion about experimental design and analysis. the support teams at doric lenses (alex cô té and the funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. olivier dupont-therrien) and tucker-davis technologies provided discussion, analysis support, and matlab code assistance. supplemental methods ex vivo electrophysiology slice preparation coronal brain slices were prepared from virus injected mice after 3 weeks from surgery. animals were anesthetized with a mixture of ketamine and xylazine (100 mg ketamine and 6 mg xylazine/kg body weight injected ip). then the mice were transcardially perfused with a sucrose-based solution (see below). after decapitation, the brain was rapidly transferred into a sucrose-based cutting solution bubbled with 95% o 2 and 5% co 2 and maintained at~3˚c. this solution contained (in mm): sucrose 230; kcl 2.5; mgso 4 10; cacl 2 0.5; nah 2 po 4 1.25; nahco 3 26; glucose 10 and pyruvate 1.5. coronal brain slices (300 mm) were prepared using a leica vt1000s vibratome (leica biosystems inc). slices were equilibrated with a mixture of oxygenated artificial cerebrospinal fluid (acsf) and sucrose-based cutting solution at room temperature (24-26˚c) for at least 1 hr before transfer to the recording chamber. pyruvate (0.15-0.75 mm) was added to reduce oxidative damage and enhance survival. with this protocol, slices are initially incubated in a mixture of 50% cutting solution with pyruvate and 50% acsf (in mm): sucrose 115; nacl 63; kcl 2.5; nah 2 po 4 1.25; mgso 4 5; cacl 2 1.25; mgcl 2 1; nahco 3 26; glucose 10; and sodium pyruvate 0.75 at 35˚c for 30 min and then transferred to a mixture of 10% cutting solution and 90% acsf (in mm): sucrose 23; nacl 113.4; kcl 2.5; nah 2 po 4 1.25; mgso 4 1; cacl 2 1.85; mgcl 2 1.8; nahco 3 26; glucose 10; and sodium pyruvate 0.15 at 35˚c for 1-4 hr before recording. the slices were continuously superfused with acsf at a rate of 2 ml/min containing (in mm); nacl 126, kcl 2.5, nah 2 po 4 1.25, nahco 3 26, cacl 2 2, mgcl 2 2 and glucose 10 bubbled with 95% o 2 and 5% co 2 at room temperature. brain slices were placed on the stage of an upright, infrared-differential interference contrast microscope (olympus bx51wi, olympus). nbm neurons were visualized with a 40 â water-immersion objective by infrared microscopy (cohu 4915 camera, cohu, inc, poway, ca). patch electrodes with a resistance of 4-6 mw were pulled with a laser-based micropipette puller (p-2000, sutter instrument company). signals were recorded with a multi clamp 700a amplifier and pclamp10 software (molecular devices, inc, san jose, ca). the pipette solution contained (in mm) 130 k-gluconate, 2 kcl, 2 mgcl 2 , 10 hepes, 0.5 egta, 1 atp and 0.2 gtp (ph = 7.3).to examine action potential firing frequency, nbm neurons were recorded in a current clamp configuration after forming a giga-ohm seal. membrane potentials were clamped at à60 mv by injecting 0-~50 pa current through the recording electrode as needed. cells that maintained steady membrane potentials for at least five mins were included in the analysis. channelrhodopsin was activated with a train of light flashes delivered through the 40â microscope objective. the light source was an olympus x-cite 120q lamp (olympus) gated with a ttl controlled shutter (lambda sc, sutter instrument). the filter cube contained an hq480/40x excitation filter, a q505lp bypass filter and an hq535/50 m emission filter (chroma technology corp., bellows falls, vt). the fluorescence illumination intensity delivered at the brain slices was adjusted to 1-3 mw/ mm 2 , measured with a pm100d optical power and energy meter (thorlabs inc, newton, nj). in the nbm, cholinergic neurons were identified by egfp fluorescence and light flashes were delivered at 1 hz, 5 hz, 10 hz, 15 hz, 20 hz, 25 hz, and 30 hz. after xtinction, responding was reinstated in training for 2 d. then mice underwent a modified training paradigm where correct nose pokes yielded only laser stimulation, without ensure delivery. locomotor data was collected using an accuscan instruments (columbus, ohio) behavior monitoring system and software. mice were individually tested in empty cages, with bedding and nesting material removed to prevent obstruction of infrared beams. mice were injected (i.p.) with saline, mecamylamine (1 mg/kg, sigma), scopolamine (0.5 mg/kg, sigma), or mecamylamine+scopolamine (1 mg/kg and 0.5 mg/kg, respectively) 30 min before locomotor testing. locomotion was monitored for 20 min using 13 photocells placed 4 cm apart to obtain an ambulatory activity count, consisting of the number of beam breaks recorded during a period of ambulatory activity (linear motion rather than quick, repetitive beam breaks associated with behaviors such as scratching and grooming). a rectangular box was divided evenly into a light (clear top, illuminated by an 8w tube light) and dark (black walls, black top) side with a black walled divider in the middle with a small door. the lid and divider were modified to allow the optical fiber and patch cord to pass through freely. mice were placed facing the corner on the light side furthest from the divider and the latency to crossing to the dark side was measured. the number of crosses and time spent on each side were measured for 6 min following the initial cross. key: cord-253459-tcn10pho authors: moreau, gregory brett; burgess, stacey l.; sturek, jeffrey m.; donlan, alexandra n.; petri, william a.; mann, barbara j. title: evaluation of k18-hace2 mice as a model of sars-cov-2 infection date: 2020-07-28 journal: am j trop med hyg doi: 10.4269/ajtmh.20-0762 sha: doc_id: 253459 cord_uid: tcn10pho murine models of sars-cov-2 infection are critical for elucidating the biological pathways underlying covid-19. because human angiotensin-converting enzyme 2 (ace2) is the receptor for sars-cov-2, mice expressing the human ace2 gene have shown promise as a potential model for covid-19. five mice from the transgenic mouse strain k18-hace2 were intranasally inoculated with sars-cov-2 hong kong/vm20001061/2020. mice were followed twice daily for 5 days and scored for weight loss and clinical symptoms. infected mice did not exhibit any signs of infection until day 4, when no other obvious clinical symptoms other than weight loss were observed. by day 5, all infected mice had lost around 10% of their original body weight but exhibited variable clinical symptoms. all infected mice showed high viral titers in the lungs as well as altered lung histology associated with proteinaceous debris in the alveolar space, interstitial inflammatory cell infiltration, and alveolar septal thickening. overall, these results show that the k18-hace2 transgenic background can be used to establish symptomatic sars-cov-2 infection and can be a useful mouse model for covid-19. an invaluable step in identifying effective vaccines and therapies to combat covid-19 is the availability of a mouse model of infection. the host receptor for sars-cov-2 is the human angiotensin-converting enzyme 2 (hace2), 1 which was previously identified as the receptor for the sars-cov-1 2 that causes sars, a disease that emerged from china in 2002. 3 the mouse ace2 ortholog, which has significant amino acid sequence variation in the viral receptor binding domain, cannot serve as an efficient receptor for either sars-cov-2 or cov-1. 4 a transgenic mouse model to study sars-cov-1 infection was developed that expresses the hace2 gene under the control of the human cytokeratin 18 promoter. 5 infection of these mice with sars-cov-1 results in a rapidly lethal infection. 5 four other hace2-expressing mouse lines have been created to date and tested for the ability to support sars-cov-2 infection. two lines express the hace2 gene under the control of the mouse ace2 promotor 6, 7 ; one was made using the crispr/cas9 technology. 7 the third strain uses the lung ciliated epithelial cell hepatocyte nuclear factor-3/ forkhead homologue 4 (hfh4) promoter. 8, 9 an additional approach was to transfect wild-type mice with an adenovirus carrying the hace2 gene. 10 overall, with the exception of the hfh4 mice, in which there was some lethality, infection of these three mouse strains with sars-cov-2 results in mild clinical symptoms and no lethality. here, we report the infection of k18-hace2 with sars-cov-2. although this infection resembled that of other strains, we observed variable clinical presentation, with some mice exhibiting more severe symptoms than reported using other models. overall, this work supports the usefulness of k18-hace2 transgenic mice as a model for human covid-19 infections. to investigate the potential of this transgenic mouse strain as a model for covid-19 infection, five k18-hace2 mice were intranasally inoculated with 8 × 10 4 median tissue culture infectious dose (tcid50) of sars-cov-2, and five mice were mock-infected with sterile dulbecco's modified eagle's medium (dmem). mice were followed twice daily for 5 days and scored for clinical symptoms (weight loss, eye closure, appearance of fur [piloerection] and posture, and respiration). the mock-infected mice did not exhibit any clinical symptoms or experience any weight loss throughout the experiment. infected mice did not exhibit any measurable clinical symptoms through day 3. on day 4, no other clinical symptoms other than weight loss were observed. on day 5, all the infected mice had lost around 10% of their original weight ( figure 1a ) and exhibited variability in other clinical signs of infection, with clinical scores ranging from 3 to 9 (maximal score 14) ( figure 1b ). although two of the infected k18-hace2 mice showed only mild symptoms at day 5 (weight loss and reduced activity), two mice exhibited piloerection. the most severe mouse had increased respiration, lethargy, and slight eye closure and met our criteria for euthanasia. because the study was ended on day 5, it is unclear whether the remaining four mice would have recovered if the study was carried past day 5. although the clinical severity was variable between infected k18-hace2 mice, our results suggest that these mice present with more symptomatic disease than other hace2 mouse models of sars-cov-2 infection. in the mouse model expressing hace2 under the mouse ace2 promoter, infected mice did not exhibit any clinical symptoms other than maximal weight loss on day 3 postinfection, and those mice recovered. 7 only mild ruffling of fur and up to 8% weight loss on day 5 were observed in the other model using the mouse ace2 promoter, and once again, all mice recovered. 6 in mice transfected with an adenovirus carrying the hace2 gene, mice exhibited about a 10% weight loss on day 4 postinfection but no lethality. 10 in contrast to these models, in which mice exhibited mild symptoms and recovered, only 60% of the mice survived past day 5 in the mouse strain expressing hace2 under the lung ciliated epithelial cell hfh4 promoter. 9 although this model had higher lethality, weight loss was only about 5% and these mice had no respiratory symptoms. the authors hypothesize that mortality may be due to neuroinvasion because virus was detected in the brain. in k18-hace2 mice infected with sars-cov-1, the course of infection is clearly different; the infection is uniformly fatal, beginning on day 4 postinfection, and mice were symptomatic with labored breathing and lethargy. 5 although the number of mice used in this study was small and we were not able to measure survival, our data support a difference in the disease progression between these two viruses. all mice were euthanized on day 5, and tissue was collected for dissection and enumeration of viral loads. no significant differences in histology of the spleen, small intestine, or liver were observed between infected and mock-infected mice, and these tissues were normal in size and appearance. dissection of the lungs of infected mice revealed a mottled or marbled appearance that was not observed in mock-infected mice (data not shown). lung sections were analyzed after staining with hematoxylin and eosin and scored based on tissue pathology. 11 sars-cov-2-infected mice exhibited significantly higher histopathology scores than mock-infected mice ( figure 2 ). the major histopathology findings in infected mice were proteinaceous debris in the alveolar space, neutrophils in the interstitial space, and alveolar septal thickening ( figure 2 ); these observations were consistent with other hace2 mouse models, which also detected signs of lung injury including interstitial pneumonia, inflammatory cell infiltrates, and alveolar septal thickening. 6, 7 consistent with the observed infiltrating neutrophils, granulocytes and inflammatory monocytes were also elevated in the bronchoalveolar lavage (bal) fluid from the infected mice ( figure 3 ). other hace2 mouse models of covid-19 infection have observed high viral titers in the lungs with limited viral load in organs such as the liver and spleen during intranasal infection. 6,7 although we did not investigate viral load in the liver or spleen, these organs appeared normal by histology, suggesting that there was limited viral titer in these tissues. virus was detected in the lungs of all infected mice, with titers generally in the range of 1 × 10 5 plaque forming units (pfu)/ml (table 1 ). viral titers in the lungs appeared somewhat associated with disease severity: mouse 1390, which had the highest lung titer, had the highest clinical score, histopathology score, and percent weight loss at day 5 (table 1 ) and the highest numbers of neutrophils, monocytes, and eosinophils in the bal (figure 3 ). in addition, mouse 1413, which had the lowest titer, had the lowest clinical score, second lowest percent weight loss at day 5 (table 1) , and lowest number of eosinophils and monocytes in the bal (figure 3 ). of note, mouse 1413 did not have the lowest histopathology score (table 1) . although there were trends toward higher viral titers in the lungs being associated with higher clinical and histopathology scores, these trends were not significant, and viral titer was not a strong predictor of percent weight loss. the power of this analysis is limited by the small sample size, but these results suggest that factors in addition to viral load, such as inflammatory responses, are driving the severity of disease. this would also potentially explain the sudden onset of clinical symptoms at 5 days post-inoculation. in this report, we have described the course of sars-cov-2 infection in k18-hace2 transgenic mice. our findings are consistent with other studies using hace2 mice, which observed successful infection with sars-cov-2 and a milder disease severity compared with sars-cov-1. 6, 7 the onset of symptoms was abrupt, manifesting on day 5. mice exhibited a similar degree of weight loss but a varying degree of symptoms and clinical/histopathological scores. the number of mice used in this study was too small to determine whether this was a result of experimental variability or natural variability in outcomes. the variance in clinical and histopathological scores may be partially explained by viral titer, but there are likely other factors, such as the host immune response, that contribute to the variance observed. the observation of more severe disease in a subset of the k18-hace2 mice is distinct from other hace2-expressing covid-19 models, which typically observed only mild clinical symptoms. 6, 7 this could be due to experimental differences such as strain differences or the challenge dose (table 2 ). to date, little is known about the possibility of virulence differences among isolates. hong kong/vm20001061/2020 and strain 2019n-cov/usa_wa1/ 2020 are closely related and have been classified as type ib. 12 the receptor-binding domains of these strains are 100% identical (data not shown). the phylogeny of hb-01 and wuhan/amms01/2020 has not been reported. the challenge dose used in each experiment is similar; our experiment used the lowest amount of inoculum. the resident microbiota in each mouse strain could also impact outcomes of infection. the other difference between these strains is in the level of hace2 receptor expression or tissue distribution. nonetheless, k18-hace2 transgenic mice may be a particularly useful , and respiratory rate (0-2). all mouse work was approved by the university's institutional animal care and use committee, and all procedures were performed in the university's certified animal biosafety level three laboratory. histology. tissues were fixed in formaldehyde. slides were scanned at ×20 magnification. histopathological scoring for lung tissues was performed according to the guidelines of the american thoracic society. 11 a two-tailed student's t test was used to determined statistical significance. viral titers. the left lobe of the lung was homogenized in 1 ml serum-free dmem with a disposable tissue grinder. plaque assays were performed as described. 13 in brief, vero c1008, clone e6 (atcc crl-1586) cells grown in dmem (gibco 11995-040) with fetal bovine serum (fbs) were seeded into at a concentration of 2 × 10 5 cells/well the night before the assay. serial dilutions were added to the wells. the plate was incubated at 37°c, 5% co 2 for 2 hours, shaking the plates every 15 minutes. after 2 hours, the media was replaced with a liquid overlay of dmem, 2.5% fbs containing 1.2% avicel ph-101 (sigma aldrich, st. louis, mo) and incubated at 37°c, 5% co 2 . after 3 days, the overlay was removed, wells were fixed with 10% formaldehyde, and stained with 0.1% crystal violet to visualize plaques. plaques were counted, and pfus were calculated according to the following equation: average # of plaques/dilution factor × volume diluted virus added to the well. 8, 9 not specified not specified ∼ 5% weight loss, no clinical symptoms, but only 60% survived adenovirus transfection 10 10 5 focus-forming units strain 2019n-cov/usa_wa1/2020 10% maximum weight loss, all recovered hace2 = human angiotensin-converting enzyme 2. this work was supported by nih grants r01 ai124214 to w. a. p., r01 ai146257 to s. l. b., and 5t32ai007496-23 to a. n. d., and the university of virginia's global infectious diseases institute. j. m. s. is a an ithriv scholar, a program supported in part by the national center for advancing translational sciences of the nih under award numbers ul1tr003015 and kl2tr003016 disclaimer: the content is solely the responsibility of the authors and does not necessarily represent the official views of the nih division of infectious diseases and international health receptor recognition by the novel coronavirus from wuhan: an analysis based on decade-long structural studies of sars coronavirus angiotensin-converting enzyme 2 is a functional receptor for the sars coronavirus a cluster of cases of severe acute respiratory syndrome in hong kong structural basis of receptor recognition by sars-cov-2 lethal infection of k18-hace2 mice infected with severe acute respiratory syndrome coronavirus the pathogenicity of sars-cov-2 in hace2 transgenic mice. nature (epub ahead of print a mouse model of sars-cov-2 infection and pathogenesis sars-like wiv1-cov poised for human emergence pathogenesis of sars-cov-2 in transgenic mice expressing human angiotensin-converting enzyme 2 a sars-cov-2 infection model in mice demonstrates protection by neutralizing antibodies an official american thoracic society workshop report: features and measurements of experimental acute lung injury in animals genomic variations of sars-cov-2 suggest multiple outbreak sources of transmission viral concentration determination through plaque assays: using traditional and novel overlay systems acknowledgments: we would like to gratefully acknowledge the advice and assistance of angelina angelucci and young hahn at the university of virginia as well as caitlin woodson and kylene kehn-hall at george mason university. publication charges for this article were waived due to the ongoing pandemic of covid-19. this is an open-access article distributed under the terms of the creative commons attribution (cc-by) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. key: cord-032982-xri24v40 authors: medinsky, m. a.; bechtold, w. e.; blrnbaum, l. s.; bond, j. a.; burt, d. g.; cheng, y. s.; glllett, n. a.; gulati, d. k.; hobbs, c. h.; plckrell, j. a. title: effect of inhaled azodicarbonamide on f344/n rats and b6c3f(1) mice with 2-week and 13-week inhalation exposures date: 1990-08-17 journal: fundam appl toxicol doi: 10.1093/toxsci/15.2.308 sha: doc_id: 32982 cord_uid: xri24v40 effect of inhaled azodicarbonamide on f344/n rats and b6c3f, mice with 2-week and 13-week inhalation exposures. medinsky, m. a., bechtold, w. e., birnbaum, l. s., bond, j. a., burt, d. g., cheng, y. s., gillftt, n. a., gulati, d. k., hobbs, c. h., and pick-rell, j. a. (1990). fundam. appl. toxicol 15, 308/319. azodicarbonamide (ada), a compound used in the baking and plastics industries, has been reported to cause pulmonary sensiti-zation and dermatitis in people. two-week repeated and 13-week subchronic inhalation exposures of f344/n rats and b6c3f, mice to ada were conducted to determine the toxicity of inhaled ada. the mean air concentrations of ada in the 2-week studies were 207, 102, 52, 9.4, or 2.0 mg/m3. no exposure-related mortality nor abnormal clinical signs were observed in rats or mice during or after exposure. the terminal body weights were slightly depressed in the highest exposure group. liver weights were lower in male rats exposed to 200 mg ada/m3. no significant lesions were noted on either gross or histologic evaluation of rats or mice. in the 13-week subchronic study, the mean air concentrations of ada were 204, 100, or 50 mg/m3. no mortality or clinical signs related to exposure were observed. the terminal body weights of exposed rats were not significantly different from those of control rats but were significantly depressed in mice exposed to 100 or 200 mg ada/m3. no histopathological lesions were noted in mice. lung weights were increased and enlarged mediastinal and/or tracheobronchial lymph nodes were noted in rats exposed to 50 mg ada/m3. no exposure-related lesions were observed microscopically in rats exposed to 100 or 200 mg ada/m3. all rats in the 50 mg ada/m3 exposure group only had lung lesions that consisted of perivascular cuffing with lymphocytes and a multifocal type ii cell hyperplasia, suggesting a possible immune reaction to an antigen in the lung. viral titers for rats exposed to 50 mg ada/m3 were negative for sendai virus and pneumonia virus of mice, which produce similar lesions. the possibility of an unknown viral antigen causing this lesion cannot be eliminated. lung tissue from male rats was analyzed for ada and biurea, the major metabolite of ada. no ada was detected. the amount of biurea in the lungs increased nonlinearly with increasing exposure concentration, suggesting that clearance was somewhat impaired with repeated exposures. however, even at the highest exposure concentration, this amount of biurea was less than 1 % of the estimated total ada deposited over the exposure period. in summary, ada is rapidly cleared from the lungs, even when inhaled at concentrations up to 200 mg/m3. exposure to ada for up to 13 weeks did not appear to be toxic to rodents ported by the fda, niosh, osha, and cpsc, because of (1) the high level of occupational exposure (~232,ooo workers) in the rubber, plastics, and baking industries; (2) levels of production as high as 10 million pounds per year, and (3) structural relationships to known carcinogens such as 3-aminotriazole, azoethane, and hydrazine. ada is an orange crystalline compound that is produced as a condensation product of urea and hydrazine. ada is an orange crystalline compound that is produced as a condensation product of urea and hydrazine. ada is manufactured predominantly as a fine yellowish powder milled to particle sizes in the range 2 to 10 mm (slovak, 1981) . principal worker exposure occurs in factories where it is ground and in bakeries where it is used as an additive in flour. because ada is used as a flour-maturing agent, toxicity testing using oral exposures was originally recommended. however, in making dough, ada is quantitatively reduced to biurea (1,2-hydrazinedicarboxylic acid diamide; h 2 nochn-nhconh 2 ). ada decomposes at temperatures > 180°c, releasing ammonia, nitrogen, and carbon monoxide and producing urazone, biurea, cyanuric acid, and cyanidine (herweh and fantazier, 1974) . subchronic toxicity testing of ada in rats and mice by gavage revealed only a nonspecific nephrotoxicity resulting from precipitation of ada (or biurea) in the kidneys of animals given 2.5 g/kg body wt or more. similarly, nonspecific nephrotoxicity was noted in dogs fed 5 or 10% biurea in their diet for up to 1 year (oser et al, 1965) . methemoglobin levels measured by oser et al. (1965) were below the limit of detection (0.2 mg/loog). ada has been reported to exhibit an antithyroid effect (gafford et al., \91\) and an inhibitory effect on cholinesterase activity in blood and liver (mel'nikova and selikhova, 1965) . anorexia, weight loss, and gross hematuria have also been observed in rats given ada intraperitoneally at a dose of 200 mg/ kg body wt daily for 1 week (gafford et al., 1971) . five out of eight rats died from this dose of ada. there were no deaths among rats given the same dose of ada orally. reports of airway constriction in workers exposed to ada suggest that ada might be an airway sensitizer or irritant. ferris et al. (1977) observed decreased forced vital capacity and forced expiratory volume in exposed workers. slovak (1981) reported the occurrence of asthma in almost one-fifth of workers in a factory manufacturing ada. whitehead et al. (1987) found symptoms similar to chronic bronchitis in workers in ada plants. one case of dermatitis, with a positive response to 1% ada in a patch test, was noted (bonsall, 1984) . studies of the effects of an acute, 1 -hr exposure of guinea pigs to ada (19, 5 8, or 97 mg/ m 3 ) demonstrated minor changes in tidal volume and respiratory frequency at the two higher concentrations (shopp et al., 1987) . no lesions were noted in respiratory tract tissue of animals euthanized immediately after exposure or 24 hr later. repeated exposure of guinea pigs to 51 or 200 mg ada/m 3 for 4 weeks did not result in either specific or nonspecific airway sensitization on inhalation challenge with ada or aerosolized histamine, respectively (gerlach et al., 1989) . the objective of the studies reported here was to describe the toxic effects in rats and mice of inhalation exposure for 2 or 13 weeks to airborne concentrations of ada as high as 200 mg/m 3 . azodicarbonamide, obtained from midwest research institute, was 98% pure, as determined by iodometric titration. the major impurity identified was biurea, which was from 0.4 to 0.7% of the bulk chemical. a compound stability study was also done to confirm that the chemical composition of ada did not change upon aerosolization. filter samples were analyzed by reverse-phase highperformance liquid chromatography (hplq, using the method of bechtold et al. (1988) . contamination of ada aerosols with biurea was less than 1 %. this was not different from the amount of contamination in the bulk samples. stainless-steel, multitiered, whole-body exposure chambers (h1000, hazleton systems, aberdeen, md), with a total internal volume of 1.0 m 3 , were used in both the 2-week and the 13-week studies. the flow rate through the chambers was 7 ± 1 ft 3 /min, corresponding to 12 ± 2 air changes per hour. chambers were maintained at a temperature between 21.2 and 25.4*c(mean 23.6"c). the average relative humidity ranged from 70 to 85%. to reduce the spatial variation of aerosol concentration and to increase the uniformity of mixing, the aerosol was diluted in a radial diluter before entering the chamber. animal cages were rotated on a regular basis to reduce any variation in the relative levels of ada inhaled by animals over the course of the study. rats and mice were housed in the same chambers, but in different cage units, for both studies. ada aerosol was generated by a jet-o-mizer/screw feed method (cheng el al., 1985) . ada powder was put into the hopper of the screw feeder (model 300, accu-rate, whitewater, wi) and delivered to the funnel of the jet-o-mizer (model 0101, fluid energy co., hatfield, pa) for dispersion. one generator was provided for each exposure chamber. the aerosol concentration in the exposure chamber was monitored by sampling at a flow rate of 0.5 liter/min for three, 2-hr periods during the 6-hr exposure. samples were collected on 25-mm fiberglass filters (type ae, gelman, ann arbor, mi). each exposure day, aerosol generation was started and sampling began after 12 min of rise time, when the chamber concentration had reached 90% of equilibrium concentration (t^). therefore, the total exposure was 6 hr plus a t^ of 12 min. the control chamber was also sampled daily. a ram-s continuous aerosol monitor (gca, bedford, ma) was used to monitor the stability of the aerosol concentration and to adjust the aerosol generator during exposure. it was operated on each chamber at the beginning, middle, and end of the filter sampling period as described previously (cheng el al., 1988) . aerosol size distribution was obtained once per study by using a lovelace multijet cascade impactor (newton et al.. 1977) , with a flow rate of 15 liters/min. thesanv pling period ranged from 1 to 6 hr, depending on the chamber concentration. two-week repeated study. four-week-old f344/n rats and b6c3f| mice were received from frederick cancer research facility (frederick, md). the animals were acclimated two per cage for the first week and then one per cage in cage units within two hazleton 1000 chambers prior to exposure [total of 21 days (males) or 22 days (females)]. exposures began when animals were 7 weeks old. animals were exposed 5 days per week for 2 weeks, plus an additional 2 (males) or 3 (females) consecutive exposure days before terminal euthanasia for a total of 12 exposure days for both sexes. exposures of females were initiated 1 day later than males. 13-week subchronic study. four-week-old f344/n rats and b6c3f, mice were received from simonsen laboratories, inc. (gilroy, ca). rats and mice were acclimated as described for the 2-week study, for a total of 18 days (males) or 22 days (females) prior to exposure. animals were exposed by inhalation, 5 days per week for a total of 13 weeks, with 2 or 3 (males) or 4 or 5 (females) consecutive dose days before terminal euthanasia. the total number of exposure days was 65 or 66 for both males and females. the feed used in both studies was zeigler nih-07 open formula rat ration (zeigler brothers, inc., gardners, pa). water was provided by an automatic watering system. the light cycle was automatically controlled to provide 12 hr of fluorescent light and 12 hr of darkness each 24 hr (lights on at 6 am and off at 6 pm). prior to study start, the rats and mice in both studies were randomly assigned by weight to treatment groups, using a computer-based system (path/tox, xybion corp.). animals within exposure groups were further randomized by use of computer-generated random numbers into groups for the basic studies or special studies and, for the 13-week study, into termination days (day 1 or day 2) for each group. in the 2-week study, serum (approximately 0.5 ml) was obtained from five male and five female rats and mice 3 days prior to the first day of exposure, and was analyzed for antibody titers to specific bacteria and viruses (mycoplasma pulmonis, m. arth, pneumonia virus of mice (pvm), sendai virus, rat cornavirus (rcv)/sda, and mycoplasma-rats; reo3, m. ad., m. pulmonis, m. arth, pvm, send, mhv, ectro, and gdvii-mice). titers were negative for these agents. in the 13-week study, serum was also obtained from five male and female rats and mice 3 days prior to study start. analyses for the agents described above showed positive titers for rcv/sda in the rats and negative titers for all agents in the mice. no gross lesions were noted in the rats on necropsy. tissue sections were taken from all lung lobes, liver, both kidneys, spleen, harderian gland, and mandibular salivary glands and processed for histology. lesions were only noted in the salivary gland or harderian gland tissue of 8 of the 10 animals. ductal squamous metaplasia was noted in both tissues and corresponded with those animals having positive titers to rcv/sda. these lesions are consistent with lesions induced by sialodacryoadenitis virus. at the end of the 13-week study, serum from 5 male and 5 female rats from all exposure groups and controls (40 rats total) were analyzed for titers to sendai virus, pvm, rcv/sda, and mycoplasma. all 40 sera were negative for titers to sendai, pvm, and mycoplasma. twenty-five of the 40 sera were positive for rcv/sda (>0.17 absorbance units by elisa assay). two-week repeated study. rats and mice in the basic study group (table 1) were weighed prior to study start, after 1 week of exposure, and at terminal euthanasia. detailed clinical observations were made at these times. morbidity/mortality checks were made twice daily on all animals. evaluations of gross and microscopic pathology and organ weight changes were made on the basic study group (table 1) . separate groups of rats and mice were used for evaluation of methemoglobin levels and cholinesterase levels in whole blood. thirteen-week subchronic study. rats and mice in the basic study group (table 1) were weighed weekly at the time of detailed clinical examinations. mortality/morbidity checks were performed twice daily on all animals. histopathology, hematology, organ weight, sperm morphology, and vaginal cytology evaluations were also made on this group of rats. each animal assigned to the special study groups (table 1) was used for the following determinations: levels of ada and biurea in lungs and kidneys, acetylcholinesterase activity in whole blood, and t3 and t4 levels in serum. necropsy and histopathology. all rats and mice in the basic study group, for both the 2-week and the 13-week studies, were given complete gross necropsy examinations. rats and mice were killed by cardiac puncture exsanguination while under halothane anesthesia and were necropsied immediately. weights of liver, thymus, right kidney, right testicle, brain, heart, and lungs (including trachea) were taken. tissues were fixed in 10% neutralbuffered formalin. tissues for microscopic examination were embedded in paraffin, sectioned at 5 nm, and stained with hematoxylin and eosin. the following tissues were trimmed and sectioned for histopathology: adrenals, bone (vertebra, with bone marrow and spinal cord; femur, rib), brain, epididymus or oviduct, esophagus, heart, small intestine (duodenum, jejunum, ileum), large intestine (cecum, colon, rectum), both kidneys, larynx, liver, lung (4 lobes), lymph nodes (bronchial, mandibular, mediastinal, mesenteric), mammary glands, nose (3 levels), pancrease (including islets), parathyroid gland, pituitary gland, prostate or uterus, salivary glands, seminal vesicles, skin, spleen, stomach (including forestomach and glandular portions), testes or ovaries, thymus, thyroid gland, trachea, and urinary bladder. all tissues from each rat and mouse exposed to filtered air or 200 mg ada/m 3 , for both the 2-week and the 13week studies, were examined microscopically. in addition, lungs of rats exposed to 50 or 100 mg ada/m 3 for 13 weeks were examined. hematology. for the 13-week study, blood was collected at necropsy from anesthetized rats and mice from the basic study group by cardiac puncture and placed in glass vials containing edta. a coulter electronics model s-550 was used for analysis of erythrocyte count, mean corpuscular volume, hemoglobin concentration, hematocrit (calculated), and leukocyte count. smears were made from the blood, stained with wright's stain, and examined under a light microscope to obtain differential leukocyte counts and counts of nucleated erythrocytes. additional blood smears were stained with new methylene blue and examined for the presence of reticulocytes. sperm morphology-vaginal cytology. in the 13-week study, vaginal cytology samples were taken on a daily basis from basic study females for 1 week before final termination. samples were obtained with sterile saline, placed on duplicate dakin slides, fixed with spray cyte (clay adams 7180), and stained with toluidine blue (0.5% in 20% ethanol). live sperm were obtained from the cauda of the right epididymis of male rats and mice at necropsy. sperm were incubated at 37*c in tyrode buffer, and viability was quantitated as the percentage of motile sperm in the sample. sperm density (number of sperm per gram of caudal tissue) was quantified on a hemocytometer. the number of sperm in the sample was divided by the weight of the cauda of the epididymis to obtain the value for sperm density. evaluations of sperm morphology were done using preparations of sperm fixed in ethanol and stained with eosin y. urinary enzymes. in the 13-week study, 1 week prior to termination, all rats in the basic study group were placed in metabolism cages for overnight urine collection. urine was collected on ice and analyzed for total amounts of lactate dehydrogenase (ldh), /3-galactosidase 03-g), a'-acetylglucosaminidase (nag), and alkaline phosphatase (ap) using methods described (medinsky el aj., 1989). lactate dehydrogenase was quantitated by using pyruvate as a substrate; 4-nitrophenyiphosphate was the substrate for alkaline phosphatase; /vnitrophenol was the substrate for both tv-acetyl-js-d-glucosaminidase and 0-galactosidase. determinations of methemoglobin in whole blood of rats and mice exposed to ada for 2 weeks were made to using the method of evelyn and malloy (1938) . acetylcholinesterase concentrations in whole blood of rats only in the 13-week study and both rats and mice in the 2week study were determined using the method of ellman el al. (1961) , in which acetylthiocholine is used as the substrate. serum thyroxine (t4 or tetraiodothyronine) and triiodothyronine (t3) levels for rats exposed to ada for 13 weeks were measured by radioimmunoassay (tietz, 1986) . 2 samples of lung and kidney from male rats exposed to ada for 13 weeks were analyzed for ada and biurea. this procedure involved derivatization of ada with triphenylphosphine and quantitation of the resulting derivative by hplc (bechtold el al, 1989) . biurea in the sample was oxidized to ada using potassium permanganate in acid solution. the ada produced was then quantitated by hplc (bechtold el al, 1989) . all data were analyzed separately for each sex. organ and terminal body weights on animals found dead or euthanized because of a moribund condition were not included in the statistical analysis. analysis of variance techniques were used for statistical evaluation. provided bartlett's test of homogeneity of variance was not significant, exposure groups were compared to controls by using dunnett's multiple range test. when bartlett's test was significant, comparisons with the control group were made by a modified student's i test, making allowance for unequal variance. all statistical tests were conducted at a 5%, two-sided risk level. the overall, mean ada concentration for each chamber was within 8% or less of target concentration ( table 2 ). the relative standard deviation of daily means was within 16%. the aerosol had an average mass median aerodynamic diameter (mm ad) of 2.13 jtm (range 1.89 to 2.45) with a mean geometric standard deviation {a%) of 1.9. there were no abnormal clinical observations during the 2-week exposures for either rats or mice. no rats died. one male (50 mg/ m 3 exposure group) and one female (200 mg/ m 3 exposure group) mouse died of undetermined causes. the mean terminal body weights for the basic study male rats exposed to 200 mg/m 3 ada were significantly less than those of controls (95% of control value). the mean terminal body weights for basic study male and female mice were significantly lower (89 or 94% of controls, respectively) for the 200 mg/m 3 exposure group. the mean liver weights of male rats and of male and female mice were significantly less at the 200 mg/m 3 exposure than those of controls (83, 79, and 79% of control values, respectively). other organ weights of either mice or rats were not influenced by ada exposure (data not shown). a complete set of tissues from rats and mice exposed to 200 and 0 mg ada/m 3 was examined histologically. the two exposure groups could not be distinguished on the basis of histologic findings. because no effect was seen at the highest exposure concentration, we did not examine tissues from rats exposed to lower concentrations. for mice, the only change noted that may have been related to the ada exposure was the degree of fine vesicular vacuolation of the hepatocyte cytoplasm, which is indicative of glycogen accumulation. all of the livers examined for both groups were considered to be within normal limits. however, the degree of cytoplasmic vacuolation varied among animals. the livers from the control and highdose groups were examined blindly and sorted on the basis of cytoplasmic vacuolation. seven of the high-dose animals and one control animal showed no cytoplasmic vacuolation, indicative of glycogen depletion. when the next lowest dose group (100 mg ada/m 3 ) was compared with the controls, four treated animals and one control showed no cytoplasmic vacuolation. it must be emphasized that none of the livers were regarded as being abnormal. however, there did appear to be a correlation between ada exposure and loss of hepatocyte vacuolation. possibly the ada-exposed animals were eating " values represent means (percentage standard deviation) of daily measurements over the 2-or 13-week exposure period. although rats and mice were housed in the same exposure chamber, the starts of exposure for each species were staggered by 1 week. * particle size was measured once during the study when both rats and mice were being exposed to ada. mmad, mass median aerodynamic diameter, 7 days or was not precisely determined. no abnormal effects were noted in female mice. there were no significant differences in acetylcholinesterase activities in whole blood of male and female rats exposed to any concentration of ada when compared to controls. t3 and t4 levels in serum from male rats increased with increasing ada exposure concentration in male rats. t3 and t4 levels in the highest exposure group were significantly elevated, relative to control. t3 was increased approximately 50%, while t4 was increased approximately 40%. t3 and t4 were unchanged in female rats exposed to ada. samples of lung and kidney of male rats exposed to ada for 13 weeks were analyzed for the presence of ada and biurea. these tissues were chosen, because they are the most likely tissues to contain significant quantities of one or both compounds, lung being the organ of exposure and kidney, because biurea had been detected in kidney (oser etal., \ 965) . the results of chemical analysis of ada and biurea in lung and kidney of male rats are summarized in table 4 . no ada was detected in either lung or kidney of male rats exposed to ada for 13 weeks. biurea, however, was detected in lungs, but not kidney, of rats exposed to 50, 100, and 200 mg/m 3 ada. the amount of biurea in the lungs increased nonlinearly with increasing exposure concentration. the percentage of biurea retained in lungs was calculated as a percentage of ada deposited on the last day of exposure (table 4 ). although 66% of the amount of ada expected to be deposited in rats exposed to 200 mg/m 3 on the last exposure day is retained in the lungs as biurea, this is a small percentage (~1%) of the total amount of ada deposited over the entire study. after inhalation of ada, the only apparently exposure-related lesions observed were those in lung and lymph nodes of rats exposed to 50 mg/m 3 for 13 weeks. the lung and lymph node lesions in rats exposed to 50 mg ada/m 3 for 13 weeks were striking and suggest an immune response to a virus or another antigen. several viral agents have been reported to produce similar pulmonary lesions in rats (jones el al, 1985; hamm, 1986) . one such agent is sendai virus. factors suggesting that sendai virus is not involved in this case are the following: (i) absence of bronchiolar epithelial involvement, including bronchiolar epithelial necrosis and hyperplasia; (ii) absence of similar lesions in mice housed in the same chamber as the rats (mice are even more susceptible to the virus than are rats); and (iii) negative viral titers for sendai virus from animals within the same chamber terminated at the same time. pvm has been reported to produce perivascular mononuclear cell infiltrates and a multifocal interstitial pneumonia in rats. however, as for sendai, negative viral titers for pvm were reported from animals within the same chamber as the rats having the lung lesions. for both sendai virus and pvm, serum antibody titers would be present at 8 to 14 days after exposure to the virus. it is unlikely that histologic lesions from such a viral infection would be present in the animals examined in the absence of positive antibody titers. rcv infection produces mild lung lesions in young adult rats, consisting of patchy interstitial pneumonia and lymphocytic perivascular infiltrates. mice are unaffected by the virus. rat coronavirus is closely related antigenically to sda, and serology cannot distinguish between exposure to either of these two coronaviruses. as previously indicated, rats in this study had positive titers to rcv/sda. we, therefore, cannot determine if the titers reflect only exposure to sda, or subsequent infection with rcv. because antibody titers for rcv/sda were equivalent across dose groups, any pulmonary lesions due to the viral infection would be expected to be present in all dose groups. 1. (a) lung section of a control rat exposed to filtered air. (b) lung section of a rat exposed to 50 mg ada/m 3 for 13 weeks. note prominent perivascular cuffs composed of lymphocytes. another possible etiology for the lung lesions we observed is that ada acts as a hapten, inducing an immune response within the lung. several reports in humans suggest that ada is capable of inducing an immune reaction and/or asthma-like responses (slovak, 1981; bonsall, 1984) . the absence of a response to the two higher exposure concentra" assuming a rat minute volume of 0.2 liter/min, a 6-hr (360 min) exposure, and a 10% deposition efficiency in the pulmonary region (lungs and bronchi), the amount of ada deposited in the lungs per day is estimated as (0.2 liter/min) x (200 mg/liter) x 0.1 x 360 min = 1440 mg/lungs and bronchi for the 200 mg/m 3 group, 720 mg for the 100 mg/m 3 group, and 360 mg for the 50 mg/m 3 group. * np, no peak was observed at the expected retention time. limit of quantitation is 100 mg per sample. ' nd, not determined. d mean mg/g tissue ± standard deviation; n = 5. tions used in the studies reported here (i.e., 100 and 200 mg/m 3 ) suggests that the lung lesions in rats are not related to ada exposure. in addition, two recent studies of acute and repeated inhalation exposure to ada in guinea pigs did not report any evidence of airway irritation (shopp, 1987) or a potential for sensitization to ada (gerlach et al., 1989) . pyelonephritis, renal tubular concretions, and intratubular renal crystals were noted after subchronic exposure of rats and mice to ada by gavage, at levels of 2.5 g/kg body wt or greater per day. in the present study, no renal lesions were observed in animals exposed to 200 mg ada/m 3 for up to 13 weeks. the lack of renal toxicity in the present study is most likely related to differences in the totaj amount of ada given to the animals in the two studies. for example, for the 2-to 3-ftm particle size used in this study, total deposition should be about 49% (raabe et al., 1988) . for animals exposed to 200 mg ada/ m 3 , with a 200 ml/min minute volume, the total amount of ada deposited should be about 20-40 mg/kg body wt per day for 338-g males or 190-g females (mean terminal body weights of 200 mg/m 3 group). this dose is 100-fold lower than that resulting in nephrotoxicity. the lack of an effect on whole blood cholinesterase activity in the inhalation studies, compared to those previously reported, is also most likely due to differences between the two studies in administered dose. mernikova and selikhova (1965) used oral exposures of up to 7000 mg/kg body wt for 5 days to achieve a 50% reduction in blood cholinesterase. the increased levels of t3 and t4 found in male rats after 13 weeks of exposure to ada differ from those observed by gafford et al. (1971) , who reported a decreased radioactive iodine uptake in rats 24 hr after being fed ada at 5% of their diet. no changes in iodine uptake were noted at lower levels of ada in the diet in studies of gafford et al. the reason for the difference between the results reported by gafford and those reported here is unclear, but may include differences in exposure route, exposure concentration, and duration ofexposure. the findings in male rats exposed to ada for 65 or 66 exposure days are generally consistent with the findings of mewhinney et al. (1987) , who showed that [ i4 c]ada deposited in the lungs of rats is rapidly absorbed into blood during the inhalation exposure and is cleared from tissues with a half-time of 1 day. the rats in the 13-week, ada subchronic study were euthanized 16 to 18 hr after exposure to ada was stopped. no ada or biurea was detected in kidney tissue. the detection limit was at least 100 mg/g tissue. thus, in the 13-week study, ada and biurea were cleared from the kidney at least as fast as for the rats in the previous studies. the nonlinearity of the amount of biurea in the lungs of rats exposed for 65 or 66 days to ada aerosols would not be expected, based on the results of the study by mewhinney et al., in which the rats were exposed once for a period of 6 hr. this may, of course, be due to the much greater amount of ada deposited in the lung over the 65-or 66-day period of exposure or to the higher exposure concentration in the 13-week study compared to that in the study involving 14 c. the amount of biurea present in the lungs of rats exposed to ada for 65 or 66 exposure days was small (~1%), compared to the total amount of ada inhaled and deposited over the 13-week period. in summary, ada is rapidly cleared from the lungs, even when inhaled at concentrations up to 200 mg/m 3 . exposure to ada for up to 13 weeks did not appear to be toxic to rodents. however, the question as to the nature of the chemical sensitization noted in workers exposed to ada still needs to be addressed. vironmental health sciences as part of the national toxicology program. the facilities used for this research were fully accredited by the american association for the accreditation of laboratory animal care. the authors gratefully acknowledge the technical and professional contributions of colleagues at the inhalation toxicology research institute and at the national institutes of environmental health sciences. the determination of biurea in the presence of azodicarbonamide by hplc azodicarbonamide: methods for the analysis in tissues of rats and inhalation disposition allergic contact dermatitis to azodicarbonamide use of a jet mill for dispersing dry power for inhalation studies evaluation of a real-time aerosol monitor (ram-s) for inhalation studies a new and rapid colorimetric determination of acetyl cholinesterase activity microdetermination of oxyhemoglobin, methemoglobin, and sulfhemoglobin in a single sample of blood apparent effect of an azodicarbonamide on the lungs effect of azodicarbonamide (i, l'-azobisformamidc) on thyroid function effect of four-week repeated inhalation exposure to azodicarbonamide on specific and nonspecific airway sensitivity of the guinea pig complications of viral and mycoplasmal infections in rodents to toxicology research and testing 1,1'-azobisformamide. ii. thermal decomposition. kinetics, products, and decomposition mechanism respiratory system correlation of urinary enzyme activity and renal lesions after injection of nickel chloride blood and liver cholinesterase in poisoning with porophor-505 and celogen the fate of inhaled azodicarbonamide in rats cascade impactor design and performance studies of the safety of azodicarbonamide as a flourmaturing agent regional deposition of inhaled monodisperse coarse and fine aerosol particles in small laboratory animals acute inhalation exposure of azodicarbonamide in the guinea pig occupational asthmas caused by a plastic blowing agent, azodicarbonamide use of doseresponse data to compare the skin sensitizing abilities of dicyclohexylmethane-4,4'-diisocyanate and picryl chloride in two animal species textbook of clinical chemistry respiratory symptoms associated with the use of azodicarbonamide foaming agent in a plastics injection molding facility this research was conducted under interagency agreement yo1-es-3o108 between the u.s. department of energy's office of health and environmental research (contract 76ev01013) and the national institute of enkey: cord-254155-860780z9 authors: wang, junyi; kaplan, nihal; wysocki, jan; yang, wending; lu, kurt; peng, han; batlle, daniel; lavker, robert m. title: the ace2‐deficient mouse: a model for a cytokine storm‐driven inflammation date: 2020-06-17 journal: faseb j doi: 10.1096/fj.202001020r sha: doc_id: 254155 cord_uid: 860780z9 angiotensin converting enzyme 2 (ace2) plays an important role in inflammation, which is attributable at least, in part, to the conversion of the pro‐inflammatory angiotensin (ang) ii peptide into angiotensin 1‐7 (ang 1‐7), a peptide which opposes the actions of angii. ace2 and angii are present in many tissues but information on the cornea is lacking. we observed that mice deficient in the ace2 gene (ace2(−/−)), developed a cloudy cornea phenotype as they aged. haze occupied the central cornea, accompanied by corneal edema and neovascularization. in severe cases with marked chronic inflammation, a cell‐fate switch from a transparent corneal epithelium to a keratinized, stratified squamous, psoriasiform‐like epidermis was observed. the stroma contained a large number of cd11c, cd68, and cd3 positive cells. corneal epithelial debridement experiments in young ace2‐deficient mice showed normal appearing corneas, devoid of haze. we hypothesized, however, that these mice are “primed” for a corneal inflammatory response, which once initiated, would persist. in vitro studies reveal that interleukins (il‐1a, il‐1b), chemokines (ccl2, cxcl8), and tnf‐α, are all significantly elevated, resulting in a cytokine storm‐like phenotype. this phenotype could be partially rescued by treatment with the angii type 1 receptor (at1r) antagonist, losartan, suggesting that the observed effect was mediated by angii acting on its main receptor. since the severe acute respiratory syndrome coronavirus 2 (sars‐cov‐2) utilizes human ace2 as the receptor for entry with subsequent downregulation of ace2, corneal inflammation in ace2(−/−) mice may have a similar mechanism with that in covid‐19 patients. thus the ace2(−/−) cornea, because of easy accessibility, may provide an attractive model to explore the molecular mechanisms, immunological changes, and treatment modalities in patients with covid‐19. angiotensin i converting enzyme 2 (ace2) is a critical component of the renin-angiotensin system (ras), due to its ability to hydrolyze angiotensin ii (angii). [1] [2] [3] angii is the major effector peptide of ras and regulates cell growth, and key events in the inflammatory process. 4 in its pro-inflammatory mode, angii directly stimulates pro-inflammatory mediators resulting in the infiltration of macrophages and moreover is profibrotic and may foster angiogenesis (4 and references therein). the expression of ace2 is most abundant in the kidney and intestine, followed by testis and the heart. [5] [6] [7] moreover, the surface expression of ace2 was found in lung epithelial cells. 8 several groups generated ace2-deficient mice [9] [10] [11] with conflicting responses on the contribution of ace2 to cardiac structure and function, and the control of blood pressure. 12, 13 due to its importance as an entry point for coronaviruses, the effects of ace2 depletion was tested in lung tissue and shown to be detrimental in the progression of lung injury following experimental perturbations. 14,15 ace2 depletion also created a "cytokine storm" like inflammation. 16, 17 a cytokine storm is a consequence of the secretion of a large number of cytokines and involves recruitment and activation of inflammatory cells such as macrophages. 18, 19 cytokine storms are known to occur in autoimmune diseases 20 and can be triggered by chemical insults such as corneal alkali burns 21 as well as infections, such as covid-19. 22 in covid-19 patients, ace2 is the target of the virus 23 and dramatic increases in plasma cytokines and chemokines such as il1b, ccl2 (mcp1), cxcl8 (il8), and tnfα have been observed. 22 ace2 is present in the retina 24 and recently, there has been a plethora of information regarding the expression in the cornea and conjunctiva due to the ongoing covid-19 pandemic. [25] [26] [27] [28] [29] [30] during our investigations using an ace2deficient mice, we noted that as the ace2-deficient mice aged, some developed cloudy corneas. in certain mice, cloudy corneas were bilateral, in others they were unilateral, whereas some adult aged mice had clear corneas. herein, we report that angii and ace2 are expressed in limbal and corneal epithelia in humans and mice. moreover, when challenged with corneal injury, ace2-deficient mice are "primed" for an increased corneal inflammatory response. once initiated, inflammation persists, which markedly alters the epithelial and stromal phenotypes. blockade of the angii type 1 receptor (at1r) partially restores the cytokine/chemokine balance due to ace2 deficiency. collectively, our findings establish a pivotal role of ace2 in the cornea and identifies angii blockade as a potential new target for corneal inflammation. moreover, the administration of soluble ace2 protein should have a therapeutic benefit by fostering the degradation of angii and the formation of ang 1-7 as it has proposed for other disease entities. 31 of note, ace2 is the main receptor for the coronavirus sars-cov-2 responsible for the current pandemic. 23 the associated organ injury, particularly acute lung injury, has been shown to involve a decrease in plasma bound ace2 and administration of such ace2 have the potential as an ideal treatment, and ace2 −/− mice a unique model to study inflammatory processes akin to those observed in severe covid-19. animal procedures were approved by the northwestern university animal care and use committee. we used an ace2-deficinet mouse (ace2 -/-) on a c57bl/6 background provided to us as a gift by susan gurley. 9 to generate debridement wounds in the central corneal epithelium, a rotating diamond burr was gently applied to the surface of the central cornea to remove the corneal epithelium while the peripheral corneal and limbal epithelia remained intact. gross images of mouse ocular globes were taken using a leica dissecting scope. corneal haze was graded on a scale of 0 through 4 32 as follows: 0, no corneal haze; 1, iris detail visible; 2, pupillary margin visible, iris detail obscured; 3, pupillary margin not visible; 4, cornea totally opaque. wound closure was examined by topically applying 20 μl of 0.5% fluorescein in pbs and imaging the wound using a leica dissecting scope under cobalt blue illumination. at the termination of the experiment, mouse whole eyes were fixed in 10% buffered formalin solution and paraffin embedded for histological analysis. h&e staining was conducted as described previously 33 and slides were imaged using an axiovision z1 fluorescence microscope system (carl zeiss, oberkochen, germany). normal human corneal tissues were obtained from the eversight eye banks (ann arbor, mi, usa) and embedded in paraffin blocks. immunohistochemical (ihc) staining of human and ace2 −/− mouse eyes were conducted as described previously. 34 antigen retrieval of the paraffin embedded sections was performed at 96°c in ph 6.0 citrate buffer for 30min. after blocking in 2.5% normal horse serum, sections were incubated overnight at 4°c with antibodies recognizing: angiotensinii (angii) rabbit polyclonal antibody (penlabs, san carlos, ca), ace2 goat polyclonal antibody(r&d systems, minneapolis, mn), cd68 rabbit polyclonal antibody (proteintech, chicago, il), cd3 rabbit polyclonal antibody (proteintech, chicago, il), and cd11c rabbit polyclonal antibody (proteintech, chicago, il) at 1:100 dilution. after rinsing with pbs containing 0.1% tween (pbst), the samples were incubated with immpress-ap (alkaline phosphatase) polymer anti-rabbit or anti-goat igg reagent (vector lab, burlingame, ca) at room temperature for 30 minutes. after rinsing with pbst, chromagen was detected using a vector red alkaline phosphatase substrate kit (vector lab, burlingame, ca) for 10-30 minutes. samples were counterstained with hematoxylin, and dehydrated with graded ethanol and xylene. images were taken using an axiovision z1 fluorescence microscope system (carl zeiss, oberkochen, germany). immortalized corneal epithelial cells, htcepi, were cultured in keratinocyte serum-free media (thermo fisher scientific, waltham, ma, usa) as described before. 35 for sirna knock-down experiments, cells were transfected with 10 nm sirna smartpools against ace2 and nontarget control (ge dharmacon, colorado, usa) as previously described. 33 two days after transfection, cells were treated with losartan (100μm) for 24 hours, and processed for total rna isolation. human monocytic thp-1-dual cells (invivogen, san diego, ca, usa) were cultured with rmpi 1640 with 10% heat inactivated fbs. about 10nm 12-o-tetradecanoylphorbol-l3acetate (pma) for 24 hours is used to induce thp-1-dual into macrophages. murine macrophagic raw-dual (invivogen, san diego, ca, usa) cells were cultured with dmem with 10% heat activated fbs. for the chemotaxis assay, the htcepi cells (5 × 10 4 cells/500 μl) transfected with sicontrol or siace2 were plated in the lower chamber of 24-well culture plates for 24 hours. the raw-dual cells (4 × 10 4 cells/200 μl) were resuspended in dmem with 10% heated-fbs media, and placed in transwell chambers (corning inc, corning, ny, usa) in 24 well culture plates. dmem with 10% heated-fbs was added to both the transwell and lower chamber. after 48 hours, transwell chambers were rinsed with pbs, and the cells on top were removed with a cotton tip applicator. the raw-dual cells that migrated to the bottom of the transwell were stained with crystal violet (sigma-aldrich, st. louis, mo, usa), and counted under an inverted zeiss microscope. total rnas were isolated from htcepi cells and purified with a mirneasy kit (qiagen, hilden, germany). real-time qpcr (rt-qpcr) was performed with a roche lightcycler 96 system using the roche faststart essential dna green master (roche, branchburg, nj, usa) according to the manufacturer's instructions. the primer pairs for rt-qpcr were designed using the idt primerquest primer design tool (idt, coralville, ia). primers (table s1) were used to recognize: human il1a, il1b, il6, ccl2, inos, cxcl8, tnfa. relative gene expression was calculated using the 2δδct. unpaired t test were performed to determine statistical significance. the data are shown as means ± standard deviation (sd). the differences were considered significant for p values of <.05. all experiments were replicated at least three times. immunohistochemical analysis revealed that the expression of angii was strong throughout the human limbal and corneal epithelia as well as the stromal vessels ( figure 1a ,b). in contrast, ace2 expression was prominent in the limbal basal cells and vasculature ( figure 1c ). angii and ace2 were detected throughout the wild-type (wt) mouse corneal epithelium (figure 2a ,c) but angii appeared to be more patchy in its distribution (figure 2a ). in the ace2-deficient mice (ace2 −/− ), no ace2 was detected in the corneal epithelium ( figure 2d ), whereas angii expression was markedly increased ( figure 2b ) compared with the wt (figure 2a ). aged ace2 −/− mice developed striking changes in corneal epithelial morphology as well as significant stromal angiogenesis and an inflammatory infiltrate ( figure 3 ). interestingly these changes appeared in approximately 70% of aged adult (60-80 weeks old) mice. in many instances, these changes only occurred in one eye. the contralateral eye appeared to have a normal corneal epithelium and a stroma containing highly organized collagen bundles with numerous keratocytes but devoid of inflammatory cells ( figure s1 ). those ace2 −/− mice that developed inflammation were readily recognized clinically by a cloudy, hazy cornea ( figure 3b-d) . a wide spectrum of corneal epithelial alterations were detected, ranging from a thin, disorganized epithelium ( figure 3f ) to a more stratified, thickened epidermoid tissue ( figure 3h ). in all eyes exhibiting haze or cloudiness the stroma consisted of a densely packed admixture of polymorphonuclear, mononuclear, and lymphocytic infiltrates along with numerous vascular profiles ( figure 3f -h). on higher magnification, the infiltrates were identified as neutrophils by h&e, and as macrophages, t cells, and dendritic cells identified by immunohistochemistry staining for cd68, cd3, and cd11c cells, respectively (figure 4 ). since in 30% (6/19 mice) of ace2 −/− mice, the cloudy corneas were not bilateral, this would suggest that the lesions are a direct sequelae of external perturbation rather than arising from a systemic deficiency. to test this idea, we made small 1mm circular debridement wounds in young ace2 −/− mice with clear corneas and compared the response to aged-matched wt littermates. in this well adopted procedure, the type of wound removes the corneal epithelium but does not result in a significant inflammatory infiltrate. 36 immediately following wounding, all mice received topical application of a 0.5% fluorescein stain, and the rate of epithelial healing was visualized. as expected, wt mice sealed wounds within 24 hours ( figure 5a ), whereas the ace2 −/− mice still had detectable fluorescein staining at this time ( figure 5a ). three days post wounding, wt mice had clear corneas devoid of fluorescein staining. similarly, the ace2 −/− mice had minimal fluorescein staining 3days post wound; however, there was development of haze prompting further clinical evaluation of corneal clarity 32 ( figure 5b ). day 7 post wounding, wt mice appeared normal, whereas the ace2 −/− mice still had cloudy corneas and patches of fluorescein staining detected on the surface, suggestive of a defective epithelial barrier. one day post wounding, the wt mice had completely re-epithelialized the surface as evidenced by a thin, 1-2 cell layered, well-organized epithelium ( figure 6a,b) . this was contrasted by the ace2 −/− mice, which were characterized by a single, thin layer of disorganized epithelial cells, lacking evidence of stratification ( figure 6c ,d). at day 1 post wounding, the stroma of the wt mice appeared normal consisting of a plywood-like organization of collagen bundles, interspersed with numerous keratocytes. few if any inflammatory cells were noted ( figure 6a,b) . the stroma of the ace2 −/− mice was filled with inflammatory cells (primarily polymorphonuclear cells) and numerous vascular profiles, characteristic of a brisk inflammation ( figure 6c,d) . seven days post wounding, wt mice had a multi-layered, stratified epithelium characteristic of an unwounded mouse ( figure 6e ,f) overlying a normal appearing stroma devoid of inflammatory cells. the corneal epithelium from ace2 −/− mice, 7 days post wounding was variable in appearance. for example, some mice had a markedly thickened multi-layered epithelium ( figure 6g ), whereas some mice had a thin, single-layered epithelium ( figure 6h ). in all cases the ace2 −/− mice, 7 days post wounding, had a stroma with variable amounts of inflammatory cells and vascular remnants ( figure 6g,h) . ace2 −/− mouse eyes (60-80 weeks old (b-d) were taken using a dissecting scope. clear and transparent corneas were observed in aged wt mice eyes (a), while increased central corneal haze with corneal neovascularization were noted in aged ace2 −/− mice eyes (b-d). (e-h) representative h&e stained histological images of wt mouse cornea with intact corneal epithelium and regular stroma (e) and ace2 −/− mouse corneas (f-h) with markedly thickened cornea and a large number of polymorphonuclear, mononuclear, and lymphocytic infiltrates along with numerous vascular profiles. twenty-six aged ace2 −/− mice (60-80 weeks old) were analyzed. about 19 mice developed corneal haze. among the 19 mice with corneal haze, 13 were bilateral and 6 were unilateral. total 32 eyes with cloudy cornea were observed 6 | wang et al. following a perturbation such as wounding, epithelial cells produce pro-inflammatory cytokines, which are known to initiate the inflammatory response. 37 to investigate the mechanism of this initial phase of inflammation in the context of ace2, we knocked-down ace2 in a corneal epithelial cell line (htcepi) and evaluated the expression of several cytokines. knockdown of ace2 in htcepi cells with an sirna smartpool increased the expression of il1a, il1b, f i g u r e 4 aged ace2-deficient mice show infiltration of immune cells. wt (a, c, e) and ace2 −/− (b, d, f) mouse corneas were stained for cd68 (marker for macrophage), cd3 (marker for t cells), and cd11c (marker for dendritic cells). n = 3 tnfa, ccl2, and cxcl8, compared to the sirna control ( figure 7) . to explore whether such an increase in cytokine expression in corneal epithelial cells enhanced recruitment of immune cells, we conducted trans-well chemotaxis assays using a modified boyden chamber co-cultured with the raw-dual macrophage cell line against htcepi cells on the bottom chamber. increased migration of macrophages was observed when ace2 was knocked-down in htcepi cells ( figure s2 ).this suggests that ace2 deficiency was at least in part responsible for the recruitment of macrophages into the inflammatory milieu. the increases observed in ccl2 and tnfa are associated with the recruitment and activation of macrophages. [38] [39] [40] [41] therefore, we explored the possibility that ace2-deficient epithelial cells could activate macrophages. we exposed a pma-stimulated thp-1-dual human monocytic cell line to conditioned media from htcepi cells lacking ace2. such treatment significantly increased the expression of il1a, il1b, il6, tnfa, ccl2, and cxcl8 compared with control htcepi conditioned media ( figure s3 ). these findings indicate that loss of ace2 in htcepi can activate macrophages. to examine if ace2 deficiency-induced cytokine production is due to an increase in angii activity, we investigated whether treatment of corneal epithelial cells with the at1r antagonist, losartan could rescue the phenotype. htcepi deficient in ace2 were treated with 100 µm losartan for 24 hours and the cytokine response was evaluated. losartan treatment decreased the expression of il1a, tnfa, and ccl2 (figure 7 ). this suggests that ace2 deficiency is responsible for the excessive expression of cytokines in the inflammatory milieu via the activation of angii. ras components are found in ocular tissues of various species, as well as humans. the major components including renin, angiotensinogen, and ace2 have been identified in the retina, ciliary body, vitreous fluid, iris, choroid, aqueous fluid, sclera, and conjunctiva 42 and references therein. until recently, little if any attention has been focused on defining ras in the limbus/cornea. [27] [28] [29] we now demonstrate that ace2 is present in both human and mouse limbal and corneal tissues and that the genetic deficiency of ace2 results in a marked inflammatory response in corneal epithelial and losartan treatment can partially reverse pro-inflammatory activity in ace2 depleted corneal epithelial cells. htcepi cells transfected with sicontrol or siace2 were treated with losartan for 24 hours. total rnas were isolated from these cells for rt-qpcr for inflammationrelated genes. n = 8. *p < .05 stromal tissues. moreover, the deficiency of ace2 resulted in marked upregulation of angii, the main peptide that is degraded normally by ace2. as ace2-deficient mice aged, more than 70% developed cloudy corneas in either one or both eyes. this led us to postulate that external stress (eg, scratching or wounding) to the corneal surface resulted in an inflammatory event that could not be resolved due to the inability to regulate angii. to test this concept, we induced gentle debridement of the corneal epithelium, which in wt mice does not result in a significant inflammatory response. 36 in the ace2 −/− , this procedure caused a significant inflammatory response in young mice with otherwise normal appearing corneas (figures 5, 6 ). this strongly supports the idea that ace2 −/− mice are "primed" for an inflammatory response and results in unresolvable inflammation after a mild perturbation. similarly, ace2 −/− mice lungs following an insult resulted in worsened inflammatory cell infiltration and lung damage compared with wt mice; while there were no differences in unperturbed lungs between ace2 −/− and wt mice. 14, 15, 43 in contrast, ace2 deficiency led to increases in inflammation in mouse kidney and aorta even without perturbation. 44, 45 although the lung and cornea are disparate tissues, the similarity in inflammatory responses raises the interesting question of what are the underlying mechanisms driving inflammation. as noted earlier in ace2-deficient mice, cloudy corneas were frequently observed in older (>60 weeks) mice and sometimes only in one eye. this most likely reflects an earlier external trauma. however, it is also possible that cloudy corneas seen in older mice are the result of an enhanced accumulation of reactive oxygen species due to alterations in ras, as it has been shown that ace2-deficient mice exhibit increased oxidative stress. 46 it is well established that with age, the well-developed corneal antioxidant defense systems diminish, leading to ros accumulation and oxidative stress (47 and references therein). this combination of ros and oxidative stress can lead to many age-related ocular diseases of the anterior segment (for reviews see 47, 48) . in other tissues, such as the brain, angii has been shown to induce nadph oxidase-dependent ros production in isolated cerebral microvessels, resulting in cerebrovascular dysregulation. 49 in the ace2-deficient mice, once an inflammatory response is initiated, inflammation persists becoming permanent, which remodels the stromal microenvironment. this microenvironmental change results in a wide range of epithelial phenotypes. the most dramatic is a cell fate switch from the transparent corneal epithelium to a keratinized, stratified squamous, psoriasiform-like epidermis. a similar cell-fate switch was reported in mice deficient in leucine-rich repeats and immunoglobulin-like domains 1 (lrig1). 50 in these mice, loss of lrig1 resulted in a pro-inflammatory state in the cornea through upregulation of stat3. the persistence of the inflammation eventually resulted in the generation of an epithelium that resembled human psoriasis. when ace2 is silenced in a corneal epithelial cell line, interleukins (il1a, il1b, il6), chemokines (ccl2, cxcl8), and tnfa, are all significantly elevated, resulting in a cytokine storm-like phenotype (51 and references therein). we observed that losartan treatment significantly blocked the induction of il1a, tnfa, and ccl2 by ace2 depletion in cell cultures but only slightly altered the expression of il1b and cxcl8, indicating a partial rescue. losartan is one of the angii receptor blockers (arbs). unlike other arbs, the effect of losartan can be overcome by high concentrations of angii, which means that losartan is surmountable. 52 in addition, losartan needs to be converted in the liver to form its active metabolite exp3174, which is 10-40 times more potent than losartan. 53 these two features of losartan may explain why we only see partial rescue in vitro. nonetheless, these findings clearly establish that the recruitment and activation of the macrophage component of the inflammatory response is related to angii acting via the at1 receptor. in the aggregate, our findings suggest that provision of ace2 may provide a new strategy for treating corneal inflammatory conditions, as well as other indications such as kidney disease. of potential clinical significance is the possibility that the ace2 −/− mouse cornea might be an excellent model for investigations into the etiology and treatment of a coronavirus-induced inflammation. 54 the severe acute respiratory system coronavirus (sars-cov), middle east respiratory syndrome coronavirus (mers-cov) and the novel human coronavirus (sars-cov-2) have all been demonstrated to utilize human ace2 as the receptor for entry. 23, 55, 56 in such a scenario, the coronavirus binds to and reduces the expression of ace2; such a reduction increases angii, leading to unregulated inflammation. recently, it was demonstrated that patients infected with sars-cov-2 had interstitial mononuclear inflammatory infiltrates, dominated by lymphocytes in both lungs. 57 as the condition worsened, a dramatic cytokine-storm-driven inflammation was noted. 57 this phenotype bears striking similarities to what we report in the ace2 −/− mice, suggestive that corneal inflammation in ace2 −/− mice may have a similar mechanism with that in sars-cov-2 infected patients. thus, the eye becomes extremely attractive as a model to explore the molecular mechanisms, immunological changes, and treatment modalities in patients with a sars-cov-2 infection for the following reasons: (i) mice cannot be infected with the sars-cov-2 making it difficult to find a direct experimental model; (ii) not having to use the live virus makes the ace2 −/− safer; and (iii) the relative ease of inducing and clinically detecting a corneal ace2-deficient inflammatory response (corneal haze) is extremely convenient for observation. angiotensin-converting enzyme-2 (ace2): comparative modeling of the active site, specificity requirements, and chloride dependence ang ii (angiotensin ii) conversion to angiotensin-(1-7) in the circulation is pop (prolyloligopeptidase)-dependent and ace2 (angiotensin-converting enzyme 2)-independent targeting the degradation of angiotensin ii with recombinant angiotensin-converting enzyme 2: prevention of angiotensin ii-dependent hypertension angiotensin ii: a double-edged sword in inflammation a novel angiotensin-converting enzyme-related carboxypeptidase (ace2) converts angiotensin i to angiotensin 1-9 a human homolog of angiotensin-converting enzyme. cloning and functional expression as a captopril-insensitive carboxypeptidase expression of the sars-cov-2 cell receptor gene ace2 in a wide variety of human tissues tissue distribution of ace2 protein, the functional receptor for sars coronavirus. a first step in understanding sars pathogenesis altered blood pressure responses and normal cardiac phenotype in ace2-null mice deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin ii angiotensin-converting enzyme 2 is an essential regulator of heart function the role of ace2 in cardiovascular physiology angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages a crucial role of angiotensin converting enzyme 2 (ace2) in sars coronavirus-induced lung injury angiotensin-converting enzyme 2 protects from severe acute lung failure the anti-inflammatory potential of ace2/angiotensin-(1-7)/mas receptor axis: evidence from basic and clinical research differences in arterial and mixed venous il-6 levels: the lungs as a source of cytokine storm in sepsis cytokine storm of graftversus-host disease: a critical effector role for interleukin-1 current concepts in the diagnosis and management of cytokine release syndrome review: cytokine storm syndrome: looking toward the precision medicine era desiccating stress-induced mmp production and activity worsens wound healing in alkali-burned corneas clinical features of patients infected with 2019 novel coronavirus in wuhan a pneumonia outbreak associated with a new coronavirus of probable bat origin identification of angiotensin converting enzyme 2 in the rodent retina the ocular surface and the coronavirus disease 2019: does a dual "ocular route" exist? strengthening basic and clinical research on ocular infection caused by coronavirus risks posed to corneal transplant recipients by covid-19-affected donors replication competence, and innate immune responses of the coronavirus sars-cov-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures expression analysis of 2019-ncov related ace2 and tmprss2 in eye tissues coronavirus disease 2019 (sars-cov-2) and colonization of ocular tissues and secretions: a systematic review novel variants of angiotensin converting enzyme-2 of shorter molecular size to target the kidney renin angiotensin system comparison of prognostic value of roper hall and dua classification systems in acute ocular burns fih-1 engages novel binding partners to positively influence epithelial proliferation via p63 micrornas-103/107 coordinately regulate macropinocytosis and autophagy microrna-31/ factor-inhibiting hypoxia-inducible factor 1 nexus regulates keratinocyte differentiation wounding the cornea to learn how it heals the corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells the cytokine tnf promotes transcription factor srebp activity and binding to inflammatory genes to activate macrophages and limit tissue repair type i interferons and the cytokine tnf cooperatively reprogram the macrophage epigenome to promote inflammatory activation specific tumor-derived ccl2 mediated by pyruvate kinase m2 in colorectal cancer cells contributes to macrophage recruitment in tumor microenvironment lnmat1 promotes lymphatic metastasis of bladder cancer via ccl2 dependent macrophage recruitment four decdes of ocular renin-angiotensin and kallikrein-kinin systems instillation of particulate matter 2.5 induced acute lung injury and attenuated the injury recovery in ace2 knockout mice deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein e-deficient mice through modulation of the nephrin and tnf-alpha-tnfrsf1a signaling genetic ace2 deficiency accentuates vascular inflammation and atherosclerosis in the apoe knockout mouse ace2 deficiency increases nadph-mediated oxidative stress in the kidney the role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults mitochondrial dysfunction and oxidative stress in corneal disease angiotensin ii impairs neurovascular coupling in neocortex through nadph oxidase-derived radicals lrig1 inhibits stat3-dependent inflammation to maintain corneal homeostasis into the eye of the cytokine storm angiotensin ii type 1 receptor blockers clinical pharmacokinetics of angiotensin ii (at1) receptor blockers in hypertension is there an association between covid-19 mortality and the renin-angiotensin system-a call for epidemiologic investigations molecular pathology of emerging coronavirus infections soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy pathological findings of covid-19 associated with acute respiratory distress syndrome we are thankful to amani a. fawzi for her initial clinical evaluation of ace2 ko eyes. the nu-sbdrc skin tissue engineering and morphology core facility assisted in morphologic analysis. the nu-sbdrc is supported by the national institute of arthritis and musculoskeletal and skin diseases grant ar075049. this research is supported by national institutes of health grants ey06769, ey017539, and ey019463 (to rml); a dermatology foundation research grant and career development award (to hp); an eversight research grant (to hp), ar064144 and ar071168 (to kql), an niddk grant r01dk104785 (to db), and the international postdoctoral exchange fellowship program key: cord-021413-1ht1xm88 authors: kraft, lisbeth m. title: viral diseases of the digestive system date: 2013-10-21 journal: diseases doi: 10.1016/b978-0-12-262502-2.50016-x sha: doc_id: 21413 cord_uid: 1ht1xm88 this chapter discusses three virus infections affecting the digestive system of mice and their properties: (1) epizootic diarrhea of infant mice (edim), (2) reovirus 3 infection, and (3) murine hepatitis virus infection (mhv). all three infections may cause serious, debilitating, and sometimes fatal diarrheal disease in nursling and weanling mice. mice of all ages can be infected by the edim virus but overt disease is restricted to animals up to about 12–13 days of age at the time of first exposure. the edim virus is worldwide in distribution. its prevalence is difficult to estimate because serologic tests have not been readily available, and it is not customary to sacrifice animals for the purpose of examining the appearance of their intestinal tract or for electron microscopic visualization of fecal contents. the acute disease of reovirus 3 infection affects mainly sucklings and weanlings, whereas the chronic disease is encountered in animals over 28 days of age. the mhv virus, on the other hand, has been found to affect cotton rats, rats, and hamsters. epidemic diarrhea of infant mice, it is common knowledge that virtually every colony of conventional mice suffered that infec tion to a greater or lesser extent. in recent years, with the advent of measures such as cesa rean derivation, barrier-sustained breeding and maintenance procedures, routine serologic surveillance, laminar flow hoods or rooms, and filter-top cages, the problems associated with these diseases have become somewhat less critical. neverthe less, they are at times and under certain circumstances still troublesome. all three infections may cause serious, debilitating, and sometimes fatal diarrheal disease in nursling and weanling mice. thus, the economic impact on commercial mouse col onies can be severe. furthermore, newborn mice, pooled from many dams and then redistributed to them at random, are used for the isolation and identification of certain viruses in diagnos tic and epidemiological studies, for example arboviruses (shope, 1980) , coronaviruses , and reoviruses (stanley, 1977) . clearly, indigenous infection with related or identical agents in only a few such infants could confound and compromise the validity of observations follow ing the inoculation of test materials. it should be pointed out, too, that collins and parker (1972) demonstrated both reovirus 3 and murine hepatitis virus as contaminants in some murine leukemia and transplantable tumor specimens. whereas it is mainly from these standpoints that the diseases in question derive importance, they should not be dismissed without considering their intrinsic value as models for elucidat ing the pathogenesis and control of related infections in man and other animals as well as their utility for the molecular biologist. cheever and mueller (1947, 1948) , pappenheimer and en ders (1947) , and pappenheimer and cheever (1948) were the first to describe the pathological changes and epidemiology of edim. runner and palm (1953) and cheever (1956) also con tributed to knowledge concerning the epidemiology and etiol ogy of the disease. thereafter kraft (1957 kraft ( , 1958 kraft ( ,1961 kraft ( ,1962b kraft ( , 1966 reported on studies regarding the etiology, mode of transmission, carrier state, immune response, pathogenesis, and control of the disease. serologic studies were also under taken by blackwell et al (1966) . kraft (1963, 1967) first demonstrated the agent in electron micrographs of infected infant mouse intestinal epithelium. banfield et al (1968) enlarged on those findings, comparing the virions to those of the reoviruses. particles of similar morphology were subsequently observed in the diarrheal feces of many species, primarily in the young: cattle (mebus et al, 1969) , man (flewett et al, 191 a) , horse (flewett et al, 1975) , pig (rodger et al, 1975) , sheep , rabbit , deer (tzipori et al, 1976) , goat (scott et al, 1978) , and dog (england and poston, 1980) . in addition, one virus, sa-11, was isolated from a nondiarrheal monkey, and another, oa (offal agent), was recovered from intestinal washings of sheep in an abattoir (els and lecatsas, 1972) . much and zajac (1972) purified edim virus from diarrheal infant mice and further characterized it. based on its moφhology and other known characters, edim virus has been placed into the genus rotavirus in the family reoviridae (matthews, 1979) . during the past decade, knowl edge of the rotaviruses as agents of diarrheal disease of young mammals has burgeoned, especially with regard to those af fecting children, calves, and piglets. reviews concerning the genus have been published by wyatt et al (1978 ), mcnulty (1978 , flewett and woode (1978) , andrewes et al (1978) , and holmes (1979) . additional comments may be found in the american veterinary medical association panel the young (anonymous, 1978) . the classification of edim virus in the genus rotavirus, family roeviridae, derives from its moφhology and mode of replication as seen in electron micrographs (adams and kraft, 1967; banfield et al, 1968) , which were later shown to re semble those observed in ultrathin sections in human intestinal material containing ''reovirus-like" particles (bishop et al, 1973) . the term rotavirus (l. rota, wheel) was proposed by flewett et al (1974) because of its moφhology as viewed in negative-contrast electron micrographs. it has become widely used in preference to duovirus, which is synonymous (david son et al, 1975) . there is no evidence that antigenic or pathogenetic variants of edim virus exist. analysis of rna segment and struc tural polypeptide variation, however, as has been accom plished for other rotaviruses derbyshire and woode, 1978; rodger and holmes, 1979) , may reveal differences among strains. further, several serotypes have been described a m o n g the h u m a n rotaviruses by m e a n s of the serum neutralization test (beards et al., 1980) . this technique may also prove useful in future studies of e d i m virus strains. a. morphology, size, and composition. kraft (1962b) , using millipore filters, determined the size of the infective e d i m virion to be between 33 and 100 n m . in electron micro graphs, a d a m s and kraft (1967) mined the m e a n diameter of 100 virions of purified e d i m virus to be 5 4 . 4 ± 2 n m . o n the other h a n d , melnick (1979) gives about 50% is lost at 4x for 24 hr or at 37t for 1 hr. although some infectivity (>0.05%) remains at either 56°c or 60°c for 30 min, it is abolished at 70t for 15 min (cheever and muel ler, 1947; kraft, 1957 kraft, , 1962b . much and zajac (1972) found that the purified virus is unstable at both 4° and -24''c for 2 weeks but found that at -70°c infectivity is retained for at least 4 weeks. c. ejfect of chemicals. in an intestinal filtrate, edim virus titer is not significantly reduced when held in ether or 0.1% sodium deoxycholate at 4°c for 24 hr (kraft, 1962b) . according to much and zajac (1972) , the purified virus is stable in 20% ether, 5% chloroform, or 0.1% sodium deoxycholate at 4°c for 1 hr and, as is true for other rotaviruses, is resistant to pancreatin. ward and ashley (1980a,b) examined the effects of the anionic detergent sodium dodecyl sulfate and of the chelating agent ethylenediaminetetraacetate on purified simian virus and determined that low concentrations and mild temper ature conditions readily inactivated the agent. both chemicals modified the viral capsid to prevent adsoφtion of the inacti vated virions to cells. indeed, this study was the outgrowth of a need to determine the survival of enteric viruses in wastewater. it had been determined that wastewater sludge reduced the heat necessary for simian rotavirus inactivation. ionic detergents in the sludge were identified as the active components. nonionic detergents did not destabilize the virus; further, these com pounds protected the virus from the destabilizing effect of sodium dodecyl sulfate. destabilization by both cationic and anionic detergents was found to be dependent on the ph of the medium. a systematic study of the stability of edim virus to extremes of ph has not been reported. much and zajac (1972) kraft (1966) replication of edim virus occurs in epithelial cells of the villi of the small intestine. in electron micrographs, kraft (1967), banfield etal. (1968) , and holmes etal. (1975) demonstrated replication by budding in distended cistemae of the endoplasmic reticulum. the significance of intracytoplas mic and intranuclear tubular structures encountered is not clear. using direct immunofluorescence, wilsnack et al. (1969) found that edim virus antigen in infant mice is limited to the cytoplasm of the villous epithelium from the duodenum to the colon and is detectable within 48 hr after peroral inoculation. stainable virus was also seen in the intestines of contact infant mice without necessarily causing clinical signs to appear. the virus could not be stained in the stomach or liver of mice infected either naturally or experimentally. kraft (1958) studied the distribution of infectious edim virus in 3-day-old mice following peroral inoculation. at 3 hr, virus was detected in the stomach and small and large intes tines (the cecum was not tested) and could not be recovered from the lungs, liver, spleen, kidney, or blood. at 22 hr, all those tissues were positive except for the kidney. the bladder and urine, as well as the brain, were also devoid of the agent, but at 30 hr, these too were positive. at 72 hr, the liver, spleen, kidney, and intestines yielded virus, but the brain was negative. the blood, stomach, lungs, bladder, and urine were not tested at that interval. at 6 days, blood, liver, and intestines, the only tissues examined, still contained virus. ingested virus from a diarrheal litter brings about an active infection in the nursing dam that previously had been nondiarrheal herself and had had only nondiarrheal litters (kraft, 1958) . blood, liver, spleen, and feces all contain infectious virus in the dam 1 week after her litter is given virus perorally as an intestinal filtrate. later, kraft (1961) determined that adult male mice can also be intestinal carriers for at least 17 days after a single peroral exposure. with regard to the mechanism of cell penetration. holmes et al. (1976) proposed that lactase of the villous brush border of the intestine may be the receptor that uncoats the rotavirus virion by attacking the glycolysated polypeptides of the outer capsid. in addition, pancreatic enzymes within the lumen may also be instrumental in the infectious process (see section ii,b,6). the question of cofactors that might enhance pathogenicity or of interfering substances, in addition to antibodies, that might inhibit edim virus replication is open. kraft (1958) found increased numbers of clostridium tertium in the intes tine of diarrheal animals, and pappenheimer and enders (1947) remarked on the persistent presence of ''coccoid bodies" in the intestines of diarrheal animals as seen by light microscopy. in both instances, these may be considered opportunistic or ganisms. their effect on the severity of the clinical disease is unknown, however. one report (labonnardiere and devaurieux, 1979) the use of standard methods to grow edim virus in tissue culture has resulted for the most part in failure. habermann (1959) (thiel et al., 1978) . further, babiuk et al. (1977) and al meida et al. (1978) state that calf rotavirus production is mark edly enhanced when passaged in the presence of trypsin. clark et al. (1979) produced high-titer calf rotavirus in a variety of continuous cell lines, also by utilizing trypsin, and matsuno et al. (1977) were successful in producing plaques with bovine rotavirus in monkey kidney cell monolayers when trypsin was incorporated in the overlay medium. estes and graham (1979) found that simian virus titers were enhanced by both trypsin and elastase in vero as well as ma 104 cells. ramia and sattar (1980) studied additional proteolytic enzymes utilizing plaque formation by simian virus sa-11 in ma 104 cells as the endpoint. elastase, a-chymotrypsin, subtilase, pronase, and pan creatin were as effective as trypsin, whereas pepsin, papain, and thermolysin were ineffective. another approach with human rotavirus has been to incoφorate the agent into cells by means of low-speed centrifugation of the two together (banatvala et al., 1975; bryden et al., 1977; schoub et al., 1979; wyatt et al., 1980) . it remains to be seen if similar treatments will lead to suc cessful cultivation of edim virus in tissue culture. chick embryos appeared unaffected when the chorioallantois was inoculated. the agent did survive up to 5 days, but an increase in infectious titer could not be demonstrated (kraft, 1958) . moon (1978) of each disease appears to be reflected not only in the particular group of cells but also in the numbers of host cells involved. lucid descriptions of the natural clinical disease are given by cheever and mueller(1947) , seamer (1967) , and mcclure et al. (1978) . the experimental disease does not differ signifi cantly (kraft, 1957 (kraft, , 1962b . overt illness is confined to pretypical appearance of infant mice infected with enterotropic mhv (pair of mice at left) or rotavirus (pair at right) compared with normal mice of the same age (center pair). note the evidence of inanition and dehydration in the mhv-infected animals, whereas those infected with rotavirus show mainly a somewhat prominent abdomen and only a slightly smaller size than the normal control mice. weanling mice. t h e first signs usually appear at 7 -8 days of age. in mild cases diarrhea is manifested by a minimal amount of pasty fecal material about the perineum. in severe cases the amount is copious, the entire infant becoming soiled. rectal impaction may occur at about 1 2 -1 6 days of a g e , and death can ensue if the impacted mass is not removed spontaneously or deliberately. death does not seem to be the result of the virus infection per se, but rather as a consequence of protracted obstipation. in pure e d i m virus infections, mice continue to nurse throughout their illness (in the absence of impaction). they may be slightly stunted (fig. 2 ), but those with mild cases soon attain the weight of their nondiarrheal peers. especially when diarrhea is mild, morbidity in the natural disease m a y be difficult to ascertain, but one could quite cor rectly assume that, if diarrheal signs are observed in a few litters, it is likely that all infants in a colony will sooner or later be affected. concerning mortality, cheever and mueller (1947) state that there was both 100% recovery and 100% lethality in their outbreaks. based on present k n o w l e d g e , the first is suggestive of e d i m virus infection and the latter of another disease, perhaps murine (mouse) hepatitis. at no time do a d u h mice exhibit signs of illness ascribable to e d i m virus infection. in the experimentally induced dis ease, the absence of external clinical signs cannot be relied upon for a negative diagnosis (kraft, 1957) . necropsy of each animal is essential. in this w a y , the appearance of the colonic contents can be observed, which in normal infant mice are burnt orange in color and semisolid but formed in consistency. t h e colon is not distended. in diarrheal m i c e , however, even in those with no external soiling, the colonic contents are fluid or m u c o i d , bright lemon yellow to amber, or gray-green, with no formed feces in evi dence. g a s is often seen in the colon and c e c u m , which are distended. t h e stomach, t o o , is distended with curdled milk (except in terminal cases with anal impaction). all other or gans appear normal. gross change is not seen in the intestines of adults exposed perorally. it is noteworthy that in germ-free infant m i c e , ex perimental e d i m virus infection appears in the gross as it does in conventional mice (kraft, 1966) . the histologic picture has been confirmed by others (adams and kraft, 1967; mcclure et al, 1978) . there is no inflam matory reaction in the intestines. inclusions may indeed be found in enterocytes near the tips of villi, especially in the jejunum, and infrequently in the sloughed cells seen in the lumen. epithelial cells near and at the tips of villi are fre quently vacuolated. acres and babiuk (1978) have pointed out that in all species studied, the rotaviruses cause diarrhea by attacking and de stroying the columnar epithelium of the small intestine. middleton (1978) considers that cell migration from the crypts is speeded in response to diarrhea and that the infected cells are relatively immature. enzyme levels, high thymidine kinase and low sucrase, are similar in such cells to those of normal crypt cells and thus support this view. the microscopic appearance belies the severity of the gross and clinical findings of edim. in this regard, d-xylose absorp tion has been studied in calves in which 60-90% reduction occurred during the acute illness with the calf rotavirus . aberrations in sodium transport have also been investigated in other animals and in humans (middleton, 1978) , but such studies have not been carried out in mice using the mouse agent. cheever and mueller (1947) and kraft (1957) demonstrated that the agent is transmissible perorally. kraft (1957) showed further that dissemination in a mouse colony is mediated prin cipally by the airborne route. kraft (1961) examined the neutralization test in edim and found that antibodies were not always formed following infec tion, and when they were present, they tended to be low in titer. sera from adult mice having had lifelong contact with the agent (in the form of consistently diarrheal litters) were more apt to neutralize the virus than those of mice exposed for the first time as adults. on the other hand, hyperimmunization of mice has resulted in the production of significant serum titers of both complement-fixing and neutralizing antibodies (blackwell etal, 1966) . antibody response measured by other serologic tests has not been investigated for edim, nor have immune substances in lacteal secretions been measured directly. suggestive of their presence, however, are data showing that infants of primiparae who themselves had been diarrheal in infancy resisted about 10 id50 more of edim virus than did offspring of previously nondiarrheal dams (kraft, 1961) . antirotaviral immunoglobu lins have been found in both colostrum and milk in man (yolken et al, 1978c; simhon and mata, 1978; thouless et al, 1977a) , bovines (acres and babiuk, 1978) , and lambs (snodgrass and wells, 1976) . indeed, local immunity afforded by lacteal immune substances is regarded as crucial for protection against any intestinal infection in the young (welliver and ogra, 1978; snodgrass and wells, 1976 as indicated, mice of all ages can be infected, but overt disease is restricted to animals up to about 12-13 days of age at the time of first exposure. there seems to be no predilection for a particular sex. the observation that first litters are more apt to show copious and protracted soiling than those of later parity has been reported by cheever and mueller (1947, 1948) and by runner and palm (1953 edim virus is probably worldwide in distribution. whether it occurs in wild mouse populations is unknown. its prevalence is difficult to estimate, since serologic tests have not been readily available, and it is not customary to sacrifice animals for the purpose of examining the appearance of their intestinal tract or for electron microscopic visualization of fecal contents. as has been shown experimentally, latent carriers can exist. the carrier rate in a diarrheal colony is not known, nor is the frequency of viral shedding under colony conditions. cheever and mueller (1948) examined seasonal variations in the weaning percentage in their mouse strains and found that there was a significant effect in only the cfw mice. they experienced the lowest weaning rate in the late fall and winter. runner and palm (1953) , studying c3h mice, indicated that there was a higher incidence of diarrhea in december/january (kraft, 1961; blackwell et al., 1966) , complement fixation (wilsnack et al., 1969; kapikian et al, 1976; thouless et al., 1977b) , direct immunofluorescent staining or precipitin (wilsnack et al., 1969; spence et al., 1975; foster α/., 1975; peterson α/., 1976) , immune electron microscopy (kapikian et al., 1974; bridger and woode, 1975) , immunoelectroosmophoresis (tufvesson and johnsson, 1976; middleton et al., 1976) , enzyme-linked im munosorbent assay (elisa) (scherrer and bernard, 1977; el lens etal., 1978; yolken etal., 1978a,b,c) , radioimmunoas say (acres and babiuk, 1978; kalica et al., 1977; middleton et al., 1977) , immunodiffusion (woode et al., 1976) , hemagglutination inhibition (fauvel et al., 1978) , enzymelinked fluorescence assay (elisa) (yolken and stopa, 1979) , an unlabeled soluble enzyme peroxidase-antiperoxidase method , plaque reduction test (estes and graham, 1980) , serologic trapping on antibody-coated electron microscope grids (nicolaieff et al., 1980) , a solid phase system (space, solid phase aggregation of coupled erythrocytes) for detection of rotaviruses in feces (bradbume et al., 1979) , and immune electron microscopy with serum in agar diffusion (lamontagne et al., 1980) . more recently, sheridan and aurelian (1981) have described an elisa test for edim virus which should prove beneficial for both practical (serologic) purposes and for investigations of the antigenic structure of the virion. in the absence of a reliable tissue culture system, edim virus isolation is generally impractical. bacteria-free filtrates of intestinal suspensions can, of course, be given to diarrheafree animals (gnotobiotes or axenics), but this is expensive and inefficient. on the other hand, such filtrates may be concen trated by ultracentrifugation and examined in the electron mi croscope for characteristic virus particles flewett, 1978) . the particles may also be identified by immune electron microscopy. a practical approach to a presumptive diagnosis would be to kill selected animals in order to examine the appearance of the colonic contents. the inclusion of sentinel dams with litters in a breeding colony should be considered. these might be sac rificed at intervals to determine the presence of edim in the colony. together with the clinical history of the mouse colony, this practice may provide a fairly reliable, although not pathognomonic, indication of the presence of edim. his topathologic examination could also be of value. based on experimental results, kraft et al. (1964) proposed the use of air-filter devices, essentially dust caps for each cage, for the practical control of airborne transmission of edim in a commercial mouse colony. it was subsequently shown (kraft, 1966 ) that 43% of first litters and 79% of all other litter parities were weaned from cages without filters, whereas in cages pro vided with filters, weaning percentages were 96 and 99%, respectively, during the same observation period. it should be pointed out that both edim and mouse hepatitis virus (livim) were present simultaneously in that colony. although the filter devices did not eliminate the disease(s), they probably reduced the pathogenic microbial load in the immediate environment of the susceptible animals, but the precise mechanism by which this control method succeeds to the extent that it does is obscure. since that time (1964), various devices based on a filter cage or filter-top design have been utilized. some of these are de scribed by simmons and brick (1970) . woods et al. (1974) evaluated them from the viewpoint of environmental factors within the cages. they found that dry bulb temperature dif ferentials, comparing environments inside and outside the cage, were not significantly different (about 2°c) between fil tered and unfiltered cages, but that dew point differentials were significantly greater in the filtered cages (about 5°c) than in unfiltered cages (about 3°c). however, they concluded that a suitable cage size for a particular species and number of ani mals could compensate for the higher wet bulb readings under filters to maintain acceptable conditions for the animals. cur rently, several types of filter covers or bonnets are available commercially. vaccination as a method of control has not been attempted. judging from the lack of reports to the contrary, caesarian derivation together with barrier maintenance apparently elimi nates and controls the infection. kunstyf (1962) attempted to control edim by decontamina tion of air by the use of triethylene glycol but was unable to do so. the use of antibiotics, too, is without value, although there seems to be amelioration of signs for a short period as secon dary organisms are temporarily reduced in number. as indicated by kraft (1966) , it may be relatively easy to establish a colony of mice free from edim virus infection. this may be accomplished by eliminating those breeding pairs whose first litter is diarrheal. filter devices are required for this, and they and the animals must be handled with the aid of a transfer or laminar flow hood using sterile techniques during observation and handling of the animals. the method is suita ble for small colonies, but it is impractical for commerce where caesarian derivation and barrier maintenance are the methods of choice. reovirus 3 was first isolated from the feces of an australian child manifesting a cough, fever, vomiting, hypertrophic tonsils, and bilateral bronchopneumonia. it was named hepatoencephalomyelitis virus by stanley et al. (1953) , who originally recovered the agent. sabin (1959) proposed the name reovirus for a group of agents associated with the respi ratory and enteric tracts of humans. they were found to be ether resistant, about 70 nm in size by membrane filtration but of unknown shape, and caused distinctive cytopathic effects in monkey kidney tissue cultures. one of the echo group of viruses, echo 10, now synonymous with reovirus, became a member of the new group on that basis. (echo is the acronym for enteric cytopathic /zuman 6>φhan, agents isolated in tissue culture from asymptomatic humans-so-called viruses in search of disease.) stanley (1961) then demonstrated that the hepatoencephalomyelitis virus was serologically identical to reovirus 3. additional strains have since been recovered from humans, other mammals, marsupials, birds, insects, and reptiles (for review, see stanley, 1974) , and from mouusks (meyers, 1979; meyers and hirai, 1980) . reoviruses have been divided into three serotypes on the basis of hemagglutination inhibition and neutralization tests (sabin, 1959; rosen, 1960) . reovirus 3 was established as an indigenous murine virus by hartley et al. (1961) and by cook (1963) . reviews concerning the biological and clinical aspects of disease caused by this agent have been prepared (stanley, 1974 (stanley, , 1977 . when gomatos et al. (1962) and discovered that reoviruses possess double-stranded rna, a unique characteristic among viruses, molecular biologists were inspired to study them in minute detail. currently, knowledge of reovirus replication on biochemical and biophysical planes is as extensive as that available for any other virus and is, for the most part, outside the scope of this chapter. interested readers are therefore referred to reviews by shatkin (1969) and joklik (1974) for extended literature coverage and detailed dis cussion and to andrewes et al. (1978) for a condensed over view. or reovirus, in the family reoviridae (melnick, 1979) . wild-type strains of reovirus 3 include: dearing, the pro totype strain (sabin, 1959) , isolated from a child with diarrhea; abney (rosen, 1960) , isolated from a child with a febrile upper respiratory infection; can 230, from a case of burkitt's lymphoma (bell et al., 1964) ; and several strains obtained from naturally infected cattle (rosen, 1960) . mutant, temperature-sensitive (ts) strains have been developed in the laboratory (fields and joklik, 1969) and have been used for studying the synthesis of viral rna and peptides (cross and fields, 1972; as well as for examining problems of pathogenesis. a neurotropic strain was also de-rived from the m o r e hepatotropic original isolate (stanley et al, 1954) . t h e reovirus 3 virion (fig. 3) has a m e a n diameter of about 6 0 -7 6 n m and is icosahedral in shape, with 5:3:2 symmetry. particles have a core, an inner layer or shell containing a n u m b e r of capsomers formalin at 56°c. ether treatment was ineffective. rozee and leers (1967) determined that although cholorform does not affect infectivity, it does destroy the hemagglutinin. wallis et al. (1964) found that mg^^ enhances the titer of reovirus at 50°c. the infective titer increased four to eight times by heat ing for 5-15 min in 2 μ mgcl2. other divalent cations and nacl were ineffective. hemagglutinin was not affected. it is thought that the high temperature and mg^+ caused activation of reovirus particles that were inactive in the original prepa rations. as with rotavirus. ward and ashley (1978) found that reovirus was sensitive to anionic detergents in wastewater sludge, i.e., these chemicals decreased the temperature needed to inactivate the virus. cationic detergents were more active than anionic, and nonionic detergents were inactive in decreas ing reovirus thermal stability. mutagens (nitrous acid, nitrosoguanidine, and proflavine) have been applied to reovirus 3 (fields and joklik, 1969) . the resulting mutants are of interest not only to the molecular biologist but to the clinical virologist as well, since some of them produce altered disease pictures (fields and raine, 1972) . for example, when inoculated into rats, wild-type virus produced a necrotizing encephalitis, whereas a mutant gave rise to a slowly progressive communicating hydrocephalus. the effects of enzymes are described below (see section iii,b,5). in phosphate-citrate buffers, stanley et al. (1953) ascertained that the virus is stable between ph 2.2 and 8.0. e. antigenic determinants. sabin (1959) demonstrated that the mammalian reoviruses known at that time could be divided into three serologic groups by neutralization tests. they could also be differentiated by hemagglutination inhibi tion (rosen, 1960 ), hull et al. (1956 having discovered that echo 10 virus possessed a hemagglutinin for human o eryth rocytes. later, reported that reovirus 3, but not reovirus 1 or 2, agglutinated ox erythro cytes. the reovirus 3 hemagglutinin was inhibited by nonspecific substances such as normal mouse, rabbit, or rat serum, and by vibrio cholerae filtrate. weiner et al. (1978) were able to show that the 57 rna segment, which is associated with type specificity, encodes the polypeptide that determines the hemagglutinating properties of the virion. complement-fixing antigens were prepared by stanley et al. (1953, 1954) and by j. c. parker et al. (1965, 1966) . these are group specific. leers et al. (1968) determined that reovirions display at least one type-specific and one to two group-specific antigens when studied by immunodiffusion. with the more sensitive im munoelectrophoresis technique, however, these authors en countered two type-specific and four group-specific precipitin lines. the agent is regarded as pantropic in mice. in neonates, stanley et al. (1953) (wolf et al., 1981) . papadimitriou (1965 papadimitriou ( , 1966 papadimitriou ( , 1968 also studied viral replica tion by electron microscopy in the mucosa of the common bile duct and in the liver. reovirus 3 has been reported to be oncolytic for a mouse ascites tumor by bennette (1960) , bennette et al. (1967,a,b) , and nelson and tamowski (1960) . most of the studies dealing with replication of the reoviruses have been accomplished in tissue culture, frequently in plaque assays in l-cell monolayers. other cells that have been suc cessfully employed are primary kidney monolayers of rhesus, patas, and capuchin monkeys, as well as those of pigs, cats, and dogs. continuous lines, such as fl human amnion, bs-c-1, and kb, have also been used (hsiung, 1958; cook, 1963; mcclain etal., 1967; rhim and melnick, 1961; harford et al., 1962) . harford et al. (1962) (1973a,b,c, 1974, 1979) . stanley et al. (1953, 1954) reported the development of pocks on the chorioallantois of 12-day-old chick embryos in oculated with infectious brain and liver. the embryos appeared unaffected, and with succeeding passages, the pocks could no longer be observed, although oral inoculation of suckling mice with chorioallantoic suspensions resulted in active disease. essentially the same results were found following amniotic inoculation. the experimental and natural diseases appear identical ex cept for variations in intensity of signs, perhaps due to dif ferences in infectious dose. up to 16 days after intraperitoneal inoculation, the mice appear emaciated and uncoordinated. the hair is oily and matted-the so-called oily hair effect (ohe)-an effect that can be demonstrated in contact animáis as well. however, in these mice it disappears as soon as the diseased animal is removed from the healthy ones. the effect was ultimately traced to a high proportion of fat in the intesti nal contents (steatorrhea): 12.9% in infected animals as com pared with 4.6% in normal mice. feces may contain as much as 29% fat in infected mice (stanley et al., 1953 (stanley et al., , 1954 . the thymus and other organs appeared normal. in the central nervous system, neuronal degeneration began about the ninth day and was most prominent in the brain stem and cerebral hemispheres. by the tenth day, perivascular cuf fing as well as neuronal satellitosis was evident. the meninges were infiltrated with round cells and netrophilic leukocytes. by the fourteenth day encephalitis was severe and widespread, with small hemorrhages occurring in necrotic regions. in suckling rats inoculated intracerebrally with reovirus types 1, 2, or 3, viral cytoplasmic inclusions and intranuclear bodies corresponding to cowdry type β inclusions have been ob served (margolis et al., 1975) . the latter were seen in cells that were free from intracytoplasmic inclusions; they were readily found in weanlings, were unassociated with inflam and their microvilli swollen. the common bile duct is dilated, and the ampullary region becomes obstructed with debris. it is this obstruction that leads to both hepatic and pancreatic dys function, for after studying the pancreatic lesions further, papadimitriou and walters (1967) concluded that, even though virions were seen in pancreatic acinar cells, the principal cause of acinar degeneration is ductal obstruction. based on the neutralization test, determined that the si genome segment is linked to type speci ficity, and finberg et al (1979) found that the same genome segment is also responsible for the production of cytolytic τ lymphocytes after reovirus infection. tytell et al (1967) , working with reovirus 3 rna, found that it was highly active in inducing interferon in rabbits and tissue culture, and lai and joklik (1973) showed that coreless virions as well as those lacking the outer capsid shell induce no interferon. the question of the role of interferon in protection of mice from either the acute or chronic infection remains an intriguing problem. in an effort to permit a precise definition of the host cellular immune response to viral antigens, weiner et al (1980b) and greene and weiner (1980) which also determined serotype-specific humoral (neutraliz ing) and cytolytic t-cell responses. it is clear that the agent can be transmitted by the oral route as well as by parenteral inoculation. mice respond to the natural infection with neutralizing, hemagglutination-inhibiting, and complement-fixing an tibodies. as indicated earlier (section iii,b,3,^), precipitating antibodies can also be demonstrated. there is no evi dence that any mouse strain is more or less susceptible to reovirus 3 infection than any other, provided the animals come from a colony that is free of the infection. the host range is broad. stanley (1974) cited at least 60 species that may be infected with reoviruses, and, as men tioned above, it is thought that the prevalence of antibodies in otherwise normal mammals is related to this fact and that mosquitoes or other insects may be operational in the spread of the infection. the acute disease affects mainly sucklings and weanlings, whereas the chronic disease is encountered in animals over 28 days of age. there is no indica tion that either sex is more or less susceptible than the other. in an epizootic described by cook (1963) , 130 of 800 first litters were affected. later-parity litters were involved hardly at all. in view of the absent or low complement-fixing antibody titers in the presence of significant hemagglutination-inhibiting titers that follow natural infection, prevalence estimation by immunologic means may be difficult to assess. the data cited by parker et al. (1966) , 82% of 34 colonies positive, and by descoteaux et al. (1977) , 100% of five colonies posifive, may be typical incidences for conventional mouse colonies. as already indicated, reovirus 3 infection is regarded as worldwide in distribution. this aspect of reovirus 3 infection has been covered above (section iii,b,l,2a,¿?). munoperoxidase method (enzyme-labeled antibody) has been employed for reovirus 1 (ubertini et al., 1971 ) and may find application for reovirus 3 diagnosis as well. although ohe may not be absolutely pathognomonic for reovirus 3 infection, it seems distinctive enough so that a provisional diagnosis may be made when it is seen. stronger evidence is afforded if the animals are also jaundiced and wasted. necropsy coupled with histopathologic examination is never a mistake and is to be encouraged. the placement of sentinel animals at strategic locations in an animal colony should be considered. such animals may be regarded as expendable for sacrific, necropsy, and virus isolation as well as for the acquisition of serum for antibody determinations. there is no evidence that epizootics occur preferentially at a particular time of the year. j. c. parker et al. (1965, 1966) discussed the serologic diagnosis of reovirus 3 infection, concluding that for these puφoses the hemagglutination inhibition test was the most reliable. in preparing type-specific antisera for standardizafion and controls, behbehani et al. (1966) found that the ubiquity of inhibitory substances (antibodies included) in most mamma lian species precluded accurate work. they therefore used domestic geese, in which virtually no hemagglutinafion inhibi tion or neutralizing antibodies could be detected prior to im munization. in any event, for routine surveillance, the hemagglutination inhibition test is currently utilized. comments similar to those expressed for edim virus recov ery and visualization apply. although it is possible to perform these procedures, they are inefficient for routine diagnostic puφoses. stanley (1977) has outlined methods for this pur pose. in brief, infectious material can be inoculated into tissue cultures (primary rhesus monkey or human kidney) or newbom mice (from reovirus 3 free colonies!), or the material may be subjected to immunofluorescent methods. an imcesarean derivation and barrier maintenance are believed to be suitable techniques for control and prevention of reovirus 3 infection. although no experimental evidence has been found, it is possible that the use of filter devices in conventional colonies might also be helpful in preventing the spread of infection. in the absence of information on the vertical trans mission of the agent, it is impossible to evaluate the influence of that route on successful control of the endemic disease. although therapy is impractical from the standpoint of con trolling epizootics of reovirus infection, it is nonetheless of considerable interest that willey and ushijima (1980) found that thymosin given intraperitoneally to 7-day-old mice that had been neonatally infected with reovirus 2 (2 ld50) signifi cantly increased their mean survival time, provided it was ad ministered at 2200 hr. when given at 0800 hr, significantly increased survival time was not observed, but when inoculated at 1200 hr, there was an apparent decrease in mean survival time. reviews on the subject include those by piazza (1969) , mcintosh (1977) , kapikian (1975) , andrewes et al (1978) , holmes (1979) , garwes (1979) , and robb and bond (1980) . based on their own electron microscopic studies and on those of david-ferreira and manaker (1965) , becker et al (1967) considered that mhv might be an 'tbv-like" (infecti ous bronchitis viruslike) agent. virions of similar moφhology seen in electron micrographs and also ether sensitive, as is ibv, were being isolated at that time from human cases of colds (almeida and tyrell, 1967) . the following year, the term coronavirus was proposed for the group (tyrell et al, 1968) , and in 1975 the coronaviridae became an official fam ily with a single genus, coronavirus (tyrell etal, 1975 additional agents may be added to this group, e.g., ''runde" virus (traavik et al, 1977) , a coronavirus causing car diomyopathy in rabbits (small et al, 1979) . as noted, many strains of mhv have been recovered from mice under various circumstances. in addition to jhm, these include: mhvl, from "white mice" (p or parkes strain), dur ing attempts to adapt human hepatitis virus to animals (the strain was originally isolated as a dual agent consisting of the virus and a protozoon parasite, eperythrozoon coccoides (gledhill and andrewes, 1951) ; mhv2, from mice used to propagate murine leukemia virus (nelson, 1952a,b) ; mhv3, also found during studies on adaptation of human hepatitis virus to mice (dick et al, 1956) ; mhv-b (ehf-120), from mice used for human epidemic hemorrhagic fever (hehf) adaptation attempts (buescher, 1952) ; an unnamed strain from mice undergoing murine leukemia chemotherapy trials (braunsteiner and friend, 1954) ; h747, following intracere bral inoculation of suckling mice with hehf materials (morris, 1959) ; mhv-a59, during transfer of moloney leukemia virus in mice (manaker et al, 1961) ; mhv-s, from cesareanderived mice that had been barrier-maintained before exposure to conventional mice ; mhv-c (mhv-balb/c), isolated during passage of spleens from leukemic mice (nelson, 1955) ; four addiiional strains from spleens of leukemic mice or from natural outbreaks (mhv-srl, -sr2, -sr3, -sr4) (nelson, 1963 (nelson, , 1965 ; lethal intestinal virus of infant mice (livim), from infant mice dying of a spontaneous infection (kraft, 1962a) , identified as an mhv strain by broderson et al (1976) and hierholzer et al (1979) ; and nuu, nua, nu66, from nude mice with hepatitis and wasting syndrome . other isolates have also been derived from nude mice (sebesteny and hill, 1974; ward et al, 1977) , and fox et al (1977) have described a strain that appeared during passage of an ascites myeloma cell line in balb/c mice. *hev may also denote the hepatoencephalomyelitis virus of stanley et al. (1954) , which is identical to reovirus 3. a s reviewed by mcintosh (1974) , coronaviruses are p l e o m o φ h i c , enveloped, and variable in size, measuring about 8 0 -1 5 0 n m in diameter. peplomers are 1 2 -2 4 n m in length (fig. 4 ) . using various techniques, a n u m b e r of workers have con firmed the diameter of m h v virions to fall within the range of the coronaviruses (gledhill et al., 1955; miyazaki et al., 1957; kraft, 1962a; starr etal., 1960) . svoboda etal. (1962) further described the virion as consisting of a nucleoid sepa rated from an outer m e m b r a n e by an electron-lucent space. david-ferreira and manaker (1965) , working with m h v -a 5 9 in tissue culture, found that the virions had a m e a n diameter of 75 nm with an electron-dense inner shell, 55 nm in diameter, separated from the outer double m e m b r a n e by an electronlucent space 8 nm wide. peplomers were 1 6 . 6 -2 3 . 4 n m long. not only was the virion significantly smaller than that of i b v , but the peplomers dif fered from those of both i b v and h c v 2 2 9 e , being conerather than club-shaped. mallucci (1965) in general, coronaviruses are inacti vated at 56°c in 10-15 min, at 37°c in several days, and at 4°c in several months (tyrell etal., 1968; kapikian, 1975) . wildtype mhv isolates also fall into this range of sensitivity gledhill and andrewes, 1951; gledhill et al., 1955; kraft, 1962a) . hirano et al. (1978) , however, indicated that mhv2 is not completely destroyed at 56°c for 30 min and is stable at 50t for 15 min in 1 μ mgclg or mgs04 but not in water. freezing and thawing or sonication at 20 kc for 3 min does not affect the virus titer. c. effect of chemicals. all coronaviruses are sensitive to ether when exposed overnight at 2°-4°c. chloroform also de stroys or reduces infectivity (mcintosh, 1974) . fifty percent glycerol inactivates mhvl after 6 weeks at 2°c (gledhill and andrewes (1951) . sodium deoxycholate reduces the titer of livim significantly (kraft, 1962a) , but calisher and rowe (1966) regard mhv virus as moderately resistant. according to hirano et al. (1978) , mhv2 is completely inactivated by ether, chloroform, sodium deoxycholate, and /3-propiolactone, but it is completely resistant to trypsin. mutagenesis has been reported by means of nmethyl-/v'-nitroguanidine or 5-fluorouridine and by 5-azacytidine or 5-fluorouracil (haspel et al., 1978) . the ph stability of all known murine hepatitis viruses has not been reported. for coronaviruses in general, acid sensitivity is regarded as variable (mcintosh, 1974) . hirano et al. (1978) found that mhv2 is stable be tween ph 3 and 9 at 37°c for 30 min. calisher and rowe (1966) although they have been sought, hemagglutinins have not been demonstrated for mhv strains (see, e.g., hirano et al., 1978; kraft, 1962a; bradbume, 1970; miyazaki etal., 1957) , but two human coronavirus strains do agglutinate human 0 erythrocytes (kaye and dowdle, 1969 cheever et al. (1949) found jhm virus to be unrelated to other neurotropic viruses, including gd vii, pseudorabies, lansing poliomyelitis, and mengo virus. kraft (1962b) found no relationship between livim, edim, and reovirus 3. with regard to other coronaviruses, the picture is somewhat different, for as a group, coronaviruses display complex serologic variability (bradburne, 1970; mcintosh et al., 1969) . mhv is serologically closely related to rcv and sdav in complement fixation tests and distantly related to rcv in cross-neutralization tests (parker et al., 1970; bhatt et al., 1972) . several strains of mhv are closely related to human coronaviruses oc 38 and oc 43 , and mhv3 is related to hcv-229e (bradbume, 1970) . antibody to mhv strains commonly found in human sera is probably present because of endemic human infection with related coronavimses (hartley et al., 1964) . electron micrographs and studies using fluorochrome stains indicate that coronaviruses develop exclusively in the cyto plasm of infected cells, that the virions collect in cytoplasmic vesicles of diverse size, that particles may also be seen in the matrix outside of the endoplasmic reticulum as well as in the golgi apparatus, and that they are not observed in the nucleus. in the main, replication involves budding into cytoplasmic cis temae, but tubular structures have also been seen within the cytoplasm during virus formation (ruebner et al., 1967; stan di α/., 1960; watanabe, 1969a,b) . wilsnack (1971) , confirming the work of boss and jones (1963) , elicited immunofluorescent antigen staining in sinusoidal lining cells in necrotic liver foci of weanling mice within 24 hr after intraperitoneal inoculation of the a59 strain. stainable antigen in intestinal impression smears of mice in fected by cage contact was also demonstrated. piazza et al. (1967) examined the fate of mhv3 after in travenous inoculation. the agent was not demonstrable be tween 40 min and 3.5 hr, when it appeared first in the spleen, then in the liver (4 hr) and blood (4.5 hr). at 5 hr it was recoverable from brain and kidney. high titers were then reached in all organs. barinsky and dementiev (1968) thereafter, the cells of the olfactory bulb and other brain re gions are affected. a number of cell systems have been successfully employed for in vitro growth of mouse hepatitis viruses: mhv-c in mouse embryo explants (mosley, 1961) ; mhvl in newborn mouse kidney explants (starr and pollard, 1959) ; mhv-s in mouse embryo explants (compels, 1953) and in liver (gallily et al, 1964) ; mhv-b in liver cell monolayers (paradisi and piccinino, 1968) ; mhv3 in liver explants (vainio, 1961) ; mhv-b in liver cells (miyazaki et al, 1957) ; mhv2 and mhv3 in dbt cells (hirano et al, 1978; takayama and kim, 1978) ; and various strains in nctc 1469 cells (david-ferreira and manaker, 1965; wilsnack etal, 1971; hartley and rowe, 1963) . mallucci (1965) , seamer (1965) , and lewis and starr (1972) described syncytium formation by mhv in mouse macrophage cultures, and a plaque assay for mhv2 in primary peritoneal macrophage cultures was described by shif and bang (1966) . laufs (1967) also described multinucleated giant cells with as many as 200 nuclei per cell in macrophage cultures infected with mhv3. using autoradiography, he ascertained that there was no dna synthesis in them and that they originated from cell fusion. macrophages derived from either liver or peritoneal wash ings are of enormous interest for the question of host cell-vims interactions. bang and warwick (1959, 1960) macrophages from the mice mirror these changes in resistance as the animals age. kantoch et al. (1963) determined that temporary susceptibility could be induced in resistant cells in culture if they were exposed to homogenates of susceptible cells, and gallily et al. (1964) showed that macrophages from genetically resistant mice treated with cortisone to enhance susceptibility behave in culture as if they were from susceptible animals. macrophages from mice susceptible to mhv2 virus can be converted to resistance by the intraperitoneal inoculation of concanavalin a in the donor mice. this enhanced resistance is also expressed in vivo (weiser and bang, 1977) . cheever etal. (1949) , nelson (1952b) , and kraft (1962a) in suckling mice, rapid wasting with or without neurologic signs may take place, accompanied in some cases by diarrhea, inanition, and dehydration (fig. 2) . mortality and morbidity are variable, ranging between al most 0 and 100% depending on factors like those affecting clinical signs. of importance to users and breeders of mice alike is the fact that a number of agents and procedures are known to modify the reactivity (and therefore the clinical signs) of mice to both spontaneous and experimental infection. examples of these, together with pertinent references, are presented in table i . leprévost et al. (1975a,b) have taken the view that there are three types of sensitivity to mhv3 infection in mice: resis tance, full susceptibility, and semisusceptibility. these are re flected in the susceptibility of their macrophages response of nuinu mice to sheep erythrocytes dba/2 mice, on the other hand, are regarded as fully suscep tible since deaths begin 4-6 days after infection, even when the mice are 90 days old, whereas the a/j strain is resistant, being susceptible to the acute disease only up to 3-4 weeks of age. although c3h mice are partially susceptible to the acute phase of the disease, they are fully susceptible to the chronic stage. in nude (nu/nu) mice, mhv takes on special significance. indeed, perhaps the best description of the clinical signs may be found in the original report describing this mutant mouse (flanagan, 1966) , published before runt disease, as the wast ing syndrome was called, came to be recognized as something other than a genetic effect. mhv-infected nude mice lose weight slowly or rapidly. they move stiffly with a stilted gait, and their faces assume a pointed, anxious appearance. partial paralysis may develop first in the hindlimbs and then in the forelimbs, resulting in almost total immobility. nu/+ heterozygotes are not affected in this way. flanagan (1966) found that at weaning, the nude animals were much smaller than controls (heterozygotes), that 55% died within 2 weeks of birth, and that 100% were dead by 25 weeks of age, whereas only 6% of controls died in the same period. it was not until sebesteny and hill (1974) uv-inactivated virus did not elicit the effect. the authors be lieve that fixed macrophages in athymic mice may be acti-vated, as was indicated by nickol and bonventre (1977) and by cheers and waller (1975) in certain bacterial infections in nude mice. t a m u r a et al (1979) (see, e . g . , r u e b n e r and bramhall, 1960; gledhill etal., 1952; nelson, 1953) . in liver regeneration m a y take place as early as 1 0 -1 4 days after infection (ruebner and bramhall, 1960) , ranging from complete healing to chronic scarring with intermediate gradations. kupffer cells were examined by r u e b n e r and miyai (1962) and r u e b n e r et al. (1967) . t h e y m a y undergo nuclear pyknosis and karyorrhexis 24 hr after intravenous inoculation of m h v 3 . in infection with neurotropic variants, such as j h m , the principal lesions appear in the central nervous system . meningitis is present but varies in degree and loca tion. in the brain, lesions m a y be found in all regions, but the hippocampus and its connections, the olfactory lobes, the periependymal tissues, and the brain stem seem to b e affected most often. necrotizing lesions predominate in the olfactory lobes and hippocampal regions, whereas demyelination is the major change in the brain stem. s o m e exudate m a y be found around blood vessels associated with lesions, and at about 5 days after infection, proliferating pericytes and scant lym phocytic cuffing can be seen. peripheral nerves show n o change. in sucklings, j h m virus produces extensive lesions in the brain and cord at 6 -8 days. meningitis is present, and large regions of necrosis with m a n y giant cells occur throughout the brain. in the cord, the lesions consist of spongy necrosis of the central gray matter. ganglion cells appear unaffected. powell and lampert (1975) resolved into small foci of fibrillary gliosis with an increased size and n u m b e r of astrocytic processes. t h e importance of this finding for investigations into the cause of multiple sclerosis and other demyelinating diseases in m a n is obvious and has been addressed b y , a m o n g others, lucas et al. (1977) and lampert (1978) . in sucklings infected with enterotropic strains (kraft, 1962a; broderson et al., 1976; ishida et al., 1978; ishida and fuji wara, 1979; r o w e et al., 1963; hierholzer et al., 1979) strains (dick et al., 1956; r u e b n e r and bramhall, 1960; hirano and ruebner, 1966) , and biggart and ruebner (1970) attribute the change to virus replication in lymphocytes. in other organs, minute superficial necrotic foci m a y be found in the stomach. n o changes are seen in the heart, lungs, pancreas, kidney, adrenals, voluntary m u s c l e , femoral o r ver tebral bone m a r r o w , or pituitary gland, although virus m a y be isolated from some of those organs. occasional giant cells are found in peripancreatic lymph nodes and in p e y e r ' s patches. flanagan (1966) islands of hepatocytes, markedly hypertrophied, remained. changes in other organs were not described. the liver lesions observed in other nude mice infected with mhv were similar. sebesteny and hill (1974) noted central nervous system lesions in their nude mice. ward et al. (1977) also encountered central nervous system lesions in addition to vascular changes, giant cell peritonitis, ascites, and giant cells in the villous epithelium of the intestines. since virus can be transmitted perorally and intranasally, it may be assumed that these are the principal routes of natural infection. transmission may be mediated by both the airborne and contact modes. feces, nasopharyngeal exudates, and perhaps urine would be sources of infection. evidence of vertical transmission is at hand, but reports are conflicting. piccinino et al. (1966) with or without booster, showed no antibody in the same colony. in a conventional colony of ddd mice, furthermore, seropositivity increased from 0 to 12% and in ddy mice from 6.3 to 45% as a result of the booster technique. in barrier-maintained animals, the booster did not elicit antibodies where there had been none before. presumably, these animals were free from mhv infection. from the foregoing, it is evident that the classic humoral immune response to mhv seems to be weak, and that a colony in contrast to the findings of bang and warwick (1960) , who concluded that one gene (or factor) was responsible for host susceptibility in mhv2 infection, stohlmann and freiinger (1978) showed that two genes are required for resistance of the central nervous system in sjl mice to fatal disease due to mhv-jhm. further, stohlmann et al. (1980) reported that there is an age-related change in resistant mice that protects them from acute central nervous system disease. they iden tified this change as due to a maturing adherent spleen or peritoneal exudate cell population. in extensive genetic studies, levy-leblond et al. (1979) found no correlation between the h-2 locus and either the acute or chronic disease in c57bl (susceptible) or a/j (resistant) animals. using congenie c3h lines, however, they were able to show that the h-2^ allele enables both heterozygous and homozygous animals to resist the development of the chronic disease. they believe, therefore, that mhv sensitivity appears to be influenced by at least two major genes: one for the acute disease, and the other, linked to the h-2 gene complex, for the chronic disease. mice also produce interferon as a result of mhv infection virelizier and gresser, 1978) , and taguchi et al (1979a) ascribe the greater susceptibility of suckling c3h/hejms mice to serum levels of interferon that are considerably lower than in weanling and aduh mice, as well as to greater macrophage sensitivity in the neonates. mhv-induced interferon may be regarded as the principal mechanism by which the virus modifies the immune respon siveness of mice to sheep red blood cells, for example. (see also (1949) infected cotton rats, rats, and hamsters intracerebrally, but rabbits and guinea pigs failed to respond. sebesteny and hill (1974) at tempted to infect infant wistar rats and hamsters using virus recovered from nude mice. all survived at least 21 days with out signs of illness. of considerable importance is a report by taguchi et al (1979c) concerning asymptomatic mhv-s infection in suckl ing rats following intranasal inoculation. the agent multiplied mainly in the nasal epithelium without any clinical signs. neu tralizing antibodies were produced, however, and could also be demonstrated in adult rats following infection. necrotic changes took place in the nasal mucosa, and cytoplasmic im munofluorescence was demonstrated in the nasal epithelium 2 days after intranasal inoculation of 10-day-old rats. age susceptibility has been amply addressed above in the consideration of virus growth in mice and tissue culture and in the discussion of the clinical picture. there appears to be no difference in susceptibility between the sexes (taguchi et al., 1976) . parker et al. (1966) found that the incidence of complement-fixing antibodies was greater in females than in males under colony conditions, as cribing this difference to continual exposure to virus-infected litters. there appears to be no evidence that first litters are significantly more susceptible than later ones. as noted above (section iv,β, 2 and c,l), the susceptibility of various mouse strains depends on the age of the host at the time of infection, the virus strain, and the host genotype. a completely resistant mouse strain has not been reported. prevalence of mhv infection in an animal colony is often difficult to ascertain. in addition to examples given earlier, descoteaux et al. (1977) found a low prevalence of hepatitis antibodies in three of five colonies studied in canada. complement-fixing antibodies ranged in titer from 8 to 32, 8 being considered positive. fewer than 20% of the animals, which were 6-9 months old at the time of testing, were posi tive. in distribution, mhv is regarded as occurring worldwide. these have been defined as occurring more than 2 months after intracerebral, intraperitoneal, intranasal, or intravenous inoculation (as reviewed in robb and bond, 1980) . the chronic clinical manifestations range from none to porenceph aly, paralysis, hepatitis, immunodeficiency manifestations, encephalitis, lymph node adenopathy, and vasculitis. virus may or may not be isolated. cells stainable by immunofluores cence may be found. demyelination with or without remyelination may occur. occasional scattered mononuclear cell infil trates may be evident. there is no evidence that seasonal changes influence the oc currence of epizootics of mhv infection. as indicated above, serologic testing is routinely carried out by means of the complement fixation test. cross-reactions with other coronaviruses must be taken into account when inteφreting the results, however. neutralization tests performed in tis sue culture systems are also possible. employing virus strain a59 as antigen in the elisa, peters et al. (1979) found a high prevalence of mhv antibodies in colonies with a low incidence of both complement-fixing and neutralizing antibodies. hierholzer and tannock (1977) have used the single radial hemolysis test for human coronavirus serodiagnosis. they then applied it to some mhv strains (hierholzer et al, 1979) . these techniques are helpful under certain circumstances, e.g., experimental investigations, but they are inefficient for field conditions. necropsy of dead or sick animals is always useful, although a definitive diagnosis in the absence of serologic evidence cannot be made. nevertheless, wherever possible, gross and microscopic pathologic examination should be undertaken. sentinel animals, especially gnotobiotes, could be ιηοοφοrated into a program of colony health surveillance. these ani mals can then be checked at predetermined intervals for clini cal, serologic, and histopathologic evidence of endemic dis ease in the colony. control of mhv is difficult in mouse colonies unless caesa rian derivation coupled with barrier maintenance is under taken. with the finding that vertical transmission is possible, however, barrier maintenance alone may not be adequate if, for example, such transmission is frequent. using small number of animals for experimental puφoses, kraft (1962a) tamura et al (1976) found that nu/nu mice could resist mhv infection when they previously received thymocytes from weanling nu/+ littermates. they were then not only able to produce antibody but survived a challenge infection as well. studies on rotaviral antibody in bovine serum and lacteal secretions, using radioimmunoassay epidemic diarrhea of infant mice. identification of the etiologic agent electron microscopic study of the intestinal epithelium of mice infected with the agent of epizootic diarrhea of infant mice (edim virus) the morphology of three pre viously uncharacterized human respiratory viruses that grow in organ culture the effect of trypsin on the growth of rotavirus viruses of verte brates panel report of the colloquium on selected diarrheal diseases of the young rotavirus isolation and cultivation in the presence of trypsin a murine virus (jhm) causing disseminated encephalomyelitis with extensive destruction of myelin. ii in vitro detection of human rotaviruses further observa tions on the virus of epizootic diarrhea of infant mice. an electron microscopic study genetics of resistance of animals to viruses: i. introduc tion and studies in mice macrophages and mouse hepatitis mouse macrophages as host cells for the mouse hepatitis virus and the genetic basis of their susceptibility virological and cytogenetic studies on the involvement of bone marrow of mice in some hepatoencephalotropic viral infections rotavirus serotypes by serum neutralisation moφhogenesis of avian infectious bronchitis virus and a related human virus (strain 229e) preparation of type-specific antisera to reoviruses isolation of a reovirus from a case of burkitt's lymphoma isolation of a non-pathogenic tumour-destroying virus from mouse ascites characteristics of a newborn runt disease induced by neonatal infection with an oncolytic strain of reovirus type 3 (reo3mh). ii. immunological aspects of the disease in mice characteristics of a newborn runt disease induced by neonatal infection with an oncolytic strain of reovirus type 3 (reo3mh). i. pathological investigations in rats and mice characterization of the virus of sialodacryoadenitis of rats: a member of the coronavirus group lymphoid necrosis in the mouse spleen produced by mouse hepatitis virus (mhv3): an electronmicroscopic study lethal intestinal virus infection of mice (livim). an important new model for study of the response of the intestinal mucosa to injury virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis serological studies with an agent of epizootic diarrhea of infant mice pathogenic murine coronaviruses. ii. characterization of virus-specific proteins of murine coronaviruses jhmv and a59v specific monovalent cation effects on modification of reovirus infectivity by chymotrypsin digestion in vitro ex traordinary effects of specific monovalent cations on activation of reovirus transcriptase by chymotrypsin in vitro new intermediate subviral particles in the in vitro uncoating of reovirus virions by chymotrypsin reovirus transcriptase activation in vitro: involvement of an endogenous uncoating activity in the second stage of the process two modes of entry of reovirus particles into l cells hepatic localization of infectious agent in murine viral hepatitis antigenic relationships amongst coronaviruses a solid-phase system (space) for the detection and quantification of rotavirus in faeces small intestinal epithelial brush border enzymatic changes in suckling mice infected with reovirus type 3 reovirus type 3 infection in a suckling mouse: the effects on pancreatic structure and enzyme content viral hepatitis associated with trans plantable mouse leukemia. i. acute hepatic manifestations following treatment with urethane or methylformamide neonatal calf diarrhoea: identifica tion of reovirus-like (rotavirus) agent in faeces by immunofluorescence and immune electron microscopy lethal en teritis in infant mice caused by mouse hepatitis virus the laboratory diagnosis of epizoo tic diarrhoea of infant mice a rabbit rotavirus. vet. ree. 99 diagnosis of rotavirus infection by cell culture a hepatitis virus of mice two coronaviruses isolated from central nervous system tissue of two multi ple sclerosis patients mouse hepatitis, reo-3, and the theiler viruses activated macrophages in congenitally athymic "nude" mice and in lethally irradiated mice epidemic diarrheal disease of suckling mice epidemic diarrheal disease of suckling mice. i. manifestations, epidemiology, and attempts to trans mit the disease epidemic diarrheal disease of suckling mice. iii. the effect of strain, litter, and season upon the incidence of the disease a murine virus (jhm) causing disseminated encephalomyelitis with extensive destruction of myelin. i. isolation and biological prop erties of the virus serological inter relationships of murine hepatitis viruses production of high-titer bovine rotavirus with trypsin murine virus contaminants of leukemia viruses and transplantable tumors reovirus type 3 infection in laboratory mice temperature-sensitive mutants of reovirus type 3: studies on the synthesis of viral rna effect of corticosteroids on mouse hepatitis virus infection an electron microscope study of the development of a mouse hepatitis virus in tissue culture cells importance of a new virus in acute sporadic enteritis in children comparison of the morphology of three coronaviruses classification of rotaviruses: report from the worid health organization/food and agriculture or ganization comparative virology program serologic study on the prevalence of murine viruses in five canadian mouse colonies a virus related to that causing hepatitis in mice (mhv) immunopathology of mouse hepatitis virus type 3. ii. effect of im munosuppression in resistant mice the appearance of a hepatotrophic virus in mice thymectomized at birth comparison of five diagnostic methods for the detection of rotavirus antigens in calf faeces morphological studies on simian virus sa 11 and the "related" 0 agent electron microscopic identification and subsequent isolation of a rotavirus from a dog with fatal neonatal diarrhea enhancement of rotavirus infectivity by trypsin and elastase identification of rotaviruses of different origins by the plaque-reduction test hemagglutination and hemagglutination-inhibition studies with a strain of nebraska calf diarrhea virus (bovine rotavirus) isolation and preliminary genetic and biochemical characterization of temperature-sensitive mutants of reovirus altered disease in rats due to mutants of reovirus type 3 temperature-sensitive mutants of reovirus type 3: studies on the synthesis of viral peptides generation of cytolytic τ lymphocytes after reovirus infection: role of the si gene nude", a new hairless gene with pleiotropic effects in the mouse electron microscopy in the diagnosis of infectious diarrhea the rotaviruses relation between viruses from acute gastroen teritis of children and newborn calves virus diarrhoea in foals and other animals. vet. ree. 96 fluorescent virus precipitin test adverse effects of mouse hepatitis virus on ascites myeloma passage in the balb/cj mouse problems in checking inapparent infections in laboratory mouse colonies: an attempt at serological checking by anamnestic re sponse implication pancréatique chez la souris infectée avec le virus de l'hépatite murine immunisation de la souris "nude" contre le virus de l'hépatite murine par transfert de lymphocytes sensibilisés carrier state of anti body and viruses in a mouse breeding colony persistently infected with sendai and mouse hepatitis viruses effect of cortisone on genetic resistance to mouse hepatitis virus in vivo and in vitro ontogeny of macrophage resistance to mouse hepatitis in vivo and in vitro structure and physicochemical properties of coronaviruses comparison of an enzyme-linked immunosorbent assay for quantitation of rotavirus an tibodies with complement fixation in an epidemiological survey enhancement of the pathogenicity of mouse hepatitis virus (mhvl) by prior infection of mice with certain leukaemia agents a hepatitis virus of mice production of hepatitis in mice by the combined action of two filterable agents mouse hepatitis virus and its pathogenic action reactive sites of reovirus type 3 and their interaction with receptor substances reovirus type 3: physical characteristics and interaction with l cells the propagation of s virus of mouse hepatitis in tissue culture comparison of methods for immunocytochemical detection of rotavirus infections delayed hypersensitivity in mice infected with reovirus. ii. induction of tolerance and suppressor τ cells to viral specific gene products spontaneous diseases and their control in laboratory animals electron microscopic examination of cells infected with reovirus tissue culture cytopathic and plaque assays for mouse hepatitis viruses recovery of reoviruses from wild and laboratory mice antibodies to mouse hepatitis viruses in human sera temperature-sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination mouse hepatitis virus-induced recurrent demyelination quantitation of antibody to non-hemagglutinating viruses by single radial hemolysis: serological test for human coronaviruses new strain of mouse hepatitis virus as the cause of lethal enteritis in infant mice isolation of low-virulent mouse hepatitis virus from nude mice with wasting syndrome and hepatitis studies on the mechanism of destruc tion of lymphoid tissue in murine hepatitis virus (mhv3) infection. i. selective prevention of lymphoid necrosis by cortisone and puromycin physico-chemical properties of mouse hepatitis virus (mhv-2) grown on dbt cell culture viral gastroenteritis infantile enteritis viruses: morphogenesis and morphology is lactase the receptor and uncoating enzyme for infantile enteritis (rota) viruses? some distinctive biological characteristics of echo-10 virus new viral agents recovered from tissue cultures of monkey kidney cells. i. origin and properties of cytopathogenic agents svj, sv2, sv4, sv5, svg, svn, sv12, and sv15 pathology of diarrhea due to mouse hepatitis virus in the infant mouse isolation of mouse hepatitis virus from infant mice with fatal diarrhea some aspects on the transmission of hepatitis β antigen; model experiments by mosquitoes with murine hepatitis virus the molecular biology of reovirus studies on the effect of chymotrypsin on reovirions reproduction of reoviridae the effect of a murine hepatitis virus on the liver the fine structure of reovirus, a new member of the icosahedral series a microtiter solid phase radioimmunoassay for detection of the human reovirus-like agent in stools detection of differences among human and animal rotaviruses using analysis of viral rna the cellular nature of genetic susceptibility to a virus the coronaviruses reoviruslike agent in stools: association with infantile diarrhea and development of serologic tests antigentic relationships among five reovirus-like agents by complement fixation vertical transmission of mouse hepatitis virus infection in mice some characteristics of hemaggluti nation of certain strains of "ibv-like" virus studies on the etiology and transmission of epidemic diarrhea of infant mice observations on the control and natural history of epidemic diarrhea of infant mice (edim) responses of the mouse to the virus of epidemic diarrhea of infant mice. neutralizing antibodies and carrier state two viruses causing diarrhea in infant mice an apparently new lethal virus disease of infant mice epizootic diarrhea of infant mice and lethal intestinal virus infection of infant mice practical control of diarrheal disease in a commercial mouse colony reovirus infection in suckl ing mice: immunofluorescent and infectivity studies discussion of kraft, l. m. two viruses causing diarrhea in infant mice in vivo interference between heterologous rotaviruses the induction of interferon by temperature-sensitive mutants of reovirus, uv-irradiated reovirus, and subviral reovirus particles diagnosis of rotavirus, adenovirus, and heφes virus infections by immune electron microscopy using a serum-in-agar diffusion method autoimmune and virus-induced demyelinating dis eases mechanism of demyelination of jhm virus encephalomyelitis untersuchungen über die entstehung von riesenzellen in mäusemakrophagenkulturen nach infektion mit dem mäusehepatitisvirus (mhv-3) differential growth of mhv(pri) and mhv(c3h) in genetically resistant c3h rendered susceptible by eperythrozoon coccoides relationship of phagocytic activity to pathogenicitiy of mouse hepatitis virus as affected by triolein and cor tisone immunodiffusion and immunoelectrophoretic studies of reovirus antigens immunopathology of mouse hepatitis virus type 3 infection. iii. clinical and virologic observation of a persistent viral infection immunopathology of mouse hepatitis virus type 3 infection. i. role of humoral and cell-mediated immunity in resistance mechanisms neonatal susceptibility to mhv3 infection in mice. i. transfer of resistance genetic study of mouse sensitivity to mhv3 infection: influence of the h-2 complex polykaryocytosis and replication of mouse hepatitis virus in peritoneal macrophages in vivo and in vitro models of demyelinating diseases: tropism of the jhm strain of murine hepatitis virus for cells of glial origin an ultrastructural study of virions and cores of reovirus type 3 infectivity assay of reoviruses: comparison of immunofluorescent cell count and plaque methods the digestive system the nature of the polypeptide encoded by each of the 10 double-stranded segments of reovirus type 3 trans-stadial maintenance of reovirus type 3 in the mosquito culex pipiens fatigans weidmann and its implications coronaviruses: a comparative review coronaviruses as causes of diseases: clinical observa tions and diagnosis growth in suckling-mouse brain of "ibv-like" viruses from patients with upper respiratory tract disease antigenic relationships among the coronaviruses of man and between human and animal coronaviruses the polypeptides of human and mouse coronaviruses rotaviruses-a review moφhology and chemical composition of rotaviruses observations on the growth of mouse hepatitis virus (mhv-3) in mouse macrophages a. hepatitis virus complicating studies with mouse leukemia identity of cowdry type β inclusions and nuclear bodies: observations in reovirus encephalitis an antigenic subunit pre sent in rotavirus infected faeces plaque assay of neonatal calf diarrhoea and the neutralising antibody in human sera the classification and nomenclature of viruses calf diarrhea (scours) reproduced with a virus from a field outbreak taxonomy of viruses a reo-like virus isolated from juvenile american oys ters (crassostrea virginica) moφhology of a reo-like virus isolated from juvenile american oysters (crassostrea virginica) pathogenesis of rotaviral infection counter-immunoelectro-osmophoresis for the detection of infantile gastroenteritis virus (orbi-group) antigen and antibody solid phase radioimmunoassay for the detection of rotavirus experimental studies on hepatitis virus of mice in tissue culture mechanisms in the pathogenesis of diarrhea: a review a new member of hepatoencephalitis group of murine viruses multiplication and cytopathogenicity of mouse hepatitis virus in mouse cell cultures purification and characterization of epi zootic diarrhea of infant mice virus acute hepatitis associated with mouse leukemia. i. etiology and host range of the causal agent in mice acute hepatitis associated with mouse leukemia. i. pathological features and transmission of the disease acute hepatitis associated with mouse leukemia. iv. the relationship of eperythrozoon coccoides to the hepatitis virus of prince ton mice acute hepatitis associated with mouse leukemia. v. the neurotropic properties of the causal virus recovery and behavior of hepatitis virus from swiss mice injected with ascites tumor pathogenicity of murine hepatitis virus recovered from infant swiss mice an oncolytic virus recovered from swiss mice during passage of an ascites tumour anomalous high native resistance of athymic mice to bacterial pathogens detection of rotavirus by serological trapping on antibody-coated electron micro scope grids further light on mouse hepatitis defective virions of reovirus virusinduced diabetes mellitus: reovirus infection of pancreatic /3-cells in mice electron micrographic features of acute murine reovirus hepatitis ultrastructural features of chronic murine hepatitis after reovirus type 3 infection an electron microscopic study of murine reovirus-3 encephalitis the biliary tract in acute murine reovirus 3 infection studies on the exocrine pancreas. π. ultrastructural investigation of reovirus pancreatitis epidemic diarrheal disease of suckling mice. iv. cytoplasmic inclusion bodies in intestinal epithelium in relation to the disease an epidemic diarrheal dis ease of suckling mice. ii. inclusions in the intestinal epithelial cells propagation of mouse hepatitis virus (mhv-3) in monolayer cell cultures from liver of newborn mice virus studies with germfree mice. i. preparation of serologic diagnostic rea gents and survey of germfree and monocontaminated mice for indige nous murine viruses prevalence of viruses in mouse colonies rat coronavirus (rcv): a prevalent, naturally occurring pneumotropic virus of rats the isolation of reovirus type 3 from mosquitoes and a sentinel infant mouse enzyme-linked immunosorbent assay for detection of antibodies to murine hepatitis virus detection of neonatal calf diarrhea virus, infant reovirus-like diarrhea virus, and a coronavirus using the fluorescent virus precipitin test chronic obstructive jaundice induced by reovirus type 3 in weanling mice experimental viral hepatitis the fate of murine hepatitis virus (mhv-3) after intravenous injection into susceptible mice lack of transplacental transmissibility of mhv-3 virus oligodendrocytes and their myelin-plasma membrane connections in jhm mouse hepatitis virus encephalomyelitis proteolytic enzymes and rotavirus sa-11 plaque formation a genetic map of reovirus. ii. assignment of the double-stranded rnanegative mutant groups c, d, and ε to genome segments plaque formation by reoviruses cytochemical, fluorescent-antibody and electron microscopic studies on the growth of reovirus (echo 10) in tissue culture pathogenic murine coronaviruses. i. characterization of biological behavior in vitro and virus-specific in tracellular rna of strongly neurotropic jhmv and weakly neurotropic a59v viruses pathogenic murine coronaviruses. iii. biological and biochemical characterization of temperature-sensitive mutants of jhmv demonstration of reovirus-like particles in intestinal contents of piglets with diarrhoea comparison of the genomes of simian, bovine, and human rotaviruses by gel electrophoresis and detec tion of genomic variation among bovine isolates serologic grouping of reoviruses by hemagglutinationinhibition mouse hepatitis virus infection as a highly contagious, prevalent, enteric infection of mice chloroform inactivation of reovirus hemagglutinins the growth of the virus of epidemic diarrhea of infant mice (edim) in organ cultures of intestinal epithelium pathology of experimental hepatitis in mice the kupffer cell reaction in murine and human viral hepatitis with particular reference to the origin of acidophilic bodies electron microscopy of the hepatocellular and kupffer-cell lesions of mouse hepatitis, with par ticular reference to the effect of cortisone factors associated with the incidence of infantile diarrhea in mice reoviruses. a new group of respiratory and enteric viruses formerly classified as echo type 10 is described application d'une technique immunoenzymologique (elisa) á la detection du rotavirus bovin et des anticorps diriges contre lui enhancement of antigen incorporation and infectivity of cell cultures by human rotavirus rotavirus in goats. vet. ree. 103 mouse macrophages as host cells for murine viruses some virus infections of mice hepatitis and brain lesions due to mouse hepatitis virus accompanied by wasting in nude mice a genetic map of reovirus. i. correlation of genome rnas between serotypes 1, 2, and 3 replication of reovirus mouse hepatitis virus (mhv) infection in thymectomized c3h mice rotavirus infection of neonatal mice: characterization of the humoral immune response plaque assay for mouse hepatitis virus (mhv-2) on primary macrophage cell cultures in vitro interaction of mouse hepatitis virus and macrophages from genetically resistant mice. i. adsorption of virus and growth curves arboviruses the mechanisms of reoviris uncoating and gene activation in vivo anti-rotavirus antibody in human colos trum the laboratory mouse. selection and management rabbit cardiomyopathy, associated with a virus antigenically related to human coronavirus strain 229e gel electrophoresis of rotavirus rna derived from six different animal species rotavirus infection in lambs: studies on passive protection a rotavirus in lambs with diarrhoea test for reovirus-like agent enhancement of reovirus infectivity by extracellular removal or alteration of the virus capsid by proteolyitic enzymes relationship of hepatoencephalomyelitis virus and reoviruses the reovirus murine models diagnosis of reovirus infection: comparative aspects murine infection with reovirus type 3 and the runting syndrome studies on the pathogenesis of a hitherto undescribed virus (hepatoencephalomyelitis) producing unusual symptoms in suckling mice studies on the hepato-encephalomyelitis virus (hev) murine infection with reovirus. ii. the chronic disease following reovirus type 3 infection propagation of mouse hepatitis virus (gledhill) in tissue culture electron and fluorescence microscopy of mouse hepatitis virus resistance to fatal central nervous system disease by mouse hepatitis virus, strain jhm. i. genetic analysis resistance to fatal central nervous system disease by mouse hepatitis virus, strain jhm. ii. adherent cell-mediated protection postsplenectomy viral hepatitis characterization of a coronavirus. i. structural pro teins: effects of preparative conditions on the migration of protein in polyacrylamide gels an electron microscopic study of viral hepatitis in mice difference in response to mouse hepatitis virus among susceptible mouse strains factors involved in the age-dependent resistance of mice infected with low virulence mouse hepatitis virus pathogenesis of mouse hepatitis infection. the role of nasal epithelial cells as a primary target of low virulence virus asymptomatic infection of mouse hepatitis virus in the rat in vitro growth characteristics and heterogeneity of mouse hepatitis virus type 3 igm and igg response to sheep red blood cells in mouse hepatitis virus-infected nude mice response of nude mice to a mouse hepatitis virus isolated from a wasting nude mouse persistent infection with mouse hepatitis virus of low virulence in nude mice the role of macrophages in the early resistance to mouse hepatitis virus infection in nude mice enhanced phagocytic activity of macrophages in mouse hepatitis virus-infected nude mice neonatal susceptibility to mhv3 infection in mice. ii. role of natural effector marrow cells in transfer of resistance techniques for rotaviral propagation rotavirus neutralization by human milk serological relation ships between rotaviruses from different species as studied by comple ment fixation and neutralization potentiating effect of k-virus on mouse hepatitis virus (mhv-s) in weanling mice runde" virus, a coronavirus-like agent associated with seabirds and ticks immunoelectroosmophoresis for de tection of reo-like virus: methodology and comparision with electron microscopy inducers of interferon and host resistance. iii. double-stranded rna from reovirus type 3 virions (reo 3-rna) isolation of rotavirus from deer use of horseradish peroxidase labelled antibody for light and electron microscopic localiza tion of reovirus antigen studies on murine hepatitis virus (mhv3) in vitro the moφhology of reovirus new inteφretation of reovirus struc ture effect of x radiation and cortisone on mouse hepatitis virus infection in germfree mice correlation of persistent mouse hepatitis virus (mhv-3) infection with its effect on mouse macrophage cultures role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti-interferon serum. v. protective role in mouse hepatitis virus type 3 infection of susceptible and resistant strains of mice neuropathological effects of persistent infection of mice by mouse hepatitis virus the role of circulating interferon in the modifications of immune responsiveness by mouse hepatitis virus (mhv-3) reovirus activation by heating and inactivation by cooling in mgcl2 solutions effects of pancreatin on the growth of reovirus murine infection with reovirus: i. pathology of the acute phase naturally occurring mouse hepatitis virus infection in the nude mouse identification of detergents as compo nents of wastewater sludge that modify the thermal stability of reovirus and enteroviruses effects of wastewater sludge and its detergents on the stability of rotavirus comparative study on the mechanisms of rotavirus inactivation by sodium dodecyl sulfate and ethylenediaminetetracetate electron microscopic studies of experimental viral hepatitis in mice. ii. ultrastructural changes of hepatocytes associated with virus multiplication electron microscopic studies of experimental viral hepatitis in mice. i. virus particles and their relationship to hepatocytes and kupffer cells structural polypeptidesofthe murinecoronavims neutralization of reovirus: the gene responsible for the neutralization antigen molecular basis of reovirus virulence: role of the si gene identification of the gene coding for the hemagglutinin of reovirus absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin delayed hypersen sitivity in mice infected with reovirus. i. identification of host and viral gene products responsible for the immune response interaction of reovirus with cell surface receptors. i. murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3 pathogenesis of demyelination induced by a mouse hepatitis vims (jhm virus) blocking of in vitro and in vivo susceptibility to mouse hepatitis vims importance of local immunity in enteric infection effect of cy clophosphamide on the genetic resistance of c3h mice to mouse hepatitis vims the circadian rhythm of thymosin therapy during acute reovirus type 3 infection of neonatal mice immunofluorescent detection of murine virus anti gens identification of an agent of epizootic diarrhea of infant mice by immunofluorescent and complement-fixation tests intestinal μ cells: a pathway for entry of reovirus into the host moφhological and an tigenic relationships between viruses (rotaviruses) from acute gastroen teritis of children, calves, piglets, mice, and foals intestinal damage in rotavirus infected calves assessed by d-xylose malabsoφtion heat and moisture transfer in fllter-top rodent cages reovirus-like agents (rotavimses) associated with diarrheal illness in animals and man human rotavirus type 2: cultivation in vitro enzyme-linked fluorescence assay: ultrasensitive solid-phase assay for detection of human rotavirus enzyme-linked immunosorbent assay for identification of rotaviruses from different animal species measurement of rotavirus antibody by an enzyme-linked immunosorbent assay blocking assay secretory antibody directed against rotavirus in human milk-measurement by means of enzyme-linked immunosorbent assay key: cord-261036-zdhg4axx authors: shirato, kazuya; maejima, madoka; hirai, asuka; ami, yasushi; takeyama, natsumi; tsuchiya, kotaro; kusanagi, kouich; nunoya, tetsuo; taguchi, fumihiro title: enhanced cell fusion activity in porcine epidemic diarrhea virus adapted to suckling mice date: 2010-09-09 journal: arch virol doi: 10.1007/s00705-010-0790-1 sha: doc_id: 261036 cord_uid: zdhg4axx porcine epidemic diarrhea virus (pedv) is the major causative agent of fatal diarrhea in piglets. to study the pathogenic features of pedv using a mouse model, pedv with virulence in mice is required. in pursuit of this, we adapted a tissue-culture-passed pedv mk strain to suckling mouse brains. pedv obtained after ten passages through the brains (mk-p10) had increased virulence for mice, and its fusion activity in cultured cells exceeded that of the original strain. however, the replication kinetics of mk and mk-p10 did not differ from each other in the brain and in cultured cells. the spike (s) protein of mk-p10 had four amino acid substitutions relative to the original strain. one of these (an h-to-r substitution at residue 1,381) was first detected in pedv isolated after eight passages, and both this virus (mk-p8) and mk-p10 showed enhanced syncytium formation relative to the original mk strain and viruses isolated after two, four, and six passages, suggesting the possibility that the h-to-r mutation was responsible for this activity. this mutation could be also involved in the increased virulence of pedv observed for mk-p10. the group i coronavirus porcine epidemic diarrhea virus (pedv) is an enveloped rna virus with a single, positive-stranded genome about 30 kb in length [9] . pedv is the causative agent of pig diarrhea and induces a loss of appetite and weight in adult pigs, whereas it is lethal in piglets [16] . however, our understanding of the pathogenesis of diseases caused by pedv is limited due to a lack of appropriate small-animal models. coronaviruses cause various diseases in a species-specific manner, and they grow in cultured cells established from susceptible host species; human, feline, and porcine coronaviruses grow only in cells isolated from the respective species [24] . one of the major factors determining species specificity is the cellular receptor, which interacts with a given virus, but not with other viruses, when the virus initially encounters cells [5] . some of the group i coronaviruses, such as porcine transmissible gastroenteritis virus (tgev) and human coronavirus 229e (hcov-229e), utilize aminopeptidase n (apn) [1, 19, 22, 23] . however, the receptor of pedv has not yet been identified, although there was a controversial report on a pedv receptor protein [10] . expression of the receptor protein for mouse hepatitis virus (mhv) and severe acute respiratory syndrome (sars)-associated coronavirus (sars-cov) in cultured cells confers susceptibility to each of these viruses [2, 4, 25] . expression of the tgev receptor in mice from a transgene rendered otherwise resistant mice susceptible to tgev [1] . however, this approach is not available for pedv. an alternative approach is to isolate viruses that have adapted for growth within the animals and which exhibit virulence. such adaptations have been reported for two other coronaviruses, ibv and oc43 [3] . in the present study, we isolated a strain of pedv that was more virulent than the original tissue-culture-adapted virus after passage through mouse brain cells. the adapted virus showed enhanced cytopathology compared with the original virus. vero cells were obtained from the american type culture collection (atcc; manassass, va, usa). the cells were maintained in dulbecco's modified eagle's medium (dmem; sigma, st. louis, mo, usa) containing 5% fetal calf serum (fcs). the pedv strain used in this study was an mk strain isolated from the jejunum of a pig that had exhibited diarrhea in 1996 in japan, and which had been passed nine times in vero cell cultures. pedv was maintained in vero cells using a slightly modified version of a reported method [8] . briefly, vero cells were infected with the virus. after 1 h, the cells were washed with phosphate-buffered saline (pbs) and cultured in dmem containing 10% tryptose phosphate broth (tpb) and 2.5 lg/ml trypsin (sigma) for 15 h. next, the cells and supernatant were pooled, ultrasonicated, and stored at -80°c until use. the pedv infectious titer was determined by a plaque assay using vero cells. briefly, vero cell monolayers grown in 24-well plates coated with type i collagen (agc techno glass, chiba, japan) were inoculated with serially diluted virus samples. after 1 h to allow for adsorption of the virus, the inoculum was removed, the cells were washed with pbs, and dmem containing 10% tpb and 1.25 lg/ml trypsin was added. for titration of the virus, half of the concentration of trypsin was used to drive cell fusion in a procedure that is gentle compared with viral propagation. after a 15-h incubation, the cells were fixed and stained with pbs containing 0.1% crystal violet and 20% formalin under ultraviolet light. after staining for 2 h, the cells were washed with water and dried, and the plaques were counted under a light microscope as described for the infectious titration of human coronavirus 229e [6] . the viral titer in the brains of the mice is given as plaqueforming units (pfu)/50 ll of 10% homogenate, whereas the titer in the supernatant is given as pfu/ml of supernatant; the cell titer is given as pfu/well of a 24-well plate. isolation of a murine-adapted variant of pedv specific-pathogen-free (spf) pregnant icr mice were obtained from japan slc (shizuoka, japan). all animal experiments were approved by the committee on experimental animals, national institute of infectious diseases, japan, and all experimental animals were handled according to the guidelines of the same committee. all spf mice were confirmed by seromonitoring to be free from infection with mhv, lactate dehydrogenase virus, and other pathogenic microorganisms. newborn (within 24 h of birth; 0-day-old) mice were used in this study. pedv strain mk (2,500 pfu) was inoculated intracerebrally (i.c.) into the brains of 0-day-old mice (n = 12-16). five days post-infection (p.i.), the mice were sacrificed and their brains collected, pooled, and homogenized in pbs to yield a 10% suspension, which was centrifuged at 2,000 rpm for 10 min at 4°c. next, 10 ll of the supernatant from the 10% brain homogenate was inoculated i.c. into suckling mouse brains, and the brains were collected as described above. this cycle was repeated ten times, and the virus obtained was designated mk-p10. mk-p10 was amplified once by vero cell culture to match its condition to that of the original virus, then stored at -80°c until use. to investigate viral virulence and replication in mouse brains, 0-day-old mice were infected i.c. with 5,000 pfu of pedv and monitored daily for clinical features; they were also weighed daily. pbs was used in a mock infection. to examine viral replication in the brains, the mice were euthanized on the indicated day p.i., their brains were collected, and 10% homogenates were prepared as described above. to determine the replication kinetics in cultured cells, vero cells were infected with pedv at a multiplicity of infection (m.o.i.) of 0.1. after 1 h, the cells were washed with pbs and cultured in dmem containing 10% tpb and 2.5 lg/ml trypsin. at the indicated hour p.i., the supernatant and cells were collected separately, the cells were ultrasonicated, and the viral titers were determined using a plaque assay as described above. sequence analysis viral rna was extracted with trizol ls reagent (invitrogen, carlsbad, ca, usa) following the manufacturer's protocol. first-strand cdna was synthesized using m-mlv reverse transcriptase (takara-bio, shiga, japan) and oligod(t) 16 to determine the statistical significance of the survival curves, log-rank and generalized wilcoxon tests were performed. significance was determined in all other cases using unpaired t tests. p \ 0.05 was considered to be statistically significant. to obtain a murine-adapted variant of pedv, passage through suckling mice was performed. zero-day-old mice were inoculated i.c. with the mk strain of pedv, and the brains of the infected mice were collected four or 5 days later. the brains were pooled and used for the next round of mouse inoculation. surprisingly, mice infected with the non-adapted, original strain (mk) showed clinical signs and mortality; these observations differ from those reported for hcov oc43 and ibv [3] . however, in subsequent passages, clinical signs in the infected mice, such as trembling, tremors, and growth retardation, became more obvious. the process was stopped after ten passages, at which point the variant was designated mk-p10. the original mk strain and the mouse-adapted variant mk-p10 were inoculated onto vero cells in the presence of trypsin and cultured for 15 h. as shown in fig. 1 , more syncytium formation was seen in the cells infected with mk-p10 than in those infected with the original strain. the mean diameter of the mk-p10 syncytia was significantly greater than that of the mk syncytia (874 ± 177 vs. 348 ± 104 lm; n = 10, p \ 0.0001). the neurovirulence of mk-p10 in suckling mice was examined. zero-day-old mice were infected i.c. with 5,000 pfu of virus and monitored daily for clinical symptoms and mortality. all mice infected with mk and mk-p10 succumbed to infection; however, the mice infected with mk-p10 died more quickly than the mk-infected mice ( fig. 2a ; n = 25, p \ 0.01). the mice were also weighed daily ( fig. 2b; n = 12 ). the weights of the mice infected with mk or mk-p10 increased for 3-4 days after infection. subsequently, the weight of the mice decreased beginning 4 days p.i., whereas the mice infected with mk began to lose weight 8 days p.i.-4 days later than the mk-p10infected mice. the body weight of the mice infected with mk-p10 was determined 7 days p.i. because most of the mice had succumbed by 7-11 days p.i. the mock-infected mice did not exhibit weight loss or clinical symptoms. as described above, a mouse-adapted variant of pedv was successfully isolated. the growth kinetics of the original strain and mk-p10 were examined in suckling mouse brains. mk and mk-p10 exhibited similar growth kinetics in suckling mouse brain, peaking on day 4 p.i. (fig. 3a) . their growth kinetics in cultured vero cells was also determined. some coronaviruses tend to remain intracellular, and viral stocks are prepared by ultrasonication or repeated freeze-thawing cycles. to compare the amounts of budded and intracellular virus, the titers in the supernatant (fig. 3b) and cells (fig. 3c) were determined separately. similar to the growth kinetics in the brains of the mice, the growth pattern in vero cells did not differ significantly between mk and mk-p10 (fig. 3b, c) . these results suggest that the increased virulence in suckling mice and syncytium formation in cultured cells is not due to increased growth in the brain or cultured cells. because the s proteins of coronaviruses are reported to be associated with viral pathogenicity [20] , table 1) . among these, the amino acid substitutions at positions 804 and 1,381 resulted in a polarity change (hydrophobic to hydrophilic). to determine at which brain passage the amino acid changes occurred, we determined the primary sequences of s protein from the viruses isolated after two, four, six, and eight passages in mouse brain. as shown in table 2 , the amino acid at position 804 differed at the second passage, while those at positions 496 and 774 changed simultaneously at the fourth passage. the amino acid change at position 1,381 occurred at the eighth passage. as described above, the plaque size of mk-p10 was larger than that of the parental strain (fig. 1) . this larger plaque morphology was also detected in pedv after eight passages, whereas the viruses isolated after four and six passages showed syncytium formation similar to that in mk (fig. 4) . these results suggest that the amino acid change at position 1,381 (h to r) first detected at the eighth passage, which is located in the cytoplasmic tail (ct) region, contributed to the larger plaques of mk-p10, though other genes must be considered. two different coronaviruses, oc43 and ibv, have successfully adapted to grow in mice and show virulence after brain-to-brain passage in suckling mice [3, 12] . these viruses initially showed low virulence (i.e., clinical symptoms such as tremor and rigidity and lethargy in suckling mice), but the virulence increased with repeated passage in mouse brains. in this study, the passage of pedv in suckling mouse brains clearly strengthened its virulence, similar to the adaptation seen in oc43 and ibv. unexpectedly, the original mouse non-adapted pedv showed significant virulence for suckling mice. the primary sequences of s protein from the viruses isolated after repeated passages were determined. pedv passed in mouse brains showed mutations in the s protein, which had accumulated after ten passages. the h-to-r mutation at residue 1,381, which was first detected after eight passages, is likely responsible for the enhanced cell-cell fusion activity, as only those viruses with this mutation showed significantly larger syncytia compared with the original pedv; the s protein is a major determinant of the fusion activity of coronaviruses [5, 20] . it would be interesting to find out whether this substitution in the s protein is responsible for the enhanced fusion activity by expressing s protein alone. those mutations found in the mouseadapted viral s proteins could be responsible for the increased virulence; however, other genes have been reported to be involved in the virulence of such coronaviruses as mhv and sars-cov [7, 15, 17, 21] . to identify the genes responsible for the increase in virulence, we would need the entire genomic sequences of the original and mouse-adapted pdevs; additionally, reverse-genetic analyses would be essential. pedv differs from most coronaviruses in that it grows in cultures of cells derived from animal species not susceptible to pedv; the virus grows efficiently in vero cells derived from the kidneys of green monkey, which is not a natural host of the virus [8] . few cases are known in which coronaviruses multiply in cells derived from non-susceptible host animals. sars-cov can grow in a variety of cells established from several animal species [13, 14, 18, 24] , and it is somewhat capable of growing in the same animals; however, efficient infection is restricted to cells from animals that support sars-cov infection [24] . the growth potential of sars-cov in a variety of animal cells correlated with the utilization of its receptor molecule, ace2 [11] . most known coronaviruses become infective in cells when their functional receptor molecule is expressed by transfection with a plasmid encoding the receptor molecule [5] . this suggests that vero cells susceptible to pedv infection express a functional receptor. in our study, both mouse-adapted and non-adapted mk strains of pedv could infect and grow in suckling mouse brains, suggesting that a receptor molecule utilized by both viruses exists in suckling mouse brain. to determine which cell types in the brain express the receptor, we are attempting to identify the cell types that are infected by pedv in suckling mouse brain. this will provide valuable information related to the receptor molecule utilized by pedv. in summary, a highly neurovirulent variant of pedv was successfully isolated by passage following the i.c. infection of 0-day-old suckling mice. the s protein of the variant had four amino acid substitutions, which might be responsible for its enhanced cell-cell fusion activity. of these substitutions, the h-to-r substitution at position 1,381 in the ct region of the s protein is likely to be the determinant of the high fusion activity. to address this possibility, the expression of wild-type and mutant s proteins in cultured cells and an analysis of their fusion activity are necessary. reverse-genetic analyses of the entire pedv genome are also required to assess the effect of s protein mutations on the virulence and pathogenesis of pedv. p2 p4 p6 p8 p10 fig. 4 plaque morphology of pedv isolates after mouse brain passage pedv passed in mouse brains two (p2), four (p4), six (p6), eight (p8), or ten (p10) times as well as the original mk (p0) was inoculated onto vero cells. cell fusion assays were performed as described in the legend to fig. 1 aminopeptidase n is a major receptor for the entero-pathogenic coronavirus tgev cloning of the mouse hepatitis virus (mhv) receptor: expression in human and hamster cell lines confers susceptibility to mhv growth of infectious bronchitis virus in suckling mice brain susceptibility to sars coronavirus s protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor coronavirus receptors. in: siddell sg (ed) the coronaviridae proteasemediated entry via the endosome of human coronavirus 229e severe acute respiratory syndrome coronavirus open reading frame (orf) 3b, orf 6, and nucleocapsid proteins function as interferon antagonists isolation and serial propagation of porcine epidemic diarrhea virus in cell cultures and partial characterization of the isolate the molecular biology of coronaviruses porcine aminopeptidase n is a functional receptor for the pedv coronavirus angiotensin-converting enzyme 2 is a functional receptor for the sars coronavirus growth in suckling-mouse brain of ''ibv-like'' viruses from patients with upper respiratory tract disease pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice inactivation of expression of gene 4 of mouse hepatitis virus strain jhm does not affect virulence in the murine cns a new coronavirus-like particle associated with diarrhea in swine reverse genetic characterization of the natural genomic deletion in sars-coronavirus strain frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in vitro and in vivo severe acute respiratory syndrome coronavirus infection of golden syrian hamsters coronavirus 229e susceptibility in man-mouse hybrids is located on human chromosome 15 coronaviruses: structure and genome expression single-amino-acid substitutions in open reading frame (orf) 1b-nsp14 and orf 2a proteins of the coronavirus mouse hepatitis virus are attenuating in mice feline aminopeptidase n serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup i feline aminopeptidase n is a receptor for all group i coronaviruses coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins acknowledgments we thank shutoku matsuyama, miyuki kawase, and makoto ujike for their valuable comments and encouragement. this work was supported by a grant-in-aid for scientific research (b; no. 19390135) from the ministry of education, culture, sports, science, and technology of japan. passage number 0 2 4 6 8 1 0 496 i i t t t t 774 t t m m m m 804 a d d d d d 1,381 h h h h r r fig. 3 the replication kinetics of mk (squares) and mk-p10 (circles). a viral replication in suckling mouse brain. zero-day-old mice were infected i.c. with 5,000 pfu of pedv. at the indicated days p.i., the brains were collected and 10% homogenates were prepared. the viral titer in the brains was determined using a plaque assay with vero cells and is expressed as pfu/50 ll of 10% homogenates (n = 3). b, c viral replication in cultured cells. vero cells were infected with pedv at an m.o.i. of 0.1. viral titers in the supernatants (b) and cells (c) were determined separately using plaque assays (n = 6). the viral titer in the supernatant is given as pfu/ml of supernatant, while that in the cells is given as pfu per well of a 24-well plate key: cord-026009-rdhuc2n2 authors: anderson, nancy l. title: pet rodents date: 2009-05-15 journal: saunders manual of small animal practice doi: 10.1016/b0-72-160422-6/50179-0 sha: doc_id: 26009 cord_uid: rdhuc2n2 nan many small rodents are commonly kept for companionship and enjoyment. this chapter provides information needed to diagnose and treat the most frequently encountered problems of mice, rats, gerbils, hamsters, guinea pigs, and chinchillas. • cages should be made of stainless steel, hard plastic, or glass. these materials are cleaned and sanitized easily and are resistant to gnawing or corrosion from urine and fecal matter. minimum floor space and height requirements are listed for each species in • guinea pigs can be housed in open-topped enclosures with walls higher than 10 inches. ensure that dogs, cats, wild animals, and small children do not have unsupervised access to these cages. • clean cages as needed, usually 1 to 3 times per week for most rodents. a scrub brush, dish soap, and water work well. if cages are not kept clean, ammonia, other irritants, moisture, and bacteria concentrations rise to harmful levels, predisposing animals to disease. • disinfect the cage twice a month with 1 part sodium hypochlorite (household bleach) mixed in 30 parts water. let the bleach solution stand for at least 15 minutes. rinse the cage well afterward. • all solid-floored cages need to be covered in bedding. shredded paper, non-resinous wood shavings, wood wool, and corn cobs are all acceptable. provide at least 2 inches of bedding. most rodents enjoy burrowing in deeper bedding when it is provided in one corner of a cage. do not, however, fill the entire cage with deeper bedding. this usually leads to poor sanitation as a result of owners' failure to recognize buildup of hidden wastes such as moisture from leaking water bottles, cached foods, urine, and feces. • wire mesh floors can be used successfully only if the dimension of the mesh is correct. size the openings to be just large enough for an adult to retract a tarsal joint back through the mesh. larger holes make it difficult for the animals to walk and cause pressure sores. smaller openings may cause injuries such as tibial fractures and self-mutilation while struggling to free trapped appendages. bedding above the wire keeps waste from dropping through the wire and therefore is not recommended. wire bottom cages do not work well for breeding animals because neonatal rodents must be surrounded by nesting material to maintain moisture in the nest and prevent dehydration. young rodents often cannot walk correctly on mesh sized for adult feet. • all pet rodents require visual security. tubes, jars, or cans made of nontoxic, nonabrasive substances work well for this purpose. also provide objects for gnawing. rodents possess open-rooted teeth, and constant wear is necessary to maintain normal dentition. mice, rats, gerbils, and hamsters enjoy and benefit from exercise wheels. • a good room temperature range for most pocket pets is 70°f to 75°f. keep rodents with disease at 85°f to 90°f unless hyperthermia is of concern (some chinchillas). • provide 10 to 12 hours of darkness to 12 to 14 hours of light. this light cycle is essential if breeding is desired. • hamsters, guinea pigs, and chinchillas that are exposed to temperatures below 65°f may hibernate for a few days or until the ambient temperature rises. heart rates may be less than 5 bpm during hibernation. m key point feed pet rodents laboratory animal chow appropriate for their species (table 177 -2). seed diets are deficient in protein and contain excessive fat. • seeds, as well as vegetables and other foods, may be fed as treats but not to provide more than 15% of calories. intermittent exposure to vegetables and seeds causes mild, transient diarrhea. • supplementation of vitamin c is recommended for all guinea pigs. • adult chinchillas that are not obese should be fed high quality, fresh grass hay ad libitum. obese animals may need to have the hay rationed. chinchillas require 1 / 8 to 1 / 4 -cup of fresh pellets per animal each day. feeding pellets free choice leads to obesity, and the high protein and calcium levels in these diets may predispose animals to urinary tract disease. most pellets also do not provide sufficient fiber to maintain normal gastrointestinal (gi) motility. • store food in tightly sealed containers at less than 60°f; keep food refrigerated if possible. • feed all diets within 90 days of milling to ensure the highest nutritional value. encourage owners to check dates on packages and ask pet store managers about providing dates on bulk items. • if possible, feed pet rodents except guinea pigs from overhead racks. these devices reduce wastage and eliminate fecal contamination of food. covered hoppers, heavy crocks, or stainless steel bowls that are attached to the side of the cage to eliminate spillage are acceptable and recommended for guinea pigs. • feed breeding females and their litters from the floor of their cages until the young are large enough to reach overhead feeders or crawl in and out of crocks. • cannibalism of neonates commonly occurs as the result of stress associated with cage cleaning. to minimize cannibalism, clean the cage and provide a 10to 13-day food supply 1 to 2 days before parturition. m key point provide fresh water in clean containers daily. • do not provide water in open crocks. these are contaminated or spilled easily and are a common cause of dehydration and poor sanitation. • sipper tubes and water bottles work well. clean with dish soap and water daily and disinfect them weekly. guinea pigs expel food from their mouths into their sipper tubes, so more frequent cleaning is needed. • some water bottles have special valves to minimize backflow. supplement guinea pigs' water daily with 200 mg vitamin c/l. if the water is not dechlorinated, it will inactivate the vitamin c. quarantine all newly acquired animals in a different room from current pets for a minimum of 30 days. feed and handle quarantined animals last. recommend that caretakers wash their hands and change clothes before handling current pets. avoid the introduction of adult animals because this frequently results in fighting. instead, place animals together while young and allow them to mature together. avoid keeping more than one male per cage because this also usually leads to fighting. a systematic history and physical examination are mandatory. many disease syndromes are caused by poor husbandry. pets that have been kept isolated from other rodents or acquired from a private breeder are less likely to harbor infectious disease than animals obtained from a pet store, laboratory, or wholesaler. see table 177 -3 for normal physiologic data. obtain the following information: • observe the pet in its cage for mentation, activity, locomotion, dyspnea, head posture, haircoat, and any grossly observable abnormalities. • note respiratory and heart rates before restraint when possible. observe the condition of cagemates. m key point if dyspnea or severe depression is detected, warn the owner that the animal is critically ill and could die of stress brought on by an examination. • handle such animals as little as possible. initially, treat severely ill animals symptomatically, then • note the type of diet and bedding as well as the level of sanitation and compare these with what was described in the history. • observe quantity and quality of feces and urine. diarrhea, soft stools, absence of stools, copious urine, and discolored urine all can be signs of illness. • coprophagy is a normal behavior in rodents. • check the diet and water supply for freshness, quantity, source, and accessibility. • evaluate the presence and suitability of cage furniture. adequate visual security and the ability to exercise and gnaw are extremely important. • an accurate weight in grams is extremely important for evaluating an animal's body condition, calculating drug dosages, and monitoring treatment. the easiest method of weighing a pet rodent is to place it in a box and then subtract the weight of the container. • restraint of pet rodents is easy with experience. pets that have been handled frequently and gently by the owners require only minimal restraint. gentle pressure directs the animal as needed. grasp less cooperative patients (except chinchillas and guinea pigs) by the scruff over the back of the neck with thumb and forefinger ( fig. 177-1) . take care to pinch enough skin to prevent the animal from turning around, yet leave enough slack for respiration. on smaller specimens, hold the base of the tail, if present, between the fourth and fifth fingers to provide additional restraint. • hold docile guinea pigs with the palm of one hand supporting the chest while the other hand supports the hind quarters ( fig. 177 -2). place the thumb and forefinger of the first hand in the axillas for additional control. • take care to minimize damage to the fur when handling chinchillas because they lose hair easily. grasp the animal by the tail and scoop it up into the palm of the same hand ( fig. 177-3 ). if necessary, grasp the thorax just behind the axillas. • calm uncooperative rodents by placing an appropriately sized towel over the head. complete the physical examination by wrapping the patient in a towel and exposing only needed areas. even oral, ophthalmic, and aural examinations can be performed with minimal effort if the animal is given the chance to relax in the towel "burrow." • remove particularly aggressive patients from their cages by scooping them up in a can or bucket; then slide them out onto a slick surface and pick them up or transfer them to a holding area or scale. m key point lift the hind quarters of mice and rats by the base of their tails to facilitate scruffing. never use the tip of the tail for restraint, or the skin of the tail may slough. once the animal is restrained properly, examine the head. assess the cranial nerves. check the nose for presence and character of discharge. examine the mouth for ptyalism, swelling, overgrown incisors, or discharges. to inspect the oral cavity, place an avian speculum across the mouth just caudal to the incisors. use a light source and a pair of hemostats as retractors to improve access. alternatively, use an otoscope with a pediatric head to examine the premolars and molars of guinea pigs and chinchillas for overgrowth. examine the cheek pouches of hamsters for swelling, impaction, or discharge. an ophthalmic examination, including a fundic examination, is important. • use a slit lamp to identify superficial pathology, especially corneal ulcers or foreign bodies. • if indicated, perform fluorescein stain and conjunctival scrapings or cultures. • note the presence of conditions such as discharge, asymmetry, and exophthalmos. m key point gerbils, rats, and mice produce red tears (chromodacryorrhea) with stress or disease. do not confuse them with hemorrhage. • guinea pigs suffering from hypovitaminosis c often produce dry, white tears. • check ears for discharge, foreign bodies, and mites. bluish discoloration of the ears is a sign of cyanosis. bright red injected coloration is associated with septicemia. sores behind the ears and on the neck are often a sequela of aural disease. • evaluate submandibular, axillary, inguinal, and popliteal lymph nodes for size and consistency. enlargements usually indicate infectious or neoplastic disease. • reevaluate respirations and heart rate after the stress of handling and compare them with the resting rate noted when the animal was in the cage. note dyspnea or respiratory sounds. auscultate animals weighing more than 200 g. counting every third or fourth beat and multiplying by the appropriate factor allows recording of heart rates up to 500 bpm. • palpate the abdomen. pay special attention to differentiating pregnancy from the bladder, kidneys, abdominal masses, enlarged cecum, and fecal balls in the colon. while palpating the abdomen, examine the mammary chain of all female rodents for signs of mastitis, lactation, or neoplasia. also check male mice and rats for mammary neoplasia. mammary tissue extends from the base of the neck to the base of the tail. gerbils typically have an elliptical sebaceous gland on their ventral midline. do not confuse this with neoplasia or infection. check the rectum and perineal area for signs of diarrhea, prolapse, irritation, parasites, and bite wounds. note that coprophagy is normal in rodents. • evaluate the urogenital tract for signs of inflammation, foreign bodies, urine scalding, and vaginal discharge. locate and palpate the testicles in males. the easiest method of determining sex in pet rodents is to compare the anogenital distance, which is twice as long in males as in females. other characteristics that allow the determination of sex are as follows: • visualization or palpation of testicles or extrusion of the penis from the prepuce indicates a male. • the presence of two external openings (i.e., anus and urethra) indicates a male. • the presence of three openings (i.e., anus, vagina, and urethra) indicates a female. • examine the skin and fur for conditions such as crusts, alopecia, masses, herniations, and wounds. • check tail and feet for swellings, coloration, sores, length of toenails, and condition of footpads. • evaluate the extremities for trauma or other abnormalities. apply cellophane tape to crusted areas of the skin and view under a microscope as an aid in diagnosing ectoparasites such as lice, mites, and fleas. skin scrapings are beneficial in detecting mites and dermatophytes. dermatophytes are diagnosed best through culture of broken hairs or crust on dermatophyte test medium. use small, cotton-tipped swabs to obtain ear swabs from animals weighing more than 25 g. mix debris with mineral oil and view under low magnification to test for ear mites, or roll onto a glass slide and gram stain to look for bacterial or yeast infections. collect urine by placing the rodent in a clean meshbottomed cage with a plastic liner. after enough urine has been produced, collect it off the bottom of the cage with hematocrit tubes or a syringe and a 25-gauge needle. perform cystocentesis on non-pregnant animals weighing more than 100 g with a 25-to 27-gauge needle. collect feces over several hours to provide a volume sufficient for fecal flotation. flotation allows the detection of nematodes and some trematodes and cestodes. cellophane tape applied to the perineal area and then viewed under a microscope often reveals oxyurid eggs. use a fresh saline smear or fecal sedimentation to diagnose protozoal parasites. fecal cultures are useful in diagnosing bacterial diarrhea. radiology is an extremely useful tool. machines capable of exposures as low as 40 kvp and 3 to 10 mas effectively image mice. most radiograph machines are capable of generating diagnostic radiographs of guinea pigs, chinchillas, and mature rats at settings used for kittens. positioning is accomplished with masking tape or velcro straps. sedate unruly animals. techniques used in cats for contrast studies of both urinary and gi systems are modified easily for use in pocket pets. • use lateral or medial saphenous veins to obtain samples in animals heavier than 100 g. liberally clip the area to allow exposure of the vessel before attempting venipuncture. place a 25-to 27-gauge needle in the vein and collect blood into microtainers or hematocrit tubes as it drips from the hub of the needle (fig. 177-4) . take extreme care not to col-lapse and lacerate the vein with overzealous aspiration if a syringe is attached to the needle. • it is also possible to use the cephalic vein in guinea pigs. • jugular veins are good alternatives in thin individuals under sedation. • an alternative technique that is useful in smaller animals is to coat the skin over the vein with a thin layer of petroleum jelly and then to puncture the vessel. blood is collected with a hematocrit tube as it exits the wound. samples up to 1% of the animal's weight are considered safe, even in stressed animals. m key point attempt tail bleeding only as a last resort in mice, rats, gerbils, and hamsters. these techniques often are not acceptable to owners. to bleed the tail, warm the tail with water or compresses to dilate the tail vessels. in large rats, perform venipuncture with a needle and obtain blood in the usual fashion. in smaller animals, lacerate the tip of the tail. blood from the wound is collected as described previously. see tables 177-5 and 177-6 for hematology and chemistry values. incorporate oral medications into a treat, or administer them in liquid form. if the medication is palatable, administer it by placing the tip of a dosing syringe into the diastema. m key point take care not to place the tip into the contralateral cheek pouch, or the patient may store the medication and expel it later. administer medication in small amounts. ensure that the animal swallows the medication in its mouth before more is administered. this technique is useful for force-feeding pellet gruels to anorexic pets if the caregiver is patient. medication or food that is administered too quickly will be spit out or aspirated. for rodents that are intractable or for administration of unpalatable substances, pass a stomach tube per os. • metal feeding needles, red rubber urinary catheters, or infant feeding tubes work well. selection is based on the size of the animal and individual preference. metal feeding needles with ball tips frequently are used in patients weighing less than 100 g . the metal provides the necessary stiffness to pass a tube of small diameter. the ball at the end of the needle makes it difficult (but not impossible) to pass the tube into the trachea. these tubes have the potential to create esophageal tears with improper restraint or when excessive force is applied. • measure the length from the tip of the nose to the last rib. ventroflex the head slightly, and place the tip of the tube through the diastema and over the tongue. if the tube does not pass easily down the esophagus to the premeasured distance, check the tube size and/or reposition the tube before attempting further advancement. the needle is easily palpable percutaneously if it is placed correctly. it is usually safe to administer up to 3 ml/100 g body weight. • a flexible catheter is ideal for use as a stomach tube in larger rodents ( fig. 177-6 ). use a speculum to prevent chewing on the tube. an otoscope head, avian speculum, or piece of wood or plastic with a hole drilled in the center works well. measure and mark the tube for the distance from the tip of the nose to the last rib. place the speculum in the mouth and over the tongue. pass the tube while holding the speculum in place and slightly ventroflexing the head. resistance is encountered if the tube is malpositioned or is an inappropriate size. the tube must pass over the tongue before it can be advanced down the esophagus. this is difficult in some animals. palpate the throat to confirm the presence of the feeding tube in the esophagus. m key point because the placement of a stomach tube is a blind procedure, administer a small volume of sterile saline into the tube before administering the medication to ensure that the tube is not in the trachea. misplaced medications are fatal. • this method is also useful for administration of nutrition to anorexic patients. place a pharyngostomy tube if repeated dosing is necessary, using the technique for cats. flush pharyngostomy tubes with water at least every 4 to 6 hours. nasogastric tubes are not recommended because they are difficult to place and maintain patency because of their small size. securely suture all tubes to the skin. place a tube collar made of radiographic film or use rear leg hobbles to prevent removal of tubes. • nutritional support is critical in rodents because of their high metabolic rate. provide supplements in animals that are anorexic for longer than 12 hours. if the gi tract is capable of digestion, use a slurry of pellets mixed with a high-calorie supplement. if the tube diameter is too small for this mixture, use avian hand-feeding formula or a mixture of vegetable and cereal baby foods in place of the pellets. if the ability of the gi tract to tolerate enteral feeding is questionable, first try isotonic electrolyte or dextrose solutions. parenteral nutrition is used successfully in research animals and may be feasible in select pet cases. administer sc injectable medications or fluids over the shoulder blades or in folds of skin on the flank. • avoid irritating substances in rats and mice because their mammary tissue extends into these areas. the resulting inflammatory response is thought to increase the occurrence of mammary neoplasia. m key point in general, avoid streptomycin and the carrier procaine in all pet rodents because of a high incidence of toxicity and hypersensitivity reaction. give im injections in the semimembranous and semitendinous muscles. inject only small volumes of nonirritating substances, or tissue damage with resulting self-mutilation may occur. use the epaxial or triceps muscles if repeated injections are necessary. m key point use intraperitoneal (ip) injections only as a last resort for large volumes of fluids or for irritating injections that cannot be administered via an iv or io route. express the bladder and aseptically prepare the abdomen. restrain the rodent with its head down to move the abdominal organs cranially. give the injection 0.5 to 2 cm lateral to the midline in the caudal abdomen. aspirate before injecting to ensure that the injection is not being given into the bladder or bowel. never use this technique in pregnant animals. give iv injections into any of the veins as previously described. in addition, the penile vein may be used in hamsters and guinea pigs. placement of iv catheters is possible in animals heavier than 100 g. for small rodents, give a bolus of fluids every 2-4 hours, followed by a diluted heparin flush. a pediatric iv pump is used for continuous infusion of fluids to mark distance from nose to last rib larger animals. maintenance of catheters in active animals is extremely difficult. for io injections, place a spinal needle into the proximal tibia or femur following the technique used for placing an intramedullary pin. once the needle is seated, remove the stylet. aspirate and check the hub of the needle for bone marrow. the tip of the needle should be in the bone marrow cavity that directly drains into the central venous system in normal bones (i.e., the cortex must be intact). administer drugs, blood, or fluids at a rate similar to that used for iv catheters. • in chinchillas and guinea pigs, withhold food for 6 hours before anesthesia. withhold food from smaller, mature rodents for 2 hours. withhold food from immature animals for up to 1 / 2 hour depending on age and condition. • use heat lamps and heating pads to prevent hypothermia. have a prewarmed incubator available for recovery. preoperative or intra-operative warmed sc or iv fluids are strongly recommended. place iv or io catheters whenever possible. • administer atropine preoperatively to reduce airway secretions. acepromazine, diazepam, or midazolam work well as premedications for other anesthetics. avoid acepromazine in gerbils because it potentiates seizures. see table 177 -7 for anesthetic drugs and dosages. surgical anesthesia is reached when toe, tail, and ear pinch fail to generate a withdrawal reaction. depth of anesthesia is best monitored by pulse and respiratory rate and character. pulses drop to within normal ranges after induction. further reduction, especially to less than 80% of the original stabilized value, is an indication to lighten the plane of anesthesia. monitor the electrocardiogram (ecg) of small patients by clamping the alligator clips onto the hubs of all-metal 27-gauge needles or steel sutures placed through the skin at the usual sites. tape cables to the table to maintain placement. doppler units taped over the chest also provide accurate heart rates. pulse oximeters are easier to use, more sensitive, and more expensive than the instruments mentioned previously. these instruments are easily taped to the patient's ear, foot, or tail and provide heart rates as well as information regarding oxygenation. respirations are often shallow and rapid during induction. they become deep and regular as a surgical plane of anesthesia is reached. the corneal reflex varies markedly between individuals and anesthetic agents. if the animal has a corneal reflex after induction and then loses it, reduce the anesthetic. induce gas anesthesia using small face masks purchased from laboratory supply houses or make them from syringe cases and latex gloves ( fig. 177-7) . induction in an anesthetic chamber is also possible. all rodents induced and maintained on gas anesthesia require some form of non-rebreathing system. usual induction is achieved between 2% and 3% for isoflurane and 2% and 4% for halothane. maintenance for isoflurane and halothane varies from 0.25% to 2%. there is marked individual variation in the amount of anesthetic required for induction and maintenance. use of 50% nitrous oxide in oxygen reduces anesthetic concentration requirements for other gases. m key point some chinchillas and guinea pigs hold their breath while being induced with gas anesthetics and then take deep rapid breaths. if the concentration of anesthetic gases is high enough, this behavior results in death. the risk of this behavior is reduced by premedication with tranquilizers, initial induction with nitrous oxide with later addition of primary anesthetic gas after relaxation, and low induction settings. changes in respirations, especially erratic or apneustic patterns and decreased respiratory rates, indicate deepening anesthesia. most pet rodents are not intubated for anesthesia because of their small size. when necessary, as in prolonged oral and other procedures, endotracheal intubation is accomplished with the animal in dorsal or ventral recumbency, depending on the clinician's preference. small non-cuffed or cole endotracheal tubes work well. a stylet usually is required to provide enough stiffness for the tube to pass the larynx. extend the animal's head and neck. grasp the tongue with forceps and use gentle traction. the tip of the tube then is advanced above the tongue and just past its base. the hard palate is used to deflect the tip of the tube ventrally into the glottis. this is a blind procedure that is difficult to master. use of a laryngoscope is helpful in larger rodents. another technique is to place an over-the-needle catheter in the trachea and move it up retrograde through the larynx to act as a guide. the catheter is removed after the endotracheal tube is in place. it is extremely important that the tube be checked for patency. rodents produce copious respiratory secretions, which frequently clog endotracheal tubes. the small diameter allows these tubes to collapse or kink, resulting in asphyxiation of the patient. check patency at least every 2 minutes by applying positive pressure ventilation at 10 to 15 cm water and watching for excursion of the chest wall. if extending the head and neck does not result in air flow, suction the tube. if this is either not successful or impossible, remove the tube and continue anesthesia with a mask or reintubate the animal with a new tube. because of the small diameter of the trachea, endotracheal tube-induced tracheitis and subsequent swelling of the trachea may become a life-threatening situation. doses and routes for injectable anesthetics are listed in table 177 -7. needed doses for injectable anesthetics are tremendously variable among species and individuals. most injectable anesthetics provide safe sedation for minor procedures, but very few induce a safe surgical plane of anesthesia on a consistent basis. • ketamine in combination with diazepam is easily obtainable, is given intramuscularly, and has a wide margin of safety, but it does not provide good analgesia. • intraperitoneal injections of barbiturates provide surgical anesthesia but have a low margin of safety and a significant mortality rate. barbiturate anesthesia can result in fatal ileus. euthanasia is performed easily by induction of inhalant anesthetic through a mask or chamber followed by an overdose of barbiturates given intraperitoneally, iv, or intracranially. euthanasia by ip injection of barbiturates alone causes pain in some animals. • surgical techniques for pet rodents are similar to those used in cats and birds. • hemostasis is critical because of small blood volumes. • electrosurgery for incisions and cautery is highly recommended. • if necessary, give fresh blood transfusions drawn from a donor of the same species and mixed with sodium heparin (1000 iu/ml) at a rate of 0.005 ml/1 ml of blood directly into an iv or io line. • the lack of a filter creates a potential for thrombosis. • transfusion reactions are possible. administer postoperative analgesics to all rodents undergoing surgical or dental procedures. common analgesics include buprenorphine, butorphanol, ketoprofen, carprofen and meloxicam. see table 177 -7 for dosages. the most common surgeries are laceration repair and removal of dermal or sc masses. • most rodents will not gnaw on skin sutures. • if this occurs, use steel sutures, subcuticular sutures, or tissue glue. • if an animal still chews at its suture line, physical restraint, such as a tube or an elizabethan collar, is required. castration is a common procedure in guinea pigs. this usually is performed when owners want to house more than one male together or do not wish to breed their female any longer. common abdominal surgeries include cystotomy for urolith removal in guinea pigs and rats, and cesarean section (c-section) in guinea pigs and chinchillas because of dystocia. use a technique similar to those described for dogs and cats. preplaced stay sutures are recommended to define incision edges for closure. use 4-0 polyglactin 910 or polydioxanone (pds) on a taper needle and suture in a simple continuous pattern to close the body wall. close the skin with a subcuticular suture (absorbable) or interrupted skin monofilament, nonabsorbable suture. fracture fixation is accomplished best with intramedullary pinning or kirschner apparatus. rodents gnaw on bandages until they remove them. if they are unable to remove a splint, self-mutilation often results in self-amputation. if a cast or splint is necessary, physical restraint often is required. healing usually takes 3 to 6 weeks. incisors can be trimmed with nail trimmers, but this technique often fractures the tooth, causing abscesses of the root. instead, use a high-speed dental burr or a flat cutting disk on a dremel hand tool. trim molars with a high-speed drill or pediatric rongeurs. a mouth speculum that deflects the tongue and other soft tissues is essential to prevent lacerations and provide working space ( fig. 177-8) . intubate the trachea to prevent aspiration pneumonia when working on molars. if a tooth is abscessed, extract both it and the occlusal tooth. • if necessary, approach cheek teeth via an incision through the cheek. • use a fine dental elevator to loosen the teeth. • patience and firm but gentle pressure are needed, or the root or surrounding bone may fracture. • the roots of the maxillary incisors curve dramatically back into the head. take care to follow the curve of the tooth. • packing an infected tooth socket with a calcium hydroxide paste may decrease the occurrence of persistent infection. remove the paste in 3 to 4 days. • administer meloxicam, carprofen or ketoprofen postoperatively to control pain. see table 177 -7 for dosages. in chinchillas with dental malocclusion, the roots of the molars can become impacted, causing swelling of the mandible or exophthalmos and epiphora. these teeth are extremely difficult to extract without causing extensive bony and soft-tissue damage. discourage breeding of animals with malocclusion, unless it was acquired as a result of trauma or infection, because this trait is hereditary. most pet and laboratory mice are derived from mus musculus, which is the common house mouse. mice sold in the pet trade are randomly bred and less likely to suffer from the genetic problems associated with inbred laboratory rodents. mice possess brown fat tissues between their scapulae that also are known as hibernating glands; these are thought to provide an energy store. the spleen in male mice is 50% larger than that of females. ectoparasites usually are found in new acquisitions. • alopecia and pruritus, especially on the back of the head and dorsal midline, usually are associated with lice (polyplax serrata), mites, or fleas. • mite infestation (e.g., mycoptes musculinus, myobia musculini, radfordia affinis) often causes a greasy haircoat and folliculitis. transmission of lice and mites occurs via direct contact. fleas are transmitted by other household pets, such as cats and dogs. • diagnosis is based on clinical signs, history, visualization of parasite, skin scrape, and cellophane tape test. • treatment of fleas and lice is with pyrethrin powder. ivermectin is recommended for treatment of mites (see table 177 -8). • change the bedding and thoroughly clean the cage between treatments to prevent reinfestation. occasionally, the surrounding environment needs to be treated with a premises spray used for killing fleas. • alopecia also may be the result of dermatophytes (see chapter 42). lesions are often hyperkeratotic. • diagnosis is made by skin scrape or isolation on culture. most dermatophytes found in pet rodents do not fluoresce under a wood's lamp. • treatment is with lime-sulfur dip or griseofulvin (table 177 -9). • ulcerative dermatitis is a common syndrome caused by staphylococcus aureus characterized by pododermatitis, mastitis, and abscesses in other areas. • administer antibiotics based on culture and sensitivity tests. chloramphenicol is recommended pending culture results (see table 177 -9). the application of hot packs, local drainage, and topical medications are also beneficial in selected cases. • mastitis also may be caused by escheria coli or pasteurella, klebsiella, pseudomonas, or streptococcus species. mastitis usually is caused by poor sanitation, abrasive bedding, or overly aggressive young. • preputial gland abscesses are fairly common in males and are usually caused by e. coli or s. aureus. local flushing and topical treatment are usually adequate. • sc abscesses can be the result of the aforementioned bacteria or actinobacillus spp. or corynebacterium kutscheri. corynebacteria is associated with widespread abscesses, septic arthritis, gangrene, and ulcerated draining tracts. diagnosis is based on finding grampositive pleomorphic rods on gram stain and isolation on culture. • the bacteria are usually sensitive to ampicillin, chloramphenicol, and tetracycline (see table 177 -9). • lymphoma and mammary neoplasia are common causes of sc masses. mammary neoplasia is usually malignant in mice, and metastasis to the lungs is common. (mice have five pairs of mammary glandsthree thoracic and two abdominal.) • obtain thoracic radiographs before surgery. • give a guarded prognosis for long-term survival. • other possibilities for sc masses are fungal granulomas, nodules from the psorergates simplex mite, hematoma, hernia, non-neoplastic lymphadenopathy, or emphysema. • otitis externa usually is caused by ear mites, although bacteria or fungi also may cause primary or secondary otitis. • clinical signs include erythema, pruritus, waxy debris, and excoriations behind the ears. • mites may be diagnosed by identification on otoscopic examination or microscopic examination of ear swabs (see "techniques"). • treatment requires cleaning debris from ears with a commercial ear cleanser followed by administration of three doses of ivermectin at 2-week intervals or topical acaricides used daily for 3 to 4 weeks (see table 177 -9). • bacterial and fungal otitis is diagnosed by identification of organisms or gram-stained specimens and isolation on culture. • treatment is similar to that used in cats. • otitis media/interna usually are caused by hematogenous spread or local invasion of bacteria from a primary abscess. • clinical signs include head tilt, circling, facial nerve paralysis, and otitis externa. • rule out mouse hepatitis virus as the cause of the head tilt (see "gastroenterology"). • if treatment of the primary disease is successful, the otitis media usually resolves, although a residual head tilt may persist. • if a cluster of pseudomonas infections occurs in a population, evaluate the water source and produce for contamination. use sodium hypochlorite in the drinking water at 10 ppm to control an outbreak while water quality is being restored. • damage to the pinnae can be associated with trauma, dermatitis, pox virus, hypersensitivity reactions, and vasculitis. dry gangrene is a common sequela and is usually self-limiting. i have observed a steroid-responsive pruritus in pet mice. the pruritus is severe enough to result in significant self-mutilation. this condition has been nonresponsive to treatment with ivermectin, lime-sulfur dips, griseofulvin, multiple antibiotics, oral prednisolone, and antihistamines. attempts at bacterial and fungal culture have failed to identify a pathogen. an inflammatory response is observed on histologic examination. mice with this condition respond to repository methylprednisolone injections every 2 to 4 weeks (1.0 mg/kg im). most owners have not elected to continue injections for longer than a few months. once the injections are stopped, the pruritus returns, often requiring euthanasia of the affected mouse. • bilateral alopecia found around the muzzle associated with no other abnormalities usually is caused by friction from overhead feeders. • alopecia occurring in smaller, weaker individuals is often the result of barbering. removal of the mice in best condition from the cage results in normal appearance of barbered mice in 2 to 3 weeks. • tailhead alopecia and scabbing are usually the result of aggression. separate affected animals, or additional trauma may occur. • other rare causes of alopecia are endocrinopathies, leprosy, and hereditary alopecia in nude mice. • epiphora is a common condition of pet mice. the most common causes in pets owned for longer than 2 months are ammonia fumes and overgrown incisors. • ammonia causing contact irritation is diagnosed by examining an uncleaned cage and checking for odor. • treatment is improved sanitation. • overgrown incisors are diagnosed easily by oral examination. treat by trimming the affected teeth and providing opportunities for gnawing. • foreign bodies and the resultant corneal ulcers can cause epiphora. an eye examination, including fluorescein stain, is indicated. treat by removing the foreign body and administering an ophthalmic antibiotic (gentamicin, tetracycline, or chloramphenicol in affected eye, q8h-q6h). • in newly acquired pets, epiphora is often the first clinical sign of an upper respiratory infection. pasteurella pneumotropica is the most common pathogen, although salmonella spp., mycoplasma, sendai virus, lymphocytic choriomeningitis, and mouse pox also may cause epiphoria. the ocular discharge later appears mucopurulent (see "respiratory"). retinal degeneration can be either hereditary or (in albino mice) may be caused by exposure to highintensity lighting. the resulting blindness often goes undetected because patients adapt well and behave normally in their cages. • clinical signs include dyspnea (often described as chattering), mucopurulent oculonasal discharge, hunched posture, and anorexia. animals with a chronic history of this disease are often cachexic. • radiology aids in determination of the extent and severity of the pneumonia and the absence or presence of distant foci of infection. • treatment with tylosin is successful in controlling the disease if it is not too advanced. tetracycline, enrofloxacin, and chloramphenicol also have been used (see table 177 -8). • many patients need nutritional support. • mice with pyometra or other abscesses require surgical debridement. • recovered animals are carriers and stress elicits clinical signs. strictly quarantine these animals. a common cause of pneumonia in newly acquired mice is sendai virus. acute fatalities are seen in suckling or weanling mice. • transmission is by aerosol or direct contact. • clinical signs in adults are caused by secondary bacterial infections and are similar to those in mrm. • diagnosis is based on clinical signs and serologic testing. • treat with antibiotics to control the secondary bacterial infection and provide supportive care as needed. • prohibit breeding for 4 to 6 weeks. • a killed vaccine is available. • recovered animals are resistant to new infection. common primary or secondary pathogens causing respiratory signs in mice are streptococcus pneumoniae, corynebacterium kutscheri, pasteurella pneumontropica, pseudomonas aeruginosa, and klebsiella pneumoniae. treatment is empiric or based on culture and sensitivity of a tracheal swab sample. dyspnea often is caused by metastasis to the lungs from mammary adenocarcinomas. primary lung tumors, especially pulmonary adenomas, also occur frequently. although not frequently diagnosed, cardiac disease can result in signs of respiratory disease. diagnosis is based on radiographic evidence of cardiomegaly and pulmonary edema. • tapeworms usually do not cause clinical signs. occasionally, heavy burdens may cause diarrhea or weight loss. the chief concern is the zoonotic potential of one species, hymenolepis nana, which is directly transmissible to humans. • diagnosis is made from visualization of eggs in the feces. treat with praziquantel or niclosamide (see table 177 -8). improve sanitation, and remove indirect hosts (e.g., fleas, beetles, roaches). • pinworms (syphacia obvelata, aspiculuris tetraptera) may cause anal pruritus and, in severe cases, rectal prolapse. • diagnosis is based on clinical signs and observation of eggs on cellophane tape after application to the perineal region. treat with piperazine or mebendazole every 7 to 10 days for three treatments or with fenbendazole once daily for 5 days (see table 177 -8) and provide improved sanitation. • the protozoal parasite spironucleus muris causes diarrhea and slow growth associated with a pot-bellied appearance in young mice. • diagnosis is by fecal wet mount, although falsenegative findings are common. • treat with oxytetracycline (see table 177 -9). supportive care to combat dehydration and hypothermia is extremely important. • control is achieved with improved sanitation. • giardia spp. and, rarely, eimeria falciformis show signs similar to spironucleus. giardiasis is zoonotic. treat with metronidazole. treat eimeria with sulfadiazine/trimethoprim (see table 177 -9). most other protozoa are considered nonpathogenic. • cysticercus fasciolarus causes nonpathologic cysts of the liver. these cysts are the infective form of taenia taeniaformis in carnivores. viral diseases • diagnosis is based on clinical presentation, serology, and presence of syncytial giant cells in the epithelium of the small intestine. • treat supportively, and quarantine affected individuals. the prognosis is grave. • although less commonly seen in pet mice, reovirus occurs in older suckling mice. it is characterized by an oily diarrhea, which results in a greasy haircoat. other signs are conjunctivitis, stunted growth, and tremors. transmission is by ingestion. • diagnosis is based on clinical signs, histology, and serology. • treat supportively. the long-term prognosis is grave. initial survivors are weak and jaundiced, suffer from alopecia, and eventually die. • transmissible murine colonic hyperplasia (mch) caused by citrobacter freundii is characterized by diarrhea followed by rectal prolapse and stunted growth. transmission is feco-oral. • diagnosis is made by clinical signs and fecal culture. • treat with neomycin, tetracycline, or sulfamethazine until sensitivity results are available (see table 177 -9). severe thickening of the distal half of the colon is observed at necropsy. • salmonellosis, also known as mouse typhoid, is transmitted by latent carriers or contaminated feed or bedding. incubation lasts for 3 to 6 days. • clinical signs are lethargy, anorexia, purulent conjunctivitis, arthritis, and diarrhea. • diagnosis is based on clinical signs and fecal culture. treat supportively. use of antibiotics is controversial. • quarantine survivors. • sanitation is extremely important because salmonella spp. are zoonotic. on gross postmortem examination, erythema of distal ileum and congestion of the spleen and liver are seen. with more chronic infections, necrotic foci are seen in the liver, spleen, and lymph nodes. prevent infection by feeding a fresh laboratory chow from a reputable source. thoroughly wash all produce and then dip it in a diluted bleach solution. rinse completely before feeding. • tyzzer disease is caused by bacillus piliformis. transmission is feco-oral. • clinical signs are precipitated by stress and consist of anorexia, diarrhea, and high mortality in weanlings. • diagnosis is made by clinical signs or isolation on culture. enteritis and multiple gray-yellow necrotic foci in the liver are seen on gross postmortem examination. • administer tetracycline for 4 to 5 days (see table 177 -9) and reduce stress to control the disease. breeding systems vary; from one to six females may be placed with one male. all animals are housed together, and the young are removed after weaning. females in proestrus have swollen vulvas. vaginal plugs are present post-copulation. female mice that have been bred within 4 days abort if a new male is placed in the cage. inappropriate light cycle, inappropriate age, crowding, and poor nutrition are the most common causes of infertility in pet mice. pyometra due to pasteurella pneumontropica, mycoplasma spp., or other bacteria is also common. desertion of litters is usually a result of stress, lack of nesting materials, agalactia, or mastitis. • urethral obstruction from proteinaceous plugs of inspissated ejaculum may develop in aged male mice. pseudomonas, e. coli, or proteus are the most frequently cultured pathogens. before complete obstruction, chronic hematuria may be noticed by the owner. • antibiotics, which are chosen based on the results of urine culture, are often curative with early presentation. complete obstruction requires surgical removal. • glomerulonephritis is very common in geriatric mice. it frequently is secondary to chronic viral infection. clinical signs are anorexia, lethargy, dehydration, and cachexia. urinalysis demonstrates proteinuria. as the disease progresses, the urine becomes isosthenuric, the blood urea nitrogen (bun) and creatinine levels rise, and other electrolyte abnormalities typical of chronic renal failure occur. treat supportively. prognosis for long-term survival is grave. • coccidia (e.g., klosseilla muris) occasionally is found in the urine. the clinical significance of its presence is unknown. • mice can be asymptomatic carriers of leptospirosis; however, this is rarely seen in pet mice. • diagnosis is based on darkfield microscopy of urine, serology, or histopathology. euthanasia of carriers is recommended. • infectious polyarthritis or mouse rheumatism is caused by streptobacillus moniliformis. in humans, it is known as rat bite or havernill fever. transmission is by direct contact. clinical signs are cachexia, keratitis, edema and ulceration of the appendages, and ankylosing arthritis. • diagnosis is based on the bacterial culture findings or the presence of caseous pericarditis and arthritis on necropsy. • treat with antibiotics chosen through the results of culture and sensitivity tests. use penicillin while awaiting results. supportive care is important. animals that recover remain arthritic. control is achieved through quarantine and sanitation. • the most frequently diagnosed neurologic disease in pet mice is head tilt resulting from bacterial otitis media (see "otitis"). the second most common cause of neurologic signs is trauma. • diagnosis is based on history and clinical signs. consider neoplasia in aged mice with slowly progressive signs. • lymphocytic choriomeningitis is a zoonotic arenavirus. transmission is airborne, transplacental, or by direct contact, fomites, or insect vectors. acute signs usually occur in mice that are 3 to 6 weeks old. approximately 20% of infected individuals show acute clinical signs, which include lethargy and photophobia followed by convulsions and paralysis. in animals that are latently infected, glomerulonephritis develops later. mice infected after weaning and before 1 year in age lose weight, appear arthritic, and show signs of conjunctivitis and photophobia. the virus runs its course in several weeks. animals that recover show no residual signs. • diagnosis is based on clinical signs and the presence of immunofluorescent antibody (ifa). pleural effusion, splenomegaly, and hepatic lipidosis are found on necropsy. treat supportively. house survivors separately. • prevent the disease by improving sanitation, providing pest control, and cleaning produce. consider euthanasia because of the zoonotic potential of the virus. • mouse poliomyelitis/encephalomyelitis, also known as theiler disease, causes clinical signs in 1 in 10,000 infected mice. two-thirds of healthy mice are carriers. transmission is by oral or respiratory routes. mice younger than 4 weeks of age show signs of encephalitis. animals that are 6 to 10 weeks old are weak in the rear legs and progress to paralysis. the tail may remain mobile. affected mice continue to eat and be alert. albino mice are predisposed to show clinical signs. • diagnosis is based on clinical signs, serology, or histopathology that shows necrosis of the ganglionic cells of the anterior horn of the spinal cord. • treat supportively. consider euthanasia because of poor prognosis. • seizures in mice commonly result from otitis media, trauma, liver or kidney failure, toxin, bacterial meningitis, neoplasia, or viral encephalitis. • leukemia in mice is usually viral in origin. transmission is trans-mammary or trans-placental. • clinical signs are anemia, dyspnea (with thymic involvement), and those signs that are compatible with chronic disease. • diagnosis is based on complete blood count (cbc), bone marrow aspirate, or histopathology. prognosis is grave. • eperythrozoon coccoides is a rickettsial red blood cell (rbc) parasite of mice. affected mice are usually asymptomatic. occasionally, fever, anemia, and splenomegaly develop in infected animals. transmission is through the louse polyplax serrata. control is by extermination of the louse. • treat with tetracyclines. pet rats are derived from the norwegian or brown rat (rattus norvegicus), which did not originate from norway, but from asia. breeds of rats are called strains when they are inbred extensively and stocks when strains are hybridized. rats have brown fat, as discussed in the section on mice. they do not possess a gallbladder. their mandibular symphysis is articulated normally. rats are neophobic; therefore, make gradual changes in food or environment when possible. • fleas, mites (e.g., radfordia ensifera, ornithonyssus bacoti), lice (i.e., polyplax spinulosa), ear mites (i.e., notoedres muris), and dermatophytes cause similar signs in both mice and rats. treatment also is similar (see "mouse"). • sc masses in rats are similar to mice. pasteurella pneumotropica is a very common pathogen in mastitis and sc abscesses. • treat with chloramphenicol until culture results are available (see table 177 -9). • mammary cancer develops in 50% to 90% of adult female rats and in approximately 15% of male rats. always submit biopsy specimens for histologic examination. most, but not all, of these tumors are fibroadenomas, which are benign. prognosis for longterm survival after surgical removal is good. other common neoplasms include interstitial cell tumors of the testes, which cause sc swellings in the inguinal region, and squamous cell carcinomas of the zymbals gland of the external ear canal. • ulcerative dermatitis occurs in rats as well as mice. staphylococcus aureus is the causative agent. c. kutscheri follows a similar course in rats and mice (see "mouse"). • ringtail is the formation of constrictive bands of fibrous tissue around the tail in nestling rats. these bands result in gangrene of the distal tail. this disease occurs when environmental humidity is less than 40%. • treat by making a longitudinal incision of the ring to release the stricture and apply topical dimethyl sulfoxide (dmso), steroid, and antibiotic solution (10 ml dmso, 6 ml 50 mg/ml amikacin, 4 ml 2 mg/ml dexamethasone) four times daily. • to prevent ringtail, keep humidity above 50%, use solid-bottom cages and provide ample nesting material. prognosis for life is excellent. prognosis for retention of the distal tail is guarded. • epiphora and blepharospasm are caused mostly by ammonia fumes, overgrown incisors, or foreign bodies (see "mouse"). • sialodacryoadenitis virus is a coronavirus that is endemic in many rat populations. • clinical signs vary from mild keratoconjunctivitis to blepharospasm, chromodacryorrhea, severe uveitis, hyphema, buphthalmos, periorbital swelling, and pneumonia. the clinical course of the disease lasts 10 to 14 days. rats maintain normal activity levels and appetite. • treatment is not necessary for mild infections. place rats showing marked ocular disease or discomfort on the appropriate ophthalmic ointments (e.g., atropine, antibiotic, steroid) based on presentation. administer parenteral antibiotics to animals that show signs of respiratory problems. recovery is usually complete unless the eye ruptures or selfmutilation occurs. • control is achieved by not introducing new animals for 4 weeks. • in contrast to mice, sendai virus rarely causes clinical signs in rats. • mucopurulent ocular discharge also may be caused by infection with mycoplasmosis, streptococcus pneumoniae, pseudomonas spp., and other less common bacterial or viral agents that cause pneumonia. • cataracts are primary hereditary defects or occur secondary to severe uveitis or diabetes mellitus. retinal dystrophy and colobomas are also inheritable traits in rats. retinal degeneration occurs in rats housed under intense lighting. • mrm is extremely common in pet rats. its presentation is similar to the disease in mice (see "mouse"). • streptococcus pneumoniae is normal flora for rats. however, during stressful situations, bacteremia may occur, resulting in pneumonia. clinical signs are similar to mrm. differentiation is based on culture and the presence of extensive fibrinopurulent pleural effusion on necropsy. • ampicillin controls clinical signs if treated early in the course of disease (see table 177 -9). prevent the condition by minimizing stress. • corynebacterium kutscheri and pasteurella pneumotropica cause signs similar to mrm (see "mouse"). there is a serologic test for c. kutscheri. see the mouse section for a discussion of pseudomonas aeruginosa. • pneumocystosis carinii is an uncommon protozoa that infects the lung. cysts and trophozoites live in the alveoli. clinical signs occur only in immunocompromised or geriatric individuals. signs are cachexia, cyanosis, and dyspnea. • diagnosis is based on clinical signs, tracheal wash, response to therapy, or histologic examination. • treat with sulfadiazine/pyrinrethamine (see table 177 -9). • myocardial degeneration and subsequent congestive heart failure are fairly common in geriatric rats. diagnosis is based on radiographs of the thorax and clinical signs. treat supportively, and use furosemide and digitalis at cat dosages to alleviate pulmonary edema. • polyarteritis nodosa is an idiopathic condition of geriatric rats that results in thickening and tortuosity of arteries, especially in the mesentery, pancreas, and testicles. affected areas are predisposed to clot formation and aneurysms. • nematode (syphacia muris), cestode, and intestinal protozoal parasite infestations are similar to those in mice. • capillaria hepatica has no clinical significance. yellow streaks on the liver are an incidental finding at necropsy. the causes and treatment of malocclusion are similar to those for mice. • epizootic diarrhea of suckling rats is a viral disorder found in rats 7 to 14 days old. the infection causes a mild diarrhea. most animals recover. occasionally, stunting occurs. treat supportively. • salmonellosis in rats is similar to that in mice. • if breeding is desired, take females showing signs of estrus (e.g., lordosis, hyperactivity, quivering ears, and swollen vulva) to a male rat's cage for 24 hours, or keep one male in a cage with up to six females. check females for a post-copulatory plug to confirm breeding. remove females just before parturition, and house females individually while raising the young. a vaginal discharge is seen 1.5 to 4 hours before labor. parturition is accompanied by stretching and extension of the rear legs. all neonates usually are delivered within 1 to 2 hours. • two extremely common conditions in geriatric rats are nephrocalcinosis and chronic progressive nephropathy. clinical signs are compatible with those of chronic renal failure. enlarged or small irregular kidneys may be found on physical or radiographic examination. isosthenuria and marked proteinuria are found in urinalysis. • definitive diagnosis is based on renal biopsy. • treat supportively. prognosis for long-term survival is grave. • trichasomoides crassicauda is an uncommon parasite of the urogenital tract. the adult worms usually reside in the kidney, but they occasionally may wander into the genital tract. the ova are passed in the urine. • clinical signs are hematuria and stranguria. proliferative mucosa of the bladder occasionally may be palpated as an abdominal mass. • treatment is somewhat successful with methyridene (see table 177 -8). sanitation is critical in control of this disease. • klossiella muris is an incidental coccidia of the urinary tract. • many geriatric pet rats have chronic progressive radiculoneuropathy. • clinical signs are compatible with cauda equina syndrome, including posterior paresis progressing to paralysis, urine retention, and incontinence. prognosis is grave. • treat supportively or euthanize. • streptobacillus moniliformis, a normal bacteria found in the oral, nasal, and pharyngeal cavities of rodents, is isolated from 43% of middle ear infections and 35% of chronic pneumonias in rats. the bacteria is nonpathogenic for gerbils and guinea pigs. • clinical signs vary with the site of infection. head tilt and circling, septic arthritis, and respiratory disease commonly are seen. • diagnosis is based on isolation on culture. the clinical signs mimic many other diseases, especially mrm and pseudomonas infection (see "mouse"). • head tilt in rats also may be the result of trauma or neoplasia, especially pituitary adenomas. • hemobartonella muris is an rbc parasite of rats that is nonpathogenic unless the rat is immunocompromised or splenectomized. transmission is through the louse polyplax spinulosa. • clinical signs result from hemolytic anemia and hemoglobinuria. • treat with tetracyclines (see table 177 -9). mesocricetus auratus, better known as the golden or syrian hamster, is a primarily nocturnal rodent that originated in the middle east. almost all hamsters in the united states are the offspring of three siblings imported in the 1930s. many color variations are available. long-haired hamsters are called "teddy bear" hamsters. the stomach has two compartments, a non-glandular forestomach, which functions like a rumen, and a glandular stomach. hamsters are very territorial. they possess flank glands, which are larger in males, that are rubbed against objects to mark their territory. females are larger than males. except during estrus, they use this size advantage to attack males. do not allow groups to estivate together or recently awakened animals may cannibalize sleeping hamsters. m key point hamsters are extremely sensitive to antibiotics. penicillins, clindamycin, lincomycin, streptomycin, tylosin, erythromycin, and cephalosporins eliminate the normal intestinal flora, allowing overgrowth of pathogenic bacteria, particularly clostridium difficile. diarrhea, which is almost always fatal within 3 to 7 days, subsequently occurs. even antibiotics considered to be safe can have this effect. treat by discontinuing antibiotics, providing a lactobacillus supplement, and giving supportive therapy. • hamsters are susceptible to demodex criceti and d. aurati mites. d. criceti is limited to skin folds. d. aurati causes hyperpigmentation, alopecia, and seborrhea sicca affecting the dorsal midline. demodex is carried by many normal-appearing hamsters. • clinical signs occur in immunosuppressed animals, as would occur with stress, chronic infection, pregnancy, or malnutrition. • diagnosis is based on clinical signs and deep-skin scrapings. • treat with amitraz every 2 weeks for two treatments past two consecutive negative skin scrapings. use the manufacturer's recommended dilution for dogs. • sarcoptes mites infrequently cause facial alopecia. diagnosis is based on skin scraping. treat with ivermectin (see table 177 -8). do not confuse this condition with alopecia caused by contact with feeders or barbering. • notoedres mites affect only the external ear canal in female hamsters but may affect the ears, feet, geni-talia, and tail in males. diagnosis is made by observation of mites on samples from ear swabs, skin scrapings, or both. treat with ivermectin (see table 177 -8). • other less common causes of alopecia in hamsters are dermatophytosis, endocrinopathies, and genetic defects. • dermal sc masses are usually abscesses caused by pasteurella pneumotropica, s. aureus, or streptococcus spp. treatment is based on results of culture and susceptibility testing. use chloramphenicol until culture results are available. other frequent causes of sc swellings are distended cheek pouches and testicles, mastitis, hernias, neoplasia, and lymphadenopathy. • epiphora and conjunctivitis are caused most frequently by increased environmental ammonia concentrations, incisor overgrowth, foreign body, or lymphocytic choriomeningitis (see "rat"; "mouse"). • mucopurulent discharge is caused by secondary infection by pasteurella or streptococcus spp. • hamsters are predisposed to rupture of the eye following trauma or infection. surgical enucleation is advised. electrosurgery is extremely helpful in controlling bleeding but do not apply heat to the stump of the optic nerve or vessels, or thermal injury to the brain may result. place gelfoam in the socket to enhance clot formation. • hamsters are susceptible to viral respiratory infections of humans. • clinical signs include nasal discharge, sneezing, otitis media, fever, and pneumonia. uncomplicated cases last 5 to 7 days. complications are usually the result of secondary bacterial infections. • treat supportively. use of antibiotics is indicated if copious nasal discharge, dyspnea, anorexia, or marked lethargy is observed. overuse of antibiotics may cause diarrhea-related death in hamsters that might have recovered uneventfully if left untreated. • most dyspnea in hamsters is caused by blunt thoracic trauma. hamsters often bite when startled. reflex actions on the part of humans, especially children, cause hamsters to be flung against hard objects. • diagnosis is by history and presence of fresh epistaxis. • treat supportively. emergency shock therapy, consisting of supplemental heat, oxygen administration, parenteral fluids, and glucocorticoids, frequently is required. • sendai virus can cause death in suckling hamsters housed with mice. adults show no clinical signs (see "mouse"). • primary bacterial pneumonia most frequently is caused by yersinia pseudotuberculosis, pasteurella pneumotropica, or streptococcus. clinical signs are compati-ble with those of pneumonia seen in other species, as well as weight loss and conjunctivitis. all three agents have a tendency to form distant abscesses, especially in the uterus. • diagnosis is based on clinical signs and isolation on culture. • treat with chloramphenicol until antibiotic susceptibility results are available. abscesses require surgical debridement; however, anesthesia in affected animals is very risky. recovered hamsters are carriers and must be quarantined from other rodents. prognosis is guarded. • cardiac thrombosis is seen in 73% of geriatric hamsters. most thromboses occur in the left atrium and are secondary to degenerative cardiomyopathy, cardiac amyloidosis, sepsis, or calcification of the great vessels. congenital myocardial necrosis also occurs. • clinical signs include cyanosis, dyspnea, and acute death. enlargement of the cardiac silhouette and pulmonary edema sometimes can be seen on thoracic radiographs. • furosemide and digitalis (using standard cat doses) may temporarily alleviate clinical signs. • hamsters can carry the zoonotic tapeworm h. nana (see "mouse"). • treat with niclosamide or praziquantel (see table 177 -8) and provide improved sanitation. • pinworms (aspicularis tetraptera, syphacia muris, s. obvelata) occur in hamsters as well as in mice. • treat with fenbendazole (see table 177 -8). • hamsters are predisposed to dental caries. a large percentage of affected teeth become abscessed, causing facial swelling, ptyalism, and anorexia. • diagnosis is based on clinical signs, oral examination, skull radiographs, and isolation on culture. • extract the tooth and administer antibiotic therapy based on results of susceptibility testing. prognosis is variable depending on the condition of the animal, tooth affected, and extent of the abscess (see "mouse"). • overgrown incisors also occur, as in mice. • the cheek pouches are very distensible. impaction of the pouches occurs on occasion. • clinical signs vary from ptyalism to swelling from abscess. in simple cases, removal of the material from the pouch with fine forceps is sufficient. sedation usually is not required. • if a fungal or bacterial infection of the pouch is present, remove the exudate, submit samples for gram staining and bacterial or fungal culture, and flush the pouch with diluted iodine solution. if cellulitis is present, administer systemic antibiotics as well. fistulas often heal spontaneously. • proliferative ileitis (i.e., wet-tail disease) is thought to be caused by a campylobacter-like organism with or without concurrent bacterial or viral infections. more than 90% of animals with clinical signs die. the highest morbidity and mortality rates occur in hamsters 3 to 8 weeks of age. teddy bear hamsters may be more susceptible to infection than shorter-haired varieties. transmission is feco-oral. • clinical signs include diarrhea, which mats on the ventrum and perineum, and results in anorexia, dehydration, and a hunched posture. the abdomen frequently seems painful on palpation. bowel loops often are distended on palpation because of ileal obstruction or intussusception. rectal prolapse usually occurs. • administer neomycin, gentamicin, metronidazole, or tetracycline (see table 177 -9). supportive care is critical. prognosis is grave, even with treatment. gross postmortem findings include gas and yellow diarrhea in the distal intestinal tract, mucosal thickening in the ileum and distal jejunum, peritonitis, and liver abscesses. • other common causes of bacterial diarrhea include e. coli, tyzzer disease, or salmonella spp. (see "mouse"). in hamsters older than 1 year of age, liver cysts that are derived from the biliary duct often develop. less frequently, similar cysts arise from the pancreas, epididymis, and seminal vesicles. this syndrome is called polycystic disease. no clinical signs are associated with cysts in these structures, which are an incidental finding on abdominal palpation. no treatment is recommended. • timing is critical to prevent injury to the male when breeding hamsters. transfer the female to the male's cage in the early evening 3 days after a creamy, viscous vaginal discharge is noticed. monitor the pair carefully. remove the male immediately if the female is aggressive. remove the male after mating or after 1 to 2 hours even if mating has not occurred. two days after successful copulation, a gray malodorous vaginal discharge is observed. pregnancy is highly likely if there is no translucent vaginal discharge 5 to 9 days post-breeding. pseudopregnancies last 8 to 12 days. normal gestation is 15 to 16 days. before par-turition, a hemorrhagic vaginal discharge appears, and the female may pant. hamsters rarely suffer from pregnancy toxemia (see "guinea pig"). • infertility may be caused by pyometra (see p. pneumotropica and lymphocytic choriomeningitis). • cannibalism is most frequently a result of stress or mastitis. • in almost 90% of geriatric hamsters, renal amyloidosis develops. the disease tends to develop more rapidly in females. • clinical signs include edema and ascites due to protein loss in the urine, as well as the typical signs of chronic renal failure. • treat supportively. prognosis for long-term survival is grave. • head tilt is usually secondary to otitis media. also consider lymphocytic choriomeningitis or neoplasia as differential diagnosis (see "rat"). • in hamsters fed all-seed diets and deprived of exercise, cage paralysis syndrome often develops. usually pets are presented for acute posterior paresis which, in reality, was slowly progressive. the distinction is important in ruling out trauma. in mild cases, the hamster is able to move its hind limbs but unable to support weight. vitamin d and e supplementation, along with nutritional improvement and providing exercise, is curative in 1 to 2 weeks. in severe cases, recovery is negligible or incomplete. lymphoma and lymphosarcoma may be viral in origin. diagnosis is made by biopsy or fine-needle aspiration of affected lymph nodes. rule out lymphadenopathy caused by lymphadenitis from infection with streptobacillus moniliformis (see "rat"). although many hamsters initially respond well to chemotherapy protocols established for cats and dogs, prognosis for long-term survival is grave. • rarely, demodex spp. mites cause alopecia in gerbils. • diagnosis is based on skin scraping. • treat with rotenone ointment or amitraz dips every 2 weeks for three to six treatments. use manufacturer's recommended dilution for dogs. • acute moist dermatitis usually is caused by s. aureus infection. infection on the face often begins with the harderian glands. the gland secretion is viscous and causes matting, with secondary staphylococcal infection occurring under the mats. attempts at grooming spread the infection to the feet and abdomen. • diagnosis is based on clinical signs and isolation on culture. • administer enrofloxacin, tetracycline, or chloramphenicol and apply warm, moist compresses to remove dried debris. remove possible irritants from cage (e.g., pine or cedar shavings, ammonia). occasionally, surgical removal of a chronically infected or inflamed gland is needed. • alopecia of the facial area, especially when it is symmetric, is usually the result of self-trauma from feeders, cage bars, or overzealous burrowing. • treat by changing cage construction or providing better visual security. • gerbils that catch their tails in crevices or are restrained inappropriately by their tails often are presented for avulsion of the skin from their tails. • treat initially by controlling hemorrhage and hypovolemic shock. • amputate the tail after patient stabilization to prevent ascending infection. in some animals, the infection is localized to the distal tail, which is sloughed in approximately 3 to 4 weeks. • generalized alopecia is normal in some weanling gerbils. the hair grows in as the animals mature. • melanomas are found most frequently on the ears, feet, or base of the tail. • diagnosis is based on biopsy. • treat by surgical removal. • sebaceous gland disease is usually the result of bacterial infections or neoplasia. • diagnosis is based on cytologic examination, culture, histologic examination, and response to antibiotic therapy. • treat bacterial infections with parenteral or topical antibiotics based on the severity of signs. • sebaceous gland adenomas, basal cell tumors, and squamous cell carcinomas are the most frequently encountered neoplasms. • take a radiograph of the thorax to diagnose metastases. prognosis for long-term survival is based on tumor type, stage, and character. • treat by surgical excision. chromodacryorrhea and epiphora occur as in mice. tapeworms (i.e., h. nana and h. diminuta) and pinworms (i.e., syphacia obvelata, dentostomella translucida, and aspicularis tetraptera) occur as in mice. incisor overgrowth occurs as in mice. • salmonella spp. cause transient diarrheas in gerbils. the source of infection is usually unwashed greens, contaminated feed, or carrier rodents of another species. most recover. animals that die have a fibrinosuppurative peritonitis. • treat supportively. use antibiotics in severe cases based on results of culture and susceptibility testing. • tyzzer disease, caused by bacillus piliformis, is seen most often in weanlings at 3 to 7 weeks of age and in post-partum females. • clinical signs include anorexia, lethargy, rough haircoat, and sometimes diarrhea. gross postmortem findings include yellow-gray nodules in the liver and hemorrhage at the ileocecal junction. • diagnosis is based on postmortem examination or response to therapy. • treat with oxytetracycline (see table 177 -9) and supportive care. hepatic lipidosis and gallstones are frequent sequela to lipemia in gerbils fed diets with excessive fat. • breeding is most successful if animals are paired at weaning and kept in these pairs. male gerbils aid in raising the young. pairing older animals causes fighting. an average of 20% of neonates fail to survive to weaning. this is usually the result of agalactia and crushing. • chronic hemorrhagic discharge from the vulva is usually the result of cystic ovaries or ovarian tumors. most tumors occur in animals older than 2 years of age and consist of granulosa cell tumors or theca cell tumors. leiomyomas of the uterus also cause similar clinical signs. • rule out urinary tract disease by performing a urinalysis via cystocentesis. large masses may be visualized on abdominal ultrasound. definitive diagnosis is based on vaginal cytology followed by exploratory laparotomy. • ovariohysterectomy is curative for cystic ovaries and tumors if they have not metastasized. • chronic renal failure develops in most gerbils older than 2.5 years of age. • clinical signs are polyuria, polydipsia, weight loss, and anorexia. urinalysis demonstrates proteinuria, hematuria, casts, and an increase in white and red blood cells. • treat supportively. prognosis for long-term survival is grave. • up to 50% of gerbils in certain family lines suffer spontaneous epileptiform seizures. the seizures are induced by stress and are self-limiting. seizures usually start as the gerbil reaches 2 months of age. • treatment is unnecessary. chinchilla laniger and c. brevicaudata are nocturnal rodents from the andes mountains in south america. most animals kept in the united states are the descendants of 11 animals. aside from pets, chinchillas are raised commercially for their pelts. the most common coat color is gray; the most valuable coat color is black. m key point chinchillas are sensitive to antibiotics (see "hamster"); therefore, avoid use of penicillins, lincomycin, erythromycin, and cephalosporins. house chinchillas in a cool environment because they are prone to overheating. if heat stroke occurs, treat with tepid water baths and supportive therapy. • chinchillas require dust baths to keep their skin in condition. use commercially available chinchilla dust only. sand substitutions do not condition the coat and occasionally cause conjunctivitis. offer dust at least once a week. • dermatophytosis occurs as in guinea pigs. • fur chewing is a serious problem in chinchillas that are farmed for pelts and often is seen in pet chinchillas that are recent culls from a ranch. the etiology of fur chewing is unknown. some cases seem to be related to chronic disease, malnutrition, poor caging, or stress. theories for undiagnosed cases include genetic abnormality; undiagnosed dermatophytosis; or adrenal, pituitary, or thyroid gland abnormalities. • diagnostics such as skin scraping, fungal culture, fecal, cbc, history profile, and biopsy are recommended. in general, if changes in diet and husbandry do not elicit a response or an underlying treatable disease condition is not discovered, prognosis for cure is grave. • one source advocates plucking all remaining underfur in chewed areas in an attempt to stimulate new hair growth. place collars after this procedure until the fur has grown in completely. • cystic sc masses may be caused by the intermediate stage of multiceps serialis. transmission is by ingestion of feed contaminated with canine feces. • diagnosis is made by histopathologic or cytologic examination of tissue samples. treat by surgical removal of the masses. • otitis caused by pseudomonas spp. occurs as in rats. • conjunctivitis occurs as in mice. • cataracts are congenital or developmental. • asteroid hyalosis occurs as a degenerative change. pneumonia occurs as in guinea pigs. parasites tapeworms (i.e., h. nana) occur as in mice. malocclusion of incisors and cheek teeth occurs as in guinea pigs. • diarrhea is caused most often by coccidia or giardia spp. or a bacterium. • clinical signs range from soft stools and weight loss to fluid diarrhea, dehydration, bloating, septicemia, and sudden death. • the protozoal parasites are best diagnosed on fresh saline smear or necropsy. • bacterial diarrhea is most often caused by contaminated feed and is diagnosed by isolation on culture. clostridium spp., pseudomonas aeruginosa, e. coli, salmonella enteritidis, and pasteurella spp. are the most common isolates. • treat supportively and use appropriate antiprotozoal or antibiotic drugs. • pasteurella pseudotuberculosis causes acute death from septicemia or a chronic weight loss with intermittent diarrhea. enlarged mesenteric lymph nodes are a hallmark of this disease. • diagnosis is based on clinical signs, histopathologic examination of tissue samples, and isolation on culture. • treat with sulfa drugs until sensitivity results are available. prognosis for recovery is poor. gross postmortem examination reveals yellow to white necrotic foci in the liver. • check male chinchillas four times per year for penile hair rings. roll back the prepuce and expose the penis. roll hair rings off the penis after application of a water-soluble lubricant. treat ulcerations topically or systemically as needed. • dystocia is fairly common in chinchillas (see "guinea pig"). • metritis is suspected when post-partum vaginal discharge, failure to return to a normal estrus cycle, anorexia, weight loss, polydipsia, polyuria, and chewing at flank and abdomen are present. • diagnosis is based on history, physical examination, abdominal radiographs, culture, ultrasound, and cbc. it usually is caused by bacteria introduced by the male or spread from an internal abscess. retained placentas, macerated fetuses, and dystocia are predisposing factors toward metritis. • treat with ovariohysterectomy after stabilization. females used only for breeding purposes may be treated with antibiotics alone, but the prognosis is poor. • female chinchillas are aggressive toward male chinchillas when not in estrus. breeding operations usually have separate cages for females and an interconnecting run for the male. females are kept out of the male's run by their larger size or collars. the young are precocious and do not need a nest. chinchillas only produce two litters per year. • clinical signs include hot, swollen mammary glands. suspect mastitis if previously healthy neonates become restless, then lethargic. • perform bacterial cultures on milk samples, and treat with antibiotics based on susceptibility testing. administer sulfa drugs until susceptibility results are available. local hot packing is also beneficial. occasionally, surgical drainage is required. foster neonates to another female if possible, or use puppy or kitten milk replacers to hand-raise babies. • chinchillas seem to be particularly sensitive to listeria monocytogenes. clinical signs can mimic p. pseudotuberculosis and include anorexia, lethargy, abortion, generalized central nervous system (cns) signs, hepatitis, mild enteritis, and mild emphysematous pneumonia. necropsy shows yellow foci in the liver. • diagnosis is based on isolation on culture. • treat with sulfa drugs (see table 177 -9) until sensitivity results are available. the prognosis is poor. • other less common causes of neurologic disease in chinchillas include lymphocytic choriomeningitis, streptococcus spp., balisascaris procyonis (i.e., aberrant migration of raccoon roundworm), lead poisoning, and thiamine deficiency. guinea pigs (caviae porcellus) are nocturnal rodents that originated in the andes mountains. they are known for their dietary need for vitamin c. they are used as a food source in their native lands. there are three basic types: english, which have short hair; abyssinian, which have short, cowlicked hair; and peruvian, which have long hair. male guinea pigs are known as boars and the females as sows. guinea pigs become neophobic as they mature. offer a variety of foods early in life and make changes in diet or environment gradually. guinea pigs stampede when excited. square cages and strategically placed barriers on external walls prevent the trampling of small or weak animals. the smooth muscle of the bronchial tree is quite developed in guinea pigs. this places them at high risk for asthmatic-type anaphylactic reactions. both male and female guinea pigs have one pair of inguinal mammary glands; however, only the female's are well developed. m key point antibiotic toxicity (see "hamster"): guinea pigs also may be sensitive to tetracyclines. • fleas occur as in mice. • lice (i.e., gliricola porcelli, gynopus ovalis) usually cause no clinical signs except occasional alopecia, seborrhea, and trauma secondary to pruritus. • diagnosis is made by observation of lice on skin scraping. • treat with ivermectin, 5% malathion dust, or pyrethrin shampoo (see table 177 -8). • the mite trixacarus caviae causes severe pruritus and is zoonotic. it mainly affects the dorsal midline and is difficult to find on skin scraping. it occurs most frequently in recently post-partum females, in which alopecia is the predominant clinical sign. treat with excellent sanitation and ivermectin (see table 177 -8). • chirodiscoides caviae lives on the hair shaft of the perineal regions. it does not cause clinical signs. • treat with 5% carbaryl or lime-sulfur dip (1:40) (see table 177 -8). sanitation is critical in preventing reinfestation. • about 6% to 13% of guinea pigs are carriers of trichophyton mentagrophytes. • clinical signs are alopecia and seborrhea sicca, usually starting on the face and spreading along the dorsum. • treat with lime-sulfur dips or griseofulvin (see table 177 -9) combined with topical povidone iodine or chlorhexadine shampoos. • other causes for alopecia are barbering, alopecia of the flanks in late-gestation females, and generalized alopecia of young at weaning. subclinical hypovitaminosis c causes a poor hair coat and seborrhea sicca, as well as anorexia and large, malodorous stools. • "lumps" is the lay terminology for cervical lymphadenitis, which is characterized by lymphadenopathy in the ventral neck region. • pododermatitis and sore hocks are very common in guinea pigs. predisposing factors are untrimmed toe nails, poor sanitation, and wire flooring. s. aureus is the most commonly cultured pathogen. • clinical signs range from small ulcers on the soles of the feet to abscesses and gangrene. radiography is essential in determining whether bony involvement is present. untreated pododermatitis usually develops into osteomyelitis, which is very difficult to cure. • treat mild cases by improving sanitation and grooming. place affected individuals in solidfloored cages with paper bedding. use sulfa drugs (see table 177 -9) until results of susceptibility testing are available. surgically remove or curette abscesses, and apply topical therapy and hot packing. amputation may be necessary when severe osteomyelitis exists. • conjunctivitis and epiphora occur as in mice. • inclusion body conjunctivitis is caused by chlamydia psittaci and is self-limiting in 3 to 4 weeks. • perform a conjunctival scraping to differentiate inflammatory conjunctivitis secondary to infection from allergy. i have observed an idiopathic, topical steroid-responsive lymphoplasmacytic conjunctivitis in guinea pigs. • white, dry ocular discharge is an early sign of hypovitaminosis c. • "pea-eyes" is the lay terminology for subscleral fatty deposits or protrusion of the lacrimal gland through the lower conjunctiva. the condition is thought to be hereditary. treatment is not required. • cataracts occur and are either congenital or developmental. • diabetes mellitus in guinea pigs also may cause cataracts. usually, no other clinical signs are present and urine glucose is greater than 100 mg/dl whereas blood glucose remains within normal limits. • corneal or scleral calcification is usually an incidental finding. a thorough workup, including serum chemistry profile and radiographs, is recommended to ensure that generalized metastatic calcification is not present. • pneumonia in guinea pigs usually is caused by infection with s. pneumoniae, s. zooepidemicus, or bordetella bronchiseptica. s. aureus, p. aeruginosa, klebsiella pneumoniae, and pasteurella multocida also are cultured frequently. transmission is by direct contact, fomites, or aerosol. hypovitaminosis c and stress often predisposes guinea pigs to bacterial respiratory infections. weanlings are particularly susceptible. clinical signs and diagnosis are similar to other small mammals (see "mouse"). • take radiographs to rule out abscesses, pleural effusion, or pericardial effusion in refractory cases. • treat with chloramphenicol, sulfa drugs, or enrofloxacin (see table 177 -9) and vitamin c (table 177 -10) until results of culture and susceptibility testing are available. cats, dogs, rabbits, and rats are reservoirs for bordetella spp. as in other rodents, respiratory infections may lead to otitis interna/media. bordetella spp. also cause pyometra and abortions. • nasal discharge is most frequently a sign of upper respiratory tract infection but also may be associated with allergies or volatile irritants. • the diagnosis of allergic rhinitis is made by exclusion and through response to antihistamines or environmental changes. • bronchogenic papillary adenoma develops in approximately 30% of guinea pigs older than 3 years of age. • diagnosis is often an incidental finding when thoracic radiography is performed for another problem. • occasionally, clinical signs are seen as a result of pressure on the heart or great vessels. • dyspnea most frequently is caused by heat stress or trauma. other causes are pregnancy toxemia, gastric bloat, volatile irritants, pleural effusion, pneumonia, or pulmonary edema. rhabdomyomatosis is a common necropsy finding. gross lesions appear as pale foci located on the endomyocardium and valves. histologic examination reveals myocardial cells that have stored excessive glycogen. do not confuse these areas with thrombi, abscesses, or neoplasia. their clinical significance is unknown. • paraspidodera ucinata is the cecal pinworm of guinea pigs. they are generally asymptomatic, but heavy infestations can cause diarrhea and weight loss. • diagnosis is based on fecal examination or cellophane tape test. • treat with piperazine or fenbendazole (see table 177 -8). • coccidiosis caused by eimeria caviae is a fairly common cause of diarrhea in guinea pigs recently purchased from pet stores. • clinical signs are tenesmus, diarrhea, dehydration, and death. • diagnosis is based on fecal examination. on gross postmortem examination, petechiation and thickening of the colon are seen. • treat supportively and administer sulfa drugs (see table 177 -9). • cryptosporidium wrairi and giardia spp. are found rarely. they cause a chronic enteritis. balantidium spp. are thought to be nonpathogenic. • malocclusion in guinea pigs is diagnosed on oral examination. • clinical signs are ptyalism and anorexia. the premolars are the most commonly affected teeth. • long-standing hypovitaminosis c predisposes guinea pigs to malocclusion. • treat malocclusion as in other rodents (see "dental procedures"). • hypovitaminosis c (i.e., scurvy) is associated with soft, malodorous feces. degeneration of the epithelium of the intestinal tract adversely affects digestion and absorption and allows secondary bacterial infections. • diagnosis of scurvy is based on clinical signs, the exclusion of other causes of diarrhea, and response to vitamin c therapy (see table 177 -10). • salmonellosis usually is contracted through contaminated feed. • clinical signs range from sudden death to diarrhea and anorexia. the diarrhea is frequently light colored. sepsis is common and may cause conjunctivitis, shock, pneumonia, abortion, and neurologic symptoms. • diagnosis is based on isolation on culture of feces or other appropriate tissue samples. • treatment is controversial because recovered individuals remain carriers. use sulfa antibiotics or enrofloxacin (see table 177 -9) until sensitivity testing results are available. supportive care is essential. • e. coli, arizona, and clostridium are other commonly cultured diarrhea-causing organisms. clostridium are diagnosed most easily by finding large numbers of spores on a gram stain fecal specimen. treat with metronidazole (see table 177 -9). • yersinia pseudotuberculosis either causes an acutely fatal diarrhea or localizes into regional lymph nodes. • diagnosis is based on culture. • treat by surgical removal or drainage of abscessed lymph nodes. mesenteric lymph node involvement necessitates abdominal surgery. treat with sulfa drugs or enrofloxacin until susceptibility testing results are available (see table 177 -9). • one male usually is housed with four to six females for breeding purposes. signs of estrus are vulvar swelling, lordosis, and opening of the vaginal closure membrane. fetuses are palpable at 4 to 5 weeks of gestation. parturition occurs within 48 hours after the pubic symphysis has reached 15 mm. neonates weighing less than 60 g have a grave prognosis for survival even with intensive care. neonates normally do not nurse for the first 12 to 24 hours. litters with five or more fetuses usually result in abortion. • dystocia commonly occurs in females bred after the age of 6 to 9 months. after this age, the symphysis fuses and is unable to open the 2 to 3 cm required to allow passage of a fetus. dystocia in younger guinea pigs may be caused by obesity, large fetal size, fetal malpresentation, subclinical ketosis, or uterine inertia. on presentation, check the pelvic symphysis. if active contractions are present and the symphyseal gap is less than 2 cm, perform a c-section. normal parturition is very rapid, with a rest of only 3 to 7 minutes between fetuses. • perform a c-section if active straining does not produce a fetus within 15 to 20 minutes. radiograph sows with a history of weak contractions to determine the stage of pregnancy and evaluate the size of the fetuses. if well-developed skeletons of appropriate size are seen and the pubis has not yet fused, give oxytocin and calcium (see table 177 -10). if no fetuses are produced within 15 to 20 minutes, perform a c-section. • if poorly developed fetuses are seen radiographically, consider fetal death, ketosis, or a nonreproductive disorder as possible causes of dystocia. m key point pregnancy toxemia usually is seen in obese sows with large litters in late pregnancy. other risk factors include systemic disease or diet change causing anorexia, genetics, stress, and first litter. • clinical signs are tachypnea, depression, malodorous breath, seizures, and icterus. a urine ph of less than 6 with marked proteinuria is compatible with pregnancy toxemia. a marked hyperkalemia and elevation of liver enzymes often occurs. thrombocytopenia may be present. • treat with iv or io saline, dextrose, glucocorticoids, and calcium. surgical abortion of the fetuses may be attempted, but the anesthesia risk is quite high. prognosis for survival is grave. do not rebreed affected females. do not breed sows heavier than 900 g. • large litters can cause a hemorrhagic syndrome. compression of the portal vein and liver causes hepatic dysfunction, which results in vitamin k and clotting factor deficiency. • treat with vitamin k supplementation (see table 177 -10). response is poor in severely compromised patients. affected individuals are at risk of ketosis developing. prognosis is guarded. • vaginitis in guinea pigs frequently is caused by foreign bodies, usually bedding. • diagnosis is made on vaginal examination. • treat by flushing the vagina to remove the foreign material. • vaginal discharge also can be caused by pyometra, uterine torsion, urinary tract infection, or urogenital neoplasia. • diagnosis is based on findings on abdominal palpation, vaginal cytology and culture, urinalysis, abdominal radiographs, ultrasound, and exploratory. • treatment varies with the condition and is similar to that used in cats. • ovarian teratomas and uterine tumors occasionally are diagnosed and usually resolve with ovariohysterectomy. • a symmetric alopecia with concurrent abdominal enlargement may be seen in female guinea pigs with cystic ovaries. • diagnosis is based on abdominal palpation, cytology, and ultrasound. • treat by performing an ovariohysterectomy. if the guinea pig is not a good candidate for surgery, human chorionic gonadotropin (hcg, 1000 usp units im, repeat in 1 week) may temporarily resolve clinical signs. • male guinea pigs are prone to preputial foreign bodies. a preputial discharge is the usual presenting complaint. • diagnosis is based on physical examination. • treat by removing foreign bodies and performing local flushing. chronic problems require a change in bedding. • male guinea pigs produce sebaceous secretions in the folds around their perineal area. clean these areas with soap and water semiannually to prevent localized pyoderma. • if pyoderma occurs, treat with topical therapy and oral antibiotics. bacterial cystitis and urolithiasis are relatively common in guinea pigs. diagnosis is based on a history of stranguria, hematuria, painful abdomen, and anorexia, in addition to abdominal palpation, urinalysis, urine culture, abdominal radiographs, and ultrasonography. treatment consists of antibiotics based on results of culture and susceptibility testing and surgical removal of calculi, if present. prevention of recurrence is difficult if the calculi are not caused by a bacterial infection. addition of vitamin c to the drinking water as well as changing the brand of diet are sometimes helpful in preventing recurrence of metabolic stones. klossiella cobayae is a coccidia that lives in the renal tubules. it has no clinical significance. the most common orthopedic problem seen in guinea pigs is overgrown toenails. this leads to pododermatitis and sore hocks as well as to degenerative joint disease and a predisposition to tibial fractures. tibial fractures are the most common fracture seen in guinea pigs. they most frequently occur after foot entanglement. internal fixation with an im pin or application of a kirschner apparatus is the repair of choice. m key point signs of hypovitaminosis c or scurvy start to develop in guinea pigs as early as 10-15 days if they are placed on diets 100% deficient in vitamin c. early signs are soft, malodorous stools, weight loss, poor hair coat, and anorexia. later, petechia, gingivitis, cutaneous and oral sores, swollen costochondral junctions, joint pain and hemorrhage resulting in lameness, and conjunctivitis become apparent. treat supportively and administer parenteral vitamin c (25 mg/day). • lymphocytic choriomeningitis occurs as in mice. • guinea pig paralysis syndrome starts with mild pyrexia and urinary incontinence, followed by weight loss and posterior paresis that progresses to paralysis. currently, the etiology is unknown, but it does not appear to be contagious. • treat with supportive care. prognosis for long-term survival is grave. • head tilt is usually the result of otitis or trauma (see "mouse"). cavian leukemia has a viral etiology. the liver, spleen, and lymph nodes are the primary organs involved. there is no current treatment. quarantine exposed individuals. death usually occurs within 5 days after discovery of lymphoblasts in the peripheral blood. neutrophils normally have red granules. kurloff bodies are normally occurring eosinophilic intracytoplasmic inclusion bodies that are found in mononuclear cells. they are seen most frequently in females and appear to correspond positively with estrogen levels. metastatic calcification occurs in most guinea pigs older than 1 year of age. it is more severe in females than in males. the stomach is one of the first organs affected. dysfunction in motility causes obstruction. the tendency appears to be exacerbated by high calcium and low phosphorus diets. exotic animal formulary the biology and medicine of rabbits and rodents veterinary clinics of north america key: cord-258129-c38q6xxs authors: russell, clark d; schwarze, jürgen title: the role of pro-resolution lipid mediators in infectious disease date: 2014-01-09 journal: immunology doi: 10.1111/imm.12206 sha: doc_id: 258129 cord_uid: c38q6xxs inflammation is an essential host defence against infection, but can be damaging when excessive. resolution of inflammation is an active process, and the pro-resolution effects of lipoxins, resolvins and protectins have received significant interest. here, we review emerging data on the role of these lipid mediators in infectious disease. lipoxins influence host control of mycobacterium tuberculosis, toxoplasma gondii, trypanosoma cruzi and plasmodium berghei cerebral malaria in mice. their effects are protective in toxoplasmosis, t. cruzi infection and cerebral malaria but detrimental in tuberculosis; related to the balance between pathogen-control and excessive immune response. topical lipoxin abrogates the tissue damage seen in a rabbit model of porphyromonas gingivalis periodontitis. the increased virulence of h5n1 influenza a virus in mice correlates with reduced expression of socs2, required to mediate the effects of lipoxin. mice unable to synthesize lipoxin suffer increased lung pathology during respiratory syncytial virus infection. protectin suppresses influenza a virus replication in vitro and increases survival in a mouse model of severe influenza infection. resolvins were investigated in a number of animal models of systemic bacterial infection, and were found to enhance phagocytic clearance of bacteria, reduce inflammation severity, promote neutrophil apoptosis, modulate neutrophil chemotaxis and importantly, reduce mortality. interestingly, resolvin also enhances the antibacterial effect of ciprofloxacin and vancomycin. topical resolvin application reduces the severity of herpes simplex virus ocular infection in mice. if the effects of these mediators translate from pre-clinical studies into successful clinical trials, they represent promising new strategies in managing infectious disease. inflammation is an essential host defence mechanism, required for protection against pathogenic micro-organisms and viruses. however, an excessive and non-resolving inflammatory response is damaging to the host. for example, in sepsis there is loss of homeostatic control over the inflammatory response mounted against an infectious agent, resulting in a pro-inflammatory, procoagulant state that can result in organ dysfunction and death. acute respiratory distress syndrome is another example, and describes the life-threatening hypoxic complication of excessive pulmonary inflammation that can be triggered by a range of insults, including pneumonia and sepsis. 1 chronic, non-resolving inflammation also underpins a number of other pulmonary diseases, including asthma, cystic fibrosis and bronchiectasis. inflamma critical events following the clearance of an infectious agent, to prevent the development of these 'complications' of excessive inflammation. this is now known to be an active process, termed catabasis, 2 driven by the pro-resolution lipid mediators resolvin, protectin and lipoxin. 3 lipoxins (trihydroxy-tetraene-containing eicosanoids) are derived from the omega-6 polyunsaturated fatty acid arachidonic acid through sequential reactions involving lipoxygenase enzymes (including 15-lipoxygenase type 1 and 5-lipoxygenase in human mucosal tissues). 4, 5 resolvins are derived from omega-3 polyunsaturated fatty acids and exist as two series (d and e). d-series resolvins are products of docosahexaenoic acid metabolism involving 15-lipoxygenase. e-series resolvins are synthesized from eicosapentaenoic acid involving aspirin-acetylated cyclo-oxygenase 2. 6 protectins are also omega-3 polyunsaturated fatty acid derivatives, generated from docosahexaenoic acid through a 15-lipoxygenase-mediated pathway. 7 the pro-resolution effects of these mediators are exemplified by their role in pulmonary inflammation, the setting in which they are best studied. resolvins, protectins and lipoxins all have a proresolution role in a mouse model of allergic airway inflammation. [8] [9] [10] [11] given that an excessive inflammatory response is implicated in the pathogenesis of a number of infectious diseases and their complications, including sepsis syndrome and acute respiratory distress syndrome, we conducted a review of the literature to determine what is currently known about the role of the pro-resolution lipid mediators lipoxin, resolvin and protectin in infectious disease. 13 in mice, h5n1 was more virulent (infection resulted in shorter survival time) than the h1n1 strain and disseminated to extra-pulmonary sites (brain and spleen) following intra-nasal inoculation. global transcriptional responses to infection were analysed and showed that the different strains of influenza a virus caused different early responses in gene expression, and that many of the differentially regulated genes were components of the inflammatory response. h5n1 infection was associated with up-regulation of inflammasome genes [including caspase 1 and interleukin-1 (il-1)], tumour necrosis factor-a (tnf-a), interferon-c (ifn-c) and protein kinase r, as well as other inflammation-related genes. using a bioinformatics approach to analyse gene expression, the authors found that extra-pulmonary dissemination was associated with down-regulation of genes involved in mediating the pro-resolution effects of lipoxin on leucocyte recruitment and counter-regulation of pro-inflammatory cytokine induction. these included the suppressor of cytokine signalling (socs) 2 gene, the product of which is activated by lipoxins and is an essential intracellular mediator of lipoxin's effects on inflammatory cell trafficking and cytokine induction. 14 therefore, loss of lipoxin's pro-resolution effects may be associated with greater influenza a virus virulence, suggesting a protective role for lipoxin in this infection, possibly related to the suppression of pro-inflammatory cytokines that are up-regulated in this model. the highly pathogenic avian h5n1 virus used in this study was less successful at spreading between human hosts compared with other influenza a virus strains, for example the 2009 h1n1 pandemic strain. a successful pathogen minimizes damage to its host to prolong the availability of its replicative niche and the high case-mortality seen with infection by this h5n1 strain indicates that it is not well adapted to humans. reduction of lipoxin-mediated pro-resolution effects may contribute to the virus's poor adaptation to humans. in a recent study, respiratory syncytial virus (rsv) infection of mice deficient in 5-lipoxygenase, an enzyme required for lipoxin production, failed to elicit alternative macrophage differentiation, which is known to be required for the resolution of rsv-induced lung injury. 15, 16 alternatively activated macrophages are thought to induce anti-inflammatory cytokine expression and drive lung tissue repair. 16 significantly, rsv infection of these 5-lipoxygenase-deficient mice resulted in greater lung pathology on histological analysis (increased peribronchiolitis, perivasculitis, interstitial pneumonitis and alveolitis) in comparison to infected wild-type mice. 15 treatment with lipoxin a4 and resolvin e1 partially restored the alternatively activated macrophage phenotype in the 5-lipoxygenase-deficient mice. these observations support a pro-resolution role for lipoxins in viral respiratory tract infection. alveolar macrophages are the major resident inflammatory cell of the respiratory tract and are able to produce lipoxins. alveolar macrophages isolated from rats that had previously been infected with a range of respiratory viruses (murine parainfluenza virus type 1, rat coronavirus, pneumonia virus of mice and mouse adenovirus) produced higher levels of lipoxin than macrophages from rats that had been kept in sterile conditions since birth. 17 these findings suggest that virus-induced pulmonary inflammation is a stimulus for the production of lipoxins. in a cell culture model of hiv central nervous system infection, following co-culture of hiv-infected monocytes with astroglia, tnf-a and il-1b were produced and this production correlated with synthesis of large amounts of leukotriene b4, leukotriene d4 and lipoxin a4. 18 this is the only study to demonstrate, albeit in vitro, that lipoxins are produced in direct response to viral infection. however, the role of lipoxin in this model of infection has not been investigated. following aerosol infection with mycobacterium tuberculosis, mice have been shown to produce high levels of lipoxin a4 during chronic infection. 19 pulmonary endothelial cells and macrophages were responsible for this. transgenic mice deficient in 5-lipoxygenase, an enzyme required for lipoxin production, were able to control m. tuberculosis infection better than wild-type mice, as demonstrated by lower pulmonary and splenic titres of viable m. tuberculosis (at 21 and 42 days). on histological examination of lung tissue, extensive inflammation and areas of necrosis were seen in wild-type mice whereas the transgenic mice had a lesser degree of inflammation and little evidence of necrosis. importantly, the transgenic mice unable to produce lipoxin enjoyed enhanced survival in this model of m. tuberculosis infection and had increased pulmonary levels of il-12, ifn-c and inducible nitric oxide synthase, which is known to have a protective role in host control of m. tuberculosis infection in mice. 20 oral administration of a lipoxin a4 analogue reversed the enhanced control of infection in the transgenic mice, and splenocytes from these mice showed reduced ifn-c production. in a mouse model of toxoplasma gondii infection (established through intraperitoneal inoculation of t. gondii cysts), serum levels of lipoxin a4 rise during infection and remain high once chronic infection has been established. 21 transgenic mice unable to produce lipoxin a4 suffered increased mortality following infection, compared with wild-type control animals. 14,21 interestingly, fewer t. gondii brain cysts were seen in the lipoxin-deficient mice and consistent with this, lower parasitic burden and increased serum levels of il-12 and ifn-c were seen when compared with wild-type mice. therefore, it seems likely that the increased mortality of the lipoxin-deficient mice is attributable to cytokine-mediated tissue damage, despite better parasite control. corroborating this, increased histological severity of meningitis and encephalitis was observed in the transgenic mice. administration of a lipoxin analogue rescued the lipoxin-deficient mice from this fatal phenotype and lowered il-12 and ifn-c levels (to wild-type levels in the case of ifn-c). interleukin-12, produced by antigen-presenting cells such as dendritic cells, has an important role in host control of intracellular pathogens such as t. gondii and viruses, but in excess can cause immunopathology. in mice, it has been shown that lipoxin a4 analogues suppress il-12 production by dendritic cells stimulated with t. gondii extract. 22 although this may be a host-driven response to curb excessive inflammation, induction of lipoxin production could be a strategy adopted by pathogens to modulate host immunity and perhaps facilitate chronic infection by reducing tissue damage. the contrasting roles of lipoxins in these two models of infection may relate to the dynamics of the specific pathogen-host interactions. toxoplasma gondii replicates more quickly than m. tuberculosis and the risk of excessive inflammation and ensuing immunopathology may therefore be greater. 19 by preventing this, lipoxins are beneficial to the host, and so enhance survival. mycobacterium tuberculosis induces a weaker t helper 1 cell response in mice than t. gondii and replicates more slowly, therefore the enhanced inflammatory response seen in the lipoxin-deficient mice may be advantageous, by 'topping-up' existing host control. the reduced tissue damage seen in lipoxin-deficient mice may be a result of better control of m. tuberculosis replication. it is also important to note that the local (lung versus peritoneum/ brain) biosynthesis and actions of lipoxin may differ between these two infection models and could provide an alternative explanation for the different outcomes observed. in a mouse model of trypanosoma cruzi infection, it was found that the administration of aspirin (acetylsalicylic acid) at doses of 25 or 50 mg/kg increased survival and decreased peak parasitaemia, whereas higher or lower doses had no effect. 23 the aspirin-triggered lipoxin, 15epi-lipoxin a4, was found to be increased by administration of aspirin in both in vitro and in vivo models of infection, with infection alone also increasing 15-epi-lipoxin a4 levels. exogenous administration of 15-epi-lipoxin a4 was found to decrease parasitaemia peaks and decrease cardiac inflammation and increase survival. the authors therefore hypothesized that the beneficial effect of aspirin on infected mice was a result of the production of 15-epi-lipoxin a4. this may represent a new therapeutic strategy in the acute phase of chagas disease. wild-type and 5-lipoxygenase-deficient mice were infected with plasmodium berghei-anka in a model of cerebral malaria. 24 wild-type mice enjoyed significantly increased survival in comparison to 5-lipoxygenase-deficient mice. levels of parasitaemia were similar between groups, but lipoxin-deficient mice had an increased cerebral parasite burden after 5 days despite reduced cerebral inflammation and less cd8 + ifn-c + t cells in brain tissue. the lipoxin-deficient mice were found to have higher serum levels of il-12 and ifn-c, both of which are associated with the pathogenesis of murine cerebral malaria. significantly, treatment with 15-epi-lipoxin a4 significantly prolonged survival in both wild-type and lipoxindeficient mice, as well as reducing expression of il-12 and ifn-c in the brain. the mortality rate did not differ significantly if lipoxin was administered on the day of infection or 3 days later. lipoxin therefore appears to increase host survival in a mouse model of cerebral malaria by limiting inflammation, not by enhancing control of parasite levels. serhan and co-workers used a rabbit model of periodontitis to investigate the effects of lipoxin in this infection. 25 the application of a dental ligature plus porphyromonas gingivalis resulted in soft tissue loss, histological (leucocyte infiltrates) and radiological (bone loss) features of periodontitis in wild-type rabbits. the authors then used a transgenic rabbit that over-expresses the enzyme 15-lipoxygenase, resulting in threefold to fourfold increased lipoxin production. in these transgenic animals, following the same procedure to establish periodontitis, none of the clinical, histological or radiographic features were found. in the wild-type animals, bone loss could be prevented by the administration of intravenous metronidazole, confirming that p. gingivalis infection was responsible for the features seen. wild-type rabbits subject to periodontitis induction were then administered a topical lipoxin analogue and this protected the animals from gross soft tissue destruction, leucocyte accumulation and bone loss. periodontitis is an infectious disease, though the tissue damage characteristic of the condition is thought to be driven by an aberrant host response to infection. 26 in this set of experiments, serhan et al. demonstrate that lipoxin has a role in curbing this excessive response and that this has a protective effect in vivo. by performing transcriptional profiling of model epithelial cells exposed to lipoxin, canny et al. 27 found that lipoxin up-regulated the expression of bactericidal/perme-ability-increasing protein (bpi). bpi is an innate immune defence molecule that is active against gram negative bacteria, through bactericidal effects on bacterial cell membranes, neutralization of lipopolysaccharide and as an opsonin. this was then confirmed in four other epithelial cell lines (okf6, t84, caco2 and pulmonary epithelial cells a549). building on the known bactericidal effect of epithelium-derived bpi on gram-negative bacteria, the authors sought to examine the effect of lipoxin on epithelial killing of salmonella typhimurium. epithelial cell culture was pre-exposed to lipoxin analogue and then incubated with s. typhimurium. this resulted in concentration-dependent increased bacterial killing compared with non-pre-treated cultures. this enhanced bactericidal activity could be significantly inhibited by the addition of anti-bpi, indicating that induction of bpi was largely responsible for this lipoxin-mediated enhanced killing of s. typhimurium. interestingly, in a mouse model of (noninfectious) dextran sodium-sulphate-induced colitis, oral administration of lipoxin analogue reduced weight loss, passage of blood per rectum and mortality, affirming its role in gastrointestinal mucosal inflammatory conditions. 28 caecal ligation and puncture in mice establishes microbial sepsis that is considered similar to the pathophysiology of sepsis in humans. 29 in this model, in comparison to a control treatment, intravenous administration of resolvin d2 reduced the viable bacterial load in blood and peritoneal exudates (in the absence of direct antibacterial effects) and reduced neutrophil migration into the peritoneal cavity. in addition, histological evidence was seen of enhanced phagocytosis of bacteria in inguinal lymph nodes and in vitro, incubation with resolvin d2 enhanced zymosan phagocytosis by macrophages obtained from the peritoneum of resolvin-naive mice. when incubated with resolvin d2, human neutrophils demonstrated enhanced phagocytosis of escherichia coli and also increased intracellular production of reactive oxygen species. furthermore, plasma levels of pro-inflammatory cytokines (il-6, il-1b, il-23 and tnf-a) were reduced in resolvin d2treated mice. importantly, the effect of these pro-resolution actions of resolvin was to increase survival from sepsis in this mouse model. chiang et al. 30 investigated the effects of resolvin using a mouse model of e. coli peritonitis, involving intraperitoneal inoculation of e. coli. they found that the intraperitoneal administration of resolvin d5 enhanced phagocytosis of bacteria in comparison to mice inoculated with e. coli without resolvin. resolvin d1 had a similar but smaller effect. administration of resolvin (d1 or d5) was also associated with a significantly lower titre of viable bacteria in the blood and peritoneal exudate, as well as a lesser degree of hypothermia. importantly, resolvin d1 increased survival in this model. as for the model of microbial sepsis discussed previously, plasma levels of pro-inflammatory cytokines (including tnf-a and il-1b) were reduced by resolvin administration. interestingly, it was found that resolvin d1 enhanced the antimicrobial effect of ciprofloxacin in resolving e. coli peritonitis. when given in combination, resolvin and ciprofloxacin had an additive effect on reducing the 'resolution interval' (time from maximum concentration of peritoneal leucocytes to 50%), greater than either agent given alone. in addition, the combined administration of ciprofloxacin and resolvin d1 resulted in lower titres of viable bacteria in blood and peritoneal exudate, and enhanced macrophage phagocytic activity (not seen with either agent alone). the effect of reducing bacterial titres was still seen even when ciprofloxacin was administered at sub-optimal concentrations with a cocktail of resolvin d1, d5 and protectin d1. in staphylococcus aureus skin infection, using mouse dorsal skin pouches, resolvins d1 and d5 plus protectin d1, when administered with vancomycin (at a sub-optimal concentration) into the pouch, enhanced the clearance of bacteria, resulting in lower viable bacterial titres in pouch exudate and reduced neutrophil infiltration. this effect was also seen when either resolvin or vancomycin was administered alone, but again, an enhanced effect was seen when both were given together. infection secondary to burns is an important clinical problem and burns-related sepsis is responsible for significant mortality in burns patients. using a rat model of burn injury, kurihara et al. 31 demonstrated that neutrophils isolated from burned rats were impaired in their ability to migrate towards a chemoattractant. this defect in neutrophil chemotaxis could result in an inability of neutrophils in burns patients to successfully reach and kill infectious agents. as a consequence, these 'lost' neutrophils activated by the burn injury may accumulate and initiate tissue damage inappropriately in healthy tissues. by administering resolvin d2 to the burned rats, kurihara et al. found that neutrophil chemotaxis was restored to almost normal. when burned rats received intravenous lipopolysaccharide 9 days after their burn injury, pretreatment with intravenous resolvin d2 improved survival significantly. similarly, resolvin d2 pre-treatment increased survival following caecal ligation after burns injury. a shorter duration of resolvin treatment that was insufficient to normalize neutrophil chemotaxis did not significantly improve survival in these two models of burns-related sepsis. therefore, this study suggests that administering resolvin d2 could improve outcomes in burns-related sepsis by modulating neutrophil chemotaxis. the role of resolvin e1 in bacterial pneumonia and acute lung injury was investigated using a mouse model of aspiration pneumonia. 32 mice were administered hydrochloric acid followed by e. coli into a lung. resolvin e1, when given intravenously before this insult, reduced pulmonary neutrophil infiltration, enhanced bacterial clearance and decreased levels of pro-inflammatory cytokines (including il-1b and il-6) present in lung tissue homogenates. importantly, mice administered resolvin e1 enjoyed increased survival (100% at 3 days, in comparison to 50% when only 0á9% saline was administered). neutrophil apoptosis is known to be a critical event in the resolution of pulmonary inflammation, and suppression of this process is thought to contribute to the pathology seen in acute respiratory distress syndrome and sepsis. in a case-control cohort study of 121 intensive therapy unit patients with or without sepsis, the level of neutrophil apoptosis in peripheral venous blood was found to inversely correlate with the severity of sepsis. 33 the role of resolvin e1 in this process has been investigated in mouse models of acute lung injury, including an e. coli pneumonia model and an e. coli peritonitis-associated acute lung injury model. 34 six hours after intra-tracheal instillation of e. coli (pneumonia model), intraperitoneal administration of resolvin e1 enhanced the resolution of e. coli-evoked pneumonia in this mouse model. in contrast to the control group, mice administered resolvin had lower bronchoalveolar lavage neutrophil counts, higher monocyte/macrophage counts, increased neutrophil apoptosis, reduced bronchoalveolar lavage il-6 levels and less severe pulmonary inflammation when assessed histologically. when a pan-caspase inhibitor was also added intraperitoneally, these pro-resolution effects of resolvin were abrogated, suggesting that neutrophil apoptosis plays a critical role here. in the e. coli peritonitis-associated acute lung injury model, intraperitoneal administration of resolvin e1 also reduced bronchoalveolar lavage neutrophil counts and il-6 levels, increased neutrophil apoptosis and reduced the histological severity of pneumonia as well as lung myeloperoxidase content (where myeloperoxidase is used as a marker of neutrophil activity). importantly, resolvin administration reduced 6 hr mortality from 70% to 30% in this model. in terms of a possible mechanism for increased neutrophil apoptosis, in vitro, resolvin e1 mitigates cellular survival signals generated in response to a number of stimuli relevant to the pathogenesis of acute lung injury in e. coli pneumonia and sepsis (neutrophil myeloperoxidase, serum amyloid a and bacterial cpg dna). similarly, 15epi-lipoxin a4 also has a pro-apoptotic effect on human neutrophils and in a mouse model of e. coli sepsisinduced lung injury, intravenous lipoxin reduced bronchoalveolar lavage neutrophil counts and increased caspase-mediated neutrophil apoptosis. 35 as discussed, although inflammation is an essential response to infection, an excessive response is detrimental and stromal keratitis demonstrates this. it is an inflammatory lesion of the cornea that is a sequela of ocular herpes simplex virus infection, usually appearing 1 week after primary infection. importantly, when stromal keratitis manifests, replicating virus cannot be detected; therefore the initiating virus has been cleared and the disease is a consequence of non-resolving excessive inflammation. in mice, ocular herpes simplex virus infection is a model of stromal keratitis in humans. topical administration of resolvin e1 was able to control the immunopathological manifestations of ocular herpes simplex virus and reduce the severity of stromal keratitis lesions. 36 the influx of cd4 + t cells and neutrophils was reduced, as were corneal levels of pro-inflammatory cytokines known to be involved in the pathogenesis of stromal keratitis. levels of the anti-inflammatory cytokine il-10 were increased. through a screen of the effect of a range of lipid mediators on the replication of h1n1 influenza a virus in human lung epithelial cells, protectin d1 was found to significantly reduce viral replication in vitro. 37 in a model of human severe influenza, virus was introduced through the intratracheal route in mice and protectin d1 levels were found to be reduced, suggesting that endogenous production was suppressed by the virus. when other influenza a virus strains were tested, the reduction in protectin levels was found to inversely correlate with the virulence of the virus strain used. in this same model of severe influenza, intravenous administration of protectin increased survival. administration of resolvin and lipoxin had no effect. significantly, the protective effect of protectin was still seen when administered 2 days after the start of infection. lipoxins, resolvins and protectins are endogenous lipid mediators with a pro-resolution effect in inflammation. much work has focused on their now well-recognized role in allergic airway inflammation. 38 however, an emerging theme is their importance in the resolution of infection and associated inflammation, and this article has reviewed emerging data relevant to this. table 1 summarizes what has been learnt from animal studies. the role of lipoxins may vary depending on the specific infection. in a mouse model of m. tuberculosis infection, transgenic mice unable to produce lipoxin were able to control the bacteria better with reduced mortality in comparison to wild-type, and expressed il-12, ifn-c and inducible nitric oxide synthase 2 at higher levels. in contrast, using the same transgenic mice in t. gondii infection, mortality was higher despite a lower parasitic burden and this was attributed to excessive cytokine-mediated tissue damage. beneficial effects were also seen in a mouse model of trypanosoma cruzi infection and cerebral malaria. topical lipoxin abrogated the tissue and bone damage seen in a rabbit model of p. gingivalis periodontitis. therefore, the proresolution effects of lipoxin may be advantageous in protecting the host from the damaging effect of excessive inflammation, but this benefit may be out-weighed in some situations by permitting unchecked pathogen replication (as seen in the model of m. tuberculosis). the finding that administration of lipoxin enhances survival in a mouse model of cerebral malaria suggests a potential new therapeutic strategy for human cerebral malaria. the effects of resolvin were investigated in a number of mouse models of systemic bacterial infection, and were found to enhance phagocytic clearance of bacteria, reduce neutrophil influx and inflammation severity, promote neutrophil apoptosis and clearance, modulate neutrophil chemotaxis and importantly, reduce mortality. interestingly, resolvin administration also enhanced the antibacterial effect of ciprofloxacin (in e. coli peritonitis) and vancomycin (in staphylococcus aureus skin infection) when the antimicrobial was administered at a sub-optimal concentration. topical resolvin application also reduced the severity of herpes simplex virus ocular infection in mice. finally, protectin was found to increase survival in a mouse model of severe influenza, even when administered 2 days after infection. given the well-recognized importance of these mediators in allergic airway inflammation, it is interesting to consider how their regulation may be disturbed in states of airway inflammation induced by infection, for examples acute respiratory distress syndrome. notably, pulmonary production of protectin was found to be suppressed by highly pathogenic influenza a strains. 37 evidence from cilloniz et al. 12 suggests that lipoxin-mediated activity is also altered during influenza a virus infection. disturbed lipoxin regulation could have a role in the predisposition towards asthma seen in infants following rsv bronchiolitis, 39, 40 especially when considering the finding that mice unable to synthesize lipoxin fail to elicit alternative macrophage differentiation, required for the resolution of rsv disease. 15, 16 if the beneficial effects of these mediators translate from pre-clinical studies into clinical trials, they represent promising new strategies in the management of infectious disease. the pro-resolution, anti-inflammatory and antimicrobial-enhancing effects of resolvins, protectin and possibly lipoxins make these appealing candidates for further study in humans. from a therapeutic perspective it is important to note that these pro-resolution mediators enjoy a substantial advantage over steroids for use in the treatment of infectious inflammation, or other systemic inflammatory states, as they are not immunosuppressive agents. 'aspirin-triggered' lipoxins and resolvins share the pro-resolution effects of lipoxin a4 and resolvin d1, respectively, and act by the same intracellular pathways. 11, 14, 41 this effect is unique to aspirin, and is not shared with non-steroidal anti-inflammatory drugs, which do not trigger the biosynthesis of these mediators. due to its ability to trigger the production of these pro-resolution mediators there may be a new role for aspirin in managing the inflammatory sequelae of infectious disease. the authors declare that they have no competing interests. the acute respiratory distress syndrome molecular circuits of resolution: formation and actions of resolvins and protectins resolvin e1 and protectin d1 activate inflammation-resolution programmes lipoxin biosynthesis and its impact in inflammatory and vascular events lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals anti-inflammatory actions of neuroprotectin d1/protectin d1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin a(4) resolvin e1 regulates interleukin 23, interferon-c and lipoxin a4 to promote the resolution of allergic airway inflammation protectin d1 is generated in asthma and dampens airway inflammation and hyperresponsiveness resolvin d1 and aspirin-triggered resolvin d1 promote resolution of allergic airways responses lethal dissemination of h5n1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection emergence and pandemic potential of swine-origin h1n1 influenza virus antiinflammatory actions of lipoxin a4 and aspirin-triggered lipoxin are socs-2 dependent role of the lipoxygenase pathway in rsv-induced alternatively activated macrophages leading to resolution of lung pathology control of rsv-induced lung injury by alternatively activated macrophages is il-4ra-, tlr4-, and ifn-b-dependent elevated formation of lipoxins in viral antibody-positive rat alveolar macrophages cytokines and arachidonic metabolites produced during human immunodeficiency virus (hiv)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of hiv disease host control of mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production identification of nitric oxide synthase as a protective locus against tuberculosis parasite-induced lipoxin a4 is an endogenous regulator of il-12 production and immunopathology in toxoplasma gondii infection lipoxin-mediated inhibition of il-12 production by dcs: a mechanism for regulation of microbial immunity protective role of acetylsalicylic acid in experimental trypanosoma cruzi infection: evidence of a 15-epi-lipoxin a₄-mediated effect lipoxin a₄ and 15-epi-lipoxin a₄ protect against experimental cerebral malaria by inhibiting il-12/ ifn-c in the brain reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases lipid mediator-induced expression of bactericidal/permeability-increasing protein (bpi) in human mucosal epithelia lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis resolvin d2 is a potent regulator of leukocytes and controls microbial sepsis infection regulates pro-resolving mediators that lower antibiotic requirements resolvin d2 restores neutrophil directionality and improves survival after burns the anti-inflammatory and proresolving mediator resolvin e1 protects mice from bacterial pneumonia and acute lung injury neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome resolvin e1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation 15-epi-lipoxin a4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin e1 the lipid mediator protectin d1 inhibits influenza virus replication and improves severe influenza resolvins: natural agonists for resolution of pulmonary inflammation severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13 respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years lipoxin (lx) a4 and aspirin-triggered 15-epi-lxa4 inhibit tumor necrosis factor 1a-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis key: cord-015569-vy49r1zd authors: nan title: abstracts from the 45(th) annual meeting of japanese association for the stusy of taste and smell (jasts 2011), kanazawa, japan, october 5-7(th), 2011 (the president of the meeting was dr. takaki miwa, kanazawa medical university) date: 2012-05-17 journal: chem senses doi: 10.1093/chemse/bjs052 sha: doc_id: 15569 cord_uid: vy49r1zd nan since umami taste receptors t1r1 and t1r3 have been identified, some reports revealed their structures and functions. umami taste receptors are member of g protein-coupled receptors, belonging to family c with long n-terminal extracellular domain. t1r1 and t1r3 percept umami taste as a heterodimer. we focused on leucine repeats of t1r1 and t1r3 in their transmembrane domains. we have reported the possibility of correlation between the food preference of animals and difference in the length of leucine repeats. poly leucine (polyl) is called homo polymeric amino acid, so called hpaa. it is reported that 1;2% of proteins in prokaryotic and eukaryotic organisms contain hpaas. it is also suggested that polyl could interact with each other more than with the other hpaas. some inherited diseases are caused by proteins in which hpaas such as polyq, polya are expanded to excessive length. activity of the protein containing hpaas is thought to be increased by expansion of hpaas, but with expansion of more than the threshold, activity of the protein is suddenly decreased. hpaas are one of the structures to be seen frequently. it is suggested that hpaas are important structures for some proteins to function. on the other hand normal function of hpaas remains unclear. from the above point of view, polyl might affect interaction of umami taste receptor t1r1 and t1r3. we also hypothesize polyl play an important role in the perception of umami. some odorant receptors also have the similar polyl structure, suggesting that under the hydrophobic condition some proteins are dimerized by interactions between leucine repeats. we named a leucine hpaas motif for protein-protein interaction as ''leucine glue.'' we are discussing the effect of polyl on protein-protein interaction by using split gfp assay. #3 comparative analysis of the umami receptor gene, t1r1 from cetaceans t1r1 and t1r3 are known to act as umami receptor. they are member of g protein-coupled receptors (gpcr) and have seven transmembrane domains. in 2010, it has been reported that the t1r1 gene of giant panda has frameshift mutation, resulting in inactivation of umami receptor. originally, they are used to be a carnivorous animal. it is suggested that the mutation of the t1r1 gene might be associated with their current food preference. we have already analyzed genomic sequences of the t1r1 genes from two different dolphins; lagenorhynchus obliquidens and tursiops truncatus. the results strongly suggested that umami receptor genes, t1r1 from both cetaceans are not functional, because frameshift mutations occurred in their coding sequences. nonsense codon caused by these framshift mutations appeared on their downstream region. in this study, we have also cloned two more t1r1 genes from cetaceans, balaenoptera acutorostrata and balaenoptera physalus. both the t1r1 genes had frameshift mutation and various mutations in their coding sequences. in addition, we have also cloned two more t1r1 genes from cetaceans, b. acutorostrata and b. physalus. both the t1r1 genes had frameshift mutations and various mutations in their coding sequences as well as dolphins described above. especially, in one allele from both b. acutorostrata and b. physalus, we found point mutiations at start codon atg which is a to g substitution, resulting in gtg. by this mutation, t1r1 could not be translated. cell-based expression studies have shown that mammalian t1r1 and t1r3 g-protein coupled receptors combine to form a broadly tuned l-amino-acid receptor. however, contradictory data in t1r3 knockout (ko) mouse models have been reported on taste nerve responsiveness. one study showed that taste nerve responses to amino acid stimuli in t1r3-ko mice were totally abolished. the other reported reduced but not abolished responses to glutamate in t1r3-ko mice. in the present study, we have tried to recharacterize the role of t1r3 for the taste nerve responses to amino acids using a wide variety of taste stimuli. we have recorded from whole-nerve chorda tympani nerve responses from t1r3-ko mice to lingual application of various amino acid stimuli including sweet-and umami-tasting amino acids. whole-nerve recordings of chorda tympani nerve in t1r3-ko mice showed robust responses to all the tested amino acids. comparing to those from c57bl/6 wild-type mice, only small reductions of responses to glycine and l-alanine, but no reduction in responses to l-proline, l-serine, l-glutamine and l-glutamate salts have been observed. these results suggest that t1r3 mediated receptor system may play limited role for detection of amino acids. type iii taste cells play to act to receive sour taste and also to act as ''taste integration cell'' to transmit taste information from type ii taste cells through atp. but, it is not known whether a type iii taste cell has both roles and whether two kinds of type iii taste cells share each role separately. using calcium imaging and immunocytochemistry, we revealed that atp activates type ii and iii taste cells and hcl activates type iii taste cells, and also that hcl and atp activate separate subpopulations of taste cells. we also showed that sour-responding taste cells do not have p2x 2 and p2y 1 as atp receptors in taste buds. moreover, we carried out double cell staining of mice circumvallate papillae using antibodies to atp receptor (p2x 2 , p2x 3 and p2y 1 ) and sour taste receptor (pkd2l1) using an antibody to type ii taste cell marker (plcb2) and type iii taste cell marker (pgp9.5). it was shown that p2x 2 and p2x 3 are expressed in taste nerves, p2y 1 is in type ii taste cells, and pkd2l1 is in type iii taste cells. no taste cell was stained by both atp receptor and sour taste receptor. although we could not cover all the atp or sour taste receptors, these results suggest that there are the two separate subpopulations of type iii taste cells: the one sensing sour taste and the other accepting the atp released from type ii taste cells. #6 development of gustatory papillae in the absence of six1 and six4 six family genes encode homeobox transcription factors, and a deficiency in them leads to abnormal structures of the sensory organs. in a previous paper, six1 was reported to be expressed in the taste bud-bearing lingual papillae of mice, and loss of six1 affected the development of these gustatory papillae. we show here that embryos lacking both six1 and six4 revealed more severe abnormalities than those lacking six1 alone during morphogenesis of their gustatory papillae. by in situ hybridization, six4 was shown to be broadly distributed in the epithelium of the lateral lingual swellings at embryonic day (e) 11.5, and in the tongue epithelium, mesenchyme, and muscles at e12.5. from e14, six4 was similar in expression pattern to six1, as previously reported; and in the fungiform papillae, six4 was expressed in the epithelium at e14-e16.5. in the circumvallate and foliate papillae, six4 expression observed in the trench wall of these papillae at e15.5-p0. although six4-deficient mice had no abnormalities, six1/six4-deficient mice showed distinct morphological changes: fusion of the lateral lingual swellings was delayed, and the tongue was poorly developed. the primordia of fungiform papillae appeared earlier than those in the wild-type or six1-deficient mice, and the papillae rapidly increased in size; thus fusion of each papilla was evident. the circumvallate papillae showed severe defects; e.g., invagination of the trenches started asymmetrically, which resulted in longer and shorter trenches. the foliate papillae elevated initially, and showed stunted trenches. therefore, six1 and six4 function synergistically to form gustatory papillae during development of the tongue. the life span of taste cells was previously estimated as 10-14 days by labeling newly proliferated taste cells with radioactive 3 hthymidine or bromo-d-uridine (brdu) incorporated during dna synthesis. to re-evaluate this observed lifetime of taste bud cells, we repeated the analysis of lingual tissues of mice after incorporation of ethynyl-d-uridine (edu) instead of brdu, followed by detection of edu by a click reaction. we injected edu into adult mice and sacrificed them 1, 3, 5, 6, 10, 15, 20, 25, 30, 35, or 40 days later. the vallate papillae were fixed, cryo-sectioned, immunostained for plcb2 (a marker for type ii cells) and examined with a confocal laser scanning microscope with optical sectioning at 2 lm. taste buds were identified in dic images captured in parallel. numerous cells with brightly fluorescent nuclei (edu+ cells) appeared at day 1 near and within taste buds. the number of those cells declined rapidly toward day 10. however, among type ii cells, very few appeared to be edu+ at day 1. the number of edu+ type ii cells increased at day 3, showed a broad peak around day 10, and then declined. occasional edu+ type ii cells were still detected at day 40. because labeling of dna with edu is much faster, brighter and more consistent than with brdu, this method will be useful to study proliferating cells in taste buds. by combining edu labeling and immunstaining for approapriate markers, the longevity of taste cell types can be examined. adiponectin is a white adipose protein that plays important roles in glucose homeostasis and lipid metabolism and is involved in cell proliferation and differentiation. the function of adiponectin is mediated by its receptors (adipor1 and adipor2), which have different expression patterns. in the gustatory system, adiponectin is contained in the saliva; however, the function of adiponectin signaling in gustatory tissues has not been elucidated yet. therefore, we have examined the expression patterns of adipor1 and adipor2 in mouse gustatory tissues. reverse transcription polymerase chain reaction assays have revealed that adipor1 and adipor2 mrnas were expressed in the circumvallate papillae. using immunohistochemistry, the anti-adipor1 antibody labeled at the taste hairs in the fungiform, foliate and circumvallate papillae. double-labeling experiments have demonstrated an expression pattern of adipor1-positive cells in a subset of basal cells within the taste buds and extragemmal epithelium cells to marker proteins for taste cell types (including types i, ii, iii, and basal cells). for the marker proteins analyzed, only shh was co-expressed with adipor1 in a subset of basal cells within the taste buds in the circumvallate papillae. these results show that adipor1 at taste hairs in gustatory tissues may detect saliva adiponectin and may play a role in taste sensing in the taste buds. in addition, adipor1 may play a role in cell proliferation and differentiation for the shh and adipor1 expressing basal cells within the taste buds. mash1 is expressed in subsets of neuronal precursors in both the central nervous system and the peripheral nervous system. however, involvement of mash1 in taste bud cell differentiation remained to be demonstrated. in the present study, to begin to understand the mechanisms that regulate taste bud cell differentiation, we have investigated the role of mash1 in regulating taste bud cell differentiation using mash1 ko mice and forced expression of mash1 in lingual epithelial cells. in mash1 ko mice, aadc-ir cells are missing both in the mash1 mutant circumvallate papilla epithelium and in the taste buds of soft palate. in mash1 ko/gad67-gfp mice, gfp-positive cells (gad67 expressing type iii cells) are also missing in the taste buds of soft palate. on the other hand, gustducin, a type ii cell marker of taste bud, is expressed in soft palate taste buds in mash1 mutant mice. these results suggest that mash1 plays an important role for expression of aadc and gad67 in type iii cells in taste buds. taste receptor cells are epithelial in sense that they have a limited life span and therefore must be replaced to maintain the structure of the epithelium. therefore gustatory nerves need to make synapse with appropriate taste receptor cells. however, mechanism of recognition of taste receptor cells which express appropriate taste receptor is still unknown. the cadherin superfamily of cell-cell adhesion molecules controls a series of interactions that regulates synapse formation. in this study, in order to test whether the cadherins are required for formation of synapse between gustatory nerve fibers and taste receptor cells, we have investigated expression patterns of cadherin superfamily in the taste buds. #10 induction of type iii-like taste cells in threedimensional co-culture and analysis of excitability of clonal cell lines derived from murine taste buds we have collected taste buds from a tongue of a p53-deficient mouse and established clonal cell lines (tbd cell lines). each of tbd cell lines expresses gustducin and neural cell adhesion molecule (ncam), suggesting that tbd cell lines have characteristics of both type ii and type iii taste cells. to reveal whether tbd cell lines have excitability or not, we analyzed the expression pattern of voltage-dependent sodium channels in one of tbd cell lines, tbd-a5 cells and performed patch clamp recording. scn2a, scn3a, scn5a and scn9a genes coding voltage-dependent sodium channels were detected in tbd-a5 cells by rt-pcr. patch clamp recording revealed that tbd-a5 cells had tonic outward currents, but lacked transient inward currents. these results suggest that functional voltage-dependent sodium channels are not expressed in tbd-a5 cells. next, we tried to establish a culture model mimicking the lingual taste cells of the mouse. tbd cell lines were co-cultured with a lingual epithelial cell line (20a cell line) and a lingual mesenchymederived cell line (tmd cell line). tbd, 20a and tmd cell lines were maintained in a triple co-culture, in which tbd cells were preseeded as aggregates or in suspension on the collagen gel containing tmd cells and 20a cells were laid over the tbd cells. tbd cells in the triple co-culture expressed ncam, however gustducin was not immunohistochemically detected in tbd cells. this result suggests that tbd cells in the co-culture exhibited a characteristic of type iii taste cells. this triple co-culture model would be useful to study morphogenesis and functions of the gustatory organ. immunohistochemistry of taste-signaling molecules is useful for the distinction of taste-bud cell types. however, the optimal immunohistochemical detection depends on specimen-preparing conditions. therefore, this study aimed to examine differences in immunoreactivities under various tissue-preparing conditions in rat vallate taste buds for some typical markers of gustatory cells as follows: gustducin, type iii inositol triphosphate receptor (ip 3 r3), synaptobrevin-2 (vamp2), protein gene product 9.5 (pgp9.5), and neural cell adhesion molecule (ncam). staining patterns and intensities of immunoreactivities for these molecules varied according to tissue-preparing conditions, especially the fixation. confirming our previous finding, gustducin immunoreactivities were localized to the upper part of the taste bud called taste hairs in case of short fixation, but to the cell body cytoplasm excluding the taste hairs in case of long fixation. the specific immunostaining for ip 3 r3 was strong in short-time fixation. on the other hand, those for vamp2, pgp9.5, and ncam were intense in long-time fixation. the present data suggest that different experimental protocols cause the discrepancies in immunoreactivities for these markers. further investigations based on this study should provide important information on the classification of the gustatory cell type. #12 immunohistochemical localization of nk1 and vpac1 receptors in the frog fungiform papilla hiroshi ando 1 , osamu tadokoro 2 , naokazu asanuma 1 , mihoko tomida 1 , takami nakamura 1 and eiji kondo 2 1 department of oral physiology and 2 department of oral anatomy, matsumoto dental university, shiojiri 399-0781, japan although the presence of substance p (sp) immunoreactive (ir) nerve fibers and vasoactive intestinal peptide (vip)-ir nerve fibers has been reported in the frog fungiform papilla, the functional roles of these fibers remain to be elucidated. to clarify whether these sp-ir and vip-ir fibers play any efferent roles in the taste disc in the fungiform papilla, we immunohistochemically examined the existence of neurokinin 1 receptor (nk1r), which is also a sp receptor, and vip and pituitary adenylate cyclase activating hormone 1 receptor (vpac1r), which is also a vip receptor, in the fungiform papilla of the frog, rana catesbeiana. many nk1r-ir structures were observed in the taste disc. these were conical in shape in the middle layer of the taste disc and had a rod-like thin apical process toward the upper layer of the taste disc. double-labeling immunohistochemistry showed that only a few nk1r-ir structures were located adjacent to the sp-ir nerve fibers in the taste disc. vpac1r immunoreactivity was observed in the taste disc cells and the glossopharyngeal nerve bundle beneath the taste disc. vpac1r-ir cells in the taste disc had either a thin or thick apical process. vip-immunonegative nerves beneath the taste disc showed vpac1r-ir. vip-ir neuronal cell bodies colocalized vapc1r in the grossopharyngeal nerve bundle within the tongue.the presence of the nk1r and vpac1r in the taste disc suggests that sp-ir and vip-ir nerve fibers play efferent roles in the taste disc in the frog fungiform papilla. #13 cesium-permeable potassium channel in the rod cells of frog taste disc in animal cells, the resting membrane potential is maintained by random open-shut gating of a leaky potassium channel. frog taste disc cells display the resting membrane potential of about -50 mv. the magnitude is not consistent with the equilibrium potential of potassium (-90 mv). when internal potassium was replaced with cesium in whole-cell configuration, the rod cells in frog taste disc increased a parabolic outward current gradually and displayed the resting membrane potential of -49 â± 2 mv (n=23). the wing cells did not possess the outward current and displayed the resting potential of 5 â± 1 mv (n=41) in the condition of internal cesium solution. the replacement of external normal saline solution with cesium saline solution turned the parabolic outward current to the inward current. the inward current reversed at 2 â± 1 mv (n=10) which is close to the equilibrium potential of cesium (4 mv). several experiments on cationic replacement showed the permeability ratio of p k :p cs :p na :p nmdg =1.67:1.00:0.29:0.15. carbenoxolone (cbx, a blocker of pannexin) inhibited the parabolic outward current moderately (ic 50 , 26 lm). the dialysis of 20 lm arachidonic acid in internal cesium solution changed the parabolic outward current to the exponential one and depolarized the membrane potential by 15 mv. the results suggest that the outward cesium current in the frog rod cells may flow through a novel channel different from mammalian cesium-permeable potassium channel. capsaicin, which is the main component of chili pepper and has many physiological functions such as increasing perspiration and energy metabolism, has negative effect of its strong pungency. capsiate was identified from ã�ch-19 sweetã� (capsicum annuun l.), a non-pungent cultivar of red pepper. like capsaicin, capsiate is thought to enhance energy metabolism by activating the sympathetic nervous system. human sensory evaluation tests demonstrated that capsiate and that analogs (capsinoids) had very weak pungency compared with capsaicin and capsaicin analogs (capsaicinoids), and the difference of threshold level between capsinoids and capsaicinoids was about 1000-fold. however, the in vivo studies focused on the reception of them in oral cavity are few because the reception mechanism of hot taste is unclear, and the reason of weak pungency of capsinoids is not well understood. therefore, this study focuses on the reception of capsinoids and capsaicinoids in the oral cavity. firstly, we performed two-bottle preference tests using rats and confirmed that they began to avoid capsinoids at about 1000 times higher concentrations than that of capsaicinoids. in addition, we recorded the lingual trigeminal nerve responses to capsinoids and capsaicinoids and found that capsinoids induced little responses while capsaicinoids evoked apparent intensive responses. such differences were also found in immunohistochemical detection of p-erk in the trigeminal ganglion after stimulation of capsinoids and capsaicinoids. recent studies using animal models of binge eating shows that the accumbal dopaminergic neurotransmission is elevated in bingeing. it suggests that the experience of bingeing modifies the activity of midbrain dopaminergic neurons in the ventral tegmental area (vta). however, few evidences directly clarify whether the activity of the vta is elevated anticipatorily, that is, before receiving the oral (taste) and/or post-oral (viscerosensory) cues of palatable food. to address the issue, we explored possible changes in the activity of the vta neurons in mice bingeing on sugar by immunohistochemical detection of c-fos expression as a marker of neuronal activation. under food restriction, mice were subjected to a binge-type eating training for 10 days (day 1-10), in which their intake of sucrose solution gradually increased day by day, resulting in its overconsumption. on day 11, mice were deeply anesthetized and transcardially perfused with 4% paraformaldehyde before receiving the sugar exposure. brain sections including the ventral midbrain were immunohistochemically processed to detect the c-fos gene expression product, fos protein. the number of fos immunopositive neurons in the vta of trained mice was larger than that of untrained naã¯ve mice. the finding suggests that the activity of the vta is elevated anticipatorily before sugar exposure and contributes to the stimulation of the mesolimbic dopamine system, resulting in sugar bingeing. #16 activation of output neurons in the basolateral nucleus of the amygdala by a learned aversive taste: a manganese-enhanced mri study tadashi inui 1 , chizuko inui-yamamoto 2 , izumi ohzawa 3 , yoshichika yoshioka 4 and tsuyoshi shimura 1 1 grad. sch. human sci., osaka univ., suita, 565-0871, japan, 2 dept. oral anatomy, osaka dental univ., hirakata 573-1121, japan, 3 grad. sch. frontier biosci., osaka univ., suita 565-0871, japan and 4 immunology frontier research center, osaka university, suita the basolateral nucleus of the amygdala (bla) is known to play an important role in conditioned taste aversion (cta). anatomical studies have shown that the bla has reciprocal neural projections with many brain regions. it is still unclear, however, which connections are involved in the retrieval of cta. to elucidate the neural circuits for the retrieval of cta, we examined the enhancement of activity of the efferents from the bla by the presentation of learned aversive taste, using a manganese-enhanced mri technique. rats received a pairing of 5 mm saccharin with 0.15 m lithium chloride or saline (cta or sham group, respectively). on the test day, thirty min after an injection of 40 mm mncl 2 into the bla, rats were intraorally infused with saccharin. sixty min after the mncl 2 injection, we acquired triple t1-weighed mr images at hourly intervals. the signal intensities of mr images, which reflect the movements of manganese by the activated bla neurons, were measured. the cta group showed significant time-dependent increase of signal intensity in the cea than did the sham group, indicating that the retrieval of cta activates efferents from the bla to the cea. furthermore, the analyses based on the injection site of mncl 2 (rostral or caudal) demonstrated the larger movements of manganese toward the cea and cortices (insular and piriform) in the rostrally-injected cta group. therefore, the outputs of efferent neurons in the rostral part of the bla may be separated in two directions, medial (cea) and lateral (cortices). this work was supported by kakenhi (22700748). the 13 c isotope-labelled acetic acid breath test is a common clinical method to evaluate gastric emptying and is a non-invasive and repeatable method in rodents. however, the sensitivity of this test to detect changes in gastric emptying of liquid diet in mice has not been studied thoroughly. the present study aimed to validate this method by using bethanechol chloride, atropine sulfate, clonidine hydrochloride, cck-8s and phenylthiocarbamide. male c57bl-6j mice after overnight fasting were placed in the metabolic chamber. commercial liquid diet containing 13 c-acetic acid was used as the test meal. after intragastric administration of the test meal, the expired air was collected at 5-min intervals for four hours by a fully automated system. the 13 co 2 / 12 co 2 levels were measured by the mass spectrometer. the 13 co 2 excretion data were analyzed for calculation of gastric half excretion time (t 1/2 ) as the gastric emptying parameter. t-test was used for statistical analysis (p<0.05). bethanechol chloride decreased t 1/2 of liquid diet and atropine sulfate and clonidine hydrochloride increased t 1/2 . cck-8s increased t 1/2 and cck1 receptor antagonist, devazepide, attenuated the delay of gastric emptying by cck-8s. bitter tastant, phenylthiocarbamide increased t 1/2 . our study indicated that the 13 c-breath test was sensitive to detect difference in gastric emptying of liquid diet induced by pharmacological agents, hormones and tastants. we concluded that this technique could be used to determine the effect of physiological, pharmacological and nutritional intervention on the motility of the gastrointestinal tract. in oral surgery treatments, acrinol hydrate is often used as a disinfectant for oral membranes; however, there are few reports about the effect on taste nerve response to this disinfectant. in this study, we tested if tongue treatment with acrinol hydrate affects taste nerve responses in mice. the chorda tympani nerve responses of c57bl/6 mice to 5 basic taste stimuli before and after treatment with acrinol hydrate were recorded and compared. the results of the treatment with acrinol hydrate indicated that the chorda tympani nerve response to 0.5m sucrose was suppressed by 60%; however, there was no change in the responses to 0.1m nacl, 0.01m hcl, 0.02m quinine hydrochloride and 0.1m monopotassium glutamate. the suppression of the sucrose response by this treatment recovered within 1 minute after washing. these results suggest that acrinol hydrate has an ability to suppress sweet taste. some mints, such as peppermint, are used as flavoring substances for foods and toothpaste widely. however, it is not clear whether mints affect the taste receptor mechanisms or not. in the present study, therefore, the chorda tympani nerve responses to 5 basic tastes were compared before and after mixing with 3 types of mints, such as 0.18% peppermint, 0.18% spearmint and 0.10% menthol, in c57bl/6 mice. when spearmint was mixed with 0.5 m sucrose, 20 mm denatonium benzoate, 0.1 m monopotassium glutamate (mpg), 5 mm 5#-inositol monophosphate (imp) and the mixture of 0.1 m mpg and 5 mm imp (m+i), the neural responses to these stimuli were suppressed. but mixing of spearmint did not change the responses to 0.1 m nacl, 20 mm quinine-hydrochloride and 10 mm hcl. mixing of peppermint or menthol did not change any responses to all tested stimuli in the present study. these results suggest that spearmint may work as a suppressant for some kind of receptors for sweet, umami and bitter. the majority of the experiments for investigating gustatory information processing in the nucleus of the solitary tract (nst) have been performed using rats as experimental animals. although the importance of mice in this kind of study is widely recognized from the view point of recent, rapid advance in gene manipulation techniques, there are very few studies using mice in this academic field. also, it is desirable for physiological studies on neural mechanisms of taste perception to use awake, or at least, weakly anesthetized animals. therefore, in the present study we tried to establish an experimental model for in vivo recording of nst neurons in slightly anesthetized or awake mice. for this, we surgically fixed a head restraining holder to the mouse scull, which made it possible to place the mouse head precisely in a stereotaxic position repeatedly without pain. after the recovery from this surgery, the gustatory area in the nst was localized electrophysiologically under anesthesia. then, single neuron activity was recorded in this area under slight anesthesia, and responsiveness to 4 standard taste solutions (nacl, sucrose, citric acid and quinine hcl) was tested. as a result, 9 gustatory neurons were recorded; of these, 4, 4 and 1 neurons were classified into nacl-best, sucrose-best and citric acid-best, respectively. furthermore, we found that the mouse could be easily trained to lick taste stimuli with the head restrained in the stereotaxic device. these results indicate that the present method is applicable to the investigation of gustatory information processing in the nst of mice under a physiological condition. #21 comparison of preference between sucrose and sugar alcohols in c57bl/6 mice yoshihisa katagawa 3 , toshiaki yasuo 1 , keika gen 3 , takashi yamamoto 2 and noritaka sako 1 1 department of oral physiology, asahi university school of dentistry, mizuho 501-0296, japan, 2 department of health and nutrition, faculty of health science, kio university, nara 635-0832, japan and although sorbitol tended to be less preferred compared to palatinit. the present study suggests that the sugar alcohols are less palatable than that to common sugars, such as sucrose, in mice. #22 novel peptides, dryamide-1, dryamide-2: comparison in regulatory effects on feeding behavior of the blowfly phormia regina because the drosophila orphan receptor cg5811 is similar to the vertebrate neuropeptide y receptor, we screened its putative ligands and purified two novel peptides: dryamide-1 and -2. to investigate their function, we injected these peptides into the thorax of the blow fly, phormia regina, and observed the subsequent changes in feeding behavior and taste sensitivity to sucrose. the blow fly was used for technical reasons, to facilitate injection. before and after peptide injection, we measured 1) the sucrose intake as an indicator of appetite, 2) the proboscis extension reflex (per) as an indicator of feeding motivation, and 3) the electrophysiological response of the labellar contact chemosensilla to measure the magnitude of the gustatory input inducing per. there was no significant change in sucrose intake after injection. injecting both peptides depressed per and reduced the percentage of flies that performed per. the electrophysiological response of the labellar taste sensillum to sucrose seemed to decrease after injecting dryamide-1, but not dryamide-2. therefore, once feeding starts, these peptides might not limit the food intake of the fly. nevertheless, the results of the per test suggest that these peptides contribute to feeding initiation. together with other peptides that restrict food intake, dryamide-1 and -2 might contribute to the overall regulation of feeding behavior in phormia regina. #23 stand off effect between the noble bioactive peptide and appetitive odor on feeding behavior in blowfly we compared the behavioral effects of feeding suppression by the two kinds of new peptides (dryamide-1, 2) in blowfly. both of gustatory and olfactory systems are required to elicit appropriate motor pattern in feeding behavior. feeding behavior was also controlled by internal condition based on many bioactive peptides. proboscis extension response (per) is indicator of feeding behavior that is generally controlled by the chemical cues from the maxillary palps. the behavioral experiment showed that they detect palatable chemical signals increasing their appetite in blowfly, phormia regina. phormia usually have detected the appetite odor like mushroom (1-octen-3-ol) by maxillary palps. however, some kinds of newly found peptide have an effect on feeding behavior. therefore, we compared the effect of two kinds of newly found peptides in drosophila. first, we test whether they affect feeding behavior by the amount of sucrose intake. after injection of one kind of peptide, food intake amount was obviously increased. in the next step, we investigated the odor of 1octen-3-ol by maxillary palps did not work as appetitive odor when they are starved sufficiently in behavioral experiments. the results showed that these peptides work as the appetitesuppressant in blowfly feeding behavior, and it did worked as counteractant to odor stimulation. sodium-deficient animals ingest sodium chloride at concentrations normally rejected, and this motivated behavioral state is known as sodium appetite. for neural mechanisms of sodium appetite, there is a line of electrophysiological evidence in rats, whereas there is less evidence in mice. in order to develop a model for sodium appetite in mice, we examined the effects of repeated sodium depletion on salt intakes in c57bl/6j mice. adult male c57bl/6j mice (n=5, 8 weeks, 21-26 g at the beginning of the experiment) were used; each animal was housed individually in a metabolism cage during the experiment. a combination of furosemide injection with sodium-deficient diet was used to induce acute sodium deficiency. in 3 of the 5 mice, furosemide was injected in the 1st week and saline was injected in the 2nd week. in the remaining 2 mice, the injection order was reversed. this pattern was repeated 4 times over 2 months. after 24 hours following the injection, intakes of 0.3 m nacl and distilled water were measured. the furosemide injection shortened the latency of, and increased the amount of, 0.3 m nacl intake. furthermore, the increase in 0.3 m nacl intake was tended to be enhanced at later furosemide injections. both urine volume and 24-h urinary sodium excretion were greater after the furosemide injection than after the saline injection, but there were no significant differences of these measures across repeated depletions. these results show that present procedure reliably elicits sodium appetite in c57bl/ 6j mice, suggesting that this is a suitable experimental model of sodium appetite in mice. the sensations of taste and smell are the important determinants guiding preference for foods and fluids. the dried-bonito dashi is a traditional japanese fish broth that enhances palatability of various dishes due to its specific flavor. however, the scientific evidence why dried-bonito dashi is important for japanese dishes is little known. in general, the main stimulus is considered as inosinate (an umami substance) but the dashi is a complex mixture of many taste substances such as lactate (sour), histidine (bitter), sodium (salty) and other minerals (generally bitter) as well as macromolecules (proteins and peptides) and over 400 odorants. here we investigated mechanisms of preference for dried-bonito dashi using 48-h two-bottle choice tests in adult male sprague-dawley rats. we found that preference for dashi was influenced by current nutrition, i.e., ingestion of high fat or high sucrose diet suppressed preference for dashi. in addition, past experience/learning of dashi ingestion was the most important determinant that could overcome the influences of current nutrition. for example, preference of the threshold concentrations (0.4%) of dashi increased gradually during repeated exposure to dashi solution. after the repeated ingestion of dashi solution, ingestion of high fat or high sucrose diet has no influence on dashi preference. in the descending concentration series, the concentration-preference function shifted 100-fold to the lower concentrations compared with the ascending one. these results suggested that postingestive consequences as well as oronasal sensations guide the preference for dashi solutions that are under the control of current nutrition and past experience/learning. food aversion learning is the long-term memory established after association of the properties of food, such as texture and taste (conditioned stimulus, cs), with visceral malaise (unconditioned stimulus, us). after the acquisition of the learning, the re-exposure to the cs induces the retrieval of the memory and the rejection of the cs occurs. previously, we showed that histamine release in the central nucleus of amygdala (cea) during the re-exposure to the cs was increased in soft pellets-conditioned rats, but not in sweet pellets-conditioned rats. in the present study, we studied the role of the histaminergic transmission in the cea in the retrieval of food aversion learning induced by two patterns of the cs. fos expression, a marker of neuronal activation, following the retrieval of food aversion learning induced by each cs (soft pellets or sweet pellets) and us pairing was examined. few fos-positive cells in the cea were observed by consuming both types of pellets in naã¯ve rats. in the conditioned rats, fos expression in the cea was increased in response to the re-exposure to soft pellets while it was not elevated by the re-exposure to sweet pellets. in addition, the microinjection of h 1 -antagonist to the bilateral cea just before the re-exposure to the cs impaired the aversive response to soft pellets but not to sweet pellets. these findings indicate that the neuronal activation through the histaminergic system via h 1 receptor is involved in the retrieval of texture aversion learning but not in that of taste aversion learning. #27 food entrained feeding behavior to highly sweet food in non-food deprived mice yasunobu yasoshima, megumi tanibuchi and tsuyoshi shimura division of behavioral physiology, department of behavioral sciences, graduate school of human sciences, osaka university, suita 565-0871, japan light-regulated circadian clock in each animal species affects its original feeding rhythm. nocturnal rodents mainly consume food during the dark phase under ad libitum food condition; however, their daily feeding rhythm is entrained to mealtime when they are restricted of food. food-entrainment is suggested to be mediated by increased arousal and food-oriented motivation derived from calorie deficiency, but recent studies indicate that taste palatability seems to be important in food-entrainment. however, the role of taste palatability (hedonic aspect of taste) in food-entrainment remains not fully understood. to study the issue, we developed a new, simple mouse model. ad libitum-fed c57bl/6j male mice received daily limited access to highly sweet chow (hsc) containing 65% sucrose for 2 hours in the light phase (9:00-11:00 a.m.). they received the regimen for 14 days as training. the intake of hsc gradually increased and was about 11-fold greater than their basal intake of normal chow at the corresponding period of time during pretraining phase. on the other hand, the intake of normal chow in another group during the corresponding timing did not increase. intake of normal chow during the dark phase in mice group receiving hsc, but not normal chow, significantly decreased during the training. the entrained increase of hsc intake was also observed in genetically hyperphagic strain, db/db (leptin receptor gene deficiency) mice. these results suggest that taste palatability and/or hedonics of sweeten food play a role in shifting of daily feeding rhythm. #28 sexual difference of gene expression of androgen receptor in the brain region related to extinction memory after conditioned taste aversion learning in immature mice mice acquire the conditioned taste aversion memory (ctam) by application of the conditioned stimulus (cs) such as a novel taste, sodium saccharin (sac), followed by the unconditioned stimulus (us) such as an malaise induced by an i.p. injection of licl. after conditioned taste aversion (cta) learning, the extinction of ctam is induced by repeated presentations of cs without us. recent studies have demonstrated that the extinction is a process of relearning, where mice acquire the extinction memory of cta. we have reported that the sexually mature male mice (c57bl/6) represented significantly higher retention of extinction memory (rem) than sexually immature male mice. in contrast, the significant difference was not observed in female mice. we have also reported that chronical administration of androgen into castrated mice during prematuration period results in an enhancement of rem in both sexes. here we investigated whether the sex difference of the gene expression of androgen receptor (ar) is observed in the ventral medial prefrontal cortex (vmpfc) and amygdala between sexually immature and mature mice by real-time pcr. the sexually immature male mice presented significantly higher level of ar gene in vmpfc and amygdala than the sexually mature male mice. however, there was no such difference in vmpfc and amygdala of the female mice. these results suggest that the sex difference in maturation process of rem is induced by androgen acting on vmpfc and amygdala during sexual prematuration period in mice. our previous study showed that weanling rats acquired conditioned flavor preference when the flavor was associated with low concentration of sucrose; while flavor aversion when associated with high concentration. the present study aims to confirm and extend this finding with various concentrations of sucrose. wister male 3-week-old rats were used. half of the rats received unsweetened grape-flavored water on odd-numbered days and sweetened (sucrose) cherry-flavored solution on even-numbered days. the remaining rats received sweetened grape-flavored solution on odd-numbered days and unsweetened cherry-flavored water on even-numbered days. during the acquisition session, the liquid was presented to each rat for 15 min daily across 6 consecutive days. in the following test session, each rat was presented with unsweetened cherry-and grape-flavored water simultaneously for 15 min daily across 4 consecutive days. the rats showed a significant preference for the flavor associated with 2% or 10% sucrose, but showed a significant aversion to the flavor associated with 30% sucrose, suggesting a hedonic shift from positive to negative with increasing the concentration. the association learning acquired at the age of 3 weeks was preserved when retested at the age of 20 weeks. short-term (5 min) drinking test showed that the volume of intake was significantly smaller for 30% than for 2% and 20% sucrose, indicating that 30% sucrose is aversive because of its oropharyngeal sensation rather than its post-ingestive effects. the present study suggests that weanling experience of food is important in the formation of feeding behavior in adulthood. tastes play important roles in detecting nutrients and irritant materials in food. preference for food tastes is critical for ingestive behavior because greater palatability is to evoke greater food intake. animals generally prefer sweetness but not bitterness. such taste preferences are known to be affected by aging which causes changes in the dietary and energy requirements. however, the mechanisms of shift in taste preference by aging still remain unclear. therefore, to elucidate differences in taste preference among the life stages, we measured the amount of intake of taste solutions by the two bottle test. we used juvenile (3-6 weeks), young-adult (8-11 weeks), adult (17-20 weeks), and middle-aged (34-37 weeks) sprague-dawley male rats. all rats were fed ad libitum during all tests. we used 0.1 m or 0.3 m nacl, 0.01 m or 0.1 m hcl, 0.3 m or 0.5 m sucrose, 5 mm saccharin-na, 3â·10 -4 m or 3â·10 -5 m quinine-hcl, and 0.1 m monosodium glutamate (msg). the preference ratio for 0.5 m sucrose and 0.1 m msg in middle-aged group was lower than that in juvenile and young-adult groups. on the other hand, the preference ratio for 3â·10 -5 m quinine-hcl in middle-aged group was higher than that in juvenile and young-adult groups. there were no significant differences in the preference for hcl and nacl tastes among groups. these results suggest that aging affects taste preferences for sucrose, msg and quinine-hcl which represent sweet, umami and bitter tastes, respectively, in humans. we investigated the effects of furanones as the maillard reaction products flavors on umami and sweet taste preferences in mice. 5-dimethyl-3-hydroxy-2,5-dihydrofuran-2-one; sotolon and 4-hydroxy-2,5-dimethyl-3(2h)-furanone; furaneol (food-grade certified products, safc supply solutions, usa) were chosen as the maillard-borne odorants. in the short time two-bottle tests, 0.001, 0.003, 0.03, 0.1 lg/kg sotolon flavored umami solutions containing 10 mm monosodium glutamate (msg) and sweet solutions containing 1 mm saccharin were significantly consumed more than distilled water. sotolon tended to enhance umami and sweet taste preference in a dose dependant manner. whereas there were no differences of intakes between sotolon flavored water and distilled water. in addition, furaneol and citral flavor agents did not enhance umami solution preferences. these results suggested that sotolon, one of the maillard reaction products, induced enhancement of umami and sweet taste preference in mice. supported by society for research on umami taste and kakenhi (22780127). zinc is one of the essential trace elements and its deficiency causes anorexia, growth retardation, and taste disorder. insulin in pancreatic beta-cells is known to be stored as microcrystals of the zinc-containing hexamer, and zinc is thought to be fundamentally important for assembly and release of insulin from beta-cells. however, the effect of dietary zinc on food intake or insulin secretion of model rats of diabetes has not been well elucidated. in this study, we followed the levels of food intake and insulin secretion in type 2 diabetes model gk (goto-kakizaki) rats fed on diets containing different levels of dietary zinc for 27 weeks. all the experimental rats were divided into four experimental groups of zinc-deficient (zn-def, rats fed on 2.2 mg/kg diet), zinc-sufficient (zn-suf, rats fed on 33.7 mg/kg diet), high-zinc (high-zn, rats fed on 67.4 mg/kg diet), and pair-fed (rats fed on zinc-sufficient diet with the same amount of diet consumed by zn-def one day later). food intake in zn-def gk rats followed typical cyclic-pattern seen with normal rats such as sd rats. plasma zinc concentrations and plasma insulin concentrations were found to have positive correlations in high-zn rats. orexins are neuropeptides synthesized mainly in the lateral hypothalamic area and are implicated in the regulation of food intake in addition to arousal. since swallowing is early step of feeding behavior, orexins might modify swallowing. in the present study, we examined the effects of orexins on the reflex swallowing using anaesthetized rats. orexin, which was dissolved in ringerã�s solution, was administered into the fourth ventricle. orexin-1 receptor antagonist (sb334867), which was dissolved in dimethyl sulfoxide, was administered into the fourth ventricle. three ll of drugs were administered using a microsyringe. swallowing was induced by the electrical stimulation (20 hz, 20 sec) of the central cut end of the superior laryngeal nerve (sln) and was monitored by recording the electromyogram of the mylohyoideus muscle. the frequency of swallowing during the electrical stimulation of the sln decreased after the administration of orexin-a in a dose-dependent manner. significant reduction in number of swallowing was observed after the administration of orexin-a at the dose of 1 or 3 nmol. the latency of the response tended to be longer in the presence of orexin-a. the administration of orexin-b did not affect the frequency of swallowing. pre-administration of sb334867 attenuated the magnitude of inhibition of swallowing frequency induced by the administration of orexin-a. these results suggest that orexin-a but not orexin-b inhibits reflex swallowing via type 1 receptors situated in the dorsal medulla where swallowing center is housed. this work was supported by a grant-in-aid for scientific research from the japan society for the promotion of science (no: 22592064 to mk). stimulation of water receptors in the laryngopharynx (lp) with water shortened the swallowing interval in voluntary swallowing in humans. we previously found that excitation of water receptors was due to absence or reduced concentration of clin fluids applied to the lp. unstimulated saliva contains a low concentration of cl -. thus, unstimulated saliva may excite water receptors in humans. the aim of the present study was to evaluate the role of unstimulated saliva in initiation of swallowing in humans. solutions were infused through a fine tube into the lp at a slow infusion rate (0.2 ml/min) that minimized the mechanical effect of infusion. facilitation of voluntary swallowing by infusion of unstimulated saliva was almost the same as that by infusion of water. topical anesthesia of the throat produced loss of facilitation of voluntary swallowing by both water infusion and unstimulated saliva infusion. the similar effects of water and unstimulated saliva on voluntary swallowing suggest that water receptors are responsible for facilitation of voluntary swallowing by unstimulated saliva. since facilitation by water infusion appeared without mechanical effect of infusion, it is likely that excitation of water receptors in the lp by a small amount of unstimulated saliva precedes excitation of mechanoreceptors caused by a certain amount of unstimulated saliva accumulated in the throat. excitation of water receptors by unstimulated saliva may initiate spontaneous swallowing and spontaneous swallowing probably plays an important role in clearance of the mouth of saliva. therefore, it appears that excitation of water receptors by unstimulated saliva may contribute to avoidance of aspiration. #35 peripheral chemical stimulation to trigger the swallowing reflex and its neuronal mechanisms in humans kensuke kawamoto 1 , takuya inoue 1 , kaya narimatsu 1 , yuki nakamura 2 , makoto inoue 2 , rika yahagi 2 and yasuyuki kitada 3 1 faculty of dentistry, niigata university, 2-5274 gakkocho-dori, chuo-ku, niigata 951-8514, japan, 2 division of dysphagia rehabilitation, niigata university graduate school of medical and dental sciences, 2-5274 gakkocho-dori, chuo-ku, niigata 951-8514, japan and 3 morioka taste and swallowing research institute, 1-15-12 higashi-kuroishino, morioka 020-0108, japan initiation of swallowing is mediated by the swallowing central pattern generator (cpg) in the brain stem. both peripheral and central inputs can activate the cpg. previous studies demonstrated that the ability to initiate repetitive voluntary swallowing varies even among healthy humans and proposed that appropriate chemosensory inputs, e.g., activation of water receptors in the pharynx and larynx, may compensate for difficulty in initiation of swallowing. however, whether variation also exists in reflexively evoked swallowing is unclear, and the nature of interindividual variation has not been clarified. the aim of this study was to investigate interindividual variation of swallowing initiated by central and peripheral inputs and to clarify the neuronal mechanisms that cause this variation. voluntary and reflexive swallowing activity was recorded during infusion of fluid (distilled water [dw] or 0.3 m nacl solution) into the pharynx and larynx at a very low rate in 20 healthy volunteers. dw and nacl were used to activate and inhibit the water receptors, the activation of which facilitates initiation of swallowing. swallowing intervals (sis) were measured between the fourth and ninth swallows, and facilitatory effects (fes) were calculated by subtraction of the si of dw from that of nacl. there was a significant positive correlation between sis of voluntary and reflexive swallowing with nacl. fes of both voluntary and reflexive swallowing appeared strongly in subjects with longer sis. the present results suggest that interindividual variation in the ability to initiate swallowing depends on the potency of the swallowing cpg. the effects of taste stimuli on the change in regional prefrontal cortex blood flow (rcbf) measured by multichannel near infrared spectroscopy (nirs) were evaluated in 10 healthy women volunteers. the test solutions were sucrose, nacl, citric acid and monosodium glutamate at three different concentrations each. six pairs of source and detector nirs probes were placed on the forehead with a 3 cm separation which allowed the measurement of 16 different channels every 0.65 sec. the changes in oxygenated hemoglobin (oxy-hb), which is the most sensitive indicator of changes in rcbf, were analyzed. subjects were positioned in a chair that supported their back and head while wearing a blindfold (eyemask) and headphones to minimize motion, visual and auditory disturbances. the entire oral area was exposed to 5 ml of solution for 15 sec applied using a syringe and rubber tube positioned above the head. another solution was applied after rinsing with deionized water, subjects were tested consecutively for 12 different solutions in random order. each subject was tested for the same solution three times, the data were averaged and the value for the water test data subtracted in order to determine subjectã�s value for a given solution. the taste hedonic tone with a five-rating scale was also measured for the preference test. oxy-hb in all channels increased during all taste stimuli. the increases in oxy-hb and preference scale values showed significant negative correlation. these findings indicate that the prefrontal cortex activation evaluated by nirs is possibly related to pleasant or unpleasant emotions associated with taste stimuli. we receive various different stimulus modalities including 5 tastants and other gustatory and / or somatosensory sensations in eating. sensory information from these modalities would be integrated and recognized as a ã�flavorã�. it is useful to understand their psychophysiological properties because it may help us to develop new functional foods. we investigated the effects of vanillyl butyl ether (vbe), l-menthol (lm) and carbonated water (cw) to the arousal level of 12 healthy subjects. these 3 stimuli were used as hot, cold, tingling stimulus respectively. the results of contingent negative variation showed that vbe, lm and cw increased subjectã�s arousal level just after ingested by aqueous solution whereas no significant change was observed after the water ingestion. the increase of the arousal level still remained for 20 min after ingesting vbe and lm. on the other hand, the arousal level of 20 min after ingesting cw decreased to the same level as before ingestion. apart of the subjects were asked to rate the general stimulus intensity by 9 point likert scale. all samples including water showed maximum intensity just after ingestion and decreased with time course. however, the significant increase of the stimulus intensity still remained for 20 min after ingesting 3 stimulus solutions. these discrepancies between the arousal level and subjective stimulus intensity of cw suggest that only stimulus intensity itself cannot explain the change of the arousal level. in order to understand the property of each stimulus, we need to look each stimulus into detail in the derived modality of the sensation, intensity, timing of appearance. we had reported that umami taste induced sustained saliva secretion. in this study, to investigate the effect of repetitive taste stimulation on saliva secretion, we compared the saliva weight secreted by single taste stimulation (single stimulation methods; ss) with repetitive taste stimulation (repetitive stimulation method; rs), using fourteen healthy adult subjects. in ss, the subjects sprayed the taste solution (approx. 0.25 ml) using a spray bottle into the mouth, and held for 30 seconds and spat the whole saliva into cups at every 30 second for 10 minutes. in rs, the subjects sprayed the taste solution into the mouth, and held for 30 seconds, then, spat the whole saliva into cup, and rested for 1 minute until the next stimulation. after this procedure was repeated ten times, the subject performed the same procedure as ss. the stimuli were 100 mm monosodium glutamate (msg) (umami), 3.8 mm citric acid (sour) and 440 mm xylitol (sweet), which had ã�moderateã� taste intensity on a labeled magnitude scale. during the repetitive stimulation in the rs of msg, the salivary flow was reduced gradually according to the decrease of umami taste intensity by adaptation. however, the msg stimulation caused a sustained salivary secretion after repetitive stimulation, and there was no significant difference in the 10 minutes saliva between ss and rs. thus, the repetitive umami stimulation did not reduce saliva secretion and could produce sustained salivary secretion. there was no adaptation in rs of citric acid and xylitol, and the saliva secretion pattern of rs was similar to that of ss, with less saliva secretion than msg. dried-bonito (db) dashi is a traditional japanese broth that enhances palatability of various cuisines due to its specific flavor. db dashi contains many components, such as histidine, lactate, inosinate, minerals, and proteins. ingestion of db dashi has been reported to have various physiological functions, e.g., effectiveness against physical and mental fatigues, enhancement of peripheral blood flow, and suppression of oxidative stress. in this study, we investigated the effects of db dashi on gastric electrical activity and hunger-satiety states in healthy japanese males. we performed a randomized crossover study for 19 healthy males (21.5 â± 0.5 yr). subjects were fasted for at least 10 h, and all measurements were performed in the morning. before and just after a single ingestion of 150 ml of db dashi (''hondzukuri ichiban-dashi katsuo'', ajinomoto co., inc., japan) or energy adjusted water as a control, gastric myoelectrical activity was measured by electrogastrography for 20 min. subjective motivation to eat (hunger and satiety) was rated by visual analogue scales before, immediately after, and 35 min after the ingestion. ingestion of db dashi significantly increased both electrogastrographic normogastric power and percentage in postprandial state. in addition, db dashi produced higher satiety sensations at 35 min after the ingestion, compared to the control diet. in conclusion, db dashi intake enhances the gastric motility and satiety in humans. we usually take sweet foods with drinking tea or coffee not only to increase nutrition but also to produce feelings of pleasantness and restfulness that belong category of emotion. when we take sweet foods, comfortable audio-visual environments, e.g. consonant interior decoration, good music and fine view may increase feelings of deliciousness. thus, it is hypothesize that environmental factors modify feelings of deliciousness. comprehensive delicious feelings during having sweet foods might be effectively produced in the comfortable environments by integration of various palatable sensory perceptions. electroencephalograms (eegs) were recorded from frontal region of the scalp of healthy participants under virtual scenes of tearoom and construction work, respectively. the participants were asked to rate deliciousness after the recordings. frequency analyses were performed from the eegs. during having the foods, occupancy rates of beta frequency band between tearoom scenes and construction work scenes were markedly different, but not in other frequency bands. during having no food, in contrast, there was no difference of occupancy rates in respective frequency bands between the two different scenes. with regard to deliciousness during having sweet foods, all participants rated high scores under the scenes of tearoom than those under the scenes of construction work. interestingly, there is a positive correlation between occupancy rates of beta frequency band and scores of deliciousness. these findings suggest that comfortable audio-visual environments play an important role for increasing delicious feelings during having sweet foods, in which beta frequency rhythms may be concerned with producing comprehensive feelings of deliciousness. though it has been reported that capsaicin possesses effects of stomach protection and appetite improvement, the influence of dietary habits of consuming pungent substance such as capsaicin on taste sensitivity has not been investigated. in order to elucidate the influence of dietary intake of capsaicin on taste and pungent sensitivities, we measured the thresholds for 5 basic tastes and capsaicin in thai and japanese, because thai have a dietary habit of much more use of pungent substances for meal than japanese. in addition, we conducted questionnaire study about dietary habits of both groups. regarding the recognition thresholds for 5 basic tastes, the threshold for umami tended to be higher in thai compared to japanese with no differences in other basic tastes. this result indicates that daily high intake of pungent substances hardly affect taste sensitivities. however, the threshold for capsaicin in thai was significantly higher than japanese, which was considered to result from much more use of hot pepper for meal in thai. when the thresholds for 5 basic tastes were measured immediately after capsaicin stimulation, the thresholds for acid and bitter tastes were elevated in thai whereas they did not change in japanese. this difference may be due to the concentration of pretreatment capsaicin because suprathreshold concentration was used in the experiment, showing that high concentration of capsaicin may cause transient impairment in some taste sensitivities. in conclusion, it was suggested that daily high consumption of pungent substances hardly affects taste sensitivities but high concentration of capsaicin causes transient hyposensitivity of some tastes. this study aimed to investigate what flavors show interaction with umami taste. twenty-one female university students participated in this study. solutions of 0.25 % msg were used as taste stimuli, and the 19 kinds of flavors were used as flavor stimuli. participants were asked to taste a pair of flavor and msg solution, and to evaluate the intensity of umami taste and the congruency of the flavor with the umami. when the participants taste msg solution with flavor of dried bonito, and of garlic, they evaluated the umami taste stronger than when they taste it without flavors (potentiation effect). when the participants taste msg solution with flavor of tomato, of garlic, and of onion, they evaluated those flavors more congruent with umami taste than when they taste it without flavors. they evaluated congruency of dried bonito and of matsutake less congruent with umami taste. there is a significant, but weak, interaction between the congruency with umami taste and the potentiation effect of umami taste (r=0.36, p<0.05). in general, the flavors that are experienced in our daily lives are evaluated more congruent with umami taste, and have potentiation effect on umami taste perception. preceding studies also suggest that the interaction between olfaction and taste, and perception of umami taste are based on learning. this study also supports the view of ''learned synesthesia'' of olfaction and taste. acknowledgment: this study was supported by society for research on umami taste. eating with someone makes the foods more palatable, and the family ties more strong. on the other hands, eating alone (ko-sho-ku, in japanese) has many problems, such as malnutrition, unbalanced meals, not good at communication etc. ko-sho-ku is very severe problems in modern japanese society. thus, we aimed to study the effect of ko-sho-ku on palatability of the foods. in the study 1, ratings for taste and palatability of confectioneries were compared between when they were eaten with friends and/or family members and when eaten alone. thirty six female university students participated in this study, and were asked to eat two kinds of chocolate and two kinds of cookies in a laboratory (alone) and in their home (with someone). palatability ratings were higher when they were eaten with someone in their home. in the study 2, ratings for taste and palatability of jellies were compared between when they were eaten with watching a child eating same jellies in a video and without watching it. fifteen female university students participated in this study, and were asked to eat three kinds of jellies in a laboratory and to rate a questionnaire about their ability of sympathy. students with high sympathy tend to rate the jellies more palatable. these results suggested that human perceptions of taste and food palatability were affected not only by foods but also by contextual and social variables. acknowledgement: part of this study was supported by a grant titled "effects of eating with someone on palatability of foods." from asahi breweries foundation. #44 taste and smell of the bread made using pre-germinated brown rice sake lees kana kogiso 1 , hiroko nakazawa 1 , yumi yoshioka 1 , akiko sato 1 and mitsuo okazaki 2 1 faculty of human life sciences, nagano prefectural collage, nagano, nagano 380-8525, japan and 2 okazaki brewer co, ltd., ueda, 386-0012, japan pre-germinated brown rice is prepared by soaking brown rice in water at 37 o c for 24-48 hours to initiate germination of sprouts not exceeding 0.5-1.0mm in length. in the traditional method of brewing sake, rice bran and embryo bud are separated from brewer's brown rice during sake brewing in order to remove the rough taste. this study tried to use sake lees in fermentation with pregerminated brown rice, since the sake made from pre-germinated brown rice has hardly appeared on the market. also, the use and benefit of pre-germinated brown rice-made sake and sake lees have not been reported. in this study, we made sensory evaluation to measure the difference in taste and smell between bread made using normal sake lees and bread made using pre-germinated brown rice sake lees. the result showed that the bread made with pre-germinated brown rice sake lees had significantly better smell (p = 0.0365) and stronger sake lees smell (p = 0.0026) as well as a stronger sake less taste (p < 0.0001) than the bread made with normal sake lees. the complex flavor (p = 0.0587) and saltiness (p = 0.0511) of the bread made with pre-germinated brown rice sake lees tended to be stronger than that of the made with normal sake lees. female college studentsã� preference to steamed and cured slices of sweet potato was evaluated to find their sensory characteristics. evaluation was carried out with the 10 sweet potato cultivars and lines, tamayutaka, izumi13, hoshikirari, kanto131, tamaotome, quick sweet, hitachi red, hamakomachi, purple sweet lord and sakukei20 in terms of appearance, fragrance, texture and taste by a rank-scoring method. the most preferable cultivars were hoshikirari, tamaotome, and kanto131; sweetness greatly contributed to the taste of the steamed and cured slices of these samples, while appearance and texture somehow influenced their taste scores. fish flakes are one of the traditional japanese ingredients for dashi. various methods are used to extract dashi depending on the thickness of flake. especially, the thick type flake that is often used for soba noodle sauce requires around 30 minutes of cooking time and extracting conditions vary as well. the energy saving has become recent tendency even in culinary field, and we focused on a cooking method using remaining heat. we analyzed the free amino acid and 5#-imp. sensory evaluation was carried out at the same time. as a result, we can suggest that there is a method for extracting the most effective use of remaining heat for 25 minutes after heating for 5 minutes. we were able to explain the taste improvement from the amino acid composition determined by accq-tag tm ultra method. this condition can be considered effective for both energy saving and flavor improvement of dashi. oolong tea is usually served with oil-rich chinese food. our group has been studying on the mechanism of oil rinsing in the mouth and, in particular, on the interactions between oolong tea components and oil. our previous studies showed that oolong tea had a higher affinity for oil than deionized water, mineral water and green tea did. it may thus be more effective in washing out remaining oil from the mouth. the objective of this study is to determine the effective oolong tea components contributing to removing the residual oily sensation. for the human sensory evaluation, sweetened whipped cream was used as an aliment, and mineral water or oolong tea was used as a washer, with the result that oolong tea more effectively reduced the sense of residual oiliness. an aqueous solution of epigallocatechin gallate (egcg) and epigallocatechin (egc) as tea constituents was used to measure its interfacial tension activity in the presence of soybean oil by a face surface tensiometer. also, we emulsified soybean oil with egcg or egc and examined the resulting average particle size with a laser diffraction particle size analyzer. it was found that egcg and egc did not influence the interfacial tension and average particle size. further studies are required to find some contributory factor. commercial granulated sugars are of 99.9% purity which is almost equivalent to the purity of a guaranteed reagent-grade sucrose. we observed that commercial sugars were different in melting point from one another and the tastes of caramel sauces prepared from these sugars were different. a white coarse bright sugar with larger grain size than that of regular granulated sugar used as an experimental sucrose crystal was milled into powder. in a differential scanning calorimetry of the crystals, a higher peak in the curve of endothermic heat flow shifted to higher temperature side after milling. the powder crystal became more stabilized on heating than the coarse crystal. using the coarse and the powder crystals, caramel sauces (''sauce c'' and ''sauce p'', respectively) were prepared. sensory tests showed that sauce c was more brownish in color and was stronger in sourness, bitterness and acridity. on the other hand, sauce p was better in aroma, stronger in sweetness and more preferable in taste and aftertaste. sauce c was lower in ph, giving stronger sourness. the use of a color difference meter showed a large difference between the two sauces (de=6.4). coarse crystal was less stable on heating and sauce c was more brownish in color, having stronger bitterness. in the sensory studies for flavor development, commercial products or trial products are often used as samples, because sensory evaluation is conducted considering usual behavior of eating habit. but in the case of odor-taste interaction studies, it is desired that odorants and tastants are completely separated and presented to subjects simultaneously. in this study, we established a simple and effective way of presenting odor and taste stimuli separately under two model systems: beverage and soup. experiment.1: evaluation of sweet/sour intensity in fruit flavor beverage firstly, we prepared simple equipment comprising clear plastic cup with scented papers attached on the upper inside edge. the use of non-flavored solution and flavor on the scented papers allow subjects to evaluate beverage. sugar-acid water solution was used as taste stimulus and, lemon and strawberry flavors were used as odor stimuli. untrained panel (n = 45) evaluated intensity of sweet and sour characters. the result showed that lemon flavor enhanced sour character and decreased sweet character when compared with non-flavored condition. experiment.2: evaluation for savory -citrus flavor interaction we prepared ordinary soup solution as taste stimulus, with two savory flavor (chicken and dried bonito) and two citrus flavor (lemon and yuzu) as odor stimuli. untrained panel (n=66) evaluated 6 characters (saltiness, umami, sourness, mild, fatty, animalic). the results showed flavor influenced taste intensity as is the case in experiment 1. in conclusion, we successfully showed the important effect of odor on taste perception by using this study. #50 added flavorings enhance salivary hemodynamic responses to tastes detected by near-infrared spectroscopy -flavor creation using optical imaging-dried-bonito (katsuobushi) broth, an important seasoning in japanese cuisine, has long been used to reinforce the flavor of appetitive foods. not only the taste but also the aroma components of the broth contribute well to the enhancement. to elucidate the effects of aroma from dried-bonito on broth tastes caused by the central integration of flavor, we performed optical imaging of salivary hemodynamic responses using near-infrared spectroscopy (nirs). when hemodynamic responses to a reconstituted dried-bonito flavored broth were compared to those of odorless broth taste solutions, the flavored broth produced a significantly larger response than the odorless broth. this was the case for five of the ten participants, who felt that the combination of the aroma with the tastes was congruent. in the remaining five who felt the combination incongruent, the flavored broth did not cause the enhancement of responses. moreover, when (z,z)-4,7-tridecadienal, one of the most important key aroma components of dried-bonito extracts, was added to the flavoring, the latter five as well as the former five participants came to feel congruency of the reconstructed aroma with broth tastes. the reconstruncted flavored broth produced significantly larger hemodynamic responses than the odorless broth in both participantsã� groups. accordingly, there is a positive correlation between the degree of congruency and increase of the salivary responses. these results indicate that nirs offers a sensitive method to detect the effect of flavoring on the taste-related salivary hemodynamic responses, dependent on the perceptual experience of the combination of aromas and tastes. minty flavors are utilized in foods, beverages, toothpastes and tobacco. minty flavors are considered to have a relaxing effect, which is necessary for us, living in modern and urban societies. the authors have reported that the participants evaluated themselves more relaxing after smelling minty odor, when they were tied out for solving hard puzzles. however, psychological and physiological effects of minty flavors are still unclear. this study was aimed to reveal brain responses to minty flavors and minty odors with nirs (near infrared spectroscopy). sixty female university students participated in this study. they received detailed explanation about the experiment and wrote consent for participating in this study. the three minty stimuli, menthol, spearmint and peppermint and the other three odor stimuli, rose, skatol and orange, were administered to the participants via the olfactometer. the participants were asked to smell the stimuli by an orthonasal or retronasal route or to taste them. brain responses were measured with nirs (bom-1, omegawave, co ltd) and recorded with ad converter (powerlab) connected to the imac. the participants were also asked to evaluate the intensity of the odor continuously with the apparatus which outputs 0;5 v being based on the participantsã� evaluations. the results showed that the stimuli were recognized faster and stronger when the stimuli were administrated via orthonasal and retronasal routes than via oral cavity. the rose odor and orange odor were recognized faster and stronger than the menthol odor. the right forebrain showed greater responses to the stimuli via an orthonasal route than via the other routes, and greater responses to the rose odor than the menthol and the peppermint odors. currently existing odorant sensors are mainly fabricated based on metal-oxide semiconductor devices, conducting polymers, quartz crystal microbalances, or surface acoustic wave detectors. these sensors have been studied for improving on various parameters, such as sensitivity, selectivity, response speed, and portability. however, it has been difficult to develop odorant sensor elements that incorporate a combination of desirable properties. in contrast, living organisms, especially insects, use numerous olfactory sensory cells, which express odorant receptors, to sensitively detect environmental odorants in real time. so far, we have developed a compact odorant sensor that consists of a multichannel fluidic device and xenopus laevis oocytes expressing insect odorant receptors. although this odorant sensor possessed fast responsiveness and good portability, it had some technical disadvantages in terms of the stability of response measurements in the oocytes. here, we report the development of new odorant sensor elements that enable us to acquire stable odorant response measurements. we introduced insect odorant receptors and the olfactory receptor co-receptor (orco) as well as a calcium indicator protein, gcamp3, into spodoptera frugiperda sf21 cells to construct sensor cell lines. when these cells were stimulated with a set of odorants in solution, intracellular calcium as monitored by fluorescence imaging showed sensitive responses in accordance to the ligand specificity of the expressed odorant receptors. these results show that our sensor cells can be applied as odorant sensor elements that detect various kinds of odorants with high sensitivity, selectivity, and stability. with promotion of globalization, our diet are changing in several directions (diversification, mass commercialization, or high quality). because of the change, objective evaluation techniques for taste or odor of foods and beverages are needed for effective r&d and strict quality control. in recent years, biomimetic sensors, such as taste sensor, have been more developed as practical objective evaluation tools for taste or odor. with development of these sensors, development of correlativity evaluation system between objective values (sensor outputs) and subjective values (sensory scores) is needed to realize objective quality evaluation of foods and beverages. mainly developing artificial-lipids-based taste sensors with global selectivity, our research group have studied for realization of ã�taste-odor fusion biosensor system,ã� which estimates quality (deliciousness and safety) of foods or beverages using several sensor outputs through analysis and evaluation of subjective-objective relation. in the studies, we have estimated relations between each taste sensory and each sensor output, but did not investigate about correlativity among quality of foods or beverages and sensor outputs. hence, in this study, we investigated correlativity among sensory of deliciousness and several sensorsã� outputs on a particular sample as the next step of realizing ã�taste-odor fusion biosensor system.ã� as a result, we found that sensory scores of deliciousness were able to be displayed on a superspace as a hyperplane and to be estimated by the hyperplane and sensor outputs. this means that a sensory score on the particular sample can be calculated using sensor outputs and an estimation equation indicating the hyperplane. it has been reported that taste disorder caused by systemic diseases is associated with zinc deficiency. this study included 101 patients with dysgeusia due to systemic diseases: 30 patients with diabetes mellitus (dm), 21 with renal failures, 19 with digestive diseases, 21 with digestive diseases post operation, and 8 with liver failure. taste function was tested by electrogustometry (egm) and filter paper disk method (fpd method) in the area controlled by the chorda tympani nerve. the severe grades of taste threshold before treatment were more than 60% for renal and liver failure patients. all patients were treated with zinc sulfate. the rates of serum zinc deficiency (< 80 lg/dl) were more than 80% for all systemic diseases. in patients with renal failure, the symptom improvement rate was the highest, and the curative period was shortest. however, in dm patients, the improvement rate was the lowest, and the curative period was longest. this study demonstrated that zinc deficiency is induced by systemic diseases, and might cause taste disorder. it is also necessary to consider the possibility of taste disorder caused by medication. this study analyzed 124 patients with bms. the threshold of the taste function was measured by electrogustometry (egm) and the filter-paper disk (fpd) method. both basal and stimulated salivary secretions were measured. in addition, the self-rating depression scale (sds) was assessed. serum zinc and copper levels were also measured. the egm threshold was more than 10 db in 80 (67.2%) of 119 patients, and the taste threshold measured by the fpd method was more than 4 points in 61 (51.3%) of 119 patients. basal and stimulated salivary secretions were less than 3 ml in 90 (78.3%) of 115 patients and less than 10 ml in 52 (45.2%) of 115 patients, respectively. based on the sds, 45 (56.2%) and 14 (17.5%) of 80 patients were diagnosed with neurosis and depression, respectively. blood tests showed that the serum levels of zinc were less than 70 or that of copper were more than 130 lg/dl, respectively, in 61 (54.5%) of 112 patients. the clinical outcome was cure in 38.1%, improvement in 13.6%, recurrence in 11.9%, unchanged in 11.0%, and dropped out in 16.9%. in this study, basal salivary secretions lower than the normal range compared with stimulated salivary secretions. this suggests that, even if the salivary secretory function is maintained to some extent, the sympathetic nerve activity is predominant due to tension. it is necessary to accumulate more clinical data, such as trigeminal sensitivity of the tongue in comparison with the electric taste threshold. postoperative oral tumor patients show a variety of conditions and often display taste dysfunction resulting from anti-cancer drugs, irradiation and defects of oral tissue. prosthetic rehabilitation should be required for the recovery of oral functional disorders. however, no reports have investigated taste disorder for patients wearing maxillofacial prostheses. the aim of this study was to clarify taste sensation in postoperative oral tumor patients using the filter-paper disc method, salivary secretions measured by gum chewing, serum zinc concentrations by blood tests. we investigated patients who had undergone prosthodontic treatment in the department of prothodontics and oral rehabilitation at iwate medical university dental center. results were as follows: 1) taste disorder was seen in 90% of cases; 2) within 2 years after radiation exposure, the degree of taste disorder was severe; 3) disease severity did not necessarily accord with awareness of taste disorder, and some patients with serious taste decline were unaware of their taste disorder; and 4) patients who were aware of their taste decline also showed declines in chewing score. objective inspection and liaison with other departments to include an otolaryngologist, doctor of psychosomatic medicine, and a dietitian is important. it is known that more than 70% of patients with taste dysfunction have zinc deficiency. carbonic anhydrase (ca) vi, also known as gustin, is a 37,000-da zinc metallo-protein found in human saliva and is involved in taste dysfunction. it can be detected by enzymelinked immunosorbent assay, but the test takes time. therefore, in this study, we developed a new quick and simple method of diagnosis using an immunochromatography assay to be used as an on-site test. first, reactivity with a serum antibody (prepared using a synthetic peptide designed from a 93-111 amino acid chain of human ca vi as a hapten conjugated to keyhole limpet hemocyanin and injected into two new zealand white rabbits) was evaluated and compared to a control (swine antirabbit igg) using a hi-flow plus120 membrane and detected with colloidal gold. a difference in color development was observed between samples of pbs (-) and the positive control (synthetic peptide). furthermore, it was density dependent, and in serially diluted parotid gland saliva, the color development was seen to be 640 times dilution density from 8 times dilution density. the results suggest that an immunochromatography assay using this novel antibody can be used to quantitatively measure ca vi, which may be useful in the diagnosis of taste dysfunction caused by zinc deficiency. #58 the epithelium of recessus olfactorius is a part of the accessory olfactory system in the japanese toad (bufo japonicus) hideo nakazawa 1 , kimiko hagino-yamagishi 2 , atsushi c. suzuki 1 and takatoshi nagai 1 the recessus olfactorius (ro) is a small pouch observed in the antero-lateral olfactory epithelium of anurans. ro is mostly covered with the epithelial cells with cilia, which is reminiscent of sensory function. however, if ro is a part of the main olfactory system has not been studied. we studied the epithelium of ro (ro epithelium) in japanese toads regarding central projection, ultrastructure and expression of proteins involved in olfactory transduction. fluorescent carbocyanine dye (dii) was placed on the ro epithelium to show a neuronal projection from ro. fluorescent signal was not detected in the main olfactory bulb, but in the accessory olfactory bulb. in contrast to the olfactory epithelium which does not contain microvillous receptor cells, the ro epithelium contained both ciliated cells and micro-villous cells. the expression of a-subunit of g-proteins (g aolf and g ao ) in the ro epithelium was examined by immunohistochemistry and in situ hybridization. regionally different expression of g aolf and g ao was detected in the ro epithelium, namely expression of g aolf in the apical cell layer and g ao in the basal cell layer. such a pattern of g-protein expression in the ro epithelium was similar to that in the vomeronasal epithelium. these results suggest that the ro epithelium belongs to the accessory olfactory system. however, the ro epithelium contained secretory cells with granules that were not contained in the vomeronasal epithelium. physiological experiments will further clarify if the ro epithelium is functionally similar to the vomeronasal epithelium. in mice, the female memorizes some urinary pheromones of the mating male, thereby preventing the pheromones from inducing pregnancy block. the memory depends on the neural changes in the accessory olfactory bulb (aob), the first relay in the vomeronasal system. microcircuits in the aob include the prominent reciprocal dendrodendritic synapse between mitral cell projection neurons and granule cell interneurons. a previous study has shown that in vivo infusion of a protein synthesis inhibitor, anisomycin, in the aob is able to prevent the pheromonal memory formation. other reports have indicated that antidromical stimulation of mitral cell axons induces long-term potentiation (ltp) at the mitral-to-granule cell synapse in slice preparations of the aob. using aob slices, we measured field epsps derived from granule cells to examine the effects of protein synthesis inhibition on ltp at the mitral-to-granule cell synapse. high frequency stimulation, consisting of a 100 hz, 100 pulse train applied four times at 3 min intervals, induced ltp lasting for 180 min. under bath application of anisomycin (20 lm), high frequency stimulation induced short-term potentiation and early-phase ltp, but failed to induce late-phase ltp. the results suggest that protein synthesis underlies late-phase ltp at the mitral-to-granule cell synapse in the aob. the goal of our research is to understand the mechanism of synaptic transmission in the aob that has been demonstrated to be critical to memory formation for male mouse pheromones. by measuring the reciprocal synaptic currents from mitral cells in the aob, we have demonstrated that an agonist for group ii metabotropic glutamate receptors (mglur2/mglur3), dcg-iv, suppressed dendrodendritic inhibition (ddi) in a reversible manner while the mglur2/mglur3 antagonist ly341495 enhanced it. the effects of these drugs were markedly impaired by genetic ablation of mglur2, indicating that dcg-iv-mediated suppression of ddi is mediated by mglur2. in these studies, glutamate release was triggered by an application of a voltage step from -70 to 0 mv. in the present study, to see whether mglur2 has similar effects on the ddi elicited by more physiological stimuli, ipsps triggered by spike trains in mitral cells in slice preparations were recorded using the patch-clamp technique in whole-cell configuration. aob slices were prepared from 23-to 36-day-old balb/c mice. ly341495 enhanced it. together with previous results, the present result suggests that mglur2/mglur3 can be activated by endogenous glutamate release from mitral cells, which results in the suppression of the synaptic transmission from mitral to granule cells in the aob. phenols are predominant in the total flavor compounds of dried bonito (katsuobushi). the influence of odors of 1,3,5-trimethoxybenzene (tm; m=168), 2,6-dimethoxyphenol (dt; m=154), and guaiacol (gu; m=124), which were the chemicals responsible for the katsuobushi aroma, on the production of b-endorphin (be) in the hypothalamus were examined in f344 male rats. rats (5 weeks of age) were exposed to 0.1% of odors dissolved in either ethyl alcohol (etoh: m=46) or triethyl citrate (tec: m=276) for 10h/ day for one or two weeks. be levels in water soluble extracts of hypothalamus were examined by elisa kits. among three phenols, tm is the most potent odor to increase be levels in rat hypothalamus, followed by dt and gu: the increasing rate as compared with the control was 170%, 160% and 140%, respectively. these phenols may activate glomeruli clusterd in the lateral domain of the dorsal surface of the mammalian olfactory bulb and probably suppress the activities of sympathetic nervous system. these results suggest that the long-term exposure to bonito bouillon-flavored diet enhanced ratã�s preference for bonito bouillon. neurogenesis occurs in the forebrain subventricular zone (svz) throughout life. these neurons migrate to the main olfactory bulb (mob) via the rostral migratory stream (rms), and upon reaching the mob they differentiate into granule cells and periglomerular cells. the information broadcast by general odorants is received by the olfactory sensory neurons and transmitted to the mob. newly generated neurons at the svz play important roles in odor discrimination and odor memory. recent studies have shown that reduction of mastication impairs neurogenesis at the hippocampus and brain functions. in the present study, bromodeoxyuridine-immunoreactive (brdu-ir) structures in the sagittal section of the svz, rms, mob and accessory olfactory bulb (aob) of female adult mice fed a soft diet were studied to explore the effects of reduction of mastication on newly generated neurons at the svz and mob. the numbers of brdu-ir cells in the svz of adult mice fed a soft diet for 1, 3, or 6 months were lower than those of mice fed a hard diet. the odor preferences of individual female mice to butyric acid were tested in a plexiglas y-maze preference apparatus. feeding the soft-diet affected the adverse responses of mice to butyric acid. the results suggest that feeding with a soft-diet reduces neurogenesis at the svz, which in turn reduces olfactory function at the mob. epigenetic mechanisms play an important role in memory formation and synaptic plasticity. specifically, histone-associated heterochromatin undergoes changes in structure during the early stages of long-term memory formation. before eye opening young rats depend on somatosensory and olfactory function for survival, as they can learn their damã�s odor and approach her without visual information. in order to establish olfactory learning, the pairing of odor and somatosensory stimulation is crucial. we have shown that synaptic plasticity in the ob underlies aversive olfactory learning. our behavioral pharmacological experiments have shown that long-term olfactory memory requires activation of creb. western blot analyses have revealed that expression of p-mapk/erk is increased for 1 hour after odor-shock training, followed by increase of p-creb lasting for 6 hours. therefore, we examined whether intrabulbar infusion of trichostatin a (tsa), a histone deacetylase (hdac) inhibitor, facilitates olfactory learning in young rats. tsa infusion during odor-shock training enhanced a conditioned odor aversion in a dose-dependent manner. we further tested whether odor-shock training leads to histone acetylation in the ob and defined the time course of the activation. the acetylation of histone h3 was significantly increased for 1 hour after odor-shock pairing compared with odor only or no stimulation. tsa infusion significantly increased histone acetylation levels as well. these results show that hdac inhibition is associated with aversive olfactory learning in young rats. the endopiriform nucleus (epn) is a large group of multipolar cells located in the depth of the pirifprm cortex (pc). although many studies have suggested that the epn plays a role in temporal lobe epilepsy, the normal function of the epn remains to be elucidated. by using optical imaging with voltage-sensitive dye in slice preparations, we previously found that paired-pulse stimulation to pc and/or gustatory cortex (gc) evoked the excitation propagation to the epn, agranular division (ai) of the insular cortex and further to the claustrum (paired-pulse facilitation). in the present study, we investigated the electrophysiological properties of neurons in the epn, claustrum and ai in anaesthetized rats. in response to electrical stimulation of the olfactory bulb, the evoked potentials with a latency of about 50 ms were elicited in these regions. paired-pulse facilitation of the evoked potential was also observed. of the 52 neurons in these regions tested with odor and gustatory stimulation, 8 (15%) showed excitatory responses to both odor and taste stimulation, 14 (27%) had excitatory responses to odor but not to taste stimulation, 2 (4%) had excitatory responses to taste but not to odor stimulation, and the remaining 28 (54%) had no response. further, we previously found significant increases in the numbers of c-fospositive cells in the pc, gc, epn, ai and claustrum following natural stimuli, such as feeding an apple. these results, together with previous results, suggest that the epn, claustrum and ai are the multimodal-chemosensory regions, where olfactory and gustatory information is centrally integrated. department of science education, faculty of education, chiba university, chiba 263-8522, japan we found that a simple and typical association learning of a flower odor with proboscis extension reflex to nectar in honeybees was inhibited by exposure to extremely low frequency (elf) alternating magnetic fields. we postulated that the elf magnetic fields could be detected by magneto-receptors. honeybees have two types of putative magneto-receptors which either contain magnetite crystals, abdominal dark short hairs or abdominal trophocystes. we previously reported that a cutting of the abdomen longitudinal connective nerve between 3rd ganglion (first ganglion in abdomen) and 4th ganglion had no effect on the inhibitory action of alternating magnetic fields. and we concluded that the trophocystes had no role in magnetoreception. in this work, we confirmed that the dark hairs had a role in magnetoreception and inhibitory action of olfactory learning by magnetic fields. an exposure to 100hz alternating magnetic fields of approximate 450lt inhibited the performance of conditioning learning in intact bees. when all dark hairs were pull out, an exposure to alternating magnetic fields had no inhibitory effects on the conditioning. so, it was shown that the dark hairs had a role in magnetoreception which impaired olfactory learning. #66 prediction of glomerular activity patterns using the graph structure of odorant molecules zu soh 1 , toshio tsuji 2 , yuichi kurita 2 , noboru takiguchi 3 and hisao ohtake 1 1 grad. school of engineering, osaka univ., suita 565-0871, 2 grad. school of engineering, hiroshima univ., higashihiroshima 739-8527, 3 grad. school of natural science and technology, kanazawa univ., quantitative evaluation of odor qualities is an important process especially in the fragrance, food and beverage industries. however, most of the conventional odor sensing systems are unable to assess odor qualities perceived by humans. this study therefore aims to develop an artificial sensory evaluation system that can be used to evaluate odors and support sensory testing. as the first step in the development of such a system, we proposed a neural network model for prediction of olfactory glomerular activity based on the results of previous studies, which reported that odors evoking similar glomerular activity patterns have similar odorant qualities. the proposed model consists of marginalized graph kernels and a multilayer neural network. the former is used to evaluate distances between odorant structures, and the latter converts these distances into glomerular activity patterns. however, a number of parameters included in the model required further discussion. we therefore explored the two parameters that most significantly influenced the prediction accuracy of the model. these were the number of the gaussian units and the number of neuron units in the neural network. the results indicated that optimal prediction ability was achieved when the number of the gaussian units was approximately sixty and the number of neuron units in the hidden layer was approximately double than in the input layer. based on these outcomes, future plans for further improvement of prediction ability were discussed. in food and beverage industries, quantitative assessment of odors is an important process in developing new products. however, conventional odor sensing systems focus on identifying or detecting specific odors, and are unable to assess odor qualities perceived by humans. against this background, our study aims to develop an odor assessment system that can be used to evaluate odors and support sensory testing. toward the development of a model for the evaluation of odor qualities, this study focuses on neural activity evoked by odorant stimuli in the olfactory system. this is because the results of previous studies suggested that odorants prompting common neural activity patterns in the olfactory system had similar odorant qualities. as a first step, we conducted a series of human sensory tests to investigate perceptual similarities between odorants, and then compared the results with activity patterns evoked on the glomerular layer of the olfactory bulb in rats. these animals were chosen because the structure of their olfactory system is similar to that of humans, and measurement data relating to their glomerular activity is available online. we defined three indices (correlation, overlap rate of activation, and sum of squares of difference between histograms) to describe similarities and differences between activity patterns, and also conducted sensory testing to determine similarities to human perception. comparison of the results revealed that each index showed a weak correlation to perceptual similarities. we therefore examined whether similarities between odorants could be predicted by combining the three indices using svm (support vector machine), and the results indicated a certain level of prediction ability. novel esters, alcohols, and ethers containing a tetrahydropyran ring were derived from (2,6,6-trimethyltetrahydropyran-2-yl)acetic acid (1) or 2-methyl-(2,6,6-trimethyltetra-hydropyran-2-yl)propanoic acid (2), and their odor properties were investigated. the relationships between the structures of the derived compounds and their odor properties were also examined. the methyl ester of carboxylic acid (1) had a refreshing, floral, and herbaceous odor, and the methyl ester of carboxylic acid (2) had a refreshing, woody odor. the propyl ester of carboxylic acid (1) had an adzuki-bean odor, and the propyl ester of carboxylic acid (2) had a vegetable and spicy odor. thus, the odor of methyl ester of carboxylic acid (1) was thus similar to that of methyl ester of carboxylic acid (2), but considerably different from that of the propyl ester. moreover, the odor of propyl ester of carboxylic acid (1) was considerably different from that of propyl ester of carboxylic acid (2). to determine the most stable structures of these esters, the molecular orbital calculation was carried out for each ester using mopac pm3. the bulkiness of the side chain of a tetrahydropyran ring of methyl ester of carboxylic acid (1) was comparable to that of methyl ester of carboxylic acid (2). however, the side chain of propyl ester of carboxylic acid (1) was bulkier than that of its methyl ester, and this increased bulkiness prevents the free rotation of the side chain of propyl ester. similarly, the bulkiness of the side chain of propyl ester of carboxylic acid (2) makes its free rotation more difficult than that of propyl ester of carboxylic acid (1). thus, the bulkiness and the degree of free rotation of the side chain of a tetrahydropyran ring influence the odor of compounds containing a tetrahydropyran ring. measured odor thresholds depend on both subject sensitivity and method. yet, threshold-methods have received relatively little systematic attention in olfaction. we measured psychometric, i.e., proportion correct detection vs. concentration, functions for acetic acid. a 2-outof-5, forced-choice procedure was used. stimuli were precisely controlled using an air-dilution olfactometer. the design had four factors, all randomized or counter-balanced: 1) practiced subjects vs. unpracticed subjects (between subjects); 2) 15-second inter-trial interval (iti) vs. 30-second iti (within subjects); 3) re-sampling allowed (i.e., subjects could smell each of the 5 stimuli presented during a trial as many times as they wished) vs. not allowed (within subjects); 4) concentrations presented in ascending order (lowest concentration first, moving up to the highest concentration, then starting again at the lowest concentration after a break) vs. random order (within subjects). a four-way anova (the above four factors) revealed a significant main effect of re-sample condition. these results highlight the importance of methods for measured thresholds, and have implications for laboratory practice. many researches have reported the influence of information to identify an odor. we tried to measure the prefrontal cortex activity during the smelling an odor using functional near-infrared spectroscopy (fnirs) to find out the effects of positive and negative information with a same odor. we used three kinds of odors which have been evaluated as moderately hedonic values by a preliminary experiment. eighteen subjects who had normal sense of odor were presented these odors with visual stimulation on a display. the visual stimulation showed the explanations of each odor with positive or negative information. during the experiment, subjects were measured for their prefrontal cortex activity with 42 channels (3x9 distributions) by fnirs (foire-3000, shimadzu corp). these odors were presented by odor-stimulation system through tubes and a mask. the experiment was conducted by the following protocol; pre-resting period (20s), task period (15s), evaluation period (25s) and post-resting period (25s). we had 24 trials (3 odors x positive/negative information x 4 trials) and 4 control tasks with odorless. during the evaluation period, subjects evaluated the intensity, pleasantness/unpleasantness and familiarity of each odor. the stimuli were presented by random order. as a result, we showed the different evaluation value on the same odor but different information condition. the positive information condition showed significantly higher pleasant value than negative information condition (p<.05). fnirs data also showed the significantly different prefrontal cortex activation between positive and negative information conditions. we showed the effects of positive and negative information on a same odor. first impression of a stranger is created by several perceptions, such as face, tone of voice, speed of words etc. there are many researches on development of first impressions, but there are few researches that study a role of olfaction on development of first impressions. we wear perfume not only because we like it, but also because we want someone to have good impressions. this study aimed to investigate whether the perfume that we wear affects othersã� first impression for us. sixty female university students participated in this study, and all of them were not acquaintance of the experimenters. ck one, citrus-floral perfume, and coco chanel, fresh oriental note perfume, were used as olfactory stimuli. the method to investigate for participantsã� impression for the female model (experimenter) was teg ii (tokyo university egogram ver. ii, published by kaneko shobo). when the model wore ck one, she was evaluated as having stronger sense of responsibility and the makings of leader. on the other hand, when the model wore coco, she was evaluated as having unique personality and strong self-assertion. these results show the perfume that we wear changes othersã� first impressions for us. the authors are continuing to study about this phenomenon, and confirm it with another models and with another perfumes. #72 a study of the image congruency between bottle appearance and fragrance of perfume appearance of bottles might influence on the evaluation of perfumes as visual information before sniffing fragrance. we investigated such congruencies/ incongruencies between visual and odor information in the market products of perfume through the two experiments. in the experiment1, we investigated broad constructs of image aroused from appearance of bottles and flagrance of perfumes, and reviewed congruencies between bottles and fragrances. we selected 10 products as samples, and used ''napping'' for experiment1. in napping, subject sort the samples on the space reflecting sensory similarities. 11 our subjects carried out napping under the two conditions. subjects were asked to sort samples according to similarities of scents. these scents were sniffed actually in the sniffing condition, but in the viewing condition, scents were imagined from appearance of bottles. distances matrixes between samples were measured from results of napping, and were used for multi-dimensional scaling (mds). the result of mds showed that dimension1 could represent major image of perfumes (for men or female) in the both conditions, and that diman-sion2 in the viewing condition could represent lightness of scents related to transparencies of bottles. however, we could not find systematic feature change of scents on dimension2 in sniffing condition. it may suggest complexity of scents sniffed actually. we then examined the qualitative aspects in congruencies/ incongruencies between bottles and flagrancies in the experiment2. we selected 5 among 10 perfumes used in experiment1, and used 10 descriptive terms to evaluate each of the samples. in the results of experiment 2, we could not find any relations between terms with perfumes. changes of the physiological parameters (saliva amylase, heart rate, and brain waves) of 10 subjects during the smelling of the bark oil of lindera umbellata were measured. the value of saliva amylase did not change during the smelling of the bark oil. the proportion of the parasympathetic nervous system increased significantly during the smelling of the oil, while that of the sympathetic nervous system decreased. on the other hand, the proportion of b-wave decreased significantly during the smelling of the oil. thus, the bark oil exhibited the relaxation effects for the subjects. the bark oils included monoterpene alcohols (73.19%) and ketones (6.99%), monoterpene oxides (5.59%), monoterpene hydrocarbons (5.18%), and others. among of these, linalool (63.70%) was the most abundant component. here we investigated relationship between the number of constituent odors and odor pleasantness. we hypothesized that the stability of the olfactory perception depends on the number of odor components and their molecular variability. we especially focused on odor pleasantness, which best explains molecular variability of odorants in the natural world. three different categories of odors, aliphatics, aromatics and terpenoids, were used in this study. we used 5 or 10 odors for preparing multi component odors. odor pleasantness for the multi component odors tended to be more stable against concentration changes than that of the single component odors. notably, multi component odors containing odorants of all categories showed higher stability than odors containing single odor category. future study for large number of components with different molecular variability will reveal rules for the prediction of the odor perception for odor mixtures. #75 fmri of brain responses to complex odor and visual stimuli one of the most important features of odor perception is the hedonic or emotional component. the purpose of this study was to measure the brain activity associated with human olfaction using functional magnetic resonance imaging (fmri) and to evaluate the influence of the pleasantness of odors by complex odor and visual stimuli. seventeen healthy right-handed subjects (9 men; 8 women) with normal olfaction participated in the study. an event-related mri method was used to analyze olfaction-induced responses on fmri. a puff of odorant was delivered to the nose of each subject through a nose mask with electrically controlled pneumatic valves. for the event-related task in the fmri experiment, two odorants (pleasant odor: amyl-acetate, unpleasant odor: iso-valeric acid) and two types of visual stimuli (pleasant image, unpleasant image) were randomly presented. two cross-modal sensual interactions were tested using spm-software for both matching/mismatching conditions and pleasant/unpleasant conditions, respectively. results revealed specific brain areas that were activated by cross-modal interactions with odor and visual stimuli. in advance of the fmri experiment, psychological odor experiments (cross-modal, complex stimuli with a visual and odor evaluation test) were conducted using a subjective judgment method or pleasantness/unpleasantness, respectively. based on the fmri and psychological experiments, we estimated the most suitable conditions for evaluating the pleasantness of odors. from analysis of the fmri experiments, two responses (1: emotional response to pleasantness/unpleasantness, and 2: response to matching/ mismatching) were obtained with the cross-modal, complex stimuli using odors and images. from the analysis of our experiments, activity associated with the response to pleasantness/unpleasantness was seen mainly in the right orbital frontal cerebrum and the supramarginal gyrus, middle frontal gyrus and amygdala. on the other hand, activity associated with the response to matching/mismatching was seen in areas of the brain corresponding to memory and cognition. thus, cross-modal, complex effects were suggested to be an emotional response to pleasantness/unpleasantness and cognitive and memory responses to matching/mismatching. as otorhinolaryngologists, it is important to grasp the grade of subjective symptoms and quality of life (qol) when we examine outpatients with olfactory dysfunction. however, the influence that the sense of smell exerts on the qol related to health is not clear. therefore, we investigated outpatientsã� qol using the ''health-related qol measure (sf-36),'' which is widely used around the world. concurrently, we applied a 1) visual analog scale (vas) to grade subjective symptoms (the smell of food and drink, perfumes, excreta and gases) and the deliciousness of meals (qol), 2) smell questionnaire for daily life, 3) t&t olfactometry, 4) intravenous olfaction test (alinamin test) and 5) card-type smell identification test (open essence). we then analyzed those tests and sf-36 for correlations. as the results, ''vitality (vt),'' which is a subscale of sf-36, correlated weakly with the subjective symptom vas for ''smell of perfume'' (r s =0.262) and the t&t recognition threshold (r s =0.203). ''role functioning emotional (re),'' which is another subscale of sf36, correlated weakly with the subjective symptom vas for each of ''smell of food and drink'' (r s =0.234), ''smell of perfume'' (r s =0.272) and ''smell of gas'' (r s =0.222). no other correlation was found for any of the olfactory tests. these results showed that, although olfactory dysfunction affected the vt and re of the patientsã� health-related qol, it was very slight. even if olfactory dysfunction develops, the effect on the overall qol of the patient is slight compared with other diseases. this likely explains why these patients are slow to consult a doctor. â½introduction olfactory dysfunction is most commonly caused by chronic rhinosinusitis (crs) in japan. within crs, eosinophilic chronic rhinosinusitis (ecrs) is said to cause severe olfactory dysfunction. however, there have been few reports that have compared ecrs with non eosinophilic chronic rhinosinusitis (necrs). â½patients and methods a prospective study was carried out at three institutions. a total of 621 patients underwent endoscopic sinus surgery between april 2007 and march 2008 and were pathologically diagnosed with crs. of those, 464 patients (318 males, 146 females; mean age: 48.2 years) were included in this study because they had undergone olfactory evaluation preoperatively. olfactory dysfunction was assessed using the standard olfactory threshold test (t&t) and subjective symptom score (0;6). data were analyzed using spss software ver. 11. â½results the 464 patients consisted of 228 necrs patients, 190 ecrs patients, 21 patients with allergic fungal rhinosinusitis (afrs), 13 patients with odontogenic maxillary sinusitis and 12 patients with fungal rhinosinusitis. t&t found that 54.9% of the total patients had olfactory dysfunction with a mean recognition threshold of â�¡4.1 (107 of 228 necrs patients; 46.9%, 119 of 190 ecrs patients; 62.6%), while 57.2% of the total patients had olfactory dysfunction with a subjective symptom score of â�¡ 3 (100 of necrs 228 patients; 43.9%, 135 of 190 ecrs patients; 71.1%). both the t&t result (or: 1.895) and the subjective symptom score (or: 3.309) were significantly worse in the ecrs patients than in the necrs patients. [introduction] we investigated the hypothesis that the prognosis of olfactory dysfunction (od) due to chronic rhinosinusitis (crs) becomes worse as the duration of od becomes longer. [patients and methods] 113 patients (70 males, 43 females; age range: 21-74 years; mean age: 50.9â±12.7 years) with od due to crs underwent appropriate surgery and postoperative treatment, and were followed up for at least 3 months. a visual analog scale (vas) was used to evaluate their pre-and post-treatment symptoms of od. [results and discussion] patients with an od duration of â�¡5 years showed significantly less improvement compared with an od duration of <5 years. the od duration and the post treatment vas showed a significant negative correlation (r s =ã�.399, n=113). it was particularly strong in male patients aged â�¡60 years (r s =ã�.632, n=27), and in the aspirin-intolerant asthma (r s =ã�.624, n=11), peripheral eosinophil count of â�¡800/microl (r s =ã�.528, n=17) and current smoking (r s =ã�.731, n=11) subgroups. multiple logistic regression analysis of 19 patients with severe od even after appropriate treatment identified the following as poor prognostic factors: 1) male gender (or=18.996), 2) od duration â�¡5 years (10.023), 3) age â�¡60 years (9.349) and 4) peripheral eosinophil count of â�¡800microl (8.234) (predictive rate: 89.4%). these results indicate that the prognosis of od due to crs becomes poorer as the duration of the disease becomes longer. in particular, patients who have these risk factors should be started on treatment as soon as possible and should be advised to quit smoking. motohiko suzuki, yoshihisa nakamura, hiroshi kawaguchi and shingo murakami causative viruses of postviral olfactory dysfunction have not yet been identified. we investigated causative viruses in patients with postviral olfactory dysfunction. we examined the presence of viruses in nasal discharge and examined the time course, with regard to changes in olfactory dysfunction and nasal obstruction in 24 patients with postviral olfactory dysfunction, using questionnaires, acoustic rhinometry, and olfactory tests. nasal discharge was collected from patients with postviral olfactory dysfunction. rhinoviruses were detected in 10 patients. viral serotypes were identified by nucleotide sequences to be human rhinovirus-40, human rhinovirus-75, human rhinovirus-78, and human rhinovirus-80. one of the four patients complained of dysosmia, whereas another complained of anosmia. results of acoustic rhinometry significantly improved in the four patients, although olfactory testing did not show significant improvement. two of the four patients complained of olfactory dysfunction even 6 months after the first visit. coronavirus and parainfluenza virus were detected in one patient each, and epstein-barr viruses were detected in three patients. the present study detected rhinovirus, coronavirus, parainfluenza virus, and epstein-barr virus in nasal discharge of patients with postviral olfactory dysfunction. furthermore, this study suggests that rhinoviruses cause olfactory dysfunction through mechanisms other than nasal obstruction. in this study, we evaluated 10 patients with olfactory dysfunction induced by central nervous damage. six of 10 patients developed hyposmia after head trauma, 2 patients by brain tumor, one patient after subarachnoid bleeding and one patient by encephalitis. five of 10 patients did not sense any smell by venous injection of prosultiamine. psychophysical evaluation of olfactory function was performed by t&t olfactometry, and the average threshold score of recognition was 5.2 (severe hyposmia). eight patients got mri brain scans and each of them had one or more intracranial lesions. frontal lobe abnormalities were seen in 7 of 8 patients. intracranial lesions were also observed in 3 temporal lobes and one parietal lobe and one occipital lobe. these mri findings suggested most of the olfactory disorders were come from damage of orbitofrontal cortex in frontal lobe, which is thought to be the olfactory center. on the other hand, 8 out of 10 patients developed taste disorder, despite no pathogenic lesion was found in medullary, thalamus and insula, which are thought to be the central pathway of taste and taste cortex. currently, we have yet to establish effective treatment of olfactory loss caused by central pathway damage. in clinical practice, some of these patients show improvements in olfactory function with several years, thus long-term follow-up of patients is needed to develop new clinical studies. the clinical study of patients with drug-induced olfactory disturbances cases (1.4 %) of drug-induced olfactory disturbance were investigated. anti-cancer drugs occupied 81 % in the frequency of causative drugs. tegafur was most common in the causes of olfactory disturbance by anti-cancer drugs. we showed the characteristics of drug-induced olfactory disturbance by tegafur. a total of 21 patients were identified. the averaged recognition threshold was 5.29 and the averaged detection threshold was 4.67 in t&t olfactometry. after treatment, re-examinations were performed in 15 patients. the averaged recognition key: cord-022082-1dq623oe authors: greaves, peter title: respiratory tract date: 2007-09-28 journal: histopathology of preclinical toxicity studies doi: 10.1016/b978-044452771-4/50007-9 sha: doc_id: 22082 cord_uid: 1dq623oe the chapter describes different aspects of the respiratory tract. in preclinical safety studies, pathologies of the respiratory system can be a result of an intercurrent disease or can be induced by systemically administered drugs. intranasal or inhalation modes of therapy pose particular challenges in terms of the formulations and technologies required to administer a drug. a complex technology is developed to support the assessment of adverse effects of inhaled substances in rodent and nonrodent species, and the extrapolation of experimental findings to humans. the nasal chambers are the structures that are first to be subjected to the effects of inhaled substances, whether microorganisms or chemical substances. in rodents, the relatively small size of the nose and nasal sinuses facilitates a histological examination. findings show that infectious agents cause inflammation in the nose and nasal sinuses, and this may be associated with inflammation in the conjunctiva, the middle ear, and the oral cavity. it has been observed that a particular response of the rodent nasal mucosa to some irritant substances, including pharmaceutical agents, is the formation of rounded eosinophilic inclusions in the cytoplasm of sustentacular cells of the olfactory epithelium, and to a lesser extent in respiratory and glandular epithelial cells. by far and away the most important pulmonary diseases in humans are related to the smoking of tobacco. however, occupational lung diseases caused by inhalation of industrial chemicals, particulate matter and antigens, are also important causes of morbidity and mortality. for this reason, considerable effort has been directed to the examination of airborne pollutants over recent years, including study of their effects in laboratory animals when administered by the inhalation route. extensive study has shown that a complex array of defensive mechanisms protects the lung against the adverse effects of airborne substances and pathogenic organisms. aerodynamic factors prevent access of particles larger than 10|im diameter for these are deposited on the walls of the nasal passages. particles measuring between 2 and 10 (im diameter tend to be trapped by the mucus-covered ciliated epithelium lining the bronchial tree and removed by mucociliary transport aided by the cough reflex. smaller particles may reach the alveoli where they are ingested and transported by pulmonary macrophages.^ considerations of airborne delivery to the lungs are also important in the development of therapies to be administered via the respiratory tract. whilst the inhalation route has been used for many years for volatile anaesthetic gases, the respiratory tract is increasingly being employed for delivery of therapy in not only for asthma and other lung diseases but also as a means of systemic delivery of polypeptides such as insulin. in contrast to the adverse pulmonary effects of cigarette smoke and industrial pollutants, therapeutic agents remain a relatively minor cause of pulmonary toxicity in humans although actual incidence is difficult to ascertain. however, drug-induced pulmonary disease appears to be an increasingly frequent clinical problem and the drugs associated with parenchymal pulmonary injury in humans continue to increase.^ although it is difficult to assess in the context of the underlying disease process, it has been suggested that about 10% of patients receiving wellestablished anticancer drugs develop various forms of pulmonary toxicity some novel antineoplastic therapies may have a similar liability.^ drug-induced toxicity usually occurs after exposure of lung tissue via the circulation to parent drug or metabolites, although increasingly the adverse effects of direct administration of drugs to the lungs needs consideration in preclinical studies. in patients a number of drugs have been associated with pulmonary toxicity which can occur through different mechanisms and take different forms.^"^ through their specific pharmacological action drugs can produce excessive effects on bronchial calibre or pulmonary function. drugs mediate allergic reactions in the bronchi or lungs. they may also produce a variety of obscure, diffuse pulmonary alveolar conditions including a pulmonary syndrome resembling systemic lupus er3^hematosis. as the respiratory tract is a major route by which microorganisms gain entry into the body, opportunistic pulmonary infections with bacteria, viruses, fungi or protozoa are consequences of immunosuppression or broad-spectrum antibacterial therapy. as in other organs, drugs that disturb coagulation may precipitate pulmonary thromboembolism or haemorrhage. localized lung lesions also result from accidental, diagnostic or therapeutic inhalation of xenobiotics. mucociliary clearance is also sensitive to therapeutic agents that affect the secretion of mucus and fluid, ciliary activity and transport.^ treatment with antacids or histamine h2 blockers can also increase the risk of pneumonia developing in patients in intensive care units through increasing gastric ph, which leads to an overgrowth of gram-negative bacteria in the stomach and retrograde pharyngeal colonization.^ in preclinical safety studies, pathology of the respiratory system can be the result of intercurrent disease or be induced by drugs administered systemically. intranasal or inhalation modes of therapy pose particular challenges in terms of the formulations and the technologies required to administer drug. the different anatomical and physiological characteristics of the airways also influence drug toxicity, disposition and metabolism. the development of drugs to be administered by inhalation or intranasal routes is particularly difficult because of the perceived risks of high local drug concentration in respiratory tissues and their use in potentially vulnerable patients with pulmonary disease.^ a complex technology has been developed to support the assessment of the adverse effects of inhaled substances in rodent and non-rodent species and the extrapolation of the experimental findings to humans.^'^ in order to administer drugs by inhalation, it is necessary to generate aerosols (suspensions of particles in a gas) with a well-defined composition, particle size and shape. they must be delivered to the respiratory tract of laboratory animals in a way that parallels the likely human exposure. in case of therapeutic agents, this should avoid non-respiratory pathways through the skin and food. when aerosols are inhaled, various fractions of the particles are deposited at different locations in the respiratory tract. site of deposition depends primarily on particle size, but variability in the sites of deposition occurs among different laboratory animal species and humans by virtue of the differences in the size and shape of the respiratory passages as well as breathing patterns. ^^ in addition, there are different types of inhalers used in human therapy to consider in the assessment, which can deliver different materials to the lungs, for example nebulizers, propellant-driven metered dose inhalers and dry powder inhalers for asthma treatment. ^^ the subsequent fate of inhaled particles depends not only on their size but also their shape, chemical nature, and solubility in body fluids. soluble substances are absorbed into the blood stream and are removed by the pulmonary circulation. they may also undergo metabolism by enzymes present in the cell populations of the respiratory tract and reactive metabolites may cause local pulmonary damage. insoluble, inert particles are removed primarily by the mucociliary transport system of the trachea and bronchi or through phagocytosis by macrophages. overload of the lung by even relatively inert, nonfibrous particles such as titanium dioxide or carbon black may impair alveolar macrophage-mediated particle clearance. ^^ this may lead in turn to accumulation of dusts over time with eventual fibrotic and tumorigenic responses, particularly in rats.^^ measurements of respiration rate, tidal volume, airway resistance, pulmonary gas exchange and the disposition of the inhaled substances have an important place in the evaluation of chemically induced lung damage in laboratory animals.^"^'^^ however, the key component of the evaluation of the adverse effects of inhaled substances is careful morphological assessment of the fixed tissues. even though there are novel and very sensitive physiological methods for the characterization of oedema following lung injury in rodents, light and electron microscopy of lung tissue provides vital qualitative evidence of the nature of injury. ^^ the nasal chambers are the structures which are first to be subjected to the effects of inhaled substances, whether microorganisms or chemical substances. although these chambers are not usually examined in great detail in conventional toxicity studies in which substances are administered orally or by parenteral routes, they are carefully examined histologically when drugs are administered by inhalation. study of nasopharyngeal silicone rubber casts has shown considerable species differences in the anatomy of this part of the airway. ^^"^^ relative to total nasal length, the nasopharynx is longest in rats and shortest in humans with the dog in an intermediate position. maxilloturbinates are relatively simple structures in man and non-human primates but highly complex in dogs and rodents. as a consequence, regional nasal airflow and disposition patterns vary considerably and this influences the distribution of lesions produced by inhaled xenobiotics in the nasal cavity.^^ however, comparison of the nasal cavity of rhesus monkey and humans using magnetic resonance imaging and nasal casts have shown that many similarities in structure exist in these species. ^^ the anterior nares are lined by stratified squamous epithelium. in other zones the sinuses are covered either by respiratory or olfactory epithelium with a zone of transitional epithelium at the junction between the two types. respiratory epithelium is similar to that found elsewhere in the respiratory passages being composed of ciliated cells, serous and mucous cells, brush cells, intermediate cells and progenitor basal cells. it represents a cellular system engaged in mucociliary clearance carrying surface secretions to the nasopharynx to be cleared by swallowing. although this epithelium is similar to that lining the other large airways, key differences are the particularly rich complement of secretory cells and the complex vasculature of the nose which can modulate capillary, arterial and venous blood flow through the mucosa.^^ mucins may be particularly important. it has been postulated that they not only have a physical protective function but also possess antioxidant properties by virtue of the scavenging behaviour of their high proportion of sugar groups. ^^ the proportion of the nose lined by olfactory mucosa is variable between species, being disposed over a much larger area in dogs and rodents than in primates. ^^ however, it is structurally similar in humans and rodents. it is located in more dorsal or posterior regions of the nasal passages out of the direct line of airflow during normal respiration. olfactory mucosa is a pseudostratified columnar epithelium composed of basal cells, sustentacular cells and sensory cells with mucus-secreting bowman's glands situated in the lamina propria. basal cells are composed of two distinct types, light and dark cells. the light type represents the primitive, stem cell population. sustentacular or supporting cells are non-ciliated, columnar cells possessing microvilli that extend into the overlying layer of mucus. cell bodies of olfactory sensory neurons are situated in the middle layer of the epithelium between sustentacular and basal cells. their dendritic processes extend above the epithelial surface to end in a ciliated expansion referred to as the olfactory vesicle that is believed to be the receptor of odour perception. olfactory axons extend from the cell body, penetrate the basement membrane in bundles to become surrounded by schwann cells and eventually join with the olfactory bulb. the olfactory system is of importance in toxicology for it can be selectively damaged by xenobiotics, including therapeutic agents, presumably as a result of its high metabolizing capacity. the superficial location of neural cells in the olfactory epithelium also provides a model system for the study of the effects of xenobiotics on neural cells. submucosal mucous glands have been well characterized in the rat, hamster and dog, where they are divided into lateral nasal glands and maxillary recess glands. these are both situated in the posterior parts of the nasal cavity and composed of mucus-secreting cells.^^"^^ immunocytochemical study using antisera raised against the major isoenzymes of rat hepatic microsomal cytochromes p450 induced by (3-napthoflavone, 3-methylcholanthrene, phenobarbitone and pregnenolone-16-a-carbonitrile as well as nadph-cytochrome p450 reductase, epoxide hydrolase and glutathione s-transferases b, c and e, has shown their presence in rat nasal mucosal cells.^^ cyp2a enzymes appear to be expressed at high levels in the respiratory tract mucosa.^^"^^ this suggests that the nasal mucosa not only has a capacity for metabolizing and activating xenobiotics by oxidation, but also for hydration and inactivation of potentially toxic epoxides and conjugating electrophilic, reactive metabolites with reduced glutathione. it has been shown that the distribution of immune-reactive enzymes is different in olfactory and respiratory mucosa.^^ xenobiotics can be metabolized within both olfactory and respiratory mucosa but the olfactory regions appear to possess greatest capability for oxidative metabolism. consequently, regional differences in nasal toxicity and tumour formation from inhaled materials may not only be a response to different water solubility and deposition patterns but also differences in the formation of reactive metabolites.^'* another feature of this metabolizing activity is that it can be induced by systemically administered xenobiotics and this can alter the distribution of enzyme activity in the nasal mucosa.^^ studies of the mouse olfactory mucosa have shown that whilst typical hepatic inducers of cyp2a5 do not significantly change its expression in the mucosa, olfactory toxicants can alter the pattern of enzyme distribution.^^'^^ like many other tissues exposed to external environmental agents, the nasal mucosa possesses aggregates of lymphoid tissue in the underlying lamina propria. in rats these areas, characterized by follicles containing both t and b cell areas, are located in the ventral aspects of the lateral walls of the nasal airways at the opening of the nasopharyngeal duct.^^'^^ like the gutassociated lymphoid tissue, these nasal follicles have been shown in the rat to be covered by specialized epithelium with islands of cells with microvilli, socalled m or membranous cells. little is known of any toxicity occurring in this tissue despite its strategic position in the respiratory tract.^^ in rodents, the relatively small size of the nose and nasal sinuses facilitates histological examination. usually this area is sectioned transversely into several standardized blocks following decalcification.^^ there have been a number of detailed publications describing the histological preparation and assessment and recording of pathology of the rodent nasal cavity.^^"^^ careful standardized histological sections, careful recording of lesions with the use of diagrams of the rodent nasal cavity are useful in the assessment of lesions in the nasal cavity found in inhalation studies."*^ in larger species, particularly dogs and primates, sectioning and blocking is more complex. although dissection is required, a similar procedure following decalcification can be adopted. careful examination of haematoxylin and eosin stained sections remains paramount in the assessment of the nasal cavity, although special stains may be helpful. examination of cytokeratin expression in the respiratory mucosa has been used as a marker of epithelial differentiation in the respiratory tract>^ a test system that relates to the innervation of the nasal mucosa is that proposed by alarie.^^ the trigeminal nerve endings in the nasal mucosa of mice mediate the response to sensory irritants and this can be measured by a decrease in respiratory rate. it has been shown that a good correlation exists between the decrease in respiration rate in mice exposed to airborne chemicals and the nasal irritancy potential of the chemicals in humans.^^ this enables the detection of airborne sensory irritants and the prediction acceptable levels of exposure to the upper respiratory tract in people. microbial pathogens infectious agents cause inflammation in the nose and nasal sinuses and this may be associated with inflammation in the conjunctiva, middle ear and oral cavity. murine pathogens may cause alterations in the respiratory tract that can confound the assessment of changes induced by xenobiotics.^^ in rats, microbiological agents implicated in the development of rhinitis and sinusitis include corynebacterium kutscheri (pseudotuberculosis), streptococcus pneumonia, pasteurella pneumotropica, klebsiella pneumoniae, mycoplasma pulmonis and the sialodacryoadenitis virus or rat corona virus.^^ rats infected with the sialodacryoadenitis virus show inflammation and necrosis of the upper respiratory epithelium as well as damage to salivary and lachrymal glands. the sendai virus, a paramyxovirus, also has marked tropism for the respiratory tract, including the nasal cavity, and is associated with systemic effects that can compromise studies in laboratory rodents. occasionally, fungal infections of the airways with. aspergillus fumigatus are reported.^^ a variable that has been shown to influence the severity of the rhinitis produced by mycoplasma pulmonis is the strain of rat. following housing of lewis and fischer 344 strains together to eliminate microbial and environmental differences it was shown that the lewis strain developed a more severe rhinitis following inoculation with mycoplasma pulmonis than fischer 344 rats, although the reason for the difference was unclear."^^ rats exposed to ammonia, a common pollutant of the air in laboratory animal cages, have also been shown to develop lesions of the dorsal meatus, dorsal nasal septum and prominence of the turbinates.^^ these lesions are characterized histologically by swelling or mild degeneration of the epithelium. it appeared that ammonia exposure potentiated the acute inflammatory response of the nasal cavity to microbiological pathogens. a microorganism reported in the nasal cavity of rhesus monkeys employed in inhalation studies is the nematode of the genus anatrichosoma.^^ sections of this nematode are found in the squamous epithelium of the nasal vestibule and are associated with acanthosis and hyperkeratosis of the epithehum and a multifocal or diffuse granulomatous inflammation in the submucosa. administration of toxic or irritant substances to laboratory animals by the inhalation route produces degenerative, inflammatory and reactive changes in the nasal mucosa. the range of histological features is similar to those found in other mucosal surfaces damaged by other exogenous agents. whilst therapeutic agents administered by the inhalation route do not usually produce a severe degenerative or inflammatory responses in the nasal mucosa, at least at therapeutic doses, the simple categories proposed by hardisty and colleagues in recording of degenerative and reactive lesions following exposure to volatile chemicals are useful.'^^ categories suggested are: degeneration, regeneration, atrophy (postdegenerative), respiratory metaplasia and basal cell hyperplasia and inflammation. degeneration is usually the earliest morphological change characterized by loss of sensory and sustentacular cells resulting in a thinner mucosa. bowman's glands and nerve bundles, individual cell necrosis may be seen in more severe cases. regeneration is characterized by proliferation of basal cells associated with an epithelium that loses its regular structural features. post-degenerative atrophy usually follows severe damage and is characterized by loss of sensory and sustentacular cells. respiratory metaplasia is a process whereby the normal olfactory mucosa is replaced by pseudostratified epithelium of respiratory type often with cilia. basal cell hyperplasia represents a longer term effect where the proliferating basal cells form a distinct layer of cells below the respiratory epithelium. an example of the type and distribution of the degenerative and inflammatory conditions which can be induced by inhaled irritants is provided by the study in which swiss-webster mice were given various irritants by inhalation for periods of 6 hours per day for 5 days at concentrations that produced a 50% decrease in respiratory rate (alarie test). although the degree of histological changes varied with different agents, the changes were broadly similar in type and distribution.^^ most agents examined produced little or no alteration in the squamous mucosa lining the anterior part of the nose apart from some mild increase in thickness of the squamous layers. principal sites of damage were shown to be the anterior respiratory epithelium adjacent to the vestibule and the olfactory epithelium of the dorsal meatus. there was a distinct decrease in severity in posterior regions. histologically, the lesions in respiratory epithelium ranged from mild loss of cilia and small areas of epithelial exfoliation to frank erosion, ulceration and necrosis of the epithelium and underlying tissues including bone. variable polymorphonuclear cell infiltration was also found. in some cases, early squamous metaplasia developed on the free margins or the naso-maxillo-turbinates. changes to the olfactory epithelium varied from focal to extensive loss of sensory cells associated with damage to sustentacular cells. in severe cases, complete loss of olfactory epithelium occurred. although the degree of histological change was shown to vary with different agents, lesions induced by the more water-soluble chemicals tended to remain localized in the anterior part of the nasal cavity whereas agents with relatively low water solubility produced lung lesions in addition. it was suggested that these findings demonstrated the powerful 'scrubbing' action of the nasal cavity for water soluble, airborne xenobiotics.^^ inflammatory alterations have been induced in the nasal cavity of rodents treated with therapeutic agents at high doses by inhalation. significantly irritant substances do not make viable therapies. however, the precise relevance of such changes for human therapy by the inhalation route are sometimes questionable when the nasal damage is limited to high doses and it is not associated with alterations in other parts of the respiratory tract. in the case of tulobuterol, a 32-adrenergic receptor agonist, it was argued that the nasal inflammation induced in rats in a one month inhalation toxicity study was the result of a particularly high exposure of the nasal epithelium to drug, not representative of the likely human exposure to tulobuterol by inhalation, where little or no nasal exposure would occur.^^ rp73401 [3cyclopentyloxy)-ar-(3,5-dichloro-4-pyridy)-4-methoxybenzamide], a novel type iv phosphodiesterase inhibitor which was being developed for the treatment of asthma and rheumatoid arthritis, was also reported to produce degeneration of the olfactory epithelium in rats but neither dogs nor mice after single and repeated oral doses and by inhalation.^^ histologically, the olfactory epithelium showed necrosis of the superflcial epithelial layers including the sustentacular and sensory cells, with sparing of the basal cell layer. there was also damage to bowman's glands. the development of proliferative lesions and ultimately tumours of principally neuroectodermal origin followed chronic treatment. as rp73401 was highly metabolized and the nasal lesions could be inhibited by treatment of rats with metyrapone, a non-speciflc inhibitor of cytochromes p450, it was postulated that the changes were the result of p450mediated activation in the olfactory tissues, not linked to its pharmacological phosphodiesterase activity.^^ nasal epithelial degeneration and necrosis has also been reported in both rats and dogs treated with another candidate anti-inflammatory drug ci-959 by the intranasal route. this agent affected olfactory epithelium more than respiratory mucosa, suggesting that metabolism was important in the generation of this toxicity^^ although the nasal cavity has not been often examined histologically in great detail in toxicity studies conducted on drugs administered orally or by parenteral routes, damage to the nasal mucosa can be induced by drugs administered by these routes. one example is methimazole, a thioureylene antithyroid drug used in clinical practice where oral doses of 0.2-2mg/kg/day are employed and abnormalities of taste and smell have been described.^^ administration of methimazole at relatively high doses to long-evans rats by single oral (50mg/kg) or intraperitoneal (25mg/kg) routes was shown to produce damage to the sustentacular and sensory cells with sparing of the basal cells and basement membrane.^^ bowman's glands were also involved. methimazole is metabolized by the flavin-containing monooxygenase system and it is employed as a model substrate for this enzyme in vitro. the presence of flavin-containing monooxygenase isoforms in olfactory mucosa of long-evans rats suggested that reactive intermediates may be responsible for the nasal toxicity ^^ similar changes have been reported in mice where depletion of glutathione in the olfactory mucosa has been demonstrated also suggesting formation of local reactive metabolites.^^ histological examination has also shown that intravenous administration of a single dose of vincristine to mice damages the olfactory epithelium.^^'^^ vincristine is a vinca alkaloid derivative used in cancer therapy which has antimitotic activity and binds to tubulin. cell death was noted in olfactory cells 2-5 days after dosing with a peak of cell proliferation at 5 days and repair after about 10 days. these features resemble those that can be seen in other proliferating tissues after single doses of antimitotic drugs. the risk of damage to human olfactory cells from agents with these effects in rat nasal mucosa often remains uncertain because an understanding of relative exposure and metabolism in different species and a better understanding of the metabolic potential of human olfactory mucosa is required. a particular response of the rodent nasal mucosa to some irritant substances, including pharmaceutical agents, is the formation of rounded eosinophilic inclusions in the cytoplasm of sustentacular cells of the olfactory epithelium and to a lesser extent in respiratory and glandular epithelial cells.^^'^^ these inclusions are pas-negative and ultrastructural examination shows that they are membrane-bound, ellipsoid bodies containing homogenous electron dense matrix. their significance remains uncertain. a consensus classification for the variety of proliferative, non-neoplastic changes and atypical epithelial lesions and neoplasms found in the rat nasal cavity has been defined by schwartz and colleagues.^^ the classification of the international agency for research on cancer provides a similar perspective for rats and mice.^^'^^ proliferative lesions may be occasionally seen in untreated rodents in carcinogenicity studies but are much more commonly induced by administration of xenobiotics in inhalation carcinogenicity studies. spontaneous nasal tumours are uncommon but most often squamous in type in rats whereas in mice spontaneous squamous tumours are extremely rare and haemangiomas and respiratory adenomas predominate.^^'^^ the generally agreed categories are described below: mucous (goblet) cell hypertrophy and hyperplasia affects the nasal respiratory epithelium and are characterized by the presence of enlarged mucus-filled goblet cells, some of which form clusters suggestive on intraepithial glands. squamous cell hyperplasia is seen in the stratified squamous epithelium of the nares and is characterized by a focal increase in the number of cell layers. cells may show atypia with irregular enlarged, pleomorphic nuclei and nucleoli. squamous metaplasia occurs to respiratory epithelium under conditions of chronic damage. it is characterized histologically by the presence of three or more layers of epithelial cells with eosinophilic cytoplasm and clear cell boundaries whereas advanced lesions show typical keratinization and formation of intercellular bridges. cellular atypia may also be seen and should be characterized when found. respiratory epithelial metaplasia (of the olfactory epithelium) represents atrophy and degeneration of the olfactory epithelium with loss of sensory cells and in advanced cases loss of sustentacular cells with replacement by ciliated and non-ciliated respiratory epithelium. it may be seen as a spontaneous focal lesion in aged rats. epithelial hyperplasia with cellular atypia (atypical hyperplasia, basal cell hyperplasia, dysplasia) is a term used to embrace proliferative lesions in the respiratory and olfactory mucosa in the nasal cavity in which there is varying degrees of altered differentiation and atypia. there is perturbation of the growth pattern of the epithelium such that the changes are not those found in the normal regenerative response to transient mucosal damage. adenomas (polypoid or villous adenoma, adenomatous or villous polyp) usually develop in the anterior part of the nasal cavity and are usually exophytic lesions that develop from respiratory epithelium or nasal glands. adenomas of respiratory epithelium may be papillary in form but are, by definition, well circumscribed with minimal cellular pleomorphism and atypia. they may very occasionally occur spontaneously in aged rats.^^ adenomas of nasal glands usually show an acinar pattern. squamous cell papillomas develop in the squamous epithelium of the nares or in areas of squamous metaplasia in respiratory or olfactory epithelium. they are exophytic lesions with limited connective tissue stroma. they may develop spontaneously in aged rats.^^ carcinomas of either squamous or glandular differentiation develop in the nasal mucosa. histologically, they have similar characteristics to those in other epithelial tissues. they are rare spontaneous lesions in aged laboratory rodents but may be induced by xenobiotics administered by inhalation, orally or by the parenteral route. squamous carcinomas have been reported to develop in a small number of untreated fischer 344 rats used in carcinogenicity studies in association with point mutations in the c-h-ras and c-k-ras gene.^^ olfactory neuroblastoma (ethesioneuroblastoma, olfactory neuroepithelioma, olfactory neuroepithelial carcinoma) show olfactory differentiation and arise from olfactory epithelium. they do not seem to occur as spontaneous lesions in rats or mice and only rarely induced.^^'^^ cells are arranged in lobules or in solid sheets with scanty stroma. cells are relatively uniform with scanty cytoplasm with round or oval hyperchromatic nuclei. true rosettes with lumens or pseudorosettes are also seen. poorly differentiated tumours of this type may require ultrastructural study for diagnosis. olfactory neuroblastomas typically show the presence of electron-dense neurosecretory granules, neurofilaments or axons. as there is no detailed understanding of the biological behaviour of these neoplasms in laboratory rodents, the generic term olfactory neuroblastoma is usually preferred. they are almost always invasive tumours.^^ olfactory carcinomas forming glands, follicles and rosettes have been occasionally reported in aged syrian hamsters.^^'^^ mesenchymal neoplasms may be seen in the nasal cavity, particularly after exposure to potent carcinogens. their histological features are similar to those in the soft tissues and bone elsewhere in the body (see chapter 2). the mucosa lining the larynx and trachea becomes involved as part of an upper or lower respiratory tract infection. for instance, in rats, an acute laryngitis or tracheitis has been shown to accompany experimental infection with mycoplasma pulmonis and the sialodycroadenitis virus."^^'^^ a spontaneous degenerative condition of tracheal and laryngeal cartilage of uncertain pathogenesis associated with granulomas has been reported in fischer 344 rats.^^ the condition increases in severity and incidence with advancing age although it is seen in rats as young as 6 weeks of age. tracheal cartilage rings may also show alterations in genetically engineered animals, such as the c57bl/6j-tgn(c3-l-tag)cjeg (tag) mice that have generalized defects in cartilage development.^^ the larynx of rodents is also susceptible to the effect of inhaled substances, notably tobacco smoke but also pharmaceutical agents and propellants.^^'^^ in view of the localized nature of induced lesions in the larynx, standardized histological sectioning techniques have been proposed for rats, mice and hamsters using anatomical landmarks.^^"^^ the target site is located on the ventral floor of the larynx near the base of the epiglottis cranial to the ventral laryngeal diverticulum. lesions tend to occur in the ventrolateral region, which is covered by respiratory epithelium and the inner aspect of the arytenoid processes which is lined by squamous mucosa. the larynx responds to inhaled irritants by inflammatory, degenerative and regenerative changes in a manner similar to other regions of the respiratory tract. these include disruption of the epithelial cells, inflammatory cell exudates and infiltration, goblet cell hyperplasia and squamous metaplasia.^^ however, these changes are not specific to inhaled irritants but also occur as a response to natural respiratory tract pathogens in conventionally housed rats.'^^ the pseudostratified ciliated and non-ciliated mucosa of the trachea may also show pathological alterations in inhalations studies, although sites at the bifurcation (carina) are those often first affected. consequently, the carina should be systematically included in examination of the respiratory tract for induced lesions.^^'^^ as in the nasal passages a range of proliferative lesions including squamous hyperplasia, mucous cell hyperplasia, as well as papilloma, carcinoma and mesenchymal tumours are occasionally reported in the airways in laboratory rodents. in humans and laboratory animals, the trachea terminates at the bifurcation giving rise to two main bronchi which serve left and right lungs. depending on species, the main bronchi subdivide into further branches that enter the different lobes. various forms of branching are recognized. bronchi may arise as side-branches from a parent or stem bronchus (monopodial). the parent bronchus can divide into two equal daughter bronchus (dichotomous) or several daughter bronchi ipolychotomous)j^ study of silicone rubber casts of the respiratory tract has shown that the bronchial trees of humans and non-human primates are essentially dichotomous, in contrast to the monopodial pattern of rodents.^^ the comparatively long trachea of the dog gives rise to dichotomous upper airways but monopodial branching develops peripherally within each lobe. the size of the lungs is generally dependent on size and weight of the different species. auometric studies have shown that lung volume, alveolar surface area and diffusing capacity increase proportionally with body weight across a broad range of mammalian species, although cell size and surface area appear to be more determined by cell function rather than species size.^^ dogs have comparatively smaller body mass and higher airway dimensions compared to humans.^^ the number of lobes is species-dependent. the human lung possesses an upper and lower left lobe and an upper, middle and lower right lobe. this contrasts with the upper, middle and lower left lobes and a fourth, azygos right lobe in rhesus monkeys and baboons.^^ the dog has three lobes on both right and left sides. rats, mice and hamsters show cranial, middle, caudal and postcaval right lobes with a single, left lobe in mice and rats and a superior and inferior lobe on the left side in hamsters. cell types lining the bronchi are generally similar between species.^ the majority of cells are the ciliated cells that are accompanied by variable but relatively smaller proportions of basal cells, intermediate cells, mucous or goblet cells, serous cells, neuroendocrine and brush cells. in addition, mucous cells line the adjacent bronchial glands.^^ unlike the tracheal mucosa, which is pseudostratified, the mucosa of intra-pulmonary bronchi is non-stratified. ciliated cells are tall, columnar cells attached to basal and intermediate cells by desmosomal junctions. tight junctions exist between adjacent specialized cells at the apex. each cell possesses 200 or more cilia that are engaged in mucociliary clearance.^^ the superficial cell surface also shows a pronounced glycocalyx. the cytoplasm of ciliated cells contains scattered profiles of rough endoplasmic reticulum, a supranuclear golgi and numerous mitochondria particularly near the apex where a prominent cytoskeleton is also found. mucous or goblet cells are typical mucus-secreting cells representing about 10% of the bronchial mucosa cell population in man but less than 1% in pathogenfree rats.^ the serous cell is a cylindrical or pyramidal cell containing small, round, closely packed serous granules.^^ basal cells are compact, pyramidal cells resting on the basement membrane. they are believed to be progenitor stem cells with the intermediate cells representing an intermediate stage of cell differentiation. the mucus-secreting and ciliated cells form the cellular basis for the mucociliary clearance mechanism of the main conducting airways. the epithelium is covered by a mucous blanket that is fairly complete in humans and rabbits but patchier in rats.^ the mucous layer is segregated into an upper layer or gel phase separated from epithelial cells by a serous layer or sol phase. the complex carbohydrates of the glycocalyx and secreted mucosubstances show species-related differences in their sugar residues, which can be demonstrated histochemically by the use of labelled-lectins.^^ mucociliary clearance mechanisms are sensitive to the effects of many therapeutic agents, particularly those that alter mucins, fluid or electrolyte balance and ciliary activity. anaesthetic gases, barbiturates, narcotics and alcohol depress clearance function. by contrast, topical, oral or parenteral administration of (3-adrenergic agonists, isoprenaline and adrenalin, produce a dose-dependent stimulation of mucociliary transport by an effect on ciliary beat frequency, probably mediated by increasing levels of cyclic adenosine monophosphate in ciuated cells rather than through vascular changes. although basal mucociliary function is dependent on normal vagal tone, parasympathomimetic agents can affect mucociliary transport. acetylcholine and cholinergic agents stimulate ciliary activity whereas anticholinergic drugs, atropine and hyoscine, inhibit ciliary activity and mucociliary transport. these substances may alter deposition of inhaled particles in the lung.^ clara cells or non-ciliated bronchiolar cells located in the bronchiolar epithelium, first described by clara in 1937, are small and cylindrical in shape with highly infolded nuclei, surface microvilli, well developed golgi, abundant endoplasmic reticulum and characteristic oval, homogeneous electron-dense granules in the apical cytoplasm. in rats, rabbits and humans the granules are pas-positive, although they are usually considered pas-negative in hamster and mouse.^^ clara cells have high metabolic activity. they contain cytochrome p450-dependent enzymes and secrete a variety of proteins.^^"^^ clara cell secretory protein is the major component of their cytoplasmic granules and they have been shown to produce mucin following antigen challenge.^^ in most laboratory rodents, the conducting airways terminate abruptly at the non-cartilaginous terminal bronchiole that opens directly into an alveolar type airway, the alveolar duct which in turn communicates with the alveoli.^^ squamous epithelial or type i cells form only about 10% of all lung cells but they line over 90% of the alveolar surface, by virtue of extremely long cytoplasmic extensions. the principal gas exchange takes place across this cell. in the rat, the typical thickness of this barrier is 20 nm for a cytoplasmic extension of a type i pneumocyte, 90 nm for basal lamina and 90 nm for an endothelial cell.^^ the type i cell contains juxtanuclear mitochondria and the long smooth cytoplasmic extensions contain many ribosomes and pinocytotic vesicles. the anatomical configuration and function of type i cells render them highly vulnerable to inhaled gases and particles. the other main alveolar lining cell is the granular pneumocyte or type ii cell which constitutes about 10% of all lung cells, but which covers only about 5% of the alveolar surface.^^ this cell does not possess the long cytoplasmic processes typical of type i cells and it shows many microvilli on its luminal surface. the cell cytoplasm contains rough endoplasmic reticulum, golgi apparatus, some mitochondria and characteristic oval, osmiophilic lamellar inclusions. surfactant, a microaggregate of phospholipid and protein which modifies alveolar surface tension at low inflation volumes, is secreted by type ii alveolar cells. ultrastructural immunocytochemistry has shown the presence of surfactant apoproteins in the synthetic organelles and in the lamellar bodies of these cells, in agreement with the concept that the surfactant apoproteins are synthesized in the rough endoplasmic reticulum, glycosylated in the golgi and are stored in lamellar bodies.^^ type ii cells are more resistant to the damaging effects of xenobiotics and unlike type i cells they retain the ability to undergo mitotic division. following damage to type i cells, increased numbers of mitoses are evident in type ii cells which results in the appearance of large undifferentiated epithelial cells which ultimately differentiate into type i and type ii cells.^^ the lung also contains a dense neural network and a population of endocrinelike cells believed to be important in lung function.^^ these neurosecretory cells (kultschitsky or apud cells) are scattered sparsely in the epithelial surface of the larynx, trachea bronchi, bronchioles and alveoli. these cells are oval or cuboidal with oval nuclei, and argyrophilic cytoplasm which electron microscopic examination shows to contain dense core granules. the role of neuroendocrine cells in the lung is uncertain but immunocytochemical study has shown them to contain a number of neuroendocrine substances including neurone-specific enolase, synaptophysin, chromogranin and a variety of other peptides similar to vasoactive intestinal peptide, bombesin, calcitonin, serotonin, leu-encephalin, p endorphin and acth.^^'^^ cells lining the bronchi, bronchioles and alveolar walls are capable of metabolizing xenobiotics. immunocytochemical study has shown the presence of immune-reactive cytochromes p450, nadph cytochrome p450 reductase, epoxide hydroxylase and glutathione s-transferase in bronchial epithelial cells, ciliated bronchiolar cells, clara cells, type ii and possibly type i pneumocytes in the rat lung.^^ different cell populations contain different amounts of enzymes, clara cells containing the greatest concentrations of the phenobarbitoneinducible isoenzyme of cytochrome p450, nadph-cytochrome p450 reductase and epoxide hydrolase. studies of microsomal enzyme activities suggest that lung tissue contains fewer p450 isoenzymes than liver, principally forms cyplal cyp2b1, cyp3a2 and cyp4bl^^ whereas p450 enzyme activity is highly concentrated in specific cell types, overall microsomal enzyme activity is low compared with liver on the basis of microsomal protein weight.^^ other important cells are the pulmonary alveolar macrophages and lymphocytes. lymphocytes are found in the epithelium of the airways, in the interstitium of alveoli and as part of follicles in bronchial walls. pulmonary macrophages form part of the specific immune defence system of the lung, involving, as elsewhere in the body, antigen presentation. in the rat and mouse, distinctive populations of pulmonary macrophages have been described based on enzyme activities and reactivity to monoclonal antibodies against monocyte and macrophages surface determinates.^^'^^ bronchus associated macrophages in rat and mouse have more acid phosphatase and less non-specific esterase activity than the populations found in the pulmonary alveoli and interstitial tissues. an important aspect of the immune system is the bronchus-associated lymphoid tissue or balt, which forms part of the mucosal lymphoid system found in other epithelia. the morphology of balt is a useful guide to the nature and degree of immune stimulus in the lung. balt is organized in a way that is characteristic of other peripheral lymphoid organs. it is structurally similar in the laboratory rat, mouse, rabbit, guinea pig as well as in man but its size and prominence is species and strain-dependent as well as a function of the degree of antigenic stimulus^"^"^^. in the rat, the balt is composed of lymphoid aggregates or fouicles located mostly between a bronchus and artery with a zone of lymphocytes situated immediately under the bronchial epithelium. as in other peripheral lymphoid tissue, balt is organized into b and t cell zones but in no predetermined manner. immunocytochemical staining has shown that b and t lymphocyte zones differ in location from one aggregate to another. there are about two t lymphoc3^es for every three b cells compared with a ratio of 2:5 in rat peyer's particles.^^ the ratios may be different in other species. quantitative observations of t cell subsets using monoclonal antibodies have also shown that rat balt normally contains twice as many t-helper as t-suppressor/cytotoxic lymphocytes.^^ the t cells are confined to one or two discrete zones with a light scattering of t cells within the b cell zones and immediately under the bronchial epithelium. in common with lymph nodes, interdigitating cells are also found. the epithelium overl3dng balt shows anatomical modifications. it is composed of ciliated and non-ciliated cells covered by microvilli. in conventional, untreated laboratory rats, balt shows little activity and germinal centres are usually absent, although balt may be more prominent in some rat colonies in association with non-specific inflammatory lesions in lungs.^^'^^ in one colony of young wistar rats germinal centres were not seen in balt in untreated animals but they developed following the administration of a single intratracheal dose of lipopolysaccharide, a t cell-independent antigen.^^^ single intratracheal doses of t cell dependent antigens such as horseradish peroxidase, bovine serum albumin and bcg have been shown to produce only minor morphological changes which include expansion of the zone of lymphocytes immediately under the epithelium and infiltration of the bronchial epithelium overlying balt by lymphocytes.^^^ in addition, perivascular, peribronchial or alveolar infiltrates of small and large lymphocytes and macrophages were observed in the lungs of rats given bcg. immunoc3^ochemical study of the rat balt following intratracheal challenge with horseradish peroxidase showed that the majority of cells that infiltrated the bronchial epithelium were t helper (cd4 positive) lymphocytes. ^^^ furthermore, la antigen expression of the epithelial cells overlying the balt was shown to increase, associated with an increase in the number and size of microvilli, a more pronounced glycocalyx and a decrease in number and size of cilia. immunocytochemical study of the balt tissue in c57b1/6 mice using monoclonal antibodies to lymphoid and macrophage populations has demonstrated quite similar arrangements of cells to those in the rat with the majority of t cells belonging to the t helper (cd4 positive) class.^^ the pulmonary lymphatic system drains into mediastinal or cervical lymph nodes. although among rat strains differences in the location of lymph nodes and their drainage occur, tracer studies in the fischer 344 rat using colloidal carbon have shown that the lung lymphatics drain mainly into posterior mediastinal lymph nodes and those in the tracheal wall drains primarily to the internal jugular and posterior cervical nodes.^^^ although a variety of fixation, embedding and staining procedures are available for light and electron microscopic examination of lung tissue, there is no substitute for initial, careful visual inspection of the lungs at autopsy. uneven collapse of lungs on opening the thoracic cavity, discoloration or alteration in texture of the pleural or cut surface, congestion and presence of fluid in the larger airways may indicate structural damage. in rodent lungs, small pulmonary adenomas may be detectable by inspection in good light. fresh lung weight is also a helpful measure in lung assessment, although passive vascular engorgement can significantly affect this value. nevertheless, studies in the normal fischer 344 rat have shown that after exsanguination, wet lung weights show a close relationship to body weight and that dry weight of lungs consistently represents about 20% of the wet weights regardless of age or body weight. ^^^ an increase in wet weight over dry weight appears to be a good index of pulmonary oedema. ^^ various methods of fixation have been employed although simple immersion fixation in formalin for conventional light microscopy has the virtue of simplicity and it avoids the risk of translocation or removal of exudates from airways and alveoli. mixtures of formaldehyde, paraformaldehyde and glutaraldehyde are used in initial fixation for electron microscopy.^^ the best overall appreciation of lung architecture is achieved by instillation of fixative via the trachea under an appropriate constant pressure or by perfusion fixation of the pulmonary arteries that is less liable to dislodge intra-alveolar exudate. in a review of methods employed routinely in rodent toxicity studies, instillation of fixative via the trachea was the preferred method in most laboratories because its advantages were seen to outweigh its disadvantages.^^ the sampling procedure is an important aspect of histological examination of the bronchi and lungs, particularly those of large laboratory animals. the extent of histological sectioning in conventional toxicity studies should be modulated to take account of lesions found by macroscopic examination, the type of study and the nature of the test substance. the bronchi should be carefully sampled to allow assessment of any alterations in bronchial epithelium. morphometric analysis represents a sensitive tool of value in the evaluation of drug-induced lung changes, but it requires particularly rigorous sampling and evaluation procedures.^^^'^^^ a tiered, multiple stage or cascade sampling technique is normally considered the most appropriate for morphometric studies.^^'^ this involves dividing the lung into a series of homogeneous compartments or strata from which randomly selected samples can be examined by appropriate light or electron microscopic techniques. conventional special stains for reticulin and collagen as well as pas and alcian blue for mucins are helpful in the characterisation of lung damage and changes to the respiratory epithelium. immunocytochemistry and enzyme cytochemistry are also useful in the study of the heterogeneous cell population of the lung. xenobiotic metabolizing activity can be studied both by enzyme cytochemical methods as well as by immunocytochemical techniques using antisera specific for pulmonary monooxygenases and related enzymes.^^ important structural components, particularly collagen and laminin can be studied both at light and ultrastructural level with immunocytochemical methods.^^^ cytokeratin immunocytochemistry can be used as a method for the characterization of changes to epithelial cells.^^ clara cells can be localized by the presence of clara cell secretory protein and ciliated cells by the presence of tubulin.^^ endocrine cells are visualized by immunocytochemistry using antibodies to general neuroendocrine markers such as chromogranin and synaptophysin or regulatory peptides.^^ other useful antigens, which can be demonstrated in the lung, include surfactants, lysozyme, immunoglobulins and those of microorganisms that infect the lung.^^^ electron microscopy is particularly useful for the detailed characterization of injury to the cells of the alveolar epithelium and endothelium ( figure 6 .1). pulmonary oedema is a component of many inflammatory conditions of the lung, including those induced by infectious agents. however, the term oedema is reserved for a poorly cellular exudate characterized by the presence of pale, homogenous eosinophilic material in the alveoli, sometimes associated with a similar exudate in the lung septae and perivascular connective tissue. it occurs in a number of spontaneous conditions such as in congestive cardiac failure, metastatic pulmonary neoplasms or as an agonal change in association with pulmonary congestion and haemorrhage. drugs may induce cardiogenic pulmonary oedema as a consequence of pulmonary hypertension or impaired ventricular contractility. cardiogenic oedema is often associated with vascular congestion and red blood cells and haemoglobin may leak into airspaces. this can give rise to the presence of haemoglobin crystals within the oedema fluid in formalin-fixed tissue sections. most importantly, pulmonary oedema may be a manifestation of acute lung injury. inhalation or systemic administration of toxic chemicals may produce acute pulmonary oedema (see figure 6 .1). some substances such as phenylthiourea and a-naphlythiourea produce massive pulmonary oedema in laboratory animals when administered orally, principally as a result of damage to the endothelium of pulmonary capillaries and venules. ^^^ over 30 drugs have been reported to produce non-cardiogenic pulmonary oedema in humans, either directly or through poorly understood immunogenic mechanisms.^ another form of pulmonary oedema involves the main airways. allergic reactions in sensitized airways of asthmatic individuals is believed to result from cross-linking of ige and activation of mast cells that degranulate and release inflammatory mediators. ^^^ this has been reproduced in the main airways of rats sensitized to ovalbumin and then challenged with ovalbumin by the intratracheal route. ^^^ this treatment leads to rapid accumulation of bronchial exudate, degranulation of mast cells and the development of mucosal oedema, most marked immediately below the respiratory epithelium. congestion and haemorrhage is a frequent finding in the lungs of laboratory animals, where it is usually related to certain modes of death. it can be associated with administration of drugs and chemicals that have adverse effects on cardiac function or on the coagulation system. administration of heparin to rats produces a characteristic extravasation of blood into the air spaces.^^^ lower respiratory tract infection is generally not a major health hazard among laboratory animals but it is nevertheless an ever-present threat that can cause overt respiratory disease within a colony or develop following administration of xenobiotics. subclinical pulmonary infections and infestations can also produce histological alterations in the bronchial airways or pulmonary parenchyma which mimic changes induced by inhaled irritants or systemically administered drugs.^^'^^ furthermore, some respiratory pathogens alter immune defences and exacerbate the effects of inhaled substances. ^^^ a range of bacterial and viral pathogens may produce inflammatory lung changes.^^ typically, bacterial pathogens such as steptococcus pneumoniae produce acute bronchitis associated with a variable degree of acute inflammation of the lung parenchyma (bronchopneumonia) or a confluent lobar pneumonia. viral agents are generally associated with histological features of bronchiolitis and interstitial pneumonia, characterized by an increase in mononuclear cells in the respiratory bronchioles and alveolar septa. the histological features are variable for they depend on the particular pathogen, species and strain, immune status, presence or absence of secondary infection and the particular stage at which the infection is examined. respiratory infections are frequently mixed. changes due to secondary bacterial infection are frequently superimposed on those induced by viruses. sequential histopathological examination of the lungs of laboratory animals following inoculation with respiratory tract pathogens has been able to characterize the evolution of pathological changes produced by individual organisms. for instance, following inoculation with mycoplasma pulmonis, one of the more important respiratory pathogens among laboratory rodents both lewis and fischer 344 rats were shown to develop upper and lower respiratory tract inflammation. in the lewis strain this was characterized after 28 days by a variable acute inflammatory exudate in bronchi and bronchioles with focal bronchiectasis, inflammation and hyperplasia of the epithelium with a predominantly macrophage infiltration of the alveoli and alveolar walls.^^'^^^ these changes were associated with marked hyperplasia of the bronchusassociated lymphoid tissue (balt), which extended down the airways and blood vessels towards the periphery of the lungs. although the lymphoid hyperplasia was also found in inoculated fischer 344 rats, it was less marked and accompanied by little or no mucopurulent exudate or active inflammation of the bronchial walls. this disparity in response suggested that differences were related to the degree of lymphocyte activation in the two strains, an imbalance in regulation of lymphocyte proliferation in lewis rats, or both.^^^ other studies have been conducted in both rats and mice infected with another important respiratory pathogen of laboratory rodents, the sendai virus (parainfluenza type 1). sequential studies showed that the initial damage to bronchial and bronchiolar epithelium is associated with polymorphonuclear and lymphocytic inflammation (bronchiolitis). immunocytochemical and ultrastructural studies revealed the presence of viral antigen in the mucosa.^^^ hyperplastic and multinucleated syncytial epithelial cells develop in the hyperplastic terminal bronchiolar epithelium and the inflammatory process extended to involve peribronchial or peribronchiolar parenchyma with infiltration of alveolar walls by mononuclear cells, macrophages and neutrophils. a similar cell population accompanied by cell debris and oedema fluid develops in air spaces. pulmonary arteries show only minor involvement with inflammatory cells and focal reactive hyperplasia of the endothelium. immunocytochemistry and ultrastructural examination suggested that virus replication takes place in alveolar type i and type ii epithelial cells and macrophages but not in endothelial or interstitial cells of the alveolar septae.^^^ it was shown that when repair occurs there may be residual distortion of bronchiolar and alveolar walls by collagen and hyperplastic cuboidal epithelium may line the thickened alveolar septa. air spaces may also contain enlarged macrophages with pale vacuolated cytoplasm.^^^ strain differences in susceptibility have also been demonstrated to this virus. there is differential pulmonary interleukin 12 (il-12) gene expression between virus-susceptible brown norway rats and resistant fischer 344 rats and il-12 treatment provides protection from virus-induced chronic airway inflammation and remodelling. moreover increased tumour necrosis factor a (tnfa) expression has been shown to be an important regulatory factor in the development of sendai virus-induced bronchiolar flbrosis in infected rats.^^^ virus-inoculated brown norway rats had increased tnfa pulmonary mrna levels and increased numbers of bronchiolar macrophages and fibroblasts expressing tnfa protein compared with virus-inoculated f344 rats.^^^ the corona virus, which causes sialodacryoadenitis in many rat colonies, also produces lower respiratory tract inflammation. this is characterized by acute bronchitis and bronchiolitis with focal extension into lung parenchyma. thickened oedematous, hypercellular alveolar walls infiltrated by monocytic cells are found.^^ immunocytochemistry has shown the presence of viral antigen in bronchial and bronchiolar epithelial cells. there is also peribronchial lymphocytic infiltration and increased prominence of balt. ultimately complete resolution occurs. viruses remain a potential source of spontaneous respiratory disease in laboratory dogs. canine adenovirus type 2, parainfiuenza sv5, canine herpes virus, coronavirus and parvovirus have all been isolated from laboratory dogs developing respiratory disease.^^^ the syndrome of visceral larva migrans also incites focal inflammation, granulomas and fibrosis in the lungs of species such as dog and primate in which parasites are prevalent. the syndrome of visceral larva migrans is usually defined as that which results from the migration of nematode larvae into the viscera. it has been well described in the beagle dog lung where it results from the larvae of toxocara species or metastrongyloid nematodes.^^^'^^^ the precise identification of parasites is not always possible in tissue sections. histological appearances of infested lungs are highly variable. nematodes surrounded by granulomas and granulomatous inflammation, mostly in a subpleural location, may be visible in sections. in affected lungs there may be perivasculitis and active arteriolitis, bronchiolitis and peribronchiolitis. pleural involvement by the inflammatory process can be marked, particularly in regions overlying granulomas. scarring develops and pleural and sub-pleural fibrosis is frequently associated with epithelial hyperplasia and squamous metaplasia of the associated airways ( figure 6 .2).^^^ the lesions may sufficiently severe to resemble those induced by high doses of anticancer drugs such as bleomycin (see below). pulmonary acariasis is a common infestation of many species of non-human primates caused by various species of the mite pneumonyssus. reproduction of the mites appears to take place in the terminal bronchioles. pneumonyssus simicola is the recognized form found in rhesus monkeys.^^^ although it is most prevalent in wild caught primates, the disease is not easily eliminated during breeding in captivity. ^^^ even when eliminated by ivemectin the lesions of chronic bronchiolitis, bronchiectasis and pigmentation may persist as an incidental finding. ^^^ as the mite can produce significant destructive pulmonary pathology and render animals susceptible to secondary pulmonary bacterial infections, it can disrupt or confound the interpretation of toxicity studies performed in primates. the lesions are located most frequently in cranial lobes and are characterized by the presence of bullae distending the pleural surface, parenchymal cysts, nodules and scar tissue.^^^'^^^ histologically, there is a wide range of inflammatory activity. fully developed lesions are characterized by granulomatous bronchiolitis and peribronchiolitis with involvement of immediately adjacent alveoli. cystic lesions involving the bronchiolar walls develop around the parasites giving rise to the appearance of walled-off cysts composed of highly cellular granulation tissue, associated with neutrophils, lymphocytes, macrophages, multinucleated giant cells and various pigments (see below). in less active lesions, dilated, cystic airways with walls composed of thick bands of smooth muscle and lined by squamous or cuboidal epithelium are found. pneumocystis carinii is an important cause of pneumonia in patients with the acquired immunodeficiency syndrome (aids) as well as in other immunocompromised patients, including those treated with immunosuppressive drugs.^^"^ the natural habitat of pneumocystis carinii is pulmonary alveoli and it is widely encountered in the human population without being associated with overt disease. both clinical and experimental evidence suggests that impaired cellular immunity is much more important as a predisposing factor than impaired humoral immunity. ^^^ as in humans, laboratory animals may have latent pneumocystis infection that becomes clinically evident following immunosuppression. it has been shown in the rat that chronic administration of various regimens of adenocorticosteroids, low protein diets, cyclophosphamide and other immunosuppressive drugs with concomitant antibiotic administration to prevent other infections gives rise to typical pneumocystis pneumonia. ^^^ rodents with genetically deficient cellular immunity also develop pneumocystis pneumonia. the importance of pneumocystis pneumonia in toxicology is that it can be considered as a sentinel of chronic immune depression. in haematoxylin and eosin stained sections, pneumocystis pneumonia is characterized in both humans and rodents by the presence of alveoli filled with foamy eosinophilic material containing a few macrophages and indistinct nuclei of pneumocystis (figure 6 .2fe). ovoid or crescent-shaped structures of the organisms become clearly visible with gomori methenamine silver or toluidine blue stains. ultrastructural study of rats with pneumocystis pneumonia shows that trophozoites attach themselves most frequently to type i pneumocytes by altering their morphology to the contours of the pneumocytes rather than by a process of invasion. ^^^ systemically administered therapeutic agents may produce histological changes within the lung parenchyma that mimic components of the normal response to respiratory pathogens. however, there is no sharp separation between agents that produce pulmonary oedema with those that are associated with acute inflammatory changes and histological features overlap because an acute inflammatory process is often accompanied by exudate within airspaces. an example of drug-induced pulmonary inflammation in laboratory animals and humans is reported following the administration of interleukin 2 (il-2). il-2 is a glycoprotein lymphokine, molecular weight 15kda, which is normally produced by activated t cells and mediates immunoregulatory responses. it has been produced in large quantities by recombinant dna technology for use in tumour immunotherapy. however, high doses have been associated with a number of adverse effects, notably the 'vascular leak' syndrome, characterized clinically by pulmonary oedema, pleural effusions and ascites. ^^^ the vascular leak syndrome has been reported in laboratory animals given high doses of this agent. histological examination of the lungs of b6d2f mice developing this syndrome following administration of il-2 showed infiltration of the alveolar walls with large lymphocytes and intra-alveolar proteinaceous exudate containing large lymphocytes, macrophages and red blood cells.^^^'^^^ pulmonary venules and arterioles showed the presence of lymphocytes attached to or lying beneath the endothelium, infiltrating vessel walls or in a perivascular location where they were accompanied by oedema fluid or red blood cells. similar, but less severe changes have been demonstrated in rats given il-2.^^^ in addition, treated rats showed an infiltration of pulmonary vasculature with eosinophils probably secondary to an eosinopoietic cytokine produced by il-2 stimulated lymphocytes. immunocytochemical evaluation of the lymphoid infiltrate in mice showed that most of the cells were thy 1.2positive (cd90) lymphocytes. furthermore, co-administration of asialo gml (ganglio-n-tetrosyl-ceremide) with il-2 not only abrogated the clinical signs but also reduced the number of asialo gml-positive lymphocytes in the tissue sections. as lymphoid cells expressing lyt-2 (cds, suppressor/cytotoxic t cells) were unaffected by asialo gml treatment, it was postulated that the vascular leak syndrome (but not antitumour efficacy) in these mice was mediated by an endogeneous subset of il-2 stimulated lymphocytes or lymphokine-activated killer cells. ^^^ corresponding changes were also observed in liver and lymphoid tissue. immunocytochemical and detailed electron microscopic studies in rats have supported the concept that il-2 induces cytotoxic vascular damage that is mediated both directly by lymphokine-activated killer cells and cytotoxic t lymphocytes with secondary release of inflammatory cytokines.^^^ as in humans, severe chronic pulmonary inflammatory disease in laboratory animals may compromise pulmonary function and lead to secondary alterations in other organs. although the mechanisms were not explored in detail, a diffuse interstitial pulmonary inflammatory process with lung haemorrhage was induced in rats treated for two years with prizidilol (skandf 92657-a2), an antihypertensive agent with both vasodilator and (3 adrenoceptor blocking properties.^^^ affected animals developed dyspnoea associated with reduction in lung volume, deformity of the thoracic spinal column and marked cardiac hypertrophy. inflammation with granulomas develops in the lungs of laboratory animals under a variety of different circumstances, which have been alluded to above. a common cause in rodents is granulomatous pulmonary inflammation resulting from aspiration of stomach contents or food particles (aspiration pneumonia). this is sporadically observed in aged rodent where it is associated with general ill health, particularly resulting from pressure effects of large pituitary adenomas and subsequent disturbance of pharyngeal or laryngeal reflex mechanisms. ^^^ histologically, the lungs show peribronchial and peribronchiolar granulomatous inflammation with macrophages and foreign body cells associated with fragments of refractive vegetable matter. the associated bronchial mucosa may also show reactive changes including goblet cell hyperplasia in long-standing cases. as dogs and primates are more liable to be infested by parasites, granulomatous inflammation in response to pulmonary larvae is more common in these species. pulmonary tuberculosis represents a potential problem among non-human primate colonies in view of its insidious onset and its liability for transmission from monkeys to humans. ^^^ pathological findings are similar to those so well known in the human disease. the disease is characterized by the presence of granulomas in lung parenchyma and lymph nodes. in florid cases there may be caseation surrounded by epithelioid and multinucleated giant cells and variable numbers of lymphocytes, plasma cells and flbroblasts. diffuse granulomatous pneumonia as a result of tuberculosis is also reported in non-human primates. granulomatous pneumonitis is also produced in laboratory animals by the intravenous injection of bcg. twenty-eight days following intravenous injection of bacille calmette-guerin (bcg), the lungs of c57b1/6 mice contained numerous granulomas composed of histiocytes and round cells which were surrounded by alveoli with thickened walls and associated with mild interstitial pneumonitis. ^^^ these histological changes were associated with an increase in the number of thy 1.2-positive (cd90) cells, especially lyt-1 (cds) positive lymphocytes. the histological changes were abrogated by treatment with cyclosporin a suggesting an important role for cd5-positive lymphocytes in the development of the granulomas. discrete granulomas occur in the lungs of experimental animals in response to intra-tracheal or intravenous injection of certain relatively insoluble substances (figure 6.3) . intra-tracheal administration of insoluble polymerized dextran and latex micro-particles to mice showed that the morphology and the systemic effects of granulomas depends on the nature of the injected substances. it has been shown that large granulomas develop rapidly in the pulmonary parenchyma around dextran particles that subsequently regress quickly, whereas latex particles produce small, discrete stable granulomas. ^^^ although both forms of granulomas are of foreign body or non-immunological in type, those produced by dextran but not latex beads, are associated with anergy-like immunosuppression, probably caused by release of soluble factors from the granulomas. it has been reported that granuloma formation after instillation of sephadex beads is associated with increases in the interleukin 1-(il-1) like activity in the lung.^^^ studies comparing the effects of inhaled crystalline silica and titanium dioxide have shown a correlation between the release of the macrophage derived cytokine il-1 and granuloma formation, suggesting that il-1 might be a useful biomarker for granuloma formation. ^^^ localized, angiocentric granulomas of foreign body type, clustered around pulmonary arteries and arterioles and occasionally alveolar capillaries and venules also develop following intravenous injection of relatively insoluble polysaccharides or other polymers. ^^^ characteristic epithelioid and large, foreign body type giant cells efface the smaller vessels although overt necrosis is not usually observed (figure 6.3) . haemosiderin-laden macrophages accumulate in the alveou of laboratory animals in association with chronic pulmonary congestion and haemorrhage. similar changes occur in patients in congestive cardiac failure where the haemosiderin-laden macrophages are termed 'heart failure' cells. the lungs of non-human primates are especially liable to contain alveolar, perivascular and peribronchial aggregates of macrophages laden with various brown pigments. iron-containing pigments have been associated with the inflammatory changes produced by simian lung mites (pneumonyssus simicola) which are prevalent in many non-human primates. in addition, lungs from some primate colonies may show perivascular and peribronchial collections of brown-grey macrophages containing highly refractive spicules and plates composed of high concentrations of silica.^^^'^^^ it has been shown that in old world primates including rhesus and cynomolgus monkeys, this pigment contains fossil diatomaceous material, compatible with the concept that the animals inhale dusts containing diatoms and other silicon fragments to which they are exposed in their semi-arid, natural habitats.^^^ chronic lung injury from a variety of different causes is frequently associated with the development of pulmonary fibrosis characterized by the replacement of the normal pulmonary structure by a thickened collagenous matrix with consequent reduction in the capacity for gas exchange. regardless of the inciting agent, the fibrogenic process appears to be generally characterized by disruption of the normal alveolar-capillary structure, leakage of exudate from the vascular compartment into the airspaces, subsequent invasion by infiammatory cells and fibroblasts associated with excess matrix formation. studies in laboratory animals with different fibrogenic agents as well as in humans have suggested that central to pulmonary fibrogenesis is increased production of tnfa by macrophages.^^'^^^'^^^"^^^ this cytokine is a not only a mitogen for fibroblasts but also a potent activator and chemo-attractant for macrophages, capable of stimulating release of other cytokines and inducing expression of adhesion molecule expression on endothelial cells. moreover, it has been shown that tnfa receptor knockout mice appear protected from the fibroproliferative effects of inhaled asbestos. ^^^ pulmonary fibrosis is a common sequel of chronic lower respiratory tract inflammation. it may be associated with, or preceded by interstitial pneumonitis, characterized by infiltration of lymphocytes, plasma cells and macrophages with scattered polymorphonuclear cells. ^^^ focal pulmonary fibrosis occurs spontaneously in laboratory animals, although this is usually most prevalent in dogs and non-human primates as a response to chronic infestation by parasites, which are not easily eliminated during breeding. in humans, conditions leading to pulmonary fibrosis vary widely. they include infections, shock lung syndrome, ionizing radiation, inhalation of irritant particulate matter, exposure to antigens or excessive amounts of oxygen as well as the results of the toxicity of paraquat and a range of both cytotoxic and noncytotoxic therapeutic agents which cause pulmonary parenchymal injury.^'^^^ the principal therapeutic agents that produce pulmonary fibrosis in both humans and laboratory animals are anticancer drugs. bleomycin, a glycopeptide preparation derived from streptomyces verticillus, is the best known example but pulmonary fibrosis is also associated with the clinical use of a number of other anticancer agents, including l,3-bis-(2-chloroethyl)-l-nitrosourea (bcnu or carmustine), cyclophosphamide, busulphan, mitomycin c and methotrexate.2 '108,147-150 the precise mechanisms involved in the induction of pulmonary fibrosis by antineoplastic drugs in humans are poorly understood. the true incidence for a particular drug is difficult to estimate because of confounding factors in cancer patients, such as concomitant administration of several drugs, radiation and oxygen therapy, diffuse pulmonary cancer and opportunistic infections. it is probable that drug-induced fibrosis is accentuated by concomitant administration of several antineoplastic agents, radiation therapy, hyperoxia, preexisting pulmonary damage and age of the patient. severity is often related to total dose of drug received.^^^ novel antineoplastic drugs may also produce lung toxicity.^ bleomycin is associated with the development of interstitial pneumonia and pulmonary fibrosis in clinical use and this can be reproduced in experimental animals. the histopathological appearances of bleomycin-induced pulmonary fibrosis in patients are in many instances different from those seen in laboratory animals because the lungs of patients treated with bleomycin are modified by the primary neoplastic disease, smoking, multiple drugs, radiation therapy and secondary pulmonary infections, interstitial pneumonitis and fibrosis.^^^ it has been postulated that tnfa is an important mediator in the development of bleomycin-induced fibrosis. ^'^ in the preclinical evaluation of bleomycin beagle dogs were given cycles of drug by the intravenous route for periods of up to 26 weeks. ^^^ dogs developed anorexia, weight loss, a variety of epithelial lesions as well as focal interstitial pneumonia and fibrosis. the focal lung lesions were characterized by increased elastic fibres, reticulin, collagen and acid mucosubstances. the lesions were situated predominantly in the pleural and subpleural zones, suggestive of a potentiating effect of friction between the pleural surfaces. histologically the lesions resembled those produced by larvae migrans in the dog (see figure 6 .2a). similar histological changes have also been described in both rats and mice treated with bleomycin by both the intravenous and intratracheal route.^^^'^^^ as fibrosis is such a consistent change, bleomycin-treated rodents have been extensively employed as a model for pulmonary fibrosis. early changes include mild, diffuse increases in interstitial lymphocytes, macrophages, polymorphonuclear cells and perivascular or interstitial oedema. after about a week, interstitial infiltrates also comprise fibroblasts with early collagen deposition, associated with proliferation of macrophages and type ii pneumocytes.^^^'^^^ subsequently, the amount of interstitial collagen increases, with eventual scarring and collapse of lung tissue in proportion to the cumulative dose given. ^^^ immunohistochemical and ultrastructural study of rats and mice treated with bleomycin shows a large accumulation of immune-reactive laminin and reduplication of the basement lamina within the thickened alveolar walls. ^^^ in bleomycin-treated rats three-dimensional scanning electron microscopy shows drug-induced capillary remodelling comprising irregular alveolar and pleural capillaries with increased diameter and decreased branching. ^^^ certain strains of mice have been shown to possess greater sensitivity to bleomycin fibrogenesis. the c57bl/6 strain produces a greater fibroblastic response than dba/2 and swiss mice and the balb/c strain demonstrates a particularly poor fibroblastic response. ^^^ therapeutic use of cyclophosphamide is also occasionally associated with the development of pulmonary interstitial fibrosis.^^^'^^^ it appears to be associated with two forms of pathology: an early-onset pneumonitis and a late onset progressive pulmonary fibrosis. ^^^ similar changes have been less easy to reproduce in laboratory animals. when mice were sequentially examined for periods of up to one year after a single intravenous dose of loomg/kg of cyclophosphamide, only slight pulmonary interstitial thickening and hypercellularity was observed in association with progressive multifocal accumulation of intra-alveolar macrophages. ^^^ however, these changes were also accompanied by a progressive increase in pulmonary hydroxyproline content and a decrease in pulmonary compliance with time in treated animals compared with controls. the changes were amplified by exposure to 70% ambient oxygen. the bronchiolitis, alveolar septal infiammation and fibrosis induced by gold therapy in patients with rheumatoid arthritis is probably immune-mediated. this condition is associated with peripheral eosinophilia and drug-induced alterations to the immune system.^^^ emphysema is characterized by abnormal, permanent enlargement of airspaces distal to terminal bronchioles, accompanied by destruction of their walls without obvious fibrosis. three principle types, centriacinar, panacinar and distal acinar emphysema, are recognized in humans. enlargement of air spaces as a result of congenital factors or fibrous scarring are grouped separately and not regarded as emphysema. ^^^ emphysema has been reported as an age-related spontaneous change in laboratory rats.^^^ however, several experimental rodent emphysema models have been developed, using intratracheal instillation of proteolytic enzymes papain, pancreatic and neutrophil elastase. this gives rise to histological appearances resembling panacinar emphysema in humans.^^^ irritant gases, notably oxides of nitrogen, are also capable of inducing changes in the lungs of laboratory rats and hamsters following long term exposure which resemble mild human, centrilobular emphysema.^^^'^^^ a variety of different names have been applied to membrane-bound, acid phosphatase-positive cytoplasmic inclusions with a lamella or crystalloid ultrastructural matrix. these include myeloid bodies, myelinoid bodies, myelin figures or myelinosomes. these lysosomal inclusions are seen in small numbers in a variety of normal cell types but they accumulate in various organs in laboratory animals following administration of a wide variety of drugs of diverse therapeutic classes.^'^^^"^^^ the generalized accumulation of these lysosomal cytoplasmic bodies is generally called phospholipidosis, a term coined to describe the tissue accumulation of phospholipids. ^^^ at the light microscopic level, phospholipids are characterized by the increase in the number of foam cells in the airspaces. examples of drug-induced phospholipidosis include the anorectic drug chlorphentermine, tricyclic antidepressants, inhibitors of cholesterol biosynthesis such as triparanol, the antihistamine chlorcyclizine and its analogues, the selective oestrogen receptor antagonist tamoxifen, chloroquine and the cardiovascular drugs amiodarone, 4,4'diethylamino-ethoxyhexestrol and perhexiline.^^^'^^^'^^^ many tissues and organs may develop the cytoplasmic inclusions, including lymphoid cells, liver, pancreas, endocrine tissue, nervous system, muscle cells, eyes and particularly lungs. aminoglycoside antibiotics may produce laminated phospholipid inclusions in the renal tubular cell and imidazol antifungals in hepatocytes (see under liver and kidney, chapters 9 and 10). many drugs that induce phospholipidosis usually share structural features, notably a hydrophilic cationic side chain, a primary, secondary or tertiary amine and a hydrophobic region that is usually an aromatic ring or ring system. as this structural pattern renders these molecules amphiphilic, these drugs probably bind with polar lipids by means of electrostatic and hydrophobic forces.^^"^ this leads to formation of drug-lipid complexes which are poorly degraded by lysosomal enzymes and which accumulate in the cell cytoplasm to form the inclusions described above. as the binding is not covalent, its reversibility depends on the dissociation rate constant under the particular intracellular conditions and drug concentration achieved. predictions of this activity based on molecular structure have shown reasonably good correlation with the ability of compounds to produce phospholipidosis in cultured rat peritoneal macrophages. more recently other cell based systems have been proposed for screening for phospholipidosis.^^^'^^^ however these perform less well in the prediction of in vivo potency, presumably because of differences in drug disposition in blood and tissues. it should be underlined that the accumulation of foamy macrophages in the alveolar spaces may also be a spontaneous change in laboratory animals. it has long been recognized as a spontaneous alteration in ageing rats.^^^ it may also be found in lung tissue distal to bronchial lesions that impede clearance mechanisms. in contrast to drug-induced changes, the spontaneous lipidosis characterized by accumulation of alveolar foam cells occurs sporadically in older rats and is observed in both controls and treated animals. drug-induced phospholipidosis occurs within a period of several months during which lungs of control animals remain fairly free of foam cell accumulation. the lungs appear especially vulnerable to drug-induced phospholipidosis, possibly because macrophages are in very close proximity to blood-borne agents. phospholipidosis is also more clearly visible microscopically in alveoli whereas it can be easily overlooked in other organs. the continuous uptake of phospholipid-rich surfactant material from the alveoli by macrophages leads to excessive accumulation of phospholipids when their catabolism is impaired.^^^'^^^ the fact that lungs are commonly affected is a potentially useful diagnostic feature because in many organs phospholipidosis can be extremely difficult to recognize in haematoxylin and eosin stained sections. although the changes in the lungs are not specific for drug-induced phospholipidosis, an increase in the number of lipid-containing lung macrophages in treated animals compared with controls is relatively easy to detect and provides a simple way for the pathologist to screen for this effect. in severe generalized phospholipidosis in rats, the lungs show irregular pale grey or yellowish patches of discoloration of the pleura and parenchyma. this is a result of patchy or confluent aggregates of large, pale, foamy macrophages. they may be free lying or packed in alveoli and accompanied by granular, extracellular material. their abundant cytoplasm shows a vacuolated appearance in which fine eosinophilic granules are sometimes visible. the nuclei are rounded and centrally located structures of variable size (figure 6.4) . multi-laminated cells are also occasionally seen, as are vacuolated cells firmly attached to alveolar walls, probably pneumocytes. these foamy cells stain typically for phospholipids (e.g. acid haematin), although neutral lipids may also be present and stain with oil red o. semi-thin plastic-embedded sections stained with toluidine blue allow better characterization of phospholipidosis in all organs, including the lungs. the macrophages in the air spaces contain unmistakable dense, dark round cytoplasmic inclusions of variable size, some over 5 mm diameter. ^^^ plasticembedded sections also show the inclusions in other pulmonary cells including pneumocytes attached to the alveolar walls, from which they can be seen discharging into the alveolar spaces. as in other organs affected by phospholipidosis, ultrastructural examination reveals dense, multi-lamellar membranes and numerous heterogeneous dense bodies of lysosomal origin (figure 6.4) . these bodies need to be distinguished from membranous bodies that form as a result of fixation for ultrastructural study. lipids tend to leach out and become hydrated to form myelinoid membranes during glutaraldehyde fixation. these structures are subsequently fixed by osmium to give rise to electron-dense membranous figures both outside and inside cells, particularly in mitochondria where they may be mistaken for pathological lesions.^^^ the lamella patterns seen in phospholipidosis may be simple alternating dense and clear lines spaced at 4-5 nm, or more complex arrangements of clear and dense lines. the other typical crystalloid inclusions of hexagonal aggregates of tubular subunits seen in other organs are not usually found in the lungs. the significance of these various forms is uncertain but they probably represent the various phases in which phospholipids exist and are influenced by proportions of lipids present. electron microscopic examination reveals that not only are pulmonary macrophages affected by these changes but that inclusions may be present in pneumocytes types i and ii, pulmonary capillary endothelial cells, smooth muscle cells, bronchiolar epithelium and occasionally neutrophils.^^^"^^^ the changes are typically still visible several weeks after withdrawal from treatment with the offending agent. although the extent of pulmonary phospholipidosis in the lungs varies between dosage regimen and animal species, studies with chlorphentermine, 4,4'diethylaminoethoxyhexestrol and amiodarone indicate that similar cytological and ultrastructural changes occur in most laboratory animal species studied including rats, mice, hamsters, guinea pigs, rabbits and dog.^^^'^^^'^^^'^^^ safety assessment -amphiphilic drugs what are the imphcations for humans of drugs that induce phosphohpidosis in laboratory animals? novel compounds continue to be found that possess the property of producing phosphohpidosis in laboratory animals with varying degrees of severity.^^^'^^^ although not all drugs that produce phosphohpidosis in animals have been studied in humans, only very few drugs that produce phosphohpidosis in animals have been shown capable of inducing significant phosphohpidosis in human clinical practice.^ agents such as chloroquine, 4,4'diethylamindethoyhexestrol and amiodarone, which have been shown to produce phosphohpidosis in patients, can also induce cellular damage in the same organs. however the phenomenon of phosphohpidosis where phospholipids are packaged behind lysosomal membranes may not be causally related to cellular damage in humans. indeed the weight of evidence suggests that druginduced phosphohpidosis per se is an adaptive phenomenon and does not in itself have functional or deleterious consequences unless excessive. ^^^ hence, the finding of phosphohpidosis in animal studies with a novel drug requires careful assessment on a case by case basis with respect to its implications for the safety of humans. an example of this issue is the iodinated benzofuran derivative amiodarone, a potent antiarrhythmic drug effective against ventricular arrhythmia. lung toxicity continues to be a problem in patients treated for cardiac arrhythmias with this drug.^^"^ not only does phosphohpidosis occur in a wide variety of organs in laboratory animals treated with amiodarone,^^^'^^^ but also in liver, peripheral nerve cells, skin, lymphoid cells and lungs in patients at therapeutic doses.^^^'^^^'^^^ although pulmonary interstitial fibrosis occurs in association with phosphohpidosis in patients, amiodarone-induced phosphohpidosis in rodents is not associated with pulmonary fibrosis or significant functional alterations. several theories have been proposed for the pulmonary alveolitis and interstitial fibrosis in humans. the weight of evidence to date suggests that the accumulation of lipid-laden histiocytes is not causally related to the alveolitis or pulmonary fibrosis. ^^^ indeed, overall there is little evidence that the mere presence of phosphohpidosis is deleterious to the organism.^^^ cytotoxicity, possibly through the metabolite desethylamiodarone, has been proposed and an immune-mediated mechanism has been postulated, possibly favoured by the binding of drug to components of pulmonary tissue.^^^ it might also involve free radical formation or indirect influences on inflammatory mechanisms.^^^ it is also possible that pulmonary disease results from an interaction of several mechanisms and metabolic factors unique to particular patients. ^^^ despite undoubted differences in tissue and species sensitivity to development of phosphohpidosis, dose, drug disposition, metabolism and elimination and the degree of tissue exposure to drug are important considerations in safety assessment of drugs that produce phosphohpidosis in laboratory animals. although phosphohpidosis is more likely to occur at high doses employed in toxicity studies than at lower therapeutic doses used in patients, it has been suggested that this may be offset by faster ehmination of the drug, characteristic of small laboratory animals. ^^^ the potential for drugs to accumulate in critical tissues such as eye and heart is especially important when drugs are administered for long periods of time, particularly as tissue/plasma ratios of some amphiphilic drug may exceed 100, following repeated administration.^^^ consequently, although phospholipidosis may not have functional consequences, any implications for humans of drugs that induce phospholipidosis in laboratory animals can only be assessed on a case by case basis, with due consideration of mechanism, drug disposition and clinical risk-benefit analysis. it is important to underline that similar morphological changes due to the increased presence of phospholipids in lysosomes can also result from treatment with compounds that are not cationic amphiphilic structures. mechanisms include direct or indirect inhibition of lysosomal enzyme activity. this reenforces the need to understand the mechanism of any chemically induced increase of phospholipids in the lungs of laboratory animals. for example, it has been shown that when glycosaminoglycans accumulate in inherited human lysosomal disorders they inhibit other lysosomal enzymes, thereby inducing lysosomal phospholipid inclusions. ^^^ this is reflected by administration of high doses of the trypanocidal drug suramin to rats which induces intracellular storage of glycosaminoglycans associated with phospholipid inclusions in diverse organs including lungs. ^^^ although at light microscopy clear vacuoles are typically seen, electron microscopic examination shows the presence of both clear vacuoles containing glycosaminoglycans and lamellar phospholipid inclusions. a similar effect seems to have been produced in rats by elmironâ®, a semi-synthetic heparin-like macromolecular carbohydrate derivative, chemically and structurally similar to glycosaminoglycans used clinically for anticoagulant effects and interstitial nephritis.^^^ another example is the induction of lysosomal inclusions in the lungs of rat and dogs by the macrolide antibiotic erythromycin.^^^ collections of foam cells were described in the lungs and lymphatic tissues of dogs and rats treated with high oral doses. foam cells in the lung showed a pattern of small whorls in vacuoles similar to that seen with other drugs that induce phospholipidosis. in vitro studies have suggested all macrolide antibiotics have the potential to cause phospholipidosis. biochemical studies suggest that drug binds to phosphatidylinositol-containing liposomes and inhibits activity of lysosomal phospholipase in close correlation with the number of cationic groups carried by each of the drugs. ^^^ hook reviewed other agents, such as oxidant gases and insoluble particles including silica, that can also increase phospholipid levels and histological appearances of phospholipidosis in the lungs.^^^ some of these agents inhibit phospholipid catabolism in the lungs giving rise to accumulation of surfactant protein a and surfactant lipoproteins and a clinico-pathological picture similar to pulmonary alveolar proteinosis in humans. studies from humans have shown that three chnically distinct forms of this condition occur: congenital, secondary or acquired. the congenital disease is caused by a diverse range of mutations in the genes encoding surfactant proteins or the (3c chain of the receptor of granulocyte-monocyte colony stimulating factor (gm-csf). the secondary form occurs in association with conditions where there is functional impairment or reduced numbers of alveolar macrophages, such as in haematological cancers, following immune suppression or inhalation of silica or toxic fumes. acquired or idiopathic alveolar proteinosis that accounts for over 90% of all cases (0.37 per 100000 persons) has been an enigma until recently. patients are at risk from infections, particularly nocardia, and the 5 year survival rate appears to be about 75%. studies from transgenic mouse models and in humans have shown that autoantibodies against gm-csf are important in the development of the acquired form of the disease as this antibody causes a defect in macrophages function which impairs the catabolism of surfactant lipids and proteins. ^^^ in this context it is of interest to note that treatment with imatinib, a tyrosine kinase inhibitor of the bcr-abl tyrosine kinase constitutively expressed in philadelphia chromosome positive myeloid leukemia, has been associated with the accumulation of lamellar inclusions in pulmonary macrophages in a leukaemia patient, although this might have been a result of the primary disease. ^^^ studies in mice have suggested that imatinib mesylate actually inhibits the fibrogenic activity of transforming growth factor (3 and prevents fibrosis induced by bleomycin.^^^ various forms of hyperplasia are found in the airways and lungs of laboratory animals. the mucosal surface of the bronchi may show hyperplasia of the goblet cells, squamous hyperplasia or metaplasia. the cells lining the terminal bronchiole and alveolus may also show hyperplasia and squamous metaplasia. standard classifications for the characterization of these changes in histological sections have been developed for use in rodent studies.^^"^^ goblet cell hyperplasia is a well-recognized response of the mucosa of conducting airways to chronic inflammation and inhalation of irritant substances such as cigarette smoke and sulphur dioxide.^^'^^'^^^'^^^ the degree of goblet cell hyperplasia is dictated by the severity and duration of the irritation or inflammatory process. florid cases of goblet cell hyperplasia are characterized by thickening and pseudostratification of the tracheal or bronchial mucosa by a population of tall, mucus secreting cells with abundant pale cytoplasm. in addition, goblet cells extend further down the airways than in normal animals and mucus may fill or distend the airways or impact in the alveoli. in less florid cases, a simple increase in the number of goblet cells may be found without other structural change.^^ goblet cell hyperplasia of the lining epithelium may be accompanied by an increase in size of the underlying submucosal glands. this has clearly been demonstrated in patients with chronic bronchitis and in rats where submucosal glands are normally quite prominent.^^^'^^^ species differences may exist because the airways of laboratory animals are variably endowed with goblet cells and submucosal mucous glands. the normal rat has more goblet cells lining the airways than either mouse or hamster. ^^^ the factors controlling these alterations are uncertain but is has been long suggested that increased mitotic activity as well as cell conversion, probably by metaplasia of serous or clara cells to mucous cells, is involved.^^^ it has more recently been shown in mice sensitized to ovalbumin and subject to a single antigen challenge by aerosol that clara cells in the proximal airways show great plasticity and become mucin-secreting cells.^^ pharmacological agents can induce goblet or mucous cell hyperplasia. rats given six or 12 daily injections of isoprenaline, a non-selective (3 receptor agonist showed a dose-and time-dependent increase in the number and size of alcian blue-positive goblet (mucous) cells as well as serous cells in the tracheal and bronchial mucosa. this was associated with an increase in length, width and depth of submucosal glands.^^^ similar changes were produced by pilocarpine, although both alcian blue-and pas-positive cells were increased in number following this agent, suggesting that pilocarpine induced both acid and neutral glycoprotein secretion. comparison of the distribution of these changes in the rat following isoprenaline, with those of salbutamol, pilocarpine and tobacco smoke, showed that there were regional differences in the distribution of these changes in the airways.^^'* isoprenaline produced a greater increase in secretory cells in peripheral airways than tobacco smoke, which itself produces a greater increase in mitotic activity. isoprenaline and pilocarpine produced a more diffuse change than the more selective (3 agonist, salbutamol. the changes induced by these therapeutic agents are presumably the result of their pharmacological activity.^^'^ sturgess and reid showed that the changes in the rat were accompanied by hypertrophy of the pancreas, submaxillary and parotid salivary glands^^^ (see digestive system, chapter 8). unlike the rat and mouse, the hamster appears predisposed to develop minor multifocal epithelial hyperplasia of the tracheal and bronchial mucosa spontaneously with advancing age. these changes are flat or polypoid in nature and are composed of clear cells and goblet cells.^^'^^ the epithelium of the bronchi shows squamous metaplasia in response to chronic irritation or injury. it is characterized by three or more layers of epithelial cells with abundant eosinophilic cytoplasm with prominent cell boundaries. it may be associated with degenerative alterations to the mucosa or goblet cell hyperplasia. squamous metaplasia can also develop in the alveolar parenchyma as a response to prolonged damage such as produced by large burden of inhaled irritant or insoluble dusts. the metaplasia is also characterized by the presence of several layers of flattened epithelial cells showing squamous differentiation. the term pulmonary keratinizing cyst has been recommended for pulmonary cystic lesions lined by non-neoplastic squamous epithelium without excessive proliferative change.^^^ hyperplasia, bronchiolo-alveolar (type ii cell hyperplasia) hyperplasia may involve the lining epithelium of the alveoli or bronchioli. this form of hyperplasia has been termed alveolar hyperplasia, adenomatosis, alveolar bronchiolization or epithelialization. it occurs spontaneously but can be induced by infections and administration of irritant xenobiotics in rats/^'^^^"^^^ j^j^g64,209 ^^^ hamsters.^^^ histologically, the lesions consist of localized but unencapsulated foci of hyperchromatic regular, cuboidal or columnar cells investing airspaces without appreciable distortion of alveolar walls. neuroendocrine hyperplasia is well described in hamsters. although small aggregates of neuroendocrine cells (neuroepithelial bodies) are found at various levels of the bronchi and bronchioli in normal hamsters, administration of nitrosamines and 4-nitroquinoline 1-oxide produces neuroendocrine hyperplasia.^^^"^^^ hyperplastic lesions are recognizable as groups of non-ciliated cuboidal, oval or columnar cells located in the bronchial or bronchiolar epithelium. they contain argyrophilic granules that show immunoreactivity for corticotrophin (acth) and neurone-specific enolase. ultrastructural examination reveals the presence of dense-core cytoplasmic granules of apud type. proliferative changes have also been reported in other species, including rats and humans in hypoxic conditions, although it has been suggested that these changes might be a result of increased peptide content rather than cell proliferation.^^'^^^ the most frequently diagnosed neoplasm world wide is lung cancer, where it is usually caused by smoking tobacco.^^^ bronchogenic squamous carcinoma is generally the most common subtype but in north america the incidence of adenocarcinoma now exceeds that of squamous cell tumours for reasons not fully understood. some of the most aggressive subtypes are small and large cell neuroendocrine lung cancers, defined as small or large tumour cells with greater than ten mitoses per 2mm^.^^^ these seem to be seen almost exclusively in heavy cigarette smokers. in contrast to findings in people, squamous cell lung tumours are only occasionally seen arising spontaneously in laboratory animals. even laboratory animals -rats, mice, hamster, monkeys and dogs -exposed to tobacco smoke for long periods and at high doses fail to develop an increase in lung tumours.^^^'^^^ moreover, there appears to be no good experimental model for neuroendocrine lung cancer. thus, particular caution is merited if using animal models for prediction of lung tumorigenic potential of inhaled substances. by far the most common primary pulmonary neoplasms found in laboratory rats, mice and hamsters are adenomas and adenocarcinomas. these appear to develop from the bronchiolar or alveolar epithelium, although their precise histogenesis is somewhat disputed. although spontaneous squamous neoplasms are uncommon in rodents cystic keratinizing lesions can be induced in rats by high burdens of particulate material in the lungs.^^^ pleural mesotheliomas and mesenchymal neoplasms also occur in these species but are uncommon. they can be induced in rodents by mineral fibres.^^^ mesenchymal tumours have similar histological features to those in soft tissues and mesotheliomas may show either epithelial or mesenchymal differentiation or both. in most rat strains alveolar or bronchiolar neoplasms occur spontaneously in relatively small numbers, but morphologically identical neoplasia can be induced by administration of chemical carcinogens.^^^ the most common are classified as bronchiolo-alveolar adenoma (pulmonary adenoma) and bronchioloalveolar carcinoma. the national toxicology program database on control fischer 344 rats used in carcinogenicity studies indicates an overall percentage of less than 3% of animals with bronchiolo-alveolar adenomas and less than 1% with bronchiolo-alveolar carcinomas.^^ however, the range of bronchioloalveolar adenomas in different studies was between 0 and 14% in this series. histologically, bronchiolo-alveolar tumours are mostly small, discrete, rounded nodules located in the lung parenchyma and composed of fairly uniform cells with moderately hyperchromatic nuclei arranged in solid (alveolar), tubular, papillary or mixed growth patterns. they usually compress surrounding tissues without infiltration or metastatic spread (adenoma), although loss of differentiation, infiltration and spread to adjacent tissues can occur (adenocarcinoma). ultrastructural study of bronchiolar-alveolar neoplasia in fischer 344 rats has shown the presence of osmiophilic, lamellated inclusion bodies similar to those found in alveolar type ii cells. therefore it has been suggested that the neoplasms are derived from this cell type.^^^ pulmonary squamous carcinoma occurs but is a very uncommon spontaneous neoplasm in the rat.^^ the large proliferative but benign cystic lesions found in the lungs of rats following accumulation of large amounts of particulate matter have been termed pulmonary cystic keratinizing epitheliomas for they have been regarded as benign neoplasms. when these lesions show evidence of tissue invasion they are regarded as pulmonary squamous cell carcinomas. similar lesions are very occasionally reported as spontaneous lesions.^^^ analogous neoplasms are found more commonly in most strains of laboratory mice used in carcinogenicity bioassays although considerable variation in incidence is reported. they are common in strain a mice where they are observed in low frequency at 3-4 months of age and incidences reach nearly 100% by 24 months of age.^^^ fewer, but significant numbers are found in b6c3fi mice, although there is considerable inter-laboratory variation.^^^ the national toxicology program database on control b6c3fi mice used in carcinogenicity studies indicates an overall percentage of about 16% of males and 6% of females with bronchiolo-alveolar adenomas but only about 5% and 2.5% respectively with bronchiolo-alveolar carcinomas.^^ however, the range of bronchioloalveolar tumour varied considerably between studies in this series. even in the same laboratory, mice housed under similar conditions show variation in incidence in these neoplasms with time. the incidence of lung adenomas and adenocarcinomas occurring in cd-i mice used as controls in 18-month carcinogenicity bioassays in the same laboratory under similar conditions for a period of 3 years varied from between 19 and 36% in males and 6 to 16% in females.^^^ by contrast, some strains of mice such as the c5781/10j strain show a very low predisposition to the development of lung adenomas.^^^ although these mouse pulmonary adenomas and adenocarcinomas do not resemble the common lung tumours in humans, strain differences have been exploited to study genetic susceptibility and resistance to pulmonary adenomas and carcinomas.^^^'^^^ histologically, pulmonary tumours of this type in mice are generally small, sharply circumscribed nodules composed of fairly uniform, closely packed columns of cuboidal or columnar cells arranged in tubular or papillary structures with scanty fibrovascular stroma ( figure 6 .5). they may be less well differentiated, with cellular pleomorphism, and show intrabronchial growth, invade lung parenchyma and produce metastatic spread. the histogenesis of mouse pulmonary adenomas and adenocarcinomas is disputed. on the basis of sequential light and electron microscopic study of pulmonary adenomas induced in bagg-webster swiss mice by transplacental exposure to ethylnitrosourea, it has been suggested that they develop from either alveolar type ii cells or clara cells.^^^'^^^ careful, stepwise analysis using light microscopic and electron microscopic examination has suggested that adenomas can be divided into three principal groups. some are composed of solid growths of uniform cuboidal cells with expanding margins limited to alveolar septae (alveolar pattern). these cells contained concentrically arranged cytoplasmic lamellar bodies and abundant, large mitochondria similar to mitochondria found in alveolar type ii cells. tubular or papillary patterns are composed of cuboidal cells showing histological and ultrastructural features of clara cell differentiation.^^^ however, immunocytochemical studies of chemically induced and spontaneous pulmonary neoplasia in b6c3f1, balb/c or a strain mice have shown that the majority of adenocarcinomas, including those showing papillary patterns, contain surfactant apoprotein, typical of type ii antigens, suggesting that most neoplasms show alveolar type ii differentiation.^^^ however, in view of the plasticity of clara cells, this does not exclude a clara cell origin of the tumours. immunocytochemistry of specific clara cell secretory protein expression in a transgenic mouse model of lung carcinomas developing from clara cells has shown that the protein is lost during tumour cell progression.^^^ it has also been shown in strain a mice that the proportion of tumours with papillary and solid/alveolar growth patterns varies with the inducing agent.^^^ this also suggests biological differences exist between histological subtypes. very few squamous carcinomas are reported in most series of mouse studies. a chemically induced mouse model of squamous cell carcinoma has been generated by administration of n-nitroso-tris-chloroethylurea. strain differences in susceptibility to squamous cancer development have been demonstrated in this model, with nih swiss, a/j and swr/j being highly susceptible, akr/j and c57bl/6j being resistant and fvb/j and balb/cj mice showing an intermediate response to carcinogen.^^^ the high incidence and the inherent variabihty of pulmonary adenomas and adenocarcinomas in conventional mouse carcinogenicity bioassays sometimes gives rise to statistically significant differences between control and treatment groups. there is considerable risk in over-interpretation of such group differences in conventional mouse bioassays. in the analysis of group differences, consideration needs to be given to tissue sampling procedure, age-standardization, historical control incidence, effects on food intake as well as the results of mutagenicity studies and carcinogenicity bioassays in other rodent species. indeed, a considerable number of widely employed therapeutic agents of different classes have produced an increase in benign or malignant pulmonary tumours in carcinogenicity studies performed in mice without this proving of any significance to humans. davies and monro counted at least 17 drugs of this type in the 1994 physicians' desk reference of the united states.^^^ for instance, in a carcinogenicity bioassay in which cfl mice were treated for 80 weeks with the synthetic analgesic tilidine fumarate, a statistically significant difference (p < 0.01) was reported in the incidence of lung adenocarcinomas between the top dose female group (24%) and concurrent controls (10%).^^^ it was argued that group differences did not indicate tumorigenic potential of tilidine fumarate on the basis that the incidence in the high dose group was within the historical control range (27%) and that there was no tumorigenic effect in a parallel 104 week rat carcinogenicity study. a more difficult evaluation concerned metronidazole, a nitroimidazole which is an important therapeutic agent active against anaerobic organisms and trichomonas species. administration of this compound led to an increased incidence of pulmonary adenomas and carcinomas in three separate mouse carcinogenicity bioassays.^^^'^^^ the analysis of these findings was somewhat complicated by evidence that metronidazole shows mutagenic activity in bacterial assays using some strains of salmonella typhimurium. it was argued that the risk to human patients was slight because the increase in prevalence in pulmonary tumours was likely to be a result of changes in nutritional status of the mice through the effect of metronidazole on gut fiora, as similar differences could occur between ad libitum fed mice and those fed the same but restricted diet.^^^ it was also postulated that the positive findings in bacterial mutagenesis assays were an inherent part of the antibacterial activity of metronidazole as a result of nitroreduction that does not occur in normal mammalian tissues. this conclusion was supported by negative effects in hamster carcinogenicity bioassays as well as lack of excess cancer risk in women followed up for 10 years or more.^^^ the common occurrence of lung adenomas in strain a mice has been utilized in the development of a quantitative bioassay for carcinogenic activity. this followed the demonstration that administration of carcinogens such as 3-methylcholanthrene to this strain could significantly increase the incidence of pulmonary adenomas within periods of up to six months.^^^ over many years the strain a mouse pulmonary tumour assay has been used to test a large number of chemicals of different classes, including polycyclic hydrocarbons, nitrosamines, food additives, alkyl halides, metals and chemotherapeutic agents.^^^'^^^ however, as with many test systems, correlation of results in the strain a test with 2 year carcinogenicity study data and genotoxicity results have been shown to be poor so prudence is needed in the use of this test.^^^ hamsters develop lung adenomas spontaneously in small numbers with advancing age. they are composed of uniform cylindrical cells similar to those found in bronchial epithelium or goblet cells showing distinct mucus production.^^'^^'^^^ an immunohistochemical study of similar pulmonary neoplasms induced in hamsters by n-nitrosodiethylamine showed the presence of clara cell antigen in early phase of development, but as the tumours developed they became more squamous in type and showed immunoreactivity for cytokeratins.^^^ a clara cell origin was suggested for most of these neoplasms. lung defenses against infection: a clinical correlation drug-induced lung toxicity pulmonary toxicity from novel antineoplastic agents drug-induced diseases. drug-induced respiratory disease mucociliary clearance and mucus secretion in the lung risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation considerations for toxicology studies of respiratory drug products overview of inhalation toxicology inhalation exposure technology, dosimetry, and regulatory issues pulmonary deposition: determinants and measurement techniques inhalation therapy: technological milestones in asthma treatment the relevance of the rat lung response to particle overload for human risk assessment: a workshop consensus report interpretation of new techniques used in determination of pulmonary function in rodents measurement of respiratory patterns in rodents using whole-body plethysmography and a pneumotachograph evaluation of lung injury in rats and mice comparative pathology of the nasal mucosa in laboratory animals exposed to inhaled irritants comparative aspects of nasal airway anatomy. relevance to inhalation toxicology comparative anatomy, physiology, and function of the upper respiratory tract comparative anatomy of mammalian respiratory tracts: the nasopharyngeal region and the tracheobronchial region airflow, gas deposition, and lesion distribution in the nasal passages a comparative analysis of primate nasal airways using magnetic resonance imaging and nasal casts the upper airways. 1. nasal physiology and defence of the lungs antioxidant protection: a function of tracheobronchial and gastrointestinal mucus the histochemical and microscopical differentiation of the respiratory glands around the maxillary sinus of the rat hamster nasal glands: their structure, sialic acid content, and vulnerability to actinomycin d the lateral nasal gland of the dog, its structure and secretory content sites for xenobiotic activation and detoxication within the respiratory tract: implications for chemically induced toxicity cytochrome-p450 2a of nasal epithelium -regulation and role in carcinogen metabolism purification and characterization of heterologously expressed mouse cyp2a5 and cyp2g1: role in metabolic activation of acetaminophen and 2,6-dichlorobenzonitrile in mouse olfactory mucosal microsomes differential xenobiotic induction of cyp2a5 in mouse liver, kidney, lung, and olfactory mucosa nasal cytochrome p450 2a: identification, regional localization, and metabolic activity toward hexamethylphosphoramide, a known nasal carcinogen cell-specific expression of cyp2a5 in the mouse respiratory tract: effects of olfactory toxicants biotransformation enzymes in the rodent nasal mucosa: the value of a histochemical approach nasal lymphoid tissue in the rat toxicity to nasal associated lymphoid tissue histopathologic examination of the rat nasal cavity structural evaluation of the respiratory system normal histology of the nasal cavity and application of special techniques approaches to the identification and recording of nasal lesions in toxicology studies nasal diagrams -a tool for recording the distribution of nasal lesions in rats and mice histopathology of nasal olfactory mucosa front selected inhalation toxicity studies conducted with volatile chemicals cytokeratin expression patterns in the rat respiratory tract as markers of epithelial differentiation in inhalation toxicology. 1. determination of normal cytokeratin expression patterns in nose, larynx, trachea, and lung irritating properties of airborne materials to the upper respiratory tract bioassay for evaluating the potency of airborne sensory irritants and predicting acceptable levels of exposure in man infectious diseases of the upper respiratory tract: implications for toxicology studies respiratory tract murine respiratory mycoplasmosis in lew and f344 rats: strain differences in lesion severity spontaneous proliferative lesions in the nasopharyngeal meatus of f344 rats spontaneous tumors and common diseases in three types of hamsters spontaneous tumors and common diseases in two colonies of syrian hamsters. ii respiratory tract and digestive system sialodacyoadenitis virus-associated lesions in the lower respiratory tract of rats oropharyngeal granulomas and tracheal cartilage degeneration in fischer-344 rats articular chondromatosis and chrondroid metaplasia in transgenic tag mice cigarette smoke induced pathology of the rat respiratory tract: a comparison of the effects of the particulate and vapour phases histological sectioning of the rodent larynx for inhalation toxicity testing histologic methods and interspecies variations in the laryngeal histology of f344/n rats and b6c3f1 mice interspecies variations in the histology of toxicologically important areas in the larynges of crl:cd rats and syrian golden hamsters revised guides for organ sampling and trimming in rats and mice. part 2: a joint publication of the rita and nacad groups a comparison of the pathology of the larynx from spf, germ-free, conventional, feral and myoplasma-infected rats modelling of biological tree structures allometric relationships of cell numbers and size in the mammalian lung the ultrastructure of various cell types in the lung of the rat length and distribution of cilia in human and canine airways lectin-binding affinities of the respiratory tract. a light microscopical study of ciliated epithelium in rat, guinea pig and hamster clara cell proteins identification, cellular-locahzation, isolation, and characterization of human clara cell-specific 10-kd protein mucin is produced by clara cells in the proximal airways of antigen-challenged mice morphology of the terminal bronchiolar region of common laboratory mammals morphological changes in the lung during the life span of fischer 344 rats immunocytochemical localization of the major surfactant apoproteins in type ii cells, clara cells and alveolar macrophages of rat lung quantitative microscopical methods for the identification and localisation of nerves and neuroendocrine cell markers in mammalian lung what can the biology of small cell cancer of the lung teach us about the endocrine lung? the role of metabolism in chemical-induced pulmonary toxicity characterization of pulmonary macrophages and bronchus-associated lymphoid tissue (balt) macrophages in the rat. an enzyme-cytochemical and immunocytochemical study subpopulations of lymphoid and non-lymphoid cells in bronchus-associated lymphoid tissue (balt) of the mouse bronchial lymphoid tissue. 1. morphologic characteristics the specificity of the high endothelial venule in bronchus-associated lymphoid tissue (balt) t cells and t cell subsets in rat bronchus associated lymphoid tissue (balt) in situ and in suspension have you seen this?' infiammatory lesions in the lungs of rats inflammatory lesions in the lungs of wistar rats histological changes in rat bronchus-associated lymphoid tissue after administration of five different antigens changes occurring in the epithelium covering the bronchus-associated lymphoid tissue of rats after intracheal challenge with horseradish peroxidase patterns of lymphatic drainage to individual thoracic and cervical lymph nodes in the rat age-body weight relationships to lung growth in the f344 rat as indexed by lung weight measurements application of morphometric methods to study diffuse and focal injury in the lung caused by toxic agents morphometric assessment of pulmonary toxicity in the rodent lung the connective tissue of the rat lung: electron immunohistochemical studies immunohistochemical techniques and their applications in the histopathology of the respiratory system systemically applied chemicals that damage lung tissue bronchial mucosal mast cells and their implications in the pathogenesis of asthma morphological-changes in rat tracheal mucosa immediately after antigen challenge comparative studies of heparin and heparin fragments: distribution and toxicity in the rat interactions between sendai virus and bacterial pathogens in the murine lung: a review murine respiratory mycoplasmosis in f344 and lew rats -evolution of lesions and lung lymphoid-cell populations pathogenesis of bronchiolitis and pneumonia induced in neonatal and weanling rats by parainfluenza (sendai) virus respiratory tact lesions in weanling outbred rats infected with sendai virus increased tumor necrosis factor-alpha (tnf-alpha) gene expression in parainfluenza type 1 (sendai) virus-induced bronchiolar fibrosis il-12 reduces the severity of sendai virus-induced bronchiolar inflammation and remodeling studies of respiratory disease in random source laboratory dogs: viral infections in unconditioned dogs visceral larva migrans in the dog lesions produced by a new lung worm in beagle dogs diagnostic exercise: macaque with dyspnoea treatment of pulmonary acariasis in rhesus macaques with ivermectin a primer of primate pathology: lesions and nonlesions attachment of microbes to host cells: relevance o^ pneumocystis carinii animal model: pneumocystis carinii pneumonia in the immunosuppressed rat attachment of pneumocystis carinii to rat pneumocytes a progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin 2 or high-dose interleukin 2 alone toxicity of human recombinant interleukin-2 in rats. pathologic changes are characterized by marked lymphocytic and eosinophilic proliferation and multisystem involvement toxicity of human recombinant interleukin-2 in the mouse is mediated by interleukin-activated lymphoc3^es. separation of efficacy and toxicity by selective lymphocyte subset depletion characterization of the pulmonary lesions induced in rats by human recombinant interleukin-2 dyspnoea and thoracic spinal deformation in rats after oral prizidilol (skandf 92657-a2) diagnostic exercise: pneumonia in a rat multidrug chemotherapy of tuberculosis in rhesus monkeys granulomatous pneumonitis induced by bacille calmette-guerin in the mouse and its treatment with cyclosporin a anergy-like immunosuppression in mice bearing pulmonary foreign body granulomatous inflammation direct evidence for granulomainducing role of interleukin-1 cytokine and growth factor release by alveolar macrophages: potential biomarkers of pulmonary toxicity animal model: pulmonary granulomatous vasculitis induced in rats by treatment with glucan naturally occurring diatomaceous pneumoconiosis in subhuman primates ultrastructural and micropulse analysis of simian lung mite pigments lung c3^okine production in bleomycin-induced pulmonary fibrosis treatment of human recombinant soluble tnf receptor of pulmonary fibrosis induced by bleomycin or silica in mice the physiology of transforming growth factor-a tnf-a receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos extensive laminin and basement membrane accumulation occurs at the onset of bleomycin-induced rodent pulmonary fibrosis gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease methotrexate pneumonitis induced by intrathecal methotrexate therapy. a case report with pharmacokinetic data cytotoxic drug-induced pulmonary disease: update 19s0 lung toxicity associated with cyclophosphamide use. two distinct patterns interstitial pneumonitis associated with bleomycin therapy bleomycin lung toxicity: who are the patients with increased risk? preclinical toxicologic evaluation of bleomycin (nsc 125 066), a new antitumor antibiotic bleomycin-induced pulmonary toxicity in the rat intratracheal versus intravenous administration of bleomycin in mice: acute effects an investigation of possible models for the production of progressive pulmonary fibrosis in the rat. the effects of repeated intraatracheal instillation of bleomycin capillary remodeling in bleomycin-induced pulmonary fibrosis the role of strain variation in murine bleomycin-induced pulmonary fibrosis pulmonary toxicology of cyclophosphamide: a 1-year study animal models of emphysema lung scleroproteins in young and adult rats and in rats with spontaneous emphysema: comparative studies by biochemical and histochemical approach a quantitative study of stenosis in the respiratory bronchiole of the rat in n02-induced emphysema long-term sequelae of bronchiolitis induced by nitrogen dioxide in hamsters cationic amphiphilic drug-induced phospholipidosis drug-induced phospholipidoses drug-induced lipidosis and the alveolar macrophage drug-induced lysosomal disorders in laboratory animals: new substances acting on lysosomes pulmonary and generalized lyosomal storage induced by amphiphilic drugs drug-induced generalized phospholipidosis tamoxifen-induced generalized lipidosis in rats subchronically treated with high doses fine structural alterations in the lungs of iprindole-treated rats a cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development validation of an in vitro screen for phospholipidosis using a high-content biology platform multifocal histiocytosis in the lungs of rats the induction of pulmonary phospholipidosis and the inhibition of lysosomal phospholipases by amiodarone collecting and processing tissues for diagnostic electron microscopy chlorphentermine-induced lipidosis like ultrastructural alterations in lungs and adrenal glands of several species amiodarone lung toxicity: a human and experimental study generalized phospholipidosis induced by amphiphilic cationic psychotropic drug morphological and biochemical changes in the liver of various species in experimental phospholipidosis after diethylaminoethoxyhexestrol recovery from amiodarone-induced lipidosis in laboratory animals. a toxicological study epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine d3 selective antagonist pnu-177864 myopathy related to administration of a cationic amphiphilic drug and the use of multidose drug distribution analysis to predict its occurrence drug-induced phospholipidosis: are there functional consequences? an 82-year-old man with dyspnea and pulmonary abnormalities amiodarone induced phospholipidosis. biochemical, morphological and functional changes in the lungs of rats chronically treated with amiodarone granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study amiodarone-associated pulmonary fibrosis. evidence of an immunologically mediated mechanism an evaluation of possible mechanisms underlying amiodarone-induced pulmonary toxicity lipidosis induced by amphiphilic cationic drugs pathological discussion. case record of the massachusetts general hospital organomegaly and histopathology in an animal model of mucopolysaccharidosis induced by suramin lysosomal-storage disorder induced by elmiron following 90-days gavage administration in rats and mice foam cell response in the lung and lymphatic tissues during long-term high-level treatment with erythromycin interactions of macrolide antibiotics (erythromycin a, roxithromycin, erythromycylamine [dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models alveolar proteinosis and phospholipidosis of the lungs pulmonary alveolar proteinosis imatinib-associated pulmonary alveolar proteinosis imatinib mesylate inhibits the profibrogenic activity of tgf-(3 and prevents bleomycin-mediated lung fibrosis an experimental study of hypersecretion of mucus in the bronchial tree goblet cell glycoprotein and tracheal gland hypertrophy in rat airways: the effect of tobacco smoke with or without the antiinflammatory agent phenylmethyloxadiazole measurement of the bronchial mucous gland layer: a diagnostic yardstick in chronic bronchitis mitotic activity of airway epithelium after short exposure to tobacco smoke and the effect of the anti-inflammatory agent phenylmethyloxadiazole the effect of isoprenaline and pilocarpine on (a) bronchial mucus-secreting tissue and (b) pancreas, salivary glands, heart, thymus, liver and spleen experimental chronic bronchitis classification of cystic keratinising squamous lesions of the rat lung: report of a workshop pathological changes during aging in barrier-reared fischer 344 male rats neoplastic and nonneoplastic lesions in aging f344 rats histopathological profile of a wistar rat stock including a survey of the literature naturally occurring sendai disease of mice immunohistochemical demonstration of clara cell antigen in lung tumors of bronchiolar origin induced by n-nitrosodiethylamine in syrian golden hamsters sequential morphologic alterations in the bronchial epithelium of syrian golden hamsters during n-nitrosomorpholine-induced pulmonary tumorigenesis lung endocrine-like cells in hamsters treated with diethylnitrosamine: alterations in vivo and in cell culture 4-nitroquinoline 1-oxide-induced pulmonary endocrine cell hyperplasia in s3rrian golden hamsters increased intracellular levels of calcitonin gene-related peptide-like immunoreactivity in pulmonary endocrine-cells of hypoxic rats the 2004 world health organization classification of lung tumors pleura, thymus and heart a review of chronic inhalation studies with mainstream cigarette smoke in rats and mice a review of chronic inhalation studies with mainstream cigarette smoke, in hamsters, dogs, and nonhuman primates animal models of mesothelioma induced by mineral fibers: implications for human risk assessment morphology of spontaneous and induced tumors in the bronchiolo-alveolar region of f344 rats spontaneous cystic keratinising epithelioma in the lung of a sprague-dawley rat strain a mouse lung tumor bioassay variability in the rates of some common naturally occurring tumors in fischer 344 rats and (c57bl/6nxc3h/hen)fl (b6c3f1) mice a carcinogenicity study in mice of a (3-adrenegic antagonist, primidolol; increased total tumour incidence without tissue specificity effect of diet on spontaneous disease in the inbred mouse strain c57b1/10j pol iota is a candidate for the mouse pulmonary adenoma resistance 2 locus, a major modifier of chemically induced lung neoplasia cancer susceptibility in the mouse: genetics, biology and implications for human cancer histogenesis of the papillary clara cell adenoma histologic and ultrastructural features of the clara cell adenoma of the mouse lung immunocytochemical localization of the surfactant apoprotein and clara cell antigen in chemically induced and naturally occurring pulmonary neoplasms of mice immunohistochemical analysis of clara cell secretory protein expression in a transgenic model of mouse lung carcinogenesis strain a/j mouse lung adenoma patterns vary when induced by different carcinogens a chemically induced model for squamous cell carcinoma of the lung in mice: histopathology and strain susceptibility marketed human pharmaceuticals reported to be tumorigenic in rodents evaluation of chronic toxicity and carcinogenesis in rodents with the synthetic analgesic, tilidine fumarate induction of lung tumors and malignant lymphomas in mice by metronidazole toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic, and teratogenic potential induced pulmonary tumors in mice. ii: reaction of lungs of strain a mice to carcinogenic hydrocarbons. arc/iii;es of pathology strain a mouse pulmonary tumor test results for chemicals previously tested in the national cancer institute carcinogenicity tests animal model: spontaneous carcinoma of the lung in hamsters key: cord-353190-7qcoxl81 authors: nicklas, werner; bleich, andré; mähler, michael title: viral infections of laboratory mice date: 2012-05-17 journal: the laboratory mouse doi: 10.1016/b978-0-12-382008-2.00019-2 sha: doc_id: 353190 cord_uid: 7qcoxl81 viral infections of laboratory mice have considerable impact on research results, and prevention of such infections is therefore of crucial importance. this chapter covers infections of mice with the following viruses: herpesviruses, mousepox virus, murine adenoviruses, polyomaviruses, parvoviruses, lactate dehydrogenase-elevating virus, lymphocytic choriomeningitis virus, mammalian orthoreovirus serotype 3, murine hepatitis virus, murine norovirus, murine pneumonia virus, murine rotavirus, sendai virus, and theiler’s murine encephalomyelitis virus. for each virus, there is a description of the agent, epizootiology, clinical symptoms, pathology, methods of diagnosis and control, and its impact on research. in interpreting the microbiological status of laboratory animals, it must be understood that infection and disease are not synonymous. infection refers to the invasion and multiplication of microorganisms in body tissues and may occur with or without apparent disease. disease refers to interruption or deviation from normal structure and function of any tissue, organ or system. many of the infections with which we are concerned may not cause discernable disease in many strains of mice. however, they may cause inapparent or subclinical changes that can interfere with research. such interference often remains undetected, and therefore modified results may be obtained and published. the types of interference of an agent with experimental results may be diverse. there is no doubt that research complications due to overt infectious disease are significant and that animals with clinical signs of disease should not be used for scientific experiments. but clinically inapparent infections may also have severe effects on animal experiments. there are numerous examples of influences of microorganisms on host physiology and hence of the interference of inapparent infections with the results of animal experiments. many microorganisms have the potential to induce activation or suppression of the immune system, or both at the same time but on different parts of the the laboratory mouse ó 2012 elsevier ltd. all rights reserved. isbn 978-0-12-382008-2 doi: 10.1016/b978-0-12-382008-2.00019-2 immune system, regardless of the level of pathogenicity. all infections, apparent or inapparent, are likely to increase interindividual variability and hence result in increased numbers of animals necessary to obtain reliable results. microorganisms, in particular viruses, present in an animal may contaminate biological materials such as sera, cells or tumours [1, 2] . this may interfere with in vitro experiments conducted with such materials and may also lead to contamination of animals [3] . mouse antibody production (map) testing or polymerase chain reaction (pcr) testing of biologics to be inoculated into mice is an important component of a disease prevention programme. finally, latent infections may be activated by environmental factors, by experimental procedures, or by the combination and interaction between various microorganisms. for all these reasons, prevention of infection, not merely prevention of clinical disease, is essential. unfortunately, research complications due to infectious agents are usually considered artefacts and published only exceptionally. information on influences of microorganisms on experiments is scattered in diverse scientific journals, and many articles are difficult to find. to address this problem, several meetings have been held on viral complications on research. the knowledge available is summarized in conference proceedings [4, 5] and has later repeatedly been reviewed [6] [7] [8] . viral infections of mice have been studied in detail, and comprehensive information on their pathogenic potential, their impact on research, and the influence of host factors such as age, genotype, and immune status on the response to infection is available. the nomenclature and taxonomy of viruses is described based on recent nomenclature rules by the international union of microbiological societies [9] and the universal virus database of the international committee on the taxonomy of viruses (http://www. ictvdb.org). retroviruses are not covered in this chapter because they are not included in routine health surveillance programmes and cannot be eradicated with the methods presently available. this is because most of them are incorporated in the mouse genome as proviruses and thus are transmitted via the germline. the ability to accurately determine whether or not laboratory animals or animal populations have been infected with a virus depends on the specificity and sensitivity of the detection methods used. most viral infections in immunocompetent mice are acute or short term, and lesions are often subtle or subclinical. the absence of clinical disease and pathological changes has therefore only limited diagnostic value. however, clinical signs, altered behaviour or lesions may be the first indicator of an infection and often provide clues for further investigations. serology is the primary means of testing mouse colonies for exposure to viruses, largely because serological tests are sensitive and specific, are relatively inexpensive and allow screening for a multitude of agents with one serum sample. they are also employed to monitor biological materials for viral contamination using the map test. serological tests detect specific antibodies, usually immunoglobulin g (igg), produced by the host against the virus and do not actually test for the presence of the virus. an animal may have been infected, mounted an effective antibody response and cleared the virus, but remains seropositive for weeks or months or for ever, even though it is no longer infected or shedding the agent. active infection can only be detected by using direct detection methods such as virus isolation, electron microscopy or pcr. meanwhile, pcr assays have been established for the detection of almost every agent of interest. they are highly sensitive and, depending on the demands, they can be designed to broadly detect all members of a genus or only one species. however, good timing and selection of the appropriate specimen is critical for establishing the diagnosis. in practice, combinations of diagnostic tests are often necessary, including the use of sentinel animals or immunosuppression to get clear aetiological results or to avoid consequences from false-positive results. reports on the prevalence of viral infections in laboratory mice throughout the world have been published frequently. in general, the microbiological quality of laboratory mice has constantly improved during the last decades, and several agents (e.g. herpesviruses and polyomaviruses) have been essentially eliminated from contemporary colonies due to advances in diagnostic methodologies and modern husbandry and rederivation practices [10] [11] [12] [13] [14] [15] . they may, however, reappear, since most have been retained or are still being used experimentally. furthermore, the general trend towards better microbiological quality is challenged by the increasing reliance of biomedical research on genetically modified and immunodeficient mice, whose responses to infection and disease can be unpredictable. increasing numbers of scientists are creating genetically modified mice, with minimal or no awareness of infectious disease issues. as a consequence, these animals are more frequently infected than 'standard' strains of mice coming from commercial breeders, and available information on their health status is often insufficient. frequently they are exchanged between laboratories, which amplifies the risk of introducing infections from a range of animal facilities. breeding cessation strategies that have been reported to eliminate viruses from immunocompetent mouse colonies may prove to be costly and ineffective in genetically modified colonies of uncertain or incompetent immune status. it must also be expected that new agents will be detected, although only occasionally. infections therefore remain a threat to biomedical research, and users of laboratory mice must be cognizant of infectious agents and the complications they can cause. two members of the family herpesviridae can cause natural infections in mice (mus musculus). mouse cytomegalovirus 1 (mcmv-1) or murid herpesvirus 1 (muhv-1) belongs to the subfamily betaherpesvirinae, genus muromegalovirus. murid herpesvirus 3 (muhv-3) or mouse thymic virus (mtv) has not yet been assigned to a genus within the family herpesviridae. both are enveloped, double-stranded dna viruses that are highly host-specific and relatively unstable to environmental conditions such as heat and acidic ph. both agents are antigenically distinct and do not cross-react in serological tests, but their epidemiology is similar [16] . mcmv-1 is very uncommon in european and american colonies of laboratory mice and is found at a very low rate [11] or reported as not found [14, 15] . seropositivity has, however, been reported from asian countries [17, 18] . testing for mtv is not frequently reported, and no sample tested positive in recent studies [11] . the data available suggest that the prevalence of both viruses in contemporary colonies and thus their importance for laboratory mice is negligible. however, both mcmv-1 and mtv are frequently found in wild mice, which may be coinfected with both viruses [8, [19] [20] [21] . mouse cytomegalovirus 1 (mcmv-1) or murid herpesvirus 1 (muhv-1) natural infection with mcmv-1 causes subclinical salivary gland infection in mice. like other cytomegaloviruses, mcmv-1 is strictly hostspecific. it persists in the salivary glands (particularly in the submaxillary glands) and also in other organs [22] [23] [24] . the virus can be cultured in mouse fibroblast lines like 3t3 cells, but primary mouse embryo fibroblasts are more sensitive to infection and produce higher virus titres. however, passage in cell culture results in its attenuation. to maintain virulence, the virus is best propagated by salivary gland passages of sublethal virus doses in weanling mice of a susceptible strain (e.g. balb/c) [25] . most information concerning the pathogenesis of mcmv-1 infection is based on experimental infection studies. these results are very difficult to summarize because the outcome of experimental infection in laboratory mice depends on various factors such as mouse strain and age, virus strain and passage history [26] , virus dose and route of inoculation [24] . in general, newborn mice are most susceptible to clinical disease and to lethal infection and develop higher levels of resistance with increasing age. infection of neonates leads to abnormal brain development [27, 28] . virus replication is observed in newborn mice in many tissues and appears in the salivary glands towards the end of the first week of infection when virus concentrations in liver and spleen have already declined. resistance develops rapidly after weaning between days 21 and 28 of age. experimental infection of adult mice results in mortality only in susceptible strains and only if high doses are administered. not even intravenous or intraperitoneal injections of adult mice usually produce signs of illness in resistant strains [29] . mice of the h-2 b (e.g. c57bl/6) and h-2 d (e.g. balb/c) haplotype are more sensitive to experimental infection than are mice of the h-2 k haplotype (e.g. c3h), which are approximately 10-fold more resistant to mortality than those of the b or d haplotype [24] . subclinical or latent infections can be activated by immunosuppression (e.g. with cyclophosphamide or cortisone) or critical illness such as sepsis [30] . reactivation of mcmv-1 also occurs after implantation of latently infected salivary glands into prkdc scid mice [31] . immunodeficient mice lacking functional t cells or natural killer (nk) cells, such as foxn1 nu and lyst bg mice are more susceptible than are immunocompetent animals. experimental infection in prkdc scid mice causes severe disease or is lethal, with necrosis in spleen, liver and other organs, and multinucleate syncythia with inclusion bodies in the liver [32] . similarly to aids patients infected with human cytomegalovirus, athymic foxn1 nu mice experimentally infected with mcmv-1 also develop adrenal necrosis [33] . the virus also replicates in the lungs, leading to pneumonitis, whereas replication and disease are not seen in heterozygous (foxn1 nu/þ ) littermates [34] . the pathogenesis of mcmv-1 infection in immunocompetent and in immunocompromised mice, as well as the role of the immune system, have been reviewed by krmpotic et al. [35] . the most prominent histological finding of cytomegaloviruses is enlarged cells (cytomegaly) of salivary gland epithelium with eosinophilic nuclear and cytoplasmic inclusion bodies. the inclusion bodies contain viral material and are found also in other organs such as liver, spleen, ovary and pancreas [24] . depending on inoculation route, dose, strain, and age of mice, experimental infections may result in inflammation or cytomegaly with inclusion bodies in a variety of tissues, pneumonitis, myocarditis, meningoencephalitis or splenic necrosis in susceptible strains [8, 24, 36] . virus is transmitted by the oronasal route, by direct contact and is excreted in saliva, tears and urine for several months. the virus is ubiquitous in wild house mice worldwide. they serve as a natural reservoir for infection and can even be infected with different virus strains [37] . the virus is most frequently transmitted horizontally through mouse-to-mouse contact but does not easily spread between cages. sexual transmission and transmission with tissues or organs is also possible. the virus does not cross the placenta in immunocompetent mice, although infection of pregnant females results in fetal death or resorption and wasting of borne pups. however, fetal infection is possible by direct injection of mcmv-1 into the placenta [38] and also occurs by transplacental transmission in mice with severe immunodeficiency [39] . vertical transmission is also possible by milk during lactation [40] . it is generally assumed that mcmv-1 has a very low prevalence in contemporary colonies of laboratory mice. the risk of introduction into facilities housing laboratory mice is very low if wild mice are strictly excluded. monitoring is necessary if populations of laboratory mice may have been contaminated by contact with wild mice. as for other viruses, different serological tests, including multiplex fluorescent immunoassay (mfia) [41] , are used for health surveillance of rodent colonies. as the virus persists, direct demonstration of mcmv-1 in infected mice is possible by pcr [42] [43] [44] or by virus isolation using mouse embryo fibroblasts (3t3 cells). although mcmv-1 does not play a significant role as a natural pathogen of laboratory mice, it is frequently used as a model for human cytomegalovirus infection [45] . these aspects have been discussed in detail by shellam et al. [24] . mcmv-1 has also been used as a vaccine vector aiming at a disseminating mouse control agent by inducing immunocontraception in mice [46] . the virus is known to influence immune reactions in infected mice [47, 48] and may therefore have an impact on immunological research [6, 8] . mtv was detected during studies in which samples from mice were passaged in newborn mice. unlike other herpesviruses, mtv is difficult to culture in vitro and is usually propagated by intraperitoneal infection of newborn mice. the thymus is removed 7-10 days later, and thymus suspensions serve as virus material for further studies. the prevalence of mtv is believed to be low in laboratory mice, and for this reason, and also due to the difficulties in virus production for serological assays, it is not included in many standard diagnostic or surveillance testing protocols. limited data are available indicating that it is common in wild mice [8, 49] . further, mtv obviously represents a significant source of contamination of mcmv-1 (and vice versa) if virus is prepared from salivary glands, since both viruses cause chronic or persistent salivary gland infections and can coinfect the same host. all mouse strains are susceptible to infection, but natural or experimental infection of adult mice is subclinical. gross lesions appear only in the thymus and only if experimental infection occurs at an age of less than about 5 days. infection results in nuclear inclusions in thymocytes and their almost complete destruction within 2 weeks. virus is present in the thymus but may also be found in the blood and in salivary glands of surviving animals. salivary glands are the only site yielding positive virus isolations if animals are infected as adults. the virus persists here and is shed via saliva for months. mtv also establishes a persistent infection in athymic foxn1 nu mice, but virus shedding is reduced compared to euthymic mice, with virus recovery possible only in a lower percentage of mice [50] . pathological changes caused by mtv occur in the thymus, and reduced thymus mass due to necrosis in suckling mice is the most characteristic gross lesion [36] . lymphoid necrosis may also occur in lymph nodes and spleen [51] , with necrosis and recovery similar to that in the thymus. in mice infected during the first 3 days after birth, necrosis of thymus becomes evident within 3-5 days, and the animals' size and weight are markedly reduced at day 12-14. intranuclear inclusions may be present in thymocytes between days 10-14 after infection. the thymus and the affected peripheral tissues regenerate within 8 weeks after infection. regardless of the age of mice at infection, a persistent infection is established in the salivary glands, and infected animals shed virus for life. several alterations of immune responses are associated with neonatal mtv infection. there is transient immunosuppression, attributable to lytic infection of t lymphocytes, but activity (e.g. response of spleen cells to t-cell mitogens) returns to normal as the histological repair progresses [51] . selective depletion of cd4þ t cells by mtv results in autoimmune disease [52, 53] . information about additional influences on the immune system is given in textbooks [6, 8] . in experimentally infected newborn mice, oral and intraperitoneal infections similarly result in thymus necrosis, seroconversion and virus shedding, suggesting that the oral-nasal route is likely to be involved in natural transmission [54] . the virus spreads to cagemates after long periods of contact. it is transmitted between mice kept in close contact, and transmissibility from cage to cage seems to be low. mtv is not transmitted to fetuses by the transplacental route, and intravenous infection of pregnant mice does not lead to congenital damage, impairment in size or development, or abortion [55] . mtv and mcmv-1 do not cross-react serologically [16] . serological monitoring of mouse populations for antibodies to mtv is possible by indirect immunofluorescent assay (ifa) testing, which is commercially available; enzyme-linked immunosorbent assays (elisa) tests have also been established [41, 56] . elisa and complement fixation yield similar results [57] . serological tests based on recombinant proteins and direct detection of virus by pcr are currently not possible because the genome of the virus has not yet been sequenced. it must be noted that the immune response depends on the age at infection. antibody responses are not detectable in mice infected as newborns, whereas adult mice develop high titres that are detectable by serological testing. if neonatal infection is suspected, homogenates of salivary glands or other materials can be inoculated into pathogen-free newborn mice followed by gross and histological examination of thymus, lymph nodes and spleens for lymphoid necrosis [49] . alternatives to the in vivo infectivity assay for detecting mtv in infected tissues include a competition elisa [58] and map testing, although this is slightly less sensitive than infectivity assays [59] . there is very little experience of eradication methods for mtv because of its low prevalence in contemporary mouse colonies. methods that eliminate other herpesviruses will likely eliminate mtv. procurement of animals of known negative mtv status is an appropriate strategy to prevent infection. strict separation of laboratory mice from wild rodents is essential to avoid introduction of the virus into laboratory animal facilities. murid herpesvirus 2 (muhv-2) or rat cytomegalovirus infects rats and is also a member of the genus muromegalovirus. murid herpesvirus 4 (muhv-4) is a member of the genus rhadinovirus in the subfamily gammaherpesvirinae and is also known as mouse herpesvirus strain 68 (mhv-68). other murid herpesviruses are not yet assigned to a subfamily within the family herpesviridae. among these is murid herpesvirus 3 (mouse thymic herpesvirus), but also murid herpesvirus 5 (field mouse herpesvirus) which infects voles (microtus pennsylvanicus), murid herpesvirus 6 (sand rat nuclear inclusion agent), and murid herpesvirus 7 [60] . furthermore, a gammaherpesvirus of house mice (mus musculus) has been described recently which is clearly distinct from mhv-68 [61] . experimental infection of laboratory mice with mhv-68 is a frequently used model system for the study of human gammaherpesvirus pathogenesis, e.g. of kaposi's sarcoma-associated herpesvirus or epstein-barr virus (ebv) [62, 63] which are members of the same subfamily. they are also important models to study viral latency and immune mechanisms controlling latency [64] [65] [66] . mus musculus is not the natural host for this virus; it was first isolated in slovakia from bank voles (myodes glareolus). additional closely related strains (mhv-60, mhv-72) exist from the same host species, and similar strains (mhv-76, mhv-78) were isolated from wood mice (apodemus flavicollis and apodemus sylvaticus). apodemus sp. seem to be the major hosts for mhv-68 in great britain [67] . different virus strains exhibit different genetic and biological properties and also differ in their pathogenicity, e.g. for prkdc scid mice [68] . infections in laboratory mice take the same course as in their natural hosts [69] . there are, however, some differences as, e.g. higher virus levels are reached in the lungs of balb/c mice, and wood mice develop higher titres of neutralizing antibodies [70] . house mice develop an acute infection in the lungs after intranasal infection. a latent infection develops within 2 weeks and the virus persists lifelong in epithelial cells in the lungs and also spreads to the spleen and other organs (e.g. bone marrow, peritoneal cells) where it persists in different cells of the immune system. it behaves like a natural pathogen in inbred strains of mice and persists without causing disease. the mousepox (ectromelia) virus (ectv) is a member of the genus orthopoxvirus belonging to the family poxviridae. it is antigenically and morphologically very similar to vaccinia virus and other orthopoxviruses. poxviruses are the largest and most complex of all viruses, with a diameter of 200 nm and a length of 250-300 nm. mousepox (ectromelia) virus contains one molecule of double-stranded dna with a total genome length of nearly 210 000 nucleotides [71] . it is the causative agent of mousepox, a generalized disease in mice. experimental transmission to young rats (up to 30 days of age) is possible [72] . unlike various other orthopoxviruses, ectromelia virus does not infect humans [73] . the virus is resistant to desiccation, dry heat and many disinfectants. it is not consistently inactivated in serum heated for 30 min at 56 c [3, 74] and remains active for months when maintained at 4 c in fetal bovine serum [75] . effective disinfectants include vapour-phase formaldehyde, sodium hypochlorite and iodophores [8, 76] . historically, ectv has been an extremely important natural pathogen of laboratory mice. the virus was widespread in mouse colonies worldwide and can still be found in several countries. between 1950 and 1980 almost 40 individual ectromelia outbreaks were reported in the usa. the last major epizootic in the usa occurred in 1979-80 and has been described in great detail [77] . severe outbreaks were also described in various european countries [78] [79] [80] . a more recent outbreak in the usa, which resulted in the eradication of almost 5000 mice in one institution, was described by dick et al. [81] . another recent and well-documented case of mousepox was published by lipman et al. [3] . few additional but unpublished cases of ectromelia have been observed since then; the latest report of an outbreak was published in 2009 [74] . in general, positive serological reactions are occasionally reported from routine health surveillance studies [17] but the virus is extremely rare in european and american colonies of laboratory mice [13] [14] [15] . natural infections manifest differently, depending on many factors. mousepox may occur as a rapidly spreading outbreak with acute disease and deaths, or may be inconspicuous with slow spreading and mild clinical signs and may therefore be very difficult to diagnose [81] . the mortality rate can be very low in populations in which the virus has been present for long periods. the infection usually takes one of three clinical courses: acute asymptomatic infection, acute lethal infection (systemic form) or subacute to chronic infection (cutaneous form) [8, [81] [82] [83] . the systemic or visceral form is characterized clinically by facial oedema, conjunctivitis, multisystemic necrosis and usually high mortality. this form is less contagious than the cutaneous form because the animals die before there is virus shedding. the cutaneous form is characterized by typical dermal lesions and variable mortality. the outcome of infection depends on many factors including strain and dose of virus; route of viral entry; strain, age, and sex of mouse; husbandry methods and duration of infection in the colony. while all mouse strains seem to be susceptible to infection with ectv, clinical signs and mortality are strain-dependent [84] [85] [86] . acute lethal (systemic) infection occurs in highly susceptible inbred strains such as dba/1, dba/2, balb/c, a and c3h/hej. immunodeficient mice may also be very susceptible [87] . outbreaks among susceptible mice can be explosive, with variable morbidity and high mortality (>80%). clinical disease may not be evident in resistant strains such as c57bl/6 and akr, and the virus can be endemic in a population for long periods before being recognized. furthermore, females seem to be more resistant to disease than males, at least in certain strains of mice [84, 85] . killer cells are necessary to control mousepox infections [88] . mice that are resistant to mousepox may lose their resistance with increasing age, most likely due to the decreased number and activity of nk cells [89] . the mechanisms determining resistance versus susceptibility are not fully understood but appear to reflect the action of multiple genes. the genetic loci considered to be important include h2d b (termed rmp3, resistance to mousepox), on chromosome 17 [90] ; the c5 genes (rmp2, on chromosome 2); rmp1, localized to a region on chromosome 6 encoding the nk cell receptor nkr-p1 alloantigens [91] ; the nitric oxide synthase 2 locus on chromosome 11 [92] ; and the signal transducer and activator of transcription 6 locus on chromosome 10 [93] . mousepox infections are controlled for several days during the initial course of infection by the complement system until the adaptive immune system can react. loss of the complement system results in lethal infection [94] . clearance of the virus by the immune system is dependent upon the effector functions of cd8þ t cells while nk cells, cd4þ t cells and macrophages are necessary for the generation of an optimal response [95, 96] . t-and b-cell interactions and antibodies play a central role during recovery from a secondary infection [97] . mousepox (ectromelia) virus usually enters the host through the skin with local replication and extension to regional lymph nodes [8, 82, 86] . it escapes into the blood (primary viraemia) and infects splenic and hepatic macrophages, resulting in necrosis of these organs and a massive secondary viraemia. this sequence takes approximately 1 week. many animals die at the end of this stage without premonitory signs of illness; others develop varying clinical signs including ruffled fur, hunched posture, swelling of the face or extremities, conjunctivitis and skin lesions (papules, erosions or encrustations mainly on ears, feet and tail; figure 3 .2.1). necrotic amputation of limbs and tails can sometimes be seen in mice that survive the acute phase, hence the common gross lesions of acute mousepox include enlarged lymph nodes, peyer's patches, spleen and liver; multifocal to semiconfluent white foci of necrosis in the spleen and liver; and haemorrhage into the small intestinal lumen [36, 81, 86, 87] . in animals that survive, necrosis and scarring of the spleen can produce a mosaic pattern of white and red-brown areas that is a striking gross finding. the most consistent histological lesions of acute mousepox are necroses of the spleen (figure 3.2. 3), lymph nodes, peyer's patches, thymus and liver [3, 36, 81, 86, 87] . occasionally, necrosis may also be observed in other organs such as ovaries, uterus, vagina, intestine and lungs. the primary skin lesion, which occurs about a week after exposure at the site of inoculation (frequently on the head), is a localized swelling that enlarges from inflammatory oedema. necrosis of dermal epithelium provokes a surface scab and heals as a deep, hairless scar. secondary skin lesions (rash) develop 2-3 days later as the result of viraemia ( natural transmission of ectv mainly occurs by direct contact and fomites [8, 82, 98, 99] . the primary route of infection is through skin abrasions. faecal-oral and aerosol routes may also be involved [98] . in addition, the common practice of cannibalism by mice may contribute to the oral route of infection [99] . intrauterine transmission is possible at least under experimental conditions [100] . virus particles are shed from infected mice (mainly via scabs and/or faeces) for about 3-4 weeks, even though the virus can persist for months in the spleen of an occasional mouse [8, 99] . cage-to-cage transmission of ectv and transmission between rooms or units is usually low and largely depends on husbandry practices (e.g. mixing mice from different cages). importantly, the virus may not be transmitted effectively to sentinel mice exposed to dirty bedding [3] . various tests have been applied for the diagnosis of ectromelia. previous epidemics were difficult to deal with because of limited published data and information on the biology of the virus and the lack of specific and sensitive assays [101] . in the 1950s, diagnosis relied on clinical signs, histopathology and animal passages of tissues from moribund and dead animals. culture of the virus on the chorioallantoic membrane of embryonated eggs was also used. serology is currently the primary means of routine health surveillance for testing mouse colonies for exposure to ectv. the methods of choice are mfia, elisa and ifa; they are more sensitive and specific than the previously used haemagglutination inhibition (hi) assay [41, 102, 103] . serological tests based on virus particles detect antibodies to orthopoxviruses and do not distinguish between ectv and vaccinia virus or other orthopoxviruses, respectively. vaccinia virus is commonly used as an antigen for serological testing to avoid the risk of infection for mice. thus, false-positive serological reactions may be found after experimental administration of replication-competent vaccinia virus. it has been shown that even cage contact sentinels may develop antibodies, and vaccinia virus leading to seroconversion may even be transmitted by dirty bedding [104] . confirmation of positive serological results is important before action is taken because vaccinia virus is increasingly prevalent in animal facilities as a research tool (e.g. for vaccination or gene therapy). as observed in different outbreaks, serological testing is of little value in the initial stages of the disease. for example, in the outbreak described by dick et al. [81] depopulation was nearly completed before serological confirmation was possible. for this reason, negative serological results should be confirmed by direct detection methods (pcr, immunohistochemistry, virus isolation) or by histopathology, especially when clinical signs suggestive of mousepox are observed. pcr assays to detect different genes of poxviruses in infected tissues have been used [3, 81, 105] . other pcr tests which were developed to detect smallpox virus have also been shown to detect ectromelia virus and can be used as well [106, 107] . the key to prevention and control of mousepox is early detection of infected mice and contaminated biological materials. all institutions that must introduce mice from other than commercial barrier facilities should have a health surveillance programme and test incoming mice. perhaps even more important than living animals are samples from mice (tumours, sera, tissues). the virus replicates in lymphoma and hybridoma cell lines [108] , and such cells or material derived from them may therefore be a vehicle for inadvertent transfer between laboratories. the last three published outbreaks of ectromelia were introduced into the facilities by mouse serum [3, 74, 81] . lipman et al. [3] found that the contaminated serum originated from a pooled lot of 43 l that had been imported from china, but in both other cases, serum was obtained from animals in the usa. because mouse serum is commonly sold to the end user in small aliquots (a few millilitres), it has to be expected that aliquots of the contaminated lot may still be stored in freezers. these published cases of ectromelia outbreaks provide excellent examples of why testing should be performed on all biological materials to be inoculated into mice. in the case of ectromelia virus it was shown that pcr is more sensitive, and map testing failed to detect contamination [74] . eradication of mousepox has usually been accomplished by elimination of the affected colonies, disinfection of rooms and equipment, and disposal of all infected tissues and sera. while culling of entire mouse colonies is the safest method for eradication of mousepox, it is not a satisfactory method because of the uniqueness of numerous lines of genetically modified animals housed in many facilities. several studies indicate that mousepox is not highly contagious [75, 84, 99] and that it may be self-limiting when adequate husbandry methods are applied. therefore, strict quarantine procedures along with cessation of breeding (to permit resolution of infection) and frequent monitoring, with removal of clinically sick and seropositive animals, are a potential alternative. the period from the last births until the first matings after cessation of breeding should be at least 6 weeks [99] . sequential testing of immunocompetent contact sentinels for seroconversion should be employed with this option. in the past, immunization with live vaccinia virus was used to suppress clinical expression of mousepox. vaccination may substantially reduce the mortality rate, but it does not prevent virus transmission or eradicate the agent from a population [109, 110] . after vaccination, typical pocks develop at the vaccination site, and infectious vaccinia virus is detectable in spleen, liver, lungs and thymus [111] . vaccination also causes seroconversion so that serological tests are not applicable for health surveillance in vaccinated populations. it is therefore more prudent to control mousepox by quarantine and serological surveillance than by relying on vaccination. mortality and clinical disease are the major factors by which ectv interferes with research. severe disruption of research can also occur when drastic measures are taken to control the infection. the loss of time, animals and financial resources can be substantial. experimental mousepox infections are frequently used as a model to study various aspects of smallpox infections of humans [112] [113] [114] . mousepox shares many aspects of virus biology and pathology, and models the course of human smallpox. experimental mousepox infections are used to study vaccination procedures [115, 116] or anti-poxvirus therapies [117] . murine adenoviruses (madv) are non-enveloped, double-stranded dna viruses of the family adenoviridae. two distinct strains have been isolated from mice. the fl strain (madv-1) was first isolated in the usa as a contaminant of a friend leukaemia [118] and has been classified as a member of the genus mastadenovirus. the k87 strain (madv-2) was isolated in japan from the faeces of a healthy mouse [119] and has not yet been assigned to a genus. both strains are considered to represent different species [120] [121] [122] . they are host species specific and are not infectious for infant rats [123] . madv-1 can be cultured in vitro in mouse fibroblasts (e.g. 3t6 or l929 cells), madv-2 is usually cultured in vitro in a mouse rectum carcinoma cell line (cmt-93). in laboratory mice, seropositivity to adenoviruses was reported to be very low [11, 14, 15, 17, 18, 124] or negative [12, 13] . antibodies to madv are also found in wild mice [21, 125] and in rats [21, 126] . neither virus is known to cause clinical disease in naturally infected, immunocompetent mice. however, madv-1 can cause a fatal systemic disease in suckling mice after experimental inoculation [118, 127, 128] . disease is characterized by scruffiness, lethargy, stunted growth and often death within 10 days. experimental infection of adult mice with madv-1 is most often subclinical and persistent but can cause fatal haemorrhagic encephalomyelitis with neurological symptoms, including tremors, seizures, ataxia and paralysis in susceptible c57bl/6 and dba/2j mice [129] . balb/c mice are relatively resistant to this condition. athymic foxn1 nu mice experimentally infected with madv-1 develop a lethal wasting disease [130] . similarly, prkdc scid mice succumb to experimental infection with madv-1 [131] . gross lesions in response to natural madv infections are not detectable. occasional lesions observed after experimental infection with madv-1 include small surface haemorrhages in the brain and spinal cord of c57bl/6 and dba/2j mice [129] , duodenal haemorrhage in foxn1 nu mice [130] and pale yellow livers in prkdc scid mice [131] . histologically, experimental madv-1 infection of suckling mice is characterized by multifocal necrosis and large basophilic intranuclear inclusion bodies in liver, adrenal gland, heart, kidney, salivary glands, spleen, brain, pancreas and brown fat [8, 36, 127, 132] . in experimentally induced haemorrhagic encephalomyelitis, multifocal petechial haemorrhages occur throughout the brain and spinal cord, predominantly in the white matter, and are attributed to infection and damage to the vascular epithelium of the central nervous system (cns) [129] . histopathological manifestations in madv-1-infected prkdc scid mice are marked by microvesicular fatty degeneration of hepatocytes [131] . in contrast to madv-1, the tissue tropism of madv-2 is limited to the intestinal epithelium. naturally or experimentally infected mice develop intranuclear inclusions in enterocytes, especially in the ileum and caecum [8, 36, 133] . transmission of madv primarily occurs by ingestion. madv-1 is excreted in the urine and may be shed for up to 2 years [134] . madv-2 infects the intestinal tract and is shed in faeces for only a few weeks in immunocompetent mice [135] ; immunodeficient mice may shed the virus for longer periods [136] . murine adenovirus infections are routinely diagnosed by serological tests. however, there is a one-sided cross-reactivity of madv-1 with madv-2 [137] . serum from mice experimentally infected with madv-1 yielded positive reactions in serological tests with both viruses, while serum from mice infected with madv-2 reacted only with the homologous antigen [138] . smith et al. [126] reported that sera might react with madv-1 or madv-2 or both antigens. occasional reports of mice with lesions suggestive of adenovirus infections and negative serology (with madv-1) indicate that the infection may not be detected if only one virus is used as an antigen [139] . it is therefore usual to test sera for antibodies to both madv-1 and madv-2. the commonly used methods are ifa, elisa and mfia. the low prevalence in colonies of laboratory mice indicates that madv can easily be eliminated (e.g. by hysterectomy derivation or embryo transfer) and that barrier maintenance has been very effective in preventing infection. the low pathogenicity and the low prevalence in contemporary mouse populations are the main reasons why adenoviruses are considered to be of little importance, which is also indicated by the fact that recent publications about murine adenoviruses are very rare. however, the viruses might easily be spread by the exchange of genetically modified mice and therefore re-emerge. only a few influences on research attributable to madv have been published. for example, it has been shown that madv-1 significantly aggravates the clinical course of scrapie disease in mice [140] . natural infections with madv could also interfere with studies using adenovirus as a gene vector. a novel murine adenovirus classified as a mastadenovirus has recently been isolated from a striped field mouse (apodemus agrarius) [141] . it was cultured in vero e6 cells and named madv type 3 (madv-3). it revealed the highest similarity to madv-1 but it represents a separate serotype. however, there is some cross-reactivity between madv-3 and both other mouse viruses [142] . in addition to serological and antigenic differences it also shows a unique organotropism and infects predominantly the heart tissue of c57bl/6n mice after experimental infection. experimentally infected mice show no clinical signs. the virus is not easily transmitted from experimentally infected mice to contact sentinels [142] . polyomaviridae are enveloped, double-stranded dna viruses. two different agents of this family exclusively infect mice (mus musculus), and both belong to the genus polyomavirus. murine pneumotropic virus (mptv) was formerly known as 'newborn mouse pneumonitis virus' or 'k virus' (named after l. kilham who first described the virus). the second is murine polyomavirus (mpyv). both are related, but antigenically distinct, from each other [143] , and also viruslike particles from the major capsid protein (vp1) do not cross-react [144] . they are enzootic in many populations of wild mice but are very uncommon in laboratory mice. even older reports indicate that both have been eradicated from the vast majority of contemporary mouse colonies, and their importance is negligible [8] . seropositivity to these viruses was not reported in a recent survey conducted in the usa [13] , and other publications also indicate that these viruses do not presently play a significant role in laboratory mice [11, 14, 15] . because of their low prevalence, neither virus is included in the list of agents for which testing is recommended on a regular basis by felasa [145] . although polyomavirus genes, especially those of sv40, are widely used in gene constructs for insertional mutagenesis, very few reports have been published on spontaneous or experimental disease due to mpyv or mptv in the last 10-15 years. the reader is therefore referred to previous review articles for details [8, 146] . natural infections with mptv are subclinical. the prevalence of infection is usually low in an infected population. the virus may persist in infected animals for months and perhaps for life depending on the age at infection and is reactivated under conditions of immunosuppression. virus replicates primarily in endothelial cells, but renal tubular epithelial cells are the major site of viral persistence [147, 148] . clinical signs are observed only after infection of infant mice less than 6-8 days of age. infected pups suddenly develop respiratory symptoms after an incubation period of approximately 1 week, and many die within a few hours of onset of symptoms with an interstitial pneumonia caused by productive infection of and damage to pulmonary endothelium (figure 3.2.5). endothelial cells in other organs are also involved in virus replication [148, 149] (figure 3 .2.6). in older suckling mice, mptv produces a more protracted infection, and the virus or viral antigen can be detected for as long as 4 months. in adult animals, the virus produces a transient asymptomatic infection. even in immunodeficient foxn1 nu mice, experimental infection of adults is clinically asymptomatic, although virus is detectable for a period of several months [150] . in vitro cultivation of mptv is difficult. no susceptible permanent cell line is known to support growth. it can be cultured in primary mouse embryonic cells, but viral titres are not sufficient for use in serological assays [151] . for this reason, the hi test using homogenates of livers and lungs of infected newborn mice is still frequently used, but ifa and elisa tests are also available [152] . furthermore, a pcr test for demonstration of mptv in biological samples has also been published [153] . mpyv was first detected as a contaminant of murine leukaemia virus (mulv) when sarcomas developed in mice after experimental inoculation of contaminated samples. it has later been shown to be a frequent contaminant of transplantable tumours [1] . natural infection of mice is subclinical, and gross lesions including tumours are usually not found. tumour formation occurs when mice are experimentally infected at a young age or when inoculated with high virus doses. development of tumours may be preceded by multifocal necrosis and mortality during the viraemic stage [36] . parotid, salivary gland and mammary tumours are common, and sarcomas or carcinomas of kidney, subcutis, adrenal glands, bone, cartilage, teeth, blood vessels and thyroid also occur. virus strains vary with regard to the tumour types or lesions that they induce, and mouse strains vary in their susceptibility to different tumour types. those of c57bl and c57br/cd lineage are considered to be the most resistant strains; athymic foxn1 nu mice are considered to be most susceptible; c3h mice are particularly susceptible to adrenal tumours and a mice tend to develop bone tumours. immunosuppression or inoculation into immunodeficient strains (e.g. foxn1 nu ) also supports the growth of tumours. on the other hand, experimental infection of adult immunocompetent mice does not result in tumour formation because the immune response suppresses tumour growth, and newborn immunocompetent mice develop runting only if inoculated with high virus doses [154] . after experimental intranasal infection, mpyv initially infects the respiratory tract followed by a systemic phase in which liver, spleen, kidney and colon become infected [155] . the virus is shed in faeces and in all body fluids, and transmission occurs rapidly by direct contact between animals, but also between cages in a room. further, intrauterine transmission has been documented after experimental infection [156] . mpyv persists in all organs in prkdc scid mice while viral dna is detectable in immunocompetent mice after experimental infection for only a limited period of about 4 weeks [157] . however, virus may persist and can be reactivated by prolonged immunosuppression [158] or during pregnancy, at least in young mice [159] . it has been shown that interferon-gamma is an important factor of the host defence against tumour formation and mpyv infection [160] . biological materials of mouse origin are likely to be the most common source of contamination of laboratory mice, emphasizing the importance of map or pcr screening of biological materials to be inoculated into mice. the most frequently used tests for health surveillance of mouse colonies are elisa, mfia and ifa; in addition, the hi test is still used. latent infections can be detected by intracerebral inoculation of neonate mice or by map testing, but direct demonstration of virus in biological samples is also possible by pcr testing [153] . while mpyv infections are of low importance for laboratory animal medicine, the virus is used in models of persistent virus infection [161, 162] . virus-like particles from both murine polyomaviruses have been used as a vector for gene therapy or vaccines [163, 164] . parvoviruses are non-enveloped small viruses (approximately 20 nm in diameter) with a singlestranded dna genome of approximately 5000 nucleotides. murine parvoviruses are members of the family parvoviridae, genus parvovirus. they are remarkably resistant to environmental conditions like heat, desiccation, acidic and basic ph-values. up to date, two distinct species that infect laboratory mice are officially listed: the minute virus of mice (mvm), previously named mice minute virus (mmv), and the mouse parvovirus (mpv). non-structural proteins (ns-1 and ns-2) are highly conserved among both viruses whereas the capsid proteins (vp-1, vp-2, vp-3) are more divergent and determine the serogroup [165] . both viruses require mitotically active cells for replication. severe clinical signs are therefore not found in mature animals because of the lack of a sufficient number of susceptible cells in tissues. general aspects of rodent parvovirus infections and their potential effects on research results have been reviewed [6, 8, [166] [167] [168] [169] [170] . already in the mid-1980s mouse colonies were identified that gave positive reactions for mvm by ifa but not by hi tests. it was subsequently shown that these colonies were infected with a novel parvovirus, initially referred to as 'mouse orphan parvovirus'. the first isolate of mpv was detected as a contaminant of cultivated t-cell clones interfering with in vitro immune responses [171] and was named 'mouse parvovirus'. it does not replicate well in currently available cell cultures, and sufficient quantities of virus for serological tests are difficult to generate. hitherto, only very few isolates of mpv have been cultured and subsequently characterized on a molecular basis [165, 172] . on the basis of epidemiological analyses, further parvoviruses were recently identified in mice, sequenced, and tentatively named serially mpv-2 and mpv-3 [173] , mpv-4 (genbank fj440683) and mpv-5 (genbank fj441297). in addition, several variants are published for mpv-1 [172, 174, 175] . at present, mpv is among the most common viruses found in colonies of laboratory mice. the prevalence of sera positive for parvoviruses ranged from 1% to nearly 10% in western europe and north america, with the majority of sera being positive for mpv in studies differentiating between the two parvovirus species [12, 14, 15, 176] . these prevalence data are based on testing at commercial laboratories and do not reflect that, despite highly specific and sensitive test methods, enzootic parvovirus infections are difficult to detect due to virus-associated characteristics [169, 170] . a recent survey conducted in the usa showed that during a 24-36 month period mouse parvoviruses were detected at almost all facilities that responded to a questionnaire, with mpv being more often diagnosed than mvm [13] . clinical disease and gross or histological lesions have not been reported for mice naturally or experimentally infected with mpv. infections are subclinical even in newborn and immunocompromised animals [177, 178] . in contrast to many other viruses infecting mice, viral replication and excretion is not terminated by the onset of host immunity. tissue necrosis has not been observed at any stage of infection in infected infant or adult mice [177, 178] . humoral immunity to mpv does not protect against mvm infections, and vice versa [179] . serological surveys have indicated that mpv naturally infects only mice, with the exception that mpv-3 shows genetic similarity to hamster parvovirus, suggesting that a cross-species transmission has occurred, where the mouse probably served as the natural host [173, 180] . differences in mouse strain susceptibility to clinical mpv infection do not exist. however, seroconversion seems to be strain-dependent. after experimental infection with mpv-1b, seroconversion occurred in all c3h/hen mice, fewer balb/c, dba/2 and icr mice, and seroconversion could not be detected in c57bl/6 mice [181] . upon mpv-1f inoculation, antibody response was absent in balb/carc mice [182] . diagnosis of mpv infection by pcr testing of small intestine and mesenteric lymph nodes also depended on the mouse strain. mpv dna was detected in all mouse strains evaluated except dba/2 even though seroconversion was detected in these mice. after oral infection, the intestine is the primary site of viral entry and replication. the virus spreads to the mesenteric lymph nodes and other lymphoid tissues, where it persists for more than 2 months [178] , and seems to be excreted via the intestinal and the urinary tract. after experimental inoculation of weanling mice, mpv is transmitted to cagemates by direct contact for 2-6 weeks [177] , and transmission by dirty bedding is also possible. these results implicate a role for urinary, faecal, and perhaps respiratory excretion of virus. another study showed that naturally infected mice might not transmit the virus under similar experimental conditions [183] . serology is a useful tool to identify mpv infections in immunocompetent hosts, but reaching a diagnosis based on serological assays may be difficult and requires a good knowledge of the available techniques. neither the virion elisa nor hi is a practical screening test for mpv because they require large quantities of purified mpv, which is difficult to obtain. diagnosis of mpv infections has long been made on the basis of an mvm hi-negative result coupled with an mvm ifa-positive result. ifa provides the opportunity to detect both serogroup-specific vp proteins as well as ns proteins that are conserved among mouse parvoviruses. a generic rodent parvovirus elisa using a recombinant ns-1 protein as antigen has been developed [184] , but mpv ifa and mpv hi assays are more sensitive techniques than the ns-1 elisa and the mvm ifa [181] . in contrast, elisa tests that use recombinant vp-2 provide sensitive and serogroup-specific assays for the diagnosis of mpv infections in mice [176, 185] , although considerable cross-reactivity with heterologous capsid antigens exists [173] . nevertheless, when using the elisa technique, one needs to consider that mpv-2 may not consistently be detected by mpv-1 vp-2 elisa [168, 173] , especially when antibody titres are low (own observations). therefore, elisas using mpv-2 vp-2 and mpv-3 vp-2 antigens are also used for diagnostics. as parvovirus diagnostics using recombinant assays should be based on a combination of antigens, bead-based mulitplex assays are a convenient extension of traditional elisa, allowing the use of multiple antigens simultaneously. in immunodeficient mice that do not generate a humoral immune response, pcr assays can be used to detect mpv [186, 187] and other parvoviruses. mpv has been shown to persist for at least 9 weeks in the mesenteric lymph nodes [178] . this tissue is considered the best suited for pcr analysis, but spleen and small intestine can also be used with good success [181] . for antemortem detection, shedding of parvoviruses can also be detected by pcr of faecal samples [188] . the virus persists sufficiently long in mesenteric lymph nodes so that pcr assays may also be used as a primary screening tool for laboratories that do not have access to specific mpv antigen-based serological assays. the pcr is further a good confirmatory method for serological assays and has also been described for the detection of parvoviruses in cell lines and tumours [189] . in addition, the map test has been reported as a sensitive tool to detect mpv [183] . given the high environmental stability of the virus and the potential fomite transmission, together with the long virus persistence in infected animals, spontaneous disappearance from a mouse population (e.g. by cessation of breeding) is unlikely. eradication of infection is possible by elimination of infected animals and subsequent replacement with uninfected mice, and the agent can be eliminated from breeding populations by embryo transfer or by hysterectomy. it should be noted that recent studies suggest a risk of virus transmission by embryo transfer, though successful sanitation of immunodeficient mice was achieved despite antibody response in recipients and progeny after embryo transfer [190, 191] . although there are few published reports of confounding effects of mpv on research, it is lymphocytotropic and may perturb immune responses in vitro and in vivo. infections with mpv have been shown to influence rejection of skin and tumour grafts [192] . mvm is the type species of the genus parvovirus. the virus was intermediately named mice minute virus (mmv). it was originally isolated by crawford [193] from a stock of mouse adenovirus, and this prototype isolate was later designated mvmp. its allotropic variant was detected as a contaminant of a transplantable mouse lymphoma [194] and designated mvmi because it exhibits immunosuppressive properties in vitro. both variants have distinct cell tropisms in vivo and in vitro. mvmp infects fibroblast cell lines and does not cause clinical disease [195, 196] . both strains are apathogenic for adult mice, but the immunosuppressive variant is more pathogenic for neonatal mice than is mvmp. a third strain, the cutter strain mvmc, was isolated from bhk-21 cells [172] . in contrast to these three strains detected as cell culture contaminants, an isolate was obtained from naturally infected mice with a b-cell maturational defect maintained at the university of missouri and therefore denominated mvmm [173] . serological surveys show that the mouse is the primary natural host [19, 125, 197] , but the virus is also infective for rats, hamsters [168, 198] , and mastomys [199] during fetal development or after parenteral inoculation. natural infections are usually asymptomatic in adults and infants, and the most common sign of infection is seroconversion. kilham and margolis [200] observed mild growth retardation a few days after experimental infection of neonatal mice with mvmp. studies of transplacental infection yielded no pathological findings in mice [201] . the immunosuppressive variant, but not the prototype strain, is able to produce a runting syndrome after experimental infection of newborn mice [195] . depending on the host genotype, experimental infections of fetal and neonatal mice with mvmi produce various clinical presentations and lesions. infection in c57bl/6 mice is asymptomatic, but the virus causes lethal infections with intestinal haemorrhage in dba/2 mice. infection of strains such as balb/c, cba, c3h/he and sjl is also lethal and mice have renal papillary haemorrhage [196] . the mvmi also infects haematopoietic stem cells and mediates an acute myelosuppression [202, 203] . because of its dependence on mitotically active tissues, the fetus is at particular risk for damage by parvoviruses. mvm and other parvoviruses may have severe teratogenic effects and cause fetal and neonatal abnormalities by destroying rapidly dividing cell populations, often resulting in fetal death. adult prkdc scid mice develop an acute leukopenia 1 month after experimental infection with mvmi and die within 3 months. the virus persists lifelong in the bone marrow of these mice [204] . during a natural concurrent outbreak of mvmm and mpv, a runting syndrome with lymphohistiocytic renal inflammation and inclusion bodies in cells resembling splenic haematopoietic progenitor cells was reported in b-cell (ighm)deficient mice [205] . mmv is shed in faeces and urine. in faecal samples, mvm was detected for up to 4-6 weeks by pcr [206, 207] , although shorter periods (9-12 days) have been observed [208] . notably, shedding re-occurred after immunosuppression by irradiation [207] . contaminated food and bedding are important factors in viral transmission because the virus is very resistant to environmental conditions. direct contact is also important and the virus does not easily spread between cages. routine health surveillance is usually conducted by serological methods. unlike mpv, mvm can easily be cultured in cell lines so that antigen production for hi and elisa (using whole purified virions) is easy. hi is a highly specific diagnostic test whereas ifa always exhibits some degree of cross-reactivity with mpv and other closely related parvoviruses. elisa is probably the most frequently used test, but depending on the purity of the antigen preparation, cross-reactions with mpv may occur due to contamination with non-structural proteins that are common to both viruses. this problem can be avoided by the use of recombinant vp-2 antigen [176] . by using serological methods, one needs to consider that the mouse strain has a considerable effect on seroconversion so that an antibody response might not be detectable despite infection; while c57bl/6j mice showed good antibody response, seroconversion was observed only in some balb/c, akr/n, dba/2j, fvb/n and c3h/hen, but not in nmri and icr mice upon contact exposure to mvmi-inoculated mice [206] . viral detection is also possible by pcr in biological materials, organs (intestine, mesenteric lymph node, kidney, spleen) and faeces from infected animals [187, 189, 206, 207, 209] . although mvm was not thought to cause persistent infection in immunocompetent mice, recent data show that it can be detected in spleens for up to 16 weeks after exposure in some mouse strains [207] . therefore, pcr may be considered as a confirmatory method for serology. the virus can be eliminated from infected breeding populations by caesarean derivation or by embryo transfer. however, certain precautions such as careful washing and accompanying testing need to be minded, as mvm has been detected in reproductive organs and gametes and this virus firmly attaches to the zona pellucida or might even cross it [210, 211] . in experimental colonies, elimination of infected animals and subsequent replacement with uninfected mice is practical if careful environmental sanitation is conducted by appropriate disinfection procedures. it is important that reintroduction is avoided by exclusion of wild mice and by strict separation from other infected populations and potentially contaminated materials in the same facility. admission of biological materials must be restricted to samples that have been tested and found to be free from viral contamination. both allotropic variants of mvm have been used as models for molecular virology, and their small size and simple structure have facilitated examination of their molecular biology and expedited understanding of cell tropism, viral genetics and structure. the significance for laboratory mouse populations was considered low or uncertain because natural infections are inapparent. however, various effects on mouse-based research have been published [6, 7, 166, 167, 170] . because of their predilection for replicating in mitotically active cells, they are frequently associated with tumour cells and have a marked oncosuppressive effect [212] . special attention is also necessary for immunological research and other studies involving rapidly dividing cells (embryology, teratology). in addition, mvm is a common contaminant of transplantable tumours, murine leukaemias and other cell lines [1, 2, 213] . lactate dehydrogenase-elevating virus (ldv) is a single-stranded rna virus of the genus arterivirus belonging to the family arteriviridae. the genome organization and replication of ldv and other arteriviruses, their cell biology and other molecular aspects have been reviewed by snijder and meulenberg [214] . ldv has repeatedly been detected in wild mice (mus musculus), which are considered to be a virus reservoir [215, 216] . after infection of mice, virus titres of 10 10 -10 11 particles per ml serum are found within 12-14 h after infection. the virus titre drops to 10 5 particles per ml within 2-3 weeks and remains constant at this level for life. it persists in infected mice for the whole lifetime although it stimulates various immune mechanisms [216] [217] [218] [219] . the virus can be stored in undiluted mouse plasma at à70 c without loss of infectivity, but it is not stable at room temperature and is very sensitive to environmental conditions. only mice and primary mouse cells are susceptible to infection with ldv. it replicates in a subpopulation of macrophages in almost all tissues and persists in lymph nodes, spleen, liver, and testes tissues [220] . as suitable cell systems have not been available for virus production, routine serology has not been easily possible so that testing for ldv was not included in serological health monitoring programs. the prevalence of ldv in contemporary colonies of laboratory rodents is likely to be very low but detailed information about its prevalence comparable to most other agents is not available. ldv was first detected during a study of methods that could be used in the early diagnosis of tumours [221] . it produces a persistent infection with continuous virus production and a lifelong viraemia despite ldv-specific immune reactions of the host [217]. ldv has been found in numerous biological materials that are serially passaged in mice such as transplantable tumours including human tumours or matrigel prepared from such materials [1, 2, 222, 223] , monoclonal antibodies or ascitic fluids [224] , or infectious agents (e.g. haemoprotozoans, k virus, clostridium piliforme). these materials are contaminated after serial passage in an infected and viraemic mouse. contamination with ldv leads to the infection of each sequential host and to transmission of the virus by the next passage and remains associated with the specimen. it is therefore the most frequently detected contaminant in biological materials [1, 2] . infection with ldv is usually asymptomatic, and there are no gross lesions in immunocompetent as well as in immunodeficient mice. the only exception is poliomyelitis with flaccid paralysis of hindlimbs developing in c58 and akr mice when they are immunosuppressed either naturally with ageing or experimentally. it has been shown that only mice harbouring cells in the cns that express a specific endogenous mulv are susceptible to poliomyelitis [225] . the characteristic feature of ldv infection is the increased activity of lactate dehydrogenase (ldh) and other plasma enzymes [8, 226] , which is due to the continuous destruction of permissive macrophages that are responsible for the clearance of ldh from the circulation. as a consequence, the activity of plasma ldh begins to rise by only 24 h after infection and peaks 3-4 days after infection at 5-10-fold normal levels, or can even be up to 20-fold in sjl/j mice. the enzyme activity declines during the next 2 weeks but remains elevated throughout life. antigen-antibody complexes produced during infection circulate in the blood and are deposited in the glomeruli [226] . in contrast to other persistent virus infections (e.g. lymphocytic choriomeningitis virus), these complexes do not lead to immune complex disease and produce only a very mild glomerulopathy. the only gross finding associated with ldv infection is mild splenomegaly. microscopically, necrosis of lymphoid tissues is visible during the first days of infection. in mouse strains that are susceptible to poliomyelitis, ldv induces lesions in the grey matter of the spinal cord and the brainstem. ldv is not easily transmitted between mice, even in animals housed in the same cage. fighting and cannibalism increase transmission between cagemates, most likely via blood and saliva. infected females transmit the virus to their fetuses if they have been infected few days prior to birth and before igg anti-ldv antibodies are produced, but developmental and immunological factors (e.g. gestational age, timing of maternal infection with ldv, placental barrier) are important in the regulation of transplacental ldv infection [227, 228] . maternal immunity protects fetuses from intrauterine infection. immunodeficient prkdc scid mice also transmit virus to their offspring during chronic infection [229] . an important means of transmission is provided by experimental procedures such as mouse-to-mouse passage of contaminated biological materials or the use of the same needle for sequential inoculation of multiple mice. in principle, serological methods such as ifa may be used for detecting ldv infection [230] but they are not of practical importance. circulating virus-antibody complexes interfere with serological tests, and sufficient quantities of virus for serological tests are difficult to generate because ldv replicates only in specific subpopulations of primary cultures of murine macrophages and monocytes for one cell cycle [226] . however, it is meanwhile possible to use recombinant viral proteins of ldv as antigens [231] in elisa and mfia tests so that routine testing by serology is possible. in the past, diagnosis of ldv infection has primarily been based on increased ldh activity in serum or plasma of mice. ldv activity in serum or plasma can be measured directly, or samples (e.g. plasma, cell or organ homogenates) are inoculated into pathogen-free mice and the increase in ldh activity within 3-4 days is measured. an 8-10-fold increase is indicative of ldv infection. detection of infectivity of a plasma sample by the induction of increased ldh activity in the recipient animal is the most reliable means of identifying an infected animal. however, it is important to use clear non-haemolysed samples because haemolysis will (falsely) elevate activities of multiple serum or plasma enzymes, including ldh. this assay was usually included in a 'map test', but antibody detection similar to other viruses was not involved for reasons mentioned earlier. persistent infection makes ldv an ideal candidate for pcr detection in plasma or in organ homogenates [232, 233] . however, reports exist that pcr may produce false-negative results and should be used cautiously [234] . just as important as detecting ldv in animals is its detection in biological materials. this may be done by assay for increased ldh activity after inoculation of suspect material into pathogenfree mice [1, 2] or by pcr [232, 233, [235] [236] [237] . ldv spreads slowly in a population because direct contact is necessary. therefore, ldv-negative breeding populations can easily be established by selecting animals with normal plasma ldh activity. embryo transfer and hysterectomy derivation are also efficient. the presence of ldv in experimental populations may be indicative of contaminated biological materials. in such cases, it is essential that the virus is also eliminated from these samples. this is easily achieved by maintenance of cells by in vitro culture instead of by animal-to-animal passages [238] . due to the extreme host specificity of the virus, contaminated tumour samples can also be sanitized by passages in nude rats [223] or other animal species. another method to remove ldv from contaminated cells, which is based on cell sorting, has recently been described [239] . ldv is a potential confounder of any research using biological materials that are passaged in mice. once present in an animal, the virus persists lifelong. the most obvious signs are increased levels of plasma ldh and several other enzymes. ldv may also exhibit numerous effects on the immune system (thymus involution, depression of cellular immunity, enhanced or diminished humoral responses, nk cell activation, development of autoimmunity, and suppression of development of diabetes in nod mice); [218, 219, 224, [240] [241] [242] [243] [244] and enhance or suppress tumour growth [6, 7, 226] . interaction with other viruses has also been described [245] . lymphocytic choriomeningitis virus (lcmv) is an enveloped, segmented single-stranded rna virus of the genus arenavirus family, arenaviridae. it can easily be propagated in several commonly used cell lines like bhk-21 cells. however, cells are not lysed and a cytopathic effect (cpe) is not visible. the virus name refers to the condition that results from experimental intracerebral inoculation of the virus into adult mice and is not considered to be a feature of natural infections. mice (mus musculus) serve as the natural virus reservoir [246] , but syrian hamsters are also important hosts [247] . additional species such as rabbits, guinea-pigs, squirrels, monkeys and humans are susceptible to natural or experimental infection [248] . natural infection of callitrichid primates (marmosets and tamarins) leads to a progressive hepatic disease that is known as 'callitrichid hepatitis' [249, 250] . antibodies to lcmv have been found in wild mice in europe [251, 252] , africa [253] , asia [254] , australia [125] and america [255] . thus, it is the only arenavirus with worldwide distribution. infection with lcmv is rarely found in laboratory mice [248] . seropositivity to lcmv in laboratory mice was reported to be low during the last decade [11, 15, 17, 124] or negative [12] [13] [14] . in addition to laboratory mice and other vertebrate hosts, the virus has frequently been found in transplantable tumours and tissue culture cell lines from mice and hamsters [2, 256] . despite the low prevalence in laboratory mice, seropositivity to this zoonotic agent should raise serious concern for human health. lcmv is frequently transmitted to humans from wild mice and is also endemic to a varying degree in the human population [257] [258] [259] [260] [261] due to contact with wild mice. it has also been transmitted to humans by infected laboratory mice [262] and by pet and laboratory syrian hamsters [263] [264] [265] [266] . in addition, contaminated biological materials are important sources of infections for humans, and several outbreaks of lcm among laboratory personnel have been traced to transplantable tumours [267, 268] . transmission of lcmv to humans also occurred repeatedly by organ transplantation and was most likely transmitted to organ donors by close contact with infected pets [266, 269] . lcmv can cause mild-to-serious or fatal disease in humans [262, 270, 271] . congenital infection in humans may result in hydrocephalus, or fetal or neonatal death [272] . in mice, clinical signs of lcmv infection vary with strain and age of mouse, strain and dose of virus, and route of inoculation [8, 248, 251] . two forms of natural lcmv infection are generally recognized: a persistent tolerant and an (acute) non-tolerant form. the persistent form results from infection of mice that are immunotolerant. this is the case if mice are infected in utero or during the first days after birth. this form is characterized by lifelong viraemia and viral shedding. mice may show growth retardation, especially during the first 3-4 weeks, but they appear otherwise normal. infectious virus is bound to specific antibodies and complement, and these complexes accumulate in the renal glomeruli, the choroid plexus, and sometimes also in synovial membranes and blood vessel walls. at 7-10 months of age, immune complex nephritis develops with ruffled fur, hunched posture, ascites and occasional deaths. this immunopathologic phenomenon is called 'late onset disease' or 'chronic immune complex disease'. the incidence of this type of disease varies between mouse strains. gross lesions include enlarged spleen and lymph nodes due to lymphoid hyperplasia. kidneys affected with glomerulonephritis may be enlarged with a granular surface texture or may be shrunken in later stages of the disease process. microscopically, there is generalized lymphoid hyperplasia and immune complex deposition in glomeruli and vessel walls, resulting in glomerulonephritis and plasmacytic, lymphocytic perivascular cuffs in all visceral organs [36] . the non-tolerant acute form occurs when infection is acquired after the development of immunocompetence (in mice older than 1 week). these animals become viraemic but do not shed virus and may die within a few days or weeks. natural infections of adults are usually asymptomatic. surviving mice are seropositive and in most cases clear the virus to below detection levels of conventional methods. however, virus may persist at low levels in tissues (particularly spleen, lung and kidney) of mice for at least 12 weeks after infection as determined by sensitive assays such as nested reverse transcriptase (rt)-pcr or immunohistochemistry [273] . such non-lethal infection leads to protection against otherwise lethal intracerebral challenge. protection from lethal challenge is also achieved by maternally derived anti-lcmv antibodies through nursing or by the administration of anti-ldv monoclonal igg2a antibodies [274] . in experimentally infected mice, the route of inoculation (subcutaneous, intraperitoneal, intravenous, intracerebral) also influences the type and degree of disease [248] . intracerebral inoculation of adult immunocompetent mice typically results in tremors, convulsions and death due to meningoencephalitis and hepatitis. neurological signs usually appear on day 6 after inoculation, and animals die within 1-3 days after the onset of symptoms, or recover within several days. the classic histological picture is of dense perivascular accumulations of lymphocytes and plasma cells in meninges and choroid plexus. while infection following subcutaneous inoculation usually remains inapparent, reaction of mice to intraperitoneal or intravenous inoculation depends on the virus strain and on the mouse strain. infection by these routes primarily causes multifocal hepatic necrosis and necrosis of lymphoid cells. athymic foxn1 nu mice and other immunodeficient mice do not develop disease but become persistently viraemic and shed virus. as a general rule, all pathological alterations following lcmv infection are immune-mediated; and mice can be protected from lcmvinduced disease by immunosuppression [275] . lcmv disease is a prototype for virus-induced t-lymphocyte-mediated immune injury and for immune complex disease. for detailed information on the pathogenesis, clinical and pathological features of lcmv infection, the reader is referred to review articles [248, 276, 277] . in nature, carrier mice with persistent infection serve as the principal source of virus. intrauterine transmission is very efficient, and with few exceptions all pups born from carrier mice are infected. furthermore, persistently infected mice and hamsters can shed large numbers of infectious virions primarily in urine, but also in saliva and milk. the virus can replicate in the gastric mucosa after intragastric infection [278, 279] . gastric inoculation elicits antibody responses of comparable magnitudes as intravenous inoculation and leads to active infection with lcmv, indicating that oral infection is possible, e.g. by ingestion of contaminated food or by cannibalism. a self-limiting infection frequently results from infection of adult mice. the virus does not spread rapidly after introduction in populations of adult mice, and the infectious chain usually ends. however, if the virus infects a pregnant dam or a newborn mouse, a lifelong infection results, and soon a whole breeding colony of mice may become infected if the mice live in close proximity (which is the case under laboratory conditions). the virus is not easily transmitted to dirty-bedding sentinels, and it is important that colony animals or animals having had direct contact with a population are tested to exclude lcmv infection [280] . lcmv is most commonly diagnosed by serological methods such as mfia, ifa and elisa [281] . all strains show a broad cross-reactivity and are serologically uniform. however, subclinical persistent infections may be difficult to detect because they may be associated with minimal or undetectable levels of circulating antibody. it is important that bleeding of mice is done carefully because of a potential risk due to viraemic animals. historically, direct viral detection was performed by inoculating body fluids or tissue homogenates into the brain of lcmv-free mice or by subcutaneous injection into mice and subsequent serological testing (map test). more recently, pcr assays have been developed for the direct detection of viral rna in clinical samples or animals [282] [283] [284] . both map test and pcr can also be used to detect contamination of biological materials [235, 237] . specifically for exclusion of contamination by lcmv, it was requested by different authorities that virus is inoculated intracerebrally at a lethal dose 3-4 weeks after administration of the material to be tested. in case of contamination by lcmv and subsequent seroconversion, animals survive the challenge infection. vertical transmission of lcmv by transuterine infection is efficient so that this virus cannot reliably be eliminated by caesarean rederivation [280] . caesarean derivation may be effective if dams acquired infection after the development of immunocompetence (non-tolerant acute infection) and subsequently eliminated the virus, but such a strategy is difficult to justify in light of lcmv's zoonotic potential. in breeding colonies of great value, virus elimination might be possible soon after introduction into the colony by selecting non-viraemic breeders. this procedure is expensive and time consuming and requires special safety precautions. fortunately, infections of laboratory mice with lcmv are very uncommon. however, once lcmv has been detected in animals, or in biological materials, immediate destruction of all contaminated animals and materials is advisable to avoid risk of human infection. foxn1 nu and prkdc scid mice may pose a special risk because infections are silent and chronic [268] . cages and equipment should be autoclaved, and animal rooms should be fumigated with disinfectants such as formaldehyde, vaporized paraformaldehyde, hydrogen peroxide or other effective disinfectants. prevention of introduction into an animal facility requires that wild mice cannot get access to the facility. similarly important is screening of biological materials originating from mice and hamsters because these can be contaminated by lcmv. finally, it has been shown that the virus can also be introduced into a population by mice with an undetected infection [280] . appropriate precautions are necessary for experiments involving lcmv, or lcmv-infected animals or materials. biological safety level (bsl) 2 will be considered to be sufficient in most cases. bsl 3 practices may be considered when working with infected animals owing to the increased risk of virus transmission by bite wounds, scratching or aerosol formation from the bedding. animal biosafety level (absl) 3 practices and facilities are generally recommended for work with infected hamsters. appropriate precautions have been defined for different bsls or absls by cdc [285] . lcmv is frequently utilized as a model organism to study virus-host interactions, immunological tolerance, virus-induced immune complex disease, and a number of immunological mechanisms in vivo and in vitro [286] [287] [288] . accidental transmission may have a severe impact on various kinds of experiments [6, 7, 248, 251] and also affect infection with other agents [289] . mammalian orthoreoviruses (mrv) are nonenveloped, segmented double-stranded rna viruses of the family reoviridae, genus orthoreovirus. they have a wide host range and are ubiquitous throughout the world. the designation reo stands for respiratory enteric orphan and reflects the original isolation of these viruses from human respiratory and intestinal tract without apparent disease. the term 'orphan' virus refers to a virus in search of a disease. mammalian orthoreovirus can be grouped into three serotypes, numbered 1-3. mammalian orthoreovirus-3 (synonyms: hepatoencephalomyelitis virus; echo 10 virus) infection remains prevalent in contemporary mouse colonies and has been reported in wild mice [20, 125, 290] . a study in france reported antibodies to mrv-3 in 9% of mouse colonies examined [10] . in more recent studies in north america and western europe, such antibodies were detected in 0.01-0.2% of mice monitored [11, 14, 15] . schoondermark-van de ven et al. [12] found antibodies to mrv-3 in 0.6% of mouse samplings from western european institutions; and in a survey conducted by carty [13] , about 6% of responding institutions in the usa reported mrv-3 infection in their mouse colonies. in addition, contamination of mouse origin tumours and cell lines by mrv-3 has been reported many times [2, 8, 290] . experimentally, mrv-3 infection of infant mice has been used to model human hepatobiliary disease, pancreatitis, diabetes mellitus and lymphoma [8, 291] . the literature on mrv-3 infections in mice is dominated by studies on experimentally infected animals. the virus can cause severe pantropic infection in infant mice [290] [291] [292] . after parenteral inoculation, virus can be recovered from the liver, brain, heart, pancreas, spleen, lymph nodes and blood vessels. following oral inoculation, reoviruses gain entry by infecting specialized epithelial cells (m cells) that overlie peyer's patches. the virus then becomes accessible to leukocytes and spreads to other organs by way of the lymphatic system and the bloodstream. neural spread to the cns has also been well documented [293, 294] . the mechanisms of viral pathogenesis and their interactions with the host cell as well as the host's immune response are reviewed in detail by tyler et al. [295] , schiff et al. [296] and ward et al. [291] . natural infection by mrv-3 in a mouse colony is usually subclinical, although diarrhoea or steatorrhoea and oily hair effect in suckling mice may be noted [8, 36, [290] [291] [292] . the latter term has been used to describe the matted, unkempt appearance of the hair coat that results from steatorrhoea due to pancreatitis, maldigestion and biliary atresia. in addition, runting (attributed to immune-mediated destruction of cells in the pituitary gland that produce growth hormone), transient alopecia, jaundice (due to excessive bilirubin in the blood, which is attributed to the liver pathology, especially biliary atresia) and neurological signs such as incoordination, tremors or paralysis may develop. when present in natural infections, clinical signs and lesions are similar to but milder than in experimental neonatal infections. early descriptions of naturally occurring disease may have been complicated by concurrent infections such as mhv (murine hepatitis virus) or murine rotavirus a (murv-a)/epizootic diarrhoea of infant mice (edim) virus that contributed to the severity of the lesions especially in liver, pancreas, cns and intestine. the outcome of mrv-3 infection depends on age and immunological status of mouse, dose of virus and route of inoculation. adult immunocompetent mice typically show no clinical signs and have no discernible lesions even in experimental infections. mucosal and maternally conferred immunity are considered to be important in protection from or resolution of disease [297, 298] . experimental infection of adult prkdc scid mice is lethal [299] . depending on the route of inoculation, experimental infection of adult foxn1 nu mice is subclinical or results in liver disease [299, 300] . histological findings reported to occur after experimental mrv-3 infection of neonatal mice include inflammation and necrosis in liver, pancreas, heart, adrenal, brain, and spinal cord; lymphoid depletion in thymus, spleen, and lymph nodes; and hepatic fibrosis with biliary atresia [36, [290] [291] [292] 298] . transmission of reoviruses probably involves the aerosol as well as the faecal-oral route [8, 291] . fomites may play an important role as passive vectors because reoviruses resist environmental conditions moderately well. serological screening with mfia, elisa or ifa is in widespread use for detection of antibodies to mrv-3 in diagnostic and health surveillance programmes. both elisa and ifa detect cross-reacting antibodies to heterologous mrv serotypes that can infect mice [301] , although a recent report indicates that some ifa-positive mrv infections in mice may not be detected by commonly used elisas [302] . the hi test does not detect such cross-reacting antibodies but is prone to give false-positive results due to nonspecific inhibitors of haemagglutination [301, 303] . rt-pcr methods for the detection of mrv-3 rna [304, 305] or mrv rna [302, 306] are also available. reports on contamination of mouse origin tumours and cell lines by mrv-3 and its interference with transplantable tumour studies [307, 308] emphasize the importance of screening of biological materials to be inoculated into mice by map test or pcr. natural seroconversion to mrv-3 without clinical disease is also observed in laboratory rats, hamsters and guinea-pigs [8, 290] . caesarean derivation and barrier maintenance have proven effective in the control and prevention of mrv-3 infection [8, 291] . the virus may interfere with research involving transplantable tumours and cell lines of mouse origin. it has the potential to alter intestinal studies and multiple immune response functions in mice. in enzootically infected colonies, protection of neonates by maternal antibody could complicate or prevent experimental infections with reoviruses. it could further complicate experiments that require evaluation of liver, pancreas, cns, heart, lymphoid organs and other tissues affected by the virus. the term murine hepatitis virus (mhv; commonly referred to as 'mouse hepatitis virus') designates a large group of antigenically and genetically related, single-stranded rna viruses belonging to the family coronaviridae, genus coronavirus. they are surrounded by an envelope with a corona of surface projections (spikes). mhv is antigenically related to rat coronaviruses and other coronaviruses of pigs, cattle and humans. numerous different strains or isolates of mhv have been described. they can be distinguished by neutralization tests that detect strainspecific spike (s) antigens, by use of monoclonal antibodies, or by sequencing [309] . the beststudied strains are the prototype strains mhv-1, mhv-2, mhv-3, jhm (mhv-4), a59, and s, of which mhv-3 is regarded as the most virulent. like other coronaviruses mhv mutates rapidly, and strains readily form recombinants, so that new (sub)strains are constantly evolving. strains vary in their virulence, organotropism and cell tropism [310] . based on their primary organotropism, mhv strains can be grouped into two biotypes: respiratory (or polytropic) and enterotropic. however, intermediate forms (enterotropic strains with tropism to other organs) also exist. murine hepatitis virus is relatively resistant to repeated freezing and thawing, heating (56 c for 30 min) and acid ph but is sensitive to drying and disinfectants, especially those with detergent activity [8] . given the environmental conditions present in mouse rooms, mhv might remain infective for several days, at low humidity (20% relative humidity) or low temperatures (4 c) even for weeks on surfaces [311] . mus musculus is the natural host of mhv. it can be found in wild and laboratory mice throughout the world and is one of the most common viral pathogens in contemporary mouse colonies. while polytropic strains have historically been considered more common, this situation is thought to have reversed. monitoring results for research institutions across north america and europe indicate that the prevalence of mhv has decreased in the past, though it seems to have remained quite stable since the 1990s [11, 12] . recently 1.57% of north american laboratory mouse serum samples tested positive [15] . in europe, prevalence rates ranged from 3.25% to 12% [12, 14, 15] . a retrospective study in france covering the period from 1988 to 1997 reported antibodies to mhv in 67% of mouse colonies examined [10] , and a survey performed in 2006 revealed that almost half of north american research institutions detected mhv in their mouse populations [13] . suckling rats inoculated experimentally with mhv had transient virus replication in the nasal mucosa and seroconversion but no clinical disease [312] . similarly, deer mice seroconverted but showed no clinical disease after experimental infection [313] . mhv is also a common contaminant of transplantable tumours [1, 2] and cell lines [314, 315] . the pathogenesis and outcome of mhv infections depend on interactions between numerous factors related to the virus (e.g. virulence and organotropism) and the host (e.g. age, genotype, immune status, and microbiological status) [8, 36, 309, 310, 316, 317] . mhv strains appear to possess a primary tropism for the upper respiratory or enteric mucosa. those strains with respiratory tropism initiate infection in the nasal mucosa and then may disseminate via blood and lymphatics to a variety of other organs because of their polytropic nature. respiratory (polytropic) strains include mhv-1, mhv-2, mhv-3, a59, s and jhm. infection of mice with virulent polytropic mhv strains, infection of mice less than 2 weeks of age, infection of genetically susceptible strains of mice or infection of immunocompromised mice favour virus dissemination. virus then secondarily replicates in vascular endothelium and parenchymal tissues, causing disease of the brain, liver, lymphoid organs, bone marrow and other sites. infection of the brain by viraemic dissemination occurs primarily in immunocompromised or neonatal mice. additionally, infection of adult mouse brain can occur by extension of virus along olfactory neural pathways, even in the absence of dissemination to other organs. in contrast, enterotropic mhv strains (e.g. livim, mhv-d, mhv-y) tend to selectively infect intestinal mucosal epithelium, with no or minimal dissemination to other organs such as mesenteric lymph nodes or liver. all ages and strains are susceptible to active infection, but disease is largely age related. infection of neonatal mice results in severe necrotizing enterocolitis with high mortality within 48 h. mortality and lesion severity diminish rapidly with advancing age at infection. adult mice develop minimal lesions although replication of equal or higher titres of virus occurs compared with neonates. the age-dependent decrease in severity of enterotropic mhv disease is probably related to the higher mucosal epithelium turnover in older mice, allowing more rapid replacement of damaged mucosa. another factor that is of considerable importance to the outcome of mhv infections is host genotype. for example, balb/c mice are highly susceptible to enterotropic mhv disease while sjl mice, at the other end of the spectrum, are highly resistant [318] . unlike in polytropic mhv infection where resistance is correlated with reduced virus replication in target cells [319] , enterotropic mhv grows to comparable titres in sjl and balb/c mice at all ages [318] . therefore, the resistance of the sjl mouse to disease caused by enterotropic mhv seems to be mediated through an entirely different mechanism than resistance to polytropic mhv. furthermore, mouse genotypes that are susceptible to disease caused by one mhv strain may be resistant to disease caused by another strain [316] . it is therefore not possible to strictly categorize mouse strains as susceptible or resistant. the genetic factors determining susceptibility versus resistance in mhv infections are as yet poorly understood. both polytropic and enterotropic mhv infections are self-limiting in immunocompetent mice. immune-mediated clearance of virus usually begins about a week after infection, and most mice eliminate the virus within 3-4 weeks [316, 318, 320] . humoral and cellular immunity appear to participate in host defences to infection, and functional t cells are an absolute requirement [321] [322] [323] [324] . therefore, immunodeficient mice such as foxn1 nu and prkdc scid mice cannot clear the virus [317, 325] . similarly, some genetically modified strains of mice may have deficits in antiviral responses or other alterations that allow the development of persistent mhv infection [326] . recovered immune mice are resistant to reinfection with the same mhv strain but remain susceptible to repeated infections with different strains of mhv [327] [328] [329] . similarly, maternal immunity protects suckling mice against homologous mhv strains but not necessarily against other strains [329, 330] . however, maternal immunity, even to homologous strains, depends on the presence of maternally acquired antibody in the lumen of the intestine [330] . therefore, the susceptibility of young mice to infection significantly increases at weaning. most mhv infections are subclinical and follow one of two epidemiological patterns in immunocompetent mice [8, 310] . enzootic (subclinical) infection, commonly seen in breeding colonies, occurs when a population has been in contact with the virus for a longer period (e.g. several weeks). adults are immune (due to prior infection), sucklings are passively protected, and infection is perpetuated in weanlings. epizootic (clinical) infection occurs when the virus is introduced into a naive population (housed in open cages). the infection rapidly spreads through the entire colony. clinical signs depend upon the virus and mouse strains and are most evident in infant mice. typically, they include diarrhoea, poor growth, lassitude, and death. in infections due to virulent enterotropic strains, mortality can reach 100% in infant mice. some strains may also cause neurological signs such as flaccid paralysis of hindlimbs, convulsions and circling. adult infections are again usually asymptomatic. as the infection becomes established in the colony, the epizootic pattern is replaced by the enzootic pattern. in immunodeficient (e.g. foxn1 nu and prkdc scid ) mice, infection with virulent polytropic mhv strains is often rapidly fatal while less virulent strains cause chronic wasting disease [317] . in contrast, adult immunodeficient mice can tolerate chronic infection by enterotropic mhv, with slow emaciation and diarrhoea, or minimal clinical disease [316, 325] . subclinical mhv infections can be activated by a variety of experimental procedures (e.g. thymectomy, whole body irradiation, treatment with chemotherapeutic agents, halothane anaesthesia) or by coinfections with other pathogens (e.g. eperythrozoon coccoides, k virus; reviewed in [8, 309] ). in most natural infections, gross lesions are not present or are transient and not observed. gross findings in neonates with clinical signs include dehydration, emaciation, and in contrast to edim, an empty stomach [309, 331, 332] . the intestine is distended and filled with watery to mucoid yellowish, sometimes gaseous contents. haemorrhage or rupture of the intestine can occur. depending on the virus strain, necrotic foci on the liver [36, 309, 332] and thymus involution [331, 333] may also be seen in susceptible mice. liver involvement may be accompanied by jaundice and haemorrhagic peritoneal exudate. splenomegaly may occur as a result of compensatory haematopoiesis [334] . histopathological changes in susceptible mice infected with polytropic mhv strains include acute necrosis with syncytia in liver, spleen, lymph nodes, gut-associated lymphoid tissue, and bone marrow [8, 36, 309, 316] (figure 3.2.7) . recently, pulmonary inflammation has been observed in susceptible mouse strains (c3h/hej and a/j) after intranasal inoculation with polytropic mhv-1 [335, 336] . neonatally infected mice can have vascular-oriented necrotizing (meningo)encephalitis with demyelination in the brainstem and periependymal areas. lesions in peritoneum, bone marrow, thymus and other tissues can be variably present. mice can develop nasoencephalitis due to extension of infection from the nasal mucosa along olfactory pathways to the brain, with meningoencephalitis and demyelination, the latter of which is thought to be largely t-cell mediated [324] . this pattern of infection regularly occurs after intranasal inoculation of many mhv strains but is a relatively rare event after natural exposure. syncytium arising from endothelium, parenchyma or leukocytes is a hallmark of infection in many tissues including intestine, lung, liver, lymph nodes, spleen, thymus, brain and bone marrow. lesions are transient and seldom fully developed in adult immunocompetent mice, but they are manifest in immunocompromised mice. highly unusual presentations can occur in mice with specific gene defects. for example, granulomatous peritonitis and pleuritis were found in interferongamma-deficient mice infected with mhv [337] . histopathological changes caused by enterotropic strains of mhv are mainly confined to the intestinal tract and associated lymphoid tissues [8, 36, 309, 316] . the most common sites are terminal ileum, caecum and proximal colon. the severity of disease is primarily age-dependent, with neonatal mice being most severely affected. these mice show segmentally distributed areas of villus attenuation, enterocytic syncytia (balloon cells) and mucosal necrosis accompanied by leukocytic infiltration. intracytoplasmic inclusions are present in enterocytes. erosions, ulceration, and haemorrhage may be seen in more severe cases. lesions can be fully developed within 24-48 h, but are usually more severe at 3-5 days after infection. surviving mice may develop compensatory mucosal hyperplasia. mesenteric lymph nodes usually contain lymphocytic syncytia, and mesenteric vessels may contain endothelial syncytia. pathological changes in older mice are generally much more subtle and may only consist of transient syncytia. an occasional exception seems to occur in immunodeficient animals such as foxn1 nu mice, which can develop chronic hyperplastic typhlocolitis of varying severity [325] , but other agents such as helicobacter spp. may have been involved. in general, enterotropic mhv strains do not disseminate, but hepatitis and encephalitis can occur with some virus strains in certain mouse genotypes. in t-cell deficient mice, multisystemic lethal infection was observed after experimental infection with the enterotropic strain mhv-y [338] . mhv is highly contagious. it is shed in faeces and nasopharyngeal secretions and appears to be transmitted via direct contact, aerosol and fomites [8, 309] . vertical (in utero) transmission has been demonstrated in experimental infections [339] but does not seem to be of practical importance under natural conditions. mhv was transmitted by ovarian transplantation after reproductive organs became infected [340] . however, risk of mhv transmission by sperm or oocytes (ivf) or by embryo transfer seems to be low, though thorough washing of gametes and embryos is required [211, [340] [341] [342] . diagnosis during the acute stage of infection can be made by histological demonstration of characteristic lesions with syncytia in target tissues, but clinical signs and lesions can be highly variable and may not be prominent. suckling, genetically susceptible or immunocompromised mice are the best candidates for evaluation. active infection can be confirmed by immunohistochemistry [343] or by virus isolation. virus recovery from infected tissues is difficult but can be accomplished using primary macrophage cultures or a number of established cell lines such as nctc 1469 or dbt [301] . these cells, however, may not be successful substrates for some enterotropic mhv strains. virus in suspect tissue can also be confirmed by bioassays such as map testing or infant or foxn1 nu mouse inoculation [301, 344] . amplification by passage in these mice increases the likelihood of detection of lesions and antigen, or virus recovery. other direct diagnostic methods that have been successfully utilized to detect mhv in faeces or tissue of infected mice include monoclonal antibody solution hybridization assay [345] and a number of rt-pcr assays [346] [347] [348] [349] . because of the transient nature of mhv infection in immunocompetent mice, serology is the most appropriate diagnostic tool for routine monitoring. multiplex fluorescent immunoassay, elisa and ifa are well established and sensitive, and all known mhv strains cross-react in these tests [301, 350, 351] . the magnitude of antibody response depends on mhv strain and mouse genotype [319, 352] . dba/2 mice are poor antibody responders whereas c57bl/6 mice produce a high antibody titre and are therefore good sentinels. antibody titres remain high over a period of at least 6 months [327, 329] . infected mice may not develop detectable antibodies for up to 14 days after initial exposure [350] . in such cases, a direct diagnostic method, as discussed above, may be useful. another drawback of serology is that mice weaned from immune dams can have maternal antibodies until they are 10 weeks of age [353] . this may impact serological monitoring because the possibility must be considered that low positive results are due to maternally derived passive immunity. because the virus can be transmitted by transplantable tumours and other biological materials from mice, including hybridomas [354] and embryonic stem cells [355, 356] these materials should also be routinely screened for mhv contamination. mouse inoculation bioassay, map test and rt-pcr can be used for this purpose. therefore, surveillance programmes should combine careful evaluation of clinically ill animals, testing of biological materials and routine health monitoring. soiled-bedding sentinel mice, which are frequently used for routine monitoring, are likely well suited for detecting enterotropic strains of mhv, but might not indicate the presence of less contagious respiratory strains of mhv [309] equally well. the mouse strain used as sentinel should be considered as a critical factor. furthermore, duration of mhv shedding and stability of the virus, which seems to be lower in static microisolator cages than in ivc cages, might interfere with detection. the amount of bedding transferred seems not to be as critical as for, e.g. parvoviruses, at least for enterotropic strains [357] . use of contact and exhaust air sentinels and testing of exhaust filters by pcr was also shown to be effective at detecting mhv [358] . the best means of mhv control is to prevent its entry into a facility. this can be accomplished by purchasing mice from virus-free sources and maintenance under effective barrier conditions monitored by a well-designed quality assurance programme. control of wild mouse populations, proper husbandry and sanitation, and strict monitoring of biological materials that may harbour virus are also important measures to prevent infection. if infection occurs, the most effective elimination strategy is to cull the affected colony and obtain clean replacement stock. however, this is not always a feasible option when working with valuable mice (e.g. genetically modified lines, breeding stocks). caesarean derivation or embryo transfer can be used to produce virus-free offspring, and foster-nursing has also been reported to be effective [359] . quarantine of an affected colony with no breeding and no introduction of new animals for approximately 2 months has been effective in immunocompetent mice [360] . the infection is likely to be terminated because mhv requires a constant supply of susceptible animals. this method works best when working with small numbers of mice. large populations favour the development of new mhv strains that may result in repeated infections with slightly different strains [361] . it may be practical to select a few future breeders from the infected population and quarantine them for approximately 3 weeks [317] . this can be achieved in isolators, or in individually ventilated cages if proper handling is guaranteed. after this interval, breeding can resume. the 3-week interval should permit recovery from active infection, and the additional 3-week gestation period effectively extends the total quarantine to 6 weeks. it is advisable to select seropositive breeders because the possibility of active infection is lower in such animals. the breeding cessation strategy may not be successful if immunodeficient mice are used because they are susceptible to chronic infection and viral excretion [325] . genetically engineered mice of unclear, unknown or deficient immune status pose a special challenge because they may develop unusual manifestations of infection or may be unable to clear virus. rederivation is likely to be the most cost-effective strategy in such situations. along with the measures described, proper sanitation and disinfection of caging and animal quarters, as well as stringent personal sanitation, are essential to eliminate infection. careful testing with sentinel mice should be applied to evaluate the effectiveness of rederivation. if transplantable tumours are contaminated with mhv, virus elimination can be achieved by passage of tumours in athymic foxn1 rnu rats [362] . mhv is one of the most important viral pathogens of laboratory mice and has been intensively studied from a number of research perspectives (e.g. as a model organism for studying coronavirus molecular biology or the pathogenesis of viral-induced demyelinating disease). numerous reports document the effects of natural and experimental infections with mhv on host physiology and research, especially in the fields of immunology and tumour biology (reviewed in [6-8, 310, 316, 317] ). noroviruses are non-enveloped, single-stranded rna viruses with high environmental resistance and belong to the family caliciviridae, genus norovirus. they were first identified after an outbreak of acute gastroenteritis at a school in norwalk (ohio, usa) in 1968 and cause about 90% of non-bacterial epidemic gastroenteritis in humans. noroviruses found in animals include bovine, porcine and murine noroviruses. noroviruses are not known to cross species. murine norovirus (mnv) is endemic in many research mouse colonies and currently the most commonly detected viral agent in laboratory mice [14, 15, 363] . in the hitherto largest survey [15] , about 32% of mouse serum samples examined had antibodies against mnv. the first norovirus to infect mice was described in 2003 [364] . experimental inoculation studies with this murine norovirus (mnv-1) show that duration of infection and disease manifestation vary depending on the mouse strain [363] [364] [365] . in immunocompetent strains, mnv infection is variable in length (e.g. !7-14 days in 129s6 mice, !5 weeks in hsd:icr mice) and does not induce clinical signs. infection is associated with mild histopathological alterations in the small intestine (increase in inflammatory cells) and spleen (red pulp hypertrophy and white pulp activation) of 129s6 mice. in certain immunodeficient strains, however, infection can cause lethal systemic disease (encephalitis, vasculitis, meningitis, hepatitis and pneumonia in interferon-alpha-beta-gamma-receptor-deficient and stat1 tm1 mice) or persist without symptoms (!90 days in rag1 à/à and rag2 à/à mice). these findings indicate that components of the innate immune system are critical for resistance to mnv-1 induced disease. consistent with this hypothesis, it was demonstrated that mnv-1 replicates in macrophages and dendritic cells [366] . meanwhile, many additional strains of mnv with diverse biological properties were isolated [367, 368] . an analysis of 26 mnv isolates revealed 15 distinct mnv strains that comprise a single genogroup and serotype [368] . experimental inoculation studies show that several mnv strains are able to persist in various tissues (small intestine, caecum, mesenteric lymph node, spleen) of immunocompetent (c57bl/6j, hsd:icr, jcl:icr) and immunodeficient (cb17-prkdc scid ) mice with viral shedding in faeces for the duration of at least 35-60 days [367] [368] [369] . murine norovirus is transmitted via the faecaloral route and is efficiently transferred to sentinel mice by soiled bedding [370, 371] . mnv infection can be detected directly by rt-pcr on faecal pellets or tissue specimens (see above) and indirectly by serology (mfia, elisa, ifa) [363, 367, 369] . detection is facilitated by high stability of mnv rna in faeces (at least 2 weeks at room temperature) [371] and by broad serological cross-reactivity among different strains of mnv [367, 368] . embryo transfer [370] and hysterectomy [369] are most likely effective means of eliminating mnv from mouse colonies. since 1-to 3-day-old pups are resistant to infection, elimination of mnv may also be achieved by transferring neonates from infected dams to uninfected foster dams ('cross-fostering') [372] . this transfer should ideally be performed within 24 h after birth. mnv is used as a surrogate to evaluate resistance of human noroviruses to disinfectants. the impact of mnv on animal experiments remains to be evaluated. recent studies show that mnv is immunmodulatory and may alter disease phenotypes in mouse models of inflammatory bowel disease [373] [374] [375] and other experimental mouse models [376, 377] . murine pneumonia virus, commonly referred to as 'pneumonia virus of mice' (pvm), is an enveloped, single-stranded rna virus of the family paramyxoviridae, genus pneumovirus. it is closely related to human respiratory syncytial virus (hrsv). the virus name is officially abbreviated as 'mpv' according to the international union of microbiological societies [9] ; however, the former designation 'pvm' will be used in this chapter to avoid confusion with the official abbreviation of mouse parvovirus (mpv). pvm infection remains prevalent in contemporary colonies of mice and rats throughout the world. a serological survey in france demonstrated antibodies to pvm in 16% of mouse colonies examined [10] . in more recent studies in north america and western europe, the prevalence of pvm-specific antibodies in mice ranged between 0% and 0.1% [11, 14, 15] . schoondermark-van de ven et al. [12] found antibodies to pvm in 0.2% of mouse samplings from western european institutions. antibodies to pvm have also been detected in hamsters, gerbils, cotton rats, guinea-pigs and rabbits [8, 378, 379] . experimentally, pvm infection of mice is used as a model for hrsv infection and has therefore been extensively studied (reviewed by rosenberg and domachowske [380] ). in immunocompetent mice, natural infection with pvm is transient and usually not associated with clinical disease or pathological findings [8, 379, 381] . however, natural disease and persistent infection may occur in immunodeficient mice [382] [383] [384] . in particular, athymic foxn1 nu mice seem to be susceptible to pvm infection, which can result in dyspnoea, cyanosis, emaciation and death due to pneumonia [383, 384] . similar clinical signs have been reported for experimentally infected immunocompetent mice [385] . necropsy findings in naturally infected foxn1 nu mice include cachexia and diffuse pulmonary oedema or lobar consolidation [384] . pulmonary consolidation (dark red or grey in color) has also been found after experimental infection of immunocompetent mice [381] . histologically, natural infection of foxn1 nu mice with pvm presents as interstitial pneumonia [383, 384] . experimental intranasal inoculation of immunocompetent mice can result in rhinitis, erosive bronchiolitis and interstitial pneumonia with prominent early pulmonary eosinophilia and neutrophilia [381, 386] . hydrocephalus may result from intracerebral inoculation of neonatal mice [387] . susceptibility to infection is influenced by age and strain of mouse, dose of virus, and a variety of local and systemic stressors [8, 379, 386] . in terms of the extent of the alveolar inflammatory response, 129/sv and dba/2 mice are susceptible to pvm infection, while balb/c and c57bl/6 mice are relatively resistant [386] . in terms of the control of viral replication, mice of strains 129/sv, dba/2, balb/c and c57bl/6 are susceptible to pvm infection, while sjl mice are relatively resistant. pvm is labile in the environment and rapidly inactivated at room temperature [8, 379] . the virus is tropic for the respiratory epithelium [382, 385] , and transmission is exclusively horizontal via the respiratory tract, mainly by direct contact and aerosol [8, 379] . therefore, transmissibility in mouse colonies is low, and infections tend to be focal enzootics. serology (mfia, elisa, ifa or hi) is the primary means of testing mouse colonies for exposure to pvm. immunohistochemistry has been applied to detect viral antigen in lung sections [382, 384] ; however, proper sampling (see chapter 4.4, 'health management and monitoring') is critical for establishing the diagnosis due to the focal nature of the infection. an rt-pcr assay to detect viral rna in respiratory tract tissues has also been reported [388] . however, the use of direct methods requires good timing because the virus is present for only up to about 10 days in immunocompetent mice [381] . embryo transfer or caesarean derivation followed by barrier maintenance can be used to rear mice that are free of pvm. because active infection is present in the individual immunocompetent mouse for only a short period, strict isolation of a few (preferably seropositive) mice with the temporary cessation of breeding might also be successful in eliminating the virus [8, 378] . pvm could interfere with studies involving the respiratory tract or immunological measurements in mice. in addition, pvm can have devastating effects on research using immunodeficient mice because they are particularly prone to develop fatal disease [383, 384] or become more susceptible to the deleterious effects of other agents such as p. murina [389] . murv-a/edim (commonly referred to as 'mouse rotavirus' or 'epizootic diarrhoea of infant mice virus') is a non-enveloped, segmented double-stranded rna virus of the family reoviridae, genus rotavirus. it is antigenically classified as a group a rotavirus, similar to rotaviruses of many other species that cause neonatal and infantile gastroenteritis [291] . murv-a/edim infection remains prevalent in contemporary mouse colonies and appears to occur worldwide. large commercial laboratories found 0.6% to 9% of mouse sera from north american and european facilities to be positive for antibodies against murv-a/edim [11, 12, 14, 15] , and up to 30% of mouse colonies in the usa were identified as affected in a survey performed in 2006 [13] . experimentally, murv-a/edim infection in mice is used as a model for human rotavirus infection, especially in investigations on the mechanisms of rotavirus immunity and in the development of vaccination strategies [390] . clinical symptoms following murv-a/edim infection range from inapparent or mild to severe, sometimes fatal, diarrhoea. 'epizootic diarrhoea of infant mice' describes the clinical syndrome associated with natural or experimental infection by murv-a/edim during the first 2 weeks of life [8, 36, 291, 391, 392] . diarrhoea usually begins around 48 h after infection and persists for about 1 week. affected suckling mice have soft, yellow faeces that wet and stain the perianal region (figure 3.2.8) . in severe instances, the mice may be stunted, have dry scaly skin, or are virtually covered with faecal material. morbidity is very high but mortality is usually low. gross lesions in affected mice are confined to the intestinal tract. the caecum and colon may be distended with gas and watery to paste-like contents that are frequently bright yellow. the stomach of diarrhoeic mice is almost always filled with milk, and this feature has been reported to be a reliable means to differentiate diarrhoea caused by rotavirus from the diarrhoea caused by mhv infection. histopathological changes may be subtle even in animals with significant diarrhoea (figure 3.2.8 ). they are most prominent at the apices of villi, where rotaviruses infect and replicate within epithelial cells; the large intestinal surface mucosa may also be affected. though inflammation is minimal, the lamina propria may be oedematous, lymphatics may be dilated and mild leukocytic infiltration in the large intestinal mucosa and submucosa has been observed in a recent outbreak of disease [36, 393] . hydropic change of villous epithelial cells is the hallmark finding of acute disease. the villi become shortened, and the cells that initially replace the damaged cells are less differentiated, typically cuboidal instead of columnar, and lack a full complement of enzymes for digestion and absorption, resulting in diarrhoea due to maldigestion and malabsorption. undigested milk in the small intestine promotes bacterial growth and exerts an osmotic effect, exacerbating damage to the villi. intestinal fluid and electrolyte secretion is further enhanced by activation of the enteric nervous system [394] and through the effects of a viral enterotoxin called nsp4 (for non-structural protein 4) [395] . it is hypothesized that nsp4 is released from virus-infected cells and then triggers a signal transduction pathway that alters epithelial cell permeability and chloride secretion. susceptibility to edim depends on the age of the host and peaks between 4 and 14 days of age [8, 36, 291, 391, 392] . mice older than about 2 weeks can still be infected with murv-a/edim, but small numbers of enterocytes become infected, there is little replication of virus and diarrhoea does not occur. the exact reason for this agerelated resistance to disease is unknown. pups suckling from immune dams are protected against edim during their period of disease susceptibility [396] . in general, the infection is self-limiting and resolves within days. successful viral control and clearance is promoted by an intact immune response [396] [397] [398] [399] , and some immunodeficient mice (e.g. prkdc scid and rag2 tm1fwa mice) may shed virus for extended periods or become persistently infected [400, 401] . protection against murv-a/edim reinfection is primarily mediated by antibodies [396, 397] . murine rotavirus-a/edim is highly contagious and transmitted by the faecal-oral route [8, 291, 391] . dissemination of the virus occurs through direct contact or contaminated fomites and aerosols and is facilitated by the general property of rotaviruses that they remain infectious outside the body, show resistance to inactivation (e.g. low ph, non-ionic detergents, hydrophobic organic liquids, proteolytic enzymes), and are shed in high quantities (>10 11 particles/g faeces) [291] . murv-a/edim is stable at à70 c but otherwise tends to be susceptible to extreme environmental conditions, detergents and disinfectants containing phenols, chlorine or ethanol [291] . mfia, elisa and ifa are in widespread use for detection of serum antibodies to murv-a/ edim in diagnostic and health surveillance programmes; other assay systems such as those using latex agglutination are also used [402] . as murv-a/edim shares the vp6 protein determined group a antigen, for example, with human, simian or bovine rotavirus strains, commercially available elisa assays utilizing polyclonal or monoclonal antibodies have been used to detect rotavirus antigen in mice; however, great care must be taken in interpreting the results because some feeds have been reported to cause false-positive reactions with certain elisa kits [403] . electron microscopy of faeces of diarrhoeic pups should reveal typical wheel-shaped rotavirus particles, 60-80 nm in diameter. rt-pcr also can be used to detect rotavirus rna in faecal samples [404] . good timing is critical for establishing the diagnosis from faeces because virus is shed for only a few days in immunocompetent mice. embryo transfer or caesarean derivation followed by barrier maintenance is recommended for rederivation of breeding stocks [8] . in immunocompetent mice in which infection is effectively cleared, a breeding suspension strategy for 8-10 weeks combined with excellent sanitation, filter tops and conscientious serological testing of offspring and sentinel mice has also been reported to be effective, and prolongation of breeding cessation up to 12 weeks resolved infection even in immunocompromised mice [393] . murv-a/edim has the potential to interfere with any research using suckling mice. it may have a significant impact on studies where the intestinal tract of neonatal or infant mice is the target organ. the infection also poses a problem for infectious disease and immune response studies, particularly those involving enteropathogens in infant mice [405] . a disease-induced stress-related thymic necrosis may occur and alter immunology experiments [36] . in addition, runting could be interpreted erroneously as the effect of genetic manipulation or other experimental manipulation. sendai virus (sev) is an enveloped, singlestranded rna virus of the family paramyxoviridae, genus respirovirus. it is antigenically related to human parainfluenza virus 1. the virus was named after sendai, japan, where it was first isolated from mice. historically, infections were relatively common in mouse and rat colonies worldwide. in addition, there is evidence that hamsters, guinea-pigs and rabbits are susceptible to infection with sev [8, 301, 406, 407] ; however, some apparently seropositive guinea-pigs may in fact be seropositive to other parainfluenza viruses instead of sev. a study in france reported antibodies to sev in 17% of mouse colonies examined [10] . a low rate of seropositive mice (0.2%) was found in a survey in north america [11] . schoondermark-van de ven et al. [12] also found antibodies to sev in 0.2% of mouse samplings from western european institutions. in more recent surveys in north america and western europe, sev infection was not detected [13] [14] [15] , indicating that sev, like most viruses, has meanwhile been eliminated from the majority of mouse colonies. sev can contaminate biological materials [1] . sev is pneumotropic and can cause significant respiratory disease in mice. the pneumotropism is partially a consequence of the action of respiratory serine proteases such as tryptase clara, which activate viral infectivity by specific cleavage of the viral fusion glycoprotein [408] . in addition, the apical budding behaviour of sev may hinder the spread of virus into subepithelial tissues and subsequently to distant organs via the blood. two epidemiologic patterns of sev infection have been recognized, an enzootic (subclinical) and epizootic (clinically apparent) type [8, 379, 409] . enzootic infections commonly occur in breeding or open colonies, where the constant supply of susceptible animals perpetuates the infection. in breeding colonies, mice are infected shortly after weaning as maternal antibody levels wane. normally, the infection is subclinical, with virus persisting for approximately 2 weeks, accompanied by seroconversion that persists for a year or longer. epizootic infections occur upon first introduction of the virus to a colony and either die out (self-cure) after 2-7 months or become enzootic depending on colony conditions. the epizootic form is generally acute, and morbidity is very high, resulting in nearly all susceptible animals becoming infected within a short time. clinical signs vary and include rough hair coat, hunched posture, chattering, respiratory distress, prolonged gestation, death of neonates and sucklings and runting in young mice. breeding colonies may return to normal productivity within 2 months and thereafter maintain the enzootic pattern of infection. factors such as strain susceptibility, age, husbandry, transport and copathogens are important in precipitating overt disease. dba and 129 strains of mice are very susceptible to sev pneumonia, whereas sjl/j and c57bl/6/j and several outbred stocks are relatively resistant. resistance to sev infection is under multigenic control with epistatic involvement [410] . there is no evidence for persistent infection in immunocompetent mice, but persistent or prolonged infection may occur in immunodeficient mice and can result in wasting and death due to progressive pneumonia [411, 412] . clearance of a primary sev infection is mediated by cd8þ and cd4þ t-cell mechanisms [413, 414] . heavier than normal, consolidated, plumcolored or grey lungs are a characteristic gross finding in severe sev pneumonia [8, 36, 379, 409] . lymphadenopathy and splenomegaly reflect the vigorous immune response to infection. histologically, three phases of disease can be recognized in susceptible immunocompetent mice: acute, reparative and resolution phases [36, 409] . lesions of the acute phase, which lasts 8-12 days, are primarily attributed to the cellmediated immune response that destroys infected respiratory epithelial cells and include necrotizing rhinitis, tracheitis, bronch(iol)itis and alveolitis. epithelial syncytiae and cytoplasmic inclusion bodies in infected cells may be seen early in this phase. alveoli contain sloughed necrotic epithelium, fibrin, neutrophils and mononuclear cells. atelectasis, bronchiectasis and emphysema may occur as a result of damage and obstruction of airways. the reparative phase, which may overlap the acute phase but continues through about the third week after infection, is indicated by regeneration of airway lining epithelium. adenomatous hyperplasia and squamous metaplasia (with multilayered flat epithelial cells instead of normal columnar cells) in the terminal bronchioles and alveoli are considered to be a hallmark of sev pneumonia. mixed inflammatory cell infiltrates in this phase tend to be primarily interstitial, rather than alveolar, as they are in the acute phase. the resolution phase may be complete by the fourth week after infection and lesions may be difficult to subsequently identify. residual, persistent lesions that may occur include organizing alveolitis and bronchiolitis fibrosa obliterans. alveoli and bronchioles are replaced by collagen and fibroblasts, foamy macrophages and lymphoid infiltrates, often with foci of emphysema, cholesterol crystals and other debris, which represent attempts to organize and wall off residual necrotic debris and fibrin. lesions are more severe and variable when additional pathogens such as mycoplasma pulmonis are present [8] . otitis media has also been reported in natural infections with sev although some of these studies have been complicated by the presence of other pathogens [415] . sev has been detected in the inner ear after experimental intracerebral inoculation of neonatal mice [416] . sev is extremely contagious. infectious virus is shed during the first 2 weeks of infection and appears to be transmitted by direct contact, contaminated fomites and respiratory aerosol [8, 379] . serology (mfia, elisa, ifa, or hi) is the approach of choice for routine monitoring because serum antibodies to sev are detectable soon after infection and persist at high levels for many months, although active infection lasts only 1-2 weeks in immunocompetent mice. the short period of active infection limits the utility of direct methods such as immunohistochemistry [382] and rt-pcr [388, 417] . although sev is considered to be highly contagious, studies have shown that dirty bedding sentinel systems do not reliably detect the infection and that outbred stocks may not seroconvert consistently [418, 419] . map testing and rt-pcr can be used to detect sev in contaminated biological materials. sev infection in mouse colonies has proved to be one of the most difficult virus infections to control because the virus is highly infectious and easily disseminated. depopulation of infected colonies is probably the most appropriate means of eliminating the virus in most situations. embryo transfer, or caesarean derivation, followed by barrier maintenance, can also be used to eliminate the virus [8, 379] . a less effective alternative is to place the infected animals under strict quarantine, remove all young and pregnant mice, suspend all breeding and prevent addition of other susceptible animals for approximately 2 months until the infection is extinguished, and then breeding and other normal activities are resumed. vaccines against the virus have been developed [8, 379, 409] , but these probably do not represent a practical means to achieve or maintain the seronegative status of colonies that is in demand today. sev has the potential to interfere with a wide variety of research involving mice. reported effects include interference with early embryonic development and fetal growth; alterations of macrophage, nk-cell, and t-and b-cell function; altered responses to transplantable tumours and respiratory carcinogens; altered isograft rejection; and delayed wound healing (reviewed in [6] [7] [8] ). pulmonary changes during sev infection can compromise interpretation of experimentally induced lesions and may lead to opportunistic infections by other agents. they could also affect the response to anaesthetics. in addition, natural sev infection would interfere with studies using sev as a gene vector. theiler's murine encephalomyelitis virus (tmev), or murine poliovirus, is a member of the genus cardiovirus in the family picornaviridae. members of this genus are non-enveloped viruses with single-stranded rna. the virus is rapidly destroyed at temperatures above 50 c. it is considered to be a primary pathogen of the cns of mice and can cause clinical disease resembling that due to poliomyelitis virus infections in humans. antibodies to tmev have been identified in mouse colonies and feral populations worldwide, and mus musculus is considered to be the natural host of tmev [420] . the best-known and most frequently mentioned tmev strain is gdvii, which is virulent for mice. infant or young hamsters and laboratory rats are also susceptible to intracerebral infection. the original isolate is designated to (theiler's original) and represents a group of tmev strains with low virulence for mice. many additional virus strains have been isolated and studied, and they all fall in the broad grouping of to and gdvii. a similar virus strain has also been isolated from rats, but in contrast to mouse isolates, this virus is not pathogenic for rats and mice after intracerebral inoculation [421] . recently, another rat isolate has been characterized and shown to be most closely related to, but quite distinct from, other tmev viruses [422] . antibodies to tmev (strain gdvii) have been detected in guinea-pigs and are considered to indicate infection with another closely related cardiovirus [423] . seropositivity to tmev was reported in approximately 48% of french mouse colonies in a retrospective study [10] . in more recent studies, the prevalence of tmev infections was found to be lower. schoondermark-van de ven et al. [12] detected antibodies to tmev in 2.2% of mouse samplings from western european institutions. in a survey conducted by carty [13] , about 9% of responding institutions in the usa reported tmev infection in their mouse colonies. further surveys in north america and western europe revealed antibodies in 0.09-0.26% of mice monitored [11, 14, 15] . tmev is primarily an enteric pathogen, and virus strains are enterotropic. in natural infections, virus can be detected in intestinal mucosa and faecal matter, and in some cases it is also found in the mesenteric lymph nodes. however, histological lesions in the intestine are not discerned. virus may be shed via intestinal contents for up to 22 weeks, sometimes intermittently [424] , and transmission under natural conditions is via the faecal-oral route, by direct contact between mice, as well as by indirect contact (e.g. dirty bedding). the host immune response limits virus spread, but it does not immediately terminate virus replication in the intestines. virus is cleared from extraneural tissues, but persists in the cns for at least a year. clinical disease due to natural tmev infection is rare, with a rate of only 1 in 1000-10 000 infected immunocompetent animals [36] . in immunodeficient mice, especially in weanlings, clinical signs may be more common and mortality may be higher [425] . this group of viruses usually causes asymptomatic infections of the intestinal tract. they may spread to the cns as a rare event where they cause different neurological disease manifestations. the most typical clinical sign of tmev infection is flaccid paralysis of hindlimbs. the animals appear otherwise healthy, and there is no mortality. experimental infection in mice provides models of poliomyelitis-like infection and virusinduced demyelinating disease including multiple sclerosis [426] . after experimental infection, tmev causes a biphasic disease in susceptible strains of mice. the acute phase is characterized by early infection of neurons in the grey matter. encephalomyelitis may develop during this phase and may be fatal, but most animals survive and enter the second phase of the disease at 1-3 months after the acute phase. this phase is characterized by viral persistence in the spinal cord white matter, mainly in macrophages, and leads to white matter demyelination. persistence and demyelination occur only in genetically susceptible mouse strains, while resistant strains clear the infection after early grey matter encephalomyelitis through a cytotoxic t lymphocyte response. the severity and nature of disease depend on virus strain, route of inoculation, host genotype and age [8, 36, 427] . in general, virus isolates with low virulence produce persistent cns infection in mice whereas virulent strains are unable to cause persistent infection. intracerebral inoculation results in the most severe infections, but the intranasal route is also effective. experimental intracerebral infections with virulent fa and gdvii strains of tmev are more likely to cause acute encephalomyelitis and death in weanling mice 4-5 days after inoculation ('early disease'). death may be preceded by neurological manifestations of encephalitis such as hyperexcitability, convulsions, tremors, circling, rolling and weakness. animals may develop typical flaccid paralysis of hindlimbs, and locomotion is possible only by use of the forelimbs. interestingly, the tail is not paralyzed. experimental infections with low-virulence virus strains (e.g. to, da, ww) are more likely to cause persistent infection with development of mild encephalomyelitis followed by a chronic demyelinating disease after a few months ('late disease'). these virus strains infect neurons in the grey matter of the brain and spinal cord during the acute phase of viral growth, followed by virus persistence in macrophages and glial cells in the spinal cord white matter. sjl, swr and dba/2 strains are most susceptible to this chronic demyelinating disease. cba and c3h/he are less susceptible strains, and strains a, c57bl/6, c57bl/10 and dba/1 are relatively resistant [428] . differences in humoral immune responses play a role in resistance to tmev infection [429] , but genetic factors are also important. several genetic loci implicated in susceptibility to virus persistence, demyelination, or clinical disease have been identified, including the h-2d region of the major histocompatibility complex [430] . furthermore, the age at infection influences the severity of clinical disease. in infant mice, intracerebral infection with low-virulence virus strains (e.g. to) is often lethal. young mice develop paralysis after an incubation period of 1-4 weeks while adult mice often show no clinical signs of infection. the only gross lesions are secondary to the posterior paralysis and may include urine scald or dermatitis due to incontinence of urine and trauma to paralyzed limbs, or wasting or atrophy of the hindlimbs in long-term survivors. tmev infects neurons and glial cells, and histological changes in the cns include nonsuppurative meningitis, perivasculitis and poliomyelitis with neuronolysis, neuronophagia and microgliosis in the brainstem and ventral horns of the spinal cord [36] . demyelination in immunocompetent mice is considered to be immunemediated. susceptible strains develop a specific delayed-type hypersensitivity response which is the basis for inflammation and demyelination. this reaction is mediated by t cells that release cytokines leading to recruitment of monocytes and macrophages as a consequence of infection of macrophages and other cns-resident cells [431] [432] [433] . protection from chronic demyelinating disease is possible by vaccination with live virus given previously by subcutaneous or intraperitoneal inoculation [434, 435] . early immunosuppression at the time of infection, e.g. by treatment with cyclophosphamide or antithymocyte serum, inhibits or diminishes demyelination. immunosuppression in mice chronically infected with tmev leads to remyelination of oligodendrocytes [436] . further details related to the pathogenesis of tmev infections and the role of immune mechanisms have been reviewed by yamada et al. [437] , kim et al. [432] and lipton et al. [433] . experimental infection of foxn1 nu mice results in acute encephalitis and demyelination. demyelination associated with minimal inflammation and neurological signs, including the typical hindlimb paresis, develop 2 weeks after inoculation, and most animals die within 4 weeks. in foxn1 nu mice, demyelination is caused by a direct lytic effect of the virus on oligodendrocytes [438] . demyelination and lethality are reduced after administration of neutralizing antibodies [439] . histopathological changes in prkdc scid mice are very similar to those in foxn1 nu mice [440] . young mice born in infected populations usually acquire infection shortly after weaning and are almost all infected by 30 days of age. intrauterine transmission to fetuses is possible during the early gestation period, but a placental barrier develops during gestation and later prevents intrauterine infection [441] . all tmev isolates are closely related antigenically and form a single serogroup, as determined by complement fixation and hi [427] . hemelt et al. [421] demonstrated cross-reactions among four strains used in experimental infections, but differences were evident in homologous and heterologous titres. the viral strain most commonly used as antigen for serological testing is gdvii. this strain agglutinates human type o erythrocytes at 4 c, and hi has been the standard test for routine screening of mouse populations. meanwhile, hi has been replaced by mfia, elisa or ifa, all of which are more sensitive and specific. virus isolation is possible from brains or spinal cords of mice with clinical disease or from the intestinal contents of asymptomatic mice. pcr techniques are also available to test for virus-specific nucleotide sequences in biological samples [442] . mice that have been shown to be free from tmev by serological testing can be selected for breeding populations. if the virus is introduced into a mouse population, depopulation of infected colonies may be the most appropriate means to eliminate tmev. embryo transfer or caesarean derivation is the method of choice for eliminating virus from valuable breeding populations. foster-nursing has been reported to be effective in generating virus-free offspring [359] , although transplacental transmission has been demonstrated with experimental infection early in gestation. lesions of demyelination in cns of mice with clinically inapparent chronic infection may interfere with investigations that require evaluation of the cns [443] . conceivably, such lesions could also affect neuromuscular responses or coordination, and affect neurological and behavioural evaluations. murine virus contaminants of leukemia viruses and transplantable tumors contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses mousepox resulting from use of ectromelia virus-contaminated, imported mouse serum viral and mycoplasmal infections of laboratory rodents: effect on biomedical research complications of viral and mycoplasmal infections in rodents to toxicology research and testing natural pathogens of laboratory animals: their effects on research implications of infectious agents on results of animal experiments committee on infectious diseases of mice and rats. infectious diseases of mice and rats virus taxonomy: eighth report of the international committee on taxonomy of viruses ten-year long monitoring of laboratory mouse and rat colonies in french facilities: a retrospective study diagnostic testing of mouse and rat colonies for infectious agents prevalence of naturally occurring viral infections, mycoplasma pulmonis and clostridium piliforme in laboratory rodents in western europe screened from opportunistic infections of mice and rats: jacoby and lindsey revisited a serological survey to evaluate contemporary prevalence of viral agents and mycoplasma pulmonis in laboratory mice and rats in western europe contemporary prevalence of infectious agents in laboratory mice and rats biology of mouse thymic virus, a herpesvirus of mice, and the antigenic relationship to mouse cytomegalovirus microbial contaminations of laboratory mice and rats in taiwan from microbiological quality assessment of laboratory mice in korea and recommendations for quality improvement the prevalence of viral antibodies during a large population fluctuation of house mice in australia serological survey of virus infection among wild house mice (mus domesticus) in the uk infectious diseases in wild mice (mus musculus) collected on and around the university of pennsylvania (philadelphia) campus persisting murine cytomegalovirus can reactivate and has unique transcriptional activity in ocular tissue james (lawson) cm. characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence murine cytomegalovirus and other herpesviruses a mouse model for cytomegalovirus infection laboratory strains of murine cytomegalovirus are genetically similar to but phenotypically distinct from wild strains of virus murine cytomegalovirus infection of neural stem cells alters neurogenesis in the developing brain effects of cytomegalovirus infection on embryogenesis and brain development acute murine cytomegalovirus infection induces lethal hepatitis antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice mouse cytomegalovirus reactivation in severe combined immune deficient mice after implantation of latently infected salivary gland experimental murine cytomegalovirus infection in severe combined immunodeficient mice murine cytomegalovirus adrenalitis in athymic nude mice murine cytomegalovirus replication in the lungs of athymic balb/c nude mice pathogenesis of murine cytomegalovirus infection pathology of laboratory rodents & rabbits mixed infection with multiple strains of murine cytomegalovirus occurs following simultaneous or sequential infection of immunocompetent mice long-term impact of intrauterine mcmv infection on development of offspring nervous system transplacental murine cytomegalovirus infection in the brain of scid mice transmission of murine cytomegalovirus in breast milk: a model of natural infection in neonates simultaneous serodetection of 10 highly prevalent mouse infectious pathogens in a single reaction by multiplex analysis development of a highly sensitive quantitative competitive pcr assay for the detection of murine cytomegalovirus dna quantitative measurement of infectious murine cytomegalovirus genomes in real-time pcr improved detection and quantification of mouse cytomegalovirus by real-time pcr acute murine cytomegalovirus infection: a model for determining antiviral activity against cmv induced hepatitis viral vectored immunocontraception: screening of multiple fertility antigens using murine cytomegalovirus as a vaccine vector latent cytomegalovirus infection exacerbates experimental colitis occult cytomegalovirus in vivariumhoused mice may influence transplant allograft acceptance mouse thymic necrosis virus: a novel murine lymphotropic agent mouse thymic virus (mtlv; murid herpesvirus 3) infection in athymic nude mice: evidence for a t lymphocyte requirement neonatal infection with mouse thymic virus: spleen and lymph node necrosis a mammalian herpesvirus cytolytic for cd4þ (l3t4þ) t lymphocytes virus and autoimmunity: induction of autoimmune disease in mice by mouse t lymphotropic virus (mtlv) destroying cd4þ t cells thymic necrosis following oral inoculation of mouse thymic virus transmission of mouse thymic virus critical factors in an enzyme immunoassay (elisa) for antibodies to mouse thymic virus (mtlv) evaluation of mouse thymic virus antibody detection techniques detection of mouse thymic virus (mtlv) antigens in infected thymus by competition immunoassay comparative sensitivity of infectivity assay and mouse antibody production (map) test for detection of mouse thymic virus (mtlv) the order herpesvirales identification of novel rodent herpesviruses, including the first gammaherpesvirus of mus musculus a mouse model for infectious mononucleosis murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis viral latency and its regulation: lessons from the gammaherpesviruses immune mechanisms in murine gammaherpesvirus-68 infection immune control of mammalian gammaherpesviruses: lessons from murid herpesvirus-4 the wood mouse is a natural host for murid herpesvirus 4 analysis of genomic homology of murine gammaherpesvirus (mhv)-72 to mhv-68 and impact of mhv-72 on the survival and tumorigenesis in the mhv-72-infected cb17 scid/scid and cb17þ/þ mice comparative study of murid gammaherpesvirus 4 infection in mice and in a natural host, bank voles pathogenesis of a model gammaherpesvirus in a natural host the genomic sequence of ectromelia virus, the causative agent of mousepox variable resistance to ectromelia (mousepox) virus among genera of mus mousepox detected in a research facility: case report and failure of mouse antibody production testing to identify ectromelia virus in contaminated mouse serum mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. i. clinical responses prevention and control of mousepox observations of an outbreak of mousepox in laboratory mice in 1979 at the university of utah medical center demonstration of an ectromelia enzootic in hairless mice reaction of mouse strains to skin test for ectromelia using an allied virus as inoculum mousepox in the netherlands mousepox outbreak in a laboratory mouse colony mousepox (infectious ectromelia): past, present, and future clinical, pathologic, and serologic features of an epizootic of mousepox in minnesota kinetics of ectromelia virus (mousepox) transmission and clinical response in c57bl/6j, balb/cbyj and akr/j inbred mice mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. v. genetics of resistance to the moscow strain the mouse in biomedical research. diseases pathology and diagnosis of mousepox induction of natural killer cell responses by ectromelia virus controls infection agedependent susceptibility to a viral disease due to decreased natural killer cell numbers and trafficking h-2-linked control of resistance to ectromelia virus infection in b10 congenic mice differential pathogenesis of lethal mousepox in congenic dba/2 mice implicates natural killer cell receptor nkr-p1 in necrotizing hepatitis and the fifth component of complement in recruitment of circulating leukocytes to spleen identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection enhanced resistance in stat6-deficient mice to infection with ectromelia virus surviving mousepox infection requires the complement system innate resistance to lethal mousepox is genetically linked to the nk gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an nk phenotype different roles for cd4þ and cd8þ t lymphocytes and macrophage subsets in the control of a generalized virus infection correlates of protective immunity in poxvirus infection: where does antibody stand? transmission of mouse-pox in colonies of mice mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. iii. experimental transmission of infection and derivation of virus-free progeny from previously infected dams intrauterine infection of mice with ectromelia virus mouse pox threat serological detection of ectromelia virus antibody evaluation of an enzyme-linked immunosorbent assay for the detection of ectromelia (mousepox) antibody administration of vaccinia virus to mice may cause contact or bedding sentinel mice to test positive for orthopoxvirus antibodies: case report and follow-up investigation specific detection of mousepox virus by polymerase chain reaction real-time pcr system for detection of orthopoxviruses and simultaneous identification of smallpox virus detection of human orthopoxvirus infections and differentiation of smallpox virus with real-time pcr observations on the replication of ectromelia virus in mouse-derived cell lines: implications for epidemiology of mousepox reexamination of the efficacy of vaccination against mousepox effect of vaccination on the clinical response, pathogenesis and transmission of mousepox pathogenesis of vaccinia (ihd-t) virus infection in balb/cann mice mouse models for studying orthopoxvirus respiratory infections animal models of orthopoxvirus infection ectromelia virus: the causative agent of mousepox a protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost postexposure immunization with modified vaccinia virus ankara or conventional lister vaccine provides solid protection in a murine model of human smallpox mousepox in the c57bl/6 strain provides an improved model for evaluating antipoxvirus therapies a new mouse virus apparently related to the adenovirus group an adenovirus isolated from the feces of mice i. isolation and identification genotypic differences between the mouse adenovirus strains fl and k87 molecular cloning, physical mapping and cross-hybridization of the murine adenovirus type 1 and type 2 genomes genetic relationship between mouse adenovirus-2 (strain k87) and human adenovirus-2 mouse adenoviruses microbiological contamination of laboratory mice and rats in korea from 1999 to a serologic survey for viruses and mycoplasma pulmonis among wild house mice (mus domesticus) in southeastern australia comparative biological characterization of mouse adenovirus strains fl and k 87 and seroprevalence in laboratory rodents pathogenesis of experimentally produced mouse adenovirus infection in mice age and susceptibility of swiss mice for mouse adenovirus, strain fl mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult c57bl/6 but not balb/c mice duodenal lesions associated with adenovirus infection in athymic 'nude' mice murine adenovirus infection of scid mice induces hepatic lesions that resemble human reye syndrome experimental adenovirus infection of the mouse adrenal gland. i. light microscopic observations electron microscope study of experimental enteric adenovirus infection in mice experimental infection with mouse adenovirus in adult mice intestinal resistance in the experimental enteric infection of mice with a mouse adenovirus. i. growth of the virus and appearance of a neutralizing substance in the intestinal tract fluctuation of antiviral resistance in the intestinal tracts of nude mice infected with a mouse adenovirus biological and biophysical characteristics of mouse adenovirus, strain fl serological relationship between mouse adenovirus strains fl and k87 a naturally occurring intestinal mouse adenovirus infection associated with negative serologic findings acceleration of scrapie disease in mice by an adenovirus a novel cardiotropic murine adenovirus representing a distinct species of mastadenoviruses serological diagnosis of murine adenovirus 3 characterization of k virus and its comparison with polyoma virus murine pneumotropic virus vp1 virus-like particles (vlps) bind to several cell types independent of sialic acid residues and do not serologically cross react with murine polyomavirus vp1 vlps recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units polyoma viruses the major site of murine k papovavirus persistence and reactivation is the renal tubular epithelium distribution of k-papovavirus in infected newborn mice morphological and immunohistochemical studies of the central nervous system involvement in papovavirus k infection in mice chronic infection of nude mice by murine k papovavirus serial passage of murine k-papovavirus in primary cultures of mouse embryo cells comparison of an enzymelinked immunosorbent assay, an immunofluorescence assay and a hemagglutination inhibition assay for detection of antibodies to k-papovavirus in mice diagnostic polymerase chain reaction assays for identification of murine polyomaviruses in biological samples a model for mixed virus disease: co-infection with moloney murine leukemia virus potentiates runting induced by polyomavirus detection of dna and rna virus genomes in organ systems of whole mice: patterns of mouse organ infection by polyomavirus transplacental transmission of polyoma virus in mice persistence of polyomavirus in adult scid c.b-17 mice immunosuppression and murine polyomavirus infection reactivation of polyoma virus in kidneys of persistently infected mice during pregnancy ifn-g controls mouse polyomavirus infection in vivo heterogeneity among viral antigen-specific cd4þ t cells and their de novo recruitment during persistent polyomavirus infection long-term infection of adult mice with murine polyomavirus following stereotaxic inoculation into the brain murine polyomavirus virus-like particles (vlps) as vectors for gene and immune therapy and vaccines against viral infections and cancer cd4þ, and cd8þ t cells can act separately in tumour rejection after immunization with murine pneumotropic virus chimeric her2/neu virus-like particles molecular characterization of a newly recognized mouse parvovirus the rodent parvoviruses viral and mycoplasmal infections of laboratory rodents: effects on biomedical research the mouse in biomedical research. diseases lurking in the shadows: emerging rodent infectious diseases coping with parvovirus infections in mice: health surveillance and control identification and propagation of a putative immunosuppressive orphan parvovirus in cloned t cells molecular characterization of newly recognized rodent parvoviruses identification of novel murine parvovirus strains by epidemiological analysis of naturally infected mice temporal transmission studies of mouse parvovirus 1 in balb/c and c.b-17/ icr-prkdc scid mice serologic prevalence of mpv1 in mouse strains in a commercial laboratory mouse colony determined by using vp1 antigen serodiagnosis of mice minute virus and mouse parvovirus infections in mice by enzyme-linked immunosorbent assay with baculovirus-expressed recombinant vp2 proteins in vivo studies with an 'orphan' parvovirus of mice characterization of mouse parvovirus infection by in situ hybridization humoral immunity and protection of mice challenged with homotypic or heterotypic parvovirus experimental infection of mice with hamster parvovirus: evidence for interspecies transmission of mouse parvovirus 3 effect of mouse strain and age on detection of mouse parvovirus 1 by use of serologic testing and polymerase chain reaction analysis strainand age-associated variation in viral persistence and antibody response to mouse parvovirus 1 in experimentally infected mice characterization of mouse parvovirus infection among balb/c mice from an enzootically infected colony expression of recombinant parvovirus ns1 protein by a baculovirus and application to serologic testing of rodents validation of an enzyme-linked immunosorbent assay for detection of mouse parvovirus infection in laboratory mice detection of newly recognized rodent parvoviruses by pcr detection of rodent parvoviruses by use of fluorogenic nuclease polymerase chain reaction assays antemortem detection of mouse parvovirus and mice minute virus by polymerase chain reaction (pcr) of faecal samples polymerase chain reaction for detection of rodent parvoviral contamination in cell lines and transplantable tumors embryo transfer rederivation of c.b-17/icr-prkdc scid mice experimentally infected with mouse parvovirus 1 detection of mouse parvovirus in mus musculus gametes, embryos, and ovarian tissues by polymerase chain reaction assay mouse parvovirus infection potentiates allogeneic skin graft rejection and induces syngeneic graft rejection a minute virus of mice immunosuppressive activity of a subline of the mouse el-4 lymphoma. evidence for minute virus of mice causing the inhibition pathogenicity of fibroblastand lymphocyte-specific variants of minute virus of mice pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype minute virus of mice. ii. prevalence, epidemiology, and occurrence as a contaminant of transplanted tumors electron microscopic localization of virions in developing teeth of young hamsters infected with minute virus of mice experimentally induced infection with autonomous parvoviruses, minute virus of mice and h-1, in the african multimammate mouse (mastomys coucha) pathogenicity of minute virus of mice (mvm) for rats, mice, and hamsters fetal infections of hamsters, rats, and mice induced with the minute virus of mice (mvm) in vitro myelosuppressive effects of the parvovirus minute virus of mice (mvmi) on hematopoietic stem and committed progenitor cells myeloid depression follows infection of susceptible newborn mice with the parvovirus minute virus of mice (strain i) severe leukopenia and dysregulated erythropoiesis in scid mice persistently infected with the parvovirus minute virus of mice reduced fecundity and death associated with parvovirus infection in b-lymphocyte deficient mice minute virus of mice: antibody response, viral shedding, and persistence of viral dna in multiple strains of mice presence of minute virus of mice in immunocompetent mice despite the onset of host immunity gender influences infectivity in c57bl/6 mice exposed to mouse minute virus a rapid and simple procedure to detect the presence of mvm in conditioned cell fluids or culture media risk assessment of minute virus of mice transmission during rederivation: detection in reproductive organs, gametes, and embryos of mice after in vivo infection transmission of mouse minute virus (mmv) but not mouse hepatitis virus (mhv) following embryo transfer with experimentally exposed in vivo-derived embryos antineoplastic activity of parvoviruses experience with viral contamination in cell culture the molecular biology of arteriviruses lactic dehydrogenase virus isolation of lactate dehydrogenase-elevating viruses from wild house mice and their biological and molecular characterization lactate dehydrogenaseelevating virus induces systemic lymphocyte activation via tlr7-dependent ifnalpha responses by plasmacytoid dendritic cells distinct gamma interferon-production pathways in mice infected with lactate dehydrogenase-elevating virus lactate dehydrogenase-elevating virus replication persists in liver, spleen, lymph node, and testis tissues and results in accumulation of viral rna in germinal centers, concomitant with polyclonal activation of b cells transmissible agent associated with 26 types of experimental mouse neoplasms from bench to cageside: risk assessment for rodent pathogen contamination of cells and biologics lactic dehydrogenase virus (ldhv) contamination in human tumor xenografts and its elimination contamination of a monoclonal antibody with ldh-virus causes interferon induction infection of central nervous system cells by ecotropic murine leukemia virus in c58 and akr mice and in in utero-infected ce/j mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus lactate dehydrogenase-elevating virus regulation of transplacental virus infection by developmental and immunological factors: studies with lactate dehydrogenaseelevating virus transplacental lactate dehydrogenase-elevating virus (ldv) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of f4/80 antigen expression regulation of maternal-fetal virus transmission in immunologically reconstituted scid mice infected with lactate dehydrogenase-elevating virus immunofluorescent antibody response to lactic dehydrogenase virus in different strains of mice characterization of lactate dehydrogenase-elevating virus orf6 protein expressed by recombinant baculoviruses enzymatic amplification of lactate dehydrogenase-elevating virus detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological assay and rt-pcr assays and its removal from the tumor cell false negative results using rt-pcr for detection of lactate dehydrogenase-elevating virus in a tumor cell line comparison of the sensitivity of in vivo antibody production tests with in vitro pcr-based methods to detect infectious contamination of biological materials detection and typing of lactate dehydrogenase-elevating virus rna from transplantable tumors, mouse liver tissues, and cell lines, using polymerase chain reaction comparison of the mouse antibody production (map) assay and polymerase chain reaction (pcr) assays for the detection of viral contaminants relationship between the lactic dehydrogenase-elevating virus and transplantable murine tumors removal of lactate dehydrogenase-elevating virus from human-in-mouse breast tumor xenografts by cell-sorting infection of mice with lactate dehydrogenase-elevating virus leads to stimulation of autoantibodies suppression of development of diabetes in nod mice by lactate dehydrogenase virus infection natural killer cell activation after infection with lactate dehydrogenase-elevating virus effects of various adjuvants and a viral infection on the antibody specificity toward native or cryptic epitopes of a protein antigen lactate dehydrogenase-elevating virus infection at the sensitization and challenge phases reduces the development of delayed eosinophilic allergic rhinitis in balb/c mice suppression of acute anti-friend virus cd8þ t-cell responses by coinfection with lactate dehydrogenase-elevating virus mammalian reservoirs of arenaviruses risk to humans through contact with golden hamsters carrying lymphocytic choriomeningitis virus (author's transl) lymphocytic choriomeningitis virus first outbreak of callitrichid hepatitis in germany: genetic characterization of the causative lymphocytic choriomeningitis virus strains arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation lymphocytic choriomeningitis virus spatial and temporal dynamics of lymphocytic choriomeningitis virus in wild rodents, northern italy antibodies to lymphocytic choriomeningitis virus in wild rodent sera in egypt seroepidemiological survey of lymphocytic choriomeningitis virus in wild house mice in china with particular reference to their subspecies lymphocytic choriomeningitis virus infection and house mouse (mus musculus) distribution in urban baltimore contamination of transplantable murine tumors with lymphocytic choriomeningitis virus human-rodent contact and infection with lymphocytic choriomeningitis and seoul viruses in an inner-city population seroprevalence of lymphocytic choriomeningitis virus in nova scotia lymphocytic choriomeningitis virus infection in a province of spain: analysis of sera from the general population and wild rodents mouse-tohuman transmission of variant lymphocytic choriomeningitis virus exposure to lymphocytic choriomeningitis virus lymphocytic choriomeningitis outbreak associated with nude mice in a research institute laboratory studies of a lymphocytic choriomeningitis virus outbreak in man and laboratory animals lymphocytic choriomeningitis virus in southern france: four case reports and a review of the literature lymphocytic choriomeningitis in laboratory personnel exposed to hamsters inadvertently infected with lcm virus pet rodents and fatal lymphocytic choriomeningitis in transplant patients outbreak of lymphocytic choriomeningitis virus infections in medical center personnel virus zoonoses and their potential for contamination of cell cultures transmission of lymphocytic choriomeningitis virus by organ transplantation lymphocytic choriomeningitis virus: an unrecognized teratogenic pathogen lymphocytic choriomeningitis virus: reemerging central nervous system pathogen lymphocytic choriomeningitis virus: emerging fetal teratogen persistence of lymphocytic choriomeningitis virus at very low levels in immune mice mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection murine hepatitis caused by lymphocytic choriomeningitis virus. ii. cells involved in pathogenesis biology and pathogenesis of lymphocytic choriomeningitis virus infection lymphocytic choriomeningitis infection of the central nervous system murine infection with lymphocytic choriomeningitis virus following gastric inoculation timed appearance of lymphocytic choriomeningitis virus after gastric inoculation of mice lymphocytic choriomeningitis infection undetected by dirty-bedding sentinel monitoring and revealed after embryo transfer of an inbred strain derived from wild mice detection of the antibody to lymphocytic choriomeningitis virus in sera of laboratory rodents infected with viruses of laboratory and newly isolated strains by elisa using purified recombinant nucleoprotein development of a reverse transcription-polymerase chain reaction assay for diagnosis of lymphocytic choriomeningitis virus infection and its use in a prospective surveillance study detection of lymphocytic choriomeningitis virus by use of fluorogenic nuclease reverse transcriptase-polymerase chain reaction analysis quantitative pcr technique for detecting lymphocytic choriomeningitis virus in vivo centers for disease control and prevention and national institutes of health mechanisms of humoral immunity explored through studies of lcmv infection lymphocytic choriomeningitis virus and immunology viral persistence: parameters, mechanisms and future predictions stage of primary infection with lymphocytic choriomeningitis virus determines predisposition or resistance of mice to secondary bacterial infections reovirus type 3 infection, liver, mouse the mouse in biomedical research. diseases reovirus infection in laboratory rodents direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers type 3 reovirus neuroinvasion after intramuscular inoculation: direct invasion of nerve terminals and age-dependent pathogenesis reoviruses and the host cell orthoreoviruses and their replication passive immunity to fatal reovirus serotype 3-induced meningoencephalitis mediated by both secretory and transplacental factors in neonatal mice infectivity, disease patterns, and serologic profiles of reovirus serotypes 1, 2, and 3 in infant and weanling mice reovirus-induced liver disease in severe combined immunodeficient (scid) mice. a model for the study of viral infection, pathogenesis, and clearance histopathological characterization of the naturally occurring hepatotropic virus infections of nude mice detection methods for the identification of rodent viral and mycoplasmal infections reverse transcriptionpolymerase chain reaction detection and nucleic acid sequence confirmation of reovirus infection in laboratory mice with discordant serologic indirect immunofluorescence assay and enzyme-linked immunosorbent assay results diagnosis of murine infections in relation to test methods employed reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease detection of reovirus type 3 by use of fluorogenic nuclease reverse transcriptase polymerase chain reaction detection of reovirus by reverse transcription-polymerase chain reaction using primers corresponding to conserved regions of the viral l1 genome segment isolation of a non-pathogenic tumour-destroying virus from mouse ascites an oncolytic virus recovered from swiss mice during passage of an ascites tumour mouse hepatitis virus enterotropic mouse hepatitis virus effects of air temperature and relative humidity on coronavirus survival on surfaces asymptomatic infection of mouse hepatitis virus in the rat effects of experimental infection of the deer mouse (peromyscus maniculatus) with mouse hepatitis virus isolation of a latent murine hepatitis virus from cultured mouse liver cells induction of lytic plaques by murine leukemia virus in murine sarcoma virus-transformed nonproducer mouse cells persistently infected with mouse hepatitis virus mhv-s mouse hepatitis virus biology and epizootiology the cellular and molecular pathogenesis of coronaviruses enterotropic coronavirus (mouse hepatitis virus) in mice: influence of host age and strain on infection and disease response of genetically susceptible and resistant mice to intranasal inoculation with mouse hepatitis virus jhm duration of mouse hepatitis virus infection: studies in immunocompetent and chemically immunosuppressed mice effective clearance of mouse hepatitis virus from the central nervous system requires both cd4þ and cd8þ t cells role of cd4þ and cd8þ t cells in mouse hepatitis virus infection in mice antibody prevents virus reactivation within the central nervous system mouse hepatitis virus enterotropic mouse hepatitis virus infection in nude mice persistent transmission of mouse hepatitis virus by transgenic mice duration of challenge immunity to coronavirus jhm in mice virus strain specificity of challenge immunity to coronavirus duration and strain-specificity of immunity to enterotropic mouse hepatitis virus passively acquired challenge immunity to enterotropic coronavirus in mice epizootic coronaviral typhlocolitis in suckling mice isolation of mouse hepatitis virus from infant mice with fatal diarrhea thymus involution induced by mouse hepatitis virus a59 in balb/c mice adverse effects of mouse hepatitis virus on ascites myeloma passage in the balb/ej mouse murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in a/j mice tolllike receptor 4 deficiency increases disease and mortality after mouse hepatitis virus type 1 infection of susceptible c3h mice granulomatous peritonitis and pleuritis in interferon-gamma gene knockout mice naturally infected with mouse hepatitis virus pathogenesis of enterotropic mouse hepatitis virus in immunocompetent and immunodeficient mice vertical transmission of mouse hepatitis virus infection in mice tissue distribution and duration of mouse hepatitis virus in naturally infected immunocompetent icr (cd-1) and immunodeficient athymic nudenu mouse strains used for ovarian transplantation and in vitro fertilization rederivation of inbred strains of mice by means of embryo transfer risk assessment of mouse hepatitis virus infection via in vitro fertilization and embryo transfer by the use of zona-intact and laser-microdissected oocytes mouse hepatitis virus immunofluorescence in formalin-or bouin's-fixed tissues using trypsin digestion comparison of isolation in cell culture with conventional and modified mouse antibody production tests for detection of murine viruses monoclonal antibody solution hybridization assay for detection of mouse hepatitis virus infection detection of rodent coronaviruses in tissues and cell cultures by using polymerase chain reaction sequence analysis and molecular detection of mouse hepatitis virus using the polymerase chain reaction detection of mouse hepatitis virus by the polymerase chain reaction and its application to the rapid diagnosis of infection detection of rodent coronaviruses by use of fluorogenic reverse transcriptase-polymerase chain reaction analysis an immunofluorescence test for detection of serum antibody to rodent coronaviruses simultaneous detection of antibodies to mouse hepatitis virus recombinant structural proteins by a microsphere-based multiplex fluorescence immunoassay differences in antibody production against mouse hepatitis virus (mhv) among mouse strains maternally-derived passive immunity to enterotropic mouse hepatitis virus mouse hepatitis virus: molecular biology and implications for pathogenesis maintenance of pluripotency in mouse embryonic stem cells persistently infected with murine coronavirus replication of murine coronaviruses in mouse embryonic stem cell lines. in vitro reliability of soiled bedding transfer for detection of mouse parvovirus and mouse hepatitis virus efficacy of three microbiological monitoring methods in a ventilated cage rack rederivation of mhv and mev antibody positive mice by cross-fostering and use of the microisolator caging system elimination of mouse hepatitis virus from a breeding colony by temporary cessation of breeding evolution of mouse hepatitis virus (mhv) during chronic infection: quasispecies nature of the persisting mhv rna the elimination of mouse hepatitis virus by temporary transplantation of human tumors from infected athymic nude mice into athymic nude rats (rnun/rnun) development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase pcr assay to detect murine norovirus 1 infection in mice stat1-dependent innate immunity to a norwalk-like virus murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by stat1-dependent interferon responses replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages persistent infection with and serologic cross-reactivity of three novel murine noroviruses murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence molecular detection of murine norovirus from experimentally and spontaneously infected mice naturally occurring murine norovirus infection in a large research institution soiled-bedding sentinel detection of murine norovirus 4 the use of cross-foster rederivation to eliminate murine norovirus, helicobacter spp., and murine hepatitis virus from a mouse colony impact of murine norovirus on a mouse model of ibd virus-plus-susceptibility gene interaction determines crohn's disease gene atg16l1 phenotypes in intestine murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease investigation of the impact of the common animal facility contaminant murine norovirus on experimental murine cytomegalovirus infection effects of murine norovirus infection on a mouse model of diet-induced obesity and insulin resistance mouse adenovirus, k virus, and pneumonia virus of mice sendai virus and pneumonia virus of mice (pvm) pneumonia virus of mice: severe respiratory infection in a natural host pneumonia virus of mice infection, lung, mouse, and rat persistence of pneumonia virus of mice and sendai virus in germ-free (nu/nu) mice fatal pneumonia with terminal emaciation in nude mice caused by pneumonia virus of mice respiratory disease and wasting in athymic mice infected with pneumonia virus of mice pathogenesis of pneumovirus infections in mice: detection of pneumonia virus of mice and human respiratory syncytial virus mrna in lungs of infected mice by in situ hybridization differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains experimental pneumovirus infections: 1. hydrocephalus of mice due to infection with pneumonia virus of mice (pvm) detection of sendai virus and pneumonia virus of mice by use of fluorogenic nuclease reverse transcriptase polymerase chain reaction analysis lethal exacerbation of pneumocystis murina. pneumonia in severe combined immunodeficiency mice after infection by pneumonia virus of mice handbook of animal models of infection mouse rotavirus murine rotavirus infection, mouse successful sanitation of an edim-infected mouse colony by breeding cessation role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhoea age-dependent diarrhoea induced by a rotaviral nonstructural glycoprotein the immunology of rotavirus infection in the mouse murine model of rotavirus infection evidence that resolution of rotavirus infection in mice is due to both cd4 and cd8 celldependent activities ifn-l determines the intestinal epithelial antiviral host defense persistent rotavirus infection in mice with severe combined immunodeficiency role of b cells and cytotoxic t lymphocytes in clearance of and immunity to rotavirus infection in mice comparison of methods for detection of serum antibody to murine rotavirus identification of nonspecific reactions in laboratory rodent specimens tested by rotazyme rotavirus elisa removal of inhibitory substances from human fecal specimens for detection of group a rotaviruses by reverse transcriptase and polymerase chain reactions synergistic rotavirus and escherichia coli diarrhoeal infection of mice infection of rabbits with sendai virus pathogenesis of sendai virus infection in the syrian hamster determinants of organ tropism of sendai virus sendai virus infection, lung, mouse, and rat multigenic control of resistance to sendai virus infection in mice naturally-occurring sendai virus infection of athymic nude mice signs and lesions of experimental sendai virus infection in two genetically distinct strains of scid/beige mice cooperation between cytotoxic and helper t lymphocytes in protection against lethal sendai virus infection. protection by t cells is mhc-restricted and mhc-regulated; a model for mhc-disease associations delayed clearance of sendai virus in mice lacking class i mhc-restricted cd8þ t cells naturally occurring sendai virus disease of mice affinity of sendai virus for the inner ear of mice detection of nucleoprotein gene of sendai virus in the lungs of rats by touchdown nested reverse transcription polymerase chain reaction the effectiveness of a microisolator cage system and sentinel mice for controlling and detecting mhv and sendai virus infections the efficacy of a dirty bedding sentinel system for detecting sendai virus infection in mice: a comparison of clinical signs and seroconversion serological evidence that mus musculus is the natural host of theiler's murine encephalomyelitis virus comparison of mhg virus with mouse encephalomyelitis viruses genetic analysis of a theiler-like virus isolated from rats a serological indication of the existence of a guineapig poliovirus duration and patterns of transmission of theiler's mouse encephalomyelitis virus infection a spontaneous outbreak of theiler's encephalomyelitis in a colony of severe combined immunodeficient mice in the uk axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis the theiler's murine encephalomyelitis viruses susceptibility of inbred mice to chronic central nervous system infection by theiler's murine encephalomyelitis virus role of the humoral immune response in resistance to theiler's virus infection the genetics of the persistent infection and demyelinating disease caused by theiler's virus infection with theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via nf-kappab activation: potential role for the initiation of demyelinating disease innate immune response induced by theiler's murine encephalomyelitis virus infection cardioviruses: encephalomyocarditis virus and theiler's murine encephalomyelitis virus effect of immunization with theiler's virus on the course of demyelinating disease protection of sjl/j mice from demyelinating disease mediated by theiler's murine encephalomyelitis virus immunosuppression promotes cns remyelination in chronic virus-induced demyelinating disease pathogenesis of theiler's murine encephalomyelitis virus mechanism of theiler's virus-induced demyelination in nude mice survival of athymic (nu/nu) mice after theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody vacuolar neuronal degeneration in the ventral horns of scid mice in naturally occurring theiler's encephalomyelitis evolution of the placental barrier to fetal infection by murine enteroviruses enhanced detection of theiler's virus rna copy equivalents in the mouse central nervous system by real-time rt-pcr spontaneous demyelinating myelopathy in aging laboratory mice key: cord-319933-yp9ofhi8 authors: ruiz, sara i.; zumbrun, elizabeth e.; nalca, aysegul title: chapter 38 animal models of human viral diseases date: 2013-12-31 journal: animal models for the study of human disease doi: 10.1016/b978-0-12-415894-8.00038-5 sha: doc_id: 319933 cord_uid: yp9ofhi8 abstract as the threat of exposure to emerging and reemerging viruses within a naive population increases, it is vital that the basic mechanisms of pathogenesis and immune response be thoroughly investigated. by using animal models in this endeavor, the response to viruses can be studied in a more natural context to identify novel drug targets, and assess the efficacy and safety of new products. this is especially true in the advent of the food and drug administration's animal rule. although no one animal model is able to recapitulate all the aspects of human disease, understanding the current limitations allows for a more targeted experimental design. important facets to be considered before an animal study are the route of challenge, species of animals, biomarkers of disease, and a humane endpoint. this chapter covers the current animal models for medically important human viruses, and demonstrates where the gaps in knowledge exist. well-developed animal models are necessary to understand the disease progression, pathogenesis, and immunologic responses in humans. furthermore, to test vaccines and medical countermeasures, well-developed animal models are essential for preclinical studies. ideally, an animal model of human viral infection should mimic the host-pathogen interactions and the disease progression that is seen in the natural disease. a good animal model of viral infection should allow many parameters of infection to be assayed, including clinical signs, growth of virus, clinicopathological parameters, cellular and humoral immune responses, and virus-host interactions. furthermore, viral replication should be accompanied by measurable clinical manifestations, and pathology should resemble that of human cases such that a better understanding of the disease process in humans is attained. there is often more than one animal model that closely represents human disease for a given pathogen. small animal models are typically used for first-line screening, and for initially testing the efficacy of vaccines or therapeutics. in contrast, nonhuman primate (nhp) models are often used for the pivotal preclinical studies. this approach is also used for basic pathogenesis studies, with most experiments performed in small animal models when possible, and nhps only used to fill in remaining gaps in knowledge. the advantages of using mice to develop animal models are low cost, low genetic variability in inbred strains, and abundant molecular biological and immunological reagents. specific pathogen-free (spf), transgenic, and knockout mice are also available. a major pitfall of mouse models is that the pathogenesis and protection afforded by vaccines and therapeutics cannot always be extrapolated. additionally, blood volumes for sampling are limited in small animals, and viruses often need to be adapted through serial passage in the species to induce a productive infection. the ferret's airways are anatomically and histologically similar to that of humans, and their size enables larger or more frequent blood samples to be collected, making them an ideal model for certain respiratory pathogens. ferrets are outbred, with no standardized breeds or strains; thus, greater numbers are required in studies to achieve statistical significance and overcome the resulting variable responses. additionally, spf and transgenic animals are not available, and molecular biological reagents are lacking. other caveats making ferret models more difficult to work with are their requirement for more space than mice (rabbit-style cages), and the development of aggressive behavior with repeated procedures. nhps are genetically the closest species to humans; thus, disease progression and host-pathogen responses to viral infections are often the most similar to that of humans. however, ethical concerns of experimentation on nhps, along with the high cost and lack of spf nhps raise barriers for such studies. nhp studies should be carefully designed to ensure that the least amount of animals are used, and the studies should address the most critical questions regarding disease pathogenesis, host-pathogen responses, and protective efficacy of vaccines and therapeutics. well-designed experiments should carefully evaluate the choice of animal, including the strain, sex, and age. furthermore, route of exposure and the dose should be as close as possible to the route of exposure and dose of human disease. the endpoint for these studies is also an important criterion. depending on the desired outcome, the model system should emulate the host responses in humans when infected with the same pathogen. in summary, small animal models are helpful for the initial screening of vaccines and therapeutics, and are also often beneficial in obtaining a basic understanding of the disease. nhp models should be used for a more detailed characterization of pathogenesis and for pivotal preclinical testing studies. ultimately, an ideal animal model may not be available. in this case, a combination of different well-characterized animal models should be considered to understand the disease progression and to test medical countermeasures against the disease. in this chapter, we will be reviewing the animal models for representative members of numerous virus families causing human diseases. we will focus on the viruses for each family that are the greatest concern for public health worldwide. poliovirus (pv) is an enterovirus in the picornavirus family and causes poliomyelitis. 1 humans are the only natural host for the virus, but a number of nhp species are also susceptible. all three serotypes of pv cause paralytic disease, but it is relatively rare with only 1-2% of infected individuals ultimately developing paralysis. humans typically acquire and transmit the virus by the oral-fecal route, although transmission by aerosol droplets may also be possible. 2 the virus replicates in the oropharyngeal and intestinal mucosa, made possible by the resistance of pv to stomach acids. 3 cd155 expression in peyer's patches and m cells suggest that these cell types may be important during initiation of infection. 4 replication at extraneural sites 38 . in vivo models of viral diseases affecting humans precedes invasion into the central nervous systems (cnss), when it occurs. two effective vaccines, the salk killed polio vaccine delivered by the intramuscular route and the sabin live attenuated polio vaccine delivered orally, have been used very successfully to eliminate the disease from most parts of the world. 5 the world health organization has led a long and hard-fought global polio eradication campaign, with much success, but full eradication has not yet been achieved. since 2003, between 1000 and 2000 cases of pv infection are reported worldwide each year. 6 thus, animal models are also needed to test new vaccine approaches that could be used toward eradication of polio in the areas where it still persists. additionally, the recent focus of work with pv animal models has been fraught with urgency, as to gain understanding of pv pathogenesis before the eradication effort is complete and work with this virus ceases. animal models for the study of pv consist of nhp models and mouse models. mice are susceptible to certain adapted pv strains: p2/lansing, p1/lsb, and a variant of p3/leon. mice infected intracerebrally with p2/lansing develop disease with some clinical and histopathological features resembling that of humans. 7 wild-type mice are not susceptible to wildtype pv; however, the discovery of the pv receptor (cd155) in 1989 led to the use of hcd155 transgenic mice as a model of pv infection. 8 these mice are not susceptible to pv by the oral route and must be exposed intranasally or by intramuscular infection to induce paralytic disease. 9 interestingly, hcd155 mice that have a disruption in the interferon (ifn)-a/b receptor gene are susceptible to oral infection. 10 this finding has given rise to speculation that an intact ifn-a/b response may be responsible for limiting infection in the majority of individuals exposed to pv. thus, mouse models have proven to be very useful in gaining a better understanding of pv disease and pathogenesis. rhesus macaques are not susceptible to pv by the oral route, but they have been used extensively to study vaccine formulations for safety and immunogenicity, for monitoring neurovirulence of the live attenuated sabin vaccine, and in the past for typing pv strains. 11 bonnet monkeys are also susceptible to oral inoculation of pv, which results in the gastrointestinal shedding of virus for several weeks, with paralysis occurring in only a small proportion of animals. consistent paralytic disease can be induced in bonnet monkeys (macaca radiata) through exposure to pv by infection into the right ulnar nerve (at the elbow), resulting in limb paralysis that resembles human paralytic poliomyelitis both clinically and pathologically. 12 as such, bonnet monkeys can be used to study pv distribution and pathology and the induction of paralytic poliomyelitis or provocation paralysis. 13 hepatitis a virus causes jaundice, which is a public health problem worldwide. the incubation period lasts from 15 to 45 days with an average of 28 days. transmission between humans occurs by the oral-fecal route, person-to-person contact, or ingestion of contaminated food and water. 14 hepatitis a virus causes an acute and self-limited infection of the liver with a spectrum of signs and symptoms ranging from subclinical disease, to jaundice, fulminant hepatitis, and in some cases death. 15, 16 the disease can be divided into four clinical phases: (1) incubation period, during which the patient is asymptomatic but virus replicates and possibly transmits to others. (2) prodromal period, which might last from a few days to a week with patients generally experiencing anorexia, fever (<103 f), fatigue, malaise, myalgia, nausea, and vomiting. (3) icteric phase, in which increased bilirubin causes characteristic dark brownish colored urine. this sign is followed by pale stool and yellowish discoloration of the mucous membranes, conjunctiva, sclera, and skin. most patients develop an enlarged liver, and approximately 5-15% of the patients have splenomegaly. (4) convalescent period, with resolution of the disease and recovery of the patient. rarely, during the icteric phase, extensive necrosis of the liver occurs. these patients show a sudden increase in body temperature, marked abdominal pain, vomiting, jaundice, and the development of hepatic encephalopathy associated with coma and seizures, all signs of fulminant hepatitis. death occurs in 70-90% of patients with fulminant hepatitis. 16 experiments showed that hepatitis a causes disease only in humans, chimpanzees, several species of south american marmosets, stump-tailed monkeys, and owl monkeys via the oral or intravenous (iv) routes. [17] [18] [19] [20] it is known that cynomolgus macaques are infected with hepatitis a virus in the wild. 21 amado et al. used cynomolgus macaques (macaca fascicularis) for experimental hepatitis a infections. 17 the animals did not exhibit clinical signs of disease, but viral shedding was observed in saliva and stool as early as 6 h postinoculation (pi) and 7 days pi, respectively. although mildto-moderate hepatic pathology was observed in all macaques, seroconversion and mildly increased alanine aminotransferase (alt), an enzyme associated with liver function, were observed in some of them. because this study had a very small group of animals (four macaques), the data should not be considered as conclusive, and more studies are needed to better define the cynomolgus macaque model. although hepatitis a virus is transmitted by the oralfecal route, studies in chimpanzees and tamarins showed that the iv route was much more infectious than oral route was. there was no correlation between dose and development of clinical disease for either species or experimental routes, and similar to cynomolgus macaques, none of these species showed clinical signs of disease. 20 inoculation of common marmosets (callithrix jacchus) with hepatitis a virus did not produce clinical signs of disease as seen in other nhp models. 22, 23 liver enzyme levels increased on day 14 pi, and monkeys had measurable antihepatitis a antibodies by day 32 pi. an experimental study with cell culture-adapted hepatitis avirus in guinea pigs challenged by oral or intraperitoneal routes did not result in clinical disease, increase in liver enzymes, or seroconversion. 24 viral load was detected in stool and serum between days 14 and 52 and 21 and 49 days, respectively. liver pathology showed mild hepatitis. furthermore, histopathology indicated that virus replicated in extrahepatic tissues such as spleen, regional lymph nodes, and intestinal tract. in summary, none of the animal models for hepatitis a infection is suitable for studying pathogenesis of the virus because all clinical and most of the laboratory parameters remain within normal range or only slightly increased after the infection. one possibility is to test the safety of vaccines against hepatitis a virus in those models with demonstrable viral shedding. noroviruses, of which norwalk is the prototypic member, are responsible for up to 85% of reported food-borne gastroenteritis cases. in developing countries, this virus is responsible for approximately 200,000 deaths annually. 25 a typical disease course is self-limiting, but there have been incidences of necrotizing enterocolitis and seizures in infants. 26, 27 symptoms of infection include diarrhea, vomiting, nausea, abdominal cramping, dehydration, and fever. incubation normally is for 1-3 days, with symptoms enduring for 2-3 days. 28 viral shedding is indicative of immunocompromised status within an individual with the elderly and young having a prolonged state of shedding. 29 transmission occurs predominately through the oral-fecal route with contaminated food and water being the major vector. 30 a major hindrance to basic research into this pathogen is the lack of a cell culture system. therefore, animal models are used not only to determine the efficacy of novel drugs and vaccines but also for understanding the pathogenesis of the virus. therapeutic intervention consists of rehydration therapy and antiemetic medication. 31 no vaccine is available, and development of one is expected to be challenging given that immunity is short lived after infection. 32 nhps including marmosets, cotton-top tamarins, and rhesus macaques infected with norwalk virus can be monitored for the extent of viral shedding; however, no clinical disease is observed in these models. disease progression and severity are measured exclusively by assay of viral shedding. 33 it was determined that more virus was needed to create an infection when challenging by the oral route than when challenging by the iv route. chimpanzees were exposed to a clinical isolate of norwalk virus by the iv route. although none of the animals developed disease symptoms, viral shedding within the feces was observed within 2-5 days postinfection and lasted anywhere from 17 days to 6 weeks. viremia never occurred, and no histopathological changes were detected. the amount and duration of viral shedding were in line with what is observed upon human infection. 34 a recently identified calicivirus of rhesus origin, named tulane virus, was used as a surrogate model of infection. rhesus macaques exposed to tulane virus intragastrically developed diarrhea and fever 2 days postinfection. viral shedding was achieved for 8 days. the immune system produced antibodies that dropped in concentration within 38 days postinfection, mirroring the short-lived immunity documented in humans. the intestine developed moderate blunting of the villi as seen in human disease. 35 a murine norovirus has been identified and is closely related to human norwalk virus. however, clinically, the viruses present a different disease. the murine norovirus does not induce diarrhea nor vomiting and can develop a persistent infection in contrast to human disease. [36] [37] [38] porcine enteric caliciviruses can induce diarrheal disease in young pigs and an asymptomatic infection in adults. 39 gnotobiotic pigs can successfully be infected with a passaged clinical noroviruses isolate orally. diarrheal disease developed in 74% of the animals, and 44% were able to shed virus in their stool. no major histopathological changes or viral persistence was noted. 40 calves are naturally infected with bovine noroviruses. experimentally challenging calves with an oral inoculation of a bovine isolate resulted in diarrheal disease [14] [15] [16] the link between equine cases and the human disease was confirmed in 1938 by observing 30 cases of fatal encephalitis in children living in the same area as the equine cases. during this outbreak, eeev was isolated from the cnss of these children as well as from pigeons and pheasants. 44 eeev primarily affects areas near salty marshes and can cause localized outbreaks of disease in the summer. the enzootic cycles are maintained in moist environments such as coastal areas, shaded marshy salt swamps in north america (na), and moist forests in central america and south america (sa). 45 birds are the primary reservoir, and the virus is transmitted via mosquitoes. furthermore, forest-dwelling rodents, bats, and marsupials frequently become infected and may provide an additional reservoir in central america and sa. despite known natural hosts, the transmission cycles in these animals are not well characterized. 44 reptiles and amphibians have also been reported to become infected by eeev. eeev pathogenesis and disease have been studied in several laboratory animals. as a natural host, birds do not generally develop encephalitis except pheasants or emus, in which eeev causes encephalitis with 50-70% mortality. 46 young chickens show signs of extensive myocarditis in early experimental infection and heart failure rather than encephalitis is the cause of death. 47 besides the heart, other organs such as pancreas and kidney show multifocal necrosis. additionally, lymphocytopenia has been observed in the thymus and spleen in birds. 45 eeev causes neuronal damage in newborn mice, and the disease progresses rapidly, resulting in death. 48 similarly, eeev produces fatal encephalitis in older mice when administered via the intracerebral route, whereas inoculation via the subcutaneous route causes a pantropic infection eventually resulting in encephalitis. 49, 50 guinea pigs and hamsters have also been used as animal models for eeev studies. 51, 52 guinea pigs developed neurological involvement with decreased activity, tremors, circling behavior, and coma. neuronal necrosis was observed and resulted in brain lesions in these animals. 52 subcutaneous inoculation of eeev produced lethal biphasic disease in hamsters with severe lesions of nerve cells. the early visceral phase with viremia was followed by neuroinvasion, encephalitis and death. in addition, parenchyma necroses were observed in the liver and lymphoid organs. 51 intradermal, intramuscular, or iv inoculations of eeev in nhps cause disease but does not always result in symptoms of the nervous system. intracerebral infection of eeev results in nervous system disease and fatality in monkeys. 53 the differences in these models indicate that the initial viremia and the secondary nervous system infection do not overlap in monkeys when they are infected by the peripheral route. 54 intranasal and intralingual inoculations of eeev also cause nervous system symptoms in monkeys, but less drastic than those caused by intracerebral injections. 54 the aerosol route of infection also progresses to uniformly lethal disease in cynomolgus macaques. 55 in this model, fever was followed by elevated white blood cells and liver enzymes. neurological signs subsequently developed, and nhps became moribund and were euthanized between days 5 and 9 days postexposure. meningoencephalomyelitis was the main pathology observed in the brains of these animals. 56 similar clinical signs and pathology were observed when common marmosets were infected with eeev by the intranasal route. 57 both aerosol and intranasal nhp models had similar disease progression and pathology as those seen in human disease. a common marmoset model was used for comparison studies of sa and na strains of eeev. 57 previous studies indicated that the sa strain is less virulent than na strain for humans. common marmosets were infected intranasally with either the na or sa strain of eeev. na strain-infected animals showed signs of anorexia and neurological involvement and were euthanized 4-5 days after the challenge. although sa strain-infected animals developed viremia, they remained healthy and survived the challenge. epizootics of viral encephalitis in horses were previously described in argentina. more than 25,000 horses died from western equine encephalitis virus (weev) in the central plains of the united states in 1912. 58 weev was first isolated from the brains of horses during the outbreak in the san joaquin valley of california in 1930. although it was suspected, the first diagnosis of weev as a cause of human encephalitis occurred in 1938, when the virus was recovered from the brain of a child with fatal encephalitis. 44 in horses, the signs of disease are fever, loss of coordination, drowsiness, and anorexia, leading to prostration, coma, and death in about 40% of affected animals. 59 weev also infects other species of birds and often causes fatal disease in sparrows. weev infection occurs throughout western na and sporadically in sa as it circulates between its mosquito vector and wild birds. 44 chickens and other domestic birds, pheasants, rodents, rabbits, ungulates, tortoises, and snakes are natural reservoirs of weev. 60,61 weev has caused epidemics of encephalitis in humans, horses, and emus, but the fatality rate is lower than that for eeev. 62 predominately young children and those older than 50 years demonstrate the clinical symptoms of the disease. 63 severe disease, seizures, fatal encephalitis, and significant sequelae are more likely to occur in infants and young children. 64, 65 typically, the disease progresses asymptomatically with seroprevalence in humans being fairly common in endemic areas. species used to develop animal models for weev are mice, hamsters, guinea pigs, and ponies. studies with ponies resulted in viremia in 100% of the animals 1-5 days pi. fever was observed in 7 of 11 animals, and six exhibited signs of encephalitis. 44 after subcutaneous inoculation with weev, suckling mice started to show signs of disease by 24 h and died within 48 h. 66 in suckling mice, the heart was the only organ in which pathologic changes were observed. conversely, adult mice exhibited signs of lethargy and ruffled fur on days 4-5 postinfection. mice were severely ill by day 8 and appeared hunched and dehydrated. death occurred between days 7 and 14, and both brain and mesodermal tissues such as heart, lungs, liver, and kidney were involved. 66, 67 intracerebral and intranasal routes of infection resulted in a fatal disease that was highly dependent on dose, while intradermal and subcutaneous inoculations caused only 50% fatality in mice regardless of the amount of virus. 49 studies demonstrated that although the length of the incubation period and the disease duration varied, weev infection resulted in mortality in hamsters by all routes of inoculation. progressive lack of coordination, shivering, rapid and noisy breathing, corneal opacity, and conjunctival discharge resulting in closing of the eyelids were indicative of disease in all cases. 68 cns involvement was evident with intracerebral, intraperitoneal, and intradermal inoculations. 68 weev is highly infectious to guinea pigs. 69 intraperitoneal inoculation of weev is fatal in guinea pigs regardless of virus inoculum, with the animals exhibiting signs of illness on days 3-4, followed by death on days 5-9 (nalca, unpublished results). very limited studies have been performed with nhps. the intranasal route of infection causes severe, lethal encephalitis in rhesus macaques. 54 reed et al. exposed cynomolgus macaques to low and high doses of aerosolized weev. the animals subsequently developed fever, increased white blood counts, and cns involvement, demonstrating that the cynomolgus macaque model would be useful for testing of vaccines and therapeutics against weev. 70 venezuelan equine encephalitis virus (veev) is maintained in nature in a cycle between small rodents and mosquitoes. 45 the spread of epizootic strains of the virus to equines leads to high viremia followed by a lethal encephalitis, and tangential spread to humans. veev can easily be spread by the aerosol route making it a considerable danger for laboratory exposure. in humans, veev infection causes a sudden onset of malaise, fever, chills, headache, and sore throat. 45, 71, 72 symptoms persist for 4-6 days, followed by a 2-to 3-week period of generalized weakness. encephalitis occurs in a small percentage of adults ( 0.5%); however, the rate in children may be as high as 4%. neurologic symptoms range from nuchal rigidity, ataxia, and convulsions to the more severe cases exhibiting coma and paralysis. the overall mortality rate in humans is <1%. 45 laboratory animals such as mice, guinea pigs, and nhps exhibit different pathologic responses when infected with veev. the lymphatic system is a general target in all animals infected with cns involvement variable between different animal species. the disease caused by veev progresses very rapidly without showing signs of cns disease in guinea pigs and hamsters. mortality is typically observed within 2-4 days after infection and fatality is not dose dependent. 44 veev infection lasts longer in mice, which develop signs of nervous system disease in 5-6 days and death 1-2 days later. lethal dose in mice changes depending on the age of mice and the route of exposure. 56 in contrast to guinea pigs and hamsters, the time of the death in mice is dose dependent. mortality is observed generally within 2-4 days after infection and fatality is not dose dependent. subcutaneous/dermal infection in the mouse model results in encephalitic disease very similar to that seen in horses and humans. 73 virus begins to replicate in the draining lymph nodes at 4 h pi. eventually, virus enters the brain primarily via the olfactory system. furthermore, aerosol exposure of mice to veev can result in massive infection of the olfactory neuroepithelium, olfactory nerves, and olfactory bulbs and viral spread to brain, resulting in necrotizing panencephalitis. 74, 75 aerosol and dermal inoculation routes cause neurological pathology in mice much faster than other routes of exposure do. the clinical signs of disease in mice infected by aerosol are ruffled fur, lethargy, and hunching progressing to death. 56, 74, 75 intranasal challenge of c3h/hen mice with high dose veev caused high morbidity and mortality. 76 viral titers in brain peaked on day 4 postchallenge and stayed high until animals died on day 9-10 postchallenge. protein cytokine array done on brains of infected mice showed elevated interleukin (il)-1a, il-1b, il-6, il-12, monocyte chemoattractant protein-1 (mcp-1), ifng, mip-1a, and regulated and normal t-cell expressed and secreted levels. this model was used successfully to test antivirals against veev. 77 xi. viral disease veev infection causes a typical biphasic febrile response in nhps. initial fever was observed at 12-72 h after infection and lasted <12 h. secondary fever generally began on day 5 and lasted 3-4 days. 78 veev-infected nhps exhibited mild symptoms such as anorexia, irritability, diarrhea, and tremors. leucopenia was common in animals exhibiting fever. 79 supporting the leucopenia, observed microscopic changes in lymphatic tissues such as early destruction of lymphocytes in lymph nodes and spleen, a mild lymphocytic infiltrate in the hepatic triads, focal myocardial necrosis with lymphocytic infiltration have been observed in monkeys infected with veev. surprisingly, characteristic lesions of the cns were observed histopathologically in monkeys in spite of the lack of any clinical signs of infection. 78 the primary lesions were lymphocytic perivascular cuffing and glial proliferation and generally observed at day 6 postinfection during the secondary febrile episode. cynomolgus macaques develop similar clinical signs including fever, viremia, lymphopenia, and encephalitis upon aerosol exposure to veev. 80 chikungunya virus is a member of the genus alphaviruses, specifically the semliki forest complex, and has been responsible for a multitude of epidemics mainly within africa and southeast asia. 45 the virus is transmitted by aedes mosquitoes. given the widespread endemicity of aedes mosquitoes, chikungunya virus has the potential to spread to previously unaffected areas. this is typified by the emergence of disease for the first time in 2005 in the islands of the southwest indian ocean, including the french la reunion island, and the appearance in central italy in 2007. 81, 82 the incubation period after a mosquito bite is 2-5 days followed by a self-limiting acute phase that lasts 3-4 days. symptoms during this period include fever, arthralgia, myalgia, and rash. headache, weakness, nausea, vomiting, and polyarthralgia have all been reported. 83 individuals typically develop a stooped posture due to the pain. for approximately 12% of infected individuals, joint pain can last months after resolution of primary disease, and has the possibility to relapse. underlying health conditions, including diabetes, alcoholism, or renal disease, increase the risk of developing a severe form of disease that includes hepatitis or encephalopathy. children between the ages of 3 and 18 years have an increased risk of developing neurological manifestations. 84 there is no effective vaccine or antiviral. wild-type c57bl/6 adult mice are not permissive to chikungunya virus infection by intradermal inoculation. however, it was demonstrated that neonatal mice were susceptible, and severity was dependent upon age at infection. six-day-old mice developed paralysis by day 6, and all died by day 12, whereas 50% of nine-day-old mice were able to recover from infection. by 12 days, mice were no longer permissive to disease. infected mice developed loss of balance, hind limb dragging, and skin lesions. neonatal mice were also used as a model for neurological complications. 85, 86 an adult mouse model has been developed by injection of the ventral side of the footpad of c57bl/6j mice. viremia lasted 4-5 days accompanied by foot swelling and noted inflammation of the musculoskeletal tissue. 87, 88 adult ifna/br knockout mice also developed mild disease with symptoms including muscle weakness and lethargy, symptoms that mirrored human infection. all adult mice died within 3 days. this model was useful in identifying the viral cellular tropism for fibroblasts. 85 imprinting control region (icr) cd1 mice can also be used as a disease model. neonatal mice subcutaneously inoculated with a passaged clinical isolate of chikungunya virus developed lethargy, loss of balance, and difficulty in walking. mortality was low, 17% and 8% for newborn cd1 and icr mice, respectively. the remaining mice fully recovered within 6 weeks after infection. 86 a drawback of both the ifna/ br and cd1 mice is that the disease is not a result of immunopathogenesis as occurs in human cases, given that the mice are immunocompromised. 89 long-tailed macaques challenged with a clinical isolate of the virus developed a similar clinical disease to humans. initially, the monkeys developed high viremia with fever and rash. after this period, viremia resolved and virus could be detected in lymphoid, liver, meninges, joint, and muscle tissue. the last stage mimicked the chronic phase in which virus could be detected up to two months after infection, although no arthralgia was noted. 90 dengue virus is transmitted via the mosquito vectors aedes aegypti and aedes albopictus. 91 given the endemicity of the vectors, it is estimated that half of the world's population is at risk for exposure to dengue virus. this results in approximately 50 million cases of dengue each year, with the burden of disease in the tropical and subtropical regions of latin america, south asia, and southeast asia. 92 it is estimated that there are 20,000 deaths each year caused by dengue hemorrhagic fever (dhf). 93 there are four serotypes of dengue virus, numbered 1-4, which are capable of causing a wide spectrum of disease that ranges from asymptomatic to severe with the development of dhf. 94 incubation can range from 3 to 14 days, with the average being 4-7 days. the virus targets dendritic cells and macrophages after a mosquito bite. 95 typical infection results in classic dengue fever (df), which is self-limiting and has flu-like symptoms in conjunction with retroorbital pain, headache, skin rash, and bone and muscle pain. dhf can follow, with vascular leak syndrome and low platelet count, resulting in hemorrhage. in the most extreme cases, dengue shock syndrome (dss) develops, characterized by hypotension, shock, and circulatory failure. 94 thrombocytopenia is a hallmark clinical sign of infection, and aids in differential diagnosis. 96 severe disease has a higher propensity to occur upon secondary infection with a different dengue virus serotype. 97 this is hypothesized to occur due to antibodydependent enhancement (ade). there is no approved vaccine or drug, and hospitalized patients receive supportive care including fluid replacement. in developing an animal model, it is important to note that mosquitoes typically deposit 10 4 -10 6 pfu, and is therefore the optimal range to be used during challenge. a comprehensive review of the literature regarding animal models of dengue infection was recently published by zompi et al. 98 several laboratory mouse strains including a/j, balb/c, and c57bl/6 are permissive to dengue infection. however, the resulting disease has little resemblance to human clinical signs, and death results from paralysis. [99] [100] [101] a higher dose of an adapted dengue virus strain induced dhf symptoms in both balb/c and c57bl/6. 102, 103 this model can also yield asymptomatic infections. a mouse-adapted (ma) strain of dengue virus 2 introduced into ag129 mice developed vascular leak syndrome similar to the severe disease seen in humans. 104 passive transfer of monoclonal dengue antibodies within mice leads to ade. during the course of infection, viremia was increased, and animals died due to vascular leak syndrome. 105 another ma strain injected into balb/c caused liver damage, hemorrhagic manifestations, and vascular permeability. 103 intracranial injection of suckling mice with dengue virus leads to death and has been used to test the efficacy of therapeutics. 106 scid mice engrafted with human tumor cells develop paralysis upon infection, and are thus not useful for pathogenesis studies. 107,108 df symptoms developed after infection in nod/scid/il2rgko mice engrafted with cd34 ã¾ human progenitor cells. 109 rag-hu mice developed fever, but no other symptoms upon infection with a passaged clinical isolate and laboratory-adapted strain of dengue virus 2. 110 a passaged clinical isolate of dengue virus type 3 was recently used to create a model in immunocompetent adult mice. interperitoneal injection in c57bl/6j and balb/c caused lethality by day 6-7 postinfection in a dose-dependent manner. the first indication of infection was weight loss beginning on day 4 followed by thrombocytopenia. a drop in systolic blood pressure along with noted increases in the liver enzymes, aspartate aminotransferase (ast) and alt, were also observed. viremia was established by day 5. this model mimicked the characteristic symptoms observed in human dhf/dss cases. 111 a novel model was developed that used infected mosquitoes as the route of transmission to hu-nsg mice. female mosquitoes were intrathoracically inoculated with a clinical isolate of dengue virus type 2. infected mosquitoes then fed upon the mouse footpad to allow for the transmission of the virus via the natural route. the amount of virus detected within the mouse was directly proportional to the amount of mosquitoes it was exposed to, with four to five being optimal. detectable viral rna was in line with what is observed during human infection. severe thrombocytopenia developed on day 14. this model is intriguing given that disease was enhanced with mosquito delivery of the virus in comparison to injection of the virus. 112 nhp models have used a subcutaneous inoculation in an attempt to induce disease. although the animals are permissive to viral replication, it is to a lower degree than that observed in human infection. 113 the immunosuppressive drug, cyclophosphamide enhances infection in rhesus macaques by allowing the virus to invade monocytes. 114 throughout these preliminary studies, no clinical disease was detected. to circumvent this, a higher dose of dengue virus was used in an iv challenge of rhesus macaques. hemorrhagic manifestations appeared by day 3 and resulted in petechiae, hematomas, and coagulopathy; however, no other symptoms developed. 115 further development would allow this model to be used for testing of novel therapeutics and vaccines. although primates do not develop disease upon infection with dengue, their immune system does produce antibodies similar to those observed during the course of human infection. this has been advantageous in studying ade. sequential infection led to a crossreactive antibody response, which has been demonstrated in both humans and mice. 116 this phenotype can also be seen upon passive transfer of a monoclonal antibody to dengue and subsequent infection with the virus. rhesus macaques exposed in this manner developed viremia that was 3-to 100-fold higher than was previously reported; however, no clinical signs were apparent. 117 the lack of inducible dhf or dss symptoms hinders further examination of pathogenesis within this model. japanese encephalitis virus ( jev) is a leading cause of childhood viral encephalitis in southern and eastern asia and is a problem among military personnel and travelers to these regions. it was first isolated from the brain of a patient who died from encephalitis in japan in 1935. 118 culex mosquitoes, which breed in rice fields, transmit the virus from birds or mammals (mostly domestic pigs) to humans. the disease symptoms range from a mild febrile illness to acute meningomyeloencephalitis. after an asymptomatic incubation period of 1-2 weeks, patients show signs of fever, headache, stupor, and generalized motor seizures, especially in children. the virus causes encephalitis by invading and destroying the cortical neurons. the fatality rate ranges from 10% to 50%, and most survivors have neurological and psychiatric sequelae. 119, 120 jev virus causes fatality in infant mice by all routes of inoculation. differences in pathogenesis and outcome are seen when the virus is given by intraperitoneal inoculation. 121 these differences depend on the amount of virus and the specific viral strains used. the biphasic viral multiplication after peripheral inoculation is observed in mice tissues. primary virus replication occurs in the peripheral tissues and the secondary replication phase in the brain. 122 hamsters are another small animal species that are used as an animal model for jev. fatality was observed in hamsters inoculated intracerebrally or intranasally, while peripheral inoculation caused asymptomatic viremia. studies with rabbits and guinea pigs showed that all routes of inoculation of jev produce asymptomatic infection. 123 serial sampling studies with 12-day-old wistar rats inoculated intracerebrally with jev indicated that jev causes the overproduction of free radicals by neurons and apoptosis of neuronal cells. 124 following a study in 2010 by the same group, showed that although cytokines tumor necrosis factor (tnf)-a, ifn-g, il-4, il-6, il-10, and chemokine mcp-1 increased gradually and peaked on days 10 pi with jevin rats, the levels eventually declined, and there was no correlation with the levels of cytokines and chemokines and neuronal damage. 125 intracerebral inoculation of jev causes severe histopathological changes in brain hemispheres of rhesus monkeys. symptoms such as weakness, tremors, and convulsions began to appear on days 6-10, with indicative signs of encephalomyelitis occurring on days 8-12 postinfection for most of the animals followed by death occurring on days 8-12 postinfection for most of the animals followed by death. 126 although intranasal inoculation of jev results in fatality in both rhesus and cynomolgus monkeys, peripheral inoculation causes asymptomatic viremia in these species. 123, 127 west nile virus west nile virus (wnv) was first isolated from the blood of a woman in the west nile district of uganda in 1937. 128 after the initial isolation of wnv, the virus was subsequently isolated from patients, birds, and mosquitoes in egypt in the early 1950s 129, 130 and was shown to cause encephalitis in humans and horses. wnv is recognized as the most widespread of the flaviviruses, with a geographical distribution that includes africa, the middle east, western asia, europe, and australia. 131 the virus first reached the western hemisphere in the summer of 1999, during an outbreak involving humans, horses, and birds in the new york city metropolitan area. 132, 133 since 1999, the range of areas affected by wnv quickly extended. older people and children are most susceptible to wnv disease. wnv generally causes asymptomatic disease or a mild undifferentiated fever (west nile fever), which can last from 3 to 6 days. 134 the mortality rate after neuroinvasive disease ranges from 4% to 11%. 131, [135] [136] [137] the most severe complications are commonly seen in the elderly, with reported case fatality rates from 4% to 11%. hepatitis, myocarditis, and pancreatitis are unusual, severe, nonneurologic manifestations of wnv infection. although many early laboratory studies of wn encephalitis were performed in nhps, mice, rat, hamster, horse, pig, dog, and cat models were used to study the disease. [138] [139] [140] [141] [142] [143] [144] inoculation of wnv into nhps intracerebrally resulted in the development of either encephalitis, febrile disease, or an asymptomatic infection, depending on the virus strain and dose. viral persistence is observed in these animals regardless of the outcome of infection (i.e. asymptomatic, fever, encephalitis). 141 thus, viral persistence is regarded as a typical result of nhp infection with various wnv strains. after both intracerebral and subcutaneous inoculation, the virus localizes predominantly in the brain and may also be found in the kidneys, spleen, and lymph nodes. wnv does not result in clinical disease in nhps although the animals show a low level of viremia. 145, 146 wnv has also been extensively studied in small animals. all classical laboratory mouse strains are susceptible to lethal infections by the intracerebral and intraperitoneal routes, resulting in encephalitis and 100% mortality. intradermal route pathogenesis studies indicated that langerhans dentritic cells are the initial viral replication sites in the skin. 147, 148 the infected langerhans cells then migrate to lymph nodes, and the virus enters the blood through lymphatic and thoracic ducts and disseminates to peripheral tissues for secondary viral replication. virus eventually travels to the cns and causes pathology that is similar to human cases. [149] [150] [151] [152] tesh et al. developed a model for wn encephalitis using the golden hamster, mesocricetus auratus. hamsters appeared normal during the first 5 days, became lethargic at approximately day 6, and developed neurologic symptoms by days 7-10. 143 many of the severely affected animals died 7-14 days after infection. viremia was detected in the hamsters within 24 h after infection and persisted for 5-6 days. although there were no substantial changes in internal organs, progressive pathologic differences were seen in the brain and spinal cord of infected animals. furthermore, similar to the above-mentioned monkey experiments by pogodina et al., persistent wnv infection was found in the brains of hamsters. the etiologic agent of severe acute respiratory syndrome (sars), sars-coronavirus (cov), emerged in 2002 as it spread throughout 32 countries in a period of 6 months, infecting >8000 people and causing nearly 800 deaths. 153, 154 the main mechanism of transmission of sars-cov is through droplet spread, but it is also viable in dry form on surfaces for up to 6 days and can be detected in stool, suggesting other modes of transmission are also possible. 155 although other members of the family usually cause mild illness, sars-cov infection has a 10% case fatality with the majority of cases in people over the age of 15 years. 156, 157 after an incubation period of 2-10 days, clinical signs of sars include general malaise, fever, chills, diarrhea, dyspnea, and cough. 158 in some sars, cases, pneumonia may develop and progress to acute respiratory distress syndrome (ards). fever usually dissipates within 2 weeks and coincides with the induction of high levels of neutralizing antibodies. 159 in humans, sars-cov replication destroys respiratory epithelium, and a great deal of the pathogenesis is due to the subsequent immune responses. 160 infiltrates persisting within the lung and diffuse alveolar damage (dad) are common sequelae of sars-cov infection. virus can be isolated from secretions of the upper airways during early, but not later stages of infection as well as from other tissues. 161 sars-cov can replicate in many species, including dogs, cats, pigs, mice, rats, ferrets, foxes, and nhps. 162 chinese palm civets, raccoon dogs, and bats are possible natural hosts. no model captures all aspects of human clinical disease (pyrexia and respiratory signs), mortality (w10%), viral replication, and pathology. 163 in general, the sars-cov disease course in the model species is much milder and of shorter duration than in humans. viral replication in the various animal models may occur without clinical illness and/or histopathologic changes. the best-characterized models use mice, hamsters, ferrets, and nhps (table 38 .1). mouse models of sars-cov typically are inoculated by the intranasal route under light anesthesia. young, 6-to 8-week old balb/c mice exposed to sars-cov have viral replication detected in the lungs and nasal turbinates, with a peak on day 2 and clearance by day 5 postexposure. there is also viral replication within the small intestines of young balb/c mice. however, young mice have no clinical signs, aside from reduced weight gain, and have little to no inflammation within the lungs (pneumonitis). intranasal sars-cov infection of c57bl/6 (b6) also yield reduced weight gain and viral replication in the lungs, with a peak on day 3 and clearance by day 9. 171 in contrast, balb/c mice 13-14 interstitial pneumonitis, alveolar damage, and death also occur in old mice, resembling the age-dependent virulence observed in humans. 129s mice and b6 mice show outcomes to sars-covinfection similar to those observed for balb/c mice but have lower titers and less prolonged disease. one problem is that it is more difficult to obtain large numbers of mice older than 1 year. a number of immunocompromised knockout mouse models of intranasal sars-cov infection have also been developed. 129svev mice infected with sars-cov by the intranasal route develop bronchiolitis, with peribronchiolar inflammatory infiltrates, and interstitial inflammation in adjacent alveolar septae. 172 viral replication and disease in these mice resolve by day 14 postexposure beige, cd1ã�/ã�, and rag1ã�/ã� mice infected with sars-cov have similar outcomes to infected balb/c mice with regard to viral replication, timing of viral clearance, and a lack of clinical signs. signal transducer and activator of transcription-1 (stat1) ko mice infected intranasally with sars-cov have severe disease, with weight loss, pneumonitis, interstitial pneumonia, and some deaths. the stat1 ko mouse model is therefore useful for studies of pathogenicity, pathology, and evaluation of vaccines. syrian golden hamsters (strain lvg) are also susceptible to intranasal exposure of sars-cov. after the administration of 10 3 tcid 50 (tissue culture infective dose), along with a period of transient viremia, sars-cov replicates in nasal turbinates and lungs, resulting in pneumonitis. there are no obvious signs of disease, but exercise wheels can be used to monitor decrease in nighttime activity. some mortality has been observed, but it was not dose dependent and could have more to do with genetic differences between animals because the strain is not inbred. 163 damage is not observed in the liver or spleen despite detection of virus within these tissues. several studies have shown that intratracheal inoculation of sars-cov in anesthetized ferrets (mustela furo) results in lethargy, fever, sneezing, and nasal discharge. 167 clinical disease has been observed in several studies. sars-cov is detected in pharyngeal swabs, trachea, tracheobronchial lymph nodes, and high titers within the lungs. mortality has been observed around day 4 postexposure as well as mild alveolar damage in 5-10% of the lungs, occasionally accompanied by severe pathology within the lungs. 173 with fever, overt respiratory signs, lung damage, and some mortality, the ferret intratracheal model of sars-cov infection is perhaps most similar to human sars, albeit with a shorter time course. sars-cov infection of nhps by intransal or intratracheal routes generally results in a very mild infection, which resolves quickly. sars-cov infection of old world monkeys, such as rhesus macaques, cynomolgus macaques (cynos), and african green monkeys (agms) have been studied with variable results, possibly due to the outbred nature of the groups studied or previous exposure to related pathogens. clinical illness and viral loads have not been consistent; however, replication within the lungs and dad are features of the infections for each of the primate species. some cynos have no illness, but others have rash, lethargy, and respiratory signs and pathology. 170 rhesus have little to no disease and only have mild findings upon histopathological analysis. agms infected with sars-cov have no overt clinical signs, but dad and pneumonitis have been documented. viral replication has been detected for up to 10 days in the lungs of agms; however, the infection resolves and does not progress to fatal ards. farmed chinese masked palm civets, sold in open markets in china, were thought to be involved in the sars-covoutbreak. intratracheal and intranasal inoculation of civets with sars-covresults in lethargy, decreased aggressiveness fever, diarrhea, and conjunctivitis. 174 leucopenia, pneumonitis, and alveolar septal enlargement, with lesions similar to those observed in ferrets and nhps, have also been observed in laboratory-infected civets. common marmosets have also been shown to be susceptible to sars-cov infection. 175 vaccines have been developed for related animal covs in chickens, cattle, dogs, cats, and swine have used live-attenuated, killed, dna and viral-vectored vaccine strategies. 176 an important issue to highlight from work on these vaccines is that cov vaccines, such as those developed for cats, may induce a more severe disease. 177 as such, immune mice had th2-type immunopathology upon sars-cov challenge. 178 severe hepatitis in vaccinated ferrets with antibody enhancement in liver has been reported. 179 additionally, rechallenge of agms showed limited viral replication but significant lung inflammation, including alveolitis and interstitial pneumonia, which persisted for long periods of time after viral clearance. 180 mouse and nhp models with increased virulence may be developed by adapting the virus by repeated passage within the species of interest. ma sars and human ace2 transgenic mice are available. 181 all mammals experimentally or naturally exposed to rabies virus have been found to be susceptible. this highly neurotropic virus is a member of the lyssavirus genus and is transmitted from the bite of an infected animal to humans. 182 the virus is able to replicate within the muscle cells at the site of the bite, and then travel to the cns. once reaching the cns by retrograde axonal transport, the virus replicates within neurons creating inflammation and necrosis. the virus subsequently spreads throughout the body via peripheral nerves. 183 a typical incubation period is 30-90 days, and is highly dependent upon the location of the bite. proximity to the brain is a major factor for the onset of symptoms. the prodromal stage lasts from 2 to 10 days and is when the virus initially invades the cns. flu-like symptoms are the norm in conjunction with pain and inflammation at the site of the bite. subsequently, there are two forms of disease that can develop. in 80% of cases, an individual develops the encephalitic or furious form. this form is marked by hyperexcitability, autonomic dysfunction, and hydrophobia. the paralytic, or dumb form, is characterized by ascending paralysis. ultimately, both forms result in death days after the onset of symptoms. once the symptoms develop, there is no proven effective therapy. in the developing world, death is caused by the lack of access to medical care including postexposure prophylaxis. in na, fatal cases result because of late diagnosis. 184 syrian hamsters have been challenged with rabies virus intracerebrally, intraperitoneally, intradermally, and intranasally. all animals died as a result of the exposure, although intracerebral and intranasal inoculation led to only the furious form depicted by extreme irritability, spasms, excessive salivation, and cries. the virus used had been isolated from an infected dog brain and passaged in swiss albino mice. animals inoculated by intracerebral injection develop disease within 4-6 days, whereas all other routes of entry develop disease within 6-12 days. 185 this model has been used to study and test novel vaccine candidates. 186 mice have been extensively studied as an animal model for rabies. it was shown that swiss albino mice intracerebrally injected with a virus isolated from a dog developed only the paralytic form of disease 6 days after the initial challenge. balb/c mice are universally susceptible to intracerebral injection of rabies virus within 9 days. disease symptoms include paralysis, cachexia, and bristling appearing 1-3 days before death. 187 a more natural route of infection via peripheral injection into masseter muscles was tested on icr mice. these mice developed neurological signs including limb paralysis, and all died within 6-12 days. 188 icr mice have been instrumental in analyzing novel vaccines and correlates of protection. 189 this line of mice was also used to assess the value of ketamine treatment to induce coma during rabies infection. 190 another mouse line used is the p75 neurotrophin receptor-deficient mouse. this mouse developed a fatal encephalitis when inoculated intracerebrally with the challenge virus standard. 191 bax-deficient mice have also been used to determine the role of apoptotic cell death in the brain during the course of infection. 192 a viral isolate from silver-haired bats can also be used in the mouse model. this strain is advantageous given that it is responsible for the majority of deaths in north na. 193 early death phenomenon is typified by a decrease to time of death in a subset of individuals and animals that have been vaccinated and subsequently exposed to rabies. 194 this trend has been demonstrated experimentally in swiss outbred mice and primates. 195, 196 cynomolgus and rhesus were both infected with passaged rabies virus to create an nhp model. a high titer of virus was needed to induce disease, but exposure was found to not be universally fatal. the animals that survived beyond 4 weeks within the experiment did not develop clinical disease nor succumb to infection. primates that did develop disease refused food and had progressively less activity until death. this lasted from 24 h up to 4 days, with all animals with symptoms dying within 2 weeks. 196 bats have been experimentally challenged with rabies. vampire bats, desmodus rotundus, intramuscularly injected with a bat viral isolate displayed clinical signs including paralysis in half of the population of the study animals. of those who did develop disease, the duration was 2 days, and incubation period ranged from 7 to 30 days. regardless of disease manifestation, 89% of challenged animals died. 197 skunks can be challenged intramuscularly or intranasally with either challenge virus strain or a skunk viral isolate. interestingly, the challenge virus strain more readily produced the paralytic form, whereas the street form of rabies developed into the furious form. however, the challenge strain virus resulted in a shorter incubation period of 7-8 days in comparison to 12-14 days seen with the street virus. 198 filoviridae consists of two well-established genera, ebola virus and marburg virus (marv) and a newly discovered group, cuevavirus 199 (table 38 200 two other ebola viruses are known; ta㯠forest (tafv; previously named cote (circumflex over the 'o') d'ivoire) (ciebov) and reston (restv), which have not caused major outbreaks or lethal disease in humans. the disease in humans is characterized by aberrant innate immunity and a number of clinical symptoms such as fever, nausea, vomiting, arthralgia/myalgia, headaches, sore throat, diarrhea, abdominal pain, anorexia, and numerous others. 201 approximately 10% of patients develop petechia and a greater percentage, depending on the specific strain, may develop bleeding from various sites (gums, puncture sites, stools, etc.). 199 natural transmission in an epidemic is thought to be through direct contact or needle sticks in hospital settings. however, much of the research interest in filoviruses primarily stems from biodefense needs, particularly from aerosol biothreats. as such, intramuscular, intraperitoneal, and aerosol models have been developed in mice, hamsters, guinea pigs, and nhps for the study of pathogenesis, correlates of immunity, and for testing countermeasures. 202 because filoviruses have such high lethality rates in humans, scientists have looked for models that are uniformly lethal to stringently test efficacy of candidate vaccines and therapeutics. immunocompetent mice have not been successfully infected with wild-type filoviruses due to the control of the infection by the murine type 1 ifn response. 203 however, wild-type inbred mice are susceptible to filovirus that has been ma by serial passage. 204 balb/c mice, which are the strain of choice for intraperitoneal inoculation of ma-ebov, are not susceptible by the aerosol route. 205 for aerosol infection of immunocompetent mice, a panel of bxd (balb/ c ã� dba) recombinant inbred strains were screened, and one strain, bxd34, was shown to be particularly susceptible to airborne ma-ebov, with 100% lethality to low or high doses (w100 or 1000 pfu). these mice developed weight loss of >15% and succumbed to infection between days 7 and 8 postexposure. the aerosol infection model uses a whole-body exposure chamber to expose mice aged 6-8 weeks to ma-ebov aerosols with a mass median aerodynamic diameter (mmad) of approximately 1.6 mm and a geometric standard deviation of approximately 2.0 for 10 min. another approach uses immunodeficient mouse strains such as scid, stat1 ko, ifn receptor ko, or perforin ko with a wild-type ebov inoculum by intraperitoneal or aerosol routes. 206 mice are typically monitored for clinical disease "scores" based on activity and appearance, weight loss, and moribund condition (survival). coagulopathy, a hallmark of filovirus infection in humans, has been observed, with bleeding in a subset of animals and failure of blood samples to coagulate late in infection. liver, kidney, spleen, and lung tissue taken from moribund mice have pathology characteristic of filovirus disease in nhps. although most mouse studies have used ma-ebov or ebov, an intraperitoneal ma marv model is also available. 207 ma-marv and ma-ebov models are particularly useful for screening novel antiviral compounds. 208 hamsters are frequently used to study cardiovascular disease, coagulation disorders, and thus serve as the basis for numerous viral hemorrhagic fever models. 209 an intraperitoneal ma-ebov infection model has been developed in syrian hamsters. 210 this model, which has been used to test a vesicular stomatitis virus vectored vaccine approach, uses male 5-to 6-week-old syrian hamsters that are infected with 100 ld50 of ma-ebov. virus is present in tissues and blood collected on day 4, and all animals succumbed to the disease by day 6. detailed accounts of this model have been presented at international scientific meetings by ebihara and feldmann et al. but have not been reported in a scientific journal at the time of writing this chapter. 211 guinea pig models of filovirus infection have been developed for intraperitoneal and aerosol routes using guinea pig-adapted ebov (gp-ebov) and marv (gp-marv). 212, 213 guinea pigs models of filovirus infection are quite useful in that they develop fever, which can be monitored at frequent (hourly) intervals by telemetry. additionally, the animals are large enough for regular blood sampling in which measurable coagulation defects are observed as the infection progresses. hartley guinea pigs exposed to aerosolized gp-marv or gp-ebov become moribund at times comparable to that of nhps, generally succumbing to the infection between 7 and 12 days postexposure. by aerosol exposure, gp-ebov is uniformly lethal at both high and low doses (100 or 1000 pfu target doses) but lethality drops with low (<1000 pfu) presented doses of airborne gp-marv, and more protracted disease is seen in some animals. 213 weight loss of between 15% and 25% is a common finding in guinea pigs exposed to gp-ebov or gp-marv. fever, which becomes apparent by day 5, occurs more rapidly in gp-ebov exposed guinea pigs than with gp-marv exposure. lymphocytes and neutrophils increase during the earlier part of the disease, and platelet levels steadily drop as the disease progresses. increases in coagulation time can be seen as early as day 6 postexposure. blood chemistries (i.e. alt, ast, alkaline phosphatase (alkp), and blood urea nitrogen) indicating problems with liver and kidney function are also altered late in the disease course. nhp models of filovirus infection are the preferred models for more advanced disease characterization and testing of countermeasures because they most closely mimic the disease and immune correlates seen in humans. 214 old world primates have been primarily used for the development of intraperitoneal, intramuscular, and aerosol models of filovirus infection. uniformly lethal filovirus models have been developed for most of the virus strains in cynomolgus macaques, rhesus macaques, and to a lesser degree, in agms and marmosets. [215] [216] [217] [218] [219] low-passage human isolates that have not been passaged in animals have been sought for development of nhp models to satisfy the food and drug administration (fda) animal rule. prominent features of the infections are onset of fever by day 5 postexposure, alteration in liver function enzymes (alt, ast, and alkp), decrease in platelets, and increased coagulation times. clinical disease parameters may have a slightly delayed onset in aerosol models. petichial rash is a common sign of filovirus disease and may be more frequently observed in cynomolgus macaques than in other nhp species. dyspnea late in infection is a prominent feature of disease after aerosol exposure. a number of pronounced pathology findings include multifocal necrosis and fibrin lesions, particularly within the liver and the spleen. lymphocytolysis and lymphoid depletion are also observed. multilead, surgically implanted telemetry devices are useful in the continuous collection of temperature, blood pressure, heart rate, and activity levels. as such, blood pressure drops as animals become moribund and heart rate variability (standard deviation of the heart rate) is altered late in infection. the most recently developed telemetry devices can aid in plethysomography to measure respiratory minute volume for accurate delivery of presented doses for aerosol exposure. hendra and nipah virus are unusual within the paramyxoviridae family given that they can infect a large range of mammalian hosts. both viruses are grouped under the genus henipavirus. the natural reservoirs of the viruses are the fruit bats from the genus pteropus. hendra and nipah have the ability to cause severe disease in humans with the potential for a high case fatality rate. 220 outbreaks caused by nipah virus have been recognized in malaysia, singapore, bangladesh, and india, while hendra outbreaks have yet to be reported outside of australia. 221, 222 hendra was the first member of the genus to be identified and was initially associated with an acute respiratory disease in horses. all human cases have been linked to transmission through close contact with an infected horse. there have been no confirmed cases of direct transmission from human to human or bat to human. nipah has the distinction of being able to be transmitted by humans, although the exact route is unknown. 223 the virus is susceptible to ph, temperature, and desiccation, and thus close contact is hypothesized to be needed for successful transmission. 224 both viruses have a tropism for the neurological and respiratory tract. hendra virus incubation period is 7-17 days and is marked by a flu-like illness. symptoms at this initial stage include myalgia, headache, lethargy, sore throat, and vomiting. 225 disease progression can continue to pneumonitis or encephalitic manifestations, with the person succumbing to multiorgan failure. 226 nipah virus has an incubation period of 4 days to 2 weeks. 227 much like hendra, the first signs of disease are nondescript. severe neurological symptoms subsequently develop including encephalitis and seizures that can progress to coma within 24-48 h. 228 survivors of infection typically make a full recovery; however, 22% suffer permanent sequelae, including persistent convulsions. 229 at this time, there is no approved vaccine or antiviral, and treatment is purely supportive. animal models are being used to not only test novel vaccines and therapeutics, but also deduce the early events of disease because observed human cases are all at terminal stages. the best small animal representative is the syrian golden hamster due to their high susceptibility to both henipaviruses. clinical signs upon infection recapitulate the disease course in humans including acute encephalitis and respiratory distress. challenged animals died xi. viral disease 38 . in vivo models of viral diseases affecting humans within 4-17 days postinfection. the progression of disease and timeline are highly dependent on dose and route of infection. intranasal inoculation leads to imbalance, limb paralysis, lethargy, and breathing difficulties whereas intraperitoneal resulted in tremors and paralysis within 24 h before death. virus was detected in lung, brain, spleen, kidney, heart, spinal cords, and urine, while the brain was the most affected organ. this model has been used for vaccination and passive protection studies. [230] [231] [232] the guinea pig model has not been widely used due to the lack of a respiratory disease upon challenge. 233, 234 inoculation with hendra virus via the subcutaneous route leads to a generalized vascular disease with 20% mortality. clinical signs were apparent 7-16 days postinfection with death occurring within 2 days of cns involvement. higher inocula have been associated with the development of encephalitis lesions. intradermal and intranasal injections do not lead to disease, although the animals are able to seroconvert upon challenge. inoculum source does not affect clinical progression. nipah virus challenge only develops disease upon intraperitoneal injection and results in weight loss and transient fever for 5-7 days. virus was shed through urine and found to be present in the brain, spleen, lymph nodes, ovary, uterus, and urinary bladder. 235 ferrets display the same clinical disease as seen in the hamster model and human cases. 236, 237 upon inoculation by the oronasal route, ferrets develop severe pulmonary and neurological disease within 6-9 days including fever, coughing, and dyspnea. lesions do develop in the ferrets' brains, but to a lesser degree than seen in humans. cats have also been used as an animal model for henipaviruses. disease symptoms are not dependent upon the route of infection. the incubation period is 4-8 days and leads to respiratory and neurological symptoms. 238, 239 this model has proven to be useful in a vaccine challenge model. squirrel and agms are representative of the nhp models. within the squirrel monkeys, nipah virus is introduced by either the intranasal or iv route and subsequently leads to clinical signs similar to that in humans, although intranasal challenge results in milder disease. upon challenge, only 50% animals develop disease manifestations including anorexia, dyspnea, and acute respiratory syndrome. neurological involvement is characterized by uncoordinated motor skills, loss of consciousness, and coma. viral rna can be detected in the lung, brain, liver, kidney, spleen, and lymph nodes but is only found upon iv challenge. 240 agms have been found to be a very consistent model of both viruses. intratracheal inoculation of the viruses results in 100% mortality, and death within 8.5 and 9-12 days postinfection for hendra and nipah, respectively. the animals develop severe respiratory and neurological disease with generalized vasculitis. 241, 242 the reservoir of the viruses, gray-headed fruit bats, has been experimentally challenged. due to their status as the host organism for henipaviruses, the bats do not develop clinical disease. however, hendra virus can be detected in kidneys, heart, spleen, and fetal tissue and nipah virus can be located in urine. 243 pigs have been investigated as a model as they develop a respiratory disease upon infection with both nipah and hendra. [244] [245] [246] oral inoculation does not produce a clinical disease, but subcutaneous injection represents a successful route of infection. live virus can be isolated from the oropharynx as early as 4 days postinfection. nipah can also be transmitted between pigs. nipah was able to induce neurological symptoms in 20% of the pigs, even though virus was present in all neurological tissues regardless of symptoms. 247 within the pig model, it seemed that nipah had a greater tropism for the respiratory tract, while hendra for the neurological system. horses also are able to develop a severe respiratory tract infection accompanied with fever and general weakness upon exposure to nipah and hendra. oronasal inoculation led to systemic disease with viral rna detected in nasal swabs within 2 days. 248, 249 animals died within 4 days postexposure and were found to have interstitial pneumonia with necrosis of alveoli. 250, 251 virus could be detected in all major systems. mice, rats, rabbits, chickens, and dogs have been tested but found to be nonpermissive to infection. 232, 252 suckling balb/c mice succumb to infection if the virus is inoculated intracranially. 253 embryonated chicken eggs have been inoculated with nipah virus leading to a universally fatal disease within 4-5 days postinfection. 254 respiratory syncytial virus is responsible for lower respiratory tract infections of 33 million children under the age of 5 years, which in turn results in three million hospitalizations and approximately 200,000 deaths. 255 within the united states, hospital costs alone amount to >600 million dollars. 256 outbreaks are common in the winter. 257 the virus is transmitted by large respiratory droplets that replicate initially within the nasopharynx and further spreads to the lower respiratory tract. incubation for the virus is 2-8 days. respiratory syncytial virus is highly virulent leading to very few asymptomatic infections. 258 disease manifestations are highly dependent upon the age of the individual. primary infections in neonates produce nonspecific symptoms including the overall failure to thrive, apnea, and feeding difficulties. infants present with a mild upper respiratory tract disease that could develop into bronchiolitis and bronchopneumonia. contracting the virus at this age results in an increased chance of developing childhood asthma. 259 young children develop recurrent wheezing, whereas adults exacerbate previous respiratory conditions. 260 common clinical symptoms are runny nose, sneezing, and coughing accompanied with fever. mortality rates in hospitalized children are 1-3% with the greatest burden of disease seen in 3-4-month-olds. 261 there is no vaccine available, and ribavirin usage is not recommended for routine treatment. 262 animal models were developed in the hopes of formulating an effective and safe vaccine unlike the formalin-inactivated respiratory syncytial virus vaccine (fi-rsv). this vaccineinduced severe respiratory illness in infants who received the vaccine and were subsequently infected with live virus. 263 mice can be used to model disease, although a very high intranasal inoculation is needed to achieve clinical symptoms. 264, 265 strain choice is crucial to reproducing a physiological relevant response. 266 age does not affect primary disease manifestations. 267 however, it does play a role in later sequelae showing increased airway hyperreactivity. 268 primary infection produces increased breathing with airway obstruction. 264, 269 virus was detected as early as day 3 and reached maximum titer at day 6 postinfection. clinical illness is defined in the mouse by weight loss and ruffled fur as opposed to runny nose, sneezing, and coughing as seen in humans. cotton rats are useful given that it is a small animal disease model. the virus is able to replicate to high titers within the lungs and can be detected in both the upper and lower airways after intranasal inoculation. 270, 271 it has been reported that viral replication is 50-to 1000-fold greater in the rat model than in the mouse model. 272 the rats develop mild-to-moderate bronchiolitis or pneumonia. 273 although age does not seem to factor in clinical outcome, it has been reported that older rats tend to take longer to achieve viral clearance. viral loads peak by the fifth day, dropping to below the levels of detection by 8. the histopathology of the lungs seems to be similar to that in humans after infection. 274 this model has limited usage in modeling the human immune response to infection as challenge with the virus creates a th2 response, whereas humans tend to skew toward th1. [275] [276] [277] fi-rsv disease was recapitulated upon challenge with live virus after being vaccinated twice with fi-rsv. chinchillas have been challenged experimentally via intranasal inoculation. the virus was permissive within the nasopharynx and eustachian tube. the animals displayed an acute respiratory tract infection. this model is thought to be useful in studying mucosal immunity during infection. 278 chimpanzees are permissive to replication and clinical symptoms of respiratory syncytial virus including rhinorrhea, sneezing, and coughing. adult squirrel monkeys, newborn rhesus macaques, and infant cebus monkeys were also challenged but did not exhibit any disease symptoms nor high levels of viral replication. 279 bonnet monkeys were also tested and found to develop an inflammatory response by day 7 with viral rna detected in both bronchial and alveolar cells. 280 the chimpanzee model has proven to be useful for vaccine studies. 281, 282 sheep have also been challenged experimentally since they develop respiratory disease when exposed to ovine respiratory syncytial virus. 283 lambs were also found to be susceptible to human respiratory syncytial infection. 284, 285 when inoculated intratracheally, the lambs developed an upper respiratory tract infection with cough after 6 days. some lambs went on to develop lower respiratory disease including bronchiolitis. the pneumonia resolved itself within 14 days. during the course of disease, viral replication peaked at 6 days, and rapidly declined. studying respiratory disease in sheep is beneficial given the shared structural features between them and humans. 286, 287 the influenza viruses consist of three types: influenza a, b, and c, based on antigenic differences. influenza a is further classified by subtypes; 16 ha and 9 na subtypes are known. seasonal influenza is the most common infection and usually causes a self-limited febrile illness with upper respiratory symptoms and malaise that resolves within 10 days. 288 the rate of infection is estimated at 10% in the general population and can result in billions of dollars of loss annually from medical costs and reduced work-force productivity. approximately 40,000 people in the united states die each year from seasonal influenza. 289 thus, vaccines and therapeutics play a critical role in controlling infection, and development using animal models is ongoing. 290 influenza virus replicates in the upper and lower airways, peaking at approximately 48 h postexposure. infection can be more severe in infants and in children under the age of 22 years, people over the age of 65 years, or immunocompromised individuals in whom viral pneumonitis or pneumonia can develop or bacterial superinfection resulting in pneumonia or sepsis. 291 pneumonia from secondary bacterial infection, such as streptococcus pneumonia, streptococcus pyrogenes, and neisseria meningitides, and more rarely, staphylococcus aureus, is more common than viral pneumonia from the influenza itself, accounting for approximately 27% of all influenza-associated fatalities. 292 death, often due to ards can occur as early as 2 days after the onset of symptoms. lung histopathology in severe cases may include dad, alveolar edema and damage, hemorrhage, fibrosis, and inflammation. 288 the h5n1 avian strain of influenza has lethality rates of approximately 60% (of known cases), likely because the virus preferentially binds to the cells of the lower respiratory tract, and thus, the potential for global spread is a major concern. 293 the most frequently used animal models of influenza infection include mice, ferrets, and nhps. a very thorough guide to working with mouse, guinea pig, ferret, and cynomolgus models was published by kroeze et al. 294 lethality rate can vary with the virus strain used (with or without adaptation), dose, route of inoculation, age, and genetic background of the animal. the various animal models can capture differing diseases caused by influenza: benign, severe, superinfection and sepsis, severe with ards, and neurologic manifestations. 290 also, models can use seasonal or avian strains and models have been developed to study transmission, important for understanding the potential for more lethal strains such as h5n1 for spreading among humans. mouse models of influenza infection are very predictive for antiviral activity and tissue tropism in humans, and are useful in testing and evaluating vaccines. 295 inoculation is by the intranasal route, using approximately 60 ml of inoculum in each nare of anesthetized mice. exposure may also be to small particle aerosols containing influenza with an mmad of <5 mm. most inbred strains are susceptible, with particularly frequent use of balb/c followed by c57bl/6j mice. males and females have equivalent disease, but influenza is generally more infectious in younger 2-to 4-week-old (8-10 g) mice. mice are of somewhat limited use in characterizing the immune response to influenza. mice lack the mxa gene, which is an important part of the human innate immune response to influenza infection. the mouse homolog to mxa, mx1, is defective in most inbred mouse strains. 296 weight loss or reduced weight gain, decreased activity, huddling, ruffled fur, and increased respiration are the most common clinical signs. for more virulent strains, mice may require euthanasia as early as 48 h postexposure, but most mortality occurs from 5 to 12 days postexposure accompanied by decreases in rectal temperature. 297 pulse oximeter readings and measurement of blood gases of oxygen saturation are also used to determine the impact of influenza infection on respiratory function. 298 virus can be isolated from bronchial lavage fluids throughout the infection and from tissues after euthanasia. for influenza strains with mild-tomoderate pathogenicity, disease is nonlethal and virus replication is detected within the lungs, but usually not other organs. increases in serum alpha-1-acidglycoprotein and lung weight are also frequently present. however, mice infected with influenza do not develop fever, dyspnea, nasal exudates, sneezing, or coughing. mice can be experimentally infected with influenza a or b, but the virus generally requires adaptation to produce clinical signs. mice express the receptors for influenza attachment in the respiratory tract; however, the distribution varies and sa 2,3 predominates over sa 2,6 which is why h1, h2, and h3 subtypes usually need to be adapted to mice and h5n1, h2, h6, and h7 viruses do not require adaptation. 299 to adapt, mice are infected intratracheally or intranasally by virus isolated from the lungs, and reinfected into mice and then the process is repeated a number of times. once adapted, influenza strains can produce severe disease, systemic spread, and neurotropism. however, h5n1 and the 1918 pandemic influenza virus can cause lethal infection without adaptation. 300 h5n1 infection of mice results in viremia and viral replication in multiple organ systems, severe lung pathology, fulminant diffuse interstitial pneumonia, pulmonary edema, high levels of proinflammatory cytokines, and marked lymphopenia. 301 as in humans, the virulence of h5n1 is attributable to damage caused by an overactive host immune response. additionally, mice infected with the 1918 h1n1 influenza produces severe lung pathology and oxygen saturation levels that decrease with increasing pneumonia. 302 in superinfection models, a sublethal dose of influenza is given to mice followed 7 days later by intranasal inoculation of a sublethal dose of a bacterial strain such as s. pneumoniae or s. pyrogenes. 303 morbidity, characterized by inflammation in the lungs, but not bacteremia, begins a couple of days after superinfection and may continue for up to 2 weeks. at least one transmission model has also been developed in mice. with h2n2 influenza, transmission rates of up to 60% among cage mates can be achieved after infection by the aerosol route and cocaging after 24 h. 304 domestic ferrets (mustela putorius furo) are frequently the animal species of choice for influenza animal studies because the susceptibility, clinical signs, peak virus shedding, kinetics of transmission, local expression of cytokine mrnas, and pathology resemble that of humans. [305] [306] [307] ferrets also have airway morphology, respiratory cell types, and a distribution of influenza receptors (sa 2,6 and sa 2,3) within the airways similar to that of humans. 308 influenza was first isolated from ferrets infected intranasally with throat washes from humans harboring the infection and ferret models have since been used to test efficacy of vaccines and therapeutic treatments. 309 when performing influenza studies in ferrets, animals should be serologically negative for circulating influenza viruses. infected animals should be placed in a separate room from uninfected animals. if animals must be placed in the same room, uninfected ferrets should be handled before infected ferrets. anesthetized ferrets are experimentally exposed to influenza by intranasal. inoculation of 0.25-0.5 ml containing approximately 10 4 -10 6 egg id50 dropwise to each nostril. influenza types a and b naturally infect ferrets, resulting in an acute illness, which usually lasts 3-5 days for mildly to moderately virulent strains. 310 ferrets are more susceptible to influenza a than to influenza b strains and are also susceptible to avian influenza h5n1 strains without adaptation. 311 virulence and degree of pneumonitis caused by different influenza subtypes and strains vary from mild to severe and generally mirror that seen in humans. nonadapted h1n1, h2n2, and h3n2 have mild-to-moderate virulence in ferrets. strains of low virulence have predominant replication in the nasal turbinates. clinical signs and other disease indicators are similar to that of humans with a mild respiratory disease, sneezing, nasal secretions containing virus, fever, weight loss, high viral titers, and inflammatory infiltrate in the airways, bronchitis, and pneumonia. 312 replication in both the upper and lower airways is associated with more severe disease and greater mortality. additionally, increased expression of proinflammatory mediators and reduced expression of antiinflammatory mediators in the lower respiratory tract ferrets correlates with severe disease and lethal outcome. h5n1-infected ferrets develop severe lethargy, greater ifn response, transient lymphopenia, and replication in respiratory tract, brain, and other organs. 313 old and new world primates are susceptible to influenza infection and have an advantage over ferret and mouse models, which are deficient for h5n1 vaccine studies because there is a lack of correlation with hemagglutination inhibition. 314 of old world primates, cynomolgus macaque (m. fascicularis) are most frequently used for studies of vaccines and antiviral drug therapies. 315, 316 h5n1 and h1n1 1918 infections of cynos are very similar to those in humans. 317 cynos develop fever and ards upon intranasal inoculation of h5n1 with necrotizing bronchial interstitial pneumonia 318 nhps are challenged by multiple routes (ocular, nasal, and tracheal) simultaneously 1 ã� 10 6 pfu per site. virus antigen is primarily localized to the tonsils and pulmonary tissues. infection of cynos with h5n1 results in fever, lethargy, nasal discharge, anorexia, weight loss, nasal and tracheal washes, pathologic and histopathologic changes, and alveolar and bronchial inflammation. the 1918 h1n1 caused a very high mortality rate due to an aberrant immune response and ards and had >50% lethality (humans only had a 1-3% lethality). ards and mortality also occur with the more pathogenic strains, but nhps show reduced susceptibility to less virulent strains such as h3n2. 299 influenzainfected rhesus macaques represent a mild disease model pathogenesis for vaccine and therapeutic efficacy studies. 319 other nhp models include influenza infection of pigtailed macaques as a mild disease model and infection of new world primates such as squirrel and cebus monkeys. 320 rats (f344 and sd) inoculated with rat-adapted h3n2 developed inflammatory infiltrates and cytokines in bronchoalveolar lavage fluids, but had no lethality and few histopathological changes. 321 additionally, an influenza transmission model has been developed in guinea pigs as an alternative to ferrets. 322 cotton rats (sigmodon hispidus) have been used to test vaccines and therapeutics in a limited number of studies. 323, 324 cotton rats have an advantage over mice in that the immune system is similar to humans (including the presence of the mx gene) and influenza viruses do not have to be adapted. 325, 326 nasal and pulmonary tissues of cotton rats were infected with unregulated cytokines and lung viral load peaking at 24 h postexposure. virus was cleared from the lung by day 3 and from the nares by day 66, but animals had bronchial and alveolar damage, and pneumonia for up to 3 weeks. there is also a s. aureus superinfection model in cotton rats. 327 coinfection resulted in bacteremia, high bacterial load in lungs, peribronchiolitis, pneumonitis, alveolitis, hypothermia, and higher mortality. domestic pig influenza models have been developed for vaccine studies for swine flu. pigs are susceptible in nature as natural or intermediate hosts but are not readily susceptible to h5n1. 328, 329 although pigs infected with influenza may have fever, anorexia, and respiratory signs such as dyspnea and cough, mortality is rare. 330 size and space requirements make this animal difficult to work with, although the development of minipig (ellegaard gottingen) models may provide an easier-to-use alternative. incubation period, animals exhibit signs of fever, hepatitis, and abortion, which is a hallmark diagnostic sign known among farmers. 331 mosquito vectors, unpasteurized milk, aerosols of infected animal's body fluids, or direct contact with infected animals are the important routes of transmission to humans. 332,333 after 2-6 days of incubation period, rvfv causes a wide range of signs and symptoms in humans ranging from asymptomatic to severe disease with hepatitis, vision loss, encephalitis, and hemorrhagic fever. [334] [335] [336] depending on the severity of the disease when the symptoms start, 10-20% of the hospitalized patients might die in 3-6 days or 12-17 days after the disease onset. 334 hepatic failure, renal failure or disseminated intravascular coagulation (dic), and encephalitis are demonstrated within patients during postmortem examination. mice are one of the most susceptible animal species to rvfv infection. subcutaneous or intraperitoneal routes of infection cause acute hepatitis and lethal encephalitis at a late stage of the disease in mice. 337, 338 mice start to exhibit signs of decreased activity and ruffled fur by day 2-3 postexposure. immediately after these signs are observed, they become lethargic and generally die 3-6 days postexposure. ocular diseases or hemorrhagic form of the disease has not been observed in mice models so far. 334 increased viremia and tissue tropism were reported in mice with 338 increased liver enzymes and lymphopenia observed in sick mice. rats and gerbils are also susceptible to rvfv infection. rats' susceptibility is dependent on the rat strain used for the challenge model. there was also noted an age dependence in susceptibility of rats. although wistar-furth and brown norway strains and young rats are highly susceptible to rvfv infection, fisher 344, buffalo and lewis strains, and old rats demonstrated resistance to infection. 339, 340 similar pathologic changes such as liver damage and encephalopathy were observed in both rats and mice. there was no liver involvement in the gerbil model and animals died from severe encephalitis. the mortality rate was dependent on the strain used and the dose given to gerbils. 341 similar to the rat model, the susceptibility of gerbils was also dependent on age. so far, studies showed that rvfv does not cause uniform lethality in an nhp model. intraperitoneal, intranasal, iv, and aerosol routes have been used to develop the nhp model. rhesus macaques, cynomolgus macaques, african monkeys, and south american monkeys were some of the nhp species used for this effort. 342 monkeys showed a variety of signs ranging from febrile disease to hemorrhagic disease and mortality. temporal viremia, increased coagulation parameters (pt, aptt), and decreased platelets were some other signs observed in nhps. animals that succumbed to disease showed very similar pathogenesis to those seen in humans such as pathological changes in liver and hemorrhagic disease. there was no ocular involvement in this model. recently, smith et al. compared iv, intranasal, and subcutaneous routes of infection in common marmosets and rhesus macaques. 343 marmosets were more susceptible to rvfv infection than were rhesus macaques with marked viremia, acute hepatitis, and late onset of encephalitis. increased liver enzymes were observed in both species. necropsy results showed enlarged livers in the marmosets exposed by iv or subcutaneous routes. although there were no gross lesions in the brains of marmosets, histopathology showed encephalitis in the brains of intranasally challenged marmosets. crimean-congo hemorrhagic fever virus (cchfv) generally circulates in nature unnoticed in an enzootic tick-vertebrate-tick cycle and similar to other zoonotic agents, seems to produce little or no disease in its natural hosts, but causes severe disease in humans. cchfv transmits to humans by ixodid ticks, direct contact with sick animals/humans, or body fluids of animals/humans. 344 incubation, prehemorrhagic, hemorrhagic, and convalescence are the four phases of the disease seen in humans. the incubation period lasts 1-9 days. during the prehemorrhagic phase, patients show signs of nonspecific flu-like disease for approximately a week. the hemorrhagic period results in circulatory shock and dic in some patients. 345, 346 over the years, several attempts have been made to establish an animal model for cchf in adult mice, guinea pigs, hamsters, rats, rabbits, sheep, nhps, etc. [347] [348] [349] [350] until recently, the only animal that manifests disease is the newborn mouse. infant mice infected with cchfv intraperitoneally caused fatality around day 8 postinfection. 351 pathogenesis studies showed that virus replication was first detected in the liver, with subsequent spread to the blood (serum). virus was detected very late during the disease course in other tissues including the heart (day 6) and the brain (day 7). the recent studies using knockout adult mice were successful to develop a lethal small animal model for cchfv infection. 352, 353 bente et al. infected stat1 knockout mice by the intraperitoneal route. in this model, after the signs of fever, leucopenia, thrombocytopenia, viremia, elevated liver enzymes, and proinflammatory cytokines, mice were moribund and succumbed to disease in 3-5 days of postexposure. the second model was developed by using ifn-alpha/beta (ifna/b) receptor knockout mice. 353 similar observations were made in this model as in the stat1 knockout mouse model. the animals were moribund and died 2-4 days after exposure with high viremia levels in the liver and spleen. other laboratory animals, including nhps, show little or no signs of infection or disease when infected with cchfv. 348 butenko et al. used agms (cercopithecus aethiops) for experimental cchfv infections. except one monkey with a fever on day 4 postinfection, the animals did not exhibit signs of disease. antibodies to the virus were detected in three out of five monkeys, including the one with fever. in 1975, fagbami et al. infected two patas monkeys (cercopithecus erythrocebuserythrocebus) and one guinea baboon (papio papio) with cchfv. 347 although all three animals had low level viremia between days 1 and 5 after inoculation, only the baboon serum had neutralizing antibody activity on day 137 postinfection. similar results were obtained when horses and donkeys have been used for experimental cchfv infections. donkeys develop a low-level viremia, 354 and horses developed little or no viremia, but high levels of virus-neutralizing antibodies, which remained stable for at least 3 months. these studies suggest that horses may be useful in the laboratory to obtain serum for diagnostic and possible therapeutic purposes. 355 shepherd et al. infected 11 species of small african wild mammals and laboratory rabbits, guinea pigs, and syrian hamsters with cchfv. 349 although scrub hares (lepus saxatilis), cape ground squirrels (xerus inauris), red veld rats (aethomys chrysophilus), white-tailed rats (mystromys pumilio), and guinea pigs had viremia; south african hedgehogs (atelerix frontalis), highveld gerbils (tatera brantsii), namaqua gerbils (desmodillus auricularis), two species of multimammate mouse (mastomys natalensis and m. coucha), and syrian hamsters were negative. all species regardless of viremia levels developed antibody responses against cchfv. iv and intracranially infected animals showed the onset of viremia earlier than those infected by the subcutaneous or intraperitoneal routes. the genus hantavirus is unique among the family bunyaviridae in that it is not transmitted by an arthropod vector, but rather by rodents. 356 rodents of the family muridae are the primary reservoir for hantaviruses. infected host animals develop a persistent infection that is typically asymptomatic. transmission is achieved by the inhalation of infected rodent saliva, feces, and urine. 357 human infections can normally be traced to a rural setting with activities such as farming, land development, hunting, and camping as possible sites of transmission. rodent control is the primary route of prevention. 358 the viruses have a tropism for endothelial cells within the microvasculature of the lungs. 359 there are two distinct clinical diseases that infection can yield; hemorrhagic fever with renal syndrome (hfrs) due to infection with old world hantaviruses or hantavirus pulmonary syndrome (hps) caused by new world hantaviruses. 360 hfrs is mainly seen outside of the americas and is associated with the hantaviruses dobrava-belgrade (also known as dobrava), hantaan, puumala, and seoul. 358 incubation lasts two to three weeks and presents as flulike in the initial stages that can further develop into hemorrhagic manifestations and ultimately renal failure. thrombocytopenia subsequently develops, which can further progress to shock in approximately 15% patients. the overall mortality rate is 7%. infection with dobrava and hantaan viruses are typically linked to the development of severe disease. hps was first diagnosed in 1993 within the southwestern united states when healthy young adults became suddenly ill, progressing to severe respiratory distress and shock. the etiological agent responsible for this outbreak was identified as sin nombre virus. 361 this virus is still the leading cause within na of hps. hps due to other hantaviruses has been reported in argentina, bolivia, brazil, canada, chile, french guiana, panama, paraguay, and uruguay. 362, 363 the first report of hps in maine was recently documented. 361 andes virus was first identified in outbreaks in chile and argentina. this hantavirus is distinct in that it can be transmitted between humans. 364 the fulminant disease is more lethal than that observed for hfrs with a mortality rate of 40%. there are four phases of disease including prodromal, pulmonary, cardiac depression, and hematologic manifestation. 365 incubation typically occurs 14-17 days after exposure. 366 unlike hfrs, renal failure is not a major contributing factor to the disease. there is a short prodromal phase that gives way to cardiopulmonary involvement accompanied by cough and gastrointestinal symptoms. it is at this point that individuals are typically admitted to the hospital. pulmonary function is hindered and continues to suffer within 48 h after cardiopulmonary involvement. interstitial edema and air-space disease normally follow. in fatal cases, cardiogenic shock has been noted. 367 vaccine development has been hampered by the vast diversity of hantaviruses and the limited number of outbreaks. 368 syrian golden hamsters are the most widely used small animal models for hantavirus infection. hamsters inoculated intramuscularly with a passaged andes viral strain died within 11 days postinfection. clinical signs did not appear until 24 h before death at which point the hamsters were moribund and in respiratory distress. mortality was dose dependent, with high inoculums leading to a shorter incubation before death. during the same study, hamsters were inoculated with a passaged sin nombre isolate. no hamsters developed any symptoms during the course of observation. although an antibody response to the virus that was not dose dependent was determined via an enzymelinked immunosorbent assay. hamsters infected with andes virus were found to have significant histopathological changes to their lung, liver, and spleen. all had an interstitial pneumonia with intraalveolar edema. infectious virus could be recovered from these organs. viremia began on day 8 and lasted up to 12 days postinfection. infection of hamsters with andes virus yielded a similar clinical disease progression as is seen in human hps including rapid progression to death, fluid in the pleural cavity, and significant histopathological changes to the lungs and spleen. a major deviation in the hamster model is the detection of infectious virus within the liver. 369 lethal disease can be induced in newborn mice but does not recapitulate the clinical symptoms observed in human disease. 370 adult mice exposed to hantaan virus leads to a fatal disease dependent upon viral strain and route of infection. the disease progression is marked by neurological or pulmonary manifestations that do not mirror human disease. 371, 372 knockout mice lacing ifn-a/b were found to be highly susceptible to hantaan virus infection. 373 in a study looking at a panel of laboratory strains of mice, c57bl/6 mice were found to be most susceptible to a passaged hantaan viral strain injected intraperitoneally. animals progressed to neurological manifestation including paralyses and convulsions and succumbed to infection within 24-36 h postinfection. clinical disease was markedly different than that observed in human cases. 372 nhps have been challenged with new world hantaviruses; however, no clinical signs were reported. 374, 375 cynomolgus monkeys challenged with a clinical isolate of puumala virus developed a mild disease. 376, 377 challenge with andes virus to cynomolgus macaques by both iv and aerosol exposure led to no signs of disease. all animals did display a drop in total lymphocytes within 5 days postinfection. aerosol exposure led to 4 of 6 monkeys and 8 of 11 iv injected monkeys developed viremia. infectious virus could not be isolated from any of the animals. the family arenaviridae is composed of two serogroups: old world arenaviruses including lassa fever virus and lymphocytic choriomeningitis virus and the new world viruses of pichinde virus and junin virus. all these viruses share common clinical manifestations. 378 lassa fever virus is endemic in parts of west africa and outbreaks are typically seen in the dry season between january and april. 379 this virus is responsible for 100,000-500,000 infections per year, leading to approximately 5,000 deaths. 380 outbreaks have been reported in guinea, sierra leone, liberia, nigeria, and central african republic. however, cases sprung up in germany, the netherlands, the united kingdom, and the united states due to transmission to travelers on commercial airlines. 381 transmission of this virus typically occurs via rodents, in particular the multimammate rat, mastomys species complex. 379 humans become infected by inhaling the aerosolized virus or eating contaminated food. there has also been noted human-to-human transmission by direct contact with infected secretions or needle-stick injuries. the majority of infections are asymptomatic; however, severe disease can occur in 20% of individuals. the incubation period is from 5 to 21 days, and the initial onset is characterized by flulike illness. this is followed by diarrheal disease that can progress to hemorrhagic symptoms including encephalopathy, encephalitis, and meningitis. a third of patients develop deafness in the early phase of disease, which is permanent for a third of those affected. the overall fatality is about 1%; however, of those admitted to the hospital, it is between 15% and 25%. there is no approved vaccine, and besides supportive measures, ribavirin is effective only if started within 7 days. 382, 383 the primary animal model used to study lassa fever is the rhesus macaque. 384 aerosolized infection of lymphocytic choriomeningitis virus has been a useful model for lassa fever. both rhesus and cynomolgus monkeys exposed to the virus developed disease, but rhesus more closely mirrored the disease course and histopathology observed in human infection. 385 iv or intragastric inoculation of the virus led to severe dehydration, erythematous skin, submucosal edema, necrotic foci in the buccal cavity, and respiratory distress. the liver was severely affected by the virus as depicted by measuring the liver enzymes ast and alt. 386 disease was dose-dependent with iv, intramuscular, and subcutaneous inoculation requiring the least amount of virus to induce disease. aerosol infections and eating contaminated food could also be used, and mimic a more natural route of infection. 387 within this model, the nhp becomes viremic after 4-6 days. clinical manifestations were present by day 7, and death typically occurred within 10-14 days. 388, 389 intramuscular injection of lassa virus into cynomolgus monkeys also produced a neurological disease due to lesions within the cns. 390 this pathogenicity is seen in select cases of human lassa fever. 391, 392 a marmoset model has recently been defined using a subcutaneous injection of lassa fever virus. virus was initially detected by day 8 and viremia achieved by day 14. liver enzymes were elevated, and an enlarged liver was noted upon autopsy. there was a gradual reduction in platelets and interstitial pneumonitis diagnosed in a minority of animals. the physiological signs were the same as seen in fatal human cases. 393 mice develop a fatal neurological disorder upon intracerebral inoculation with lassa, although the outcome of infection is completely dependent upon the major histocompatibility complex (mhc) background and age of animal along with the route of inoculation. 394 guinea pig inbred strain 13 was found to be highly susceptible to lassa virus infection. the outbreed hartley strain was less susceptible, and thus, strain 13 has been the preferred model given its assured lethality. the clinical manifestations mirror those seen in humans and rhesus. 395 infection with pichinde virus that has been passaged in guinea pigs has also been used. disease signs include fever, weight loss, vascular collapse, and eventual death. 396, 397 the guinea pig is an excellent model given that it not only results in similar disease pattern as humans but also the viral distribution is similar along with the histopathology and immune response. 398, 399 infection of hamsters with a cotton rat isolate of pirital virus is similar to what is characterized in humans, and the nhp and guinea pig model. the virus was injected intraperitoneally resulting in the animals becoming lethargic and anorexic within 6-7 days. virus was first detected at 3 days and reached maximum titers within 5 days. neurological symptoms began to appear at the same time, and all the animals died by day 9. pneumonitis, pulmonary hemorrhage, and edema were also present. 400 these results were recapitulated with a nonadapted pichinde virus. [401] [402] [403] globally, diarrheal disease is the leading cause of death with rotavirus being one of the main etiological agents responsible. according to the world health organization, rotavirus alone is responsible for a third of all hospitalization related to diarrhea and 500,000-600,000 deaths per year. 404 the virus is very stable due to its three-layer capsid, which allows it to be transmitted via the oral-fecal route, depositing itself in the small intestine. rotavirus is highly contagious, and only 10 viruses are needed to cause symptomatic disease. 405 the host determinant with the greatest influence on clinical outcome is age. neonates typically are asymptomatic, which is suggested to be due to the existence of maternal antibodies. hence, the most susceptible age group is 3 months to 2 years, coinciding with a drop in these protective antibodies. 406 within this age range, children will develop noninflammatory diarrhea. virus replicates in the intestinal villus enterocytes resulting in their destruction and malabsorption of needed electrolytes and nutrients. symptoms of disease include watery, nonbloody diarrhea with vomiting, fever, and potentially dehydration that lasts up to a week. 407 there is a short episode of viremia during the course of infection. 408 mice can be used as both an infection and disease model depending upon age at challenge. mice <14 days old develop disease, whereas older mice are able to clear the infection before the onset of symptoms. 409 this halts the study of active vaccination against disease in the infection model. in the adult mouse model, the course of the infection is monitored via viral shedding within the stool. 410 infant mice, specifically balb/c, receiving an oral inoculation of a clinical strain of virus developed diarrhea within 24 h postinfection, and 95% of those exposed developed symptoms within 72 h postinfection. symptoms lasted from 2 to 4 days with no mortality. viral shedding was at its peak at 24 h and lasted up to 5 days. there were noted histopathological changes within the small intestine localized to the villi that was reversible. 407 within the adult mouse model, oral inoculation of a mouse rotavirus strain showed viral shedding by 3 days lasting up until 6 days postinfection. 410 these mouse models have been used to study correlates of protection and therapeutic efficacy including gastro-gard ã� . 409, 411, 412 rats can also be used as disease models depending upon the strain of rat. 413, 414 suckling fischer 344 rats were exposed to a simian strain of rotavirus orally. the rats were susceptible to diarrheal disease till they were 8 days old with age determining the length of viral shedding. 415 rats have mainly been used to study the correct formulation for oral rehydration. these rodents are large enough to perform in situ intestinal perfusions. within these studies, 8-day-old rats were infected with a rat strain of rotavirus by orogastric intubation. within 24 h postinfection, the rats developed diarrhea, at which point the small intestine was perfused to compare differing solutions of oral rehydration. 416 gnotobiotic pigs are also used given that they can be infected with both porcine and human strains. 417 they are susceptible to developing clinical disease from human strains up to 6 weeks of age. they allow for the analysis of the primary immune response to the virus given that they do not receive transplacental maternal antibodies and are immune competent at birth. 418 another advantage of this model is that the gastrointestinal physiology and mucosal immune system closely resemble that of humans. 419 this model has been useful in studying correlates of protection. gnotobiotic and colostrum-deprived calves have also been used as an experimental model of rotavirus infection. they are able to develop diarrhea and shed live virus. 420 gnotobiotic lambs can also develop clinical disease upon oral inoculation with clinical strains. 421 infant baboons, agms, and rhesus macaques have all proven to be infection models with severity measure by viral shedding. 422, 423 retroviridae human immunodeficiency virus type 1 the lentiviruses are a subfamily of retroviridae, which includes human immunodeficiency virus (hiv), a virus that infects 0.6% of the world's population. a greater proportion of infections and deaths occur in sub-saharan africa. worldwide, there are approximately 1.8 million deaths per year with >260,000 being children. transmission of hiv occurs by exposure to infectious body fluids. there are two species, hiv-1 and hiv-2, with hiv-2 having lower infectivity and virulence (confined mostly to west africa). the vast majority of cases worldwide are hiv-1. 424 hiv targets t-helper cells (cd4ã¾), macrophages, and dendritic cells. 425 acute infection occurs 2-4 weeks after exposure, with flu-like symptoms and viremia followed by chronic infection. symptoms in the acute phase may include fever, body aches, nausea, vomiting, headache, lymphadenopathy, pharyngitis, rash, and sores in the mouth or esophagus. cd8ã¾ t-cells are activated which kill hiv-infected cells, and are responsible for antibody production and seroconversion. acquired immune deficiency syndrome (aids) develops when cd4ã¾ t-cells decline to <200 cells per microliter; thus, cell-mediated immunity becomes impaired, and the person is more susceptible to opportunistic infections and certain cancers. humanized mice, created by engrafting human cells and tissues into scid mice, have been critical for the development of mouse models for the study of hiv infection. a number of different humanized mouse models allow for the study of hiv infection in the context of intact and functional human innate and adaptive immune responses. 426 the scidhu hiv infection model has proven to be useful, particularly in screening antivirals and therapeutics. 427 a number of different humanized mouse models have been developed for the study of hiv, including rag1ã�/ã�gcã�/ã�, rag2ã�/ ã�gcã�/ã�, nod/scidgcã�/ã� (hnog), nod/ scidgcã�/ã� (hnsg), nod/scid blt, and nod/ scidgcã�/ã� (hnsg) blt. cd34ã¾ human stem cells derived from the umbilical cord blood or fetal liver are used for humanization. 428 hiv-1 infection by intraperitoneal injection can be successful with as little as 5% peripheral blood engraftment. 429 vaginal and rectal transmission models have been developed in blt scidhu mice in which mice harbor human bone marrow, liver, and thymus tissue. hiv-1 viremia occurs within approximately 7 days pi. 430 in many of these models, spleen, lymph nodes, and thymus tissues are highly positive for virus, similar to humans. 431 importantly, depletion of human t-cells can be observed in blood and lymphoid tissues of hiv-infected humanized mice, and at least some mechanisms of pathogenesis that occur in hiv-infected humans also occur in the hiv-infected humanized mouse models. 432 the advantage of these models is that these mice are susceptible to hiv infection, and thus, the impact of drugs on the intended viral targets can be tested. one caveat is that although mice have a "common mucosal immune system," humans do not, due to the differences in the distribution of addressins. 433 thus, murine mucosal immune responses to hiv do not reflect those of humans. there are a number of important nhp models for human hiv infection. simian immunodeficiency virus (siv) infection of macaques is widely considered to be the best platform for modeling hiv infection of humans. importantly, nhps have similar, pharmacokinetics, metabolism, mucosal t-cell homing receptors, and vascular addressins to those of humans. thus, although the correlates of protection against hiv are still not completely known, immune responses to hiv infection and vaccination are likely comparable. these models mimic infection through the use of contaminated needles (iv), sexual transmission (vaginal or rectal), and maternal transmission in utero, or through breast milk. [434] [435] [436] there are also macaque models to study the emergence and clinical implications of hiv drug resistance. 437 these models most routinely use rhesus macaques (macaca mulatta), cynomolgus macaques (macaca fasicularis), and pigtailed macaque (macaca nemestrina). animals of all ages are used, depending on the needs of the study. for instance, the use of newborn macaques may be more practical for evaluating the effect of prolonged drug therapy on disease progression; however, adult nhps are more frequently used. studies are performed in bsl-2 animal laboratories, and nhps must be of simian type-d retrovirus free and siv seronegative. siv infection of pigtailed macaques is a useful model for hiv peripheral nervous system pathology, wherein an axotomy is performed and regeneration of axons is studied. 438 challenges may be through a single high dose. iv infection of rhesus macaques with 100 tcid 50 of the highly pathogenic siv/deltab670 induces aids in most macaques within 5-17 months (mean of 11 months). 439 peak viremia occurs around week 4. aids in such models is often defined as cd4ã¾ t-cells that have dropped to <50% of the baseline values. alternatively, repeated low-dose challenges are often used, depending on the requirements of the model. 440, 441 because nhps infected with hiv do not develop an infection with a clinical disease course similar to that in humans, siv or siv/hiv-1 laboratory-engineered chimeric viruses (simian-human immunodeficiency virus or shiv) are used as surrogates. nhps infected with pathogenic siv may develop clinical disease, which progresses to aids and are thus useful pathogenesis models. a disadvantage is that siv is not identical to hiv-1 and is more closely related to hiv-2. however, the polymerase region of siv is 60% homologous to that of hiv-1, and it is susceptible to many reverse transcriptase (rt) and protease inhibitors. siv is generally not susceptible to nonnucleoside inhibitors; thus, hiv-1 rt is usually put into siv for such studies. 442 sivmac239 is similar to hiv in the polymerase region and is therefore susceptible to nucleoside, rt or integrase inhibition. 443 nhps infected with sivmac239 have an asymptomatic period and disease progression resembling aids in humans, characterized by weight loss/wasting, cd4ã¾ t-cell depletion. additionally, sivmac239 uses the cxcr5 chemokine receptor as a coreceptor, similar to hiv, which is important for drugs that target entry. 444 nhps infected with shiv strains may not develop aids, but these models are useful in testing vaccine efficacy. for example, rt-shivs and env-shivs are useful for the testing and evaluation of drugs that may target the envelope or rt, respectively. 442 one disadvantage of the highly virulent env-shiv (shiv-89.6 p) is that it uses the cxcr4 coreceptor. of note, env-shivs that do use the cxcr5 coreceptor are less virulent; viremia develops and then resolves without further disease progression. 445 simian-tropic (st) hiv-1 contains the vif gene from siv. infection of pigtailed macaques with this virus results in viremia, which can be detected for three months, followed by clearance. 446 a number of routes are used for siv or shiv infection of nhps, with iv inoculation being the most common route. mucosal routes include vaginal, rectal, and intracolonic. mucosal routes require a higher one-time dose than does the iv route for infection. for the vaginal route, female macaques are treated with depo-provera (estrogen) one month before infection to synchronize the menstrual cycle, thin the epithelial lining of the vagina, and increase the susceptibility to infection by atraumatic vaginal instillation. 447 upon vaginal instillation of 500 tcid50 of shiv-162p3, peak viremia was seen around 12 days postexposure with >10 7 copies per milliliter and dropping thereafter to a constant level of 10 4 rna copies per milliliter at 60 days and beyond. in another example, in an investigation of the effect of vaccine plus vaginal microbicide on preventing infection, rhesus macaques were vaginally infected with a high dose of sivmac251. 448 an example of an intrarectal model used juvenile (2year-old) pigtailed macaques, challenged intrarectally with 10 4 tcid 50s of siv mne027 to study the pathogenesis related to the virulence factor, vpx. 449 here, viremia peaked at approximately 10 days with >10 8 copies per milliliter. viral rna was expressed in the cells of the mesenteric lymph nodes. the male genital tract is seen as a viral sanctuary with persistently high levels of hiv shedding even with antiretroviral therapy. to better understand the effect of highly active antiretroviral therapy on virus and t-cells in the male genital tract, adult (3-to 4-year old) male cynomolgus macaques were intravenously inoculated with 50 aid50s of sivmac251, and the male genital tract tissues were tested after euthanasia by pcr, ihc, and in situ hybridization. 450 pediatric models have been developed in infant rhesus macaques through the infection of siv, allowing for the study of the impact of developmental and immunological differences on the disease course. 451 importantly, mother-to-infant transmission models have also been developed. 452 pregnant female pigtailed macaques were infected during the second trimester with 100 mid 50 shiv-sf162p3 by the iv route. four of nine infants were infected; one in utero and three either intrapartum or immediately postpartum through nursing. this model is useful for the study of factors involved in transmission and the underlying immunology. nhps infected with siv or shiv are routinely evaluated for weight loss, activity level, stool consistency, appetite, virus levels in blood, and t-cell populations. cytokine and chemokine levels, antibody responses, and cytotoxic t-lymphocyte responses may also be evaluated. the ultimate goal of an hiv vaccine is sterilizing immunity (preventing infection). however, a more realistic result may be to reduce severity of infection and permanently prevent progression. strategies have included live attenuated, nonreplicating and subunit vaccines. these have variable efficacy in nhps due to the genetics of the host (mhc and terminal-repeat retrotransposon in miniature (trim) alleles), differences between challenge strains, and challenge routes. 453 nhp models have led to the development of antiviral treatments that are effective at reducing viral load and indeed transmission of hiv among humans. one preferred variation on the models for testing the longterm clinical consequences of antiviral treatment is to use newborn macaques and treat from birth onward, in some cases more than a decade. 454 unfortunately, however, successes in nhp studies do not always translate to success in humans, as seen with the recent step study that used an adenovirus-based vaccine approach. 455 vaccinated humans were not protected and may have even been more susceptible to hiv, viremia was not reduced, and the infections were not attenuated as hoped. with regard to challenge route, iv is more difficult to protect than mucosal and is used as a "worst-case scenario." however, efficacy at one mucosal route is usually comparable to that at other mucosal routes. human and animal papillomaviruses cause benign epithelial proliferations (warts) and malignant tumors of the various tissues that they infect. 456 there are >100 human papillomaviruses (hpvs), with different strains causing warts on the skin, oropharynx, nasopharynx, larynx, and anogenital tissues. approximately a third of these are transmitted sexually. of these, virulent subtypes such as hpv-16, hpv-18, hpv-31, hpv-33, and hpv-45 place individuals at high risk for cervical and other cancers. major challenges in the study of these viruses are that papillomaviruses generally do not infect any other species outside of the natural hosts and can cause a very large spectrum of severity. thus, no animal models have been identified that are susceptible to hpv. however, a number of useful surrogate models exist that use animal papillomaviruses in their natural host, or a very closely related species. 457, 458 these models have facilitated the recent development of useful and highly effective prophylactic hpv vaccines. 459 wild cottontail rabbits (sylvilagus floridanus) are the natural host for cottontail rabbit papillomavirus (crpv), but this virus also infects domestic rabbits (oryctolagus cuniculus), which are a very closely related species. 460 in this model, papillomas can range from cutaneous squamous cell carcinomas on the one end of the spectrum, and spontaneous regression on the other. lesions resulting from crpv in domestic rabbits do not typically contain infectious virus. canine oral papillomavirus (copv) cause florid warty lesions in the mucosa of the oral cavity within 4-8 weeks postexposure in experimental settings. 461 the mucosatrophic nature of these viruses and the resulting oropharyngeal papillomas that are morphologically similar to human vaginal papillomas caused by hpv-6 and hpv-11 make this a useful model. 462 these lesions typically spontaneously regress 4-8 weeks after appearing; this model is therefore useful in understanding the interplay between the host immune defense and viral pathogenesis. male and female beagles, aged 10 weeks to 2 years, with no history of copv, are typically used for these studies. infection is achieved by the application of a 10 ml droplet of virus extract to multiple 0.5 cm 2 scarified areas within the mucosa of the upper lip of anesthetized beagles. 463 bovine papillomavirus (bpv) has a wider host range than do most papillomaviruses, infecting the fibroblasts cells of numerous ungulates. 458 bpv-4 infection of cattle feeding on bracken fern, which is carcinogenic, can result in lesions of the oral and esophageal mucosa that lack detectable viral dna. bpv infections in cattle can result in a range of diseases such as skin warts, cancer of the upper gastrointestinal tract and urinary bladder, and papillomatosis of the penis, teats, and udder. finally, sexually transmitted papillomaviruses in rhesus macaques and cynomolgus macaques, rhesus papillomavirus, is very similar to hpv-16 and is associated with the development of cervical cancer. 464 mice cannot be used to study disease caused by papillomaviruses unless they are engrafted with relevant tissue, but they are often used to look at immunogenicity of vaccines. 465, 466 herpesviridae please see chapter 25. monkeypox virus (mpxv) causes disease in both animals and humans. human monkeypox, which is clinically almost identical to ordinary smallpox, occurs mostly in the rainforest of central and western africa. the virus is maintained in nature in rodent reservoirs including squirrels. 467, 468 mpxv was discovered during the pox-like disease outbreak among laboratory java macaques in denmark in 1958. no human cases were observed during this outbreak. the first human case was not recognized as a distinct disease until 1970 in zaire (the present drc) with the continued occurrence of a smallpox-like illness despite eradication efforts of smallpox in this area. during the global eradication campaign, extensive vaccination in central africa decreased the incidence of human monkeypox, but the absence of immunity in the generation born since that time and increased dependence on bush meat have resulted in renewed emergence of the disease. in the summer of 2003, a well-known outbreak in the midwest was the first occurrence of monkeypox disease in the united states and the western hemisphere. among 72 reported cases, 37 human cases were laboratory confirmed during an outbreak. 469, 470 it was determined that native prairie dogs (cynomys sp.) housed with rodents imported from ghana in west africa were the primary source of outbreak. the virus is mainly transmitted to humans while handling infected animals or by direct contact with the infected animal's body fluids, or lesions. person-toperson spread occurs by large respiratory droplets or direct contact. 471 most of the clinical features of human monkeypox are very similar to those of ordinary smallpox. 472 after a 7-to 21-day incubation period, the disease begins with fever, malaise, headache, sore throat, and cough. the main sign of the disease that distinguishes monkeypox from smallpox is swollen lymph nodes (lymphadenitis), which is observed in most of the patients before the development of rash. 471, 473 typical maculopapular rash follows the prodromal period generally lasting 1-3 days. the average size of the skin lesions is 0.5-1 cm, and the progress of lesions follows the order macules through papules, vesicles, pustules, umblication then scab and desquamation and lasts typically 2-4 weeks. fatality rate is 10% among the unvaccinated population and death generally occurs during the second week of the disease. 469, 471 mpxv is highly pathogenic for a variety of laboratory animals, and so far, many animal models have been developed by using different species and different routes of exposure (table 38. 3). because of the unavailability of variola virus to develop animal models and resulting disease manifestations in humans that are similar, mpxv is one of the pox viruses that are used very heavily to develop a number of small animal models via different routes of exposure. wild-derived inbred mouse, stat1-deficient c57bl/6 mouse, prairie dogs, african dormice, ground squirrels are highly susceptible to mpxv by different exposure routes. [474] [475] [476] [477] [478] [479] [480] [481] cast/eij mice, one of the 38 inbred mouse strains tested for susceptibility to mpxv, showed weight loss and dose-dependent mortality after intranasal exposure to mpxv. studies with the intraperitoneal route of challenge indicated a higher susceptibility to mpxv with an almost 50-fold less ld50 when compared to the intranasal route. 474 scid-balb/c mice were also susceptible to the intraperitoneal challenge route, and the disease resulted in mortality day 9 postinfection. 476 similarly c57bl/6 stat1 ã�/ã� mice were infected intranasally with mpxv, and the infection resulted in weight loss and mortality 10 days postexposure. mice models mentioned here are very promising for screening of therapeutics against pox viruses, but testing in additional models will be required for advanced development. high doses of mpxv by intraperitoneal or intranasal route caused 100% mortality in 6 days postexposure and 8 days postexposure, respectively, in ground squirrels. 480 the disease progressed very quickly, and most of the animals were lethargic and moribund by day 5 postexposure without any pox lesions or respiratory changes. a comparison study of usa mpxv and central african strain of mpxv in ground squirrels by subcutaneous route resulted in systemic disease and the mortality in 6-11 days postexposure. the disease resembles hemorrhagic smallpox with nose bleeds, impaired coagulation parameters, and hemorrhage in the lungs of the animals. because in the us outbreak the virus was transmitted by infected prairie dogs, this animal model has recently been studied much further and used to test therapeutics and vaccines compared to other small animal models. 475, 481, 491, 492 studies using intranasal, intraperitoneal, and intradermal routes of exposure showed that mpxv was highly infectious to prairie dogs. by using the west african mpxv strain, the intraperitoneal route caused a more severe disease and 100% mortality than challenge by the intranasal route. anorexia and lethargy were common signs of the disease for both exposure routes. in contrast to the intraperitoneal route, the intranasal route of exposure caused severe pulmonary edema and necrosis of lungs in prairie dogs, while splenic necrosis and hepatic lesions were observed in intraperitoneally infected animals. 481 recent studies by hutson et al. used intranasal and intradermal infections with west african and congo basin strains and showed that both strains and routes caused smallpox-like disease with longer incubation periods and generalized pox lesions. 475 therefore, this model can be used for testing therapeutics and vaccines against pox viruses. the african dormouse is susceptible to mpxv by the foodpad injection route or intranasal route. 478 mice exhibited decreased activity, hunched posture, dehydration, conjunctivitis, and weight loss. viral doses of 200 and 2000 pfu provided 100% mortality with a mean time to death of 8 days. upper gastrointestinal hemorrhage, hepatomegaly, lymphadenopathy, and hemorrhage in lungs were observed during necropsy. with the hemorrhage in several organs, this model resembles hemorrhagic smallpox. considering the limited availability of ground squirrels and african dormice, lack of reagents to these species, and resemblance to hemorrhagic smallpox disease, these models are not very attractive for further characterization and vaccine and countermeasure testing studies. nhps were exposed to mpxv by several different routes to develop animal models for mpxv. 482, 483, 485, 489, 490 during our studies by using an aerosol route of exposure, we observed that macaques had mild anorexia, depression, fever, and lymphadenopathy on day 6 postexposure. 482 complete blood count and clinical chemistries showed abnormalities similar to those of human monkeypox cases with leukocytosis and thrombocytopenia. 493 whole-blood and throat swabs had viral loads peak around day 10, and in survivors, gradually decrease until day 28 postexposure. because doses of 4 ã� 10 4 , 1 ã� 10 5 , or 1 ã� 10 6 pfu resulted in lethality for 70% of the animals, whereas a dose of 4 ã� 10 5 pfu resulted in 85% lethality, survival was not dose dependent. the main pitfall of this model was the lack of pox lesions. with the high dose, before animals can develop pox lesions, they succumbed to disease. with the low challenge dose, pox lesions were observed, but they were few in comparison to the iv model. mpxv causes dose-dependent disease in nhps when given by the iv route. 490 studies showed that with 1ã� 10 7 pfu iv, challenge results in systemic disease with fever, lymphadenopathy, macula-papular rash, and mortality. an intratracheal infection model deposits virus into the trachea, delivering directly to the airways without regard to particle size and the physiological deposition that occurs during the process of inhalation by skipping the upper respiratory system. fibrinonecrotic bronchopneumonia was described in animals that received 10 7 pfu of mpxv intratracheally. 489 although a similar challenge dose of intratracheal mpxv infection resulted in a similar viremia in nhps than with the aerosol route of infection, the timing of the first peak was delayed by 5 days in intratracheally exposed macaques compared to aerosol infection, and the amount of virus detected by qpcr was approximately 100-fold lower. this suggests that local replication is more prominent after aerosol delivery compared to that after intratracheal delivery. an intrabronchial route of exposure resulted in pneumonia in nhps. 490 delayed onset of clinical signs and viremia were observed during the disease progression. in this model, similar to aerosol and the intratracheal route of infection models, the number of pox lesions was much less than in the iv route of the infection model. a major downside of the iv, intratracheal and intrabronchial models is that the initial infection of respiratory tissue, incubation, and prodromal phases are circumvented with the direct inoculation of virus into the blood stream or into the lung. this is an important limitation when the utility of these models is to test possible vaccines and treatments in which the efficacy may depend on protecting the respiratory mucosa and targeting subsequent early stages of the infection, which are not represented in these challenge models. although the aerosol model is the natural route of transmission for human variola virus (varv) infections and a secondary route for human mpxv infections, the lack of pox lesions is the main drawback of this model. therefore, when this model is decided to be used to test medical countermeasures, the endpoints and the biomarkers to initiate treatment should be chosen carefully. hepatitis b is one of the most common infections worldwide with >400 million people chronically infected and 316,000 cases per year of liver cancer due to infection. 494 the virus can naturally infect both humans and chimpanzees. 495 hepatitis b is transmitted parenterally or postnatally from infected mothers. it can also be transmitted by sexual contact, iv drug use, blood transfusion, and acupuncture. 496 the age at which one is infected dictates the risk of developing chronic disease. 497 acute infection during adulthood is self-limiting and results in flu-like symptoms that can progress to hepatocellular involvement as observed with the development of jaundice. the clinical symptoms last for a few weeks before resolving. 498 after this acute phase, life time immunity is achieved. 499 of those infected, <5% will develop the chronic form of disease. chronicity is the most serious outcome of disease as it can result in cirrhosis or liver cancer. hepatocellular carcinoma is 100 times more likely to develop in a chronically infected individual than in a noncarrier. 500 the viral determinant for cellular transformation has yet to be determined, although studies involving the woodchuck hepadna virus suggest that x protein may be responsible. 501 many individuals are asymptomatic until complications emerge related to chronic carriage. chimpanzees have a unique strain that circulates within the population. 502, 503 it was found that 3-6% of all wild-caught animals from africa are positive for hepatitis b antigen. 504 natural and experimental challenge with the virus follows the same course as human disease; however, this is only an acute model of disease. 505 to date, the use of chimpanzees provides the only reliable method to ensure that plasma vaccines are free from infectious particles. 506 this animal model has been used to study new therapeutics and vaccines. chimpanzees are especially attuned to these studies given that their immune response to infection directly mirrors humans. 507 other nhps that have been evaluated are gibbons, orangutans, and rhesus monkeys. although these animals can be infected with hepatitis b, none develop hepatic lesions or liver damage as noted by monitoring of liver enzymes. 508 mice are not permissible to infection, and thus, numerous transgenic and humanized lines that express hepatitis b proteins have been created to facilitate their usage as an animal model. these include both immunocompetent and immunosuppressed hosts. the caveat to all of these mouse lines is that they reproduce only the acute form of disease. 495 recently, the entire genome of hepatitis b was transferred to an immunocompetent mouse line via adenovirus. this provides a model for persistent infection. 509 hepatitis b can also be studied using surrogate viruses, naturally occurring mammalian hepadna viruses. 510 the woodchuck hepatitis virus was found to induce hepatocellular carcinoma. 511 within a population, 65-75% of all neonatal woodchucks are susceptible to chronic infection. 512 a major difference between the two hepatitis isolates is the rate at which they induce cancer; almost all chronic carriers developed hepatocellular carcinoma within 3 years of the initial infection in woodchucks, whereas human infection takes much longer. 513 the acute infection strongly resembles what occurs during the course of disease in humans. there is a self-limiting acute phase resulting in a transient viremia that has the potential of chronic carriage. 514 challenge with virus in neonates leads to a chronic infection, while adults only develop the acute phase of disease. 515 a closely related species to the woodchuck is the marmota himalayan. this animal is also susceptible to the woodchuck hepadna virus upon iv injection. it was found to develop an acute hepatitis with a productive infection. 516 hepatitis d is dependent upon hepatitis b to undergo replication and successful infection in its human host. 517 there are two modes of infection possible between the viruses: coinfection in which a person is simultaneously infected or superinfection in which a chronic carrier of hepatitis b is subsequently infected with hepatitis d. 518 coinfection leads to a similar disease as seen with hepatitis b alone; however, superinfection can result in chronic hepatitis d infection and severe liver damage. 519 both coinfection and superinfection can be demonstrated within the chimpanzee and woodchuck by inoculation of human hepatitis d. 520 a recently published report demonstrated the use of a humanized chimeric mouse to study the interactions between the two viruses and drug testing. 521 the ideal animal model for human viral disease should closely recapitulate the spectrum of clinical symptoms and pathogenesis observed during the course of human infection. whenever feasible, the model should use the same virus and strain that infects humans. it is also preferable that the virus be a low passage clinical isolate; thus, animal passage or adaptation should be avoided if model species can be identified that are susceptible. ideally, the experimental route of infection would mirror that which occurs in natural disease. to understand the interplay and contribution of the immune system during infection, an immunocompetent animal should be used. the above characteristics cannot always be satisfied, however, and often virus must be adapted, knockout mice must be used, and/or the disease is not perfectly mimicked in the animal model. well-characterized animal models are critical for licensure to satisfy the food and fda's "animal rule." this rule applies to situations in which vaccines and therapeutics cannot safely or ethically be tested in humans; thus, licensure will come only after preclinical tests are performed in animal models. many fields in virology are moving toward standardized models that can be used across institutions to test vaccines and therapeutics. a current example of such an effort is within the filovirus community, where animal models, euthanasia criteria, assays, and virus strains are in the process of being standardized. the hope is that these efforts will enable results of efficacy tests on medical countermeasures to be compared across institutions. this chapter has summarized the best models available for each of the viruses described. fields' virology pathogenesis of poliomyelitis: reappraisal in the light of new data one hundred years of poliovirus pathogenesis expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut present status of attenuated live-virus poliomyelitis vaccine world health organization. polio global eradication initiative annual report pathogenesis of human poliovirus infection in mice. ii. age-dependency of paralysis the poliovirus receptor protein is produced both as membranebound and secreted forms poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: agedependent paralysis and a mucosal route of infection establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor macaque models of human infectious disease ulnar nerve inoculation of poliovirus in bonnet monkey: a new primate model to investigate neurovirulence experimental poliomyelitis in bonnet monkey. clinical features, virology and pathology hepatitis a in day-care centers. a community-wide assessment persistence of hepatitis a virus in fulminant hepatitis and after liver transplantation acute liver failure: redefining the syndromes experimental hepatitis a virus (hav) infection in cynomolgus monkeys (macaca fascicularis): evidence of active extrahepatic site of hav replication experimental hepatitis a virus (hav) infection in callithrix jacchus: early detection of hav antigen and viral fate animal models of hepatitis a and e relative infectivity of hepatitis a virus by the oral and intravenous routes in 2 species of nonhuman primates wild malaysian cynomolgus monkeys are exposed to hepatitis a virus histopathological and immunohistochemical studies of hepatitis a virus infection in marmoset callithrix jacchus intragastric infection induced in marmosets (callithrix jacchus) by a brazilian hepatitis a virus (haf-203) experimental hepatitis a virus infection in guinea pigs systematic literature review of role of noroviruses in sporadic gastroenteritis norovirus infection as a cause of diarrhea-associated benign infantile seizures outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit progress in understanding norovirus epidemiology natural history of human calicivirus infection: a prospective cohort study foodborne viruses: an emerging problem pediatric norovirus diarrhea in nicaragua clinical immunity in acute gastroenteritis caused by norwalk agent experimental norovirus infections in nonhuman primates chimpanzees as an animal model for human norovirus infection and vaccine development experimental inoculation of juvenile rhesus macaques with primate enteric caliciviruses molecular characterization of three novel murine noroviruses persistent infection with and serologic cross-reactivity of three novel murine noroviruses [comparative study research support, n.i.h., extramural research support gastrointestinal norovirus infection associated with exacerbation of inflammatory bowel disease porcine enteric caliciviruses: genetic and antigenic relatedness to human caliciviruses, diagnosis and epidemiology pathogenesis of a genogroup ii human norovirus in gnotobiotic pigs infection of calves with bovine norovirus giii.1 strain jena virus: an experimental model to study the pathogenesis of norovirus infection an epizootic of equine encephalomyelitis that occurred in massachusetts in 1831 eastern equine encephalomyelitis virus: epidemiology and evolution of mosquito transmission vaccines and animal models for arboviral encephalitides fields virology studies on avian encephalomyelitis. ii. flock survey for embryo susceptibility to the virus the occurrence in nature of "equine encephalomyelitis" in the ring-necked pheasant eastern equine encephalitis virus infection: electron microscopic studies of mouse central nervous system a comparative study of the pathogenesis of western equine and eastern equine encephalomyelitis viral infections in mice by intracerebral and subcutaneous inoculations influence of age on susceptibility and on immune response of mice to eastern equine encephalomyelitis virus the hamster as an animal model for eastern equine encephalitiisdand its use in studies of virus entrance into the brain pathogenesis of aerosolized eastern equine encephalitis virus infection in guinea pigs eastern equine encephalitis. distribution of central nervous system lesions in man and rhesus monkey encephalomyelitis in monkeys severe encephalitis in cynomolgus macaques exposed to aerosolized eastern equine encephalitis virus pathology of animal models of alphavirus encephalitis common marmosets (callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains arbovirus investigations in argentina historical aspects and description of study sites western encephalitis in illinois horses and ponies medically important arboviruses of the united states and canada the ecology of western equine encephalomyelitis virus in the central valley of california an epizootic attributable to western equine encephalitis virus infection in emus in texas epidemiologic observations on acute infectious encephalitis in california, with special reference to the 1952 outbreak neurologic, intellectual, and psychologic sequelae following western encephalitis. a follow-up study of 35 cases louis encephalitis; preliminary report of a clinical follow-up study in california pathological changes in brain and other target organs of infant and weanling mice after infection with nonneuroadapted western equine encephalitis virus necrotizing myocarditis in mice infected with western equine encephalitis virus: clinical, electrocardiographic, and histopathologic correlations the pathogenesis of western equine encephalitis virus (w.e.e.) in adult hamsters with special reference to the long and short term effects on the c.n.s. of the attenuated clone 15 variant viruses of the bunya-and togaviridae families: potential as bioterrorism agents and means of control aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques venezuelan equine encephalitis recovery of venezuelan equine encephalomyelitis virus in panama. a fatal case in man role of dendritic cell targeting in venezuelan equine encephalitis virus pathogenesis mechanism of neuroinvasion of venezuelan equine encephalitis virus in the mouse comparative neurovirulence and tissue tropism of wild-type and attenuated strains of venezuelan equine encephalitis virus administered by aerosol in c3h/hen and balb/c mice c3h/hen mouse model for the evaluation of antiviral agents for the treatment of venezuelan equine encephalitis virus infection treatment of venezuelan equine encephalitis virus infection with (-)-carbodine studies on the virus of venezuelan equine encephalomyelitis. i modification by cortisone of the response of the central nervous system of macaca mulatta experimental studies of rhesus monkeys infected with epizootic and enzootic subtypes of venezuelan equine encephalitis virus aerosol infection of cynomolgus macaques with enzootic strains of venezuelan equine encephalitis viruses chikungunya outbreaksdthe globalization of vectorborne diseases infection with chikungunya virus in italy: an outbreak in a temperate region changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus chikungunya and the nervous system: what we do and do not know [review] a mouse model for chikungunya: young age and inefficient type-i interferon signaling are risk factors for severe disease an animal model for studying the pathogenesis of chikungunya virus infection chikungunya virus arthritis in adult wild-type mice a mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence mouse models for chikungunya virus: deciphering immune mechanisms responsible for disease and pathology chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages aedes albopictus in the united states: tenyear presence and public health implications epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century dengue: an update dengue haemorrhagic fever: diagnosis, treatment, prevention, and control tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining clinical and laboratory features that differentiate dengue from other febrile illnesses in an endemic areadpuerto rico risk factors in dengue shock syndrome animal models of dengue virus infection manifestation of thrombocytopenia in dengue-2-virus-infected mice liver injury and viremia in mice infected with dengue-2 virus early activation of natural killer and b cells in response to primary dengue virus infection in a/j mice induction of tetravalent protective immunity against four dengue serotypes by the tandem domain iii of the envelope protein essential role of platelet-activating factor receptor in the pathogenesis of dengue virus infection murine model for dengue virus-induced lethal disease with increased vascular permeability lethal antibody enhancement of dengue disease in mice is prevented by fc modification inhibitory potential of neem (azadirachta indica juss) leaves on dengue virus type-2 replication genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in scid mice transplanted with human liver cells study of dengue virus infection in scid mice engrafted with human k562 cells dengue virus tropism in humanized mice recapitulates human dengue fever dengue virus infection and immune response in humanized rag2(ã�/ã�) gamma(c)(ã�/ã�) (rag-hu) mice a model of denv-3 infection that recapitulates severe disease and highlights the importance of ifn-gamma in host resistance to infection mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice studies on the pathogenesis of dengue infection in monkeys. 3. sequential distribution of virus in primary and heterologous infections studies on dengue 2 virus infection in cyclophosphamide-treated rhesus monkeys dengue virus-induced hemorrhage in a nonhuman primate model an in-depth analysis of original antigenic sin in dengue virus infection monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention the arboviruses: epidemiology and ecology screening of protective antigens of japanese encephalitis virus by dna immunization: a comparative study with conventional viral vaccines immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-japanese encephalitis virus (chimerivax-je) as a live, attenuated vaccine candidate against japanese encephalitis studies on host factors in inapparent infection with japanese b encephalitis: influence of age, nutrition and luminal induced sleep on the course of infection in mice relation of the peripheral multiplication of japanese b encephalitis virus to the pathogenesis of the infection in mice field's virology free radical generation by neurons in a rat model of japanese encephalitis sequential changes in serum cytokines and chemokines in a rat model of japanese encephalitis experimental infections of monkeys with langat virus. i. comparison of viremia following peripheral inoculation of langat and japanese encephalitis viruses intranasal infection of monkeys with japanese encephalitis virus: clinical response and treatment with a nuclease-resistant derivative of poly (i).poly (c) a neurotropic virus isolated from the blood of a native uganda isolation from human sera in egypt of a virus apparently identical to west nile virus isolation of west nile virus from culex mosquitoes the arboviruses: epidemiology and ecology centers for disease control & prevention. outbreak of west nile-like viral encephalitisdnew york origin of the west nile virus responsible for an outbreak of encephalitis in the northeastern united states clinical virology the west nile virus outbreak of 1999 in new york: the flushing hospital experience nile feverda reemerging mosquito-borne viral disease in europe west nile viral encephalitis experimental infection of cats and dogs with west nile virus experimental infection of horses with west nile virus pathogenesis of west nile virus encephalitis in mice and rats. 1. influence of age and species on mortality and infection study on west nile virus persistence in monkeys experimental infection of pigs with west nile virus persistent west nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections experimental encephalitis following peripheral inoculation of west nile virus in mice of different ages immunogenicity and protective efficacy of a recombinant subunit west nile virus vaccine in rhesus monkeys molecularly engineered live-attenuated chimeric west nile/dengue virus vaccines protect rhesus monkeys from west nile virus tissue tropism and neuroinvasion of west nile virus do not differ for two mouse strains with different survival rates phenotypic changes in langerhans' cells after infection with arboviruses: a role in the immune response to epidermally acquired viral infection? interleukin-1beta but not tumor necrosis factor is involved in west nile virusinduced langerhans cell migration from the skin in c57bl/6 mice profound and prolonged lymphocytopenia with west nile encephalitis innate and adaptive immune responses determine protection against disseminated infection by west nile encephalitis virus spinal cord neuropathology in human west nile virus infection animal models for sars world health organization. the world health report 2003d shaping the future stability and inactivation of sars coronavirus the severe acute respiratory syndrome clinical manifestations, laboratory findings, and treatment outcomes of sars patients identification of a novel coronavirus in patients with severe acute respiratory syndrome profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers the immunobiology of sars* viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome sars vaccines: where are we? animal models and vaccines for sars-cov infection replication of sars coronavirus administered into the respiratory tract of african green, rhesus and cynomolgus monkeys aged balb/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice severe acute respiratory syndrome (sars): a year in review koch's postulates fulfilled for sars virus pegylated interferon-alpha protects type 1 pneumocytes against sars coronavirus infection in macaques macaque model for severe acute respiratory syndrome mechanisms of host defense following severe acute respiratory syndromecoronavirus (sars-cov) pulmonary infection of mice resolution of primary severe acute respiratory syndromeassociated coronavirus infection requires stat1 virology: sars virus infection of cats and ferrets civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates pneumonitis and multi-organ system disease in common marmosets (callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus immunopathogenesis of coronavirus infections: implications for sars immunization with sars coronavirus vaccines leads to pulmonary immunopathology on challenge with the sars virus immunization with modified vaccinia virus ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge a mouse-adapted sars-coronavirus causes disease and mortality in balb/c mice rabies re-examined rabies and other lyssavirus diseases overview, prevention, and treatment of rabies studies of rabies street virus in the syrian hamster live attenuated rabies virus co-infected with street rabies virus protects animals against rabies spread and pathogenic characteristics of a g-deficient rabies virus recombinant: an in vitro and in vivo study biological basis of rabies virus neurovirulence in mice: comparative pathogenesis study using the immunoperoxidase technique intracerebral vaccination suppresses the spread of rabies virus in the mouse brain human rabies therapy: lessons learned from experimental studies in mouse models experimental rabies virus infection of p.75 neurotrophin receptor-deficient mice apoptosis in experimental rabies in bax-deficient mice emerging pattern of rabies deaths and increased viral infectivity effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine a model in mice for the pathogenesis and treatment of rabies a model in mice for the study of the early death phenomenon after vaccination and challenge with rabies virus experimental rabies infection and oral vaccination in vampire bats (desmodus rotundus the distribution of challenge virus standard rabies virus versus skunk street rabies virus in the brains of experimentally infected rabid skunks a compendium of 40 years of epidemiological, clinical, and laboratory studies proportion of deaths and clinical features in bundibugyo ebola virus infection clinical aspects of marburg hemorrhagic fever correlates of immunity to filovirus infection the role of the type i interferon response in the resistance of mice to filovirus infection a mouse model for evaluation of prophylaxis and therapy of ebola hemorrhagic fever development of a murine model for aerosolized filovirus infection using a panel of bxd recombinant inbred mice. viruses lethality and pathogenesis of airborne infection with filoviruses in a129 alpha/betaã�/ã� interferon receptordeficient mice development and characterization of a mouse model for marburg hemorrhagic fever identification of an antioxidant small-molecule with broad-spectrum antiviral activity animal models of highly pathogenic rna viral infections: hemorrhagic fever viruses protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the syrian hamster model of lethal ebola virus infection pathogenesis of filoviruses in small animal models program abstr 5th int symp filoviruses pathogenesis of experimental ebola virus infection in guinea pigs characterization of disease and pathogenesis following airborne exposure of guinea pigs to filoviruses manuscripts in preparation postexposure antibody prophylaxis protects nonhuman primates from filovirus disease aerosol exposure to the angola strain of marburg virus causes lethal viral hemorrhagic fever in cynomolgus macaques a small nonhuman primate model for filovirus-induced disease pathology of experimental ebola virus infection in african green monkeys. involvement of fibroblastic reticular cells pathogenesis of marburg hemorrhagic fever in cynomolgus macaques a characterization of aerosolized sudan ebolavirus infection in african green monkeys, cynomolgus macaques, and rhesus macaques recent progress in henipavirus research: molecular biology, genetic diversity, animal models transmission of human infection with nipah virus recurrent zoonotic transmission of nipah virus into humans nipah virus outbreak with person-to-person transmission in a district of bangladesh henipavirus susceptibility to environmental variables hendra virus infection in a veterinarian human hendra virus encephalitis associated with equine outbreak clinical features of nipah virus encephalitis among pig farmers in malaysia the emergence of nipah virus, a highly pathogenic paramyxovirus nipah virus encephalitis acute hendra virus infection: analysis of the pathogenesis and passive antibody protection in the hamster model clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection a golden hamster model for human acute nipah virus infection histopathologic and immunohistochemical characterization of nipah virus infection in the guinea pig a guinea-pig model of hendra virus encephalitis the lesions of experimental equine morbillivirus disease in cats and guinea pigs a neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection a recombinant hendra virus g glycoproteinbased subunit vaccine protects ferrets from lethal hendra virus challenge vertical transmission and fetal replication of nipah virus in an experimentally infected cat susceptibility of cats to equine morbillivirus experimental infection of squirrel monkeys with nipah virus development of an acute and highly pathogenic nonhuman primate model of nipah virus infection a novel model of lethal hendra virus infection in african green monkeys and the effectiveness of ribavirin treatment experimental nipah virus infection in pteropid bats (pteropus poliocephalus) bacterial infections in pigs experimentally infected with nipah virus experimental inoculation study indicates swine as a potential host for hendra virus experimental nipah virus infection in pigs and cats invasion of the central nervous system in a porcine host by nipah virus experimental infection of horses with hendra virus/australia/horse/2008/redlands transmission studies of hendra virus (equine morbillivirus) in fruit bats, horses and cats a novel morbillivirus pneumonia of horses and its transmission to humans a morbillivirus that caused fatal disease in horses and humans equine morbillivirus pneumonia: susceptibility of laboratory animals to the virus feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine distribution of viral antigens and development of lesions in chicken embryos inoculated with nipah virus global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis [meta-analysis research support economic impact of respiratory syncytial virus-related illness in the us: an analysis of national databases the relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus viral and host factors in human respiratory syncytial virus pathogenesis evidence of a causal role of winter virus infection during infancy in early childhood asthma respiratory syncytial virus infection in elderly and high-risk adults respiratory syncytial virus american academy of pediatrics subcommittee on diagnosis & management of bronchiolitis. diagnosis and management of bronchiolitis respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice genetic susceptibility to respiratory syncytial virus infection in inbred mice differential pathogenesis of respiratory syncytial virus clinical isolates in balb/c mice primary respiratory syncytial virus infection in mice the use of a neonatal mouse model to study respiratory syncytial virus infections respiratory syncytial virus affects pulmonary function in balb/c mice the cotton rat model of respiratory viral infections diversifying animal models: the use of hispid cotton rats (sigmodon hispidus) in infectious diseases the antiviral activity of sp-303, a natural polyphenolic polymer, against respiratory syncytial and parainfluenza type 3 viruses in cotton rats pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat bovine respiratory syncytial virus protects cotton rats against human respiratory syncytial virus infection age at first viral infection determines the pattern of t cell-mediated disease during reinfection in adulthood the enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and il-13 production [comparative study research support immunomodulation with il-4r alpha antisense oligonucleotide prevents respiratory syncytial virusmediated pulmonary disease chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus experimental respiratory syncytial virus infection of four species of primates respiratory syncytial virus infects the bonnet monkey serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus reduced clearance of respiratory syncytial virus infection in a preterm lamb model human respiratory syncytial virus a2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs structure as revealed by airway dissection. a comparison of mammalian lungs biomedical applications of sheep models: from asthma to vaccines the pathology of influenza virus infections mortality due to influenza in the united statesdan annualized regression approach using multiple-cause mortality data animal models for the study of influenza pathogenesis and therapy serious morbidity and mortality associated with influenza epidemics centers for disease control & prevention. bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza a (h1n1)dunited states human and avian influenza viruses target different cell types in cultures of human airway epithelium animal models head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model [comparative study interferon-induced mx protein: a mediator of cellular resistance to influenza virus in vitro and in vivo assay systems for study of influenza virus inhibitors utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice the contribution of animal models to the understanding of the host range and virulence of influenza a viruses biological heterogeneity, including systemic replication in mice, of h5n1 influenza a virus isolates from humans in hong kong distinct pathogenesis of hong kong-origin h5n1 viruses in mice compared to that of other highly pathogenic h5 avian influenza viruses effect of oral gavage treatment with znal42 and other metallo-ion formulations on influenza a h5n1 and h1n1 virus infections in mice inactivated and live, attenuated influenza vaccines protect mice against influenza: streptococcus pyogenes super-infections [comparative study research support the use of an animal model to study transmission of influenza virus infection strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine local innate immune responses and influenza virus transmission and virulence in ferrets regional t-and b-cell responses in influenza-infected ferrets human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals live, attenuated influenza virus (laiv) vehicles are strong inducers of immunity toward influenza b virus [comparative study the ferret: an animal model to study influenza virus pathogenesis of avian influenza a (h5n1) viruses in ferrets severe seasonal influenza in ferrets correlates with reduced interferon and increased il-6 induction neuropathology of h5n1 virus infection in ferrets evaluation of three strains of influenza a virus in humans and in owl, cebus, and squirrel monkeys a computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from h5n1 infection evaluation of intravenous zanamivir against experimental influenza a (h5n1) virus infection in cynomolgus macaques aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus pathology of human influenza a (h5n1) virus infection in cynomolgus macaques (macaca fascicularis integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics integration of clinical data, pathology, and cdna microarrays in influenza virus-infected pigtailed macaques (macaca nemestrina kinetic profile of influenza virus infection in three rat strains the guinea pig as a transmission model for human influenza viruses influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor the antiviral potential of interferon-induced cotton rat mx proteins against orthomyxovirus (influenza), rhabdovirus, and bunyavirus the cotton rat as a model to study influenza pathogenesis and immunity the cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis co-infection of the cotton rat (sigmodon hispidus) with staphylococcus aureus and influenza a virus results in synergistic disease pathogenicity of a highly pathogenic avian influenza virus, a/chicken/yamaguchi/7/04 (h5n1) in different species of birds and mammals domestic pigs have low susceptibility to h5n1 highly pathogenic avian influenza viruses [comparative study research support animal models in influenza vaccine testing rift valley fever: an uninvited zoonosis in the arabian peninsula prevalence of anti-rift-valley-fever igm antibody in abattoir workers in the nile delta during the 1993 outbreak in egypt rift valley fever the occurrence of human cases in johannesburg the pathogenesis of rift valley fever epidemic rift valley fever in egypt: observations of the spectrum of human illness crc handbook series in zoonoses rift valley fever virus in mice. i. general features of the infection the pathogenesis of rift valley fever virus in the mouse model the susceptibility of rats to rift valley fever in relation to age inbred rat strains mimic the disparate human response to rift valley fever virus infection the gerbil, meriones unguiculatus, a model for rift valley fever viral encephalitis experimental rift valley fever in rhesus macaques development of a novel nonhuman primate model for rift valley fever crimean-congo hemorrhagic fever: a global perspective crimean-congo hemorrhagic fever the clinical pathology of crimean-congo hemorrhagic fever experimental congo virus (ib-an7620) infection in primates crimean congo hemorrhagic fever: a global perspective viremia and antibody response of small african and laboratory animals to crimean-congo hemorrhagic fever virus infection a comparative study of the crimean hemorrhagic faverdcongo group of viruses [comparative study ribavirin efficacy in an in vivo model of crimean-congo hemorrhagic fever virus (cchf) infection pathogenesis and immune response of crimean-congo hemorrhagic fever virus in a stat-1 knockout mouse model crimean-congo hemorrhagic fever virus infection is lethal for adult type i interferon receptorknockout mice possibility of extracting hyperimmune gammaglobulin against chf from donkey blood sera study of susceptibility to crimean hemorrhagic fever (chf) virus in european and long-eared hedgehogs. tezisy konf vop med virus field's virology epidemiological studies of hemorrhagic fever with renal syndrome: analysis of risk factors and mode of transmission a short review hantavirus pulmonary syndrome. pathogenesis of an emerging infectious disease field's virology centers for disease control & prevention. outbreak of acute illness-southwestern united states genetic diversity, distribution, and serological features of hantavirus infection in five countries in south america first reported cases of hantavirus pulmonary syndrome in canada [case reports an unusual hantavirus outbreak in southern argentina: person-to-person transmission? hantavirus pulmonary syndrome study group for patagonia hantavirus pulmonary syndrome: the new american hemorrhagic fever the incubation period of hantavirus pulmonary syndrome cardiopulmonary manifestations of hantavirus pulmonary syndrome hantavirus pulmonary syndrome a lethal disease model for hantavirus pulmonary syndrome pathogenesis of hantaan virus infection in suckling mice: clinical, virologic, and serologic observations infection of hantaan virus strain aa57 leading to pulmonary disease in laboratory mice hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice functional role of type i and type ii interferons in antiviral defense andes virus dna vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates andes virus infection of cynomolgus macaques wild-type puumala hantavirus infection induces cytokines, c-reactive protein, creatinine, and nitric oxide in cynomolgus macaques pathology of puumala hantavirus infection in macaques viral haemorrhagic fevers caused by lassa, ebola, and marburg viruses new opportunities for field research on the pathogenesis and treatment of lassa fever imported lassa fever lassa fever. effective therapy with ribavirin lassa virus hepatitis: a study of fatal lassa fever in humans lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin experimental inhalation infection of monkeys of the macacus cynomolgus and macacus rhesus species with the virus of lymphocytic choriomeningitis (we) arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation experimental studies of arenaviral hemorrhagic fevers lcmv-mediated hepatitis in rhesus macaques: we but not arm strain activates hepatocytes and induces liver regeneration mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever pathogenesis of lassa fever in cynomolgus macaques lassa fever encephalopathy: clinical and laboratory findings lassa fever encephalopathy: lassa virus in cerebrospinal fluid but not in serum lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues virus taxonomy, viiith report of the international committee on taxonomy of viruses pathogenesis of lassa virus infection in guinea pigs the effect of an arenavirus infection on liver morphology and function cardiovascular and pulmonary responses to pichinde virus infection in strain 13 guinea pigs pathogenesis of pichinde virus infection in strain 13 guinea pigs: an immunocytochemical, virologic, and clinical chemistry study pichinde virus infection in strain 13 guinea pigs reduces intestinal protein reflection coefficient with compensation clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with pirital virus (arenaviridae): a rodent model of lassa fever variation between strains of hamsters in the lethality of pichinde virus infections interferon alfacon-1 protects hamsters from lethal pichinde virus infection treatment of lethal pichinde virus infections in weanling lvg/lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen [comparative study research support global mortality associated with rotavirus disease among children in minimal infective dose of rotavirus rotavirus immunoglobulin levels among indian mothers of two socio-economic groups and occurrence of rotavirus infections among their infants up to six months analyses of clinical, pathological and virological features of human rotavirus strain, yo induced gastroenteritis in infant balb/c mice epizootic diarrhea of infant mice: identification of the etiologic agent immunity to rotavirus infection in mice development of an adult mouse model for studies on protection against rotavirus a gastrointestinal rotavirus infection mouse model for immune modulation studies protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin a rotavirus viremia and extraintestinal viral infection in the neonatal rat model [comparative study research support characterization of clinical and immune response in a rotavirus diarrhea model in suckling lewis rats development of a heterologous model in germfree suckling rats for studies of rotavirus diarrhea studies of oral rehydration solutions in animal models induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model developmental immunity in the piglet swine in biomedical research neonatal calf diarrhea induced by rotavirus characterisation of the primary local and systemic immune response in gnotobiotic lambs against rotavirus infection experimental infection of non-human primates with a human rotavirus isolate development of a rotavirus-shedding model in rhesus macaques, using a homologous wild-type rotavirus of a new p genotype reflections on 30 years of aids hivs and their replication the utility of the new generation of humanized mice to study hiv-1 infection: transmission, prevention, pathogenesis, and treatment antiretroviral pre-exposure prophylaxis prevents vaginal transmission of hiv-1 in humanized blt mice hematopoietic stem cell-engrafted nod/ scid/il2rgamma null mice develop human lymphoid systems and induce long-lasting hiv-1 infection with specific humoral immune responses hiv-1 infection and cd4 t cell depletion in the humanized rag2ã�/ã� gamma cã�/ã� (rag-hu) mouse model hiv-1 infection and pathogenesis in a novel humanized mouse model induction of robust cellular and humoral virusspecific adaptive immune responses in human immunodeficiency virus-infected humanized blt mice an aptamer-sirna chimera suppresses hiv-1 viral loads and protects from helper cd4(ã¾) t cell decline in humanized mice mucosal immunity and vaccines low-dose rectal inoculation of rhesus macaques by sivsme660 or sivmac251 recapitulates human mucosal infection by hiv-1 propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus limited dissemination of pathogenic siv after vaginal challenge of rhesus monkeys immunized with a live virulence and reduced fitness of simian immunodeficiency virus with the m184v mutation in reverse transcriptase siv-induced impairment of neurovascular repair: a potential role for vegf therapeutic dna vaccine induces broad t cell responses in the gut and sustained protection from viral rebound and aids in siv-infected rhesus macaques a nonfucosylated variant of the anti-hiv-1 monoclonal antibody b12 has enhanced fcgammariiiamediated antiviral activity in vitro but does not improve protection against mucosal shiv challenge in macaques a trivalent recombinant ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous siv challenge animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors susceptibility of hiv-2, siv and shiv to various anti-hiv-1 compounds: implications for treatment and postexposure prophylaxis use of a small molecule ccr5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection shiv-1157i and passaged progeny viruses encoding r5 hiv-1 clade c env cause aids in rhesus monkeys update on animal models for hiv research limited or no protection by weakly or nonneutralizing antibodies against vaginal shiv challenge of macaques compared with a strongly neutralizing antibody macaque studies of vaccine and microbicide combinations for preventing hiv-1 sexual transmission vpx is critical for sivmne infection of pigtail macaques impact of short-term haart initiated during the chronic stage or shortly post-exposure on siv infection of male genital organs the rhesus macaque pediatric siv infection modeld a valuable tool in understanding infant hiv-1 pathogenesis and for designing pediatric hiv-1 prevention strategies perinatal transmission of shiv-sf162p3 in macaca nemestrina immune and genetic correlates of vaccine protection against mucosal infection by siv in monkeys chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects efficacy assessment of a cell-mediated immunity hiv-1 vaccine (the step study): a double-blind, randomised, placebo-controlled, test-of-concept trial human papillomavirus in cervical cancer human papillomavirus research: do we still need animal models? animal models of papillomavirus pathogenesis evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of california public family planning administrative claims data the rabbit viral skin papillomas and carcinomas: a model for the immunogenetics of hpv-associated carcinogenesis protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection regression of canine oral papillomas is associated with infiltration of cd4ã¾ and cd8ã¾ lymphocytes characterization and experimental transmission of an oncogenic papillomavirus in female macaques a multimeric l2 vaccine for prevention of animal papillomavirus infections preclinical development of highly effective and safe dna vaccines directed against hpv 16 e6 and e7 us doctors investigate more than 50 possible cases of monkeypox isolation of monkeypox virus from wild squirrel infected in nature reemergence of monkeypox: prevalence, diagnostics, and countermeasures human monkeypox infection: a family cluster in the midwestern united states human monkeypox and other poxvirus infections of man the confirmation and maintenance of smallpox eradication human monkeypox identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models a prairie dog animal model of systemic orthopoxvirus disease using west african and congo basin strains of monkeypox virus comparison of monkeypox viruses pathogenesis in mice by in vivo imaging comparative pathology of north american and central african strains of monkeypox virus in a ground squirrel model of the disease experimental infection of an african dormouse (graphiurus kelleni) with monkeypox virus a mouse model of lethal infection for evaluating prophylactics and therapeutics against monkeypox virus experimental infection of ground squirrels (spermophilus tridecemlineatus) with monkeypox virus experimental infection of prairie dogs with monkeypox virus experimental infection of cynomolgus macaques (macaca fascicularis) with aerosolized monkeypox virus the pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (macaca fascicularis) immunogenicity of a highly attenuated mva smallpox vaccine and protection against monkeypox smallpox vaccine does not protect macaques with aids from a lethal monkeypox virus challenge smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus virulence and pathophysiology of the congo basin and west african strains of monkeypox virus in non-human primates a novel respiratory model of infection with monkeypox virus in cynomolgus macaques antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route establishment of the black-tailed prairie dog (cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high-and low-dose monkeypox virus challenges effective antiviral treatment of systemic orthopoxvirus disease: st-246 treatment of prairie dogs infected with monkeypox virus clinical characteristics of human monkeypox, and risk factors for severe disease hepatitis b virus infection cell culture and animal models of viral hepatitis. part i: hepatitis b risks of chronicity following acute hepatitis b virus infection: a review hepatitis b virus infectiondnatural history and clinical consequences clinical aspects of hepatitis b virus infection hepatitis b virus. the major etiology of hepatocellular carcinoma trans-activation of viral enhancers by the hepatitis b virus x protein identification of hepatitis b virus indigenous to chimpanzees detection of hepatitis b virus infection in wild-born chimpanzees (pan troglodytes verus): phylogenetic relationships with human and other primate genotypes antibody to hepatitis-associated antigen. frequency and pattern of response as detected by radioimmunoprecipitation hepatitis and blood transfusion perspectives on hepatitis b studies with chimpanzees hla a2 restricted cytotoxic t lymphocyte responses to multiple hepatitis b surface antigen epitopes during hepatitis b virus infection primates in the study of hepatitis viruses transfer of hbv genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice asymmetric replication of duck hepatitis b virus dna in liver cells: free minus-strand dna a virus similar to human hepatitis b virus associated with hepatitis and hepatoma in woodchucks effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection hepadnavirusinduced liver cancer in woodchucks animal models of hepadnavirus-associated hepatocellular carcinoma hepatitis b viruses and hepatocellular carcinoma hepatitis b virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model animal models of hepatitis delta virus infection and disease experimental hepatitis delta virus infection in the chimpanzee expression of the hepatitis delta virus large and small antigens in transgenic mice experimental hepatitis delta virus infection in the animal model humanized chimeric upa mouse model for the study of hepatitis b and d virus interactions and preclinical drug evaluation key: cord-031279-8rckjc41 authors: enriquez, josue; mims, brianyell mc daniel; trasti, scott; furr, kathryn l.; grisham, matthew b. title: genomic, microbial and environmental standardization in animal experimentation limiting immunological discovery date: 2020-09-02 journal: bmc immunol doi: 10.1186/s12865-020-00380-x sha: doc_id: 31279 cord_uid: 8rckjc41 background: the use of inbred mice housed under standardized environmental conditions has been critical in identifying immuno-pathological mechanisms in different infectious and inflammatory diseases as well as revealing new therapeutic targets for clinical trials. unfortunately, only a small percentage of preclinical intervention studies using well-defined mouse models of disease have progressed to clinically-effective treatments in patients. the reasons for this lack of bench-to-bedside transition are not completely understood; however, emerging data suggest that genetic diversity and housing environment may greatly influence muring immunity and inflammation. results: accumulating evidence suggests that certain immune responses and/or disease phenotypes observed in inbred mice may be quite different than those observed in their outbred counterparts. these differences have been thought to contribute to differing immune responses to foreign and/or auto-antigens in mice vs. humans. there is also a growing literature demonstrating that mice housed under specific pathogen free conditions possess an immature immune system that remarkably affects their ability to respond to pathogens and/or inflammation when compared with mice exposed to a more diverse spectrum of microorganisms. furthermore, recent studies demonstrate that mice develop chronic cold stress when housed at standard animal care facility temperatures (i.e. 22–24 °c). these temperatures have been shown alter immune responses to foreign and auto-antigens when compared with mice housed at their thermo-neutral body temperature of 30–32 °c. conclusions: exposure of genetically diverse mice to a spectrum of environmentally-relevant microorganisms at housing temperatures that approximate their thermo-neutral zone may improve the chances of identifying new and more potent therapeutics to treat infectious and inflammatory diseases. use of genetically standardized mice exposed to a welldefined, pathogen free microbiota has markedly reduced the variability of disease phenotype reported by different laboratories. despite these important advancements, only 10% of promising therapeutic strategies reported in mouse models of disease have gone on to be used as clinically-effective treatments in patients [2] [3] [4] . it has been suggested that differences in murine vs. human immune systems may account for the reduced success of translation of preclinical data [3, [5] [6] [7] [8] [9] [10] [11] . it is well-known that the structure and cellular composition of the murine immune system is, in some cases, substantially different than that of humans [6, [12] [13] [14] [15] [16] . these differences are thought to contribute to differing immune responses to foreign and/or self-antigens in mice vs. humans [17] . indeed, the debate continues as to whether genomic responses of mice during inflammation mimic those in humans [18] [19] [20] . in addition to differences in immunological responses between the two species, there is a growing literature suggesting that housing inbred mice in ultra-clean conditions at temperatures well-below their thermoneutral zone, may significantly alter their response to infectious micro-organisms and tumor cells as wells as to allo-and auto-antigens. for example, inbred mice housed under specific pathogen free (spf)/ barrier conditions may respond to microbial infections or inflammatory mediators differently than do outbred mice or inbred mice colonized with more diverse communities of microorganisms [12, 15] . in addition, virtually all animal care facilities house mice at 22-24°c that is well below their thermoneutral zone. these housing temperatures create chronic cold stress that are known to alter murine immune responses to different foreign or auto antigens when compared with mice housed at their thermo-neutral body temperature of 30-32°c [15, [21] [22] [23] [24] . when taken together, it is reasonable to assume that these intrinsic and extrinsic factors may markedly affect the translational nature of preclinical studies using mouse models of infectious and inflammatory diseases. this review discusses how genetic diversity and the environment affects immunity and inflammation in mice and describes how potential modifications of current animal husbandry and experimental protocols may help to more closely model infectious and inflammatory diseases. the use of mice to study immune responses to infection and inflammation have revealed a number of fundamental principles that have been confirmed in humans. one paradigm-changing example of how mouse models have advanced our understanding of immune regulation is recognition that failure to maintain tolerance to commensal bacteria and/or autoantigens results in the development of chronic inflammatory diseases [25] [26] [27] . although these and other important studies have helped to uncover a number of novel immuno-pathogenic mechanisms underlying infectious and inflammatory diseases, relatively few of the promising therapeutic treatments or interventions reported in follow up studies have been translated into effective therapies in humans [2-4, 7, 17] . as discussed above, several reasons have been proposed to account for the low bench-to-bedside transition that have largely focused on differences in immune system composition and function in mice vs. humans. more recent studies have begun to address the likelihood that the restricted genetic diversity of inbred mice may limit their ability to express the full range of immune responses that are observed in diverse human populations. accumulating evidence suggests that certain immune responses and/or disease phenotypes observed in inbred mice may be quite different than those observed in their outbred counterparts [28] [29] [30] [31] [32] . this is not surprising given the fact that inbred strains of mice are produced by single lineage brother/sister mating for at least 20 generations. because this type of breeding scheme produces mice that are genetically identical, there is far less inter-animal variability. however, it should be noted that this type of breeding scheme produces inbreeding depression and reduced genetic diversity [33] . the use of inbred mice to model human disease is tantamount to using "multiple copies of one individual" [17] . while this tool has been crucial to our understanding of innate and adaptive immunity, it most likely does not capture the hybrid vigor and genetic diversity present in humans. historically, outbred mice have been used for toxicological, pharmacological, cancer and aging research. the most common outbred stocks used in preclinical studies include cd-1, institute for cancer research (icr), swiss webster (sw) and nih swiss mice [33] . the majority of outbred mice used in the u.s. today are derived from 2 male and 7 female, non-inbred albino mice that were imported from switzerland by dr. carla lynch to the rockefeller institute for medical research in 1926 [34] . these original stocks were collectively referred to as "swiss" mice. it should be noted that different lineages of outbred mice are referred to as "stocks" whereas inbred lineages of mice are referred to as "strains" [33] . by definition, outbred stocks are "a closed population … of genetically variable animals that are bred to maintain maximum heterozygosity" [34] . in theory, no two individuals are genetically identical within an outbred stock. siblings of inbred strains of mice are genetically identical that are maintained through brother and sister mating for 20 or more generations [33] . because outbred stocks are genetically more diverse than inbred strains, data obtained using these mice tend to be more variable requiring substantially larger numbers of animals for statistical power [34] . thus, the majority of published studies exploring the immuno-pathogenesis of infectious and inflammatory diseases have used the more genetically homogeneous inbred strains. despite the advantages of using inbred strains, there is a clear need to understand how genetic diversity influences immunity and inflammation. below, we present an overview of several studies that highlight the differences in immune responses between different strains and stocks of mice subjected to infection or inflammation. it is now well-known that the susceptibility of inbred and outbred mice to infectious micro-organisms may be quite different. thus, translation of preclinical data based upon only one strain or stock may be problematic. for example, citrobacter rodentium (c. rodentium) infection induces severe but self-limiting diarrhea, colonic epithelial hyperplasia and mild intestinal inflammation in a variety of mice on different genetic backgrounds. borenstein et al. demonstrated that infection of outbred sw mice with c. rodentium recapitulated this phenotype i.e. subclinical and self-limiting intestinal inflammation [35] . however, when inbred mice derived from the sw stock [called friend virus b (fvb)] mice were infected with c. rodentium, they developed a lethal disease characterized by severe ulcerative colitis [35] . in a more recent study, sunagar et al. compared the immune responses of sw vs. inbred c57bl/6 mice to infection with the highly virulent pathogen franscisella tularensis (ft) [36] . this tier 1 bio-threat has been extensively studied over the past several years yet no fda-approved vaccine has been developed. sunagar et al. found that outbred sw mice were more resistant to ft challenge and were better protected from the lethal effects of this pathogen following vaccination than were inbred c57bl/6 mice [36] . the authors concluded that outbred mice may more accurately reflect the genetic diversity of human immunity to this deadly pathogen. another example of differential susceptibility between inbred and outbred mice to an infectious agent was recently reported by carreras et al [37] .. these investigators found that c57bl/6 mice were more susceptible than cd1 mice to the lethal effects of sepsis induced by intravenous administration of the fungus candida albicans when compared with c57bl/6 [37] . in another study using a mouse model of streptococcus suis (s. suis)-induced sepsis and cerebral inflammation, dominguez-punaro et al. reported that while infection of different inbred strains of mice (e.g. balb/c, c57bl/6, a/j) with s. suis caused septic shock and death, it did not induce meningitis and encephalitis [38] . in contrast, these investigators showed that infection of outbred cd1 mice with s. suis induced rapid and systemic production of high levels of several different inflammatory cytokines that likely contributed to the death of 20% of the mice within the first 48 h following infection [39] . in those mice that survived, approximately 40% developed clinical signs of meningitis between days 4 and 9 post-infection. these exciting studies provided the first demonstration that hematogenous infection with s. suis produces both septic shock and cerebral inflammation. one immune cell that plays a critical role in recognizing and eliminating intracellular pathogens (e.g. viruses, bacteria, protozoan) and tumor cells is the cd8 + t cell [40] . the ability to accurately define the magnitude and kinetics as well as the phenotypic and functional characteristics of cd8 t cells following pathogen infection is not only important for our understanding of immune regulation but it is also crucial for developing new and more robust vaccination protocols. much of what we have learned about t cell-mediated immunity has come from studies using inbred mice [31, 41] . recent studies from the badovinac laboratory have shown that infection of outbred sw mice with either listeria monocytogenes (lm) or armstrong strain of lymphocytic choriomeningitis virus (lcmv) results in large animal-to-animal variations in pathogen-specific cd8 t cell responses when compared with their inbred c57bl/6 counterparts. these data suggest that genetic background may control the magnitude of cd8 t cell expansion in response to pathogen infection [31, 41] . in addition, martin et.al. found that infection of sw mice with lm or lcmv generated a number of different populations of pathogen-specific cd8 t cells and much greater variability in the kinetics of phenotypic progression of agspecific cd8 t cells when compared with c57bl/6 mice [31] . importantly, these investigators found, using an infection/reinfection protocol, that c57bl/6 mice were protected from the lethal effects of lm whereas survival of sw mice was significantly more variable. these studies illustrate the larger degree of variability of t cell responses to pathogen infection in outbred mice. allograft rejection the use of genetically restricted, inbred mice have been the mainstay for the large majority of studies exploring the immunopathogenesis of transplant rejection a variety of different tissue allografts. in one of the few studies that has assessed the effects of genetic diversity of donor and recipient on allograft survival in mice, reichenbach et al. performed vascularized, heterotopic heart transplantation in outbred and inbred mice [29] . they found that all heart allografts that were obtained from an inbred strain and transplanted into a different recipient strain (e.g. inbred→inbred) or into an outbred stock (inbred→outbred) were rejected within 6-16 days. in contrast, when heart allografts obtained from outbred donors and transplanted into an inbred (outbre-d→inbred) or outbred recipient (outbred→outbred), they observed a spectrum of outcomes that included very early rejection (< 4 days) in 30% of the recipients, acute rejection (6-24 days) in 54% of the transplanted recipients and chronic rejection (> 75 days) in 17% of the recipients [29] . the striking, very early rejection observed in 30% of the outbred→inbred and outbre-d→outbred mice did not appear to be classic hyperacute rejection since the presence of preformed, anti-donor antibodies in recipients was very low or absent. in fact, very early allograft rejection was characterized by neutrophilic vasculitis and hemorrhagic necrosis that could be abrogated by depletion of neutrophils or complement [29] . these investigators concluded that very early allograft failure was dependent on the genetic diversity of outbred donor mice and not the recipient. intestinal inflammation a number of mouse models of the inflammatory bowel diseases (e.g. ibd; crohn's disease, ulcerative colitis) have been developed to investigate the immuno-pathogenesis of these chronic inflammatory disorders. although a great deal of important mechanistic information has been obtained using these preclinical mouse models, only a small percentage (< 10%) of promising targets and therapeutic interventions have been translated to patient treatment [3, 7] . a recent study by barone et al. sought to determine how genetic diversity (and gender) affects the onset and severity of chronic colonic inflammation induced by intra-rectal administration of the haptenating agent dinitrobenzene sulfonic acid (dnbs) in c57bl/6 inbred vs cd1 outbred male and female mice [32] . colonic inflammation was induced via two intra-rectal injections of dnbs spaced 21 days apart and assessed for evidence of colonic inflammation. barone et al. found that colonic administration of dnbs significantly reduced survival of cd1 male and female mice compared with c57bl/6 mice as well as reduced body weight to a greater extent in cd1 vs. c57bl/6 mice. in addition, cd1 mice displayed greater macroscopic and histopathological evidence of colitis when compared with their inbred counterparts, suggesting that cd1 outbred mice may be more susceptible to chemically-induced colitis [32] . these findings suggest that the use of outbred mice may provide investigators with new information to better understand the immunomodulatory mechanisms associated with this model of chronic colitis. inflammatory angiogenesis inflammation and angiogenesis are important physiological responses that are required for fibrovascular tissue growth and wound healing. however, dysregulation of this proliferative response may result in the development of chronic inflammatory diseases such as atherosclerosis, rheumatoid arthritis, asthma and inflammatory bowel disease, to name just a few [42] [43] [44] [45] [46] [47] . recent studies by andrade and coworkers examined how host genetic diversity may influence the development and perpetuation of inflammatory angiogenesis and fibrogenesis. using a wellcharacterized mouse model of peritonitis, they compared the immuno-pathological responses (e.g. inflammatory cell infiltration, angiogenesis and fibrosis) in three inbred strains (dba-1, balb/c, c57bl/6) and one outbred strain (swiss) [47, 48] . these investigators observed highly variable responses among the four different groups of mice at 7 days following implantation. for example, angiogenesis and macrophage infiltration were greatest in c57bl/6 mice when compared with the other three inbred strains of mice [47] . interestingly, fibrogenesis markers, as assessed by implant-derived transforming growth factor beta-1 and collagen were consistently lower in dba/1 mice when compared with the other three inbred strains. in addition to defining the angiogenic and fibrogenic profiles among the different inbred and outbred mice, marques et al. investigated how host genetics affected the anti-platelet activity of dipyridamole (dp) in their peritonitis model [47] . overall, they found that dp treatment exerted a more generalized anti-inflammatory response in inbred strains vs outbred swiss mice with significant anti-fibrogenic effects observed only in c57bl/6 mice [47] . taken together, these data demonstrate that inflammatory angiogenesis is highly strain dependent and highlight the importance of host genetics in these models of peritonitis. neuroinflammation murine experimental autoimmune encephalomyelitis (eae) is a mouse model of t cellmediated demyelinating disease of the central nervous system (cns) that is used to study the immunepathogenesis of human multiple sclerosis (ms) [49, 50] . this autoimmune model of ms is induced in mice via immunization with different myelin-derived antigens such as myelin basic protein (mbp), myelin oligodentrocyte glycoprotein (mog) or proteolipid protein (plp) [49, 50] . it is well-recognized that different inbred strains of mice exhibit differential susceptibility to antigeninduced eae [49, 50] . one of the few published studies that have compared the immunological responses of susceptible c57bl/6 mice to those of resistant outbred cd1 mice following immunization with the mog peptide has been reported by marin et al. [51] . using identical immunization protocols, these investigators found that t cells obtained from immunized c57bl/6 mice were capable of enhanced proliferation when challenged with mog in vitro whereas t cells from cd1 mice showed little or no proliferation. in addition, marin and coworkers found that immunization of cd1 mice with mog 35-55 peptide increased the percentages of regulatory t and b cells when compared with c57bl/6 mice. the authors concluded that the resistance of cd1 mice to mog induced eae may be mediated by expansion of regulatory t and b cells via mhc-independent mechanisms. nikodemova et al. compared neuro-inflammatory responses of microglial cells obtained from inbred c57bl/ 6 vs. outbred icr/cd1 mice subjected to lipopolysaccharide (lps) administration in vitro and in vivo. for their in vitro studies, they used bv2 and n9 microglial cell lines that were originally derived from either c57bl/6 inbred mice or icr/cd1 outbred mice, respectively as well as primary microglial cells derived from the brains of the two different mice [28] . they found that addition of lps to n9 cells (derived from icr/cd1 mice) induced large and significant production of tnfα and the nitric oxide (no)-derived metabolite, nitrite that were significantly greater than those produced by the lps-activated bv2 (c57bl/6) microglial cells [28] . in addition, they found that addition of lps to icr/cd1 primary microglial cells induced greater amounts of tnfα and nitrite when compared with lpsactivated microglial cells obtained from c57bl/6 mice. furthermore, intra-parenchymal injection of lps induced greater expression of mrna for tnfα, il-6 and inducible no synthase in microglial cells from icr/cd1 vs c57bl/6 mice [28] . taken together, these data demonstrate the influence of host genetics on microglial responses to inflammatory mediators in vitro and in vivo. the use of the commercially available stocks of outbred mice has provided investigators with a greater understanding of range and variability of immune responses that may not be observed using inbred strains. nevertheless, outbred stocks may in many cases, exhibit genetic lability as well as a poorly defined genotype and genetic variation within and between different stocks [34] . in an attempt to approximate the complex interactions of genes involved in human immune responses, a genetically-diverse reference population of mice has been generated that is referred to as collaborative cross (cc) mice [52, 53] . this unique panel of genetically diverse mice was generated by combinational "funnel" breeding schemes using 8 unique and genetically diverse founder strains of mice that included 3 inbred strains (c57bl/6, a/j, 129s1/svimj), 2 inbred mouse models of disease (nod/shiltj-type 1 diabetes and new zealandobese/type 2 diabetes mice) and 3 wild-derived strains (cast/eij, pwk/phj, and watkins star line b (wsb)/ eij mice) ( fig. 1 ) [30, [53] [54] [55] . partial recombinant inbred strains of cc mice (termed pre-cc mice) were produced by three generations of funnel breeding followed by brother-sister/inbred mating for 4-5 generations. over the past few years, different strains of the pre-cc mice were interbred for at least 20 generations thereby creating numerous recombinant inbred cc strains termed cc-ri strains. both pre-cc and cc-ri strains contain genetic contributions from all eight of the original founders that display~90% of the known genetic variation present in wild mice (mus musculus) [30, 53] . each mouse within a given cc-ri strain is genetically identical containing maximum allelic variation whereas each cc-ri strain is genetically distinct from all other cc-ri strains. to date, more than 60 individual cc-ri strains have been created at the university of north carolina (http://www.csbio.unc.edu/ccstatus/index.py?run= ccv). additional cc strains of mice have been created by interbreeding two different cc-ri strains to generate f1 recombinant intercross offspring (cc-rix) that are heterozygous for the h-2b major histocompatibility complex (mhc) [30, 56] . this type of breeding scheme allows investigators to use specific reagents (e.g. mhc tetramers) to examine different aspects of t cellmediated immunity. pre-cc, cc-ri and cc-rix mice have been used to characterize immune responses to human viral pathogens (e.g. influenza, west nile and ebola), chronic inflammation and cancer [30] (and references therein). by observing the spectrum of disease phenotypes in models of infectious and inflammatory diseases using well-defined strains of cc-ri or cc-rix strains in which the genetics have been wellcharacterized, investigators may be able to identify disease susceptibility loci [54] . multiple cc strains have been used to identify promising candidate genes that influence susceptibility or resistance to viral infections [54] . the studies outlined above provide examples of how murine genetic diversity may affect immune responses to pathogens and/or inflammatory mediators. these studies suggest that inbred strains may be better suited for initial investigations to define specific immunopathological mechanisms of infectious and inflammatory diseases with follow up studies using outbred mice to address the role of genetic diversity in these models. the mammalian body is home to a plethora of microorganisms that include prokaryotes (bacteria and archaea), viruses and eukaryotes (fungi, helminths and protozoa). a recent reevaluation of the total numbers of bacteria in the human body reports that the colon contains 10 14 bacteria followed by the small bowel (10 11 ), skin (10 11 ) and saliva (10 11 ) [57, 58] . under normal, steady state conditions, these commensals play a critical role in the development, instruction and function of the host immune system [59] . although the host immune system limits translocation of commensal bacteria into tissue and the systemic circulation, emerging evidence demonstrates that bacterial components and metabolites gain access to the systemic circulation and peripheral tissues where they may modulate tissue function [60] . josefsdottir et al. recently reported that intestinal bacterial products such as microbial-associated molecular patterns are required for robust hematopoiesis [61] other groups of commensal microorganisms that are particularly prevalent in the gut lumen are eukaryote and bacterial viruses [62] . in addition to their well-known pathogenic properties, both groups of viruses are known to possess potent immunomodulatory properties. for example, studies have shown that infection of mice with certain eurkaryote viruses are capable of attenuating development of chronic inflammation in mouse models of type i diabetes and sle-like disease (see [62] and references therein). in addition, liu et al. recently reported that eukaryotic viruses are required for maintaining appropriate numbers of intraepithelial lymphocytes in the small and large bowel [63] . bacterial viruses (i.e. bacteriophage) are also thought to protect the gut and host by infecting and killing pathogenic bacteria. a study by barr et.al . demonstrated that bacteriophage are highly enriched in the gut mucus layer where they are thought to interfere with adhesion of pathogenic bacteria to the gut epithelium thereby preventing or limiting their invasion into the tissue [64] . the mammalian gut and skin are also colonized with a diverse population of fungi. although not as well studied as other commensals, data suggest that certain fungi play important roles in immune system development. zhang et al. reported that intra-gastric administration of candida tropicalis (but not trichosporon asahii nor saccharomyces cerevisiae) to immune cell-deficient germ free mice or wild type mice treated with an antifungal cocktail promoted the migration of retinaldehyde dehydrogenase positive dendritic fig. 1 generation of collaborative cross mice. a. this unique panel of genetically diverse mice was generated by interbreeding 8 unique and genetically diverse founder strains of mice that included 3 inbred laboratory strains (c57bl/6, a/j, 129s1/svimj), 2 inbred mouse models of disease (nod/shiltj-type 1 diabetes and new zealand-obese/type 2 diabetes mice) and 3 wild-derived strains (cast/eij, pwk/phj, and watkins star line b (wsb)/eij mice). each strain was assigned both a letter (a-h) and a specific color. b a combinational funnel breeding scheme was used to produce offspring with equal distribution of founder alleles. this figure illustrates the specific breeding funnel for the generation of the cc strain cc001. c color illustration of founder genome contributions to cc001 strain. reproduced from [54] with permission cells into lymph nodes (lns) draining the gut and skin thereby stimulating the development of functional lns and gut-associated lymphoid tissue [65] . in another study, markey et al. reported that colonization of mice with candida albicans protects mice from a subsequent lethal challenge with the bacterial pathogen clostridium difficile [66] . although the vast majority of all microbiome studies have focused on prokaryotes, emerging studies are demonstrating multi-cellular helminths and unicellular protozoa represent additional groups of commensal residents in the healthy gut that possess immunomodulatory activity. historically, past investigations have focused almost exclusively on the parasitic and pathogenic properties of these eukaryotes. although these multicellular organisms can produce severe disease, colonization does not necessarily result in disease [67] recent studies suggest that these organisms may in fact, represent true commensal microbiota that may possibly protect their host [68, 69] . for example, helminths are known to release a variety of excretory-secretory (es) components that have been shown to modulate the functions of several immune cells as well as induce the generation of immunosuppressive regulatory t cells (tregs) and modify the intestinal microbiota (reviewed in [68] . indeed, there is a growing literature demonstrating that colonization of animals with helminths or treatment with certain es components attenuate allergic and chronic inflammatory diseases [68, 70] . in addition to helmiths, the parasitic and disease producing properties of protozoa have been studied extensively over the past several decades. recent evidence suggests that while many protozoa are indeed pathogens, several of these unicellular microorganisms have been identified in the healthy microbiota [69] . one such commensal is blastocystis spp. this protozoa has been shown to enhance the diversity and alter the microbial composition of individuals in industrialized countries, suggesting that microorganisms may exert a beneficial effect to the host [69] . these observations are particularly important given the fact that industrialized countries have attempted to eliminate both helminths and protozoa thereby limiting parasitic infections. loss of these and possibly other commensal eukaryotes appears to be associated with dramatic increases in allergic and inflammatory diseases over the past five decades [68, 69] . a major breakthrough in our fundamental understanding of innate and adaptive immunity occurred following the generation of mice containing spontaneous or genetically-engineered alterations in specific genes related to immune system development and/or function. because many of these mutant mice were immunocompromised, it was necessary to develop animal housing conditions that would prevent the introduction of pathogens into the mouse colonies. in addition to maintaining a healthy environment for these mice, eliminating the introduction of known mouse pathogens into the vivarium allowed for more consistent breeding of mice as well as more reproducible induction disease phenotypes [71] . although the term "specific pathogen-free" (spf) was first used in the 1950s, it wasn't until the 1980s when animal care facilities began to use filter top micro-isolator cages in conjunction with meticulous biocontainment protocols to limit the introduction of murine pathogens into these facilities [71] . currently, all animal care facilities in the u.s. continuously monitor for (and exclude) known murine pathogenic viruses, bacteria and parasites to create spf conditions. in addition, mice are housed under barrier conditions that require animals to be kept in micro-isolator cages with filter top lids or in individually ventilated cages (ivc) that use hepa filtered air rather than ambient air. furthermore, barrier facilities use sterilized cages, food, and water. these ultra-hygienic housing conditions have been incredibly important for the biomedical research community because they essentially "standardized" the mouse microbiome that appeared to reduce the variability of results observed by different laboratories. however, recent evidence suggests the immune system of mice raised under spf/barrier conditions is immature when compared with their wild (i.e. feral) counterparts and to adult humans suggesting natural exposure to pathogens may be important in promoting maturation of the immune system [12, 16, 71] . the following sections will focus on how the composition of intestinal bacteria influences immunity and inflammation. infection a recent study by beura et al. demonstrated that feral (i.e. wild) or pet store-housed mice exhibited an immune cell composition similar to adult humans whereas spf/barrier-housed mice possessed an immune system that was more akin to neonatal humans (fig. 2a & b) [12] . these investigators found that spf/barrier mice and neonatal humans have many fewer antigenexperienced, cd8 + memory/effector t cells when compared with feral or pet store-housed mice or adult humans (fig. 2c & d) . these and other analyses suggested that exposure of mice to the diverse spectrum of microorganisms that are normally encountered during the wild greatly influences the maturation and cellular composition of their immune system. furthermore, these investigators showed that infection of spf/barrierhoused c57bl/6 mice with the intracellular pathogenic bacteria listeria monocytogenes (lm) had > 10,000-fold greater bacterial load than did pet store mice infected with same pathogen suggesting that exposure to diverse microbiota greatly increases resistance to pathogenic bacteria [12] . although pet store mice do in fact possess a more diverse microbiota than spf/barrier mice, it is likely to be less diverse than free-living feral mice and humans who are exposed to an even greater spectrum of viral, bacterial and parasitic micro-organisms. rosshart et al. recently tested the hypothesis that colonization of spf/barrier-housed mice with intestinal microbiota obtained from feral mice would greatly influence immune responses to viral pathogens [15] . these investigators captured over 800 feral mice from horse barns located in several different regions of maryland and washington d.c. of these, 98 mice were found to be mus musculus domesticus, the feral species of mouse that is most closely related to common laboratory mice such as c57bl/6 mice. surprising, despite being exposed to pathogens in the wild, a number of captured mice were found to be pathogen-free with no observable evidence of disease. not surprisingly, rosshart et al. determined that the intestinal microbiota of feral mice was significantly different from that of commercially available c57bl/6 mice [15] . colonization of pregnant, germ free c57bl/6 mice was performed using daily oral gavage of microbiota (for 3 days) from pathogen-free feral mice or from spf/barrier c57bl/6 microbiota. these mice were referred to as wildr and labr mice, respectively. spf/barrier-housed c57bl/6 mice (called lab mice) were used to compare to wildr and labr mice. all three groups of mice were then infected via intranasal administration of the mouse-adapted, influenza a virus (iav; puertorico/8/1934 h1n1 strain). surprisingly, 92% of the wildr mice infected with iav survived for 18 days post-infection whereas only 17% of the labr and lab mice were alive at 18 days post-infection (fig. 3a) [15] . survival of wildr mice was associated with ∼10-fold lower titers of lung-residing iav as well as significantly lower lung histopathology scores and fig. 2 mice housed under spf/barrier conditions lack differentiated memory cd8 + t cell subsets compared with feral mice, pet store mice and adult humans. a percentages of cd8 + t-cell phenotypes in laboratory/spf mouse blood, adult human blood and human neonatal cord blood. the top panels are gated on cd3 + /cd8 + cells with naïve t cells highlighted in blue, central memory t cells highlighted in green and effector memory t cells highlighted in red as defined by established lineage markers in each species. bottom panels are gated on antigen-experienced subsets as defined in the green and red quadrants above). b percentages of granzyme b + /cd8 + t-cells are much less in the antigen-experienced subsets of laboratory mice and neonatal humans when compared with adult humans. c and d percentages of naïve cd8 + t cells (cd44 lo / cd62l hi ) in pbmcs from laboratory mice are much greater than those in pbmcs from feral and pet store mice whereas percentages of antigenexperienced c8 + t cells (cd44 hi /cd62l lo ) were significantly greater in feral and pet store mice when compared those in laboratory mice. reproduced from [12] with permission inflammatory cytokine levels when compared with labr and lab mice (fig. 3b) . overall, these exciting studies strongly suggested that colonization of laboratory mice with feral microbiota protects the host from a potentially lethal viral infection observed in spf/barrier mice. fig. 3 colonization of germ free mice with microbiota obtained from feral mice protects against viral infection and inflammation-induced cancer. pregnant, germ free c57bl/6 mice were colonized via oral gavage of gut microbiota obtained from feral mice (wildr mice) or from spf c57bl/6 mice (labr mice). barrier-housed c57bl/6 mice (lab mice) were used as controls to compare to wildr and labr mice. a male and female mice in all three groups of mice were infected (intranasally) with influenza a virus (iav; puerto rico/8/1934 h1n1 strain). approximately 92% of the wildr mice infected with iav survived for 18 days post-infection whereas only 17% of the labr and lab mice were alive at 18 days post-infection. b survival of wildr mice was associated with ∼10-fold lower titers of lung-residing iav as well as significantly lower lung histopathology scores and inflammatory cytokine levels when compared with labr and lab mice. c inflammation-induced colorectal cancer was induced in all three groups of mice via a single injection (i.p.) of the mutagen azoxymethane (10 mg/kg of body weight) followed by induction of colonic inflammation via oral (ab libitum) administration of dextran sodium sulfate (2-2.5%) in the drinking water. representative images of dissected colons demonstrated greater numbers of colonic tumors (tumors indicated by red dots) in lab and labr mice when compared with wildr mice. d top panel: representative histopathology (10x magnification) of h&e-stained sections of longitudinal colon tumors with arrows indicating well-differentiated adenocarcinoma in the mucosa. histopathological analyses revealed that lab and labr developed tubular adenoma, well-differentiated tubular adenocarcinoma and mucinous carcinoma. furthermore, mucinous carcinoma cells were found invading the submucosa and muscular layer where moderate-severe inflammation was also noted. asterisks identify mucinous nodules. in contrast, wildr mice developed smaller numbers of colonic tumors, reduced tumor area/colon area, diminished tumor invasion and less inflammation when compared with the labr and lab mice that received the same treatment protocol. bottom panel: movat's staining of serial sections from the same tumors presented in the top panels clearly shows the presence of mucinous nodules (mucin stains green) containing mucinous carcinoma cells in submucosa and muscle layers of lab and labr but not wildr tumors. reproduced from [15] with permission the studies described above are consistent with two other reports that characterized the differences in immune cell composition and responses in feral vs. laboratory mice infected with different pathogens. abolins et al. foud that innate and adaptive immune cells in feral mice exist in a much higher state of activation when compared with barrier-housed laboratory mice [72] . because feral but not spf/barrier mice were found to be seropositive for several microbial, parasitic and myocoptes (mites) organisms, the authors suggested that alterations in the different immune cell populations and their responses were most likely driven by pathogen infection of these free-living rodents. these data agreed well with those reported by reese et al. who found that sequential infection of spf/barrier mice with three viral, bacterial and parasitic pathogens known to infect children, induced gene expression patterns in blood cells that were quite similar to those observed in pet storehoused mice and human adults [73] . autoimmune and chronic inflammatory diseases it is well known that the phenotype of different mouse models of autoimmune and chronic inflammatory diseases may be dramatically altered by changes in institution, housing conditions, and/or diet [74] [75] [76] [77] . this is not surprising given the evidence demonstrating that the intestinal microbiota of mice may vary greatly among different animal care facilities and animal vendors [74, 75, [78] [79] [80] . several laboratories including our own, have shown that the incidence and severity of chronic gut inflammation in different mouse models of inflammatory bowel disease is markedly altered by changing animal care facilities or by purposely altering the gut bacteria [81] [82] [83] [84] [85] [86] [87] . in addition to its effects on intestinal inflammation, alterations in gut bacteria have been found to greatly influence the onset and severity of joint inflammation. using the k/bxn t cell receptor transgenic mouse (kbn) model of autoimmune arthritis [88] , wu et al. demonstrated that when kbn mice were housed under spf/barrier conditions, they developed chronic and severe arthritis whereas housing these mice under germ free (gf) conditions exhibited greatly reduced disease [89] . in addition, when newborn kbn mice were continuously treated with vancomycin or ampicillin for several weeks, disease severity was markedly reduced suggesting that commensal microbiota were required for induction of disease [89] . ivanov et al. had previously reported that a single bacterial species within the commensal flora called segmented filamentous bacteria (sfb) was capable of inducing the generation of intestinal lamina propria (i-lp) th17 cells that are thought to play a role in the development of arthritis [79] . thus, wu et al. colonized gf mice with sfb to determine whether this one bacterial species could recapitulate the disease-producing effects of the spf microbiota. indeed, they found that colonization with sfb induced the generation of i-lp th17 cells that produced robust autoimmune arthritis [89] . similar findings were reported by lee et al. who showed that while gf mice failed to develop eae, gf mice colonized with sfb developed severe eae [90] . these important studies demonstrated that a single group of commensal bacteria is capable of inducing autoimmune disease in different tissues via the generation of a specific disease-producing t cells. although sfb are important in promoting inflammatory tissue damage in mouse models of arthritis and ms, other studies demonstrate that the presence of sfb may limit the development of other chronic inflammatory diseases such as diabetes. it has been known for more than 25 years that the incidence and severity of experimental autoimmune diabetes is markedly increased when nonobese diabetic (nod) mice are housed under gf conditions suggesting that commensal bacteria may protect against autoimmune destruction of islet cells [76, 80] . kriegel et al. took advantage of the fact that their nod mouse colony was variably colonized with sfb to examine whether the presence or absence of sfb affected the incidence and/or severity of diabetes in males and females. they found that 91% of the sfb-negative (sfb-) females developed robust disease by week 30 whereas only 16% of the sfb-colonized (sfb+) females developed hyperglycemia [80] . in contrast, both sfb+ and sfbmales developed little or no disease with an overall incidence of < 20%. furthermore, development of insulitis occurred in both sfb+ and sfb-females suggesting that the presence of sfb somehow interferes with the progression of islet inflammation to hyperglycemia. inflammation and tumorigenesis colorectal cancer (crc) is one of the most common forms of cancer in modernized (i.e. westernized) societies that is predicted to increase over the next 20 years [91, 92] . it is becoming increasingly appreciated that changes in diet in modernized societies may contribute to the development of crc by altering intestinal microbiota communities and immune responses that may promote gut inflammation [91, 93] . because rosshart et al. demonstrated that colonization of barrier mice with feral mouse microbiota protected these wildr mice from the lethal effects of the viral pathogen iav (discussed above), this same group wished to determine whether wildr mice would also be protected in a mouse model of crc [15] . to do this they used the well-characterized mutagen and inflammation model of crc in which mice were injected (i.p.) with the mutagen azoxymethane followed by induction of colonic inflammation via oral administration of dextran sodium sulfate. this model exhibits chronic colitis that progresses to high grade dysplasia and development of crc [15, 94] . they found that wildr mice developed smaller numbers of colonic tumors, reduced tumor area/colon area and diminished tumor and inflammatory cell invasion when compared with the labr and lab mice that received the same treatment protocol [15] (fig. 3c) . there is no question that spf/barrier housing has greatly enhanced reproducibility of immune responses and disease phenotypes. nevertheless, the lack of exposure of lab mice to the spectrum of naturally occurring microorganisms, produces mice with an immune system that differs quite dramatically from feral mice and humans. it is becoming increasingly apparent immune system development in both mice and humans is shaped by exposure to a multitude of diverse immunological experiences that begin at birth (fig. 4) . although there is a growing interest in the use of "dirty" mice to enhance translation of preclinical studies, the generation, use and housing of these mice may be quite difficult to implement. because feral or pet store colonized mice would likely contain a plethora of viral, bacterial and parasitic pathogens that could quickly contaminate barrier facilities, dirty mice would have to be housed in a location that is physically separated from the barrier facility [71] . for example, dirty mice could be housed in a quarantine facility or in a location that does not house rodents. in order to prevent the spread of pathogens in these facilities, several protocols would have to be implemented such as the use of dedicated equipment for caging and for sanitation of cages and water bottles. in addition, it would be necessary to carefully control the movement and hygiene of animal care and laboratory workers as well as employ directional airflow to limit the spread of airborne pathogens outside of the animal room. finally, the cost of housing these mice would undoubtedly be much greater than barrier housing. one intriguing protocol that creates mice that are colonized with natural/wild microbiota is called "rewilding". graham and coworkers recently reported that when lab mice are transferred to outdoor enclosures where they are exposed to the weather and microbiome that inhabits the soil and vegetation, they display maturation and differentiation of different t cell subsets, increased numbers of circulating granulocytes and changes in intestinal microbiota that are similar to those described above in feral and pet store mice [95] [96] [97] . when taken together, it is becoming clear that colonization of mice with diverse populations of naturally occurring microorganisms protects them against an environment that contains potentially lethal infectious microbes, inflammogens and carcinogens. fig. 4 genetic variability, immunologic experiences and antigenic challenges in humans and mice. humans are genetically more diverse and are subjected to highly variable, immunological experiences that shapes immune system development and function. immunologic experiences in mice can be manipulated using different animal housing and husbandry protocols as well as exposure to a more diverse or natural microbiota. reproduced from [71] with permission another environmental parameter that has received a great deal of attention over the past several years is the influence of housing temperature on murine physiology and immunology. virtually all animal care facilities in the u.s. house mice at 20-24°c, a temperature range that is comfortable for human caregivers. however, this temperature range induces mild but chronic cold stress in these rodents as their thermoneutral temperature (tnt) is 30-32°c [22] [23] [24] [98] [99] [100] . murine tnt is defined as "the temperature range within which the heat produced as a byproduct of normal metabolism alone, combined with blood flow movements from the core to the surface of the body, enables an animal to maintain a normal core body temperature of~37°c" [22, 23] . housing mice at standard animal care temperatures (st; 20-24°c) is known to increase their resting heart rate and basal metabolic rate when compared with mice housed at their tnt [24] . in addition, housing mice at st activates the sympathetic nervous system (sns) resulting in the release of the catecholamines epinephrine (epi) and norepinephrine (ne) as well as activates the hypothalamic-pituitary-adrenal axis (hpa) to induce production of glucocorticoids [22] . because catecholamine and glucocorticoid receptors are found on nearly all cells within the body, cold stress-induced activation of the sns and hpa produces marked alterations in the cardiovascular, skeletal-muscular and immune systems [23, 101] . (fig. 5) . furthermore, it is becoming increasing appreciated that cold stress may exert profound effects on intestinal homeostasis and microbial composition [22, 102, 103] . this inconvenient reality has prompted investigators to examine how housing temperature may influence immune responses in mice. it is well known that primary lymphoid tissue (thymus, bone marrow) as well as the spleen, lymph nodes and mucosa-associated lymphoid tissue are innervated by sympathetic nerves suggesting that ne, the major neurotransmitter released by sympathetic nerves, is involved in modulating immune responses [104] [105] [106] . indeed, it has been shown that ne-induced β2 adrenergic receptor (β2-ar) signaling in t and b cells, myeloid cells and dendritic cells (dcs) modulates antigen-processing and presentation as well as t cell activation, differentiation and recirculation [104, [106] [107] [108] [109] [110] [111] [112] [113] . a recent study by araujo et al. fig. 5 housing temperature affects the physiology, immunology and immunopathogenesis pathogenesis of mouse models. this illustration depicts a number of different experimental settings and models in which outcomes differ in mice housed under standard animal care temperatures (∼22°c) vs. housing at their thermoneutral temperature (∼30°c). reproduced from [23] with permission. references for the different studies in this figure appear in reference [23] demonstrated that the sns limits the development of mog 35-53 /cfa-induced experimental autoimmune encephalomyelitis (eae) in mice via β2-ar signaling in cd4 + t cells that constrains the generation of encephalogenic effector cells [107] . in contrast, when β2-ardeficient (β2-ar −/− ) mice were immunized with mog 35-53 /cfa, they developed more severe disease when compared with wild type mice. taken together, these data clearly demonstrate that the sns plays an important role in regulating cns autoimmunity. it will be interesting to assess the role of the sns in mouse models eae or other autoimmune disease housed at their tnt. the following section presents a brief overview of the effects of housing temperature on infection, immunity and inflammation. the reader is referred to the following references that summarize the role of housing temperature in mouse models of cancer and antitumor immunity [22, 23, 112, 114, 115] . in addition, investigators have shown that cold stress may exert profound effects on intestinal homeostasis and microbial composition [22, 102, 103] . as pointed out above, β2-ar are found on all myeloid cells as well as t and b cells. stress induced release of ne and its engagement with the β2-ar modulates immune responses to infectious microorganisms [21] . although relatively few studies have directly assessed the effects of housing temperature on infection and immunity, there are numerous studies demonstrating that β2-ar signaling is generally immunosuppressive and results in increased susceptibility of the mice to pathogen infection (the reader is referred to these reviews: [21, 104, 106, 114] . using selective β2-ar agonists and antagonists or genetic ablation of the receptor, several laboratories have described the role that β2-ar signaling pathways play in infection with different bacterial (l. monocytogenes, p. aeruginosa, s. typhimurium, k. pneumonia, e. coli) or viral pathogens (cytomegalovirus, herpes simplex, influenza, vesicular stomatitis) [21, 114] . cold stress-induced immune suppression has been suggested to account for the high mortality rate and lack of clinical translation of mouse models of infectious disease [24, [116] [117] [118] . in a recent study, rubin directly compared different immune responses to the francisella tularensis (ft) live vaccine strain in mice housed at st (22°c) to mice housed at temperatures approximating their tnt (28°c). rubin demonstrated that when mice were housed at their tnt they exhibited increased antigen-specific t-cell responses compared with mice housed at 22°c [116] . in addition, rubin found that intranasal challenge of ft to immunized mice housed at 22°c was consistently fatal whereas immunized mice housed near their tnt (28°c) survived the same intranasal challenge. when taken together, this study demonstrates that mice housed below their tnt exhibit diminished t cell responses to this intracellular pathogen resulting in animal death. furthermore, this study as well as others referenced above suggest that housing mice at their tnt may help to improve the translation of data obtained from mouse models of infectious disease and vaccine development. obesity, metabolic inflammation and atherosclerosis excessive ingestion of lipid-laden foods is known to induce low grade but chronic inflammation that is thought to play a role in the pathogenesis of different metabolic diseases such as obesity, atherosclerosis, chronic liver disease, type 2 diabetes and cancer [119, 120] . indeed, obesity has become an international epidemic that is the second most preventable cause of death in modernized societies [121] . one life-threatening disease associated with obesity is atherosclerosis. this cardiovascular disease is the leading cause of death of men and women in the u.s. [69] . histopathological examination of atherosclerotic vessels reveals the presence of cholesterol and immune cells in the arterial wall that ultimately progresses to plaque formation and occlusion of blood flow. defining the immuno-pathogenic mechanisms responsible for obesity-induced vascular plaque formation and progression has been difficult to model in mice since wild type mice do not develop atherosclerosis when placed on a high fat/high cholesterol western diet (wd). much of what we have learned has come from the use of genetically-engineered mice that lack the lowdensity lipoprotein receptor (ldr −/− ) or apolipoprotein e (apoe −/− ). data obtained from studies using these mutant mice have been important in revealing the role of lipid accumulation and immune cell infiltration in hyperlipidemia-induced vascular inflammation and plaque formation; however, neither mouse model exhibits lipid profiles and vascular pathology that are identical to patients with atherosclerosis [122, 123] . differences between these models of atherosclerosis and human disease have prompted investigators to develop additional mouse models that more closely recapitulate the pathophysiology of this vascular occlusive disease. recent studies demonstrating that housing mice at their tnt affects cardiovascular physiology, inflammation and metabolism have motivated investigators to examine how housing temperature may influence the development and progression of obesity, metabolic inflammation and atherosclerosis in mice fed a high fat diet (hfd). giles et al. reported that feeding a wd to c57bl/6 mice housed at their tnt (30°c) enhanced weight gain and fat mass when compared with mice fed a wd diet while housed at st (22°c) [124] . in addition, they demonstrated that tnt housing in combination with wd induced mild atherosclerosis that was associated with increases in serum concentrations of total cholesterol and ldl, aortic plaque formation, and greater immune cell infiltration into the vascular lesions when compared to mice fed a wd and housed at st [124] . furthermore, both giles et al. [124] and tian et al. [119] demonstrated that feeding a wd to apoe −/− mice housed at their tnt greatly enhanced the development of obesity as well as accelerated the onset and severity of atherosclerosis when compared with their st controls. thus, both studies demonstrate that housing temperature plays an important role in the development of metabolic inflammation, obesity and atherosclerosis. the development of increased weight gain and adiposity at tnt has also been reported by stemmer et al. in t cell-deficient, c57bl/6 nude (nu/nu) mice [125] . these results have important implications for investigators who wish to model the effects of obesity on human tumor development in vivo. obesity has been linked to the development of a variety of different types of cancers; however, the vast majority of human tumor xenograft studies have been performed using obesity-resistant balb/c nude mice. thus, the data reported by stemmer et al. may provide a novel mouse model for assessing the impact of obesity on human tumor growth in vivo. nonalcoholic fatty liver disease another, potentially life-threatening condition that is strongly associated with obesity is nonalcoholic fatty liver disease (nafld). this chronic condition is characterized by the accumulation of excess fat in the liver of individuals who drink little or no alcohol. the most common form of nafld is a relatively innocuous condition referred to as nonalcoholic fatty liver (nafl). although fat accumulation within hepatocytes is alarming, liver function does not appear to be impaired by this condition. some individuals with nafl may go on to develop a more serious condition called nonalcoholic steatohepatitis (nash). the livers of these individuals exhibit fat accumulation, inflammatory cell infiltration and varied levels of fibrosis. if left untreated, nash may ultimately progress to cirrhosis and hepatocellular carcinoma [126] [127] [128] [129] . although current mouse models of nafld have been important in delineating certain aspects of disease pathogenesis, they do not fully recapitulate human disease. for example, mouse models are restricted to the use of male mice since females do not develop high fat diet (hfd)-induced obesity and nafld. in addition, mouse models of nafld do not develop the fibrosis (called "bridging fibrosis") that is observed in humans. therefore, investigators are attempting to develop mouse models that more closely recapitulate nash in both male and female mice. giles et al. recently reported that feeding male c57bl/6 mice with a hfd housed at their tnt (30°c) induced an acceleration in weight gain, increased liver weight and steatosis and an increase in liver immune cell infiltration when compared with mice that were fed a hfd and housed at st (22°c) [126] . in addition, they found that hfd and tnt housing enhanced expression of chemokine and fibrosis genes as well as increased infiltration of macrophages when compared with hfd/st mice. these tnt-induced alterations were associated with increased hepatocellular injury as determined by an increase in serum levels of alanine transaminase. interestingly, the authors did not observe overt fibrosis in these mice which is not surprising given the well-known fact that c57bl/6 mice are resistant to developing hepatic fibrosis [126] . in a second series of studies, giles et al. used male akr mice, an inbred strain that has been shown to develop marked obesity and nafld when fed a hfd at st (22°c). when these mice were housed at their tnt (30°c) and fed a hfd, they developed many of the same features and histopathological characteristics of nafld as did c57bl/6 mice; however, hfd/tnt akr mice developed hepatic fibrosis suggesting that these mice may be better suited to model human nash [126] . as noted above, the vast majority of preclinical studies have been performed using male mice since a hfd does not induce obesity and nafld in females. however, the prevalence of nafld in male and female humans is virtually the same [126] . therefore, giles et al. assessed the development of nafld in female c57bl/6 mice when housed at their tnt. they found that when female mice were housed at their tnt and fed a hfd, they displayed remarkable increases in body weight, liver weight, tissue adiposity and hepatic steatosis when compared with female hfd/st mice [126] . similar to male hfd/tnt mice, females housed under the same nafld-producing conditions exhibited increased expression of genes associated with fibrosis and augmented hepatocellular injury but no overt fibrosis. nevertheless, the development of these novel mouse models may allow investigators to identify novel the immuno-pathogenic mechanisms responsible for the development and progression of nafl d in both sexes. another interesting aspect of nafld development in both mice and humans is the relationship among intestinal dysbiosis, increased intestinal permeability and hepatocellular damage. in their recent study, giles et al. also observed greater increased numbers of live bacteria in the livers of hfd/tnt mice that appeared to correlate with dysbiosis and increased intestinal permeability when compared with their hfd/st counterparts. in fact, these investigators demonstrated that the bacterial composition of the dysbiotic microbiome in hfd/tnt mice was similar to that observed in humans with nash [126] . administration of neomycin and polymixin b sulfate reduced intestinal permeability, hepatic inflammation scores and liver damage when compared with obese, antibiotic-treated hfd/st mice. taken together, these data suggest that exacerbation of nafld in hfd/tnt mice may be mediated by alterations in intestinal bacterial composition. acute graft vs. host disease allogeneic hematopoietic stem cell transplantation (hsct) is a potentially lifesaving treatment for certain blood cancers, autoimmune diseases or hematologic disorders (sickle cell disease, fanconi anemia) [130] . although allogeneic hsct is a potential cure for these diseases,~50% of patients receiving this treatment will develop a potentially lifethreatening, multi-organ inflammatory condition called acute graft versus host disease (agvhd) [131, 132] . clinically, inflammation may occur in the gastrointestinal (gi) tract, skin, liver, lungs, bone marrow and lymphoid tissue [131] [132] [133] [134] [135] [136] [137] . the immuno-pathogenesis of agvhd has not been completely defined; however, experimental and clinical studies demonstrate that donor cd4 + and/or cd8 + t cells are the major effector cells responsible for mediating inflammatory tissue injury in the different target tissues [132] . the large majority of mouse models of agvhd use lethal, whole body irradiation to ablate the immune system prior to engraftment of allogeneic bone marrow (bm) that is supplemented with allogeneic t cells [138] . adoptive transfer of bm alone serves as the control group for these studies since recipients do not develop agvhd when housed at standard animal housing temperatures of 20-22°c. it should be noted that this contrasts with clinical hsct in which great care is taken to eliminate all t cells from the donor graft as the presence of even small numbers of residual, graft-associated t cells may induce fulminant disease [132] . in a landmark study using the conventional mouse model of agvhd described above, leigh et al. demonstrated that agvhd does develop in lethally-irradiated recipients engrafted with allogeneic bm alone, provided that the mice are housed at their tnt of 30°c [98] (fig. 6 ). in contrast, these investigators confirmed numerous other studies demonstrating that agvhd fails to develop in bm-engrafted mice housed at st of 22°c. they found that st-mediated suppression of disease was due to cold stress-induced β2-ar signaling by ne [98] . treatment of bm-engrafted mice housed at 22°c with a selective β2-ar antagonist reversed the cold stress-induced, ne-mediated suppression of agvhd such that these mice developed disease that was similar to bm-engrafted mice housed at 30°c [98] . conversely, when bm-engrafted mice were housed at 30°c and then treated with a selective β2-ar agonist, little or no disease was observed demonstrating that β2-ar signaling is crucial for suppression of agvhd. a recent study by mohammadpour et al. extended these findings using different models of allogeneic and xenogeneic models of hsct. they found that adoptive transfer of allogeneic, β2-ar deficient (β2-ar −/− ) cd4 + t cells (with bm) into lethally irradiated recipients induced more severe agvhd than did engraftment with wild type (wt) allogeneic t cells [139] . the exacerbation of disease in mice engrafted with β2-ar −/− cd4 + t cells was associated with increased numbers th1 effector cells whereas transfer of wt t cells resulted in increases in tregs, th2 cells and myeloid derived suppressor cells [139] . taken together, these data suggest that selective β2-ar agonists may prove useful in attenuating agvhd. asthma approximately 70% of patients suffering from asthma have reported difficulty breathing in cold air during the winter months [140] . although investigators and clinicians have suggested that inhalation of cold air may exacerbate asthma by inducing epithelial cell injury as well as immune cell infiltration and mast cell activation in the airways [141] [142] [143] , few mechanistic studies have fig. 6 housing mice at their thermoneutral body temperature (30°c) exacerbates the development of acute graft vs. host disease (agvhd). disease was induced by adoptive transfer of allogeneic c57bl/6 bone marrow (bm) alone into lethally-irradiated balb/c recipients. mice were housed at either 22°c or 30°c and monitored for signs of gvhd such as weight loss (a) and survival (b). reproduced from [98] with permission been reported to address whether ambient air temperature may alter the onset and/or severity of this chronic respiratory disease. a recent study by liao et al. compared disease symptoms and immune responses in asthmatic mice housed at st (20°c) or at tnt (30°c). airway inflammation was induced using a well characterized mouse model of acute asthma induced by intraperitoneal sensitization of the mice with ovalbumin (ova) followed by intratracheal challenge with aerosolized ova in saline. this protocol induces airway hyper-responsiveness, eosinophil infiltration into the bronchi and overproduction of mucus [144] . these investigators found that when asthmatic mice were housed at their tnt, inflammatory cell numbers, il-4 and il-13 levels were all significantly reduced in the bronchoalveolar lavage fluid as were serum levels of ige and airway hyper-responsiveness in tnt vs st mice. these data provide some of the first evidence that housing temperature may influence the onset and/or severity of acute bronchial inflammation and dysfunction. the use of genetically standardized mice and housing conditions have greatly advanced our fundamental understanding of innate and adaptive immunity as well as increased the reproducibility of animal studies. nevertheless, translation of promising therapeutic strategies observed in mouse models of infectious and inflammatory diseases to patient treatment has been disappointing. the reasons for the poor bench-to-beside transition have not been definitely defined; however, emerging evidence suggests that exposure of genetically constrained mice to pathogen-free microbiota at suboptimal housing temperatures may impair maturation of the immune system thereby altering the animal's immune responses to infectious microorganisms and inflammatory mediators. we propose that by using genetically diverse mice housed under more immunologically-and environmentally-relevant conditions may improve the chance of identifying new and more potent therapeutics to treat human disease. the mouse ascending: perspectives for humandisease models translation of research evidence from animals to humans pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies can animal models of disease reliably inform human studies genetic background and the dilemma of translating mouse studies to humans thinking bedside at the bench: the nod mouse model of t1dm the value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases using the mouse to model human disease: increasing validity and reproducibility conservation and divergence in the transcriptional programs of the human and mouse immune systems a prescription for human immunology the habitual, diverse and surmountable obstacles to human immunology research normalizing the environment recapitulates adult human immune traits in laboratory mice species differences in the structure and function of the immune system of mice and not men: differences between mouse and human immunology wild mouse gut microbiota promotes host fitness and improves disease resistance making mouse models that reflect human immune responses lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity genomic responses in mouse models poorly mimic human inflammatory diseases genomic responses in mouse models greatly mimic human inflammatory diseases mice are not men an overview of the role of sympathetic regulation of immune responses in infectious disease and autoimmunity manipulation of ambient housing temperature to study the impact of chronic stress on immunity and cancer in mice thermoneutrality, mice, and cancer: a heated opinion unstressing intemperate models: how cold stress undermines mouse modeling regulatory t cells: mechanisms of differentiation and function phenotypically distinct subsets of cd4+ t cells induce or protect from chronic intestinal inflammation in c. b-17 scid mice immunologic selftolerance maintained by activated t cells expressing il-2 receptor alphachains (cd25) outbred icr/cd1 mice display more severe neuroinflammation mediated by microglial tlr4/cd14 activation than inbred c57bl/6 mice allograft outcomes in outbred mice extensive homeostatic t cell phenotypic variation within the collaborative cross revealing the complexity in cd8 t cell responses to infection in inbred c57b/6 versus outbred swiss mice a versatile new model of chemically induced chronic colitis using an outbred murine strain strains, stocks and mutant mice the origins and uses of mouse outbred stocks development of fatal colitis in fvb mice infected with citrobacter rodentium evaluation of an outbred mouse model for francisella tularensis vaccine development and testing discordant susceptibility of inbred c57bl/6 versus outbred cd1 mice to experimental fungal sepsis comparison of the susceptibilities of c57bl/6 and a/j mouse strains to streptococcus suis serotype 2 infection streptococcus suis serotype 2, an important swine and human pathogen, induces strong systemic and cerebral inflammatory responses in a mouse model of infection cd8(+) t cells: foot soldiers of the immune system tracking the total cd8 t cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts angiogenesis in the atherosclerotic plaque )(4) isoform specific regulation of t-cell-dependent experimental colitis in mice pathogenic angiogenesis in ibd and experimental colitis: new ideas and therapeutic avenues the pathogenic role of angiogenesis in rheumatoid arthritis genetic background determines mouse strain differences in inflammatory angiogenesis genetic strain differences in the development of peritoneal fibroproliferative processes in mice the sponge implant model of angiogenesis animal models of multiple sclerosis: from rodents to zebrafish experimental autoimmune encephalomyelitis in mice regulatory lymphocytes are key factors in mhc-independent resistance to eae the genome architecture of the collaborative cross mouse genetic reference population ten years of the collaborative cross giving the genes a shuffle: using natural variation to understand host genetic contributions to viral infections using the emerging collaborative cross to probe the immune system genetic diversity in the collaborative cross model recapitulates human west nile virus disease outcomes revised estimates for the number of human and bacteria cells in the body are we really vastly outnumbered? revisiting the ratio of bacterial to host cells in humans homeostatic immunity and the microbiota microbiota-derived compounds drive steady-state granulopoiesis via myd88/ticam signaling antibiotics impair murine hematopoiesis by depleting the intestinal microbiota the virome in host health and disease commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical rig-i signaling bacteriophage adhering to mucus provide a non-host-derived immunity peripheral lymphoid volume expansion and maintenance are controlled by gut microbiota via raldh+ dendritic cells precolonization with the commensal fungus candida albicans reduces murine susceptibility to clostridium difficile infection review series on helminths, immune modulation and the hygiene hypothesis: immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies? the impact of a helminth-modified microbiome on host immunity gut protozoa: friends or foes of the human gut microbiota? the parasitic worm product es-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis of mice, dirty mice, and men: using mice to understand human immunology the comparative immunology of wild and laboratory mice. mus musculus domesticus sequential infection with common pathogens promotes human-like immune gene expression and altered vaccine response effects of vendor and genetic background on the composition of the fecal microbiota of inbred mice manipulating the gut microbiota: methods and challenges the influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding conventional housing conditions attenuate the development of experimental autoimmune encephalomyelitis the gut microbiota: challenging immunology induction of intestinal th17 cells by segmented filamentous bacteria naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with helicobacter hepaticus helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis differential susceptibility to t cell-induced colitis in mice: role of the intestinal microbiota segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in scid mice reconstituted with cd45rbhigh cd4+ t cells intestinal microbiota composition of interleukin-10 deficient c57bl/6j mice and susceptibility to helicobacter hepaticus-induced colitis attenuation of immune-mediated bone marrow damage in conventionally housed mice organ-specific disease provoked by systemic autoimmunity gut-residing segmented filamentous bacteria drive autoimmune arthritis via t helper 17 cells proinflammatory t-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis the intestinal microbiota in colorectal cancer global patterns and trends in colorectal cancer incidence and mortality nutrients, foods, and colorectal cancer prevention a novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate rewilding nod2 and atg16l1 mutant mice uncovers genetic and environmental contributions to microbial responses and immune cell composition altered immunity of laboratory mice in the natural environment is associated with fungal colonization new insights into the immune system using dirty mice housing temperature-induced stress is suppressing murine graft-versus-host disease through beta2-adrenergic receptor signaling translating animal model research: does it matter that our rodents are cold? optimal housing temperatures for mice to mimic the thermal environment of humans: an experimental study effects of rodent thermoregulation on animal models in the research environment gut microbiota orchestrates energy homeostasis during cold effects of psychological, environmental and physical stressors on the gut microbiota the sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system autonomic innervation and regulation of the immune system norepinephrine and beta 2-adrenergic receptor stimulation regulate cd4+ t and b lymphocyte function in vitro and in vivo the sympathetic nervous system mitigates cns autoimmunity via beta2-adrenergic receptor signaling in immune cells norepinephrine controls effector t cell differentiation through beta2-adrenergic receptor-mediated inhibition of nf-kappab and ap-1 in dendritic cells beta2-adrenoreceptor agonist inhibits antigen cross-presentation by dendritic cells control of lymphocyte egress from lymph nodes through beta2-adrenergic receptors adrenergic control of the adaptive immune response by diurnal lymphocyte recirculation through lymph nodes adrenergic signaling: a targetable checkpoint limiting development of the antitumor immune response beta2-adrenergic receptor signaling in cd4+ foxp3+ regulatory t cells enhances their suppressive function in a pka-dependent manner beta-adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in cd8(+) t cells and undermines checkpoint inhibitor therapy baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature mice housed at elevated vivarium temperatures display enhanced t-cell response and survival to francisella tularensis febrile core temperature is essential for optimal host defense in bacterial peritonitis febrile-range hyperthermia modifies endothelial and neutrophilic functions to promote extravasation thermoneutral housing accelerates metabolic inflammation to potentiate atherosclerosis but not insulin resistance overweight, obesity and cancer: epidemiological evidence and proposed mechanisms animal models of atherosclerosis mouse models for atherosclerosis and pharmaceutical modifiers modulation of ambient temperature promotes inflammation and initiates atherosclerosis in wild type c57bl/6 mice thermoneutral housing is a critical factor for immune function and dietinduced obesity in c57bl/6 nude mice thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling nafld causes selective cd4(+) t lymphocyte loss and promotes hepatocarcinogenesis nonalcoholic fatty liver disease: pathology and pathogenesis will the increased prevalence of nonalcoholic steatohepatitis (nash) in the age of better hepatitis c virus therapy make nash the deadlier disease? longterm survival and late events after allogeneic stem cell transplantation from hla-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of european group for blood and marrow transplantation murine models of steroid refractory graft-versus-host disease acute graft-versus-host disease -biologic process, prevention, and therapy bone marrow graft-versus-host disease: early destruction of hematopoietic niche after mhc-mismatched hematopoietic stem cell transplantation bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation hematopoietic niches: targets of gvhd association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation immunological basis of bone marrow failure after allogeneic hematopoietic stem cell transplantation mouse models of graft-versus-host disease: advances and limitations beta2-adrenergic receptor activation on donor cells ameliorates acute gvhd effects of cold weather on mortality: results from 15 european cities within the phewe project inhalation of cold air increases the number of inflammatory cells in the lungs in healthy subjects exercise and airway injury in athletes mechanisms and management of exercise-induced asthma in elite athletes thermoneutral housing temperature regulates t-regulatory cell function and inhibits ovabumin-induced asthma development in mice springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations none. authors' contributions mbg was responsible for the overall conception and focus of the manuscript. je, bmm, st and kf were responsible for composing the different sections of the review. the authors wrote, read and approved the final manuscript. the datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. all experimental procedures involving the use of animals were reviewed and approved by the institutional animal care and use committee of ttuhsc and performed according to the criteria outlined by the national institutes of health. not applicable. the authors declare that they do not have competing interests. key: cord-265847-oq34lc26 authors: yagami, k.; hirai, k.; hirano, n. title: pathogenesis of haemagglutinating encephalomyelitis virus (hev) in mice experimentally infected by different routes date: 1986-11-30 journal: journal of comparative pathology doi: 10.1016/0021-9975(86)90061-7 sha: doc_id: 265847 cord_uid: oq34lc26 abstract three-day-old suckling mice inoculated intracerebrally (i.c.) with the 67n strain of haemagglutinating encephalomyelitis virus (hev) showed nervous signs and died. the virus was passaged 10 times in suckling mice and was designated the mb-67n strain. the pathogenesis of mb-67n was studied with various ages of mice and inoculation routes. all mice inoculated i.c. with a large dose of virus died regardless of age, although a smaller dose caused fatal infection only in suckling mice. by intranasal, intraperitoneal and subcutaneous inoculation, the virus also killed suckling mice under 16 days old, but not older mice, even with a large dose. the susceptibility of mice for the mb-67n strain was influenced by age and inoculation routes. high titres of virus were re-isolated from the brain of diseased mice after inoculation by any route, but not from other organs. histologically, numerous areas of severe tocal necrosis were produced in the cerebral cortex. specific immuno-fluorescence and numerous viral particles were found in the cytoplasm of nerve cells by immuno-fluorescence staining and electron microscopy. these findings indicate that the mb-67n propagates mainly in the central nervous system and nerve cells serve as a main target of virus replication. haemagglutinating encephalomyelitis virus (hev), classified as a coronavirus, causes encephalomyelitis or so-called vomiting and wasting disease in suckling piglets. some strains of hev cause fatal encephalomyelitis characterized by squealing, vomiting, constipation, progressive paralysis and nervous signs in suckling piglets up to one week of age (mitchell, 1963) . other strains have been shown to cause vomiting and wasting disease of piglets under 2 weeks of age, i.e. signs of gastrointestinal infection rather than encephalomyelitis (alexander and saunders, 1969; cartwright, lucas, cavill, gush and blandford, 1969; kershaw, 1969) . on the other hand, mengeling, boothe and ritchie (1972) have isolated hev from tonsillar swabs of asymptomatic adult pigs. several coronaviruses are known to propagate in suckling mouse brain (simpson and group& 1959; mcintosh, becker and chanock, 1967; bhatt, percy and jonas, 1972; weiner, 1973; horzinek, osterhause, wirahadiredja and der kreek, 1978) . hev, however, replicates only in porcine kidney (pk) cell culture (greig and girard, 1963; mengeling et al., 1972) . appel, greig and corner (1965) have reported that when some laboratory animals are inoculated orally with hev-1 strain, they develop no clinical signs and virus cannot be re-isolated. so far as the authors are aware, the attempt to demonstrate the growth of hev in laboratory animals has not been successful. in this report, we present some basic experiments elucidating the pathogenesis of hev in mice, and the target cell for vjral replication by immuno-fluorescent and electron-microscopic observations. random-bred ddy mice were obtained from the shizuoka laboratory animal centre, hamamatsu, japan, and bred at our laboratory. litters were weaned at 3 weeks of age and given a commercial diet and water ad libitum. et al. the 67n strain of hev used was supplied by dr w. l. mengeling, national animal disease laboratory, ames, iowa, u.s.a., and was passaged 12 times in primary pk cell cultures and 10 times in suckling mouse brain. the suckling mouse-propagated strain, designated mb-67n strain, was used for further experiments. antiserum against the 67n strain of hev was prepared in rabbits by intravenous injections of the virus propagated in pk cell cultures. inoculation of mice with the virus was made by the intracerebral (i.c.), intranasal (i.n.), intraperitoneal (i-p.) and subcutaneous (s.c.) routes. the inoculum was o-02 ml for the i.c. and i.n. routes and 0.1 ml for the i.p. and s.c. routes. the mice were observed for clinical signs for 2 weeks after inoculation. for determination of infectivity titres, lo-fold dilutions of the virus or 10 per cent tissue suspensions were made in phosphate buffered saline (pbs, ph 7.2) containing antibiotics and clarified by centrifugation at 2000 rpm for 10 min. at each dilution 0.02 ml was inoculated by the i.c. route into 3-day-old suckling mice, using 4 mice per dilution. the inoculated mice were observed daily for 10 days. the ld,, of virus suspensions was calculated by the method of reed and muench (1938) . haemagglutinating activity (ha) and haemagglutination inhibition (hi) tests were performed by the method described by hirai, chang and shimakura (1974) . a virus suspension of 0.5 ml ( 10' ld,, per 0.02 ml) was mixed with an equal volume of serial 2-fold dilutions of serum heated at 56 "c for 30 min and incubated at room temperature for 60 min. each virus-serum mixture was assayed in four 3-day-old mice by i.c. inoculation. the neutralizing antibody titre was expressed as the reciprocal of the highest serum dilution at which at least 2 of 4 mice survived. anti-hev serum was collected from a rabbit inoculated intravenously with the 67n strain. anti-rabbit igg was prepared in guinea-pigs by intravenous injections of rabbit igg, and conjugated with fluorescein isothiocyanate (fitc). the tissues were rapidly frozen in n-hexane chilled in dry ice and acetone, cut by cryostat to approximately 4pm thickness and immersed in acetone at -20 "c for 20 min. staining was by the indirect method at room temperature. the brains of suckling mice were fixed for 2 h in chilled 50 mm phosphate buffer (pb, ph 7.2) containing 2 per cent glutaraldehyde. post-fixation was carried out in 1 per cent osmium tetroxide in 50 mm pb. fixed specimens were rinsed with 200 itim pb containing 0.4 per cent sucrose, dehydrated in a graduated ethanol-water series and propylene oxide and embedded in epon 812. sections were cut on a porter blum mt 2-b ultramicrotome, stained with many1 acetate and lead citrate and examined with a hitachi model hu-12 electron microscope at an accelerating voltage of 70 kv. the 67n strain of hev propagated in pk cells was serially passaged in suckling mice by i.c. inoculation. on the first passage, 67n strain caused illness with an onset at 4 to 8 days post-inoculation (p.i.) and characterized by emaciation and weakness, followed by paralysis and death at 6 to 10 days. all 8 mice inoculated with 67n strain were affected. at the same time, 8 control mice inoculated with culture fluid of uninfected pk cells remained well. the subsequent passages were performed by i.c. inoculation with 10 per cent suspensions of pooled brain obtained from moribund or dead mice. in the course of serial passages, the incubation period decreased progressively, and death occurred consistently at 2 to 3 days p.i. control material passaged in parallel with the infected passage series produced no clinical signs. in a 10 per cent suspension of the tenth passaged brain, infectivity titres assayed in 3-day-old mice and pk cell cultures were 107'4 ld,, per 0.02 ml and 104" tcid,, per o-2 ml, respectively. the adaptation of 67n to suckling mouse brain was repeated a second time. the 67n strain of hev passaged 10 times in suckling mice was designated the mb-67n strain and was employed for further experiments. haemagglutination activity (ha) the mb-67n strain was tested for ha with erythrocytes of various species at room temperature. the virus agglutinated the erythrocytes of chicken, mouse and rat and their ha titres were 16 400, 8200 and 8200, respectively. erythrocytes of guinea-pig, rabbit, dog, goat, sheep, calf, goose, turkey and human (o-type) failed to agglutinate under test conditions,, the serological specificity of the mb-67n strain against anti-67n rabbit serum was examined by neutralization and hi tests. as shown in table 1 , the mb-67n and original 67n strains were neutralized by a 1 in 256 and a 1 in 5 12 dilution of anti-67n serum, respectively. the hi titre of anti-67n serum against the mb-67n was 160, compared with 1280 for the original 67n strain. forty 3-day-old mice were inoculated i.c. with io3 ld,, of mb-67n. three mice each were killed at 6-or 12-h intervals and a 10 per cent suspension of pooled brains was made in pbs for assays of infectivity and ha. dead mice further experiments on the pathogenesis of mb-67n were performed using various ages of mice and routes. groups of 5 to io mice aged 3, 6, 9, 12, 16, 20 and 35 days were inoculated with a large dose (io6 ld,,) of virus by the i.c., i.n., i.p. and s.c. routes. all mice inoculated by the i.c. route developed nervous signs and died regardless of age. following i.n., i.p. and s.c. inoculation, suckling mice under 16 days old died with similar signs, whereas 20-day-old or older mice failed to show signs during the 14-day observation period (table 2) . since all mice inoculated by the i.c. route with a large dose of virus died regardless of age, 3-to 35-day-old mice were inoculated with lo-fold dilutions of virus suspension by the i.c. route and infectivity titres of the virus were calculated for each age group. titres were 107'4, 106'5, 105'3, 104s, 104.3, 104'3 and 104" ld,, per 0.02 ml in 3-, 6-, 9-, 12-, 16-, 20-and 35-day-old mice by i.c. inoculation, respectively. similarly, comparative titration was performed in 3-day-old mice inoculated by the i.n., i.p. and s.c. routes. titres in 3-day-old mice by i.n., i.p. and s.c. inoculation were 10"' ld,, per 0.02 ml, 103.' and 1 03.' ld,, per 0.1 ml, respectively (table 3) . groups of five 3-and 35-day-old mice were inoculated with lo6 ld,, of mb-67n by different routes and killed when moribund or after 14 days' observation. ten per cent suspensions of pooled organs were assayed in 3-day-old mice by i.c. inoculation. as shown in table 4 , the infectivity titres of brain suspensions from 3-day-old mice inoculated by the i.c., i.n., i.p. and s.c. routes were 107", 10s5, 1 05.6 and 103'6 ld,, per 0.02 ml, respectively. low titres or no virus was re-isolated from organs other than lung following in. inoculation. in 35-day-old mice, the virus was re-isolated only from the brain after i.c. inoculation. neither signs nor virus re-isolation were detected in other routes. in the final experiment, 3 each of g-day-old mice inoculated with 107'5 ld,, of the virus by the in. route were killed at 24 h, 4% h and 72 h and viral distribution was examined. virus was detectable in the olfactory bulb, cerebrum and lung at 24 h p.i. and titres became higher in the olfactory bulb, cerebrum and cerebellum in the course of infection. viral recovery from the olfactory bulb seemed to precede the appearance of virus in cerebrum and cerebellum. similar titres of virus were detected in the lung for 72 h until the late stage of infection. in other organs, very low titres were detectable only at 72 h p.i. (table 5 ). histological examination of the brain was carried out in the late stages of infection. areas of focal necrosis were numerous in all parts of the cerebral cortex after all inoculation routes (fig. 2) . the lesions following i.c. and i.n. inoculation appeared to be more severe than those following i.p. and s.c. routes. the distribution of virus-specific fluorescence was closely correlated with that of the histological lesions (fig. 3) . a bright fluorescence was found in the cytoplasm of neurons and ependymal cells in sections at 48 h p.i. various features of the developmental process of the virus were found in brain sections from 3-day-old mice after i.c. inoculation. in the early stage, swelling of mitochondria and increase in endoplasmic reticulum were associated with accumulation of free ribosomes. particles, presumably virions, approximately 90 nm in diameter, appeared individually or in short rows in the space between membranes of endoplasmic reticulum in some areas (fig. 4) . similar particles were visible within electron-dense areas enclosed by a membrane or a double membrane (fig. 5) . in the next stage, the particles became more numerous. amorphous tubular structures and a large number of vesicles containing virions were observed in the cytoplasmic space of the nerve cells (fig. 6) . the developmental process of individual particles appeared to be that of budding from intracytoplasmic membranes (figs 7 to 9 ). in the late stage, vesicular or cellular walls were broken and the particles were frequently noted in the extracellular space. the mature particles had club-shaped projections and were 100 to 130 nm in diameter. discussion several coronaviruses have been shown to grow in suckling mouse brain (simpson and group& 1959; mcintosh et al., 1967; bhatt et al., 1972; weiner, 1973; horzinek et al., 1978) , but hev has not. hev replicates only in porcine kidney cell cultures, because of its fastidious growth requirements. appel et al. (1965) have reported that suckling mice inoculated orally with hev-i strain developed no clinical signs and that virus was not re-isolated from oral swabs. we have demonstrated the growth of the 67n strain of hev in suckling mouse brain following i.c. inoculation. to be the segment of a crescent developing on vesicular wall (short arrow i n fig. 7) . the crescent bulged further into the vesicle (fig. 8) . it bulged away from the cytoplasm into the vesicle, and devel oped a dense underlying layer on the cytoplasmic side. cl ub-shaped projections were already visible on the surface of the vesicular side of particles (fig. 9) . a mature &i on has been rel eased into the vesicles (long arrow i n fig. 7) . the underlying layer remained on the vesicular wall. et&. brain is identical in serological and morphological properties with the cell-propagated 67n strain of hev. mouse hepatitis virus (mhv), a coronavirus, is common and causes persistent infection in laboratory mouse colonies (fujiwara, takenaka and shumiya, 1976 ), but does not agglutinate erythrocytes of any species. the mb-67n strain could agglutinate the erythrocytes of chicken, mouse and rat, and react with antiserum against the original 67n strain of hev. thus, the mb-67n was confirmed to be identical to hev. hev infection of pigs is known to occur as three different types: fatal encephalomyelitis in suckling piglets (mitchell, 1963) , vomiting and wasting disease in piglets under 2 weeks of age (alexander and saunders, 1969; cartwright et al., 1969; kershaw, 1969) and asymptomatic infection of adults (mengeling et al., 1972) . in the present study, mice inoculated with the mb-67n strain by the i.c. route were shown to succumb without age difference, although a smaller dose of virus was fatal for suckling mice only. adults did not die after i.n., i.p. or s.c. inoculation, even with a large dose of the mb-67n strain. death occurred in suckling mice under 16 days old by i.n., i.p. and s.c. inoculation. these findings indicate that the susceptibility of mice for the mb-67n strain was influenced by age and inoculation routes, and appears to resemble that of hev infection in pigs. in transmission studies on piglets, virus was re-isolated from tonsil, respiratory tract, brain and spinal cord in late stages but not in the early stages of infection (appel et al., 1965; cutlip and mengeling, 1972; mengeling and cutlip, 1972) . the present results of viral distribution revealed that a high titre of virus was re-isolated from the brain of diseased mice after i.c., i.n., i.p. and s.c. inoculation with the mb-67n strain in the late stages of infection. these findings indicate that the mb-67n strain replicates mainly in certain cells of the central nervous system (cns). also, the finding that the virus found in the olfactory bulb preceded the appearance of the virus in the cerebrum and the cerebellum in in. inoculated mice, suggests neural transmission through the olfactory nerve. recently, andries, pensaert and callebaut (1978) and andries and pensaert (1980a, 1980b) h ave determined the preliminary sites of viral replication and the route of viral spread in oro-nasally infected piglets by the direct fluorescent antibody technique and viral isolation. they stated that nasal mucosa, tonsil, lung and small intestine served as primary sites of replication and the virus then progressed via peripheral nerves to the cns. the trigeminal nerve, vagal nerve and intestinal plexuses were also proposed as pathways to the cns (andries and pensaert, 1981) . our findings in mice support their concepts in pigs. furthermore, the olfactory nerve may also serve as one of the pathways to the cns in i.n. inoculated mice. the relation between age-dependent susceptibility and maturation of the nervous system, regarded as the pathway of viral spread, will be an interesting subject for future research. because of the high fatality rate after a rapid course of infection, it was possible to examine the histological changes of the disease over a short period only. these findings revealed the characteristic lesions consisting of necrosis in almost all areas of the brain inoculated by the i.c. route. similar necrosis of the brain was observed after i.n. inoculation, but the reaction was slightly milder in i.p. and s.c. routes. mcintosh et al. (1967) reported that the predominant histological finding in mouse brain affected with human coronavirus (hcv) was round cell infiltration of the meninges and perivascular spaces of the cerebral cortex. in mice inoculated with sialodacryoadenitis virus (sdav) of rats, diffuse and focal neuronal degeneration with minimal inflammatory cell response were found by bhatt et al. (1972) . the findings with the mb-67n strain are considered to be more severe than the findings cited above. the morphogenesis of the virions in the infected brain was essentially in accord with that in pk cell culture (mengeling et al., 1972) . in addition, the amorphous tubular structures found in infected cells with hcv (mcintosh et al., 1967; oshiro, scieble and lennette, 1971 ) and mhv (david-ferreira and manaker, 1965) were also observed in this study. the relationship of these structures to the developmental process of virus particles has not been elucidated. the findings by immuno-fluorescence and electron microscopy revealed the localization of large numbers of virus particles in the nerve cells. thus, the nerve cell is considered to serve as a main target of virus replication. in this study, fatal infection of suckling mice caused by hev was shown and a few similarities between infections of mice and pigs were also represented. mice infected with the mb-67n strain will be utilized as an experimental model for hev infection in pigs. summary three-day-old suckling mice inoculated intracerebrally ( 1i.c.) with the 67n strain of haemagglutinating encephalomyelitis virus (he\ ') showed nervous signs and died. the virus was passaged 10 times in suck1 ing mice and was designated the mb-67n strain. the pathogenesis of mb-67n was studied with various ages of mice and inoculation routes. all mice inoculated i.c. with a large dose of virus died regardless of age, although a smaller dose caused fatal infection only in suckling mice. by intranasal, intraperitoneal and subcutaneous inoculation, the virus also killed suckling mice under 16 days old, but not older mice, even with a large dose. the susceptibilily of mice for the mb-67n strain was influenced by age and inoculation routes. high titres of virus were re-isolated from the brain of diseased mice after inoculation by any route, but not from other organs. histologically, numerous areas of severe focal necrosis were produced in the cerebral cortex. specific immuno-fluorescence and numerous viral particles were found in the cytoplasm of nerve cells by immuno-fluorescence staining and electron microscopy. these findings indicate that the mb-67n propagates mainly in the central nervous system and nerve cells serve as a main target of virus replication. encephalomyelitis of swine caused by a hemagglutinating virus. i. case histories electron microscopic studies of coronavirus a simple method of estimating fifty per cent endpoints temperature of incubation as a critical factor in the behaviour of avian bronchitis virus in chicken embryos we wish to thank professor dr s. shimakura, department of veterinary microbiology, gifu university, for his suggestion and encouragement of this study. key: cord-256903-8lyw27gh authors: guzman, efrain; montoya, maria title: contributions of farm animals to immunology date: 2018-12-06 journal: front vet sci doi: 10.3389/fvets.2018.00307 sha: doc_id: 256903 cord_uid: 8lyw27gh by their very nature, great advances in immunology are usually underpinned by experiments carried out in animal models and inbred lines of mice. also, their corresponding knock-out or knock-in derivatives have been the most commonly used animal systems in immunological studies. with much credit to their usefulness, laboratory mice will never provide all the answers to fully understand immunological processes. large animal models offer unique biological and experimental advantages that have been and continue to be of great value to the understanding of biological and immunological processes. from the identification of b cells to the realization that γδ t cells can function as professional antigen presenting cells, farm animals have contributed significantly to a better understanding of immunity. great advances in immunology are usually supported by experiments carried out in animal models and by far, inbred lines of mice and their corresponding knock-out or knock-in derivatives, are the most commonly used animal systems in immunological studies. though with much credit to their usefulness, laboratory mice will never provide all the answers to fully understand immunological processes. also, some answers provided in mouse models are not applicable to other species of animals or humans. large animal models offer unique biological and experimental advantages that have been and continue to be of great value to the understanding of biological and immunological processes. the humble cow, the underestimated pig and the unassuming chicken have greatly influenced our current understanding of human immunology. for most immunologists dedicated to fundamental and applied research, it is easy to forget that b cells were first identified in chickens and vaccination first occurred because of a cow. although there are far too many important events to discuss in this paper, we have chosen to highlight a few of the most important contributions of farm animals to the current understanding of immunology ( table 1) . edward jenner published in 1798 a booklet entitled "an inquiry into the causes and effects of the variolae vaccinae, a disease discovered in some of the western counties of england, particularly gloucestershire and known by the name of cow pox" (1, 2) and although strictly speaking jenner did not discover vaccination, he was the first person to use scientific rigor to prove protection from disease through targeted intervention. the english dairy farmer benjamin jesty (1737-1816) was the first person known to vaccinate against smallpox (3) protecting his family against the virus even after numerous exposures (3) . however, the idea and indeed the term vaccination, only came into the light spot 100 years later thanks to louis pasteur. this time the chicken takes a privileged position and the story was beautifully explained by pasteur himself (4, 5) and has been romanticized in paul de kruif 's book "microbe hunters" (6) . in 1878 pasteur inoculated chickens with "stale" cultures of pasteurella multocida. the chickens became sick but recovered so he decided to re-inoculate them with a fresh culture. the chickens that had received the "stale" culture recovered whereas chickens that had not been pre-exposed to the stale cultures died. pasteur recognized the similarities between his studies in chickens and what jenner had published with smallpox. he coined the term "vaccine" (4, 5, 7) in honor of jenner. by the early 1880s, william smith greenfield in the uk (8, 9) and pasteur working with henri thullier, charles chamberland and pierre paul émile roux in france (10, 11) had begun developing and testing vaccines against anthrax in sheep and cattle. a decade later, the german scientists friedrich loffler and paul frosch identified the first ever filterable infectious agent in mammals: foot and mouth disease virus (fmdv) and developed a fully protective heat-inactivated vaccine against it (12, 13) ; however an effective long-lasting and broadly protective vaccine against fmdv remains elusive. pigs also played an important role in early vaccinology studies. by the late 1800s swine plague or hog cholera (later discovered to be caused by a virus now called classical swine fever virus, csfv (14) was killing hundreds of thousands of pigs across the word and was particularly of concern to the us pig producing industry, causing an impressive us$15 million a year in losses in 1875 (15) and us$20 million by 1878 1 . once again, pasteur and thullier developed a vaccine to what is now thought to be the first ever vaccine against a viral infectious disease (16) and the first mass-vaccination campaign in history. in addition, it is rarely recognized that csfv was the first animal virus ever to be cultured in vitro (17) and the techniques developed by carl tenbroek continue to be used today. horses have also contributed to the understanding of fundamental immunological mechanisms. in a series of experiments, emile roux working with alexandre yersin and followed by emil von behring and shibasaburo kitasato immunized horses to produce an "antidote" or immune sera against the diphtheria toxin that was eventually used to treat humans, an important step in understanding antibodies and humoral immunity (18) . behring won the nobel prize for medicine in 1901 for this work. another milestone in vaccine development was the generation in the 1970's of vaccines to control marek's disease (md), a naturally occurring neoplastic disease in chickens caused by an oncogenic herpesvirus (19) . md vaccines are the first examples of the use of vaccination to protect against cancer (20, 21) . with the discovery of molecular biology techniques in the 1960's and 70's, the race was on to develop recombinant vaccines against numerous infectious diseases. the first report of a biosynthesized polypeptide vaccine was published in 1981 (22) . the structural protein vp3 of fmdv was cloned 1 (1881). swine plague. science 2, 121 and expressed in e. coli and the purified protein used to vaccinate six cattle and two swine, which developed neutralizing antibodies and were protected against challenge with fmdv (22) . and new technologies have only helped to highlight the importance of farm animals in vaccine development: using a computational approach to assess protein-protein stability, kotecha and colleagues (23) used molecular dynamic ranking to predict fmdv capsid stabilities and produced stabilized fmdv capsids based on these predictions, assessed their stability using x-ray crystallography and demonstrated their improved immunogenicity in vivo by vaccinating cattle. this demonstrates the potential value of structure-based design of vaccines to develop stabilized vaccine antigens for animals and humans alike. although the innate immune system of animals is largely conserved, there are significant variations in the pattern-recognition-receptor (prr) structures of various species (24) . it has been suggested that laboratory mice have not been subjected to the selective pressures that other animals have and so innate immune studies carried out in laboratory animals do not accurately inform human biology (25) . it has been demonstrated that human and farm animal prr responses to their ligands (24, 26) are more similar to each other than human-mouse prr responses (26) (27) (28) . because prr recognition is associated with adaptive immunity, a better understanding of these molecules in farm animals is likely to better inform on their effect in these animals as well as humans. a major contribution of the chicken to fundamental innate immunity was the description in 1957 of the first interferon. chicken embryos were exposed to influenza virus by alick issacs and jean lindenmann (29) and they identified an immune soluble element responsible for regulating virus infection. this discovery was certainly one of the scientific landmarks in cell biology in the twentieth century and one which opened the doors of what we now know as innate immunity. perhaps the most recognizable contribution of the chicken to science, and immunology in particular, was in the definition of the two elements of adaptive immunity: the b-dependent and the t-dependent immunity. the avian bursa of fabricius, named after hieronymus fabricius of aquapendente (30) is a sac-like structure located in the cloacal passage of the bird and its function remained elusive until well into the twentieth century. bruce glick and timothy chang working at the poultry science department at ohio state university (30, 31) described how following the surgical removal of the bursa, chickens injected with salmonella typhimurium "o" antigen failed to develop bacteria-specific antibodies. glick and chang wrote a paper entitled: "the role of the bursa of fabricius in antibody production" and was rejected by leading scientific journals (30) and eventually published in poultry science (32) . several years later, the bone marrow in mammals was shown to be the equivalent of the bursa in birds (33) , and so the term "b-lymphocyte" originated from "bursa-derived lymphocyte". several years later, cooper et al. published a fundamental paper on the demarcation of the thymic and bursal and systems in birds and proposed the existence of equivalent systems in mammals (34) . the cannulation of lymphatic vessels was developed in the early twentieth century in rats to study the lymphatic system but due to the complexity of the surgical procedure, sheep and then cattle were used extensively in the 1960s and 70s in lymphatic cannulation studies (35) . in a series of adoptive transfers of lymph-migrating cells and fluid, hall and colleagues first identified in sheep that antibody-secreting cells (acs) encounter antigens and are activated in the lymph nodes (36), then migrate via the efferent lymphatics to the circulatory system, and that the immune response depends on an intact lymphatic system. cattle have also contributed to fundamental b cell immunology and the generation of a highly diverse antibody repertoire. most vertebrates encode a large number of variable (v), diversity (d), and joining (j) gene segments and antibody diversity is achieved by recombination of these 3 segments. in contrast, cattle only express a limited number of v genes and so it is thought that antibody diversity is achieved recombination events and endogenous mutation mechanisms in the cdr3 region (37) . another unusual feature of bovine antibodies is their exceptionally long cdr3 regions (38) . these long cdr3 and unusual mutation mechanisms result in "microfolds" within the cdr3 region that allow bovine antibodies to bind antigens that would normally be inaccessible (38) . a recent report demonstrated that cows can be immunized with a single hiv env trimer and this results in potent hivspecific nabs which are dependent on the length of the cdr3 loops of bovine ig (39) . it has been suggested that this could be an efficient way of producing super-antibodies against other human pathogens. transchromosomal cows have been engineered to produce large amounts of full human igg molecules with pathogen specificity: mers-cov (40) , hanta virus (41), veev (42) , and ebola virus (43) . this technology has the potential to generate prophylactic antibodies against emerging viral diseases. on the other hand, chickens have serum igm and iga both of which are homologs of their mammalian counterparts; in addition, they express igy, not found in mammals but thought to be an evolutionary ancestor for mammalian igg and ige. chickens however do not have either ige nor igd but instead use a distinct process for generating antibody diversity that is distinctly different to mammals (44) . engineers frequently look to nature for inspiration. antibody engineers are no exception, modeling new therapeutics on molecules found in animals such as camels and cows. indeed, 10% of bovine antibodies have unusually long heavy-chain cdr3s as part of their antigen-recognition sites. stanfield et al. (45) have solved crystal structures of three new bovine fab fragments and analyzed the five known structures to show that their ultra-long cdr h3s all adopt similar architectures composed of a knob domain containing a small conserved β-sheet connected by diverse disulfide-bonded loops that is separated from the antibody surface by a long conserved stalk. they propose that varying the length of the stalk and the positions and number of disulphide links in the knob may help drive antibody diversity. these structural insights could be leveraged to tailor antibody-based therapeutics. in contrast to all other mammals, camelids (dromedaries, camels, llamas, etc) also have an unique antibody type similar igg but with identical heavy chains lacking the ch1 domain and which do not pair with their corresponding light chains. these "heavy-chain antibodies" (hcabs) display antigenspecific variable domains or "vhh" which are structurally and functionally similar to an igg fv but have only three cdr loops defining the antigen biding sites. camel vhh domains, also called "nanobodies, " have been of great interest because of their stability and small size and strong affinity to their corresponding antigens. in fact, several camel vhh domain antibodies are in early preclinical development in oncology, infectious, inflammatory, and neurodegenerative diseases (44), the most recent example being the generation of broadly neutralizing antibodies to influenza in llamas (46) . cytotoxic and helper t cells are generally considered to be phenotypically different due to the mutually exclusive expression of the co-receptors cd8αβ and cd4 and differences in mhcrestriction (class i vs. class ii). however, between 3 (in normal individuals) and 60% (in certain pathologies) of human peripheral blood lymphocytes have been shown to be cd4/cd8 double positive (dp) t cells (47) . thymic and extra-thymic development of t cells has been studied mainly in mice and because the expression of cd8 and cd4 in mouse t cells for the most part mutually exclusive, cd4/cd8 dp lymphocytes have generally been ignored. nevertheless, the presence of cd4/cd8 dp t cells in many animals makes it impossible to ignore these cells. studies in pigs have shown that cd4/cd8 dp are a distinct subset of activated and/or memory t helper cells (48) and in humans the increase in circulating cd4/cd8 dp t cell frequency has been identified in autoimmune and chronic inflammatory diseases (49) (50) (51) (52) (53) suggesting the importance of this particular t cell population in human health. most circulating t cells in humans and mice are conventional t cells expressing the αβ t cell receptor (tcr) and either cd4 or cd8. unlike mice, other species like cattle, pigs and chickens possess a substantial proportion of t cells expressing the γδ tcr cells in the circulation suggesting that circulating γδ tcr t cells have a more important role immunity than previously thought (54) . the fact that the phenotype and frequency of circulating and tissue resident t cells is so vastly inconsistent in different species suggests that immune responses to (vaccine) antigens are also distinct. it is assumed that that all animal species have a similar immune response to a particular antigen, but this is a statement to be reviewed in light of each host particularities. in addition, the th1/th2 polarization of t cells observed in response to particular antigens is a phenomenon of certain strains of laboratory mice and not of outbred mammals including farm animals and humans (55, 56) . in fact, it has been shown that cytokine profiles defining th1/th2 responses to antigens in cattle are more similar to human responses than those observed in mice (57). dendritic cells (dc) as such, and their role in immunity were first described in the 1970s and in 1995 ralph steinman published a series of papers describing that a cellular receptor called "dec-205" (now cd205) was expressed on mouse dc, was involved in antigen processing (58, 59) and was detected by the monoclonal antibody nldc-145. in fact, it was 2 years earlier in 1993, that chris howard, a bovine immunologist working at the then called "institute for animal heath" in the uk published a series of papers identifying an important and until then uncharacterized marker expressed on pseudoafferent lymph veiled cells (also called aldc) detected by the monoclonal antibody wc9 (now cc98) (60-63). although steinman's identification of mouse cd205 helped characterize the binding of cc98 to bovine cd205 (64), the importance of cd205 in identifying dc was first evident in cattle. as mentioned above, steinman's seminal work in characterizing dc using the mouse system has been one of the most important developments in cellular immunology of the twentieth century, and one which lead to his nobel laureate. however, the idea that a component of the immune system was involved in antigen processing and presentation had been proposed many times before. as mentioned above, cannulation of the lymphatic vessels is more practical in large than small animals, and this technique has been used to investigate dc biology. afferent or peripheral lymph dc were first described in sheep in 1972 (65) as "very phagocytic dendritic macrophages that are involved in long term immunological reactions" that are very potent antigen presenting non-lymphoid cells (66) and that their phagocytic and antigen presentation capacities differed from "classical" peritoneal macrophages (67) , therefore indicating that dc and macrophages were different cell types (67) several years before steinman's observations (68) . in addition, lymphatic cannulation of sheep has revealed important ontologic, phenotypic and functional characteristics of dc subsets that are relevant in other mammals, particularly humans (69, 70) . similitudes and differences between swine and human dc/macrophage populations have recently been described (71) . in one striking example and in contrast to studies performed in mice, swine and human cdc2, which are associated with th2 responses, both express fcεriα and are localized in or next to the tracheal and bronchial epithelia. these observations have been proposed to imply that swine and humans have similar allergen responses as opposed to mice. this theory is supported by the fact that localization of cdc2 helps them access antigens such as airborne allergens, and fcεriα expression on these cells might help proliferation observed in allergic responses. as mentioned before and unlike mice, horses and humans, most other animals have a large γδ t cell compartment. for example, up to 70% of all blood lymphocytes in young calves are t cell expressing the γδ t cell receptor (tcr). although the reasons for the enlarged t cell compartment in cattle, pigs and chickens is still unknown, their large numbers and ease of collection has resulted in great advances in γδ t cell biology knowledge not only for farm animals, but also for humans. for example, apcs were shown to influence γδ t cell proliferation (72, 73) . cynthia baldwin's lab has defined antigen-specific bovine γδ t cell responses in various systems (74) (75) (76) and adrian smith's lab has done similar observations in chickens (77, 78) . it has also been shown that bovine γδ t are potent regulatory t cells (79) , an observation that is also true for a subset of human γδ t cells (80, 81) . these results in farm animals have and continue to enhance our understanding of human γδ t biology (82) . perhaps the most important one was the realization that a subset of bovine γδ t cells expressed mhc class ii and co-stimulatory molecules on their surface, a characteristic normally attributed to macrophages, b cells and dc but not t cells (83) . bovine γδ t cells were also shown to phagocyte antigens and of mhc iirestricted presentation to cd4+ t cells (83) . this function of bovine γδ t cells was subsequently reported in pigs (84) and much later in mouse (85) and human (86) (87) (88) γδ t cells. perhaps the best known contribution of any farm animal to scientific progress was the somatic cell nuclear transfer that gave origin to dolly, the sheep (89) . although nuclear transfer itself is not a direct contribution to immunology, nuclear transfer technology has directly influenced many immunological concepts underpinned by technologies such as induced pluripotent stem (ips) cells and crispr-cas systems. clustered regularly interspaced short palindromic repeats (crispr) is a rna-guided endonuclease used both in vivo and in vitro. genetically modified animals becoming more common and their availability can be exploited in many applications such as comparative immunology, physiology and disease, to generate in vivo bioreactors to produce complex proteins, or to produce genetically modified organs for transplantation in humans (90) . although the majority of pharmaceutical research is performed in laboratory mice models, it is clear that humans are not "large mice." by a large extent, studies in laboratory mice have been the victim of over interpretation; for example, by extrapolating successful pre-treatment in mice to therapeutic treatment in men. the weakness of the mouse model in pharmaceutical research was recently highlighted in a study showing that inflammatory responses in mouse models do not correlate with human inflammatory disease (91) . an additional study showed a close similarity in expression profiles of immune-related genes between humans and pigs (92) . cattle, pigs, and chickens, are useful, valid, and valuable models to study human infectious diseases and important clinical targets in their own right. both humans and cattle are the natural hosts for tuberculosis (being infected with the geneticallyrelated mycobacterium bovis and mycobacterium tuberculosis, respectively) and the bovine and human diseases share many similarities in terms of immunity and pathology (93) , whereas the mouse model of tuberculosis does not provide a faithful representation of the disease in humans (94) . similarly, bovine respiratory syncytial virus (brsv) is closely related to human (h) rsv and the pulmonary pathology, immune responses and epidemiology seen in young calves and children are very similar (95) . swine have been shown to be a more faithful model for human influenza infection and immunity studies and the same strains of influenza infect both humans and pigs because the distribution of influenza virus receptors and physiopathology are similar in both species. the transfer of maternal-derived antibodies (mda) to new born pigs enables fancy vaccine study design to elucidate the role of mda in immunity (96, 97) , vaccine efficacy and in enhancement of respiratory disease (98) . gnotobiotic piglets have been used to study various human gastrointestinal pathogens. for example, human noroviruses are antigenically and genetically related to swine noroviruses and unlike mice, humans and pigs show genetic susceptibilities to noroviruses depending on their histoblood group antigen phenotypes and the virus strain. similarly, gnotobiotic pigs have been used in rotavirus research to study disease pathogenesis and identify virus-specific iga and asc as correlates for protection and vaccine efficacy in children (99) . pigs have also been proposed to be better models than mice for many other infectious diseases including female genital infection with chlamydia trachomatis, helycobacter pylori, neisseria meningitides, and nipah virus among others because of the natural susceptibility of pigs to these pathogens (100) . endogenous retroviruses were first discovered in pig kidney cell lines in 1971 (101) and are now known to be present in most, if not all, mammalians. the presence and potential reactivation of endogenous retroviruses has very important consequences in both allo-and xeno-transplantation. immunotherapy is becoming more popular in clinical trials and vaccine efficacy studies. the success of immune cell therapies partially depends on the effective delivery of cells to target organs, a process that invariably involves the lymphatic system. dc migration in mice has not proven to be very informative, however, dc migration in pigs may be able to answer several question on dc migration that cannot be addressed otherwise. these studies demonstrate that using large animals to investigate immune cell trafficking will help improve immunotherapies in humans (102) . in 1906 the french surgeon mathieu jaboulay (1860-1913) implanted a pig's kidney into one woman and a goat's liver into another thus starting the idea of xenotransplantation; unsurprisingly, both women died (103) . the acceptance or rejection of a donor's organ or cells is fundamentally an immunological event. cellular rejection involves nk and t cells that recognize foreign antigens on the grafted tissue. using xenotransplantation models (pig-to-rat, pig-to-primate, and pigto-human), the main mechanism for organ and tissue rejection has been proposed to involve arteriosclerosis, or thickening of the arterial walls. this process if thought to be caused by activated and allo-reactive lymphocytes that migrate over time to the transplanted organ (104) . arteriosclerosis is a major cause of chronic organ rejection (103) . studies in laboratory mice have underpinned many concepts of immune tolerance and the generation of immune responses in the neonate. however, the peripheral immune system in mice remains unpopulated during pregnancy and it is only after birth that b and t cells begin to emmigrate to the periphery. in contrast, lymphoid cells circulate through the fetus in humans and large animals well-before birth and specialized lymphoid tissues are also well-developed and populated by the time of birth and are able to respond to a number of antigens (105, 106) . certainly the immune system in neonate humans and large animals is not matured, but calves, lambs and piglets can be more useful than mice in understanding immune responses during pregnancy and in new borns and these studies can be used to better inform human developmental immunology. this advantage over mice has recently been used to develop extracorporeal support technologies using neonatal lambs with the ultimate objective to use these technologies in premature children (107) . perhaps one of the most common uses of large animal models is in the development of vaccines with several advantages over mice. the serial collection of peripheral blood from animals such as pigs, cattle, chickens, and horses allows for immunokinetic studies to be possible in response to vaccination or infection at the level of the individual. these immunokinetic studies can be used to correlate immune responses generated with protection after challenge with the relevant pathogen. in vaccinology studies using mice, the typical approach would be to sacrifice groups of mice sequentially and harvest spleen and blood, so the immune response to vaccination at the individual level is not normally achieved. large animals also provide several advantages over mice when investigating mucosal immunity. when mice are vaccinated or inoculated intranasally, it is common for the inoculum to be digested because anesthetized mice can both swallow and inhale the material placed on their nose. in addition, the structure of the mucosal associated lymphoid tissue (malt) differs significantly in mice from that of large animals and humans; for example mice do not have tonsils but instead have undefined networks of malt, whereas cattle, pigs and sheep have well-defined tonsils (108) (109) (110) . in the case of vaccine delivery through the skin, cattle, and pigs appear to be better suited than mice for these studies. skin thickness, structure of the epidermis and the presence and distribution of langerhan's cells are among many characteristics that humans and cattle and pigs have in common and which are practically relevant in transcutaneous immunizations (111) . the process of selecting a relevant and appropriate animal model is a balanced and complicated exercise due to the diversity in vertebrate physiology, adaptive and innate immunity. studies in mice, for example, have shown the efficacy of vaccines against fmdv, however these efficacy studies have failed to be translated to the target species (cattle and pigs), presumably due to fundamental differences in the immune systems of model organisms and target species and the ability of the virus to mutate in these animals (112) . it has recently been shown that because immunoglobulin subclass diversification occurred after speciation (113, 114) a particular immunoglobulin subclass in one species bears no functional homology to one of the same name of another species (115) . thus, our knowledge of the functions of igg1 in mice cannot be extrapolated to other mammals. characterizing generating reagents for each animal model hinders the development and usefulness of any of these models and therefore limiting the usefulness of cows, cattle or chickens as models for human immunology. mice and rats are and will probably continue to be the chosen model organisms over farm animals. mice can be readily mutated (knock in or knock out) to study immunological pathways; so far this has been proven to be very difficult-and expensive-in large animals. as mentioned above, the availability of reagents to study immune cells and processes in mice far out competes the availability of these reagents for large animals. pharmacokinetic and toxicology studies would be prohibitively expensive in pigs, horses or cattle, so small rodents and rabbits are the best organisms to use in these studies. in addition, studies in mice have been fundamental in the discovery of antibiotics, chemotherapy agents and more recently car-t cell therapies that can be directly applied to humans. genetic homogeneity, low cost, the availability of biologically-relevant mutants and reagents make the mouse the optimal animal model for many academic and industrial researchers. farm animals have historically contributed and continue to contribute to fundamental and applied immunology. the use of these animals in research is not difficult as long as the appropriate facilities and reagents are available. dedicated housing, cost, biosecurity, and genetic variability are some of the many disadvantages confronted when using farm animals in research. however, selecting an appropriate animal model should be more than just a matter of accessibility and common practice (116) but should be based on the scientific question to be addressed and its relevance. not just a country doctor: edward jenner, scientist edward jenner and the eradication of smallpox new light in the dawn of vaccination on the germ theory on chicken cholera: study of the conditions of non-recidivation and of some other characteristics of this disease microbe hunters the life and works of louis pasteur lectures on some recent investigations into the pathology of infective and contagious diseases professor superintendent, the brown animal sanatory institution concerning the priority due to him for the production of the first vaccine against anthrax remarks on anthracic vaccination as a prophylactic of splenic fever summary report of the experiments conducted at pouilly-le-fort, near melun, on the anthrax vaccination, 1881 summarischer bericht uber die ergebnisse der untersuchungen der kommission zur erforschung der maul-und klauenseuche bei dem institut fur infektionskrankheiten in berlin. centralblatt fur bakteriologie berichte der kommission zur erforschung der maulund klauenseuche bei dem institut fur infektionskrankheiten in berlin. centralblatt fuxr bakteriologie the survival of the hog-cholera virus in laboratory animals, particularly the rat swine plague, or hog cholera correspondence of pasteur and thuillier concerning anthrax and swine fever vaccinations cultivation of the hog cholera virus remembering emil von behring: from tetanus treatment to antibody cooperation with phagocytes studies on the epidemiology of marek's disease herpesvirus in broiler flocks effect of vaccination with herpesvirus of turkeys (hvt) on horizontal spread of marek's disease herpesvirus protective efficacy of marek's disease vaccines cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design toll-like receptors in domestic animals variation matters: tlr structure and species-specific pathogen recognition human but not murine toll-like receptor 2 discriminates between tripalmitoylated and tri-lauroylated peptides human toll-like receptor 4 recognizes host-specific lps modifications identification of full length bovine tlr1 and functional characterization of lipopeptide recognition by bovine tlr2/1 heterodimer virus interference. i the interferon a landmark contribution to poultry science-immunological function of the bursa of fabricius growth of the bursa of fabricius and its relationship to the adrenal gland in the white pekin duck, white leghorn, outbred new-hampshire, and inbred new-hampshire the bursa of fabricius and antibody production cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells restoration of gamma globulin production in agammaglobulinemic chickens surgical techniques for the collection of lymph from unanaesthetized sheep the ultrastructure and function of the cells in lymph following antigenic stimulation maintenance of antibody to pathogen epitopes generated by segmental gene conversion is highly dynamic during long-term persistent infection reshaping antibody diversity rapid elicitation of broadly neutralizing antibodies to hiv by immunization in cows human polyclonal immunoglobulin g from transchromosomic bovines inhibits mers-cov in vivo dna vaccine-derived human igg produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome antibody preparations from human transchromosomic cows exhibit prophylactic and therapeutic efficacy against venezuelan equine encephalitis virus production of potent fully human polyclonal antibodies against ebola zaire virus in transchromosomal cattle structural and genetic diversity in antibody repertoires from diverse species conservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin coexpression of t4 and t8 on peripheral blood t cells demonstrated by two-color fluorescence flow cytometry phenotypic maturation of porcine nk-and t-cell subsets evaluation of t cell subsets in myasthenia gravis using anti-t cell monoclonal antibodies circulating cd3+ cd4+ cd8+ t lymphocytes in multiple sclerosis circulating cd4+cd8+ t lymphocytes in patients with kawasaki disease cd4+ cd8+ double positive (dp) t cells in health and disease peripheral cd4cd8 double positive t cells with a distinct helper cytokine profile are increased in rheumatoid arthritis porcine gammadelta t cells: possible roles on the innate and adaptive immune responses following virus infection the relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species differences in immune responses against leishmania induced by infection and by immunization with killed parasite antigen: implications for vaccine discovery type 1 and type 2 responses in regulation of ig isotype expression in cattle the receptor dec-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing dec-205, a 205-kda protein abundant on mouse dendritic cells and thymic epithelium that is detected by the monoclonal antibody nldc-145: purification, characterization, and n-terminal amino acid sequence summary of workshop findings for cattle (tables 1 and 2) leukocyte antigens of cattle and sheep. monoclonal antibodies submitted to the second workshop studies of monoclonal antibodies identifying two novel bovine lymphocyte antigen differentiation clusters: workshop clusters (wc) 6 and 7 phenotypic variation and functional differences within dendritic cells isolated from afferent lymph dec-205 expression on migrating dendritic cells in afferent lymph the cells of lymph and their role in immunological reactions. handbuch der allgemeinen pathologie the properties and functional activity of non-lymphoid cells from bovine afferent (peripheral) lymph some properties of dendritic macrophages from peripheral lymph identification of a novel cell type in peripheral lymphoid organs of mice. morphology, i., quantitation, tissue distribution plasmacytoid dendritic cells migrate in afferent skin lymph existence of cd8alpha-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species the respiratory dc/macrophage network at steady-state and upon influenza infection in the swine biomedical model monocytes control gamma/delta t-cell responses by a secreted product bovine gamma/delta t-cell proliferation is associated with self-derived molecules constitutively expressed in vivo on mononuclear phagocytes protective killed leptospira borgpetersenii vaccine induces potent th1 immunity comprising responses by cd4 and gammadelta t lymphocytes the role of bovine γδ t cells and their wc1 co-receptor in response to bacterial pathogens and promoting vaccine efficacy: a model for cattle and humans the bovine model for elucidating the role of γδ t cells in controlling infectious diseases of importance to cattle and humans an alphabeta t-cell-independent immunoprotective response towards gut coccidia is supported by gammadelta cells γδ t cells play a protective role during infection with nippostrongylus brasiliensis by promoting goblet cell function in the small intestine bovine γδ t cells are a major regulatory t cell subset antigen-specific regulation of ige antibodies by non-antigen-specific γδ t cells a new effect of il-4 on human γδ t cells: promoting regulatory vδ1 t cells via il-10 production and inhibiting function of vδ2 t cells bovine γδ t cells: cells with multiple functions and important roles in immunity gammadelta t cells present antigen to cd4+ alphabeta t cells a sub-population of circulating porcine gammadelta t cells can act as professional antigen presenting cells mouse gammadelta t cells are capable of expressing mhc class ii molecules, and of functioning as antigen-presenting cells professional antigen-presentation function by human gammadelta t cells cross-presenting human gammadelta t cells induce robust cd8+ alphabeta t cell responses prolonged antigen survival and cytosolic export in cross-presenting human gammadelta t cells sheep cloned by nuclear transfer from a cultured cell line crispr is knocking on barn door genomic responses in mouse models poorly mimic human inflammatory diseases structural and functional annotation of the porcine immunome tuberculosis immunity: opportunities from studies with cattle animal models of tuberculosis for vaccine development animal models of respiratory syncytial virus infection influence of antibody-mediated immune suppression on clinical, viral, and immune responses to swine influenza infection live attenuated influenza virus vaccine reduces virus shedding of newborn piglets in the presence of maternal antibody. influenza other respir viruses universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture the gnotobiotic piglet as a model for studies of disease pathogenesis and immunity to human rotaviruses the pig: a model for human infectious diseases de madrid at. c-type virus particles in pig kidney cell lines in vivo tracking and immunological properties of pulsed porcine monocyte-derived dendritic cells xeno's paradox: why pig cells are better for tissue transplants than human cells xenoislet rejection following pig-to-rat, pig-to-primate, and pig-to-man transplantation expanding the role of peyer's patches in b-cell ontogeny induction of immune responses in newborn lambs following enteric immunization with a human adenovirus vaccine vector an extra-uterine system to physiologically support the extreme premature lamb of mice and not men: differences between mouse and human immunology revisiting the b-cell compartment in mouse and humans: more than one b-cell subset exists in the marginal zone and beyond the lymphoid system: a review of species differences transcutaneous immunization of domestic animals: opportunities and challenges laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity antibody repertoire development in fetal and neonatal piglets. xiii hybrid vh genes and the preimmune repertoire revisited genomic organization of the immunoglobulin light chain gene loci in xenopus tropicalis: evolutionary implications therapeutic administration of broadly neutralizing fi6 antibody reveals lack of interaction between human igg1 and pig fc receptors model organisms: there's more to life than rats and flies all authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication. the authors were funded by the uk's bbsrc grants bbs/e/i/00002067 and bbs/e/i/00002014. the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.copyright © 2018 guzman and montoya. this is an open-access article distributed under the terms of the creative commons attribution license (cc by). the use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. no use, distribution or reproduction is permitted which does not comply with these terms. key: cord-254190-bxfne94u authors: tu, wenwei; zheng, jian title: application of humanized mice in immunological research date: 2015-07-07 journal: suppression and regulation of immune responses doi: 10.1007/978-1-4939-3139-2_10 sha: doc_id: 254190 cord_uid: bxfne94u during the past decade, the development of humanized mouse models and their general applications in biomedical research greatly accelerated the translation of outcomes obtained from basic research into potential diagnostic and therapeutic strategies in clinic. in this chapter, we firstly present an overview on the history and current progress of diverse humanized mouse models and then focus on those equipped with reconstituted human immune system. the update advancement in the establishment of humanized immune system mice and their applications in the studies of the development of human immune system and the pathogenesis of multiple human immune-related diseases are intensively reviewed here, while the shortcoming and perspective of these potent tools are discussed as well. as a valuable bridge across the gap between bench work and clinical trial, progressive humanized mouse models will undoubtedly continue to play an indispensable role in the wide area of biomedical research. during the past century, the application of rodent animal models , especially diverse gene-engineered mouse models , provided indispensable platforms and numerous valuable information for the advances in experimental medicine and biological research. however, the gap between species is still the most challenging obstacle for translation of results from rodents to humans . with the great advancement of technology in molecular biology and gene modifi cation, the attempt to establish "humanized" mouse models has made a leap since 1990s [ 1 -3 ] . nowadays, a wide variety of humanized mouse models have been generated and applied in nearly all fi elds of biomedical research [ 4 ] . in this chapter, we briefl y review the history and classifi cation of humanized mouse models and then summarize the current situation and recent advancement of their application in biomedical research, especially in the research of immune-related diseases. in general, the "humanized mice" are composed of three main classes: human gene-expressed transgenic mice ( human genetransgenic mice ), which are modifi ed by gene knock-in or replacement technology to express one or more human specifi c genes; humanized mice carrying human tissue, such as the liver ( humanized liver mice ) in which murine hepatocytes are completely or partly replaced by infused human-original hepatocytes; humanized mice equipped with functional human immune system ( humanized immune system mice ), which are established on immunodefi cient mice by transplanting human immune organs or cells to reconstitute human immune system in mice and thus referred to special "humanized mice." in the following section, we briefl y review the history and current advance of human gene-transgenic mice and humanized liver mice, and then focus on humanized immune system mice. human gene-transgenic mice are closer to gene engineered mice rather than "humanized mice." although the expressions of human gene or protein in transgenic mice provides the platform for studying in vivo role of specifi c human gene or molecule, the value of these data is limited in translational medicine due to the lack of human microenvironment and signal networks in these mice. the most widely used human gene-transgenic mice are human leukocyte antigen (hla)-transgenic mice [ 5 ] . these hlaexpressed transgenic mice represent for a useful tool in studying in vivo tcr-restricted immune responses and thus were adopted in the studies of immune-related diseases during the fi rst 10 years of this century. for example, hla-a0201-transgenic mice were used in inducing cd8 + t cell-restricted type i diabetes (t1d) [ 6 ] and experimental autoimmune encephalitis (eae) [ 7 ] , while hla-drb1-transgenic mice were applied in establishing cd4 + t cellmediated eae [ 8 ], system lupus erythematosus (sle) [ 9 ] and rheumatoid arthritis (ra) models [ 10 ] . more recently, the respective role of hla-dr2 and hla-dq8 in eae [ 11 ] and autoimmune diabetes [ 12 ] was also studied through transgenic mice. meanwhile, transgenic mice with distinct hla subtype expression favor the study of hla-related susceptibility on specifi c diseases, such as eae [ 13 ] , experimental autoimmune uveitis [ 14 ] , arthritis [ 15 -17 ] , allergic bronchopulmonary aspergillosis-like pulmonary responses [ 18 ] , and celiac disease [ 19 ] . although the application of hla-transgenic mice has been reduced due to the simplifi cation of diseases into specialized immune responses, the combination of hla-transgenic technology and reconstitution of human immune system in immunodefi cient mice has re-assigned them vitality in biomedical research, which will be discussed in the next section. other , which had all been blocked by the lack of optimal animal models in "pre-humanized mice time." on the other side, chen et al. tried to stabilize the function of cryopreserved human hepatocytes in immune competent mice through a novel system called "human ectopic artifi cial livers (heals)," which involved juxtacrine and paracrine signal in polymeric scaffolds. they claimed that mice transplanted with heals exhibited persistent normal liver function for weeks and thus provided a window for drugrelated investigation [ 34 ] . however, the effi cacy and value of humanized liver mice in the development of drug are still on debate due to the proposed side effects such as ongoing liver injury caused by transgenic and the infl uences on "normal metabolism" mediated by exogenous treatment [ 35 , 36 ] . apart from these, the potential application of humanized liver mice in immune-related research also deserves further exploration because liver also represents for a critical component of human immune system. the development of humanized immune system mice could be divided into three phases corresponding to the establishment of prkdc scid (protein kinase, dna activated, catalytic polypeptide; severe combined immunodefi ciency) mutation in cb17 mice, the development of nod (non-obese diabetic)-scid mice, and the generation of immunodefi cient mice homozygous for mutation at il (interleukin)-2 receptor γ chain locus [ 2 , 37 ] . each breakthrough mentioned previously signifi cantly improved the engraftment of human immune cells or pluripotent stem cells and stood as milestone on the way to "real humanized mice." the engraftment of multiple human immune components in these mice surpassed conventional human-gene knock-in in breaking the limited viewpoint of studying specifi c molecules under isolated environment. this unique advantage of humanized immune system mice favors their general application in immune-related studies, and opens a window for researchers to observe the interaction among human immune cells in vivo. in the following content, we focus on the characteristics and application of these mouse models and simply refer them as "humanized mice" if not otherwise specifi ed. currently, il2γc −/− mice established on nod/scid and recombination activating gene 2 (rag2) −/− balb/c background were most widely used strains for the reconstitution of human immune system in vivo [ 38 -40 ] . recently, by using bone marrow, liver, thymus (blt) co-transplantation, lavender et al. engrafted high levels of multi-lineage hematopoiesis and organized lymphoid tissues in c57bl/6-rag2 −/− γc −/− cd47 −/− triple-knockout mice. these humanized mice sustained human cell and tissue engraftment as long as 29 weeks post-transplantation without the development of chronic graft-versus-host diseases (gvhd), and thus represented for a new advancement in establishment of humanized mice [ 41 ] . the reconstitution of functional immune system is the key to evaluate the successful establishment of humanized mice. the graft used for reconstituting human immune system includes stem cells [ 42 ] , blt [ 41 ] , and peripheral blood cells [ 43 ] according to specifi c objectives. generally, stem cell and blt transplantation exhibit advantage in establishing stable multi-lineage hematopoietic cells but might need additional treatment for improving development of specifi c cell subpopulations. on the contrary, humanized mice established by peripheral blood cells provide a ready platform for studying the functions of mature immune cells but the length of window appropriate for research is still limited by chronic gvhd and ongoing reduced engraftment. to maximize the potential of humanized mouse model , some progresses have been made recently. firstly, pretreatment or gene-engineering of pluripotent stem cell exhibited satisfactory effects on improving engraftment of immune cells [ 38 , 42 , 44 ] . secondly, human growth factors, cytokines [ 44 , 45 ] or signal regulatory protein alpha (sirpa)expressed [ 46 ] immunodefi cient mice demonstrated superior engraftment for specifi c immune cell subpopulations as well. in the following paragraphs, we briefl y review current status of the reconstitution of specifi c immune cell subpopulations in humanized mice. lymphocytes are most important components of immune system and thus draw a major attention. although human peripheral blood mononuclear cells (pbmc) transplantation led to rapid reconstitution of human lymphocytes in humanized mice, it was found that after initial activation and induction of antibody production, human t cell lymphocytes enter an unresponsiveness status due to loss of human professional antigen-presenting cells (apc), which could be reversed by adoptive transfer of human apc [ 47 ] or activating organ-resident myeloid dendritic cells (dc) through poly(i:c) treating [ 48 ] . meanwhile, stem celltransplanted humanized mice displayed diversifi ed t cell repertoire, but the gap between hla and murine major histocompatibility complex (mhc) molecules prohibited the induction of effi cient t cell-mediated primary immune responses in vivo [ 49 , 50 ]. to overcome these problems, hla-expressed immunodefi cient mice were generated and their effi cacy has been confi rmed [ 51 ] . another concern origins from th1 and th17 immunocompetence in humanized mice [ 52 ] , which supports the utility of their application as surrogate model in transplantation rejection and autoimmunity but might cause some unwanted immune responses against murine tissue antigen as well. distinct from their t cell companion, reconstitution of functional b lymphocytes is generally poor in humanized mice and needed to improve in the future although their primary repertoire were principally unaltered by the differences between mouse and human stromal environments [ 53 ] and their ability to produce antigen-specifi c antibody was partly developed [ 54 ] . as described previously, the reconstitution of myeloid cells not only guarantees immune system intact, but also determines the development and function of both adaptive and innate lymphocytes [ 47 , 48 , 55 ] . unfortunately, monocytes and other myeloid cells usually exhibit immature phenotype and impaired function in humanized mice [ 56 ] , which could be partly rescued by human colony stimulating factor (csf)-1 [ 57 ]. however, the improvements in their survival, differentiation and even migration and residence [ 58 ] are still urgently required. besides leukocytes, other blood components also play important roles during immune response and regulation. recently, hu et al. established the full reconstitution of human platelets in humanized mice after depletion of murine macrophage [ 59 ] , which represents for an interesting attempt in constructing a more "humanized" circulation in mice. in summary, the optimization of humanized mouse model is still on the way and the advances in molecular biology, cellular biology, and system biology will defi nitely bring new era to the development of this useful tool. the applications of humanized mice cover nearly all fi elds of biomedical research and here we concentrate on immune-related studies, especially those aiming at the mechanisms and translational potentials of immune regulation and suppression . we also briefl y summarize the benefi ts brought by these potent models in tumor, infectious diseases, and vaccine studies. cd34 + cd38 lo cd1a − (early t lineage progenitors, etp), and cd34 + cd38 + cd1a + pre-t cells in liver of humanized mice by intrahepatic injection of cd34 + stem cells, establishing a wonderful platform for investigating human t cell development [ 60 ] . however, joo et al. found that human t cells educated by murine mhc in mice without a human thymus differ from normal human t cells marked as higher expression of cd45ro and promyelocytic leukemia zinc fi gure protein (plzf) regardless of similar development stages [ 61 ] . correspondingly, danner et al. generated hla-dr4-expressed nod-rag1 −/− γc −/− mice and demonstrated the critical role of hla class ii molecule for development of functional t cells by infusion with hla-dr-matched human hematopoietic stem cells [ 62 ] . meanwhile, the roles of il-12 [ 63 ] and notch [ 64 ] signals during the development of human cd4 + and cd8 + t cells were evaluated by human hematopoietic stem cell-transplanted mice. moreover, using a human stem cell factor, granulocyte-macrophage colony-stimulating factor (gm-csf) and il-3-expressed nod/scid-γc −/− mice, billerbeck et al. found the increased accumulation of human cd4 + foxp3 + t cells in blood, spleen, bone marrow and liver. most importantly, these cd4 + foxp3 + t cells exhibited potent suppressive capability on t cell proliferation, which made a signifi cant contribution to study of human regulatory t cells (treg) development in vivo [ 65 ] . as described previously, the development of human b cells in humanized mice is relatively weak compared to t cells. in 2011, choi et al. evaluated the effi cacy of busulfan, a chemotherapeutic agent, and claimed that it could effi ciently improve the reconstitution of human specifi c antibody -producing b cells, t cells, macrophage, and even dc from cd34 + cord blood cells with less toxic effects [ 66 ] . on the other hand, kim et al. found that cotransplantation of fetal bone tissue with fetal thymus could facilitate the development and reconstitution of human b cells from fetal liver-derived cd34 + cells together with t cells [ 67 ] . besides adaptive lymphocytes like t and b cells , innate lymphocytes development-related factors were also illustrated in humanized mouse model . as early as in 2008, huntington and di santo made a periodic review on the application of humanized mice in the research of nk cell development [ 68 ] . in 2011, pek et al. further confi rmed the crucial role of il-15 in nk cell development in bone marrow and liver with humanized mouse model [ 69 ] . we believe that more studies in the development of other innate lymphocytes such as nkt, γδ-t cells and innate-like t cells (ilt) will be reported in the near future. myeloid cells are generally regarded as more fragile and diffi cult to survive in "strange environment", which made it attractive and subtle to improve reconstitution of these sensitive cells. addition of human original cytokines such as gm-csf and il-4 was generally accepted as an effi cient way to improve dc maturation [ 70 ] . similarly, the effects of macrophage colony-stimulating factor (m-csf) and fms-related tyrosine kinase (flt)-3 ligand on promoting the development of macrophage [ 71 ] , and cd141 + and cd1c + dc [ 72 ] have also been confi rmed in humanized mouse model respectively. moreover, the development of megakaryocytes was replicated and used as index of dengue virusinfection in humanized mouse model recently [ 73 ] , which also supported the multi-lineage hematopoietic cell development in humanized mice. finally, transplantation of human stem cells from bone marrow of patients with bone marrow failure syndrome into humanized mice provided invaluable tools for evaluating novel gene-targeted therapy before clinical trial [ 74 ] . in summary, the reconstitution of diverse human immune cell populations from their pluripotent progenitors in immunodeficient mice has become a potent platform for investigating the development of human immune system while the next question is how to create a more "humanized" environment in mice for human cells [ 75 ] . the advances in the study of autoimmune diseases in humanized mice, especially those t cell-mediated diseases, are always correlated with development of hla-transgenic technology. in 1999, bachmaier et al. generated a cd4−cd8− double-knockout mice transgenic for human cd4 and hla-dq6 to specifi cally reconstitute the human hla-dq6/cd4 arm in mice and established a dilated cardiomyopathy model [ 76 ] , which was one of the earliest attempt for applying humanized mouse model in the study of autoimmune diseases. using similar strategy, eming et al. established a ra model in a hla-dr4/human cd4/tcr combined transgenic mice with the stimulation of a ra-related human autogenic protein hcgp-39 in 2002 [ 77 ] . however, the lack of human immune system reconstitution in these models constrained their representative for the whole map occurring during autoimmune diseases. on the other side, shultz et al. established t1d model in nod/scid-γc −/− mice by co-transplanting with human stem cell and islet cells [ 78 , 79 ] . importantly, this group pointed out the potential of hla-transgenic immunodefi cient mice in optimization of these models and provided some interesting preliminary data [ 78 ] . soon after, infl ammatory arthritis and type 2 diabetes models were established in hla-transgenic humanized mice by david [ 80 ] and schultz groups [ 81 ] respectively. as we mentioned previously, t cell-mediated immune responses were generally incomplete in humanized mice established on conventional immunodefi cient mice, which usually led to insignifi cant clinical symptoms [ 82 ] and thus limited the application of these models. the involvement of hla not only improves the effi cacy of immune responses, but also provides a platform for study of the relationship between hla subtypes and specifi c diseases susceptibility. nevertheless, the complexity and individuality of hla phenotypes in healthy donors or patients still remain as the biggest challenge in rebuild of physiopathology process in relatively limited hla-expressed humanized mice. due to relatively weak reconstitution of human b cells in humanized mice, the establishment of b cell or antibody -mediated autoimmune diseases seems to be more diffi cult than those t cellmediated autoimmune diseases. kerekov et al. rebuilt the clinical pathogenesis in humanized mice with cells transferred from sle patients and evaluated the potential of b cell-targeted therapy with a chimeric molecule containing a monoclonal antibody against human inhibitory complement receptor type i coupled to a decapeptide that mimic dna antigenicity [ 83 ] . in 2012, another group led by duffi eld recapitulated systemic vasculitis in humanized mice by treating them with anti-proteinase-3 igg isolated from patients [ 84 ] . with the improvement in reconstitution of multiple components of human immune system in humanized mice, it is predictable that the induction of diverse human b cellmediated autoimmune diseases in vivo will be accessible soon. application of humanized mice models in transplantation-related diseases arises as early as the birth of humanized mice but the process is so tortuous till now due to chronic exogenous rejection and ongoing decrease of immune cells . in above three studies, investigators planted solid grafts into immunodefi cient mice before reconstitution of human immune system and induced rejection by infusion of mature human cells. however, the longterm outcome of these models is still not clear. in order to further mimic clinical situation, human cd34 + stem cells were applied in establishing humanized mice. using this strategy, three independent groups reported allogeneic islet transplantation [ 89 ], xenogeneic islet rejection [ 90 ], and xenogeneic skin rejection [ 91 ] models during 2010-2012. unfortunately, insuffi cient development of immune cell populations in these humanized mice still stayed as an obstacle and even led to the failure of rejection [ 89 ] . to solve this problem, some other groups tried to develop a more "mature" human immune system in humanized mice by transplanting human peripheral blood cells. in 2013, our group reported a novel human allogenic gvhd model established on humanized mice reconstituted with human pbmc [ 92 ] . this model reproduced typical clinical process of acute gvhd occurring during allogeneic bone marrow transplantation without apparent interruption of exogenous reactivity. using this model, we evaluated the protective effects of human cd8 + treg induced ex vivo by allogeneic cd40-activated b cells and found that human cd8 + treg could inhibit gvhd and induce long-term tolerance without compromising general immunity and graft-versus-tumor (gvt) activity [ 92 ] . the potent regulatory activity of the cd8 + treg was mainly mediated by the expression of cytotoxic lymphocyte antigen (ctla)-4 on cell surface, while their alloantigen-specifi city and the ability to induce the long-term tolerance favor their clinical application. more importantly, this strategy might reduce clinical dependence on limited hla-match donors and largely improve the survival chance of millions of patients who are waiting for bone marrow transplantation. humanized mouse model undoubtedly brings new hope for transplantation research, but we also need to keep in mind that a lot of questions are still waiting to be answered on this way. as emphasized by brehm and shultz, keys to successful humanized mouse model included available immunodefi cient mouse strains, the choice of tissue to transplant and the specifi c human immune cell population that can be grafted [ 85 ] . besides autoimmune diseases and transplantation-related diseases, humanized mice models are also useful to study some other infl ammatory diseases. in 2002, hammad et al. compared the th2 allergic infl ammation in the lung of humanized mice reconstituted with pbmc. to induce infl ammatory reaction, dcs from home dust mite (hdm)allergic patients or healthy donors were injected intratracheally and mice were then repeated exposed to aerosol of hdm. in contrast to ifn-γ secretion induced in mice receiving normal dcs, those injected with dcs from patients induced il-4 and il-5 production accompanied with the increase of ige production, which represents characteristics of th2 response lymphadenopathy, and other infl ammatory sequelae in humanized mouse model [ 97 ] . in addition to immunopathology study, humanized mouse model was also applied in studying the underlying mechanisms of injury repair. by plating retroviral vector-modifi ed human skin on nude mice and adding human keratinocyte growth factor (kgf) to artifi cial wound in the skin, the re-epithelialization was signifi cantly accelerated [ 98 ] . although this model could not be described as "real" humanized mice because no human immune system was involved in it, this attempt initiated an innovative application of humanized mice. compared to satisfactory reconstitution of circulating blood cells, the successful reconstitution of mucosa immunity in humanized mice is still absent till now. mucosa, especially respiratory and digestive tract surface, plays indispensable role in protection and immune regulation. however, the residence and exchange of immune components in the locus are still diffi cult to rebuild in animal models because the physiological dynamics remains largely unknown the occurrence of humanized mouse model provided a perfect platform for evaluating immunotherapy against tumor. the earliest attempts of inducing antitumor immune responses in humanized mice focused on the generation of specifi c antibody but the outcome varied due to unstable humanization of models [ 104 , 105 ] . in the new century, researchers started to pay more attention on developing complete tumorigenicity, especially metastasis process and its relationship with stromal cells, in immunocompetent humanized mice, and made some signifi cant advances in multiple fi elds like human prostate cancer [ 106 ], mixed-lineage leukemia [ 109 ] . based on these progresses, some novel immunotherapy strategies were evaluated on humanized mouse models, such as inhibitory receptor ig-like transcript (ilt)-3 depletion or blockade in melanoma [ 110 ] and il-15-enhanced nk cell-mediated cytotoxicity against human breast cancer [ 111 ] . recently, our group reported a novel application of pamidronate, a phosphoantigen generally used to treat osteoporosis, in treating epstein-barr virus (ebv)-induced b cell lymphoproliferative disease in humanized mouse model reconstituted with human pbmc [ 112 ] . this "new application of an old drug" was mediated by expanding and activating human vγ9vδ2-t cells, a small cell population of human lymphocytes, which might inspire further exploration of currently available resources. more importantly, the established of donorand tissue-specifi c humanized mouse tumor models will undoubtedly play an indispensable role during the development of individual therapies in the future [ 113 ] . the development of humanized mice represents a milestone in the history of human immunodefi ciency virus (hiv) study. the new generation of humanized mice not only improved our understanding on transmission, latency, and pathogenesis of hiv [ 114 -119 ] , but also provided unprecedented platform for antiviral study. besides further exploration of effi cient virus-specifi c neutralization antibodies [ 120 -125 ] and conventional antiretroviral or antimicrobial therapies [ 126 -128 ] in these models, the effi cacy of vectored immunoprophylaxis [ 129 ] and ccr5-targetd treatment [ 130 -132 ] in preventing hiv transmission were evaluated as well. meanwhile, the crucial roles of hiv-specifi c cd8 + t cells [ 133 , 134 ] and plasmacytoid dc (pdc) [ 135 , 136 ] in the replication of virus and activation of immune responses, and their potentials in targeted therapy were also investigated. other novel immunotherapy assays performed in humanized mouse model included blockade of programmed cell death (pd)-1 receptor [ 137 , 138 ] , engineering hiv-resistant t cells from short-hairpin rna (shrna)-expressing hematopoietic stem/progenitor cells [ 139 ] , and inhibition of hiv replication by a chimera containing an rna aptamer with high binding affi nity to the hiv envelop protein gp120 and virus neutralization properties and a small interfering rna (sirna) triggering sequence-specifi c degradation of hiv rnas [ 140 ] . moreover, a preliminary study on mechanisms underlying viral controlling in hla-b*57 elite controller or suppressor (es) was completed in humanized blt mice and demonstrated that elite suppressors are capable of controlling hiv-1 due to the possession of unique host factors rather than infection with defective virus in vivo [ 141 ] . nowadays, we could even make in-depth study on the cell dynamics in hiv-infected humanized mice model with the help of intravital microscopy [ 142 ] . therefore, it is countable that the future molecular biology will bring more surprise to the efforts of gene therapy against hiv [ 143 ] . except for application in hiv-related studies, humanized mouse model also brought span-new opportunities for other human infectious diseases [ 144 ] , especially those blood-borne pathogencaused diseases such as dengue virus infection [ 145 -149 ] , ebv infection [ 150 -155 ] , hcmv infection [ 156 ] , htlv infection [ 157 ] , and malaria parasite infection [ 158 ] . on the other hand, humanized mouse models for leishmaniasis [ 159 ] , salmonella typhi infection [ 160 , 161 ] , herpesvirus infection [ 162 , 163 ] , mycobacteria infection [ 164 , 165 ] , and group b streptococcus (gbs) infection [ 166 ] have been established. these efforts fi ll in the lacks of suitable animal models for those human-specifi c pathogen-caused diseases and push forward the correlating investigations on development of prevention and treatment , although some technological obstacles like the replication of natural infection and transmission routes are still needed to resolved. in 2011, our group used pbmc-transplanted humanized mouse model to evaluate a novel therapeutic strategy by targeting the host rather than the virus for treating infl uenza virus infection. we demonstrated that aminobisphosphonate can control infl uenza disease through boosting human vγ9vδ2-t cell immunity and this benefi cial effect is active against viruses of varying subtypes and virulence [ 43 ] . nevertheless, differences in the characteristics of molecules, tissues, and organs between human and mice might impair effi ciency of pathogen infection and initiation of specifi c immune responses [ 167 ] . in 2005, lassning et al. increased the susceptibility of mice on human coronavirus by crossing aminopeptidase n (apn), the receptor for human coronavirus (hcov)-229e, and transgenic mice into signal transducer and activator of transcription (stat)-1 null mice [ 168 ] . this work, together with hla-and human cytokines/growth factor-transgenic technology [ 169 ] , provided successful examples for future studying human infectious agents in humanized mice. in the next stage, improvement of versatility and variability of human immune system in humanized mouse model and application of gene-modifi ed pathogens [ 170 ] will defi nitely enhance translational effi ciency of these models. the usage of humanized mice in the development of vaccines targeting human diseases including ebv, hiv-1, dengue virus, infl uenza virus, severe acute respiratory syndrome (sars) corona virus, and carcino-embryonic antigen (cea) has obtained outstanding achievements during the past decade, while the introduction of hla transgenic immunodefi cient mice further accelerated the advancement in this fi eld [ 171 -173 ] . with the improvement of immune cell population reconstitution, more and more novel vaccination protocol will be carried out in humanized mice. compared to conventional mice and non-human primate model, humanized mice exhibit great advantage in translational potential, reproductive capacity and data repeatability, economical and ethical concerns. the increasing applications of diverse humanized mice models in biomedical research during the past two decades significantly improved our understanding on human physiological and pathological, especially immunological process at systemic, cellular, and molecular levels. this further accelerated the development of current translational medicine signifi cantly. nevertheless, there are several major caveats on their development remain to be dealt with, including complete replacement of murine mhc with diversifi ed hla molecules and effi cient methodology to express corresponding growth factors and cytokines at specifi c time and organs [ 174 ] ; how to prolong the maintenance of human engraftment, promote the development of myeloid cells and increase relatively weak quantity and quality of immune cells [ 175 ] ; and the limited development of lymph nodes, inter-organ traffi c of immune cells, and the reconstitution of red blood cells and granulocytes [ 176 ] . in another word, the most important issue is to fi nd the convenient and cost-effective ways to construct appropriate human-like microenvironment including physical structure, intercellular contact and molecular signals transfer in humanized mice. it is foreseeable that knowledge exchange in the age of big data will bring an even more bright future to this advancing tool than ever. analysis of candidate human blood stem cells in "humanized" immune-defi ciency scid mice humanized mice in translational biomedical research mighty mice. scientists are still improving the humanized mouse model but are optimistic about its future role in evaluating aids vaccine candidates humanized mice as a preclinical tool for infectious disease and biomedical research hla transgenic mice as humanized mouse models of disease and immunity prevention of "humanized" diabetogenic cd8 t-cell responses in hla-transgenic nod mice by a multipeptide coupled-cell approach cd8 t cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized hla-a*0201 humanized mice for studying human leukocyte integrins in vivo full reconstitution of human platelets in humanized mice after macrophage depletion human t cell development in the liver of humanized nod/scid/ il-2rgamma(null)(nsg) mice generated by intrahepatic injection of cd34(+) human (h) cord blood (cb) cells systemic human t cell developmental processes in humanized mice cotransplanted with human fetal thymus/ liver tissue and hematopoietic stem cells expression of hla class ii molecules in humanized nod. rag1ko.il2rgcko mice is critical for development and function of human t and b cells insuffi cient interleukin-12 signalling favours differentiation of human cd4(+) and cd8(+) t cells into gata-3(+) and gata-3(+) t-bet(+) subsets in humanized mice activation of notch1 promotes development of human cd8(+) single positive t cells in humanized mice development of human cd4+foxp3+ regulatory t cells in human stem cell factor-, granulocytemacrophage colony-stimulating factor-, and interleukin-3-expressing nod-scid il2rgamma(null) humanized mice human b cell development and antibody production in humanized nod/scid/il-2rgamma(null) (nsg) mice conditioned by busulfan co-transplantation of fetal bone tissue facilitates the development and reconstitution in human b cells in humanized nod/scid/il-2rgammanull (nsg) mice humanized immune system (his) mice as a tool to study human nk cell development characterization and il-15 dependence of nk cells in humanized mice gm-csf and il-4 stimulate antibody responses in humanized mice by promoting t, b, and dendritic cell maturation induction of functional human macrophages from bone marrow promonocytes by m-csf in humanized mice flt3-ligand treatment of humanized mice results in the generation of large numbers of cd141+ and cd1c+ dendritic cells in vivo inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice a novel lentiviral vector targets gene transfer into human hematopoietic stem cells in marrow from patients with bone marrow failure syndrome and in vivo in humanized mice humanized mice as a model to study human hematopoietic stem cell transplantation generation of humanized mice susceptible to peptideinduced infl ammatory heart disease humanized mice as a model for rheumatoid arthritis humanized nod/ ltsz-scid il2 receptor common gamma chain knockout mice in diabetes research humanized mice for the study of type 1 diabetes and beta cell function role of hla class ii genes in susceptibility/resistance to infl ammatory arthritis: studies with humanized mice humanized mice for the study of type 1 and type 2 diabetes subclinical cns infl ammation as response to a myelin antigen in humanized mice humanized scid mice models of sle anti-proteinase 3 antineutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system targeted activation of human vgamma9vdelta2-t cells controls epstein-barr virus-induced b cell lymphoproliferative disease humanized nod-scid il2rg-/-mice as a preclinical model for cancer research and its potential use for individualized cancer therapies the utility of the new generation of humanized mice to study hiv-1 infection: transmission, prevention, pathogenesis, and treatment generation of hiv latency in humanized blt mice can humanized mice refl ect the complex pathobiology of hiv-associated neurocognitive disorders? blt humanized mice as model to study hiv vaginal transmission hiv-1 infection of hematopoietic progenitor cells in vivo in humanized mice mucosal hiv-1 transmission and prevention strategies in blt humanized mice hiv therapy by a combination of broadly neutralizing antibodies in humanized mice inhibition of in vivo hiv infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-hiv antibody inhibitory effect of hiv-specifi c neutralizing iga on mucosal transmission of hiv in humanized mice hiv-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice broadly neutralizing antibodies and viral inducers decrease rebound from hiv-1 latent reservoirs in humanized mice humoral immune responses in humanized blt mice immunized with west nile virus and hiv-1 envelope proteins are largely mediated via human cd5+ b cells long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in hiv-1-infected humanized mice humanized mice recapitulate key features of hiv-1 infection: a novel concept using long-acting antiretroviral drugs for treating hiv-1 minocycline attenuates hiv-1 infection and suppresses chronic immune activation in humanized nod/ltsz-scidil-2rgamma(null) mice vectored immunoprophylaxis protects humanized mice from mucosal hiv transmission pre-clinical modeling of ccr5 knockout in human hematopoietic stem cells by zinc fi nger nucleases using humanized mice a topical microbicide gel formulation of ccr5 antagonist maraviroc prevents hiv-1 vaginal transmission in humanized rag-hu mice expansion of activated memory cd4+ t cells affects infectivity of ccr5-tropic hiv-1 in humanized nod/ scid/jak3null mice hiv-specifi c cd8(+) t-cell immunity in humanized bone marrow-liver-thymus mice rapid evolution of hiv-1 to functional cd8(+) t cell responses in humanized blt mice effi cient infection, activation, and impairment of pdcs in the bm and peripheral lymphoid organs during early hiv-1 infection in humanized rag2(-)/(-) gamma c(-)/(-) mice in vivo plasmacytoid dendritic cells suppress hiv-1 replication but contribute to hiv-1 induced immunopathogenesis in humanized mice in vivo blockade of the pd-1 receptor suppresses hiv-1 viral loads and improves cd4+ t cell levels in humanized mice pd-1 blockade in chronically hiv-1-infected humanized mice suppresses viral loads engineering hiv-1-resistant t-cells from short-hairpin rnaexpressing hematopoietic stem/progenitor cells in humanized blt mice an aptamer-sirna chimera suppresses hiv-1 viral loads and protects from helper cd4(+) t cell decline in humanized mice hla-b*57 elite suppressor and chronic progressor hiv-1 isolates replicate vigorously and cause cd4+ t cell depletion in humanized blt mice intravital microscopy in blt-humanized mice to study cellular dynamics in hiv infection gene therapy strategies for hiv/aids: preclinical modeling in humanized mice humanized mice for modeling human infectious disease: challenges, progress, and outlook mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice utility of humanized blt mice for analysis of dengue virus infection and antiviral drug testing enhanced humoral and hla-a2-restricted dengue virus-specifi c t-cell responses in humanized blt nsg mice dengue virus infection induces broadly cross-reactive human igm antibodies that recognize intact virions in humanized blt-nsg mice dengue virus tropism in humanized mice recapitulates human dengue fever ebna3b-defi cient ebv promotes b cell lymphomagenesis in humanized mice and is found in human tumors a novel animal model of epstein-barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice epstein-barr virus induces erosive arthritis in humanized mice t cells modulate epstein-barr virus latency phenotypes during infection of humanized mice reproduction of epstein-barr virus infection and pathogenesis in humanized mice adoptive transfer of ebv specifi c cd8+ t cell clones can transiently control ebv infection in humanized mice hcmv infection of humanized mice after transplantation of g-csf-mobilized peripheral blood stem cells from hcmv-seropositive donors adult t-cell leukemia/lymphoma development in htlv-1-infected humanized scid mice of men in mice: the success and promise of humanized mouse models for human malaria parasite infections leishmania major infection in humanized mice induces systemic infection and provokes a nonprotective human immune response humanized nonobese diabetic-scid il2rgammanull mice are susceptible to lethal salmonella typhi infection humanized mice for salmonella typhi infection: new tools for an old problem modeling of human herpesvirus infections in humanized mice human herpesvirus 6a infection and immunopathogenesis in humanized rag2(-)/(-) gammac(-)/(-) mice engrafted human cells generate adaptive immune responses to mycobacterium bovis bcg infection in humanized mice cd4+ cell-dependent granuloma formation in humanized mice infected with mycobacteria humanized mice, a new model to study the infl uence of drug treatment on neonatal sepsis humanized mice for the study of infectious diseases development of a transgenic mouse model susceptible to human coronavirus 229e new generation humanized mice for virus research: comparative aspects and future prospects infectious diseases in humanized mice use of humanized severe combined immunodeficient mice for human vaccine development human immune responses and potential for vaccine assessment in humanized mice broad infl uenza-specifi c cd8+ t-cell responses in humanized mice vaccinated with infl uenza virus vaccines humanized mice: are we there yet? humanized mice: current states and perspectives humanized mice for immune system investigation: progress, promise and challenges this work was supported in part by the area of excellence program supported by the university grants committee of the hong kong sar, china (aoe/m-12/06 and aoe/m-06/08). key: cord-278136-ol2buwld authors: gonzales, natalia m.; howell, viive m.; smith, clare m. title: 29th international mammalian genome conference meeting report date: 2016-05-02 journal: mamm genome doi: 10.1007/s00335-016-9640-0 sha: doc_id: 278136 cord_uid: ol2buwld nan during november 8-15, 2015, the 29th annual international mammalian genome conference (imgc) attracted researchers from all over the world to yokohama, japan to discuss the latest advances, tools, and techniques in mammalian genetics. organized by piero carninci (riken) and the international mammalian genome society (imgs; www.imgs.org), the meeting brought together 336 scientists from 28 countries, not to mention hundreds of online participants that followed the live tweeting of talks (#imgc15). social media has become an integral part of the imgc, complementing the scientific content and facilitating ongoing discussions between scientists around the globe. the conference opened with a bioinformatics workshop, guided tours of riken laboratories, and a trainee symposium, giving ph.d. students and early-career postdoctoral researchers an opportunity to share their works in a collegiate and mentoring setting and vie for the chance to present at the main meeting. participants were officially welcomed to yokohama at the evening reception, where old friends and new were met over a smorgasbord of local cuisine. the main meeting was divided into sessions showcasing the wide-ranging research interests of imgs members. these included human disease models and immunology, neuroscience, development and stem cells, genomics and computational analysis, epigenomics and noncoding rnas, advances in genome editing, and largescale resources. the verne chapman lecture was given by professor john mattick, director of the garvan institute of medical research in sydney, and the inaugural darla miller distinguished service lectureship was awarded to janan eppig, professor at the jackson laboratory and a pioneer of the mouse genome informatics (mgi) program project. several poster sessions, a mentor lunch for trainees and workshops on bioinformatics, systems genetics, scientific literature curation, gene enrichment analysis, and fantom were also featured in the meeting program, which culminated in a feast of epic proportions. abstracts from the meeting are available at www.imgc2015.jp. the imgc has a strong reputation for advocating new scientific talent, epitomized by the 33 trainee scholarships awarded for conference travel, the mentor-trainee lunch, presentation awards, and numerous opportunities to present work and receive feedback. the trainee symposium is an integral part of the meeting, featuring oral presentations from 16 graduate students and postdoctoral researchers. the wide variety of topics presented exemplified the diversity and utility of mammalian model systems for both clinical and basic research. xenograft mouse models were utilized by hiroyuki yoda (ts-01; chiba cancer centre research institute) and takahiro inoue (ts-13; chiba cancer centre research institute) to demonstrate the in vivo anti-tumor effects of novel alkylating agents targeting the oncogenes mycn in neuroblastoma, and kras g12d/v in colorectal cancer, respectively. the power of forward genetics was demonstrated by lisa gralinski (ts-02; university of north carolina) using the precollaborative cross to identify sars-coronavirus susceptibility loci and irina treise (ts-16; german mouse clinic), exploiting n-ethyl-n-nitrosourea (enu) mutagenesis to uncover molecular mechanisms of immunodeficiency. the sanger knockout mouse resources were highlighted by kifaythullah liakath-ali (ts-12; kings college london), who conducted a phenogenomics screen to investigate the genetic basis of skin phenotypes. gennadiy tenin (ts-10; university of manchester) followed up on human genomewide association studies (gwas) of the congenital heart defect tetralogy of fallot by developing an in vitro mouse heart culture for testing candidate genes by sirna knockdown. ximena ibarra-soria (ts-07; wellcome trust sanger institute) took us on a journey through the mouse olfactory system, demonstrating that novel olfactory receptor genes can be identified, characterized, and distinguished from environmental regulators despite the system's overwhelming complexity. several speakers focused on behavioral traits, including yuki matsumoto (ts-04; national institute of genetics), who identified a locus on chromosome 11 associated with mouse tameness in wild-derived heterogeneous mouse stocks, and akira tanave (ts-09; national institute of genetics) who is exploring the etiology of anxiety and stress by studying strain differences between wild-derived msm mice and c57bl/6 mice. guzel gazizova (ts-03; kazan federal university) introduced the dormouse as a genetic model, discussing how transcriptome-level differences between two genera of dormice can be analyzed to yield insights into the evolution of hibernation and to clarify the status of the dormouse in the mammalian phylogeny. belinda goldie (ts-06; kyoto university) took us further into the world of gene expression, demonstrating the importance of extending micro-rna (mirna) analysis beyond evolutionarily conserved targets when exploring gene regulation of human neuronal synapses. hazuki takahashi (ts-14; riken) demonstrated a high-throughput system to optimize antisense long-noncoding rnas that increase translation of target mrnas, and riti roy (ts-15; university of western australia) examined expression profiles of receptors and ligands in cell lines profiled in the fantom5 project and tumors profiled by the cancer genome atlas (tcga) to understand how cancer cells communicate. mice were not the only model system represented by trainee symposium talks. pavel mazin (ts-05; skolkovo institute of science and technology) examined brain rna-seq data from humans, chimpanzees, and macaques to identify species and age-related differences in alternative splicing patterns. pavel prosselkov (ts-11; riken) branched from the mammalian tree, using the sea squirt to investigate the role of gene paralogs in cognition. finally, brandon velie (ts-08; swedish university of agricultural sciences) showcased the horse, an underutilized organism in mammalian genetics, as a model for identifying genetic factors related to locomotion, allergic diseases, and eczema. ximena ibarra-soria, akira tanave, hazuki takahashi, and irina treise were named as the lorraine flaherty awardees for their talks during the trainee symposium ( fig. 1 ; table 1 ) and received the opportunity to present their work at the main conference. several plenary sessions focused on a range of mammalian tools and resources for modeling human disease. the session showcased tools such as recombinant inbred lines (rils), outbred populations, classic crosses, and enu mutagenesis to yield new understanding and identify candidate genes for disease susceptibility, while knockout and patient-derived xenograft mice enabled further mechanistic insight. the session featured many talks utilizing the phenotypic diversity and genetic mapping power of diversity outbred (do) mice and the collaborative cross (cc), community resources *10 years in the making. fernando pardoumass medical school) showed that resistance loci underlying tuberculosis pathogenesis could be mapped in *60 cc lines and *20 lines of the incipient c57bl/ 6 9 dba/2 (bxd) cross. interestingly, bacterial modules could be mapped onto the host genome to understand how both host and pathogen genomes determine disease outcome. the mapping resolution of the do population was also highlighted in cancer, with nigel crawford (o-19; national institutes of health, bethesda, md) using quantitative trait locus (qtl) mapping in tramp 9 j:do f1 males to identify metastasis susceptibility loci for prostate cancer. the power of the enu approach was demonstrated by several talks. gaetan burgio (o-02; australian national university) identified host factors altering malaria infection outcomes that could be targeted as a novel host-directed antimalarial therapy, and kart tomberg (o-16; university of michigan) mapped thrombosis modifier genes by bulk exome sequencing mice from a sensitized enu suppressor screen. both talks featured the use of gene editing candidate mutations with crispr/cas9 to validate causative alleles. the impact of mouse models on precision oncology was showcased by carol bult (o-01; the jackson laboratory), who discussed how patient-derived xenograft models can provide a platform for testing therapeutic options to guide treatments for breast and other cancers (fig. 2) . kate ackerman (o-22; university of rochester) used inducible wt1 creert2 to determine the impact of loss of ctnnb1 at different time-points, concluding that b-catenin is critical for diaphragm development during a defined window of time. han kyu lee (o-18; duke university) analyzed polymorphisms among the ancestral haplotypes of 32 inbred mouse strains to map loci for ischemic stroke outcomes, validating the interleukin 21 receptor as a candidate by analysis of gene expression patterns and knockout models. other features of this session included a gwas of aerobic capacity in rats segregated on running ability by yu wang german center for neurodegenerative diseases tuebingen) conducted a massive forward genetic screen using human exome data, followed by systematic rnai screens in worms, flies, and human cell lines to identify genes and pathways involved in parkinson's disease. this year's imgc included a mini-session that sought to address the question of whether or not the mouse is still relevant as a model for human disease. while this particular audience needed no convincing of the fundamental scientific understanding gained through use of the mouse as a model, tsuyoshi miyakawa (o-23; fujita health university) gave a thought-provoking narration of his lab's response to a controversial publication claiming otherwise. his careful consideration of arguments made from both sides of the controversy emphasized the importance of understanding the experimental design and methods for analyzing a study before interpreting its results. miyakawa compared his re-analysis of mouse genomic data from seok et al. (2013) with the original study, which had concluded that genomic responses in mouse models poorly mimic human inflammatory diseases. miyakawa's group drew the opposite conclusion from the data, demonstrating that responses in mouse models greatly mimic human inflammatory diseases (takao and miyakawa 2015) . alterations to the seok et al. (2013) analysis included comparing genes that exist in both mouse and human, not just human disease genes that lack rodent homologs. he emphasized the need to define appropriate phenotypes and choose appropriate statistical methods. ultimately, he concluded, the 15 % overlap in gene expression between mouse and human does not mean that the mouse is a bad model; instead, the overlapping 15 % probably contain the genes that are the most important for disease. the panel responses also emphasized other advantages of mouse models, including but not limited to access to tissue, ability to measure responses at different time-points on the same background and the capacity to do epigenetic studies. the symposium also raised a conundrum of the scientific review process by highlighting ways in which the design and methods chosen to address a question can either obscure or reveal scientific truths, inciting a thoughtful series of questions about training and the process of peer review. how can we ensure that future generations of biologists are adequately trained to evaluate statistical methods? when the same data can be analyzed to show very different results, potentially affecting funding decisions on models, is the ultimate onus for publication on the journal or expert scientific reviewers? these questions were discussed in the open forum and reflect a larger conversation taking place within the wider scientific community, where they will undoubtedly continue to be discussed. this plenary session encompassed the use of mouse embryonic stem cells (mescs), gene expression analysis, and recent advances in genome engineering to address fundamental questions about development and degenerative disease. anne czechanski (o-06; the jackson laboratory) described how her experience deriving novel pluripotent mescs with the inhibitor cocktail 2i led to the unexpected observation that female cell lines experience a higher rate of attrition than male cell lines. future transcriptional profiling may uncover why the combination of x chromosome dosage and 2i culture conditions leads to attrition of female lines and will have important implications for those using mescs. sandra richardson (o-07; university of queensland) used retrotransposon capture sequencing (rc-seq) to deduce the timing and frequency of retrotransposon insertions in multigeneration c57bl/6 pedigrees. she presented data showing retrotransposition in the early embryo resulting in somatic and germline genetic mosaicism, adding to the evidence for retrotransposition as an important source of genetic diversity. patrizia rizzu (o-08; german center for neurodegenerative diseases) shared how she used fantom5 data to understand how a hexanucleotide repeat expansion influences the transcriptional profile of c9orf72, a gene involved in neurodegenerative disease. yasuhide furuta (o-09; riken) derived compound mutant mice from mescs containing multiple targeted mutations in the fibroblast growth factor (fgf) signaling system to study the role of fgf family genes in eye development. due to tight linkage between the genes of interest and reduced fertility in fgf mutant lines, it was previously impossible to generate compound mutants from an experimental cross. however, the development of crispr/cas9 allowed furuta's group to measure the extent of functional redundancy within the fgf pathway and uncover novel roles for its constituents. gabriela sanchez-andrade (o-10; wellcome trust sanger institute), recipient of this year's verne chapman young investigator award (table 1) , closed the session with a discussion of her efforts to identify new biomarkers of neurodegenerative disease in a mouse model of frontotemporal dementia and parkinsonism (ftdp) with severe olfactory deficits. olfactory dysfunction is one of the earliest and most common symptoms of neurodegenerative disease in humans, yet the underlying molecular mechanisms are unknown. sanchez-andrade's impressive analysis of the olfactory epithelium measured differential expression and protein dynamics in wild-type and transgenic mice to identify a set of candidate genes correlated with onset of ftdp. furthermore, she demonstrated that similar changes in the expression of these genes occur in other brain regions relevant to ftdp pathology, highlighting the potential of her approach to identify additional biomarkers of human disease. the imgc featured three sessions on genomics and computational analysis. although the 13 selected talks were diverse in both content and approach, each of them touched upon at least one of the following themes: advances in omic technology, molecular mechanisms underlying complex traits, and the relationship between genomic architecture and mammalian evolution. speakers in the first session discussed their experiences with single-cell rna-seq to address a series of questions that remain integral to the imgc each year; namely, what tools and technologies are driving our field forward? what exciting possibilities do they create, and what obstacles do we face in using these methods and interpreting their results? anna mantoski (o-11; roslin institute) shared her solutions to some of the analytical puzzles that technical variability can create for single-cell sequencing experiments and described how studying differences in gene in describing cap analysis of gene expression (cage), a method for capturing single-cell transcriptomes, charles plessy (o-12; riken) highlighted many of the challenges familiar to researchers using rna-seq and shared how his strategy of combining cage with techniques including ''pseudo-random'' primers to remove rrna, molecular tagging, and fragmentation can improve the quality of single-cell data. anton kratz (o-13; riken) further emphasized cage's potential as he described how his group applied translating ribosome affinity purification (trap), which can isolate the ribosome-associated transcriptome (the translatome) to purkinje dendrites to measure transcription at the subcellular level and identify biomarkers for specific cell types. much of the remaining work sought to address broad evolutionary questions dealing with the relationship between biological mechanisms, complex traits, and genomic architecture. martin taylor (o-33; university of edinburgh) discussed how the distribution of replicationassociated polymorphisms in mouse and human genomes may be explained in part by patterns of transcription factor binding and chromatin accessibility in the paternal germline. satoshi oota (o-52; riken) used enu mutagenesis in the mouse to observe evolution in real time, which allowed gaining insight into how the distribution of gc content has evolved in mammalian genomes. andrew morgan (o-34; university of north carolina chapel hill) explored the functional and evolutionary impacts of large copy number variations at a specific locus in the mouse genome. another prominent theme among the research featured in the sessions on genomics and computational analysis was the relationship between genotypes and quantitative phenotypes at both the level of the cell and the organism. jason lin (o-36; chiba cancer center research institute) discussed how a new class of molecules that combine the histone deactylase inhibitor saha and dna-binding pyrrole-imidazole polyamide (saha-pip) can induce epigenetic reprogramming and regulate pluripotency. steven munger (o-53; the jackson laboratory) used a system's genetics approach in the do to resolve the conflict between the expectation of high mrna-protein expression correlation from the central dogma of biology and recent observations suggesting a weak correlation. his work showed that while the levels of many proteins are regulated by nearby variants that influence mrna expression levels (cis-eqtl), the relative stoichiometry of proteins in stable partnerships and complexes is a key posttranslational regulator of protein abundance that can act to buffer individual member proteins against cis-acting transcriptional variation. robert young (o-35; university of edinburgh) presented evidence of divergence in the patterns of promoter gain and loss in humans and mice, offering insight into the evolutionary processes that contribute to gene expression and phenotypic diversity in both species. peter williamson (o-54; university of sydney) used a panel of inbred mouse strains to identify qtl related to metabolism, body composition, lactation, and other complex traits. a common approach featured at the imgc each year is the use of the mouse as a model for understanding how biological processes influence and respond to changes in the mammalian genomic landscape. notably, this year's sessions on genomics and computational analysis also included speakers that used a variety of other organisms in their research. in addition to the several talks mentioned above, we heard from david beier (o-32; seattle children's research institute) who analyzed the genomewide distribution of nonsense mutations in the exomes of individuals without severe mendelian disorders. he found that the strength of heterozygote selection correlated with the likelihood of recessive lethality and that many genes with established roles in developmental diseases had high heterozygote selection. martin frith (o-51; national institute of advanced industrial science and technology, tokyo) used sequence data from humans, chimps, orangutans, and dogs to classify different types of human chromosomal rearrangements, which occur in slowly evolving regions. finally, isaac adeyemi babarinde (o-37; national institute of genetics) introduced the audience to the capybara (the world's largest living rodent) and shared how he used its genome to understand the relationship between mutation rate and body size in rodents. for the first time at an imgc, two plenary sessions were devoted to epigenomics and noncoding rnas. this highlights the increasing awareness of looking beyond the traditional gene-protein relationship for understanding transcriptional control in both normal and diseased states in mammals. the influence of parental diet was featured in two presentations. joseph nadeau (o-25; pacific northwest research institute) illustrated that both folate supplementation and mutations in rna modulating genes such as dnd1, a1cf, and apobec1 bias fertilization toward wildtype genotypes. johannes beckers (o-26; helmholtz zentrum, munich) reported the epigenetic inheritance of an acquired metabolic disorder. he showed that a parental high-fat diet increased offspring susceptibility to obesity and type 2 diabetes. both speakers stressed the importance of understanding the underlying mechanisms related to diet for guiding future public health policies. different aspects of genomic location as a determinant of transcriptional regulation were also discussed in the first plenary session. through determination of the three-dimensional configuration of x chromosomes in different tissues and cells, christine disteche (o-24; university of washington) demonstrated that genes that escape x inactivation preferentially localize at the periphery of the nucleus. she also showed that the expressed alleles of imprinted genes have greater chromatin contacts than the silent alleles, suggesting that these expressed regions are under greater organizational constraints. reanalysis of the publicly available encode data led siddharth sethi mrc harwell) to the discovery that transcription factor-binding sites are highly enriched in dnase1 hypersensitive sites compared to promoter and enhancer regions. as such, dnase1 hypersensitivity data could be used as an alternative method for discovering enriched regulatory motifs with the aim of improving understanding phenotypic variability. the second plenary session continued the theme of using genomewide data to understand transcriptional control by different noncoding elements-promoters, enhancers, microrna, and l1-transposable elements. to dissect the relationship between dynamic changes in mrna and enhancer rna, erik arner (o-44; riken) measured the activities of promoters and enhancers over time in a number of cell types following different biological stimuli. he presented data supporting enhancer transcription as the earliest event in successive waves of transcriptional change. this phenomenon was observed in multiple biological systems, suggesting this may be a general feature of mammalian transcriptional regulation, contrary to models showing coexpressions of enhancers and promoters. albin sandilan (o-43; university of copenhagen) provided a clinical application, presenting rna-seq data profiling colon specimens from patients with inflammatory bowel disease. a promoter set was identified, which could accurately distinguish between the primary disease subtypes: crohn's disease and ulcerative colitis. moreover, 20,000 active enhancer regions were identified with subsets induced in general inflammation or specifically in one subtype. these enhancers had links to both known and novel genes involved in the pathogenesis of inflammatory bowel disease. michiel de hoon (o-45; riken) turned attention toward the role of mirna in gene regulation. he presented the results from a collaboration spanning 31 centers internationally, which analyzed deep, sequencing data of paired small rna and cage libraries across a wide range of cell types. this analysis revealed two classes of mirna: celltype-specific mirnas and ubiquitous mirnas. cell-typespecific mirnas are highly expressed in only a few cell types and may act as buffers of gene expression. ubiquitous mirnas are expressed in most cell types, but depleted in particular cell types and may be important in preventing inappropriate activation of transcriptional programs. valerio orlando (o-46; ircss fondazione santa lucia) presented the last talk in the plenary session focusing on the epigenetic role of retrotransposable elements, specifically long interspersed nuclear elements 1 (l1). analysis of l1 transcription followed that of enhancer elements and myogenic program in normal muscle cells but was absent in duchenne muscular dystrophy (dmd)-affected muscle cells. pharmacological rescue of the dmd phenotype by histone deacetylase inhibitors or gene therapy was accompanied by normal l1 expression. he proposed that deregulation of l1 mobilization is a key trait in loss of cell identity and disease. genome editing using crispr/cas9 technology has taken the scientific world by storm, allowing rapid and efficient editing in eukaryotic cells. the in vitro and in vivo applications of crispr/cas9 genome editing was a strong theme at this year's meeting, with every plenary session including talks that made use of this technology, as well as the plenary session being completely devoted specifically to advances in genome editing. marie-christine birling (o-29; institut clinique de la souris) kicked off the session demonstrating crispr/cas9 genome editing in rats. she described her group's effort to generate alleles with precise gene deletions and duplications of a 24-mb region by means of two different guide rnas on both sides of the target region. kazuto yoshimi (o-30; national institute of genetics) then combined crispr/cas9 ''scissors'' with single-stranded oligodeoxyribonucleotides as the ''paste'' mechanism to ligate the cut sites for efficient replacement of rat genes with human genes. finally, dave bergstrom (o-31; jackson laboratory) presented his lab's modified crispr approach to enable rapid ''humanizing'' of large segments of the mouse genome, giving the example of replacement of a mouse tumor suppressor gene with 25 kb of the orthologous human gene. inbred strains with whole-genome illumina sequencing and discussed the challenges of making alignments in complex regions. attendees were treated to the test site launch of the latest data available through the uscd genome browser (http://www.hgwdev-mus-strain.sdsc.edu/cgi-bin/hggateway). the 2015 verne chapman lecture titled ''the hidden layer of regulatory rna in mammalian genome biology'' was delivered by eminent molecular biologist john mattick (o-42; garvan institute of medical research). mattick is known for his research in revealing the central role of nonprotein-coding dna in the production of regulatory nonprotein-coding rnas (ncrnas) and his efforts to understand how ncrna regulation contributes to the staggering level of phenotypic complexity observed throughout the animal kingdom. he began his lecture with the quote ''are we letting a philosophy of the protein-coding gene control (our) reasoning? what then is the philosophy of the gene?'' he pointed out that this quote was not from this year or even this century-it was in fact a concern attributed to nobel laureate barbara mcclintock 75 years ago. he reminded us that the mammalian genome contains only *20,000 protein-coding genes, the same number as in simple nematodes. on the other hand, the extent of nonprotein-coding dna increases with increasing developmental and cognitive complexity, reaching 98.5 % in humans. he guided us through the events leading up to his discovery and the explosion of studies that followed, peppering his tale with vivid descriptions of the findings and figures that have influenced him over the years. he shifted effortlessly between concrete descriptions of data and philosophical speculations on the evolution of paradigm shifts, the mysteries of biological complexity, and the silent assumptions that inform (and occasionally hinder) scientific practice. he entertained the audience with his encyclopedic knowledge of molecular genetics, framing his research within a larger historical context that served to complement data-driven descriptions of his and others' work establishing ncrnas as prominent regulators of development, cognition, and disease in the mammalian genome. mattick also elaborated on the relevance of ncrnas to incipient areas of research and technology development in epigenomics and neurobiology, creating a memorable and thought-provoking experience for both experienced investigators and trainees (fig. 3) . this year there were two additional keynote lectures, both showcasing scientific advancements using induced pluripotent stem cells (ipscs). masayo takahashi (o-28; riken center for developmental biology) provided a historical perspective of ipscs, from basic research to clinical application. it is remarkable that the field has gone from the invention of ipsc technology to the clinic in only 7 years. dr. takahashi presented the first human application of ipsc-derived targeting age-related macular degeneration, a retinal disease. she described an impressive panel of experimental validations for retinal pigment epithelial cell sheets derived from ipscs, including whole genome, genotyping arrays, methylome, and single-cell analysis. next, her group hopes not only to treat the retinal epithelium but also to use ipscs to derive photoreceptors to completely restore vision in patients. the talk discussed the use of allogenic as well as autologous ipscs and treated the audience to an early view of potentially revolutionary treatments utilizing ipscs, highlighting the steadily growing wave of interest in this technology. hideyuki okano (o-47; keio university graduate school of medicine) then went on to discuss the use of ipscs in the study and treatment of neurological disorders. he described work to establish ipscs from patients with psychiatric disorders and characterize their pathophysiology. in a quest to investigate human psychiatric and neurological disorders more effectively, hideyuki then presented his group's impressive work generating transgenic marmoset models of parkinson's disease. the marmosets express human synuclein and recapitulate typical human diseases including sleep disturbances, lewy bodies, tremors, and gait abnormalities. in summary, the 2015 meeting showcased a variety of cutting edge mammalian genetic approaches, concepts, and results-from large-scale mapping to single gene approaches and everything in between. the meeting ended in a spectacular fashion, with attendees treated to the spa and fig. 4 a spectacular finale for an amazing conference massage facilities at the yokohama minatomirai manyo club, donning kimonos and yakutas for a traditional banquet (fig. 4) . attendees were entertained by local performers before awards were made to acknowledge exceptional trainee oral and poster presentations, and to thank the outgoing imgs secretariat and nominations and elections committee. it is certainly the first and only imgs meeting to date where ongoing scientific collaborations were made and discussed in a traditional japanese onsen: a most fitting end to a wonderful meeting. we eagerly await the next imgc, which will be part of mouse genetics 2016 at the allied genetics conference (tagc) in orlando, florida in july 2016. that conference will bring the mouse genetics community together with yeast, ciliate, c. elegans, drosophila, and zebrafish communities to highlight the importance of model systems in understanding and translating fundamental advances in genetics. updates about tagc 2016 and the following imgc in heidelberg, germany in 2017 can be found at www.imgs. org. follow us on twitter (https://www.twitter.com/imgs_ news) or facebook (https://www.facebook.com/mamma lian.genome/). genomic responses in mouse models poorly mimic human inflammatory diseases genomic responses in mouse models greatly mimic human inflammatory diseases key: cord-022393-s26d54ew authors: e. newcomer, christian; g. fox, james title: zoonoses and other human health hazards date: 2007-09-02 journal: the mouse in biomedical research doi: 10.1016/b978-012369454-6/50054-6 sha: doc_id: 22393 cord_uid: s26d54ew zoonoses refers to the infectious diseases and infestations that are transmissible directly from an animal host to humans. the biomedical literature contains numerous reports of zoonotic diseases and parasitic infestations from laboratory mice and their wild counterparts. the extended maintenance of the laboratory mouse over a number of generations under controlled and increasingly sophisticated laboratory animal housing conditions with veterinary oversight and effective infection control measures has markedly reduced the likelihood that zoonotic agents would be encountered in a modem animal care and use environment. wild caught mice that are maintained in naturalistic housing environments in the laboratory, laboratory mice that have contact with wild or feral mice, and mice kept as pets in the home environment are examples of animal management conditions that would be conducive to the expression and transmission of zoonotic diseases and other mouse-associated hazards. in addition to the zoonoses, mice are capable of inflicting bites on inadequately trained personnel and are a rich source of allergens for a substantial number of persons predisposed to develop mouse-associated allergic sensitivities. this chapter discusses the mouse-associated zoonotic diseases and other health hazards and explains the strategies that are helpful for reducing or eliminating the risk of personnel exposure to these conditions. zoonoses is derived from the greek words zoon (meaning animals), and noses (meaning disease), and refers to the infectious diseases and infestations that are transmissible directly from an animal host to humans. the biomedical literature contains numerous reports of zoonotic diseases and parasitic infestations from laboratory mice and their wild counterparts. the extended maintenance of the laboratory mouse over a number of generations under controlled and increasingly sophisticated laboratory animal housing conditions with veterinary oversight and effective infection control measures has markedly reduced the likelihood that zoonotic agents would be encountered in a modem animal care and use environment. however, when these essential animal program quality measures fail or are not incorporated into the animal facility operations, zoonotic pathogens may be unwittingly introduced and perpetuated, placing personnel at increased risk of exposure. wild caught mice that are maintained in naturalistic housing environments in the laboratory, laboratory mice that have contact with wild or feral mice, and mice kept as pets in the home environment are examples of animal management conditions that would be conducive to the expression and transmission of zoonotic diseases and other mouse-associated implications in the new world serocomplex group are present among the wild rodents endemic to the united states such as neotoma spp. and peromyscus spp. buchmeier et al. 2001; fulhorst et al. 2002) . research animal programs that import wild rodents for laboratory studies should stay abreast of the developments on the identification and host-range characteristics of the new world arenaviruses of emerging importance. this section will focus only on lymphocytic choriomeningitis (lcm), a naturally occurring viral zoonosis of the laboratory mouse. many published reports of human lcm infection are associated with laboratory animal and pet contact, particularly mice and hamsters, and these studies now span many decades (armstrong and lillie 1934; bowen et al. 1975; dykewicz et al. 1992; jahrling and peters 1992; lehmann-grube et al. 1979; rousseau et al. 1997) . there seems to be a resurgent awareness among physicians that lcm should be sought as an etiology in human neurological disease and in pediatric congenital brain disorders (barton and hyndman 2000; barton et al. 1995 barton et al. , 2002 romero and newland 2003) . lcmv is widely distributed among the wild mouse population throughout most of the world presenting a zoonotic hazard (childs et al. 1992; childs and peters 1993; morita et al. 1996; smith et al. 1993 ). surveys conducted within the urban environment of baltimore, maryland, reported that 9% of house mice and 4.7% of persons tested had measurable lcmv antibody titers (childs et al. 1991 (childs et al. , 1992 . a similar serological survey conducted in spain across urban and rural ecological settings also found a 9% prevalence in mice and a 1.7% prevalence among persons by immunofluorescence assay (lledo et al. 2003) . the recent serological detection of lcmv in five mice on the treeless, sub-antarctic, macquarie island of australia, indicates the extent of distribution of this agent to the remotest areas of our planet (moro et al. 2003) . the apparent ease with which lcmv is transmitted to humans also occurs in a variety of other laboratory animal species; hamsters, guinea pigs, swine, dogs, and nonhuman primates, especially callitrichids, which readily sustain natural infections. in the case of the callitrichids, there have been numerous reports of epizootic infectious hepatitis (callitrichid hepatitis) due to lcmv, with a high mortality rate in zoological parks in both the united states and england over the past two decades (lucke and bennett 1982; montali et al. 1989; stephensen et al. 1990 stephensen et al. , 1991 stephensen et al. , 1995 . rodent (mouse) infestations of these zoos and/or the supplementation of the diets of tamarins and marmosets with suckling mice, a common practice (richter et al. 1984) , are potentially rich sources for lcmv. in the research animal facility environment, the laboratory mouse continues to merit attention as the species of primary concern as a reservoir for cases of human lcm (dykewicz et al. 1992 ). in the laboratory mouse, and to a lesser degree the hamster, breeding colonies can become endemically infected when the virus is transmitted to pups in utero or early in the neonatal period, producing a tolerant subclinical infection characterized by chronic viremia and viruria. when infected, athymic and other immunodeficient mouse strains may be predisposed to harboring silent, persistent infections and present a higher risk to personnel (dykewicz et al. 1992) . under some circumstances lcmv also produces a pantropic infection and may be copiously present in blood, cerebrospinal fluid, urine, nasopharyngeal secretions, feces, and tissues of infected natural hosts and possibly humans. bedding material and other fomites contaminated by lcmv-infected animals can also be important sources of infection for humans, as demonstrated in a recent outbreak among laboratory animal technicians and on many previous occasions (biggar et al. 1975; dykewicz et al. 1992) . the experimental passage of tumors and cell lines contaminated with lcmv has long been recognized (haas and stewart 1956) and represents one of the biggest threats for the introduction of lcmv into animal facilities at the present time (bhatt et al. 1986; dykewicz et al. 1992; nicklas et al. 1993) . reported that 17 of 63 rodent transplantable tumors screened were positive for lcmv and identified contamination in 4 of 14 hamster tumors and 2 of 81 mouse tumors that had been propagated in animals (nicklas et al. 1993) . the growth of lcmv in insect cell lines has also been demonstrated (rahacek 1965) , and the article by hotchin summarized the work of others indicating that numerous experimentally infected, bloodsucking ectoparasites are capable of transmitting the disease to laboratory rodents (hotchin 1971) . lcm virus also has been recovered from cockroaches (armstrong and lillie 1934) . the diagnosis and control of lcmv infection in mouse colonies has been reviewed in chapter 7 of this volume. tumor and cell-line screening before animal passage, the control of wild rodent infestations in areas where animals are housed or used, and the early detection of colony infections through sound colony health surveillance practices are of critical importance to the prevention of infection in mouse colonies. once established in mouse breeding colonies, the high viral load characteristically shed by mice infected congenitally or neonatally represents a very serious hazard to personnel. most of the cases of human infection, whether involving exposure in the home, agricultural, or laboratory setting, have involved contact with live mice and their excreta or mouse carcasses (dykewicz et al. 1992; havens 1948; morbidity and mortality weekly report 1984) . several authors have emphasized the association between the actual handling of infected mice and the contraction of the disease by humans (dykewicz et al. 1992; havens 1948; smithard and macrae 1951) . several cases of human infection have suggested the possibility that infected rodent tissues can serve as a source of infection for laboratory personnel (baum et al. 1966; dykewicz et al. 1992; tobin 1968 ). humans may be infected by inhalation or by the contamination of mucous membranes or broken skin with infectious tissues or fluids from infected animals. the transmission of lcmv by the bite of an infected mouse can also occur (scheid et al. 1964) . also, hotchin reported the findings of other researchers that lcmv was transmissible experimentally through the intact skin of the guinea pig, but this finding has not been reported in humans (hotchin 1971) . airborne transmission is well documented and plays a very important role in human infections, especially through the ready dispersion and inhalation of viral-contaminated dust from the animal cage or room (biggar et al. 1975; hinman et al. 1975) . following an incubation period of 1 to 3 weeks, humans may experience asymptomatic or a mild febrile disease ranging to a serious flu-like illness characterized by anorexia, malaise, diffuse myalgia and arthralgia, fever, chills, vomiting, headache, stiff neck, and photophobia. some patients enter a second stage of the disease several days after the resolution of early mild symptoms, developing meningoencephalitis and exhibiting additional signs such as drowsiness, confusion, sensory disturbances, and motor abnormalities. patients can also develop more serious nonneurological manifestations of the disease such as maculopapular rash, lymphadenopathy, parotitis, orchitis, arthritis, and epicarditis (peters 1997 ). central nervous system involvement has resulted in death in several cases. infections during pregnancy pose a risk of infection for the human fetus (wright et al. 1997). wright et al. reported 26 cases in human infants, with lcmv confirmed serologically over a two-year period in a major u.s. medical center (wright et al. 1997) . these infants presented with ocular abnormalities, macrocephaly, and hydrocephalus with microcephaly. fifty percent of the mothers reported having had illnesses compatible with lcmv infection, and over half reported exposures to rodents during their pregnancies. the diagnosis of lcm infection in humans is currently made by serological testing using either the immunofluorescent antibody (ifa) test or the enzyme-linked immunosorbent assay (elisa) (barton et al. 2002) . both of these tests are available through the centers for disease control and prevention and are superior to the complement fixation test that is widely available commercially. although there are no proven effective antiviral therapies for lcm infection, intravenous ribavirin therapy reduces mortality in patients infected with lassa fever virus (a member of the old world arenavirus serocomplex) and may be of some benefit in patients with severe lcmv infections (andrei and de clercq 1993; mccormick et al. 1986 ). this disease can be prevented in the laboratory through periodic serological surveillance using elisa and ifa tests of newly introduced animals with inadequate disease profiles and of resident animal colonies at risk. thorough screening of all tumors and cell lines intended for animal passage using the highly sensitive mouse antibody production assay or newer pcr-based laboratory tests for the presence of lcmv is another crucial element in the program to prevent the introduction of lcmv into established animal colonies (besselsen et al. 2003 and chapter 7 of this volume). sound animal facility sanitation practices and the use of microbarrier caging systems with proper infection-control techniques should prevent or suppress the spread of lcmv if present in the environment. the elimination of wild rodent infestations in animal facilities is very important to prevent the introduction of lcmv into the animal facility environment. also, facilities with wild rodent infestations may encounter the relatively common, free-living, bloodsucking mite of the rodent, ornithonyssus bacoti, in abundance (personal communication). although the natural lcmv transmission to humans from bloodsucking ectoparasites is unproven, the control of potential ectoparasitic vectors of this type would be a prudent measure. rabies is an acute, almost invariably fatal disease that occurs worldwide with the exception of a few countries, generally island nations, and other regions that have excluded the disease through animal importation and control programs and the aid of geographic barriers. neither the laboratory mouse nor other small wild rodent hosts appear to be important as reservoirs of natural rabies infection. hence, the principal reason for our discussion of rabies as a zoonotic disease of the laboratory mouse is to provide information that should quickly allay the fears of uninformed research and animal facility staff who suffer the bite of a mouse. on the other hand, the experimental use of mice in the study and characterization of rabies virus and in rabies vaccine development is an important component of some animal care and use programs that deserves special attention by the institution during all phases of research planning and implementation. there are no known cases of human rabies from rodents in the united states (2002). the incidence in larger wild rodent species within the united states has increased in recent years, however. during the interval 1971-1984, a total of 97 cases of rabies in rodents were recorded, but from 1995 to 2000 approximately 52 cases were reported in large rodents annually (2002) . the rodents involved were woodchucks and beavers, both species presumably large enough to survive the chance encounter and attack by a wild rabid carnivore such as the raccoon, skunk, fox, or feral cat. earlier literature on the federal republic of germany summarized findings from 1961 to 1967, which indicated that three mice, one rat (species not given), nine norway rats, and three muskrats were infected with rabies and had bitten humans (scholz and weinhold 1969) . despite rare reports of this nature, rodents are not a proven source of rabies transmission to humans (johnson 1989 ). all mammals are generally regarded as susceptible to rabies. in humans, the course of the disease proceeds through several phases: incubation, prodromal, acute neurological, coma, and rarely, recovery (johnson 1989) . the incubation period varies from 9 days to over 8 months. during the prodromal stage lasting 2 to 4 days, patients experience a period of apprehension and develop headache, malaise, and fever. an abnormal, indefinite sensation at the site of a prior animal bite wound is the first specific symptom. patients also may develop intermittent periods of excitation, nervousness, or anxiety interspersed with quiet periods when the mental state appears normal. further progression of the disease involves paresis or paralysis, inability to swallow, and the related hydrophobia, delirium, convulsions, and coma. rabies produces an almost invariably fatal acute viral encephalomyelitis, with death due to respiratory paralysis. adult mice used experimentally in rabies studies usually exhibit clinical signs between 5 and 15 days following inoculation and die within 5 days of the onset of clinical signs coinciding with the period of viral shedding. clinical signs in the mouse consist of muscular tremors, incoordination, excitation, or paralysis. certain rabies virus isolates from skunks produce a spastic paralysis in adult mice followed by recovery in a high percentage of infected mice. also, infant mice inoculated with certain strains of street rabies virus are capable of full recovery (johnson 1989 ). personnel working with mice experimentally infected with rabies virus should adhere to the well-established and detailed procedures that have been described in other sources for animal inoculation, husbandry, and tissue harvest procedures (johnson 1989) . vaccination of personnel involved in rabies studies with laboratory animals also is clearly indicated, regardless of the animal species involved. four other viruses that produce natural infections in the mouse have been implicated previously or are known to be infectious for humans. these include hantavirus, sendai virus, reovirus 3, and mouse hepatitis virus. for none of these viral agents is there documented evidence of zoonotic transmission of the agent from naturally infected laboratory mice to personnel in the laboratory. hantaviruses are zoonotic viruses comprising at least 22 species that are maintained among natural rodent reservoirs, despite the presence of neutralizing antibody in the rodent host (elliott et al. 2000; meyer and schmaljohn 2000) . approximately half of the hantaviruses are known human pathogens producing virus-specific patterns of disease that include hantavirus pulmonary syndrome, hemorrhagic fever with renal syndrome, and its benign form, nephropathia endemica (mills and childs 1998) . although mus musculus can exhibit the pattern of persistent hantavirus infection in the presence of neutralizing antibody when induced experimentally (araki et al. 2003) , this does not occur in natural infections of the mouse (meyer and schmaljohn 2000) . this is the likely reason that the wild mouse apparently is not important as a natural reservoir for the hantaviruses. this interpretation is supported by serological studies of wild mus musculus that detected either no or a very low incidence of serological evidence to hantavirus exposure even when other wild rodent species in the vicinity had a high level of endemic infection (kantakamalakul et al. 2003; meyer and schmaljohn 2000; pacsa et al. 2002; zuo et al. 2004) . mus musculus is used in the laboratory as an animal model to study various aspects of hantavirus infection ranging from vaccine development (choi et al. 2003) , viral pathogenicity (ebihara et al. 2000; kim and mckee 1985) , and immunological aspects of persistence (araki et al. 2003) , and it is primarily in this context that hantavirus deserves mention as a zoonotic infection in the mouse. the control of wild rodent infestations in animal facilities, quarantine and testing of wild caught rodent species during importation, and proper observance of animal biosafety guidelines for hantavirus-infected animals would be expected to virtually eliminate the risk of this zoonosis in laboratory maintained mice. mouse hepatitis virus (mhv) remains a prevalent infection in many mouse colonies where it potentially impacts colony health and disrupts experimental studies (see chapter 6). earlier studies have demonstrated that human sera contained complement-fixing and neutralizing antibodies to mhv (hartley et al. 1964) . later studies suggested that this was most likely due to cross-reactive antibodies from human cold virus infections (bradburne 1970; mcintosh et al. 1967 ). mouse hepatitis virus and the two prototype human cold viruses (oc43 and 229e) are members of the antigenic group 2 coronaviruses, and it is now known that members of this group share four, and in some cases five, structural genes that could account for this crossreactivity (navas-martin and weiss 2003). the coronaviruses have a very narrow host range and generally replicate only in the cells of the host species (navas-martin and weiss 2003). however, under unique laboratory conditions involving persistent cell culture infection, the use of mixed cell cultures of murine and of a nonpermissive species, or the use of cells possessing modified receptors, mhv has been adapted to grow in human, nonhuman primate, and hamster cells. also, the many strains of mhv in combination with use of targeted rna recombinant system have also been very useful for experimental study of the molecular basis of coronavirus pathogenicity (masters 1999) . application of the targeted rna recombinant system to mhv for exploring of emerging coronavirus infections such as sars may delineate the molecular basis for expanding of host range. these studies may warrant the reader's future attention, but at the present, mhv can be reasonably dismissed as a zoonotic infection. sendai virus was once a prevalent agent in mouse colonies but has become a rarity in most institutions. this is due to its ease of eradication through the use of temporary cessation of breeding to eliminate a naive population that is susceptible to infection and through the use of caging systems that prevent transmission (see chapter 11). sendai virus was originally isolated and described in the 1950s during the investigation of cases of human respiratory illness (gerngoss 1957; kuroya et al. 1953a kuroya et al. , 1953b sano et al. 1953; zhandoff et al. 1957 ). in the original report involving the isolation of sendai virus from japanese newborn human infants suffering from fatal pneumonitis, lung suspensions from the newborns were inoculated intranasally into mice, producing lung consolidation and death in several cases (kuroya et al. 1953b) . in later studies, sendai virus isolates were reported to produce disease in human volunteers (kuroya et al. 1953a; yamada 1956) , and reports from many countries indicated that serological evidence of sendai virus infection was associated with outbreaks of human respiratory illness (demeio and walker 1958; gardner 1957; jensen et al. 1955). tennant et al. demonstrated that personnel working with laboratory animals had antibody titers to sendai virus, but personnel with no known exposure to laboratory animals also had significant titers to the agent (tennant et al. 1967) . recombinant sendai virus is widely used for gene transfer experiments, and these vectors can readily infect human airway epithelium and a variety of other human tissues under experimental conditions (nagai 1999; pinkenburg et al. 2004) . although these recent studies have clearly demonstrated that sendai virus is capable of infecting human tissues, the initial evidence for its role as a human pathogen remains doubtful. the mice used for the early isolations of the agent may have already been endemically infected with sendai and served as the source, or it may be that other serologically cross-reactive parainfluenza viruses, which were not characterized during this era, were responsible for producing false positive reactions to sendai virus (ishida and homma 1978) . reoviruses are generally regarded as the cause of childhood infections producing asymptomatic or very mild disease, and there are few reports linking these infections with a particular disease (tsai 2000) . reovirus 3 was originally isolated from the feces of a clinically ill child (stanley et al. 1953) , and it continues to receive attention as a possible etiology for neonatal hepatitis and extrahepatic biliary atresia in infants (richardson et al. 1994; steele et al. 1995) . reovirus 3 is highly infectious for infant laboratory mice and still receives some attention in the health-screening programs for the mouse and laboratory rodent species. jacoby and lindsey (1997) reported that mouse colonies in the united states continue to have a 5 to 20% prevalence of reovirus 3 infection. although there are no confirmed reports of reovirus 3 transmission from mice (or other laboratory animal species) to humans, the laboratory mouse should be considered a possible source for this infectious agent for humans and other susceptible species. the rickettsiae are fastidious, small pleomorphic coccobacilliary organisms maintained in nature in a cycle of infection involving mammalian hosts and arthropod vectors as reservoirs (saah 2000) . in most rickettsial infections, humans serve only as an incidental host and do not contribute to the propagation of the organism in nature. such is the case for rickettsialpox, a nonfatal, self-limiting zoonotic disease caused by rickettsia akari, which is perpetuated in a cycle of infection involving mus musculus as the primary host and a mite vector (liponyssoides sanguineus). isolation of the organisms from rats (rattus) and voles (microtus) has also been reported. the first cases of human rickettsialpox were described in patients in new york city (huebner et al. 1946a (huebner et al. , 1946b , and outbreaks of the disease have generally remained clustered within large urban areas of the united states and in rural north carolina, utah, south africa, korea, and the former soviet union . according to koss et al. approximately 800 cases of rickettsialpox have been reported in the literature, with nearly 500 of these within the three years following the original description of the disease . prior to the report by koss et al. the largest case study included 13 patients accumulated over a 10-year period. the recent report by koss et al., however, included 18 patients in new york city reporting over only a 20-month period in the wake of the september 11, 2001 attacks, suggesting that perhaps the heightened sensitivities to possible bioterrorism events stimulated an upsurge in the reporting of cases as a byproduct of increased patient concerns . authors have commented on a variety of other social and demographic factors that may also be contributing to the noticeable increase in the incidence of rickettsialpox and murine typhus in the urban environment (comer et al. 1999; paddock et al. 2003) . there are no reported cases of rickettsialpox in personnel related to exposure to naturally infected laboratory mice. the mite vector l. sanguineus has not been reported in laboratory mouse colonies either historically or contemporarily. however, the tropical rat mite (ornithonyssus bacoti) can be experimentally infected with r. akari but has not been shown to play a role in the natural cycle of infection. in the authors' experience of ornithonyssus bacoti infestations of laboratory mouse or rat colonies are still seen with some frequency in facilities that have resident wild or feral mouse populations and should be addressed in the institution's pest control and infection control programs. rickettsialpox has an incubation period of 7 to 21 days following the bite of the infected mite (saah 2000 mild to severe with an abrupt onset, and it typically presents with a classic triad of an eschar, fever, and a papulovesicular rash. the papule develops at the site of the bite and later ulcerates and progresses to an eschar, 0.5 to 3 cm in diameter, as r. akari proliferates locally in the skin and vasculitis develops saah 2000) . the rash begins with firm, generally nonpruritic, erythematous papules, 2 to 10 mm in diameter, that develop into vesicles and heal by crusting. in addition to fever, patients may experience chills and headache, and less commonly, backache, myalgia, and photophobia. the disease is mild and self-limiting within 6 to 10 days, and serious complications or death have rarely been reported (saah 2000) . patients typically respond quickly after the initiation of antirickettsial therapy with tetracycline, doxycycline, or other appropriate agent saah 2000) . however, following resolution of the infection, headache and lassitude can persist for 1 to 2 weeks. the reader should refer to koss et al. for information on other rash-producing or eschar-related diseases that should be considered in the differential diagnosis to rickettsialpox . rickettsia akari are diagnosed by complement fixation tests or the more sensitive indirect immunofluorescent antibody test. serum antibody to r. akari generally takes 2 weeks to develop, and paired sera are needed to confirm a four-fold rise in antibody titer (saah 2000) . during the acute phase of the infection, immunohistochemistry or pcr analysis can be used for a rapid diagnosis on biopsy material obtained from the papulovesicular rash or eschar paddock et al. 2003) . laboratory mice infected with r. akari develop fatal pneumonia with intranasal inoculation and severe illness and death with intraperitoneal inoculation. mice develop anorexia, depression, and dyspnea. peritonitis, splenomegaly, and lymphadenitis are found upon necropsy examination. subcutaneous inoculation produces an active infection for 1 month, with organisms being recovered from the spleen but not the feces or urine (bell 1970) . the control and eradicaton of r. akari infections depend on the prevention of wild mice and the mite vector from entering laboratory animal facilities and human dwellings. murine typhus is a rickettsial disease caused by rickettsia typhi (previously r. mooseri) that occurs worldwide with epidemics or with high prevalence in particular geographic areas (dumler and walker 2000) . in the united states, most human cases of the disease are concentrated in texas and southern california. the disease is now predominantly associated with the rat as the primary host species for the oriental rat flea (xenopsylla cheopis), which serves as the principal ectoparasitic vector transmitting the disease to humans. however, the mouse can also serve as a host for this flea, as well as for the northern rat flea (nasopsyllus fasciatus) and the mouse flea (leptosylla segnis), which also bite man and can be involved in the transmission of r. typhi (flynn 1973; pratt and wiseman 1962; yunker 1964 ). an early report in the literature indicated that x. cheopis was easily established in an animal facility inhabiting rooms used for housing laboratory mice (yunker 1964) . it is now also known that the cat and opossum and the cat flea (ctenocephalides felis) can be involved in sustaining the cycle in some geographic localities (azad et al. 1997) . clark and will (1994) reported on use of the laboratory mouse as an experimental host for rearing x. cheopis, but there have been no reports of natural infestations of mouse colonies with any of the flea vectors of r. typhi for several decades. also, r. typhi has not been isolated from natural infections in laboratory mice. murine typhus is a more serious disease than rickettsialpox and presents with fever, headache, chills, nausea, and vomiting. splenomegaly, hepatomegaly, central nervous system involvement, and multiorgan failure can occur as severe and potentially fatal complications. a skin rash, which is typically maculopapular in the case of murine typhus, occurs much less commonly than in rickettsialpox, and its absence should not dissuade the clinician from making a diagnosis of murine typhus and from promptly instituting therapy due to the potential severity of the disease (dumler and walker 2000) . the methods used for the laboratory diagnosis and treatment of the disease in humans and the principles of preventing the introduction of r. typhi into laboratory animal colonies are similar to those for r. akari. leptospirosis microorganisms were discovered in 1914 when they were isolated from jaundiced patients (inada et al. 1916) ; after further study they were named in 1917 (noguchi 1918) . leptospirosis is solely a zoonotic disease of livestock, pet and stray dogs, and wildlife, including wild rodents. rodent reservoir hosts of leptospirosis include, in addition to rats, mice, field moles, hedgehogs, gerbils, squirrels, rabbits, and hamsters (fox and lipman 1991; torten 1979) . human to human transmission is extremely rare. leptospira interrogans (comprising more than 200 serovars) have been isolated worldwide (tappero et al. 2000) . l. interrogans contains 23 serogroups with strains pathogenic for amphibians, reptiles, and mammals including humans. serovars australis, ballum, bataviae, hardjo, grippotyphosa, icterohemorrgagiae, javanica, and pomona are associated with rodent infections. leptospira serovars, including l. australis, bataviae, grippotyphosa, hebdomidis, icterohaemorrhagiae, pomona, and pyrogenes, are found in the house mouse (torten 1979) . leptospira ballum has also been reported from mice and is e. newcomer and james g. fox most commonly associated with zoonotic outbreaks (borst et al. 1948; friedmann et al. 1973; stoenner and maclean 1958) . although particular serovars usually have distinct host species, most serovars can be carried by several hosts. leptospira are well adapted to a variety of mammals, particularly wild animals and rodents. in the chronic form, the organism chronically infects the host and is shed in the urine inconspicuously for long periods of time. rodents are the only major animal species that can shed leptospires throughout their lifespan without clinical manifestations (fox and lipman 1991; torten 1979) . active shedding of leptospires by rodents can go unrecognized until personnel handling the animals become clinically infected or are infected by exposure to water or food contaminated by urine. rats and mice are common animal hosts for serotype, l. ballum, although it has been found in other wildlife as well. water can often be contaminated with infected rodent urine. the infection can persist unnoticed in laboratory rodents, though their carrier rates for laboratory-maintained rodents in the united states are unknown, but it is probably low. the organism is not routinely screened on health surveillance protocols for mouse colonies; however, there was a report of leptospirosis in 1984 in a research colony of mice in the united states being housed in a large research institution (alexander 1984) . l. icterohaemorrhagiaes antibody when compared to children living in the detroit suburbs. therefore, children living in rodent-infested tenements may be at increased risk of infection (demers et al. 1983) . in europe and more recently in north america, rodents including house mice have provided a source of leptospira infection for swine and by extension could also infect personnel working in swine production units (galton 1966; smith et al. 1992) . leptospira interrogans serovar bratislava is commonly reported in these mice. the disease may vary from unapparent infection to severe infection and death. a self-limited systemic illness is seen in approximately 90% of infected humans. the incubation period is usually 5 to 14 days. individuals infected with leptospira experience a biphasic disease (faine 1991; sanger and thiermann 1988; stoenner and maclean 1958) . they become suddenly ill with weakness, headache, myalgia, malaise, chills, and fever and usually exhibit leukocytosis. during the second phase of the disease, conjunctival suffusion and a rash may occur. upon examination, renal, hepatic, pulmonary, and gastrointestinal findings may be abnormal. intravenous penicillin is the drug of choice in treating early-onset and late-stage leptospirosis infection (faine 1991; taber and feigin 1979; watt et al. 1988 ). ampicillin and doxycycline also have been effective in treating people with mild to moderate forms of leptospirosis. because leptospirosis in humans is often difficult to diagnose, the low incidence of reported infection in humans may be misleading. from 1974 to 1979, only 498 cases were reported, for an incidence of 0.05 per 100,000 people per year (sanger and thiermann 1988) . leptospirosis was removed from the reportable disease category in the united states in 1995 because of the small number of cases reported. outbreaks have been documented in the united states from personnel working with laboratory mice (barkin et al. 1974; stoenner and maclean 1958) . in one study, 8 of 58 employees handling the infected laboratory mice (80% of breeding females were excreting l. ballum in their urine) contracted leptospirosis (stoenner and maclean 1958) . infection with leptospira most frequently results from handling infected animals (contaminating the hands with urine) or from aerosol exposure during cage cleaning (barkin et al. 1974; friedmann et al. 1973; stoenner and maclean 1958) . skin abrasions or exposure to mucous membranes may serve as the portal of entry. all secretions and excretions from infected animals should be considered infective. in one instance, a father apparently was infected after his daughter used his toothbrush to clean a contaminated pet mouse cage (boak et al. 1960) . rodent bites can also transmit the disease (looke 1986 ). in detroit, children from the inner city had a significantly higher because of the variability in clinical symptoms and the lack of pathognomonic pathologic findings in humans and animals, serologic diagnosis or actual isolation of leptospires is imperative (faine 1991) . as an aid to diagnosis, leptospires can sometimes be observed by examination or direct staining of body fluids or fresh tissue suspensions (sulzer et al. 1968 ). the definitive diagnosis in humans or animals is made by culturing the organisms from tissue or fluid samples, or by animal inoculation (particularly in 3-to 4-week-old hamsters) and subsequent culture and isolation. culture media with long-chain fatty acids with 1% bovine serum albumin are routinely used as a detoxicant (faine 1991) . serologic assessment is accomplished by indirect hemagglutination, agglutination analysis, complement fixation, microscopic agglutination, and fluorescent antibody techniques (faine 1991) . the serologic test most frequently used is the modified microtiter agglutination test. titers of 1:100 or greater are considered significant. molecular techniques including pcr and randomly amplified polymorphic dna fingerprinting are used for identification of serovars (tappero et al. 2000) . in mouse colonies infected with l. ballum, antibodies against l. ballum were detected in sera of mice of all ages, but 26. zoonoses and other human health hazards 727 leptospires could be recovered only from mature mice. progeny of seropositive females had detectable serum antibodies at 51 days of age but not at 65 days. it was also reported that progeny of seropositive female mice, which possessed antibody at birth and acquired additional antibody from colostrums, remained free of leptospires if isolated from their mothers at 21 days of age, despite exposure during the nursing period (stoenner 1957) . studies in mice experimentally infected with l. grippotyphosa demonstrated that maternal antibodies, whether passed through milk or placental transfer, conferred protection of long duration against the carrier state and shedding of leptospires. thus, serologically positive immune mothers do not transmit the disease to their offspring. however, mice born to nonimmune mothers, if infected at 1 day postpartum, become carriers with no trace of antibodies. thus a population of carrier pregnant mice without antibody could serve as a precipitator in outbreaks among susceptible mouse populations (birnbaum et al. 1972) . field surveys have supported this data in that a significant percentage of carrier mice do not have antibodies. this led to the diagnostic approach, which specifies that both serologic and isolation methods must be utilized to determine the rate of leptospiral infection in rodents (galton et al. 1962) . leptospira ballum is frequently found in the common house mouse (m. musculus) (brown and gorman 1960; yager et al. 1953) . therefore, eradication of infected colonies, use of surgically derived and barrier-maintained mice or of conventional laboratory mice free of leptospira infection, coupled with the prevention of ingress of wild rodents, should effectively preclude introducing of the organism into research and commercial laboratories (loosli 1967) . leptospira ballum has been eliminated from a mouse colony by administration of feed containing 1000 gm chlorotetracycline hydrochloride per ton for 10 days. after 7 days of antibiotic therapy, mice were transferred to clean containers and administered clean water, both having been sterilized by steam. mouse traps and rodenticides were used to destroy escaped mice and to prevent reintroduction of l. ballum by the common house mouse . commercial animal colonies maintained in research vivarium today are not routinely screened for leptospirosis, assuming that the organism has been effectively eliminated from commercial and research-maintained mice. rat bite fever can be caused by either of two microorganisms: streptobacillus moniliformis or spirillum minus. streptobacillus moniliformis causes the diseases designated as streptobacillary fever, streptobacillary rat bite fever, or streptobacillosis. haverhill fever and epidemic arthritic erythemia are diseases associated with ingestion of water, food, or raw milk contaminated with str. moniliformis. sodoku, derived from the japanese words for rat (so) and poison (doku), spirilosis, and spirillary rat bite fever are caused by another bacterium, spirillum minus. the bite of an infected rat is the usual source of infection. in some cases, other animal bites, including mice, gerbils, squirrels, weasels, ferrets, dogs, and cats, or rare traumatic injuries unassociated with animal contact, cause the infection. in a retrospective analysis coveting three decades of 45 s. moniliformis isolates (91% from humans) from the department of public health in berkeley, california, 50% of the isolates were from children < 9 years of age (graves and janda 2001) . in 75% of the human infections where a diagnosis was made, rat bite fever (rbf) was suspected; 83% of those suspected cases involved either known rat bite or exposure to rodents. two cases of rbf were attributed to exposurem in one case a squirrel, and in the second a mouse (graves and janda 2001). interestingly, > 9% of the cases could not be attributed to a rat bite or scratch, indicating that close contact with infected rodents can be sufficient to become infected (graves and janda 2001) . other reports have indicated that the disease can occur in individuals who have no history of rat bites, but reside or work in rat-infested areas or have pet rats with whom they have close contact (fordham et al. 1992; holroyd et al. 1988; rumley et al. 1987) . rat scratches can also be the source of the organism (edwards and finch 1986; shanson et al. 1985) . exposure to cats and dogs that prey on wild rodents may also be the source of the organisms. these organisms are present in the oral cavity and upper respiratory passages of asymptomatic rodents, usually rats (wilkins et al. 1988 ). mice can be infected with resulting morbidity and mortality due to arthritis and pneumonia. in one study, streptobacillus moniliformis was isolated as the predominant microorganism from the upper trachea of laboratory rats (paegle et al. 1976) . presumably the incidence of str. moniliformis is now lower in high-quality, commercially reared specific pathogen-free rats. surveys in wild mice indicate 0 to 25% infection with spirillum minus (hull 1955) . (2004). streptobacillus moniliformis incubation varies from a few hours to 2 to 10 days, whereas spirillum minus incubation ranges from 1 to 6 weeks (table 26-1) . fever is present in either form. inflammation associated with the bite and lymphadenopathy are frequently accompanied by headache, general malaise, myalgia, and chills (arkless 1970; cole et al. 1969; gilbert et al. 1971; mcgill et al. 1966) . the discrete macular rash that often appears on the extremities may generalize into pustular or petechial sequelae. arthritis occurs in 50% of all cases of s. moniliformis but is less common in spirillum minus. streptobacillus moniliformis may be cultured from serous to purulent effusion, which is recovered from affected larger joints. a total of 18 cases of endocarditis due to s. moniliformis were reported from 1915 to 2000 (shvartsblat et al. 2004 ). death has occurred in cases of s. moniliformis involving preexistent valvular disease or as a result of endocarditits in a previously healthy individual. infants can also die of the infection (sens et al. 1989) . if antibiotic treatmentmusually penicillin at doses of 400,000 to 600,000 daily for 7 daysmis not instituted early, complications such as pneumonia, hepatitis, pyelonephritis, enteritis, and endocarditis may develop (richter 1954 ). if endocarditis is present, the penicillin should be given parenterally at doses of 15 to 20 million units daily for 4 for 6 weeks. streptomycin and tetracyclines are also effective antibiotics for those individuals with penicillin-associated allergies. addition of streptomycin to standard therapy is also advised in cases where isolates of sir.. moniliformis are cell wall deficient (rupp 1992) . spirillum minus does not grow in vitro and requires inoculation of culture specimens into laboratory animals, with subsequent identification of the bacteria by dark-field microscopy. streptobacillus moniliformis grows slowly on artificial media but only in the presence of 15% blood and sera, usually 10% to 20% rabbit or horse serum incubated at reduced partial pressures of oxygen. sodium polyanethol sulfonate sometimes found in blood-based media because of its properties as a bacterial growth promoter should not be used due to its inhibitory effects on sir. moniliformis (lambe et al. 1973; shanson et al. 1985) . growth on agar consists of 1 to 2 mm gray, glistening colonies. the api zym diagnostic system can be used for rapid biochemical analysis and diagnosis. a pcr-based assay has also been described to diagnose sir. moniliformis (berger et al. 2001) . the genus salmonella are gram-negative bacteria with approximately 2000 serotypes. nontyphoidal salmonellosis is caused by any of these serotypes. other than salmonella typhi, the causative agent of typhoid fever, salmonellosis occurs worldwide and is important in humans and animals. s. typhi and salmonella choleraesuis have only one serotype, whereas the remaining 2000 serotypes are within the species salmonella enteritidis. references to the salmonella enteritidis serotypes are abbreviated such that "enteritidis" is dropped; for example, s. enteritidis serotype typhimurium is called salmonella typhimurium. salmonella typhimurium is the serotype most commonly associated with disease in both animals and humans. other serotypes most commonly reported from humans and animals are salmonella heidelberg, salmonella agona, salmonella montevideo, and salmonella newport. salmonellae are pathogenic to a variety of animals. salmonella are ubiquitous in nature and are routinely found in water or food contaminated with animal or human excreta. fecal-oral transmission is the primary mode for spreading infection from animal to animal or to humans. transmission is enhanced by crowding and poor sanitation. during the early 1900s, rodenticides containing live cultures of s. enteritidis were distributed on a large-scale basis by commercial and public health organizations in an attempt to eliminate feral rats. these cultures were known as "rat viruses" and were widely used in europe, england, and the united states as "rat poisons" (weisbroth 1979). however, enthusiasm for their use waned when it was discovered that the spread of the organisms couldn't be limited; predictably, the baiting program was implicated in several epidemics among exposed human populations (weisbroth 1979) . surprisingly, as late as the 1950s in england, s. enteritidis (serovar danzy) was isolated from adults living four miles apart. the source of infection was traced to contaminated cakes from a local bakery. mice that had acquired the (brown and parker 1957) . as with other fecal-oral transmitted diseases, control depends on eliminating contact with feces, food, or water contaminated with salmonella or animal reservoirs excreting the organism. salmonella survive for months in feces and are readily cultured from sediments in ponds and streams previously contaminated with sewage or animal feces. fat and moisture in food promote survival of salmonella. pasteurization of milk and proper cooking of food (56~ for 10 to 20 minutes) effectively destroys salmonella. municipal water supplies should be routinely monitored for coliform contamination (pavia and tauxe 1991) . clinical signs of salmonellosis in humans include acute sudden gastroenteritis, abdominal pain, diarrhea, nausea, and fever. diarrhea and anorexia may persist for several days. organisms invading the intestine may create septicemia without severe intestinal involvement; most clinical signs are attributed to hematogenous spread of the organisms. as with other microbial infections, the severity of the disease relates to the organism's serotype, the number of bacteria ingested, and the host's susceptibility. in experimental studies with volunteers, several serovars induced a spectrum of clinical disease ranging from brief enteritis to serious debilitation. incubation varied from 7 to 72 hours. cases of asymptomatic carriers, persisting for several weeks, were common (hull 1955) . salmonella are flagellated, nonsporulating, aerobic gramnegative bacilli that can be readily isolated from feces on selective media designed to suppress bacterial growth of other enteric bacteria. salmonella serotyping requires antigenic analysis (fox 1991) . salmonella gastroenteritis is usually mild and self-limiting. with careful management of fluid and electrolyte balance, antimicrobial therapy is not necessary. in humans, antimicrobial therapy may prolong rather than shorten the period that salmonella are shed in the feces (nelson et al. 1980; pavia and tauxe 1991) . in one double-blind placebo study of infants, oral antibiotics did not significantly affect the duration of salmonella carriage. bacteriologic relapse after antibiotic treatment occurred in 53% of the patients, and 33% of these suffered a recurrence of diarrhea, whereas none of the placebo group relapsed (nelson et al. 1980 ). tick-borne relapsing fever occurs primarily in foci in the western part of the united states, as well as other parts of the world. the disease is caused by at least 15 borrelia species and is transmitted to humans from a variety of rodents (chipmunks, squirrels, rats, mice, prairie dogs, hedgehogs) via soft ticks of the genus ornithodorus. of recent interest are the increasingly recognized enterohepatic helicobacter spp., which cause both hepatic and intestinal disease in mice (whary and fox 2004) . one of these, h. bilis, isolated routinely from mice, has been found using pcr-based assays in bile and gallbladder of chilean patients with chronic cholecystitis and in biliary cancers in japanese patients (fox et al. 1998; matsukura et al. 2002) . whether these new helicobacters will be linked to zoonotic transmission from wild or laboratory rodents will require further studies. pathogenic staphylococcus aureus of human phage type can cause clinical disease in mice and rats. this organism has been (davies and shewell 1964) 1 lab worker % not determined, alopecia, increased scaling on head (booth 1952) and back, 10 mice 1 bacteriologist 60 of 400, crusted or crustless plaques, circular with (cetin et al. 1965 ) prominent periphery; general alopecia; mortality in some mice 1 technician 20% colony with alopecia and scaly skin (dolan et al. 1958 ) 1 technician alopecia with crusting an erythema (povar 1965) introduced into spf barrier-maintained mouse colonies and spf rats and guinea pigs; the same phage type was isolated from their animal caretakers (davey 1962; shults et al. 1973) . colonization by normal s. aureus strains in the nasopharyngeal area of humans presumably minimizes the zoonotic potential of animal-originated s. aureus. as reviewed comprehensively in blank, reports of ringworm (favus) in the mouse began to appear in the european literature in the mid-nineteenth century and in the north american literature during the early twentieth century (blank 1957) . several of the early authors noted the similarities between the lesions of favus in the mouse and in humans. quincke, who is generally credited with isolating the causative agent which he named 3~-pilz (now trichophyton mentagrophytes), suggested that the infection in the mouse was also a source of infection of the cat, and thereby, of humans. earlier reports of murine ringworm referred to the causative agent as t. quinckeanum, but the successful crossing of t. quinckeanum with the perfect state of t. mentagrophytes, arthroderma behamiae, indicates that t. quinckeanum is not a distinct species (ajello et al. 1968) . a later study of the two varieties, t. mentagrophytes var. mentagrophytes and t. m. var. quinckeanum, noted that the conidia from both produced two morphological variants on cultivation (granular and fluffy), and these variants were a. behamiae type + and pathogenic (hejtmanek and hejtmankova 1989) . in addition to t. mentagrophytes, epidermophyton floccosum, mircrosporum gallinae, m. gypseum, m. canis, t. erinacai, t. schoenleini, and t. (keratinomyces) ajello have been reported as zoophilic dermatophytes that can infect mice and cause ringworm in humans (dvorak 1964; krempl-lamprecht and bosse 1964; marples 1967; papini et al. 1997; refai and ali 1970) . the dermatophytes are distributed worldwide and can involve a variety of small animal host species in addition to the mouse. chmel et al. (1975) conducted field studies in a wooded farm setting in czechoslovakia and detected an overall prevalence rate of 4.4% (57 positive of 1288) for t. mentagrophytes infection in 6 of 13 species sampled; the prevalence in mus musculus was 3.4%, with mice comprising 15.8% of the infections detected. of the species that harbored the infection, all frequented the barn or granary area; the seasonal incidence was highest during the winter months when the rodent carriers were more likely to seek harborage indoors. chmel et al. (1975) also analyzed patient data and demonstrated that t. mentagrophytes was the predominant isolate from those who did agricultural work, while t. verrucosum was the main isolate from individuals who worked with farm animals. also, human t. mentagrophytes infections were most common on the hands, wrist, forearm, face, and neck, unprotected skin sites readily contaminated by fodder, litter, or other materials while working in the barns. ringworm infections associated with the handling of bags of grain in which mice had been living have also been reported (alteras 1965; blank 1957) . ringworm infection in laboratory mice is often asymptomatic, remaining unrecognized until laboratory personnel become infected. early reports in the literature indicated that the prevalence of t. mentagrophytes was 80 to 90% among some laboratory mouse stocks (davies and shewell 1964; dolan et al. 1958 ). however, these reports predated the era of modem laboratory animal colony management marked by the commercial availability of cesarean-derived, barrier-maintained rodents. moreover, the modem production practices that have been universally adopted by the industry for decades and the use of microbarrier cages with appropriate technique have further reduced the opportunity for ringworm to become a significant problem in contemporary colonies. in recognition of this fact, none of the major commercial vendors in the united states survey their colonies for dermatophyte infections as part of routine health monitoring. sporadic cases of ringworm infections in rodents have been reported in the past three decades (hironaga et al. 1981; mizoguchi et al. 1986; papini et al. 1997) . programs involved in importing mice from sources that fail to meet contemporary rodent production and husbandry practices should consider screening mice for dermatophytes during the quarantine period. the ease of transmission of dermatophytes from animals to humans is well known and is a significant health hazard. laboratory mice, as well as other laboratory animal species, can harbor dermatophyte infection, with few or no visible skin lesions transmitting the infection to unsuspecting personnel (dolan et al. 1958) . transmission can occur through direct contact with the infected animal or through indirect contact with animal bedding or other materials in the environment of the contaminated animal room. rigorous facility and equipment sanitation has long been recognized as an essential element of an effective control program and should be undertaken in conjunction with efforts to treat valuable animals or to repopulate previously contaminated areas of a facility (davies and shewell 1964; dolan et al. 1958; mizoguchi et al. 1986 ). the importance of barrier protections by donning appropriate clothing, using gloves and other personal protective equipment, and modifying work practices to minimize skin exposure to dermatophytes has also been acknowledged for the prevention of transmission (dolan et al. 1958) . when prevention methods fail, allowing the introduction of dermatophyte infection into a mouse colony, and when transmission to humans occurs, clinical cases of dermatophytosis routinely respond well either to topical or systemic antifungal therapy. *found in laboratory animals that cause allergic dermatitis or from which zoonotic agents have been recovered in nature (see yunker 1964) . **wee, western equine encephalitis. +sle, st. louis equine encephalitis. ++rmse rocky mountain spotted fever. dermatophytosis or ringworm in humans can be asymptomatic and minor, often self-limiting and drawing little attention from the affected individual. the infection usually causes an expanding, scaly and erythematous inflammatory plaque on the skin that occasionally contains fissures or vesicles when severely eczematous. on the trunk and extremities, the lesion may consist of one or more circular lesions with a central clearing and sharply defined margins, forming a ring, and hence the name "ringworm" (fig. 26-1) (merlin et al. 1994) . other dermatophytes are named according to the sites of involvement on the body (e.g., tinea pedis for foot infections, tinea capitis for scalp infections). the dermatophyte infections of humans associated with direct or indirect contact from mice usually involve the body or extremities, especially the arms and hands. zoophilic t. mentagrophytes infection usually produces a highly inflammatory lesion and often undergoes rapid resolution. however, it can also produce furunculosis--deep infection of the hair follicles or widespread tinea corporism which is also seen in infections of e. f l o c c o s u m . in a laboratory-acquired infection with t. (keratinomyces) ajelloi, mice were the source of infection for a laboratory technican who developed small, grayish-white, scaly lesions on both hands. hand lesions yielded the organism, as did 2 of 250 apparently health mice (refai and ali 1970) . a. tapeworms a. reservoir and incidence although this parasite occurs in the mouse intestine, it is more commonly associated with rats and is especially common in wild norway (rattus norvegicus) and black (rattus rattus) rats throughout the world (faust and russell 1970; stone and manwell 1966; wardle and mcleod 1952 (voge and heyneman 1957) . larval development in tribolium sp. at 30~ requires 8 days. therefore, humans become infected only through ingestion of infected insects, such as flour beetles, which may contaminate rodent food or cereal marketed for human consumption. c. clinical signs the infection in humans is usually asymptomatic, but in moderate to heavy infections it may cause headaches, dizziness, abdominal discomfort, and diarrhea. the greatest length of an adult parasite removed from a patient was 1 meter. usually, adult parasites are 20 to 50 cm long and as much as 4 mm wide (markell et al. 1999 ). a. reservoir and incidence the dwarf tapeworm is a common parasite of both the wild house mouse and the laboratory mouse. as indicated earlier in the text, in most well-managed mouse colonies, r. nana incidence is low compared to earlier reports of its high incidence in rodent colonies (wescott 1982) . the estimate that 20 million humans in the world are infected was made many years ago but probably is an underestimate (markell et al. 1999) . surveys conducted in central europe report that this tapeworm in humans is more prevalent in warm than in temperate regions. an incidence of 10% has been noted in some south american countries (jelliffe and stanfield 1978) . it is most commonly diagnosed in children. diagnosis is made by observing characteristic eggs in the feces. b. mode of transmission r. nana is unique among tapeworms in that the adult worm develops after the egg is ingested. the hooked oncosphere then invades the intestinal mucosa and develops into a cysticeroid larva. rodentolepsis nana eggs can contaminate hands, be trapped on particulate matter, or be aerosolized, and then accidentally ingested. since no intermediate host is required, the eggs are readily infective for the reciprocal hosts (faust and russell 1970) . precautions against infection include strict personal hygiene, appropriate laboratory uniforms, and use of disposable gloves and face masks when handling contaminated bedding and feces. c. clinical signs the clinical picture of r. nana infection is quite cosmopolitan. in well-nourished persons, essentially no symptoms occur; the infection is noted when the proglottids or ova are seen in the stool. in other persons, the symptoms include headaches, dizziness, anorexia, inanition, pruritis of the nose and anus, periodic diarrhea, and abdominal distress. a tapeworm identified as r. nana was found in a tumor removed from the chest wall (jelliffe and stanfield 1978) . the diagnosis is based on identification of the characteristic eggs or proglottids in the stool. d. treatment praziquantfel, given orally in a single dose of 25 mg/kg body weight is the drug of choice. alternatively, niclosamide is given daily for 5 days because of the tissue phase of the parasite. the dose is 2 gm for adults and 1.5 gm for children > 34 kg, and 1.0 gm for children between 11 and 34 kg (markell et al. 1999) . recently, a parasite known to naturally colonize mice, r. microstoma, has been identified in the feces of humans living in the northwest of western australia (macnish et al. 2003) . although r. nana was the most common enteric parasite based on microscopic examination of feces, r. microstoma was identified as a mixed infection in 4 of 11 individuals by using a molecular-based assay consisting of restriction fragment length polymorphism of tapeworm dna as well as a sequencing of the pcr product of the internal transcribed spacer 1 region of ribosomal dna (macnish et al. 2002) . given that r. microstoma requires an intermediate host, tribolium confusum for its life cycle, it is understandable why it was not as common as r. nana in this study. however, given the morphological similarities of the eggs of r. nana and r. microstoma, the true prevalence of r. microstoma in humans won't be known until molecular techniques to differentiate the two species are utilized in future studies. syphacia obvelata is an ubiquitous parasite in both wild and laboratory mice. although parasitology texts report that syphacia is infectious to humans, this citation originates from a publication in 1919, in which two s. obvelata adult worms and eggs reportedly were found in the formalin preserved feces of a filipino child whose entire family of five was infected with h. nana (riley 1919) . no mention is made of the method of collecting the feces, nor is it known whether the feces could have been contaminated with murine feces or with the parasite and/or eggs. the only other report is an unpublished finding of s. muris eggs in the feces of two children and two rhesus monkeys, cited in a personal letter from dr. e. e. faust of tulane university, dated january 6, 1965 (stone and manwell 1966) . both of these cases may therefore be examples of spurious parasitism, but definitive information for that conclusion is lacking. regardless, no published information indicates that laboratory personnel have been infected by working with syphacia-infected mice. contamination of food or utensils or accidental ingestion of syphacia ova (e.g., via contaminated hands) could result in infection of humans. people working with infected mice probably ingest ova occasionally, but there is no evidence that this exposure results in active infection. because syphacia infection in humans has not been described, clinical signs have not been noted. there are striking differences in size between specimens of female s. obvelata and those of enterobius vermicularis, the pinworm, in humans (markell and voge 1965) . syphacia is 3.5 to 5.8 mm long, whereas the enterobius sp. female reaches a length of 8 to 13 mm. the male syphacia sp. measures 1.1 to 1.5 mm compared to 2.5 mm for enterobius. the size difference between the eggs of the two species is also marked: syphacia eggs are more than twice as long (125 gm versus 52/am as those of enterobius). it is unlikely therefore that syphacia sp. would be misdiagnosed as enterobius sp., assuming, of course, that the observer was aware of the size difference and measured the eggs. although many species of mites are found on laboratory mice, only ornithonyssus bacoti, the tropical rat mite, and liponysoides sanguineus, the house mouse mite, are vectors of human disease. ornithonyssus bacoti is seen in laboratory mice (fox 1982) ; l. sanguineus has been identified only on wild mice. bites from these mites, as well as from another mouse mite, haemalaelaps casalis, are responsible for allergic dermatitis, or local inflammation, in humans. ornithonyssus bacoti can be found on many rodents; the brown norway rat and the black roof rat are probably the primary host species (beaver and jung 1985) . since the time of the first report of human ornithonyssus bacoti-associated dermatitis in australia in 1913, and a 1923 report in humans in the united states, many other cases have continued to be described throughout the world (see table 26 -4) (charlesworth and clegern 1977; chung et al. 1998; dove and shelmire 1931; dowlati and maguire 1970; engel et al. 1998; fox 1982; haggard 1955; hetherington et al. 1971; riley 1940; theis et al. 1981; wainschel 1971; weber 1940) . ornithonyssus bacoti is an obligate bloodsucking parasite, usually tan but red when engorged with blood. both the male and female feed on a rodent as their preferred host. the female is 700 ~tm to 1 mm in length; the male is smaller (fig. 26-2) . eggs are laid in bedding or wall crevices by the female, which survives for about 70 days and feeds about every two days during this period. the mite has five developmental stages: adult, egg, nonfeeding larva, bloodsucking protonymph, and nonfeeding deutonymph. after feeding, the adults and protonymphs leave their host and seek refuge in cracks and crevices. the life cycle from adult to egg requires 7 to 16 days at room temperature. unfed protonymphs have survived for 43 days (brettman et al. 1981) . the mite often gains access to the premises on wild rodents and lives in crevices. if wild rodents are not readily available or are captured, the mite will seek blood elsewhere, either from the wild or laboratory rodent (if in an animal research facility) and/or humans. in some infestations, the rodent shows no clinical signs. however, in more chronic cases, dermatitis and anemia may develop. historically, this mite has been a troublesome parasite in certain laboratory animals, especially rats, mice, and hamsters (fox 1982; keefe et al. 1964 ). a. clinical signs tropical rat mites produce painful, pruritic lesions in humans. examination of patients often discloses papular lesions on the wrists, arms, abdomen, and chest. raised erythematous papules and nodules several millimeters to greater than 1 cm in size occur singly or in linear configuration ( fig. 26-3) . epidemiologically, cases usually occur in clusters that involve a common source of exposure to the mite. experimentally, cases have been shown to be a vector of pathogens. in the laboratory, mite transmission of various rickettsial species, pasteurella tularensis, and coxsackie virus between different laboratory animals has been shown (hopla 1951; petrov 1971; philip and hughes 1948; schwab et al. 1952) . affected individuals may be treated with topical lindane or treated symptomatically, given that the mite does not reside on humans for any extended periods. papular dermatitis will regress after a period of 7 to 10 days post-therapy. recurrence of ornithonyssus bacoti infestations is common unless the premises have been treated with an appropriate insecticide, and any feral rodents eradicated (engel et al. 1998 ). fleas are seldom found in laboratory mice but are common parasites of feral rodents. the oriental rat flea, xenopsylla cheopis, and another flea, nasopsyllus fasciatus, both naturally infest mice and rats; they are vectors for murine typhus. apparently, x. cheopis is easily established in animal facilities. at a midwestern u.s. university, it inhabited a room housing laboratory mice where, on two separate occasions, the flea caused distress by biting students (yunker 1964) . leptopsylla segnis, the mouse flea, bites humans and is a vector for plague and typhus, serious diseases in humans. also, l. segnis can serve as an intermediate host for the rodent tapeworms r. nana and r. diminuta, which can infect people. the flea's bite can also be irritating and cause allergic dermatitis. epidemiological perspective on the transmission of infectious diseases, principally rabies. the bite of the rat is far more powerful and more likely to be disfiguring than that of the mouse, and rat bites are known to be associated with the transmission of bacterial zoonoses such as rat bite fever and leptospirosis (see elsewhere in this chapter). one should assume that the mouse is also capable of transmitting these agents via bite. rabies transmission from small rodents in the wild occurs but is exceedingly rare (gdalevich et al. 2000) ; therefore, rabies is of concern only if experimental studies with the virus are being conducted in mice. mice can also transmit hantavirus infection and lymphocytic choriomeningitis virus infection via bites. anecdotally, most animal care and use programs report that rodent bites among personnel are a reasonably common occurrence that often are unreported to an institution's occupational medical service, despite the fact that bites inflict pain, produce anxiety, and may have significant health consequences. in addition to the hazard of zoonotic disease or local wound infection with pyogenic or toxin producing bacteria such as clostridium tetani, staphylococcus spp., streptococcus spp., escherichia coli, and bacillus subtilis, rodent bites, including those of the mouse, can induce a severe local allergic reaction or anaphylaxis in individuals previously sensitized to allergen (hesford et al. 1995; teasdale et al. 1983; thewes et al. 1999) . thus, bite wounds from mice should be immediately cleaned thoroughly and reported to the institutional occupational medical service to permit evaluation of the person's tetanus immunization status and need for additional local wound or other medical care. the need for additional training of bitten persons in animal handling may also be indicated. authoritative information on the incidence and impact of animal bites in the general population over the past several decades is scant, and reliable data on the incidence of mouse bites among personnel who work in laboratory animal facilities or among the general populace is lacking. there have been occasional studies on the occurrence and clinical characteristics of rat bites within urban populations, including a recent investigation of 622 bites over the period 1974-1996 that associated this phenomenon with urban blight, poverty, and unemployed populations (hirschhorn and hodge 1999) . traditionally, animal bites have received attention from the clinical perspective of wound management and complications and from the allergic skin and respiratory reactions to laboratory mice are very common in laboratory animal caretakers and technicians who work with these animals. a survey by lutsky (1987) demonstrated that three-fourths of all institutions with laboratory animals had animal care personnel with allergic symptoms. the prevalence of symptoms of laboratory animal-associated allergy (laa) among personnel working with laboratory animals has been estimated as between 10 and 46% in numerous recent studies, and among these individuals, approximately 10% are estimated to eventually proceed to the development of asthma (chan-yeung and malo 1994; eggleston and wood 1992; hollander et al. 1996; hunskaar and fosse 1990; knysak 1989; renstrom et al. 1994) . furthermore, other sources have suggested that among atopic individuals with preexisting allergic disease, up to 73% of persons exposed to lab animal allergens may eventually develop laa (committee on occupational health and safety in research animal facilities/national research council allergens 1997). the population at risk for work-related exposure to rodents was estimated at 90,000 (newill et al. 1986 ); this population has likely grown in the intervening years to the expanding populations of genetically modified mice that are used in contemporary biomedical research programs and require care. moreover, a recent study would seem to suggest that the risk of exposure to mouse allergens is not confined to those working in the laboratory animal facility environment. data analyzed from the first national survey of lead and allergens in housing in the united states demonstrated that 82% of homes of diverse types and income levels across geographic locations had evidence of mouse allergen; 57% had detectable levels on the kitchen floors specifically; and 22% had allergen concentrations greater that 1.6 ~tg/g of dust collected, a level previously correlated with the significantly increased rate of sensitization to mouse allergen (cohn et al. 2004) . the large number of staff at risk of exposure in the workplace or already presensitized, in combination with the substantial added costs to employers for the medical management, operational disruptions, and retraining efforts related to employees who develop laa and later proceed to asthma, should provide the impetus for many institutions to pay grater attention to this element of the occupational health and safety program (schweitzer et al. 2003) . the major allergen of the laboratory mouse is the mus m 1 protein, a member of the mouse major urinary proteins encoded by a multigene family consisting of approximately 35 genes (clark et al. 1984a (clark et al. , 1984b . the earlier literature on the subject of mouse allergy referred to the mouse urinary proteins (mups), whereas recent literature cites the specific protein (mus m 1) that is now known to be the primary offending allergen in the mup multigene family. the mus m 1 protein is in the lipocalin family of proteins that are produced in the saliva and liver and are excreted in the urine at levels 100 times higher than are present in mouse serum. lipocalins serve to bind small hydrophobic molecules and function biologically to transport vitamins, small volatile odorants, and pheromones conferring the characteristic odor to mouse urine (cavaggioni et al. 1999; flower et al. 1993; konieczny et al. 1997; santa et al. 1998; virtanen et al. 1999) . several studies have indicated that production of mus m 1 is under hormonal control and that the urine of male mice contains four-fold higher levels than the urine of female mice (hastie et al. 1979; lorusso et al. 1986; price and longbottom 1987) . in addition to being present in the saliva and urine, mus m 1 in the serum becomes incorporated into the pelt, conferring the allergenic property to mouse dander. the main allergens of many furred animals are structurally similar proteins within the lipocalin family, including those of the cow (bos d 2), horse (equ c 1), dog (can f 1), and rat (rat n 1) (virtanen et al. 1999) . the mus m 1 and rat n 1 lipocalin allergens, to which 90% of mouse and rat allergic individuals react, respectively, are closely related, sharing a 66% homology (clark et al. 1984a) . some have proposed that personnel exposed to laboratory animal allergens can be categorized into four basic risk groups based on their history of allergic disease and sensitization to animal proteins (committee on occupational health and safety in research animal facilities/national research council allergens 1997). these risk groups are (1) normal individuals, (2) atopic individuals with preexisting allergic disease, (3) asymptomatic individuals with ige antibodies to allergic animal proteins, and (4) symptomatic individuals with clinical symptoms upon exposure to animal allergens. individuals in the normal risk group do not have a history of allergic disease, and 90% will never develop symptoms of laa. if laa develops in individuals in the normal risk group, it usually appears during the first three years of exposure. however, infrequently individuals in this risk group who have remained free of laa for 10 or more years of exposure have developed a delayed onset of the condition (department of health and human services, national institute of occupational safety and health 1997). atopic individuals have a genetic predisposition for an exaggerated tendency to mount ige responses to common environmental allergens. atopic individuals have higher total levels of ige in the circulation and higher blood eosinophil counts compared to normal individuals, possibly as a result of the activation of cytokines involved in ige isotype switching, eosinophil survival, and mast cell proliferation (janeway et al. 2001 ). among atopic individuals, up to 73% of those exposed to allergenic animal proteins eventually develop symptoms (agrup et al. 1986) . in asymptomatic individuals with elevated circulating ige antibodies to animal allergens, up to 100% are at risk of developing allergic symptoms. of the individuals in risk groups that are already symptomatic for laa, approximately 33% will develop chest symptoms and 10% are likely to develop occupational asthma and face the prospect that continued exposure will result in permanent impairment. allergic rhinitis, allergic conjunctivitis, and contact urticaria are the most common disorders seen in laa (committee on occupational health and safety in research animal facilities/ national research council allergens 1997). clinically, allergic rhinitis and conjunctivitis present with the symptoms of sneezing, clear nasal discharge, nasal congestion, itchiness, and watery eyes. contact urticaria presenting as raised, circumscribed, erythematous lesions may also be present in laa patients who report an intense itchiness to the skin in the area of contact with the allergen. figs. 26-4 and 26-5 (fox and brayton 1982) illustrate the typical wheal and flare reaction on the skin provoked in an individual who had developed hypersensitivity to mouse urine over a period of several years and who was exposed by having a mouse with urine-contaminated feet walk over his arm (ohman 1978) . one large survey of laboratory animal workers summarized in the niosh alert (department of health and human services, national institute of occupational safety and health 1997) reported that of 5641 animal workers from 137 animal facilities, 23% developed allergic symptoms related to laboratory animals. of the workers reporting symptoms, 82% had nasal or eye symptoms, 46% had skin complaints, and 33% had asthma. patients who develop asthma as a more serious complication of laa manifest symptoms of wheezing, intermittent dyspnea or shortness of breath, cough, often nocturnal or in the early morning, and tightness of the chest. the key clinical sign in these patients is wheezing on auscultation, and physiological abnormalities include airflow obstruction, which may vary over time, bronchodilator responsiveness, and increased airway responsiveness (airway hyperreactivity) (tang et al. 2003) . though quite rare, generalized anaphylactic reactions that are potentially life threatening can occur in individuals highly sensitized to animal allergens. anaphylaxis may manifest as diffuse itching, hives, and swelling of the face, lips, and tongue. in some individuals, breathing becomes difficult owing to laryngeal edema, and others develop asthma and wheezing. laboratory animal-associated allergy is an example of the type i, ige antibody-mediated, immune reaction, and the reader should refer to other sources for a detailed discussion of the molecular mechanisms involved in developing this reaction (janeway et al. 2001 ). in the case of animal allergens, the usual route of initial exposure is airborne, although bite exposures (saliva) and direct contact with the skin can also become important in later clinical symptoms. in the type i reaction, upon exposure to antigen, which is often a protein or glycoprotein, the allergen is taken up and processed by cells of the innate and adaptive immune systems and by dendritic cells located in the mucosal-associated lymphoid cells, gut-associated lymphoid cells, and/or the dermis. the cytokine profiles of these cells favor the development of na'fve cd4 t cells into th2 cells that induce b cells to produce ige specific for the allergen. once the ige response is initiated, it can be further enhanced by basophils, mast cells, and eosinophils that also drive allergen-specific ige production (janeway et al. 2001) . ige is normally found only in low levels in the circulation because it binds to tissue mast cells and circulating basophils. in the sensitized individual, restimulation with the sensitizing allergen results in allergen binding to ige and the release of histamine and other chemical mediators from the mast cells and basophils. these mediators produce the array of clinical signs and symptoms that are characteristic of the allergy: itchiness, nasal congestion, sneezing, nasal and ocular drainage, coughing, wheezing, and shortness of breath. to establish the diagnosis of laa related to mouse exposure, the physician should begin by considering the strength of the history, physical examination findings, the temporal relationship between the patient symptoms and the environmental exposure to mice, and possibilities of alternative explanations for the patient's problems such as exposure to other potential allergens in the workplace or allergens of a nonoccupational nature. the development of clinical symptoms concomitant with or following exposure to an environment containing mice or mus m 1 laden mouse products should help in narrowing the number of allergens tested. the patient's family history of allergy is also very important to consider because atopy is a proven risk factor in developing laa (botham et al. 1995; meijer et al. 2002; venables et al. 1988 ). physical examination of the patient and clinical monitoring for the progression of allergic disease incorporate a number of approaches. pulmonary function tests such as bronchial hyperresponsiveness (in response to pharmacologic challenge with methacholine and not the specific allergen) and the forced expiratory volume in one second (fev1) are commonly used to evaluate the degree of airway impairment and the response to bronchodilators, glucocorticoids, and other therapeutic agents. radiographs may also be useful in patients with pulmonary involvement. routine laboratory tests may also aid in the characterization and management of the patient's condition, such as complete blood count and nasal smears for eosinophilia which is common in allergic individuals but also can be seen in those with perennial nonallergic rhinitis (dykewicz et al. 1998) . measurement of total serum ige has little value to the physician as an aid in distinguishing whether a particular patient has allergic disease, but it may offer some potential for the identifying of populations at risk for developing of laa as indicated in both prospective and cross-sectional studies of laboratory animal workers (hollander et al. 1996; renstrom et al. 1995) . use of the radioallergosorbent test (rast) for the detection of human ige antibodies of defined allergen specificity is also available for patient evaluation. however, the quality of the laboratory performing the in vitro rast assays, the specificity of the allergens used, and the potential for cross-reactivity are important considerations in adopting the rast as a diagnostic tool (hamilton 2003) . even when properly conducted, in vitro tests usually fail to detect a modest number of skin testpositive individuals, and on a per-test basis, skin tests have lower time and reagent costs (hamilton 2003) . clinicians agree that when properly performed, prick-puncture skin tests are generally considered the most convenient and least expensive screening method for detecting allergic reactions in most patients (demoly et al. 2003) . the valid interpretation of these tests relies on standardized allergens and methods, and negative prick-puncture tests may be confirmed by more sensitive intradermal techniques. even after falsepositive and false-negative tests have been eliminated, the proper interpretation of results requires thorough knowledge of the patient's history and physical findings. a positive skin test alone does not confirm a definite clinical sensitivity to an allergen in the asymptomatic patient but possibly predicts the onset of allergic symptoms. a positive skin test in conjunction with a history suggestive of clinical sensitivity strongly indicates the allergen as the cause of the disease (horak 1985) . strong positive skin tests along with a suggestive clinical history also correlate well with results of bronchial or nasal challenges with the antigen. the animal facility conditions and practices that contribute to mouse-associated laa as a serious and prevalent workplace hazard have received considerable study over the past several decades, enabling effective strategies for achieving control of exposures in most research animal care and use settings. in summary, these strategies involve exposure reduction through source reduction, containment of hazard through the use of modern equipment and engineering controls, and barrier protection with personal protective equipment. the mus m 1 allergen load in the environment is markedly increased when male mice are used in studies due to the fact that they excrete 4-fold higher levels of allergen in the urine than do female mice (lorusso et al. 1986 ). therefore, sources have recommended, that whenever scientifically possible, use of only female mice would be a means of reducing allergen load in the environment and minimizing the exposure of personnel (department of health and human services, national institute of occupational safety and health 1997; renstrom et al. 2001 ). furthermore renstrom et al. (2001) reported a three-fold higher rate of allergic sensitization in technicians who worked with male rodents. although this approach may be useful in a few studies, this method of source reduction would appear to have only very limited applicability across the broad scope of contemporary studies using mouse models. source reduction of mouse allergen is also achieved through reduction of animal density within an animal room (the number of animals per room volume) and through use of frequent, effective facility sanitation practices (department of health and human services, national institute of occupational safety and health 1997). the risk of exposure to mouse allergen varies by the type of animal-related activities conducted by personnel and by the type of animal housing systems and equipment containment devices employed in the use and maintenance of laboratory mice (gordon et al. 1997 (gordon et al. , 2001 schweitzer et al. 2003; thulin et al. 2002) . many studies have examined the different caging systems used for mouse housing, and the ability of each cage system design to reduce environmental allergen is well known (gordon et al. 2001; schweitzer et al. 2003) . the application of just a simple filter sheet top or fitted filter bonnet to an open cage is effective in reducing ambient allergen levels (reeb-whitaker et al. 1999) . however, studies indicate the clear superiority of individually ventilated caging (ivc) systems run under negative pressure for the purpose of controlling room allergen levels (gordon et al. 2001; reeb-whitaker et al. 1999; schweitzer et al. 2003) . gordon et al. (2001) suggested that the use of efficient negative ivc in combination with other engineering controls for allergen containment during procedures and waste processing would potentially produce a virtually allergen-free work environment. when negative pressure ivc housing is not available, the placement of cages in a hepafiltered, ventilated cabinet is effective at reducing room allergen loads (thulin et al. 2002) . gordon et al. (1997) reported that individuals who have direct contact with mice (animal technicians) have the highest exposure, followed by those who have intermittent contact with anesthetized animals or mouse tissues (scientists and necropsy technicians), followed by those with indirect contact (office workers or histology technicians). the specific animal husbandry activities that are known to result in high exposure of personnel to mouse allergen are cage-changing activities, including animal transfer, stacking dirty cages, and manual emptying of cages; handling animals directly (particularly males); and room sweeping (gordon et al. 1997) . for each of these activities, use of improved containment equipment and changes in equipment handling procedures are effective in the controlling the allergen hazard and should be encouraged. for example, use of ventilated cabinets or biological safety cabinets during cage changing and animal handling is effective in conjunction with the use of microisolation cages (gordon et al. 2001; schweitzer et al. 2003; thulin et al. 2002) . containment equipment has also been designed for the capture of airborne allergens generated when the bottom of one dirty cage is placed into the opening of another to stack the cages for transport to the cage wash area or when dirty bedding is removed prior to cage washing (gordon et al. 1997; kacergis et al. 1996) . room cleaning with a vacuum equipped with hepa filtration followed by mopping with a damp mop also aids in reducing the environmental allergen load and personnel exposure (kacergis et al. 1996) . use of personal protective equipment and dedicated work clothing for personnel involved in high-exposure activities is an important asset in reducing allergen exposure. it is important for the work clothing to remain at work, as evidenced by the finding that children of laboratory animal workers had a higher incidence of clinical signs during provocative testing, positive skin tests, and ige specific to laboratory rodents than did the children of parents who worked in other occupations (krakowiak et al. 1999) . full sleeve protection and gloves should be worn to prevent the urticarial reactions in persons who are highly sensitive to the mus m 1 allergen. personnel should also be provided with respiratory protection and eye or face protection when warranted. either filtering facepiece particulate respirators (n95 equivalent) or powered air purified respirators are effective in reducing exposure and alleviating clinical symptoms (schweitzer et al. 2003; thulin et al. 2002) . special attention must be paid to the selection and fitting of n95 filtering facepiece particulate respirators to ensure proper function (morbidity and mortality weekly report 1998). when the elimination of mouse allergen exposure in the workplace is not achieved through the use of engineering controls, work practices, and personal protective equipment, allergic reactions in persons sensitive to mus m 1 can be managed with pharmacological agents that have a long history of use for this condition. these include antihistamines, topical ~-adrenergic agents (bronchodilators), cromolyn sodium as a nasal spray, and intranasal potent glucocorticoids (austen 2004) . prophylaxis in patients with mild symptoms is often provided by topical cromolyn sodium on a continuous basis, supplemented with the intermittent use of antihistamines often at bedtime. the selection of the antihistamine has been an area of considerable discussion, and the reader should refer to casale et al. (2003) for further insights into this matter. in more serious cases, potent topical glucocorticoids may be necessary for alleviating clinical signs. immunotherapy, or hyposensitization, is typically reserved for patients who are unable or unwilling to escape the allergen provoking the response. although allergy to the dog or the cat can be ameliorated by immunotherapy (norman 1998 (norman , 2004 , the infrequent reports in the literature of immunotherapy for allergy to mice and other small laboratory animals have failed to establish the usefulness of this approach for the control of allergy to these species (sorrell and gottesman 1957; wahn and siraganian 1980) . the progress made in the past two decades in the evolution of health care systems responsible for the monitoring, control, and elimination of infectious diseases in laboratory mice as well as the advancements in the facilities, equipment, and techniques used to maintain mice in contemporary animal care and use programs, has vastly reduced the likelihood that personnel will encounter zoonotic diseases or other health hazards in the laboratory under most circumstances. continued program success in the control of mouse-associated hazards relies on the use of well-designed and maintained animal facilities, exclusion of wild rodents and other vermin, and quality control in animal care and veterinary care practices. in unique experimental situations that place personnel at a high risk of exposure to mouse-associated hazards, institutional review should ensure that procedures are carefully planned and conducted using personal protective equipment for worker safety. allergy to laboratory animals in laboratory technicians and animal keepers the relationship of trichophyton quinckeanum to trichophyton mentagrophytes alteras, i. (1965) human infection from laboratory animals rat-bite fever in animal research laboratory personnel molecular approaches for the treatment of hemorrhagic fever virus infections fatal illnesses associated with a new world arenavirus---calif~ rabies in a beaver--florida hantavirus-specific cd8(+)-t-cell responses in newborn mice persistently infected with hantaan virus rat bite fever at albert einstein medical center experimental lymphocytic choriomeningitis of monkeys and mice produced by a virus encountered in studies of the 1933 st. louis encephalitis epidemic allergies, anaphylaxis and systemic mastocytosis flea-borne rickettsioses: ecologic considerations infection by leptospira ballum: a laboratory-associated case lymphocytic choriomeningitis virus: reemerging central nervous system pathogen lymphocytic choriomeningitis virus: emerging fetal teratogen lymphocytic choriomeningitis virus: an unrecognized teratogenic pathogen epidemic nonmeningitic lymphocytic-choriomeningitis-virus infection. an outbreak in a population of laboratory personnel animal agents and vectors of human disease tick-borne (pasture) fever and rickettsial pox broad range polymerase chain reaction for diagnosis of rat-bite fever caused by streptobacillus moniliformis detection of lymphocytic choriomeningitis virus by use of fluorogenic nuclease reverse transcriptase-polymerase chain reaction analysis contamination of transplantable murine tumors with lymphocytic choriomeningitis virus lymphocytic choriomeningitis outbreak associated with pet hamsters. fiftyseven cases from new york state the influence of maternal antibodies on the epidemiology of leptospiral cartier state in mice favus of mice a case of leptospirosis ballum in california mouse ringworm eeen geval van leptospirosis ballum allergy to laboratory animals: a follow up study of its incidence and of the influence of atopy and pre-existing sensitisation on its development laboratory studies of a lymphocytic choriomeningitis virus outbreak in man and laboratory animals antigenic relationships amongst coronaviruses. archiv fur die gesante virusforschung 31 rickettsialpox: report of an outbreak and a contemporary review salmonella infections in rodents in manchester, with special reference to salmonella enteritidis var. danysz the occurrence of leptospiral infections in feral rodents in southwestern georgia arenaviridae: the viruses and their replication first do no harm: managing antihistamine impairment in patients with allergic rhinitis pheromone signalling in the mouse: role of urinary proteins and vomeronasal organ epizootic of trichophyton mentagrophytes (interdigitale) in white mice aetiological agents in occupational asthma tropical rat mite dermatitis lymphocytic choriomeningitis virus infection and house mouse (mus musculus) distribution in urban baltimore human-rodent contact and infection with lymphocytic choriomeningitis and seoul viruses in an inner-city population ecology and epidemiology of arenaviruses and their hosts spread of trichophyton mentagrophytes var. gran. infection to man inactivated hantaan virus vaccine derived from suspension culture of vero cells outbreak of rat mite dermatitis in medical students structure of mouse major urinary protein genes: different splicing configurations in the 3'-non-coding region a 45-kb dna domain with two divergently orientated genes is the unit of organisation of the murine major urinary protein genes an advancement in cage design to provide environmental enrichment for mice when rearing the plague flea xenopsylla cheopis (roths) for behavioural studies national prevalence and exposure risk for mouse allergen in us households rat-bite fever. report of three cases serologic evidence of rickettsialpox (rickettsia akari) infection among intravenous drug users in inner-city occupational health and safety in the care and use of research animals the use of pathogen-free animals control of mouse ringworm sendai virus antibody in acute respiratory infections and infectious mononucleosis exposure to leptospira icterohaemorrhagiae in inner-city and suburban children: a serologic comparison department of health and human services. national institute of occupational safety and health ringworm epizootics in laboratory mice and rats: experimental and accidental transmission of infection the tropical rat mite, liponyssus bacoti hirst 1914: the cause of a skin eruption of man, and a possible vector of endemic typhus fever rat mite dermatitis: a family affair rickettsia typhi (murine typhus) geophites zoophilic and anthropohilic dermatophytes: a review lymphocytic choriomeningitis outbreak associated with nude mice in a research institute diagnosis and management of rhinitis: complete guidelines of the joint task force on practice parameters in allergy pathogenicity of hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein g1 is related to virulence characterisation and antibiotic susceptibilities of streptobacillus moniliformis management of allergies to animals family bunyaviridae tropical rat mite dermatitis: case report and review leptospirosis craig and faust's clinical parasitology structure and sequence relationships in the lipocalins and related proteins parasites of laboratory animals rat bite fever without the bite man's worst friend (the rat) outbreak of tropical rat mite dermatitis in laboratory personnel zoonotic diseases. campylobacter infections and salmonellosis. semin zoonoses and other human health hazards hepatic helicobacter species identified in bile and gallbladder tissue from chileans with chronic cholecystitis infections transmitted from large and small laboratory animals leptospirosis ballum contracted from pet mice bear canyon virus: an arenavirus naturally associated with the california mouse (peromyscus californicus) leptospiral serotype distribution lists according to host and geographic area serological evidence of infection with sendai virus in england rabies in israel: decades of prevention and a human case peculiarities of the 1956 influenza outbreak in vladisvostok due to d virus rat-bite fever elimination of mouse allergens in the working environment: assessment of individually ventilated cage systems and ventilated cabinets in the containment of mouse allergens measurement of exposure to mouse urinary proteins in an epidemiological study rat-bite fever (streptobacillus moniliformis): a potential emerging disease lymphocytic choriomeningitis virus in mouse neoplasms rat mite dermatitis in children laboratory tests for allergic and immunodeficiency diseases antibodies to mouse hepatitis viruses in human sera multiple genes coding for the androgen-regulated major urinary proteins of the mouse lymphocytic choriomeningitis virus teleomorphs and mating types in trichophyton mentagrophytes complex anaphylaxis after laboratory rat bite: an occupational hazard rat mite dermatitis outbreak of lymphocytic choriomeningitis virus infections in medical center personnel trichophyton mentagrophytes skin infections in laboratory animals as a cause of zoonosis identification of risk factors in rat bite incidents involving humans cat and dog allergy and total ige as risk factors of laboratory animal allergy streptobacillus moniliformis polyarthritis mimicking rheumatoid arthritis: an urban case of rat bite fever experimental transmission of tularemia by the tropical rat mite manifestation of allergic rhinitis in latent-sensitized patients. a prospective study the contamination of laboratory animals with lymphocytic choriomeningitis virus rickettsialpox--a newly recognized rickettsial disease. v. recovery of rickettsia akari from a house mouse (mus musculus) rickettsialpoxma newyly recognized rickettsial disease. iv. isolation of a rickettsia apparently identical with the causative agent of rickettsialpox from allerdermanyssus sanguineus, a rodent mite rickettsialpox--a newly recognized rickettsial disease. i. isolation of the etiological agent diseases transmitted from animals to man allergy to laboratory mice and rats: a review of the pathophysiology, epidemiology and clinical aspects the etiology, mode of infection and specific therapy of weil's disease sendai virus health care for research animals is essential and affordable lymphocytic choriomeningitis virus. a neglected pathogen of man allergy and hypersensitivity diseases of children in the subtropics and tropics serologic evidence of american experience with newborn pneumonitis virus rabies virus air quality in an animal facility: particulates, ammonia, and volatile organic compounds prevalence of rabies virus and hantaan virus infections in commensal rodents and shrews trapped in bangkok ornithonyssus bacoti (hirst) infestation in mouse and hamster colonies pathogenesis of hantaan virus infection in suckling mice: clinical, virologic, and serologic observations animal aeroallergens the major dog allergens, can f 1 and can f 2, are salivary lipocalin proteins: cloning and immunological characterization of the recombinant forms increased detection of rickettsialpox in a new york city hospital following the anthrax outbreak of 2001: use of immunohistochemistry for the rapid confirmation of cases in an era of bioterrorism allergy to laboratory animals in children of parents occupationally exposed to mice, rats and hamsters epidermophyton floccosum (harz) langeron and milochevitsch als spontanin fektion bei mausen newborn virus pneumonitis (type sendai) ii. the isolation of a new virus newborn virus pneumonitis (type sendai) ii. the isolation of a new virus possessing hemagglutinin activity streptobacillus moniliformis isolated from a case of haverhill fever: biochemical characterization and inhibitory effect of sodium polyanethol sulfonate lymphocytic choriomeningitis virus infection in a province of spain: analysis of sera from the general population and wild rodents weil's syndrome in a zoologist zoonoses in common laboratory animals immunologic and biochemical properties of the major mouse urinary allergen (mus m 1) an outbreak of hepatitis in marmosets in a zoological collection a worldwide survey of management practices in laboratory animal allergy trichophyton mentagrophytes in mice: infections of humans and incidence amongst laboratory animals a molecular phylogeny of nuclear and mitochondrial sequences in hymenolepis nana (cestoda) supports the existence of a cryptic species detection of the rodent tapeworm rodentolepis (=hymenolepis) microstoma in humans. a new zoonosis? medical parisitology non-domestic animals in new zealand and in rarotonga as a reservoir of the agents of ringworm reverse genetics of the largest rna viruses association between helicobacter bilis in bile and biliary tract malignancies: h. bilis in bile from japanese and thai patients with benign and malignant diseases in the biliary tract lassa fever. effective therapy with ribavirin rat-bite fever due to streptobacillus moniliformis growth in sucklingmouse brain of "ibv-like" viruses from patients with upper respiratory tract disease detection of workers sensitised to high molecular weight allergens: a diagnostic study in laboratory animal workers infectious and parasitic disease persistent hantavirus infections: characteristics and mechanisms ecologic studies of rodent reservoirs: their relevance for human health a new transmissible viral hepatitis of marmosets and tamarins epidemiologic notes and report: lymphocytic choriomeningitis virus-georgia mmwr seroepidemiological survey of lymphocytic choriomeningitis virus in wild house mice in china with particular reference to their subspecies pathogens of house mice on arid boullanger island and subantarctic macquarie island paramyxovirus replication and pathogenesis. reverse genetics transforms understanding sars: lessons learned from other coronaviruses treatment of salmonella gastroenteritis with ampicillin, amoxicillin, or placebo preemployment screening for allergy to laboratory animals: epidemiologic evaluation of its potential usefulness contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses morphological characteristics and nomenclature of leptospira (spirochaeta) icterohemorrhagiae (inada and ido) immunotherapy: past and present immunotherapy: 1999-2004 allergy in man caused by exposure to mammals hantavirus-specific antibodies in rodents and humans living in kuwait rickettsialpox in new york city: a persistent urban zoonosis microbial flora of the larynx, trachea, and large intestine of the rat after long-term inhalation of 100 per cent oxygen survey of dermatophytes isolated from the coats of laboratory animals in italy nontyphoidal. in bacterial infections of humans arenaviruses on the role of the mite ornithonyssus bacoti hirst as a reservoir and vector of the agent of tularemia the tropical rat mite, liponyssus bacoti, as an experimental vector of rickettsial pox recombinant sendai virus for efficient gene transfer to human airway epithelium ringworm (trichophyton mentagrophytes) infection in a colony of albino norway rats fleas of public health importance and their control allergy to mice. i. identification of two major mouse allergens (ag 1 and ag 3) and investigation of their possible origin cultivation of different viruses in tick tissue culture control strategies for aeroallergens in an animal facility laboratory acquired infection with keratinomyces ajelloi working with male rodents may increase risk of allergy to laboratory animals allergic sensitization is associated with increased bronchial responsiveness: a prospective study of allergy to laboratory animals prospective study of laboratory-animal allergy: factors predisposing to sensitization and development of allergic symptoms reovirus serotype 3 infection in infants with extrahepatic biliary atresia or neonatal hepatitis incidence of rat bites and rat bite fever in baltimore primates. in laboratory animal medicine a mouse oxyurid, syphacia obvelata, as a parasite of man rat mite dermatitis in minnesota viral meningitis and encephalitis: traditional and emerging viral agents lymphocytic choriomeningitis virus in southern france: four case reports and a review of the literature rat-bite fever as a cause of septic arthritis: a diagnostic dilemma streptobacillus moniliformis endocarditis: case report and review rickettsia akari newborn virus pneumonitis (type sendai) i. report: clinical observation of a new virus pneumonitis of the newborn a bovine dander allergen, comparative modeling, and similarities and differences in folding with related proteins distribution of the virus lymphocytic choriomeningitis virus in west germany the tropical rat mite (liponyssus bacoti) as an experimental vector of coxsackie virus reducing exposure to laboratory animal allergens fatal streptobacillus moniliformis infection in a two-month-old infant comparison of media with and without 'panmede' for the isolation of streptobacillus moniliformis from blood cultures and observations on the inhibitory effect of sodium polyanethol sulphonate staphylococcal botryomycosis in a specific-pathogen-free mouse colony fatal rat bite fever in a pet shop employee a serologic survey for viruses and mycoplasma pulmonis among wild house mice (mus domesticus) in southeastern australia a survey of house mice from iowa swine farms for infection with leptospira interrogans serovar bratislava lcm: associated human and mouse infections mouse allergy: case report studies on the pathogenesis of a hitherto undescribed virus (hepato-encephalomyelitis) producing unusual symptoms in suckling mice reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease isolation of an arenavirus from a marmoset with callitrichid hepatitis and its serologic association with disease identification, using sera from exposed animals, of putative viral antigens in livers of primates with callitrichid hepatitis cdna sequence analysis confirms that the etiologic agent of callitrichid hepatitis is lymphocytic choriomeningitis virus the laboratory diagnosis of leptospirosis leptospirosis (ballum) contracted from swiss albino mice elimination of leptospira ballum from a colony of swiss albino mice by use of chlortetracycline hydrochloride potential helminth infections in humans from pet or laboratory mice and hamsters comparison of diagnostic technics for the detection of leptospirosis in rats spirochetal infections in middleton's allergy: principles and practice anaphylaxis after bites by rodents incidence of murine virus antibody in humans in contact with experimental animals tropical rat mite dermatitis. report of six cases and review of mite infestations anaphylactic reaction after a mouse bite in a 9-year-old girl reduction of exposure to laboratory animal allergens in a research laboratory viruses transmissible from laboratory animals to man leptospirosis. in crc handbook series in zoonoses orthoreoviruses. in principles and practices of infectious diseases laboratory animal allergy in a pharmaceutical company important animal allergens are lipocalin proteins: why are they allergenic? development of hymenolepis nana and hymenolepis diminuta (cestoda: hymenolepididae) in the intermediate host tribolium confusum efficacy and specificity of immunotherapy with laboratory animal allergen extracts rat mite bite the zoology of tapeworms placebo-controlled trial of intravenous penicillin for severe and late leptospirosis bacterial and mycotic diseases helminths natural and experimental helicobacter infections rat-bite fever in a gerbil breeder congenital lymphocytic choriomeningitis virus syndrome: a disease that mimics congenital toxoplasmosis or cytomegalovirus infection natural occurrence of leptospira ballum in rural house mice and in an opossum on the biological character of hvj akitsugu strain and its pathogenicity in human beings as revealed after experimental inoculation of it in volunteers infections of laboratory animals potentially dangerous to man: ectoparasites and other arthropods, with emphasis on mites influenza d in early infancy key: cord-287527-ep6ug9c3 authors: algaissi, abdullah; agrawal, anurodh s; han, song; peng, bi-hung; luo, chuming; li, fang; chan, teh-sheng; couch, robert b; tseng, chien-te k title: elevated human dipeptidyl peptidase 4 expression reduces the susceptibility of hdpp4 transgenic mice to middle east respiratory syndrome coronavirus infection and disease date: 2018-09-26 journal: the journal of infectious diseases doi: 10.1093/infdis/jiy574 sha: doc_id: 287527 cord_uid: ep6ug9c3 background: the ongoing middle east respiratory syndrome coronavirus (mers-cov) infections pose threats to public health worldwide, making an understanding of mers pathogenesis and development of effective medical countermeasures (mcms) urgent. methods: we used homozygous (+/+) and heterozygous (+/−) human dipeptidyl peptidase 4 (hdpp4) transgenic mice to study the effect of hdpp4 on mers-cov infection. specifically, we determined values of 50% lethal dose (ld(50)) of mers-cov for the 2 strains of mice, compared and correlated their levels of soluble (s)hdpp4 expression to susceptibility, and explored recombinant (r)shdpp4 as an effective mcm for mers infection. results: hdpp4(+/+) mice were unexpectedly more resistant than hdpp4(+/−) mice to mers-cov infection, as judged by increased ld(50), reduced lung viral infection, attenuated morbidity and mortality, and reduced histopathology. additionally, the resistance to mers-cov infection directly correlated with increased serum shdpp4 and serum virus neutralizing activity. finally, administration of rshdpp4 led to reduced lung virus titer and histopathology. conclusions: our studies suggest that the serum shdpp4 levels play a role in mers pathogenesis and demonstrate a potential of rshdpp4 as a treatment option for mers. additionally, it offers a validated pair of tg mice strains for characterizing the effect of shdpp4 on mers pathogenesis. middle east respiratory syndrome (mers) is an emerging infectious disease caused by a coronavirus (mers-cov), first identified in saudi arabia in 2012, that has since spread to 27 mostly surrounding countries, resulting in more than 2229 laboratory-confirmed cases of infection and 791 deaths (approximately 36%), as of june 2018 [1] . the pandemic potential of this infection calls for a better understanding of mers pathogenesis and the development of effective medical countermeasures (mcms) for humans. like other human covs, mers-cov uses an exoaminopeptidase, human dipeptidyl peptidase 4 (dpp4), as the entry receptor for infection of permissive cells [2] . dpp4, also known as cd26, is involved in many physiological functions via its ubiquitous expression in a variety of tissues, its propensity to interact with adenosine deaminase and other important regulatory molecules of the immune system, and its intrinsic proteolytic activity that cleaves many biologically active peptides or proteins that contain proline or alanine at the penultimate position [3, 4] . not only is dpp4 expressed as a type ii transmembrane glycoprotein, primarily on endothelial and epithelial cells and subsets of immune cells, but it is also present in a functionally intact soluble form (sdpp4) in the circulation and other body fluids [3, 4] . because wild type mice are not susceptible to mers-cov, we established a heterozygous (+/−) transgenic (tg) mouse model globally expressing hdpp4 for studies of mers pathogenesis and development of mcms against mers-cov infection [5, 6] . to ensure a steady and cost-effective supply of the animals, a tg mouse model with homozygous expression of hdpp4, designated hdpp4 +/+ tg mice, was developed through mating of hdpp4 +/− mice and used as breeders for generating offspring of both genotypes of hdpp4 tg mice. because hdpp4 is the functional mers-cov receptor, the doubling of encoded hdpp4 gene in hdpp4 +/+ tg mice could render them more susceptible than their hdpp4 +/− counterparts to mers-cov infection and disease. to our surprise, we found that hdpp4 +/+ mice are more resistant than their hdpp4 +/− counterparts to mers-cov infection. we subsequently found that an increased expression of functionally intact soluble hdpp4 (shdpp4) in the circulation of hdpp4 +/+ tg mice, relative to that of hdpp4 +/− mice, was associated with this increased resistance and might be, at least in part, accountable for the seemingly counterintuitive findings on susceptibility to mers-cov infection. this notion was supported by studies showing that elevated shdpp4 levels, brought about by administration of recombinant shdpp4 (rshdpp4), resulted in increased resistance of recipient hdpp4 +/− mice to mers-cov. together, our results indicate that manipulation of shdpp4 might serve as a strategy for counteracting mers-cov infection and disease in humans. hdpp4 +/− transgenic mice were established, as previously reported [5, 6] . hdpp4 +/+ breeder mice were derived by mating 2 parental hdpp4 +/− mice. the homozygosity was determined by quantitative polymerase chain reaction analysis of tail dna (data not shown) and verified by their subsequent mating with wildtype (wt) mice. only those mice uniformly yielding heterozygous offspring were selected as hdpp4 +/+ breeders. interbreeding between hdpp4 +/+ mice produced additional hdpp4 +/+ mice, whereas backcrossing them to wt mice generated hdpp4 +/− mice. all of the in vitro and animal studies involving infectious mers-cov were conducted at the biosafety level 3 (bsl3) laboratory and animal bsl3 facilities at the galveston national laboratory in accordance with approved protocols and the guidelines and regulations of the national institutes of health (nih) and association for assessment and accreditation of laboratory animal care (aaalac). detailed methodologies for viral infection, isolation from infected lungs and brain, and determination of infectious viral loads have been established and routinely used in our laboratory [5, 6] . the original stock of mers-cov emc-2012 strain, a gift of heinz feldmann (nih, hamilton, mt) and ron a. fouchier (erasmus medical center, rotterdam, netherlands), was expanded in vero e6 cells 3 times consecutively. passage 3 containing a titer of approximately 5 × 10 6 50% cell culture infectious dose (tcid 50 )/ml of virus was used throughout the study. the 50% lethal dose (ld 50 ) values for hdpp4 +/+ and hdpp4 +/− mice was determined by using traditional virus dilution assays and the reed-muench method, as we previously described [6] . briefly, groups of 4 young (6-8 weeks) or old (7-10 months) hdpp4 +/+ and hdpp4 +/− mice were inoculated, via intranasal route, with dosages of emc-2012 mers-cov in 10-fold decrements from 10 2 to 10 -1 tcid 50 in a volume of 60 µl. mice were monitored daily for clinical manifestations (weight loss) and mortality for at least 21 days postinfection (dpi). ld 50 values for each strain of mice were estimated based on the ratio of the surviving mice to the total inoculated mice, as previously described [6] . those surviving for more than 21 days were also evaluated for specific antibody responses to mers-cov receptor binding domain (rbd) protein by enzymelinked immunosorbent assay (elisa) [6] . only those showing specific antibody to rbd were considered as "mers-cov infected. " to quantify the circulating shdpp4 in the sera of naive dpp4 +/+ , dpp4 +/− , and dpp4 −/− mice, a commercial elisa-based assay was used, following the manufacturer's instructions (ebioscience catalog no. bms235). absorbance at 450 nm in 96-well plates was read in an elisa plate reader (molecular device). elisa-based and vero e6 cell-based microneutralization assays, previously described [7] , were used to determine the titers of mers-cov rbd-specific serum igg and neutralizing antibodies in hdpp4 tg mice in response to mers-cov infection. purified insect cell-derived human dpp4 ectodomain (residues 39-766; genbank accession no. np_001926.2) containing an n-terminal human cd5 signal peptide and a c-terminal his6 tag, as we previously described and characterized [7, 8] , was prepared and used for treatment studies. testing binding specificity of the rshdpp4 to the rbd proteins of mers-cov and severe acute respiratory syndrome coronavirus (sars-cov; both rbds were generous gifts of drs du and jiang at new york blood center, ny) was determined in elisa-based assays [7, 9] . for determining the capacity of rshdpp4 to inhibit mers-cov infection in vitro we initially used our standard microneutralization procedure with cytopathic effect (cpe) inhibition as the endpoint. these assays revealed a dose-dependent reduction of cpe at 72 hours, ranging from less than 5% for 100, 50, and 25 μg/ml and gradually increased to approximately 30% for 12.5 μg/ml of rshdpp4. in addition to standard microneutralization assay with a cpe endpoint, we measured the antiviral effect of rshdpp4 using virus yield of each rshdpp4 dilution from 100 to 0.8 μg/ml, expressed as log 10 tcid 50 /ml. the effect of rshdpp4 for inhibiting mers-cov infection in tg mice was determined using hdpp4 +/− mice in 2 pilot studies with 2 different batches of rshdpp4 showing similar, but not identical, binding capacity to mers-cov rbd and in vitro neutralizing activity. briefly, groups of hdpp4 +/− mice (n = 3 per group) were treated twice with either 100 µg or 400 µg of rshdpp4 or phosphate-buffered saline (pbs) as control, via the intraperitoneal route 2 hours before (−2 hours) and 24 hours after (+24 hours) infection (intranasal) with 10 3 tcid 50 of mers-cov. mice were sacrificed at 3 dpi to assess infectious viral loads and histopathology in the lungs. inflated lung specimens and brain tissues were fixed in 10% neutral buffered formalin for 48 hours before paraffin embedding and processing for routine hematoxylin and eosin stain (h&e) to assess the histopathology, as we previously described [5, 6] . statistical analyses were performed using graphpad prism software. neutralizing antibody titers and virus titers were averaged for each group of mice and compared using students t test, 1-way anova, or others as indicated. for the initial comparison of the susceptibility of hdpp4 +/+ and hdpp4 +/− mice to mers-cov, we determined the ld 50 values for mice 7-10 months of age, as we previously described [6] . because hdpp4 is the functional receptor of mers-cov, we anticipated that dpp4 +/+ mice might be more, or at least equally, permissive as dpp4 +/− mice to mers-cov infection. to our surprise, we found that hdpp4 +/+ mice were more resistant than hdpp4 +/− mice as indicated by ld 50 values of 4.3 and 32.4 tcid 50 of mers-cov for hdpp4 +/− and hdpp4 +/+ mice, respectively. to confirm this seemingly counterintuitive finding and rule out any potential effect of age and gender, we repeated the study using age-(6-8 weeks old) and sex-matched tg mice of both genotypes. shown in figure 1a is a representative of 2 independently performed experiments that confirmed the ld50 difference; values for the hdpp4 +/− and hdpp4 +/+ mice were 7.7 and 70.0 tcid 50 of mers-cov, respectively, indicating that hdpp4 +/+ mice are more resistant than their age-and sex-matched hdpp4 +/− counterparts to mers-cov infection. using sera collected 21 dpi from each strain of tg mice that survived the lower challenge dosages, we quantified mers-cov rbd-specific igg antibodies by elisa. we found that infection had occurred in tg mice of both strains. infection rates for those given 100 tcid 50 were similar (1/1 for dpp4 +/− mice and 2/2 for dpp4 +/+ mice) and 10 tcid 50 (2/2 for each strain) but were greater for dpp4 +/− mice (3/3) than dpp4 +/+ mice (1/4) for 1 tcid 50 . the difference in infection rates is consistent with the increased resistance of dpp4 +/+ mice described earlier. to further verify the difference in susceptibility to mers-cov infection, we infected (intranasal) hdpp4 +/+ (n = 9) and hdpp4 +/− (n = 11) tg mice with an equal dose of mers-cov (10 3 tcid 50 /per mouse) and monitored them daily for morbidity (weight loss) and mortality. three mice of each strain, unless indicated otherwise, were euthanized at 3, 5, and 7 dpi to assess infectious viral titers and the histopathology of lungs and brains. in contrast to dpp4 +/− mice, which exhibited marked weight loss, starting at 3-4 dpi, and 2 deaths at 6 dpi (data not shown), infected hdpp4 +/+ mice exhibited minimal weight changes and uniformly survived through 7 dpi when the experiment was terminated ( figure 1b) . when the viral loads were measured at 3 dpi, we readily recovered infectious virus from the lungs, but not the brains, of all 3 hdpp4 +/− mice examined, but from the lung of only 1 of 3 hdpp4 +/+ mice. although we usually recover virus from lungs of some mice, efforts to recover infectious virus from both lung and brain specimens of both strains of tg mice at 5 dpi were unsuccessful (data not shown); however, we were able to retrieve infectious virus from the brain (but not lungs) of the sole hdpp4 +/− survivor and from all 3 hdpp4 +/+ mice that survived to 7 dpi. the virus titer in the brain was 10 6.2 /g for the single hdpp4 +/− mouse, a titer significantly higher than the average of 10 3.7 /g for 3 hdpp4 +/+ mice ( figure 1c ). this ability to recover infectious virus from the lungs approximately 2-3 days earlier than from the brains is consistent with the pattern, kinetics, and tissue distribution of mers-cov infection in dpp4 tg mice we have previously reported [6] . we also compared the histopathology of lungs and brains, 2 of the prime targets of mers-cov infection of hdpp4 tg mice [5] . although infected dpp4 +/− mice elicited mild-to-moderate histopathological changes within the lungs at 3 dpi after a dose of 10 3 tcid 50 of mers-cov infection, as in our earlier study [6] , infected dpp4 +/+ mice exhibited reduced or no lung histopathology (data not shown). brain histopathology at 7 dpi for the sole hdpp4 +/− survivor had infiltrations of mononuclear cells in the meninges ( figure 1d , below), perivascular cuffing ( figure 1d , above and below), microglial nodules ( figure 1d , below), microhemorrhage ( figure 1d , above) and cell death at the junctions of gray and white matter ( figure 1d , above) but not in dpp4 +/+ mice. collectively, the significant differences between these 2 strains of mice in their ld 50 values, seroconversion rates, viral loads, weight loss, and histopathology support the notion that dpp4 +/+ mice are more resistant than dpp4 +/− mice to mers-cov infection. . sera of naive human dipeptidyl peptidase 4 (hdpp4 +/+ ) mice contain significantly higher levels of soluble hdpp4 (shdpp4) that exhibit higher levels of neutralizing antibody-like activity than those of naive hdpp4 +/− mice. a, groups of at least 10 age-and sex-matched hdpp4 +/+ , hdpp4 +/− , and their transgene-negative (hdpp4 −/− ) littermates were subjected to retroorbital bleeding to assess the contents of shdpp4, using commercially available elisa kits that quantify specific hdpp4 (hdpp4 +/+ vs hdpp4 +/− , p < .001 t test). b, sera obtained from naive hdpp4 +/+ and hdpp4 +/− mice (n = 10 of each) and hdpp4 −/− mice (n = 6) were subjected to the standard vero e6-based microneutralization tests to determine their potential to neutralize mers-cov. data are presented as the geometric mean neutralization titers (gmt log 2 ) of 50% neutralization titer (nt 50 ). a 1-10 dilution of sera is approximately 3.4 log 2 . (* p = .026, t test and mann-whitney rank sum test, when compared to those of hdpp4 +/− mice). the gmt titers of hdpp4 −/− mice were uniformly below the limit of detection. abbreviations: elisa, enzyme-linked immunosorbent assay; mers-cov, middle east respiratory syndrome-associated coronavirus. dotted line, limit of detection. tg mice could be different, thereby contributing to their difference in susceptibility to mers-cov infection. using a commercial elisa-based analysis, we were unable to detect shdpp4 in age-and sex-matched hdpp4-negative (hdpp4 −/− ) littermates. however, as shown in figure 2a , a representative of 2 independently performed studies, an average of 8.1 ± 0.2 μg/ml (mean ± sd) and 6.2 ± 0.4 μg/ml of shdpp4 was detected in hdpp4 +/+ (n = 16) and dpp4 +/− mice (n = 10), respectively. as shdpp4 retains its binding specificity to mers-cov rbd protein [7] , the significantly different expression of shdpp4 in the sera of these 2 strains of tg mice (p < .001) prompted us to examine if elevated shdpp4 expression might relate to the higher resistance of dpp4 +/+ to mers-cov infection by possibly acting like a decoy that binds mers-cov rbd and prevents virus infection. using microneutralization tests, we noted that the 50% neutralization titers (nt 50 ), expressed as the geometric mean titers (gmt), were 3.9 ± 0.3 and 3.1 ± 0.1 for hdpp4 +/+ and hdpp4 +/− mice, respectively (p = .026), compared to those of hdpp4 −/− mice which were uniformly below the limit of detection (i.e., ~3.0) ( figure 2b ). because the significantly higher expression of shdpp4 with better neutralizing activity might contribute to the increased resistance of hdpp4 +/+ mice to mers-cov infection, we explored whether an increased shdpp4 expression might increase resistance of naive hdpp4 +/− mice to mers-cov infection. using our limited amount of insect cell-derived rshdpp4, known to specifically bind to rbd of mers-cov but not sars-cov, and to neutralize mers-cov in vitro in a dose-dependent manner ( figure 3a and 3b), we administered 100 μg of rshdpp4, via the intraperitoneal route, into each of 3 dpp4 +/− mice 2 hours before (−2 hours) and 24 hours after (+ 24 hours) infection with 10 3 tcid 50 of mers-cov. the effect of the rshdpp4 against mers-cov infection was assessed at 3 dpi by using the titers of infectious virus within the lungs as the end point for this pilot study. while all of 3 pbs-treated mice exhibited moderate titers of live virus, we were unable to recover infectious virus from any of 3 rshdpp4-treated mice ( table 1 , experiment 1). encouraged by the preliminary data, we generated another batch of rshdpp4 shown to inhibit mers-cov infection in a dose-dependent manner ( figure 3b ) to repeat the experiment. we gave groups of 3 dpp4 +/− mice either 100 or 400 μg of rsh-dpp4, or pbs (as control) 2 hours before and 24 hours after virus infection as before. to determine if administration of rshdpp4 would increase the circulating levels of shdpp4, serum levels of shdpp4 in mice prior to and 2 hours after the first administration and before challenge with mers-cov were measured. we found that titers at 0 and 2 hours of tg mice given 100 μg (6.6 ± 0.4 versus 6.6 ± 0.9 μg/ml), were similar to those of pbs-treated mice (7.5 ± 0.8 versus 7.3 ± 1.0 μg/ml). however, mice treated with 400 μg of rshdspp4 showed significantly increased titers 2 hours after treatment (6.6 ± 0.6 increased to 13.7 ± 0.8 μg/ml; p = .002, t test). these results suggest that an increased serum level of shdpp4 can be achieved by administration of rshdpp4 in a dose-dependent manner. in addition to the viral loads within the lungs at 3 dpi, the pulmonary histopathology was examined to investigate the effect of rshdpp4 on mers-cov infection. unlike the first study in which treatment with 2 doses of 100 μg (at −2 hours and +24 hours) of rshdpp4 fully protected against mers-cov infection, we were able to recover reduced titers of infectious virus from each of 3 mice given 100 μg of the second batch of rshdpp4 when compared to those of pbs-treated controls (p = .077, elisa 96-well plates, precoated with rbd protein of mers-cov or sars-cov, were used to determine the binding specificity of rshdpp4 by using the standard elisa-based assays. absorbance was measured at a wavelength of 450 nm. b, the dose-dependent neutralizing activities of 2 different batches of rshdpp4 (rshdpp4-1 and -2) against mers-cov. the modified vero e6-based microneutralization test (virus yield) was used to quantify the neutralizing antibody-like capacity of rshdpp4, as described earlier [12] and in the methods. *p < .05; **p < .01. abbreviations: elisa, enzyme-linked immunosorbent assay; od, optical density; tcid 50 , 50% cell culture infectious dose. t test). however, as shown in table 1 , experiment 2, the titers of infectious virus in mice treated with 400 μg of rshdpp4 were significantly reduced from an average of 4.3 ± 0.3 (mean ± se) in control mice to 2.6 ± 0.1 tcid 50 /g (p = .011, t test). this finding is consistent with the reduced potency of batch 2 of rshdpp4, as shown in figure 3b . however, the histopathology in mice treated with the high dose of rshdpp4 (ie, 400 μg) was reduced as well when compared to that of the pbs controls (data not shown). in this study we found that hdpp4 +/+ mice were more resistant than hdpp4 +/− mice to mers-cov infection, as evidenced by approximately 10-fold increases of ld 50 , reduced infectious viral yields, and seroconversion rates, as well as less weight loss and lower mortality than their age-and sex-matched hdpp4 +/− counterparts ( figure 1 ). we also found that hdpp4 +/+ mice had significantly higher levels of shdpp4 in their circulation than did hdpp4 +/− mice ( figure 2 ). moreover, these higher serum levels of shdpp4 exhibited higher titers of neutralizing activity against mers-cov in vero e6 cell-based assays. finally, we showed that administration with functionally active rhsdpp4 proteins (figure 3 ) enabled hdpp4 +/− mice to better resist mers-cov infection in a dose-dependent manner (table 1) , a finding in accordance with increased levels of shdpp4 in their circulation. taken together, these results support the notion that increasing the levels of shdpp4 is a potential option for counteracting mers-cov infection and disease in humans. dpp4, ubiquitously expressed on many types of cells and tissues, has been well characterized as critically involved in regulating many important physiological functions, in part through its intrinsic enzymatic activity and propensity to interact with other key regulatory molecules of the immune system [3, 13] . as the functional receptor that mediates entry of mers-cov to permissive host cells, the membrane-associated hdpp4 plays a pivotal role in mers-cov infection and disease. however, specific role(s) that shdpp4 might have in mers pathogenesis remain much less understood. while the levels of sdpp4 vary significantly, even among healthy individuals, it has been shown that the intensities of sdpp4 expression in the circulation, along with its intrinsic enzymatic activity, could be a factor in dictating the severity of many human diseases, including malignancies, autoimmune and inflammatory diseases, diabetes mellitus and other metabolic syndromes, and chronic infectious disease such as aids and hepatitis c [4, 10, 11, 14, 15] . it has been recently reported that serum levels of sdpp4 expression in confirmed mers patients were significantly reduced when compared to those of healthy individuals [16] ; however, the suggestion that these reduced levels could serve as biomarkers for susceptibility requires knowledge regarding the levels in mers cases before onset of infection and disease. in addition, further studies of the therapeutic value of shdpp4 as either a significant resistance factor or a potential countermeasure for mers-cov in humans is warranted. of note, the soluble forms of the viral receptors for several other viruses, including those caused by sars-cov, rhinovirus, and hiv, have been proposed as potentially effective antiviral therapeutics [17] [18] [19] . we showed in this study that sera derived from naive hdpp4 tg mice of either strain, especially hdpp4 +/+ , possess detectable neutralizing antibody-like activity against mers-cov ( figure 2b ). whether the significantly higher shdpp4 expression of hdpp4 +/+ mice could be solely accountable for its greater resistance to mers-cov infection through functioning as receptor decoys seems unlikely, because it took at least 12.5 μg of rsh-dpp4, a level higher that the approximately 8 μg/ml in sera of hdpp4 +/+ mice, to significantly inhibit mers-cov infection in vero e6 cells ( figure 3b ). additional studies are needed to better understand the shdpp4-related protective mechanisms against mers-cov, especially those of the immune system. however, the validated direct correlation between the level of shdpp4 and the susceptibility to mers-cov infection, as shown in this study, may provide a possible genetic basis for the observed wide spectrum of diseases, ranging from asymptomatic, mild-to-moderate, to severe infection and death, in mers patients [20, 21] . with the limited supplies of rshdpp4, we have shown in 2 independently performed proof-of-principle studies that administration of exogenous rshdpp4 might be a treatment a mice (n = 3 each group) were given either 100 μl of pbs or pbs containing 100 or 400 μg of rshdpp4/per mouse by the intraperitoneal route 2 hours before and 24 hours after intranasal challenge with 100 ld 50 (approximately 10 3 tcid 50 ) of mers-cov. lung infectious viral titers were quantified at 3 dpi using a standard vero e6 cell-based infectivity assay. b mean ± se. c none detected (limit of detection was 2.5 log 10 tcid 50 /g). d p = .038 (t test) using 2.4 as the value for nondetectable samples. e p = .011, 1-way anova. option for mers-cov infection (table 1) . additional studies are required to determine if increasing shdpp4 levels by rsh-dpp4 treatment could be a useful treatment option for human mers. the study presented in this report demonstrates the usefulness of this homozygous and heterozygous pair of hdpp4 tg mice to fully explore the interactions between hdpp4 and mers-cov infection and disease, studies that could lead to identification of novel molecular and cellular targets for mcms against mers-cov infection and disease in humans. financial support. this work was supported by the national institute of allergy and infectious diseases, national institutes of health (grant numbers r21ai113206 to c.-t. k. t. and r01ai110700 to f.l). potential conflicts of interest. all authors: no reported conflicts of interest. all authors have submitted the icmje form for disclosure of potential conflicts of interest. conflicts that the editors consider relevant to the content of the manuscript have been disclosed. world health organization regional office for the eastern mediterranean dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-emc cut to the chase: a review of cd26/dipeptidyl peptidase-4's (dpp4) entanglement in the immune system unravelling the immunological roles of dipeptidyl peptidase 4 (dpp4) activity and/or structure homologue (dash) proteins generation of a transgenic mouse model of middle east respiratory syndrome coronavirus infection and disease characterization and demonstration of the value of a lethal mouse model of middle east respiratory syndrome coronavirus infection and disease a truncated receptor-binding domain of mers-cov spike protein potently inhibits mers-cov infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines receptor usage and cell entry of bat coronavirus hku4 provide insight into bat-to-human transmission of mers coronavirus molecular basis of binding between novel human coronavirus mers-cov and its receptor cd26 imunomodulatory activity of dpp4 dipeptidyl-peptidase iv from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme dpp iv immunization with inactivated middle east respiratory syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus the structure and function of cd26 in the t-cell immune response a dipeptidyl peptidase-4 inhibitor directly suppresses inflammation and foam cell formation in monocytes/macrophages beyond incretins dipeptidyl peptidase-4: a key player in chronic liver disease reduction of soluble dipeptidyl peptidase 4 levels in plasma of patients infected with middle east respiratory syndrome coronavirus susceptibility to sars coronavirus s protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1 aavexpressed ecd4-ig provides durable protection from multiple shiv challenges clinical aspects and outcomes of 70 patients with middle east respiratory syndrome coronavirus infection: a single-center experience in saudi arabia middle east respiratory syndrome key: cord-281161-u896icp9 authors: wang, jing; tricoche, nancy; du, lanying; hunter, meredith; zhan, bin; goud, gaddam; didier, elizabeth s.; liu, jing; lu, lu; marx, preston a.; jiang, shibo; lustigman, sara title: the adjuvanticity of an o. volvulus-derived rov-asp-1 protein in mice using sequential vaccinations and in non-human primates date: 2012-05-17 journal: plos one doi: 10.1371/journal.pone.0037019 sha: doc_id: 281161 cord_uid: u896icp9 adjuvants potentiate antigen-specific protective immune responses and can be key elements promoting vaccine effectiveness. we previously reported that the onchocerca volvulus recombinant protein rov-asp-1 can induce activation and maturation of naïve human dcs and therefore could be used as an innate adjuvant to promote balanced th1 and th2 responses to bystander vaccine antigens in mice. with a few vaccine antigens, it also promoted a th1-biased response based on pronounced induction of th1-associated igg2a and igg2b antibody responses and the upregulated production of th1 cytokines, including il-2, ifn-γ, tnf-α and il-6. however, because it is a protein, the rov-asp-1 adjuvant may also induce anti-self-antibodies. therefore, it was important to verify that the host responses to self will not affect the adjuvanticity of rov-asp-1 when it is used in subsequent vaccinations with the same or different vaccine antigens. in this study, we have established rov-asp-1's adjuvanticity in mice during the course of two sequential vaccinations using two vaccine model systems: the receptor-binding domain (rbd) of sars-cov spike protein and a commercial influenza virus hemagglutinin (ha) vaccine comprised of three virus strains. moreover, the adjuvanticity of rov-asp-1 was retained with an efficacy similar to that obtained when it was used for a first vaccination, even though a high level of anti-rov-asp-1 antibodies was present in the sera of mice before the administration of the second vaccine. to further demonstrate its utility as an adjuvant for human use, we also immunized non-human primates (nhps) with rbd plus rov-asp-1 and showed that rov-asp-1 could induce high titres of functional and protective anti-rbd antibody responses in nhps. notably, the rov-asp-1 adjuvant did not induce high titer antibodies against self in nhps. thus, the present study provided a sound scientific foundation for future strategies in the development of this novel protein adjuvant. the use of an adjuvant is a key element in promoting vaccine effectiveness because it can stimulate the immune system and accelerate, prolong, or enhance antigen-specific immune responses, even when used in combination with weak vaccine antigens [1] . adjuvants have been used in vaccines since the early 20th century following more than 100 years of research. in the u.s., alum remains the sole fda-approved adjuvant for general use of vaccines [2] . however, few adjuvants have been licensed for use around the world [3] . no new adjuvants have been approved in the united states since the 1930s, and only recently has the european heads of medicines agencies licensed the mf59, as03 and as04 adjuvants for use with the fluadh, fendrix tm and cervarix tm defined vaccines, respectively [4] . cervarix tm which uses as04, a combination of aluminum hydroxide and monopho-sphoryl lipid a (mpl), in its formulation was also licensed by fda on october 16, 2009 , to prevent cervical cancer caused by human papillomavirus types 16 and 18. adjuvants are important in guiding the type of adaptive response that is induced after vaccination and that is most effective against incoming infections. the development of novel adjuvants that stimulate discrete subsets of immune cells, in particular, cytotoxic t-lymphocytes (ctl), is required to unleash the full potential of new vaccines and immunotherapy strategies [5] . although tremendous progress has been made in the development of many vaccine platforms, including dna-based vaccines, recombinant subunit vaccines, viruses and conjugates, the absence of safe and effective adjuvants impedes the clinical development of such new generations of vaccines. interest in developing new adjuvants has increased significantly over the past decade, as highlighted by the following issues [6, 7] : 1) the inability of traditional approaches to develop successful vaccines against ''difficult'' organisms such as hiv and hcv; 2) the emergence of epidemics or outbreaks of new infectious diseases with high mortality, especially those causing serious threats to public health and socioeconomic stability worldwide (e.g., sars, ebola, west nile, dengue, pandemic flu and nvcjd); 3) the re-emergence of ''old'' infections like tuberculosis; 4) the continuing spread of antibiotic-resistant bacteria; and 5) the increased threat of bioterrorism. therefore, the molecular design of potently adjuvanted vaccines that would enhance antigen uptake in vivo and potentially also simplify their adjuvant requirements would be highly desirable [8] . there are many reports showing that helminth-derived molecules have potent regulatory or stimulatory effects on the immune system of their mammalian hosts (reviewed in [9] , [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] ). some of these molecules were shown to contain pathogen associated molecular pattern that bind to endocytic-pattern recognition receptors on antigen presenting cells (apcs). three helminth products have also been reported to act as adjuvants in experimental vaccine models. proteins secreted by adult nippostrongylus brasiliensis (nes) induced strong th2 responses in mice immunized with hen egg lysozyme [22] . nes actively matured dendritic cells (dc) and selectively up-regulated cd86 and ox40l, together with il-6 production, while blocking il-12p70 responsiveness in a manner consistent with th2 generation in vivo [23] . similarly, lacto-n-fucopentaose iii (lnfpiii), a carbohydrate found on the surface of the eggs of a human parasite, schistosoma mansoni, acted as a th2 adjuvant for human serum albumin when injected intranasally, subcutaneously or intraperitonealy into mice [24] . it functions as an innate th2 promoter via its action on murine dcs. its ability to drive dc2 maturation was shown to be dependent on signaling via toll-like receptor 4 (tlr4) [25] . finally, when co-administered with an inactivated antiinfluenza vaccine in both young and aged mice, a 19 aa synthetic peptide (gk-1) from taenia crassiceps cysticerci has induced increased levels of anti-influenza antibodies in aged mice, both before and after infection, reduced the local inflammation that accompanied influenza vaccination itself, and favored virus clearance after infection in both young and aged mice [26] . a recombinant onchocerca volvulus activation-associated protein-1, rov-asp-1, has been shown to be a novel protein adjuvant that can increase specific immune responses in mice, both humoral and cellular responses, against recombinant protein or peptide-based figure 1 . anti-rbd antibody responses in vaccinated mice. rbd-specific responses in mice immunized with recombinant sars-cov rbd in the presence of the rov-asp-1, alum or cpg. titer of rbd-specific igg and igg subtypes was detected by elisa using sera from mice before (preimmune) and 10 days after each vaccination. * indicates significant difference (p,0.05) among multiple comparisons; in particular between mice that were immunized in the presence of rov-asp-1 or control adjuvants vs. no adjuvant. doi:10.1371/journal.pone.0037019.g001 antigens when formulated in aqueous mixtures [14, 27, 28, 29] . we have previously suggested that these effects are probably attained through the cellular activation of apcs such as dendritic cells via tlr-2 and tlr-4 [27] . the rov-asp-1 adjuvant is able to induce balanced th2 and th1-associated igg1 and igg2a antibodies to proteins, polypeptides and small peptides. with a few antigens such as rgp41, rbd and hbsag, it also promoted a putative th1biased response based on pronounced induction of th1-associated igg2a and igg2b antibody responses and/or a significantly upregulated production of th1 cytokines, including il-2, ifn-c, tnf-a, and il-6 [14, 27, 29, 30] . its ability to augment th1associated antibody responses was further demonstrated in studies using three commercial inactivated vaccines against hemorrhagic fever with renal syndrome, flu and rabies [29] . moreover, in a novel recombinant configuration, rov-asp-1 fused to 3 copies of the highly conserved extracellular domain of the h5n1 influenza m2 protein sequence was able to induce high levels of m2especific igg, igg1, igg2a providing strong cross-protection from a lethal challenge with 3ld 50 or 10 ld 50 of h5n1 viruses of different clades (clade 1: vn/1194, or clade 2.3.4: sz/406h [28] . in this study, we further demonstrated the adjuvanticity of rov-asp-1 in sequential vaccines in mice and also confirmed its ability to be a potent innate adjuvant in nhps. the rov-asp-1 adjuvant enhances humoral and cellular responses after immunization with rrbd of sars-cov in mice to evaluate the adjuvant activity of rov-asp-1, mice were immunized with sars-cov rrbd in the presence or absence of rov-asp-1 or with alum or cpg for comparison. we previously reported that rov-asp-1 could effectively induce a mixed, but th1-skewed immune response against rs and rrbd in immunized mice [27] . as shown in figure 1 , the titers of rbd-specific igg, igg1, igg2a and igg2b antibodies increase after the first or second boost immunization in the sera of mice immunized with rrbd plus rov-asp-1, which were all significantly higher than in mice immunized with rrbd alone. the igg and igg2a responses in mice vaccinated with rrbd in the presence of alum were significantly higher only after the second boost; only the igg1 response was significantly higher after the first boost. the anti-rrbd igg response was significantly higher in the presence of cpg only after the second boost when compared to mice vaccinated only with rrbd (1:102,400 vs. 1:11,314) . notably, the rov-asp-1 augmented igg antibody response to rrbd was almost 4 times higher than the alum vaccination group (64,000 vs. 16,000) and 5.7 times higher than the cpg vaccination group (64,000 vs. 11,200) already after the first boost. further comparison of the rov-asp-1 and the alum induced rrbd antibody responses after the second boost revealed similar levels of igg1 (1,884,544 vs. 1,722,156); two-fold higher level of igg2a (935,763 vs. 512,000) as well as ten times higher level of igg2b (430,538 vs. 45,255) endpoint titers in the rov-asp-1 vaccine group. comparison of the rov-asp-1 and the cpg induced rrbd antibody responses after the second boost revealed a 27 fold increase in igg1 (1,884,544 vs. 68,000), 14.6 fold increase in igg2a (935,763 vs. 64,000), and 215 fold increase in igg2b (430,538 vs. 2,000) endpoint titers. each adjuvant/rrbd model performed differently depending on the adjuvant, e.g., a skewed th2 response with alum (igg1/igg2a = 3.3), but a mixed th1/ th2 response with cpg (igg2a/igg1 = 0.94) and rov-asp-1(igg2a/igg1 = 2), with a predominance of th1-associated antibodies (when both igg2a and igg2b are taken into account) with rov-asp-1. these results further supported our previous studies showing that rov-asp-1 can induce a more balanced antibody response with some bias towards a skewed th1associated antibody response than other adjuvants used with the same bystander antigen such as alum or cpg (this study) or the mlp plus tdm adjuvant [14, 27, 29] . to further evaluate whether the induced igg antibodies could neutralize infection of sars-cov in vitro (fig. 2) , we tested the antisera from the 10-day post-second boost immunization and found that mice immunized with rrbd in the presence of rov-asp-1 contained a very high titer of neutralizing antibodies against infection by sars-cov pseudovirus (nt 50 = 1:76,592), which was not significantly different than in neutralizing antibodies found in sera from mice immunized with rrbd plus the alum adjuvant (nt 50 = 1:64,666). the subclass of immunoglobulin induced after immunization is an indirect measure of the relative contribution of th1-type cytokines vs.th2-type cytokines. in this study, the data from the cba analyses showed that the levels of th1-and th2-type cytokine secretion were significantly higher in mice immunized with rrbd+rov-asp-1 or alum than in those who were immunized with rrbd alone ( table 1 ). the rov-asp-1 induced the production of type i proinflammatory cytokines (il-2, ifn-c, tnf-a, il-17a and il-6) to the same extent as alum, as well as the th2/regulatory cytokines il-6 and il-10. there was no significant recall induction of the th2 il-4 or il-5 cytokines by rrbd (data not shown). notably, the responses to rrbd when formulated with cpg are in comparison more ifn-c and il-17a dominant with diminished il-2, tnf-a, il-10 and il-6 responses. we found that the variation between individual mice was very low [31, 32] , and therefore we are confident that the results obtained using the pooled spleens are a good representation of what would have been the outcome if we had used individual mice. distinct from the previous studies are the responses to two rbd-specific peptides; n50 (cd8 + t cell epitope) and n60 (cd4 + t cell epitope) (table 1) . interestingly, the cytokine levels in the culture supernatants of the murine splenocytes when stimulated with either n50 or n60 were similar to those produced by stimulation with the full length rrbd in mice vaccinated with rrbd+rov-asp-1, thus further confirming the ability of rov-asp-1 to elicit rbd-specific cd8 + and cd4 + cellular responses in the tested vaccine formulation. naïve balb/c mice or mice ten weeks after immunization with rrbd in the presence of rov-asp-1 were immunized with has of influenza viruses in the absence or presence of yeast expressed rov-asp-1 (100 mg/mice). the mice that were previously immunized with rrbd in the presence of rov-asp-1 had endpoint total anti-rov-asp-1 antibody titers of 1:256,000-1:512,000 at the time of the priming with the second vaccine. as shown in table 2 , similar igg1 and igg2a humoral immune responses against the influenza viruses were induced in the mice vaccinated previously with rrbd plus rov-asp-1 adjuvant and those administered with pbs only. moreover, the igg2b was higher in the group that got the sequential vaccine (162,000 vs. 54,000). the anti-ha igg1 and igg2b antibody responses were much higher in mice that were immunized with the has vaccine in the presence of rov-asp-1 adjuvant than those immunized in the absence of rov-asp-1 adjuvant (igg1: 1,458,000 vs. 607,000 or 729,000; igg2b: 243,000 vs. 162,000 or 54,000). all levels of igg isotype responses in mice when the flu vaccine was formulated with rov-asp-1 were statistically higher than when mice were immunized with no adjuvant (p.0.05; fig. 3 ). there was no significant difference in the igg1 and igg2a responses if the flu vaccine was given to naïve mice or to mice that were previously immunized with another vaccine; rrbd of sars-cov+rov-asp-1. the adjuvanticity of rov-asp-1 was evaluated in a rhesus macaque immunization model using rrbd as the target antigen of table 2 . titers of anti-ha antibody response in rrbd+ rov-asp-1 vaccinated mice and naïve mice after vaccination with an influenza vaccine or an influenza vaccine in combination with rov-asp-1. the sars-cov vaccine. as shown in table 3 , all of the nhps vaccinated with rrbd protein plus 50 mg (n = 2), 100 mg rov-asp-1 (n = 2) or 500 mg cpg (n = 1) as the adjuvant developed rbdspecific igg antibody response with increasing antibody level after each boost. rbd-specific antibodies were not detected in the preimmune sera of the vaccinated rhesus macaques or the rhesus macaques injected with rbd+pbs control (n = 1). immunization with rrbd plus an optimized quantity of the cpg (500 mg) as the adjuvant as used in other vaccine studies [33, 34] was the most effective for the induction of rbd-specific antibodies, with endpoint igg titer of 102,400 after third boost. although this was a limited pilot experiment using only two concentrations of the e. coli expressed rov-asp-1 adjuvant for the formulation (50 mg, 100 mg), which was two or four times the amount used in our mouse model experiments (25 mg), we clearly show that immunization with 50 or 100 mg of the rov-asp-1 adjuvant exhibited a dose-dependent efficacy in the induction of rbd-specific antibodies in the two macaques per group; endpoint igg titers of 3,200 (50 mg ) or 6,400 (100 mg). notably, the anti-rov-asp-1 antibody response titers to the adjuvant itself were lower in the nhps than we might have expected based on the data in mice; the range in all the 4 immunized macaque monkeys was: 1:100-1:800 after first boost, 1:800-1:1,600 after second boost and 1:200-1;1600 after the third boost. although the anti-rbd endpoint tiers were much higher in the nhp that was immunized with cpg, the differences in the nt 50 titers were less prominent. sera from all rhesus macaques vaccinated with the rrbd+adjuvant formulation effectively neutralized the infection of sars pseudovirus in 293t cells expressing the receptor ace2 (ace2/293t) with nt 50 values of 1:3,500-1:6,392. as shown in figure 4 , sera from macaques immunized with rrbd protein plus 100 mg rov-asp-1 induced a slightly higher titer of neutralizing antibody than the 50 mg rov-asp-1 group; 4,167/5,376 vs. 3,724/3,509. the macaques that were immunized with cpg had a higher nt 50 titer at 1:6,392. in an in vitro study, as described above, we showed that mice immunized with rrbd+rov-asp-1 had a strong cytokine production ex vivo when stimulated with rrbd protein or rbd-specific peptides n50 and n60. notably, only a significant tnf-a response was obtained in nhps that were immunized with rrbd in the presence of rov-asp-1 or cpg ex vivo when pbmcs were stimulated with 5 mg/ml of rrbd ( table 4 ). the cytokine response was similar regardless of the amount of rov-asp-1 used as the adjuvant. all other secreted cytokines, such as ifn-c, il-2, il-4, il-5 and il-6 were negligible. vaccines remain the most effective means of preventing or eradicating infectious diseases, and there are ongoing efforts to apply active immunization approaches to prevent and treat table 3 . rbd-specific igg responses in nhps immunized with rrbd in the presence of rov-asp-1 or cpg adjuvant. table 4 . tnf-a response in immunized nhps. autoimmune diseases and cancer [35, 36] . adjuvants potentiate antigen-specific immune responses and can be a key element of vaccine effectiveness [1, 37, 38] . adjuvants can be broadly separated into two classes based on their principal mechanism of action: vaccine delivery systems and immunostimulation. vaccine delivery systems are generally particulate and function mainly to target associated antigens into apcs, e.g., emulsions, microparticles, iscoms, and liposomes [6, 39] . immunostimulatory adjuvants contain residues that are recognized by receptors on apcs, such as tlrs, which play an important role in the innate recognition of pathogens by dcs, and thus directly activate innate immune responses. these adjuvants are now regarded as the most effective means by which an adjuvant-antigen complex can target apcs [40] . adjuvants targeting multiple innate immune receptors may prove to be the most effective adjuvants, as they may induce different arms of the immune responses in the host. a number of microbial products, including bacterial lps, peptidoglycan, dsrna, muramyl peptides, cpg, flagellin and microbial proteins, were shown to act as vaccine adjuvants [41] [42] [43] [44] [45] . some of these immunomodulators could skew acquired immune responses towards a th1-type immune response. adjuvants can also be classified according to their capacity to stimulate either innate or adaptive immunity based on significant differences in their cellular receptors and mechanisms of action [46] . as previously noted, alum is the only adjuvant licensed in the u.s. for general use in humans. yet, alum is not effective in stimulating th1 and/or cytotoxic t cell responses to a number of pathogens and is therefore limited in its applications, in particular for new-generation vaccines [47] . some of the adjuvants being developed in clinical testing include mpl, the saponin derivative qs-21, cpg, flagellin, and combinations of some of these adjuvants [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] . one of the major concerns regarding the use of immunostimulatory adjuvants in humans is the possible increased risk of autoimmune diseases due to targeting pattern recognition receptors by such adjuvants. however, the recombinant ov-asp-1 adjuvant we studied corresponds to a secreted filarial protein, which is presented as an antigen in the o. volvulus exposed or infected individuals in africa. there is no evidence to show that this secreted filarial protein could induce autoimmune disease in the infected patients, thus excluding such a concern. polarized th1-type immunity can be achieved by the addition of complete freund's adjuvant and cpg dna to an antigen [52] [53] [54] . on the other hand, th2 antibody responses can be induced by the alum or incomplete freund's adjuvant, as indicated by increased igg1 relative to igg2a [53] [54] [55] . however, in situations where both th1 and th2 responses are required for protection, the choice of one regimen over another might be counter effective. this has led to additional research for alternative adjuvants or adjuvant combinations that promote balanced mixed th1/th2 responses. the present study clearly demonstrated that rov-asp-1 could effectively induce mixed rbd-or ha-specific th1/th2 antibody associated responses, when used as an adjuvant with recombinant subunit vaccine or as an addition to a commercial flu vaccine (fluvirin; using 20% of the dose recommended for human use). since the rov-asp-1 adjuvant is a protein, it is potentially processed and presented to the immune system and subsequently induces antibodies against self. therefore, concerns might be raised whether preexisting anti-rov-asp-1 antibodies may suppress its adjuvanticity when it is used in subsequent vaccine formulations. previously we demonstrated that antibody response to the adjuvant itself did not hindered the development of ova, rs or rrbd antigen-specific antibody responses after each boost; in all cases the responses in the presence of rov-asp-1 were more elevated than those in the presence of mpl+tmp or alum adjuvants. our present results further confirmed that antibodies induced against the adjuvant had no impact on its ability to induce immune responses against bystander antigens when used as an adjuvant in a sequential vaccine when two vaccine model systems were used: the rbd of sars-cov spike protein and a commercial influenza virus ha vaccine comprised of three virus strains. even though a high level of anti-rov-asp-1 antibodies (1:256,000-1:512,000) was present in the sera of mice before the administration of the second vaccine, the adjuvanticity of rov-asp-1 was retained with efficacy similar to that obtained when it was used as an adjuvant in a first vaccine immunization of naïve mice (table 2 and figure 3) ; no difference in the igg titers was observed between the two vaccine groups, mice pre-immunized with rrbd+rov-asp-1 or pbs. thus, we confirmed that the preexisting anti-rov-asp-1 antibodies induced by a previously administrated rov-asp-1-based vaccine do not have a significant effect on the adjuvanticity of rov-asp-1 when formulated in a subsequent vaccine. notably, immunization of nhps with rov-asp-1 did not induce high titers of anti-self-antibodies, for reasons that are not yet clear. future studies will be needed to further validate that even these reasonably low antibody responses to the adjuvant have no impact on subsequent use of this adjuvant with other vaccines also in nhps. the pilot immunogenicity studies in the nhps have provided us with extremely valuable ''proof of principal'' information in an outbred primate model. firstly, no adverse reactions were observed at the site of the immunizations, indicating the safety of rov-asp-1 as an adjuvant. secondly, using two concentration of the rov-asp-1 adjuvant, 50 or 100 mg, and rrbd as the vaccine antigen, we were able to induce after three immunizations high titers of neutralizing antibodies (1:3,500-1:6,392) that much exceed what is needed for protection against sars-cov infection in vivo (.1:500) [56] . moreover, our studies have shown that rov-asp-1 was able to support the induction of functional antibodies against a pathogen in nhps, thus clearing the way for its future development for human vaccines as well. thus, this pilot nhp study is a definitive step for demonstrating relevance of rov-asp-1 for human vaccine formulations, even though more studies will be needed to find the optimized amount of the adjuvant in vaccine formulations, which will specify the putative starting adjuvant dose for future clinical trials of rov-asp-1-based vaccines. interestingly, we did not see augmented recall rbd specific cellular responses except tnf-á. therefore, future studies will be needed to validate the adjuvanticity of rov-asp-1 in primates from the point of its ability to augment the desired types of cellular responses are associated with protective immunity against possibly other pathogens, duration of immunity and the potential to establish t cell memory. in summary, the present studies have advanced our confidence that the rov-asp-1 protein adjuvant can be further developed for human use, particularly when strong functional balanced antibody responses are needed against the pathogens. importantly, the rov-asp-1 that was used to immunize mice previously immunized with rbd+rov-asp-1 or the naïve mice with the ha vaccine was expressed in the yeast. having a functional yeast expressed adjuvant will support future development of a scalable process for the downstream manufacture of rov-asp-1, including the development of a series of critical biochemical and biophysical assays for in-process, release and stability testing, which will result in a high-yield reproducible production process and a stable product that is highly potent and stimulates the desired antibody and cellular responses to co-administered vaccine antigens in nhps for further analyses and for future clinical trials in humans. animal protocols were approved by the institutional animal care and use committee at the new york blood center (mice, protocols #255 and #194) and the tulane national primate research center (nhps, protocol #p0052). the tulane national primate research center tnprc is a usda-inspected and association for assessment and accreditation of laboratory animal care international (aaalac)-approved facility, and has an animal welfare assurance on file with the office of laboratory animal welfare. all animal studies were carried out in strict accordance with the recommendations of the american veterinary medical association (avma) guidelines and the approved protocols. the animals were handled delicately. any treatment was done with extreme care and professionalism to avoid any unnecessary discomfort for the animals. forty-two female balb/c mice aged 4-6 weeks and six purpose-bred adult male indian-origin rhesus macaques aged 6-10 years were used in this study. animal housing and environmental conditions met all applicable standards. blood was collected retro-orbitally for mice and from the femoral vein using the sarstedt s-monovette system for nhps. the animals were anesthetized using ketamine (0.1 ml/kg im), which ameliorate any suffering of the animals during the blood draw or immunization. the nhp protocol also included a full cbc and chem20 profile, which were taken at each blood drawing, with results falling within normal levels. their body weight was frequently monitored and physical examinations were performed regularly by the attending veterinarian. the rov-asp-1 protein was expressed as a histidine-tagged protein in escherichia coli and purified as previously described [27] . the purified rov-asp-1 was tested negative in a limulus amoebocyte lysate assay. a quantitative lps testing by cambrex bioscience showed that purified rov-asp-1 contained ,0.25 endotoxin units per milligram of the protein (25 pg endotoxin/ mg), and we considered it as an lps-free stock. in addition, we expressed rov-asp-1 in yeast. yeast codon optimized ov-asp-1 cdna sequence (af020586) without the region encoding the n-terminal signal peptide was cloned into the pichia expression vector ppiczaa (invitrogen) using the ecori and xbai restriction sites. the recombinant plasmid was linearized with saci digestion and transformed into pichia pastoris x33 strain as described previously [57] . the positive transformants were screened on zeocin-resistant ypd plates, and the highest expression clone was selected by scale up culturing. the expression of rov-asp-1 with 66his and c-myc tag at c-terminus was induced with 0.5% methanol and scaled up in 10 liters fermentation as described previously [58] . the rov-asp-1 was purified from the fermentation culture with sp sepharose fast flow exchange chromatography as described previously [58] . briefly, the fermentation supernatant was filtered through a 0.22 mm membrane and the ph was adjusted to 4.8 by adding glacial acetic acid. the positively charged rov-asp-1 was captured onto cation sp sepharose ff column and eluted with 50 mm sodium acetate, ph 4.8 containing 200 mm nacl. the eluted rov-asp-1 pool was then purified and buffer exchanged using gel filtration chromatography (sephadex g-25 fine) into pbs, ph 7.2 [28, 57] . the product was tested for its adjuvanticity in mice using ova as the model antigen as previously described [27] and it was established that 100 mg yeast-expressed rov-asp-1 per mouse was as effective as 25 mg per mice of the e. coli expressed rov-asp-1; both eliciting after two immunizations end point anti-ova igg titers of 1:25,600 (data not shown). thus, the e. coli or the yeast expressed rov-asp-1 at their optimal quantities can be used intermittently with assurance. mice were vaccinated subcutaneously with rrbd protein purified from culture supernatant of transfected human embryonic kidney cell-line 293t (hek293t) (atcc, va) according to the previously described protocol [31, 59, 60] using 20 mg/mouse of the protein mixed in aqueous solution with the e. coli-expressed optimized quantity of rov-asp-1 (25 mg/mouse) in 200 ml. as adjuvant controls we immunized mice with rrbd mixed with imject alum (40 mg/ml aluminum hydroxide+40 mg/ml magnesium hydroxide, thermo scientific) diluted 1:1 with the vaccine antigen in a total volume of 200 ml per mouse or with rrbd mixed with 50 mg cpg-odn1826 (invivogen, san diego ca) in a total volume of 200 ml per mouse. mice immunized with rrbd in pbs were used as the negative control. the mice were boosted twice 3 weeks apart with 10 mg/mouse of rrbd protein in pbs, rov-asp-1, imject alum or cpg. all mice were bled retro-orbitally under anaesthesia prior to immunizations and 10 days post injections. sera were stored at 280uc. to test the adjuvanticity of rov-asp-1 in a sequential vaccine model, we immunized intramuscularly naïve mice or mice that were previously immunized with the rrbd+rov-asp-1 with a commercial flu vaccine (100 ml/mouse) containing 3 mg (fluvirin, novartis) . the immunization was done in the presence or absence of the yeastexpressed optimized quantity of rov-asp-1 (100 mg/mouse). the mice were boosted once with the same dose of vaccines three weeks later. all mice were bled prior to immunization and 7 days post immunization as described above and sera were stored at 280uc. rhesus macaques were vaccinated subcutaneously with rrbd protein (50 mg) with either 50 mg (n = 2) or 100 mg (n = 2) of e. coliexpressed rov-asp-1, cpg-c-iss-odn c274 (500 mg; n = 1) (donated by dynavax technologies corporation, berkeley, ca) or pbs (n = 1). they were boosted with the same dose at 1-, 2-and 6month intervals. the macaques were bled before immunization and 7 days post-immunization. sera were collected for serological testing, and pbmcs were purified for in vitro assays. a baseline bleed was also provided. elisa was used to detect specific antibody responses induced in the vaccinated mouse or nhp. briefly, 96-well micro titer plates (costar) were coated with rrbd (1 mg/ml), rov-asp-1 (1 mg/ml) or has (2.5 mg/ml) at 4uc overnight. the plates were blocked with 2% non-fat milk in pbs-tween (0.05%) for 2 h at 37uc. after washing the plates six times with pbs-t, serial diluted sera in binding buffer (1% non-fat milk in pbs-t) were added into each well in duplicate and incubated for 1 h at 37uc. bound antibodies were detected with hrp-conjugated goat anti-mouse igg, igg1, igg2a or igg2b (molecular probes-invitrogen) (1:2000 dilution) or mouse anti-monkey igg-hrp (clone sb108a, southern biotech) (diluted 1:1000) in binding buffer. after incubation for 1 h at 37uc, plates were washed and tmb substrate (kpl) was added, and the reaction was stopped by the addition of 2 n h 2 so 4 . absorbance at 450 nm was measured using spectramax 190 (molecular devices, sunnyvale, ca). end point titers were defined as the highest dilutions giving an a 450 measurement of 0.1. this cutoff value represents the value of mean optical density (od) plus 2 standard deviations (sd) of 10 normal mouse serum samples tested at 1:100 dilutions or the 6 pre-bleeds from the normal nhp serum samples also tested at 1:100 dilutions. the neutralization assay against sars pseudovirus infection was performed as previously described [61] . in brief, plasmid dna encoding sars-cov spike protein and a plasmid dna encoding env-defective, luciferase-expressing hiv-1 genome (pnl4-3.luc.re) were co-transfected into hek293t cells (attc, ga). culture supernatant containing sars pseudovirus was collected at 72 h and used for single-cycle infection in vitro. the sars pseudovirus was incubated in the presence or absence of serially diluted antisera from vaccinated mice or nhps for 1 h at 37uc. subsequently, the antisera-virus mixtures were added to 293t cells expressing the sars receptor angiotensin-converting enzyme 2 (293t/ace2) in 96-well plates, and the infection was allowed to proceed for 48 h, followed by lysing the infected cells using cell lysis buffer included in the luciferase kit (promega). aliquots of cell lysates were transferred to 96-well costar flatbottom luminometer plates (corning costar), followed by addition of luciferase substrate (promega). relative light units were determined immediately in the ultra 384 luminometer (tecan). the neutralization of sars pseudovirus is presented as 50% neutralizing antibody titer (nt 50 ) [60] . th1/th2/th17 cytokine assay was used to estimate the corresponding cytokine production ex vivo from splenocytes of the vaccinated mice. briefly, splenocytes were harvested from the immunized mice and resuspended in rpmi 1640 medium (invitrogen, carlsbad, ca) supplemented with 10% fbs (hyclone laboratories, inc.), 2 mm l-glutamine, 10 mm hepes, and antibiotic-antimycotic (invitrogen, carlsbad, ca). the cells were plated at 4610 5 cells into 96-well u-bottom culture plates for in vitro stimulation with 5.0 mg of rrbd, or with the sars-cov rbd-specific n50 (cd8 + t cell epitope) or n60 (cd4 + t cell epitope) peptide [31] ; a concentration that was pre-determined to be optimal. cells were stimulated with or without pma (10 ng/ml) plus ionomycin (1 mg/ml) as the positive and negative controls, respectively. the plates were incubated at 37uc for 72 h, and the secreted cytokines were quantified from the culture supernatants using the mouse th1/th2/th17 bd cytometric bead array kit (bd biosciences) according to the manufacture's protocols. theoretical limit of detection data is il-2 = 0.1 pg/ml; il-4 = 0.03 pg/ml; il-6 = 1.4 pg/ml; il-10 = 16.8 pg/ml; tnfa = 0.9 pg/ml, inf-c = 0.5 pg/ml; and il-17a = 0.8 pg/ml. detection of the th1/th2 cytokine production in the vaccinated nhps was done using similar protocol as above with some modifications. pbmcs were isolated following a ficoll-hypaque density gradient (sigma). single-cell suspensions were then stimulated at 4610 5 cells with 5 mg of rrbd, n50 or n60 peptides, or pma (10 ng/ml) plus ionomycin (1 mg/ml) for positive control and culture media alone for negative control. the cells were stimulated for 5 days, and cytokines were quantified using the non-human primate th1/th2 bd cytometric bead array kit (bd biosciences) according to the manufacture's protocols. results are expressed as mean 6 sem. the data were analyzed using graphpad version 5.01 for windows (graphpad software). unpaired two-tailed student's t test or mann-whitney test was used to compare means between different groups. one-way anova with bonferroni post-test was considered appropriate for multiple comparisons. p value less than 0.05 was considered significant. alum's adjuvant action: grease is the word alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity immunological mechanisms of vaccination vaccine adjuvants: putting innate immunity to work adjuvants for the future recent advances in vaccine adjuvants rationally-designed vaccine adjuvants: separating efficacy from toxicity enhancing oral vaccine potency by targeting intestinal m cells diversity and dialogue in immunity to helminths immune regulation by helminth parasites: cellular and molecular mechanisms t helper type-2 cytokine responses: potential therapeutic targets helminth antigens modulate tlr-initiated dendritic cell activation tlr11 activation of dendritic cells by a protozoan profilin-like protein rov-asp-1, a recombinant secreted protein of the helminth onchocerca volvulus, is a potent adjuvant for inducing antibodies to ovalbumin, hiv-1 polypeptide and sars-cov peptide antigens immune evasion genes from filarial nematodes helminth parasites-masters of regulation a novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein es-62 es-62, a filarial nematode-derived immunomodulator with anti-inflammatory potential modulation of a heterologous immune response by the products of ascaris suum taenia crassiceps carbohydrates stimulate il-6 expression in naive murine macrophages via toll-like receptors (tlrs) a novel host-parasite lipid cross-talk. schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization proteins secreted by the parasitic nematode nippostrongylus brasiliensis act as adjuvants for th2 responses selective maturation of dendritic cells by nippostrongylus brasiliensis-secreted proteins drives th2 immune responses lacto-n-fucopentaose iii found on schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing th2-type response maturation of dendritic cell 2 phenotype by a helminth glycan uses a toll-like receptor 4-dependent mechanism a novel synthetic adjuvant effectively enhances the immunogenicity of the influenza vaccine recombinant ov-asp-1, a th1-biased protein adjuvant derived from the helminth onchocerca volvulus, can directly bind and activate antigen-presenting cells induction of protection against divergent h5n1 influenza viruses using a recombinant fusion protein linking influenza m2e to onchocerca volvulus activation associated protein-1 (asp-1) adjuvant evaluation of recombinant onchocerca volvulus activation associated protein-1 (asp-1) as a potent th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines a novel, helminth-derived immunostimulant enhances human recall responses to hepatitis c virus and tetanus toxoid and is dependent on cd56+ cells for its action priming with raav encoding rbd of sars-cov s protein and boosting with rbd-specific peptides for t cell epitopes elevated humoral and cellular immune responses against sars-cov infection intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (sars-cov) spike protein induces strong mucosal immune responses and provides long-term protection against sars-cov infection local and systemic effects of intranodally injected cpg-c immunostimulatoryoligodeoxyribonucleotides in macaques cpg-c iss-odn activation of blood-derived b cells from healthy and chronic immunodeficiency virus-infected macaques anticytokine vaccination in autoimmune diseases cancer vaccines. any future? trends in vaccine adjuvants recent developments in cancer vaccines adjuvants-a classification and review of their modes of action dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors adjuvant activities of immune response modifier r-848: comparison with cpg odn targeting the innate immune response with improved vaccine adjuvants vaccination with recombinant fusion proteins incorporating toll-like receptor ligands induces rapid cellular and humoral immunity a west nile virus recombinant protein vaccine that coactivates innate and adaptive immunity the science of adjuvants vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity aluminium adjuvants-in retrospect and prospect immunisation of metastatic cancer patients with mage-3 protein combined with adjuvant sbas-2: a clinical report potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza m2e to the tlr5 ligand flagellin effect of monophosphoryl lipid a (mpl) on t-helper cells when administered as an adjuvant with pneumocococcal-crm197 conjugate vaccine in healthy toddlers three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant qs-21 cpg dna is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis b surface antigen adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response induction of skewed th1/th2 t-cell differentiation via subcutaneous immunization with freund's adjuvant adjuvant-dependent modulation of th1 and th2 responses to immunization with beta-amyloid receptor-binding domain of sars-cov spike protein induces long-term protective immunity in an animal model biochemical characterization and vaccine potential of a heme-binding glutathione transferase from the adult hookworm ancylostoma caninum expression of the necator americanus hookworm larval antigen na-asp-2 in pichia pastoris and purification of the recombinant protein for use in human clinical trials recombinant receptorbinding domain of sars-cov spike protein expressed in mammalian, insect and e. coli cells elicits potent neutralizing antibody and protective immunity protocol for recombinant rbd-based sars vaccines: protein preparation, animal vaccination and neutralization detection a 219-mer cho-expressing receptor-binding domain of sars-cov s protein induces potent immune responses and protective immunity we would like to thank dynavax technologies corporation for donating the cpg-c iss-odn c274 used in the nhp experiment. key: cord-264408-vk4lt83x authors: ruiz, sara i.; zumbrun, elizabeth e.; nalca, aysegul title: animal models of human viral diseases date: 2017-06-23 journal: animal models for the study of human disease doi: 10.1016/b978-0-12-809468-6.00033-4 sha: doc_id: 264408 cord_uid: vk4lt83x as the threat of exposure to emerging and reemerging viruses within a naïve population increases, it is vital that the basic mechanisms of pathogenesis and immune response be thoroughly investigated. recent outbreaks of middle east respiratory syndrome corona virus, ebola virus, chikungunya virus, and zika virus illustrate the emerging threats that are encountered. by utilizing animal models in this endeavor, the host response to viruses can be studied in a more complex and integrated context to identify novel drug targets, and assess the efficacy and safety of new products rapidly. this is especially true in the advent and implementation of the fda animal rule. although no one animal model is able to recapitulate all aspects of human disease, understanding the current limitations allows for a more targeted experimental design. important facets to consider prior to an animal study are route of viral exposure, species of animal, biomarkers of disease, and a humane endpoint. this chapter covers the current animal models for medically important human viruses, and demonstrates where the gaps in knowledge exist. well-developed animal models are necessary to understand disease progression, pathogenesis, and immunologic responses to viral infections in humans. furthermore, to test vaccines and medical countermeasures, animal models are essential for preclinical studies. ideally, an animal model of human viral infection should mimic the host-pathogen interactions and the disease progression that is seen in the natural disease course. a good animal model of viral infection should allow assay of many parameters of infection, including clinical signs, growth of virus, clinicopathological parameters, cellular and humoral immune responses, and virus-host interactions. furthermore, viral replication should be accompanied by measurable clinical manifestations and pathology should resemble that of human cases such that a better understanding of the disease process in humans is attained. there is often more than one animal model that closely represents human disease for a given pathogen. small animal models are typically used for first-line screening, and for testing the efficacy of vaccines or therapeutics. in contrast, nonhuman primate (nhp) models are often used for pivotal preclinical studies. this approach is also used for basic pathogenesis studies, with most studies in small animal models when possible, and studies in nhps to fill in the remaining gaps in knowledge. the advantages of using mice to develop animal models are low cost, low genetic variability in inbred strains, and abundant molecular biological and immunological reagents. specific pathogen free (spf), transgenic and knockout mice are also available. a major pitfall of mouse models is that the pathogenesis and protection afforded by vaccines and therapeutics cannot always be extrapolated to humans. additionally, blood volumes for sampling are limited in small animals, and viruses often need to be adapted through serial passage in the species to induce a productive infection. the ferret's airways are anatomically and histologically similar to that of humans, and their size enables collection of larger or more frequent blood samples, making them an ideal model for certain respiratory pathogens. ferrets are outbred, with no standardized breeds or strains, thus greater numbers are required in studies to achieve statistical significance and overcome the resulting variable responses. additionally, spf and transgenic ferrets are not available, and molecular biological reagents are lacking. other caveats making ferret models more difficult to work with are their requirement for more space than mice (rabbit-style cages), and the development of aggressive behavior with repeated procedures. nhps are genetically, the closest species to humans, thus disease progression and host-pathogen responses to viral infections are often the most similar to that of humans. however, ethical concerns pertaining to experimentation on nhps along with the high cost and lack of spf nhps raise barriers for such studies. nhp studies should be carefully designed to ensure the fewest number of animals are used, and the studies should address the most critical questions regarding disease pathogenesis, host-pathogen responses, and protective efficacy of vaccines and therapeutics. well-designed experiments should carefully evaluate the choice of animal, including the strain, sex, and age. furthermore, depending on the pathogen, the route of exposure and the dose should mimic the route of exposure and dose of human disease. the endpoint for these studies is also an important criterion. depending on the desired outcome, the model system should emulate the host responses in humans when infected with the same pathogen. in summary, small animal models are helpful for the initial screening of vaccines and therapeutics, and are often beneficial in obtaining a basic understanding of the disease. nhp models should be used for a more detailed characterization of pathogenesis and for pivotal preclinical testing studies. ultimately, an ideal animal model may not be available. in this case, a combination of different well-characterized animal models should be considered to understand the disease progression and to test medical countermeasures against the disease. in this chapter, we will be reviewing the animal models for representative members of numerous virus families causing human diseases. we will focus on viruses for each family that are of the greatest concern for public health worldwide. norovirus, the genus of which norwalk is the prototypic member, is the most common cause of gastroenteritis in the united states (hall et al., 2013) . there are five distinct genogroups (gi-gv) and numerous strains of norwalk virus, including the particularly significant human pathogens gi.1 norwalk virus, gii.2 snow mountain virus, and gii.1 hawaii virus. in developing countries, norwalk virus, also known as "winter vomiting virus," is responsible for approximately 200,000 deaths annually (patel et al., 2008) . a typical disease course is self-limiting, but there have been incidences of necrotizing enterocolitis and seizures in infants (chen et al., 2009; lutgehetmann et al., 2012; turcios-ruiz et al., 2008) . symptoms of infection include diarrhea, vomiting, nausea, abdominal cramping, dehydration, and fever. incubation is normally 1-3 days, with symptoms persisting for 2-3 days (koopmans and duizer, 2004) . viral shedding can range from 6 to 55 days in healthy individuals (atmar et al., 2014) . however, longer illness duration can be indicative of immunocompromised status, with the elderly and young having a prolonged state of shedding (harris et al., 2008; rockx et al., 2002) . interestingly, individuals vary greatly in susceptibility to norovirus infection depending on their fucosyl transferase 2 (fut2) allele functionality and histoblood group antigen status, with type a and o individuals susceptible and types ab and b resistant (hutson et al., 2005) . transmission occurs predominately through the oralfecal route with contaminated food and water being a major vector (atmar and estes, 2001; becker et al., 2000; koopmans and duizer, 2004) . vomiting results in airborne dissemination of the virus with areas of 7.8 m 2 being contaminated and subsequent transmission from oral deposition of airborne particles or contact with contaminated fomites, which can remain contaminated for up to 42 days (makison booth, 2014; tung-thompson et al., 2015) . each vomiting event in a classroom setting elevates the risk of norovirus illness among elementary students with proximity correlating with attack rates (evans et al., 2002; marks et al., 2003) . viral titers in emesis and fecal suspensions are as high as 1.2 × 10 7 and 1.6 × 10 11 ges (genomic equivalent copies per milliliter), respectively and the 50% infectious dose is 1320 ges (atmar et al., 2014) . therefore, outbreaks can be extremely difficult to contain. therapeutic intervention consists of rehydration therapy and antiemetic medication (bucardo et al., 2008; moe et al., 2001) . no approved vaccine or therapeutic is available, and development has been challenging given that immunity is short-lived after infection, new strains rapidly evolve and the correlates of protection are not completely understood (chen et al., 2013) . however, one promising strategy utilized a virus-like particle (vlp)-based vaccine that protected or reduced infection by almost 50% in human volunteers (aliabadi et al., 2015; atmar et al., 2011) . given the relatively benign disease in adults, experimental challenge has been carried out on human volunteers (ball et al., 1999; tacket et al., 2000) . viral titers are determined by shedding in feces and sera with histopathology changes monitored by biopsies particularly of the duodenum. the ph of emesis samples collected containing virus is consistent with viral replication in the small intestine with reflux to the stomach (kirby et al., 2016) . additionally, norwalk virus has been shown to bind to duodenal tissue (chan et al., 2011) . however, this type of research is technically difficult and expensive, and thus other models have been developed. a major hindrance to basic research into this pathogen is the lack of permissive cell culture systems or animal models for norwalk virus. nhps including marmosets, cotton-top tamarins, and rhesus macaques infected with norwalk virus are monitored for the extent of viral shedding; however, no clinical disease is observed in these models. disease progression and severity is measured exclusively by assay of viral shedding (rockx et al., 2005) . incidentally, more viruses were needed to create an infection when challenging by the oral route than by the intravenous (iv) route (purcell et al., 2002) . chimpanzees were exposed to a clinical isolate of norwalk virus by the iv route (bok et al., 2011) . although none of the animals developed disease symptoms, viral shedding within the feces was observed within 2-5 days postinfection and lasted anywhere from 17 days to 6 weeks. viremia never occurred and no histopathological changes were detected. the amount and duration of viral shedding was in-line with what is observed upon human infection. as such, chimeric chimpanzee-human antinorovirus neutralizing antibodies have been explored as a possible therapeutic strategy (chen et al., 2013) . a recently identified calicivirus of rhesus origin, named tulane virus, has been used as a surrogate model of infection. unlike norwalk virus, tulane virus can be cultured in cells. rhesus macaques exposed to tulane virus intragastrically developed diarrhea and fever 2 days postinfection. viral shedding was detected for 8 days. the immune system produced antibodies that dropped in concentration within 38 days postinfection, mirroring the short-lived immunity documented in humans. the intestine developed moderate blunting of the villi as seen in human disease (sestak et al., 2012) . a murine norovirus has been identified and is closely related to human norwalk virus (karst et al., 2003) . however, clinically the virus presents a different disease. the murine norovirus model does not include observable gastrointestinal clinical signs, possibly in part because rodents lack a vomiting reflex. additionally, mice infected with norovirus develop a persistent infection in contrast to human disease (hsu et al., 2006 (hsu et al., , 2007 khan et al., 2009) . porcine enteric caliciviruses can induce diarrheal disease in young pigs, and an asymptomatic infection in adults (wang et al., 2006 . gnotobiotic pigs can successfully be infected with a passaged clinical norovirus isolate by the oral route. diarrheal disease developed in 74% of the animals and virus was detected in the stool of 44% of the animals. no major histopathological changes or viral persistence was noted (cheetham et al., 2006) . calves are naturally infected with bovine noroviruses (scipioni et al., 2008) . experimental challenge of calves by oral inoculation with a bovine isolate resulted in diarrheal disease 14-16 h postinfection. recovery of virus was achieved after 53.5 and 67 h postinfection (otto et al., 2011) . eastern equine encephalitis virus (eeev), western equine encephalitis virus (weev), and venezuelan equine encephalitis virus (veev) present with near synonymous symptoms. the majorities of human cases are asymptomatic, but can present as a flu-like illness progressing to central nervous system (cns) involvement to include seizures and paralysis. mortality rates vary among the virus, with the highest reported for eev at 36%-75% followed by weev and lastly veev at less than 1% (ayers et al., 1994; griffin, 2007; steele and twenhafel, 2010) . there are currently no licensed vaccines or therapies but a recent phase 1 clinical trial of a veev dna vaccine resulted in veev-neutralizing antibody responses in 100% of the subjects (hannaman et al., 2016) . mouse models have been developed for numerous routes of infection including cutaneous, intranasal (in), intracranial (ic), and aerosol. eeev susceptibility in mouse models is correlated with age, with younger mice being more susceptible than adults. importantly, eeev pathogenesis is dependent on route of infection with delayed progression upon subcutaneous (subq) exposure (honnold et al., 2015) . newborn mice display neuronal damage with rapid disease progression, resulting in death (murphy and whitfield, 1970) . similarly, eeev produces fatal encephalitis in older mice when administered via the intracerebral route, while inoculation via the subq route causes a pantropic infection eventually resulting in encephalitis (liu et al., 1970; morgan, 1941) . a general drawback to the usage of the mouse model is the lack of vascular involvement during the disease course (liu et al., 1970) . after subq inoculation with weev, suckling mice started to show signs of disease by 24 h and died within 48 h (aguilar, 1970) . the heart was the only organ in which pathologic changes were observed. conversely, adult mice exhibited signs of lethargy and ruffled fur on day 4-5 postinfection. mice were severely ill by day 8 and appeared hunched and dehydrated. death occurred between days 7 and 14 with brain and mesodermal tissues, such as heart, lungs, liver, and kidney involvement (aguilar, 1970; monath et al., 1978) . intracerebral and in routes of infection resulted in a fatal disease that was highly dependent on dose while intradermal (id) and subq inoculations caused only 50% fatality in mice regardless of the amount of virus (liu et al., 1970) . comparing susceptibility of inbred and outbred strains revealed that cd-1, balb/c, a/j, and c57bl6 mice were all highly susceptible to experimental infection via subq inoculation when challenged prior to 10 weeks old with cns involvement and lethality (blakely et al., 2015) . subq/dermal infection in the mouse model results in encephalitic disease very similar to that seen in horses and humans (macdonald and johnston, 2000) . virus begins to replicate in the draining lymph nodes at 4 h postinoculation. eventually, virus enters the brain primarily via the olfactory system. furthermore, aerosol exposure of mice to veev can result in massive infection of the olfactory neuroepithelium, olfactory nerves, and olfactory bulbs and viral spread to brain, resulting in necrotizing panencephalitis (charles et al., 1995; steele et al., 1998) . aerosol and dermal inoculation routes cause neurological pathology in mice much faster than other routes of exposure. the clinical signs of disease in mice infected by aerosol are ruffled fur, lethargy, and hunching progressing to death (charles et al., 1995; steele and twenhafel, 2010; steele et al., 1998) . in challenge of c3h/hen mice with high dose veev caused high morbidity and mortality (julander et al., 2008b) . viral titers in brain peaked on day 4 postchallenge and remained elevated until animals succumbed on day 9-10 postchallenge. protein cytokine array performed on brains of infected mice showed elevated il-1a, il-1b, il-6, il-12, mcp-1, ifnγ, mip-1a, and rantes levels. this model was used successfully to test antivirals against veev (julander et al., 2008a) . additionally, a veev vaccine inactivated with 1,5-iodonaphthyl azide v3526 protects against both footpad and aerosol challenge with virulent veev in a mouse model (gupta et al., 2016) . guinea pigs and hamsters have also been developed as animal models for eeev studies (paessler et al., 2004; roy et al., 2009) . guinea pigs developed neurological involvement with decreased activity, tremors, circling behavior, and coma. neuronal necrosis was observed in brain lesions in the experimentally challenged animals (roy et al., 2009) . subq inoculation of eeev produced lethal biphasic disease in hamsters with severe lesions of nerve cells. the early visceral phase with viremia was followed by neuroinvasion, encephalitis, and death. in addition, parenchyma necrosis were observed in the liver and lymphoid organs (paessler et al., 2004) . harlan sprague-dawley hamsters develop viremia and progress to respiratory, gastrointestinal, and nervous system involvement when inoculated via subq route. vasculitis and encephalitis were both evident in this model, which mirrors the human disease clinical spectrum (paessler et al., 2004) . weev is highly infectious to guinea pigs and has been utilized for prophylactic screening (sidwell and smee, 2003) . studies demonstrated that although the length of the incubation period and the disease duration varied, weev infection resulted in mortality in hamsters by all routes of inoculation. progressive lack of coordination, shivering, rapid and noisy breathing, corneal opacity, and conjunctival discharge resulting in closing of the eyelids were indicative of disease in all cases (zlotnik et al., 1972) . cns involvement was evident with intracerebral, intraperitoneal (ip), and id inoculations (zlotnik et al., 1972) . ip inoculation of weev is fatal in guinea pigs regardless of amount of virus inoculum, with the animals exhibiting signs of illness on day 3-4, followed by death on day 5-9 (nalca, unpublished results) . id, im, or iv inoculations of eeev in nhps cause disease, but does not reliably result in neurological symptoms (dupuy and reed, 2012) . intracerebral infection of eeev produces nervous system disease and fatality in monkeys (nathanson et al., 1969) . the differences in these models indicate that the initial viremia and the secondary nervous system infection do not overlap in nhps when they are inoculated by the peripheral route (wyckoff, 1939) . in and intralingual inoculations of eeev also cause nervous system symptoms in monkeys, but are less drastic than intracerebral injections (wyckoff, 1939) . the aerosol route of delivery will result in uniformly lethal disease in cynomolgus macaques (reed et al., 2007) . in this model, fever was followed by elevated white blood cells and liver enzymes. neurological signs subsequently developed and nhps became moribund and were euthanized between 5-9 days postexposure. meningoencephalomyelitis was the main pathology observed in the brains of these animals (steele and twenhafel, 2010) . similar clinical signs and pathology were observed when common marmosets were infected with eeev by the in route (adams et al., 2008) . both aerosol and in nhp models had similar disease progression and pathology as seen in human disease. very limited studies have been performed with nhps. reed et al. exposed cynomolgus macaques to low and high doses of aerosolized weev. the animals subsequently developed fever, increased white blood counts, and cns involvement, demonstrating that the cynomolgus macaque model could be useful for testing of vaccines and therapeutics against weev (reed et al., 2005) . veev infection causes a typical biphasic febrile response in nhps. initial fever was observed at 12-72 h after infection and lasted less than 12 h. secondary fever generally began on day 5 and lasted 3-4 days (gleiser et al., 1961) . veev-infected nhps exhibited mild symptoms, such as anorexia, irritability, diarrhea, and tremors. leukopenia was common in animals exhibiting fever (monath et al., 1974) . supporting the leukopenia, microscopic changes in lymphatic tissues, such as early destruction of lymphocytes in lymph nodes and spleen, a mild lymphocytic infiltrate in the hepatic triads, and focal myocardial necrosis with lymphocytic infiltration have been observed in monkeys infected with veev. surprisingly, characteristic lesions of the cns were observed histopathologically in monkeys in spite of the lack of any clinical signs of infection (gleiser et al., 1961) . the primary lesions were lymphocytic perivascular cuffing and glial proliferation and generally observed at day 6 postinfection during the secondary febrile episode. similar to these observations, when cynomolgus macaques were exposed to aerosolized veev, fever, viremia, lymphopenia, and clinical signs of encephalitis were observed but the nhps did not succumb to disease (reed et al., 2004) . a common marmoset model was utilized for comparison studies of south america (sa) and north america (na) strains of eeev (adams et al., 2008) . previous studies indicated that the sa strain is less virulent than na strain for humans. common marmosets were infected in with either the na or sa strain of eeev. na strain-infected animals showed signs of anorexia and neurological involvement and were euthanized 4-5 days after the challenge. although sa strain-infected animals developed viremia, they remained asymptomatic and survived until the end of study. chikungunya virus (chikv) is a member of the genus alphaviruses, specifically the semliki forest complex, and has been responsible for a multitude of epidemics centered within africa and southeast asia (griffin, 2007) . the virus is transmitted by aedes aegypti and aedes albopictus mosquitoes. given the widespread endemicity of aedes mosquitoes, chikv has the potential to spread to previously unaffected areas. this is typified by the emergence of disease reported for the first time in 2005 in the islands of south-west indian ocean, including the french la reunion island, and the appearance in central italy in 2007 (charrel et al., 2007; rezza et al., 2007) . the incubation period following a mosquito bite is 2-5 days, leading to a self-limiting acute phase that lasts 3-4 days. symptoms during this period include fever, arthralgia, myalgia, and rash. headache, weakness, nausea, vomiting, and polyarthralgia have all been reported (powers and logue, 2007) . individuals typically develop a stooped posture due to the pain. for approximately 12% of infected individuals, joint pain can last months after resolution of primary disease, and has the possibility to relapse. underlying health conditions including diabetes, alcoholism, or renal disease, increase the risk of developing a severe form of disease that includes hepatitis or encephalopathy. children between the ages of 3 and 18 years old have an increased risk of developing neurological manifestations (arpino et al., 2009) . there is currently no approved vaccine or antiviral. wild-type c57bl/6 adult mice are not permissive to chikv infection by id inoculation. however, it was demonstrated that neonatal mice were susceptible and severity was dependent upon age at infection. six-dayold mice developed paralysis by day 6, and all succumbed by day 12, whereas 50% of 9-day-old mice were able to recover from infection. by 12 days, mice were no longer permissive to disease. symptomatic mice developed loss of balance, hind limb dragging, and skin lesions. neonatal mice were also used as a model for neurological complications (couderc et al., 2008; ziegler et al., 2008) . an adult mouse model has been developed by injection of the ventral side of the footpad of c57bl/6j mice. viremia lasted 4-5 days accompanied with foot swelling and noted inflammation of the musculoskeletal tissue morrison et al., 2011) . adult ifnα/βr knockout mice also developed mild disease with symptoms including muscle weakness and lethargy, symptoms that mirrored human infection. all adult mice died within 3 days. this model was useful in identifying the viral cellular tropism for fibroblasts (couderc et al., 2008) . icr and cd-1 mice can also be utilized as a disease model. neonatal mice inoculated subq with a passaged clinical isolate of chikv developed lethargy, loss of balance, and difficulty walking. mortality was low, 17 and 8% for newborn cd-1 and icr mice, respectively. the remaining mice fully recovered within 6 weeks after infection (ziegler et al., 2008) . a drawback of both the ifnα/βr and cd-1 mice is that the disease is not a result of immunopathogenesis as occurs in human cases, given that the mice are immunocompromised (teo et al., 2012) . a chronic infection model was developed using recombinant activating gene 1 (rag1 −/− ) knockout mice. in this study, mice inoculated via the footpad lost weight in comparison to the control group. both footpad and subq injected mice developed viremia 5-6 days postinfection, which was detectable up to 28 days postinfection. inflammation was evident in the brain, liver, and lung of the subq inoculated animals at 28-56 days postinfection. despite minimal footpad swelling on day 2 postinfection, on day 14 there was severe muscle damage noted at necropsy, which resolved by day 28 (seymour et al., 2015) . golden hamsters serve as another option for small animal modeling. although hamsters do not appear to develop overt clinical symptoms following subq inoculation, viremia developed in the majority of animals within 1 day postinfection with clearance following from day 3 to 4. histologically, inflammation was noted at the skeletal muscle, fascia, and tendon sheaths of numerous limbs. this study was limited in the number of animals utilized, and more work is needed to further develop the hamster model (bosco-lauth et al., 2015) . nhp models of disease include adult, aged, and pregnant rhesus macaques in addition to cynomolgus macaques (broeckel et al., 2015) . differing routes of infection (subq, iv, and im) have been successfully administered, although there is not a clear understanding of the role that route of transmission plays in subsequent pathogenesis and clinical symptoms. typically, viremia is observed 4-5 days postinfection with a correlation between infectious titer and time to viremia observed in cynomolgus but not rhesus (labadie et al., 2010; messaoudi et al., 2013) . fever began at 1-2 days postinfection and persisted for 2-7 days and 3-7 days in cynomolgus and rhesus, respectively and coincided with rash (chen et al., 2010; labadie et al., 2010; messaoudi et al., 2013) . overall blood chemistries changed in conjunction with initiation of viremia, and returned to baseline 10-15 days postexposure (chen et al., 2010) . cns involvement has been difficult to reproduce in nhp models, although it was reported that high inoculum in cynomolgus did result in meningoencephalitis (labadie et al., 2010) . the nhp models have been utilized to conduct efficacy testing on novel vaccines and therapeutics (broeckel et al., 2015) . dengue virus (denv) is transmitted via the mosquito vectors a. aegypti and a. albopictus (moore and mitchell, 1997) . given the endemicity of the vectors, it is estimated that half of the world's population is at risk for exposure to denv. this results in approximately 50 million cases of dengue each year, with the burden of disease in the tropical and subtropical regions of latin america, south asia, and southeast asia (gubler, 2002) . it is estimated that there are 20,000 deaths each year due to dengue hemorrhagic fever (dhf) (guzman and kouri, 2002) . there are four distinct serotypes of denv, numbered 1-4, which are capable of causing a wide clinical spectrum that ranges from asymptomatic to severe with the development of dhf (world health organization, 1997) . incubation can range from 3 to 14 days, with the average being 4-7 days. the virus targets dendritic cells and macrophages following a mosquito bite (balsitis et al., 2009) . typical infection results in classic dengue fever (df), which is self-limiting and has flu-like symptoms in conjunction with retroorbital pain, headache, skin rash, and bone and muscle pain. dhf can follow, with vascular leak syndrome and low platelet count, resulting in hemorrhage. in the most extreme cases, dengue shock syndrome (dss) develops, characterized by hypotension, shock, and circulatory failure (world health organization, 1997) . thrombocytopenia is a hallmark clinical sign of infection, and aids in differential diagnosis (gregory et al., 2010) . severe disease has a higher propensity to occur upon secondary infection with a different denv serotype (thein et al., 1997) . this is hypothesized to occur due to antibody dependent enhancement (ade). there is no approved vaccine or drug, and hospitalized patients receive supportive care including fluid replacement. in order to further progress toward an effective drug or vaccine, small human cohort studies have taken place. however, to provide statistically relevant results, testing must progress in an animal model. in developing an animal model, it is important to note that mosquitoes typically deposit 10 4 -10 6 pfu, and is considered the optimal range during experimental challenge . denv does not naturally replicate effectively in rodent cells, creating the need for mouse-adapted strains, engineered mouse lines, and a variety of inoculation routes to overcome the initial barrier. several laboratory mouse strains including a/j, balb/c, and c57bl/6 are permissive to dengue infection. however, the resulting disease has little resemblance to human clinical signs, and death results from paralysis (huang et al., 2000; paes et al., 2005; shresta et al., 2004) . a higher dose of an adapted denv strain induced dhf symptoms in both balb/c and c57bl/6 souza et al., 2009) . this model can also yield asymptomatic infections. a mouse-adapted strain of denv 2 introduced into ag129 mice developed vascular leak syndrome similar to the severe disease seen in humans (shresta et al., 2006) . passive transfer of monoclonal dengue antibodies within mice leads to ade. during the course of infection, viremia was increased and animals died due to vascular leak syndrome (balsitis et al., 2010) . another mouse-adapted strain injected into balb/c caused liver damage, hemorrhagic manifestations, and vascular permeability (souza et al., 2009) . ic injection of suckling mice with denv leads to death by paralysis and encephalitis, which is rare in human infection (lee et al., 2015; parida et al., 2002; zhao et al., 2014a) . immunocompromised mice have also been used to gain an understanding of the pathogenesis of denv. the most well-defined model is ag129 which is deficient in ifnα/β and γ receptors and can recapitulate dhf/dss if a mouse-adapted strain is utilized yauch et al., 2009) . scid mice engrafted with human tumor cells develop paralysis upon infection, and thus are not useful for pathogenesis studies (blaney et al., 2002; lin et al., 1998) . df symptoms developed after infection in nod/scid/il2rγko mice engrafted with cd34 + human progenitor cells (mota and rico-hesse, 2011) . rag-hu mice developed fever, but no other symptoms upon infection with a passaged clinical isolate and labadapted strain of denv 2 (kuruvilla et al., 2007) . a passaged clinical isolate of denv 3 was used to create a model in immunocompetent adult mice. ip injection in c57bl/6j and balb/c caused lethality by day 6-7 postinfection in a dose dependent manner. the first indication of infection was weight loss beginning on day 4 followed by thrombocytopenia. a drop in systolic blood pressure along with noted increases in the liver enzymes, ast and alt, were also observed. viremia was established by day 5. this model mimicked the characteristic symptoms observed in human dhf/dss cases (costa et al., 2012) . vascular leakage was also observed when c57bl/6 were inoculated with denv 2 (st john et al., 2013) . a murine model was developed that utilized infected mosquitoes as the route of transmission to hu-nsg mice. female mosquitoes were intrathoracically inoculated with a clinical isolate of denv 2. infected mosquitoes then fed upon the mouse footpad to allow for transmission of the virus via the natural route. the amount of virus detected within the mouse was directly proportional to the number of mosquitoes it was exposed to, with 4-5 being optimal. detectable viral rna was in line with historical human infection data. severe thrombocytopenia developed on day 14. this model is notable in that disease was enhanced with mosquito delivery of the virus in comparison to injection of the virus (cox et al., 2012) . nhp models have used a subq inoculation in an attempt to induce disease. although the animals are permissive to viral replication, it is to a lower degree than that observed in human infection (marchette et al., 1973) . the immunosuppressive drug, cyclophosphamide enhances infection in rhesus macaques by allowing the virus to invade monocytes (marchette et al., 1980) . throughout these preliminary studies, no clinical disease was detected. in order to circumvent this, a higher dose of denv was used in an iv challenge of rhesus macaques. hemorrhagic manifestations appeared by day 3 and resulted in petechiae, hematomas, and coagulopathy; however, no other symptoms developed (onlamoon et al., 2010) . a robust antibody response was observed in multiple studies (marchette et al., 1973; onlamoon et al., 2010) . marmosets also mirror human dengue infection, developing fever, leukopenia, and thrombocytopenia following subq inoculation (omatsu et al., 2011 (omatsu et al., , 2012 . nhps are able to produce antibodies similar to those observed during the course of human infection, making them advantageous in studying ade. sequential infection led to a cross-reactive antibody response which has been demonstrated in both humans and mice (midgley et al., 2011) . this phenotype can also be seen upon passive transfer of a monoclonal antibody to dengue and subsequent infection with the virus. rhesus macaques exposed in this manner developed viremia that was 3-to 100-fold higher than previously reported, however, no clinical signs were apparent (goncalvez et al., 2007) . the lack of inducible dhf or dss symptoms hinders further examination of pathogenesis within this model. west nile virus (wnv) was first isolated from the blood of a woman in the west nile district of uganda in 1937 uganda in (smithburn et al., 1940 . after the initial isolation of wnv, the virus was subsequently isolated from patients, birds, and mosquitoes in egypt in the early 1950s (melnick et al., 1951; taylor et al., 1953) and was shown to cause encephalitis in humans and horses. wnv is recognized as the most widespread of the flaviviruses, with a geographical distribution that includes africa, the middle east, western asia, europe, and australia (hayes, 1989) . the virus first reached the western hemisphere in the summer of 1999, during an outbreak involving humans, horses, and birds in the new york city metropolitan area (centers for disease control and prevention, 1999; lanciotti et al., 1999) . since 1999, the range of areas affected by wnv quickly extended. older people and children are most susceptible to wnv disease. wnv generally causes asymptomatic disease or a mild undifferentiated fever (west nile fever), which can last from 3 to 6 days (monath and tsai, 2002) . the mortality rate following neuroinvasive disease ranges from 4% to 11% (asnis et al., 2000; hayes, 1989; hubalek and halouzka, 1999; komar, 2000) . the most severe complications are commonly seen in the elderly, with reported case fatality rates from 4% to 11%. hepatitis, myocarditis, and pancreatitis are unusual, severe, nonneurologic manifestations of wnv infection. inoculation of wnv into nhps intracerebrally resulted in the development of either encephalitis, febrile disease, or an asymptomatic infection, depending on the virus strain and dose. viral persistence is observed in these animals regardless of the outcome of infection (i.e., asymptomatic, fever, encephalitis) (pogodina et al., 1983) . thus, viral persistence is regarded as a typical result of nhp infection with various wnv strains. after both intracerebral and subq inoculation, the virus localizes predominantly in the brain and may also be found in the kidneys, spleen, and lymph nodes. wnv does not result in clinical disease in nhps although the animals show a low level of viremia (lieberman et al., 2009; pletnev et al., 2003) . this is mirrored in new zealand white rabbits in that they only develop fever and low levels of viremia following inoculation via footpad (suen et al., 2015) . id inoculation of both marmosets and rhesus macaques did not yield any clinical signs of disease including fever. viremia was detected in both nhp species, but marmosets developed a higher titer for a greater duration than rhesus (verstrepen et al., 2014) . wnv has also been extensively studied in small animals. all classical laboratory mouse strains are susceptible to lethal infections by the intracerebral and ip routes, resulting in encephalitis and 100% mortality. id route pathogenesis studies indicated that langerhans dendritic cells are the initial viral replication sites in the skin (brown et al., 2007; johnston et al., 1996) . the infected langerhans cells then migrate to lymph nodes and the virus enters the blood through lymphatic and thoracic ducts and disseminates to peripheral tissues for secondary viral replication. virus eventually travels to the cns and causes pathology that is similar to human cases (byrne et al., 2001; cunha et al., 2000; diamond et al., 2003; fratkin et al., 2004) . the swiss mouse strain was inoculated ip in order to screen a variety of viral lineages to assess differences in pathogenesis (bingham et al., 2014) . tesh et al. developed a model for wn encephalitis using the golden hamster, mesocricetus auratus. hamsters appeared asymptomatic during the first 5 days, became lethargic at approximately day 6, and developed neurologic symptoms between days 7 and 10 . many of the severely affected animals died 7-14 days after infection. viremia was detected in the hamsters within 24 h after infection and persisted for 5-6 days. although there were no substantial changes in internal organs, progressive pathologic differences were seen in the brain and spinal cord of infected animals. furthermore, similar to the previously mentioned monkey experiments by pogodina et al. (1983) , persistent wnv infection was found in the brains of hamsters. zika virus recently came to the forefront of public health concerns with the outbreak in brazil at the end of 2015. the clinical disease spectrum is highly variable with reports of a flu-like illness accompanied by rash, guillan-barre syndrome, and microcephaly in newborns (ramos da silva and gao, 2016) . to date, a correlation between gestational age at which exposure to the virus occurs and severity of microcephaly is not fully understood (brasil et al., 2016) . however, a recent study of pregnant women in columbia found that infection with zika virus during the third trimester was not associated with any obvious structural abnormalities of the fetus (pacheco et al., 2016) . transmission of the virus occurs via the bite from an infected a. aegypti or a. albopictus (ramos da silva and gao, 2016) . other reported routes of exposure include sexual transmission and blood transfusion (cunha et al., 2016; d'ortenzio et al., 2016; hills et al., 2016; mccarthy, 2016) . the emergence of this virus with no approved vaccine or therapy, and few diagnostic options demonstrates the utility of well-characterized animal model development. it was first demonstrated in 1956 that experimentally infected mosquitoes could be used to transmit the virus to mice and nhps (boorman and porterfield, 1956) . a129 mice were susceptible to nonadapted zika virus infection following subq inoculation of the limbs. mice began to lose weight 3 days postinfection and met euthanasia criteria by day 6. microscopic lesions within the brain were noted upon necropsy. in conjunction, viral rna was detected in the blood, brain, ovary, spleen, and liver of the infected mice. wild-type 129sv/ev mice were also challenged with no observable clinical disease. however, viral rna was detected at day 3 postinfection in the blood, ovary and spleen, and then remained at detectable levels in the ovaries and spleen on day 7 (dowall et al., 2016) . footpad inoculation of the virus leads to a fatal disease in ag129 mice by day 7 postinoculation with significant histopathological changes in the brain noted at necropsy (aliota et al., 2016) . ag129 mice were also observed to develop neurologic disease by day 6 postexposure (rossi et al., 2016) . immunocompetent mice are resistant to infection via the subq route (rossi et al., 2016) . recently, a mouse model was identified to verify vertical transmission of the virus. pregnant c57 mice were injected either ip or in utero into the lateral ventricle of the fetal brain. ip inoculation induced transient viremia in the pregnant mice on day 1. viral rna was detected in five out of nine placentas on day 3 postinfection. the virus was able to infect the radial glia cells in the fetal brain and leads to a reduction in the cortical neural progenitors . viral exposure via cerebroventricular space/ lateral ventricle of the fetal brain exhibited small brain size at day 5 postexposure in addition to cortical thinning (cugola et al., 2016; li et al., 2016a) . ifnar1 −/− pregnant mice exposed to the virus had nonviable fetuses. in the same study, wild-type mice were given an anti-ifnar antibody prior to and during infection resulting in detectable virus in the fetal head with mild intrauterine growth restriction (miner et al., 2016) . all of these murine studies will further study of the pathogenesis of vertical transmission and the resulting neurological disorders in conjunction with screening novel countermeasures. nhp studies are currently ongoing for animal model development. numerous viruses from the coronavirus (cov) family exist that infect a wide range of animals. six species have been identified that can infect humans. two of these are alpha coronavirues: hcov-229e and hcov-nl63. four are beta coronavirueses: hcov-oc43, hcov-hku1, hcov-sars, and mers-cov. hcov-229e and hcov-oc43 were first detected in the 1960s from the nasal passages of humans with the "common cold" (gaunt et al., 2010) . hcov-nl63, which was first isolated in 2004, causes upper and lower respiratory infections of varying intensity and has been continuously circulating among humans (van der hoek et al., 2006) . hcov-hku1, first isolated in 2002, has been identified more sporadically but also causes respiratory infections (lau et al., 2006) . a significant portion of common cold infections in humans are caused by coronaviruses. in 2002 and 2012, two human coronaviruses, sars-cov and mers-cov, emerged that caused a great deal of alarm since these infections have resulted in nearly 10 and 40% fatality, respectively (assiri et al., 2013; peiris et al., 2004) . the etiologic agent of severe acute respiratory syndrome (sars), sars-cov, emerged in 2002 as it spread throughout 32 countries in a period of 6 months, with 8437 confirmed infections and 813 deaths (roberts and subbarao, 2006; world health organization, 2003) . no additional cases of community acquired sars-cov infection have been reported since 2004. the natural reservoir of sars-cov is the horseshoe bat and the palm civet is an intermediate host (lau et al., 2005) . the main mechanism of transmission of sars-cov is through droplet spread, but it is also viable in dry form on surfaces for up to 6 days and can be detected in stool, suggesting other modes of transmission are also possible (pearson et al., 2003; rabenau et al., 2005; rota et al., 2003) . sars-cov infection has a 10% case fatality with the majority of cases in people over the age of 15 (peiris et al., 2003; wang et al., 2004) . after an incubation period of 2-10 days, clinical signs of sars include general malaise, fever, chills, diarrhea, dyspnea, and cough (drosten et al., 2003) . in some sars cases, pneumonia may develop and progress to acute respiratory distress syndrome (ards). fever usually dissipates within 2 weeks and coincides with the induction of high levels of neutralizing antibodies (tan et al., 2004) . in humans, sars-cov replication destroys respiratory epithelium, and a great deal of the pathogenesis is due to the subsequent immune responses (chen and subbarao, 2007; perlman and dandekar, 2005) . infiltrates persisting within the lung and diffuse alveolar damage (dad) are common sequelae of sars-cov infection (perlman and dandekar, 2005) . virus can be isolated from secretions of the upper airways during early, but not later stages of infection as well as from other tissues (cheng et al., 2004) . sars-cov can replicate in many species, including: dogs, cats, pigs, mice, rats, ferrets, foxes, and monkeys (roper and rehm, 2009) . no model captures all aspects of human clinical disease (pyrexia and respiratory signs), mortality (∼10%), viral replication, and pathology (roberts et al., 2008) . in general, the sars-cov disease course in the model species is much milder and of shorter duration than in humans. viral replication in the various animal models may occur without clinical illness and/or histopathologic changes. the best-characterized models utilize mice, hamsters, ferrets, and nhps. mouse models of sars-cov typically are inoculated by the in route under light anesthesia (roberts et al., 2005) . young, 6-to 8-week-old balb/c mice exposed to sars-cov have viral replication detected in the lungs and nasal turbinate, with a peak on day 2 and clearance by day 5 postexposure (mcauliffe et al., 2004) . there is also viral replication within the small intestines of young balb/c mice. however, young mice have no clinical signs, aside from reduced weight gain, and have little to no inflammation within the lungs (pneumonitis) . in sars-cov infection of c57bl/6 (b6), also yields reduced weight gain and viral k. viral disease replication in the lungs, with a peak on day 3 and clearance by day 9 (glass et al., 2004) . in contrast, balb/c mice 13-14 months of age show weight loss, hunched posture, dehydration, and ruffled fur on day 3-6 postexposure (bisht et al., 2004) . interstitial pneumonitis, alveolar damage, and death also occur in old mice, resembling the age-dependent virulence observed in humans. 129s mice and b6 mice show outcomes to sars-cov infection similar to those observed for balb/c mice but have lower titers and less prolonged disease. while the aged mouse model is more frequently used then young mice, it is more difficult to obtain large numbers of mice older than 1 year (table 33 .1). a number of immunocompromised knockout mouse models of in sars-cov infection have also been developed. 129svev mice infected with sars-cov by the in route develop bronchiolitis, with peribronchiolar inflammatory infiltrates and interstitial inflammation in adjacent alveolar septae . viral replication and disease in these mice resolves by day 14 postexposure. beige, cd1 −/− , and rag1 −/− mice infected with sars-cov have similar outcomes to infected balb/c mice with regard to viral replication, timing of viral clearance, and a lack of clinical signs (glass et al., 2004) . stat1 ko mice infected in with sars-cov have severe disease, with weight loss, pneumonitis, interstitial pneumonia, and some deaths . the stat1 ko mouse model is therefore useful for studies of pathogenicity, pathology, and evaluation of vaccines. angiotensin converting enzyme 2 (ace2) and cd209l were identified as cellular receptors for sars-cov, with affinity for the spike (s) protein of the virus (jeffers et al., 2004) . the variations in the ace2 sequence across animal species could partially explain the differences in infection severity (li et al., 2016b; sutton and subbarao, 2015) . since mice in particular have a greater number of sequence differences in ace2, transgenic mice were created that express human ace2 (mccray et al., 2007; netland et al., 2008; yang et al., 2007) . unlike other murine models of sars-cov, mice expressing hace2 had up to 100% mortality, with severity correlating to the level of hace2 expression (tseng et al., 2007) . with high levels of hace2 expression, mice developed a severe lung and brain infection. however, cns k. viral disease infection is only rarely observed in humans infected with sars-cov. syrian golden hamsters (strain lvg) are also susceptible to in exposure of sars-cov. after the administration of 10 3 tcid 50, along with a period of transient viremia, sars-cov replicates in nasal turbinates and lungs, resulting in pneumonitis (roberts et al., 2005) . there are no obvious signs of disease, but exercise wheels can be used to monitor decrease in nighttime activity. limited mortality has been observed, but it was not dose dependent and could have more to do with genetic differences between animals because the strain is not inbred (roberts et al., 2008) . damage is not observed in the liver or spleen despite detection of virus within these tissues. several studies have shown that intratracheal (it) inoculation of sars-cov in anesthetized ferrets (mustela furo) results in lethargy, fever, sneezing, and nasal discharge (skowronski et al., 2005) . clinical disease has been observed in several studies excluding one, perhaps due to characteristics of the inoculating virus (kobinger et al., 2007) . sars-cov is detected in pharyngeal swabs, trachea, tracheobronchial lymph nodes, and high titers within the lungs. mortality has been observed around day 4 postexposure as well as mild alveolar damage in 5%-10% of the lungs, occasionally accompanied by severe pathology within the lungs (martina et al., 2003; ter meulen et al., 2004) . with fever, overt respiratory signs, lung damage, and some mortality, the ferret intratracheal model of sars-cov infection is perhaps most similar to human sars, albeit with a shorter time course. sars-cov infection of nhps by intransal or it routes generally results in a very mild infection that resolves quickly. sars-cov infection of old world monkeys, such as rhesus macaques, cynomolgus macaques (cynos), and african green monkeys (agms) have been studied with variable results, possibly due to the outbred nature of the groups studied or previous exposure to related pathogens. clinical illness and viral loads have not been consistent; however, replication within the lungs and dad are features of the infections for each of the primate species. some cynos have no illness but others have rash, lethargy, and respiratory signs and pathology martina et al., 2003; mcauliffe et al., 2004; rowe et al., 2004) . rhesus have little to no disease and only have mild findings upon histopathological analysis (rowe et al., 2004) . agms infected with sars-cov have no overt clinical signs but dad and pneumonitis has been documented (mcauliffe et al., 2004) . viral replication has been detected for up to 10 days in the lungs of agms; however, the infection resolves, and does not progress to fatal ards. farmed chinese masked palm civets, sold in open markets in china, were involved in the sars-cov outbreak. it and in inoculation of civets with sars-cov results in lethargy, decreased aggressiveness, fever, diarrhea, and conjunctivitis . leucopenia, pneumonitis, and alveolar septal enlargement, with lesions similar to those observed in ferrets and nhps, have also been observed in laboratory-infected civets. squirrel monkeys, mustached tamarinds, and common marmosets have not been susceptible to sars-cov infection (greenough et al., 2005; roberts et al., 2008) . vaccines have been developed for related animal covs in chickens, cattle, dogs, cats, and swine, and have included live-attenuated, killed, dna and viral-vectored vaccine strategies (cavanagh, 2003) . an important issue to highlight from work on these vaccines is that cov vaccines, such as those developed for cats, may induce a more severe disease (perlman and dandekar, 2005; weiss and scott, 1981) . as such, immune mice had th2type immunopathology upon sars-cov challenge (tseng et al., 2012) . severe hepatitis in vaccinated ferrets with antibody enhancement in liver has been reported (weingartl et al., 2004) . additionally, rechallenge of agms showed limited viral replication but significant lung inflammation, including alveolitis and interstitial pneumonia, which persisted for long periods of time after viral clearance (clay et al., 2012) . mouse and nhp models with increased virulence may be developed by adapting the virus by repeated passage within the species of interest. mouse-adapted sars with uniform lethality was developed from 15 serial passages in the lungs of young balb/c mice (mccray et al., 2007; roberts et al., 2007; rockx et al., 2007) . middle east respiratory syndrome (mers-cov) emerged in saudi arabia and is associated with fever, severe lower respiratory tract infection, and oftentimes renal failure (al-tawfiq et al., 2016; omrani et al., 2015) . mers patients can also occasionally manifest with neurological symptoms. mers-cov infection has a high fatality rate. infections in humans can also be asymptomatic. as of october 2015, there were 1589 confirmed cases and 567 deaths (li et al., 2016b) . bats serve as the likely natural reservoir since virus with 100% nucleotide identity to the index case was isolated from egyptian tomb bats (memish et al., 2013) . spread to humans likely comes from infected dromedary camels (adney et al., 2014; azhar et al., 2014) . the host range for mers-cov is dependent on the binding of the viral s protein to the host receptor, which is human dipeptidyl peptidase four (hdpp4), also known as cd26 (raj et al., 2013) . the expression and distribution of dpp4 in the human respiratory tract has recently been well characterized (meyerholz et al., 2016) . interestingly, dpp4 expression is preferentially localized to alveolar regions, perhaps explaining why mers predominantly manifests as an infection of the lower respiratory tract. humans with preexisting pulmonary disease have increased dpp4 expression in alveolar epithelia. small animals typically used for viral disease research, such as mice, hamsters, guinea pigs, and ferrets are naturally nonpermissive to mers-cov infection due to a low binding efficiency of the viral s protein to the host dpp4 (sutton and subbarao, 2015). in contrast the rhesus macaque and common marmoset have complete homology to human dpp4, allowing productive mers-cov infection to occur falzarano et al., 2014; munster et al., 2013; yao et al., 2014) . new zealand white rabbits can be infected with mers-cov, and virus was isolated from the upper respiratory tract, but there were no clinical symptoms or significant histopathological changes (haagmans et al., 2015) . due to the lack of strong binding affinity of the mers-cov s protein to the murine dpp4 receptor, wildtype mice are not susceptible to mers-cov infection. as such, several approaches have been used to create susceptible murine animal models of mers-cov infection by inducing the expression of hdpp4. one approach utilized an adenovirus vector expressing hdpp4 to transduce mice (zhao et al., 2014b) . these mice developed pneumonia but survived mers-cov infection. in mers-cov infection of mice with global expression of hdpp4 resulted in id 50 and ld 50 values of <1 and 10 tcid 50 , respectively (tao et al., 2016) . thus, mers-cov infection of these transgenic mice can be either sublethal or uniformly lethal depending on the dose. inflammatory infiltrates were found in the lungs and brain stems of mice with some focal infiltrates in the liver as well. another strategy uses transgenic mice expressing hdpp4 under either a surfactant protein c or cytokeratin 10 promoter (li et al., 2016b) . in mers-cov infection in these mice resulted in a uniformly lethal disease characterized by alveolar edema and microvascular thrombosis and mononuclear clear cell infiltration in the lungs. the brain stem was also impacted by the infection. dpp4 expression with an ubiquitously expressing promoter from cytomegalovirus also had a uniformly lethal infection with predominant lung and brain involvement, but numerous other tissues were also impacted and contained virus (agrawal et al., 2015) . common marmosets infected with 5.2 × 10 6 tcid 50 (emc-2012) mers-cov by the combined in, oral, ocular, and it routes capitulate the severe disease in human infections (falzarano et al., 2014) . the animals manifested moderate to severe clinical disease, with interstitial infiltration of both lower lung lobes. two of nine animals became moribund between days 4 and 6. viral rna was detected in nasal and throat swabs, various organs, and in the blood of some animals, indicating a systemic infection. histologically, animals showed evidence of acute bronchial interstitial pneumonia as well as other pathological defects. infection of rhesus macaques with mers-cov results in a mild clinical disease characterized by a transient lung infection with pneumonia. rhesus macaques were inoculated with at least 10 7 tcid 50 (emc-2012) mers-cov either by the it route or a combined in, it, oral, and ocular inoculation . the result was a mild respiratory illness including nasal swelling and a short fever with all animals surviving. viral rna was recovered from nasal swab samples and replicating virus was found in lung tissue . mild pathological lesions were found only in the lungs. radiographic imaging of the lungs revealed interstitial infiltrates, which are signs of pneumonia (yao et al., 2014) . interestingly, mer-cov infection is more severe in marmosets compared to rhesus macaques (falzarano et al., 2014) . this is despite the finding that both species have complete homology with humans within the dpp4 domain that interacts with the viral s protein. other host factors influencing disease severity have not yet been identified. transgenic mouse models expressing hdpp4 are ideal for initial development and screening of mers-cov countermeasures, and marmosets can be used for final selection and characterization. filoviridae consists of three genera, ebolavirus and marburgvirus, and a newly discovered group, cuevavirus (kuhn, 2008) . it is thought that various species of bats are the natural host reservoir for these viruses that have lethality rates from 40% to 82% in humans. there is evidence that the egyptian rousette bat (rousettus aegyptiacus) is the natural reservoir for marburgviruses but may not be for ebolaviruses (jones et al., 2015) . marburg virus (marv) first emerged in 1967 in germany when laboratory workers contracted the virus from agms (chlorocebus aerthiops) that were shipped from uganda. ebolaviruses sudan and zaire (sudv and ebov) caused nearly simultaneous outbreaks in 1976 in what is now the democratic republic of congo (drc). the most recent outbreak of ebov in west africa was by far the largest with over 28,000 suspected, probable and confirmed cases and over 11,000 deaths. bundibugyo virus (bdbv) first emerged in 2007 in bundibugyo, uganda with 56 confirmed cases . two other ebolaviruses are known: taï forest (tafv) (previously named cote d'ivoire) (ciebov) and reston (restv), which have not caused major outbreaks or lethal disease in humans. filovirus disease in humans is a characterized by aberrant innate immunity and a number of clinical symptoms: fever, nausea, vomiting, k. viral disease arthralgia/myalgia, headaches, sore throat, diarrhea, abdominal pain, and anorexia as well as numerous others (mehedi et al., 2011; wauquier et al., 2010) . approximately 10% of patients develop petechia and a greater percentage, depending on the specific strain, may develop bleeding from various sites (gums, puncture sites, stools, etc.) (table 33 .2). natural transmission in an epidemic is through direct contact or needle sticks in hospital settings. however, much of the research interest in filoviruses primarily stems from biodefense needs, particularly from aerosol biothreats. as such, im, ip, and aerosol models have been developed in mice, hamsters, guinea pigs, and nhps for the study of pathogenesis, correlates of immunity, and for testing countermeasures . since filoviruses have such high lethality rates in humans, scientists have looked for models that are uniformly lethal to stringently test efficacy of candidate vaccines and therapeutics. one issue to take note of in animal model development of filovirus infection is the impact of particle to plaque-forming unit (pfu) ratios on lethality, wherein it is possible that increasing the dose could actually decrease infectivity due to an immunogenic effect produced by inactive virions in the stock. additionally, the plaque assay used to measure live virions in a stock may greatly underestimate the true quantity of infectious virions in a preparation (alfson et al., 2015; smither et al., 2013a) . immunocompetent mice have not been successfully infected with wild-type filoviruses due to the control of the infection by the murine type 1 interferon response (bray, 2001) . however, wild-type inbred mice are susceptible to filovirus that has been mouse adapted (ma) by serial passage in mice (bray et al., 1999) . marv angola was particularly resistant to adaptation, but after 24 serial passages in scid mice, infection caused severe disease in balb/c and c57bl/6 mice when administered in or ip (qiu et al., 2014) . these mice had pathology with some similarities to infection in humans including lymphopenia, thrombocytopenia, liver damage, and viremia. balb/c mice, which are the strain of choice for ip inoculation of ma-ebov, are not susceptible by the aerosol route (bray et al., 1999; zumbrun et al., 2012a) . for aerosol infection of immunocompetent mice, a panel of bxd (balb/c x dba) recombinant inbred strains were screened and one strain, bxd34, was particularly susceptible to airborne ma-ebov, with 100% lethality to low or high doses (approximately 100 or 1000 pfu) ( zumbrun et al., 2012a) . these mice developed weight loss of greater than 15% and succumbed to infection between days 7 and 8 postexposure. the aerosol infection model utilizes a whole-body exposure chamber to expose mice aged 6-8 weeks to ma-ebov aerosols with a mass median aerodynamic diameter (mmad) of approximately 1.6 µm and a geometric standard deviation (gsd) of approximately 2.0 for 10 min. another approach uses immunodeficient mouse strains, such as scid, stat1 ko, ifn receptor ko, or perforin ko with a wild-type ebov inoculum by ip or aerosol routes (bray, 2001; lever et al., 2012; zumbrun et al., 2012a) . mice are typically monitored for clinical disease "scores" based on activity and appearance, weight loss, and moribund condition (survival). coagulopathy, a hallmark of filovirus infection in humans, has been observed, with bleeding in a subset of animals and failure of blood samples to coagulate late in infection (bray et al., 1999) . liver, kidney, spleen, and lung tissue taken from moribund mice have pathology characteristic of filovirus disease in nhps (zumbrun et al., 2012a) . while most mouse studies have used ma-ebov or ebov, an ip mouse-adapted marv model is also available (warfield et al., 2007 (warfield et al., , 2009 ). ma-marv and ma-ebov models are particularly useful for screening novel antiviral compounds (panchal et al., 2012) . recently, a model was created using immunodeficient nsg [nonobese diabetic (nod)/scid/il-2 receptor chain knockout] mice with transplanted human hematopoietic stem cells from umbilical cord blood. these mice were susceptible to lethal wt (nonadapted) ebov by ip and in exposure (ludtke et al., 2015) . the transplanted mice had all of the cellular components of a fully functional adaptive human immune system and upon ebov (brannan et al., 2015; lever et al., 2012) . interestingly, inoculation of infa/br −/− mice with tafv and restv does not result in clinical signs. yet another strategy uses knockout mice lacking possible receptors for filovirus entry, such as niemann-pick c1 and c2 (npc1 and npc2). npc2 (−/−) mice were fully susceptible to infection with ebov but npc1 (−/−) mice were completely resistant (herbert et al., 2015) . hamsters are frequently used to study cardiovascular disease, coagulation disorders, and thus serve as the basis for numerous viral hemorrhagic fever models (gowen and holbrook, 2008; herbert et al., 2015) . an ip ma-ebov infection model has been developed in syrian hamsters gowen and holbrook, 2008; herbert et al., 2015; tsuda et al., 2011) . this model, which has been used to test a vesicular stomatitis virus vectored vaccine approach, utilizes male 5-to 6-week-old syrian hamsters which are infected with 100 ld 50 of ma-ebov. virus is present in tissues and blood collected on day 4 and all animals succumbed to the disease by day 6. infected hamsters had severe coagulopathy and uncontrolled host immune responses, similar to what is observed in primates. (ebihara et al., 2010) guinea pig models of filovirus infection have been developed for ip and aerosol routes using guinea pigadapted ebov (gp-ebov) and marv (gp-marv) (choi et al., 2012; connolly et al., 1999; twenhafel et al., 2015; zumbrun et al., 2012c) . guinea pig models of filovirus infection are quite useful in that they develop fever, which can be monitored at frequent intervals by telemetry. additionally, the animals are large enough for regular blood sampling in which measurable coagulation defects are observed as the infection progresses. a comparison of ip infection of outbred guinea pigs with guinea pig-adapted marv angola and marv ravn revealed similar pathogenesis (cross et al., 2015) . infection with either strain resulted in features of the disease that are similar to what is seen in human and nhp infection, such as viremia, fever, coagulopathy, lymphopenia, elevated liver enzymes (alt and ast), thrombocytopenia, and splenic, gastrointestinal and hepatic lesions. gp-marv-ravn had a delayed disease progression relative to gp-marv-ang. hartley guinea pigs exposed to aerosolized gp-ebov develop lethal interstitial pneumonia. this is in contrast to subq infection of guinea pigs, aerosol ebov challenge of nhps, and natural human infection (twenhafel et al., 2015) . both subq and aerosol exposure of guinea pigs to gp-ebov resulted in only mild lesions in the liver and spleen. by aerosol exposure, gp-ebov is uniformly lethal at both high and low doses (100 or 1000 pfu target doses) but lethality drops with low (less than 1000 pfu) presented doses of airborne gp-marv and more protracted disease is seen in some animals (our unpublished observations) (zumbrun et al., 2012c) . weight loss of between 15% and 25% is a common finding in guinea pigs exposed to gp-ebov or gp-marv. fever, which becomes apparent by day 5, occurs more rapidly in gp-ebov exposed guinea pigs than with gp-marv exposure. lymphocytes and neutrophils increase during the earlier part of the disease, and platelet levels steadily drop as the disease progresses. increases in coagulation time can be seen as early as day 6 postexposure. blood chemistries (i.e., alt, ast, alkp, and bun) indicating problems with liver and kidney function are also altered late in the disease course. transmission of ebov has been documented from swine to nhps via the respiratory tract (kobinger et al., 2011) . as such, guinea pigs have been used to establish transmission models (wong et al., 2015a,b) . nonexposed guinea pigs were placed in the cages with infected guinea pigs 1 day postexposure to gp-ebov. guinea pigs challenged intanasally were more likely to transmit virus to naive cagemates than those that were exposed by the ip route. nhp models of filovirus infection are the preferred models for more advanced disease characterization and testing of countermeasures because they most closely mimic the disease and immune correlates seen in humans (dye et al., 2012) . old world primates have been primarily used for development of ip, im, and aerosol models of filovirus infection ( twenhafel et al., 2013) . uniformly lethal filovirus models have been developed for most of the virus strains in cynomolgus macaques, rhesus macaques, and to a lesser degree, agms (alves et al., 2010; carrion et al., 2011; davis et al., 1997; hensley et al., 2011a; reed et al., 2007; zumbrun et al., 2012b) . low-passage human isolates that have not been passaged in animals have been sought for development of nhp models to satisfy the food and drug administration (fda) animal rule. ebov-makona, the strain responsible for the recent large outbreak in west africa, was compared to the "prototype" 1976 ebov strain (marzi et al., 2015) . the disease in cynos was similar for both viruses, but disease progression was delayed for ebov-makona. this delay as well as the lower fatality rate in the 2014 epidemic compared to the 1976 outbreak suggest that ebov-makona is less virulent. the large number of cases in the 2014-15 ebov outbreak brought to light previously underappreciated eye pathology and ocular viral persistence in survivors. while survivors of nhp filovirus infection are infrequent, necrotizing scleritis, conjunctivitis, and other ocular pathology has been observed in ebov-infected animals (alves et al., 2016) . prominent features of the filovirus infections in nhps are onset of fever by day 5 postexposure, viremia, lymphopenia, tachycardia, azotemia, alteration in liver function enzymes (alt, ast, and alkp), decrease in platelets, and increased coagulation times. petechial rash is a common sign of filovirus disease and may be more frequently observed in cynomolgus macaques than in other nhp species (zumbrun et al., 2012b) . immunological parameters have been evaluated and t, b, and natural killer cells are greatly diminished as the infection progresses (fernando et al., 2015) . a cytokine storm occurs with rises in ifnγ, tnf, il-6, and ccl2 (fernando et al., 2015) . however, there is also evidence from transcriptional profiling of circulating immune cells that the early immune response is skewed toward a th2 response (connor et al., 2015) . strikingly, animals surviving challenge may have a delay in the production of inflammatory cytokines and chemokines (martins et al., 2015) . clinical disease parameters may have a slightly delayed onset in aerosol models. dyspnea late in infection is a prominent feature of disease after aerosol exposure (zumbrun et al., 2012b) . aerosol filovirus infection of nhps results in early infection of respiratory lymphoid tissues, dendritic cells, alveolar macrophages, blood monocytes, and fibroblastic reticular cells followed by spread to regional lymph nodes then multiple organs (ewers et al., 2016; twenhafel et al., 2013) . a number of pronounced pathology findings include multifocal hepatic necrosis and fibrin accumulation, particularly within the liver and the spleen. for aerosolized marv infection of rhesus, the most significant pathology included destruction of the tracheobronchial and mediastinal lymph nodes (ewers et al., 2016) . lymphocytolysis and lymphoid depletion are also observed (alves et al., 2010) . multilead, surgically implanted telemetry devices are useful in continuous collection of temperature, blood pressure, heart rate, and activity levels. as such, blood pressure drops as animals become moribund and heart rate variability (standard deviation of the heart rate) is altered late in infection (zumbrun et al., 2012b) . the most recently developed telemetry devices can also aid in plethysmography to measure respiratory minute volume for accurate delivery of presented doses for aerosol exposure. standardized filovirus-infected nhp euthanasia criteria have also been developed to enhance reproducibility for studies that evaluate therapeutic and vaccine countermeasures (warren et al., 2014) . filovirus infection of common marmosets (callithrix jacchus) is also a viable model to study the disease course. respiratory infection of marmosets with marv results in a lethal infection with fever, hemorrhaging, transient rash, disseminated viral infection, increases in liver function enzymes, coagulopathy, hepatitis, and histological lesions particularly in the kidney and liver (smither et al., 2013b) . marmosets are similarly susceptible to infection with ebovkikwit (smither et al., 2015) . thus, ebov or marv infection of marmosets produces features of the disease that are very similar to that of other nhps and humans. hendra and nipah virus are unusual within the paramyxoviridae family given that they can infect a large range of mammalian hosts. both viruses are grouped under the genus henipavirus. the natural reservoirs of the viruses are the fruit bats from the genus pteropus. hendra and nipah have the ability to cause severe disease in humans with the potential for a high case fatality rate (rockx et al., 2012) . outbreaks due to nipah virus have been recognized in malaysia, singapore, bangladesh, and india, while hendra virus outbreaks have yet to be reported outside of australia (luby et al., 2009a,b) . hendra was the first member of the genus identified and was initially associated with an acute respiratory disease in horses. all human cases have been linked to transmission through close contact with an infected horse. there have been no confirmed cases of direct transmission from bat to human. nipah has the distinction of transmission among, although the exact route is unknown (homaira et al., 2010) . the virus is susceptible to ph, temperature, and desiccation, and thus close contact is hypothesized as needed for successful transmission (fogarty et al., 2008) . both viruses have a tropism for the neurological and respiratory tracts. the incubation period for hendra virus is 7-17 days and is marked by a flu-like illness. symptoms at this initial stage include myalgia, headache, lethargy, sore throat, and vomiting (hanna et al., 2006) . disease progression can continue to pneumonitis or encephalitic manifestations, with the person succumbing to multiorgan failure (playford et al., 2010) . nipah virus has an incubation period of 4 days to 2 weeks (goh et al., 2000) . much like hendra, the first signs of disease are nondescript. severe neurological symptoms subsequently develop including encephalitis and seizures that can progress to coma within 24-48 h (lo and rota, 2008). survivors of infection typically make a full recovery; however, 22% suffer permanent sequelae, including persistent convulsions (tan and chua, 2008) . at this time, there is no approved vaccine or antiviral, and treatment is purely supportive. animal models are being used to not only test novel vaccines and therapeutics, but also deduce the early events of disease because documentation of human cases is at terminal stages. the best small animal model is the syrian golden hamster due to their high susceptibility to both henipaviruses. clinical signs upon infection recapitulate the disease course in humans including acute encephalitis and respiratory distress. challenged animals died within 4-17 days postinfection. the progression of disease and timeline is highly dependent on dose and route of infection. in inoculation leads to imbalance, limb paralysis, lethargy, and breathing difficulties whereas ip resulted in tremors and paralysis within 24 h before death. virus was detected in lung, brain, spleen, kidney, heart, spinal cords, and urine, with the brain having the highest titer. this model is used for vaccination and passive protection studies (guillaume et al., 2009; rockx et al., 2011; wong et al., 2003) . the guinea pig model has not been widely used due to the lack of a respiratory disease upon challenge (torres-velez et al., 2008; williamson et al., 2001) . inoculation with hendra virus via the subq route leads to a generalized vascular disease with 20% mortality. clinical signs were apparent 7-16 days postinfection with death occurring within 2 days of cns involvement. higher inoculum has been associated with development of encephalitis and cns lesions. id and in injection does not lead to disease, although the animals are able to seroconvert upon challenge. the inoculum source does not affect clinical progression. nipah virus challenge only causes disease upon ip injection and results in weight loss and transient fever for 5-7 days. virus was shed through urine and was present in the brain, spleen, lymph nodes, ovary, uterus, and urinary bladder (hooper et al., 1997) . ferrets infected with hendra or nipah virus display the same clinical disease as seen in the hamster model and human cases (bossart et al., 2009; pallister et al., 2011) . upon inoculation by the oronasal route, ferrets develop severe pulmonary and neurological disease within 6-9 days including fever, coughing, and dyspnea. lesions do develop in the ferret's brains, but to a lesser degree than seen in humans. cats have also been utilized as an animal model for henipaviruses. disease symptoms are not dependent upon the route of infection. the incubation period is 4-8 days and leads to respiratory and neurological symptoms (mungall et al., 2007; johnston et al., 2015; westbury et al., 1996) . this model has proven useful for vaccine efficacy studies. squirrel and agms are representative of the nhp models. for squirrel monkeys, nipah virus is introduced by either the in or iv route and subsequently leads to clinical signs similar to humans, although in challenge results in milder disease. upon challenge, only 50% of animals develop disease manifestations including anorexia, dyspnea, and acute respiratory syndrome. neurological involvement is characterized by uncoordinated motor skills, loss of consciousness, and coma. viral rna can be detected in lung, brain, liver, kidney, spleen, and lymph nodes but is only found upon iv challenge (marianneau et al., 2010) . agms are very consistent model of both viruses. it inoculation of the viruses results in 100% mortality, and death within 8.5 and 9-12 days postinfection for hendra and nipah viruses, respectively. the animals develop severe respiratory and neurological disease with generalized vasculitis rockx et al., 2010) . the reservoir of the viruses, gray-headed fruit bats, has been experimentally challenged. due to their status as the host organism for henipaviruses, the bats do not develop clinical disease. however, hendra virus can be detected in kidneys, heart, spleen, and fetal tissue, and nipah virus can be located in urine . pigs develop a respiratory disease upon infection with both nipah and hendra viruses (berhane et al., 2008; li et al., 2010; middleton et al., 2002) . oral inoculation does not produce a clinical disease, but subq injection represents a successful route of infection. live virus can be isolated from the oropharynx as early as 4 days postinfection. nipah virus can also be transmitted between pigs. nipah virus was able to induce neurological symptoms in 20% of the pigs, even though virus was present in all neurological tissues regardless of symptoms (weingartl et al., 2005) . within the pig model, it appeared that nipah virus had a greater tropism for the respiratory tract, while hendra for the neurological system. horses are also able to develop a severe respiratory tract infection accompanied with fever and general weakness upon exposure to nipah and hendra viruses. oronasal inoculation led to systemic disease with viral rna detected in nasal swabs within 2 days (marsh et al., 2011; williamson et al., 1998) . animals died within 4 days postexposure and have interstitial pneumonia with necrosis of alveoli (murray et al., 1995a,b) . virus could be detected in all major systems. mice, rats, rabbits, chickens, and dogs have been tested but are nonpermissive to infection (westbury et al., 1995; wong et al., 2003) . suckling balb/c mice succumb to infection if the virus is inoculated intracranially (mungall et al., 2006) . in exposure with nipah does not induce a clinical disease; however, there is evidence of a subclinical infection in the lungs following euthanasia of the mice (dups et al., 2014) . in addition, a human lung xenograph model in nsg mice demonstrated that the human lung is highly susceptible to nipah viral replication and damage (valbuena et al., 2014) . embryonated chicken eggs have been inoculated with nipah virus leading to a universally fatal disease within 4-5 days postinfection (tanimura et al., 2006) . annually, respiratory syncytial virus (rsv) is responsible for the lower respiratory tract infections of 33 million children under the age of 5, which in turn results in 3 million hospitalizations and approximately 200,000 deaths (nair et al., 2010) . within the united states, hospital costs alone amount to over 600 million dollars per year (paramore et al., 2004) . outbreaks are common in the winter (yusuf et al., 2007) . the virus is transmitted by large respiratory droplets that replicate initially within the nasopharynx and spreads to the lower respiratory tract. incubation for the virus is 2-8 days. rsv is highly virulent leading to very few asymptomatic infections (collins and graham, 2008) . disease manifestations are highly dependent upon the age of the individual. rsv infections in neonates produce nonspecific symptoms including overall failure to thrive, apnea, and feeding difficulties. infants present with a mild upper respiratory tract disease that could develop into bronchiolitis and bronchopneumonia. contracting rsv at this age results in an increased chance of developing childhood asthma (wu et al., 2008) . young children develop recurrent wheezing while adults have exacerbation of previously existing respiratory conditions (falsey et al., 2005) . common clinical symptoms are runny nose, sneezing, and coughing accompanied by fever. mortality rates from rsv in hospitalized children are 1%-3% with the greatest burden of disease seen in 3-4 month olds (ruuskanen and ogra, 1993). hematopoietic stem cell transplant patients, solid organ transplant patients, and copd patients are particularly vulnerable to rsv infection and have mortality rates between 7.3% and 13.3% upon infection (anderson et al., 2016) . although there are almost 60 rsv vaccine candidates which are in preclinical and clinical phases, there is no licensed vaccine available and ribavirin usage is not recommended for routine treatment (american academy of pediatrics subcommittee on diagnosis and management of bronchiolitis, 2006; higgins et al., 2016; kim and chang, 2016) . animal models of rsv were developed in the hopes of formulating an effective and safe vaccine unlike the formalin-inactivated rsv (fi-rsv) vaccine. this vaccine induced severe respiratory illness in infants whom received the vaccine and were subsequently infected with live virus (kim et al., 1969) . mice can be used to model rsv infection, although a very high in inoculation is needed to achieve clinical symptoms (jafri et al., 2004; stark et al., 2002) . strain choice is crucial to reproducing a physiological relevant response (stokes et al., 2011). age does not affect primary disease manifestations (graham et al., 1988) . however, it does play a role in later sequelae showing increased airway hyperreactivity . primary rsv infection produces increased breathing with airway obstruction (jafri et al., 2004; van schaik et al., 1998) . virus was detected as early as day 3 and reached maximum titer at day 6 postinfection. clinical illness is defined in the mouse by weight loss and ruffled fur as opposed to runny nose, sneezing, and coughing as seen in humans. a humanized mouse model was recently developed by in inoculation. the challenged mice experienced weight loss and demonstrated a humoral and cellular immune response to the infection (sharma et al., 2016) . cotton rats are useful given that rsv is able to replicate to high titers within the lungs and can be detected in both the upper and lower airways after in inoculation (boukhvalova et al., 2009; niewiesk and prince, 2002) . viral replication is 50-to 1000-fold greater in the cotton rat model than mouse model (wyde et al., 1993) . the cotton rats develop mild to moderate bronchiolitis or pneumonia (grieves et al., 2015; prince et al., 1999) . although age does not appear to factor into clinical outcome, it has been reported that older cotton rats tend to take longer to achieve viral clearance. viral loads peak by the 5th day, dropping to below the levels of detection by day 8. the histopathology of the lungs appears similar to that of humans after infection (piazza et al., 1993) . this model has limited use in modeling the human immune response to infection as challenge with the virus induces a th2 response in cotton rats, whereas humans tend to have a response skewed toward th1 (culley et al., 2002; dakhama et al., 2005; ripple et al., 2010) . fi-rsv disease was recapitulated upon challenge with live virus after being vaccinated twice with fi-rsv. chinchillas have been challenged experimentally with rsv via in inoculation. the virus was permissive within the nasopharynx and eustachian tube. the animals displayed an acute respiratory tract infection. this model is therefore useful in studying mucosal immunity during infection (gitiban et al., 2005) . ferrets infected by it were found to have detectable rsv in throat swabs up to day 7 postinfection, and positive qpcr up to day 10. immunocompromised ferrets were observed to have higher viral loads accompanied with detectable viral replication in the upper respiratory tract (stittelaar et al., 2016) . chimpanzees are permissive to replication and clinical symptoms of rsv including rhinorrhea, sneezing, and coughing. adult squirrel monkeys, newborn rhesus macaques, and infant cebus monkeys were also challenged but did not exhibit any disease symptoms or high levels of viral replication (belshe et al., 1977) . bonnet monkeys were developed an inflammatory response by day 7 with viral rna detected in both bronchial and alveolar cells (simoes et al., 1999) . the chimpanzee model has been proven useful for vaccine studies (hancock et al., 2000; teng et al., 2000) . sheep have also been challenged experimentally since they develop respiratory disease when exposed to ovine rsv (meyerholz et al., 2004) . lambs are also susceptible to human respiratory syncytial infection (olivier et al., 2009; sow et al., 2011) . when inoculated intratracheally, the lambs developed an upper respiratory tract infection with cough after 6 days. some lambs went on to develop lower respiratory disease including bronchiolitis. the pneumonia resolved itself within 14 days. rsv replication peaked at 6 days, and rapidly declined. studying respiratory disease in sheep is beneficial given the shared structural features with humans (plopper et al., 1983; scheerlinck et al., 2008) . the influenza viruses consist of three types: influenza a, b, and c, based on antigenic differences. influenza a is further classified by subtypes; 16 ha and 9 na subtypes are known. seasonal influenza is the most common infection and usually causes a self-limited febrile illness with upper respiratory symptoms and malaise that resolves within 10 days (taubenberger and morens, 2008) . the rate of infection is estimated at 10% in the general population and can result in billions of dollars of loss annually from medical costs and reduced work-force productivity. approximately 40,000 people in the united states die each year from seasonal influenza (dushoff et al., 2006) . thus, vaccines and therapeutics play a critical role in controlling infection, and development using animal models is ongoing (braun et al., 2007b) . influenza virus replicates in the upper and lower airways, peaking at approximately 48-h postexposure. infection can be more severe in infants and children under the age of 22, people over the age of 65, or immunocompromised individuals where viral pneumonitis or pneumonia can develop or bacterial superinfection resulting in pneumonia or sepsis (barnard, 2009; glezen, 1982) . pneumonia from secondary bacterial infection, such as streptococcus pneumonia, streptococcus pyogenes, and neisseria meningitides, and more rarely, staphylococcus aureus, is more common than viral pneumonia from the influenza virus itself, accounting for ∼27% of all influenza associated fatalities (alonso et al., 2003; ison and lee, 2010; speshock et al., 2007) . death, often due to ards can occur as early as 2 days after onset of symptoms. lung histopathology in severe cases may include dad, alveolar edema and damage, hemorrhage, fibrosis, and inflammation (taubenberger and morens, 2008) . the h5n1 avian strain of influenza, has lethality rates of around ∼50% (of known cases), likely because the virus preferentially binds to the cells of the lower respiratory tract, and thus the potential for global spread is a major concern (matrosovich et al., 2004; wang et al., 2016) . h7n9 is another avian influenza a strain that infected more than 130 people and was implicated in 37 deaths. approximately 75% of infected people had a known exposure to birds. there is no evidence of sustained spread between humans but these viruses are of great concern for their pandemic potential (zhang et al., 2013) . the most frequently used animal models of influenza infection include mice, ferrets, and nhps. a very thorough guide to working with mouse, guinea pig, ferret, and cynomolgus models was published by kroeze et al. (2012) . swine are not frequently utilized but are also a potentially useful model for influenza research since they share many similarities to human anatomy, genetics, susceptibility, and pathogenesis (rajao and vincent, 2015). lethality rates can vary with virus strain used (with or without adaptation), dose, route of inoculation, age, and genetic background of the animal. the various animal models can capture differing diseases caused by influenza: benign, severe, super infection, and sepsis, severe with ards, and neurologic manifestations (barnard, 2009) . also, models can utilize seasonal or avian strains and have been developed to study transmission, important for understanding the potential for more lethal strains, such as h5n1 for spreading among humans. mouse models of influenza infection are very predictive for antiviral activity and tissue tropism in humans, and are useful in testing and evaluating vaccines (gilbert and mcleay, 2008; hagenaars et al., 2008; ortigoza et al., 2012) . inoculation is by the in route, utilizing approximately 60 µl of inoculum in each nare of anesthetized mice. exposure may also be to small particle aerosols containing influenza with a mmad of <5 µl. most inbred strains are susceptible, with particularly frequent use of balb/c followed by c57bl/6j mice. males and females have equivalent disease but influenza is generally more infectious in younger 2-to 4-week-old (8-10 g) mice. mice are of somewhat limited use in characterizing the immune response to influenza. most inbred laboratory mice lack the mxa gene which is an important part of human innate immune response to influenza infection. the mouse homolog to mxa, mx1 is defective in most inbred mouse strains (staeheli and haller, 1987) . mice with the knocked-in mx1 gene have a 1000-fold higher ld-50 for an influenza a strain (pr8) than wildtype background c57bl/6 mice (grimm et al., 2007) . weight loss or reduced weight gain, decreased activity, huddling, ruffled fur, and increased respiration are the most common clinical signs in influenza infected mice. for more virulent strains, mice may require euthanasia as early as 48 h postexposure, but most mortality occurs from 5 to 12 days postexposure accompanied by decreases in rectal temperature (sidwell and smee, 2000). pulse oximeter readings and measurement of blood gases for oxygen saturation are also used to determine the impact of influenza infection on respiratory function (sidwell et al., 1992) . virus can be isolated from bronchial lavage (bal) fluids throughout the infection and from tissues after euthanasia. for influenza strains with mild to moderate pathogenicity, disease is nonlethal and virus replication is detected within the lungs, but usually not other organs. increases in serum alpha-1-acidglycoprotein and lung weight also frequently occur. however, mice infected with influenza do not develop fever, dyspnea, nasal exudates, sneezing, or coughing. mice can be experimentally infected with influenza a or b, but the virus generally requires adaptation to produce clinical signs. mice express the receptors for influenza attachment in the respiratory tract; however, the distribution varies and sa 2,3 predominates over sa 2,6 which is why h1, h2, and h3 subtypes usually need to be adapted to mice and h5n1, h2, h6, and h7 viruses do not require adaptation (o'donnell and subbarao, 2011). to adapt, mice are infected intratracheally or intranasally by virus isolated from the lungs, and reinfected into mice and then the process is repeated a number of times. once adapted, influenza strains can produce severe disease, systemic spread, and neurotropism. h5n1 and the 1918 pandemic influenza virus can cause lethal infection in mice without adaptation (gao et al., 1999; taubenberger, 2006) . h5n1 infection of mice results in viremia and viral replication in multiple organ systems, severe lung pathology, fulminant diffuse interstitial pneumonia, pulmonary edema, high levels of proinflammatory cytokines, and marked lymphopenia ( dybing et al., 2000; gubareva et al., 1998; lu et al., 1999) . as in humans, the virulence of h5n1 is attributable to damage caused by an overactive host immune response. additionally, mice infected with the 1918 h1n1 influenza virus produce severe lung pathology and oxygen saturation levels that decrease with increasing pneumonia (barnard et al., 2007) . reassortment influenza viruses of the 2009 h1n1 virus and a low-pathogenicity avian h7n3 virus can also induce disease in mice without adaptation . in superinfection models, a sublethal dose of influenza is given to mice followed 7 days later by in inoculation of a sublethal dose of a bacterial strain, such as s. pneumoniae or s. pyogenes (chaussee et al., 2011) . morbidity, characterized by inflammation in the lungs, but not bacteremia, begins a couple of days after superinfection and may continue for up to 2 weeks. at least one transmission model has also been developed in mice. with h2n2 influenza, transmission rates of up to 60% among cagemates can be achieved after infection by the aerosol route and cocaging after 24 h (schulman, 1968). rats (f344 and sd) inoculated with rat-adapted h3n2 developed inflammatory infiltrates and cytokines in bronchoalveolar lavage fluids, but had no lethality and few histopathological changes (daniels et al., 2003) . additionally, an influenza transmission model has been developed in guinea pigs as an alternative to ferrets (lowen et al., 2006) . cotton rats (sigmodon hispidus) have been used to test vaccines and therapeutics in a limited number of studies (eichelberger et al., 2004) . cotton rats have an advantage over mice in that the immune system is similar to humans (including the presence of the mx gene) and influenza viruses do not have to be adapted (eichelberger et al., 2006; ottolini et al., 2005) . nasal and pulmonary tissues of cotton rats were infected with unregulated cytokines and lung viral load peaking at 24 h postexposure. virus was cleared from the lung by day 3 and from the nares by day 66, but animals had bronchial and alveolar damage, and pneumonia for up to 3 weeks. there is also a s. aureus superinfection model in cotton rats (braun et al., 2007a) . coinfection resulted in bacteremia, high bacterial load in lungs, peribronchiolitis, pneumonitis, alveolitis, hypothermia, and higher mortality. domestic ferrets (mustela putorius furo) are frequently the animal species of choice for influenza animal studies because the susceptibility, clinical signs, peak virus shedding, kinetics of transmission, local expression of cytokine mrnas, and pathology resemble that of humans (lambkin et al., 2004; maines et al., 2012; mclaren and butchko, 1978) . like humans, ferrets exclusively express neu5ac, which acts as a receptor for influenza a virus, a feature likely contributing to the susceptibility of ferrets to human-adapted influenza a virus strains (ng et al., 2014) . the glycomic characterization of ferret respiratory tract tissues demonstrated some similarities and some differences to humans in terms of the potential glycan binding sites for the influenza virus (jia et al., 2014) . ferrets also have airway morphology, respiratory cell types, and a distribution of influenza receptors (sa 2,6 and sa 2,3) within the airways similar to that of humans (van riel et al., 2007) . influenza was first isolated from ferrets infected in with throat washes from humans harboring the infection and ferret models have since been used to test efficacy of vaccines and therapeutic treatments (huber et al., 2008; lambkin et al., 2004; maines et al., 2012) . when performing influenza studies in ferrets, animals should be serologically negative for circulating influenza viruses. infected animals should be placed in a separate room from uninfected animals. if animals must be placed in the same room, uninfected ferrets should be handled before infected ferrets. anesthetized ferrets are experimentally exposed to influenza by in inoculation of 0.25-0.5 ml containing approximately 10 4 -10 6 egg id 50 dropwise to each nostril. however, a larger inoculum volume of 1.0 ml has also been explored as being more appropriate, yielding more severe and consistent respiratory tract pathology, likely because the larger inoculum is more widely distributed in the lower respiratory tract (moore et al., 2014) . video tracking to assign values to activity levels in ferrets can aid ferret studies, eliminating the need for collection of subjective and arbitrary clinical scores (oh et al., 2015) . viral replication in the upper respiratory tract is typically measured by nasal washes, but virus can also be measured in bronchoalveolar lavage fluid using a noninvasive technique (lee et al., 2014) . influenza types a and b naturally infect ferrets, resulting in an acute illness, which usually lasts 3-5 days for mild to moderately virulent strains (maher and destefano, 2004) . ferrets are more susceptible to influenza a than influenza b strains and are also susceptible to avian influenza h5n1 strains without adaptation (zitzow et al., 2002) . however, the localized immune responses within the respiratory tract of ferrets infected with influenza a and b have been characterized and are similar (carolan et al., 2015) . virulence and degree of pneumonitis caused by different influenza subtypes and strains vary from mild to severe and generally mirrors that seen in humans (stark et al., 2013) . nonadapted h1n1, h2n2, and h3n2 have mild to moderate virulence in ferrets. the sequencing of the ferret genome has allowed for the characterization of the ferret host response using rnaseq analysis . distinct signatures were obtained depending on the particular influenza strain to inoculate the ferrets. also helpful is the sequencing and characterization of the influenza ferret infectome during different stages of the infection in naïve or immune ferrets (leon et al., 2013) . since influenza infection is particularly devastating to the elderly population, an aged ferret model of h1n1 influenza infection was developed (paquette et al., 2014) . features associated with increased clinical disease are weakened hemagglutinin antibody generation and attenuated th1 responses. pregnant and breastfeeding women and infants are also susceptible to more severe illness from influenza virus. to study this dynamic, a breastfeeding mother-infant ferret influenza infection model was created (paquette et al., 2015) . notably, the mammary gland itself harbored virus and transcript analysis showed downregulation of milk production genes. in support of the development of therapies, the ferret influenza model for pharmacokinetic/pharmacodynamics studies of antiviral drugs as also been developed (reddy et al., 2015) . critical to this model is ensuring pronounced clinical signs and robust viral replication upon influenza infection. strains of low virulence have predominant replication in the nasal turbinates of ferrets. clinical signs and other disease indicators in ferrets are similar to that of humans with mild respiratory disease, sneezing, nasal secretions containing virus, fever, weight loss, high viral titers, and inflammatory infiltrate in the airways, bronchitis, and pneumonia (svitek et al., 2008) . replication in both the upper and lower airways is associated with more severe disease and greater mortality. additionally, increased expression of proinflammatory mediators and reduced expression of antiinflammatory mediators in the lower respiratory tract of ferrets correlates with severe disease and lethal outcome. h5n1-infected ferrets develop severe lethargy, greater interferon response, transient lymphopenia, and replication in respiratory tract, brain, and other organs (peng et al., 2012; zitzow et al., 2002) . immunocompromised humans have influenza illness of greater duration and complications. immunocompromised ferrets infected with influenza similarly had prolonged virus shedding (van der vries et al., 2013) . interestingly, antiviral resistance emerged in both humans and ferrets with immunocompromised status infected with influenza. alveolar macrophage depleted of ferrets infected with 2009 pandemic h1n1 influenza also had a more severe disease with greater viral replication in the lungs and greater induction of inflammatory chemokines (kim et al., 2013) . a superinfection model resembling that of mice has been developed by in instillation of influenza in 6-to 8-week-old ferrets followed by in inoculation of s. pneumonia 5 days later (peltola et al., 2006) . this typically resulted in otitis media, sinusitis, and pneumonia. transmission models in ferrets have recently met with worldwide media attention and controversy with regard to the study of h5n1 (enserink, 2013; fouchier et al., 2012; herfst et al., 2012; oh et al., 2014) . in general, some subtypes, such as the 2009 h1n1, can transmit easily through aerosol and respiratory droplets (munster et al., 2009) . of concern, h7n9 isolated from humans was more pathogenic and readily transmissible between ferrets by larger respiratory droplets and smaller particle aerosols (kreijtz et al., 2013; richard et al., 2013; zhang et al., 2013) . h5n1 became transmissible by adopting just four mutations, spreading between ferrets in separate cages (imai et al., 2012) . transmission occurs more readily at the height of pyrexia, but for the 2009 h1n1 in particular, can occur before fever is detected (roberts et al., 2012) . ferret-to-ferret transmission of a mouseadapted influenza b virus has also been demonstrated (kim et al., 2015) . since ferrets can be expensive and cumbersome, influenza infection has been characterized and a transmission model developed in the guinea pig; however, this is a newer model with infrequent utilization thus far (lowen et al., 2014) . old and new world primates are susceptible to influenza infection and have an advantage over ferret and mouse models which are deficient for h5n1 vaccine studies because there is a lack of correlation with hemagglutination inhibition (murphy et al., 1980) . of old world primates, cynomolgus macaque (macaca fascicularis) is most frequently utilized for studies of vaccines and antiviral drug therapies (stittelaar et al., 2008) . h5n1 and h1n1 1918 infection of cynos is very similar to humans (rimmelzwaan et al., 2001) . cynos develop fever and ards upon in inoculation of h5n1 with necrotizing bronchial interstitial pneumonia . nhps are challenged by multiple routes k. viral disease (ocular, nasal, and tracheal) simultaneously 1 × 10 6 pfu per site. virus antigen is primarily localized to the tonsils and pulmonary tissues. infection of cynos with h5n1 results in fever, lethargy, nasal discharge, anorexia, weight loss, nasal and tracheal washes, pathologic and histopathologic changes, and alveolar and bronchial inflammation. the 1918 h1n1 caused a very high mortality rate due to an aberrant immune response and ards and had more than 50% lethality (humans only had a 1%-3% lethality) (kobasa et al., 2007) . ards and mortality also occur with the more pathogenic strains, but nhps show reduced susceptibility to less virulent strains, such as h3n2 (o'donnell and subbarao, 2011) . influenza-infected rhesus macaques represent a mild disease model for vaccine and therapeutic efficacy studies (baas et al., 2006) . host microarray and qrt-pcr proved useful for analysis of infected lung tissues. other nhp models include influenza infection of pigtailed macaques as a mild disease model and infection of new world primates, such as squirrel and cebus monkeys (baskin et al., 2009) . domestic pig models have been developed for vaccine studies for swine flu. pigs are susceptible in nature as natural or intermediate hosts but are not readily susceptible to h5n1 (isoda et al., 2006; lipatov et al., 2008) . while pigs infected with influenza may have fever, anorexia, and respiratory signs, such as dyspnea and cough, mortality is rare (van der laan et al., 2008) . size and space requirements make this animal difficult to work with, although the development of minipig models may provide an easier to use alternative. cat and dog influenza models have primarily been utilized to study their susceptibility to h5n1 with the thought that these animals could act as sentinels or could serve to transmit the virus to humans (giese et al., 2008; rimmelzwaan et al., 2006) . these models are not generally used to better understand the disease in humans or for testing vaccines or antivirals. rift valley fever virus (rvfv) causes epizootics and human epidemics in africa. rvfv mainly infects livestock, such as sheep, cattle, goats, etc. after 2-4 days incubation period, animals show signs of fever, hepatitis, and abortion, which is a hallmark diagnostic sign known among farmers (balkhy and memish, 2003) . mosquito vectors, unpasteurized milk, aerosols of infected animal's body fluids, or direct contact with infected animals are the important routes of transmission to humans (abu-elyazeed et al., 1996; mundel and gear, 1951) . after 2-to 6-day-incubation period, rvfv causes a wide range of signs and symptoms in humans ranging from asymptomatic to severe disease with hepatitis, vision loss, encephalitis, and hemorrhagic fever (ikegami and makino, 2011; laughlin et al., 1979; peters and linthicum, 1994) . depending on the severity of the disease when the symptoms start, 10%-20% of the hospitalized patients might die in 3-6 days or 12-17 days after the disease onset (ikegami and makino, 2011) . hepatic failure, renal failure or dic, and encephalitis are demonstrated within patients during postmortem examination. live domestic animals especially sheep and goats were used to develop animal models of rvfv (weingartl et al., 2014) . this study indicated that goats were more resistant to the disease compared to sheep. the viremia in goats was lower and had a shorter duration with only some animals developing fever. the susceptibility is influenced by route of infection, breed of animals, the rvfv strain, and growth conditions as well as the passage history. therefore, it might be difficult to establish an animal model with domestic ruminants. mice are one of the most susceptible animal species to rvfv infection. several mouse models including balb/c, ifnar −/− , mbt/pas, 129 and c57bl/6 were exposed to rvfv via parental or aerosol routes of infection (ross et al., 2012) . subq or ip routes of infection cause acute hepatitis and lethal encephalitis at a late stage of the disease in mice (mims, 1956; smith et al., 2010) . mice start to show signs of decreased activity and ruffled fur by day 2-3 postexposure. immediately following these signs, they become lethargic and generally die 3-6 days postexposure. ocular disease or the hemorrhagic form of the disease has not been observed in mouse models so far (ikegami and makino, 2011) . increased viremia and tissue tropism were reported in mice with (smith et al., 2010) increased liver enzymes and lymphopenia observed in sick mice. aerosolized rvfv causes faster and more severe neuropathy in mice compared to the parental route (dodd et al., 2014; reed et al., 2014) . the liver is a target organ following aerosol exposure and liver failure results in fatality. rats and gerbils are also susceptible to rvfv infection. the rat's susceptibility is dependent on the rat strain utilized for the challenge model and route of exposure. there is also noted age dependence in the susceptibility of rats. while wistar-furth and brown norway strains, and young rats are highly susceptible to rvfv infection, fisher 344, buffalo and lewis strains, and old rats demonstrated resistance to infection via subq route of infection (findlay and howard, 1952; peters and slone, 1982) . similar pathologic changes, such as liver damage and encephalopathy were observed in both rats and mice. the recent study by bales et al. (2012) showed that aerosolized rvfv caused similar disease outcome in wistar-furth and aci rats while lewis rats developed fatal encephalitis which was much more severe than the subq route of infection. there was no liver involvement in the gerbil model and animals died from severe encephalitis. the mortality rate was dependent on the strain used and the dose given to gerbils (anderson et al., 1988) . similar to the rat model, the susceptibility of gerbils was also dependent on age. natural history studies with syrian hamsters indicated that the liver was the target organ with highly elevated alt levels and viral titers (scharton et al., 2015) . lethargy, ruffled fur, and hunched posture were observed in hamsters by day 2 post-subq inoculation and the disease was uniformly lethal by day 2-3 postexposure. this model has been successfully used to test antivirals against rvfv (scharton et al., 2015) . studies thus far showed that rvfv does not cause uniform lethality in a nhp model. ip, in, iv, and aerosol routes have been utilized to develop nhp model. rhesus macaques, cynomolgus macaques, african monkeys, and south american monkeys were some of the nhp species used for this effort . monkeys showed a variety of signs ranging from febrile disease to hemorrhagic disease and mortality. temporal viremia, increased coagulation parameters (pt, aptt), and decreased platelets were some other signs observed in nhps. animals that succumbed to disease showed very similar pathogenesis to humans, such as pathological changes in the liver and hemorrhagic disease. there was no ocular involvement in this model. smith et al. compared iv, in and subq routes of infection in common marmosets and rhesus macaques (peng et al., 2012) . marmosets were more susceptible to rvfv infection than rhesus macaques with marked viremia, acute hepatitis, and late onset of encephalitis. increased liver enzymes were observed in both species. necropsy results showed enlarged livers in the marmosets exposed by iv or subq routes. although there were no gross lesions in the brains of marmosets, histopathology showed encephalitis in the brains of in challenged marmosets. a recent study by hartman et al. (2014) demonstrated that aerosolized rvfv only caused mild fever in cynomolgus macaques and rhesus macaques, while agms and marmosets had encephalitis and succumbed to disease between days 9 and 11 postexposure. in contrast to other lethal models, the brain was the target organ in agms and marmosets. although no change was observed in ast levels, alp levels were increased in marmosets. little or no change was observed in hepatic enzyme levels in agms. lack of information regarding human disease concerning the aerosol route of exposure makes it difficult to evaluate these animal models. crimean-congo hemorrhagic fever virus (cchfv) generally circulates in nature unnoticed in an enzootic tick-vertebrate-tick cycle and similar to other zoonotic agents, appears to produce little or no disease in its natural hosts, but causes severe disease in humans. cchfv transmits to humans by ixodid ticks, direct contact with sick animals/humans, or body fluids of animals/humans (ergonul and whitehouse, 2007) . incubation, prehemorrhagic, hemorrhagic, and convalescence are the four phases of the disease seen in humans. the incubation period lasts 1-9 days. during the prehemorragic phase, patients show signs of nonspecific flu-like disease for approximately a week. the hemorrhagic period results in circulatory shock and dic in some patients (mardani and keshtkar-jahromi, 2007; swanepoel et al., 1989) . over the years, several attempts have been made to establish an animal model for cchf in adult mice, guinea pigs, hamsters, rats, rabbits, sheep, nhps, etc. (fagbami et al., 1975; nalca and whitehouse, 2007; shepherd et al., 1989; smirnova, 1979) . until recently, the only animal that manifests disease is the newborn mouse. infant mice ip infected with cchfv resulted in fatality around day 8 postinfection (tignor and hanham, 1993) . pathogenesis studies showed that virus replication was first detected in the liver, with subsequent spread to the blood (serum). virus was detected very late during the disease course in other tissues including the heart (day 6) and the brain (day 7). the recent studies utilizing knockout adult mice were successful to develop a lethal small animal model for cchfv infection (bente et al., 2010; bereczky et al., 2010) . bente et al. infected stat1 knockout mice by the ip route. in this model, after the signs of fever, leukopenia, thrombocytopenia, viremia, elevated liver enzymes and proinflammatory cytokines, mice were moribund and succumbed to disease in 3-5 days postexposure. the second model was developed by using interferon alpha/beta (ifnα/β) receptor knockout mice (ifnar −/− ) (bereczky et al., 2010) . similar observations were made in this model as in the stat1 knockout mouse model. animals were moribund and died 2-4 days after exposure with high viremia levels in liver and spleen. characterization studies with ifnar −/− mice challenged with different routes (ip, in, im, and subq) showed that cchfv causes acute disease with high viral loads, pathology in liver and lymphoid tissues, increased proinflammatory response, severe thrombocytopenia, coagulopathy, and death, all of which are characteristics of human disease . proinflammatory cytokines and chemokines, such as g-csf, ifnγ, cxc-cl10, ccl2 increased dramatically day 3 postchallenge and gm-csf, il-1a, il-1b, il-2, il-6, il-12p70, il-13, il-17, cxcl1, ccl3, ccl5, and tnf-α concentrations were extremely elevated at the time of death/euthanasia. this model is also utilized to test therapeutics, such as ribavirin, arbidol, and t-705 (favipiravir) successfully (oestereich et al., 2014) . experimental vaccines developed for cchf were evaluated in this model provided protection compare to unvaccinated mice (buttigieg et al., 2014; canakoglu et al., 2015, p. 725) . thus, the ifnar −/− mouse model would be a good choice to test medical countermeasures against cchfv, although they have an impaired ifn and immune response phenotype. other laboratory animals, including nhps, show little or no sign of infection or disease when infected with cchfv (nalca and whitehouse, 2007) . butenko et al. utilized agms (cercopithecus aethiops) for experimental cchfv infections. except one monkey with a fever on day 4 postinfection, the animals did not show signs of disease. antibodies to the virus were detected in three out of five monkeys, including the one with fever. fagbami et al. (1975) infected two patas monkeys (erythrocebus patas) and one guinea baboon (papio papio) with cchfv. whereas all three animals had low-level viremia between days 1 and 5 after inoculation, only the baboon serum had neutralizing antibody activity on day 137 postinfection. similar results were obtained when horses and donkeys have been used for experimental cchfv infections. donkeys develop a low-level viremia (rabinovich et al., 1972) and horses developed little or no viremia, but high levels of virus-neutralizing antibodies, which remained stable for at least 3 months. these studies suggest that horses may be useful in the laboratory to obtain serum for diagnostic and possible therapeutic purposes (blagoveshchenskaya et al., 1975 (blagoveshchenskaya et al., ). shepherd et al. (1989 infected 11 species of small african wild mammals and laboratory rabbits, guinea pigs, and syrian hamsters with cchfv. whereas scrub hares (lepus saxatilis), cape ground squirrels (xerus inauris), red veld rats (aethomys chrysophilus), white-tailed rats (mystromys pumilio), and guinea pigs had viremia; south african hedgehogs (atelerix frontalis), highveld gerbils (gerbilliscus brantsii), namaqua gerbils (desmodillus auricularis), two species of multimammate mouse (mastomys natalensis and mastomys coucha), and syrian hamsters were negative for virus. all species regardless of viremia levels developed antibody responses against cchfv. iv and intracranially infected animals showed onset of viremia earlier than those infected by the subq or ip routes. the genus hantavirus is unique among the family bunyaviridae in that it is not transmitted by an arthropod vector, but rather rodents (schmaljohn and nichol, 2007) . rodents of the family muridae are the primary reservoir for hantaviruses. infected host animals develop a persistent infection that is typically asymptomatic. transmission is achieved by inhalation of infected rodent saliva, feces, and urine (xu et al., 1985) . human infections can normally be traced to a rural setting with activities, such as farming, land development, hunting, and camping as possible sites of transmission. rodent control is the primary route of prevention (lednicky, 2003) . the viruses have a tropism for endothelial cells within the microvasculature of the lungs (zaki et al., 1995) . there are two distinct clinical diseases that infection can yield: hemorrhagic fever with renal syndrome (hfrs) due to infection with old world hantaviruses or hantavirus pulmonary syndrome (hps) caused by new world hantaviruses (nichol, 2001) . hfrs is mainly seen outside of the americas and is associated with the hantaviruses dobrava-belgrade (also known as dobrava), hantaan, puumala, and seoul (lednicky, 2003) . incubation lasts 2-3 weeks and presents as flu-like in the initial stages that can further develop into hemorrhagic manifestations and ultimately renal failure. thrombocytopenia subsequently develops which can further progress to shock in approximately 15% patients. overall mortality rate is 7%. infection with dobrava and hantaan viruses are typically linked to development of severe disease. hps was first diagnosed in 1993 within southwestern united states when healthy young adults became suddenly ill, progressing to severe respiratory distress and shock. the etiological agent responsible for this outbreak was identified as sin nombre virus (snv) (centers for disease control and prevention, 1993) . this virus is still the leading cause within north america of hps. hps due to other hantaviruses has been reported in argentina, bolivia, brazil, canada, chile, french guiana, panama, paraguay, and uruguay (padula et al., 2000; stephen et al., 1994) . the first report of hps in maine was recently documented (centers for disease control and prevention, 1993). andes virus (andv) was first identified in outbreaks in chile and argentina. this hantavirus is distinct in that it can be transmitted between humans (wells et al., 1997) . the fulminant disease is more lethal than that observed of hfrs with a mortality rate of 40%. there are four phases of disease including prodromal, pulmonary, cardiac depression, and hematologic manifestation (peters and khan, 2002) . incubation typically occurs 14-17 days following exposure (young et al., 2000) . unlike hfrs, renal failure is not a major contributing factor to the disease. there is a short prodromal phase that gives way to cardiopulmonary involvement accompanied by cough and gastrointestinal symptoms. it is at this point that individuals are typically admitted to the hospital. pulmonary function is hindered and continues to suffer within 48 h after cardiopulmonary involvement. interstitial edema and air-space disease normally follow. in fatal cases, cardiogenic shock has been noted (hallin et al., 1996) . syrian golden hamsters are the most widely utilized small animal model for hantavirus infection. hamsters inoculated im with a passaged andes viral strain died within 11 days postinfection. clinical signs did not appear until 24 h prior to death at which point the hamsters were moribund and in respiratory distress. mortality was dose dependent, with high inoculums leading to a shorter incubation before death. during the same study, hamsters were inoculated with a passaged snv isolate. no hamsters developed any symptoms during the course of observation. however, an antibody response to the virus that was not dose dependent was determined via elisa. hamsters infected with andv have significant histopathological changes to their lung, liver, and spleen. all had an interstitial pneumonia with intraalveolar edema. infectious virus could be recovered from these organs. viremia began on day 8 and lasted up to 12 days postinfection. infection of hamsters with andv yielded a similar clinical disease progression as is seen in human hps including rapid progression to death, fluid in the pleural cavity, and significant histopathological changes to the lungs and spleen. a major deviation in the hamster model is the detection of infectious virus within the liver . normally, snv does not cause a disease in hamsters (wahl-jensen et al., 2007) . but a recent study showed that immunosuppression with dexamethasone and cyclophosphamide in combination causes lethal disease with snv in hamsters (brocato et al., 2014) . the disease was very similar to the disease caused by andv in hamsters. lethal disease can be induced in newborn mice, but does not recapitulate the clinical symptoms observed in human disease (kim and mckee, 1985) . the disease outcome is very much dependent on the age of the mice. younger mice are much more susceptible to virus than the adult mice. adult mice exposed to hanta virus leads to a fatal disease dependent upon viral strain and route of infection. the disease progression is marked by neurological or pulmonary manifestations that do not mirror human disease (seto et al., 2012; wichmann et al., 2002) . knockout mice lacking ifnα/β are highly susceptible to hanta virus infection (muller et al., 1994) . in a study of panel of laboratory strains of mice, c57bl/6 mice were most susceptible to a passaged hanta viral strain injected ip. animals progressed to neurological manifestation including paralyses and convulsions, and succumbed to infection within 24-36 h postinfection. clinical disease was markedly different from that observed in human cases (wichmann et al., 2002) . in a recent study, 2-weekold icr mice was exposed to htnv strain aa57 via the subq route (seto et al., 2012) . mice started to show signs of disease by day 11 postinoculation. piloerection, trembling, hunching, loss of body weight, labored breathing, and severe respiratory disease were observed in mice. studies to develop nhp models were not successful until recently. nhps have been challenged with new world hantaviruses; however, no clinical signs were reported (hooper et al., 2006; mcelroy et al., 2002) . cynomolgus monkeys challenged with a clinical isolate of puumala virus developed a mild disease (klingstrom et al., 2002; sironen et al., 2008) . challenge with andv to cynomolgus macaques by both iv and aerosol exposure led to no signs of disease. all animals did display a drop in total lymphocytes within 5 days postinfection. four of six aerosol exposed monkeys and 8 of 11 iv injected monkeys developed viremia. infectious virus could not be isolated from any of the animals. in a recent study, rhesus macaques were inoculated by the intramuscular route with snv passaged only in deer mice (safronetz et al., 2014) . characteristics of hps disease including rapid onset of respiratory distress, severe pulmonary edema, thrombocytopenia, and leukocytosis were observed in this promising model. viremia was observed 4-10 days prior to respiratory signs of the disease that were observed on days 14-16 postinoculation. with all aspects, this animal model would be very useful to test medical countermeasures against hanta virus. the family arenaviridae is composed of two serogroups: old world arenaviruses including lassa fever virus and lymphocytic choriomeningitis virus and the new world viruses of pichinde virus and junin virus. all of these viruses share common clinical manifestations (mccormick and fisher-hoch, 2002) . lassa fever virus is endemic in parts of west africa and outbreaks are typically seen in the dry season between january and april (curtis, 2006) . this virus is responsible for 100,000-500,000 infections per year, leading to approximately 5000 deaths (khan et al., 2008) . outbreaks have been reported in guinea, sierra leone, liberia, nigeria, and central african republic. however, cases have sprung up in germany, netherlands, united kingdom, and the united states due to transmission to travelers on commercial airlines (amorosa et al., 2010) . transmission of this virus typically occurs via rodents, in particular the multimammate rat, mastomys species complex (curtis, 2006) . humans become infected by inhaling the aerosolized virus or eating contaminated food. there has also been noted human-to-human transmission by direct contact with infected secretions or needle-stick injuries. the majority of infections are asymptomatic; however, severe disease occurs in 20% of individuals. the incubation period is from 5 to 21 days and initial onset is characterized by flu-like illness. this is followed by diarrheal disease that can progress to hemorrhagic symptoms including encephalopathy, encephalitis, and meningitis. a third of patients develop deafness in the early phase of disease that is permanent for a third of those affected. the overall fatality is about 1%; however, of those admitted to the hospital it is between 15% and 25%. there is no approved vaccine and besides supportive measures, ribavirin is effective only if started within 7 days (mccormick et al., 1986a,b) . the primary animal model used to study lassa fever is the rhesus macaque (jahrling et al., 1980) . aerosolized infection of lymphocytic choriomeningitis virus has been a useful model for lassa fever. both rhesus and cynomolgus monkeys exposed to the virus developed disease, but rhesus mirrored more closely the disease course and histopathology observed in human infection (danes et al., 1963) . iv or intragastric inoculation of the virus led to severe dehydration, erythematous skin, submucosal edema, necrotic foci in the buccal cavity, and respiratory distress. the liver was severely affected by the virus as depicted by measuring the liver enzymes ast and alt (lukashevich et al., 2003) . disease was dose dependent with iv, intramuscular, and subq inoculation requiring the least amount of virus to induce disease. aerosol infections and eating contaminated food could also be utilized, and mimic a more natural route of infection (peters et al., 1987) . within this model, the nhp becomes viremic after 4-6 days. clinical manifestations were present by day 7 and death typically occurred within 10-14 days (lukashevich et al., 2004; rodas et al., 2004) . intramuscular injection of lassa virus into cynomolgus monkeys also produced a neurological disease due to lesions within the cns (hensley et al., 2011b) . this pathogenicity is seen in select cases of human lassa fever (cummins et al., 1992; gunther et al., 2001) . a marmoset model has recently been defined utilizing a subq injection of lassa fever virus. virus was initially detected by day 8 and viremia achieved by day 14. liver enzymes were elevated and an enlarged liver was noted upon autopsy. there was a gradual reduction in platelets and interstitial pneumonitis diagnosed in a minority of animals. the physiological signs were the same as seen in fatal human cases (carrion et al., 2007) . mice develop a fatal neurological disorder upon intracerebral inoculation with lassa, although the outcome of infection is dependent on the mhc background, age of the animal, and inoculation route (salvato et al., 2005) . stat1 knockout mice inoculated ip with both lethal and nonlethal lassa virus strains develop hearing loss accompanied by damage to the inner ear hair cells and auditory nerve (yun et al., 2015) . guinea pig inbred strain 13 was highly susceptible to lassa virus infection. the outbred hartley strain was less susceptible, and thus strain 13 has been the preferred model given its assured lethality. the clinical manifestations mirror those seen in humans and rhesus (jahrling et al., 1982) . infection with pichinde virus passaged in guinea pigs has also been used. disease signs include fever, weight loss, vascular collapse, and eventual death (lucia et al., 1990; qian et al., 1994) . the guinea pig is an excellent model given that it not only results in similar disease pattern, viral distribution, histopathology, and immune response to humans (connolly et al., 1993; katz and starr, 1990) . infection of hamsters with a cotton rat isolate of pirital virus is similar to what is characterized in humans, and the nhp and guinea pig models. the virus was injected ip resulting in lethargy and anorexia within 6-7 days. virus was first detected at 3 days, and reached maximum titers within 5 days. neurological symptoms began to appear at the same time, and all animals died by day 9. pneumonitis, pulmonary hemorrhage, and edema were also present (sbrana et al., 2006) . these results were recapitulated with a nonadapted pichinde virus (buchmeier and rawls, 1977; gowen et al., 2005; smee et al., 1993) . the lentiviruses are a subfamily of retroviridae, which includes human immunodeficiency virus (hiv), a virus that infects 0.6% of the world's population. a greater proportion of infections and deaths occur in subsaharan africa. worldwide, there are approximately 1.8 million deaths per year with over 260,000 being children. transmission of hiv occurs by exposure to infectious body fluids. there are two species, hiv-1 and hiv-2, with hiv-2 having lower infectivity and virulence (confined mostly to west africa). the vast majority of cases worldwide are hiv-1 (de cock et al., 2011) . hiv targets t-helper cells (cd4+), macrophages, dendritic cells (fields et al., 2007) . acute infection occurs 2-4 weeks after exposure, with flu-like symptoms and viremia followed by chronic infection. symptoms in the acute phase may include fever, body aches, nausea, vomiting, headache, lymphadenopathy, pharyngitis, rash, and sores in the mouth or esophagus. cd8+ t-cells are activated which kill hiv-infected cells, and are responsible for antibody production and seroconversion. acquired immune deficiency syndrome (aids) develops when cd4+ t-cells decline to less than 200 cells/µl; thus cell-mediated immunity becomes impaired and the person is more susceptible to opportunistic infections as well as certain cancers. hiv has a narrow host range likely because the virus is unable to antagonize and evade effector molecules of the interferon response (thippeshappa et al., 2012) . humanized mice, created by engrafting human cells and tissues into scid mice, have been critical for the development of mouse models for the study of hiv infection. a number of different humanized mouse models allow for the study of hiv infection in the context of an intact and functional human innate and adaptive immune responses (berges and rowan, 2011) . the scidhu hiv infection model has proven useful, particularly in screening antivirals and therapeutics (denton et al., 2008; melkus et al., 2006) . a number of different humanized mouse models have been developed for the study of hiv, including rag1 −/− γc −/− , rag2 −/− γc −/− , nod/scidγc −/− (hnog), nod/scidγc −/− (hnsg), nod/scid blt, and nod/scidγc −/− (hnsg) blt (karpel et al., 2015; li et al., 2015; shimizu et al., 2015) . cd34+ human stem cells derived from umbilical cord blood or fetal liver are used for humanization (baenziger et al., 2006; watanabe et al., 2007) . hiv-1 infection by ip injection can be successful with as little as 5% peripheral blood engraftment (berges et al., 2006) . vaginal and rectal transmission models have been developed in blt scid hu mice in which mice harbor human bone marrow, liver, and thymus tissue. hiv-1 viremia occurs within approximately 7 days postinoculation . in many of these models, spleen, lymph nodes, and thymus tissues are highly positive for virus, similar to humans (brainard et al., 2009) . importantly, depletion of human t-cells can be observed in blood and lymphoid tissues of hivinfected humanized mice and at least some mechanisms of pathogenesis that occur in hiv-infected humans, also occur in the hiv-infected humanized mouse models (baenziger et al., 2006; neff et al., 2011) . the advantage of these models is that these mice are susceptible to hiv infection and thus the impact of drugs on the intended viral targets can be tested. one caveat is that while mice have a "common mucosal immune system," humans do not, due to differences in the distribution of addressins (holmgren and czerkinsky, 2005) . thus, murine mucosal immune responses to hiv do not reflect those of humans. another strategy uses a human cd4-and human ccr5-expressing transgenic luciferase reporter mouse to study hiv-1 pseudovirus entry (gruell et al., 2013) . hiv-1 transgenic (tg) rats are also used to study hiv related pathology, immunopathogenesis, and neuropathology (lentz et al., 2014; reid et al., 2001) . the clinical signs include skin lesions, wasting, respiratory difficulty, and neurological signs. brain volume decreases have been documented and the hiv-1 tg rat is thus used as a model of neuropathology in particular. there are a number of important nhp models for human hiv infection (hessell and haigwood, 2015) . an adaptation of hiv-1 was obtained by four passages in pigtailed macaques transiently depleted of cd8(+) cells during acute infection (hatziioannou et al., 2014) . the resulting disease has several similarities to aids in humans, such as depletion of cd4(+) t-cells (kimata, 2014) . simian immunodeficiency virus (siv) infection of macaques has been widely used as a platform for modeling hiv infection of humans (demberg and robert-guroff, 2015; walker et al., 2015) . importantly, nhps have similar, pharmacokinetics, metabolism, mucosal tcell homing receptors, and vascular addressins to those of humans. thus, while the correlates of protection against hiv are still not completely known, immune responses to hiv infection and vaccination are likely comparable. these models mimic infection through use of contaminated needles (iv), sexual transmission (vaginal or rectal), and maternal transmission in utero or through breast milk (keele et al., 2009; miller et al., 2005; stone et al., 2009) . there are also macaque models to study the emergence and clinical implications of hiv drug resistance (van rompay et al., 2002) . these models most routinely utilize rhesus macaques (macaca mulatta), cynomolgus macaques (m. fasicularis), and pigtailed macaques (macaca nemestrina). all ages are used, depending on the needs of the study. for instance, use of newborn macaques may be more practical for evaluating the effect of prolonged drug therapy on disease progression; however, adult nhps are more frequently employed. female pigtailed macaques have been used to investigate the effect of the menstrual cycle on hiv susceptibility (vishwanathan et al., 2015) . studies are performed in bsl-2 animal laboratories and nhps must be simian type-d retrovirus free and siv seronegative. siv infection of pigtailed macaques is a useful model for hiv peripheral nervous system pathology, wherein an axotomy is performed and regeneration of axons is studied (ebenezer et al., 2012) . exposure in model systems is typically through a single high-dose challenge. iv infection of rhesus macaques with 100 tcid 50 of the highly pathogenic siv/ deltab670 induces aids in most macaques within 5-17 months (mean of 11 months) (fuller et al., 2012) . peak viremia occurs around week 4. aids in such models is often defined as cd4+ t-cells that have dropped to less than 50% of the baseline values. alternatively, repeated low dose challenges are often utilized, depending on the requirements of the model (henning et al., 2014; moldt et al., 2012; reynolds et al., 2012) . since nhps infected with hiv do not develop an infection with a clinical disease course similar to humans, siv or siv/hiv-1 laboratory-engineered chimeric viruses (shivs) are used as surrogates. nhps infected with pathogenic siv may develop clinical disease which progresses to aids, and are thus useful pathogenesis models. a disadvantage is that siv is not identical to hiv-1 and is more closely related to hiv-2. however, the polymerase region of siv is 60% homologous to that of hiv-1 and it is susceptible to many reverse transcriptase (rt) and protease inhibitors. siv is generally not susceptible to nonnucleoside inhibitors, thus hiv-1 rt is usually put into siv for such studies (uberla et al., 1995) . sivmac239 is similar to hiv in the polymerase region and is therefore susceptible to nucleoside, rt, or integrase inhibition (witvrouw et al., 2004) . nhps infected with sivmac239 have an asymptomatic period and disease progression resembling aids in humans, characterized by weight loss/wasting, cd4+ t-cell depletion. additionally, sivmac239 utilizes the cxcr5 chemokine receptor as a coreceptor, similar to hiv, which is important for drugs that target entry (veazey et al., 2003) . nhps infected with shiv strains, may not develop aids, but these models are useful in testing vaccine efficacy . for example, rt-shivs and env-shivs are useful for testing and evaluation of drugs that may target the envelope or rt, respectively (uberla et al., 1995) . one disadvantage of the highly virulent env-shiv (shiv-89.6 p), is that it uses the cxcr4 coreceptor. of note, env-shivs that do use the cxcr5 coreceptor are less virulent; viremia develops then resolves without further disease progression (humbert et al., 2008) . simian-tropic (st) hiv-1 contains the vif gene from siv. infection of pigtailed macaques with this virus results in viremia, which can be detected for 3 months, followed by clearance (haigwood, 2009) . a number of routes are utilized for siv or shiv infection of nhps, with iv inoculation the most common route. mucosal routes include vaginal, rectal, and intracolonic. mucosal routes require a higher one-time dose than the iv route for infection. for the vaginal route, female macaques are treated with depo-provera (estrogen) 1 month before infection to synchronize the menstrual cycle, thin the epithelial lining of the vagina, and increase susceptibility to infection by atraumatic vaginal instillation (burton et al., 2011) . upon vaginal instillation of 500 tcid 50 of shiv-162p3, peak viremia was seen around 12 days postexposure with greater than 10 7 copies/ml and dropping thereafter to a constant level of 10 4 rna copies/ml at 60 days and beyond. in another example, in an investigation of the effect of vaccine plus vaginal microbicide on preventing infection, rhesus macaques were vaginally infected with a high dose of sivmac251 (barouch et al., 2012) . an example of an intrarectal model utilized juvenile (2-year-old) pigtailed macaques, challenged intrarectally with 10 4 tcid 50s of siv mne027 to study the pathogenesis related to the virulence factor, vpx (belshan et al., 2012) . here, viremia peaked at approximately 10 days with more than 10 8 copies/ml. viral rna was expressed in the cells of the mesenteric lymph nodes. the male genital tract is seen as a viral sanctuary with persistent high levels of hiv shedding even with antiretroviral therapy. to better understand the effect of haart therapy on virus and t-cells in the male genital tract, adult (3-to 4-year-old) male cynomolgus macaques were intravenously inoculated with 50 aid50s of sivmac251 and the male genital tract tissues were tested after euthanasia by pcr, ihc, and in situ hybridization (moreau et al., 2012) . pediatric models have been developed in infant rhesus macaques through the infection of siv, allowing for the study of the impact of developmental and immunological differences on the disease course (abel, 2009) . importantly, mother-to-infant transmission models have also been developed (jayaraman et al., 2004) . pregnant female pigtailed macaques were infected during the second trimester with 100 mid 50 shiv-sf162p3 by the iv route. four of nine infants were infected, one in utero and three either intrapartum or immediately postpartum through nursing. this model is useful for the study of factors involved in transmission as well as the underlying immunology. nhps infected with siv or shiv are routinely evaluated for weight loss, activity level, stool consistency, appetite, virus levels in blood, and t-cell populations. cytokine and chemokine levels, antibody responses, and cytotoxic t-lymphocyte responses may also be evaluated. the ultimate goal of an hiv vaccine is sterilizing immunity (preventing infection). however, a more realistic result may be to reduce severity of infection and permanently prevent progression. strategies have included live attenuated, nonreplicating, and subunit vaccines. these have variable efficacy in nhps due to the genetics of the host (mhc and trim alleles), differences between challenge strains, and challenge routes (letvin et al., 2011) . nhp models have led to the development of antiviral treatments that are effective at reducing viral load and indeed transmission of hiv among humans. one preferred variation on the models for testing the long-term clinical consequences of antiviral treatment is to use newborn macaques and treat from birth onward, in some cases more than a decade (van rompay et al., 2008) . unfortunately, however, successes in nhp studies do not always translate to success in humans, as seen with the recent step study which used an adenovirus-based vaccine approach (buchbinder et al., 2008) . vaccinated humans were not protected and may have even been more susceptible to hiv, viremia was not reduced, and the infections were not attenuated as hoped. with regard to challenge route, iv exposure is more difficult to protect than mucosal exposure and is used as a "worst case scenario." however, efficacy at one mucosal route is usually comparable to other mucosal routes. human and animal papillomaviruses cause benign epithelial proliferations (warts) and malignant tumors of the various tissues that they infect (bosch and de sanjose, 2002) . there are over 100 human papillomaviruses, with different strains causing warts on the skin, oropharynx, nasopharynx, larynx, and anogenital tissues. approximately one third of papillomaviruses are transmitted sexually. of these, virulent subtypes, such as hpv-16, hpv-18, hpv-31, hpv-33, and hpv-45 place individuals at high risk for cervical and other cancers. up to 35% of head and neck cancers are caused by hpv-16, particularly oropharyngeal cancers. major challenges in the study of these viruses are that papillomaviruses generally do not infect any other species outside of the natural hosts and can cause a very large spectrum of severity. thus, no wild-type animal models have been identified that are susceptible to hpv. however, a number of useful surrogate models exist which use animal papillomaviruses in their natural host or a very closely related species (borzacchiello et al., 2009; brandsma, 1994; campo, 2002) . these models have facilitated the recent development of useful and highly effective prophylactic hpv vaccines (rabenau et al., 2005) . wild-type inbred mice cannot be used to study disease caused by papillomaviruses unless they are engrafted with relevant tissue, orthotopically transplanted or transgenic, but they are often used to look at immunogenicity of vaccines (jagu et al., 2011; oosterhuis et al., 2011) . transgenic mice used for hpv animal modeling typically express the viral oncogenes e5, e6, e7, or the entire early region of hpv-16 from the keratin 14 promoter which is only active in the basal cells of the mouse epithelium (chow, 2015) . cancers in these models develop upon extended estrogen exposure (maufort et al., 2010; ocadiz-delgado et al., 2009; stelzer et al., 2010; thomas et al., 2011) . transgenic mice with constitutively active wnt/b-catenin signaling in cervical epithelial cells expressing the hpb oncoprotein e7 develop invasive cervical squamous carcinomas (bulut and uren, 2015) . the tumors occur within 6 months approximately 94% of the time. another model uses c57bl/6 mice expressing the hpv16-e7 transgene which are then treated topically with 7,12-dimethylbenz(a)anthracene (dmba) (de azambuja et al., 2014) . these mice developed benign and malignant cutaneous lesions. cervical cancers can also be induced in human cervical cancer xenografts transplanted onto the flanks of athymic mice and serially transplanted thereafter ( hiroshima et al., 2015; siolas and hannon, 2013) . a wild-type immunocompetent rodent model uses m. coucha, which is naturally infected with mastomys natalensis papillomavirus (mnpv) (vinzon et al., 2014) . mnpv induces papillomas, keratoacanthomas, and squamous cell carcinomas and provides a means to study vaccination in an immunocompetent small animal model. wild cottontail rabbits (sylvilagus floridanus) are the natural host for cottontail rabbit papillomavirus (crpv), but this virus also infects domestic rabbits (oryctolagus cuniculus), which is a very closely related species ( breitburd et al., 1997) . in this model, papillomas can range from cutaneous squamous cell carcinomas on one end of spectrum, and spontaneous regression on the other. lesions resulting from crpv in domestic rabbits do not typically contain infectious virus. canine oral papillomavirus (copv) causes florid warty lesions in mucosa of the oral cavity within 4-8 weeks postexposure in experimental settings (johnston et al., 2005) . the mucosatrophic nature of these viruses and the resulting oropharyngeal papillomas that are morphologically similar to human vaginal papillomas caused by hpv-6 and hpv-11 make this a useful model (nicholls et al., 1999) . these lesions typically spontaneously regress 4-8 weeks after appearing; this model is therefore useful in understanding the interplay between the host immune defense and viral pathogenesis. male and female beagles, aged 10 weeks to 2 years, with no history of copv, are typically used for these studies. infection is achieved by application of a 10 µl droplet of virus extract to multiple 0.5 cm 2 scarified areas within the mucosa of the upper lip of anesthetized beagles (nicholls et al., 2001) . some investigators have raised concerns that dogs are not a suitable model for high-risk hpv-induced oral cancer (staff, 2015) . bovine papillomavirus (bpv) has a wider host range than most papillomaviruses, infecting the fibroblasts cells of numerous ungulates (campo, 2002) . bpv-4 infection of cattle feeding on bracken fern, which is carcinogenic, can result in lesions of the oral and esophageal mucosa that lack detectable viral dna. bpv infections in cattle can result in a range of diseases, such as skin warts, cancer of the upper gastrointestinal tract and urinary bladder, and papillomatosis of the penis, teats, and udder. finally, rhesus papillomavirus (rhpv), a sexually transmitted papillomaviruses in rhesus macaques and cynomolgus macaques is very similar to hpv-16 and is associated with the development of cervical cancer ( ostrow et al., 1990; wood et al., 2007) . monkeypox virus (mpxv) causes disease in both animals and humans. human monkeypox, which is clinically almost identical to ordinary smallpox, occurs mostly in the rainforest of central and western africa. the virus is maintained in nature in rodent reservoirs including k. viral disease squirrels (charatan, 2003; khodakevich et al., 1986) . mpxv was discovered during the pox-like disease outbreak among laboratory monkeys (mostly cynomolgus and rhesus macaques) in denmark in 1958. no human cases were observed during this outbreak. the first human case was not recognized as a distinct disease until 1970 in zaire (the present drc) with continued occurrence of a smallpox-like illness despite eradication efforts of smallpox in this area. during the global eradication campaign, extensive vaccination in central africa decreased the incidence of human monkeypox, but the absence of immunity in the generation born since that time and increased dependence on bush meat have resulted in renewed emergence of the disease. in the summer of 2003, a well-known outbreak in the midwest was the first occurrence of monkeypox disease in the united states and western hemisphere. among 72 reported cases, 37 human cases were laboratory confirmed during an outbreak (nalca et al., 2005; sejvar et al., 2004) . it was determined that native prairie dogs (cynomys sp.) housed with rodents imported from ghana in west africa were the primary source of outbreak. the virus is mainly transmitted to humans while handling infected animals or by direct contact with the infected animal's body fluids, or lesions. person-to-person spread occurs by large respiratory droplets or direct contact (jeézek and fenner, 1988) . most of the clinical features of human monkeypox are very similar to those of ordinary smallpox (breman and arita, 1980) . after a 7-to 21-dayincubation period, the disease begins with fever, malaise, headache, sore throat, and cough. the main sign of the disease that distinguishes monkeypox from smallpox is swollen lymph nodes (lymphadenitis), which is observed in most of the patients before the development of rash (di giulio and eckburg, 2004; jeézek and fenner, 1988) . a typical maculopapular rash follows the prodromal period, generally lasting 1-3 days. the average size of the skin lesions are 0.5-1 cm and the progress of lesions follows the order: macules, papules, vesicles, pustules, umblication then scab, and desquamation and lasts typically 2-4 weeks. the fatality rate is 10% among the unvaccinated population and death generally occurs during the 2nd week of the disease (jeézek and fenner, 1988; nalca et al., 2005) . mpxv is highly pathogenic for a variety of laboratory animals and many animal models have been developed by using different species and different routes of exposure (table 33 .3). due to unavailability of variola virus (smallpox) to develop animal models and similar disease manifestations in humans that are similar, mpxv is one of the pox viruses that are utilized very heavily to develop a number of small animal models via different routes of exposure. wild-derived inbred mouse, stat1-deficient c57bl/6 mouse, icr mouse, prairie dogs, african dormice, ground squirrels, and gambian pouched rats are highly susceptible to mpxv by different exposure routes (americo et al., 2010; falendysz et al., 2015; hutson et al., 2009; osorio et al., 2009; sbrana et al., 2007; schultz et al., 2009; sergeev et al., 2016; stabenow et al., 2010; tesh et al., 2004; xiao et al., 2005) . cast/eij mice, one of the 38 inbred mouse strains tested for susceptibility to mpxv, showed weight loss and dose dependent mortality after in exposure to mpxv. studies with ip route of challenge indicated a 50fold higher susceptibility to mpxv when compared to in route (americo et al., 2010) . scid-balb/c mice were also susceptible to the ip challenge route and the disease resulted in mortality on day 9 postinfection (osorio et al., 2009) . similarly, c57bl/6 stat1 −/− mice were infected in with mpxv and the infection resulted in weight loss and mortality 10 days postexposure. recently sergeev et al. (2016) showed that in challenge of icr mice with mpxv resulted in purulent conjunctivitis, blepharitis, and ruffled fur in these mice although there was no death. the mouse models mentioned here are very promising for screening therapeutics against poxviruses but testing in additional models will be required for advanced development. high doses of the mpxv by ip or in routes caused 100% mortality in 6 days postexposure and 8 days postexposure, respectively, in ground squirrels (tesh et al., 2004) . the disease progressed very quickly and most of the animals were lethargic and moribund by day 5 postexposure without any pox lesions or respiratory changes. a comparison study of usa mpxv and central african strain of mpxv strains in ground squirrels by the subq route resulted in systemic disease and mortality in 6-11 days postexposure. the disease resembles hemorrhagic smallpox with nosebleeds, impaired coagulation parameters, and hemorrhage in the lungs of the animals. another study by sergeev et al. (2017) showed that in challenge with mpxv caused fever, lymphadenitis, and skin rash in ground squirrels 7-9 days postexposure. mortality was observed in 40% of the animals 13-22 days postexposure (sergeev et al., 2017) . since mpxv was transmitted by infected prairie dogs in the us outbreak, this animal model has been more thoroughly studied and utilized to test therapeutics and vaccines compared to other small animal models ( hutson et al., 2009; keckler et al., 2011; smith et al., 2011; xiao et al., 2005) . studies using in, ip, and id routes of exposure showed that mpxv was highly infectious to prairie dogs, ip infection with the west african mpxv strain caused a more severe disease and 100% mortality than challenge by the in route. anorexia and lethargy were common signs of the disease for both exposure routes. in contrast to ip route, the in route of exposure caused severe pulmonary edema and necrosis of lungs in prairie dogs, while splenic necrosis and hepatic lesions were observed in ip-infected animals (xiao et al., 2005) . hutson et al. (2009) african and congo basin strains and showed that both strains and routes caused smallpox-like disease with longer incubation periods and most importantly generalized pox lesions. therefore, this model has the utility for testing therapeutics and vaccines against pox viruses. furthermore, mpxv challenged prairie dogs were used to perform in vivo bioluminescent imaging (bli) studies (falendysz et al., 2015) . bli studies showed real time spread of virus in prairie dogs as well as potential routes for shedding and transmission. the african dormouse is susceptible to mpxv by a footpad injection or in routes (schultz et al., 2009) . mice had decreased activity, hunched posture, dehydration, conjunctivitis, and weight loss. viral doses of 200 and 2000 pfu provided 100% mortality with a mean time to death of 8 days. upper gastrointestinal hemorrhage, hepatomegaly, lymphadenopathy, and lung hemorrhage were observed during necropsy. with the hemorrhage in several organs, this model resembles hemorrhagic smallpox. in a recent study, comparison of the disease pathogenesis was performed by using live bioluminescence imaging in the cast/eij mouse and african dormouse challenged with low dose of mpxv (earl et al., 2015) . following in challenge, mpxv dissemination occurred through the blood or lymphatic system in dormice compared to dissemination that was through the nasal cavity and lungs in cast/eij mice. the disease course was much faster in cast/eij mice (earl et al., 2015) . considering the limited availability of prairie dogs, ground squirrels and african dormice, lack of reagents specific for these species, and not having commercial sources of these species, these small animal models are as attractive for further characterization and vaccine, and countermeasure testing studies. nhps were exposed to mpxv by several different routes to develop animal model for mpxv (edghill-smith et al., 2005; johnson et al., 2011; nalca et al., 2010; stittelaar et al., 2006; zaucha et al., 2001) . during our studies using an aerosol route of exposure, we observed that macaques had mild anorexia, depression, fever, and lymphadenopathy on day 6 postexposure (nalca et al., 2010) . complete blood count and clinical chemistries showed abnormalities similar to human monkeypox cases with leukocytosis and thrombocytopenia (huhn et al., 2005) . whole blood and throat swabs had viral loads peak around day 10, and in survivors, gradually decrease until day 28 postexposure. since doses of 4 × 10 4 pfu, 1 × 10 5 pfu, or 1 × 10 6 pfu resulted in lethality for 70% of the animals, whereas a dose of 4 × 10 5 pfu resulted in 85% lethality, survival was not dose dependent. the main pitfall of this model was the lack of pox lesions. with the high dose, animals succumbed to disease before developing pox lesions. with the low challenge dose, pox lesions were observed but they were few in comparison to the iv model. a recent study also evaluated the cytokine levels in aerosol challenged animals. (tree et al., 2015) . tree et al. (2015) showed that ifnγ, il-1rα, and il-6 increased dramatically on day 8 postexposure the day that death was most likely to occur, and viral dna was detected in most of the tissues. these results support the idea of a cytokine storm causing mortality in monkeypox disease. mpxv causes dose dependent disease in nhps when given by the iv route (johnson et al., 2011) . studies showed that a 1 × 10 7 pfu iv challenge results in systemic disease with fever, lymphadenopathy, macula-papular rash, and mortality. an it infection model skips the upper respiratory system and deposits virus into the trachea, delivering the virus directly to the airways without regard to particle size and the physiological deposition that occurs during the process of inhalation. fibrinonecrotic bronchopneumonia was described in animals that received 10 7 pfu of mpxv intratracheally (stittelaar et al., 2006) . although a similar challenge dose of it mpxv infection resulted in a similar viremia in nhps to the aerosol route of infection, the timing of the first peak was delayed by 5 days in intratracheally exposed macaques compared to aerosol infection, and the amount of virus detected by qpcr was approximately 100-fold lower. this suggests that local replication is more prominent after aerosol delivery compared to the it route. an intrabronchial route of exposure resulted in pneumonia in nhps (johnson et al., 2011) . delayed onset of clinical signs and viremia were observed during the disease progression. in this model, similar to aerosol and it infection models, the number of pox lesions was much less than in the iv infection model. a major downside of the iv, it, and intrabronchial models is that the initial infection of respiratory tissue, incubation, and prodromal phases are circumvented with the direct inoculation of virus to the blood stream or to the lung. this is an important limitation when the utility of these models is to test possible vaccines and treatments in which the efficacy may depend on protecting the respiratory mucosa and targeting the subsequent early stages of the infection, which are not represented in these challenge models. although the aerosol model is the natural route of transmission for human varv infections and a secondary route for human mpxv infections, the lack of pox lesions is the main drawback of this model. therefore, when this model is used to test medical countermeasures, the endpoints and the biomarkers to initiate treatment should be chosen carefully. hepatitis b virus (hbv) is one of the most common infections worldwide with over 400 million people chronically infected and 316,000 cases per year of liver cancer due to infection (lee, 1997) . the virus can naturally infect both humans and chimpanzees (guha et al., 2004) . hbv is transmitted parenterally or postnatally from infected mothers. it can also be transmitted by sexual contact, iv drug use, blood transfusion, and acupuncture (lai et al., 2003) . the age at which one is infected dictates the risk of developing chronic disease (hyams, 1995) . acute infection during adulthood is self-limiting and results in flu-like symptoms that can progress to hepatocellular involvement as observed with the development of jaundice. the clinical symptoms of hbv infection last for a few weeks before resolving (ganem and prince, 2004) . after this acute phase, lifetime immunity is achieved (wright and lau, 1993) . of those infected, less than 5% will develop the chronic form of the disease. chronicity is the most serious outcome of the disease as it can result in cirrhosis or liver cancer. hepatocellular carcinoma is 100 times more likely to develop in a chronically infected individual than a noncarrier (beasley, 1988) . the viral determinant for cellular transformation has yet to be determined, although studies involving the woodchuck hepatitis virus suggest that x protein may be responsible (spandau and lee, 1988). many individuals are asymptomatic until complications emerge related to chronic hbv carriage. chimpanzees have a unique strain that circulates within the population (hu et al., 2000; . it was found that 3%-6% of all wild-caught animals from africa are positive for hbv antigen ( lander et al., 1972) . natural and experimental challenge with the virus follows the same course as human disease; however, this is only an acute model of disease (prince, 1972) . to date, chimpanzees are the only reliable method to ensure that plasma vaccines are free from infectious particles (prince and brotman, 2001 ). this animal model has been used to study new therapeutics and vaccines. chimpanzees are especially ideal for these studies given that their immune response to infection directly mirrors humans (nayersina et al., 1993) . recent regulations by the national institute of health (nih) and restrictions to use great apes as animal models forced researches to find alternate models for hbv infection. other nhps that have been evaluated are gibbons, orangutans, and rhesus monkeys. although these animals can be infected with hbv, none develops hepatic lesions or liver damage as noted by monitoring of liver enzymes (pillot, 1990 ). mice are not permissible to infection, and thus numerous transgenic and humanized lines that express hbv proteins have been created to facilitate their usage as an animal model. these include both immunocompetent and immunosuppressed hosts. the caveat to all of these mouse lines is that they reproduce only the acute form of disease (guha et al., 2004) . recently, the entire genome of hbv was transferred to an immunocompetent mouse line via adenovirus. this provides a model for persistent infection (huang et al., 2012) . another model that has been developed is hydrodynamic injection of hbv genomes in the liver of mice (liu et al., 1999; yang et al., 2002) . although this model is very stressful to mice and has liver toxicity, it is successfully used to evaluate antivirals against hbv (mccaffrey et al., 2003) . liver chimeric mouse models are an additional set of surrogate models for hbv infection (dandri and lutgehetmann, 2014) . in these models human hepatocytes are integrated into the murine liver parenchyma (allweiss and dandri, 2016) . this model might be used to test antivirals as well as to study the molecular biology of hbv infection. hbv can also be studied using surrogate viruses, naturally occurring mammalian hepadna viruses (mason et al., 1982) . the woodchuck hepatitis virus induces hepatocellular carcinoma (summers et al., 1978) . within a population, 65%-75% of all neonatal woodchucks are susceptible to chronic infection (cote et al., 2000) . a major difference between the two hepatitis isolates is the rate at which they induce cancer; almost all chronic carriers developed hepatocellular carcinoma within 3 years of the initial infection in woodchucks, whereas human carcinogenesis takes much longer (gerin et al., 1989) . the acute infection strongly resembles what occurs during the course of human disease. there is a self-limiting acute phase resulting in a transient viremia that has the potential of chronic carriage (tennant, 2001) . challenge with virus in neonates leads to a chronic infection while adults only develop the acute phase of disease (buendia, 1992) . a closely related species to the woodchuck is the marmota himalayan. this animal is also susceptible to the woodchuck hepadna virus upon iv injection. the marmot himalayan develops an acute hepatitis with a productive infection (lucifora et al., 2010) . hepatitis d virus (hdv) is dependent upon hbv to undergo replication and successful infection in its human host (gerin, 2001) . there are two modes of infection possible between the viruses: coinfection where a person is simultaneously infected or superinfection in which a chronic carrier of hbv is subsequently infected with hdv (purcell et al., 1987) . coinfection leads to a similar disease as seen with hbv alone; however, superinfection can result in chronic hdv infection and severe liver damage (guilhot et al., 1994) . both coinfection and superinfection can be demonstrated within the chimpanzee and woodchuck by inoculation of human hepatitis d (ponzetto et al., 1991) . a recently published report demonstrated the use of a humanized chimeric upa mouse to study interactions between the two viruses and drug testing (lutgehetmann et al., 2012) new models ranging from nhps to small animals and representing the disease characteristics in humans are necessary to study viral and host factors that drive disease pathogenesis and evaluate medical countermeasures. the ideal animal model for human viral disease should closely recapitulate the spectrum of clinical symptoms and pathogenesis observed during the course of human infection. whenever feasible, the model should use the same virus and strain that infects humans. it is also preferable that the virus is a low passage clinical isolate thus animal passage or adaptation should be avoided if model species can be identified that are susceptible. ideally, the experimental route of infection would mirror that occurs in natural disease. in order to understand the interplay and contribution of the immune system during infection, an immunocompetent animal should be used. the aforementioned characteristics cannot always be satisfied; however, and often virus must be adapted, knockout mice must be used, and/or the disease is not perfectly mimicked in the animal model. well-characterized animal models are critical for licensure to satisfy fda "animal rule." this rule applies to situations in which vaccine and therapeutic efficacy cannot safely or ethically be tested in humans; thus licensure will come only after preclinical tests are performed in animal models. many fields in virology are moving toward standardized models that can be used across institutions to test vaccines and therapeutics. a current example of such an effort is within the filovirus community, where animal models, euthanasia criteria, assays, and virus strains are in the process of being standardized. the hope is that these efforts will enable results of efficacy tests on medical countermeasures compared across institutions. this chapter has summarized the best models available for each of the viruses described. the rhesus macaque pediatric siv infection model-a valuable tool in understanding infant hiv-1 pathogenesis and for designing pediatric hiv-1 prevention strategies prevalence of anti-rift-valley-fever igm antibody in abattoir workers in the nile delta during the 1993 outbreak in egypt common marmosets (callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains replication and shedding of mers-cov in upper respiratory tract of inoculated dromedary camels. emerg generation of a transgenic mouse model of middle east respiratory syndrome coronavirus infection and disease pathological changes in brain and other target organs of infant and weanling mice after infection with nonneuroadapted western equine encephalitis virus particle-to-pfu ratio of ebola virus influences disease course and survival in cynomolgus macaques progress toward norovirus vaccines: considerations for further development and implementation in potential target populations characterization of lethal zika virus infection in ag129 mice experimental in vitro and in vivo models for the study of human hepatitis b virus infection a model of meningococcal bacteremia after respiratory superinfection in influenza a virus-infected mice middle east respiratory syndrome coronavirus: current situation and travel-associated concerns aerosol exposure to the angola strain of marburg virus causes lethal viral hemorrhagic fever in cynomolgus macaques necrotizing scleritis, conjunctivitis, and other pathologic findings in the left eye and brain of an ebola virus-infected rhesus macaque (macaca mulatta) with apparent recovery and a delayed time of death american academy of pediatrics subcommittee on diagnosis and management of bronchiolitis identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models the gerbil, meriones unguiculatus, a model for rift valley fever viral encephalitis morbidity and mortality among patients with respiratory syncytial virus infection: a 2-year retrospective review chikungunya and the nervous system: what we do and do not know the west nile virus outbreak of 1999 in new york: the flushing hospital experience hospital outbreak of middle east respiratory syndrome coronavirus diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses norovirus vaccine against experimental human norwalk virus illness determination of the 50% human infectious dose for norwalk virus an epizootic attributable to western equine encephalitis virus infection in emus in texas evidence for camel-to-human transmission of mers coronavirus integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics disseminated and sustained hiv infection in cd34+ cord blood cell-transplanted rag2 −/− gamma c −/− mice choice of inbred rat strain impacts lethality and disease course after respiratory infection with rift valley fever virus rift valley fever: an uninvited zoonosis in the arabian peninsula recombinant norwalk virus-like particles given orally to volunteers: phase i study tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining lethal antibody enhancement of dengue disease in mice is prevented by fc modification animal models for the study of influenza pathogenesis and therapy effect of oral gavage treatment with znal42 and other metallo-ion formulations on influenza a h5n1 and h1n1 virus infections in mice macaque studies of vaccine and microbicide combinations for preventing hiv-1 sexual transmission early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus hepatitis b virus. the major etiology of hepatocellular carcinoma transmission of norwalk virus during football game vpx is critical for sivmne infection of pigtail macaques experimental respiratory syncytial virus infection of four species of primates pathogenesis and immune response of crimean-congo hemorrhagic fever virus in a stat-1 knockout mouse model crimean-congo hemorrhagic fever virus infection is lethal for adult type i interferon receptor-knockout mice the utility of the new generation of humanized mice to study hiv-1 infection: transmission, prevention, pathogenesis, and treatment hiv-1 infection and cd4 t cell depletion in the humanized rag2 −/− gamma c −/− (rag-hu) mouse model bacterial infections in pigs experimentally infected with nipah virus evaluation of a mouse model for the west nile virus group for the purpose of determining viral pathotypes severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice study of susceptibility to crimean hemorrhagic fever (chf) virus in european and long-eared hedgehogs. tezisy konf manipulation of host factors optimizes the pathogenesis of western equine encephalitis virus infections in mice for antiviral drug development genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in scid mice transplanted with human liver cells chimpanzees as an animal model for human norovirus infection and vaccine development a simple technique for infection of mosquitoes with viruses; transmission of zika virus human papillomavirus research: do we still need animal models? human papillomavirus in cervical cancer development of a hamster model for chikungunya virus infection and pathogenesis a neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection the cotton rat model of respiratory viral infections correlates of immunity to filovirus infection filovirus vaccines induction of robust cellular and humoral virusspecific adaptive immune responses in human immunodeficiency virus-infected humanized blt mice animal models of human-papillomavirus-associated oncogenesis interferon alpha/beta receptor-deficient mice as a model for ebola virus disease zika virus outbreak in rio de janeiro, brazil: clinical characterization, epidemiological and virological aspects co-infection of the cotton rat (sigmodon hispidus) with staphylococcus aureus and influenza a virus results in synergistic disease effectiveness of influenza vaccination the role of the type i interferon response in the resistance of mice to filovirus infection a mouse model for evaluation of prophylaxis and therapy of ebola hemorrhagic fever the rabbit viral skin papillomas and carcinomas: a model for the immunogenetics of hpv-associated carcinogenesis the confirmation and maintenance of smallpox eradication a lethal disease model for hantavirus pulmonary syndrome in immunosuppressed syrian hamsters infected with sin nombre virus nonhuman primate models of chikungunya virus infection and disease tissue tropism and neuroinvasion of west nile virus do not differ for two mouse strains with different survival rates pediatric norovirus diarrhea in nicaragua efficacy assessment of a cell-mediated immunity hiv-1 vaccine (the step study): a double-blind, randomised, placebo-controlled, test-of-concept trial variation between strains of hamsters in the lethality of pichinde virus infections hepatitis b viruses and hepatocellular carcinoma generation of k14-e7/n87betacat double transgenic mice as a model of cervical cancer limited or no protection by weakly or nonneutralizing antibodies against vaginal shiv challenge of macaques compared with a strongly neutralizing antibody a novel vaccine against crimean-congo haemorrhagic fever protects 100% of animals against lethal challenge in a mouse model interleukin-1beta but not tumor necrosis factor is involved in west nile virusinduced langerhans cell migration from the skin in c57bl/6 mice animal models of papillomavirus pathogenesis immunization of knock-out alpha/beta interferon receptor mice against high lethal dose of crimean-congo hemorrhagic fever virus with a cell culture based vaccine characterization of the localized immune response in the respiratory tract of ferrets following infection with influenza a and b viruses lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues a small nonhuman primate model for filovirus-induced disease severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus outbreak of acute illness-southwestern united states outbreak of west nile-like viral encephalitis-new york, 1999. mmwr morb. mortal in vitro whole-virus binding of a norovirus genogroup ii genotype 4 strain to cells of the lamina propria and brunner's glands in the human duodenum animal models for studying dengue pathogenesis and therapy us doctors investigate more than 50 possible cases of monkeypox mechanism of neuroinvasion of venezuelan equine encephalitis virus in the mouse chikungunya outbreaks-the globalization of vectorborne diseases inactivated and live, attenuated influenza vaccines protect mice against influenza: streptococcus pyogenes super-infections pathogenesis of a genogroup ii human norovirus in gnotobiotic pigs the immunobiology of sars* induction of tetravalent protective immunity against four dengue serotypes by the tandem domain iii of the envelope protein norovirus infection as a cause of diarrhea-associated benign infantile seizures comparative pathogenesis of epidemic and enzootic chikungunya viruses in a pregnant rhesus macaque model development of norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of norwalk virus gastroenteritis viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome a single sublingual dose of an adenovirus-based vaccine protects against lethal ebola challenge in mice and guinea pigs model systems to study the life cycle of human papillomaviruses and hpv-associated cancers primary severe acute respiratory syndrome coronavirus i nfection limits replication but not lung inflammation upon homologous rechallenge viral and host factors in human respiratory syncytial virus pathogenesis pathogenesis of pichinde virus infection in strain 13 guinea pigs: an immunocytochemical, virologic, and clinical chemistry study pathogenesis of experimental ebola virus infection in guinea pigs transcriptional profiling of the immune response to marburg virus infection the use of a neonatal mouse model to study respiratory syncytial virus infections a model of denv-3 infection that recapitulates severe disease and highlights the importance of ifn-gamma in host resistance to infection effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection a mouse model for chikungunya: young age and inefficient type-i interferon signaling are risk factors for severe disease mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice comparison of the pathogenesis of the angola and ravn strains of marburg virus in the outbred guinea pig model the brazilian zika virus strain causes birth defects in experimental models age at first viral infection determines the pattern of t cell-mediated disease during reinfection in adulthood lassa fever encephalopathy: clinical and laboratory findings profound and prolonged lymphocytopenia with west nile encephalitis first complete genome sequence of zika virus (flaviviridae, flavivirus) from an autochthonous transmission in brazil viral haemorrhagic fevers caused by lassa, ebola, and marburg viruses the enhancement or prevention of airway hyperresponsiveness during reinfection with respiratory syncytial virus is critically dependent on the age at first infection and il-13 production mouse models of hepatitis b and delta virus infection [experimental inhalation infection of monkeys of the macacus cynomolgus and macacus rhesus species with the virus kinetic profile of influenza virus infection in three rat strains pathology of experimental ebola virus infection in african green monkeys. involvement of fibroblastic reticular cells validation of an hpv16-mediated carcinogenesis mouse model middle east respiratory syndrome coronavirus (mers-cov) causes transient lower respiratory tract infection in rhesus macaques selection of unadapted, pathogenic shivs encoding newly transmitted hiv-1 envelope proteins b-cells and the use of non-human primates for evaluation of hiv vaccine candidates antiretroviral pre-exposure prophylaxis prevents vaginal transmission of hiv-1 in humanized blt mice innate and adaptive immune responses determine protection against disseminated infection by west nile encephalitis virus rift valley fever virus encephalitis is associated with an ineffective systemic immune response and activated t cell infiltration into the cns in an immunocompetent mouse model evidence of sexual transmission of zika virus a susceptible mouse model for zika virus infection identification of a novel coronavirus in patients with severe acute respiratory syndrome subclinical infection without encephalitis in mice following intranasal exposure to nipah virus-malaysia and nipah virus-bangladesh nonhuman primate models of encephalitic alphavirus infection: historical review and future perspectives mortality due to influenza in the united states-an annualized regression approach using multiple-cause mortality data distinct pathogenesis of hong kong-origin h5n1 viruses in mice compared to that of other highly pathogenic h5 avian influenza viruses postexposure antibody prophylaxis protects nonhuman primates from filovirus disease comparative live bioluminescence imaging of monkeypox virus dissemination in a wild-derived inbred mouse (mus musculus castaneus) and outbred african dormouse (graphiurus kelleni) siv-induced impairment of neurovascular repair: a potential role for vegf smallpox vaccine does not protect macaques with aids from a lethal monkeypox virus challenge influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor distinct cellular immune responses following primary and secondary influenza virus challenge in cotton rats an outbreak of viral gastroenteritis following environmental contamination at a concert hall natural history of aerosol exposure with marburg virus in rhesus macaques experimental congo virus (ib-an7620) infection in primates further assessment of monkeypox virus infection in gambian pouched rats (cricetomys gambianus) using in vivo bioluminescent imaging respiratory syncytial virus infection in elderly and high-risk adults infection with mers-cov causes lethal pneumonia in the common marmoset immune response to marburg virus angola infection in nonhuman primates fields' virology the susceptibility of rats to rift valley fever in relation to age henipavirus susceptibility to environmental variables pause on avian flu transmission research aetiology: koch's postulates fulfilled for sars virus spinal cord neuropathology in human west nile virus infection therapeutic dna vaccine induces broad t cell responses in the gut and sustained protection from viral rebound and aids in siv-infected rhesus macaques hepatitis b virus infection-natural history and clinical consequences biological heterogeneity, including systemic replication in mice, of h5n1 influenza a virus isolates from humans in hong kong chikungunya virus arthritis in adult wild-type mice epidemiology and clinical presentations of the four human coronaviruses 229e, hku1, nl63, and oc43 detected over 3 years using a novel multiplex real-time pcr method development of an acute and highly pathogenic nonhuman primate model of nipah virus infection animal models of hepatitis delta virus infection and disease hepadnavirusinduced liver cancer in woodchucks experimental infection and natural contact exposure of dogs with avian influenza virus (h5n1). emerg megaribavirin aerosol for the treatment of influenza a virus infections in mice discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-pcr chinchilla and murine models of upper respiratory tract infections with respiratory syncytial virus mechanisms of host defense following severe acute respiratory syndromecoronavirus (sars-cov) pulmonary infection of mice studies on the virus of venezuelan equine encephalomyelitis. i. modification by cortisone of the response of the central nervous system of macaca mulatta serious morbidity and mortality associated with influenza epidemics a novel respiratory model of infection with monkeypox virus in cynomolgus macaques clinical features of nipah virus encephalitis among pig farmers in malaysia monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention animal models of highly pathogenic rna viral infections: hemorrhagic fever viruses interferon alfacon-1 protects hamsters from lethal pichinde virus infection primary respiratory syncytial virus infection in mice pneumonitis and multiorgan system disease in common marmosets (callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus clinical and laboratory features that differentiate dengue from other febrile illnesses in an endemic area-puerto rico acute and chronic airway disease after human respiratory syncytial virus infection in cotton rats (sigmodon hispidus) alphaviruses replication fitness determines high virulence of influenza a virus in mice carrying functional mx1 resistance gene antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal hiv-1 infection in a transgenic mouse model characterization of influenza a/hongkong/156/97 (h5n1) virus in a mouse model and protective effect of zanamivir on h5n1 infection in mice epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century cell culture and animal models of viral hepatitis. part i: hepatitis b expression of the hepatitis delta virus large and small antigens in transgenic mice acute hendra virus infection: analysis of the pathogenesis and passive antibody protection in the hamster model lassa fever encephalopathy: lassa virus in cerebrospinal fluid but not in serum 1, 5-iodonaphthyl azide-inactivated v3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus dengue: an update pegylated interferonalpha protects type 1 pneumocytes against sars coronavirus infection in macaques asymptomatic middle east respiratory syndrome coronavirus infection in rabbits head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model update on animal models for hiv research norovirus disease in the united states. emerg cardiopulmonary manifestations of hantavirus pulmonary syndrome serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus hendra virus infection in a veterinarian a phase 1 clinical trial of a dna vaccine for venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation deaths from norovirus among the elderly, england and wales. emerg aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets hiv-1-induced aids in monkeys west nile fever short communication: viremic control is independent of repeated low-dose shivsf162p3 exposures pathogenesis of marburg hemorrhagic fever in cynomolgus macaques pathogenesis of lassa fever in cynomolgus macaques niemann-pick c1 is essential for ebolavirus replication and pathogenesis in vivo airborne transmission of influenza a/ h5n1 virus between ferrets animal models in hiv-1 protection and therapy advances in rsv vaccine research and development-a global agenda transmission of zika virus through sexual contact with travelers to areas of ongoing transmissioncontinental united states establishment of a patient-derived orthotopic xenograft (pdox) model of her-2-positive cervical cancer expressing the clinical metastatic pattern resolution of primary severe acute respiratory syndromeassociated coronavirus infection requires stat1 mucosal immunity and vaccines nipah virus outbreak with person-to-person transmission in a district of bangladesh eastern equine encephalitis virus in mice i: clinical course and outcome are dependent on route of exposure the lesions of experimental equine morbillivirus disease in cats and guinea pigs a lethal disease model for hantavirus pulmonary syndrome hantaan/ andes virus dna vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates persistent infection with and serologic cross-reactivity of three novel murine noroviruses molecular characterization of three novel murine noroviruses identification of hepatitis b virus indigenous to chimpanzees manifestation of thrombocytopenia in dengue-2-virusinfected mice transfer of hbv genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice west nile fever-a reemerging mosquito-borne viral disease in europe. emerg live, attenuated influenza virus (laiv) vehicles are strong inducers of immunity toward influenza b virus clinical characteristics of human monkeypox, and risk factors for severe disease shiv-1157i and passaged progeny viruses encoding r5 hiv-1 clade c env cause aids in rhesus monkeys norwalk virus infection associates with secretor status genotyped from sera a prairie dog animal model of systemic orthopoxvirus disease using west african and congo basin strains of monkeypox virus risks of chronicity following acute hepatitis b virus infection: a review the pathogenesis of rift valley fever experimental adaptation of an influenza h5 ha confers respiratory droplet transmission to a reassortant h5 ha/h1n1 virus in ferrets pathogenicity of a highly pathogenic avian influenza virus, a/chicken/yamaguchi/7/04 (h5n1) in different species of birds and mammals respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice a multimeric l2 vaccine for prevention of animal papillomavirus infections lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin pathogenesis of lassa virus infection in guinea pigs perinatal transmission of shiv-sf162p3 in macaca nemestrina human monkeypox and other poxvirus infections of man cd209l (l-sign) is a receptor for severe acute respiratory syndrome coronavirus glycomic characterization of respiratory tract tissues of ferrets: implications for its use in influenza virus infection studies comparative analysis of monkeypox virus infection of cynomolgus macaques by the intravenous or intrabronchial inoculation route phenotypic changes in langerhans' cells after infection with arboviruses: a role in the immune response to epidermally acquired viral infection? protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes detailed analysis of the african green monkey model of nipah virus disease experimental inoculation of egyptian rousette bats (rousettus aegyptiacus) with viruses of the ebolavirus and marburgvirus genera treatment of venezuelan equine encephalitis virus infection with (-)-carbodine c3h/hen mouse model for the evaluation of antiviral agents for the treatment of venezuelan equine encephalitis virus infection blt humanized mice as a small animal model of hiv infection stat1-dependent innate immunity to a norwalk-like virus pichinde virus infection in strain 13 guinea pigs reduces intestinal protein reflection coefficient with compensation establishment of the black-tailed prairie dog (cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high-and low-dose monkeypox virus challenges low-dose rectal inoculation of rhesus macaques by sivsme660 or sivmac251 recapitulates human mucosal infection by hiv-1 new opportunities for field research on the pathogenesis and treatment of lassa fever gastrointestinal norovirus infection associated with exacerbation of inflammatory bowel disease isolation of monkeypox virus from wild squirrel infected in nature in hot pursuit of the first vaccine against respiratory syncytial virus pathogenesis of hantaan virus infection in suckling mice: clinical, virologic, and serologic observations respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine the severe pathogenicity of alveolar macrophage-depleted ferrets infected with 2009 pandemic h1n1 influenza virus mouse adaptation of influenza b virus increases replication in the upper respiratory tract and results in droplet transmissibility in ferrets stepping toward a macaque model of hiv-1 induced vomiting as a symptom and transmission risk in norovirus illness: evidence from human challenge studies wild-type puumala hantavirus infection induces cytokines, c-reactive protein, creatinine, and nitric oxide in cynomolgus macaques aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus adenovirus-based vaccine prevents pneumonia in ferrets challenged with the sars coronavirus and stimulates robust immune responses in macaques replication, pathogenicity, shedding, and transmission of zaire ebolavirus in pigs west nile viral encephalitis foodborne viruses: an emerging problem low pathogenic avian influenza a(h7n9) virus causes high mortality in ferrets upon intratracheal challenge: a model to study intervention strategies filoviruses: a compendium of 40 years of epidemiological, clinical, and laboratory studies pathology of human influenza a (h5n1) virus infection in cynomolgus macaques (macaca fascicularis) dengue virus infection and immune response in humanized rag2(-/-)gamma(c) (-/-) (rag-hu) mice chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages viral hepatitis b strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine origin of the west nile virus responsible for an outbreak of encephalitis in the northeastern united states antibody to hepatitis-associated antigen. frequency and pattern of response as detected by radioimmunoprecipitation severe acute respiratory syndrome coronavirus-like virus in chinese horseshoe bats coronavirus hku1 and other coronavirus infections in hong kong epidemic rift valley fever in egypt: observations of the spectrum of human illness hantaviruses. a short review hepatitis b virus infection quantitative measurement of influenza virus replication using consecutive bronchoalveolar lavage in the lower respiratory tract of a ferret model characterization of the activity of 2'-c-methylcytidine against dengue virus replication diffusion tensor and volumetric magnetic resonance measures as biomarkers of brain damage in a small animal model of hiv sequencing, annotation, and characterization of the influenza ferret infectome lethality and pathogenesis of airborne infection with filoviruses in a129 alpha/beta −/− interferon receptor-deficient mice experimental inoculation study indicates swine as a potential host for hendra virus early initiation of antiretroviral therapy can functionally control productive hiv-1 infection in humanized-blt mice zika virus disrupts neural progenitor development and leads to microcephaly in mice middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4 immunogenicity and protective efficacy of a recombinant subunit west nile virus vaccine in rhesus monkeys study of dengue virus infection in scid mice engrafted with human k562 cells a comparative study of the pathogenesis of western equine and eastern equine encephalomyelitis viral infections in mice by intracerebral and subcutaneous inoculations hydrodynamics-based transfection in animals by systemic administration of plasmid dna the emergence of nipah virus, a highly pathogenic paramyxovirus the guinea pig as a transmission model for human influenza viruses transmission in the guinea pig model a mouse model for the evaluation of pathogenesis and immunity to influenza a (h5n1) viruses isolated from humans transmission of human infection with nipah virus recurrent zoonotic transmission of nipah virus into humans the effect of an arenavirus infection on liver morphology and function hepatitis b virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model ebola virus disease in mice with transplanted human hematopoietic stem cells arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation humanized chimeric upa mouse model for the study of hepatitis b and d virus interactions and preclinical drug evaluation role of dendritic cell targeting in venezuelan equine encephalitis virus pathogenesis detection of hepatitis b virus infection in wild-born chimpanzees (pan troglodytes verus): phylogenetic relationships with human and other primate genotypes proportion of deaths and clinical features in bundibugyo ebola virus infection the ferret: an animal model to study influenza virus local innate immune responses and influenza virus transmission and virulence in ferrets vomiting larry: a simulated vomiting system for assessing environmental contamination from projectile vomiting related to norovirus infection studies on the pathogenesis of dengue infection in monkeys. 3. sequential distribution of virus in primary and heterologous infections studies on dengue 2 virus infection in cyclophosphamide-treated rhesus monkeys crimean-congo hemorrhagic fever experimental infection of squirrel monkeys with nipah virus. emerg a school outbreak of norwalk-like virus: evidence for airborne transmission virology: sars virus infection of cats and ferrets characterization of clinical and immunological parameters during ebola virus infection of rhesus macaques delayed disease progression in cynomolgus macaques infected with ebola virus makona strain. emerg asymmetric replication of duck hepatitis b virus dna in liver cells: free minusstrand dna human and avian influenza viruses target different cell types in cultures of human airway epithelium a role for hpv16 e5 in cervical carcinogenesis replication of sars coronavirus administered into the respiratory tract of african green, rhesus and cynomolgus monkeys inhibition of hepatitis b virus in mice by rna interference zika virus was transmitted by sexual contact in texas, health officials report lassa fever. effective therapy with ribavirin lassa virus hepatitis: a study of fatal lassa fever in humans lethal infection of k18-hace2 mice infected with severe acute respiratory syndrome coronavirus andes virus infection of cynomolgus macaques regional t-and b-cell responses in influenza-infected ferrets clinical aspects of marburg hemorrhagic fever humanized mice mount specific adaptive and innate immune responses to ebv and tsst-1 isolation from human sera in egypt of a virus apparently identical to west nile virus middle east respiratory syndrome coronavirus in bats, saudi arabia. emerg chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity reduced clearance of respiratory syncytial virus infection in a preterm lamb model dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the middle east respiratory syndrome experimental nipah virus infection in pigs and cats experimental nipah virus infection in pteropid bats (pteropus poliocephalus) an in-depth analysis of original antigenic sin in dengue virus infection propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus rift valley fever virus in mice. i. general features of the infection zika virus infection during pregnancy in mice causes placental damage and fetal demise outbreaks of acute gastroenteritis associated with norwalk-like viruses in campus settings a nonfucosylated variant of the anti-hiv-1 monoclonal antibody b12 has enhanced fcgammariiiamediated antiviral activity in vitro but does not improve protection against mucosal shiv challenge in macaques flaviviruses experimental studies of rhesus monkeys infected with epizootic and enzootic subtypes of venezuelan equine encephalitis virus necrotizing myocarditis in mice infected with western equine encephalitis virus: clinical, electrocardiographic, and histopathologic correlations aedes albopictus in the united states: ten-year presence and public health implications. emerg severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume impact of short-term haart initiated during the chronic stage or shortly post-exposure on siv infection of male genital organs influence of age on susceptibility and on immune response of mice to eastern equine encephalomyelitis virus a mouse model of chikungunya virusinduced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence dengue virus tropism in humanized mice recapitulates human dengue fever functional role of type i and type ii interferons in antiviral defense the occurrence of human cases in johannesburg. s feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine vertical transmission and fetal replication of nipah virus in an experimentally infected cat pathogenesis and transmission of swine-origin 2009 a(h1n1) influenza virus in ferrets pneumonia from human coronavirus in a macaque model eastern equine encephalitis virus infection: electron microscopic studies of mouse central nervous system evaluation of three strains of influenza a virus in humans and in owl, cebus, and squirrel monkeys a novel morbillivirus pneumonia of horses and its transmission to humans. emerg a morbillivirus that caused fatal disease in horses and humans global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis cchf infection among animals reemergence of monkeypox: prevalence, diagnostics, and countermeasures experimental infection of cynomolgus macaques (macaca fascicularis) with aerosolized monkeypox virus eastern equine encephalitis. distribution of central nervous system lesions in man and rhesus monkey hla a2 restricted cytotoxic t lymphocyte responses to multiple hepatitis b surface antigen epitopes during hepatitis b virus infection an aptamer-sirna chimera suppresses hiv-1 viral loads and protects from helper cd4(+) t cell decline in humanized mice severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ace2 ferrets exclusively synthesize neu5ac and express naturally humanized influenza a virus receptors field's virology naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection regression of canine oral papillomas is associated with infiltration of cd4+ and cd8+ lymphocytes diversifying animal models: the use of hispid cotton rats (sigmodon hispidus) in infectious diseases induction of focal epithelial hyperplasia in tongue of young bk6-e6/e7 hpv16 transgenic mice the contribution of animal models to the understanding of the host range and virulence of influenza a viruses evaluation of antiviral efficacy of ribavirin, arbidol, and t-705 (favipiravir) in a mouse model for crimean-congo hemorrhagic fever evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact a novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activity human respiratory syncytial virus a2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs common marmoset (callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity changes in hematological and serum biochemical parameters in common marmosets (callithrix jacchus) after inoculation with dengue virus middle east respiratory syndrome coronavirus (mers-cov): animal to human interaction dengue virus-induced hemorrhage in a nonhuman primate model preclinical development of highly effective and safe dna vaccines directed against hpv 16 e6 and e7 a novel small molecule inhibitor of influenza a viruses that targets polymerase function and indirectly induces interferon comparison of monkeypox viruses pathogenesis in mice by in vivo imaging a rhesus monkey model for sexual transmission of a papillomavirus isolated from a squamous cell carcinoma infection of calves with bovine norovirus giii. 1 strain jena virus: an experimental model to study the pathogenesis of norovirus infection the cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis zika virus disease in colombia-preliminary report genetic diversity, distribution, and serological features of hantavirus infection in five countries in south america liver injury and viremia in mice infected with dengue-2 virus the hamster as an animal model for eastern equine encephalitis-and its use in studies of virus entrance into the brain a recombinant hendra virus g glycoprotein-based subunit vaccine protects ferrets from lethal hendra virus challenge identification of an antioxidant small-molecule with broad-spectrum antiviral activity impaired heterologous immunity in aged ferrets during sequential influenza a h1n1 infection influenza transmission in the mother-infant dyad leads to severe disease, mammary gland infection, and pathogenesis by regulating host responses economic impact of respiratory syncytial virus-related illness in the us: an analysis of national databases inhibitory potential of neem (azadirachta indica juss) leaves on dengue virus type-2 replication systematic literature review of role of noroviruses in sporadic gastroenteritis. emerg sars: what have we learned? the severe acute respiratory syndrome severe acute respiratory syndrome bacterial sinusitis and otitis media following influenza virus infection in ferrets neuropathology of h5n1 virus infection in ferrets the draft genome sequence of the ferret (mustela putorius furo) facilitates study of human respiratory disease immunopathogenesis of coronavirus infections: implications for sars hantavirus pulmonary syndrome: the new american hemorrhagic fever rift valley fever inbred rat strains mimic the disparate human response to rift valley fever virus infection experimental studies of arenaviral hemorrhagic fevers experimental rift valley fever in rhesus macaques bovine respiratory syncytial virus protects cotton rats against human respiratory syncytial virus infection human hendra virus encephalitis associated with equine outbreak molecularly engineered live-attenuated chimeric west nile/dengue virus vaccines protect rhesus monkeys from west nile virus structure as revealed by airway dissection. a comparison of mammalian lungs study on west nile virus persistence in monkeys experimental hepatitis delta virus infection in the animal model changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus grune and stratton. hepatitis and blood transfusion perspectives on hepatitis b studies with chimpanzees pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (sigmodon hispidus) experimental hepatitis delta virus infection in the chimpanzee relative infectivity of hepatitis a virus by the oral and intravenous routes in 2 species of nonhuman primates cardiovascular and pulmonary responses to pichinde virus infection in strain 13 guinea pigs establishment and characterization of a lethal mouse model for the angola strain of marburg virus stability and inactivation of sars coronavirus possibility of extracting hyperimmune gammaglobulin against chf from doneky blood sera dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-emc swine as a model for influenza a virus infection and immunity zika virus: an update on epidemiology, pathology, molecular biology, and animal model oseltamivir population pharmacokinetics in the ferret: model application for pharmacokinetic/pharmacodynamic study design aerosol exposure to western equine encephalitis virus causes fever and encephalitis in cynomolgus macaques severe encephalitis in cynomolgus macaques exposed to aerosolized eastern equine encephalitis virus differences in aerosolization of rift valley fever virus resulting from choice of inhalation exposure chamber: implications for animal challenge studies an hiv-1 transgenic rat that develops hiv-related pathology and immunologic dysfunction a trivalent recombinant ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous siv challenge infection with chikungunya virus in italy: an outbreak in a temperate region a single dose of an iscom influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect cynomolgus macaques against distant drift variants of influenza a (h3n2) viruses influenza a virus (h5n1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts immunomodulation with il-4r alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease animal models for sars aged balb/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans a mouse-adapted sars-coronavirus causes disease and mortality in balb/c mice transmission of a 2009 h1n1 pandemic influenza virus occurs before fever is detected, in the ferret model experimental norovirus infections in non-human primates synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice a novel model of lethal hendra virus infection in african green monkeys and the effectiveness of ribavirin treatment clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection recent progress in henipavirus research: molecular biology, genetic diversity, animal models mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever sars vaccines: where are we? animal models of rift valley fever virus infection characterization of a novel coronavirus associated with severe acute respiratory syndrome macaque model for severe acute respiratory syndrome pathogenesis of aerosolized eastern equine encephalitis virus infection in guinea pigs pathophysiology of hantavirus pulmonary syndrome in rhesus macaques virulence and pathophysiology of the congo basin and west african strains of monkeypox virus in non-human primates arenaviridae. virus taxonomy, viiith report of the international committee on taxonomy of viruses clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with pirital virus (arenaviridae): a rodent model of lassa fever comparative pathology of north american and central african strains of monkeypox virus in a ground squirrel model of the disease biomedical applications of sheep models: from asthma to vaccines bunyaviruses the use of an animal model to study transmission of influenza virus infection experimental infection of an african dormouse (graphiurus kelleni) with monkeypox virus animal noroviruses human monkeypox infection: a family cluster in the midwestern united states the possibility of using the icr mouse as an animal model to assess antimonkeypox drug efficacy using the ground squirrel (marmota bobak) as an animal model to assess monkeypox drug efficacy experimental inoculation of juvenile rhesus macaques with primate enteric caliciviruses a rodent model of chikungunya virus infection in rag1 −/− mice, with features of persistence, for vaccine safety evaluation respiratory syncytial virus (rsv) pulmonary infection in humanized mice induces human anti-rsv immune responses and pathology viremia and antibody response of small african and laboratory animals to crimean-congo hemorrhagic fever virus infection early activation of natural killer and b cells in response to primary dengue virus infection in a/j mice murine model for dengue virus-induced lethal disease with increased vascular permeability in vitro and in vivo assay systems for study of influenza virus inhibitors viruses of the bunya-and togaviridae families: potential as bioterrorism agents and means of control potential role of immunomodulators for treatment of phlebovirus infections of animals patient-derived tumor xenografts: transforming clinical samples into mouse models treatment of lethal pichinde virus infections in weanling lvg/lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen a comparative study of the crimean hemorrhagic fever-congo group of viruses the pathogenesis of rift valley fever virus in the mouse model effective antiviral treatment of systemic orthopoxvirus disease: st-246 treatment of prairie dogs infected with monkeypox virus a neurotropic virus isolated from the blood of a native uganda comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity experimental respiratory marburg virus haemorrhagic fever infection in the common marmoset experimental respiratory infection of marmosets (callithrix jacchus) with ebola virus kikwit essential role of platelet-activating factor receptor in the pathogenesis of dengue virus infection respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs trans-activation of viral enhancers by the hepatitis b virus x protein filamentous influenza a virus infection predisposes mice to fatal septicemia following superinfection with streptococcus pneumoniae serotype 3 contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. elife 2, e00481. stabenow correction: a retrospective investigation on canine papillomavirus 1 (cpv1) in oral oncogenesis reveals dogs are not a suitable animal model for high-risk hpv-induced oral cancer clinical profiles associated with influenza disease in the ferret model comparative neurovirulence and tissue tropism of wild-type and attenuated strains of venezuelan equine encephalitis virus administered by aerosol in c3h/hen and balb/c mice a mouse model for human anal cancer first reported cases of hantavirus pulmonary syndrome in canada antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection evaluation of intravenous zanamivir against experimental influenza a (h5n1) virus infection in cynomolgus macaques ferrets as a novel animal model for studying human respiratory syncytial virus infections in immunocompetent and immunocompromised hosts differential pathogenesis of respiratory syncytial virus clinical isolates in balb/c mice limited dissemination of pathogenic siv after vaginal challenge of rhesus monkeys immunized with a live, attenuated lentivirus experimental west nile virus infection in rabbits: an alternative model for studying induction of disease and virus control a virus similar to human hepatitis b virus associated with hepatitis and hepatoma in woodchucks development of animal models against emerging coronaviruses: from sars to mers coronavirus severe seasonal influenza in ferrets correlates with reduced interferon and increased il-6 induction the clinical pathology of crimean-congo hemorrhagic fever human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes nipah virus encephalitis profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers distribution of viral antigens and development of lesions in chicken embryos inoculated with nipah virus characterization and demonstration of the value of a lethal mouse model of middle east respiratory syndrome coronavirus infection and disease the origin and virulence of the 1918 "spanish" influenza virus the pathology of influenza virus infections isolation of west nile virus from culex mosquitoes recombinant respiratory syncytial virus that does not express the ns1 or m2-2 protein is highly attenuated and immunogenic in chimpanzees animal models of hepadnavirus-associated hepatocellular carcinoma mouse models for chikungunya virus: deciphering immune mechanisms responsible for disease and pathology human monoclonal antibody as prophylaxis for sars coronavirus infection in ferrets experimental infection of ground squirrels (spermophilus tridecemlineatus) with monkeypox virus. emerg persistent west nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections risk factors in dengue shock syndrome breaking barriers to an aids model with macaque-tropic hiv-1 derivatives dominant role of hpv16 e7 in anal carcinogenesis ribavirin efficacy in an in vivo model of crimean-congo hemorrhagic fever virus (cchf) infection histopathologic and immunohistochemical characterization of nipah virus infection in the guinea pig sequence of pathogenic events in cynomolgus macaques infected with aerosolized monkeypox virus severe acute respiratory syndrome coronavirus infection of mice transgenic for the human angiotensin-converting enzyme 2 virus receptor immunization with sars coronavirus vaccines leads to pulmonary immunopathology on challenge with the sars virus protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the syrian hamster model of lethal ebola virus infection persistence of human norovirus rt-qpcr signals in simulated gastric fluid outbreak of necrotizing enterocolitis caused by norovirus in a neonatal intensive care unit pathology of experimental aerosol zaire ebolavirus infection in rhesus macaques experimental aerosolized guinea pig-adapted zaire ebolavirus (variant: mayinga) causes lethal pneumonia in guinea pigs animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors a human lung xenograft mouse model of nipah virus infection human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals virulence and reduced fitness of simian immunodeficiency virus with the m184v mutation in reverse transcriptase chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects use of a small molecule ccr5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection experimental infection of rhesus macaques and common marmosets with a european strain of west nile virus protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model cataloguing of potential hiv susceptibility factors during the menstrual cycle of pig-tailed macaques by using a systems biology approach temporal analysis of andes virus and sin nombre virus infections of syrian hamsters anti-alpha4 integrin antibody blocks monocyte/macrophage traffic to the heart and decreases cardiac pathology in a siv infection model of aids clinical manifestations, laboratory findings, and treatment outcomes of sars patients. emerg prevalence of noroviruses and sapoviruses in swine of various ages determined by reverse transcription-pcr and microwell hybridization assays porcine enteric caliciviruses: genetic and antigenic relatedness to human caliciviruses, diagnosis and epidemiology avian influenza viruses, inflammation, and cd8(+) development of a model for marburgvirus based on severe-combined immunodeficiency mice development and characterization of a mouse model for marburg hemorrhagic fever euthanasia assessment in ebola virus infected nonhuman primates hematopoietic stem cell-engrafted nod/scid/ il2rgamma null mice develop human lymphoid systems and induce long-lasting hiv-1 infection with specific humoral immune responses the magnitude of dengue virus ns1 protein secretion is strain dependent and does not correlate with severe pathologies in the mouse infection model human fatal zaire ebolavirus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis immunization with modified vaccinia virus ankarabased recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets invasion of the central nervous system in a porcine host by nipah virus development of a rift valley fever virus viremia challenge model in sheep and goats antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever an unusual hantavirus outbreak in southern argentina: person-to-person transmission? hantavirus pulmonary syndrome study group for patagonia. emerg equine morbillivirus pneumonia: susceptibility of laboratory animals to the virus susceptibility of cats to equine morbillivirus hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice a north american h7n3 influenza virus supports reassortment with 2009 pandemic h1n1 and induces disease in mice without prior adaptation transmission studies of hendra virus (equine morbillivirus) in fruit bats, horses and cats a guinea-pig model of hendra virus encephalitis susceptibility of hiv-2, siv and shiv to various anti-hiv-1 compounds: implications for treatment and postexposure prophylaxis a golden hamster model for human acute nipah virus infection ebola virus transmission in guinea pigs intranasal immunization with an adenovirus vaccine protects guinea pigs from ebola virus transmission by infected animals characterization and experimental transmission of an oncogenic papillomavirus in female macaques dengue haemorrhagic fever: diagnosis, treatment, prevention and control, second ed. world health organization, geneva. world health organization clinical aspects of hepatitis b virus infection civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates evidence of a causal role of winter virus infection during infancy in early childhood asthma vertical transmission of zika virus targeting the radial glial cells affects cortex development of offspring mice the antiviral activity of sp-303, a natural polyphenolic polymer, against respiratory syncytial and parainfluenza type 3 viruses in cotton rats experimental infection of prairie dogs with monkeypox virus. emerg epidemiological studies of hemorrhagic fever with renal syndrome: analysis of risk factors and mode of transmission hydrodynamic injection of viral dna: a mouse model of acute hepatitis b virus infection mice transgenic for human angiotensin-converting enzyme 2 provide a model for sars coronavirus infection an animal model of mers produced by infection of rhesus macaques with mers coronavirus a protective role for dengue virus-specific cd8+ t cells the incubation period of hantavirus pulmonary syndrome animal model of sensorineural hearing loss associated with lassa virus infection the relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. epidemiol hantavirus pulmonary syndrome. pathogenesis of an emerging infectious disease the pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (macaca fascicularis) hiv-1 infection and pathogenesis in a novel humanized mouse model h7n9 influenza viruses are transmissible in ferrets by respiratory droplet induction of neutralizing antibodies against four serotypes of dengue viruses by mixbiediii, a tetravalent dengue vaccine rapid generation of a mouse model for middle east respiratory syndrome an animal model for studying the pathogenesis of chikungunya virus infection pathogenesis of avian influenza a (h5n1) viruses in ferrets lethal crimean-congo hemorrhagic fever virus infection in interferon alpha/beta receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy the pathogenesis of western equine encephalitis virus (w.e.e.) in adult hamsters with special reference to the long and short term effects on the c.n.s. of the attenuated clone 15 variant development of a murine model for aerosolized filovirus infection using a panel of bxd recombinant inbred mice a characterization of aerosolized sudan ebolavirus infection in african green monkeys, cynomolgus macaques, and rhesus macaques characterization of disease and pathogenesis following airborne exposure of guinea pigs to filoviruses manuscripts in preparation opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the us army. key: cord-021499-up5vftj4 authors: brayton, cory; mähler, michael; nicklas, werner title: viral infections date: 2007-09-02 journal: the laboratory mouse doi: 10.1016/b978-012336425-8/50076-5 sha: doc_id: 21499 cord_uid: up5vftj4 nan in interpreting the microbiological status of laboratory animals, it must be understood that infection and disease are not synonymous. infection refers to the invasion and multiplication of microorganisms in body tissues and may occur with or without apparent disease. disease refers to interruption or deviation from normal structure and function of any tissue, organ, or system. many of the infections with which we are concerned may not cause discernable disease in many strains of mice. however, they may cause inapparent or subclinical changes that can interfere with research. such interference often remains undetected, and therefore modified results may be obtained and published. the types of interference of an agent with experimental results may be diverse. there is no doubt that research complications due to overt infectious disease are significant and that animals with clinical signs of disease should not be used for scientific experiments. but also clinically inapparent infections may have severe effects on animal experiments. there are numerous examples of influences of microorganisms on host physiology and hence of the interference of inapparent infections with the results of animal experiments. many microorganisms have the potential to induce activation or suppression of the immune system or both at the same time but on different parts of the immune system, regardless of the level of pathogenicity. all infections, apparent or inapparent, are likely to increase inter-individual variability and hence result in increased numbers of animals necessary to obtain reliable results. microorganisms, in particular viruses, present in an animal may contaminate biological materials such as sera, cells, or tumours (collins and parker, 1972; nicklas et al., 1993) . this may interfere with in vitro experiments conducted with such materials and may also lead to contamination of animals (lipman et al., polymerase chain reaction (pcr) testing of biologics to be inoculated into mice is an important component of a disease prevention programme. finally, latent infections may be activated by environmental factors, by experimental procedures, or by the combination and interaction between various microorganisms. for all these reasons, prevention of infection, not merely prevention of clinical disease, is essential. unfortunately, research complications due to infectious agents are usually considered artefacts and published only exceptionally. information on influences of microorganisms on experiments is scattered in diverse scientific journals, and many articles are difficult to detect. to address this problem, several congresses were held on viral complications on research. the knowledge available was summarized in conference proceedings (melby and balk, 1983; bhatt et al., 1986b; hamm, 1986) and has later repeatedly been reviewed (lussier, 1988; national research council, 1991; baker, 1998; nicklas et al., 1999) . this chapter covers only viral infections of laboratory mice. viral infections of mice have been studied in detail, and comprehensive information on their pathogenic potential, their impact on research, and the influence of host factors such as age, genotype, and immune status on the response to infection is available. bacterial agents may be similarly important, but with few exceptions (e.g. helicobacter species) little is known about their potential to influence host physiology and experiments. even less is known about most parasites in this regard. among fungal agents, only pneumocystis carinii can be expected to play a significant role in contemporary mouse colonies. the nomenclature and taxonomy of viruses described are based on recent nomenclature rules by the international union of microbiological societies (2000) and the universal virus database of the international committee on the taxonomy of viruses (http://www.ictvdb.iacr.ac.uk). retroviruses are not covered in this chapter because they are not included in routine health surveillance programmes and cannot be eradicated with presently available methods. this is because most of them are incorporated in the mouse genome as proviruses and thus are transmitted via germline. the ability to accurately determine whether or not laboratory animals or animal populations have been infected with virus depends on the specificity and sensitivity of the detection methods used. most viral infections in immunocompetent mice are acute or short-term, and lesions are often subtle or subclinical. the absence of clinical disease and pathological changes has therefore only limited diagnostic value. however, clinical signs, altered behaviour, or lesions may be the first indicator of an infection and often provide clues for further investigations. serology is the primary means of testing mouse colonies for exposure to viruses, largely because serological tests are sensitive and specific, are relatively inexpensive, and allow screening for a multitude of agents with one serum sample. they are also employed to monitor biological materials for viral contamination using the map test. serological tests detect specific antibodies, usually immunoglobulin g (igg), produced by the host against the virus and do not actually test for the presence of virus. an animal may have been infected, mounted an effective antibody response, and cleared the virus, but remains seropositive for weeks or months or forever, even though it is no longer infected or shedding the agent. active infection can only be detected by using direct diagnostic methods such as virus isolation, electron microscopy, or pcr. meanwhile, pcr assays have been established for the detection of almost every agent of interest. they are highly sensitive and depending on the demands, they can be designed to broadly detect all members of a genus or only one species. however, good timing and selection of the appropriate specimen is critical for establishing the diagnosis. in practice, combinations of diagnostic tests are often necessary including the use of sentinel animals or immunosuppression to get clear aetiological results or to avoid consequences from false-positive results. reports on the prevalence of viral infections in laboratory mice throughout the world have been published frequently. in general, the microbiological quality of laboratory mice has constantly improved during the last decades, and several agents (e.g. herpes-and polyomaviruses) have been essentially eliminated from contemporary colonies due to advances in diagnostic methodologies and modern husbandry and rederivation practices (jacoby and lindsey, 1998; zenner and regnault, 2000; livingston and riley, 2003) . they may, however, reappear, since most have been retained or are still being used experimentally. furthermore, the general trend towards better microbiological quality is challenged by the increasing reliance of biomedical research on genetically modified and immunodeficient mice, whose responses to infection and disease can be unpredictable. increasing numbers of scientists are creating genetically modified mice, with minimal or no awareness of infectious disease issues. as a consequence, they are more frequently infected than 'standard' strains of mice coming from commercial breeders, and available information on their health status is often insufficient. frequently, they are exchanged between laboratories, which amplifies the risk of introducing infections from a range of animal facilities. breeding cessation strategies that have been reported to eliminate viruses from immunocompetent mouse colonies may prove to be costly and ineffective in genetically modified colonies of uncertain or incompetent immune status. it must also be expected that new agents will be detected, although only occasionally. infections therefore remain a threat to biomedical research, and users of laboratory mice must be cognizant of infectious agents and the complications they can cause. two members of the family herpesviridae can infect mice (mus musculus). mouse cytomegalovirus 1 (mcmv-1) or murid herpesvirus 1 (muhv-1) belongs to the subfamily betaherpesvirinae, genus muromegalovirus. murid herpesvirus 3 (muhv-3) or mouse thymic virus (mtv) has not yet been assigned to a genus within the family herpesviridae. both viruses are enveloped, doublestranded dna viruses that are highly host-specific and relatively unstable to environmental conditions such as heat and acidic ph. both agents are antigenically distinct and do not cross-react in serological tests, but their epidemiology is similar (cross et al., 1979) . seropositivity to mcmv-1 was reported in less than 5% of specified pathogen-free (spf) mouse colonies in the usa in 1996 (jacoby and lindsey, 1998) , and some institutions reported to have mice 'on campus' that were positive for mtv. in a more recent study, a low rate (0.1%) of samples was found to be positive for mcmv-1 whereas no sample tested positive for mtv (livingston and riley, 2003) . the data available suggest that the prevalence of both viruses in contemporary colonies and thus their importance for laboratory mice is negligible. however, both mcmv-1 and mtv are frequently found in wild mice, which may be coinfected with both viruses (national research council, 1991; singleton et al., 2000) . natural infection with mcmv-1 causes subclinical salivary gland infection in mice. the virus persists in the salivary glands (particularly in the submaxillary glands) and also in other organs (osborn, 1982; kercher and mitchell, 2002; lenzo et al., 2002) . most information concerning the pathogenesis of mcmv-1 infection is based on experimental infection studies. these results are very difficult to summarize because the outcome of experimental infection in laboratory mice depends on various factors such as mouse strain and age, virus strain and passage history, virus dose, and route of inoculation (osborn, 1982) . in general, newborn mice are most susceptible to clinical disease and to lethal infection. virus replication is observed in newborn mice in many tissues (for details, see osborn, 1982) and appears in the salivary glands towards the end of the first week of infection when virus concentrations in liver and spleen have already declined. resistance develops rapidly after weaning between days 21 and 28 of age. experimental infection of adult mice results in mortality only in susceptible strains and only if high doses are administered. not even intravenous or intraperitoneal injections of adult mice usually produce signs of illness in resistant strains (shanley et al., 1993) . mice of the h-2 b (e.g. c57bl/6) and h-2 d (e.g. balb/c) haplotype are more sensitive to experimental infection than are mice of the h-2 k haplotype (e.g. c3h), which are approximately 10-fold more resistant to mortality than are those of the b or d haplotype (osborn, 1986) . subclinical or latent infections can be activated by immunosuppression (e.g. with cyclophosphamide or cortisone). reactivation of mcmv-1 occurs also after implantation of latently infected salivary glands into prkdc scid mice (schmader et al., 1995) . immunodeficient mice lacking functional t cells or natural killer (nk) cells, such as foxn1 nu and lyst bg mice, are more susceptible than are immunocompetent animals. experimental infection in prkdc scid mice causes severe disease or is lethal, with necrosis in spleen, liver, and other organs, and multinucleate syncytia with inclusion bodies in the liver (reynolds et al., 1993) . similar to aids patients infected with human cytomegalovirus, athymic foxn1 nu mice experimentally infected with mcmv also develop adrenal necrosis (shanley and pesanti, 1986) . the virus also replicates in the lungs leading to pneumonitis whereas in heterozygous (foxn1 nu / ϩ ) littermates replication and disease are not seen (shanley et al., 1997) . the most prominent histological finding of cytomegaloviruses is enlarged cells (cytomegaly) of salivary gland epithelium with eosinophilic nuclear and cytoplasmic inclusion bodies. the inclusion bodies contain viral material and occur in other organs such as liver, spleen, ovary, and pancreas (osborn, 1982) . depending on inoculation route, dose, strain, and age of mice, experimental infections may result in inflammation or cytomegaly with inclusion bodies in a variety of tissues, pneumonitis, myocarditis, meningoencephalitis, or splenic necrosis in susceptible strains (national research council, 1991; osborn, 1982; percy and barthold, 2001) . virus is transmitted oronasally by direct contact and is excreted in saliva, tears, and urine for several months. wild mice serve as a natural reservoir for infection. the virus is most frequently transmitted horizontally through mouse-to-mouse contact but does not easily spread between cages. it is generally assumed that mcmv-1 has a very low prevalence in contemporary colonies of laboratory mice. the risk of introduction into facilities housing laboratory mice is very low if wild mice are strictly excluded. monitoring is necessary if populations of laboratory mice may have been contaminated by contact with wild mice. as for other viruses, enzyme-linked immunosorbent assay (elisa) and indirect immunofluorescence assay (ifa) are the most appropriate tests for detecting antibodies. as the virus persists, direct demonstration of mcmv-1 in infected mice is possible by pcr (palmon et al., 2000) or by virus isolation using mouse embryo fibroblasts (3t3 cells). although mcmv-1 does not play a significant role as a natural pathogen of laboratory mice, it is frequently used as a model for human cytomegalovirus infection (bolger et al., 1999) . however, the virus is known to influence immune reactions in infected mice and may therefore have impact on immunological research (osborn, 1986; national research council, 1991; baker, 1998) . mouse thymic virus was detected during studies in which samples from mice were passaged in newborn mice. unlike other herpesviruses, the virus can not yet be cultured in vitro and is propagated by intraperitoneal infection of newborn mice. the thymus is removed 7-10 days later, and thymus suspensions serve as virus material for further studies. the prevalence of mtv is believed to be low in laboratory mice, and for this reason and also due to the difficulties in virus production for serological assays, it is not included in many standard diagnostic or surveillance testing protocols. limited data are available indicating that it is common in wild mice, and it is also found in laboratory mice (osborn, 1982; morse, 1987; national research council, 1991) . further, mtv obviously represents a significant source of contamination of mcmv-1 (and vice versa) if virus is prepared from salivary glands since both viruses cause chronic or persistent salivary gland infections and can coinfect the same host. all mouse strains are susceptible to infection, but natural or experimental infection of adult mice is subclinical. gross lesions appear only in the thymus and only if experimental infection occurs at an age of less than about 5 days. virus is present in the thymus but may also be found in the blood and in salivary glands of surviving animals. salivary glands are the only site yielding positive virus isolations if animals are infected as adults. mouse thymic virus also establishes a persistent infection in athymic foxn1 nu mice, but virus shedding is reduced compared to euthymic mice and virus recovery is possible only in a lower percentage of mice (morse, 1988) . pathological changes caused by mtv occur in the thymus, and reduced thymus mass due to necrosis in suckling mice is the most characteristic gross lesion (percy and barthold, 2001) . lymphoid necrosis also may occur in lymph nodes and spleen (wood et al., 1981) , with necrosis and recovery similar to that in the thymus. in mice infected during the first 3 days after birth, necrosis of thymus becomes evident within 3-5 days, and its size and weight are markedly reduced at day 12-14. intranuclear inclusions may be present in thymocytes between days 10-14 post infection. the thymus and the affected peripheral tissues regenerate within 8 weeks after infection. regardless of the age of mice at infection, a persistent infection is established in the salivary glands, and infected animals shed virus for life. several alterations of immune responses are associated with neonatal mtv infection. there is transient immunosuppression, attributable to lytic infection of t lymphocytes, but activity (e.g. response of spleen cells to t cell mitogens) returns to normal as the histological repair progresses (wood et al., 1981) . selective depletion of cd4 ϩ t cells by mtv results in autoimmune disease (morse and valinsky, 1989; morse et al., 1999) . information about additional influences on the immune system is given by osborn (1982 ), national research council (1991 ), and baker (1998 . in experimentally infected newborn mice, oral and intraperitoneal infections similarly result in thymus necrosis, seroconversion, and virus shedding suggesting that the oral-nasal route is likely to be involved in natural transmission (morse, 1989) . the virus spreads to cage mates after long periods of contact. it is transmitted between mice kept in close contact, and transmissibility from cage to cage seems to be low. mouse thymic virus is not transmitted to foetuses by the transplacental route, and intravenous infection of pregnant mice does not lead to congenital damage, impairment in size or development, or abortion (st-pierre et al., 1987) . mouse thymic virus and mcmv-1 do not crossreact serologically (cross et al., 1979) . serological monitoring of mouse populations for antibodies to mtv is possible by ifa testing, which is commercially available; elisa tests have also been established (morse, 1990b) . elisa and complement fixation yield similar results . it must be noted that the immune response depends on the age at infection. antibody responses are not detectable in mice infected as newborns whereas adult mice develop high titres that are detectable by serological testing. if neonatal infection is suspected, homogenates of salivary glands or other materials can be inoculated into pathogen-free newborn mice followed by gross and histological examination of thymus, lymph nodes, and spleens for lymphoid necrosis (morse, 1987) . alternatives to the in vivo infectivity assay for detecting mtv in infected tissues include a competition elisa (prattis and morse, 1990) and map testing, although this is slightly less sensitive than infectivity assays (morse, 1990a) . very little experience exists on eradication methods for mtv due to its low prevalence in contemporary mouse colonies. methods that eliminate other herpesviruses likely will eliminate mtv. procurement of animals of known negative mtv status is an appropriate strategy to prevent infection. strict separation of laboratory mice from wild rodents is essential to avoid introduction into laboratory animal facilities. mousepox (ectromelia) virus (ectv) is a member of the genus orthopoxvirus belonging to the family poxviridae. it is antigenically and morphologically very similar to vaccinia virus and other orthopoxviruses. poxviruses are the largest and most complex of all viruses with a diameter of 200 nm and a length of 250-300 nm. mousepox (ectromelia) virus contains one molecule of double-stranded dna with a total genome length of 185,000 nucleotides. it is the causative agent of mousepox, a generalized disease in mice. experimental transmission to young rats (up to 30 days of age) is possible (jandasek, 1968; buller et al., 1986) . the virus is resistant to desiccation, dry heat, and many disinfectants. it is not consistently inactivated in serum heated 30 min at 56њc (lipman et al., 2000b) and persists for 26 weeks when maintained at 4њc in foetal bovine serum (bhatt and jacoby, 1987a) . effective disinfectants include vapour-phase formaldehyde, sodium hypochlorite, and iodophores (small and new, 1981; national research council, 1991) . historically, ectv has been an extremely important natural pathogen of laboratory mice. the virus was widespread in mouse colonies worldwide and can still be found in several countries. between 1950 and 1980 almost 40 individual ectromelia outbreaks were reported in the usa. the last major epizootic in the usa occurred in 1979-80 and has been described in great detail (e.g. wagner and daynes, 1981) . severe outbreaks were also described in various european countries (deerberg et al., 1973; owen et al., 1975; osterhaus et al., 1981) . a more recent outbreak in the usa, which resulted in the eradication of almost 5000 mice in one institution, was described by dick et al. (1996) . the most recent well-documented case of mousepox was published by lipman et al. (2000b) . few additional but unpublished cases of ectromelia have been observed thereafter. in a recent survey conducted in the usa, one population was reported to be seropositive for mousepox (jacoby and lindsey, 1998) . natural infections manifest differently depending on many factors. mousepox may occur as a rapidly spreading outbreak with acute disease and deaths, or may be inconspicuous with slow spreading and mild clinical signs. the mortality rate can be very low in populations in which the virus has been present for long periods. the infection usually takes one of three clinical courses: acute asymptomatic infection, acute lethal infection (systemic form), or subacute to chronic infection (cutaneous form ; fenner, 1981 fenner, , 1982 manning and frisk, 1981; national research council, 1991; dick et al., 1996) . the systemic or visceral form is characterized clinically by facial oedema, conjunctivitis, multisystemic necrosis, and usually high mortality. this form is less contagious than the cutaneous form because the animals die before there is virus shedding. the cutaneous form is characterized by typical dermal lesions and variable mortality. the outcome of infection depends on many factors including strain and dose of virus; route of viral entry; strain, age, and sex of mouse; husbandry methods; and duration of infection in the colony. while all mouse strains seem to be susceptible to infection with ectv, clinical signs and mortality are strain-dependent (fenner, 1982; wallace and buller, 1985, 1986; brownstein et al., 1989b) . acute lethal (systemic) infection occurs in highly susceptible inbred strains such as dba/1, dba/2, balb/c, a, and c3h/hej. immunodeficient mice may also be very susceptible (allen et al., 1981) . outbreaks among susceptible mice can be explosive, with variable morbidity and high mortality (ͼ80%). clinical disease may not be evident in resistant strains such as c57bl/6 and akr, and the virus can be endemic in a population for long periods before being recognized. furthermore, females seem to be more resistant to disease than males, at least in certain strains of mice brownstein et al., 1989b) . the mechanisms determining resistance versus susceptibility are not fully understood but appear to reflect the action of multiple genes. the genetic loci considered to be important include h-2d b (termed rmp-3, resistance to mousepox, on chromosome 17; o'neill et al., 1983) , the c5 genes (rmp-2, on chromosome 2), rmp-1, localized to a region on chromosome 6 encoding the nk cell receptor nkr-p1 alloantigens (brownstein and gras, 1997) , the nitric oxide synthase 2 locus on chromosome 11 (karupiah et al., 1998) , and the signal transducer and activator of transcription 6 locus on chromosome 10 (mahalingam et al., 2001) . clearance of the virus by the immune system is absolutely dependent upon the effector functions of cd8 ϩ t cells while nk cells, cd4 ϩ t cells, and macrophages are necessary for the generation of an optimal response (niemialtowski et al., 1994; delano and brownstein, 1995; karupiah et al., 1996) . mousepox (ectromelia) virus usually enters the host through the skin with local replication and extension to regional lymph nodes (fenner, 1981 (fenner, , 1982 wallace and buller, 1986; national research council, 1991) . it escapes into the blood (primary viraemia) and infects splenic and hepatic macrophages resulting in necrosis of these organs and a massive secondary viraemia. this sequence takes approximately 1 week. many animals die at the end of this stage without premonitory signs of illness; others develop varying clinical signs including ruffled fur, hunched posture, swelling of the face or extremities, conjunctivitis, and skin lesions (papules, erosions, or encrustations mainly on ears, feet, and tail; figure 23 .1). necrotic amputation of limbs and tails can sometimes be seen in mice that survive the acute phase, hence the original name of the disease 'ectromelia' (meaning absent or short limbs; figure 23 .2). common gross lesions of acute mousepox include enlarged lymph nodes, peyer's patches, spleen, and liver; multifocal to semiconfluent white foci of necrosis in the spleen and liver; and haemorrhage into the small intestinal lumen (allen et al., 1981; fenner, 1982; dick et al., 1996; percy and barthold, 2001) . in animals that survive, necrosis and scarring of the spleen can produce a mosaic pattern of white and red-brown areas that is a striking gross finding. the most consistent histological lesions of acute mousepox are necroses of the spleen (figure 23 lymph nodes, peyer's patches, thymus, and liver (allen et al., 1981; fenner, 1982; dick et al., 1996; lipman et al., 2000b; percy and barthold, 2001) . occasionally, necrosis may also be observed in other organs such as ovaries, uterus, vagina, intestine, and lungs. the primary skin lesion, which occurs about a week after exposure at the site of inoculation (frequently on the head), is a localized swelling that enlarges from inflammatory oedema. necrosis of dermal epithelium provokes a surface scab and heals as a deep, hairless scar. secondary skin lesions (rash) develop 2-3 days later as the result of viraemia (figure 23 .1). they are often multiple and widespread and can be associated with conjunctivitis. the skin lesions also can ulcerate and scab before scarring. mucosal and dermal epithelial cells may have characteristic intracytoplasmic eosinophilic (cowdry type a) inclusion bodies ( figure 23 .4). basophilic (cowdry type b) inclusions may be found in the cytoplasm of all infected cells, especially in hepatocytes. natural transmission of ectv mainly occurs by direct contact and fomites (fenner, 1981; wallace and buller, 1986; national research council, 1991) . the primary route of infection is through skin abrasions. faecal-oral and aerosol routes may also be involved (werner, 1982) . in addition, the common practice of cannibalism by mice may contribute to the oral route of infection (bhatt and jacoby, 1987b) . intrauterine transmission is possible at least under experimental conditions (schwanzer et al., 1975) . virus particles are shed from infected mice (mainly via scabs and/or faeces) for about 3-4 weeks, even though the virus can persist for months in the spleen of an occasional mouse (bhatt and jacoby, 1987b; national research council, 1991) . cage-to-cage transmission of ectv and transmission between rooms or units is usually low and largely depends on husbandry practices (e.g. mixing mice from different cages). importantly, the virus may not be transmitted effectively to sentinel mice exposed to dirty bedding (lipman et al., 2000b) . various tests have been applied for the diagnosis of ectromelia. previous epidemics were difficult to deal with because of limited published data and information on the biology of the virus and the lack of specific and sensitive assays (wallace, 1981) . in the 1950s, diagnosis relied on clinical signs, histopathology, and animal passages of tissues from moribund and dead animals. culture of the virus on the chorioallantoic membrane of embryonated eggs was also applied. serology is currently the primary means of testing mouse colonies for exposure to ectv. the methods of choice are elisa and ifa; they are more sensitive and specific than the previously used haemagglutination inhibition (hi) assay (collins et al., 1981; buller et al., 1983; aclad, 1991) . both tests detect antibodies to orthopoxviruses and do not distinguish between ectv and vaccinia virus. vaccinia virus is commonly used as antigen for serological testing to avoid the risk of infection for mice. thus, false-positive serological reactions may be found after experimental administration of replication-competent vaccinia virus. it has been shown that even cage contact sentinels may develop antibodies, and vaccinia virus leading to seroconversion may even be transmitted by dirty bedding (gaertner et al., 2003) . confirmation of positive serological results is important before action is taken because vaccinia virus is increasingly prevalent in animal facilities as a research tool (e.g. for vaccination or gene therapy). as observed in different outbreaks, serological testing is of little value in the initial stages of the disease. for example, in the outbreak described by dick et al. (1996) depopulation was nearly completed before serological confirmation was possible. for this reason, negative serological results should be confirmed by direct detection methods (pcr, immunohistochemistry, virus isolation) or by histopathology, especially when clinical cases suggestive of mousepox are observed. polymerase chain reaction assays to detect different genes of poxviruses in infected tissues have been described by dick et al. (1996) , neubauer et al. (1997) , and lipman et al. (2000b) . the key to prevention and control of mousepox is early detection of infected mice and contaminated biological materials. all institutions that must introduce mice from other than commercial barrier facilities should have a health surveillance programme and test incoming mice. perhaps even more important than living animals are samples from mice (tumours, sera, tissues). the virus replicates in lymphoma and hybridoma cell lines (buller et al., 1987) , and such cells or material derived from them may therefore be a vehicle for inadvertent transfer between laboratories. the last two published outbreaks of ectromelia were both introduced into the facilities by mouse serum (dick et al., 1996; lipman et al., 2000b) . lipman et al. (2000b) found that the contaminated serum originated from a pooled lot of 43 l that had been imported from china. because mouse serum commonly is sold to the end user in small aliquots (few millilitres), it has to be expected that aliquots of the contaminated lot are still stored in numerous freezers. both cases provide excellent examples of why map or pcr testing should be performed on all biological materials to be inoculated into mice. eradication of mousepox usually has been accomplished by elimination of the affected colonies, disinfection of rooms and equipment, and disposal of all infected tissues and sera. while culling of entire mouse colonies is the safest method for eradication of mousepox, it is not a satisfactory method due to the uniqueness of numerous lines of genetically modified animals housed in many facilities. several studies indicate that mousepox is not highly contagious bhatt and jacoby 1987a,b ) and that it may be self-limiting when adequate husbandry methods are applied. therefore, strict quarantine procedures along with cessation of breeding (to permit resolution of infection) and frequent monitoring with removal of clinically sick and seropositive animals are a potential alternative. the period from the last births before the break until the first matings after the break should be at least 6 weeks (bhatt and jacoby, 1987b) . sequential testing of immunocompetent contact sentinels for seroconversion should be employed with this option. in the past, immunization with live vaccinia virus was used to suppress clinical expression of mousepox. vaccination may substantially reduce the mortality rate, but it does not prevent virus transmission or eradicate the agent from a population bhatt and jacoby, 1987c) . after vaccination, typical pocks develop at the vaccination site, and infectious vaccinia virus is detectable in spleen, liver, lungs, and thymus (jacoby et al., 1983) . vaccination also causes seroconversion so that serological tests are not applicable for health surveillance in vaccinated populations. it is therefore more prudent to control mousepox by quarantine and serological surveillance than by relying on vaccination. mortality and clinical disease are the major factors by which ectv interferes with research. severe disruption of research can also occur when drastic measures are taken to control the infection. the loss of time, animals, and financial resources can be substantial. murine adenoviruses (madv) are non-enveloped, double-stranded dna viruses of the family adenoviridae, genus mastadenovirus. two distinct strains have been isolated from mice. the fl strain (madv-1) was first isolated in the usa as a contaminant of a friend leukaemia (hartley and rowe, 1960) ; the k87 strain (madv-2) was first isolated in japan from the faeces of a healthy mouse (hashimoto et al., 1966) . both strains are now considered to represent different species (hamelin and lussier, 1988; jacques et al., 1994a,b) . in laboratory mice, seropositivity to adenoviruses was reported in 2% of spf colonies and in 8% of non-spf colonies in the usa (jacoby and lindsey, 1998) . antibodies were also detected at a low prevalence rate in french colonies (zenner and regnault, 2000) , but the virus strain used as antigen is not mentioned. a similar range of positive samples was reported by livingston and riley (2003) . antibodies to madv were also found in wild mice and in rats (otten and tennant, 1982; smith et al., 1986) . both viruses are not known to cause clinical disease in naturally infected, immunocompetent mice. however, madv-1 can cause a fatal systemic disease in suckling mice after experimental inoculation (hartley and rowe, 1960; heck et al., 1972; wigand, 1980) . disease is characterized by scruffiness, lethargy, stunted growth, and often death within 10 days. experimental infection of adult mice with madv-1 is most often subclinical and persistent (richter, 1986 ) but can cause fatal haemorrhagic encephalomyelitis with neurological symptoms, including tremors, seizures, ataxia, and paralysis, in susceptible c57bl/6 and dba/2j mice (guida et al., 1995) . balb/c mice are relatively resistant to this condition. athymic foxn1 nu mice experimentally infected with madv-1 develop a lethal wasting disease (winters and brown, 1980) . similarly, prkdc scid mice succumb to experimental infection with madv-1 (pirofski et al., 1991) . gross lesions in response to natural madv infections are not detectable. occasional lesions observed after experimental infection with madv-1 include small surface haemorrhages in the brain and spinal cord of c57bl/6 and dba/2j mice (guida et al., 1995) , duodenal haemorrhage in foxn1 nu mice (winters and brown, 1980) , and pale yellow livers in prkdc scid mice (pirofski et al., 1991) . histologically, experimental madv-1 infection of suckling mice is characterized by multifocal necrosis and large basophilic intranuclear inclusion bodies in liver, adrenal gland, heart, kidney, salivary glands, spleen, brain, pancreas, and brown fat (heck et al., 1972; margolis et al., 1974; national research council, 1991; percy and barthold, 2001) . in experimentally induced haemorrhagic encephalomyelitis, multifocal petechial haemorrhages occur throughout the brain and spinal cord, predominantly in the white matter, and are attributed to infection and damage to the vascular epithelium of the central nervous system (cns; guida et al., 1995) . histopathological manifestations in madv-1-infected prkdc scid mice are marked by microvesicular fatty degeneration of hepatocytes (pirofski et al., 1991) . in contrast to madv-1, the tissue tropism of madv-2 is limited to the intestinal epithelium. naturally or experimentally infected mice develop intranuclear inclusions in enterocytes, especially in the ileum and caecum (takeuchi and hashimoto, 1976; otten and tennant, 1982; national research council, 1991; percy and barthold, 2001) . transmission of madv primarily occurs by ingestion. madv-1 is excreted in the urine and may be shed for up to 2 years (van der veen and mes, 1973). murine adenovirus-2 infects the intestinal tract and is shed in faeces for only a few weeks in immunocompetent mice (hashimoto et al., 1970) ; immunodeficient mice may shed the virus for longer periods (umehara et al., 1984) . murine adenovirus infections are routinely diagnosed by serological tests. however, there is a one-sided cross reactivity of madv-1 with madv-2 (wigand et al., 1977) . serum from mice experimentally infected with madv-1 yielded positive reactions in serological tests with both viruses while serum from mice infected with madv-2 reacted only with the homologous antigen . smith et al. (1986) reported that sera may react with madv-1 or madv-2 or both antigens. occasional reports of mice with lesions suggestive of adenovirus infections and negative serology (with madv-1) indicate that the infection may not be detected if only one virus is used as antigen (luethans and wagner, 1983) . it has therefore become standard practice to test sera for antibodies to both madv-1 and madv-2. the common methods are ifa and elisa, and both are more sensitive than the previously used complement fixation test. the low prevalence in colonies of laboratory mice indicate that madv can easily be eliminated (e.g. by hysterectomy derivation or embryo transfer) and that barrier maintenance has been very effective in preventing infection. the low pathogenicity and the low prevalence in contemporary mouse populations are the main reasons why adenoviruses are considered to be of little importance. however, immunodeficient mice are increasingly used and candidates for natural infections and wasting disease (richter, 1986) , and the viruses might easily be spread by the exchange of genetically modified mice and therefore re-emerge. only few influences on research attributable to madv have been published. for example, it has been shown that madv-1 significantly aggravates the clinical course of scrapie disease in mice (ehresmann and hogan, 1986) . natural infections with madv could also interfere with studies using adenovirus as a gene vector. polyomaviridae are enveloped, double-stranded dna viruses. two different agents of this family exclusively infect mice (mus musculus), and both belong to the genus polyomavirus. murine pneumotropic virus (mptv) has formerly been known as 'newborn mouse pneumonitis virus' or 'k virus' (named after l. kilham who first described the virus). the second is murine polyomavirus (mpyv). both are related but antigenically distinct from each other (bond et al., 1978) . they are enzootic in many populations of wild mice but are very uncommon in laboratory mice. even older reports indicate that both have been eradicated from the vast majority of contemporary mouse colonies, and their importance is negligible (national research council, 1991) . seropositivity to these viruses was not reported in a survey conducted in the usa (jacoby and lindsey, 1998) . in a retrospective study in french facilities, antibodies to mpyv were found in 1 of 69 colonies, and all samples tested for mptv were negative (zenner and regnault, 2000) . comparable data were reported by livingston and riley (2003) . due to their low prevalence, both viruses are not included in the list of agents for which testing is recommended on a regular basis by felasa (nicklas et al., 2002) . although polyomavirus genes, especially those of sv40 are used widely in gene constructs for insertional mutagenesis, very few reports have been published on spontaneous or experimental disease due to mpyv or mptv in the last 10-15 years. the reader is therefore referred to previous review articles for details (eddy 1982; parker and richter, 1982; richter, 1986; shah and christian, 1986; national research council, 1991; orcutt, 1994; porterfield and richter, 1994) . natural infections with mptv are subclinical. the prevalence of infection is usually low in an infected population. the virus may persist in infected animals for months and perhaps for life depending on the age at infection and is reactivated under conditions of immunosuppression. virus replicates primarily in endothelial cells, but renal tubular epithelial cells are the major site of viral persistence (greenlee et al., 1991 (greenlee et al., , 1994 . clinical signs are observed only after infection of infant mice less than 6-8 days of age. infected pups suddenly develop respiratory symptoms after an incubation period of approximately 1 week, and many die within a few hours of onset of symptoms with an interstitial pneumonia caused by productive infection of and damage to pulmonary endothelium. endothelial cells in other organs are involved in virus replication also (ikeda et al., 1988; greenlee et al., 1994) . in older suckling mice, mptv produces a more protracted infection, and the virus or viral antigen can be detected for as long as 4 months. in adult animals, the virus produces a transient asymptomatic infection. even in immunodeficient foxn1 nu mice, experimental infection of adults is clinically asymptomatic although virus is detectable for a period of several months (greenlee, 1986) . in vitro cultivation of mptv is difficult. no susceptible permanent cell line is known to support growth. it can be cultured in primary mouse embryonic cells, but viral titres are not sufficient for use in serological assays (greenlee and dodd, 1987) . for this reason, the hi test using homogenates of livers and lungs of infected newborn mice is still frequently used, but ifa and elisa tests are also available (groen et al., 1989) . furthermore, a pcr test for demonstration of mptv in biological samples has been published (carty et al., 2001) . murine polyomavirus was first detected as a contaminant of murine leukaemia virus (mulv) when sarcomas developed in mice after experimental inoculation of contaminated samples. it has later been shown to be a frequent contaminant of transplantable tumours (collins and parker, 1972) . natural infection of mice is subclinical, and gross lesions including tumours are usually not found. tumour formation occurs if mice are experimentally infected at a young age or if they are inoculated with high virus doses. development of tumours may be preceded by multifocal necrosis and mortality during the viraemic stage (percy and barthold, 2001) . parotid, salivary gland, and mammary tumours are common, and sarcomas or carcinomas of kidney, subcutis, adrenal glands, bone, cartilage, teeth, blood vessels, and thyroid occur also. virus strains vary with regard to the tumour types or lesions that they induce, and mouse strains vary in their susceptibility to different tumour types. those of c57bl and c57br/cd lineage are considered to be the most resistant strains; athymic foxn1 nu mice are considered to be most susceptible; c3h mice are particularly susceptible to adrenal tumours and a mice tend to develop bone tumours. immunosuppression or inoculation into immunodeficient strains (e.g. foxn1 nu ) also support the growth of tumours. on the other hand, experimental infection of adult immunocompetent mice does not result in tumour formation because the immune response suppresses tumour growth, and newborn immunocompetent mice develop runting only if inoculated with high virus doses (atencio et al., 1995) . after experimental intranasal infection, mpyv initially infects the respiratory tract followed by a systemic phase in which liver, spleen, kidney, and the colon become infected (dubensky et al., 1984) . the virus is shed in faeces and in all body fluids, and transmission occurs rapidly by direct contact between animals, but also between cages in a room. further, intrauterine transmission has been documented after experimental infection (mccance and mims, 1977) . murine polyomavirus persists in all organs in prkdc scid mice while viral dna is detectable in immunocompetent mice after experimental infection for only a limited period of about 4 weeks (berke et al., 1994) . however, virus may persist and can be reactivated by prolonged immunosuppression (rubino and walker, 1988) or during pregnancy, at least in young mice (mccance and mims, 1979) . biological materials of mouse origin are likely to be the most common source of contamination of laboratory mice emphasizing the importance of map or pcr screening of biological materials to be inoculated into mice. the most frequently used tests for health surveillance of mouse colonies are elisa and ifa (aclad, 1991) ; in addition, the hi test is still used. latent infections can be detected by intracerebral inoculation of neonate mice or by map testing, but direct demonstration of virus in biological samples is also possible by pcr testing (porterfield and richter, 1994; carty et al., 2001) . parvoviruses are non-enveloped small viruses (approximately 20 nm in diameter) with a single-stranded dna genome of approximately 5000 nucleotides. murine parvoviruses are members of the family parvoviridae, genus parvovirus. they are remarkably resistant to environmental conditions like heat, desiccation, acidic and basic ph-values. two distinct serotypes infect laboratory mice: the mice minute virus (mmv) and the mouse parvovirus 1 (mpv). nonstructural proteins (ns-1 and ns-2) are highly conserved among both viruses whereas the capsid proteins (vp-1, vp-2, vp-3) are more divergent and determine the serogroup (ball-goodrich and johnson, 1994) . both viruses require mitotically active cells for replication. severe infections are therefore not found in mature animals due to the lack of a sufficient number of susceptible cells in tissues. general aspects of rodent parvovirus infections and their potential effects on research results have been reviewed (tattersall and cotmore, 1986; national research council, 1991; jacoby et al., 1996) . already in the mid-1980s mouse colonies were identified that gave positive reactions for mmv by ifa but not by hi tests. it was subsequently shown that these colonies were infected with a novel parvovirus, initially referred to as 'mouse orphan parvovirus'. the first isolate of mpv was detected as a contaminant of cultivated t-cell clones interfering with in vitro immune responses (mckisic et al., 1993) and was named 'mouse parvovirus'. it does not replicate well in currently available cell cultures, and sufficient quantities of virus for serological tests are difficult to generate. hitherto, only very few isolates of mpv have been cultured and characterized on a molecular basis (ball-goodrich and johnson, 1994; besselsen et al., 1996) . at present, mpv is among the most common viruses in colonies of laboratory mice. the prevalence of sera positive for parvoviruses was nearly 10% in a study from livingston et al. (2002) , with the majority of sera being positive for mpv. this is consistent with a recent survey conducted in the usa showing that almost 40% of non-spf colonies were seropositive (jacoby and lindsey, 1998) . similar results were obtained for genetically modified mice in japan (yamamoto et al., 2001) , in contrast to earlier studies indicating that the infection was rare in japan (ueno et al., 1998) . clinical disease and gross or histological lesions have not been reported for mice naturally or experimentally infected with mpv. infections are subclinical even in newborn and immunocompromised animals . in contrast to many other viruses infecting mice, viral replication and excretion is not terminated by the onset of host immunity. tissue necrosis has not been observed at any stage of infection in infected infant or adult mice . humoral immunity to mpv does not protect against mmv infections and vice versa (hansen et al., 1999) . serological surveys have indicated that mpv naturally infects only mice. differences in mouse strain susceptibility to clinical mpv infection do not exist. however, seroconversion seems to be strain-dependent. after experimental infection, seroconversion occurred in all c3h/hen mice, fewer balb/c, dba/2, and icr mice, and seroconversion could not be detected in c57bl/6 mice (besselsen et al., 2000) . diagnosis of mpv infection by pcr testing of small intestine and mesenteric lymph nodes also depended on the mouse strain. mpv dna was detected in all mouse strains evaluated except dba/2 even though seroconversion was detected in these mice. after oral infection, the intestine is the primary site of viral entry and replication. the virus spreads to the mesenteric lymph nodes and other lymphoid tissues, where it persists for more than 2 months , and seems to be excreted via the intestinal and the urinary tract. after experimental inoculation of weanling mice, mpv is transmitted to cagemates by direct contact for 2-4 weeks , and transmission by dirty bedding is also possible. these results implicate a role for urinary, faecal, and perhaps respiratory excretion of virus. another study showed that naturally infected mice may not transmit the virus under similar experimental conditions (shek et al., 1998) . serology is a useful tool to identify mpv infections in immunocompetent hosts, but reaching a diagnosis based on serological assays may be difficult and requires a good knowledge of the available techniques. neither the virion elisa nor hi are practical screening tests for mpv because they require large quantities of purified mpv which is difficult to obtain. diagnosis of mpv infections has long been made on the basis of an mmv hi-negative result coupled with an mmv ifapositive result. a generic rodent parvovirus elisa using a recombinant ns-1 protein as antigen has been developed , but mpv ifa and mpv hi assays are more sensitive techniques than the ns-1 elisa and the mmv ifa (besselsen et al., 2000) . recently, elisa tests have been described that use recombinant vp-2 and provide sensitive and serogroupspecific assays for the diagnosis of mpv infections in mice (ball-goodrich et al., 2002; livingston et al., 2002) . in immunodeficient mice that do not generate a humoral immune response, pcr assays can be used to detect mpv (besselsen et al., 1995; redig and besselsen, 2001 ) and other parvoviruses. mpv has been shown to persist for at least 9 weeks in the mesenteric lymph nodes . this tissue is considered the best suited for pcr analysis, but spleen and small intestine can also be used with good success (besselsen et al., 2000) . the virus persists sufficiently long in mesenteric lymph nodes so that pcr assays may also be used as a primary screening tool for laboratories that do not have access to specific mpv antigenbased serological assays. polymerase chain reaction is further a good confirmatory method for serological assays and has also been described for the detection of parvoviruses in cell lines and tumours (yagami et al., 1995) . in addition, the map test has been reported as a sensitive tool to detect mpv (shek et al., 1998) . given the high environmental stability of the virus and the potential fomite transmission together with the long virus persistence in infected animals, spontaneous disappearance from a mouse population (e.g. by cessation of breeding) is very unlikely. eradication of infection is possible by elimination of infected animals and subsequent replacement with uninfected mice, and the agent can be eliminated from breeding populations only by embryo transfer or by hysterectomy. although there are few published reports of confounding effects of mpv on research, it is lymphocytotropic and may perturb immune responses in vitro and in vivo. infections with mpv have been shown to influence rejection of skin and tumour grafts (mckisic et al., , 1998 . mice minute virus is the type species of the genus parvovirus. the virus was formerly called 'minute virus of mice' (mvm) and was renamed recently (international union of microbiological societies, 2000) . it was originally isolated by crawford (1966) from a stock of mouse adenovirus, and this prototype isolate was later designated mvmp. its allotropic variant was detected as a contaminant of a transplantable mouse lymphoma (bonnard et al., 1976) and designated mvmi because it exhibits immunosuppressive properties in vitro. both variants have distinct cell tropisms in vivo and in vitro. the mmvp infects fibroblast cell lines and does not cause clinical disease (kimsey et al., 1986 , brownstein et al., 1991 . the mmvi grows lytically in t cells and inhibits various functions mediated by these cells in vitro. both strains are apathogenic for adult mice, but the immunosuppressive variant is more pathogenic for neonatal mice than is mmvp. serological surveys show that the mouse is the primary natural host (parker et al., 1970; smith et al., 1993b; singleton et al., 2000) , but the virus is also infective for rats, hamsters (garant et al., 1980; ward and tattersall, 1982) , and mastomys (haag et al., 2000) during foetal development or after parenteral inoculation. natural infections are usually asymptomatic in adults and infants, and the most common sign of infection is seroconversion. kilham and margolis (1970) observed mild growth retardation a few days after experimental infection of neonatal mice with mmvp. studies of transplacental infection yielded no pathological findings in mice (kilham and margolis, 1971 ). the immunosuppressive variant but not the prototype strain is able to produce a runting syndrome after experimental infection of newborn mice (kimsey et al., 1986) . depending on the host genotype, experimental infections of foetal and neonatal mice with mmvi produce various clinical presentations and lesions. infection in c57bl/6 mice is asymptomatic, but the virus causes lethal infections with intestinal haemorrhage in dba/2 mice. infection of strains such as balb/c, cba, c3h/he, and sjl is also lethal and mice have renal papillary haemorrhage (brownstein et al., 1991) . the mmvi also infects haematopoietic stem cells and mediates an acute myelosuppression (segovia et al., 1991 (segovia et al., , 1995 . due to their dependency on mitotically active tissues, the foetus is at particular risk for damage by parvoviruses. mice minute virus and other parvoviruses may have severe teratogenic effects and cause foetal and neonatal abnormalities by destroying rapidly dividing cell populations, often resulting in foetal death. adult prkdc scid mice develop an acute leukopenia 1 month after experimental infection with mmvi and die within 3 months. the virus persists lifelong in the bone marrow of these mice (segovia et al., 1999) . mice minute virus is shed in faeces and urine. contaminated food and bedding are important factors in viral transmission because the virus is very resistant to environmental conditions. direct contact is also important and the virus does not easily spread between cages. routine health surveillance is usually conducted by serological methods. unlike mpv, mmv can easily be cultured in cell lines so that antigen production for hi and elisa (using whole purified virions) is easy. haemagglutination inhibition is a highly specific diagnostic test whereas ifa always exhibits some degree of cross reactivity with mpv and other closely related parvoviruses. enzyme-linked immunosorbent assay is probably the most frequently used test, but depending on the purity of the antigen preparation, cross reactions with mpv may occur due to contamination with nonstructural proteins that are common to both viruses. this problem can be avoided by the use of recombinant vp-2 antigen (livingston et al., 2002) . viral detection is also possible by pcr in biological materials and in organs (intestines, kidney, spleen) from infected animals (yagami et al., 1995; chang et al., 1997; redig and besselsen, 2001) . in contrast to mpv, pcr is not appropriate as a confirmatory method for serology because mmv has not been shown to persist in immunocompetent animals for sufficiently long periods. the virus can be eliminated from infected breeding populations by caesarean derivation or by embryo transfer. in experimental colonies, elimination of infected animals and subsequent replacement with uninfected mice is practical if careful environmental sanitation is conducted by appropriate disinfection procedures. it is important that reintroduction is avoided by exclusion of wild mice and by strict separation from other infected populations and potentially contaminated materials in the same facility. admission of biological materials must be restricted to samples that have been tested and found free from viral contamination. both allotropic variants of mmv have been used as models for molecular virology, and their small size and simple structure have facilitated examination of their molecular biology and expedited understanding of cell tropism, viral genetics, and structure. the significance for laboratory mouse populations was considered low or uncertain because natural infections are inapparent. however, various effects on mouse-based research have been published (tattersall and cotmore, 1986; jacoby et al., 1996; baker, 1998; nicklas et al., 1999) . due to their predilection for replicating in mitotically active cells, they are frequently associated with tumour cells and have a marked oncosuppressive effect (rommelaere and cornelis, 1991) . special attention is also necessary for immunological research and other studies involving rapidly dividing cells (embryology, teratology). in addition, mmv is a common contaminant of transplantable tumours, murine leukaemias, and other cell lines (collins and parker, 1972; nicklas et al., 1993; garnick, 1996) . lactate dehydrogenase-elevating virus (ldv) is a single-stranded rna virus of the genus arterivirus belonging to the family arteriviridae. lactate dehydrogenase-elevating virus has repeatedly been detected in feral mice (mus musculus), which are considered to be a virus reservoir (rowson and mahy, 1975; li et al., 2000) . only mice and primary mouse cells are susceptible to infection with ldv. after infection, virus titres of 10 10 -10 11 particles per ml serum are found within 12-14 h after infection. the virus titre drops to 10 5 particles per ml within 2-3 weeks and remains constant at this level for life. lactate dehydrogenase-elevating virus replicates in a subpopulation of macrophages in almost all tissues and persists in lymph nodes, spleen, liver, and testes tissues (anderson et al., 1995a) . the virus can be stored in undiluted mouse plasma at ϫ70њc without loss of infectivity, but it is not stable at room temperature and is very sensitive to environmental conditions. lactate dehydrogenase-elevating virus was first detected during a study of methods that could be used in the early diagnosis of tumours (riley et al., 1960) . it produces a persistent infection with continuous virus production and a lifelong viraemia despite ldv-specific immune reactions of the host ( van den broek et al., 1997) . lactate dehydrogenase-elevating virus has been found in numerous biological materials that are serially passaged in mice such as transplantable tumours including human tumours (nicklas et al., 1993; ohnishi et al., 1995) , monoclonal antibodies or ascitic fluids (nicklas et al., 1988) , or infectious agents (e.g. haemoprotozoans, k virus, clostridium piliforme). these materials are contaminated after passage in an infected and viraemic animal. contamination with ldv leads to the infection of each sequential host and to transmission of the virus by the next passage and remains associated with the specimen. it is therefore the most frequently detected contaminant in biological materials (collins and parker, 1972; nicklas et al., 1993) . infection with ldv is usually asymptomatic, and there are no gross lesions in immunocompetent as well as in immunodeficient mice. the only exception is polyomyelitis with flaccid paralysis of hind limbs developing in c58 and akr mice when they are immunosuppressed either naturally with aging or experimentally (anderson et al., 1995b; monteyne et al., 1997) . it has been shown that only mice harbouring cells in the cns that express a specific endogenous mulv are susceptible to poliomyelitis (anderson et al., 1995c) . the characteristic feature of ldv infection is the increased activity of lactate dehydrogenase (ldh) and other plasma enzymes (brinton, 1986; national research council, 1991) , which is due to the continuous destruction of permissive macrophages that are responsible for the clearance of ldh from the circulation. as a consequence, the activity of plasma ldh begins to rise by only 24 h after infection and peaks 3-4 days after infection at 5-10-fold normal levels, or even be up to 20-fold in sjl/j mice. the enzyme activity declines during the next 2 weeks but remains elevated throughout life. antigen-antibody complexes produced during infection circulate in the blood and are deposited in the glomeruli (brinton, 1986; national research council, 1991) . in contrast to other persistent virus infections (e.g. lymphocytic choriomeningitis virus lcmv), these complexes do not lead to immune complex disease and produce only a very mild glomerulopathy. the only gross finding associated with ldv infection is mild splenomegaly. microscopically, necrosis of lymphoid tissues is visible during the first days of infection. in mouse strains that are susceptible to poliomyelitis, ldv induces lesions in the grey matter of the spinal cord and the brain stem (brinton, 1986) . lactate dehydrogenase-elevating virus is not easily transmitted between mice, even in animals housed in the same cage. fighting and cannibalism increase transmission between cage mates most likely via blood and saliva. infected females transmit the virus to their foetuses if they have been infected few days prior to birth and before igg anti-ldv antibodies are produced, but developmental and immunological factors (e.g. gestational age, timing of maternal infection with ldv, placental barrier) are important in the regulation of transplacental ldv infection (haven et al., 1996; zitterkopf et al., 2002) . maternal immunity protects foetuses from intrauterine infection. immunodeficient prkdc scid mice transmit virus to their offspring also during chronic infection (broen et al., 1992 ). an important means of transmission is provided by experimental procedures such as mouse-to-mouse passage of contaminated biological materials or the use of the same needle for sequential inoculation of multiple mice. in principal, serological methods such as ifa may be used for detecting ldv infection (hayashi et al., 1992) but they are not of practical importance. circulating virus-antibody complexes interfere with serological tests (aclad, 1991) , and sufficient quantities of virus for serological tests are difficult to generate because ldv replicates only in specific subpopulations of primary cultures of murine macrophages and monocytes for one cell cycle (brinton, 1986) . therefore, diagnosis of ldv infection is primarily based on increased ldh activity in serum or plasma of mice. lactate dehydrogenase-elevating virus activity in serum or plasma can be measured directly, or samples (e.g. plasma, cell or organ homogenates) are inoculated into pathogen-free mice and the increase in ldh activity within 3-4 days is measured. an 8-10-fold increase is indicative of ldv infection. detection of infectivity of a plasma sample by the induction of increased ldh activity in the recipient animal is the most reliable means of identifying an infected animal. however, it is important to use clear nonhaemolysed samples because haemolysis will (falsely) elevate activities of multiple serum or plasma enzymes, including ldh. while this assay may be included in a commercial 'map test', it does not involve antibody detection. persistent infection makes ldv an ideal candidate for pcr detection in plasma or in organ homogenates (van der logt et al., 1994; chen and plagemann, 1997) . however, reports exist that pcr may produce false-negative results and should be used cautiously (lipman et al., 2000a) . similarly important as detecting ldv in animals is its detection in biological materials. this may be done by assay for increased ldh activity after inoculation of suspect material into pathogen-free mice (collins and parker, 1972; nicklas et al., 1993) or by pcr (goto et al., 1998; bootz and sieber, 2002) . lactate dehydrogenase-elevating virus spreads slowly in a population because direct contact is necessary. therefore ldv-negative breeding populations can easily be established by selecting animals with normal plasma ldh activity. embryo transfer and hysterectomy derivation are also efficient. the presence of ldv in experimental populations is indicative of contaminated biological materials. in such cases, it is essential that the virus is also eliminated from these samples. this is easily achieved by maintenance of cells by in vitro culture instead of by animal-to-animal passages (plagemann and swim, 1966) . due to the extreme host specificity of the virus, contaminated tumour samples can also be sanitized by passages in nude rats or other animal species. lactate dehydrogenase-elevating virus is a potential confounder of any research using biological materials that are passaged in mice. once present in an animal, the virus persists lifelong. the most obvious signs are increased levels of plasma ldh and several other enzymes. lactate dehydrogenase-elevating virus may also exhibit numerous effects on the immune system (thymus involution, depression of cellular immunity, enhanced or diminished humoral responses, nk cell activation, development of autoimmunity, and suppression of development of diabetes in nod mice; cafruny and hovinen, 1988; nicklas et al., 1988; takei et al., 1992; markine-goriaynoff et al., 2002; gomez et al., 2003) and enhance or suppress tumour growth (brinton, 1982; baker, 1998; nicklas et al., 1999) . lymphocytic choriomeningitis virus is an enveloped, segmented single-stranded rna virus of the genus arenavirus, family arenaviridae. its name refers to the condition that results from experimental intracerebral inoculation of the virus into adult mice and is not considered to be a feature of natural infections. mice (mus musculus) serve as the natural virus reservoir (salazar-bravo et al., 2002) , but syrian hamsters are also important hosts (ackermann, 1977) . additional species such as rabbits, guinea pigs, squirrels, monkeys, and humans are susceptible to natural or experimental infection. infection in hamsters is considered to be asymptomatic (national research council, 1991) . natural infection of callitrichid primates (marmosets and tamarins) leads to a progressive hepatic disease that is known as 'callitrichid hepatitis' (montali et al., 1995; asper et al., 2001; lukashevich et al., 2003) . antibodies to lcmv have been found in wild mice in europe (ackermann et al., 1964) , africa (el karamany and imam, 1991), asia (morita et al., 1991 (morita et al., , 1996 , australia , and america (childs et al., 1992) . thus, it is the only arenavirus with worldwide distribution. infection with lcmv is rarely found in laboratory mice (smith et al., 1984) . seropositivity to lcmv was reported in approximately 5% of non-spf mouse colonies in the usa in 1996 (jacoby and lindsey, 1998) and in 4% of french colonies in 1996-97 (zenner and regnault, 2000) . recent studies confirm that only a small percentage of mice tested are positive for lcmv (livingston and riley, 2003) . in addition to laboratory mice and other vertebrate hosts, the virus has frequently been found in transplantable tumours and tissue culture cell lines from mice and hamsters (bhatt et al., 1986a; nicklas et al., 1993) . despite the low prevalence in laboratory mice, seropositivity to this zoonotic agent should raise serious concern for human health. lymphocytic choriomeningitis virus is frequently transmitted to humans from wild mice (childs et al., 1991) and is also endemic to a varying degree in the human population (childs et al., 1991; marrie and saron, 1998; lledo et al., 2003) due to contact with wild mice. lymphocytic choriomeningitis virus is further transmitted to humans by domestic syrian hamsters rousseau et al., 1997) . in addition, infected laboratory mice (dykewicz et al., 1992) and contaminated biological materials are important sources of infections for humans, and several outbreaks of lcm among laboratory personnel have been traced to transplantable tumours biggar et al., 1977; mahy et al., 1991) . in mice, clinical signs of lcmv infection vary with strain and age of mouse, strain and dose of virus, and route of inoculation (lehmann-grube, 1982; national research council, 1991) . two forms of natural lcmv infection are generally recognized: a persistent tolerant and an (acute) nontolerant form. the persistent form results from infection of mice that are immunotolerant. this is the case if mice are infected in utero or during the first days after birth. this form is characterized by lifelong viraemia and shedding. mice may show growth retardation, especially during the first 3-4 weeks, but appear otherwise normal. infectious virus is bound to specific antibodies and complement, and these complexes accumulate in the renal glomeruli, the choroid plexus, and sometimes also in synovial membranes and blood vessel walls. at 7-10 months of age, immune complex nephritis develops with ruffled fur, hunched posture, ascites, and occasional deaths. this immunopathological phenomenon is called 'late onset disease' or 'chronic immune complex disease'. the incidence of this type of disease varies between mouse strains. gross lesions include enlarged spleen and lymph nodes due to lymphoid hyperplasia. kidneys affected with glomerulonephritis may be enlarged with a granular surface texture or may be shrunken in later stages of the disease process. microscopically, there is generalized lymphoid hyperplasia and immune complex deposition in glomeruli and vessel walls, resulting in glomerulonephritis and plasmacytic, lymphocytic perivascular cuffs in all visceral organs (percy and barthold, 2001) . the nontolerant acute form occurs when infection is acquired after the development of immunocompetence (in mice older than 1 week). these animals become viraemic but do not shed virus and may die within a few days or weeks. natural infections of adults are usually asymptomatic. surviving mice are seropositive and in most cases clear the virus to below detection levels of conventional methods. however, virus may persist at low levels in tissues (particularly spleen, lung, and kidney) of mice for at least 12 weeks after infection as determined by sensitive assays such as nested reverse transcriptasepolymerase chain reaction (rt-pcr) or immunohistochemisty (ciurea et al., 1999) . such nonlethal infection leads to protection against otherwise lethal intracerebral challenge. protection from lethal challenge is also achieved by maternally derived anti-lcmv antibodies through nursing or by the administration of anti-ldv monoclonal igg2a antibodies (baldridge and buchmeier, 1992) . in experimentally infected animals, the route of inoculation (subcutaneous, intraperitoneal, intravenous, intracerebral) also influences the type and degree of disease (lehmann-grube, 1982; national research council, 1991) . intracerebral inoculation of adult immunocompetent mice typically results in tremors, convulsions, and death due to meningoencephalitis and hepatitis. neurological signs usually appear on day 6 postinoculation, and animals die within 1-3 days after the onset of symptoms or recover within several days. the classic histological picture is of dense perivascular accumulations of lymphocytes and plasma cells in meninges and choroid plexus. while infection following subcutaneous inoculation usually remains inapparent, reaction of mice to intraperitoneal or intravenous inoculation depends on the virus strain and on the mouse strain. infection by these routes primarily causes multifocal hepatic necrosis and necrosis of lymphoid cells. athymic foxn1 nu mice and other immunodeficient mice do not develop disease but become persistently viraemic and shed virus. as a general rule, all pathological alterations following lcmv infection are immune-mediated; and mice can be protected from lcmv-induced disease by immunosuppression (gossmann et al., 1995) . lymphocytic choriomeningitis virus disease is a prototype for virus-induced t-lymphocyte-mediated immune injury and for immune complex disease. for detailed information on the pathogenesis of lcmv infection, the reader is referred to a recent review article by oldstone (2002) . extensive information on the clinical and pathological features of lcmv infection in mice has been assembled by lehmann-grube (1982) . in nature, carrier mice with persistent infection serve as the principal source of virus. intrauterine transmission is very efficient, and with few exceptions all pups born from carrier mice are infected. furthermore, persistently infected mice and hamsters can shed large numbers of infectious virions primarily in urine, but also in saliva and milk. the virus can replicate in the gastric mucosa after intragastric infection (rai et al., 1996 (rai et al., , 1997 . gastric inoculation elicits antibody responses of comparable magnitudes as intravenous inoculation and leads to active infection with lcmv indicating that oral infection is possible, e.g., by ingestion of contaminated food or cannibalism. a self-limiting infection frequently results from infection of adult mice. the virus does not spread rapidly after introduction in populations of adult mice, and the infectious chain usually ends. however, if the virus infects a pregnant dam or a newborn mouse, a lifelong infection results, and soon a whole breeding colony of mice may become infected if the mice live in close proximity (which is the case under laboratory conditions). lymphocytic choriomeningitis virus is most commonly diagnosed by serological methods. methods of choice are ifa and elisa, which have replaced the relatively insensitive complement fixation test. it is important that bleeding of mice is done carefully because of a potential risk due to viraemic animals. historically, direct viral detection was performed by inoculating body fluids or tissue homogenates into the brain of lcmv-free mice or by subcutaneous injection into mice and subsequent serological testing (map test). more recently, pcr assays have been developed for the direct detection of viral rna in clinical samples or animals (park et al., 1997 . both map test and pcr can also be used to detect contamination of biological materials (bootz and sieber, 2002) . vertical transmission of lcmv by transuterine infection is efficient so this virus cannot reliably be eliminated by caesarean rederivation. caesarean derivation may be effective if dams acquired infection after the development of immunocompetence (nontolerant acute infection) and subsequently eliminated the virus, but such a strategy is difficult to justify in light of lcmv's zoonotic potential. in breeding colonies of great value, virus elimination might be possible soon after introduction into the colony by selecting nonviraemic breeders. this procedure is expensive and time consuming and requires special safety precautions. fortunately, infections of laboratory mice with lcmv are very uncommon. however, once lcmv has been detected in animals or in biological materials, immediate destruction of all contaminated animals and materials is advisable to avoid risk of human infection. foxn1 nu and prkdc scid mice may pose a special risk because infections are silent and chronic (mahy et al., 1991) . cages and equipment should be autoclaved, and animal rooms should be fumigated with disinfectants such as formaldehyde, vaporized paraformaldehyde, and hydrogen peroxide. appropriate precautions are necessary for experiments involving lcmv, or lcmv-infected animals or materials. biological safety level (bsl) 2 will be considered to be sufficient in most cases. biological safety level 3 practices may be considered when working with infected animals owing to the increased risk of virus transmission by bite wounds, scratching, or aerosol formation from the bedding. animal biosafety level (absl) 3 practices and facilities are generally recommended for work with infected hamsters. appropriate precautions have been defined for different bsls or animal biology safety levels by cdc (1999) . lymphocytic choriomeningitis virus is an important zoonotic agent. it has been transmitted to humans working with infected animals or with contaminated biological materials and can cause mild to serious or fatal disease in humans (dykewicz et al., 1992; barton et al., 1995; barton and hyndman, 2000) . congenital infection in humans may result in hydrocephalus, or foetal or neonatal death (barton et al., 2002) . lymphocytic choriomeningitis virus is also frequently utilized as a model organism to study virus-host interactions, immunological tolerance, virus-induced immune complex disease, and a number of immunological mechanisms in vivo and in vitro (slifka, 2002; zinkernagel, 2002) . accidental transmission may have a severe impact on various kinds of experiments (for details, see lehmann-grube, 1982; bhatt et al., 1986b; national research council, 1991; baker, 1998; nicklas et al., 1999) . mammalian orthoreoviruses (mrv) are nonenveloped, segmented double-stranded rna viruses of the family reoviridae, genus orthoreovirus. they have a wide host range and are ubiquitous throughout the world. the designation reo stands for respiratory enteric orphan and reflects the original isolation of these viruses from human respiratory and intestinal tract without apparent disease. the term 'orphan' virus refers to a virus in search of a disease. mammalian orthoreovirus can be grouped into three serotypes (1, 2, 3). mammalian orthoreovirus-3 (synonyms: hepatoencephalomyelitis virus; echo 10 virus) infection remains prevalent in contemporary mouse colonies and has been reported in wild mice barthold, 1997a) . seropositivity to mrv-3 was found in less than 5% of spf colonies and in approximately 20% of non-spf mouse colonies in the usa in 1996 (jacoby and lindsey, 1998) . a study in france reported antibodies to mrv-3 in 9% of mouse colonies examined (zenner and regnault, 2000) . more recently, a study in north america found a low rate (0.2%) of mouse sera to be positive for antibodies against this virus (livingston and riley, 2003) . in addition, contamination of mouse origin tumours and cell lines by mrv-3 has been reported many times (national research council, 1991; nicklas et al., 1993; barthold, 1997a) . experimentally, mrv-3 infection of infant mice has been used to model human hepatobiliary disease, pancreatitis, diabetes mellitus, and lymphoma (kraft, 1982; national research council, 1991; fenner et al., 1993) . the literature on mrv-3 infections in mice is dominated by studies on experimentally infected animals. the virus can cause severe pantropic infection in infant mice (kraft, 1982; tyler and fields, 1986; barthold, 1997a) . after parenteral inoculation, virus can be recovered from the liver, brain, heart, pancreas, spleen, lymph nodes, and blood vessels. following oral inoculation, reoviruses gain entry by infecting specialized epithelial cells (m cells) that overlie peyer's patches. the virus then becomes accessible to leukocytes and spreads to other organs by way of the lymphatic system and the bloodstream. neural spread to the cns has also been well documented (morrison et al., 1991) . the mechanisms of viral pathogenesis and their interactions with the host cell are reviewed in detail by and . natural infection by mrv-3 in a mouse colony usually is subclinical although diarrhoea or steatorrhoea and oily hair effect in suckling mice may be noted (kraft, 1982; tyler and fields, 1986; national research council, 1991; barthold, 1997a; percy and barthold, 2001) . the latter term has been used to describe the matted, unkempt appearance of the hair coat that results from steatorrhoea due to pancreatitis, maldigestion, and biliary atresia. in addition, runting (attributed to immune-mediated destruction of cells in the pituitary gland that produce growth hormone), transient alopecia, jaundice (due to excessive bilirubin in the blood, which is attributed to the liver pathology, especially biliary atresia), and neurological signs such as incoordination, tremors, or paralysis may develop. when present in natural infections, clinical signs and lesions are similar to but milder than in experimental neonatal infections. early descriptions of naturally occurring disease may have been complicated by concurrent infections such as mhv or murine rotavirus a (murv-a)/epizootic diarrhoea of infant mice (edim) virus that contributed to the severity of the lesions especially in liver, pancreas, cns, and intestine. the outcome of mrv-3 infection depends on age and immunological status of mouse, dose of virus, and route of inoculation. adult immunocompetent mice typically show no clinical signs and have no discernible lesions even in experimental infections. mucosal and maternally conferred immunity are considered to be important in protection from or resolution of disease (cuff et al., 1990; barthold et al., 1993b) . experimental infection of adult prkdc scid mice is lethal (george et al., 1990) . depending on the route of inoculation, experimental infection of adult foxn1 nu mice is subclinical or results in liver disease (carthew, 1984; george et al., 1990) . histological findings reported to occur after experimental mrv-3 infection of neonatal mice include inflammation and necrosis in liver, pancreas, heart, adrenal, brain, and spinal cord; lymphoid depletion in thymus, spleen, and lymph nodes; and hepatic fibrosis with biliary atresia (papadimitriou and robertson, 1976; tyler and fields, 1986; barthold et al., 1993b; barthold, 1997a; percy and barthold, 2001) . transmission of reoviruses probably involves the aerosol as well as the faecal-oral route (national research council, 1991) . fomites may play an important role as passive vectors because reoviruses resist environmental conditions moderately well. serological screening with elisa or ifa is in widespread use for detection of antibodies to mrv-3 in diagnostic and health surveillance programmes. both elisa and ifa detect cross-reacting antibodies to heterologous mrv serotypes that can infect mice (aclad, 1991) . the hi test does not detect such cross-reacting antibodies but is prone to give false positive results due to nonspecific inhibitors of haemagglutination (kraft and meyer, 1986; van der logt, 1986; aclad, 1991) . reverse transcriptase-polymerase chain reaction methods for the detection of mrv-3 rna (steele et al., 1995) or mrv rna (leary et al., 2002) are also available. reports on contamination of mouse origin tumours and cell lines by mrv-3 and its interference with transplantable tumour studies (bennette, 1960; nelson and tarnowski, 1960) emphasize the importance of screening of biological materials to be inoculated into mice by map test or pcr. natural seroconversion to mrv-3 without clinical disease is also observed in laboratory rats, hamsters, and guinea pigs (national research council, 1991; barthold, 1997a) . caesarean derivation and barrier maintenance have proven effective in the control and prevention of mrv-3 infection (kraft, 1982; national research council, 1991) . the virus may interfere with research involving transplantable tumours and cell lines of mouse origin. it has the potential to alter intestinal studies and multiple immune response functions in mice. in enzootically infected colonies, protection of neonates by maternal antibody could complicate or prevent experimental infections with reoviruses. it could further complicate experiments that require evaluation of liver, pancreas, cns, heart, lymphoid organs, and other tissues affected by the virus. the term murine hepatitis virus (mhv; commonly referred to as 'mouse hepatitis virus') designates a large group of antigenically and genetically related, singlestranded rna viruses belonging to the family coronaviridae, genus coronavirus. they are surrounded by an envelope with a corona of surface projections (spikes). murine hepatitis virus is antigenically related to rat coronaviruses and other coronaviruses of pigs, cattle, and humans. numerous different strains or isolates of mhv have been described. they can be distinguished by neutralization tests that detect strain-specific spike (s) antigens. the best studied strains are the prototype strains mhv-1, mhv-2, mhv-3, jhm (mhv-4), a59, and s, of which mhv-3 is regarded as the most virulent. murine hepatitis virus, like other coronaviruses, mutates rapidly, and strains readily form recombinants, so that new (sub)strains are constantly evolving. strains vary in their virulence, organotropism, and cell tropism (homberger, 1997) . based on their primary organotropism, mhv strains can be grouped into two biotypes: respiratory (or polytropic) and enterotropic. however, intermediate forms (enterotropic strains with tropism to other organs) exist. murine hepatitis virus is relatively resistant to repeated freezing and thawing, heating (56њc for 30 min), and acid ph but is sensitive to drying and disinfectants, especially those with detergent activity (national research council, 1991) . mus musculus is the natural host of mhv. it can be found in wild and laboratory mice throughout the world and is one of the most common viral pathogens in contemporary mouse colonies. while polytropic strains have historically been considered more common, this situation is thought to have reversed. a survey conducted in the usa in 1996 reported antibodies to mhv in more than 10% of spf mouse colonies and more than 70% of non-spf colonies (jacoby and lindsey, 1998) , though very recent monitoring results for research institutions across north america indicate that the prevalence of mhv has decreased during the past few years (livingston and riley, 2003) . a retrospective study in france covering the period from 1988 to 1997 reported antibodies to mhv in 67% of mouse colonies examined (zenner and regnault, 2000) . suckling rats inoculated experimentally with mhv had transient virus replication in the nasal mucosa and seroconversion but no clinical disease . similarly, deer mice seroconverted but showed no clinical disease after experimental infection (silverman et al., 1982) . murine hepatitis virus is also a common contaminant of transplantable tumours (collins and parker, 1972; nicklas et al., 1993) and cell lines (sabesin, 1972; yoshikura and taguchi, 1979) . the pathogenesis and outcome of mhv infections depend on interactions among numerous factors related to the virus (e.g. virulence and organotropism) and the host (e.g. age, genotype, immune status, and microbiological status; kraft, 1982; barthold, 1986; national research council, 1991; compton et al., 1993; homberger, 1997; percy and barthold, 2001) . murine hepatitis virus strains appear to possess a primary tropism for the upper respiratory or enteric mucosa. those strains with respiratory tropism initiate infection in the nasal mucosa and then may disseminate via blood and lymphatics to a variety of other organs because of their polytropic nature. respiratory (polytropic) strains include mhv-1, mhv-2, mhv-3, a59, s, and jhm. infection of mice with virulent polytropic mhv strains, infection of mice less than 2 weeks of age, infection of genetically susceptible strains of mice, or infection of immunocompromised mice favour virus dissemination. virus then secondarily replicates in vascular endothelium and parenchymal tissues, causing disease of brain, liver, lymphoid organs, bone marrow, and other sites. infection of the brain by viraemic dissemination occurs primarily in immunocompromised or neonatal mice. additionally, infection of adult mouse brain can occur by extension of virus along olfactory neural pathways, even in the absence of dissemination to other organs. in contrast, enterotropic mhv strains (e.g. livim, mhv-d, and mhv-y) tend to selectively infect intestinal mucosal epithelium, with no or minimal dissemination to other organs such as mesenteric lymph nodes or liver. all ages and strains are susceptible to active infection, but disease is largely age-related. infection of neonatal mice results in severe necrotizing enterocolitis with high mortality within 48 h. mortality and lesion severity diminish rapidly with advancing age at infection. adult mice develop minimal lesions although replication of equal or higher titres of virus occurs compared with neonates. the age-dependent decrease in severity of enterotropic mhv disease is probably related to the higher mucosal epithelium turnover in older mice, allowing more rapid replacement of damaged mucosa. another factor that is of considerable importance to the outcome of mhv infections is host genotype. for example, balb/c mice are highly susceptible to enterotropic mhv disease while sjl mice, at the other end of the spectrum, are highly resistant (barthold et al., 1993a) . unlike in polytropic mhv infection where resistance is correlated with reduced virus replication in target cells (barthold and smith, 1987) , enterotropic mhv grows to comparable titres in sjl and balb/c mice at all ages (barthold et al., 1993a) . therefore, the resistance of the sjl mouse to disease caused by enterotropic mhv seems to be mediated through an entirely different mechanism than resistance to polytropic mhv. furthermore, mouse genotypes that are susceptible to disease caused by one mhv strain may be resistant to disease caused by another strain (barthold, 1986) . it is therefore not possible to strictly categorize mouse strains as susceptible or resistant. the genetic factors determining susceptibility versus resistance in mhv infections are as yet poorly understood. both polytropic and enterotropic mhv infections are selflimiting in immunocompetent mice. immune-mediated clearance of virus usually begins about a week after infection, and most mice eliminate the virus within 3-4 weeks (barthold, 1986; barthold and smith, 1990; barthold et al., 1993a) . humoral and cellular immunity appear to participate in host defences to infection, and functional t cells are an absolute requirement (williamson and stohlman, 1990; kyuwa et al., 1996; lin et al., 1999; haring and perlman, 2001) . therefore, immunodeficient mice such as foxn1 nu and prkdc scid mice cannot clear the virus (barthold et al., 1985; compton et al., 1993) . similarly, some genetically modified strains of mice may have deficits in antiviral responses or other alterations that allow the development of persistent mhv infection (rehg et al., 2001) . recovered immune mice are resistant to reinfection with the same mhv strain but remain susceptible to repeated infections with different strains of mhv (barthold and smith, 1989a,b; . similarly, maternal immunity protects suckling mice against homologous mhv strains but not necessarily against other strains . however, maternal immunity, even to homologous strains, depends on the presence of maternally acquired antibody in the lumen of the intestine . therefore, the susceptibility of young mice to infection significantly increases at weaning. most mhv infections are subclinical and follow one of two epidemiological patterns in immunocompetent mice (national research council, 1991; homberger, 1997) . enzootic (subclinical) infection, commonly seen in breeding colonies, occurs when a population has been in contact with the virus for a longer period (e.g. several weeks). adults are immune (due to prior infection), sucklings are passively protected, and infection is perpetuated in weanlings. epizootic (clinical) infection occurs when the virus is introduced into a naive population (housed in open cages). the infection rapidly spreads through the entire colony. clinical signs depend upon the virus and mouse strains and are most evident in infant mice. typically, they include diarrhoea, poor growth, lassitude, and death. in infections due to virulent enterotropic strains, mortality can reach 100% in infant mice. some strains may also cause neurological signs such as flaccid paralysis of hind limbs, convulsions, and circling. adult infections are again usually asymptomatic. as the infection becomes established in the colony, the epizootic pattern is replaced by the enzootic pattern. in immunodeficient (e.g. foxn1 nu and prkdc scid ) mice, infection with virulent polytropic mhv strains often is rapidly fatal while less virulent strains cause chronic wasting disease (compton et al., 1993) . in contrast, adult immunodeficient mice can tolerate chronic infection by enterotropic mhv, with slow emaciation and diarrhoea, or minimal clinical disease (barthold et al., 1985; barthold, 1986) . subclinical mhv infections can be activated by a variety of experimental procedures (e.g. thymectomy, whole body irradiation, treatment with chemotherapeutic agents, halothane anaesthesia) or by co-infections with other pathogens (e.g. eperythrozoon coccoides, k virus; reviewed by kraft, 1982; national research council, 1991) . in most natural infections, gross lesions are not present or are transient and not observed. gross findings in neonates with clinical signs include dehydration, emaciation, and in contrast to edim, an empty stomach (ishida et al., 1978; barthold et al., 1982; kraft, 1982) . the intestine is distended and filled with watery to mucoid yellowish, sometimes gaseous contents. haemorrhage or rupture of the intestine can occur. depending on the virus strain, necrotic foci on the liver (ishida et al., 1978; kraft, 1982; percy and barthold, 2001) and thymus involution godfraind et al., 1995) may also be seen in susceptible mice. liver involvement may be accompanied by jaundice and haemorrhagic peritoneal exudate. splenomegaly may occur as a result of compensatory haematopoiesis (fox et al., 1977) . histopathological changes in susceptible mice infected with polytropic mhv strains include acute necrosis with syncytia in liver, spleen, lymph nodes, gut-associated lymphoid tissue, and bone marrow (kraft, 1982; barthold, 1986; national research council, 1991; percy and barthold, 2001) . neonatally infected mice can have vascular-oriented necrotizing (meningo)encephalitis with demyelination in the brain stem and peri-ependymal areas. lesions in peritoneum, bone marrow, thymus, and other tissues can be variably present. mice can develop nasoencephalitis due to extension of infection from the nasal mucosa along olfactory pathways to the brain, with meningoencephalitis and demyelination, the latter of which is thought to be largely t cell-mediated (haring and perlman, 2001) . this pattern of infection regularly occurs after intranasal inoculation of many mhv strains but is a relatively rare event after natural exposure. syncytia arising from endothelium, parenchyma, or leukocytes is a hallmark of infection in many tissues including intestine, lung, liver, lymph nodes, spleen, thymus, brain, and bone marrow. lesions are transient and seldom fully developed in adult immunocompetent mice, but they are manifest in immunocompromised mice. highly unusual presentations can occur in mice with specific gene defects. for example, granulomatous peritonitis and pleuritis were found in interferon-␥-deficient mice infected with mhv (france et al., 1999) . histopathological changes caused by enterotropic strains of mhv are mainly confined to the intestinal tract and associated lymphoid tissues (kraft, 1982; barthold, 1986; national research council, 1991; percy and barthold, 2001) . the most common sites are terminal ileum, caecum, and proximal colon. the severity of disease is primarily age-dependent, with neonatal mice being most severely affected. these mice show segmentally distributed areas of villus attenuation, enterocytic syncytia (balloon cells), and mucosal necrosis accompanied by leukocytic infiltration. intracytoplasmic inclusions are present in enterocytes. erosions, ulceration, and haemorrhage may be seen in more severe cases. lesions can be fully developed within 24-48 h, but are usually more severe at 3-5 days after infection. surviving mice may develop compensatory mucosal hyperplasia. mesenteric lymph nodes usually contain lymphocytic syncytia, and mesenteric vessels may contain endothelial syncytia. pathological changes in older mice are generally much more subtle and may only consist of transient syncytia. an occasional exception seems to occur in immunodeficient animals such as foxn1 nu mice, which can develop chronic hyperplastic typhlocolitis of varying severity (barthold et al., 1985) , but other agents such as helicobacter species may have been involved. in general, enterotropic mhv strains do not disseminate, but hepatitis and encephalitis can occur with some virus strains in certain mouse genotypes. murine hepatitis virus is highly contagious. it is shed in faeces and nasopharyngeal secretions and appears to be transmitted via direct contact, aerosol, and fomites (kraft, 1982; national research council, 1991) . vertical (in utero) transmission has been demonstrated in experimental infections (katami et al., 1978) but does not seem to be of practical importance under natural conditions. diagnosis during the acute stage of infection can be made by histological demonstration of characteristic lesions with syncytia in target tissues, but clinical signs and lesions can be highly variable and may not be prominent. suckling, genetically susceptible or immunocompromised mice are the best candidates for evaluation. active infection can be confirmed by immunohistochemistry (brownstein and barthold, 1982) or by virus isolation. virus recovery from infected tissues is difficult but can be accomplished using primary macrophage cultures or a number of established cell lines such as nctc 1469 or dbt (aclad, 1991) . these cells, however, may not be successful substrates for some enterotropic mhv strains. virus in suspect tissue can also be confirmed by bioassays such as map testing or infant or foxn1 nu mouse inoculation (de souza and smith, 1989; aclad, 1991) . amplification by passage in these mice increases the likelihood of detection of lesions and antigen, or virus recovery. other direct diagnostic methods that have been successfully utilized to detect mhv in faeces or tissue of infected mice include monoclonal antibody solution hybridization assay (casebolt and stephensen, 1992 ) and a number of rt-pcr assays (homberger et al., 1991; kunita et al., 1992; yamada et al., 1993; besselsen et al., 2002) . because of the transient nature of mhv infection in immunocompetent mice, serology is the most appropriate diagnostic tool for routine monitoring. enzyme-linked immunosorbent assay and ifa are well established and sensitive, and all known mhv strains cross-react in both tests (smith, 1983; aclad, 1991) . the magnitude of antibody response depends on mhv strain and mouse genotype (nakanaga et al., 1983; barthold and smith, 1987) . dba/2 mice are poor antibody responders whereas c57bl/6 mice produce a high antibody titre and are therefore good sentinels. antibody titres remain high over a period of at least 6 months (barthold and smith, 1989b; . infected mice may not develop detectable antibodies for up to 14 days after initial exposure (smith, 1983 ). in such cases, a direct diagnostic method as discussed above may be useful. another drawback of serology is that mice weaned from immune dams can have maternal antibodies until they are 10 weeks of age (homberger, 1992) . this may impact serological monitoring because the possibility must be considered that low positive results are due to maternally-derived passive immunity. because the virus can be transmitted by transplantable tumours and other biological materials from mice, including hybridomas (holmes et al., 1986) and embryonic stem cells (okumura et al., 1996; kyuwa, 1997) , these materials should also be routinely screened for mhv contamination. mouse inoculation bioassay, map test, and rt-pcr can be used for this purpose. the best means of mhv control is to prevent its entry into a facility. this can be accomplished by purchase of mice from virus-free sources and maintenance under effective barrier conditions monitored by a welldesigned quality assurance programme. control of wild mouse populations, proper husbandry and sanitation, and strict monitoring of biological materials that may harbour virus are also important measures to prevent infection. if infection occurs, the most effective elimination strategy is to cull the affected colony and obtain clean replacement stock. however, this is not always a feasible option when working with valuable mice (e.g. genetically modified lines, breeding stocks). caesarean derivation or embryo transfer can be used to produce virus-free offspring, and foster-nursing also has been reported to be effective (lipman et al., 1987) . quarantine of an affected colony with no breeding and no introduction of new animals for approximately 2 months has been effective in immunocompetent mice (weir et al., 1987) . the infection is likely to be terminated because mhv requires a constant supply of susceptible animals. this method works best when working with small numbers of mice. large populations favour the development of new mhv strains that may result in repeated infections with slightly different strains (adami et al., 1995) . it may be practical to select a few future breeders from the infected population and quarantine them for approximately 3 weeks (compton et al., 1993) . this can be achieved in isolators, or in individually ventilated cages if proper handling is guaranteed. after this interval, breeding can resume. the 3-week interval should permit recovery from active infection, and the additional 3-week gestation period effectively extends the total quarantine to 6 weeks. it is advisible to select seropositive breeders because the possibility of active infection is lower in such animals. the breeding cessation strategy may not be successful if immunodeficient mice are used because they are susceptible to chronic infection and viral excretion (barthold et al., 1985) . genetically engineered mice of unclear, unknown or deficient immune status pose a special challenge because they may develop unusual manifestations of infection or may be unable to clear virus. rederivation likely is the most cost effective strategy in such situations. along with the measures described, proper sanitation and disinfection of caging and animal quarters as well as stringent personal sanitation are essential to eliminate infection. careful testing with sentinel mice should be applied to evaluate the effectiveness of rederivation. if transplantable tumours are contaminated with mhv, virus elimination can be achieved by passage of tumours in athymic whn rnu rats (rülicke et al., 1991) . murine hepatitis virus is one of the most important viral pathogens of laboratory mice and has been intensively studied from a number of research perspectives (e.g. as a model organism for studying coronavirus molecular biology or the pathogenesis of viral-induced demyelinating disease). numerous reports document the effects of natural and experimental infections with mhv on host physiology and research, especially in the fields of immunology and tumour biology (reviewed by barthold, 1986; national research council, 1991; compton et al., 1993; homberger, 1997; baker, 1998; nicklas et al., 1999) . murine pneumonia virus, commonly referred to as 'pneumonia virus of mice' (pvm), is an enveloped, singlestranded rna virus of the family paramyxoviridae, genus pneumovirus. it is closely related to human respiratory syncytial virus (hrsv). the virus name is officially abbreviated as 'mpv' according to the international union of microbiological societies (2000); however, the former designation 'pvm' will be used in this chapter to avoid confusion with the official abbreviation of mouse parvovirus 1 (mpv). 'pneumonia virus of mice' infection is relatively common in colonies of mice and rats throughout the world. seropositivity to pvm was reported in less than 5% of spf mouse colonies and in approximately 20% of non-spf mouse colonies in the usa (jacoby and lindsey, 1998) . a serological survey in france demonstrated antibodies to pvm in 16% of mouse colonies examined (zenner and regnault, 2000) . in a more recent study in north america, such antibodies were found in only 0.1% of mice monitored (livingston and riley, 2003) . antibodies to pvm have also been detected in hamsters, gerbils, cotton rats, guinea pigs, and rabbits (parker and richter, 1982; richter, 1986; national research council, 1991) . experimentally, pvm infection of mice is used as a model for hrsv infection (domachowske et al., 2000) . in immunocompetent mice, natural infection with pvm is transient and usually not associated with clinical disease or pathological findings (parker and richter, 1982; national research council, 1991; brownstein, 1996b) . however, natural disease and persistent infection may occur in immunodeficient mice (carthew and sparrow, 1980; richter et al., 1988; weir et al., 1988) . in particular, athymic foxn1 nu mice seem to be susceptible to pvm infection, which can result in dyspnoea, cyanosis, emaciation, and death due to pneumonia (richter et al., 1988; weir et al., 1988) . similar clinical signs have been reported for experimentally infected, immunocompetent mice (cook et al., 1998) . necropsy findings in naturally infected foxn1 nu mice include cachexia and diffuse pulmonary oedema or lobar consolidation (weir et al., 1988) . pulmonary consolidation (dark red or grey in colour) also has been found after experimental infection of immunocompetent mice (brownstein, 1996b) . histologically, natural infection of foxn1 nu mice with pvm presents as interstitial pneumonia (richter et al., 1988; weir et al., 1988) . experimental intranasal inoculation of immunocompetent mice can result in rhinitis, erosive bronchiolitis, and interstitial pneumonia with prominent early pulmonary eosinophilia and neutrophilia (brownstein, 1996b; domachowske et al., 2000) . hydrocephalus may result from intracerebral inoculation of neonatal mice (lagace-simard et al., 1980) . susceptibility to infection is influenced by age of mouse, dose of virus, and a variety of local and systemic stressors (parker and richter, 1982; national research council, 1991) . pneumonia virus of mice is labile in the environment and rapidly inactivated at room temperature (parker and richter, 1982; national research council, 1991) . the virus is tropic for the respiratory epithelium (carthew and sparrow, 1980; cook et al., 1998) , and transmission is exclusively horizontal via the respiratory tract, mainly by direct contact and aerosol (parker and richter, 1982; national research council, 1991) . therefore, transmissibility in mouse colonies is low, and infections tend to be focal enzootics. serology (elisa, ifa, or hi) is the primary means of testing mouse colonies for exposure to pvm. immunohistochemistry has been applied to detect viral antigen in lung sections (carthew and sparrow, 1980; weir et al., 1988) , however, proper sampling (see chapter on health monitoring) is critical for establishing the diagnosis due to the focal nature of the infection. an rt-pcr assay to detect viral rna in respiratory tract tissues has also been reported . however, the use of direct methods requires good timing because the virus is present for only up to about 10 days in immunocompetent mice (brownstein, 1996b) . embryo transfer or caesarean derivation followed by barrier maintenance can be used to rear mice that are free of pvm. because active infection is present in the individual immunocompetent mouse for only a short period, strict isolation of a few (preferably seropositive) mice with the temporary cessation of breeding might also be successful in eliminating the virus (richter, 1986; national research council, 1991) . pneumonia virus of mice could interfere with studies involving the respiratory tract or immunological measurements in mice. in addition, pvm can have devastating effects on research using immunodeficient mice because they are particularly prone to develop fatal disease (richter et al., 1988; weir et al., 1988) or become more susceptible to the deleterious effects of other agents such as pneumocystis carinii (roths et al., 1993) . murine rotavirus-a/edim (commonly referred to as 'mouse rotavirus' or 'epizootic diarrhoea of infant mice virus') is a nonenveloped, segmented double-stranded rna virus of the family reoviridae, genus rotavirus. it is antigenically classified as a group a rotavirus, similar to rotaviruses of many other species that cause neonatal and infantile gastroenteritis (fenner et al., 1993) . murine rotavirus-a/edim infection remains prevalent in contemporary mouse colonies and appears to occur worldwide. seropositivity to murv-a/edim was reported in approximately 5% of spf colonies and in almost 30% of non-spf mouse colonies in the usa in 1996 (jacoby and lindsey, 1998) . more recently, livingston and riley (2003) found a low rate (1%) of mouse sera to be positive for antibodies against murv-a/edim. experimentally, murv-a/edim infection in mice is used as a model for human rotavirus infection, especially in investigations on the mechanisms of rotavirus immunity and in the development of vaccination strategies (ward and mcneal, 1999) . clinical symptoms following murv-a/edim infection range from inapparent or mild to severe, sometimes fatal, diarrhoea. 'epizootic diarrhoea of infant mice' describes the clinical syndrome associated with natural or experimental infection by murv-a/edim during the first 2 weeks of life (kraft, 1982; sheridan and vonderfecht, 1986; national research council, 1991; barthold, 1997b; percy and barthold, 2001) . diarrhoea usually begins around 48 h after infection and persists for about 1 week. affected suckling mice have soft, yellow faeces that wet and stain the perianal region. in severe instances, the mice may be stunted, have dry scaly skin, or are virtually covered with faecal material. morbidity is very high but mortality is usually low. gross lesions in affected mice are confined to the intestinal tract. the caecum and colon may be distended with gas and watery to paste-like contents that are frequently bright yellow. the stomach of diarrheic mice is almost always filled with milk, and this feature has been reported to be a reliable means to differentiate diarrhoea caused by rotavirus from the diarrhoea caused by mhv infection. histopathological changes may be subtle even in animals with significant diarrhoea. they are confined to the small intestine and are most prominent at the apices of villi, where rotaviruses infect and replicate within epithelial cells. hydropic change of villous epithelial cells is the hallmark finding of acute disease. the villi become shortened, and the cells that initially replace the damaged cells are less differentiated, typically cuboidal instead of columnar, and lack a full complement of enzymes for digestion and absorption, resulting in diarrhoea due to maldigestion and malabsorption. undigested milk in the small intestine promotes bacterial growth and exerts an osmotic effect, exacerbating damage to the villi. intestinal fluid and electrolyte secretion is further enhanced by activation of the enteric nervous system (lundgren et al., 2000) and through the effects of a viral enterotoxin called nsp4 (for nonstructural protein 4; ball et al., 1996) . it is hypothesized that nsp4 is released from virusinfected cells and then triggers a signal transduction pathway that alters epithelial cell permeability and chloride secretion. susceptibility to edim depends on the age of the host and peaks between 4 and 14 days of age (kraft, 1982; sheridan and vonderfecht, 1986; national research council, 1991; barthold, 1997b; percy and barthold, 2001) . mice older than about 2 weeks can still be infected with murv-a/edim, but small numbers of enterocytes become infected, there is little replication of virus, and diarrhoea does not occur. the exact reason for this age-related resistance to disease is unknown. pups suckling immune dams are protected against edim during their period of disease susceptibility (rosé et al., 1998) . in general, the infection is selflimiting and resolves within days. successful viral clearance is promoted by an intact immune response (feng et al., 1997; mcneal et al., 1997; rosé et al., 1998) , and some immunodeficient mice (e.g. prkdc scid and rag2 tm1fwa mice) may shed virus for extended periods or become persistently infected (riepenhoff-talty et al., 1987; franco and greenberg, 1995) . protection against murv-a/edim reinfection is primarily mediated by antibodies (feng et al., 1997; rosé et al., 1998) . murine rotavirus-a/edim is highly contagious and transmitted by the faecal-oral route (kraft, 1982; sheridan and vonderfecht, 1986; national research council, 1991) . dissemination of the virus occurs through direct contact or contaminated fomites and aerosols. murv-a/edim is stable at ϫ70њc but otherwise tends to be susceptible to extreme environmental conditions, detergents, and disinfectants. enzyme-linked immunosorbent assay and ifa are in widespread use for detection of serum antibodies to murv-a/edim in diagnostic and health surveillance programmes; other assay systems such as those using latex agglutination are also utilized (ferner et al., 1987) . rotazyme ii is a commercially available elisa for detection of rotavirus antigen in faeces; however, great care must be used in interpreting the results because some feeds have been reported to cause false positive reactions (jure et al., 1988) . electron microscopy of faeces of diarrheic pups should reveal typical wheelshaped rotavirus particles, 60-80 nm in diameter. reverse transcriptase-polymerase chain reaction also can be used to detect rotavirus rna in faecal samples (wilde et al., 1990) . good timing is critical for establishing the diagnosis from faeces because virus is shed for only a few days in immunocompetent mice. embryo transfer or caesarean derivation followed by barrier maintenance is recommended for rederivation of breeding stocks (kraft, 1982; national research council, 1991) . in immunocompetent mice in which infection is effectively cleared, a breeding suspension strategy combined with excellent sanitation, filter tops, and conscientious serological testing of offspring may also be effective. murine rotavirus-a/edim has the potential to interfere with any research utilizing suckling mice. it may have a significant impact on studies where the intestinal tract of neonatal or infant mice is the target organ. the infection also poses a problem for infectious disease and immune response studies, particularly those involving enteropathogens in infant mice (newsome and coney, 1985) . in addition, runting could be interpreted erroneously as the effect of genetic manipulation or other experimental manipulation. sendai virus (sev) is an enveloped, single-stranded rna virus of the family paramyxoviridae, genus respirovirus. it is antigenically related to human parainfluenza virus 1. the virus was named for sendai, japan, where it was first isolated from mice. infections of mice and rats are relatively common and occur worldwide. in addition, there is evidence that hamsters, guinea pigs, and rabbits are susceptible to infection with sev (machii et al., 1989; aclad, 1991; national research council, 1991; percy and palmer, 1997) ; however, some apparently seropositive guinea pigs may in fact be seropositive to other parainfluenza viruses instead of sev. seropositivity to sev was reported to be absent from spf mouse colonies and to be approximately 20% in non-spf mouse colonies in the usa (jacoby and lindsey, 1998) . a study in france reported antibodies to sev in 17% of mouse colonies examined (zenner and regnault, 2000) . a low rate of seropositive mice (0.2%) was found in a recent survey in north america (livingston and riley, 2003) . furthermore, sev can contaminate biological materials (collins and parker, 1972) . sendai virus is pneumotropic and the leading cause of viral respiratory disease in mice. the pneumotropism is partially a consequence of the action of respiratory serine proteases such as tryptase clara, which activate viral infectivity by specific cleavage of the viral fusion glycoprotein (tashiro et al., 1999) . in addition, the apical budding behaviour of sev may hinder the spread of virus into subepithelial tissues and subsequently to distant organs via the blood. two epidemiologic patterns of sev infection have been recognized, an enzootic (subclinical) and epizootic (clinically apparent) type (parker and richter, 1982; national research council, 1991; brownstein, 1996a) . enzootic infections commonly occur in breeding or open colonies, where the constant supply of susceptible animals perpetuates the infection. in breeding colonies, mice are infected shortly after weaning as maternal antibody levels wane. normally, the infection is subclinical, with virus persisting for approximately 2 weeks, accompanied by seroconversion that persists for a year or longer. epizootic infections occur upon first introduction of the virus to a colony and either die out (self-cure) after 2-7 months or become enzootic depending on colony conditions. the epizootic form is generally acute, and morbidity is very high resulting in nearly all susceptible animals becoming infected within a short time. clinical signs vary and include rough hair coat, hunched posture, chattering, respiratory distress, prolonged gestation, death of neonates and sucklings, and runting in young mice. breeding colonies may return to normal productivity in 2 months and thereafter maintain the enzootic pattern of infection. factors such as strain susceptibility, age, husbandry, transport, and copathogens are important in precipitating overt disease. dba and 129/j strains of mice are very susceptible to sev pneumonia whereas sjl/j and c57bl/6/j strains and several outbred stocks are relatively resistant. a/j, balb/c, and swr/j are among the strains that show intermediate susceptibility. there is no evidence for persistent infection in immunocompetent mice, but persistent or prolonged infection may occur in immunodeficient mice and can result in wasting and death due to progressive pneumonia (ward et al., 1976; iwai et al., 1979; percy et al., 1994) . clearance of a primary sev infection is mediated by cd8 ϩ and cd4 ϩ t cell mechanisms (kast et al., 1986; hou et al., 1992) . heavier than normal, consolidated, plum-coloured or grey lungs are a characteristic gross finding in severe sev pneumonia (parker and richter, 1982; national research council, 1991; brownstein, 1996a; percy and barthold, 2001) . lymphadenopathy and splenomegaly reflect the vigorous immune response to infection. histologically, three phases of disease can be recognized in susceptible immunocompetent mice: acute, reparative, and resolution phases (brownstein, 1996a; percy and barthold, 2001) . lesions of the acute phase, which lasts 8-12 days, are primarily attributed to the cell-mediated immune response that destroys infected respiratory epithelial cells and include necrotizing rhinitis, tracheitis, bronch(iol)itis, and alveolitis. epithelial syncytiae and cytoplasmic inclusion bodies in infected cells may be seen early in this phase. alveoli contain sloughed necrotic epithelium, fibrin, neutrophils, and mononuclear cells. atelectasis, bronchiectasis, and emphysema may occur as a result of damage and obstruction of airways. the reparative phase, which may overlap the acute phase but continues through about the third week post infection, is indicated by regeneration of airway lining epithelium. adenomatous hyperplasia and squamous metaplasia (with multilayered flat epithelial cells instead of normal columnar cells) in the terminal bronchioles and alveoli are considered to be a hallmark of sev pneumonia. mixed inflammatory cell infiltrates in this phase tend to be primarily interstitial rather than alveolar as they are in the acute phase. the resolution phase may be complete by the fourth week post infection and lesions may be difficult to identify subsequently. residual, persistent lesions that may occur include organizing alveolitis and bronchiolitis fibrosa obliterans. alveoli and bronchioles are replaced by collagen and fibroblasts, foamy macrophages, and lymphoid infiltrates, often with foci of emphysema, cholesterol crystals, and other debris, which represent attempts to organize and wall off residual necrotic debris and fibrin. lesions are more severe and variable when additional pathogens such as mycoplasma pulmonis are present (national research council, 1991) . otitis media has also been reported in natural infections with sev although some of these studies have been complicated by the presence of other pathogens (ward, 1974) . sendai virus has been detected in the inner ear after experimental intracerebral inoculation of neonatal mice (shimokata et al., 1977) . sendai virus is extremely contagious. infectious virus is shed during the first 2 weeks of infection and appears to be transmitted by direct contact, contaminated fomites, and respiratory aerosol (parker and reynolds, 1968; parker and richter, 1982; national research council, 1991) . serology (elisa, ifa, or hi) is the approach of choice for routine monitoring because serum antibodies to sev are detectable soon after infection and persist at high levels for many months, although active infection lasts only 1-2 weeks in immunocompetent mice. the short period of active infection limits the utility of direct methods such as immunohistochemistry (carthew and sparrow, 1980) and rt-pcr (hayase et al., 1997; wagner et al., 2003) . although sev is considered to be highly contagious, studies have shown that dirty bedding sentinel systems do not reliably detect the infection and that outbred stocks may not seroconvert consistently (dillehay et al., 1990; artwohl et al., 1994) . mouse antibody production test and rt-pcr can be used to detect sev in contaminated biological materials. sendai virus infection in mouse colonies has proven to be one of the most difficult virus infections to control because the virus is highly infectious and easily disseminated. depopulation of infected colonies probably is the most appropriate means to eliminate the virus in most situations. embryo transfer followed by barrier maintenance has also been used successfully in eliminating the virus (national research council, 1991) . a less effective alternative is to place the infected animals under strict quarantine, remove all young and pregnant mice, suspend all breeding, and prevent addition of other susceptible animals for approximately 2 months until the infection is extinguished and then breeding and other normal acitivities are resumed (parker and richter, 1982; national research council, 1991) . vaccines against the virus have been developed (brownstein, 1986; national research council, 1991) , but these probably do not represent a practical means to achieve or maintain the seronegative status of colonies that is in demand today. sendai virus has the potential to interfere with a wide variety of research involving mice. reported effects include interference with early embryonic development and foetal growth; alterations of macrophage, nk cell, and t and b cell function; altered responses to transplantable tumours and respiratory carcinogens; altered isograft rejection; and delayed wound healing (reviewed by national research council, 1991; baker, 1998; nicklas et al., 1999) . pulmonary changes during sev infection can compromise interpretation of experimentally induced lesions and may lead to opportunistic infections by other agents. they could also affect the response to anaesthetics. in addition, natural sev infection would interfere with studies using sev as a gene vector. theiler's murine encephalomyelitis virus (tmev) or murine poliovirus is a member of the genus cardiovirus in the family picornaviridae. members of this genus are nonenveloped viruses with singlestranded rna. the virus is rapidly destroyed at temperatures above 50њc. it is considered to be a primary pathogen of the cns of mice and can cause clinical disease resembling that due to poliomyelitis virus infections in humans. antibodies to tmev have been identified in mouse colonies and feral populations worldwide, and mus musculus is considered to be the natural host of tmev (lipton et al., 2001) . the most well-known and most frequently mentioned tmev strain is gdvii, which is virulent for mice. infant or young hamsters and laboratory rats are also susceptible to intracerebral infection. the original isolate is designated to (theiler's original) and represents a group of tmev strains with low virulence for mice. many additional virus strains have been isolated and studied, and they all fall in the broad grouping of to and gdvii. a similar virus strain has also been isolated from rats, but in contrast to mouse isolates this virus is not pathogenic for rats and mice after intracerebral inoculation (hemelt et al., 1974) . recently, another rat isolate has been characterized and shown to be most closely related to but quite distinct from other tmev viruses (ohsawa et al., 2003) . antibodies to tmev (strain gdvii) have been detected in guinea pigs and are considered to indicate infection with another closely related cardiovirus (hansen et al., 1997) . seropositivity to tmev was reported in approximately 5% of spf mouse colonies and approximately 35% of non-spf mouse colonies in the usa (jacoby and lindsey, 1998) . zenner and regnault (2000) reported a prevalence rate of 9% in french mouse colonies in a retrospective study, and it has been one of the most common virus infections in rodent colonies. in a recent study, antibodies were found in 0.2% of mice monitored (livingston and riley, 2003) indicating that tmev, like most viruses, has meanwhile been eliminated from the majority of mouse colonies. theiler's murine encephalomyelitis virus is primarily an enteric pathogen, and virus strains are enterotropic. in natural infections, virus can be detected in intestinal mucosa and faecal matter, and in some cases it is also found in the mesenteric lymph nodes. however, histological lesions in the intestine are not discerned. virus may be shed via intestinal contents for up to 22 weeks, sometimes intermittently (brownstein et al., 1989a) , and transmission under natural conditions is via the faecal-oral route by direct contact between mice as well as by indirect contact (e.g. dirty bedding). the host immune response limits virus spread, but it does not immediately terminate virus replication in the intestines. virus is cleared from extraneural tissues, but it persists in the cns for at least a year. clinical disease due to natural tmev infection is rare, with a rate of only 1 in 1000-10,000 infected immunocompetent animals (percy and barthold, 2001) . in immunodeficient mice, especially in weanlings, clinical signs may be more common and mortality may be higher (rozengurt and sanchez, 1993) . this group of viruses usually causes asymptomatic infections of the intestinal tract. they may spread to the cns as a rare event where they cause different neurological disease manifestations. the most typical clinical sign of tmev infection is flaccid paralysis of hind legs. the animals appear otherwise healthy, and there is no mortality. experimental infection in mice provides models of poliomyelitis-like infection and virus-induced demyelinating disease including multiple sclerosis (mcgavern et al., 2000) . after experimental infection, tmev causes a biphasic disease in susceptible strains of mice. the acute phase is characterized by early infection of neurons in the grey matter. encephalomyelitis may develop during this phase and may be fatal, but most animals survive and enter the second phase of the disease at 1-3 months after the acute phase. this phase is characterized by viral persistence in the spinal cord white matter, mainly in macrophages, and leads to white matter demyelination. persistence and demyelination occur only in genetically susceptible mouse strains while resistant strains clear the infection after early grey matter encephalomyelitis through a cytotoxic t lymphocyte response. for this reason, the nude mutation (foxn1 nu ) confers susceptibility on mice with an otherwise resistant background. the severity and nature of disease depend on virus strain, route of inoculation, host genotype and age (downs, 1982; lipton and rozhon, 1986; national research council, 1991; percy and barthold, 2001) . in general, virus isolates with low virulence produce persistent cns infection in mice whereas virulent strains are unable to cause persistent infection. intracerebral inoculation results in the most severe infections, but the intranasal route is effective also. experimental intracerebral infections with virulent fa and gdvii strains of tmev are more likely to cause acute encephalomyelitis and death in weanling mice 4-5 days after inoculation ('early disease'). death may be preceded by neurological manifestations of encephalitis such as hyperexcitability, convulsions, tremors, circling and rolling, and weakness. animals may develop typical flaccid paralysis of hind limbs, and locomotion is possible only by use of the forelimbs. interestingly, the tail is not paralysed. experimental infections with low virulence virus strains (e.g. to, da, ww) are more likely to cause persistent infection with development of mild encephalomyelitis followed by a chronic demyelinating disease after a few months ('late disease'). these virus strains infect neurons in the grey matter of the brain and spinal cord during the acute phase of viral growth, followed by virus persistence in macrophages and glial cells in the spinal cord white matter. sjl, swr, and dba/2 strains are most susceptible to this chronic demyelinating disease. cba and c3h/he are less susceptible strains, and strains a, c57bl/6, c57bl/10, and dba/1 are relatively resistant (lipton and dal canto, 1979) . differences in humoral immune responses play a role in resistance to tmev infection (pena rossi et al., 1991a) , but genetic factors are also important. several genetic loci implicated in susceptibility to virus persistence, demyelination, or clinical disease have been identified, including the h-2d region of the major histocompatibility complex (brahic and bureau, 1998) . furthermore, the age at infection influences the severity of clinical disease. in infant mice, intracerebral infection with low virulence virus strains (e.g. to) is often lethal. young mice develop paralysis after an incubation period of 1-4 weeks while adult mice often show no clinical signs of infection (downs, 1982) . the only gross lesions are secondary to the posterior paralysis and may include urine scald or dermatitis due to incontinence of urine and trauma to paralysed limbs, or wasting or atrophy of the hind limbs in long term survivors. theiler's murine encephalomyelitis virus infects neurons and glial cells, and histological changes in the cns include nonsuppurative meningitis, perivasculitis, and poliomyelitis with neuronolysis, neuronophagia, and microgliosis in the brainstem and ventral horns of the spinal cord (percy and barthold, 2001) . demyelination in immunocompetent mice is considered to be immune-mediated. susceptible strains develop a specific delayed-type hypersensitivity response which is the basis for inflammation and demyelination. this reaction is mediated by cytotoxic t lymphocytes (lindsley et al., 1991; pena rossi et al., 1991b) and by the activation of cytokines as a consequence of infection of macrophages and other cells of the cns (rubio and capa, 1993; sierra and rubio, 1993; palma et al., 2003) . protection from chronic demyelinating disease is possible by vaccination with live virus given previously by subcutaneous or intraperitoneal inoculation (crane et al., 1993; kurtz et al., 1995) . early immunosuppression at the time of infection, e.g. by treatment with cyclophosphamide or antithymocyte serum, inhibits or diminishes demyelination. immunosuppression in mice chronically infected with tmev leads to remyelination of oligodendrocytes (rodriguez and lindsley, 1992) . further details related to the pathogenesis of tmev infections and the role of immune mechanisms have been reviewed by yamada et al. (1991) . experimental infection of foxn1 nu mice results in acute encephalitis and demyelination. demyelination associated with minimal inflammation and neurological signs including the typical hind limb paresis develop 2 weeks after inoculation, and most animals die within 4 weeks. in foxn1 nu mice, demyelination is caused by a direct lytic effect of the virus on oligodendrocytes (rosenthal et al., 1986) . demyelination and lethality are reduced after administration of neutralizing antibodies (fujinami et al., 1989) . histopathological changes in prkdc scid mice are very similar to those in foxn1 nu mice (rozengurt and sanchez, 1992) . young mice born in infected populations usually acquire infection shortly after weaning and are almost all infected by 30 days of age. intrauterine transmission to foetuses is possible during the early gestation period, but a placental barrier develops during gestation and later prevents intrauterine infection (miyamae, 1990; abzug et al., 1991) . all tmev isolates are closely related antigenically and form a single serogroup as determined by complement fixation and hi (lipton and rozhon, 1986) . hemelt et al. (1974) demonstrated cross reactions among four strains used in experimental infections, but differences were evident in homologous and heterologous titres. the viral strain most commonly used as antigen for serological testing is gdvii. this strain agglutinates human type 0 erythrocytes at 4њc, and hi has been the standard test for routine screening of mouse populations. meanwhile, hi has been replaced by elisa or ifa, both of which are more sensitive and specific. virus isolation is possible from brains or spinal cords of mice with clinical disease or from the intestinal contents of asymptomatic mice. pcr techniques also are available to test for virus-specific nucleotide sequences in biological samples (trottier et al., 2002) . mice that have been shown to be free from tmev by serological testing can be selected for breeding populations. if the virus is introduced into a mouse population, depopulation of infected colonies may be the most appropriate means to eliminate tmev. embryo transfer or caesarean derivation are the methods of choice for eliminating virus from valuable breeding populations. foster-nursing has been reported to be effective in generating virus-free offspring (lipman et al., 1987) although transplacental transmission has been demonstrated with experimental infection early in gestation. lesions of demyelination in cns of mice with clinically inapparent chronic infection may interfere with investigations that require evaluation of the cns (krinke and zurbriggen, 1997) . conceivably, such lesions also could affect neuromuscular responses or coordination, and affect neurological and behavioural evaluations. viral and mycoplasmal infections of laboratory rodents: effects on biomedical research monographs on pathology of laboratory animals: digestive system monographs on pathology of laboratory animals: digestive system viral and mycoplasmal infections of laboratory rodents: effects on biomedical research the mouse in biomedical research viral and mycoplasmal infections of laboratory rodents: effects on biomedical research viral and mycoplasmal infections of laboratory rodents: effects on biomedical research monographs on pathology of laboratory animals: respiratory system monographs on pathology of laboratory animals: respiratory system biosafety in microbiological and biomedical laboratories (bmbl), 4th edn. u.s. department of health and human services proc. natl. acad. sci. usa 96 the mouse in biomedical research the mouse in biomedical research the mouse in biomedical research veterinary virology complications of viral and mycoplasmal infections in rodents to toxicology research and testing viral and mycoplasmal infections of laboratory rodents: effects on biomedical research virus taxonomy. seventh report of the international committee on taxonomy of viruses the mouse in biomedical research the mouse in biomedical research viral and mycoplasmal infections of laboratory rodents: effects on biomedical research proc. natl. acad. sci. usa the importance of laboratory animal genetics, health, and the environment in biomedical research proc. natl. acad. sci. usa national research council, committee on infectious diseases of mice and rats manual of microbiologic monitoring of laboratory animals the mouse in biomedical research viral and mycoplasmal infections of laboratory rodents: effects on biomedical research the mouse in biomedical research the mouse in biomedical research pathology of laboratory rodents and rabbits proc. natl. acad. sci. usa manual of microbiologic monitoring of laboratory animals viral and mycoplasmal infections of laboratory rodents: effects on biomedical research lactic dehydrogenase virus viral and mycoplasmal infections of laboratory rodents: effects on biomedical research viral and mycoplasmal infections of laboratory rodents: effects on biomedical research viral and mycoplasma infections of laboratory rodents: effects on biomedical research viral and mycoplasmal infections of laboratory rodents: effects on biomedical research viral and mycoplasmal infections of laboratory rodents: effects on biomedical research handbook of animal models of infection the mouse in biomedical research key: cord-320172-qw47pf9r authors: greaves, peter title: vii digestive system 1 date: 2000-12-31 journal: histopathology of preclinical toxicity studies doi: 10.1016/b978-044450514-9/50007-3 sha: doc_id: 320172 cord_uid: qw47pf9r publisher summary this chapter deals with the digestive system. the major and minor salivary glands and their secretions also represent and integral part of the protective mechanism of the oral cavity, and derangement of saliva production may lead to loss of integrity of the oral mucosa. drug-induced abnormalities of taste sensation are also well-described phenomena occurring in man although human studies are necessary for the detection of these effects. inflammation of the oral cavity may involve the buccal mucosa, the gingiva (gingivitis), the tongue (glossitis), and the peridontal tissues (peridontitis). therapeutic agents can induce inflammatory lesions in the tongue. moreover, a protective layer of mucus, a visco-elastic material containing high molecular weight glycoproteins produced by the major and minor salivary glands, covers the stratified squamous mucosa of the oral cavity. salivary secretions also possess digestive enzyme activity although in herbivores and carnivores, it is usually low in contrast to high digestive enzyme activity in omnivorous species. the oral mucosa can be damaged by excessive local trauma from foreign materials, hard fragments in food and damaged teeth may produce ulceration of the mucosa with subsequent infection. however, the oral mucosa may show manifestations of local or systemic disease or derangement produced by therapeutic agents. excessive contact by therapeutic agents such as aspirin, potassium supplements and corticosteroids have been reported to produce local ulceration in the mouth (zentler-monro and northfield, 1979) . the increased use of mouthwashes over the last 20 years has resulted in a number of reported adverse effects to the buccal mucosa in people (gargari and kabani, 1995) . systemic disorders produced by anticoagulants or chemotherapeutic drugs may also be evident by bleeding or ulceration in the oral cavity (goepp, 1982) . buccal ulceration is also described as part of a generalised hypersensitivity reaction to drugs (zentler-monro and northfield, 1979) . the major and minor salivary glands and their secretions also represent and integral part of the protective mechanism of the oral cavity and derangement of saliva production may lead to loss of integrity of the oral mucosa. drugs that effect motor co-ordination can give rise to drooling and disruption of cricopharyngeal co-ordination (wyllie et al., 1986) . drug-induced abnormalities of taste sensation are also well-described phenomena occurring in man although human studies are necessary for the detection of these effects. indeed, many alterations in the oral mucosa are those that are more readily detected by careful clinical and macroscopic observation rather than exhaustive histopathological examination of the buccal mucosa in laboratory animals -provided the basic toxicity profile of a novel agent is adequately assessed in the usual preclinical studies. oral irritation studies are used in the testing of products for use in the oral cavity, mainly for surgical, dental and hygiene purposes but also therapeutic agents administered by the sublingual route. this route may be selected for substances that are broken down in the stomach or show a rapid first pass effect. as it is technically not feasible to perform full preclinical toxicity studies by the sublingual route, conventional oral or parenteral routes are preferred for systemic toxicity studies on such compounds. the choice of the best route will to a large extent be dictated by pharmacokinetic considerations. however, it is necessary to assess local irritancy potential to oral mucosa using a laboratory animal model. test species for oral irritation studies are usually rats, hamsters (cheek pouch), guinea pigs, dogs or primates using gross and histopathological assessment. a similar scheme to that employed in the histological assessment of skin irritancy is appropriate. inflammation of the oral cavity (stomatitis) may involve the buccal mucosa, the gingiva (gingivitis), the tongue (glossitis) and the peridontal tissues (peridontitis). although inflammatory lesions are found sporadically in untreated laboratory rodents, dogs and primates, stomatitis can be induced by systemic administration of high doses of therapeutic agents. anticancer and antimitotic agents are particularly liable to induce stomatitis. a notable example is bleomycin that is capable of producing stomatitis as part of its general effect on squamous cells (thompson et al., 1972) . in humans, the adverse effects on therapeutic ionising radiation on the salivary glands may also give rise to inflammatory changes in the oral cavity (fox, 1998) diuretics and other agents, which are capable of producing severe electrolyte disturbances and uraemia at excessive doses, can also produce stomatitis when then are administered in high doses to laboratory animals (garthoff et al., 1982) . these lesions may be analogous to the well-described association of ulcerative stomatitis and uraemia in man and laboratory animals (boyd, 1978; barker and van dreumel, 1985) . the dog appears very sensitive to the ulcerogenic effects of uraemia in the oral cavity, although as there is a poor correlation between actual levels of blood urea and stomatitis, other biochemical factors are undoubtedly involved. compounds, which effect pigmentation of the skin, can produce similar changes in pigmented oral mucosa. a number of drugs including chlorpromazine, quinacrine, chloroquine, amodiaquine and pyrimethamine cause pigmentation of the oral mucosa in man notably over the hard palate. chloroquine and pyrimethamine have also been shown to significantly increase numbers of active melano-cytes within the palatal mucosa of pigmented da rats when treated orally for 12 weeks (savage et al., 1986) . melanocytes in treated rats were shown to be enlarged and packed with melanin pigment and to possess extensive arborisation of cell processes between squamous cells. an experimental inhibitor of platelet aggregation, which produced pigment loss in the dark hair of long-evans rats and the skin of beagle dogs, also induced pallor of the normally pigmented oral mucous membranes in dogs (gracon et al., 1982; walsh and gough, 1989) . apart from loss of pigment, the histology of the mucous membranes and skin was normal. the tongue is conveniently sectioned for histological study, although reliance is often placed on careful visual inspection, because the usefulness of systematic histological examination of the tongue in routine preclinical safety studies has not been clearly established. a few lesions occur which are fairly specific to the tongue. amyloid may become deposited in the muscular and connective tissue of the tongue in amyloid-prone species, particularly mice (dunn, 1967) . mice, especially dba and dba/2ncrj strains, are liable to develop calcification in the lingual muscle spontaneously, even at a young age (imaoka et al., 1986) . calcified lesions are seen in the longitudinal muscle under the dorsolateral epithelium and the central part of the tongue, which, when severe, are associated with inflammation, granulation tissue, polypoid change, hyperplasia of the overlying squamous epithelium and ulceration. the histogenesis of this lesion is uncertain. in the dba/2ncrj mice, mineralisation of the tongue is associated with myocardial and aortic mineralisation (doi et al., 1985) . therapeutic agents can induce inflammatory lesions in the tongue. an example is provided by the investigational anticancer immunotoxin, zd0490, a mouse monoclonal antibody (c242) against colorectal carcinoma antigen conjugated to recombinant ricin a-chain. when administered to wistar-derived rats, this agent produced myocyte necrosis and inflammation specifically located below the ventral subepithelial surface of the tongue (westwood et al., 1996) . as the changes were different to the low grade myositis seen elsewhere in treated animals, these authors speculated that the changes in the tongue may have been related to the particular receptor profile of this area targeted by the monoclonal antibody. in common with other changes induced in the digestive tract of rats and cynomolgus monkeys by the administration of recombinant human epidermal growth factor, the tongue showed squamous epithelial hyperplasia characterised by a uniform increase in the thickness of the squamous epithelium in both species (breider et al., 1996; reindel et al., 1996) . at high doses, the squamous epithelium of the tongue of the primates was twice the thickness of control mucosa associated with elongation of rete pegs. teeth are usually only inspected by naked eye in conventional toxicity studies and this is appropriate for the assessment of a mature dentition. however, there has been an increasing awareness of dental lesions in toxicity studies, particularly as the teeth are visualised when the maxilla is examined histologically in inhalation studies. study of the rodent dentition in inhalation studies has shown that spontaneous lesions of the dentition are quite common. in one laboratory, malformations (dental dysplasia) of the maxillary incisors were observed in 3% of female and 9% of male cd-1 mice and 14.5% female and 10.5% sprague-dawley rats in 24 and 18 month inhalation studies respectively (losco, 1995) . the rat incisor and its pathology has been the subject of an excellent review (kuijpers et al., 1996) . unlike in humans, the rodent incisor continues to grow and differentiate throughout life and is renewed every 40-50 days. located at the centre of the tooth is the vascular pulp. this is surrounded by proliferating ondotoblasts which form predentin which when calcified becomes dentin. surrounding ameloblasts when induced by the presence of dentin produce the overlying enamel layer. it is these active cellular layers, which can be modified or damaged by xenobiotics, vitamin deficiencies, calcium, phosphate or magnesium deficiency, parathyroidectomy, hypophysectomy, hyperparathyroidism, adrenal insufficiency and fluorosis (kuijpers et al., 1996) . although in humans the mature dentition is no longer growing, in children the dentition is in a growth phase that starts in utero and lasts into the second decade. as increasing numbers of children survive malignant disease, damage to the mature dentition can occur as a result of cytotoxic therapy during childhood. clinical study of the teeth of children treated for malignancy have shown increased incidence of enamel hypoplasia and missing teeth (welbury et al., 1984) . histological examination of teeth from children treated with vincristine or combination chemotherapy for malignant disease has demonstrated prominent incremental lines in dentine correlating with the number of times the intravenous cytotoxic agents were administered (macleod et al., 1987) . it has also been shown that vincristine, a drug which interferes with the assembly of microtubules and reduces secretory activity in a number of cells including osteoblasts and chondroblasts, also effects dentine formation in the rat incisor (stene and koppang, 1976) . two weeks following a single intravenous dose of vincristine to young adult rats, a faint incremental line in the dentine was observed, probably a reflection of a direct effect of the drug on the dentinogenic tissue at the time of injection. at higher doses, focal niche-like or punched out defects in dentine were observed, expression of more severe injury to highly sensitive dentinogenic populations at the time of injection (stene and koppang, 1976 ). the precise mechanism of damage is not fully understood although decreased secretion of dentine matrix by odontoblasts has been demonstrated. calcification appears unaltered (stene and koppang, 1980) . administration of the alkylating anticancer agent cyclophosphamide or a sin-gle exposure to ionising radiation, produces localised niche-like or punched out defects in the rat incisor, rather than the more diffuse changes induced by vincristine. this presumably reflects more localised injury to a sensitive subpopulation of dentinogenic cells (koppang, 1973; vahlsing et al., 1997) . anticonvulsant drugs also produce changes in the dentition of man and experimental animals. in humans, reported alterations include tooth root resorption, small teeth, delayed shedding of deciduous teeth and retarded eruption of permanent teeth, features similar to those found in hypoparathyroid or pseudohypoparathyroid conditions (robinson et al., 1983) . tooth root alterations were also reported in a study in which young male wistar rats were treated with diphenylhyantoin for 1 month. treated rats showed evidence of molar root resorption lacunae that penetrated the cementum and involved the dentine. the lacunae contained a dense infiltrate of cells contiguous with similar cells in the surrounding periodontal ligament. robinson and harvey (1989) showed that the changes were similar to those occurring in parathyroidectomized rats but not those in rats made hypocalcaemic with a calcium deficient diet. they suggested that the changes induced by diphenylhydantoin in rats were similar to those in pseudohypoparathyroidism in which resistance of tooth roots to resorption is reduced. discoloration of teeth and bone is a well-described side effect of tetracycline administration and it has also been reported in patients treated with the semisynthetic derivative, minocycline (cale et al., 1988) . interestingly the ameloblastic epithelium of the enamel forming tissues of growing incisors in wistar rats treated with high doses of human recombinant epidermal growth factor showed hyperplasia characterised by pseudostratification, increased nuclear-cytoplasmic ratio and increased cytoplasmic eosinophilia (breider et al., 1996) . this finding is consistent with the presence of epidermal growth factor receptors in the cells of the enamel organ (martineau et al., 1991) . periodontitis is a common and important disease in man and animals although overt cases are not usually seen in toxicity studies. however, periodontitis of a degree sufficient to disrupt chronic rat toxicity and carcinogenicity studies has been reported. robinson (1985) described periodontitis in alpk/ap rats in which there were erosive granulomatous cavities adjacent to molar teeth with fistulas opening into the nasal cavity. these changes were associated with penetrating food fibres in the gingival sulcus and it was suggested that the presence of long pointed food fibres in the powdered diet was the main reason for occurrence of periodontitis. peridontitis in rodents also results from the effects of dental pathology such as fractures, malformation or malposition of incisors (losco, 1995) . drug-induced overgrowth of the gingival tissues is a well-described phenomenon in both humans and laboratory animals including dogs, cats, and rats. in man, these changes have been associated with diphenylhydantoin (phenytoin) (beghi et al., 1986) nifedipine, calcium channel blockers (ledermann et al., 1984) , cyclosporin a (barthold, 1987) and valproic acid (syrjamen and syrjamen, 1979) . cyclosporin a, diphenylhydantoin and calcium channel blockers have been associated with similar changes in laboratory animals (do'nascimento et al., 1985; latimer et al., 1986; waner et al., 1988) . in most instances there is swelling of the gingiva by firm nodular overgrowths around the teeth. histologically, these overgrowths are characterised by marked acanthosis of the squamous epithelium overlying connective tissue that is infiltrated by large numbers of chronic inflammatory cells. fibrovascular proliferation may be marked. in patients treated with cyclosporin, myxomatous degeneration is described in association with dense infiltration of plasma cells and lymphocytes (barthold, 1987) . secondary acute inflammation in association with food debris and hair shafts is described in dogs treated with oxodipine (waner et al., 1988) . the forces behind these changes are unclear. studies of changed induced by nifedipine and hydantoin have shown increases in extracellular ground substance and increased numbers of fibroblasts containing sulphated acid mucopolysaccharides (kantor and hassel, 1983; lucas et al., 1985) . these drugs may alter fibroblastic proliferative and synthetic activity, possibly by selection of a subpopulation of fibroblasts (hassel et al., 1976) . it has also been suggested that an underlying mechanism in phenytoin-induced gingival hyperplasia involves the decrease in salivary iga that develops in some patients (beghi et al., 1986) . study of cyclosporin a-induced changes have suggested that impairment of t lymphocyte function may permit overgrowth of oral bacteria and bacterial products which may influence fibroblast function (barthold, 1987) . a spontaneous form of gingival hyperplasia has been described in non-human primates (macaca mulata). this is characterised by an enlargement of the marginal and alveolar gingiva by connective tissue consisting of relatively poorly cellular bundles of collagen fibres. the lesions show little inflammatory alterations and the overlying squamous epithelium shows mild hyperkeratosis only (schiã¸dt et al., 1994) . this pathology is similar to hereditary gingival fibromatosis in humans. sessile or pedunculated squamous papillomas and infiltrating squamous carcinomas are occasionally found in the oral cavity of most laboratory animals including rodents (odashima, 1979; emminger and mohr, 1982; leiniger and jokinen, 1994; takahashi and okamiya, 1996; mohr, 1997) , rabbits (sundberg et al., 1985; sundberg and everitt, 1986) , and beagle dogs (watrach et al., 1970) . the microscopic structure of these neoplasms in rodents resembles those occurring in squamous epithelium in other sites. although a number of agents induce squamous neoplasms in the oral cavity, spontaneous squamous carcinomas are generally uncommon spontaneous lesions in laboratory animals. however, some strains of rodent may develop squamous neoplasms more commonly. for instance, in life time studies ad libitum fed brown-norway rats, 21% of males and 32% females developed oral squamous cell carcinomas although only 9% and 10% in food-restricted animals respectively (thurman et al., 1997) . it was suggested that certain pedigrees possessed a genetic predisposition to these neoplasms. papillomas occurring in rabbits and dogs are of note because they can occur in quite young animals, apparently as a result of infection with viruses of the papilloma group. viral inclusions may be seen in histological sections. the implications of papilloma viruses in laboratory species are that the progression of virally induced papillomas to malignant squamous carcinomas can be potentiated by nonviral factors including application of xenobiotics (howley et al., 1986) . in rabbits, the prevalence of oral papillomas varies considerably but they are quite common in some laboratory strains. they are overlooked because of their small size and a distribution limited to the ventral surface of the tongue (sundberg et al., 1985) . microscopically, they are typical squamous papillomas composed of irregular acanthotic squamous epithelium and a fibrovascular stalk of variable size. squamous cells at the margins of papillomas at the junction with normal mucosa, often show large, oval nuclei, marginated chromatin and central, basophilic, intranuclear inclusions, which electron microscopic examination shows to contain viral particles. oral papillomas in dogs develop as multiple growths, regressing spontaneously after a few months. they are also caused by a virus of the papilloma group, which possesses a high degree of specificity for the mucosa of the oral cavity and adjacent skin (watrach et al., 1970) . histologically, they are composed of proliferative masses of epithelial cells, keratinised on the surface and resting on an irregular connective tissue stroma or pedicule. large vesicular cells with basophilic intranuclear inclusions are also found in the granular cell layer, identifiable as virus arrays by electron microscopy (cheville and olson, 1964) . malignant change has been described in these canine lesions and this can occur in young beagle dogs (watrach et al., 1970) . although many types of papilloma viruses have been identified in both man and animals (pfister, 1984) , common antigenic determinants exist between viruses in different species. this immunological cross-reactivity can be exploited in the immunocytochemical localisation of papilloma viruses in epithelial lesions of many animal species. papilloma virus antigen has been demonstrated in oral papilloma of dogs and rabbits using antisera to bovine papilloma virus type i (sundberg et al., 1984) . cells positive for virus and viral inclusions are located in the upper layers of the epithelium, especially within cells of the granular layer. spontaneously developing odontogenic tumours are rare in rodents but they have been induced in laboratory animals given carcinogens such as nitrosoureas or exposed to ionising radiation (gã¶ssner and luz, 1994) . a range of tumours originating from dental tissues with epithelial, mesenchymal or mixed appearances has been reported in rodents (kuijpers et al., 1996) . the classification of odontogenic tumours is complex and confusing. they range from benign anomalies and cystic structures through to malignant neoplasms. the ameloblastoma comprises cords, nests, anastomosing strands or islands of ondontogenic epithelial cells within a fibrous stroma. the tumour cells resemble ameloblasts with the cords of spindle shaped cells similar to the stellate epithelium bounded by a peripheral layer of cuboidal or columnar cells resembling the inner enamel epithelium. other tumours of the odontogenic epithelium show induction of the mesenchymal elements or develop a complete sequence of odontogenic epithelium, odontogenic mesenchyme and dental hard tissues including dentine, enamel and cementum. in the rat these have been classified as odontoma characterised by the presence of all dental hard tissues and odontogenic fibroma composed of undifferentiated or primitive mesenchymal cells of developing dental tissue (mohr, 1997) . odontogenic tumours developing in fischer rats treated with aflatoxin were located in the upper jaw associated with the incisor teeth and were composed of proliferating fibroblast-like cells within which ovoid calcified bodies resembling cementum were seen (cullen et al., 1987) . occasional inclusions of solid epithelial nests were also seen. no metastatic deposits were found although the neoplasms were locally aggressive. in addition, squamous tumours and neoplasms of mesenchymal origin typical of other organs, bones and soft tissues are found in this region. although salivary glands may not represent vital organs in the same sense as the kidneys or heart, severe derangement of their secretions can alter both the quality and quantity of saliva. depending on the particular glands and cells affected, dry mouth, mucositis, and dental caries may develop . the severe oral complications of irreversible salivary damage and dysfunction, which can occur patients with head and neck cancer as a consequence of local irradiation, may have a significant impact on the efficacy of therapy, quality of life and survival (fox, 1998) . a protective layer of mucus, a visco-elastic material containing high molecular weight glycoproteins produced by the major and minor salivary glands, covers the stratified squamous mucosa of the oral cavity. these mucins usually contain more than 50% carbohydrate in the form of neutral and acidic oligosaccharide chains, o-glycosidically linked to threonine or serine. mucins possess several roles including mechanical flushing of the oral cavity, protection and lubrication of soft and hard tissues, modulation of oral microbial flora, buffering activity, regulation of calcium/phosphate equilibrium, digestion and extracellular post translation processing of molecules present in saliva . the heterogeneity of salivary glycoproteins suggests that they act as a defence against pathogenic microorganisms by competing with microbial binding sites of similar structure on the surface of cells lining the digestive tract (schulte, 1987) . minor salivary glands may also play an important part in the local immunosurveillance of the oral cavity for their ducts are anatomically closely associated with lymphoid tissue (nair and schroeder, 1986; nair et al., 1987) . salivary secretions also possess digestive enzyme activity although in herbivores and carnivores, it is usually low in contrast to high digestive enzyme activity in omnivorous species (junqueira et al., 1973) . the phylogenetic association of the salivary glands with the thyroid gland is evident functionally because salivary glands are capable of concentrating iodide in their secretions, although this is not under control of thyroid stimulating hormone (ingbar, 1985) . it has been shown that thyroxine accelerates the differentiation of the granular convoluted tubule cells and the appearance of epidermal growth factor in the submandibular gland of the neonatal mouse (chabot et al., 1987) . the structure of the salivary glands differs among laboratory species, between different glands in the same species and between sexes. it is usually considered that there are three major salivary glands, the parotid, the sublingual and the submandibular (submaxillary) glands. minor salivary glands are scattered in other locations throughout the mouth and oropharynx. in dogs and other carnivores, the zygomatic (infra-orbital) gland, located just below the zygomatic arch and the buccal (molar) gland are also often referred to as major salivary glands. microscopically, salivary glands are composed of secretory glands or 'endpieces' attached to a connecting system of intralobular and extralobular (secretory) ducts. secretory endpieces may be acinar or tubulo-acinar in nature. the secretory cells have been subdivided into serous, mucous, seromucous and special serous types. controversy remains about the precise nature of the secretory cells found in the various salivary glands of different species and this makes critical interspecies comparisons difficult (see detailed discussion of this problem by pinkstaff, 1980 ). the duct system is less complex. this comprises an intercalated duct which leads from the secretory endpiece into a striated (secretory or intralobular) duct, so termed because their lining cells are striated by delicate eosinophilic cytoplasmic rods. the striated ducts converge into interlobular ducts and a main excretory duct system. in rats, mice and hamsters, an overall similarity in gross and microscopic anatomy of the various salivary glands exists although there are histochemical differences (munhoz, 1971; glucksmann and cherry, 1973; dawe, 1979; pinkstaff, 1980; emmiger and mohr, 1982) . moreover, it has been demonstrated that salivary glands in rodents as well as a number of other species show morphological and histochemical sexual dimorphism (pinkstaff, 1998) . the sublingual gland in rats, mice and hamsters is composed principally of mucous acini, with indistinct serous demilunes. acini open into fairly long intercalated ducts lined by flat or cuboidal cells devoid of granules. the parotid gland is composed of serous-type secretory cells containing zymogen granules and prominent hyperchromatic basal cytoplasmic poles. the submandibular gland is anatomically the most complex salivary gland in rodents. secretory endpieces are composed of small or moderately sized cells with foamy cytoplasm and basophilic basal poles. the most striking feature is the presence of an additional duct segment interposed between the intercalated and striated ducts. this segment is lined by cylindrical epithelium with basal nuclei and eosinophilic cytoplasm containing secretory granules. this duct segment is termed the granular duct or granular convoluted tubule. these granular cells are of special interest because they contain a large number of heterologous biologically active peptides including nerve growth factor, epidermal growth factor, renin, and kallikrinins (barka, 1980; mori et al., 1983 ). the precise physiological role of many of these peptides in salivary gland remains uncertain. epidermal growth factor was originally isolated from the mouse salivary gland. it initiates premature eyelid opening and incisor eruption when injected into the neonatal mouse (cohen, 1962) . study of the mouse submandibular gland has shown that both epidermal growth factor and nerve growth factor are released into saliva following the administration of phenylephrine, sympathomimetic amine acting mainly on î±receptors and isoprenaline (isoproterenol), a î²-adrenergic agent (murphy et al., 1980) . immunohistochemical study also demonstrates that epidermal growth factor becomes depleted in mouse salivary tissue following administration of phenylephrine and similar agents (tsukitani and mori, 1987) . phenylephrine has been shown to cause marked secretory activity accompanied by loss of granules from granular cells, as well as loss of immune reactive carbonic anhydrase, an enzyme which participates both in membrane transport of bicarbonate ions into saliva and glandular secretion (noda, 1986) . morphological studies have shown that both acinar and granular tubular cells participate in this response to adrenergic agents (murphy et al., 1980) . this is in contrast to the effects of pilocarpine, a cholinergic agent, which elicits the secretion of saliva deficient in serous proteins with little or none of the growth factors, as its effects are more limited to acinar cells. glycoprotein secretion of rodent salivary glands has stimulated histochemical study using both conventional mucin histochemical techniques and labelled lectins which possess affinity for specific sugars or sugar sequences (tables 1 and 2 , pages 340 and 342). studies of rat, mouse and hamster salivary glands using batteries of labelled lectins have shown a greater heterogeneity of oligosaccharides in salivary glands than seen by classical histochemical techniques. there are considerable species differences and variations between murine strains and sexes of the same strain as well as heterogeneity among morphologically similar cells within one gland (schulte and spicer, 1983, 1984; schulte, 1987) . the results of histochemical studies are in excellent agreement with studies using biochemical methods but suggest a significant influence of genetic and hormonal factors on the synthesis of salivary glycoproteins. less attention has been paid to the structure and cytochemistry of the dog salivary glands. there appears to be little variation between the structure of salivary tissues between beagles and other strains although variation with age has been reported (reifel and travill, 1972; nagoyo and tandler, 1986) . munhoz (1971) has described the histochemical features of the dog parotid gland. the dog parotid is of seromucinous type secreting both acidic and neutral mucosubstances, in contrast to the more neutral mucosubstances secreted by rodent glands. the salivary glands of non-human primates are similar to those in man. they possess parotid glands of serous or seromucous type, submandibular glands with both serous and mucous acini and sublingual glands of mainly mucous type. the salivary glands of the non-human primate react to adverse stimuli such as ionising radiation in a similar manner to human salivary tissue . focal chronic inflammation of the salivary glands occurs sporadically in untreated rats, mice, hamsters, dogs or primates employed in toxicology although severity and prevalence is variable. sialoadenitis as a result of a corona virus, the sialodacryoadenitis virus, is a well-known and fairly ubiquitous condition in rats, first described by innes and stanton (1961) . the condition is characterised histologically by oedema and congestion of submandibular and parotid salivary glands as well as extra-orbital lachrymal and harderian glands. it is accompanied by inflammation of variable severity and chronicity in both glandular and connective tissue as well as degeneration and necrosis of duct epithelium (fig. 44) . the regenerative hyperplasia of the duct epithelium may be quite intense about a week after infection but all changes regress after about 2 weeks and glands are essentially normal after 3 or 4 weeks (carthew and slinger, 1981; percy and wojcinski, 1986) . there may be a delay in the appearance of inflammatory cells and the onset of repair in rats immunosuppressed with cyclophosphamide (hanna et al., 1984) . depletion of salivary gland epidermal growth factor also occurs during the infection (percy et al., 1988) . suppurative infections in the neck region of the rat such as those produced by klebsiella aerogenes also cause acute and chronic inflammation of salivary glands with fibrosis and glandular proliferation of salivary tissue (arseculeratne et al., 1981) . sialadenitis occurs spontaneously in autoimmune-prone strains of mice such as the nzb/nzw and sl/ni strains and it has been reported in ageing female, but not male bdf1 mice (hayashi et al., 1988) . the non-obese diabetic mouse known for its spontaneous insulin-dependent diabetes mellitus also develops immune mediated damage to submandibular glands (fujino-kurihara et al., 1985; tã¶rnwall et al., 1999) . in ageing bdf1 females the submandibular gland was shown to be involved by a destructive inflammatory process characterised by an intense infiltration by small and medium sized lymphocytes, associated with mild inflammation in other organs such as the parotid and sublingual glands, pancreas and kidney. immunocytochemistry showed that most of the lymphocytes were t cells (thy-1.2 and lyt-1 positive) of the helper/inducer subset (l3t4 or cd4 positive) and less than 10% were of suppresser/cytotoxic (lyt-2 or cd8 fig. 44 . section from salivary tissue from a sprague-dawley rat during an infection with the sialodacryoadenitis virus showing intense ductular inflammation. (he, ã�25.) positive) type (see haemopoietic and lymphatic systems, chapter iii). circulating anti-salivary duct antibody of igg was also detected in afflicted mice. it was suggested that helper/inducer t cells played a key role in the production of this change, unlike induced autoimmune sialoadenitis in which cytoxic t-cell subsets may directly destroy glandular tissue. it has been suggested that this process in ageing females is related to the decline in the number of splenic lyt-2 cells in mice with advancing age (hayashi et al., 1988) . these cells are believe to be the most susceptible to ageing (see haemopoietic and lymphatic systems, chapter iii) in the non-obese diabetic strain of mouse derived from jcl-icr mice, a periductal chronic inflammatory infiltrate is found in the submandibular gland at about the same time that immune-mediated insulitis is most marked. this suggests that there is an extension of the autoimmune process to salivary tissue (fujino-kurihara et al., 1985) . it is probable that helper/inducer cd4 t cells are essential components of this infiltrate and a number of cytokines and their receptors such as ip-10 (interferon-î³ inducible protein 10) and rantes (regulated upon activation normal t cell expressed and secreted) may have an important role (tã¶rnwall et al., 1999) . an autoimmune type of sialoadenitis can also be experimentally induced certain strains of mice. crj:cd1 mice, thymectomized at 3 days, a time point at which lyt-2 positive cells (cd8 suppresser t lymphocytes) can be maximally reduced, followed by immunisation at 28 and 42 days after birth with homogenates of salivary gland and complete freund's adjuvent, develop a distinctive sialoadenitis in the submandibular and to some extent the parotid glands (hayashi et al., 1985) . this sialoadenitis is characterised by degenerative changes in salivary glandular tissue associated with an extensive and intense infiltrate of small and medium sized lymphocytes. these cells appear shortly after immunisation but increase in number with time. immunocytochemical study has shown that many of these cells are reactive to antisera to thy-1.2 and lyt-2 (cd8) features of suppresser/cytotoxic t lymphocytes. later appearing cells demonstrate features of plasmacytoid lymphocytes and contain immunoglobulin of mainly igg class (hayashi et al., 1985) . these authors therefore suggested the sialoadenitis appeared as both a result of cytotoxic/suppresser t-cell activity and an antibody-dependent cell-mediated cytotoxicity. in the hamster salivary glands, interstitial infiltrates of lymphocytes and plasma cell are quite common and may become more marked with advancing age (mcmartin, 1979) . whereas necrosis of the parotid gland of uncertain aetiology sometimes occurs in the dog, mild focal chronic inflammation is quite a common incidental finding in canine salivary glands and has been reported in about 5% of normal beagle dogs (kelly et al., 1982) . although the inflammation in salivary tissue which results from ionising radiation is only indirectly relevant to drug safety evaluation, it is of interest in view of the notable species differences in sensitivity to this form of insult. serous acinar cells in man and rhesus monkey appear least resistant to the effects of ionising radiation, where damage is characterised by widespread degranulation and degeneration of acini, infiltration by polymorphonuclear cells followed by lymphocytes, plasma cells and subsequent atrophy and fibrosis . these changes contrast with the lesser effects of ionisation radiation on the rodent salivary glands in which there is little or no acute inflammatory response. lymphoid bodies are sharply circumscribed collections of lymphoid cells generally located between the parotid and sublingual glands close to a cervical lymph node in mice. they are apparently normal aggregates of lymphoid tissue. like many other glandular organs, the size of the secretory tissue of the salivary gland is responsive to functional demand and is subject to age-related changes. in man, the gland parenchyma frequently becomes atrophic and replaced by connective tissue or fat with advancing age, possibly partly related to vascular changes (waterhouse et al., 1973; scott, 1977) . in ageing rats, the extent and height of granular ducts and their content of mature secretory granules has also been shown to decrease with age (sashima, 1986) . dietary factors influence salivary gland size. decreased food consumption or protein starvation can reduce the weight of salivary glands in rats. there is shrinking of mucous and serous glands and loss of zymogen granules associated with decreased rna but unchanged dna content, attributable to the reduced requirements for protein synthesis , mcbride et al., 1987 . as salivary gland function is responsive to adrenergic stimulation, it is not surprising that atrophy occurs following adrenergic blockade. the weights of the submandibular gland in mice were shown to decrease following administration of the î²-adrenergic blocking agent, propranolol (smith and butler, 1977) . this was associated with a reduction in stainable neutral mucins and a decrease in the thickness of the acinar cells making the gland lumens appear larger than normal. the cytotoxic agent, alloxan, known primarily for its specific effect on pancreatic b cells, has also been shown to produce weight loss of the rat submandibular gland, associated with lipid inclusions in the acinar cells, capillary basement membrane thickening and reduced salivary flow (reuterving et al., 1987) . it is probable that alloxan exerts a cytotoxic effect on the acinar cells of the rat submandibular gland (sagstrã¶m et al., 1987) . methotrexate, a folic acid antagonist, has also been reported to cause vacuolization of acinar and ductular cells with reduction of secretory granules in rat salivary glands (mcbride et al., 1987) . ligation of the main excretory ducts has frequently been used as an ex-perimental model for study of salivary gland atrophy as well as the regeneration that follows removal of the ligature. there is marked atrophy of all cell types but most markedly the acinar cells through apoptosis. although overt necrosis has been reported following ligation of the excretory duct, it appears that this may have been the result of constriction of the vasculature for acinar cells are relatively intolerant to a decrease in oxygen and nutrient (denny et al., 1997) . a number of therapeutic agents increase salivary gland size in man, although the scarcity of biopsy data precludes a critical assessment of the precise mechanism in many cases. drugs reported to produce salivary gland enlargement in man include iodide-containing radiological contrast media, isoprenaline and anti-inflammatory agents phenylbutazone and oxyphenbutazone. enlargement may also occur after endotracheal anaesthesia and upper gastrointestinal tract endoscopy in man (riddell, 1982) . some of these agents and procedures may produce spasm of large salivary ducts and retention of secretions. several pharmacological agents, particularly sympathomimetic amines, have been shown to produce increases in salivary gland size in rodents following repeated dosing (brenner and stanton, 1970) . there is an intimate relationship of sympathomimetic amines with the control of the secretory process in salivary tissue. whereas a single injection of isoprenaline (isoprotorenol) in the range of 20-200 mg/kg induces discharge of preformed secretory granules followed by gradual re-synthesis and reconstitution, repeated injections produces an increase in the size of salivary glands (simson et al., 1974) . histologically, the enlarged glands are composed of secretory cells of increased size that contain increased amounts of secretory substances in the cytoplasm (simson et al., 1974) . although these histological features are principally those of diffuse cellular hypertrophy, the increase in dna content and radioactive thymidine uptake described in the salivary tissue following repeated administration of isoprenaline suggests that a degree of hyperplasia also occurs (barka et al., 1972) . these effects do not depend on the integrity of the autonomic nerves because they occur after ablation of the autonomic ganglia (barka et al., 1972) . they appear to be mediated by an effect on adrenergic î²-receptors. the effects can be blocked by propranalol, a î²-receptor antagonist but not by phenoxybenzamine, an î±-receptor antagonist (brenner and stanton, 1970) . as theophylline and caffeine also elicit salivary gland enlargement in rats, a role for cyclic 3',5-adenosine monophosphate (camp) in salivary gland enlargement has been postulated (brenner and stanton, 1970) . detailed study of hypertrophy, protein synthesis, and intracellular camp activity in the salivary glands of rats treated for 10 days with isoprenaline (isoproterenol), a series of î²-adrenergic receptor agonists and the phosphodiesterase inhibitors, theophylline and caffeine, showed that similar effects occurred with all agents although differences in the degree of hypertrophy, the nature of pro-tein and glycoprotein synthesis and golgi membrane enzyme activity were recorded (wells and humphreys-beher, 1985) . the parotoid gland showed the most pronounced hypertrophy followed by the submandibular gland but the sublingual gland appeared to be unaffected by treatment. the degree and nature of the changes induced by the various î²1/î²2 receptor agonists suggested that most of these effects were mediated through î²1 receptors which are present in greatest numbers on the parotid and salivary cells. it was suggested that the effects of î²-adrenergic agonists on salivary gland are produced by a receptor-mediated stimulation of adenylate cyclase activity causing an increase in levels of intracellular camp. however, other factors may be important for wells and humphreys-beher (1985) also showed that although isoproterenol and caffeine increased salivary cell camp to comparable levels, the hypertrophy was greater with isoproterenol. cardioactive phosphodiesterase inhibitors were shown to produce submaxillary hypertrophy in rat subacute toxicity studies (rogers et al., 1985; jayasekara et al., 1986; smith et al., 1988) . parotid and submaxillary glands were those most affected by the inotropic phosphodiesterase inhibitor ici 153,110 (westwood et al., 1991) . as the agents produced their positive inotropic action via selective inhibition of the cardiac phosphodiesterase subfraction iii specifically requiring camp as its substrate, it was suggested that the salivary gland hypertrophy was a result of phosphodiesterase inhibition (smith et al., 1988) . other classes of drugs can also produce salivary gland enlargement in rats in repeated dose studies. doxylamine, a representative of the widely used ethanolamine group of antihistamines, has been reported to produce marked cytomegaly in the fischer 344 rat parotid gland. enlarged cells were characterised by a basophilic and coarsely granular or vacuolated cytoplasm (jackson and blackwell, 1988) . the b6c3f1 mouse did not develop these changes after a similar treatment schedule. in view of the presence of considerable amount of epidermal growth factor in salivary glands, it is of interest to note the effects of its administration to laboratory animals. salivary gland weights were increased in rats and cynomolgus monkeys infused with high doses of recombinant human epidermal growth factor (breider et al., 1996; reindel et al., 1996) . however histological features seen are primarily those of ductular epithelial hyperplasia (see below under hyperplasia). epithelial cells characterised by abundant granular eosinophilic cytoplasm as a result of the accumulation of mitochondria are often referred to as oncocytes, a term used by hamperl (1950) to describe similar cells in hã¼rthle tumours of the thyroid gland. they may be found in various focal nodular and neoplastic states of the salivary glands in both man and laboratory animals. the precise significance of these cells is uncertain. the mitochondria usually appear unremarkable except for lack of dense granules and it has been suggested that the mito-chondrial changes represent an adaptive phenomenon or compensatory hyperplasia (ghadially, 1982) . in human salivary tissue their prevalence seems to increase with advancing age and they can be associated with hyperplastic lesions or neoplasms such as oxyphil adenomas and adenolymphomas. eosinophilic cells also occur in the salivary glands of certain strains of aged rats (bogart, 1970) and in mice with experimentally induced autoallergic sialoadenitis (takeda et al., 1985) . in the study of takeda et al. (1985) the eosinophilic cells appeared to arise predominantly in the secretory (glandular) ducts of the submandibular glands, although eosinophilic cells can apparently develop from either duct or acinar cells. well-defined, unencapsulated foci of enlarged acinar cells occur spontaneously in the salivary glands, particularly the parotid of rats, mice (chiu and chen, 1986) , and hamsters although their reported incidence varies between laboratory. the enlarged cells possess greatly expanded cytoplasmic volume that retains a vesicular, vacuolated or foamy appearance or possesses a pale eosinophilic granular texture. the basal parts of the cells usually stain intensely blue in haematoxylin and eosin stained sections and contain large, dense, irregular hyperchromatic or pyknotic nuclei showing little evidence of mitotic activity. although there has been little ultrastructural study of these foci, the cytoplasmic alterations appear to be distinct from those of so-called oncocytes that characterised by granular eosinophilic cytoplasm packed with mitochondria. the biological nature of these foci is uncertain. the lack of any prominent mitotic activity, cell proliferation or expansive growth suggests that they are most aptly regarded as hypertrophic lesions (chiu and chen, 1986 ). although they increase in prevalence with increasing age in certain strains of rat, there is no evidence to suggest that they represent pre-neoplastic lesions or possess any relationship with development of neoplasia in salivary tissue (dawe, 1979) . hyperplasia and squamous metaplasia of the salivary ducts are common features of many inflammatory and reactive conditions in the salivary glands of rodents, dogs, non-human primates and man and can be associated with the presence of stones and calculi with the duct system. squamous metaplasia and regenerative change in the ducts occurs in rats afflicted with sialodacryoadenitis (carthew and slinger, 1981) . it is also described specifically located in the ducts of the sublingual glands in the wistar rat in the absence of obvious sialodacryoadenitis or evidence of any specific disease. similar regenerative hyperplastic duct changes are also seen in necrotic and inflammatory conditions in the dog salivary gland . detailed morphological examination with immunocytochemical study of epi-dermal cytokeratins of the rat salivary gland after arterial ligation has shown that the acinar units can also undergo squamous metaplasia (dardick et al., 1985) . it appears that the acinar-intercalated duct complexes can rapidly reprogram to produce epidermal cytokeratin filaments in ischaemic or inflammatory states. hyperplasia of the ductular epithelium appears to be the principle result of the administration of epidermal growth factor to rats and cynomolgus monkeys. in rats histological features were primarily of ductular epithelial hyperplasia without evidence of significant acinar hyperplasia (breider et al., 1996; reindel et al., 1996) . in primates the changes were most striking in the interlobular and large intralobular ducts where the epithelium showed multilayered and papilliform projections. however, mitotic activity was evident throughout the duct epithelia and acinar cells showed hypertrophy with depletion secretory granules and the presence of large vesicular nuclei . focal duct and acinar hyperplasia, showing minimal compression of the surrounding parenchyma and distinct from focal hypertrophy is also described in the classification of rat salivary lesions (mohr, 1997) . primary neoplasms of salivary glands are uncommon in the usual strain of rats and mice employed in carcinogenicity bioassays (haseman et al., 1998) . acinar and tubular adenomas and adenocarcinomas as well as squamous carcinomas are reported in rats (mohr, 1997) , mice (frith and heath, 1994) and hamsters (takahashi and okamiya, 1996) . some carcinomas showing squamous or glandular differentiation may be observed infiltrating the salivary gland that originate in other local structures of the head and neck region. occasionally, salivary gland neoplasms show adenomyomatous differentiation. mixed glandular and lymphoid tissue patterns resembling wartin's tumour in man are also sometimes seen. neoplasms of soft tissues also develop in and around the major salivary gland in rodents (see integumentary system chapter i). in humans the oesophagus is not considered a common site for drug-induced injury although some studies have suggested that medication-induced changes are more prevalent than previously supposed (bonavina et al., 1987) . severe damage can occur following prolonged contact between mucosa and ingested tablets or capsules which results in local high concentrations of potentially irritant substances (bott and mccallum, 1986; brors, 1987; kikendall, 1999; levine, 1999) . damage as a result of local contact may be more common in elderly subjects as the amplitude of oesophageal contractions decrease with age and capsules more liable to lodge in the lumen of the oesophagus (bonavina et al., 1987) . however patients of all ages may be affected. women have been injured more frequently than men probably because of the greater likelihood of their being treated with potentially injurious drugs (kikendall, 1999) . the shape and surface coating of tablets may influence their tendency to adhere to the mucosa and lodge in the oesophagus (marvola et al., 1983) . a wide variety of drugs have been implicated. in the united states the majority of cases appear to be caused by ingestion of tetracycline or doxacycline (levine, 1999) . some of the causative agents such as potassium chloride, aspirin and other non-steroidal anti-inflammatory drugs are also implicated in ulceration lower in the gastrointestinal tract. over recent years the bisphosphonate, alendronate has been one of the most commonly reported causes of adverse effects in the oesophagus with severe injury being reported. although injury is linked to ingestion without water or failing to remain upright after swallowing the medication, alendronate is particularly caustic (kikendall, 1999) . oesophagitis due to candida albicans is a well-described complication of antibiotic therapy. administration of immunosuppressive drugs may predispose to viral infections in the oesophagus. a number of agents affecting neuromuscular co-ordination may also predispose to gastro-oesophageal regurgitation and reflux oesophagitis (bott and mccallum, 1986) . in laboratory rodents spontaneous lesions of the oesophagus are occasionally seen. oesophageal impaction has been described in untreated srl:bhe rats. this is characterised by massive dilatation of the oesophagus with food or bedding (ruben et al., 1983) . histologically, the muscle fibres in the wall of the oesophagus show varying degrees of degeneration including swelling or shrinking of fibres, myofibrillar fragmentation, cytoplasmic vacuolation and mineralisation. so-called megaoesophagus, characterised by enlargement of the oesophagus, degeneration of muscle fibres and ganglion cells in the myenteric plexus has also been described in certain strains of rats and mice (harkness and ferguson, 1979; randelia and lalitha, 1988) . its cause is unknown. a commonly occurring lesion reported in fischer 344 rats is oesophageal hyperkeratosis, which occurs at all ages . in the study by maeda et al. (1985) , it occurred more commonly in rats fed a protein-restricted, calorie unrestricted diet than in rats fed ad libitum with normal diet. it was suggested that the particular high prevalence of oesophageal hyperkeratosis observed in all groups in this particular study was related to acidification of drinking water . another pathological findings in rodents is perforation of the oesophagus as a result of a gavage accident. under these circumstances there is a variable inflammatory and purulent exudate localised around the perforation or spread within the pleural or occasionally the pericardial cavities. the oesophagus and surrounding tissues need careful examination by the pathologist for it is not always clear from clinical findings that oesophageal damage has occurred. spontaneous oesophageal lesions are uncommon in laboratory beagles, even though emesis and vomiting are frequent responses of this species following dosing in toxicity studies. local oesophageal irritancy potential of drugs has been assessed in a number of animal models, notably the cat and pig (carlborg and densert, 1980; olovson et al., 1983) . in these models, the test drugs are placed in the upper oesophagus using endoscopic techniques for periods of several hours to allow dissolution of the preparation. subsequently, the animals are followed for 3-6 days and histopathological assessment performed on the oesophagus. the degree of inflammation, erosion of mucosa or deep ulceration is recorded in a semiquantitative manner. the degree of ulcerogenic activity of drugs in these models seems to correlate with reported ulcerogenic activity in the human oesophagus (carlborg et al., 1983) . systemic administration of drugs with radiomimetic or antimitotic activity can cause hypoplastic changes in the oesophageal mucosa as well as the remaining gastrointestinal tract mucosa (tucker et al., 1983) . conversely, hyperplasia with increased keratinization has been reported in the oesophagus of the rat following chronic high dose administration of alcohol (mascrã¨s et al., 1984) . acanthosis with hyperkeratosis and parakeratosis has been reported in the oesophagus but not stomach of rats treated for up to 18 months with mesuprine hydrochloride, a î²-adrenergic receptor stimulator (nelson et al., 1972) . as part of its effects on the gastrointestinal tract, the oesophagus in rats and primates has been reported to develop uniform hyperplasia of the squamous epithelium following infusion of recombinant epidermal growth factor (breider et al., 1996; reindel et al., 1996; vinter-jensen, 1999) . in the rat, mouse and hamster the forestomach occupies about two-thirds of the proximal stomach area and is lined by cornified stratified squamous epithelium. the limiting ridge is a distinct elevated mucosal fold at the junction between the forestomach and the mucosa of the glandular part of the stomach. as humans lack a forestomach, the relevance of changes produced by drugs and chemicals in the rodent forestomach is disputed. studies in rats in which the forestomach has been removed have suggested that the forestomach acts as a storage organ releasing relatively undigested food into glandular stomach in response to energy demand (gã¤rtner and pfaff, 1979) . hence, the forestomach mucosa may be exposed to xenobiotics mixed in undigested food for far longer periods than elsewhere in the gastrointestinal tract. the interpretation of forestomach changes should take into account physiological factors, residence time and exposure differences to drugs between the rodent forestomach and human oesophagus. however the squamous mucosa lining the oesophagus in species without a forestomach may react to xenobiotics in a similar way to the forestomach mucosa of rodents if equivalent exposure levels are attained. inflammation and ulceration of the forestomach mucosa are some of the commonest spontaneous gastrointestinal lesions in laboratory rats, mice and hamsters. the prevalence of these gastric lesions varies between species, strains of laboratory rodents as well as between different laboratories. the precise causes of forestomach ulceration remain unclear although a variety of factors have been associated with its development including advanced age, infection, parasitism, diet, feeding regimens and stress. in rats, conflict-induced ulceration occurs in the forestomach and there is an age-related susceptibility, older rats developing more ulcers than younger rats (sawrey and sawrey, 1966) . in rats and mice dying of spontaneous disease, ulceration of the forestomach is also quite frequently observed. protein restriction or starvation has also been shown to produce forestomach ulceration in rats . ulceration of the forestomach in rodent toxicology studies may be incidental, particularly if the lesions are few and show no clear relationship to dose. if limited to high dose groups, ulceration may be a result of non-specific toxicity and stress-related. however, administered chemicals may have direct local effects of sufficient severity to cause focal damage to the forestomach mucosa. histological features of ulcers and inflammatory lesions of the forestomach are similar in rats, mice and hamsters. in mild cases, a scattering of acute inflammatory cells is seen in the intact squamous mucosa. ulcers can be single or multiple and are characterised by loss of squamous epithelium with a variable accumulation of neutrophils, mononuclear cells, cellular debris, fibrin and hair fragments in the ulcer crater. the inflammatory process may extend deeply into the stomach wall and be associated with intramural inflammation, oedema, endarteritis and fibrosis. haemosiderin pigment is also found in the ulcer margins. profuse haemorrhage may follow erosion of large blood vessels and complete perforation of the stomach wall with peritoneal involvement also occurs (greaves and faccini, 1992) . in long-standing cases of ulceration, hyperplasia of the adjoining squamous epithelium occurs, characterised by irregular acanthosis and down-growths of squamous epithelium into the submucosa . xenobiotics may produce inflammatory changes in the forestomach mucosa following initial dosing but subsequently, repair occurs even though treatment continues. an example of this phenomenon is illustrated by butylated hydroxyanisole. after 1 week of administration of this agent in a 2% mixture in diet to rats, a vesicular inflammatory reaction characterised histologically by the presence of subepithelial vesicles containing inflammatory cells and exudate was seen (altmann et al., 1985) . after further treatment, only hyperplasia of the squamous epithelium was evident, presumably as an adaptive response to the effects of the continued insult. hyperkeratosis associated with hyperplasia of the squamous epithelium is seen sporadically in untreated aged rodents. these changes may be localised to the margins of chronic forestomach ulcers or they can be associated with diffuse inflammation of the mucosa. occasionally, the forestomach mucosa of untreated, aged rodents exhibits hyperkeratosis with hyperplasia without inflammation (fig. 45 ). such changes may be diffuse or focal, but they are often localised to the zone adjoining the glandular stomach mucosa. there may be evidence of basal cell proliferation and downgrowth of the epithelium into the underlying stroma. dietary factors also influence the thickness of the forestomach mucosa. vitamin a deficiency, known to produce squamous metaplasia in glandular tissues may produce forestomach hyperplasia and hyperkeratosis in rats. when spf fischer 344 rats were maintained in a vitamin a deficient state for over 3 months, hyperplasia with hyperkeratosis, not unlike that produced by known carcinogens was reported (klein-szanto et al., 1982) . administration of a wide range of both industrial chemicals, therapeutic agents including both genotoxic and non-genotoxic carcinogens produces hyperkeratosis and hyperplasia of the forestomach epithelium which may be followed by preneoplastic lesions and squamous carcinoma (see below). histologically, the changes are characterised by hyperkeratosis, parakeratosis with varying degrees of acanthosis and papillomatosis (greaves and faccini, 1992) . the changes can be florid and it may be difficult to make a clear distinction between severe hyperplasia and neoplasia. nevertheless, it has been shown that the florid hyperplasia of the forestomach epithelium without evidence of cellular atypia can be completely reversible following the withdrawal of an inciting stimulus, ethyl acrylate (ghanayem et al., 1991) . hence, a critical feature may be the presence of cellular atypia in view of its association with agents with potent (genotoxic) carcinogenic activity. neoplasms arising in the forestomach of rodents are usually squamous carcinomas although basaloid features are also seen (fukushima and leiniger and jokinen, 1994; mohr, 1997; tatematsu, 1997) . squamous carcinomas, as at other sites, show variable differentiation being composed of proliferating squamous epithelium with moderate to marked cellular atypia, pleomorphism and mitotic activity with clear evidence of invasion into the muscularis. although they are relatively uncommon spontaneous lesions in aged rodents, they can be induced in rodents by administration of nitroso compounds (tatematsu 1997) as well as a range of non-genotoxic agents (see below). some authors report basal cell carcinoma when basaloid features are pronounced (tatematsu, 1997) . a wide range of agents is capable of producing squamous hyperplasia of the rodent forestomach and a number of these also induce squamous carcinomas. in 1986 kroes and wester reviewed over 60 genotoxic and non-genotoxic compounds that were reported to produce hyperplasia and carcinoma in the forestomach of rats, mice or hamsters. a well-studied example is butylated hydroxyanisole (bha) an important food antioxidant (reviewed by whysner and williams, 1996) . structurally related phenols and acids produce similar changes (rodrigues et al., 1986) . ethyl acrylate, used in the production of materials for dental and medical devices is also capable of inducing marked squamous hyperplasia, papillomas and carcinomas after long-term treatment of f344 rats and b6c3f1 mice (ntp, 1986; ghanayem et al., 1991) . sk&f 93479, an experimental histamine h 2 receptor antagonist produced atypical forestomach hyperplasia in rats following administration by gavage for 1 year by a mechanism which appeared unrelated to the inhibition of the h 2 receptor (betton and salmon, 1984) . other therapeutic agents associated with squamous hyperplasia and neoplasia include the 3-hydroxy-3-methylglutaryl coenzyme a (hmg-coa) reductase inhibitors (kloss et al., 1991; bueld et al., 1996; akiba et al., 1998; physicians' desk reference, 1999) and aristolochic acid (gã¶ggelmann et al., 1982; schmeiser et al., 1988) . some cytoprotective prostaglandins appear capable of inducing hyperkeratosis and hyperplasia without neoplasia presumably through a mechanism related to their pharmacological activity (levin, 1988) . this occurs in rats treated with misprostol, a synthetic prostaglandin e1 methyl ester analogue with gastric anti-secretory and anti-ulcer activity (kotsonis et al., 1985) , cl115,574, a synthetic analogue of prostaglandin e1 type (kramer et al., 1985) and 16,16-dimethyl prostaglandin e2 (reinhart et al., 1983) . even the extensively used antibiotic, ampicillin has been associated inflammation, ulceration with acanthosis and hyperkeratosis in mice but not rats treated for 2 years (national toxicology program technical report, 1987) . sodium saccharin is also reported to produce hyperplasia without neoplasia of the forestomach in f344 rats (hibino et al., 1985) . among its wide range of pharmacological effects on the gastrointestinal tract, the forestomach has also responds to recombinant epidermal growth factor when infused into rats (breider et al., 1996; vinter-jensen, 1999) . histological examination showed hyperkeratosis and hyperplasia of the squamous epithelium. the large body of studies performed with butylated hydroxyanisole illustrates the various factors that can influence the development of treatment-induced hyperplasia and neoplasia of the rodent forestomach and subsequent assessment of human risk. butylated hydroxyanisole possesses little or no mutagenic activity in vitro but when administered to rats for 2 years as a 2% mixture in the diet, it produced squamous hyperplasia, squamous papillomas and squamous carcinomas of the forestomach. at 0.5% in the diet butylated hydroxyanisole induced only hyperplasia . it also produces proliferative lesions in the forestomach of both mouse and hamster (ito et al., 1986) . studies in which butylated hydroxyanisole was fed in the diet to rats for shorter periods have shown that squamous epithelial hyperplasia occurs after only 1 week of treatment preferentially over the lesser curvature, the site at which carcinomas developed in the 2-year studies (altmann et al., 1985) . after 13 weeks' treatment, mucosal hyperplasia characterised by pronounced hyperkeratosis, parakeratosis and acanthosis most pronounced over the lesser curvature, was present in rats given 2% butylated hydroxyanisole in diet but not in rats given 0.5, 0.25 and 0.1% mixtures . abundant mitoses were found in the basal cells layers and tritiated-thymidine labelling confirmed that the changes were accompanied by a high rate of cell proliferation. following cessation of administration of butylated hydroxyanisole after 13 weeks, the tritiatedthymidine labelling index rapidly reverted to control levels within about 1 week although hyperplasia took longer to regress. nearly complete regression of the hyperplasia occurred after about 9 weeks of normal diet . the distribution of squamous hyperplasia induced in the rodent stomach by butylated hydroxyanisole is influenced by the mode of administration. whereas following feeding of rats with butylated hydroxyanisole mixed in the diet lesions tended to be located near the limiting ridge, altmann et al. (1985) showed that gavage of butylated hydroxyanisole in corn oil produced similar changes at the apex of the forestomach. it was suggested that this difference was due to incomplete mixing of butylated hydroxyanisole in the stomach lumen when given by gavage and prolonged contact of the gavage mixture with the upper segment of the forestomach (altmann et al., 1985) . more recently, it was shown that fischer 344, shr, lewis and sprague-dawley rats differ in their response to the hyperplastic and carcinogenic effects of 2% butylated hydroxyanisole in pelleted diet. the most sensitive was the shr strain followed by the f334 rats and the differences correlated with the cytotoxic effects of butylated hydroxyanisole in the different strains (tamano et al., 1998) . it was suggested that the presence of vascular damage in the stomachs of the shr rats might have contributed to the response to cytotoxicity and subsequent carcinogenicity. residence time of administered compounds in the forestomach may influence the development of lesions. although it has been demonstrated that butylated hydroxyanisole does not produce hyperplasia in the oesophagus of animals without a forestomach, have shown that high-doses given to primates are capable of producing an increase in mitotic activity in the lower end of the oesophagus similar to that occurring at equivalent exposure levels in the rat. the implication is that these interspecies differences may simply be a question of differences in exposure of the squamous mucosa to compound. this underlines the fact that mechanisms of action and exposure levels of xenobiotics attained in the gastrointestinal tract of rodent and non-rodent species as well as of man need to be carefully assessed when hyperplastic changes are induced in the forestomach mucosa of rodents. such information can be helpful in facilitating regulatory decisions in this area (moch, 1988) . on balance, the evidence suggests that the tumour development by butylated hydroxyanisole in rodents represents an epigenetic phenomenon related to largely reversible cytotoxicity and increased cell proliferation (whysner and williams, 1996) . in view of the low levels of exposure to butylated hydroxyanisole that occurs with the usual use of this agent, carcinogenic hazard for the human stomach is therefore probably very small. similar phenomena have also been reported in studies of phenols and acids that are structurally related to butylated hydroxyanisole (rodrigues et al., 1986) . these agents include n-butyl and n-propyl-4-hydroxybenzoic acid esters, propionic acid and 4-methoxyphenol. however, these studies suggested that certain areas of the forestomach epithelium react differently to structurally related chemicals, possibly due to the variable levels of activating enzymes within different zones of the forestomach epithelium. co-administration of acetylsalicylic acid was shown to abrogate some of these effects, suggesting that prostaglandin synthetase may be involved in the hyperplastic response (rodrigues et al., 1986) . a number of hmg-coa reductase inhibitors with different chemical structures including marketed products such as lovastatin, simvastatin and fluvastatin are also associated with the development of squamous hyperplasia of the rodent forestomach. the hyperplasia is time and dose dependent and may be associated with oedema and some inflammation of the submucosa. some, but not all of these agents are also capable of producing squamous neoplasia of the forestomach mucosa of rats, or mice or both after long-term treatment (kloss et al., 1991; bueld et al., 1996; akiba et al., 1998; physicians' desk reference, 1999) . the mechanism of action remains unclear although the degree of hyperplasia seems related to pharmacological potency. their carcinogenic potential in rodent bioassays does not seem to relate to the degree of hyperplasia in shortterm studies. moreover, the development of hyperplasia depends on local high concentrations of drug because when administered by non-oral routes, hyperplasia does not occur (kloss et al., 1991) . as most of these drugs are non-mutagenic, these findings are presumably also epigenetic in origin and possess relatively little risk for humans when given in the usual therapeutic doses. a contrasting example is provided by aristolochic acid, a nitrophenanthrene derivative of the ancient medicinal plant aristolochia clematis which was used as an anti-inflammatory component in a number of medicinal preparations in germany until 1982 (gã¶ggelmann et al., 1982; schmeiser et al., 1988) . aristolochic acid is a direct acting mutagen in salmonella typhimurium. when fed to rats at doses of 1.0 and 10 mg/kg/day, aristolochic acid produced severe papillomatosis of the entire forestomach within a period of 3 months. this was characterised histologically by the presence of branched squamous papillomas up to 6 mm high with focal dysplastic features. invasive squamous carcinomas with metastases were found subsequently, 3 or 6 months later without further treatment (mengs et al., 1982) . even at a low dose of 0.1 mg/kg/day papillomas and squamous carcinomas developed 9 months after a 3-month period of treatment. quite clearly the complexity of the hyperplastic response of the rodent stomach to xenobiotics, the association of hyperplasia induced by non-mutagenic compounds with the development of forestomach carcinomas, and the similarity of response in the forestomach to that of the oesophagus, dictates the need for a careful analysis of hyperplasia induced by novel drugs in the forestomach. the prelude to this assessment is careful histopathological characterisation of the changes. unlike the mouth and oesophagus through which tablets, capsules, gavage fluids and drug/diet mixtures pass relatively rapidly, the human stomach mucosa remains in contact with high local concentrations of administered compounds for much longer periods of time. administration of compounds in liquid or solid form, particle size, fasting and feeding all affect the gastric motility pattern. in the fasted state there is a cyclical pattern of motility consisting of three main phases. the first is a quiescent phase, followed by a phase of irregular contractions that increase in amplitude and frequency to reach a maximum in a third phase. feeding results in the replacement of this cyclic pattern by regular tonic contractions that move food towards the antrum and mix it with gastric secretions. these patterns have been well studied in both dog and man and appear to be qualitatively similar in the two species (sarna, 1985) . these motility patterns may have an impact on the length of time drugs remain in contact with stomach mucosa. for instance, the residence time of large non-disintegrating capsules or tablets administered in the fasting state is more dependent on the frequency of powerful phase iii contraction than if drugs are given as fluids or mixed with diet. for dosage forms released in the stomach, gastric residence time will influence drug supply to the main absorptive surfaces in the small intestine, which in turn may affect drug absorption (dressman, 1986) . gastric acid is also important in making ingested salts soluble. although the presence of food in the stomach is a stimulus of acid production, the ph in the forestomach of rats is highest in full stomachs and lowest when empty, presumably as a consequence of the buffering action of food (ward and coates, 1987) . the glandular stomach is conveniently divided into the fundus characterised by mucosal folds or rugae and the smoother antrum, which opens into the pylorus and duodenum. in species devoid of a forestomach, the proximal stomach mucosa or cardia is also lined by glandular mucosa. the glandular mucosa is covered by surface epithelium of regular columnar cells that extends downwards to form small gastric pits or foveolae. the gastric glands are simple tubular structures usually considered to comprise three segments. the base is the deepest part, the neck the mid-region, and the most superficial is the isthmus, continuous with the gastric pit. the upper part of the gastric gland contains mucous neck cells. small cuboidal chief or zymogenic cells, which secrete pepsinogen and stain blue or purple in haematoxylin and eosin sections, are located in deeper parts of the gland. the eosinophilic-staining parietal (oxyntic) cells, which produce hydrochloric acid, are distributed more randomly throughout the gastric glands. parietal cells can also be visualised by immunocytochemical staining with antibodies directed at h + k + -atpase (canfield et al., 1996) . the gastric glands situated near the limiting ridge in rodents, show a modified structure. in species not endowed with a forestomach, the mucosa near the cardia is composed of simplified branched glands lined by columnar epithelium. the antral mucosa is covered by a surface epithelium with gastric pits similar to that of the fundus but mucous secreting columnar glands line the glands. the stomach mucosa is richly endowed with endocrine cells, not all of which have been well characterised. enterochromaffin cells are quite numerous in the basal parts of the gastric glands of the fundus, particularly in the rat . they are generally argyrophilic, staining with silver staining techniques such as that of grimelius (grimelius, 1968; grimelius and willander, 1980 ) that utilise exogenous reducing agents. these cells contain histamine and histamine-related enzymes such as histidine decarboxylase in the rat and other species . endocrine cells which are argentaffin in type stain with silver stains such as that of masson (1914) because of the presence of endogenous reducing substances including 5-hydroxytryptamine and catechol-amines are also reported in the mucosa of the fundus of some species including man but apparently not in the rat . enterochromaffin cells are characterised ultrastructurally by the presence of numerous rounded or oval, vesicular, electron-lucent granules frequently containing a small eccentric electron dense core. gastric enterochromaffin cells can also be stained by immunocytochemical techniques using antisera to histamine and histidine decarboxylase as well as to non-specific enolase and chromogranin a betton et al., 1988) . immunocytochemical study of the rat fundus using a battery of antisera to a variety of gastrointestinal peptides has shown somatostatin containing (d) cells and glucagon staining cells but no cells with gastrin (g cells) or serotonin reactivity (bishop et al., 1986) . gastrin or g cells possess apical processes reaching the stomach lumen believed to be important in stimulation of gastrin release as a result in increases in antral lumen ph or the presence of amino acids or peptides . glucagon and serotonin containing endocrine cells have also been located in the rat antral mucosa (bishop et al., 1986) . increased gastric acid secretion is initiated by activation of central vagal efferent pathways but acid secretion is maintained by both neural and endocrine reflexes activated by the presence of food in the stomach. gastrin secreted from the g cells of antrum is the main stimulant of acid secretion. somatostatin is secreted from antral d cells when the luminal ph falls to below 3.5 to act by a paracrine mechanism to suppress g cell function thus forming a negative feedback loop (dockray, 1999) . the two main endocrine cell types from the body mucosa integrate neurohumoral stimuli rather than respond to luminal chemicals. although gastrin is capable of stimulating parietal cells directly, it has an even greater effect through stimulation of enterochromaffin cells to release histamine, a potent paracrine stimulator of parietal cells (hinkle and samuelson, 1999) . gastrin stimulates release of histamine from enterochromaffin cells of the body mucosa, which increases acid secretion through activation of parietal cell histamine-h 2 receptors. both parietal and enterochromaffin cells are inhibited by somatostatin released from the d cells of the body mucosa in response to a variety of neurohumoral stimuli such as noradrenaline, vasoactive intestinal peptide, calcitonin gene-related peptide, and cholecystokinin. it should also be noted that gastrin has a role in kinetics and differentiation of both parietal and enterochromaffin cells (dockray, 1999) . gastrin acts at the gastrin/cholecystokin-b receptor that is expressed by gastric epithelial cells and by neurones in the central nervous system (kopin et al., 1992; wank, 1995) . the gastrin receptor is simply the cholecystokinin-b receptor located in the stomach. the other cholecystokinin receptor, cholecystokin-a has high affinity for cholecystokinin. stimulation of this receptor in the stomach mediates secretion of pepsin from gastric chief cells and release of somatostatin from d cells resulting in inhibition of acid secretion. in the central nervous system cholecystokinin and its receptors contribute to the regulation of satiety, anxiety, analgesia and dopamine-related behaviour (wank, 1995) . finally, it is worth recording that both progesterone and oestrogen receptors have been identified in both normal and pathological gastric tissues of humans (wu et al., 1992) . generative cells in the gastric mucosa as shown by uptake of tritiated thymidine for dna synthesis are distributed principally in the isthmus (inokuchi et al., 1983) . tracing of cells using thymidine labelling have shown that most of the cells in the generative zone migrate in a successive manner to the mucosal surface to form columnar epithelium. the life span of surface epithelium in the stomach of rats, mice and hamsters has been calculated to be about 3-4 days. studies of cell cycle and dna synthesis time in the proliferative zones in the stomach of rat, hamster and man have suggested that the generative cells in the isthmus undergo mitoses at about 30-hour intervals in rodents and 40-hour intervals in man (inokuchi et al., 1983) . although this process of migration from the proliferating cell zone of the isthmus renews surface epithelial cells rapidly, cell migration to the lower parts of the gastric glands is much slower and more complex. detailed studies have show that undifferentiated cells in the region of the isthmus represent a common source for surface mucous cells and mucous neck cells (karam and leblond, 1995) . electron microscopic and ultrastructural cytochemistry has suggested note: saccharide binding specifications are much more complex than the inhibition by simpler sugars outlined above suggests. see review by nicholson (1974) . *source: nicholson, 1974; goldstein and hayes, 1978; schulte and spicer, 1983; giannasca et al., 1994. that chief cells in the adult rat stomach develop from undifferentiated stem cells in the isthmus (suzuki et al., 1983) . graft experiments in mice have also suggested that immature cells of the isthmus differentiate into chief cells as well as parietal cells (matsuyama and suzuki, 1970) . studies in transgenic mice have shown that mature parietal cells influence the fate of other gastric epithelial cells because targeted degeneration of parietal cells is associated with loss of chief cells suggesting interactions between these cell populations in determining their differentiation (li et al., 1996; canfield et al., 1996) . gastrin is also an important regulator of parietal cell and enterochromaffin differentiation and number (dockray, 1999; montgomery et al., 1999) . labelling experiments in the hamster stomach have shown that both chief and parietal cells possess a similar but quite long life span of about 200 days (hattori, 1974; hattori and fujita, 1976) . it has been suggested that the relative distribution of chief and parietal cells in the gastric gland represents an expression of their different migration patterns downwards from the proliferative zones in the isthmus. this type of migration pattern in which cells are able to overtake each other has been termed a 'stochastic flow system' (inokuchi et al., 1983) . the origin and kinetics of endocrine cells of the stomach has also been the subject of debate but the available morphological, cytochemical and kinetic evidence suggests that the majority of these cells develop from the same stem cells as the other non-endocrine cells of the gastric mucosa, although self replication also occurs (matsuyama and suzuki, 1970; inokuchi et al., 1983; solcia et al., 1986) . much of our knowledge about mucins produced by the epithelial cells lining the gastrointestinal tract has been obtained using histochemical techniques and these approaches continue to be helpful in the understanding of spontaneous and drug-induced gastrointestinal disease (sheahan and jarvis, 1978; filipe, 1979; tsiftsis et al., 1980; jass and roberton, 1994) . for these reasons, mucin histochemical techniques represent useful tools for the characterisation and elucidation of experimentally or drug-induced changes in the glandular mucosa of gastrointestinal tract. techniques commonly employed are presented in table 2 . the physiochemical properties of gastrointestinal mucins are dependent on their glycoprotein constituents. these glycoproteins are high molecular weight compounds with large numbers of sugar chains attached to a polypeptide backbone by o-glycosidic linkages between n-acetylgalactosamine and serine or threonine (berger et al., 1982) . the principle monosaccharides present are fucose, galactose, n-acetylgalactosamine, n-acetylglucosamine and sialic acid. traces of mannose may be present and ester sulphate residues are common (filipe, 1979) . due to this extensive glycosylation, mucins have a filamentous conformation, which is often negatively charged. this is believed to be important in forming a protective barrier to the cell. however, this property is a two-edged sword because when opposing cells have specific receptors for mucins, adhesion may become the predominant factor (van klinken et al., 1995) . although mucins are important in the gastrointestinal tract, it should be remembered that other products secreted by goblet cells might be important in mucosal defence. it has been recently recognised that trefoil proteins, a family of small proteins secreted by goblet cells and present on the mucosal cell surface, can also protect against a variety of deleterious agents, including bacteria, toxins and drugs (podolsky, 1999) . there are considerable regional variations in glycoprotein constituents in the gastrointestinal tract and these differences are probably related to physiological and functional factors. furthermore, synthesis and secretion of glycoproteins alter with changes in cell differentiation. alterations also occur in mucins in various inflammatory and neoplastic disease states as well as following administration of certain drugs and chemicals (ishihara et al., 1984) . terminal sugars or sugar sequences can be demonstrated histochemically by the use of labelled lectins, mostly plant proteins which combine non-enzymatically with particular sugar molecules, see table 1 (goldstein and hayes, 1978; debray et al., 1981; rudiger, 1982) . magenta: all mucosubstances containing hexoses schiff d-pas (pearse, 1968) and deoxyhexoses with vicinal glycol groups. some non-sulphated acid mucosubstances. neutral mucosubstances. periodate-borohydride/ magenta: pas activity following periodate borosaponification/pas, hydride/potassium hydroxide indicates pb/koh/pas presence of o-acylated sialic acids. (reid et al., 1973; periodate borohydride reduces periodate culling et al., 1974; generated aldehydes. potassium hydroxide removes o-acylesters from potential vicinoldiols and sialic residues linked glycosidically to a potential vicinoldiol. alcian blue ph 2.5 basophilia: weakly sulphated mucins. carboxyl (pearse, 1968) groups of sialomucins alcian blue ph 1.0 basophilia: sulphated mucins (lev & spicer, 1964) alcian blue ph 2.5 -magenta: neutral mucins periodic acid schiff, ab/pas basophilia: acid mucins (mowry & morard, 1957) purple-blue: neutral and periodate reactive acid mucins high iron-diamine, brown-black: sulphated mucins hid (spicer, 1965) unstained: sialomucins high iron-diamine-alcian brown-black: sulphated mucins blue ph 2.5, hid/ab basophilia: non-sulphated acid mucins (sialomucins) (spicer, 1965) source: adapted from filipe, 1979. when gastrointestinal mucins were studied in several species using histochemical techniques under uniform conditions, species differences were most obvious in the stomach and duodenum (sheahan and jarvis, 1976) . neutral mucins generally predominate in the stomach, contrasting with acid mucins in the small intestine, and sulphated mucins in the colon. in the stomach neutral mucins staining purple with the pas/alcian blue stain, predominate in the surface and foveolar mucosa, whereas mucous neck cells and antral glands contain acidic mucins that stain blue with pas/alcian blue procedure. sulphated mucins, as shown by the high iron diamine technique (hid) are also found in the deep glandular mucosa of the antrum in rat, mouse and man (filipe, 1979; jass, 1980; greaves and boiziau, 1984) . extremely heterologous staining patterns are seen in the gastric mucosa with labelled lectins, each lectin staining quite different cell populations. there are considerable interspecies differences in staining patterns with the same lectins (kuhlmann et al., 1983; suganuma et al., 1984) . the so-called paradoxical concanavalin a stain, in which conjugated concanavalin a is used to label mucins before and after periodate oxidation, has also been used to classify the alterations in mucins in proliferative and neoplastic conditions of the rat stomach mucosa (kobayasi et al., 1991; tatematsu 1997 ). although gastric erosions and ulcers in the glandular mucosa occur quite commonly in laboratory animals in toxicity studies, it is often difficult to determine whether such lesions in treated animals indicate a real ulcerogenic risk for the test compound. there is little that is histologically specific to drug-induced ulceration of the gastric glandular mucosa. mucosal haemorrhage, depletion of mucin, erosions and ulcers with or without inflammation may all be found. erosions represent mucosal breaks superficial to the muscularis mucosa. ulcers are lesions that extend through the muscularis mucosa. whilst the histopathological features of gastric erosions and ulcers are themselves relatively non-specific, it is important to look for any associated pathology in the stomach such as mucus depletion, epithelial hyperplasia or dysplasia, intestinal metaplasia and vascular lesions (see below). in humans, biopsy data suggests that drug-induced ulceration is characteristically devoid of an inflammatory component, but the most usual histological appearances are those of underlying gastric pathology (riddell, 1982) . formation of gastric and duodenal ulcers is dependent on the presence of both acid and peptic activity in gastric juice because acid without pepsin appears to have little digestive power. important predisposing factors in human patients with peptic ulceration include helicobacter pylori (campylobacter pylori) infection of the antrum, cigarette smoking and ingestion of non-steroidal anti-inflammatory drugs (soll, 1990) . helicobacter pylori is believed to infect over half the human population and its presence in the gastric mucosa is associated with chronic atrophic gastritis and peptic ulceration (cover and blaser, 1996) . it is a microaerophilic, gram-negative organism that possesses potent urease activity crucial for its survival at acidic ph. genome sequence analysis has shown that helicobacter pylori has well developed sequences for motility, scavenging iron and dna restriction and modification systems used by bacteria to degrade foreign dna. the link between helicobacter pylori infection and peptic ulceration is related to increases in gastrin release, perhaps through bacterial products or cytokines released from activated lymphocytes (richter-dahlfors et al., 1998) . although helicobacter pylori can infect other species, apart from non-human primates, the usual laboratory animal models do not appear to develop the inflammatory disease seen in humans (nedrud, 1999) . erosions and ulcers also develop following stress, reflux of intestinal contents and bile, changes in acid secretion and hypoxia, all of which may develop under the conditions occurring in high-dose toxicity studies. the requirement to give the test compound in high doses may also dictate the need to administer exceedingly high concentrations of test agent. this may produce damaging high local concentrations on the mucosa not relevant to therapeutic doses used in clinical practice. it has been demonstrated that hyperosmolar solutions of quite innocuous substances such as glucose can cause haemorrhage, erosions and ulcers of the rat gastric mucosa (puurunen et al., 1980) . the well-known association of gastric erosions and haemorrhage with uraemia may also be manifest following administration of high doses of drugs such as diuretics which severely derange fluid and electrolyte balance (garthoff et al., 1982) . stress ulceration may be linked to temporary ischaemia of the mucosa (dubois, 1987) . synergism between the ulcerogenic action of drugs and stress is a well-described phenomenon (rainsford, 1975; beattie, 1977) . protein depletion and starvation is also capable of inducing gastric ulceration in rats . although gastric pathology represents the largest cause of morbidity and mortality in man following therapy with non-steroidal inflammatory agents (fowler, 1987) , the reasons for this are probably multifactorial. the acidic properties of some of these drugs may cause direct local damage of gastric epithelial cells, demonstrable by the fact that appropriate formulation can reduce gastric toxicity of these agents in man (brors, 1987) . anti-inflammatory agents are capable of decreasing synthesis of glycoproteins and this may adversely influence protective mucus production of gastric mucosa (azuumi et al., 1980; ishihara et al., 1984) . it has also been suggested that non-steroidal anti-inflammatory agents cause cellular damage to the gastric mucosa by back-diffusion of gastric acid into mucosal tissues (davenport, 1964) or by causing damage to the gastric capillary bed with subsequent mucosal infarction (robins, 1980) . the theory that has gained widespread acceptance is that the ulcerogenic potential of non-steroidal anti-inflammatory drugs is related to their pharma-cological activity. vane (1971) proposed that the ulcerogenic potential of these agents was largely a result of their ability to inhibit prostaglandin synthetase, thereby reducing the protective effects of prostaglandins. pharmacokinetic factors may also be important. lipid solubility in the low ph environment of the stomach may influence local penetration into the mucosa (mccormack and brune, 1987) . moreover, it has been proposed that certain anti-inflammatory agents may possess lesser ulcerogenic potential in man because their inhibition of prostaglandin production is more limited to sites of inflammation, sparing gastric mucosa (whittle et al., 1980; whittle and vane, 1984) . it has also been demonstrated that factors altering the enterohepatic circulation of drugs can influence the expression of gastric damage (overvold et al., 1987) . comparative studies of the ulcerogenic activity of indomethacin in beagle dogs and domestic pigs has suggested that the dog may be an excessively sensitive species as a result of extensive enterohepatic circulation of indomethacin in this species (hanhijarvi et al., 1986) . prediction of ulcerogenic potential for man based on data from animal models is clouded by the lack of good comparative data on the relative ulcerogenic potential of non-steroidal anti-inflammatory agents in man because of extensive differences in side effect reporting (fowler, 1987) . moreover proper comparisons in man require not only equivalent therapeutic doses but also comparable dosage forms (brors, 1987) . in laboratory animals, a variety of different patterns of drug-induced gastric damage have been described. the study by shriver et al. (1975) in which a wide variety of different anti-inflammatory drugs were administered to fasted sprague-dawley rats under identical conditions, suggested the drugs could be divided into three groups based on their profiles of gastrointestinal toxicity. immunological agents such as azathiaprine, cyclophosphamide, methotrexate and d-penicillamine produced gastric mucosal haemorrhage whereas aspirin and related agents produced gastric mucosal haemorrhage and ulcers. the powerful nonsteroidal anti-inflammatory drugs indomethacin and phenybutazone produced gastric mucosal erosion and ulcers as well as small intestinal damage. comparative single oral dose studies of several different non-steroidal antiinflammatory agents at three different dose levels by suwa et al. (1987) in the rat using histology and measurement of faecal blood loss with 51 cr-labelled blood cells have also shown that different patterns of ulceration can be produced by different agents when administered under identical conditions. single oral doses of some non-steroidal anti-inflammatory drugs including aspirin produced widespread superficial damage and desquamation of gastric epithelium with little or no inflammation at 6 hours following dosing which completely healed 2 weeks later. this damage was associated with transient faecal blood loss. by contrast, indomethacin and ibuprofen produced both gastric damage and circumscribed, penetrating ulcers along the mesenteric border of the jejunum and ileum. furthermore, ulcers were still present after 2 weeks and were associated with prolonged or biphasic blood loss (see small intestine). in addition feeding conditions can influence the distribution of erosions and ulcers in laboratory animals. in fasted rats, erosions due to indomethacin treatment are found in the body of the stomach whilst in conventionally fed rats they are most prominent in the small intestine. detailed studies by satoh et al. (1981) showed that rats fed for 1 hour after a 24 hour-fast and given a single dose of indomethacin within 2 hours of re-feeding developed erosions and ulcers in the antrum primarily along the lesser curvature. indomethacin given to fasted rats produced erosions in the body mucosa. a further factor that needs to be kept in mind is that chronic administration of ulcerogenic compounds may produce quite different pathological appearances to those found following single dose administration. administration of aspirin to rats for 4 weeks has been shown to stimulate epithelial proliferation of the gastric body but not antral mucosa, possibly by an effect on cyclic adenosine 3',5' monophosphate (cyclic amp) or though increasing the rate of epithelial exfoliation (eastwood and quimby, 1982) . such a response may be the basis for increased resistance of the gastric mucosa to the chronic affects of these agents. it also may explain the tendency for ulcers to occur in the antrum following chronic administration of aspirin-like drugs as the proliferative response and presumably the adaptive potential appears less in this part of the gastric mucosa. both interspecies variations and strain differences have been reported in the response to ulcerogenic compounds. rainsford et al. (1982) showed that extravasation of red blood cells and greater vascular damage was observed in rats treated with aspirin or benoxprofen than in pigs given similar doses. sprague-dawley rats appear less susceptible to the ulcerogenic effects of cold-restraint stress than wistar rats (goldenberg, 1973) . diuretics and some angiotensin converting enzyme (ace) inhibitors and angiotensin ii antagonists have been associated with the development of gastric erosions and ulceration when administered in high doses to laboratory animals ( fig. 46 ) (imai et al., 1981; garthoff et al., 1982) . however, these effects appear related to the severe electrolyte disturbances produced by excessive doses of these drugs. this is perhaps analogous to the well-known association of gastrointestinal tract erosion and haemorrhage with uraemia. dogs appear to have a particular predisposition to this effect where it may be associated with deposition of basophilic ground substance and mineral in connective tissues and blood vessels in the mucosa (barker and van dreumel, 1985) . although inflammatory conditions due to microorganisms are generally uncommon in the stomach, gastritis is reported in laboratory rhesus monkeys in association with the presence of helicobacter organisms (reed and berridge, 1988) . as in the analogous condition in man, the stomach of affected animals shows an infiltration of the central mucosa by small lymphocytes and plasma cells, associated with reactive or atrophic changes in the mucosa and the presence of small curved bacteria in glands, visualised best with the warthin-starry stain. infiltration of the stomach by lymphocytes in rats treated with human recombinant interleukin-2 without ulceration was reported as part of a multisystem involvement induced by this agent (anderson and hayes, 1989 ). decrease in gastric mucus secretion may accompany both spontaneous inflammatory conditions and drug-induced lesions in the stomach of man and experimental animals. mucus depletion is characterised histologically by the presence of an intact epithelial layer in which cells show loss of the normal clear cytoplasm replete with mucous substances by more basophilic cells that contain little or no mucin. qualitative changes in mucus composition can also accompany mucus depletion. gastric epithelium in man may show decreases in sulphated mucosubstances following stress, high alcohol consumption or after aspirin administration (filipe, 1979) . similar changes occur in laboratory animals subjected to ulcerogenic regimens. stress ulceration in the rat is accompanied by decreased sulphation of gastric glycoproteins, presumably an expression of the changes in gastric cellular activity accompanying stress (lambert et al., 1969) . administration of aspirin and other anti-inflammatory agents including adrenocortical steroids to laboratory animals also reduces the content of sulphomucins in the gastric mucosa, probably by reducing their synthesis (denko, 1958; gerard, 1965; ishihara et al., 1984) . rather surprisingly, administration of histamine h 2 -receptor antagonists and fig. 46 . section from the glandular stomach from a rat treated with ah high dose of an angiotensin ii antagonist that shows superficial degeneration and ulceration (erosion) of the mucosa. (he, ã�30.) proton pump inhibitors associated with reduction of gastric acid output and increases in gastrin secretion have also been associated with alterations in gastric mucus. administration of omeprazole or famotidine to rats for 4 weeks was shown to inhibit prostaglandins pge 2 as well as the synthesis of both total and sulphated glycoprotein synthesis along with histochemical evidence of reduction in pas staining of the surface mucus (yoshimura et al., 1996) . although the mechanism for this change is unclear, the reduction in mucus, particularly sulphated mucus that is believed to be particularly resistant to peptic digestion, may have implications for mucosal defence. intestinal metaplasia of the stomach is characterised by the presence of differentiated epithelium, which resembles small intestine on the basis of light microscopic and ultrastructural morphology, mucin patterns and enzyme histochemistry (morson, 1955; planteydt and willighagen, 1960; lev, 1966; goldman and ming, 1968; . it develops in man in gastric mucosa altered by chronic atrophic gastritis and its significance is due to the fact that a link exists between intestinal metaplasia and gastric cancer. although intestinal metaplasia is found much less commonly in laboratory animals, it has also been reported to occur in association with gastric cancer induced by polychlorinated biphenyls (ward, 1985) . in view of this association with gastric cancer, it has been suggested that intestinal metaplasia represents a pre-neoplastic lesion. however, over recent years prospective clinical studies and experimental data have suggested that it is an epiphenomenon, coexisting with, but unrelated to the development of cancer. in man, several forms of intestinal metaplasia have been described. these variants fall into two main groups, an incomplete type and a complete form (teglbjaerg and nielson, 1978; jass and filipe, 1979; jass, 1980) . complete intestinal metaplasia is characterised by the presence of goblet cells, paneth cells and absorptive cells with brush borders and variably developed intestinal villi. incomplete forms are more heterogeneous characterised by goblet and mucous columnar cells but no absorptive cells and variable patterns of mucin. the routine alcian blue: ph 2.5, periodic acid-schiff stain (ab/pas) ( table 2) distinguishes between the intestinal acid mucins (blue) from the neutral mucins of gastric type. however, variable sialomucin and sulphomucin staining patterns are seen in intestinal metaplasia in man with the high iron-diamine/alcian blue stain (hid/ab) (jass, 1980) . the incomplete form of intestinal metaplasia, showing marked sulphomucin secretion, has been found more commonly in association with gastric cancer in man (jass and filipe, 1979; jass, 1980; wells et al., 1982) . however, prospective studies have tended to indicate that intestinal metaplasia with sulphomucin secretion may be an age-related form of chronic atrophic gastritis and not a premalignant lesion (ectors and dixon, 1986) . it has been suggested that intestinal metaplasia represents an adaptive response to long-standing chronic inflammation and reduced acid secretion. it may also represent an adaptive defensive response to long-standing helicobacter pylori infection because intestinal mucosa is more resistant to these organisms (steer, 1984; ectors and dixon, 1986) . intestinal metaplasia has been found in association with gastric cancer in laboratory animals. fischer 344 rats treated with the polychlorinated biphenyl, aroclor 1254, mixed in the diet for 2 years developed foci of intestinal metaplasia in the stomach epithelium in association with gastric adenocarcinomas (ward, 1985) . these lesions were characterised by abundant mucin-containing cells and alkaline phosphatase activity typical of the small intestine (morgan et al., 1981; ward, 1985) . similar, but more diffuse intestinal metaplasia was reported in the stomach of primates treated with polychlorinated biphenyls, although unassociated with gastric neoplasia (allen, 1975; mcconnell et al., 1979) . intestinal metaplasia is also found in the stomach of laboratory animals treated with powerful genotoxic gastric carcinogens. although tsiftsis et al. (1980) showed hyperplasia and foci of atypical changes (dysplasia) but little or no intestinal metaplasia in rats following administration of n-methyl-nâ´-nitro-n-nitroguanidine, tatematsu et al. (1983) were able to show intestinal metaplasia in rats treated with the same agent. however, intestinal metaplasia can be induced in rodents by a variety of different procedures that are not associated with the development of gastric cancer. intestinal metaplasia can be induced in the glandular stomach of rodents by fractionated, localised, ionising radiation (watanabe, 1978; watanabe et al., 1980) , injection of xenogenic stomach antigens as well as propantheline bromide and the non-carcinogen, iodoacetamine shirai et al., 1985) . the characteristics of intestinal metaplasia in laboratory rodents are similar to those seen in man with early increases in intestinal enzyme activity (alkaline phosphatase, lactase, trehalase, sucrose and maltase), development of goblet cells containing neutral, sialo-, or sulphomucins, and intestinal crypts with or without paneth cells. both the fundus and antrum can show changes although as in man, males appear more prone to develop intestinal metaplasia than females . based on these experimental findings, have also proposed that intestinal metaplasia is not a precancerous condition but an adaptive response to a chronic elevation in ph in gastric secretion due to the early loss of parietal cell mass brought about by these various procedures. on balance therefore, the evidence to date suggests that although intestinal metaplasia is associated with cancer and may consequently be considered a helpful morphological feature in the evaluation of human gastric biopsies, the finding of isolated intestinal metaplasia in safety studies does not indicate a preneoplastic state. finally, a form of metaplasia in which hepatocytes have been found has been reported as rare incidental findings in the glandular stomach of mice sacrificed at the end of 2-year carcinogenicity bioassays (leiniger et al., 1990) . histologically, focal accumulation of well-differentiated hepatocytes were found in the submucosa and lamina propria adjacent to the limiting ridge with dilated adjacent gastric glands showing epithelial hyperplasia and mineralisation with herniation into the submusosa. whilst these foci were not believed to be related to treatment with xenobiotics, it is not clear whether represented metaplasia or congenital ectopia. the gastric glandular epithelium is predisposed to the deposition of calcium possibly as it is a site at which marked ion exchange normally takes place. focal aggregates or concretions of densely blue-staining mineral are fairly commonly observed in haematoxylin-stained sections from the stomachs of aged rats where they are associated with cystic dilatation of the gastric glands (greaves and faccini, 1992) . mice and hamsters occasionally show similar changes. small concretions are also observed in gastric glands in the beagle dog. these appear to represent aggregates of calcium around mucoid material. gastric mineralisation may become marked in rodents and dogs when there is disturbance of mineral metabolism, particularly in association with renal pathology. this has been well described in rats with severe renal disease (glomerulosclerosis) and parathyroid hyperplasia (snell, 1967) . a similar phenomenon has been described in the stomach of dogs in uraemic states (cheville, 1979) . identical changes result from the administration of drugs that induce prolonged azotemia or electrolyte disturbances. these changes are characterised by diffuse deposition of mineral in the intestinal tissue of the mucosa of the gastric body but not cardia, antrum or pylorus. mineral deposits develop around basement membranes surrounding epithelium and blood vessels. the lamina propria becomes expanded by oedema and fibroplasia of the interstitium also develops. the gastric glands themselves become distorted with swelling and degeneration of parietal cells and atrophy of chief cells. erosion of the glandular epithelium with haemorrhage occurs presumably as a result of the ischaemia caused by diffuse vascular injury and altered parietal cell function. focal atrophy of the gastric glandular mucosa is a sporadic occurrence in laboratory rodents, usually as a result of previous focal gastric inflammation, ulceration, mineralisation or vascular occlusion. these changes, characterised histologically by focal fibrosis of the mucosa, gastric glandular dilatation and atrophy variably accompanied by polymorphonuclear cells and mast cells are common in certain strains of rats when 2 years or more in age (anver et al., 1982) . whereas diffuse mucosal atrophy occurs following severe inflammatory insult, diffuse atrophy of the stomach glandular mucosa without inflammation can be a result of surgically or drug-induced reduction in trophic factors necessary for the maintenance of normal gastric morphology and function. this is observed in man and experimental animals following antrectomy because this removes the peptide-producing cells of the antrum (gjurldsen et al., 1968; neilsen et al., 1972) . in the rat, antrectomy is accompanied by hypogastrinaemia, reduced weight and height of the oxyntic mucosa and a reduced number of argyrophil cells (hã¥kanson et al., 1976 . this is in contrast to procedures such as antral exclusion that lead to hypergastrinemia and increased thickness of the oxyntic mucosa. mice with genetic deletion of the gastrin gene also show reduction in the thickness of the gastric mucosa. whilst all cell types are present, there is a most pronounced decrease in the numbers of parietal cells as well as enterochromaffin cells associated with an increase in surface mucous cells. these changes are linked to a profound decrease in acid secretion, which becomes unresponsive to histaminergic, cholinergic and gastrinergic stimulation (hinkle and samuelson, 1999) . analogous atrophic changes have been reported following pharmacological removal of trophic stimuli. for instance, administration of the cholecystokinin-b/gastrin receptor antagonist, ci-988 to cynomolgus monkeys for periods of up to 13 weeks was associated with an initial phase of multifocal degeneration of gastric glands primarily in the fundus followed by diffuse reduction in the thickness of the glandular mucosa with little or no qualitative changes to the cell populations (dethloff et al., 1997) . although bilateral vagotomy produces profound functional changes in the stomach, notably reduction of gastric acid secretion, morphological changes in the fundal mucosa are not marked either in experimental animals or in man (crean et al., 1969; aase and roland, 1977) . studies in the rat have shown that diffuse atrophy of the gastric glands characterised by a decrease in the number and size of parietal, chief and mucous cells occurs transiently following truncal vagotomy but histological features return to normal by about 1 month after surgery (nakamura, 1985) . by contrast, unilateral vagotomy in the rat leads to marked and persistent atrophy of the oxyntic zone on the denervated side. this is characterised histologically by reduced height of the mucosa and reduced numbers and staining intensity of argyrophil cells (hakanson et al., 1984) . hã¥kanson and his colleagues argued that this unilateral atrophy was due to the removal of the trophic action of the vagus. the lack of lasting atrophy after bilateral but not unilateral vagotomy was explained by the subsequent rise in gastrin that occurs after bilateral vagotomy as a result of lack of acid feedback inhibition of gastrin release (hã¥kanson et al., 1984) . removal or reduction in extra-gastric trophic factors or hormones may also reduce the thickness of the gastric mucosa. this is has been demonstrated in the rat by hypophysectomy which causes a reduction in thickness of oxyntic and antral mucosa, compared with pair-fed controls. although there was little or no change in peptic:parietal cell ratios, a significant decrease in cell volume and secretory activity of gastric glandular cells were demonstrated which suggested a widespread disturbance of synthesis and secretory mechanisms (bastie et al., 1985) . atrophic changes in the chief cells were observed in rats treated for 6 months with high doses of omeprazole, an inhibitor of acid secretion. the findings were considered to represent disuse atrophy secondary to the inhibition of acid secretion (hansson et al., 1986) . another inhibitor of gastric acid secretion, the tricyclic agent pirenzepin, also produced atrophy of the fundic mucosa of rats following 3 months but not 1 month of treatment (lehy et al., 1978) . the atrophy was characterised by reduction in parietal cell numbers associated with lower numbers of gastrin-containing cells in the antrum, features unlike those following prolonged treatment with histamine h 2 -receptor antagonists. an increase in the thickness of the gastric mucosa can be the result of hypertrophy or hyperplasia of the mucosal cells and this occurs both spontaneously or following administration of drugs and chemicals. in view of the different cell populations in the gastric mucosa and the variety of morphological alterations that occur, it is difficult to make a clear distinction between hypertrophy and hyperplasia without morphometric techniques. morphometric techniques have shown that hypertrophy of some mucosal cells can coexist with hyperplasia of other gastric cell populations. a distinction also needs to be made between diffuse or uniform hyperplasia involving one or more of the cell populations from the hyperplasia associated with proliferative or adenomatous overgrowth. adenomatous hyperplasia also needs to be evaluated for atypical cytological features (dysplasia), which are linked to development of gastric carcinoma (see below). cells of gastric glandular mucosa undergo increases in size or number in response to the effects of gastrointestinal trophic hormones or their synthetic analogues. similar changes also follow administration of compounds that inhibit gastric acid secretion or modify other trophic hormones or growth factors. when gastrin or its synthetic analogue, pentagastrin is administered subcutaneously to rats and mice for several weeks, there is both an increase in the number and size of parietal cells without concomitant increase in zymogenic chief cells (willems and lehy, 1975; crean et al., 1978; balas et al., 1985) . in addition, diffuse hyperplasia of enterochromaffin cells also occurs. by contrast, cholecystokinin, a trophic peptide found in the duodenum and sharing the same c-terminal tetrapeptide sequence as gastrin, increases in the number of chief cells but not parietal cells when administered to mice under similar conditions . drugs which inhibit or neutralise gastric acid secretion such as histamine h 2antagonists, proton pump inhibitors and antacids also induce hypertrophy or hyperplasia of the parietal cell population (witzel et al., 1977; crean et al., 1978; mazzacca et al., 1978; kaduk and hauser, 1980; betton et al., 1988; white et al., 1998) . these agents are associated with a rise in serum gastrin levels, probably as a result of loss of feedback inhibition of low antral ph on gastrin-producing g cells (witzel et al., 1977) . not all histamine h 2 antagonists produce identical effects. other cytological changes have been reported with famotidine, another h 2 -receptor antagonist. this agent produced a dose-related increase in the prevalence and degree of eosinophilic granularity in chief cells of the stomach in toxicity studies in rats but not dogs (burek et al., 1985) . electron microscopy showed an increase in electron density of zymogen granules and it was argued that these effects were the result of secondary inhibition of pepsin secretion or turnover due to inhibition of acid secretion. cytoprotective agents of prostaglandin type produce different forms of diffuse gastric hyperplasia. rats treated with 16,16-dimethyl prostaglandin e2 hourly for 3 weeks, not only developed forestomach alterations (see above) but also thickening of both the body and antral mucosa. in the body mucosa, these changes were the result of a proportional increase in the total mass of surface and foveolar mucous cells, mucous neck cells, chief cells, parietal and endocrine cells as well as connective tissue. this was largely as a result of increase in cell number, although parietal cells also increased in size (reinhart et al., 1983) . unlike treatment with gastrin and gastrin analogues there was an increase in number of surface and foveolar mucous cells associated with increase in mucus content. misprostal, a synthetic prostaglandin e1 methyl ester analogue also produced diffuse glandular hyperplasia, characterised by lengthening of gastric pits and increased mucous secretion in the preclinical safety studies in dogs and rats (kotsonis et al., 1985) . this glandular hyperplasia not only affected the body but also the antral mucosal. studies with tritiated thymidine showed that the labelling index was reduced in rats treated with misprostal, suggesting hyperplasia following administration of prostanoids is a result of an increase in cell survival and decrease in cell shedding rather than an increase in cell proliferation (fich et al., 1988) . levin (1988) has reviewed the effects of prostaglandins of the e series on the gastrointestinal tract of dogs and rodents. a dose-related diffuse hyperplasia of the gastric glandular mucosa has been reported in both rats and cynomolgus monkeys given human recombinant epidermal growth factor. the gastric mucosa was thickened and there was a increase in the number of undifferentiated cells particularly in the neck region and upper part of the gastric glands (breider et al., 1996; reindel et al., 1996) . mitotic figures were also numerous in the upper reaches of the mucosa. the lower parts of the gastric glands were generally less affected. the large increase in the number of undifferentiated cells may have a functional effect on gastric acidity and function (vinter-jensen, 1999) . administration of recombinant growth hormone has also been reported to induce thickening of the gastric glandular mucosa in dog toxicity studies along with typical growth hormone-induced changes in other organs, body weight increases and insulin-like growth factor (prahalada et al., 1998) . the pyloric and fundic mucosa showed histological evidence of hyperplasia of the mucous neck cells. thickening of the gastric glandular mucosa as a result of an irregular proliferation and cystic dilatation of gastric glands associated with inflammation characterises a number of non-neoplastic conditions in the stomach of man and laboratory animals. cystic change with chronic inflammation and foveolar hyperplasia is observed in biopsies taken from the edge of chronic gastric ulcers in man (franzin and novelli, 1981) . mã©nã©trier's disease ('polydadenomes en nappes'), a rare disease found primarily in middle-aged men is also characterised by enlarged gastric folds, foveolar hyperplasia and gastric glandular cystic dilation (berenson et al., 1976; wilkerson et al., 1998) . although its pathogenesis remains elusive, increased expression of transforming growth factor î± (tgfî±) and the epidermal growth factor receptor has been described (demsey et al., 1992) . as tgfî± is an epithelial cell mitogen that inhibits gastric acid secretion and increases gastric mucin, and transgenic mice that overexpress tgfî± in gastric mucosa develop a similar condition (see below), it was suggested by demsey et al. (1992) that tgfî± might have an important role in this condition. similar changes have been observed in animals in association with infestation of the gastrointestinal tract by parasites (jubb and kennedy, 1970; cook et al., 1981) . laboratory rodents may develop a similar pattern of changes spontaneously with advancing age, although the cause of this change remains uncertain. the distinction between adenomatous hyperplasia and adenoma is not clear cut. nevertheless, adenomas are usually defined as localised or focal proliferative lesions with well-ordered glandular patterns with a clear boundary with the surrounding normal mucosa. they are usually exophytic or polypoid in nature but adenomas with localised downward growth are described (mohr, 1997) . proliferation of the gastric glandular mucosa has been well characterised in the laboratory mouse because certain strains have a particular tendency to develop this condition spontaneously with advancing age (stewart and andervont, 1936; rowlatt et al., 1969) . hyperplasia also occurs spontaneously in conventional laboratory strains employed in carcinogenicity bioassays. its prevalence can be influenced by environmental factors such as housing (chvã©doff et al., 1980) , food restriction (rehm et al., 1987) and the administration of xenobiotics (poynter et al., 1985; betton et al., 1987) . similar gastric changes have also been reported to occur in mice thymectomised shortly after birth (suzuki et al., 1981) . histologically, these changes in mice are characterised by hyperplasia of the foveolar and neck regions of the body mucosa (fig. 47) . in advanced cases this is accompanied by elongated, tortuous, or dilated glands lined by simple columnar or cuboidal epithelium, devoid of parietal or chief cells. the abnormal cells show only mild cellular pleomorphism and mitotic activity. the abnormal glands dis-place normal glandular tissue and may penetrate through the muscularis mucosa to reach the muscularis externa and serosa. step sections demonstrate continuity between these glandular elements and a total absence of metastatic spread in the adjacent tissues and lymph nodes. the lamina propria also shows increased amounts of smooth muscle and collagen accompanied by variable numbers of lymphocytes and other chronic inflammatory cells. oedema may be observed and blood vessels are often dilated. the antral mucosa remains relatively unaffected. histochemistry has shown variable mucin secretion of the altered glands. some glands are devoid of mucin, others show an increase in sulphomucin as revealed by the high-iron diamine technique (greaves and boiziau, 1984) . it has been suggested that these features are similar to mã©nã©trier's disease in man and might have a similar pathogenesis (dempsey et al., 1992; takagi et al., 1992) . the aetiology of the spontaneous condition in the mouse is uncertain. the occurrence of similar lesions in thymectomized mice has given rise to the suggestion that autoimmune damage to the gastric mucosa may be responsible (kojima et al., 1980) . the presence of circulating anti-parietal antibodies and the decrease in the number of parietal cells in thymectomized mice suggested that autoimmune damage can occur to parietal cells with compensatory chronic stimulation and proliferation of the generative zones (suzuki et al., 1981) . however, based on findings in female han nmri mice, rehm et al. (1987) showed that this proliferative condition can develop in mice in the absence of antiparietal antibodies. they demonstrated that this change is associated with an increase in the number of antral gastrin cells, raising the possibility of a hormone or paracrine mechanism. a similar proliferative form of gastropathy has been reported in mice which overexpression transforming growth factor î± (tgfî±), a potent mitogen and member of the epidermal growth factor family of peptides. tgfî± acts by binding to and activating the tyrosine kinase of the epidermal growth factor receptor. transgenic mice overexpressing tgfî± develop severe adenomatous and cystic hyperplasia of the gastric glandular mucosa starting from about 2 months of age along with loss of mature parietal cell numbers and a diminution in gastric acid production (takagi et al., 1992) . the degree of change was to some extent dependent on the genetic background on which the transgene operated. an increased prevalence of similar changes have been reported in cd-1 mice treated with the novel histamine h 2 -receptor antagonist sk&f 93479 for 21 months (betton et al., 1987; . although treated mice developed hyperplasia of gastric neuroendocrine cells similar to that observed in rodents treated with other antisecretory agents, they also showed an increase in the severity of glandular hyperplasia. like the spontaneous condition, these changes were characterised by thickening of the mucosa by hyperplasia of the foveolar and neck regions, and downward proliferation of glandular elements into gastric glands (betton et al., 1988) . poynter et al. (1985) have also reported similar glandular hyperplasia in the mouse stomach associated with histamine h 2 -blockade with the agent ioxtidine. these findings were similarly associated with hyperplasia of neuroendocrine cells. adenomatous polyps have also been reported in the pyloric antrum of c57bl/ 10j mice treated for 52 weeks with the synthetic progestin, cyproterone acetate (tucker et al., 1996) . these were single, pedunculated and well-differentiated lesions showing little evidence of dysplasia. the mechanism for the induction of these polyps is unclear although they may have been hormonally mediated as progesterone receptors have been identified in gastric tissue (wu et al., 1992) . although usually less prevalent and less exuberant than in mice, the aged rat also develops proliferative gastric glandular changes spontaneously. these changes are characterised by hyperplasia of the foveolar and mucin-secreting cells of the body mucosa, development of cystic glands lined by simple mucous or flattened cells, accompanied by chronic inflammatory cells, prominent blood vessels and smooth muscle in the lamina propria (greaves and faccini, 1992) . the antrum remains relatively unaffected. proliferative alterations can be induced by administration variety of xenobiotics as well as following surgical procedures that induce chronic reflux of normal intestinal contents. for instance, hyperplasia of the gastric mucosa, notably over the lesser curvature has been described in rats following the so-called bilroth ii gastrectomy that allows reflux of intestinal and biliary secretions into the stomach (kobayashi et al., 1991) . a proliferative condition of the gastric mucosa has been shown to develop following long-term treatment of rats with an ulcerogenic regimen of aspirin. female sprague-dawley rats given 250 mg/kg of aspirin in 1% methylcellulose once daily orally by gavage for 6 months followed for periods of up to 18 months without treatment, developed focal proliferative changes at the sites of healed ulcers, mainly in the mucosa of antrum or antral-body junction (st john et al., 1977) . these lesions were characterised by the presence of proliferating gastric glands lined by columnar, cuboidal or flattened epithelial cells in the mucosa, which also extended through the muscularis mucosa. mucus content of these glands was variable but when present was principally acidic in type, as shown by staining with alcian blue at ph 2.5. the lesions were accompanied by increased collagen in the lamina propria, endarteritis and an infiltration of lymphocytes, plasma cells and mast cells. the lesions were not associated with the development of carcinoma following 18 months' observation and it is probable that they were the result of the chronic damage and repair induced by aspirin treatment. hyperplasia of the gastric glandular mucosa also occurs in rats following the administration of powerful genotoxic carcinogens, although characteristically in association with of atypical histological changes and ultimately carcinoma. these changes have been best characterised in sequential studies with the rat using the carcinogen n-methyl-nâ´-nitro-n-nitrosoguanidine at doses low enough to avoid overt gastric ulceration and regenerative hyperplasia. it was shown that hyperplasia developing under these conditions occurs diffusely both in the body and antral mucosa. furthermore, the changes occurred earlier in the antrum than in the body and were focal or polypoid in character (tsiftsis et al., 1980) . involvement of the antrum in this way is quite unlike the spontaneous hyperplasia of the rat gastric mucosa. histologically, this form of hyperplasia is characterised by lengthening of the foveolae and neck regions both in the antrum and body. hyperplastic pits or foveolae show increased secretion of sialomucins and sulphomucins with a concomitant loss of neutral mucins. polychlorinated biphenyls such as arochlor 1254, which produce intestinal metaplasia and adenocarcinoma in the stomach of rats, also induce proliferative alterations characterised by proliferative cystic lesions in the mucosa associated with inflammation and fibrosis (morgan et al., 1981) . in common with lesions induced by genotoxic agents, these changes are found primarily in the antrum and pyloric regions, zones of predilection for the development of gastric carcinoma in man and experimental animals. it is important to distinguish between the various hyperplastic and adenomatous conditions found in the gastric glandular mucosa in laboratory animals that are not associated with neoplasia from those which precede the development of carcinoma. this distinction is complicated by the fact that proliferative changes associated with the development of cancer both in man and laboratory animals possess features in common with lesions not associated with neoplasia. however, a key distinctive feature is the degree of epithelial dysplasia. dysplasia is considered to be the lesion common to gastric conditions in man such as atrophic gastritis and gastric polyps that have been linked with a significantly increased risk of gastric cancer. although the term dysplasia may be less widely employed in experimental pathology, similar dysplastic changes to those occurring in man have been characterised in laboratory animals in which precancerous gastric lesions have been studied (tsiftsis et al., 1980) . it therefore represents a unifying concept in the assessment of proliferative changes in the gastric glandular mucosa of laboratory animals. as defined by an international group concerned with the diagnosis of preneoplastic conditions in the stomach of man, the principle features of dysplasia are (i) cellular atypia; (ii) abnormal differentiation; and (iii) disorganised mucosal architecture (morson et al., 1980; nagayo, 1981) . cellular atypia is characterised by nuclear pleomorphism, hyperchromasia and stratification of nuclei, increased nuclear-cytoplasmic ratio and loss of cellular and nuclear polarity. abnormal differentiation is shown by reduction or alteration in the normal secretory products of the mucosa. disorganised mucosal architecture is shown by irregularity of crypt structure, back-to-back glands, budding and branching of crypts and intraluminal and surface papillary growths. it is important to assess gastric mucosa very carefully for the features of dysplasia when hyperplastic gastric changes are found in treated animals. in the rat gastric cancer model employing the carcinogen n-methyl-nâ´-nitro-n-nitrosoguanidine, dysplastic changes were shown to start in the proliferating neck region of hyperplastic zones (tsiftsis et al., 1980) . these changes were characterised histologically by irregular growth patterns of glandular cells showing reduced mucin secretion, numerous mitoses and enlarged pleomorphic nuclei. these atypical glands were observed to extend downwards, eventually replacing normal gastric glands and ultimately penetrating the muscularis mucosa forming infiltrating adenocarcinomas of variable differentiation. the antrum developed these changes earlier than the body mucosa (tsiftsis et al., 1980) . these considerations were important in the safety evaluation of the histamine h 2 receptor antagonist, tiotidine (ici 125,211) a guanidino-thiazole derivative that also produced proliferative gastric lesions in the stomach of rats in a 24month carcinogenicity study (streett et al., 1984; . these changes were found mainly in the pyloric region and were characterised histologically by superficial erosions and irregular pyloric glands lined by cells with basophilic cytoplasm and enlarged hyperchromatic nuclei. some atypical glands penetrated the muscularis mucosae. dysplastic lesions situated primarily in the pyloric region were also associated with the development of invasive carcinoma in some rats. extensive histological sectioning of the stomach in rats treated with tiotidine for only 6 months also revealed evidence of early proliferative changes (streett et al., 1988) . therefore, these lesions produced by tiotidine possessed more in common with those induced by powerful carcinogens such as n-methyl-nâ´-nitro-n-nitrosoguanidine than the benign, species-specific proliferative change of little or no relevance for human safety. interestingly, mice treated for 18 months with tiotidine were devoid of dysplastic changes in the gastric mucosa (streett et al., 1988) . one of the most remarkable examples of drug-induced gastric alterations in rodent bioassays is the hyperplasia of enterochromaffin cells and development of carcinoid-like neoplasms in the stomach of rats treated with omeprazole (havu, 1986) . omeprazole is a substituted benzimidazole which inhibits gastric acid secretion by blocking the enzyme h + , k + -atpase, the proton pump of the parietal cells, in a specific and dose-dependent manner (fellenius et al., 1981) . although in rats there is a increase in number of gastric argyophilic cells with increasing age, rats treated with omeprazole for 104 weeks showed a marked, dose-related and diffuse increase of argyophilic, non-argentaffin cells in the basal half of the oxyntic fundal mucosa (havu, 1986) . these changes were more marked in female than in male rats but were not observed in the bioassay in which cd-1 mice were treated with similar doses of omeprazole for 78 weeks. these diffuse changes in the rat stomach were associated with focal hyperplasia of argyrophilic cells. these focal lesions were also associated with a doserelated increase in larger focal nodular lesions of argyrophilic cells, some of which were undoubtedly locally infiltrating carcinoid tumours. these nodular argyrophil lesions posed the usual problems of differential diagnosis of endocrine hyperplasia and neoplasia (see endocrine system, chapter xiii) and distinction of hyperplasia from neoplasia was uncertain. histologically, nodular lesions were composed of multifocal anastomosing solid or pseudoacinar cords of proliferating, regular cells with uniform nuclei and moderately abundant fine granular pale cytoplasm. these nodules showed little or no cellular pleomorphism or mitotic activity but clear evidence of submucosal infiltration without involvement of the muscularis externa was observed in some cases. the overall light microscopic features were similar to those of gastrointestinal carcinoid tumours reported in man. the incidence of gastric carcinoids was reported to be as high as 40% in females in the high dose group but only a few cases observed in similarly treated males (ekman et al., 1985; havu, 1986) . electron microscopy of the altered argyophil cells confirmed the presence of electron-lucent, vesicular granules, frequently with small irregular dense cores characteristic of enterochromaffin cells of the stomach. immunocytochemical study showed that these cells contained histidine decarboxylase which is found normally in gastric enterochromaffin cells which produce and store histamine . other findings reported in rats treated with omeprazole have been a proportional increase in the number and size of non-endocrine cells of the fundus (blom, 1986) , an increase in the number and immunostaining properties of the antral gastrin-containing g cells and hypergastrinaemia (bishop et al., 1986; creutzfeldt et al., 1986) . all functional and morphological changes following treatment for 60 days were fully reversible after 42 days' drug withdrawal (creutzfeldt et al., 1986) . as a result of these treatment-related increases of these normally rare gastric carcinoids in the rat bioassay with omeprazole, clinical trials with this agent were suspended until it was agreed that the endocrine alterations were a result of prolonged drug-induced achlorhydria. it was postulated that omeprazole causes a prolonged inhibition of acid secretion in the rat, which causes activation, and subsequently hyperplasia of antral gastrin cells and marked hypergastrinaemia. hypergastrinaemia in turn stimulates enterochromaffin cells of the fundus, which in time results in enterochromaffin hyperplasia . this argument is supported by the fact that similar morphological findings are reported in chronic atrophic gastritis and other achlorhydric sites in man (solchia et al., 1986; mã¼ller et al., 1987) and that antrectomy in the rat prevents the appearance of enterochromaffin hyperplasia following treatment with omeprazole . although mild dose-related gastric argyrophil cell hyperplasia was noted in dogs treated with omeprazole for 1 year, neoplasms of the stomach were not observed during this time period. why mice neither developed neither argyrophil hyperplasia nor gastric carcinoids with a similar treatment regimen is not clear, as the mechanism of action of omeprazole is similar in rat, dog and mouse. however, as the duration of action of omeprazole is shorter in the mouse, it was postulated that sustained inhibition of gastric acid secretion over 24 hours is necessary to activate increased gastrin secretion from antral cells (havu, 1986) . it has also been suggested that the mouse possesses fewer gastric enterochromaffin cells than the rat and shows a much lower serum gastrin response to omeprazole treatment (ekman et al., 1985) . duration of action or potency may also be the explanation for the lack of reports of carcinoid neoplasms in rats following inhibition of gastric acid secretion by the histamine h 2 -receptor blockers cimetidine and ranitidine. neither of these drugs completely inhibits gastric acid secretion in the rat for 24 hours (leslie and walker, 1977; larsson et al., 1986) , although mild gastric neuroendocrine hyperplasia has been recently described in cimetidine-treated rats (hirth et al., 1988) . however, the long-acting h 2 -receptor antagonist sk&f 93479 produced gastric carcinoid neoplasms when administered at a high dose (1000 mg/kg) to rats for 2 years (figs. 48 and 49) (betton et al., 1987; . although this dose level of sk&f 93479 did not entirely suppress gastric acid secretion and control gastric ph over 24 hours, plasma gastrin levels remained elevated at 3-4 times control values over this period. in a 21-month oral carcinogenicity study in cd-1 mice at the same dose level (1000 mg/kg), a diffuse neuroendocrine cell hyperplasia and multifocal glandular hyperplasia or neoplasia was also observed (betton et al., 1987) . similarly, loxitidine, a potent, non-competitive, insurmountable histamine h 2 -antagonist produced hyperplasia of neuroendocrine cells and carcinoid tumours in the gastric fundus of both rats and mice after 2 years' treatment in diet and drinking water, respectively (poynter et al., 1985 (poynter et al., , 1986 . other histamine antagonists bl-6341 and ici 162846 have been reported to produce neuroendocrine neoplasms in the stomach of rats and rats and mice, respectively (hirth et al., 1988; streett et al., 1988) . wormsley (1984) reviewed the considerations in the risk-benefit analysis of agents intended for long-term administration for peptic disease. drugs of other classes also cause hyperplasia of gastrin-containing cells. immunocytochemical study using antigastrin antibody revealed increased gastrin cell numbers in the antral mucosa of dogs given high doses of adrenocorticosteroids for 4 weeks and these changes were accompanied by enhanced serum and tissue gastrin levels (delaney et al., 1979) . these results suggest that adrenocorticosteroids have a trophic effect on gastrin-containing cells. in human patients hypergastrinaemia is also produced by pharmacologically induced hypochlorhydria although this is usually only slight and hyperplasia of enterochromaffin cells has not been observed (soll, 1990) . a complicating factor in drug safety evaluation is the association of gastric cancer in both man and laboratory animals with n-nitroso compounds. some of the most effective stomach carcinogens in laboratory animals have proved to be nnitroso compounds particularly since sugimura and fujimura (1967) induced gastric adenocarcinomas in rats with n-methyl-nâ´-nitro-n-nitrosoguanidine dissolved in drinking water. furthermore, epidemiological evidence associating nnitroso compounds with human cancer is also fairly strong for the stomach (corea et al., 1975; pocock, 1985) . the formation of n-nitroso compounds is theoretically possible with a variety of compounds that contain amino groups. it has been suggested that the formation of nitrosamines occurs in vivo under the acidic conditions in the stomach following dietary ingestion of nitrite, nitrates and secondary amines (mirvish, 1975 (mirvish, , 1983 . low levels of preformed nitrosamines are also present in some commercial pelleted diets for laboratory animals, principally derived from fishmeal (edwards et al., 1979) . calculations based on dietary intake and nitrosatability of precursors and carcinogenicity of derivatives have suggested that the risk that arises from endogeneous nitrosation is highly variable but highest from ureas and aromatic amines (shephard et al., 1987) . a number of drugs in widespread clinical use have been shown to produce nnitroso products in acidic aqueous media, although the extent to which this occurs in actual therapeutic use is unclear (gillatt et al., 1985) . some clinical evidence suggests that nitrosation of therapeutic agents can occur in clinical practice. for instance piperazine, a cyclic secondary amine, widely used as an antihelmintic drug, has been shown to form small quantities of n-mononitrosopiperazine in the human stomach as measured by gas chromatography-thermal energy analysis (bellander et al., 1985) . however, n-mononitrosopiperazine has not been shown to be carcinogenic in rodents (love et al., 1977) . n,nâ´-dinitrosopiperazine, carcinogenic to the upper gastrointestinal tract in rodents (lijinsky and taylor, 1975) , was not detected in man after administration of piperazine under the same circumstances (bellander et al., 1985) . the possibility of nitrosation is not usually taken into account in the testing of carcinogenic potential of novel drugs as bioassays are usually only performed with parent compound. however, concerns about nitrosation have arisen in subsequent clinical practice. an example of this was the proposal that a few gastric cancers found in patients whilst being treated with the histamine h 2 receptor antagonist cimetidine, were the result of treatment (elder et al., 1979; reed et al., 1979; hawker et al., 1980) . it now seems likely that all those observed cancers associated with cimetidine were incidental (penston and wormsley, 1986) . however, at that time concerns were increased by the theoretical possibility that cimetidine has the potential be nitrosated in vivo (elder et al., 1982) . a further factor was the concept that the treatment-induced gastric secretory inhibition with subsequent bacterial colonisation of the stomach rendered the conditions conducive to the generation of n-nitroso compounds from normal dietary constituents (reed et al., 1981; penston and wormsley, 1986) . these concerns appear to be unfounded. long-term surveillance studies with cimetidine have shown no causal link between its clinical usage and gastric malignancy (colin-jones et al., 1965; langman, 1985) . in addition, carcinogenicity bioassays performed with cimetidine, cimetidine plus nitrite and nitrosocimetidine have not shown any tumorigenic effect in the gastric mucosa (anderson et al., 1985) . a 7-year study in dogs in which multiple gastric biopsies were taken at intervals of approximately 6 months have also shown no indication of gastric hyperplasia, dysplasia, intestinal metaplasia or neoplastic change . although complacency is certainly not warranted with respect to the nitrosation of therapeutic agents in vivo, the risks of development of gastric malignancy from such drugs when administered on a short-term basis are probably very small (world health organisation, 1978) . even for gastric antisecretory agents which may be administered for longer periods of time, the balanced view would also permit development of novel agents provided they are not obviously mutagenic or carcinogenic in the usual preclinical studies and are not particularly liable to undergo rapid nitrosation. most carcinomas of the glandular mucosa are adenocarcinomas, whether induced by the potent genotoxic carcinogens or therapeutic agents. these tend to develop in the antral region in rodents (streett et al., 1984; szentirmay and sugar, 1985) . they range from those with well differentiated tubular or papillary features to poorly differentiated forms with trabecular, mucoid or signet ring features (tatematsu, 1997) . squamous metaplasia within adenocarcinoma can also be observed. stroma may be abundant with pronounced chronic inflammatory infiltration and hyalinisation. metaplastic cartilage and bone has also been described (szentirmay and sugar, 1985; mohr, 1997) . gastric adenocarcinomas induced in dogs by n-methyl-nâ´-nitro-n-nitrosoguamide show similar histological features although their reported distribution in the stomach appears more variable (fujita et al., 1974) . histological criteria for the diagnosis of invasive adenocarcinoma in experimental animals may vary between individual pathologists. some retain the old criteria of stewart and co-workers (1961) who defined invasive cancer as a neoplastic growth reaching the serosa. it is now considered more appropriate to apply criteria of use in human diagnostic pathology (see mohr, 1997) . unequivocal invasion of the submucosa is sufficient evidence of an invasive and therefore malignant process (greaves and faccini, 1992) . the small intestine is of major importance in drug safety evaluation for it represents the primary site of drug absorption. in view of its length and the presence of villi, it possesses an enormous surface area of specialised absorptive epithelium. furthermore, ingested substances have an extended residence time in this part of the gastrointestinal tract. the canine model has been one of the most popular for the study of drug absorption because the dimensions of the canine gastrointestinal tract permit administration of dosage forms intended for clinical use in humans. for this reason, factors, which influence drug absorption, have been better studied in dog and man than many other species. however, data from dog and man not only suggest that diverse factors influence drug absorption from the small intestine but that there are considerable species differences. residence time is of particular importance for drugs, which are incompletely absorbed because differences in mucosal contact time can be expected to result in differences in the fraction absorbed. dressman (1986) has shown using the heidelberg capsule technique that small intestine transit time in dogs is varies from between 15 and over 200 minutes whereas in man equivalent times are between 180 and 300 minutes. these results suggest that absorption of poorly absorbable drugs is likely to be quantitatively less although more variable in dogs than in man. however, these differences do not explain why some poorly lipophilic drugs such as chlorothiazine, acyclovir and phosphalinic acid are more extensively absorbed in dogs than in man. intestinal ph is consistently higher in dogs than in man so that drugs with half maximal absorption ph in the range ph 5-7 may also be expected to be absorbed at different rates in man and dog (dressman, 1986) . physiological and anatomical differences in the small intestine of other test species particularly rodents and humans are also likely to have an impact on drug absorption although many of these factors are still poorly understood. in addition to the small intestine acting as an absorptive surface, it is becoming increasingly obvious that it plays an important part in the metabolism of drugs (breckenridge, 1987) . although monoxygenase activity is relatively low in the gut compared with the liver, conjugation mechanisms are efficient and activity of udp-glucuronosyltransferase and glutathione-s-transferase are as high or even higher than in the liver (hã¤nninen et al., 1987) . in addition, the gastrointestinal microflora not only possesses metabolic capacity itself but also can influence the turnover rate of mucosal cells and subsequent exfoliation and release of enzymes into the lumen (hã¤nninen et al., 1987) . gastrointestinal metabolising activity is important because that the mucosa is exposed to high concentrations of xenobiotics in toxicity studies, and this can influence their overall bioavailability (chhabra and eastin, 1984) . studies in untreated rats have shown that the concentration of total cytochrome p450 in small intestinal microsomes is only about 10% of that found in liver microsomes (bonkovsky et al., 1985) . however, it exists in at least two forms and as in the liver, its activity can be induced by xenobiotics. it has been shown that in the rat, the concentration of cytochrome p450 and drug metabolising enzyme activity increases in intestinal epithelial cells as they move from crypt to villous tips and they are found in greater concentration in the proximal two-thirds of the small intestine than in the distal third (hoensch et al., 1976; bonkovsky et al., 1985) . bonkovsky et al. (1985) also showed that the phenobarbital-inducible form of cytochrome p450 represents less than 5% of total p450 in the small bowel, but as in the liver, phenobarbital treatment can increase this form to about 50% of total cytochrome p450 in small intestine cells. furthermore, it has been shown that drug metabolising activity in the tips of the villi in the duodenum is greater in rats fed a conventional diet than a semisynthetic diet and that the activity depends critically on the absorption of iron from the intestine (hoensch et al., 1976) . glutathione is also present throughout the entire mucosa, although in rats, cells at the tips of the villi contain less than cells located more basally, whereas related enzymes î³-glutamyl transpeptidase and glutathione-s-transferase show highest activity in the villous tip region (ogasawara et al., 1985) . the fact that these enzyme activities are highest in the duodenum and lowest in the terminal ileum suggests that detoxification systems for exogenous compounds are greater in the proximal small intestine. the small intestinal mucosa is constructed not only to act as an absorptive surface but also as a barrier to potentially pathogenic substances and microorganisms. although the main cell population of the epithelium is composed of absorptive cells, other major epithelial cell types, the mucous (goblet) cells, paneth cells and endocrine cells have important protective functions. in addition, specialised epithelial cells, the microfold (membranous or m) cells are located in the epithelium over peyer's patches. these cells form part of the other important protective system of the intestine, the gut associated lymphoid tissue (galt) or mucosal associated lymphoid tissue (malt). the mucosal lining is in a constant state of renewal. enteric epithelium possesses the fastest rate of turnover of any tissue exceeded only by a few rapidly growing neoplasms . in normal circumstances, the constant turnover of small bowel mucosa is maintained by equilibrium between cell production in the crypts and cell loss at the tips of the villi. there are intrinsic controls within the mucosa itself. exogeneous substances, intraluminal secretions, mechanical and neural factors as well as alterations in blood flow all possess potential to influence mucosal cell kinetics . all main epithelial cell types are believed to arise from undifferentiation columnar cells at the crypt base (cheng and leblond, 1974) , although mucous cells may also arise by proliferation of partly differentiated mucous cells in the crypts. as cell division is limited to crypts, the cell population in the crypts have high activities of enzymes such as thymidine kinase that are involved in nucleic acid synthesis (imondi et al., 1969) . the complete cell cycle lasts about 10-17 hours in rodents and at least 24 hours in man. enteric epithelium is completely replaced within 2-3 days in mice and rats and within 3-6 days in man . after two or more divisions in the crypt cells migrate to the villus, lose ability to incorporate thymidine and differentiate into mature cells equipped with enzymes associated with nutrient absorption (imondi et al., 1969) . cell migration in the rat is completed more rapidly in the ileum than in the jejunum principally as a result of the lower villous height in the ileal mucosa (altman and enesco, 1967). migration terminates by loss of cells from the tip of the villi. surrounding the crypt is a sheath of fibroblastic cells. these cells also undergo synchronous division and migration with the epithelial cells, maintaining the intimate relationship between the epithelium and supporting tissues (parker et al., 1974) . mature absorptive cells are important in the active and passive transport of nutrients as well as in the endocytosis of macromolecules. they are characterised by the presence of a striated or brush border which is seen in haematoxylin and eosin-stained sections as a refractile bi-laminar band. the inner, wider lamina corresponds to the microvillous region that is associated with the presence of neutral mucosubstances in most species. the outer, thinner band corresponds to the glycocalyx, which is composed principally of acidic mucosubstances (sheahan and jarvis, 1976) . this outer band of the brush border shows histochemical staining predominantly for sulphomucins in most species including mouse, hamster, dog and rhesus monkey, although in the duodenum of the rats and in the entire human small bowel sialomucins predominate in this layer. electron microscopy of the absorptive cells shows that the surface of absorptive cells is covered by tightly packed and well developed microvilli approximately 1 âµm long and 0.1 âµm wide. these are considered the first site of entry of food substances into the cell. the plasma membrane of microvilli is associated with fine filamentous projections, which probably represent the polysaccharide chains of the glycocalyx (bennett, 1969) . as the glycocalyx is composed of a network of polysaccharides, it has been suggested that it may behave like an ionexchange resin, be able to bind certain lectin-like molecules or trap substances in its matrix so providing a site for efficient intraluminal digestion (bennett, 1969; goldberg et al., 1969; king et al., 1986 ). the plasma membrane shows a trilamina structure at ultrastructural level. freeze fracture replicas from the microvilli which cleave this membrane through the plane of apposed non-polar groups of the lipid bilayer, demonstrate smooth complementary surfaces studded with small particles. these particles represent integral globular proteins of the plasma membrane. some of these intramembranous particles, mostly those of 10 nm diameter show irregular outlines with a central pit and are believed to represent gap junctions or transport channels (yamamoto, 1982) . a particularly important aspect of the absorptive cell membrane is its high concentration of disaccharidases such as sucrase, maltase and lactase, related to the absorption of sugars. alkaline phosphatase activity is also abundant on the surface of absorptive cells, although its precise role here uncertain (owen and bhalla, 1983) . immunocytochemical demonstration of alkaline phosphatase provides a useful tool to examine the effects of xenobiotics on intrinsic membrane glycoproteins in the small intestine (hasegawa et al., 1987) . enterokinase, the glycoprotein enzyme, which initiates the activation of pancreatic zymogens by converting trypsinogen to trypsin, is also present in the brush border and glycocalyx of the small intestinal epithelium, both in man and animals. immunocytochemical studies have demonstrated that in man this enzyme is located in the duodenum and proximal jejunum but not ileum, colon and stomach (hermon-taylor et al., 1977) . these enzymes constitute integral structural proteins of the cell membrane with active sites protruding from the cell surface. they are synthesised by the absorptive cells (blok et al., 1984) . the lateral surfaces of absorptive cells are in direct contact with neighbouring cells and firmly attached to each other by terminal bars or junctional complexes. a terminal bar comprises an apically situated tight junction or zonula accludens, a central zone, the zonula adherens, below which is situated a desmosome or macula adherens. the junctional complexes are relatively impermeable to macromolecules. studies with labelled tracers in the rat jejunum have shown that horseradish peroxidase (molecular weight 40,000, diameter 5 nm) and ferri-tin (molecular weight 100,000, diameter 10 nm) do not penetrate junctional complexes (yamamoto, 1982) . below the junctional complexes, the cell membranes interdigitate and the intercellular space widens towards the cell base, a feature that may be important in the movement of electrolytes and water across the intestinal epithelium (rhodin, 1974) . the cytoplasm of absorptive cells contains smooth and granular endoplasmic reticulum, free ribosomes and mitochondria. the golgi apparatus is located above the nucleus. the apical part of the cytoplasm is devoid of organelles except for a tight meshwork of filaments called the terminal web. filaments of actin within the microvilli are linked to the terminal web and this is believed to be important in the movement of microvilli (moosker and tilney, 1975; moosker et al., 1978) . goblet cells are much fewer in number than absorptive cells in the small intestine but they increase in number from the duodenum to the lower ileum. they are important in the production of mucus, which remains on the surface of the mucosa as a viscous layer and acts as the first line of defence against intestinal pathogens. goblet cells are characterised by the presence of abundant mucous droplets formed by the golgi complex and which accumulate in the apical part of the cell cytoplasm. histochemical study shows that neutral mucosubstances are present in the goblet cells found in crypts and on the villi in the entire small bowel mucosa of most species including man but there is an interspecies variation in the population of sialo-and sulphomucins (sheahan and jarvis, 1976) . in the mouse, sulphomucins predominate but among rats considerable individual variation in the proportion of sialo-and sulphomucins is reported. in the hamster, sulphomucins are more prominent in the proximal and sialomucins in the distal small bowel. in the dog, both sulphomucins and sialomucins are found with predominance of one or other in individual animals. staining for acidic mucins is less intense in the goblet cells of the small intestine in man compared with non-human primates but sialomucins are predominant in both species. a few goblet cells in the distal ileum in man also contain sulphated mucins (sheahan and jarvis, 1976) . paneth cells remain located near the crypt base throughout the small intestine (sandow and whitehead, 1979) . they are found in rodents and man but typically not in carnivores such as dog and cat (rhodin, 1974; . they are characterised by the presence of numerous eosinophilic cytoplasmic secretory granules between about 1.0 and 2 âµm diameter that contain various enzymes and mucosubstances. particular care is needed in fixation and staining for optimal demonstration of paneth cells for they rapidly degranulate after death and granules are destroyed by acetic acid fixation. formalin and mercuric fixatives appear appropriate methods and they permit staining with methylene blue, lendrum's phloxine-tartrazine and masson's trichrome (lewin, 1969) . the apical parts of paneth cells show glucose-6-phosphatase, carbonic anhydrase and monoamine oxidase activity and they have been shown to contain lysozyme and immunoglobulins, particularly iga (speece, 1964; riecken and pearse, 1966; ghoos and vantrappen, 1971; . staining for lysozyme appears to be the most practical immunocytochemical stain for the detection of paneth cells in formalin fixed paraffin wax embedded tissue sections. however, other immunocytochemical reagents have been employed in human and rodent tissues. these include antibodies to the cd15 antigen (ariza et al., 1996) and to a rat paneth cell zinc binding protein (sawada et al., 1994) as well as the use of pokeweed lectin for murine paneth cells (evans et al., 1994) . the paneth cell granules not only contain lysozyme but also a range of antimicrobial peptides such as secretory phospholipid a 2 , î±-defensins, also called cryptins. these are believed not only to possess antimicrobial activity but also important in the regulation of cell volume, chemotaxis, mitogenesis and inhibition of natural killer cell activity (ouellette, 1997) . it has been shown that these substances are released from paneth cells when germ free rats are dosed with the intestinal flora from specific pathogen free rats (satoh and vollrath, 1986; . however, it has been shown that paneth cells develop under germ free conditions and do not require luminal bacteria or dietary material for their development (ouellette, 1999) . endocrine cells are also scattered throughout the small intestinal mucosa. they are of both argentaffin and argyrophil types and are situated predominately in crypts. immunocytochemical study shows that they contain a variety of different peptides although gastrin, secretion and serotonin-containing cells have been those most extensively studied (inokuchi et al., 1983) . in addition to the barrier formed by mucus and epithelial cells, lymphocytes, plasma cells, macrophages, dendritic cells and mast cells also form part of the protective function of the small intestine. some lymphocytes are located within the epithelium mostly, above the basal lamina but below epithelial nuclei (pabst, 1987) . these lymphocytes are termed intraepithelial lymphocytes and are predominantly of t-suppresser/cytotoxic type in man and laboratory animals (selby, 1981; martin et al., 1986; pabst, 1987) . most lymphocytes in the lamina propria are also t cells but t-helper (cd4 positive) cells outnumber the t-suppresser/cytotoxic or cd8 positive phenotype (hirata et al., 1986; pabst, 1987; bruder et al., 1999) . intraepithelial lymphocytes are also mainly t cells (bruder et al., 1999) . many plasma cells present in the lamina propria produce iga, the major immunoglobulin of mucosal secretions (michalek et al., 1975) . iga represents another important component of the mucosal barrier between the gastrointestinal mucosa and intraluminal antigens. the main function of iga is to effect immune exclusion by intimate co-operation with non-specific defence mechanisms (brandtzaeg et al., 1985) . plasma cells in the lamina propria produce dimeric iga with two dimeric molecules joined by a joint (j) piece. a secretory component (sc), a glycoprotein expressed on the basolateral surface of epithelial cells acts as a receptor for dimeric iga and as a transport system for iga to the gut lumen where monomeric iga is secreted (brandtzaeg et al., 1985) . morphometric analysis of iga-containing immunocytes in the rat ileal mucosa using immunocytochemical staining has shown that the number of these cells varies with alterations in the microbiological status of intestinal contents (rodning et al., 1983) . a significant reduction in iga-containing lymphocytes and plasma cells was observed following microbial reduction associated with gnotobiosis, probably reflecting decreased microbial antigenic stimulation. experimental studies using labelled mesenteric lymphocytes also suggests that local microenvironments are important in the distribution of there cells in the intestinal wall (mcdermott et al., 1985) . peyer's patches are the most prominent aggregates of lymphoid tissue in the gastrointestinal tract and constitute important sites at which antigens from the gut lumen encounter immune competent cells which are responsible for the initiation of immune responses. peyer's patches are located on the ante-mesenteric wall of the small bowel and consist principally of collections of lymphoid follicles. in man, peyer's patches are more common in the ileum (cornes, 1965) but in mice they are more uniformly distributed (owen and neumanic, 1978) . in rats they are also more numerous in the distal than in the proximal small intestine and the number of follicles in patches usually varies from 2 to 6 but sometimes many more may be seen in any particular section (martin et al., 1986) . peyer's patches vary between rat strains. a comparative study showed that in fischer 344 rats they are smaller than those in wistar rats (bruder et al., 1999) . particular care in selection and orientation of tissue blocks is therefore essential for any form of quantitative or semiquantitative assessment of peyer's patches. peyer's patches are more than simple aggregates of lymphoid follicles. they consist of lymphoid follicles surrounded by a corona of small lymphocytes principally of b-cell type. the interfollicular area contains post-capillary venules with specialised cobblestone type epithelium (yamaguchi and schoefl, 1983 ) and many t lymphocytes. beneath the epithelium, over the bulging follicles (dome area), mixtures of t and b lymphocytes, plasma cells and macrophages can be seen (pabst, 1987) . immunohistochemical study in rats demonstrates the presence of w3/13-positive t (cd43) cells in the interfollicular area. in the rat, many cells with macrophage morphology also stain with the w3/25 (cd4) monoclonal antibody in the interfollicular zone (bland and warren, 1985; martin et al., 1986) . immunocytochemical study of the peyer's patches in the mouse has also shown considerable heterogeneity of staining patterns, particularly under the dome epithelium (ermak and owen, 1986) . similar patterns have been observed following immunohistochemical study of peyer's patches in man (spencer et al., 1986) . the epithelium overlying the peyer's patch follicles (dome area) contains specialised epithelial cells, called microfold, membranous or simply m cells. these cells have been identified in many species including rats, mice, hamsters, dogs, monkeys and man (owen and bhalla, 1983; wolf and bye, 1984) . these cells differ functionally from other enterocytes by their ability to transport large molecules such as ferritin and horseradish peroxidase and particulate matter from the lumen to the underlying lymphoid tissue (owen, 1977; jeurissen et al., 1985) . they have also been shown to be the site of penetration of reoviruses into the epithelium and they can transport vibrio cholerae and other organisms (wolf and bye, 1974; smith et al., 1987) . m cells therefore form weak points in the intestinal wall which transport intact antigen and macromolecules to the follicles where they can be processed and be transported to lymph nodes with consequent iga immune responses. this contrasts with the uptake of soluble antigens, which can be taken up by ordinary epithelial cells and transported in the circulation of the villi to be ultimately trapped in the spleen possibly to evoke an igm/ igg response (jeurissen et al., 1985) . understanding of these cellular and molecular characteristics is critical for the design of mucosal vaccines for pathogens that exploit this pathway (neutra, 1998) . no simple, specific histological markers for m cells have been identified for use in routine histological sections although many specialist techniques can be applied (reviewed by gebert et al., 1996) . this has hampered their study because they are still best identified on the basis of their ultrastructural characteristics or ability to capture and transport macromolecules (hamzaoui and pringault, 1998) . the m cell shares tight junctions and desmosomes with adjacent epithelial cells but it has fewer and shorter microvilli than absorptive cells. there is lack of a well organised terminal web. vesicles are abundant in the apical cytoplasm but lysosomes are reduced in number. attenuated cytoplasmic processes may be seen embracing lymphocytes (owen and nemanic, 1978; wolf and bye, 1984) . a cardinal feature is the presence of a intraepithelial pocket on the basal membrane which acts as an internal docking site for lymphocytes, such that they are filled by b and cd4 positive lymphocytes, macrophages and dendritic cells that move between underlying follicles and the epithelium (ermak et al., 1990; farstad et al., 1994) . with care, these attenuated microvilli can be seen at light microscopy in semithin plastic sections (wolf and bye, 1984) . cytochemical analysis has also demonstrated that they can be distinguished at light microscopic level by markedly reduced alkaline phosphatase activity on their terminal surface, in contrast to the dense reaction product produced by other enterocytes (owen and bhalla, 1983) . as the glycoproteins on the surface of m cells are different to those on surrounding cells, they can be selectively stained by labelled lectins, although these patterns are different in different species. for instance, mouse m cells are labelled by the fucose-specific probe ulex europaeus and to some extent anguilla anguilla (giannasca et al., 1994) . mucosal mast cells also appear to be involved in the immunological defence of the gastrointestinal tract. they respond by proliferation, migration and discharge of granules during nematode infestations (miller, 1980) . it has been shown in the rat that mucosal mast cells of the gut differ in several ways from connective tissue mast cells. these differences result in poor preservation of mast cells of the gut if the usual metachromatic staining techniques employed for the demonstration of mast cells in tissue sections (wingren and enerbã¤ck, 1983) . histochemical study suggests that mucosal mast cells differ from connective tissue mast cells by a lower degree of sulphation of glycosaminoglycans and different spatial relationships of protein and glycosaminoglycans in their granules. these cross link following formalin fixation in a way, which is sufficient to prohibit cationic dye binding. wingren and enerbã¤ck (1983) showed that these staining difficulties can be surmounted in tissues fixed in formaldehyde by staining in toluidine blue for prolonged periods of time (5-7 days), a procedure which allows adequate penetration of the toluidine blue molecule. optimal histopathological study of the small intestine is complicated by its length and mucosal fragility. it is important to avoid vigorous washing procedures or any form of excessive manipulation of the unfixed bowel, as artefact caused by washing may confound interpretation of changes induced by xenobiotics (roe, 1984) . combination of artefact due to washing, autolysis and the presence of neutrophils can produce a histological appearance that mimics in vivo damage. although careful visual inspection of the intestine and sampling of appropriate segments for histological examination is usually sufficient for routine examination, various forms of 'swiss roll' techniques are helpful for more complete study. rolling the unfixed, opened rodent intestine around a wooden stick prior to freezing or fixation is one proposed method (moolenbeck and ruitenberg, 1981) , although this method risks undue manipulation of the unfixed tissue. another more versatile technique applicable to rodent, large animal and human intestine can be performed after fixation. the unfixed opened bowel is pinned flat on a cork or board and fixed in a bath of formal saline. after fixation, the full thickness of rodent intestine can be rolled, transfixed by a pin and embedded in paraffin wax. likewise the mucosa of the intestine of large animal species or humans can be rolled after fixation by separating it from the muscularis externa (filipe and branfoot, 1974) . inflammation and ulceration of the mucosa occurs as a result of stress, infection with bacteria, viruses, and infestation by parasites or as a direct result of the effects of xenobiotics or ionising radiation. antimitotic or radiomimetic agents as well as ionising radiation are liable to adversely affect the rapidly dividing cells of the small intestine with resulting breakdown of the mucosal barrier. the ulcerogenic activity of non-steroidal anti-inflammatory drugs may also be expressed in the small bowel mucosa. different agents also act in synergy to enhance damage to the small bowel mucosa. an important example is the effect of drugs that depress the immune system and permit the development of pathological infections by microorganisms of the opportunistic type in the small intestine. the histological features of the inflammatory process in the small intestine are not usually specific for a particular agent. it is important to search for evi-dence of microbiological organisms and viral inclusions, which can indicate the cause of intestinal inflammation and ulceration. associated features in non-ulcerated mucosa such as morphology of the villi, accumulation of abnormal cells or foreign substances and changes in lymphoid cells or blood vessels are also important in the assessment of these changes. a number of organisms including those, which are normal residents of the gastrointestinal tract, can cause inflammatory changes in the intestinal mucosa of laboratory animals. with the notable exception of non-human primates, inflammatory bowel disease caused by microbiological organisms is not usually evident or of concern in most toxicity or carcinogenicity studies. however, when animals are treated with antibiotics, immunosuppressive agents or other drugs, which alter the normal intestinal flora, conditions may favour the proliferation of potentially pathogenic organisms in sufficient quantities to cause overt damage to the mucosa. certain bacterial flora may also act synergistically with intestinal protozoans to produce pathological changes (boorman et al., 1973) . in non-human primate colonies, gastrointestinal disease remains one of the most important causes of death . in contrast to other laboratory species, histological evidence of intestinal infectious disease is relatively common and may confound the interpretation of gastrointestinal alterations occurring in toxicity studies. although the majority of potentially pathogenic organisms affect the primate colon, a number of bacteria, protozoa and metazoa occur in the small intestine. a detailed review of the protozoa and metazoa occurring in the primate gastrointestinal tract has been published (toft, 1982) . owen (1993) has reviewed the parasites of laboratory animals including those of the gastrointestinal tract and the principle reference for identification of metazoa in tissue sections remains that of chitwood and lichtenfels (1973) . organisms which can cause inflammatory disease in the small bowel but which are primarily agents that produce inflammatory disease in large bowel are reviewed under 'colon' (see below). bacillus piliformis is the agent responsible for tyzzer's disease produces intestinal inflammation and ulcers in rats, mice and hamsters. susceptibility of different species and strains to experimental infection with bacillus piliformis is variable. for instance, c57bl, balb mice and f344 rats appear more resistant to infection than outbred syrian hamsters (waggie et al., 1987) . lesions of variable severity usually occur in the ileum but may also extend into the caecum and colon. severe infections are characterised histologically by ulceration of the mucosa, oedema and acute inflammation of the submucosa and muscle coats. muscle may also show focal necrosis. non-ulcerated mucosa is typically infiltrated by polymorphonuclear cells and crypt abscesses form. there is blunting and fusion of villi and reactive hyperplasia and mucin depletion of the overlying epithelium . mucosal lymphoid tissue may also show reactive changes or hyperplasia. filamentous bundles of bacillus piliformis can usually be found in the cytoplasm of both epithelial cells and smooth muscle cells at the edges of necrotic zones. methylene blue, giemsa or silver impregnation techniques such as warthin-starry or levaditi stains are the best stains for the demonstration of these organisms although with care they can be visualised in haematoxylin and eosin stained sections (weisbroth, 1979) . they are gram negative and pas positive. intestinal infections due to salmonella species are relatively common in the mouse but also occur in the hamster and rat . salmonella typhimurium and salmonella enteritidis are regarded as the organisms typical of murine salmonellosis (weisbroth, 1979) . lesions occur in the ileum and may extend into the jejunum and caecum. they are characterised by the presence of ulcers covered by fibrinous exudate and associated with diffuse infiltration of the adjacent mucosa by macrophages, neutrophils and lymphocytes. intact crypt epithelium shows mucin loss and reactive proliferative changes. a characteristic feature is the presence of poorly defined granulomatous lesions composed of macrophages mainly in associated lymphoid tissue or peyer's patches. clostridia species, especially clostridia difficile which cause a pseudomembranous colitis in man and laboratory animals (especially hamsters) may also produce inflammation and ulceration in the terminal ileum with histological features similar to those found in the colon (see following). proliferative ileitis (transmissible ileal hyperplasia) is a striking lesion of hamsters affecting the distal segment of the ileum that is associated with intracellular invasion of the intestine mucosa epithelium by bacteria. the organism has not been cultivated, but has been suggested that it is a campylobacter (jacoby, 1985) although other organisms have been identified in this condition (fox et al., 1993; peace et al., 1994) . although it is characterised by hyperplasia of the ileal mucosa in its early stages, an inflammatory phase intervenes in which there is focal necrosis and haemorrhage of the mucosa, crypt abscesses and infiltration of the lamina propria by acute inflammatory cells and macrophages. the histological features of the associated hyperplasia are characteristic. the mucosa is covered by immature, mucin-depleted pseudostratified hyperchromatic epithelium with mitoses extending to the tips of villi and densely basophilic intracytoplasmic inclusions (jacoby, 1985) . helicobacter jejuni (campylobacter jejuni) is a common cause of diarrhoea in man and may be the causative agent in small intestinal inflammation in laboratory dogs and primates. campylobacter species may be more prevalent in beagle dogs and primates than commonly appreciated. it is important to recognise that dogs colonised with these agents may be susceptible to stress-induced, acute onset gastroenteritis (fox et al., 1988; reed and berridge, 1988) . in man this form of bacterial disease is characterised histologically by mucin-depletion, flat-tening and reactive changes in the small bowel epithelium, crypt abscesses, oedema and infiltration of the mucosa by neutrophils, lymphocytes and plasma cells. similar histological findings have been reported in dogs infected with this organism (prescott and monroe, 1982) . the organisms are gram-negative curved, slender rods, which can be visualised in tissue sections with the warthin-starry stain, a recognised technique for spiral bacteria. the carbol fuchsin technique of gimenez (1964) , first used for the identification of ricketsiae in yolk sac culture and a cresyl fast violet technique are also useful methods for the identification of campylobacter species in paraffin sections (burnett et al., 1987; mcmullen et al., 1987) . another campylobacter-like organism, helicobacter pylori (campylobacter pylori) has been identified in human patients with gastritis, gastric and duodenal ulcers. it is an aetiological or predisposing factor in these forms of gastrointestinal disease (marshall and warren, 1984; rouvroy et al., 1987; richter-dahlfors et al., 1998) . spironucleus muris (hexamitis muris) is also a cause of inflammation in the small bowel of rats, mice and hamsters. during overt infestation, organisms are seen extracellularly in crypts and intervillous spaces associated with blunting of intestinal villi, epithelial degeneration and mucin-depletion, reactive epithelial hyperplasia, oedema and leucocyte infiltration (boorman et al., 1973; wagner et al., 1974) . the morphological expression of damage is accompanied by decreased levels of disaccharidases such as maltase, sucrase and lactase, which may represent a direct effect of the trophozoites on the brush border enzymes (gillon et al., 1982) . trophozoites are characteristically elongated symmetrical flagellates approximately 2-5 âµm wide, 12-20 âµm long. giardia species represent marginally pathogenic flagellates, which are found in the upper gastrointestinal tract. they are opportunistic agents that can become important in both animals and man with depressed immune function. studies in mice infected experimentally with giardia muris have shown that an early response is an increased infiltration of the epithelium by lymphocytes, predominantly t cells (gillon et al., 1982) . this has led to the suggestion that the response to infection by these parasite is primarily a cell-mediated immune reaction similar to experimental graft versus host reaction in the small intestine of mice (mowat and furguson, 1981; gillon et al., 1982) . depression of the immune response by treatment with corticosteroids has been shown not only to increase parasite numbers in murine giardiasis but also cause recrudescence of occult infections (nair et al., 1981) . it has also been suggested that decreased gastric acidity can predispose to giardiasis in man (nalin et al., 1978) . giardia muris (lamblia muris) is sometimes found in the small intestine of rat and mouse but it is common in the hamster (fig. 50) . trophozoites appear in histological sections as crescent-shaped structures on the brush border of the intestinal mucosa or in the adjacent lumen. mucosal lesions may be totally ab-sent or there may be blunting of villi, reactive epithelial hyperplasia. a typical feature is increased infiltration of the epithelium and lamina propria by mononuclear cells (boorman et al., 1973) . another important finding is that lactase, sucrase and maltase levels have been shown to decrease in the small intestine in mice infested with giardia muris (gillon et al., 1982) . giardia lamblia may colonise the small intestine of non-human primates and of man and produce similar morphological appearances to those found with infestations in rodents by giardia muris. other flagellates such as tritrichomonas muris are also be found in the small intestine of mice, rats and hamsters. the coccidian protozoan parasite cryptosporidium represents a striking example of the close relationship between some human and animal diseases. this organism was first recognised in the gastric glands of mice by tyzzer in 1907 and has since been confirmed as a cause of diarrhoea in animals and as a human pathogen. it causes mild diarrhoea in normal subjects especially children and young adults but it can produce severe intestinal disease in immunocompromised individuals (casemore et al., 1985) . histological examination of the small intestine of laboratory animals infested by cryptosporidium reveals the presence of organisms attached to the mucosal surface, often associated, as in man, with other parasites or infections. they are rounded, weakly basophilic structures 1-4 âµm diameter in haematoxylin and eosin stained sections but are strongly basophilic following romanowsky staining. transmission electron microscopy reveals the detailed internal structure of cryptosporidium attached to the microvillous surface of the epithelial cells. the various stages in the life cycle have been visualised by light and electron microscopy. infection starts with ingestion of an oocyst containing four sporozoites, which are probably released by the action of digestive enzymes. these attach themselves to the intestinal mucosa and undertake their life cycle attached to the epithelial cells (casemore et al., 1985) . these organisms have been demonstrated in laboratory species including mice, hamsters, rabbits, dogs and nonhuman primates (cockrell et al., 1974; rehg et al., 1979; toft, 1982; fukushima and helman, 1984; davis and jenkins, 1986) . hymenolepis nana (dwarf tapeworm) and hymenolepis diminuta (rat tapeworn) are described in the intestine of rats, mice, hamsters, non-human primates and man (hsu, 1979) . a variety of other metazoan patients are found in the small intestine of non-human primates, see review by toft (1982) . certain viruses produce inflammatory small bowel changes in mice. mouse hepatitis virus (lethal intestinal virus of infant mice) can cause mucosal epithelial necrosis and inflammation with characteristic compensatory epithelial hyperplasia and the formation of epithelial syncytia . murine rotavirus (epidemic diarrhoea of infant mice) produces swollen enterocytes of small and large bowel with fine cytoplasmic vesiculation with little or no inflammation but dilated lymphatics and vascular congestion. cytoplasmic acidophilic inclusions, 1-4 âµm diameter, are characteristic findings . electron microscopic examination shows cytoplasmic vesicles arising from the rough endoplasmic reticulum, which contain virus particles and electron dense granular material . a mouse adenovirus may also produce large basophilic intranuclear inclusions in the epithelial cells of the small intestine and caecum. k virus infection produces lesions in the jejunal and ileal mucosa of mice. histological features are characterised by mild polymorphonuclear infiltration, with ballooning of occasional endothelial cells within intestinal villi. intranuclear inclusions can be demonstrated in these endothelial cells by light microscopy using appropriate fixation (greenlee, 1985) . a variety of viruses have been isolated from the gastrointestinal tract of nonhuman primates including viruses of man (kalter, 1982) . however, they appear to be relatively infrequent causes of gastrointestinal disease and when disease is caused by these viruses it usually affects other organs. not only can non-steroidal anti-inflammatory agents such as indomethacin and phenylbutazone produce gastric ulceration but also penetrating ulcers of the small bowel of laboratory animals (shriver et al., 1975) . imaging studies with 111 indium-labelled leukocytes in man have also suggested that subclinical intestinal inflammation is associated with long-term therapy with non-steroidal anti-inflammatory drugs (bjarnason et al., 1987) . it has been postulated that indomethacin-induced intestinal ulcers in rats and dogs are produced by a prostaglandin-independent mechanism, different from the manner in which gastric ulceration is induced (tabata and okabe, 1980; whittle, 1981) . conversely, satoh et al. (1981) have suggested that similar mechanisms are responsible for both gastric and intestinal ulceration. they showed that indomethacin-induced gastric ulceration developed in the body mucosa in fasted rats but in the antrum and small intestine in rats given indomethacin 30 minutes after a 1-hour period of refeeding following a 24-hour fast. there was good temporal correlation between the development of intestinal ulcers and inhibition of prostaglandin synthesis (satoh et al., 1981) . the ulcers in the small intestine were morphologically similar to those occurring in the stomach and they were distributed mainly in the mucosa on the mesenteric aspect of the bowel wall. single-dose studies with indomethacin and ibuprofen in rats conducted by suwa et al. (1987) have demonstrated differences between pathology of induced gastric and intestinal damage. gastric damage was superficial, occurred within 6 hours and was fully repaired 2 weeks after dosing. ulcers in the jejunum and ileum reached a maximum area at 48-72 hours after dosing, occurred on the mesenteric border, penetrated through the muscularis mucosa and were accompanied by inflammation and oedema. ulcers were still present 2 weeks later. rainsford (1978) has shown that potent intestinal ulcerogens such as indomethacin inhibit the incorporation of radioactive 35 s sulphate into glycoproteins of the upper intestinal mucosa as well as the stomach of rats. this may decrease the capacity of the mucus in the intestine to act as a buffer for hydrogen ions. indomethacin given orally to dogs in doses of 2.5 mg/kg/day for 1-23 days was also shown to produce intestinal ulceration. these ulcers were deep, punchedout lesions, many of which were lying over peyer's patches (stewart et al., 1980) . some ulcers involved the whole circumference of the small intestine wall. histologically, the ulcers were associated with an intense inflammatory response principally of mononuclear cells, which infiltrated the bowel wall to the serosa particularly adjacent to peyer's patches. it was suggested that this distribution of ulcers was a result of an exaggerated immune response to normal intestinal antigens. these antigens may have been produced by inhibition of suppresser cells in peyer's patches, following depression of prostaglandin synthetase by indomethacin (stewart et al., 1980) . special dye techniques, scanning and transmission electron microscopy have also shown that non-steroidal anti-inflammatory drugs also produce adverse effects on the small intestine mucosa without overt pathological changes being evident by light microscopy (brodie et al., 1970; djaldetti and fishman, 1981) . following administration of aspirin to mice for 5 weeks, shortening and erosion of microvilli and increased numbers of goblet cells were only demonstrated in the duodenum and jejunum by scanning and transmission electron microscopy (djaldetti and fishman, 1981) . morphometric studies of the intestinal mucosa of indomethacin-treated mice have also shown widespread alterations to columnar cells, goblet cells and paneth cells suggesting generalised effects on mitotic activity and crypt loss (ettarh and carr, 1996) . such submicroscopic findings support the idea that non-steroidal anti-inflammatory agents may induce damage to the small intestine more commonly than supposed. although non-steroidal, anti-inflammatory drugs are the best-known drugs with adverse effects on gastrointestinal mucosa, small intestinal inflammation and ulceration can also produced by other agents through different mechanisms. anticancer drugs and other therapeutic agents, which affect cell proliferation, depress the bone marrow or the immune system can also produce intestinal mucosal necrosis, haemorrhage, inflammation and opportunistic gastrointestinal overgrowth when administered to dogs or rodents in high doses (fig. 51 ) bregman et al., 1987) . lymphoid infiltrates without tissue fig. 51 . section of small intestine from a wistar rat treated with a 5-day course of an antiproliferative anticancer drug. the mucosa shows mucus-depletion, loss of villous architecture as well as a reparative and inflammatory response. (he, ã�25.) damage were also reported in the small intestine of rats treated with human recombinant interleukin-2 (anderson and hayes, 1989) . agents of particular toxicological interest are cysteamine, propionitrile and their structural analogues as well as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp) which are capable of producing ulcers of chronic type in the duodenum of rats and mice (szabo and cho, 1988) . these compounds vary in their ulcerogenic capacity but they are all able to produce ulcers of chronic type with crater formation, granulation tissue and reactive changes in adjacent mucosa in the anterior and posterior wall of the proximal segment of the duodenum of rodents. although these different agents influence gastric acid secretion in different ways, structure-activity relationships suggest that they produce duodenal dysmotility, decrease bicarbonate production and reduce its delivery from the distal to proximal duodenum. these factors decrease the neutralisation of gastric acid in the first part of the duodenum and this may contribute to the development of ulceration (szabo and cho, 1988) . furthermore, these effects can be attenuated or prevented by dopamine agonists or their precursors whereas dopamine antagonists can potentiate their effects. this suggests that the central or peripheral dopamine-mediated actions of these agents may be involved in the pathogenesis of duodenal ulceration (szabo, 1979; . using appropriate fixation and staining procedures, fine granular lipid droplets can be normally visualised in the apical parts of epithelial cells covering the upper third of small intestinal villi. administration of drugs and chemicals may produce an excessive accumulation of lipid through specific effects on lipid metabolism or as part of general cellular toxicity. in the preclinical toxicity studies with 2,6-di-tert-butylamino-3-acetyl-4-methylpyridine (sa h51-055), an inhibitor of glucose transport intended for use as an anti-obesity drug, lipid accumulation occurred in the lamina propria of the small intestinal villi of sprague-dawley rats and guinea pigs but not in dogs or primates (visscher et al., 1980) . after administration of sa h51-055 to rats, there was progressive accumulation of lipid droplets in the epithelial cells over the tips of the duodenal villi demonstrable by osmium tetroxide staining. ultrastructural examination revealed uniform electron-lucent droplets within profiles of the smooth endoplasmic reticulum and golgi apparatus. lipid droplets increased with time, accumulated and coalesced to form large droplets in the lamina propria. larger droplets were phagocytosed by macrophages in the lamina propria but there was no evidence of epithelial damage or necrosis. changes were most pronounced in the duodenum but were also noted to a lesser extent in jejunum and ileum but not in colon or stomach. sequential studies using electron microscopy showed that lipid rapidly accumulated within several hours in the profiles of smooth endoplasmic reticulum and golgi apparatus of the epithelial cells and formed droplets or chylomicra in the intercellular space. the absence of any other subcellular changes or evidence of derangement of protein synthesis suggested that sa h51-055 altered the pathways of lipid resynthesis or transport. this was consistent with the distribution of the lipid in the upper third of the jejunal villous epithelium, a zone most active in lipid absorption, resynthesis and transport (dobbins, 1969) . it was suggested fatty change might have taken place because of alterations in the sugar moiety of chylomicra brought about by interference with glucose transport (visscher et al., 1980) . lipid droplets which stained with oil-red-o in formalin-fixed frozen sections and showed uniform electron density characteristic of neutral lipid were also observed in the epithelial cells and macrophages in the lamina propria of jejunum and duodenum and mesenteric lymph nodes in rats given a synthetic 2'-dodecyl glutaramide ester of erythromycin (gray et al., 1974) . unlike the erythromycin base, rats poorly tolerated this ester. it appeared that the ester was absorbed unhydrolyzed and converted to chylomicron-like droplets, which then accumulated in the macrophages of the lamina propria and local mesenteric lymph nodes, without overt damage to epithelial cells. accumulation of lipid in epithelial cells of intestinal villi has been observed in rats following administration of puromycin (friedman and cardell, 1972) and ethionine (hyams et al., 1966) , agents which have inhibitory effects on protein synthesis. detailed morphological study of the intestinal epithelial cell in rats treated with puromycin have shown that there is concomitant accumulation of lipid with a decrease in the quantity of rough endoplasmic reticulum and golgi membranes (friedman and cardell, 1972) . these changes were in keeping with the concept that lipid accumulates as a result of inhibition of the synthesis of membrane components of the golgi by the rough endoplasmic reticulum which are important for the transport of lipid. in addition to lipid droplets forming as a result of altered lipid metabolism, they may form in the epithelial cells of the intestinal mucosal as a result of a direct toxic effect of the ingested drugs on the small intestinal mucosa. in such instances atrophy of villi and degenerative changes in the epithelial cells may also be observed (see following). the small intestinal mucosa is also one of the many sites at which drug-induced accumulation of polar lipids form laminated structures (myeloid bodies) or crystalloid structures within lysosomes. this form of lipid storage disorder is produced by diverse amphiphilic cationic drugs in both man and laboratory animals probably as a result of drug interaction with polar lipids rendering them difficult to digest (lã¼llmann-rauch, 1979) . species differences in susceptibility and tissue distribution of phospholipid are probably not only related to physiochemical characteristics of the inducing drugs which influences their ability to permeate selective biomembranes and react with different lipids, but also to tissue concentrations of drugs achieved and the ability of organs to metabolise parent drug to less amphiphilic products. in general terms, this form of disorder is characterised by membrane-bound, acid phosphatase-positive cytoplasmic inclusions, which on ultra-structural study are seen as lamellated or crystalloid structures in lysosomes. these appearances are characteristically reversible on cessation of treatment with the inciting agent. an example of this phenomenon occurring in the small intestine is provided by the iodinated amphiphilic drug, amiodarone, which has been used clinically in europe for the past 20 years in the treatment of angina and more recently in the control of supraventricular cardiac arrhythmias. its adverse effects in man are believed to be the result of accumulation of drug in lysosomes particularly in liver, skin and eye (d'amico et al., 1981; shepherd et al., 1987) . when high doses of amiodarone were administered orally to rats and beagle dogs, multilamellated lysosomal inclusion bodies accumulated first in the jejunal mucosa and mesenteric lymph nodes before becoming widely distributed in other organs particularly in the lungs (mazuã© et al., 1984) . in both rats and dogs the small intestinal lesions were characterised by the presence of foamy macrophages with pale finely vacuolated cytoplasm and condensed eccentric nuclei within the lamina propria of the jejunal villi (mazuã© et al., 1984) . mesenteric lymph nodes were also involved early after the onset of treatment. in the dog, jejunal villi were somewhat flattened and widened or showed a variable degree of villous atrophy, most marked in the proximal and middle jejunum (vic et al., 1985) . electron microscopy confirmed the presence of lamellated lysosomal bodies distending macrophages. the early accumulation of foam cells in the jejunal macrophages was probably a reflection of the disposition of drug following oral absorption. although similar lipidosis was seen in many organs following intravenous administration in dogs, more lipidosis was seen in the jejunum after oral dosing. moreover, there were species differences in sensitivity to these changes, baboons being relatively insensitive compared to dogs. fischer 344 rats were very sensitive to these changes compared to sprague-dawley rats and wistar rats were almost completely resistant to lipidosis induced by amiodarone under similar conditions (mazuã© et al., 1984) . similar cytological changes have been reported in cells of some organs in patients treated with amiodarone (d'amico et al., 1981; shepherd et al., 1987) . villous shortening or stunting results when the proliferative activity of the crypt epithelium is reduced or under circumstances in which crypt cell proliferation is insufficient to compensate for increased cell loss as a result of mucosal cell damage. decreased cell proliferation can be seen segments, which are surgically bypassed, or following decreased food intake, parenteral nutrition, hypophysectomy or thyroidectomy bastie et al., 1982) . as adrenergic factors are important in the control of small intestinal epithelial cell division, drugs that alter î± or î² adrenoreceptor activity may influence the proliferative capacity of the epithelium. in mice, increased î±1 or î² receptor stimulation by appropriate agonists (e.g. phenylephrine) diminishes proliferation of crypt cells but proliferation is increased by stimulation of î±2 receptor activity (kennedy et al., 1983) . yohimbine, a î±2-antagonist also reduces cell proliferation in the same animal model. some of the effects of these agents may be mediated by changes in splanchnic blood flow . the detailed morphological study of the small intestinal mucosa in the rat following hypophysectomy by bastie et al. (1982) has shown a reduction in the height of the small intestinal villi associated with reduction in mitoses in the crypt epithelium. the number of goblet cells was shown to fall particularly in the jejunum and the number of paneth cells increase in the ileum. ultrastructural examination showed decreased height of the microvilli of absorptive cells and a lower number of their intracytoplasmic organelles and ribosomes. there were also significant decreases in brush border enzyme activities of alkaline phosphatase, aminopeptidase, maltase and lactase reported about 1 week following hypophysectomy. substances which reduce mitotic activity and therefore lower regenerative capacity of the intestinal epithelium also produce shortening or stunting of small intestinal villi and eventually flattening of the mucosa. a wide variety of anticancer agents and antiviral drugs with radiomimetic properties interfere with cell division in the crypts thereby reducing the number of epithelial cells produced. histologically, the effects of such agents are characterised by blunting, shortening or complete atrophy of villi. mitotic activity is reduced in the crypts and the crypts become dilated and lined by flattened cells. the overlying epithelium loses its normal regular arrangement and cells show pleomorphic nuclei with irregular chromatin patterns. increased numbers of inflammatory cells may infiltrate the lamina propria and epithelium. ulceration, haemorrhage and secondary infection of the gut wall ensue if there is overwhelming cell damage. comparison of the gastrointestinal toxicity expressed by antimitotic anticancer drugs of different classes in rodents, dogs, non-human primates and man have suggested that there is a higher degree of correspondence between effects in man and dog than between man and other species (owens, 1962; schein et al., 1970) . in studies with the antiviral agent acyclovir, a radiomimetic effect was noted in the gastrointestinal tract of dogs at high doses but not rodents (tucker et al., 1983) . another example is the villous atrophy described in rats following treatment with an antibacterial agent ici 17,363. this was believed to arise as a result of both interference with cell division and a direct effect on the surface epithelial cells (murgatroyd, 1980) . the effects of ici 17,363 were characterised by atrophy of villi with dilatation of crypts and atypical features in the crypt epithelium suggestive of an effect on mitotic activity. in addition, vacuolated lipid-laden epithelial cells were observed over the tips of villi accompanied by reductions in the numbers of goblet cells and reduced activity of acid and alkaline phosphatase, esterase, adenosine triphosphatase, glucose-6-phosphatase and succinic dehydrogenase, compatible with a direct adverse effect on superficial mature epithelial cells. a variety of factors stimulate cell proliferation in the small intestinal epithelium. these include enterectomy, increased feeding and stimulation of autonomic nerves. administration of neurotransmitters, thyroxine, growth hormone, corticosteroids, testosterone, gastrin, glucagon and recombinant epidermal growth factor may also stimulate epithelial cell proliferation breider et al., 1996; reindel et al., 1996; vinter-jensen, 1999) . in rats hypothalamic damage, hyperthyroidism, tube feeding, diabetes mellitus and insulin injections have been shown to produce intestinal hyperplasia (mackay et al., 1940; levin and smyth, 1963; jarvis and levin, 1966; forrester, 1972) . most causes of greater cell production lead to increased villous height and mucosal hyperplasia, although intense crypt cell proliferation as a compensatory regenerative response can be associated with villous atrophy (see previous). the compensatory response to the surgically resected or bypassed intestine has been the focus of the most detailed studies of increased cell renewal in the small intestine. partial resection in both rats and man is accompanied by increased villous height and crypt length (hanson et al., 1977) . this is primarily the result of hyperplasia for it has been shown that the numbers of cells per unit length of villus remains unchanged (hanson et al., 1977) but there is an overall increase in the cell population of villus and crypt (hanson and osborne, 1971) . dna/rna ratios also remain largely unaltered . no gross changes in villous shape have been reported after resection and the total number of crypts remains constant. although increased intestinal uptake of substances from the bowel lumen occurs in hypertrophied segments per unit length of bowel, disaccharide and dipeptidase activities are normal or even decreased after resection suggesting a comparative immaturity of cells in the residual mucosa. functional adaptation therefore is achieved by a larger number of cells, the individual absorptive capacity of which is not increased . increased numbers of specific goblet cell populations are also seen in hyperfunctional states. following jejuno-ileal bypass operations in rats, increased numbers of pas-positive goblet cells develop in the villi and crypts of the hyperfunctional segments of the duodenum, jejunum and ileum (olubuyide et al., 1984) . mucin histochemistry using the high-iron diamine and alcian blue techniques have shown that the goblet cells in the hyperfunctional segments contain increased sialomucins in the villi and crypts of the jejunum and ileum but not in the duodenum and increased sulphomucins in the distal ileal segment. sialomucin production may reflect relative cellular immaturity of the more rapidly proliferating cells under these circumstances. however, as sialic acid conveys more viscoelastic properties to mucin, it has been suggested that the goblet cells change following intestinal bypass fulfils a protective function against the increased flow of gastrointestinal contents (olubuyide et al., 1984) . a number of nutritional factors, particularly dietary fibre, can influence the proliferative characteristics of the small bowel mucosa. carefully controlled studies in rats given different forms of dietary fibre have shown that the prolif-erative characteristics of the small intestine can be modified by both the quantity and the quality of the fibre. one study has shown a decrease in the length of villi, crypt cell hyperplasia and shorter transit times in rats fed pectin-supplemented diet but an increase in mucosal growth without alteration in relative differences in crypt and villous length with guar supplementation compared with rats fed fibre-free diet (jacobs, 1983) . another rat study has shown that pectin feeding leads to increased mucosal area and height associated with an increase muscle mass (stark et al., 1996) . these different effects may be the result of differences in solubility, gel formation, water holding capacity, effect on transit time and ion exchange activity or bile acid adsorption of the different fibres. interactions between dietary constituents are complex. for instance, in rats the effects of 2% dietary cholestyramine, a non-absorbable ion exchange resin, on small intestinal histomorphology have be shown to depend on interaction of dietary factors (burkhardt et al., 1998) . administration of an inhibitor of cholesterol biosynthesis, 5î±-cholest-8-(14)en-3î²-ol-15-one, to rats for up to 9 days was also shown to produce enlargement of the small intestine in a way which was morphologically similar to the changes found following intestinal bypass (smith et al., 1989) . the enlargement was most marked in the proximal segment of the small intestine and progressively diminished towards the ileocaecal junction, sparing the stomach, caecum and colon. histological examination and morphometric analysis revealed an increase in smooth muscle mass, lengthening of the villi as well as an increase in the depth and cellular proliferation in the crypts of lieberkuhn without evidence of cell damage or fatty change. like the changes following jejunal bypass procedures, there was also an increase in acid mucosubstances in the goblet cell population overlying the villous mucosa (smith et al., 1989) . the mechanism for this change in the rat was not clear, particularly as intestinal hyperplasia was not seen in baboons treated with this 15-ketosterol for long periods. however, it was suggested that it was an adaptive response, possibly related to inhibition of cholesterol metabolism and cholesterol absorption from the diet, particularly as the laboratory diet employed in the rat study was particularly low in cholesterol. local and systemic changes in hormones and various transmitter substances also influence the number of cells in the small intestinal epithelium. morphometric studies of the small intestinal mucosa in mice following gastrin administration have shown increases in villous area associated with decreases in microvillous area, increased number of goblet cells and paneth cells . studies in which rats were treated with the prolactin-inhibitor, ergocryptine, have shown that the total number of mucous cells and the number staining with alcian blue at ph 1.0 increase in the ileal crypts, possibly as a result of increased synthesis of sulphated mucosubstances (gona, 1981) . in this context, it is of interest that chronic treatment with the rauwolfia neuroleptic, reserpine, causes an increase in the sulphation of goblet cell mucin in the small intestine as demonstrated by alcian blue staining at ph 1.0 and the high iron diamine technique without changes in the goblet cell numbers (park et al., 1987) . agents which affect activity of the sympathetic nervous system can also alter epithelial cell proliferation in the small (and large) intestine. treatment of rats with adrenaline, isoprenaline, phenylephrine, phentolamine and yohimbine all result in decreased mitotic activity of jejunal and colonic crypt cells (tutton and helme, 1974; kennedy et al., 1983) . by contrast, administration of metaraminol, clonidine, propranolol, prazosin and labetolol as well as simultaneous injection of propranolol and adrenaline all resulted in an increased rate of crypt cell proliferation (kennedy et al., 1983) . these results suggest that agents that stimulate î±2 adrenergic receptor activity and those that are î±1-antagonists and î²-adrenergic receptor antagonists increase proliferative activity in the rodent intestinal mucosa. caffeine is also reported to produce an increase in thickness of the intestinal mucosa when administered in high doses to rats (lachance, 1982) . this raises the possibility that intestinal mucosal hyperplasia can be produced by phosphodiesterase inhibition and resultant increases in intracellular camp in a similar way to the hypertrophy induced in salivary tissue. this is supported by recent findings in rats treated for periods of up to 6 months with the inotropic vasodilator, ici 153,110, a phosphodiesterase inhibitor intended for treatment of congestive cardiac failure. administration of high doses not only produced salivary gland hypertrophy but also marked thickening of the small and large intestinal mucosa. this was characterised histologically by an increase in villous length and deepening of intestinal glands, with a relatively unchanged number of epithelial cells per unit length of gland or villus (westwood et al., 1990) . although prostaglandin e analogues produce most of their effects in the stomach, increased thickness of the small intestine characterised by longer villi, deeper crypts and increase in cell size have been reported in rats treated with these agents (levin, 1988) . focal hyperplasia, focal avillous hyperplasia, focal atypical hyperplasia, duodenal plaque, polypoid hyperplasia, polyp -mouse irregular, atypical single or multiple foci of glandular hyperplasia may be found in the small intestinal mucosa of several strains of aged, untreated mice. the lesions are usually located in the first part of the duodenum where they form discrete, raised plaques composed of elongated, irregular or branched glands which replace the normal villous structure of the mucosa (rowlatt and chesterman, 1979) . the glands are lined by hyperchromatic columnar cells, which show marked pseudostratification and proliferative activity. paneth cells and mucinsecreting goblet cells may also be prominent. some glands are cystic and the stroma is fibrous and infiltrated by chronic inflammatory cells. the lesions become pedunculated or polypoid in appearance and show a fibrovascular core that is infiltrated by inflammatory cells. they resemble adenomatous polyps described in man. the cause of these changes in the mouse small intestine is unknown but their prevalence can be altered by dietary fibre and panthothenic acid deficiency as well as by administration of drugs and chemicals (hare and stewart, 1956; seronde, 1965; ito et al., 1981) . in their study of dba mice, hare and stewart (1956) considered that the lesions were not genuine neoplasms since they were composed of a mixture of cell types, which normally populate the mucosa. furthermore, they suggested that the presence of an inflammatory component in the stroma and the fact that the prevalence of these lesions was increased in mice fed a high roughage diet were consistent with the concept that they represent an inflammatory adenomatoid hyperplasia. seronde (1965 seronde ( , 1970 reported these lesions in mice fed purified diets, particularly when deficient in panthothenic acid. panthothenic acid deficiency was also associated with inflammation and deep penetrating chronic ulcers of the duodenum in affected mice, compatible with an inflammatory aetiology of the lesions. an increase in the prevalence of these duodenal changes was described in cd-1 mice treated with the synthetic prostaglandin e1 analogue, misoprostol for 21 months . these authors suggested that the findings posed no real concerns for the safety of patients treated with misoprostol on the grounds that the mouse was unique in this aspect of the response to misoprostol because the mouse had a particular liability to develop such changes in the small intestine. the proliferative lesions were found in a few control cd-1 mice in the same study. in addition, it was also argued that the lesions were neither neoplastic nor preneoplastic in nature . they were not seen in rats treated with misoprostol for 2 years . lesions characterised by such intense proliferative activity may be difficult to distinguish from neoplastic lesion. indeed chronic administration of hydrogen peroxide to c57bl/6j mice in drinking water was not only shown to potentiate the development of a similar type of duodenal hyperplasia but also to produce frankly invasive adenocarcinomas (ito et al., 1981) . anatomically the large intestine is broadly similar in man and laboratory animals but there are significant functional differences. the rat colon is probably one of the best studied of the laboratory animal species because the rat is widely used for experimental work on colon carcinogenesis . as the canine model is popular for oral dosage-form testing, differences in colonic physiology between dog and man may be better understood than between man and many other species (dressman, 1986) . in man, as well as in the non-human primates, the large intestine can be divided anatomically into caecum, appendix, ascending colon, transverse colon, sigmoid colon rectum and anal canal. like the small bowel, the colon comprises mucosa, submucosa, muscularis mucosa and serosa. mucosal plicae are only found in the rectum although plicae semilumaris, formed by folds of the entire thickness of the bowel wall, are found in the colon. the large intestine of the dog resembles that of man more than that of most other domestic species. it is a simplified tubular structure only slightly larger in diameter than the small intestine. the colon of the dog is divided anatomically into ascending, transverse and descending parts, but there is no well-defined sigmoid segment. the caecum in dog is a small diverticulum, similar to that found in other carnivorous species and it communicates directly with the colon. the colon of the rat and mouse is shaped like an inverted v that can be divided into ascending and descending segments. there is no clearly defined transverse colon. a characteristic feature in both rat and mouse is the presence of a curved kidney-shaped caecum. its size is intermediate between the large and anatomically complex caecum of herbivores such as the rabbit and the small caecum of carnivorous species. this probably reflects the omnivorous nature and flexibility of the rat and mouse in their dietary habits, particularly their ability to breakdown cellulose (rerat, 1978) . the caecum of the rat and mouse is a blind pouch from which the colon and ileum exit in close proximity and in which antiperistaltic movements occur. this structure and the presence of bacteria undoubtedly contribute to its ability to function as a fermentation organ in which breakdown of substances can occur in a reasonably controlled milieu (snipes, 1981) . in rat and mouse, the caecum is the site of absorption of many substances including calcium, magnesium, water and electrolytes vitamin k and fatty acids (snipes, 1981) . caecectomy has been shown to decrease digestion of carbohydrates and protein and increase loss of faecal water in these species (ambuhl et al., 1979) . the activity of intestinal microflora in the metabolism of both endogenous and exogenous substances has been demonstrated in the rodent caecum rowland, 1988) . the usual stock diets for rodents contain abundant plant fibre which provides bulk and fermentable carbohydrate for the microbial population in the caecum. rats fed stock diets have been shown to possess high levels of reductive and hydrolytic enzyme activity (e.g. azoreductase, nitroreductase, nitrate reductase, î²-glucosidase and î²-glucuronidase) in their caecal contents compared with rats fed purified fibre-free diets . intestines of germ free animals have thinner lamina propria, lower cell turnover, enlarged caecum, altered metabolism of cholesterol, bilirubin and bile salts and larger amounts of mucin in faeces compared with animals possessing normal gastrointestinal microflora (midtvedt, 1987) . species differences in microflora are also reported. comparative studies with human and rat intestinal microflora have suggested that each population of organisms possesses a degree of autonomous self-regulation and capable of responding quite differently to dietary changes (mallett et al., 1987) . comparative studies have shown large differences in the numbers of facultative anaerobic gram-negative bacteria in the gastro-intestinal tract of mice from three, major specific pathogen free units in australian laboratories. it was shown that these differences could influence the immune system, susceptibility to infection and experimental results (o'rourke et al., 1988) . the colon and caecum in man and laboratory animals are lined by a fairly uniform mucosa devoid of villi. columnar cells of two main types cover the surface epithelium. these are absorptive and mucous cells similar to those found in the small intestine. intestinal glands or crypts of lieberkuhn extend downwards from the surface generally as simple, unbranched tubules lined principally by mucous cells with smaller populations of absorptive, endocrine and undifferentiated cells. the mucosa in man and laboratory animals is not entirely flat but shows a slightly corrugated or uneven pattern, which varies with the particular site within the colon. in histological sections of the colon in man, this corrugated pattern is seen as an anthemion-like structure of crypts reminiscent of a greek architectural feature (filipe and branfoot, 1974) . this is also seen in larger laboratory animal species. in rats and mice the crypts of the caecal mucosa are wider near the lumen than in the crypt base and crypts may be branched, features which may be related to the absorptive function of this zone (snipes, 1981) . the proliferative zone in the large bowel is found in the lower part of the gland and mitotic figures are normally limited to this zone. as in the small bowel, multipotent, undifferentiated stem cells situated in the gland base give rise to the principle cell types which migrate to the cell surface with subsequent differentiation and alteration of their enzyme activities and morphological features (chang and leblond, 1971 ). in studies with mouse aggregation chimaeras in which mosaic cell populations of the intestinal epithelium were localised immunocytochemically, it was demonstrated that the entire epithelium of each adult gland descended from a single progenitor cell (ponder et al., 1985) . the single progenitor may itself give rise to several stem cells responsible for the cell renewal in the complete crypt. absorptive cells are found most commonly in the surface epithelium but also to a lesser extent in the glandular epithelium. they are morphologically similar to those in the small intestine each possessing apical plasma membranes with uniform microvilli and a well-formed glycocalyx. microvilli of absorptive cells have been shown by electron microscopic study to become longer and denser with increasing distance distally in the gastro-intestinal tract. thus, they are longer and more dense in the ileum than in the caecum and least dense and shortest in the colon, perhaps reflecting their relative absorptive capacity (snipes, 1981) . this is reflected at light microscopic level by the less conspicuous brush border in the large intestine compared with that in the small intestine. there are species and regional differences in the glycoconjugates found in the brush border of the large intestine, although they generally contain predominantly acidic mucosubstances. in the mouse and rat, sialomucins with some neutral mucins are found. in hamsters, dogs, non-human primates and man both sulphomucins and sialomucins may be seen in the brush border (sheahan and jervis, 1976) . the glycocalyx is important in the protective function of the colonic mucosa for its disruption by agents such as salicylates has been shown to increase absorption of xenobiotics from the rat rectal mucosa (sithigorngul et al., 1983) . although there has been some debate about the precise nature of the mucous cell populations based on structural studies in mice and rats (chang, 1981; , for practical purposes two principle types of mucous cell can be defined. one of these is the typical goblet cell with cytoplasmic mucous droplets forming a goblet shape, which is found both in glandular and surface epithelium. the other type, the so-called vacuolated cell or mucous cell, is found only in the crypts (chang and leblond, 1971; thomopoulos et al., 1983) . these vacuolated or mucous cells show empty-appearing vacuoles in the cytoplasm which rather than being empty contain abundant sialomucins of a type different from those in goblet cells (spicer, 1965; wetzel et al., 1966) . detailed structural studies and cytochemistry using lectin probes have suggested that these vacuolated cells are able to differentiate into absorptive cells with the cellular apparatus to produce the cell surface glycoconjugates of the glycocalyx (thomopoulos et al., 1983) . sulphomucins, as demonstrated by the high-iron diamine technique (table 2) , generally predominate in the distal colonic segment. in both rat and mouse, goblet cells of the proximal colonic mucosa contain largely sialomucins in the lower parts of the crypts with sulphomucins predominating in the upper parts of the crypt. the distal colon contains largely sulphomucins. the only difference between rat and mouse appears to be the fact that the mouse caecum contains almost exclusively sulphomucins but sulphomucins and sialomucins are found in the rat caecal mucosa. in hamsters, the entire colon contains predominantly sulphomucins. neutral mucins and sulphomucins predominate throughout the dog colon with occasional goblet cells containing sialomucin. in non-human primates, neutral mucins, sialomucins and sulphomucins are seen throughout the colon with sialomucins generally more prominent in the proximal colon and sulphomucins in the distal segment. in man, neutral mucins are found mostly in the caecum. in the caecum and ascending colon, sulphomucins are found in the upper crypts and sialomucins in the crypt base. the converse occurs in the distal colon where sulphomucins predominate in the lower two-thirds of the glands and sialomucins in the upper third of the glands and in the surface epithelium. lectin-labelling (table 1) shows even greater heterogeneity of mucins in the colonic mucosal cell population, probably reflecting differentiation patterns and changes in glycosyltransferase activity as cells migrate upwards (freeman et al., 1980; thomopoulos et al., 1983) . it has been suggested by jass and roberton (1994) that the two principle changes in pathological processes in the human colonic mucins are loss of oacylation substituents at sialic acid c 4 and c 7,8,9 and increased sialylation, neither being specific for neoplasia. the colon, like many other tissues also possess drug metabolising activity, although less than in the liver. it has been shown that the activity of cytochromes p450 involved in hydroxylation of benzo[a]pyrene in microsomes prepared from the colons of sprague-dawley rats retain their activity and responsiveness to inducers better than those in the liver with advancing age (sun and strobel, 1986) . the lamina propria of the large bowel is arranged in a similar way to that of the small bowel. by virtue of the presence of lymphocytes, plasma cells, macrophages and dendritic cells as well as scattered small lymphoid aggregates or patches, it forms an integral and important part in the mucosal immune defence system. most of the lymphocytes in the lamina propria of the human colonic mucosa, like that of the ileum, have been shown to be t cells with helper t cells out numbering the t-suppresser phenotype (hirata et al., 1986; pabst, 1987) . this contrasts with intra-epithelial lymphocytes of the human colonic mucosa which are also t cells but more than 80% of which possess characteristics of the suppresser/cytotoxic phenotype and only 10-20% being helper t cells. this distribution of lymphocyte subsets is seen immunocytochemically in the rat colon using the monoclonal antibodies w3/13, w3/25 and mrc ox8 (see haemopoietic and lymphatic systems, chapter iii). the pan t-cell marker w3/ 13 shows the presence of t lymphocytes in the lamina propria and most of these are labelled by w3/25 demonstrating their cd4 helper phenotype (bland and warren, 1985) . mrc ox8 demonstrates that few lymphocytes in the lamina propria are of suppresser/cytotoxic (cd8) type, which contrasts, with the high proportion of mrc ox8 positive lymphocytes in the colonic epithelium (bland and warren, 1985) . the monoclonal antibodies mrc ox6 and mrc ox17, specific for the rat ia antigen, also label numerous cells with macrophage and dendritic cell morphology in the large bowel of the rat (bland and warren, 1985; martin et al., 1986) . mature, small b lymphocytes are relatively uncommon in the colonic lamina propria of man and laboratory animals. however, the lamina propria contains large numbers of plasma cells, which are mainly of iga type, followed by smaller numbers of igm an igg subtypes (pabst, 1987) . a feature of the colonic mucosa is the presence of lymphoid aggregates also called lymphoid nodules, patches, lymphoid-glandular complexes or microbursa. these are similar to peyer's patches of the small intestine as they are composed principally of lymphoid cells of the b-cell series arranged in follicles with germinal centres with interfollicular and perifollicular zones composed of t cells (pabst, 1987) . they are distributed along the entire length of the colonic mucosa although they are generally smaller than peyer's patches. in sprague-dawley rats, lymphoid aggregates are usually about 5 mm diameter except in the distal colon where they attain sizes of up to 10 mm in maximum diameter (martin et al., 1986) . unlike peyer's patches which are characteristically not associated with crypts or villi, the colonic lymphoid aggregates frequently contain irregular atypical mucosal glands which may enter deeply in the lymphoid tissue and penetrate below the muscularis mucosa both in man and laboratory animals scott, 1982; martin et al., 1986) . in some strains of rat, cells in these glands express the ia antigen, unlike the other parts of the colonic epithelium (martin et al., 1986) . these glandular structures, which are intimately associated with lymphoid tissue, may be important in the immune protection of the colonic mucosa, perhaps by acting as a special local receptor for antigens . it has been proposed that these glandular structures represent sites of predilection for the spread of inflammatory disease to the submucosa by allowing microorganisms to pass through the muscularis mucosa (scott, 1982) . it has also been suggested that they constitute physical weak points in the bowel wall and may play a part in the pathogenesis of diverticular disease of the colon in man . colonic carcinomas induced by dimethylhydrazine in the rat also appear to develop more commonly in the lymphoid aggregates than in other zones (martin et al., 1986) . m cells have been described over the lymphoid aggregates in the caecum of the mouse (owen and nemanic, 1978) , see small intestine. although microorganisms are important causes of inflammatory disease in the large intestine of man and animals, among laboratory animals they are usually only significant problems in non-human primates and hamsters. in the strains of rats and mice and in beagle dogs commonly employed in drug safety evaluation, spontaneous disease of the colon as a result of infectious agents is uncommon. nevertheless, treatment with some therapeutic agents may alter the normal bacterial flora to permit overgrowth of pathogenic organisms or disturb the normal balance between antigens in the lumen or control mechanism to evoke inflammation. inflammation induced by organisms may also confound the histological assessment of drug-induced changes in the colon. ulceration and inflammation of the colon as a direct result of administration of potential therapeutic agents is reported in humans although less commonly that in the small intestine. it has been suggested from studies of the effects of anticancer compounds on neoplastic colonic cells that intestinal cells may possess inherent protective properties in the form of an accelerated efflux pump which can serve to protect them from potentially damaging agents (klohs and steinkampf, 1986) . ulceration and inflammation can be induced by the local application of drugs and vehicles to the rectal mucosa. assessment of these effects in an appropriate animal model is important in the safety evaluation of preparations designed for use in man as rectal suppositories. although inflammatory conditions of the large bowel may possess morphological features typical for some inducing agents, inflammation of the large intestinal mucosa is usually characterised by non-specific histological features. in early or mild inflammation, the surface and glandular mucosa remains intact but shows mucin depletion. this is characterised by reduction in the mucus in goblet cells and increased cytoplasmic basophilia. scattered neutrophils may be seen in the epithelium and adjacent lamina propria. in more severe cases, crypts become filled or distended with acute inflammatory cells (crypt abscesses). the lamina propria is variably hyperaemic and congested and contains increased numbers of mononuclear cells. severe changes are characterised by attenuation or frank erosion of the epithelium and the formation of penetrating ulcers filled with fibrinous exudate and surrounded by intense inflammation, granulation tissue and eventually fibrosis. residual glands may be dilated and lined by flattened epithelium or show reactive changes and mitotic activity. regenerative hyperplasia, which can become florid in chronic ulcerative conditions, is characterised by lengthening, irregularity and cystic dilatation of glands which are often lined by hyperplastic epithelial cells and goblet cells distended with mucin. where ulcerative damage has destroyed glands and supporting stroma, regeneration of glands may not occur in the normal regular fashion and branching of crypts may be evident. clostridium difficile may cause inflammatory changes in the colon of laboratory animals, particularly hamsters, and this may extend into the distal ileum. as in man this form of colitis, often referred to as pseudomembranous colitis, is usually associated with antibiotic therapy. in man it was originally associated with lincomycin and clindamycin therapy but other antibiotics have been implicated. it has been shown that both in man and the hamster experimental model that the enteritis is the result of the toxin produced by clostridium difficile (bartlett et al., 1977; milligan and kelly, 1979) . in man this condition is histologically characterised by the presence of plaques or pseudomembranes on the colonic mucosal surface. the pseudomembrane is composed of mucus, fibrin, blood cells, inflammatory cells and cell debris, which has an appearance of streaming from the underlying mucosa. the mucosa may be partly necrotic or mucosal glands are dilated and lined by flattened or hyperplastic cells. the ileal mucosa may show similar changes (milligan and kelly, 1979) . similar features are observed in the antibiotic-treated hamster although the pseudomembrane is less prominent and it may be distributed more proximally with involvement of the terminal ileum (rehg, 1985) . in the hamster, the condition is characterised histologically by erosion of the colonic epithelium and the variable presence of a pseudomembranous plaque of mucin and cell debris. intact but affected mucosa is thickened with reactive changes accompanied by mucin loss in the epithelium and infiltration of a hyperaemic and oedematous lamina propria and submucosa by polymorphonuclear cells (rehg, 1985) . although most instances of this form of clostridia colitis in the hamster have been associated with antibacterial therapy, it has also been reported in untreated hamsters (rehg and lu, 1982) and those treated with antineoplastic drugs (cudmore et al., 1980) . similar changes have been reported in antibiotic-treated guinea pigs and rabbits (rehg and lu, 1981; rehg and pakes, 1981) . guinea pigs are particularly sensitive to antibiotics especially those active against gram-positive organisms (young et al., 1987) . as in man, these drugs are believed to alter the intestinal flora, permitting overgrowth of clostridium difficile as well as gram-negative organisms, resulting in a severe and frequently fatal enterocolitis. a study of the disposition of ampicillin administered parenterally to guinea pigs showed that this drug was rapidly eliminated from the systemic circulation and excreted in urine and bile, possibly favouring this effect on flora in the colon (young et al., 1987) . citrobacter freundii, a gram-negative, short, plump rod and member of the family of enterobacteriaceae, is the causative agent of naturally occurring transmissible colonic hyperplasia of mice. this agent usually produces a mild or even asymptomatic enteritis in susceptible mouse populations, although it is a cause of rectal prolapse in mice (ediger et al., 1974) . marked strain differences have been noted in mice infected with this organism. nih swiss mice show the most severe histological changes and c57bl/6j mice appear the least affected (barthold et al., 1977) . rats and hamsters seem to be unaffected by citrobacter freundii (barthold et al., 1977) . microscopic changes are found primarily in the descending colon, although proximal segments of the colon and the caecum may also be affected. an important morphological feature is epithelial hyperplasia, which occurs maximally 2-3 weeks after experimental inoculation with citrobacter freundii (barthold et al., 1977) . the colonic glands are elongated and lined by cells that show mucin depletion or loss of goblet cells, considerable immaturity and mitotic activity. the surface epithelium may be covered with numerous coccobacilli, which can be visualised in routine haematoxylin, and eosin stained sections. crypt abscesses, inflammatory cells in the lamina propria, mucosal erosions and ulceration are also features (barthold et al., 1976; . in regressing lesions there is a rebound increase in goblet cells, which are often distended with mucin. the colonic glands may be branched or irregular (barthold et al., 1978) . most laboratory animals are naturally resistant to shigella infections but this is not the case for most non-human primates (takeuchi, 1982) . in infections with shigella, the colon shows a superficial acute inflammatory reaction comprising oedema, congestion, haemorrhage and infiltration by acute inflammatory cells. the surface epithelium shows mucin loss and formation of microulcers where total destruction of the epithelium has occurred. ulcers can extend into the lamina propria but in general terms the inflammatory process remains relatively superficial (takeuchi, 1982) . organisms are also located predominantly in the superficial epithelium. another bacterial infection of the gastrointestinal tract, which affects the colon in primates, is that produced by non-tuberculous mycobacteria . large intestinal lesions are characterised by massive accumulation of epitheloid macrophages in the lamina propria, which may extend into the submucosa and muscular layers and along lymphatics to involve mesenteric lymph nodes. small intestinal lesions may also occur, characterised by the presence of similar large macrophages in the lamina propria of villus tips. superficial ulcers may occur in severely affected segments of intestine . acid-fast bacteria are typically found within macrophages. other organs, including spleen, liver, bone marrow and lungs, may also be involved by focal accumulations of bacteria-laden macrophages or occasionally discrete granulomas with multinucleated giant cells. numerous protozoa and metazoa have been described as inhabitants of the caecum and colon of the non-human primate (toft, 1982) . far fewer are observed in the usual laboratory rodents and beagle dogs. amoebiasis caused by entamoeba histolytica is a widespread disease among non-human primates. it is characterised histologically by the presence of necrotizing ulcers, which reach the muscularis mucosa to form typical flank-shaped ulcers containing or surrounded by trophozoites. extensive haemorrhage may be seen as well as an inflammatory infiltrate composed of neutrophils and mononuclear cells (toft, 1982) . the ciliate, balantidium coli, can also cause an ulcerative process in the colon of primates, characterised by ulcers which extend down to the muscularis mucosa accompanied by lymphocytic infiltrate and balantidium coli trophozoites of up to 150 âµm in greatest diameter (toft, 1982) . a variety of metazoan parasites can be observed in the primate colon and usually can be reasonably well identified in tissue sections (see review by chitwood and lichtenfels, 1973) . the nematode of species strongyloides is an important parasite, which may be observed in the intestinal mucosa of primates. oxyurids commonly known as pinworms are essentially innocuous parasites seen in man, non-human primates and rodents. enterobius vermicularis is found in the large intestine and appendix of man and non-human primates, syphacia muris and syphacia obvelata in rodents. oesophagostomum species (nodular worms) are especially common nematode parasites of non-human primates forming characteristic nodules up to 5 mm diameter most frequently on the serosal surface of the large intestine and caecum and adjoining mesentery as well as in other sites in the peritoneal cavity. histologically, the nodules are composed of parasite cell debris surrounded by fibrous tissue and a variable mantle of chronic inflammatory cells and occasional foreign-body giant cells. they are frequently found in close proximity to small arteries and arterioles in the submucosa and subserosa of the colon and may be associated with a local granulomatous arteritis (lumb et al., 1985) . the inflammatory process may spread to surrounding or draining tissues, particularly if nodules rupture. mild periportal hepatic chronic inflammation is sometimes associated with the presence of this parasite in the mesentery, which may confound interpretation of drug-induced hepatic changes in the non-human primate. although the stomach and to a certain extent the small intestine remain the primary sites of predilection for the ulcerogenic action of non-steroidal anti-inflammatory, the colonic mucosa may become involved under certain conditions. less common complications of non-steroidal anti-inflammatory drugs and potassium chloride therapy in humans are colonic strictures. it appears that nonsteroidal anti-inflammatory drugs produce local inflammation followed by focal scarring of the submucosa with constriction and formation of a mucosal diaphragm whereas potassium causes segmental full thickness scarring and constriction (fellows et al., 1992; haque et al., 1992; van velzen et al., 1996; wolfe et al., 1999) . another form of induced colon damage has been reported in children with cystic fibrosis, the majority of who take high strength pancreatic-enzyme supplements to control malabsorption (smyth et al., 1994; fitzsimmons et al., 1997) . this condition has distinctive pathological features. there is involvement a long segment of ascending colon by a fusiform stenosis primarily as a result of submucosal thickening by deposition of mature collagen. the mucosa appears relatively spared but shows some ulceration and reparative changes (van velzen et al., 1996) . although it has been suggested that the changes may have been linked to the methylacrylate copolymer used for enteric coating of the high-strength preparations, a case-control study showed a strong relation between high daily doses of the enzyme supplements, accentuated by more recent availability of high dose forms (fitzsimmons et al., 1997) . in view of their usage for over 50 years, preclinical data on this material is scarce. colonic damage can be induced experimentally by administration of therapeutic agents. dogs administered 2.5 mg/kg indomethecin orally each day for periods of up to 23 days developed not only gastric and small intestinal ulceration but also scattered haemorrhagic erosions in the colon and rectum. histologically, these lesions were characterised by loss of superficial epithelial cells, mucus-depletion of glandular epithelium, crypt abscesses, frequently with acute inflammation in adjacent lymphoid aggregates in the submucosa (stewart et al., 1980) . an example of chemically induced colitis of relevance to safety assessment of therapeutic agents is that induced by degraded carrageenans or synthetic sulphated dextrans. carrageenans are a heterogeneous group of sulphated polysaccharides composed mainly of long chains of d-galactose subunits (d-galactan) derived from red seaweed species which are widely used as food emulsifiers, stabilisers, thickeners and gelling agents (ishioka et al., 1987) . when carrageenans are degraded by acid hydrolysis into smaller molecular weight fragments of about 20,000-40,000 and administered orally in high doses (e.g. 10% of diet) to rats, mice, guinea pigs, rabbits and rhesus monkeys, colitis results (sharratt et al., 1970; marcus and watt, 1971; benitz et al., 1973; fath et al., 1984; kitano et al., 1986) . similarly, colitis has been induced in rats following administration of a 5% dietary admixture of dextran sulphate sodium, a sulphated polymer of glucose (a d-glucose) of molecular weight of 54,000 (hirono et al., 1981) and a very high molecular weight d-glucan, amylopectin sulphate (ishioka et al., 1987) . although histological features of this form of induced colitis vary between study, species and strain, the colitis is generally characterised mucosal ulceration mainly in the caecum but also in the distal ileum, distal colon and rectum. there is mucus-depletion with variable acute inflammatory infiltrate of the in-tact epithelium, crypt abscesses, inflammatory infiltrate of the lamina propria with oedema, hyperaemia and even vascular thrombosis in the submucosa (hirono et al., 1981; fath et al., 1984) . increased proliferative activity of the mucosa is confirmed by an increase in the tritiated thymidine index compared with controls (fath et al., 1984) . in the caecum of rats, ulcers are linear but often circulating the entire circumference of the intestinal wall with subsequent scarring and stricture formation (oohashi et al., 1981) . ulcerating lesions in the rectum and at the anal margin are associated with squamous metaplasia. both the squamous metaplasia and the regenerative hyperplasia of the columnar epithelium have been shown to progress even after cessation of treatment (oohashi et al., 1981) . foamy macrophages containing metachromatic material, presumably polysaccharide, are also seen in the lamina propria, submucosa, regional lymph nodes, liver and spleen (hirono et al., 1981; oohashi et al., 1981) . the cause of this colitis is unclear. low dose levels, which may be expected to mimic human exposure, do not produce colitis. dextrans, carrageenans and other polysaccharides of molecular weights outside the range 20,000-60,000 tend not to incite colitis. an exception to this is the agent amylopectin sulphate, which has a far higher molecular weight. however, amylopectin is composed of polysaccharide chains, which can be degraded by amylase, and therefore smaller molecular weight fragments may be formed in vivo (ishioka et al., 1987) . it has been suggested that colonic disease produced by these agents is in some way linked to induced changes in intestinal microflora (marcus and watt, 1971) although the evidence for this is conflicting (ishioka et al., 1987) . a recent study in guinea pigs and rats using permeability markers of different molecular weights has suggested that degraded carrageenans enhance intestinal permeability in the absence of overt ulceration (delahunty et al., 1987) . it was therefore proposed that carrageenan-induced colitis could be the result of increased intestinal permeability to antigenic or inflammatory substances normally resident in the large intestine. moreover, long-term administration of high doses of these agents to rats leads to the development of colorectal cancer despite their being devoid of any mutagenic potential (see below). the only obvious features, which are common to a number of these non-genotoxic agents, is chronic inflammation and increased proliferative activity. the rectal administration of therapeutic agents and surfactants may also induce similar ulcerative and inflammatory changes. chemical colitis resembling pseudomembranous colitis has been reported in man as a result of chemical cleaning agents accidentally induced by endoscopic examination (jonas et al., 1988) . cellular degeneration, with loss of mitotic activity and mucin depletion can also occur in the colon following treatment with antimitotic drugs. lymphoid infiltrates without tissue damage were reported in the large bowel of rats treated with human recombinant interleukin-2 (anderson & hayes 1989) . melanosis coli is a well-described phenomenon in man associated with chronic ingestion of anthraquinone purgatives. it is considered to be due to the excessive accumulation of lipofuscin-like pigment in the macrophages of the colonic lamina propria (schrodt, 1963; ghadially and parry, 1966; steer and colin-jones, 1975) . this pigment probably originates from organelles of epithelial cells or macrophages, which are damaged by treatment. similar morphological changes have been induced in laboratory animals (guinea pigs) by treatment with anthraquinones (walker et al., 1988) . as a result of these animal studies, walker et al. (1988) suggested that the primary process is a treatment-induced increase in apoptotic bodies in the surface colonic epithelium that are phagocytosed by intraepithelial macrophages and transported to the lamina propria. lipofuscin and iron pigment is occasionally observed in the lamina propria of untreated rodents, notably hamsters, presumably a result of ageing, previous inflammatory processes and haemorrhage. as in other glandular epithelial tissues, hyperplasia may be focal or diffuse with or without atypical cellular features. the term used for hyperplasia with atypical features is atypical hyperplasia in the iarc classification (mohr, 1997) although others use the term dysplasia. like small intestine, cell proliferation in the large intestinal mucosa can be stimulated by a variety of different factors although these functional adaptive responses have been less well studied. physical stimulation by distension or increased dietary bulk is sufficient to initiate hyperplasia including thickening of the muscle coats (dowling et al., 1967; stragand and hagemann, 1977) . one of the most clearly documented forms of compensatory hyperplasia is that which occurs as a response to surgical resection or bypass of a segment of the colon. following resection of a segment of colon in rats, barkla and tutton (1985) showed that the remaining proximal segment of the right side of the colon showed an increase in the thickness of the mucosa and the muscularis externa as well as enlargement of lymphoid aggregates. histologically, the mucosa of the right side of the colon was uniformly thickened showing accentuated folds, elongated mucosal glands with increased height of the surface columnar cells. the changes were most marked up to 30 days following surgery but were less pronounced after 72 days. there was also a significant increase in the mitotic index in the proximal segment at 7 days although at 14 days and later the mitotic index had returned to normal. the distal, down-stream segment showed little or no morphological change but rather a long-lived increase in mitotic activity. it was suggested that these differences were related to the different embryological origin of the segments (barkla and tutton, 1985) . a similar form of uniform colonic hyperplasia affecting principally the caecal and right-sided colonic mucosa also occurs in rats following oral administration of sulphated dextrans of molecular weight of approximately 400,000 (figs 52 and 53). oral administration of a wide range of compounds such as raw and chemically modified starches, various dietary fibres, caramels, sugar alcohols (lactitol, sorbitol, mannitol, xylilol), lactose, a synthetic polydextrose, polyethylene glycol and magnesium sulphate to rats or hamsters has also been linked to an increase caecal size and colonic mucosal hyperplasia (leegwater et al., 1974; roe and bã¤r, 1985; newberne et al., 1988; stark et al., 1996) . the characteristic histological appearance of the caecum following administration of these agents is lengthening of the mucosal glands which are lined by epithelium composed of increased numbers of enlarged epithelial cells (i.e. hypertrophy and hyperplasia) showing increased proliferative activity and more rapid incorporation of tritiated thymidine (newberne et al., 1988) . in addition, mucosal and submucosal oedema has been reported in association with the administration of lactose and increased mucosal lymphoid aggregates following lactose or xylitol feeding (newberne et al., 1988) . changes in the colon due to fibre are complex. morphometric analysis has shown that changes to the mucosa depend on the fibre type (stark et al., 1996) . there may also be an interaction between dietary fibre content and colonic microflora that influences mucosal growth, although the mechanism is unclear (whiteley et al., 1998) . hypertrophy of the muscularis external is also reported in rats fed high fibre diets (stark et al., 1996) . as the increase in caecal size and mucosal hypertrophy appears generally related to the osmotic activity of the caecal contents in rodents treated with these agents, it has been postulated that the changes represent a physiological adaptation to increased osmotic forces, irrespective of the contributing compounds (leegwater et al., 1974) . treatment of rodents with antibiotics also causes caecal enlargement or dilatation without significant histopathological changes, probably as a result of changes in caecal microflora. it has been suggested that the enlargement relates to accumulation of urea as a result of inhibition of bacterial ureases (juhr and ladeburg, 1988) . however, histochemical studies of the intestinal mucosa of rats treated with neomycin have also shown treatment-related reductions in activities of nad tetrazolium reductase, succinate dehydrogenase, esterase, alkaline and acid phosphatase in the distal ileum, suggesting that some antibiotics also posses the potential to directly influence absorption and metabolic functions of mucosal cells (van leeuwen et al., 1986) . long-term administration of 16,16-dimethyl prostaglandin e2 to rats also produced thickening of the proximal colonic mucosa, although this was less fig. 53 . similar area of colonic mucosa to that seen in fig. 52 at the same magnification but from a rat treated with 10% dextran (molecular weight 500,000) in the diet for 2 weeks. this shows diffuse hyperplasia of the mucosa with elongation of colonic glands that are lined by relatively normal epithelial cells with abundant mucin and prominent vesicular nuclei. (he, ã�40.) marked than in the stomach and duodenum (reinhart et al., 1983 ) and similar changes have been reported in rats treated with other prostaglandin e analogues (levin, 1988) . as in the small intestine, administration of epidermal growth factor to rats and cynomolgus monkeys induces hyperplasia of the colonic mucosa characterised histologically by hyperplasia and increased mitotic activity of crypt cells and reduction in goblet cell numbers with an increase in crypt depth and a slight increase in the numbers of infiltrating neutrophils (breider et al., 1996; reindel et al., 1996) . in common with other epithelial surfaces, atypical hyperplasia is associated with the development of colonic cancer in both man and laboratory animals. the early alterations observed in rats treated with colonic carcinogens are similar to those found in the immediate vicinity of human colorectal carcinomas. the changes are characterised by lengthening, dilatation and branching of glands. the epithelium lining these glands shows mucous cell hyperplasia (goblet cell hyperplasia, see fig. 54 ), goblet cells containing predominantly sialomucin instead of the normal sulphomucin (filipe and branfoot, 1974; filipe, 1975; olubuyide et al., 1985) . despite mucin alterations, activities of glucose-6-phosphatase, glucose-6-phosphate dehydrogenase and glyfig. 54 . section from the colon of an aged hamster from a colony that developed intestinal inflammation and neoplasia spontaneously. this shows focal mucous cell hyperplasia characterised by enlargement and lengthening of the colonic glands with lining cells replete with mucins. (he, ã�25.) ceraldehyde-3-phosphate dehydrogenase were shown to be normal in this epithelium in rats treated with 1,2-dimethylhydrazine (mayer et al., 1987) . in man, this form of hyperplastic mucosa associated with cancer, has been termed 'transitional mucosa' (filipe and branfoot, 1974) . as lesions become more atypical, these dilated, branched glands become more complex and lined by epithelium that shows increasing pseudostratification and vesicular cell nuclei. for example in rats treated with the carcinogens azoxymethane or 1,2-dimethylhydrazine, crypts show diminution of mucus secretion, increased cytoplasmic basophilia, prominent, rounded or enlarged nuclei which show variable degrees of pseudostratification and which eventually develop into frankly invasive glands . in contrast to goblet cell hyperplasia, these atypical zones show increased activity of glucose-6-phosphate, glucose-6-phosphate dehydrogenase and glyceraldehyde-3-phosphate dehydrogenase (mayer et al., 1987) . described similar alterations in rats treated with azoxymethane and the non-genotoxic agent dextran sulphate. these authors also demonstrated that these atypical foci could be identified by low power microscopy as aberrant crypt foci by translumination of the whole mounts of the fixed mucosa stained with methylene blue. note: some compounds may induce qualitative and quantitative changes in mucin content in the colonic mucosa without marked morphological alterations. an example of this phenomenon was described in rats treated with reserpine for 7 days. the colonic mucosa showed an increase in sulphomucin (high-iron diamine positive) containing goblet cells in the surface epithelium (park et al., 1987) . adenomas and adenocarcinomas of the small and large intestine are infrequent spontaneous neoplasms in laboratory animals compared with man where colorectal carcinoma is one of the most prevalent neoplasms in the western world. adenomas and adenocarcinomas probably occur spontaneously in older dogs more than in any other animal species and as in man these are located most frequently in the distal colon and rectum (lingeman and garner, 1972) . in nonhuman primates glandular neoplasms of the intestine occur with increasing age in the ileum and in the colon with a predilection for the zones near the ileocaecal valve (depaoli and mcclure, 1982) . in rats and mice, spontaneous intestinal neoplasms are uncommon although adenocarcinomas are occasionally observed in the ileum or colon in mice and rats used in chronic toxicity studies and carcinogenicity bioassays (burn et al., 1966; wells, 1971; maeda et al., 1985; greaves and faccini, 1992; zwicker et al., 1992) . most of these arise in the small intestine and appear to originate in the distal part of the small intestine, caecum and right side of the colon. they may produce metastases, mostly to liver and lungs. in a review of spontaneous adeno-carcinomas developing over a 17-year period in wistar rats, vandenberghe et al. (1985) identified 17 adenocarcinomas, all in ascending colon. in 15 of these cases there appeared to be an intimate relationship with campylobacter-like organisms together with diverticulae and chronic inflammation. these authors suggested that the organisms and the associated inflammation were involved in the pathogenesis of these cancers. in view of the importance of colon cancer in humans, a number of new genetic mouse models predisposed to colon cancer have been developed over recent years (heyer et al., 1999) . some hamster colonies, liable to develop inflammatory bowel disease (see above), also have a high incidence of small and large intestinal polyps, adenomas and adenocarcinomas (fortner, 1957; van hoosier et al., 1971; personal observations) . poorly differentiated carcinomas may infiltrate local lymph nodes and it may be difficult to locate the primary neoplasm. polyps are predominantly adenomatous in nature although inflammatory or regenerative polyps are observed (van hoosier et al., 1971) . adenocarcinomas are induced experimentally in the rodent intestine by the carcinogens 1,2-dimethylhydrazine and azoxymethane. the histogenesis of these induced carcinomas has been extensively studied and it is generally accepted that they resemble human colorectal cancer (ward, 1974; freeman, 1983) . however, there are differences between reported studies. some have shown that these experimental carcinomas arise from pre-existing adenomas consistent with the 'adenoma-carcinoma sequence' theory (ward, 1974; ward et al., 1977) . others suggest that they arise 'de novo' from altered mucosa as microinvasive carcinomas (sunter et al., 1978; maskens and dujardin-loits, 1981; rubio et al., 1986) . these differences may be partly the result of different dosage schedules. rubio et al. (1988) have shown that a single dose of 1,2-dimethyhydrazine produces non-polypoid, micro-invasive carcinomas, particularly in the mucosa overlying lymphoid aggregates, whereas in their earlier studies using multiple doses in the same strain of rat, an adenoma-carcinoma sequence was more evident. in addition, there are undoubtedly species and strain differences in the response to these agents. teague et al. (1981) demonstrated clear differences in the distribution and both macroscopic and histological types of adenomas and adenocarcinomas between three different inbred strains of rat given a similar dosage regimen of 1,2-dimethylhydrazine. in general, many of these carcinomas develop in the distal colonic segments similar to the distribution of human colorectal cancer, although tumours also develop in the proximal colon and in the ileum in rats treated with this agent (ward, 1974; teague et al., 1981) . neoplasms occurring in the rat colon following administration of high doses of degraded carrageenans and sulphated dextran also commonly occur in the distal colon and rectum and are commonly polypoid adenomas and adenocarcinomas (hirono et al., 1981; oohashi et al., 1981; ishioka et al., 1987) . however, in these models adenomas and adenocarcinomas also occur in the caecum and proximal colon and squamous carcinomas are sometimes seen in association with squamous metaplasia at the colorectal junction (oohashi et al., 1981) . the pathogenesis of neoplasms induced by carrageenans and dextrans remains unexplained. although they are biologically active compounds, they are non-mutagenic in the usual short-term tests (ishioka et al., 1987) . it has been suggested that carrageenans act as tumour promoters as they potentiate the appearance of carcinomas in rats treated with standard intestinal carcinogens hirono et al., 1981) . conversely it has been proposed that these agents are tumour initiators based on the development of carcinomas in rats treated with degraded carrageenans for only 2 months (oohashi et al., 1981) . however, despite only a short period of treatment, inflammation, regenerative changes and squamous metaplasia persisted throughout a period of 18 months after treatment was withdrawn before development of cancer in these rats. the only consistent association of carrageenans with development of carcinoma in rats is that of chronic inflammation and increased cell proliferation. although dose levels needed to produce inflammation are far higher than any exposure likely to be achieved in man, interpretation of this inflammation-cancer sequence in rats remains a challenge in safety assessment for similar xenobiotics. this situation is interest in view of the unquestionable risk of carcinogenesis in ulcerative colitis in man (riddell et al., 1983) . a similar range of neoplasms can be defined histologically in both human and experimental pathology. it is appropriate, to use the same classification for all species including man. lingeman and garner (1972) who reviewed a range of tumours from domestic and laboratory animals were able to employ the classification for human gastrointestinal neoplasms. a similar approach has been used in the iarc classification of rat intestinal tumours (mohr, 1997) . this classification can be summarised as follows: these represent localised, sessile or polypoid neoplasms composed of proliferating tubular glands, which show varying degrees of nuclear hyperchromatism, pseudostratification and cellular pleomorphism. a useful scheme for grading the carcinogenic potential of hyperplastic mucosa and adenomatous polyps in man based on the degree of epithelial pseudostratification has been proposed by kozuka (1975) . although experimental neoplasms may not always show the full spectrum of these changes reported in man, this grading provides a useful baseline concept for the assessment of these non-invasive proliferative lesions. with increased nuclear pseudostratification and atypical branching of the glandular structures of these polyps becomes more prominent. if neoplastic cells or glands are seen in the stroma of the stalk or base the diagnosis of carcinoma is made. villous adenoma is a form of adenoma in which the epithelial proliferation takes the form of elongated villi with a sparse fibrovascular stroma. they can be graded in a similar way to other adenomas. these are glandular neoplasms of variable differentiation, sometimes originating in adenomatous polyps or villous adenomas but which show infiltration of the intestinal wall, i.e. beyond the boundary of the muscularis mucosa. squamous carcinomas also occur in the anorectal zone but are similar to those which occur in squamous epithelium elsewhere. similarly, mesenchymal neoplasms also are found in the small and large intestinal wall (see integumentary system, chapter i). light and electron microscopical studies of parietal cells before and one year after proximal vagotomy in duodenal ulcer patients six-month repeated oral toxicity study of nk-104 in rats response of the non-human primate to polychlorinated biphenyl exposure cell number as a measure of distribution and renewal of epithelial cells in the small intestine of growing and adult rats induction of early lesions in the forestomach of rats by 3-tert-butyl-4-hydroxyamisole (bha) effects of caecetomy in the young adult female rat on digestibility of food offered and libitum and in restricted amounts toxicity of human recombinant interleukin-2 in rats. pathologic changes are characterized by marked lymphocytic and eosinophilic proliferation and multisystem involvement effects of cimetidine, cimetidine plus nitrite, and nitrosocimetidine on tumors in mice following transplancental chronic lifetime exposure age-associated lesions in barrier-reared male sprague-dawley rats: a comparison between hap: (sd) and crl:cobs[r] cd[r] (sd) stocks expression of cd15 in normal and metaplastic paneth cells of the digestive tract an epizootic of klebsiella aerogenes infection in laboratory rats correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats long-term comparative effect cholecystokinin and gastrin on mouse stomach, antrum, intestine, and exocrine pancreas the effect of 6-hydro-xydopamine on rat salivary glands and on their response to isoproterenol biologically active peptides in submandibular glands the alimentary system proliferative and morphologic changes in rat colon following bypass surgery cyclosporin and gingival overgrowth the etiology of transmissible murine colonic hyperplasia dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia transmissible murine colonic hyperplasia mouse hepatitis virus infection, intestine, mouse murine rotavirus infection, intestine, mouse adenovirus infection, intestine, mouse clindamycinassociated colitis due to a toxin-producing species of clostridium in hamsters antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia histological variations jejunal and ileal mucosa on days 8 and 15 after hypophysectomy in rat: morphometric analysis in light and electron microscopy comparative study of histological and kinetic variations of the digestive mucosa and pancreatic parenchyma after hypophysectomy in the rat effect of drugs on rats exposed to cold-restraint stress adverse effects of anticonvulsant drugs: a critical review formation of n-mono-nitrosopiperazine in the stomach and its secretion in the urine after oral intake of piperazine intestinal effects of carrageenans in the rhesus monkey (macaca mulatta) the cell surface: components and configurations mã©nã©trier's disease. serial morphological, secretory, and serological observations structure, biosynthesis and functions of glycoprotein glycans. experientia pathology of the forestomach in rats treated for 1 year with a new histamine h2-receptor antagonist, sk&f 93479 trihydrochloride fundic mucosal ecl cell hyperplasia and carcinoids in rodents following chronic administration of the histamine h2-receptor antagonist sk&f 93479 and other antisecretory agents gastric ecl-cell hyperplasia and carinoids in rodents following chronic administration of the h2 antagonist sk&f 93479 and oxmetidine and omeprazole gastric regulatory peptides in rats with reduced acid secretion non-steroidal anti-inflammation in humans immunohistologic analysis of the t-cell and macrophage infiltrate in 1,2-dimethylhydrazine-induced colon tumors in the rat turnover of brush-border glycoproteins in human intestinal absorptive cells: do lysosomes have regulatory function? alterations in gastric mucosal morphology induced by long-term treatment with omeprazole in rats the effect of aging on the rat submandibular gland. an ultrastructural, cytochemical and biochemical study drug-induced esophageal strictures cytochrome p450 of small intestinal epithelial cells. immunocytochemical characterization of the increase in cytochrome p450 caused by phenobarbital synergistic role of intestinal flagellates and normal intestinal bacteria in a post-weaning mortality of mice medication-induced oesophageal injury. survey of the literature resistance to starvation in albino rats fed from weaning on diets containing from 0 to 81% of protein as casein diseases of the kidney the human gastrointestinal secretory immune system in health and disease clinical aspects: an overview single-dose and multiple-dose intravenous toxicity studies of bmy-25282 in rats cellular hyperplasia in rats following continuous intravenous infusion of recombinant human epidermal growth factor adrenergic mechanisms responsible for submandibular salivary glandular hypertrophy in the rat aspirin: intestinal damage in rats gastrointestinal mucosal lesions: a drug formulation problem intestinal t lymphocytes of different rats strains in immunotoxicity effects of propionic acid and pravastatin on hmg-coa reductase activity in relation to forestomach lesions in the rat famotidine: summary of preclinical safety assessment effects of cholestyramine and diet on small intestinal histomorphology in rats spontaneous carcinoma of the colon of the rat cresyl fast violet staining method for campylobacter-like organisms pigmentation of the jawbone and teeth secondary to minocycline hydrochloride therapy genetic ablation of parietal cells in transgenic mice: a new model for analyzing cell lineage relationships in the gastric mucosa esophageal lesions caused by orally administered drugs. an experimental study in the cat tetracycline induced esophageal ulcers. a clinical and experimental study diagnosis of silodacryoadenitis virus infection of rats in a virulent enzootic outbreak cryptosporidium species a 'new' human pathogen thyroxine accelerates the differentiation of granular convoluted tubule cells and the appearance of epidermal growth factor in the submandibular gland of the neonatal mouse. a fine structural immunocytochemical study renewal of the epithelium in the descending colon of the mouse. i. presence of three cell populations: vaculated-columnar, mucous and argentaffin two types of mucous cells in the colon crypt origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. iii entero-endocrine cells cytology of the canine oral papilloma uremic gastropathy in the dog intestinal absorption and metabolism of xenobiotics in laboratory animals parasitological review. identification of parasitic metazoa in tissue section spontaneous basophilic hypertrophic foci of the parotid glands in rats and mice effects of housing conditions on food intake, body weight and spontaneous lesions in mice. a review of the literature and results of an 18-month study cryptosporidiosis in the intestines of rhesus monkeys (macaca mulatta) isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal post marketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow-up hyperplastic gastropathy in the rat due to taenia taeniaeformis infection: parabiotic transfer and hypergastrinaemia. gastroenterology number, size and distribution of peyer's patches in the human small intestine a model for gastric cancer epidemiology helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention the effects of vagotomy on the gastric mucosa of the rat the effect of prolonged administration of large doses of cimetidine on the gastric mucosa of rats effect of short-and long-term feeding of omeprazole on rat gastric endocrine cells clostridial enterocolitis produced by antineoplastic agents in hamsters and humans odontogenic tumours in fischer rats the histo-chemical demonstration of o-acylated sialic acid in gastrointestinal mucins: their association with the potassium hydroxide-periodic acid-schiff effect a new histochemical method for the identification and visualization of both side chain acylated and non-acylated sialic acids amiodarone keratopathy, drug-induced lipid storage disease salivary gland components involved in the formation of squamous metaplasia gastric mucosal injury by fatty and acetylsalicylic acids cryptosporidosis and proliferative ileitis in a hamster specificity of twelve lectins towards oligosaccharides and glycopeptides related to n-glycosylproteins intestinal permeability changes in rodents. a possible mechanism for degraded carageenan-induced colitis adrenal corticosteroids cause gastrin cell hyperplasia possible role of transforming growth factor alpha in the pathogenesis of menetrier's disease: supporting evidence from humans and transgenic mice the effect of hydrocortisone and cortisone on fixation of 35s in the stomach the effect of phenylbutazone and its derivatives, oxyphenbutazone and sulfinpyrazole, on 35s sulfate incorporation in cartilage and stomach salivary glands: a paradigm for diversity of gland development gastrointestinal neoplasms in non-human primates: a review and report of new cases gastric gland degeneration induced in monkeys by the cck-b/gastrin receptor antagonist ci-988 the effect of aspirin on small intestinal mucosa morphologic aspects of lipid absorption gastric and gastric epithelial physiology two-year evaluation of misprostol for carcinogenicity in cd sprague-dawley rats distribution and incidences of calcified lesions in dba/2ncrj and balb/canncrj mice interaction of phenytoin and inflammation induces gingival overgrowth in rats the intestinal response to high bulk feeding in the rat comparison of canine and human gastrointestinal physiology stress ulceration-clinical relevance of animal and human studies pathology of laboratory rats and mice effect of chronic aspirin ingestion on epithelial proliferation in rat fundus, antrum and duodenum the prognostic value of sulphomucin positive intestinal metaplasia in the the development of gastric cancer colitis in mice with high incidence of rectal prolapse volatile nitrosamine contamination of laboratory animal diets toxicological studies on omeprazole possible role of cimetidine and its nitrostated products in human stomach cancer cimetidine and gastric cancer tumours of the oral cavity, check pouch, salivary glands, oesophagus, stomach and intestines differential distribution of lymphocytes and accessory cells in mouse peyer's patches phenotypically distinct subpopulations of t cells in domes and m-cell pockets of rabbit gut-associated lymphoid tissues morphometric analysis of the small intestinal epithelium in the indomethacin-treated mouse expression of pokeweed lectin binding in murine intestinal paneth cells heterogeneity of m-cell-associated b and t cells in human payer's patches degraded carrageenan-induced colitis in cf1 mice. a clinical, histo-pathological and kinetic analysis substituted benzimidazoles inhibit acid secretion by blocking (h ++ k + ) atpase nonsteroidal anti-inflammatory drug induced jejunal and colonic diaphragm disease: a report of two cases effect of chronic misoprostol ingestion on rat gastric morphology and turnover abnormal patterns of mucous secretion in apparently normal mucosa of large intestine with carcinoma mucous secretion in rat colonic mucosa during carcinogenesis induced by dimethylhydrazine. a morphological and histo-chemical study mucins in the human gastrointestinal epithelium: a review. invest high-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis the number of villi in rat's jejunum and ileum: effect of normal growth, partial enterectomy and tube feeding spontaneous tumors including gastrointestinal neoplasms and malignant melanoma, in syrian hamster aspirin, paracetamol and non-steroidal anti-inflammatory drugs. a comparative review of side effects campylobacter jejuni/coli in commercially reared beagles. prevalance and serotypes antigen specificity and morphological characteristics of chlamydia trachomatis, strain sfpd, isolated from hamsters with proliferative ileitis acquired salivary dysfunction. drugs and radiation gastritis cystica profunda application of lectins for detection of goblet cell glycoconjugate differences in proximal and distal colon of the rat lectin histochemistry of 1,2-dimethylhydrazine-induced rat colon neoplasia effects of puromycin on the structure of rat intestinal epithelial cells during fat absorption morphological aspects on pancreatic islets of non-obese diabetic (nod) mice carcinoma and related lesions in dog stomach induced by oral administration of n-methyl-nâ´-nitro-n-nitrosoguanidine cryptosporidiosis in a pup with distemper. vet.pathol squamous cell carcinoma, forestomach, rat adverse effects of mouthwash use. a review. oral surg.oral med.oral pathol tyzzer's disease, intestine, mouse, rat, hamster salmonellosis, intestine, mouse, rat, hamster adequate substitution with electrolytes in toxicological testing of 'loop' diuretics in the dog the forestomach in rats and mice, a food store without bacterial protein digestion m cells in peyer's patches of the intestine histochemie de la muqueuse gastrique fundique du chien traitã© par des drogues ulcã©rigã¨ne an electron-microscope and histo-chemical study of melanoisis coli mitochondria. in: ultrastructural pathology of the cell and matrix sustainability of forestomach hyperplasia treated with ethyl acrylate for 13 weeks and regression after cessation of dosing the cytochemical localization of lysozyme in paneth cell granules regional differences in glycoconjugates of intestinal m cells in mice: potential targets for mucosa vaccines susceptibilities of drug to nitrosation under simulated gastric conditions features of small intestinal pathology (epithelial cell kinetics, intra-epithelial lymphocytes, disaccharidases) in a primary giardia muris infection staining rickettsiae in yolk sac cultures alterations of gastric mucosa following a graded partial gastrectomy tumours of the salivary glands the oral cavity aristolochic acid is a direct mutagen in s. typhimurim studies of the binding of trypsin and chymotrypsin by human intestinal mucosa study of cold plus restraint stress gastric lesions in spontaneously hypertensive, wistar and sprague-dawley rats mucins in normal and neoplastic gastrointestinal epithelium the lectins: carbohydrate-binding proteins of plants and animals prolactin and ergocryptine effects mucus glycoproteins of the rat ileum tumours of the jaws hypopigmentary changes with a platelet aggregation inhibitor (abstract no. 2526). fed.proc drug induced enteropathy characterized by lipid in macrophages altered patterns of mucin secretion in gastric hyperplasia in mice digestive system. in: rat histopathology. a glossary for use in toxicity and carcinogenicity studies k virus infection, intestinem mouse a silver nitrate stain for alpha-2 cells in human pancratic islets silver stains in the study of endocrine cells of the gut and pancreas effects of antrectomy or porta-aval shunting on the histamine-storing endocrine-like cells in oxyntic mucosa of rat stomach. a fluorescence histochemical, electron microscopic and chemical study the vagus exerts trophic control of the stomach in the rat activation and hyperplasia of gastrin and enterochromaffin-like cells in the stomach gastrin and the trophic control of gastric mucosa onkocytes and so-called hã¼rthle cell tumor interaction of microorganisms, epithelium, and lymphoid cells of the mucosa-associated lymphoid tissue dog and swine as models for testing indomethacin-induced gastrointestinal irritation sialodacryoadenitis in the rat: effects of immunosuppression on the course of the disease role of gut in zenobiotic metabolism epithelial cell kinetics in the small intestine of the rat 60 days after resection of 70 percent of the ileum and jejunum compensation by the residual intestine after intestinal resection in the rat proceedings of the lst international symposium on omeprazole a cecal diaphragm associated with the use of nonsteroidal anti-inflammatory drugs chronic gastritis of the glandular stomach, adenomatous polyps of the duodenum, and calcareous pericarditis in strain dba mice idiopathic megaoesophagus in rat immunocytochemical localization of alkaline phosphatase in absorptive cells of rat small intestine after colchicine treatment spontaneous neoplasm incidences in fischer 344 rats and b6c3f1 mice in two-year carcinogenicity studies: a national toxicology program update diphenyldydantoin (dilantin) gingival hyperplasia: drug-induced abnormality of connective tissue on cell proliferation and differentiation of the fundic mucosa of the golden hamster. fractographic study combines microscopy and 3 h-thymidine autoradiography tritiated thymidine autoradiographic study on cellular migration in the gastric gland of the golden hamster enterochromaffin-like cell carcinoids of gastric mucosa in rats after life long inhibition of gastric secretion gastric cancer after cimetidine in a patient with two negative pre-treatment biopsies induction of experimental allergi sialadenitis in mice spontaneous development of auto-immune sialodenitis in aging bdf1 mice i mmunofluorescent localization of enterokinase in human small intestine mouse models for colorectal cancer morphologic changes in the urinary bladder and stomach after long-term administration of sodium saccharin in f344 rats lessons from genetically engineered animal models iii. lessons learned from gastrin gene deletion in mice immunohistological characterization of intra-epithelial and lamina propria lymphocytes in control ileum and colon and inflammatory bowel disease induction of intestinal tumors in rats by dextran sulphate sodium gastric enterochromaffin-like hyperplasia and neoplasia in the rat: an indirect effect of the histamine h2-receptor antagonist bl-6341 oxidative metabolism of foreign compounds in rats small intestine: cellular localization and dependence on dietary iron clinicopathological studies of gastrointestinal disease in macaques non-tuberculous myobacterial disease in rhesus monkeys on human papillomaviruses the laboratory rat. biology, diseases inhibition of intestinal protein synthesis and lipid transport by ethionine experimental toxicity studies with captopril, an inhibitor of angiotesin 1-converting enzymes 2. one month studies of chronic toxicity of captopril in rats development of spontaneous tongue calcification and polypoid lesions in dba/2ncrj mice changes in enzyme levels accompanying differentiation of intestinal epithelial cells textbook of endocrinology acute disease of the submaxillary and harderian glands (sialodacryoadenitis) of rats with cytomegaly and no inclusion bodies cellular kinetics of gastrointestinal mucosa, with special reference of gut endocrinecells changes of gastric mucus glycoproteins with aspirin administration in rats induction of colorectal tumours in rats by sulpated polysaccharides induction of duodenal tumors in mice by oral administration of hydrogen peroxide carcinogencity of butylated hydroxyanisole in f344 rats modifying effects anti-oxidants on chemical carcinogenesis a 13 week feeding study of butylated hydroxyanisole: the subsequent regression of the induced lesions in male fischer 344 rat forestomach epithelium an 85-day study of butylated ydroxyanisole in the cynomolgus monkey subchronic studies of doxylamine in fischer 344 rats effects of dietary fiber on mucosal growth and cell proliferation in the small intestine of the rat: a comparison of oat, bran, pectin, and guar with total fiber deprevation transmissible ileal hyperplasia, hamster anatomic adaption of the alimentary tract of the rat to the hyperphagia of chronic alloxan-diabetes a variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study role of intestinal metaplasia in the histogenesis of gastric carcinoma colorectal mucin histochemistry in health and disease: a critical review uptake of particulate and soluble antigens in the small intestines of the rat chemical colitis due to endoscopic cleaning solutions: a mimic of pseudomembranous colitis pathology of domestic animals intestinal accumulation of urea in germ-free animals: a factor in caecal enlargement digestive enzymes in the parotid and submandibular glands of mammals morphologishe verã¤nderungen der magenmukosa von ratten nach chronischer antazidagabe enteric viruses of non human primates increased accumulation of sulfated glycoaminoglycans in cultures of human fibroblasts from phenytoin-induced gingival overgrowth new insights into the stem cells and the precursors of gastric epithelium colonic lymphoid-glandular complex (microbursa): nature and morphology lymphoid tissue and lymphoid-glandular complexes of the colon: relation to diverticulosis histology of salivary gland infarction in the dog adrenergic factors involved in the control of crypt cell proliferation in jejunum and descending colon of mouse pill esophagitis immunogold localization of ingested kidney bean (phaseolus vugaris) lectins in epithelial cells of the rat small intestine epithelial dysplasia of the rabbit colon induced by degraded carrageenan hyperkeratinization and hyperplasia of the forestomach epithelium in vitamin a deficient rats intrinsic resistance of colon tumors to anthrapyrazoles and antracyclines may be linked with a detoxification mechanism of intestinal cells (abstract no. 1040) studies on the effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on the rodent forestomach reversibility of adenomatous hyperplasia in the gastric stump after diversion of bile reflux in rats experimental production of possible autoimmune gastritis followed by macrocytic anemia in athymic mice expression cloning and characterization of the canine parietal cell gastrin receptor histomorphologic investigations on the effect of cyclophosphamide on dentinogenesis of the rat incisor. scand preclinical toxicology profile of misoprostol premalignancy of the mucosal polyp in the large intestine: i. histologic gradation of the polyp on the basis of epithelial pseudostratification and glandular branching morphologic changes in the gastric mucosa of rats and dogs treated with an analog of prostaglandin e1 forestomach carcinogens: possible mechanisms of action lectin-peroxidase conjugates in histopathology of gastrointestinal mucosa the rat incisor in toxicologic pathology the pharmacology and toxicology of caffeine incorporation of radiosulfate in the gastric mucosa of the rat subjected to restraint antisecretory drugs and gastric cancer plasma gastrin and gastric enterochromaffin-like cell activation and proliferation. studies with omeprazole and ranitidine in intact and antrectomized rats effects of cyclosporin a administration in cats gingival hyperplasia associated with nifedipine therapy the aetiology of caecal enlargement in the rat effect de l'administration prolongã©e d'un antisã©crã©toire gastrique, le pirenzepin, sur les populations cellulaires de l'estomac de rat hepatocytes in the mouse stomach tumours of the oral cavity, pharynx, oesophagus and stomach a toxicological profile of cimetidine specific staining of sulphate groups with alcian blue at low ph the mucin histochemistry of normal and neoplastic gastric mucosa the effect of the thyroid gland on intestinal absorption of hexoses structural changes of the gastrointestinal mucosa induced by prostaglandins structural aspects of salivary glycoproteins drug-induced disorders of the esophagus histochemical observations on paneth cells diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice carcinogencity of methylated dinitro-sopiperazines in rats comparative study of intestinal adenocarcinoma of animals and man dental dysplasia in rats and mice chronic oral administration of 1-nitrosopiperazine at high doses to mrc rats nifedipine-induced gingival hyperplasia: a histochemical and ultrastructural study drug-induced lysosomal storage disorders oesophagostomiasis in feral monkeys (macaca mulatta) hyperalimentation in normal animals produced by protamine insulin effects of cytotoxic chemotherapy on dental development nutritional influences on aging of fischer 344 rats: ii the use of rats associated with human faecal flora as a model for studying the effects of diet on the human gut microflora colonic ulceration in young rats fed degraded carrageenan unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration gut-associated lymphoid tissue and 1,2-demethylhydrazine intestinal tumors in the rat: a histological and immunoenzymatic study leucocyte and bone marrow effects of a thiomorpholine quninazosin antihypertensive agent localization of epidermal growth factor receptors in cells of the enamel organ of the rat incisor effect of dosage form and formulation factors on the adherence of drugs to the esophagus morphologic changes of esophageal mucosa in the rat after chronic alcohol ingestion experimental adenomas and carcinomas of the large intestine behave as distinct entities: most carcinomas arise de novo in flat mucosa la glande endocrine de l'intestin chez l'homme differentiation of immature mucous cells into parietal, argryophil, and chief cells in stomach grafs sequential histochemical and morphometric studies on preneoplastic and neoplastic lesions induced in rat colon by 1,2-dimethylhydrazine recovery from amiodarone-induced lipidosis in laboratory animals: a toxicological study parietal cell hyperplasia indued by long-term administration of antacids to rats methotrexate-induced changes in rat parotid and submandibular gland function a spontaneous outbreak of polychlorinated biphenyl (pcb) toxicity in rhesus monkeys (macaca mulatta): toxicopathology classical absorption theory and the development of gastric mucosal damage associated with non-steroidal anti-inflammatory drugs mesenteric lymphoblast localization throughout the murine small intestine: temporal analysis relating intestinal length and lymphoblast division morphologic lesions in ageing syrian hamsters histological identification of campylobacter using gimenez technique in gastric antral mucosal the carcinogenic action of aristolochic acid in rats rat immunoglobulins in serum and secretions: comparison of iga and igg in serum, colostrum, milk and saliva of protein malnourished and normal rats influence of ofloxacin on the faecal flora the structure, origin and function of mucosal mast cells. a brief review pseudomembranous colitis in a leukaemia unit: a report of five fatal cases formulation of n-nitroso compounds: chemistry kinetics, and in vivo occurrence the etiology of gastric cancer: intragastric nitro-samide formation and other theories forestomach lesions induced by butylated hydroxyanisole and ethylene dibromide: a scientific and regulatory perspective international classification of rodent tumours. part 1, the rat the 'swiss roll'. a simple technique for histological studies of the rodent intestine organization of an actin filament-membrane attachment in the microvilli of intestinal epithelial cells charaterization and localization of myosin in the brush border of intestinal epithelial cells development of the human gastrointestinal tract: twenty years of progress aroclor 1254-induced intestinal metaplasia and adenocarcinoma in the glandular stomach of f344 rats immuno-histochemical localization of epidermal growth factor in rodent submandibular glands intestinal metaplasia of the gastric mucosa precancerous conditions and epithelial dysplasia in the stomach hypersensitivity reactions in the small intestine. 6. pathogenesis of the graft-versus-host reaction in the small intestinal mucosa of the mouse the distribution of acid mucopoly-saccharides in normal kidneys as shown by the alcian blue feulgan (ab-f) and alcian blue-periodic acid-schiff (ab-pas) stains gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type a histochemical classification of acini and ducts of parotid glands from artiodactyles, carnivores and rodents a morphological and histrochemical study of a drug-induced enteropathy in the alderley park rat the mouse submandibular gland: an exocrine organ for growth factors dysplasia of the gastric mucosa and its relation to the precancerous state ultrastructure of dog parotid gland corticosteroid treatment increases parasite numbers in murine giardiasis duct-associated lymphoid tissue (dalt) of minor salivary glands and mucosal immunity minor salivary gland duct-associated lymphoid tissues (dalt) in monkeys, changes with age quantitative light and electron microscopic studies on the effect of vagotomy on parietal cells in rats toxicology and carcinogenesis studies of ampicillin trihydrate in f344/n rats and b6c3f1 mice animal models for gastric helicobacter immunology and vaccine studies fundal gastritis after billroth-ii type resection in patients with duodenal ulcer mesovarial leiomyomas in rats in a chronic toxicity study of musuprine hydrochloride current concepts in mucosal immunity v. role of m cells in transepithelial transport of antigens and pathogens to the mucosal immune system the influence of food additives and related materials on lower bowel structure and function the interactions of lectins with animal cell surfaces immunohistochemical localization of carbonic anhydrase in submandibular salivary glands of mice and hamsters treated with phenylephrine, testosterone or duct ligation tumours of the oral cavity, pharynx, oesophagus and stomach distribution of glutathione and its related enzymes in small intestinal mucosa of rats the ulcerogenic effect on the oesophagus of three î²-adrenoceptor antagonists, investigated in a new porcine oesophagus test model goblet cell hyperplasia is a feature of the adaptive response to jejunoileal bypass in rats a study on carcinogenesis induced by degraded carrageenan arising from squamous metaplasia of the rat coloretum differences in thegastro-intestinal mirobiota of specific pathogen free mice: an often unknown variable in biomedical research paneth cells and innate immunity in the crypt microenvironment. gastroenterology mucosal immunity and inflammation iv. paneth cell antimicrobial peptides and the biology of the mucosal barrier entero-hepatic cycling in rats plays a major role in fatal nsaid intestinal ulcerogenicity sequential uptake of horseradish peroxidase by lymphoid follicle epithelium of peyer's patches in the normal unobstructed mouse intestine: an ultrastructural study antigen processing structures of the mammalian intestinal tract: an sem study of lymphoepithelial organs cytochemical analysis of alkaline phosphatase and esterase activities and of lectin-binding and anionic sites in rat and mouse peyer's patch m cells predicting anticancer drug effects in man from laboratory animal studies the anatomical basis for the immune function of the gut morphological and histochemical changes in intestinal mucosa in the reserpine-treated rat model of cystic fibrosis the pericryptal fibroblast sheath. iv. replication, migration and differentiation of the subepithelial fibroblasts of the crypts and villus of the rabbit jejunum comparative analysis of the 16s rna gene sequence of the putative agent of proliferative ileitis of hamsters histochemistry: theoretical and applied h2-receptor antagonists and gastric cancer diagnostic exercise: inter-mandibular swelling in rats depletion of salivary gland epidermal growth factor by silodacryoadenitis virus infection in the wistar rat biology and biochemistry of papillomaviruses lescol (fluvastatin sodium) the cytology of salivary glands salivary gland sexual dimorphism: a brief review enzyme histochemistry of the human stomach with special reference to intestinal metaplasia nitrates and gastric cancer mucosal immunity and inflammation v. innate mechanisms of mucosal defense and repair: the best offense is the best defense derivation of mouse intestinal rypts from single progenitor cells twenty-one month evaluation of misoprostol for carcinogenicity in cd-1 mice association of long lasting unsurmountable histamine h2 blockade and gastric carcinoid tumours in the rat changes in the gastric mucosa of the mouse associated with long lasting unsurmountable histamine h2 blockade pharmacological and toxicological effects of chronic porcine growth hormone administration in dogs campylobacter jejuni enteritis in man and domestic animals is ethanol-induced damage of the gastric muosa a hyperosmotic effect? comparative studies on the effects of ethanol, some other hypperosmotic solutions and acetyl-salicylic acid on rat gastric mucosa synergistic interaction between aspirin, or other non-steroidal antiinflammatory drugs, and stress which produces severe gastric mucosal damage in rats and pigs the effects of aspirin and other non-steroid anti-inflammatory/analgesic drugs on gastrointestinal mucus glycoprotein biosynthesis in vivo: relationship to ulcerogenic actions electron microscopic observations comparing the gastric mucosal damage induced in rats and pigs by benoxaprofen and aspirin, reflecting their differing actions as prostaglandin-synthesis-inhibitors megaoesophagus in icrc mice compylobacter-like organisms in the gastric mucosa of rhesus monkeys gastric cancer in patients who have taken cimetidine effect of cimetidine on gastric juice n-nitrosamine concentration cryptosporidium cuniculus in the rabbit clostridium difficile colitis in a rabbit following antibiotic therapy for pasteurellosis clostridium difficile antitoxin neutralization of cecal toxin(s) from guinea pigs with penicillin-associated colitis clostridium difficile typhlitis in hamsters not associated with antibiotic therapy clostridial enteropathies, hamster spontaneous non-neoplastic gastric lesions in female han: nmri mice, and influence of food restriction throughout life saponification-induced increase in the periodic-acid-schiff reaction in the gastrointestinal tract. mechanism and distribution of reactive substance structure and carbohydrate histo-chemistry of postnatal canine salivary glands recombinant human epidermal growth factor 1-48 -induced structural changes in the digestive tract of cynomolgus monkeys (macaca fascicularis) influence of long-term 16,16-dimethyl prostaglandin e2 treatment on the rat gastrointestinal mucosa digestion and absorption of carbohydrate and nitrogeneous matter in hindgut of the omnivorous non-reminant animal salivary glands in longterm alloxan-diabetic rats. a quantitative light and electron-microscopic study digestive system: intestines. in: histology. a text and atlas helicobacter pylori-infected human antral primary cell cultures: effect on gastrin cell function the gastrointestinal tract dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications histochemical study on the paneth cell in the rat ultrastructural observations on the pathogenesis of aspirin-induced gastric erosions dietary related periodontitis and oro-nasal fistulation in rats abnormal skeletal and dental growth in epileptic children tooth root resorption induced in rats by diphenylhydantoin and parathyroidecotomy light microscopic morphometric analysis of rat ileal mucosa. i. component quantitation if iga-containing immunocytes short-term effects of various phenols and acids on the fischer 344 male forestomach epithelium enzootic and epizootic adrenal medullary proliferative diseases of rats: influence of dietary factors which affect calcium absorption campylobacter pylori, gastritis, and peptic ulcer disease in central africa the effect of diet on the mammalian gut flora and its metabolic activities interactions of the gut microflora and the host in toxicology naturally occurring tumors and other lesions of the digestive tract in untreated c57bl mice pathology of tumours in laboratory animals. tumours of the mouse esophageal impaction in the bhe rats minimal invasive carcinoma of the colon in rats early effects of alloxan on rat submandibular gland cyclic motor activity; migrating motor complex age-related changes of rat submandibular gland: a morphometric and ultrastructural study indomethacin produces gastric antral ulcers in the refed rat quantitative electron microscopic observations on paneth cells of germ-free and ex-germ-free wistar rats immunohistochemical observations of immunoglobin a in the paneth cells of germ-free and formerly-germ-free rats pigmentary changes in the rat oral mucosa following antimalaria therapy monoclonal antibodies to a zinc-binding protein of rat paneth cells age, weight and social effects on ulceration in rats the evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man gingival fibromatosis, macaca mulatta identification and mutagenicity of metabolites of aristolochic acid formed by rat liver melanosis coli: a study with the electron microscope light microscopic detection of sugar residues in glycoconjugates of salivary glands and the pancreas with lectin-horseradish peroxidase conjugates. i. mouse light microscopic detection of sugar residues in glycoconjugates of salivary glands and the pancreas with lectin-horseradish peroxidase conjugates genetic and sex-related differences in the structure of subnmandibular glycoconjugates mucosal microhernias in the nonhuman primate colon: their role in the pathogenesis of colonic diseases quantitative age changes in the histological structure of human submandibular salivary glands immunohistological characterization of intra-epithelial lymphocytes of the human gastrointestinal tract chronic duodenal ulcers in pantothenate deficient mice focal avillous hyperplasia of the mouse duodenum colon epithelium. i. light microscopic, histochemical, and ultrastructural features of normal colon epithelium of male fischer 344 rats colon epithelium. ii. in vivo studies of colon carcinogenesis. light microscopic, histrochemical, and ultrastructural studies of histogenesis of azoxymethane-induced colon carcinomas in fischer 344 rats two types of mucous cells in the colon crypt carrageenan ulceration as a model for human ulcerative colitis. lancet, ii comparative histochemistry of gastro-intestinal mucosubstances assessment of risk of formulation of carcinogenic n-nitroso compounds from dietary precursors in the stomach granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study marked epithelial hyperplasia of the rat glandular stomach induced by long-term administration of iodoacetamide a profile of the gastrointestinal toxicity of drugs used to treat inflammatory diseases morphology and cyto-chemistry of rat salivary gland acinar secretory granules and their alteration by isoproterenol. i. parotid gland effects of sodium salicylate on epithelial cells of the rectal mucosa of the rat: a light and electron microscopic study the effects of long-term propranolol on the salivary glands and intestinal mucosa of the mouse effects of cardiotonic phosphodiesterase inhibitors on rat salivary gland. presented at the 39th annual acvp meeting inhibitors of sterol synthesis. morphological studies in rats after dietary administration, administration of 5 î±-cholest-8(14)-en-3î²-ol-15-one, a potent hypocholesterolemic compound m cell numbers increase after transfer of spf mice to a normal animal house environment strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes pathology of laboratory rats and mice anatomy of the cecum of the laboratory mouse and rat gastric carcinoids and related endocrine growths pathogenesis of peptic ulcer and implications for therapy histochemical distribution of lysozyme activity in organs of normal mice and radiation chimeras human peyer's patches: an immunohistochemical study diamine methods for differentiating mucosubstances histochemically metabolic and morphometric changes in small and large intestine in rats fed high-fiber diets melanosis coli: studies of the toxic effects of irritant purgatives surface morphology of the gastroduodenal mucosa in duodenal ulceration the effect of vincristine on dentino-genesis in the rat incisor. scand autoradiographic investigation of dentine production in rats incisosrs after vincristine administration. scand acute and late radiation injury in rhesus monkey parotid glands. evidence of interphase death unique radiosensitivity of serous cells in rhesus monkey submandibular glands pathologic observations on the adenomatous lesions of the stomach in mice of strain i carcinoma of the glandular stomach of rats ingesting n,nâ´2 ulcerative enterocolitis in dogs induced by drugs aspirininduced glandular dysplasia of the stomach. histologic and histochemical studies in rats effect of lumenal contents on colonic cell replacement pathologic findings in the stomach of rats treated with the h2-receptor antagonist tiotidine morphologic stomach findings in rats and mice treated with the h2-receptor antagonists, ici 125211 and ici 162846 lectin-peroxidase reactivity in rat gastric mucosa tumour production in glandular stomach of rat by nmethyl-nâ´nitro-n-nitrosoguanidine ageing affects the drug metabolism systems of rat liver, kidney, colon and lung in a differential fashion oral papillomatosis in new zealand white rabbits diagnostic exercise: lingual growths in rabbits immunoperoxidase localization of papillomaviruses in hyperplastic and neoplastic epithelial lesions of animals hypergastrinemia after blockade of acid secretion in the rat. trophic effects pathological features of the colonic tumors induced in rats by the administration of 1,2-dimethylhydrazine comparative studies on the gastrointestinal lesions caused by serveral non-steroidal anti-inflammatory agents in the rats cells intermediate between mucous neck cells and chief cells in rat stomach fine structure of giant hypertrophic gastritis developed in thymectomized mice hyperplastic gingivitis in a child receiving sodium valproate treatment dopamine disorderin dodenal ulceration biology of disease. pathogenesis of duodenal ulcer disease from cysteamine to mptp: structure-activity studies with duodenal ulcerogens digestive system. monographs on pathology of laboratory animals role of salivary mucins in the protection of the oral cavity effects of 16,16-dimethyl prostaglandin e2-methyl ester on aspirin-and indomethacin-induced gastrointestinal lesions in dogs hypertrophic gastropathy resembling menetrier's disease in transgenic mice overexpressing transforming growth factor î± in the stomach tumours of the oral cavity, buccal pouch, oesophagus, forestomach and salivary glands nodular hyperplasia of oncocytes in mouse submandibular glands early colonic lesions in experimental shigella infections in rhesus monkeys: revisited variation in susceptibility to the induction of forestomach tumours by butylated hydroxyanisole among rats of different strains pathology of neoplasia and preneoplasia in rodents independent induction of intestinal metaplasia and gastric cancer in rats treated with n-methyl-nâ´-nitro-n-nitrosoguanidine the response of three inbred strains of rat to the carcinogen 1,2-dimethylhydrazine small intestinal type' and 'colonic type' intestinal metaplasia of the human stomach and their relationship to the histogenetic types of gastric adenocarcinoma light and electron microscopic cytochemistry of glycoconjugates in the recto-sigmoid colonic epithelim of the mouse and rat preclinical toxicologic evaluation of bleomycin (nsc 125 006), a new anti-tumor antibiotic oral squamous cell carcinoma in ad libitum-fed and food restricted brown-norway rats the pathoparasitology of the alimentary tract and pancreas of non-human primates: a review t cell attractant chemokine expression initiates lacrimal gland destruction in nonobese diabetic mice altered patterns of mucin secretion in the precancerous lesions induced in the glandular part of the rat stomach by the carcinogen n-methyl-nâ´nitro-n-nitrosogaunidine immunohistochemistry and radioimmunoassay of egf in submanidbular glands of mice treated with secretogogues carcinogenicity of cyproterone acetate preclinical toxicology studies with acylovir: acute and sub-chronic tests the influence of adrenoreceptor activity on crypt cell proliferation in rat jejunum a sporozoan found in the peptic glands of the common mouse cyclophosphamide-induced abnormalities in the incisors of the rat spontaneous adencarcinoma of the ascending colon in wistar rats: the intracytoplasmic presence of a campylobacter-like bacterium inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs spontaneous hyperplastic and metaplastic duct epithelium in the sublingual salivary glands of wistar rats spontaneous tuors of the syrian hamster: observations in a closed breeding colony and a review of the literature mucin gene structure and expression: protection vs. adhesion morphological effects of high dose neomycin sulphate on the small and large intestine comparative and experimental pathology of fibrosing colonopathy intestinal pathology in the dog induced by sublethal doses of amiodarone pharmacological effects of epidermal growth factor (egf) with focus on the urinary and gastrointestinal tracts chemically induced lipidosis of the small intestinal villi in the rat lesions of experimentally induced tyzzer's disease in syrian hamsters, guinea pigs, mice and rats hexamitis in laboratory mice, hamsters, and rats melanosis coli: a consequence of anthraquinone-induced apoptosis of colonic epithelial cells safety evaluation of cimetidine: report at the termination of a seven-year study in dogs hypopigmentation in dogs treated with an inhibitor of platelet aggregation gingival hyperplasia in dogs induced by oxodipine, a calcium channel blocking agent cholecystokinin receptors gastrointestinal ph measurement in rats: influence of microbial flora, diet and fasting morphogenesis of chemically induced neoplasms of the colon and small intestine in rats natural history of intestinal neoplasms induced in rats by a single injection of methyl (acetoxymethyl) nitrosamine proliferative lesions of the glandular stomach and liver in f344 rats fed diets containing aroclor 1254 experimentally induced intestinal metaplasia in wistar rats by x-ray irradition. gastroenterolgy effect of dietary undegraded carrageenan on colon carcinogenesis in f344 treated with azoxymethane or methyl-nitrosourea induction of intestinal metaplasia in the rat gastric mucosa by local x-irradiation the effect of sex difference on induction of intestinal metaplasia in rats distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboylase as a marker replacement of functional parenchymal cells by fat and connective tissue in human submandibular salivary glands. an age related change canine papilloma: progression of oral papilloma to carcinoma bacterial and mycotic disease dental health of survivors of malignant disease analysis of protein synthesis in rat salivary glands after chronic treatment with î²-receptor agonists and phosphodiesterase inhibitors mucinous carcinoma of the ileum in the rat mucin histochemistry of gastric intestinal metaplasia long-term effects of an inotropic phosphodiesterase inhibitor (ici 153,110) on rat salivary gland, hardarian gland and intestinal mucosa the synovial membrane, liver, and tongue: target organs for a ricin a-chain immunotoxicin (zd0490) ultrastructural localization of acid mucosubstances in the mouse colon with iron-containing stains quantitation of glandular gastric changes in rats given a proton pump inhibitor for 3 months with emphasis on sampling scheme selection aberrant crypt foci in the colonic mucosa of rats treated with genotoxic and nongenotoxic colon carcinogen the interactions of diet and colonic microflora regulating colonic mucosal growth selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastro-intestinal damage iinduced by indomethacin in the rat a biochemical basis for the gastro-intestinal toxicity of non-steroid antirheumatoid drugs butylated hydroxianisole mechanistic data and risk assessment: conditional species-specific cytotoxicity, enhanced cell proliferation, and tumor promotion menetrier's disease presenting as iron deficiency anaemia radioautographic and quantitative studies on parietal and peptic cell kinetics in the mouse: a selective effect of gastrin on parietal cell proliferation intestinal adaptation. structural, functionaland cytokinetic changes instestinal adaptation. mechanisms of control mucosal mast cells of the rat intestine: a re-evaluation of fixation and staining properties with special reference to protein blocking and solubility of the granular glycosaminoglycan effect of mixtures of dietary fibres on the enzyme activity of the rat caecal microflora effect of prolonged metiamide medication on the fundic mucosa the membraneous epithelial (m) cell and the mucosal immune system medical progress: gastrointestinal toxicity of nonsteroidal antiinflammatory drugs nitrosatable drugs: an assessment of the risks assessing the safety of drugs for the long-term treatment of peptic ulcers the mechanism of mitrazepam-induced drooling and aspiration blood vessels of the peyer's patch in the mouse. iii high endothelial venules ultrastructural basis of intestinal absorption the effects of omeprazole and famotidine on mucin and pge 2 release in the rat stomach forestomach ulcers in crj:b6c3 (c57bl/6ncrj ã� c3h/hencrj) f1 mice forestomach ulcers in crj:b6c3 (c57bl/6ncrj ã� c3h/hencrj) f1 mice an evaluation of ampicillin pharmacokinetics and toxicity in guinea pigs drug-induced gastro-intestinal disease naturally occurring intestinal neoplasms in aged crl:cd â® br rats key: cord-265299-oovkoiyj authors: hickman, d.l.; johnson, j.; vemulapalli, t.h.; crisler, j.r.; shepherd, r. title: commonly used animal models date: 2016-11-25 journal: principles of animal research for graduate and undergraduate students doi: 10.1016/b978-0-12-802151-4.00007-4 sha: doc_id: 265299 cord_uid: oovkoiyj this chapter provides an introduction to animals that are commonly used for research. it presents information on basic care topics such as biology, behavior, housing, feeding, sexing, and breeding of these animals. the chapter provides some insight into the reasons why these animals are used in research. it also gives an overview of techniques that can be utilized to collect blood or to administer drugs or medicine. each section concludes with a brief description of how to recognize abnormal signs, in addition to lists of various diseases. the mouse is a small mammal that belongs to the order rodentia ( fig. 7 .1). the house mouse of north america and europe, mus musculus, is the species most commonly used for biomedical research. it is likely that the mouse originated in eurasia and utilized its commensal relationship with humans to spread through to other continents as humans explored and colonized. mouse fanciers around the turn of the 20th century are the source of the majority of the laboratory mice that are in use today. a summary of the overarching categories of mouse models that are available is presented in table 7 .1. physiology; and the possibility for breeding genetically manipulated mice and mice that have spontaneous mutations. mice have been used as research subjects for studies ranging from biology to psychology to engineering. they are used to model human diseases for the purpose of finding treatments or cures. some of the diseases they model include: hypertension, diabetes, cataracts, obesity, seizures, respiratory problems, deafness, parkinson's disease, alzheimer's disease, various cancers, cystic fibrosis, and acquired immunodeficiency syndrome (aids), heart disease, muscular dystrophy, and spinal cord injuries. mice are also used in behavioral, sensory, aging, nutrition, and genetic studies. this list is in no way complete as geneticists, biologists, and other scientists are rapidly finding new uses for the domestic mouse in research. mice are mammals and their organ systems are very similar to organ systems in humans in terms of shape, structure, and physiology. basic physiologic data are presented in table 7 .2. mice have very long loops of henle in the kidneys, thus allowing for maximal concentration of their urine. as a result, urine output in mice usually consists of only a drop or two of highly concentrated urine at a time. they also excrete large amounts of protein in their urine with sexually mature male mice excreting the largest levels of protein possibly as pheromones. mice have only two types of teeth, incisors and molars. the incisors are openrooted and erupt (i.e., grow) continuously throughout their lives. this predisposes mice to malocclusion if not given feeds or objects such as nylon bones to help wear down the teeth during mastication. the molars are rooted and, thus, do not continuously erupt. the stomach has two compartments with the proximal portion completely keratinized and the distal portion entirely glandular. their intestines are simple, but the rectum is very short (1e2 mm) and hence is prone to prolapse, especially if the animal has colitis. the gastrointestinal flora consists of more than 100 species of bacteria that form a complex ecosystem that aids digestion and health of the mouse. mice have no sweat glands but have a relatively large surface area per gram of body weight. this results in dramatic changes in physiology and behavior in response to fluctuations in ambient temperature. when too cold, mice will respond by nonshivering thermogenesis (i.e., metabolism of brown adipose tissue). in addition to the lack of sweat glands, they cannot pant or produce large amounts of saliva to aid in cooling their body temperature. therefore, when exposed to very hot situations, mice increase the blood flow to their ears to maximize heat loss; and in the wild, they move into their burrows which are at cooler temperatures. the thermoneutral zone, the range of ambient temperatures at which the mouse does not have to perform regulatory changes in metabolic heat production or evaporative heat loss to maintain its core temperature, is about 85.3 fe86.9 f (29.6 ce30.5 c). the female reproductive system is comprised of paired ovaries and oviducts, uterus, cervix, vagina, clitoris, and paired clitoral glands. pregnant female mice have hemochorial placentation, similar to humans (i.e., maternal blood is in direct contact with the chorion, the outermost layer of the fetal placental membranes). the female mouse also has five pairs of mammary glands. the male reproductive system consists of paired testes, penis, and associated sexual ducts and glands. the inguinal canals are open in the male mouse, and the testes can retract easily into the abdominal cavity. both sexes have well-developed preputial glands, which can become infected. males have a number of accessory sex glands, including large seminal vesicles, coagulating glands, and a prostate. secretions from these glands make up a large part of the mouse's ejaculate. when mice ejaculate, the semen forms a coagulum or copulatory plug. mice breed continuously throughout the year unless conditions are very unfavorable to them (e.g., lack of food). their reproductive potential can be affected by a number of external influences such as noise, diet, light cycles, population density, or cage environment. genotype also can affect reproductive performance as it is common knowledge that some inbred strains of mice are poor breeders, and if pups are born they may receive poor maternal care. additional reproductive physiologic data are presented in table 7 .3. mice can be bred using a one-on-one system (one male to one female; monogamous) or in a harem mating system (polygamous mating). in a monogamous system, the male and female are always left together, but at weaning the pups are removed from the cage. this system allows for maximal use of the postpartum estrus and the maximum number of litters for the females involved, and facilitates recordkeeping and monitoring of specific breeders in the colony. in a harem mating system, multiple males are placed with multiple females, usually at a ratio of one male to two to six females. usually, females are removed to separate cages just before parturition and the postpartum estrus is underutilized. mouse pups are born hairless, blind, and deaf and require extensive parental care that is provided mainly by the mother. due to the ruddy coloration of the skin of the hairless pups, they are also known as "pinkies." while mouse pups can increase their body temperature through the metabolism of brown fat stores, they are unable to adequately conserve body heat until they develop an adequate fur coat. thus, inclusion of nesting materials in the cage is highly recommended as huddling inside the nest can provide much needed warmth and safeguard against temperature-associated neonatal losses. the most reliable method for determining the sex of a mouse is by measuring the length of the anogenital distance, i.e., the distance from the anus to the genitalia. this distance can be measured with a ruler or animals assessed side by side with the rear ends held up by their tails. the anogenital distance is longer in males than females. in sexually mature animals one can also determine the sex of mice by the presence or absence of testicles in a testicular sac. mice are social creatures and can be group housed easily. their main method of communication is via pheromones. they use these olfactory cues to establish a pecking order (i.e., a hierarchical system of social organization). these chemicals are so important that when cage environments are changed, such as by simple cleaning or with bedding changes, a bout of fighting may occur until scent marking of the cage is completed as a way to reestablish the pecking order and social organization in that cage. pheromones also play a vital role in reproduction of these animals. this is demonstrated by the whitten effect and the bruce effect. the whitten effect occurs when a group of female mice that are not cycling are exposed to male urine, which contains a large quantity of pheromones. the females will all resume cycling as a group soon after the introduction of the male. in contrast, the bruce effect is characterized by abortion of litters when pregnant females are exposed to the urine of a strange male. as with most rodents, mice are nocturnal animals exhibiting peak levels of activity at night. because mice are a prey species, they display thigmotactic behavior or wall hugging. they avoid open spaces where they might be easily caught by predators. despite this, mice are very curious about any new objects in their territory and will often examine them at length. mice not only have poorly developed eyesight but they are also color blind. a number of inbred strains (e.g., fvb/n and c3h/he) are functionally blind by weaning. they rely on their very sensitive hearing to escape detection and on their sense of smell and taste to detect food (and possibly avoid poisons). mice can hear over a range of frequencies between 0.5 and 120 khz; however, normal mice are most sensitive to frequencies of 12e24 khz. it is important to note here that some inbred strains of mice, e.g., c57bl/6, suffer significant hearing loss before 1 year of age. mice can climb, swim, and jump (up to a foot), though they normally prefer to avoid swimming, if possible. under certain conditions they display stereotypies, which are obsessiveecompulsive behaviors. the behaviors may be strain-related, environment-related, or study-related and include wire gnawing, circling, jumping, and aggression. the use of environmental enrichment items such as cardboard tubes or other structures offer the animal an area for retreat from cage mates and add complexity to the environment. aggression is another important behavior that commonly occurs in group-housed male mice. it can also occur in group-housed females and mixed-sex cages. indications that there is an aggressive animal in the cage include bite wounds on the tail, rump, ears, and shoulders of mice ( fig. 7 .2). the wounds can be so severe as to cause significant blood loss and abscess formation at bite sites. aggression has been shown to be influenced by strain, age, and prior encounters. in terms of strains, the more aggressive strains are balb/c, c57bl/10, c57bl/6, dba/2, and outbred swiss. methods to prevent or reduce aggression include use of properly designed enrichment devices; provision of adequate space and shelter for each animal; grouping of mice before they reach puberty; use of docile strains; and removal of dominant animals as soon as possible. a common manifestation of social organization in group-housed mice is barbering, a behavior in which a dominant mouse will trim, by chewing, the hair or whiskers of other mice in the cage. barbering is also sometimes referred to as the dalila effect. it is usually instigated by a dominant male or female mouse. the dominant animals retain their whiskers and full hair coats, while their cage mates have "shaved faces and bodies" (fig. 7. 3) . although barbering does not generally result in any physical harm to the animal, removing the dominant mouse (the nonbarbered one) from the cage is a good approach to control. general types of housing mice in a laboratory setting include: conventional, specific pathogen free (spf), and germ free. in conventional housing, no attempt is made to keep out adventitious microbial and parasitic organisms. mice housed in this manner can be found in open-topped cages. room air, along with any airborne contaminants, is allowed to freely circulate into the mouse's cage. in addition, the food and water are not sterilized, though it should be noted that microbial contaminants may enter into the mouse population in this way. spf mice are raised in barrier conditions to ensure that they remain free of a specific list of pathogens. care is taken to ensure that adventitious microbes and parasites are excluded from the animals. spf mice are typically raised in specialized caging such as microisolator cages. these cages contain a 0.22 mm filter top that aids in the exclusion of microbes and parasites. individually ventilated caging systems include a rack of microisolator cages, each of which receives a filtered air supply ( fig. 7.4) . under spf conditions, everything that comes into contact with the animal should be sterilized or disinfected. this includes, but is not limited to, the water, food, bedding, and caging. special care must be taken by anyone handling the mice, including researchers, to ensure that handling and experimental procedures do not introduce potential pathogens into the colony. thus, all handling and procedures done on spf mice are often performed under hepa-filtered air conditions, such as within a biosafety cabinet. placing the mouse in an unfiltered environment ("room" air), even for a moment, is enough to potentially colonize the mouse with a whole host of adventitious microorganisms, thus destroying its spf status. once a contaminated mouse is placed back into the colony, the entire colony is at risk for infection. germ-free, or axenic, mice are raised to contain no microbes or parasites whatsoever. raising germ-free mice requires strict barrier maintenance. usually, this requires the use of flexible film isolators which provide hepa-filtered air to the mice within the isolator. additionally, any materials (e.g., food, water, and bedding) must be sterilized or thoroughly disinfected prior to being moved into the isolator unit so as not to contaminate the living space of the germ-free rodents with adventitious microorganisms. all procedures performed within the flexible film isolator must utilize strict aseptic technique for the same reason. in addition to the microbiological environment of the animal's housing systems, mice need to be housed at specific environmental parameters otherwise they may experience stress. the guide for the care and use of laboratory animals, 8th edition (national research council, 2011) is an internationally accepted document that outlines and discusses globally accepted environmental parameters for housing different species of animals including the mouse. table 7 .4 outlines the specific environmental requirements listed in this document for housing mice. mice are omnivorous and coprophagic with at least one-third of their diet being the consumption of their feces. in the laboratory setting mice are fed a clean, wholesome, and nutritious pelleted rodent diet ad lib. there are many commercially formulated diets for the various stages of life and for animals with specific induced diseases such as diabetes mellitus or hypertension. these diets may be available as autoclavable or irradiated forms to prevent transmission of disease via contaminated feed. there are also a variety of "pet" treats available for mice. however, the treats should not make up more than 5e10% of the daily diet. mice should be provided with a continuous supply of water daily. if the animals do not get enough water daily, their food consumption will decrease. the animals will also look scruffy and unhealthy. mice can be provided with water from water bottles or pouches, automatic watering systems with nipples, or water-based gel packs. some general signs of ill health include: weight loss, depression or lethargy, anorexia, obesity, diarrhea, scruffiness or ruffled coats, abnormal breathing, sneezing, weakness, dehydration, enlarged abdomen, discolorations (e.g., yellow for jaundiced animals or very pale for anemic animals), masses or swellings, and abnormal posture or gait. body condition scoring is an objective measure to truly assess how fat or thin the animal is and can be used for accurate determination of endpoints in studies where animals are expected to lose or gain weight ( fig. 7 .5) (ullman-cullere and foltz, 1999) . some of the more commonly found diseases of mice are presented in table 7 .5. noninfectious disorders are presented in table 7 .6. based on their genetic and physiologic makeup, mice can be either immunocompetent or immunodeficient. immunocompetent means that the mouse has a normal functioning immune system and can stage an immune response to any insult or injury. in contrast, immunodeficient means that some component or components of the mouse's immune system is not working or functioning normally, and so they cannot stage an adequate immune response and are more susceptible to infectious disease. immunosuppressed mice are mice that have a complete immune system but because of a drug or chemical or disease state, the immunological response is attenuated. rats and humans have a long history of coexistence. the origins of the laboratory rat, also known as the norway rat, stretch back centuries to the areas of modern day china and mongolia (burt, 2006; song et al., 2014) . the dispersal of the norway rat has occurred across the centuries and its natural habitat stretches from the mediterranean across southeast asia and down into australia and new guinea . unfortunately, most people associate rats with disease and destruction. throughout history, outbreaks of bubonic plague, typhus, and hantaviruses have had an unwitting accomplice in the rat (zinsser, 1935; benedictow, 2004; firth et al., 2014) . over the centuries, rats have also been used for food (e.g., in imperial china), companionship, and sport (gorn and goldstein, 2004; hopkins et al., 2004; burt, 2006) . ratting, a vicious blood sport where people laid bets on the dog that could kill the most rats in a given period of time was especially popular in both the victorian england and american underworld (thomas and mayhew, 1998; gorn and goldstein, 2004) . at the turn of the 20th century, breeding rats as a hobby or for companionship (i.e., "fancy rats") was recognized by the addition of "rat" to both the name and mission of national mouse club in the united kingdom (american fancy rat and mouse association, 2014). however, as interest in pet rats waned over the following years, the club reorganized and dropped "rat" from its name. a similar club, the american fancy rat and mouse association, was founded in the united states in 1983 (american fancy rat and mouse association, 2014). the first recorded use of rats as research subjects occurred in 1828 (hedrich, 2000) , and the first known rat breeding experiments occurred in the late 1800s (lindsey and baker, 2006) . the first major effort to perform research in the united states using laboratory rats occurred at the wistar institute of philadelphia, the oldest independent research institute in the united states, in 1894 (lindsey and baker, 2006) . rattus norvegicus constitutes one of the most commonly used laboratory species ( fig. 7 .6), second only to the laboratory mouse. because rats and mice are not included under the animal welfare act regulations, the precise number of these species used per year within the united states is unavailable. however, examining the data collected within the european union can give some indication of their use relative to other common laboratory animal species. in 2011, rats accounted for just fewer than 14% (1.6 million) of the total animals (11.5 million) used in research within the european union (european commission, 2013) . this contrasts to mice, which constituted 61% (6.9 million) of the total animals used within the european union (european commission, 2013). rats possess a number of qualities which make them a highly suitable and much preferred animal model. like mice, these traits include relatively small size; known genetic background; short generation time; similarities to human disease conditions; and known microbial status. their tractable nature makes them easier to handle in a laboratory setting than many other rodents. rats rarely bite their handlers unless extremely stressed or in pain. rats have been used as animal models in numerous areas of research from space exploration to answering more basic scientific questions regarding nutrition, genetics, immunology, neurology, infectious disease, metabolic disease, and behavior. perhaps their largest use is in drug discovery, efficacy, and toxicity studies. in the united states, the approval of any new drug for use in humans or animals usually necessitates that toxicity testing be done in at least one small animal species (e.g., rodents) and one large animal or target species (e.g., dog, nonhuman primate). there are known physiologic differences between the numerous outbred stocks and inbred strains of rats. the rat genome database (rgd) is an extensive, free resource filled with information regarding the different phenotypes, models, and genomic tools used in rat research (laulederkind et al., 2013) . vendors of commercially available rat stocks and strains are often good resources for normal physiologic data of these strains. many provide stock-and strain-specific data directly on their websites such as growth curves, complete blood count and serum biochemistry panels, and spontaneous lesions seen on histopathology. a summary table of normal physiologic references is in table 7 .7. sexual dimorphism exists between male and female rats. sexing of adult rats is most easily done by examining the perineal area of the rat and identifying the external reproductive structures such as the penis, testes, or vagina. in addition, male rats are typically larger and weigh significantly more than their age-and strainmatched female counterparts. sexing of rat pups is most easily performed by examining the distance between the anus and genital opening in the pup. males have a greater anogenital distance than females. male rats possess paired testicles that descend from the abdomen into the scrotal sac at approximately 15 days of age (russell, 1992) . due to the lack of closure of the inguinal rings, the testes may be retracted into the abdominal cavity even as an adult. the male rat also possesses a number of accessory sex glands. a four-lobed prostate is present along with four other paired glands, including: the seminal vesicles, coagulating glands, ampullary glands, and bulbourethral glands (noted in some texts by the older name, cowper's gland) (popesko et al., 1992) . due to the unusual bihorned shape of the closely associated coagulating gland and seminal vesicles, individuals unfamiliar with rodent male anatomy may initially mistake these structures for the female uterus. however, the apices of these glands are freely mobile and easily exteriorized from the abdominal cavity unlike the uterus, which is attached to the dorsal body wall bilaterally via paired ovaries and their respective ovarian ligaments. the reproductive anatomy of the female rat contains some distinct features. the uterus of the female rat is classified as a duplex uterus, because the vagina is separated from the uterus by two individual cervices with each cervix leading to a separate uterine horn (popesko et al., 1992) . the placentation of the pregnant rat is hemotrichorial (three layers) rather than the hemomonochorial (single layer) placentation present in humans (wooding and burton, 2008) . the rest of the reproductive anatomy (e.g., ovary, oviduct) is structurally and functionally similar to other mammals. a summary of basic reproductive physiology is presented in table 7 .8. rat pups are born hairless, blind, and deaf and require extensive parental care that is provided mainly by the mother. as with mice, the skin of the hairless rat pups has a pink coloration, thus they are also referred to as "pinkies." the inclusion of nesting materials in the cage is recommended to assist the rat pups with thermal regulation until they have a full hair coat (whishaw and kolb, 2005). like other rodents, rattus norvegicus is a nocturnal species with the highest level of activity occurring during the dark phase. behaviors exhibited by rats include grooming, nesting, eating, and other social behaviors. nesting behavior serves several purposes among rats and mice (gaskill et al., 2012 (gaskill et al., , 2013a . nests allow for better thermoregulatory control within a given environment as well as protection against predation (gaskill et al., 2013c) . recent work in mice suggests that energy not diverted to thermoregulation can be shunted to other activities as seen via improved feed conversion and breeding performance (gaskill et al., 2013c) . however, anecdotal evidence suggests that nest building in rats is largely a learned behavior, and it appears that there is a developmental period in young rats whereupon if exposed to nesting materials during this time they will begin using the materials to build at least rudimentary nests (gaskill, 2014) . at a minimum, rats benefit from having a structural shelter or nest box into which they may rest away from prying eyes ( fig. 7 .7). rats emit alarm vocalizations during times of distress. however, these negatively associated vocalizations typically register in the ultrasonic wavelengths (approximately 22 khz), well outside of the human hearing range (burman et al., 2007; parsana et al., 2012) . rodents may also emit high-pitched audible vocalizations when extremely alarmed, distressed, or in pain (jourdan et al., 1995; han et al., 2005) . as discussed in chapter 5, rats exhibiting abnormal behaviors and stereotypies can create variables in the research findings and should not be used in a study unless abnormal behavior is the object of the study subjects (baenninger, 1967; callard et al., 2000; garner and mason, 2002; cabib, 2005; ibi et al., 2008) . examples of stereotypies seen in rats include: bar-gnawing, pawing behavior, repetitive circling, and backflipping. it is critical that rats should be provided some form of environmental enrichment to stimulate positive species-typical behaviors. the housing of rats in a laboratory setting is similar to that described previously for mice: conventional, spf, and germ free. as rats are social animals, at minimum, they should be housed in pairs whenever possible. there is a preponderance of evidence that shows the differences in affiliative versus aggressive behavior, biochemical changes, and changes in learning between rats raised and housed in social isolation versus those housed in social groups (baenninger, 1967; einon and morgan, 1977; robbins et al., 1996) . enrichment items, such as a hut, nesting box, or similar type of shelter may be included in the cage to provide a visual barrier between the rat and the rest of the animal room. evidence suggests that rats prefer shelters made from opaque plastic (patterson-kane, 2003) . rats also spend a lot of time in the wild chewing either for eating or for manipulating objects for nest building. providing objects made of safe materials in the cage allows the rats to exhibit this natural behavior and encourage the normal wear of the rat's incisors, minimizing the incidence of malocclusion of the teeth. rodents can benefit from frequent gentle handling by the researcher and animal care staff. this concept is also known as "gentling" and has been demonstrated to reduce the stress experienced by rats during experimental handling and procedures (hirsjarvi et al., 1990; van bergeijk et al., 1990) . another positive interaction between humans and rats is found in the "tickling" of rodents. based on ultrasonic vocalization data, rodents find tickling a pleasurable experience (burgdorf and panksepp, 2001; panksepp, 2007; hori et al., 2014) . tickling may also decrease the stress response seen in rodents after experimental manipulations like intraperitoneal injections (cloutier et al., 2014 ). a multilevel cage with an intracage shelter. this style of caging provides opportunities for exercise for the rats. photo provided by melissa swan. as for mice, some general signs of ill health would include: weight loss, depression or lethargy, anorexia, obesity, diarrhea, scruffiness or ruffled coats, abnormal breathing, sneezing, weakness, dehydration, enlarged abdomen, discolorations (e.g., yellow for jaundiced animals or very pale for anemic animals), masses or swellings, and abnormal posture or gait. when assessing animals, a body condition score can be used as an objective measure or scale to truly assess how fat or thin the animal is; and it allows for the accurate determination of endpoints in studies where animals are expected to lose or gain weight (hickman and swan, 2010) (fig. 7.8) . some of the more commonly found diseases of rats are presented in table 7 .9. the ancestral home of the european rabbit (oryctolagus cuniculus) is the iberian peninsula (hardy et al., 1995) . the earliest archeological evidence of the coexistence of humans and rabbits can be found in excavation sites dated at approximately 120,000 years bce in nice, france (dickenson, 2013) . in antiquity, romans used rabbits as a food source and are thought to be responsible for their dispersal throughout europe, although there is no evidence that they attempted to actually domesticate them (dickenson, 2013) . domestication and selective breeding is thought to have begun in france in the middle ages where monks began to breed rabbits in their monasteries (dickenson, 2013) . the rabbits were kept confined in enclosures called "clapiers"(dickenson, 2013). they were kept largely as a source of food for the monks especially since 600 ce when pope gregory i officially classified them as "fish" and thus eligible to being eaten during lent. however, rabbit wool production soon became a welcome by-product of these domestication efforts. european rabbits have been used in research since the middle of the 19th century. early work with the species was concentrated on the comparative anatomy of the rabbit with other species, such as the frog, and the unique features of the rabbit's heart and circulatory system (champneys, 1874; roy, 1879; smith, 1891) . louis pasteur used rabbits in a series of experiments that led to the development of the world's first rabies vaccine (rappuoli, 2014) . while there are numerous so-called "fancy" breeds of rabbits available in the pet trade, the list of breeds routinely used in research is much shorter. the new zealand white (nzw) rabbit is the most frequent breed of used in research (fig. 7.9 ). the california and dutch-belted rabbit breeds are also occasionally used. researchers have developed genetically inbred rabbit strains for particular research applications. for example, the watanabe heritable hyperlipidemic (whhl) and the myocardial infarction-prone whhl rabbit (whhlmi), both developed by researchers in japan, are used to explore diseases associated with dyslipidemia such as atherosclerosis (shiomi et al., 2003; shiomi and ito, 2009) . rabbits have been used as a model of human pregnancy and for the production of polyclonal antibodies for use in immunology research (hanly et al., 1995; ema et al., 2010; ito et al., 2011; fischer et al., 2012) . rabbits are routinely used in (southard et al., 2000; arslan et al., 2003; mcmahon et al., 2005; castaneda et al., 2008; habjanec et al., 2008; manabe et al., 2008; xiangdong et al., 2011; panda et al., 2014; sriram et al., 2014; wei et al., 2014; zhou et al., 2014) . the production of polyclonal antibodies is preferentially performed in the rabbit due to its relatively large blood volume compared to rodents (hanly et al., 1995) . their tractable nature and larger body size also make them suitable for surgical implantation of biomedical devices (gotfredsen et al., 1995; swindle et al., 2005; ronisz et al., 2013) . additionally, rabbits are a favored model in pharmacologic studies for teratogenicity testing of novel pharmaceutic compounds (gibson et al., 1966; lloyd et al., 1999; foote and carney, 2000; jiangbo et al., 2009; oi et al., 2011) . while much of the anatomy of the rabbit is similar to other mammalian species, it should be noted that there are a number of key differences. for example, the skin of the rabbit is quite thin and fragile. care should be taken when restraining a rabbit or shaving a rabbit's fur (e.g., in preparation for surgery) to avoid tearing the skin. unlike rodents and other laboratory animals, rabbits do not have pads on their feet; rather, the plantar surface is covered with fur (quesenberry and carpenter, 2012). new zealand white rabbits are commonly used in research. photo provided by kay stewart. the long ears of the rabbit serve several purposes. the most obvious is for hearing. in addition, the central ear artery and marginal ear veins are easily accessible for both intravenous administration and blood sampling (diehl et al., 2001; parasuraman et al., 2010) (fig. 7.10) . the ears also serve as a means of thermoregulation, as excess heat may be exchanged across the large surface area of the ears (sohn and couto, 2012) . the skin of rabbits lacks sweat glands and is therefore unable to sweat; panting is insufficient to dissipate the excess heat (sohn and couto, 2012) . thus, the ears play a vital role in maintaining proper body temperature. other unique features of the skin and adnexa are the presence of chin and inguinal glands used in scent marking. additionally, the female rabbit (doe) is noted by the presence of a large skin fold filled with subcutaneous fat just under the chin (the dewlap) (sohn and couto, 2012) . the skeleton of rabbits makes up only 8% of the body weight by mass (brewer, 2006) . this is in contrast to other similarly sized mammals. for example, the cat skeleton makes up 12e13% of body weight (brewer, 2006) . the small skeletal mass of the rabbit coupled with strong back muscles mean that the back is prone to traumatic fracture (meredith and richardson, 2015) . proper holding and restraint techniques are necessary to avoid this undesirable outcome. there are several unique features of both the respiratory and cardiovascular systems of rabbits. for example, rabbits are obligate nose breathers (varga, 2014) . this is especially important during procedures involving anesthesia and placement of an endotracheal tube. with respect to the cardiovascular system, the rabbit heart is unique in that the right atrioventricular (av) valve has only two leaflets instead of three (brewer, 2006) . additionally, due to the similarity to humans with respect to the neural anatomy of the ventricles, the rabbit is the species of choice for purkinje fiber research (brewer, 2006) . rabbit teeth are "open-rooted" meaning that they continue to erupt and grow throughout life. this applies to all of the teeth in the rabbit dental arcade (i.e., incisors, premolars, and molars; rabbits do not have canines). this contrasts with rodents, where the incisors are the only open-rooted (or hypsodontic) teeth (sohn and couto, 2012) . thus, rabbit teeth are subject to overgrowth. another unique feature of rabbit dentition that sets them apart from rodents is the presence of a second set of incisors just behind the first set of upper incisors known as "peg" teeth (sohn and couto, 2012) . they are thought to aid in tearing off the succulent leaves of plants while grazing. as an obligate herbivore, the gastrointestinal tract of rabbits differs greatly from that of carnivores and omnivores. rabbits require a high fiber diet of between 14 and 20% (sohn and couto, 2012) . the small intestine is divided up into three main sections: the duodenum, jejunum, and ileum. the ileum connects to the cecum via a structure called the sacculus rotundus. the presence of lymph follicles suggests that the sacculus rotundus has immunological functions. it is sometimes referred to as the ileocecal "tonsil" (jenkins, 2000) . in the rabbit, gastric associated lymphoid tissue is also present in the small intestine and the vermiform appendix (lanning et al., 2000) . the cecum, a large distensible outpouching of the large intestine, holds up to an estimated 40% of the total ingesta (sohn and couto, 2012) . rabbits are considered to be "hindgut fermenters." bacteria present in the cecum ferment the digestible fiber found within the diet. the product of this fermentative process becomes cecotrophs (also known as "night feces"). cecotrophs are excreted roughly 8 h after the initial foodstuffs are ingested (sohn and couto, 2012) . they are softer and more mucoid in appearance than the hard, dry "day feces" produced just 4 h after consuming food (sohn and couto, 2012) . the bulk of day feces consists of the indigestible fiber found in the diet. the sorting of foodstuffs destined to become either day feces or cecotrophs and the timing of their relative excretion is largely dependent upon the neural input of the fusus coli, also termed the "pacemaker" of the colon (sohn and couto, 2012) . the fusus coli is anatomically located between the ascending and transverse colons of the rabbit (popesko, 1992) . consumption of cecotrophs by rabbits is an important part of the digestive process in rabbits as they are rich in b vitamins, such as niacin and b12, and vitamin k (hã¶rnicke, 1981) . while cecotrophs are known colloquially as "night feces," rabbits produce and eat them at all hours of the day (sohn and couto, 2012) . rabbits are agile enough to eat these night feces directly from their anus (sohn and couto, 2012) . those researchers performing digestive research (e.g., fecal collection via metabolism cages) should keep this in mind. sexing of adult rabbits is aided by the sexual dimorphism present in the species. mature females are readily identified by the presence of the dewlap (sohn and couto, 2012) . females have 8e10 nipples, while in males these nipples are present, but rudimentary (sohn and couto, 2012) . nzw rabbits reach sexual maturity between 5 and 7 months (suckow et al., 2002) . reproductive data are summarized in table 7 .10. mature bucks have paired testicles enclosed in paired hairless scrotal sacs (sohn and couto, 2012) . like rodents, the inguinal rings do not close. accessory sex glands include several bilobed organs: the seminal vesicle, vesicular gland, prostate, and paraprostatic gland. the bulbourethral glands of bucks are paired (sohn and couto, 2012) . female rabbits are induced ovulators (dal bosco et al., 2011; sohn and couto, 2012) . that is, the egg does not ovulate spontaneously from the ovary, rather manual stimulation via copulation is required. ovulation occurs approximately 10 h postcopulation (sohn and couto, 2012) . because they are induced ovulators, does do not have a defined estrous cycle. rather, they have periods of sexual receptivity lasting approximately 14e16 days followed by 1e2 days of nonreceptivity. nonfertile matings may result in a period of pseudopregnancy of up to 15e16 days (sohn and couto, 2012) . fertile matings result in pregnancy lasting 31e32 days (sohn and couto, 2012) . the placenta of rabbits is classified as hemodichorial; this is in contrast to humans which have a hemomonochorial placenta (furukawa et al., 2014) . birthing (i.e., parturition; also known as "kindling") occurs most often during the early morning hours (sohn and couto, 2012) . kits are born deaf and blind. by 7 and 10 days of age they can hear and see, respectively (quesenberry and carpenter, 2012) . amazingly, does suckle their young ones daily, usually during the dark phase, and for approximately only 5e6 min (sohn and couto, 2012) . the kits are able to drink about 30% of their entire body weight in that time. wild and domesticated does both follow this nursing behavior. rabbit kits may be weaned between 5 and 8 weeks of age (suckow et al., 2002) . earlier weaning should not be attempted as there may be profound detrimental effects on the functioning of the gastrointestinal system (bivolarski and vachkova, 2014). rabbits are very social, nocturnal creatures. scent marking is a normal and important part of their behavior repertoire. rabbits will rub the secretions from their chin scent glands against inanimate objects, other rabbits, and human handlers in a process called "chinning" (sohn and couto, 2012) . dominance hierarchies are established behaviorally. dominant animals may mount, "barber," or scent-mark subordinates (sohn and couto, 2012) . barbering is the act of chewing the hair of a subordinate animal, usually on the neck and back in the case of rabbits, very close to the skin giving the appearance of having been cut or "barbered" (bays, 2006). rabbits will "thump" one or both back feet on the ground when frightened or as an alarm call to other rabbits (bays, 2006) . highly stressed rabbits may actually emit a loud, piercing scream, especially when roughly caught by an untrained individual (bays, 2006) . it is important to approach rabbits calmly and quietly. relaxed, content rabbits may be heard making a purring sound (bays, 2006) . rabbits benefit by repeated, positive interactions with people similar to the concept of "gentling" in rats (see section 7.2). changes in behavior are often first indication that an animal is in pain. given that rabbits are a prey species, it is evolutionarily speaking not in a rabbit's best interest to display signs of pain. thus, these behaviors are most often quite subtle in nature and may be easily missed if particular attention is not paid. the first sign often seen in a rabbit experiencing pain is a decreased appetite resulting in little to no food intake (sohn and couto, 2012) . rabbits will often grind their teeth (i.e., bruxism) when experiencing pain (sohn and couto, 2012) . other rabbits may simply appear very dull and inactive. as with rodents, rabbits can develop stereotypies. due to the sensitivity of the rabbit's nose and lips many stereotypies involve chewing behaviors. bar chewing, chewing on the water bottle, and self-barbering are all stereotypical behaviors seen in rabbits (gunn and morton, 1995; chu et al., 2004) . in addition, rabbits may engage in "nose sliding" against solid surfaces like the cage walls and head swaying (sohn and couto, 2012) . animals that exhibit stereotypies do not make good research animals. efforts should be made, where possible, to prevent these behaviors through the use of environmental enrichment. enrichment may be in the form of chew-resistant objects (such as plastic dumbbells and stainless steel rattles) and food treats (poggiagliolmi et al., 2011). as a prey species, rabbits benefit from the inclusion of a hut in the cage or at least a visual barrier into which they may retreat when psychologically stressed (baumans, 2005) . breeding females should always have access to a nest box to allow for the necessary expression of normal nesting behavior (baumans, 2005) . being social creatures, ideally rabbits should be housed in compatible pairs or trios unless contraindicated by the research objectives or by incompatibility of the animals (sohn and couto, 2012) . stable social groups formed shortly after weaning, where animals are not added or removed, is most beneficial (boers et al., 2002) . structurally, rabbits benefit from housing that has both adequate vertical and horizontal space (boers et al., 2002) . one recommendation on the space requirements of laboratory rabbits stipulates 16 in. as the minimum vertical cage height (national research council, 2011) . at a minimum, rabbits must be able to comfortably sit upright in the cage without their ears bending over (national research council, 2011) . laboratory rabbits are typically housed in easily sanitized stainless steel cage racks ( fig. 7.11 ). slatted flooring allows for urine and feces to fall through the slats onto special pans fixed below the cage, thus providing for easier sanitation of the cages. however, care must be taken that the slats are of sufficient width so as to prevent a condition known as bumblefoot (see section 7.3.7). dog runs with elevated, slatted flooring or a solid floor with bedding have also been used by some investigators in group-housed rabbits with success (personal observations). again, attention should be paid to the flooring and its effect on foot health. commercially available research diets specifically formulated for rabbits are available. these diets are preferred to so-called "natural diets" and feeding individual vegetables. this is because rabbits tend to be very selective eaters which can lead to nutritional imbalances (fraser and girling, 2009 ). additionally, the use of fresh vegetables may lead to the introduction of unwanted pathogens like salmonella (varga, 2014) . commercial diets are available in maintenance and reproductiveperformance dietary formulations as well as presterilized diets for rabbits housed under spf conditions. rabbits are very easily heat stressed and thus must be kept at significantly lower temperatures than other laboratory animals like rats and mice. noise is another significant stressor to rabbits (verga et al., 2007) . sudden, high-pitched, sharp noises are most disruptive. however, in general, noise within the animal rooms should be avoided as much as possible. for this reason, rabbits should not be housed, even temporarily for short procedures, near areas of high noise. problems in rabbits related to the gastrointestinal system are relatively common. these problems can become serious very quickly. therefore, it is critical that abnormalities seen (e.g., rabbit not eating or abnormal feces) be reported to the veterinary care staff immediately. even if a researcher is unsure if there is a problem, it is best to report suspicions because without prompt intervention, seemingly minor problems can escalate to potentially life-threatening conditions. some of the most commonly seen clinical conditions in rabbits are summarized in table 7 .11. the zebrafish, danio rerio of the cyprinidae family, is a small, dark blue and yellow striped, shoaling, teleost fish, popular among aquarium enthusiasts, and increasingly among the research community (fig. 7.12) . the adult fish are 4e5 cm in length, with an incomplete lateral line and two pairs of barbels (laale, 1977) . males have larger anal fins and more yellow coloration; females have a small genital papilla just rostral to the anal fin (laale, 1977; creaser, 1934) . zebrafish are hardy, fresh water fish originating from a tropical region with an annual monsoon season. the fish are generally found among slow moving waters of rivers, streams, and wetlands, across the south asia region of india, bangladesh, example of rabbit caging for a laboratory setting. photo provided by deb hickman. and nepal (engeszer et al., 2007; spence et al., 2008) . the waters tend to be shallow, relatively clear with substrates of clay, silt, or stone of varying size (mcclure et al., 2006; engeszer et al., 2007) . the fish feed mostly on insects and plankton, with evidence of feeding along the water column as well as water surface (mcclure et al., 2006; engeszer et al., 2007; spence et al., 2008) . gastrointestinal upset generally secondary to the use of broad spectrum antibiotics, such as penicillin. misalignment and subsequent overgrowth of the continuously growing teeth pododermatitis ("bumblefoot") infection of the underside of the feet pasteurella multocida common cause of respiratory infections and abscesses male zebrafish have a more stream-lined body with darker blue strips while the females have a white protruding belly. photo provided by kay stewart. the small size of zebrafish, the ease of keeping large numbers, frequent spawning, large egg clutches, translucent nonadherent eggs, rapid development and complex sequencing of the zebrafish genome are all key components that make the zebrafish an attractive research model. interestingly, approximately 70% of zebrafish genes have at least one orthologous human gene (howe et al., 2013) . publications on the use of zebrafish in research are cited as early as the 1930s (creaser, 1934) . until the early 1970s, the use of zebrafish stayed fairly low, with the number of articles published staying below 20 per year. in the mid-1970s, publications increased to about 40 per year, doubling again in the 1980s, increasing to almost 200 articles per year in the early 1990s, and rapidly expanding to 1929 publications by 2012. developmental biology was the initial focus of zebrafish research use. however, in recent years, use of the zebrafish in research related to biochemistry and molecular biology, cell biology, neurological sciences, and genetics has been rapidly increasing. zebrafish are known to live for only a year in the wild (spence et al., 2008) . for most of the year, the fish reside in shallow streams. with the onset of monsoon rains, they move to flooded, highly vegetated shallow wetlands and floodplains, including rice paddies, with little to no current and often silt bottoms for spawning (engeszer et al., 2007) . the offspring then develop in these waters until the seasonal waters diminish (engeszer et al., 2007) . zebrafish rapidly mature, reaching sexual maturity as early as 2 months postfertilization . the zebrafish continues to grow throughout life, which is much longer in captivity, with a mean lifespan of 3.5 years in captivity (gerhard et al., 2002) . in nature, spawning behavior occurs within small groups of three to seven fish. males within the group pursue females, with spawning occurring along the substrate (spence et al., 2008) . similar behaviors are noted in laboratory zebrafish, with spawning often occurring with the first light of day. courtship behavior involves a rapid chase of the female, the male swimming around the female, nudging her, or swimming back and forth working the female to the spawning site. interestingly, zebrafish prefer spawning near artificial plants. once there, the male remains close to the female, extending his fins to bring his genital pore in line with the female. the male may also rapidly undulate his tail against the side of the female to initiate egg release by the female, coinciding with sperm discharge by the male. the female produces eggs in batches of 5e20 over several encounters with the male for up to an hour. most eggs are released within the first 30 min, with a peak in production during the first 10 min (darrow and harris, 2004; spence et al., 2008) . zebrafish produce large clutches of eggs, from 150 to 400 eggs per clutch (laale, 1977) . the eggs, approximately 0.7 mn in diameter, are transparent and protected within a chorionic membrane (kimmel et al., 1995) . first body movements and beginning stages of organ development occur 10e24 h postfertilization (kimmel et al., 1995) . as development continues, the larva hatches from the egg two to three days postfertilization (kimmel et al., 1995) . the early larva has special secretory cells within multicellular regions of the head epidermis that allow the larvae to attach to various hard surfaces and plants until the swim bladder inflates 4 or 5 days postfertilization (laale, 1977; kimmel et al., 1995) . once the air bladder inflates, the fish can maneuver through the water column. in captivity, zebrafish can breed year round. the presence of males, or even just the male pheromones, is needed to induce ovulation (gerlach, 2006) . if females are housed away from males for an extended period, they can retain the eggs resulting in egg-associated inflammation, which can be lethal (kent et al., 2012a) . to accommodate the fish life cycle, zebrafish are typically housed in static spawning cages to allow for fertilized egg production. spawning cages include a housing tank containing a clear slotted bottom insert, and a plastic plant. the insert is often placed in the holding tank at an angle to create a shallow region for spawning and the slotted bottom of the insert allows for ease of egg collection (lawrence and mason, 2012; nasiadka and clark, 2012) (fig. 7.13 ). the embryos are then incubated at around 28.5 c in a petri dish for at least 3e4 days postfertilization (wilson, 2012) . the fish are then kept in static or slow water flow containment and can be fed paramecium, rotifer, a powdered food, or a combination of these feed types. unfortunately, other than the need for essential fatty acids in their diet, little is yet known on the nutritional requirements of zebrafish. zebrafish in research settings are typically fed live feed like artemia (brine shrimp), rotifers, bloodworms example of a zebrafish spawning system. the system is designed to allow eggs to fall beneath a slotted insert to the bottom of the tank as a way to prevent the adult fish from consuming the eggs. photo provided by robin crisler. (chironomid larvae), commercial feed, or a combination of all (lawrence, 2007) . the size of the feed is necessary to suit the gape size of the larvae, approximately 100 mm (lawrence, 2007; wilson, 2012) . water flow and feed size increase with development, with transition of the feed to artemia (brine shrimp), and/or use of a larger particle commercial feed during the 8e15 days postfertilization (wilson, 2012) . once the juvenile stage is reached, around 29 days postfertilization, the fish are housed more like adult fish, with more frequent feeding and slower water flow to accommodate their remaining development and smaller size, respectively (wilson, 2012). as early as 2 months of age the fish are sexually mature . adult zebrafish can be housed in traditional glass aquaria or elaborate computerized and automated systems that monitor and control water quality parameters such as temperature (typically 28.5 c), ph, water hardness, salinity, dissolved oxygen, and nitrogenous wastes (lawrence, 2007; lawrence and mason, 2012) . whether maintained manually or computerized, these parameters are important to monitor and maintain at appropriate levels to maximize the health of the fish. poor water quality can lead to disease in the fish (kent et al., 2012b) . many of the organisms that cause disease in zebrafish are opportunists in the environment and remain subclinical until the fish is stressed, often due to problems with husbandry. appropriately maintained housing, combined with a healthy water quality, avoidance of overcrowding, and a functional quarantine and health surveillance program are key components to avoiding stress and disease. to date, there are currently no known viruses documented in zebrafish as naturally occurring disease concerns (kent et al., 2012b) . mycobacterium infections are the most frequently documented bacterial infections (kent et al., 2012a,b) . class reptilia is made up of four orders classified as chelonia, rhynchocephalia, squamata, and crocodilia (frye, 1991) . in class amphibia, animals more commonly encountered in research setting are in the order anura, containing frogs and toads (such as xenopus, bufo, rana, hyla, and dendrobates spp.); and in the order caudata, containing salamanders such as the tiger salamander, ambystoma tigrinum and the axolotl, ambystoma mexicanum (national research council, 1974) (figs. 7.14 and 7.15). snakes and lizards are in class reptilia, order squamata; chelonians (turtles, tortoises, terrapins) are in order chelonia; and alligators, caimans, and crocodiles are in order crocodilia. in contrast to research in mammals, there is a tendency for reptile and amphibian research to be more oriented to studying evolution and ecology as opposed to basic science evaluating models of human disease (pough, 1991) . salamanders and frogs are important for studying embryonic development, metamorphosis, regeneration, figure 7.14 a commonly used amphibians in research is the axolotl, ambystoma mexicanum. provided by chris konz. african clawed frogs, xenopus laevis, a commonly used amphibian. provided by randalyn shepherd. physiology, and climate change (burggren and warburton, 2007; hopkins, 2007; pough, 2007) . reptiles are often studied because of their more simple cardiovascular systems as well as for evaluating mechanisms of immune responses, hormonal controls, and unique reproduction methods such as parthenogenesis (frye, 1991) . of the amphibians, xenopus laevis (south african clawed frog) and xenopus tropicalis (western clawed frog) are commonly studied in the research setting. x. laevis is a prominent research model in comparative medicine and developmental studies, and is the most commonly studied species in the genus xenopus (denardo, 1995; schultz and dawson, 2003; o'rourke, 2007) . advantages include large-sized eggs for ease of observing embryo development, as well as the wealth of published literature in areas of research such as evolution, neurobiology, regeneration, endocrinology, and toxicology (koustubhan et al., 2008; gibbs et al., 2011) . rana catesbeiana (bullfrogs) have been used for developmental and toxicological studies, and for infectious disease study of the chytrid fungus batrachochytrium dendrobatidis (alworth and vazquez, 2009) . a. mexicanum, in particular, is studied to understand the regenerative ability of the blastema of amputated limbs at the molecular level (gresens, 2004; rao et al., 2014) . ambystoma tigrarium has been studied in regard to general amphibian decline in north america, environmental contaminants such as pesticides and effects of infection with a. tigrarium virus (sheafor et al., 2008; kerby and storfer, 2009; chen and robert, 2011; kerby et al., 2011) . a variety of snakes, crocodiles, lizards, and turtles have been studied in research. for example, anolis carolinensis (the green anole) has been used for the study of reproduction biology (lovern et al., 2004) . caiman crocodilus and alligator mississippiensis (crocodiles), trachemys scripta elegans (red-eared sliders) represent a few other examples of reptiles used in research (o'rourke and schumacher, 2002). amphibians and reptiles are considered to be ectotherms (greene, 1995) . unlike mammals and birds, ectotherms are unable to internally regulate body temperatures above that of the ambient environment through metabolism and require complex behavioral and thermoregulatory adaptations to regulate temperature (pough, 1991; seebacher and franklin, 2005) . in captivity, ectotherms typically require supplemental sources of heat to mimic the thermoregulatory effects of basking in the sun. some amphibians and reptiles are aquatic (xenopus frog spp.) whereas others are semiaquatic or terrestrial. x. laevis and x. tropicalis are from geographically distinct areas and have different temperature requirement depending on life stage, with x. tropicalis adults generally around 25 c in their natural habitat versus about 20 c for x. laevis (tinsley et al., 2010) . the skin of amphibians is permeable to water and some adults (semiterrestrial tree frogs in family hylidae, arboreal and terrestrial toads in bufonidae) may receive a significant portion of their daily water requirement via absorption through a vascular-rich area on the pelvic area termed the pelvic patch (pough, 2007; ogushi et al., 2010) . the skin of some amphibians contains toxins which can cause arrhythmias in human handlers, for example, alkaloids from dendrobatid frogs, and bufotoxins from toads of the genus bufo (denardo, 1995) . the toxins serve to keep predators away but, as with xenopus, may harm the animals themselves by continued direct contact or diffusion through the water (tinsley et al., 2010; chum et al., 2013) . the skin of amphibians is easily damaged thus to protect the animal during handling powder-free gloves should be worn (gentz, 2007) . researchers and animal care providers should investigate the natural environment of each species within their care and critically evaluate what features are required for normal behavior and physiology to provide the essential elements in the research setting (pough, 1991) . in the wild, amphibians and reptiles live in ecological environments that span a range of diversity from topical forest areas to dry desert. they may be arboreal, aquatic, or terrestrial. they are often secretive and hide when in natural habitats, preferring to hide under vegetation or in crevices. parameters from the natural habitat to evaluate include temperature, humidity, nutritional requirements, natural diet, nocturnal versus diurnal behavior, and housing density. temperature and lighting gradients should be established so animals can choose to move toward or away from the heat source as a way to avoid overheating. most amphibian species in the wild are nocturnal (pough, 2007; tinsley et al., 2010) . amphibians and reptiles are sensitive to chemicals in the environment. water quality parameters (such as ph, hardness, ammonia, nitrate/nitrite, salinity, conductivity) should be regularly monitored. chloramine and chloramines are often present in municipal water supplies and are toxic to aquatic species. water should be treated prior to use for aquatic species with an agent like sodium thiosulfate, since chloramine does not readily dissipate (browne et al., 2007) . ammonia is a breakdown product between the chloramine and sodium thiosfulfate reaction and is a concern for aquatic animals (browne et al., 2007; koustubhan et al., 2008; o'rourke and schultz, 2002) . a wide variety of caging materials may be used for housing such as glass, plastic, stainless steel, or fiberglass but should be free of contaminants or harmful chemicals like bisphenol a that could leach from the caging into the water (levy et al., 2004; browne et al., 2007; bhandari et al., 2015) . agents used to sanitize caging should be chosen to minimize likelihood of harmful residues. environmental enrichment should be provided to encourage natural behaviors and can include providing cage mates for social interaction, cage accessories that serve as hiding spots or shelters (fig. 7 .16) as well as providing a variety of food treats in changing locations for foraging opportunities (hurme et al., 2003) . scents, sounds, and color choices may also be incorporated into enrichment strategies provided that they are carefully evaluated to ensure that they are beneficial and do not cause stress. for example, the tortoise, chelonoidis denticulata, may show a color preference for red-colored enrichment items (passos et al., 2014) . pvc tubes are another example of enrichment that has been provided to x. laevis for use as hiding cover (koustubhan et al., 2008) . some species may require haul-out ramps, areas for sun basking, floating rest areas, or enrichment devices along the water's surface to help prevent drowning. one should consider the possibility of ingestion, as reptiles and amphibians may attempt to consume the substrates provided to them. the degree to which amphibians are social varies significantly depending on the species and is not always well understood. they use visual and olfactory discrimination to help them find food, forage, and avoid predators (vitt and caldwell, 2014) . both in the wild and in captivity, reptiles and amphibians may exhibit excitatory behavior when fed (sometimes described as a "feeding frenzy") which may result in animal injury where animals are in close proximity (divers and mader, 2006; tinsley et al., 2010) . overcrowded tanks can result in competition for food and subsequent trauma. thus, when placed together for the first time, animals should always be observed for compatibility; and only members of the same species should be housed together. many reptiles and amphibians are escape artists and prevention of escape and injury is a critical factor when considering housing design. species that are prone to jumping must have secured lids on their enclosures. the diets of amphibians and reptiles are highly variable in the wild and are species dependent. commercially prepared pelleted diets may be available and accepted by reptiles and aquatic amphibians, however, terrestrial amphibians and many use of a rabbit feeder for xenopus enrichment. photo by randalyn shepherd. reptiles may prefer live diets (pough, 2007) . it is not unusual for some species to go several days of fasting between meals in nature (pough, 1991) . consultation with those experienced at successful housing and feeding the species in question (zoos, nutritionists, herpetologists) is recommended. there are many different types of infectious agents such as bacteria, viruses, fungi, and parasites that can cause health problems in amphibians and reptiles in addition to noninfectious conditions such as those resulting from nutritional imbalances, metabolic disease, neoplasia, trauma, and other spontaneous maladies. although significant advances in knowledge have been made over the past 100 years regarding disease in these species, much still remains unknown. it is not possible to go into detail here, but there are excellent reference texts for diseases in amphibians and reptiles that can be consulted (jacobson, 2007; frye, 1991; wright and whitaker, 2001) . from a taxonomic standpoint, birds are placed into class aves which includes multiple orders based on anatomical, physiological, and genetic characteristics. passeriformes is the largest order and contains songbirds and perching birds such as the finch, canary, and cardinal ( fig. 7.17 ). order columbiformes contains pigeons and doves; order psittaciformes contains budgies and parrots such as the african gray; and order galliformes contains domestic fowl such as the chicken and quail (proctor and lynch, 1993; ritchie et al., 1994) (fig. 7.18 ). birds have been used as research models of human disease and are important in evaluation of aging, memory, parasitology, atherosclerosis, reproduction, and infectious disease among other topics (austad, 1997 (austad, , 2011 maekawa et al., 2014) . the genomes of several avian species have now been sequenced (jarvis et al., 2014) . historically, chickens (gallus domesticus) are the most common bird species studied in biomedical and agricultural research and are a classic model in areas such as immunology, virology, infectious disease, embryology, and toxicology (scanes and mcnabb, 2003; kaiser, 2012) . chickens are also studied to evaluate reproductive development and retinal disease. embryonated chicken eggs have been used to commercially produce vaccines (such as for human influenza), studied for developmental analysis, and are now being treated with viral vectors like lentivirus to produce transgenic embryos. inbred lines with improved disease resistance are being developed and transgenic technology in the future may allow embryos to be used as bioreactors to produce therapeutic proteins of interest and potentially to generate transgenic chickens which have improved resistance to pathogens (bacon et al., 2000; scott et al., 2010) . because chickens develop spontaneous ovarian cancers at an incidence of up to 35%, they are also a prominent model of ovarian cancer in humans (bahr and wolf, 2012; hawkridge, 2014) . quail the zebra finch is a common avian species used in research. from http://www.redorbit.com/news/science/1112751282/male-zebra-finches-fake-song-121912/. the domesticated chicken commonly used in research. provided by kay stewart. (coturnix coturnix and coturnix japonica) have been studied in many of the same research disciplines as chickens, but offer advantages because of their smaller size and because they are among the shortest-lived bird species (austad, 1997) . japanese quail (c. japonica) have been selected as a model to evaluate reproductive biology and social behaviors such as mate selection because they readily show sexual behavior in captivity (ball and balthazart, 2010) . as with the chicken, methods to study transgenic quail are now becoming available and offer a useful tool to study gene function (seidl et al., 2013) . of the psittaciformes, amazon parrots and budgies (melopsittacus undulates) are among the most commonly studied, with research topics including veterinary medicine, diagnostics, behavioral, cognition, aging, and sensory studies (austad, 2011; kalmar et al., 2010) . the african gray parrot has been studied for its cognition and communication abilities (hesse and potter, 2004; harrington, 2014) . of the passerines studied in laboratory research, the most commonly evaluated include the zebra finch (taeniopygia guttata), european starling (sturnus vulgaris and sturnus roseus), and house sparrow (passer domesticus) (bateson and feenders, 2010). zebra finches and other songbirds are commonly studied in regard to aging and neurogenesis in addition to speech, learning, and memory because of their ability to learn and communicate intricate bird songs (harding, 2004; scott et al., 2010; austad, 2011; mello, 2014) . the most popular songbird species for neurobiological research include the zebra finch, canary, and other types of small finches such as lonchura striata domestica (schmidt, 2010) . zebra finches are favored in research settings since they are easy to house due to their small size, for their compatibility in groups, and proclivity for breeding. they are also studied for their biologic features such as sexual dimorphism, year-round singing in captivity, age-dependent period of song-learning propensity, and for ease of measurement with respect to their bird song (fee and scharff, 2010; mello, 2014) . pigeons (columba livia) have been evaluated in areas such as comparative psychology, neuroanatomy, neuroendocrinology, and atherosclerosis (santerre et al., 1972; austad, 1997; shanahan et al., 2013) . they are studied to understand their navigational skills and memory which allow homing, vision and discrimination ability. barn owls (tyto alba) are an example of a nocturnal avian species and are studied for neuroanatomy, vision, hearing, and for understanding learning mechanisms during auditory space mapping (pena and debello, 2010; rosania, 2014) . birds are warm-blooded vertebrates that have feathers for the purpose of flight and plumage. their respiratory system includes avascular air sacs, some of which attach to the lung and bronchi, but do not serve as sites for gas exchange as does the lung (maina, 2006; ritchie et al., 1994) . air sacs serve as internal compartments which hold air and facilitate internal air passage to allow birds to have a continuous flow of large volumes of air through the lungs as a way to increase oxygen exchange capacity and efficiency. birds lack a functional diaphragm and use muscles of the thorax to assist with respiration (ritchie et al., 1994) . care must be taken to ensure that use of physical restraint does not interfere with respiratory movement, cause the bird to struggle, or become stressed. the skeletal system includes pneumatic bones which are lined with air sac epithelium and are considered pneumatized by connection to the respiratory system (frandson et al., 2009 ). the specific bones which are pneumatized depend on the species but typically include the humerus, cervical vertebrae, sternum, sternal ribs, and sometimes the femur (ritchie et al., 1994) . the esophagus in birds leads to the crop, which is an outpocketing where food is held temporarily, and then continues to the proventriculus (also called the true stomach) which produces enzymes to break down food. food travels from the proventriculus to the ventriculus (gizzard) and then on into the small and large intestines. the presence or absence of a gallbladder is species dependent (tully et al., 2009; kalmar et al., 2010) . the rectum and urinary tract terminate in the cloaca, resulting in excreta where the fecal portion of waste is mixed with urate (white and/or creamy component). there are many additional unique and complex anatomic and physiologic adaptations of birds. other excellent references are available in the literature (scanes, 2015). housing requirements of birds held in captivity vary significantly depending on the particular species. basic parameters that apply to all birds include the necessity to provide an enclosure which is safe and permits species-specific behaviors to the greatest extent possible. consideration should be given to ensure that the type of structure is nontoxic, as some birds such as parrots have a powerful beak with the ability to chew through substrates. enclosures may be made of metals or durable plastic, but it is important to note that zinc wire, as well as leaded paint, can be toxic to birds and is best avoided. bar spacing on caging should be appropriate to prevent escape and injury based on the size of the bird. caging size varies and can include large aviaries where full short-distance flight is possible, to individual housing in smaller sized cages where flight may not be feasible. use of environmental enrichment and provision of opportunity for interaction is important to include as part of the cage structure, complexity, and social dynamic. some types of birds are considered social, polygamous, and benefit from group housing, whereas others such as those that pair-bond (such as new world quail) may prefer housing with a single mate (ritchie et al., 1994) . some species, genders, or individuals show aggression and may not be compatible. for example, sexually active male quail may injure each other and are generally considered incompatible (huss et al., 2008) . to help reduce aggression, housing densities should be kept low and multiple points of access to resources, such as feed and perches, should be provided. enrichment in the form of manipulanda can take the form of toys and food items. some types of birds may demonstrate foraging behavior in nature and may like to manipulate their feed. parrots, for example, typically grasp their food with their feet and may peel or strip the outer portion of the foodstuff prior to ingesting. toys should be size appropriate for the species, easily sanitized, free from sharp edges, and replaced once wear shows. birds can become easily caught in items that hang from the cage and as toys deteriorate they can become a hazard. for example, rope toys may begin to fray and become a hazard, causing entrapment; and some types of toys contain weights which pose a choking hazard or may be made of toxic materials such as lead. some types of birds spend considerable time perching and require perches, which vary in diameter, for comfort and to prevent pressure sores from developing on their feet. the respiratory system of the bird is very sensitive and caution must be taken by animal care staff to avoid exposure of birds to aerosols from chemicals that may arise from disinfectants used in the laboratory animal facility. scented cleaners, perfumes, hairspray, and emissions from teflon-coated materials are all examples of products which can be especially harmful to birds and may cause death. feeding requirements vary by species and life stage, but commercial pelleted diets designed to meet the nutritional needs can generally be provided. although many birds are seed eaters, a diet of seeds alone is unlikely to provide adequate or balanced nutrition. many birds have a requirement for dietary calcium, especially those that are reproductively active, and should be provided with calcium supplementation in the form of soluble grit such as cuttlebone or crushed oyster shells (sandmeier and coutteel, 2006; tully et al., 2009 ). birds often display neophobic behavior and may require long acclimation periods before fully accepting novel foodstuffs. for this reason, dietary changes should not be made abruptly and daily intake should be closely monitored. for birds in the laboratory setting, clean, fresh water should be provided daily either by use of nonbreakable bowls or sipper tubes. water intake will vary by species and environmental housing conditions. birds can mask disease and are easily stressed. it is best to first observe the bird in its normal home environment whenever possible and only perform restraint for physical exam or collection procedures when indicated. general indications of sickness may include decreased appetite, depressed behavior, loose stools, distended abdomen, ruffled feathers or unkempt appearance, skin lesions, openmouth breathing, abnormal respiratory sounds such as wheezing or sneezing, or signs of dehydration such as reduced skin turgor and sunken eyes. a healthy bird should have well-groomed feathers, appear alert, active and inquisitive, and should show species-typical behaviors. its eyes should be clear and bright. no evidence of discharge should be present from the eyes, nares, mouth, or urogenital area. numerous types of infectious (example, fig. 7.19 ) and noninfectious disease presentations are described in birds. additional reference resources should be consulted for in-depth information (ritchie et al., 1994; tully et al., 2009; doneley, 2010) . to provide the reader a broader view of animal use in research, descriptions of some less commonly used small mammal models follow. guinea pigs (cavia porcellus) are rodents, related to porcupines and chinchillas in the suborder hystricomorpha (fig. 7.20) . they originate from the mountain and grassland regions along the mid-range of the andes mountains in south america. they are small, stocky, nonburrowing, crepuscular herbivores with short legs and little to no tail, ranging from 700 to 1200 g, females being smaller than males (harkness et al., 2010) . guinea pigs have a long-standing historical role in research stretching as far back as the 1600s, when they were first used in anatomical studies (pritt, 2012) . further, they were used by louis pasteur and robert koch in their example of skin pox on the feet of a dark-eyed junco (junco hyemalis). photo from randalyn shepherd. investigations of infectious disease, and have contributed to the work of several nobel prize worthy studies (pritt, 2012) . specifically, the guinea pig has been used as a model for infectious diseases such as tuberculosis, legionnaires disease, sexually transmitted diseases such as chlamydia and syphilis, and one of the more common causes of nosocomial infections in people, staphylococcus aureus (padilla-carlin et al., 2008) . guinea pigs have also been useful tools in researching cholesterol metabolism, asthma, fetus and placental development and aspects of childbirth, as well as alzheimer's disease (bahr and wolf, 2012) . guinea pigs have many similarities to humans hormonally, immunologically, and physiologically. unlike other rodents, and more like primates (including people), guinea pigs are prone to scurvy if they do not receive adequate vitamin c, typically in their diet (gresham et al., 2012) . guinea pigs are housed similarly to other rodents, although they require more room than the smaller rodents. hamsters are of the rodentia order, suborder myomorpha along with the mouse and the rat. there are over 24 species of hamsters described in the literature, with the most common hamster used in research being the golden or syrian hamster, mesocricetus auratus (harkness et al., 2010) (fig. 7.21) . originating from the northwest region of syria, golden hamsters are thought to be descendants of only three or four littermates collected from syria in 1930 (adler, 1948; smith, 2012) . as their name implies, the typical wild-type coat is reddish gold along their dorsum, with a gray underside. they are granivores and insectivores, weighing 85e150 g, females weighing more than males, with short legs and short tail, and large cheek pouches (harkness et al., 2010) . specific anatomical and physiological features including their susceptibility to disease and infection make them a useful model for study. initially hamsters were utilized in studies of infectious disease, parasitology and dental disease, transitioning into cancer research in the 1960s (smith, 2012) . hamsters are still used in many areas of research, including investigations into metabolic diseases like diabetes mellitus (hein et al., 2013) , cardiovascular disease (russell and proctor, 2006) , reproductive endocrinology (ancel et al., 2012) , and oncology (tysome et al., 2012) . guinea pigs have also been used as models for infectious disease associated with bacteria, parasites, and viruses, such as leptospirosis (harris et al., 2011 ), leishmaniasis (gomes-silva et al., 2013 , and severe acute respiratory syndrome (sars) and ebola viruses (roberts et al., 2010; wahl-jensen et al., 2012) . other species of hamsters used have been used in research. for example, chinese and african hamsters have been used for investigations into diabetes mellitus (kumar et al., 2012) ; european and turkish hamsters have been useful to evaluate aspects of hibernation (batavia et al., 2013) ; and siberian and turkish hamsters have been used to study circadian rhythm and pineal gland activity (butler et al., 2008) (fig. 7.22) . chinchillas (fig. 7.23 ) are in the order rodentia, suborder hystricomorpha, as are the guinea pig and the degu. there are the long-tailed chinchilla, chinchilla lanigera, and the short-tailed chinchilla, chinchilla chinchilla. chinchillas originate from the andes mountains of south america (martin et al., 2012) . they are 400e800 g in size, females weighing more than males, with compact bodies and long, strong hind limbs and dense fur coats (alworth et al., 2012) . the lushness of the coat is what led them close to extinction in the wild due to excessive hunting siberian hamsters. photo from greg demas. chinchilla. photo from bill shofner jr. in the early to mid-1900s (jimenez, 1996) . the chinchilla has a large head, large eyes and ears. the large inner ear anatomy is of specific note as chinchillas are the traditional model for auditory studies (shofner and chaney, 2013) and otitis media (morton et al., 2012) . the gerbil is a rodent, suborder myomorpha, used in research. there are over 100 species of gerbil-like rodents documented, but the mongolian gerbil (meriones unguiculatus) is the species most commonly used in the united states (fig. 7.24 ). mongolian gerbils originate from a desert terrain in mongolia and northeast china. they are long-tailed, burrowing, herbivorous rodents, 55e130 g in size, males being larger than females (harkness et al., 2010) . due to anatomical variations in the blood supply to the brain in an anatomical region known as the "circle of willis," gerbils have been used most notably as a model for cerebral ischemia or stroke (small and buchan, 2000) . an interesting animal model to note among the small mammals is the nine-banded armadillo (dasypus novemcinctus), a new world mammal ranging from the southeastern half of north america, extending south through the americas to the northern region of argentina (balamayooran et al., 2015) . armadillos have a banded carapace, and, importantly, a low core body temperature of 33e35 c. the breeding season is in the summer, but embryo implantation is delayed until late fall, at which gerbil. photo used with permission of american association for laboratory animal science. point identical quadruplicates are always formed (balamayooran et al., 2015) . the armadillo's low body temperature, and susceptibility and physiologic response to the infectious organism, mycobacterium leprae, have made it an ideal model for studying leprosy (balamayooran et al., 2015) . the consistent polyembryony of the species has also made the animal a model of interest in understanding various aspects of twinning (blickstein and keith, 2007) . choosing the correct animal model is an essential component to the success of biomedical research. each species used in biomedical research must be provided with adequate housing and care to ensure the well-being of the animals. because good science and good animal care go hand in hand, it is important to understand and address the biological and behavioral needs of the animals being studied. origin of the golden hamster cricetus auratus as a laboratory animal chinchillas: anatomy, physiology and behavior a novel system for individually housing bullfrogs american fancy rat and mouse association the effects of osteoporosis on distraction osteogenesis: an experimental study in an ovariectomised rabbit model birds as models of aging in biomedical research a review of the development of chicken lines to resolve genes determining resistance to diseases comparison of behavioural development in socially isolated and grouped rats the armadillo as an animal model and reservoir host for mycobacterium leprae japanese quail as a model system for studying the neuroendocrine control of reproductive and social behaviors the effects of day length, hibernation, and ambient temperature on incisor dentin in the turkish hamster (mesocricetus brandti) environmental enrichment for laboratory rodents and rabbits: requirements of rodents, rabbits, and research the black death, 1346e1353: the complete history effects of the environmental estrogenic contaminants bisphenol a and 17alpha-ethinyl estradiol on sexual development and adult behaviors in aquatic wildlife species morphological and functional events associated to weaning in rabbits on the possible cause of monozygotic twinning: lessons from the 9-banded armadillo and from assisted reproduction biology of the rabbit facility design and associated services for the study of amphibians tickling induces reward in adolescent rats ultrasonic vocalizations as indicators of welfare for laboratory rats (rattus norvegicus) a melatonin-independent seasonal timer induces neuroendocrine refractoriness to short day lengths repetitive backflipping behaviour in captive roof rats (rattus rattus) and the effects of cage enrichment characterization of a new experimental model of osteoporosis in rabbits 1874. the septum atriorum of the frog and the rabbit antiviral immunity in amphibians a behavioral comparison of new zealand white rabbits (oryctolagus cuniculus) housed individually or in pairs in conventional laboratory cages the social buffering effect of playful handling on responses to repeated intraperitoneal injections in laboratory rats the technic of handling the zebra fish (brachydanio rerio) for the production of eggs which are favorable for embryological research and are available at any specified time throughout the year ovulation induction in rabbit does: current knowledge and perspectives characterization and development of courtship in zebrafish, danio rerio amphibians as laboratory animals a good practice guide to the administration of substances and removal of blood, including routes and volumes avian medicine and surgery in practice a critical period for social isolation in the rat reproductive and developmental toxicity of hydrofluorocarbons used as refrigerants zebrafish in the wild: a review of natural history and new notes from the field the songbird as a model for the generation and learning of complex sequential behaviors detection of zoonotic pathogens and characterization of novel viruses carried by commensal rattus nor rabbit as a reproductive model for human health the rabbit as a model for reproductive and developmental toxicity studies anatomy and physiology of farm animals rabbit medicine and surgery for veterinary nurses biomedical and surgical aspects of captive reptile husbandry a comparison of the histological structure of the placenta in experimental animals social and husbandry factors affecting the prevalence and severity of barbering ('whisker trimming') by laboratory mice evidence for a relationship between cage stereotypies and behavioural disinhibition in laboratory rodents heat or insulation: behavioral titration of mouse preference for warmth or access to a nest impact of nesting material on mouse body temperature and physiology nest building as an indicator of health and welfare in laboratory mice energy reallocation to breeding performance through improved nest building in laboratory mice medicine and surgery of amphibians pheromonal regulation of reproductive success in female zebrafish: female suppression and male enhancement metamorphosis and the regenerative capacity of spinal cord axons in xenopus laevis golden hamster (mesocricetus auratus) as an experimental model for leishmania (viannia) braziliensis infection nonavian reptiles as laboratory animals an introduction to the mexican axolotl (ambystoma mexicanum) guinea pigs: managment, husbandry and colony health inventory of the behaviour of new zealand white rabbits in laboratory cages comparison of mouse and rabbit model for the assessment of strong pgm-containing oil-based adjuvants computerized analysis of audible and ultrasonic vocalizations of rats as a standardized measure of pain-related behavior review of polyclonal antibody production procedures in mammals and poultry learning from bird brains: how the study of songbird brains revolutionized neuroscience rabbit mitochondrial dna diversity from prehistoric to modern times harkness and wagner's biology and medicine of rabbits and rodents speaking of psittacine research in vitro and in vivo activity of first generation cephalosporins against leptospira the chicken model of spontaneous ovarian cancer glp-1 and glp-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of glp-2-stimulated postprandial lipemia in normal and insulin-resistant states a behavioral look at the training of alex: a review of pepperberg's the alex studies: cognitive and communicative abilities of grey parrots. anal. verbal behav use of a body condition score technique to assess health status in a rat model of polycystic kidney disease extreme cuisine: the weird & wonderful foods that people eat amphibians as models for studying environmental change tickling during adolescence alters fear-related and cognitive behaviors in rats after prolonged isolation utilization of caecal digesta by caecotrophy (soft faeces ingestion) in the rabbit the zebrafish reference genome sequence and its relationship to the human genome environmental enrichment for dendrobatid frogs japanese quail (coturnix japonica) as a laboratory animal model social isolation rearinginduced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice teratogenic effects of thalidomide: molecular mechanisms infectious diseases and pathology of reptiles: color atlas and text effect of astragaloside iv on the embryo-fetal development of sprague-dawley rats and new zealand white rabbits the extirpation and current status of wild chinchillas chinchilla lanigera and c-brevicaudata audible and ultrasonic vocalization elicited by single electrical nociceptive stimuli to the tail in the rat the long view: a bright past, a brighter future? forty years of chicken immunology pre-and post-genome guidelines and ethical considerations for housing and management of psittacine birds used in research documented and potential research impacts of subclinical diseases in zebrafish diseases of zebrafish in research facilities combined effects of virus, pesticide, and predator cue on the larval tiger salamander (ambystoma tigrinum) combined effects of atrazine and chlorpyrifos on susceptibility of the tiger salamander to ambystoma tigrinum virus stages of embryonic development of the zebrafish establishing and maintaining a xenopus laevis colony for research laboratories acute and chronic animal models for the evaluation of anti-diabetic agents the biology and use of zebrafish, brachydanio rerio in fisheries research. a literature review development of the antibody repertoire in rabbit: gut-associated lymphoid tissue, microbes, and selection the husbandry of zebrafish (danio rerio): a review generation time of zebrafish (danio rerio) and medakas (oryzias latipes) housed in the same aquaculture facility zebrafish housing systems: a review of basic operating principles and considerations for design and functionality historical perspectives the effects of methotrexate on pregnancy, fertility and lactation the green anole (anolis carolinensis): a reptilian model for laboratory studies of reproductive morphology and behavior the mechanisms underlying sexual differentiation of behavior and physiology in mammals and birds: relative contributions of sex steroids and sex chromosomes development, structure, and function of a novel respiratory organ, the lung-air sac system of birds: to go where no other vertebrate has gone the aerosol rabbit model of tb latency, reactivation and immune reconstitution inflammatory syndrome chinchillas: taxonomy and history notes on the natural diet and habitat of eight danionin fishes, including the zebrafish danio rerio animal models of atherosclerosis progression: current concepts the zebra finch, taeniopygia guttata: an avian model for investigating the neurobiological basis of vocal learning neurological diseases of rabbits and rodents a functional tonb gene is required for both virulence and competitive fitness in a chinchilla model of haemophilus influenzae otitis media a rabbit model of non-typhoidal salmonella bacteremia neuroevolutionary sources of laughter and social joy: modeling primal human laughter in laboratory rats blood sample collection in small laboratory animals positive and negative ultrasonic social signals elicit opposing firing patterns in rat amygdala enriching tortoises: assessing color preference shelter enrichment for rats environmental enrichment of new zealand white rabbits living in laboratory cages recommendations for the care of amphibians and reptiles in academic institutions manual of ornithology: avian structure & function ferrets, rabbits, and rodents: clinical medicine and surgery proteomic analysis of fibroblastema formation in regenerating hind limbs of xenopus laevis froglets and comparison to axolotl inner workings: 1885, the first rabies vaccination in humans avian medicine: principles and application behavioural and neurochemical effects of early social deprivation in the rat immunogenicity and protective efficacy in mice and hamsters of a beta-propiolactone inactivated whole virus sars-cov vaccine ny) 43, 157. roy, c.s., 1879. the form of the pulse-wave: as studied in the carotid of the rabbit small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis normal development of the testes management of canaries, finches, and mynahs spontaneous atherosclerosis in pigeons. a model system for studying metabolic parameters associated with atherogenesis an iacuc perspective on songbirds and their use in neurobiological research housing and husbandry of xenopus for oocyte production applications of avian transgenesis physiological mechanisms of thermoregulation in reptiles: a review transgenic quail as a model for research in the avian nervous system: a comparative study of the auditory brainstem large-scale network organization in the avian forebrain: a connectivity matrix and theoretical analysis antimicrobial peptide defenses in the salamander the watanabe heritable hyperlipidemic (whhl) rabbit, its characteristics and history of development: a tribute to the late dr development of an animal model for spontaneous myocardial infarction (whhlmi rabbit) processing pitch in a nonhuman mammal (chinchilla laniger) abnormal arrangement of the right subclavian artery in a rabbit anatomy, physiology, and behavior mitochondrial dna phylogeography of the norway rat mandibular bone density and fractal dimension in rabbits with induced osteoporosis. oral surg the behaviour and ecology of the zebrafish, danio rerio assessment of anti-scarring therapies in ex vivo organ cultured rabbit corneas vascular access port (vap) usage in large animal species the victorian underworld amphibians, with special reference to xenopus handbook of avian medicine a novel therapeutic regimen to eradicate established solid tumors with an effective induction of tumorspecific immunity effects of husbandry and management systems on physiology and behaviour of farmed and laboratory rabbits herpetology: an introductory biology of amphibians and reptiles use of the syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers pseudomonas aeruginosa infectious keratitis in a high oxygen transmissible rigid contact lens rabbit model. invest. ophthalmol amphibian medicine and captive husbandry animal models for the atherosclerosis research: a review construction of corneal epithelium with human amniotic epithelial cells and repair of limbal deficiency in rabbit models rats, lice, and history key: cord-262445-54ng7m92 authors: gabellini, davide; musarò, antonio title: 16th meeting of the interuniversity institute of myology (iim) assisi (italy), october 17-20, 2019: foreword, program and abstracts date: 2020-09-15 journal: eur j transl myol doi: 10.4081/ejtm.2020.9345 sha: doc_id: 262445 cord_uid: 54ng7m92 the 16th meeting of the interuniversity institute of myology (iim), october 17-20, 2019, assisi, italy brought together scientists, pharma and patient organization representatives discussing new results on muscle research. internationally renowned keynote speakers presented advances on muscle development, homeostasis, metabolism, and disease. speakers selected among submitted abstracts presented their new, unpublished data in seven scientific sessions. the remaining abstracts were showcased in two poster sessions. young trainees where directly involved in the selection of keynote speakers, the organizing scientific sessions and roundtables discussions tailored to the interests of their peers. a broad italian, european and north-american audience participated to the different initiatives. the meeting allowed muscle biology researchers to discuss ideas and scientific collaborations aimed at better understanding the mechanisms underlying muscle diseases in order to develop better therapeutic strategies. the active participation of young trainees was facilitated by the friendly and inclusive atmosphere, which fostered lively discussions identifying emerging areas of myology research and stimulated scientific cross-fertilization. the meeting was a success and the iim community will continue to bring forward significant contributions to the understanding of muscle development and function, the pathogenesis of muscular diseases and the development of novel therapeutic approaches. here, we report abstracts of the meeting illustrating novel results of basic, translational, and clinical research, which confirms that the myology field is strong and healthy. -2 -associated with muscle diseases. 1 leading experts of the muscle field, along with speakers selected from submitted abstracts, provided important insights into the extracellular agonists, receptors, protein kinases, intermediate molecules, transcription factors, and epigenetic mechanisms involved in the modulation of specific cellular responses in embryonic and adult myocytes/myofibers. [2] [3] [4] [5] olivier pourquié demonstrated that, mimicking key signaling events leading to muscle formation in the embryo, it is possible to efficiently produce striated, millimeter-long muscle fibers together with satellite-like cells from human pluripotent stem cells (es/ips), avoiding the requirement for genetic modifications or cell sorting. bente klarlund pedersen discussed the important role of skeletal muscle as an endocrine organ, which has the capacity to produce hundreds of myokines, providing a conceptual basis for understanding how muscles communicate with other organs such as adipose tissue, liver, pancreas, bones, and brain. alessandra sacco discussed the dynamics of muscle stem cells during tissue growth and regeneration, whereas bénédicte chazaud discussed the roles of macrophages in normal skeletal muscle regeneration versus muscle disease. muscle regeneration recapitulates many aspects of embryonic myogenesis and it is an important homeostatic process of adult skeletal muscle, which, after development, retains the capacity to regenerate in response to appropriate stimuli, activating the muscle compartment of stem cells, namely satellite cells, and other precursor cells. 3, [6] [7] [8] skeletal muscle stem cells (musc), also known as satellite cells, are the main source of skeletal muscle growth and regeneration. within their native tissue microenvironment, or stem cell niche, they are exposed to signals emanating from neighboring cells, as well as the extracellular space that instruct their cell fate decisions, whether to undergo self-renewal or commitment and differentiation upon cell division. by utilizing genetic and pharmacological tools, sacco and co-workers have identified stat3 signaling as a critical regulator of musc fate decisions. the inflammatory response of injured skeletal muscle plays an important and critical role in muscle homeostasis and regeneration and consists in the recruitment of specific myeloid cell populations within the injured area. 3, 7, 8 macrophages rapidly increases within 24 hours after injury, are the predominant inflammatory cell type within the injured area, detectable at the level of perimysium and epimysium. because of their high versatility and their impact on their environment, they sustain both the mounting and the dampening of the inflammatory response. in a context of adult tissue damage, that is post-injury skeletal muscle regeneration, accumulating lines of evidence of the beneficial and pleiotropic roles of macrophages in tissue repair indicate that inflammation should not be considered as a bad or detrimental process. conversely, as discussed by chazaud, it should be viewed as a dynamic process of which sequential steps must be tightly coordinated in space and time to be fully efficient to support skeletal muscle regeneration. based on the submitted abstracts, thirty five contributions were selected for oral communications that were grouped in seven sessions chaired by young trainees: 1. genetic and epigenetic alterations in muscle dystrophies and myopathies; 2. satellite cells and muscle regeneration in healthy muscle and in diseases; 3. biophysics and e-c coupling in the pathophysiology of neuromuscular diseases; 4. signaling in muscle growth, homeostasis and disease; 5. metabolic alterations and muscle diseases; 6. muscle fibrosis, sarcopenia and cachexia; 7. therapeutic approaches for muscle diseases. twenty seven poster presentations, always on display during the entire meeting, completed the program. presentations provided breakthroughs in the muscle field, at a fundamental and therapeutic level, and stimulated lively and exciting scientific discussions, which were continued through spontaneous gatherings of several groups at coffee breaks and after lunch and dinner leading to the development of new collaborations. on the first evening of the meeting, there were three roundtable discussions organized by young trainees and moderated by the invited speakers and selected members of the iim. the participants discussed about new ideas concerning muscle development & regeneration; inflammation, metabolism; oxidative muscle damage. the roundtables allowed to discuss muscle research in an informal way, over food and drinks provided by local producers. on the second evening of the meeting, guided tours were organized to the historic section of the city of montefalco and the "cantina lungarotti" winery, terminating with a wine tasting and banquet dinner. finally, an award ceremony was held on the last evening of the meeting to congratulate marco rosina, martina sandonà and valentina taglietti, winners of prices for best poster, oral and active participation awards, respectively, selected by an international panel composed by the invited speakers and key members of the iim. for the first time, the iim meeting was joined with a high training course on "advanced myology", organized together with the university of perugia and reserved to young trainees. the highlight of the course was on october 20th with lectures on muscle development and response to exercise by international speakers taking place in palazzo bernabei, a beautiful 1400 building located in front of the st. francis basilica. the meeting and the course were very successful and instrumental to foster new ideas and facilitate collaborations among the different stakeholders. taken together, the attendees of the iim and of the paduamuscledays (pmds, a meeting more oriented to advanced translational myology) and the authors of papers e-printed in the european journal of translational myology (ejtm) are a substantial part of the international community of myologists. 9,10,11 here, the muscle as an endocrine organ skeletal muscle works as an endocrine organ with the capacity to produce hundreds of myokines. this finding provides a conceptual basis for understanding how muscles communicate with other organs such as adipose tissue, liver, pancreas, bones, and brain. some myokines are thought to induce anti-inflammatory responses with each bout of exercise and other mediate long-term exercise-induced improvements in cardiovascular risk factors, having an indirect anti-inflammatory effect. myokines also mediate anticancer effects and contribute to regulate metabolism and cognitive function. the myokine il-6 is released into the blood during exercise and it has been shown that il-6 has multiple immunologic and metabolic effects. recent advances regarding the physiology of il-6 will be discussed. human studies show that il-6 infusion delays gastric emptying, reduces postprandial glucose concentrations and reduces insulin secretion, whereas experimental studies suggest a role for il-6 in appetite regulation. evidence is also accumulating for a central role of il-6 in training-induced loss of visceral adipose tissue mass in humans. moreover, recent experimental studies in mice show that voluntary exercise suppresses tumor growth through epinephrine-and il-6-dependent mobilization and redistribution of cytotoxic nk cells. it has been known for a while that il-6 is a pleiotropic molecule, however, recent advances suggest that the physiological roles of il-6 involve multiple aspects of metabolism as well as a role in tumor defense. bente klarlund pedersen, md mdsc, is professor of integrative medicine and a specialist in infectious diseases and internal medicine. she is the director of the centre of inflammation and metabolism (cim) and the centre for physical activity research (cfas) funded by trygfonden. cim and cfas count 17 senior researchers/postdocs, 17 phd students, 21 other academic and technical personnel, 5 pre-graduate students and an administration of 5 persons (http://aktivsundhed.dk). she has supervised 47 phd projects and been a mentor of 5 doctoral theses. the research group has identified skeletal muscle as an endocrine organ that produces and releases so-called "myokines". the identification of myokines provides a conceptual basis for understanding how muscles communicate with other organs. through translational research, the aim is to develop targeted exercise training regimes for specific disease groups by applying a translational strategy: "from bedside to bench and back". bkp has had many positions of trust and is a member of the royal danish academy of sciences and letters. bkp has more than 650 scientific publications, > 41.000 citation and her "h"-index is 107 (web of science). inflammation after a tissue damage encompasses several sequential phases including: (1) the mounting of the inflammatory response, characterized by the infiltration of immune cells to the site of injury and the release of proinflammatory effectors; (2) the resolution of inflammation, characterized by a shift from a proinflammatory environment to the establishment of the anti-inflammatory phase of inflammation; and (3) tissue repair/regeneration including angiogenesis, matrix remodeling and return to homeostasis. almost all immune cell types participate in this inflammatory process. however, macrophages are present in high number and during all the sequences of the inflammatory response. because of their high versatility and their impact on their environment, they sustain both the mounting and the dampening of the inflammatory response. in a context of adult tissue damage, that is post-injury skeletal muscle regeneration, accumulating lines of evidence of the beneficial and pleiotropic roles of macrophages in tissue repair indicate that inflammation should not be considered as a bad or detrimental process. conversely, it should be viewed as a dynamic process of which sequential steps must be tightly coordinated in space and time to be fully efficient to support skeletal muscle regeneration. particularly, macrophages exert specific actions on muscle stem cells during the sequential phases of myogenesis, as they first support the expansion of muscle stem cells, then their differentiation and fusion into new functional myofibers. conversely, in chronic degenerative muscle diseases, such as in muscle dystrophies, phenotypes and functions of macrophages are altered, participating to the pathogeny of the disease. our recent investigations indicate that the inflammatory status of macrophages may be a therapeutic target to alleviate muscle dystrophies. dr. bénédicte chazaud is director of research class 1 (eq. of professor) and leader of the team "stem cell environment and skeletal muscle homeostasis" at institut neuromyogène (inmg) inserm u1217-cnrs 5310, université claude bernard in lyon, france. the research of her team is dedicated on the role of environmental cells on adult muscle stem cell behavior in skeletal muscle regeneration and during myopathies. the chazaud lab was pioneer in bringing the concept of a stromal support for these cells to promote an efficient muscle regeneration. particularly, they have been extensively studying macrophage biology in this process. they described that beyond their role in innate immunity through scavenging debris, macrophages directly act on muscle stem cells to regulate adult myogenesis. similarly, while vessels are usually considered only as oxygen and nutriment providers, the work from dr. chazaud identified new interactions between endothelial or peri-endothelial cells with muscle stem cells that regulate their fate. the goal of these studies is to decipher the cell interactions that allow a proper myogenesis after muscle injury and to identify the molecular mechanisms underlying these interactions. these investigations are pursued in both normal muscle regeneration as well as in the context of degenerating myopathies. in vitro modeling of human muscle development and disease progress toward finding a cure for muscle diseases has been slow because of the absence of relevant cellular models and the lack of a reliable source of muscle progenitors for biomedical investigation. we have developed an optimized serum-free differentiation protocol to efficiently produce striated, millimeter-long muscle fibers together with satellite-like cells from human pluripotent stem cells (es/ips) in vitro. by mimicking key signaling events leading to muscle formation in the embryo, this directed differentiation protocol recapitulates the developmental sequence of myogenesis and avoids the requirement for genetic modifications or cell sorting. we engineered a series of human ips reporter lines including pax7-yfp, myog-yfp and pax7-yfp/myod1-cherry that we used to characterize the differentiation of the myogenic lineage in human myogenic cultures. we are particularly interested in the ontogeny of the human pax7-expressing lineage that leads to the adult satellite cells. we show that human pax7-yfp cells produced in vitro exhibit characteristics of fetal satellite cells. we performed single cell rna sequencing of the pax7-yfp cells generated in vitro and identified the major steps of the differentiation of this lineage. this work provides a framework to study early stages of human myogenesis which are poorly accessible in the embryo. olivier pourquie is professor in the department of genetics at harvard medical school and professor of pathology at the brigham and women's hospital. he is an associate member of the broad institute and a principal faculty member at the harvard stem cell institute. he was the director of the institute for genetics and molecular and cellular biology (igbmc) in france and before that a howard hughes medical institute investigator at the stowers institute for medical institute in kansas city. the pourquie laboratory is a world leader in vertebrate musculo-skeletal axis development. using chicken and mouse embryos as model systems, they combine developmental biology and genomic approaches to study patterning and differentiation of the precursors of muscles and vertebrae. they also develop quantitative approaches at the interface with physics to study morphogenesis of the vertebral column. while most of this work is being carried out in vivo, they also develop protocols to recapitulate these early developmental processes in vitro using mouse and human embryonic or reprogrammed stem cells. they are also turning to translational approaches, using their understanding of the early development to produce cells of the muscle and vertebral lineages in vitro from pluripotent cells to study human diseases of the musculo-skeletal axis and for cell therapy approaches. dr. pourquie graduated as an engineer in france and trained with nicole le douarin in paris. he authored more than 100 peer-reviewed publications. he is an elected member of the european molecular biology organization and of the academia europea. his work on the segmentation clock that controls the periodicity of vertebrae was recognized as one of the milestones in developmental biology of the 20th century by nature magazine. amyotrophic lateral sclerosis (als) is a fatal neurodegenerative disease, characterised by muscle atrophy, weakness, and progressive degeneration of motor neurons, leading to death by respiratory failure within 2/5 years from the onset of clinical symptoms. diagnosis of als relies only on clinical, electrophysiological and neuropathological examination, and is based on the exclusion of alternative related pathologies. nowadays specific molecular markers for als diagnosis or prognosis are not available. micrornas are a class of highly stable molecules, detectable in serum samples, recently proposed as biomarkers for several human diseases, such as cancer and muscular disorders. the aim of the present study was to identify circulating micrornas as serum molecular markers of als disease. indeed, we performed an ngs analysis on a sub-cohort of patients, and we identified several differentially expressed micrornas. moreover, we analysed a subset of micrornas preferentially expressed in skeletal muscle (myo-mirnas), involved in myogenesis, and skeletal muscle differentiation and regeneration. here we provide a longitudinal study on serum samples of 27 spinalonset als patients, analysed every three months by absolute rt quantification. we associated serum levels of the identified micrornas with the disease stage, evaluated by als -health state scale (als-hss), and we observed that some micrornas significantly changed during disease progression, while the others were good biomarkers for early and late stages of the disease. furthermore, since als disease progression is variable in terms of velocity and aggressiveness, we divided patients cohort into two subgroups with a different disease progression rate (slow and fast), evaluated by als -functional rating scale (als-frs). we identified a group of micrornas differentially modulated in slow and fast progressing patients, that resulted as good prognostic biomarkers for als patients at the moment of the diagnosis. overall the results of our study can contribute to define a molecular signature of als phenotypes, and can allow to better characterise patients to enrol in clinical trials. exon skipping is one of the promising strategies to treat duchenne muscular dystrophy. recently we have studied the case of a duchenne patient (gs44) characterized by a slower progression of the pathology and healthier conditions, if compared to other age-matched duchenne patients. studies in our lab revealed that his situation is due to a natural exon skipping occurring in his cells. briefly, muscles of this subject lack the expression of celf2a splicing enhancer. this protein is involved in splicing of exon 45, and when is absent, like in gs44, this exon isn't properly recognized and, in a sub-population of dystrophin transcripts, is skipped. this phenomenon, in a dmd 44 context, like the gs44 one, allows the restoration of the frame of the transcript and the production of a small amount of the dystrophin protein. starting from this evidence, it seemed interesting to deepen the study of the regulation of this protein since its inhibition could be a treatment for those patients in which the skipping of exon 45 could recover the dystrophin mrna frame. at first, we investigated the reason of the absence of the protein in this individual. genetic mutations were identified nor in the promoter neither in the coding sequence. moreover, ipsc derived from gs44 fibroblasts and differentiated to myotubes, regain the expression of celf2a. these data suggest that an aberrant epigenetic control doesn't allow celf2a expression in the patient. in order to elucidate this regulation, we decided to perform chip-seq and atac-seq in gs44 versus control myoblasts. the first was performed to study common histones modifications, the latter to take a snapshot of the genome wide conformation of the chromatin. in this way we discriminate loci characterized by opened and actively transcribed chromatin and closed and inactive regions. celf2a regulatory region is marked by closed chromatin and repressive histone labels in gs44 (h3k27me3), while in control is open and shows histone modifications that are usually enriched at active chromatin regions (h3k4me3 and h3k27ac), in line with our observations. to further understand the reason of the missing expression of celf2a in the patient, rna-seq analysis was performed on gs44 and control myoblasts, in order to find a regulator of the factor. no differences in transcription factor expression, between the two condition, were found. instead we identified some long noncoding differentially expressed. among these, one is particular interesting: some experiments correlated its presence in the patient to the absence of celf2a. we hypothesize that this long noncoding could repress celf2a expression through the fine-tuning of chromatin accessibility. at the same time, fibroblasts derived from a 44 patient were reprogramed to ipsc and clones knock out for celf2a were obtained through crispr/cas9 technique. interestingly these clones are able to skip exon 45 thus confirming the therapeutical potential of the inhibition of celf2a. histone deacetylase 4 (hdac4) is a member of class ii hdacs which, by cooperating with class i hdacs, deacetylates proteins, thereby mediating the response to different stimuli in skeletal muscle. recently its protective, essential role in maintaining skeletal muscle homeostasis after long-term denervation (1) or in amyotrophic lateral sclerosis (2) and in satellite cell proliferation and differentiation (3) has been clarified. further, hdac4 is crucial for skeletal muscle regeneration by mediating soluble factors that influence musclederived cell proliferation and differentiation after injury (4). duchenne muscular dystrophy (dmd) is a fatal inherited muscle-wasting disease, caused by mutations in the dystrophin gene (5) and characterized by progressive muscle weakness and degeneration. the membrane repair response, which involves multiple proteins such as dysferlin, mg53 and annexin 1, is enhanced to actively maintain membrane integrity in dmd (6) . the pan-hdac inhibitor givinostat is presently in phase iii clinical trial for the treatment of dmd, despite no efficacy in skeletal muscle function has been registered in dmd patients (7) , highlighting the needs to study the hdac functions in skeletal muscle in dmd further. while the function of class i hdacs in dmd has been partially elucidated (8) , little is known about the role of class ii hdacs. to shed light on additional functions of hdac4 in skeletal muscle, we are currently studying the role of hdac4 in dmd by using a genetic approach. we generated dmd mice with hdac4 deleted in skeletal muscle (mdx;hdac4mko), by crossing mice with a skeletal muscle-specific deletion of hdac4 (hdac4 mko) with mdx mice, a mouse model of dmd. to determine hdac4 functions, muscular dystrophy progression has been analyzed over time, by histological and functional analyses. the deletion of hdac4 in skeletal muscles exacerbates muscle degeneration, increases circulating creatine kinase levels and decreases muscle functionality over time. further investigations have highlighted an impaired membrane repair mechanism in mdx;hdac4mko mice that may underpin the more pronounced progression of the pathology. from our results, we conclude that hdac4 is important for maintaining skeletal muscle integrity in dmd mice. ongoing studies are necessary to define the molecular signaling modulated by hdac4 in dmd in order to provide the experimental basis for a more efficacious pharmacological therapy. cerebral palsy (cp) is the single largest condition leading to childhood physical disability. this neurodevelopmental disorder is characterized primarily by neural deficits caused by a non-progressive lesion in the immature brain, and secondly by musculoskeletal problems that progress with age. alterations at the level of the muscle have been observed in comparison to normal developing children on both macroscopic (e.g. reduced muscle volume, shorter muscle belly, longer tendons) and microscopic (e.g. hypertrophic extracellular matrix and fibrotic tissue accumulation) levels. unfortunately, the onset and the development of these muscle alterations are not well understood, since data on young cp patients are still lacking. the skeletal muscle is a highly dynamic tissue and resident stem cells are the postnatal actors of repair and remodelling processes. therefore, to better understand the impaired development of the muscle and the underlying mechanisms responsible for the alterations reported in cp children, we aim to comprehensively describe the features of the stem cells from cp children compared to stem cells from typically developing children (td). as a starting point for an extended research project on the macroscopic and microscopic muscle properties of these children, the current study reports the pilot results on the microscopic level. a minimally invasive needle microbiopsy (16g) was applied to obtain muscle biopsies from the medial gastrocnemius, during interventions that required general anaesthesia. a total of 10 cp patients with gross motor function classification system level i-iii were included within a range from 2 to 9 years old. biopsies on td children are currently ongoing. the microbiopsy technique was well-tolerated. the explant technique resulted in a reasonable number of cells for all the planned in vitro examinations. satellite cells (scs), mesoangioblasts and fibro-adipogenic progenitor-like cells were isolated using fluorescence-activated cell sorting based on respectively cd56, alkaline phosphatase and pdgfra protein expression. all cell types were characterised by their myogenic and/or adipogenic differentiation potential. six-day differentiation of scs led to heterogeneous levels of differentiation and maturation based on the expression of myosin heavy chain protein and on fusion indexes. in addition, on these myotubes, disturbed nuclear migration was observed. in conclusion, microbiopsy proved to be harmless and efficient for our purposes. in ongoing research, a higher number of patients and multiple age-matched td children are being included to confirm our preliminary observations. future analysis will focus on nuclear migration and other impaired features that will be further assessed in the upcoming months. mitochondrial calcium uptake plays a key role in modulating cell metabolism, cell survival and other crucial cell functions. calcium accumulates into the mitochondrial matrix through the mitochondrial calcium uniporter (mcu). few years ago a mcu homolog has been discovered, that was called mcub. mcu and mcub share a 50% sequence and structure similarity although some conserved differences in the primary sequence prevent mcub from forming a ca 2+ -permeable channel, thus acting as a dominant-negative subunit. interestingly, mcub/mcu expression ratio varies greatly among tissues, suggesting that it might contribute to the spatiotemporal control of mitochondrial calcium uptake. here we show that mcub is highly expressed during skeletal muscle regeneration, a process that is mainly regulated by phenotypic skewing of tissue resident and freshly recruited macrophages. we have demonstrated that mcub expression is specifically induced in macrophages, the most abundant cell population in a regenerating muscle that drive both the proliferation and differentiation of the muscle stem cells, satellite cells, thus affecting the progression of healing after muscle damage. in vitro and in vivo experiments demonstrated that the absence of mcu affects macrophages skewing from a pro (m1) to an anti-inflammatory profile (m2). indeed, macrophages of mice lacking mcub are more prone to acquire a pro-inflammatory m1 profile. since m2 macrophages have a proregenerative role and promote myogenic precursor cell differentiation, we hypothesized that mcub absence, by affecting m2 polarization, might influence the correct remodeling and reorganization of skeletal muscle structure after damage. our results clearly show that regenerating muscles lacking mcub show a decrease in the expression level of myogenic regulatory transcription factors involved in satellite cells activation and differentiation. we also observed a decrease in the percentage of regenerating myofibers and a decrease in collagen deposition. in addition, co-culture experiments demonstrated that macrophage-conditioned medium from m2 mcub ko macrophages drastically decreases satellite cell differentiation. altogether these results demonstrate the role of mitochondrial ca 2+ uptake in promoting the polarization of macrophages towards an m2 pro-regenerative profile during skeletal muscle regeneration. further experiments will help to clarify the role of mitochondrial calcium during skeletal muscle regeneration. dystrophic muscle is characterised by chronic injury, and a steady recruitment of inflammatory ly6c hi monocytes. recent studies have identified the spleen as the dominant reservoir of these cells during chronic inflammation. here we investigated the hitherto unexplored contribution of splenic ly6c hi monocytes to dystrophic muscle pathology. using the mdx mouse model of muscular dystrophy, we show that ly6c hi monocytes accumulate in great numbers in the spleen over the course of the disease. the chemokine receptor ccr2 was upregulated before disease onset, enabling their egress from the spleen. splenectomy performed before disease onset significantly reduced the number of ly6c hi monocytes infiltrating dystrophic limb muscle. moreover, in the absence of splenic ly6c hi monocytes there was a significant reduction in dystrophic muscle inflammation and necrosis, along with improved regeneration during early disease. however, during late disease, lack of splenic ly6c hi monocytes adversely affected muscle fiber repair, caused a delay in the phenotypic shift of pro-inflammatory f4/80 + /ly6c hi /cd206 lo to anti-inflammatory f4/80 + /ly6c lo /cd206 + macrophages, and was associated with increased fibrosis. overall, we show that the spleen is an indispensable source of ly6c hi monocytes in muscular dystrophy, and that splenic monocytes are critical players in both muscle fiber injury and repair. muscular dystrophies (mds) are severe genetic disorders mainly due to mutations in structural proteins, causing contraction-induced damages. previous attempts to treat these diseases raised from the idea that accelerating muscle growth and regeneration would exert beneficial effects. we recently demonstrated that slowing down the degeneration-regeneration cycles and switching muscle fibers towards a slow-twitching phenotype by silencing the transcription factor nfix leads to a morphological and functional amelioration of the dystrophic phenotype. on the basis of the identification of the molecular pathways regulating nfix expression, we are now developing a pharmacological approach to inhibit nfix in mds which is based on the inhibition of the erk pathway by using two fda-and ema approved drugs for cancer. at the same time, another strategy considered is the use of antioxidants to protect myofibers from oxidative stress generated by muscular contraction. different evidences are indeed establishing the importance of dietary anthocyanin's for preventive and ameliorative strategies against chronic diseases. we therefore tested the therapeutic benefit of a cyanidinenriched diet in the progression of the md. interestingly, dystrophic mice fed with a cyanidin-enriched diet show a morphological and functional amelioration of the dystrophic phenotype through mechanisms that involve both cell survival and anti-inflammatory pathways. all this evidence, strongly demonstrate that promising therapeutic and supporting strategies to slow down the disease progression in dystrophic patients is to reduce, the oxidative stress, muscle regeneration and muscle contraction achievable through different and synergistic strategies. profiled both the cytokines and the evs at different time points during muscle regeneration of the cardiotoxin injured mouse model. we performed a multiplex elisa assay of the mononuclear cell compartment lysate to analyze the expression kinetics of 90 cytokines. in addition, by profiling the rna expression profile of four cell populations, we determined the cell types that have the potential to secrete the different cytokines and those that synthetize the specific receptors. based on the kinetic of their expression during damage recovery, we selected 15 cytokines to be tested in vitro on fibro-adipogenic progenitors (faps). using this approach we identified cytokines that influence fap proliferation and differentiation decisions. in addition, by culturing injured muscles ex-vivo, we obtained the evs secreted by the tissue during the regeneration process. to analyze their cargo, we characterized the vesicle heterogeneity by using a flow cytometry approach. specifically, we identified and quantified the rnas-and enzymes-containing evs. finally, we investigated their ability to interact with different muscle-derived cell populations, influencing their proliferation and differentiation potential. our data, combined with in silico modeling, will increase our understanding of cell-cell communication during muscle regeneration. the neuromuscular junction (nmj) is a chemical synapse localized between the terminal branches of the spinal motor neurons and the skeletal muscle fibers. in the past two decades co-culture systems to recreate the nmj in vitro were developed to address concerns about animal models, nevertheless the complexity of its highly specialized structure makes the in vitro modeling a challenging task. however, a further improvement in this issue was recently provided by microfluidics that, unlike in mass co-cultures, allow spatial and temporal control over different microenvironment by manipulating either neural cells or muscle cells populations independently. this enables the investigation of mechanisms involved in the formation and the maintenance of a stable and functional nmj. therefore, exploiting an organ-on-a-chip approach, our aim is to obtain a reliable and predictive in vitro human model of nmj in physiological and pathological conditions, to investigate the occurrence of synapse detriment in neuromuscular diseases. for this purpose, motor neurons derived from human ipscs and human skeletal muscle cells derived from either perivascular muscle progenitors, namely pericytes, or immortalized myoblasts are seeded in two separated chambers of a microfluidic device. the two side of the device are linked together through microchannels that enable the axonal outgrowth to the muscle side, but not cell bodies migration, allowing the compartmentalization of the cell populations without interrupting cell-cell communication. while being designed as a reliable platform to investigate the molecular actors of nmj processes, the setup is versatile enough to host patient-specific cells and perform functional and molecular analysis. spinal and bulbar muscular atrophy (sbma) is caused by polyglutamine (polyq) expansions in the ar gene. although clinical and experimental evidence highlight a primary role for skeletal muscle in the onset, progression, and outcome of sbma, the pathophysiological and molecular processes underlying sbma muscle atrophy are poorly understood. we show that polyq-expanded ar alters intrinsic muscle force generation before denervation. reduced muscle force was associated with a switch in fiber-type composition, disrupted muscle striation, altered calcium (ca++) dynamics in response to muscle contraction, and aberrant expression of excitation-contraction coupling (ecc) machinery genes in transgenic, knock-in and inducible sbma mice and patients. acute suppression of ar activation by surgical castration elicited similar ecc gene expression changes in normal mice, suggesting that ar regulates the expression of these genes in physiological conditions. importantly, treatment to suppress polyq-expanded ar expression restored ecc gene expression back to normal. bioinformatic analysis revealed the presence of androgen-responsive elements on several genes involved in muscle function and homeostasis. experimental evidence showed ardependent regulation of expression and promoter occupancy of the most up-regulated gene from transcriptomic analysis in sbma muscle. these observations reveal an unpredicted role for ar in the regulation of expression of genes involved in muscle contraction and ca++ dynamics, a level of muscle function regulation that is disrupted in sbma muscle, yet restored by pharmacologic treatment. the aim of this project is to dissect the identity and localization of the nascent muscle proteome in vivo. the tool of choice is the transgenic mouse metrs, expressing a mutant methionyl-trna synthetase together with a green fluorescent protein. we crossed this mouse with a skeletal muscle specific cre-expressing mouse to obtain a tissue specific expression. the mutated methionyl-trna synthetase can integrate a synthetic amino acid (anl) instead of a methionine in a nascent peptide chain. the synthetic amino acid side chain ends with an azide, allowing the formation of a covalent bond with an alkyne by a click chemistry reaction. to visualize the gfp-2a-metrs expression, a western-blot with anti gfp antibody has been performed as well as immunohistochemistry on cryosections. the flexibility of the click reaction allows the visualization of nascent peptide chains either by western blot or immunofluorescence. intraperitoneal injections of anl for different time periods resulted in a significant labelling of the muscle proteome after 1, 2 and 7 days. after the protein extraction, each whole cell lysate has been clicked with biotin labelled alkyne in the presence of copper (ii) sulphate and ascorbic acid and labelled proteins were revealed by western blotting. labelled proteins can also be revealed by ihc performing funcat (fluorescent non-canonical amino-acid tagging) on cryosections. this way we were able to identify that a specific proteome was synthesized during a determined amount of time. these preliminary studies will give us the necessary tools to better understand the skeletal muscle proteome in physiological and pathological conditions. mitochondria change distribution across cells following a variety of pathophysiological stimuli. the mechanisms presiding over this redistribution are yet undefined. in a murine model overexpressing drp1 specifically in skeletal muscle, we find marked mitochondria repositioning in muscle fibres and we demonstrate that drp1 is involved in this process. drp1 binds klc1 and enhances microtubule-dependent transport of mitochondria. drp1-klc1 coupling triggers the displacement of kif5b from kinesin-1 complex increasing its binding to microtubule tracks and mitochondrial transport. high levels of drp1 exacerbate this mechanism leading to the repositioning of mitochondria closer to nuclei. the reduction of drp1 levels decreases kinesin-1 activation and induces the partial recovery of mitochondrial distribution, thus linking mitochondrial movements to drp1 levels. this aberrant positioning of mitochondria is accompanied by the collapse and aggregation of desmin confirming that the loss of mitochondria anchoring system may contribute to mitochondria distribution. we conclude that desmin alterations accompanied by increased drp1 levels enhance microtubule-dependent trafficking promoting changes in mitochondrial positioning unravelling a hitherto unknown function of drp1 in the regulation of kinesin-1 complex. valentina taglietti the "ubiquitous" ccaat-binding transcription factor nf-y is a trimer formed by the histone-like nf-yb/nf-yc and the sequence-specific nf-ya, present in two isoforms. all three subunits are required for dna-binding and function. the role of nf-y in muscle physiology is not clear: if overexpressed, the "long" nf-ya isoform favors differentiation, yet it is negatively regulated during the process. we targeted nf-ya exon 3 by crispr-cas9 in mouse c2c12, thus ablating the "long" nf-ya: despite expression of nf-ya "short", differentiation is blocked. to understand the nf-y regulome in a more physiological system, we turned to primary mouse fetal myoblasts, performing chip-seq, rna-seq after nf-yb rnai, and monitoring gene expression from myoblasts to myotubes. nf-y locations are similar before and after differentiation, despite far lower levels of nf-ya. notably, the nf-y regulome is devoid of binding sites of mrfs -muscle regulatory factors-and myotubes-specific genes are not targeted. instead, we observe a positive functional partnership with srebps, master regulators of lipids biosynthesis, and a negative one on cell-cycle genes. srebp-2 is active in differentiation and bound to promoters of genes co-regulated with nf-y. these data establish that nf-y, and specifically the "long" nf-ya isoform, is essential for myotubes formation, but marginally, if at all, through direct activation of muscle-specific genes. instead, it teams up with srebps to activate crucial steps of lipids metabolic pathways required for the process. the nf-y/srebps partnership will be discussed. ck2 is a tetrameric protein-kinase, composed of two catalytic ( and/or ') and two regulatory β-subunits. our study provides the first molecular and cellular characterization of the different ck2-subunits highlighting their individual roles in skeletal muscle specification and differentiation. analysis of c2c12 cells knockout for each ck2-subunit reveals that: i) ck2β is mandatory for the expression of the muscle master-regulator myod in proliferating myoblasts, thus controlling both myogenic commitment and subsequent muscle-specific gene expression and myotube formation; ii) ck2 is involved in the activation of the muscle-specific gene-program; iii) ck2'-activity regulates myoblast fusion by mediating plasma membrane translocation of fusogenic proteins essential for membrane coalescence, like myomixer. accordingly, ck2' overexpression in c2c12 cells and in mouse regenerating muscle is sufficient to increase myofiber size and myonuclei content via enhanced satellite cell fusion. consistent with these results, pharmacological inhibition of ck2-activity substantially blocks the expression of myogenic markers and muscle cell fusion both in vitro, in c2c12 and primary myoblasts, and in vivo, in mouse regenerating muscle and zebrafish development. concluding, our work describes the specific and coordinated functions of ck2-subunits in orchestrating muscle differentiation and fusogenic activity, highlighting ck2 relevance in the physiopathology of skeletal muscle tissue. fibro/adipogenic progenitors (faps) are muscle interstitial progenitors mediating pro-myogenic signals that are critical in muscle homeostasis and regeneration. in pathological conditions, including ageing and myopathies, the autocrine/paracrine constraints controlling fap adipogenic potential are released causing the formation of fat infiltrates. to reveal pathways that transduce the niche messages controlling fap adipogenesis, we have screened a library of inhibitors targeting a large fraction of the human/murine kinome, looking for molecules with a potential to modulate fap differentiation. hit selection criteria enrich compounds targeting glycogen synthase kinase 3 (gsk3), thus unveiling its crucial role in fap adipogenesis. consistently, we show that the pharmacological blockade of gsk3, by using the high-selective inhibitor ly2090314, severely impedes fap adipogenesis ex vivo while limiting intramuscular fat infiltrations upon glycerol-induced muscle injury, in vivo. by exploiting high-dimensional single-cell mass cytometry, we demonstrate that -catenin down-regulation is critical for ppar expression. ly2090314, by targeting gsk3, counteracts this process and prevents fap adipogenesis. by combining computational strategies based on the interrogation of single-cell transcriptomes, in silico network modeling and rnaseq data integration, we conclude that: i) faps are the main source of wnt ligands in the muscle and that the release of these cytokines may trigger autocrine/paracrine responses; ii) the wnt pathway has a dominant role in regulating the adipogenic network of faps; iii) wnt5a expression is impaired in faps from dystrophic mice. finally, we show that exogenous treatment of dystrophic faps with wnt5a is sufficient to repress ppar expression and the adipogenic conversion of faps into adipocytes. these results suggest that by modulating the wnt pathway either by targeting gsk3 or by restoring autocrine wnt5a signaling in faps might be a strategy to counteract intramuscular fat infiltrations in myopathies. in skeletal muscle, mitochondrial ca 2+ uptake plays important roles in organ homeostasis, ranging from control of metabolism to regulation of fiber trophism. still debated is whether in muscle mitochondria can buffer cytosolic ca 2+ increases. to answer to this question, we explored the effect of removing parvalbumin (pv), the most important muscle cytosolic ca 2+ buffer. by using a pv knockout (ko) mouse model, we are investigating whether the absence of pv induces compensatory mechanisms on the expression and function of the mitochondrial ca 2+ uptake machinery (mcu). the data obtained so far confirm that the absence of pv induces an increase of mitochondrial ca 2+ uptake and this is accompanied by the induction of the expression of the mcu coin vitromplex components. moreover, electron microscopy analysis performed on extensor digitorum longus (edl) muscle of wt and pv ko mice, demonstrated that pv ko mitochondria are significantly larger than wt controls and with a different redistribution in the muscular tissue, suggesting a strict connection and regulation between pv expression and mitochondrial morphology and function in muscle cells. furthermore, cytosolic ca 2+ transients in pv ko muscle fibers show that the time to reach the peak upon stimulation and the time to half relaxation are prolonged in pv ko muscles. to verify whether the increase of mitochondrial ca 2+ uptake in ko fibers is due to mitochondrial adaptation and whether mcu is responsible of buffering cytosolic ca 2+ increase, we decided to silencing mcu and measure [ca 2+ ]cyt on fdb muscles of wt and pv ko animals. [ca 2+ ]cyt was almost unaffected by the absence of mcu in wt animals while, in pv ko fibers, [ca 2+ ]cyt was significantly higher upon stimulation. furthermore, since pv is one of the most downregulated atrogenes, the genes commonly up-and down-regulated during several types of atrophy, and that mitochondrial ca 2+ controls skeletal muscle trophism, we decided to study the role of pv on muscle mass through denervation experiments. when pv is absent, loss of muscle mass is reduced compared to wt fibers, demonstrating that pv can partially protect muscles from denervation-induced atrophy. overall, our results indicate that pv plays an important role in spatiotemporal control of cytosolic ca 2+ responses on mitochondrial ca 2+ uptake and have a profound impact on skeletal muscle trophism. the second messenger ca 2+ regulates a broad repertoire of cellular processes. upon physiological stimuli, skeletal muscle mitochondria rapidly and efficiently accumulate ca 2+ into their matrix via an electrogenic pathway, that relies on the driving force of a steep electrochemical gradient. a large [ca 2+ ]mt peak occurs dynamically in parallel to agonist-induced [ca 2+ ]cyt increases, thanks to the activity of the mitochondrial calcium uniporter (mcu), the highly selective channel responsible for mitochondrial ca 2+ accumulation. mcu positively regulates myofiber size in physiological conditions, and counteracts pathological loss of muscle mass. we have previously demonstrated that skeletal muscle-specific mcu deletion (mcu -/-) inhibits myofiber mitochondrial ca 2+ uptake, impairs muscle force and exercise performance. mitochondrial ca 2+ uptake is required for effective glucose oxidation and efficient mitochondrial activity. nonetheless in mcu -/myofibres, impaired oxidative capacity is partially sustained by increased fatty acid (fa) oxidation. the main trigger of this metabolic rewiring is the decreased pyruvate dehydrogenase activity which is tightly controlled by mitochondrial ca 2+ accumulation. here, we have investigated the role of mitochondrial ca 2+ uptake during skeletal muscle aging. in detail, we show that mitochondrial ca 2+ accumulation is decreased in 24 months old mice and this condition is accompanied by a decreased pyruvate dehydrogenase activity. in this scenario we demonstrate a rewiring of skeletal muscle metabolism where mitochondrial activity is sustained by fa oxidation rather than glucose. further studies are needed to evaluate whether the restore of glucose as the main fuel for oxidative metabolism will be sufficient to counteracting aging process, including force and performance, in skeletal muscles. dystrophin deficiency causes chronic wasting of the skeletal muscle tissue leading to patient respiratory or heart failure and, finally, death. in addition to fiber fragility, the absence of the dystrophin protein, as in duchenne muscular dystrophy (dmd), causes a variety of poorly understood secondary effects. notably muscle fibers of dystrophic individuals are characterized by mitochondrial dysfunctions, as revealed by a reduced atp production rate and by defective oxidative phosphorylation (oxphos). we recently discovered that in a mouse model of dmd (mdx), the interstitial fibro/adipogenic progenitor (fap) cells are also characterized by a dysfunctional mitochondrial metabolism which correlates with an increased adipogenic differentiation potential. using high-sensitivity mass spectrometry-based proteomics, we highlighted that a short-term high-fat diet regimen reprograms dystrophic fap metabolism in vivo. by combining our proteomic dataset with a literature-derived signaling network, we discovered a high-fat dependent modulation of the crucial hub protein, -catenin, which controls follistatin expression. our results reveal that a short-term highfat diet restores the key role of faps in enhancing the myogenic activity of the skeletal muscle stem cells in dystrophic mice. consistently, we observe that muscle regeneration in the mdx mouse is significantly improved by the short-term high-fat diet. our results support metabolic reprogramming of muscle interstitial progenitor cells as a novel approach to alleviate some of the adverse outcomes of duchenne muscular dystrophy. if we concentrate homo sapiens existence in just 24 hours, the time he started to be totally sedentary is just 30 seconds ago, while his life expectation exceeded the 60-year during the last 25 seconds. the combination of a novel life-style with an increased life-span, two conditions that our species never experienced before, resulted in the onset of many chronic and metabolic diseases. nevertheless, emerging evidence shows that readopting a "more active" life-style is associated with healthier and longer life-span. whole-body beneficial effects of physical activity are the consequence of adaptive metabolic changes established in the entire organism to sustain the high energy expenditure of contracting skeletal muscles. during last years, many efforts have been made to dissect the molecular mechanisms explaining why physical activity sustains and improves life quality. recently, our group identified the trascription-factor eb as a muscular master metabolic regulator that translocates into myonuclei in response to exercise promoting the expression of genes for different fuel disposal and utilization. these findings strongly support tfeb activity as crucial for the beneficial effects of exercise. starting from this evidence we decided to discover new uncharacterized genes that may mechanistically explain adaptive effects of tfeb on skeletal muscle. by crossing gene expression data of tfeb transgenic and trained muscles, we found a gene of unknown function belonging to the riken cdna collection that we called exe-riken.exe-riken encodes a putative 125 residues protein highly conserved among mammals; interestingly, exe-riken coding sequence translates in a real protein when expressed in vitro and in vivo. based on gene expression databases, brown adipose and gut are the tissues with higher basal exe-riken expression in mice. on the other hand, skeletal muscle transcript levels are very low, type of muscle specific and finely tuned with different exercise protocol. in addition, exe-riken protein sequence presents a nuclear export signal (nes) and nuclear localization signal (nls), suggesting a potential shuttling behavior upon appropriate stimuli. supporting this idea, in vivo experiments demonstrate exe-riken nuclear translocation upon exercise. finally, overexpression studies in adult tibialis anterior muscle showed an increased sdh activity and a decreased pas staining, suggesting its impact in muscle metabolism. overall these findings highlight a possible role of this new gene in controlling metabolic adaptations during physical activity. cholecalciferol, or vitamin d3 (vd hereafter for brevity), besides its well-known role in regulation of calcium and phosphate homeostasis, impacts on skeletal muscle homeostasis as well, and vd deficiency has been correlated with decrease in muscle mass, function, and performance in elderly subjects, as well as in cachectic cancer patients. while vd supplementation was able to restore muscle strength and prevent muscle mass loss in frail elderly subjects, it was ineffective in the case of cancer cachexia-associated muscle wasting. investigating the direct effects of the main cholecalciferol-derived metabolites -namely 1,25-(oh)2-vd and its precursor 25-oh-vd-on skeletal muscle cells, we found divergent effects of these molecules in promoting/preserving from atrophy induced by pro-cachectic cytokines. given the anti-atrophic action of 25-oh-vd, we wondered if also the pro-hormone vd could have a direct activity on skeletal muscle cells. for this purpose, we used an in vitro model of cytokine-induced atrophy and found that also vd has a protective action. intriguingly, the activity of vd is notmediated by an intracellular conversion in the protective form 25-oh-vd. our recent study revealed the existence of a novel embryonic isoform of cavβ1 (cavβ1e), the beta subunit of cav1.1, which expression increases in adult muscle after denervation. the increase of cavβ1e expression boosts downstream gdf5 signaling to counteract muscle atrophy due to nerve damage. we further reported that aged muscle expresses significantly reduced levels of cavβ1e and that its overexpression improves mass wasting in aging muscle by increasing gdf5 expression. crucially, we also identified the human cavβ1e analogous and showed a correlation between the decrease of cavβ1e expression and the age-related muscle mass decline in people. altogether, our data open a new field in the development of strategies against muscle mass loss during senescence. here, we have preliminary data indicating that the systemic administration of the recombinant gdf5 protein (rgdf5) represents a promising therapeutic approach to improve age-related muscle wasting. in a pilot study, old mice (90 weeks old) were treated with rgdf5, by systemic delivery, for ten weeks. strikingly, rgdf5 implementation induced a significant increase of lean mass and a decrease of the fat mass. indeed, muscle/body-weight ratios of tas and quadriceps (quad) were significantly increased in the rgdf5-100 weeks old mice compared to vehicle-treated old mice. in order to evaluate the possible mechanisms behind rgdf5 effects in muscle, we analyzed: a) myostatin (gdf8) pathway, involved in protein degradation; b) neuromuscular junction (nmj) status by measuring the expression of acetylcholin receptor subunit epsilon (chrnε). we found a significant decrease in myostatin pathway activation in muscle treated with rgdf5, suggesting his protective role against myostatin-dependent protein degradation. furthermore, while chrnε transcription was significantly decreased during aging revealing an alteration of nmj, rgdf5 administration led to chrnε re-expression suggesting an improvement of nmj state. all together these data show that rgdf5 implementation efficiently counteracts age-related muscle wasting and, more generally, could ameliorate neuromuscular decline and protein degradation underlying several (neuro) muscular diseases. cachexia is a highly debilitating multifactorial syndrome associated with various diseases and is characterized by severe muscle wasting leading to pronounced weight loss, impaired quality of life, reduced response to therapy, and premature death. vitamin d binding protein (vdbp), also known as group-specific component (gc-globulin), is a multifunctional serum glycoprotein synthesized by hepatocytes that belongs to the albumin gene family. besides the binding and transport of vitamin d metabolites in blood, vdbp has other activities, including binding and clearance of monomeric g-actin released from dead cells and acting as a chemotactic cofactor for c5a.proteomic analysis of samples from patients affected by pathologies susceptible to progressive muscle loss or cachexia, including several types of cancers, shows upregulation of vitamin d binding protein (vdbp), raising the hypothesis that vdbp might play a role in cancer cachexia-associated muscle loss. we found that vdbp expression increases in tumor-bearing mice undergoing cachexia, further supporting the notion that vdbp could play a role in the onset/progression of cancer-associated muscle wasting. we explored the direct action of vdbp in skeletal muscle and found that vdbp indeed induces atrophy in c2c12 myotubes and that mice devoid of vdbp are protected from cancer-associated cachexia. our preliminary results demonstrate that vdbp is not a simple carrier that modulates the bioavailability of vitamin d but an active hormone in itself with pro-cachectic effects on skeletal muscle cancer cachexia is a devasting multifactorial syndrome characterized by the progressive unintentional body weight loss mainly due to skeletal muscle wasting and atrophy that occurs in the majority of terminally-ill cancer patients. notably, cancer-induced muscle wasting markedly results in a drastic worsening of patient prognosis and quality of life. furthermore, cancer-driven cachexia also limits the therapeutic options, as cachectic patients usually manifest reduced tolerance and response to antineoplastic treatments. aside from this, cachexia directly accounts for nearly 20% of all cancer-related deaths, as the cachectic skeletal muscle wasting also affects survival needed muscles such as diaphragm and cardiac muscle, leading to respiratory and cardiac failure. in the last decade, the pivotal role of cancer-driven inflammation both in tumour progression and cachexia onset has clearly emerged, as well as cancer cachexia is associated to a broad range of metabolic and endocrine impairments leading to tissue function disruptions. nevertheless, the potential role of muscle metabolic alterations in the activation and development of cancer cachexia has been little studied so far. here, we report that conditioned media (cm) from murine and human carcinoma cell lines able to trigger cachexia in vivo, induce cachexia in c2c12 myotubes that is associated to a metabolic shift towards fermentation. our findings suggest that this metabolic shift is crucially involved in the activation of cachexia in c2c12 myotubes, since the abolishment through glycolysis block or lactate dehydrogenase inhibition, prevents the onset of the cachectic phenotype. furthermore, our evidences suggest that cm from cancer cell lines able to induce cachexia express high levels of ifn-γ and il-6 and that these two proinflammatory cytokines could be involved in the metabolic shift towards fermentation that occurs in cm-treated myotubes, thus leading to cachectic phenotype. overall, our results show the possible key role of the metabolic reprogramming towards fermentation in the induction of cachexia in myotubes, thus opening the study to new drugs that could counteract the metabolic shift and inhibit the cachectic phenotype. aging is associated with a progressive loss in skeletal muscle mass and strength, known as sarcopenia. sarcopenia results in a decrease in mobility and an increased risk of developing chronic metabolic disease, thus it represents a major socio-economical problem. age-related muscle loss cannot be consistently prevented by physical therapy and a pharmacologic therapy does not exist, probably because the molecular basis of this condition is still largely unknown. many factors such as mitochondrial dysfunction, oxidative stress, inflammation, changes in the innervation of muscle fibers probably play an important role in age-related muscle decline. pin1 is a widely expressed peptydyl prolyl cis/trans isomerase, involved in post-phosphorylation control of the function of multiple target proteins. many evidences indicate that pin1 controls signaling pathways involved in skeletal muscle wasting. our results indicate that skeletal muscle of pin1 ko mice is protected against muscle loss and weakness during aging. at the molecular level, we found 1) an increased expression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (pgc1α), a transcription factor that promotes mitochondrial biogenesis, in skeletal muscle of pin1 ko mice. coherently with their resistance to muscle loss, we also found 2) an increase in the expression of the protein synthetic signaling proteins p70 ribosomal s6 kinase (s6k) and of its phosphorylated form in aged skeletal muscle of pin1 ko mice compared to the wild type controls, suggesting that in these mice protein synthesis is maintained efficient. we also found 3) a significant decrease of myostatin levels in skeletal muscle of aged pin1 ko mice. it is well known that myostatin is up regulated sarcopenia; it activates smad2/3 signaling and contributes to protein degradation and muscle atrophy. the transcriptional effects of pin1 depletion on pgc1α and s6k genes must be mediated by a transcription factor. a putative candidate to mediate these effects is represented by the transcription factor myocyte enhancer factor 2c (mef2c), a known pin1 target. in skeletal muscle cells a specific splice variant of mef2c, mef2c α1, activates the increase of skeletal muscle mass by activating the expression of igf1 and s6k. these activities are repressed by its phosphorylation, that renders it a target for the inhibitory effect of pin1 on its protein stability and activity. coherently with these premises, we found 4) a decrease of mef2c protein phosphorylation levels in aged ko mice compared to the control animals. this might at least partially contribute to the increased expression of pgc1α and of s6k. our results indicate that pin1 could represent a valuable pharmacological target to counteract age-related muscle loss, simultaneously modulating multiple targets in a concerted way. skeletal muscle (skm) atrophy is determined by several physiological and pathological conditions, such as cancer and neuromuscular disorders. biomolecular characteristics of most types of skm atrophy are the suppression of protein synthesis and the increase in protein degradation. although the signalling pathways involved in the control of skm waste are multiple, the regulatory role of lipids is only in part known. sphingolipids (sls) represent a class of bioactive molecules capable of modulating the destiny of many cell types, including skm cells. here, we investigated the role of ceramide kinase (cerk), the enzyme involved in the phosphorylation of ceramide (cer) to ceramide 1-phosphate (c1p). we found that the expression of cerk was comparable in c2c12 myoblasts and in terminally differentiated myotubes excluding that cerk expression modulators may be required for the achievement of myogenic differentiation. however, cerk inhibition promotes myoblast cell growth arrest and myotubes reduction in size suggesting a role of cer/cerk axis in the maintenance of normal mature phenotype. notably a drastic decrease of cerk protein expression was observed in skm tissues obtained from animals bearing the c26 tumor, a well-characterized experimental model of cancer cachexia, and in c2c12 myotubes treated with the glucocorticoid dexamethasone. these findings provide the evidence that cer/cerk axis acts as a molecular regulator of skm atrophy, thereby representing a new possible target for therapy in pathophysiological muscle conditions. cachexia is a debilitating syndrome affecting the majority of patients with advanced cancer, and directly responsible for about 20% of all cancer-associated deaths. the major clinical feature of cachexia is skeletal muscle atrophy that leads to pronounced weight loss, drastically dampens patients' quality of life, reduces the response and tolerance to chemotherapy, and is associated with poor prognosis and outcome (1). the identification of reliable biomarkers of cachexia is of great importance to identify patients in the different phases of the disease and to monitor the treatment outcome (2) . rage (receptor for advanced glycation end-products) is a multiligand receptor of the immunoglobulin superfamily physiologically involved in skeletal muscle development and homeostasis (3). in cancer conditions, the increase of rage ligands levels leads to hyperstimulation of the receptor translating into systemic inflammation and muscle wasting, and reducing mouse survival (4). we analysed rage expression in muscle tissue of different preclinical mouse models of cancer cachexia [lewis lung carcinoma (llc)-bearing c57bl/6 and colon adenocarcinoma (c26-adk)-bearing balb/c mice] in the absence or presence of voluntary endurance exercise (wheel), which has been reported to partially antagonize muscle wasting in mice (5), and correlated rage expression with myofiber crosssectional area (csa) and hallmarks of muscle atrophy (body and muscle weights, protein degradation extent, and activation of proteolytic systems). we also analysed rage expression in muscle biopsies from cancer patients. we found that: i) llc-and c26-adk-bearing mice express rage in myofibers in coincidence with reduced body and muscle weights and induction of proteolysis; ii) an inverse relationship exists between rage expression in muscles and tumor masses and the beneficial effects of endurance exercise in llc-bearing mice; iii) rage expression increases in muscles during cachexia progression; iv) rage is not expressed in myofibers of athymic-nude mice injected subcutaneously with llc or melanoma a375 cells, which do not develop cachexia; and v) muscles of cachectic patients express higher amounts of rage than non-cachectic subjects. altogether, our results suggest that rage might represent a biomarker to monitor the cachectic stage at muscle level. tissue engineering (te) and regenerative medicine approaches are designed to increase skeletal muscle damage response. scientific advances in biomaterials and stem cells allowed the opportunities to generate tissues from combinations of engineered extracellular matrices, cells and biologically active molecules in order to promote muscle regenerative response. therefore, functional contractile properties as close as possible to that of healthy muscles are requested to allow for a good compatibility and a proper functional contribution. the x-met is an engineering vascularized skeletal muscle tissue able to recapitulate the complex morphological properties, the architecture and the function of skeletal muscle. the x-met shows biomechanical properties like muscles, can contract spontaneously as well as to respond to electrical stimulation. the aim of our study is to define the functional plasticity of x-met subjected to mechanical stimuli. interestingly, preliminary evidences suggest that different mechanical tensions induce a functional remodeling of x-met toward a non-skeletal muscle phenotype. in this work, we demonstrated that x-met show preserved cellular communication junctions, endogenous extracellular matrix (ecm), and integrative adhesive agents that could create a favorable environment for survival and integration of the x-met in the host tissue. for this features, x-met can be considered a useful experimental tool for in vitro and in vivo studies to improve drug discovery technologies, to supersede current preclinical animal models of disease and to restore the lost function of muscles. sertoli cells (sec) are the major component of the seminiferous tubules in the testes, where they secrete a plethora of trophic and immunomodulatory factors necessary for development of germ cells and to protect developing germ cells against the immune system attack, respectively. naked or encapsulated sec have been widely used as a therapeutic approach to many pre-clinical studies [1, 2] . a single intraperitoneal (i.p.) injection of microencapsulated porcine sec (sec-mc) translated into recovery of muscle morphology and performance in dystrophic (mdx) mice in the absence of pharmacological immunosuppression, thanks to a double sec effect, i.e., an antiinflammatory action and heregulin beta 1-dependent induction of utrophin at the sarcolemma [3] . this opened a new route of treatment for duchenne muscular dystrophy (dmd) patients. however, it is still debating if sec exert immunomodulatory or immunosuppressive effects, which is of relevance in view of their application in humans. here we show that mice previously injected i.p. with sec-mc were more able to solve pulmonary infection by aspergillus fumigatus, one of the most common species causing disease in immunodeficient individuals, compared to control mice injected with empty microcapsules (e-mc), as evaluated by analysis of bronchoalveolar lavage, fungal growth, histology (pas and grocott staining), and inflammatory chemokines and cytokines expression (rt-pcr) in lungs. moreover, mice previously injected i.p. with sec-mc and later injected subcutaneously with llc (lewis lung carcinoma) cells showed similar tumor growth over time to mice injected with e-mc, further suggesting that sec do not exert an immunosuppressive role. this was also confirmed by the observation that one year from i.p. injection sec-mc-injected mdx mice did not show neither adverse effects nor increased incidence of tumor formation. altogether, our data suggest that sec exert immunomodulatory rather than immunosuppressive effect, further supporting the use of i.p. injection of sec-mc as a potential treatment of dmd patients and diseases characterized by an inflammatory or autoimmunity environment. duchenne muscular dystrophy (dmd), caused by genetic mutations leading to the absence of dystrophin, is the most common and severe muscular dystrophy, characterised by progressive muscle degeneration leading to premature death by the age of 20-30 years old. in dmd skeletal muscle, the repeated episodes of muscle fiber injury and necrosis, and the subsequent fibrosis are driven to a large extent by complex interactions between dystrophin deficiency and the host immune response. this has been demonstrated by removing macrophages and other inflammatory cell types in the mdx mouse model of dmd as well as through the inhibition of key mediators of inflammation. the approved therapies, based on corticosteroids, support the evidence of the major role of inflammation in this disease. nevertheless, due to their limitations in terms of efficacy and adverse events, they encourage us to find alternative approaches derived from the identification of novel suitable therapeutic targets. to this end we have been investigating, in dmd progression, the pathway of the sphingolipid metabolising enzyme, acid sphingomyelinase (a-smase), which has recently been demonstrated to be involved in inflammatory related disorders. our results in mdx mice muscles revealed an upregulation of a-smase expression and activity strongly connected to inflammation. muscle regeneration in dmd can be impaired due to an imbalance in m1 (pro-inflammatory) and m2 (anti-inflammatory) macrophage phenotypes. our studies in a-smase -/mice, to investigate deeper the role of a-smase show that this enzyme is fundamental for m1 macrophage polarization and that following injury in a-smase -/mice there is a short m1 macrophage phenotype retention phase and a corresponding enhanced m2 macrophage phenotype function. as a proof-of-concept of pharmacological inhibition of a-smase as a potential strategy for dmd we analysed a-smase expression or activity in mice treated with drugs already proven to be beneficial for mdx mice: the anti-inflammatory drugs naproxen/naproxcinod and amitriptyline, a functional inhibitor of a-smase (fiasma). we found that the anti-inflammatory drugs inhibited expression and activity of a-smase while amitriptyline reduced the enzyme activity. our next step is to test the in vivo efficacy of other fiasmas (i.e. the ssri fluoxetine and sertraline) with a better safety profile than amitriptyline. the advantage of this strategy is manifold: i. these drugs are already approved by the ema and the fda, confirmed minimally toxic and potentially rapidly available for clinical use as repositioned drugs; ii. they can also alleviate the depressive symptoms often displayed by patients; iii. they can synergise with the gene-based therapies currently under investigation. the skeletal muscle tissue exhibits regenerative capabilities related to damage extension. in fact, it is able to restore limited injuries while, following volumetric muscle loss (vml), the recovery is poor accompanied by scar formation and functional detriment. this condition negatively affects the quality of life of patients affected by vml, making necessary reconstructive therapeutic approaches. even if surgical autologous transplantation is a standardized procedure, the outcomes are often unsatisfactory. hence, the pressing need to develop engineered artificial tissues to replace wasted muscle. tissue engineering (te), exploiting stem cells embedded in biomimetic scaffolds, aims to mimic organogenesis by building artificial tissues to replace the damaged ones. skeletal muscle te is an up-and-coming biotechnology with great potential for muscle repair, but no conclusive strategy has been conceived yet. reconstructing the skeletal muscle architecture and function is still a challenge requiring the parallel alignment of myofibrils arranged into organized sarcomeres. recently we demonstrated the great potential of a hybrid biomimetic matrix, namely peg-fibrinogen, for enhancing the engraftment of myogenic cell progenitors by providing a suitable 3d environment for mouse muscle reconstruction. starting from these observations, we chose to use a novel approach for the regeneration and/or reconstruction of skeletal muscle tissue combining muscle progenitors with 3d bio-printing technology to guarantee a functional architecture. in particular we have developed a microfluidic wet-spinning system that allows to fabricate rapidly macroscopic yarns of cell-laden hydrogel microfibers that closely mimic the structure of skeletal muscle tissue. in vitro and in vivo characterization of cell-laden constructs showed enhanced myogenesis and positive myo-structure alignment. oxidative stress and mitochondrial dysfunction play a crucial role in the pathophysiology of muscular dystrophies. we recently reported that the reactive oxygen species (ros) produced by the mitochondrial enzyme monoamine oxidase b (mao-b) are causally involved in duchenne pathophysiology, as demonstrated by the results we obtained by treating mdx mice with the mao-b specific inhibitor safinamide. we now show that a novel drug, pxs, designed to inhibit both mao-b and the amino oxidase vap-1 (a glycoprotein found on the plasma membrane of several cell types), provides comparable or superior effect to safinamide, but at a much lower dosage. specifically, we found that a 30-day treatment with pxs in one-and three-month-old mdx mice greatly reduced fibrosis, inflammation and oxidative stress in both diaphragm and tibialis anterior, while also improving muscle contractile properties in diaphragm and gastrocnemius. importantly, we have also obtained preliminary indications that a 90-day treatment with pxs led to a decrease in heart fibrosis in ninemonth-old animals. considering that mao-b inhibitors have been in clinical use for many years and that pxs has already passed all toxicity tests in several animal models, our findings indicate that pxs could be a promising candidate for the treatment of dmd. lurbinectedin (pm01183, pm) is a synthetic alkaloid derivate of trabectedin (et743, et), a marine-derived anticancer agent. pm is a dna minor groove covalent binder that has been tested in different phase i-iii trials. it affects tumor microenvironment by limiting the production of inflammatory cytokines. some of these cytokines are elevated in various cancers characterized by rapid body wasting with muscle, fat and cardiac tissue depletion (i.e. cachexia). differing from et, pm displays less liver toxicity, and less endothelial inflammation at the site of injection. mice injected with murine colon adenocarcinoma c26 cells display cachexia, increased circulating levels of inflammatory cytokines, acute phase response activation and subsequent splenomegaly. thus, we tested whether pm, at doses with no antitumoral activity on c26 colon adenocarcinoma, has any beneficial effects in mice against c26-induced cachexia. 10-weeks old balb/c mice were injected subcutaneously with c26 cells and three days later randomized to receive into their tail vein, three times a week for three weeks 0.07 mg/kg pm (n = 8) or vehicle (n = 8). c26-carrying mice showed decreased body weights and premature death. strikingly, pm was able to extend the lifespan of c26-bearing mice by about 85% from a median survival time of 20 days (range day 10-31) to a median survival time of 37 (range day 14-41). this occurred without affecting tumor growth or food intake or the number of lung metastases. another set of mice were sacrificed at 10-13 days from c26 implant. pm did not grossly protect multiple tissues (fat, muscle, heart) from cachexia. preliminary data showed that c26-induced splenomegaly was inhibited by pm administration as long as pm treatment lasted. in c26-bearing mice, this effect exerted by pm seems to be associated also to restrained circulating levels of m-csf, but not of other inflammatory cytokines (i.e. il-6, g-csf or gm-csf). further studied are necessary to correlate the improved survival with the pharmacodynamic effect observed. oxytocin, classically known for its effects on uterus, lactation, cns, is also a powerful regulator of myogenic differentiation and muscular homeostasis. previous works have shown that the addition of ot stimulates differentiation of myogenic precursors and induces myotube hypertrophy. interestingly, in sarcopenia (senile muscular atrophy) exogenous ot antagonizes skeletal muscle atrophy and restores skeletal muscle trophism in mice. neoplastic cachexia has a strong negative prognostic significance in cancer patients, being associated with a reduction in quality of life and response to therapies. several pharmacological and hormonal treatment have been proposed to counteract cachexia, but this syndrome is still incurable. oxytocin (ot) plays a physiological role in the maintenance of muscle homeostasis in aging. therefore, we propose to study whether the administration of ot counteracts skeletal musculature atrophy in cancer-cachexia. to mimic cancer cellmediated effects on muscle cells, we incubated l6 myoblasts with c26 tumor-conditioned medium (c26 cm). preliminary observations suggest that in vitro the inhibition of differentiation by c26 cm is reversed by the addition of ot in the culture medium of myogenic cells. we also showed that in vivo, ot counteracts the tnf effects on muscle regeneration of the tibialis muscle following freeze-injury. since hampered muscle regeneration and satellite cell function is a key feature of cachexia, contributing to muscle wasting, our preliminary data suggest that indeed ot treatment may have a beneficial effect on muscle homeostasis in tumor bearing mice. thanks to the fact that ot is already approved for clinical use, this work seems promising to prevent cancer-cachexia skeletal muscle atrophy in patients. -41 -ameliorate muscle wasting. in addition, we recently described the essential role of autophagy in driving msc function toward efficient muscle regeneration. the established role of autophagy in maintaining muscle mass and tissue homeostasis together with the emerging role of stat3 in regulating the autophagic process inspired the rationale behind this work which resides in the study of the autophagic contribution in mediating stat3 signalling toward skeletal muscle repair, a function that is compromised during aging. our hypothesis is that stat3 might have a role in regulating myogenic lineage and regeneration process by affecting the autophagic process thereby restoring the pro-myogenic niche that support muscle regeneration. we show that the autophagic process influences msc activation and proliferation suggesting that autophagy might exert different functions depending on msc proliferative vs. myogenic state and in muscle fibers. likely, a combination of autophagy impairment in both compartments cooperates in muscle wasting during sarcopenia. our further analysis indicates that stat3 displays nuclear localization in conditions of active autophagy -i.e. young mice-while stat3 localize in the cytoplasm in aged muscles, characterized by reduced autophagic process. altogether, these evidences suggest that the nuclear/cytoplasmic compartmentalization of stat3 regulates the autophagic process and the regenerative drive, highlighting potential biological targets that preclude an efficient regenerative response in aged mice. ageing, in humans, is characterized by a progressive loss of muscle mass and strength, known as sarcopenia. in the sarcopenic muscle, the regenerative capacity of satellite cells (scs), adult muscle stem cells, is compromised. the scs are responsible for the postnatal muscle growth and the maintenance of muscular mass in the adulthood. these cells are the main source of muscle stem cells able to regenerate the skeletal muscle tissue. during aging, the myogenic capability of scs decreased and it results in the failure to complete the differentiation program. however, the mechanisms behind the impaired myogenic differentiation process of elderly are not fully understood. moreover, during ageing in the skeletal muscle, there is an imbalance between reactive oxygen species (ros) production and antioxidant enzyme activity and alterations in the gene expression 1 . the oxidative stress is harmful for the maintenance of skeletal muscle structure and function, and is considered one of the main contributors causing cellular aging. an effective exercise protocol might be particularly useful to counteract the detrimental decline that occurs in sarcopenic muscle. indeed, the exercise could promote cellular and molecular adaptation mediated by micrornas modulation 2 . furthermore, we showed that during aging activated scs display a complex picture of impaired regenerative potential, linked to altered ros production and mir-1 and mir-133 dysregulation 3 . the aim of this study was to determine whether endurance and resistance training and neuromuscular electrical stimulation (nmes) affect muscle regeneration modulating micrornas and oxidative management in healthy elderly. to achieve this goal, healthy male elderly subjects (76.6±3.7 years; n=50) volunteers were recruited and randomly assigned to different training and control groups; training plans consisted in 12 weeks, 3 sessions/w. functional evaluation tests revealed specific improvements of elderly performance. furthermore, at the volunteer were done the skeletal muscle biopsy before (pre-) and after (post-) training. in detailed 1) pre-and post-scs were isolated and characterized; 2) myo-micrornas (mir133a, mir133b, mir-1, mir206) were analyzed; 3) oxidative status were assessed. in conclusion, our data suggested that endurance and nmes protocols promoted a higher antioxidant status. strikingly, we found that physical intervention is able to modify myo-micrornas expression. indeed, they were specifically down-or up-regulated by the training typologies. -42 -glycosylation inhibition on myoblast differentiation. c2c12 cells were treated with the n-glycosylation inhibitor tunicamycin (tm) (0.01µg/ml) and the mrna expression of ccnd1, pax7, myogenin, myod, mrf4 and desmin was quantified in proliferative myoblasts and differentiated myotubes. pcna, myosin (mf20), igf-1r, igf-1r pathway activation and myogenic index were also quantified by western blot and fluorescent imaging, respectively. finally, we tested whether the sirna knockdown of the pmm2 gene produces effects on myoblast differentiation resembling the tm administration. as expected, ccnd1 and pax7 were expressed in control myoblasts and were downregulated in myotubes, while myogenin and desmin showed the opposite trend. tmtreated myoblasts failed to down-regulate ccnd1 mrna after induction of differentiation and the expression of ccnd1 and pax7 remained higher in tm-treated compared to control myotubes. conversely, tm-treated myotubes expressed lower level of myogenin and desmin compared to control. moreover, mf20 protein and myogenic index were significantly reduced in tm-treated myotubes. glycosylation inhibition also decreased the igf-1r level and markedly attenuated the igf-1-induced erk-1/2 and akt phosphorylation. interestingly, 70% mrna knockdown of pmm2 increased ccnd1 in myoblasts and reduced myogenin, myod and mrf4 mrnas and mf20 expression in myotubes. in conclusion, we found a reduction of myoblast differentiation after n-glycosylation inhibition by tm and pmm2 silencing. tm administration also affected the igf-1r pathway reducing the igf-1r expression and inhibiting erk-1/2 and akt activation. the decrement in the expression of differentiation markers observed here after pmm2 silencing, suggests that a deficit in muscle cell differentiation could be present in cdg patients. duchenne muscular dystrophy (dmd) is an x-linked genetic disorder resulting from mutations and deletions of the dystrophin gene that leads to severe degeneration of muscle tissue that is progressively substituted by fat and fibrous tissue. among the cytokines involved in this process, tgf- is a key player polypeptide that orchestrates the crosstalk between parenchymal, inflammatory and collagen-expressing cells with a recognized pro-fibrotic role. in dmd patients, tgf- is elevated both in plasma and in muscles and its expression correlates with increased fibrosis. in vitro, it has been found highly expressed in dmd myotubes and in muscle derived fibroblasts. tgf- activity is strictly controlled at various levels and the cytokine is secreted as a latent complex where it is tightly bound to the so-called latent tgf- binding protein (ltbp) and released as active polypeptide upon specific proteolytic cleavage. among the ltbps described, the ltbp4 gene was discovered as a modifier of murine muscular dystrophy. studies in dmd patients revealed that four ltbp4 snps were predictive of the age at onset of loss of ambulation and of dilated cardiomyopathy. further studies in mice and cell culture demonstrated that more tgf-β is released from the ltbp4 vttt variant compared to the iaam-containing ltbp4 variant, the latter being associated with older age at loss of ambulation and less tgf-β signaling. histone deacetylases (hdacs) are involved in fibrogenesis and reduction of hdac activity by inhibitors targeting both class i and ii, hinders tgf-β induced fibrosis. moreover, it was observed that our proprietary hdac inhibitor givinostat significantly reduced fibrosis in mdx mice and in dmd boys. the aim of this study was to investigate the molecular effects of givinostat on tgf-β induced fibrotic gene program in an in vitro model of human healthy and dmd-derived skeletal muscle cells. in agreement with its role, tgf-β induced the expression of pro-fibrotic genes such as alpha smooth muscle actin (sma), fibronectin (fn1) and collagen iii, both in healthy and dmd cells. givinostat clearly reduced the upregulation of sma and fn1 in healthy cells while the effect on dmd cells was negligible for sma, and fn1 expression was further increased. downregulation of collagen iii was observed in both cell types. a different epigenetic regulation of key genes in the tgf-β pathway was also highlighted by the effects on the expression of tgf-β receptor subunits tgf r1 an r2. thus, tgf r1 was upregulated by the cytokine and downregulated by givinostat in both cell types while tgf r2 was downmodulated by tgf-β in dmd cells only and givinostat increased its expression in both cell types. a differential regulation of matrix metalloproteinases and their inhibitors was also observed. these data emphasize how a different epigenetic regulation of key fibrotic genes takes place in healthy and dmd cells. furthermore, they also highlight the importance of having an in vitro model whereby both healthy and dmd cells are used to study the specific pathways that can be targeted in diseased cells to more accurately advance drug candidates into in vivo studies. introduction: cancer-associated cachexia is a multifactorial syndrome characterized by anorexia and body weight loss, mainly due to muscle and fat wasting (1) . micrornas (mirnas) are a class of non-coding posttranscriptional regulators that play, among other functions, a central role in appropriated muscle cell commitment, proliferation and differentiation by modulating the translation of specific genes (2) . the present study was aimed to evaluate the possibility to use dysregulated mirnas as biomarkers of cancer cachexia. methods: total rna was extracted from both skeletal muscles and plasma-derived microvesicles from controls and c26 tumor-bearing balb/c mice. next-generation sequencing (ngs) was used to sequence whole mirna transcriptome. those mirnas differentially regulated were validated by real time pcr. results: clear differences in mirna expression between the two experimental groups were observed. in particular, mir-21a-5p, mir-29a-3p, mir-29c-3p, mir-185-5p, mir-185-3p, mir-223-3p were statistically upregulated in the tumor-bearing mice. by contrast, mirnas from microvesicles were poorly modulated in the c26 host, only three mirnas (mir-181a-5p, mir-375-3p, mir-455-5p) were found dysregulated at ngs analysis, suggesting that their use as a circulating biomarker might be limited. conclusion: the results obtained in the present study suggest that modulations of the skeletal muscle mirnaome can be used as effective biomarkers in the pathogenesis of cancer-associated cachexia in murine models. -44 -decreases in c26 tumor bearing mice, and that exercise can rescue. indeed, we showed a decrease of srf expression at the protein level in cancer cachexia. consistently, we showed a decrease in the expression of srf target genes such as myod and sk-actin, which suggest a decrease of the srf transcriptional activity. these effects were counteracted by wheel running. since we observed opposite effects of tumor and exercise on myod and pax7 we hypothesized the involvement of a myogenic program in stem cell recruitment to muscle fibers upon exercise: indeed, we observed the recruitment of nuclei within the muscle fibers in response to exercise, which could contribute to muscle homeostasis. our preliminary results suggest that physical activity rescues srf expression as well as its transcriptional activity, highlighting the importance of genetic activation induced by skeletal muscle activity for muscle rescue and homeostasis. these effects could be extended to the fiber microenvironment, including myogenic stem cell activity. vitamin (vit) d is a pleiotropic hormone synthesized mainly in the skin via a uv-dependent reaction. vitd circulates in the blood bound to vitamin d-binding proteins, reaching its target tissues, where exerts its endocrine actions through the vitd3 receptor (vdr), a member of the nuclear receptor family expressed in different tissues, including skeletal muscle. some vitd actions have been shown to be at long term and others at more immediate term, suggesting the engagement of nuclear vdr for gene expression regulation and of membrane-associated vdr for the control of specific signalling pathways. vitd deficiency has been shown to cause abnormalities in skeletal muscle, such as reduced actomyosin content and decrease in mitochondrial ca 2+ levels. moreover, in vitro experiments suggest that vdr is likely to play an important role during myoblast differentiation, regulating the expression of myogenin. despite several evidence demonstrating a protective role of vitd in skeletal muscle cells, the characterization of biomolecules that positively affect vdr expression /function are limited. in the present study we investigate the role of sphingolipids in the regulation of vdr expression in c2c12 myoblasts/myotubes and the molecular mechanisms by which sls metabolites, in particular sphingosine-1-phosphate, determine an increase in vdr expression in skeletal muscle cells. oxidative stress and chronic inflammation have been proposed as important interconnected mechanisms affecting skeletal muscle homeostasis under pathologic conditions, being mutually induced processes. although reactive species are physiologically formed inside of skeletal muscle by inflammatory cells as well as myofibers, the endogenous antioxidant defense is able to maintain reactive radicals at functional levels. instead, under pathological conditions the excess of reactive species can overwhelm antioxidant defense leading to oxidative damages and to the activation of pro-inflammatory pathways. on the other hand, inflammatory response is considered one of the principal determinants of degenerative processes in degenerative disorders. however, the clear connection between the extent of oxidative stress and inflammation has still to be understood. hence the needs of identifying and studying key factors involved in the intimate relation between these two important pathogenic mechanisms that might allow relevant advances in the field of chronic diseases. among factors playing a critical role in skeletal muscle physiopathology interleukin-6 (il-6) is an elective candidate. here we reported that increased levels of circulating il-6 are sufficient to alter the physiologic redox balance of skeletal muscle tissue and to induce the establishment of an inflammatory milieu. we revealed that high levels of il-6 in the bloodstream enhance the production and accumulation of reactive species in diaphragm muscles of adult nse/il-6 mice, by impinging the muscle redox balance and impairing the nrf2-mediated antioxidant response. in addition, the occurrence of pro-oxidant conditions in muscles exposed to abnormal amounts of il-6 stimulates the establishment of a delicate inflammatory balance within muscle environment, characterized by the induction of pro-inflammatory mediators. thus, uncontrolled levels of this cytokine, which characterize chronic degenerative conditions, can alter muscle milieu, linking the generation of oxidative stimuli to the promotion of inflammatory changes. background: facioscapulohumeral muscular dystrophy (fshd) is a frequent neuromuscular disease caused by epigenetic alterations on the 4q35 chromosome leading to gain of expression of the double homeobox 4 (dux4) gene. our laboratory previously showed that the long non-coding rna dbe-t is required for aberrant dux4 expression in fshd. using affinity purification followed by proteomics, we identified the chromatin remodeling protein wdr5, a core component of the mll/set1 epigenetic activation complex, as a novel dbe-t interactor. the goal of this work is to analyze the role of wdr5 on the regulation of dux4 in fshd. methods: primary myoblast isolated from both fshd and healthy control subjects were differentiated in myotubes in presence of sirnas. 24 hours after induction of differentiation, myotubes have been transfected with sirna on-target wdr5 and sirna non-targeting as control. four days after differentiation in mature myotubes the expression level of dux4 and its known targets have been assessed with qrt-pcr. moreover, the myogenic differentiating level and the fusion index have been assessed through immunofluorescence analysis of the myosin heavy chain (mhc) differentiation marker. results: we found that the expression level of dux4 and its target mbd3l2, trim43 and trim48 are significantly reduced by silencing wdr5. similar results were obtained using a wdr5 small molecule inhibitor. remarkably, wdr5 knockdown leads to rescue of the myogenic defects of fshd muscle cells at both the differentiation level and the fusion index. conclusion: these results show the pivotal role played by wdr5 in dux4 expression and candidate wdr5 as potential therapeutic target for fshd treatment. . the purpose of this work has been to study the skeletal muscle strength development, the main feature of this tissue, when sedentary adult mice were exposed to elf-emfs. male c57bl/6 sedentary adult mice were exposed to elf-emfs (0.1 or 1 mt) generated by a solenoid for 1h/die up to 5 weeks and fed with a standard diet or a n-acetyl-cysteine (nac) enriched diet. grip strength and body weight were measured weekly, and after 5 week exposure the mice were sacrificed and skeletal muscle from hind limbs were isolated and collected for biochemical analyses. the elf-emfs did not affect the body weight and, conversely, increased the grip strength in exposed mice in comparison to non-exposed ones. in addition, both the expression levels of pax7 and of myosin heavy chain were found increased in muscle isolated from exposed mice. the elf-emfs failed to trigger their effects when the mice were fed with an nac-enriched diet. these preliminary data suggest that elf-emfs may provide some benefits improving the muscle fitness in sedentary adult mice. the current leading cause of death in duchenne's muscular dystrophy (dmd) patients is cardio-respiratory failure, mainly due to heart and diaphragm (dia) damage and fibrosis during the late stage of the disease. given that fibrosis is considered a consequence of muscle inflammation, the role of the immune response in dmd heart and diaphragm should be considered, to better understand the pathological events during and prior to the onset of fibrosis. indeed, very little is known about the kinetics of immune cells infiltration in dystrophic heart and diaphragm, that likely contributes to the fibrosis and chronic inflammation. the treatment of choice in dystrophic patient is the use of corticosteroids, supporting an important role of the inflammatory compartment in the disease progress. the several and severe adverse effects of long-term corticosteroid treatment also highlight the need for other anti-inflammatory approaches. our group recently found that pharmaceutical -46 -inhibition of protein kinase c theta prevented damage in limb skeletal muscle and ameliorated disease when administered in young (2week-old) mdx mice, acting predominantly through inhibition of early t cell infiltration of dystrophic muscle. we now plan to study in detail the inflammatory compartment of dystrophic heart and dia using the mouse model of dmd, mdx. we will characterize in detail the kinetics and quality of inflammatory cell populations in mdx heart and dia, using our established 9 color cytofluorimetric protocol, analysing mice from 4 weeks of age up to 11 months. morphological analysis on muscle fibrosis, necrosis and organization will be performed, as well as molecular analyses to assess cytokines levels and fibrosis markers. given that mdx mice often show a poor heart pathology, we are currently defining an exercise protocol in order to worsen the dystrophic phenotype, in order to mirror the human pathology. the data we will collect in this part of the study will be instrumental to design new pharmacological treatments using specific inhibitors (as we did for skeletal muscle) instead of broad-spectrum anti-inflammatory compounds. we hope that our study will help developing more effective and fine targeted treatments, with less adverse effects for patients thyroid hormone (th) has a major role in the control of systemic metabolism, influencing carbohydrate, protein and lipid metabolism. moreover, t3 regulates mitochondrial function and turnover controlling mitochondrial biogenesis, proton leak, oxphos and ros generation. the deiodinases enzymes enable intracellular th activation or inactivation, regardless of circulating hormone levels. to address the physiological function of deiodinases in skeletal muscle metabolism, we used muscle-specific gain-of-function approaches. here, we show that muscle-specific hypothyroidism in mice by d3 overexpression (tg-d3 mice) induces a metabolic reprograming of muscle fibers reducing glycolytic and lipid metabolism. d3 overexpression in muscle also reduces mitochondrial dynamics. immunofluorescence analysis revealed a structural alteration of mitochondria. facs analysis highlighted a reduced mitochondrial density with increased size. however, the increased mitochondrial size did not correlate with increased activity. consistently with these findings, mitochondria turnover genes drp-1, mfn-1 and opa-1, as well as pgc-1α, were reduced in tg-d3 muscles. these data suggest that metabolic differences between tg-d3 and control muscles are associated with an alteration in number and function of the mitochondria. interestingly, the overexpression of pgc-1α in tg-d3 muscles rescued the mitochondrial defects, reactivating the expression of genes involved in mitochondrial fusion and fission. altogether these results indicate that the mitochondrial dysfunction of tg-d3 muscles is mediated by the downregulation of pgc-1α, the master regulator of mitochondrial biogenesis. our findings indicate that muscle-specific hypothyroidism via d3 overexpression potently impacts on mitochondrial metabolism, identifying the deiodinases as critical metabolic regulators. understanding the mechanisms of action of deiodinases in metabolism might be relevant for therapeutic treatment of metabolic disorders. background: physical activity ameliorates the prognosis of cancer patients, also by contrasting the associated muscle wasting (i.e. cachexia). since aerobic exercise seems to be the most effective to preserve muscles during cancer, we asked whether it promotes secretion of proteins by muscles (i.e. myokines) that may contrast cachexia. methods: to mimic aerobic exercise, we infected c2c12 myotubes with pgc1α expressing adenoviruses. in vitro we evaluated the effects of supernatants from gfp or pgc1α-overexpressing cells on protein synthesis and degradation of atrophying myotubes and in lucassay. by microarray, we identified putatively secreted proteins inducible by pgc1α and confirmed by q-pcr. we measured by q-pcr their expression in tibialis anterior (ta) muscle of c26-bearing mice during cachexia and plasma levels by elisa. to induce aerobic exercise adaptations, mice were run on treadmill. anaerobic exercise-like effects were obtained in vivo in overloaded plantaris muscle and in vitro in myotubes expressing myristoylated akt. results: our microarray and q-pcr analyses showed musclin as a pgc1α-induced myokine. conversely, its expression was unchanged in myotubes hypertrophying because of activated akt. dexamethazone-treated myotubes or constitutively active (ca)foxo3-expressing ones undergo atrophy as measured by increased proteolysis and murf1 induction. unlike to gfp, musclin restrained the dexamethazone-induced murf1 expression in luciferase assays. consistently, musclin-containing supernatants reduced the cafoxo3-induced rates of long-lived protein degradation. among the newly identified pgc1α-induced myokines, we found that -47 -only musclin (and its receptor npr3) was strongly downregulated in cachectic muscles and plasma of c26bearing mice. thus, we electroporated ta of c26-bearing mice with musclin or npr3-encoding plasmids and found either musclin or npr3 to preserve fiber area. interestingly, treadmill exercise protected c26-bearing mice from muscle loss, with no effect on tumor growth, and rescued the c26-induced downregulation of musclin in muscles and plasma. by contrast, musclin expression did not change in overloaded plantaris of adult mice. conclusions: musclin is a myokine induced specifically by pgc1α, typically increased upon aerobic exercise and preserves muscles from wasting during c26 growth or myotubes from atrophy. overall, musclin could be beneficial to cancer patients that cannot exercise and are at risk of developing cachexia. reconstruction of the skeletal muscle tissues after damage relies on the activation of satellite cells (scs), a population of resident muscle stem cells. several transcription factors are involved in scs activation and proliferation and ensure proper temporal and spatial expression of muscle-specific genes during muscle regeneration. the transcription factor nf-y, composed by nf-ya, nf-yb and nf-yc subunits, has an important role in the regulation of cellular proliferation and differentiation in different cell types, among which muscle cells. while nf-ya, the dna binding subunit of nf-y, is down-regulated in the adult muscle of wt mice, its expression is observed in the mdx mouse and correlates with euchromatic markers and expression of nf-y target genes controlling cell growth. with the aim to investigate the role of nf-ya in the scs proliferation and differentiation, we generated and characterized a conditional knock out mouse model in which nf-ya is deleted in pax7+ scs by tamoxifen induction in adult nf-ya flox/flox :pax7 creer mice (nf-ya cko). cellular and molecular analysis carried out on isolated myofibers and scs from wt and nf-ya cko mice highlighted that nf-y activity is important for the maintenance of scs homeostasis. nf-ya loss depletes pax7+ scs pool and impairs their proliferation. moreover, scs-mediated regeneration following muscle damage induced by cardiotoxin is delayed in nf-ya cko. the effect of nf-ya abrogation was also explored in post-natal muscle growth. immunohistological analysis showed defects in muscle morphology and a decrease in scs number in 3 weeks aged nf-ya cko mice, period of major increment of muscle mass by scs-mediated myonuclear accretion. the molecular mechanism underlying the impairment of scs activity following nf-ya loss was investigated by gene expression profiling. overall, our results highlight a role of nf-y in muscle regeneration and in scs fate, whose modulation could be useful to improve stem cell based therapies to treat muscular dystrophies. thyroid hormone (th) is a key metabolic regulator that acts by coordinating short-term and long-term energy needs. accordingly, significant metabolic changes are depending on thyroid status. although it is established that hyperthyroidism augments basal energy consumption, thus resulting in enhanced metabolic state, the net effects on cellular respiration and generation of reactive oxygen species (ros) remain unclear. to elucidate the effects of augmented th signal in muscle cells, we generated a doxycycline-inducible cell line, in which the expression of the th-activating enzyme, type ii deiodinase (d2) is reversibly turned on by the "tet-on" system. interestingly, increased intracellular th caused a net shift from oxidative phosphorylation (oxphos) to glycolysis and a consequent increase in extracellular acidification rate. as a result, the mitochondrial ros production, and both the basal and doxorubicin-induced production of cellular ros were reduced. importantly, the expression of a set of antioxidant genes was up-regulated, and, among them, the mitochondrial scavenger sod2 was specifically induced at transcriptional level, by d2-mediated th activation. finally, we observed that the attenuation of the oxidative stress and increased levels of sod2 are key elements of the differentiating cascade triggered by the th and d2, thereby establishing that d2 is essential in coordinating metabolic reprogramming of myocytes during myogenic differentiation. in conclusion, our findings indicate that th plays a key role in oxidative stress dynamics by regulating ros generation. our novel finding that th and its intracellular metabolism act as mitochondrial detoxifying agents sheds new light on metabolic processes relevant to muscle physiology the functional exhaustion of muscle stem cells (muscs) contributes to duchenne muscular dystrophy (dmd) progression by compromising the compensatory regeneration of diseased muscles. muscs activity is influenced by functional interactions with cell types that compose their niche, including fibro-adipogenic progenitors (faps) that regulate the regenerative ability of skeletal muscles in physiological and pathological conditions. we have recently discovered that fap-derived extracellular vesicles (evs) support functional interactions with muscs, and contribute to the beneficial effect of hdac inhibitors (hdaci) on dmd muscles. fap-derived evs mediate microrna transfer to muscs, and that exposure of dystrophic faps to hdac inhibitors (hdaci) increases the intra-ev levels of a subset of micrornas (mirs), which cooperatively target biological processes of therapeutic interest, including regeneration, fibrosis and inflammation. in particular, increased levels of mir206 in evs released from faps of muscles from dmd patients or mdx mice exposed to hdaci correlated with improvement of key histological parameters, such as compensatory regeneration and inhibition of fibrosis. we found that evs from hdaci-treated dystrophic faps stimulated musc activation and expansion ex vivo, and promoted regeneration, while inhibiting fibrosis and inflammation of dystrophic muscles, upon intramuscular transplantation, in vivo. these data reveal a potential for pharmacological modulation of fap-derived ev's content as novel strategy for local therapeutic interventions in muscular diseases. sarcopenia is the age-related loss of muscle mass, strength and function. muscle mass decrease is directly responsible for functional impairment with loss of strength, increased likelihood of falls and loss of autonomy. satellite cells are myogenic progenitors and sarcopenia is predicted to be the result of reduced satellite cell number and/or function. despite several investigations, the precise molecular mechanisms underlying stem cell dysfunctions in the age-associated muscle decline remains unclear. recently cutting-edge studies highlighted the role of epigenetic mechanisms in muscle senescence and sarcopenia. among the biological mechanisms involved in the regulation of heterochromatin conformation, we recently described a functional and evolutionary conserved crosstalk between the nuclear lamin a/c and the pcg proteins. this functional interplay is required for the maintenance of the pcg repressive functions at the onset of muscle differentiation -49 -and does not work properly in the pathological emery dreifuss muscular dystrophy. based on these findings we hypothesize that in aged satellite cells an altered lamin/pcg axis could determine a pathological remodelling of the heterochromatin organization leading to the loss of muscle stem cell functions. taking advantage of a new technique developed in our laboratory, named sequential analysis of macromolecules accessibility (sammy-seq) we were able to map lamina associated heterochromatic regions in small amount of primary cells. the protocol is based on the sequential extraction of multiple chromatin fractions, corresponding to increasingly compacted and less accessible chromatin regions, which are mapped along the genome using high-throughput sequencing. we will show results obtained in muscle tissue or stem cells derived from mice and human at different stage of muscular aging and sarcopenia with the purpose to highlight age-related chromatin structural changes, opening up the possibility to identify coding and/or noncoding genomic regions, dependent or not by polycomb proteins, involved in premature senescence of sarcopenic muscles. telocytes (tcs) represent unique stromal cells characterized by a small cell body and distinctive extremely long, thin and moniliform cytoplasmic extensions called telopodes alternating slender segments (podomers) with dilatations (podoms). tcs have been identified in the skeletal muscle interstitium with their telopodes being strategically positioned in the close vicinity of striated myofiber s with regenerative features, nerve endings, small blood vessels, and often of resident muscle stem cells, namely satellite cells (scs). a "nursing" role for tcs in sc-mediated skeletal muscle regeneration has been supposed; however, to date there is no experimental evidence demonstrating a morpho-functional interaction between these two cell types in an injured skeletal muscle. hence, the aim of present morphological study was to explore the presence and the behavior of tcs in an ex vivo murine model of skeletal muscle (extensor digitorum longus) damage induced by forced eccentric contraction (ec) in isometric condition, focusing on their interaction with scs. ec-damaged skeletal muscles showed evidence of structural and ultrastructural injury as judged by light microscopic and transmission electron microscopy (tem) examination and along with significant electrophysiological changes of sarcolemnic properties. specifically, we observed a resting membrane potential depolarization, an increase of membrane capac itance, a reduction of membrane resistance and a reduction of the outward k + current amplitude, leading to an overall alteration of myofiber excitability. tcs were identified in both control and ec-injured muscles within the interstitium, alongside the myofibers and in close vicinity of vascular structures either by cd34/cd31 double confocal immunofluorescence staining (i.e. tcs: cd34 + /cd31 -; endothelial cells: cd34 + /cd31 + ) or by tem. of note, in ec-damaged muscles, the telopode network was more extended and arranged around activated scs displaying nuclear positivity for pax7, the most reliable marker of scs, and for myod, the sc activation marker. tem analysis clearly demonstrated the presence of tcs invading the sc niche passing with their telopodes a broken basal lamina to contact the underlying activated sc that exhibited a swollen appearance and an euchromatic nucleus. the interaction between tcs and scs was confirmed by in vitro experiments performed by culturing single living endomysial sheath-covered myofibers isolated from ecdamaged muscle and the derived stromal cells/tcs and scs. interestingly, tcs from ec -damaged myofibers showed an increased expression of vascular endothelial growth factor (vegf) -a, whose role in promoting myoblast proliferation and differentiation is documented. scs isolated from the same samples exhibited an increased myod expression as well as a major tendency to fuse into myotubes. these findings establish for the first time a morphological interaction between tcs and scs in a damaged muscle and suggest a juxtacrine-paracrine cell-cell interaction involving vegf-a, which worth investigating further. facioscapulohumeral muscular dystrophy (fshd), the third most common hereditary myopathy, is not due to a classical mutation within a protein-coding gene. instead, almost all fshd patients carry deletions of an integral number of tandem 3.3-kilobase repeat units, termed d4z4, located on chromosome 4q35. d4z4 deletion leads to modifications of chromatin structure and inappropriate overexpression of 4q35 genes. studies have proposed several candidate genes within this genomic region and several mouse models have been generated. among these models, mice overexpressing facioscapulohumeral muscular dystrophy region gene 1 (frg1) present a progressive myopathy that recapitulate features of human disease. frg1 encodes for an rna binding protein whose biological function is not well understood. to investigate the molecular mechanism triggered by frg1 overexpression leading to overt myopathy we analyzed molecular changes occurring during disease development. at first, gene expression profiles of skeletal muscles of mice overexpressing increasing levels of frg1 were examined at 28 days (dystrophy onset) and at 96 days (full dystrophy). we found a profound transcriptional deregulation correlating the severity of the muscle phenotype and frg1 expression. gene set enrichment analysis and gene ontology revealed alterations in pathways related to muscle function, energy metabolism and inflammation. indeed, genes associated with adult and normal myogenesis were down-regulated with a significant enrichment of genes specifically expressed during embryogenesis. by contrast, we observed the incremental activation of inflammatory pathways through time. we found that frg1 overexpression causes the global perturbation in the mechanisms that guide postnatal muscle maturation. this process includes the anomalous expression of embryonic/neonatal proteins fundamental for muscle structures and metabolic pathways, the lack of mature proteins and the lag of muscle growth throughout postnatal life. in particular at 7 days and 14 days the expression of the embryonic isoforms of myosin remain high in frg1 mice instead of following the physiological down-regulation occurring in wt mice, meanwhile the expression of the mature isoforms is reduced. starting from 14 days we observed the deceleration of body weight growth curve and a reduction of muscle cross-sectional area. moreover, frg1 muscles displayed the significant reduction of atp and the phosphocreatine in association with the transcriptional downregulation of glut4, hk2 and aldoa. our results indicate that frg1 overexpression induce the impairment of muscle maturation and energy metabolism that precedes dystrophy. our study opens new perspectives on the molecular mechanisms at the basis of muscular dystrophies. p. 25. effects of aerobic, resistance and combined exercises on 24-hr glucose variability, metabolism and muscle signalling pathways regulation in type 1 diabetics giosuè annibalini a# , dean minnock b# , giacomo valli a , serena contarelli a , roberta saltarelli a , carel leroux c , vilberto stocchi a , elena barbieri a,d , giuseppe de vito b ; # equally contributing authors duchenne muscular dystrophy (dmd) is a neuromuscular disease caused by a deficiency of the dystrophin protein. currently no cure is available for the disease and numerous pharmacological approaches are being studied to extend the regenerative phase of dystrophic muscles. in this project we aim to investigate if the modulation of the epi-transcriptome could represent a new pharmacological tool for dmd. in recent years, genetic and biochemical studies have revealed how post-transcriptional modifications of rna influence various cellular mechanisms, in particular splicing, mirna processing and transcripts stability. one of the most important changes in rna is n6-methyladenosine (m6a). this modification is added from a complex containing the mettl3 / mettl14 heterodimer and removed from rna demethylases such as fto and alkbh5. we have recently observed an increase in m6a levels in skeletal muscles derived from dystrophic mice compared to wilde type animals, suggesting that under pathological conditions the n6-methyladenosine modification could influence muscle regeneration through the modulation of various cellular pathways. to validate this hypothesis, we conducted several experiments both in vivo and ex vivo using pharmacological and genetic approaches, aimed at modulating the expression and activity of components of the methylation machinery. in the pharmacological approach we have treated dystrophic mice with a drug approved by the fda that has recently shown to increase rna methylation through the inhibition of fto demethylase; the genetic approach instead involves the use of sirna against metll3 in primary myoblasts. our preliminary results showed that the rna methylome (m6a) is dynamically modulated during skeletal muscle differentiation and regeneration, pointing at the epi-transcriptome as a new potential target for therapeutic interventions. in addition, we identified new mettl3 direct targets in muscle cells through rna-seq experiments. finally, increasing rna methylation by fto inhibition modulates the regenerative response in dystrophic mice. altogether, the results derived from these studies will set up the basis for a new therapy based on the modulation of the epi-transcriptome for dmd. italy muscular dystrophies are a group of heterogenous genetic neuromuscular pathologies, usually manifesting a progressive muscle degeneration accompanied by strength detriment. despite muscular dystrophies are present in more than 40 forms, many of these affect the dystrophin associated glycoprotein complex (dagc) being responsible for phenotype affection. concretely, the involvement of sarcoglycan (sg) complex, dystrophin, or α-dystroglycan, present a relative common clinical manifestation affecting proximal muscles differing on pathological severity. nowadays, no cure is available for these disease, however different strategies are emerging against muscle degeneration likewise gene and cell therapy, or anti-inflammatory treatments. these strategies aim to reestablish the genetic disorders and muscle integrity, or at least to reduce fibrosis and stop fat replacement. nevertheless, spontaneously several muscle groups resist degeneration and wasting process as it occurs with tongue and calf in human patients. we analyzed mdx and α-sarcoglycan mouse model revealing differences on myofibers degeneration among muscle groups of the same subject, presenting common affection frequency. our objective is to go deeper on characterization of these mice models epigenetic tuning of mir in fap-derived extracellular vesicles promotes regeneration and inhibits fibrosis in dystrophic muscles clinical r&d italfarmaco spa, cinisello balsamo. -50 -60, and mainly extracts proteins from multimeric structures. in particular, by interacting with ufd1 or p47, it facilitates the rapid degradation of myofibrillar proteins during muscle atrophy caused by denervation or fasting. the aim of this study was to investigate if p97 (and through which of its adaptors) plays a role also during cancer cachexia and if this is modulated by physical exercise. to induce cachexia, we injected subcutaneously one million of colon adenocarcinoma (c26) cells in balb/c mice. this tumour causes massive muscle depletion with premature death in mice. interestingly, by microarrays, we found that 8 out of 58 p97-binding proteins were induced in cachectic tibialis anterior (ta) from c26 mice 24 the rna binding protein frg1 controls transcription landscape regulating muscle maturation and metabolism mattia forcato a , ernesto picardi b , elena germinario c , bert blaauw c , graziano pesole b , giuseppe d'antona d , rossella tupler a . a school of public health physiotherapy and sports science t1dm patients tend to avoid exercise to reduce the risk of hypoglycaemia [2] and losing the beneficial effects of exercise. furthermore, t1dm patients show an impairment of the skeletal muscle growth, energy metabolism and repair mechanisms interstitial glucose (ig) was measured with a flash glucose monitoring (fgm, abbott freestyle libre) for 24-hr pre and post exercise. the mean amplitude of glycaemic excursions (mage), standard deviation (sd) and coefficient variation (cv) of ig were calculated from fgm data. muscle biopsies were collected immediately before and after each session. myogenesis-(myogenin, myod, mrf4, myf5), inflammation-(il-6, tnfα, mcp1), oxidative capacity/metabolism-(pgc-1α1, pgc-1α4, glut-4) and muscle growth-related genes (igf-1 isoforms) were quantified by real-time pcr. the exercise-induced skeletal muscle signalling pathways (phosphorylation of akt, p38, erk1/2, eef2, ampk) were quantified by western blot. mage, sd and cv decreased 24-hr post comb. all exercise sessions reduced the cv over a 6 to12-hr period after exercise. no severe hypoglycaemic events occurred. both res and comb increased the activation of the igf-1/akt/mtor signalling pathway (akt and p38mapk phosphorylation), while eef2 activation (dephosphorylation) and gene expression of myogenin and mrf4 increased only after comb and res. both aer and comb promoted the splicing of igf-1ea variant and increased pgc-1α isoforms expression. the expression of inflammation-related genes (tnf-α, il-6 and mcp-1) increased after all exercise sessions diabetes care diabetes care n6-methyladenosine as a novel pharmacological target involved in muscle regeneration costantin heil a , francesco millozzi a , luca madaro b , marco de bardi c , daniela palacios a a. laboratory of epigenetics and signal transduction, irccs fondazione santa lucia, via del fosso di fiorano identification of a phytotherapy formulation to counteract muscle atrophy skeletal muscle atrophy is a loss of muscle mass and strength associated with several pathologies including diseases characterized by systemic chronic inflammation the increase of a catabolic state resulting in the breakdown of myofibrillary proteins, especially myosin heavy chain (myhc), is recognized as the main process promoting muscle atrophy [3]. recently, the interest in plant extracts/metabolites active in the pathophysiology of muscle is obtaining growing attention [4]. starting from one hundred hydroalcoholic extracts from medical plants, our work was aimed to individuate a herbal formulation efficient in counteracting muscle atrophy. by using well-characterized in vitro experimental models mimicking muscle atrophy, i.e., treatment of myotubes from c2c12 myoblasts with proinflammatory cytokines (tnfα/ifnγ) or excess gcs (dexamethasone) [3], we firstly identified fifteen extracts able to rescue myotube atrophy, by morphological analysis after may-grunwald/giemsa staining. ten extracts displayed an extremely potent protective effect against myotube atrophy and myhc degradation, as indicated by measurement of myotube diameters after immunofluorescence staining for myhc-iia, even if at different extent in the presence of cytokines or dexamethasone. based on their anti-atrophic potential and nmr-based metabolic profiles, we selected six extracts (withania somnifera dunal, panax ginseng meyer, silybum marianum gaertner, peumus boldus molina, trigonella foenum-graecum l. and urtica dioica l.) to obtain twenty combinations of three extracts to test on myotube cultures. three herbal formulations showed a surprising ability to counter the reduction of myotube diameters and degradation of myhc in the presence of different atrophic stimuli the emerging awareness that cell populations are heterogeneous has changed our criteria to define a cell type. among the non-genetic sources of cell to cell variability, a spread in a bell-shaped distribution of a feature defines a condition called micro-heterogeneity. the effect at cellular and physiological level of this type of heterogeneity remains to be investigated. we chose skeletal muscle regeneration and fibro/adipogenic progenitors (faps) to address this issue. faps are a population of mesenchymal progenitors that resides in the interstitium of skeletal muscle and are identified by the expression of sca1. in the mdx mouse, an animal model of duchenne muscular dystrophy (dmd), faps are one of the populations responsible for the development of ectopic tissues, such as intramuscular adipose tissue (imat) and fibrotic tissue. taking advantage of a multiplex flow cytometry analysis we defined two fap cell states characterised by high and low sca1 expression (sca1 high and sca1 low). these two sub-populations are differentially represented in wild type and mdx mouse. next, we isolated the two fap sub-populations by fluorescence activated cell sorting (facs) from mdx mouse and we studied their differentiation potential ex vivo. we found that sca1 high faps have a higher capability to express ppar-gamma and to differentiate into mature adipocytes. whereas, sca1 low faps differentiate readily into myofibroblasts in a pro-fibrogenic environment. moreover, sca1 high faps exhibit a higher proliferation rate than sca1 low cells. overall, we demonstrate that micro-heterogeneity contributes to determine the fate of a mesenchymal population in vitro. these findings raise several questions about its interaction with in vivo microenvironment and its impact in pathology progression. cancer-cachexia results in severe muscle tissue wasting affecting patients' quality of life and survival. recent studies showed that physical activity increased survival in cancer patient and animal models. the underlying mechanisms, however, are still largely unknown. to identify signaling pathways involved in exercisedependent maintenance of muscle mass and function in cachexia, we investigated the role of serum response factor (srf), a transcription factor of the mads-box family, having a major role in muscular growth, differentiation and regeneration. we hypothesize that the expression and/or transcriptional activity of srf key: cord-348091-pnvn0x4q authors: nolte, thomas; brander-weber, patricia; dangler, charles; deschl, ulrich; elwell, michael r.; greaves, peter; hailey, richard; leach, michael w.; pandiri, arun r.; rogers, arlin; shackelford, cynthia c.; spencer, andrew; tanaka, takuji; ward, jerrold m. title: nonproliferative and proliferative lesions of the gastrointestinal tract, pancreas and salivary glands of the rat and mouse date: 2016-02-13 journal: j toxicol pathol doi: 10.1293/tox.29.1s sha: doc_id: 348091 cord_uid: pnvn0x4q the inhand (international harmonization of nomenclature and diagnostic criteria for lesions in rats and mice) project is a joint initiative of the societies of toxicologic pathology from europe (estp), great britain (bstp), japan (jstp), and north america (stp) to develop an internationally accepted nomenclature and diagnostic criteria for nonproliferative and proliferative lesions in laboratory animals. the purpose of this publication is to provide a standardized nomenclature and diagnostic criteria for classifying lesions in the digestive system including the salivary glands and the exocrine pancreas of laboratory rats and mice. most lesions are illustrated by color photomicrographs. the standardized nomenclature, the diagnostic criteria, and the photomicrographs are also available electronically on the internet (http://www.goreni.org/). sources of material included histopathology databases from government, academia, and industrial laboratories throughout the world. content includes spontaneous and age related lesions as well as lesions induced by exposure to test items. relevant infectious and parasitic lesions are included as well. a widely accepted and utilized international harmonization of nomenclature and diagnostic criteria for the digestive system will decrease misunderstandings among regulatory and scientific research organizations in different countries and provide a common language to increase and enrich international exchanges of information among toxicologists and pathologists. the digestive tract is the entry site into the body for orally administered test articles. an irritant test article may lead to local acute lesions at this first site of contact to the body and the digestive tract has been identified as the organ most commonly affected in british patients admitted to hospital with adverse drug reactions (pirmohamed et al. 2004 ). on the other hand, orally administered test articles may be highly toxic to other organs yet having little or no noticeable effect on the digestive tract. a distinctive feature of the digestive tract is the high proliferative rate of the epithelium, making it particularly sensitive to agents interfering with cell division, but resulting also in a high regenerative capacity. the villi enhance the surface of the intestine to 400-500 m² in humans. because of the large surface area of these tissues, accurate assessment of potential treatment effects is almost entirely dependent on a thorough gross examination and sampling of focal lesions. standardized nomenclature and diagnostic criteria are essential to harmonize the classification and reporting of nonproliferative as well as proliferative histopathological lesions. they should facilitate communication between different research groups and regulatory authorities. in this way they should reduce time and efforts in the review of histopathology data by regulators and minimize clarifying questions to the sponsor. furthermore, standardized diagnostic criteria are a prerequisite for the generation of any historical control database of histopathological lesions. discussions about the future need of concurrent control groups highlight the importance of these standards. the inhand project (international harmonization of nomenclature and diagnostic criteria for lesions in rats and mice) is a joint initiative of the societies of toxicologic pathology from europe (european society of toxicologic pathology -estp), uk (british society of toxicological pathologists -bstp), japan (japanese society of toxicologic pathology -jstp), and north america (society of toxicologic pathology -stp) to unify, update and complete the existing who/ iarc and stp/ssndc nomenclature systems. the inhand nomenclature and the related diagnostic criteria should represent the future international standard in toxicologic pathology. they represent a consensus of senior toxicologic pathologists and were reviewed by the inhand-gesc (inhand-global editorial and steering committee) for compliance with in-hand principles. all members of the societies of toxicologic pathology involved in the inhand process had the opportunity to comment to the draft version during a 6-week period. however, these recommendations for diagnostic criteria and preferred terminology may not be applicable in all situations. purposes of specific experiments or the specific context of a given study may require deviation from this standardized nomenclature and diagnostic criteria. the appropriate diagnoses are ultimately based upon on the discretion of the senior toxicologic study pathologist. the present publication provides a set of standardized terms, diagnostic criteria and example images for the upper and lower digestive tract as well as for the salivary glands and the pancreas. the nomenclature of liver lesions has been published separately (thoolen et al. 2010 ) and that of tooth lesions is in preparation. like all other inhand publications, the nomenclature and diagnostic criteria for the digestive tract are also available online (website.goreni.org/). the online version contains additional images and useful links to differential diagnoses characterizing it as a practical tool for diagnostic work. the recommended nomenclature is generally descriptive rather than diagnostic. the diagnostic criteria used require standard hematoxylin and eosin stained paraffin sections only. histochemical or immunohistochemical staining characteristics may be addressed in the comments section of the respective lesion. such special techniques may be required in some situations, but a comprehensive discussion of these methods is outside the scope of this publication. lesions of disseminated organs like blood vessels, soft tissues or peripheral nerves are generally described in separate publications , greaves et al. 2013 . they are described here only in cases where the digestive tract is a major site of manifestation, e.g. leiomyoma of the intestine. lesions included in this nomenclature system may be further specified by modifiers. criteria are given for modifiers that are considered to be of particular relevance. these modifiers should be consistently applied. it is upon the discretion of the pathologist to use additional modifiers not suggested in this nomenclature system. such modifiers may describe the location, tissue type or duration among others. further principles of the inhand nomenclature have been published separately (mann et al. 2012) . findings that can reliably be diagnosed grossly are also not covered by this monograph. this applies in particular to some congenital malformations like intestinal duplication (elangbam et al. 1998; tamai et al. 1999 ). this nomenclature system describes lesions that occur in conventional (wildtype) strains of rats and mice. previous rodent nomenclatures for the digestive tract have been published by our societies and international who and other collaborative committees (betton et al. 2001; deschl et al. 1997; deschl et al. 2001; frantz et al. 1991; leininger and jokinen 1994; takahashi and hasegawa 1990; whiteley et al. 1996) . lesions occurring in specific genetically engineered mouse models only are not covered in this document. for more information on these specific lesions the reader should refer to relevant publications of workshops on genetically engineered mouse models (e.g. boivin et al. 2003; hruban et al. 2006 ). the oral cavity/pharynx, tongue, and esophagus are components of the upper alimentary tract, and each has a mucosa lined by a stratified squamous epithelium with a keratinized surface. incidental nonproliferative or proliferative microscopic findings may occur in these tissues as well as microscopic findings that are associated with effects of the test article (systemic or direct contact exposure) or, rarely, changes related to injury from the dosing (gavage) procedure. the borders of the oral cavity are defined by several general landmarks, including the hard and soft palate/pharynx dorsally; the gingiva, teeth, and mucosal surfaces of the lips/ cheeks laterally; and the floor of the mouth/tongue ventrally. oral cavity/pharynx is typically not a protocol-required tissue for microscopic evaluation, but portions may be sampled for examination due to a clinical sign or gross finding at necropsy. the oral cavity/pharynx tissue samples may include minor salivary glands (palatine, buccal), adjacent muscle, bone, teeth, or haired skin, in addition to the vascular and connective tissue of the keratinized, squamous epithelium of the mucosal surface. the tongue is comprised of the interlacing bundles of striated muscle interspersed with adipocytes, scant to numerous mast cells, nerves, and vascular tissue lined with a squamous mucosal surface. in the tongue of aged rats, the amount of adipose tissue has been reported to be decreased with a relative increase in its fibrous connective tissue as compared to that in younger animals (brown and leininger 1994) . the squamous mucosa of the dorsal tongue surface contains numerous papillae and a large circumvallated papilla, while the lateral/ventral surface is a simple stratified squamous mucosa (hebel and stromberg 1976; brown and hardisty 1990) . the thin, compact lamina propria of the mucosa of the tongue is less dense on the ventral surface nearer the root attachment (frenulum) to the oral cavity surface. in the more caudal, ventral area, there are large lymphatic vessels, veins, and ducts from the minor salivary glands in the adjacent oral mucosa. the esophagus consists of a muscle (tunica muscularis) layer with longitudinal and circular-oriented striated muscle fibers and a squamous mucosa with a keratinized surface that typically has small aggregates of bacterial coccoid organisms within the superficial layers of keratin. the physiology of the oral cavity, tongue, and esophagus is related primarily to their function as a conduit for food. effects on function with the development of megaesophagus have been reported in mice with abnormal myogenic plexus (randelia and lalitha 1988; randelia et al. 1990) , and esophageal obstruction, secondary to effects of scopolamine on salivary secretion and the swallowing reflex, had been described for rats (ntp tr 445 1997) . the routine necropsy includes gross examination of the oral cavity (oropharynx), tongue, and esophagus. although sampling and histologic examination of the oral cavity/pharynx are generally limited to necropsy observations, portions of these tissues may be included with routine nasal or tooth sections required for possible histopathology examination. in those circumstances when oral cavity structures may be considered as potential targets sites for nonneoplastic or neoplastic changes, whole-head fixation (calvarium and brain removed), may be the better approach for consistent examination of required tissues. with whole-head fixation, sectioning of the nasal/oral cavities, mandible, and associated tissues can be performed at various levels and result in consistent orientation for sectioning of desired tissue sites in these special circumstances. unlike the oral cavity/pharynx, routine histologic sections of the tongue and esophagus are usually protocol-required for microscopic evaluation in all animals from toxicity and carcinogenicity studies. for microscopic evaluation, the tongue may be prepared as a longitudinal histologic section (see rita trimming guide ruehl-fehlert et al. 2003 , website//reni.item. fraunhofer.de/reni/trimming) that provides for examination of lingual glands; it often may prepared as a transverse section congenital/developmental lesions in the oral cavity/pharynx, tongue, and esophagus have been rarely reported in mice and rats from toxicity and carcinogenicity studies. this is most likely due to their uncommon occurrence, exclusion of animals with these findings prior to study initiation, and minimal routine sampling of this location in the absence of a gross observation. in developmental and reproductive studies, congenital/ developmental lesions are more commonly observed. (figures 1 and 2 ) synonym: fordyce's granules pathogenesis: this developmental change consists of aggregates of ectopic dermal sebaceous glands (fordyce's granules) in the oral cavity of rats (yoshitomi et al. 1990 ) and is associated with gingival mucosa. this is most common in the f344 strain and seen primarily in males. • may appear grossly as white nodule or cyst in the gingival mucosa. • most commonly observed in gingival mucosa of upper incisors. • consists of normal sebaceous gland acini with ducts opening to mucosal surface. • presence of cysts (dilated ducts) with or without inflammation may be components of these ectopic glands. • sebaceous gland adenoma: absence of common duct/lumen and presence of mitotic figures; adenoma of ectopic sebaceous gland in the gingiva of rats has not been reported. comment: this finding is more likely observed in routine nasal cavity sections that may include teeth and gingival tissue. with the exception of its correlation to a gross observation when a cyst/inflammation has developed, this finding is of little or no apparent pathologic significance. synonyms: palatoschisis; congenital malformation pathogenesis: defect in the fusion of the bone and overlying mucosa of the hard palate. • midline space defect in oral mucosa and hard palate. • visible grossly or microscopically. • no evidence of trauma. • trauma: evidence of necrosis, fracture, or inflammatory response. comment: cleft palate is a longitudinal defect in bone and mucosa of the midline of the hard palate resulting from failure of fusion of the lateral palatine shelves from the maxillary processes (jones et al. 1997) . cleft palate in mice and rats has been attributed to maternal treatment with high doses of vitamin a (kalter and warkany 1961) and recently been reported as a genetic mutation in the mouse (stottmann et al. 2010) . this condition has also been produced in mice (era et al. 2009 ) and rats with in utero chemical exposure or as an effect from puncture of the amniotic sac (ferguson 1981; schuepbach and schroeder 1984) . diagnosis is based primarily on the gross observation. synonyms: distention; megaesophagus; dilatation; impaction pathogenesis: may be spontaneous/idiopathic, due to food impaction, or secondary to an alteration of the esophageal neuromuscular function, decreased secretion of the salivary glands or an altered swallowing reflex. • thinning of the muscle and mucosal layers as result of distention of the esophagus with food/bedding material. differential diagnosis • none. comment: this condition is typically related to a grossly distended esophagus containing food/bedding material and has also been diagnosed as impaction because of the gross appearance. this has been described as a spontaneous or idiopathic change (harkness and ferguson 1979; ruben et al. 1983) in rats and also attributed to feeding a powdered food diet (brown and hardisty 1990) . esophageal dilation associated with obstruction occurred in rats administered scopolamine (national toxicology program 1997a) and as a background finding in several mouse strains mahler et al. 2000) , in particular in mice with an abnormal myogenic plexus (randelia and lalitha 1988; randelia et al. 1990) . esophageal dilation, described as megaesophagus, has also been reported as an induced finding in mice with intrauterine exposure to diethylnitrosamine (ghaisas et al. 1989 ) and in rats secondary to effects of scopolamine on salivary secretion and the swallowing reflex (national toxicology program 1997b). synonym: pharyngoesophageal diverticulum pathogenesis: usually caused by mechanical or biochemical disruption of esophageal wall structures resulting in loss of extracellular matrix integrity and internal projection of surface lining into deeper layers; may alternatively represent a congenital abnormality. • irregular cyst-like extension of the mucosal lumen into or through the muscularis layer in the esophagus. • lumen of diverticulum that opens to mucosal surface. • focal. • cyst: isolated from mucosal surface. comment: diverticulum of the esophageal mucosa has been reported in rats (brown and hardisty 1990) . pathogenesis: rare developmental defects have been reported for the esophagus. duplication of the esophagus has been reported in an adult male rat as a spontaneous occurrence (canpolat et al. 1998 ) and tracheal-esophageal malformation represents one of many teratogenic effects reported in mice with intrauterine exposure to adriamycin (dawrant, et al. 2007 ). • gross observation of congenital/developmental structural alterations. differential diagnosis • none. pathogenesis: epithelial cysts may occur as downgrowth of entrapped surface mucosa or a dilated salivary duct in the oral cavity/pharynx, tongue, or esophagus and have been observed in the oral cavity/pharynx of rats with dilated glands/ ducts associated with ectopic sebaceous glands (yoshitomi et al. 1990) . • dilated gland/ducts lined by simple squamous epithelium. • lumen of cyst may contain sebaceous secretion or keratin debris. • inflammation associated with larger or ruptured cysts. • esophageal diverticulum: lumen opens into the esophagus lumen, epithelial connection to the surface mucosa of the esophagus. pathogenesis: decrease in normal thickness/cellularity of squamous mucosa of tongue, pharynx or esophagus. • decreased thickness of mucosal epithelial layer. • focally extensive or diffuse lesion. • erosion/ulcer: focal or focally extensive absence of superficial or, in severe cases, of all epithelial layers with extension of the alteration into the muscularis. unlike atrophy, this finding is typically associated with surface cellular debris and an inflammatory cell infiltrate in mucosa or as a surface exudate. synonyms: erosion; ulcer; ulceration pathogenesis: localized disruption in the uniform thickness/continuity of the squamous epithelium in the oral cavity/pharynx, tongue, or esophagus with either partial (erosion) or full penetration of the squamous epithelium (ulcer). • focal or focally extensive loss of surface epithelium in the oral cavity/pharynx, tongue, or esophagus. • basal lamina may remain intact (erosion) or in more severe lesions the defect in the mucosa may extend into the muscularis (ulcer). • intraepithelial inflammatory cell infiltrate frequently associated with more severe lesions. • squamous cell carcinoma: may present with erosion/ulcer appearance on the mucosal surface. the presence of this neoplasm would preclude diagnosis of an associated erosion/ulcer. • atrophy, epithelial: reduced thickness of all layers of the squamous epithelium or, in severe cases, absence of basal germinative layers; usually no inflammatory cell infiltrate. comment: although there are specific morphologic criteria to differentiate the more superficial lesion (erosion; confined to the epithelial surface) from the deeper ulcer (extension of the epithelial defect through basal cell layer/basal lamina), the plane of section through smaller, focal lesions often impacts on the appearance (depth of the epithelial loss) of this finding. in most instances it is not practical to separate these changes and they are typically diagnosed under the single, combined term of erosion/ulcer with an appropriate severity grade. erosion/ulcer usually is the result of epithelial necrosis. because of its unique topography adjacent to the lumen and often involving multiple organ layers, which uniquely affects the progression and resolution of the lesion (e.g. margin hyperplasia, granulomatous tissue, inflammation), it is useful to record erosion/ulcer separately from epithelial necrosis. a deep ulcer of the esophagus may be perforating if it destroys all layers of the esophagus wall, and may be designated as such by a free text entry. however, a perforation resulting from a physical insult, e.g. gavage-related, typically is a macroscopic lesion and generally not recorded on the light microscopic level. pathogenesis: gene regulated, energy dependent process leading to formation of apoptotic bodies which are phagocytosed by adjacent cells; typically associated with cytotoxic chemotherapeutics that affect the mucosal epithelium of the tongue, esophagus and/or pharynx. • single cells or small clusters of cells. • cell shrinkage. • hypereosinophilic cytoplasm. • nuclear shrinkage, pyknosis, karyorrhexis.intact cell membrane. • apoptotic bodies. • cytoplasm retained in apoptotic bodies. • phagocytosis of apoptotic bodies tissue macrophages or other adjacent cells. • necrosis, epithelium: the morphologic features of cell death clearly fit with necrotic diagnostic criteria (cells and nuclei swollen, pale cytoplasm etc.). • apoptosis/necrosis, epithelium: both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. the term is also used when the type of cell death cannot be determined unequivocally. • erosion/ulcer: focal or focally extensive absence of superficial or, in severe cases, of all epithelial layers with extension of the alteration into the muscularis. the approach for the nomenclature and diagnostic criteria of cell death applied here is based on a draft recommendation of the inhand cell death nomenclature working group. apoptosis is not synonymous with necrosis. the main morphological differences between these two types of cell death are cell shrinkage with nuclear fragmentation and tingible body macrophages in apoptosis versus cell swelling, rupture and inflammation in necrosis; however, other morphologies (e.g. nucelar pyknosis and karyorrhexis) overlap. in routine h&e sections where the morphology clearly represents apoptosis or single cell necrosis, or whereby special procedures (e.g. tem or ihc for caspases) prove one or the other, individual diagnoses may be used. however, because of the overlapping morphologies, necrosis and apoptosis are not always readily distinguishable via routine examination, and the two processes may occur sequentially and/or simultaneously depending on intensity and duration of the noxious agent (zeiss 2003) . this often makes it difficult and impractical to differentiate between both during routine light microscopic examination. therefore, the complex term apoptosis/necrosis may be used in routine toxicity studies. a differentiation between apoptosis and single cell necrosis may be required in the context of a given study, in particular if it aims for mechanistic investigations. transmission electron microscopy is considered to represent the gold standard to confirm apoptosis. other confirmatory techniques include dna-laddering (easy to perform but insensitive), tunel (false positives from necrotic cells) or immunohistochemistry for caspases, in particular caspase 3. these techniques are reviewed in detail by elmore (elmore 2007) . some of these confirmatory techniques detect early phases of apoptosis, in contrast to the evaluation of h&e stained sections, which detects late phases only; overall interpretation of findings should take into account these potential differences. thus, low grades of apoptosis may remain unrecognized by evaluation of h&e stained slides only. certain studies may require the consideration of forms of programmed cell death other than apoptosis which requires specific confirmatory techniques (galluzzi et al. 2012) . synonyms: oncotic cell death; oncotic necrosis; necrosis pathogenesis: unregulated, energy independent, passive cell death with leakage of cytoplasm into surrounding tissue and subsequent inflammatory reaction; may be induced by direct contact with a test article after oral uptake/administration. • cells swollen with pale eosinophilic cytoplasm. • loss of nuclear basophilia, pyknosis and/or karyorrhexis that affects aggregates of cells. • in more severe cases, there may be clefting and detachment of the epithelium from the submucosa. • typically, the presence of degenerative cells is a component of necrosis. • minimal or slight inflammatory cell infiltrates may be present as a feature of necrosis. single cell • only single cells affected. • apoptosis, epithelium: the morphologic features of cell death clearly fit with apoptosis (cell and nucleus shrunken, hypereosinophilic cytoplasm, nuclear pyknosis etc.) and/or special techniques demonstrate apoptosis. • apoptosis/necrosis: both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. the term is also used when the type of cell death cannot be determined unequivocally. atrophy, epithelium: reduced thickness of all layers of the squamous epithelium or, in severe cases, absence of basal germinative layers; usually no cellular degeneration or necrosis. • erosion/ulcer: focal or focally extensive absence of su-perficial or, in severe cases, of all epithelial layers with distention of alteration into the muscularis. comments: epithelial necrosis usually develops into erosion/ ulcer and in the past has frequently been recorded as such. a separate recording of necrosis as the initial event in this process is recommended when the structure of the mucosa is still intact. synonym: cell death pathogenesis: unregulated, energy independent, passive cell death with leakage of cytoplasm into surrounding tissue and subsequent inflammatory reaction (single cell necrosis) and/ or gene regulated, energy dependent process leading to formation of apoptotic bodies which are phagocytosed by adjacent cells (apoptosis); typically associated with cytotoxic chemotherapeutics that affect the mucosal epithelium of the tongue, esophagus and/or pharynx. • both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. • the type of cell death cannot be determined unequivocally. • apoptosis, epithelium: the morphologic features of cell death clearly fit with apoptosis (cell and nucleus shrunken, hypereosinophilic cytoplasm, nuclear pyknosis etc.) and/or special techniques demonstrate apoptosis and there is a requirement for recording apoptosis and necrosis separately. • necrosis, epithelium: the morphologic features of cell death clearly fit with necrotic diagnostic criteria (cells and nuclei swollen, pale cytoplasm etc.) and there is a requirement for recording apoptosis and necrosis separately. • erosion/ulcer: focal or focally extensive absence of superficial or, in severe cases, of all epithelial layers with distention of alteration into the muscularis. comments: necrosis and apoptosis are not always readily distinguishable via routine examination, and the two processes may occur sequentially and/or simultaneously depending on intensity and duration of the noxious agent (zeiss 2003) . this often makes it difficult and impractical to differentiate between both during routine light microscopic examination. in these cases, the combined term apoptosis/necrosis may be used. it is recommended to explain in detail the use of this combined term in the narrative part of the pathology report. degeneration/necrosis, muscle (figure 12) pathogenesis: degeneration and necrosis of muscle fibers in the tongue or esophagus. • myocyte degeneration/necrosis of muscle fibers characterized typically by the presence of both swollen or contracted hyperchromatic or pale eosinophilic degenerative fibers and necrotic fibers with coagulative necrosis and nuclear pyknosis or lysis. • usually a focal change of minimal severity. • amphophilic muscle fibers consistent with a regenerative response may be present and a primary feature of this finding. differential diagnosis • degeneration/necrosis or regeneration of muscular layer in conjunction with inflammation, edema and/or hemorrhage associated with gavage-related injury (discussed below under inflammation, mixed cell, gavage-related). comment: this change can occur as a focal lesion in the esophagus that also variably includes the presence of several degenerative and/or regenerative muscle fibers. while potentially a test article-related or incidental finding, it may be related to very minor physical effects from the gavage procedure. morphologic features more conclusive of gavagerelated injury such as perforation and inflammation are not present. in the absence of such clear, gavage-related inflammatory changes, degeneration/necrosis is the preferred diagnosis for this esophagus finding. degeneration/necrosis of muscle fibers in the tongue may be related to test article administration (greaves 2012) . synonyms: amyloidosis; amyloid deposition pathogenesis: extracellular deposits of polypeptide fragments of a chemically diverse group of glycoproteins. • affects medium or larger vessels (arterioles) of the tongue. • accumulates as a thin layer of homogenous and pale eosinophilic amyloid material in basal lamina of mucosa in the tongue and esophagus. • green birefringence using polarized light with congo red stain. • fibrinoid change (necrosis) in vessel walls: deeply eosinophilic homogenous or coagulative appearance of the vascular media. comment: amyloid deposition occurs in the tongue and esophagus of mice, although much less frequently at these locations as compared to other locations (e.g. kidney, intestine). the characteristic morphologic appearance and location of amyloid in h&e sections that is usually adequate to make this diagnosis. confirmation of the deposits as amyloid can be accomplished with light microscopy using special stains such as congo red. amyloid appears apple green under polarized light with this stain. the term "hyaline" should be used in case of uncertainties about the nature of extracellular deposits of hyaline material in h&e sections and the unavailability of a congo red stain. hyaline is also the appropriate term for homogenously eosinophilic extracellular deposits that react negative with congo red. synonyms: calcification; mineral deposition pathogenesis: mineralization of blood vessel walls and muscle fibers of the oral cavity/pharynx, tongue, or esophagus. • basophilic granular deposits in the wall of arteries as well as within individual muscle fibers. • mineral deposits usually easily identified in routine sections but can be further characterized by special stains (alizarin red, von kossa). differential diagnosis • none. pathogenesis: increased pigment has been described in the tongue muscle of aging rats (bodner et al. 1991 ) and in the oral mucosa of rats (ag strain) given antimalarial drugs (savage et al. 1986 ). • yellow/brown pigment (lipofuscin) in muscle fibers of the tongue. • brown/black pigment (melanin) within oral mucosa. • none. comment: pigment (increased pigmentation) is not a common finding in the oral cavity/pharynx, tongue, and esophagus. when this is present, histochemistry, immunohistochemistry, ultrastructural, or other laboratory methods may be required to characterize this material. synonyms: hpyerkeratosis, orthokeratotitc may have been identified as hyperkeratosis hyperkeratosis, parakeratotic may have been identified as parakeratosis pathogenesis: increased production and/or retention of keratin by squamous epithelium of the mucosa with normal (orthokeratotic) or abnormal (parakeratotic) maturation of the keratin layer. • increase in keratin on the surface of the mucosa. • focal or diffuse. • often accompanied by hyperplasia of squamous epithelium. orthokeratotic • thickened keratin layer with non-nucleated keratinized cells. parakeratotic • thickened keratin layer with nucleated keratinized cells. • normal: keratin layer that is normally less than the thickness of the mucosal squamous epithelium. hyperplasia, squamous cell: proliferation and thickening of the stratum spinosum. comment: parakeratosis of the esophagus has been described in zinc-deficient rats (barney et al. 1968 ). it may also be induced by vitamin imbalances or hydroxymethylglutaryl-coa reductase inhibitors (sigler et al. 1992 ). it is recommended that when possible, descriptive terminology should be used to best characterize the type (e.g., neutrophil, mixed cell, mononuclear cell, lymphocyte, etc.) of cellular component(s)/infiltrates rather than a specific type/duration of inflammation (e.g., acute, ulcerative, suppurative, subacute, chronic) for changes in the oral cavity, pharynx, tongue and esophagus. the presence of various inflammatory cell infiltrates in the absence of other features of inflammation should be diagnosed as an 'infiltrate' with predominate/appropriate cell type(s) identified. however, when other prominent morphologic features (congestion, hyperemia, hemorrhage, edema, necrosis, fibrosis, foreign material, bacterial organisms, etc.) are present, it is preferable to characterize the change as an inflammatory process (inflammation) with specific descriptors. the reader is referred to the nomenclature and review of basic principles document for discussion on the preferred use of descriptive, rather than diagnostic terminology (mann et al. 2012) . listed below are descriptive diagnostic terms and examples of inflammatory cell infiltrates or types of inflammation. many of the examples provided in this manuscript are more consistent with inflammation, as indicated by figure legends. subsequently we describe common types of inflammation in an exemplary manner, while we give only a general description of inflammation for other parts of the digestive tract. (figures 17 and 18 ) synonyms: infiltrate inflammatory; infiltrate inflammatory cell; infiltration (plus modifier); infiltration, inflammatory; infiltration, inflammatory cell modifiers: type of inflammatory cell that represents the predominant cell type in the infiltrate pathogenesis: infiltrate of lymphocytes, plasma cells, macrophages, neutrophils, eosinophils or mixtures thereof within the mucosa or muscle layers of the oral cavity/pharynx, tongue, or esophagus without other histological features of inflammation as noted above. • focal, multifocal or diffuse cellular infiltrate in mucosa/ muscle layers. • presence of mononuclear or polymorphonuclear leucocytes but no other histological criteria of inflammation. • lesion may be associated with overlying ulceration, distended/ruptured cyst, self-induced traumatic lesions or dysplasia/neoplasia of the teeth in the oral cavity/pharynx. • inflammation: in addition to the infiltrate, other morphologic features of inflammation such as edema, hemorrhage, necrosis and/or fibroplasia will be present. • granulocytic leukemia: infiltration of neutrophil precursors and/or abnormal neutrophils will probably be present along with mature neutrophils; infiltration of similar neoplastic cells is likely present in other organs. • lymphoma: infiltration of monomorphic population of lymphocytes (often with atypical, increased and/or abnormal mitoses); infiltration of similar neoplastic cells is likely present in other organs. • fibrosis may be a prominent component in a more chronic inflammatory change. • may be associated with overlying ulcer, distended/ruptured cyst, or self-induced traumatic lesions. in the oral cavity/pharynx, the process may be associated with dysplasia/neoplasia of the teeth. • infiltrate, lymphocytes or infiltrate mononuclear cell: other morphological features of inflammation such as edema, hemorrhage, necrosis and/or fibroplasia will be absent. • lymphoma: infiltration of monomorphic population of lymphocytes (often with atypical, increased and/or abnormal mitoses); infiltration of similar neoplastic cells is likely present in other organs. comment: when a mononuclear cell infiltrate is considered to represent an inflammatory process (inflammation, mononuclear cell) and other morphologic features (fibrosis, mineralization) associated with the infiltrate suggest an ongoing/ continuing inflammatory process, the modifier 'chronic' may be included in the diagnosis (i.e. inflammation, mononuclear cell, chronic) to better characterize the finding. pathogenesis: inflammatory cell response within the mucosa or muscle layers of the oral cavity/pharynx, tongue, or esophagus. • mixed inflammatory cell infiltrate consisting of variable numbers of neutrophils, lymphocytes or macrophages without predominance of one cell type. • edema, congestion/hemorrhage, and/or cell debris are components of the mixed cell infiltrates more consistent with an inflammatory process. • may be associated with overlying ulcer, distended/ruptured cyst, self-induced traumatic lesions or dysplasia/ neoplasia of the teeth in the oral cavity/pharynx. • in the oral cavity/pharynx, the inflammatory process may be associated with dysplasia/neoplasia of the teeth. reactive/regenerative hyperplasia of the overlying mucosal epithelium may also be a feature of this inflammatory response. • infiltrate, neutrophils: other morphological features of inflammation such as edema, hemorrhage, necrosis and/ or fibroplasia will be absent. comment: when a mixed cell infiltrate is considered to represent an inflammatory process (inflammation, mixed cell) with the presence of other morphologic features (fibrosis; granulomatous inflammation, granulation tissue and a prominence of neutrophils), the modifier 'chronic' may be included in the diagnosis (inflammation, mixed cell, chronic) to better characterize the finding. inflammation, mixed cell is commonly observed with gavage-related injury (figures 21 and 22 ). it may have variable histopathological appearance, dependent on extent of damage and duration/onset of the lesion to include: perforation (typically seen macroscopically), bacterial organisms, or foreign material in the pharyngeal / esophageal or peripharyngeal / periesophageal tissue with the variable presence of degeneration/necrosis and/or regeneration of muscular layer in conjunction with inflammation, edema or hemorrhage. if the lesion is interpreted to be secondary to gavage-related injury, this may be addressed in the pathology narrative, or alternatively may be diagnosed as inflammation, mixed cell, gavage-related to distinguish from spontaneous and/or test article-related findings. pathogenesis: inflammatory cell response to presence of foreign material; observed primarily in the tongue. • focal inflammatory lesion, most often seen in mucosa, ducts of minor salivary glands or muscle layers of the tongue. • mixed inflammatory cell infiltrate (macrophage/multinucleated giant cell, lymphocyte, neutrophil) sometimes associated with an imbedded hairshaft fragment or other ingested foreign material (food/bedding material). • abscess: circumscribed and grossly visible globular process with characteristic zonation of inner cell debris, neutrophils, and outer capsule of fibrosis/fibroplasias with numerous capillaries (granulation tissue). • inflammation, mixed cell: the inflammatory process lacks foreign material and/or multinucleated giant cells. synonyms: arteritis; vasculitis; polyarteritis pathogenesis: inflammation of vascular wall of the oral cavity/pharynx, tongue, or esophagus. • typically affects muscular wall of arteries in tongue. • variable mixed inflammatory cell infiltrate within and around vessel. • possible presence of fibrinoid necrosis of vessel wall. • proliferation of endothelium and thickening (fibrosis) of vessel wall. • infiltrate, inflammatory cell: may occur perivascular, but the vessel wall itself is unaffected. comment: more information and differential diagnoses are given in the inhand publication of nomenclature and diagnostic criteria of the cardiovascular system (berridge b et al. in preparation) . pathogenesis: accumulation of tissue fluid in the interstitium resulting from increased vascular permeability. • increased eosinophilic fluid (interstitial fluid) within interstitium. • inflammation, neutrophils: usually associated with tissue and vascular damage resulting in exudative edema and inflammatory cell infiltrate. edema accompanying an inflammatory process should be recorded separately if it is a predominant lesion. pathogenesis: increased vascular permeability (diapedesis) or rupture of blood vessels. histogenesis: basal layer of the stratified squamous epithelium. • proliferation of the basal cell layer, basophilic staining increased. • focal or diffuse. • endophytic growth pattern. • no alteration of basement membrane integrity. • hyperplasia, squamous cell: thickening of the epithelium with all normally existing layers. • carcinoma, squamous cell: evidence for lost basement membrane integrity, spinous cells and keratinized cells proliferate, cellular atypia. comment: basal cell hyperplasia and squamous cell hyperplasia may occur concurrently. isolated nests of basal cells may occur in the lamina propria, dependent on the plane of section through the rete peg structures. however, their discrete border indicates an intact basement membrane. neoplastic lesions in the oral cavity/pharynx, tongue, and esophagus are usually correlated to a gross observation. in addition to the proliferative lesions of squamous cell origin, neoplasms of the bone, tooth, or adjacent soft tissues (malignant schwannoma, zymbal's gland tumor) may extend into the oral cavity and be associated with a gross observation at this location. these tumors are described in separate inhand publications on "musculoskeletal system", "soft tissue", and "mammary, zymbal's, and clitorial glands". histogenesis: epithelial squamous cells of the mucosa in the oral cavity/pharynx, tongue, and esophagus. • central fibrovascular stalk with multiple finger/frondlike projections covered with variably thick squamous epithelium. • squamous epithelium often heavily keratinized. • cells show orderly maturation. • when occurring on the tongue, are generally dorsally located. • aggregates, granular cell (although there are no reports this has been observed in the tongue, this likely could occur early in the process, as described in the inhand cns/pns and female reproductive systems): few scattered cells to small aggregates with minimal disturbance of normal tissue architecture and no compression of adjacent tissue. • tumor, granular cell malignant (although there are no reports this has been observed in the tongue, there is the potential for this lesion to progress to malignancy, as described in the inhand cns/pns and female reproductive systems): prominent pleomorphism and/or invasion of surrounding tissue. comment: benign granular cell tumor (gct) of the tongue is rare and has not been previously reported in rodents. we are currently aware of several cases of granular cell tumors in the tongue of wistar rats (4 females and one male) and one case in a sprague dawley rat (male) but are unaware of this neoplasm occurring in the tongue of mice. gcts have been reported in the tongue as well as other sites in the dog, cat, horse, and a bird (patnaik 1993) . although uncommon, gcts most frequently occur in the head and neck region (often in the tongue) of humans with a slight predominance in females (becelli et al. 2001; van de loo et al., 2015) . gcts in the meninges of rats and the reproductive tract (uterus/cervix/vagina) of rats and mice have also been described (dixon et al, 2014) but their relationship to the gct observed in the tongue of rats is unknown. the rodent stomach is morphologically different from the stomach of other laboratory species and from that of humans. in the rat and mouse the proximal portion, the nonglandular stomach (synonym forestomach), is lined by stratified squamous epithelium and comprises approximately half of the total area of the stomach. it is separated from the distal glandular stomach by the limiting ridge (squamocolumnar junction), where the squamous epithelium is thicker than elsewhere in the stomach. as humans lack a nonglandular stomach, the relevance of test article-related changes in this tissue for humans can be challenged. however, it is likely that the squamous mucosa of the esophagus (in species without the nonglandular stomach), will react to test articles in a similar way as the nonglandular stomach epithelium, if equivalent exposure levels are attained. therefore, interpretations of changes in the nonglandular region need to take account of retention time of a test article in the stomach and physiological functioning of the stomach (greaves 2012) . exposure to the rodent nonglandular stomach by gavage can mimic aspects of skin painting studies, i.e. direct contact of test chemical to the keratinized squamous epithelium. the glandular stomach of rodents has histological and functional similarities to that of other mammals with both corpus and antral regions. it anatomically differs from other non-rodent laboratory animal species and humans by the lack of a notable cardiac region in the glandular mucosa and the absence of the dorsal/anterior pouch in the glandular region known as the fundus. in rodents, the analogous dorsal/anterior pouch is nonglandular although the term glandular fundus is frequently used for the corpus. the term "fundic gland" has been generically applied to the human stomach to denote glands containing parietal (oxyntic) and/or chief (zymogenic) cells, regardless of anatomic site. rodents do not have glands in their fundus; however, the ubiquitous use of the term in medical pathology has led to its frequent use in rodent studies. similarly, pylorus is sometimes used to denote the antrum; however, its use should be limited to designating the portion of the antrum adjoining the gastroduodenal junction. the surface epithelium of the glandular mucosa is a simple columnar mucous epithelium that extends into the gastric pits; the depth of the gastric pit varies based on location in the corpus or antrum, being most shallow close to the limiting ridge and becoming deeper approaching the antrum. accordingly, the proportion of fundic glands (synonym: oxyntic glands) contributing to the thickness of the corpus mucosa is greatest near the limiting ridge on the greater curvature and progressively diminishes toward the corpus/antral junction. the fundic glands are continuous with the gastric pit and have a simple tubular structure with isthmus, neck and base regions. there are 4 cell types in the corpus: mucous neck cells which produce mucus; parietal or oxyntic cells which produce hydrochloric acid and intrinsic factor; chief or zymogenic cells which produce pepsinogen; and argentaffin or neuroendocrine cells that produce a variety of endocrine and paracrine hormones. the isthmus region serves as the site of proliferation with mucous neck cells acting as progenitor cells that differentiate luminally to become mucous epithelium and basally to become the specialized cells of the fundic glands (karam, 1999) . this is reflected in differences of the turnover rate, which is at around 3 days in mucous cells compared to 194 day in oxyntic and 54 day in parietal cells (karam, 1999) . in the antrum, the glands are lined by mucous cells and neuroendocrine cells including those that produce gastrin. the turnover rate of mucus cells is much faster at around 3 days than oxyntic or parietal cells (about 194 and 54, respectively) (karam, 1999) . the mucus phenotype of gastric epithelium and glandular cells can be identified by histochemical methods, e.g. the combination alcian blue ph 2.5 followed by pas stain ( table 1) . the mucosa is supported by the connective tissue of the lamina propria and the continuous muscle layer of the muscularis mucosa. beneath the muscularis mucosa is the relatively loose connective tissue of the submucosa, which contains larger blood vessels, lymphatics and nerves, and the tunica muscularis. the external surface is covered by the serosal membrane. the esophagus enters into the nonglandular region of the rodent stomach. functionally, the nonglandular stomach serves as a temporary storage organ and, due to prolonged exposure, is potentially a major site for interaction with test articles entering the body via oral ingestion. as a result of this storage function, the presence of irritants in the diet may quickly lead to damage and inflammation in this area. the lower ph in the nonglandular stomach when compared to the esophagus may be of major importance, as it may influence the diffusion of test articles into the lipophilic squamous epithelium. in the stomach, food undergoes mechanical and chemical breakdown to form chyme which then passes into the duodenum for further digestion. mechanical breakdown is achieved through the churning action of the tunica muscularis and chemical breakdown results from the action of digestive juices secreted from the glandular mucosa. the glandular mucosa produces an acidic watery secretion containing pepsinogen. pepsinogen is converted into active pepsin in the acid environment which then hydrolyses proteins into polypeptide fragments. self digestion of the stomach mucosa is prevented by a layer of surface mucous which has a higher ph than the gastric juice due to secretion of bicarbonate ions by the surface mucous cells. changes in, or loss of, the mucous layer by test articles may quickly lead to erosion and ulceration of the glandular epithelium. on the other hand complete inhibition of acid secretion by test articles will lead to hypergastrinemia which, if maintained, leads to proliferation of the enterochromaffinlike cells. attention should be paid to the amount and nature of the stomach contents at necropsy. a stomach abnormally distended with food, particularly in a rodent fasted overnight, may indicate that the test article and/or vehicle is inhibiting gastric function, and this may have lead to reflux of stomach contents and entry of gastric contents into the respiratory tract (damsch et al. 2011 ). conversely, a stomach grossly distended with gas is often an indication in a rodent that there has been a blockage in the upper respiratory tract resulting in dyspnoea, mouth breathing and aerophagia. in its natural configuration, the non-distended stomach has an irregularly folded mucosa and submucosa. consistent opening and positioning during fixation and trimming are necessary to obtain standardized sections of both glandular corpus and antrum and nonglandular stomach with correct orientation of the muscularis, submucosa and mucosa. at necropsy, the stomach should be opened along its greater curvature to the proximal part of the duodenum, any ingesta washed off with isotonic saline and then pinned to a rigid surface (e.g. cork). the stomach should be gently but sufficiently stretched to produce a flattened surface of both nonglandular and glandular regions but excessive stretching should be avoided. alternatively, the pylorus may be ligated and the stomach inflated with fixative for a short period, before opening and flattening between filter paper prior to further fixation (mahler et al. 2000) however, an excessive volume must not be used to avoid excessive stretching. trimming of stomach should be undertaken as specified in the goreni trimming guide (website.reni.item.fraunhofer.de/ reni/trimming) so that standardized sections of nonglandular epithelium, corpus, antrum and pyloric-duodenal junction are obtained. the ratios of parietal and chief cells in the fundic glands and the height of the mucosa vary between lesser and greater curvature so inter-animal variation in trimming needs to be avoided and a sensitivity to topography maintained. furthermore it is important to recognize that the glandular corpus mucosa may be minimal or absent along the lesser curvature with the antral mucosa extending to the limiting ridge. in the following sections, lesions that may affect the nonglandular and glandular regions in a similar manner are described only once. congenital/developmental lesions occur occasionally in rodents. most occur as isolated cases and the pathologist must distinguish such background changes from test article-induced lesions. synonym: cyst, epithelial pathogenesis: invagination of stratified squamous epithelium into the wall of the nonglandular stomach. • most commonly seen in nonglandular stomach or near the limiting ridge in glandular mucosa. • keratinized stratified squamous epithelium. • mucous cells occasionally present. • may extend into submucosa/tunica muscularis. • lumen frequently contains keratinized material which may be mineralized. • may be surrounded by chronic inflammation. • carcinoma, squamous cell: epithelial atypia and invasive growth patterns with penetration of basement membrane by single cells or nests of neoplastic cells. comment: while squamous cysts are most likely to be of congenital origin they may potentially form during life sec-ondary to derangement of the epithelium e.g. in an inflammatory process. if post-inflammatory extension is the suspected pathogenesis, the pathologist may choose to interpret the focal change as a diverticulum, rather than a congenital cyst. ectopic tissue (figures 37, 38, 39 and 40) modifiers: hepatocytes, pancreas pathogenesis: presence of pancreatic or hepatic tissue in the mucosa or submucosa. • normally formed pancreatic acini in mucosa or submucosa. islets of langerhans may also be present. • normally formed hepatocytes present in cords or nests in mucosa or submucosa; binucleate cells may be present. • adenocarcinoma: formation of hepatocyte-like cells has been reported in human gastric adenocarcinoma. comment: ectopic pancreatic acini or hepatocytes are rare incidental findings in rats and mice (maekawa et al. 1996; brown and hardisty 1990) , but ectopic differentiation may be a feature of some engineered mice (fukuda et al. 2006) . in one publication, hepatocytes accompanied fundic gland abnormalities in the mouse and it was not clear whether they represented metaplasia or congenital heterotopia ; the same conundrum may apply to ectopic pancreatic foci. metaplasia to a pancreatic cell type was reported as part of a hypertrophic gastropathy in a strain of rat (wtcdfk) which has a deletion of the potassium channel kcnq1 gene (kuwamura et al. 2008) . ectopic pancreatic tissue also may occur rarely in the pyloric submucosa of mice (maekawa et al. 1996) . pathogenesis: decrease in normal thickness/cellularity of squamous mucosa. • focally extensive or diffuse lesion. • decreased thickness of mucosal epithelial layer. • erosion/ulcer: focal or focally extensive absence of superficial or, in severe cases (ulcer) of all epithelial layers. • artifact: excessive stretching due to food contents or stretching stomach at necropsy leads to decreased thickness of all layers of the gastric wall. vacuolation, squamous epithelium ( figure 43 ) pathogenesis: degenerative change in the squamous epithelial cells which may precede necrosis, erosion or ulceration of the nonglandular epithelium. • cells of squamous epithelium have a pale staining, vacuolated appearance. • may be accompanied by edema in the submucosa and vacuolation of the muscularis. differential diagnosis • artifacts. comment: epithelial vacuolation and vesiculation along with submucosal edema was described in rats after administration of ethyl acrylate as a forerunner to necrosis and erosion/ ulcer (ghanayem et al. 1985) . certain compounds may specifically cause vacuolation of the squamous epithelium adjacent to the limiting ridge. pathogenesis: gene regulated, energy dependent process leading to formation of apoptotic bodies which are phagocytosed by adjacent cells; typically associated with cytotoxic chemotherapeutics that affect the mucosal epithelium of the nonglandular stomach. • necrosis, epithelium: the morphologic features of cell death clearly fit with necrotic diagnostic criteria (cells and nuclei swollen, pale cytoplasm etc.). • apoptosis/necrosis, epithelium: both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. the term is also used when the type of cell death cannot be determined unequivocally. • erosion/ulcer: focal or focally extensive absence of superficial or, in severe cases, of all epithelial layers with extension of the alteration into the muscularis. the approach for the nomenclature and diagnostic criteria of cell death applied here is based on a draft recommendation of the inhand cell death nomenclature working group. apoptosis is not synonymous with necrosis. the main morphological differences between these two types of cell death are cell shrinkage with nuclear fragmentation and tingible body macrophages in apoptosis versus cell swelling, rupture and inflammation in necrosis; however, other morphologies (e.g. nucelar pyknosis and karyorrhexis) overlap. in routine h&e sections where the morphology clearly represents apoptosis or single cell necrosis, or whereby special procedures (e.g. tem or ihc for caspases) prove one or the other, individual diagnoses may be used. however, because of the overlapping morphologies, necrosis and apoptosis are not always readily distinguishable via routine examination, and the two processes may occur sequentially and/or simultaneously depending on intensity and duration of the noxious agent (zeiss 2003) . this often makes it difficult and impractical to differentiate between both during routine light microscopic examination. therefore, the complex term apoptosis/necrosis may be used in routine toxicity studies. a differentiation between apoptosis and single cell necrosis may be required in the context of a given study, in particular if it aims for mechanistic investigations. transmission electron microscopy is considered to represent the gold standard to confirm apoptosis. other confirmatory techniques include dna-laddering (easy to perform but insensitive), tunel (false positives from necrotic cells) or immunohistochemistry for caspases, in particular caspase 3. these techniques are reviewed in detail by elmore (elmore 2007) . some of these confirmatory techniques detect early phases of apoptosis, in contrast to the evaluation of h&e stained sections, which detects late phases only; overall interpretation of findings should take into account these potential differences. thus, low grades of apoptosis may remain unrecognized by evaluation of h&e stained slides only. certain studies may require the consideration of forms of programmed cell death other than apoptosis which requires specific confirmatory techniques (galluzzi et al. 2012) . synonyms: oncotic cell death; oncotic necrosis; necrosis pathogenesis: unregulated, energy independent, passive cell death with leakage of cytoplasm into surrounding tissue and subsequent inflammatory reaction; may be induced by direct contact with a test article after oral uptake/administration. • cells swollen with pale eosinophilic cytoplasm. • loss of nuclear basophilia, pyknosis and/or karyorrhexis that affects aggregates of cells. • in more severe cases, there may be detachment of the epithelium from the submucosa. • typically, the presence of degenerative cells is a compo-nent of necrosis. • minimal or slight inflammatory cell infiltrates may be present as a feature of necrosis. single cell • only single cells affected. • apoptosis, squamous epithelium: the morphologic features of cell death clearly fit with apoptosis (cell and nucleus shrunken, hypereosinophilic cytoplasm, nuclear pyknosis etc.) and/or special techniques demonstrate apoptosis. • apoptosis/necrosis, squamous epithelium: both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. the term is also used when the type of cell death cannot be determined unequivocally. • atrophy, squamous epithelium: reduced thickness of all layers of the squamous epithelium or, in severe cases, absence of basal germinative layers; usually no cellular degeneration or necrosis. • erosion/ulcer: focal or focally extensive absence of superficial or, in severe cases, of all epithelial layers with distention of alteration into the muscularis. comments: epithelial necrosis usually develops into erosion/ ulcer and in the past has frequently been recorded as such. a separate recording of necrosis as the initial event in this process is recommended when the structure of the mucosa is still intact. synonym: cell death pathogenesis: unregulated, energy independent, passive cell death with leakage of cytoplasm into surrounding tissue and subsequent inflammatory reaction (single cell necrosis) and/or gene regulated, energy dependent process leading to formation of apoptotic bodies which are phagocytosed by adjacent cells (apoptosis); typically associated with cytotoxic chemotherapeutics that affect the mucosal epithelium of the nonglandular stomach. • both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. • the type of cell death cannot be determined unequivocally. • apoptosis, squamous epithelium: the morphologic features of cell death clearly fit with apoptosis (cell and nucleus shrunken, hypereosinophilic cytoplasm, nuclear pyknosis etc.) and/or special techniques demonstrate apoptosis and there is a requirement for recording apoptosis and necrosis separately. • necrosis, squamous epithelium: the morphologic features of cell death clearly fit with necrotic diagnostic criteria (cells and nuclei swollen, pale cytoplasm etc.) and there is a requirement for recording apoptosis and necrosis separately. • erosion/ulcer: focal or focally extensive absence of superficial or, in severe cases, of all epithelial layers with distention of alteration into the muscularis. comments: necrosis and apoptosis are not always readily distinguishable via routine examination, and the two processes may occur sequentially and/or simultaneously depending on intensity and duration of the noxious agent (zeiss 2003) . this often makes it difficult and impractical to differentiate between both during routine light microscopic examination. in these cases, the combined term apoptosis/necrosis may be used. it is recommended to explain in detail the use of this combined term in the narrative part of the pathology report. pathogenesis: localized loss of mucosa with either partial mucosal penetration (erosion) or with full penetration of the mucosa to the muscularis mucosa (ulcer). • focal or multifocal. • ulcers will be associated with acute/chronic inflammatory cell infiltration in submucosa. • basal lamina may remain intact (erosion) or in the more severe cases defect in the mucosa and inflammation will extend to the tunica muscularis and serosa (ulcer). • hyperplasia is often present in the surrounding epithelium. • hemorrhage may be seen with larger ulcers. • carcinoma, squamous cell: may show secondary ulceration, but always penetration of basement membrane by single cells or nests of neoplastic cells. • necrosis, squamous epithelial: no superficial or deep loss of epithelial cells. • artifacts: mucosal loss due to manual or processing artifact -inflammation will be absent. comment: ulcers in the nonglandular epithelium are often seen macroscopically as multiple small dark depressed areas surrounded by raised areas of whitened epithelium (maekawa 1994) . whilst ulcers have been induced by a wide range of irritant agents, the cause of ulceration in control animals is often unclear, although advanced age, parasitism, infection, diet, feeding regimen, generalized debility and stress can play a role (maekawa 1994; maekawa et al. 1996; greaves 2012) . protein restriction and starvation have also been shown to produce ulcers (boyd et al. 1970) . although there are specific morphologic criteria to differentiate the more superficial lesion (erosion; confined to the epithelial surface) from the deeper ulcer (full penetration of the mucosa to the muscularis mucosa), the plane of section through smaller, focal lesions often impacts on the appearance (depth of the epithelial loss) of this finding. in most instances it is not practical to separate these changes and they are typically diagnosed under the single, combined term of erosion/ulcer with an appropriate severity grade. erosion/ulcer usually is the result of epithelial necrosis. because of its unique topography adjacent to the lumen and often involving multiple organ layers, which uniquely affects the progression and resolution of the lesion (e.g. margin hyperplasia, granulomatous tissue, inflammation), it is useful to record erosion/ulcer separately from epithelial necrosis. a deep ulcer may be perforating if it destroys all layers of the gastric wall, and may be designated as such by a free text entry. however, a perforation resulting from a physical insult, e.g. gavage-related, typically is a macroscopic lesion and generally not recorded on the light microscopic level. hyperkeratosis (figure 45, 46 and 47) synonyms: hpyerkeratosis, orthokeratotic may have been identified as hyperkeratosis hyperkeratosis, parakeratotic may have been identified as parakeratosis pathogenesis: keratinization of squamous epithelium faster than desquamation of keratinized layers with normal (hyperkeratotic) or abnormal (parakeratotic) maturation of the keratin layers • increase in the thickness of the keratin layer on the luminal epithelial surface. orthokeratotic • thickened keratin layer with non-nucleated keratinized cells. parakeratotic • thickened keratin layer with nucleated keratinized cells. • hyperplasia, squamous cell: proliferation and thickening of the stratum spinosum. comments: hyperkeratosis occurs often in association with hyperplasia of underlying epithelium. alternatively, it may be observed in the absence of hyperplasia under circumstances suggesting anorexia and a presumptive lack of mechanical abrasion. hyperkeratosis can be a frequent observation attributable to local irritation of orally administered test articles in toxicity studies (til et al. 1988 ). the local irritant effect is presumably potentiated by increased duration of exposure associated with intragastric storage and increased contact, if test article precipitates in the gastric compartment. comment: glandular cysts may be congenital but most are acquired as their incidence increases with age in both rats and mice (brown and hardisty 1990; maekawa et al. 1996) . in the fischer rat they are more common in the antrum than in the fundus (brown and hardisty 1990) . when cysts extend through the muscularis mucosae, the diagnostic term "diverticulum, cystic" or "diverticulum, atypical, cystic" should be used. modifiers: mucosa or specific cell type (e.g., chief cell, parietal or mucous cell) pathogenesis: decreased number and/or size of epithelial cells reducing the mucosal thickness and function of the glandular mucosa. in the fundic glands, it may affect one or all cell types. in most instances chief cells are lost before other cell types. • decreased numbers of a one or more cell types. remaining cells may be small and/or poorly differentiated. • reduced mucosal thickness in advanced cases, although compensatory hyperplasia of less differentiated epithelial cells can mask this. • dilatation of atrophic glands. • focal areas of atrophy may be seen with aging. • artifact: over stretched stomach during 'pinning' at necropsy leading to a reduction in thickness of all layers of the gastric wall. • secretory depletion, mucus: reduction of mucous cell size due to reduced amounts of mucus but no loss of cells. comment: at least two different types of atrophy can be distinguished. in one type, atrophy broadly affects all mucosal cell types resulting in an overall reduction in mucosal height with maintenance of relatively normal cellular composition. under other circumstances a specific cell type may be atrophic with the loss of specific functionality. atrophy affecting all cell types of the gastric mucosa can be produced by starvation, antrectomy or deletion of the gastrin gene which removes the trophic stimulation of gastrin (greaves 2012) . analogous changes may be produced by test articles that block the secretion or activity of gastrin (dethloff et al. 1997) . in contrast, chronic inflammation and some xenobiotics can cause loss of specific cell types (greaves 2012 ). in addition, in the lesions associated with helicobacter infections in mice it has been noted that chief cells are lost before parietal cells (rogers and houghton 2009; rogers 2012) . focal or diffuse atrophy of the mucosa can occur with age in rodents where there is partial replacement of the glands by fibrous connective tissue (brown and hardisty 1990) . modifiers: mucosa or specific cell type (e.g., chief cell, parietal or mucous cell) pathogenesis: vacuolation with/without degeneration of epithelial cells. may affect all cell types or be primarily chief, parietal or mucous cell. • cytoplasmic vacuolation, swelling. • occasional apoptosis/single cell necrosis may also be present. • autolysis: destruction and loss of cell types but often occurs preferentially at the luminal surface. • depletion, mucus: only mucous cells affected, no other cytological changes. comment: vacuolation with no or minimal evidence of cell loss can be induced by agents that inhibit gastric acid secretion (dethloff et al. 1997; karam and alexander 2001) . in addition, degeneration is observed with anticancer cytotoxic agents, ulcerogenic agents and agents that decrease mucosal blood supply, or test articles that sequester in parietal cells (ito et al. 2000; bertram et al. 2013; greaves 2012) . depending on the nature and severity of the insult, degeneration will be followed by necrosis, erosion/ulcer of the epithelium, inflammation and/or hemorrhage. pathogenesis: decreased mucus content of mucous cells. • intact epithelial layer. • replacement of normal clear cytoplasm with more basophilic cytoplasm containing little or no mucus. • degeneration, epithelial: additional cytological features apart from reduction in mucus. • atrophy, mucous cell: reduced number of mucus cells in addition to mucus depletion. comment: mucus depletion may develop secondary to spontaneous inflammatory lesions and drug-induced lesions (greaves 2012) . qualitative changes in mucus composition may accompany depletion as described following administration of aspirin, anti-inflammatory agents and adrenocortical steroids (ishihara et al. 1984; bertram et al. 2013; greaves 2012) . these substances may also alter the phospholipids present in the mucus layer thereby reducing the protective hydrophobic barrier properties and a loss of functional integrity. administration of histamine h2 receptor antagonists and proton pump inhibitors that reduce gastric acid secretion have also been shown to reduce total and sulphated glycoproteins along with reduction in mucus (yoshimura et al. 1996) . pathogenesis: transformation of any glandular epithelial cell to produce hyaline cytoplasm. • intensely pink-red cytoplasmic droplets and/or crystals in surface/mucous cells, most often adjacent to the limiting ridge. • may extend into and/or replace fundic glands in advanced cases. • cells are usually hypertrophic. • can be single or multiple (focal or multifocal). • crystals if present may be intracellular or extracellular. • none. comment: mucous epithelial cells distended with bright, hyaline eosinophilic cytoplasm occur infrequently in rodents either as a spontaneous change or associated with another lesion e.g. inflammation (especially eosinophilic) or lymphoma infiltration (bertram et al. 1996) . they are usually observed in mucus neck cells of the glandular mucosa near the limiting ridge and occasionally may be accompanied by hyaline eosinophilic crystals. eosinophilic globules may be considered a precursor of these crystals. formation of these cells is also associated with the administration of gastric antisecretory agents although the incidence is not proportional to the neuroendocrine cell hyperplasia which also occurs with these agents (betton et al. 1988 ). the eosinophilic granules are similar to those seen in other epithelia e.g. upper and lower respiratory tract or pancreas (leininger et al. 1999; renne et al. 2009 ). once thought to be accumulation of mucosubstances or pepsinogen, they have been shown to be composed of a ym1/ym2 a chitinase-like protein that may be produced in response to mucosal irritation rogers and houghton 2009) . the use of the term hyalinosis for this lesion will potentially cause confusion in safety assessment as the same term may also be used for a distinctly different clinical disorder in humans and can be used to describe vascular and renal glomerular changes. pathogenesis: gene regulated, energy dependent process leading to formation of apoptotic bodies which are phagocytosed by adjacent cells. • necrosis, mucosa: the morphologic features of cell death clearly fit with necrotic diagnostic criteria (cells and nuclei swollen, pale cytoplasm etc.). • apoptosis/necrosis, mucosa: both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. the term is also used when the type of cell death cannot be determined unequivocally. • erosion/ulcer: focal or focally extensive penetration of the mucosa, either partial (erosion) or full to the muscularis mucosa (ulcer). the approach for the nomenclature and diagnostic criteria of cell death applied here is based on a draft recommendation of the inhand cell death nomenclature working group. apoptosis is not synonymous with necrosis. the main morphological differences between these two types of cell death are cell shrinkage with nuclear fragmentation and tingible body macrophages in apoptosis versus cell swelling, rupture and inflammation in necrosis; however, other morphologies (e.g. nucelar pyknosis and karyorrhexis) overlap. in routine h&e sections where the morphology clearly represents apoptosis or single cell necrosis, or whereby special procedures (e.g. tem or ihc for caspases) prove one or the other, individual diagnoses may be used. however, because of the overlapping morphologies, necrosis and apoptosis are not always readily distinguishable via routine examination, and the two processes may occur sequentially and/or simultaneously depending on intensity and duration of the noxious agent (zeiss 2003) . this often makes it difficult and impractical to differentiate between both during routine light microscopic examination. therefore, the complex term apoptosis/necrosis may be used in routine toxicity studies. a differentiation between apoptosis and single cell necrosis may be required in the context of a given study, in particular if it aims for mechanistic investigations. transmission electron microscopy is considered to represent the gold standard to confirm apoptosis. other confirmatory techniques include dna-laddering (easy to perform but insensitive), tunel (false positives from necrotic cells) or immunohistochemistry for caspases, in particular caspase 3. these techniques are reviewed in detail by elmore (elmore 2007) . some of these confirmatory techniques detect early phases of apoptosis, in contrast to the evaluation of h&e stained sections, which detects late phases only; overall interpretation of findings should take into account these potential differences. thus, low grades of apoptosis may remain unrecognized by evaluation of h&e stained slides only. certain studies may require the consideration of forms of programmed cell death other than apoptosis which requires specific confirmatory techniques (galluzzi et al. 2012) . synonyms: oncotic cell death; oncotic necrosis; necrosis pathogenesis: unregulated, energy independent, passive cell death with leakage of cytoplasm into surrounding tissue and subsequent inflammatory reaction; may be induced by direct contact with a test article after oral uptake/administration. • cells swollen with pale eosinophilic cytoplasm. • loss of nuclear basophilia, pyknosis and/or karyorrhexis that affects aggregates of cells. • in more severe cases, there may be detachment of the epithelium from the submucosa. • typically, the presence of degenerative cells is a component of necrosis. • minimal or slight inflammatory cell infiltrates may be present as a feature of necrosis. single cell • only single cells affected. • apoptosis, mucosa: the morphologic features of cell death clearly fit with apoptosis (cell and nucleus shrunken, hypereosinophilic cytoplasm, nuclear pyknosis etc.) and/or special techniques demonstrate apoptosis. • apoptosis/necrosis, mucosa: both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. the term is also used when the type of cell death cannot be determined unequivocally. • atrophy: reduced thickness of all layers of the squamous epithelium or, in severe cases, absence of basal germinative layers; usually no cellular degeneration or necrosis. • erosion/ulcer: focal or focally extensive penetration of the mucosa, either partial (erosion) or full to the muscularis mucosa (ulcer). comments: epithelial necrosis usually develops into erosion/ ulcer and in the past has frequently been recorded as such. a separate recording of necrosis as the initial event in this process is recommended when the structure of the mucosa is still intact. synonym: cell death pathogenesis: unregulated, energy independent, passive cell death with leakage of cytoplasm into surrounding tissue and subsequent inflammatory reaction (single cell necrosis) and/ or gene regulated, energy dependent process leading to formation of apoptotic bodies which are phagocytosed by adjacent cells (apoptosis). • both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. • the type of cell death cannot be determined unequivocally. • apoptosis: the morphologic features of cell death clearly fit with apoptosis (cell and nucleus shrunken, hypereosinophilic cytoplasm, nuclear pyknosis etc.) and/or special techniques demonstrate apoptosis and there is a requirement for recording apoptosis and necrosis separately. • necrosis, mucosa: the morphologic features of cell death clearly fit with necrotic diagnostic criteria (cells and nuclei swollen, pale cytoplasm etc.) and there is a requirement for recording apoptosis and necrosis separately. • erosion/ulcer: focal or focally extensive penetration of the mucosa, either partial (erosion) or full to the muscularis mucosa (ulcer). comments: necrosis and apoptosis are not always readily distinguishable via routine examination, and the two processes may occur sequentially and/or simultaneously depending on intensity and duration of the noxious agent (zeiss 2003) . this often makes it difficult and impractical to differentiate between both during routine light microscopic examination. in these cases, the combined term apoptosis/necrosis may be used. it is recommended to explain in detail the use of this combined term in the narrative part of the pathology report. pathogenesis: loss of superficial mucosa with preservation of the muscularis mucosa (erosion) or with penetration of muscularis mucosa and exposure of submucosa (ulcer). • focal or multifocal. • epithelial cells are absent but muscolaris mucosa is intact (erosion). • epithelial cells are absent and muscularis mucosa has been destroyed (ulcer). • ulceration will be associated with acute/chronic inflammatory cell infiltration in submucosa. • in the more severe cases ulceration and/or inflammation will extend into the tunica muscularis and serosa. • hyperplasia is often present in the surrounding epithelium. • may be associated with foreign bodies (plant fibers) in submucosa. • hemorrhage may be seen with larger ulcers. • adenocarcinoma: may show secondary ulceration, but penetration of basement membrane by single cells or nests of neoplastic cells always present. • artifacts: mechanical loss of mucosa during necropsy; plane of section due to orientation of tissue in block. • autolysis: all tissues in stomach affected but there is often preferential destruction and loss of cells at the luminal surface. comment: erosions and ulcers develop in rodents following stress, bile reflux, changes in acid secretion and hypoxia (bertram et al. 2013; greaves 2012; haschek et al. 2010) . certain types of xenobiotics e.g. non-steroidal anti-inflammatory drugs and ethyl alcohol are well known ulcerogenic agents but ulcers have also been induced by innocuous substances e.g. saline glucose when given as hyperosmolar solutions (puurunen et al. 1980) . ulcers can also reflect systemic disease e.g. associated with uremia. small focal erosions can occur in the glandular corpus of both rats and mice following overnight fasting. although there are specific morphologic criteria to differentiate the more superficial lesion (erosion; confined to the epithelial surface) from the deeper ulcer (full penetration of the mucosa to the muscularis mucosa), the plane of section through smaller, focal lesions often impacts on the appearance (depth of the epithelial loss) of this finding. in most instances it is not practical to separate these changes and they are typically diagnosed under the single, combined term of erosion/ulcer with an appropriate severity grade. erosion/ulcer usually is the result of epithelial necrosis. because of its unique topography adjacent to the lumen and often involving multiple organ layers, which uniquely affects the progression and resolution of the lesion (e.g. margin hyperplasia, granulomatous tissue, inflammation), it is useful to record erosion/ulcer separately from epithelial necrosis. a deep ulcer may be perforating if it destroys all layers of the gastric wall, and may be designated as such by a free text entry. however, a perforation resulting from a physical insult, e.g. gavage-related, typically is a macroscopic lesion and generally not recorded on the light microscopic level. pathogenesis: enlargement of mucous cells that line gastric glands, accompanied by loss of parietal and/or chief cells. the mucous cells may manifest foamy cytoplasm. • parietal and/or chief cells in corpus mucosa replaced by round, foamy, lightly basophilic cells resembling duodenal brunner's gland cells. concurrent loss of oxyntic glandular cells implicates an effect on the differentiation of the glandular epithelium. • increased numbers of such cells may be present (hyperplasia). • histochemical staining with alcian blue/pas ph 2.5 shows that cells express increased gastric-type neutral mucins (red) as well as antral gland and intestinal-type acid mucins (blue). differential diagnosis • none. comment: evaluation in h&e sections limits the characterization of this mucosal change to hypertrophy, hyperplasia and/or vacuolation. this may occur spontaneously or in response to chronic injury. histochemical stains and immunochemical markers facilitate further characterization of the change as a metaplastic shift in the mucous secretory phenotype of the cells. several classes of metaplasia have been identified based on these additional techniques, which may have relevance for modeling human gastric pathogenesis. true intestinal metaplasia (metaplasia with development of a genuine intestinal phenotype) is very rare in rodents but has been induced by pcbs in mice (morgan et al. 1981) . "pseudopyloric" metaplasia where the cells resemble antral cells morphologically and histochemically is much more common. authentic intestinal metaplasia is best confirmed by immunohistochemistry for the intestinal-specific nuclear protein cdx2 (fox et al. 2007 ). pseudopyloric/intestinal metaplasia occurs in the rodent stomach as a change associated with some experimentally induced cancers (e.g. following administration of polychlorinated biphenyls), localized ionizing radiation, injection of xenogenic stomach antigens and the non carcinogen, iodoacetamide (greaves 2012) , as well as infectious models in mice such as h. felis and h. pylori (leininger et al. 1999; rogers and fox 2004) . pathogenesis: extracellular deposits of polypeptide fragments of a chemically diverse group of glycoproteins, in various tissues including stomach mucosa. • deposition of pale amorphous, homogenous eosinophilic material. • location is extracellular in connective tissue and/or blood vessel walls. • green birefringence with congo red stain when viewed under polarized light. • hyaline connective tissue: congo red negative. • fibrinoid necrosis of blood vessels: other evidence of tissue damage in section. comment: amyloid deposition may occur in the stomach mucosa as part of systemic amyloidosis but it is not one of the predilection sites. amyloidosis is extremely rare in rats but common in some strains of mice. in susceptible strains a number of factors including gender, diet, housing conditions, stress, endocrine status and microbiological status can influence the occurrence of amyloidosis (lipman et al. 1993) . for as yet unidentified reasons the previously susceptible cd-1 strain in europe now rarely develops amyloidosis. the characteristic morphologic appearance and location of amyloid in h&e sections that is usually adequate to make this diagnosis. confirmation of the deposits as amyloid can be accomplished with light microscopy using special stains such as congo red. amyloid appears apple green under polarized light with this stain. the term "hyaline" should be used in case of uncertainties about the nature of extracellular deposits of hyaline material in h&e sections and the unavailability of a congo red stain. hyaline is also the appropriate term for homogenously eosinophilic extracellular deposits that react negative with congo red. pathogenesis: deposition of mineral in muscle, fibrous or elastic tissues secondary to necrosis (dystrophic mineralization) or hypercalcemia (metastatic mineralization). • mineral may be found in the muscle layers, blood vessels, basement membranes and/or in the interstitium of mucosa and submucosa. • interstitial mineral occurs predominantly in a band paralleling the parietal cell-rich region of the corpus mucosa. • acellular basophilic material. • mucosal mineralization can be limited to small focal deposits. • diffuse mineralization of the corpus mucosa may be accompanied by degenerative changes or mucous cell hyperplasia in neighboring glands. • artifact: hematoxylin stain precipitate. • bacteria: colonies of bacteria may be confused with mineral due to their basophilic staining. ante mortem bacterial invasion will be accompanied by necrosis and usually inflammation; postmortem bacterial invasion will be accompanied by autolysis. • osseous metaplasia: osteoid present. comment: presence of mineral can be confirmed with von kossa or alizarin red stains but these are rarely needed to make a diagnosis. multifocal or diffuse mineralization occurs secondary to chronic renal disease in rodents (leininger et al. 1999; brown and hardisty 1990) and in situations where serum calcium and/or phosphate balances are perturbed e.g. following intravenous administration of salts of rare earth metals such as gadolinium chloride (rees et al. 1997) . mineralization can sometimes be observed in combination with inflammation and neoplasia. infiltrate ( figure 64 ) synonyms: infiltrate inflammatory; infiltrate inflammatory cell; infiltration (plus modifier); infiltration, inflammatory; infiltration, inflammatory cell modifiers: type of inflammatory cell that represents the predominant cell type in the infiltrate pathogenesis: infiltration of lamina propria and/or submucosa with neutrophils (infiltrate, neutrophil), eosinophils (infiltrate, eosinophil), mononuclear cells (infiltrate, mononuclear cell) or a combination of more than one type (infiltrate, mixed) without other histological features of inflammation e.g. hemorrhage, edema, fibroplasia. • focal, multifocal or diffuse infiltration of cells in the lamina propria and/or submucosa. • presence of mononuclear or polymorphonuclear leucocytes but no other histological criteria of inflammation. • inflammation: other histological features of inflammation such as edema, hemorrhage, necrosis and/or fibroplasia will be present. • granulocytic leukemia: infiltration of neutrophil precursors and/or abnormal neutrophils will probably be present along with mature neutrophils; infiltration of similar neoplastic cells is likely present in other organs. • lymphoma: infiltration of monomorphic population of lymphocytes (often with atypical, increased and/or abnormal mitoses); infiltration of similar neoplastic cells is likely present in other organs. comment: a minimal/mild infiltration of eosinophilic leucocytes is common in the submucosa of the corpus of rats and the infiltrate may also extend into the non-glandular region near the limiting ridge (mcinnes 2012). the stimulus for this infiltration is unknown. modifiers: type of inflammatory cell that represents the predominant cell type in the infiltrate pathogenesis: infiltration of lamina propria and/or submucosa with neutrophils (inflammation, neutrophil) or mononuclear cell (inflammation, mononuclear cell) or a combination (inflammation, mixed) with additional histological features of inflammation e.g. hemorrhage, edema, fibroplasia. propria and/or submucosa. • presence of other histological criteria of inflammation e.g. hemorrhage, edema, fibroplasia. • infiltrate, inflammatory cell: other morphologic features of inflammation such as edema, hemorrhage, necrosis and/or fibroplasia will be absent. • granulocytic leukemia: infiltration of neutrophil precursors and/or abnormal neutrophils will probably be present along with mature neutrophils; infiltration of similar neoplastic cells is likely present in other organs. • lymphoma: infiltration of monomorphic population of lymphocytes (often with atypical, increased and/or abnormal mitoses); infiltration of similar neoplastic cells is likely present in other organs. comment: inflammation in the both glandular and nonglandular stomach is most often seen in combination with erosion or ulceration. pathogenesis: presence of helicobacter spp. in mice. • spiral shaped bacteria in the glands primarily usually near border of antrum and corpus. • infection by h. felis and h. pylori in some strains of mice results in inflammatory, dysplastic and eventually neoplastic changes. • proliferation of gut associated lymphoid tissue (galt), resembling human malt lymphoma, may occur in certain strains of mice (e.g. balb/c). • inflammation: non-helicobacter opportunists may colonize the achlorhydric rodent stomach (e.g. gastrin-deficient mice) and invoke a similar chronic inflammatory disease. comment: the progression from infection by h. pylori and h. felis to the formation of gastric adenocarcinoma in various mouse strains has been well described (rogers and fox, 2004; rogers and houghton 2009) . host immunity plays a crucial role in determining the outcome of gastric helicobacter infection. mouse strains such as c57bl/6 that mount a strong th1 responses to helicobacter infection demonstrate lower colonization but increased inflammation and hyperplasia/dysplasia compared to strains such as balb/c with th2 predominant responses (rogers and houghton 2009 ). silver stains e.g. wartin-starry can be used to confirm the presence of helicobacter in tissues section. pathogenesis: infection of the glandular stomach in compromised host, e.g. immunodeficiency. • presence of a layer of round yeast-like structures along the glandular stomach epithelial surface lining and in the gastric contents. • maybe be large numbers of yeasts or few. • budding maybe seen. • associated inflammation is usually not observed but may be seen. • stains with giemsa stain. • bacteria: do not show budding. • cryptosporidia: are more within or intergrated with the surface epithelium. comments: this infection appears to be rare histologically but may be more commonly found by culture (mackinnon 1959, savage and dubos 1967) . a variety of similar organisms have been reported in many species (kurtzman et al. 2005) . these organisms usually are not pathogenic but may be under specific conditions such as immunodeficiency. edema and hemorrhage of the stomach are similar to those described for the upper digestive tract. other vascular lesions in the stomach and mesentery are dealt with in the inhand monograph on the cardiovascular system. histogenesis: squamous epithelium of the nonglandular stomach. diagnostic features • proliferation and thickening of the stratum spinosum, often in association with a thickened keratin layer (parakeratotic or hyperkeratotic). • focal, multifocal or diffuse. • exophytic (papillary hyperplasia) or endophytic growth pattern. • papillary projections not or only minimally branched and without fibrovascular stroma. • broad-based hyperplastic foci might have multiple straight or minimally branched projections. • polarity of differentiation to keratinocytes is orderly and complete. • rete peg formation may be exaggerated, i.e. papillary body may show undulation due to enlarged germinal layers. • endophytic growth with cyst-like structures may occur; cysts lined by well-differentiated squamous epithelium and filled with keratin; may extend into the submucosa, but basement membrane is intact. • mitotic activity may be increased. • dysplasia of spinous and basal cells may occur. • reactive as a descriptive term: evidence for a primary irritating process, e.g. ulcer, irritating chemical, foreign material. • papilloma, squamous cell: papillary projection with a single and complex branching fibrovascular connective tissue core. • hyperplasia, basal cell: endophytic proliferation of basal cells; cytoplasm of proliferative cells is basophilic. • carcinoma, squamous cell: true invasion, i.e. lost basement membrane integrity; in the poorly differentiated type: lost polarity of differentiation to keratinocytes. comments: there may be a morphologic continuum from hyperplasia to papilloma and the distinction between severe hyperplasia and papilloma may in these cases be subjective. the squamous epithelium at the border of nonglandular and glandular stomach (limiting ridge) is generally thickened relative to the adjacent squamous mucosa. this area may be folded and, thus, cut tangentially or obliquely, if the stomach was not properly stretched prior to fixation. hyperkeratosis or parakeratosis alone should be distinguished from squamous hyperplasia. acanthosis is a synonym for hyperplasia of the squamous cell epithelium of the skin and should not be used in this organ. diffuse squamous cell hyperplasia is relatively common in oral gavage studies when the test article has an irritating potential. the modifier "reactive" should be used if proliferation of stratified squamous epithelium is associated with or secondary to local erosion, ulcer or inflammation. the absence of an ulcer or erosion in the plane of section does not preclude the presence of such in adjacent unexamined tissue. florid hyperplasia of the nonglandular stomach epithelium without evidence of cellular atypia can be completely reversible following the withdrawal of an inciting stimulus. nonglandular stomach carcinogens may induce dysplasia of spinous and basal cells, especially if the hyperplasia is a precursor to a papilloma or squamous cell carcinoma. squamous cell hyperplasia and basal cell hyperplasia may occur concurrently. this change has been observed in association with test article exposure (e.g. butylated hydroxyanisole) or chronic vitamin a deficiency (klein-szanto et al. 1982) . histogenesis: basal layer of the stratified squamous epithelium. • proliferation of the basal cell layer, basophilic staining increased. • focal or diffuse. • endophytic growth pattern. • no alteration of basement membrane integrity. • papillary body shows marked undulation but rete peg structure still present. • hyperplasia, squamous cell: thickening of the epithelium with all normally existing layers. • carcinoma, squamous cell: evidence for lost basement membrane integrity, spinous cells and keratinized cells proliferate, cellular atypia. • tumor, basal cell, benign: circumscribed proliferation of basal cells with loss of rete peg structure and leading to compression of surrounding tissue or prominent elevation of overlying epithelial layers. • tumor, basal cell, malignant: basal cells predominate, keratinization is absent, evidence for lost basement membrane integrity. comment: basal cell hyperplasia and squamous cell hyperplasia may occur concurrently. isolated nests of basal cells may occur in the lamina propria, dependent on the plane of section through the rete peg structures. however, their discrete border indicates an intact basement membrane. basal cell hyperplasia and dysplasia are more frequently associated with chemicals (e.g., butylated hydroxyanisole) that result in neoplasms of the nonglandular mucosa. dysplasia of basal cells, characterized by keratinization within the basal layer, may be observed. foci of basal cell hyperplasia may be found in the mucosa of the glandular stomach in the vicinity to the limiting ridge ( figure 49b and c). due to their similarity to basal cell hyperplasia of the nonglandular stomach and their specific location they are considered to originate from the nonglandular stomach. such lesions should be recorded under "nonglandular stomach, hyperplasia, basal cell". papilloma, squamous cell ( figure 72 ) histogenesis: stratified squamous epithelium. • solitary or multiple. • exophytic or endophytic (usually exophytic). • formation of a single complex branching fibrovascular core by exophytic tumors; the stroma typically forms secondary branches or finger-like projections which blend with the underlying lamina propria. • well-differentiated squamous cell layer (orderly maturation of the epithelium), often with prominent hyperkeratosis or parakeratosis. • penetration of muscularis mucosae is possible (papillomas extend into the submucosa), but no evidence for lost basement membrane integrity. • lack of cellular atypia. • mitotic figures are rare. • local inflammatory reactions are common (lymphocytic infiltrations in the stromal stalk). • hyperplasia, squamous cell: papillary projections are minimally branched at the most and lack a fibrovascular stromal stalk. • carcinoma, squamous cell: evidence for lost basement membrane integrity is obligatory; invading tumor cells generally with varying degrees of structural and cellular atypia. comment: there is a morphologic continuum from hyperplasia to papilloma and the distinction between severe hyperplasia and papilloma is sometimes subjective. also comparative diagnosis and distinction of well differentiated squamous cell carcinomas from papillomas may be difficult: the tumor tissue of papillomas may extend into the submucosa; a growth pattern suggestive of intact basement membranes and the lack of cellular and structural atypia distinguishes it from squamous cell carcinomas. invasive squamous cell carcinomas may have papillary lesions on their luminal surface. in carcinomas arising within papillomas, invasion of the fibrovascular connective tissue stalk is present. the spontaneous papilloma in the nonglandular stomach is a rare event in rats, but more common in mice and in some lines of genetically-engineered mice (sundberg et al. 1992 ). papillomas occur more often in gavage studies than with other routes of exposure. histogenesis: stratified squamous epithelium. • exophytic and/or endophytic growth pattern. • penetration of basal membrane by single cells or nests of neoplastic cells. • loss of cellular differentiation, anaplasia. • submucosa, muscle layer and serosa can be infiltrated. • well-differentiated type: nearly normal squamous epithelium with irregular structure of the papillary body, frequently showing foci with central hyperkeratinization (keratin pearls); in areas of invasion, predominance of polygonal and pleomorphic cells with varying degrees of keratinization. poorly differentiated type (anaplastic): solid sheets or strands of spindle cells leading to varying degrees of desmoplastic appearance; keratinization may be difficult to detect. • cells show varying size (frequently larger than normal) and shape; nuclei are hyperchromatic, enlarged and have prominent nucleoli. • mitotic figures may be numerous. • superficial ulceration and inflammation or fibroplasia of the lamina propria or submucosa are common features. • may metastasize to the abdominal cavity, regional lymph nodes, or the lung. • papilloma, squamous cell: no evidence of lost basement membrane integrity or invasion and no cellular atypia. • tumor, basal cell, benign or tumor, basal cell, malignant: exclusively endophytic growth pattern and a typical arrangement of the small basophilic basal cells in garlands or rows; poorly differentiated squamous cell carcinomas can have a prominent basal cell component but this is often associated with extensive invasion and a scirrhous response. • hyperplasia, squamous cell: no evidence of lost basement membrane integrity or of invasive growth although muscularis mucosae may be displaced; no evidence of cellular atypia. • hyperplasia, basal cell: can form round or oval clusters which extend into the underlying lamina propria; these clusters usually have discrete borders (suggestive of maintained basement membrane integrity) and no cellular atypia. comment: depending on the plane of section, it can be difficult to distinguish a well-differentiated carcinomas from a papilloma. papillomas may also extend into the submucosa and thereby displace the muscularis mucosa. the presence of carcinomatous foci in an otherwise benign appearing papilloma is indicative of malignancy (fukushima and ito, 1985; tsukamoto et al. 2007 ). in general, the lack of cellular atypia allows a distinction to be made. many squamous cell carcinomas in the nonglandular stomach are exophytic which can result in partial or total occlusion of the lumen. the exophytic portion can be papillary resembling papilloma. chemically-induced (e.g. butylated hydroxyanisole, 1,2-dibromo-ethane) squamous cell carcinomas may contain mostly basal or spindle cells with little squamous differentiation. these tumors are considered a morphological variant of the more typical squamous cell carcinoma. ultrastructurally, squamous cell carcinomas contain typical desmosomes and bundles of electron-dense tonofilaments. some chemicals especially when given by gavage cause highly malignant squamous cells carcinomas in rats which metastasize to the peritoneal cavity and lungs (olson et al. 1973) . histogenesis: basal layer of the stratified squamous epithelium. • endophytic growth pattern. • closely packed small or oval cells from the stratum germinativum forming garlands or nests with peripherally palisade-like cells. • loss of rete peg structure. • growth pattern suggests that basement membrane is intact. • compression of surrounding tissue or elevation of overlying epithelium which itself does not show neoplastic alteration. • no keratinization. • hyperplasia, basal cell: proliferation of basal cells with preservation of rete peg structure; no or only slight compression of surrounding tissue or elevation of overlying epithelial layers. • carcinoma, basal cell: growth pattern suggests that basement membrane integrity is lost. • carcinoma, squamous cell: growth pattern suggests that basement membrane integrity is lost, spinous cells and keratinized cells proliferate. comment: the absence of differentiation and therefore the predominant proliferation of the basal cell is a criterion for the basal cell tumor diagnosis. this tumor type is very rare, and no images were available at point of publication. synonym: carcinoma, basal cell histogenesis: basal layer of the stratified squamous epithelium. • endophytic growth pattern. • superficial layers almost normal, but sometimes ulcerated, while neoplastic basal cells infiltrate into the lamina propria of the mucosa and submucosa. • round to oval closely packed nonspinous cells with dark nuclei and little cytoplasm, often forming palisade-like garlands or chains. • keratinization generally absent. • growth pattern suggests that basement membrane integrity is lost. • frequent mitotic figures. • carcinoma, squamous cell: well differentiated squamous cell carcinomas with prominent keratinization; poorly differentiated variants can have a prominent basal cell component but this is generally associated with extensive invasion and a scirrhous response. • hyperplasia, basal cell: proliferation of basal cells with preservation of rete peg structure; no or only slight compression of surrounding tissue or elevation of overlying epithelial layers; growth pattern indicates that basement membrane integrity is maintained. • tumor, basal cell, benign: growth pattern indicates that basement membrane integrity is maintained. comment: the absence of differentiation and therefore the predominant proliferation of the basal cell is a criterion for the basal cell tumor diagnosis. this tumor type is very rare, and no images were available at point of publication. diverticulum (figures 75, 76, 77, 78, 79 and 88) synonyms: cystic adenomatous hyperplasia; diverticulosis; diverticulum, atypical, may have been identified as: atypical cystic hyperplasia; cystic hyperplasia with growth into the gastric wall; cystic adenomatous hyperplasia; herniation atypical; "pseudoinvasion", atypical; hamartoma, atypical pathogenesis: usually caused by mechanical or biochemical disruption of gastric wall structures resulting in loss of extracellular matrix integrity and internal projection of surface lining into deeper layers; may alternatively represent a congenital abnormality. • extension of glands through muscularis mucosae, into submucosa and further in some cases. • morphology of epithelial lining is variable, ranging from single layer cuboidal or columnar cells to complete mucosa. • epithelium may show features of regeneration like increased basophilia, increased nucleus-to-cytoplasm ratio and gradual loss of polarity, but atypia is minimal at the most. • basement membrane integrity is always maintained. • more often seen in the antrum of mice. • often accompanied by inflammation and regenerative / reparative processes. • may contain ingesta, hair, or other foreign material. cystic: • rounded cystic structures in lamina propria or deeper layers. • compression of surrounding tissue, some degree of compression atrophy of the epithelium lining the cyst. • may contain mucus. atypical: • extension of atypical/dysplastic mucosal glands into or through muscularis mucosa, submucosa, and deeper in some cases. • hyperplastic atypical (dysplastic) epithelial cells forming cystic glands that may appear to be "invading" into deeper layers of the stomach. • atypical change often focal in an otherwise normal appearing epithelium. differential diagnoses • adenoma: polypoid or papillary growth into gastric lumen obligatory, but pseudo-invasion into stalk may be seen. • adenocarcinoma: multiple layers of lining epithelium with varying degrees of dysplasia. true infiltrative growth with loss of basement membrane integrity and often with a scirrhous stromal reaction. comment: glandular diverticula of the stomach, frequently observed in mice (especially in genetically-engineered mice and in mice with chronic experimental gastric infections), may be associated with local mucosal defects (e.g. postulcerative repair), suggesting opportunistic expansion, but these have also been observed within submucosal veins in the absence of mucosal defects, suggesting there may be a vascular route of penetration from the mucosa. these structures are typically lined by a simple cuboidal mucus epithelium, which may have an antral or intestinal mucus phenotype that can be characterized by histochemical stains (e.g. alcian blue). these focal gastric lesions do not resemble diverticulosis in human colon which may be focal, multifocal or diffuse. they do not appear to be neoplastic, although they do create an increased risk of rupture and septic peritonitis. it is not recommended to record "diverticulum" (plus modifier) as a separate finding, if it occurs in association with another proliferative process (e.g. hyperplasia, adenoma). small glandular diverticula lined by a single layer of cuboidal or columnar epithelium resemble "crypt herniation" of human gastrointestinal pathology (e.g. rex et al. 2012) . such herniation of crypts through the muscularis mucosae is interpreted as "pseudoinvasive" or "inverted" growth pattern. although the process-related term "crypt herniation" is common in literature (e.g. betton et al. 2001) , the term "diverticulum" is considered to better fit to the inhand principle to use descriptive terms and to avoid process-related ones (mann et al. 2012) . also the misnomer "adenomatous diverticulum" has been used to describe these structures and the prefix "adenomatous" should be avoided. atypical diverticula must be distinguished from genuine neoplastic invasion (e.g. loss of basement membrane and other signs of malignancy in the latter). they are associated with preexisting mucosal atypical hyperplasia/dysplasia as seen under specific experimental conditions, tumor-associated gastric toxins, genetically-engineered mice and chronic helicobacter pylori infection (andersson et al. 2005; boivin et al. 1996; boivin et al. 2003; fernandez-salguero et al. 1997; miyoshi et al. 2002; rogers and houghton 2009 ). whereas they often do not progress to unequivocal adenocarcinoma, atypical glandular and cellular features are consistent with neoplastic potential. atypical diverticula may be associated with atypical hyperplasia and adenoma, but usually not with adenocarcinoma. as noted above for the simple diverticula, they should not be recorded as a separate diagnostic entity when associated with another proliferative process. synonyms: regenerative hyperplasia, focal hyperplasia, focal (mucosa), atypical may have been identified as: adenomatous hyperplasia, dysplasia, or gastric intraepithelial neoplasia (gin) histogenesis: glandular and/or surface epithelial cells. • focal or multifocal due to underlying injury (e.g. ulcer); mucosal defects/injury and inflammation may be observed in tandem with proliferative changes. • confined to the gastric mucosa. • no significant compression of adjacent tissue. • proliferation may be manifested as an increase in mucosal thickness or penetration of glands through the muscularis mucosae to the submucosa, tunica muscularis, or serosa forming cystic or glandular diverticula. these structures are typically lined by a simple cuboidal mucus epithelium. • with the exception of diverticula, no distortion of regular mucosal structure by the proliferative process itself. • may be associated with a reduction of parietal cells. • eosinophilic globules may be present in the epithelial cell cytoplasm. • mitoses may be increased. atypical: • abnormal structure of gastric glands. • focal penetration by glandular diverticula into lamina propria or deeper layers but basement membrane is always intact. • hyperchromatic foci with cellular atypia and pleomorphism. • loss of epithelial polarity. • adenoma: typically arise as singular foci in the distal antral/pyloric region, often with polypoid architecture. nodular (polypoid, papillary) lesions growing into the lumen of the stomach; distortion of glandular architec-ture and in case of non-papillary adenomas also compression of surrounding tissue. • adenocarcinoma: invasion of nests and cords of neoplastic cells into lamina propria or deeper layers, indicating loss of basement membrane integrity; cellular atypia. comment: focal hyperplasia may be accompanied by metaplasia of the mucus epithelium, characterized by a shift from a neutral mucin phenotype of the surface epithelium to an acidic antral or intestinal mucin phenotype. this may be associated with a reduction in parietal cells (atrophy) and a presumptive shift in local ph. distinct patterns of hyperplastic changes may arise in the glandular stomach because of the cellular complexity, regional differences in architecture, and selectivity of stimuli. focal atypical hyperplasia represents an altered proliferation of mucosal epithelium. it may be associated with chronic inflammation. an example is the helicobacter pylori mouse model. the lesion may progress into an adenoma or adenocarcinoma. although frequently considered as preneoplastic by nature, this needs to be proven in a given case in order to be classified as such. focal intra-epithelial atypical proliferations resembling morphologically an invasive adenocarcinoma have been found in specific genetically modified mouse lines and after chemical induction. they have been termed gastric intraepithelial neoplasia (gin). other terms occasionally used but not preferred as synonyms are microadenoma, carcinoma in situ, and intra-epithelial carcinoma. synonyms: regenerative hyperplasia diffuse; hypertrophic gastritis; mucosal hypertrophy histogenesis: glandular and/or surface epithelial cells. • may be diffuse within a specific regional zone (corpus, antrum, pylorus). • mitotic activity may be increased. • within a region of mucosa, thickening of the mucosa may affect the full thickness or may be compartmentalized within discrete glandular zones or cell types. • with increasing severity, basophilia, decreased epithelial differentiation, and structural disorganization may be observed. • metaplasia of the mucus epithelium may arise, characterized by a shift from a neutral mucin phenotype to an intestinal mucin phenotype. this may be associated with a reduction in parietal cells and a presumptive shift in local ph. • a cause may be evident (irritating substance, gavage material). • adenoma: nodular lesions growing exophytic (polypoid, papillary). comment: diffuse hyperplasia may be induced by chemicals (e.g. misprostal) or by larval (taenia taeniaeformis) infestation in the liver. the latter results in hypergastrinemia and diffuse glandular mucosal hyperplasia. the incidence of mitotic figures at the base of the gastric pit and the ratio of the lengths of the foveolus (gastric pit) to the deeper oxyntic region can be indices of proliferative activity; however, the latter will normally increase moving distally from the squamocolumnar junction. diffuse fundic hyperplasia is a common finding in aged mice, where it is often accompanied by degenerative changes like glandular cysts or diverticula. synonym: enterochromaffin-like (ecl) cell hyperplasia histogenesis: neuroendocrine cells of the gastric mucosa. the enterochromaffin-like (ecl) cell is the predominant neuroendocrine cell of the oxyntic mucosa. • focal: aggregates of neuroendocrine cells no greater than 3 glands in diameter. • growth pattern often polypoid, sessile, or papillary with or without a fibrovascular stalk; in polypoid adenomas of the antral mucosa, gland architecture may be retained. • focal penetration by glandular diverticula into lamina propria or deeper layers may be present but basement membrane is always intact. • cells are a basophilic, less differentiated glandular epithelium, but with little atypia; polarity is maintained. • epithelial nuclei are unilayered or organized with varying degree of stratification. • hyperplasia, focal (mucosal): linear mucosal orientation without polypoid or papillary architecture. • adenocarcinoma: infiltration as evidenced by penetration into lamina propria or deeper layers with a growth pattern indicative of lost basement membrane integrity; scirrhous stromal reaction. • tumor, neuroendocrine cell, benign: discrete intramucosal foci, which typically arise in hyperplastic areas in the oxyntic mucosa (i.e. corpus region). closely organized clusters of neuroendocrine cells with eosinophilic cytoplasm, separated by thin fibrovascular stroma. argyrophilic and characteristic immunohistochemical phenotype. comment: well-differentiated, hyperplastic glands may be entrapped in the adjoining lamina propria or submucosa, such structures originate from herniation of glands, are well demarcated, lack a scirrhotic stromal response and should not be interpreted as neoplastic infiltration. adenomas, as well as atypical hyperplasia, may exhibit some degree of dysplasia and distortion of pre-existing architecture. macroscopic visibility has been suggested as a differential diagnostic criterion by some authors. this criterion is not used in the context of this description of histologic criteria. any lesion exhibiting a papillary or polypoid growth pattern is an adenoma, irrespective whether it was grossly visible or not. an intra-epithelial small focus with cytological characteristics seen in adenomas should not be diagnosed as an adenoma but as atypical hyperplasia. an adenoma must possess a polypoid, sessile or papillary growth pattern, whether grossly visible or not. gastric adenomas are an uncommon observation in untreated rodents, but may be frequent in some genetically modified mouse strains miyoshi et al. 2002) . they are associated with specific mutations, which may be similar to those of humans with gastric polyps. • hyperplasia focal (mucosal): proliferation with maintained mucosal structure, except of glandular diverticula; no atypia in simple hyperplasia; in case of glandular diverticula, localized and discrete penetration into lamina propria or deeper layers with maintained basement membrane integrity and surrounded by pre-existing mature tissues lacking a scirrhotic stromal response. • hyperplasia focal (mucosal) atypical: limited to the mucosal lining, no infiltrative growth; focal penetration by glandular diverticula into lamina propria or deeper layers may be present but basement membrane always intact. • diverticulum: localized and discrete penetration into lamina propria or deeper layers with maintained basement membrane integrity and surrounded by pre-existing mature tissues lacking a scirrhotic stromal response. • adenoma: no infiltrative growth; focal penetration by glandular diverticula into lamina propria or deeper layers may be present but basement membrane always intact. ▪ tumor, neuroendocrine cell, malignant: typically arise in hyperplastic areas in the oxyntic mucosa (i.e., corpus region); closely organized clusters of neuroendocrine cells with eosinophilic cytoplasm, separated by thin fibrovascular stroma; argyrophilic and characteristic immunohistochemical phenotype. comment: gastric adenocarcinomas are uncommon spontaneous tumors in rodents, except of some genetically modified mouse strains. chemically-induced tumors in routine mouse/rat strains are not common except for induction by specific chemicals, e.g. n-methyl-n'-nitrosoguanidine, nmu, mnng in rats, while mice are more resistant (tsukamoto et al. 2007 ). the morphologic type may depend on the etiology / carcinogen. synonyms: enterochromaffin-like cell tumor; apudoma [apud = amine precursor uptake and decarboxylase]; intramucosal neuroendocrine cell tumor histogenesis: neuroendocrine cells of the gastric mucosa; the enterochromaffin-like (ecl) cell is the predominant neuroendocrine cell of the oxyntic mucosa. • discrete, well-demarcated aggregates of neuroendocrine cells, which may arise from hyperplastic areas in the oxyntic mucosa (i.e. corpus region). • size of the aggregates exceeds 3 gastric glands in diameter. • restricted to intramucosal involvement. • compression or necrosis of adjoining mucosa glands may be observed. • hyperplasia, neuroendocrine cell: scattered distribution of individual or small clusters of well-differentiated cells; discrete foci no more than 3 gastric glands in diameter. • tumor, neuroendocrine cell, malignant: infiltration through muscularis mucosae by neoplastic, often less differentiated cells arranged in cords or nodules or serosal deposits or distant metastases. • ectopic hepatocytes: absence of neoplastic behavior or cytologic alteration. absence of characteristic markers for neuroendocrine cells (e.g. argyrophilia, immunohistochemical profile). comment: neuroendocrine cell hyperplasia and neoplasia may be seen in response to hypergastrinemia following antisecretory drug treatment (spencer et al. 1989 ). fundic mucosal hyperplasia is usually also evident. small numbers of normal neuroendocrine cells can be observed in the submucosa and should not be categorized as neoplasia. synonyms: neuroendocrine carcinoma; carcinoid; enterochromaffin-like cell tumor; apudoma [apud = amine precursor uptake, decarboxylase]; intramucosal neuroendocrine cell tumor (benign) histogenesis: neoplastic transformation of neuroendocrine cells. • aggregates of neuroendocrine cells, which may arise from hyperplastic areas in the oxyntic mucosa (i.e., corpus region). • growth is intramucosal as nodules of pale staining or eosinophilic cells, sometimes with larger submucosal nodules. • infiltration through muscularis mucosae by neoplastic, often less-differentiated, cells arranged in cords or nodules. • metastasis to regional lymph nodes or liver may be present. • hyperplasia, neuroendocrine cell: scattered distribution of individual or small clusters of well-differentiated cells. discrete foci are less than 3 gastric glands in diameter. • ectopic hepatocytes: absence of neoplastic behavior or cytologic alteration. absence of characteristic markers for neuroendocrine cells (e.g. argyrophilia, immunohistochemical profile). comment: neuroendocrine cell hyperplasia and neoplasia may be seen in response to hypergastrinemia following antisecretory drug treatment (spencer et al. 1989 ). fundic mucosal hyperplasia is usually also evident. small numbers of normal neuroendocrine cells can be observed in the submucosa and should not be categorized as neoplasia. interlacing bundles and whorls of uniform spindle cells arranged in criss-cross pattern; blunt-ended, fusiform nuclei with hyperchromasia, pleomorphism, and high mitotic index; phosphotungstic acid-hematoxylin positive myofibrils. • schwannoma: cd117 negative, s-100 positive; indistinct cell borders, elongate cells with eosinophilic cytoplasm; nuclei sometime arranged in palisades (i.e., antoni a pattern). comment: gist will generally not be easily differentiated from leiomyomas / leiomyosarcomas or other soft tissue tumors. however, immunohistochemical differentiation of the different tumor types, including gist, needs to be performed in case of imbalances in the incidence of smooth muscle tumors in a given study. experimentally-induced gist in the glandular stomach of rats and a spontaneous gist in rat nonglandular stomach have been reported mukaisho et al. 2006 ). cecal gist have been identified in gem mice overexpressing a mutant kit (nakai et al. 2008 ). the question arises whether some conventionally diagnosed rodent stromal tumors (e.g., leiomyoma) were actually gist. synonyms: interstitial cajal cell tumor, malignant; gastrointestinal pacemaker cell tumor, malignant histogenesis: specialized smooth muscle cells (i.e. interstitial cells of cajal) in the tunica muscularis or myenteric plexus. • locally infiltrative growth pattern. • cells may be arranged in bundles with storiform architecture, myxoid areas may be present. • spindle, epithelioid, or pleomorphic cell morphology. indistinct cell borders and fibrillary cytoplasm. • spindle-or irregular-shaped nuclei. • typically cd117 positive (cytokine receptor encoded by c-kit). • distant metastases may be present. • gastrointestinal stromal tumor, benign: expansive growth pattern, no distant metastases. • leiomyoma: cd117 negative, desmin positive; interlacing bundles and whorls of uniform spindle cells arranged in criss-cross pattern; blunt-ended, fusiform nuclei, minimal nuclear pleomorphism; phosphotungstic acid-hematoxylin positive myofibrils. • leiomyoscarcoma: cd117 negative, desmin positive; interlacing bundles and whorls of uniform spindle cells arranged in criss-cross pattern; blunt-ended, fusiform nuclei with hyperchromasia, pleomorphism, and high mitotic index; phosphotungstic acid-hematoxylin positive myofibrils. • schwannoma: cd117 negative, s-100 positive; indistinct cell borders, elongate cells with eosinophilic cytoplasm; nuclei sometime arranged in palisades (i.e. antoni a pattern). comment: gist will generally not be easily differentiated from leiomyomas / leiomyosarcomas or other soft tissue tumors. however, immunohistochemical differentiation of the different tumor types, including gist, needs to be performed in case of imbalances in the incidence of smooth muscle tumors in a given study. experimentally-induced gist in the glandular stomach of rats and a spontaneous gist in rat nonglandular stomach have been reported mukaisho et al. 2006 ). cecal gist have been identified in gem mice overexpressing a mutant kit (nakai et al. 2008 ). the question arises whether some conventionally diagnosed rodent stromal tumors (e.g. leiomyoma) were actually gist. the small intestine in rodents, as in other mammals, is subdivided into duodenum, jejunum and ileum and is designed for the digestion and absorption of ingested products (treuting and dintzis, 2012) . the large intestine is composed of cecum, colon and rectum. the cecum is a large blind end sac with considerable fermentation potential. the colon has an ascending section, a short transverse section and a descending section leading to the rectum which terminates at the anus. all parts, except the terminal rectum, are connected to the body wall by the mesentery which functions as a conduit for vascular, lymphatic and nervous supply. the terminal rectum lies outside the pelvic cavity and consequently lacks a surrounding serosal membrane. very rarely, congenital developmental abnormalities can occur, e.g. intestinal duplication (elangbam et al. 1998) . such pathologic conditions that can be reliably diagnosed grossly are not covered by this monograph. histologically, the mucosa of the small intestine is composed of basal crypts (also known as crypts of lieberkuhn) and villi which extend into the lumen. the base of the crypt is lined by stem cells; the remainder of the crypt is composed of proliferating epithelial cells which either migrate up the villi as they differentiate into absorptive cells with microvilli or goblet cells, with a turnover time of about 3 days, or remain in the crypt and differentiate into paneth cells. the villous epithelium is composed of tall columnar cells with surface microvilli (the main absorptive cells), goblet cells containing mucus and scattered neuroendocrine cells covering a lamina propria composed of connective tissue with a rich vascular and lymphatic network. the lamina propria contains variable numbers of lymphocytes, macrophages, plasma cells, eosinophils and/ or mast cells whilst occasional intraepithelial lymphocytes can also be observed. paneth cells, which have an exocrine serous morphology and produce antimicrobial peptides, are present in higher numbers in the crypts of jejunum and ileum compared to the duodenum. brunner's glands, which produce a bicarbonate rich secretion, are present in the submucosa immediately following the pyloric-duodenal junction. villi in the duodenum are taller than those in jejunum and ileum. jejunum and ileum can be hard to differentiate in cross section except that the terminal ileum has two serosal attachments (mesentery and ligamentum ileocecale) compared to the single mesenteric attachment of the jejunum. with age, the duodenal villi tend to become shorter and thicker due to increased amounts of fibrous connective tissue in the core, whilst those in the ileum become longer probably related to reduced absorption in the proximal intestine resulting in greater amounts of nutrients passing into the distal intestine (shackelford and elwell 1999) . in the jejunum and ileum there are well defined aggrega-tions of lymphoid tissue (peyer's patches) located opposite the mesenteric attachment; these may show formation of germinal centers. similar aggregations are present in other parts of the gastrointestinal tract and are collectively referred to as gastrointestinal-associated lymphoid tissue (galt). villi are absent from the large intestine and instead the mucosa is thrown into transverse or longitudinal folds. in mice and rats the folds of the proximal colon have a distinctive spiral orientation. the mucosa is lined by a single layer of three cell types: absorptive cells, goblet (mucous) cells and neuroendocrine cells. there is a zone of proliferation in each gland and cells either migrate outwards and differentiate into absorptive or goblet cells or remain in the basal part of the gland as secretory cells. the turnover time of the absorptive and outer goblet cells is 4.6 days, that of the deep crypt secretory cells 14 to 21 days (karam 1999) . aggregates of lymphoid cells may be found in the mucosa and submucosa of all parts of the large intestine, but these are not limited to the antimesenteric aspect as in the small intestine. the mucosa in both small and large intestines is supported by the connective tissue of the lamina propria and the continuous muscle layer of the muscularis mucosa. beneath the muscularis mucosa is the relatively loose connective tissue of the submucosa which contains larger blood vessels, lymphatics and nerves and the tunica muscularis (also known as muscularis propria or muscularis externa). the external surface, except for the terminal rectum, is covered by the serosal membrane. the rectum also is enclosed by a notably thicker tunica muscularis. the enteric nervous system in the intestine is in the form of the submucosal and myenteric plexi, the latter being located between the longitudinal and circular layers of the tunica muscularis. the primary function of the small intestine is to complete the chemical digestion of food by pancreatic enzymes and bile salts and allow for efficient absorption of the products of digestion. the primary functions of the large intestine are to allow for further digestion by fermentation in the cecum, absorption of water, and temporary storage of waste material in the rectum before defecation. disease processes or test articles that interfere with these processes will often produce diarrhea. less commonly muscle function is compromised leading to impaction of rectum and colon and clinical constipation. the mucosa of the small intestine is a site of high enzyme activity and conjugation reactions and consequently orally administered test articles may be metabolized, activated or deactivated in the intestine. the galt plays a primary role in the defense of the body against invasion by micro-organisms in the food and those normally resident in the lumen. the small intestine is the primary site for absorption of test articles given orally so it must be carefully evaluated in safety evaluation studies. due to variations in morphology along the length of both small and large intestine it is important there is consistent sampling at necropsy and consistent orientation on the slide. the goreni trimming guide (website.reni.item. fraunhofer.de/reni/trimming) specifies the following sites for routine examination: 1) duodenum: 1 cm distal to the pyloric sphincter; 2) jejunum: central section; 3) ileum: 1 cm proximal to cecum; 4) cecum; 5) colon: central section; and 6) rectum: 2 cm proximal to the anus. for investigative studies involving induction of intestinal tumors, the entire intestine can be opened, lesion location and size recorded and individual tumors may be fixed for sectioning in additional to the 6 standard sections. alternatively the whole length of the intestine can be fixed using the swiss roll method. however, opening the intestine and washing away contents with normal saline brings the risk of damaging the delicate mucosa which degenerates quickly due to post mortem autolysis; tissue orientation may be less reliable during subsequent tissue trimming and blocking using this method. in addition, it is important to note the amount and quality of ingesta/digesta present in the segments of intestine sampled for histological examination as this may affect the height of the mucosa. attempts should be made at necropsy to sample peyer's patches (which are visible macroscopically) from the jejunum or ileum so that microscopic evaluation of galt can be undertaken on the routine section of small intestines. toxicological evaluation of the intestine should also include examination of the tunica muscularis and the submucosal and myenteric nerve plexi which occasionally show changes related to test article administration. ectopic tissue ( figure 99 ) pathogenesis: presence of pancreatic cells in the mucosa or submucosa. • normally formed pancreatic acini in mucosa or submucosa. islets of langerhans may also be present. • present near the site of mesenteric attachment. • none. comment: presence of ductular (biliary or pancreatic) tissue in the duodenal wall is a normal finding in the anterior duodenum (shackelford and elwell 1999) . cyst, squamous ( figure 100 ) pathogenesis: presence of a cyst(s) lined by squamous cells in the mucosa, muscularis or serosa. • cyst lined by keratinized stratified squamous epithelium. • lumen frequently contains keratinized material. • diverticulum, simple, cystic or diverticulum, atypical, cystic: lined by glandular epithelium; no keratin formation. comment: while squamous cysts are most likely to be of congenital origin they may potentially form secondary to derangement of the epithelium e.g. in an inflammatory process. squamous cysts been observed very occasionally in the muscularis of the colon and rectum of b6c3f1 mice (shackelford and elwell 1999) . they are thought to be associated with focal weakness or discontinuity of the muscularis resulting in herniation through the submucosa and mucosa to the serosa. if post-inflammatory extension is the suspected pathogenesis, the pathologist may choose to interpret the focal change as a diverticulum, rather than a congential cyst. atrophy, brunner's gland ( figure 101 ) pathogenesis: reduction in size and number of brunner's glands. • reduction in size and number of the acini that comprise the brunner's glands. • may be accompanied by an inflammatory reaction. • may be accompanied by fibrosis. • none. atrophy ( figure 102 ) pathogenesis: atrophy of the mucosa related to reduced mitotic capabilities. in the small intestine, there is a reduction in villus height and crypt length; in the large intestine there is a decrease in size and number of mucous cells leading to a reduction in mucosal thickness. • villi show reduced height but increased width. • reduced depth of crypts in small intestine and mucous glands in large intestine. • reduced mitotic rate and/or increased cell loss through apoptosis or necrosis. • epithelium loses normal regular arrangement and may be flattened, cuboidal or vacuolated in appearance. • dilatation: dilatation of the intestine by fluid or gas will reduce villous height and thickness of the large intestinal mucosa by mechanical means. • autolysis: preferential destruction and loss of cells at the tips of villi; no inflammatory reaction. • normal topography: villi overlying brunner's glands may be smaller/fewer than in neighboring areas of the duodenum. comment: villous atrophy can be induced by withdrawal of food, administration of antimitotic cytotoxic agents, secondary to chronic inflammation or following rotavirus infection (maekawa 1994; shackelford and elwell 1999; percy and barthold 2007; kramer et al. 2010; haschek et al. 2010 ). in addition, villous atrophy can be induced experimentally by hypophysectomy, thyroidectomy and in segments of surgically bypassed intestine (greaves 2012) . villous atrophy may be accompanied by other degenerative changes e.g. lipidosis (murgatroyd 1980) . villous and mucosal atrophy without damage to the underlying lamina propria or to the proliferative cell population is reversible. however, if there is a sustained effect on proliferation e.g. with cytotoxic agents, the atrophy will be followed by erosion/ulceration, hemorrhage and secondary infection. mucosal atrophy induced by agents that interfere with the spindle apparatus may also show nuclear abnormalities including karyomegaly. hypertrophy (figures 103 and 104) synonyms: hyperplasia mucosa diffuse pathogenesis: increased in height of villi and depth of crypts. • increased length of villi in the small intestine. • increased mucosal thickness in the large intestine. • increased mitotic activity may be observed. • artifacts: villi are longer in the duodenum compared to jejunum and ileum, so inconsistency of sampling at necropsy could lead to an erroneous diagnosis. comment: increased mucosal thickness or villous length reflects hyperplasia of all cellular elements. villous hypertrophy has been induced by test articles (e.g. alloxan, polychlorinated aromatics, thyroid mimetic test articles), and by hormonal changes e.g. lactation and hyperthyroid states (bertram et al. 1996; greaves 2012) . villous length can also be influenced by nutritional factors e.g. amount of dietary fiber (burkhardt et al. 1998) . pathogenesis: reduction in paneth cell granules and/or loss of paneth cells in small intestine. differential diagnosis • none; however, it is necessary to verify the location of the intestinal specimen because paneth cell density varies based on topography with considerably fewer cells present in the duodenum. comment: recent literature identifies paneth cells as particularly sensitive targets of endoplasmic reticulum stress responses and disruption of their function is a risk factor in inflammatory bowel disease (ouellette 2010) . reduction in paneth cells is observed in norovirus infection in certain transgenic mice strains (cadwell et al. 2010) . pathogenesis: enlargement of paneth cells in small intestine. • hypertrophic paneth cells. • may accompany villous atrophy. • paneth cell hyperplasia may also be present. differential diagnosis • none. comment: hypertrophy and hyperplasia of the paneth cells, accompanying villous atrophy, were induced experimentally by surgical isolation of ileal loops (keren et al. 1975) . pathogenesis: presence of paneth cells in the large intestinal mucosa. differential diagnosis • none. comment: in colitis induced by the administration of dextran sodium sulphate and 1,2-dimethylhyadrazine, paneth cell metaplasia occurred 4 weeks after induction of inflammatory lesions (imai et al. 2007 ) paneth cells showed increased expression of ß-catenin (imai et al. 2007 ). paneth cell differentiation is also seen in tumors that develop in this model. accumulation of intracytoplasmic lipid in villous epithelial cells has been reported with several xenobiotics, including glucose transport inhibitors, puromycin, ethionine and vanadium compounds which alter lipid synthesis or transport (murgatroyd 1980; greaves 2012; imura et al. 2013) . in addition, lipid droplets were described where an ester of erythromycin was administered and the compound appeared to be absorbed unhydrolysed and converted to chylomicron-like droplets which accumulated in macrophages (visscher et al. 1980) . a fine cytoplasmic vacuolation, resulting in foamy appearance, may give the suspicion of phospholipidosis. in such cases, the modifier "foamy" should be used. if the change reflects phospholipidosis, increases in size and number of lysosomes can be identified by histochemistry (for alkaline phosphatase), immunostains (for lysosomal membrane proteins, e.g. lamp-2) or by transmission electron microscopy. with the later technique, concentric multilaminated structures (myeloid bodies/lamellar bodies) are observed in the lysosomes. the term phospholipidosis should only be used when confirmation by one of these techniques has been achieved. in the intestines, changes due to phospholipidosis are most commonly observed in macrophages, but epithelial cells, myocytes and neuronal ganglia can also be affected depending on the particular cellular distribution of the test article (reasor et al. 2006) . affected cells will probably be present in other organs and tissues of the body, but the intestines are likely to be one of the more severely affected sites following oral administration of a phospholipidosis-inducing test article (mazue et al. 1984) . the intestines can also be affected following intravenous administration of such test articles depending on the tissue distribution of the test article in the body. the classical definitive diagnostic feature is the identification of lysosomal lamellar bodies by electron microscopy, but immunohistochemical staining for lysosomal membrane proteins can clearly distinguish lysosomes from neutral fat vacuole membranes stained immunohistochemically for adipophilin (obert et al. 2007 ). pathogenesis: degeneration/necrosis of brunner's glands. • degeneration and necrosis of epithelial cells. • disorganisation of gland acini with disruption of basement membranes. • glands may be dilated and lined with flattened, atrophic epithelial cells. • accompanied by an inflammatory reaction. • may be accompanied by reactive hyperplasia of the duodenal epithelium. • atrophy, brunner's glands: reduction in size and number of cells is present but necrosis and inflammation are absent. comment: degeneration/necrosis of brunner's glands in rats has been described following administration of receptor tyrosine kinase (rtk) inhibitors directed against vascular endothelial growth factor (vegf) (inomata et al. 2014) . degeneration and necrosis of the glands is followed by disruption of the basement membrane leading to dilation of the glands and a neutrophilic inflammatory reaction. in the most severe lesions, inflammation extends into the surrounding mucosa and muscle layers. with more prolonged administration, dilated brunner's glands lined with flattened atrophic epithelium are observed and these may form cystic spaces which can extend into the muscle layers. a mixed neutrophilic and lymphocytic inflammatory reaction with fibrosis and reactive hyperplasia of neighbouring duodenal epithelium accompanies these brunner's gland changes after prolonged administration. lymphangiectasis ( figure 110 ) pathogenesis: lacteals are dilated with lipid. • dilated lacteals are present in the villi. • subcapsular sinuses of the mesenteric lymph node may also be dilated. • may be accompanied by minimal vacuolation of epithelial cells and/or macrophages in the lamina propria. differential diagnosis • none. comment: lymphangiectasis may be primary, due to a metabolic alteration affecting the formation of chylomicrons or transit of lipid in the lacteals, or secondary to blockage or inflammatory conditions e.g. neoplasia, fibrosis, granulomatous infections. lymphangiectasis in the small intestine due to the accumulation of large lipid droplets was described in rats administered indole-3-carbinol, possibly due to an impairment of lipid transport in the lacteals (boyle et al. 2012) . although there were vacuolated macrophages and giant cells in the lamina propria, the epithelial cells were unaffected (boyle et al. 2012) . pathogenesis: distrubance of cell division (cytokinesis), e.g. after infection by enterotropic strains of mouse hepatitis virus (mhv), a coronavirus. • formation of enterocyte syncytia (balloon cells occasionally containing eosinophilic intracytoplasmic inclusions). • villous atrophy and mucosal necrosis also present, particularly in young mice. differential diagnosis • none. comment: epithelial syncytia are common in mhv infection and mhv infection should be considered as an etiological agent when epithelial syncytia are observed. with enterotropic mhv strains lesions are limited to the intestines and are generally located in ileum, cecum and proximal colon (percy and barthold 2007; shackelford and elwell 1999) . lesions are most severe in young mice and are limited to syncytia in adult mice. compensatory hyperplasia of the intestinal epithelium develops in mice that survive the infection. with respiratory strains, enteric lesions are rare with infection largely restricted to galt. pathogenesis: gene regulated, energy dependent process leading to formation of apoptotic bodies which are phagocytosed by adjacent cells. • single cells or small clusters of cells. • necrosis, mucosa: the morphologic features of cell death clearly fit with necrotic diagnostic criteria (cells and nuclei swollen, pale cytoplasm etc.). • apoptosis/necrosis, mucosa: both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. the term is also used when the type of cell death cannot be determined unequivocally. • erosion/ulcer: focal or focally extensive penetration of the mucosa, either partial (erosion) or full to the muscularis mucosa (ulcer). the approach for the nomenclature and diagnostic criteria of cell death applied here is based on a draft recommendation of the inhand cell death nomenclature working group. apoptosis is not synonymous with necrosis. the main morphological differences between these two types of cell death are cell shrinkage with nuclear fragmentation and tingible body macrophages in apoptosis versus cell swelling, rupture and inflammation in necrosis; however, other morphologies (e.g. nucelar pyknosis and karyorrhexis) overlap. in routine h&e sections where the morphology clearly represents apoptosis or single cell necrosis, or whereby special procedures (e.g. tem or ihc for caspases) prove one or the other, individual diagnoses may be used. however, because of the overlapping morphologies, necrosis and apoptosis are not always readily distinguishable via routine examination, and the two processes may occur sequentially and/or simultaneously depending on intensity and duration of the noxious agent (zeiss 2003) . this often makes it difficult and impractical to differentiate between both during routine light microscopic examination. therefore, the complex term apoptosis/necrosis may be used in routine toxicity studies. a differentiation between apoptosis and single cell necrosis may be required in the context of a given study, in particular if it aims for mechanistic investigations. transmission electron microscopy is considered to represent the gold standard to confirm apoptosis. other confirmatory techniques include dna-laddering (easy to perform but insensitive), tunel (false positives from necrotic cells) or immunohistochemistry for caspases, in particular caspase 3. these techniques are reviewed in detail by elmore (2007) . some of these confirmatory techniques detect early phases of apoptosis, in contrast to the evaluation of h&e stained sections, which detects late phases only; overall interpretation of findings should take into account these potential differences. thus, low grades of apoptosis may remain unrecognized by evalu-ation of h&e stained slides only. certain studies may require the consideration of forms of programmed cell death other than apoptosis which requires specific confirmatory techniques (galluzzi et al. 2012) . synonyms: oncotic cell death; oncotic necrosis; necrosis pathogenesis: unregulated, energy independent, passive cell death with leakage of cytoplasm into surrounding tissue and subsequent inflammatory reaction; may be induced by direct contact with a test article after oral uptake/administration. • cells swollen with pale eosinophilic cytoplasm. • loss of nuclear basophilia, pyknosis and/or karyorrhexis that affects aggregates of cells. • in more severe cases, there may be detachment of the epithelium from the submucosa. • typically, the presence of degenerative cells is a component of necrosis. • minimal or slight inflammatory cell infiltrates may be present as a feature of necrosis. single cell • only single cells affected. • apoptosis: the morphologic features of cell death clearly fit with apoptosis (cell and nucleus shrunken, hypereosinophilic cytoplasm, nuclear pyknosis etc.) and/or special techniques demonstrate apoptosis. • apoptosis/necrosis, mucosa: both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. the term is also used when the type of cell death cannot be determined unequivocally. • atrophy, mucosa: reduced thickness of all layers of the squamous epithelium or, in severe cases, absence of basal germinative layers; usually no cellular degeneration or necrosis. • erosion/ulcer: focal or focally extensive penetration of the mucosa, either partial (erosion) or full to the muscularis mucosa (ulcer). comments: epithelial necrosis usually develops into erosion/ ulcer and in the past has frequently been recorded as such. a separate recording of necrosis as the initial event in this process is recommended when the structure of the mucosa is still intact. synonym: cell death pathogenesis: unregulated, energy independent, passive cell death with leakage of cytoplasm into surrounding tissue and subsequent inflammatory reaction (single cell necrosis) and/or gene regulated, energy dependent process leading to formation of apoptotic bodies which are phagocytosed by adjacent cells (apoptosis). • both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. • the type of cell death cannot be determined unequivocally. • apoptosis: the morphologic features of cell death clearly fit with apoptosis (cell and nucleus shrunken, hypereosinophilic cytoplasm, nuclear pyknosis etc.) and/or special techniques demonstrate apoptosis and there is a requirement for recording apoptosis and necrosis separately. • necrosis, mucosa: the morphologic features of cell death clearly fit with necrotic diagnostic criteria (cells and nuclei swollen, pale cytoplasm etc.) and there is a requirement for recording apoptosis and necrosis separately. • erosion/ulcer: focal or focally extensive penetration of the mucosa, either partial (erosion) or full to the muscularis mucosa (ulcer). comments: necrosis and apoptosis are not always readily distinguishable via routine examination, and the two processes may occur sequentially and/or simultaneously depending on intensity and duration of the noxious agent (zeiss 2003) . this often makes it difficult and impractical to differentiate between both during routine light microscopic examination. in these cases, the combined term apoptosis/necrosis may be used. it is recommended to explain in detail the use of this combined term in the narrative part of the pathology report. erosion/ulcer (figure 114 and 124) pathogenesis: localized loss of mucosa with either partial mucosal penetration (erosion) or with full penetration of the mucosa to the muscularis mucosa (ulcer). • epithelial cells are necrotic or absent but muscularis mucosa is intact (erosion). • epithelial cell are necrotic or absent and muscularis mucosa has been destroyed (ulcer). • submucosal edema may be present, particularly with ulceration. • hemorrhage and hemosiderin may be present, particularly with ulcers. • epithelial cells adjacent to an erosion or ulcer may be necrotic, cuboidal to flat or basophilic. • inflammatory cell infiltration is present, except in recently formed lesions. • chronic lesions will show chronic inflammatory cell infiltration, granulation tissue, fibrosis and regenerative epithelial hyperplasia which results in irregular, cystic glands in the mucosa and submucosa. • artifact: mechanical loss of mucosa during necropsy; plane of section related to presentation of tissue in block. • autolysis: preferential destruction and loss of cells at the luminal surface; no inflammatory reaction. the most likely cause of erosions and ulcers in immunocompetent barrier maintained rodents is the administration of xenobiotics (greaves 2012) . acute erosion and ulceration of the distal small intestine has been described following administration of non-steroidal anti-inflammatory agents, the newer inhibitors of cyclooxygenase 2 (cox-2) and cytotoxic anticancer drugs, whereas ionizing radiation produces acute lesions followed by fibrosis and arteriolar sclerosis (langberg and hauer-jensen 1996; haschek et al. 2010) . a variety of agents e.g. cysteamine, proprionitrile and 1-methy-4-pheny-1,2,3,6-tetrahydropyridine (mptp) are capable of producing chronic ulcers in the duodenum possibly by altering gastric acid secretion, bicarbonate production and its delivery to the duodenum, changes in duodenal motility and/or dopamine inhibition (szabo and cho 1988) . some viral and bacterial infections may induce erosion and ulceration, particularly in immunodeficient mice or rats (haines et al. 1998 ). erosion/ulcer usually is the result of epithelial necrosis. because of its unique topography adjacent to the lumen and often involving multiple organ layers, which uniquely affects the progression and resolution of the lesion (e.g. margin hyperplasia, granulomatous tissue, inflammation), it is useful to record erosion/ulcer separately from epithelial necrosis. pathogenesis: extracellular deposits of polypeptide fragments of a chemically diverse group of glycoproteins, in various tissues including intestinal mucosa. • deposition of pale amorphous, homogenous eosinophilic material. • extracellular location in connective tissue and/or blood vessel walls. • green birefringence with congo red stain when viewed under polarized light. • hyaline connective tissue: congo red negative. • fibrinoid necrosis of blood vessels: other evidence of tissue damage in section. comment: amyloidosis is extremely rare in rats but common in some strains of mice in which the lamina propria of the intestinal villi is a common site for deposition of amyloid. in susceptible strains of mice a number of factors including sex, diet, housing conditions, stress, endocrine status and microbiological status can influence the occurrence of amyloidosis (korenaga et al. 2004; lipman et al. 1993) . for as yet unidentified reasons the previously susceptible cd-1 strain in europe now rarely develops amyloidosis. the characteristic morphologic appearance and location of amyloid in h&e sections that is usually adequate to make this diagnosis. confirmation of the deposits as amyloid can be accomplished with light microscopy using special stains such as congo red. amyloid appears apple green under polarized light with this stain. the term "hyaline" should be used in case of uncertainties about the nature of extracellular deposits hyaline material in h&e sections and the unavailability of a congo red stain. hyaline is also the appropriate term for homogenously eosinophilic extracellular deposits that react negative with congo red. mineralization ( figure 116 ) pathogenesis: deposition of mineral in muscle, fibrous or elastic tissues secondary to necrosis (dystrophic mineralization) or hypercalcemia (metastatic mineralization). • mineral may be found in muscle layers, blood vessels, basement membranes and/or in the interstitium of mucosa and submucosa. • amorphous basophilic material. • mucosal mineralization can be limited to small focal deposits. • artifact: hematoxylin stain precipitate. • bacteria: colonies of bacteria may be confused with mineral due to their basophilic staining. ante mortem bacterial invasion will be accompanied by necrosis and usually inflammation; postmortem bacterial invasion will be accompanied by autolysis. • osseous metaplasia: osteoid present. comment: presence of mineral can be confirmed with von kossa or alizarin red stains but these are rarely needed to make a diagnosis. diffuse superficial mineralization of the colonic and rectal mucosa has been observed following administration of xenobiotics that decrease peristalsis and cause fecal retention (gopinathet al. 1987) . multifocal or diffuse mineralization occurs secondary to chronic renal disease in rodents and in situations where serum calcium and/or phosphate balance are perturbed, but the intestines are not as susceptible as the glandular mucosa of the stomach. (figure 117 ) pathogenesis: presence of osteoid. • presence of mineralized or non-mineralized bone matrix. • mineralization: osteoid absent. • sarcomas: osseous metaplasia may be present in stroma of sarcomas. comment: osseous metaplasia has been described in the submucosa and lamina propria of old rats in association with chronic inflammation, ulceration or regenerative hyperplasia (elwell and mcconnell 1990; maekawa 1994; bertram et al. 1996) . dilatation ( figure 118 ) synonyms: dilation, megaileus; cecomegaly; megacolon pathogenesis: dilatation of the lumen due to a defect in neuromuscular function. • dilatation of the lumen is observable macroscopically. • mucosa, submucosa and muscularis are thin due to stretching. • degeneration of muscle fibers and ganglia cells in the nerve plexus may be present. • meteorism: dilatation of the lumen due to the accumulation of air occurs as the result of mouth breathing and consequent aerophagia follows obstruction of nasal turbinates and/or nasopharynx in rodents as they are obligate nose breathers; the stomach will be more severely affected than the intestines. • obstruction: dilatation of the lumen due to simple mechanical obstruction e.g. proximal to a tumor. comment: megaileus with inflammation (megaileitis) is often present in rats with tyzzer's disease (infection with clostridium piliforme); the lesions are characterized by a necrotizing transmural ileitis with necrosis of the mucosa and muscularis, edema and infiltration primarily of mononuclear cells (percy and barthold 2007) . cecomegaly is observed following administration of some antibiotics, starches, polyols, lactose, fibers and vehicles which have an osmotic effect (newberne et al. 1988 ). megacolon as a result of constipation was induced in rats by a calcium channel antagonist; secondary mucosal necrosis, hemorrhage and inflammation were present in some rats (nyska et al. 1994) . tribromoethanol (avertin) administered intraperitoneally as an anesthetic has been associated with ileus in rodents (king and russell 2006) . figure 119 ) pathogenesis: invagination of a one portion of intestine into its immediate distal section ('telescoping'). • observable macroscopically. • invagination of a portion of intestine into its immediate distal section. • intestinal lumen proximal to the site of intussusception may be dilated whilst distally the lumen may be contracted and devoid of contents. • histologically ischemic necrosis, inflammation, congestion and hemorrhage will often be present in the involved segments; the degree of such changes will depend on the length of time that the intussusception has been formed. • adhesions may develop between the invaginating intussusceptum and the receiving intussuscipiens. • associated with intestinal tumors, especially polyps. • artifacts, post mortem invagination of the intestine: no reactive changes present. comment: intussusceptions are very rare in barrier maintained rodents but may occur in animals with intestinal tumors and rarely with high nematode infestations (percy and barthold 2007) . very occasionally an intussusception may be induced by a test article (gopinath et al. 1987 ). although intussusception is primarily a gross pathological term, it is recommended to use it also microscopically, as an unequivocal macroscopic diagnosis is not always possible. pathogenesis: eversion of rectum through the anus. • observable macroscopically. • eversion of rectum through the anus. • microscopic lesions of mucosal necrosis, hemorrhage, edema and inflammation. differential diagnosis • none. comment: rectal prolapses are rare in barrier maintained rodents but may occur secondarily to inflammatory conditions in the colon and rectum such as occur with citrobacter and helicobacter infection in mice, weakening of anal sphincter and with a high nematode load percy and barthold 2007; mcinnes 2012; miller et al. 2014 ). the diagnosis of prolape is usually possible by gross pathological examination. nevertheless it is recommended to confirm the gross observation histopathologically. infiltrate ( figure 123 ) • inflammation: other morphologic features of inflammation such as edema, hemorrhage, necrosis and/or fibroplasia will be present. • granulocytic leukemia: infiltration of neutrophil precursors and/or abnormal neutrophils will probably be present along with mature neutrophils; infiltration of similar neoplastic cells is likely present in other organs. • lymphoma: infiltration of monomorphic population of lymphocytes (often with atypical, increased and/or abnormal mitoses); infiltration of similar neoplastic cells is likely present in other organs. comment: the number of mononuclear cells is the lamina propria of the large intestine (particularly cecum) is variable in healthy animals and care must be taken not to 'over diagnose' infiltration of inflammatory cells. modifiers: type of inflammatory cell that represents the predominant cell type in the inflammation pathogenesis: infiltration of the lamina propria and/or submucosa with neutrophils (inflammation, neutrophil) or mononuclear cell (inflammation, mononuclear cell) or a combination (inflammation, mixed) with additional histological features of inflammation e.g. hemorrhage, edema, fibroplasia. diagnostic features • focal, multifocal or diffuse infiltration of cells in the lamina propria and/or submucosa. • presence of other histological criteria of inflammation e.g. hemorrhage, edema, fibroplasia. • infiltrate, inflammatory cell: other morphologic features of inflammation such as edema, hemorrhage, necrosis and/or fibroplasia will be absent. • granulocytic leukemia: infiltration of neutrophil precursors and/or abnormal neutrophils will probably be present along with mature neutrophils; infiltration of similar neoplastic cells is likely present in other organs. • lymphoma: infiltration of monomorphic population of lymphocytes (often with atypical, increased and/or abnormal mitoses); infiltration of similar neoplastic cells is likely present in other organs. features of specific bacterial and viral infections have been discussed in the previous sections. nematode and protozoa are dealt with separately below. pathogenesis: presence of protozoan or nematode parasitess in the intestinal lumen. • presence of cross sections of protozoa in large intestinal lumen; morphology will depend on whether ameboid, ciliate or flagellates are present. • inflammatory cell infiltration and/or edema may be present in lamina propria. nematodes • presence of cross sections of parasites in large intestinal lumen. • rarely submucosal granulomata may be present. • none. comment: it is now uncommon for intestinal parasites to be present in barrier-reared and maintained rodents. protozoa that have been reported in laboratory rodents include spironucleus muris, giadia muris and cryptosporidia muris, but infections are often subclinical especially in adults of immunocompetent strains (percy and barthold 2007) . the reader is referred to standard texts for a full list of intestinal protozoan that may be present in non-barrier maintained or wild rodents (percy and barthold 2007; baker 2007) . the most likely nematodes to be seen in the event of a barrier break down in a rodent unit are the pinworms syphacia muris, syphacia obvelata and/or aspicularis tetrapertera which inhabit the large intestine (percy and barthold 2007) . the reader is referred to standard texts for a full list of intestinal parasites that may be present in non-barrier maintained or wild rodents (percy and barthold 2007; baker 2007) . histogenesis: degenerative changes in neurons of the myenteric/submucosal plexi. differential diagnosis • none. the degenerative changes and inclusions have only been seen with flaviviral infections (ward, personal observation). viral antigen is abundant in these ganglion cells. edema and hemorrhage of the intestine are similar to those described for the upper digestive tract. other vascular lesions in the intestine and mesentery are dealt with in the inhand monograph on the cardiovascular system. diverticulum (figures 122, 129, 130 and 131) synonyms: cystic adenomatous hyperplasia; diverticulosis; herniated crypt; crypt herniation diverticulum, atypical, may have been identified as: atypical cystic hyperplasia; cystic hyperplasia with growth into the gastric wall; cystic adenomatous hyperplasia; herniation, atypical; "pseudoinvasion", atypical pathogenesis: usually caused by mechanical or biochemical disruption of intestinal wall structures resulting in loss of extracellular matrix integrity and internal projection of surface lining into deeper layers; may alternatively represent a congenital abnormality. • extension of crypts through muscularis mucosa, into submucosa and further in some cases. • morphology of epithelial lining is variable, ranging from single layer cuboidal or columnar cells to complete mucosa. • epithelium may show features of regeneration like increased basophilia, increased nucleus to cytoplasm ratio and gradual loss of polarity. • basement membrane integrity always maintained. • often accompanied by inflammation and regenerative / reparative processes. • may contain ingesta, hair, or other foreign material. cystic: • rounded cystic structures in lamina propria or deeper layers. • compression of surrounding structures, some degree of compression atrophy of the epithelium lining the cyst. • may contain mucus. • extension of atypical/dysplastic mucosal glands into or through muscularis mucosa, submucosa, and deeper in some cases. • hyperplastic atypical (dysplastic) epithelial cells forming cystic glands that may appear to be "invading" into deeper layers of the intestine. • basement membrane always intact. • adenoma: proliferation beyond the confinements of the intestinal mucosa. • adenocarcinoma: true infiltrative growth with loss of basement membrane integrity and often with a scirrhous stromal reaction. comment: these focal intestinal lesions are primarily formed by extensions of mucosal epithelium and do not involve evaginations of the other mural layers; as such they do not resemble diverticulosis in human colon, which may be focal, multifocal or diffuse. diverticula do not appear to be neoplastic, although they do create an increased risk of rupture and septic peritonitis. these structures are typically lined by a simple cuboidal mucus epithelium. it is not recommended to record "diverticulum" and its modifier as a separate finding, if it occurs in association with another proliferative process (e.g. hyperplasia, adenoma). small glandular diverticula lined by a single layer of cuboidal or columnar epithelium resemble "crypt herniation" of human gastrointestinal pathology (e.g. rex et al. 2012) . such herniation of crypts through the muscularis mucosa is interpreted as "pseudoinvasive" or "inverted" growth pattern. although the process-related term "crypt herniation" is common in literature (e.g. betton et al. 2001) , the term "diverticulum" is considered to better fit to the inhand prin-ciple to use descriptive terms and to avoid process-related terms (mann et al. 2012 ). spontaneous and induced intestinal diverticula occur more frequently in mice than in rats. they have been reported in the colon of cdx-2 knockout mice due to a developmental defect (tamai et al. 1999) . in this model they appeared as polyps with herniation and due to the congenital etiology the authors termed it hamatoma. atypical diverticula must be distinguished from genuine neoplastic invasion (e.g. loss of basement membrane and other signs of malignancy in the latter). they are associated with preexisting mucosal atypical hyperplasia/dysplasia as seen in specific experimental conditions, tumor-associated intestinal toxins and genetically-engineered mice. whereas they often do not progress to unequivocal adenocarcinoma, atypical glandular and cellular features are consistent with neoplastic potential. atypical diverticula may be associated with atypical hyperplasia and adenoma, but usually not with adenocarcinoma. as noted above for the simple diverticula, they should not be recorded as a separate diagnostic entity when associated with another proliferative process. synonyms: hyperplasia, regenerative synonyms for atypical hyperplasia may include dysplasia, gastrointestinal intraepithelial neoplasia (gin, mice), early neoplastic lesion, atypical crypts, dysplastic crypts, dysplastic foci, or aberrant crypt foci. histogenesis: enterocytes of the intestinal mucosa. • focal or diffuse process accompanying epithelial damage; no evidence of compression. • villous and glandular architecture is not altered by the proliferative process itself but in regenerative hyperplasia may have been altered by the initiating event (degeneration and necrosis). • focal penetration by glandular diverticula into lamina propria or deeper layers may be present but basement membrane is always intact. • no cellular or nuclear atypia. • focal lesion of the duodenum in aging mice. • smooth luminal surface lacking intestinal villi. • hyperplastic crypts may often be interspersed between hyperplastic brunner's glands. • goblet cells may be reduced or increased. • crypt dilatation and diverticula may be present in larger lesions. • frequently accompanied by submucosal edema and inflammatory cell infiltration. propria or deeper layers may be present but basement membrane is always intact. • cellular atypia and pleomorphism as evidenced by hyperchromatism with increased cytoplasmic basophilia and lost polarity, nuclear pleomorphism, increased n/c ratio, hyperchromasia, increased mitotic activity. goblet cell: • increased proportion of goblet cells, predominantly in crypts; crypts exhibit normal length or are enlaged. differential diagnosis • adenoma: exophytic or endophytic growth pattern extending beyond the confinement of the mucosa; compression of adjacent tissue if growth pattern is not exclusively polypoid. comment: reactive or reparative (regenerative) hyperplasias often follow injury due to chemicals, infectious agents and irradiation. focal or diffuse reactive hyperplasia is seen in the cecum, colon and rectum of immuno-compromised mice following helicobacter infection. diffuse reactive hyperplasia is observed in the distal colon of mice infected with the gram negative bacterium citrobacter freundii (transmissible murine colonic hyperplasia). occasionally the transverse and ascending colon and the cecum are affected. in such cases of hyperplasia the surface epithelium is covered by myriads of cocobacillary bacteria. the lamina propria shows diffuse leukocytic infiltration. diffuse non-reactive hyperplasia of the mucosa with increased height of the villi and depth of the crypts is synonymous with hypertrophy, mucosa. hypertrophy is the recommended term for such lesions. an increased proportion of goblet cells has been reported in the literature as both goblet cell hyperplasia or metaplasia. we recommend the term hyperplasia, as goblet cells are normal constituents of the intestinal mucosa. hyperplasia of goblet cells has been induced in the small and large intestine of rats by treatment with a gamma secretase inhibitor (aguirre et al. 2014). focal hyperplasia of the proximal duodenum, adjacent to the pylorus, occurs in aged mice has been referred to in the literature as avillous hyperplasia (facinni, et al. 1990; mc-innes 2012) . it may be visible macroscopically as a thickened plaque and is characterised by hyperplasia of all cells in the epithelium including brunner's glands, but with loss of villi. the epithelium can show erosion/ulcer formation with associated inflammation. in the more severe cases dilated mucosal glands can extend towards the submucosa and be interspersed with dilated brunner's glands. focal atypical hyperplasia is a frequent finding in mice treat-ed with test articles which affect the intestinal mucosa or in genetically-engineered mice. under such conditions they often occur in multiple foci. it has not been described in untreated wild type animals so far. the term gin or dysplasia has been used in genetically-engineered mice. other terms occasionally used but not preferred as synonyms are microadenoma, carcinoma in situ, intra-epithelial carcinoma. dysplasia is often used for similar lesions in human colon (bosman et al. 2010 ). colon crypts exhibiting focal atypia ("aberrant crypt foci") can be demonstrated by the examination of methylene blue stained colon whole mounts with a dissecting microscope (raju 2008) . they are usually not seen grossly until 1 mm in size. atypical hyperplasia may be low-grade to high-grade, but this grading is usually not included in the diagnosis. under conditions of experimental intestinal carcinogenesis, focal atypical hyperplasia is considered as a preneoplastic lesion that may progress to an adenoma or adenocarcinoma. rectal prolapse often due to helicobacter sp or citrobacter sp infection, often shows severe degrees of simple hyperplasia, atypical hyperplasia and the appearance of a invasivelike growth pattern. these cases should be recorded as rectal prolapse. histogenesis: cells of brunner's glands. • brunner's glands cells are often hypertrophic with more extensive cytoplasm, larger nuclei, or both. • glands are more branched and coiled, compared with normal glandular structure. • brunner's glands cells and underlying stroma may form pedunculated structures within the spaces of cystic glands. • cellular polarity is maintained. • cells are tall columnar, with extensive, poorly-stained, or somewhat eosinophilic-stained cytoplasm with dense, basally-located nuclei. • glands may expand into the underlying circular muscle layer, but basement membrane integrity always maintained. • diverticulum: localized and discrete penetration of intestinal crypts into lamina propria or deeper layers with maintained basement membrane integrity and surrounded by pre-existing mature tissues lacking a desmoplastic stromal response. • carcinoma, brunner's glands: effacement of brunner's glands structures, prominent desmoplasia; invasive growth. comment: brunner's glands hyperplasia has been observed in transgenic mice (hemizygous rash2) after dosing for one month with a receptor tyrosine kinase inhibitor that targets multiple cellular kinase receptors, including those of vascular endothelial growth factor (vegf), platelet-derived growth factor (pdgf), stem cell factor receptor (kit), fmslike tyrosine kinase 3 (flt-3) and glial cell line-derived neurotrophic factor rearranged during transfection (ret). progression from preneoplastic hyperplasia to carcinoma/ adenocarcinoma can occur. to appropriately capture the area of interest in the rodent, it is important to retain the gastroduodenal junction in a manner that allows a comprehensive evaluation of the area of interest and prevents folding of the stomach and gastroduodenal region that can obscure brunner's glands. this can be accomplished by opening the stomach along the greater curvature, leaving the duodenum attached, and pinning the tissue flat for fixation. synonyms: squamous metaplasia. histogenesis: colon or rectum epithelium. • focal, multifocal or diffuse • replacement of normal epithelium with squamous epithelium. • frequently associated with chronic inflammation. • carcinoma, squamous cell: invasion, areas with moderate to poor differentiation or anaplasia, ususally prominent mitoses. • extension of anal mucosa into rectum: usually in proximity to the anus and without concomitant inflammatory reaction. comment: squamous metaplasia is often seen in chronic colitis models in mice, usually in the dextran sulfate model. squamous cell carcinomas have not been reported to arise in the lesions (seamons et al. 2013 ). adenoma (figures 138, 139 • branching villi or tubular crypt proliferation can be present. • squamous metaplasia and focal mineralization may be present. • may be associated with glandular or cystic diverticula, but basement membrane always intact. • one cell type is predominant and goblet cells are absent or reduced in number. • the epithelium may contain foci of varying degrees of dysplasia. • signs of cellular atypia / dysplasia include cellular basophilia, loss of cellular polarity, hyperchromatic and pleomorphic nuclei, and nuclear stratification. • hyperplasia, atypical: circumscribed proliferation with varying degree of atypia, but limited to the confinements of the intestinal mucosa. • diverticulum: extension of crypts through muscularis mucosa, into submucosa and further in some cases. morphology of epithelial lining is variable, ranging from single layer cuboidal to columnar cells to complete mucosa. epithelium may show features of regeneration like increased basophilia, increased nucleus to cytoplasm ratio and gradual loss of polarity. often accompanied by inflammation and regenerative / reparative processes. • adenocarcinoma: true invasion by individual, groups or areas of tumor cells, with or without a stromal response. the term "polyp" was avoided, because of implied uncertainty about the neoplastic nature of this proliferative lesion. benign neoplasms may develop dysplastic foci and evolve into malignant neoplasms. chemicals causing benign intestinal tumors often also cause intestinal adenocarcinomas (chandra et al. 2010; pandiri et al. 2011; ward 1974) . adenomas, as well as atypical hyperplasia, exhibit some degree of dysplasia and distortion of pre-existing architecture. macroscopic visibility has been suggested as a differential diagnostic criterion by some authors. this criterion is not used in the context of this description of histologic criteria. any lesion exhibiting a papillary or polypoid growth pattern is an adenoma, irrespective whether it was grossly visible or not. an intra-epithelial small focus (compatible with atypical hyperplasia) with cytological characteristics seen in adenomas should not be diagnosed as an adenoma. the frequency of spontaneous intestinal adenomas varies with the intestinal segment. incidences up to 51% are reported for the duodenum and anterior part of the jejunum (hare and stewart 1956) . in the other intestinal segments the incidence of adenomas is below 5%. however, the detection frequency is highly dependent on the mode of macroscopic examination of the intestines, e.g. random blocks, naked eye inspection of mucosal surface, transillumination or swiss roll technique. the determination of the malignancy status of a papillary or polypoid intestinal tumor requires a good fixation and trimming protocol, to obtain an optimal section through the middle of the tumor with its connecting area to the normal intestine. if there is no connection to the intestine, it is impossible to determine if invasion is present. the cytology of a non-invasive adenoma may include high grade dysplasia. in most rat and mouse chemically-induced or genetically-engineered tumor models, true invasion of the stalk is unusual but may occur commonly in other models. adenocarcinoma (figures 143, 144, 145 • diverticulum: localized and discrete penetration into lamina propria or deeper layers with maintained basement membrane integrity and surrounded by pre-existing mature tissues lacking a scirrhotic stromal response. • hyperplasia atypical and adenoma: may be associated with glandular or cystic diverticula, but basement membrane always intact. ▪ rectal prolapse (mice): associated with helicobacter sp or citrobacter sp infection in mice; hyperplastic epithelium extending as diverticula through muscularis mucosa and into submucosa, with associated inflammation. comment: an intestinal adenocarcinoma may arise de novo from normal epithelium, but more commonly from a preneoplastic lesion such as atypical hyperplasia or from an ad-enoma. the histogenesis, morphology and biology of tumor progression often depend on the etiology, i.e. the chemical carcinogen or the kind of genetic change in a gem model. in contrast to humans, spontaneous rodent adenocarcinomas show a predilection for the small intestine, especially the jejunum and ileum, rather than the large intestine. the descriptions available indicate that the morphology of spontaneous lesions does obviously differ from the induced ones and that the etiology may determine the morphologic phenotype. in addition, induced adenocarcinomas have their preferred localization in the distal colon and show high invasiveness combined with a low tendency to metastasize. helicobacter sp has been shown to be a colon co-carcinogen in some experimental mouse models involving gem or immunodeficient mice (erdman and poutahidis 2010) . inflammatory mouse models of colon adenocarcinoma are often scirrhous and mucinous (erdman and poutahidis 2010; kosa et al. 2012) . metastases are often associated with a specific method of tumor induction. in rats, the mucinous adenocarcinoma induced by some carcinogens commonly metastasizes, predominantly to the lung. mucinous intestinal adenocarcinomas are often the most malignant type of intestinal tumor in rats and mice . histogenesis: cells of brunner's glands. • there is effacement of brunner's glandular structures and the gastroduodenal junction. • desmoplasia is prominent and can be the most dominant feature. • glandular structure is diminished or completely lost. • the mitotic index is usually low. • there is moderate pleomorphism of brunner's glandular cells. • cells have well-stained cytoplasm that may be eosinophilic, amphophilic or basophilic. • attenuated glandular cells may line cystic areas that contain mucus. • invasion through the muscularis mucosa and/or through the circular and longitudinal muscles, as well as the serosa, can be extensive. the basement membrane of the glands is breached or not evident. • hyperplasia, brunner's glands: glandular architecture may be slightly altered, but still recognizable; cell polarity maintained; glands may penetrate into the underlying circular muscle layer, but basement membrane maintained. • diverticulum: localized and discrete penetration of intestinal crypts into lamina propria or deeper layers with maintained basement membrane integrity and surround-ed by pre-existing mature tissues lacking a desmoplastic stromal response. comment: brunner's glands carcinoma is a rare tumor, although a high occurrence can be induced with certain test articles. brunner's glands carcinoma has been observed in transgenic mice (cb6/f1/jic tg rash2 hemizygous) and sprague-dawley rats after dosing for 6 and 24 months, respectively, with a receptor tyrosine kinase inhibitor that targets multiple cellular kinase receptors (see brunner's glands hyperplasia; comment). the investigations in the transgenic model indicated that the rapid occurrence and high incidence of brunner's glands carcinoma is more consistent with altered transcriptional regulation rather than a genotoxic mechanism. knowledge of the site of the incipient lesion or the use of immunohistochemical methods are often required to diagnose the origin of the change because invasion of a gastric glandular cell or duodenal enterocyte carcinoma can have similar morphologic features to those of a malignant neoplasm of brunner's glands that has progressed extensively. histogenesis: smooth muscle cells from tunica muscularis. • intramural involvement. • interlacing bundles and whorls of uniform spindle cells arranged in criss-cross patterns of bundles. • nuclei typically blunt-ended or cigar shaped. • eosinophilic cytoplasm contains longitudinal myofilaments and perinuclear clear space and show immunoreactivity for desmin. • leiomyosarcoma: shows mitotic activity and cellular pleomorphism. histogenesis: smooth muscle cells from tunica muscularis. • intramural involvement. • similar to leiomyoma, but more pleomorphic and with mitotic activity. • necrosis, cystic change and mineralization are common features. • distant metastases. • leiomyoma: shows little or no cellular pleomorphism or mitotic activity. synonyms: interstitial cajal cell tumor, benign; gastrointestinal pacemaker cell tumor, benign histogenesis: specialized smooth muscle cells (i.e., interstitial cells of cajal) in the tunica muscularis or myenteric plexus. • well demarcated tumor, expansive growth. • cells may be arranged in bundles with storiform archi-tecture, myxoid areas may be present. • spindle, epithelioid, or pleomorphic cell morphology. indistinct cell borders and fibrillary cytoplasm. • spindle-or irregular-shaped nuclei. • typically cd117 positive (cytokine receptor encoded by c-kit). • gastrointestinal stromal tumor, malignant: infiltrative growth, distant metastases may be present. • leiomyoma: cd117 negative, desmin positive; interlacing bundles and whorls of uniform spindle cells arranged in criss-cross pattern; blunt-ended, fusiform nuclei. minimal nuclear pleomorphism; phosphotungstic acid-hematoxylin positive myofibrils. • leiomyoscarcoma: cd117 negative, desmin positive; interlacing bundles and whorls of uniform spindle cells arranged in criss-cross pattern; blunt-ended, fusiform nuclei with hyperchromasia, pleomorphism, and high mitotic index; phosphotungstic acid-hematoxylin positive myofibrils. • schwannoma: cd117 negative, s-100 positive; indistinct cell borders, elongate cells with eosinophilic cytoplasm; nuclei sometime arranged in palisades (i.e., antoni a pattern). comment: gist will generally not be easily differentiated from leiomyomas / leiomyosarcomas or other soft tissue tumors. however, immunohistochemical differentiation of the different tumor types, including gist, needs to be performed in case of imbalances in the incidence of smooth muscle tumors in a given study. cecal gist have been induced in gem mice over-expressing a mutant kit (nakai et al. 2008 ). the question arises whether conventionally classified stromal tumors (e.g., leiomyoma) previously were actually gist. synonyms: interstitial cajal cell tumor, malignant; gastrointestinal pacemaker cell tumor, malignant histogenesis: specialized smooth muscle cells (i.e., interstitial cells of cajal) in the tunica muscularis or myenteric plexus. • locally infiltrative growth pattern. • cells may be arranged in bundles with storiform architecture, myxoid areas may be present. • spindle, epithelioid, or pleomorphic cell morphology. indistinct cell borders and fibrillary cytoplasm. • spindle-or irregular-shaped nuclei. • typically cd117 positive (cytokine receptor encoded by c-kit). • distant metastases may be present. • gastrointestinal stromal tumor, benign: expansive growth pattern, no distant metastases. • leiomyoma: cd117 negative, desmin positive; interlacing bundles and whorls of uniform spindle cells arranged in criss-cross pattern; blunt-ended, fusiform nuclei. minimal nuclear pleomorphism; phosphotungstic acid-hematoxylin positive myofibrils. • leiomyoscarcoma: cd117 negative, desmin positive; interlacing bundles and whorls of uniform spindle cells arranged in criss-cross pattern; blunt-ended, fusiform nuclei with hyperchromasia, pleomorphism, and high mitotic index; phosphotungstic acid-hematoxylin positive myofibrils. • schwannoma: cd117 negative, s-100 positive; indistinct cell borders, elongate cells with eosinophilic cytoplasm; nuclei sometime arranged in palisades (i.e., antoni a pattern). comment: gist will generally not be easily differentiated from leiomyomas / leiomyosarcomas or other soft tissue tumors. however, immunohistochemical differentiation of the different tumor types, including gist, needs to be performed in case of imbalances in the incidence of smooth muscle tumors in a given study. cecal gist have been induced in gem mice over-expressing a mutant kit (nakai et al. 2008) . the question arises whether conventionally classified stromal tumors (e.g., leiomyoma) previously were actually gist. the salivary glands consist of major and minor glands and develop from the endodermal lining of the embryonal gut. the major salivary glands are grossly apparent and include the parotid, sublingual and submandibular glands. the minor salivary glands are microscopic and are distributed throughout the oral cavity encompassing the lingual (von ebner's glands around the vallate and foliate papillae, weber's glands at base of the tongue), sublingual, buccal, palatine, laryngeal and pharyngeal tissues. the submandibular gland matures with age and progress from rudimentary lobules of mesenchyme with ductular structures at birth to acinar development and complete maturation by about 30 days postnatally in rats (proctor and carpenter, 2007) . the sublingual salivary glands are mature at birth unlike the parotid and submandibular salivary glands. the major salivary glands are located on the ventral and lateral areas of the cervical region and extend to the base of the ear and are closely associated with the extraorbital lachrymal gland and mandibular lymph nodes. the largest of the three major salivary glands, the submandibular (mandibular or submaxillary) salivary gland is a tan, multilobular gland that is located in the ventral cervical region. it extends rostrally to the mandibular lymph nodes, caudally to the thoracic inlet, and is bordered bilaterally by the parotid glands. the sublingual glands consist of tan-brown bilateral single lobes located on the rostro-lateral surface of each of the submandibular glands and directly below the mandibular lymph nodes. the parotid glands are bilateral and consist of pink to off white, multiple flattened lobes extending from the submandibular gland ventrally, to the base of the ear dorsally, to the extraorbital lacrimal gland rostrally, and to the clavicle caudally. the parotid glands drain into the parotid duct while the submandibular and sublingual glands drain into the oral cavity via wharton's duct that terminates in small papillae near the incisors. the submandibular gland is a seromucinous (mixed) compound tubuloacinar gland. in the mouse it is predominantly seromucinous, where as, in the rat it is mostly mucinous with a small serous component (gresik, 1994; ozono et al. 1991; tucker, 2007) ). the submandibular gland is comprised of several adenomeres with large pyramidal mucous cells that are flanked basally by variable numbers of cresentric serous demilunes. the large pyramidal mucous cells have abundant vesicular basophilic cytoplasm and basally located nuclei and the cresentric serous demilunes have scant eosinophilic cytoplasm and hyperchromatic nuclei. the acinar secretions from the adenomeres empty into intercalated ducts lined by low cuboidal to columnar epithelial cells. few oncocytes are interspersed between the cuboidal epithelial cells of the intercalated ducts of aged rats. these cells are characterized by abundant granular eosinophilic cytoplasm (abundant mitochondria) and a central hyperchromatic nucleus. thin fusiform myoepithelial cells are located between the basal lamina and epithelial cells of acini and intercalated ducts (bogart, 10970; sashima, 1986) . only in the submandibular gland, the intercalated ducts continue into granular (convoluted) ducts. the granular ducts are lined by tall columnar epithelial cells with abundant eosinophilic granular cytoplasm. the granulation of these ducts is much more prominent in sexually mature males when compared to females (figures 156 and 157) . these ducts continue into striated (intralobular) ducts that are lined by a single layer of tall columnar epithelial cells with marked basal infoldings (hence, striated cells) and central to apically located nuclei. several of the striated (intralobular) ducts merge into interlobular excretory ducts that are lined by tall columnar epithelial cells with more apically located nuclei and prominent cytoplasmic striations. several interlobular excretory ducts continue into one main excretory duct that expands into a diverticulum lined by simple columnar epithelium and end as squamous epithelium at the oral surface. the sublingual gland is predominantly mucous secreting and has the largest acini. they are comprised of large pyramidal mucus cells with basally located nuclei and are infrequently capped by serous demilunes. the acinar secretions empty into intercalated ducts that in turn empty into striated (intralobular) ducts. the multiple striated ducts empty into the main excretory duct. the microscopic anatomy of the ducts is similar to their counterparts within the submandibular gland. the parotid gland contains serous acini, which are morphologically very similar to the exocrine pancreatic acini (wolff et al. 2002) . the acinar cells are pyramidal with broad basophilic base and tapered apices. the eosinophilic granular cytoplasm contains zymogen granules, the nuclei are basally located. the duct system of the parotid gland is similar to the submandibular gland. the minor salivary glands lack a true connective tissue capsules and are usually located within the submucosa or are interspaced between connective tissue stroma or muscle fibers. the glands are morphologically diverse and are organized into distinct serous (von ebner's glands), mucous (anterior and posterior buccal glands and minor sublingual glands) or mucous glands with serous demilunes (glossopalatal, palatal, and weber's glands, figure 155 ) glands (redman 2011) . the acini are organized into lobule-like structures and collections of secretory end pieces and ducts open onto the mucosal surface. the salivary glands secrete a hypotonic sero-mucinous saliva containing electrolytes and enzymes that aid in lubrication and partial digestion of food. the serous secretions contain water, electrolytes (rich in k + and hco3 -and poor in na + and clcompared to plasma), iga and enzymes (ptyalin (amylase), lysozyme, lipase) and the mucinous secretions contain water, and glycoproteins. the minor salivary glands contribute about 14% protein and 1% amylase of the total salivary secretions, as determined by pilocarpine stimulation (blazsek and varga 1999) . the salivary secretions are tightly regulated by the sympathetic (adrenergic) and parasympathetic (cholinergic) nervous system (garrett 1987) . most cell types within the submaxillary and parotid glands have both sympathetic and parasympathetic innervations while the sublingual glands have scant sympathetic innervation limited to striated ducts and blood vessels (garrett et al. 1991 ). the parasympathetic system and the α-adrenergic sympathetic system regulate the water and inorganic ion phase of the primary secretory fluid, whereas the β-adrenergic sympathetic system effects primarily the macromolecular (enzymes) phase. parasympathetic stimulation is mainly responsible for stimulation of the salivary acini resulting in copious secretion of saliva, however, the sympathetic stimulation does not inhibit salivary secretion but it modulates the saliva composition and causes salivary secretion to a lesser extent (proctor and carpenter 2007) . the sympathetic and parasympathetic stimulation of the myoepithelial cells surrounding the acini results in contraction of acini and directing the saliva into the ducts (tucker 2007) . surprisingly, it is the sympathetic stimulation but not parasympathetic stimulation that results in morphologically obvious depletion of storage granules within the acini (garrett et al. 1991) . β-adrenergic sympathomimetic agonists such as isoprenaline (selye et al. 1961 ) and terbutaline (sodicoff et al. 1980 ) first cause rapid depletion of secretory granules and later promotes re-synthesis of secretory material leading to acinar cell hypertrophy and hyperplasia. on the other hand, β-adrenergic antagonists like propranolol suppress salivary secretions and eventually cause acinar atrophy (fukuda 1968) . the sexual dimorphism of the submandibular gland salivary glands is dependent on testosterone levels (harvey 1952) . the increased granularity in males ( figure 156) is accompanied by an about 10 times higher aminotransferase activity compared to females that have very little if any ductal secretory granules ( figure 156 ) (hosoi et al. 1978 ). a typical approach for toxicological examination includes all the three grossly visible major salivary glands, i.e., submandibular, sublingual, and parotid gland. at necropsy, all three major salivary glands are removed in one piece, usually together with the mandibular lymph nodes. trimming of the salivary glands is then undertaken as specified in the rita trimming guide (website//reni.item.fraunhofer.de/reni/trimming): the salivary glands are trimmed longitudinally and through the largest surface. all three salivary glands should be present in the section. the typical approach may be varied according to study protocol requirements, e.g. determination of organ weights and tissues required for pathology examination. the microscopic minor lingual glands are routinely examined if the entire tongue, including its base, is removed at necropsy and trimmed longitudinally. the other minor salivary glands located within the oral cavity and pharynx are examined only occasionally during microscopic evaluation of these tissues. ectopic tissue (figures 158 and 159) pathogenesis: remnant of embryonic cell rests. diagnostic features • focal. • circumscribed normal parotid, submandibular or sublingual gland acini within a heterotopic salivary gland. • none. comment: care should be taken to differentiate sectioning artifacts ("floaters") from the ectopic parotid gland in the sublingual glands. vacuolation ( figure 160 ) synonyms: hydropic change, cloudy swelling, hydropic degeneration, fatty degeneration, lipidosis, lipid accumulation pathogenesis: accumulation of substances of different character, including fluids, , lipids, phospholipids, and glycoproteins within cells. • distribution may be focal or multifocal and involve several lobules or a diffuse change involving all the lobes. • cells may be swollen with pale eosinophilic cytoplasm and have intracytoplasmic vacuoles with variably margins. • the size of vacuoles may vary from small (microvesicular) to large when multiple small vacuoles coalesce together (macrovesicular) often resulting in nuclear displacement. • variable loss of zymogen granules or mucinous secretions within the affected cells • lobular architecture of gland is retained. • hypertrophic cells with foamy cytoplasm characterized by clear vesicles with eosinophilic fine granules differential diagnoses • artifact: medium-sized clear vesicles within the cytoplasm of acinar cells, especially at the periphery. no positive staining by fat stains. comments: based solely on light microscopic evaluation of hematoxylin and eosin stained tissue sections, it is not possible to conclusively characterize the nature of the intracytoplasmic vacuoles. hence, vacuolation, cytoplasmic is the preferred terminology of the lesion that was previously diagnosed as fatty change, hydropic degeneration, cloudy swelling etc. any chemical/factor affecting the integrity of the cell membranes can potentially cause poorly defined intracytoplasmic vacuoles that was previously diagnosed as hydropic degeneration (sela et al. 1977; simson, 1972) . care should be taken to discriminate artifactual vacuolation induced by processing from the lesion induced by treatment. some metabolic insults cause disruption of normal lipid transport and metabolism and subsequently cause accumulation of lipid within the cytoplasm. in the streptozotocin-diabetes rat model, the parotid is the major salivary gland most susceptible to cytoplasmic vacuolation (anderson 1998) . cytoplasmic vacuolation within the parotid was observed in doxylamine treated f344 rats (jackson and blackwell 1988) . cytoplasmic vacuolation within the parotid but not submandibular glands was noted in aged wistar rats (andrew 1949 a fine cytoplasmic vacuolation, resulting from foamy appearance, may give the suspicion of phospholipidosis. in such cases, the modifier "foamy" should be used. if the change reflects phospholipidosis, increases in size and number of lysosomes can be identified by histochemistry (for alkaline phosphatase), immunostains (for lysosomal membrane proteins, e.g. lamp-2) or by transmission electron microscopy. with the later technique, multilamellated structures (myeloid bodies/lamellar bodies) are observed in the lysosomes. the term phospholipidosis should only be used when confirmation by one of these techniques has been achieved. pathogenesis: unknown. • multifocal to coalescing accumulations of adipocytes within the interstitium. • compression of the adjacent acini, ducts and lobes. • moderate replacement (loss) of acini in rare cases. • disruption of lobular structure. • vacuolation due to storage of lipids: moderate to abundant intracytoplasmic lipid vacuoles; acinar and ductular architecture is retained. • atrophy: reduction in the number/size of acini is the predominant finding. comment: the accumulation of adipocytes within salivary glands is an uncommon lesion and it may be an age related change. it occurs predominantly in parotid and less commonly in submandibular and sublingual salivary glands (andrew 1949) . apoptosis ( figure 162 ) pathogenesis: gene regulated, energy dependent process leading to formation of apoptotic bodies which are phagocytosed by adjacent cells. • necrosis: the morphologic features of cell death clearly fit with necrotic diagnostic criteria (cells and nuclei swollen, pale cytoplasm etc.). • apoptosis/necrosis: both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. the term is also used when the type of cell death cannot be determined unequivocally. the approach for the nomenclature and diagnostic criteria of cell death applied here is based on a draft recommendation of the inhand cell death nomenclature working group. apoptosis is not synonymous with necrosis. the main morphological differences between these two types of cell death are cell shrinkage with nuclear fragmentation and tingible body macrophages in apoptosis versus cell swelling, rupture and inflammation in necrosis; however, other morphologies (e.g. nucelar pyknosis and karyorrhexis) overlap. in routine h&e sections where the morphology clearly represents apoptosis or single cell necrosis, or whereby special procedures (e.g. tem or ihc for caspases) prove one or the other, individual diagnoses may be used. however, because of the overlapping morphologies, necrosis and apoptosis are not always readily distinguishable via routine examination, and the two processes may occur sequentially and/or simultaneously depending on intensity and duration of the noxious agent (zeiss 2003) . this often makes it difficult and impractical to differentiate between both during routine light microscopic examination. therefore, the complex term apoptosis/necrosis may be used in routine toxicity studies. a differentiation between apoptosis and single cell necrosis may be required in the context of a given study, in particular if it aims for mechanistic investigations. transmission electron microscopy is considered to represent the gold standard to confirm apoptosis. other confirmatory techniques include dna-laddering (easy to perform but insensitive), tunel (false positives from necrotic cells) or immunohistochemistry for caspases, in particular caspase 3. these techniques are reviewed in detail by elmore (elmore 2007) . some of these confirmatory techniques detect early phases of apoptosis, in contrast to the evaluation of h&e stained sections, which detects late phases only; overall interpretation of findings should take into account these potential differences. thus, low grades of apoptosis may remain unrecognized by evaluation of h&e stained slides only. certain studies may require the consideration of forms of programmed cell death other than apoptosis which requires specific confirmatory techniques (galluzzi et al. 2012) . synonyms: oncotic cell death; oncotic necrosis; necrosis pathogenesis: unregulated, energy independent, passive cell death with leakage of cytoplasm into surrounding tissue and subsequent inflammatory reaction; may be induced by direct contact with a test article after oral uptake/administration. • focal affecting cell groups, lobular, diffuse. • cells swollen with pale eosinophilic cytoplasm. • loss of nuclear basophilia, pyknosis and/or karyorrhexis that affects aggregates of cells. • in more severe cases, there may be detachment of the epithelium from the submucosa. • typically, the presence of degenerative cells is a component of necrosis. • minimal or slight inflammatory cell infiltrates, edema and fibrin may be present as a feature of necrosis. single cell • only single cells affected. • apoptosis: the morphologic features of cell death clearly fit with apoptosis (cell and nucleus shrunken, hypereosinophilic cytoplasm, nuclear pyknosis etc.) and/or special techniques demonstrate apoptosis. • apoptosis/necrosis: both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. the term is also used when the type of cell death cannot be determined unequivocally. • inflammation, acute: infiltrates of inflammatory cells, edema, and fibrin predominate; necrosis may be present, but is a minor component. comments: necrosis is usually accompanied by inflammatory cell infiltrate and is usually a significant component of acute inflammation (levin et al. 1999) . necrosis of salivary glands may be due to chemical toxicity or emboli. synonym: cell death pathogenesis: unregulated, energy independent, passive cell death with leakage of cytoplasm into surrounding tissue and subsequent inflammatory reaction (single cell necrosis) and/ or gene regulated, energy dependent process leading to formation of apoptotic bodies which are phagocytosed by adjacent cells (apoptosis). • both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. • the type of cell death cannot be determined unequivocally. • apoptosis: the morphologic features of cell death clearly fit with apoptosis (cell and nucleus shrunken, hypereosinophilic cytoplasm, nuclear pyknosis etc.) and/or special techniques demonstrate apoptosis and there is a requirement for recording apoptosis and necrosis separately. • necrosis: the morphologic features of cell death clearly fit with necrotic diagnostic criteria (cells and nuclei swollen, pale cytoplasm etc.) and there is a requirement for recording apoptosis and necrosis separately. comments: necrosis and apoptosis are not always readily distinguishable via routine examination, and the two processes may occur sequentially and/or simultaneously depending on intensity and duration of the noxious agent (zeiss 2003) . this often makes it difficult and impractical to differentiate between both during routine light microscopic examination. in these cases, the combined term apoptosis/necrosis may be used. it is recommended to explain in detail the use of this combined term in the narrative part of the pathology report. (figures 164 and 165 ) synonym: degranulation, acinar cell pathogenesis: decrease of acinar cell zymogen granules or mucin leading to shrunken acinar cells. • focal, lobular or diffuse. • reduced acinar diameter. • partial or complete loss of acinar cell zymogen granules or mucin leading to a reduced cell size and increased basophilia. • lack of fibrosis or adipocyte infiltration. • atrophy, acinar cell: complete degranulation of acini may be accompanied by fibrosis, mononuclear cell infiltrates, prominent intra-and inter-lobular ducts. the morphology of the acini may be altered due to several physiological conditions, such as anorexia/inanition. degranulation of the acini may also be noted in rodents treated with sympathomimetic agents like isoprenaline (selye et al. 1961 ) and terbutaline (sodicoff et al. 1980) . synonym: feminization of the granular duct; degranulation granular duct pathogenesis: decrease of granulated duct cell serous granules leading to shrunken granulated duct cells. • may be focal or multifocal, but usually diffuse. • affects males, not females. • partial or complete loss of serous granules leading to a reduced cell size. • reduced cell diameter of the granulated duct cell. • lack of fibrosis or adipocyte infiltration. • may be accompanied by degranulation of the acinar cells. differential diagnosis • none. the morphology of the granular ducts is androgen dependent. secretory depletion and subsequent atrophy of granular ducts may be observed in male rats and mice with decreased androgen levels. it is also observed in the streptozotocin-induced chronic diabetes rat model. the acinar cells are less susceptible compared to the granular ducts. the atrophy of the granular ducts in chronic diabetic rats may be due to the hypogonadal effect of diabetes. in cases of sympathetic but not parasympathetic nerve stimulation, extensive degranulation may be observed in both acinar (betaadrenergic) and granular duct (alpha-adrenergic) cells. pathogenesis: increased androgenic stimulus in females. • diffuse, limited to the submandibular gland of females. • prominent large granular ducts with increased eosinophilic granules within female animals. • increased granularity of the granular duct. • increased diameter of the granular cells. • except for the change in the granular duct, rest of the histomorphology is normal. differential diagnosis • none. the submandibular salivary gland is sexually dimorphic and shows increased granularity of the convoluted (granular) ducts in males compared to females. when female rats or mice are treated with androgenic test articles (e.g. androstenedione or oxymetholone) or have increased endogenous androgen levels, their granular ducts of the submandibular glands acquires male morphology. pathogenesis: spontaneous or experimentally induced. • focal, lobular or diffuse. • variable reduction in the number and/or size of acini to total loss of acini. • degranulation (parotid), reduced mucin (submandibular and sublingual). • relatively more numerous, prominent, occasionally dilated, intra-and inter-lobular ducts lined by cuboidal or flattened epithelial cells. • pyknotic and karyorrhectic nuclei, apoptotic bodies may be present,. • variable degree of interstitial fibrosis with/without lymphocytes and plasma cells. • scattered to coalescing adipocytes may be present within the interstitium. • may be accompanied by mineralization of luminal contents, salivary calculus, ductular foreign bodies. • secretory depletion, acinar cell: variable loss of serous or mucinous granules resulting in reduced cellular size, lack of fibrosis or adipocyte infiltration, or lack of chronic inflammatory cell infiltrate. • accumulation, adipocytes: accumulation of adipocytes is the predominant finding. comment: atrophy more commonly affects the submandibular and parotid glands than the sublingual gland. it may be an age related lesion or may be induced experimentally, usually as a secondary response after obstruction of excretory ducts or after alteration of trophic factors. examples for obstruction of excretory ducts include ligation (bhaskar et al. 1956; standish and shafer 1957) , sialoliths and foreign bodies. testosterone, adrenocorticoids, and sympathetic stimulation are important trophic factors for the salivary glands. any experimental condition that acts on their homeostasis may potentially induce diffuse salivary gland atrophy. this has been shown for hypophysectomy (koerker 1967) , adrenalectomy, denervation and α-and β-adrenergic antagonists. also decreased food consumption, and protein starvation lead to salivary gland atrophy. atrophy of salivary glands due to liquid diet affects parotid and submandibular glands but the sublingual glands are apparently spared (hall and schneyer 1964; scott and gunn 1991) . also, the sublingual glands lack sympathetic innervation and thus are spared in situations where the chemicals act on the sympathetic nervous system. salivary gland atrophy was noted in f344 rats treated with sodium dichromate dihydrate (ntp, 2008) . often, salivary atrophy is accompanied by mild chronic inflammation and mild interstitial fibrosis. pathogenesis: deposition of mineral either secondary to cellular necrosis (dystrophic mineralization) or secondary to hypercalcemia (metastatic mineralization). • focal, lobular, diffuse. • affected structures are ducts and arteries (metastatic mineralization) or areas of degeneration / necrosis (dystrophic mineralization). • dark basophilic granular material (on h&e) replacing acini, ducts or interstitium. • artifacts: hematoxylin stain deposits (distribution unrelated to tissue structures), acid hematin (birefringent in polarized light). • pigment: lipofusin and porphyrin stain brown to golden brown on h&e and may further be differentiated from mineralization by special stains. • calculi (concretions, sialoliths): localization in the lumen of ductules or ducts. comment: dystrophic calcification occurs in necrotic/injured tissue even in animals with reference range serum calcium levels, whereas metastatic calcification occurs throughout the body, in hypercalcemic animals, especially within interstitial tissues and blood vessel walls. special stains like alizarin red s and von kossa can help identify calcium salts within tissue sections. amyloid ( figure 172 ) pathogenesis: extracellular deposits of chemically diverse complex insoluble polypeptide fragments. • light eosinophilic amorphous extracellular material within the tunica media of blood vessels, within the interstitium and basement membrane. • variable degree of atrophy and loss of intervening acini and ducts may occur, if amyloid deposition is prominent. • green birefringence using polarized light with congo red stain. • necrosis: loss of cellular detail, but without extracellular congo red positive material. • fibrinoid change (necrosis) in vessel walls: deep eosinophilic homogenization of vascular media. comment: amyloid and amyloid-like material has been observed in various tissues, including salivary glands of aged rodents, especially mice. rats are much more resistant to develop amyloidosis than mice. the characteristic morphologic appearance and location of amyloid in h&e sections that is usually adequate to make this diagnosis. confirmation of the deposits as amyloid can be accomplished with light microscopy using special stains such as congo red. amyloid appears apple green under polarized light with this stain. the term "hyaline" should be used in case of uncertainties about the nature of extracellular deposits hyaline material in h&e sections and the unavailability of a congo red stain. hyaline is also the appropriate term for homogenously eosinophilic extracellular deposits that react negative with congo red. infiltrate ( figure 173 ) diagnostic features • focal, multifocal or diffuse. • presence of mononuclear or polymorphonuclear leukocytes but without other histological features of inflammation like edema, congestion or necrosis. • mild atrophy of surrounding cells may be present. • usually no acinar cell degranulation or mucus depletion. • inflammation: an inflammatory cell infiltrate associated with additional morphologic features of inflammation such as edema, hemorrhage, necrosis, and/or fibroplasia. • granulocytic leukemia: infiltration of neutrophil precursors and/or abnormal neutrophils will probably be present along with mature neutrophils; infiltration of similar neoplastic cells is likely present in other organs. • lymphoma: infiltration of monomorphic population of lymphocytes (often with atypical, increased and/or abnormal mitoses); infiltration of similar neoplastic cells is likely present in other organs. comment: in toxicity studies, inflammatory cell infiltrates are encountered more commonly than inflammation (sialadenitis). the term inflammation (or sialadenitis) should not be confused with or used in lieu of inflammatory cell infiltrate. the term inflammatory cell infiltrate should be used rather than sialadenitis (or inflammation) when there is no tissue in-jury/reaction associated with the inflammatory cell infiltrate. also, these inflammatory cell infiltrates should be qualified with the type of inflammatory cells that are predominant, such as mononuclear, lymphocyte, neutrophil, etc. the use of terminology summarizing the nature of the infiltrates as acute or suppurative (in lieu of neutrophilic), granulomatous (in lieu of histiocytic), and chronic (in lieu of lymphocytic, plasmacytic, mononuclear, etc.) is not recommended since these terms may imply inflammation. the term inflammation (or sialadenitis) should be reserved for lesions where the inflammatory cell infiltrate is associated with obvious tissue injury/reaction associated with inflammation such as edema, congestion, acinar (parotid) cell degranulation, hemorrhage or necrosis. inflammation (figures 174, 175, 176 and 177) modifiers: type of inflammatory cell that represents the predominant cell type in the inflammation pathogenesis: infiltration of the lamina propria and/or submucosa with neutrophils (inflammation, neutrophil) or mononuclear cell (inflammation, mononuclear cell) or a combination (inflammation, mixed) with additional histological features of inflammation e.g. hemorrhage, edema, fibroplasia. • focal, multifocal, or diffuse. • infiltrate of mononuclear or polymorphonuclear leukocytes into the gland parenchyma. • presence of other histological criteria of inflammation, e.g. hemorrhage, edema, fibroplasia inflammation, neutrophil • infiltrate predominantly neutrophilic; frequently accompanied by edema and congestion, parotid acinar cell degranulation, acinar and ductular degeneration and necrosis. • infiltrate predominantly mononuclear cell; frequently accompanied by acinar cell atrophy and mild acinar cell degeneration, ductal proliferation, interstitial fibrosis; mineralization or nonkeratinizing squamous metaplasia of acini and ducts may be present. • infiltrate, inflammatory cell: other morphologic features associated with inflammation such as edema, hemorrhage, necrosis, and/or fibroplasias will be absent. • granulocytic leukemia: infiltration of neutrophil precursors and/or abnormal neutrophils will probably be present along with mature neutrophils; infiltration of similar neoplastic cells is likely present in other organs. • lymphoma: infiltration of monomorphic population of lymphocytes (often with atypical, increased and/or abnormal mitoses); infiltration of similar neoplastic cells is likely present in other organs. comment: when a mononuclear or mixed cell infiltrate is considered to represent an inflammatory process (inflammation, mononuclear cell or inflammation, mixed) and other morphologic features (fibrosis, mineralization) associated with the infiltrate suggest an ongoing/continuing inflammatory process, the modifier 'chronic' may be included in the diagnosis (i.e. inflammation, mononuclear cell, chronic) to better characterize the finding. inflammation, neutrophilic of the salivary glands is uncommon in toxicological evaluation of tissues. infection with murine cytomegalovirus (mcmv) and sialodacryoadenitis virus (sdav) were once common causes of acute sialodacryoadenitis in mice and rats (jacoby et al. 1975 ), respectively, but are now rare in barrier bred and maintained colonies. mcmv predominantly affects the submandibular glands and in rare cases the parotid glands. sdav has a tropism for tubuloalveolar glandular tissue of serous (parotid) or mucous/serous (submandibular) glands. the sublingual gland is spared in sdav infections in rats. sialadenitis may be differentiated by their respective pathognomonic clinical signs and lesions. bacterial infections due to klebsiella aerogenes and staphylococcus aureus may also cause severe acute necrotizing sialadenitis as well as abscesses. spontaneous autoimmune sialadenitis is seen in several strains of mice (nod, nzb/nzw, sl/ni, bdf females) and rats (percy and barthold 2007) . the infiltrating lymphocytic population is predominantly cd4+ t cells and less than 10% cells are c8+ t cells. variable degree of chronic inflammation of the salivary glands may be seen occasionally in aged animals of other strains. chronic infections of mcmv and sdav or regenerative lesions from acute mcmv and sdav infections may appear morphologically similar to chronic inflammatory lesions (ohyama et al. 2006) . rats treated with sympathomimetics like isoproterenol present with mild chronic inflammation in the submandibular salivary gland (cohen et al. 1992 ). refer also to the inhand monograph on the cardiovascular system. pathogenesis: accumulation of fluid in salivary interstitium resulting from increased vascular permeability due to damage to capillaries and blood vessels, increased hydrostatic pressure in vasculature, decreased oncotic pressure, or impaired lymphatic drainage. • diffuse. • increased clear spaces between acini and interstitium. • increase in total lobe volume. • rare inflammatory cell infiltrate secondary to diapedesis may be present. • inflammation, neutrophil: tissue and capillary damage accompanied by exudative edema, granulocytic infiltration, fibrin, congestion and hemorrhage. comment: edema within the salivary glands is very uncommon. it may be exudative (inflammatory edema due to capillary injury secondary to leakage of enzymes) or transudative (hydrodynamic derangement secondary to increased hydrostatic osmotic pressure and decreased oncotic pressure). the diagnosis of edema should be reserved for a transudative type of edema since exudative edema is usually accompanied by abundant inflammatory cell infiltrate and possibly tissue injury. hence, the primary diagnosis in cases of exudative edema should be inflammation, neutrophil. chemical induced salivary gland edema has been noted in mice treated with p-nitrophenol and rats administered d & c yellow no. 11 in us-ntp studies. pathogenesis: increased vascular permeability (diapedesis) or rupture of blood vessels. • presence of erythrocytes in parenchymal or interstitial tissue or lumina of ductules and ducts. • angiectasis: blood present within dilated vascular lumina. • artifact: erythrocytes on the surface of tissues as a result of necropsy procedures. synonyms: sialoliths; sialolithiasis; salivary concretion; duct concretion; salivary calculus; inspissated material pathogenesis: precipitation of secretory components after reabsorption of the water component by the ductular cells. • basophilic or eosinophilic inspissated material within the ductular lumen. • ductular epithelium may be low to flattened cuboidal epithelium. • may be accompanied by mild periductular mononuclear inflammatory cell infiltrate. • ectasia, duct: salivary calculi are absent. • foreign body: foreign body within the duct is usually associated with some tissue damage and elicits an inflammatory response. a diagnosis of ductular ectasia should not be used in the presence of the ductular calculi, even though they share other morphologic features. synonyms: dilatation; luminal distension pathogenesis/cell of origin: luminal dilatation due to obliteration of the intralobular or interlobular ducts. • solitary or multiple tortuous irregularly enlarged lumina that may or may not contain gland-specific secretory material. • lined by flat cuboidal epithelial cells. • may be accompanied by mild interstitial infiltration of lymphocytes and plasma cells. • calculus, ductular: salivary calculi are present. comment: usually ectasia results from blockage of inter-and intra-lobular ducts either proximally or distally due to rare inspissated secretory material (sialolithiasis), sialodacryoadenitis tumors, or foreign bodies. however, a diagnosis of ectasia is used only in the absence of the calculi or the foreign body within the histologic section. fibrosis ( figure 181 ) pathogenesis: collagen deposition by fibroblasts following inflammation, necrosis or hemorrhage. • focal, lobular, or diffuse. • increase in the interstitial tissue due to collagen deposition and fibroblast cell proliferation. • amyloid: there is abundant extracellular eosinophilic amorphous ground substance that exhibits apple green birefringence in congo red stained sections under polarized light and there is an absence of fibroblast cell proliferation. • inflammation, mixed cell, chronic: fibrosis associated with inflammatory cell infiltrates and degenerative parenchymal changes. comment: fibrosis may be minimal to marked depending on the severity and duration of insult. it is usually a significant component of chronic inflammation and may be a component of healing after acute toxic insults. mature collagen in h&e sections is birefringent under polarized light. pathogenesis: usually secondary to increased functional demand or due to sympathomimetic stimulation. • focal, multifocal or diffuse. • acinar structure not altered, no encapsulation, no compression. • enlarged cells with abundant cytoplasm of normal staining pattern. • large nuclei with euchromatin and prominent nucleoli. • relative reduction in the number of secretory ducts due to separation by enlarged acini. • basophilic hypertrophic focus (parotid gland): discrete non-compressing foci of hypertrophic cells with increased basophilia within discrete non-compressing foci. • hyperplasia, non-regenerative: may be associated with hypertrophy, but always increase in cell number; minimal compression or distortion of architecture may be present. • hyperplasia, regenerative: may be associated with hypertrophy, but always increase in cell number and cytoplasmic basophilia; minimal compression or distortion of architecture may be present. comment: acinar hyperplasia is often associated with hypertrophy. in these cases, it is recommended to record hyperplasia, but not hypertrophy. hypertrophy (and hyperplasia) of the parotid and submandibular glands has been observed after administration of certain drugs such as isoproterenol (selye et al. 1961, brenner and stanton, 1970) , methoxamine and pilocarpine (inanaga et al. 1988 ), terbutaline (sodicoff et al. 1980) , methacholine, epinephrine, phenylephrine, reserpine, furosemide (scarlett et al. 1988 ), alloxan (sagstrom et al. 1987 , thyroxine, and dexamethasone (sagulin and roomans 1989) . single or repeated mandibular incisor tooth amputation also resulted in enlargement of submandibular glands, presumably due to neural regulation (wells 1963) . this enlargement was due to abundant intracytoplasmic accumulation of mucus along with calcium, amylase and other protein. (figures 182 and 183) synonyms: focus, basophilic; basophilic focus; basophilic hypertrophic focus; focus, basophilic, hypertrophic; focus of cellular alteration; pathogenesis/cell of origin: unknown. diagnostic features • focal, multifocal or diffuse. • discrete unencapsulated, noncompressing foci involv-ing one or multiple acini. • enlarged cells with increased cytoplasm and occasionally enlarged nuclei. • apical regions of the acinar cells have an eosinophilic granular or fine vesicular cytoplasm on h&e stain. • basal regions of the acinar cells have intensely basophilic cytoplasm with large hyperchromatic nuclei. • the enlarged cells can be diffusely basophilic in extreme cases where most of the parotid is affected. • pyknotic nuclei or mitoses may be observed. • in diffusely affected cases, the acinar enlargement is not as prominent as seen in smaller focal basophilic foci. • relative reduction in the number of secretory ducts due to separation by enlarged acini. • hyperplasia, non-regenerative or hyperplasia, regenerative: increase in cell number that may or may not be associated with hypertrophy; minimal compression or distortion of architecture may be present. • hypertrophy, acinar cell: cells in single or multiple acini (foci) enlarged without increased cytoplasmic basophilia. comment: in untreated animals, basophilic hypertrophic foci are more common in rats than in mice (chiu and chen 1986) . the incidence of basophilic hypertrophic foci slightly increases with age. in addition, several chemicals such as doxylamine (jackson and blackwell 1993) , triprolidine (greenman et al. 1995) , glyphosate (ntp, 1992a), methyleugenol (ntp, 2000) , and diethanolamine (ntp, 1992b) induce basophilic hypertrophic foci in rodents. these foci are considered adaptive hypertrophic lesions rather than precursors of neoplasia. pathogenesis: transdifferentiation of one fully differentiated salivary gland epithelium into a different type of fully differentiated salivary gland epithelium. • focal to multifocal scattered distribution. • usually accompanied by prior tissue injury. • presence of fully differentiated epithelial cells that are not native to the tissue, e.g. presence of parotid gland epithelial cells within the submandibular gland. ectopic tissue: usually focal, circumscribed and not associated with prior tissue injury. comment: documenting prior injury and the corresponding chronic inflammation as well as the multifocal nature of the lesion supports the diagnosis of metaplasia instead of ectopic tissue. (figures 185 and 186 ) synonyms: squamous metaplasia; ductal squamous metaplasia histogenesis: ductular epithelial structures of the salivary glands. • cuboidal ductular epithelium replaced by squamous epithelium. • squamous epithelial cells may be uni-or multilayered. • keratinization may be present. • may be accompanied by duct hyperplasia. • carcinoma, squamous cell: local invasion of adjacent tissue, distant metastasis, or marked cellular atypia. • hyperplasia: hyperplastic cells cuboidal to columnar in shape and unilayered. • hyperplasia, atypical: multiple layers of cuboidal to columnar epithelial cells with lost polarity and increased basophilia; no horizontal flattening as in squamous metaplasia. comment: ductal squamous cell metaplasia is usually seen as a part of the regenerative response following necrosis of the ductal epithelium. in rats, a common cause of this lesion in parotid and submandibular glands is due to sialodacryoadenitis viral (sdav) infection. the sublingual glands are reportedly spared from pathologic changes in sdav infections (jacoby 1985) . however, the sublingual excretory ducts may have ductal squamous metaplasia in the absence of sdav infections. vitamin a deficient diet induced squamous metaplasia in the ducts of parotid, submandibular and sublingual glands in sprague-dawley rats (horn et al. 1996) . squamous cell metaplasia in the submandibular gland was described in mice after treatment with dmba and was proven to be of ductal segment origin by the presence of keratin proteins (takai et al. 1986 ). light and electron microscopy studies have demonstrated that the principal portion of salivary gland tissue undergoing squamous metaplasia is the acinar-intercalated duct cell complex (dardick et al. 1985) . though, squamous cell metaplasia of the ductular epithelium has been considered as a preneoplastic condition progressing to neoplasia (neuenschwander and elwell 1990) , the potential for progression of hyperplasia and squamous metaplasia of the ductular epithelium is unclear. these changes in the sublingual gland of wistar rats, often associated with inflammation/fibrosis, were not associated with neoplasia at that site (van esch et al. 1986 ). in addition, treatment-related squamous cell metaplasia of the salivary gland in a chronic f344 rat study with iodinated glycerol was not associated with neoplastic findings in the salivary gland after two years (ntp, 1990) . squamous cell metaplasia was induced with chlorodibromomethane in f344 rats but not in b6c3f1 mice after 13-week treatment, but no tumor progression was noted after 2 years treatment (dunnick et al. 1985) . on the other hand, transition of squamous metaplasia into squamous cell carcinoma in the submandibular gland via a non-genotoxic, proliferation-dependent mechanism was postulated after 2-year treatment with potassium iodide in f344 rats (takegawa et al. 1998 ). in addition, in experiments with implanted sponge pellets containing dmba inducing squamous cell carcinomas in sprague-dawley rats, the authors concluded that ductal segments undergoing squamous cell metaplasia may have participated in the genesis of neoplasia during experimental carcinogenesis (cao et al. 2000 , sumitomo et al. 1996 . hyperplasia ( figure 187 ) modifiers: acinar, ductal, reactive, atypical histogenesis: ductal and/or acinar epithelium of the salivary glands. diagnostic features • focal, multifocal or diffuse. • glandular architecture is preserved or only minimally altered. • minimal compression of the surrounding tissue may be present. • often rounded circumference, but maintenance of normal acinar or ductal architecture. • no capsule. acinar: • acinar cells with atypia may occur. ductal: • ducts may show dilated lumina lined by flattened epithelium. reactive: • acinar or ductular proliferation with cytoplasmic basophilia; evidence of an underlying process, e.g. inflammation, fibroplasias, ductal obstruction or foreign material. atypical: • focal or multifocal, not diffuse. • multiple layers of acinar / ductular epithelial cells. • gradual loss of cellular polarity and differentiation, cytoplasm may be amphophilic, increased nucleus to cytoplasm ratio. differential diagnoses • adenoma: loss or distortion of the normal acinar/ductular structure; well-demarcated and distinct compression of the surrounding tissue. • ectopic parotid gland: foci of serous acini between mucous acini of the sublingual gland. • hypertrophy: enlarged acinar cells without increase in cell number; no compression, no alteration of glandular architecture. • focus, hypertrophic, basophilic: enlarged acinar structures with increased basophilia; no compression. comment: hyperplastic or preneoplastic changes associated with spontaneously occurring neoplasms have not been identified in f344 rats (neuenschwander and elwell. 1990) . spontaneous hyperplastic and metaplastic duct epithelium was described in the sublingual glands of wistar rats (van esch et al. 1986 ). hyperplasia of the salivary ducts is a common feature of many inflammatory and reactive conditions in the salivary glands of rodents (greaves 2012) . multifocal ductal cell hyperplasia was induced in the intercalated duct cells of the submandibular salivary glands of wistar rats after chronic treatment with a steroidal test article comprising prostagenic and estrogenic properties (de rijk et al. 2003) . spontaneous hyperplastic changes of the salivary gland have not been observed in b6c3f1 mice (botts et al. 1999) . transgenic mice models were reported to show hyperplasia of the submandibular glands in serous acinar cells expressing a retinoid acid receptor (bérard et al. 1994) and ductular cells expressing simian virus 40 t antigen (ewald et al. 1996) , respectively. spontaneous and primary tumors of the rodent major salivary glands are rare (elwell and leininger 1990; frith and heath 1985; greaves 2012) . salivary gland adenomas in rats and mice may arise from either acinar or ductular components (neuenschwander and elwell 1990; botts et al. 1999) . few carcinomas and adenocarcinomas have been reported in mice and rats (botts et al. 1999; hosokawa et al. 2000; nishikawa et al. 2010; tsunenari et al. 1997) . malignant tumors in the salivary glands may be induced with chemical substances in rats (neuenschwander and elwell 1990; sumitomo et al.1996; cao et al. 1999; zaman et al. 1996) and mice (botts et al. 1999; takegawa et al. 1998; takai et al. 1986; yura et al. 1995) or in various transgenic animal models (dardick et al. 2000; declercq et al. 2005; nielsen et al. 1991; nielsen et al. 1995) . adenoma (figures 188, 189, 190, 191 and 192) modifiers: acinar, tubular, papillary, solid, mixed acinar/ tubular histogenesis: ductal or acinar epithelium of salivary glands. • well demarcated. • compression of the adjacent parenchyma or connective tissue. • alteration of normal acinar or ductular architecture. • may be surrounded partially or completely by a thin capsule. • nuclei are hyperchromatic and basally oriented when cytoplasmic mucus present. • mitotic figures are rare. • growth pattern may be acinar, tubular, papillary, solid, or mixed. acinar: • show some signs of secretory activity. minor areas with solid growth pattern may be present; excretory ducts are usually absent. tubular: • consists of lobules or aggregates of tubules lined by squamous to cuboidal or columnar epithelium, separated by a variable amount of fibrous stroma. some ducts may have dilated lumina. papillary: • papillary projections dominate and cystic dilatation may be present. solid: • diffuse sheet of epithelial cells without acinar or ductular structure. mixed acinar/tubular: • a mixture of acinar and tubular forms is not infrequent. • hyperplasia: acinar structure preserved or only minimally altered; no or only minimal compression, no capsule; in case of reactive hyperplasia evidence of an underlying process, e.g. inflammation, fibroplasia, ductal obstruction or foreign material. • hyperplasia, atypical: focal proliferation of acinar or tubular epithelium with no or only minimal compression, with multiple epithelial layers and cellular atypia; no capsule. • adenocarcinoma: cellular pleomorphism and cytoplasmic amphophilia; numerous mitotic figures, invasive growth. • tumor, mixed, benign: consists of two proliferative cell types, one myoepithelium and the other glandular acinar epithelium. • adenoma of the mammary gland (anterior part): glandular structure is not as compact; staining characteristics of epithelium different. comment: in mice, only acinar adenomas of the salivary glands have been described, while rats may develop the different growth patterns listed as modifiers. multinodular acinar adenomas may be difficult to distinguish from well-differentiated adenocarcinomas. salivary gland adenomas in rats may arise from either acinar or ductular components (neuenschwander and elwell 1990) . few adenomas have been observed in mice and it is unclear if they arise from ducts or acini (botts et al. 1999) . therefore it is recommended to use the modifiers acinar and tubular not in the sense of histogenesis but as a description of the predominant growth pattern. mice transgenic for the pleomorphic adenoma gene (plag1 or plag2) developed a high incidence of submandibular gland adenomas. these tumors developed pleomorphic characteristics, similar to human pleomorphic adenomas of the salivary glands. they were composed of epithelial and myoepithelial structures. the epithelial component showed various growth patterns, including keratinization. the spindle-shaped myoepithelial cells were embedded in a myxoid stroma (declercq et al. 2005) . adenocarcinoma (figures 193, 194, 195 and 196) modifiers: acinar, tubular, papillary, solid, mixed acinar/tubular/solid histogenesis: ductal or acinar epithelium of salivary glands. diagnostic features • grows in whorls or spindle pattern. • necrosis frequently present. • areas of squamous differentiation may be present. • cells are large, pleomorphic and polyhedral with amphophilic cytoplasm. • nucleus to cytoplasm ratio high. • nuclei are large vesicular and have multiple nucleoli. • mitotic figures numerous. • invasion of the surrounding tissue present. • metastasis to the lung may be present. • growth pattern may be acinar, tubular, papillary, solid, or mixed. acinar: • show some signs of secretory activity. • minor areas with solid growth pattern may be present, excretory ducts are usually absent. tubular: • differentiation pattern variable, ranging from wellformed tubular structures to poorly formed tubules or nodular masses of anaplastic epithelial cells. • some ducts may have dilated lumina. • diffuse sheet of epithelial cells without acinar or ductular structure. mixed acinar/tubular/solid: • may have different patterns in one tumor: acinar, tubular and solid. papillary: • papillary projections dominate and cystic dilatation may be present. • hyperplasia: no evidence of invasion, glandular structure preserved or only slightly altered (acinar hyperplasia; in case of reactive hyperplasia evidence of an underlying process like inflammation, fibroplasia, ductal obstruction or foreign material. • hyperplasia, atypical: focal proliferation of acinar or tubular epithelium with multiple layers and cellular atypia; no invasion of surrounding tissue. • adenoma: minimal cellular pleomorphism; acinar cells well differentiated with secretory granules; no or only minimal pleomorphism; non-invasive; mitotic figures rare. • adenocarcinoma of the mammary gland: cytoplasmic staining differences and lipid vacuolation may be present. comment: multinodular acinar adenomas may be difficult to distinguish from well-differentiated adenocarcinomas. spontaneous tumors of the major salivary glands are rare in the rat (elwell and leininger 1990; glucksmann and cherry 1973) . poorly differentiated carcinomas of the parotid gland of young sprague-dawley rats (tsunenari, et al. 1997; nishikawa et al. 2010) and papillary cystadenocarcinoma in the parotid gland of a f344 rat (hosokawa et al. 2000) were reported. induction of adenocarcinomas in the submandibular gland was reported after intraglandular injection of dmba in female wistar rats (zaman et al. 1996) and female mice (yura et al. 1995) . adenocarcinomas have rarely been reported in mice (botts et al. 1999) . a naturally occurring mucoepidermoid carcinoma in the salivary gland associated with both myoepithelium and duct epithelium was described in two mice (ishikawa et al. 1998 ). submandibular gland adenocarcinomas of intercalated duct origin were induced in smgb-tag mice (dardick et al. 2000) . in these mice the oncogene sv40 t antigen is expressed from the neonatal submandibular gland secretory protein b (smgb) gene promoter. development of pleomorphic adenoma with malignant characteristics and lung metastasis was described in the submandibular gland of transgenic mice with plag1 proto-oncogene over expression (declercq et al. 2005) . transgenic mice expressing a human ha-ras oncogene developed adenosquamous carcinomas arising from the serous areas from the submandibular gland (nielsen et al. 1991) . in wap-ras transgenic mice adenocarcinomas arising from the submandibular gland were reported to develop spontaneously by one year of age (nielsen et al.1995) . (figures 197, 198 and 199) synonym: carcinoma, epidermoid histogenesis: probably ductular epithelial structures of the salivary glands. • well-differentiated islands and cords with keratin formation. • variable mitotic activity. • invasion of adjacent tissues or metastasis. • high grades of anaplasia may occur. • tumors may be extensively keratinized. comment: spontaneous squamous cell carcinomas in rodents are rare, but have been induced with chemicals in rats (neuenschwander and elwell 1990; sumitomo et al. 1996; cao et al. 1999) and mice (botts et al. 1999; takegawa et al.1998; takai et al. 1986) , and occur spontaneously in mice with the v-ha-ras oncogene (cardiff et al. 1993) . transgenic mice expressing a human ha-ras oncogene developed adenosquamous carcinomas arising from the serous areas of the submandibular gland (nielsen et al.1991) . also adenosquamous carcinomas of the mammary gland, which are not uncommon in mice, need to be considered as a differential diagnosis. squamous cell carcinomas of the salivary glands should be distinguished from invasive zymbal's gland carcinomas with squamous differentiation by their location in situ (neuenschwander and elwell 1990) . (botts et al. 1999; frith and heath 1994; dawe 1979 (botts et al. 1999; frith and heath 1994) . the differentiation between the mixed malignant tumor and the malignant myoepithelioma with epithelioid and spindeloid growth pattern may be difficult based on hematoxylin and eosin stained slides. confirmatory immunohistochemistry may be required which in case of the mixed tumor would demonstrate two different tissue compartments that show either epithelial or mesenchymal immunophenotype, but usually not a mixed one. in contrast, mixed epithelial and mesenchymal antigenic expression would be demonstrated in case of the myoepithelioma. histogenesis: myoepithelial cells, extraglandular ductal origin, salivary glands (possibly other glandular tissues). • unencapsulated tumor; may show invasive cords of solid tissue extending into adjacent structures. • in larger tumors, central degeneration and necrosis may form pseudo-cysts, which may be filled by brown, mucoid material or cell debris. comment: myoepitheliomas of the salivary glands have not been described in rats. they are rare in most strains of mice but occur more often in the balb/c, a/j, and c58 strains (mainly females). the most frequent locations are the parotid and submandibular glands (frith and ward 1988 ), but they are not limited to salivary glands or the cervical region. neoplastic myoepithelial cells have been reported to stain positive for cytokeratin and for keratins k5 and k14 and vimentin. also ptah staining will aid in confirmation of the intracytoplasmic fibrils within the myoepithelial cells (botts et al. 1999; sundberg et al. 1991) . they are negative for smooth muscle cell alpha-actin immunohistochemistry, in contrast to normal myoepithelial cells; furthermore, sundberg et al. has suggested that the neoplasms arise from a subset of extraglandular ductal myoepithelial cells that are negative for smooth muscle cell alpha-actin (sundberg et al. 1991) . such confirmatory stains may be required for differentiation of myoepitheliomas from scirrhous/anaplastic squamous cell carcinomas or mixed malignant tumors. myoepitheliomas in mice preferably occur in the ventral neck region (sundberg et al. 1991) . although most of these tumors have been ascribed to the salivary glands, it needs to be taken into account that they may occur from any other glandular tissue, e.g. the mammary gland or extraorbital lacrimal gland. the frequent poor encapsulation, pleomorphic morphology, and central necrosis are compatible with a malignant interpretation; however, sundberg et al. suggested few are malignant based on stringent criteria of metastasis to the lung or infiltration of underlying bone (sundberg et al. 1991) . the morphology of tumors with confirmed metastases is not unique, as compared to those without, and the clinical appearance of the neoplasms may lead to culling prior to development of readily defined metastases, so it is recommended that they should be regarded as potentially malignant. during embryonic development the pancreas is formed by fusion of its dorsal and ventral buds derived from the septum transversum at the embryonic foregut/midgut junction. the pancreas consists of both exocrine and endocrine components. the exocrine pancreas forms the bulk of the pancreas and produces numerous enzymes (in proenzyme form) that aid in digestion. the pancreas of rat and mouse is classified as mesenteric type (versus compact type) since discrete pancreatic tissues are diffusely distributed in the mesentery of the duodenal loop, transverse colon, and greater omentum adjacent to stomach and spleen. the large interlobular ducts open into a common hepatic (biliary)/pancreatic duct that enters the duodenum. in addition, there are some ducts that open directly into the duodenum boorman and sills 1999) . the exocrine pancreas is classified as a compound tubuloalveolar or compound acinar gland. the pancreatic acinus consists of a single layer of pyramidal acinar cells arranged concentrically around a lumen. the apex of the pyramidal cells facing the lumen contains eosinophilic zymogen granules and the base of the pyramidal cells is basophilic due to abundant rough endoplasmic reticulum and also contains the nucleus. each pancreatic acinus is surrounded by a thin basal lamina, scant reticular stroma, and pancreatic stellate cells (akin to the hepatic stellate cells). located centrally within the acinus, the centroacinar cells form an interface between the acinus and the intercalated duct. the intercalated duct continues into intralobular ducts formed by the ductular cells. the intralobular ducts fuse to form the interlobular ducts that finally open into the pancreato-hepatic (biliary) duct boorman and sills 1999) . the exocrine pancreas is physiologically and morphologically compartmentalized into peri-and tele-insular regions. the peri-insular acinar cells are in the immediate proximity of the islets of langerhans and are larger due to more abundant cytoplasm, larger zymogen granules and larger nuclei than the tele-insular acinar cells that are farther from the islets. due to differences in sizes of the peri-and tele-insular acinar cells, at lower magnification, the islets of langerhans appear to be surrounded by "halos" (peri-insular halos) (greaves 2012) . the histologic constituents of the pancreatic tissue such as the exocrine acini, centro-acinar cells, ductal cells and the endocrine cells within the islets have a unique ability to de-differentiate and transdifferentiate into other pancreatic histologic cell types based on the severity and type of injury, distinct transcriptional and protein alterations and epigenetic factors (stanger and hebrok 2013) . as a result, tissue injury in exocrine pancreas may resolve by forming a histologic constituent that may be similar or different from the damaged tissue type. after certain types of pancreatic tissue injury, the exocrine acini undergo de-differentiation and may attain a ductular morphology and in some cases even attain an endocrine phenotype. notch, wnt and hedgehog signaling pathways play important roles in these de-differentiation and transdifferentiation pathways (stanger and hebrok 2013) . the pancreas is a dual function gland with both exocrine (acini) and endocrine (islets of langerhans) functions. the acinar cells store the digestive enzymes in heterogeneously composed vacuoles and the release of these enzymes occurs in a cyclic and secretagogue-specific fashion. the exocrine acinar secretions collect within the acinar lumen and then accumulate within the interlobular ducts that subsequently drain into the duodenum via the pancreato-biliary duct. hormones like gastrin (from g-cells in the stomach) and cholecystokinin (from i-cells in the duodenum) stimulate the exocrine pancreas to secrete inactive proenzymes (zymogens like trypsinogen, chymotrypsinogen, elastase and carboxypeptidase) as well as active enzymes such as lipase, amylase and nuclease. in addition, the duodenal hormone secretin stimulates the centroacinar cells (in addition to the brunner's glands) to secrete bicarbonate ions that aid in neutralizing acidic chyme from the stomach and stabilizing the enzymes. the intestinal enteropeptidases activate the trypsinogen to trypsin that in turn cleaves the rest of trypsinogen and chymotrypsinogen to their active forms resulting in protein digestion. lipase and amylase aid in the digestion of lipids and carbohydrates, respectively (greaves 2012) . the exocrine pancreas has great reserve capacity and no clinical evidence of exocrine pancreatic insufficiency is noted with up to 90% destruction of exocrine pancreas. exocrine pancreatic function deficits > 90% results in improper digestion of food and malabsorption of nutrients (hotz et al. 1973 ). at necropsy, the whole left lobe of the pancreas (located in the omentum close to the spleen) is removed for trimming. for microscopic evaluation, a large part of the left lobe is cut in longitudinally in the horizontal plane, making the cut surface as large as possible. the right lobe is removed together with the adjacent small intestine (ruehl-fehlert et al. 2003 ). ectopic tissue (figure 202 ) pathogenesis: congenital abnormalities resulting in splenic or liver tissues in pancreas. • usually focal distribution. • fully differentiated non-pancreatic tissue in the pancreas. • usually circumscribed and not wholly integrated into the 'host' tissue. • no evidence of dysplasia or history of tissue injury. • metaplasia: the metaplastic tissue is usually integrated into the histological pattern of the host tissue and is usually a result of tissue reaction and adaptation. comment: ectopic tissues are usually a rare finding in toxicity studies and care should be taken to properly interpret them and not be confused with metaplasia or neoplasia. vacuolation, acinar cell ( figure 203 ) comments: based solely on light microscopic evaluation of hematoxylin and eosin stained tissue sections, it is not possible to conclusively characterize the nature of the intracytoplasmic vacuoles. hence, vacuolation is the preferred terminology of the lesion that was previously diagnosed as fatty change, hydropic degeneration, cloudy swelling etc. acinar cell vacuolation is a reversible change and is usually a reflection of hypoxia and metabolic insults resulting in damage to mitochondria, endoplasmic reticulum, protein machinery, and plasma membrane. oil red o and sudan black stains on frozen sections help to identify the neutral lipids within the micro/macro vesicles. it is useful to differentiate from cytoplasmic vacuoles due to water accumulation (hydropic change) resulting from cell injury due to hypoxia. marked vacuolation of the exocrine pancreatic acini has been documented in female sprague-dawley rats exposed to dioxins and dioxin-like compounds (yoshizawa et al. 2005) . a fine cytoplasmic vacuolation, resulting from foamy appearance, may give the suspicion of phospholipidosis. in such cases, the modifier "foamy" should be used. if the change reflects phospholipidosis, increases in size and number of lysosomes can be identified by histochemistry (for alkaline phosphatase), immunostains (for lysosomal membrane proteins, e.g. lamp-2) or by transmission electron microscopy. with the later technique, multilamellated structures (myeloid bodies/lamellar bodies) are observed in the lysosomes. the term phospholipidosis should only be used when confirmation by one of these techniques has been achieved. pathogenesis: replacement of exocrine parenchyma after age-related or chemically-induced atrophy or in case of obesity. • multifocal to coalescing adipocytes within the interstitium. • compression of the adjacent exocrine tissue only occasionally. • multifocal to diffuse atrophy of exocrine acini and replacement by adipose tissue. • islets of langerhans unaffected. • vacuolation, acinar cell: moderate to abundant intracytoplasmic vesicles with a multifocal to diffuse distribution. the exocrine acinar architecture is retained. comments: fatty infiltration of exocrine pancreas is an uncommon lesion which may be age related. the pathogenesis is not usually apparent but may be secondary to atrophy or is the cause of atrophy. synonyms: hyalinosis; eosinophilic change pathogenesis: storage of hyaline material within the cytoplasm of ductal cells. • focal or multifocal. • intensely pink-red cytoplasmic droplets and/or crystals in ductal cells. • cells are usually hypertrophic. • crystals, if present, may be intracellular or extracellular. • none. comments: aged mice of the c57bl/6, 129 and b6,129 strains develop a high incidence of eosinophilic globules in various epithelia, including glandular stomach, respiratory tract, bile duct, gall bladder and pancreatic duct . the protein isolated from the characteristic eosinophilic lesions has been identified as ym1/ym2 a member of the chitinase family that may be produced in response to mucosal irritation rogers and houghton 2009) . the use of the term hyalinosis for this lesion will potentially cause confusion in safety assessment as the same term may also be used for a distinctly different clinical disorder in humans and can be used to describe vascular and renal glomerular changes. synonyms: autophagy, acinar cell pathogenesis: increased autophagocytosis by segregation of cytoplasmic organelles or cytoplasmic contents in sublethally injured acinar cells. diagnostic features • multifocal. • retained lobular architecture. • intracytoplasmic hypereosinophilic to basophilic globules surrounded by a thin clear halo. • apoptosis: apoptotic bodies also have a hypereosinophilic cytoplasm and are surrounded by a clear halo but they always contain basophilic condensed nuclear fragments. apoptosis may be differentiated from autophagy by using tunel staining that marks the nuclear fragments (zhang et al. 2014 ). comments: autophagy is a homeostatic mechanism that plays a major role in the catabolism by lysosomal digestion of organelles and/or aged cytoplasmic contents. autophagy occurs at basal levels in all tissues to maintain cellular homeostasis. however, it is rapidly increased during energy depletion, hypoxia, endoplasmic reticulum stress, high temperature, hormonal stimulation, or cellular remodeling to combat oxidative stress. alterations in autophagy may lead to disruption of cellular homeostasis and can result in pancreatitis and cell death (helin et al. 1980; gukovskaya and gukovsky 2012) . increased autophagic vacuoles in a treated group should always be considered in the context of the control group. autophagy and apoptosis are not necessarily mutually exclusive entities. there is evidence that apoptosis can occur simultaneously with autophagy (maiuri et al. 2007 ). the exocrine acini are very sensitive to agents affecting autophagic flux such as vinblastine (enhances autophagic segregation) or cycloheximide (regression of the autophagic compartment). autophagy may be detected by electron microscopy, by the fluorescent localization pattern of lc3 puncta (intracytoplasmic granular fluorescent material) or by immunohistochemistry using antibodies against lc3-ii (processed lc3). the autophagosomes within the cytoplasm, under light microscopy, appear as discrete vacuoles with some dark eosinophilic or amphophilic contents and under electron microscopy, remnants of mitochondria or endoplasmic reticulum may be observed. it is important to note that accumulation of autophagosomes is not always indicative of autophagy induction since it could be the result of blockage of autophagosomal maturation or increased generation of autophagosomes. autophagic flux assays may measure lc3 turnover, levels of autophagic substrates, mrfp-gfp-lc3 color change, free gfp generated from gfp-lc3, and lysosome-dependent long-lived protein degradation (iovanna and vaccaro 2010) . pathogenesis: gene regulated, energy dependent process leading to formation of apoptotic bodies which are phagocytosed by adjacent cells. and there is no requirement to record them separately or a combined term is preferred for statistical reasons. the term is also used when the type of cell death cannot be determined unequivocally. the approach for the nomenclature and diagnostic criteria of cell death applied here is based on a draft recommendation of the inhand cell death nomenclature working group. apoptosis is not synonymous with necrosis. the main morphological differences between these two types of cell death are cell shrinkage with nuclear fragmentation and tingible body macrophages in apoptosis versus cell swelling, rupture and inflammation in necrosis; however, other morphologies (e.g. nucelar pyknosis and karyorrhexis) overlap. in routine h&e sections where the morphology clearly represents apoptosis or single cell necrosis, or whereby special procedures (e.g. tem or ihc for caspases) prove one or the other, individual diagnoses may be used. however, because of the overlapping morphologies, necrosis and apoptosis are not always readily distinguishable via routine examination, and the two processes may occur sequentially and/or simultaneously depending on intensity and duration of the noxious agent (zeiss 2003) . this often makes it difficult and impractical to differentiate between both during routine light microscopic examination. therefore, the complex term apoptosis/necrosis may be used in routine toxicity studies. a differentiation between apoptosis and single cell necrosis may be required in the context of a given study, in particular if it aims for mechanistic investigations. transmission electron microscopy is considered to represent the gold standard to confirm apoptosis. other confirmatory techniques include dna-laddering (easy to perform but insensitive), tunel (false positives from necrotic cells) or immunohistochemistry for caspases, in particular caspase 3. these techniques are reviewed in detail by elmore (elmore 2007) . some of these confirmatory techniques detect early phases of apoptosis, in contrast to the evaluation of h&e stained sections, which detects late phases only; overall interpretation of findings should take into account these potential differences. thus, low grades of apoptosis may remain unrecognized by evaluation of h&e stained slides only. certain studies may require the consideration of forms of programmed cell death other than apoptosis which requires specific confirmatory techniques (galluzzi et al. 2012) . acinar cell apoptosis is classically manifested in many cases of xenobiotic-induced injury. it is considered a "preferred" response to injury, as it does not lead to subsequent inflammation. an inverse relationship between apoptosis and necrosis in acinar cell injury has been described for various experimental models. stimulation of apoptosis seems to protect against acute necrotizing reactions, while inhibition of apoptosis leads to necrosis and acute inflammation (wallig and sullivan 2013) . exocrine pancreatic acinar apoptosis is observed in rodents treated with synthetic cholecystokinin analog caerulein (reid and walker 1999) , ethionine (fitzgerald and alvizouri 1952; walker et al. 1993) , physical blockage of the pancreas by ductal ligation doi et al. 1997) , duct obstruction involution following soy flour-induced hyperplasia (oates et al. 1986 ) and zinc toxicants (kazacos and van vleet 1989) , copper-deficient diet supplemented with a copper-chelating agent (rao et al. 1993) , azaserine (woutersen 1996) , lipopolysaccharide (laine et al. 1996) and pan cdk inhibitor (ramiro-ibáñez et al. 2005 ). in addition, exocrine pancreatic apoptosis is also observed in some genetically modified mice such as serpini2-deficient mouse model for pancreatic insufficiency (loftus et al. 2005) . non-treatment associated sporadic apoptosis may be noted in pancreas from rodents and this is part of the normal tissue homeostasis and is considered as a background change. acinar cell apoptosis may be increased in fasted or chronically anorectic animals. the degree of apoptosis is in these cases lower than that of acute pancreatic injury. synonyms: oncotic cell death; oncotic necrosis; necrosis pathogenesis: unregulated, energy independent, passive cell death with leakage of cytoplasm into surrounding tissue and subsequent inflammatory reaction; may be induced by direct contact with a test article after oral uptake/administration. • focal affecting cell groups, lobular, diffuse. • cells swollen with pale eosinophilic cytoplasm. • loss of nuclear basophilia, pyknosis and/or karyorrhexis that affects aggregates of cells. • in more severe cases, there may be detachment of the epithelium from the submucosa. • typically, the presence of degenerative cells is a component of necrosis. • minimal or slight inflammatory cell infiltrates, edema and fibrin may be present as a feature of necrosis. single cell • only single cells affected. • apoptosis: the morphologic features of cell death clearly fit with apoptosis (cell and nucleus shrunken, hypereosinophilic cytoplasm, nuclear pyknosis etc.) and/or special techniques demonstrate apoptosis. • apoptosis/necrosis: both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons. the term is also used when the type of cell death cannot be determined unequivocally. • inflammation, acute: infiltrates of inflammatory cells, edema, and fibrin predominate; necrosis may be present, but is a minor component. comments: necrosis is usually accompanied by an inflammatory cell infiltrate and may be a significant component of acute inflammation. usually, either necrosis or acute inflammation will be recorded. however, in the context of a specific study it may be more appropriate to record both processes separately. in the pancreas, dead cells quickly pass through the stage of coagulation necrosis to liquefaction because of the high content of hydrolytic enzymes activated and released into the interstitial tissue. necrosis of acinar tissue develops very rapidly and is best recognized within 12-48 hours after the insult (wallig and sullivan 2013) . pathogenesis: unregulated, energy independent, passive cell death with leakage of cytoplasm into surrounding tissue and subsequent inflammatory reaction (single cell necrosis) and/or gene regulated, energy dependent process leading to formation of apoptotic bodies which are phagocytosed by adjacent cells (apoptosis). • both types of cell death are present and there is no requirement to record them separately or a combined term is preferred for statistical reasons or • the type of cell death cannot be determined unequivocally. • apoptosis: the morphologic features of cell death clearly fit with apoptosis (cell and nucleus shrunken, hypereosinophilic cytoplasm, nuclear pyknosis etc.) and/or special techniques demonstrate apoptosis and there is a requirement for recording apoptosis and necrosis separately. • necrosis: the morphologic features of cell death clearly fit with necrotic diagnostic criteria (cells and nuclei swollen, pale cytoplasm etc.) and there is a requirement for recording apoptosis and necrosis separately. comments: necrosis and apoptosis are not always readily distinguishable via routine examination, and the two processes may occur sequentially and/or simultaneously depending on intensity and duration of the noxious agent (zeiss 2003) . this often makes it difficult and impractical to differentiate between both during routine light microscopic examination. in these cases, the combined term apoptosis/necrosis may be used. it is recommended to explain in detail the use of this combined term in the narrative part of the pathology report. pathogenesis: decrease of acinar cell zymogen granules leading to shrunken acinar cells with increased basophilia. • focal, lobular, or diffuse lesion. • reduced acinar diameter. • partial or complete loss of acinar cell zymogen granules leading to a reduced cell size and increased basophilia. • nuclei of acinar cells inactive • lack of fibrosis or adipocyte infiltration. • islets of langerhans are unaffected. • atrophy, acinar cell: loss of acinar cell basophilia and decreased zymogen granules resulting in small acini lined by small columnar cells almost completely devoid of cytoplasm and with a small and inactive nucleus; may be accompanied by fibrosis and minimal mononuclear cell infiltrates. • focus, basophilic: basophilic cells of normal size and commonly slightly enlarged; nulcei slightly enlarged and with prominent nucleoli. • peri-insular halos: tele-insular acinar cells have relatively less zymogen granules when compared to periinsular acinar cells. the morphology of the exocrine pancreatic acini may be altered due to several physiological conditions, such as anorexia/inanition. the volume of the zymogen granules and rer is reciprocally related. during protein synthesis, rer is increased with a proportionate decrease in zymogen granules. in moribund and/or anorexic animals with protein deficiency, the zymogen granules are decreased and the cells are shrunken with apparently increased basophilia due to relative predominance of the basally located basophilic cytoplasm (longnecker and wilson 2002) . pathogenesis: decrease in number and/or size of acinar cells may be due to spontaneous or experimentally induced degenerative changes, apoptosis, or a sequel of chronic inflammation. • focal, lobular, or diffuse. • reduction in the number and/or size of acini. • loss of acinar cell basophilia and decreased zymogen granules resulting in small acini lined by small columnar cells almost completely devoid of cytoplasm and with a small and inactive nucleus. • relatively prominent intra and inter-lobular ducts. • pyknotic and karyorrhectic nuclei, apoptotic bodies, and mitotic figures may be present. • scattered to coalescing adipocytes within the interstitium. • variable degree of interstitial fibrosis. • variably dilated cyst-like or duct-like acini and/or ducts lined by cuboidal or flattened epithelial cells. • transitional structures containing mixtures of normal acinar cells, atrophic acinar cells, and cuboidal ductal cells. • may be accompanied by minimal to mild infiltration of lymphocytes or macrophages. • islets of langerhans are unaffected. • degranulation, acinar cell: diffuse reduction of zymogen granules but maintenance of the basophilic basal cytoplasm; no fibrosis or adipocyte infiltration. • peri-insular halos: tele-insular acinar cells have relatively less zymogen granules and more rer when compared to peri-insular acinar cells. in certain planes of section, areas with more tele-insular regions may give a false impression of atrophy. • inflammation, chronic: infiltration of mononuclear inflammatory cells and interstitial fibrosis are frequently accompanied by acinar cell atrophy of variable degree. comment: exocrine acinar atrophy is the most common spontaneous degenerative change in pancreas of both rats and mice. acinar atrophy may range from focal atrophic exocrine acini with no inflammation or fibrosis to diffuse atrophy of exocrine acini with replacement by adipose tissue and residual ducts, vasculature and islets of langerhans. acinar atrophy frequently represents the sequel of chronic inflammation and, as such, is often accompanied by infiltrates of mononuclear cells and fibrosis. it is recommended to record in standard toxicity studies for such lesions either atrophy or chronic inflammation, but not both. inflammation, chronic, should be recorded only, if the inflammatory changes are the predominant component. in rats, the acinar atrophy increases with age and the incidence varies with sex (males > females) and strain (bn/bi/wag/rij(f1) > crl:cd(sd) br = bn/bi > slc:wistar > hap:(sd) > f344 > osborne-mendel). in b6c3f1 mice, the incidence of spontaneous exocrine pancreatic atrophy is 1-2% in 2-year studies (boorman and sills 1999) . in rats, chronic protein or essential amino acid deficiency, copper deficiency, zinc deficiency, ethionine, hypophysectomy or high doses of glucagon induce loss of zymogen granules and pancreatic atrophy (svoboda et al. 1966; kitagawa and ono 1986; rao et al. 1987; koo and turk 1977) . malonaldehyde caused atrophy of exocrine pancreas in both male and female mice (ntp, 1988) . acinar atrophy has also been induced by pancreatic duct ligation eustis et al. 1990) . pathogenesis: deposition of mineral either secondary to cellular necrosis (dystrophic mineralization) or secondary to hypercalemia (metastatic mineralization). • focal, lobular, or diffuse. • deposits of dark basophilic granular material (on h&e) within exocrine acini, ducts or interstitium. • artifacts: hematoxylin stain deposits (distribution unrelated to tissue structures), acid hematin (use of unbuffered formalin; dark brown to black, tropism for erythrocytes). • pigment: lipofuscin and porphyrin appear brown to golden brown in h&e slides and may further be differentiated from mineralization by special stains. comment: dystrophic calcification occurs in necrotic/injured tissue even in animals with reference range serum calcium levels, whereas metastatic calcification occurs in hypercalcemic animals throughout the body, especially within interstitial tissues and blood vessel walls. the two commonly used stains for detecting calcium are alizarin red and von kossa. pathogenesis: extracellular deposits of chemically diverse complex insoluble polypeptides. • light eosinophilic homogenous amorphous extracellular material within the tunica media of blood vessels, within the interstitium and along basement membranes. • variable degree of atrophy and loss of intervening acini and ducts may occur, if amyloid deposition is prominent. • green birefringence using polarized light with congo red stain. • inflammation: the inflammatory cell infiltrate is associated with additional morphological features of inflammation such as edema, hemorrhage, necrosis, and/or fibroplasia. • granulocytic leukemia: infiltration of neutrophil precursors and/or abnormal neutrophils will probably be present along with mature neutrophils; infiltration of similar neoplastic cells is likely present in other organs. • lymphoma: infiltration of monomorphic population of lymphocytes (often with atypical, increased and/or abnormal mitoses); infiltration of similar neoplastic cells is likely present in other organs. in toxicity studies, inflammatory cell infiltrates are encountered more commonly than inflammation (pancreatitis). the term pancreatitis (or inflammation) should not be confused with or used in lieu of infiltrate (plus cell type). the term infiltrate (plus cell type) should be used instead of inflammation (or pancreatitis) when there is no tissue injury/reaction associated with the inflammatory cell infiltrate. also, the inflammatory cell infiltrate should be qualified with the type (name) of the cells that are predominant, such as lymphocytic, neutrophilic, etc. the use of terminology summarizing the nature of the infiltrates as suppurative (in lieu of neutrophilic), granulomatous (in lieu of macrophage), and chronic (in lieu of lymphocytic, plasmacytic, mononuclear) is not recommended since these terms imply inflammation. the term inflammation (pancreatitis) should be reserved for lesions where the inflammatory cell infiltrate is associated with tissue injury/reaction such as edema, congestion, acinar cell degranulation, necrosis, vascular fibrinoid necrosis, hemorrhage, fat necrosis or saponification (mann et al. 2012) . modifier: type of inflammatory cell that represents the predominant cell type in the inflammation pathogenesis: infiltration with neutrophils (infiltrate, neutrophil), eosinophils (infiltrate, eosinophil), mononuclear cells (infiltrate, mononuclear cell) or a combination of more than one type (infiltrate, mixed) with additional histological features of inflammation, e.g. hemorrhage, edema, fibroplasia. in control rats, the most common cause of inflammation is spontaneous arteritis involving the pancreatoduodenal artery (coleman et al. 1977) . for pancreatitis induced by xenobiotics, the pathogenesis usually involves release of inactive proenzymes from exocrine pancreas and activation of these digestive enzymes locally and systemically. • focally extensive or diffuse, involving predominantly the interstitium, but also acinar cells and intra-or interlobular ducts. • infiltrate of mononuclear or polymorphonuclear leukocytes into the gland parenchyma. • presence of other histological criteria of inflammation, e.g. hemorrhage, edema, fibroplasias. • islets of langerhans may be entrapped within the inflammation. inflammation, neutrophil • infiltrate predominantly neutrophilic; frequently accompanied by edema and congestion; acinar cell degranulation and necrosis, fibrinoid necrosis of small vessels and hemorrhage as well as fat necrosis and saponification may be present. • infiltrate predominantly mononuclear cell; frequently accompanied by acinar cell atrophy and mild acinar cell degeneration, ductal proliferation, interstitial fibrosis; mineralization of acini may be present. • infiltrate, inflammatory cell: other histologic features of inflammation such as edema, hemorrhage, necrosis, and/ or fibroplasias will be absent. • granulocytic leukemia: infiltration of neutrophil precursors and/or abnormal neutrophils will probably be present along with mature neutrophils; infiltration of similar neoplastic cells is likely present in other organs. • lymphoma: infiltration of monomorphic population of lymphocytes (often with atypical, increased and/or abnormal mitoses); infiltration of similar neoplastic cells is likely present in other organs. • postmortem autolysis: uniform and often diffuse change in acinar cells starting with loss of basophilia, gradual loss of definition and final lysis; no inflammatory cell infiltration, congestion or edema. • atrophic, acinar cell: minimal to mild infiltrates of mononuclear cells and fibrosis, but atrophy is the predominant component. comment: when a mononuclear cell or mixed infiltrate is considered to represent an inflammatory process (inflammation, mononuclear cell or inflammation, mixed) and other morphologic features (acinar cell atrophy and mild acinar cell degeneration, ductal proliferation, interstitial fibrosis; mineralization of acini) associated with the infiltrate suggest an ongoing/continuing inflammatory process, the modifier 'chronic' may be included in the diagnosis (i.e. inflammation, mononuclear cell, chronic) to better characterize the finding. spontaneous inflammation, neutrophilic or mixed of the pancreas is very uncommon in control mice and rats. the severity of inflammation within pancreas can range from mild edematous inflammation to severe necrotizing inflammation. acute inflammation is observed in humans and some rodents treated with several classes of drugs belonging to antimicrobials, estrogens, corticosteroids, diuretics, antibiotics, analgesics/anti-inflammatory agents, statins, ace inhibitors, and highly active antiretroviral therapy (haart) drugs (badalov et al. 2007) . several animal models are used for studying pancreatitis such as choline-deficient ethionine supplemented diet; intraperitoneal injection of arginine; intraperitoneal or intravenous administration of secretogogues such as cholecystokinin analogue (caerulein), muscarinic receptor agonist (carbachol), anticholinesterases (organophosphate); sepsis (lps); vascular compromise (hypovolemic shock, occlusion of pancreatoduodenal artery, occlusion of splenic and/or gastroduodenal vein occlusion); closed duodenal loop procedure; and obstruction of pancreatic duct or common biliopancreatic duct (chan and leung 2007) . acute pancreatitis and necrosis are also seen in cases of zinc toxicity, copper deficiency and extension of inflammation from other lesions such as gastritis secondary to oral gavage of irritating chemicals (boorman and sills 1999; greaves 2012) . spontaneous chronic inflammation is sporadically found in aged rats and mice. chronic inflammation occurs more commonly in diabetic (bb) wistar rats than their non-diabetic counterparts (wright et al. 1983) . chronic exposure to manganese causes chronic pancreatitis, fibrosis and acinar atrophy in rats (scheuhammer 1983) . in many cases, chronic inflammation progresses into pancreatic atrophy and subsequent multifocal to diffuse fatty infiltration. acinar atrophy frequently represents the sequel of chronic inflammation and, as such, is often accompanied by infiltrates of mononuclear cells and fibrosis. it is recommended to record in standard toxicity studies for such lesions the predominant morphology, either atrophy or chronic inflammation, not both. inflammation, chronic, should be recorded only, if the inflammatory changes are the predominant component. refer also to the inhand monograph on the cardiovascular system. synonyms: arteritis; vasculitis; polyarteritis pathogenesis: spontaneous or induced inflammation of vascular wall in the pancreas. • typically affects muscular wall of small to medium sized arteries or veins. • variable mixed inflammatory cell infiltrate within and around vessel. • possible presence of fibrinoid necrosis of vessel wall. • proliferation of endothelium and thickening (fibrosis) of vessel wall. • inflammation, acute: inflammatory processes predominantly within the parenchyma; vascular involvement only secondary and representing a minor proportion of the inflammatory process. • infiltrate, inflammatory cell: lack of vascular orientation, no other features of inflammation such as hemorrhage or fibrinoid necrosis. comment: inflammation of the vasculature, if present, is frequently noted in histological sections of pancreas due to the prominent pancreato-duodenal artery and other small caliber interlobular pancreatic arteries, and mesenteric vessels in the vicinity. arteritis lesions may be due to immune-mediated etiology as seen in (nzbxnzw)f1 hybrid, and mrl/mp mice or due to hypertension as seen in spontaneously hypertensive rat (shr) strains. arteritis due to drug/chemical treatment is occasionally observed and may depend on the species, strain and sex. examples include vasoactive agents like angiotensin, norepinephrine, dopamine agonists (like fenoldopam mesylate) and xanthine compounds which cause focal to diffuse medial necrosis and hemorrhage especially within the small and medium-caliber mesenteric, pancreatic and renal arteries; and non-vasoactive compounds like 2-amino-5-nitrophenol, nitrofurantoin, or phenacetin. pathogenesis: accumulation of tissue fluid in the interstitium resulting from increased vascular permeability due to release of pancreatic enzymes, increased hydrostatic pressure in vasculature, decreased oncotic pressure, impaired coagulation system, or impaired lymphatic drainage. • focally extensive or diffuse. • distension of the interstitial tissue forming clear spaces or spaces filled with lightly eosinophilic material. • minimal inflammatory cell infiltrate may be present in some cases. • increase in total pancreatic volume and weight. • inflammation, acute: usually associated with tissue and vascular damage resulting in exudative edema and inflammatory cell infiltrate. comment: edema within the exocrine pancreas may be exudative (inflammatory edema due to capillary injury secondary to leakage of pancreatic enzymes) or transudative (hydrodynamic derangement secondary to increased hydrostatic osmotic pressure and decreased oncotic pressure). the exudative edema is usually accompanied by inflammatory cell infiltrate and tissue injury. examples of chemical induced pancreatic edema have been documented in mice treated with p-nitrophenol and rats treated with d & c yellow no. 11 and pcb mixtures in us-ntp studies. pathogenesis: hemorrhage can occur from acinar necrosis, inflammation, vascular injury, or tumors. • presence of erythrocytes in interstitial tissue, acini, ductules, or ducts. • angiectasis: blood present within dilated vascular lumina. • artifact: erythrocytes on the surface of the pancreas sample or infiltrating from the surface into interstitial tissue; a result of necropsy procedure. comment: islet hemorrhage has been described as a spontaneous finding in sprague-dawley rats (imaoka et. al. 2007 ). if prominent, this may involve peri-insular exocrine tissue. pathogenesis: increased size of pancreatic exocrine acinar cells due to increased trophic factors. • usually diffuse distribution. • enlarged acinar cells with more abundant cytoplasmic volume and more numerous zymogen granules. • no increase in the number of cells per acinus. • larger nuclei with prominent nucleoli. • increase in pancreas to body weight ratios. • halos, peri-insular, increased: characteristic distribution pattern; exocrine acini (peri-insular) surrounding the islets of langerhans have more zymogen granules and slightly larger nuclei than their distal (tele-insular) counterparts. • hyperplasia, acinar cell: increased number of cells per acinus. comment: exocrine pancreatic acinar hypertrophy results from dietary and trophic factors. feeding rats with raw but not heat-treated soy flour (lack trypsin inhibitors) caused acinar hypertrophy initially. however, with continued feeding, the hypertrophic change progressed to hyperplasia with marked increase in dna content. this hypertrophic change is attributed to the presence of trypsin inhibitors within the raw soy flour and its ability to stimulate the secretion of cholecystokinin by feed back mechanism (crass and morgan 1982; folsch et al. 1978) . similarly, administration of gastrin (but not secretin analogues) like pentagastrin, pancreozymin, and peptavlon also caused pancreatic acinar cell hypertrophy (rothman, and wells 1967) . administration of isoprenaline (isoproterenol) also cased an increase in pancreatic weight due to acinar cell hypertrophy and increase in zymogen granules (sturgess and reid 1973) . however, pancreas weight and pancreas to body weight ratios are not commonly recorded or calculated in toxicity studies. synonyms: eosinophilic change; focal eosinophilic hypertrophic cells; hypertrophy, peri-insular pathogenesis: hypertrophy of pancreatic exocrine acinar cells surrounding the islets of langerhans. • hypertrophy of exocrine pancreatic acini surrounding the islets of langerhans. • acinar cells with more abundant cytoplasmic volume with larger zymogen granules than tele-insular acinar cells (located distantly from the islets). • larger nuclei with more nucleoli than tele-insular acinar cells. • hypertrophy, acinar cell: no local association with islets, usually multifocal to diffuse distribution. the difference in the size of peri-and tele-insular acinar cells is greater in mice than in rats, resulting in more prominent peri-insular halos in mice. the peri-insular acinar cells are more resistant (3 hours) to pilocarpine-induced degranulation than the tele-insular acinar cells (1 hour). the size of peri-insular halos is markedly reduced in alloxaninduced diabetic pancreata compared to control non-diabetic rats. these features of the peri-insular halos are due to the hormones (mainly ghrelin and insulin) secreted by the betacells in islets of langerhans that are locally enriched due to the insulo-acinar capillary anastomoses or due to diffusion. the peri-insular halos are not recorded in routine toxicity studies but recording any alterations within these halos may provide important information about chemicals affecting islet cells such as alloxan or about chemicals directly affecting the exocrine pancreas like pilocarpine. pathogenesis: degranulation of the peri-insular acinar cells following loss or decrease in trophic factors released from the surrounding the islets of langerhans. • decreased zymogen granules within exocrine pancreatic acini surrounding the islets of langerhans. • loss of size distinction between the peri-insular acini located adjacent to the islets of langerhans (usually larger) and the tele-insular acini located distantly from the islets (usually smaller than peri-insular acini) comment: the difference in the size of peri-and tele-insular acinar cells is greater in mice than in rats, resulting in more prominent peri-insular halos in mice. the peri-insular acinar cells are more resistant (3 hours) to pilocarpine-induced degranulation than the tele-insular acinar cells (1 hour). the size of peri-insular halos is markedly reduced in alloxaninduced diabetic pancreata compared to control non-diabetic rats. these features of the peri-insular halos are due to the hormones (mainly insulin) secreted by the β-cells in islets of langerhans that are locally enriched due to the insulo-acinar capillary anastomoses or due to diffusion. the peri-insular halos are not recorded in routine toxicity studies but recording any alterations within these halos may provide important information about chemicals affecting islet cells such as alloxan or about chemicals directly affecting the exocrine pancreas like pilocarpine. synonyms: basophilic-atypical acinar cell focus; focal cellular change; focal basophilic cellular change; cytological alteration pathogenesis: focal formation of morphologically atypical pancreatic exocrine acinar cells. • tinctorially distinct focus with decreased zymogen granules and increased basophilia due to abundance of rer. • affects single or multiple contiguous acini with oval to irregular shape without encapsulation and with retained angular shape of the pancreatic lobe. • no compression or displacement of adjacent pancreatic acini • cellular hypertrophy is commonly seen. • slightly enlarged basal to parabasal nuclei with prominent nucleoli. • hyperplasia, acinar cell, focal: increased number of cells per acinus, usually no increase of cytoplasmic basophilia. • zymogen granules decreased, acinar cell: reduced cell size due to loss of zymogen granules, nuclei inactive, the incidence of basophilic foci is 6.6% in control and 5.4% in corn oil gavage historical control male f344 rats in the ntp database . basophilic foci occur also in mice, but at a much lower incidence than in rats (roebuck et al. 1980) . there is an increase in the incidence of basophilic foci in rats treated with 4-hydroxyaminoquinoline-1-oxide (4haqo), 7,12-dimethyl-benzanthracene (dmba), n5-(n-methyl-n-nitrosocarbamoyl)-l-ornithine (mnco), raw soy bean flour, plant trypsin inhibitors, and azaserine. the proliferative ability of exocrine acinar cytological alterations as measured by tritiated thymidine autoradiography and mitotic index indicated that basophilic foci have similar proliferative ability as the surrounding normal exocrine acini (rao et al. 1989 ). thus, unlike focal hyperplasia, the basophilic foci should not be considered as preneoplastic . the cytologic appearance of acinar cells within the basophilic foci may indicate an altered capacity for, or a defect in, the synthesis of secretory proteins. basophilic foci stained positively with gammaglutamyltranspetidase (ggt) while eosinophilic foci stained negatively. a microscopic morphological entity described as spontaneous pancreatic acinar hypertrophic foci in rats by chiu (chiu 1983 ) may indeed be basophilic foci because they share several features such as increased incidence with age, and they are non-hyperplastic and non-neoplastic. pathogenesis: periductal oval cells or acinar/endocrine intermediate transitional cells transdifferentiate into foci morphologically identical to hepatocytes within the liver. • polygonal cells with central nuclei and abundant finely granular eosinophilic cytoplasm (morphologically identical to hepatocytes). • located adjacent to ducts and islets of langerhans. • usually well integrated into surrounding tissue. • hepatocytes have well developed bile canaliculi • hypertrophy, acinar cell: pancreatic exocrine acini; focal to lobar distribution. • halos, peri-insular: pancreatic exocrine acini; almost always surrounding islets. • ectopic liver tissue: usually circumscribed and not wholly integrated into the 'host' tissue; no evidence of dysplasia or history of tissue injury. comment: the incidence of metaplastic hepatic foci is less than 1% in control rats and mice. these lesions are occasionally observed in the rat pancreas and less frequently in the mouse pancreas. the pathogenesis of these sporadic lesions is not known. experimentally, these metaplastic hepatic foci within the rat exocrine pancreas may be induced by several protocols such as copper depletion followed by copper repletion (s), ciprofibrate feed model , and multiple subcutaneous injections of cadmium chloride (konishi et al. 1990) . metaplastic hepatic foci in the pancreas were also induced in a transgenic mouse model where kgf (fgf7) was over-expressed in the pancreas under the control of the rat insulin promoter (krakowski et al. 1999 ). an increase in metaplastic hepatic foci in toxicological studies may also be due to the result of test article-induced pancreatic atrophy and subsequent hepatic transdifferentiation. synonym: tubular complexes pathogenesis: acinar cells transdifferentiate or take the appearance of ducts especially in areas of chronic pancreatitis. • focal, circumscribed lesions surrounded by normal exocrine acini. • variable caliber ductules lined by flat cuboidal epithelial cells. • located in the acinar compartment rather than in the native ducts. • intermixed with pale atrophic exocrine acini. • islets not usually involved. • hyperplasia, ductular: do not have intermixed pale exocrine acini. • atrophy, acinar cell: ductular metaplasia may a component in some cases of atrophy and is considered a reparative process. comment: exocrine acinar ductular metaplasia is usually secondary to chronic pancreatitis and atrophy and is considered a reparative process. the diagnosis of ductular metaplasia is not commonly used in toxicologic studies since it is one of the features of atrophy. in dmba implantation studies in rats that resulted in pancreatic ductular adenocarcinoma, these lesions were considered preneoplastic; however, in the majority of cases these lesions do not progress to neoplasia and are of reparative or adaptive nature. the diagnosis of ductular metaplasia may be considered in those studies where a progression to ductular hyperplasia and neoplasia is noted. synonyms: dilatation; luminal distension; cystic duct; ductal cyst pathogenesis: luminal dilatation due blockage of the intralobular or interlobular ducts secondary to fibrosis or due to calculi. • solitary or multiple tortuous irregular enlarged lumina. • lined by flattened cuboidal epithelial cells. • may be accompanied by mild interstitial infiltration of lymphocytes and plasma cells. • inspissated secretions may be present. comment: duct ectasia is the most common age-associated ductal change in albino and gray norway, august hooded, fisher 344, hap:(sd), and crl:cobs cd (sd) rats (denda et al. 1994) . the lesions of duct ectasia or interlobular cystic ducts are uncommon and the incidence is usually less than 1% in rats and mice. these lesions usually result from blockage of inter-and intra-lobular ducts either proximally or distally due to chronic pancreatitis or rare inspissated secretory material. pathogenesis: pancreatic stellate cells reaction to acute or chronic inflammation or toxicity. • focal, lobular, or diffuse. • increase in the interstitial connective tissue due to pancreatic stellate cell proliferation and collagen deposition. • may be accompanied by inflammatory cell infiltrates. • amyloid: abundant extracellular eosinophilic amorphous ground substance that exhibits apple green birefringence in congo red stained sections under polarized light and absence of fibroblast cell proliferation. comment: collagen may be identified by its birefringence under polarized light and can be stained histochemically using masson's trichrome, and van gieson protocols. in some adult control rats, there may be some peri-insular interstitial fibrosis that extends for short distance into exocrine pancreas. this should be distinguished from fibrosis resulting from tissue insults based on the severity, distribution and the accompanying chronic inflammatory cell infiltrates. the lesions described here cover the currently known spectrum of proliferative findings in conventional strains of (wildtype) rats and mice. the majority of proliferative lesions in transgenic mouse models of human pancreatic cancer resemble the lesions of wildtype animals. lesions that occur only in specific transgenic mouse models, like mucinous cystadenomas with ovarian-like stroma, are not described here (hruban et al. 2006) . hyperplasias and tumors of the exocrine pancreas are rare and age-related conditions in control rats and mice (longnecker and millar 1990; boorman and sills 1999) . the separation of acinar hyperplasia and adenoma can be difficult and in the end may be arbitrary as these lesions seem to represent a continuum. hyperplasia of ducts in circumscribed fibrous areas is often found in aged rats. duct-like structures do not indicate an origin from pancreatic ducts as is the case in humans. although hyperplasia of ducts may be seen in aged rats, it is still questionable if true ductular neoplasia occurs in rats such as humans (cystadenoma, cystadenocarcinoma) (greaves and faccini 1992) . in mice, no spontaneous ductal cell hyperplasia or neoplasia has been described. animal models with carcinogens revealed that rats develop acinar cell carcinomas whereas hamsters develop ductal carcinomas with the same carcinogen. this suggests that the species is a major determinant of the phenotype in carcinomas of the pancreas (longnecker 1986; longnecker 1994) . mice are relatively insensitive to the induction of pancreatic tumors with chemicals that are known to be tumorigens in rats (boorman and sills 1999) . hyperplasia, acinar cell (figures 228 and 229) synonym: focus, eosinophilic histogenesis: acinar cells. • focal lesions usually larger than an average, unchanged islet. • increased number of cells per acinus. • may exhibit tinctorial variation from surrounding tissue. • merge usually imperceptibly with adjacent tissue; no or only minimal compression or displacement of adjacent acinar tissue. • usually non-encapsulated. • acinar architecture usually maintained or slightly altered at the most. • low to high mitotic index, nuclear polymorphism and nuclear crowding possible. • adenoma, acinar cell: distinct demarcation from the surrounding tissue with compression and sometimes encapsulation; altered architecture. • focus, basophilic: enlarged acinar structures with increased basophilia due to abundance of rer; number of cells per acinus not increased; no compression, acinar structure not altered. • hypertrophy, acinar cell: enlarged acinar cells with increased zymogen granules; number of cells per acinus not increased; usually diffuse distribution. comment: the separation of acinar hyperplasia and adenoma can be difficult and in the end may be arbitrary as these seem to be a continuum. some foci of hyperplasia may be just at the edge of an adenoma and thus categorized as such due to plane of section. the grade of alteration of acinar structure and compression of adjacent tissue are the most important differential diagnostic criteria. a sub-category of focal acinar hyperplasia with cell en-largement due to an increase of zymogen granules has been termed "focus, eosinophilic". eosinophilic foci are thought to be part of a continuum of lesions that subsequently progress into adenomas and adenocarcinoma (rao et al. 1989; scarpelli et al. 1984) . in contrast to basophilic foci, these foci are positive for atpase and glutathione-s-transferase µ histochemical stains. the incidence of eosinophilic foci is 2.6% in male f344 rats (eustis and boorman 1985) . eosinophilic foci occur also in mice, but at a much lower incidence than in rats (roebuck et al. 1980 ). due to the difficulties to differentiate eosinophilic foci from focal hyperplasia in h&e stained sections, it is recommended to diagnose eosinophilic foci not separately but to collect them under focal hyperplasia in this nomenclature system. acinar hyperplasias have a low spontaneous incidence in rats and mice that increase with age (longnecker and millar 1990; boorman and sills 1999) . histogenesis: intra-and inter-lobular pancreatic ducts. • multiple cross section profiles of tortuous hyperchromatic ductular cells within the acinar parenchyma. • ducts with increased number of lining epithelial cells often forming papillae. • protruding papillae may cause partial obliteration of the lumen. • varying levels of cellular pleomorphism and atypia may be present. • dilated tubules lined by flattened epithelium may occur. • mucus metaplasia in hyperplastic duct epithelium may occur in transgenic mouse models of pancreatic neoplasia. • adenoma, ductal cell: complex of ductular structures; focal acinar atrophy leading to increased numbers of ducts/unit area. comment: hyperplasia ductal cell is more frequently noted within the intrapancreatic ducts than in the extrapancreatic ducts. hyperplasia of ducts in circumscribed fibrous areas is often found in aged rats. in mice, no spontaneous ductal cell hyperplasia or neoplasia has been described. ductal phenotype may occur under experimental conditions after administration of dmba (wendt et al. 2007 ), infection with reovirus 3 (greaves 2012), feeding a western-style diet (xue et al. 1996) , and in transgenic mice (kras oncogene) (grippo et al. 2003) . transgenic mouse models for human pancreatic cancer may develop atypical ductal hyperplasia with mucin accumulation within tall columnar cells lining the ducts (figure 231 ) (hingorani et al. 2003; aguirre et al. 2003) . following human pathology, these preneoplastic lesions are termed murine pancreatic intraepithelial neoplasia (mpanins) (hruban et al. 2006 ). morphologically they range from ducts lined with an increased number of monomorphic tall columnar mucinous cells to multilayered lesions with cribriform growth and loss of cell polarity (figure 232) . a grading scheme of panin has been introduced (hruban et al. 2006) . adenoma, acinar cell (figures 233 and 234) histogenesis: acinar cells • compression of adjacent tissue often present. • encapsulation may occur but is often not present. • sharp demarcation from surrounding normal pancreatic tissue. • architecture is increasingly altered with increasing size. • cells usually well-differentiated. • exhibit variable degree of mitotic index, and nuclear polymorphism. • hyperplasia, acinar cell: no encapsulation or sharp demarcation, no or only slight alteration of acinar structure. • adenocarcinoma, acinar cell: local invasion or metastases. comment the separation of acinar hyperplasia and adenoma can be difficult and in the end may be arbitrary as these seem to be a continuum. some foci of hyperplasia may be just at the edge of an adenoma and thus categorized as such due to plane of section. histogenesis: intrapancreatic ducts. • complex of ductular structures lined by a high cuboidal epithelium resembling that of normal ductules. • hyperplasia, ductal cell: ducts with hyperplastic cells, only partly obliterating the lumen, found within focal fibrous areas. comment: duct-like structures do not indicate an origin from pancreatic ducts such as occurs in humans. although hyperplasia of ducts may be seen in aged rats, it is still questionable if true ductular neoplasia occurs in rats as it does in humans (cystadenoma, cystadenocarcinoma) (greaves and faccini 1992) . in mice, no spontaneous ductal cell hyperplasia or neoplasia have been described. pancreatic neoplasm with ductal phenotype may occur under experimental conditions after administration with dmba (wendt et al. 2007 ), infection with reo-virus 3 (greaves 2012), feeding a western-style diet (xue et al. 1996) , and in transgenic mice (kras oncogene) (grippo et al. 2003) . histogenesis: acinar cells. diagnostic features • glandular, trabecular or solid growth pattern. • loss of acinar architecture. • cellular pleomorphism and anaplasia. • local invasion or distant metastases. • may be associated with scirrhous reactions. • adenoma, acinar cell: no local invasion or metastases. comment: animal models of chemical carcinogenesis revealed that rats develop acinar cell carcinomas whereas hamsters develop ductal carcinomas with the same carcinogen. this suggests that the species is a major determinant of the phenotype in carcinomas of the pancreas (longnecker 1986; longnecker 1994) . azaserine is an effective pancreatic carcinogen in rats which initiates a sequence of focal proliferative changes in acinar cells that develop into carcinomas. the acinar phenotype is mostly retained but focal development of duct-like structures has been noted in a few carcinomas (longnecker et al. 1992) . mice are relatively insensitive to the induction of pancreatic tumors with chemicals that are known to be tumorigenic in rats (boorman and sills 1999) . squamous cell carcinoma of the exocrine pancreas has been experimentally induced in mice and has morphologic features of squamous cell carcinoma that occurs at other sites (dixon and maronpot 1994) . the transgenic mouse model bearing the elastase promoter-sv40-early antigen construct (ela-1-sv40 t) develop focal acinar cell proliferation that progresses into acinar cell carcinomas while mostly retaining acinar differentiation, although in some cases they can develop into undifferentiated tumors (glasner et al. 1992) . a consensus report and recommendations for a standardized nomenclature with definitions and associated images was developed for the pathology of genetically-engineered mouse models of pancreatic exocrine neoplasia (hruban et al. 2006) . histogenesis: intrapancreatic ducts. • malignant features, invasive growth. • cell atypia. • duct-like structures often accompanied by a dense fibrous stroma. • adenocarcinoma, acinar cell: normally no ductular structure. comment: duct-like structures do not indicate an origin from pancreatic ducts such as occurs in humans. although hyperplasia of ducts may be seen in aged rats, it is still questionable if true ductular neoplasia occurs in rats as it does in humans (cystadenoma, cystadenocarcinoma) (greaves and faccini 1992) . pancreatic adenocarcinomas induced by dmba implantation in rats showed strong keratin, cytokeratin 19 and cytokeratin 20 expression by immunohistochemistry, consistent with a ductal phenotype (jimenez et al. 1999) . implantation of dmba in rats induced transdifferentiation of acinar cells to ductal cells and provided precursor lesions (tubular complexes) for the development of ductal adenocarcinoma (bockman et al. 2003) . in mice, no spontaneous ductal cell hyperplasia or neoplasia has been described. pancreatic intraepithelial precursor lesions in small caliber pancreatic ducts and ductal adenocarcinoma were induced by dmba implantation in mice (wendt et al. 2007 ). aggressive pancreatic ductal adenocarcinomas may occur in transgenic mice (kras oncogene) after blockage of tgf-β signalling (ijichi et al. 2006) . a consensus report and recommendations for a standardized nomenclature with definitions and associated images was developed for the pathology of genetically-engineered mouse models of pancreatic exocrine neoplasia (hruban et al. 2006) . in genetically-engineered mice, panin has been described as a preneoplastic lesion for adenocarcinomas, but conclusive histopathogenesis has not been shown. we thank dr. rupert kellner for manuscript review and ms. beth mahler, epl inc., for image editing. in addition, we acknowledge the tremendous help provided by ms. emily singletary, epl inc., in providing several images from the national toxicology program image database. we also thank dr. kyathanahalli janardhan, ils inc., for providing immunohistochemistry and hematoxylin & esoin images of gastrointestinal stromal tumors and gastric neuroendocrine tumors. figure 67 indicating maintained polarity of epithelium and complete differentiation to keratinocytes. figure 73 ---rat nonglandular stomach. carcinoma squamous cell, arising from diffuse severe hyperplasia, squamous cell. foci of hyperplastic basal cells in the glandular mucosa close to the limiting ridge. as this lesion is considered to originate from nonglandular stomach it should be collected under the term "nonglandular stomach, hyperplasia, basal cell". figure 71 ---higher magnification of figure 70, showing the basal cell character of the lesion. figure 72 ---mouse nonglandular stomach. papilloma, squamous cell. figure 127 --mouse colon. protozoa, probably trichomonas muris. figure 128 --mouse colon. neuronal degeneration, myenteric plexus with formation of hyaline inclusions in ganglion cells (flavivirus infection). figure 129 --mouse colon. diverticulum, characterized by extension of intact mucosa into subserosal tissue. figure 130 --mouse colon. multiple diverticula, some of them cystic (arrows) inflammation, mononuclear cell. the vacuolation of acinar cells and other degenerative processes are covered by this term; viral etiology. figure 176 --mouse parotid gland. inflammation, mononuclear cell. intranuclear inclusion bodies, some of them indicated by arrows figure 178 --mouse parotid gland. edema. figure 179 --rat parotid gland. calculi, ductular, accompanied by atrophy, accumulation adipocytes and fibrosis. figure 180 --rat submandibular gland. ectasia, duct. figure 181 --mouse sublingual gland. fibrosis, accompanied by atrophy and angiectasis. figure 182 --rat parotid gland. focus, hypertrophic, basophilic. figure 183 --rat parotid gland. focus, hypertrophic, basophilic, exaggerated lesion. figure 184 --rat submandibular gland. metaplasia, acinar cell (arrows) aquiring the morphology of parotid acinar cells. figure 185 --rat submandibular gland. metaplasia squamous cell. figure 186 --rat sublingual gland. metaplasia, squamous cell. figure 199 --mouse parotid gland. carcinoma, squamous cell. higher magnification of figure 197. figure 200 -mouse submandibular gland. tumor mixed, malignant. figure 201 --mouse submandibular gland. myoepithelioma, malignant. pancreas figure 202--mouse pancreas. ectopic tissue, spleen. figure 203 --rat pancreas. vacuolation, acinar cell. figure 204 -mouse pancreas. accumulation adipocytes after severe atrophy, acinar cell. figure 223 --mouse pancreas. halo, peri-insular. figure 224--rat pancreas. focus, basophilic. figure 225 --rat pancreas. metaplasia,hepatocytic at the interface between endocrine and exocrine tissue apoptosis of mouse pancreatic acinar cells after duct ligation activated kras and ink4a/arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma intermittent oral coadministration of a gamma secretase inhibitor with dexamethasone mitigates intestinal goblet cell hyperplasia in rats salivary gland structure and function in experimental diabetes mellitus gastric hamartomatous tumours in a transgenic mouse model expressing an activated dioxin/ah receptor age changes in the salivary glands of wistar institute rats with particular reference to the submandibular glands druginduced acute pancreatitis: an evidence-based review in flynn's parasites of laboratory animals 2nd ed. american college of laboratory animal medicine genesis of esophageal parakeratosis and histologic changes in the testes of the zinc-deficient rat and their reversal by zinc repletion abrikossoff's tumor hyperplasia and tumours in lung, breast and other tissues in mice carrying a rar beta 4-like transgene proliferative and nonproliferative lesions of the rat and mouse cardiovascular system non-proliferative lesions of the alimentary canal in rats handbook of toxicologic pathology gastric ecl-cell hyperplasia and carcinoids in rodents following chronic administration of h2-antagonists sk&f 93479 and oxmetidine and omeprazole international classification of rodent tumors: the mouse. u mohr experimental obstructive adenitis in the mouse origin and development of the precursor lesions in experimental pancreatic cancer in rats lipid pigment (lipofuscin) accumulation in rat tongue muscle with aging secretion from minor salivary glands following ablation of the major salivary glands in rats the effect of aging on the rat submandibular gland: an ultrastructural, cytochemical and biochemical study gastric lesions in transforming growth factor beta-1 heterozygous mice pathology of mouse models of intestinal cancer: consensus report and recommendations exocrine and endocrine pancreas iarc who classification of tumours of the digestive system harderian and lacrimal glands resistance to starvation in albino rats fed from weaning on diets containing from 0 to 81 per cent of protein as casein intestinal lymphangiectasis and lipidosis in rats following subchronic exposure to indole-3-carbinol via oral gavage adrenergic mechanism responsible for submandibular salivary glandular hypertrophy in the rat san diego. 9-30. 1990. brown hr, and leininger jr. changes in the oral cavity lipofuscin in salivary glands in health and disease. oral surg oral med oral pathol effects of cholestyramine and diet on small intestinal histomorphometry in rats virus-plus-susceptibility gene interaction determines crohn's disease gene atg16l1 phenotypes in intestine case report: a rare congenital esophageal malformation on double esophagus in the rat multiple tumor types appear in a transgenic mouse with the ras oncogene acute pancreatitis: animal models and recent advances in basic research chemical carcinogenesis of the gastrointestinal tract in rodents: an overview with emphasis on ntp carcinogenesis bioassays spontaneous basophilic hypertrophic foci of the parotid glands in rats and mice spontaneous hypertrophic foci of pancreatic acinar cells in cd rats phenotypic characterization of resident macrophages in submandibular salivary glands of normal and isoproterenol-treated rats pathological changes during aging in barrier-reared fischer 344 male rats the effect of long-term feeding of soya-bean flour diets on pancreatic growth in the rat gavage-related reflux in rats: identification, pathogenesis, and toxicological implications (review) (review) salivary gland components involved in the formation of squamous metaplasia submandibular gland adenocarcinoma of intercalated duct origin in smgb-tag mice tumours of the salivary and lachrymal glands, nasal fossa and maxillary sinuses adriamycin produces a reproducible teratogenic model of vertebral, anal, cardiovascular, tracheal, esophageal, renal, and limb anomalies in the mouse salivary gland tumors in transgenic mice with targeted plag1 proto-oncogene overexpression exocrine pancreas multifocal ductal cell hyperplasia in the submandibular salivary glands of wistar rats chronically treated with a novel steroidal compound digestive system international classification of rodent tumors: the mouse. u mohr gastric gland degeneration induced in monkeys by the cck-b/gastrin receptor antagonist ci-988 tumours of the pancreas nonproliferative and proliferative lesions of the rat and mouse female reproductive system role of apoptosis in duct obstructioninduced pancreatic involution in rats toxicity and carcinogenicity of chlorodibromomethane in fischer 344/n rats and b6c3f1 mice ulcerative typhlocolitis associated with helicobacter mastomyrinus in telomerase-deficient mice a communicating intestinal duplication in a sprague-dawley rat apoptosis: a review of programmed cell death tumours of the salivary and lacrimal glands small and large intestine cleft palate caused by perfluorooctane sulfonate is caused mainly by extrinsic factors roles for inflammation and regulatory t cells in colon cancer proliferative lesions of the exocrine pancreas: relationship to corn oil gavage in the national toxicology program pathology of the fisher rat: reference and atlas time-sensitive reversal of hyperplasia in transgenic mice expressing sv40 t antigen mouse histopathology developmental mechanisms in normal and abnormal palate formation with particular reference to the aetiology, pathogenesis and prevention of cleft palate lesions of aryl-hydrocarbon receptor-deficient mice rapid restitution of the rat pancreas following acinar cell necrosis subsequent to ethionine influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat accelerated progression of gastritis to dysplasia in the pyloric antrum of tff2 -/-c57bl6 x sv129 helicobacter pylori-infected mice proliferative lesions of the non-glandular and glandular stomach in rats adenoma, adenocarcinoma, salivary gland, mouse tumours of the salivary gland color atlas of neoplastic and non-neoplastic lesions in aging mice a case report of a spontaneous gastrointestinal stromal tumor (gist) occurring in a f344 rat the influence of isoprenaline and propranolol on the submaxillary gland of the rat ectopic pancreas formation in hes1 -knockout mice reveals plasticity of endodermal progenitors of the gut, bile duct, and pancreas squamous cell carcinoma, forestomach, rat molecular definitions of cell death subroutines: recommendations of the nomenclature committee on cell death the proper role of nerves in salivary secretion: a review secretory responses in granular ducts and acini of submandibular glands in vivo to parasympathetic or sympathetic nerve stimulation in rats ethyl acrylate-induced gastric toxicity. i. effect of single and repetitive dosing icrc mouse with congenital megaesophagus as a model to study esophageal tumorigenesis. carcinogenesis characterization of the elsv transgenic mouse model of pancreatic carcinoma. histologic type of large and small tumors atlas of experimental toxicological pathology rat histopathology. a glossary for use in toxicity and carcinogenicity studies histopathology of preclinical toxicity studies. interpretation and relevance in drug safety evaluation proliferative and non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle and mesothelium triprolidine: 104-week feeding study in rats the granular convoluted tubule (gct) cell of rodent submandibular glands preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant kras in transgenic mice autophagy and pancreatitis inflammatory large bowel disease in immunodeficient rats naturally and experimentally infected with helicobacter bilis pathology of aging b6;129 mice salivary gland atrophy in rat induced by liquid diet chronic gastritis of the glandular stomach, adenomatous polyps of the duodenum, and calcareous pericarditis in strain dba mice idiopathic megaesophagus in a rat (rattus norvegicus) sexual dimorphism of submaxillary glands in mice in relation to reproductive maturity and sex hormones fundamentals of toxicologic pathology anatomy of the laboratory rat. the williams & wilkins company pancreatic acinar ultrastructure in human acute pancreatitis preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse response of rat salivary glands to mastication of pelleted vitamin a-deficient diet parotid gland papillary cystadenocarcinoma in a fischer 344 rat sex difference in l-glutamine d-fructose-6-phosphate aminotransferase activity of mouse submandibular gland enzyme secretion and fecal fat assimilation in the 95 percent pancreatectomized rat pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-β signaling in cooperation with active kras expression significance of inflammation-associated regenerative mucosa characterized by paneth cell metaplasia and beta-catenin accumulation for the onset of colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine age-and sex-related differences in spontaneous hemorrhage and fibrosis of the pancreatic islets in sprague-dawley rats brunner's gland lesions in rats induced by a vascular endothelial growth factor receptor inhibitor vanadium toxicity in mice: possible impairment of lipid metabolism and mucosal epithelial cell necrosis in the small intestine age changes in secretory function of male and female rat parotid glands in response to methoxamine and pilocarpine quantitation of autophagy in the pancreas at the tissue and cell levels. the pancreapedia. version 1.0 changes of gastric mucus glycoproteins with aspirin administration in rats naturally occurring mucoepidermoid carcinoma in the submandibular salivary gland of two mice acute parietal and chief cell changes induced by a lethal dose of lipopolysaccharide in mouse stomach before thrombus formation subchronic studies of doxylamine in fischer 344 rats 2-year toxicity study of doxylamine succinate in the fischer 344 rat sialodacryoadenitis (sda) infection, rat pathogenesis of sialodacryoadenitis in gnotobiotic rats immunohistochemical characterization of pancreatic tumors induced by dimethylbenzanthracene in rats experimental production of congenital malformations in strains of inbred mice by maternal treatment with hypervitaminosis a lineage commitment and maturation of epithelial cells in the gut blocking of histamine h2 receptors enhances parietal cell degeneration in the mouse stomach proliferative and nonproliferative lesions of the rat and mouse central and peripheral nervous systems sequential ultrastructural changes of the pancreas in zinc toxicosis in ducklings atrophy of villi with hypertrophy and hyperplasia of paneth cells in isolated (thiry-vella) ileal loops in rabbits. light-microscopic studies metabolic, traumatic, and miscellaneous diseases ultrastructure of pancreatic exocrine cells of the rat during starvation hyperkeratinization and hyperplasia of the forestomach epithelium in vitamin a deficient rats the effects of hypophysectomy on the digestive glands of the mouse pancreatic hepatocytes in fischer and wistar rats induced by repeated injections of cadmium chloride effect of zinc deficiency on the ultrastructure of the pancreatic acinar cell and intestinal epithelium in the rat tissue distribution, biochemical properties, and transmission of mouse type a aapoaii amyloid fibrils suppression of tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitisassociated colon carcinogenesis pancreatic expression of keratinocyte growth factor leads to differentiation of islet hepatocytes and proliferation of duct cells early toxicology signal generation in the mouse multigene phylogenetic analysis of pathogenic candida species in the kazachstania (arxiozyma) telluris complex and description of their ascosporic states as kazachstania bovina sp. nov., k. heterogenica sp. nov., k. pintolopesii sp. nov., and k. slooffiae sp. nov pancreatic metaplasia in the gastro-achlorhydria in wtc-dfk rat, a potassium channel kcnq1 mutant lipopolysaccharide induced apoptosis of rat pancreatic acinar cells influence of fraction size on the development of late radiation enteropathy. an experimental study in the rat hepatocytes in the mouse stomach oral cavity, esophagus and stomach cache river press tumors of the stomach the nomenclature of cell death: recommendations of an ad hoc committee of the society of toxicologic pathologists husbandry factors and the prevalence of age-related amyloidosis in mice acinar cell apoptosis in serpini2-deficient mice models pancreatic insufficiency experimental models of exocrine pancreatic tumours preneoplastic and neoplastic lesions of the pancreas in hamsters, mouse and rats handbook of toxicologic pathology recent results in animal models of pancreatic carcinoma: histogenesis of tumors tumours of the pancreas a yeast in the stomach of the mouse changes in the upper digestive tract and stomach dual infection with helicobacter bilis and helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/-mice results in colitis that progresses to dysplasia self-eating and selfkilling: crosstalk between autophagy and apoptosis international harmonization of toxicologic pathology nomenclature: an overview and review of basic principles recovery from amiodarone-induced lipidosis in laboratory animals: a toxicological study background lesions in laboratory animals. a color atlas isolation of helicobacter spp. from mice with rectal prolapses gastrointestinal hamartomatous polyposis in lkb1 heterozygous knockout mice aroclor 1254-induced intestinal metaplasia and adenocarcinoma in the glandular stomach of f344 rats induction of gastric gist in rat and establishment of gist cell line a morphological and histochemical study of a drug-induced enteropathy in the alderley park rat medline] national toxicology program ntp toxicology and carcinogenesis studies of malonaldehyde, sodium salt (3-hydroxy-2-propenal medline] national toxicology program ntp technical report on the toxicity studies of diethanolamine (cas no. 111-42-2) administered topically and in drinking water to f344/n rats and b6c3f1 mice national toxicology program ntp toxicology and carcinogenesis studies of scopolamine hydrobromide trihydrate (cas no. 6533-68-2) in f344 rats and b6c3f1 mice (gavage studies) medline] national toxicology program toxicology and carcinogenesis studies of sodium dichromate dihydrate (cas no. 7789-12-0) in f344/n rats and b6c3f1 mice (drinking water studies) salivary glands the influence of food additives and related materials on lower bowel structure and function histopathology of salivary and mammary gland tumors in transgenic mice expressing a human ha-ras oncogene in wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic background spontaneous poorly differentiated carcinoma with cells positive for vimentin in a salivary gland of a young rat constipation and megacolon in rats related to treatment with oxodipine, a calcium antagonist cell death (apoptosis) during pancreatic involution after raw soya flour feeding in the rat an immunohistochemical approach to differentiate hepatic lipidosis from hepatic phospholipidosis in rats severe focal sialadenitis and dacryoadenitis in nzm2328 mice induced by mcmv: a novel model for human sjögren's syndrome induction of stomach cancer in rats and mice by halogenated aliphatic fumigants paneth cells and innate mucosal immunity immunohistochemical evidence for the presence of progesterone receptor in rat submandibular glands aloe vera non-decolorized whole leaf extract-induced large intestinal tumors in f344 rats share similar molecular pathways with human sporadic colorectal tumors histologic and immunohistochemical studies of granular cell tumors in seven dogs, three cats, one horse, and one bird pathology of laboratory rodents and rabbits adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients regulation of salivary gland function by autonomic nerves is ethanol-induced damage of the gastric mucosa a hyperosmotic effect? comparative studies on the effects of ethanol, some other hyperosmotic solutions and acetylsalicylic acid on rat gastric mucosa azoxymethane-induced rat aberrant crypt foci: relevance in studying chemoprevention of colon cancer gastric and pancreatic lesions in rats treated with a pan-cdk inhibitor megaoesophagus in icrc mice megaoesophagus in the mouse: histochemical and ultrastructural studies pancreatic acinar cell regeneration following copper deficiency-induced pancreatic necrosis two populations of cells with differing proliferative capacities in atypical acinar cell foci induced by 4-hydroxyaminoquinoline-1-oxide in the rat pancreas role of periductular and ductular epithelial cells of the adult rat pancreas in pancreatic hepatocyte lineage role of periductal and ductular epithelial cells of the adult rat pancreas in pancreatic hepatocyte lineage. a change in the differentiation commitment drug-induced phospholipidosis: issues and future directions induction and origin of hepatocytes in rat pancreas acinar cell apoptosis and the origin of tubular complexes in caerulein-induced pancreatitis morphologic diversity of the minor salivary glands of the rat: fertile ground for studies in gene function and proteomics time course of stomach mineralization, plasma, and urinary changes after a single intravenous administration of gadolinium(iii) chloride in the male rat proliferative and nonproliferative lesions of the rat and mouse respiratory tract serrated lesions of the colorectum: review and recommendations from an expert panel pathologic and biochemical effects of azaserine in inbred wistar/lewis rats and noninbred cd-1 mice enhancement of pancreatic enzyme synthesis by pancreozymin inflammation and cancer. i. rodent models of infectious gastrointestinal and liver cancer helicobater-based models of digestive system carcinogenesis histologic scoring of gastritis and gastric cancer in mouse models esophageal impaction in bhe rats rita group nacad group revised guides for organ sampling and trimming in rats and mice-part effects of thyroxine and dexamethasone on rat submandibular glands early effects of alloxan on rat submandibular gland age-related changes of rat submandibular gland: a morphometric and ultrastructural study localization of indigenous yeast in the murine stomach pigmentary changes in rat oral mucosa following antimalarial therapy effects of chronic furosemide treatment on rat exocrine glands studies of pancreatic carcinogenesis in different animal models chronic manganese exposure in rats: histological changes in the pancreas prenatal repair of experimentally induced clefts in the secondary palate of the rat a comparative quantitative histological investigation of atrophic changes in the major salivary glands of liquid-fed rats characterization of dextran sodium sulfate-induced inflammation and colonic tumorigenesis in smad3(-/-) mice with dysregulated tgfβ acinar cell hydropic degeneration induced by intraductal instillation of solutions into the parotid glands of the rats virchows arch a excessive stimulation of salivary gland growth by isoproterenol small and large intestine, and mesentery subacute toxicity of a halogenated pyrrole hydroxymethylglutaryl-coenzyme a reductase inhibitor in wistar rats evidence of cell damage in rat salivary glands after isoproterenol terbutaline-induced enlargement of the rat parotid gland gastric morphological changes including carcinoid tumors in animals treated with a potent hypolipidemic agent, ciprofibrate serial histologic effects of rat submaxillary and sublingual salivary gland duct and blood vessel ligation control of cell identity in pancreas development and regeneration identification of a van der woude syndrome mutation in the cleft palate 1 mutant mouse growth pattern of experimental squamous cell carcinoma in rat submandibular glands-an immunohistochemical evaluation myoepitheliomas in inbred laboratory mice forestomach papillomas in flaky skin and steel-dickie mutant mice the effect of isoprenaline and pilocarpine on (a) bronchial mucus-secreting tissue and (b) pancreas, salivary glands, heart, thymus, liver and spleen the effects of chronic protein deficiency in rats. ii. biochemical and ultrastructural changes from cysteamine to mptp: structure-activity studies with duodenal ulcerogens tumors of the stomach immunohistochemical localization of keratin in experimental carcinoma of the mouse submandibular gland gastric and duodenal polyps in smad4 (dpc4) knockout mice induction of squamous cell carcinomas in the salivary glands of rats by potassium iodide colonic hamartoma development by anomalous duplication in cdx2 knockout mice proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system evaluation of the oral toxicity of acetaldehyde and formaldehyde in a 4-week drinking-water study in rats lower gastrointestinal tract animal models of stomach carcinogenesis poorly differentiated carcinoma of the parotid gland in a six-week-old sprague-dawley rat granular cell tumor of the oral cavity; a case series including a case of metachronous occurrence in the tongue and the lung spontaneous hyperplastic and metaplastic duct epithelium in the sublingual salivary glands of wistar rats chemically induced lipidosis of the small intestinal villi in the rat ethionine-induced atrophy of rat pancreas involves apoptosis of acinar cells. pancreas exocrine pancreas. in: haschek and rousseaux's handbook of toxicologic pathology transplantation of chemically induced metastatic mucinous adenocarcinomas of the jejunum and colon in rats morphogenesis of chemically induced neoplasms of the colon and small intestine in rats inflammatory large bowel disease in immunodeficient mice naturally infected with helicobacter hepaticus hyalinosis and ym1/ym2 gene expression in the stomach and respiratory tract of 129s4/svjae and wild-type and cyp1a2-null b6, 129 mice changes in the mouse exocrine pancreas after pancreatic duct ligation: a qualitative and quantitative histological study the neural regulation of salivary gland growth pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by dmba in mice: effects of alcohol and caffeine proliferative lesions of the intestine, salivary glands, oral cavity and esophagus in rats development of the rat sublingual gland: a light and electron microscopic immunocytochemical study cell proliferation and apoptosis in the exocrine pancreas of azaserine-treated rats and n-nitrosobis(2-oxopropyl)amine-treated hamsters pathological lesions in the spontaneously diabetic bb wistar rat: a comprehensive autopsy study epithelial cell hyperproliferation induced in the exocrine pancreas of mice by a western-style diet fordyce's granules of the incisor and molar gingiva in f344 rats the effects of omeprazole and famotidine on mucin and pge2 release in the rat stomach mechanisms of exocrine pancreatic toxicity induced by oral treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in female harlan sprague-dawley rats effects of testosterone on tumor induction and epidermal growth factor production in the mouse submandibular gland induction of adenocarcinomas in the submandibular salivary glands of female wistar rats treated with 7,12-dimethylbenz(a)anthracene the apoptosis-necrosis continuum: insights from genetically altered mice autophagy in pancreatic acinar cells in caerulein-treated mice: immunolocalization of related proteins and their potential as markers of pancreatitis key: cord-022353-q2k2krnm authors: w. quimby, fred; h. luong, richard title: clinical chemistry of the laboratory mouse date: 2007-09-02 journal: the mouse in biomedical research doi: 10.1016/b978-012369454-6/50060-1 sha: doc_id: 22353 cord_uid: q2k2krnm the frontier of clinical chemistry in the mouse has advanced and expanded because of two major events such as, the increasing reliance on mice in biomedical research, and increasing availability of practical yet sophisticated techniques and instrumentations that have allowed for the detection of a wider variety of biomarkers of disease. the progression of these two events is partially driven by the increasing regulatory demands related to safety/toxicity assessment of novel drug development. the availability of inbred strains has led to major breakthroughs in cancer, biology, and immunology. in addition, outbred stocks continue to be utilized in a wide variety of studies but particularly in the fields of toxicology and pharmacology. the power of these models to elucidate the genetic basis of disease cannot be overemphasized. this provided complete nucleotide sequences for each genome allowing investigators to quickly develop the equivalent murine model for many of the inherited human diseases. transgenic and knockout mice have helped clarify disease pathogenesis in virtually every area of medicine and often elucidated biochemical pathways, previously unknown, which are now subject to testing and quantification. it has been more than 20 years since publication of the first edition of the mouse in biomedical research, and since that time new emphasis has been placed on the mouse as a model for the pathophysiology and treatment of human diseases. during this time, the frontier of clinical chemistry in the mouse has advanced and expanded because of two major events: the increasing reliance on mice in biomedical research, and increasing availability of practical yet sophisticated techniques and instrumentations that have allowed for the detection of a wider variety of biomarkers of disease. the progression of these two events has been partially driven by the increasing regulatory demands related to safety/toxicity assessment of novel drug development. abbreviations used in this chapter are summarized in appendix 6-1. for the last quarter century, mice have been the most frequently used mammal in biomedical research, rising from 61% of all mammals used in 1983 to 71% in 1993 (national center for research resources 1997 . the nature of their use has changed dramatically during this time. during the first half of the 20th century, a great deal of emphasis was placed on the development of inbred strains. the availability of inbred strains has led to major breakthroughs in cancer, biology, and immunology (quimby 2002) . by 1970 there were approximately 250 inbred strains available. in addition, outbred stocks continue to be utilized in a wide variety of studies but particularly in the fields of toxicology and pharmacology. during the second half of the 20th century, investigators developed congenic lines and recombinant inbred strains, each having an impact on elucidating the role of individual genes and assigning new traits to linkage groups respectively (paigen 2003a ). however, beginning in the early 1980s scientists began to genetically engineer mice by either adding a new gene (transgenic) or deleting a normal mouse gene (knockout, ko) (paigen 2003b) . the power of these models to elucidate the genetic basis of disease cannot be overemphasized. over the past 15 years, publications citing transgenic and ko mice have increased exponentially and at the time of this writing the mutant mouse resource of the jackson laboratory listed more than 10,000 such unique lines. during this same period the results of both the human and mouse genome projects were published (international human genome sequencing consortium 2001; mouse genome sequencing consortium 2002) . this provided complete nucleotide sequences for each genome allowing investigators to quickly develop the equivalent murine model for many of the inherited human diseases. transgenic and ko mice have helped clarify disease pathogenesis in virtually every area of medicine and often elucidated biochemical pathways, previously unknown, which are now subject to testing and quantification. as a result, clinical chemistry in the mouse has grown from evaluation of 15-20 analytes found in plasma (or urine), to hundreds of biomarkers that can monitor disease status at the cellular level. due to the massive amount of new information characterizing each of the standard strains and mutant lines of mice, a mouse phenome database has been developed to manage data and provide researchers with the ability to explore raw phenotypic data (including clinical chemistry) and summary analyses. the resource allows investigators to select the appropriate murine model for physiology testing, drug discovery, toxicology studies, mutagenesis, modeling human disease, quantitative trait loci (qtl) analyses, identification of new genes, and unraveling the influence of environment on genotype (bogue and grubb 2004) . by far, the most important new technology in the rapidly growing and changing field of clinical chemistry is the discipline of proteomics. proteomics combines the disciplines of molecular biology, biochemistry, and genetics to the analysis of the structure, function, and interactions of proteins produced by the genes of a particular cell, tissue, or organism. the field of proteomics has grown mainly due to the development of new instruments that are based on sophisticated techniques, yet amenable to practical implementation. for example, the development of surface-enhanced laser desorption/ionization (seldi) platform time-of-flight (tof) mass spectroscopy (ms) allowed petricoin et al. (2002a) to identify five peptides in the sera of women with ovarian cancer that were not found in women without ovarian cancer, even though the structure and function of some of these peptides were not actually known. building on these findings, zhang et al. (2004) combined the seldi-tof ms with protein separation procedures to develop a multianalyte immunoassay for rapidly screening potential cancer patients. this process of identifying proteins (biomarkers) that are predictive for a disease is known as plasma protein profiling. similar technology has been used to develop plasma protein profiles for neoplastic conditions in humans, such as prostate cancer petricoin et al. 2002b; qu et al. 2002) and bladder cancer (adam et al. 2001; vlahou et al. 2001) , as well as a variety of non-neoplastic conditions, such as ischemic versus hemorrhagic stroke , severe acute respiratory syndrome (kang et al. 2005 ), alzheimer's disease (carrette et al. 2003) , and creutzfeldt-jakob disease (sanchez et al. 2004) . plasma protein profiling has also begun in mouse models. xiang et al. (2004) used a combination of two-dimensional gel electrophoresis (2d-ge) and matrix-assisted laser desorption/ionization (maldi) tof ms to quantify serum protein profiles of c57bl/6 mice harboring the lewis carcinoma with and without treatment using acetazolamide. they found upregulation of many peptides associated with tumor growth and metastasis, and many of these same peptides were modified during treatment. two specific targets of acetazolamide antitumor activity were subsequently identified as histone h2b and croci (a ubc-like peptide). park et al. (2004) used similar technology to determine plasma protein profiles for high (c57bl/6) and low (c3h) atherosclerosis prone strains of mice on normal or atherogenic diets. they identified 30 proteins in which the levels had changed after eating an atherogenic diet. of these, 14 were differentially changed in c57bl/6 mice and an additional 16 were changed in both strains. in addition, 28 proteins were differentially expressed between the two strains regardless of diets. four of these proteins were upregulated in c57bl/6 and 11 were upregulated in c3h. nine of those protein markers were definitively identified and their roles in the pathogenesis of atherosclerosis discussed in the "atherosclerosis" section. plasma protein profiling in mice has the potential to become an important discovery tool for translational research, particularly in identifying cancer-associated plasma biomarkers in humans. for example, juan et al. (2004) also used 2d-ge and maldi tof ms to identify plasma biomarkers in balb/c-nude mice harboring human xenotransplanted tumors. in mice bearing a human stomach cancer cell line, serum amyloid a (saa) was elevated. the authors then went back to screen the sera of human stomach cancer patients and were able to demonstrate that, when compared to controls, humans with stomach cancer also had significantly elevated levels of saa. all of these examples illustrate the power of proteomics. proteomic pattern diagnostics offers a means to look at molecular diagnostic information in human or mouse serum, without preconceived assumptions about the existence or identity of the biomarkers. this allows for the development of sensitive and specific peptide assays for identified biomarkers of disease. practical applications of proteomics have been facilitated by the creation of instrumentation that can analyze multiple analytes from small sample volumes with fast through-put (such as multiplex technology, which are discussed in the "multiplex technology" section). in an attempt to manage all the experimental data arising from the fields of proteomics, metabolomics and transcriptomics (gene array), the chemical effects in biological systems (cebs) knowledge base was developed (xirasagar et al. 2004 ). this is a useful, searchable database that integrates experimental findings from all three disciplines, by biosource identification (animal, test article, genotype, and investigator). by making the cross correlation from data arising from three different streams it is hoped that combination groups of predictive markers for disease and toxicity will emerge. the cost of bringing a new drug to market is estimated at $0.8-1.7 billion (food and drug administration 2004), of which a large proportion is spent on safety/toxicity assessments during the preclinical phase of the development of a drug. although expensive, safety/toxicity regulations are necessary, as illustrated by the fact that a new drug entering phase i clinical trials has only an 8% chance of reaching the marketplace due to toxicity issues. the ability to decrease the costs of drug development due to safety/toxicity issues is becoming increasingly reliant on the use of the laboratory mouse as a model for human disease and the identification of sensitive biomarkers for toxicity and disease. the underlying basis of using laboratory mice as models for human disease was demonstrated by everett and harrison (1983) , who showed that the predictive reliability of mice for quantitative toxicity of five chemotherapeutic drugs in humans was at least as good, if not better, that the predictive reliability demonstrative by dogs and monkeys. more recently, newell et al. (2004) presented data on predictive performance of rats and mice to demonstrate qualitative human toxicity when given 39 novel cancer chemotherapeutic agents. they claim that nonrodent species are unnecessary for identification of a safe phase 1 starting dose for human trials. furthermore, the two rodent species (rats and mice) used gave similar quantitative and qualitative results. the arrival of genetically engineered mice has further enhanced the relevance of using mice in research, especially in terms of basic mechanistic research and applied screening for genotoxicity and carcinogenicity. transgenic mice carrying a human gene and expressing the protein are said to be "humanized." these animals are invaluable in drug assessment especially when the drug interacts only with the human protein (bolon 2004) . zambrowicz and sands (2003a) showed that the ko phenotype of mice correlated well with the molecular targets of the 100 best selling drugs available to the u.s. market. zambrowicz et al. (2003b) compared the physiology of ko mice, where the deleted gene was known to produce a novel target for each of the 24 new drugs in the developmental pipeline of the 10 largest pharmaceutical companies, and found that 85% of these targets demonstrated a sound biologic rationale for the selected disease. transgenic and ko mice have been used successfully to screen new drug candidates for safety and to elucidate basic mechanisms of toxicity. a large number of drug metabolizing enzyme (dme) ko lines have been employed in safety screening. dmes may be involved in the safe metabolism of a drug or they may generate toxic intermediates. removal of the dme gene may result in the animal being more sensitive to the test article, and it may provide protection against toxic effects of the drug. for instance, ko mice lacking the nqo-1 gene have increased menadione toxicity, and mice lacking the cyp2e1 gene are resistant to acetaminophen hepatotoxicity (henderson and wolf 2003) . murine models are also available for evaluation of chemical mutagenicity (big blue mouse; stratagene, la jolla, ca and muta mouse; covance research products, denver, pa). these marker genes are present in mice of different genetic backgrounds (bolon 2004) . ko lines have been created with the increased sensitivity to chemically induced carcinogenesis. mice carrying a single p53 allele, or over expressing ha-ras, or having a complete deletion of the xpa (xeroderma pigmentosum) gene, have all been used for screening xenobiotics in vivo (bolon 2004) . these same transgenic and ko models are useful in screening environmental chemicals for toxicities (jacobson-kram et al. 2004) . it is clear that the mouse will continue to be essential for discovery and in evaluating the safety of new drugs. equally relevant is the development of clinical chemistry assays needed to study the associated metabolic events in mice (especially in transgenic and ko lines) and assess serum/plasma biomarkers. these biomarkers should either be quantitative measures of the biologic effects (which provide informative links between mechanism of action and clinical effectiveness) or surrogate markers (which are quantitative measures that predict effectiveness). in this arena, the field of proteomics is likely to make a dramatic impact on clinical chemistry. although we hope all readers of this chapter will benefit from this section on assays and instruments, the primary purpose of this chapter is to briefly introduce the reader to areas where methods in clinical chemistry are changing and provide sources of information for services, reagents (including test kits), and instrumentation, specifically for testing biomarkers (including traditional analytes) in mouse serum, plasma, or urine. those seeking a detailed description of clinical chemistry methods and instruments should refer to the fundamentals of clinical chemistry (burtis and ashwood 2001) . some dramatic changes have occurred over the past two decades that have revolutionized the discipline of clinical chemistry. historically, most analytes were measured by a colorimetric end point assay (based on the binding of an analyte to another molecule creating a new substance that absorbs light of a specific wavelength). some of these analytes and the newer biomarkers are now measured by enzymatic tests that have higher specificities and sensitivities. another change has been the substitution of electrochemical assays, such as ion-selective electrodes, for flame photometry used in the quantitation of sodium and potassium. perhaps the change that has had the largest impact on clinical chemistry is the development of monoclonal antibodies and their use as reagents in immunoassays (to be discussed later). many commercial companies now offer services that measure analytes and biomarkers in the blood of mice using a combination of colorimetric-, enzymatic-, electrochemical-, and immunologic-based methods, and many of the instruments used are capable of running multiple assay types simultaneously. the use of laboratories that offer validated assays specifically for mouse blood is important to ensure accurate and precise results. a summary of a few laboratories that provide validated murine assays is presented in table 6 -1. the increasing availability of mouse-specific reagents has resulted in many new assay techniques that provide a high degree of sensitivity and specificity. growth in the number of reagents capable of quantitating analytes in mouse serum is illustrated in table 6 -2. techniques employing nonisotopic labels for detection such as enzyme cascade, fluorescence, chemiluminescence, and electrochemiluminescence, are rapidly replacing older radioimmunoassay (ria) techniques. enzyme immunoassays, such as enzyme-linked immunosorbent assay (elisa), enzyme-multiplier immunoassay technique (emit), and cloned enzyme donor immunoassay (cedia), provide quantitative results based on photometric methods. enzyme immunoassay is popular because it generates compounds that can be quantitated photometrically. typical enzymatic labels include ~-galactosidase, horseradish peroxidase, alkaline phosphatase, and glucose-6-dehydrogenase. in addition these elisa test kits are compact, easy to use, and quantitated with inexpensive instruments. these kits (usually in a well format) are available for quantitation of a wide range of mouse serum and plasma biomarkers (table 6-3) . fluoroimmunoassay (fia), which utilizes a fluorescent molecule as an indicator label, was previously subject to problems associated with background fluorescence. today this problem has been largely resolved by using chelates of lanthanide as a label. modifications of fia have eliminated the need to separate free from bound label (homogenous assay). chemiluminescent and electrochemilumiscent immunoassays are similar to enzyme immunoassays, except that quantitation of results is based on the emission of light after a chemical label is exposed to an oxidation reaction (chemiluminescence) or to an electrochemical reaction (electrochemiluminescence). the number of biomarkers that can be quantified by commercially available test kits based on immunoassays is likely to grow at unparalleled rates as a result of proteomics research where mice are the favored model. mulitplex immunoassay is a unique technology that combines four distinct components in a manner that allows for simultaneous analysis of up to 90 different analytes from 50 ktl of serum/plasma. the core component is an inexpensive, consumable, 5.6 ~tm diameter polystyrene microsphere that are encoded into 100 different fluorescent color sets using two fluorophores (red and infrared) at multiple concentrations. the second component is a biologic assay (combined with an mmp-3 (matrix metalloproteinases) pro-mmp-9 mmp-9 tissue inhibitor of metalloprotease 1 (timp-1) orange fluorescent reporter molecule) that is built onto the surface of the microspheres. a diverse range of biologic assays can be built onto the microsphere surface, including immunoassays, nucleic acid assays, enzymatic reaction assays, or receptor-ligand analysis assays. the third component is a flow cytometer that focuses the microspheres into a single file in front of a two interrogating lasers, which allow for high throughout. one laser is a red diode emitting at 635 nm, which illuminates each microsphere. the resulting red and infrared fluorescence provides classification information for that particular microsphere set. the other laser is a green yag diode emitting at 532 nm that excites the orange fluorescent reporter molecules of the surface of the microsphere, providing a quantitative signal for that particular biologic assay. the last component is digital signal processing data acquisition hardware that provides the speed necessary to read the microspheres at up to 5000 per second. because multiplex technology can analyze a wide range of biomarkers simultaneously, dynamic reference results (plasma profiles) can be developed based on the changing concentrations of the biomarkers during the course of a disease. the known and potential applications of developing plasma profiles of diseases are powerful. plasma profiles can be used to screen and identify diseases (especially during the early development of a disease) and characterize the efficacy of drugs targeted against these diseases. multiplex technology can help elucidate new biomarkers of disease. furthermore, plasma profiles could also potentially be developed to monitor the blood concentrations of drugs as well. investigators seeking additional information on availability of reagents and test kits should refer to "clinical laboratory reference" (nelson 2006 ) and the linscott's directory of immunologic and biologic reagents (linscott 2005) . sections of these two references provide the names and addresses of sources. the catalogs of individual companies may be fruitful, but many reagents for use in human blood and have not been validated for use in other species (including the mouse). each of the various instruments mentioned in this section may be found in the 8th annual analyzers buyer's guide (advance for administrator of the laboratory 2003). this guide lists all manufacturers and gives detailed information on each instrument including technology platforms, methods used, through-put capability, purchase price, maintenance costs, reagent package cost, as well as a variety of options available. contact information, including web site, is available for each manufacturer. additional information regarding clinical chemistry on animal blood is available on the web site of the division of animal clinical chemistry at the american association of clinical chemistry (www.aacc.org/divisions/animal). with a mean body size of 35 g, adult mice have approximately 2.4 ml of blood volume, allowing 75 ~tl to be removed weekly without consequence to health and welfare (loeb 1997; loeb and quimby 1999) . four blood collection sites for acquiring 75 ~tl of blood repetitively from adult mice include the orbital plexus, the tail vein, the jugular vein, and cardiac puncture (quimby 1999b) . general anesthesia is recommended for orbital plexus and cardiac puncture, although terrilrobb et al. (1996) claim that topical application of proparacaine hydrochloride is an acceptable procedure for collecting orbital plexus blood. the jugular vein is punctured using a lancet directed at the rear of the jaw, exposing the jugular vein and its tributaries and the submandibular and facial veins (golde et al. 2005) . collection of blood from any of these veins at this site works well, and the animal does not require anesthesia or a restraint device. the blood should be collected with a small centrifuge tube or capillary tube. nerenberg and zedler (1975) describe a vacuum apparatus used to collect larger volumes of blood from the tail vein. lewis et al. (1976) found that heparinization of mice before tail bleeding increases the yield. prewarming the mouse under a lamp or through immersion in warm water facilitates tail bleeding. the use of heparinized microhematocrit tubes, during tail or orbital plexus bleeding can maximize the plasma volume with minimal hemolysis (quimby 1999b) . hem and smith (1998) recommend a saphenous vein prick method over the orbital plexus method for collecting repeated small volumes from conscious mice. macleod and shapiro (1988) used indwelling fight atrial catheters for repetitive bleeding of conscious, unstressed mice. disadvantages of specific procedures have been described. sakaki et al. (1961) reported sympathetic nervous system stimulation associated with tail bleeding and the mixing of venous and arterial blood with the orbital plexus method. patrick et al. (1983) found that, compared to jugular vein collection, cardiac puncture was associated with higher plasma glucose concentrations and lower creatine kinase (ck) activity. plasma glucose concentrations are higher in blood collected from the orbital sinus compared to the tail vein. differences associated with the method of anesthesia are also important. halothane, methoxyflurane, isoflurane, and pentobarbital sodium have been widely used and are considered safe. however, caution should be exercised in the interpretation of certain chemistry values. higher plasma glucose levels are reported with tail vein sampling in mice anesthetized with pentobarbital or methoxyflurane compared with conscious mice (chuang and luo 1997) . plasma glucose levels are higher after collection from the orbital plexus if pentobarbital or proparacaine hydrochloride is administered. methoxyflurane has no glucose elevating effect on samples collected from the orbital plexus. cunliffe-beamer (1983) claims that carbon dioxide narcosis provides sedation and analgesic for 1-2 minutes and is an appropriate anesthetic for orbital plexus bleeding. when greater volumes of blood are required, four collection sites can be used that require anesthesia and subsequent euthanasia of the mouse. these sites include the jugular vein (ambrus et al. 1951) , the abdominal aorta (lushbough and moline 1961) , the brachial artery (young and chambers 1973) , and the heart (cubitt and barrett 1978; mitruka and rawnsley 1977) . blood collection from a newborn mouse can be accomplished by decapitation. injection of two units of heparin subcutaneously several minutes before decapitation may allow collection of up to 40 ~tl of blood (20 ~tl of plasma). although collection of urine is possible in mice, it is impractical due to anatomic and physiologic restrictions. the total urinary bladder volume is less than 0.5 ml, and total urinary output per day is less than 2 ml (jung et al. 2003) , meaning that mice frequently micturate. this restricts the amount urine that can be collected at any one time point and, therefore, will also restrict the number of analytes that can be assessed from any one urine sample. to be able to collect enough urine for assessment from a single live mouse, mice can be placed in a plastic cage without absorbent bedding material and urine then collected from the bottom of the cage after 4-6 h. however, a disadvantage of this technique is that the urine is exposed to the contamination by feces and other environmental contaminants and organisms. pooled urine samples collected from a group of live mice using the same technique can increase the total amount of urine collected but will not allow specific results to be related back to specific individuals from that group. mice removed quickly from their cage and held over a piece of parafilm will frequently void and the parafilm helps prevent the urine from spreading. urine can also be collected directly from the urinary bladder from mice after euthanasia. this technique allows for a sterile sampling, but the volume that can be collected is restricted by total urinary bladder volume (0.5 ml). often, the volume is much less because mice typically void urine from the urinary bladder at the time of death. reference ranges refer to the range of an analyte or biomarker in a population that has not been selected for the presence of disease or abnormality. reference ranges are usually generated from a large number of individuals from a population, so reference ranges for the same analyte or biomarker can vary between two different populations. table 6-4 lists the reference ranges for selected analytes in two inbred strains and an outbred stock. in some situations, reference ranges that have been published or generated by laboratories cannot be relied on to accurately some variables known to adversely affect the host include environmental factors, pathogens, and shipment. in addition, nutrition, time of sample collection, and storage techniques may all contribute to variability. age has an effect on analytes in the mouse. in an early study, barrett et al. (1975) found that serum calcium levels in 4-monthold c3h/fg and a/fg inbred mice were significant higher than 7-month-old mice of the same strains. more recent and more comprehensive analyses completed by loeb et al. (1996) reinforces the effect that age has on clinical chemistry parameters in five inbred strains and two f1 hybrids, including serum protein. the effect sex has on chemistry parameters is most demonstrable with sex hormones, including follicle-stimulating hormone (fsh), luteinizing hormone (lh), and progesterone. table 6 -3 illustrates these differences between male and female mice, and between female mice in estrus and out of estrus. strain-associated changes appearing in healthy animals have been documented for complement components (goldman and goldman 1976) , cholesterol (dunnington et al. 1981; meade and gore 1982) , testosterone (ivanyi et al. 1972) , cortisol-binding protein (goldman et al. 1977) , and serum protein (borovkov and svirdov 1975; loeb 1997) . cyclic biorhythms, whether circadian or ultradian, influence blood levels of various analytes in mice. blood levels of adrenocorticotropic hormone (acth), corticosterone, growth hormone (gh), and lh may peak one or more times daily, and thus special attention must be given to both the time of collection and the order of sampling individuals between groups if between-group comparisons are to be made (loeb 1997) . the degree of hydration, exposure to noise, degree of confinement, and environmental temperatures has all been shown to affect serum chemistry analytes (quimby 1999b) . diet is known to influence the blood levels of many analytes. perhaps the best studied is the effect of atherogenic diets on serum cholesterol. similarly, significant differences in both serum cholesterol and urea nitrogen are seen in mice maindetermine the presence or absence of disease or abnormality, tained on a semipurified (ain-76) diet. the mouse is unique these situations include evaluating analytes and biomarkers in j among mammals because murine muscles do not contain transgenic and ko mouse populations (especially in experiments in which population sizes are small) and evaluating certain analytes and biomarkers (such as those assessing immune function). instead, baseline data compiled from controls (the population of wild-type mice from which the transgenic and ko mice were derived from) should be used. the usefulness of compiled baseline data depends on controlling a large number of variables known to influence chemistry determinations. several studies have demonstrated significant differences in selected serum analyte concentrations with age difference in the same strain, between sexes in the same strain, and among strains (everett and harrison 1983) . carnosine or anserine. carnosine serves as a source of histidine when histidine is restricted. unlike other mammals, mice on histidine-free diets show signs of histidine deficiency. fasting may also affect the levels of certain analytes (quimby 1999b) . the presence or absence (axenic mice) of intestinal microbial flora is associated with dramatic changes in immunoglobulin (ig) levels and may be associated with changes in other analytes as well. for example, axenic mice have significantly lower levels of iga compared to conventional mice (moreau et al. 1982) . the presence of pathogens may be associated with dramatic changes in various analytes, even with subclinical infection. for instance, infection with lactic dehydrogenase-elevating virus (ldv) is associated with major elevations in serum lactic dehydrogenase, isocitric dehydrogenase, malic dehydrogenase, aspartate aminotransferase, and glutathione reductase activities (quimby 1999b ). asummarized from loeb and quimby (1999) . alterations in clinicopathologic parameters can be attributed to stress in mice. landi et al. (1982) found that plasma corticosterone concentrations in mice tested within 48 h after arrival (by plane or truck transport) were significantly higher than tested after 48 h post arrival. mice sensitized on arrival with sheep red cells as an antigen had significantly lower antibody titers, fewer plaque-forming cells, and a decreased delayed type of hypersensitivity reaction when compared to normal mice allowed to acclimate to the facility for 48 h before being sensitized. elevated serum corticosterone levels can arise from excessive handling of mice prior to blood collection. the effect of sample storage at various temperatures and for varying periods has been described. falk et al. (1981) evaluated the effect of storage time (after freezing) on 20 serum analytes in six laboratory species. they found that in the mouse, only creatine kinase activity changed significantly with storage up to 28 days. hemolysis is a common problem during blood collection in mice. hemolyzed samples are associated with changes in various enzymes, such as increased ck activity and decreased lipase activity. to minimize this, everett and harrison (1983) recommend heparinized plasma and careful selection of collection sites for routine chemical determinations. the effect of lipemia, various anticoagulants, and pharmacologic agents on clinical chemistry values has been reviewed for domestic animals (meyer and harvey 1998) . using several methods. regardless of the distribution of data, it is generally useful to describe the limits that include 95% of the test results in a disease-free population. for values exhibiting a gaussian distribution, parametric methods (such as mean and standard deviation) are appropriate. for gaussian distributed data, this is the range that includes two standard deviations above and below the mean. certain murine analytes have non-gaussian distributions and must be evaluated using nonparametric methods. a variety of methods are available, including the percentile method and logarithm-transformed data analyzed with parametric methods. the method of percentile estimates is more vulnerable to bias due to extreme values (outliers) than is the log-transformed parametric method. boyd (1985) asserts that a sample size of at least 120 is required to give 90% confidence intervals using the percentile method, whereas a sample size of 50 may give reliable ranges if parametric analyses are used. neither statistical method just described will replace raw data in certain situations, such as when assessing analytes for immune function, nor when using data derived from wild-type mice as comparison baseline data for transgenic and ko mice. the issue of quality control and test validity has been thoroughly discussed for common domestic animals and is applicable to chemistry determinations in mice (meyer and harvey 1998) . quality assurance in clinical chemistry determinations is important to ensure that consistently accurate and precise results are achieved. everett and harrison (1983) stressed the importance of a clinical pathology quality assurance program that includes regular assays of pooled and commercially prepared pre-assayed sera. in addition, they encourage participation in a subscription quality assurance program, such as with a veterinary laboratory association. the within-day and day-to-day coefficient of variation should be known for each analyte measured. due to the tremendous number of variables known to influence clinical chemistry values in mice, it is often prudent to test adequate numbers of control specimens along with the experimental samples. this technique is often impractical when tests are being conducted strictly for diagnostic purposes, and in those situations, compiled values that are controlled for as many variables as possible may be sufficient. the values that define a reference range for a particular analyte or biomarker in normal or healthy mice may be described this section is intended to serve as a review of specific tests for routine analytes. additionally, a more comprehensive discussion is presented for analytes and biomarkers involved in two areas of translational research of intense interest (obesity/diabetes and atherosclerosis) and novel biomarkers of disease (such as immune function tests). only analytes and biomarkers for which there are currently available commercial tests for mice serum, plasma, and/or urine are discussed; certain analytes and biomarkers for which commercially available tests are not available for the mouse (such as calcitonin) are not covered. for more complete information for the routine analytes, please refer to loeb and quimby (1999) . glucose is the main source of energy in mice. blood glucose concentrations depend on the rates of entry and the removal rate from the blood. the rate of entry is dependent on intestinal absorption of dietary sources of glucose, the breakdown of body glycogen stores (glycogenolysis), and synthesis from gluconeogenic metabolites (gluconeogenesis). the removal rate is mainly dependent on insulin, which is released from [3-cells of the pancreatic islets. insulin promotes cellular uptake of blood glucose (mainly in muscle, liver, and fat) by stimulating the translocation of glucose transporters, glut-1 to glut-7 to the cell membrane. when removed from circulation, blood glucose may either be utilized (to maintain cell function) or converted to fat and glycogen in liver and muscle as an energy store. however, the effect of insulin is modulated by other hormones (such as glucagon, corticosterone, gh, epinephrine, somatostatin, and amylin) that ultimately result in the tight control the levels of blood glucose, depending on tissue demands for energy. glucagon is released from t~-cells of the pancreatic islets in response to low circulating glucose, stimulating the liver to increase circulating glucose through glycogenolysis and gluconeogenesis. corticosterone and gh antagonize the action of insulin. epinephrine suppresses insulin release and stimulates glucagon release and glycogenolysis. somatostatin suppresses both insulin and glucagon secretion, whereas amylin increases blood glucose, blood insulin, and insulin resistance (burtis and ashwood 2001; kaneko 1999) . glucose determinations are generally conducted on fresh serum. however, plasma glucose determination is acceptable if delay of greater than 30 minutes before separation of erythrocytes is anticipated. in this case, fluoride should be used as the anticoagulant because it inhibits glycolysis by erythrocytes. blood glucose in mice is measured using the hexokinase or glucose oxidase. these tests may be performed as an analytical method or by using glucose oxidase coated test strips (for urine glucose), or small portable analyzers (seidelmann et al. 2005) . assessment of long-term average blood glucose levels in mice is also available by rias measuring glycosylated hemoglobin and glycosylated serum proteins (collectively known as fructosamines) (gould et al. 1986 ). the mouse phenome database lists serum glucose levels of 41 strains with blood collected after a 4-h fast on 7-9 week old males and females on a standard laboratory diet. for all mice, the overall mean was 179 + 30.9 mg/dl (naggert et al. 2003) , but blood glucose levels varied with age, sex, and strain. females of a strain tended to have lower levels than males, with lp/j mice showing the lowest values (f = 125 + 22.0 and m = 146 _+ 18.8 mg/dl) and c57b1/10j mice showing the highest values (f = 230 _+ 25.5; m = 263 _+ 57.3 mg/dl). in mice serum glucose levels decrease between the 3rd and 12th month of age and in c57bl/6 and balb/c strains the glucose level rises again after 24 months (loeb 1997) . serum or plasma glucose levels may also vary depending on the site of collection and anesthetic used (quimby 1999b) . patrick et al. (1983) found that compared to jugular vein collection, cardiac puncture was associated with higher blood glucose. differences associated with the method of anesthesia are also important. higher plasma glucose levels are reported after tail vein sampling under either pentobarbital or methoxyflurane compared to sampling conscious mice (chuang and luo 1997) . plasma glucose levels were higher after orbital plexus sampling of mice if pentobarbital or proparacaine hydrochloride was provided. methoxyflurane had no glucose elevating effect on samples collected from the orbital plexus; however, in conscious animals, plasma glucose levels were higher in blood collected by retro-orbital sinus compared to tail bleeding. hyperglycemia (increased blood glucose levels) in the mouse can be due to increased peripheral resistance of tissues to insulin (such as with exogenous corticosteroid administration, increased endogenous corticosterone release, glucagons administration, and gh administration), and diabetes (see discussion later). hypoglycemia (decreased blood glucose levels) can be due to excessive circulating insulin (such as with excessive insulin administration and transgenic mice with [3-cell tumors of the pancreatic islets), reduced glycogen stores (such as with advanced liver disease), excessive glucose use (such as with pregnancy, septicemia, and neoplasia), and reduced glucose intake (such as with starvation and diseases of malabsorption). diabetes in mice is defined as persistent blood glucose levels of greater than 300 mg/dl in fasting mice. this level also corresponds to the renal threshold for glucose urine excretion in mice, so urine glucose assessment is useful in this regard for mice. nonobese diabetic mice (a model of type 1 diabetes) have nonfasting plasma glucose levels in young prediabetic mice between 130-180 mg/dl, which rises to >300 mg/dl between 10-30 weeks of age (leiter 1997) . genetically modified mice have been identified for virtually every ligand and receptor regulating glucose metabolism and, depending on the gene mutation, may exhibit altered levels of plasma glucose. for example, adenosine monophosphate-activated protein kinase (ampk) is a critical enzyme in energy metabolism (including cellular glucose uptake and fatty acid oxidation in muscle, and fatty acid synthesis and gluconeogenesis in hepatocytes). using ko mice, shaw et al. (2005) demonstrated that kinase lkb 1 is an important activator of ampk in the liver under energy-stress conditions, and that ko mice deficient in kinase lkb1 were persistently hyperglycemic. the authors also demonstrated that kinase lkb 1 is the target of the type 2 diabetic therapeutic drug, metformin. glucose tolerance tests (gtt) have been performed in mice. one-, 3-, and 4-h tests have been conducted. in the 1-h test, glucose concentrations are evaluated before and 1 h following the administration of 2 mg/g glucose administered intraperitoneally (ip) (oldstone et al. 1984) . the 3-h test compares pre-injection serum to serum collected at 15, 30, 60, and 120 minutes following administration of 3 mg/g glucose given ip (hotamisligil et al. 1996) . a sensitive 4-h gtt has also been described in which mice are given 10 ml/kg of 10% glucose orally (gates et al. 1972) . the hypoglycemic response to insulin in mice has also been described (hotamisligil et al. 1996) . kaku et al. (1988) measured glucose, glycosylated hemoglobin and insulin levels in six inbred strains undergoing gtt (either in fed or fasted mice). to estimate the number of genes involved in phenotypic differences in glucose tolerance, the least glucose tolerant strain (c57bl/6) was bred to the most tolerant strain (c3h/hej) and f1 hybrids and backcross animals tested. the authors concluded that glucose tolerance in six commonly used inbred strains is a polygenic trait. thrifty genes have been hypothesized to give early human hunter-gatherers a survival advantage by providing an economic mechanism to store energy during periods of famine (zimmet and thomas 2003) . because the most efficient mechanism for energy storage is through promotion of adipose tissue, it seems reasonable that at least some of these "thrifty" genes may function in this manner. another hypothesis holds that during periods of famine it is essential to conserve glucose for use by the brain and that the mechanism responsible involves insulin resistance in peripheral tissues (neel 1962) . should both hypotheses be true it is easy to envision an association between obesity and type 2 diabetes, especially where sedentary lifestyle and unrestricted access to food occur together (lazar 2005) . one candidate thrifty gene encodes the hormone leptin. leptin is produced by adipose tissue, and its absence leads to obesity and insulin resistance. during times of high adipose storage blood levels of leptin are high and it promotes energy metabolism and inhibits food intake. the opposite occurs during starvation. but leptin is only one of a number of adipokines, secreted by adipose tissue, which aid in the regulating appetite and metabolism. in fact the location of the adipose tissue, the size of average adipocytes, and adipocyte metabolism of glucose and corticosteroids each modify the endocrine function of adipose tissue (lazar 2005) . among the proteins secreted by adipose tissue are adiponectin, adipsin, resistin, visfatin, tumor necrosis factor-a (tnf-a), interleukin-6 (il-6), macrophage chemoattractant protein-1 (mcp-1), plasminogen activator inhibitor-1 (pai-1), angiotensinogen, saa, and a-acid glycoprotein. like adipocyte-derived free fatty acids, which have been shown to contribute to insulin resistance in liver and muscle, most of these proteins are capable of modulating glucose metabolism and insulin action. adiponectin and visfatin work synergistically with insulin to enhance glucose uptake by muscle and block glucose synthesis by the liver (hug and lodish 2005) . blood levels of visfatin increase in obesity and the cytokine can bind to and stimulate the insulin receptor (fukuhara et al. 2005) . blood levels of adiponectin negatively correlate with body mass and are lower in obese humans and mice, suggesting that reduced mrna expression of the adiponectin gene may be involved with obesity (masaki et al. 2004) . increases in adiponectin downregulate the hepatic expression of tnf-a. it mediates its antidiabetogenic effects via receptors on peripheral tissues, especially liver. tnf-a, resistin, and il-6 each induce resistance to insulin. however tnf-a also suppresses expression of adipocyte specific fred w. quimby and richard h. luong t genes; resistin maintains glucose during fasting; and il-6 production increases in the obese. the cytokines tnf-~ and il-6 are proinflammatory, are also produced by monocytes, and act on the liver to produce acute phase reactants. they also induce suppressor of cytokine signaling-3 (socs-3), an intracellular signaling molecule that impairs neuronal signaling by leptin and insulin, and thus causes resistance to the central actions of both hormones (schwartz and porte 2005) . resistin mediates its effects principally by decreasing the expression of gluconeogenic enzymes in the liver (banerjee et al. 2004 ). certain cytokines, increased endoplasmic reticulum stress, chronic hyperglycemia, chronic hyperlipidemia, and oxidative stress may all induce apoptosis of insulin producing ~l-cells in the islets of the pancreas (rhodes 2005) . insulin receptor substrate-2 (irs-2) is a key molecule promoting ~-cell growth and survival. these molecules act immediately downstream from surface receptors for insulin and insulin-like growth factor-1 and inhibition of irs-2 has been shown to lead to insulin resistance. inhibition may result from accumulation of reactive oxygen species in ~-cells chronically exposed to increased glucose metabolism or from chronic exposure to elevated fatty acid (which through production of long chain acyl-coa active protein kinase c-isoforms degrade irs-2). leptin has been shown to modulate interleukin-l~ (il-i~), a potent inducer of apoptosis. tnf-t~ and il-6 induce ~-cell apoptosis by activating the transcription factor nuclear factor k:i] (nf-~:[3). centrally the actions of both insulin and leptin take place in the mediobasal hypothalamus, where the neurons exert potent effects on food intake and energy expenditure. here neurons co-express neuropeptide y (npy) and agouti-related peptide (agrp), which stimulate food intake and reduce energy expenditure. leptin and insulin inhibit these neurons. under conditions of reduced leptin and insulin signaling, npy increases, inducing hyperphagia, weight gain, insulin resistance, and glucose intolerance. the anabolic effects of agrp arise from its antagonism of the melanocortin receptors mc3r and mc4r, which serve to limit food intake. blockage of mc3r and mc4r leads to weight gain and insulin resistance. precursor proopiomelanocortin (pomc) and pomc neurons in the arcuate nucleus are stimulated by leptin and insulin and the resultant production of melanocortin and its binding to mc3r and mc4r inhibits food intake and promotes weight loss (schwartz and porte 2005) . however, in the absence of leptin, as seen in lep ~176 mice, neurons of the arcuate nucleus of the hypothalamus are permanently disrupted and treatment in adulthood cannot reverse this defect (bouret et al. 2004) . orexin a (hypocretin-1) and orexin b (hypocretin-2) are neuropeptides produced in the lateral hypothalamus by neurons with axonal projections to many sites including those that control feeding behavior and sleep/wakefulness (taylor and samson 2003) . orexin ko mice develop hypophagia with obesity and insulin-resistant diabetes (hara et al. 2001 ). ghrelin, a peptide made predominantly by the stomach, is also known to act centrally and affect food intake and increase secretion of gh (ghigo et al. 2004; korbonits et al. 2004 ). in the periphery leptin has been shown to specifically repress rna levels and enzymatic activity of hepatic stearoyl-coa desaturase-1 (sld-1), which catalyzes the biosynthesis of monounsaturated fatty acids. this effect was found to be an important metabolic action of leptin (cohen et al. 2002) . leptin resistance, a common feature of obesity in mice and humans, has also been shown to result, in part, from the shedding of membrane-bound hepatic leptin receptors into the plasma, where soluble receptors modulate circulating leptin levels and possibly its biologic activity (cohen et al. 2005) . thus the connections between factors regulating obesity and insulin resistance (diabetes) are complex and occur both centrally and peripherally. further investigations in mice will involve quantifying glucose, adipokines, insulin, leptin, soluble leptin receptor, and sld-1. for further discussion of mouse models of obesity and diabetes please refer to chapter 19 in this text. metabolism and food intake insulin, leptin, amylin (also called islet amyloid polypeptide, iapp), glucagon, ghrelin, obestatin, orexin a, orexin b, gh, and corticosterone have been measured in mice, and ria and elisa kits are commercially available (see table 6 -3). in addition, these hormones may be measured as part of a multiplex panel (see "multiplex technology" section). leptin values in c57bl/6, 129, and fvb/n strains range from 1-3 ng/ml, insulin values range from 2.2-5.2 ~t iu/ml, corticosterone levels range from 5-40 ~tg/dl, and gh ranges from 1-90 ~tg/ml. epinephrine is measured by ria, and the range for mice is 0-200 pg/dl (depaolo and masoro 1989). adipokines secreted entirely by adipose tissue include adiponectin, adipsin, and resistin. adiponectin and resistin have been measured in mouse serum and commercial elisa test kits are available for this species. a polyclonal antibody that cross-reacts with a conserved sequence of mouse adipsin has been created (searfoss et al. 2003) . tnf-ct, il-6, and visfatin are adipokines that are synthesized also by macrophages and lymphocytes; as such they provide a common link between regulation of obesity, resistance to insulin and inflammation (lazar 2005) . both tnf-t~ and il-6 may be measured by commercially available elisa kits (see the "cytokines and chemokines" section). a method has also been published for measurement of visfatin (fukuhara et al. 2005 ). reagents for quantifying the soluble leptin receptor and sdl-1 are not commercially available at this time, although methods for measurement of these analytes in mouse serum have been published (cohen et al. 2002; cohen et al. 2005 ). the four main types of lipids in plasma are free cholesterol, esterified cholesterol, triglycerides, and phospholipids. lipids are derived from the diet (mainly from long-chain fatty acids), although endogenous recycling (mainly in the liver) occurs. plasma lipids have poor water solubility; thus, they require water-soluble protein molecules for their transport in plasma. the complex of plasma lipids and proteins are known as apoproteins (also known as apolipoproteins), which contain a core of nonpolar lipids surrounded by a surface layer of phospholipids, free cholesterol, and apoproteins. apoproteins are classified according to physical and chemical parameters, and include (in order of increasing density) chylomicrons, very low-density lipoproteins (vldl), intermediate density lipoproteins (idl), low-density lipoproteins (ldl), and high-density lipoprotein (hdl). particle density is proportionally related to the amounts of phospholipid, protein, and triglycerides they contain; increasing particle density corresponds with increasing proportions of phospholipid and protein, and decreasing density corresponds with decreasing proportions of triglyceride. chylomicrons and vldl are often referred to as triglyceride-rich lipoproteins. apoproteins on the surface of the particles serve as ligands for receptors, cofactors of enzyme interaction and structural components (wagner et al. 1999 ). table 6 -5 lists the mouse apoproteins and describes their known function. the largest lipoprotein particle is the chylomicron, which transports dietary lipids in the form of triglycerides from the intestines. chylomicrons contain apoproteins a and b48 and are absorbed into the lymphatics from the intestine, eventually entering the blood. they deliver fatty acids to the tissues with assistance from lipoprotein lipase (lpl) and release glycerol into the blood. as chylomicrons lose triglycerides they become smaller and are called remnants. these remnants acquire apoprotein e from plasma hdl and are rapidly cleared by the liver by the apoprotein e receptor or chylomicron remnant receptor. vldl is the second most prevalent lipoprotein particle in normal mouse blood (after hdl) and it transports triglyceride from liver to extrahepatic tissues. vldl is synthesized in the liver with apoprotein b 100, c, and e attached. lpl aids in the release of fatty acids (from triglycerides) to peripheral tissues. ldl, which is present in very low concentrations in normal mice, carries cholesterol to extrahepatic tissues. ldl contains apoprotein b 100 and is the primary source of cholesterol deposited in the intima of arteries in mice. apoprotein b 100 binds to the ldl receptor (ldlr). hdl is synthesized in the liver and contains large amounts of free cholesterol and apoproteins a, c, and e. during metabolism hdl free cholesterol is esterified by the action of lecithin:cholesterol acyltransferase (lcat). the exchange of cholesterol ester for triglycerides (from vldl) results in a less dense hdl subfraction that is completely removed from the circulation by the liver. exchange of esterified cholesterol for triglycerides is mediated by cholesteryl ester transfer protein (cetp) in humans; however, this activity is absent in mice. phospholipid transfer from vldl to hdl is mediated by phospholipids transfer protein (pltp). high levels of soluble hepatic lipase are found in mouse plasma (lusis, 2000; wagner et al. 1999) . hdl is thought to transport cholesterol from peripheral tissue to liver by a process known as reverse cholesterol transport (rct). this process is believed to be facilitated by the adenosine triphosphate (atp)binding cassette transporter a1 (abca1), which transports phospholipids and cholesterol to the acceptors apoprotein a-1 and apoprotein e (aiello et al. 2002) . hdl also serves as a reserve of apoprotein c and apoprotein e necessary for vldl metabolism. table 6 -6 lists the apolipoprotein receptors found in mice and describes their ligands and functions. atherosclerosis is a major factor in heart disease, stroke, and peripheral vascular disease in humans, and as such, is the principal cause of death in western countries. the etiology is complex, involving both genetic and environmental components. although there are some examples of single gene defects in humans that lead to atherosclerosis, these conditions are rare and do not explain disease prevalence. atherosclerosis is characterized by the formation of plaques in the intima of large and medium size arteries, usually in locations where blood flow is disturbed. the plaques contain a variety of cells including endothelial cells, monocytes or macrophages, smooth muscle cells, and lymphocytes, which secrete products that modulate progression of plaque formation. in addition plaques contain a complex mix of collagen, proteoglycans, occasional cartilaginous tissue with calcification and lipoprotein (primarily ldl). disease risk correlates directly with elevated circulating levels of ldl cholesterol and risk is indirectly correlated to levels of hdl. thus, although ldl promotes atherosclerosis, hdl protects against it (national cholesterol education program 1993). the combination of high ldl and low hdl is termed dyslipidemia and is found in human patients with insulin resistance syndrome. mice do not develop spontaneous atherosclerosis, because they have low circulating levels of ldl and lack cetp activity. however, genetically engineered mice that over-or under-express genes involved in lipid metabolism have contributed greatly to our understanding of lipoprotein metabolism (marschang and herz 2003) . in particular, transgenic mice have been developed with plasma lipid profiles that are similar to those of humans with atherosclerosis (breslow 1994 (breslow , 1996 . in humans and transgenic mice with elevated ldl (or low hdl), ldl passively diffuses across the endothelium, especially in areas where endothelial cell morphology has been altered by the sheer forces generated by blood turbulence. once ldl is within the intima there is an interaction between ldlapoprotein b and matrix proteoglycans resulting in ldl trapping. ldl undergoes modifications associated with oxidation, lipolysis, proteolysis, and aggregation that contribute to inflammation and uptake of ldl by tissue macrophages. lipoxygenases (los) insert molecular oxygen into polyenoic fatty acids producing hydroperoxyeicosatetraenoic acid (hete). endothelial cells release hete into the vessel wall, where it initiates oxidation of ldl. further oxidation of ldl is aided by myeloperoxidase and sphingomyelinase. mice lacking los have diminished atherosclerosis. macrophages and monocytes recognize oxidized ldl via their surface scavenger receptors and become loaded with cholesterol ester, forming a fatty streak appearing along the vessel wall. hdl, on the other hand, removes excess cholesterol from peripheral tissue and inhibits lipoprotein oxidation. hdl carries paraoxonase, which degrades oxidized phospholipids (lusis 2000) and protects against subsequent oxidative damage. oxidized ldl stimulates endothelial cells to express adhesion molecules (such as icam, vla-4, and vcam) and monocyte colony-stimulating factor (m-csf) on their luminal surface, which attracts additional monocytes and lymphocytes. oxidized ldl also inhibits nitric oxide production. infiltrating thymic-derived lymphocytes (t cells) and macrophages initiate migration of smooth muscle cells from the media to the intima, where they synthesize matrix components. mcp-1 is also released by macrophages, inducing monocyte differentiation, migration, and scavenger receptor expression. the accumulation of excess free cholesterol can be inhibited by activation of acyl coa:cholesterol acyltransferase (acat)mediated cholesterol esterification and cellular cholesterol effiux. one mechanism responsible for cholesterol effiux is secretion of apoprotein e by macrophages that promotes effiux via hdl. if this fails, as in the case of cholesterol-laden macrophages in plaques, apoptosis of the macrophages ensues. loading of the endoplasmic reticulum with free cholesterol activates er resident protein kinase and the unfolded protein response (upr) that initiates apoptosis through activation of caspase-12 (feng et al. 2003a) . as macrophages undergo apoptosis they create a necrotic core in the plaque, promoting extracellular cholesterol cleft formation. smooth muscle cells create a fibrous cap over the plaque near the luminal surface. the lesion advances as t cells, activated by cd40-cd40l ligation, release cytokines such as interferon-3, (ifn-y) and tnf-ct. these substances activate matrix degrading proteases and adhesion molecules, promoting additional inflammation. as the inflammation progresses the fibrous cap becomes compromised, leading to physical rupture and the generation of a thrombogenic surface. oxidized ldl increases the production of tissue factor that, on the thrombogenic surface, initiates the coagulation cascade and thrombus formation. each of these details have been elucidated using genetically modified mice (auerbach et al. 1992; choudhury et al. 2004; feng et al. 2003b; lusis 2000; reardon and getz 2001; tailleux et al. 2003; trigatti et al. 2004) . for a further discussion of these models readers are urged to read chapter 16 in this book. for measurements of plasma lipids, serum is the preferred sample. serum can be stored at 4~ for 5-7 days without adverse effect on measurements. a. serum cholesterol and triglycerides serum cholesterol in mice can be measured using the enzymatic oxidation method of roschlay (meade and gore 1982) , the lipid research clinic program protocol (morrisett et al. 1982) , or the abell technique (mitruka and rawnsley 1977) . the most common enzymatic method employs cholesterol ester hydrolase (to convert cholesterol ester to cholesterol), cholesterol oxidase (which oxidizes cholesterol to hydrogen peroxide and cholest-4-en-3-one) and peroxidase (which catalyzes a reaction involving hydrogen peroxide, phenol and 4-aminoantipyrine to form the dye quinonelmine). all of these components of this test are combined in a single reagent mix. the dye absorbance is measured at 500 nm (choudhury et al. 2004) . triglyceride (tg) levels, which are mainly reflective of the tg content of chylomicrons and vldl in the mouse, are quantified using a variety of enzymatic methods. the most popular method combines lipoprotein lipase, glycerol kinase, and glycerol-phosphate oxidase with peroxidase and 4-aminoantipyrine (usually in two reagents). in this method, serum tgs are converted to glycerol by lpl via hydrolysis. next the glycerol is phosphorylated in an atp-dependent reaction catalyzed by glycerol kinase. glycerol-phosphate is catalyzed to dihydroxyacetone and hydrogen peroxide by glycerophosphate oxidase and peroxidase catalyzes the final reaction in which peroxide and 4-aminoantipyrine are converted to a stable dye and absorbance can be read at 500 nm (tsimikas et al. 2000) . reagents for both total cholesterol and total tgs may be used in an automated analyzer or purchased directly from a chemical company with instructions for manual laboratory analysis. total serum cholesterol and tg levels vary by strain, gender, age, length of fast, and diet. jiao et al. (1990) studied total plasma cholesterol (tpc) and tg levels of various inbred strains fed a standard diet. after 18-20 h of fasting, tpc levels ranged from 55 mg/dl (akr/j) to 128 mg/dl (nzb/b 1nj), and tg levels ranged from 13 mg/dl (c57bl/6) to 67 mg/dl c3h/hej; each much lower than seen in normal humans. albers and piagen (1999) quantified total cholesterol levels in 15 strains give a standard laboratory diet and fasted for 4 h before blood collection. levels (in 6-to 8-week-old mice) varied greatly between strains with c57blks/j females having the lowest level (39 mg/dl) and nzb/b 1nj males having the highest levels (127 mg/dl). for a given strain, males always had higher levels than females. trends in total hdl levels in the same strains paralleled total cholesterol levels. triglyceride levels also varied greatly among strains but did not parallel cholesterol levels. among the strains tested, c57bl/6j mice had the lowest tg levels (71-80 mg/dl) and c3h/hesnj the highest (f, 162 mg/dl; m, 231 mg/dl). differences between genders of the same strain were less pronounced, compared to cholesterol and males generally had higher levels than females. a transient cause of plasma lipid elevation (hyperlipidemia) in the mouse is related to recent feeding (postprandial hyperlipidemia), especially on a high-fat diet. causes of persistent hyperlipidemia include diabetes, sustained feeding of a high-fat diet, and nephrotic syndrome. b. hdl, ldl, idl, and vldl levels of individual apolipoproteins can be measured by density gradient ultracentrifugation combined with either electrophoretic, immunologic, chemical, or morphologic analyses. although published reference ranges are not available, the distribution and characterization of murine apoproteins has been reported (camus et al. 1983 ). similar methods were used to evaluate plasma apoproteins in mice consuming atherogenic diets (moltisett et al. 1982) . more recently the profile of murine plasma lipoprotein cholesterol has been determined by fast protein liquid chromatography with on-line post-column analysis of superose 6 gel-filtration eluates (sehayek et al. 2003; strauss et al. 2001) . in contrast to humans, mice normally have low levels of ldl in their plasma (15 mg/dl), with the major plasma lipoprotein being hdl. the low ldl concentration is due to editing of 70% of apoprotein b mrna transcripts in mouse liver leading to apoprotein b48 containing particles that are cleared much faster than ldl in humans (lusis 2000) . in contrast, human apoprotein b mrna transcript editing only occurs in the intestine. a much simpler methodology has been developed to measure hdl and non-hdl lipoproteins in mice, based on precipitation and enzymatic analysis. when phosphotungstate and magnesium salt is added to serum (or plasma), all lipoprotein, except hdl, is precipitated and can be removed. the remaining solution is then tested for cholesterol as described previously. the non-hdl-cholesterol component is calculated by subtracting hdl-cholesterol from total cholesterol in the nonprecipitated sample (sehayek et al. 2003) . some strains develop elevated cholesterol levels associated with increases in non-hdl levels after consuming high fat diets (breslow 1994) . c. mouse apoproteins commercial antibodies against mouse apoprotein a1 and apoprotein a2 are available and elisas have been described for the measurement of these apoproteins in plasma and in hdl fractions of plasma (dansky et al. 1999) . plasma apoprotein a1 levels can also be measured by multiplex analysis. an assay for mouse apoprotein j (apoj or clusterin) has also been described (navab et al. 1997) . apoj, which is a ubiquitous glycoprotein postulated to have multiple functions, is associated with hdl and is the amyloid-associated protein associated with amyloid plaque formation in alzheimer's disease in humans. d. other analytes associated with lipid metabolism and atherosclerosis in mice elisa kits are commercially available for the quantitation of many mouse coagulation proteins including: fibrinogen, factor vii, d-dimer, tissue factor, and von willebrand's factor antigen. elisa kits are also available to quantify many murine products of arachidonic acid metabolism including hete. reagents, elisa kits, and multiplex assays are available for murine inflammatory cytokines and chemokines (see the "cytokines and chemokines" section), as well as monocyte colony stimulating factor. dansky et al. (1999) have described assays for the quantitation of murine aryl esterase and paraoxonase. table 6 -7 lists the mouse enzymes involved in lipid metabolism with references that describe their measurement. the innate and adaptive immune responses have been extensively studied (see volume 4 of this series) and therefore we will not attempt to describe all the features of mouse immunity in detail here. readers are directed to volume 4, molecular and cellular immunology of the mouse, for a general overview, and the 15 chapters that follow for a more detailed description. this section describes the growing number of quantifiable soluble serum proteins and lipids associated with immunity and inflammation in the mouse (see table 6 -3). furthermore, in addition to immunodeficiency, autoimmunity, and allergy, investigations of atherosclerosis, obesity, diabetes, cancer, as well as infectious diseases, each have immunologic and inflammatory components. 1. immunoglobulins (ig) as in humans, mouse immunoglobulins (ig) are molecules composed of four polypeptide chains; two of lower molecular weight called light (l) chains, and two with higher molecular weight called heavy (h) chains. disulfide bonds link one l chain to one h chain, and the two h chains to each other. immunoglobulin h chains are composed of four to five domains, including an n-terminal variable region domain and four constant-region domains. in addition, structural differences in the constant-region domains of the heavy chain are used to classify the five different classes of immunoglobulin, igm, igg, iga, ige, and igd. l chains are composed of only two domains and structural differences in these domains are used to classify l chains as either kappa or lambda type. in the mouse, 95% of serum ig has kappa l chains. any individual antibody secreting b cell (or plasma cell) will make a single ig molecule composed of two identical h chains and two identical l chains. mice make four subtypes of igg: igg1, igg2a, igg2b, and igg3. certain strains, c57bl/6, c57b1/10, sjl, and nod, do not make igg2a but rather make a novel igg2c. the igg subtypes in mice are not exact homologues of human subtypes (mestas and hughes 2004) . prenatal (transplacental) transfer of maternal ig as well as postnatal transfer across the intestinal epithelium is limited to the igg2a, 2b, and 3 subclasses of immunoglobulin and is mediated by neonatal fc receptors (fcrn) located in the placenta or on the intestinal brush border of the proximal small intestine (bankert and mazzaferro 1999) . mouse igg2b fixes complement by the classical pathway and igg 1 and igg2a fix complement by the alternative pathway. ige and igg1 are homocytotropic antibodies capable of binding to receptors on mast cells and basophils and mediate immediate hypersensitivity reactions. although igg and ige circulate in the mouse as monomers, igm circulates as a pentamer and iga circulates as a polymeric molecule. normally very little igd can be detected in serum. serum levels of igm, iga, igg, and ige are influenced by the rate of synthesis and rate of catabolism. like humans, the rate of igg catabolism in mice is directly proportional to the serum concentration of the subclass. the average half-life of murine igg is 4.5 days. the catabolic rate of iga is independent of serum concentration. mice synthesize from 50-130 mg/kg/day of total ig, although this is dependent on strain and level of antigenic stimulation. certain strains have a propensity to develop specific t-helper (th, cd4+) cell subclasses in response to antigenic stimulation, and these strains are referred to as having principally a th1 or th2-1ike phenotype. typically cd4+ lymphocytes modulate immune responses by the cytokines they secrete. those secreting il-1, ifn-y, and lymphotoxin are generally referred to as th1 (and are favored responses for immunity against viruses and intracellular pathogens) and those secreting il-4, il-5, il-10, and il-13 are referred to as th2 (and enhance humoral immunity while suppressing cell mediated immunity). when confronted with the same antigen, balb/c mice exhibit a th2-dominant response, and c57bl/6 mice exhibit a thl-dominant response. il-4 participates in immunoglobulin (antibody) class switching (see volume 4, chapter 5). consequently, th2 strains are the models of choice for investigations of allergic inflammation because they produce higher concentrations of il-4 induced immunoglobulin classes (ige and igg1). the cba/n strain is deficient in its ability to produce igm and igg3. immunoglobulin levels are also greatly reduced in germ-free mice, offspring of mice on zinc-deficient diets, and mice on protein-deficient diets (quimby 1999b) . quantifying the various classes and subclasses of murine ig can be done using various immunoassays including: radial immunodiffusion, ria, or enzyme immunoassay. both ria and enzyme immunoassay have the higher degrees of sensitivity that are needed to accurately quantitate levels of ige and igd in murine serum. enzyme immunoassay has become the favored assay to avoid isotope handling and disposal. the reported concentrations of normal balb/c mice are: igg1 (6.5 mg/ml), igg2a (4.2 mg/ml), igg2b (1.2 mg/ml), igg3 (0.1-0.2 mg/ml), iga (0.7 mg/ml), igm (1.0 mg/ml), and ige and igd are both less than 0.01 mg/ml (bankert and mazzaferro 1999) . in addition, there are many commercial sources of enzyme-linked antibodies that supply reagents (and instructions) for developing assays to measure antigen-specific antibody concentrations by subclass of antibody. the complement system is composed of 40 or more chemically and immunologically distinct proteins capable of interacting with antibodies, certain bacterial products, and cell membranes. a brief summary of this system is described later. please refer to two recent publications (quimby 1999a; turnberg and botto 2003) for more details about the structural and functional aspects of each protein of the complement system. the role of the complement system in mouse immunity is described in volume 4 (overview) of this series. the sequential activation of individual complement proteins from inactive to active substances is a dynamic event called the complement cascade. the ability of the first component of complement, c1, to bind specific sites on the heavy chain of mouse igg2b and activate a sequence of reactions leading to production of a molecular unit capable of lysing a target cell membrane has established the complement system as the primary mediator of antibody-antigen reactions. recent findings suggest that the pentraxins, c-reactive protein (crp), serum amyloid protein (sap), and pentraxin 3 (ptx3) can bind to complement component clq and activate the classical pathway. this may be an important mechanism for removal of apoptotic cells that might otherwise predispose to autoimmune disease (nauta et al. 2003) . each protein of the complement system is normally present in the circulation as an inactive molecule. although the complement cascade may be activated by any of four separate pathways, the central event for each is activation of c3 to c3b yielding a small c3 cz chain fragment. the two c3 convertases are c4b2a (for the classical, lectin, or pentraxin pathways) and c3bbb for the alternative pathway. each c3 convertase cleaves c3 and adds the c3b fragment to the convertase complex forming c5 convertase. cleavage of c5 leads to the membrane attack complex (mac) common to all activation pathways (goldsby et al. 2003) . assemblage of the mac on the surface of a target cell leads to the formation of a large channel enabling ions and other small molecules to diffuse out leading to cell death. the activated components of complement also participate in chemotaxis, phagocytosis, cell adhesion, and b-cell differentiation. there are many notable differences between mice and humans regarding expression of complement components and regulation of cascade activation. mice have both an active and inactive form of circulating c4 and the genes (both on chromosome 17) are designated ss and slp, respectively. many inbred strains do not synthesize active c5 (e.g., dba/2 and a/j strain) due to a post-translational defect and therefore they cannot generate a mac. some strains are deficient in the production of c8 (e.g., dba/2j strain). complement component 6 exists as two allelic forms in mice with 90 and 100 kda molecular weights. similarly there are several notable differences in the regulators of complement activation. most of these regulators are found in the regulator of complement activation (rca) locus on murine chromosome 1 and, as in humans, restrict assembly and stability of convertase enzymes. in mice, decay acceleration factor (daf) is encoded by two genes. however, only the product of daf-1 is widely dispersed on all tissues. this membrane-anchored protein inhibits c3 cleavage by accelerating decay of c3 convertases. in mice it is the major regulator of c3 in the skin (not kidney) and is a ligand for cd97 which, on cross-linking, leads to lymphocyte activation. cd59 is a membrane-anchored inhibitor of c5b-9 formation (mac) and prevents c9 from binding the c5b-8 complex. deficiencies of cd59 in humans lead to hemolytic anemia but not in mice. membrane cofactor protein (mcp) is a major cofactor for factor i in humans causing cleavage of c3b and c4b deposited on self-tissue. in mouse mcp is only expressed in the testis. complement receptors 1 and 2 are encoded by separategenes in humans but are produced by alternative splicing of a single gene in mouse. mice have a complement receptor 1 (cr-1) related gene/protein y (crry) not found in humans, which is a membrane-anchored c3 inhibitor. it is the major regulator of c3 in mouse kidney and has some of the functions as mcp and cr1 in humans. crry has daf activity and serves as a cofactor for factor i (which enzymatically cleaves c3b). the mouse has been widely used in studies on the biosynthesis and molecular biology of individual components of complement. the genes encoding 39 components, subcomponents, receptors, and inhibitors have been identified in mice. the complement components may be quantified by assays designed to measure the functional properties of these proteins or their antigenic properties. tests designed to measure antigenic properties of complement are generally simpler, less subject to error, and less expensive; however, they have the disadvantage of measuring both active and inactive forms of their proteins and therefore may not correlate well with functionally active protein. functional assays measure the ability of the entire classical or alternative pathway, or individual components of pathways to lyse (hemolyze) antibody-coated (sensitized) or noncoated (for the alternative pathway) red cells in suspension or in agarose gel. these assays are precise and sensitive (quimby 1999a) . antigenic assays include radial immunodiffusion, electroimmunodiffusion (rocket electrophoresis), automated immunoprecipitation, crossed immunoelectrophoresis, and more recently elisa (quimby 1999a) . elisa kits are commercially available for quantifying murine c lq, c3, c4, c3a (desarg), and c3a. in addition antibodies are commercially available for these as well as murine c4a, c4d, c5, and c6. complement components c2, c5, c6, c7, and factor b may be quantified using functional assays (quimby 1999a) . membrane-bound complement regulators, crry, cd59, and daf, can all be detected using previously published antibodies (lin et al. 2001 (lin et al. , 2002 . the principle mediator of the lectin activation pathway is mannose-binding lectin (mbl). after binding to mannose residues on the surface of microorganisms, two mbl-associated serine proteases (masps), masp-1 and masp-2, bind to mbl. this complex causes cleavage and activation of c4 and c2 (masp1 and 2 mimic the activities of c14 and cls). commercially available elisa kits are available for murine mbl-a and mbl-c quantitation. other activators of complement include members of the pentraxin family. in mice this may include crp or sap, although the concentration of crp in normal mice is very low. immunologic reagents are available to quantify both pentraxins in mice (gentry 1999; quimby 1999b ). circulating immune complexes (cic) are multimolecular substances composed of antigen, antibody, and activated complement components. in mice, igm, igg1, igg2a, and igg2b have complement activation regions. although cic may form following exposure to circulating foreign antigens, such as those associated with microorganisms, they are also common manifestations of spontaneous autoimmune disease such as that seen in (nzb x nzw)f1, mrl/lpr, bxsb, and krn strains. cic are cleared from the circulation by both cr-1, cr-2, and fcr. tissue deposition of immune complexes may lead to vasculitis. cic have been quantified in mice by capitalizing on their binding to various complement receptors, by precipitation of clq with polyethylene glycol, or by immunoassay. commercially available elisa kits are commonly employed today (quimby 1999b ). more than 100 inbred strains or mutant lines spontaneously develop autoimmune disease or are susceptible to autoimmune disease induction. the details of many of these lines may be found in volume 4, chapters l l and 12 in this series. autoimmune diseases in mice include: thyroiditis, rheumatoid arthritis, sj6gren's syndrome (ss), hemolytic anemia, lupus erythematosus, type 1 diabetes mellitus, experimental allergic encephalitis, oophoritis, orchitis, gastritis, ulcerative colitis, and polyendocrine disease (boyton and altmann 2002; ravirajan and isenberg 2002; sakaguchi 2000) . antibodies directed to self-antigens in the mouse have been quantified using a wide range of methods from immunofluorescence to elisa. table 6 -3 lists the commercially available elisa kits used to quantify murine autoantibodies. those antigenic targets associated with systemic lupus erythematosus include: cardiolipin, double-stranded deoxyribonucleic acid (dsdna), single-stranded deoxyribonucleic acid (ssdna), histone, [~-2 glycoprotein, proliferating cell nuclear antigen (pcna), neutrophil cytoplasmic antibody (canca), ribosomal p, and smith. antigenic targets for arthritis include: rheumatoid factor (rf), collagen type 1, collagen type 2, and ssdna. antibodies against insulin and glutamic acid decarboxylase are seen in type 1 (juvenile) diabetes. mixed connective tissue diseases are characterized by antibodies to ribonuclearprotein (rnp). antibodies to myeloperoxidase (mpo) may be observed in vasculitis. mice with ss develop autoantibodies to ss antigens a and b (ssa and ssb, respectively). panels containing 14 autoantigens are available as multiplex assays for quantifying murine autoantibodies. a. interleukins (il) (ils are cytokines that are secreted by leukocytes and act on other leukocytes. interleukins have been classified based on the secretory cell type (i.e., monokines vs. lymphokines), and they have been classified based on whether they are primarily involved in innate (il-1, il-6, il-12, tnf-t~, ifn-t~), or adaptive (il-2, il-4, il-5, il-10) immunity. commercially available elisa kits are available to quantify most murine interleukins, as demonstrated in table 6 -3. i. interleukin-1 (il-1) il-1 is a name for two proteins, il-lt~ and il-1 [3, that are encoded by separate genes. along with il-1 receptor antagonist, il-18, il-6, and tnf-t~, these proteins modulate acute inflammation. the effects of il-1 are pleotrophic and involve bone remodeling, insulin secretion, appetite regulation, fever induction, neuronal development, and many others. both il-1 o~ and il-1 [3 are secreted as 269-271 amino acid (aa) pro-cytokines that are enzymatically cleaved into bioactive 17-kda segments. unlike il-1 [3, the intact procytokine of il-1 ct is also bioactive, both within the cytoplasm and on the cell surface, where it is anchored to the cell membrane via a mannose glycosylation residue that attaches to the membrane-associated lectin. there is 78% sequence identify between mouse and human il-i~ genes and 58% identity between mouse and human il-1 t~ genes. a third gene encodes il-1 receptor antagonist, a soluble 25-kda molecule with 19% sequence homology to il-lt~ and 26% homology with il-113. mouse il-lra is 75% homologous with human il-lra. there are two il-1 receptors, types i and ii, but only il-1ri is capable of signal transduction. il-lra inhibits the action of il-lt~ and il-1b by binding il-1ri. a 60-kda form of il-1ri has also been described that is soluble and preferentially binds il-lra. il-1rii has no signal transducing associated protein and serves to modulate levels of il-1 t~, il-i[3, and il-lra by binding them on the cell surface. it can also occur as a soluble receptor. with the recent finding of six new members in the il-1 ligand family (in humans), a revised nomenclature for both il-1 ligands fred w. quimby and richard h. luong and il-1/il-18 receptor families has been developed (sims 2002) . further details may be found in volume 4 (overview and chapter 8) of this series. ii. interleukin-2 (il-2) il-2 is a lymphokine secreted by activated t-helper cells. it acts in an autocrine fashion to induce the expression of il-2 receptor on t cells, resulting in t-cell proliferation (cogoli-greuter et al. 2004) . il-2 also acts in a paracrine fashion modulating the activities of b cells, natural killer (nk) cells, and lymphocyte activated killer (lak) cells. il-2 is a glycoprotein of 133 amino acids (in humans) with 63% homology between mouse and human. the il-2 receptor (il-2r) is a multisubunit cellular receptor belonging to the class 1 cytokine receptor family (hematopoietin receptor family). the il-2r has a-, [~-, and y-chains. [3-and y-chains interact to transduce the il-2r signal and the y-chain is shared with receptors for il-4, il-7, il-9, and il-15. iii igg1 in mice and is responsible for the downstream events leading to differentiation and activation of th2 cells. il-4 also induces expression of adhesion molecules like vcam, th2 cytokines such as il-5, il-6, and il-9 and chemokines like eotaxin-1 and-2. il-4 primes mast cells and basophils leading to enhanced activation during allergic challenge (mueller et al. 2002) . homology between mouse and human molecules is low (25%) and each is species-specific in its biologic activity. it induces the growth of b-1 progenitors and igm production by b-1 cells. il-5 induces class switch, favoring production of iga, igg1, and ige. on eosinophils, il-5 induces iga and igg receptors and stimulates leukotriene (lt), c4, and paf secretion, in addition to inducing eosinophil growth and maturation. the receptors for il-5 consist of a ligand binding tx-subunit and a non-ligand binding (common) signal transducing ~-subunit that is shared by receptors for il-3 and granulocyte-monocyte colony-stimulating factor (gm-csf) (sato and miyajima 1994) . vi. interleukin-6 (il-6) il-6 is secreted by a wide variety of cells including t cells, b cells, monocytes, fibroblasts, hepatocytes, keratinocytes, astrocytes, and endothelial cells. it has broad pleiotropic effects on host defense, acute phase responses, immune responses, and hematopoiesis. il-6 is classified as an inflammatory cytokine and based on a helical cytokine structure and subunit makeup, il-6 is the prototypic member of a family of molecules that includes leukemia inhibitory factor (lif), oncostatin m (osm), ciliary neurotrophic factor (cntf), cardiotrophin (ct-1), and il-11. mouse il-6 is 25 kda and contains four cysteines and contains o-glycosylation sites and shares 40% homology with the human molecule (van snick 1990). the il-6 receptor has two subunits, a nonsignal transducing subunit binding with low affinity (~-subunit), and a signal transducing subunit (~-subunit) that does not bind il-6 by itself but participates in high-affinity binding. the soluble il-6r~ chain binds il-6 and the complex induces expression of mcp-1, which attracts monocytes into areas of inflammation (kaplanski et al. 2003) . vii. interleukin-7 (il-7) il-7, previously called lymphopoietin-1, is expressed by stromal cells, especially in the bone marrow and thymus, where it promotes thymopoiesis of t cells and the differentiation of pro-b cells into pre-b cells (aspinall et al. 2004; goldsby et al. 2003) . mouse il-7 has 65% amino acid sequence homology with human il-7 and both proteins exhibit cross-species activity. viii. interleukin-8 (il-8) il-8 is not expressed in the mouse; however, another protein, kc, is secreted and has many properties of the human chemokine, gro, which is known to bind the il-8 receptor (see the "cytokines and chemokines" section). ix. inrelclevlcln-io (il-io) il-10 is the prototypic member of the il-10 cytokine family comprising ill0, il-19, il-20, il-22, il-24 (fisp), and il-26. il-10 is a 178 amino acid protein with an 18 amino acid signaling sequence. both mouse and human il-10s have two intrachain disulfide bonds and form non-disulfide linked homodimers. mouse and human il-10 are 72% homologous. il-10 is a th2 cytokine, which inhibits ifn-y and gm-csf production by th1 cells. additionally it induces cd8 + t-cell chemotaxis, inhibits t-cell apoptosis, participates in iga class switch in b cells, induces histamine release from mast cells, and promotes tnf-tx and gm-csf production by nk cells. il-10 inhibits secretion of the neutrophil chemokines mip-lt~ and mip-i~ and blocks production of il-1~ and tnf-ct by neutrophils. it is immunosuppressive to dendritic cells and induces the differentiation of a subset of regulatory cd4 + t cells (trl) (grouz and cottrez 2003; morel et al. 1997 ). x. il-11, also known as adipogenesis inhibitory factor (agif), is a pleiotropic cytokine with effects that overlap that of il-6. il-11 is a member of the il-6 cytokine family and as such has a four-helix bundle fold motif. it binds to the multimeric il-11 receptor that shares the promiscuous gpl30 signaling ~-subunit with other receptors in this family. the il-11r ~ chain is unique and binds il-11 but does not have a cytoplasmic domain; instead binding leads to homodimerization of the ~-chain that activates the janus kinases. il-11 stimulates proliferation and differentiation of monocytes and megakaryocytes causing thrombopoiesis. it also activates osteoclasts and enhances bone resorption, decreases new bone formation, and stimulates chondrocyte and synoviocyte production. il-11 protects small intestinal epithelial cells from chemotherapy and radiation injury and ameliorates inflammatory bowel disease (schwertschlag et al. 1999) . il-11 inhibits adipogenesis, regulates neuronal differentiation, and regulates t-cell function (enhances th2 and inhibits th1 cytokine production). overexpression of il-11 in the lung causes airway remodeling, fibrosis, and mononuclear nodules analogous to the clinical picture in chronic asthma. il-11 is also required for the uterine decidualization response (robb et al. 2002; zheng et al. 2001) . xi. il-12, also known as natural killer cell stimulatory factor (nksf), is a heterodimeric cytokine composed of a 40-kda (p40) subunit and a 35 kda (p35) subunit. the p40 subunit is shared by il-23, a cytokine with similar activities. macrophage, monocytes, and dendritic cells produce il-12 after activation of toll-like receptors (tlr) on these cells by bacterial ligands. il-12 induces production of ifn-7by th1 and nk cells and intact il-12 skews the balance between th subsets in favor of th1 cells. il-12 binds to the il-12 receptor that is composed of two subunits, [31 and ~2, on the surface of nk and th1 cells. il-12p40 interacts with il-12r[31, and il-12p35 binds il-12r[32. negative feedback regulation of il-12 production involves down regulation of tlr signaling by phosphoinositide 3-kinases (piks). thus il-12 is centrally involved at the interface of innate and adaptive immunity (fukao and koyasu 2003" ottenhoff et al. 2002) . xit, il-13, along with il-4 and il-5, is a member of the type-2 cytokine family and as such is involved in inflammation, mucus production, tissue remodeling, and fibrosis. this single-chain protein shares 58% amino acid sequence homology with human il-13. il-13 is produced by activated t cells, mast cells, and nk cells and promotes th2 responses including synthesis of ige. signaling is mediated by the type-2 il-4 receptor which consists of il-4r~ and il-13rc~i chains. another il-13 binding protein, il-13r~2, strongly inhibits the activity of il-13 (goldsby et al. 2003; mentink-kane and wynn, 2004) . xiii. il-17, also known as cytotoxic t lymphocyte-associated antigen-8 (ctla-8), is produced by t cells and is pleiotropic in activity. il-17 is a 158 amino acid residue polypeptide with a 21 amino acid signal sequence and a mature polypeptide of 137 amino acids. it is a disulfide-linked homodimer. based on the presence of spatially conserved cysteine residues in the il-17 family of proteins, there are six family members in humans and mice, il-17, il-17b, il-17c, il-17d, il-17e, and il-17f (aggarwal and gurney 2002) . like il-17 itself, several of the family members appear to modulate immune function. produced by mouse cd4 ⧠t cells, il-17 induces il-6, mcp-1, prostaglandin-e2 (pge2) and granulocyte colony-stimulating factor (g-csf) by fibroblasts, keratinocytes, epithelial cells, and endothelial cells. it induces icam-1 surface expression, proliferation of t cells, and the differentiation of cd34 + marrow progenitors into neutrophils (fossiez et al. 1998 ). the ubiquitously distributed receptor is a type 1 transmembrane glycoprotein of 830 amino acids in length. xiv. il-18 is a 24-kda, nonglycosylated polypeptide that lacks a classical signaling sequence. its structure resembles il-1 and the propeptide undergoes proteolytic cleavage by interleukin-1 [3-converting enzyme (ice) or another caspase to produce an 18-kda bioactive molecule. there is 64% sequence homology between mouse and human il-18. il-18 induces the production of ifn-7 by t cells and nk cells and the expression of fas ligand (fasl) on a variety of all types. il-18 activates nf-~:[3 and the induction of various chemokines. il-18 plays an important role in the early antibacterial host response (weijer et al. 2003) . xv. and il-20 induces keratinocyte differentiation and proliferation. il-21 is a four-helix-bundle cytokine similar in structure to il-15 and sharing sequence homology with il-2 and il-4. murine il-21 is 57% homologous to human il-21. the il-21 receptor utilizes the common 7-chain. il-21 is produced by the th2 cells. the actions of il-21 are pleiotropic and seen on b cells, t cells, nk cells, and dendritic cells. il-21 induces apoptosis in resting and activated b cells, an effect counteracted by activation of cd40. it also upregulates production of igg1 and inhibits ige, in fact it inhibits many il-4 activities. il-21 also inhibits dendritic cell differentiation. il-21 enhances the activity of activated nk cells and mediates the proliferation and expansion of t-cell subsets. il-22 induces acute phase reactants by hepatocytes and reduces il-4 production by th2 (mehta et al. 2004) . recombinant antigens and antibodies are commercially available for murine il-20, il-21, and il-22. b. the transforming growth factor-~ superfamily (tgf-~sf) of cytoi~nes members of tgf-~ family share 25-40% sequence homology with tfg-~i and a monomeric structure that consists of two antiparallel pairs of [3-strands forming a flat curved surface, a separate long cz-helix, and a disulfide rich core with a characteristic cysteine knot. most tgf-~sf members are disulfide-linked homodimers; however, three members lack the seventh conserved cysteine residue and are not covalent homodimers. members of the tgf-[3sf include tgf-[31, tgf-132, tgf-133, activins, inhibins, bone morphogenic proteins (bmp), growth differentiation factors (gdf), glial-derived neutrophic factors (gdnf), and mtillerian inhibiting substance (mis). tgf-[31 is stimulatory for cells of mesenchymal origin and inhibitory for cells of epithelial or neuroectodermal origin. in the murine immune system tgf-[31 is the mediator of immune suppression via cd4+cd25+tr cells and, at least in the case of suppressing cd8 + effector t cells, involves tgf-[3 receptor ii on these cells (powrie 2004; von boehmer 2005) . in addition tgf-[3 is known to inhibit b-cell proliferation and it promotes isotype switch to iga. oral tolerance to th2 responses (against food allergins) is mediated by tgf-~i1 (mucida et al. 2005 ). tgf-[3 has a wide range of effects on cell growth differentiation and malignant transformation (letterio 2005) . murine tgf-~i 1 may be quantified in serum or plasma using commercially available elisa kits. antibodies are also available which specifically bind murine bmp, activin a, activin c, and gdf-1,-3,-5,-8, and-9, although they are not recommended for elisa development. c. the tumor necrosis factor superfamily (tnfsf) tnf-related ligands share many features but high amino acid sequence homology is not one of them. with the exception of nerve growth factor and tnf-~, all ligands are type ii tramsmembrane proteins (extracellular c-terminus) that contain a short cytoplasmic segment and a long extracellular region. tnf-~ is fully secreted and has a nonfunctional transmembrane segment. tnfsf members form trimeric structures and their monomers are composed of ~-strands oriented into a twosheet structure. receptors for the tnfsf ligands also belong to a superfamily, tnfrsf (gruss and dower 1995) , and are characterized as type i transmembrane proteins (with their amino termini outside of the cell), with extracellular cysteine-rich structural motifs. tnfrsf members exist both as membrane and soluble forms. commercially available elisa kits or matched antibody for development of assays are available to quantify the murine receptors and ligands of the tnfsf discussed in this section. i. tumor necrosis factor-ix (tnf-ix) tnf-tx is expressed as a 26-kda membrane glycoprotein and the soluble glycoprotein is generated by proteolytic cleavage via tnf-ct converting enzyme (tace). the 17-kda homotrimer cleavage product circulates. mouse tnf-tx has 79% sequence homology with human. tnf-tx is expressed widely on tissues throughout the body (goetz et al. 2004) . tnf-tx is a strong mediator of inflammation and immune function, or regulates on growth and differentiation, and is cytotoxic for many transformed cells. ii iii. cd40l cd40l (tnfsf5, cd154) is a 39-kda, type ii, transmembrane glycoprotein that can be proteolytically cleaved to 15-to 18-kda soluble forms with full biologic activity. it forms natural trimeric structures and the mouse cd40l shares 73% sequence identity with human cd40l. cells expressing cd40l include b cells, cd4 + and cd8 ⧠t cells, monocytes, nk cells, and y t cells (toubi and shoenfeld 2004) . on binding cd40, the complex initiates signals important for cell proliferation or apoptosis. cross-linkage between t and b cells allows cd40 to transduce the tyrosine kinases lyn and syk, and activate phospholipase c, ip3, and dag. when combined with other cytokines, ligation of b-cell cd40 provides the second signal allowing differentiation of b cells to plasma cells (goldsby et al. 2003) . iv. cd30l cd30l (tnf5f8, cd153) is a 40-kda glycoprotein with 72% sequence homology between murine and human molecules. cd30l is expressed on monocytes, macrophages, b cells, activated t cells, neutrophils, megakaryocytes, resting cd2 ⧠t cells, erythroid precursors, and eosinophils. ligation to cd30 can induce either proliferation or apoptosis. v. fas ligand (fasl) fasl (also known as tnfsf6), is a 40-kda glycoprotein that, after cleavage, forms a 70-kda homotrimer that is active only in membrane form in the mouse. polymorphisms in fasl also exist and a single amino acid substitution in position 273 (phe to leu) results in the generalized lymphoproliferative disease (gld) mutation. fasl is expressed on cells of the adaptive and innate immune systems, as well as cells of the lung and intestine. there is 77% sequence homology between murine fasl and human fasl (lynch et al. 1994) . ligation of fas by fasl on mature t cells leads to activation of the caspase cascade and apoptosis. this is a major homeostatic mechanism regulating the size of the t-cell pool and for eliminating t cells that repeatedly encounter self-antigens (goldsby et al. 2003) . vi. tnf-relateo activation-induced cytokines (trance) trance, also called rank ligand and osteoprotegerin ligand (opgl), is an osteoclast differentiation factor. mouse and human share 85% sequence homology, and trance is expressed on t cells and t-cell rich organs such as thymus and lymph nodes. vii. tnf-receeror superfamily (tnfrsf) tnfrsf members mediate the cellular effects of tnfsf members. tnfri and tnfrii bind tnf-~ and it appears tnf-~ complexes with lt-[3 and the complex binds to tnfri or lt-[~ receptor. cd40 is associated with b-cell proliferation but is expressed on many cells throughout the body. mouse cd40 shares 62% sequence homology with human cd40; however, the mouse molecule has a 28 amino acid extension of its cytoplasmic tail. cd30 has 480 amino acid residues and a 90 amino acid deletion in the extracellular region compared to human. it is expressed on cd4 + and cd5 + t cells and ligation results in production of il-5. murine fas lacks 8 amino acid residues found in human and shares only 50% sequence homology. soluble forms result from alternative gene splicing and circulate as dimers or trimers. fas is expressed by cd34 stem cells, fibroblasts, nk cells, keratinocytes, hepatocytes, b and t cells (and their precursors), and eosinophils. osteoprotegerin (opg) inhibits the action of osteoclasts and is a secreted member of the tnfrse although it has no transmembrane segment and circulates as a disulfide-linked homodimer. murine troy, also named toxicity and jnk inducer (taj) and tnfrsf19, shares 92% homology with human in its extracellular domains. d. interferons interferons are a group of related but distinct proteins that share more than 95% amino acid sequence homology. members of the type i interferon family share a common cell surface receptor composed of two subunits. commercially available elisa kits may be used to quantify murine io interferon-~ (ifn-~) ifn-~ is induced in a wide variety of cells, including monocytes and macrophages, in response to viral infection. one known inducer is double stranded ribonucleic acid (dsrna). induce resistance to viral replication by binding the ifn-~/~ receptor, which activates the jak-stat pathway, inducing several genes. one of those genes is ribonuclease, which degrades viral rna. binding of ifn-~ to nk cells enhances their lytic activity for virally infected cells. ifn-~ is secreted by leukocytes. iii inreturelcon-'t(ifn-y) ifn-y is secreted by th1 cells, nk cells, and cytotoxic t cells (tc), which activates macrophages to secrete tnf-ct, express class ii major histocompatibility complex (mhc) molecules, and produce antimicrobial activities. ifn-y secretion by th1 also induces antibody-class switch to igg2a, which supports phagocytosis and complement fixation. ifn-y promotes differentiation of tc from cd8 + precursors that will be involved in the effector response to viral infections and intracellular pathogens. ifn-y also inhibits the expansion of th2 cells. ifn-y secretion is induced by successful stimulation of t cells by antigen presenting cells. e. chemo~s chemokines, along with adhesion molecules, are the principle controllers of leukocyte migration and as such directly affect leukocyte retention and relocation during hematopoiesis and at sites of immune defense and inflammatory disease (moser et al. 2004) . chemokine-induced signaling is via g-protein coupled cell surface receptors. although most chemokines are secreted proteins, two chemokines, cxcl16 and cx3cl 1, are membrane bound. two primary subfamilies are recognized based on the arrangement of two nh2-terminal cysteine residues that are either located adjacent to each other (cc) or are separated by a single amino acid (cxc). two minor subfamilies include chemokines with a single cysteine resides (xcl1, xcl2) and a chemokine with three amino acids separating the cysteine residues (cx3cl1). functionally conserved regions of the n-terminus of each member mediate receptor binding and extracellular matrix fixation (or binding cell surface glycosaminoglycans). many chemokines are designated with a name given at the time of their identification; all have also been assigned a name based on their structural motif (cc, cxc, xc, cx3c) followed by l for ligand. receptors are heterotrimers and their activated g-protein subunits stimulate phospholipase c[3, piks, and c-src tyrosine kinases (moser et al. 2004) . receptors are designated by the type of chemokine they bind (i.e., cxc, cc, xc, or cx3c), followed by r. mice lack the cxcr1 family of chemokines and receptors found in humans. table 6 -8 lists the murine chemokine receptors and the known ligands. table 6 -3 lists the murine chemokines for which there are either commercial test kits or matched antibodies for kit development. two main functional groups define chemokines. inflammatory chemokines recruit effector leukocytes to sites of infection, inflammation, and repair. homeostatic chemokines control the navigation of leukocytes during hematopoiesis in the bone marrow and thymus, control homing of cells to spleen, lymph nodes, and peyer's patches during the adaptive immune response and control immune surveillance in peripheral tissues. some chemokines participate in both inflammation and homeostasis and are called dual-function chemokines. many dual function chemokines are highly selective for the recruitment of t cells. other chemokines have ill-defined functions regarding homeostasis and inflammation but participate in other vital activities such as the role of pf4 (cxcl4) in thrombosis and the role of cxcl 10 in gut epithelial cell turnover (cliffe et al. 2005) . most inflammatory chemokines are thought to be induced and the variety of stimuli that induce their expression is broad. by contrast most homeostatic chemokines are thought to be constitutively expressed. an exception is the inducing effect of lymphotoxin and tnf-~ on b-cell attracting chemokine-1 (bca-i, cxcl13), ccl19, and secondary lymphoid tissue chemokine (slc, ccl21), which also participate in inflammation. leukocytes also release several kinds of proteases that degrade chemokines at their n-terminus, resulting in the loss of receptor binding, antagonist generation, or enhancing their biologic function. leukocyte cd26, dipeptidyl peptidase iv is known to act on cxcl9, cxcl10, cxcl11, and cxcl12. murine sulphostin inhibits the action of cd26 and stimulates g-csf and granulopoiesis (abe et al. 2005) . matrix metalloproteases (mmps) are enzymes that degrade extracellular matrix proteins, including stromal cell derived factor-1 (sdf-1, cxcl12) and mcp-1. table 6 -3 lists the murine mmps that can be quantified by commercially available elisa kits. in addition to mmps, cathepsins have been shown to modify chemokines. table 6 -9 lists the murine chemokines and the proteases that degrade them and stimuli that induce them. certain chemokines may antagonize the activity of other chemokines; for instance, three agonists for the receptor cxcr3 are also antagonists for receptor ccr3 (which is agonized by eotaxin [ccl11]). because cxcr3 and ccr3 are differentially expressed on th1 and th2 cells, these chemokines [monokine induced by ifn-y (mig/cxcl9), ifninducible protein-10 (ip-10/cxcl10), and ifn-inducible t-cell chemoattractant (i-tac/cxcl11)] modulate the th subpopulation allowed to enter tissue sites favoring th1 immune polarization (moser et al. 2004) . table 6 -10 summarizes some known effects of murine chemokines. because chemokines and their receptors are known to modulate many inflammatory diseases including the autoimmune diseases, they have become target for new therapeutics. the chemokine antagonist, met-rantes, has been shown to be an effective inhibitor of allergic airway disease in mice. likewise, deficiencies of chemokines and their receptors in mice have modified disease progression in atherosclerosis, autoimmunity, and also prolong allograft survival (mackay 2001 ). in addition, many viral genomes are known to encode structural genes for chemokine antagonists, which appears to be a principal mechanism used by many viruses to evade the host immune system. these present another target for drug intervention for viral infections. finally, pepducins, derived from the intracellular loops of cxcr1, cxcr2, and cxcr4, specifically inhibit receptor g-protein signaling in mice and prevent fatal sepsis and disseminated intravascular coagulation (kaneider et al. 2005 ). certain growth factors (see table 6 -3) and cytokines activate phospholipases after binding their cell surface receptors. these phospholipases act on membrane phospholipids to release arachidonic acid, a precursor for several eicosanoids. arachidonic acid is metabolized by any one of three biochemical pathways: the cyclooxygenase (cox) pathway, which forms pgs and thromboxane, the lo pathway, which forms hetes and leukotrienes (lts), and the cytochrome p-450 monooxygenase pathway, which forms epoxides and hetes. the cox enzymes, cox-1 and cox-2, catalyze the first step in the synthesis of pgs by converting arachidonic acid to prostaglandin h 2 (pgh2). pgh 2 is chemically unstable and is the precursor for enzymatic and nonenzymatic production of pgd 2, pge 2, and pgfza. thromboxane synthetase converts pgh 2 to thromboxane a 2 (txa2) that is quickly converted to thromboxane b 2 (txb2). in vascular tissue, pgh 2 is converted to pgi 2 or prostacyclin by prostacyclin synthetase (natarajan and nadler 2004; reimers 1999) . although cox-1 is constitutively expressed in most tissues, cox-2 is induced by bacterial lipopolysaccharides, il-i~, il-ll~, and tnf-~ (see the "cytokines and chemokines" section). in the circulation, pge 2 and pgi 2 cause vasodilation, whereas pgfza and txb 2 are potent vasoconstrictors. in the kidney, pge1, pge2, pgd2, pgg2, pgi2, and pgh2 produce vasodilation, increased renal blood flow, and urinary excretion of sodium. renal production is increased by pgd2, pge2, and pgi2. pgg2, pgh2, and txa 2 modulate platelet aggregation and, following platelet adhesion, they release catecholamines, serotonin, and adenosine diphosphate, which enhance platelet aggregation. pgi 2 is a potent inhibitor of platelet aggregation. pge1 increases, whereas pge2 decreases, the ability of red cells to pass through capillaries. pge2 and pgfza inhibit the activities of t and b cells and the production of ils and chemokines, which attract monocytes. pgd 2 is a potent inducer of chemotaxis for th 2 cells and plays a major role in allergic airway disease. through the varied activities of vasodilation, vascular permeability, and leukocyte migration, the pgs are potent modulators of inflammation. in addition pge1 inhibits mackay 2001 rossi et al. 1999 niess et al. 2005 mackay 2001 huang and xiang 2004 yamaguchi et al. 2005 insulin secretion and release after glucose challenge (see the "glucose and carbohydrate metabolism" section), and it inhibits the lipolytic effects of glucagons, adrenocorticotropic hormone, and epinephrine (see the lipid metabolism section) and inhibits the secretion of corticosterone, prolactin (prl), gh, thyroid stimulating hormone (tsh), and lh. in fact, pgs have a multitude of effects associated with female reproduction (reimers 1999 table 6 under the action of 5-lo, arachidonic acid is converted to 5-hydroxyperoxyeicosatetraenoic acid (5-hpete) and then leukotriene a4 (lta4), which is unstable. lta4 is metabolized to ltb4 by lta4 hydrolase or to cysteinyl leukotrienes (ltc4, ltd4h, and ltc45) by ltc4 synthase. 5-lo expression is limited to neutrophils, eosinophils, monocytes, and mast cells; however, lta4 hydrolase is expressed in erythrocytes, t cells, platelets, airway and intestinal epithelial cells, fibroblasts, heart, kidney, and adrenal cortex. because the latter cells and tissues do not express 5-lo, lta4 must be delivered to them via myeloid cells by a process known as transcellular biosynthesis (maclouf 1993) . receptors for ltb4 (blt1 and blt2) have been identified and are either widely expressed (blt2) or are confined to myeloid cells, t cells, and lung cells (blt1). in addition to attracting myeloid cells to sites of inflammation, ltb4 is a potent inducer of th1 and th2 t effector cell chemotaxis (as potent as cxcl12 in the mouse) and cd8+t-effector cell chemotaxis (as potent as rantes). like pgd2, ltb4 plays a major role in allergic airway disease (luster and tager 2004) . additional information on murine prostanoids and their receptors is available in recent reviews (jala and haribabu 2004; kobayashi and narumiya 2002) . all the arachidonic acid metabolites discussed in this section may be quantified using commercially available elisa kits (see table 6 -3). e. enzymes ap is an inducible enzyme in which serum activity is increased due to increased synthesis. the exact physiologic function of ap is not known but is thought to transport metabolites across cell membranes. quantification of serum ap is based on a reaction between ap and a suitable phosphorylated substrate that is susceptible to ap activity. as in other species, there are two major forms of ap in mice: intestinal ap (lap) and tissue nonspecific ap (tnap). unlike other domestic animal species, iap activity contributes to serum ap activity, in addition to tnap. lap is located along the brush-border of the enterocytes. intestinal ap activity was shown to vary four-fold between two strains of swiss mice (nayudu and moog 1967) . this difference in activity was under polygenic control and influenced by a strain-specific factor in milk. tnap is found in various tissues, and in each location, post-translation modifications may result in a different isoenzyme. hoshi et al. (1997) used immunohistochemistry to localize these isoenzymes in mice to the following locations: bone tissue (specifically the entire cell surface of preosteoblasts and the basolateral cell membrane of osteoblasts), cartilage (mostly in chondrocytes of the proliferative and hypertrophic zones), the incisors (particularly the cells of the stratum intermedium, the subodontoblastic layer, the proximal portion of secretory ameloblasts, and the basolateral portion of odontoblasts), kidneys (on the brush borders of proximal renal tubules in kidney), liver (on cell membrane of the biliary canaliculi), and the placenta (on trophoblasts). serum ap activity can vary due to the type of assay used, age, sex, and strain. different ap assays vary in the type of substrate used, the ph of the reaction, and the incubation temperature of the reaction, all of which can affect quantitation of ap activity. for example, the hausamen technique can detect renal and intestinal ap activity, but not hepatic ap activity (hausamen et al. 1967 ). loeb et al. (1996 ) and frith et al. (1980 demonstrated that serum ap activity decrease significantly after 3 months of age in balb/c and c57bl/6 mice of both sexes but increase again in very old (36 month old) mice. the high levels of serum ap seen in juveniles is related to increases in the bone ap isoenzymes, which is associated with osteoblastic activity due to rapid growth. picketing and picketing (1984) showed that serum ap activity is lower in males than in females. quantification of serum ap measures the total ap activity from all sources, and therefore elevations in ap activity can be a nonspecific determinant of tissue dysfunction, depending on the tissue (and therefore ap isoenzyme) involved. for example, changes in the serum activity of ap due to liver disease only occur if cholestasis is concurrently involved. mice lacking the gene that modifies tnap into the bone isoenzyme suffer from skeletal hypomineralization (anderson et al. 2004 ). alt is a cytoplasmic enzyme in which serum activity is increased due to leakage across damaged cytoplasmic membranes. alt (also known as glutamic pyruvic transaminase [gpt]) reversibly catalyzes the conversion of alanine to pyruvate. quantification of serum alt is based on a reaction between alt and a suitable substrate (such as alanine). in mice, alt is found in the highest concentrations in the liver, although activity has also been demonstrated in intestine, kidney, heart, muscle, and brain (clampitt and hart 1978) . despite its widespread tissue distribution, alt is mostly used as an analyte to assess hepatocellular damage (masaki et al. 2005; taieb et al. 2005 ). an 11,000% increase in serum alt activity has been reported following infection with mouse hepatitis virus, and significant increases follow infection by helicobacter hepaticus (mccathey et al. 1997 ). ast is a cytoplasmic and mitochondrial enzyme in which serum activity is increased due to leakage across damaged cytoplasmic and mitochondrial membranes. ast (also known as glutamic oxaloacetate transaminase [got]) reversibly catalyzes the conversion of aspartate to oxaloacetate. quantification of serum ast is based on a reaction between ast and a suitable substrate (such as aspartate). in mice, ast is found in a variety of tissues, including liver, skeletal muscle, cardiac muscle, erythrocytes, blood vessels, brain, intestine, kidney, lung, testes (papadimitriou and van duijn 1970) . the highest specific activity of ast is found in mouse cardiac muscle and lowest in skeletal muscle (herzfeld and knox 1971) . in the liver, ast is found mainly in periportal hepatocytes based on histochemical studies (papadimitriou and van duijn 1970) . activity in lung, kidney, intestine, and skeletal muscle is very low when measured by the technique of bergmeyer and bernt (1974) . loeb et al. (1996) demonstrate significant age-associated increases in serum ast activity in two inbred and two f1 hybrid strains. although widely distributed, alt is mainly used to assess hepatocellular damage, cardiac muscle damage (naraoka et al. 2005; ray et al. 2005) , and testicular injury (santos et al. 2005) . alt activity has been used as an indicator of hepatic injury of mice infected with mouse hepatitis virus (fassati et al. 1969 ). ldh is a cytoplasmic enzyme in which serum activity is increased due to leakage across damaged cytoplasmic membranes. ldh reversibly catalyzes the conversion of pyruvate to lactate. quantification of serum ldh is based on a reaction between ldh and a suitable substrate (such as pyruvate or lactate). as in other species, ldh in the mouse is a tetrameric enzyme consisting of either a or b subunits. there are five isoenzymes of ldh (based on differences subunit a and b composition), and these are ldh-1 (b4), ldh-2 (a1b3), ldh-3 (a2b2), ldh-4 (a3b1), and ldh-5 (a4). specific isoenzyme distribution depends on differential expression of either the a and b subunits (quimby 1999b) . for instance, all embryonic murine tissues contain ldh-5 because the a subunit is only expressed during early fetal development. as the embryo matures, subunit expression can involve both a or b subunits in different tissues, meaning that by birth and sexual maturity, each tissue contain a characteristic ldh subunit profile. in adult mice, the heart and erythrocytes contain ldh-1 and ldh-2, whereas most other tissues have ldh-3. skeletal muscle and hepatocytes fail to express subunit b and therefore are composed predominantly of ldh-5. serum ldh activity can vary due to age and sex. ldh levels have been shown to be higher in males versus females of the balb/c strain (frith et al. 1980) . serum ldh levels increase with age in balb/c and c57bl/6 mice of both sexes (frith et al. 1980) . serum ldh can also be elevated falsely by hemolysis. quantification of serum ldh measures the total ldh activity from all sources. however, damage to a particular tissue will result in increased activity of that isoenzyme in serum. in general, the highest activity of ldh in the mouse is in skeletal muscle, with decreasing activity in the heart, liver, kidney, and intestine. serum ldh-5 activity rises within 72 h after inoculating mice with the mouse hepatitis virus (fassati et al. 1969) . mice infected with the ldh virus (ldv) exhibit increased serum concentrations of ldh, isocitric dehydrogenase, malic dehydrogenase, phosphohexase isomerase, and ast (notkins 1965) . along with ast and ck, ldh is considered an excellent marker for cardiac injury (naraoka et al. 2005; ray et al. 2005) . otc is a mitochondrial enzyme in which serum activity is increased due to leakage across damaged mitochondrial membranes. otc is found primarily in the liver of mice, and there increases in serum activity reflect severe injury to hepatocytes. abnormal otc activity has been described in mice having the sparse-fur (spf/y) mutation. they serve as a model for the most common inborn error of urea synthesis in humans. assays for mouse otc have been developed to monitor activity levels following gene transfer or liver transplantation (batshaw et al. 1999; ye et al. 2001 ). ck is a cytoplasmic and mitochondrial enzyme in which serum activity is increased due to leakage across damaged cytoplasmic and mitochondrial membranes. ck reversibly catalyzes the phosphorylation of adenosine diphosphate (adp) to ate using creatine phosphate as the donor for the phosphate group. quantification of serum ck is based on a reaction between ck and a suitable substrate (such as creatine phosphate). as in other species, cytoplasmic ck is a dimeric enzyme consisting of either m or b subunits. there are three isoenzymes of ck (based on differences subunit m and b composition), and these are ck-1 (bb), ck-2 (mb), and ck-3 (mm). brain contains ck-1, skeletal muscle contains ck-3 (mm), and cardiac muscle contains ck-1, ck-3, and ck-2 (mb) (quimby 1999b ). in the mouse, the greatest ck activity is found in skeletal muscle, with much less activity found in the heart and brain. mitochondrial ck (ck-mt) is found in mitochondria of many tissues. serum ck activity is affected by age, sex, and method of collection and anesthesia. patrick et al. (1983) found that compared to jugular vein collection, cardiac puncture was associated with lower ck activity. levels of serum ck activity have been reported for balc/cann mice and c57bl/10 mice of varying ages and sex (sub et al. 1994) . serum ck activity is a useful and specific marker enzyme of muscle injury, because ck in central nervous tissue does not cross the blood-brain barrier. sub et al (1994) compared normal c57bl/10 mice with heterozygous male and homozygous female mice carrying the mdx (mutant dystrophin) allele, and found that homozygous females have 12-to 15-fold increases and heterozygous males (mdx/y) have 30 fold increases in plasma ck compared to wild-type mice. plasma ck levels correlated with skeletal muscle necrosis in these dystrophic mice. mice have been engineered that lack cytoplasmic ck and ck-mt . mitochondria from heart or skeletal muscle from double kos had higher adp concentrations compared to wild-type animals, suggesting the higher concentrations contribute to the control of the reduced cytosolic atp free energy potentials seen in double kos. aldolase is a cytosolic enzyme that can alter its distribution between soluble and particulate forms, according to the metabolic status of the tissue. in adult mice, nine aldolase isoenzymes are known to occur in tissues with significant activities in the muscle, brain, liver, kidney, and spleen. in the mouse liver aldolase, together with fructokinase and triokinase, metabolize fructose (hagopian et al. 2005) . everett and harrison (1983) report no apparent advantages in mice in the measurement of aldolase over other enzymes known to have specific liver or muscle activity. sdh is a cytoplasmic and mitochondrial enzyme in which serum activity is increased due to leakage across damaged cytoplasmic and mitochondrial membranes. sdh (also known as iditol dehydrogenase [idh]) reversibly catalyzes the conversion of fructose to sorbitol. quantification of serum sdh is based on a reaction between sdh and a suitable substrate (such as fructose). sdh is located primarily liver, kidney, and seminal vesicles. the activity of sdh is usually low in the serum and rises during hepatic injury. however, the labile nature of sdh during handling makes is less suitable overall as a indicator of hepatic dysfunction compared to over liver-specific enzymes (such as ast). mice with the gene for sdh knocked out have been used to study the role of sorbitol accumulation in diabetic albuminuria (ii et al. 2004 ). amylase is a cytoplasmic enzyme in which serum activity is increased due to leakage across damaged cytoplasmic membranes. amylase hydrolyzes complex carbohydrates to form maltose and glucose in the presence of free calcium ions. quantification of serum amylase is based on a reaction between amylase and a suitable substrate (such as starch). similar to humans and pigs (but not dogs, cats, cattle, and horses), expression of amylase in mice is related to two distinct but closely linked loci (meisler et al. 1983) . salivary amylase is the gene product of amy-1 (salivary), and appears to be a single enzyme. pancreatic amylase is the gene product of amy-2, and based on electrophoretic studies in inbred mice, there appear to four isoenzyme classes: a1, a2, b 1, and b2. similar to other domestic animal species, pancreatic amylase is filtered through the glomerulus, but unlike other domestic species, pancreatic amylase is not resorbed by renal tubular epithelial cells and is excreted rapidly in the urine. therefore normal serum amylase activity in mice consists mainly of salivary amylase (mackenzie and messer 1976) . despite this, elevations in serum amylase activity is usually considered a reliable marker for pancreatitis in mice (nathan et al. 2005) . ross et al. (1974) reported two-to three-fold increases in serum amylase activity in mice infected with coxsackievirus of salivary and pancreatic trophism. alterations in the activity of specific pancreatic isoenzymes have been shown in streptozotocin-induced diabetes in mice (quimby 1999b) . there are two pancreatic lipase isoenzymes in mice. serum lipase activity has been used to monitor cerulean-induced acute pancreatitis in mice (cuzzocrea et al. 2004) . recently a new colipase-dependent lipase has been described in suckling mice (d'agostino and lowe 2004) . the enzyme 5'-nucleotidase was measured in the serum of normal mice using a simple one-step kinetic method (dooley and racich 1980) . a reference range of 10.9 + 4.5 (sd) u/1 has been recorded in 100 mice, and it is thought but not proven to be a good indicator of hepatic injury (clampitt and hart 1978) . glutamate dehydrogenase (gdh) has been measured in the tissues and serum of mice. gdh is known to play a key role in insulin secretion (carobbio et al 2004) . the activity of gdh is fivefold greater in the liver than in the kidney and brain, and the authors speculated that its measurement in serum would be a sensitive indicator of hepatic cell injury. serum gdh activity is also elevated in mice on caloric restriction (hagopian et al. 2003 ). corticosterone is the major glucocorticoid secreted by the adrenal cortex of mice. it functions as a regulator of carbohydrate, protein, and fat metabolism and modifies the host response to stress. the male mouse has a well-defined diurnal concentration pattern, with a maximum concentration of 9 ktg/dl at the start of the dark cycle and a minimum concentration of 5 btg/dl shortly before the end of the dark cycle (ottenweller et al. 1979) . in contrast, female mice have a minimum concentration of 13.5 ktg/dl at the beginning of the dark cycle and a maximum of 40 ~tg/dl well into the dark period (scheving et al. 1983) . the length of the dark cycle was different in each study. it may be measured using radioimmunoassay, elisa, or fluorometric assay in mouse serum or plasma. corticosterone circulates in both free and protein bound forms. in the mouse, greater than 99% circulates bound to cortisol-binding globulin (cbg) and albumin. the diurnal variation in corticosterone levels is paralleled by the diurnal pattern of cbg. urinary and salivary corticosterone is derived only from the free plasma fraction. corticosterone synthesis and secretion may be influenced by many drugs (woodman 1997) . measurements of corticosterone in unrestrained mice using indwelling catheters have elucidated the necessity of eliminating stress for accurate interpretation of data (macleod and shapiro 1988) . both handling and crowding laboratory mice can cause elevations in corticosterone (balcombe et al. 2004; fullwood et al. 1998) . c57bl/6 ob/ob mice have elevated corticosterone levels that increase markedly after 40 weeks of age, preceding elevations in serum glucose (garthwaite et al. 1980) . lean c57bl/6 controls had lower serum concentrations of corticosterone that declined between 5 and 20 weeks of age. food restriction (to 60% of ad libitum) profoundly affects the diurnal increase in plasma corticosterone in mice. at 20:00 hours (8 p.m.), the daily maximum in this study, food restricted balb/c mice had 300% more corticosterone compared to controls. these mice also had significantly reduced thymic weight and inflammation in response to the injection of carrageenan subcutaneously. the authors report that the magnitude of carrageenan-induced inflammation fluctuates with a diurnal trough, which coincides with peak corticosterone levels (klebanov et al. 1995) . corticosterone is synthesized in response to acth, which is made in the anterior pituitary. acth release is episodic (not at fixed intervals) and does not involve steroid feedback. acth concentration peaks in the early evening in mice and can be reversed by reversing the light cycle. acth is highly conserved with the mouse acth differing from human by only two amino acid residues. ria may be used to measure acth in the mouse (daily levels vary from 2.6-5.4 ng/ml) and to demonstrate rhythmic cycling. samples must be collected at 5-to 30-minute intervals. commercial elisa kits for acth are also available (quimby 1999b) ko mice incapable of synthesizing corticotrophin releasing hormone or acth may require corticosterone supplementation in drinking water and are particularly susceptible to hypoglycemia during fasting. fetuses of homozygous ko crh null mothers must be supplemented from gestational day 12 to weaning with 30 mg/ml corticosterone in drinking water (mugila et al. 1995) . oxytocin gene ko mice respond to a psychogenic stressor with more anxiety-related behavior and more corticosterone production (amico et al. 2004 ). lh promotes follicular development, increases estradiol secretion in the preovulatory follicle, causes follicular rupture, converts the preovulatory follicle into a corpus luteum, increases progesterone production by the corpus luteum, and, in the male, increases production of testosterone from leydig cells (woodman 1997) . lh is a glycoprotein composed of t~-and ~-chains. the amino acid sequence of the t~-chain is identical to that of follicle-stimulating hormone (fsh); however, the ~l-chain is specific and confers the receptor binding properties on the hormone. a homologous ria for rat lh using antisera to rat lh and purified rat lh has been employed to measure lh in mice (quimby 1999b) . lh and folliclestimulating hormone (fsh) are secreted by the same anterior pituitary cell in response to stimulation by gonadotrophinreleasing hormone (gnrh), which is synthesized in the hypothalamus. gnrh is identical in mouse and humans, and its differential stimulatory effect on gonadotropes, producing fsh or lh is controlled through gnrh pulse frequency. pulsatile secretion of lh leads to great variations in blood concentration. in female mice, there is a 10-to 25-fold increase in basal lh levels in the afternoon of proestrus. in a study comparing young cycling c57bl/6 female mice to old females (40% of which not cycling), flurkey et al. (1982) found lower lh levels in the older group and a more rapid rise in lh among younger cycling mice. these authors found that reproductive failure in male mice correlated with the loss of episodic release of lh. female homozygous ko mice lacking the gene for the immediate early transcription factor ngfi-a were infertile secondary to lh-[3 deficiency. although ovaries from these mice had a similar number of follicles, they lacked corpora lutea (lee et al. 1996) . basal levels of serum progesterone were lower in ngfi-a females (6.3 + 2.4 ng/ml) compared to wild type (11.3 +_ 3.6 ng/ml), whereas serum estradiol levels were similar in deficient (50.7 + 36.9 pg/ml) and wild-type (52.0 _+ 34.3 pg/ml) mice. decreased amounts of mrna encoding lh-[3, but not fsh-[3, were observed in ngfi-a-deficient mice; no changes were observed in mrna levels for prl or gnrh receptor between deficient and wild-type mice. an ovariectomy normally removes gonadal feedback inhibition, allowing for increased amounts of lh-~ and fsh-[3 in the pituitary; however, ovariectomy of ngfi-a deficient female mice lead to an increase in fsh-~ only. homozygous ngfi-a deficient males did make lower amounts of lh-~ compared to wild-type males, but they made significantly more lh-[3 than did ngfi-a-deficient females. the levels of lh in males appeared to be sufficient for fertility, and they had normal serum testosterone levels. these results suggest that ngfi-a acts synergistically with transcription factor sf-1 to regulate the promoter for lh-[3 gene expression. the simultaneous activation of both sf-1 and ngfi-a by gnrh appears to confer the specificity of lh-~ synthesis. female transgenic mice overexpressing lh are anovulatory, develop granulosa cell tumors, and undergo precocious puberty (mann et al. 2003) . excellent reviews detailing the use of transgenic and ko mice in elucidating the secretion and function of lh have been published (bums and matzuk 2002; huhtaniemi et al. 2002; wells and murphy 2003) . fsh stimulates the growth and maturation of ovarian follicles in the female and promotes the latter stages of spermatogenesis in males. it acts principally on the sertoli cells of the seminiferous tubules of the testis and induces the secretion of androgen-binding protein and inhibin. in females, fsh and lh have distinct secretory patterns that are synchronized to the estrous cycle; mouse estrous cycles have a 4-to 5-day periodicity. in addition to estrous cycle dependent rhythms, both lh and fsh have ultradian pulses and show circadian periodicity, with highest levels occurring during the dark period of the light cycle. testosterone, estrogen, and progesterone all provide feedback regulation of lh and fsh secretion (woodman 1997) . because rat and mice share considerable sequence homology for the fsh-~ chain, the rat ria kit from national institute of diabetes and digestive and kidney diseases (niddk) can be used to measure fsh in the mouse (dalterio et al. 1981) . a mouse specific ria is commercially available. in cycling female mice, the plasma levels of fsh increase from 80 to 120 ng/ml during proestrus and 250-300 ng/ml during estrus. although bronson and desjardins (1977) found age associated decreases in serum lh and testosterone in male cbf 1 mice experiencing decreased sperm production, no similar decreases were observed in fsh concentration. no significant differences in the twofold increased fsh levels were seen among young versus old males following castration. this appears to differ from results obtained from young versus old rats (finch et al. 1977) . the regulation and function of fsh has been studied in transgenic and ko mice (cooke and saunders 2002; wells and murphy 2003) . testosterone promotes spermatogenesis and provides feedback regulation of gonadotrophin synthesis. through its action on the epididymis, proteins necessary for spermatozoal maturation are synthesized. dihydrotestosterone (dht) promotes the growth and differentiation of accessory sex organs (depaolo and masoro 1989) . in addition to their effects on reproductive organs, testosterone and dht have physiologic functions on the central nervous system, cardiac tissue, and the liver. in the mouse, testosterone stimulates the growth of kidneys and synthesis of erythropoietin (woodman 1997) . lh stimulates synthesis of testosterone from cholesterol by the interstitial leydig cells of the testis. in target tissues, the enzyme 5r converts testosterone to dht. in the fetal testes, leydig cells first become identifiable during the rise of testosterone. in most mammalian species, leydig cells disappear when testosterone levels fall during gestation. however, the mouse is an exception and leydig cells do not undergo regression postnatally (aoki 1970) . testosterone and dht circulate in both free and protein bound forms. ninety-eight percent of total testosterone is bound to protein, mainly albumin. mice, unlike humans, dogs, monkeys, and cats, do not have circulating sex hormone-binding globulin. in mice, a pulse release pattern may be seen within their diurnal rhythm of testosterone. testosterone can be measured in mice using ria or elisa. plasma testosterone was not found to change during the average lifespan of c57bl/6 and dba/2j mice (finch et al. 1977) . this is in contrast to cbf1 mice, wistar and long-evans rats, and humans, which experience greater than a 30% decrease in testosterone at midlife (bronson and desjardins 1977) . in contrast to testosterone levels in older mice, castration-induced elevation of lh was impaired in 28-month-old c57bl/6j mice compared to 12-month-old mice. androgen receptor ko mice have been described (cooke and saunders 2002) . 5. estradiol (e2) the granulosa cells of the mature graafian follicle are the main source of 17[3-estradiol (e2) in mammals. fsh stimulates the activation of aromatase in follicles, which is responsible for the conversion of androgens to e2. e 2 is also synthesized by the testis, adrenal, liver, and skin, although in much lower amounts than by the ovary. e2 provides negative feedback control over lh secretion, and it stimulates prl secretion in mice. e 2 promotes the growth and development of the female reproductive tract, external genitalia, and the ductal system of the mammary glands. in addition, e 2 sensitizes the follicle to fsh. e 2 is measured in mice using ria and elisa. high circulating levels of e 2 precede the preovulatory surge in lh. ryan and schwartz (1980) reported basal levels of e 2 in mice of 1 to 5 pg/ml. holinka et al. (1978) studied circulating levels of progesterone and estradiol in young and old c57bl/6 female mice during gestation. they found that the old multiparous females have delayed and reduced preparturitional rise is plasma e 2 compared to young females. because preparturitional e 2 is thought to regulate uterine progesterone levels, the decline in e 2 seen in older females coupled with elevated progesterone may delay the onset of labor and lead to prolonged gestation. when sex steroid hormones such as e 2 bind their receptor, they induce a conformational change that allows the complex to bind dna response elements on nuclear target genes and associate with coactivators and transcription factors to form an active transcriptional complex. this complex is responsible for initiating the transcription of the target gene. one coactivator that associates with the active transcriptional complex involving sex hormones is steroid receptor coactivator-1 (src-1). to better understand its physiologic role during sex hormone-receptor binding, ko mice that were deficient in src-1 were created (xu et al. 1998 ). deficient male mice had a 34% reduction in testosterone-stimulated prostate growth and small testes compared to wild-type mice. deficient females had a half-normal uterine growth response to exogenous e 2 and only a partial ductal growth response (in the mammary gland) following exogenous e 2 and progesterone. serum concentrations of e 2 and testosterone were elevated 1.2 to 1.5 times wild-type levels, indicating an abnormality in the endocrine feedback control system. although src-1 was shown to clearly be necessary for optimal sex hormone-induced cellular activation, the lesion created in this ko mouse was not nearly as profound as that seen in mice with disrupted e 2 receptors (korach et al. 1996) . mice with the genes for the e 2 receptors and aromatase knocked out have been described (simpson et al. 2005 synthesized by the corpus luteum before implantation and by both corpus luteum and placenta following implantation, progesterone is necessary for preparing the uterus for implantation and maintaining pregnancy. in addition, a small amount of progesterone is synthesized by the adrenal gland. activation of the corpus luteum to secrete progesterone requires both lh and prl. progesterone provides negative feedback control over lh. in mice, progesterone is measured using ria or elisa. in cycling mice, the levels of progesterone increased from 5 to 35 ng/ml on proestrus and returned back to baseline on estrus. flurkey et al. (1982) compared the plasma levels of lh, progesterone, and prl in cycling young (10-week) and old (8month) female c57bl/6j mice. they showed age-related deficits in the preovulatory levels of all three hormones. the lh elevations during the ascending and descending portions of the preovulatory surge were smaller; the slower rises in lh during the ascending phase of the surge correlated with decreased progesterone in older females. there was no correlation between lh or progesterone level and length of estrus cycle. holinka et al. (1978) observed changes in plasma progesterone levels in young and old female mice during gestation. older mothers had a much slower decline in circulating progesterone than younger mothers between gestational days 17-23. because a major decrease in plasma progesterone is thought to be essential for the onset of uterine contractions and parturition in mice, the authors hypothesized that the attenuated decline in older mothers may account for their prolonged gestation. surgimoto et al. (1997) engineered mice lacking the pgfzareceptor (fp) and found that deficient female mice had normal estrous cycles, ovulation, fertilization, and implantation but did not undergo parturition. these pregnant females were characterized by a decline in preparturition progesterone levels due to delayed luteolysis and failure to develop labor. close examination revealed that near term there was no expression of the oxytocin receptor in the uterus of fp-deficient mice. when the ovaries of fp-deficient pregnant females were removed on day 19 of pregnancy, progesterone levels fell, uterine oxytocin receptors were expressed, and pups were born alive within 24 h. this study demonstrated that the role of pgf2~ is to initiate luteolysis, resulting in an immediate decline in progesterone levels. the subsequent induction of oxytocin receptors and their activation by bound oxytocin initiate labor. it is feasible that the age-associated prolongation of gestation in old female mice may involve a defect in pgfz,~-induced luteolysis. this mechanism for the induction of labor also explains the well-known observation that aspirin-like drugs (that inhibit cox metabolism) may delay parturition in women. prl, a 23-kda single-chain polypeptide, is principally made by the pituitary gland but may be also be found in brain, thymus, spleen, lymph nodes, mammary gland, myometrium, sweat gland, lacrimal gland, and bone marrow. more than 300 functions have been attributed to prl, involving reproduction and lactation, growth and development, endocrinology and metabolism, brain and behavior, immunomodulation, and electrolyte balance. it mediates effects by endocrine, paracrine, and autocrine mechanisms. in mice, prl is of major importance for maintenance of the structure, life span, and function of the corpora lutea and the development and maintenance of the mammary gland and lactation. however, prl-receptor ko males have no major defect in fertility. prl plays a role in anxiety-related behaviors, bone development, and abdominal fat deposition in both sexes (kelly et al. 2001) . its role in immune function is more controversial, although it appears to modulate immunity during times of stress (dorshkind and horseman 2000) . prl mediates its effects by binding the prl receptor (prlr). mice have two major forms of prlr that are created via alternative splicing of a single gene. the prlrs are members of the class i cytokine receptor superfamily. although most functions of prl are mediated by the unmodified 23-kda peptide, post-translational modification allows variants of prl to bind its receptor eliciting transcription of genes necessary for tissue specific changes (harris et al. 2004) . prl secretion is under inhibitory control by dopamine and among its secretagogues are thyrotropin-releasing hormone (trh), vasoactive intestinal peptide, gastrin, serotonin, ~-endorphin, oxytocin, angiotensin ii, gnrh, and arginine vasopressin. prl in mice is quantified using ria using the nih rp-1 reference standard. male mice measured during the light phase have <1 ng/ml whereas the range during the dark phase was 10-20 ng/ml (depaolo and masoro 989). oxytocin, a 21-kda nonapeptide, is synthesized as a prohormone in neurons whose bodies are located in the supraoptic and paraventricular nuclei at the base of the hypothalamus. once synthesized, the prohormone is packaged into neurosecretory granules and transported down the axons of these neurons transport synthesized oxytocin to the pars nervosa of the pituitary gland. during transport, the molecule is cleaved to yield the 10-kda carrier proteins, neurophysin i, and the l l-kda oxytocin. the primary stimulus for oxytocin release is mechanical stimulation of the mammary gland and distention of the reproductive tract (reimers 1999) . there is a single oxytocin receptor (otr). investigations using ko mice have shown that oxytocin is required for milk let down by the mammary gland as well as for postpartum alveolar proliferation. in males, oxytocin is required for normal spermiation and sperm transfer. in both genders, oxytocin helps control normal blood pressure and salt intake. kos display reduced aggression and a striking deficit in the ability to recognize a previously encountered mouse (young and gainer 2003) . oxytocin may be quantified in mice using commercially available elisa kits or by species-specific ria. values in one recent publication showed plasma oxytocin at 1.5 _+ 0.6 pg/ml in male c57bl/6 mice ). avp is synthesized and released by the same neurons previously described for oxytocin, although the two secretory granules rarely colocalize in the same neuron. the carrier protein for avp is neurophysin ii. avp is released from neuron secretory granules by electrical signals from osmoreceptors measuring the osmolarity of extracellular fluid. action potentials, generated in the receptors, cause calcium influx into axon terminals and exocytosis of ave avp is transported in the blood to the kidneys, where it binds receptors in the distal segment of the nephron and collecting ducts leading to increased resorption of water (reimers 1999) . there are three avp receptors, v l ar, vlbr, and v2r; and these are all g-protein coupled receptors. nonsense mutations of the avp gene (as seen in the brattleboro rat) or kd mice develop neurohypophysial (central) diabetes insipidus. mice with the v2r knocked out develop nephrogenic diabetes insipidus characterized by polyuria, polydipsia, and failure to concentrate urine. when the v1 ar gene is knocked out, mice develop an enhanced proliferation of splenic b cells and enhanced igg1 and igg2b production to thymicdependent antigens. when v lbr is knocked out the mice display a marked reduction in social aggression and a deficit in social recognition (young and gainer 2003) . avp can be measured by ria or elisa and the reported values in normal male c57bl/6 mice are 5.1 + 1.5 pg/ml in plasma ). tsh is a 28-kda glycoprotein made by the anterior pituitary gland on stimulation by thyrotropin-releasing hormone (trh). trh is made in the hypothalamus. tsh is secreted in a pulsatile manner, similar to acth. tsh secretion is regulated by triiodothyronine (t3), which acts on the hypothalamus to inhibit secretion of trh and acts on the pituitary gland to inhibit tsh synthesis (reimers 1999) . tsh plays a role in stimulating the thyroid gland to produce thyroxine and it influences the outcome of t-cell development in thymus and intestine. in addition to the thyroid gland, tsh receptors are found on many different populations of hematopoietic cells in bone marrow, subsets of dendritic cells, monocytes, and lymphocytes in the spleen and lymph nodes (klein 2003; scofield et al. 2005) . ko mice have been created in which genes for trh (wells and murphy 2003; yamada et al. 2003) and tsh receptors (biesiada et al. 1996) have been deleted. in addition, spontaneous mutations in the pitl gene lead to deficiencies of gh, prl, and tsh (yeap and leedman 1999) . tsh is measured by ria and reference ranges established around a 3.1 u/mg reference standard were 1-90 ng/ml (depaolo and masoro 1989). 11. thyroxine (t4) and triiodothyronine (t3) t 4 is synthesized entirely in the thyroid gland, whereas t 3 is produced primarily by conversion of t 4 to t 3 in extrathyroidal tissues. in the thyroid, thyroglobulin is synthesized and stored, and later hydrolyzed to form t 4. the tyrosine residues, held in peptide linkage within thyroglobulin, are first iodinated and later iodotyrosines are chemically coupled to form hormonally active t 4 and t 3. production of t 4 depends on adequate supplies of iodine. both t 3 and t 4 circulate in the blood primarily bound to albumin and m-globulin; however, mouse transthyretin does not bind t 4. approximately 85% of t3, the active thyroid hormone, in blood is made through the monodeiodination of the outer ring of t 4 in a variety of tissues. certain drugs, food deprivation, and illness can all effect monodeiodinase activity (reimers 1999) . t3 actions are mediated via two t3 receptors, tr~x and tr[3, which act as hormone-inducible transcription factors and belong to a large superfamily of nuclear hormone receptors including the steroid hormone, vitamin d, retinoic acid, and peroxisomal proliferator receptors (yen 2003) . in mouse and human tr~ and tr[3 encode nine mrna isoforms through alternative splicing; four isoforms tr~i, trc~2, tr[31, and tri]2, are expressed as proteins. trc~ ~ ko mice, which lack all products from the tr~ locus, are fertile and have normal basal thyroid status but have increased sensitivity to thyroid hormones in the pituitary and liver following provocative testing with increasing doses of t3. tr~x -/-have a disruption of the first coding exon in the tr~x locus, which prevents transcription of tr~i and try2 mrnas but not tra~i or tra~2. these pups die shortly after weaning unless supplemented with t3 for the first 2.5 months of life, after which they develop normal thyroxine levels. however, both genders are infertile. try2 -/-overexpresses tr~i and are hypothyroid but have inappropriately normal tsh levels. they exhibit some signs of hyperthyroidism, such as increased heart rate, weight loss, and elevated body temperature. tr~ -/-lack all tr[3 isoforms and display resistance to thyroid hormones demonstrating the key role of tr~ in set-point control of the pituitary-thyroid feedback axis. tr[32 -/-ko mice have resistance to thyroid hormones and elevated t3, t4, and tsh. they have defective tsh suppression by t3. several double kos (both tr~ and tri]) have been developed with profound resistance to t3. these targeted mutants have helped to elucidate the full function of thyroid hormones involving: bone formation and mineralization, abnormal development of skeletal muscle, disrupted development of the cones in the retina, abnormalities in the auditory system, cochlear and vestibular structures, delayed small intestine development, impaired thermogenesis, and altered development of the central nervous system and immune system (o'shea and williams 2002). both total t 4 and t3 can be measured by ria in mice, and reference ranges vary greatly by strain and age. although t3 is the active hormone, its serum levels are so low that it is a less reliable indicator of thyroid status. total t 4 ranges in swiss webster and icr mice are 5.5 _+ 0.7 and 4.7 + 0.3 jag/ml, respectively. total t3 levels range from 65-85 ng/100 ml in both sw and icr stocks (depaolo and masoro 1989). many factors, including autoantibodies, are known to interfere with thyroid hormone assays (despres and grant 1998; reimers 1999) . 12. parathyroid hormone (pth) pth is synthesized by the chief cells of the parathyroid gland and secreted as an 84 amino acid peptide. circulating levels of ionized calcium induce synthesis of pth. low calcium stimulates pth synthesis, and high calcium inhibits secretion. the primary function of pth is to control calcium concentrations in extracellular fluid and prevent hypocalcemia by increasing calcium resorption from bone, glomerular filtrate, and intestines (reimers 1999) . pth mediates its effect via its g-protein coupled receptor, pth1r. interestingly a second protein, pth related protein (pthrp), which is secreted by a variety of tissues and acts by autocrine and paracrine signaling, uses the same pth1r. pthrp modulates a wide range of physiologic and developmental responses (goltzman and white 2000) . mice with targeted mutations of the pth, pthrp, and pth1r genes have demonstrated the critical role of these proteins in regulating both the switch between proliferation and differentiation of chondrocytes and their replacement by bone cells (schipani and provost 2003) . serum levels of pth may be quantified in mice using a commercially available elisa kit, which can also be used to quantify the protein in rats. 13. other hormones elisa kits are commercially available to quantify many additional hormones in the serum of mice, including insulin, leptin, gh, epinephrine, orexin a, orexin b, adiponectin, adipsin, and resistin. each of these hormones have been briefly discussed in the "glucose and carbohydrate metabolism" section. the liver has many complex functions including protein metabolism, carbohydrate metabolism, and lipid metabolism. the liver is involved with the synthesis of many plasma proteins (including albumin), the conversion of ammonia to urea, and the production of glucose from glucogenic amino acids). the liver is implicated with the regulation of blood glucose levels (via glycogenolysis and gluconeogenesis, as discussed in the "glucose and carbohydrate metabolism" section), the removal of glucose from the blood via glut-1 and glut-2 membrane transporters, and storage in the form of glycogen. the liver is also involved in cholesterol and triglyceride synthesis, the formation of lipoproteins (discussed in the "lipid metabolism" section), and the synthesis of carbohydrates from fats. there are also other more specific functions that the liver facilitates, including the synthesis of heme, the synthesis of many coenzymes, detoxification/biotransformation of exogenous and endogenous substances via the cytochrome p-450 microsomal enzymes, and the synthesis of bile. the role of the liver in these functions for various animals has been reviewed (tennant 1999; woodman 1988 ). the elevation of plasma or serum enzymes usually confined to the cytosol or mitochondria of hepatocytes is helpful in elucidating liver injury. many factors influence the duration of elevated serum enzyme levels including molecular size, intracellular location, rate of plasma clearance, rate of enzyme inactivation, and hepatic production. hepatic necrosis is associated with elevations of alt, ast, sd, and otc in mice, and extrahepatic cholestasis is associated with elevated ap (tennant 1999) . please refer to the "enzymes" section for a description of each enzyme. bilirubin is a pigment that is produced by the degradation of the hemoglobin by cells of the mononuclear phagocyte system. there are two main types of bilirubin. unconjugated bilirubin is a non-water soluble molecule that is transported in blood bound to albumin. hepatocytes uptake unconjugated bilirubin, where it undergoes glucuronidation to produce the water-soluble form, conjugated bilirubin. conjugated bilirubin is then excreted via the hepatobiliary system and excreted in bile. quantification of serum bilirubin levels is based on the van den bergh or diazo reaction. diazo reacts directly with conjugated bilirubin, and with unconjugated bilirubin only after addition of alcohol to the reaction. therefore, measuring serum bilirubin involves the following steps. first, the level of conjugated bilirubin is measured. second, alcohol is added to the reactants, which allows quantification of total bilirubin levels. finally, the level of unconjugated bilirubin is determined by subtracting the conjugated measurement from the total measurement. the excretory capacity of the liver may be assessed by measuring serum bilirubin. elevated levels of unconjugated bilirubin are usually observed in situations of increased erythrocyte breakdown, such as in hemolytic diseases. unconjugated hyperbilirubinemia is also seen in disease in which hepatic uptake, conjugation, and secretion of bilirubin are diminished. increased levels of conjugated bilirubin are usually associated with intrahepatic cholestasis or extrahepatic bile duct obstruction. conjugated bilirubin in blood is normally filtered by the glomerulus in small amounts. conjugated hyperbilirubinemia may result in bilirubinuria (tennant 1999) . bilirubin clearance from blood and the role of the constitutive androstane receptor in this process has been studied in normal and transgenic mice (huang et al. 2003; . studies documenting the bilirubin-metabolism/detoxifying enzymes, their regulatory nuclear receptors, and lipid transporters in mice have been reported (wagner et al. 2005) . bile acids are cholesterol breakdown products that are secreted by hepatocytes into the hepatobiliary system, and ultimately into the intestinal tract. bile acids aid digestion by emulsifying dietary lipid aggregates, and solubilizing and transporting lipids in an aqueous environment (in particular fat-soluble vitamins). in the liver, bile acids also play a role regulating the secretion of apolipoprotein b (elzinga et al. 2003) . extensive enterohepatic recirculation results in almost 99% return of bile acids secreted by the liver from the intestinal tract. absorption occurs mainly in the ileum under the influence of the apical na ⧠bile acid transporter on epithelial cells (kida et al. 2003) . some absorption also takes place in the large intestine. absorbed conjugated bile acids (from ileum) pass unaltered to the portal circulation where they are removed by na+-taurocholate cotransporting polypeptide located on the basolateral hepatocyte membrane (jung et al 2004) . there are two types of bile acids, cholic acid and chenodeoxycholic acid. in mice, they are conjugated with taurine before secretion by the liver. the liver-specific enzymes, bile acid coa ligase and bile acid-coa:amino acid n-acyltransferase, are responsible for conjugation (inoue et al. 2004 ). stedman et al. (2004) described normal serum bile acid levels in normal and transgenic mice. elevated serum bile acid levels in mice is usually due to decreased bile acid recycling by the liver, and mainly includes diseases associated with decreased hepatic functional mass and cholestasis (tennant 1999) . hoda and green (2003) measured increased levels of serum bile acids after bile duct ligation. albumin is a nonglycosylated protein and is the most abundant protein in plasma. it serves as the most important determinant of plasma oncotic pressure, and it is a major transport protein for both endogenous metabolites and xenobiotics. it is made exclusively by the liver. serum albumin may be measured by radial immunodiffusion, dye binding reactions (using bromcresol green or bromcresol purple), electrophoresis, and elisa. serum albumin levels decrease with age in many inbred strains (quimby 1999b) . hypoalbuminemia is usually reflective of decreased hepatic synthesis (due to hepatic disease, inflammation, and malabsorptive/maldigestive diseases), increased loss due to hemorrhage or via the intestinal tract (protein-losing enteropathies) and kidneys (protein-losing nephropathies) (tennant 1999) . most of the proteins associated with coagulation are synthesized by the liver (except factor viii), and measurement of fibrinogen or prothrombin time has served as a marker for decreased synthesis due to hepatic injury (tennant 1999) . prothrombin time will also be increased due to consumption of clotting components and in vitamin k deficiency. fibrinogen is also an acute phase reactant, and plasma elevations are seen during inflammation (tennant 1999) . fibrinogen may be quantified in mouse plasma by elisa. ceruloplasmin is copper-containing acute phase reactant and iron transport protein made exclusively in hepatocytes of mice. its serum levels may be decreased during hepatic injury and increased in response to inflammatory stimuli (min et al. 1991; shim and harris 2003) . many of the complement components are also made in the mouse liver, especially c2, c3, c4, and factor b. decreased circulating levels may be seen due to hepatic injury or due to consumption during activation. please refer to the "complement" section for further details on complement function and measurement. two dyes, sulfobromophthalein and indocyanine green, have been used to assess hepatocellular or bile tract function. following an intravenous bolus, these dyes are rapidly cleared from the plasma by hepatocytes and excreted into the bile. both dyes have been used to assess liver function in mice (hurwitz et al. 1994; huang and vore 2001) . the kidney plays a complex role in maintaining homeostasis in the body and is involved in such functions as water and electrolyte balance, nutrient conservation, maintenance of blood ph, and removal of the end products of nitrogen metabolism (such as urea, creatinine, and allantoin). in addition, the kidney produces and responds to a variety of hormones. however, assessing renal function is complicated by the large functional reserve of the kidneys. for instance, increases in urea nitrogen do not occur until 70-75% of renal mass has become functionally compromised. additionally, assessment of analytes in urine is difficult due to the small size of mice (as discussed in the "sampling" section). urea is produced in the liver as a waste product of protein catabolism (specifically a breakdown product of ammonia). urea is a small molecule that freely diffuses across cell membranes, and therefore the urea concentration is the same in blood, serum, and plasma. traditionally, urea concentrations is measured in terms of urea nitrogen (the amount of nitrogen contained within urea). determination of urea nitrogen is usually made from serum, but whole blood can be used (hence the term blood urea nitrogen [bun] ). quantification of urea nitrogen is based on spectrophotometry assays, measuring the amount of urea that is hydrolyzed by urease. frith et al. (1980) investigated urea nitrogen levels in balb/c and c57bl/6 mice. urea nitrogen levels decreased after 3 months of age but increased again after 12 months in both sexes. in balb/c mice, levels were higher in males than females, whereas in c57bl/6 mice, females had significantly higher levels than males. elevated urea nitrogen (azotemia) can be caused by prerenal, renal, and postrenal conditions. prerenal causes include increased protein catabolism (such as with inflammation, starvation, and high-protein diets). renal causes usually are associated with conditions that compromise more than 70-75% of functional renal mass and include conditions such as renal amyloidosis, glomerular immune complex disease, and polycystic disease. postrenal include any cause that results in obstruction of the lower urinary system. decreased urea nitrogen is found with disease associated with hepatic insufficiency and low-protein diets. creatinine is a degradation product of creatine and creatine phosphate and represents an end-product of muscle metabolism. quantification of creatinine is based on spectrophotometry assays. baseline serum levels are directly related to muscular conditioning and total muscular mass, which varies between individuals. pathologically elevated serum creatinine levels are caused by the same prerenal, renal, and postrenal causes that elevate urea nitrogen in serum. therefore, quantification of serum creatinine offers no interpretative advantage over urea nitrogen (everett and harrison 1983) . proteinuria is a common finding in normal mice, and includes rodent-specific proteins such as uromucoid, small quantities of c~-and [3-globulins, and a family of prealbumins known as major urinary protein (mup). the mup has three electrophoretic variants, designated as mup-1, mup-2, and mup-3, that are under both genetic and hormonal control. a regulatory locus designated mup-1 with codominantly expressed alleles a and b (located on chromosome 4) controls the urinary levels of the three variants. the mup is synthesized in the liver, secreted into blood, and excreted into urine. males are have higher levels of proteinuria than are females, with levels of 5 mg/ml, and age-related increases are seen in mice of both sexes. increases in other urinary proteins have been associated with a variety of renal diseases in mice. the concentration of urine (amount of solutes dissolved in urine) can be measured by urine specific gravity (usg) or osmolality. urine concentration in healthy mice is very high. watts (1975) determined the usg of healthy cba mice, which ranged from 1.060 to 1.080. the author also found the usg increased from 20 to 80 days of age. the urine concentrating ability of transgenic mice expressing human sickle cell hemoglobin (kos for mouse hb) was assessed by ryan et al. (1997) . they found that sickled cells caused vascular, tubular, and glomerular changes, as well as corresponding hyposthenuria (4-h water deprived osmolality of affected mice was 807 + 285 mosm compared to 1541 + 360 mosm in controls). i. electrolytes 1. sodium, potassium, chloride, and phosphorus sodium and potassium levels are easily measured in murine serum using flame photometry (lithium reference) or ion-specific electrodes. serum sodium levels are slightly higher in mice than in most other mammalian species, with reported values of 174 + 23 (sd) meq/1 (finch and foster 1973) , 147 + 15 (sd) meq/l (everett and harrison 1983) , and 155-161 meq/1 (loeb et al. 1996) . no differences in serum sodium were seen during aging, between sexes, or among strains. serum chloride has been measured using mercuric thiocyanate and the chloridimetric or ion-specific electrode techniques, and inorganic phosphorus in mice has been measured using the phosphomolybdate technique. serum inorganic phosphorus levels decreased as mice aged between 1 and 12 months. this change was documented in balb/c and c57bl/6 strains, as well as in outbred mice (loeb et al. 1996) . total serum calcium reflects both ionized (active calcium) and protein-bound calcium (mainly bound to albumin). ionized calcium is biologically active in bone formation, neuromuscular activity, cellular biochemical processes, and blood coagulation. decreased serum albumin levels are also expected to decrease total calcium levels, by decreasing the amount of protein-bound calcium. however, hypoalbuminemia does not result in clinical signs of hypocalcemia. in mice, total serum calcium has been measured using the sodium alizarin sulfonate technique or atomic absorption spectrometry. two reports, using different techniques, list similar reference ranges of 9 + 1 (sd) mg/dl, whereas a third report lists reference ranges of 5.6 + 0.4 (sd) mg/dl for male and 7.4 + 0.50 (sd) mg/dl for female albino mice. the latter values reported for male mice were significantly lower than those for six inbred strains of mice in two different age-groups using the same techniques (quimby 1999b) . likewise, no differences associated with sex were reported by everett and harrison (1983) , who also examined random bred albino mice. however, bonella et al. (1968) demonstrated significantly higher levels in female swiss albino mice. serum calcium levels appear to decline between 3 and 12 months of age in the balb/c and c57bl/6 strains as well as in outbred mice . frith et al. (1980) found that female c57bl/6 mice had lower calcium levels than males. bonella et al. (1968) demonstrated significantly elevated calcium levels when blood was collected by orbital puncture versus cardiac puncture. hypercalcemia in mice can results as a response to increased levels of pth (such as with hyperparathyroidism) or pthrp (such as with certain neoplasms like multiple myeloma). in mice, the response of parathyroid chief cells to hypercalcemia appears different from other species. grone et al. (1992) studied this response in nude mice with pthrp secreting tumor cells or infusions of pthrp, and found prominent membranous whorls and increased cytoplasmic area of chief cells in mice with hypercalcemia (17.0 + 3.1 mg/dl), which marked these cells as distinctly different from parathyroid chief cells of other species. hypocalcemia can be due to hypoalbuminemia (as previously discussed), renal disease, pancreatitis, and hypomagnesemia. alcock and shils (1974) found that mice fed magnesium-deficient diets developed hypocalcemia, as did mice receiving intramuscular injections of heparin. total serum protein has been evaluated in mice using either the lowry or biuret methods, although the lowry method is preferred for analysis of small volume samples. hypoproteinemia is seen in hepatic injury (also see the "liver function tests" section) or during protein-losing enteropathies or nephropathies. hyperproteinemia is seen during dehydration. age-related changes have been described in a number of strains, such as increased total serum protein in older balb/c and b6 mice and lower levels in dba/2 mice (loeb et al. 1996) . each of the major classes of serum protein ((xl-, (x2-, ~-, and y-globulins) in mice can be distinguished by electrophoresis. changes in serum levels have been associated with a wide variety of diseases in mice. for instance, hypergammaglobulinemia was found in scid mice injected with human cag multiple myeloma cells . the acute phase reactants ceruloplasmin and fibrinogen have been discussed in the "serum proteins" section and crp and sap in the "complement" section. saa is an acute phase reactant synthesized by the liver and may be induced by the inflammatory cytokines il-1 or il-6 (see the "cytokines and chemokines" section). normally saa is quickly cleaved to a small molecular weight product, but during chronic infection or failure in the degradation pathway, tissue deposition of amyloid may occur. differences in serum concentrations have been described in various mouse strains and during disease. commercial ria and elisa kits are available for its quantitation in mice (quimby 1999b) . alpha-1-fetoprotein (afp) is encoded by the afp gene which is nearly identical in its organization to the mouse albumin gene, albl. it is likely afp arose due to gene duplication. afp is present in fetal serum but the synthesis declines shortly after birth. serum levels are regulated by two loci, afr-1 and afr-2, which are not linked to afp. the action of these genes may be modified by tgf-~ and p53 (wilkinson et al. 2005) . levels in mouse serum have been quantified by immunoelectrophoresis (zizkovsky 1975 ) and both polyclonal antibodies and recombinant dna-derived mouse afp are available for assay development (boismenu et al. 1997) and are elevated in mice with certain neoplasms and during hepatic regeneration (jin et al. 2005; quimby 1999b ). sulphostin, a novel inhibitor of dipeptidyl peptidases iv (dppiv) that stimulates hematopoiesis in mice proteomic approaches to biomarker discovery in prostate and bladder cancers 8th annual analyzers buyer's guide il-17: prototype member of an emerging cytokine family increased atherosclerosis in hypeflipidemic mice with inactivation of abca-1 in microphages diet-induced changes in plasma phospholipids transfer protein activity, lipids, and lipoproteins. mpd: 801, 802, 828. mouse phenome database web site comparison of magnesium deficiency in the rat and mouse apoc-1 and apoc-iii as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke comparison of methods for obtaining blood from mice anxiety and stress responses in female oxytocin deficient mice impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice hormonal control of leydig cell differentiation interleukin-7 an interleukin for rejuvenating the immune system a spectrophotometric microtiter-based assay for the detection of hydroperoxy derivatives of linoleic acid mast cell lineage development and phenotypic regulation laboratory routines cause animal stress regulation of fasting blood glucose by resistin biochemistry of immunoglobulins variations in serum calcium between strains of inbred mice correction of ureagenesis after gene transfer in an animal model and after liver transplantation in humans with ornithine transcarbamylase deficiency biology of the congenitally hypothyroid hyt/hyt mouse the chemokine stromal cell-derived factor-1 regulates the migration of sensory neutron progenitors methods of enzymatic analysis the mouse phenome project purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in escherichia coli genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research effects of heparin on serum calcium in mice albumin content in blood of inbred mice strains lentiviral shrna silencing of murine bone marrow cell ccr2 leads to persistent knockdown of ccr2 function in vivo trophic action of leptin on hypothalamic neurons that regulate feeding the interpretation of serum biochemistry test results in domestic animals transgenic models of autoimmune disease lipoprotein metabolism and atherosclerosis susceptibility in transgenic mic mouse models of atherosclerosis reproductive failure in aged cbf male mice: interrelationships between pituitary gonadotropic hormones, testicular function, and mating success stromal cell derived factor 1/cxcl12 selectively counteracts inhibitory effects of myelosuppressive chemokines on hematopoieteic progenitor cell proliferation in vitro minireview: genetic models for the study of gonadotropin actions recruitment of cxcr3 and ccr5 t-cells and production of interferon-gamma inducible chemokines in rejecting human arteries tietz fundamentals of clinical chemistry distribution and characterization of the serum lipoproteins and apolipoproteins in the mouse, mus musculus disparate lymphoid chemokine expression in mice and men: no evidence for ccl21 synthesis by human high endothelial venules insulin secretion profiles are modified by over expression of glutamate dehydrogenase in pancreatic islets a panel of cerebrospinal fluid biomarkers for the diagnosis of alzheimer's disease normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry chemokine-cytokine cross talk. the elrt cxc chemokine lix (cxcls) amplifies a proinflammatory cytokine response via a phosphatedy linositol 3-kinase-nf-kappa b pathway rapid neurosecretory and cardiovascular response to osmotic stimulation in conscious mice high density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation influence of blood collection sites and use of anesthesia on plasma glucose concentration in mice the tissue activities of some diagnostic enzymes in ten mammalian species accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion signal transduction in t cells: an overview role of stearoyl-coa desaturase-1 in leptinmediated weight loss induction of leptin receptor expression in the liver by leptin and food deprivation mouse models of male infertility the primary germinal center response in mice a comparison of serum calcium levels obtained by two methods of cardiac puncture in mice biomethodology and surgical techniques reduction in the development of cerulean-induced acute pancreatitis by treatment with m40401, a new selective superoxide dismutase mimetic pancreatic lipase-related protein 2 is the major colipase-dependent pancreatic lipase in suckling mice effects of cannabinoids and female exposure on the pituitary testicular axis in mice: possible involvement of prostaglandins genetic background determines the extent of atherosclerosis in apoe-deficient mice endocrine hormones in laboratory animals antibody interference in thyroid assays: a potential for clinical misinformation a new kinetic determination of serum 5'-nucleotidase activity, with modifications for a centrifugal analyzer the roles of prolactin, growth hormone, insulin-like growth factor-l, and thyroid hormones in lymphocyte development and function; insights from genetic models of hormone and hormone receptor deficiency selection for serum cholesterol, voluntary physical activity, 56-day body weight, and feed intake in random bred mice. ii. correlated response ccr2 expression by brain microvascular endothelial cells critical for macrophage transendothelial migration in response to ccl2 inhibition of apolipoprotein b secretion by taurocholate is controlled by n-terminal end of the protein in rat hepatoma mcardle-rh7777 cells clinical biochemistry the effect of freezing on various serum chemistry parameters of common laboratory animals alkaline phosphatase, lactate dehydrogenase, and aspartate aminotransferase and their isoenzymes as indicators of the development of experimental hepatitis in mic the endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages niemann-pick c heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis hematologic and serum electrolyte values of the c57bl/6j male mouse in maturity and senescence hormone production by the pituitary and testes of male c57bl/6j mice during aging age effects of luteinizing hormone, progesterone, and prolactin in proestrus and acyclic c57bl/6j mice innovation~stagnation: challenge and opportunity on the critical path to new medical products interleukin-17 hematologic and clinical chemistry findings in control balb/c and c57bl/6 mice pi3k and negative regulation of tlr signaling visfatin: a protein secreted by visceral fat that mimics the effects of insulin floor space needs for laboratory mice: c57bl/6males in solid-bottom cages with bedding a longitudinal hormonal profile of the genetically obese mouse return to normal of blood-glucose, plasma insulin, and weight gain in new zealand obese mice after implantation of islets of langerhans acute phase proteins ghrelin: more than a new frontier in neuroendocrinology tumor necrosis factors a rapid, simple, and humane method for submandibular bleeding of mice using a lancet palatal cytosol cortisol-binding protein associated with cleft palate susceptibility and h-2 genotype relationship in the functional levels of early components of complement to the h-2 complex of mice developmental and tissue-specific regulation of parathyroid hormone (pth)/pth-related peptide receptor gene expression ccl1-ccr8 interactions: an axis mediating the recruitment of t-cells and langerhans-type dendritic cells to sites of atopic skin inflammation measurement of glycosylated haemoglobins and glycosylated plasma proteins in animal models with diabetes or inappropriate hypoglycaemia effects of humoral hypercalcemia of malignancy on the parathyroid gland in nude mice the complex role of interlukin-10 in autoimmunity tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas caloric restriction increases gluconeogenic and transaminase enzyme activities in mouse liver fructose metabolizing enzymes from mouse livers influence of age and caloric restriction genetic ablation of orexin neurons in mice result in narcolepsy, hypophagia, and obesity prolactin and the prolactin receptor: new targets of an old hormone optimal conditions for the determination of serum alkaline phosphatase by a new kinetic method blood collection in mice using the saphenous vein: an alternative to retroorbital collection transgenic analysis of drug-metabolizing enzymes: pre-clinical drug development and toxicology the distribution of aspartate aminotransferases in normal and neoplastic rat and mouse tissues hepatic canalicular membrane transport of bile salt in c57l/j and akr/j mice: implications for cholesterol gallstone formation prolonged gestation, elevated preparturitional plasma progesterone, and reproductive aging in c57bl/6j mice mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene immunolocalization of tissue non-specific alkaline phosphatase in mice uncoupling of obesity from insulin resistance through a targeted mutation in a p2, the adipocyte fatty acid binding protein synergistic effect of lymphotactin and interferongamma-inducible protein-10 transgene expression in t-cell localization and adoptive t-cell therapy of tumors multidrug resistance p-glycoprotein 2 is essential for the biliary excretion of indocyanine green induction of bilirubin clearance by the constitutive androstane receptor a traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor car visfatin: a new adipokine transgenic and ko mouse models for the study of luteinizing hormone and luteinizing hormone reception function loperamide effects on hepatobiliary function, intestinal transit, and analgesia in mice redox state-dependent and sorbitol accumulationindependent diabetic albuminaria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency hepatocyte nuclear factor 4 alpha is a central regulator of bile acid conjugation genetic association between h-2 gene and testosterone metabolism in mice use of transgenic mice in carcinogenicity hazard assessment leukotrienes and atherosclerosis: new roles for old mediators endothelial lipase and hdl metabolism targeted mutation of plasma phospholipids transfer protein gene markedly reduces high density lipoprotein levels genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gel permeation chromatography afp gene expression after acute diethylnitrosamine intoxication is not afr2 regulated identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human role of liver enriched transcription factors and nuclear receptors in regulating the human, mouse, rand rat ntcp gene expression of urea transporters in potassium-depleted mouse kidney genetic analysis of glucose tolerance in inbred mouse strains. evidence for polygenic control reversing systemic inflammatory response syndrome with chemokine receptor pepducins carbohydrate metabolism proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome il-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation implications of multiple phenotypes observed in prolactin receptor ko mice. front neuroendocrino122 vectorial transport of bile acids in immortalized mouse bile duct cells hyperadrenocorticism, attenuated inflammation, and the life prolonging action of food restriction in mice physiological relevance of thyroid stimulating hormone and thyroid stimulating hormone receptor in tissues other than the thyroid genetic modifiers of atherosclerosis in mice function of prostanoid receptors: studies in ko mice estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes ghrelin--a hormone with multiple functions effects of shipping on immune functions of mice how obesity causes diabetes: not a tall tale luteinizing hormone deficiency and female infertility current protocols in immunology disruption of the tgf-i] pathway and modeling human cancer in mice a new technique for obtaining blood from mice decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis tissue distribution of products of the mouse decay-accelerating factor (daf) genes: exploitation of a daf-1 knockout mouse and site-specific monoclonal antibodies linscott's directory of immunological and biological reagents clinical biochemistry of laboratory rodents and rabbits. in clinical biochemistry of domestic animals clinical biochemistry the clinical chemistry of laboratory animals improved terminal bleeding method t-cell trafficking in asthma: lipid mediators grease the way the mouse fas-ligand gene is mutated in gld mice and is part of a tnf family gene cluster chemokines: immunology's high impact factors studies on the origin and excretion of serum alpha-amylase in the mouse repetitive blood sampling in unrestrained mice using a chronic indwelling right atrial catheterization apparatus transcellular biosynthesis of arachidonic acid metabolites: from in vitro investigations to in vivo reality consequences of elevated luteinizing hormone on diverse physiological systems: use of the lh beta ctp transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology mouse models as tools for dissecting disorders of lipoprotein metabolism ccl19 and ccl21 induce a potent proinflammatory differentiation program in licensed dendritic cells the role of histamine hi receptor and h2 receptor in lps-induced liver injury adiponectin protects lps-induced liver injury through modification of tnf-t~ in kk-ay obese mice in vivo administration of helicobacter hepaticus cytotoxin is associated with hepatic inflammation and necrosis an h-2-associated difference in murine serum cholesterol levels tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins, and lipases towards a less atherogenic profile biology of il-21 and the il-21 receptor multiple genes encode mouse pancreatic amylases opposing roles for il-13 and il-13 receptor ct2 in health and disease of mice and not men: differences between mouse and human immunology veterinary laboratory medicine: interpretation and diagnosis induction of hepatic metallothionein by non-metallic compounds associated with the acute phase response in inflammation clinical biochemistry and hematological reference values in normal experimental animals relationship between the development of the intestinal iga immune system and the establishment of microbial flora in the digestive tract of young holoxenic mice split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step genetic susceptibility and resistance to diet-induced atherosclerosis and hyperlipoproteinemia chemokines; multiple levels of leukocyte migration control initial sequencing and comparative analysis of the mouse genome oral tolerance in the absence of naturally occurring tregs structure, binding, and antagonists in the il-4/il-13 receptor system corticotropinreleasing hormone deficiency reveals major fetal, but not adult, glucocorticoid need diet effects on bone mineral density and content, body composition, and plasma glucose, leptin and insulin levels. mpd: 143. mouse phenome database web site evaluation of h-fabp as a marker of ongoing myocardial damage using hgh transgenic mice lipid inflammatory mediators in diabetic vascular disease transgenic expression of pancreatic secretory trypsin inhibitor-1 ameliorates secretagogue-induced pancreatitis in mice summary of the second report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults recognition and clearance of apoptotic cells: a role for complement and pentraxins mildly oxidized ldl induces an increase apolipoprotein j/paraoxonase ration the genetic control of alkaline phosphatase activity in the duodenum of the mouse diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? cx3crl-mediated dendritic cell access to the intestinal lumen and bacterial clearance clinical laboratory reference sequential blood samples from the tail vein of rats and mice obtained with modified liebig condenser jackets and vacuum the cancer research uk experience of pre-clinical toxicology studies to support early clinical trials with novel cancer therapies lactic dehydrogenase virus insight into the physiological actions of thyroid hormone receptors from genetically modified mice ccr7 governs skin dendritic cell migration under inflammatory and steady state conditions viral pertubation of endocrine function: disordered cell function leads to disturbed homeostasis and disease targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity genetics, cytokines, and human infectious disease: lessons from weekly pathogenic mycobacteria and salmonellae circadian rhythms of plasma corticosterone binding activity in the rat and mouse one hundred years of mouse genetics: an intellectual history. i. the classical period one hundred years of mouse genetics: an intellectual history. ii. the molecular revolution the ultrastructural localization of the isoenzymes of aspartate aminotransferase in murine tissues proteomic analysis of diet-induced hypercholesterolemic mic clinical chemistry values of the n:nih(s) mice and parameter variations due to sampling techniques use of proteomic patterns in serum to identify ovarian cancer lessons from kitty hawk: from feasibility to routine clinical use for the field of proteomic pattern diagnostics alkaline phosphatase activity of the mouse immune regulation in the intestine boosted decision tree analysis of surface enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from non-cancer patients animal models in biomedical research complement the mouse transgenic models of tolerance and autoimmunity: with special reference to systemic lupus erythematosus short-term and long-term in vivo exposure to an ephedra-and caffeine-containing metabolic nutrition system does not induce cardiotoxicity in b6c3f1 mice model models of atherosclerosis hormones type 2 diabetes: a matter of beta-cell life and death leukemia inhibitory factor and interleukin-ll: cytokines with key roles in implantation virus induced pancreatic disease; alterations in concentrations of glucose and amylase in blood lungkine, a novel cxc chemokine, specifically expressed by lung bronchoepithelial cells changes in serum hormone levels associated with male-induced ovulation in group housed adult female mice ko transgenic mouse model of sickle cell disease animal models of autoimmunity and their relevance to human diseases hematological comparison of the mouse blood taken from the eye and tail cystatin c as a potential cerebrospinal fluid marker for the diagnosis of creutzfeldt-jakob disease efficacy of 2, 3-dimercapto-l-propanesulfonic acid (dmps) and diphenyl diselenide on cadmium induced testicular damage in mice multimeric cytokine receptors: common versus specific functions bilateral lesions in the suprachiasmatic nuclei affect circadian rhythms and h-thymidine incorporation into deoxyribonucleic acid in mouse intestinal tract, mitotic index of corneal epithelium, and serum corticosterone pthrp, pth, and the pth/pthrp receptor in endochondral bone development diabetes, obesity, and the brain hematopoietic, immunomodulatory and epithelial effects of interleukin-11 intestinal tsh production is localized in crypt enterocytes and in villus 'hotblocks' and is coupled to il-7 production: evidence for involvement of tsh during acute enteric virus infection adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor loci controlling plasma non-hdl and hdl cholesterol levels in a c57bl/6j x casa/rk intercross quantitative trait loci mapping of genetic modifiers of metabolic syndrome and atherosclerosis in low-density lipoprotein receptor-deficient mice the kinase lkb 1 mediates glucose homeostasis in liver and therapeutic effects of metformin genetic defects in copper metabolism estrogen: the good, the bad, and the unexpected il-1 and il-18 receptors, and their extended family b-cell-and monocyte-activating chemokine (bmac), a novel non-elr ct-chemokine feed-forward regulation of bile acid detoxification oby cyp3a4: studies in humanized transgenic mice adenovirus-mediated rescue of lipoprotein lipase-deficient mice breeding of the gad-mdx mouse: influence of genetically induced denervation on dystrophic muscle fibers failure of parturition in mice lacking the prostaglandin f receptor inactivation of stress protein p8 increases murine carbon tetrachloride hepatotoxicity via preserved cyp2e1 activity murine models to investigate pharmacological compounds acting as ligands of ppars in dyslipidemia and atherosclerosis the other side of the orexins: endocrine and metabolic actions assessment of hepatic function mitochondrial affinity for adp is twofold lower in creatine kinase ko muscles. possible role in rescuing cellular energy homeostasis evaluation of proparacaine hydrochloride as a topical anesthetic for the collection of blood from the orbital sinus of mice mitochondrial affinity for adp is twofold lower in creatine kinase knockout muscles. possible role in rescuing cellular energy homeostasis the role of cd40-cd154 interactions in autoimmunity and the benefit of disrupting this pathway scavenger receptor class b type 1 in high-density lipoprotein metabolism, atherosclerosis, and heart disease: lessons from gene targeted mice cxc chemokine receptor cxcr2 is essential for protective innate host response in murine pseudomonas aeruginosa pneumonia in vivo uptake of radiolabeled mda2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized ldl and is highly sensitive to their regression the regulation of the complement system: insights from genetically-engineered mice interleukin-6: an overview development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine mechanisms of suppression by suppressor t-cells lipids and lipoproteins car and pxr agonists stimulate hepatic bile acid and bilirubin detoxification and elimination in mice pneumocystis carinii activates the nf-kappa[~ signaling pathway in alveolar epithelial cells a simple capillary tube method for the determination of the specific gravity of 25 and 50 micro 1 quantities of urine interleukin-18 facilitates the early antimicrobial host response to escherichia coli peritonitis transgenic studies on the regulation of the anterior pituitary gland function by the hypothalamus cxcr3 and its ligand participate in the host response to bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung a direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene assessment of hepatic function and damage in animal species laboratory animal endocrinology investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo the protein profile of acetazolamidetreated sera in mice bearing lewis neoplasm cebs object modes for systems biology data, sysbio-om partal hormone resistance in mice with disruption of the steroid receptor coactivator-1 (src-1) gene platelet factor 4 gene transfection into tumor cells inhibits angrogenesis tumor growth and metastasis mice lacking the thyrotropin-releasing hormone gene: what do they tell us? differences in the human and mouse amino-terminal leader peptides of ornithine transcarbamylase affect mitochondrial import and efficacy of adenoviral vectors combined pituitary hormone deficiency: lessons from the murine models molecular basis of resistance to thyroid hormone a mouse bleeding technique yielding consistent volume with minimal hemolysis transgenesis and the study of expression, cellular targeting, and function of oxytocin, vasopressin and their receptors kos model the 100 best-selling drugs: will they model the next 100? predicting drug efficacy: kos model pipeline drugs of the pharmaceutical industry three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer cxc chemokine ligand 129 stromal cell-derived factor 1 alpha and cxcr4-dependent migration of ctls toward melanoma cells in organotypic culture il-ii: insights in asthma from overexpression transgenic modeling genotype, obesity, and cardiovascular disease: has technical and social advance outstripped evolution? specific fetal serum proteins of 13 mammalian species t3 t4 tace taj tc tg tgf-i3 tgf-~isf th tlr tnap tnf tnfrsf tnfsf tof tpc trance trh tsh tx upr usg vldl serum amyloid a serum amyloid protein standard deviation stromal cell-derived factor-1 sorbitol dehydrogenase surface-enhanced laser desorption/ionization secondary lymphoid tissue chemokine stearoyl-coa desaturase-1 suppressor of cytokine signaling-3 steroid receptor coactivator-1 sj6gren's syndrome single-strand deoxyribonucleic acid triiodothyronine thyroxine tumor necrosis factor-a converting enzyme toxicity and jnk inducer cytotoxic t-cells triglyceride transforming growth factor-j3 transforming growth factor-13 superfamily t-helper toll-like receptors tissue nonspecific alkaline phosphatase tumor necrosis factor tumor necrosis factor receptor superfamily tumor necrosis factor superfamily time-of-flight total plasma cholesterol tumor necrosis factor-related activation-induced cytokines thyrotropin-releasing hormone thyroid-stimulating hormone thromboxane unfolded protein response urine specific gravity very low-density lipoprotein key: cord-256998-or73in8m authors: nguyen, khue g.; vrabel, maura r.; mantooth, siena m.; hopkins, jared j.; wagner, ethan s.; gabaldon, taylor a.; zaharoff, david a. title: localized interleukin-12 for cancer immunotherapy date: 2020-10-15 journal: front immunol doi: 10.3389/fimmu.2020.575597 sha: doc_id: 256998 cord_uid: or73in8m interleukin-12 (il-12) is a potent, pro-inflammatory type 1 cytokine that has long been studied as a potential immunotherapy for cancer. unfortunately, il-12's remarkable antitumor efficacy in preclinical models has yet to be replicated in humans. early clinical trials in the mid-1990's showed that systemic delivery of il-12 incurred dose-limiting toxicities. nevertheless, il-12's pleiotropic activity, i.e., its ability to engage multiple effector mechanisms and reverse tumor-induced immunosuppression, continues to entice cancer researchers. the development of strategies which maximize il-12 delivery to the tumor microenvironment while minimizing systemic exposure are of increasing interest. diverse il-12 delivery systems, from immunocytokine fusions to polymeric nanoparticles, have demonstrated robust antitumor immunity with reduced adverse events in preclinical studies. several localized il-12 delivery approaches have recently reached the clinical stage with several more at the precipice of translation. taken together, localized delivery systems are supporting an il-12 renaissance which may finally allow this potent cytokine to fulfill its considerable clinical potential. this review begins with a brief historical account of cytokine monotherapies and describes how il-12 went from promising new cure to ostracized black sheep following multiple on-study deaths. the bulk of this comprehensive review focuses on developments in diverse localized delivery strategies for il-12-based cancer immunotherapies. advantages and limitations of different delivery technologies are highlighted. finally, perspectives on how il-12-based immunotherapies may be utilized for widespread clinical application in the very near future are offered. interleukin-12 (il-12) is a potent, pro-inflammatory type 1 cytokine that has long been studied as a potential immunotherapy for cancer. unfortunately, il-12's remarkable antitumor efficacy in preclinical models has yet to be replicated in humans. early clinical trials in the mid-1990's showed that systemic delivery of il-12 incurred dose-limiting toxicities. nevertheless, il-12's pleiotropic activity, i.e., its ability to engage multiple effector mechanisms and reverse tumor-induced immunosuppression, continues to entice cancer researchers. the development of strategies which maximize il-12 delivery to the tumor microenvironment while minimizing systemic exposure are of increasing interest. diverse il-12 delivery systems, from immunocytokine fusions to polymeric nanoparticles, have demonstrated robust antitumor immunity with reduced adverse events in preclinical studies. several localized il-12 delivery approaches have recently reached the clinical stage with several more at the precipice of translation. taken together, localized delivery systems are supporting an il-12 renaissance which may finally allow this potent cytokine to fulfill its considerable clinical potential. this review begins with a brief historical account of cytokine monotherapies and describes how il-12 went from promising new cure to ostracized black sheep following multiple on-study deaths. the bulk of this comprehensive review focuses on developments in diverse localized delivery strategies for il-12-based cancer immunotherapies. advantages and limitations of different delivery technologies are highlighted. finally, perspectives on how il-12-based immunotherapies may be utilized for widespread clinical application in the very near future are offered. keywords: interleukin-12 (il-12), cancer immunotherapy, cancer vaccine, cytokine delivery system, localized delivery, intratumoral administration overview of il-12-based immunotherapies a brief history of cytokine and il-12 immunotherapies since the discovery of an "endogenous pyrogen, " now known as il-1, in 1953, scientists have anticipated the use of exogenous cytokines to manipulate a patient's immune system in an effort to control malignant neoplasms (1) . early obstacles to cytokine-based immunotherapy centered on difficulties achieving reproducible manufacture of a sufficient and pure supply of cytokines for clinical trials. in the early 1980s, recombinant dna technology and advances in the biochemical characterization of proteins combined to overcome this hurdle. finally, in 1986, ifn-α broke through as the first cytokine to win fda approval as a single agent cytokine therapy for cancer (2) . since then, hundreds, if not thousands, of studies have evaluated more than 40 cytokines against a range of preclinical tumor models. a number of promising cytokines, including gm-csf, il-1, tnfα, ifn-γ, and il-12, subsequently entered clinical trials as single agents but failed to provide clinical benefit. currently, only 2 of 40+ identified cytokines are approved as single agent immunotherapies for a limited number of indications ( table 1) . another fda approved cancer immunotherapy, talimogene laherparepvec (t-vec; imlygic tm ) is an oncolytic herpes simplex virus that uses gm-csf expression as an immune enhancer (7) . perhaps the greatest disappointment in cytokine immunotherapy development thus far is il-12. il-12 is a potent, pro-inflammatory cytokine produced by antigen presenting cells typically in response to microbial pathogens. it is comprised of two subunits, p35 and p40, that are linked by three disulfide bridges to form a p70 heterodimer (7) (8) (9) (10) . il-12 is chiefly responsible for the induction and enhancement of cell-mediated immunity. among its diverse functions, il-12 has been shown to: (i) induce t h 1 cell differentiation; (ii) increase activation and cytotoxic capacities of t and nk cells; and (iii) inhibit or reprogram immunosuppressive cells, such as tumor associated macrophages (tams) and myeloid-derived suppressor cells (mdscs) (11) (12) (13) (14) (15) (16) . il-12 also induces the production of large amounts of ifnγ which itself is cytostatic/cytotoxic (17, 18) , anti-angiogenic (19, 20) and can upregulate mhc i and ii expression on tumor cells for enhanced recognition and lysis (21) . not surprisingly then, il-12 has demonstrated remarkable antitumor effects against a range of malignancies in preclinical studies (22) (23) (24) (25) . these effects are largely dependent on cd8 + t cells, nk cells, and nk t cells (23, 26, 27) . in clinical studies, il-12 has been evaluated as an experimental treatment for numerous malignancies (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) . unfortunately, the efficacy of il-12 at tolerated doses has been minimal (29, 30, 33) . atkins and colleagues were the first to employ il-12 immunotherapy in a clinical trial (28) . this phase i study enrolled 40 patients, including 20 with renal cancer and 12 with melanoma, to investigate intravenous administration of recombinant hil-12 (rhil-12). one melanoma patient experienced a transient complete response and one renal cancer patient had a partial response (28) . subcutaneous rhil-12 was employed in a separate pilot study that enrolled 10 advanced melanoma patients (29) . in this study, a fixed dose of rhil-12 (0.5 µg/kg) was given to patients on days 1, 8, and 15 for two sequential cycles of 28 days. no partial or complete responses were reported. minor tumor shrinkages involving some subcutaneous metastases and hepatic metastases were observed (29) . in yet another early melanoma study, the administration of il-12 was found to induce a striking peripheral burst of hla-restricted ctl precursors directed to autologous tumors and to multiple immunogenic tumor-associated antigens (39) . significantly, the infiltration of cd8 + t cells with an effector-memory phenotype was identified in posttreatment metastatic lesions, but not in pretreatment metastatic lesions of three patients (39) . il-12 has also been shown to induce productive antitumor responses against cutaneous t cell lymphoma variants (38) , aids-related kaposi sarcoma (37) , and non-hodgkin's lymphoma (38) . although il-12 has demonstrated robust antitumor activity in preclinical studies and potent immune-stimulating potential in humans, systemic administrations of il-12 have been shown to be exceedingly toxic. in one phase ii trial, a maximal dose of 0.5 µg/kg per day resulted in severe side effects in 12 out of 17 enrolled patients and the deaths of two patients (40) . interestingly, the same dose of 0.5 µg/kg il-12 per day was found to be well-tolerated in patients that were enrolled in a previous phase i study. a change in dosing schedule accounted for the differences in toxicity between the phase i and phase ii trials. in the phase i trial, a single tester dose of il-12 was administered 1 week before a multiple-dose regimen. the tester dose was found to blunt the toxicity induced by subsequent doses (41) . overall, severe toxicities in early clinical trials, including 2 on-study deaths (42) due to frequent systemic injections of il-12, together with disappointing clinical responses in large phase 2 studies (43, 44) , dampened enthusiasm for il-12-based immunotherapy. the disappointing antitumor responses in clinical trials raised the possibility that il-12 is simply less active in humans. however, the severe toxicities outlined above indicate that il-12 has potent biological activity in humans. another possibility for the limited clinical efficacy is insufficient delivery of il-12 to the tumor microenvironment in humans. il-12, like most cytokines, functions locally through paracrine and autocrine mechanisms. the ideal targets of il-12 immunotherapy are not lymphocytes in circulation, but rather immune cells within the tumor and nearby lymph nodes, including activated but exhausted t cells, nk cells, tams, and mdscs. therefore, maximizing the amount of il-12 that reaches the tumor seems critical for a robust antitumor response. we and others have noted that il-12 immunotherapeutics would be more effective and less toxic if delivered and maintained in the tumor through the use of novel delivery technologies. there are five benefits of local, persistent il-12 delivery. the first is enhanced spatiotemporal distribution of il-12 compared to systemic delivery. the failure of il-12-based immunotherapies to achieve widespread clinical success may be at least partially attributed to the inability of a tolerated dose of systemically administered il-12 to reach therapeutic concentrations within human tumors. in mice, implanted or induced tumors are disproportionately large. for example, a 1.5-g tumor (∼1.25 cm 3 ) comprises 6% of the body weight of a 25-g mouse. a comparably sized tumor in a 70 kg (154 lbs) human would weigh 4.2 kg (9.2 lbs). furthermore, rapidly growing murine tumors are highly vascularized relative to their human counterparts (45, 46) . taken together, a significantly larger fraction of a systemically administered il-12 dose can be expected to reach the tumor in a mouse compared to a human. localized delivery strategies, on the other hand, are capable of enhancing il-12 concentrations in the tumor microenvironment by one or more orders of magnitude (47) (48) (49) (50) . a second benefit of localized il-12 delivery is the ability to generate systemic antitumor immunity from a locally initiated intravenous injection (4, 5) talimogene laherparepvec (t-vec) unresectable advanced melanoma intratumoral injection (6) * subcutaneous and intramuscular injections are local deliveries. however, they result in systemic cytokine distribution and are utilized in the clinic as systemic therapies. immune response. as cancer metastasizes and becomes a "systemic" disease, conventional wisdom has suggested that metastases must be treated with systemic therapies such as i.v. administered chemotherapies or immune checkpoint inhibitors. however, systemic delivery increases the frequency of adverse events through off-target interactions. for instance, systemic il-12 therapy has the potential to cause activation and/or differentiation of all circulating t cells whereas activation/differentiation of only tumor-specific or tumor antigen-experienced t cells is preferred. fortunately, a growing mountain of evidence demonstrates that localized il-12 can generate systemic, adaptive immunological memory capable of controlling anestic tumors, inhibiting metastases, and preventing tumor recurrences (51) (52) (53) . in particular, local administration of il-12 has been shown to activate or reactivate tumor infiltrating cd8 + t cells, improve antigen presenting machinery and subsequently cause the expansion of tumor-specific cd8 + effector t cells. this often leads to enhanced infiltration of contralateral untreated tumors (54) . research from our own lab demonstrated that local/intravesical administration of il-12 eliminated untreated flank tumors only when a primary orthotopic bladder tumor was treated. these data indicated that t cells must be educated with antigens from a primary tumor in order to find and eliminate abscopal tumors. similarly, intratumoral injections of il-12 neoadjuvant to resection have been shown to inhibit metastases by multiple groups in a t cell, nk cell, or ifn-γ dependent manner (52, 55) . taken together, the convincing evidence demonstrating that localized il-12 can induce abscopal immunity renders systemic il-12 delivery unnecessary even for the treatment of metastatic disease. third, as mentioned above, il-12 is a pleiotropic cytokine with context dependent consequences. when il-12 is administered systemically, it induces rapid increases in pro-inflammatory cytokines, such as ifn-γ, tnf-α, and il-6 (56). this "cytokine storm" combined with rapid decreases in peripheral blood lymphocytes, monocytes, and neutrophils can be lethal (42) . however, when controlled locally, pleiotropic cytokines have the potential to engage multiple antitumor effector mechanisms. for instance, il-12 increases the activation and cytolytic capacity of cd8 + t cells and nk cells and induces the production of ifn-γ. ifn-γ, in turn, may kill tumor cells directly, inhibit angiogenesis (57) (58) (59) (60) , and stimulate nk cells, ctls (61, 62) , and macrophages (63) while upregulating mhc i and ii molecules (64) on the surfaces of tumor cells. fourth, high levels of locally administered il-12 can reverse tumor-supporting immunosuppression. the immunosuppressive tumor microenvironment is a major hindrance to the clinical efficacy of all cancer immunotherapies. in fact, the cancer vaccine literature teaches that the majority of patients in clinical studies are able to mount significant antigen-specific t cell responses, yet few patients experience clinical benefit (65) (66) (67) . similarly, the extraordinary activity of car t cells against hematologic malignancies becomes less than ordinary against solid tumors. many solid tumors lack the chemokines and inflammation necessary to recruit cytotoxic t cells (68) . moreover, dense tumor stroma prevents t cell penetration while immunosuppressive factors released by tumor cells, suppressor t cells and tams can cause t cell anergy. regarding the latter, many tumors bathe in a cocktail of immunosuppressive factors such as tgfβ, il-10, ido, and larginase. fortunately, high intratumoral concentrations of il-12 can cause apoptosis and elimination of cd4 + cd25 + foxp3 + suppressor t cells in tumors (69) . in addition, the tumor suppressive phenotype of tams can be converted to a cytotoxic, antitumor phenotype in the presence of localized il-12 (11) . finally, il-12 has been shown to modulate and alter the suppressive activities of tumor-associated mdscs (12) . lastly, and perhaps most importantly, activation of t cells in the presence of il-12 can not only enhance ctl function, but also reduce negative regulatory mechanisms such as pd-1/pd-l1 signaling and autocrine ifnγ-induced apoptosis. this "protective" effect has been observed mostly in the cellular immunotherapy literature. standard protocols for ex vivo expansion of tumor infiltrating lymphocytes for adoptive cell therapy (act) traditionally used high dose il-2 to facilitate t cell proliferation (70) . the inclusion of il-12 in conditioning/expansion media has been explored recently because it had been shown previously to result in optimal t cell priming (71) . indeed, adoptive transfer of tumor-specific cd8 + t cells primed ex vivo in the presence of il-12 resulted in enhanced antitumor responses (72, 73) , increased persistence of infused t cells (73, 74) , as well as increased expression of il-2rα (cd25], icos, ox40, granzyme b, and ifnγ (73) . importantly, cytotoxic t lymphocytes (ctls) stimulated with il-12 were more effective in controlling tumors following adoptive transfer than ctls stimulated with ifnα (75) . il-12-stimulated t cells expressed lower levels of pd-1 and higher levels of ifnγ and il-2 compared to ifnα-stimulated t cells (75) . il-12 conditioning caused downregulation of ifnγr2 with a concomitant decrease in susceptibility to ifnγ-induced apoptosis of tumor-infiltrating cd8 + t cells (74, 76) . il-12 delivery strategies can be divided into three general approaches. the first involves fusion of a targeting moiety to il-12 in order to facilitate accumulation in a tumor following a systemic injection. the most common of class of fusion molecules are immunocytokines, which involve linking a tumor binding antibody fragment to a cytokine. the second approach involves delivery of genetic material encoding il-12 directly to the tumor or a tissue of interest. this category can be further divided based on the type or method of gene delivery. plasmids, mrna, viruses, and transduced cells are all capable of expressing and delivering il-12 after a local injection. the third major approach involves controlled release of recombinant il-12 protein from a sustained delivery system. here, the cytokine delivery system is injected or implanted directly in a tumor or tissue of interest. the remainder of this section will present and discuss the most relevant preclinical and clinical data pertaining to each il-12 delivery strategy. a summary of current clinical trials utilizing localized il-12 delivery is presented in table 2 . as mentioned above, immunocytokines are part or whole cytokines that have been engineered to contain antibody fragments or other targeting moieties. these "targeted" cytokines are administered systemically but are expected to accumulate within tumors at higher levels compared to non-targeted cytokines. various tumor-related features have been targeted by immunocytokines including: (1) tumor antigens which are overexpressed or uniquely expressed by tumor cells; (2) cryptic extracellular matrix epitopes found only in tumors; and (3) neovasculature markers as tumors require angiogenesis for growth. developments in immunocytokines are discussed below. the pan-carcinoma antigen, epithelial cell adhesion molecule (epcam), is highly expressed by cancer cells of epithelial origin such as colon, prostate, breast, and lung carcinomas. huks-il-12 is an immunocytokine of il-12 fused to the fc fragment of a humanized antibody that recognizes epcam. in a murine prostate cancer model, huks-il-12 was found to suppress experimental metastases in scid mice reconstituted with activated human t and nk cells lymphocytes (78) . another immunocytokine, hu14.18-il-12, which is irrelevant in this system due to its targeting of ganglioside gd2, was found to be somewhat less effective than huks-il-12, although differences in antitumor activity were not statistically significant (78) . dual immunocytokines in which both il-2 and il-12 were fused to the huks1/4 antibody fragment were found to eliminate epcam-expressing llc flank tumors following intratumoral (i.t.) injection (79) . interestingly, a mixture of huks-il-2 and huks-il-12 was less effective than the dual immunocytokine if delivered i.t., but exhibited similar in antitumor activity if administered i.v. (79) . the epidermal growth factor receptor her2/neu is overexpressed in roughly a third of breast and ovarian cancers, with high expression correlating with poor prognosis. trastuzumab, a monoclonal antibody targeting her2, has been approved for the treatment of certain breast cancers for more than 20 years. a mouse single chain il-12 fused to an anti-her2/neu igg3 (mscil-12.her2.igg3) retarded the growth of ct26-her2/neu tumors in immunocompetent mice (80) . a direct comparison demonstrated that mscil-12.her2.igg3 and free il-12 induced similar activities against ct26-her2/neu tumors (81) . follow up studies revealed that mscil-12.her2.igg3 also displayed robust antitumor activity against mc38/her2/neu and d2f2/e2 tumors (82, 83) . a more recent study revealed that disruption of the heparin binding domain in the mscil-12.her2.igg3 immunocytokine, reduced il-12 bioactivity (84) . this result was consistent with recent studies showing that heparin and heparan sulfate bind to and enhance the activity of il-12 (85) (86) (87) (88) (89) . while eliminating heparin binding reduces il-12 activity, we speculate that this reduction could be counterbalanced by an enhancement in tumor targeting as the il-12 immunocytokine may no longer bind to ubiquitous sulfated glycosaminoglycans in non-targeted tissues. mesothelin is a differentiation antigen that is highly expressed in a number of human cancers including mesotheliomas, pancreatic and lung adenocarcinomas, and ovarian and breast carcinomas. to direct il-12 to mesothelin expressing cancer cells, a scfv, called ss1, that specifically binds to mesothelin was fused to the p35 subunit of a single-chain il-12 (90) . human peritoneal mesotheliomas established in nude mice were significantly inhibited by i.p. injections of il12-ss1 (90) . that these studies were successful in nude mice seems to imply a prominent role for nk cells in this model. ca166-9 is a cancer antigen that is expressed in about half of human ovarian cancers (91) . a scfv of the 6b11 monoclonal antibody that binds to ca166-9 was fused to mil-12 (92) . systemically (i.v.) administered 6b11scfv-mil-12 was found to inhibit the growth of subcutaneously implanted id8 ovarian tumors more effectively than non-targeted mil-12 (92) . cd30 is expressed by activated lymphocytes and thus serves as a useful target for several types of lymphoma. a cd30-targeted il-12 fusion protein was developed for cd30 + hodgkin's lymphoma therapy (93) . the immunocytokine was found to induce activation of t and nk cells and secretion of proinflammatory cytokines resulting in enhanced cytotoxicity of cd30 + mc38 cells. interestingly, a cd30-targeted il12-il2 fusion protein outperformed targeted il-2 or il-12 alone in all in vitro measures. the dual cytokine construct induced regression of cd30 + but not cd30-mc38 tumors in vivo (93) . whether the dual cytokine fusion protein was better than the single cytokine constructs is not known as the latter were not evaluated in vivo. many solid tumors overexpress extracellular matrix (ecm) which serves as transport barrier to the penetration of therapeutics and immune cells. in ecm-rich solid tumors, it may frontiers in immunology | www.frontiersin.org targeting ecm proteins instead of cancer cells, therefore, is a promising strategy to encourage immunocytokine accumulation in tumors. there are two immunocytokines, hubc1-il12 and il-12-l19, that have been developed to target the splice variant extra domain b (ed-b) of fibronectin, which is highly expressed in tumor tissues but undetectable in normal adult tissues with the exception of endometrium (94) . bc-1 is a monoclonal antibody that recognizes the ed-b isoform, thus a hubc1-il12 immunocytokine has been constructed from two molecules of il-12 fused to each of the igg heavy chains of humanized bc-1. systemic administration of hubc1-il12 was found to eliminate experimental pc3 metastases and suppress the growth of multiple human tumor lines in immunocompromised mice more effectively than il-12 alone (95) . a phase i trial evaluated the safety of weekly infusions of as1409 (hubc1-il12) in 13 renal carcinoma and malignant melanoma patients (96) . the maximum tolerated dose (mtd) was found to be 15 µg/kg. in contrast, the mtd of twice weekly i.v. il-12 was previously found to be 0.5 µg/kg (97) . dose limiting toxicities, including fever, fatigue, and elevated transaminase levels, were consistent with known toxicities of il-12 (96) . the second ed-b targeted immunocytokine, il-12-l19, is comprised of the ed-b-binding l19 scfv and il-12 (98) . l19-targeted cytokines have been shown to selectively accumulate in tumors following i.v. administration (99, 100) . intravenous administration of il-12-l19 every 48 h was found to control the growth of primary c51 colon adenocarcinomas, f9 teratocarcinomas as well as experimental pulmonary c51 metastasis (101) . biodistribution studies confirmed that a greater percentage of the injected dose of il-12-l19 was found in tumors as compared to an il-12-fusion negative control. il-12-l19 also demonstrated synergistic antitumor activity when combined with l19-tnfα (102) . most recently, il-12 was fused to the collagen-binding proteoglycan lumican and mouse serum albumin (msa), to create il12-msa-lumican (103) . lumican binds to collagen types i and iv, components of the thick fibrotic capsule surrounding tumors and perivascular basement membrane, respectively. in mice bearing established subcutaneous flank b16f10 tumors, treatment with il12-msa-lumican resulted in prolonged tumor control and longer survival. significant weight loss was observed following il12-msa compared to il12-msa-lumican treatment, indicating that collagen targeting may reduce systemic toxicities of il-12. finally, the combined treatment of lumican-msa-il2 and il12-msa-lumican potentiated anti-pd-1 increasing survival in multiple models and completely protecting cured mice from live tumor rechallenge (103) . another collagen-binding immunocytokine comprised of the a3 cbd of von willebrand factor fused to both subunits of il-12 was also recently developed (104) . systemic (i.v.) administration of this cbd-il12 was found to accumulate in emt6 mammary carcinomas at significantly higher levels and induce higher rates of complete tumor regression against 1-week old b16f10 and emt6 tumors compared to il-12 (104) . inclusion of the cbd resulted in a 5-6-fold decrease in plasma half-life despite the larger size of cbd-il12. the distributions of cbd-il12 and il-12 in normal tissues following i.v. injection were surprisingly similar although typical sites of collagen targeted drugs, e.g., bone and skin, were not examined. most importantly, although elevated liver enzymes were observed, levels following cbd-il12 at an impressive dose of 50µg/mouse were similar to 10µg/mouse of il-12 (104) . in general, the key advantage of systemically administered immunocytokines is their ability to preferentially accumulate within a site of disease, e.g., a tumor. however, immunocytokines retain complete cytokine activity in circulation which allows them to interact with circulating lymphocytes and induce similar cytokine-induced toxicities as parental cytokines (105) . one clever strategy has been developed to reduce adverse effects associated with systemic il-12 by separating the targeted delivery of the p35 and p40 subunits. this split-immunocytokine approach involves first delivering a bivalent p35-based antibody fusion protein (f8-p35s-f8). f8 binds to the alternatively spliced extra domain a (ed-a) domain which is present on the subendothelial extracellular matrix of tumor neovasculature (106) . after allowing time for binding and clearance of unbound f8-p35s-f8, a subsequent administration of p40, which has no activity by itself, interacts with p35 to recover il-12 activity. quantitative biodistribution investigation in f9 teratocarcinomas bearing mice showed that both targeted subunits accumulated in the tumor (106) . furthermore, the recombined subunits displayed robust il-12 activity in terms of ifnγ production and stat4 phosphorylation (106) . tumor necrosis is a common feature of most advanced solid tumors. approaches to target dna strands that become uniquely exposed in necrotic foci are under investigation. the monoclonal antibody, chtnt-3, recognizes single-stranded dna (107) . a fusion between the variable heavy chain of chtnt-3 and hil-12 forms the necrosis-targeting immunocytokine, chtnt-3/hil-12 (94) . chtnt-3/hil-12 was retained in a subcutaneous tumor after i.v. injection and resulted in a significant inhibition of du145 prostate tumors in human pbl-engrafted scid mice (94) . another necrosis-targeting il-12, capitalizes on the specificity of the nhs76 antibody for ssdna and dsdna (108, 109) . nhs-il12 is comprised of the full length nhs76 antibody fused to 2 single-chain il-12 molecules. systemic administration of a murine analog, nhs-muil12, has been shown to delay the growth of mc38-cea+ colorectal carcinomas in cea.tg mice (108) . furthermore, tumorbearing mice treated with nhs-muil12 developed cd8 + t cell responses against an endogenous tumor antigen, p15e. in vivo imaging studies have shown that nhs-muil12 accumulated in flank tumors following a s.c. injection (108) . subcutaneous administrations of nhs-muil12 were also recently shown to provide significant reductions in orthotopic mb49luc bladder tumors (110) . tumor control was associated with a noticeable reduction in markers of immunosuppression, e.g., mdscs, macrophages and tumor-associated tgf-β (110) . the combination of nhs-muil12 with avelumab, an anti-pd-l1 antibody, resulted in improved control of both mc38 and mb49 flank tumors with higher frequencies of cd8 + t cells and enhanced t cell activation compared to either agent alone (111) . against orthotopic emt-6 mammary tumors (∼100 mm 3 ) the combination of nhs-muil12 and avelumab induced complete regression in 7 of 8 mice (112) . the same treatment was shown to delay, but not completely regress, the growth of 350-400 mm 3 established emt-6 tumors. importantly, nhs-muil12 plus avelumab was shown to induce protective immunity as all cured mice resist an emt-6 tumor challenge but not a 4t1 challenge. furthermore, treatments enhanced cytotoxic nk and cd8 + tcell proliferation, t-bet expression, plasma cytokine levels, and innate and adaptive immune genes (112) . combining nhs-il12 with fcil-7 or il-2mab602 resulted in improved antitumor immunity, increased survival, and longterm remission in sarcoma-bearing mice (113) . fcil-7 is a fusion of interleukin-7 and an fc fragment while il-2mab602 is a fusion of il-2 and a monoclonal antibody against il-2, mab602. separately, the combination of nhs-il12 with local tumor irradiation was shown to increase treatment efficacy (114, 115) . in preparation for first-in-human clinical trials, a comparative oncology study in client-owned dogs with melanoma revealed that s.c. injections of nhs-il-12 induced transient increases in serum ifnγ and il-10. two of 7 dogs in a dose escalation cohort experienced a partial response while 5 of 7 dogs had increased levels of tumor-infiltrating cd8 + t cells (116) . nhs-il12 is currently in phase i clinical studies either as a monotherapy (nct01417546) or in combination with avelumab (nct02994953). in the former study, nhs-il12 induced transient lymphopenia and elevated liver transaminases, but was otherwise well-tolerated with a mtd of 16.8 µg/kg (117) . no objective tumor responses were observed, however, 5 of 59 patients experienced stable disease. immune assays revealed that nhs-il12 treatment increased nk cell frequencies and broadened the tcr diversity of tumor-infiltrating t cells (117) . systemically administered immunocytokines can significantly reduce but are unlikely to completely avoid il-12-related toxicities. as mentioned above, in circulation, immunocytokines will interact with immune cells and induce signaling outside of the tumor. in addition, all targeting moieties are susceptible to non-specific binding and distribution in normal, untargeted tissues. for example, radiolabeled nhs76 has been found in all major tissues in mice for 2-3 days after i.v. administration (109) . furthermore, substantial amounts of il-12-l19 were found in the livers of treated animals, likely leading to hepatotoxicity (101) . on-target/off-tissue specific binding may create additional concerns. in the case of nhs-targeting moieties, cancer patients have high levels of circulating cell-free dna that is shed from tumors (108). it is not clear how circulating dna impacts nhs targeting. in the case of neovasculature targeting moieties, angiogenesis is a normal process of wound healing and promotes collateral circulation for atherosclerotic blood vessels. disrupting non-cancerous angiogenesis could induce hypertension and cardiac ischemia which are among the adverse events associated with anti-angiogenic agents, such as bevacizumab. moreover, the potential immunogenicity of a nonendogenous immunocytokine is another factor that may limit therapeutic potential. as non-native proteins, immunocytokines could contain immunogenic epitopes against which an immune response, likely an antibody response, could be raised. antiimmunocytokine antibodies could induce pharmacological abrogation, therapeutic alteration, or hypersensitivity reactions (118) . because of the potential for anti-immunocytokine antibodies, novel immunocytokines should be engineered to minimize the presence of immunogenic epitopes. overall, although immunocytokines remain capable of inducing il-12-related adverse events, the use of targeting moieties may improve biodistribution enough to expand the therapeutic window of il-12-based immunotherapies. intratumoral (i.t.) injections of dna and rna encoding il-12 have the potential to localize and sustain the production of il-12 in the tumor microenvironment. nucleic acids are much easier to produce, purify and manipulate than recombinant cytokines. however, mammalian host cells are not easy to transfect and typically require chemical, physical, or electrical assistance to achieve reasonable transfection rates. this section will highlight progress in nucleic acid-based approaches both preclinically and clinically. around the same time that recombinant il-12 was failing in clinical trials, a limited number of preclinical and clinical studies explored i.t. injection of plasmid dna encoding il-12 (pil-12) as a potentially less toxic approach. preclinically, i.t. pil-12 inhibited but did not eliminate b16 melanomas (119) . in this study, il-12 was not detected in the serum following i.t. injection. in another study involving gray horses with metastatic melanoma, i.t. pil-12 resulted in detectable levels of pil-12 in the serum for up to 36 h (120). however, it is not clear if systemic dissemination of pil-12 resulted in significant systemic increases in serum il-12 or ifnγ as these were not measured (120) . in a phase i/ii trial of intralesional injections with pil-12, 3 of 9 and 8 of 9 patients with stage iv malignant melanoma experienced clinical and local responses, respectively (121) . in a phase i/ib study, i.t. pil-12 was found to reduce the size of treated lesions by at least 30% in 5 of 12 malignant melanomas and renal cell carcinomas (122) . pil-12 injections were welltolerated as no patient in either study experienced a significant treatment-related adverse event. despite successful safety studies, the use of naked pil-12 for cancer immunotherapy has not progressed, mostly likely due to poor transfection efficiency. the application of pulsed, high electric fields to facilitate cellular uptake and expression of genes has been a part of the molecular biologist's toolbox for decades. intratumoral injection of pil-12 immediately followed by electroporation, referred to here as pil-12+ep, has been explored in several murine tumor models (123) (124) (125) (126) (127) (128) (129) (130) . as expected, the benefit of adding electroporation was immediately apparent as one early study showed pil-12 alone had no effect on b16f10 tumor growth while pil-12+ep significantly inhibited tumors and extended survival (123) . importantly, the increase in antitumor efficacy was not associated with an increase in systemic il-12 levels (123) . among the more notable responses in other early preclinical studies, nearly half of mice bearing established b16f10 melanomas experienced complete tumor regression following 2 weekly treatments with pil-12+ep (124) . in a follow up study, pil-12+ep induced tumor regression in up to 80% of mice, whereas i.t. injections of pil-12 alone delayed but could not eliminate b16f10 primary tumors (125) . cured mice displayed protective immunity as 20 of 21 rejected a b16f10 challenge (125) . in the sccvii squamous cell carcinoma (scc) model, complete regressions were observed in 40% of mice following pil-12+ep (127). furthermore, 3 of 6 cured mice resisted a tumor challenge containing five times the original dose of tumor cells (127, 128) . against bjmc3879 murine mammary adenocarcinomas, ct26 murine colon adenocarcinomas and renca renal cell carcinomas, pil-12+ep significantly suppressed, but did not eliminate implanted tumors (129, 131) . against murine sa-1 fibrosarcomas, pil-12+ep suppressed tumor growth and induced complete regression in 90% of treated mice with 11 of 18 becoming resistant to tumor rechallenge (132) . in this study, il-12 and ifnγ were detected in the serum of treated mice, however, no side effects were observed (132) . abscopal responses have been documented in several studies. against bilateral sa-1 tumors, pil-12+ep treatment consistently eliminated primary, treated tumors, while slowing the growth of secondary, untreated tumors (132) . similarly, pil-12+ep treatment of mh134 hepatocellular carcinomas, inhibited both treated and untreated tumors while preventing spontaneous pulmonary metastases (133) . a recent study using bilateral b16 tumors demonstrated that an optimized pil-12+ep protocol (134) was capable of regressing treated lesions while inhibiting the growth of contralateral untreated tumors (54) . injecting pil-12 directly into tumors is important as multiple studies have confirmed that i.t. pil-12+ep treatments were significantly more effective than either peritumoral or intramuscular (i.m.) routes (124, 125, 128, 132) . the i.m. route also resulted in significantly more il-12 and ifn-γ in the serum (124, 128) . in terms of mechanism, multiple studies agreed that pil-12+ep treatment was associated with increased t cell infiltration, increased ifnγ expression and decreased angiogenesis (124, 127, 128, 131, 133, 135) . these findings are consistent with known antitumor mechanisms of il-12. more recent mechanistic studies have focused on changes in immune cell phenotype and function. for example, b16f10 tumor regression following pil-12+ep was mediated via the perforin/granzyme lytic pathway while antigen-specific cd8 + t cell responses were directed against tyrosinase-related protein epitope trp2 [180] [181] [182] [183] [184] [185] [186] [187] [188] (136) . in another study, pil-12+ep-induced elimination of b16f10 tumors was associated with increased tumor infiltration and polarization of macrophages toward an m1 phenotype (137) . another group found that pil-12+epinduced antitumor responses against b16f10 tumors were correlated with a reduction in pd-1 expression on cd4 + and cd8 + t cells (138) . yet, another group found that the treatment of bilateral b16f10 tumors induced a unique population of cd8 + effector t cells with low pd-1 expression in both untreated tumors and systemically (54) . this finding suggested that a subset of cd8 + effectors generated by pil-12+ep may be protected or "armored" against checkpoint-mediated exhaustion (54) . a unique feature of pil-12+ep immunotherapy is the potential to manipulate electric field parameters to enhance transfection, and therefore, efficacy. an exploration of electric field parameters demonstrated that pil-12+ep-induced cures ranged from 65 to 80% in b16f10 tumor-bearing mice depending on pulsing conditions (138) . about half of these cured mice resisted a b16f10 rechallenge (138) . by further enhancing electric field intensity and/or pulse length, it is possible to directly kill tumor cells and release tumor antigens via irreversible electroporation. in one recent study, partial-irreversible electropermeabilization (pire) administered after peritumoral electrotransfection with pil-12 caused complete regression of about 40-50% of treated b16f10 tumors (139) . two of 4 cured mice completely resisted tumor rechallenge while the remaining two experienced delayed tumor growth from the rechallenge. this pil-12 plus pire approach was found to delay, but not eliminate distant, untreated tumors in about half of the mice (139) . there have been several attempts to enhance antitumor activity through the incorporation of additional cytokineencoding plasmids. of note, two studies have demonstrated that ep using a combination of il-12 and il-18 plasmids outperformed il-12 alone in terms of antitumor activity (140, 141) . the rationale to combine these two cytokines is wellsupported given that il-12 and il-18 synergize to enhance th1 responses and ifn-γ production. however, adverse events are also enhanced as systemic co-administration of recombinant il-12 and il-18 proteins leads to lethal toxicity in mice (142) . in one study, addition of pil-18 to pil-12 increased serum il-12 and ifn-γ levels for at least 6 days after ep although no inflammation was observed in liver, lung, and intestine samples (140) . in a second study, pil-18 did not increase il-12-induced serum ifn-γ, but intratumoral ifn-γ was significantly higher (141) . several notable canine clinical studies have explored pil-12+ep in dogs with naturally occurring tumors. in one such study, pil-12+ep resulted in a 13-83% reduction in mast cell tumor volume (143) . treated nodules displayed increases in leukocytic inflammation and decreases in the number of malignant mast cells (143) . in beagles with canine transmissible venereal tumors (ctvts), pil-12+ep induced complete regression of all treated lesions (144) . contralateral untreated tumors were also significantly inhibited. serum il-12 levels peaked 7 days after treatment; however, relevant blood chemistries, i.e., liver and kidney enzymes, as well as cell counts were not different from those of control dogs (144) . another study investigated pil-12+ep for the treatment of canine oral malignant melanoma (omm). there were no differences in the percentages of helper cd4 + and cd8 + cells before and after treatment, while t reg frequencies declined from 1.2 to 0.3%. one month post treatment, the objective response rate was 67% (6/9) but by the end of the observation period, all but one of the dogs developed progressive disease (145) . a more recent study in 9 dogs with a range of spontaneous cancers, demonstrated that pil-12+ep induced immunostimulatory and anti-angiogenic effects (146) . administration of three pil-12+ep treatments every other day caused significant systemic toxicities, including anemia and thrombocytopenia. after switching to a weekly schedule, treatments were well-tolerated, however, all treated tumors continued to progress (146) . several human clinical trials, mainly against advanced melanoma, have investigated the safety and efficacy of pil-12+ep. in a phase i study, 24 patients with stage iii or iv melanoma received i.t. pil-12+ep (six 100 µs, 1,300v/cm pulses) on days 1, 5, and 8 during a single 39-day cycle. fifty three percent of patients experienced a systemic response, defined as either stable disease or regression of untreated lesions, following pil-12+ep (147) . most notably, 2 of 19 patients showed complete regression of all metastases. no grade 3 or higher adverse events were observed and neither il-12 nor ifnγ was detectable in serum samples. in a follow up phase ii study, 29 patients with in-transit or m1a melanoma were treated with up to four 12-week cycles of pil-12+ep as described above (148) . intermediate results revealed an objective response rate of 33% with 11% complete responses. the treatment was found to increase nk cell levels both intratumorally and systemically (148) . no grade 3/4 drug-related adverse events were noted. a subsequent analysis of clinical samples revealed that responses were associated with increased intratumoral infiltration of cd3 + t cells (148) . in addition, t cell receptor beta chain (tcrβ) sequencing revealed a focusing of the tcr repertoire following treatment. however, there were no differences in t cell clonality between responders and non-responders to pil-12+ep (148) . a second study from the same trial, nct01502293, found a complete response rate of up to 17.9% and a best overall response rate of 35.7% in patients with stage iii/iv melanoma (149) . nearly half of these patients experienced regression of at least one anenestic lesion. an analysis of transcripts in melanoma biopsies found increases in t cell trafficking, immune activation, and antigen presentation (149) . genes associated with adaptive resistance, e.g., pd-l1, tgfβ, and trail, were also increased (149) . recent results from a safety study in 3 patients with locoregional merkel cell carcinoma (mcc) and 12 patients with metastatic mcc received 1 or up to 4 cycles of pil-12+ep, respectively (150) . the overall response rate in the metastatic mcc cohort was 25% (3/12). of 10 patients with measurable untreated lesions, 3 experienced abscopal regressions. in addition, 2 patients experienced clinical responses lasting 16 and 55+ months, respectively. two of the locoregional mcc patients, all of whom were treated with definitive surgery after pil-12+ep, were recurrence-free at 44+ and 75+ months, respectively (150) . serum il-12 levels were not measured, but treatments were well-tolerated, and no serious adverse events were observed. lipoplexes, polyplexes, and lipopolyplexes are complexes of lipids, polymers, and lipids plus polymers, respectively, with dna. these complexes are under investigation to enhance the delivery and transfection efficiency of plasmids encoding genes of interest, including pil-12. numerous studies have explored a range of different materials to create novel pil-12 complexes (151) (152) (153) (154) (155) . studies demonstrating antitumor efficacy following local or targeted delivery of pil-12 complexes are highlighted below. polyethyleneimine (pei), a highly cationic polymer that readily complexes with negatively charged dna, has been widely used to enhance gene delivery. pei protects dna from degradation in vivo, encourages interaction with negatively charged cell membranes, and enhances release from lysosomes by acting as proton sponge (156) . pei:il-12 complexes were shown to transfect lung tissue following delivery via nebulization (157) . this approach led to production of il-12 in the lungs which was not detectable in the plasma of treated mice (157, 158) . weekly or twice weekly administration of aerosolized pei:il-12 was found to suppress or eliminate experimental pulmonary metastases of saos-2 human osteosarcomas in athymic nude mice (157) . recent attempts to enhance uptake and il-12 production have focused on modification of pei with tetraiodothyroacetic acid (tetrac) which binds the α v β 3 integrin receptor that is overexpressed in some tumors (159) or diethylene triamine penta-acetic acid (dpta) which can reduce the surface charge of pei:il-12 complexes (160, 161) . as of this writing, no in vivo data using either modification have been published. polyvinylpyrridilone (pvp) is another cationic polymer that readily complexes with dna. twice weekly i.t. injections of pil-12/pvp complexes were found to eliminate 30 and 50% of 8-10 mm 3 renca and ct26 tumors, respectively (162) . most mice that were cured of a primary tumor rejected a subsequent rechallenge (162) . in a follow-up study, pil-12/pvp was found to be more effective than pifnα/pvp in controlling preclinical tumors, while the combination of pil-12/pvp and pifnα/pvp synergized to eliminate 100% of renca and 50% of ct26 tumors (163) . in both studies, cd8 + t cells but not cd4 + t cells were identified as primary effectors. complexation with poly-a-(4-aminobutyl)-l-glycolic acid (paga), a biodegradable polyester, enhanced transfection efficiency of pil-12 and expression of il-12 in vitro and in vivo (164, 165) . however, t cell infiltration of injected ct26 colon adenocarcinomas and antitumor activities following repeated injections of paga/pil-12 and naked pil-12 were similar (164) . encapsulation of pil-12 in nanoparticles comprised of poly-(d,l-lactic-co-glycolic acid) (plga) and 1,2-dioleoyl-3-(trimethylammonium) propane (dotap) demonstrated complete regression of up to 75% of established heterotopic bnl hepatocarcinomas following a single i.t. injection (166) . importantly, treatment with encapsulated pil-12 was more effective than treatment with nanoparticles with pil-12 adsorbed to the surface (166) . long term expression of inflammatory cytokines could be a concern as both il-12 and ifnγ were detected in the serum for up to 30 days after treatment (166) . a similar, so-called dmp nanoparticle, comprised of dotap and methoxy-poly(ethylene glycol)-poly(lactide) (mpeg-pla), has been developed to facilitate gene delivery (167) . complexation with pil-12 resulted in inhibition of ct26 tumors with no signs of systemic toxicity, as determined by appearance, body weight, fecal output, and urinary excretion (167) . a slightly different dmp nanoparticle that uses polycaprolactone (pcl) instead of pla, inhibited the growth of intraperitoneal c26 colon carcinomas and ll/2 lewis lung carcinomas (168) . in addition to delaying tumor growth, dmp/il-12 particles resulted in high il-12 gene expression and t cell infiltration although the treatment regimen consisted of 7 daily or every other day treatments (168) . plasmids complexed with mannosylated chitosan (mc) are under development as a method to target mannose receptors on i.t. dcs. chitosan is a linear co-polymer of β-linked dglucosamine and n-acetyl-d-glucosamine. it is primarily derived from the structural polysaccharide, chitin, found in shells of crustaceans. i.t. injection of mc/pil-12 complexes elicited modest growth delay of ct26 tumors, which was associated with increased tumor cell apoptosis and decreased angiogenesis (169) . lipopolymers, which incorporate a lipid tail on a polymer backbone, are also under exploration for non-viral gene delivery. water soluble lipopolymers (wslp) comprised of cholesterol conjugated to pei have been developed to increase cell membrane permeability and reduce pei-mediated toxicity (170) . wslp/p2cmvmil-12 dna complexes inhibited the growth of ct26 tumors and improved survival following a single i.t. injection (170) . however, the antitumor efficacies of wslp/pil-12 complexes and naked pil-12 appeared similar. in a later study, wslp/p2cmvmil-12 complexes injected every 4 days outperformed single injections and multiple injections with naked pil-12 or pei/pil-12 complexes (171) . the vast majority of injected wslp/p2cmvmil-12 was found in the tumor for up to 24 h with small but increasing accumulation in the liver and blood (171) . subsequent studies demonstrated that i.t. wslp/p2cmvmil-12 significantly suppressed the growth of primary and metastatic 4t1, tsa, and emt-6 mammary carcinomas (172, 173) . polytraxane (prx) is a composite molecule made of polyethylene glycol (peg) and cationic cyclodextrin (cd) that self assembles with dna into a spherical particle (174) . a 4-arm configuration, rather than a linear configuration, had a higher accumulation in mc38-luc tumors and lower accumulation in the lungs following systemic delivery. the 4-arm prx/pil-12 also produced higher levels of il-12 and significantly slowed mc38-luc tumor growth after five i.v. injections of the complex starting 10 days after tumor implantation. (174) systemic injections of prx/pil-12 complexes induced moderate lymphopenia, but no elevation of liver enzymes (174) . pil-12 complexed with a polyethyleneglycolpolyethylenimine-cholesterol (ppc) lipopolymer was shown to inhibit 4t1 and sccvii tumors (175) and increase survival in mice with intracranial gl261 gliomas (176) following localized injections. of note, although the i.p. route is frequently used to deliver drugs systemically, i.p. injections of pmil-12/ppc for treatment of id8 ovarian carcinomas resulted in high levels of il-12 and ifn-γ in ascites but low levels in serum (177) . in this study, i.p. pmil-12/ppc was well-tolerated with no significant changes in serum chemistries (177) . in a phase i study, phil-12/ppc was administered i.p. to 13 women with chemo-resistant recurrent ovarian cancer (178) . escalating doses of phil-12/ppc were well-tolerated with no dose-limiting toxicities. five of the 13 treated patients reported a serious adverse event, however, only one was possibly related to the phil-12/ppc (178) . similar to preclinical studies, no detectable increase in serum il-12 was found following phil-12/ppc treatment (178) . a subsequent phase ii study in 20 patients with platinum-resistant recurrent ovarian cancer demonstrated similar safety following weekly i.p. phil-12/ppc, however, with no objective clinical responses observed (179) . a different phase i trial evaluated the safety of phil-12/ppc in ovarian cancer patients when combined with carboplatin and docetaxel chemotherapy (180) . while there were no dose limiting toxicities, grade 3 adverse events included manageable abdominal pain and cytokine release syndrome. two of 12 patients experienced complete response while 4 of 12 experienced a partial response (180) . a more recent phase i trial combined weekly i.p. pil-12/ppc with i.v. pegylated liposomal doxorubicin in 14 patients with persistent or recurrent platinum-resistant ovarian or peritoneal cancers (181) . although increased levels of il-12, ifn-γ, and tnf-α were found in peritoneal fluid, no dose limiting toxicities were observed and a maximum tolerated dose was not reached. the best partial response (28.6%) and stable disease (57.1%) rates were found at the highest dose (36 mg/m 2 ) of pil-12/ppc (181) . pil-12 complexed with a cationic lipid (+/-)-n-(2-hydroxyethyl)-n,ndimethyl-2,3-bis(tetradecyloxy)-1propanaminium bromide/dioleoylphosphatidylethanolamine (dmrie/dope), and injected i.t. was found to inhibit and eliminate ct26 and renca tumors while protecting up to 96 and 100%, respectively, of mice from rechallenge (182) . interestingly, a direct comparison between naked pil-12 and dmrie/dope/pil-12 revealed no difference in antitumor activity (182) . polyphosphazene particles were modified with hydrophobic n,n-diisopropylethylenediamine (dpa) and hydrophilic monomethoxy poly-(ethylene glycol) (mpeg) to create weakly cationic particles to complex with pil-12 (183) . mpeg/pil-12 polymersomes delayed ct26 tumor growth when administered i.v. body weights were unaffected by mpeg/pmil-12 treatments. tumor il-12 levels steadily increased, reaching about 80 pg/g tumor on day 16, while serum il-12 concentration remained on average about 40 pg/ml after day 9 and continued to day 16. the concentration of ifn-γ in the tumor reached a maximum of 350 pg/g tumor on day 9, while serum levels of ifn-γ slightly increased from day 9 to day 16, reaching a concentration of only 4 pg/ml. while mpeg/pmil-12 polymersomes did not affect cd3 + cd4 + cells in the tumor, there was a 2-fold increase of cd3 + cd8 + cells and significant increases of cd3 − nk1.1 + and cd3 + nk1.1 + cells in the tumor. in another study, all-trans-retinoic acid (atra) was incorporated in cationic liposomes and complexed with pil-12 (184) . atra was previously found to increase the expression of tnf receptor 1 and mediate apoptosis of lung cancer cells via tnfα (185, 186) . i.v. injections of atra-cationic liposome/pil-12 reduced lung nodules and extended survival compared to cationic liposome/pil-12 treatment in an experimental pulmonary metastasis model using c26 cells expressing luciferase (184) . concentration of il-12 in the lungs reached a maximum of 12 pg/mg protein at 6 h post injection, while levels of il-12 in the spleen and liver were significantly lower and nearly eliminated by 24 h. interestingly, the incorporation of atra reduced liver enzymes levels and thus hepatic toxicity suggesting a possible anti-inflammatory role (184) . recently, mrna delivery platforms have received tremendous attention, most notably as front running vaccines against sars-cov-2. mrna, like dna, can encode an unlimited number of proteins and polypeptides. although mrna-based platforms are less stable than dna-based platforms, mrna can be protected from digestion through encapsulation in polymeric or lipidbased micro-or nanoparticles. a key advantage of mrna is their ability to directly translate encoded proteins in the cytoplasm. in contrast, dna must first translocate to the nucleus to be transcribed to mrna before translation in the cytoplasm. regarding the use of mrna to deliver il-12 locally, a recent study demonstrated that weekly i.v. delivery of lipid nanoparticles (lnp) loaded with mrna encoding il-12 reduced tumor burden in a myc-driven transgenic mouse model of hepatocellular carcinoma (hcc) (187) . the tumor inhibition and extended survival were attributed to increased infiltration of cd3 + cd4 + cd44 + immune cells and not suppression of myc (188) . similarly, moderna/astrazeneca has developed, medi1191, an lnp formulation with il-12 mrna. medi1191 is currently in phase i clinical trials for intratumoral injection of advanced solid tumors in combination with durvalumab ( table 2 ) (189) . in preclinical studies, a single intratumoral injection of mrna encoding murine il-12 (mil-12) increased ifnγ expression and genes associated with a th1 response in mc38 tumor-bearing mice (190) . when combined with anti-pd-l1, enhanced t cell infiltration and expanded tumor-specific t cell subsets were observed (190) . in another phase i clinical trial, sanofi and biontech are testing sar44100 (bnt131), an mrna platform encoding a cocktail of il-12sc, il-15sushi, ifnα, and gm-csf for intratumoral injection as a monotherapy and in combination with cemiplimab (191) . to our knowledge, no preclinical data with sar44100 have been disclosed. in general, nucleic acid-based il-12 delivery approaches are limited by variable transfection rates as well as unregulated production of gene products. in other words, it is easy to control the amount of pil-12 or il-12 mrna delivered but it is not easy to control the dose of recombinant il-12 that each subject receives. variable transfection rates may be responsible for conflicting reports on whether pil-12+ep does (131-133, 140, 143, 144) or does not (124, 126, 130) produce significant increases in serum il-12 and ifn-γ. fortunately, lethal il-12-related toxicities have not been reported in the any of the preclinical or clinical studies detailed above. nevertheless, the potential for severe il-12-related adverse events caused by continued and/or unregulated production of il-12 remains. strategies to enhance safety and efficacy, either by localizing gene-based il-12 though incorporation of an anchoring or binding domain or by incorporation of an inducible safety switch to turn off il-12 production, will help improve the therapeutic window of promising nucleic-acid-based il-12 delivery technologies. another potential limitation that must be considered, is any type of adverse reaction against components of the delivery vehicle or against the nucleic acid vector itself. regarding the former, foreign delivery components have the potential to induce immune responses which could influence il-12 delivery. most notably, it has been reported that about 7 in 10 humans have circulating anti-peg antibodies (192) . the high prevalence of anti-peg antibodies could limit the efficacy of any peg-based delivery vehicle. regarding the immune responses against il-12 vectors, nucleic acids, particularly dna that is found in the cytoplasm have the potential to stimulate the cgas-sting pathway, which may induce its own inflammatory response. thus, studies utilizing nucleic acid-based delivery must take care to decouple the effects of il-12 from sting activation. lastly, although an exceedingly rare event, dna vectors could become integrated within a cell's genome. depending on the site, such integration could have deleterious or even transforming effects. given that only transient il-12 expression is desirable, strategies capable for preventing integration, like the use of circular instead of linearized plasmids, should be preferred. adenoviruses, herpes simplex viruses, semliki forest viruses, poxviruses, and other viral vectors have been engineered to express biologically active il-12. these engineered viruses injected directly into a tumor are able to infect cancer cells and induce expression of il-12 within the tumor microenvironment. furthermore, many viruses have the unique ability to selectively lyse cancers cells after infection. such oncolytic viruses take advantage of defective cell cycle and interferon signaling pathways that are hallmarks of cancer cells but not normal cells (193) . oncolytic viruses can kill compromised cancer cells in a variety of ways from direct virus-mediated cytotoxicity to indirect destruction of tumor-feeding blood vessels (194) . the following sections discuss the progress and limitations of il-12encoding viral vectors. adenoviruses are the most well-studied among the il-12 expressing vectors (47, (195) (196) (197) (198) (199) (200) (201) . in preclinical studies, i.t. injections of adenoviruses encoding il-12 (ad-il-12) have mediated regressions of murine colorectal carcinomas (202) (203) (204) , breast carcinomas (47, 201, 202) , prostate carcinomas (205, 206) gliomas (207, 208) , bladder carcinomas (209) , fibrosarcomas (202, 210) , laryngeal squamous cell carcinoma (211) , hepatomas (212) and hepatocellular carcinomas (213, 214) medullary thyroid carcinomas (215) , thyroid follicular cancer (216) , and ewing's sarcoma (217) . among the more robust responses, ad-il-12 induced complete regression of subcutaneous neuro-2a neuroblastomas in nearly half of mice receiving a single i.t. injection (218) . mice becoming tumor-free also rejected a subsequent tumor rechallenge (218) . similar results were found against ct26 colon adenocarcinomas with more than three-fourths of mice completely eliminating their tumors and all cured mice rejecting a tumor rechallenge (203) . the antitumor immune response was mediated primarily by cd8 + t cells. impressively, 3 of 7 mice with bilateral tumors experienced complete regression of an untreated tumor (203) . against 6-23 rat medullary thyroid carcinomas, i.t. injection of adtcpmil-12 caused complete regression of more than 60% of treated tumors (215) . all cured rats rejected a tumor rechallenge while separate experiments showed that treatment of a single tumor resulted in inhibition of a distant untreated tumor (215) . while liver infection following i.t. adtcpmil-12 injection was documented, no toxicity was observed (215) . a follow up study found similar antitumor and abscopal responses against rat thyroid follicular cancer (216) . in the pymt-derived transplanted mammary carcinoma model, adenoviral vectors encoding il-12 induced complete regression in 31% and partial regression in 47% of mice (47) . ten of 11 tumor-free mice completely rejected a tumor rechallenge. in contrast with similar studies using ad vectors expressing il-2, no obvious toxic side effects due to admil-12 were noted (47) . in another difficult model, a single i.t. injection of ad.5/3.crgd-mil12p70 resulted in >60% long term survival of mice with intracranial gl261 gliomas (207) . in a murine model of ewing's sarcoma (tc71), twice weekly i.t. injections of ad.mil-12 significantly delayed treated tumors as well as untreated tumors (217) . ad.mil-12 also induced complete regression in all treated mice bearing heterotopic mb49 bladder carcinomas (209) . although body weights were not affected, serum ifn-γ levels due to i.t. ad.mil-12 were maximal from 2 (∼3,500 pg/ml) to 5 days (∼1,500 pg/ml) post injection (209) . in a useful comparison against other cytokines, one study demonstrated that ad-ifn-γ had no greater antitumor activity than an empty ad vector, whereas admil-12 induced complete regressions of p815 mastocytomas in >80% of treated mice (219) . similarly, ad-gm-csf inhibited the growth of frtl-tc rat thyroid tumors, however, adil-12 was found to be much more effective (220) . adil-12 also generated systemic immunity capable of inhibiting the growth of distant tumors (220) . an adenoviral vector expressing a single chain il-12 (scil-12) was developed to enhance bioactivity over the native heterodimeric form (221) . long-term tumor-free survival was observed in up to 90% of rats with established mh-7777a hepatocellular carcinomas following i.t. infections with ad.scil-12 (221) . all tumor-free mice were protected from tumor rechallenge. however, despite i.t. injections, il-12 and ifn-γ were detected in the serum of treated mice (221) . an oncolytic adenovirus expressing single-chain il-12 (ad-dhscil12) was more effective than non-replicating (nononcolytic) adenoviruses expressing il-12 at controlling liver metastases of pancreatic cancer in hamsters (222) . however, il-12 levels in serum and non-tumor tissues were similar (222) . in clinical studies, i.t. ad.il-12 was well-tolerated with no dose-limiting toxicities in a phase i trial in 21 patients with advanced pancreatic, colorectal, or primary liver malignancies (223) . serum ifnγ levels peaked 1 day after ad.il-12 administration and was likely responsible for the 16 grade 3 adverse events observed. one patient had a partial response and 29% of patients experienced stable disease. four of 10 assessable patients experienced increases in tumor infiltrating cd4 + and cd8 + cells. delayed-type hypersensitivity tests with inactivated adenovirus indicated that all patients developed an immune response against the adenovirus (223) . despite robust antitumor immune responses, interest in ad-il-12 waned in the mid-2000s due to the aforementioned lethal toxicities associated with systemic administration of ril-12 and the inability of ad-il-12, even if administered intratumorally, to prevent systemic dissemination of the cytokine. in recent efforts to mitigate systemic il-12 dissemination and associated toxicities, two strategies have been developed. the first involves engineering il-12 to prevent its dissemination. this has been accomplished either by anchoring il-12 to the surface of tumor cells via fusing a transmembrane domain or glycosylphosphatidylinositol (gpi)-anchored signal sequence to the cytokine (224, 225) or by deleting the n-terminal signal peptide and thus preventing il-12 secretion (226) . using the former technology, i.t. injection of an adenoviral vector encoding membrane-anchored il-12 (ad/scil-12-b7tm) eliminated the majority of primary ct26 tumors and suppressed the growth of untreated contralateral tumors (5 out of 5 mice), in which complete regression occurred in 1 out of 5 mice (227). importantly, negligible il-12 was found in the circulation of mice treated with ad/scil-12-b7tm. the second technology deletes the signal peptide from the p35 subunit of il-12 to prohibit il-12 secretion (226) . newly designed oncolytic adenoviral vectors with three genes deleted, i.e., triple deletion (td), and encoding either wild-type il-12 (ad-td-il-12) or a non-secreting il-12 (ad-td-nsil-12) were evaluated in syrian hamster models of pancreatic cancer. six i.t. injections of either ad-td-il-12 or ad-td-nsil-12 were found to eliminate subcutaneous hpd1nr tumors in all mice (226) . against peritoneally disseminated shpc6 tumors and orthotopic hap-t1 pancreatic tumors, ad-td-nsil-12 outperformed ad-td-il-12 in terms of overall survival (226) . most importantly, ad-td-nsil-12 resulted in significantly lower serum il-12 levels and reduced systemic inflammatory cytokine expression (226) . the second strategy to mitigate systemic il-12 dissemination involves conditional expression of il-12. the rheoswitch therapeutic system r (rts) is an ecdysone receptor-based gene regulation platform in which a transcription factor becomes activated only in the presence of a synthetic small molecule ligand (228) . an adenoviral vector encoding the rts switch and mil-12 (ad-rts-mil-12) and controlled by the oral activator, veledimex (vdx) was recently shown to extend survival in mice bearing intracranial gl261 gliomas (229) . intratumoral ad-rts-mil-12 plus oral vdx was found to induce il-12 expression in a dose-dependent manner. local il-12 expression correlated with increases in tumor-infiltrating lymphocytes. il-12 and ifnγ were detected in the sera of treated animals, albeit at an order of magnitude lower than levels found in tumors (229) . several clinical studies utilizing the regulatable ad-rts-il-12 platform are underway ( table 2) . recent results from a phase i study in 31 patients undergoing resection of recurrent highgrade glioma demonstrated that vdx induced il-12 expression in a dose-dependent manner (230) . likewise, the frequency and severity of adverse events, including grade 3 cytokine release syndrome, also increased with vdx dose. demonstrating the advantage of the inducible system, all serious adverse events were reversible with vdx discontinuation. interestingly, the use of corticosteroids negatively impacted survival (230) . at the optimal dose, and in the absence of corticosteroids, the median overall survival of 17.8 months was encouraging (230) . while the localized injection of ad-rts-hil-12 in the resected tumor bed induced il-12 expression in a recurrent tumor microenvironment, systemic dissemination of il-12 and its resultant toxicities could not be avoided. herpes simplex viruses (hsvs) are another family of viruses that have been widely explored for localized il-12 delivery. wild-type hsv are cytolytic and thus must be significantly attenuated or rendered replication-incompetent to avoid systemic infection. injection of replication-incompetent hsv-il-12 into established hepatomas prior to partial hepatectomy inhibited the engraftment of an intraportal tumor cell challenge in preclinical studies (231) . importantly, no changes in serum il-12 were detected in treated buffalo rats (231) . in order to capitalize on their lytic potential, hsvs have been engineered, through deletion or mutation of genes responsible for viral replication such that only cancer cells are lysed. not surprisingly, these oncolytic hsvs (ohsvs) have been shown to exhibit greater antitumor potential than their replicationincompetent, parental counterparts. for instance, treatment of established hepatomas with a non-cytokine encoding ohsv exhibited significant antitumor activity which was further increased with an il-12 insert (232). the ohsv-il-12 treatment was also more effective than ohsv at protecting animals from a tumor rechallenge (232) . similar antitumor responses to ohsv and increased efficacy with ohsv-il-12 were observed against flank ct26 and sccvii tumor models (233) (234) (235) . a single i.t. injection was able to delay the growth of established sccvii tumors whereas multiple injections induced complete regressions in 5 of 6 treated mice (235) . in contrast, multiple injections of ohsv-gm-csf cured only half of treated mice (235) . in the ct26 model, ohsv-il-12 inhibited or eliminated injected 5 mm tumors while inhibiting non-injected, contralateral tumors (236, 237) . when low dose mil-12 was added to i.t. ohsv-il-12, both treated and untreated ct26 tumors were eliminated in more than two-thirds of mice (237) . the importance of t cells in this model was established as ohsv-il-12 had no antitumor effect in ct26-bearing nude mice (236, 237) . intraperitoneal administration of ohsv-il-12 also increased survival in misiir-tag mice bearing ovarian carcinomas (238) . treatment was associated with tumor antigen-specific cd8 + t cell infiltration (238) . against flank sarc-043 and sarc-045 sarcomas, ohsv-il-12 extended survival compared to saline injections (239) . although there was no difference is survival between control and il-12 encoding ohsv, the ohsv-il-12 was found to increase tumor-infiltrating effector t cells while decreasing immunosuppressive mdsc and t reg populations (239) . in an interesting comparison of cytokines, ohsv-il-12 was more effective at inhibiting flank prostate tumors, tramp-c2 and pr14-2, than ohsv encoding gm-csf (ohsv-gm-csf) which was no more effective than non-cytokine encoding ohsv (240) . only 1 of 18 mice treated with ohsv-il-12 exhibited an increase in serum il-12 4 days after treatment (240) . ohsv-il-12 also significantly outperformed ohsv-gm-csf in a model of ct26 metastasis (241) . in addition to localizing il-12, i.t. injections may be key in assuring safety as intrasplenic injections of ohsv-il-12 induced concerning increases in il-12 and ifnγ in both serum and liver specimens (241) . frequent and worthwhile targets of ohsv-il-12 immunotherapy are the various forms of brain cancer. in one early study, ohsv-il-12 was found to extend survival and cure approximately one-fourth of mice bearing 5-day-old intracranial neuro-2a neuroblastomas (242) . treatment was associated with an influx of cd4 + and cd8 + t cells as well as macrophages. the inclusion of il-12 was critical, as median survivals of mice treated with the parental, non-cytokine encoding ohsv or saline were similar (242) . likewise, ohsv-il-12 but not non-cytokine ohsv was effective at extending survival against intracerebral mouse 005 glioblastomas (243) . in an intracranial 4c8 glioma model, ohsv-il-12 was significantly more effective than ohsv at extending survival and curing mice (244) . in a model of breast cancer metastasizing to the brain, i.t. ohsv-il-12 modestly extended the survival of mice bearing intracranial sck tumors (245) . intracerebral injections of ohsv-il-12 in owl monkeys resulted in neither histopathological changes in brain tissue nor clinical evidence of toxicity, as assessed by changes in temperature, neurologic performance, feeding or social behavior, or weight (246) . in addition to encoding cytokines, hsvs can be engineered to target cancer-associated antigens. four i.t. injections of a her2-targeted ohsv-il-12 was significantly more effective at inhibiting both day 3 and day 10 tumors than the non-cytokine encoding parental hsv (day 3: 15/22 ohsv-il-12 vs. 7/20 hsv becoming tumor free; day 10: 3/18 ohsv-il-12 vs. 1/12 hsv becoming tumor free) (247) . immune responses to ohsv-il-12 included elevated levels of ifnγ, il-2, granzyme b, tbet, and tnfα as well as th1 polarization and nk activation (247) . this her-2 targeted ohsv-il-12 was also found to induce complete remission in more than one-fourth of treated mice bearing orthotopic high grade gliomas (hgg) expressing her2 (248) . cured mice were protected from hgg rechallenge regardless of her2 expression (248) . this is an important finding given the heterogeneity of her2 expression among and within tumors. the clinical precedence for hsv has been established with talimogene laherparepvec, which encodes for gm-csf and is approved for intratumoral injection in patients with advanced, non-resectable melanoma. a clinical grade preparation of hsv-1 encoding hil-12 (m032) induced no adverse clinical signs after intracerebral injection in non-human primates (249) . a phase 1 clinical trial exploring the safety of m032 in patients with recurrent or progressive glioblastoma multiforme, anaplastic astrocytoma, or gliosarcoma is currently recruiting [nct02062827]. semliki forest virus (sfv) is an alphavirus that was first isolated from mosquitos in uganda and has a broad range of hosts, making it ideal for translation (250) . in addition, modified sfv can produce higher levels of recombinant protein than retroviral vectors, and expresses protein more stably than adenoviral vectors (251) . sfv is also less pathogenic in humans, and induces apoptosis of tumor cells at the end stage of virulence (250) . sfv encoding il-12 (sfv-il-12) was found to extend the survival of mice with established orthotopic 203 gliomas (252) . because sfv infection induces apoptosis, uptake of infected tumor cells by dendritic cells in the presence of il-12 is posited as a potential mechanism of enhanced antitumor activity. in a b16 brain tumor model, the same group demonstrated a prolonged median survival by 5 days when immunizing with sfv-il-12 pulsed dendritic cells, compared to a retroviral vector encoding il-12 (253) . in a woodchuck hcc model, induced by chronic infection with woodchuck hepatitis virus (whv), using a single intratumoral treatment with sfv-enhil-12, which included 10 separate injections at different sites of one tumor, partial tumor regressions of up to 80% occurred in 5 out of 6 animals (254) . although all tumors regrew after treatment, injections of sfv-enhil-12 resulted in a favorable safety profile with only transient reductions in body weight (254) . in a transgenic mouse model of spontaneous hcc, i.t. sfv-il-12 treatments achieved 100% survival for at least 135 days (255) . interestingly, sfv-il-12, which induces transient infection and expression of il-12, was found to be more effective and less toxic than long-term il-12 expression induced by a plasmid encoding il-12 which was delivered hydrodynamically (255) . i.t. sfv-il-12 inhibited tumor growth and extended survival in mice bearing orthotopic 4t1 mammary carcinomas (256) . when administered neoadjuvant to resection and combined with attenuated salmonella (lvr01) as a post-surgery adjuvant, an impressive 90% long-term tumor free survival was achieved (256) . while there is consensus on its benefits, the mechanism of sfv-il-12-induced tumor regression is debated. initial studies performed in a subcutaneous b16 melanoma model did not find a significant decrease in tumor regression when using t cell-deficient nude or nk cell-deficient beige mice. rather, this group suggested that inhibition of angiogenesis mediated by ifnγ production causes massive tumor necrosis (257) . a decade later, the same group further supported this conclusion using inos deficient mice that express high levels of vegf (258) . the effect of il-12 was even more pronounced, with fewer tumor vessels in inos −/− mice than in wild-type mice given the same treatment with sfv-il-12 (258) . however, they did find immunohistochemical evidence that nk cell activation and recruitment is correlated with murine endothelial cell death (258) . more recently, the efficacy of sfv-il-12 was found to be dependent on type i interferons produced by macrophages and dendritic cells (259) . furthermore, the type i interferon receptor, ifnar, is necessary for il-12-dependent cd8 + t cell expansion (259) . different routes of administration were compared using a subcutaneous p815 model and demonstrated that i.t. injection of sfv-il-12 was superior in producing ifnγ compared to either s.c. or i.v. routes (260) . importantly, none of the sfv-il-12 injections resulted in increased serum levels of ifnγ (260) . the combination of sfv-il-12 with monoclonal antibodies or adjuvants is another strategy that has been studied. by administering sfv-il-12 and anti-cd137 to provide costimulation to t cells, survival was improved in both s.c. b16-ova and s.c. tc-1 models with a maximum longterm survival of 75% in both models (261) . in the bilateral b16-ova model, 90% of treated and 22% of untreated tumors experienced complete regression with 10 8 sfv-il-12 viral particles and anti-cd137 (261) . cd8 + t cells were crucial for this tumor regression and sfv-il-12 increased the ratio of cd8 t/t regs compared to anti-cd137 alone. a subsequent paper further demonstrated that sfv-il-12 induces pd-l1 expression on b16-ova cells and therefore combined pd-1/pd-l1 blockade with the viral construct (262) . this combination significantly enhanced survival compared to individual components using b16-ova and mc38 models, with long-term survival >75% (262) . modifications to improve the performance of sfv-il-12 vectors have also been explored. an enhanced (sfv-enhil-12) vector with separate promoters for each subunit of il-12 increased il-12 expression 8-fold over the single promoter construct (251) . one i.t. injection of 10 8 viral particles using either the original or enhanced constructs resulted in >80% longterm tumor free survival of mc38 tumor-bearing mice (251) . lower doses of sfv-enhil-12 induced tumor regression more efficiently than sfv-il-12, although the enhanced vector induced higher levels of serum il-12 (251) . a separate enhanced sfv vector with 10x higher gene expression, called psfv10-e-il12, has also been developed (263) . this vector also included separate promoters for p40 and p35 with an additional capsid enhancer to drive enhanced expression of the recombinant protein. two helper vectors with instructions for structural proteins were cotransfected with the enhanced sfv to produce virus-like particles (vlps). intratumoral injections in subcutaneous k-balb and ct26 tumors caused complete regression and furthermore inhibited primary tumor growth and reduced metastases in a heterotopic 4t1 model (263) . in an effort to limit undesirable virus-mediated cytotoxicity for intracranial applications, sfv vlps expressing il-12 have been developed (264) . low dose (5 × 10 7 vlps) treatment decreased orthotopic rg2 rat glioma volumes by 70% and extended survival by a little more than 20% over vehicle controls. high dose (5 × 10 8 vlps) treatment resulted in enhanced tumor reduction but also caused cns inflammation, necrosis, and treatment-related death (264) . the broad infectivity of sfv-based vectors is a major limitation to their use in cns applications. vaccinia virus (vv), which was used extensively during the eradication of smallpox, has a large capacity for gene insertion, a wide host range and high gene expression efficiency. vv expressing il-12 (vv-il-12) has been found to inhibit, but not eliminate, c6 gliomas in nude mice following i.t. injection (265) . low vv-il-12 doses, 10 2 -10 4 pfu, and high vv-il-12 doses, 10 5 -10 7 pfu, resulted in similar levels of tumor inhibition (265) . all doses above 10 pfu resulted in cytokine-associated toxicities punctuated with a 40% mortality rate in the high dose group (265) . similar tumor inhibition and mortality were found in a subsequent publication which also correlated high plasma levels of ifnγ and tnfα with toxicity (266) . vv-il-12 and il-2 expressing vv (vv-il-2) exhibited similar inhibition of c6 gliomas (265, 266) however, against ae17 mesotheliomas, vv-il-12 cured 80% of mice compared to only 20% of mice treated with vv-il2 (267) . recently, an oncolytic vv-il-12 was shown to increase lymphocytic infiltration and inhibit llc and b16f10 tumors with 14-25% complete responses (268) . antitumor efficacy was enhanced by the addition of an il-7 expressing vv (vv-il7) as well as immune checkpoint inhibitors (268) . the combination of vv-il-12 and vv-il7 did not affect mouse body weight (268) and appears to be better tolerated than previous vv-il-12 treatments which utilized different vv strains (265, 266) . a recombinant canarypox virus (alvac) encoding il-12 has been shown to induce complete regression of ts/a mammary carcinomas after six i.t. injections, whereas a single i.t. injection of alvac-il-12 had no effect on tumor growth (269) . of the mice that were rendered tumor-free, 70% were protected from a contralateral rechallenge. antitumor activity was driven by il-12 as the alvac vector itself displayed very limited tumor inhibition. in a phase i study in 9 patients with unresectable metastatic melanoma, i.t. injections of alvac-il-12 resulted in increased intratumoral il-12 mrna expression in only 4 of 9 patients (270) . three patients experienced modest increases in serum il-12 and ifnγ levels and no dose-limiting toxicities were observed. one patient had a complete response of an injected lesion and an uninjected in-transit metastases (270) . in a similar phase i study performed by the same group, only 1 of 4 evaluable patients exhibited an increase in intratumoral il-12 mrna after alvac-il-12 administration (271) . attenuated measles viruses (mevac) have been used safely as a vaccine to prevent measles in billions of people. mevac is another type of oncolytic virus which makes it an attractive potential cancer therapy. mevac encoding il-12 (mevac fmil-12) achieved complete regression of carcinoembryonic antigen (cea) expressing mc38 tumors in 90% of mice treated i.t. (272) . mev encoding anti-pd-l1 or igg-fc induced complete regressions in 60 and 40% of treated mice, respectively. antitumor activity was cd8 + t cell dependent and correlated with high levels of intratumoral ifnγ. all mice experiencing complete regressions following mevac fmil-12 also complete rejected tumor rechallenge (272) . a follow up study demonstrated that mevac fmil-12 was more effective at controlling tumors than mev encoding il-15 in two murine tumor models (273) . against mc38-cea tumors, mevac fmil-12 eliminated tumors in all treated mice whereas mev-il15 induced complete tumor regressions in 60% of mice (273) . effects appear to be model dependent as treatment of b16 tumors expressing human cd46 with mev-il-12 and mev-il15 only modestly extended survival (273) . vesicular stomatitis virus (vsv) is another potent oncolytic virus under exploration for cancer therapy. vsvs engineered to express il-12 (vsv-il-12) were recently evaluated in an orthotopic floor of mouth model of sccvii murine squamous cell carcinoma (274) . multiple i.t. injections of vsv-il-12 were more effective at eliminating tumors and induced higher longterm survival rates (40 vs. 0%) compared to non-cytokine encoding vsv (274) . moloney murine leukemia virus (momlv) is a positive sense, single-stranded rna (ssrna) retrovirus. a momlv expressing il-12 was engineered to display an anti-erbb2 scfv against the her2 receptor (275) . eight daily i.t. injections of 6-day-old flank mbt2 tumors was found to result in inhibition and complete regression in about one-fifth of mice treated with the her2targeted momlv-il-12 (275) . a hybrid viral vector which pairs the high infectivity of adenoviruses with the high gene expression of sfv has been engineered to specifically infect and express il-12 in hepatocellular carcinoma cells (276) . in buffalo rats bearing orthotopic mca-rh7777, the adv-sfv hybrid vector expressing il-12 induced complete regression in 4 of 12 treated animals. while the non-hybrid sfv-il-12 induced complete regression in 50% of treated rats, treatment was accompanied by elevated liver enzymes indicating hepatotoxicity (276) . in contrast, liver enzyme levels following administration with the tissue-specific, hybrid vector were no different than levels in saline-treated control rats (276) . newcastle disease virus (ndv) is an oncolytic, enveloped, negative-sense, single-stranded rna virus. ndvs have been engineered to express checkpoint inhibitor molecules and checkpoint inhibitor-cytokine conjugates (277) . although the antitumor activity of i.t. ndv expressing il-12 alone was not tested, 5 i.t. injections of ndv-anti-cd28-mil-12 plus i.p. anti-ctla-4 or ndv-antipdl1-mil-12 plus i.p. anti-ctla-4 resulting in complete responses in 77 or 70%, respectively of mice bearing 9 day-old b16f10 flank tumors (277) . the same treatments of one of two bilateral tumors resulted in 10 and 62% complete responses, respectively, of untreated tumors (277) . a major benefit of virus-based il-12 delivery is high transfection rates, particularly when compared to non-viral vectors. however, virus-based delivery is limited in several aspects. first, neutralizing immune responses including anti-viral antibody production (271, 278, 279) and dth responses (223) may preclude repeated injections with the same vector. however, the extent to which anti-viral immunity limits repeated injections is unclear. mice previously exposed to a viral vector demonstrated a 2.4-fold reduction in intratumoral transgene expression. this level of reduction did not affect antitumor activity; however, the potential exists for reduced antitumor immune responses when lower doses of virus are used (280) . on the positive side, viral dissemination and transgene expression in non-targeted liver tissue was reduced by more than 1,000-fold in mice pre-exposed to the viral vector (280) . secondly, viral il-12 delivery requires transfection of host cells, which has been shown to be highly heterogeneous due to inherent susceptibility or previous exposure to related vectors (223) . in an extreme example of susceptibility, a dose of adcmvmil-12 that was found to be lethal in 100% of treated c57bl/6 mice did not result in a single death in the balb/c strain (281) . livers of c57bl/6 mice exhibited much higher levels of adenovirus transduction (281) . the current coronavirus outbreak further illustrates the point that some individuals appear to be more susceptible than others to viral infections. third, although clinical trials have shown that recombinant viruses are tolerated, viral dissemination, and infection in liver cells following i.t. injection were reported at an alarming degree (282) (283) (284) . even when small volumes (10-20 µl) of recombinant adenoviruses were injected i.t., transgene expression was found in the liver, intestine, spleen, kidney, and brain. as much as 34% of the injected adv infected non-targeted normal tissues (284) . similar levels of transgene expression was found in the liver and tumor 3 days after an i.t. injection (280) . fourth, some viral vectors, such as momlv and mev, can insert their genetic information into an infected cell's genome causing undesirable mutations and uncontrolled longterm expression of il-12. the benefits of using such integrating vectors must be weighed against these risks as other viruses, such as adv, hsv, vsv, and ndv, are non-integrating and induce transient expression (285) . lastly, and most relevant to the topic of localizing il-12, even local injections of viruses encoding il-12 are not able to prevent il-12 dissemination (47, 202, 282, 286, 287) . consequently, antitumor responses and il-12-mediated adverse events are strongly correlated with virus dose. similar to plasmidbased il-12 delivery, novel strategies that anchor il-12 to an injection site or prevent its secretion appear best suited to break this correlation and widen the therapeutic window of virusencoding il-12. dendritic cells (288, 289) , fibroblasts (290, 291) , macrophages (292, 293) , tumor cells (294, 295) , and mesenchymal stem cells (mscs) (296) (297) (298) have all been engineered to express il-12. transduced dcs, fibroblasts, tumor cells, and macrophages have been directly injected into tumors, while mscs have been injected systemically for migration to tumor beds (296, 297) . a much larger number of preclinical and clinical studies have used il-12-transduced tumor cells for s.c. immunization. these studies are not covered in this review as il-12 in this context is functioning as a vaccine adjuvant following injection of transduced cells in healthy, non-cancerous s.c. tissue rather than a strategy to localize il-12 to a tumor. dendritic cells and macrophages have been engineered to express a variety of cytokines including il-12. in addition to supplying the tumor microenvironment with il-12, transduction of these antigen presenting cells increases their ability to induce robust antitumor immune responses. following i.t. injection, dcs and macrophages are capable of capturing tumor antigen, migrating to draining lymph nodes, presenting antigen and priming tumorspecific t cell responses. transfection of antigen presenting cells with il-12 helps polarize t cells to a th1 phenotype and facilitate robust tumor-specific ctl responses (288) . in an early preclinical study, bone marrow-derived dendritic cells (bmdcs) expressing il-12 were more effective than dcs expressing il-2 in controlling the growth of b16f10 melanomas and generating tumor-specific ctl activity (299) . il-12-transduced bmdcs were also found to significantly suppress established mca205 fibrosarcomas, b16 melanomas, d122 adenocarcinomas, and 178-2 bma prostate carcinomas following a single i.t. injection (288, 300, 301) . in one study, 36% of treated mca205 tumors were completely rejected. tumor-free mice also rejected a subsequent mca205 rechallenge (288) . the growth of contralateral, non-treated tumors was also suppressed, implying that systemic tumor-specific immunity can be induced following i.t. injection. il-12-transduced bmdcs were substantially more effective than il-12-transduced fibroblasts or non-transduced bmdcs at inducing tumor-specific ctl activity and ifnγ production by draining lymph node cells and splenocytes (288) . enhanced trafficking of dcs to regional lymph nodes provides a major advantage over non-migratory cells such as il-12transduced tumor cells or fibroblasts. dcs transfected with adenovirus to express il-12 (dc-adcmvil-12) were found to eliminate ct26 and mc38 colon adenocarcinomas in 67-84% and 50% of mice, respectively (289, 302) . mice experiencing complete regression exhibited tumor-specific ctl activity and rejected tumor rechallenge. i.t. injections of adcmvil-12-infected fibroblasts or allogeneic dc-adcmvil-12 were not effective (289) . in a similar study, dc-adcmvil-12 reversed immune suppression mediated by tbj neuroblastomas and induced complete tumor regression (303) . dcs engineered to co-express both il-12 and il-18 displayed synergistic antitumor activity that was greater than either dcencoding cytokine alone (304) . all mice experienced complete regression of cms4 tumors while treated metha tumors were substantially reduced (304) . while serum ifn-γ levels reached 400 pg/ml 2 days after dc administration, no toxicities were noted (304) . bmdcs transfected by simian virus 40 (sv40) to express il-12 or il-15 demonstrated complete regression of ct26 colon adenocarcinomas in 40 or 73% of mice, respectively (305) . there was no synergy between il-12 and il-15 when delivered together. interestingly, maturation of dcs with lps prior to i.t. injection impaired antitumor activity, presumably due to reduced antigen loading in the tumor. however, this hypothesis was not evaluated (305) . transfection of bmdcs isolated from cms4 sarcoma-bearing mice with an adenoviral vector expressing il-12 was shown to restore antigen-presenting and allostimulatory functions (306) . direct injections of the rescued bmdcs were shown to eliminate intrahepatic cms4 tumors and induce protective immunity (306) . dcs can also be isolated from mouse spleens prior to transduction with an il-12 encoding vector. a recent study demonstrated that splenic dcs overexpressing il-12 can inhibit the growth of melanomas in mice (307) . il-12-transduced macrophages are less well-studied, however, like dcs, macrophages have antigen presenting capabilities that can be enhanced by il-12. a single i.t. injection of peritoneal exudate-derived macrophages transduced by admil-12 induced suppression of primary and metastatic 178-2 bma orthotopic prostate tumors (293) . serum il-12 levels peaked 3 days after injection and remained elevated for at least 2 weeks. antitumor activity was correlated with increased leukocytic infiltrate and cytolytic activity (293) . the admil-12-transduced macrophages were found to migrate to draining lymph nodes following i.t. injection. similar to some viral constructs, to reduce the potential for toxicity, il-12 expression can be placed under the control of an inducible promoter. one inducible system consists of 2 cassettes including gal4-ecr;vp16-rxr and il-12. first, gal4-ecr and vp16-rxr are expressed under the constitutive ubiquitin c promoter. the heterodimerization of gal4-ecr and vp16-rxr are triggered by addition of small-molecule ligand, e.g., pharmacologically inert diacylhydrazine. gal4-ecr-vp16-rxr heterodimers bind to a synthetic promoter containing gal4 binding site and induce the expression of il-12 (308) . dcs with inducible il-12 demonstrated inhibition of renca and metha tumors following i.t. administration (309) . combining il-12expressing dcs with either il-21-or ifnα expressing dcs did not improve antitumor efficacy (309) . the ability to turn cytokine expression "on" and "off " is an attractive feature which may potentially allow for better control over cytokine delivery. to date, only one clinical study has been published. in a phase i study, autologous dendritic cells transfected to express il-12 were administered i.t. to patients with metastatic gastrointestinal carcinomas (310) . of the 17 treated patients, one experienced a partial response and two experienced stable disease. serum ifnγ, but not il-12, levels were elevated following treatment. four instances of transient grade 3 lymphopenia were observed, but no grade 4 toxicities were observed. in vitro il-12 production was highly variable, most likely due to differences in susceptibility of dendritic cell infection with adenoviruses encoding il-12 (310) . fibroblasts expressing il-12 caused the elimination of 7-day mca207 tumors in 70-100% of mice after a single peritumoral injection (291) . in addition, local il-12-mediated regression was also able to control tumors on the contralateral flank. as has been shown in other systems, i.t. injections were more effective than distant s.c. injections at controlling tumor growth. repeated injections of il-12-engineered fibroblasts were welltolerated, with no abnormalities detected in liver and renal function tests (291) . a similar peritumoral implantation of alginate encapsulated nih3t3 fibroblasts expressing il-12 was found to inhibit ct26 tumor growth (311) . in a phase i study, peritumoral injections of il-12-transduced autologous fibroblasts induced transient tumor reductions in four of nine patients with disseminated cancers (312) . treatment with fibroblasts capable of secreting up to 5,000 ng of il-12 per day was well-tolerated (312) . mesenchymal stem cells (mscs) are multipotent adult stem cells that divide and differentiate in order to repair skeletal tissues, such as bone, cartilage, and muscle. as such, mscs are predisposed to traffic from bone marrow to a wound site based on expression of soluble factors and unique receptors in damaged tissues. tumors can express many of the same factors and receptors which results in mscs trafficking to, and infiltrating tumors following systemic injections (313) . thus, using il-12 transduced mscs as a "trojan horse" to target tumors and deliver il-12 is a promising approach. in one preclinical study, ad.il-12-transduced mscs inhibited the growth of tc71 human ewing sarcomas in mice (314) . one potential concern about il-12-expressing mscs (msc/il-12) is their tropism for some normal tissues. in the above study, msc/il-12 were found in tumor, liver, lung and spleen tissues but not kidney, heart, or brain tissues 10 days after i.v. injection (314) . in a different study, high levels of msc/il-12 were found in the tumor but not in the liver, lung, and spleen 20 days after administration (297) . earlier time points were not presented. il-12 levels were high in the tumor; however, significant serum il-12 levels were found to persist for at least 2 weeks after msc/il-12 administration (297) . these high levels of intratumoral il-12 resulted in the inhibition of 786-0 renal cell carcinomas in nude mice (297) . in a study that illustrates the importance of tropism, mscs that were non-virally transfected with pil-12 significantly inhibited b16f10 lung metastases but not subcutaneous b16f10 tumors following i.v. administration (315) . only when administered i.t., were msc/il-12 cells able to inhibit s.c. b16f10 tumors (315) . despite the tumor-homing potential of mscs, published data suggest that msc/il-12 may be most effective at treating tumors in tissues where mscs have a natural tropism, e.g., lung, liver and bone (315) . several other studies have favored local over systemic administration of msc/il-12 to treat various tumors. intracranial gl26 glioma-bearing mice treated with i.t. ucb-msc-il12m generated from human umbilical cord blood experienced significantly prolonged survival (316) . specifically, 70% of ucb-msc-il12m treated mice survived more than 90 days post tumor implantation whereas all mice treated with mscs expressing gfp succumbed within 65 days (316) . cured mice were completely protected from ipsilateral and contralateral tumor rechallenge (316) . in another study, bone marrow derived mscs were transfected with a lentivirus to express mil-12 (317) . these lenti-mil-12-mscs reduced the volume of h22 and metha ascites and increased survival when administered i.p. 2 and 7 days after tumor inoculation (317) . no pathological abnormalities were noted on biopsies taken from internal organs of lenti-mil-12-msc treated mice (317) . human mscs transduced with a retroviral vector expressing a modified il-12 (mscs/il-12m) inhibited b16f10 melanomas following five i.t. injections over 3 weeks (298) . safety was implied as no il-12 was detected in the serum following treatment. interestingly, the antitumor activities elicited by i.t. injections of mscs/il-12m and il-12 plasmid dna were similar (298) . in a rare comparison of cytokine delivery technologies, i.t. injections of mscs transfected with rad/il-12m inhibited b16f10 primary and metastatic tumors more effectively than i.t. injections of rad/il-12m alone (318) . despite the homing feature tsa mammary carcinoma cells transduced to secrete il-12 were found to cure 10 of 40 mice bearing 1-day established tsa tumors following local injection (294) . when tumors were allowed to establish for seven days prior to treatment, antitumor efficacy dropped, with only 2 of 40 mice experiencing tumor regression. local delivery of 9l gliosarcoma cells engineered to express il-12 (9l-il12) significantly prolonged the survival of rats challenged intracranially with wild-type 9l tumors (295) . similar results were observed whether the 9l-il12 treatment was given at the same time or 5 days later than the tumor inoculation. the authors noted that only mice receiving the delayed treatment were protected from tumor rechallenge (295) . natural killer (nk) cells and chimeric antigen receptor (car) t cells have also been transduced to produce il-12. in one recent study, primary nk cells isolated from c57bl/6 mice and transduced to express il-12 (nk il−12 ) increased mhc class i expression in ova-transfected melanoma cells (b16m05) compared to mock plasmid transduced nk cells (319) . combination treatment studies involving tumor-specific cytotoxic t lymphocytes (ctls), pegylated il-2, and activated nk il−12 revealed that only groups containing activated nk il−12 demonstrated statistically significant prolonged survival over mock constructs, untreated, and ctl alone controls in b16-ova tumor bearing mouse models. in particular, nk il−12 plus il-2 treatment increased survival by 11.5 days, while nk il−12 plus ctl and il-2 prolonged survival for 16.5 days. nevertheless, all mice eventually succumbed to the disease and no stable tumor regressions were reported (319) . car t cells have shown remarkable efficacy against hematologic malignancies but have yet to achieve clinical benefit against solid tumors. engineering car-t cells to express il-12 is under investigation to improve antitumor efficacy against solid tumors. in one study, i.v. infusion of il-12 expressing anti-vegfr2 car t cells induced curative regressions in 40-80% of mice in five different tumor models including 10-12-day-old b16f10 melanomas, mca-205 sarcomas, mc38 colorectal adenocarcinomas, mc17-51 sarcomas or 12-14 days old ct26 colon adenocarcinomas (320) . t cells singularly transduced with either anti-vegfr-2 or il-12 were markedly less effective (320) . because constitutive systemic expression of il-12 can be toxic, inducible il-12 expression strategies have been developed. by using an nfat-responsive promoter, il-12 could be expressed only after tcr engagement (320) (321) (322) . this modification reduced toxicity but required lymphodepletion to achieve durable tumor regressions (320) . the efficacy of car t cell therapy in general is dependent upon lymphodepletion via chemotherapy or radiotherapy. in an attempt to eliminate the need for lymphodepleting preconditioning, cd19 car t cells expressing il-12 (cd19/il-12) have been investigated (323, 324) . indeed, treatment with cd19/il-12 car t cells significantly enhanced the survival of cd19-el4 tumor-bearing mice vs. treatment with cd19 car t cells (75 vs . 0% survival at day 60 after tumor inoculation) (323) . similarly, second generation cd19/il-12 car t cells produced a 25% long-term survival rate in mice with established a20 b cell lymphomas. without the il-12 insert, all mice treated with cd19 car t cells succumbed to disease (324) . 4h11-28z/il-12 car t cells, which are specific for the muc-16 ecto antigen and secrete il-12, controlled skov3 human ovarian carcinomas in scid-beige mice following i.p. infusion 2 or 4 weeks after tumor implantation (325) . specifically, ∼80 or 100% of mice treated 4 or 2 weeks, respectively, after tumor implantation with 4h11-28z/il-12 car t cells survived for 90 days. in contrast, ∼0% and 20% of mice treated 4 or 2 weeks, respectively, after tumor implantation with 4h11-28z car t cells, not containing the il-12 gene, survived for 90 days (325). glypican-3 (gpc3)-specific car t cells with inducible expression of il-12 (gpc3-28z-nfat-il-12 car t) significantly inhibited or eliminated established plc/prf/5 and huh-7 human hccs (326) . the il-12 secreting car t cells resulted in decreased t reg infiltration. serum ifnγ and il-12 levels were elevated although neither pathological changes to critical organs nor significant loss in body weight were observed (326) . it should be noted, however, that these studies were performed in immunocompromised mice which is not a reliable model for immune-related adverse events. from a clinical standpoint, administrations of il-12-transduced cells have been well-tolerated, with patients experiencing only transient symptoms of lymphopenia, fever, and malaise; however, significant, durable clinical responses have been elusive. from a manufacturing perspective, the transduction of allogeneic and xenogeneic cells is easier and more reproducible. however, these cells are rapidly recognized and rejected by the host immune system. thankfully, recent advances in autologous cell transduction due to the emergence of car t cell immunotherapy has eliminated many concerns related to technical feasibility and patient heterogeneity (310) . local administration of recombinant il-12 protein is the most direct and most quantifiable strategy in terms of ensuring the accuracy and reproducibility of a delivered dose. however, recombinant cytokines disseminate rapidly from local injection sites into the systemic circulation (327) . thus, in order to maintain high levels of recombinant il-12 in the tumor microenvironment while minimizing systemic exposure, sustained delivery technologies, capable of locally releasing proteins and cytokines over extended periods of time following direct injection, are under development (328) . the encapsulation of pharmaceuticals in polymeric microspheres for sustained delivery has been explored for several decades (329, 330) . the use of microspheres to deliver cytokines is a more recent trend. synthetic polymers, such as poly-lactic coglycolic acid (plga), poly-caprolactone (pcl), and poly-lactic acid (pla), that have been widely explored for drug delivery, are being adapted to encapsulate and deliver various cytokines including il-12 (55, (331) (332) (333) (334) (335) . human il-12-loaded pcl:pla microspheres, when co-delivered with human peripheral blood lymphocytes (pbls), were shown to prevent engraftment of human tumors in scid mice (333) . peg-il-2 also suppressed tumor engraftment and growth, but not as effectively as il-12-loaded microspheres. although high levels of il-12 and ifn-γ were found in sera after administration of il-12-loaded microspheres, this localized delivery strategy was more effective at preventing tumor engraftment than repeated i.p. injections of il-12 (336) . similarly, a single i.t. injection of il-12-loaded pcl:pla microspheres outperformed bolus injections of il-12 in the inhibition of human head and neck tumor tissue xenografts containing human pbls (337) . il-12-loaded microspheres completely suppressed engraftment in 50% of mice, whereas il-12 alone slowed but could not eliminate tumor growth (337). in the above xenograft studies, antitumor activity was mediated by cd8 + t cells and cd56 + natural killer cells (333, 337) . in yet another study, lung tumor xenografts using non-disrupted human lung tumor tissue were completely suppressed when injected with il-12-loaded pla microspheres 1 week after implantation (338) . mechanistically, quiescent cd4 + effector memory t cells present within the tumor microenvironment were reactivated upon exposure to high local levels of il-12 (339) . the proliferation of reactivated cd4 + cells and their production of ifn-γ facilitated tumor destruction (339) . in murine tumor models, i.t. injections of il-12-loaded pla microspheres eliminated up to 70% of line-1 lung alveolar carcinomas (332) . in contrast, i.t. injections of free il-12 induced a complete response in only one of five treated mice. interestingly, mice experiencing complete tumor regression following microsphere administration were more resistant to tumor rechallenge than mice vaccinated with either live or irradiated line-1 cells co-injected with il-12-loaded microspheres (332) . in other studies, i.t. injections of il-12loaded pla microspheres significantly reduced the incidence and number of spontaneous pulmonary tumor nodules (331, 340) . when administered neoadjuvant to tumor resection, il-12-loaded microspheres inhibited local recurrence, reduced pulmonary metastases, and improved disease-free survival as compared to resection alone (331) . a similar study using more advanced line-1 tumors, which were 1,000-1,300 mm 3 at study onset, demonstrated that neoadjuvant i.t. injections of il-12-loaded microspheres prevented both local recurrence and pulmonary metastases better than surgery alone (341) . the addition of gm-csf-loaded pla microspheres enhanced antitumor activity and survival. however, more cytokines were not always better, as the addition of low dose il-2 to neoadjuvant immunotherapy with il-12-and gm-csf-loaded microspheres abrogated antitumor immunity (341) . a theme common to nearly all il-12-based immunotherapies was that il-12-loaded microspheres induced cd8 + t cell and nk cell activation, including increases in cytolytic function and ifn-γ expression. in-depth effector mechanisms are elegantly described in a series of papers by egilmez and kilinc et al. (69, 340, (342) (343) (344) (345) . in addition to inducing a strong effector response, a potentially more important feature of i.t. injected il-12-loaded microspheres is their potential to reverse immunosuppression in the tumor microenvironment. for example, a single i.t. injection of il-12-loaded microspheres with and without gm-csf-loaded microspheres induced apoptosis and elimination of tumor-infiltrating cd4 + cd25 + foxp3 + t suppressor cells (69, 344) . il-12-loaded microspheres were also shown to reprogram immunosuppressive tumor-infiltrating macrophages (tims) and tumor-associated macrophages (tams) to a proinflammatory, antitumor phenotype (11, 346) . microsphere platforms are well-suited to explore codelivery of multiple cytokines. the combination of il-12-and tnfα-loaded pla microspheres was shown to be more effective than il-12 and gm-csf-loaded microspheres at eliminating mt-901 mammary carcinomas (347) and b16 melanomas (55) . nearly 70 and 40% of mt-901 tumor-bearing mice were rendered tumor-free following i.t. injections with dual cytokine loaded microspheres of il-12/tnfα and il-12/gm-csf, respectively (347) . dual cytokine loaded microspheres of il-12/tnfα also induced increases in tumor-specific cytokine release from effector cells as compared to microspheres containing either cytokine alone (334) or the combination of il-12 and gm-csf (55, 347) . a single i.t. injection of il-12-and il-18-loaded pla microspheres outperformed injections of either cytokine-loaded microsphere alone in terms of delaying the growth of b16 melanomas (348) . unlike previous studies demonstrating the elimination of 70% of line-1 tumors (332) and impressive reductions in metastatic lesions (331, 341) , il-12-loaded microspheres had no impact on either primary b16 tumor growth or pulmonary metastases (348) . interestingly, the triple combination of il-18/il-12/tnfα loaded in microspheres was found to reduce antitumor activity in the 4t1 model (335) . in her-2/neu transgenic mice, which develop spontaneous, multifocal mammary carcinomas, il-12-and gm-csf-loaded microspheres injected intratumorally caused complete regression of primary tumors in up to 40% of mice (349) . unfortunately, responses were temporary, and all tumors recurred. interestingly, chronic immunotherapy with cytokine-loaded microspheres could not control tumor burden due to a progressive decline in the intensity of antitumor t cells and an increase in tumor-infiltrating cd4 + cd25 + foxp3 + t suppressor cells with repeated injections (349, 350) . subsequent studies have shown that administration of cyclophosphamide can block the postimmunotherapy increase in t suppressor cells (351, 352) . recently, intratumoral delivery of il-12 microspheres (il-12 ms) in combination with stereotactic body radiation (sbrt) resulted in remarkable tumor regression in several types of preclinical pancreatic ductal adenocarcinoma mouse models (353). this study showed that intratumoral levels of ifnγ were enhanced following the treatment of sbrt/il-12 ms, which in turn increased cd8 + t cell activation. sbrt/il-12 ms treatments also established systemic tumor immunity that was confirmed by antitumor effects on liver metastases (353). chitosan (cs) is a bioadhesive polysaccharide derived primarily from the exoskeletons of crustaceans. it is nontoxic, biodegradable, and non-immunoreactive (354) with an established safety profile in humans. co-formulation of il-12 in cs (cs/il-12) has been shown to increase the i.t. residence of il-12 from 1-2 days to 1-2 weeks (23) . cs is believed to hinder il-12 diffusion through viscous and electrostatic interactions. the sustained presence of cs/il-12 induced complete regression of 80-100% of mice bearing mc38, panc02, ct26, e0771, and mb49 tumors (23, 355) . administration of cs/il-12 neoadjuvant to 4t1 tumor resection resulted in complete clearance of lung metastases and long-term survival in about two-thirds of mice. in contrast, all mice treated with surgery alone died within 38 days and mice receiving il-12 without cs neoadjuvant to resection had a median survival of 46 days (52). cured mice rejected a subsequent challenge with live 4t1 cells, but not live renca cells illustrating the specificity of the antitumor immune response. in another demonstration of systemic tumorspecific immunity from localized il-12, 70% of mice bearing both flank and orthotopic mb49 bladder tumors were able to clear the flank tumor following intravesical administration of cs/il-12 (53) . in contrast, mice with only a flank tumor, did not benefit from intravesical cs/il-12 in a naïve bladder. these data indicate that intravesical cs/il-12 induced systemic tumor-specific immunity only when il-12 was localized in or near a tumor. in a subsequent study, orthotopic bladder tumor regression following intravesical cs/il-12 immunotherapy was associated with a rapid infiltration of macrophages and granulocytes followed by increases in cd4 + and cd8 + effector t cells along with a reduction of immunosuppressive t regs and mdscs (14) . importantly, local administrations of cs/il-12 did not result in significant toxicity, such as elevated liver enzymes, commonly observed following regular, free il-12 injections (52) . a polysaccharide gel matrix, designated f2 gel, is comprised of 70% deacetylated poly-n-acetyl glucosamine (p-glcnac) coformulated with lactate salt. p-glcnac gels were evaluated as slow-release cytokine depots for gm-csf, il-2, and il-12 (356) (357) (358) (359) (360) . in particular, i.t. injections of il-2 in p-glcnac gel delayed the growth of ova-transfected ae17 malignant mesotheliomas (359) . interestingly, gm-csf and il-12 depots had no impact on mesothelioma growth, although only a single i.t. injection was given. the p-glcnac gel by itself induced a strong, transient inflammatory response which was thought to be due to a foreign body reaction or toxic species that may have been contained within the gel (361, 362) . human il-12 has been encapsulated in multilamellar liposomes for sustained release after i.t. injection (363) . antitumor activity on xenografts of human lung tissues indicated that liposomal encapsulation is a promising approach capable of eliminating tumor cells and inducing lymphocyte infiltration 2 weeks after i.t. injection. liposomal leakage and/or il-12 liposome dissemination could be problematic following delivery of large doses (10 µg/mouse) as significant sustained levels of il-12 and ifn-γ were found in sera of treated mice (363) . capitalizing on the tumor disruption caused by cationic liposomes, il-12-and tlr4 ligand monophosphoryl lipid a (mpl)-loaded cationic liposomes were injected i.t. to treat 4t1 tumors. this combination produced an abscopal effect which arrested growth in both treated and distal tumors but did not result in tumor elimination (364) . to date, sustained release technologies for recombinant il-12 have not been evaluated in clinical studies. while sustained release technologies are designed to maximize il-12 concentrations in the tumor microenvironment, some amount of delivered il-12 can be expected to reach the systemic circulation. however, due to the infrequency of administration for these long-acting platforms, they are unlikely to induce the same lethal toxicities that were observed following the frequent systemic il-12 administrations in early clinical trials (42) . nevertheless, it will be essential to perform rigorous pharmacokinetic and toxicology studies prior to clinical translation of any sustained recombinant il-12 platform. a possible limitation of the microsphere encapsulation technology is the use of organic solvents during the encapsulation process. organic solvents can denature cytokines immediately or adversely affect long term storage. one study indicated that cytokines lose about half of their bioactivity during microencapsulation (365) . loss of bioactivity appears to be cytokine dependent (366) . specific activity of il-12 after encapsulation in pla microspheres was 90%. however, more than 80% of the bioactivity of il-12 was lost when pla/il-12 microspheres were stored for 8 days (366) . in addition, because many commonly used biodegradable polymers are comprise of acidic monomers, polymer degradation often forms highly acidic microenvironments that may inactivate cytokines (188) . a number of techniques are under investigation to either raise ph (367) or stabilize encapsulated cytokines (368) . a common limitation of liposomal carriers is their inherent leakiness, and therefore the choice of lipid and modifications to stabilize the bilayer are critical for sustained release. high temperature phase-transition lipids, such as dspc, increase the retention of cargo and enhance drug circulation time. incorporation of cholesterol into the lipid bilayer increases the rigidity and further decreases leakage of interior cargo (369) . another major limitation of liposomes is opsonization by serum proteins and clearance by phagocytes of the reticuloendothelial system (res). pegylation can reduced res clearance, however, peg can sterically inhibit ligand-cell interaction (370) . if administered i.t., loss of tumor targeting is likely not detrimental. while some localized il-12 immunotherapies have shown limited efficacy in clinical studies, a long-awaited breakthrough leading to widespread application of localized il-12 as a monotherapy does not appear imminent. however, there are a number of near-term opportunities to combine localized il-12 with traditional or experimental cancer management approaches. and in fact, most contemporary experimental therapies for aggressive or advanced cancers involve combination approaches. thus, near future opportunities involving translatable combination approaches are explored in the following sections. the majority of cancer patients with solid tumors undergo tumor resection as part of their treatment. surgery, by itself, is unable to prevent recurrence and/or metastasis which is responsible for 9 out of 10 cancer-related deaths. patients at high risk of recurrence receive adjuvant chemotherapy and/or radiotherapy following resection. while chemotherapy and radiotherapy may help reduce the risk of recurrence, they induce life-altering side effects and fail in a significant fraction of patients. as a result, most metastatic cancers arise from previously treated non-metastatic disease (371) (372) (373) . administration of localized il-12 to the tumor microenvironment prior to surgery has the potential to reduce recurrence rates and/or eliminate occult metastases through the induction of systemic, tumor-specific immunity. as mentioned above, our own investigation demonstrated that neoadjuvant i.t. injections of cs/il-12 prior to resection can improve overall survival from 0 to 65% in a highly metastatic 4t1 breast carcinoma model (52) . cured mice demonstrated tumor-specific immunity via tumor rechallenge, ctl activity, and elispot assays. if proven to be safe, localized il-12 can be administered neoadjuvant to any solid tumor resection, not just in high risk patients. in fact, at the time of surgery, it is likely that a significant fraction of patients already has occult metastases that cannot be detected via radiographic imaging. the median primary breast tumor size for which 100% of patients had micrometastases was found to be only 1.8 cm (374) . while most immune-oncology trials focus on developing therapies for metastatic disease, an approach, such as neoadjuvant localized il-12, capable of preventing metastasis in the first place, may be a more effective strategy to reducing cancer mortality. the combination of il-12-based immunotherapy and chemotherapy ("biochemotherapy") is also under exploration. several clinical studies have shown significant clinical benefit when certain cytotoxic drugs are combined with il-12 (181, 375, 376) . there are three distinct advantages for combining chemotherapy with il-12 immunotherapy. first, chemotherapy provides a debulking benefit with the elimination of some or most of the tumor. second, some chemotherapeutics can deplete immunosuppressive cells. cyclophosphamide has been shown to deplete t regs while 5-fluorouricil and gemcitabine have been shown to deplete mdscs. third, some chemotherapies cause upregulation of t cell-attracting chemokines in the tumor (377) . for example, melanoma-bearing mice treated with temozolomide, cisplatin, or dacarbazine increase expression of ccl5, cxcl9, and cxcl10 (378) . the timing of chemotherapy relative to local il-12 immunotherapy is expected to be critical. unlike the neoadjuvant resection approach mentioned above, chemotherapy should be administered prior to il-12 therapy to avoid elimination of beneficial proliferating immune cells. chemotherapy may synergize with il-12 by reducing tumor burden and creating a source of tumor antigen for in situ vaccination. in fact, certain chemotherapies can induce an immunogenic cell death that is capable of priming an antitumor immune response (379) . to date, several examples demonstrate the promise of chemotherapy plus local il-12 delivery. antitumor efficacy of pil-12/ppc is improved with paclitaxel, cyclophosphamide, or taxol/paraplatin (172, 175, 177) . the antitumor effect of il-12 lipoplexes against intracranial glioma was substantially improved when combined with fda-approved carmustine (bcnu) wafers (176) . finally, a phase-1 clinical trial found that intraperitoneal il-12 gene therapy in combination with intravenous pegylated liposomal doxorubicin resulted in greater clinical benefit relative to the chemotherapeutic alone (57.1% vs. 40-45.3%) in patients (n = 11) with platinum-resistant epithelial ovarian cancer (181) . standard-of-care radiotherapy of inoperable tumors can be administered prior to local il-12 delivery. radiation-induced tumor cell death can supply a source of tumor antigens, while radiation has been shown to upregulate co-stimulatory molecules on the surface of tumor cells which makes them more susceptible to immune-mediated killing (380) . the addition of tumor irradiation after pil-12+ep was found to improve antitumor activity (130) . similarly, radiotherapy improved the antitumor activity of i.t. oncolytic adenoviruses expressing il-12 and gm-csf (381) . it has also been found that radiotherapy can induce infiltration of mscs in the tumor site. through a combination of radiation and il-12-expressing mscs, both primary tumor growth and metastases were reduced in hca-i and hepa 1-6 hepatoma models (382) . in another study, radiation along with an i.t. injection of an il-12-encoding adenoviral vector greatly reduced tumor growth and metastasis compared to either treatment alone in a bnl-p2 hepatocellular carcinoma model, while a near-complete abscopal response occurred in a ct26 colorectal cancer model (383) . an abscopal response was also induced in a fully humanized rhabdomyosarcoma xenograft model. mice with bilateral tumors were treated with a combination of single-tumor radiation and systemic nhs-il12, which resulted in significantly lower tumor burdens than either individual treatment (114) . cryoablation, radiofrequency ablation (rfa), microwave ablation (mwa), embolic microspheres and high intensity focused ultrasound (hifu) are routinely used in the clinic to destroy some operable and many inoperable solid tumors. irreversible electroporation is another ablative technology in clinical and preclinical development (384) (385) (386) (387) . all of these strategies have the potential to induce in situ vaccinations through the release of tumor antigen, although abscopal responses or robust anti-tumor immune responses are rare. among the ablation strategies, cryoablation appears distinct from most other ablation approaches that kill via high temperatures and result in coagulation, enzyme inactivation, and antigen denaturation. cryoablation is thought to mostly preserve tumor antigen structure (388, 389) and has been shown to induce greater levels of tumor antigen uptake by dendritic cells compared to rfa (390) . in addition, cryoablation also induces higher levels of inflammatory cytokines, such as il 1, il 6, and tnfα, compared to rfa and mwa (391, 392) . perhaps most importantly, cryoablation was recently shown to induce expansion of oligoclonal t cells both in tumor tissues and in peripheral blood of kidney cancer patients (393) . the addition of localized il-12 to the above ablation strategies may enhance tumor control as well as antitumor immunity. our recent preclinical data, demonstrated that the combination of cryoablation and cs/il-12 could eliminate multiple tumor types and induce abscopal immunity in a bilateral flank model (394) . ongoing studies are aimed at determining mechanisms of systemic tumor control. immune checkpoint inhibitors are ineffective against noninflamed, "cold" tumors. localized il-12 induces profound intratumoral infiltration that can be expected to synergize with checkpoint inhibitors. indeed, the addition of anti-pd-1 or anti-ctla-4 improved the antitumor activity of l19-il-12 in multiple murine tumor models (395) . similarly, systemic anti-ctla-4 in combination with intratumoral il-12 induced synergistic antitumor responses in gl-26 glioblastoma and sma-560 astrocytoma models (396) . also, as mentioned in a previous section, i.t. injections of vv-il-12 and vv-il7 enhanced the responsiveness of poorly immunogenic tumors to checkpoint inhibition (268) . finally, a recent phase ii study of i.t. pil-12+ep and systemic pembrolizumab in patients with non-infiltrated melanomas resulted in a 41% objective response rate with 36% complete responses (397) . correlative studies demonstrated increased antigen cross-presentation along with enhance t cell infiltration and activity leading to higher than expected clinical responses (397) . il-12 enhances cytotoxic t and nk cell activity while reversing tumor-induced immunosuppression, inhibiting angiogenesis, increasing lymphocyte trafficking and antigen presentation either directly or through induction of ifnγ (398) . based on these diverse mechanisms as well as its profound antitumor activity in numerous preclinical studies, il-12 is arguably one of, if not, the most potent antitumor cytokine evaluated to date. unfortunately, the much-anticipated clinical translation of il-12-based immunotherapies suffered a tremendous setback in the late 1990s/early 2000s due to severe clinical toxicities associated with systemic il-12 injections. through the development of several clever approaches to localize il-12 to the tumor microenvironment while limiting systemic exposure, il-12-based immunotherapies are making a comeback. several clinical studies evaluating localized il-12 have been initiated ( table 2 ) with more on the way. while each delivery strategy has limitations, the approaches reviewed above may retain enough il-12 in the tumor while eliminating the need for frequent systemic injections. by reducing the potential for il-12-mediated toxicities associated with systemic injections, localized il-12 can expand the therapeutic window and finally allow il-12 to fulfill its considerable potential. as exemplified by the current immune-oncology clinical trial landscape, combination approaches appear to be most effective for accelerating clinical impact. several promising preclinical combination approaches with localized il-12 are likely to be translated in the near future. there is unprecedented interest in finding immunomodulators that can enhance lymphocytic infiltration in order to improve the efficacy of checkpoint inhibitors. localized il-12, based on its ability to drive th1 responses, enhance cytolytic activity, and protect t cells from pd-1/pd-l1 exhaustion and ifnγ-induced apoptosis may be an ideal partner for checkpoint inhibitors. if safety concerns are assuaged, localized il-12 could be used in earlier stage cancer patients as a neoadjuvant to resection. for tumors that are inoperable, combining localized il-12 with ablation may help increase local as well as distant tumor control. with the interesting combination approaches, as well as the uptick in il-12-based immunotherapies in clinical trials, there is reason to believe that localized il-12 may play a major role in cancer immunotherapy in the near future. studies on the pathogenesis of fever. ii. characterization of fever-producing substances from polymorphonuclear leukocytes and from the fluid of sterile exudates anticancer cytokines: biology and clinical effects of interferon-alpha2, interleukin (il)-2, il-15, il-21, and il-12 melanoma: therapeutic options with recombinant interferons results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy high-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and (1993) talimogene laherparepvec improves durable response rate in patients with advanced melanoma coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor identification and purification of natural killer cell stimulatory factor (nksf), a cytokine with multiple biologic effects on human lymphocytes cloning of cdna for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on t and natural killer cells cloning and expression of murine il-12 il-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo the role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis interleukin-12: a master regulator immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer. oncoimmunology differential effects of il-12 on tregs and non-treg t cells: roles of ifn-gamma, il-2 and il-2r il-12 triggers a programmatic change in dysfunctional myeloidderived cells within mouse tumors antiproliferative effects of four different cytokines on renal carcinoma cell lines ifn-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro inhibition of angiogenesis in vivo by interleukin 12 inhibition of tumor-induced angiogenesis by the administration of recombinant interferon-gamma followed by a synthetic lipid-a subunit analogue (gla-60) cellular responses to interferon-gamma interleukin-12 in anti-tumor immunity and immunotherapy intratumoral immunotherapy of established solid tumors with chitosan/il-12 effect of interleukin 12 on tumor induction by 3-methylcholanthrene therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased antitumour cytotoxic t-lymphocyte activity the anti-tumor activity of il-12: mechanisms of innate immunity that are model and dose dependent antitumor and antimetastatic activity of interleukin 12 against murine tumors phase i evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma phase i trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma interleukin-12 therapy of cutaneous t-cell lymphoma induces lesion regression and cytotoxic t-cell responses phase i study of intraperitoneal recombinant human interleukin 12 in patients with mullerian carcinoma, gastrointestinal primary malignancies, and mesothelioma phase 1 study of the intravesical administration of recombinant human interleukin-12 in patients with recurrent superficial transitional cell carcinoma of the bladder a phase ii trial of interleukin-12 in patients with advanced cervical cancer: clinical and immunologic correlates. eastern cooperative oncology group study e1e96 nk and cd8+ t cell-mediated eradication of poorly immunogenic b16-f10 melanoma by the combined action of il-12 gene therapy and 4-1bb costimulation intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor activity of subcutaneous interleukin-12 in aids-related kaposi sarcoma phase ii clinical trial of interleukin-12 in patients with relapsed and refractory non-hodgkin's lymphoma and hodgkin's disease peripheral burst of tumor-specific cytotoxic t lymphocytes and infiltration of metastatic lesions by memory cd8+ t cells in melanoma patients receiving interleukin 12 after initial setback, il-12 regaining popularity interleukin 12: still a promising candidate for tumor immunotherapy? effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production evaluation of recombinant human interleukin-12 in patients with recurrent or refractory ovarian cancer: a gynecologic oncology group study randomized multicenter phase ii trial of subcutaneous recombinant human interleukin-12 versus interferon-alpha 2a for patients with advanced renal cell carcinoma selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal patterns of vasculature in mouse models of lung cancer are dependent on location direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12 co-delivery of antigen and il-12 by venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects right time and place for il12: targeted delivery stimulates immune therapy new insights into il-12-mediated tumor suppression gene therapy of cancer based on interleukin 12 neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis intravesical chitosan/interleukin-12 immunotherapy induces tumorspecific systemic immunity against murine bladder cancer characterization of abscopal effects of intratumoral electroporation-mediated il-12 gene therapy neoadjuvant intratumoral cytokine-loaded microspheres are superior to postoperative autologous cellular vaccines in generating systemic anti-tumor immunity repeated administrations of interleukin (il)-12 are associated with persistently elevated plasma levels of il-10 and declining ifn-gamma, tumor necrosis factor-alpha, il-6, and il-8 responses transcriptionally active stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma ifn-gamma regulates donor cd8 t cell expansion, migration, and leads to apoptosis of cells of a solid tumor ifn-gamma-mediated upmodulation of mhc class i expression activates tumor-specific immune response in a mouse model of prostate cancer ifn-gamma-mediated inhibition of tumor angiogenesis by natural killer t-cell ligand, alpha-galactosylceramide interferon: a cytotoxic t lymphocyte differentiation signal il-2 and ifn-gamma are two necessary lymphokines in the development of cytolytic t cells gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors interferon and major histocompatibility complex genes: a model to analyse eukaryotic gene regulation? placebo-controlled phase iii trial of patient-specific immunotherapy with mitumprotimut-t and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a gm-csf gene in previously treated pancreatic cancer cancer immunotherapy comes of age cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment reversing tumor immune suppression with intratumoral il-12: activation of tumor-associated t effector/memory cells, induction of t suppressor apoptosis, and infiltration of cd8+ t effectors use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. a preliminary report il-12 priming during in vitro antigenic stimulation changes properties of cd8 t cells and increases generation of effector and memory cells synergy of brief activation of cd8 t-cells in the presence of il-12 and adoptive transfer into lymphopenic hosts promotes tumor clearance and anti-tumor memory ex vivo interleukin-12-priming during cd8 + t cell activation dramatically improves adoptive t cell transfer antitumor efficacy in a lymphodepleted host ex vivo conditioning with il-12 protects tumor-infiltrating cd8 + t cells from negative regulation by local ifn-gamma cutting edge: il-12 and type i ifn differentially program cd8 t cells for programmed death 1 re-expression levels and tumor control switching on of the proliferation or apoptosis of activated human t lymphocytes by ifn-gamma is correlated with the differential expression of the alpha-and beta-chains of its receptor clinical trial listed in this table meet the following four criteria: 1) involve a delivery technology; 2) be administered locally, i.e. intratumoral or peritumoral; 3) use il-12 as an effector and 4) demonstrate antitumor activity of il-12. clinical trials listed in this table include: 1) nhs-il12 for solid tumors 14) a first-in-human dose escalation and expansion study to evaluate intratumoral administration of sar441000 as monotherapy and in combination with cemiplimab in patients with advanced solid tumors antibody-il-12 fusion proteins are effective in scid mouse models of prostate and colon carcinoma metastases bifunctional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer a single-chain il-12 igg3 antibody fusion protein retains antibody specificity and il-12 bioactivity and demonstrates antitumor activity mechanism of antitumor activity of a single-chain interleukin-12 igg3 antibody fusion protein (mscil-12.her2.igg3) cytokines fused to antibodies and their combinations as therapeutic agents against different peritoneal her2/neu expressing tumors long-term immunity elicited by antibody-cytokine fusion proteins protects against sequential challenge with murine mammary and colon malignancies amino acid residues involved in the heparin-binding activity of murine il-12 in the context of an antibody-cytokine fusion protein modulation of interleukin-12 activity in the presence of heparin molecular mechanisms of heparin-induced modulation of human interleukin 12 bioactivity species-specific differences in heparin-induced modulation of il-12 family cytokines efficient production and purification of recombinant human interleukin-12 (il-12) overexpressed in mammalian cells without affinity tag novel immunocytokine il12-ss1 (fv) inhibits mesothelioma tumor growth in nude mice prognostic value and characterization of the ovarian cancer-specific antigen ca166-9 construction, expression, and function of 6b11scfv-mil-12, a fusion protein that attacks human ovarian carcinoma an il12-il2-antibody fusion protein targeting hodgkin's lymphoma cells potentiates activation of nk and t cells for an anti-tumor attack expression of the extra domain b of fibronectin, a marker of angiogenesis, in head and neck tumors hubc1-il12, an immunocytokine which targets edb-containing oncofetal fibronectin in tumors and tumor vasculature, shows potent anti-tumor activity in human tumor models a phase 1 study of as1409, a novel antibody-cytokine fusion protein, in patients with malignant melanoma or renal cell carcinoma phase i trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain ifn-gamma induction is associated with clinical response an engineered antibody-interleukin-12 fusion protein with enhanced tumor vascular targeting properties enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix engineered vascular-targeting antibody-interferon-gamma fusion protein for cancer therapy enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy collagen-binding il-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours a dose-escalation and signal-generating study of the immunocytokine l19-il2 in combination with dacarbazine for the therapy of patients with metastatic melanoma targeted reconstitution of cytokine activity upon antigen binding using split cytokine antibody fusion proteins a new chemically modified chimeric tnt-3 monoclonal antibody directed against dna for the radioimmunotherapy of solid tumors the immunocytokine nhs-il12 as a potential cancer therapeutic characterization of a phage display-derived human monoclonal antibody (nhs76) counterpart to chimeric tnt-1 directed against necrotic regions of solid tumors temporal changes within the (bladder) tumor microenvironment that accompany the therapeutic effects of the immunocytokine nhs-il12 enhanced antitumor effects by combining an il-12/anti-dna fusion protein with avelumab, an anti-pd-l1 antibody combination therapy with nhs-muil12 and avelumab (anti-pd-l1) enhances antitumor efficacy in preclinical cancer models cancer-targeted il-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation tumortargeted il-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo. oncoimmunology enhanced binding of necrosis-targeting immunocytokine nhs-il12 after local tumour irradiation in murine xenograft models defining the pharmacodynamic profile and therapeutic index of nhs-il12 immunocytokine in dogs with malignant melanoma first-in-human phase i trial of a tumor-targeted cytokine (nhs-il12) in subjects with metastatic solid tumors immunogenicity to biotherapeutics -the role of anti-drug immune complexes tumor regression of human and murine melanoma after intratumoral injection of il-12-encoding plasmid dna in mice in vivo induction of interferon gamma expression in grey horses with metastatic melanoma resulting from direct injection of plasmid dna coding for equine interleukin 12 intratumoral injection of dna encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy intratumoral injection of il-12 plasmid dna-results of a phase i/ib clinical trial effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation il-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous b16.f10 melanoma il-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a b16 mouse melanoma model regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy administration route-and immune cell activation-dependent tumor eradication by il12 electrotransfer intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma in vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas local and systemic antitumor effect of intratumoral and peritumoral il-12 electrogene therapy on murine sarcoma electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model improving therapeutic efficacy of il-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters systemic administration of interleukin-12 can restore the antitumor potential of b16 melanoma-draining lymph node cells impaired at a late tumor-bearing state intratumoral electroporation of il-12 cdna eradicates established melanomas by trp2(180-188)-specific cd8+ ctls in a perforin/granzyme-mediated and ifn-gamma-dependent manner: application of trp2(180-188) peptides gene electrotransfer of plasmid-encoding il-12 recruits the m1 macrophages and antigen-presenting cells inducing the eradication of aggressive b16f10 murine melanoma il-12 gene electrotransfer triggers a change in immune response within mouse tumors pre-clinical investigation of the synergy effect of interleukin-12 gene-electro-transfer during partially irreversible electropermeabilization against melanoma in vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice combination of il-12 and il-18 of electro-gene therapy synergistically inhibits tumor growth coadministration of interleukin-18 and interleukin-12 induces a fatal inflammatory response in mice: critical role of natural killer cell interferongamma production and stat-mediated signal transduction electrogene therapy with interleukin-12 in canine mast cell tumors electroporation-mediated il-12 gene therapy in a transplantable canine cancer model a combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine il-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer phase i trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma intratumoral plasmid il12 electroporation therapy in patients with advanced melanoma induces systemic and intratumoral t-cell responses intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients intratumoral delivery of plasmid il12 via electroporation leads to regression of injected and noninjected tumors in merkel cell carcinoma integrin-targeted nanocomplexes for tumour specific delivery and therapy by systemic administration conjugation of poly(amidoamine) dendrimers with various acrylates for improved delivery of plasmid encoding interleukin-12 gene preparation and characterization of gelatin nanoparticles containing pdna encoding il-12 and their expression in ct-26 carcinoma cells preparation and characterization of chitosan/beta-cyclodextrin nanoparticles containing plasmid dna encoding interleukin-12 efficient gene delivery by egf-lipoplexes in vitro and in vivo polyethylenimine: a versatile, multifunctional nonviral vector for nucleic acid delivery aerosol gene therapy with pei: il-12 eradicates osteosarcoma lung metastases eradication of osteosarcoma lung metastases following intranasal interleukin-12 gene therapy using a nonviral polyethylenimine vector tetraiodothyroacetic acid-conjugated polyethylenimine for integrin receptor mediated delivery of the plasmid encoding il-12 gene enhanced delivery of plasmid encoding interleukin-12 gene by diethylene triamine penta-acetic acid (dtpa)-conjugated pei nanoparticles delivery of plasmid encoding interleukin-12 gene into hepatocytes by conjugated polyethylenimine-based nanoparticles intratumoral delivery of il-12 gene by polyvinyl polymeric vector system to murine renal and colon carcinoma results in potent antitumor immunity combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma biodegradable polymer-based interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity soluble biodegradable polymer-based cytokine gene delivery for cancer treatment in vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma modified nanoparticle mediated il-12 immunogene therapy for colon cancer local and systemic delivery of interleukin-12 gene by cationic micelles for cancer immunogene therapy mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in balb/c mice bearing ct-26 carcinoma cells intratumoral delivery of p2cmvmil-12 using water-soluble lipopolymers tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2cmvmil-12 complexes combination of local, nonviral il12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model local, non-viral il-12 gene therapy using a water soluble lipopolymer as carrier system combined with systemic paclitaxel for cancer treatment development of self-assembled multi-arm polyrotaxanes nanocarriers for systemic plasmid delivery in vivo synthesis and application of a non-viral gene delivery system for immunogene therapy of cancer a safety and efficacy study of local delivery of interleukin-12 transgene by ppc polymer in a model of experimental glioma treatment of disseminated ovarian cancer using nonviral interleukin-12 gene therapy delivered intraperitoneally phase-i clinical trial of il-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer a phase ii trial of intraperitoneal egen-001, an il-12 plasmid formulated with peg-pei-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study phase i trial of a formulated il-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer a phase i trial of intraperitoneal gen-1, an il-12 plasmid formulated with peg-pei-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: an nrg oncology/gynecologic oncology group study intratumoral injection of interleukin-12 plasmid dna, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model cationic polyphosphazene vesicles for cancer immunotherapy by efficient in vivo cytokine il-12 plasmid delivery enhanced growth inhibition of metastatic lung tumors by intravenous injection of atra-cationic liposome/il-12 pdna complexes in mice retinoic acid receptors and cancers all-trans-retinoic acid upregulates tnf receptors and potentiates tnf-induced activation of nuclear factors-kappab, activated protein-1 and apoptosis in human lung cancer cells lipid nanoparticles that deliver il-12 messenger rna suppress tumorigenesis in myc oncogene-driven hepatocellular carcinoma visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (plga) microspheres a study of medi1191 in sequential and concurrent combination with durvalumab in subjects with advanced solid tumors abstract 5017: medi1191, a novel il-12 mrna therapy for intratumoral injection to promote th1 transformation of the patient tumor microenvironment a first-in-human dose escalation and expansion study to evaluate intratumoral administration of sar441000 as monotherapy and in combination with cemiplimab in patients with advanced solid tumors analysis of pre-existing igg and igm antibodies against polyethylene glycol (peg) in the general population viruses as anticancer drugs oncolytic virotherapy adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12 adenovirus-mediated expression of interleukin-12 induces natural killer cell activity and complements adenovirus-directed gp75 treatment of melanoma lung metastases construction and characterization of a recombinant adenoviral vector expressing human interleukin-12 intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases antitumor mechanism of intratumoral injection with il-12-expressing adenoviral vector against il-12-unresponsive tumor the antitumor effects of adenoviralmediated, intratumoral delivery of interleukin 23 require endogenous il-12 induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12 regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12 role of nk and t cells in il-12-induced anti-tumor response against hepatic colon carcinoma adenovirusmediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model attenuation of the glucocorticoid response during ad5il-12 adenovirus vector treatment enhances natural killer cell-mediated killing of mhc class i-negative lncap prostate tumors depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma in situ adenoviral interleukin 12 gene transfer confers potent and longlasting cytotoxic immunity in glioma eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cdnas for the il-12 heterodimer and its inhibition by the il-12 p40 subunit homodimer a single intratumoral injection of a fiber-mutant adenoviral vector encoding interleukin 12 induces remarkable anti-tumor and anti-metastatic activity in mice with meth-a fibrosarcoma growth suppression of human laryngeal squamous cell carcinoma by adenoviral-mediated interleukin-12 enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on cd1-restricted natural killer t cells gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12 effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12 gene therapy of a rat follicular thyroid carcinoma model with adenoviral vectors transducing murine interleukin-12 intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant ewing's sarcoma neuroblastoma regression and immunity induced by transgenic expression of interleukin-12 high frequency of specific cd8+ t cells in the tumor and blood is associated with efficient local il-12 gene therapy of cancer thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model low-dose adenoviral immunotherapy of rat hepatocellular carcinoma using single-chain interleukin-12 treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in syrian hamsters phase i trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors membrane-tethered proteins for basic research, imaging, and therapy tumor therapy applying membrane-bound form of cytokines re-designing interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent cancer immunotherapy using a membrane-bound interleukin-12 with b7-1 transmembrane and cytoplasmic domains the rheoswitch system for inducible up-and down-regulation of gene expression regulated intratumoral expression of il-12 using a rheoswitch therapeutic system((r)) (rts((r))) gene switch as gene therapy for the treatment of glioma regulatable interleukin-12 gene therapy in patients with recurrent highgrade glioma: results of a phase 1 trial neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing il-12 effectively treats the parent tumor and protects against recurrence-after resection interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12 cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma in situ cancer vaccination: an il-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity augmentation of antitumor immune responses by multiple intratumoral inoculations of replicationconditional hsv and interleukin-12 il-12 expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice newly characterized murine undifferentiated sarcoma models sensitive to virotherapy with oncolytic hsv-1 m002 enhanced therapeutic efficacy of il-12, but not gm-csf, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers cytokine-secreting herpes viral mutants effectively treat tumor in a murine metastatic colorectal liver model by oncolytic and t-cell-dependent mechanisms engineered herpes simplex virus expressing il-12 in the treatment of experimental murine brain tumors multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model preclinical evaluation of oncolytic deltagamma(1)34.5 herpes simplex virus expressing interleukin-12 for therapy of breast cancer brain metastases preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12 a fully-virulent retargeted oncolytic hsv armed with il-12 elicits local immunity and vaccine therapy towards distant tumors eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic hsv in a preclinical model evaluation of the safety and biodistribution of m032, an attenuated herpes simplex virus type 1 expressing hil-12, after intracerebral administration to aotus nonhuman primates the molecular pathogenesis of semliki forest virus: a model virus made useful? semliki forest virus vectors engineered to express higher il-12 levels induce efficient elimination of murine colon adenocarcinomas induction of a therapeutic antitumor immunological response by intratumoral injection of genetically engineered semliki forest virus to produce interleukin-12 marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing semliki forest virus-mediated interleukin-12 semliki forest virus expressing interleukin-12 induces antiviral and antitumoral responses in woodchucks with chronic viral hepatitis and hepatocellular carcinoma short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas neoadjuvant administration of semliki forest virus expressing interleukin-12 combined with attenuated salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice transfer of the murine interleukin-12 gene in vivo by a semliki forest virus vector induces b16 tumor regression through inhibition of tumor blood vessel formation monitored by doppler ultrasonography the anti-angiogenic activity of il-12 is increased in inos-/-mice and involves nk cells strict requirement for vector-induced type i interferon in efficacious antitumor responses to virally encoded il12 immunotherapy with recombinant sfv-replicons expressing the p815a tumor antigen or il-12 induces tumor regression immunotherapeutic synergy between anti-cd137 mab and intratumoral administration of a cytopathic semliki forest virus encoding il-12 virotherapy with a semliki forest virus-based vector encoding il12 synergizes with pd-1/pd-l1 blockade regression of mouse tumours and inhibition of metastases following administration of a semliki forest virus vector with enhanced expression of il-12 semliki forest virus-mediated gene therapy of the rg2 rat glioma low-dose vaccinia virus-mediated cytokine gene therapy of glioma evaluation of cytokine toxicity induced by vaccinia virus-mediated il-2 and il-12 antitumour immunotherapy cytokine-armed vaccinia virus infects the mesothelioma tumor microenvironment to overcome immune tolerance and mediate tumor resolution intratumoral expression of il-7 and il-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade canarypox virus-mediated interleukin 12 gene transfer into murine mammary adenocarcinoma induces tumor suppression and long-term antitumoral immunity intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma phase i study of the intratumoral administration of recombinant canarypox viruses expressing b7.1 and interleukin 12 in patients with metastatic melanoma oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through t cell activation. oncoimmunology immunological effects and viral gene expression determine the efficacy of oncolytic measles vaccines encoding il-12 or il-15 agonists interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma enhancement of antitumor activity of gammaretrovirus carrying il-12 gene through genetic modification of envelope targeting her2 receptor: a promising strategy for bladder cancer therapy increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector engineering newcastle disease virus as an oncolytic vector for intratumoral delivery of immune checkpoint inhibitors and immunocytokines immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human il-2 cdna: induction of cd8 + t-cell immunity and nk activity effect of viral dose on neutralizing antibody response and transgene expression after aav1 vector re-administration in mice pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing il-12 but inhibits virus dissemination genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12 systemic vector leakage and transgene expression by intratumorally injected recombinant adenovirus vectors systemic dissemination of viral vectors during intratumoral injection in vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector gene therapy leaves a vicious cycle intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12 intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo cancer immunotherapy of established tumors with il-12. effective delivery by genetically engineered fibroblasts therapeutic effects of gelatin matrix-embedded il-12 gene-modified macrophages in a mouse model of residual prostate cancer macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (il-12) or other cytokines compared with exogenous il-12 paracrine delivery of il-12 against intracranial 9l gliosarcoma in rats expression of interleukin-12 by adipose-derived mesenchymal stem cells for treatment of lung adenocarcinoma. thorac cancer therapeutic potential of human mesenchymal stem cells producing il-12 in a mouse xenograft model of renal cell carcinoma anti-tumor activity of mesenchymal stem cells producing il-12 in a mouse melanoma model enhancement of antitumor immunity against b16 melanoma tumor using genetically modified dendritic cells to produce cytokines route of administration influences the antitumor effects of bone marrowderived dendritic cells engineered to produce interleukin-12 in a metastatic mouse prostate cancer model augmented anti-tumor effect of dendritic cells genetically engineered by interleukin-12 plasmid dna upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12 interleukin-12 transduced dendritic cells induce regression of established murine neuroblastoma intratumoral delivery of dendritic cells engineered to secrete both interleukin (il)-12 and il-18 effectively treats local and distant disease in association with broadly reactive tc1-type immunity intratumoral injection of dendritic cells transduced by an sv40-based vector expressing interleukin-15 induces curative immunity mediated by cd8+ t lymphocytes and nk cells injection of il-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity intratumoral injection of dendritic cells overexpressing interleukin12 inhibits melanoma growth conditional interleukin-12 gene therapy promotes safe and effective antitumor immunity therapeutic effect of intratumoral administration of dcs with conditional expression of combination of different cytokines intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas continuous release of interleukin 12 from microencapsulated engineered cells for colon cancer therapy interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase i study concise review: mesenchymal stem cell tumorhoming: detection methods in disease model systems murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into ewing sarcoma tumors reversal of tumor growth by gene modification of mesenchymal stem cells using spermine-pullulan/dna nanoparticles gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells mesenchymal stem cells genetically modified by lentivirus-mediated interleukin-12 inhibit malignant ascites in mice the effects of mesenchymal stem cells injected via different routes on modified il-12-mediated antitumor activity adoptive transfer of natural killer cells promotes the anti-tumor efficacy of t cells local delivery of interleukin-12 using t cells targeting vegf receptor-2 eradicates multiple vascularized tumors in mice il-12 release by engineered t cells expressing chimeric antigen receptors can effectively muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression improving adoptive t cell therapy by targeting and controlling il-12 expression to the tumor environment tumor-targeted t cells modified to secrete il-12 eradicate systemic tumors without need for prior conditioning cd19 car t cells expressing il-12 eradicate lymphoma in fully lymphoreplete mice through induction of host immunity il-12 secreting tumor-targeted chimeric antigen receptor t cells eradicate ovarian tumors in vivo armored inducible expression of il-12 enhances antitumor activity of glypican-3-targeted chimeric antigen receptor-engineered t cells in hepatocellular carcinoma chitosan solution enhances the immunoadjuvant properties of gm-csf sustained release technology and its application in environmental remediation: a review designing hydrogels for controlled drug delivery recent advances in hydrogel based drug delivery systems for the human body neoadjuvant therapy with interleukin-12-loaded polylactic acid microspheres reduces local recurrence and distant metastases in situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity cytokines delivered by biodegradable microspheres promote effective suppression of human tumors by human peripheral blood lymphocytes in the scid-winn model synergistic effect of intratumoral il-12 and tnf-alpha microspheres: systemic antitumor immunity is mediated by both cd8+ ctl and nk cells intratumoral delivery of encapsulated il-12, il-18 and tnf-alpha in a model of metastatic breast cancer antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/scid mouse model human cd4+ t cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of il-12 to kill tumors in situ by indirect effects of ifn-gamma human cd4+ effector memory t cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of il-12 to proliferate, produce ifn-gamma, and eradicate tumor cells transient activation of tumor-associated t-effector/memory cells promotes tumor eradication via nk-cell recruitment: minimal role for long-term t-cell immunity in cure of metastatic disease cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease dichotomous effects of ifn-gamma on dendritic cell function determine the extent of il-12-driven antitumor t cell immunity central role of tumorassociated cd8+ t effector/memory cells in restoring systemic antitumor immunity activated cd8+ t-effector/memory cells eliminate cd4+ cd25+ foxp3+ tsuppressor cells from tumors via fasl mediated apoptosis central role of ifngamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity rapid release of cytoplasmic il-15 from tumor-associated macrophages is an initial and critical event in il-12-initiated tumor regression intratumoral il-12 and tnf-alpha-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity generation of a tumor-specific systemic response after intratumoral injection of il-12 and il-18-loaded polylactic acid microspheres il-12 + gm-csf microsphere therapy induces eradication of advanced spontaneous tumors in her-2/neu transgenic mice but fails to achieve long-term cure due to the inability to maintain effector t-cell activity chronic immune therapy induces a progressive increase in intratumoral t suppressor activity and a concurrent loss of tumor-specific cd8+ t effectors in her-2/neu transgenic mice bearing advanced spontaneous tumors chronic chemoimmunotherapy achieves cure of spontaneous murine mammary tumors via persistent blockade of posttherapy counterregulation effect of chitosan properties on immunoreactivity intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12 characterization of a sustained-release delivery system for combined cytokine/peptide vaccination using a poly-n-acetyl glucosamine-based polymer matrix sustained release of granulocyte-macrophage colony-stimulating factor from a modular peptide-based cancer vaccine alters vaccine microenvironment and enhances the antigen-specific t-cell response paracrine release of il-12 stimulates ifn-gamma production and dramatically enhances the antigen-specific t cell response after vaccination with a novel peptide-based cancer vaccine intratumoral poly-n-acetyl glucosamine-based polymer matrix provokes a prolonged local inflammatory response that, when combined with il-2, induces regression of malignant mesothelioma in a murine model using poly-n-acetyl glucosamine gel matrix to deliver il-12 with anti-schistosomasis vaccination evaluation of the biocompatibility of a chitosan scaffold in mice biocompatibility evaluation of crosslinked chitosan hydrogels after subcutaneous and intraperitoneal implantation in the rat il-12 delivered intratumorally by multilamellar liposomes reactivates memory t cells in human tumor microenvironments adjuvant cationic liposomes presenting mpl and il-12 induce cell death, suppress tumor growth, and alter the cellular phenotype of tumors in a murine model of breast cancer cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft/scid mouse model characterization of cytokine-encapsulated controlled-release microsphere adjuvants stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) biodegradable microand nanoparticles as long-term delivery vehicles for interferon-alpha challenges in development of targeted liposomal therapeutics advances and challenges of liposome assisted drug delivery surgery for cancer: a trigger for metastases chemotherapy-induced metastasis in breast cancer radiotherapy targeting cancer stem cells "awakens" them to induce tumour relapse and metastasis in oral cancer biological behavior of human breast cancer micrometastases a novel synergistic combination of cyclophosphamide and gene transfer of interleukin-12 eradicates colorectal carcinoma in mice a phase i clinical trial of adoptive t cell therapy using il-12 secreting muc-16(ecto) directed chimeric antigen receptors for recurrent ovarian cancer the next challenge in cancer immunotherapy: controlling t-cell traffic to the tumor chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring t-cell infiltration and tumor control immunogenic effects of chemotherapy-induced tumor cell death radiation-induced effects and the immune system in cancer a novel combination treatment of armed oncolytic adenovirus expressing il-12 and gm-csf with radiotherapy in murine hepatocarcinoma irradiation-induced localization of il-12-expressing mesenchymal stem cells to enhance the curative effect in murine metastatic hepatoma combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment the role of irreversible electroporation (ire) for locally advanced pancreatic cancer: a systematic review of safety and efficacy irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer systematic review of surgical and percutaneous irreversible electroporation in the treatment of locally advanced pancreatic cancer high-frequency irreversible electroporation is an effective tumor ablation strategy that induces immunologic cell death and promotes systemic anti-tumor immunity immunologic response to cryoablation of breast cancer thermal ablation of tumours: biological mechanisms and advances in therapy synergy between in situ cryoablation and tlr9 stimulation results in a highly effective in vivo dendritic cell vaccine changes in interleukin-1beta and 6 after hepatic microwave tissue ablation compared with radiofrequency, cryotherapy and surgical resections image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10 characterization of the cryoablation-induced immune response in kidney cancer patients abscopal immunity achieved via in situ vaccination using a novel combination of cryoablation and interleukin-12 the antibody-based delivery of interleukin-12 to solid tumors boosts nk and cd8 + t cell activity and synergizes with immune checkpoint inhibitors intratumoral il-12 combined with ctla-4 blockade elicits t cell-mediated glioma rejection phase ii trial of il-12 plasmid transfection and pd-1 blockade in immunologically quiescent melanoma revisiting interleukin-12 as a cancer immunotherapy agent abbreviations a-nk il−12 or activated nk il−12 , activated primary natural killer (nk) cells transduced to express il-12 adcmvil-12 or adcmvmil-12, recombinant defective adenovirus expressing il-12 or mil-12 under control of a cmv promoter adenoviral vector expressing murinedil-12 protein under the control of the hcmv promoter and sv40 polyadenylation sequences; ad-dhscil12, adenovirus with replication dependent on hypoxia-inducible factor (hif) activity expressing single-chain il-12; ad-il-12 or adil-12 or ad.il-12 or admil-12 or ad.mil-12 inducible adenoviral vector engineered to express il-12 under the control of the rheoswitch therapeutic system r (rts) gene switch adtcpmil-12, recombinant replication-defective adenoviral vector expressing murine interleukin-12 (mil-12), driven by a modified calc-i promoter oncolytic triple-deletion (td) adenoviral vector encoding wild-type il-12 oncolytic triple-deletion (td) adenoviral vector encoding non-secreting il-12 antibody-dependent cellular cytotoxicity; ad.scil-12, adenoviral vector expressing single-chain il-12 ad5-ycd/muttksr39rep-hil12, a replication-competent oncolytic adenovirus encoding the murine pro-inflammatory cytokine interleukin-12 (il-12) gene and two suicide fusion genes, a yeast cytosine deaminase (ycd) and a mutant form of herpes simplex virus type 1 thymidine kinase /3.crgd-mil12p70, a replication-deficient double targeted ad5 backbone-based vector carrying a chimeric ad5/3 fiber with integrin-binding rgd motif incorporated in its ad3 knob domain expressing murine il-12p70 adenoviral vector encoding membrane-anchored murine single-chain il-12 with b7-1 transmembrane and cytoplasmic domains atra-cationic liposome/il-12 pdna, pil-12 complexed with cationic liposomes incorporating all-trans-retinoic acid chimeric antigen receptor; cbd, collagen binding domain; cbd-il-12, collagen-binding immunocytokine comprised of a3 cbd of von willebrand factor fused to both subunits of il-12 chtnt-3/huil-12, necrosis-targeting immunocytokine comprised of huil-12 fused to the variable heavy chain of chtnt-3 antibody dendritic cells transfected with adenovirus expressing il-12 under control of the cmv promoter enzyme-linked immune absorbent spot fda, food and drug administration; gm-csf, granulocyte-macrophage colony-stimulating factor glypican-3-specific car t cells with nfat-inducible expression of il-12 herpes simplex viruses (hsv) encoding il-12; hubc1-il12, immunocytokine comprised of two molecules of il-12 fused to each of the igg heavy chains of humanized bc-1 antibody immunocytokine comprised of il-12 fused to the fc fragment of humanized ks antibody; hu-14.18-il-12, immunocytokine comprised of il-12 fused to gd2 targeting hu14 dmp/il-12, pil-12 complexed with dmp cationic micelles 3-dimyristyloxypropyl)-n,n-dimethyl-(2-hydroxyethyl)ammonium bromide/dioleoyl phosphatidylethanolamine (dmrie/dope) cationic lipids; il-12, interleukin-12; il-12m, modified il-12; an n-glycosylation mutant of il-12 at asn220; il12-il2, immunocytokine comprised of il-12 and il-2 fused to anti-cd30 scfv antibody immunocytokine comprised of il-12 fused to l19 scfv antibody; il12-msa, il-12 fused to mouse serum albumin (msa) il-12 fused to mouse serum albumin (msa) and lumican, a collagen-binding proteoglycan immunocytokine comprised of p35 subunit of single-chain il-12 fused to ss1, a mesothelin-binding single-chain variable fragment lenti-mil-12-mscs, bone-marrow derived mscs transfected with lentivirus to express il-12 mc/pmil-12, pmil-12 complexed with mannosylated chitosan (mc) myeloid-derived suppressor cells mevac fmil-12, attenuated measles viruses (mevac) encoding il-12 histocompatibility complex; momlv-mil-12, moloney murine leukemia virus (momlv) expressing il-12; mpeg/pmil-12, polymersomes comprised of pmil-12 complexed with polyphosphazene particles modified with dpa and mpeg; mscs, mesenchymal stem cells; mscil-12.her2.igg3, mouse single-chain il-12 fused mesenchymal stem cells (mscs) expressing il-12; l19-mil12, immunocytokine comprised of murine il-12 fused to l19 scfv antibody; nhs-il12, necrosis-targeting immunocytokine comprised of two single-chain il-12 molecules fused to fulllength nhs76 antibody; nhs-muil12, murine analog of nhs-il12; nk cells a biodegradable polyester; pbl, peripheral blood lymphocytes; pd-1, programmed cell death protein 1; pd-l1, programmed death-ligand 1; pei:il-12, il-12 complexed with polyethyleneimine (pei); pil-12 enhanced sfv vector with 10x higher gene expression of recombinant il-12 protein; rad/il-12m, recombinant adenovirus expressing il-12m; rndv-anti-cd28-mil-12, newcastle disease virus (ndv) expressing immunocytokine comprised of anti-cd28 antibody fused to mil-12; rndvanti-pdl1-mil-12, newcastle disease virus (ndv) expressing immunocytokine comprised of anti-pdl1 antibody fused to mil-12; rsfv/il12, recombinant semliki forest viruses (sfv) encoding il-12; rvsv-il12, recombinant vesicular stomatitis virus (vsv) encoding il-12; rvv-mil-12 severe combined immunodeficient; scil-12, single-chain il-12; sfv-il12, semliki forest viruses encoding il-12 sfv-il-12, semliki forest viruses encoding il-12 tumor associated macrophages; tlr, toll-like receptor; tnf, tumor necrosis factor; ucb-msc-il12m, human umbilical cord blood-derived mesenchymal stem cells (ucb-mscs) expressing il-12m vv-il-12, vaccinia virus (vv) expressing il-12 il-12 expression plasmid complexed with water-soluble lipopolymers car t cells which are specific for the muc-16ecto antigen and secrete il-12; 6b11scfv-mil-12, immunocytokine comprised of mil-12 fused to scfv of 6b11 antibody key: cord-267671-ys43n672 authors: whary, mark t.; baumgarth, nicole; fox, james g.; barthold, stephen w. title: biology and diseases of mice date: 2015-07-10 journal: laboratory animal medicine doi: 10.1016/b978-0-12-409527-4.00003-1 sha: doc_id: 267671 cord_uid: ys43n672 today’s laboratory mouse, mus musculus, has its origins as the ‘house mouse’ of north america and europe. beginning with mice bred by mouse fanciers, laboratory stocks (outbred) derived from m. musculus musculus from eastern europe and m. m. domesticus from western europe were developed into inbred strains. since the mid-1980s, additional strains have been developed from asian mice (m. m. castaneus from thailand and m. m. molossinus from japan) and from m. spretus which originated from the western mediterranean region. laboratory animal medicine development of the 'modern' laboratory mouse. research use of mice has grown exponentially during the past and current century with the recognition of the power of the mouse for gene and comparative mapping and have made the laboratory mouse, in genetic terms, the most thoroughly characterized mammal on earth (silver, 1995; lyon et al., 1996; morse, 2007a) . the current ability to create highly sophisticated, genetically engineered mice by inserting transgenes or targeted mutations into endogenous genes has also made the laboratory mouse the most widely and heavily used experimental animal. historical reviews have documented the origins of the laboratory mouse, which extend thousands of years into antiquity (keeler, 1931; morse, 1978; silver, 1995) . the laboratory mouse belongs within the genus mus, subfamily murinae, family muridae, superfamily muroidea, order rodentia, and within the m. musculus clade collectively called the 'house mouse' (lundrigan et al., 2002) . anatomic features of molar teeth and cranial bones were traditionally used by zoologists to identify over 100 different species within the genus, and to differentiate them from other murids. because of considerable phenotypic variation within a single mus species, this approach has proven to be inaccurate, and given way to contemporary genetic analysis. the native range of the genus mus is eurasia and north africa. members of this genus are generally classified as aboriginal, consisting of species that live independent of humans, or commensal, which includes taxa that have coevolved and geographically radiated with human civilization since the dawn of agriculture 12,000 years before present (bp). this close association with human agrarian society gave rise to the genus name, derived from sanskrit, mush: to steal. the commensal group is known as the 'house mouse' clade, consisting of several subspecies of mus musculus, including m. m. domesticus, m. m. musculus, m. m. castaneus, m. m. bactrianus , and a lesser known lineage, m. m. gentilulus (prager et al., 1998) . the japanese house mouse, m. m. molossinus, is a natural hybrid of m. m. musculus and m. m. castaneus. the progenitor of the m. musculus clade arose in the northern indian subcontinent and diverged into genetically isolated and distinct species or subspecies due to geographic barriers (mountain ranges). there is debate whether these taxa are species or subspecies, and some have referred to them as 'incipient species,' but their genetic divergence is now blurring as they colonize the world and hybridize. the native ranges of these taxa are important for understanding the origins of various laboratory mice, whose genomes are mosaics derived from m.m. domesticus (~60%), m.m. musculus (~30%), and m.m. castaneus (~10%) (wade and daly, 2005; wade et al., 2002) . it is now apparent that the m.m. musculus and m.m. castaneus contributions to the laboratory mouse genome were primarily derived from m.m. molossinus japanese fancy mice (takada et al., 2013) . mus m. domesticus is indigenous to western europe and southwest asia, m.m. musculus to eastern europe and northern asia, m.m. castaneus to southeast asia, and m.m. molossinus to japan and the korean peninsula. the cohabitation of humans with commensal mice gave rise to captive breeding for coat color and behavioral variants in china over 3000 years bp. by the 1700s, mouse 'fanciers' in asia had created many varieties of fancy mice, as did european fanciers, who subsequently acquired asian stocks, particularly japanese fancy mice (m.m. molossinus) , to mix with european (m.m. domesticus) fancy mouse varieties. this genetic mixing for fancy variants was also occurring in the united states, and these mouse lines contributed to many of the major laboratory mice used today. meanwhile, the european colonial expansion era contributed to the worldwide dissemination of m.m. domesticus, which now occupies every continent of the world. it is well documented that wild-caught m.m. domesticus also contributed to the genetic composition of fancy and laboratory mice on multiple occasions. despite their diverse genetic origins and phenotypic differences, most laboratory mouse strains are closely related, since many were derived from a genetically mixed but small number of fancy mice from a single mouse breeder (abbie lathrop's granby mouse farm, massachusetts) at the beginning of the 20th century. most inbred laboratory mice share a common maternal mitochondrial genome derived from m.m. domesticus (ferris et al., 1982; yu et al., 2009) , and a common y chromosome contributed by m.m. musculus (bishop et al., 1985) through its contribution to the genome of m.m. molossinus (nagamine et al., 1992) . thus, the most inclusive name that can be assigned to the genetically mosaic laboratory mouse is m. musculus, the over-arching name for the entire commensal clade. there are exceptions, however. c57bl/6 mice contain minor genetic elements derived from m. spretus (hardies et al., 2000) , and a number of wild aboriginal species that are not members of the m. musculus clade, including m. spretus, m. caroli, and others, have been established as inbred lines of mice. genetic mapping in mice began in the early 1900s with a focus on inheritance of coat color. the first autosomal genes, albino and pink-eyed dilution, were linked in 1915 (haldane et al., 1915) . extensive linkage maps and an impressive array of inbred strains are now available to expedite genetic research (table 3 .1) (lyon et al., 1996) . mice have 20 pairs of telocentric chromosomes that are differentiated by their size and patterns of transverse bands. the chromosomes are designated by arabic numbers in order of decreasing size. during the 1970s, chromosome rearrangements were used to assign known genetic linkage groups -identified by roman numerals -to specific chromosomes and for determining locus order with respect to the centromere. genes can be located physically on chromosomes by fluorescent in situ hybridization (fish). development of quantitative trait loci (qtl) methodology for mapping genes and the similarity between mouse and human genomes have made the mouse invaluable for identifying genes and underlying complex traits that are inherent to the most common human genetic diseases (moore and nagle, 2000) . for more information on comparative genomics, see chapter 35 animal models in biomedical research, subsection c. one of the most thoroughly studied genetic systems of the mouse is the histocompatibility complex. histocompatibility (h) loci control expression of cell surface molecules that modulate critical immune responses, such as the recognition of foreign tissue. for example, the time, onset, and speed of skin graft rejection are controlled by two groups of h loci. the major group is located in the major histocompatibility complex (mhc, h2) on chromosome 17. the h2 complex contains several loci, including k, d, l, i-a, and i-e. inbred strains of mice, being homozygous, each have unique sets of h2 alleles, termed h2 haplotypes. for example, the balb h2 haplotype is h2 d and the c57bl h2 haplotype is h2 b . the international immunogenetics (imgt) information system provides details on h2 haplotypes for various inbred mice (www.imgt.org/imgtrepertoiremhc/polymorphism/ haplotypes/mouse/mhc/mu_haplotypes.html). minor h loci groups are scattered throughout the genome and are responsible for delayed graft rejection. genes associated with the h2 complex also control other immunological functions, such as cell-cell interactions in primary immune responses and the level of response to a given antigen. immune-mediated responses to infectious agents such as viruses and complement activity are influenced directly or indirectly by the h2 complex (stuart, 2010) . non-mhc or minor histocompatibility systems also are under active study (roopenian et al., 2000) . mouse genomics have accelerated tremendously in the last two decades, heralded by the development of a robust physical map and high-quality genome sequence of the c57bl/6j mouse in 2002 by the international mouse genome sequencing consortium (waterston et al., 2001) . the mouse genomes project/wellcome trust sanger institute is extending this effort to include the genomic sequences of 17 key mouse strains. completed and evolving sequence data are available through the european nucleotide archive (www.ebi.ac.uk/ena/home). the burgeoning numbers of inbred mouse strains, natural mutants, induced mutants, transgenic lines, and targeted mutant lines of mice are cataloged in the mouse genome informatics (mgi) database: http://www.informatics.jax.org/mgihome). the growing number of mutant mice has fostered the development of a number of mouse repositories, from which specific mice can be located and acquired. in the united states, there are four regional national institutes of health (nih)-supported mutant mouse regional resource centers (http://www.mmrrc.org), which link to international repositories in europe, japan, china, australia, and canada, as well as additional resource programs in the united states through the international mouse strain resource (imsr; http://www.informatics.jax.org/ imsr/index.jsp) for depositing, archiving, and distributing mutant mouse and embryonic stem cell lines to the scientific community. in addition to numerous mutant mice produced independently by scientists in various academic institutions, three major targeted gene knockout programs, all utilizing c57bl/6n embryonic stem cells, are under way internationally, and funded by the nih, the european community, and genome canada (collins et al., 2007; skarnes et al., 2011) . these include the knock out mouse project (komp; http://www.knockoutmouse.org), the european conditional mouse mutagenesis program (eucomm; http://www.eucomm.org), and the north american conditional mouse mutagenesis project (norcomm; http://norcomm.phenogenomics.ca/index. htm). these mouse lines will be available through laboratory animal medicine three distribution centers: the german resource center for genome research (rzpd; http://www.rzpd.de), the komp repository (https://komp.org), and the canadian mouse consortium (cmc; http://www.mousecanada. ca/index.htm). the repositories are all linked to the imsr, and provide access to mice, germplasm, genomic detail, and phenotypic data. genetic, genomic, and biological data are also available through the international mouse phenotyping consortium (impc; www.mousephenotype. org) and the mouse genome database (mgd; http://www. informatics.jax.org) (eppig et al., 2012) . inbreeding is a fundamental genetic tool applied to the laboratory mouse and detailed information is available on the web (table 3 .2). the first inbred strain (dba) was developed by c.c. little in 1909, with the subsequent creation of over 1000 inbred strains and stocks of mice (festing, 1996) . genetic origins, basic characteristics, references, and breeding performance of inbred strains of mice are available through michael festing's online version of inbred strain characteristics (http:// www.informatics.jax.org/external/festing/mouse/ strains.shtml). overviews of genetic manipulation for the creation of different types of mice are available (lyon et al., 1996; silver, 1995) . inbred mouse lines are termed strains, and are achieved by 20 or more brother × sister (filial; f) generations (table 3 .3). mice within an inbred strain, for practical purposes, are genetically identical (syngeneic or isogenic) to other mice of the same strain and sex. because of residual heterozygosity, a strain is not fully inbred until after 60 f generations. most commonly used inbred mouse strains represent 200 or more f generations, providing a high degree of experimental reproducibility. the mouse genome is not static, so when branches of an inbred strain are separated, spontaneous mutations, residual heterozygosity, and retroelement integrations result in genetic differences. therefore, if branches of an inbred strain are separated before f 40 , if branches have separated for 100 generations, or if genetic differences arise, the different branches become substrains. the same holds true if branches of a substrain diverge, resulting in substrains of the inbred substrain. when two inbred mouse strains are crossed, the f 1 hybrids are genetically identical to one another (isogenic), but maximally heterozygous (with chromosomes of each chromosomal pair separately contributed by each parental strain), whereas f 2 hybrids are maximally genetically diverse from one another (with chromosomes of both chromosomal pairs containing a mixture of contributions from each parental strain). with each subsequent f generation, mice once again approach inbred status. this technique is used for creating recombinant inbred (ri) strains. ri strains are sets of inbred strains of mice derived from crossing two inbred strains, and developed by singlepair random matings of sibling mice from the f 2 generation, thereby creating separate breeding lines. each line created is maintained separately, and then propagated by brother-sister matings for 20 generations, with each line becoming a separate inbred strain, but belonging to a set of ri strains. ri mice are useful for mapping phenotypic or quantitative traits that differ between the progenitor strains (bailey, 1971) . ri sets are generally limited to two parental strains. an ongoing international effort has been undertaken to increase allelic diversity among ri strains by creating the collaborative cross (cc) in which a panel of ri strains are being generated mixing the genomes from eight disparately related inbred (octo-parental) mouse strains, including a/j, c57bl/6j, 129s1/svimj, nonobese diabetic (nod)/shiltj, nzo/ hlltj, cast/eij, pwk/phj, and wsb/eij. these eight strains capture nearly 90% of the known genetic variation present among laboratory mice. future applications of the cc will utilize ri intercrosses of pairs of ri cc lines (threadgill and churchill, 2012; welsh et al., 2012) . recombinant congenic strains are sets of inbred strains derived in a manner similar to that for ri sets, except that one or more backcrosses to one parental strain (designated the background strain) are made after the f 1 generation, before inbreeding is begun. the other parental strain is designated as the donor strain. the proportion of background and donor genomes is determined by the number of backcrosses preceding inbreeding (demant and hart, 1986) . advanced intercross lines (ails) are another type of ri lines. they are made by producing an f 2 generation between two inbred strains and then, in each subsequent generation, intercrossing mice but avoiding sibling matings. the purpose is to increase the possibility of recombination between tightly linked genes. when a mutation arises spontaneously or is induced within an inbred strain, that mutant mouse becomes co-isogenic with the parental inbred strain, being virtually identical except for the single mutant allele. frequently, a mutation that arose in one inbred strain may be desired within the genetic background of another inbred strain. this can be accomplished by backcrossing, in which an f 1 hybrid is created by mating the donor mutant strain to the desired background strain, with subsequent matings to the background strain while retaining the mutant locus. after 10 backcross generations (n generations), the mutant mouse line is now congenic to the background inbred strain. backcrossing to create congenic strains of mice has been used extensively when targeted mutations have been induced in 129 embryonic stem cells, with backcrossing onto c57bl/6 inbred mice. congenic mice are never co-isogenic, as the preserved locus in a congenic mouse is invariably surrounded by flanking dna, which may significantly influence phenotype (linder, 2006) . in contrast to inbred mice, outbred mice are genetically heterogeneous and are maintained by breeding systems that intentionally minimize inbreeding. outbred mice are called stocks, which are defined as a closed population (for at least four generations) of genetically variable mice that are bred to maintain maximal heterozygosity. outbred mice may be used when high genetic heterogeneity is desired or for experiments requiring large numbers of mice. outbreeding can be achieved only in a large breeding population using a systematic breeding scheme, or randomized selection of breeders from the population. a small breeding population or passage through the genetic 'bottleneck' of rederivation to improve health status will reduce genetic heterogeneity and lead eventually to some degree of inbreeding. in a population of 25 breeding pairs, e.g., heterozygosity will decrease at 1% per generation with standard randomization techniques. random breeding involves the statistically random selection of breeders by using a random numbers table or computer program. an outbreeding program that is easy to manage is the circular pair mating system, in which each pair is mated only once. conceptually, cages are visualized in a circle, and each cage contains one breeding pair in the nth generation. another 'circular' set of cages serves as the breeding nucleus for the n + 1 generation. each mated pair in the nth generation contributes one female and one male to the n + 1 generation. outbreeding is accomplished by assigning the female and male derived from each nth generation cage to different cages in the n + 1 generation. most outbred mouse stocks are of 'swiss' origin, derived from nine mice imported to the united states in 1926, and are therefore quite homogeneous genetically (chia et al., 2005) . various lines of these mice have been maintained at different institutions, giving rise to numerous closely related stocks. although considered outbred, they have a high degree of homozygosity, exemplified by the fact that many swiss mouse stocks are blind due to the homozygous recessive rd1 allele (serfilippi et al., 2004b) . it is preferable to ensure genetic heterogeneity by intercrossing multiple inbred strains to achieve heterogeneity with known genetic input. in that regard, the diversity outbred mouse has been developed, which is a heterogeneous stock derived from the same eight founder inbred strains of the cc . additional types of inbred mice are utilized in research, including consomic and conplastic strains. consomic strains, also known as chromosome substitution strains, are inbred mice that are congenic for entire chromosomes, and are useful for studying polygenic traits (singer et al., 2004) . conplastic mice are inbred mice that are congenic for different mitochondrial genomes (mtdna) contributed by other inbred strains, other subspecies, or other species of mus (yu et al., 2009 ). in addition to spontaneously occurring mutations that are maintained as co-isogenic strains (such as the c57bl/6 beige mouse), mutant lines of mice have been created by radiation mutagenesis, chemical mutagenesis, or transgenesis. radiation was one of the earlier methods for in vivo mutagenesis (silver, 1995) , but in vitro radiation of embryonic stem (es) cells is also performed (thomas et al., 1998) . chemical mutagenesis involves in vivo treatment of male mice or in vitro treatment of es cells with mutagenic chemicals such as ethylmethanesulphonate (ems) or n-ethyl-n-nitrosourea (enu) , which induce point mutations in dna (o'brien and frankel, 2003; justice et al., 1999 justice et al., , 2000 . technically, a transgenic mouse is any mouse in which foreign dna has been integrated into its genome, regardless of method. however, the term transgenic commonly refers to mice that are genetically altered by additive transgenesis through microinjection of foreign dna into the pronucleus of a fertilized egg. each ensuing embryo results in a genetically different founder mouse, since the transgene is integrated in random sites of the genome of each founder mouse. since the injected dna is not homologous to the mouse genome and is not an allele, transgenic founders are hemizygous (rather than heterozygous) for the transgene until the mice carrying the transgene are bred into homozygosity for the transgene. transgenes typically integrate as tandem repeats, copy numbers affect phenotype of each founder, and may be lost in subsequent generations, thereby changing the phenotype of the mouse line (tinkle and jay, 2002) . transgenes are often constructed with an upstream promoter, which confers widespread (ubiquitous) or tissuespecific expression of the cdna, so that the transgene expression pattern reflects the expression pattern of the promoter. transcriptional regulation of the transgene can be inducible by drug-dependent regulatory control, such as the widely used tetracycline (tet) regulatory system, in which treatment of mice with tetracycline or doxycycline induces up-or down-regulation of the transgene (jaisser, 2000) . es cells are used for the less efficient integration of genetic material by homologous dna recombination, but allow large-scale screening of es cell clones for transformation. integration can be achieved in a random fashion by gene trapping, or by targeted mutation. both methods involve homologous dna recombination. gene trapping is a high-throughput approach that randomly introduces insertional mutations within the genome. vectors contain a gene trapping cassette with a promoter-less reporter gene and/or selectable genetic marker flanked by an upstream 3′ splice site and a downstream termination sequence. when inserted into an laboratory animal medicine intron of an expressed gene, the gene trap is transcribed from the endogenous promoter of that gene. gene traps simultaneously inactivate and report the expression of the trapped gene at the insertion site, and provide a dna tag for the rapid identification of the disrupted gene (skarnes et al., 2011) . targeted gene mutations are achieved by homologous recombination of specific sites within the genome of es cells. homologous sequences flank the upstream and downstream regions of the targeted gene, and the construct between the flanking sequences may inactivate (knock out) or replace (knock in) a gene, and typically contains a reporter gene to track the integration. a variation on this approach is site-specific recombinase (ssr) technology. two of the most common recombinases are cre from the coliphage p1 and flp from saccharomyces cerevisiae. cre and flp mediate recombination between target sites, termed loxp and frt, respectively. for example, cre loxp target sites are engineered to flank the gene target, which can be used in different ways to achieve different outcomes (conditional mutations), depending upon the orientation and location of the flanking loxp sites. if the loxp sites are oriented in opposite directions, cre recombinase mediates inversion of the floxed segment. if the loxp sites are on different chromosomes (trans), cre recombinase mediates a chromosomal translocation. if the loxp sites are oriented in the same direction on the same chromosome (cis), cre recombinase mediates deletion of the floxed segment. once the floxed mutation is created in es cells, the transformed es cells are developed into a mouse with the conditional mutation. the conditional mutant mouse is then genetically crossed with a cre transgenic mouse, in which cre recombinase is under the control of a ubiquitous or tissue-specific promoter. wherever and whenever cre is expressed, cre recombinase will recognize and recombine the loxp sites. this approach can include insertion of reporter genes and selectable markers, and can be under the control of inducible gene expression systems (http:// www.eucomm.org/docs/protocols/mouse_protocol_1_ sanger) (nagy, 2000) . es cells are pluripotent with the full genetic capacity to develop into mice when implanted into the blastocyst of a developing embryo. interest in 'embryonal carcinomas' (teratomas) that arose in relatively high frequency in the testes of 129 mice and early gene transfer experiments in the late 1970s and early 1980s led to the development of es cell lines derived from several different 129 strains. this early emphasis on teratomas prompted creation of 'better' 129 mouse lines that were more prone to development of testicular teratomas, resulting in genetic corruption of the 129 mouse (simpson et al., 1997; threadgill et al., 1997) . this realization gave rise to the need to revise 129 mouse nomenclature (festing et al., 1999) . this was necessary because genetic variation significantly impacts homologous recombination in order to match genome sequence of the es cell line with the mouse from which it was derived. es cells can be created from any mouse strain or hybrid, but 129 es cell lines have been commonly used. recent international knockout mouse program efforts use c57bl/6n es cells. transformed es cells are microinjected into the inner cell mass of recipient blastocysts, which are then implanted into the uteri of pseudopregnant surrogate mothers. the pups that are born are composed of a mixture of cells derived from recipient blastocysts and the transformed es cells (chimeras). the goal is for male chimeric progeny to produce spermatozoa of es cell origin (containing the mutation), in order to create f 1 progeny by mating the chimera with the desired background strain (http://www.eucomm.org/docs/protocols/mouse_protocol_1_sanger). for this reason, most es cell lines are xy, which favors 129 male chimerism. if the es cells are of 129 (or other) strain origin, the chimeras are often bred to a desired background mouse strain (commonly c57bl/6) and backcrossed for n10 generations, thereby creating congenic inbred mouse lines. recent international knockout mouse efforts utilize c57bl/6n es cells, so that chimeric males are bred directly with c57bl/6 mice, thereby creating co-isogenic lines. the latter approach saves time and money, and creates a more genetically refined mutant mouse. an alternate approach is to allow es cells to aggregate with a developing embryo to form blastocysts in culture (aggregation chimera), then implant the chimeric blastocysts (tanaka et al., 2001) . rna interference (rnai), which functions through short double-stranded rna (dsrna), has also been utilized to produce transgenic mice, known as gene knockdown mice (gao and zhang, 2007; peng et al., 2006) . the dsrna is enzymatically processed into small molecules, termed small interfering rna (sirna), which find homologous target mrnas, resulting in interference. this phenomenon is believed to be a self-defense mechanism against viral infection. in order to adapt this approach to generation of transgenic mice, small hairpin rna (shrna) can be expressed in the same way as other transgenes in mice, resulting in processing of the shrna into sirna with gene-silencing effects. constructs are introduced into mouse es cells by electroporation or lentiviral infection. this method can be embellished conditionally, as with other transgenes. although rnai knockdown mice are genetically stable, rnai-mediated transgenesis is never complete, has variable tissue expression, and cannot induce point mutations (peng et al., 2006) . recent advances in engineered endonuclease (ee) technology, including zinc finger nucleases (zfns), laboratory animal medicine transcription activator-like effector nucleases (talens), and rna-guided endonucleases (rgens), have revolutionized the field of transgenics (sung et al., 2014; wijshake et al., 2014; gaj et al., 2013) . zfns and talens consist of engineered proteins that target dna fused to the nonspecific endonuclease, fok1 (cathomen and joung, 2008; joung and sander, 2013) . zfns are comprised of three to six tandem zinc finger proteins, each of which targets a specific 3 bp nucleotide sequence. paired zfns are generated, with each half of the pair targeting opposite dna strands, allowing dimerization of fok1 which is required for introduction of double-stranded breaks (dsbs) in the dna of interest (cathomen and joung, 2008) . talens function similarly, but are composed of tandem repeats of 33-35 amino acids, each with nucleotide specificity occurring in two hypervariable amino acids, the 'repeat variable di-residue (rvd)', at positions 12 and 13 (joung and sander, 2013) . in contrast to zfns and talens, clustered regularly interspaced short palindromic repeats (crisprs) paired with crispr-associated (crispr/cas) systems are rgen systems that target specific dna sequences. cas proteins, rather than fok1, produce dsb (hsu et al., 2014) . dsb generated by ee are repaired by host cells by either nonhomologous end joining (nhej) or, less commonly, by homologous recombination (hr). nhej is an error-prone repair system and results in insertions or deletions (indels) with a relatively high frequency, which can result in gene disruption. hr is a less common repair pathway, but certain manipulations of the engineered nucleases can increase hr efficiency. for example, nucleases can be engineered to generate a break in a single strand of dna rather than inducing dsb, and the resulting nickases increase the incidence of hr with high fidelity (gaj et al., 2013; wijshake et al., 2014) . hr allows for the introduction of donor dna to generate knock-ins, specific point mutations, or for the generation of larger modifications such as insertions of loxp sites (brown et al., 2013; wijshake et al., 2014) . vectors encoding the ee can be injected into mouse embryos by pronuclear injection of dna, intracytoplasmic injection of rna, or transfection of mouse es cells (sung et al., 2014; wijshake et al., 2014) . one advantage of ee technologies over more traditional transgenic methods is the ability to target dna and induce mutations in any background strain of mouse negating the need to backcross onto the desired strain. multiple genes can be targeted with crisprs simultaneously, thus avoiding the need to cross single knockout animals (zhou et al., 2014) . in addition, it is possible to obtain bi-allelic mutations in some cases, allowing for the generation of functional gene knockout animals in a single generation (zhou et al., 2014; wijshake et al., 2014) . vectors for generating ee are available through plasmid repositories; websites are available to assist in identifying appropriate dna sequences to target; and multiple websites post protocols for generating the various types of engineered endonucleases (xie et al., 2014; sander et al., 2010; bae et al., 2014; reyon et al., 2011; herscovitch et al., 2012; wolfson, 2013) . crisprs tend to be particularly cost effective and easy to design, with minimal restrictions for targeting specific dna sequences. there are currently more than 1000 separate outbred stocks and traditional inbred strains, often with multiple substrains (table 3 .4). in addition, there are thousands of induced mutant strains. therefore, it is critical that strain or stock designations be complete and accurate to avoid semantic and genetic confusion, and to ensure reproducibility of research results. as an example of substrain variation that makes precise nomenclature important, cba/j mice are homozygous for the retinal degeneration allele (rd1), whereas cba/caj mice do not carry this allele. the international committee on standardized genetic nomenclature for mice and rats, established in the early 1950s, is responsible for genetic nomenclature rules. the rules are available online at the mgi website (http:// www.informatics.jax.org/mgihome/nomen). inbred mouse strains are designated by a series of capital letters and/or numbers, which often provide a shorthand description of the origin and history of the strain. the c57bl/6j mouse serves as an example. the inbred strain c57bl originated from abbie lathrop's female 57 (and male 52) at the cold spring harbor laboratory (c), and was the black (bl) line from this female. early in their history, inbred c57bl mice split into major substrains, e.g., c57bl/6 and c57bl/10. substrains are identified by appending a forward slash (/) after the inbred strain name. since 1950, uniform international nomenclature has been built upon these historical names, so that substrains of an inbred strain are now designated using lab codes that are registered in the international laboratory code registry maintained at the institute for laboratory animal research (ilar) of the national academies (dels. nas.edu/global/ilar/lab-codes). laboratory codes are composed of one to five letters that identify an institute, laboratory, or investigator. each lab code starts with an uppercase letter, followed by lowercase letters if more than one letter is used (such as n, j, jci, crl, and tac). the j in c57bl/6j means it is a substrain maintained at the jackson laboratory (j). another common substrain of c57bl/6 mice is c57bl/6n, which is maintained at nih (n). substrains can be cumulative, reflecting the genetic history of the mouse strain. for example, there are a number of c57bl/6j substrains (such as c57bl/6jjci and c57bl/6jjmsslc), and a number of c57bl/6n substrains (such as c57bl/6njci, c57bl/6ncrlcrlj, dba/2j inbred strain named for its characteristic coat color genes (using their original gene symbols), dilute (d), brown (b), and nonagouti (a); it is the second of two sublines separated before 20 generations of brother × sister breeding and is the subline maintained at the jackson laboratory (j) c3h/hesn-ash/+ co-isogenic segregating inbred mutant strain carrying the ashen (ash) mutation, which arose on c3h/hesn c57bl/6j-tyrc-2j /+ co-isogenic segregating inbred mutant strain carrying the albino 2j mutant allele of the cloned tyrosinase gene (tyr) aej/gnj-a e /a w-j inbred strain segregating for two alleles at the agouti gene congenic inbred strain in which the b haplotype at the h2 complex was transferred from c57bl/6j (b6) to the akr background b6.cba-d4mit25-d4mit80 congenic strain in which the chromosomal segment between d4mit25 and d4mit80 was transferred from cba to b6 b6.cg m lepr db /++ congenic inbred strain in which the linked mutant genes misty (m) and diabetes (lepr db ) were transferred from multiple, mixed, or unknown genetic backgrounds to b6 and are carried in coupling, i.e., on the same chromosome b6.cg-m +/+ lepr db congenic inbred strain in which the m and lepr db mutations are carried in repulsion bxd-1/ty recombinant inbred (ri) strain number 1 in a set of ri strains derived from a c57bl/6j (b) female mated to a dba/2j (d) male and made by taylor (ty) recombinant congenic (rc) strain number 1 in a set made by crossing the balb/c (c) and sts (s) strains, backcrossing one or two times to balb/c and then inbreeding as with ri strains and c57bl/6ntac). significant differences may exist among these substrains (mekada et al., 2009 ). thus, a string of substrain designations indicate the genetic progression of the substrain, which can be identified when reading the entire strain name. this nomenclature is highly nuanced, as c57bl/6ncrlcrlj mice, whose last letter is a lowercase j, are not a substrain maintained at the jackson laboratory (j), but rather at charles river japan (crlj), underscoring the importance of upper-and lowercase lettering in rodent nomenclature. balb/c mice are another popular inbred strain with numerous substrains. like the '6' in c57bl/6, the 'c' that follows laboratory animal medicine of the mutational event as a superscript. for example, cftr tm1unc is a targeted mutation (tm), first line (1) congenic mice are often derived from 129 es cells, backcrossed onto a background strain, such as c57bl/6. under such circumstances, when the backcross generation is at n10, the '.' symbol is used between the background inbred strain and the donor strain (e.g., c57bl/6n.129p2/olahsd-abc tm1zzz , abbreviated as b6.129-abc tm1zzz . when backcrossing is incomplete but at the n5 generation, the mouse is an incipient congenic, designated with a ';' in lieu of a '.': b6;129-abc tm1zzz . if the background strain is mixed genetic origin, it is designated stock.129-abc tm1zzz . if the donor strain is mixed origin, it is designated 'cg'. for example, b6.cg-abc tm1zzz outbred stock that meets specific criteria is designated by placing the lab code before the stock symbol, separated by a full colon (':'). for example, hsd:icr designates an icr (swiss) outbred stock maintained by harlan sprague dawley (hsd). the above overview covers the nomenclature of commonly encountered types of mice. there are numerous additional specifications for nomenclature of mice. details are available at the mgi website (http://www. informatics.jax.org/mgihome/nomen). optimum housing conditions and husbandry practices for research mice should be guided by program requirements to ensure biosecurity, occupational health, efficient use of equipment, labor and financial resources, behavioral needs of mice, and investigator needs for consistent colony maintenance, including standardized husbandry practices and nutrition. the emerging interest in the mouse microbiome in combination with the immune competency of diverse genetically engineered mouse strains demands high standards of mouse care. mouse colonies are optimally maintained as specificpathogen-free (spf) which obligates veterinary and facility management to exclude specific organisms. housing options for spf immunocompetent mice typically include static or individually ventilated microisolator cages, which differ significantly in cost and labor required to maintain. severely immunodeficient strains such as nod.cg-prkdcscid il2rgtm1wjl/szj (nsg) mice require staff training, caging systems and husbandry practices that minimize risk for opportunistic infections the '/' in balb/c is a lowercase letter because of historical precedent. subsequent substrains follow accepted nomenclature, e.g., balb/cbyj and balb/cann. hybrids of two inbred strains are often used in research, and are particularly common with engineered mutations that are created in 129-derived es cells, followed by intercrossing the 129 chimeric mice with c57bl/6 or other background strains of mouse. when an f 1 hybrid is created, the female partner is listed first, e.g., a c57bl/6j × 129s2/svpas hybrid would be designated: c57bl/6j129s2/svpasf1. ri strain sets that are derived from two parental inbred strains are identified by an x between the two parental strains followed by a hyphen designating the specific ri line, e.g., c57bl/6jxdba/2j-1, c57bl/6jxdba/2j-2, etc. cc ri strains do not use the x between the parental strains because they are derived from eight parental strains, so they are designated cc-1, cc-2, etc. in order to simplify the complexity of this nomenclature, abbreviations are used for common inbred strains and substrains of mice (table 3 .4), but it is important to include the full genetic nomenclature in publications. using the abbreviated nomenclature, c57bl/6j129s2/svpasf1 mice would be b6129f1 and c57bl/6jxdba/2j-1 ri mice would be bxd-1. parental order is an important consideration in nomenclature, as a b6129 mouse is genetically different from a 129b6 mouse due to mitochondrial dna (from the female) and y chromosome (from the male) differences. mutant genes are designated by a brief abbreviation for the mutation (e.g., bg for beige which arose at the jackson laboratory, j). the symbol for the parent gene is noted in italics, starting with an uppercase letter (e.g., lyst) and the mutant allele is designated in superscript (e.g., lyst bgj ). thus, the beige mutation arose in c57bl/6j mice, so that c57bl/6j beige mice, which are co-isogenic with c57bl/6j mice, are designated c57bl/6j-lyst bgj . a transgenic strain is designated by the strain and substrain name, followed by a symbol for the transgene. transgene symbols take the form tg(yyy)#zzz, where 'tg' indicates transgenic, yyy defines the transgene as a brief description of the inserted dna (such as a gene symbol), '#' is the assigned number in the series of events generated using a given construct, and 'zzz' is the lab code. for example, fvb/n-tg(mmtv-erb2)1led mice are inbred fvb/n mice in which the rat erb2 gene was introduced under control of the mouse mammary tumor virus (mmtv) ltr promoter (mmtv-erb2), the first line (1) created in the laboratory of phil leder (lab code led). when a transgene causes an insertional mutation in an identified endogenous gene, the mutant allele of the gene is designated by using the gene symbol and an abbreviation for the transgene as a superscript (-abc tg1zzz ). a targeted mutation, or knockout, is designated by the mutated gene with the identification laboratory animal medicine (foreman et al., 2011) . barrier practices and microisolator techniques may include autoclaved or irradiated feed and bedding, autoclaved or acidified water, cage-tocage transfer of mice using disinfected forceps, positive displacement change hoods, and verified sanitation of caging and equipment through tunnel or rack washers to prevent fomite transmission of infectious agents (compton et al., 2012) . in addition to husbandry staff, it is critical to maintenance of colony health status that investigators who handle cages are also trained in these techniques. the microenvironment for mice is the cage which will vary in design, size, and composition. vendors often successfully house production colonies in open-top cages to expedite detection of pathogen transmission should a break occur. end-users usually prefer filter-top microisolator cages which prevent (at least) gross contamination between cages by fecal contamination and aerosolized debris. the objective is to keep mice in an uncrowded, socially compatible, low-odor, dry and clean environment. ambient temperature should minimize any confounding impact on the animal model and energy expenditure for the mice, while also being suitable for staff and investigators. shoebox static cages made of polycarbonate, polypropylene, or polystyrene plastic (in order of decreasing cost and durability) with filtered microisolator tops continue to be used for housing and breeding mice. older cage designs are being rapidly supplanted by individually ventilated caging systems that promote the advantages of increasing housing capacity, decreasing labor costs, and mitigating exposure of mice to noxious gases such as ammonia and exposure of humans to allergens. as more advanced caging systems are developed, the level of biosecurity may be increased but at the cost of increased health surveillance efforts to detect the source of an infectious outbreak (shek, 2008) . disposable, recyclable polyethylene caging is a recent innovation, particularly for facilities not equipped with a cage wash facility. animal care programs should carefully consider the necessity for housing mice on wire-mesh flooring because of injury risk to limbs and thermoregulation issues in neonates and hairless mice which are more difficult to maintain without nesting material. solidbottom cages should contain sanitary bedding, such as hardwood chips, paper products, or ground corn cob. criteria for selecting bedding vary with experimental and husbandry needs. it may be preferable to irradiate or autoclave bedding, but if this is not done, the bedding should be used only after its origin and microbial content have been evaluated (table 3 .5). germfree and gnotobiotic mice require positive pressure isolators, most usually flexible film, with additional protection provided by sterile air through high-efficiency particulate air (hepa) filters. this equipment can be negatively pressurized when the objective is to contain known or unknown pathogens. animal care programs should establish enrichment policies which for mice should include social housing when mice are compatible and experiments do not require single housing. species-specific behaviors are encouraged by nesting material and hiding places such as tubes or shacks. nutrient requirements for the mouse are influenced by genetic background, disease status, growth rate, pregnancy, lactation, and environmental factors such as ambient temperature. the best current estimate of nutritional requirements is shown in table 3 .6. nutritional requirements for laboratory mice are also published periodically by the national research council and have been reviewed by knapka and coworkers (knapka et al., 1974; knapka, 1983) . feed intake and weight gain data are used to estimate the nutritional needs of a particular stock or strain. mice consume about 3-5 g of feed per day after weaning, and maintain this intake throughout life. outbred mice tend to gain weight faster than inbred mice and are heavier at maturity (figs. 3.1 and 3.2). diet is often neglected as a variable in animal-related research. diet can influence responses to drugs, chemicals, or other factors and lead to biased research results. therefore, diet must provide a balance of essential kraft (1980) . knapka (1983) . b linoleic acid: 0.6% is adequate. c john and bell (1976) . d theuer (1971) . e knapka et al. (1974 ). f nutrition (1977 . g hurley and bell (1974) . h pleasants et al. (1973) . nutrients, and contaminants must be kept to a minimum (see also chapter 29). natural-product commercial diets for mice are usually satisfactory for breeding and maintenance. animal care programs should avoid using fresh produce, grains, fish meal, or other supplements to minimize exposure of colonies to pathogens or harmful chemicals such as pesticide residues or phytoestrogens (guerrero-bosagna et al., 2008) . mouse diets can be purchased as open-formula, fixedformula, constant nutrition, and closed-formula which laboratory animal medicine are designed to reduce variation in experimental data attributable to diet (reviewed in barnard et al. (2009) ). diets are supplied in standard, irradiated, or autoclavable formulations. irradiated diets will be virtually free of live microorganisms but have the risk of residual, radio-resistant bacteria. autoclavable diets are higher in heat-labile nutrient content. many programs use sterilized mouse chow exclusively to minimize risk of opportunistic infections. because commercial diets vary in nutrient content, diets should be selected for optimal maintenance of adult mice or for growth and reproduction in breeding colonies. mice should have continuous access to potable water even if a high-moisture diet is fed. water is needed for lubrication of dry food and for hydration. adult mice drink 6-7 ml of water per day. decreased water intake will decrease food consumption. water imbalance may occur immediately post weaning and weanlings on automatic watering systems need extra attention. water intake will decrease in sick mice. therefore, dosing mice with medicated water requires careful assessment of hydration and clinical or experimental efficacy of the compound administered. the main reference used to update this section of the 3rd edition is volume iii; normative biology, husbandry and models in the mouse in biomedical research, 2nd edition, aclam series published by academic press. normative data on the mouse are presented in table 3 .7, and clinical chemistry reference ranges are summarized in table 3 .8. mice have a relatively large surface area per gram of body weight. this results in dramatic physiologic changes in response to fluctuations in the ambient temperature (t a ). the mouse responds to cold exposure, e.g., by nonshivering thermogenesis. a resting mouse acclimated to cold can generate heat equivalent to triple the basal metabolic rate, a change that is greater than for any other animal. a mouse must generate about 46 kcal/m 2 per 24 h to maintain body temperature for each 1°c drop in t a below the thermoneutral zone. mice cannot tolerate nocturnal cooling as well as larger animals that have a greater heat sink. therefore, it is not advisable to conserve energy in animal quarters at night by lowering t a . because of the ratio of evaporative surface to body mass, the mouse has a greater sensitivity than most mammals to water loss. its biological half-time for turnover of water (1.1 days) is more rapid than for larger mammals. water conservation is enhanced by cooling of expired air in the nasal passages and by highly efficient concentration of urine. the conservation of water can preempt thermal stability. if the mouse had to depend on the evaporation of body water to prevent elevations of body temperature, it would go into shock from dehydration. the mouse has no sweat glands, it cannot pant, and its ability to salivate is severely limited. mice can partially compensate for changes in t a increases from 20°c to 35°c. it adapts to moderate but persistent increases in environmental temperature by a persistent increase in body temperature, a persistent decrease in metabolic rate, and increased blood flow to the ears to increase heat loss. its primary means of cooling in the wild is behavioral -retreat into a burrow. in the confinement of a cage, truck, or plane, mice do not survive well in heat and begin to die at an ambient temperature of 37°c or higher. thus, the mouse is not a true endotherm. in fact, the neonatal mouse is ectothermic and does not have well-developed temperature control before 20 days of age. the thermoneutral zone for mice varies with strain and with conditioning but is about 29.6-30.5°c, narrower than that of any other mammal measured thus far. thermoneutrality should not be equated with comfort or physiological economy. recent data have suggested that mice housed under routine vivarium conditions are chronically cold-stressed. mice maintained at 21°c were shown to expend more energy compared with mice housed at intermediate (26°c) and a higher temperature (31°c) with an increase in glucose utilization and activation of brown adipose tissue (david et al., 2013) . in contrast, other studies report that mice in a t a range of 21-25°c grow faster, have larger litters, and have more viable pups than those maintained in the thermoneutral zone. the respiratory tract has three main portions: the anterior respiratory tract consists of nostrils, nasal cavities, and nasopharnyx; the intermediate section consists of larynx, trachea, and bronchi, all of which have cartilaginous support; and the posterior portion of the respiratory tract consists of the lungs. the left lung is a single lobe. the right lung is divided into four lobes: superior, middle, inferior, and postcaval (cook, 1983) (fig. 3.3 loeb and quimby (1999) . a mouse at rest uses about 3.5 ml o 2 /g/h, which is about 22 times more o 2 /g/h than is used by an elephant. to accommodate for this high metabolic rate, the mouse has a high alveolar p o 2 ; a rapid respiratory rate; a short air passage; a moderately high erythrocyte (rbc) concentration; high rbc hemoglobin and carbonic anhydrase concentrations; a high blood o 2 capacity; a slight shift in the o 2 -dissociation curve, enabling o 2 to be unloaded in the tissue capillaries at a high p o 2 ; a more pronounced bohr effect, i.e., the hemoglobin affinity for o 2 with changes in ph is more pronounced; a high capillary density; and a high blood sugar concentration. the kidneys, ureters, urinary bladder, and urethra form the urinary system. the paired kidneys lie against the dorsal body wall of the abdomen on either side of the midline. the right kidney is normally located anterior to the left kidney. kidneys from males of many inbred strains are consistently heavier than kidneys from females. the glomeruli of mice are small, about 74 μm in diameter, or about half the size of glomeruli in rats. there are, however, 4.8 times as many glomeruli in the mouse, and the filtering surface per gram of tissue is twice that of the rat. mice excrete only a drop or two of urine at a time, and it is highly concentrated (table 3 .8). the high concentration is made possible by long loops of henle and by the organization of giant vascular bundles (vasa recta) associated with the loops of henle in the medulla. the mouse can concentrate urine to 4300 mosm/l, whereas humans can concentrate to a maximum of 1160 mosm/l. mice normally excrete large amounts of protein in the urine. taurine is always present in mouse urine, whereas tryptophan is always absent. creatinine is also excreted in mouse urine, a trait in which mice differ from other mammals. the creatinine/creatine ratio for fasting mice is about 1:1.4. mice excrete much more allantoin than uric acid. the submaxillary salivary gland, a mixed gland in most animals, secretes only one type of saliva (seromucoid) in the mouse. the tubular portion of the gastrointestinal (gi) tract consists of esophagus, stomach, small intestine, cecum, and colon. the esophagus of the mouse is lined by a thick cornified squamous epithelium, making gavage a relatively simple procedure. the proximal portion of the stomach is also keratinized, whereas the distal part of the stomach is glandular. gastric secretion continues whether or not food is present. the gastrointestinal flora consists of (at least) 1000 species of bacteria that begin to colonize the alimentary canal selectively shortly after birth. the ceca of normal mice contain up to 10 11 bacteria/g of feces. the bacteria throughout the gastrointestinal tract form a complex ecosystem that provides beneficial effects, such as an increase in resistance to certain intestinal pathogens, production of essential vitamins, and homeostasis of important physiological functions. gnotobiotic animals colonized with known microbiota have been used to great advantage as models for biomedical research (see chapter 39). for certain studies, it is desirable to colonize germfree mice with a defined microbiota. in the mid-1960s, schaedler was the first to colonize germfree mice with selected bacteria isolated from normal mice (schaedler and orcutt, 1983) . he subsequently supplied animal breeders with this group of microorganisms. these defined bacteria included aerobic bacteria and some less oxygen-sensitive anaerobic organisms. the so-called extremely oxygen-sensitive (eos) fusiform bacteria, which make up the majority of the normal microbiota of rodents, were not included, because of technical difficulties in isolation and cultivation. of the defined microbiotas later used for gnotobiotic studies, the one known as the 'schaedler flora' was the most popular. in 1978, the national cancer institute (nci) decided to revise the schaedler flora, or 'cocktail' consisting of eight bacteria, in order to standardize the microbiota used to colonize germfree rodents. the new defined microbiota, now known as the 'altered schaedler flora' (asf), consisted of four members of the original schaedler flora (two lactobacilli, bacteroides distasonis, and the eos fusiform bacterium), a spiral-shaped bacterium, and three new fusiform eos bacteria. studies have quantified the regional colonization of the asf strains along the gastrointestinal tract (sarma-rupavtarm et al., 2004) (fig. 3.4) . individual strain abundance was dependent on oxygen sensitivity, with microaerotolerant lactobacillus murinus asf361 present at 10 5 -10 7 cells/g of tissue in the upper gastrointestinal tract and obligate anaerobic asf strains being predominant in the cecal and colonic flora at 10 8 -10 10 cells/g of tissue. it is difficult to monitor a gnotobiotic mouse colony with a defined microbiota. it is necessary to demonstrate that microorganisms of the specified microbiota are present and that adventitious microorganisms are absent. in the past, monitoring relied on bacterial morphology, limited evaluation of biochemical traits, and growth characteristics. with the advent of polymerase chain reaction (pcr) technology, the eight asf strains were identified taxonomically by 16s rrna sequence analysis . three strains were previously identified as lactobacillus acidophilus (strain asf 360), l. salivarius (strain asf 361), and bacteroides distasonis (strain asf 519), based on phenotypic criteria. 16s rrna analysis and genome sequencing indicated that each of the strains differed from its presumptive identity (wannemuehler et al., 2014) . the 16s rrna sequence of strain asf 361 is essentially identical to the 16s rrna sequences of the type strains of l. murinus and l. animalis (both isolated laboratory animal medicine from mice), and all of these strains probably belong to a single species. strain asf 360 is a novel lactobacillus that clusters with l. acidophilus and l. lactis. strain asf 519 is a parabacteroides sp. the spiral-shaped strain, strain asf 457, is in the flexistipes phylum, exhibits sequence identity with rodent isolates of robertson, and has been formally named, mucispirillum schaedleri (robertson et al., 2005) . the remaining four asf strains, which are eos fusiform bacteria, group phylogenetically with the low-g + c content gram-positive bacteria (firmicutes, bacillus-clostridium group) (asf 492 -eubacterium plexicaudatium; asf 500 -firmicutes bacterium; asf 502 and asf 356 -clostridium sp.) (fig. 3.5) . the 16s rrna sequence information was determined by dewhirst et al. (1999) and draft genome sequences for each member of asf were recently published (wannemuehler et al., 2014) . this genetic data will permit detailed analysis of the interactions of asf organisms during development of intestinal disease in mice that are coinfected with a variety of pathogenic microorganisms. the lymphatic system consists of lymph vessels, thymus, lymph nodes, spleen, solitary peripheral nodes ( fig. 3.6) , and intestinal peyer's patches. mouse lymph nodes are numerous but typically are small, reaching only a few millimeters. the typical lymph node is beanshaped and consists of a cortex and a medulla. the cortex is divided into b lymphocyte domains, called primary follicles, and t lymphocyte domains, known s2 i1 i2 i3 i4 i5 i6 c1 c2 l1 l2 l3 e1 s1 s2 i1 i2 i3 i4 i5 i6 c1 c2 l1 l2 l3 e1 s1 s2 i1 i2 i3 i4 i5 i6 c1 c2 l1 l2 l3 e1 s1 s2 i1 i2 i3 i4 i5 i6 c1 c2 l1 l2 section of the gi tract bacteroides sp. asf519 the sections are taken from the esophagus (esop.) (section e1), stomach (sections s1 and s2), small intestine (sections i1 to i6), ileocecal junction and apical cecum (sections c1 and c2, respectively), and colon (sections l1 to l3). from sarma-rupavtarm et al. (2004). as the diffuse cortex. the mouse does not have palatine or pharyngeal tonsils. the spleen lies adjacent to the greater curvature of the stomach. different strains of mice have varying degrees of accessory splenic tissue. age, strain, sex, and health status can affect the size, shape, and appearance of the spleen. male spleens, e.g., may be 50% larger than those of females. most lymphocytes enter and leave the spleen in the bloodstream. the so-called white pulp of the spleen is organized along the central arteriole and is subdivided into t-and b-cell zones. the periarteriolar sheath is composed mainly of cd4 + and cd8 + t cells, and lymph follicles, which often contain germinal centers, are located at the periphery. the red pulp consists of sinusoids and hemoreticular tissue. cellular and humoral components of immunity are distributed to the bloodstream and tissues by efferent lymphatic vessels and lymphatic ducts, which empty into the venous system. the thymus is a bilobed lymphoid organ lying in the anterior mediastinum. it reaches maximum size around the time of sexual maturity and involutes between 35 and 80 days of age. the thymus plays a major role in maturation and differentiation of t lymphocytes. this function is not complete in newborn mice. thymectomy is routinely performed in immunological research for experimental manipulation of the immune system. thymectomy of newborn mice causes a decrease in circulating lymphocytes and marked impairment of certain immune responses, particularly cellular immune responses. thymectomy in adult mice produces no immediate effect, but several months later mice may develop a progressive decline of circulating lymphocytes and impaired cellular immune responses. the mutant athymic nude mouse is a powerful experimental tool in the study of the thymus in immune regulation (fogh, 1982) . the mucosa-associated lymph tissue (malt) contains more lymphoid cells and produces greater amounts of immunoglobulin than both the spleen and the lymph nodes. the term malt designates all peripheral lymphoid tissues connecting to cavities communicating with the external milieu. they include the peyer's patches, the cecal lymphoid tissue, and the lymphoid tissue in upper and lower respiratory tract, as well as the respiratory and genitourinary system. lymphatics drain these lymphoid-rich areas, thus providing a direct link with lymph nodes and the bloodstream. bone marrow and splenic red pulp produce erythrocytic, granulocytic, and megakaryocytic precursors over the life of the mouse. bone marrow is located in the protected matrix of cancellous bone and is sustained by reticular tissue rich in blood vessels and adipose cells (pastoret et al., 1998) . normal hematologic values are listed in table 3 .7. bone marrow-derived mononuclear phagocytes remove particulate antigens and act as antigen-presenting cells for lymphocytes. tissue macrophages, which often function in a similar way, are found in many tissues, including peripheral lymphoid tissues, lung, liver, intestine, and skin. the cardiovascular system of mice is reviewed extensively by hoyt et al. in the 2nd edition of volume iii; normative biology, husbandry and models in the aclam series the mouse in biomedical research (hoyt, 2007) . the heart consists of four chambers, the thin-walled atria and the thick-walled ventricles ( fig. 3.7) . mice conditioned to a recording apparatus have mean systolic blood pressures ranging from 84 to 105 mmhg. an increase in body temperature does not lead to an increase in blood pressure. heart rate, cardiac output, and the width of cardiac myofibers are related to the size of the animal. heart rates from 310 to 840/min have been recorded for mice, and there are wide variations in rates and blood pressure among strains. the skeleton is composed of two parts: the axial skeleton, which consists of the skull, vertebrae, ribs, and sternum, and the appendicular skeleton, which consists of the pectoral and pelvic girdles and the paired limbs. the normal vertebral formula for the mouse is c7t13l6s4c28, with some variations among strains, especially in the thoracic and lumbar regions. normal mouse dentition consists of an incisor and three molars in each quadrant. these develop and erupt in sequence from front to rear. the third molar is the smallest tooth in both jaws; the upper and lower third molar may be missing in wild mice and in some inbred strains. the incisors grow continuously and are worn down during mastication. the mouse brain has a typical mammalian structure as documented by a detailed study of the neuroanatomy of the c57bl/6j mouse (sidman et al., 1971) . more recently, gene expression patterns have been used to study the functional anatomy of the mouse brain (bohland et al., 2010) . use of wild-type and genetically modified mice in behavior, learning, and memory paradigms has exponentially increased over the last decade. the male reproductive organs consist of paired testes, urethra, penis, prostate and associated ducts and glands ( fig. 3.8) . the female reproductive organs consist of paired ovaries and oviducts, uterus, cervix, vagina, clitoris, and paired clitoral glands ( fig. 3.9 ). the clitoral glands are homologous to the male preputial glands and secrete a sebaceous substance through ducts entering the lateral wall of the clitoral fossa. the female mouse normally has five pairs of mammary glands, three in the cervicothoracic region and two in the inguinoabdominal region ( fig. 3 .10). the mammary glands are often not appreciated for how far they extend over the cervical, axillary, and inguinoabdominal flank regions which become the following section summarizes normal reproduction in the mouse. the reader is referred to a more comprehensive text in the aclam series (pritchett and taft, 2007) and online resources such as the jackson laboratories publication of the biology of the laboratory mouse (http://jaxmice.jax.org/jaxnotes/509/509j.html). external influences, such as noise, vibration, diet, light cycle, and cage density, and intrinsic factors, such as health status, genetics, and parity impact reproductive success by directly or indirectly influencing the hypothalamic-pituitary axis for hormonal control of ovarian and testicular function. genotype also dramatically affects the reproductive performance of the mouse. coincident with the explosion in the number of mouse strains, each with unique induced or spontaneous mutations, a sound breeding program must include training of care staff to recognize anticipated and unanticipated breeding performance and strain or stock characteristics. in the new age of genomics, older methods of confirming genetic purity of mouse lines are being replaced with formal genetic monitoring by comparing strain-specific panels of single-nucleotide polymorphisms (snps). follicle-stimulating hormone promotes gametogenesis in both sexes. luteinizing hormone promotes the secretion of estrogen and progesterone in the female and androgen in the male. prolactin promotes lactation and development of the ovary during pregnancy. these gonadal hormones also ensure proper maintenance of the reproductive tract and modulate behavior to promote successful mating. the hypophysis is usually responsive to hormonal influence by day 6 in the male and day 12 in the female. ovarian follicle development begins at 3 weeks of age and matures by 30 days. rising levels of gonadotropins evoke signs of sexual maturity at about the same age. in the female, estrogen-dependent changes such as cornification of vaginal epithelium at the vaginal opening can occur as early as 24-28 days. puberty is slightly later in the male (up to 2 weeks). sexual maturation varies among strains and stocks of mice and is subject to seasonal and environmental influences. mating behavior and the ability to conceive and carry fetuses to parturition are under complex hormonal control mediated by the anterior pituitary. the mouse is polyestrous and cycles every 4-5 days. in the first two phases (proestrus and estrus), active epithelial growth in the genital tract culminates in ovulation. degenerative epithelial changes occur during the third phase, followed by diestrus, a period of quiescence or slow cell growth. the cycle can be followed by changes in the vaginal epithelium that are often used to determine optimum receptivity of the female for mating and fertilization (table 3 .9). patency of the vaginal orifice and swelling of the vulva are useful signs of proestrus and estrus ( fig. 3.11) . irregularities of the estrous cycle occur during aging. seasonal and dietary factors, such as estrogenic substances found in a variety of feeds, and genetic backgrounds also influence estrous cycles. estrus is routinely observed in mice at about 14-24 h after parturition (postpartum estrus). however, cornification of the vagina is not complete, and fertile matings are not as frequent compared with normal estrus. mice are spontaneous ovulators. ovulation does not accompany every estrus, and estrus may not coincide with every ovulation, because estrus is dependent on gonadal hormones, whereas ovulation is responsive to gonadotropin. the cyclicity of estrus and ovulation is controlled by the diurnal rhythm of the photoperiod. mating, estrus, and ovulation most often occur during the dark phase of the photoperiod. reversing the timing cook (1983) . laboratory animal medicine of the light-dark cycle reverses the time of estrus, ovulation, and mating. pheromones (table 3 .10) and social environment also affect the estrous cycle. for example, estrus may be suppressed in group-housed female mice and reentry into estrus can be synchronized by exposure to pheromones in male mouse urine ('whitten effect'). once exposed to male urine, most female mice will be in estrus within 3 days with a second estrus in about 11 days. hence, estrus can be synchronized by group-housing females prior to pairing with males. in contrast, pheromones from a strange male mouse, particularly of a different strain, may prevent implantation or pseudopregnancy in recently bred females and is known as the 'bruce effect'. see section ii.c on behavior for more detail on the effect of pheromones on mouse reproductive behavior. mating is normally detected by formation of a vaginal plug (a mixture of the secretions of the vesicular and coagulating glands of the male) whose prevalence is highly strain dependent. the plug usually fills the vagina from cervix to vulva (fig. 3.11 ). plug detection is often coupled with vaginal cytology to evaluate fertility and conception. when the cervix and vagina are stimulated physically during estrus, prolactin is released from the anterior pituitary to enable the corpus luteum to secrete progesterone. secretion continues for about 13 days. if fertilization has occurred, the placenta takes over progesterone production. if fertilization does not occur, a pseudopregnant period ensues, during which estrus and ovulation do not occur. fertilization usually takes place (1) testis, (2) head of epididymitis, (3) caudal epididymitis, (4) vas deferens, (5) testicular vein, (6) ampullary gland, (7) seminal vesicle, (8) anterior prostate, (9) ureter, (10) bladder, (11) ventral prostate, (11') dorsal prostate, (12) urethra, (13) bulbourethral muscle, (14) ischiocavernosus, (15) bulbourethral gland, (16) diverticulum of bulbourethral gland, (17) penis, (18) preputial gland, (19) glans penis, (20) prepuce, (21) testicular artery, and (22) vas deferens artery. adapted from (komarek, 2007) . fallopian tube, (3) uterine horn, (4) endometrium, (5) cervix, (6) vagina, (7) vaginal vestibulum, (8) clitoris, (9) clitoral gland, (10) urethra, (11) bladder, (12) medial ligament of bladder, (13) lateral ligament of bladder, (14) left ureter, (14') right ureter, (15) mesovarium, (16) mesometrium, (17) ovarian artery, (18) uterine horn artery, and (19) ovarian artery and vein. adapted from (komarek, 2007) . adapted from komarek (2007) . in the ampulla or the upper portion of the oviduct. ova can be fertilized to produce normal embryos for 10-12 h after ovulation. gestation is usually 19-21 days. because of postpartum estrus, lactation and gestation can occur simultaneously. lactation can delay gestation because of delayed implantation. this may cause prolongation of gestation for up to 12-13 days in certain inbred strains. the effective reproductive life of some inbred strains approaches 2 years where optimum environmental conditions are maintained, but litter size usually decreases as the female ages. therefore, females are usually retired by 6 months of age. average litter size is strain dependent and commonly ranges from 1 to 12 pups. maternal care can account for about 70% of the variation in body weight of neonatal mice. nursing females usually lactate for 3 weeks. milk production increases up to 12 days postpartum and then declines until weaning at 21 days. interestingly, oxytocin is required for nursing but is not essential for parturition or reproductive behavior (nishimori et al., 1996) . some transmission of humoral immunity from dam to progeny occurs in utero, but the majority of antibody is transferred through colostrum. transmission of passive immunity by colostral antibodies has been demonstrated to a wide variety of antigens, including viruses, bacteria, and parasites. antibodies continue to be secreted in the milk throughout lactation. decay of maternally acquired immunity occurs within several months after weaning. loss of maternal immunity increases susceptibility to infection and warrants continued care of weaned mice under barrier conditions. mice are socially gregarious animals with strong family bonds who communicate through complex olfactory, auditory, tactile, and visual signals. wild mice aggregate into groups called demes with low exchange of individuals between different groups. each deme consists of kinrelated members with a high degree of natural inbreeding, higher mutation rates compared to other mammals, and a wide range of developmental flexibility based on early life experience, which all contribute to their remarkably successful environmental adaptability. the deme is composed of a dominant breeding male, a hierarchy of females, subordinate males, and juveniles. wild mice occupy territories measuring just a few square meters when food is abundant to several square kilometers. mice are crepuscular (active during the twilight hours of dawn and dusk), strongly territorial, and omnivorous. coprophagy contributes to approximately one-third of their ingesta as an essential nutritional activity. aside from territoriality, social interactions, breeding, burrowing (when conducive substrates are available), and nest building are major activities. in managing laboratory mice, it is important to understand the complex behavioral biology of their free-living counterparts (latham and mason, 2004) . chemo-olfactory communication is mediated through extremely diverse chemical factors that trigger innate (non-learned) social responses among conspecifics, known as pheromones (table 3 .10). pheromones have been traditionally divided into two broad categories: releaser pheromones, which elicit an immediate behavioral response, and primer pheromones, which mediate a slowly developing and longer-lasting endocrine response. this original definition of pheromone categories has been expanded to another category, termed signaler pheromones, which convey individual or group identity, as well as mediating parent-offspring recognition and mate choice. the biology and genetics of pheromone signaling is being extensively studied in the mouse as a model of mammalian pheromone communication (brennan and zufall, 2006; rodriguez and boehm, 2009) . mouse pheromones are excreted in the urine, as well as plantar, salivary, lacrimal, preputial, and mammary glands. in the urine, major urinary proteins (mups), small peptides, mhc class i peptides, volatile chemicals, and sex hormones all contribute to chemosignals that communicate dominance, kinship, diversity, and gender. wild mice possess a great deal of individual variations of roberts et al. (2012) . c ferrero et al. (2013) . laboratory animal medicine these elements, providing a 'bar code' that distinguishes individuals. inbreeding of laboratory mice has reduced individual variation, but each inbred strain possesses a characteristic array of signals, and to a certain extent, unique signals exist among individuals within a strain (sharrow et al., 2001; sturm et al., 2013) . pheromones are detected by sensory neurons in the vomeronasal organ, the olfactory epithelium, and the lesser known septal organ of masera within the olfactory epithelium, and the gruenberg ganglion, which is located at the anterior end of the nasal cavity (breer et al., 2006; chamero et al., 2012; liberles and buck, 2006; restrepo et al., 2004) . neuronal signals are transmitted to the ganglion layer of the olfactory bulb, and thence to the brain. mups are important components of chemosensory communication in mice, and also an important occupational hazard to human handlers. chromosome 4 contains a cluster of 21 mup genes, plus a number of pseudogenes. mups are small soluble proteins known as lipocalins, which bind small organic chemicals (pheromones) with high affinity, and function as pheromone transporters and stabilizers (thereby contributing to slow release), but also act as protein pheromones themselves. they are synthesized in the liver and excreted in the urine, as well as nasal mucosa, lacrimal glands, and salivary glands. their endogenous role on metabolic activity is not yet understood. male mice excrete significantly more mups in the urine than females. one wellcharacterized mup is 'darcin', named after fitzwilliam darcy, the romantic hero in pride and prejudice. as its name implies, it is a female attractant. mups also act as kairomones, which function as chemical signals between species. for example, cat and rat mups invoke fear in mice. mups are important in the laboratory animal management context, as they are excreted in copious amounts (1-5 mg/ml in urine) and are potent allergens for humans, particularly mus m 1 (ag1 or ma1), which is encoded by the mup 17 gene (sharrow et al., 2001) . chemosensory communication has numerous behavioral effects that influence mouse social interactions. one of the most studied behavioral effects is the bruce effect, or pregnancy block, which is a complex physiologic response in which recently conceived females resorb fetuses during early pregnancy in the presence of an unrelated male, particularly a dominant male. the continued presence of the original mate protects the female from this effect (bruce, 1959) . the vandenbergh effect results in acceleration of puberty of juvenile females in response to male urine (vandenbergh, 1973) . the lee-boot effect occurs among group-housed females that are isolated from males, in which there is suppression of estrus cyclicity (van der lee and boot, 1955) . the whitten effect results in synchronization of estrus among a group of females in response to a male (whitten et al., 1968) . the lee-boot and whitten effects are utilized in the laboratory to assist in induction of synchronized timed pregnancy, but the bruce effect can have deleterious consequences on breeding colonies when foreign males are introduced to a breeding colony, as pheromone communication can occur in the absence of direct contact. the above effects are well-defined pheromone-driven behavioral responses, but chemosensory communication has a myriad of other effects. estrus, pregnant, or lactating females also accelerate puberty among juvenile females. females use odor cues to avoid parasite-laden males, males prefer odors of estrus females, and estrus females prefer odors of dominant males. mice have strong mating and social preferences based upon mhc proteins, which indicate genetic relatedness. maternal recognition of young is also mhc-related, and pups prefer nest odors of maternal and sibling pups based upon mhc relatedness. male aggression against unrelated males is also a strong mhc-related phenomenon. mhc haplotypes determine not only mhc proteins in the urine, and mhc-specific olfactory receptors, but also the composition of volatile chemicals in the urine (kelliher and wersinger, 2009) . the complexity of social communication extends to auditory stimuli as well. male mice utilize ultrasonic 'birdsong' to vocally communicate and attract females. mouse vocalization patterns are largely genetically innate and unique to each strain of mouse, but they can also be modified, or learned, to a limited extent (arriaga et al., 2012) . the behavioral biology of the mouse is highly complex, and depends upon genetic, physiologic, social, and environmental variables, which all impact on how laboratory mice can best be managed in captivity. it is clear that this rich complexity cannot be fully addressed under laboratory conditions, but that does not mean that basic needs, such as nest building, burrowing, foraging, and olfactory environments, cannot be provided. for example, intermale aggression, which is particularly apparent in some strains of mice such as balb/c and swiss-origin stocks and strains, can be minimized by maintaining males from infancy as sibling groups, since adult siblings tend not be aggressive to one another. this sibling bond, however, can be easily broken by short-term separation. environmental enrichment often features provision of plastic houses, which may make vivarium managers feel good, but maximal enrichment can be provided by provision of nesting material, which includes structural scaffolding, such as crinkled cardboard, which facilitates construction of three-dimensional nests. mouse nests are replete with 'appeasement' pheromones, thereby contributing to harmony within the cage, whereas introduction of dirty bedding has the opposite effect. frequent cage changing, including removal of established nests, is highly stressful and disruptive to social harmony within a cage. provision of appropriate and adequate amounts of bedding material that is conducive to burrowing is desirable. it is important to remember that mice are socially gregarious, and that mouse welfare is optimally enriched by other mice within a socially harmonious deme (latham and mason, 2004; van loo et al., 2003) . a laboratory mouse ethogram, defined as an operationalized list of mouse behaviors, arranged by their adaptive meaning to the animal, is available on the web: www. mousebehavior.org. behavioral phenotyping, particularly of transgenic mice, is used extensively in genomic research. a wide variety of standardized test batteries and approaches are used, depending upon the focus of research (reviewed in crawley 2008) . initial behavioral evaluations include general health, body weight, body temperature, appearance of the fur and whiskers, and neurological reflexes assessment. specific tests include observations of home cage behaviors, righting reflex, acoustic startle, eye blink, pupil constriction, vibrissae reflex, pinna reflex, digiscan open field locomotion, rotarod motor coordination, hanging wire, footprint pathway, visual cliff, auditory threshold, pain threshold, and olfactory acuity. novel and complex environmental enrichment in animal housing conditions facilitates enhanced sensory and cognitive stimulation as well as physical activity. environmental enrichment and exercise have beneficial effects such as cognitive enhancement, delayed disease onset, enhanced cellular plasticity, and associated molecular processes in animal models of brain disorders (pang and hannan, 2013) . the immune system of the mouse is very similar to that of humans. the availability of inbred mouse strains, in which each individual animal expresses identical mhc alleles so that tissues and cells can be transplanted without tissue rejection, greatly simplifies and indeed enables functional analyses of immune system components not possible with any other outbred mammalian species. in addition, the ability to genetically manipulate the mouse genome, adding to, altering, and deleting existing genes, enables unprecedented in vivo analysis of immune cell functions. it is for these reasons that the mouse is the primary animal model for immunology research. the immune system is an unusual organ system in that it consists of both solid tissues and various migrating cell populations. the bone marrow and thymus are considered primary lymphoid organs, as sites of hematopoiesis and b-and t-lymphocyte development, respectively. lymph nodes, spleen, and intestinal peyer's patches are considered secondary lymphoid tissues, as sites of immune response initiation. lymph nodes and spleen are analyzed frequently for studies of immune responses and as organs for immune cell isolation. tertiary lymphoid tissue sites are those that form in other solid organs in response to an insult or microbial exposure. among them are the lymphoid cell aggregates of the gastrointestinal and respiratory tract, also called 'gut-associated lymphoid tissue' (galt) and bronchusassociated lymphoid tissues (balt). leukocytes are classified as belonging to the innate or adaptive immune system. the innate immune system responds rapidly to an antigen insult via recognition of pathogen-associated molecular patterns (pamps), such as lipopolysaccharide, bacterial flagellin, single (s)-and double-stranded (ds) rna, and non-methylated dna, via extracellular or intracellular pattern recognition receptors (prrs). receptors include the toll-like receptors (tlrs), such as tlr4 (recognizing lps), tlr3/7 (ss and dsrna) and tlr9 (dna), nod-like receptors (nod1/2), and rig-like receptors (rig-i, mda-5) among others (takeuchi and akira, 2010) . cells of the innate immune system are monocytes/macrophages, granulocytes and dendritic cells as well as innate-like lymphocyte populations (ilc) 1, 2 and 3, which include natural killer (nk) cells (spits et al., 2013) . cells of the adaptive immune system (t and b lymphocytes) express a highly antigen-specific receptor that has arisen through gene rearrangement (t-cell and b-cell receptors, respectively). b cells of the b-1 lineage and γδ t cells are regarded as innate-like cells, as they express a rearranged antigen receptor but seem to respond in an innate-like manner. leukocytes are identified and classified by sets of monoclonal antibodies (mab) against uniquely expressed surface receptors, typically measured by flow cytometry. identification of a unique receptor by one or more mab of the same specificity leads to the assignment of a receptor name, as a 'cluster of differentiation (cd)'. for example, t cells are differentiated into two subsets based on their expression of either cd4 or cd8. cd4 + t cells (t helper cells) recognize peptides presented in mhc class ii and promote b-lymphocyte activation and activate and regulate cellular immune responses via secretion of differing cytokines (see below). cd8 + t cells recognize antigenic peptides presented in mhc class i and serve as cytotoxic cells during the cell-mediated immune response where they can destroy infected cells (e.g., against cells containing infectious agents). the major function of b cells is to respond to an encounter with an antigen/pathogen with the production of highly antigen-specific immunoglobulins (ig; antibodies), which can bind to and inactivate pathogens and toxins. activation of b cells can lead to their differentiation to plasma cells, which produce large amounts of ig. five laboratory animal medicine classes or ig 'isotypes' can be distinguished, which differ in effector function: igm, igg, iga, ige, and igd. the latter is expressed only on the surface of b cells in mice. the igg class, the most abundant antibody class in the serum, is further divided into subtypes: igg 1 , igg 2a/c , igg 2b , and igg 3 . polymorphisms exist on the ig locus such that some strains of mice produce the igg2a subtype (e.g., balb/c), whereas others produce igg2c (e.g., c57bl/6) (zhang et al., 2012) . additional allelic polymorphisms of the locus also exist. for example, balb/c and 129sv mice express the igh-a allotype, whereas c57bl/6 mice express the igh-b allotype. recombinant inbred strains of mice exist for both balb/c and c57bl/6, which harbor the reciprocal igh locus (i.e., igh-b for balb/c and igh-a for c57bl/6 mice). these mice are useful tools for tracking b cells following adaptive cell transfer via allotype-specific mab (see below). immunoglobulin isotype production varies according to the type of immunogen used to evoke the response. igm is secreted short term after initial exposure to an antigen, followed by the other ig isotypes. in viral and intracellular bacterial infections, igg 2a/c is dominant, whereas in extracellular bacterial infections igg 1 dominates the response. igg 2b and igg 3 are usually induced to carbohydrate or lipid antigens. ige is linked to parasitic infections and to allergy. serum antibodies specific for an immunogen can often be measured for the life of the animal. while serum iga levels are low, iga is the highest produced ig in mice. iga production, however, occurs in plasma cells lodged in the lamina propria of mucosal tissues, from where the iga is actively transported in dimeric form onto the luminal surface of mucosal tissues as 'secretory' iga (brandtzaeg, 2009 ). cytokines are secreted signaling molecules involved in cell-cell communication in a complex biological system (table 3 .11). these include the large family of interleukins (ils, currently il-1 to il-37), tumor necrosis factors (tnfs), interferons (type i, ii, and iii) and growth factors such as granulocyte-macrophage colonystimulating factor (gm-csf) and stem cell factor (scf). cytokine secretion often occurs in response to recognition of antigen via prr or tcr. because of their importance in modulating immunity to antigenic stimuli, mice with specific deletions or overexpression of individual cytokines have been made and have contributed to a detailed understanding of many of their often pleotropic functions (akdis et al., 2011) . chemokines are a similarly large group of small, secreted molecules that regulate cell trafficking to sites of antigen encounter but also facilitate cell-cell contact by acting as chemoattractants. chemokines are grouped according to the number of cysteines and disulfide bonds in the molecule into c-x-c-, c-c, c, and cx 3 cl chemokine ligands (l) and receptors (r) and designated accordingly as cxcr1-7/cxcl1-16 and ccr1-10/ccl 1-28 (allen et al., 2007) . immune responses must be coordinated to provide the most appropriate effector functions for the type of pathogen/antigen encountered. immune effector responses differ depending on the life cycle (facultative or obligate intracellular, extracellular, localized, systemic, etc.) and antigen types displayed by the encountered antigen/ pathogen, because this affects the type of prr engaged and activated. prr engagement leads to cytokine and chemokine responses by the first responders, i.e., epithelial cells, local macrophage populations and other innate cells. the type of cytokines and chemokines produced then dictates the types of cells recruited to the site of infection and their subsequent differentiation and functions. the prr engagement also leads to antigen uptake, activation and migration of dendritic cells (dcs) from the site of insult to the regional lymph nodes, where dcs present antigen peptides on mhc molecules to t cells. in addition, the dcs secrete cytokines induced by the initial prr activation, which cause the differentiation of cd4 t cells towards a particular effector response. for example, secretion of il-12 in response to activation of tlr2 or 4 will result in the induction of interferongamma (ifn-γ) production by cd4 t cells, whereas il-6 and tgf-β production by dc will induce cd4 t cells to secrete il-17 (kara et al., 2014) . because the dc translates signals from prr at the site of infection into differentiation signals for t cells in the lymph tissues, these cells are regarded as a 'bridge' between the innate and adaptive immune systems. the specific ig isotype secreted in response to a pathogen depends to a large degree on the type of cytokine produced by cd4 t cells that provide 't-cell help' for b cells. t cells that interact with b cells are identified as a discrete subset termed 't follicular helper cells (t fh )' and it is their cytokine profile that directs b cells to secrete a particular ig isotype (kara et al., 2014) . the classic t h 1/t h 2 dichotomy outlined above was in part shaped by the observation that ifn-γ production will lead to switching of b cells to secrete igg2a/c, whereas production of il-4 leads to the secretion of igg1. interestingly, it appears that the cytokine profile induced by the effector t-cell population is mirrored by the innate immune response. innate-like lymphocytes also have effector phenotypes that correspond to those of cd4 t cells and are induced by the same signals and transcriptional regulators (spits et al., 2013) and the same appears to be true also for macrophages and other innate immune cells (sica and mantovani, 2012) . while initial studies identified two particular antagonistic effector response types (termed t h 1 and t h 2 and classified by t-cell production of ifn-γ and il-4, respectively), more recent studies now demonstrate a much wider array of effector responses in which innate and adaptive immunity acts together to reinforce an immune response phenotype as well as modulate its size by induction of t regulatory cells (t regs ) that generate inhibitory cytokines (kara et al., 2014; sica and mantovani, 2012; spits et al., 2013) . the use of cytokine-deficient and reporter mice that enabled the identification of cytokine-producing cells via expression of a fluorescent reporter was particularly valuable for the development of this more nuanced view of the quality of immune responses. spontaneous mouse models of immune deficiencies have been used extensively in research. their use, plus the expanding number of knockout, transgenic, and dominant negative mouse mutants, has advanced understanding of human immune deficiency diseases as well as basic understanding of the immune system (table 3 .12). interbreeding of multiple immune-deficient mice has allowed the development of 'humanized' mice in which immune cells of the mouse are replaced with those of humans. while many challenges remain to fully replenish mice with components of the human immune system, the use of immune-deficient nod/severe combined immunodeficient (scid)/il-2rγ -/recipients for transfer of human peripheral blood lymphocytes, cordblood or bone marrow-derived cd34+ stem cells with human liver and thymus (blt-mice) is yielding promising results (akkina, 2013) . investigators using genetically engineered mice are constantly reminded that phenotypic analysis of these animals must be done cautiously because the immune system may be profoundly affected and in ways that are not always anticipated. this may make it difficult to determine whether a given gene product is directly involved or may be secondary to a more global dysregulation of the immune system. as with other biological systems, compensation mechanisms also may mask the phenotype. experimental approaches are being increasingly used to refine the knockout technology by restricting a specific genetic deficiency to a particular tissue of interest using the cre-lox system, in which tissue-specific or temporal restricted expression of the cre recombinase induces the deletion of a 'floxed' gene (mak et al., 2001) . transgenic mice are available that restrict cre expression to various hematopoietic cells or tissue or drive cre recombination following injection of tamoxifen. other approaches are the generation of 'bone marrow irradiation' chimeras. here, inbred wild-type mice or mice deficient in certain immune cells (table 3 .12) are lethally irradiated by exposure to a gamma-irradiation source to deplete the hematopoietic stem cells. these are then replaced by transfer of bone marrow cells to the irradiated mice. reconstitution of the hematopoietic system is usually achieved within about 6 weeks, during which time mice are provided with antibiotic-containing drinking water to avoid infections of these temporarily immune-compromised animals. transfer of bone marrow from a congenic knockout restricts the genetic defect to the hematopoietic system. a mix of bone marrow from two sources is also often used to generate tissue-specific knockouts. for example, mixing a bone marrow from t-cell-deficient mice (75%) with that of a gene knockout (25%) generates 'mixed bone marrow chimeras' in which all t cells only develop from the knockout, thus lack the gene of interest, whereas most of the other cells t from the wild-type source, effectively constraining the genetic defect to the t-cell population. sets of congenic mice with defined allotypic differences are often used to confirm the source of individual cells. such markers include the gene locus cd45.1/cdc45.2 or cd90.1/cd90.2 (thy1.1/thy1.2). alternatively, cells may express a fluorescent transgene, such as green-fluorescent protein (gfp). identification is usually performed by flow cytometry, or less commonly by immunofluorescence or immunohistochemistry. generation of bone marrow chimeras circumvents the time-consuming breeding of cre recombinase-expressing flx/flx mice. however, numerous controls are needed to exclude off-target effects due to irradiation damage. repeat injection of antibodies targeting specific cell populations is another rapid approach that avoids the potential for irradiation damage and allows short-term depletion of individual cell subsets. its main disadvantage is the need to identify mab that bind to surface receptors uniquely expressed by a cell subset of interest and the verification of the efficacy of the depletion. frequently used is antibody treatment for the short-term depletion of t-cell subsets using mab against cd4 or cd8 as well as individual cytokines. contemporary knowledge about diseases of laboratory mice has developed primarily from examining the effects of disease on traditional strains and stocks. the widespread use of genetically engineered mice is likely to modify current concepts because of novel or unpredictable interactions among genetic alterations, the genetic backgrounds on which they are expressed, and exogenous factors, such as infectious agents. because the number of combinations is extraordinarily high, clinical and laboratory diagnosticians should be alert to the potential for altered disease expression in genetically engineered mice and not be misled by unexpected signs, lesions, and epizootiology. many microbial agents have the potential to cause disease in mice or interfere with mouse-based research. housing and husbandry in microbiologically sheltered environments are designed to reduce the risks of disruptive infection, especially among immunologically dysfunctional mice, but must be accompanied by effective microbiological surveillance. surveillance should encompass resident mice and mouse products (serum, cell lines, transplantable tumors) procured from external sources. because surveillance strategies will vary with research needs and operating conditions, it is prudent to consult a number of sources, such as the federation of european laboratory animal science associations (felasa) (nicklas et al., 2002) and commercial laboratories, for guidance. detailed discussion of microbial quality control is provided in chapter 10. there are also recommendations regarding specific agents in following sections. diagnostic methods involve gross and microscopic pathology, parasitology, microbial isolation and culture, serology, and pcr. serology is particularly important for viral surveillance, and now relies principally on enzyme-linked immunosorbent assay (elisa), multiplex fluorescent immunoassay (mfi) for simultaneous detection of antibodies to multiple agents (hsu et al., 2007) , indirect fluorescent antibody (ifa) assay, or hemagglutination inhibition (hai), with the latter two methods generally used for confirmation (livingston and riley, 2003; pritchett-corning et al., 2009) . mouse antibody production (map) testing has been historically used for testing biological materials for contamination by infectious agents. pcr panels for murine infectious agents are now commercially available and have cost and time-saving advantages as well as improved assay sensitivity and specificity. beyond the classic bacterial and viral murine infections, pcr assays are now available for endo-and ectoparasites (see chapter 11). etiology mousepox is caused by ectromelia virus (ectv), an orthopoxvirus that is antigenically and genetically closely related to a number of other poxviruses, including vaccinia, variola, and cowpox viruses. the original isolate of ectv, known as the hampstead strain, was discovered by j. marchal in 1930 (marchal, 1930 as the cause of epizootic disease among laboratory mice in england. the disease featured amputation of extremities, which marchal termed ectromelia (from the greek, ectro, amputation and melia, limb). other strains of the virus include moscow, nih-79, washington university, st. louis 69, beijing 70, ishibahsi i-iii, and naval (nav) strains, which vary in virulence, but are essentially indistinguishable genetically and serologically, suggesting a common origin. virus can be isolated from infected tissues by inoculation of cell cultures (bs-c-1, hela, l cells) or embryonated eggs. the natural host (and original source of infection of laboratory mice) of ectv remains unknown. clinical signs the expression of clinical signs reflects an interplay among virus-related factors, including virus strain, dose and portal of entry, and host-related factors, including age, genotype, immunological competence, and gender (brownstein et al., 1991a) . during natural epizootics, it was observed that a, bc, dba/1, dba/2, and cba strains developed acute fatal infections, whereas c57bl/6 mice were resistant to severe disease (briody, 1966) . experimental studies have shown that all strains of mice are susceptible to infection, but balb/c, a, dba/2, and c3h/he mice were highly susceptible, akr and sjl mice were moderately susceptible, and c57bl/6 mice were highly resistant to lethal infection (bhatt and jacoby, 1987c; wallace and buller, 1985) . the mechanisms of genetic resistance are not fully understood but appear to reflect multiple genes, some of which appear to be expressed through lymphoreticular cells, including nk cells (brownstein et al., 1991a; jacoby et al., 1989) . the nuances of cytokine and cellular immune responses to ectv infection have received recent attention (reviewed in buller and fenner (2007) and esteban and buller (2005) ). outbreaks among susceptible mice are often volatile, with variable morbidity and high mortality in susceptible strains of mice. clinical signs such as ruffled fur or prostration may occur for only a few hours before death. mice that survive acute infection may develop chronic disease characterized by a focal or generalized rash anywhere on the body ( fig. 3 .12). conjunctivitis also may occur. skin lesions usually recede within several weeks, but hairless scars may remain. additionally, severe viral infection of the feet and tail during the rash syndrome can lead to necrosis and amputation. epizootiology mousepox is not a common disease. outbreaks occur sporadically and recent outbreaks have been traced to the importation of contaminated mice or mouse products. for example, contaminated mouse serum was responsible for recent outbreaks in the united states (dick et al., 1996; . natural exposure is thought to occur through direct contact and skin abrasions. cage-to-cage transmission is low and can be virtually nil if filter-topped cages are used (bhatt and jacoby, 1987b) . ectromelia virus is highly stable at room temperature, especially under dry conditions, leading to the potential for prolonged environmental contamination in infected colonies (bhatt and jacoby, 1987d) . aerogenic exposure is not a major factor in natural outbreaks, and arthropod-borne transmission does not appear to occur. virus-free progeny can be obtained laboratory animal medicine from immune dams (bhatt and jacoby, 1987b) . however, intrauterine infection and fetal deaths, albeit rare, have been reported. natural transmission is facilitated by intermediately resistant mice, which survive long enough to develop skin lesions that can shed virus for relatively long periods of time. the risks for transmission are further increased by persistence of infectious virus in excreta and exfoliated scabs. although virus excretion typically lasts for about 3 weeks, virus has been found in scabs and/or feces for up to 16 weeks. resistant mouse strains also are dangerous because they can shed virus during subclinical infections. however, infections in resistant mice tend to be short-lived. highly susceptible mice are a relatively small hazard for dissemination of infection, if properly discarded, because they die before virus shedding becomes prominent. thus, juxtaposition of resistant or intermediately resistant infected mice with highly susceptible mice can provoke explosive outbreaks. infant and aged mice are usually more susceptible to lethal infection than young adult mice. maternal immunity among enzootically infected breeding mice may perpetuate infection by protecting young mice from death, but not from infection. such mice may subsequently transmit infection by contact exposure. pathology the classic descriptions of ectv pathogenesis by fenner remain timely, including the frequently cited and reproduced figure summarizing the pathogenesis of infection ( fig. 3 .13) (fenner, 1948b) . interest in smallpox has renewed the interest in ectv as a model of host response to infection (esteban and buller, 2005) . ectv multiplies in the cell cytoplasm and produces two types of inclusion bodies. the a type (marchal body) is well demarcated and acidophilic in histological sections. it is found primarily in epithelial cells of skin ( fig. 3 .14) or mucous membranes and can also be found in intestinal mucosa. the b type of inclusion is basophilic and can be found in all ectromelia-infected cells. however, it is difficult to visualize unless cells are stained intensely with hematoxylin. ectv antigen can be readily visualized by immunohistochemistry on formalin-fixed, paraffin-embedded tissue sections (esteban and buller, 2005; jacoby and bhatt, 1987) . following skin invasion, viral multiplication occurs in the draining lymph node and a primary viremia ensues. splenic and hepatic involvement begin within 3-4 days, whereupon larger quantities of virus are disseminated in blood to the skin. this sequence takes approximately 1 week and, unless mice die of acute hepatosplenic infection, ends with the development of a primary skin lesion at the original site of viral entry. the primary lesion is due to the development of antiviral cellular immunity. severe hepatocellular necrosis occurs in susceptible mice during acute stages of mousepox. white spots indicative of necrosis develop throughout the liver ( fig. 3.15 ). in nonfatal cases, regeneration begins at the margins of necrotic areas, but inflammation is variable. splenic necrosis in acute disease commonly precedes hepatic necrosis but is equally or more severe. necrosis and scarring of red and white pulp can produce a macroscopic 'mosaic' pattern of white and red-brown the primary skin lesion, which occurs 6-10 days after exposure, is a localized swelling that enlarges from inflammatory edema. necrosis of dermal epithelium provokes a surface scab and heals as a deep, hairless scar. secondary skin lesions (rash) develop 2-3 days later as the result of viremia. they are often multiple and widespread and can be associated with conjunctivitis, with blepharitis, and, in severe cases, with buccal and lingual ulcers. the skin lesions also can ulcerate and scab before scarring. diagnosis mousepox can be diagnosed from clinical signs, lesions, serological tests, and demonstration of virus or viral antigen in tissues. observation of characteristic intracytoplasmic eosinophilic inclusions aids detection of infection. several serological tests are available to detect mousepox. historically, the standard test was hai, using vaccinia antigen as a source of hemagglutinin. elisa is more sensitive and specific and has replaced hai for serological monitoring among nonvaccinated mice (buller et al., 1983) . ectv infection also can be detected by ifa (buller et al., 1983) and pcr. serological differentiation of mousepox from vaccinia infection in vaccinated mice is based on the lack of hemagglutinin in the vaccine strain of virus. thus, serum from vaccinated mice may react by elisa but should not react by hai. differential diagnosis mousepox must be differentiated from other infectious diseases associated with high morbidity and high mortality. these include sendai pneumonia, mouse hepatitis, and tyzzer's disease. the latter two can be expressed by acute necrosis in parenchymal organs, but they can be differentiated by morphological, serological, and virological criteria. the skin lesions of chronic mousepox must be differentiated from other skin diseases caused by opportunistic or pathogenic bacteria, ascariasis, and bite wounds. prevention and control mousepox is a dangerous disease because of its virulence for susceptible mice. therefore, infected colonies should be quarantined immediately. depopulation has been used as a primary means for control, but confirmation of infection should be obtained before exposed mice are destroyed. tissues, supplies, instruments, or other items that have had potential contact with infected mice should be disinfected by heat or chemicals such as formalin, sodium hypochlorite, or chlorine dioxide. materials should be autoclaved or, preferably, incinerated. disinfected rooms should be challenged with susceptible sentinel animals that are observed for clinical signs and tested for seroconversion after several weeks. depopulation and disinfection must be carried out vigorously. because modern housing and husbandry methods based on the use of microbarrier caging are effective for containing infection, testing and culling properly isolated mice is a potential alternative, especially for irreplaceable breeding mice. such mice can be quarantined along with cessation of breeding to permit resolution of infection (bhatt and jacoby, 1987b) . sequential testing with contact-exposed sentinels should be employed with this option. additionally, maternal immunity from fully recovered dams can protect mice from infection, thereby enhancing opportunities to derive virus-free mice from previously infected dams, with the caveat that progeny will be transiently seropositive with maternally derived antibody. vaccination can control or prevent clinically apparent mousepox. the hemagglutinin-deficient strain of vaccinia virus (ihd-t) is used to scarify skin on the dorsum of the tail. 'takes' should occur in previously uninfected mice by 6-10 days, but not in infected mice (bhatt and jacoby, 1987a) (fig. 3.17 ). infected mice should be quarantined separately or eliminated. vaccination may not prevent infection, although infection in vaccinated mice is often transient. furthermore, vaccinia virus can be shed from scarification sites for at least several days. therefore, other preventive measures, such as strict controls on the entry of mice or mouse products, combined with periodic serological monitoring, should not be relaxed until diagnostic testing has confirmed the elimination of vaccinia and ectromelia virus. additionally, seroconversion evoked by vaccination must be taken into account in serological monitoring of vaccinated colonies. finally, vaccinia virus is a human pathogen, so vaccination procedures should include personnel protective measures to prevent exposure. research complications the primary threat from mousepox is mortality in susceptible mice. the loss of time, animals, and financial resources can be substantial. (shellam, 2007, 96) mice are naturally susceptible to two herpesviruses from the subfamily betaherpesvirinae and in the genus muromegalovirus, the two species murid herpesvirus 1 (of which one of the members is mouse cytomegalovirus (mcmv)) and murid herpesvirus 3 (of which one of the members is mouse thymic virus (mtv)). they are species-specific viruses and distinct from each other and from other rodent herpesviruses. mctv has received considerable attention as a model of human cmv infection. etiology mouse cytomegalovirus (mcmv) is a mouse-specific betaherpesvirus. it can, however, replicate in cell cultures from several species, including mouse (fibroblasts and 3t3 cells), hamster, rabbit, sheep, and nonhuman primate. cocultivation may be required to rescue latent virus. clinical signs mcmv causes subclinical infection in adult immunocompetent mice, but experimental inoculation of neonates can cause lethal disease due to multisystemic necrosis and inflammation. epizootiology the prevalence of mcmv in laboratory mice is probably uncommon but undefined, since infection is clinically silent and serological surveillance is not widely practiced. wild mice are commonly infected and serve as a natural reservoir for infection, which implies that the entry of virus into a modern vivarium is most likely to occur from contaminated animal products. persistence is a central feature of nonlethal infection. persistently infected mice excrete virus in saliva, urine, and tears for many months, resulting in horizontal transmission through mouse-to-mouse contact. virus also can infect prostate, testicle, and pancreas, implicating other modes of excretion. vertical transmission does not appear to be a common factor in natural infection. further, maternal immunity protects sucklings from infection. pathology mouse cytomegalovirus can replicate in many tissues, and viremia commonly occurs. lesions are not remarkable during natural infection and may be limited to occasional enlarged cells (megalocytosis) containing eosinophilic intranuclear and/or cytoplasmic inclusions associated with lymphoplasmacytic interstitial inflammation, especially in the cervical salivary glands. susceptibility to experimental infection varies with age, dose, route, virus strain, and host genotype. infection can occur in young and adult mice. however, the pathogenicity of mcmv for mice decreases with age. neonates are highly susceptible to lethal infection, but resistance to disease develops by the time mice are weaned. immunodeficient mice, however, remain susceptible to pathogenic infection as adults. persistent infection often affects the salivary glands and pancreas. the persistence of salivary gland infection appears to be dose dependent. there is experimental evidence that mcmv can produce latent infection of b cells, probably t cells as well as aforementioned tissues. persistent infection may lead to immune complex glomerulonephritis. latent persistent infection can be reactivated by lymphoproliferative stimuli and by immunosuppression. diagnosis mcmv antigens appear to be weak stimuli for humoral antibody production, which is consistent with the fact that cellular immunity is critical for protection against infection. neutralizing antibody titers are low during acute infection and difficult to find during chronic infection. serology and pcr-based diagnosis are available, but neither is widely used because of assumptions that infection has a very low prevalence. detection of enlarged cells with intranuclear inclusions, especially in salivary glands, is diagnostic, if they are present. in situ hybridization can be used as an adjunct to routine histopathology. differential diagnosis mcmv infection must be differentiated from infection with mtv. the latter virus can produce necrosis of thymic and peripheral lymphoid tissue when infant mice are experimentally inoculated. lytic lesions of lymphoid tissues are not a hallmark of mcmv. the viruses can also be distinguished from each other serologically. sialoadenitis with inclusions can occur during infection with mouse polyoma virus. like mcmv, mtv infects the salivary gland as its primary target organ. prevention and control control measures for mcmv have not been established, because it has not been considered an important infection of laboratory mice. cage-to-cage transmission has not been demonstrated, but horizontal infection from contaminated saliva must be considered. the exclusion of wild mice is essential. research complications mcmv can suppress immune responses. apart from the potential for interfering with immunology research, it can exacerbate the pathogenicity of opportunistic organisms such as pseudomonas aeruginosa. etiology mouse thymic virus (mtv) is a herpesvirus (murid herpesvirus 3) that is antigenically distinct from mcmv. no suitable in vitro method for cultivation has been developed; therefore, viral propagation depends on mouse inoculation. clinical signs natural infections are subclinical. epizootiology the prevalence of mtv is thought to be low. mice can be infected at any age, although lesions develop only in mice infected perinatally. mice infected as infants or adults can develop persistent infection of the salivary glands lasting several months or more. excretion of virus in saliva is considered the primary factor in transmission. seroconversion occurs in adults but does not eliminate infection. infection in neonates may not elicit seroconversion, rendering such mice serologically negative carriers. the mode of infection is obscure, but virus is excreted in saliva, suggesting that transmission from infected dams to neonatal mice occurs by ingestion. mtv also has been isolated from the mammary tissue of a lactating mouse, suggesting the potential for transmission during nursing. prenatal transmission has not been found. pathology mtv causes severe, diffuse necrosis of the thymus and lymphoid tissue with tropism for cd4 + t cells in mice inoculated within approximately 1 week after birth. the severity of thymic and lymph node necrosis can be mouse strain-dependent. grossly, the thymus is smaller than normal. infected thymocytes display mtv-positive intranuclear inclusions. necrosis is followed by granulomatous inflammation and syncytium formation. reconstitution of lymphoid organs takes 3-8 weeks. diagnosis thymic necrosis associated with intranuclear viral inclusions is the hallmark lesion. viral antigen can be detected by immunohistochemistry. serologic detection is effective, but generally not utilized, and is potentially negative in neonatally exposed mice. suspicion of infection in seronegative mice can be tested by inoculation of virus-free neonatal mice with homogenates of salivary gland or with saliva. inoculated mice should be examined for thymic necrosis 10-14 days later. pcr or the mouse antibody production (map) test can also be used to detect infection. differential diagnosis reduction of thymus mass can occur in severe mouse coronavirus infection, during epizootic diarrhea of infant mice, or following stress. prevention and control because mtv induces persistent salivary infection, rederivation or restocking should be considered if infection cannot be tolerated as a research variable. research complications mtv transiently suppresses cellular and humoral immune responses because of its destructive effects on neonatal t lymphocytes. parvoviruses are among the most common viral infections in contemporary laboratory mouse populations (livingston et al., 2002) (pritchett-corning et al., 2009) , and pose major challenges to both detection and control. the mouse parvoviruses are composed of two antigenically and genetically distinct but related groups, including minute virus of mice (mvm) and mouse parvovirus (mpv), with each group containing a number of strains. the international committee on taxonomy of viruses classifies mpv, mvm, and several other rodent parvoviruses into one genus, protoparvovirus, and species, rodent protoparvovirus 1, but these viruses will be treated separately herein. etiology minute virus of mice (mvm) is a small (5-kb) single-stranded dna virus. the prototypic strain is designated mvmp. an allotropic variant with immunosuppressive properties in vitro is named mvmi, and additional laboratory animal medicine named strains include mvmc and mvmm. the genome encodes two nonstructural proteins, ns-1 and ns-2, which are highly conserved among the rodent parvoviruses and account for prominent cross-reactivity in serological assays that utilize whole virus antigen. the viral capsid proteins, vp-1 and vp-2, are virus-specific and form the basis for serological differentiation of mvm from mpv. mvm has a broad in vitro host range. it replicates in monolayer cultures of mouse fibroblasts (a9 cells), c6 rat glial cells, sv40 (simian virus 40)-transformed human newborn kidney (324k cells), t-cell lymphomas (el4), and rat or mouse embryo cells, producing cytopathic effects that can include the development of intranuclear inclusions. clinical signs natural mvm infections are subclinical. neonatal mice of some inbred strains are experimentally susceptible to lethal renal and/or intestinal hemorrhage during mvmi infection, but this syndrome has not been reported in natural outbreaks. experimental inoculation of adult c.b-17-prkdc scid (scid) mice with mvmi results in lethal infection (lamana et al., 2001; segovia et al., 1999) , and similar severe illness has been noted in naturally infected b-cell-deficient nod. cg-h2h4-igh6 null mice (naugler et al., 2001) . epizootiology mvm is a common virus that naturally infects laboratory mice, but appears to be less common than mpv (besselsen et al., 2006; livingston et al., 2002) . mvm is moderately contagious for mice, its only known natural host. virus can infect the gastrointestinal tract and is excreted in feces and urine. the resistance of rodent parvoviruses to environmental inactivation increases the risks of transmission after virus is excreted. therefore, contamination of caging, bedding, food, and clothing must be considered a risk for the spread of infection. transmission occurs by oronasal exposure, but viral contamination of biologicals used for experimental inoculation, such as transplantable tumors, also can be a source of infection. continuous contact exposure to infected animals or soiled bedding usually induces a humoral immune response within 3 weeks, but limited exposure may delay seroconversion. young mice in enzootically infected colonies are protected by maternal antibody, but actively acquired immunity develops from infection sustained after the decay of maternal immunity. mvm, in contrast to mpv, is not thought to cause persistent infection; infection in immunocompetent adult mice usually lasts less than 3 weeks (smith, 1983; smith and paturzo, 1988 ). infection appears to last less than 1 month, even in oronasally inoculated neonatal mice, but immunodeficient mice may be persistently infected. there is no evidence that mvm is transmitted in utero. pathology natural infections or experimental inoculation of adult mice appears to be nonpathogenic. contact-exposed neonates have been reported to develop cerebellar lesions, but these are very rare. experimental infection of neonatal balb/c, swr, sjl, cba, and c3h mice with mvmi can cause renal hemorrhage and infarction (brownstein et al., 1991b) . dba/2 mice also developed intestinal hemorrhages and accelerated involution of hepatic hematopoiesis. c57bl/6 neonates are resistant to vascular disease. this lesion has been attributed to viral infection of endothelium. infection of immunodeficient mice, including scid and b-cell-deficient mice, results in lethal damage to granulomacrophagic, megakaryocytic, and erythrocytic hematopoietic tissue with severe leukopenia (lamana et al., 2001; naugler et al., 2001; segovia et al., 1999) . intranuclear viral inclusions and viral antigen have been observed in splenic mononuclear cells of b-cell deficient mice (naugler et al., 2001) . diagnosis serology is the primary method of detecting infection, which utilizes recombinant mvm and mpv major capsid viral proteins (vp2) as antigens, which discriminate between the two groups of mouse parvoviruses. in contrast, the conserved nonstructural protein, ns1 can be used to detect antibody to both groups, but is less sensitive than vp2 assays (livingston et al., 2002) . mvm infection also can be detected by pcr, in situ hybridization, and immunohistochemistry. pcr assays can be used to detect mvm-or mpv-specific vp2 or all rodent parvovirus group specific ns1 exons (besselsen, 1998; besselsen et al., 2006) . mvm can be isolated from the spleen, kidney, intestine, and other tissues by inoculation of the c6 rat glial cell line. it also can be detected by the mouse antibody production test. prevention and control because mvm does not persist in immunocompetent mice, control and elimination should exploit quarantine combined with thorough disinfection of the environment, because parvoviruses are resistant to environmental inactivation. mpv has been shown to be successfully eliminated by a cage-bycage test (serology and fecal pcr) and cull approach, although there are no published reports confirming the success of this strategy for eliminating mvm (macy et al., 2011) . cesarean rederivation or embryo transfer may also be used to rederive virus-free progeny. prevention of mvm infection depends on strict barrier husbandry and regular surveillance of mice and mouse products destined for use in vivo. research complications mvm contamination of transplantable neoplasms can occur; therefore, infection can be introduced to a colony through inoculation of contaminated cell lines. failure to establish long-term cell cultures from infected mice or a low incidence of tumor 'takes' should alert researchers to the possibility of mvm contamination. mvmi has the potential to inhibit the generation of cytotoxic t cells in mixed lymphocyte cultures. etiology mouse parvovirus (mpv) is among the more common viruses detected within contemporary laboratory animal medicine mouse colonies, and is more common than mvm (livingston et al., 2002; livingston and riley, 2003; pritchett-corning et al., 2009) . mpv was initially isolated following its detection as a lymphocytotropic contaminant in in vitro assays for cellular immunity. the virus grew lytically in a cd8 + t-cell clone designated l3 and inhibited the proliferation of cloned t cells stimulated with antigen or interleukin 2 (il-2) (mckisic et al., 1993) . molecular analysis of mpv indicates that regions encoding the ns proteins are similar to those of mvm (and other rodent parvoviruses). however, they differ significantly in regions encoding the capsid proteins, accounting for their antigenic specificity. the prototype isolate was first called an 'orphan' parvovirus of mice because its biology and significance were obscure, but it has subsequently been named mouse parvovirus (mpv). immortalized t cells (l3) are the only cells found thus far to support replication of mpv. there are three genetically distinct variants of mpv, including mpv-1, mpv-2, and mpv-3. mpv-1 includes a number of closely related variants, including mpv-1a, mpv-1b, and mpv-1c. in addition, a hamster parvovirus isolate is closely related to mpv-3, which is infectious to mice and likely to be of mouse origin (besselsen et al., 2006; christie et al., 2010) . clinical signs mpv infection is clinically silent in infant mice and adult immunocompetent or immunodeficient mice (besselsen et al., 2007) . immunologic perturbations are the most likely signs of infection (mckisic et al., 1993) . epizootiology mpv causes persistent infection in infant and adult mice, a property that differentiates it from mvm. in situ hybridization has identified the small intestine as a site of viral entry and early replication, but respiratory infection cannot be excluded. experimental studies following inoculation of neonatal balb/c and c.b-17-prkdc scid (scid) mice revealed that balb/c mice shed high levels of virus for 3 weeks, with transmission to sentinels exposed during the first 2 weeks of infection. thereafter, balb/c mice shed extremely low virus intermittently. in contrast, scid mice shed high levels of virus until weaning, but lower levels at 6 weeks of age, yet they effectively transmitted infection to sentinels at all stages of infection (besselsen et al., 2007) . others have shown that transmission of mpv by sencar mice inoculated as infants was intermittent up to 6 weeks, whereas transmission by mice inoculated as weanlings occurred during the first 2 weeks of infection . transmission to balb/c progeny from infected dams was shown to occur, but embryo transfer rederivation was found to be successful in experimentally infected scid mice (besselsen et al., 2008) . humoral (e.g., passively or maternally acquired) immunity can protect against mpv infection. however, immunity to mvm may not confer cross-immunity to mpv (hansen et al., 1999) . pathology mpv appears to enter through the intestinal mucosa, which is a site of early virus replication ( fig. 3.18 ). acute infection is widespread but mild, involving the lung, kidney, liver, and lymphoid organs. histological lesions are not discernible. lymphocytotropism is a characteristic of acute and persistent mpv infection in infant and adult mice. during acute infection, virus is dispersed within lymph nodes, but during persistent infection virus localizes in germinal centers (fig. 3.19) . diagnosis because infected mice do not manifest signs or lesions and the virus is very difficult to propagate in cell culture, detection and diagnosis rely on serology and molecular methods. serology that utilizes mpv vp2 as antigen is a sensitive and specific assay that differentiates mpv from mvm (livingston et al., 2002) . the map test also can be used to detect parvovirus infections but is relatively time-consuming and expensive. as noted for mvm, pcr for murine parvoviruses, using nucleoprotein gene sequences that are conserved among murine parvoviruses, can be used as a screening test. pcr also can be used to detect mpv-specific sequences in the vp2 gene. although diagnostic pcr is sensitive and specific, it is effective only in actively infected animals. it can be used on feces to detect virus shedding, or applied to tissues, such as mesenteric lymph nodes, obtained at necropsy. differential diagnosis mpv infection must be differentiated from mvm infection. because both viruses are enterotropic and lymphocytotropic, serology and pcr must be used to distinguish between them. prevention and control the persistence of mpv in individual mice, its potential for provoking immune dysfunction, and the resistance of murine parvoviruses to environmental inactivation favor active control and prevention of mpv infection. quarantine of infected rooms is appropriate. elimination (depopulation) of infected mice should be considered if they are an immediate threat to experimental or breeding colonies and can be replaced, but a cage-by-cage test and cull approach has been shown to be successful under natural conditions (macy et al., 2011) . for mice that are not easily replaced, virus persistence in the absence of transplacental transmission favors cesarean rederivation or embryo transfer as relatively rapid options to eliminate infection. control of infection also should include environmental decontamination. chemical disinfection of suspect animal rooms and heat sterilization of caging and other housing equipment are prudent steps. prevention is based on sound serological monitoring of mice and surveillance of biologicals destined for inoculation of mice. with the increasing use of mouse germplasm, it is important to note that mouse sperm, oocytes, ovarian tissue, and preimplantation embryos from enzootically mpvinfected mouse colonies may have a high prevalence of mpv contamination, based upon pcr (agca et al., 2007) . research complications murine parvoviruses can distort biological responses that depend on cell proliferation. for mpv, such effects are seen on immune function and include augmentation or suppression of humoral and cellular immune responses. etiology adenoviruses are nonenveloped dna viruses that produce intranuclear inclusions in vitro and in vivo. two adenovirus species in the genus mastadenovirus have been associated with mice: murine mastadenovirus a (with the representative strain being mav-1 or fl) and murine mastadenovirus b (with the representative strain being mav-2 or k87). both strains replicate in mouse kidney tissue culture but are antigenically distinct. clinical signs mav-1 can cause severe clinical disease after experimental inoculation of infant mice. signs include scruffiness, lethargy, stunted growth, and often death within 10 days. mav-2 virus is enterotropic and is responsible for virtually all naturally occurring infections in contemporary mouse populations. infection is usually subclinical in immunocompetent mice, with the possible exception of transient runting among infant mice. wasting disease can occur in athymic mice infected with mav-1. epizootiology the prevalence of adenovirus infection in mouse colonies is low, particularly mav-1 riley, 2003, pritchett-corning et al., 2009) . transmission occurs by ingestion. adult mice experimentally infected with mav-1 may remain persistently infected and excrete virus in the urine for prolonged periods. adult mice experimentally infected with mav-2 excrete virus in feces for at least 3 weeks but eventually recover. athymic mice can shed mav-2 for at least 6 weeks and episodically for at least 6 months. pathology infection with mav-1 causes multisystemic disease characterized by necrosis. infant mice are especially susceptible to rapidly fatal infection characterized by necrosis of brown fat, myocardium, adrenal cortex, salivary gland, and kidney, with the development of intranuclear inclusions. more mature mice usually develop subclinical infection leading to seroconversion; however, athymic and scid mice can develop intestinal hemorrhage and wasting, with fatal disseminated infection (lenaerts et al., 2005) . infection with mav-2 produces amphophilic, intranuclear inclusions in intestinal epithelium, especially in the distal small intestine (fig. 3.20) . inclusions are easier to detect in infant mice than in adults. infection of c.b-17-prkdc scid mice with mav-2 results in enteric infection, but also hepatic lesions resembling reye's syndrome (pirofski et al., 1991) . diagnosis although mav strains can be isolated in tissue culture, routine diagnosis depends on detection of infection by serological assay and/or demonstration of adenoviral inclusions, most commonly in the intestinal mucosa. cross-neutralization tests have revealed that antiserum to mav-2 neutralizes both strains, but antiserum to mav-1 neutralizes mav-2 weakly at best. therefore, mav-2 antigen should be used for the serological detection of adenovirus infection irrespective of the assay employed. mav also can be detected by pcr. differential diagnosis intranuclear adenoviral inclusions in intestinal epithelium are pathognomonic laboratory animal medicine and differentiate mav-2 infection from other known viral infections of mice. infection may resemble rotavirus infection, with runting and abdominal bloating in infant mice. prevention and control prevention requires serological monitoring of mice and examination for contamination of animal products such as transplantable tumors. because mav-2 infection appears to be transient in individual mice, segregation of infected colonies may be effective for control. however, rederivation coupled with subsequent barrier housing is a more conservative approach. research complications mav infection is unlikely to affect research using immunocompetent mice. however, it has the potential for pathogenicity in immunodeficient mice. mice can incur natural infection with two polyomaviruses: polyoma virus (pyv) and k virus. these viruses belong to the family polyomaviridae. k virus belongs to the genus polyomavirus and the species murine pneumotropic virus, while the classical polyoma virus belongs to the species murine polyomavirus. etiology polyoma virus (pyv) is a small dna virus that derives its name 'polyoma' (many tumors) from its ability to experimentally induce multiple types of tumors in mice experimentally infected as neonates. its primary importance stems from use in murine models of experimental oncogenesis, with natural infection being rare. the transformative activity is mediated by 't' (tumor) antigens, encoded by large t, middle t, and small t genes, with middle t (mt) being considered the major viral oncogene, and as a result has been used extensively in transgenic constructs. clinical signs natural infections in immunocompetent mice are usually subclinical. however, tumor induction, neurological disease, and wasting can occur in naturally exposed immunodeficient mice (mccance et al., 1983; sebesteny et al., 1980) . epizootiology modern husbandry and health care have essentially eliminated natural exposure in laboratory mice. pyv is used for experimental studies and thus can inadvertently be introduced to mouse colonies. inoculation of mice with contaminated biologicals or cell cultures is a potential source of entry and spread. natural transmission occurs via the respiratory route. exposure of neonatal mice results in persistent infection and shedding of the virus in urine, feces, and saliva, thereby contaminating the environment for spread to other mice. infection of adult mice is transient, with minimal virus shedding, although pcr has revealed infection lasting up to 5 months in cba mice inoculated with virus as adults (berke and dalianis, 1993) . maternal antibody is highly effective at preventing infection of newborn mice, but as maternal antibody wanes, mice are partially susceptible, with transient virus shedding. thus, the natural cycle of transmission in enzootically infected populations requires contamination of bedding and nesting material in order to infect and be inefficiently transmitted, which is readily precluded by modern husbandry. intrauterine infection also can occur, and persistent renal infection, contracted neonatally, can be reactivated during pregnancy. as in immunologically immature neonatal mice, pyv infection can persist in adult immunodeficient mice. pathology pyv-induced tumors are essentially a laboratory phenomenon, optimized by virus strain and mouse strain, with akr, c3h, c58, cba, swr, and others being most susceptible, and c57bl/6 being among the most resistant to pyv oncogenesis. intranasal inoculation of neonatal mice results in initial replication in pulmonary respiratory epithelium (gottlieb and villarreal, 2000) followed by viremic dissemination and acute, lethal disease. tumors appear 2-12 months after inoculation of surviving mice. tumors of both epithelial and mesenchymal origin arise in multiple organs, particularly mammary carcinomas, basal cell tumors of the skin, carcinomas of salivary glands, thymomas, and various types of sarcomas. athymic mice can develop cytolytic and inflammatory lesions, followed by multisystemic tumor formation. intranuclear inclusions may be present in cytolytic lesions. demyelinating disease and skeletal tumors have been reported in experimentally . laboratory animal medicine inoculated and naturally exposed athymic mice, and myeloproliferative disease has been reported in experimentally inoculated c57bl/6-scid mice (szomolanyi-tsuda et al., 1994) . diagnosis pyv can be isolated in mouse fibroblast cell lines, but infection is ordinarily detected serologically. additionally, pcr and immunohistochemistry can be used. differential diagnosis wasting in athymic mice can be caused by other infectious agents, including coronaviruses, sendai virus (sv), and pneumocystis. intranuclear inclusions can occur in infections caused by mouse adenovirus, mouse cytomegalovirus, and k virus. prevention and control control depends on elimination of infected mice and material, together with prevention of airborne spread. biological material destined for mouse inoculation should be tested for pyv by the map test or molecular diagnostics. research complications pyv infection can affect experiments by inadvertent contamination of cell lines or transplantable tumors, leading to infection of inoculated mice and the potential for epizootic spread. k virus infection k virus has historical importance, and is apparently absent from contemporary mouse populations (livingston and riley, 2003; pritchett-corning et al., 2009) , but it continues to be tested for, adding to the expense of infectious disease surveillance. oral inoculation of neonatal mice results in initial infection of capillary endothelium in the intestine, followed by viremic spread. vascular endothelium is the primary target in affected tissues, which often include the lung, liver, spleen, and adrenal glands. dyspnea occurs from pulmonary infection because of edema and hemorrhage. infection of immunocompetent adult mice is subclinical and results in a vigorous immune response. however, both adults and infant mice develop persistent infection. the primary organ for persistence is the kidney, with shedding of virus from tubular epithelium, and shedding can be reactivated by immunosuppression (greenlee et al., 1991) . additionally, infection of athymic mice can lead to clinical signs and lesions akin to those described for neonatally inoculated mice. gross lesions are limited to pulmonary hemorrhage and edema. histologically, intranuclear inclusions, which are visualized more easily using immunohistochemistry, are present in vascular endothelium of infected tissues. mild hepatitis with hepatocyte degeneration also may develop. infection can be detected by serology or pcr. prevention and control measures, if ever to be found within a mouse population, are similar to those described for pyv. etiology lactate dehydrogenase-elevating virus (ldv) is a mouse-specific small enveloped rna virus belonging to the family arteriviridae. infected mice are persistently viremic, resulting in increased concentration of several serum enzymes, most notably lactate dehydrogenase (ldh). infection is common among wild mice, but is now rare in contemporary laboratory mouse populations. however, surveys of biologic material indicate that ldv may be a common contaminant of biologic materials (nicklas et al., 1993) . clinical signs infection is subclinical. however, poliomyelitis has occurred in immunosuppressed c58 and akr mice inoculated with ldv, and has recently been observed in icr-scid mice following inoculation with contaminated biologic material (carlson-scholz et al., 2011) . epizootiology the primary mode of mouse-tomouse transmission is mechanical transfer from aggressive behavior (e.g., bite wounds). inoculation of mice with contaminated animal products such as cell lines, transplantable tumors, or serum is probably the most common source of induced infection. it is important to note, with respect to mechanical transmission, that infection induces lifelong viremia. natural transmission between cagemates or between mother and young is rare even though infected mice may excrete virus in feces, urine, milk, and probably saliva. pathology viremia peaks within 1 day after inoculation, then persists at a diminished level. the elevation of enzyme levels in blood is thought to result primarily from viral interference with clearance functions of the reticuloendothelial system. ldv selectively targets mature f4/f8-positive macrophages, which are continually produced by uninfected progenitor cell populations, thereby maintaining persistent infection. virus also escapes immune clearance by evolution of neutralizing antibody-resistant quasi-species. no lesions are seen in naturally infected mice. the only significant lesion that can arise from experimental infection is poliomyelitis. this syndrome requires a combination of immunosuppression (due to age, genetics or induced means), mouse strain (c58, akr, c3h/fg, and pl), neurotropic ldv strains, and endogenous ecotropic murine leukemia virus. the mouse strain-dependent element is homozygosity for the fv-1 n allele, which permits replication of endogenous n-tropic ectotropic murine leukemia virus. mice develop spongiosis, neuronal necrosis, and astrocytosis of the ventral spinal cord and brain stem, with axonal degeneration of ventral roots. lesions contain both ldv and retrovirus. although this syndrome is largely experimentally induced, a natural outbreak of poliomyelitis has been reported in fv-1 homozygous icr-scid mice following inoculation with contaminated biologic material (carlson-scholz et al., 2011) . diagnosis plasma ldh levels are elevated, a response that is used to detect and titrate ldv infectivity. of the five isoenzymes of ldh in mouse plasma, only laboratory animal medicine ldh-v is elevated. sjl/j mice in particular show spectacular increases in ldh levels (15-20 times normal), a response controlled by a recessive somatic gene. ldv is detected by measuring ldh levels in mouse plasma before and 4 days after inoculation of specific pathogenfree (spf) mice with suspect material. it is important to use nonhemolyzed samples because hemolysis will produce falsely elevated readings. plasma enzyme levels are measured in conventional units/ml, 1 conventional unit being equivalent to 0.5 international units (iu). normal plasma levels are 400-800 iu, whereas in ldv infection, levels as high as 7000 iu can occur. ldv also interferes with the clearance of other serum enzymes and results in their elevation in serum. in a recent survey, 6000 serum samples were tested by serum ldh enzyme assays, among which 10% were deemed potentially positive. however, pcr revealed that all were false-positives (pritchett-corning et al., 2009) , emphasizing the inaccuracy of traditional enzyme assays. infection provokes a modest humoral antibody response, but it is difficult to detect because of formation of virus-antibody immune complexes. molecular diagnostics also can be used to diagnose infection in mouse tissues and serum and biologic materials. however, inhibitory factors in cells and serum may cause falsenegative results in pcr testing, so appropriate quality control measures are essential if this method is used (lipman and henderson, 2000) . prevention and control transplantable tumors have been a common source of ldv historically. therefore, tumors or cell lines destined for mouse inoculation should be monitored for ldv contamination. although ldv can contaminate tumor cell lines, it does not replicate in the tumor cells. therefore, one can attempt to free tumors of virus by passaging them through athymic nude rats, which are not nonpermissive to ldv but are permissive to xenografts. research complications ldv has numerous potential effects on immunological function. it may reduce autoantibody production, cause transient thymic necrosis and lymphopenia, suppress cell-mediated immune responses, and enhance or suppress tumor growth. etiology the house mouse is the natural host for lymphocytic choriomeningitis virus (lcmv), an old world member of the arenaviridae family that has spread worldwide along with m. musculus. lcmv virions are pleomorphic, containing single-stranded rna, and bud from the cell membrane. disease associated with infection is due to host immune response to the otherwise non-cytolytic virus. its name is derived from the immune-mediated inflammation resulting from the intracerebral inoculation of virus into immunologically competent mice. lcmv is a zoonotic virus that may cause a variety of clinical manifestations in humans, including meningitis. it has been extensively studied as an experimental model of virus-induced immune injury, using a number of closely related strains, including ones that have been selected for their relative neurotropism or viscerotropism. lcmv can be propagated in a variety of mammalian, avian, and even tick cell lines, with minimal cytopathic effect. these characteristics favor its propensity to persistently and silently contaminate biologic products, such as tumor cell lines. clinical signs natural infection in immunocompetent adult mice is usually self-limiting and subclinical. during enzootic infection of a mouse population, lcmv is transmitted in utero from persistently infected dams to their fetuses or to neonates, which are persistently infected and immunologically tolerant to lcmv. since lcmv is non-cytolytic in and of itself is minimally pathogenic, congenitally infected mice grow into adulthood, reproduce, and therefore transmit infection to the next generation. however, with age, immune tolerance breaks down, and mice develop a syndrome known as 'late disease' in which mice will progressively lose weight and die. in utero infection results in a low level of fetal mortality and maternal cannibalism of infected pups. the immune tolerance to lcmv is virus-specific, with the mice capable of eliciting effective immune responses against other agents. clinical signs following experimental inoculation of lcmv vary with age and strain of mouse, route of inoculation, and strain of virus. when virus is inoculated intracerebrally into immunocompetent adult mice, mice develop immune-mediated lymphocytic choriomeningitis, characterized by illness beginning 5-6 days after inoculation. sudden death may result or subacute illness associated with one or more of the following signs may develop: ruffled fur, hunched posture, motionlessness, and neurological deficits. mice suspended by the tail display coarse tremors of the head and extremities, culminating in clonic convulsions and tonic extension of the rear legs. spontaneous convulsions also can occur. animals usually die or recover in several days. a visceral form of infection can occur in adult mice inoculated by peripheral routes with 'viscerotropic' strains. it can be subclinical or lead to clinical signs, including ruffled fur, conjunctivitis, ascites, somnolescence, and death. if mice survive, recovery may take several weeks. surviving mice may have immune exhaustion due to consumption of lymphoid tissue, in contrast to immune tolerance that occurs when mice are infected in utero or as neonates. runting and death from lcmv infection may occur in neonatally infected mice and can lead to transient illness or to death. clinical signs are nonspecific, recovery is slow, and survivors may remain runted. this early form of disease is attributed to endocrine dysfunction caused laboratory animal medicine by lcmv infection. late-onset disease can occur in previously subclinical carrier mice that develop immune complex glomerulonephritis. it is usually the result of prenatal or neonatal infection and occurs in persistently infected mice when they are 9-12 months old. clinical signs are nonspecific and include ruffled fur, hunched posture, weight loss, proteinuria, and ascites. epizootiology lcmv is distributed widely in wild m. musculus throughout the world. among common laboratory species, mice, hamsters, guinea pigs, and nonhuman primates are susceptible to infection, but only the mouse and the hamster are known to transmit virus. lcmv infection is rare in laboratory mice produced and maintained in modern quarters (livingston and riley, 2003; pritchett-corning et al., 2009) . infection is usually introduced through inoculation of virusinfected biologicals, such as transplantable tumors, or by feral mice. wild mice are a natural reservoir of infection and a potential threat to research colonies if they gain entry inadvertently. naturally infected carrier mice can have persistently high concentrations of virus in many organs, thereby facilitating virus excretion in saliva, nasal secretions, and urine. persistently infected neonates usually reach breeding age and can perpetuate infection in a breeding colony. thus introduction of a single lcmv carrier mouse to a breeding colony can eventually result in a high prevalence of persistently infected mice. infection in adult mice, in contrast, is often acute because of the onset of effective immunity, and the spread of virus is halted. horizontal spread of infection is enhanced by close contact, but rapid horizontal spread is not characteristic. mice can transmit lcmv to hamsters, which can remain viremic and viruric for many months, even if they contract infection as adults. infected hamsters can transmit virus to other hamsters and mice and are the primary source of human lcmv infection. persistent infection in immunodeficient mice may carry greater risks for viral excretion and zoonotic transmission. pathology lcmv disease is a prototype for virusinduced, t-lymphocyte-mediated immune injury, noncytolytic endocrine dysfunction, and immune complex disease. however, lesions comparable to experimentally induced disease are rare during natural infection. intracerebral inoculation of virus into immunocompetent adult mice induces nonsuppurative leptomeningitis, choroiditis, and focal perivascular lymphocytic infiltrates. host tissues are damaged during the course of the cellular immune response to the virus. the character of visceral lesions depends on virus strain and mouse strain; the ratio of cytolytic to proliferative responses in lymphoid organs is mouse strain-dependent. in severe infection, nonsuppurative inflammation can occur in many tissues. the severity of accompanying cytolytic lesions seems to parallel the intensity of cellular immunity. liver lesions can include hepatocyte necrosis accompanied by nodular infiltrates of lymphoid cells and kupffer cells, activated sinusoidal endothelium, an occasional granulocyte or megakaryocyte, and fatty metamorphosis. cytolysis, cell proliferation, and fibrinoid necrosis can develop in lymphoid organs. necrosis of cortical thymocytes can lead to thymic involution. lesions of late-onset disease are characterized by formation of immune complexes and associated inflammation. renal glomeruli and the choroid plexus are most severely affected, but complexes may also be trapped in synovial membranes, blood vessel walls, and skin. lymphoid nodules can form in various organs. lesions associated with early deaths in neonatally infected mice have not been thoroughly described but include hepatic necrosis. the lesions of acute and persistent lcmv infection reflect separate immunopathologic processes. in adult mice with acute lcmv infection, virus multiplies in dcs, b cells, and macrophages, whereas t cells are resistant. internal viral epitopes induce humoral immune responses, but surface epitopes elicit cell-mediated immunity and neutralizing antibodies. thus, elimination of virus and virus-associated immunological injury are both t-cell-mediated. this apparent paradox has been explained by the view that prompt cellular immunity limits viral replication and leads to host survival, whereas slower cellular immune responses permit viral spread and increase the number of virus-infected target cells subject to attack once immunity is fully developed. antibody can be detected by 1 week after infection but does not play a significant role in eliciting acute disease. lesions of lcmv infection appear to develop from direct t-cell-mediated damage to virus-infected cells and may involve humoral factors released from immune effector t cells. lcmv also can suppress humoral and cellular immunity in acutely infected mice. persistent infection commonly evolves from exposure early in pregnancy, and virus has been demonstrated in the ovaries of carrier mice. prenatal or neonatal infection induces immunological tolerance to lcmv, which can then replicate to high titer in many tissues. nevertheless, persistently infected mice develop humoral antibody to lcmv. antibody can complex with persistent virus to elicit complement-dependent inflammation in small vessels. immune complex glomerulonephritis exemplifies this process, as noted above. diagnosis lcmv infection can be diagnosed serologically. whereas immunocompetent adult mice will normally seroconvert after exposure, carrier mice may develop poor humoral immune responses. therefore, testing must avoid false-negative results. employment of adult contact sentinel mice is a useful strategy for detecting lcmv infection by seroconversion. tissues, including biologic products and cell lines, can be tested laboratory animal medicine by pcr. a traditional method for detection involved collection of small blood samples from persistently infected live suspects, which are often viremic, and using them to inoculate cultured cells or adult and neonatal mice. intracerebral inoculation of lcmv-positive tissues should elicit neurological signs in adult mice within 10 days, whereas infant mice should remain subclinical. histological examination of brains from affected adults may reveal nonsuppurative inflammation, but lesions may be minimal in mice infected with viscerotropic isolates. immunohistochemistry can be used to detect viral antigen in brains of suckling and adult mice. intraperitoneal inoculation of adult mice may yield short-lived infection with seroconversion, i.e., the map test. virus can be grown and quantified in several continuous cell lines, including mouse neuroblastoma (n-18) cells, bhk-21 cells, and l cells. application of immunofluorescence staining to detect lcmv antigen in inoculated cultured cells yields results more quickly than animal inoculation. of course, all diagnostic procedures involving potential contact with live virus should be carried out under strict containment conditions to avoid infection of laboratory personnel (see chapter 29). the use of in vitro detection has the added advantage, in this regard, of reducing biohazardous exposure and the use of live animals for testing. differential diagnosis neurological signs must be differentiated from those due to mouse hepatitis virus, mouse encephalomyelitis virus, and meningoencephalitis from bacterial infection. trauma, neoplasia, and toxicities also must be ruled out in neurological disease with low prevalence. late-onset disease is associated with characteristic renal lesions, including deposition of viral antigen in tissues. early-onset disease must be differentiated from other causes of early mortality, such as mouse hepatitis virus, ectromelia virus, reovirus 3 infection, tyzzer's disease, or husbandry-related insults. prevention and control adequate safeguards for procurement and testing of animals and animal products are essential to prevent entry. because mouse-to-mouse spread is slow, selective testing and culling for seropositive or carrier mice is possible. if mice are easily replaced, however, depopulation is a safer and more reliable option. valuable stock can be rederived, but progeny must be tested to preclude in utero transmission. because infected hamsters can excrete large quantities of virus, exposed hamsters should be destroyed and hamsters should not be housed with mice. infection of immunodeficient mice poses similar risk. lcmv can be transmitted to human beings, who can contract flu-like illness or severe cns disease. more frequently, human infection is subclinical. the zoonotic potential of lcmv infection makes it especially important to detect and eliminate carrier animals and other potentially contaminated sources, such as cell cultures, transplantable neoplasms, and vaccines to prevent human exposure. serum banking and periodic serological testing of highrisk human populations, such as those working with lcmv experimentally, are recommended. research complications lcmv may stimulate or suppress immunological responses in vivo and in vitro, and it can replicate in cells used as targets or effectors for immunological studies. introduction of immune cells to a carrier animal may elicit an immunopathological response. immune complex disease can complicate longterm experiments and morphological interpretations. illness and death in mice and zoonotic risk to humans are obvious research-related hazards. etiology sv is a paramyxovirus that is antigenically related to human parainfluenza virus 1. viral particles are pleomorphic, contain single-stranded rna, and have a lipid solvent-sensitive envelope that contains glycoproteins with hemagglutinating, neuraminidase, and cell fusion properties. sv grows well on embryonated hens' eggs and in several mammalian cell lines (e.g., monkey kidney, baby hamster kidney , and mouse fibroblast [l]). virus replicates in the cytoplasm and by budding through cell outer membranes. once common in laboratory rodent populations, sv is now rare or absent (livingston and riley, 2003; pritchett-corning et al., 2009) . clinical signs clinically affected adult mice often assume a hunched position and have an erect hair coat. rapid weight loss and dyspnea occur, and there may be chattering sounds and crusting of the eyes. although highly susceptible adults may die, lethal infection is more common in suckling mice. sex differences in susceptibility have not been found. genetically resistant mice usually have subclinical infection. athymic mice and immunodeficient mice are at high risk for development of a wasting syndrome. they develop illness later than their immunocompetent counterparts, since clinical signs in immunocompetent mice are related to immune-mediated destruction of respiratory epithelium. opportunistic infections can complicate the clinical presentation. for example, secondary bacterial infections of the ear can cause vestibular signs. epizootiology sv is transmitted by aerosol and is highly contagious. morbidity in infected colonies is commonly 100%, and mortality can vary from 0% to 100%, partly because strains of mice vary greatly in their susceptibility to lethal sv infection. for example, c57bl/6 mice are highly resistant to clinically apparent infection, whereas dba/2 mice are highly susceptible. aerogenic infection is promoted by high relative humidity and by low air turnover. prenatal infection does not occur. enzootic infection is commonly detected in postweaned mice (5-7 weeks old) and is associated with seroconversion within 7-14 days and the termination of infection. therefore, entrenched infection is perpetuated by the introduction of susceptible animals. there is no evidence for persistent infection in immunocompetent mice, but prolonged infection is common in immunodeficient mice. maternally acquired immunity protects young mice from infection, and actively acquired immunity is thought to be long-lived. rats, hamsters, and guinea pigs also are susceptible to sv infection. therefore, bidirectional cross-infection is a risk during outbreaks. pathology viral replication is nominally restricted to the respiratory tract and peaks by the first week after infection. gross lesions feature partial to complete consolidation of the lungs (fig. 3.21) . individual lobes are meaty and plum-colored, and the cut surface may exude a frothy serosanguinous fluid. pleural adhesions or lung abscesses caused by secondary bacterial infection are seen occasionally, and fluid may accumulate in the pleural and pericardial cavities. sv targets airway epithelium and type ii pneumocytes. type i pneumocytes are less severely affected. histologically, the pattern of pneumonia is influenced by mouse genotype. susceptible mice usually have significant bronchopneumonia and interstitial pneumonia, whereas the interstitial component may be less prominent in resistant mice. typical changes begin with inflammatory edema of bronchiolar lamina propria, which may extend to alveolar ducts, alveoli, and perivascular spaces. necrosis and exfoliation of bronchiolar epithelium ensue, frequently in a segmental pattern (fig. 3.22 ). alveolar epithelium also may desquamate, especially in severe disease, and necrotic cell debris and inflammatory cells can accumulate in airways and alveolar spaces. alveolar septae are usually infiltrated by leukocytes to produce interstitial pneumonia (fig. 3.23) . lymphoid cells also invade peribronchiolar and perivascular spaces. the lymphocytic response to sv infection reflects the fact that cellular immunity contributes both to lesions and to recovery. local immunoglobulin synthesis by infiltrating cells also occurs. the extent of inflammatory cell infiltration corresponds to the level of genetic resistance expressed by the infected host, with clinically susceptible hosts mounting a more florid immune response than resistant hosts. additionally, strain-related differences in the severity of infection may reflect differences in airway mucociliary transport. multinucleated syncytia are occasionally seen in affected sucklings and scid mice, and inclusion bodies have been reported in infected athymic mice. regeneration and repair begin shortly after the lytic phase and are characterized by hyperplasia and squamous metaplasia of bronchial epithelium, which may extend into alveolar septae. proliferation of cuboidal laboratory animal medicine epithelium may give terminal bronchioles an adenomatoid appearance. repair of damaged lungs is relatively complete in surviving mice, but lymphocytic infiltrates, foci of atypical epithelium, and mild scarring can persist. acute phase lesions are prolonged in immunodeficient mice, which can lead to wasting and death. aged mice also have a prolonged recovery phase accompanied by focal pulmonary fibrosis (jacoby et al., 1994) . diagnosis sv is notable for its ability to cause epizootics of acute respiratory distress in adult genetically susceptible strains. serology is an effective means to detect infection in all strains of immunocompetent mice. antibody can be detected by 7 days postinfection and coincides with development of clinical signs related to the immune-mediated necrotizing bronchiolitis and alveolitis. repeated serologic sampling over several weeks can help stage infection within a population. alternatively, sentinel animals can be added to seropositive colonies to detect active infection. irrespective of serologic results, histopathology, immunohistochemistry (which can be performed on formalin-fixed, paraffin-embedded sections), and, where possible, virus isolation should be used to confirm infection. virus can be isolated from the respiratory tract for up to 2 weeks, with peak titers occurring at about 9 days postinfection. nasopharyngeal washings or lung tissue homogenates are most reliable and should be inoculated into embryonated hens' eggs or bhk-21 cell monolayer cultures. sv infection of cultured cells is non-cytolytic, so erythrocyte agglutination or antigen detection methods must be used. rt-pcr also can be used to detect virus in infected lungs. differential diagnosis respiratory infection caused by pneumonia virus of mice (pvm) is generally milder or subclinical. histologically, necrosis of airway epithelium is less severe. bacterial pneumonias of mice, including murine respiratory mycoplasmosis, are sporadic and can be differentiated morphologically and by isolation of causative organisms. because sv pneumonia may predispose the lung to opportunistic bacterial infections, the presence of bacteria should not deter evaluation for a primary viral insult. control and prevention sv infection is self-limiting in surviving immunocompetent mice. suckling mice from immune dams are protected from infection by maternal antibody until after weaning. control and eradication measures must eliminate exposure of susceptible animals, so that infection can 'burn out.' this is most easily accomplished by a quarantine period of 4-6 weeks wherein no new animals are introduced either as adults or through breeding. control also is aided by the fact that sv is highly labile. barrier housing is preferred for prevention and for control of transmission. vaccination with formalin-killed virus can provide short-term protection of valuable mice but is not commonly used for prevention. research complications sv can cause immunosuppression and can inhibit growth of transplantable tumors. this effect has been attributed to virus-induced modification of tumor cell surface membranes. pulmonary changes during sv pneumonia can compromise interpretation of experimentally induced lesions and may lead to opportunistic infections by other bacteria. they also have been associated with breeding difficulties in mice. this sign is thought to be an indirect effect due to stress, fever, or related changes during acute infection. clinical signs natural pvm infection in mice is subclinical. therefore, its name is clinically misleading, being derived from pneumonic illness that occurred after serial passage of the agent in mice. however, dyspnea, listlessness, and wasting may develop in immunodeficient mice infected with pvm (weir et al., 1988) . pvm is used experimentally as a model to study acute respiratory infection, using highly pathogenic strains of the virus (dyer et al., 2012) . epizootiology pvm causes natural infections of mice, rats, hamsters, and probably other rodents and may be infectious for rabbits. serological data indicate that pvm was once common, but is now relatively uncommon (livingston and riley, 2003; pritchett-corning et al., 2009 ). pvm appears to spread less rapidly than sv. intimate contact between mice is probably required for effective transmission. this characteristic may reflect the fact that environmental inactivation of virus occurs rapidly. infection is acute and self-limiting in immunocompetent mice but may persist in immunodeficient mice. pathology pvm replicates exclusively in the respiratory tract and reaches peak titers in the lung 6-8 days after infection. although pulmonary consolidation can occur in experimentally infected mice, gross lesions are rare during natural infection. histological lesions can occur in the upper and lower respiratory tract. they consist of mild necrotizing rhinitis, necrotizing bronchiolitis, and interstitial pneumonia, which usually occur within 2 weeks after exposure to virus and are largely resolved by 3 weeks. the predominant inflammatory infiltrate is comprised of mononuclear cells, but some neutrophils laboratory animal medicine are usually present. immunohistochemistry on paraffinembedded tissues can be used to detect viral antigen in bronchiolar epithelium, alveolar macrophages, and alveolar epithelium during acute infection. residual lesions include nonsuppurative perivasculitis, which can persist for several weeks after acute infection has ceased. severe progressive pneumonia, with wasting, can occur in immunodeficient mice. it is characterized by generalized pulmonary consolidation that reflects severe interstitial pneumonia with desquamated alveolar pneumocytes and leukocytes filling alveolar spaces (fig. 3.24) . diagnosis diagnosis is based primarily on serological detection that can be supplemented by histopathology, immunohistochemistry, in situ hybridization, and virus isolation. virus replication in bhk-21 cells is detected by immunofluorescence or other antigen detection methods. virus also can be detected in tissues by rt-pcr. differential diagnosis because pvm is antigenically distinct from other murine viruses, serology is the most useful method to separate pvm infection from other respiratory infections of mice. however, in immunodeficient mice, where clinical signs and lesions are typical, it must be differentiated from other pneumonias, especially those due to sv and pneumocystis. additionally, pvm can coexist with and exacerbate pneumocystis infection in immunodeficient mice (bray et al., 1993) . prevention and control pvm infection is acute and self-limiting in immunocompetent mice, but persistent in immunodeficient mice. seropositive mice should be viewed as either immune or in the final stages of acute infection. therefore, control and prevention follows guidelines applicable to sv infection. research complications pvm can exacerbate pneumocystosis, as noted above. (ward et al., 2007) two members of the family reoviridae infect laboratory mice: reovirus per se (species: mammalian orthoreovirus) and murine rotavirus (species: rotavirus a), also known as epizootic diarrhea of infant mice (edim) virus. etiology reoviruses of mammals, although taxonomically considered one type species, have been divided into three cross-reacting prototypic serotypes: reovirus 1, 2 and 3, which can be differentiated by cross-serum neutralization. mice can be infected with any serotype, but reovirus 3 is emphasized because it has been associated with naturally occurring disease. natural infections in mice are usually not caused by pure serotypes, because reoviruses actively recombine. a number of wild-type and laboratory strains have been characterized, and related viruses have been recovered from virtually every mammal tested, as well as birds, reptiles, and insects. the virion contains segmented, double-stranded rna and is relatively heat stable. reoviruses replicate well in bhk-21 cells and other continuous cell lines, as well as in primary monolayer cultures from several mammals. clinical signs clinical disease is rare and age dependent. acute disease affects sucklings at about 2 weeks of age, whereas adults have subclinical infection. signs in sucklings include emaciation, abdominal distension, and oily, matted hair due to steatorrhea. icterus may develop and is most easily discerned as discoloration in the feet, tail, and nose. incoordination, tremors, and paralysis occur just before death. convalescent mice are often partially alopecic and are typically runted. alopecia, runting, and icterus may persist for several weeks, even though infectious virus can no longer be recovered. infants born to immune dams are protected from disease by maternal immunity. epizootiology the prevalence of reovirus 3 infection in contemporary mouse colonies is rare (livingston and riley, 2003; pritchett-corning et al., 2009 ). reoviruses are highly contagious among infant mice and can be transmitted by the oral-fecal or aerosol routes, but mechanical transmission by arthropods has also been documented. additionally, virus may be carried by transplantable neoplasms and transmitted inadvertently by injection. transmission is inefficient among adult mice. there is no evidence that vertical transmission is important or that genetic resistance or gender influence expression of disease. infection in immunocompetent mice appears to be self-limiting, lasting up to several weeks but terminating with the development of host immunity. the course of infection in immunodeficient mice should be considered prolonged, but the duration has not been determined. pathology reovirus 3 can cause severe pantropic infection in infant mice. after parenteral inoculation, virus can be recovered from the liver, brain, heart, pancreas, spleen, lymph nodes, and blood vessels. following ingestion, reoviruses gain entry by infecting intestinal epithelial cells (m cells) that cover peyer's patches. virus can be carried to the liver in leukocytes, where it is taken up by kupffer cells prior to infecting hepatocytes. in acute disease, livers may be large and dark, with yellow foci of necrosis. the intestine may be red and distended, and, in infants, intestinal contents may be bright yellow. myocardial necrosis and pulmonary hemorrhages have been reported. myocardial edema and necrosis are especially prominent in papillary muscles of the left ventricle. the brain may be swollen and congested. central nervous system lesions have a vascular distribution, and are most prevalent in the brain stem and cerebral hemispheres. neuronal degeneration and necrosis are followed quickly by meningoencephalitis and satellitosis. severe encephalitis may evoke focal hemorrhage. in the chronic phase, wasting, alopecia, icterus, and hepatosplenomegaly may persist. orally infected suckling mice can develop multifocal hepatocyte necrosis, which may include the accumulation of dense eosinophilic structures resembling councilman bodies. hepatocytomegaly, kupffer cell hyperplasia, and intrasinusoidal infiltrates of mononuclear cells and neutrophilic leukocytes also can develop. in experimentally inoculated mice, necrotic foci can persist in the liver for at least 4 weeks. chronic active hepatitis may develop after acute infection and result in biliary obstruction. acinar cells of the pancreas and salivary glands can undergo degeneration and necrosis. because pancreatic duct epithelium is susceptible to infection, parenchymal lesions in the pancreas may be caused by obstruction rather than by viral invasion of parenchyma. pulmonary hemorrhage and degeneration of skeletal muscles also have been observed. both humoral and cellular immunity seem to participate in host defenses, but it is unclear how host immunity may influence the course of chronic infection. oronasal inoculation of infant mice with reovirus 1 results in a similar distribution but significantly milder lesions compared to reovirus 3. in contrast, reovirus 2 is highly enterotropic, inducing mild enteritis without lesions in other tissues, similar to epizootic diarrhea of infant mice (edim) . diagnosis serology uses reovirus 3 as antigen, which detects seroconversion to all serotypes, and viral rna can be detected by rt-pcr. a presumptive diagnosis of reovirus infection is aided clinically by detection of the oily hair effect, accompanied by jaundice and wasting. the presence histologically of multisystemic necrosis is consistent with severe reovirus 3 infection but should be confirmed by immunohistochemistry or virus isolation. differential diagnosis reovirus infection must be differentiated from other diarrheal diseases of infant mice, including those caused by mouse coronaviruses, edim virus, salmonella spp., or clostridium piliforme. prevention and control although surviving mice appear to recover completely from infection, the potential for a carrier state is unresolved. therefore, it may be necessary, after adequate testing for the continued presence of virus by the use of sentinels, map testing, or other appropriate means, to rederive or replace infected stock. prevention depends on adequate barrier husbandry coupled with adequate serological monitoring. research complications reovirus 3 infection can interfere with research in several ways. infections in breeding colonies can result in high mortality among sucklings from nonimmune dams. virus has been commonly recovered from transplantable neoplasms and is suspected of being oncolytic. the potential exists for interference with hepatic, pancreatic, cardiovascular, or neurological research. etiology rotaviruses are double-stranded, segmented rna viruses that have a wheel-like ultrastructural appearance. edim virus is a group a rotavirus that replicates in differentiated epithelial cells of the small intestine by budding into cisternae of endoplasmic reticulum. currently, only a single antigenic strain is recognized, but antigenically distinct variants may exist. edim virus shares an inner capsid antigen with rotaviruses of rabbits, fowl, nonhuman primates, human beings, and domestic and companion animals. these agents tend to be species-specific under natural conditions and can be differentiated by serum neutralization tests. cultivation of edim virus requires the presence of proteolytic enzymes to cleave an outer capsid polypeptide. clinical signs clinical signs occur in infant mice less than 2 weeks old. this age-related susceptibility also applies to infection in immunodeficient mice. furthermore, clinical signs occur only in offspring of nonimmune dams, because maternal immunity protects infants until they have outgrown susceptibility to clinical disease. the cardinal signs are bloated abdomens with fecal soiling of the perineum, which may extend to the entire pelage in severe cases. despite high morbidity, mortality is low because affected mice continue to nurse. transient weight loss does occur, and there may be a delay in reaching adult weight. recovery from infection usually occurs in about 2 weeks and, once weight is regained, is clinically complete. epizootiology edim virus appears to be infectious only for mice and occurs episodically in mouse colonies, and infection is probably widespread geographically (livingston and riley, 2003; pritchett-corning laboratory animal medicine et al., 2009) . all ages and both sexes can be infected, but genetic resistance and susceptibility have not been determined. the virus is highly contagious and is transmitted by the oral-fecal route. subclinically infected adult mice can shed virus in feces for at least 17 days, an interval that may be extended in immunodeficient mice. after oral inoculation, virus is essentially restricted to the gastrointestinal tract, although small amounts of virus may be present in the liver, spleen, kidney, and blood. nursing dams can contract infection from their litters. transplacental transmission has not been demonstrated. pathology gross lesions occur primarily in the gastrointestinal tract, but thymic involution can result from infection-related stress. the intestine is often distended, flaccid, and filled with gray-green gaseous liquid or mucoid fecal material that soils the pelage. the stomach contains curdled milk, except in terminal cases with anal impaction due to caking of dried feces. virus preferentially infects terminally differentiated enterocytes in the small and large intestines, which accounts for the agerelated susceptibility to disease; the number of such cells decreases as the intestinal tract matures. characteristic histological lesions are often very subtle, but are most easily discerned in the small intestine in mice less than 2 weeks old. they consist of vacuolation of villar epithelial cells with cytoplasmic swelling, which give villi a clubbed appearance (fig. 3.25) . the vacuoles must be differentiated from normal absorption vacuoles in nursing mice. the lamina propria may be edematous, but necrosis and inflammation are not prevalent. diagnosis edim virus infection is readily detected serologically. clinical disease is diagnosed from signs and typical histological lesions in the intestine, which can be confirmed by immunohistochemical or ultrastructural demonstration of virus in the intestine or in intestinal filtrates or smears. rotavirus antigen can be detected in feces by elisa, but certain dietary ingredients can cause false-positive reactions. infection can also be diagnosed by rt-pcr. differential diagnosis edim virus infection must be differentiated from other diarrheal diseases of suckling mice such as intestinal coronavirus (mouse hepatitis virus) infection, reovirus 3 infection, tyzzer's disease, and salmonellosis. the presence of milk in the stomach can be helpful in differentiating edim virus infection from more severe enteric infections, such as those caused by pathogenic coronaviruses, during which cessation of nursing often occurs. the possibility of dual infections must also be considered. thymic necrosis in edim virus-infected mice, although nonspecific, must be differentiated from that due to mouse thymic virus (mtv) infection or other stressors. prevention and control the spread of edim can be controlled effectively by the use of microbarrier cages and good sanitation. because infection appears to be acute and self-limiting, cessation of breeding for 4-6 weeks to allow immunity to build in adults while preventing access to susceptible neonates also is recommended. alternatively, litters with diarrhea can be culled, in combination with the use of microbarrier cages. the duration of infection in immunodeficient mice has not been determined, but it is reasonable to assume that chronic infection occurs. therefore, such animals should be eliminated. litters from immune dams are more resistant to infection. if edim virus is allowed to become enzootic within a colony, clinical signs will disappear within the population, which may be an appropriate management approach in conventional colonies. prevention of edim virus infection depends on maintenance of sanitary barrier housing with adequate serological surveillance. research complications the research complications of edim infection pertain to clinical illness with diarrhea and retarded growth. transient thymic necrosis may perturb immunological responses. infection (barthold, 1997a,b) etiology coronaviruses are large, pleomorphic, enveloped rna viruses with radially arranged peplomers (spikes). in mice, early clinical and laboratory investigations emphasized their potential to induce hepatitis, so their original designation, which is still used actively, is mouse hepatitis virus (mhv). during that time, enteritis in infant mice was recognized as a separate entity caused by an uncharacterized virus, known as lethal intestinal virus of infant mice (livim). subsequent studies revealed that hepatitis-causing mhv and enteritis-causing livim were closely related coronaviruses, now collectively termed mhv. mhv isolates differ in biologic behavior according to their organ tropism into two biotypes: enterotropic strains, which infect primarily the intestinal tract, and polytropic strains, which initially infect the respiratory tract but may progress to multisystemic dissemination, including the liver and brain. these differences are often reflected in their cell tropism in vitro. however, natural isolates may contain features of both biotypes. several prototype polytropic strains have been extensively studied as experimental models of hepatitis and encephalitis. they include jhm (mhv4), mhv-1, mhv-3, mhv-s, and mhv-a59. numerous additional strains have been identified that differ in virulence, tissue tropism, and antigenicity. differentiation by strain, particularly under natural conditions, is irrelevant, since mutation is common among coronaviruses, and even named prototype strains differ significantly depending upon passage history. although mhv isolates and strains share internal antigens (m and n), they can be distinguished by neutralization tests that detect strainspecific spike (s) antigens. mhv shares antigens with the coronaviruses of rats, a finding that has been exploited to develop heterologous antigens for serological tests. mhv also is related to human coronavirus oc43. a number of established cell lines may be used for propagating polytropic mhv strains in vitro. however, field isolates are difficult to maintain in vitro. nctc 1469 mouse liver cells are useful for growing many polytropic strains. mhv can also be grown in mouse macrophages, cells that have been used for genetic studies of resistance and susceptibility to infection. enterotropic strains, because of their tendency to be strictly enterotropic, have been grown in cmt-93 cells derived from a rectal carcinoma in a c57bl mouse, but are generally difficult to propagate in cell culture. irrespective of cellular substrate used for isolation or propagation, syncytium formation is emblematic of mhv infection (fig. 3.26) . clinical signs clinical signs depend primarily on the age, strain, and immunological status of infected mouse and strain and tropism of virus. as with many murine viruses, infection is often clinically silent among immunologically competent mature mice. clinical morbidity is most often associated with suckling mice less than 2 weeks old or with immunodeficient mice. suckling mice infected with enterotropic mhv develop inappetence, diarrhea, and dehydration, often terminating in death (fig. 3.27) . epizootics of enterotropic mhv have been known to result in 100% mortality among neonatal mice in a breeding colony. older mice (2-3 weeks of age) may have ruffled pelage and runting. neurotropic strains such as mhv-jhm may induce flaccid paralysis of the hindlimb, but this sign is rarely encountered alone during natural infection. conjunctivitis, convulsions, and circling may be seen occasionally. enterotropic strains may not cause acute disease in athymic mice when exposed as adults, whereas mildly pathogenic polytropic strains can cause a progressive wasting syndrome that may be accompanied by progressive paralysis. epizootiology mhv infection, despite constant surveillance and preventive programs, continues to be a common threat to laboratory mouse populations (livingston and riley, 2003; pritchett-corning et al., 2009 ). there are no reports of natural transmission from mice to other species, but suckling rats have been found to develop necrotizing rhinitis after intranasal inoculation with mhv-s. mhv is highly contagious, with natural transmission occurring by respiratory or oral routes. mouse appears normal and has a milk-filled stomach. lower mouse is runted and dehydrated and has an empty stomach. from barthold et al. (1982) . enterotropic biotypes predominate in natural infections in contemporary laboratory animal facilities, since they tend to be the most contagious due to copious excretion of virus in feces, whereas polytropic strains generally spread by direct respiratory contact. natural vertical transmission has not been demonstrated. introduction of mhv through injection of contaminated biologicals can be an important factor in epizootics, especially because some isolates infect b lymphocytes and, by implication, hybridomas nonlytically. infection in immunocompetent mice is self-limiting. immune-mediated clearance of virus associated with seroconversion usually begins about a week after infection, and mice recover fully within 3-4 weeks. humoral and cellular immunity participate in host defenses to infection, and t-cell-dependent immunity is an absolute requirement. thus, age-related resistance to mhv correlates with maturation of lymphoreticular tissues, but intestinal proliferative kinetics are critical determinants of disease susceptibility with enterotropic mhv. enzootic infection had been construed to include persistent infection in individual mice. current evidence suggests, however, that enzootic infection results either from the fresh and continuous introduction of immunologically naive or deficient mice or from the recurrent infection of immune mice with mhv variants that arise by natural mutation. mutation is favored by immune pressure in enzootically infected colonies as well as missteps during natural replication, which include copying errors and recombination. thus, mice that have developed immunity to one strain of mhv can remain susceptible to one or more genetically and antigenically divergent strains, resulting in reinfection. this caveat has practical importance for breeding colonies. maternal immunity protects suckling mice against homologous mhv strains but not against antigenically variant strains. however, maternal immunity, even to homologous strains, depends on the presence of maternally acquired antibody in the lumen of the intestine. therefore, the susceptibility of young mice to infection increases significantly at weaning. strain differences in resistance and susceptibility to polytropic mhv can be inherited as an autosomal dominant trait. for example, dba/2 mice are highly susceptible to mhv-3 and die acutely even as adults, whereas a/j mice develop resistance to lethal infection shortly after weaning. however, genetic resistance is also virus strain-dependent. therefore, mice resistant to one strain of mhv may be susceptible to another strain. it also is worth noting that the expanded use of genetically altered mice with novel or unanticipated deficits in antiviral responses may alter the outcome of virus-host interactions unpredictably. this pertains to mhv as well as other agents. for example, mhv infection has presented as granulomatous peritonitis and pleuritis in interferongamma (ifn-γ) knockout mice (france et al., 1999) . pathology polytropic strains replicate initially in the nasal mucosa, where necrotizing rhinitis may occur. viremic dissemination can follow if virus gains access to regional blood vessels and lymphatics. thus, viremia leads to secondary infection of vascular endothelium and parenchymal tissues in multiple organs including liver, brain, lymphoid organs, and other sites. mice also may develop central nervous system disease by direct extension of infection from the olfactory mucosa along olfactory tracts. at necropsy, yellow-white foci indicative of necrosis can occur in multiple tissues, with the involvement of the liver as the classical lesion. liver involvement may be accompanied by icterus and peritonitis. histologically, necrosis can be focal or confluent and may be infiltrated by inflammatory cells (fig. 3.28) . syncytia commonly form at the margin of necrotic areas and, in mild infections, may develop in the absence of frank necrosis. syncytia formation is a hallmark of infection in many tissues, including the intestine (fig. 3.26) , lung, liver, lymph nodes, spleen, thymus, brain, and bone marrow and in vascular endothelium in general. although syncytia are transient in immunocompetent mice, they are a persistent feature in chronically infected, immunodeficient mice ( fig. 3.29) . neurotropic variants cause acute necrotizing encephalitis or meningoencephalitis in suckling mice, with demyelination in the brain stem and in peri-ependymal areas secondary to viral invasion of oligodendroglia. convalescent mice may have residual mononuclear cell infiltrates around vessels or as focal lesions in the liver. immunodeficient mice can develop progressive necrotic lesions in the liver and elsewhere. compensatory splenomegaly may occur because of expansion of hematopoietic tissue. enterotropic strains infect primarily the intestine and associated lymphoid tissues, although some may also figure 3.28 necrosis, inflammation, and syncytium in the liver of a mouse infected with mhv. courtesy of s.w. barthold. cause systemic lesions, especially in the liver and brain. the most common sites are terminal ileum, cecum, and proximal colon. the severity of disease is age-related, and dependent upon intestinal proliferative kinetics, similar to edim, with young infants being at highest risk for lethal infection. pathogenic strains can cause lesions ranging from villus attenuation to fulminant necrotizing enterotyphlocolitis, which can kill suckling mice within a few days (fig. 3.27) . the stomach is often empty, and the intestine is filled with watery to mucoid yellowish, sometimes gaseous contents. syncytia are a consistent feature in viable mucosa (fig. 3.30) and not only are formed in intestine but also may be present in mesenteric lymph nodes and endothelium of mesenteric vessels. enterocytes may contain intracytoplasmic inclusions, but they are not diagnostic. surviving mice develop compensatory mucosal hyperplasia, which eventually recedes, but may contribute to clinical signs due to osmotic, secretory, and malabsorptive diarrhea. older mice are equally susceptible to infection, but are resistant to severe disease due to their mature (more rapid) intestinal proliferative kinetics. pathology may be subtle, consisting of transient syncytia without necrotic lesions. in adult mice, syncytia can be found most often in the surface mucosal epithelium of the ascending colon. the exception occurs in immunodeficient mice, such as athymic and scid mice, which can develop chronic proliferative bowel disease of varying severity with mhv antigen in mucosal epithelium (figs. 3.31 and 3.32). this may not always be present, as athymic nude mice exposed as adults may only manifest a few enterocytic syncytia without hyperplasia. diagnosis because mhv infection is often subclinical, serological testing is the most reliable diagnostic tool. many animal resources rely on sentinel mouse protocols for continuous serological surveillance. serology is well established, sensitive, and reliable. neutralization tests are used to differentiate individual virus strains in the research laboratory but are inappropriate for routine use, because of cost, technical complexity, and serologic identification per se does not predict biological behavior, including virulence or tissue tropism. serology also can be used in the context of map testing in which adult mice are inoculated with suspect tissues to elicit seroconversion. rt-pcr protocols to detect virus in tissues or excreta are available. the detection of syncytia augmented, when possible, by immunohistochemistry to laboratory animal medicine detect mhv antigen is a useful and practical means to confirm infection. this strategy should attempt to select mice that are in early stages of infection, because necrosis in infant mice or seroconversion in older mice may reduce the chances of detecting syncytia or viral antigens. the option of using immunodeficient mice as sentinels can be considered, because they sustain prolonged infection. however, they should be securely confined because they also amplify virus loads. if properly controlled, amplification in immunodeficient mice can, however, facilitate subsequent virus isolation in tissue culture. differential diagnosis mhv infection must be differentiated from other infectious diseases that cause diarrheal illness, runting, or death in suckling mice and wasting disease in immunodeficient mice. these include edim, mousepox, reovirus 3 infection, tyzzer's disease, and salmonellosis. neurological signs or demyelinating lesions must be differentiated from mouse encephalomyelitis virus infection or noninfectious cns lesions, such as neoplasms, including polyoma virus-induced tumors in athymic mice. prevention and control control and prevention of mhv infection can be difficult because of the numerous variables that influence its expression. perhaps the most important factor is the duration of infection in individual mice and in mouse colonies. there is evidence that infection in an individual immunocompetent mouse is acute and self-limiting. such mice can be expected to develop immunity and eliminate virus within 30 days. therefore, selective quarantine at the cage (not room) level with the temporary cessation of breeding can be used effectively to eliminate infection. quarantine at the room basis is likely to fail, since mutations arise and continually reinfect the mouse population. additionally, maternally derived immunity can protect infant mice from infection until they are weaned and moved to uncontaminated quarters. careful testing with sentinel mice should be used to assess the effectiveness of quarantine or 'natural rederivation,' as just described. immunodeficient mice, in contrast, are susceptible to chronic infection and viral excretion. mice with unrecognized or unanticipated immune dysfunction or with selective immune dysfunction may impact on mhv infection and its control. such colonies, which may contain highly valuable or irreplaceable mice, may be rescued by cesarean rederivation or embryo transfer if vertical transmission of mhv infection is subsequently ruled out. although rodent coronaviruses are not viable for extended periods in the environment, excreted virus may remain infectious for up to several days, so proper sanitation and disinfection of caging and animal quarters as well as stringent personal sanitation are essential to eliminate infection. the prevention of mhv requires procurement of animals from virus-free sources and maintenance under effective barrier conditions monitored by a well-designed quality assurance program. control of feral mouse populations, proper husbandry and sanitation, and strict monitoring of biological materials that may harbor virus (e.g., transplantable neoplasms, cell lines) are also important strategies to prevent adventitious infection. research complications numerous research complications have been attributed to mhv, and the unpredictable outcome of infection in genetically altered mice is likely to lengthen the list. for example, apart from its clinical impact, mhv may stimulate or suppress immune responses, contaminate transplantable neoplasms, and be reactivated by treatment of subclinically infected animals with several classes of drugs, including immunosuppressive agents, and by intercurrent infections. it also can alter tissue enzyme levels. additionally, the ubiquitous threat of mhv infection and uncertainty about its potential effects on a given research project provoke concerns that may exceed its true impact. for example, transient infection with a mild enterotropic strain is unlikely to disrupt systemic immune responses, whereas infection with a polytropic strain may be highly disruptive. this is not to say that subclinical or strictly enterotropic infection should be taken lightly but simply to caution against overreaction in assessing the impact of an outbreak. etiology mice are susceptible to infection by two members of the cardiovirus genus within the theilovirus. emcv has a less selective host range and can infect wild mice, but is not known to infect laboratory mice. tmev is a small, nonenveloped, rna virus that was discovered by max theiler during experimental studies of yellow fever virus in mice. established prototype strains include to (theiler's original), fa, da, and gd vii, the last of which is named after george martine (george's disease), an assistant in theiler's laboratory. tmev is rapidly destroyed by temperatures over 50°c and by alcohol but not by ether. it can be cultivated in vitro in several continuous cell lines, but bhk-21 cells are routinely used for isolation and propagation. tmev is antigenically related to emcv. as with other nonenveloped viruses, tmev is resistant to environmental inactivation, a factor that must be considered in control and prevention of infection. clinical signs the development of clinical disease depends on virus strain, mouse strain, and route of exposure, but natural disease is exceedingly rare (estimated at 0.1-0.01% of infected mice). when clinical signs occur, they are expressed as neurological disease. the characteristic sign is flaccid posterior paralysis, which may be preceded by weakness in the forelimbs or hindlimbs, but in mice that are otherwise alert (fig. 3.33) . some mice may recover, but death frequently ensues, often because of failure to obtain food or water. furthermore, mice that recover from the paralytic syndrome are disposed to a chronic demyelinating phase, which is expressed as a gait disturbance. epizootiology infection occurs primarily in laboratory mice with the exception of the mgh strain, which has been isolated from laboratory rats and is pathogenic in mice and rats after experimental inoculation. the prevalence of tmev in mouse colonies is low, a reflection of the slow rate at which virus is transmitted from mouse to mouse, but it continues to be among the more common viral contaminants of mouse colonies (livingston and riley, 2003; pritchett-corning et al., 2009) . tmev infection is acquired by ingestion and replicates primarily in the intestinal mucosa. enteric infection can persist after the development of host immunity and can result in chronic or intermittent excretion of virus in feces over several months . mice often become infected shortly after weaning, but virus is seldom recovered in mice over 6 months of age. however, neurologic infection can persist in the brain and spinal cord for at least 1 year. immunity to one strain of tmev provides cross-protection to other strains. there are no reports of differences in mice with respect to susceptibility to infection under natural conditions. prenatal transmission has not been found. pathology intestinal tmev infection does not cause lesions, but virus can be detected in enterocytes by immunohistochemistry or in situ hybridization. poliomyelitis-like disease, the syndrome that may be encountered during natural infections, is characterized by acute necrosis of ganglion cells and neurons, neuronophagia, and perivascular inflammation, which occur particularly in the ventral horn of the spinal cord gray matter but also can involve higher centers such as the hippocampus, thalamus, and brain stem. during the subsequent demyelinating phase, mononuclear cell inflammation develops in the leptomeninges and white matter of the spinal cord, accompanied by patchy demyelination. the white-matter lesions are due to immune injury. spontaneous demyelinating myelopathy, affecting the thoracic spinal cord and associated with mev infection, has also been reported in aged mice. virulent strains may cause acute encephalitis after experimental inoculation, whereas less virulent isolates produce acute poliomyelitis followed by chronic demyelinating disease. diagnosis infection is usually detected serologically or by pcr of feces, but virus shedding from infected mice may be intermittent. clinical signs are striking, if they occur, but are too rare to rely on for routine diagnosis. histological lesions in the cns and especially the spinal cord are characteristic when present. differential diagnosis neurotropic variants of mhv may, on occasion, cause similar neurological signs. injury or neoplasia affecting the spinal cord can also produce posterior paralysis. polyoma virus infection in athymic mice can induce tumors or demyelination in the cns, which may result in clinical signs resembling those of tmev infection. prevention and control disease-free stocks were originally developed by foster-nursing infant mice. this technique, cesarean rederivation, or embryo transfer can be used successfully to eliminate infection. in either case, foster mothers should be surveyed in advance to ensure their mev-free status. selective culling can be considered as an option to eliminate infection, because laboratory animal medicine infection spreads slowly. however, the virus is hardy in the environment and resists chemical inactivation, so it may be prudent to depopulate and disinfect rooms if the presence of infection is unacceptable. research complications the principal hazard from tmev for research relates to its potential effects on the cns. noroviruses are nonenveloped rna viruses that belong to the family caliciviridae. they are notoriously resistant to environmental inactivation, and cause significant gastrointestinal morbidity in humans. noroviruses are species-specific, including mnv, which exclusively infects mice. until the discovery of mnv, replication of noroviruses in vitro has not been possible. for this reason, mnv has emerged as an important small animal model of norovirus pathogenesis. mnv was relatively recently discovered in 2003, and subsequent surveillance has revealed that it is the most common adventitious virus infection in laboratory mice (hsu et al., 2005; pritchett-corning et al., 2009) . over 35 mnv isolates have been found in mouse research colonies around the world, which display nearly 90% genetic identity, comprising a single genetic cluster. although genetically homogeneous, significant biological differences exist among mnv strains (thackray et al., 2007) . mnv effectively replicates in macrophages and dendritic cells, including the mouse macrophage-like raw264.7 cell line, as well as a microglial cell line (wobus et al., 2004) . clinical signs clinical signs of infection in immunocompetent mice are usually absent, but infection leads to systemic disease with high mortality in interferon αβγ receptor and stat1 null mice. affected mice have loss of body weight, ruffled fur, and hunched posture (ward et al., 2006) . experimental infection of 129 and c3h mice with mnv-1 caused mild diarrhea (kahan et al., 2011) . epizootiology mnv is transmitted by the fecaloral route, and contaminates the environment as an environmentally resistant virus. for this reason, it can efficiently infect sentinel mice with soiled bedding (manuel et al., 2008) . duration of infection varies with mnv strain, mouse immunocompetence and mouse genotype. experimental studies have revealed that several mnv strains persist in various tissues of c57bl/6j, hsd:icr, and jcl:icr and c.b-17-prkdc scid mice, with fecal shedding for at least 35-60 days (goto et al., 2009; hsu et al., 2006; thackray et al., 2007) . although not clinically ill, rag1 null mice are unable to clear infection . comparative studies with mnv-1 and mnv-3 have shown differences in virus replication and shedding (kahan et al., 2011) . mnv has a tropism for macrophages and dendritic cells, and virus can be detected in the intestine, intestinal lymphoid tissue, liver, and spleen (hsu et al., 2006; kahan et al., 2011; wobus et al., 2006) . pathology naturally and experimentally infected stat1 or ifnγr null mice may develop splenomegaly and multifocal pale spots on the liver. microscopic findings include varying degrees of hepatitis, focal interstitial pneumonia, vasculitis, peritonitis, and pleuritis (karst et al., 2003; ward et al., 2006) . encephalitis, cerebral vasculitis, pneumonia, and hepatitis have also been described in intracerebrally infected stat1 null mice (karst et al., 2003) . infection of immunocompetent mice may be associated with mild inflammation of the intestine, splenic hypertrophy, and lymphoid hyperplasia of spleen and lymph nodes (mumphrey et al., 2007) . diagnosis mnv infection can be detected by serology or rt-pcr. sentinel mouse surveillance, using soiled bedding, is an effective strategy for detecting mnv (manuel et al., 2008) differential diagnosis the mild change in fecal consistency associated with mnv in adult mice may mimic rotavirus, coronavirus, helicobacter spp., citrobacter rodentium, or other enteric diseases. disseminated lesions in stat1 or ifnγr null mice must be differentiated from other polytropic viral diseases in immunodeficient mice, including mhv. prevention and control depopulation and decontamination has been shown to be effective at eliminating mnv from an enzootically infected colony, whereas testand-removal of positive mice was found to be ineffective (kastenmayer et al., 2008) . embryo transfer and cesarean rederivation are also effective (goto et al., 2009; perdue et al., 2007) . neonatal mice are resistant to infection, so that cross-fostering neonates onto uninfected dams is another effective means of rederivation mnv-free mice (artwohl et al., 2008; compton, 2008) . research complications the tropism of mnv for macrophages and dendritic cells is likely to modify immune responses, and mnv infection may interfere with studies involving enteric disease. hantaviruses are rna viruses belonging to the very large bunyaviridae family. they differ from other members of this family by not being arthropod-borne. each hantavirus is antigenically distinct and maintained within single or at most a few rodent or insectivore hosts, but are infectious for other hosts. infection is lifelong, and virus is transmitted by shedding of virus in urine, feces, and saliva. several hantaviruses are zoonotic and may cause severe disease in humans. although there is overlap, hantaviruses in asia and europe cause hemorrhagic fever with renal syndrome (hfrs) in humans, a multisystem disease with significant renal involvement, and hantaviruses that are endemic in the americas cause laboratory animal medicine hantavirus pulmonary syndrome (hps) in humans, which is a multisystem disease with pulmonary involvement. among the better-known old world hfrs hantaviruses are hantaan, seoul, puumala, and dobrava-belgrade viruses. sin nombre virus is the best known new world phs hantavirus, among many others. most notably from the perspective of laboratory animal medicine, the norway rat, rattus norvegicus, serves as a reservoir host for hantavirus in the wild, but infection has also been associated with laboratory rats. in addition to being endemic in wild rats in asia, it has been found to be endemic in wild rats in the eastern united states and associated with human cases of hfrs (childs et al., 1988; leduc et al., 1984; tsai et al., 1985) . over 120 cases of hantavirus infection have been transmitted to humans from laboratory rats in japan, belgium, and the united kingdom (desmyter et al., 1983; kawamata et al., 1987; lloyd et al., 1984; umenai et al., 1979) . m. musculus is not considered to be a primary reservoir host, but hantavirus infection has been documented serologically in conventional and barrier-maintained laboratory mice and rats in korea (won et al., 2006) , infection of wild m. musculus has been documented in the united states (baek et al., 1988) , and infection of wild mice in europe has been associated with human exposure (diglisic et al., 1994) . hantaviruses are difficult to culture in vitro. infection in rodents is subclinical and is detected by serology or rt-pcr. the main research complication from natural infection is the zoonotic risk and potentially subclinical effects on the immune response associated with viral defenses such as cd8 + t cell (taruishi et al., 2007) and nk function as demonstrated in human studies (braun et al., 2014) . the mouse is host to a number of enveloped rna viruses of the family retroviridae, subfamily orthovirinae, including the two type species (and their variants) mouse mammary tumor virus (mmtv) and murine leukemia virus (mlv). these viruses belong to a diverse assemblage of related mobile dna elements that are integrated into the host genome, and collectively termed 'retroelements', which include retrovirus-related elements and nonviral elements. during cell division, retroelements are transcribed into rna, and subsequently reverse-transcribed into dna copies that become integrated into a new location within the genome. this process utilizes reverse transcriptase, which is encoded by the retroelement. over millennia, retroelements have been repeatedly integrated within the genome in large numbers, comprising approximately 40% of the mammalian genome. various families of mouse retroelements share sequence similarity, despite their random distribution throughout the mouse genome, and the majority of them are truncated, mutated, and methylated to become incapable of infectivity. nevertheless, many of them continue to be mobile within the genome. noninfectious retrovirus-related retroelements include iap, vl30, musd, and etn elements. replication-competent retroviruses represent the pinnacle of the retroelement constellation and are best considered as the most evolutionarily recent members. these include mmtv and mlv. mtv and mlv share similar genetic structure, except that the long terminal repeat (ltr) region of the mmtv genome encodes an additional superantigen (sag). both mmtv and mlv include exogenous viruses, which are horizontally transmitted, replication-competent viruses, and endogenous viruses, which are closely related to exogenous viruses, encoded within the mouse genome, and transmitted by mendelian inheritance. exogenous mmtv and mlv exist in wild mouse populations, but have been eliminated from contemporary laboratory mice. however, they may continue to be used experimentally, including bittner mmtv, and gross, friend, moloney, and rauscher mlvs. in particular, mouse colonies may be purposely infected with mmtv for mammary cancer research and are termed 'mmtv-positive', reflecting their exogenous virus status, even though the mice may also carry endogenous mmtv. the genomes of all inbred strains of mice encode one or more (over 50 in some mouse strains) endogenous mmtv loci, the distribution of which is unique to each inbred strain of mouse. most mmtv genomic loci do not encode infectious virus or are transcriptionally inactive, except for mouse strains (dba, c3h, grs) that carry mtv1 or mtv2 loci. these loci encode infectious virus, which can be visualized as b-type particles by electron microscopy. likewise, all mouse strains carry endogenous mlv loci within their genome, but not all mice carry replication-competent mlv sequences. some endogenous mlvs encode infectious virus, which can be visualized as c-type particles by electron microscopy. mice have often evolved mechanisms to counter the deleterious effects of retroviruses by preventing reentry or replication of virus into other cells. if an endogenous retrovirus is still infectious to other mouse cell targets, it is termed ecotropic, whereas if it is no longer infectious for mouse cells, but can infect cells of other species, it is termed xenotropic. viruses capable of infecting cells of mice as well as other species are termed polytropic. the combinations of endogenous replication-competent mlvs and cell tropism factors are a reflection of selective breeding of mouse strains for susceptibility to various types of cancer. clinical signs mice were originally inbred for specific phenotypes, including mammary tumors and lymphomas. thus, some strains of mice were genetically selected for unique combinations of endogenous mmtv and mlv in concert with susceptibility factors laboratory animal medicine that favored their expression and disease manifestations. in addition, noninfectious retroelements continue to reintegrate randomly within the genome during cell division as retro transposons. these ongoing integrations contribute to genetic drift, spontaneous mutations, and well-recognized mouse strain phenotypes, including the athymic nude allele, the hairless allele, and the rodless retina allele, among others. epizootiology exogenous mmtv and mlv are horizontally transmissible, primarily through the milk of lactating females. endogenous retroviruses and retroelements are inherited through the genome. replicationcompetent endogenous mmtvs and mlvs are also transmissible like their exogenous counterparts, but differ by being integrated within the genome of the mouse. pathology replication-competent mmtv and mlv, regardless of their exogenous or endogenous origin, are usually clinically silent. their ability to cause neoplasia is a reflection of genetic selection for susceptibility factors that are genetically encoded within individual mouse strain genomes. mmtv derives its name from its association with induction of mammary carcinomas in mammary cancer-susceptible strains of mice. mlv is associated with lymphomas, the pattern of which is mouse strain specific. for example, akr mice develop 100% prevalence of thymic lymphoma between 6 and 12 months of age, whereas aging balb/c mice commonly develop multicentric lymphoma. in these strains of mice, multiple endogenous mlvs are coexpressed in tissues and undergo recombination events that allow them to target and transform cells into neoplasia. despite its name, mmtv can induce lymphomas in some strains of mice, such as sjl mice which develop lymphomas arising from enteric lymphoid tissue and mesenteric lymph nodes. diagnosis exogenous retroviruses have been eliminated from contemporary mouse populations, unless purposely introduced for experimental purposes. because endogenous retroviruses and retroelements are encoded within the genome, and reflect the unique genetic composition of each strain of mouse, they are not targets of diagnostic pursuit. differential diagnosis patterns of some types of neoplasia within individual inbred strains of mice are a reflection of their endogenous retroviral integration. prevention and control exogenous retroviruses have been eliminated from laboratory mice by cesarean rederivation and foster nursing. mmtv-s, the 'bittner agent', continues to be purposely maintained in some mouse breeding populations, but can be eliminated by foster-nursing or other means. caution is advised when re-deriving such mouse colonies for other purposes, as elimination of exogenous mmtv will be an unintended consequence. research complications endogenous retroviruses and retroelements influence the life span of individual strains of mice, and random integrations during cell division can give rise to spontaneous mutations and genetic drift. it is estimated that significant mutations may arise due to mobile retroelement integrations every 50 generations. astroviruses are small, nonenveloped, singlestranded rna viruses that have been associated with human gastroenteritis and detected in association with other enteric pathogens. the viral family astroviridae is split into two genuses: avastrovirus for those astroviruses infecting avians and mamastrovirus for those infecting mammals. astrovirus infection has been detected in research mice (muastv) using metagenomic analyses and appears to have a wide geographical, institutional, and host strain distribution. clinical signs none reported. epizootiology pcr screening has found muastv infection in up to 22% of a variety of mouse strains housed in vendor and academic facilities in the united states and japan. the virus has been detected most commonly in immunocompromised mice (nsg, nod-scid, nsg-3gs, c57bl6-timp-3 −/− , and upa-nog), but also in immuncompetent strains (b6j, icr, bash2, and balb/c). both immunodeficient and immunocompetent mice are susceptible to muastv, but adaptive immunity is required to clear the virus. based on human epidemiology indicating children are at highest risk for infection, the virus may preferentially infect young mice. pathology immunodeficient mice showed no sign of pathology based on histopathology. diagnosis pcr data has indicated that muastv causes a systemic, chronic infection in immunocompromised mice, indicating samples from most tissues will be pcr positive. yokoyama et al. (2012) detected high viral load (up to 10 9 genome copies) per fecal pellet from immunocompetent mice. differential diagnosis none, in the absence of lesions and clinical disease. prevention and control because immunocompetent mice clear the infection, quarantine may be successful but lack of routine screening for muastv in laboratory mice will allow for uncontrolled spread of the infection. research complications based on limited surveys, muastv may have a high prevalence in laboratory mice. the impact of infection on both innate and adaptive immune responses warrants further investigation to assess the potential for confounding research data. this section briefly describes the etiology, clinical signs, epizootiology, pathology, diagnosis, differential diagnoses, prevention and control, and research complications of the most common bacterial diseases encountered in research colonies of mice. as sequencing technology becomes more available, the number and genus/species classification of bacteria potentially responsible for infections, in particular, opportunistic infections, will grow (benga et al., 2014) . potential candidates include members of pasteurellacaeae, bordetella hinzii, streptococcus danielae, acinetobacter spp., and others, for which little is currently known about their pathogenic potential. etiology lawsonia intracellularis, an obligate intracellular bacterium and the causative agent of proliferative enteropathy, is not a pathogen encountered in research colonies of mice but has been reported to infect wild mice and rats in close contact with infected livestock (collins et al., 2011) . clinical signs none reported but should consider lawsonia as a differential in necropsy cases with gross or histologic evidence of proliferative lower bowel lesions. epizootiology although mice are experimentally susceptible to infection and develop classic lesions of hyperplastic ileitis and typhlocolitis (murakata et al., 2008) , susceptibility varied with mouse strain and source of inoculum from rabbits or swine, suggesting important differences in l. intracellularis strains. pathology lawsonia infection may result in hyperplastic ileitis, typhlitis and/or colitis, and hemorrhagic intestines may be noted (percy and barthold, 2007) . diagnosis lawsonia spp. has been diagnosed using a variety of techniques, including pcr, immunohistochemistry, in situ hybridization, and warthin-starry silver stains. differential diagnosis bacterial infections associated with hyperplastic intestinal epithelium, including c. rodentium and enterohepatic helicobacter species in susceptible (typically immunodeficient) mouse strains. prevention and control species separation from hosts more commonly associated with natural infection (hamsters, ferrets, pigs). research complications none reported. the following section describes infection due to mycoplasma pulmonis and summarizes infections associated with other murine mycoplasmas including m. arthriditis, m. neurolyticum, m. collis, and m. muris. antigenic cross-reactivity among these species, and especially between m. pulmonis and m. arthriditis, mandates that reliable diagnostic strategies incremental to serology (elisa, ifa, mfia) such as culture (often false negative) and pcr be employed to distinguish potentially pathogenic infections. when screening cell lines for opportunistic pathogens, pcr is the most efficient method to discriminate between m. pulmonis and mycplasma contaminants associated with cell culture. etiology m. pulmonis is a pleomorphic, gram-negative bacterium that lacks a cell wall and has a single outer limiting membrane. it causes murine respiratory mycoplasmosis (mrm). clinical signs mice are relatively resistant to florid mrm; thus, subclinical infection is more common. when clinical signs occur, they reflect suppurative rhinitis, otitis media, and chronic pneumonia. affected mice may display inactivity, weight loss, and ruffled hair coat, but the most prominent signs are 'chattering' and dyspnea, due to rhinitis and purulent exudate in nasal passages. otitis media may cause a head tilt, whereas suppurative inflammation in the brain and spinal cord, although rare, can cause flaccid paralysis. experimental infection of the genital tract can cause oophoritis, salpingitis, and metritis, which may lead to infertility or fetal deaths. experimental inoculation of scid mice has caused systemic infection accompanied by severe arthritis (evengard et al., 1994) . epizootiology mrm historically was a common infectious disease of mice, but improved housing, husbandry, and health surveillance have reduced its prevalence dramatically. serologic data from a large diagnostic laboratory indicated m. pulmonis infection affects about 0.01% of conventionally housed mouse colonies in the united states and 0.16% in europe (pritchett-corning et al., 2009) . m. pulmonis infection is contracted by inhalation and can occur in suckling and adult mice. therefore, infection should be considered highly contagious. mice injected with cells harvested from m. pulmonis contaminated cell cultures may develop disease. m. pulmonis can also be transmitted venerally; in utero infection has been demonstrated in rats but not in mice. because transplacental infection occurs in rats, the same route may be possible in mice, particularly immunocompromised strains. concomitant viral pneumonia (sv, mouse coronavirus) or elevated environmental ammonia concentrations may increase susceptibility to mrm. m. pulmonis also infects rats, hamsters, guinea pigs, and rabbits. among these species, only rats are significant reservoirs of infection for mice. pathology m. pulmonis is an extracellular organism that colonizes the apical cell membranes of respiratory epithelium. attachment occurs anywhere from the anterior nasal passages to the alveoli and may be mediated by surface glycoproteins. the organism may injure host cells through competition for metabolites such as carbohydrates and nucleic acids or by release of toxic substances such as peroxides. ciliostasis, reduction in the number of cilia, and ultrastructural changes leading to laboratory animal medicine cell death have also been described. detrimental effects on ciliated epithelium can lead to disrupted mucociliary transport, which exacerbates pulmonary disease. experimental infection of mrm is dose dependent. doses of 10 4 colony-forming units (cfus) or less cause mild, transient disease involving the upper respiratory tract and middle ears, whereas higher doses often lead to acute, lethal pneumonia. additionally, m. pulmonis strains can differ in virulence. survivors of severe infection may develop chronic bronchopneumonia with bronchiectasis and spread infection to other mice. intravenous inoculation of m. pulmonis can cause arthritis in mice, but arthritis is not a significant feature of natural infection. host genotype also is a major factor in the outcome of infection, with resistance being expressed phenotypically through the bactericidal efficiency of alveolar macrophages. strains derived from a c57bl background appear to be resistant to pathogenic infection, whereas balb/c, c3h, dba/2, swr, akr, cba, sjl, and other strains have varying degrees of increased susceptibility (cartner et al., 1996; lai et al., 1993) . the initial lesion of mrm is suppurative rhinitis, which may involve the trachea and major airways. early inflammatory lesions, if not quickly resolved, progress to prominent squamous metaplasia. transient hyperplasia of submucosal glands may occur, and lymphoid infiltration of the submucosa can persist for weeks. syncytia can sometimes be found in nasal passages, in association with purulent exudate (fig. 3.34) . affected mice also develop suppurative otitis media and chronic laryngotracheitis with mucosal hyperplasia and lymphoid cell infiltrates. pulmonary lesions are typified by bronchopneumonia, which spreads from the hilus. lymphoid cells and plasma cells accumulate around bronchi which often contain neutrophils in their lumen. chronic lung disease features suppurative bronchitis, bronchiolitis, and alveolitis (fig. 3.35) . chronicity also increases the prevalence of bronchiectasis and abcessation. diagnosis accurate diagnosis should exploit the complementary use of clinical, serological, microbiological, molecular, and morphological methods. clinical signs are variable but can be characteristic when they occur. serology is sensitive but although antibodies do not clear the infection, seroconversion may be weak or take months and may not accurately differentiate between m. pulmonis infection and m. arthriditis infection (cassell et al., 1981) . therefore samples for culture and pcr of the upper respiratory tract should be obtained to confirm diagnosis. buffered saline or mycoplasma broth should be used to lavage the trachea, larynx, pharynx, and nasal passages. specimens for culture from the genital tract are warranted if this site is suspected. mycoplasma spp. may be difficult to grow, so it is prudent to confirm that the relevant expertise and quality control exist in the diagnostic laboratory. speciation can be accomplished by immunofluorescence or immunoperoxidase staining or by growth inhibition. immunohistochemistry should be considered to supplement basic histopathologic examination. immunofluorescence and immunoperoxidase techniques are available to identify mycoplasma antigens in tissue sections or in cytological preparations of tracheobronchial or genital tract lavages (brunnert et al., 1994) . pcr assays for m. pulmonis at veterinary diagnostic laboratories and pcr kits to screen cell culures for mycoplasma are readily available. differential diagnosis mrm must be differentiated from bronchopneumonia associated with ciliaassociated respiratory (car) bacillus. silver stains may reveal car bacilli adherent to the respiratory epithelium. sv also can cause bronchopneumonia in mice but can be detected by serology and immunohistochemistry. other causes of respiratory infection include pvm, corynebacteriosis and, in immunodeficient mice, pneumocystis murina infection. combined infections with known pathogens or secondary opportunists also must be considered. prevention and control mice mount an effective immune response to m. pulmonis, as measured by their recovery from mild infection and their resistance to infection after active or passive immunization (cartner et al., 1998) . antibodies of various classes are produced locally and systemically, but clearance of the infection has been attributed to innate immune responses (love et al., 2010; sun et al., 2013) . there is some evidence that antibody may facilitate phagocytosis of m. pulmonis. t-cell responses, however, appear to exacerbate m. pulmonis in mice, because immunity cannot be transferred with immune cells. in addition, athymic and neonatally thymectomized mice are not more susceptible than immunocompetent mice to m. pulmonis pneumonia. nude and scid mice develop less severe respiratory disease than immunocompetent mice but infection becomes systemic and they may develop suppurative disease in multiple organs and joints (arthritis). host immunity aside, effective control and prevention of mrm depend primarily on maintenance of mycoplasma-free colonies under barrier conditions supported by careful surveillance for infection by serology, microbiology, pcr, and histopathology. cesarean or embryo rederivation may eliminate infection, although vertical transmission may occur in immunocompromised mice. treatment with tetracycline suppresses clinical disease but does not eliminate infection. earlier interest in developing dna-based vaccines against m. pulmonis has not achieved clinical application (lai et al., 1997) . research complications m. pulmonis can interfere with research by causing clinical disease or death. experiments involving the respiratory tract, such as inhalation toxicology, can be compromised by chronic progressive infection. additionally, affected mice are at greater risk during general anesthesia. m. pulmonis may alter immunological responsiveness. for example, it is mitogenic for t and b lymphocytes and can increase nk cell activity. perhaps one of the most important complications of mycoplasma infection is contamination of cell lines and transplantable tumors. other murine mycoplasmas cell lines are often contaminated with mycoplasma species such as m. arginini, m. hyorhinis, m. orale, or m. fermentans that can distort the results of in vitro assays (garner et al., 2000) . initial evidence of a contamination is often by pcr evidence of mycoplasma at the genus level when cell lines are pcr screened for opportunistic murine pathogens prior to use in mice. other than m. pulmonis, these mycoplasmas are not normally considered mouse pathogens in immunocompetent mice. in contrast, injection of mycoplasma contaminated cells into immunodeficient mice (e.g., xenografts) may result in clinical disease or confounding effects on immune responses (peterson, 2008) . mycoplasma contamination of murine embryonic stem cells has adversely affected germline transmission and postnatal health of chimeric progeny (markoullis et al., 2009) . mycoplasma arthritidis is antigenically related to m. pulmonis. therefore, serological evidence of mycoplasma infection must be supplemented by other diagnostic tests, as outlined above, to differentiate between these agents. differentiation is important because m. arthritidis, though arthritogenic in mice after intravenous inoculation, is nonpathogenic during natural infection. mycoplasma collis has been isolated from the genital tract of mice but does not appear to cause natural disease. mycoplasma neurolyticum is the etiological agent of rolling disease, a rare syndrome which occurs within hours after intravenous inoculation of m. neurolyticum exotoxin. characteristic clinical signs include spasmodic hyperextension of the head and the raising of one foreleg followed by intermittent rolling on the long axis of the body. the rolling becomes more constant, but mice occasionally leap or move rapidly. after 1-2 h of rolling, animals become comatose and usually die within 4 h. all published reports of rolling disease are associated with experimental inoculation of m. neurolyticum or exotoxin. large numbers of organisms are needed to produce disease, and there is no indication that, under natural conditions, organisms replicate in the brain to concentrations required for the induction of these signs. because animals are frequently inoculated with biological materials by parenteral routes, contamination with m. neurolyticum may induce rolling disease inadvertently. diagnosis can be made from the appearance of typical clinical signs, astrocytic swelling, and isolation of the causative organism. clinical signs must be differentiated from rolling associated with pseudomonas-and p. pneumotropica-caused otitis. m. pulmonis has been recovered from the brain of mice but does not seem to cause overt neurological disease. hemotropic mycoplasmas ribosomal rna sequencing has reclassified hemobartonella muris and eperythrozoon coccoides as mycoplasma hemomuris and mycoplasma coccoides, respectively (neimark et al., 2005; percy and barthold, 2007) . distinct from the mycoplasmas just discussed, these agents are trophic for red blood cells and cause anemia and hemolytic disease. these laboratory animal medicine infections could be encountered in wild mice but are rarely found in research mice. diagnosis is by morphologic assessment of blood smears and pcr. clinical signs mice infected with m. coccoides may remain clinically normal or develop febrile, hemolytic anemia and splenomegaly, which can be fatal. hepatocellular degeneration and multifocal necrosis have been recorded in acute infections. hemotropic mycoplasma infections are long-lived and are expressed clinically in one of two ways: acute febrile anemia and latent or subclinical infection that can be reactivated by splenectomy. the carrier state may be lifelong. epizootiology the primary natural vector of m. coccoides, historically, is the mouse louse, polyplax serrata. infection was associated with primitive housing and husbandry conditions that no longer occur in modern vivaria. although the risks for infection have been reduced substantially by modern animal care procedures, m. coccoides can be transmitted to mice from contaminated biological products such as transplantable tumors or blood plasma. diagnosis splenectomy or inoculation of test material into splenectomized mice is the most sensitive means of detecting m. coccoides infection. these procedures provoke mycoplasmemia, usually within 2-4 days. because mycoplasmemia may be transient, blood smears stained by the romanowsky or indirect immunofluorescence procedures of the blood should be prepared every 6 h, beginning at 48 h after splenectomy of index animals or inoculation of test specimens into splenectomized animals to ensure that mycoplasmemia is not missed. prevention and control treatment of m. coccoides infection is not practical. control is based on culling or rederivation of infected stock. if replacement animals are readily available, euthanasia is a more prudent course. suspect biological materials destined for animal inoculation should be screened for mycoplasma contamination by inoculation of splenectomized mice. research complications subclinical infection can be reactivated by irradiation, immunosuppressive therapy, or intercurrent disease. conversely, m. coccoides may potentiate coincident viral infections in mice. this effect has been clearly demonstrated for mouse coronavirus and has been suspected for lymphocytic choriomeningitis virus and ldv. active infection also may suppress interferon production. etiology car bacillus is a slender, gram-negative, non-spore-forming bacillus, which, in rats, produces clinical disease and lesions that closely resemble those of mrm (see chapter 4). clinical signs chronic respiratory disease has been produced in mice by experimental inoculation, but natural clinical disease is rare (griffith et al., 1988; pritchett-corning et al., 2009) . furthermore, putative natural cases were reported in mice that were seropositive for sv and pneumonia virus of mice. therefore, car bacillus may exacerbate respiratory disease as an opportunist rather than as a primary pathogen. on balance, it is assumed that mice contract natural infection, but attributing severe chronic respiratory disease in mice solely to car bacillus should be supported by screening for other respiratory pathogens. epizootiology car bacillus is transmitted by direct contact; dirty bedding transfer to sentinel mice may not reflect colony infection status. pathology lung lesions are typically mild in mice and are similar to respiratory mycoplasmosis. uncomplicated car bacillus infection results in peribronchiole cuffing with lymphocytes and plasma cells. severe bronchiolitis and pneumonia are possible (fig. 3.36) . fatal bronchopneumonia was reported in ob/ob mice (griffith et al., 1988) . diagnosis an elisa for serological screening is routinely used; pcr and histology are used for definitive diagnosis. in active infection, histologic assessment using warthin-starry or similar stains will reveal argyrophilic bacilli adherent to the apical membranes of bronchial respiratory epithelium along with the presence of peribronchial lymphocytes (fig. 3.37) . alternatively, immunohistochemistry assays have also been used successfully to detect infection. recovery of car bacillus requires cell culture or culture in embryonated eggs. differential diagnosis respiratory mycoplasmosis, bordetella (avium, hinzii). prevention and control given car bacillus does not form spores, disinfection of the environment should be effective. treatment using sulfamerazine (500 mg/l) in drinking water may eradicate infection (matsushita and suzuki, 1995) but culling or embryo rederivation is recommended. research complications infection is most often subclinical, but like other infectious agents for mice, may confound studies particularly when mice are immunocompromised (griffith et al., 1988) . etiology the causative agent of transmissible murine colonic hyperplasia, c. rodentium (formerly citrobacter freundii strain 4280), is a nonmotile, gramnegative rod that ferments lactose but does not utilize citrate or does so marginally (barthold, 1980; schauer et al., 1995) . clinical signs c. rodentium infection can be a selflimiting colitis with sterilizing immunity or lead to severe colitis with life-threatening dehydration. clinically apparent infection is characterized by retarded growth, ruffled fur, soft feces or diarrhea, rectal prolapse, and moderate mortality in older suckling or recently weaned mice (barthold et al., 1978) . epizootiology c. rodentium is not detected in the gastrointestinal flora of normal mice, and therefore, there is not a carrier state. it is thought to be introduced by contaminated mice, food, or bedding, from which it spreads by contact or additional fecal contamination. c. rodentium shares several pathogenic mechanisms, such as attaching and effacing lesions mediated by the intimin receptor, with select escherichia coli (reviewed in collins et al. (2014) ). c. rodentium is used experimentally to model colitis caused by enteropathogenic (epec) and enterohemorrhagic e. coli (ehec) in humans (mallick et al., 2012; collins et al., 2014) . host genotype can influence the course and severity of disease (barthold et al., 1977) . for example, dba, nih swiss, and c57bl mice are relatively resistant to mortality, whereas c3h/hej mice are relatively susceptible both as sucklings and as adults. interestingly, c57bl mice obtained from different commercial sources have varying susceptibility to c. rodentium (ostensibly due to the presence or absence of segmented filamentous bacteria). diet also can modulate infection, but specific dietary factors responsible for this effect have not been identified. pathology c. rodentium attaches to the mucosa of the descending colon and displaces the normal flora. attachment is accompanied by effacement of the microvillus border and formation of pedestal-like structures (attaching and effacing lesions) (schauer and falkow, 1993; newman et al., 1999) . colonization results in prominent mucosal hyperplasia, by unknown mechanisms. the characteristic gross finding is severe thickening of the descending colon, which may extend to the transverse colon and lasts for 2-3 weeks in surviving animals ( fig. 3.38) . affected colon segments are rigid and either are empty or contain semiformed feces. histologically, accelerated mitotic activity results in a markedly hyperplastic mucosa, which may be associated with secondary inflammation and ulceration (fig. 3.39 ). lesions subside after several weeks. intestinal repair is rapid and complete in adults but slower in sucklings. diagnosis diagnosis depends on clinical signs, characteristic gross and histological lesions, and isolation of c. rodentium from the gastrointestinal tract or feces. the organism can be cultured on macconkey's agar during early phases of infection, whereas the intestine may be free of c. rodentium during later stages of the disease. c. rodentium also can be detected by molecular hybridization (schauer et al., 1995) . barthold et al. (1978) . diagnosis transmissible murine colonic hyperplasia must be differentiated from other diarrheal diseases of mice, including infections caused by coronavirus, rotavirus, adenovirus, reovirus, salmonella, c. piliforme, and helicobacter spp. prevention and control some success in curtailing epizootics has been achieved by adding antimicrobials to the drinking water (barthold, 1980; silverman et al., 1979) . because c. rodentium may contaminate food, bedding, or water, proper disinfection of such materials is prudent before they are used for susceptible animals. additionally, the employment of microbarrier caging can reduce transmission. surveillance for c. rodentium should be incorporated into quality-assurance programs, and the organism screened for during quarantine of incoming mice from atypical sources. research complications the potential effects on research of colonic hyperplasia as a clinically severe disease are obvious. colonic hyperplasia has been shown to increase the sensitivity of colonic mucosa to chemical carcinogens and to decrease the latent period between administration of carcinogen and the appearance of focal atypical cell growth (barthold and beck, 1980) . c. rodentium infection has been incriminated in immune dysfunction, poor reproductive performance, and failure to thrive in t-cell receptor transgenic mice (maggio-price et al., 1998) . immunocompromised mice infected with c. rodentium will die from sepsis. etiology pseudomonas aeruginosa is a motile, gramnegative rod. clinical signs p. aeruginosa infections are almost always silent, but immunologically compromised animals are prone to septicemia (brownstein, 1978) . p. aeruginosa can, e.g., cause severe or lethal infections in athymic and scid mice. sick mice may have equilibrium disturbances, conjunctivitis, serosanguinous nasal discharge, edema of the head, weight loss, and skin infections. immunosuppressed mice may also develop gastrointestinal ulcers. generalized infection is associated with severe leukopenia, especially neutropenia. neurologic signs are rare, but there are reports of central nervous system infection. chronic proliferative inflammation in the cochlea and vestibular apparatus with dissolution of surrounding bone may cause torticollis. epizootiology p. aeruginosa is not considered a component of the normal flora. however, it is an opportunist that inhabits moist, warm environments such as water and skin. once established in a host, it may be found chronically in the nasopharynx, oropharynx, and gastrointestinal tract, all sites from which additional environmental contamination or direct transmission to susceptible mice can occur. pathology pathogenic infection is most common in immunodeficient mice. organisms enter at the squamocolumnar junction of the upper respiratory tract and, in some cases, the periodontal gingiva. bacteremia is followed by necrosis or abscess formation in the liver, spleen, or other tissues. if otitis media occurs, the tympanic bullae may contain green suppurative exudate. the bowel may be distended with fluid, and gastrointestinal ulceration has been reported. diagnosis infection is diagnosed on the basis of history (e.g., immune dysfunction or recent immunosuppression), clinical signs, lesions, and isolation of p. aeruginosa from affected mice. carrier mice can be detected either by nasal culture or by placing bottles of sterile, nonacidified, nonchlorinated water on cages for 24-48 h and then culturing the sipper tubes. p. aeruginosa can also be cultured from feces. differential diagnosis pseudomoniasis must be differentiated from other bacterial septicemias that may occur in immunodeficient mice. these include, but are not limited to, corynebacteriosis, salmonellosis, colibacillosis, staphylococcosis, and tyzzer's disease. prevention and control infection can be prevented by acidification or hyperchlorination of the drinking water (homberger et al., 1993) . these procedures will not, however, eliminate established infections. entry of infected animals can be prevented by surveillance of commercially procured colonies. maintenance of pseudomonas-free animals usually requires barrierquality housing and husbandry. p. aeruginosa has a long history in the literature of antibiotic resistance and resistance to quaternary amine disinfectants. research complications p. aeruginosa infection is not a substantial threat to immunocompetent mice but can complicate experimental studies by causing fatal septicemia in immunodeficient mice. viral infections that alter host defense mechanisms, such as mcmv may enhance susceptibility to pseudomoniasis. (lindsey et al., 1991a; percy and barthold, 2007) etiology pasteurella pneumotropica is a short, gramnegative rod. clinical signs many early observations concerning the pathogenicity of p. pneumotropica are questionable because they were made on colonies of mice with varying levels of bacterial and viral contamination. infection is usually subclinical. therefore, p. pneumotropica is most properly viewed as an opportunistic pathogen. studies of experimental p. pneumotropica suggest that it may complicate pneumonias due to mycoplasma pulmonis or sv. it has also been associated with suppurative or exudative lesions of the eye, conjunctiva, skin, mammary glands, and other tissues, especially in immunodeficient mice or in mice with a predisposing primary infection. epizootiology p. pneumotropica is a ubiquitous inhabitant of the skin, upper respiratory tract, and gastrointestinal tract of mice. litters from infected dams can become infected during the first week after birth. pathology infections can cause suppurative inflammation, which may include abcessation. dermatitis, conjunctivitis, dacryoadenitis, panophthalmitis, mastitis, and infections of the bulbourethral glands have been attributed to p. pneumotropica. preputial and orbital abscesses also occur, especially in athymic mice (fig. 3.40 ). its role in metritis is unclear, but it has been cultured from the uterus, and there is some evidence that it may cause abortion or infertility. cutaneous lesions can occur without systemic disease. they include suppurative lesions of the skin and subcutaneous tissues of the shoulders and trunk. diagnosis diagnosis requires isolation of the organism on standard bacteriological media. although infection can be detected serologically by elisa (wullenweber-schmidt et al., 1988; boot et al., 1995a, b) , subclinical carriers often do not seroconvert. pcr assays also are available (dole et al., 2010) and have shown that p. pneumotropica did not transmit from infected mice to contact or dirty bedding sentinels (ouellet et al., 2011; dole et al., 2013) . differential diagnosis suppurative lesions in mice may be caused by other bacteria, including staphylococcus, streptococcus, corynebacterium, klebsiella, and mycoplasma. treatment antibiotic sensitivity testing in vitro indicated p. pneumotropica was significantly more sensitive than p. aeruginosa to enrofloxacin (sasaki et al., 2007) . enrofloxacin in the drinking water at 85 mg/kg daily for 7 days eliminated clinical signs and infection in a closed breeding colonic of transgenic mice and after 14 days of treatment there were no detectable carriers when the colony was screened 4 weeks later (matsumiya and lavoie, 2003) . prevention and control because p. pneumotropica is an opportunistic organism, it should be excluded from colonies containing immunodeficient mice and from breeding colonies. achieving this goal will normally require barrier housing supported by sound microbiological monitoring. rederivation should be considered to eliminate infection in circumstances where infection presents a potential threat to animal health or experimentation. research complications clinically severe infection in immunodeficient mice is the major complication. although clinically silent, experimental evidence has shown that p. pneumotropica infection in immunocompetent mice (c57bl/6) stimulated transcription of multiple proinflammatory cytokines for at least 7 days with residual elevation detectable 28 days later (patten et al., 2010) . pioneering studies conducted in the 1990s first linked a novel microaerobic bacterium, helicobacter hepaticus, with chronic active hepatitis and hepatic tumors in a/jcr mice (fox et al., , 2011 ward et al., 1994) . the organism could be visualized by electron microscopy in the bile canaliculi of the liver in susceptible mouse strains (fig. 3.41 ). subsequently, it was associated with inflammatory bowel disease in several murine models (table 3 .13) which were further developed to examine the role of immune cell subsets, such as t regulatory cells, in the pathogenesis of inflammatory bowel disease (ibd) and colon cancer (fig. 3.42 ). helicobacteriosis is laboratory animal medicine now appreciated to be a common infection of laboratory mice. it is caused by a growing list of helicobacter spp. that vary in clinical, pathologic, and epidemiologic significance (whary and fox, 2004; fox et al., 2011) . because recognition and investigation of helicobacteriosis continues to evolve, many important questions about the impact of this infection on mice remain unresolved. h. hepaticus infection is emphasized here, because it is among the most prevalent causes of helicobacteriosis and has been studied more extensively than other murine enterohepatic helicobacter spp. (ehs) (fox et al., , 2011 ward et al., 1994; suerbaum et al., 2003) . however, current information about other murine helicobacters is summarized in the concluding section. etiology helicobacter spp. are gram-negative, microaerophilic, curved to spiral-shaped organisms that have been isolated from the gastrointestinal mucosa of many mammals, including humans and mice whary and fox, 2004) . to date, the genus includes 20 formally named helicobacter spp. assigned on the basis of 16s rrna analysis, complemented by biochemical, molecular, and morphological characteristics. the organisms can be grown on freshly prepared antibiotic impregnated blood agar or in broth supplemented with fetal bovine serum in a microaerobic atmosphere (5% co 2 , 80% n 2 , 10% h 2 ). there are currently 11 formally named helicobacter species have been isolated from laboratory mice, as well as several other novel helicobacter spp. awaiting formal naming. species isolated from mice include h. hepaticus, h. bilis (which also infects rats), h. muridarum, h. rappini, and h. rodentium, h. ganmani, h. mastomyrinus, h. magdeburgensis, and h. typhlonius , each of which cahill et al. (1997) tcrα, β mutants defective t-receptors typhlocolitis chin et al. (2000) scid icr-defined flora b t-and b-cell deficient typhlocolitis shomer et al. (1998 ), shomer et al. (1997 c57bl/il-10 −/−c lacks il-10 typhlocolitis burich et al. (2001) , kullberg et al. (2001) , kullberg et al. (2006) , kullberg et al. (2002) c57blrag2 mice infected with h. bilis also developed ibd (shomer et al., 1997) . c ibd also developed in c57bl/il-10 −/− mice experimentally infected with a novel urease-negative helicobacter spp. now named h. typhlonius (franklin et al., 2001) ; also ibd produced with h. trogontum (whary et al., 2006) and h. cinaedi (shen et al., 2009) . d h. bilis produces ibd (maggio-price et al., 2002 and colon cancer (maggio-price et al., 2006) . have been formally named (except for h. rappini) (fox and lee, 1997; franklin et al., 1999; whary and fox, 2004) . most recently, helicobacter pullorum, a human pathogen, has been isolated from commercial, barriermaintained mice (boutin et al., 2010) . these ehs are most commonly urease-, catalase-, and oxidase-positive. however, h. rodentium, h. typhlonicus, and another novel helicobacter sp. are urease-negative. clinical signs helicobacteriosis in adult immunocompetent mice is usually asymptomatic. liver enzymes are elevated in h. hepaticus-infected a/jcr mice (fox et al., 1996a) . infection of immune-dysregulated mice with h. hepaticus can cause inflammatory bowel disease, which may present as rectal prolapse and/or diarrhea (miller et al., 2014) . epizootiology recent surveys and anecdotal evidence suggest that helicobacteriosis is widespread among conventional and barrier-maintained mouse colonies (shames et al., 1995; fox et al., 1998b; taylor et al., 2007; lofgren et al., 2011) . furthermore, h. hepaticus (and probably other helicobacters) can persist in the gastrointestinal tract, particularly the cecum and colon, and is readily detected in feces. these results indicate that transmission occurs primarily by the fecal-oral route and imply that carrier mice can spread infection chronically in enzootically infected colonies. pathology helicobacter spp. colonize the crypts of the lower bowel, where, depending on host genotype, the organisms can be pathogenic or nonpathogenic. h. hepaticus and h. bilis, e.g., can cause inflammation in the gastrointestinal tract, which is expressed as ibd and colon cancer in immunodeficient mice or typhlitis in a/jcr mice infected with h. hepaticus (ward et al., 1996; knutson et al., 2013; shomer et al., 1997; erdman et al., 2003b; nguyen et al., 2013) . thickening of the cecum and large bowel develops because of proliferative typhlitis, colitis, proctitis, and lower bowel carcinoma. these lesions can occur without coincident hepatitis. indeed, helicobacter spp. induced ibd and colon carcinoma are increasingly popular models to study pathogenesis of the disease in humans (table 3 .13). helicobacter spp. also can cause liver disease. bacterial translocation is thought to occur and results in colonization of the liver and progressive hepatitis. it is characterized by angiocentric nonsuppurative hepatitis and hepatic necrosis (fig. 3.43) . inflammation originates in portal triads and spreads to adjacent hepatic parenchyma. hepatic necrosis also may occur adjacent to intralobular venules, which can contain microthrombi. additionally, phlebitis may affect central veins. this lesion has been linked to the presence of organisms in bile canaliculi by silver stains and electron microscopy. age-related hepatocytic proliferation can develop in infected livers, a response that is more pronounced in male mice than in female mice (fox et al., 1996a) . this lesion may laboratory animal medicine increase susceptibility to hepatomas and hepatocellular carcinomas among aged male a/jcr and b6c3f1 mice from infected colonies. an increased incidence of hepatic hemangiosarcoma also has been noted in h. hepaticusinfected male b6c3f1 mice. in this context, a/jcr, c3h/ hencr, and sjl/ncr mice are susceptible to hepatitis, whereas c57bl/6 mice are resistant (ward et al., 1994) . the finding of severe liver disease and tumor induction in b6c3f1 mice infected with h. hepaticus infers that genetic susceptibility to h. hepaticus-induced neoplasia has a dominant pattern of inheritance. studies with h. hepaticus in recombinant inbred mice also indicate that disease susceptibility has multigenetic properties (hailey et al., 1998; fox and lee, 1997; ihrig et al., 1999; franklin, 2006; hillhouse et al., 2011) . diagnosis rapid generic diagnosis can be accomplished by pcr detection of the highly conserved 16s rrna region of the helicobacter genome in feces or tissues, using suitable oligonucleotide primers (fox et al., 1998a; shames et al., 1995; beckwith et al., 1997) . however, genus-specific pcr does not differentiate among different helicobacter spp. molecular speciation can be accomplished by 16s rrna sequencing, restriction fragment length polymorphism analysis of the pcr product or use of species-specific pcr assays. this procedure requires suitable skill and experience to avoid technological pitfalls and should be performed by qualified laboratories. an igg elisa using the outer membrane protein as the antigen has been proposed for serological diagnosis, but shared antigens among ehs create lack of specificity for the assay. as noted above, helicobacters can be isolated on antibiotic-impregnated blood agar under microaerobic conditions and can then be speciated biochemically, and by helicobacter species-specific pcr. isolation of h. hepaticus and from other helicobacter spp. with spiral to curved morphology from feces should be preceded by passing slurried samples through a 0.45-μm filter before plating. if infection with larger fusiform helicobacters (h. bilis, h. rappini) is suspected, filtration at 0.65 μm is preferred. helicobacters grow slowly and require prolonged incubation of cultures (up to 3 weeks) before they can be deemed negative. signs (rectal prolapse) and lesions (hepatitis, typhlocolitis), depending on host genotype, can be suggestive of infection. histopathological examination should include silver stains, especially of liver, to attempt to visualize spiral or curved organisms (whary and fox, 2004) . differential diagnosis clinically apparent helicobacteriosis must be differentiated from other gastrointestinal or hepatic infections of mice. coronavirus infection, clostridium piliforme, and salmonella spp. can cause enterocolitis and/or hepatitis. c. rodentium also causes colonic hyperplasia, which can present as rectal prolapse. infections caused by other helicobacters of mice h. bilis has been isolated from the livers and intestines of aged mice and experimentally induces ibd in scid mice as does h. hepaticus. h. bilis also experimentally produces lower bowel cancer in immunocompromised mice (nguyen et al., 2013) . helicobacter muridarum colonizes the ileum, cecum, and colon. it appears to be nonpathogenic, although it can colonize the stomach of mice and induce gastritis under certain circumstances. h. 'rappini' has been isolated from the feces of mice without clinical signs. h. rodentium also colonizes the intestine and may be a component of normal flora. a dual infection of h. bilis and h. rodentium was noted in a natural outbreak of ibd in immunocompromised mice (shomer et al., 1998) . a novel urease negative helicobacter, which has been named h. typhlonius, causes ibd in il-10 −/− and scid mice (franklin et al., 1999 (franklin et al., , 2001 fox et al., 1999) . decreased reproductive efficiency has been reported in il10 knockout mice infected with h. rodentium and/or h. typhlonius (sharp et al., 2008) . prevention and control eradication of infection from small numbers of mice, such as quarantine groups, can be achieved by standard rederivation or intensive antibiotic therapy. the best results have been obtained by triple therapy with amoxicillin, metronidazole, and bismuth given for 2 weeks (del carmen martino-cardona et al., 2010) . this strategy requires repeated daily gavage rather than administration in drinking water, but it has successfully eliminated h. hepaticus from naturally infected mice. antibiotic impregnated wafers have been used to eradicate helicobacter spp. in mouse colonies (kerton and warden, 2006) . wide-scale, eradication of enzootic helicobacteriosis can be expensive and time-consuming, without guarantee of success. careful husbandry procedures can limit infection within a colony (whary et al., 2000) . therefore, strategies have to be weighed carefully against risks of enzootic infection for the health and use of mice. in contrast, infection should be avoided in immunodeficient mice, including genetically engineered mice with targeted or serendipitous immune dysfunction. lastly, the outcome of opportunistic helicobacteriosis has not been thoroughly examined. this condition could occur during simultaneous infection with two or more helicobacter species or during combined infection with an intestinal virus (e.g., coronavirus) and helicobacter spp. if highly valuable animals are exposed, antibiotic therapy or rederivation may be warranted. research complications chronic inflammation of the liver and or gastrointestinal tract may be injurious to health. additionally, it may impede the development and assessment of noninfectious disease models, such as ibd models in mice with targeted deletions in t-lymphocyte receptors (fox et al., 2011) . h. hepaticus infections provoke a strong th1 proinflammatory response, which may perturb other immunological responses. h. hepaticus infection also has been incriminated as a cofactor or promoter in the development of hepatic neoplasia in a/ jcr, b6c3f1, ab6f1, b6af1, and carko mice (hailey et al., 1998; fox et al., 1998a; garcia et al., 2008 garcia et al., , 2011 h. salmonellosis (ganaway, 1982; lindsey et al., etiology the genus salmonella contains two species, s. bongori which infects mainly poikilotherms and rarely, humans, and s. enterica which includes approximately 2500 serovars and are a major cause of food-borne illness in humans (fookes et al., 2011) . the salmonella of historical importance in mice that are now rare include s. enterica subsp. enterica serovar typhimurium (aka s. typhimurium) and serovar enteritidis (s. enteritidis). s. enteritidis is a motile, gram-negative rod that rarely ferments lactose. the genomes of many strains have been sequenced. virulence factors carried on pathogenicity islands and plasmids include antimicrobial resistance genes, type iii secretion systems, vi antigen, lipopolysaccharide and other surface polysaccharides, flagella, and factors essential for a intracellular life cycle in macrophages (de jong et al., 2012) . pathogenassociated molecular patterns (pamps) unique to salmonella interact with tlrs and nod-like receptors (nlrs) which recruit neutrophils and macrophages leading to inflammasome formation and release of pro-inflammatory il-6, il-1β, tnf-α, and ifn-γ. clinical signs acute infection is especially severe in young mice (casebolt and schoeb, 1988) . it is characterized by anorexia, weight loss, lethargy, dull coat, humped posture, and occasionally conjunctivitis. gastroenteritis is a common sign, but feces may remain formed. subacute infection can produce distended abdomens from hepatomegaly and splenomegaly. chronic disease is expressed as anorexia and weight loss. enzootic salmonellosis in a breeding colony can produce episodic disease with alternating periods of quiescence and high mortality. the latter can be associated with diarrhea, anorexia, weight loss, roughened hair coat, and reduced production. epizootiology s. typhimurium is commonly used experimentally and cross-contamination in a mouse facility is a risk. modern production and husbandry methods have reduced the importance of salmonellosis as a natural infection of mice. however, the organisms are widespread in nature. therefore, cross-infection from other species or from feral mice remains a potential hazard. salmonellas are primarily intestinal microorganisms that can contaminate food and water supplies. infection occurs primarily by ingestion. salmonella have a broad host range and vermin, birds, feral rodents, and human carriers are potential sources of infection. other common laboratory species such as nonhuman primates, dogs, and cats also can serve as carriers. conversely, murine salmonellosis presents a zoonotic hazard to humans. the induction and course of infection are influenced by the virulence and dose of the organism, route of infection, host sex and genetic factors, nutrition, and intercurrent disease. suckling and weanling mice are more susceptible to disease than mature mice. immune deficiency, exposure to heavy metals, and environmental factors such as abnormal ambient temperatures can increase the severity of disease. nutritional iron deficiency has an attenuating effect on salmonella infection in mice, whereas iron overload appears to promote bacterial growth and enhance virulence. resistance to natural infection is increased by the presence of normal gastrointestinal microflora. resistance to infection also can be an inherited trait among inbred strains. among the most important considerations is that mice that recover from acute infection can become subclinical carriers and a chronic source of contamination from fecal shedding. pathology the virulence of s. enteritidis depends on its ability to penetrate intestinal walls, enter lymphatic tissue, multiply, and disseminate. organisms reach peyer's patches within 12 h after inoculation and spread quickly to the mesenteric lymph nodes. bacteremia results in spread to other lymph nodes, spleen, and liver within several days. in chronic infections, organisms persist in the spleen and lymph nodes as well as in the liver and gallbladder and from the latter are discharged into the intestinal contents. bacteria reaching the intestine can reinvade the mucosa and can be shed intermittently in the feces for months. s. enteritidis infection also has been associated with chronic arthritis. acute deaths may occur without gross lesions, but visceral hyperemia, pale livers, and catarrhal enteritis are more common. if mice survive for up to several laboratory animal medicine weeks, the intestine may be distended and reddened, whereas the liver and spleen are enlarged and contain yellow-gray foci of necrosis. affected lymph nodes are also enlarged, red, and focally necrotic. focal inflammation can develop in many organs, including the myocardium (percy and barthold, 2007) . histologic lesions reflect the course of disease and the number of bacteria in affected tissues. during acute infection, necrotic foci are found in the intestine, mesenteric lymph nodes, liver, and spleen. neutrophilic leukocytes and histiocytes accumulate in lymphoid tissues. thrombosis from septic venous embolism may occur, especially in the liver. granulomatous lesions are particularly characteristic of chronic salmonellosis, especially in the liver. diagnosis diagnosis is based on isolation of salmonellas together with documentation of compatible clinical signs and lesions. in mice with systemic disease, bacteria may persist in the liver and spleen for weeks. during acute stages, bacteria can also be isolated from the blood. subclinically infected animals can be detected by fecal culture using selective enrichment media (selenite f broth plus cystine followed by streaking on brilliant green agar). culture of the mesenteric lymph nodes may be more reliable, because fecal shedding can be intermittent. isolates can be speciated with commercial serotyping reagents. alternatively, isolates can be sent to a reference laboratory for confirmation. antibodies to salmonellas can be detected in the serum of infected mice by an agglutination test. however, this method is not entirely reliable, because serological crossreactivity is common even among bacteria of different genera. pcr-based assays are also available. differential diagnosis salmonellosis must be differentiated from other bacterial diseases, including tyzzer's disease, helicobacter spp., pseudomoniasis, corynebacteriosis, c. rodentium, and pasteurellosis. viral infections that cause enteritis or hepatitis must also be considered, especially infections caused by coronavirus, ectromelia virus, and reoviruses. among noninfectious conditions, mesenteric lymphadenopathy is an agingassociated lesion in mice and is not indicative of chronic salmonellosis. prevention and control salmonellosis can be prevented by proper husbandry and sanitation. contact between mice and potential carriers, such as nonhuman primates, dogs, and cats, should be prevented. diets should be cultured periodically to check for inadvertent contamination. contaminated colonies should be replaced to eliminate infection and its zoonotic potential. research complications apart from the clinical manifestations, the zoonotic potential for salmonellosis is a major concern. this includes transmission among laboratory species, but especially between mice and the personnel working with them. i. streptobacillosis (lindsey et al., 1991e; percy and barthold, 2007) etiology streptobacillus moniliformis is a nonmotile, gram-negative, pleomorphic rod that can exist as a nonpathogenic l-phase variant in vivo. however, it can revert to the virulent bacillus form. clinical signs streptobacillosis generally has an acute phase with high mortality, followed by a subacute phase and finally a chronic phase that may persist for months. signs of acute disease include a dull, damp hair coat and keratoconjunctivitis. variable signs include anemia, diarrhea, hemoglobinuria, cyanosis, and emaciation. cutaneous ulceration, arthritis, and gangrenous amputation may occur during chronic infection. the arthritis can leave joints deformed and ankylosed. hindlimb paralysis with urinary bladder distention, incontinence, kyphosis, and priapism may occur if vertebral lesions impinge on motor nerves. breeding mice may have stillbirths or abortions. epizootiology streptobacillosis has historical importance as a disease of rats and mice, but modern husbandry, production, and health surveillance strategies have reduced its impact dramatically (wullenweber, 1995) . subclinical, persistently infected rats are the most likely source of dissemination to mice, but mouse-tomouse transmission then ensues. transmission may occur from aerogenic exposure, bite wounds, or contaminated equipment, feed, or bedding. s. moniliformis is also pathogenic for humans, causing rat bite fever (haverhill fever). pathology during acute disease, necrotic lesions develop in thoracic and abdominal viscera, especially in the liver, spleen, and lymph nodes. histological lesions include necrosis, septic thrombosis of small vessels, acute inflammation, fibrin deposition, and abscesses. chronically infected mice may develop purulent polyarthritis because of the organism's affinity for joints. diagnosis diagnosis depends on clinical and pathological evidence of septicemia and isolation of the organism on blood agar. the organism has been recovered from joint fluid as long as 26 months after infection. isolation from chronic lesions requires serumenriched medium. s. moniliformis as a cause of septic joints in humans has been diagnosed using pcr and electrospray-ionization followed by mass spectrometry (mackey et al., 2014) . differential diagnosis clinical signs must be differentiated from septicemic conditions, including mousepox, tyzzer's disease, corynebacteriosis, salmonellosis, mycoplasmosis, pseudomoniasis, and traumatic lesions. prevention and control control is based on exclusion of wild rodents or carrier animals such as latently infected laboratory rats. bacterins and antibiotic therapy are not adequately effective. the potential laboratory animal medicine for cross-infection is a reason not to house rats and mice in the same room. research complications infection can be disabling or lethal in mice and has zoonotic potential for humans. j. corynebacteriosis (lindsey et al., 1982; weisbroth, 1994; percy and barthold, 2007) etiology corynebacteria are short gram-positive rods. corynebacterium kutscheri is the cause of pseudotuberculosis in mice and rats. corynebacterium bovis has been associated with hyperkeratosis, especially in immunodeficient mice (clifford et al., 1995; scanziani et al., 1998; dole et al., 2013) . clinical signs c. kutscheri infection is often subclinical in otherwise healthy mice. active disease is precipitated by immunosuppression or environmental stresses and is expressed as an acute illness with high mortality or a chronic syndrome with low mortality. clinical signs include inappetence, emaciation, rough hair coat, hunched posture, hyperpnea, nasal and ocular discharge, cutaneous ulceration, and arthritis. c. bovis infection causes hyperkeratotic dermatitis characterized by scaly skin, which is accompanied by alopecia in haired mice. severe infection may cause death. corynebacterial keratoconjunctivitis has been reported in aged c57bl/6 mice (mcwilliams et al., 1993) . epizootiology subclinically infected animals harbor c. kutscheri in the upper alimentary tract, colon, respiratory tract, regional lymph nodes, middle ear, and preputial gland. c. bovis colonizes skin and is shed in feces. therefore, transmission is by direct contact, fecaloral contact, and aerosol. resistance to infection appears to be under genetic control in some mouse strains. rats are susceptible to c. kutscheri, so cross-infection to mice may occur. pathology lesions caused by c. kutscheri develop from hematogenous spread to various internal organs and appear as gray-white nodules in the kidney, liver, lung, and other sites. cervical lymphadenopathy and arthritis of the carpometacarpal and tarsometatarsal joints also may occur. septic, necrotic lesions often contain caseous material or liquefied exudate. histologic lesions are characterized by coagulative or caseous necrosis bordered by intense neutrophilic infiltration. colonies of gram-positive organisms with 'chinese letter' configurations can usually be demonstrated using tissue gram stains of caseous lesions. mucopurulent arthritis of carpal, metacarpal, tarsal, and metatarsal joints are related to bacterial colonization of synovium accompanied by necrosis, cartilage erosion, ulceration, and eventually ankylosing pan arthritis. c. kutscheri is not a primary skin pathogen, but skin ulcers or fistulas follow bacterial embolization and infarction of dermal vessels. subcutaneous abscesses have also been reported. hyperkeratotic dermatitis caused by c. bovis is characterized grossly by skin scaliness and alopecia. microscopically, skin lesions consist of prominent acanthosis and moderate hyperkeratosis accompanied by mild nonsuppurative inflammation (fig. 3.44) . hyperkeratosis is typically more severe in glabrous athymic mice than in haired mice. organisms can be demonstrated in hyperkeratotic layers by gram stain. diagnosis c. kutscheri is usually diagnosed by culture and tissue gram stains on lesions from clinically apparent cases. agglutination serology is available, and immunofluorescence, immunodiffusion, and elisa tests have been reported (boot et al., 1995a) . pcr of skin swabs or feces is a sensitive and specific method for the detection of c. bovis infection in mice (dole et al., 2013) . differential diagnosis the caseous nature of c. kutscheri-induced lesions helps separate them from necrotic changes or abscesses caused by other infectious agents of mice. thus, they can be differentiated from streptococcosis, mycoplasmosis, and other septicemic bacterial infections in which caseous necrosis does not occur. because mice can sustain natural infections with mycobacterium avium, histochemical techniques for acidfast bacilli and appropriate culture methods for mycobacteria should be considered if nodular inflammatory lesions of the lung are detected. diffuse scaling dermatitis in athymic nude mice is classic for c. bovis infection; however, in one case report staphylococcus xylosus was instead isolated in high numbers from the skin lesions (russo et al., 2013) . hyperkeratotic dermatitis caused by laboratory animal medicine c. bovis must be differentiated from scaly skin caused by low humidity in glabrous mice. prevention and control c. kutscheri infection occurs sporadically and infected colonies should be culled or rederived into an spf facility as treatment is not curative and control is difficult. c. bovis can be endemic in athymic nude mouse colonies. prevention and control are difficult because both immunocompetent and athymic mice as well as humans can carry c. bovis on the skin and in the upper respiratory system, respectively. c. bovis readily contaminates the environment as aerosolization within a class ii biosafety cabinet was shown to spread the bacterium during cage-change procedures (burr et al., 2012) . antibiotic treatment has been unrewarding (burr et al., 2011) research complications corynebacteriosis can cause morbidity and mortality, especially among immunodeficient mice. dermatologic disease in suckling mice can be fatal but is less severe and transient in weanling mice. etiology staphylococci are gram-positive organisms that commonly infect skin and mucous membranes of mice and other animals. the two most frequently encountered species are staphylococcus aureus, which can be highly pathogenic, and s. epidermidis, which is generally nonpathogenic. species subtypes are identified by phage typing and biochemistry profiles. pathogenic staphylococci are typically coagulase-positive, although s. xylosus has caused serious infections and is coagulasenegative (gozalo et al., 2010) . clinical signs staphylococcosis causes suppurative conjunctivitis, periorbital and retroorbital abscesses, preputial adenitis, and pyoderma in mice, particularly in immunocompromised strains such as nude mice. some evidence suggests that staphylococci can produce primary cutaneous infections, but they are more likely opportunistic organisms that induce lesions after contamination of skin wounds. eczematous dermatitis develops primarily on the face, ears, neck, shoulders, and forelegs and can progress to ulcerative dermatitis, abscessation (including botryomycotic granulomas), and cellulitis. because lesions are often pruritic, scratching causes additional trauma and autoinoculation. staphylococcal infection in the genital mucosa of males may produce preputial gland abscesses. these occur as firm, raised nodules in the inguinal region or at the base of the penis and may rupture to spread infection to surrounding tissues. male mice also may develop septic balanoposthitis secondary to penile self-mutilation. retrobulbar abscesses caused by s. aureus are frequently noted in athymic mice. sjl mice, which are nk cell deficient, are prone to necrotic dermatitis on the tail secondary to s. xylosus infection. epizootiology staphylococci are ubiquitous and can be carried on the skin and in the nasopharnyx and gastrointestinal tract. they also can be cultured from cages, room surfaces, and personnel. the prevalence of staphylococcal dermatitis appears to be influenced by host genotype, the overall health of the animal, and the degree of environmental contamination with staphylococcus spp. c57bl/6, c3h, dba, and balb/c mice are among the most susceptible strains. age may also influence susceptibility, with young mice being more susceptible than adults. immunodeficient mice (e.g., athymic mice) contaminated with staphylococci often develop abscesses or furunculosis (fig. 3.45 ). as noted above, behavioral dysfunction resulting in selfmutilation, including scratching and trichotillomania, is a likely predisposing factor. once virulent staphylococci contaminate the environment, colonization of the gastrointestinal tract can occur and produce a carrier state. phage typing can help to determine the source of infection. human phage types of staphylococci can infect mice, but the zoonotic importance of this connection is not clear. pathology gross lesions are typified by suppurative, ulcerative and necrotic dermatitis involving the head and neck but may extend to the shoulders and forelegs (percy and barthold, 2007) . superficial or deep abscesses may occur in conjunction with dermatitis or separately, as, e.g., in the external male genitalia. histologically, acute skin infections result in ulceration with neutrophils in the dermis and subcutis. chronic lesions contain lymphocytes, macrophages, and fibroblasts. deep infections appear as coalescing botryomycotic pyogranulomas with necrotic centers containing bacterial colonies. infected athymic mice may develop laboratory animal medicine furunculosis of the muzzle and face accompanied by regional lymphadenitis. diagnosis diagnosis is made by documenting gross and histological lesions, including gram staining of suspect tissues, complemented by isolation of grampositive, coagulase-positive (s. aureus), or coagulasenegative staphylococcus species. differential diagnosis staphylococcosis must be differentiated from other suppurative infections of mice, including pasteurellosis, streptococcosis, corynebacteriosis, and pseudomoniasis. ectoparasitism, fight wounds, and self-mutilation per se should also be considered. prevention, control, and treatment removal of affected animals, sterilization of food and bedding, and frequent changing of bedding may limit or reduce transmission. in affected animals, nail trimming can reduce self-inflicted trauma. conditions that facilitate aggressive or self-mutilating behavior should be avoided. research complications staphylococcosis can cause illness and disfigurement in mice. immunodeficient mice are at increased risk. etiology streptococci are ubiquitous commensal gram-positive organisms and in some cases, primary pathogens. pathogenic streptococcal infections in laboratory mice are caused by β-hemolytic organisms in lancefield's group c, but epizootics caused by group a streptococci have occurred, and group g organisms have been isolated occasionally. group d has been reclassified as an enterococcus. alpha-hemolytic streptococci can cause systemic disease in scid mice, and group b streptococcus sp. infection has been reported to cause meningoencephalitis in athymic mice (schenkman et al., 1994) . additionally, streptococcus dysgalactiae subsp. equisimilis has lancefield group g or c antigens and was isolated from visceral abscesses of immunocompetent mice (greenstein et al., 1994) . clinical signs cutaneous infections can cause ulcerative dermatitis over the trunk, which may appear gangrenous, whereas systemic infections may be expressed as conjunctivitis, rough hair coat, hyperpnea, somnolescence, and emaciation. epizootiology mice can carry streptococci subclinically in their upper respiratory tracts. lethal epizootics can occur, but factors leading to clinical disease are unknown, although some infections may be secondary to wound contamination. pathology systemic lesions reflect hematogenous dissemination and include abscessation, endocarditis, splenomegaly, and lymphadenopathy (percy and barthold, 2007) . streptococcal cervical lymphadenitis can lead to fistulous drainage to the neck complicated by ulcerative dermatitis. infection with α-hemolytic streptococci can cause inflammatory lesions affecting kidney and heart. diagnosis diagnosis and differential diagnosis depend on isolation of organisms from infected tissues, combined with histopathologic confirmation. differential diagnosis streptococcosis must be differentiated from other suppurative infections of mice, including staphylococcosis, pasteurellosis, corynebacteriosis, and pseudomoniasis. prevention and control removal of affected animals, sterilization of food and bedding, and frequent changing of bedding may limit or reduce transmission. research complications immunodeficient mice are at increased risk for streptococcosis. etiology e. coli is a small gram-negative rod that is a normal inhabitant of the mouse intestine. epizootiology infection is considered nonpathogenic in immunocompetent mice. however, hyperplastic typhlocolitis resembling transmissible murine colonic hyperplasia has been reported in scid mice infected with a non-lactose-fermenting e. coli (waggie et al., 1988; arthur et al., 2012) . clinical signs affected mice develop lethargy and fecal staining. pathology gross lesions consist of segmental thickening of the colon or cecum, which may contain blood-tinged feces. microscopically, affected mucosa is hyperplastic and may be inflamed and eroded. diagnosis diagnosis depends on demonstrating lesions and isolating non-lactose-fermenting e. coli. differential diagnosis this condition must be differentiated from proliferative and inflammatory intestinal disease caused by lawsonia intracellularis, c. rodentium, or enterotropic mouse hepatitis virus, especially in immunodeficient mice. colibacillosis provides an example of the morbidity associated with a nominally innocuous organism when it affects an immunocompromised host. prevention and control removal of affected animals and disinfection of caging and equipment will limit or reduce transmission. research complications clinical illness may develop in immunodeficient mice. historically, klebsiella pneumoniae is a ubiquitous gram-negative organism that is a natural inhabitant of the mouse alimentary tract. most commercial vendors have excluded it from their barriers. it can be pathogenic for the respiratory and urinary tract of mice after experimental inoculation but is not a significant cause of naturally occurring disease. etiology klebsiella oxytoca is an opportunistic pathogen implicated in various clinical diseases in animals and humans. epizootiology k. oxytoca also is purported to be an etiological agent of antibiotic-associated hemorrhagic colitis (aahc) in adult humans and adolescents. in animals, k. oxytoca has been isolated from apparently healthy sentinel rodents being monitored for pathogens in health surveillance programs and from utero-ovarian infections including suppurative endometritis, salpingitis, perioophoritis, and peritonitis in aged b6c3f1 mice (davis et al., 1987; rao et al., 1987) . a model of aahc has been developed in rats by administering amoxicillinclavulanate followed by orally infecting rats with a strain of k. oxytoca cultured from a patient with aahc. studies in humans suggest that k. oxytoca exerts its pathogenicity in part through a cytotoxin. recently, authors have showed that several animal isolates of k. oxytoca, including clinical isolates, produced secreted products in bacterial culture supernatant that display cytotoxicity on hep-2 and hela cells, indicating the ability to produce cytotoxin. using mass spectroscopy techniques, they also confirmed tilivalline as the cytotoxin present in animal k. oxytoca strains. tilivalline may serve as a biomarker for k. oxytoca-induced cytotoxicity (darby et al., 2014) . clinical signs k. oxytoca has been cultured from cases of suppurative otitis media, urogenital tract infections, and pneumonia in c3h/hej and nmri-foxn1 (nu) mice (bleich et al., 2008) . additionally, k. oxytoca was recently cultured from three breeding colonies of nod. cg-prkdc scid il2rg tm1wjl /szj (nsg) mice with chronic renal inflammation and ascending urinary tract infections (foreman et al., 2011) . differential diagnosis other bacterial infections capable of causing suppurative lesions, including staphylococci, streptococci, pasteurella sp., and e. coli, among others are considered a differential diagnosis. research complications morbidity and mortality from spontaneous infections can affect ongoing research. etiology clostridium difficile was identified as the etiology of antimicrobial-associated pseudomembranous colitis in humans and currently a considerable cause of morbidity in hospitalized patients who acquire nosocomial infections. in the early 2000s, an increased interest in c. difficile infection (cdi) resulted from the emergence of a hyper-virulent strain (nap1/bi/027) associated with frequent recurrences and more severe clinical disease (abou chakra et al., 2014; mcfarland, 2009; kuijper et al., 2006) . c. difficile has also been implicated in antibioticassociated colitis in syrian hamsters (bartlett et al., 1977) , guinea pigs (lowe et al., 1980) , rabbits (thilsted et al., 1981; ryden et al., 1991) , prairie dogs (muller et al., 1987) , ostriches (frazier et al., 1993) , and horses (diab et al., 2013) . c. difficile is a rod-shaped strict anaerobe. cycloserinecefoxitin-fructose agar (ccfa) is a commonly used selective medium for c. difficile. cultures are incubated under anaerobic conditions at 35-37°c. when grown on blood agar, c. difficile colonies are nonhemolytic and gray, and have a slightly raised umbonate profile with filamentous edges and a ground-glass appearance. colonies grown on blood agar have fluorescence under ultraviolet light. c. difficile forms acid from glucose and fructose, but is negative on lactose, maltose, and sucrose. two closely related exotoxins, toxin a and toxin b, are produced by c. difficile. recent taxonomic classification support placement of c. difficile and its close relatives within the family peptostreptococcaceae. the authors suggested renaming it peptoclostridium difficile (yutin and galperin, 2013) . epizootiology it is estimated that c. difficile spores germinate and establish infection less than 10 h after ingestion. spores rapidly transit through the upper gastrointestinal tract and colonize the colon and cecum. spore shedding begins less than 2 h postingestion. when c57bl mice were challenged with 10 8 cfu of c. difficile spores, severe cdi signs developed and all mice were clinically affected by 48 h postchallenge (chen et al., 2008) . specific methods to control and prevent c. difficile infections in mice have not been described. given the method of transmission of c. difficile and c. perfringens are via ingestion or spores, these clostridia can probably be excluded from mouse colonies by maintaining strict husbandry practices, robust sanitation, and use of autoclaved feed, bedding, cages, and cage accessories. sudden dietary changes should be avoided and antibiotics should be used judiciously to minimize disruption of the normal gut microbiota of mice. diagnosis of c. difficile-associated disease is generally based on detection of cytotoxin using a tissue culture cytotoxicity assay. pcr assays for detection of both c. difficile and its cytotoxins have been developed (eastwood et al., 2009) . there are no published regimens specifically for the treatment of natural c. difficile infections in mice. oral doses given twice daily of 2 mg vancomycin for 7 days to experimentally infected gnotobiotic mice caused a 2-to 3-log decrease in vegetative bacterial cell count and no detectable cytotoxin. bacterial counts and cytotoxin levels returned to previous levels after treatment was discontinued. clinical signs untreated mice are relatively resistant to infection with c. difficile and do not develop fatal infections, although these mice can become asymptomatic carriers that persistently shed low numbers of spores (lawley et al., 2009) . susceptibility of mice to infection must be induced by disrupting the microbiota through antibiotic treatment. brief exposure to environmental laboratory animal medicine spore contamination is sufficient for transmission of c. difficile to naïve but susceptible mice. the cdi transmission model has been used to demonstrate that clindamycin treatment of asymptomatic carriers of c. difficile can inadvertently trigger the excretion of high levels of spores (lawley et al., 2009) . a c57bl mouse model of recurrence/relapse cdi has been reported (sun et al., 2011) . the primary bout of cdi induced little or no protective antibody response against c. difficile toxins and mice continued shedding c. difficile spores. antibiotic treatment of surviving mice induced a second episode of diarrhea. a simultaneous reexposure of mice to c. difficile bacteria or spores elicited a full clinical spectrum of cdi similar to that of the primary infection. immunosuppressive agents resulted in more severe and fulminant recurrent disease. vancomycin treatment only delayed disease recurrence; however, neutralizing polysera against both tcda and tcdb completely protected mice against cdi relapse (sun et al., 2011) . a recent study in c57bl mice demonstrated that antibiotic-mediated alteration of the gut microbiome favors a global metabolic profile, and therefore increases susceptibility to c. difficile clinical diseases (theriot et al., 2014) . c. difficile is not tissue invasive and only toxigenic strains are associated with disease. experimental c. difficile infections include diarrhea, cecitis, polymorphonuclear cell infiltration of the lamina propria, inflammation, pseudomembrane formation, and death. differential diagnosis c. difficile-induced diarrhea is most often associated with antibiotic treatment. other clostridial diseases in mice must be ruled out as well as other enteric pathogens in mice causing diarrhea and mortality. salmonella spp. and c. rodentium should be considered in the differential diagnosis. etiology clostridium perfringens is associated with a number of diseases in domestic animals and humans. c. perfringens is a nonmotile, rod-shaped, encapsulated, anaerobic bacterium measuring 4-8 µm in length and 0.8-1.5 µm in diameter (murray et al., 2002) . c. perfringens grow rapidly on blood agar, and colonies are smooth, round, and grayish in color, and are surrounded by a double zone of hemolysis. c. perfringens is grouped into five types based on the production and secretion of four major toxins. c. perfringens produces a number of other virulence-enhancing toxins and hydrolytic enzymes. the most significant of these is probably enterotoxin, released with the bacterial spore after cell lysis. epizootiology c. perfringens is most likely acquired by the ingestion of spores that originated in the soil or in the intestinal tract of a carrier animal. the organism can be a member of the normal microbiota in human and domestic animals. factors that have been associated with the proliferation of the organism of these species include poor husbandry and sudden dietary changes (quinn et al., 2002) . methods to control and prevent c. perfringens infections have not been evaluated in mice. because the bacterium is most likely acquired by the ingestion of spores, it can probably be excluded from mouse colonies by maintaining good sanitation and sterilizing feed, bedding, cages, and cage accessories. sudden dietary changes have also been associated with proliferation of the organism and should be avoided if possible (quinn et al., 2002) . clinical signs only a few reports in the literature exist describing clinical disease associated with c. perfringens infection in mice (matsushita and matsumoto, 1986; rozengurt and sanchez) . disease has been observed in mice of both sexes, from 2 to 32 days old, and in female mice of breeding age. clinical signs have included hunched posture, ruffled hair coat, enlarged painful abdomen, soft or impacted feces, hindquarter paralysis, and dyspnea. sudden death without premonitory signs has also been reported. the toxin types of c. perfringens isolated from these cases were reported to be non-type a (matsushita and matsumoto, 1986) , type b (rozengurt and sanchez, 1999) , and type d (clapp and graham, 1970) . mucosal necrosis in both the large and small intestine is a consistent finding on microscopic examination of tissues from mice with clinically apparent c. perfringens infections. differential diagnosis c. perfringens produces a number of major and minor toxins. different types of the bacterium produce different toxins which account for different disease outcomes. c. perfringens type a is a constituent of the normal microbiota of the intestine of humans and other animal species. bacterial culture should be obtained from live or recently dead animals, and placed in anaerobic transfer medium for transport to a microbiology laboratory and should be cultured soon after their arrival. a presumptive diagnosis for c. perfringens can be based on the presence of large grampositive rods in fecal smears or in histologic sections of intestines (quinn et al., 2002) . definitive diagnosis is based on toxin identification. mice treated with chlortetracycline hydrochloride in drinking water at a level of 11 mg/l for 2 weeks have eliminated c. perfringens-associated disease (matsushita and matsumoto, 1986) . penicillin g in the diet or changing the diet has also been reported to be effective in disease remission. c. perfringens treatments in domestic species include ampicillin, amoxicillin-clavulanate, tylosin, clindamycin, metronidazole, and bacitracin (marks, 2013; mcgorum et al., 1998) . commercially available bacterins for use in mice were not effective in controlling the disease (clapp and graham, 1970) . research complications clostridia are large, rodshaped, gram-positive anaerobic bacteria. naturally occurring clostridial infection in mice is rare. epizootics of c. perfringens type d infection with high mortality laboratory animal medicine have been reported in a barrier colony where heavy mortality occurred in 2-to 3-week-old suckling mice. clinical signs included scruffy hair coats, paralysis of the hindquarters, and diarrhea or fecal impaction. however, attempts to reproduce the disease experimentally with clostridia isolated from naturally infected animals were unsuccessful. c. perfringens also has been isolated from sporadic cases of necrotizing enteritis in recently weaned mice. clostridium piliforme -tyzzer's disease (fujiwara and ganaway, 1994; ganaway, 1982; ganaway et al., 1971; percy and barthold, 2007) etiology tyzzer's disease is named for ernest tyzzer, who first described it in a colony of japanese waltzing mice. the causative organism, c. piliforme (formerly bacillus piliformis), is a long, thin, gram-negative spore-forming bacterium that appears to require living cells for in vitro growth. it has not been grown successfully on cell-free media, but it can be propagated by inoculation of susceptible vertebrates, in select cell lines, the yolk sac of embryonated eggs, or hepatocyte cell cultures obtained from mice (ganaway et al., 1985; kawamura et al., 1983) . clinical signs clinical disease occurs as unexpected deaths that may be preceded by diarrhea and inactivity. although outbreaks can be explosive and mortality is usually high, morbidity varies. additionally, subclinical infections can occur, accompanied by the development of antibodies to c. piliforme. stresses, such as overcrowding, high temperature and humidity, moist food, and immunosuppression, and young age, may predispose mice to tyzzer's disease. susceptibility and resistance also are influenced by host genotype. it has been shown, e.g., that c57bl/6 mice are more resistant than dba/2 mice to tyzzer's disease (waggie et al., 1981) . resistance to severe infection appears to be due, in part, to b-lymphocyte function. the role of t cells in resistance is not clear, because susceptibility among athymic mice appears to vary (livingston et al., 1996) . however, the involvement of t cells can be inferred by the fact that several interleukins modulate resistance and susceptibility. depletion of neutrophils or nk cells also increases susceptibility to infection. epizootiology current prevalence rates, reservoirs of infection, carrier states, and the mechanism of spread remain speculative. tyzzer's disease occurs in many species of laboratory animals and in domestic and free-living species. some strains appear capable of cross-infecting mice, rats, and hamsters, whereas others have a more restricted host range (franklin et al., 1994) . therefore, the risks for cross-infection depend on the strain causing a given outbreak. although the vegetative form of c. piliforme is unstable, spores can retain infectivity at room temperature for at least 1 year and should be viewed as the primary means of spread. natural infection is probably due to ingestion of organisms, which are subsequently shed in feces. feces-contaminated food and soiled bedding are the most likely sources of environmental contamination. prenatal infection can be induced by intravenous inoculation of pregnant mice, but its importance in the natural transmission of infection has not been determined. pathology infection begins in the gastrointestinal tract, followed by bacteremic spread to the liver and, to a smaller extent, the heart. the lesions are characterized by necrosis in these tissues and in the mesenteric lymph nodes. grossly, segments of the ileum, cecum, and colon may be red and dilated, with watery, fetid contents, whereas the liver, mesenteric lymph nodes, and heart often contain gray-white foci. histologically, intestinal lesions include necrosis of mucosal epithelium, which may be accompanied by acute inflammation and hemorrhage. in the liver, foci of coagulation necrosis are generally distributed along branches of the portal vein, a finding compatible with embolic infection from the intestine. peracute lesions are largely free of inflammation, but neutrophils and lymphocytes may infiltrate less fulminant lesions. myocardial necrosis is sporadic in natural infection. diagnosis tyzzer's disease is diagnosed most directly by the demonstration of characteristic intracellular organisms in tissue sections of liver and intestine. bundles of long, slender rods occur in the cytoplasm of viable cells bordering necrotic foci, especially in the liver (fig. 3 .46) and intestine. they are found more easily during early stages of infection. organisms in tissue sections do not stain well with hematoxylin-eosin stain. silver stains, giemsa stains, or periodic acid-schiff stains are usually required for visualization of the organism. pcr and serologic assays are readily available at diagnostic laboratories. older supplemental procedures included inoculation of cortisonized mice or embryonated eggs laboratory animal medicine with suspect material, followed by histological or immunocytochemical demonstration of organisms in tissues. differential diagnosis the histological detection of organisms is essential for differentiating tyzzer's disease from other infections that can produce similar signs and lesions, especially mousepox, coronaviral hepatitis, reoviral hepatitis, helicobacteriosis, and salmonellosis. it also is important not to misconstrue extracellular rods as c. piliforme. prevention and control barrier housing and husbandry that incorporate sanitation measures to avoid the introduction or buildup of spores in the environment are the bases for control or prevention of tyzzer's disease. if infection occurs, spore formation will make control or elimination by antibiotic therapy problematic. therefore, strict quarantine, followed by replacement of affected or exposed stock, must be considered. rederivation by embryo transfer or cesarean section should take the potential for prenatal transmission of infection into account in housing and testing offspring. thorough decontamination of the environment with an oxidizing disinfectant must be included in any control program. additionally, procurement of food and bedding from suppliers with thorough quality assurance and vermin control programs is essential for both prevention and control. husbandry supplies should be stored in vermin-proof quarters, and the option of heat sterilization of food and bedding should be considered. research complications research complications stem from clinical morbidity and mortality. mice with immune dysfunction are at increased risk. there is recent evidence that infection causes elevations in selected cytokines (van andel et al., 2000) . etiology two mycobacteria are known to be pathogenic for laboratory mice: mycobacterium avium-intracellulare and m. lepraemurium. both are acid-fast, obligate intracellular bacteria. epizootiology mycobacteria are widespread in water and soil. their presence in laboratory mice would indicate a significant break in husbandry practices. infection with m. avium-intracellulare should be considered extremely rare, with the only published report describing an episode in a breeding colony of c57bl/6 mice . the source of the outbreak was presumed to be drinking water. mycobacterium lepraemurium has been isolated from healthy laboratory mice and can persist as a latent infection, but its significance is primarily historical, as a model for human leprosy. it is highly unlikely to encounter this infection in a modern, well-managed mouse colony. clinical signs m. avium-intracellulare infection is typically subclinical but mice have developed granulomatous pneumonia . pathology lesions are classically a chronic granulomatous disease with granulomas, langhans giant cells, and concurrent presence of acid-fast bacteria in various organs including the lungs, liver, spleen and lymph nodes. m. lepraemurium may cause alopecia, thickening of skin, subcutaneous swellings, and ulceration of the skin. disease can lead to death or clinical recovery. gross lesions are characterized by nodules in subcutaneous tissues and in reticuloendothelial tissues and organs (lung, spleen, bone marrow, thymus, and lymph nodes). lesions can also occur in the lung, skeletal muscle, myocardium, kidneys, nerves, and adrenal glands. the histologic hallmark is perivascular granulomatosis with accumulation of large, foamy epitheloid macrophages (lepra cells) packed with acid-fast bacilli. diagnosis acid-fast bacilli in lesions are the hallmark of presumptive diagnosis of mycobacteriosis. definitive diagnosis results from positive culture which takes days to weeks to rule out or positive pcr assays which are more time-efficient but require associated expertise. differential diagnosis other bacterial species that cause granulomatous lesions in mice. research complications natural infection is very rare. etiology proteus mirabilis is a ubiquitous gram-negative organism that can remain latent in the respiratory and intestinal tracts of normal mice (percy and barthold, 2007) . epizootiology proteus mirabilis colonizes the intestinal tract of most humans and is commonly found in research mice unless specifically excluded. clinical signs clinical disease can occur following stress or induced immunosuppression. immunodeficient mice have a heightened susceptibility to pathogenic infection. pathology proteus has been associated with ulcerative lesions in the gastrointestinal tract of immunodeficient mice. infected animals lose weight, develop diarrhea, and die within several weeks. if septicemia develops, suppurative or necrotic lesions, including septic thrombi, may be found in many organs, but the kidney is commonly affected. proteus pyelonephritis is characterized by abscessation and scarring. ascending lesions may occur following urinary stasis, but hematogenous spread cannot be ruled out. proteus mirabilis and pseudomonas aeruginosa have been isolated concomitantly from cases of suppurative nephritis or pyelonephritis. infection in immunodeficient mice is typified by splenomegaly and focal necrotizing hepatitis. pulmonary lesions include edema and macrophage activation. septic thrombi can occur, however, in many tissues. diagnosis culture recovery of proteus mirabilis as a predominant or single isolate confirms an opportunistic local or systemic infection. differential diagnosis gram-negative bacterial infections. research complications natural infections are typically isolated cases. etiology leptospirosis remains one of the most common zoonoses transmissible from rodents (desvars et al., 2011) but is exceedingly rare in laboratory mice. infection with leptospira interrogans serovar ballum has been reported on several occasions (see chapter 29). epizootiology leptospira are gram-negative organisms that, after a septicemic phase, establish persistent infection in the renal tubules and are periodically excreted in the urine. clinical signs natural infection is subclinical and causes no significant lesions. experimental infections can result in severe vascular, hepatic and renal lesions dependent on serovar, mouse strain and immunocompetency. diagnosis diagnosis requires isolation of organisms in kidney culture. serological testing should be used with caution because neonatal exposure can lead to persistent infection without seroconversion. histologic examination of kidney using silver stains can also be attempted. pcr assays are reliable for preliminary diagnosis. differential diagnosis not applicable in research colonies. research complications persistent murine infections associated with active shedding present a zoonotic hazard for humans; therefore, infected mice should be culled. elimination of infection from highly valuable mice requires rederivation. (percy and barthold, 2007) etiology chlamydia trachomatis is an intracellular organism that produces glycogen-positive intracytoplasmic inclusions (elementary bodies). c. trachomatis causes ocular and urogenital disease in humans. however, at least one strain historically referred to as the 'nigg agent' after clara nigg, is most recently classified as chlamydia muridarum and is used experimentally to model human chlamydia infection. epizootiology mice are susceptible to natural infection and experimental infection with c. trachomatis and chlamydophila psittaci, especially immunodeficient mouse strains. clinical signs natural infections are typically subclinical but persistent. pathology c. muridarum is also known as the 'mouse pneumonitis agent' due to severe acute infection which is characterized by ruffled fur, hunched posture, and labored respiration due to interstitial pneumonitis and death in 24 h. mice with more chronic infections may develop progressive emaciation and cyanosis of the ears and tail. experimental infections to model human venereal chlamydia infections will develop hydrosalpinx, cervical, and vaginal infections in female mice and urethritis in male mice. diagnosis chlamydia can be diagnosed by impression smears stained with giemsa or macchiavello stains, cell culture, or inoculation of embryonated eggs. pcr and sequencing can be used to speciate the type of chlamydia. differential diagnosis c. muridarum, c. trachomatis, and c. psittaci are included in the differential diagnosis. research complications chlamydia is a rare spontaneous infection in research mice; its potential significance is low. etiology pneumocystis murina (pm) is a common opportunistic organism of laboratory mice and other mammals. when first described by chagas in 1909, p. carinii was misidentified as trypanosoma cruzi and was considered a protozoan (chagas, 1909) . it was renamed as a new species, p. carinii, when observed in a rat in 1912 (delanoë, p. and delanoë, m. 1912) . p. carinii, however, has now been grouped taxonomically with the fungi based on dna analysis and the homology of p. murina housekeeping genes with those found in fungi (edman et al., 1989; stringer et al., 2002; wakefield et al., 1992) . these dna studies and apparent differences of host susceptibility prompted a new name, p. jiroveci, for pneumocystis isolated from humans (stringer et al., 2002; frenkel, 1999) . p. carinii is now used to name the organism in rats and p. murina, the organism in mice. clinical signs pm infection is subclinical in immunocompetent mice. however, it can be clinically severe in immunodeficient mice, because an adequate complement of functional t lymphocytes is required to suppress infection (roths et al., 1990; shultz and sidman, 1987; walzer et al., 1989; weir et al., 1986) . b cells have also been shown to be critical to clearance of infection and the mechanism appears only partially related to igg and has a more important role in promoting activation and expansion of t cells (lund et al., 2003) . b cells may also protect early hematopoietic progenitor activity during systemic responses to pneumocystis infection (hoyt et al., 2014) . infection proceeds slowly, but relentlessly in immunodeficient mice leading to clinical signs of pneumonia, usually within several months. primary signs include dyspnea and hunched posture, which may laboratory animal medicine be accompanied by wasting and scaly skin. severe cases, such as those that occur in advanced disease in scid mice, may be fatal. epizootiology pm is known to infect a number of mammalian hosts, including ferrets, rats, mice, and humans. pm is a ubiquitous organism that is often present as a latent infection. although firm prevalence data are not available, because detection methods are not simple to apply, infection is assumed to be present in mouse colonies unless ruled out by extensive surveillance. although these organisms appear morphologically similar, there are antigenic and genetic differences among p. murina isolated from different hosts (weinberg and durant, 1994; cushion, 1998) . furthermore, studies indicate that p. carinii isolated from one host species is unable to survive and replicate after inoculation into a different immunodeficient host species (gigliotti et al., 1993b) . pm infection also occurs in human beings, but transmission between rodents and human beings has not been documented. pm is transmitted by aerosol and establishes persistent, quiescent infection in the lungs of immunocompetent mice. prenatal infection has not been demonstrated. pathology pm is normally not pathogenic but can be activated by intercurrent immunosuppression. activation fills the lung with trophic and cystic forms. gross lesions occur in the lungs, which are often rubbery and fail to deflate (fig. 3.47 ). histopathological changes are characterized by interstitial alveolitis with thickening of alveolar septa from proteinaceous exudate and infiltration with mononuclear cells (fig. 3 .48) (roths et al., 1990) . alveolar spaces may contain vacuolated eosinophilic material and macrophages. special stains are required to visualize pm. silver-based stains reveal round or partially flattened 3-to 5-mm cysts in affected parenchyma (fig. 3.49) . in florid cases, alveolar spaces may be filled with cysts, but cysts may be sparse in mild cases. disease can be especially severe when subclinically infected immunodeficient mice are reconstituted with competent immune cells that subsequently promote pneumonitis. diagnosis respiratory distress in immunodeficient mice should elicit consideration of pneumocystosis. pathologic examination of the lung, including silver laboratory animal medicine methenamine staining, is essential to confirm a presumptive clinical diagnosis. past infections of immunocompetent mice also can be detected by elisa (furuta et al., 1985) . pcr can be used to detect active infection (gigliotti et al., 1993a; reddy et al., 1992) and is particularly useful for screening immunodeficient mice. differential diagnosis pneumocystosis must be differentiated from viral pneumonias of mice. it is worth noting, in this regard, that pneumonia virus of mice has been shown to accelerate the development of pneumocystosis in scid mice (bray et al., 1993; roths et al., 1993) . prevention and control pm infection is a significant disease threat to immunodeficient mice. its widespread distribution strongly suggests that susceptible mice should be protected by microbarrier combined, where possible, with macrobarrier housing. husbandry procedures should include proper sterilization of food, water, and housing equipment and the use of hepa-filtered change stations. infected colonies can be rederived by embryo transfer or cesarean methods, because infection does not appear to be transmitted in utero. research complications pneumonia in immunodeficient mice is the major complication of pm infection. trichophyton mentagrophytes is the most common fungal agent of mice. however, infection rarely causes clinical disease. clinical signs include sparse hair coats or well-demarcated crusty lesions, with a chalky surface on the head, tail, and legs (favus or ringworm). skin lesions are composed of exfoliated debris, exudate, mycelia, and arthrospores with underlying dermatitis. invasion of hair shafts is not characteristic. diagnosis depends on effective specimen collection. hairs should be selected from the periphery of the lesion, and hairless skin should be scraped deeply to obtain diagnostic specimens. t. mentagrophytes rarely fluoresces under ultraviolet light, and hyphae must be differentiated from bedding fibers, food particles, and epidermal debris. histological sections should be stained with a silver stain or schiff's reagent to reveal organisms. trichophyton also can be cultured on sabouraud agar. plates are incubated at room temperature (22-30°c), and growth is observed at 5-10 days. ringworm is not easily eradicated from laboratory mice. the use of antifungal agents to treat individual mice is time-consuming, expensive, and variably effective. rederivation is a more prudent course. cages and equipment should be sterilized before reuse. concurrent infection with ectoparasites also must be considered during eradication steps. candida albicans and other systemic mycoses are not important causes of disease in mice, but they can be opportunistic pathogens in immunodeficient mice. etiology giardia muris is a pear-shaped, flagellated organism with an anterior sucking disk. it inhabits the duodenum of young and adult mice, rats, and hamsters. clinical signs infection is often subclinical, unless organisms proliferate extensively, and can cause weight loss, a rough hair coat, sluggish movement, and abdominal distension, usually without diarrhea. additionally, immunodeficient mice may die during heavy infestation. epizootiology the contemporary prevalence of affected mouse colonies is not well documented, but surveys during the 1980s found the rates exceeding 50%. transmission occurs by the fecal-oral route. crossinfection between mice and hamsters after experimental inoculation of organisms has been demonstrated, whereas rats were resistant to isolates from mice and hamsters (kunstyr et al., 1992) . c3h/he mice are particularly susceptible to giardiasis, whereas balb/c and c57bl/10 mice are more resistant. additionally, female mice appear to be more resistant to infection than male mice (daniels and belosevic, 1995) . c57bl/6 females, e.g., have lower trophozoite burdens and for a shorter interval than male mice. females also shed cysts later than male mice. these differences may be related to a more potent humoral immune response to giardia in female mice. pathology gross lesions are limited to the small intestine, which may contain yellow or white watery fluid. histopathology reveals organisms in the lumen that often adhere to microvilli of enterocytes or reside in mucosal crevices or mucus. the crypt/villus ratio may be reduced, and the lamina propria may have elevated numbers of inflammatory cells. diagnosis diagnosis is based on detection of trophozoites in the small intestine or in wet mounts of fecal material. organisms can be recognized in wet preparations by their characteristic rolling and tumbling movements. ellipsoidal cysts with four nuclei also may be detected in feces. infection also can be detected by serology (daniels and belosevic, 1994) and by pcr (mahbubani et al., 1991) . treatment, prevention, and control murine giardiasis can be treated by the addition of 0.1% dimetridazole to drinking water for 14 days. prevention and control depend on proper sanitation and management, including adequate disinfection of contaminated rooms. research complications accelerated cryptal cell turnover and suppression of the immune response to sheep erythrocytes have been observed in infected mice. the potential for severe or lethal infection in immunodeficient mice was noted previously. etiology spironucleus muris is an elongated, pearshaped, bilaterally symmetrical flagellated protozoan that commonly inhabits the duodenum, usually in the crypts of lieberkühn. it is smaller than giardia muris and lacks an anterior sucking disk. clinical signs s. muris infection is usually subclinical in normal adult mice. it is more pathogenic, however, for young, stressed, or immunocompromised mice (kunstyr et al., 1977) . additionally, clinical morbidity may indicate an underlying primary infection with an unrelated organism. clinically affected mice can have a poor hair coat, sluggish behavior, and weight loss. mice at 3-6 weeks of age are at notably higher risk for clinically evident infection. they can develop dehydration, hunched posture, abdominal distension, and diarrhea. severe infections can be lethal. epizootiology transmission occurs by the fecaloral route and can occur between hamsters and mice as well as between mice. it does not appear to be transmitted between mice and rats (schagemann et al., 1990) . the most recent surveys, which are somewhat dated, indicated that prevalence rates exceeded 60% among domestic mouse colonies in the mid-1980s. there is some evidence that inbred strains vary in their susceptibility to infection and their rate of recovery (baker et al., 1998; brett and cox, 1982) . pathology gross findings associated with infection include watery, red-brown, gaseous intestinal contents. however, it is essential to rule out primary or coinfection by other organisms before attributing these lesions to spironucleosis. microscopically, acute disease is associated with distension of crypts and intervillous spaces by pear-shaped trophozoites and inflammatory edema of the lamina propria. organisms can be visualized more easily with periodic acid-schiff staining, which may reveal invasion of organisms between enterocytes and in the lamina propria. chronic infection is associated with lymphoplasmacytic infiltration of the lamina propria and occasional intracryptal inflammatory exudate. diagnosis diagnosis is based on identification of trophozoites in the intestinal tract. they can be distinguished from giardia muris and tritrichomonas muris by their small size, horizontal or zigzag movements, and the absence of a sucking disk or undulating membrane. pcr-based detection also is available (rozario et al., 1996) . it is not clear whether duodenitis is a primary pathogenic effect of s. muris or represents opportunism secondary to a primary bacterial or viral enteritis. therefore, it is prudent to search for underlying or predisposing infections. treatment, prevention, and control treatment consists of adding 0.1% dimetridazole to drinking water for 14 days, as described for giardiasis. prevention and control require good husbandry and sanitation. research complications as with giardiasis, infection can accelerate enterocytic turnover in the small intestine. there is some evidence that infected mice may have activated macrophages that kill tumor cells nonspecifically and that infection can diminish responses to soluble and particulate antigens. additionally, infected mice also have increased sensitivity to irradiation. such effects should, however, be interpreted cautiously in order to rule out intercurrent viral infections. tritrichomoniasis t. muris is a nonpathogenic protozoan that occurs in the cecum, colon, and small intestine of mice, rats, and hamsters. no cysts are formed, and transmission is by ingestion of trophozoites passed in the feces. it can be detected by microscopy or by pcr (viscogliosi et al., 1993) . coccidiosis eimeria falciformis is a pathogenic coccidian that occurs in epithelial cells of the large intestines of mice. it was common in european mice historically but is seldom observed in the united states. heavy infection may cause diarrhea and catarrhal enteritis. klosiella muris causes renal coccidioisis in wild mice but is rare in laboratory mice. mice are infected by ingestion of sporulated sporocysts. sporozoites released from the sporocysts enter the bloodstream and infect endothelial cells lining renal arterioles and glomerular capillaries, where schizogony occurs. mature schizonts rupture into bowman's capsule to release merozoites into the lumen of renal tubules. merozoites can enter epithelial cells lining convoluted tubules, where the sexual phase of the life cycle is completed. sporocysts form in renal tubular epithelium and eventually rupture host cells and are excreted in the urine, but oocysts are not formed. infection is usually nonpathogenic and subclinical. gray spots may occur in heavily affected kidneys and are the result of necrosis, granulomatous inflammation, and focal hyperplasia. destruction of tubular epithelium may impair renal physiology. diagnosis is based on detection of organisms in tissues. prevention and control require proper sanitation and management techniques. there is no effective treatment. cryptosporidiosis cryptosporidium muris is a sporozoan that adheres to the gastric mucosa. it is uncommon in laboratory mice and is only slightly pathogenic. cryptosporidium parvum inhabits the small intestine and is usually nonpathogenic in immunocompetent and athymic mice (ozkul and aydin, 1994; taylor et al., 1999) . athymic mice may develop cholangitis and hepatitis, however, if organisms gain access to the biliary tract. entamoebiasis entamoeba muris is found in the cecum and colon of mice, rats, and hamsters throughout the world. organisms live in the lumen, where they feed on particles of food and bacteria. they are considered nonpathogenic. encephalitozoonosis encephalitozoon cuniculi is a gram-positive microsporidian that infects rabbits, mice, rats, guinea pigs, dogs, nonhuman primates, humans, and other mammals. infection is extremely rare among laboratory mice. the life cycle of the organism is direct, and animals are infected by ingesting spores or by cannibalism. spore cells are disseminated in the blood to the brain and other sites. infection can last more than 1 year, and spores shed in the urine serve as a source of infection. vertical transmission has not been confirmed in mice. e. cuniculi is an obligate intracellular parasite, but infection usually elicits no clinical signs of disease. organisms proliferate in peritoneal macrophages by asexual binary fission. they have a capsule that accepts giemsa and goodpasture stains but is poorly stained by hematoxylin. fulminating infection can cause lymphocytic meningoencephalitis and focal granulomatous hepatitis. in contrast to encephalitozoonosis in rabbits, affected mice do not develop interstitial nephritis. infection is diagnosed by cytological examination of ascitic fluid smears, histopathologic examination of brain tissues stained with goodpasture stain, and elisa serology. no effective treatment has been reported. prevention and control require rigid testing and elimination of infected colonies and cell lines. pcr-based assays may also be useful. toxoplasmosis toxoplasma gondii is a ubiquitous gram-negative coccidian parasite for which the mouse serves as a principal intermediate host. however, the prevalence of natural infection is negligible because laboratory mice no longer have access to sporulated cysts shed by infected cats, which were historically the major source for cross-infection. toxoplasmosis can cause necrosis and granulomatous inflammation in the intestine, mesenteric lymph nodes, eyes, heart, adrenals, spleen, brain, lung, liver, placenta, and muscles. diagnosis is based on elisa serology, histopathology, and pcr. control and prevention depend largely on precluding access of mice to cat feces or to materials contaminated with cat feces. oocytes are very resistant to adverse temperatures, drying, and chemical disinfectants; therefore, thorough cleaning of infected environments is required. b. cestodiasis baker, 2007) etiology hymenolepis (rodentolepis) nana, the dwarf tapeworm, infects mice, rats, and humans although the zoonotic risk has been questioned (macnish et al., 2002) . adults are extremely small (25-40 mm) and have eggs with prominent polar filaments and rostellar hooks (fig. 3.50) . clinical signs young adult mice are most frequently infected. signs and lesions include weight loss and focal enteritis, but clinical disease is rare unless infestation is severe. epizootiology the life cycle may be direct or indirect (r. nana is the only cestode known that does not require an intermediate host). the indirect cycle utilizes arthropods as intermediate hosts. liberated oncospheres penetrate intestinal villi and develop into a cercocystis stage before reemerging into the intestinal lumen 10-12 days later. the scolex attaches to the intestinal mucosa, where the worm grows to adult size in 2 weeks. the cycle from ingestion to patency takes 20-30 days. pathology cysticerci are found in the lamina propria of the small intestine and sporadically in the mesenteric lymph nodes, whereas adults, which have a serrated profile, are found in the lumen. inflammation is not a feature of infection. diagnosis infection can be diagnosed by demonstrating eggs in fecal flotation preparations or by opening the intestine in petri dishes containing warm tap water to facilitate detection of adults. r. nana can be differentiated from another species of rodent tapeworm, h. diminuta, by the fact that r. nana has rostellar hooks and eggs with polar filaments. however, h. diminuta requires an intermediate arthropod host, so it is rarely found in contemporary mouse colonies. treatment, prevention, and control drugs recommended for treatment and elimination include praziquantel (0.05% in the diet for 5 days), albendazole, mebendazole, and thiabendazole. although the benzimidazoles have an excellent activity against cestodes and nematodes in rats, they have not been tested extensively in mice. the potential for successful treatment is high, however, because eggs do not survive well outside the host and because the prevalence of infestation is low in caged mice kept in properly sanitized facilities. because r. nana can directly infect humans, proper precautions should be taken to avoid oral contamination during handling of rodents (see chapter 28). hymenolepis microstoma is found in the bile ducts of rodents and could be confused with r. nana in the mouse. however, the location of the adult as well as the large size of h. microstoma eggs compared with those of r. nana make differential diagnosis relatively simple. the mouse and the rat are intermediate hosts of the cestode taenia taeniaformis. the definitive host is the cat. this parasite should not be found in laboratory mice housed separately from cats. c. nematodiasis (wescott, 1982) syphacia obvelata (mouse pinworm) infestation etiology syphacia obvelata, the common mouse pinworm, is a ubiquitous parasite of wild and laboratory mice. the rat, gerbil, and hamster are also occasionally infected. female worms range from 3.4 to 5.8 mm in length, and male worms are smaller (1.1-1.5 mm). eggs are flattened on one side and have pointed ends (fig. 3.51 ). the nucleus fills the shell and is frequently at a larval stage when eggs are laid. clinical signs infestation is usually subclinical, although heavily infested mice can occasionally sustain intestinal lesions, including rectal prolapse, intussusception, enteritis, and fecal impaction. epizootiology pinworm infestation is one of the most commonly encountered problems in laboratory mice. a national survey revealed that more than 30% of barrier colonies and about 70% of conventional colonies were affected (jacoby and lindsey, 1997; carty, 2008) . syphacia obvelata infestation can occur unexpectedly in commercial barrier murine colonies, resulting in widespread dissemination of the parasite into academic mouse colonies. the epizootiological impact of pinworm infestation is increased by the airborne dissemination of eggs, which can remain infectious even after drying. the life-cycle is direct and completed in 11-15 days. females deposit their eggs on the skin and hairs of the perianal region. ingested eggs liberate larvae in the small intestine and they migrate to the cecum within 24 h. worms remain in the cecum for 10-11 days, where they mature and mate. the females then migrate to the large intestine to deposit their eggs as they leave the host. there is unconfirmed speculation that larvae may reenter the rectum. infestation usually begins in young mice and can recur, but adult mice tend to be more resistant. syphacia infestation often occurs in combination with aspiculuris tetraptera. because the life cycle of syphacia is much shorter than that of aspiculuris, the number of mice that are apt to be infected with s. obvelata is correspondingly greater. there is evidence that resistance to infestation may be mouse strain-specific (derothe et al., 1997) . pathology gross lesions are not prevalent, aside from the presence of adults in the lumen of the intestine. diagnosis infestation is diagnosed by demonstrating reniform-shaped eggs in the perianal area or adult worms in the cecum or large intestine. four-to 5-weekold mice should be examined because the prevalence is higher in this age group than in older mice. because most eggs are deposited outside the gastrointestinal tract, fecal examination is not reliable. eggs are usually detected by pressing cellophane tape to the perineal area and then to a glass slide that is examined by microscopy. aspiculuris tetraptera eggs are not ordinarily found in tape preparations and are easily differentiated from eggs of s. obvelata (see below). adult worms can be found in cecal or colonic contents diluted in a petri dish of warm tap water. they are readily observed with the naked eye or with a dissecting microscope. an elisa also is available to detect serum antibodies to s. obvelata somatic antigens (sato et al., 1995) . pcr assays are increasingly being used to augment traditional diagnostic methods and to discriminate between pinworm species (dole et al., 2011) . pcr panels for pinworm detection using fecal pellets are available from commercial diagnostic laboratories. treatment, prevention, and control pinworm infestation can be treated effectively by a number of regimens, which include the use of anthelmintics such as piperazine, ivermectin, and benzimidazole compounds alone or in combination (klement et al., 1996; le blanc et al., 1993; lipman et al., 1994; flynn et al., 1989; wescott, 1982; zenner, 1998) . because some of the recommended therapies have the potential for toxicity, it is prudent to keep mice under close clinical observation during treatment (davis et al., 1999; skopets et al., 1996; toth et al., 2000) . fenbendazole diets can be fed with 1 week on/1 week off rotation with normal chow although the potential impact on experimental data must be considered (duan et al., 2012; gadad et al., 2010; landin et al., 2009) . prevention of reinfestation requires strict isolation because syphacia eggs become infective as soon as 6 h after they are laid, and they survive for weeks, even in dry conditions. strict sanitation, sterilization of feed and bedding, and periodic anthelmintic treatment are required to control infestation. the use of microbarrier cages can reduce the spread of infective eggs. syphacia muris is the common rat pinworm. it can potentially infest mice but is not found in well-managed colonies. it can be differentiated from s. obvelata because s. muris eggs are smaller. treatment is the same as for pinworms of mice. etiology aspiculuris tetraptera is the other major oxyurid of the mouse and may coinfect mice carrying s. obvelata. females are 2.6-4.7 mm long, and males are slightly smaller. the eggs are ellipsoidal (fig. 3.52) . clinical signs ingested eggs hatch, and larvae reach the middle colon, where they enter crypts and remain for 4-5 days. they move to the proximal colon about 3 weeks after infection of the host. because the life cycle is 10-12 days longer than in s. obvelata, infestations appear in somewhat older mice; heaviest infestation is expected in 5-6 weeks after initial exposure. infection is usually subclinical, but heavy loads can produce signs similar to those discussed for s. obvelata. light to moderate loads do not produce clinical disease. epizootiology as noted under s. obvelata, pinworm infestation is highly prevalent and contagious in laboratory mice. the life cycle is direct and takes approximately 23-25 days. mature females inhabit the large intestine, where they survive from 45 to 50 days and lay their eggs. the eggs are deposited at night and are excreted in a mucous layer, covering fecal pellets. they require 6-7 days at 24°c to become infective and can survive for weeks outside the host. pathology see s. obvelata (section iii, a,5,c). diagnosis aspiculuris tetraptera eggs can be detected in the feces, and adult worms are found in the large intestine. eggs are not deposited in the perianal area; therefore, cellophane tape techniques are not useful. measures for treatment, prevention, and control are similar to those described for s. obvelata. because a. tetraptera takes longer to mature and because eggs are deposited in feces rather than on the host, adult parasites are more amenable to treatment by frequent cage rotations. immune expulsion of parasites and resistance to reinfection are hallmarks of a. tetraptera infection. research complications see s. obvelata (section iii, a,5,c). several species of mites infest laboratory mice. they include myobia musculi, radfordia affinis, myocoptes musculinus, and, less commonly, psorergates simplex. the common murine mites are described below, while less frequently encountered species are listed in table 3 .14. these include the mouse mite trichoecius romboutsi, which resembles myocoptes and ornithonyssus bacoti, the tropical rat mite, which can infect laboratory mice. characteristics of specific infestations are described after a general introductory section. clinical signs mites generally favor the dorsal anterior regions of the body, particularly the top of (jacoby and lindsey, 1997; carty, 2008) reported mite infestations in 40% of colonies. acarids spend their entire lives on the host. populations are limited by factors such as self-grooming, mutual grooming, the presence of hair, and immunological responses, which tend to produce hypersensitivity dermatitis. inherited resistance and susceptibility also affect clinical expression of acariasis. mite populations, e.g., vary widely among different stocks and strains of mice housed under similar conditions. pathology gross lesions include scaly skin, regional hair loss, abrasions, and ulcerations. histologically, hyperkeratosis, acanthosis, and chronic dermatitis may occur. long-standing infestation provokes chronic inflammation, fibrosis, and proliferation of granulation tissue. ulcerative dermatitis associated with acariasis may have an allergic pathogenesis but often results in secondary bacterial infections. lesions resemble allergic acariasis in other species and are associated with mast cell accumulations in the dermis. diagnosis classic methods of detection include direct observation of the hair and skin of dead or anesthetized mice. hairs are parted with pins or sticks and examined with a dissecting microscope. examination of young mice, prior to the onset of immune-mediated equilibrium, is likely to be more productive. alternatively, recently euthanized mice can be placed on a black paper, and double-sided cellophane tape can be used to line the perimeter to contain the parasites. as the carcass cools, parasites will vacate the pelage and crawl onto the paper. sealed petri dishes can also be used. cellophane tape also can be pressed against areas of the pelt of freshly euthanatized mice and examined microscopically. skin scrapings made with a scalpel blade can be macerated in 10% koh/glycerin or immersion oil and examined microscopically. this method has the disadvantage of missing highly motile species and low-level populations of slower moving immature forms. it is important to remember that mite infestations may be mixed, so the identification of one species does not rule out the presence of others. detecting mites in sentinels exposed to dirty bedding from colony animals has been reported to be unreliable (lindstrom et al., 2011) . thus, pcr assays offered by commercial diagnostic laboratories are increasingly being used to augment traditional diagnostic methods and to test individual animals or equipment using a swabbing technique; samples can be pooled to decrease cost (jensen et al., 2013) . gross anatomical features facilitate differentiation of intact mites. myocoptes has an oval profile with heavily chitinized body, pigmented third and fourth legs, and tarsal suckers (fig. 3.54) . myobia and radfordia have a similar elongated profile, with bulges between the legs. myobia has a single tarsal claw on the second pair of legs (fig. 3.55) , whereas radfordia has two claws of unequal size on the terminal tarsal structure of its second pair of legs (fig. 3.56) . histopathological examination of skin is helpful for diagnosing unique forms of acariasis, such as the keratotic cysts associated with psorergates simplex infestation. treatment, prevention, and control ivermectin can be used topically, in drinking water or as a medicated feed and often is the first-choice approach for attempting eradication although cost and potential toxicity are concerns. because of potential differences in laboratory animal medicine blood-brain barrier permeability to ivermectin, pilot treatments should be evaluated. for large facilities, ivermectin medicated feed may be an attractive option (ricart arbona et al., 2010) . for valuable lines of mice, rederivation may be cost-and time-effective. control and prevention programs should be carried out on a colony-wide basis, which includes thorough sanitation of housing space and equipment to remove residual eggs. research complications hypersensitivity dermatitis has the potential to confound immunological studies (jungmann et al., 1996) , especially those involving skin, and has been shown to elevate serum ige (morita et al., 1999) . heavy mite infestations can cause severe skin lesions and have been associated with weight loss, infertility, and premature deaths. chronic acariasis also may provoke secondary amyloidosis due to long-standing dermatitis. myocoptes musculinus this is the most common ectoparasite of the laboratory mouse but frequently occurs in conjunction with myobia musculi. the life cycle includes egg, larva, protonymph, tridonymph, and adult stages. eggs hatch in 5 days and are usually attached to the middle third of the hair shaft. the life cycle may range from 8 to 14 days. transmission requires direct contact, for mice separated by wire screens do not contract infestations from infested hosts. bedding does not seem to serve as a vector. neonates may become infested within 4-5 days of birth, and parasites may live for 8-9 days on dead hosts. myocoptes appears to inhabit larger areas of the body than myobia and tends to displace myobia during heavy infestations. it has some predilection for the skin of the inguinal region, abdominal skin, and back, but it will also infest the head and neck. it is a surface dweller that feeds on superficial epidermis. infestation can cause patchy thinning of the hair, alopecia, or erythema. lesions can be pruritic, but ulceration has not been reported. chronic infestations induce epidermal hyperplasia and nonsuppurative dermatitis. myobia musculi this is a common mite of laboratory mice. the life cycle of myobia can be completed in 23 days and includes an egg stage, first and second larval stages, protonymph, deutonymph, and adult. eggs attach at the base of hair shafts and hatch in 7-8 days. larval forms last about 10 days, followed by nymphal forms on day 11. adults appear by day 15 and lay eggs within 24 h. myobia are thought to feed on skin secretions and interstitial fluid but not on blood. they are transmitted primarily by contact. mite populations increase during new infestations, followed by a decrease to equilibrium in 8-10 weeks. the equilibrated population can be carried in colonies for long periods (up to years). population fluctuations may represent waves of egg hatchings. because mites are thermotactic, they crawl to the end of hair shafts on dead hosts, where they may live for up to 4 days. infestation may result in hypersensitivity dermatitis, to which c57bl mice are highly susceptible. clinical signs vary from ruffled fur and alopecia to pruritic ulcerative dermatitis. therefore, lesions can be exacerbated by self-inflicted trauma. radfordia affinis radfordia is thought to be common in laboratory mice, but it closely resembles myobia and may occur as a mixed infestation. therefore, its true prevalence is conjectural. additionally, its life cycle has not been described. it does not appear to cause clinical morbidity. psorergates simplex this species has not been reported as a naturally occurring infection in well-managed colonies for several decades, but it is unique in that it inhabits hair follicles. its life cycle is unknown, but developmental stages from egg to adult may be found in a single dermal nodule. transmission is by direct contact. invasion of hair follicles leads to development of cyst-like nodules, which appear as small white nodules in the subcutis. histologically, they are invaginated sacs of squamous epithelium, excretory products, and keratinaceous debris. there is usually no inflammatory reaction, but healing may be accompanied by granulomatous inflammation. diagnosis is made by examining the subcuticular surface of the pelt grossly or by histological examination. sac contents also can be expressed by pressure with a scalpel blade or scraped and mounted for microscopic exam. mesostigmoid mites rarely, blood-sucking ornithonyssus bacoti and laelaps echidnina, normally limited to wild rodents, can also infect laboratory rodent colonies (watson, 2008; fox, 1982) . these mites may also transiently bite humans and can transmit zoonotic infections (see chapter 29). unlike the more common rodent fur mites, mesostigmoid mites live off the host and can travel a long distance in search of a blood meal. they access research colonies via contaminated supplies or wild rats and mice gaining access to the facility. polyplax serrata, the mouse louse, is encountered in wild mice but no longer is a significant issue in research colonies. eggs are deposited at the base of hair shafts and nymph stages and adults can be found principally on the dorsum. p. serrata causes pruritus with associated dermatitis, anemia and debilitation and historically is the vector for mycoplasma coccoides. amyloidosis is caused by the deposition of insoluble (polymerized), mis-folded amyloid protein fibrils in organs and/or tissues. primary amyloidosis is a naturally occurring disease in mice, associated with the deposition of amyloid proteins consisting primarily of immunoglobulin light chains. secondary amyloidosis is associated with antecedent and often chronic inflammation. it results from a complex cascade of reactions involving release of multiple cytokines that stimulate amyloid synthesis in the liver (falk and skinner, 2000) . primary amyloidosis is common among aging mice (lipman et al., 1993) but also may occur in young mice of highly susceptible strains such as a and sjl or somewhat older c57bl mice. other strains, such as balb/c and c3h are highly resistant to amyloidosis (percy and barthold, 2007) . secondary amyloidosis is usually associated with chronic inflammatory lesions, including dermatitis resulting from prolonged acariasis. it can be induced experimentally, however, by injection of casein and may occur locally in association with neoplasia or in ovarian corpora lutea in the absence of other disease. in reactive amyloid a (aa) amyloidosis, serum aa (saa) protein forms deposits in mice, domestic and wild animals, and humans that experience chronic inflammation. aa amyloid fibrils are abnormal β-sheet-rich forms of the serum precursor saa, with conformational changes that promote fibril formation. similar to prion diseases, recent findings suggest that aa amyloidosis could be transmissible in mice and other species (murakami et al., 2014) . amyloid fibrils induce a seeding-nucleation process that may lead to development of aa amyloidosis. amyloidosis can shorten the life span of mice and can be accelerated by stress from intercurrent disease. amyloid appears histologically as interstitial deposition of a lightly eosinophilic, acellular material in tissues stained with hematoxylin and eosin. however, it is birefringent after staining with congo red when viewed with polarized light. deposition patterns vary with mouse strain and amyloid type. although virtually any tissue may be affected, the following sites are common: hepatic portal triads, periarteriolar lymphoid sheaths in spleen, renal glomeruli and interstitium (which can lead to papillary necrosis), intestinal lamina propria, myocardium (and in association with atrial thrombosis), nasal submucosa, pulmonary alveolar septa, gonads, endocrine tissues, and great vessels (fig. 3.57) . naturally occurring mineralization of the myocardium and epicardium and other soft tissues is a common finding at necropsy in some inbred strains of mice. although this condition is usually an incidental finding at necropsy, interference with organ function such as the heart cannot be ruled out if lesions are severe. it occurs in balb/c, c3h, and especially dba mice (eaton et al., 1978; brownstein, 1983; brunnert et al., 1999) . it is found in the myocardium of the left ventricle ( fig. 3.58) , in the intraventricular systems, and in skeletal muscle, kidneys, arteries, and lung and may be accompanied by fibrosis and mononuclear inflammatory infiltrates. dba mice also can develop mineralization in the tongue and cornea. dietary, environmental, disease-related, and endocrine-related factors are thought to influence the prevalence of this lesion. ectopic mineralization is associated clinically with skin and vascular connective tissue conditions in humans and mouse models have been developed to study metastatic and dystrophic tissue mineralization (li and uitto, 2013) . pseudoxanthoma elasticum (pxe), a heritable ectopic mineralization disorder in humans, is caused by mutations in the abcc6 gene. knockout abcc6 −/− mice model the histopathologic and ultrastructural features of pxe, notably with mineralization of the vibrissae dermal sheath, serving as a biomarker of tissue mineralization (benga et al., 2014) . other inbred mouse strains, including kk/hlj and 129s1/svimj, also develop vibrissae dermal mineralization and have an snp (rs32756904) in the abcc6 gene associated with low levels of abcc6 protein expression in the liver. dba/2j and c3h/hej mice have the same polymorphism and low abcc6 protein levels; however, these mice only develop tissue mineralization when fed an experimental diet enriched in phosphate and low in magnesium. a reye's-like syndrome has been reported in balb/ cbyj mice (brownstein et al., 1984) . the etiology is unknown; however, antecedent viral infection may be involved. affected mice rapidly become lethargic and then comatose. they also tend to hyperventilate. high mortality ensues within 6-18 h, but some mice may recover. lesions are characterized grossly by swollen, pale liver and kidneys. the major histopathological findings include swollen hepatocytes with fatty change and nuclear swelling among astrocytes in the brain. hepatic lesions resembling changes in reye's syndrome have been reported in scid mice infected with madv-1 (pirofski et al., 1991) . deficiencies (tobin et al., 2007) vitamin deficiencies in mice have not been thoroughly described. unfortunately, much of the information that does exist reflects work carried out 30-50 years ago; thus, the reliability and specificity of some of these syndromes is questionable. vitamin a deficiency may produce tremors, diarrhea, rough hair coat, keratitis, poor growth, abscesses, hemorrhages, and sterility or abortion. vitamin a is recognized for its importance in development of the immune system (ross, 2012) and knockout mouse models have been used to demonstrate genetic polymorphisms in humans that negatively regulate intestinal β-carotene absorption and conversion to retinoids in response to vitamin a requirements for growth and reproduction (von lintig, 2012) . vitamin e deficiency can cause convulsions and heart failure, as well as muscular dystrophy and hyaline degeneration of muscles. two knockout mouse models of severe vitamin e deficiency were independently developed and lack α-tocopherol transfer protein (α-ttp), a gene that controls plasma and tissue α-tocopherol concentrations by exporting α-tocopherol from the liver. ttpa −/− mice have very low to undetectable levels of α-tocopherol and are infertile. the phenotype includes neuronal degeneration associated with progressive ataxia and age-related behavioral defects (yu and schellhorn, 2013) . deficiency of b complex vitamins produces nonspecific signs such as alopecia, decreased feed consumption, poor growth, poor reproduction and lactation, as well as a variety of neurological abnormalities. choline deficiency produces fatty livers and nodular hepatic hyperplasia, as well as myocardial lesions, decreased conception, and decreased viability of litters. folic acid-deficient diets cause marked decreases in red and white cell blood counts and the disappearance of megakaryocytes and nucleated cells from the spleen. pantothenic acid deficiency is characterized by nonspecific signs, such as weight loss, alopecia, achromotrichia, and posterior paralysis, as well as other neurological abnormalities. thiamin deficiency is associated with neurological signs, such as violent convulsions, cartwheel movements, and decreased food consumption. dietary requirements for ascorbic acid have not been shown in mice, and mouse diets are generally not fortified with ascorbic acid. the gulonolactone oxidase knockout mouse (gulo −/− ) on the c57bl/6 background requires vitamin c supplementation although the plasma ascorbate concentration of gulo −/− mice fed a vitamin c-deficient diet is maintained at 15% of wild-type concentrations, suggesting an uncharacterized pathway to generate a small amount of ascorbate (yu and schellhorn, 2013) . the gulo −/− mouse has become the model of choice in studying the role of vitamin c in complex diseases. vitamin c production has been successfully restored in gulo −/− mice using adenovirus vectors, making it possible to robustly manipulate physiological ascorbate concentrations in an inbred mouse. mineral deficiencies have been described only for several elements, and the consequences of the deficiencies are similar to those observed for other species. for example, iodine-deficient diets produce thyroid goiters; magnesium-deficient diets may cause fatal convulsions; manganese deficiency may cause congenital ataxia from abnormal development of the inner ear; and zinc deficiency may cause hair loss on the shoulders and neck, emaciation, decreased liver and kidney catalase activity, and immunosuppression. chronic essential fatty acid deficiency may cause hair loss, dermatitis with scaling and crusting of the skin, and occasional diarrhea. infertility has also been associated with this syndrome. mice have an absolute requirement for a dietary source of linoleic and/or arachidonic acid. (sundberg, 1994; ward, 2000) the significant syndrome of ulcerative dermatitis (ud) is a common idiopathic skin lesion that causes morbidity and early euthanasia losses in c57bl/6 and related lines of mice. significant pruritus leads to skin trauma associated with opportunistic bacterial infection and deep dermal ulcerations. initial signs include alopecia and papular dermatitis, which usually occur over the dorsal trunk (fig. 3.59) . progressive inflammation can be halted, sometimes reversed, by nail trimming and therapy with a wide spectrum of topical or systemic antibiotics, steroids, and other drugs such as vitamin e and aloe, all of which speak to the frustrating search for a primary etiology. treatment should be based on microbiological culture and sensitivity and screening for ectoparasites as hypersensitivity to acariasis has been proposed. seasonal fluctuation in the incidence of disease suggests that environmental factors may play a role. the incidence appears to increase during periods of significant seasonal changes in temperature and humidity, i.e., the onset of winter and early spring. there is some evidence that incidence is related to dietary fat with mice on high fat or ad libitum diets being more susceptible than those on restricted diets (neuhaus et al., 2012) . ileus associated with high mortality has been reported to occur in primiparous female mice during the second week of lactation (kunstyr, 1986) . this disorder has been described as acute intestinal pseudo-obstruction (ipo) in c57bl/6 mice free of known pathogens (feinstein et al., 2008) . lactating mice are either found dead or becoming moribund. segments of the small intestine become distended with fluid contents and histologically there is apoptosis of the villus epithelium of the small intestine and superficial epithelial cells of the large intestine. the enteric nervous system appears morphologically normal but necrotic enterocytes, mucosal erosions, and acute mucosal inflammation are commonly observed. there is no strong evidence for metabolic issues such as hypocalcemia or low blood glucose. the direct cause is unknown but death probably results from sepsis secondary to loss of barrier function reflected in apoptosis of the gut epithelium during peak lactation. environmental variables can affect responses of mice in experimental situations. changes in respiratory epithelial physiology and function from elevated levels of ammonia, effects of temperature and humidity on metabolism, effects of light on eye lesions and retinal function, and effects of noise on neurophysiology are examples of complications that can vary with the form of insult and the strain of mouse employed. mice do not easily acclimatize to sudden and dramatic changes in temperature. therefore, they are susceptible to both hypothermia and hyperthermia. mice also are susceptible to dehydration. poorly functioning automatic watering system valves or water bottles, resulting in spills (hypothermia) or obstructed sipper tubes (dehydration), are a significant cause of husbandry-related morbidity. shipping mice between facilities, irrespective of distance, warrants institutional guidelines to minimize exposure to temperature extremes. reheat coils should be designed to fail in the closed position to avoid overheating holding rooms. ringtail is a condition associated with low relative humidity. clinical signs include annular constriction of the tail and occasionally of the feet or digits, resulting in localized edema that can progress to dry gangrene ( fig. 3 .60). it should be differentiated from dryness and gangrene that may occur in hairless mice exposed to low temperatures and perhaps other environmental or nutritional imbalances. necrosis of legs, feet, or digits also can occur in suckling mice because of disruption of circulation by wraps of stringy nesting material such as cotton wool. corneal opacities can result from acute or chronic keratitis, injury (unilateral) and developmental defects; the latter may occur in combination with inherited microphthalmia in c57 black mice (koch and gowen, 1939) . there is some evidence that the buildup of ammonia in mouse cages may contribute to inflammatory keratitis, because it can be controlled by increasing the frequency of cage cleaning. corneal opacities and anterior polar cataracts are a developmental defect in inbred c57 black mice (pierro and spiggle, 1967) . corneal opacity may be associated with keratolenticular adhesions involving a persistent epithelial stalk of the lens vesicle, which normally disappears around day 11 of gestation (koch and gowen, 1939) . typically noted in runted or cachectic mice soon after weaning, malocclusion of the open-rooted, continually growing incisor teeth is an inherited trait expressed as poorly aligned incisors, especially of the lower incisors causing osteomyelitis, soft tissue abscesses, or necrosis in the lips or oral cavity. the incidence of inherited malocclusion varies with mouse strain (petznek et al., 2002) . malocclusion in older mice may be the result of trauma or oral neoplasia. overgrown molar teeth have been associated with trauma to developing tooth buds. skin lesions can be caused by fighting, tail biting, and overgrooming such as whisker chewing. barbering of facial hair and whiskers in subordinate mice by a dominant cagemate is common and may be solved by removing the dominant, normally haired mouse. hair or whisker chewing (barbering) has long been interpreted to be a manifestation of social dominance. apparent dominant animals retain whiskers, whereas cagemates have 'shaved faces' (fig. 3.61 ). chronic hair chewing can produce histological abnormalities such as poorly formed or pigmented club hairs. once chewing has ceased, many mice regrow previously lost hair in several weeks. both sexes may engage in this activity, and sometimes females may be dominant. barbering of whiskers and fur-plucking behavior in mice has been suggested to model human trichotillomania (compulsive hair plucking) because of similarities including elevated serotonin levels (dufour et al., 2010) , 'barbers' predominately pluck hair from the scalp and around the eyes and the genitals; the behavior is female biased, and begins during puberty and is impacted by genetic background (garner et al., 2004) . fighting is more common in male mice and more aggressive in some strains (sjl, fvb, balb/c) with bite wounds typically located on the head, neck, shoulders, perineal area, and tail. often one mouse in the cage is free of lesions and is the likely aggressor. removal of the unaffected male may end the fighting or simply reorder the dominance order. removing males for breeding and then regrouping them often results in fighting. for programs that produce sentinel mice in-house, castration is an option to reduce aggression in group-housed male sentinels (lofgren et al., 2012) . regional alopecia, especially around the muzzle, may result from abrasion against cage surfaces. improperly diluted disinfectants may also cause regional hair loss. ear tags used for identification may cause pruritis and self-induced trauma. hair removal products or clipping prior to imaging or application of experimental compounds to the skin may cause pruritus and can augment lesions that interfere with test results. dermatophytosis, ectoparasitism, or idiopathic hair loss must be considered in the differential diagnoses for muzzle or body alopecia. (burek et al., 1982; percy and barthold, 2007) common idiopathic lesions in aging mice include cardiomyopathy (with or without mineralization or arteritis), chronic nephropathy (frequently with mineralization), myelofibrosis (fibrotic change in the bone marrow) especially in female mice, melanosis in the meninges, ovarian atrophy (with or without hyaline material), pigment (ceroid-lipofuscin), tubular or stromal hyperplasia, cystic endometrial hyperplasia, testicular tubular degeneration or mineralization, prostate atypical epithelial hyperplasia, gastric glandular epithelial hyperplasia, pancreatic islet cell hyperplasia, dental dysplasia of incisor teeth, pituitary hyperplasia of pars intermedia and pars distalis, cataracts, increased extramedullary hematopoiesis in spleen, and lymphocytic infiltrates or other inflammatory changes in various tissues, including harderian gland, salivary gland, kidney, liver, gall bladder, nasal, trachea, thyroid, periovarian fat, epididymis, and urinary bladder. lymphoma is also very common . spontaneous atrial thrombosis is rare in mice (<1% in 2-year-old mice) and appears to be strain-related, with a high prevalence in rfm mice. it also is more common in aged mice affected by kidney disease and amyloidosis. organizing thrombi will be found usually in an enlarged, hyperemic left atrium and auricle and may be accompanied by amyloidosis. affected mice may display signs of heart failure, particularly severe dyspnea. induction of atrial thrombosis in b6c3f1 mice has been used to assess cardiovascular risk of chemical exposures (yoshizawa et al., 2005) . myocardial and epicardial mineralization is described above (section iii,b,2). periarteritis, also known as arteritis, polyarteritis, or systemic arteritis, impacts older mice and lesions may be observed in multiple tissues, including the spleen, heart, tongue, uterus, testes, kidney, and urinary bladder. the media of the affected vessels is homogenous and intensely eosinophilic with hematoxylin and eosin stain. fibrosis and mononuclear cells infiltrate the vessel wall. experimental coronary arteritis with cardiac hypertrophy has been model in dba/2 and other strains by intraperitoneal administration of mannoprotein-beta-glucan complex isolated from c. albicans (nagi-miura et al., 2006) . hyperplasia of alveolar or bronchial epithelium occurs in old mice and must be differentiated from pulmonary tumors. pulmonary histiocytosis, acidophilic macrophage pneumonia, and acidophilic crystalline pneumonia are synonymous morphologic descriptions of an idiopathic lung lesion that can be incidental or the cause of significant morbidity. incidence varies with mouse strain or stock, with c57bl, 129s4/svjae and swiss mice and older mice in general particularly susceptible. histologically, alveoli and bronchioles are filled with varying quantities of macrophages containing eosinophilic crystalline material . the crystalline material consists of ym1 and/or ym2 chitanases and can be found in other tissues including the upper respiratory tract, stomach, gall bladder, and bone marrow where it is described as hyalinosis (nio et al., 2004) . gastric lesions include crypt dilatation, submucosal fibrosis, adenomatous gastric hyperplasia, mineralization, and erosion or ulceration. gastric ulcers have been induced by cold stress, food restriction (rehm et al., 1987) , chemical injury (yadav et al., 2013) , and gastritis and gastric tumors by helicobacter infection (fox et al., 2003) . germfree mice have reduced muscle tone in the intestinal tract. cecal volvulus is a common cause of death in germfree mice and is caused by rotation of the large, thin-walled cecum. age-associated lesions are common in the livers of mice. cellular and nuclear pleomorphism, including binucleated and multinucleated cells, are detectable by 6 months. mild focal necrosis occurs with or without inflammation, but an association of mild focal hepatitis with a specific infectious disease is often hard to confirm. other geriatric hepatic lesions include biliary hyperplasia with varying degrees of portal hepatitis, hepatocellular vacuolization, amyloid deposition (especially in periportal areas), strangulated or herniated lobes, hemosiderosis, lipofuscinosis, and fibrosis. extramedullary hematopoiesis occurs in young mice and in response to anemia. exocrine pancreatic insufficiency has been reported in cba/j mice. acinar cell atrophy is common but is strain-and sex-dependent. blood-filled mesenteric lymph nodes may occur in aged mice, especially c3h mice. this condition is an incidental finding and should not be confused with infectious lymphadenopathy such as that associated with salmonellosis. aggregates, or nodules of mononuclear cells, are found in many tissues of aged mice, including the salivary gland, thymus, ovary, uterus, mesentery and mediastinum, urinary bladder, and gastrointestinal tract. these nodules should not be mistaken for lymphosarcomas. grossly observable black pigmentation in the spleen of c57bl/6 is normal and is melanosis caused by melanin deposition (weissman, 1967) . the spleen is subject to amyloidosis and hemosiderin deposition. lipofuscin deposition is common, especially in older mice. the thymus undergoes age-associated atrophy. a variety of genetic immunodeficiencies have been described in mice, many of which increase susceptibility to infectious diseases. perhaps the most widely known of these is the athymic nude mouse that lacks a significant hair coat and, more importantly, fails to develop a thymus and thus has a severe deficit of t-cellmediated immune function. additionally, scid mice, which lack both t and b lymphocytes, are used widely and are highly susceptible to opportunistic agents such as pneumocystis murina. specific immune deficits have become excellent models for studying the ontogeny and mechanisms of immune responsiveness (table 3 .12). age-associated osteoporosis or senile osteodystrophy can occur in some mice. it is not associated with severe renal disease or parathyroid hyperplasia. nearly all strains of mice develop some form of osteoarthrosis. it is generally noninflammatory, affects articulating surfaces, and results in secondary bone degeneration. glomerulonephritis is a common kidney lesion of mice. it is more often associated with persistent viral infections or immune disorders rather than with bacterial infections. its prevalence in some strains approaches 100%. nzb and nzb × nzw f 1 hybrid mice, e.g., develop immune complex glomerulonephritis as an autoimmune disease resembling human lupus erythematosus, whereas glomerular disease is relatively mild in nzb mice (nzb mice have a high incidence of autoimmune hemolytic anemia). renal changes occur as early as 4 months of age, but clinical signs and severe disease are not present until 6-9 months. the disease is associated with wasting and proteinuria, and lesions progress until death intervenes. histologically, glomeruli have proteinaceous deposits in the capillaries and mesangium. later, tubular atrophy and proteinaceous casts occur throughout the kidney. immunofluorescence studies show deposits of immunoglobulin and the third component of complement, which lodge as immune complexes with nuclear antigens and antigens of murine leukemia virus in glomerular capillary loops. mice infected with lcmv or with retroviruses can also develop immune complex glomerulonephritis. mice also can develop chronic glomerulopathy characterized by progressive thickening of glomerular basement membrane by pas-positive material that does not stain for amyloid. this lesion can be accompanied by proliferation of mesangial cells; local, regional, or diffuse mononuclear cell infiltration; and fibrosis. advanced cases may lead to renal insufficiency or failure. interstitial nephritis can be caused by bacterial or viral infections but may also be idiopathic. typical lesions include focal, regional, or diffuse interstitial infiltration of tubular parenchyma by mononuclear cells, but glomerular regions also may be involved. severe lesions can be accompanied by fibrosis, distortion of renal parenchyma, and intratubular casts, but not by mineralization. if renal insufficiency or failure ensues, it can lead to ascites. some strains of mice, such as balb/c, can develop polycystic kidney disease, which, if severe, can compromise normal renal function. urinary tract obstruction occurs as an acute or chronic condition in male mice. clinical signs usually include wetting of the perineum from incontinence. in severe or chronic cases, wetting predisposes to cellulitis and ulceration. at necropsy, the bladder is distended, and proteinaceous plugs are often found in the neck of the bladder and proximal urethra. in chronic cases the urine may be cloudy, and calculi may develop in the bladder. additionally, cystitis, urethritis, prostatitis, laboratory animal medicine balanoposthitis, and hydronephrosis may develop. this condition must be differentiated from infectious cystitis or pyelonephritis and from the agonal release of secretions from accessory sex glands, which is not associated with an inflammatory response. hydronephrosis also may occur without urinary tract obstruction. ascending pyelitis occurs in mice secondary to urinary tract infection. parvovarian cysts are observed frequently and may be related to the fact that mouse ovaries are enclosed in membranous pouches. amyloidosis is also common in the ovaries of old mice. cystic endometrial hyperplasia may develop unilaterally or bilaterally and may be segmental. in some strains, the prevalence in mice older than 18 months is 100%. endometrial hyperplasia is often associated with ovarian atrophy. mucometra is relatively common in adult female mice. the primary clinical sign is abdominal distension resembling pregnancy among mice that do not whelp. testicular atrophy, sperm granulomas, and tubular mineralization occur with varying incidence. preputial glands, especially of immunodeficient mice, can become infected with opportunistic or pathogenic bacteria. spontaneous lesions in prostate, coagulating gland (anterior prostatic lobe), seminal vesicles, and ampullary glands were described in control b6c3f1 mice from 12 national toxicology program 2-year carcinogenicity and toxicity studies conducted in one of four different laboratories (suwa et al., 2002) . lymphocytic infiltration, inflammation, edema, epithelial hyperplasia, mucinous cyst, mucinous metaplasia, adenoma, adenocarcinoma, granular cell tumor, and glandular atrophy were variously observed in accessory sex glands. accessory adrenal cortical nodules are found in periadrenal and perirenal fat, especially in females. these nodules have little functional significance other than their potential effect on failures of surgical adrenalectomy. lipofuscinosis, subcapsular spindle cell hyperplasia, and cystic dilatation of cortical sinusoids are found in the adrenal cortices of aged mice. some inbred strains have deficiencies of thyrotropic hormone, resulting in thyroid atrophy. thyroid cysts lined by stratified squamous epithelium and generally of ultimo-branchial origin may be seen in old mice. amyloid can be deposited in the thyroid and parathyroid glands as well as in the adrenal glands. spontaneous diabetes mellitus occurs in outbred swiss mice and genetic variants of several strains such as nod mice (lemke et al., 2008) . high levels of estrogen in pregnancy may influence postpartum hair shedding. various endocrine effects on hair growth have also been described. abdominal and thoracic alopecia have been reported in b6c3f 1 mice. symmetrical mineral deposits commonly occur in the thalamus of aged mice. they may also be found in the midbrain, cerebellum, and cerebrum and are particularly common in a/j mice. lipofuscin accumulates in the neurons of old mice. age-associated peripheral neuropathy with demyelination can be found in the nerves of the hindlimbs in c57bl/6 mice. deposits of melanin pigment occur in heavily pigmented strains, especially in the frontal lobe. a number of neurologically mutant mice have been described. they commonly have correlative anatomical malformations or inborn errors of metabolism. a seizure syndrome in fvb mice has been described (goelz et al., 1998) and can be spontaneous or associated with tail tattooing, fur clipping, and fire alarms. mice are most often female with a mean age of 5.8 months (range, 2-16 months) and can exhibit facial grimace, chewing automatism, ptyalism with matting of the fur of the ventral aspect of the neck and/or forelimbs, and clonic convulsions that may progress to tonic convulsions and death. ischemic neuronal necrosis was consistently observed in these mice and is consistent with status epilepticus in humans. unilateral and bilateral microphthalmia and anophthalmia are frequent (as high as 12%) developmental defects in inbred and congenic strains of c57bl mice, especially impacting the right eye and female mice. these conditions may first be recognized due to ocular infections, secondary to inadequate tear drainage. other common findings include central corneal opacities, iridocorneal and corneal-lenticular adhesions, abnormal formation of the iris and ciliary body, cataracts, extrusion of lens cortical material with dispersion throughout the eye, failure of vitreous development, and retinal folding. these syndromes can be reproduced by exposure to alcohol at critical stages of embryogenesis when the optic cup and lens vesicle are developing and impacting normal development of other ocular structures, including the iris, ciliary body, vitreous, and retina . retinal degeneration can occur as either an environmental or a genetic disorder (chang et al., 2007) in mice. nonpigmented mice, both inbred and outbred, can develop retinal degeneration from exposure to light, with the progression of blindness being related to light intensity and duration of exposure. mouse genetics have laboratory animal medicine been shown to be more important than potential light associated tissue injury (serfilippi et al., 2004a) . other strains such as c3h, cba, and fvb are genetically predisposed to retinal degeneration because they carry the rd gene, which leads to retinal degeneration within the first few weeks of life and has been used extensively as a model for retinitis pigmentosa (farber and danciger, 1994) . presence of the rd gene in some mouse strains highlights that impaired vision must be a consideration when selecting strains for behavioral assays that rely on visual clues (garcia et al., 2004) . blindness does not interfere with health or reproduction and blind mice cannot be distinguished from non-blind mice housed in standard caging. cataracts can occur in old mice and have a higher prevalence in certain mutant strains. vestibular syndrome associated with head tilt, circling, or imbalance can result from infectious otitis or from necrotizing vasculitis of unknown etiology affecting small and medium-sized arteries in the vicinity of the middle and inner ears. (jones et al., 1983 (jones et al., -1993 maronpot et al., 1999; percy and barthold, 2007) neoplasms of lymphoid and hematopoietic tissues are estimated to have a spontaneous prevalence of 1-2%. there are, however, some strains of mice that have been specifically inbred and selected for susceptibility to spontaneous tumors. leukemogenesis in mice may involve viruses and chemical or physical agents. viruses associated with lymphopoietic and hematopoietic neoplasia belong to the family retroviridae (type c oncornaviruses) and contain rna-dependent dna polymerase (reverse transcriptase). these viruses are generally noncytopathogenic for infected cells, and mice appear to harbor them as normal components of their genome. although they may be involved in spontaneous leukemia, they are not consistently expressed in this disease. recombinant viruses have recently been discovered that can infect mouse cells and heterologous cells and are associated with spontaneous leukemia development in high leukemia strains such as akr mice. their phenotypic expression is controlled by mouse genotype. endogenous retroviruses are transmitted vertically through the germ line. horizontal transmission is inefficient but can occur by intrauterine infection or through saliva, sputum, urine, feces, or milk. the leukemia induced by a given endogenous virus is usually of a single histopathological type. loss of function in nucleic acid-recognizing, tlr3, tlr7, and tlr9 can result in spontaneous retroviral viremia and acute t-cell lymphoblastic leukemia (yu et al., 2012) . chemical carcinogens, such as polycyclic hydrocarbons, nitrosoureas, and nitrosamines, and physical agents such as x-irradiation can also induce hematological malignancies in mice. the most common hematopoietic malignancy in the mouse is lymphocytic leukemia that originates in the thymus. disease begins with unilateral atrophy and then enlargement of one lobe of thymus as tumor cells proliferate. cells can spread to the other lobe and then to other hematopoietic organs, such as the spleen, bone marrow, liver, and peripheral lymph nodes. clinical signs include dyspnea and ocular protrusion. the latter sign is due to compression of venous blood returning from the head. tumor cells spill into the circulation late in disease. most of these tumors originate from t lymphocytes or lymphoblasts, but there are leukemias of b-lymphocyte or null cell lineage. in the last two syndromes, the lymph nodes and spleen are often involved, but the thymus is generally normal. reticulum cell sarcomas are common in older mice, especially in inbred strains such as c57bl/6 and sjl. primary tumor cell types have been divided into several categories based on morphological and immunohistochemical features. histiocytic sarcomas correspond to the older dunn classification as type a sarcomas and are composed primarily of reticulum cells. the tumor typically causes splenomegaly and nodular lesions in other organs, including the liver, lung, kidney, and the female reproductive tract. follicular center cell lymphomas correspond to dunn type b sarcomas. they originate from b-cell regions (germinal centers) of peripheral lymphoid tissues, including the spleen, lymph nodes, and peyer's patches. typical tumor cells have large vesiculated, folded, or cleaved nuclei and ill-defined cytoplasmic borders. tumors also often contain small lymphocytes. type c reticulum cell tumors often involve one or several lymph nodes rather than assuming a wide distribution. they consist of reticulum cells with a prominent component of well-differentiated lymphocytes. myelogenous leukemia is uncommon in mice and is associated with retrovirus infection. disease begins in the spleen, resulting in marked splenomegaly, but leukemic spread results in involvement of many tissues including the liver, lung, and bone marrow. leukemic cells in various stages of differentiation can be found in peripheral blood. in older animals, affected organs may appear green because of myeloperoxidase activity, giving rise to the term chloroleukemia. the green hue fades on contact with air. affected mice are often clinically anemic and dyspneic. erythroleukemia is rare in mice. the major lesion is massive splenomegaly, which is accompanied by anemia and polycythemia. hepatomegaly can follow, but there is little change in the thymus or lymph nodes. erythroleukemia can be experimentally induced in mice by friend spleen focus-forming virus (sffv) which initially activates the erythropoietin (epo) receptor and the receptor tyrosine kinase sf-stk in erythroid cells, resulting in proliferation, differentiation, and survival. in a second stage, sffv activates the myeloid transcription factor pu.1, blocking erythroid cell differentiation, and in conjunction with the loss of p53 tumor suppressor activity, results in the outgrowth of malignant cells (cmarik and ruscetti, 2010 ). mast cell tumors are also very rare in mice. they are found almost exclusively in old mice and grow slowly. they should not be confused with mast cell hyperplasia observed in the skin following painting with carcinogens or x-irradiation. natural plasma cell tumors are infrequent in the mouse. they can, however, be induced by intraperitoneal inoculation of granulomatogenic agents such as plastic filters, plastic shavings, or a variety of oils, particularly in balb/c mice. mineral oil-induced plasmacytomas in balb/c mice produce large amounts of endogenous retroelements such as ecotropic and polytropic murine leukemia virus and intracisternal a particles. associated inflammation may promote retroelement insertion into cancer genes, thereby promoting tumors (knittel et al., 2014) . similar to other spontaneous cancers, plasmacytoma development in mice is inhibited by innate immune responses of nk cells which when activated by viruses will release γinf (thirion et al., 2014) . mammary tumors can be induced or modulated by a variety of factors, including viruses, chemical carcinogens, radiation, hormones, genetic background, diet, and immune status. certain inbred strains of mice, such as c3h, a, and dba/2, have a high natural prevalence of mammary tumors. other strains, such as balb/c, c57bl, and akr, have a low prevalence. among the most important factors contributing to the development of mammary tumors are mammary tumor viruses. several major variants are known. the primary tumor virus mmtv-s (bittner virus) is highly oncogenic and is transmitted through the milk of nursing females. infected mice typically develop a precursor lesion, the hyperplastic alveolar nodule, which can be serially transplanted. spontaneous mammary tumors metastasize with high frequency, but this property is somewhat mouse strain dependent. metastases go primarily to the lung. some mammary tumors are hormone dependent, some are ovary dependent, and others are pregnancy dependent. ovary-dependent tumors contain estrogen and progesterone receptors, whereas pregnancy-dependent tumors have prolactin receptors. ovariectomy will dramatically reduce the incidence of mammary tumors in c3h mice. if surgery is done in adult mice 2-5 months of age, mammary tumors will develop, but at a later age than normal. grossly, mammary tumors may occur anywhere in the mammary chain. they present as one or more firm, welldelineated masses, which are often lobular and maybe cystic (fig. 3.62) . histologically, mammary tumors have been categorized into three major groups: carcinomas, carcinomas with squamous cell differentiation, and carcinosarcomas. the carcinomas are divided into adenocarcinoma types a, b, c, y, l, and p. most tumors are type a or b. type a consists of adenomas, tubular carcinomas, and alveolar carcinomas. type b tumors have a variable pattern with both well-differentiated and poorly differentiated regions. they may consist of regular cords or sheets of cells or papillomatous areas. these two types are locally invasive and may metastasize to the lungs. type c tumors are rare and are characterized by multiple cysts lined by low cuboidal to squamous epithelial cells, and they have abundant stroma. type y tumors, which are also rare, are characterized by tubular branching of cuboidal epithelium and abundant stroma. adenocarcinomas with a lacelike morphology (types l and p) are hormone dependent and have a branching tubular structure. the control or prevention of mammary neoplasms depends on the fact that some strains of mammary tumor virus are transmitted horizontally, whereas others are transmitted vertically. although horizontally transmitted virus such as mmtv-s can be determined by cesarean rederivation or by foster nursing, endogenous strains of tumor virus may remain. fortunately, these latter tumor viruses have generally low oncogenicity relative to the bittner virus. mammary tumors are increased in frequency in c57bl apc +/− female mice infected with h. hepaticus (rao et al., 2007) . mice develop an assortment of liver changes as they age, including proliferative lesions which can progress from hyperplastic foci to hepatomas to hepatocellular carcinomas. almost all strains of mice have a significant prevalence of hepatic tumors, some of which appear to result from dietary contamination or deficiency and h. hepaticus infections in susceptible strains of mice such as the a/jcr male mouse ward et al., 1994) . the prevalence of spontaneous liver tumors in b6c3f 1 hybrids is increased by feeding choline-deficient diets or when infected with h. hepaticus (hailey et al., 1998) . tumors also can develop in mice exposed to environmental chemicals, many of which are carcinogenic or potentially carcinogenic (hoenerhoff et al., 2009) . spontaneous liver tumors in mice occur grossly as gray to tan nodules or large, poorly demarcated darkred masses. they are usually derived from hepatocytes, whereas cholangiocellular tumors are rare. hepatomas are well circumscribed and well differentiated, but they compress adjacent liver tissue as they develop. hepatocellular carcinomas are usually invasive and display histopathological patterns ranging from medullary to trabecular. large carcinomas also may contain hemorrhage and necrosis. carcinomas also may metastasize to the lungs. primary respiratory tumors of mice occur in relatively high frequency. it has been estimated that more than 95% of these tumors are pulmonary adenomas that arise either from type 2 pneumocytes or from clara cells lining terminal bronchioles. pulmonary adenomas usually appear as distinct whitish nodules that are easily detected by examination of the lung surface. malignant alveologenic tumors are infrequent and consist of adenocarcinomas and squamous cell carcinomas. they invade pulmonary parenchyma and are prone to metastasize. the prevalence of spontaneous respiratory tumors is mouse straindependent. for example, the prevalence is high in aging a strain mice but low in aging c57bl mice. the number of tumors per lung is also higher in susceptible mice. pulmonary tumors often occur as well-defined gray nodules. microscopically, adenomas of alveolar origin consist of dense ribbons of cuboidal to columnar cells with sparse stroma. adenomas of clara cell origin are usually associated with bronchioles. they have a tubular to papillary architecture consisting of columnar cells with basal nuclei. pulmonary adenocarcinomas, though comparatively rare, are locally invasive. they often form papillary structures and have considerable cellular pleomorphism. given the rapid development of mouse strains genetically predisposed to neoplasia, the mouse tumor biology database maintained by jackson laboratory is a valuable centralized resource for the most current tumor descriptions. the database contains information on more than 4400 strains and substrains, 348 tissues and organs, over 42,000 tumor frequency records, and nearly 4800 histopathological images and descriptions. risk factors for recurrence, complications and mortality in clostridium difficile infection: a systematic review detection of mouse parvovirus in mus musculus gametes, embryos, and ovarian tissues by polymerase chain reaction interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases new generation humanized mice for virus research: comparative aspects and future prospects chemokine: receptor structure, interactions, and antagonism of mice, birds, and men: the mouse ultrasonic song system has some features similar to humans and song-learning birds intestinal inflammation targets cancerinducing activity of the microbiota the use of cross-foster rederivation to eliminate murine norovirus cas-offinder: a fast and versatile algorithm that searches for potential off-target sites of cas9 rnaguided endonucleases leaky virus: a new hantavirus isolated from mus musculus in the united states recombinant-inbred strains: an aid to finding identity, linkage, and function of histocompatibility and other genes experimental infection of inbred mouse strains with spironucleus muris open-and closed-formula laboratory animal diets and their importance to research the microbiology of transmissible murine colonic hyperplasia mouse hepatitis virus infection, intestine, mouse mouse hepatitis virus infection, liver, mouse murine rotavirus infection, intestine, mouse modification of early dimethylhydrazine carcinogenesis by colonic mucosal hyperplasia lymphocytic choriomeningitis virus dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia transmissible murine colonic hyperplasia epizootic coronaviral typhlocolitis in suckling mice infectivity, disease patterns, and serologic profiles of reovirus serotypes 1, 2, and 3 in infant and weanling mice clindamycin-associated colitis due to a toxin-producing species of clostridium in hamsters fecal pcr assay for diagnosis of helicobacter infection in laboratory rodents 16s ribosomal dna sequence-based identification of bacteria in laboratory rodents: a practical approach in laboratory animal bacteriology diagnostics polyoma viruses persistence of polyomavirus in mice infected as adults differs from that observed in mice infected as newborns aerobic gram-positive organisms detection of rodent parvoviruses by pcr identification of novel murine parvovirus strains by epidemiological analysis of naturally infected mice temporal transmission studies of mouse parvovirus 1 in balb/c and c.b-17/icr-prkdc(scid) mice embryo transfer rederivation of c.b-17/icr-prkdc(scid) mice experimentally infected with mouse parvovirus 1 effect of vaccination on the clinical response, pathogenesis, and transmission of mousepox mousepox in inbred mice innately resistant or susceptible to lethal infeciton with ectromelia virus. iii. experimental transmission of infection and derivation of virus-free progeny from previously infected dams mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. i. clinical responses stability of ectromelia virus strain nih-79 under various laboratory conditions most classical mus musculus domesticus laboratory mice carry a mus musculus musculus y chromosome klebsiella oxytoca: opportunistic infections in laboratory rodents clustering of spatial gene expression patterns in the mouse brain and comparison with classical neuroanatomy serological studies of corynebacterium kutscheri and coryneform bacteria using an enzyme-linked immunosorbent assay (elisa) an enzymelinked immunosorbent assay (elisa) for monitoring rodent colonies for pasteurella pneumotropica antibodies helicobacter pullorum outbreak in c57bl/6ntac and c3h/hentac barrier-maintained mice mucosal immunity: induction, dissemination, and effector functions nk cell activation in human hantavirus infection explained by virus-induced il-15/il15ralpha expression exacerbation of pneumocystis carinii pneumonia in immunodefi-� cient (scid) mice by concurrent infection with a pneumovirus the sense of smell: multiple olfactory subsystems pheromonal communication in vertebrates immunological aspects of giardia muris and spironucleus muris infections in inbred and outbred strains of laboratory mice: a comparative study the natural history of mousepox reproduction whole-rat conditional gene knockout via genome editing pathogenesis of bacteremia due to pseudomonas aeruginosa in cyclophosphamide-treated mice and potentiation of virulence of endogenous streptococci genetics of dystrophic epicardial mineralization in dba/2 mice sendai virus and pneumonia virus of mice (pvm) spontaneous reye'slike syndrome in balb/cbyj mice duration and patterns of transmission of theiler's mouse encephalomyelitis virus infection chromosomal locations and gonadal dependence of genes that mediate resistance to ectromelia (mousepox) virus-induced mortality pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype an exteroceptive block to pregnancy in the mouse comparison of polymerase chain reaction and immunohistochemistry for the detection of mycoplasma pulmonis in paraffin-embedded tissue chromosomal localization of the loci responsible for dystrophic cardiac calcinosis in dba/2 mice evaluation of an enzymelinked immunosorbent assay for the detection of ectromelia (mousepox) antibody mousepox selected non-neoplastic diseases helicobacter-induced inflammatory bowel disease in il-10-and t cell-deficient mice strategies to prevent, treat, and provoke corynebacteriumassociated hyperkeratosis in athymic nude mice corynebacterium bovis: epizootiologic features and environmental contamination in an enzootically infected rodent room inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with helicobacter hepaticus poliomyelitis in mulv-infected icr-scid mice after injection of basement membrane matrix contaminated with lactate dehydrogenase-elevating virus resistance to mycoplasmal lung disease in mice is a complex genetic trait roles of innate and adaptive immunity in respiratory mycoplasmosis opportunistic infections of mice and rats: jacoby and lindsey revisited an outbreak in mice of salmonellosis caused by salmonella enteritidis serotype enteritidis detection of natural mycoplasma pulmonis infection in rats and mice by an enzyme linked immunosorbent assay (elisa) zinc-finger nucleases: the next generation emerges uber eine neue trypoanosomiasis des menschen from genes to social communication: molecular sensing by the vomeronasal organ two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cgmp phosphodiesterase gene a mouse model of clostridium difficileassociated disease the origins and uses of mouse outbred stocks evidence of human infection with a rat-associated hantavirus in helicobacter hepaticus infection triggers inflammatory bowel disease in t cell receptor alphabeta mutant mice experimental infection of mice with hamster parvovirus: evidence for interspecies transmission of mouse parvovirus 3 the diversity outbred mouse population an experience with clostridium perfringens in cesarean derived barrier sustained mice hyperkeratosis in athymic nude mice caused by a coryneform bacterium: microbiology, transmission, clinical signs, and pathology friend spleen focus-forming virus activates the tyrosine kinase sf-stk and the transcription factor pu.1 to cause a multi-stage erythroleukemia in mice colonisation and shedding of lawsonia intracellularis in experimentally inoculated rodents and in wild rodents on pig farms a mouse for all reasons citrobacter rodentium: infection, inflammation and the microbiota prevention of murine norovirus infection in neonatal mice by fostering transmission of mouse parvovirus by fomites anatomy lactate dehydrogenase-elevating virus behavioral phenotyping strategies for mutant mice genetic heterogeneity of rat-derived pneumocystis serum antibody responses by male and female c57bl/6 mice infected with giardia muris comparison of the course of infection with giardia muris in male and female mice cytotoxic and pathogenic properties of klebsiella oxytoca isolated from laboratory animals the hidden cost of housing practices: using noninvasive imaging to quantify the metabolic demands of chronic cold stress of laboratory mice the role of klebsiella oxytoca in utero-ovarian infection of b6c3f1 mice behavioral effects of ivermectin in mice host-pathogen interaction in invasive salmonellosis sur les rapports des kystes de carini du poumon des rats avec le trypanosoma lewisi eradication of helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor d recombinat congenic strains -a new tool for analyzing genetic traits by more than one gene comparison between patterns of pinworm infection (aspiculuris tetraptera) in wild and laboratory strains of mice, mus musculus laboratory rat associated outbreak of haemorrhagic fever with renal syndrome due to hantaan-like virus in belgium animal leptospirosis in small tropical areas phylogeny of the defined murine microbiota: altered schaedler flora clostridium difficile infection in horses: a review mousepox outbreak in a laboratory mouse colony isolation of a puumala-like virus from mus musculus captured in yugoslavia and its association with severe hemorrhagic fever with renal syndrome assessment of rpob and 16s rrna genes as targets for pcrbased identification of pasteurella pneumotropica comparison of traditional and pcr methods during screening for and confirmation of aspiculuris tetraptera in a mouse facility pathogenicity and genetic variation of 3 strains of corynebacterium bovis in immunodeficient mice use of fenbendazole-containing therapeutic diets for mice in experimental cancer therapy studies nutritional up-regulation of serotonin paradoxically induces compulsive behavior the pneumonia virus of mice (mpnv) model of acute respiratory infection comparison of nine commercially available clostridium difficile toxin detection assays, a real-time pcr assay for c. difficile tcdb, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods dystrophic cardiac calcinosis in mice: genetic, hormonal, and dietary influences isolation and expression of the pneumocystis carinii dihydrofolate reductase gene the mouse genome database (mgd): comprehensive resource for genetics and genomics of the laboratory mouse typhlocolitis in nf-kappa b-deficient mice cd4+ cd25+ regulatory t lymphocytes inhibit microbially induced colon cancer in rag2-deficient mice cd4(+)cd25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice nitric oxide and tnf-alpha trigger colonic inflammation and carcinogenesis in helicobacter hepaticusinfected, rag2-deficient mice ectromelia virus: the causative agent of mousepox intranasal inoculation of mycoplasma pulmonis in mice with severe combined immunodeficiency (scid) causes a wasting disease with grave arthritis the systemic amyloidoses: an overview inherited retinal degenerations in the mouse molecular detection of novel picornaviruses in chickens and turkeys fatal acute intestinal pseudoobstruction in mice the epizootic behaviour of mouse-pox (infectious ectromelia) the pathogenesis of acute exanthema. an interpretation based on experimental investigations with mouse-pox (infectious ectromelia of mice) studies in mousepox, infectious ectromelia of mice; a comparison of the virulence and infectivity of three strains of ectomelia virus studies in mousepox, infectious ectromelia of mice; the effect of age of the host upon the response to infection a juvenile mouse pheromone inhibits sexual behaviour through the vomeronasal system evidence from mtdna sequences that common laboratory strains of inbred mice are descended from a single female origins and characteristics of inbred strains of mice revised nomenclature for strain 129 mice congenic strains treatment of syphacia obvelata in mice using ivermectin the nude mouse in experimental and clinical research opportunistic bacterial infections in breeding colonies of the nsg mouse strain outbreak of tropical rat mite dermatitis in laboratory personnel the role of helicobacter species in newly recognized gastrointestinal tract diseases of animals helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice chronic proliferative hepatitis in a/jcr mice associated with persistent helicobacter hepaticus infection: a model of helicobacterinduced carcinogenesis persistent hepatitis and enterocolitis in germfree mice infected with helicobacter hepaticus hepatic helicobacter species identified in bile and gallbladder tissue from chileans with chronic cholecystitis comparison of methods of identifying helicobacter hepaticus in b6c3f1 mice used in a carcinogenesis bioassay a novel urease-negative helicobacter species associated with colitis and typhlitis in il-10-deficient mice inflammatory bowel disease in mouse models: role of gastrointestinal microbiota as proinflammatory modulators host and microbial constituents influence helicobacter pylori-induced cancer in a murine model of hypergastrinemia helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer granulomatous peritonitis in interferon-gamma gene knockout mice naturally infected with mouse hepatitis virus microbial considerations in genetically engineered mouse research tyzzer's infection: host specificity of clostridium piliforme isolates enteric lesions in scid mice infected with 'helicobacter typhlonicus,' a novel urease-negative helicobacter species helicobacter typhlonius sp. nov., a novel murine urease-negative helicobacter species diagnosis of enteritis and enterotoxemia due to clostridium difficile in captive ostriches (struthio camelus) pneumocystis pneumonia, an immunodeficiencydependent disease (idd): a critical historical overview manual of microbiological monitoring of laboratory animals detection of antibodies to pneumocystis carinii by enzyme-linked immunosorbent assay in experimentally infected mice effect of fenbendazole on three behavioral tests in male c57bl/6n mice zfn, talen, and crispr/cas-based methods for genome engineering animal transgenesis: an overview bacterial and mycotic diseases of the digestive system tyzzer's disease propagation of the etiologic agent of tyzzer's disease (bacillus piliformis) in cell culture. contribution of laboratory animal science to the welfare of man and animals: past, present, and future transgenic rna interference in mice genetic susceptibility to chronic hepatitis is inherited codominantly in helicobacter hepaticus-infected ab6f1 and b6af1 hybrid male mice, and progression to hepatocellular carcinoma is linked to hepatic expression of lipogenic genes and immune function-associated networks helicobacter hepaticus-induced liver tumor promotion is associated with increased serum bile acid and a persistent microbial-induced immune response the retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and alzheimer's transgenic mice mycoplasma detection in cell cultures: a comparison of four methods barbering (fur and whisker trimming) by laboratory mice as a model of human trichotillomania and obsessive-compulsive spectrum disorders further evidence of host species-specific variation in antigens of pneumocystis carinii using the polymerase chain reaction pneumocystis carinii is not universally transmissable between mammalian species fungal diseases in laboratory mice neuropathologic findings associated with seizures in fvb mice molecular detection of murine norovirus from experimentally and spontaneously infected mice the distribution and kinetics of polyomavirus in lungs of intranasally infected neonatal mice spontaneous staphylococcus xylosus infection in mice deficient in nadph oxidase and comparison with other laboratory mouse strains genetics and probability in animal breeding experiments the major site of murine k papovavirus persistence and reactivation is the renal tubular epithelium isolation of streptococcus equisimilis from abscesses detected in specific pathogen-free mice ciliaassociated respiratory (car) bacillus infection of obese mice epigenetic and phenotypic changes result from a continuous pre and post natal dietary exposure to phytoestrogens in an experimental population of mice impact of helicobacter hepaticus infection in b6c3f1 mice from twelve national toxicology program two-year carcinogenesis studies pathology of aging b6;129 mice reduplication in mice humoral immunity and protection of mice challenged with homotypic or heterotypic parvovirus line-1 (l1) lineages in the mouse addgene provides an open forum for plasmid sharing quantitative trait loci in a bacterially induced model of inflammatory bowel disease a review of the molecular mechanisms of chemically induced neoplasia in rat and mouse models in national toxicology program bioassays and their relevance to human cancer control of pseudomonas aeruginosa infection in mice by chlorine treatment of drinking water mouse phyisology b cells modulate systemic responses to pneumocystis lung infection and protect on-demand hematopoiesis via t cell-independent, innate mechanism when type-i-ifn-signaling is absent development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase pcr assay to detect murine norovirus 1 infection in mice persistent infection with and serologic cross-reactivity of three novel murine noroviruses multiplex fluorescent immunoassay for the simultaneous detection of serum antibodies to multiple rodent pathogens development and applications of crispr-cas9 for genome engineering genetic influence on response to dietary manganese deficiency in mice differential susceptibility to hepatic inflammation and proliferation in axb recombinant inbred mice chronically infected with helicobacter hepaticus parvoviruses mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. 2 pathogenesis of vaccinia (ihd-t) virus infection in balb/cann mice evidence that nk cells and interferon are required for genetic resistance to infection with ectromelia virus sendai virus pneumonia in aged balb/c mice health care for research animals is essential and affordable inducible gene expression and gene modification in transgenic mice pcr testing of a ventilated caging system to detect murine fur mites amino acid requirements of the growing mouse monographs on pathology of laboratory animals talens: a widely applicable technology for targeted genome editing murine acariasis. ii. immunological dysfunction and evidence for chronic activation of th-2 lymphocytes mouse enu mutagenesis effects of enu dosage on mouse strains comparative murine norovirus studies reveal a lack of correlation between intestinal virus titers and enteric pathology tailored immune responses: novel effector helper t cell subsets in protective immunity stat1-dependent innate immunity to a norwalk-like virus eradication of murine norovirus from a mouse barrier facility control of laboratory acquired hemorrhagic fever with renal syndrome (hfrs) in japan growth of tyzzer's organism in primary monolayer cultures of adult mouse hepatocytes the laboratory mouse. its origin, heredity, and culture olfactory regulation of the sexual behavior and reproductive physiology of the laboratory mouse: effects and neural mechanisms review of successful treatment for helicobacter species in laboratory mice on the maximum avoidance of inbreeding an oral ivermectin regimen that eradicates pinworms (syphacia spp.) in laboratory rats and mice nutrition effect of open and closed formula rations on the performance of three strains of laboratory mice insertional hypermutation in mineral oil-induced plasmacytomas chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease gross anatomy the manufacture, shipping and receiving and quality control of rodent bedding materials emergence of clostridium difficile-associated disease in north america and europe helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation bacteria-triggered cd4(+) t regulatory cells suppress helicobacter hepaticus-induced colitis il-23 plays a key role in helicobacter hepaticus-induced t cell-dependent colitis paresis of peristalsis and ileus lead to death in lactating mice experimental spironucleosis (hexamitiasis) in the nude mouse as a model for immunologic and pharmacologic studies host specificity of giardia muris isolates from mouse and golden hamster genetic control of resistance to mycoplasma pulmonis infection in mice therapeutic effect of dna immunization of genetically susceptible mice infected with virulent mycoplasma pulmonis in vitro and in vivo susceptibility of mouse megakaryocytic progenitors to strain i of parvovirus minute virus of mice effects of fenbendazole on the murine humoral immune system from house mouse to mouse house: the behavioral biology of free-living mus musculus and its implications in the laboratory antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts use of topical ivermectin treatment for syphacia obvelata in mice hantaan-like viruses from domestic rats captured in the united states obesity and non-insulin-dependent diabetes mellitus in swiss-webster mice associated with late-onset hepatocellular carcinoma mouse adenovirus type 1 infection in scid mice: an experimental model for antiviral therapy of systemic adenovirus infections mineralization/anti-mineralization networks in the skin and vascular connective tissues a second class of olfactory chemosensory receptors in the olfactory epithelium genetic variables that influence phenotype mycoplasma and other bacterial diseases of the respiratory system pasteurella pneumotropica pseudomonas aeruginosa salmonella enteritidis staphylococcus aureus streptobacillus moniliformis streptococcus pneumoniae soiled bedding sentinels for the detection of fur mites in mice false negative results using rt-pcr for detection of lactate dehydrogenase-elevating virus in a tumor cell line eradication of pinworms (syphacia obvelata) from a large mouse breeding colony by combination oral anthelmintic therapy mousepox resulting from use of ectromelia virus-contaminated, imported mouse serum husbandry factors and the prevalence of age-related amyloidosis in mice cardioviruses: encephalomyocarditis virus and theiler's murine encephalitis virus diagnostic testing of mouse and rat colonies for infectious agents a novel presentation of clostridium piliforme infection (tyzzer's disease) in nude mice serodiagnosis of mice minute virus and mouse parvovirus infections in mice by enzyme-linked immunosorbent assay with baculovirus-expressed recombinant vp2 proteins hfrs outbreak associated with laboratory rats in uk the clinical chemistry of laboratory animals lack of commensal flora in helicobacter pylori-infected ins-gas mice reduces gastritis and delays intraepithelial neoplasia castration eliminates conspecific aggression in group-housed cd1 male surveillance mice toll-like receptor 2 (tlr2) plays a major role in innate resistance in the lung against murine mycoplasma clostridium difficile-associated cecitis in guinea pigs exposed to penicillin clearance of pneumocystis carinii in mice is dependent on b cells but not on p-carinii-specific antibody phylogenetic relationships in the genus mus, based on paternally, maternally, and biparentally inherited characteristics genetic variants and strains of the laboratory mouse direct detection of indirect transmission of streptobacillus moniliformis rat bite fever infection fenner's veterinary virology failure to infect laboratory rodent hosts with human isolates of rodentolepis (=hymenolepis) nana detection and control of mouse parvovirus diminished reproduction, failure to thrive, and altered immunologic function in a colony of t-cell receptor transgenic mice: possible role of citrobacter rodentium helicobacter bilis infection accelerates and h. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a −/−) mice helicobacter infection is required for inflammation and colon cancer in smad3-deficient mice detection of giardia cysts by using the polymerase chain reaction and distinguishing live from dead cysts knockout mice: a paradigm shift in modern immunology a novel murine infection model for shiga toxin-producing escherichia coli infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and dna damage leading to colon cancer soiledbedding sentinel detection of murine norovirus 4 infectious ectromelia. a hitherto undescribed virus disease of mice mycoplasma contamination of murine embryonic stem cells affects cell parameters, germline transmission and chimeric progeny clostridium perfringens and clostridium difficile-associated diarrhea pathology of the mouse from sexual attraction to maternal aggression: when pheromones change their behavioural significance an outbreak of pasteurella pneumotropica in genetically modified mice: treatment and elimination spontaneous necrotic enteritis in young rfm/ms mice prevention and treatment of ciliaassociated respiratory bacillus in mice by use of antibiotics a paralytic disease in nude mice associated with polyomavirus infection renewed interest in a difficult disease: clostridium difficile infections -epidemiology and current treatment strategies use of metronidazole in equine acute idiopathic toxaemic colitis identification and propogation of a putative immunosuppressive orphan parvovirus in cloned t cells corynebacterium species-associated keratoconjunctivitis in aged male c57bl/6j mice genetic differences among c57bl/6 substrains isolation of helicobacter spp. from mice with rectal prolapses complex trait analysis in the mouse: the strengths, the limitations, and the promise yet to come fur mites induce dermatitis associated with ige hyperproduction in an inbred strain of mice, nc/kuj origins of inbred mice: proceedings of a workshop building a better mouse: one hundred years of genetics and biology retroelements in the mouse a mammalian herpesvirus cytolytic for cd4+ (l3t4+) t lymphocytes prairie dog model for antimicrobial agent-induced clostridium difficile diarrhea murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by stat1-dependent interferon responses transmission of systemic aa amyloidosis in animals infection of different strains of mice with lawsonia intracellularis derived from rabbit or porcine proliferative enteropathy the musculus-type y chromosome of the laboratory mouse is of asian origin lethal and severe coronary arteritis in dba/2 mice induced by fungal pathogen, caws, candida albicans water-soluble fraction cre recombinase: the universal reagent for genome tailoring manual of microbiological monitoring of laboratory animals reduced fecundity and death associated with parvovirus infection in b-lymphocyte deficient mice phylogenetic analysis and description of eperythrozoon coccoides, proposal to transfer to the genus mycoplasma as mycoplasma coccoides comb. nov. and request for an opinion experimental analysis of risk factors for ulcerative dermatitis in mice citrobacter rodentium espb is necessary for signal transduction and for infection of laboratory mice colitis and colon cancer in waspdeficient mice require helicobacter species contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units cellular expression of murine ym1 and ym2, chitinase family proteins, as revealed by in situ hybridization and immunohistochemistry oxytocin is required for nursing but is not essential for parturition or reproductive behavior report of the american institute of nutrition ad hoc committee on standards for nutritional studies moving forward with chemical mutagenesis in the mouse implementation of a pcr assay of pasteurella pneumotropica to accurately screen for contaminated laboratory mice natural cryptosporidium muris infection of the stomach in laboratory mice enhancement of cognitive function in models of brain disease through environmental enrichment and physical activity handbook of vertebrate immunology perturbations in cytokine gene expression after inoculation of c57bl/6 mice with pasteurella pneumotropica a transgenic approach for rna interference-based genetic screening in mice mouse pathology of laboratory rodents and rabbits naturally occurring murine norovirus infection in a large research institution from bench to cageside: risk assessment for rodent pathogen contamination of cells and biologics reduced body growth and excessive incisor length in insertional mutants mapping to mouse chromosome 13 congenital eye defects in the mouse. i. corneal opacity in c57black mice murine adenovirus infection of scid mice induces hepatic lesions that resemble human reye syndrome improved lactation in germfree mice following changes in the amino acid and fat components of a chemically defined diet a systematic method of breeder rotation for noninbred laboratory animal colonies genetic variation and phylogeography of central asian and other house mouse mice, including a major new mitochondrial lineage in yemen reproductive biology of the laboratory mouse helminth parasites of laboratory mice contemporary prevalence of infectious agents in laboratory mice and rats clostridium species. veterinary microbiology and microbial disease uteroovarian infection in aged b6c3f1 mice breast cancer: should gastrointestinal bacteria be on our radar screen? detection of pneumocystis carinii in a rat model of infection by polymerase chain reaction spontaneous nonneoplastic gastric lesions in female han:nmri mice, and influence of food restriction throughout life emerging views on the distinct but related roles of the main and accessory olfactory systems in responsiveness to chemosensory signals in mice zfngenome: a comprehensive resource for locating zinc finger nuclease target sites in model organisms treatment and eradication of murine fur mites: iii. treatment of a large mouse colony with ivermectin-compounded feed pheromonal induction of spatial learning in mice mucispirillum schaedleri gen. nov., sp. nov., a spiral-shaped bacterium colonizing the mucus layer of the gastrointestinal tract of laboratory rodents pheromone sensing in mice minor histocompatibility antigens: from the laboratory to the clinic vitamin a and retinoic acid in t cell-related immunity spontaneous pneumocystis carinii pneumonia in immunodeficient mutant scid mice. natural history and pathobiology lethal exacerbation of pneumocystis carinii pneumonia in severe combined immunodeficiency mice after infection by pneumonia virus of mice primary structure and phylogenetic relationships of glyceraldehyde-3-phosphate dehydrogenase genes of free-living and parasitic diplomonad flagellates duodenal adenomas in balb/-c mice monoinfected with clostridium perfringens diffuse scaling dermatitis in an athymic nude mouse clostridium difficile typhlitis associated with cecal mucosal hyperplasia in syrian hamsters zifit (zinc finger targeter): an updated zinc finger engineering tool spatial distribution and stability of the eight microbial species of the altered schaedler flora in the mouse gastrointestinal tract comparison of the in vitro susceptibility of rodent isolates of pseudomonas aeruginosa and pasteurella pneumotropica to enrofloxacin antibody production in syphacia obvelata infected mice hyperkeratosis-associated coryneform infection in severe combined immunodeficient mice gastrointestinal microflora host specificity of cloned spironucleus muris in laboratory rodents the eae gene of citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia genetic and biochemical characterization of citrobacter rodentium sp. nov outbreak of group b streptococcal meningoencephalitis in athymic mice demylination and wasting associated wigh polyomavirus infection in nude (nu/nu) mice severe leukopenia and dysregulated erythropoiesis in scid mice persistently infected with the parvovirus minute virus of mice assessment of retinal degeneration in outbred albino mice assessment of retinal degeneration in outbred albino mice identification of widespread helicobacter hepaticus infection in feces in commercial mouse colonies by culture and pcr assay helicobacter infection decreases reproductive performance of il10-deficient mice pheromone binding by polymorphic mouse major urinary proteins role of housing modalities on management and surveillance strategies for adventitious agents of rodents murine cytomegalovirus and other herpesviruses cytolethal distending toxin promotes helicobacter cinaediassociated typhlocolitis in interleukin-10-deficient mice manual of microbiological monitoring of laboratory animals helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora helicobacter bilis/helicobacter rodentium co-infection associated with diarrhea in a colony of scid mice genetically determined murine models of immunodeficiency macrophage plasticity and polarization: in vivo veritas atlas of the mouse brain and spinal cord mouse genetics: concepts and applications a natural outbreak of transmissible murine colonic hyperplasia in a/j mice genetic variation among 129 mouse substrains and its importance for targeted mutagenesis in mice genetic dissection of complex traits with chromosome substitution strains of mice a conditional knock out resource for the genome-wide study of mouse gene function ivermectin toxicity in young mice response of weanling random-bred mice to inoculation with minute virus of mice explant cultures for detection of minute virus of mice in infected mouse tissue in vivo studies with an 'orphan' parvovirus microphthalmia and associated abnormalities in inbred black mice mouse adenoviruses innate lymphoid cells -a proposal for uniform nomenclature a new name (pneumocystis jiroveci) for pneumocystis from humans major histocompatibility complex (mhc): mouse. els mouse urinary peptides provide a molecular basis for genotype discrimination by nasal sensory neurons the complete genome sequence of the carcinogenic bacterium helicobacter hepaticus mouse relapse model of clostridium difficile infection dendritic cells are the major antigen presenting cells in inflammatory lesions of murine mycoplasma respiratory disease chronic ulcerative dermatitis in black mice generation of knockout mice using engineered nucleases spontaneous lesions in control b6c3f1 mice and recommended sectioning of male accessory sex organs acute, lethal, natural killer cell-resistant myeloproliferative disease induced by polyomavirus in severe combined immunodeficient mice the ancestor of extant japanese fancy mice contributed to the mosaic genomes of classical inbred strains pattern recognition receptors and inflammation aggregation chimeras: combining es cells, diploid and tetraploid embryos analysis of the immune response of hantaan virus nucleocapsid protein-specific cd8+ t cells in mice the pathogenesis of experimental infections of cryptosporidium muris (strain rn 66) in outbred nude mice enterohepatic helicobacter species are prevalent in mice from commercial and academic institutions in asia, europe, and north america murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to clostridium difficile infection effect of essential amino acid restriction on the growth of female c57bl mice and their implanted bw10232 adenocarcinomas fatal diarrhea in rabbits resulting from the feeding of antibiotic-contaminated feed modulation of the host microenvironment by a common non-oncolytic mouse virus leads to inhibition of plasmacytoma development through nk cell activation x-ray-induced mutations in mouse embryonic stem cells ten years of the collaborative cross geneology of the 129 inbred strains: 129/svj is a contaminated inbred strain molecular biology, analysis, and enabling technologies: analysis of transgene integration nutrition toxicity evaluation of prophylactic treatments for mites and pinworms in mice serological and virological evidence of hantaan virus-related enzootic in the united states korean hemorrhagic fever in staff in an animal laboratory prolonged perturbations of tumour necrosis factoralpha and interferon-gamma in mice inoculated with clostridium piliforme acceleration and inhibition of puberty in female mice by pheromones spontaneous pseudopregnancy in mice male management: coping with aggression problems in male laboratory mice phylogeny of trichomonads based on partial sequences of large subunit rrna and on cladistic analysis of morphological data il-7 deficiency prevents development of a non-t cell non-b cell-mediated colitis provitamin a metabolism and functions in mammalian biology genetic variation in laboratory mice the mosaic structure of variation in the laboratory mouse genome a study of mouse strains susceptibility to bacillus piliformis (tyzzer's disease): the association of b-cell function and resistance a naturally occurring outbreak of mycobacterium avium-intracellulare infections in c57bl/6n mice cecocolitis in immunodeficient mice associated with an enteroinvasive lactose negative e. coli pneumocystis carinii shows dna homology with the ustomycetous red yeast fungi kinetics of ectromelia virus (mousepox) transmission and clinical response in c57bl/6j, balb,cbyj and akr inbred mice outbreaks of pneumocystis carinii pneumonia in colonies of immunodeficient mice draft genome sequences of the altered schaedler flora, a defined bacterial community from gnotobiotic mice pathology of genetically engineered mice chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel helicobacter species inflammatory large bowel disease in immunodeficient mice naturally infected with helicobacter hepaticus hyalinosis and ym1/ym2 gene expression in the stomach and respiratory tract of 129s4/svjae and wild-type and cyp1a2-null b6, 129 mice pathology of immunodeficient mice with naturally occurring murine norovirus infection reoviridae protozoa initial sequencing and comparative analysis of the mouse genome new building, old parasite: mesostigmatid mites -an ever-present threat to barrier facilities genetic diversity of pneumocystis carinii derived from infected rats, mice, ferrets, and cell cultures spontaneous wasting disease in nude mice associated with pneumocystis carinii infection respiratory disease and wasting in athymic mice infected with pneumonia virus of mice arthropods manual of microbiological monitoring of laboratory animals genetic and histochemical studies on mouse spleen black spots status and acces to the collaborative cross population helminths natural and experimental helicobacter infections monitoring sentinel mice for helicobacter hepaticus, h rodentium, and h bilis infection by use of polymerase chain reaction analysis and serologic testing rapid onset of ulcerative typhlocolitis in b6.129p2-il10tm1cgn (il-10−/−) mice infected with helicobacter trogontum is associated with decreased colonization by altered schaedler's flora estrus-inducing pheromone of male mice. transport by movement of air endonucleases: new tools to edit the mouse genome replication of a norovirus in cell culture reveals a tropism for dendritic cells and macrophages murine norovirus: a model system to study norovirus biology and pathogenesis addgene: the bank that gives points for (plasmid) deposits microbiological contamination of laboratory mice and rats in korea from streptobacillus moniliformis -a zoonotic pathogen. taxonomic considerations, host species, diagnosis, therapy, geographical distribution an enzyme-linked immunosorbent assay (elisa) for the detection of antibodies to pasteurella pneumotropica in murine colonies sgrnacas9: a software package for designing crispr sgrna and evaluating potential off-target cleavage sites inhibition of tnf-alpha, and nf-kappab and jnk pathways accounts for the prophylactic action of the natural phenolic, allylpyrocatechol against indomethacin gastropathy adaptive immunity restricts replication of novel murine astroviruses chemical-induced atrial thrombosis in ntp rodent studies nucleic acid-sensing toll-like receptors are essential for the control of endogenous retrovirus viremia and erv-induced tumors recent applications of engineered animal antioxidant deficiency models in human nutrition and chronic disease dissecting the effects of mtdna variations on complex traits using mouse conplastic strains a genomic update on clostridial phylogeny: gram-negative spore formers and other misplaced clostridia effective eradication of pinworms (syphacia muris, syphacia obvelata and aspiculuris tetraptera) from a rodent breeding colony by oral anthelmintic therapy possible allelic structure of igg2a and igg2c in mice one-step generation of different immunodeficient mice with multiple gene modifications by crispr/cas9 mediated genome engineering key: cord-023143-fcno330z authors: nan title: molecular aspects of viral immunity date: 2004-02-19 journal: j cell biochem doi: 10.1002/jcb.240591009 sha: doc_id: 23143 cord_uid: fcno330z nan mechanisms of t-cell mediated clearance of viruses from the central nervous system are poorly understood, but likely to differ from those employed in the periphery because the cns lacks lymphatic drainage and constitutive expression of mhc class i antigen, and the unique structure of the cns vasculature imposes constraints on access by leukocytes and soluble immune mediators. to study the mechanism by which viruses are cleared from neurons in the central nervous system, we have developed a mouse model involving infection with a neurotropic variant of mouse hepatitis virus (oblv60). grew preferentially in the olfactory bulbs of balbk mice. using in situ hybridization, we found viral rna localized primarily in the outer layers of the olfactory bulb, including neurons of the mitral cell layer. virus was cleared rapidly from the olfactory bulb between 5 and 11 days. athymic nude mice failed to eliminate the virus demonstrating a requirement for t lymphocytes. immunosuppression of normal mice with cyclophosphamide also prevented clearance. both cd4+ and cd8+ t-cell subsets were important as depletion of either of these subsets delayed viral clearance. gliosis and infiltrates of cd4+ and cd8+ cells were detected by immunohistochemistry at 6 days. the role of cytokines in clearance was investigated using an rnase protection assay for il-la, il-lp, il-2, il-3, il-4, il-5, il-6, tnfa, tnfp and ifny. in immunocompetent mice there was upregulation of rna for il-la, il-lp, il-6, tnfa and ifny at the time of clearance. nude mice had comparable increases in these cytokine messages with the exception of ifny. induction of mhc-i molecules on cells in infected brains was demonstrated by immunohistochemistry in normal and nude mice, suggesting that ifny may not be necessary for induction of mhc-i on neural cells in vivo. luca g. guidotti, kazuki ando, tetsuya ishikawa, lisa tsui and francis v. chisari. the scripps research institute, la jolla, ca 92037 although cytotoxic t lymphocytes (ctl) are known to clear viral infections by killing infected cells, recent studies suggest that they can also suppress the replication of certain viruses by noncytolytic mechanisms. we have examined this area by monitoring the immunopathological and antiviral consequences of antigen recognition by hepatitis b virus (hbv) specific ctl in hbv transgenic mice that express the viral gene products in their hepatocytes. we have shown that intravenously injected ctl rapidly trigger their target hepatocytes to undergo apoptosis, but that the direct cytopathic effect of the ctl is minimal in comparison with the cytopathic effects of the antigen-nonspecific intrahepatic inflammatoly response that they activate. in addition to killing the hepatocyte, the same ctl also downregulate hbv gene expression and completely abolish hbv replication in the hepatocytes that they don't destroy. this noncytolytic antiviral ctl effect is mediated by at least two distinct processes in these animals. first, the ctl cause a quantitative reduction in the steady state content of all hbv mrna species in the hepatocyte, and this is followed by disappearance of all of the corresponding viral proteins in the liver and serum. the ctl initiate this process by secreting ifny and tnfa when they are activated by antigen recognition. since the regulatory effect of the ctl can he prevented completely by prior administration of the corresponding antibodies. nuclear run-on experiments reveal that viral mrna transcription is unaffected despite the profound reduction in hbv mrna content in the liver, suggesting that the ctl-derived cytokines accelerate viral mrna degradation in the hepatocyte. a second noncytolytic antiviral pathway is also activated by the ctl. we have recently shown that hbv nucleocapsid particles, and the replicative hbv dna intermediates that they contain, disappear from the transgenic mouse liver following either ctl administration or partial hepatectomy. the latter of which triggers hepatocellular regeneration without any change in hepatocellular hbv mrna content. these results suggest that preformed hbv nucleocapsid particles may be actively degraded during hepatocyte turnover, and they raise the possibility that similar events might also occur in nondividing hepatocytes that are activated by noncytolytic signals delivered by the ctl. we propose that, in addition to their pathogenetic effect, the comhined effects of the ctl response at die hbv mrna. nucleocapsid and rcplicative dna levels may represent a curative antiviral stimulus during hbv infection. since the virus must contain molecular elements that iespond to these ctl-induced antiviral signals. inactivating mutations at these loci could be very efficiently selected by immune pressure, because a single mutation could abrogate the antiviral effect of a wide spectrum of t cell responses, irrespectrve of epitope specificity. identification of these viral response elements and the intracellular pathways that interact with them may lead to the development of new strategies for antiviral drug design. human fibroblasts infected with hsv are resistant to lysis by cd8+ cytotoxic t lymphocytes (ctl), yet human b cell lines can be efficiently lysed by these ctl. the effect on human fibroblasts is rapid (within 2 hr of infection of cells), occurring before synthesis of mhc class i is altered by virus infection. a recombinant hsv, f-usbmhc, which expresses mouse mhc class i proteins does not render human fibroblasts sensitive to lysis by mouse ctl. mhc class i molecules are retained in the er of hsv-infected fibroblasts i n a misfolded, unstable form and stability of the mhc complex can be restored by addition of exogenous peptides. using a panel of hsv mutants and ad expression vectors we demonstrated that the hsv ie protein icp47 was both necessary and s f i c i e n t to cause retention of class i and icp47 expression in fibroblasts caused the cells to resist lysis by cd8+ t lymphocytes. icp47 is a soluble, cytosolic protein and we have found no evidence of membrane association. therefore, it appears that icp47 inhibits cytosolic stages of the antigen presentation pathway so that antigenic peptides do not reach the er. to date, polyclonal and monoclonal antibodies directed to icp47 have not specifically precipitated any of the previously described components of the antigen presentation pathway and we have not found icp47 associated with tap transporter proteins or proteosomes i n these experiments. the effects of icp47 are being assessed in proteosome and tap transporter assays. gst-icp47 fusion proteins tightly bind a 8.5 kda cytosolic cellular protein which is found in a number of adherent human cell lines but not lymphocytes. the protein has been purified and sequencing is in progress. in addition, radiolabelled icp47 binds to a single cellular protein of =55 kda on ligand blots. these proteins are good candidates as cellular targets of icp47 and as novel components of the antigen presentation pathway. preliminary experiments support the hypothesis that icp47 is very effective i n blocking cd8+ t lymphocyte responses in vivo, perhaps explaining the predominance of cd4+ vs. cd8+ anti-hsv ctl i n vivo. we expect that icp47 may be very useful, not only to elucidate antigen presentation pathways, but also to prevent immune recognition of gene transfer vectors and a s a immunosuppressive agent. susceftibility to polyoma virus-induced tumors is conferred by an endogenous mmtv superantigen. aron e. lukacherl, yupo ma2, john p. carroll2, sara r. abromson-leeman2, joseph c. laning2, martin e. dorf2, and thomas l. benjamin2. idepartment of pathology, emory university school of medicine, atlanta, ga 30322, and 2department of pathology, harvard medical school, boston, ma 02115. susceptibility to tumors induced by mouse polyoma virus varies among inbred mouse strains. we have previously shown that polyoma tumor susceptibility is controlled by products of mhc as well as non-mhc genes. in crosses between mhc-nonidentical strains differing in tumor susceptibility, resistance correlates with dominantkodominant inheritance of the resistant h-2 haplotype. we have observed the opposite pattern of inheritance of susceptibility in crosses between mhc-identical strains. in crosses between the highly susceptible c3wbida mouse and the highly resistant but mhc-identical (h-2k) c57bwcd.i mouse, polyoma tumor susceptibility is conferred by a single autosomal dominant gene, which we have designated pyvs. pyj does not encode cell receptors for the virus, affect viral dissemination or anti-viral antibody responses, or affect intracellular events essential for productive infection or cell transformation by the virus. whole-body irradiation renders cs7bwcd.i mice fully susceptible to polyoma-induced tumors, indicating an immunological basis for this strain's resistance. we hypothesized that p y j encodes an mtv superantigen (sag) that confers susceptibility to c3wbida mice by deleting precursors of polyoma-specific t cells. we found that tumor susceptibility in (c3wbida x c57bwcd.i) x c57bwcdj backcross mice cosegregated with mtv-7. inheritance of mtv-7 showed perfect concordance with absence of peripheral vp6+ t cells. genotyping of backcrossmice using markers of simple sequence repeat polymorphisms flanking mtv-7 showed no evidence of recombination between pyvs and mtv-7. strongly biased usage of vp6 by (a) polyoma-specific cd8+ ctl from virus-infected c57bwcdj mice and by @) cd8+ t cells infiltrating a polyoma tumor in a virus-immune c57bwcd.i host provide further evidence that t cells bearing this mtv-7 sag-reactive vp domain are critical anti-polyoma tumor effector cells. these results indicate identity between p y j and mtv-7 sag, and demonstrate a novel mechanism of inherited susceptibility to virus-induced tumors based on effects of an endogenous superantigen on the host's t cell repertoire. infection of mice with lymphocytic choriomeningitis virus (lcmv) causes a transient to longlasting immunosuppression dependent upon virus-isolate dose of virus and age, h-2, non h-2, level of cd4+ t cells, of cd8+ t cells and kinetics of neutralizing antibodies of the host. the immunohistological analysis suggests that cd8+ t cell dependent disappearence of marginal zone macrophages of follicular dendritic cells and of virus infected cells in general correlates with immunosuppression. the details of mechanisms responsible for these findings are now being analysed. a role of this cd8+ t cell dependent immunosuppression in the establishment of a lcmv carrier state in immunocompetent mice is suggested by the following experiments: the otherwise slow and low neutralizing antibody response agamst lcmv is accelerated and enhanced by cd8+ t cell depletion at the time of infection, suggesting virus-specific immunopathology being responsible at least partially. the elisa antibody response is not significantly altered under the same conditions but is abrogated if lcmv-specific t cell receptor transgenic mice are infected with high doses of lcmv, indicating, that suppression of the specific antibody response depends upon the relative kinetics of ctl versus antibody responses. whether exhaustion of specific ctl responses is enhanced by similar mechanisms remains to be tested. the role of interleukins of the relative distribution of virus in the mouse and in the various aspects of immunosuppression are now being studied. immunosuppression, caused by cd8+ t cell-dependent immunopathology, may also be operational in hiv infection in humans. such a pathogenesis of hiv-triggered aids could explain several aspects of the disease process not readily fitting the (unproven) conventional idea that hiv is causing immunodeficiency via direct viral pathogenicity. the cellular immunity against two dna tumor viruses (i.e. human adenovirus type 5 (ad 5) and human papillomavirus type 16 (hpv16)) was studied with respect to possible immune escape mechanisms and to the development of ctl epitope based peptide vaccines. after identifying an immunorelevant ctl epitope in the ad 5e1a protein to which ctl clones were directed that could eradicate ad 5e1 induced tumors in nude mice, an amino acid replacement study of this epitope revealed a point mutation that totally eliminated the possibility to recognize the mutant peptide by the ctl clones directed against the wild-type peptide sequence. new viral constructs were made that contained this point mutation and used to transform mouse embryo cells. however, these mutant tumor cells were still immunogenic and ctl clones specific for these mutant tumor cells were shown to react with a peptide derived from the ad 5e1b protein. these ad 5eib specific ctl clones, however, were as effective as the ad 5e1a specific ctl clones in the eradication of ad 5e1 induced tumors in nude animals, indicating that a choice can be made of immunorelevant epitopes to which an immunization strategy could be developed. in addition, we discovered that by supertransfection of ad 5e1 induced tumor cells with the activated ras oncogen the possibility of ad 5e1b specific ctl to recognize the ad 5e1 induced tumors was eliminated whereas the ad 5e1a specific ctl could still kill these tumor cells. this might indicate a new mechanism of tumors to escape ctl. in an hpv16 induced mouse tumor model an immunosubdominant ctl epitope was identified in the e7 protein that could, upon immunization with that peptide,protect mice against a subsequent challenge with hpv16 induced tumor cells. by changing the anchor residues in that peptide an even more immunoprotective peptide could be generated. combined, these data indicated a successful use of a ctl epitope based peptide vaccine in the prevention of hpv16 induced tumors in mice. subsequently this led us to identify relevant ctl epitopes of hpv16, that is highly associated with cervical carcinoma in humans, for the major hla-a alleles (i.e. hla-a *0101, a *0201, a"0301, a*1101 and a *2401). together these alleles cover a majority of all humans. ctl epitopes were identified through peptide-mhc binding assays followed by in v i m peptide immunizations with high affinity binding peptides to induce primary ctl responses and immunogenicity studies in hla-a transgenic mice. thereafter, memory ctl responses were measured in cervical cancer patients against selected peptides. combined, these data led us to develop a ctl epitope based peptide vaccine that could be of use in hpv16 induced cervical cancer patients. a clinical trial for this disease is scheduled to start in the fall of 1994. class ii presentation of an endogenously synthesized glycoprotein. carol s. re is^'.'.^, shirley m. bartido', miriam stein', and stephanie diment3.4, biology department', and center in contrast to class i presentation which is well characterized to use peptide fragements of proteins sythesized in the cytoplasm, exogenously administered experimental antigens enter the class ii mhc pathway through endocytosis. we have been studying the recognition of the glycoprotein of vesicular stomatitis virus (vsv) which can enter either the exogenous or endogenous pathways for presentation to cd4 + t cells. investigations of the intracellular sites involved, the proteolytic processes involved in the epitope generation, will be discussed. the glycoprotein studied in detail is a truncated form of the wt type 1 glycoprotein, termed poison tail (gpt) . expressed with a vaccinia virus vector, the gpt remains endo h sensitive and never becomes endo d sensitive, indicating that it is restricted to the endoplasmic reticulum. gpt is degraded in the er, and w e believe the degradation products include the immunogenic epitopes recognized by a panel of lad and i-ed t cell clones and hybridomas. lmmunofluorescence studies have confirmed the er localization. flow cytometric evaluations s h o w that the gpt never appears on the cell surface, in contrast to the wt g. the peptides generated are not secreted; using an innocent bystander assay, gpt-infected cells are incapable of sensitizing 5'cr-labeled uninfected apc. this contrasts with the rapid ability of supernatants from wt g-vaccinia virus-infected cells to sensitize apc for t cell recognition. investigations of the characteristics of the enzymes contributing to the degradation of the gpt have shown that a reducing environment is essential, as diamide treatment of cells prevents degradation. lysosomotropic drugs (eg. nh,ci and leupeptin) d o not alter the half-life of the protein, but do prevent presentation of the peptides; this is inconsistent with an autophagic component to the proteolysis. ph optima are physiological, as ph8 environment inhibits the enzyme activity. inhibitors of enzyme classes are consistent with a trypsin-like, and not cystein-, cathepsin b-, or chymotrypsin-like class. supported by nih grant al 18083 to csr. (emcv) and mengovirus are related members of the cardiovirus genus of picomaviruses. their rna genomes encode a large polyprotein which is cleaved proteolytically in co-and post-translational reactions to yield all mature viral proteins necessary to establish an infection. although originally thought to be exclusively murine in host range, both viruses actually infect a wide range of mammals. emcv has caused devastating epizootics in captive primates (eg: macaques, chimps and baboons), domestic pigs and exotic zoo collections (elephants, lions and tigers). death, following ingestion of virus-contaminated material, is rapid, and caused by extensive meningoencephalitis and virus-induced damage to the cns. myocarditic lesions are common in older animals. when administered intracerebrally, the ld,, for emcv strain r is about 1 pfu. we are studying the pathogenesis of emcv and mengo with engineered cdna plasmids containing infectious viral sequences. many plasmids contain h'uncated versions of the unusual 5' noncoding homopolymeric poly(c) tract that is a hallmark of these cardioviruses. short poly(c) mengoviruses grow very well in tissue culture but are 106-10'z fold less pathogenic to mice than the wild-type strains. animals receiving sublethal doses of short-tract mengo strains develop high titers of neutralizing antibodies, exhibit potent ctl responses and acquire lifelong protective immunity against challenge with wild-type virus. the genetic stability of the short-tract strains, even upon serial brain passage, mark them as safe, efficacious live vaccines. currently, we believe the poly(c) phenomenon is due to interference by the wild-type virus sequences (long poly(c) tract) with normal cellular cytokine induction mechanisms (ie: ifa and ifp) during the initial stages of animal infection. the targeted cells are probably macrophages, and their singular ability to correctly respond or not respond to poly(c) tract length during the first few hours of infection determines whether an inoculated animal will live (protectively vaccinated) or die. the short-tract viruses probably induce if in the macrophages, and are consequently killed then rapidly cleared from the host in related experiments we've found that attenuated mengo strains can easily carry large heterologous insertions within their genomes, and express these sequences into protein them during replication in animals. the resulting immune response (b cell and ctl) to the chimeras is directed towards the foreign sequences (epitopes) as well as towards the mengo proteins. a chimeric hiv vaccine, a rabies vaccine and an lcmv vaccine have been developed and tested. the lcmv chimera seems especially effective, as a single pfu of this engineered mengo strain, administered orally to a mouse, is sufficient for complete immunogenic protection against intracerebral challenge with wild-type lcmv virus. rsv is the most common cause of serious viral lower respiratory tract disease in infants and children. we have recently renewed our efforts to generate a safe and effective live attenuated rsv vaccine for topical administration that will overcome the deficiencies of previously studied live and non-living rsv vaccines. this vaccine will be a bivalent vaccine consisting of subgroup a and b live attenuated virus components. since the peak incidence of severe disease caused by rsv is in the 2-month old infant, an rsv vaccine will need to be effective when given to 1-month old infants. based on the success of live poliovirus vaccines given early in infancy, it is anticipated that the intranasally administered live virus vaccine will infect and induce a protective local and systemic immune response even in infants with passively acquired maternal antibodies. the main approach that we have taken in this effort to develop the live rsv vaccine is to introduce one or more ts mutations by chemical mutagenesis into a cold-passaged virus (cprsv) that had been partially attenuated by the acquisition of host-range mutations selected by passage in cells of a heterologous host species. we have developed a large set of cprsv subgroup a rs mutants (termed cprs mutants) that contain the host-range mutations selected during cold passage and two or more ts mutations introduced by chemical mutagenesis. these mutants have been evaluated in virro for their level of temperature sensitivity and in vivo in rodents, chimpanzees, and humans. a large set of rsv subgroup b cpts mutants has been similarly produced and evaluated. the immunogenicity and protective efficacy of three candidate live attenuated rsv vaccine strains that represent a specaum of attenuation were evaluated for protective efficacy in chimpanzees. prior to infection some of these animals were given rsv immune globulin by the iv route to simulate the condition of the very young infant who possesses passively-acquired maternal rsv antibodies. the three candidate vaccine strains were immunogenic and induced significant resistance to rsv challenge in both groups of chimpanzees. interestingly, the chimpanzees infused with rsv antibodies prior to immunization were primed more effectively for an unusually high serum neutralizing antibody response to infection with challenge virus than chimpanzees which did not receive such antibodies. this high booster response occurred despite marked reshiction of replication of the challenge virus. the evaluation of two candidate vaccines in seronegative human infants will also be described. rs virus is immunologically interesting for at least t w o reasons: 1) upper respiratory reinfection occurs despite previous exposure and demonstrable immunological memory: 2) humans or rodents previously immunised against virus infection can show enhanced disease during reinfection. others have shown that passive transfer of antiviral antibody either protects against virus infection or has no effect, and there is no evidence of antibody enhancement of disease in vivo. by contrast, t cell immunity appears closely associated with disease augmentation. we have focused on examining the immunological mechanisms of disease enhancement in mice. initial studies showed that transfer of cd8+ cytotoxic t lymphocytes (ctl) causes rapid virus clearance from the lungs of rs virusinfected mice, but also increased disease severity with alveolar haemorrhage and polymorphonuclear (pmn) cell recruitment to the lung. this disease (reminiscent of shock lung) could sometimes be fatal, whereas normal mice recover well from similar doses of rs virus. next, we compared the effects of cd4' and cd8+ t cells, using polyclonal t cells separated immunomagnetically from mixed lines grown in vitro with viral antigen. cd4' t cells were more pathogenic than cd8+ t cells in a dose-for-dose comparison, but that the type of pathology varied depending on the type of cell injected. while testing recombinant vaccinia viruses expressing single rs viral proteins for their ability to protect mice against infection, we observed that animals sensitised t o the major surface glycoprotein g (attachment protein) developed lung eosinophilia after challenge with rs virus intranasally. t cell lines from the spleens of mice sensitised with various recombinant vaccinia viruses were established. those form mice primed with the m 2 (22k) protein were predominantly cd8' ctl, and that produced few cytokines. those from mice primed with fusion protein (f) generated mixed t cell lines with both t h l cd4+ t cells, and ctl. mice primed to g protein gave rise to predominantly cd4' t cells producing th2 cytokines. ln vivo transfer of these cell lines into na'ive rsv infected mice reproduces the patterns of disease seen in mice sensitised in vivo with the respective antigens. the mouse model of rs virus disease therefore has excellent potential for illustrating mechanisms of lung immunopathology. the eye is a complex organ whose function is to transmit light images through different cell and tissue layers and liquid media to a neurosensory retina. elements as could occur when invading pathogens arrive and an inflammatory response with its swelling, plasma protein extravasation, leukocyte infiltration and tissue damage results. inflammatory responses when possible and rely on immune defenses which do not involve tissue distortion and damage. restricting tissue damaging responses is not always effective and the process is best developed in response to agents delivered to locations such as the anterior chamber. where an inflammatory response is initiated which may result in ocular impairment. such herpetic stromal keratitis (hsk) is a common cause of blindness in man. animal model studies indicate that hsk is a multi-step process initiated by virus in an avascular structure. hsk fails to occur in the absence of t cells or replicating virus. disappears several days before a visible inflammatory response becomes evident. evidence will be presented that the secondary agonists which drive the inflammatory response may not be viral antigen(s) per s e . multiple cell types are involved in hsk, with the respective role of functional sets of lymphocytes changing according to the clinical phase of the disease. in addition, nonspecific inflammatory cells such as neutrophils and nk cells also influence the severity of lesions. basically the reaction begins with t cells that produce type one cytokines, particularly ifn-y, dominating the scene, but during remission type 2 cytokines, notably il-10, appear as mechanistically involved. from the use of knockout mice for various immunological parameters, evidence will be presented that numerous mechanisms of pathogenesis may be at play during hsk. damage to corneal tissues in all systems appear to involve tnfo. a second ocular damaging event in which immunopathology is at least partially involved is herpetic retinal necrosis. evidence that this disease may involve the immunopathological role of cd4 t cells and protective effects by cd8' t cells will be presented, as will be suggestions by which the pathological events are mediated at the molecular level. thus it is in the eye's functional interest to limit acute viral infections and live vaccines often confer long-term immunity the nature of t and b cell memory is different. b cell memory is manifested not only by the presence of memory b cells but also by continuous antibody production in contrast, the effector phase of the t cell response i s shortlived and long-term t cell memory is due to the presence of 'quiescent' antigen specific memory t cells that are present at higher frequencies and are able to respond faster upon re-exposure to virus due to increased levels of adhesion molecules in this talk i w i l l present our results on. (i) the bone marrow as a major site of long-term antibody production after acute viral infection, (ii) the role of c d 4 ' t cells and b cells (immune complexes) in maintaining cd8+ t cell memory, (iii) the role offas antigen in regulating t cell responses, and (iv) the efficacy ofvarious antigen delivery systems in inducing long-term t cell memory sendai virus is a natural respiratory viral pathogen of mice. intranasal infection of mice with the virus provokes a virus specific antibody-forming-cell reaction that exhibits a distinct kinetic pattern in the lymph nodes that drain the respiratory tract, in the spleen, and in the bone marrow. the bone marrow afc population is extremely long-sustained, and supports an active humoral response that essentially persists for the lifetime of the infected animal. thus the conventional categories of "primary" and "secondary" response may not apply to the humoral response of mice naturally exposed to respiratory viruses. paradoxically, the population of b cells that reacts most rapidly to sendai virus infection does not itself secrete antibody, but can he demonstrated by the recovery of hyhridomas that secrete "polyspecific" antibodies. the activation of this polyspecific b cell population is, like the humoral response, extremely persistant. viral infection thus sets in train multiple b cell "memory" processes. variation in the rules of development and turnover of different b cell populations constrains the mechanisms that may operate to generate these different forms of memory. establishment and maintenance of t cell memory to respiratory viruses, peter c. doherty, sam hou, christine ewing, david topham, anthony mcmickle, james houston, and ralph tripp, department of immunology, st. jude children's research hospital, memphis, tn 38105. the analysis of the development and memory phases of the cd4+ "helper" n h ) and cd8+ cytotoxic t lymphocyte (ctl) responses to the respiratory pathogens, influenza virus and sendai virus (parainfluenza type 1) have been characterized by a combination of limiting dilution analysis (lda) for determining th and ctl precursor @) frequency and facs separation of lymphocytes with different activation phenotypes. the interpretation at this stage, largely based on the analysis of the ctl response, is that the development phase of t cell memory and the primary response are synonymous. virus-specific ctlp are produced in considerable excess of the numbers required to provide the effector ctl that terminate the primary infection, with only a fairly small proportion localizing to the target organ (the lung) that supports virus growth. even when many of the proliferating ctlp are killed by administration of a small dose (20 mgkg) of the dna-targeted drug cyclophosphamide (cy), there is no indication of immune exhaustion. the cd4+ th response has, at this stage, not been analyzed through the course of the primary infection. use of the lda approach to determine thp frequencies is inherently more difficult, as the "read-out'' is lymphokine production and there is considerable "bystander" activation in these primary responses to respiratory viruses. memory thp and ctlp are characterized initially by the expression of an "activated" phenotype: cd44-high, l-selectin-low, cd49d (vla-4) high. after some months, an increasing proportion of the memory t cells revert to the l-selectin-high cd49d-low form typical of naive ctlp. the change, which is never absolute, seems to occur first with cd49d and the rate varies for different viruses. current experiments are addressing the possibility that intercurrent infection, particularly with the mouse y-herpesvirus 68 which causes persistent infection of lymphoid tissue, may be inducing a switch back to the activated pattern, as a consequence of "bystander" effects, or "low affmity" stimulation via the clonotypic tcr in responding lymphoid tissue. the question of such cross-reactivity and/or exposure to "high lymphokine" environments for the long-term maintenance of memory is also being addressed. to study the factors which regulate the generation and persistence of specific t cell memory we have used model systems utilizing t cell receptor transgenic mice as a source of enriched naive cells which can be either cultured in vitro to generate effector populations or restimulated in adoptive hosts. in either case one can visualize the development of an expanded effector population. we have documented that the proliferation and il-2 production of the naive t cells depends on their activation by apc expressing high levels of co-stimulatory molecules. we find that b7.1 and icam-i as costimulators strongly synergize and that increased t cell receptor triggering can both increase the magnitude of the response and decrease its dependence on costimulation. when cytokines il-4 vs il-i2/ifny are present at the initiation of the response of either cd8 or cd4 cells they dictate that the effectors generated will be polarized either towards il-4 and il-5 secretion or il-2 and ifny secretion, respectively. the fate of the effector population generated and followed in vitro, also is tightly regulated by ag, cytokines and probably by costimulation. cd4 effector cells not re-exposed to ag, produce no cytokines and they die within 3-4 days. effectors restimulated with ag make massive amounts of cytokines, regardless of the presence of cytokines, at low densities of ag and with little dependence on costimulation. when there is little il-2 produced and no cytokines added, effectors die rapidly by apoptosis. however the combination of il-2 and tgfp block apoptosis and support expansion of the effector population which is greatly enhanced by periodic ag stimulation. some conditions favor the reversion of effector-like cells to a more resting memory phenotype and these are being further explored. we have also examined the development and maintenance of memory after transfer of effector cells to adoptive hosts. long-lived polarized memory populations are generated from the polarized effectors and these persist for prolonged period in the absence of apparent ag stimulation. this supports the idea that factors other than antigenic stimulation, present in situ can support the expansion and maintenance of memory cells. the rabies glycoprotein (g) is the only external protein of the virion and is therefore responsible for any interaction that rabies makes with the host cell during the first steps of the virus cycle. the g protein is also the target of neutralizing antibodies. there are around 450 trimers of g at the virion surface which constitute the spikes visible by electron microscopy. upon exposure to slightly acidic ph, the glycoprotein undergoes a conformational change which results in ion er and less regular spikes. strikingly and quite differently from influenza hemagglutinin, this conformational change is reversible: if the p d is risen back to 7.0, the s ikes re ain their neutral configuration (1). probably as a consequence, the viral infectivity is totally preserved after an exposure of 2 hours at p 8 6.4 an cf 37t, which induces the conformational change, followed by an incubation at neutral ph. since the conformational change is reversible, there is a ph-dependant equilibrium between the native and the low-ph conformation: the higher the ph, the more spikes are in their native configuration. two main antigenic sites and several minor sites have been identified on the native rabies glycoprotein (2). specific amino acids belonging to each of the two major antigenic sites are important or essential for viral virulence. for instance a lysine in position 198, which is part of antigenic site 11, is important, although not essential, for the viral virulence. similarly, the arginine 333, which belongs to antigenic site 111, is essential for pathogenicity while dispensable for multiplication in cell culture (reviewed in 3). viral strains mutated at arginine 333 have lost the capability to penetrate certain categories of neurons, suggesting that this mutation affected the recognition of specific receptors or subsequent interactions necessaly for the penetration of the virus at nerve terminals. therefore the two main antigenic sites are regions of the glycoprotein which also interact specifically with neurons in the animals. we have found that neutralization requires the fixation of at least one or two igg for every three spikes, irrelevant of the anti enic site recognized by the antibody (4). most neutralizing antibodies recognize conformational epitopes which are accessible on the native configuration of the protein. some epitopes remain accessible also on the acidic configuration while others are not. in addition, a minority of antibodies recognize epitopes which are only accessible on the acidic conformation. this is not unlikely in view that each spike has a certain probability to undergo a conformational change, even at neutral ph. in consequence the surface of the virus probably fluctuates and g epitopes which are not accessible on the native glycoprotein could be transiently exposed. conformational flexibility at neutral ph and physiological temperatures has also been observed for poliovirus (5). structural flexibility of external proteins could have important implications in virus-host interactions. katpus, norlhwestern university medical school, chicago, il 6061 1 theiler's murine encephalomyelitis viruses (tmev) are endemic enteric pathogens of wild and colony-reared mice. lntracerebral inoculation of susceptible mouse strains leads to a chronic, progressive inflammatory demyelinating disease of the central nervous system (cns) characterized clinically by an abnormal gait, progressive spastic hind limb paralysis and urinary incontinence, and histologically by parenchymal and perivascular mononuclear cell infiltration and demyelination of cns white matter tracts. demyelination is related to persistent cns viral infection. due to the similarity in clinical and histological presentation, tmev-induced demyelination is considered to be a highly relevant model of multiple sclerosis (ms). our current interests are in determining the phenotype, fine specificity, lymphokine profile and tcr usage of cns-infiltrating cells involved in the effector stages of tmev-induced demyelination. based on a variety of experimental evidence, it is clear that demyelination induced in sjuj mice by infection with the bean strain of tmev is a thl-mediated event: (a) disease induction is suppressed in t cell-deprived mice and by in vivo treatment with anti-i-a and anti-cd4 antibodies; (b) disease susceptibility correlates temporally with the development of tmev-specific, mhc-class il-restricted dth responses and with a predominance of anti-viral lgg2a antibody; (c) activated (le., ll-2rc) t cells infiltrating the cns are exclusively of the cd4+ phenotype, and (d) proinflammatory cytokines (ifnq and tnf-p) are predominantly produced in the cns. we have mapped the predominant thl epitope on the virion to amino acids 74-86 of the vp2 capsid protein. a thl line specific for vp274-86 exacerbates the onset of demyelination in recipient mice infected with a suboptimal dose of tmev. tmev-infected sjuj mice fail to exhibit peripheral dth and t cell proliferative responses to the major myelin proteins, mbp and plp, and pre-tolerization with neuroantigens has no affect on the incidence or severity of tmev-induced demyelinating disease, whereas neuroantigen-specific tolerance prevents the induction of relapsing experimental autoimmune encephalomyelitis (eae). in contrast, tolerance induced with intact tmev virions specifically anergizes virus-specific thl responses and results in a dramatic reduction of the incidence and severity of clinical disease and cns dernyelination in sjuj mice subsequently infected with tmev. these results have important implications for a possible viral trigger in ms as they indicate that chronic demyelination in tmev-infected mice is initiated in the absence of demonstrable neuroantigen-specific autoimmune responses and are consistent with a model wherein early myelin damage is mediated via primarily by mononuclear phagocytes recruited to the cns and activated by pro-inflammatory cytokines produced by tmev-specific thl cells. the concept that prions m novel pathogens which are different fium both viroids and viruses has received increasing support from many avenues of investigation over the past decade. enriching fractions from syrian hamster (sha) brain for scrap= prion infectivity led to the discovery of the prion protein 0. prion diseases of animals include scrapie and mad cow disease; those of humans present as inherited, sporadic and w o r n neurodegenemive disorders. the inhecited human pion diseases m genetically linked to mutatim in the prp gene that result in non-conswative amino acid substitutions. transgenic v g ) mice expressing both sha and m o w @lo) prp genes were used to demonstrate that the "specie9 bank?' for -pie prions resides in the primary structure of pip. this concept was strengthened by the results of studies with mice expressing chimeric mdsha transgenes &om which "artificial" prions have been synthesized. similar chimeric mdhuman (hu) rp transgenes were constructed which differ from m o w by 9 amino acids between residues 96 and 167. au of the tg(mhu2m) mice developed neurologic drsease -200 days after inmulation with brain homogenates from three patients who died of creutzfeldt-jakob disease (cjd). inoculation of tg(mhu2m) mice with cjd prims produced mhu2mprpsc, inoculation with mo prions produced moprw. ihe patterns of meluzmprpc and mom% accumulation in the brains of tg(mhu2m) mice wen differenl about 10% of tg(huprp) mice expressing huf" and non-tg mice developed neurologic diseane >500 days after inoculation with cn, prions. the different susce@uies of tg(hw) and tg(mhu2m) mice to human prions indiate that additional species specific factors such as chaperone proteins are involved in prion replicaton. diagnosis, prevention and treament of human @on diseases should be faciliated by tg(mhu2m) mice. in other sindies, tg mice were compared expressing wt and mutant moprp. overexpression of the wtmoprp-a aansgene -8-fold was not deleterious to themiw but it did shorten scrapie incubation times from -145 d to -45 d after inoculation with murine m p i e pnons. in contrast, overexpression at the same level of l morp-a transgene mutated at codon 101 (corresponding to codon 102 in hurp) pmdnced spontaneous, fatal neurcdegeneration between 150 and 300 d of age in two lines of tg(mohp-pio1l) mice designated 2866 and 2247. genetic crosses of tg(moprp-p101l)2866 mice with gene targeted mice lacking both rp alleles ( p m -p ) produced anhats with a highly synchronous onset of illness between 150 and 160 days of age. the t g~o p r p -p l o l l ) 2 8 6~~ mice had numerous prp plaques and widespread spongiform degeneration in contrast 10 the tg2866 and 2247 mice that exhibited spongifonn degeneration but only a few prp amyloid plaques. another line of mice designated tg2862 overexpress the mutant transgene -32-fold and develop fatal neurodegeneration behveen 200 and 400 d of age. tg2862 mice exhibited the most severe spongiform degeneration and had numerous, large pip amyloid plaques. while mutant moprpccploll) clearly produces neurodegeneration, wtmoprpc profoundly modifies both the age of onset of illness md the mumpathology for a given level of transgene expression. our tidigs and those from other smdies suggest that mutant and wtprp interact, phaps through achaperone-like protein as noted above in sndies of tg(mhu2m) mice, to modify the pathogenesis of the dominantly inhe&ed prion diseases. anton, heidi t. link, and jonathan w. yewdell, laboratory of viral diseases, niaid, bethesda, md 20892-0440. cd8' lymphocytes (tcd8+) play an important role in host immunity to viruses and other intracellular parasites. virus-specific tcdi+ recognize mhc class i molecules in association with peptides of 8 to 10 residues derived from viral proteins. this presentation will focus on how and where antigenic peptides are generated by cells. to begin to characterize the nature of proteases involved in the generation of antigenic peptides from cytosolic proteins, we used a panel of recombinant vaccinia viruses expressing different forms of influenza virus nucleoprotein (np). we found that the efficiency of generation of two np peptides is related to the metabolic stability of the source gene product. there has been considerable speculation that such short lived proteins are degraded by proteasomes in a ubiquitin-targeted process. our observations, however, call into question the importance of ubiquitin targeted-proteolysis in generating antigenic peptides from exogenously provided or endogenously synthesized viral proteins. we also examined the extent to which antigenic peptides can be generated in the endoplasmic reticulum (er). we found that antigenic peptides could be produced from short precursors (17 residues) hut not from a number of full length proteins (influenza virus hemagglutinin, np, ovalbumin) that are targeted to the er by a nh2-terminal signal sequence. peptides were generated much more efficiently from the cooh-terminus of the 17 residue precursor than from the nh2-terminus. these findings indicate that the er has a much more limited capacity than the cytosol to generate antigenic peptides, but that er proteases (particularly aminopeptidases) could perform the final proteolytic steps in the generation of class i binding peptides from precursors imported from the cytosol by tap, the mhc encoded peptide transporter. potential advantages of synthetic peptide or engineered recombinant vaccines are that they can be limited to contain only the specific antigenic determinants for desired responses without other determinants that elicit unwanted responses, and that the sequences of the determinants themselves can be modified to enhance potency or breadth of crossreactivity. however, they can have the disadvantage that any single determinant may be presented by only a limited selection of major histocompatibility complex (mhc) molecules of the species. to overcome the problem of mhc polymorphism, we have identified determinants presented by multiple mhc molecules, and have also located multideterminant regions of the hiv-1 envelope protein that contain overlapping determinants each presented by different class i1 mhc molecules, so that the whole multideterminant region is presented by multiple mhc molecules of both mouse and human. we have made use of "cluster peptides" spanning these multideterminant regions of the hiv-1 envelope to provide help for neutralizing antibody (ab) and cd8+ cytotoxic t lymphocyte (ctl) responses to peptides attached to these helper regions. these synthetic peptide vaccine constructs containing the p18 peptide from the v3 loop of hiv-1 iiib or mn, elicited both neutralizing ab and ctl in multiple strains of mice. the cluster peptides inducing helper t cells were essential for elicitation of ab and ctl to the p18 segment of both iiib and mn strains of hiv-1 in mice of several mhc haplotypes. several adjuvants were compared for their ability to elicit both ctl and ab simultaneously, without one response inhibiting the other. a single formulation in incomplete freund's adjuvant (ifa) could elicit all 3 responses, neutralizing ab, ctl, and th1 helper cells. the ctl specific for the mn strain p18 peptide crossreacted with strains sc, sf2,2321, and cdc4. the peptides in f a also elicit high titers of antibodies in rabbits. boosting was found to enhance ctl responses as well as ab responses. these constructs are being prepared for a human immunotherapy trial. these vaccine constructs are potent and also avoid sites on gp160 that are known to elicit enhancing antibodies or autoimmune responses that might conmbute to disease pathogenesis. however, we can potentially improve on these by tinkering with the internal structure of the individual epitopes. we have found that replacing a negatively charged glutamic acid residue with an uncharged amino acid in one of the helper determinants makes it 10 to 100-fold more potent in binding to the class i1 mhc molecule and in eliciting murine helper t cells that still recognize the natural hiv-1 sequence. thus, such a modified peptide should be more potent as a vaccine, while retaining the ability to elicit t cells that will respond to hiv proteins that of course do not have the altered sequence. we are currently mapping the critical residues for presentation of one of these peptides by human hla-a2, with the intent of developing modified peptides that will be more potent as components of a human vaccine. thus, by leaming how these peptides bind to mhc molecules and tcell receptors, we can design internally modified determinants to construct more potent or more crossreactive second generation vaccines. we are testing these vaccine approaches in a mouse model in which mice can be protected against tumor cells expressing hiv proteins as would an hivinfected cell. dna vaccines, comprised of non-replicating plasmids encoding viral proteins, are capable of generating protective immunity in animal models of several viral diseases. in preclinical models of influenza infection, reduced viral shedding was observed in dna-vaccinated ferrets after challenge with the human clinical virus strain, a/georgia/93. cross-strain protection was conferred by dna encoding the major internal proteins (nucleoprotein, np, and matrix, m1) and the surface protein haemagglutinin (ha) from the antigenically-distinct previous virus strains, a/beijing/89 and a/hawaii/91. this protective efficacy was greater than that seen by immunization with the widely-used clinical vaccine composed of killed a/beijing/89 virus. thus, compared to a killed virus vaccine, protection seen with the dna vacane against a drifted virus strain was greater. we previously demonstrated that immunization of mice with np dna generated mhc class i-restricted cytotoxic t lymphocytes. mice likewise were protected from death and morbidity following cross-strain challenge'. ha dna vaccines generated neutralizing antibodies in mice, ferrets and primates, and provided protection in m i d and ferret models of influenza. in animal models of other viral diseases, immune responses and protection against viral challenge have been seen after immunization with dna encoding viral proteins. dna encoding hiv gp120 generated ctl and neutralizing antibodies in monkeys. antigen-specific proliferative responses and, in mice, secretion of high levels of yifn relative to levels of il-4, months after immunization were also observed . immunization of rabbits with dna encoding l1, the major viral capsid protein of cotton tail rabbit papilloma virus (crpv), resulted in neutralizing antibodies and protected against the development of warts after inoculation with crpv. mice immunized with dna encoding the glycoprotein gd from herpes simplex virus type 2 (hsv-2), developed neutralizing antibodies and were protected from death when subsequently challenged with hsv-2. dna vaccines were protective in animal models of various viral diseases. neutralizing antibodies, helper t cells (thl) and cytotoxic t cells were generated. cross-strain protection due to cellular immunity was demonstrated. ' science, 1993 2593745-1749 , 2dna cell biol, 1993 the profile of a neurovirulent virus is determined by its mechanism of entry into the cns (neuroinvasion), the type of cns cell in which it replicates (neurotropism) and its ability to cause pathologic effects in the brain (neurovimlence). whereas neuroectodermal cells, especially neurons, are the target cells of most neurovirulent viruses, the main target cell in the brain for siv and other lentiviruses is the macrophage. infection in, expression of viral antigens by and products of siv replication exported from these cells result in inflammation and degenerative changes in the brain and concomitant loss of neurons. siv strains that are mainly t-cell tropic cause transient activation of t-cells and during this period, infected t-cells cross the blood brain barrier and localize in the brain causing persistent hut minimally productive infection and minimal neuro pathologic effects. viral proteins but not virions are produced continuously. by virtue of the tropism of the virus for cd4 t cells, many infected animals eventually become immunosuppressed and develop aids, but not classical ueurological disease. viruses which are macrophage tropic invade the brain presumably also in t lymphocytes and the viruses infect macrophages in the brain. however, productive virus replication is minimized by antiviral cd8 t cells which suppress (kill?) all virus producing cells throughout the body, including the cns. productive virus replication in brain macrophages and accompanying inflammatory changes develop only when cd8 cells fail i.e. after profound immunosuppression sets in. the neurological disease that results from productive virus replication in macrophages in the brain therefore depends on presence of an appropriate macrophage-tropic viral phenotype invading the neuropil and development of immunosuppression in the host. the neurological disease could therefore be defined as one of the aids syndromes. the adenovirus (ad) early transcription region (e3) codes for more than 7 polypeptides, four of which have already been shown to alter the immune response to ad infection. the amount of the class i major histocompatibility complex (mhc) on the plasma membrane can be reduced by the binding of the ad e3 gpl9k protein to the mhc heavy chain, which prevents transport of the complex out of the endoplasmic reticulum. this process interferes with presentation of viral peptides to cytotoxic t lymphocytes. cytolysis by tumor necrosis factor-o (tnf) is inhibited by 4 distinct viral polypeptides, 3 of which (the ad e3 14.7k or the complex of the 10.4k and 14.5k proteins) are coded in the e3 region. the e3 polypeptides are translated from a family of viral mrnas, that are synthesized from a single viral promoter and processed by alternative splicing. we have studied the functions of the e3 polypeptides in several murine models. the goals of these experiments were to determine the effects of the ad e3 polypeptides in acute and persistent viral infections as well as in a transplantation model designed to measure whether these viral immunoregulatory proteins would abrogate allogeneic graft rejection. in a vaccinia virus (v.v.) pneumonia model, in which the isolated ad e3 14.7k or ad e3 gpl9k genes were inserted into the v.v. pathogen, the ad anti tnf polypeptide increased viral virulence but the ad anti mhc had no effects. in addition to manipulating the ad e3 genes in viral constructs, several transgenic mouse lines containing the ad e3 genes have been constructed for these experiments. the e3 genomic dna behind the rat insulin promoter (rip) has been used to generate transgenic animals. islets from rip-e3 transgenic animals (h-2b'd) have been transplanted allogeneically to h-2d recipients and remained viable, secreting insulin until the end of the experiment at 94 days; in contrast, control nontransgenic islets of the same genotype were rejected by 21-28 days. the e3 genes behind the native e3 promoter have been inserted into mouse embryos to generate transgenic animals, and the expression of the transgene monitored in multiple organs. the e3 promoter of the transgene is responsive to stimulation by the ad e1a following infection with an e3 minus ad 7001 and can also be upregulated by administration of bacterial lipopolysaccharide. the effects of this transgene on ad pathogenesis are currently being studied. thus, these viral immunoregulatory genes have been shown to alter viral pathogenicity during acute infection and to downregulate the host immune response sufficiently to permit islet cell transplantation. these results on manipulating the ad e3 genes for the control of the host immune response also have implications for designing adenovirus vectors for gene therapy. "emerging" infections can be defined as infectious diseases that either have newly appeared in the population, or that are rapidly increasing their incidence or expanding their geographic range. recent viral examples include aids, ebola, and hantavirus pulmonary syndrome (fnst identified in a 1993 outbreak in the southwestern u.s.). emerging viral infections show a number of common features. most "new" viruses derive from existing viruses that move into new areas or acquire new hosts ("viral traffic"). many are zoonotic (originating from animal sources) (even pandemic influenza appears usually to be a reassortant originating in wildfowl). ecological or environmental changes (either natural, or, often, man-made) may precipitate emergence of new diseases by placing people in contact with a previously unfamiliar zoonotic reservoir or by increasing the density of a mtud host or vector of a pathogen, increasing the chances of human exposure. upon introduction into a human population from a zoonotic reservoir, the newly introduced virus may cause localized outbreaks of disease. some may show rapid variation and evolution upon introduction, and some evidence suggests a role for immune selection in this process. a few viruses (such as hiv) may succeed in establishing themselves and disseminating in the human population, becoming truly "human" infections. human activities can also play an important role in establishment and dissemination. migrations from rural areas to cities, now an accelerating worldwide phenomenon, or other displacements, can introduce remote viruses to a larger population; the virus may then spread along highways and (globally) by air travel. the development of an effective system of surveillance and rapid response is essential, but resources for this are presently inadequate. vaccine development, production, and deployment problems also need to be addressed. immunopathology may be a key feature of many of these infections, a number of which manifest as hemorrhagic fevers. many of the life threatening complications are due to increased vascular permeability. the resemblances to septic shock suggest that cytokines (such as tnf) are likely to be important in the pathogenesis of these infections. the response of cells, such as the macrophage, that induce or synthesize key cytokines, may be an important element, and the ability to infect these cells may be one common denominator. why some viruses elicit this response, while other closely related viruses do not, cannot yet be predicted from molecular data. better understanding of these aspects of the immune response should lead to additional therapeutic strategies. (supported by nih grant roi rr03121.) genetic approaches have been used to detect and characterize numerous previously unidentified hantaviruses. puumalarrospect hilvsin nombre-like viruses or virus variants are present throughout north and south america, europe and russia. several of the american viruses identified are associated with the newly recognized hantavirus pulmonary syndrome (hps), a severe respiratory illness with high mortality. the genetic relationships of these and previously characterized hantaviruses have been studied by phylogenetic analysis of the nucleotide sequence differences located in pcr bgments amplified from the g2 encoding region of the virus m segments. the relationships observed are consistent with a long-term association of viruses with their primary rodent reservoirs and suggestive of coevolution of host and virus. a sin nombre virus isolate is now available and its genetic characterization has been completed. various virus antigens have been expressed and are being used to probe the interaction of the virus with the host immune system. hantaviruses cause significant morbidity and mortality throughout the world. more than 200,000 cases of hemorrhagic fever with renal syndrome (hfrs) are reported annually in asia, europe and scandinavia. the etiologic agents of hfrs are hantaan, seoul and puumala viruses, with hantaan virus causing the most severe form of the disease. in 1993, a new hantavirus was discovered in the united states (initially termed four comers virus), and was identified as the etiologic agent of hantavirus pulmonary syndrome (hi's). vaccines for hantaviruses are not readily available, although a number of inactivated viral preparations have been made and tested in asia. recurrent problems with inactivated hantaviral vaccines have been lot to lot variability, the need for repeated immunizations, and their inability to elicit long-lasting neutralizing antibody responses in immunized volunteers. because of such limitations on traditional vaccine development for these viruses, as well as the viruses' hazardous nature and slow, low-titer replication in cell culture, we used a recombinant dna approach to develop a vaccine for i-ifrs. our vaccine is a recombinant vaccinia virus expressing the m segment of hantaan virus under control of the vaccinia virus 7.5 k promoter and the s segment under control of the 11 k promoter. the m segment, which encodes the g1 and g2 envelope proteins, was included because of our findings that: (1) immunization with vaccinia or baculovirus-expressed g1 and g2 induced a neutralizing and protective immune response in hamsters; and, (2) neutralizing antibodies to g1 or g2 could passively protect hamsters from challenge with virulent virus. the s segment, which encodes the nucleocapsid protein (n), was included because of our finding that hamsters immunized with baculovirus-expressed n also were protected from subsequent infection. although the protective immune response to n is probably cell-mediated, the importance of such a response is presently not well defined. assessment of our vaccine in preclinical studies, indicated that immunized hamsters developed neutralizing antibodies and were protected from displaying viral antigen in their lungs after challenge. in a phase i, dose escalation, clinical study, the vaccine induced neutralizing antibodies in individuals immunized subcutaneously with approximately lo7 pfu of the recombinant virus. in addition to humoral responses, immunized volunteers developed a cell-mediated immune response as indicated in lymphocyte proliferation assays. larger clinical studies, including alternate routes or booster immunizations, are planned. based on these studies, we anticipate that the vaccine will be efficacious for preventing hfrs caused by hantaan and the antigenically closely related seoul virus. we are studying the cross-protective properties of this vaccine with more distantly related hantaviruses such as puumala virus. although we expect this vaccine to be safe as well as effective, we also are investigating the use of more attenuated pox-viruses as vaccine vectors. infection of mice with lymphocytic choriomenigitis virus (lcmv) results in a profound expansion in the number of spleen cd8 t cells and in the induction of virus-specific ctl activity. thereafter, the cd8 t cell number declines, and the ctl activity diminishes, though the frequency of lcmvspecific precursor ctl per cd8 cell, as assessed by limiting dilution assays (lda), is remarkably stable throughout long-term immunity. the decline in t cell and total spleen leukocyte number at the late stages of acute infection is associated with high levels of apoptosis, as detected by the in situ nucleotidyl transferase assay. apoptosis occurred in both the t cell and b cell populations, with the b cells dying in clusters. this apoptosis was also seen in tfansgenic mice ectopically expressing bcl-2 in the t and b cells and in c57bl/6 ipr/@r mice, which have a mutation in the fas gene. t cells from the infected animal underwent apoptosis in vitro when stimulated through the tcr with anti-cd3, thereby explaining some of the immunosuppression seen during acute viral infections. memory cells persisted for over a year and could be found in blast-size cell populations. challenge of lcmv-immune mice with either pichinde virus, vaccinia virus, or murine cytomegalovirus led to the reactivation of the lcmv-specific ctl response. lda analyses showed unexpectedly that these heterologous viruses crossreacted with subpopulations of lcmv-specific memory t cells. this memory t cell response to virus from an earlier infection was associated with enhanced immunopathology and enhanced clearance of virus during a heterologous virus challenge. over the course of the acute infection, ctl specific for the second virus were preferentially expanded over the crossreactive ctl, and after the acute infection, when the t cell response had subsided, ctl memory to the first infection had decreased. there is therefore a network of memory t cells which contribute to and are modulated by infections with putatively unrelated viruses, and apoptosis plays a homeostatic role in the course of these t cell responses. immune responses to live attenuated retroviral vaccines, r. paul johnson*?, cara wilsont, kelledy mansons, michael wyands, bruce walker?, ronald c. desrosiers* *new england regional primate research center, southborough, ma 01772 thfectious disease unit, massachusetts general hospital, boston, ma 021 14 â§tsi/mason, worcester, ma immunization of rhesus macaques with live attenuated retroviruses deleted in nef can induce protective immunity against challenge with pathogenic siv. development of protective immunity in these vaccinated animals occurs only after several months of infection, with maximal protection observed after one year. the specific immune responses responsible for mediating protection have not been defined, and little is known about the cellular immune responses in animals vaccinated with these live attenuated retroviruses. we have analyzed cellular and humoral immune responses in rhesus macaques and chimpanzees infected with live attenuated retroviruses. siv-specific neutralizing antibodies were present in vaccinated animals, but did not clearly correlate with protection against challenge. ctl specific for envelope and gag were identified in vaccinated macaques studied 12 or more months after vaccination. quantitation of siv-specific ctl activity in one of these animals using limiting dilution analysis revealed a relatively high precursor frequency of cytotoxic t lymphocytes, up to moo0 for gag and 1/8500 for envelope. cd8+ lymphocytes obtained from vaccinated macaques were also able to suppress siv replication in autologous cd4+ cells. suppression mediated by unstimulated cd8 autologous cells was maximal when cells were in direct contact with siv-infected lymphocytes, but cd8+ cells activated by an anti-cd3-specific monoclonal antibody were able to release. a potent soluble inhibitor of siv replication. in contrast to the relatively vigorous ctl response present in vaccinated macaques, we were not able to detect consistent ctl activity in chimpanzees infected with a hiv-1 molecular clone (nl43) or attenuated viruses at periods up to one year after infection, despite the use of a variety of stimulation techniques. proliferative responses to hiv p24 and gp160 were observed in chimpanzees infected with n u 3 and attenuated variants. although the relative contribution of these immune responses to protective immunity is not known, the relative vigor of the cellular immune responses observed in vaccinated macaques suggest they may play a role in mediating resistance to challenge. obiectives: to analyze the magnitude and specificity of the ctl response to hiv-1, and to determine the tcr usage by clonal ctl responses in infected persons, including persons with documented infection of up to 15 years with cd4 cells > 500/mm3. methods: hiv-l-specific ctl activity was evaluated in pbmc as well as in pbmc stimulated in vitro with hn-1 infected autologous cd4 cells, using target cells infected with recombinant vaccinia viruses expressing hn-1 proteins. ctl epitopes recognized by these individuals were determined using cloned effector cells. quantitative cultures were performed by endpoint dilution, and viral quantitation was determined by qc-pcr tcr analysis was performed by pcr, using both family-specific primers and anchored pcr, followed by sequencing. sequence analysis of ctl epitopes in autologous viruses was determined by pcr amplification and sequencing. clonal frequency was analyzed in pbmc by oligonucleotide probe to the cdr3 region of the tcr. studies performed in long-term non-progressing persons indicate the presence of a vigorous and broadly directed ctl response. detailed epitope mapping in a person infected for 15 years, who by qc-pcr had i00 ngld induce profound immunotoxicities characterized as almost complete inhibition of virus-induced cd8+ t cell expansion and ctl activation, and up to 2 log increases in viral replication [orange, wolf, and biron, j. immunol. 152:1253, 19941 . serum tumor necrosis factor (tnf) is also observed under these conditions. the studies reported here further characterize the expression and function of tnf in this context. northern blot and in sifu hybridization analyses demonstrated that il-12 induced tnf-cx expression and that lcmv infection synergized with il-12 for this induction. administration of antibodies neutralizing tnf reversed the il-12-induced immunotoxicities in lcmv-infected mice and restored anti-viral defenses. the tnf-mediated immunotoxicities appeared to result from an induced cellular sensitivity to the factor, as splenic leukocytes and cd8+ t cells isolated from lcmv-infected mice were more sensitive to tnfmediated cytotoxicity in culture than were equivalent populations prepared from uninfected mice. additional physiological changes were observed in il-12-treated uninfected mice and were dramatically elevated in il-12-treated virus-infected mice, including: 1) decreases in body weights; 2) elevation of circulating glucocorticoid levels: and 3) decreases in thymic mass. these changes were also reversed by anti-tnf. the results delineate a unique tnf-mediated immunotoxicity and have significant implications concerning detrimental consequences of in vivo tnf andlor il-12 for protective anti-viral responses. lactate dehydrogenase-elevating virus (ldv), a naturally occurring virus, causes a persistent infection in mice and presents an ideal model for the study of immune modulation during acute and persistent virus infections. within a few days following infection with ldv there is a pronounced polyclonal activation of b cells followed by the suppression of primary b cell responses to t-dependent ag. we investigated the effect of acute and persistent ldv infection on the development of a memory b cell response to the model protein antigen, horse cytochrome c (cyt), by employing a modification of the splenic fragment assay. about a 50% decrease in the frequency of responding agspecific memory b cells was observed in balb/c mice infected with ldv, whether the mice were immunized with cyt at the time of ldv infection or three weeks later. this may be due in part to a defect in t cell help, since in cultures of normal memory b cells and t cells derived from ldv acutelyinfected mice the frequency of responding b cells was also decreased two-fold. in situ hybridization using a cdna probe specific for ldv revealed two patterns of ldv rna within the spleen. twenty-four hr p.i. ldv rna was located within the marginal zone, surrounding each follicle. this pattern is consistent with permissive macrophages. during persistence viral rna could no longer be detected in the marginal zone, but was located within the follicles. the absence of ldv-permissive cells within the follicular region suggests that the source of ldv rna is not due to ongoing viral replication. one possibility is that circulating virus is trapped by a specific cell population within the follicle. the effect of virus trapping within the spleen provides a mechanism by which ldv and other viruses can modulate immune cell function during persistent infections. ifn-y can be produced by activated nk cells. this cytokine enhances immune responses by augmenting macrophage antigen presentation. viral infection induces ifn-dp and nk cell activation. changes in splenic architecture, cell trafficking, and cytokine expression were examined during viral infections of c57bu6 mice. at times coinciding with ifn-dp production and nk cell activation, there was a redistribution of nucleated cells from red pulp to white pulp regions in spleens isolated from mice infected with either lymphocytic choriomeningitis virus (lcmv) or murine cytomegalovirus (mcmv). cell transfer experiments with dioctadecyl-3,3,3',3'-tetramethyl indocarbocyanine perchlorate-or pkh26-gl-labeled bone marrow cells isolated from normal mice demonstrated an infection-induced accumulation of non-t/non-b cell populations along recipient splenic marginal zones. flow cytometric analyses demonstrated that approximately 10% of the transferred bone marrow cells accumulated in spleens after 20 hrs and 30% of these expressed the nk cell marker, nkl.l+. in vivo antibody treatment procedures, to eliminate cell subsets in donor mice, demonstrated that the cells localizing at the marginal zone were derived from agmi+ and n k l . l + populations. a small subpopulation of marginal zone cells in infected mice were shown to be expressing high levels of ifn-7 mrna by in sifu hybridization. treatment with anti-agmi or anti-nk1 .i antibodies eliminated both endogenous nk cells and the ifn-y mrna positive cells. these data demonstrate that newly derived nk cells accumulate along marginal zones. the results also suggest that this trafficking pattern may act to enhance immune responses by facilitating delivery of cytokines to specialized antigen presenting cells. david segal, janet ruby, alistair ramsay and ian ramshaw. depamnent of cell biology, john curtin school of medical research, po box 334, canberra, act, 2601 australia cytokine expression has been shown to correlate with protective or ineffective immune responses in a number of disease models. recently there has been the suggestion that immunity to some retroviruses is associated with the production of ceaain patterns of cytokines. to explore this further we have have used rauscher murine leukemia virus (r-mulv) infection of c57bu6 (resistant) and balb/c (susceptible) mice to elucidate the role of cytokines immunity to retroviruses. initially the in viho proliferation of spleen and lymph node cells from infected mice was examined. in response to stimulation with immohilised anti-cd3 antibodies the proliferation of spleen hut not lymph node cells from infected mice. was found to he rapidly suppressed. suceptible balb/c mice exhibited a much greater suppression than resistant c57bu6 mice. the cause of this suppression is under investigation however, the immunosuppressive molecules nitric oxide and prostaglandins are not involved. in vitro cytokine production by spleen and lymph node cells from r-mulv infected mice was determined. in response to stimulation with immobilised anti-cd3 antibodies, spleen cells from infected balb/c mice produced diminishing amounts of ifn-7 and il-2. in contrast spleen cells from infected c57bu6 mice produced ifn-y and l-2 to levels that were only slightly less than uninfected controls. a-6 production by spleen cells from infected mice of both strains was at levels higher uninfected controls. anti-cd3 stimulated lymph node cells from infected mice produced elevated ifn-1 suggesting that suppressed cytokine production is spleen specific. expression of cytokine genes in vivo is currently being investigated using rt-pcr to detect cytokine mrna in the spleens of infected mice. we have previously shown that primary resting murine b lymphocytes are non-permissive for vesicular stomatitis virus (vsv), however, a productive infection can be induced when infected b cells are activated with anti-immunoglobulin (a-lg) plus il-4 or lipopolysaccharide (lps). we posit vsv in unactivated primary b cells provides a paradigm of persistently infected lymphocytes and activation dependent recall of an active infection. analysis of the behavior of virus in unstimulated b cells during long term culture and the requirements for subsequent induction of productive infection has been limited by the poor survival of primary cells in culture. we circumvented this limitation by using highly purified small b cells from mice transgenic for the bcl-2 proto-oncogene, expression markedly extends in vitro survival of unstimulated primary b cells. overexpression of bcl-2 does not alter b cell infection or induction of a productive infection by activators during acute infection. infection does not effect b cell survival in culture. unstimulated virus infected b cells produce primary viral mrnas but not viral proteins or infectious particles (pfu) during culture. persistently infected b cells stimulated with a-lg plus il-4 produced a fully productive vsv infection at all times analyzed, up to 3 weeks post infection. in contrast, vsv production in persistently infected b cells activated with lps markedly declined relative to acutely infected activated cells (50-1 00 fold by week 1 and 1,000 fold by week 2). cells were not completely refractory to lps activation as vsv protein was produced. the selective lps deficiency is unique to persistently infected cells as uninfected cultured b cells proliferate and differentiate to produce antibody upon lps activation. these data show that a persistent infection may selectively alter the host cell response to previously productive activators which may as a consequence interfere with immune regulation. rsv-g glycoprotein specific t cells preferentially secrete il-5 and predispose to pulmonary eosinophillia., anon srikiatkhachorn. and thomas j. braciale, the beirne b. carter center for immunology research and the departments of microbiology, pathology, and pediatrics, university of virginia health sciences center, charlottesville, va 22908 we studied the immune responses to two different glycoproteins of respiratory syncytial virus (rsv) in a murine model. balb/c mice were immunized with recombinant vaccinia virus expressing either rsv-fusion glycoprotein ( vac-f), attachment glycoprotein (vac-g) or 8-galactosidase (as a control). these mice were given rsv intranasally three weeks after priming and then sacrificed 5 or 14 days later. spleens and bronchial lymph nodes were harvested for in vitro culture and lungs were harvested for histologic studies . we found that bulk cultures obtained from both vac-f and vac-g immunized animals secreted both thl and th2 type cytokines when stimulated with rsv infected spleen cells . however, the levels of 11-5 and 1fn-y were higher in bulk cultures derived from vac-g primed animals while the levels of il-2 were higher in the bulk culture from vac-f primed animals. the il-4 and il-5 production was relatively short lived since spleen cells and bronchial lymph node cells obtaind form mice sacrificed 14 days after intranasal inoculation produced much lower levels of il-4 and 11-5 while the levels of il-2 and ifn-y production were comparable to bulk cultures obtained from mice at the peak of infection. there was little inflammatory response in the lungs obtained from mice immunized with the control vaccinia. in contrast , lungs from mice immunized with vac-f or vac-g showed significant infiltration of inflammatory cells. there was a striking infiltration of eosinophils in the lungs from mice primed with vac-g. these eosinophils could be detected aroud major bronchi and blood vessels, as well as, in some cases, in lung parenchyma. this study suggests that the immune responses to different viral glycoproteins may be distinct and may play important roles in viral pathogenesis. during infection of normal mice with lymphocytic choriomeningitis virus (lcmv), nk cell responses peak on day 3 and subside as cd8+ t cell responses are activated at day 7 post-infection. in contrast, 02m-/-mice, lacking cd8+ t cells, have dramatically elevated nk cell responses on day 7 postinfection. the 02m-/-response is evidenced by increased nk cell activity, as well as up to 5-fold increases in blast and total nki.i+cd3-cell numbers. nk cell responses in normal mice are cyclosporin a (csa)-resistant and interleukin (il)-2independent, whereas day 7 nk cell responses in 02m-/-mice are csa-sensitive and il-2-dependent. to investigate the role of additional cytokines in regulating cellular responses during acute viral infections, production and function of il-4 and transforming growth factor4 (tgf-0) were examined. induction of il-4 mrna, at late times post-infection of normal mice, was shown by in situ hybridization of t cell-enriched splenic leukocytes and polymerase chain reaction (pcr) amplification of cdna from rna. ellsas of media cor.aitioned with cells isolated on days 0, 3, 5, 7, 9, and 14 post-infection demonstrated delayed induction of il-4 protein as compared to ctl activation. tgf-0, evaluated in biological and elisa assays, was induced maximally at days 7 to 9 post-infection. the kinetics of tgf-0 production by cells from infected 82m-/mice was similar to that of normal mice. however, cells from 02m-/-mice produced il-4 at early but not at late times postinfection. together, these results suggest that either il-4 is a critical cytokine for shutting off nk cells during normal responses to viral infection, or that the 02m-l context modulates responsiveness of nk cell subsets to other late cytokines. studies are in progress to distinguish between these two possible mechanisms. the induction of fever in response to infection is an important host defense mechanism that enhances aspects of the immune response and restricts the replication of some microorganism. vaccinia virus, a member of the poxvirus family, is a complex cytoplasmic dna virus that encodes a variety of proteins that interfere with host immune functions, such as complement regulatory factors and soluble receptors for il-lp, tnf and ifny. here we show that expression of the vaccinia virus il-1p receptor (vil-lpr) in the w r strain prevents the febrile response and reduces the severity of infection in intranasally inoculated mice. fever was recorded on days 1-6 after infection of mice with a vil-lpr deletion mutant, but not in animals infected with wild type wr or a virus revertant. these studies were extended to other virus strains that were used as smallpox vaccines, and expression of the vil-lpr was consistently found to prevent the onset of fever. vaccinia virus induced a severe hypothermia after 6 days in infected mice that was independent on vil-lpr expression and correlated with virus replication in the brain, the organ that controls body temperature. these results represent the first example of a virus mechanism to inhibit the host febrile response and suggest a central role for soluble il-lp in the induction of fever in poxvirus infections. measles virus (mv) infection can depress cell-mediated immune responses for months following clinical disease. mv is known to infect the thymus during human illness and this may contribute to immune suppression. we have used the scid-hu m o w with co-implants of human fetal thymus and liver to determine the effect of virulent and avirulent strains of mv on the thymus. scid-hu mice were. infected by direct inoculation of the graft with 103 pfu of either a wild type strain of mv(chicago-1,chi-1) or an attenu-ated strain (moraten, mor) and sacrificed at intervals over 28 days. peak viral titers, as judged by plaque assay on vero cells, were reached by chi-1 on d4 (105.7 pfu/ third of implant), and moron d21 (103.2 pfu/ third of implant). hematoxylideosin stained sections of chi-1-infected thymuses showed marked distortion of the cortex and medulla by d4 with thymocyte poilolosis and decreased cellularity. by d14, these. implants were mostly devoid of normal thymocytes. mor-infected thymuses showed relatively preserved architecture and cellularity. suspensions of the cells from implants stained with mabs to cd3,cd4 and cd8 were analyzed by flow cytomehy. there were significant decreases in the cd4+cd8+ cell pop-ulation by d10 with complete loss of all such cells by d28 with chi-1, and only modest reductions with mor. immune fluorescence staining of sections with a mv mab to hemagluttinin(ha) and abs for either human cytokera-tins(ael/ae3) or cd15 co-localized mv predominantly to epithelial and monocytic cells. additionally, mv antigen was present diffusely by d4 in both cortex and medulla in chi-i infection whereas mor-infected implants had only patchy distribution by d21. only rare cells stained both with mv ha and cd2 or cd4. mv ha was not expressed over background on any cd4+ cells judged by facs. we conclude that mv replicates in the scid-hu thymic implant primarily in epithelial and monocytic cells, and that the attenuated virus reproduces more slowly and with less cellular disruption. little mv ha could be demonstrated in thymocytes, therefore the data suggest that significant infection of the thymic epithelial stroma disrupts the thymic microenvironment which normally supports and aids in selection of immature t cells. part of the long-term immune suppression seen in mv infection may be due to infection of the thymic epithelial stroma with subsequent loss of thymocytes. it is becoming increasingly evident that many poxviruses contain genes that enable the virus to evade the host's immune system. myxoma virus is a leporipoxvirus and is the causative agent of myxomatosis, a rapidly lethal disease in the european rabbit (oryctolagus cuniculus). one possible mechanism of immune evasion is virus-induced downregulation of cell-surface receptors important for an immune response. cell-surface levels of several receptors on a rabbit t cell lymphoma cell line (rl-5) were monitored by flow cytometry. following infection with myxoma virus, cellsurface levels of cd4 were found to drop dramatically. other cell surface antigens such as cd18, cd43, and cd45 were unaffected during infection with myxoma virus. further more, the downregulation of cd4 by myxoma virus could be inhibited by treating cells for an extended period of time with pma, suggesting that the downregulation was not simply a masking of the epitope via viral antigens. analysis of cd4 levels in the presence of cytosine arabinoside indicates that late gene expression is not necessary for the modulation. since the tyrosine specific protein kinase p56lck associates with the cytoplasmic domain of cd4 we have also examined the association of p56lck with cd4 as well as steady state levels of p56lck during viral infection. the modulation of surface cd4 has also been described in hiv infected t cells suggesting that the loss of cell-surface cd4 may be a common viral immune evasion tactic by lymphotrophic viruses. i n addition, stably-transfected cell l i n e s expressing e i t h e r u s 1 1 o r us2-6 gene products s i g n i f i c a n t l y reduced l e v e l s of mhc class i heavy chain. studies are i n progress t o f u r t h e r d e f i n e t h e mechanism by which t h e s e v i r a l gene products a l t e r immune recognition. cytotoxic t lymphocytes (ctl) may play a significant role in containing the spread of hiv in infected individuals. although hiv-infection is associated with immune suppression, a vigorous ctl response has been detected in infected adults. hiv can be transmitted from mother to child. one third of vertically infected children has a rapid evolution toward disease, with onset of aids before 18 months. the other two thirds remain asymptomatic for years. the bimodal course of disease evolution in hiv-infected children could be related to differences in the host immune control of viral replication. hiv-specific ctl response from fresh and in vitro activated pbmc of hiv-infected children was measured. the vast majority of infected chidren had detectable hiv-specific ctl, which where cds+cd8+. we previously showed that among children with a slow disease progression, fresh ctl were more frequent in the p2a(paucisymptomatic) group than in the pl(asymptomatic) and the p2b-f groups (symptomatic group). the cohort of children has now been followed during 4 years, and 46 children have been tested at least once. we found that ctl responses were less frequent in the children with a rapid disease progression than in the children with a slow disease progression at the same age. our data suggest that ctl response is an important factor in delaying disease evolution. we, as well as others. have proposed that sag function is critical to the ability of milk-borne m m n to infect mice. to determine whether this is the case, we created transgenic mice (hyb pro/cla) with a frameshift mutation int the sag gene. young hyb pro/cla mice (c 10 weeks of age) showed no deletion of their cognate vp14* t cells, unlike transgenic mice carrying a functional sag gene however, a slow, progressive loss was seen in the hyb prolcla mice as they aged, indicating that it was due to expression of wild type sag protein. thus, as the hyb pro/cla mice aged, there was production of virus that appeared to lose the cla mutation. the hyb pro/cla mice produced transgene rna in their lactating mammary gland and shed virus in their milk. their nontransgenic offspring of showed infection with transgene-encoded mmtv because they had the typical slow deletion of vp14+ t cells characteristic of c3h mmtv infection and because we detected transgene-derived m m n rna in their mammary glands. cloning and sequencing of the viral rna produced by the nontransgenic offspring of the hyb pro/cla mice showed that recombination between the mtv-1 endogenous viral rna and the transgene-encoded rna occurred, such that the frameshift introduced by the cia mutation was repaired. these results show that there is selection of infectious virus that contains a functional sag gene. thus, it appears that the only virus that is capable of being transmitted by the milk borne infection pathway is that which encodes a functional sag protein. hepatitis b virus (hbv) causes acute and chronic liver diseases and is closely associated with hepatocellular carcinoma. in order to understand the cellular immune response against hbv in chronic hbv infection, t cell proliferation, cytotoxicity and cytokine production were studied. we found that although the majority of asymptomatic hbsag carriers and patients of chronic hepatitis b (chb) had no proliferative response to hbsag, some individuals in both groups showed significant t cell proliferation against hbsag. in contrast, the proliferative t cell response to hbcag in asyrnpatomatic hbsag carriers was significantly stronger than that in patients of chb with acute exacerbation. in addition, the frequency of hbcag-reactive t cell precursors measured by limiting dilution assay was much higher in asymptomatic hbsag carriers than in patients of chb. therefore, t cell responses against hbsag and hbcag are regulated differently in chronic hbv infection. furthermore, we demonstrated hbsag-and hbcag-specific cytotoxic t lymphocyte (ctl) activity in asymptomatic hbsag carriers, using autologous hbsag-and hbcag-expressing lymphoblastoid cell lines (lcl) as target cells, respectively. the cloned ctl were able to produce ifn-y, tnf-a or gm-csf after stimulation. these findings demonstrate that t cell response to hbv is not completely suppressed in asymptomatic hbsag carriers. most of them have strong hbcag-specific response and some of them have hbsag-specific response. transcription and tax the human t-lymphotropic virus type i (htlv-i) promoter contains the structural features of a typical rna polymerase i1 (pol 11) template. the promoter contains a tata box 30 bp upstream of the transcription initiation site, binding sites for several pol i1 transcription factors, and long poly a+ rna is synthesized from the integrated htlv-i proviral dna in vivo. consistent with these characteristics, htlv-i transcription activity was reconstituted in v i m using tbp, tfiia, rtfiib, rtfiie, rtfiif, tfiih and pol 11. in hela whole cell extracts, however, the htlv-i ltr also contains an overlapping transcription unit (otu). htlv-i otu transcription is initiated at the same nucleotide site as the rna isolated from the htlv-i-infected cell line, mt-2, but was not inhibited by the presence of a-amanitin at concentrations which inhibited the adenovirus major late pol i1 promoter (6 pglml). htlv-i transcription was inhibited when higher concentrations of a-amanitin were used (60 pglml), in the range of a typical polymerase in (pol 111) promoter (va-i). purified tax, transactivates this promoter 5-to 10-fold in v i m . interestingly, basal and tax,-transactivated transcriptional activity of the htlv-i ltr could be reconstituted with the 0.5 m phosphocellulose fraction. these observations suggest that the htlv-i ltr contains overlapping tax,responsive promoters, a typical pol i1 promoter and a unique pol i11 promoter which requires a distinct set of transcription factors. tax, further in vifro transactivates a polymerase i1 template containing the 21 base pair repeats cloned upstream of the ovalbumin promoter and g-free cassette. tax,-transactivated transcription was concentration dependent and inhibited by low concentrations of a-amanitin. flaviviruses are arthropod-borne viruses whose route of infection is via the skin. they are mostly neurotropic and responsible for significant human morbidity and mortality. the classic cell-mediated immune response to a viral infection may be influenced by the ability of these viruses to modify expression of cell-surface molecules involved in the presentation of antigen to, and activation of, t cells. the skin langerhans cell is the prototypic nonlymphoid dendritic cell and as such is uniquely placed to participate in a response against epidermally-acquired viral infections. the migratory properties of these cells contribute to their role as initiators of t cell-mediated immune responses within the draining lymph node. we have previously shown infection of epidermal cells in vifro by the flavivirus west nile (wnv) results in an increase in mhc class i and i1 expression on the majority of epidermal cells and langerhans cells respectively. in this study a technique for infecting the epidermis with wnv in vivo was developed. tme-dependent increases in the surface expression of a number of antigens which are involved either directly or in a co-stimulatory capacity in initiating a cell-mediated immune response, were detected on both the majority of epidermal cells and the langerhans cell population using flow cytometry. these increases were detectable as early as 16 hours after infection. a significant decrease in the percentage of langerhans cells remaining in the epidermis was observed within 48 hours of infection. the phenotypic changes observed in vivo are analogous to those described following in vifro culture of langerhans cells. these results, together with the reduction in langerhans cell numbers, may represent the in situ maturation and concomitant migration of these. cells as a consequence of virus-induced cytokines within the skin microenvironment. which cause a wide variety of illnesses with high morbidity and mortality in humans throughout the world. their high genomic stability argues for a survival strategy related more to interaction with the vertebrate host immune response, than a dependence on viral genetic mutation. our previous work has shown that west nile virus (wnv) infection of many cell types directly induces functional increases in class i and 11 mhc expression. we report here that wnv infection of human embryonic fibroblasts (hef) results in the increased expression of cd54 by two distinct mechanisms. an early, direct cytokine-independent mechanism operates within 2 h of virus infection, while an indirect mechanism, regulated by type 1 interferon (ifn), operates within 24 h of virus infection. cd54 expression increased by 4-5 fold within 2h of wnv infection on hef, and by 6-7-fold within 24h. wnv-inactivated, conditioned supematants removed from infected hef cultures after 4 h incubation did not alter cd54 expression on unqimulated hef. whereas conditioned supernatants from 24 h-infected cultures increased cd54 expression by about 1.5-2-fold after incubation for 24 h, but not after 4 h, similar to cd54 induction by 200ulml of ifn-p. increased cd54 expression on hef by wnv was also cell-cycle dependent. cd54 increased only in quiescent, contact-inhibited infected hef in go phase. in contrast, induction of cd54 by types 1 and 2 ifn was not cell-cycle dependent. other viruses, including double-stranded dna viruses, vaccinia, and adenovirus 2 and 5, and the single, positive-stranded rna alphavirus, semiliki forest virus, did not induce cd54 expression on hef after 24 h. another alphavirus, ross river, was able to induce cd54 but only by the indirect mechanism of type 1 ifn-dependent release. poly i.c, also, increased cd54 expression to the same extent as ifn-p after 24 h, making it unlikely that the early increase was due to a nonspecific viral effect. the closely related flavivirus, kunjin, induced increased cd54 expression in a manner similar to wnv. the ability of flavivhses to induce increased cd54 expression directly within a few hours of infection may be an important virus-host survival strategy promoting cell-cell adhesion and hence possible further viral infectiodreplication. recognition of viral peptides presented on the cell surface in association with class i mhc molecules leads to lysis by cytotoxic t cells (ctl) and forms an important part of the immune response to hiv infection. hiv virus has a high mutation rate and variation in the region of the viral epitope may allow evasion of this immune response. variation could theoretically affect processing of the antigen, binding of the epitope to the hla molecule or recognition of the presented epitope on the cell surface. we have studied proviral sequence variation in gag and ctl responses in a number of hla b8 patients infected with hiv. amino acid substitutions, such as a lysine to arginine change at position 3 of the pi7 gag nonamer cckkkyklk, lead to loss of recognition of the peptide by ctl from the patient whose provirus contained this sequence. these variant peptides bind to hla 68 with comparable affinity to the index peptide suggesting that this loss of recognition is likely to be caused by changes in the interaction between the hla-peptide complex and the t cell receptor. other changes, such as lysine to arginine or glutamine at position 7, not only cause loss of recognition, but also lead to inhibition of lysis of targets bearing the index peptide. thus it appears that in addition to loss of recognition by cytotoxic t cells, naturally occurring epitope variants may act as "antagonists", as has been demonstrated in mhc class ii systems. antagonism may be an important mechanism allowing immune escape by the hiv virus. genes. subsequent complex formation between peptide, class i and p2microglobulin in the er results in stable cell surface expression of the trimeric mhc-1 molecule. in previous studies we showed that in hpv-16 positive cervical carcinomas there was a loss of mhc-1 protein expression, which correlated at the single cell level with loss of tap protein. in this study we investigated whether loss of tap and mhc-1 is mediated by an hpv-16 encoded protein. human keratinocytes were transfected withvarious hpv-16 constructs including pat16, the full length genome, pat16esx the full length genome with a premature stop codon in e5, puc.et16, the e6 and e7 oncogenes only, and pkve5, expressing e5 from mouse moloney ltr the different constructs were transfected into primary keratinocytes, cloned cells grown in medium supplemented with and without y-interferon ( y -a r ) for 48 hours. cells were harvested and total rna and protein harvested for northern and western blots respectively. western blots showed very low steady state levels of tap-1 and mhc-1 heavy chains in the cells with pat16 as well as those containing es alone, which was marginally increased by y-lfn. in contrast, primary keratinocytes, pat16esx and puc.et16 lines showed comparable tap-1 and mhc-1 protein levels, which increased a & y-ifn treatment. northem blots showed no differences in the amounts of tap-1 and mhc-1 mrna between the different cell lines. the data indicate that expression ofhf'v-16 e5 leads to post-transcriptional loss of mhc-1, presumably by interfering with tap. to map and characterize functional differences between e1a of ad5 and adl2, we previously constructed a series of hybrid ad5/12 e1a genes and used them with ad12 e1b to transform primary hooded lister rat kidney cells. at least two regions within the first exon of ad12 e1a were identified which influenced tumorigenicity. this study further examines the role of these regions in tumorigenicity by analyzing their affect on cell surface mhc class i expression and sensitivity to class i-restricted cd8+ as well as to non-class irestricted nks. the bcrfl open reading frame of epstein-barr virus exhibits remarkable sequence homology with the coding sequences of interleukin-10 from a variety of organisms. many of the numerous immunological properties ascribed to interleukin-10 are shared by the product of bcrfl and this has led to it being termed viral interleukin-10. in order to investigate the activity of viral interleukin-i0 (vil-10) and its interactions with the human interleukin-10 receptor we have expressed the protein in a bacterial and the eukaryotic cos-7 expression systems. the bacterially expressed vil-i0 was partially purified and used to set up two assays to measure i l l o activity: i)the increase in igm secretion from an ebv transformed b cell line -mt4.l and ii)the downregulation of class ii hla expression on the human monocytic cell line thp-1. a series of deletion mutants (both n-and c-terminal as well as an internal deletion to remove a putative heparin binding domain) were constructed to identify possible domains within the vil-10 protein that interact with the hil-10 receptor and confer its biological activity. a number of these mutants have been expressed in the cos-7 expression system and their structure and biological activity are currently being assessed. the identification of the domains within vil-10 that interact with the receptor or accessory proteins may aid in the understanding of the possible role of vil-i0 within the ebv life cycle and in the pathogenesis of the numerous diseases associated with the virus. generation. to further test the role of ctl in ad pathogenesis, viruses lacking the cll epitopes were tested when mutants that lack the immunodominate ctl epitope in eia where used, a second immun-ssive epitope in elb becorns the predominate target of clu. these findings arc important since human ad is currently being tested as a vector for gene therapy of cystic fibrosis. our data suggest that when consuucting ad vectors to be. used for gene therapy, one must retain either the 10.4k or 14.7k genes to decrease pathology and that meting the genes that encode the antigens that a n recognized by clu does not prevent the generation of ad specific clu. the interferons (ifns) a n ? a family of cytokines whose functions include the protection of cells against viral infection. type i ifns include the 15 ifna subtypes and ifnp that compete for binding to the same cell surface receptor, while type ii ifn (ifny) binds to a different receptor. the orthopoxviruses, of which vaccinia virus (vv) is the prototypic member, have developed a number of anti-ifn strategies. the vv e3l protein competitively binds dsrna and prevents the activation of ifninduced and dsrna-activated protein kinase (pkr), while the vv k3l protein shows sequence similarity to the eukaryotic initiation factor 2a (eif2a) that is phosphorylated and inactivated by pkr. the k3l protein competitively binds the kinase and blocks host eif2a phosphorylation and hence ifn-induced inhibition of host protein synthesis. onhopoxviruses also suppress cytokine action by expressing soluble cytokine receptors that bind and sequester the ligand; to date soluble receptors for interleukin-18, tumour necrosis factor and ifny have been described. supernatants from vv-infected cells were found to contain a soluble inhibitor of type i ifn that was conserved in most of the orthopoxviruses tested. the inhibitor was produced early in infection and did not inhibit ifny. the ifna/p inhibitor was mapped and the gene expressed from recombinant baculovirus. the inhibitor blocked the binding of 125i-ifna to u937 cells and binding of 125i-ifna to supernatants from baculovirus and vv-infected cells demonstrated that the inhibitor functioned as a soluble receptor for 1fnc1fp. direct binding of 1251-ifna to vv wr supernatants revealed that the soluble ifna/p receptor had a high affinity for type i ifn. deletion of the gene from the vv genome and ligand blotting of the soluble receptor demonstrated that ifn binding was encoded by a single protein. competitive binding curves using ifna from other species revealed that the poxvirus soluble ifndp receptor bound human and bovine ifn with high affinity but murine ifn with relatively low affmity. interestingly, the soluble ifncrip receptor is highly conserved in variola virus. given the importance of ifn in antiviral defense it is likely that the soluble ifndp receptor plays an important role in the virulence of the orthopoxviruses. endogenous processing of a viral glycoprotein for presentation t o cd4+ t cells has defined a previously under-investigated pathway in antigen processing and presentation. it may be important not only for pathogens, but also for self-proteins, and thus may be involved in self-tolerance. we have been characterizing the processing o f the er-restricted gpt glycoprotein of vesicular stomatitis virus (vsv) biochemically and enzymatically, by cellular localization using confocal immunofluorescence, cellular fractionation, and by t cell recognition assays. by flow cytometry, gpt is undetected on the plasma membrane; in contrast, the wild type protein (g) is readily found following infection of a20 cells with a vaccinia virus vector, leading t o endogenous synthesis. the gpt can be found exclusively in the er compartment using co-localization with markers for er (signal peptide binding protein, calnexin), and not in the golgi compartment (a-mannosidase 11, wheat germ agglutinin), endosome, lysosome, or surface plasma membrane. this is consistent with the characteristics o f the localization of the proteases which appear to be responsible for its degradation. work is in progress to localize the site of peptide binding to mhc heterodimers. supported by nih grant a118083 t o csr. presentation of an out-of-frame class i restricted epitope. t.n.j.bullock and l.c.eisenlohr, department of immunology, thomas jefferson university, philadelphia, pa 19107. antigen presentation by class i mhc molecules is thought to require the degradation of fully formed proteins in the cytosol. this degradative process supplies oligopeptide epitopes for transport into the endoplasmic reticulum (er) where they can interact with and stabilize class i molecules. stable class i molecules, associated with p2-microglobulin, can then proceed to the cell surface where they present the epitopes to t cell receptors. the generally accepted model for protein translation, the scanning hypothesis proposed by ko&, is thought to describe the traditional method of translation for the majority of proteins. we wished to test the hypothesis that any internal methionine that is in good translation initiation context can be a source of short peptides, which may then be processed into class i epitopes. nucleoprotein gene (np), the target of the ctl response of several inbred mouse strains. np contains three class i restricted epitopes at amino acids 50-57 (h2-kk), 147-155 (h2-kd) and 366-374 (h2-db). the frameshift was introduced 26 amino acids upstream of the h2-kd epitope. the mutated genes were then recombined with vaccinia virus and tested for presentation using ctl restricted to each of the epito s described above. we found that, whilst presentation of the h2-i@ epitope was unaffected by the frame shift, the epitope proximal to the frameshift (h2-kd) was no longer presented to appro riately restricted ctl. however, presentation of the distal h2-dg epitope was retained. therefore we have shown, using a viral protein and a viral expression system, that out-of-frame epitopes can be processed and presented to ctl. work is ongoing to c o n f m that internal methionines are capable of providing a platform for the initiation of translation for in-frame and out-of-frame epitopes. we have created a frameshift mutation in the influenza pr8 the fine specificity of t cell recognition of peptide analogues of the influenza nucleoprotein epitope np 383-391 srywairtr was studied using hla b27-restricted influenza-specific cytotoxic t cell (ctl) clones, of defined t cell receptor (tcr) usage, derived from unrelated individuals following natural infection. synthetic analogue peptides were synthesized containing single amino acid substitutions, and tested both for binding to hla b'2705 in vitro, and for presentation to ctl clones by hla 827positive targets. even conservative amino acid substitutions of the peptide residues p 4 , 7, and 8 profoundly influenced ctl recognition, without affecting binding to hla 8'2705. these amino acid side chains are thus probably directly contacted by the tcr. ctl clones which used the tcr v a l 4 gene segment (but not those using tcr va12) were also sensitive to p1 substitutions, suggesting that the tcr alpha chain of these clones lies over the n terminus of bound peptide, and that the "footprint" of certain tcrs can span all exposed residues of a peptide bound to mhc class 1. these results, taken together with previous structural and functional data, suggest that, for nonarner peptides bound to hla 827, p i , p4 and p8 are "flag" residues with tcr accessible side chains. the e3/19k protein of human adenovirus type 2 (ad2) is a resident transmembrane glycoprotein of the endoplasmic reticulum. its capacity to associate with class i histocompatibility (mhc) antigens abrogates cell surface expression and the antigen presentation function of mhc antigens. at present, it is unclear exactly which structure of the e3/19k protein mediates binding to mhc molecules. apart from a stretch of approximately 20 conserved amino acids in front of the transmembrane segment, e3/19k molecules from different adenovirus subgroups (b and c) share little homology. remarkably, the majority of cysteines is conserved. in this report, we examined the importance of cysteine residues (cys) for structure and function of the ad2 e3/19k protein. we show that e3/19k contains intramolecular disulfide bonds. by using sitedirected rnutagenesis, individual cysteines were substituted by serines and alanines, and mutant proteins were stably expressed in 293 cells. based on the differential binding of monoclonal antibody tw1.3 and cyanogen bromide cleavage experiments, a structural model of e3/19k is proposed, in which cys 11 and cys 28 as well as cys 22 and cys 83 are linked by disulfide bonds. both disulfide bonds (all four cysteines) are absolutely critical for the interaction with human mhc antigens. this was demonstrated by three criteria: loss of e3/19k coprecipitation, lack of transport inhibition and normal cell surface expression of mhc molecules in cells expressing mutant e3/19k molecules. mutation of the three other cysteines at position 101, 109 and 122 had no effect. this indicates that a conformational determinant based on two disulfide bonds is crucial for the function of the e3/19k molecule, namely, to bind and to inhibit transport of mhc antigens. previous studies have suggested that several abundant cmv proteins are major immunogenic targets in seropositive adults. we are interested in defining the major viral protein targets of a cd8' ctl response, in order to derive a vaccine strategy for individuals who are unable to mount immune responses which are lymphokinedependent because of immunosuppression. hla-typed and cmv-pgsitive normal volunteers who have hla-a alleles that represent -75% of the u.s. population are being tested to determine which of 5 abundant cmv proteins they recognize by a cd8' ctl response: p28, p65, p150, ie, and gb. t cell lines will be derived in order to unambiguously determine the hla restriction of the cd8' ctl response to each of these proteins. proteins which are recognized by the most hla diverse population will be further characterized in terms of mapping of class 1 epitopes through the use of t cell clones derived from the polyclonal cell lines by limiting dilution. the defined epitopes will form the basis of a vaccine strategy to augment the memory responses of seropositive volunteers against cmv. these epitopes will be used to boost the ctl precursor frequency of bone marrow transplant donors as a means to transfer cellular immunity to immunosuppressed hematologic transplant recipients. an alternative strategy is to immunize seropositive individuals with recombinant viral proteins as a means to boost immunologic memory. we are pursuing that strategy in a transgenic murine model of hla-a2.1 developed by dr. l. sherman (scripps institute, la jolla). we are vaccinating the transgenic mice with two well defined cmv proteins, p65 and gb together with either of two lipid-based adjuvants, commercially available d0tapm (bcehringer-mannheim) or mf5gth (chiron, emeryville, ca). our preliminary studies with hsv-2 gb demonstrate that both adjuvants are effective at eliciting murine class i restricted responses against the protein. current studies are evaluating the recognition properties of the adjuvant-cmv protein complexes by hwa2 as a restriction element in the transgenic model. the ctl response to sendai virus in c57by6 mice is directed almost exclusively to a single h-2kb-restricted epitope derived from the virus nucleoprotein, npj24-332 (sev-9). analysis of 18 independent t cell hybridomas generated from c57by6 mice following primary sendai virus infection has shown that a very diverse repertoire of tcr is selected in response to this epitope. crystallographic analysis of sev-9 bound to kb has shown that the side chaiis of peptide residues phpi, gl484, a d s , and alaps protrude towards the solvent and are potentially available for recognition by the tcr notably, residues gi484 and a d 5 protrude prominently from the peptide binding site due to their l o c a l i o n on a bulge in the center of sev-9. to determine the importance of each of these residues for t cell recognition, we analyzed hybridoma responses to sev-9 analogs substituted at each of these four positions. preliminary data showed there generally appeared to be dominant recognition of glyp4 and asnm. however, individual hybridomas exhibited distinct patterns of fine specificity for residues phep1 and alaps. thus, individual hybridomas were dependent on one, both, or neither of these residues for recognition of sev-9. these data are consistent with a critical role for the gi94 and a d 5 in governing tcr-sev-9eb recognition and suggest a structural basis for the diversity of the tcr repertoire selected by this @tope. previous results from this laboratoty demonstrated that the dominant influenza a epitope recognized by hla42.1 restricted ctl from hla-a2.1 uansgenic mice was the m1 peptide epitope that is immunodominant in human ctl responses. however, analysis of a large number of ctl lines revealed a subset of influenza a/pr/8/34-specific murine ctl that recognized an hla-a2.1 restricted epitope distinct from m1. using recombinant vaccinia viruses encoding werent influenza gene segments, the epitope recognized by these ctl was shown to be derived from the a/pr/8 nsl protein. because these ctl did not recognize targets infected with the a/alaska/6/77 saain of influenza, candidate peptide epitopes were synthesized based on sequences that included an hla-a2.1 specific binding motif and that differed between a/pw and nalaska all of these ctl recognized a nonamer and a decamer peptide which contained a common 8 amino acid sequence and two distinct sets of bmding mtif residues. however, the n0name.r peptide was able to sensitize ctl for half maximal lysis at 80-2500 fold lower doses than either the octamer or decamer. the homologous peptide derived from nalaska nsl contained conservative amino acid changes at positions 4 and 8 and was not recognized at any tested concentration, although it bound with higher &ity to hla-a2.1 than the peptide from a/pw8. the a/pr/8 nsl nonamer epitope was also recognized by human influenza a specific ctl derived from two individuals. these results substantiate the general utility of hla class i aansgenic mice for the identification of human cn epitopes for other pathogens. furthemore, the recombinant dhfr was functional in the induction of gb epitope-specific ctl response upon immunization of c57bv6 mice. these results indicate that an viral epitope expressed in a cellular protein can be. efficiently processed, presented and recognized by epitope-specific ctl, and suggest that the cellular proteins can be used to express ctl epitopes for induction of cd8+ immune responses. virus-specific cytotoxic t lymphocytes (ctl.) were generated a day later at this site. to determine which apc was capable of stimulating virusspecific ctl precursors in the mln, b, t and dendritic cells from the mln of influenza-infkcted mice were separated and examined for the presence of virus. the predominant cell type which contained infectious virus was the dendritic cell. b and t cells from the mln contained little, ifany, virus. the apc capacity ofthese populations was tested by their ability to stimulate vir~~-~pecific t cell hybridomas. only dendritic cells from the mln of influenza-infected mice were able to stimulate virusspecific t cell hybridomas, althwgh all apc populations from both naive and influenza-infected mice were effective stimulators after in y h pulsing with the appropriate intluenza peptide. potential apc populations were also separated from the lung. v i s was detected in bronchioalveolar macrophages and dendritic cells but not b or t cells. both macrophages and dendritic cells isolated from intlum-infected lungs could stimulate virus-specific t cell hybridomas. the ability of the mln and lung apc populations to stimulate naive cd8' t cells and generate virus-specific ctl is currently being examined. virus infected cells present only a very limited number of peptides intracellularly processed from a viral protein to ctl even when many peptides hearing the mhc class i-restricted binding motif are present in the protein. infection of h-2b mice w i t h lymphqtic choriomeningitis virus (lcmv) induces a cd8+ ctl response directed against three wellcharacterized epitopes presented by h-2db molecules: "396-404 (fqpq-ngqfi), gp33-43 (kavynfatcgi) and gp276-286 (sgven-pggycl). the h-2db motif is characterized by a sequence of 9 to 11 a.a. with two anchor residues: asn at position 5 and hydrophobic (met, ile, leu) at the c-terminus. the lcmv np and gp proteins contain thirly-one other peptides exhibiting the db motif. however, no ctl response against one (or more) of these peptides has been characterized. peptide binding to mhc is a critical step in antigen presentation. the aim of this study was therefore to analyze the binding properties of the potential db lcmv peptides. the 34 lcmv peptides and 11 known db-selective peptides were synthesized and their mhc binding affinities measured in two db-specific binding assays. most of the lcmv peptides (28/34) did not bind to db. the other 6 (including the 3 epitopes) and all the known db peptides showed good affinity. comparison of the sequences (good vs. non binders) allowed the identification of auxilliary anchors required for high binding affinity or of negative elements hampering mhc binding. in addition to the main anchors, the positive and negative factors at secondary residues play a crucial role in governing peptidemhc interactions. knowledge of such factors might he of importance for the prediction of mhcrestricted ctl epitopes. etienne joly, andrea gonzalez, carol clarkson, jonathan c. howard and geoffrey w. butcher. laboratory of immunogenetics, department of immunology, the babraham institute, cambs cb2 4at, uk. tap transporters from rats can be divided into two allelic groups, depending on their capacity to provide the rt1.aa molecule with an appropriate level of suitable peptidesl. recent results suggest that this might correlate with the rt1.aa molecule requiring arginine-ended peptides (powis et al., manuscript submitted), which the tapb allele of the transporter is unable to translocate across the er membrane efficiently2~3. rt1.a alleles are naturally linked with the tapa or the tapb allelic group4. we have set out to characterise various alleles for the rt1.a molecule, and find that, for the majority of tapaassociated rt1.a molecules, 3 acidic residues line the c/e pocket, dictating arginine as c-terminal anchor residue for the bound peptides. on the other hand, in tapb-associated rt1.a molecules, one acidic residue at the most is found in the c/e pocket, which certainly results in a different anchor residue for the bound peptides. the selective pressure of viral infections must have driven this coevolution which affects dramatically the array of peptides presented to cytotoxic t lymphocytes. cytotoxic t lymphocyte responses in hiv infection can be impaired due to variation in the epitope regions of viral proteins such as gag. we show here an analysis of variant epitope peptides in three gag epitopes presented by hla b8. seventeen variant peptides were examined for their binding to hla b8; all but one bind at concentrations comparable to known epitopes. all except two could be seen by ctl clones grown from hla b8 positive hiv-1 infected patients and were therefore immunogenic. however, in one haemophiliac patient studied in detail, there was a failure to respond to some of the peptides that represented virus present as provirus in his peripheral blood. in one case his ctl had previously responded to the peptide. thus there was a selective failure of the ctlresponse to variant epitopes. this impaired reaction to new variants and failure to maintain responses to some epitopes late in hiv infection could contribute to the loss of immune control of the infection. pira, anna ferraris, daniele saverino, peifang sun and annalisa kunkl; dept. immunology, san martino hosp. univ. of genoa, 16132 genoa, italy. th epitopes present on viral proteins can be recognized by specific th cells if appropriately expressed by antigen presenting cells (apc) as a result of uptake and processing. since viral epitopes are not simply present in the context of viral proteins, but also in the context of whole viral particles, it is important to determine the role of the molecular and/or structural context on antigen uptake-processing-presentation. therefore we have generated panels of cd4+ human t cell lines and clones specific for different hiv antigens (gp120, p66, p24), in order to test their ability to respond to the same epitopes present within synthetic peptides, recombinant proteins or inactivated virions (provided by g. lewis, dept. microbiology, univ. maryland, baltimore). we could identify t cell lines and clones that were able to discriminate the molecular and structural context of the epitops. certain t cells, in fact, responded to peptides and proteins, but not to viral particles, whereas other t cells were also able to proliferate when challanged in vitro with autologous apc and viral particles. the data suggest that in the human th cell repertoire specific for viral antigens t cells exist that can discriminate the molecularstructural context of th epitopes. it will be interesting to ascertain whether t cells specific for epitopes that can only be recognized when provided in the context of a soluble molecule, but not of a viral particle, have any relevance in viva protection, or are a simple by-product of the cellular immune response. eric g. pamer, merceditas s. villanueva, section of infectious diseases, yale university school of medicine, new haven, ct 06520 listeria monocytogenes is a gram positive bacterium that infects macrophages and secretes proteins into host cell cytosol. the murein hydrolase p60 is secreted by l. monocytogenes and is required for complete bacterial septation. in the infected macrophage secreted p60 is processed by the host cell into the nonamer peptide p60 217-225 and is presented to cytotoxic t lymphocytes by the h-2kd mhc class i molecule. we have used strains of l. monocytogenes that secrete different amounts of p60 to show that the rate of p60 217-225 production is proportional to the amount of antigen secreted into the host cell cytosol. p60 is degraded in the host cell cytosol with a half life of 90 minutes. the appearance of p60 217-225 is coupled to the degradation of newly synthesized p60. we have determined the rate of intracellular p60 secretion and by accounting for the rate of p60 degradation we estimate that approximately 35 p60 molecules are degraded to produce one p60 217-225 epitope. this ratio is maintained over a range of intracellular antigen concentrations. our findings provide an estimate of the efficiency of antigen processing and demonstrate the remarkable capacity of the mhc class i antigen processing pathway to accommodate new epitopes. we have isolated and characterized three cytotoxic t lymphocyte (ctl) clones from the peripheral blood of two acute seroconversion patients and one patient in the first trimester of pregnancy. these clones were cd8+ and class i hlarestricted by the b7 molecule. all three clones recognized lllb and rf but not mn strains of hiv-1. using vaccinia vectors expressing truncated versions of the hiv-1 envelope, the clones were found to recognize an epitope within amino acids 287-364, but not including 312-328 of gp120. further mapping of the epitope with synthetic 20-mer peptides overlapping by 10, or 25-mers overlapping by 8, was unsuccessful. the sequence of the region of gp120 recognized by these clones was compared to the predicted hla-87 peptide binding motif and a possible matching region was found. using shorter peptides corresponding to this potential epitope recognition site, the minimum epitope recognized by the clones was determined to be the 10 aa sequence rpnnntrksi spanning amino acids we have further pursued a strategy to define a minimal cytotoxic epitope for a vaccine against cmv infection using t cell clones derived from individuals who have the mhc 835 gene (kind gifts of drs. riddell and greenberg, fred hutchinson cancer research center and dr. robert siliciano, johns hopkins university medical center). we tested by chromium release assay (cra) the recognition of a series of 835 allelic variants of ebv-lcl. by 835 restricted and cmv or hiv-specific t cell clones. several conclusions quickly became apparent. the previously described 8'3501 peptide epitope from pp65 was not able to prime the autologous 835 ebv-lcl for killing by the pp65-specific ctl, whereas a recombinant vaccinia virus expressing whole pp65 could cause the same cell line to be recognized and killed in the same experiment. in addition, an hiv gp41-specific cd8' ctl which has a defined minimal cytotoxic epitope will only recognize and kill a subset of 835 ebv-lcl. the two t cell clones will not recognize each other's autologous ebv-lcl. the resolution of this interesting phenomena comes from sequence analysis of the hla class i b genes from both ebv-lcl. ebv-lcl which contain the b'3502 allele are recognized and killed by the pp65-specific t cell clone, and cell lines carrying 8'3501 alleles are recognized by the hiv gp41-t cell clone. we conclude that the reported cmv pp65 b"3501 restricted epitope is not correct, since the ctl in question will only recognize 6'3502 alleles in combination with the correct pp65 epitope. fragments with or without a signal sequence sensitize rma-s/kd to a similar limited extent. this data i s consistent with an inefficient movement of peptides from the cytoplasm into the er by a tap independent mechanism and does not reveal a processing competent compartment within the secretory pathway. peptide transport by the transporter associated with antigen processing (tap) was studied using a microsome system as previously reported by heemels et. al.. in this system, a radiolabeled synthetic peptide which can be n-link glycosylated is used as the indicator peptide for the transport studies. the transport efficiency of synthetic peptides corresponding to antigenic peptides restricted to the murine kd molecule was measured by inhibition of labeled peptide transported into the microsomes. the transport efficiency of three kd epitopes in the type a influenza virus "147-155, ha204-212 and ha210-219 was found to be similar. an 11 amino acid peptide corresponding to ha204-214 which contains the 204-212 epitope was transported at a similar efficiency as the 9 amino acid minimum epitope. however, when the peptide sequence is further extended by one amino acid to residue 215, this peptide is poorly transported. these results suggest that the flanking region of an epitope can dramatically influence the transport of the epitope. when the transport kinetics of tap was studied using the microsome system, the vmax for transporting the indicator peptide (a variant of np epitope that has the sequence tynrtrali) was found at 260.8 fmolelminute (+/-30.5). the km for this peptide was found to be 231.9nm(+/-31.8). bypassing a block in antigen processing for class i-restricted cytotoxic t cell recognition. amy j. yellen-shaw and laurence c. eisenlohr. thomas jeferson universitv. hiladelphia, pa., 19107. previous work from our laboratory showed that processing of an influenza nucleoprotein (np) epitope (amino acids 147-155) expressed endogenously from a recombinant vaccinia virus "minigene" is severely impaired when a flanking sequence (the dipeptide threonine-glycine) is appended to the cterminus of the construct (147-158/r-). the inhibition of processing is overcome by placing the unprocessed peptide in the context of the fulllength np molecule, demonstrating that regions of a protein outside the epitope itself critically affect the ability of the proteolytic machinery to fragment the protein appropriately. to determine the requirements for bypassing the block in antigen processing, we have constructed an array of "minigene"-expressing vaccinia recombinants in which the unprocessed epitope is extended by varying lengths toward either the c-terminus or the n-terminus of the np molecule. our results show that while an extension of the c-terminus by only one amino acid restores processability, a much longer extension of the n-terminus (75 < n < 100 amino acids) will also allow the substrate to be processed. it is therefore clear that a full-length, properly folded molecule is not required for liberation of the blocked epitope, and that probably more than one mechanism can contribute to enhancement of substrate proteolysis. we hypothesize that the c-terminal extension allows recruitment of an endopeptidase versus exopeptidase ("trimming") activity which is capable of cleaving the difficult bond. we considered the possibility that the n-terminal extension rescues processing by recruitment of the ubiquitin-dependent degradation system. to address this possibility we replaced all available ubiquitination sites (lysine residues) in one of the rescued constructs (50-158/r-) to see if the construct would still be processed and presented. the six available lysine residues were changed to arginine using pcr-based mutagenesis. the resulting construct (termed 6r) was recombined into vaccinia virus and tested for presentation to np-specific ctl. the 6r construct was presented at a level equivalent to that seen with the wild-type 50-158/rconstruct. this result provides clear evidence that entry into the ubiquitindependent degradation pathway is not responsible for rescue of presentation in this system and more importantly, that ubiquitination is not required for processing of all large substrates. chia-chi ku, li-jung chien ,and chwan-chuen king, institute of epidemiology, national taiwan university, taipei, taiwan, r.o.c. dengue virus (den) can cause dengue fever (df) and dengue hemorrhagic fever (dhf) i dengue shock syndrome (dss) and den-2 was the most common serotype found in dhf outbreaks globally. current hypotheses suggested that dhf may be associated either with antibodydependent enhancement (ade) or with viral virulence. den can replicate predominantly in monocytedmacrophages (mim), but whether peripheral blood lymhocytes (pbls) are the target cells of den still remain controversial. in order to compare whether various clinically derived den-2 will interact with mim and lymphocytes in different manners, we used two isolates --plo46 strain (obtained from a df patient during taiwan 1981 outbreaks) and 16681 strain (isolated from a dhf patient in thailand by cdc, usa) to infect primary mim and lymphocytes as well as several types of cell lines. primary lymphocyte culture was nonadherent cells obtained after 24 hr adherence of pbmcs, whereas the primary mim culture was collected by depletion of lymphocytes using anti-cd3icdi9 mab and complement prior to adherence procedure and the purity of mim culture was checked by cd14 surface marker staining. supernatants (sn) of virus were harvested at various time points post infection after with several or without treatments. our prelimanary data showed that dhf-associated den-2 strain had higher viral yield in certain age of mim and a promonocytic cell line (hl-cz) than taiwan df-associated den2 strain. in addition, this dhf-den2 strain was more likely to infect the promonocytic (hl-cz) than well differentiated monocytic (ctv-1) and lymphocytic (h9) cell lines and also had higher peak yields than den-i virus in hl-cz cells. interestingly, dhf-den2 strain replicated much more efficiently in primary lymphocytes no matter these cells were activated with pha or not, whereas taiwan df-den2 strain virus was hardly detectable in sn of both activated and non-activated lymphocyte cultures. therefore we conclude that (1) different strains of dengue virus could orchestrate quite differently with immune cells, (2) different stage of mim differentiation might be an important permissive determinants for dengue virus infection and replication, and (3) den virus strain virulence -a more important factor than lymphocyte activation status -seemed to determine whether this strain would infect human pbls. further studies should be focused on searching for detaied mechanisms of virus and immune cell interactions. (2) when viral yields were enhanced early than day5 post infection, it provided tremendous opportunity to attack the immune system and finally may lead to severe disease. hiv-1 using recombinant immunoglobulin molecules, marie-claire gauduin, graham p. allaway, paul j. maddon, carlos f. barbas, dennis r. burton, and richard a. university school of medicine, new york. ny 10016. primary isolates of hiv-1 have been shown to be less sensitive to neutralization by immune sera, monoclonal antibodies and cd4-based molecules than t cell line-adapted strains of hiv-i. we studied two immunoglobulin molecules for ability to neutralize primary isolates of hiv-i. lgg12 is an immunoglobulin molecule created from a combinatorial phage expression library and reacts with the cd4 binding site (cd4-bs) on gp120. cd4-lgg2 is a recombinant molecule in which the variable domains of both heavy and light chains of lgg2 were replaced with the first and second immunoglobulin-like domains of human cd4. both molecules have been previously shown to effectively neutralize hiv-i in vitro. ex vivo neutralizations were performed as follows: lgg12 and cd4-lgg2 were added at 25 pg/ml to wells containing serial dilutions of plasma from hiv-i-infected patients and phastimulated peripheral blood mononuclear cells from seronegative donors. p24 production was measured over 14 days of culture and an end-point titer of hiv-1 in the presence and absence of added antibody was determined. both igg12 and cd4-lgg2 were found to reduce the original hiv titer from seven plasma samples with high virus titer (>250 tcid50/ml) by up to 625-fold. this is in comparison to soluble cd4 which only reduced viral infectivity by 55-fold at the same concentration. in vitro binding and neutralization assays on isolates recovered from plasma confirm the potency and breadth of neutralization by these two molecules. these studies suggest that recombinant antibodies directed at the cd4-bs of hiv-1 gp120 are able to effectively neutralize primary isolates of hiv-1 and may be useful in dissecting the mechanisms of resistance to neutralization by other antibodies. dillner and p. heino, microbiology & tumor biology center, karolinska institute, stockholm, sweden hpv 16 the major cause of anogenital precancers in man. the search for neutralizing epitopes that could form the basis for a preventive vaccine has shown that the surface-exposed imunodominant epitopes of the capsid are strongly conformationdependent, which has precluded detailed epitope analysis. similarly, immunization with whole, denatured capsid proteins has only identified linear immunodominant epitopes positioned on the inside of the capsid. reasoning that linear surface-exposed epitopes should exist, but might be cryptic, a set of 66 overlapping synthetic peptides corresponding to the entire hpv16 capsid proteins was used to generate hyperimmune sera. several antisera against 3 different peptides were reactive with intact hpv16 capsids at titers up to 1:150.000. hiv-1 serum antibodies and mucosal iga. basil golding, john inman, paul beining, jody manischewitz, robert blackburn and hana golding. div. of hematology and viral products, cber, fda, and lab. of immunology, niaid, bethesda md 20892. previously, we showed that hiv-1 proteins conjugated to 8. abortus (ba) could generate anti-hiv-1 neutralizing antibodies in mice even after depletion of cd4* t cells. in this study a 14-mer peptide from the v3 loop of hiv-1 (mn) was synthesized 013) and coupled to ba and klh. balb/c mice were immunized twice i.p. with these conjugates at two week intervals. v3-klh induced mainly igg1, whereas v3-ba induced all igg isotypes but lgg2a predominated. fecal extracts from mice immunized with v3-ba were shown by elsa to contain iga antibodies. sera from these mice bound gp120, expressed on the surface of infected cells. sera from mice immunized with v3-ba inhibited syncytia formed between cd4' t cells and chronically infected [hiv-i (mn)] h9 cells. inhibition of syncytia, formed by other hiv-1 lab. strains correlated with the degree of their homology with the v3 region of hiv-i (mn). to mimic the efffect of hiv-1, mice were depleted of cd4' cells using anti-l3t4 at the time of primary or secondary immunization. following primary immunization, cd4+ t cell depletion abrogated v3-klh antibody responses, whereas responses to v3-ba were retained and sera from these mice were able to inhibit gp-120mediated syncytia. in secondary responses, cd4' t cell-depletion prevented boosting to v3-klh, but v3-ba increased anti43 and syncytia-inhibiting antibodies. these results suggest that: 1. 8. abortus, can provide carrier function for a peptide and induce both serum and mucosal antibody responses, and 2. that infection with hiv-1 with subsequent impairment of cd4' t cell function would not abrogate anti-hiv-1 antibody responses if 8. abortus is used as a carrier to stimulate memory responses. nucleotide sequence analysis of the vh genes revealed the usage of one particular vh germline element (vh61-1p) in all clones. this finding allowed the determination of somatically mutated positions in the vh regions. two vsv-ind neutralizing antibodies expressed vh and vl genes in complete germline configuration whereas the rest of the clones showed somatic mutations which obviously were antigen dependently selected for. however, binding affinities of mutated and unmutated antibodies were comparably high. in order to determine the influence of somatic point mutations on one single antibody we generated a monovalent single chain antibody (fv-ck) of a mutated clone and reversed it stepwise to germline configuration by means of site directed mutagenesis. surprisingly, already the germline configuration of fv-ck could neutralize vsv-ind, even though the binding affinty was lower than that of the mutated fv-ck. every single somatic point mutation tested improved the binding avidity although some mutations reduced affinity. thus, during the course of vsv-ind infection some antibodies are subjected to avidity maturation although this is not required for the generation of high affme, efficiently virus neutralizing antibodies, lisa hyland'", sam hou'.~, and peter c. doherty'. 'department of immunology, st. jude children's research hospital, memphis, tn 38 10 i, 2departments of immunology and microbiology, and 'pathology, university of otago,dunedin, new zealand. the b and t cell responses in c57bl/6j(b6) mice treated with the mab mel-14 to l-selectin have been analysed following i.n. infection with sendai virus. mel-14 treatment caused a 70-90% decrease in the lymphocyte recruitment to the mediastinal (h4ln) and cervical (cln) lymph nodes following infection with sendai virus. the cellularity of the spleen was unchanged. the clonal expansion of cd8+ ctl precursors in the mln was slightly delayed, but potent ctl effectors were present in the virusinfected lung by day 10 after infection and the overall magnitude of the response was not compromised. the prevalence of iga antibody forming cells (afcs) was greatly increased in both the mln and the cln of the mice given the mel-14 antibody. the igm response was prolonged and the igg response, particularly iggl, was delayed compared to controls. the altered pattern of the antibody response may reflect the limited availability in mel-14-treated mice of th cells secreting lymphokines which are involved in ig class switching, by blocking the entry of cd4+ th precursor cells into lymph nodes. facs sorting for l-selectin+, 8220+, and l-selectin-, b220+ cell populations from the mln and the cln of normal b6 mice 9 days post sendai virus infection, showed that the afcs were from the l-selectin-, b220+ cell population, a population which comprised 6-10% ofthe total cell population. we have distinguished targets of broadly neutralizing antibodies present in hiv-1 infected individuals by imunoselection in vitro and by the use of chimeric virus. one target of neutralizing antibodies, defined by an escape mutant with an ala to thr substitution at position 582 in gp41, is resistant to human monoclonal antibodies that map to a site closely congruent with that for cd4 binding. substitution of gly, ser, and val fail to confer resistance. a second, defined by an ala to val substitution at position 281, upstream from the v3 loop, does not involve the same site and does not involve v3. substitution of thr or ile also confers resistance. replacement of the v3 loop of hiv-l(mn) into a clone of hiv-l(iiib) allows the detection of two other broadly neutralizing targets. one recognizes the v3 peptide of mn but is affected by regions outside v3. the other appears to be conformational and outside v3, but its functional recognition is influenced by the v3 loop. all of these sites seem to depend on the overall conformation of the envelope protein rather than a single discrete linear epitope. antibodies against amino acids 579-613 of the hiv transmembrane (tm) glycoprotein have been shown to enhance hiv infection in vitro in the presence of complement. there has been no study demonstrating that enhancing antibodies to this region of hiv, despite increasing levels of infectious virus 10 to 100 fold in vitro, adversely affect disease pathogenesis. in two separate studies reported herein, it is shown that animals which have high levels of antibody against this region of siv, amino acids 603-622 of the envelope, fair poorly compared to animals with lower antibody levels against this region when subsequently challenged with siv. when actively immunized with a synthetic peptide from this region of siv, animals died earlier and failed to clear antigen at two weeks after infection compared to animals that received a control peptide (p<0.05). when animals were passively immunized with antibodies from a longterm survivor of siv infection, those animals that received higher levels of antibody against the tm peptide died within six months compared to longer intervals for those animals that had lower levels of antibody to this region. when taken together, these data suggest that antibody to the tm region of siv and hiv in general, and to this highly conserved peptide in particular, are detrimental to the host. therefore, immunization strategies that minimize the immune response against tm or treatment protocols that decrease antibody levels against tm may lead to prolonged survival following exposure to lentiviruses. we have developed a mouse model to examine the immune response to hpv 16 proteins when these proteins are presented to the immune system via the epithelial route. in this model animals are grafted with keratinocytes expressing hpv e6 a n d e7 genes using a transplantation procedure which permits epithelial reformation. animals so grafted when challenged intradermally with e7 either as protein or via a recombinant vaccinia virus exhibit a delayed type hypersensitivity response which is e7-specific and cd4+ t cell mediated. animals grafted with a sub optimal priming inoculum of cells develop immune non-responsiveness and have an abrogated dth response when challenged subsequently with a priming cell graft. in the present study w e have examined the antibody status in these animals. the e7 protein of hpv 16 was expressed in e. coli as a maltose binding fusion protein using the plasmid vector pmalc. after cleavage and affinity purification this protein was used in a n elisa assay to measure antibody levels in 4 groups of mice (1) those not challenged with e7 (2) mice not grafted but challenged with e7 protein in the ear (3) mice primed by grafting with 107 hpv e7 expressing cells and challenged with e7 protein (4) mice primed by grafting with 5 x 105 hpv 16 e7 cells on day 7, grafted again with lo7 hpv 16 e7 cells on day 14 and challenged with e7 protein in the ear. mice optimally grafted and challenged (group 3) exhibited high titres of igg antibodies, particularly elevated levels of iggza. mice sub-optimally grafted (group 4) exhibited igg antibody levels comparable to the control group (1). the possible mechanisms of this immune attenuation are discussed. the hepatitis c virus is a frequent cause of chronic liver disease. a proposed mechanism responsible for virus persistence is evasion of the host immune response through a high mutation rate of crucial regions of the viral genome. the portion of hcv genome coding for the amino-terminal part of the putative envelope protein (gp70) undergoes frequent mutation during the course of infection. we have cloned and sequenced the hypervariable region (hvri) of the virus isolated from an hcv asymptomatic patient at three time points during 18 months follow up. sequence analysis has allowed the identification of variants of this region and multiple antigenic peptides (map), corresponding to three hvrl variants, sequentially foundin the blood stream of the patient, have been synthesized. maps have been used as antigens for detection of specific antibodies in elisa. our results show that anti-hvri antibodies and their cognate viral sequence coexist in the blood stream but a viral sequence becomes undetectable when the specific antibodies reach maximum levels of reactivity. thus humoral immunity against the hvrl may play a role for virus clearence. the presence of anti-hvr1 antibodies was also investigated in 100 hepatitis c viremic individuals and 25 non-viremic patients. a high frequency of positive reaction (90%) against at least one of the three hvrl variants analysed in this study was detected in the viremic patients. finally, competition experiments show that antibodies crossreacting with more than one hvrl variant are produced by hcv infected individuals. this results suggest that complex cross-reactivity exist between hcv isolates for antibodies against the hvrl region as described for antibodies against the gp120 v3 loop of hiv. we propose as mechanism for viral escape in hcv chronic infections the one described as the "original antigenic sin", observed firstly in influenza, in togavirus, paramixovirus, enterovirus, and recently in hiv infection. using an adult mouse model to study active immunity against rotavirus infection, it was previously shown that oral immunization with some, but not all, animal rotavirus strains induced protection against subsequent infection following oral challenge witb the murine rotavirus strain edim (ward et al., 1992) . to determine i f a specific rotavirus protein could be associated with protection in this model, mice were immunized with a series of 18 reassortants between the fully protective edim strain and a partially protective heterologous rotavirus strain (rrv-g). reassortants that contained genes for edim proteins responsible for protection were anticipated to provide complete protection; however, no edim proteins were found to be both necessary and sd3cient for full protection. instead, protection was found to be highly correlated with viral shedding (p = ,005) and with serum rotavirus iga titers stimulated by the different reassortants (p < ,001). this indicated that protection was related to the intestinal replication properties of the different reassortants rather than to specific immunogenic properties of edim proteins. this conclusion was supported by the finding that the titers of serum rotavirus i& but not igg, stimulated in mice following oral immunization with a series of animal rotaviruses was directly related to protection against edim. if these findings can be extended to humans, they suggest that the efficiency of intestinal replication following oral inoculation with a live rotavirus vaccine candidate may be the primary determinant of successful immunization. h a l l medical center, 55 individuals with adequate serum samples were identified as either rapidly progressing (rp) or slowly progressing (sp) by clinical and surrogate marker criteria. anti-v3 profiles were determined using synthetic proteins derived from the amino acid sequences of the v3 region of 5 laboratory strains of hiv-1 in standard capture elisa format. serum obtained from each patient at multiple different time points was screened against these peptides. the majority of individuals in both groups demonstrated broad recognition, with reactivity to peptides corresponding to the v3 regions of mn, sf2, ny5 and han/sc. less than 50% of individual in each group recognized the v3 peptide derived from iiib, @=ns, between groups). as the rp progressed to aids there was significant nonspecific narrowing of response, while the sp remained broadly reactivity (p< .001). in v i m neutralizing activity of the homologous laboratory isolates was determined with cytotoxicity, cytopathic effect and p24 ag inhibition assays. although most patient serum was capable of inhibiting p24 ag production in homologous lab strains while aids-free, there was no relationship with the ability to inhibit homologous virus effects on target cells and anti-v3 profiles. model, we show that after resolution of the acute infection, when antiviral plasma cells in the spleen decline, a population of virus-specific plasma cells appear in the bone m w and constitute the major sou~ce of longterm antibody production. following infection of adult mice, wspecific antibody secreting cells (asc) peaked in the spleen at 8 days postinfection, but were at this time undetectable in the bone marmw. the infection was essentially cleared by 15 days and the asc numbers in the spleen rapidly declined while an increasing population of lcmv-specific asc appeared in the bone marrow. when compared to the peak response at 8 days post-infection, timepoints from 30 days to more than one year later demonstrated greater than a l@fold reduction in splenic asc. in contrast, jltvlv-specific plasma cells in the bone marrow remained at high numbers and correlated with the high levels of antiviral serum antibody. the prewnce of antiviral plasma cells in the bone marrow was not due to a persistent infection at this site, since virus was cleared from both the spleen and bone marrow with similar kinetics as determined by infectivity and pcr assays. the igg subclass profile of antibody m e t i n g cells derived from bone manuw and spleen correlated with the igg subclass distribution of lcmv-specific antibody in the serum. upon rechallenge with w , the spleen exhibited a substantial increase in virus-specific plasma cell numbers during the early phase of the secondary response, followed by an equally sharp decline. bone marrow asc populations and lcmv-specific antibody levels in the serum did not change during the early phase of the reinfection but both increased about 2-fold by 15 days post-challenge. after both primary and secondary viral infection, lcmv-specific plasma cells were maintained in the bone marrow showing that the bone marrow is a major site of long-term antibody production after acute viral infection. "memory" t cells, and associated with responsiveness to soluble and recall antigens. cd4+ lymphocytes staining bright, dim, or negative (equivalent to an isotype control) for cd29 were evaluated in 49 uninfected controls (group l), 84 hiv-1 positive patients with 220% cd4+ t cells (group 2), and 47 hiv-i-infected patients with ~2 0 % cd4+ t cells (group 3). most of these subjects also had 3-color staining for cd4\cd45ro\cd45ra. the appearance of positive cd29 and cd45ro on hivinfected and uninfected cells correlated well (r=.82 p<.ool). the percentage of cells staining cd4+\cd29+.(bright plus dim) was 43.3 (95%cl 37.3-49.4) in group 1, 28.9 (27.5-30.4 ) in group 2, and 10.2(8.6-11.9) in group 3. the respective values for these groups that were cd4+\cd2gbwm was 30.6 (26.9-34.3), 20.7 (1 9.3-22.2), and 7.4(6.3-8.6). values for cd4+\cd45ro+ were 33.7 (31.8-35.5), 21.8 (20.5-23.1), and 9.9 (8.5-11.3), respectively. in single factor discriminate function tests, the %cd4+\cd29+ cells best predicted subject group (87% correct), proving to be a better discriminator than %cd4+\cd29b'h' (77% ~orrect),cd4+\cd29~"" (5 l%), cd4+\cd45ro+ (75%) and cd4+\cd45ro+\cd45ra-(63%). overall, no advantage was seen to splitting the cd4+\cd29+ cells into bright and dim positive subsets in the subjects studied for the purpose of stratifying early vs. late hiv infection. likewise, splitting the cd4+\cd45ro+ compartment into cd45ra+ subsets did not improve the ability to distinguish between uninfected and early or late hiv-1 infected patients. the relationship between the virus-specific cytotoxic response in hiv infected patients and disease progression support the concept that a vaccine candidate should also induce a virus-specific ctl activity. immunization of uninfected adult volunteers by a hiv-gpl60 recombinant canarypox virus was carried out in a phase i trial.two injections of a recombinant canarypox expressing the hiv-l/mn gp160 were performed at month 0 and 1 and two boosts of recombinant gpl60mn/lai at month 3 and 6 in alum or incomplete freund adjuvant(1fa). hiv-envelope specific cytotoxic activities were detected from ctl lines derived from pbmc stimulated by specific stimulation with autologous hiv infected blasts. ctl lines were obtained from 18 out of 20 donors : seven out of eighteen (39%) were found to present envelope specific cytotoxic activity at months 2, 4, 7 or 12 post immunization ; this activity was characterized as a cd3+,cd8+, mhc class-i restricted cytotoxic activity, and for at least two volunteers, this activity was still present two years after the first canari-pox/env injection. because avian poxviruses are incapable of complete replication and undergo abortive replication in mammalian cells , this is a n example of the persistence of long term memory cd8+ cytotoxic t lymphocytes in the absence of the priming antigen, indicating that t-cell memory might be independent of continued antigenic exposure. the university of alabama at birmingham, al 35294. mhc class i restricted cd8' ctl activity plays an important role in the control of influenza virus infection as indicated in studies in mice and humans. cytokines such as il-2 and ifn-y regulate the generation of virus-specific ctl responses. we recently demonstrated a good correlation between the induction of influenza virus-specific ctl activity and the production of ifn-y by the cd8' t cells at the single cell level using an if?-specific elispot assay, secreted ifn-y by an elisa, and ifn-y specific mrna expression by rt-pcr. several recent studies have characterized cd4+ and cd8' t cells by their expression on the surface of distinct d45r isoforms. cd45ra is expressed on naive or virgin t cells, while cd45ro is expressed on memory t cells. in the present study, pbmc of healthy young adult subjects were stimulated with influenza a virus and then enriched for cd8+ t cells. the cd8' cells were stained for cd45ro' (pe) and cd45ra' (fitc) cells and sorted. ctl activity against virus-infected autologous target cells was determined in a 4 hour 'lcr release assay while ifn-y production and expression was assessed by elispot and quantitative rt-pcr, respectively. cds+/cd45ro+ (memory) cells exhibited significant mhc class i ctl while cds+/cd45ra+ cells exhibited no lytic activity. no activity was exhibited by freshly isolated or unstimulated cd8+/cd45ro+ t cells. similarly, cd8+/cd45rot t cells contained significantly higher numbers of ifn-y spot forming cells and higher quantity of ifn-y-specific mrna than cd8+/cd45rac cells. these data support our previous findings that ifn-y may serve as a useful surrogate marker for influenza virus-specific ctl activity in humans. in studying the kinetics of the cd8+ t cell response in lcmv infection we have observed a profound activation and proliferation of cd8+ t cells with a 10-40 fold increase in total number peaking at day 8-9 post infection. in c57bw6 mice, most of the viral antigen is cleared by day seven, and after day 9 the total cd8+ number per spleen drops about 10-fold. however, the relative specificity of the viral peptidespecific precursor ctl frequencies @ctwf) per cd8+ cell remains remarkably stable between day 7-8 of the acute infection and for many months thereafter. thus, the decline in the cd8' t cell number is not a function of the tcr specificities but is rather an across-the-board event. in contrast, we found that subsequent to the decline of the ctl response to a second heterologous virus infection such that the mouse was in a "resting, immune'' state, there often was a reduction in pctl/f to the first virus. for example, infections with w or mcmv substantially reduced the pctuf to lcmv or pv in all memory compartments, including spleen, lymph nodes, peritoneal exudate cells. reinfection with the original virus substantially elevated its pctuf and restored the pctuf that had been reduced by a heterologous viral infection. analyses of the progression of ctl responses during a heterologous virus challenge of a virus-immune mouse indicated a high frequency of crossreactive ctl appearing early during infection, but as the infection progressed there was a higher proportion of ctl specific only for the second virus. thus, we believe that when the across-the-board apoptosis of t cells occurs late in the infection, ctl specific for the first virus are diluted by those responding to the second virus. this may cause the reduction in memory to the first virus and may be one of the mechanisms contributing to the waning of secondary immune responses to certain viruses over time if there is no re-exposure to the original infectious agent. t-cells which arise after virus infection will aid our understanding of tcell memory and be useful in the design of vaccines which augment the memory response. to estimate the sendai virus specific precursor frequency in memory mice, cd4+ cells from c57bl6 female mice which had been infected with sendai virus intranasally (i.n.) more than two months earlier were subjected to limiting dilution analysis. responder cell populations were enriched for cd4+ cells either by magnetic bead depletion of non-cd4+ cells, or by facs after staining with anti-cd4 monoclonal antibody these enriched (>90% cd4+) responders were cultured with sendai virus-infected, irradiated, t-cell depleted splenic antigen presenting cells (apc). supernatants from these cultures were tested for activity on the cytokine-dependent ctll cell line. duplicate cultures of responders on uninfected apc were used to set the level of rejection (mean cpm + 3x std. dev.). using this type of analysis we were able to demonstrate a frequency of memory thp at 111600 cd4+ cells, compared to a frequency greater than 1/1ooooo in naive controls. the memory cd4+ cells were further characterized as cd45rb-low (1/472) , cd44-high (1/294), lselectin-low (1/364), and cd49d-high (vla-4-high) (v102). this is close agreement with other phenotyping studies on cd4+ memory cell specific for soluble antigens. t cells, ralph a. tripp, sam hou, anthony mcmickle, james houston and peter c. doherty, department of immunology, st. jude children's research hospital, memphis, tn 38105. the immune response of influenza a and sendai-virusspecific, memory cd8' cytotoxic t lymphocyte precursors (ctlp) have been analyzed in c57bu6 mice infected intranasally with unrelated or cross-reactive respiratory viruses. the numbers of influenza a-specific memory t cells increased in the regional lymph nodes (ln), spleen and bronchoalveolar lavage through the course of an irrelevant infection (influenza b). memory t cells showed evidence of enhanced steady-state activation. profiles of ctlp recruitment were analyzed in association with t cell proliferation and activation to determine whether signaling via the t cell receptor is necessary to induce "bystander" stimulation of the memory t cell pool. the extent of t cell proliferation was addressed by treating mice with low doses of cyclophosphamide (cy). "resting" sendai virus-specific memory t cells were unaffected by cy treatment, however upon challenge with influenza and treated 5 or 6 days later, the emergence of influenzaspecific ctlp was severely diminished. cell cycle analysis showed that cy eliminated the majority of cd8' t cells from the ln and spleen resulting in dna fragmentation of 12-18% ofthis lymphocyte subset. a decrease (though smaller) in the numbers of sendai virus-specific ctlp indicated that some of the cycling cells killed by cy were memory t cells, presumably activated in a "bystander" manner. the decrease in ctlp numbers for both influenza and sendai virus-specific ctlp was still apparent 9 days after cy treatment, long after the viral elimination. thus, immune responses to unrelated antigens may be a mechanism involved in maintaining the pool of memory t cells. experimentally vsv can result in an acute cns infection of mice. data from our in vitro experiments indicate that no has inhibitory effect on productive vsv infection. vsv infection at neuroblastoma nb41 a3 cells was significantly inhibited by loopm of a no donor s-nitro-n-acetylpencillamine (snap), while 1oopm of the control compound n-acetylpencillamine (nap) had no effect. when vsv infected nb41a3 cells were treated with 500pm of a constitutive no synthase (cnos) activator n-methyl-d-aspartate (nmda), a significant inhibition of vsv production was observed. inhibition by 500pm of nmda was reversed by 300pm of nos inhibitor n-methyl-l-arginine (l-nma). work is in progress to determine the effects of inducible nos (inos) in a glioma cell line c6 on vsv infection. levels of no and expressions of both cnos in neurons and inos in glial cells in the cns following vsv will be further investlgated. supported by nih grant a118083 to carol s. reiss. pediatrics, university of iowa, iowa city, ia. 52242 mouse hepatitis virus, strain jhm (mhv-jhm), is a neurotmpic coronavirus which causes acute encephalitis and acute and chronic demyelinating encephalomyelitis in susceptible rodents. 40.90% of suckling c57bu6 (kbdb) mice inoculated intranasally with mhv-jhm at 10 days and nursed by dams immunized against the virus develop a chronic demyelinating encephalomyelitis characterized clinically b hindlimb paralysis, at 3-8 weeks postinoculation. the chronic demyelinating encephalomyelitis nor the clinical symptoms. recently, it was shown that lymphocytes isolated from the central nervous system (cns) of c57bu6 mice both acutely and persistently infected with mhv-jhm display a cytotoxic t lymphocyte (ctl) response to the s protein of mhv-jhm. this response was further characterized by identifying the ctl epitopes that are recognized by a bulk population of ctls from the cns of mhv-jhm infected c57bv6 mice. three epitopes were identified using synthetic peptides and truncated forms of the s protein in primary ciz assays. the epitopes recognized were amino acids 510-518 (cslwngphl, db), 598-605 (rcqifani, kb), and 1143-1151 (nfcgngnhi, db). thus, the results indicate that cytotoxic t lymphocytes responsive to the s protein of mhv-jhm in c57bu6 mice recognize both kb and db-restricted cil epitopes. ctl lines and clones specific to these peptides and the entire s protein are being developed to test their biological significance in vivo with respect to the acute encephalitis and chronic demyelinating disease caused by mhv-jhm. a marked change in susceptibility to some neurotropic viruses during the first few postnatal weeks has long been recognised in rodents. infection of neonatal or suckling mice with the neurotropic alphavirus, semliii forest virus results in lethal encephalitis. infection of weaned animals is not lethal. earlier investigations focusing on changes in specific immunity have shown this not to be the explanation. infection of 3-4 week old mice with severe combined immunodeficiency does not result in acute rapidly fatal encephalitis. we have studied mortality, neuroanatomical distribution and spread of infection in mice of different ages and the effect of gold compounds on rendering infection of 3-4 week old mice lethal. neuroanatomical distribution of infection correlates with synaptogenesis. as this is completed in different systems within the first two weeks postnatal, systems no longer transmit virus and infection switches from disseminated to focal and restricted. complete productive replication and transmission of infection require smooth membrane synthesis which is present in neurones undergoing synaptogenesis, absent in mature neurones but inducible by administration of gold compounds. infection of neurones undergoing synaptogenesis is productive and virus is transmitted along neuralpathways, infection spreads rapidly around the brain, destroys cells and animlas die of a fulminant encephalitis. in mice infected after 14 days of age replication in mature neurones is restricted, nonproductive, cannot be transmitted, does not spread, is non-destructive and non-lethal. as a consequence, in the absence of immune responses virus can persist in isolated cns cells for life and can even be detected by reverse transcriptase pcr in immunocompetent mice months after infection. in the presence of an immune response, cd8+ t-cells recognise and destroy infected glial cells leading to dem yelination. a~k e r m a n n ,~ virology swine,' virology cattle,' and avian diseases3 research units, national animal disease center, usoa, agricultural research service, ames, ia 5001 0 a recombinant pseudorabies virus (prv) (lltbap) was constructed which contains a 3.0 kb deletion spanning the standard recombination junction of the unique long and internal repeat sequences replaced by e lacz expression cassette. this deletion interrupted the large latency transcript gene (llt) and truncated one copy of the diploid immediate early iel80 gene. replication and viral gene expression of lltbaz in madin-darby bovine kidney cells was similar to that of the parental virus and a virus rescued for the deleted sequences (lltbres). when inoculated intranasally in 4-week-old or 4-day-old pigs, lltba2 replicated efficiently at the site of inoculation yet caused markedly reduced fatality when compared to the parent or lltbres viruses. in particular, the lltba2-infected pigs did not exhibit neurological symptoms characteristic of prv infection. to further examine the pathogenesis of lltba2, 4-day-old pigs were infected intranasally with lltpa2 or lltbres and necropsied at various times postinfection. virus isolation from the nasal turbinate, tonsils, and trigeminal ganglia was comparable between the two viruses. although both viruses spread to the brain and induced an inflammatory response in cns tissues, virus isolation from brain tissues was reduced about 20-fold for lltpa2. abundant prv antigen was detected in the cerebrum and cerebellum of lltpresinfected pigs, but only a few antigen positive neurons were observed in the cerebrum of lltba2-infected pigs. while replication of lltbres in the brain progressed until death at 7 days post-infection, replication of lltpa2 in the brain ceased by 9 days post-infection and the pigs exhibited only mild clinical signs. since lltba2 is capable of spread to the cns, reduced neurovirulence of lltbaz is likely the result of its decreased ability to replicate in cns tissues. the cns is a target for hiv infection, and in individuals with aids this can lead to a devastatin dementia. only certain viral variants appear capable 07 invading the cns and infecting microglia and brain macrophages. in order to determine whether the virus entering the brain may be particularly pathogenic to the cns, we isolated microglia from the brains of siv-infected rhesus monkeys. transfer of these cells into naive animals indicated that productive siv infection could indeed be transferred. furthermore, cns infection occurred within a relatively short time span, and was associated with viral gene expression in the brain and pathology characteristic of hiv encephalitis. serial transfer of microglia into additional animals also resulted in successful transfer of infection, neuroinvasion, and neuropathology. behavioral analysis in a trained group of animals is ongoing. this result demonstrates that neuropathogenic virions partition into the cns during natural siv infection, likely driven by mutational events that occur during the course of infection. molecular characterization of the microglia-associated virus has revealed that a distinct pattern of sequence changes in the envelope gene occurs concomitantly with this in vivo selection. our approach will allow the dissection of functional neuropathogenic elements present in these viruses. in non-specific host defense mechanisms. ifn-y-induced nitric oxide (no) in murine macrophages was previously shown to inhibit the replication of poxviruses and herpes simplex virus type 1 (hsv-1) . we now demonstrate that murine macrophages activated as a consequence of vaccinia virus (vv) infection in viva express inducible nitric oxide synthase (ios). the vvelicited macrophages were resistant to infection with w and efficiently blocked the replication of w and hsv-1 in infected bystander cells of epithelial and fibroblast origin. this inhibition was arginine dependent, correlated with no production in cultures and was reversible by the nos inhibitor nqjmonomethyl-l-arginine. the mechanism of no mediated inhibition of virus replication was studied by treating vv-infected 293 cells with the noproducing compound, s-niuoso-n-afetyl-penicillamine. antibodies specific for temporally expressed viral proteins, a vv-specific dna probe and transmission electron microscopy were employed to show that no inhibited late gene protein synthesis, viral dna replication and virus particle formation, but not expression of the early proteins analyzed. further, we have also identified putative enzymatic targets of inactivation by no that results in inhibition vv replication. although antiviral ctl are important for virus elimination. they can only halt further virus spread, and cannot reduce the number of infectious particles already present. the beneficial effect of ctl-mediated lysis is apparent only if infected cells are lysed before assembly of progeny virus. if infectious virus was released from infected cells in solid tissues before the generation of neutralizing antibody or in sites where antibody did not readily penetrate, then recruitment of mononuclear phagocytes, which phagocytose and destroy infectious material and/or become non-productively infected, would definitely help control virus dissemination. in this context, inos induction in macrophages may be an important antiviral strategy. in addition, the inhibition of virus replication in infected contiguous cells by inos-expressing macrophages at infectious foci would prevent release of mature viral particles after lysis by nk cells and ctl. since viral early proteins are expressed in such infected cells, their recognition and subsequent lysis by ctls will not be hindered. cns persistence, tropism and genetic j. pedro s i s , anthony a. nash and john k. fazakerley, department of pathology, university of cambridge, cb2 iqp, uk theiler's murine enchephalomyelitis virus, a natural occuring enteric pathogen of mice, is a picomavirus belonging to the curdovirus genus. following intracerebral inoculation of 3-4 week old cba or balb/c mice, the bean strain causes a chronic persistent cns demyelinating infection in a proportion of the cba that survive acute infection. balb/c mice are resistant to chronic demyeliating disease. we have studied the tropism, persistence and genetic variability of bean, in cba and balb/c mice in the chronic phase of this disease. by in situ hybridisation and reverse transcription (rt) pcr and southern blot analysis, no viral rna could be detected in the cns of any balb/c mice later than day 60 post-infection. in contrast, in a large group of cba mice studied up until 393 days post-infwtion, viral rna could be detected by both techniques in 50% of mice until as late as 268 days post-infection. by employing a combination of, in situ hybridisation for viral genome followed by immunocytochemistry for cell phenotypic markers, bean rna was observed predominantly in oligodendrocytes and occasionally in astrocytes during persistent infection, in both brain and spinal cord. in the persistently infected mice, the striking total destruction of the pyramidal layer of the hippocampus, substantia nigra and anterior thalamic nuclei indicated that these were the mice that had had greatest dissemination of virus and highest virus titers during the preceeding acute phase of infection. direct pcr t h d cycle sequencing of uncloned rt-pcr products, revealed that during persistent infection, loops i and ii of the vpi capsid protein gene did not undergo any genetic variability. furthermore, no changes were detected in this region in sequenced pcr products amplified from the cns of mice with severe combined immunodeficiency in which no selective immunological pressure would have been operative. infection, thomas e. lane, michael j. buchmeier, dorota jakubowski, debbie d. watry, and howard s. fox, department of neuropharmacology, the scripps research institute, la jolla, ca 92037 our laboratory is interested in the effects of siv infection in the central nervous system of rhesus macaques. to enrich for neuroinvasive and neurovirulent viruses, microglia were isolated from infected monkeys and used t o infect new, uninfected monkeys. such microglia-mediated infection resulted in the production of neuropathological changes, including giant cells, macrophage infiltrates and microglial nodules in recipient animals within 4 months. microglial cells isolated from siv-infected monkeys produced virus in vitro as measured by reverse transcription (rt) and p27 production. treatment of microglia with recombinant human interferon alpha (rhulfn-a) resulted in a sharp decrease in viral activity (both rt and p27 production) suggesting that rhulfn-a is able t o modulate viral activity in infected microglia. we have analyzed slvenv sequences by pcr amplification directly from microglia dna preparations from monkeys. nucleotide sequence analysis results in an enrichment of unique sequences in the v1 region of the siv env gene. the majority (>95%) of nucleotide changes encoded amino acid changes, indicating that these envelope sequences evolved as a result of selection. moreover, sequential passage of sivassociated microglia resulted in an increase in potential n-linked glycosylation sites within the v1 region of the env gene when compared with the parental virus. these data suggest that sequential passage of microgliaassociated siv may select for neuroinvasive, neurovirulent variants. the adoptive transfer of ctl specific for an ld-restricted epitope within the nucleocapsid protein of the jhmv strain of mouse hepatitis virus both protect from acute infection and reduce virus replication in the mhc class 1 positive cells within the cns. the source of these ctl and the route of their delivery is critical in the outcome of this protection. for example, 10 fold less spleen cells activated in vitro with the pn peptide are required for protection via the direct i.c. route than the i.v. route. in addition, ctl clones are unable to protect via the i.v. route and are very efficient via the i.c. route. these data suggested the possibility that the cd4+ t cells within the polyclonal activated spleen cell population derived from in vitro culture on the pn peptide were facilitating access to the cns. to examine this question, polyclonal pn-specific t cells were either depleted of cd4+ t cells prior to transfer to infected recipients or untreated cells were transferred to recipients depleted of cd4+ t cells with monoclonal antibody gk1.5. both of these treatments eliminated the ability of the ctl to reduce virus replication within the cns, suggesting that cd4+ t cells in the peripheral compartment are required for the entry of ctl into the parenchyma of the cns during acute cns encephalomyelitis. division of retrovirology, walter reed army institute of research and henry m. jackson foundation, rockville, md 20850; department of retrovirology, armed forces research institute of medical sciences, bangkok, thailand background the hn-1 epidemic in thailand is largely due to two highly divergent subtypes of virus, b and e. dual infection with distinct hn-1 subtypes, which has not been reported previously, would suggest that antiviral immunity evoked by one subtype can be incompletely protective against a second. merhoak: pcr typing and serologic typing were used to screen a panel of non-random convenience specimens from hiv-1 infected subjects in thailand. specimens that showed dual subtype reactivity in these assays were subjected to differential pmbe hybridization and nucleotide sequence analysis of multiple molecular clones to c o n f m the presence of dual infection. results. two individuals were shown to simultaneously harbor hiv-1 of env subtypes b and e (table) . additionally, both subtypes were identified in co-cultured pbmc from one individual. conclusions. these data provide the fmt evidence of dual hiv-i infection in humans and reinforce the need for polyvalent vaccines. infection by herpes simplex virus wsv) induces in man and in mice cytolytic t lymphocytes (ctl) which recognize the immediateearly protein icp27. because of its early expression during the hsv replication cycle, lcp27 represents a prime target for specific t cell responses susceptible of controlling virus replication. we have expressed in e. coli a remmbinant construct coding for a fusion protein consisting of a fragment of influenza virus non-structural protein4 (nsi) and the lcp27 sequence of hsv-2. the nsi-icp27 protein was purified by preparative eleclmplmresis and formulated in oil-in-water emulsions with monophosphoryl lipid a (mpl) and qszl adjuvants. balwc mice were immunized by two intrafootpad injections of formulations containing 5 pg of nsi-icp27. responder cells obtained from draining lymphnodes were re-stimulated in vitro with p815 cells lransfected with icp27 and then lesled for cytolytic activity on icp27-p815 and control p815. the induction of icp27 specific ctl by different formulations was observed and will be discussed. the induction of heterologous cytotoxic t lymphocytes (ctl) using cassettes of multiple conserved t cell epitopes derived from different proteins and/or virus strains is envisioned as a promising vaccine approach. to study the effects of antigen processing on peptide presentation from chimeric epitope precursors we are using a model system comprising two distinct viral epitopes which are immunodominant in the h-2d haplotype: a dd restricted epitope from the gp160 protein of hiv-1 and an ld restricted epitope from the murine hepatitis virus nucleocapsid protein (mhv n). the influence of proximity and flanking sequences of epitopes on antigen presentation was analyzed using vaccinia virus (vv) recombinants in which the epitopes were expressed as chimeras containing the individual epitopes in reverse order or separated by different spacer residues. whereas individually expressed epitopes were efficiently recognized by protein-specific ctl, recognition of peptides derived from tandem constructs varied significantly with closer epitope proximity and sequential order. following immunization with the recombinant viruses, the chimeras were all able to induce antiviral ctl specific for the native proteins. however, cn, frequency analysis indicated that the number of responder cells to the same epitope dramatically depends on its context within the chimera and correlates with antigen recognition in vitro. the profound effect of flanking regions on ctl induction suggests that the context of an epitope will require careful evaluation in the design of recombinant multivalent minigene vaccines to induce an optimal t cell mediated immune response. and robert e. johnston', departments of 'microbiology & immunology and %iochemistxy, univ. of north carolina, chapel hill, nc 27599 a hll-length cdna clone of venezuelan equine encephalitis virus w e ) has been altered to contain two strongly attenuating mutations and a second subgenomic rna promoter immediately downstream of the structural gene region. expression ofthe influenza ha protein from this second promoter in baby hamster kidney (bhk) cells was approximately 50?? of the level in influenza virus-infected cells, as measured by immunoprecipitation. fourweek-old cd-1 mice were inoculated subcutaneously with 2 x 10' p h of the ha vector, vector alone or diluent. expression of ha mrna was detected in the draining lymph node of ha vector-inoculated mice by in situ hybridization, consistent with the organ tropism of vee. mice were challenged three weeks after imnmization by intranasal administration of lo5 ed, of influenza h s . au 24 corn1 mice suffered severe disease and 50% died. only one of 12 ha vector-inoculated mice died, and another exhibited signs of disease for one day and recovered. the geometric mean elisa titer of anti-ha serum igg in the ha-vector inoculated mice was 246, while only three control mice had measurable serum reactivity, and that was at the lowest dilution tested, 150. in a parallel experiment, no influenza infectivity was detected in the lungs of 12 ha vector immunized mice at 4 days postchallenge. in contrast, 8/12 pbs-inoculated mice and 5/12 inoculated with vector alone were positive for influenza infectivity and had geometric mean titers of 3.04 and 1.93 x lo6 pwgm, respectively. this vector also has been used to express the h n w c a protein in a form recognized by patient sera and a specific antibody on western blots. these experiments demonstrate the feasibility of using vectors based on attenuated vee cdna clones for protective immunization against heterologous human and animal pathogens. dose/response curves have been used to compare different routes of immunization with plasmid dna encoding the h1 hemagglutinin glycoprotein of influenza virus. routes of inoculation included intramuscular, intradermal and gene gun delivery of dna. from 100 to 0.1 ug of dna was inoculated by intramuscular and intradermal routes. from 0.4 ug to 0.0004 ug of dna was inoculated by gene gun. each route was evaluated for single and boosted immunizations. antibody titers were followed over a 20 week period, following which animals were evaluated for protection against a lethal challenge. each of the routes raised both antibody and protective responses. gene gun-delivery of dna required 250 to 2,500 times less dna to raise responses than the intramuscular and intradermal inoculations. boosts did not have much of an effect on antibody titer or protection except at low dose inoculations (4 ng and lower for the gene gun). for each of the routes, antibody responses showed good persistence over the 20 weeks of the experiment. inoculation of mice with plasmid vectors carrying a microbial gene under the control of an appropriate promoter results in a full spectrum of immune responses to the vectorencoded antigen. using a murine rabies model a plasmid termed psgsrab.gp expressing the full-length rabies virus glycoprotein regulated by an sv40 promoter was shown to induce upon inmuscular inoculation a rabies virus specific t helper cell response. of the thl type, cytolytic t cells and virus neutralizing antibodies resulting in protection against a subsequent challenge with live rabies virus given either peripherally or directly into the cenaal nervous system. a response comparable in magnitude was also induce upon inoculation of a vector expressing a secreted form of the rabies virus glycoprotein. the immune response to the dna vaccine could be modulated by co-injection of the rabies virus glycoprotein-expressing vector with plasmids expressing mouse cytokines. inoculation of mice with the psg5rab.gp vector and a vector expressing granulocyte/macrophage colony stimulating factor (gm-csf) enhanced both the t helper and the b cell response to rabies virus thus improving vaccine efficacy. co-inoculation with vectors expressing interferon-g failed to improve the response. co-inoculation of the antigen-expressing vector with a plasmid encoding mouse i l 4 caused a reduction of both the t helper cell response and the b cell response to rabies vlns. hpvl6 e7 hpv associated cervical cancer cells express hpv16e7 protein and antibody to hpv16 e7 can be detected in the blood of cancer patients, yet the twnours are. not rejected. a mouse transgenic for the e7 protein of hpv16, and expressing e7 protein in the skin, has recently been described (1) and these mice develop spontaneous humoral immunity to e7 protein similar to patients with cervical cancer(2). to determine whether immunisation could induce immunity to e7 sufficient to allow tumour rejection, we firstly demonstrated that immunisation of h-zb mice with hpv16e7 protein with quil a as adjuvant could induce cytotoxic t cells able to kill hpv16 e7 expressing tumour cells in nrro. we then used similar immunisation with e7iquil a to induce e7 specific immunity in fvb (h-29) mice. h-2qskin @s expressing e7 were not rejected by e7 immunised h-zq mice, though immunisation induced antibody to e7, and similar grafts were rejected, as expected, across an doantigen mismatch in h-zb mice. we conclude either that hpvl6 e7 lack a tc epitope in the context of h-zq, or that expression ofe7 in the skin from the e7 transgenic mice is insufficient for recognition by primed effector cells, and further experiments will address this distinction. cervical carcinoma is strongly associated with infection by human papillomavirus (hpv) types 16 or 18, and continued expression of the e6 and e7 gene products. this provides an opportunity for an immunotherapeutic approach to the treatment of cervical carcinoma by activation of immune reponses directed against these virally encoded tumour specific antigens. we have constructed a recornbinant vaccinia virus expressing e6 and e7 from hpv16 and 18 with the aim of inducing e6 and e7 specific hla class i restricted cytotoxic t lymphocytes (ctl). the sequences have been inserted into the wyeth vaccine strain of vaccinia virus at a single locus in the form of two separate fused e6/e7 reading frames, each under the control of an early v a d n i a promoter, and each modified to inactivate the rb binding site. the virus has been characterised with respect to its ability to synthesise the expected hpv proteins, its genetic stability, and growth and virulence in a mouse model prior to use in human clinical trials. analysis of hpv16 â�¬7 specific ctl from c57bu6 mice immunised with this recombinant virus show the response to be equivalent to that generated by a control vaccinia recombinant expressing non-modified hpvi 6 e7 alone, with similar recognition of the defined immunodominant h-2db restricted epitope, e7 residues 49-57. ability of mice to resist influenza challenge, arthur friedman, douglas martinez, john j. donnelly and margaret a. liu, department of virus and cell biology research, merck research laboratories, west point, pa 19486 mice infected with the laboratory strains of a/pr/8/34 (hln1) or the mouse adapted a/hk/68 (h3n2) show complete protection against challenge with a different strain of influenza a. humans, however, undergo multiple influenza infections as previous infections appear to provide weak or short-lived protection against the continual antigenic change of strains. we have previously shown that immunization of naive mice with dna encoding the conserved internal antigen nucleoprotein (np) provides protection against both h1 and h3 strains of a/influenza. although such mice became infected they were resistant to weight loss and death this differed substantially from a/pr8 and a/hk recovered mice which were resistant to subsequent infection. to produce a more representative model of human infection, we infected the lungs of mice with currently circulating strains of human influenza. mice that had been given lung infections with a/beijing/92 were susceptible to subsequent infection with the a/hk/68 strain although they were resistant to weight loss and death. other strains such as a/beijing/89 or a/georgia/93 provided only marginal protection against weight loss and death against a/hk challenge. mice that were immunized with np dna had greater resistance to weight loss and death after a/hk/68 challenge than mice previously infected with a/bei/89 and a/ga/93, and were similar to mice that had been previously infected with a/bei/92. thus, infection with different virus strains provide various levels of cross strain protection and the level of protection provided by immunization with dna can exceed that induced by live influenza infection. the development of sendai virus-specific cytotoxic t lymphocyte (ctl) effectors and precursors (p) has been compared for mice that are homozygous (-/-) for a disruption of the h-21-ab class ii major histocompatibility complex (mhc) glycoprotein, and for normal (+i+) controls. the generation of cd8+ ctlp was not diminished in the (-/-) mice, although they failed to make virusspecific igg class antibodies. while the cellularity of the regional lymph nodes was decreased, the inflammatory process assayed by bronchoalveolar lavage (bal) of the infected lung was not modified and potent ctl effectors were present in bal populations recovered from both groups at day 10 after infection. there was little effect on virus clearance. as found previously with cd4-depleted h-2b mice, the absence of a concurrent class il-mhc-restricted response does not compromise the development of sendai virus -specific cd8+ t cell-mediated immunity. the importance of cytoxic t lymphocytes in defense against acute and chronic viral infections is gaining increasing recognition. our approach to investigating the structure-function relationship between immunogens and their in vivo ability to elicit cytotoxic t lymphocyte responses has been to formulate simple, well-defined structures that vary in their ability to introduce associated antigens directly into the cytoplasm of antigen presenting cells. we have introduced methods for the preparation of unique, lipid-matrix based immunogens, which are highly effective in mice and monkeys for stimulating strong cd8+ cytotoxic t cell responses, (ctl). antigens used have been proteins or peptides derived from influenza, parainfluenza, and hiv viruses, and whole formalin-fixed siv. ctl can be induced by parenteral as well as oral administration. comparing the physical and chemical nature of our formulations with those from other laboratories which have reported the use of subunit preparations to induce cd8+ ctl, leads us to propose that a minimal immunogenic formulation capable of eliciting cd8+, mhc class i restricted cytotoxic t lymphocytes includes: i) a peptide that represents a mhc class i epitope; ii) a component that enhances the aftinity of the immunogen for mhc class i positive antigen presenting cells ; iii) properties that can compromise the integrity of a lipid bilayer, facilitating delivery of the antigen directly into the cytoplasm for class i presentation. cd8+ responses to peptides, glycoproteins, and even whole fixed viruses, makes them attractive candidates for diseases where clearance of infected cells is important in protection and recovery. cani ne rabies is uncontrolled. rabies also is epizootifally active in several species in most areas of the wor!d. thm, vaccination of animals, both wild and domestic, as well as postexposure treatment of humans remains a global concern. unfortunately, in those countries in which,people most need postexposure prophylaxis, the best vaccines are expenswe and in limited supply, whereas available vaccines are of questionable immunogenic efficiency, are otten contaminated and may produce neurological complications. the goal of this study was to determine whether a rabies vaccine for global use is complete one round of replication have the potential to be used as vaccines. we have previously reported the abiliity of a ghdeleted herpes simplex virus type 1 (hsv-1) to protect mice and guinea-pigs from subsequent challenge with wild-type hsv. this virus, which we have called disc (disabled infectious single cycle) virus, can infect normal cells but the absence of gh in the progeny virus prevents further rounds of infection. as disc hsv clearly has potential as a vaccine, it is important to determine the durability of the immune response elicited by this virus. we have investigated the ability of disc hsv-1 to protect mice from a wild-type virus challenge six months post vaccination using the ear model of hsv infection. two immunisations on day 0 and day 21 resulted in a considerable reduction in virus titres in the challenged ears, and an almost complete absence of virus in the dorsal root ganglia. hsv-specific antibody titres as determined by neutralisation and ellsa were maintained for the six months period. it was possible to demonstrate an hsvspecific cytotoxic t-cell response in the disc hsv-1 vaccinated mice following challenge; this ctl activity was similar to that observed in mice vaccinated with wild-type virus and challenged after the same time period. animals vaccinated with inactivated virus or control mock-vaccinated mice showed a low level of ctl activity typical of a primary ctl response following challenge. these results indicate that an effective cell-mediated and humoral anti-hsv immune response can be maintained for at least six months following vaccination with disc hsv-1. viruses which lack an essential gene and thus can only the lmmunogenicity of two ctl @topes. influenza npl47-158 and plasmodium berghei cs protein 252-260 were studled in balblc mice. paptides were formulated as a) a iipopepudepeplkle conlugated to irlpalmltoyl-sgly~~l cysteine (pam3cyj) and dissolved in a 1% dmsolglycerol solution. b) micmparticles prepared with poly @.l ladide-coglywlide) using a solvent evaporation technique. the micropaltides were administered as a suspension in phosphate buffered saline or c) an emulsion prepared wilh egg lecithin and 10% soya oil in water. 1 wpg of peptide or controls (the welght equivalent of blanks) were administered to groups of 3 mice intra-peritoneally or subcutaneously at 1.10 and 20 days. 7 days following the last immunization splenocytes were cukured in vlro in the presence of appropriate pepwe or wntml m h rat con a supematant as a source of omwth fadors. ctl adivity was measured in a standard 4 hour chromium release assay and results expressed as % specific lysis. ctl could be elicited in vivo with all three formulations. at an ewedoctarget ratio of 1w:l the plasmodium berghei peptide encapsulated in micmpartides gave 47% iysls on peptide pulsed target calls. levels of lysis were similar for the peptide in emulslons. the iipopeplide p3ccs252-260 gave a level of lysis of 82% at an e:t ralioof1w1. these results demonstrate that peplides edminldered in a variety of formulations can induce a systemic ctl response in vivo. peplide vaccines using such formulations wuld be used to stimulate ctl responses as part of a prophyladic vaccines or as immunotherapeulics. attenuated the attenuated sabin strains of poliovirus have been used for many years to elicit protective immunity to poliovirus. oral vaccination with replicating polioviruses generates both mucosal and systemic immunity. therefore, use of recombinant polioviruses expressing heterologous antigens as vaccine delivery vectors should provide a system for generating protective immunity to those antigens. cdna copies of the poliovirus genome has been used to construct vectors containing a multiple cloning site for insertion of heterologous genes. a pilot enhanced-potency inactivated poliovirus vaccine (ejpv) with assumably improved immunogenicity containing win-treated type 3 poliovirus (shah sauketf) together with the regular type 1 and type 2 canponena was subjected to s*mdard safety and potency tesls in the labmatory and laken through wase i and i1 clinical aials. in balb/c mice, the lrypin-mcdit%d e-if' v cfryipv) was found to induce antibodies targeted ouaide the uypsin-sensitive bc-loop of capsid protein vp1. as previously shown for hypsin-mated type 3 poliovirus @vm alone. trypsin used to modify the type 3 component at the bulk phase was removed by the vaccine manufacturer (rivm) in the regular purification process. absence of uypsin in the final product was further confumed by immunizing mice and rabbits with 10-fold concentrated type 3 component of tryipv. assays for lrypin antibodies using eia and westem blot techniques were newve. in the clinical phase 1 aial six adult volunteers with existing immunity to poliovirus were given increasing doses of tryipv. already one tenth of the regular dose induced a booster effect in neuarlizing antibodies to both intact and mypsin-treated type 3 poliovirus. no unexpected sideeffects were recorded phase i1 trials comprised 50 adult volunteers with at least 5 years since the last dose of poliovirus vaccine and 50 children who were due to receive the third dose of the regular immunization schedule at about 2 years. in both groups. 25 individuals received tryipv and 25 were injected with the regular enhanced potency ipv (e-ipv). serum specimens drawn before injection and one month after were tested for neunalizing antibodies using standard microneuwlization assays (all mutypes) and the racina test (intact and uypsin-mated type 3 poliovirus). in all volunteers tryipv was at least as immunogenic t w the regular e-ipv according to all assays. no statistically significant differences in side effects were reported. a murine/influenza virus model has been used to evaluate the longevity of antibody and protective responses raised by gene gun delivery of a hemagglutinin-expressing dna. mice were immunized and boosted at one month with 0.4 ug of an h1 expressing plasmid dna (pcmvri1). antibody responses and protection against a lethal challenge were followed over the next year. antibody responses had good longevity exhibiting comparable titers at one year post boost as at 10 days post boost protection against the lethal challenge was complete at 10 days, 1 month and four months post boost, but only partial at one year. a transgenic mouse model for identifing htlv-1 t-cell epitopes: generation of hla-b*3501-restricted ctl directed against synthetic peptides and naturally processed viral antigens, christian schiinbach*, ai kariyone*, kiyoshi nokiharaa+, karl-heinz wiesmulle6 and masafumi takiguchil, departments of tumor biology* and immunology#, institute of medical science, university of tokyo, tokyo "tokyo university of agriculture and technology, tokyo +biotechnology instruments department, shimadzu corp., kyoto, japan $natural and medical science institute at the university of tubingen, reutlingen, germany the majority of human t-cell leukemia virus type-i (htlv-l), hla class i-resmcted t-cell epitopes have been identified by cloning htlv-1 patient-derived t cells. here we describe for the frst time a rapid method (reverse immunogenetics) for identifing t-cell epitopes, together with a transgenic mouse model as a guide for testing the cellular immune response to a mixture of the lipohexapeptide immunoadjuvant pamgcys-ser-(lys)4 and synthetic htlv-1 peptides which seem suitable for vaccine design. htlv-1 amino acid sequences were searched for eight to 14mer patterns carrying the anchor residues of the hla-b*3501 peptide motif at positions two and eight to fourteen. 65 candidate peptides were synthesized according to the matched sequence patterns. their hla-b*3501 affinity was quantitatively analyzed in an indirect immunofluorescence peptide binding assay using rma-s-b*3501 cells. the fourth group (controls) were inoculated with h3n2 (in) thereby providing heterotypic ctl immunity in the context of a natural infection without the confounding effects of humoral immunity against surface antigens. all four types of inoculations have been shown to protect normal (class i expressing) mice from a lethal challenge with influenza, presumably mediated by class i restricted cytotoxic t cells. the two groups inoculated via the intranasal route may gain additional protection by activating the mucosal immune system (iga). none of these types of inoculations has been evaluated in the context of class i1 restricted cytotoxic t cells, the only ctls found in class i deficient mice. for all four types of inoculations, mhc class i deficient mice lost significantly more weight than the class i expressing control groups (seven mice per group) indicating the importance of class i restricted t-cells in protection. within the class i expressing groups, there was no significant difference between the four types of inoculations; within the class i deficient groups the vac-np im immunized mice lost significantly more weight than the h3n2 group;the other two groups, vac-np in and genetically immunized groups had intermediary results. these data lend support for a protective role for mucosal immunity. results on both class i and class i1 ctl activity for the four types of inoculations will also be presented. we tested the pbmcs of patients participating in two vaccine therapy trials for their ability to recognize overlapping peptides of the gp120 la1 sequence. seventeen patients participating in a phase i gp160 protocol and 13 patients participating in a phase i gp120 protocol had their pbmcs isolated by ficoll separation of heparinized venous blood. the fresh pbmcs were plated, in triplicate, into 96 well plates containing peptides overlapping the la1 sequence of gp120, pulsed on day 7 with tritiated thymidine and harvested and counted on day 8. results: the percentage of patient's pbmcs from each trial with an lsi 2 5 to each peptide are depicted below. conclusions: the pbmcs of hiv-infected volunteers who have been multiply immunized with either gp160 or gp120 proliferate to multiple peptides within the gp120 molecule. reactivity from the end of c1 through early c2 (lai #i 12-21 1) is particularly prominent and contains previously undescribed th epitopes (asterisks). conspicuously missing is reactivity to the v3 loop peptide (la1 #300). although the percent reactivity to the entire gp120 molecule is similar between the immunization groups, there is differential recognition of some of the individual peptides, particularly peptides in early c3 (lai #319-348). the intracytoplasmic lifecycle of listeriu mmcytogenes (lm) enables it to be a convenient vaccine vehicle for the introduction of foreign proteins into the mhc class i pathway of antigen presentation. taking advantage of these properties, we have inserted the nucleoprotein (np) gene from lymphocytic choriorneningitis virus (lcmv) into the lm chromosome by site specific homologous recombination. infection of mice with recombinant lm expressing lcmv-np elicited a virus-specific ctl response. we were able to recover lcmv-np specific ctl precursers from recombinant lm vaccinated mice as shown by vigorous secondary ctl responses after in vitro stimulation. in contrast to mice immunized with wild type lm, mice vaccinated with np-recombinant lm were protected against challenge with immunosuppressive lcmv variants. protection was demonstrated by reduced viral titers or complete clearance of lcmv from serum and various organs including, spleen, liver, lung, kidney, and brain. the kinetics of the lcmv challenge indicate that mice vaccinated with recombinant lm were able to arrest viral growth early in the infection due to a strong ctl response and did not exhibit the immunopathology associated with infection of naive mice. since lm not only delivers antigens into the mhc class i pathway but also induces il-12 production, it has the potential to function simultaneously as a vehicle for expressing foreign antigens and as an adjuvant promoting cell mediated immunity. , latent membrane protein [lmp] 1 and 2a) in chromium release assays. we were fortunate in identifying one child from whom cryopresetved pbmc samples were available before. and during ebv seroconversion. ebv-specific ctl activity was demonstrated concurrent with initial detection of virus in the peripheral blood by ebv-dna pcr. in the absence of detectable serum antibody. ctl lines from all nine children recognized one or more ebv latent gene prcduct(s). all children demonstrated ctl responses against one or more ebna 3 proteins (3a, 3b, 3c). and ebna 3c was recognized most frequently. no ctl responses were detected against the ebv latent proteins ebna 1, 2, lp or lmp 1. the ebv-specific ctl lines expressed cd3/cd8 and mab blocking experiments demonstrated that the majority of target cell lysis was inhibited by antibody against mhc class-i but not antibody against mhc class-11. these results represent one of the first reports characterizing ebv-specific ctl responses in young children. the striking similarity between ebv-specific ctl responses described here in young children and those reported for adults suggests that the ebna 3 family of proteins and lmp 2a should be considered for inclusion in candidate ebv vaccines. evaluation of cellular immune responses to adenovirus vectors in the cotton rat. soonpin yei,' gary kikuchi,' ke tang' and bruce c. trapnell.' departments of virology' and immunology,2 genetic therapy, inc., gaithersburg, maryland 20878 replication deficient recombinant adenovirus (av) vectors are efficient gene delivery vehicles currently being developed for a variety of in vivo gene therapy strategies such a s for the fatal pulmonary component of cystic fibrosis. the cotton rat (sigmodon hispidus) is one of the most widely accepted animal models for studying these av vectors because wild type human adenovirus replicates in cotton rats and because of the histopathologic similarities of infected respiratory epithelial tissues from humans and cotton rats. despite this, methods for studying immunologic responses in the cotton rat have not been developed. importantly, recent studies in the cotton rat (gene tber. 1 :192-200; 1994) in our laboratory suggest that a dose-dependent specific immune response to av vectors can limit expression of the transgene. in this context, w e have established methods to evaluate cytotoxic lymphocyte (ctl) responses to av vectors in the cotton rat. to accomplish this, a ctl target cell line was established consisting of primary cotton rat lung fibroblasts (crlf). splenocytes from cotton rats exposed previously to an av vector were harvested, cultured in virro with irradiated, addb274nfected crlf. cultured (effector) splenocytes were then incubated with s'cr-labelled crlf (target) cells a t effectoctarget (e:t) ratios of 100, 50 and 10. in parallel, splenocytes from naive cotton rats served as negative controls. results demonstrated vector-specific ctl lysis of target cells significantly greater than controls: 80.3 f 1.3% vs 6.2* 0.5%. 49.6*1.6% v s 5.7*0.4%. and 22.8*3.5% vs4.8*0.5% (meanrts.e.m., n=3; p500 celllpl after more than 8 years of infection were selected from the amsterdam cohort study on aids versus 10 subjects who progressed to aids < 5 years. ctl activity was measured on "cr labelled hla matched or autologous b-lcl, infected with rvv expressing hiv-1 ag. both bulk and limiting dilution ctl assays were performed longitudinally with pbmc after ag-specific stimulation. sequences of ctl epitopes were determined in homologous virus isolates resulrs: different kinetics of anti-gag ctl responses were observed in rapid progressors. in any case ctl responses disappeared during progression to aids. in long-term asymptomatic subjects persistent ctl responses were observed together with low viral load. conclusions: sustained, broad anti-hiv cellular immunity may correlate with maintenance of the asymptomatic state in long-term survival by controlling viral replication. enteroviruses are a large group of positive stranded rna viruses known to be responsible for a number of distinct disease entities. recombination is thought to be capable of generating new enterovirus strains that cause significant morbidity. for example, enterovirus 70 which was responsible for a pandemic of haemorrhagic conjunctivitis and poliomyelitis is thought to have originated by recombination between a coxsackie b like virus and another unidentified enterovirus. we are studying a group of echovirus 11 isolates from an outbreak of disease in southem india. sequence analysis within the 5' untranslated region reveals that these isolates fall into two groups that differ by -20% (equivalent diversity to that seen between between published sequences of poliovirus 1 and coxsackie a 9 virus). these two groups of viruses also differ in their cell tropism. isolates defined as group 1 by their 5'utr sequence grow equally well on ht29 cells (a human colon carcinoma cell line) and vero cells. isolates of group 2, with one exception, grow only on ht29 cells. analysis of the structural proteins of these isolates revealed differences in migration that correlated with their cellular tropism. thus, significant genotypic and biological diversity exists amongst these virus isolates. one virus isolate had the 5' untranslated region sequence of a group 1 virus but the protein profile and cellular tropism of a group 2 virus. the best explanation of these findings is that this anornolous isolate is a natural recombinant between the parented strains. both the ease with which viable recombinants are generated and the diversity present within this one enterovirus serotype increase the potential for the production of novel pathogenic enterovirus strains. dominant susceptibility to polyoma tumors in inbred wild mice, sharon r. nahill, yupo ma, john carroll and thomas l. benjamin, department of pathology, harvard medical school, boston, ma 021 15 polyoma virus (f' y) is a mouse dna tumor virus which, under appropriate conditions, causes tumors in a wide variety of cell types. generation of tumors is a function of both the viral and host genomes. lukacher et al. have recently described a dominant gene, pyv', carried by the c3-i mouse strain, which confers susceptibility to py-induced tumors mapping and immunological analyses indicate that py4 is the mouse mammary tumor virus 7 superantigen (mtv 7 sad gene, which deletes t cells required for py tumor immunosurveillance in h-2' mice. to determine the generality of endogenous superantigens as determinants of susceptibility and to reveal potentially novel mechanisms of susceptibility, we have looked for dominant susceptibility @ s ) gene(s) id newly established and genetically diverse inbred wild mouse strains, czech i1 and pedatteck (peru). both strains are susceptible to py as 100% of infected animals develop a full profile of tumors. crosses between cs7br, whose resistance is contributed by the major histocompatibility (mhc) locus, and susceptible peru or czech 11, yield f1 progeny which are fully susceptible, indicating a dominant inheritance pattern of susceptibility the incidence of tumor-bearing backcross animals [((peru x cs7br) x c57br) and ((czech i1 x cs7br) x c57br)i suggests that ds is due to at least one, but not more than two genes. amplification of genomic dna from the czech i1 and peru mice by pcr using primers specific for mtv 7 sag indicates that both strains are negative for proviral mtv 7 sag. furthermore, the mechanism ofds in these mice may be independent of all mtv sag as pcr using primers specific for the highly conserved region of mtv sag is unable to amplify mtv dna from peru or czech i1 genomic dna. these results indicate that, like the c3hibi, the pedatteck and czech i1 contain gene(s) which overide the resistance to py-induced tumors contributed by the mhc of the c57br parent and which may cause tumors via a novel, mtv sag-independent mechanism. we have initiated efforts to map the ds in peru and czech i1 mice using pcr and primer pairs flanking simple sequence length polymorphisms. fis-2 is a low leukemogenic, but relatively strong immunosuppressive variant of friend murine leukemia virus (f-mulv). this variant was originally isolated from t-helper cells of flc-infected adult nmrl mice. compared to f-mulv, fis-2 suppresses primary antibody response more efficiently in infected mice. some of the fts-2 infected adult nmri mice developed a disease resembling the acquired immunodeficiency syndrome induced by hiv. restriction mapping and nucleotide sequence analysis of fis-2 show a high degee of homology between this variant and the prototype f-mulv clone 57. in this study we have attempted to localize the genomic determinant of fis-2 which is responsible for induction of a strong suppression of primary antibody response. six chimeric viruses of fis-2 and f-mulv were constructed. the primary antibody response of the mice infected with these chimeric viruses were investigated. the results of these experiments will be presented. anti-fmdv antibodies, as measured in an elisa capture assay, were cross reactive. b) cellular: proliferative (cd4) t cell responses of peripheral blood mononuclear cells (pbmc) were low or undetectable during primary responses to vaccine or virus, and frequently low during secondary responses. for good t cell proliferation in vitro, multiple immunisation is required. this may reflect preferential stimulation of the th2 cd4 t cell subset. interestingly, when cd4 responses were observed, cd8 tcell responses were also detectable. 2 . recognition of individual viral proteins a) expression cloning: structural and non-structural protein pseudogenes were cloned from cdna by pcr. expressed in pgex-3xuc. and purified by sds-page. b) humoral: structural and non-structural proteins were recognised by infected animals. a good anamneetic antinon-structural response was only observed when the boosting serotype differed from the serotype stimulating the primary response. c) cellular: both structural and non-structural proteins were recognised and some were cross reactive. interestingly, vp1 was strain specific, and the polymerase (3d) was the most immunogenic and cross reactive. d) a construct comprising 3d and the immunodominant vp1 epitopes was prepared and tested. in common with other herpesviruses, the envelope glycoproteins of equine herpesvirus 1 (ehv-1; equine abortion virus) are major determinants of the infectious process and pathogenicity, and are inducers of humoral and cell-mediated immune responses. as such, they are candidates for components of subunit vaccines against ehv-1. to generate useful amounts of individual ehv-1 glycoproteins, we have constructed recombinant badoviruses capable of expressing glycoproteins c, d, h (gc, gd, gh ) in insect cells, and have evaluated the recombinant products as innnunogens in a murine model of ehv-1 infection. au three glycoproteins induced serum (elisa) antihodies to ehv-1, and ehv-1 gc and gd also induced neutralizing antibody responses. following intranad challenge with infectious ehv-1, protective immunity, as demonstrated by acelerated clearance of virus fiom respiratory tissues to below detectable levels, was evident in mice immunized with either recombinant gc or gd. in contrast, gh-immmkd mice did not develop detectable neutralizing antibody, and did not clear challenge virus more rapidly than controls. delayed type hypersensitivity and lymphoproliferation responses to ehv-1 antigen were observed for each of the ehv-1 glycoproteins, and in experiments with gdimmunized mice, a role for cell mediated immunity in protection was confirmed by adoptive transfer and t-cell depletion experiments. the data provide support for the potential of glycoproteins c and d as a subunit vaccine against ehv-1. molecular pathogenesis of ural infeetiom 52-331 enterovirus-immune cell interactions: implications in enterovirus-induced diseases we have also evaluated the effect of virus infection on the humoral immune response to cvb3, infection in adolescent c3h/hesnj mice. antigen presenting cell, 1-helper cell and 8-cell function were evaluated utllizlng a sheep red blood cell (srbc) plaque assay. mice were injected intrapentoneally (ip) with lo5 plaque forming units of cvb3, at day 0 and with lo7 srbc's at days 0, 2, 3 and 4 post-cvbb, infection. splenocytes were harvested 4 days post-srbc injection, mixed with target srbc's and guinea pig complement and incubated. plaques were then quantitated. results: cvb3, was associated with 12.9% to 17.4% of cd-8 positive t-cells and w a 11 % to 26% of adherent splenocytes. after mitogen (lps and con a) stimulation, b-cells and adherent cells were demonstrated to be permissive for viral replication. a 248% and 738% under non-stimulated conditions. an average of 1 % of virus is cell-associated (plaque north america. bruce anderson, teny yates, norah torrez-martinez, wanmin song, brian hjelle. university of new mexico, albuquerque, n.m.we recently identified a new species of hantavirus (hmv) associated with the harvest mouse reithrodontomys megalotis (hjelle b et al, j. viroj. 1994, in press ). an arizona woodrat (neotoma mexicana) was found to he infected with hmv, presumably through "spillover". hmv is most closely related to the four comers hantavirus (fcv) of deer mice (genus peromyscus). the nucleocapsid gene and protein of hmv differ from those of fcv by 24% and 15% of residues, and the 1896 nt s genome is shorter by 163 nt. we surveyed 174 reithrodontomys animals captured in the u.s. and mexico for hantavirus antibodies; 27 (15.6%) were positive. s segment cdnas were amplified and sequenced from seropositive animals captured in california (4), arizona (3), new mexico (l), and mexico (2). a monophyletic clade of hmv-like agents was identified at all sites, although an r. megalotis infected with an fcv-like virus was also identified in the state of zacatecas, mexico. nucleotide sequence distances among members of the hmv clade were up to 15.5%. but amino acid distances were less than 2%. hmv is enzootic in harvest mice throughout much of north america, and can also infect wood rats. htlv i-associated myelopathy/tropical spastic paraparesis (hamnsp) is a slowly pro ressive neurological disease characterized by perivascuaar mononuclear infiltrates in the cns. htlv i-specific cd8+ ctl are found in pbl and csf of infected patients with htlv i-associated neurological disease but not in htlv i seropositive individuals without neurological involvement. previous studies have shown that in hla-a2+ patients, htlv i-specific cd8+ ctl restricted by hla-a2 recognize a peptide derived from the htlv i tax protein (tax 11-19 llfgypvw). in the present study, we have analyzed the potential of these tax-specific ctl to recognize addtional peptides. our results demonstrate that a subpopulation of high affinity cd8' tax 11-19 specific ctl clones cross-react on a self peptide derived from the se uence of myelin-associated glycoprotein (mag 556-564 vl&sdfri) presented by hla-a2. these obsenatlons suggest that the demyelination process in hamltsp may be,due, in part, to virus-specific ctl recognition of a self myelin component that is independent of htlv i infection. development of pathology varies widely between different strains of mice after intracerebral inoculation with the so-called 'docile' isolate of lymphocytic choriomeningitis (lcm) virus. the c3hebfej and blo.br/sgsnj mouse strains have been of special interest because they display autoimmune hemolytic anaemia with varying degrees of apparent immunological involvement. in this study, we examined the role of cd4+ t helper cells in this autoimmune response by treating mice with the cw-specific gk1.5 monoclonal antibody. we also determined if polyclonal activation of b lymphocytes, induced either by lcm virus or by lactate dehydrogenase-elevating virus, another well known b cell activator, correlated with the development of anaemia in these mice. our results strengthened the central role of the immune system in the anaemia in c3h mice by showing that depletion of cd4+ cells largely, if not completely, abrogated this anti-erythrocyte autoimmune reaction. as reported by others, we found that the anaemia was more mild in b 1o.br mice than in c3h mice. however, we could not confirm the difference in the degree of b lymphocyte polyclonal activation between these mice. furthermore, lactate dehydrogenase-elevating virus had no apparent effect on erythrocytes, even though this virus also induced a sharp increase in plasma igg levels. one of the two class i mhc (h-pkd)-restricted immunogenic sites identified on the influenza strain aijapanl57 (h2n2) hemagglutinin (ha) encompasses two distinct partially overlapping epitopes, mapping to residues 204-212 and 210.219. when we investigated the magnitude of the ctl responses of balwc mice to the two overlapping epitopes, we found that while the nhrterminal nonamer epitope is immunodominant, eliciting vigorous ctl responses in njapanl57-immunized balb/c mice, the ctl responses to the cooh-terminal decamer epitope are weak and variable. the c-terminal epitope subdominance seems to be due to factors other than inefficient processing of the epitope in vivo because ctls generated by priming mice with recombinant sindbis viruses expressing only one of the ha 204-219 subsites displayed patterns of responsiveness similar to that of influenza virus primed ctls. limiting dilution ctl assays showed that the ctl precursor frequency (pctl) of the nterminal epitope is at least ten fold higher than the pctl of the cterminal epitope, implying that the low and variable pattern of cterminal specific responsiveness was due to the limited t cell precursors in the c-terminal specific ctl repertoire. this was further confirmed by the limited heterogeneity in the cross reactivity patterns displayed by the c-terminal specific ctl for an ig vh fragment and the ha 210-219 epitope of influenza strain a i m 5 7 in short term bulk cultures, and the facs analysis of tcr vg chain usage. taking these together with our previous observation that some jha 210-219 specific ctls can also crossrecognize an ig vh fragment. these studies had provided a strong evidence that ig gene products may influence t lymphocyte function and repertoire development. we have previously described the identification of homologous regions in the c-terminus of hiv-1 gp41 and in the n-terminus of hla class i1 beta chains. forty percent of patients infected with hiv-i virus were shown to have antibodies which bind to the homologous sequences, as well as to native hla class i1 molecules. affinity purified crossreactive antibodies (crab) were shown to have direct blocking effects on normal t cell responses to recall antigens, and could mediate adcc of hla class ii+ cell lines.in order to determine the contribution of such antibodies to disease progression, we obtained longitudinal plasma samples from patients in the macs study. in a first study, it was found that the presence of high titers crabs correlated with a more rapid disease progression (p = 0.027 by fisher two tail analysis)in a second, 7 year-longitudinal study of 12 progre.ssors and 12 stable patients we found: (1) the production of crab was seen in 70 -80% of rapid progresson, while the true stables produce only infrequent low-titers crab. (2) in rapid pmgressors, production of crab preceded by 2-3 years the marked drop in cd4 counts. (3) crab production did not correlate with the degree of hyperglobulinemia in these patients. (4) the presence of crab during the asymptomatic stage correlated with early loss of t-helper responses to recall antigens.we are currently establishing whether periodic measurements of crab in patients sera could be valuable in predicting a drop in cd4 counts and disease progression. the lymphokine ifn-y is i pleiotropic insnunomodulator and possesses intrinsic antiviral activity. we studied its significance in the development of antiviral immune responses using ifn-7 receptor deficient (ifn-yr-'.) mice. after inoculation with live attenuated pseudorabies virus (prv) the mutant mice showed no infectivity titers in various tissues and transient viral ag expression only in the spleen similar as in wild-type mice. however, the absence of the ifn-yr resulted in increased proliferative splenocyte responses. the prv-immune animals showed a normal ifn-1 and 11-2 production, without detectable 11-4, and with decreased 11-10 secretion in response to viral ag or con a. immunohistochemically, an increased ratio of ifny/i1-4 producing spleen cells was found. after immunization with either live attenuated or inactivated prv, ifn-yr"' mice produced significantly less antiviral antibody (ab), and more succumbed to challenge infection than the intact control animals. the reduction in ah titers in the mutant mice correlated with lower protection by their sera in transfer experiments. thes? findings are in line with the strong enhancing effect of exogenous ifn-y on rabies virusand prv-specific igg responses. our data demonstrate that a physiological ifn-y system is surprisingly not critical for the generation of antiviral th-i-type and the suppression of th-2-type cytokine responses. the lymphokine, however, is an important mediator in the generation of protective antiviral ab. key: cord-023055-ntbvmssh authors: nan title: immunogenicity date: 2004-02-19 journal: j cell biochem doi: 10.1002/jcb.240410506 sha: doc_id: 23055 cord_uid: ntbvmssh nan ia moyecules with respect to their roles as peptide receptors and target structures for tcr interaction. particular attention has been paid to distinguishing between local and distant effects of amino acid substitutions on ia function and to determining which residues interact with peptide antigen and which (if any) with the tcr. this ex erimental approach has led to the identification of several regions of the pofvorphic amino-terminal domains of the a and p chains as playing critical roles in chain-chain association and quaternary ia conformation. the a1 and p l putative helical regions have been found to have distinct degrees of structural lability, with the a1 helix showing much greater susceptibility to conformational change due to allelic variation in other re ions of the molecule. allelically polymor hic residues in the a1 and p 1 domainstave been shown to play important roles in &e activity of the assembly/folding control regions, and hence, analysis of local binding roles of specific residues in ia molecules must take this additional effect of substitutions at these positions into account. by controlling for large scale conformational effects, individual residues in the p chain have been assigned to desetopic ( eptide interaction) and histotopic (tcr interaction) roles. in the cytochrome c molel, a putative peptide bindin "pocket" involvin residues from both the postulated p l a helix and also the p-stran% floor has been defined, residues controlling both the extent of binding and the orientation of the bound peptide have been identified, and at least one residue with tcr interaction potential without obvious peptide binding properties has been localized. combining these data with those of other investigators leads us to propose a general model of class i1 mhc structure-function relationships. we have shown previously that memory b cells transferred into k-allotype distinct congenic rats in the absence of any priming antigen are deleted from the adoptive host within a matter of weeks (half-life of 1-2 weeks). in contrast co-injection of antigen with the cells facilitates their survival and the maintenance of a donor response for periods in excess of one year. in the experiments reported here we ask if the persistence of t cell memory is also dependent on antigen. 10. carrier (klh) primed t cells were transferred in the presence or absence of antigen into irradiated, k-allotype distinct adoptive host. a t various times after transfer these rats were injected with 2x10' hapten-carrier (dnp-klh) primed b cells together with 50 ig of soluble dnp-klh. this limiting number of b cells makes a secondary type response only if carrier-specific memory t cells survive in the adoptive host. we found that already at 6 weeks following transfer without antigen, no memory t cell help was available for these b cells. in contrast t cells transferred together with 10 ~g klh provided help for secondary type donor responses at 6 and 12 weeks after transfer. we conclude that longterm memory at both the t and b cell levels does not reside with small, very long-lived, resting cells but. with active clones that are maintained by small amounts of antigen that may persist for long periods. once antigen is lost from lymphoid tissues both t and b cell memory wanes within a relatively short time. t cells recognize antigen in the form of short peptides associated to class i or class i1 mhc molecules. each mhc molecule has the ability to bind a large number of peptides and peptides with unrelated sequences can compete for binding to the same mhc molecule, as well as in vitro. in vivo competition strictly correlates with the capacity of the competitor peptide to bind to the mhc molecule presenting the antigenic peptide and its extent dependes on the molar ratio between antigen and competitor. competition among different peptides derived by processing of hen egg-white lysozyme (hel) appears to exert a major influence on the immunodominance of antigenic determinants recognized by t cells. thus, the h l peptides 1-18 and 25-43 are both generated by hel processing and are both able to bind to the i-e molecule but only 1-18 becomes immunodominant because it has th ability to compete in vivq with other hel peptides, such as 25-43, for the available sites on the i-e molecule. however, two immunodominant t cell epitopes, such as those in hel peptides 51-66 and 112-129, both interacting with i-ak molecules, do not compete with each other when injected together at equimolar concentrations. such a coexistance is anticipated between peptides that bind with relatively high affinity to the presenting molecule and thus have both the chance to occupy a number of binding sites sufficient for t cell activation. r v s e iii xen ic tr lantation. in v i m lnvesti$ation uslng mocloml a n t m i e s r e 4 e -t e x e y skin gracs-val on m i c e w a s significantl pr:lrd l g anti-antihdy trea-t but n o t a b anti-antibody: w i d e r the saue animals but a n t i c d 4 antibody did prolong minor a n t w -d i allqrdts. in v i m studies r m that primary proliferation a n f z . 2 prcdwtion & -f i cells in response to mmkey stimulators was weak conpared to allogeneic reqonses. secondary responses t o xenogeneic stinulation were strong after in v i m priming but required the presence of responder nc's. assays for c y g t s t cell effectors in m i c e which had rejected monkey skin revealed few such cells. zhese results est that widely d i a t e xencgeneic processing and presentation, since xenogeneic antigens require that such presentation be in association with the.= antigens of regponder apc's, the xenogeneic r a f t s have a functional similarity t o aff2 leted allografts. shoved t h a t f e t a l r e n a l and f e t a l and p o s t n a t a l testis a l l o g r a f t s survived longer than corresponding a d u l t t i s s u e i n non-immunosuppressed outbred r a t hosts. the c u r r e n t study a s k s v h e t h e r t h e d i f f e r e n c e i n s u r v i v a l betveen r e n a l and t e s t i c u l a r g r a f t s and between g r a f t s of d i f f e r e n t ages is r e l a t e d t o d i f f e r e n t i a l t i s s u e expression of class i and class i1 mrna t r a n s c r i p t s or s u r f a c e antigens. and i f t h e s e p a t t e r n s change w i t h t r a n s p l a n t a t i o n . congeneic mice w e found t h a t prolonged s u r v i v a l of c57bl/6 f e t a l r e n a l (n=42; p<0.008) and f e t a l (n=14; ~( 0 . 0 5 ) and p o s t n a t a l (n= 8; ~( 0 . 0 5 ) t e s t i s mouse a l l o g r a f t s t r a n s p l a n t e d beneath t h e r e n a l c a p s u l e of a d u l t r e c i p i e n t bio.a mice and t h i s s u r v i v a l c o r r e l a t e s i n v e r s e l y w i t h t h e expression of class i and class i1 mrna (northern a n a l y s i s ) and p r o t e i n s (immunohistochemistryy) and t h a t both p r o t e i n and mrna increased throughout ontogeny f o r both t h e testis and kidney. after t r a n s p l a n t a t i o n t h e r e vas a marked i n d u c t i o n of mhc mrna t r a n s c r i p t s f o r both testis (n=207) and kidney (n=320). implanted f e t a l kidney t i s s u e t h a t survives. however. f a i l e d t o express d e t e c t a b l e mhc p r o t e i n , i n d i c a t i n g t h a t some p o s t -t r a n s c r i p t i o n a l modification i n t h i s t i s s u e occurs. t o a f f o r d it p r o t e c t i o n from r e j e c t i o n . implanted testis shoved i n d u c t i o n of both mrna and p r o t e i n v e l l above i t s much lower baseline. i n d i c a t i n g t h a t i t s r e g u l a t i o n , i n c o n t r a s t t o t h e kidney may be t r a n s c r i p t i o n a l . thus t h e f e t u s may lower t h e mhc burden as a s t r a t e g y t o escape r e j e c t i o n e i t h e r by p o s t t r a n s c r i p t i o n a l modification of p r o t e i n expression a s i n t h e kidney or by t r a n s c r i p t i o n a l modification of mrna as i n t h e testis. culture of thymus tissue in 2-deoxyguanosine (2dgua) is thought to reduce tissue immunogenicity by selectively depleting highly immunogenic, thymic immigrants of bone marrow origin. in the mouse 2dgua treated thymus tissue survival is markedly enhanced compared to untreated tissue when transplanted under the kidney capsule of allogeneic recipients. these experiments were repeated in the rat. as expected, strain da neonatal thymus tissue was rejected when transplanted under the kidney capsule of normal allogeneic strain pvg rats. surprisingly. acute rejection occurred even when the tissue was cultured for 14 days in 4 mm pdgua (3x the effective dose in mice). by in vitro criteria this dose was very effective in destroying thymocytes. to test whether residual marrow derived cells that escaped pdgua treatment were responsible for inducing rejection we "parked" the 2dgua treated da tissue in t cell depleted pvg rats. our working hypothesis was that the few remaining donor derived cells of marrow origin would be overgrown by host type cells. when pdgua-treated da thymus tissue was transplanted into t cell depleted pvg recipients graft rejection did not occur. however da pdgua treated thymus tissue, parked for as long as 200 days in t cell depleted pvg rats, was acutely rejected when retransplanted into normal pvg recipients. we interpret these results to suggest that rat thymic epithelium devoid of marrow derived cells is innately immunogenic. c 104 corinne amiel, violaine gugrin, thierry may, philippe canton, gilbert c faure, laboratoire d'immunologie and maladies infectieuses, chu de nancy, facult6 de mgdecine, 54500 vandoeuvre les nancy, france. lfal is a dimeric membrane molecule composed of a specific alpha chain (cdlla) and a beta chain (cd18) common to three members of the lfa family. lfal is physiologically expressed on all white blood cells, while other molecules of the lfa family (with cdllb and cdllc alpha chains) are restricted to cells of myeloid lineage. a defective expression of lfal has been described in some congenital immune deficiency and in aids. we investigated the lfal defect on peripheral blood lymphocytes from 100 hiv+ patients. three different monoclonal antibodies were used, respectively directed to chain-specific epitopes of cdlla (spvl7, sanbio) and cd18 (iot18, immunotech) and to a conformational epitope involving both chains (iot16, immunotech). cell suspensions were stained in indirect immunofluorescence and a flow cytometer (epics profile, coultronics) was used to assess the percentages of stained cell, the fluorescence intensity and the shape of fluorescent peaks. our data suggest that lfal expression is impaired in hiv+ patients both through the quantitative expression of each chain and through conformational alterations. the adhesion molecule lfa-1 is known to be important in antigen presentation. we have previously shown that both monocyte and t cell lfa-1 play a role in the interaction between these two cells (eji d; 943, 1987) . antibody to icam-1 (known to act as a ligand for lfa-1) also inhibits antigen presentation, although icam-1 is not thought to be expressed on resting t cells (eji 18: 35, 1988) . we have looked at the expression of icam-1 on t cells after incubation with 12 cytokines and found that only il-2 consistently effects an increase in both the percentage of icam-1 positive cells and in the level of expression. in addition we have found that a proportion of resting t cells express very low levels of icam-1. double labelling experiments have shown that these cells are part of the memory t cell population as defined by antibodies to uchli, lfa-3 and lfa-1, and furthermore that icam-1 negative cells are unable to respond to to antigens such as ppd and flu but are able to respond to pha. this suggests that icam-1 represents an additional marker on the memory t cell population which more precisely defines the subset able to respond to recall antigens icam-1 expression on t cells, anne-marie buckle and nancy hogg, macrophage lab. icrf, lincolns inn fields, london, wc2a 3px, u.k. immunization, francis r. carbone and michael j. bevan, department of immunology, research institute of scripps clinic, la jolla, ca 92037. ctl recognize peptide forms of processed, foreign antigens in association with class i molecules of the mhc and are usually directed against endogenously synthesized "cellular antigens" such as those expressed by virusinfected cells. in vifro studies have shown that small exogenous peptides can directly associate with class i molecules on the cell surface and mimic the target complex derived by intracellular processing and presentation. we have recently generated ova-specific, h-2kb-restricted ctl by immunizing c57bl/6 mice with a syngeneic tumor line transfected with the ova cdna. the ctl recognize the ova transfectant eg7-ova and the synthetic peptide ova but fail to recognize the native protein. we reasoned that given the potential for direct peptide/class ?'&$%ation observed in vifro, ova2s,-2ra may induce ctl after in vivo priming. however, we found that this is not the case. ova,,,-,,, and peptides of increasing lengths up to which are all able to form the target complex in vitro, are inefficient at priming ~% -%~~ specific ?h%sponses following intravenous injection. this is also true for both native and denatured ova. in contrast to these results, the synthetic peptide ova22g:z76 corresponding to a peptide in a partial tryptic digestion of ova can efficiently prime c57bl/6 mice in vrvo following intravenous injection. this peptide elicits ctl which appear identical to those derived from animals immunized with syngeneic cells producing ova endogenously. it is now well established that human t lymphocytes can be activated via the t cell specific cd2 antigen. in order to determine if a factor@) other than the single cd2 polypeptide is involved in cd2 mediated signal transduction, we have stamy transfected murine l cells with the human cd2 cdna. we report that such transfectants expressed hah levels of cd2 at the cell surface. formed sheep erythrocyte rosettes and expressed the three cd2 epitqm previously defined on human t lymphocytes, including the "activation associated' t i 13 epitope. the latter observation unequivocally demonstrating that expression of the ti13 epitope, in contrast to a previous report, is entirely independent of t cell specific factors. combinations of cd2 mabs that are potent stimulators of human t cells. however, failed to elicit either an increase in the concentration of intracellular free calcium or augment [3h]-thymidine inmrporatbn in the transfectants. these results provide both formal identification of the cd2 cdna and dearly demonstrate that the single cd2 polypeptide expressed in an heterokgous cell system devoid of t cell specific factors, cannot alone transduce intracellular signals in response to stimulatory combinations of cd2 mabs. the results are therefore consistent with the notion. that the functional cd2 antigen expressed in human t lymphocytes, requlres the association of another, as yet, undefined factor@). this conclusion was based on several lines of evid nce incl ding the observation that mabs specific for the class i a3 domain of either h-zl8 or l 2 d b interfered with t e generation of cd8-dependent (low substitution at position 227 in the a3 domain are not lysed by cd8-dependent primary ctl but are lysed by secondary cd8-independent (high affinity) ctl generated in the presence of antibody to the a3 domain. populations of ctl. we have isolated and characterized a c d w , cd4-da-specific cpl line. this line is cd8-independent and is capable of lysing the addition, we are currently generating clones from primary $-specific ctl cultures to obtain cd8-dependent (low affinity) ctl. directed rnutagenesis are being tested with the cd8-dependent and cd8-independent clones to define additional residues important for cd8 recognition. the comparison of ctl clones with different cd8 dependencies will allow us to more precisely define the role of cd8 in t cell recognition. percolle from the buffy coat of one unit ot blood. these cells (=400x10 ) are introduced into a curame 5000 elutriation centrifuge (rotor speed of 3000 rpm; loading flow of 10 ml/min). nine fractions can be obtained. the first three containing >90% lymphocytes; fraction 4 (3000 rpm-18 ml/min) and fraction 5 (2900 rpm-18 ml/min! contain both lymphocytes and monocytes and the next three fractions contain >90% monocytes; the finat fraction (rotor off) contains monocytes + granulocytes. cells from each fraction (5x10 /well) are incubatee for five days with tetanus toxoid (1.5lf/well) and an enriched population of t cells (5x10 /well). quadriplicate samples are then pulsed for 16 hours with 'h methyl thymidine. maximum apc activity is found in fractions 4 and 5 representing 4 to 7% of the mononuclear cells. apc activity for these two fractions can be further purified by selective absorption of the cells onto gelatin coated surfaces that have been preincubated with plasma. the non adherent lymphocytes are rgmoved after two hours. after overnight incubation spontaneously released cells (1-5x10 ) can be harvested which have a higher apc activity than cells rotated by elutriation alone. these methods are now highly reproducible in our laboratory, so we can now begin to characterize and study these cells. the male s p e c i f i c h-y a n t i g e n h a s been shown t o behave as a minor histocompatibility a n t i g e n in man and mouse. i n t r a n s p l a n t a t i o n , male t i s s u e may t r i g g e r t h e c l o n a l expansion of h-y reactive hhc r e s t r i c t e d effector cells of female o r i g i n . although male epidermal cells (ec) can induce an anti-h-y t cell response in female mice, so far in v i t r o techniques have f a i l e d t o i d e n t i f y t h e cell-defined h-y a n t i g e n on murine ec (1). here w e developed a 51cr release assay t o use human c u l t u r e d k e r a t i n o c y t e s (k) as t a r g e t cells for hla-a2 specific and ma-a2 r e s t r i c t e d h-y s p e c i f i c t cell clones. hla-a2+ but n o t h l a -a t k were l y s e d by anti-ma-a2 ctls i n a dose dependent manner. low but d e t e c t a b l e l e v e l s of anti-h-y k i l l i n g were found a g a i n s t ma-a2+ male k b u t n o t a g a i n s t h l a -a t male or hla-a2+ female k. both l e v e l s of a l l o r e a c t i v e and h-y s p e c i f i c l y s i s were d r a m a t i c a l l y enhanced after exposure of k t o ifn gamma. these r e s u l t s s t r o n g l y suggest t h a t h m a n male s k i n cells are d i r e c t l y s u s c e p t i b l e for h-y d i r e c t e d t c e l l k i l l i n g through t h e expression of f u n c t i o n a l h-y/hla complexes on t h e i r cell s u r f a c e . i n view of t h e s e f i n d i n g s , t o g e t h e r w i t h our r e c e n t s t u d i e s on t h e expression of h-y ctl determinants on h m a n hematopoietic p r o g e n i t o r c e l l s (21, t h e r o l e of h-y a s a t a r g e t s t r u c t u r e f o r c e l l mediated immunity i n o l i n i c a l t r a n s p l a n t a t i o n should be s e r i o u s l y taken i n t o account. 1. steinmuller d. and burlingham w.j. t r a n s p l a n t a t i o n 19@4,37,1,22. 2. voogt p.j., goulmy e., fibbe w.e., e t a l . j . clin. invest. sept.1988. c 116 diphteria toxoid (dt) presentation by hla dr7 transfected murine fibroblasts bismuth, laboratory of c e l l u l a r and t i s s u l a r immunology, chu p i t i e s a l p b t r i b r e , p a r i s , france and veterans medical c e n t e r , iowa c i t y , usa. l t r a n s f e c t a n t s e x p r e s s i n g s i n g l e type of human mhc c l a s s i1 molecules produced by dna conjugate formation has been studied with cloned t cell lines and a b cell hybridoma and with t cells and b cells from normal mice. resting t cells and b cells do not form appreciable numbers of conjugates but conjugates are formed between t cells stimulated with alloantigen for four days and b cells activated by 24 hour culture with lps. irrelevant lymphocytes do not affect the rate of specific conjugate formation in suspensions of cells agitated by gentle rocking but impair conjugate formation when cells are allowed to settle in round bottom tubes. in further experiments, it was shown that the conditions for the induction of lymphokine secretion by the t cell were not indentical to the conditions for conjugate formation.the significance of these and other observations for the interaction of t cells and b cells in vivo will be discussed. of the primary mixed leukocyte reaction (mlr) and that this reaction occurs in multicellular dendritic cell-cd4+ t cell clusters [cellular immunology 111, 183-195(1988) dendritic cells are able to contact, cluster, and retain allogeneic t cells and induce these alloreactive cells to proliferate and divide. tions labeled with a vital flvorescent dye, we show that only dendritic cells efficiently form stable clusters. labeled monocytes and b cells do not form clusters with t cells. when labeled monocytes and unlabeled dendritic cells are used to stimulate t cells, unlabeled clusters form. labeled monocytes do not move into the clusters until the third day of the mlr. significant levels of il-2 and a-ifn appear in the culture supernatant by the first or second day. blast transformation by the second day of the mlr as demonstrated by giemsa staining of cluster cytopreps. also been studied by immunoperoxidase staining. it is known that human peripheral blood dendritic cells are potent stimulators using purified dendritic cell populathe distribution of certain adhesion molecules within clusters has c1m microbiology and immunology, emory university, atlanta, ga 30322. immunization of sjl/j mice with myelin basic protein (mbp) induces the t cell-mediated autoimmune central nervous system disease, experimental allergic encephalomyelitis. response against a dominant epitope (residues 89-101) leads to disease. lymph node t cells from mbp-immune mice react against several epitopes in addition to 89-101 indicating that the i-as molecule is able to form immunogenic complexes with several mbp peptides. the question asked in these studies was whether subdominant epitopes from the same molecule would compete with the dominant epitope for binding sites on the i-as molecule. to address this question two t cell clones, one specific for 89-101 (sp4.2) and a second specific for a second epitope present in peptide 89-170 (sp4.7) were tested for responsiveness when cultured with the dominant epitope alone or with mixtures of peptides containing dominant and subdominant epitopes. reactivity of sp4.2 against peptide 89-101 was inhibited by peptides 1-37 and 43-88. reactivity of sp4.7 against peptide 89-170 was not inhibited by peptide 89-101 although peptides 1-37 and 43-88 were inhibitory. controls indicated that inhibitory reactivity was not due to toxicity at high concentrations of peptides. these findings imply that subdominant epitopes are able to compete with dominant epitopes of mbp for binding sites on i-as molecules. linda r. gooding, frances c . rawle, david i . kusher, w i l l i a m s . m. wold+ and barbara knowles*. department of microbiology and immunology, emory university school of medicine, atlanta, ga 30322, 'institute f o r molecular virology, s t . louis university school of medicine, s t . louis, mo 63110 and *the wistar i n s t i t u t e , philadelphia, pa 19104. i n several v i r u s systems e a r l y non-structural proteins localized predominantly i n the nucleus of infected cells are major t a r g e t antigens f o r cytotoxic t lymphocytes (ctl). whether early synthesis o r nuclear l o c a l i z a t i o n are important factors i n immunodominance is not known. w e have recently developed a system f o r studying the ctl response t o human group c adenoviruses i n mice. by us ng both transfected t a r g e t s and virus deletion mutants w e have shown t h a t , response t o wild type ad5. there are two e1a t r a n s c r i p t s , 12s and 1 3 s . which both encode major e a r l y nuclear antigens d i f f e r i n g by a 46 amino a c i d insertion: both antigens are recognized equally w e l l by ctl. the e3 encoded 19k glycoprotein (gpl9k) of ad5 binds t o mhc c l a s s i antigens i n the endoplasmic reticulum preventing t h e i r translocation t o the c e l l surface and strongly inhibiting l y s i s by ad5 specific ctl. however, the presence of gpl9k i n the priming v i r u s does not a f f e c t the s p e c i f i c i t y of the ctl generated f o r e l a , so the immunodominance of t h i s protein cannot be due t o the fact t h a t i t is the only major protein synthesized before gpl9k i n the course of infection. using virus deletion mutants we are investigating whether ctl s p e c i f i c f o r other ad5 antigens can be induced i n the absence of ela, and whether e1a is also the dominant antigen recognized i n mice of other mhc haplotypes. respond to antigens present on non-replicative virions. in contrast, we have obtained balc/c i-erestricted t hybridomas specific for the neuraminidase (na) glycoprotein of a/pr8 influenza which recognize infectious, but not non-replicative virus, closely resembling recognition requirements observed for most class i mhc-restricted responses to influenza. recognition correlated with the rte nova synthesis of viral na within antigen-presenting cells, but did not depend strictly upon the amount of na present in cultures, since high na concentrations could be achieved by addition of non-replicative virus without being stimulatory for na-specific t cells. recognition of a neo-antigen was ruled out, since, in high concentration, na isolated from purified virions, even if reduced and alkylated, was recognized by the t hybridoma clone. isolated na was recognized when added to pre-fixed apc, suggesting that this form of antigen was able to bypass the usual processing pathway of exogenous proteins. this suggests that endogenously-synthesized antigen may use different pathways to achieve class 11-associated presentation. t lymphocyte activation is a complex event which is influenced by a variety of distinct cell surface molecules. in order to determine the role of individual molecules in the activation process, we have developed an efficient methodology for generating cell variants in which expression of molecules is selectively inhibited by expression of anti-sense rna from an epstein-barr virus episomal replicon. in a previous study, we reported that marked inhibition of cd8 cell surface expression could be achieved in a human t cell clone using this approach. we have now extended this strategy to another t cell surface molecule, cd2, as a first ste towards ascertaining its role in t cell activation. to this end, we s nthesized a &-mer oli onucleotide corresponding to a sequence in. the 5: end of the c d i n g re ion of human cd'i and inserted it in an anti-sense orientation into this replicon. this a-c%2/rep3 construct was electroporated into jurkat cells. analysis of stable a-cd2irep3 transfectants by immunofluorescence staining and flow cytometry demonstrated complete and selective inhibition of cd2 expression. in contrast to the nontransfected arent, this cd2-variant demonstrated a partial loss in its ability to form conjugates a n 8 to secrete interleukin 2 when stimulated with anti-cd2 monoclonal antibodies. however, stimulation of the cd2-variant with a23187 and pma did result in interleukin 2 secretion. several observations suggest that cd8 functions not only as an adhesion molecule recognising mhc class i on the adjacent cells but also potentiate the transducting capacity of the tcr/cdg complex. comparison of the mouse ly 2 protein sequence with the homolog rat ox8 and human t8 sequences revealed most highly conserved regions in the membrane and cytoplasmic part of the molecule. the conservation of the transmembrane and cytoplasmic sequences in different species may be significant for the function of the cd8 molecule. in order to initiate the functional dissection of the cd8-molecule we constructed mutations in different parts of the molecule. by transfecting the a and b chain genes donated by a cd8 dependent cytotoxic t cell clone(kb5 c20) into the mhc class i1 restricted agd cd4 t cell hybridoma do-11.10 we were able to reconstitute the ability to respond to k only if the transfer was done with the ly 2 molecules (gabert et al., 1987. cell, 50. 545-554) . in this system surface expression of mutated and non mutated ly-2 molecules were checked by facs-analysis and the molecuar size of the proteins were analysed by immunoprecipitation with the anti-ly-2 monoclonal antibody 19/lj8. finally functional effects of the mutations were investigated in response towards the k alloantigen. we have simulated graft versus host and host versus graft reactivity in vitro by studying primary anti-minor h responses in a limiting dilution culture system. the ability of bmm and peripheral blood mononuclear cells (pbm) to stimulate and respond in this system were compared by estimating the number of proliferating cells. in gvh-direction the combination of donor-bmm (d-beim) and host-pbm (h-pbm) was 2 to 15 times more effective in stimulating proliferation than any other combination; the same applied to the combination h-pbm/d-bmm in hvg-direction.-using these combinations the median frequency of proliferating cells in gvh-direction was 1/5300 (range 1/59c-1/18100) in 10 pairs, in hvg-direction (7 pairs) 1/2330 (range 1/115-1/6100). 85% of the proliferating cells had the phenotype of mature t-cells.-using the same combination of responder/stimulator cells we have also estimated the number of cytotoxic cells specific for the hla-identical target cell. in gvh-direction the median estimate (n=8) was 1/10300 (range 1/66o-1/45700), in hvg-direction (n=5) 1/2250 (range 1/400-1/6500). by split well analysis similar or higher frequencies of cytotoxic cells with specificity for nk-targets were detected (gvhr: 1/5750, hvgr: 1/3620). it was however possible to identify a significant number of minor h-specific clones by segregation analysis; their specificity could be confirmed after clonal expansion. the clones had the phenotype of typical cytotoxic t-cells.-the relevance of the two cytotoxic subpopulations described above to clinical events such as gvhd, graft rejection and relapse needs to be clarified.molecular cloning of murine icah-1, k.j. horley, b. baker, and f. takei, terry pathology, university of british columbia, vancouver, b.c., canada. we have previously reported a novel cell surface antigen expressed on activated and proliferating murine lymphocytes. the antigen, termed hala-2, is absent or present at low densities on thymocytes, lymph node cells, and fibroblast cell lines, indicating it is not a universal proliferation antigen. some cells of the spleen and bone marrow express mala-2 at a high density possibly representing in vivo proliferation in these tissues. apparent molecular weight of 95-100 kd under both reducing and nonreducing conditions, and is susceptible to endo f digestion. the monoclonal antibody yn1/1.7 that reacts with this antigen, profoundly inhibits mlr. a xgtlo cdna library was constructed from ns-1 cells that express a high level of mala-2, and screened with synthetic oligonucleotides resulting in the isolation of a full length cdna clone (-3.2 kb). the cdna sequence has high homology with the human icau-1 sequence, indicating that hala-2 may be the murine homologue of this characterized protein. hines, trudeau i n s t i t u t e , inc., p.o. box 59, saranac lake, ny 12983 a tumor c e l l l i n e , et-5, has been derived from an apparent fibrosarcoma t h a t arose i n a c57bl/6 male mouse. antigens. mice t h a t have r e j e c t e d et-5 become imnune t o these minor h antigens, judged by accelerated s k i n g r a f t r e j e c t i o n , and t h i s imnunity can be t r a n s f e r r e d t o imnunod e f i c i e n t mice w i t h lymphoid c e l l s . however, spleen c e l l s from mice t h a t have r e j e c t e d according to the widely accepted view, cd2 (t11, sheep erythrocyte receptor) is the first t cell-specific antigen to appear on differentiating thymocytes during ontogeny. it follows that cd2 should be expressed on all immature and mature t cells. using two-color cytofluorometry i have here identified subsets of cd2-cd3+ t cells both in fetal human thymus or spleen and in adult peripheral blood. cd2-cd3+ t cells constitute 1-25% of fetal thymocytes and 0.1-0.8% of peripheral blood t cells. il-2-dependent longterm clones of cdi-cdj+ cells do not react with a panel of monoclonal antibodies (mab) directed against the t1ll, tlll or t113 epitopes of cd2 and do not transcribe cd2 mrna. fetal tissue-derived clones react with the tigammaa mab and thus express a functional tcr gamma chain, while cd2-cd3+ clones from peripheral blood are bha031+ and express a full-length 1.3 kb tcr c s .ria. the clones established here are currently being characterized with respect to functional capacities. i conclude that expression of cd2 is not an absolute prerequisite for the expression of the cd3/tcr molecular complex on human t cells. if they are added after 24 hours. these interactions are bidirectional. since both cdlla and cd18. and t h e i r ligand i-cam 1. are expressed on the presenting c e l l s as well as the t cells. however, a l l such e a r l y adhesion related events are not bidirectional since anti-cdz and anti-lfa-3. which are expressed d i f f e r e n t i a l l y on t c e l l s and presenting c e l l s respectively are also effective as inhibitors. antibodies, a n t i cd4 and a n t i cd25 antibodies do not i n h i b i t clustering but do i n h i b i t p r o l i f e r a t i o n , and t h i s i s seen irrespective o f when the antibodies are added i n t o the assay. our findings suggest t h a t there are two mechanisms involved i n dendritic c e l l -t c e l l interaction, f i r s t l y an inrnediate cell-cell adhesion step and l a t e r a secondary signal transduction process possibly mediated v i a cytokines. the q u a l i t a t i v e d i fferences between dendritic c e l l and b c e l l induced i m n o g e n l c i t y may thus l i e i n e i t h e r o f these two steps. king, department o f eathology, the bland-sutton i n s t i t u t e . university college and middlesex school i n contrast, a n t i class i1 m c lmmunogenicity c130 cultvred tissue is capable of stimulating an rggwwse when l " s p l m l e d ~e n e i c w y , robert j. ketchum and orion d. hegre, dept. of cell biology and neumanatoay, university of uinnesota, minneapolis hn 55455. neonatal rat islets derived by culture-isolation have teen shown to k free of mlc class 11+ cells, and are immunologically silent when transplanted to either syngeneic or allogeneic hosts. allogeneic transplantation of cultured neonatal non-islet pancreatic tissue, which is known to contain class 11+ cells, results in rapid allograft rejection. unexpectedly, m i c transplantation of cultured non-islet ductal tissue also resulted in lononuclear lm,me cell (hnc) infiltration of the graft in 86% of grafts examined. highly purified syngeneic islets and ductal elements grafted syngeneically at remote sites display an i u n e response in the ductal element graft, while the islet graft is free of any imnme cell infiltrate. this syngeneic imune response does not result from the use of xenogeneic serum in the medium, since cultures carried out using syngeneic rat serum supplemented medium yielded identical results. uncultured neonatal pancreatic tissue grafted syngeneically does not result in iqk: infiltrate, thi6 i.rmne response to a syngeneic stimulus correlates with the presence of class 11+ (antigen presenting) cells. in grafts free of class 11+ cells (culture-isolated islet grafts) no i.rmne responrrc to syngeneic stimulus was observed, while a response was present when syngeneic ductal elements, known to include class 11+ cells, were grafted. this indicates a need for cells capable of antigen presentation to stimulate this syngeneic rerrponne, and suggests that either a modified self antigen or a nomally sequestered antigen is being presented. this syngeneic imune response demonstrates many of the same characteristics of, and may be analagous to, the in vitro syngeneic, or autologous, mixed lymphocyte reactions. indicating this response is not to developnental antigen. c 132 the presence of "self" mhc class i1 (ma-dr) antigens determines whether blood transfusions ihmunise or suppress. el lagaaij, a termijtelen. e goulmy, & jj van rood, leiden university hospital, the netherlands. blood transfusions can immunise the recipient, as well as induce prolonged allograft survival. it is not known what makes that some transfusions inrrmnise the recipient whereas others induce immune suppression. we investigated if certain mhc compatibilities or differences between recipient and transfusion donor and organ donor are required to induce the beneficial "transfusion effect" in man. we studied graft survival and blood transfusion induced changes in cellular and humoral immunity in 4 different patient groups. the patients received a single blood transfusion of a randomly choosen donor. we found in all 4 groups that to induce a beneficial "transfusion effect" compatibility for at least 1 hla-dr antigen between recipient and transfusion donor is required. if the transfusion and recipient are mismatched for both ma-dr antigens, the recipient is immunised, resulting in an increased antibody production (p=o.ool), an increased cytoxicity (cml) (p=o.oos), an increased mixed lymfocyte reaction (mlr) (p=o.oos) and a decreased graft survival (p-0.003). after a beneficial (ma-dr sharing) transfusion. the in vitro test remain unchanged or decrease. graft survival increases with the number of shared antigens between transfusion donor and organ donor (p=o.o2), suggesting that a donor specific suppression is induced. recent experiments have revealed a direct interaction between the cd4 molecule and hla-dr antigen. to address the nature of this interaction we have used a xenogeneic system in which a human cd4 cdna was expressed in the murine cd4-and cd8-negative hybridoma 3dt52.5.8. the tcr of 3d3752.5.8 recognizes the murine class i molecule od. a class i 1 expressing dd-positive cell line was obtained by cotransfection of the human class i1 cdnas together with the murine od gene int.0 the murine fibroblast line dap3. coculture of 3dt52.5.8 and dap3 expressing dp-dd resulted in a 20 fold increase in il-2 production and in rosette formation only when both cd4 and dp were present on the responding t hybridoma and the presenting cell, respectively. we are using this system to map regions of the cd4 molecule that interact with the class i1 mhc ag. the cd4 molecule has also been shown to be the receptor for the human immunodeficiency virus (hiv) via the gp120 molecule. since gp120 and class i1 both interact kith cd4, we have used our functional assay to verify if gp120 exerts an inhibitory function on cd4 class i 1 interaction. recombinant gp120 inhibits the functional interaction and rosette formation in a concentration dependent fashion with maximal inhibition at about 10 pg/ml.. this inhibition is specific since it can be reversed by recombinant soluble cd4. the fact that recombinant. gp120 can inhibit the functional interaction between cd4 and its physiological ligand (class i1 ags) suggests that the use of gp120 on a vaccine against hiv infection could alter the immune response of such individuals. this work was supported by src, mrc and nci. t lymphocytes discern self from non-self molecules through the interaction of their antigen-specific receptors and proteins encoded by the mhc. although the nature of this association is not well-defined, a model has been proposed whereby the v-segments of the t cell receptor interact with residues along the 2 alpha helices of the class i antigen (davis et al.; 334:395, 1988) . we have recently shown that ctl generated against the class i molecule qiod crossreact on several unrelated murine class i antigens containing the shared qiod residues at amino acid positions 152, 155, and 156 (mann et al.; j x 168:307, 1988) . these residues contributed by the a-2 domain occur in the alpha helical portion of the class i molecule and amino acids 152 and 155 could interact directly with the t cell receptor. to further characterize the role of these amino acids, we are in the process of determining whether insertion of these 3 residues by site-directed mutagenesis into a human class i molecule will allow for the antigen's recognition by anti-910 ctl. here the t cell repertoire becomes restricted, so that foreign antigen can be recognized only when associated with the mhc products of the host, and mature t cells are tolerized to self antigens, a process which also seems to be mhc-restricted. thus, t cells should be non-reactive to self antigens when they are associated with mhc products present on the tolerance-inducing thymic cells, whereas they may still react to the same self antigens when associated with different mhc products. to examine mhcrestricted tolerance in vivo, a model system must have: a) self antigen in the context of one mhc haplotype. and b) tolerance to both that and a second mhc haplotype. chimeras were prepared by aggregation of preimplantation embryos of two strains of mice, c57bl/6 (b6) and balb/c. the thymus of such chimeras should be composed of two distinct and completely intermixed populations of cells, one from each parental strain (isozyme analysis indicates no detectable fusion of cells). thus, t cells maturing in the chimeric thymus should be exposed to and tolerized to minor histocompatibility antigens (mhas) of one parental strain only in association with the mhc of that strain. for example, mice might be expected to express b6 mhas only with h-2b (the 8 6 mhc). however, our chimeras were fully tolerant to f1 skin grafts, which have "hybrid" combinations of mhas and mhc (e.g., b6 mhas with h-2d). these results are most consistent with either, a) "wholesale" antigen processing and presentation of all mhas by the tolerizing thymic cells, and/or, b) functional sharing of mhc products between the parental thymic cell populations. many of the events critical to the maturation of t lymphocytes occur in the thymus. in the case of t-cell responses against viruses such response defects are associated with a marked increase in disease susceptibility as illustrated by class i mhc controlled susceptibility to lethal pneumonia induction by sendai virus. certain class i or class i1 mhc determined tc response defects (four out of six tested by us) can be restored by imunization in vivo and/or restimulation in vitro with dc. dc are the most effective apc. their superior apc capacity is due to 1) a very high absolute number of class i and class i1 mhc molecules, and 2 ) a low degree of sialylation of mhc and other surface molecules, reducing negative charge and facilitating access of the t-cell receptor to the mhc groove presenting the antigenic peptide and/or improved clustering with t cells. the more effective antigen presentation by dc allows a more prominent role for a cd4+ q cell independent pathway of cd8+ tc activation. it is postulated that the more effective direct triggering of cd8+ tc precursors lowers the threshold for il-2 production by cd8+ cells, reducing the requirement for il-2 production by the cd4+ cells. failure of dc to overcome certain mhc-linked specific tc response defects probably reflects complete failure of any foreign peptide derived from the processed antigen to interact efficiently with the mhc or a true tc repertoire defect. donald pious, department of pediatrics, university of washington, seattle, w 98195 mhc class i1 molecules bind inmunogenic peptides derivsd fro13 soluble antigen and the complex is recognized by specific t cells. ue have isolated eight independent mutant b -l u clones which are altered in their ability to present antigen. in standard proliferation assays using four different soluble protein antigens, the mutants are unable to stimulate the majority of t cell clones restricted to hlfl dr or dp. cllthough unable to present *hole hepatitis b surface antigen (hbdg), they effcctively present a hbdg peptide to a dprestricted t cell clone. the fact that both dr and dp restricted antigen presentation is abnormal in these mutants made it likely that the class i 1 structurual genes are unaltered. this hypothesis is supported by the finding that dno sequences from the dr genes of one mutant are norml. however, two observations indicate that the uture class i1 di-expmsccd by the mutants are structurally altered. binding to the mutants with tuo polymorphic anti-dr antibodies and one anti-dp antibody is reduced, although the level of cell surface class i1 expression is normal. second, the class i1 diners from the mutants dissociate into no-rs under in vitro conditions (sds-pwe) which preserve dimers in the progenitor line. together, these functional and structural data suggest that the mutants are defective in a molecule that either associates with or post-translationally modifies class i1 molecules and is required for the physiologic formation of an twc/antigen complex. they do not function as restriction elements presenting foreign antigens to t-cells. to investigate the nature of this functional defect we have constructed 3 different recombinant class i genes using dna segments from the b10 q9 (qa-2) or h-2db genes. structural protein encoded by the recombinant genes is derived entirely from the q9 gene whereas the cis-acting transcriptional regulatory elements or the dna segment encoding the membrane anchoring domain is derived from the h-2db gene. into fertilised cba/ca embryos by microinjection and transgenic lines were established. to date we have established 13 transgenic lines. we have shown that the q9 (qa-2) antigen encoded by the recombinant genes behaves as a major transplantation antigen in skin grafts and provokes strong secondary cytotoxic t-cell responses in grafted animals irrespective of the tissue distribution or mode of membrane anchorage of the q9 antigen. at present, we are investigating whether the q9 antigens encoded by the recombinant genes are able to present influenza virus or mouse minor histocompatibility antigens to t-cells during immune responses and hence whether they can function as restriction elements. is a distinctive system because it permits an analysis of the activation requirements for antigen specific, resting t cells. been isolated following culture with anti-ig-sepharose and compared to dendritic cells as stimulators of cd4' t cells in the mix. i1 mhc products and independently stimulated the 1 ' mlr and the production of several t derived lymphokines, including il-2 and 11-4. however, the relative potencies of dendritic cells and anti-ig blasts as 1'mir stimulators varied in a strain dependent fashion. times more active in stimulating hls-mismatched. mhc-matched t cells, relative to syngeneic t cells. anti-ig blasts when stimulating acroas an mhc barrier and were likewise more effective in binding iqic-disparate t cells to form the clusters in which the mix was generated. dendritic cell-t cell clustering was resistant to anti-lfa-1 mab, while b blast-t cell clustering was totally blocked. thus, anti-ig b lymphoblasts and dendritic cells, two cell types which differ markedly in phenotype, also differ in efficiency and mechanism for initiating responses in allogeneic t cells. only anti-ig blasts could stimulate across an mls barrier, being at least 100 in contrast, dendritic cells were 10-30 times more potent than the as the lymphocyte f u n c t i o n antigen 3 (lfa-3) and the i n t r a c e l l u l a r adhesion molecule (icam). we i n t e r p r e t t h i s as an increase i n the membrane expression o f these s t r u c t u r e s f o l l o w i n g incubation. the increase i s blocked by the t r a n s l a t i o n i n h i b i t o r , cycloheximide, implying t h a t p r o t e i n synthesis i s involved. helper t cell responses to soluble globular proteins require processing of the protein by ia-expressing antigen presenting cells (apc). antigen is internalized into acidic vesicles, proteolyzed, and peptides containing t ceu antigenic determinants are transported to the apc surface where they are recognized by the antigen-specific t cell in conjunction with ia. most ia-"pressing cells are competent apc, however, only b cells have antigen-specilic receptors on their surface auowing bound antigen to be processed and presented at 1/lw the antigen concentration required by nonspecific apc little is known about b cell antigen processing function during differentiation, or if ig-mediated apc function is altered at different maturational stages, thus allowing regulation of b cell-helper t cell interactions. neonatal acquisition of apc function was examined in mice ages day 1 to day 15. splenic cells from d l to d10 mice process and present pigeon qochrome $, pg at 0-20% of adult levels. by d15 neonatal spleen cells acquire the ability to process and present soluble pg at 3 5 4 of adult levels. the ability to internalize antigen through ig rwptors was determined using an antigen-antibody conjugate, p$-&(ab')z. neonatal spleen cells acquire the ability to process antigen through ig simultaneously with the ability to process soluble antigen. lack of prowsing by neonatal spleen cells prior to d10 is not attributable to insufficient levels of surface ia. since d3 neonate spleen cells are able to activate t cell hybrids to 50% of adult levels when provided with p$ 81-104, containing the t cell determinant. dlod15 neonate presentation of p@1-104 is indistinguishable from adult levels. b cell maturation into memory b cells was identified by the loss of the jlld differentiation marker. splenic jlld'o b cells increase from 540% following immunization and return to nonimmune levels after 4 weeks. during antigen-induced b cell maturation, jllb b cells are indistinguishable from splenic b cells in the ability to present antigen introduced into the processing pathway either pinocytotically or via surface ig. p p antibody conjugates specific for mouse f(ab')z i n , igd, or igg are presented equally well by both splenic and jll@ b cells. thus, acquisition of b cell processing function appears to be developmentally regulated and may play an important role in b cell tolerance meshanisms. once b cells have acquired the ability to process antigen this function is maintained and is not regulated during maturation into memory b cells. we are currently investigating the role of ig isotype during neonatal acquisition of antigen processing. (supponed by nih grants ai-18939, ai-12001, and ai-2317) as the preliminary studies suggested that carrier sc (apc) for ts vs. tcs activation might be distinct, studies were done to directly address this possibility by assessing tha ability of s3 coupled to various cell populations to activate ts and tcs. the results indicated that ts activation required that s3 be coupled to plastic adherent cells which bear both i-a and i-j determinants. these cells are nonadberent to anti-ig and nonfunctional in cyclophosphamide (cy) treated mice. i n contrast activation of tcs required coupling of s3 to plastic non-adherent and anti-ig adherent cells. these cells are functional in cy treated mice and bear the b cell markers jlld and i-a but not 1-3. thus s3-specific ts are activated by i-a+ i-j+ adherent cells (presumably macrophages) whereas tcs are activated when antigen is presented by b cells. (nih grant ca25054.) interleukin-2 activated killer (iak) lymphocytes (also known as lak cells) which destroy a broader spectrum of tumors invitro than nk cells have been used sucessfully in an adoptive immuno-therapy protocol for the treatment of patients with a variety of advanced cancers. the cell suface molecule(s) on tumor cells that a r e involved in specific binding to iak cells and in programming iak cells for cytolysis (iak acceptor molecules) have not been characterized. inorder to identify such acceptor molecules a crude membrane digest of the lung carcinoma cell line a549 was biotinylated and adsorbed to iak cells or to unstimulated human peripheral blood lymphocytes (upbl) (each from the same person). proteins from the washed solubilized cells were separated by page, western blotted and probed with streptavidin-alkaline phosphatase. several experiments demonstrated that different tumor membrane proteins bound to iak cells compared to upbl. the unstimulated cells bound one tumor membrance protein (about 40kd) not found on the iak-adsorded blot. the iak cells bound three tumor proteins (approximately 30,46 & 50kd) not found on the upbl-adsorded blot. three other proteins (about 35,44 & 55kd) were found to adhere equally well t o iak cells and upbl. utilizing a streptavidin affinity column, solubilized tumor membrane proteins that bound to iak cells could be separated from solubilized iak membrane proteins. the isolated tumor membrane proteins that adsorded to iak cells inhibited iak mediated lysis of a549 tumor cells by >85%. these studies suggest that specific cellular adsorption techniques may be useful in isolating and characterizing tumor membrane proteins involved in interactions unique to cytolytic lymphocyte-tumor cell target binding and lysis. activation of human t lymphocytes occurs via the t cell receptor-cd3 complex but can also be induced through the non-antigen-specific cd2 molecule. selected combinations of mabs or the soluble cd2 ligand, namely lfa-3 and a unique anti-cdz mab (cd2.1) induce human t cell activatlon. cd4 is an accessory molecule implicated in t h e activation of human t lymphocytes. this molecule may exert this function by increasing intercellular avidity through binding to mhc class i1 molecules and/or by transmitting intracellular signals. we have investigated the action of mabs directed against different epitopes on the cd4 molecules in the activation of human t cells via the cdz pathway. we show that anti-cd4 mabs inhibit cd2 induced t cell proliferation in an epitope-depe dent fashion. this inhibition does not appear to be linked to the lower cd2 mediated [ c a ' + ] response induced by anti-cd4 mabs, since [ca"] response is equally affected by anti-cd4 mabs whether or not they inhibi ed t cell proliferation. in conclusion, the partial inhibition of the cd2 induced [cb'] response of t cells by various anti-cd4 mabs suggest that : 1) this inhibition does not totally account for the inhibitory effect of anti-cd4 mabs, 2) and the proliferation induced by anti-cdz mabs may not be completely ascribed to the [ca2+] response of t cells. rosenberg. and alfred singer, experimental immunology branch, nci, nih, bethesda, md 20892 . we have devised a model to study the in vivo generation of suppressor cells by using mice congenic at qa-1, a class i-like molecule encoded to the right of h-2d. disparate tail skin grafts (tsg) unless a second graft with additional helper determinants was also present. without any source of additional help, failed to reject their qa-1 graft, and were unable to reject them even upon the subsequent addition of exogenous help. thus, exposure to qa-1 disparate grafts, in the absence of additional help, either led to qa-1 specific tolerance or suppression. mice failing to reject qa-1 allografts revealed the presence of qa-1 specific suppressor cells that inhibited the in vivo activation of antigen specific effector cells capable of rejecting qa-1 bearing allografts. experiments using t cell subpopulations should allow for further characterization of these qa-1 specific suppressor cells. we found that b6 mice did not reject qa-1 however, animals engrafted with a qa-1 graft alone, in the thymus, the t-cell receptor genes are rearranged, the t cells learn to recognize their own major histoconpatibilitp complex "hc). and they learn to respond to foreing hec. these events seem to be linked to the interaction between t-cell precursors and the stromal cells of the thyms. thus increasing evidence points to an essential role for the thymus epithelial cells (te cells) in development of at least hec class i1 recognition by the t cells. to be able to study the importance of te cells in t cell maturation. we have developed a method for growing murine t cells in serum-free pediun with well defined constituents. the m d i u a allows far growth of te cells without concomitant growth of bone marrow derived cells as macrophages and fibroblasts. data obtained by en and lmmunocytochenistry showing the epithelial nature of the cultured cells, as well as autoradiographic data on the growth pattern, and characterization of tb cell supernatants will be provided in addition to results obtained from co-culture of te cells and t-cell precursors (cm-cds-thymytes). lmmunogenicity c 152 branch, national cancer institute, bethesda, md 20892 the effector limb mediating skin allograft rejection is highly antigen specific, rejecting cells that express allogeneic mhc antigens while sparing those which fail to express allogeneic mhc determinants. disparate skin grafts are completely rejected in spite of the fact that only a small percentage of the cells within the graft express ia antigens. thus, it is possible that mhc class i1 disparate grafts are rejected by a mechanism that does not assess the expression of mhc determinants on each cell. we assessed the specificity of the rejection of ia disparate grafts by using allophenic skin grafts in an adoptive transfer system and concluded that skin grift rejection across an mhc class i1 disparity required recognition of allo-ia determinants expressed by every cell in the graft. therefore, we reasoned that mhc class i1 antigens must be induced on these ia negative populations. indeed, injection of mice with gamma interferon dramatically induced ia antigens on previously negative keratinocytes. we next tested whether the induction of allogeneic ia determinants on keratinocytes was necessary for graft rejection by engrafting parental strain mice with skin from f >parent bone marrow chimeras. such grafts failed to be rejected, in spite of the speciic rejection of the allogeneic langerhans cells, indicating that the failure of keratinocytes to express allogeneic class i1 determinants leads to graft preservation. conclusion, mhc class i1 disparate skin allografts are rejected in a highly antigen specific fashion, secondary to the induction of mhc class i1 antigens on skin cells that fail to constitutively express them. to address whether the extensive polymorphism characteristic of class i molecules influences cd8 binding, we have screened a panel of transfectants expressing individual class i mhc alleles. of 18 alleles tested, only aw68.1 did not bind. all other molecules dld bind, including a2.1 and aw69, which differ by 13 and 7 amino acids respectively from aw68.1. position 245 in the alpha 3 domain was identified by sitedirected mutagenesls as the critical residue differing between a2.1 and aw68.1 which determines binding. a mutant aw68.1 molecule containin alanine at position 245 bound cd8, while a mutant of a2.1 with valine at 245 did not. alanine is found at position 245 of all human and murine class i molecules sequenced to date except aw68.1 and aw68.2, which have valine at that position. bulk cultures of a2-allospecific ctl were also sensitive to this substitution, and preferenhally recognized both molecules with alanine at 245. this study shows that aw68.1 differs from other class i molecules in its capacity to bind cd8, and raises the possibility that aw68.1 may not function as a restriction element as effectively as other class i alleles. t cell hybridomas derived from h-zd lnc recognked s and pres2 antigens in a i-ad restricted way, while t cell hybridmas from h-2k lnc manifested a specificity for either pres2 in association w i t h i-ak or for s in association with i-!& the activation of lhese hybridomas by antigen and antigen presenting cells (af'c), as measured by il-2 secretion, was found to be sensitive to prostaglandines and could be completely inhibited by anti-lfa-1 moncclonal antihxlies. different aft populations were tested for their capacity to present spresz particles to these t cell hybridomas. various macmphage like populations such as resident, con a induced, thiiglycolate induced peritoneal exudate cells as well as splenic adherent cells were found to present efficiently the spres2 antigen. in conhast b cells and la+ b cell lines (ta3, m12.4) could not function as accessory cells in the spresz specific stimulation of these t cell hybridomas. the inability of these cells to present this antigen was not due t o inhibitory effects since these cells did not inhibit the presentation capacity of other potent apc's. funhcnnore addition of apc's of a different haplotype could not complement for the defective presentatiw of spresz by b cells and b ceu lines indicating that mhc independent accessory factors are not implicated in this process. hence it is clear that maaophage-like apc's and b cells d i f f a in their capacity to process and present spdz antigens. since spresz is a very stable particle composed of lipids and proteins it is conceivable that such antigen quires a smng degradation and swh plocessing might occur in cenain -phage-like apc's but not in b cells. recombinant human insulin biosynthetically labeled with k n d " s at several amino acids was used as an antigen and was exposed for varyillg lengths of time to ta3 mouse b cell apc. subcellular fractionation and hplc chromatography permitted several of the processed peptides distributed throughout the insulin molecule to be monitored. many insulin peptides localized to both the extracellular (8 peptides) and intracellular (4 peptides) compartments of ta3 cells were detected. membrane-associated peptides is in progress. many of the peptides processed by ta3 apc in situ co-elute with those obtained upon digestion i n vitro by the insulin-specific insulin degrading enzylg5 (ide). f o r the processing of 51-labelled human insulin suggest that insulin may be processed in b cell apc into immunogenic peptides by an enzyme(s) present on the plasma-membrane, intracellularly and extracellularly. (supported by mrc and cda) . we investigated the pathway of antigen processing 5 itu in cell apc. hurine ctl clones specific for hia-a2 were generatef with the human cell line jy. four of five ctl clones were found to lyse a2k transfected murine cells more effectively than a2 transfectants. anti-cd8 specific mab inhibited t 3 lysis by these four clones, and this inhibition was more pronouncgd for a2k one clone, which lysed a2 and a2k transfectants equivalently, was shown to be insensitive to anti-cd8 antibody inhibition. these findings indicate that a2-specific t r i n e ctl clones possess greater avidity for murine target cells expressing the a2k hybrid molecule relative to those expressing the a2 molecule. this implies that a cd8 interaction with the same molecule seen by the t cell receptor is important for target cell recognition. hla class i1 antigens are highly polymorphic cell surface proteins involved in initiation and regulation of the immune response. allelic sequence variation primarily affects the structure of the first external domains of the a and j3 component chains. here we provide evidence for other types of allelic polymorphism for these genes. the sequences of two cdna clones corresponding to the hla-dqp mrnas from an hla homozygous cell line exhibit both alternative splicing and readthrough of polyadenylation. furthermore, the alternative splicing event is associated with only a subset of hla-dqb alleles, while the polyadenylation site readthrough is found in a larger subset. this suggests that polymorphic & acting elements within the hla-dqp gene control both processing steps. proteins, presumably encoded by the alternatively spliced mrnas lacking transmembrane exons, are immunoprecipitated with a monomorphic monoclonal antibody directed against hla-dq. these proteins are found in supernatants of cultured cell lines for which secretion is predicted, but not in those of cell lines which do not contain the alternatively spliced mrnas. such secretion class of i1 allelic products could profoundly affect interactions between effector and target cells in an immune response. departments of biology and chemistry and the cancer center, q-063, university of california at san diego, la jolla, ca 92093. we are studying the murine icam-1 gene and the effects of icam-1 on antigen recognition. using the human icam-i cdna, we have isolated cdna and genomic clones encoding the murine homologue. the murine icam-1 gene is a single-copy gene that consists of multiple exom spanning 25kb of dna and encodes a 2.5kb mrna that is expressed at high levels in a wide variety of different cell types. sequence analysis indicates that murine icam-1 is 50% and 6096 homologous to human icam-1 on the protein and dna levels, respectively, and is a member of the immunoglobulin gene superfamily, consisting of several v-like domains linked tanddy. we are also studying the effects of icam-1 on antigen recognition. the t-cell clone 14d m s f 1988). this response is blocked with the anti lfa-1 antibody fd441.8 when antigen is presented by blo.a(2r) spleen cells but not when antigen is presented by dcek, a fibroblast transfected with i-ek. we are currently aansfecting the murine icam-1 cdna into dcek in order to determine if we can enhance the 14d response and to determine if the enhancement is lfa-1 dependent. wth an alp a beta tcr that recognizes moth the t cell differentiation anti en, cd4, is expressed by mhc class i1 restricted t lymphocytes. mhc class i1 products. the association between cd4 expression and restriction by mhc class i1 rfioducts has led to the hypothesis that cd4 may interact with monomorphic determinants of a large body of experimental evidence suggests that cd4 interaction with mhc class i1 molecules leads to an increase in the binding avidity of t cell-stimulator cell interactions. a direct test for a functional cd4-mhc class i1 interaction in t cell activation requires a separate evaluation of cd4-ia interactions from tcr-a /ia recognition. however, a separate evaluation proves difficult since the t cell receptor and cb4 may interact with the same mhc class i1 molecule. in this report, we use a t cell activation protocol, where tcr-ag/ia recognition is replaced by tcr complex-antlcd3 antibodies interactions. using this activation protocol, we pave analyzed the effects of monoclonal anti-mhc class i1 antibodies on the activation o$a cd4 hybridoma in the absence of its tcr restr$tinj mhc class i1 molecule (ie ) but in the presence of unrelated mhc class i1 molecules (ie ,ia ). the data obtained clearly indicate a functional role for cd4-mhc class i1 interactions in t cell triggering. we have targeted hen egg lysozyme (hel) to murine b cells using heterocrosslinked antibodies which specifically bind to surface igd or different mhc molecules. occurred more quickly with targeting to igd than to mhc structures as assessed by fixation and pronase stripping experiments. hel was internalized quickly into acidic compartments when targeted to igd but was detected much later when targeted to mhc molecules, as assessed by shifts of fluorescent signal of internalized fitc-hel. however, the data indicate that not all endocytosed hel entered low ph (<5.5) compartments. degraded hel was released from b cells following endocytosis of 125-i-hel. this release was detected earlier with targeting to igd than to mhc structures. interestingly, the total amount of internal 125-i-hel decreased with time after endocytosis via igd, but the internal 125-i-hel was almost entirely whole undegraded hel at all times following endocytosis. these data and those of chloroquine and leupeptin inhibition studies indicate differences in the fate of antigen entering b cells via igd or mhc structures, and support the notion of a neutral ph storage compartment for antigen endocytosed via surface igd on normal splenic b cells. internalization and presentation of hel to hybridoma t cells laboratories, department of surgery, university o f iowa, iowa city, ia 52242 target cell lysis by cd8' ctl is a highly specific phenomenon in vitro, as we have confirmed repeatedly in reverse labelling tests by showing that admixed "third party" target cells are not lysed in the presence of specific ctl-mediated cytolysis. however, when mixtures of ctl and their specific targets are inoculated into the skin of hosts syngeneic to the ctl, host cells at the site of inoculation are destroyed, often to an extent that results in grossly observable, full -thickness necrotic lesions. we have evoked these "innocent bystander" reactions in mice with ctl directed against single and multiple non-h-2 antigens and tnphapten and influenza a virus-specific antigens. thus, the ability to trigger bystander tissue destruction appears to be a general characteristic of ctl-target cell interaction in vivo. our current evidence suggests that host inflamatory cells recruited and activated by factors stimulated by ctl-target cell recognition actually mediate the tissue destruction. these ctl-initiated bystander reactions may be the basis of the non-specific tissue destruction that contributes to allograft rejection and that is observed in many serious virus infections and in intense dth reactions and contact dermatitis. rong h a lin. baael i n s t i t u t e f o r i u m l o g y , baael, snitzerland. w e have investigated the b a d e for i n u n i t y or tolerance t o a m a e aezw proteinthe f i f t h caponent of c o l p l a c n t (a). i n c5 deficient nice t h i s protein is absent from s e r m and as a cnrwquence they are not tolerized t o cs. c5 deficient dca generate uy bearing t c e l l s which recognize c5 i n the c m t e x t of clasa 11. i n contrast, c5 s u f f i c i e n t mice i n which c5 protein is continuously probced d m t mtmt t c e l l reaponsea againmt u. we have tested i f t h i s self protein i s proceseed and presented with clase i1 i n n o m l mice and can be recognized by c5 specific t c e l l s i n the absence of exogenewsly added antigen. a l l clasa i1 bearing c e l l s fm c5 s u f f i c i e n t l i c e activated c5 specific t c e l l clonea without additional antigen. presentation was mt a cansaquence o f c5 secretion by macrophages i n culture but was a h t o be derived prom endqlenewaly generated cs/cl.ss i1 caplexea. thus t h i s self protein is e f f i c i e n t l y preaented ,inin and available f o r tolerance in&xtion. although c5 deficient dca cannot secrete c5 they s t i l l synthesize a precursor mlecule, pro-c5, i n accumulating evidence from a number of models suggests that unique subsets of antigenpresenting cells a r e responsible for the induction of specific t cell-mediated responses. w e have previously described an age-dependent maturational defect in the ability of the sjl strain of mice to activate dth-inducer t cells to a wide variety of antigenic stimuli. none of the other 14 strains tested exhibited a similar defect and all other accessory cell dependent responses were unaffected in the dth unresponsive sjl. w e have also shown that the adoptive transfer a macrophage from older dth responsive sjl or other dth responsive las strains can overcome this defect in dth responsiveness. w e have recently found that a subpopulation with the mac-i+, mac-3' and mac-2-surface phenotype a r e able to transfer responsiveness. facs analysis indicate that the mac-3 phenotype is expressed on less than 20% of macrophages. titrations of the mac-3' cells isolated by facs indicate that adoptive transfer of o ly 100 mac-3' cells can overcome the defect in dth responsiveness. by contrast, transfer of 10 mac 3-or mac 2' cells were unable to overcome the defect. our data suggest that the induction of cd4' antigen specific cells dth-inducer t cells is mediated by a phenotypically unique small subset of macrophage accessory cells. in our studies, we have examined the effect of administering fab' fragments of anti-l3t4 moab (fabl-gk1.5) on the inhibition of humoral immunity. treatment of klh-primed mice with 0.5 mg fabl-gk1.5 depleted l3t4' cells from lymph node tissue while leaving other lymphocyte subpopulations intact. after injection of klh in complete freund's adjuvant, these t,depleted mice were unable to produce anti-klh antibodies. long-lasting unresponsiveness against klh (12 weeks) was observed despite the apparent regeneration of the t, population of the lymph node. the results obtained using either fab' or intact gk1.5 antibody were comparable and suggest that a transient depletion of t, does not account entirely for the long-term humoral unresponsiveness. the aim of this study was to gain a more detailed insight into the molecular aspects of antigen processing during the imune response. as a first approach, endosomal vesicles were isolated from bovine alveolar macrophages and their proteolytic activity with respect to a model protein antigen, sperm whale myoglobin (mb), was characterized. during the first stage of digestion of mb by the endosomes, a limited number of fragments were preferentially released from the antigen. we have isolated and identified these fragments. the digestion of myoglobin is completely prevented by pepstatin, a specific inhibitor of aspartic proteinases, and only marginally by other proteinase inhibitors. when mb fragments preferentially released upon digestion with purified bovine cathepsin d, an aspartic proteinase abundant in macrophages, were identified, almost all coincided with the fragments released by the endosomes. to define in more detail the selectivity of cathepsin d under the mild conditions applied, other protein antigens were similarly treated with the enzyme and the peptides released were identified. the location of the preferential cleavage siteswhen related to known t-cell epitopessuggests a dominant role for cathepsin d in the processing of protein antigens to yield fragments for presentation to t-cells. possibly, the observed selectivity of the enzyme may account for the structural similarities among t-cell epitopes, noted by others. actively acquired tolerance in mice to the antigens of the mhc (h-2) is induced by exposure of the animals to allogeneic lymphocytes within 24 hours of birth. actively acquired tolerance to the mhc in humans (hla) cannot be studied in the same way. however, we have evidence for the existence of actively acquired tolerance in humans in a study of 26 highly sensitized patients waiting for a renal allograft. they had developed complement dependent antibodies to the hla antigens of almost all unrelated caucasoid donors. the sera of these highly sensitized patients were tested against a panel of lymphocytes that were mismatched for only one hla class i antigen. we found for these 73 patients hla class i antigens that, although different from those present in the recipient, did not lead to a positive crossmatch. we called such antigens "permissible mismatches" and show that they often included those hla antigens of the patient's mother that the patient had not inherited (noninherited maternal antigens; nima). in 15 of the 26 patients, the permissible class i mismatches included the nimaa. the noninherited paternal antigens (nipas) were analyzed as a control; only two of the 25 nipas tested were acceptable mismatches, which emphasized the preferential nonresponsiveness to nima. recent experiments indicate that what holds true for antibody formation also holds true for t cell activation. of hla class i and hia class i1 allospecific cd8-positive ctl clones. monoclonal antibodies (mcab) directed against the cd8 structure were only found to inhibit antigen-specific cytotoxicity of a series of class i allospecific cd8-positive ctl clones and not of a class i1 allospecific cd8-positive ctl clone. however cytotoxicity induced by cd3 mcab (used at suboptimal concentrations) or cd2 mcabs in both types of ctl clone was blocked by cd8 mcabs. the absence of cd8 mcab blocking of antigen-specific cytotoxicity of the class-11-specific cd8positive ctl clone may be explained by assuming that it results from a triggering signal which is to strong to be overcome by the down-regulatory signal of the cd8 antigen. these combined findings clearly suggest a functional involvement of cd8 not only in tcr/cd3 activation, but also in tcr/cd3 controlled alternative activation routes, such as the cd2 activation pathway. moreover it shows that even an hla class i1 allospecific cd8-positive ctl clone expresses a functional active cd8 antigen. the absence of hia class i expression on the target cells (daudi cells) used in the experiments described indicate that the cd8 antigens not act solely in an adhesion-like fashion, but exhibit also a more general regulatory function in t-cell activation. this regulatory role of cd8 may be explained by assuming the induction of a threshold for activation, which is triggered after binding of cd8 mcab or binding to its natural ligand, hla class i. in our view, cde-mediated regulation of t-cell activation could therefore prevent non-specific triggering of cytotoxicity by interactions of insufficient affinity. *this study was supported by a grant from the dutch kidney foundation. the cd4 t-cell surface antigen 1s felt to have the dual functlon of stabilizlng the interaction of the t-lymphocyte with the antigen presenting cell (apc) a s well as transduclng an independent signal that can potentiate the actlvatlon related alteratlons generated through the t-cell receptor. we have found that upon antibody-mediated cross-linklng of the cd4 molecules of cloned murlne t-lymphocytes there is a time and temperature dependent decrease in the abundance of the lymphocyte-speciflc tyroslne klnase p66lok. this co-modulation is speclflc for cd4 and p66lck slnce cross-linking of other t-cell surface antlgens (cd3. t200, thyl.2) does not result in detectable alteratlons in the abundance of the lck protein and slnce cd4 cross-llnklng does not induce any alteratlon in the abundance of p60*.. another srcrelated tyrosine klnase highly expressed in t-cells. such data suggest that cd4 and the internal membrane lck protein are in close proximity within the cell. further analysls has revealed that slgnlflcant amounts of lck can be immunopreclpitated by antl-cd4 antibodies. in addltlon. cd4 can be speciflcally preclpltated by anti-lck antibodies. our data imply that cd4 and p661ok are physically associated in cd4+ t-lymphocytes. the flndlngs that cd4 is msoclated to the lck proteln in either murlne or human t-cells and that cd8 is also complexed to p66lck ln cd8* t-cells suggest that the lck tyroslne klnase is involved in the functlon of the cd4 and cd8 accessory molecules. these apc do not appear to present processed klsa determinants. in light of these findings, of apparent interest is the issue of which cells types are responsible for hlsa-specific t cell tolerance induction. studies in mice treated from birth with anti-p antibodies suggest an important but perhaps not exclusive role for b cells in this process. we are currently pursuing the identity of other cell types which may be involved. in addition, lmmunogenlclty c173 university of texas southwestern medical center at dallas, dallas, texas75235 qlo is a soluble class i-like major histocompatibility antigen produced specifically by the liver. previously, it has been shown that mice possessing soluble qlo can generate anti-q10 cytotoxic t lymphocytes (ctl), suggesting that this soluble molecule does not function as a tolerogen. we have recently constructed c3h transgenic animals which express an exon shuffled q10 (al, p2)/ld (03, tm) molecule. this qio/ld molecule is expressed specifically in the liver on hepatocytes but not on nonparenchymal liver cells, spleen, thymus, kidney or brain. the expression of qio/ld in the transgenic hepatocytes is equivalent to la expression on balb/c hepatocytes, suggesting the animals are expressing physiologic levels of the transgene. the presence of membrane bound qio/ld in c3h animals has not caused anti-910 ctl precursors to be deleted, however, because primary in vitro ctl assays show these transgenic animals can specifically lyse qio/ld targets. histopathologic examination of the livers of these animals does not show extensive lymphocytic infiltration or inflammation. in addition, serum levels of alanine aminotransferase. aspartate aminotransferase, and alkaline phosphatase are also normal, confirming that these animals do not show overt signs of liver rejection. results are ampatable with a t least two different pathways of antigen hardling, a pathway for degradaticm of antigen, and a "pmcessiq" pathway for antigen presenbtim. my+ l monocytcq enes appear t o i n t e r f e r e with t h e processing pathway, either by i n h i b i t i n g production of antigenic material t h a t can associate with ia o r by i n h i b i t i n g putative intracellular event@) imr0lvb-q the binding of ia to processed antigen and tmnsprt of annplexes to the cell surface the immunogenicity and antigenicity of synthetic peptides (sp) derived from the sequences of a streptococcal antigen were investigated in macaque monkeys. immunization with the free peptides of 17 and 21 residues failed to elicit serum antibodies or t cell responses. however, both serum antibodies and lymphocyte responses were elicited by immunization with the sp linked to tetanus toxoid (t) as a carrier. indeed, spl7-lt and sp21-tt elicited serum antibodies and proliferative responses of lymphocytes, not only to the sp but also to the native strtptococcal antigen. recall of sp17-tt or sp21-1t immunized monkeys w i t h suboptimal doses of the native srreptococcal antigen resulted in a significant increase in antibodies, both to the sp and native antigen, confirming that the two sp share antigenic epitopes with the native antigen. the b and t cell epitopes were then determined and the b cell epitopes resides in residue 8-13, whereas the t cell epitope overlaps and consists of residue 7-15. the t cell epitope has an amino-terminal leucine and carboxy-terminal glycine and alanine added to residue 8-13 of the b cell epitope. in spite of the b and t cell epitopes being expressed in sp17 (residues 1-15), the monomer failed to induce serum antibodies without a carrier. however, immunization with dimers of peptide-linked or disulphide-linked residues 1-15, without a canier, elicited both serum antibodies and proliferative responses of lymphocytes. the results suggest that the monomeric sp17 is not immunogenic, whereas the dimeric peptide elicits both antibodies and t cell responses. the minimal t cell-b cell structure required for immunogenicity is now being determined. lmmunogenlclty section a departments of immunology and rheumatology, mayo clinic, rochester, pin 55905. susceptibility to collagen induced arthritis (cia) in mice maps to the i-a loci in h-29 mice. however, swr (h-29) mice are cia resistant, suggesting a role of non-mhc genes. we have recently shown gene complementation between h-29 from swr and tcr v genes from several non-susceptible strains. cia has been induced in b10, c3h.a and a fackcrosses with swr with similar high incidences; 63, 71 and 67% respectively. c57l shares a similar background with b10 and is h-2b, but has the same v tcr mutation as swr. backcrosses showed a very low incidence (17%) of cia, and tte arthritis observed was of a much milder and transient nature. the invariant chain associated with hla class i1 molecules is a 31-33 kd glycoprotein implicated in antigen processing and assembly and intracellular transport of class i1 molecules. class i1 molecules and invariant chain are expressed primarily by b lymphocytes and antigen-presenting cells such as macrophages and can be induced by interferon-y in a variety of cell types. to define sequences involved in the human invariant chain gene regulation, 790 bp 5 ' to the initiation of transcription were subcloned upstream of the cat gene. transfection into invariant chain-producing cell lines and non-producing cell lines demonstrated that this 5 ' region displayed tissue specificity and responsiveness to interferon-y. deletion mutants were constructed to ascertain the functional properties of specific regions of the invariant chain upstream regulatory regions. these deletion mutants have led to the identification of 3 putative regulatory regions: 394 to 239, 2 3 to 216, and 216 to 165 bp 5 ' to the cap site of the invariant chain gene. deletion of any one of these 3 regions results in decreased cat activity. protein-dna interactions of these sequences have been characterized by mobility gel shift assay and dnase i footprinting. two regions have been identified that exhibit cell type dependent binding of nuclear proteins. two color flow cytometry was used to characterize the surface phenotypes of human bronchoalveolar lymphocytes (n=32). the cd4/cd8 ratio was highly variable (0.3-6.6, mean-2.1). a high proportion of the t cells expressed hla-dr (9-38%, mean=2l%) indicative of t cell activation. however, detectable levels of the i+-2 receptor were expressed on <3% of the cells. cd45r was absent from cd4 cells in most preparations (0-10% mean=3%) suggesting that the cells are inducers of ig synthesis. uchl1, a marker of memory cells was present on 68-100 % of lung t cells. uchll+ cd45r-lung lymphocytes responded poorly to pha and cona but did respond to il-2 in the presence of accessory cells. together these data suggest that lung lymphocytes are recently activated memory cells. il-2 induced lung t cell lines were also characterized for antigen expression and w ( activity. high lak activity was obtained in preparations containing a high proportion of cd8 cells. these cultures appeared to be suicidal. in contrast, lines with a high proportion of cd4+ had low or absent lak activity but proliferated in the presence of il-2 for at least 3 months expressing a cd2 cd45r-phenotype. this abstract is a proposed presentation and does not necessarily reflect epa policy. the polymorphic second exons of the hla-dp, and dpd genes have been specifically amplified in vitro by the polymerase chain reaction (pcr) method, using the thermostable dna polymerase of aauaticus. sequence analysis of mi3 clones containing the amplified dp sequences from a panel of thirty-four df typed cell lines revealed only the two previously characterized alleles for dp, . fourteen allelic variants were defined for dpw eight of these are associated with the t-celldefined dpwl-6 types; two subtypes were found for both dpw2 and dpw4. six additional dp alleles which were previously typed in the t cell assay as blanks were also idenlfied. based on this sequence information, non-isotopic sequence specific oligonucleotide probes have been developed and used to type a margarita betz, dominic dordai, brian e. lacy, and barbara s. fox. department of medicine, university of maryland school of medicine, baltimore md 21201. murine type 2 helper t cells (th2) secrete interleukin 4 (il 4) in response to antigen. despite the likely importance of these cells, little is known about their priming and expansion in vivo. we have demonstrated il 4 production in response to a cytochrome p peptide following t cell expansion in vitro. this antigen has not previously been shown to induce th2 cells. bio.a mice were primed with a peptide fragment of pigeon cytochrome c in cfa. lymph node cells were restimulated in vitro with antigen for 5-7 days, ficolled and rested for 3 days without antigen. cells were then tested by limiting dilution for the presence of antigen-specific il 4 producing cells. il 4 was detected using the il 4 sensitive cell line ct4s (provided by dr. w. e. paul, nih). the specificity of the response was confirmed by blocking with the anti-ll 4 antibody 11 b1 1. following in vitro restimulation of the primed lymphocytes with antigen, il 4 production was detectable from as few as1 03 cells per well. il 4 secretion was antigen dependent and required both in vivo priming and restimulation in order to be detected. it is not clear why primed lymph node cells, placed in limiting dilution culture directly after removal from the animal, failed to secrete detectable amounts of il 4 in response to antigen. suppression is an unlikely mechanism as fresh primed lymph node cells were unable to inhibit il 4 production by restimulated cells. we are now investigating the factors that may regulate the development of il 4 producing t cells. mark r. boothby, ellen gravallese, hsiou-chi liou. and laurie h. glimcher, department o f cancer biology, harvard school o f public health, boston, ma 02115. regulated pattern, and normally expression is limited to certain cell types such as 6 cells and macrophages. cells is accompanied by the loss o f class i 1 mhc expression. these genes also respond to external stimuli such as the cytokine il-4, which increases b cell ia. a region o f the aa mhc gene activated expression of a cat reporter gene in a b lymphoma cell line but not in a myeloma cell line. a nuclear protein that bound to two sites within this region was found. this binding activity was present in spleeiis that lack t cells and in b cell lines, but it was absent from all three myeloma cell lines tested. il-4 treatment of normal and athymic mouse spleen cells greatly increased the binding of this nuclear protein to its a a target sites, concomitant with increased aa transcription; "thus, 6 cells contain a sequence-specific binding activity regulated both by il-4 and by differentiation. the differentiation o f b cells to plasma lmmunogenicity c210 peter van den elsen3. ldepartment of immunology, the netherlands cancer institute, amsterdam, zdepartment of immunology, erasmus university, rotterdam, 3department of immunohaematology, academic hospital, leiden, the netherlands. human tcr y6 occurs in disulphide-linked (type 1) or non-disulphide-linked (type 2) forms, dependent on the use of the cyl or cy2 gene segment. the cyz gene segment can contain a duplication or triplication of exon 2 , which gives rise to different protein forms (types 2bc or zabc). it is not known whether functional differences exist between these receptor types. protein chemical analysis of type 1 and type 2bc receptors on functional human t cell clones derived from peripheral blood (pb) has indicated that not only the y chains, but also the 6 chains have a molecular mass and charge which set apart type 1 and q p e 2bc receptors. two sets of fifteen clones were randomly generated from pb of two normal donors after selection with the anti-tcr y6-1 mab, which recognizes all receptor types. dna rearrangement and mrna expression analysis of y and 6 genes allowed us to map the specificity of the anti-tcr y6 mabs 6tcs-1 and tiya to the v6l and vy9 gene segments respectively. subsequently it could be concluded from the analysis of random clones that the majority of type 1 receptors use vy9, while this preference seems absent in type 2 receptors. the great majority of type 1 receptors do not use v6l. while the majority of type 2 receptors do. this was confirmed by fluorescence analysis of pbl of a large panel of normal donors. we conclude that vy and v6 gene segments in functional tcr y6 in pb are used in non random combination and that their expression is correlated with rearrangement of the y gene to cyl or cy2. we have previously shown that polymorphic residues in the nh2-tenninal half of the p1 domain (amino acids 1-48; hypervariable regions 1 and 2 [phvl and 21) determine with which allelic or isotypic a chain a particular b chain can achieve efficient cell surface beterodimer expression. this result might be understood in terms of the current model for ia smcture which predicts that w v l would lie adjacent to region. therefore, to examine the role of ahvl residues in conmlling hetcroduncr expression. a mutant a d cdna was created in which the codon for amino acid 11 was mutated to code for the auk residue at this position. in addition, recombinant a d and a& cdnas, in which the segments encoding the three a hypervariable regions were exchanged between the two alleles, were used to study the connibutions of other a chain polymorphisms to this process. interestingly, the polymorphic residues in ahv2 are predicted to lie in a region of the a a chain a-helix which is adjacent to the phv4 region of the p chain a-helix. allelic substitutions in this latter region of ad have been shown to similarly affect surface ia h e t e r o d i i expression. taken together, these results suggest that there are at least two spatially separate areas in which the a and p chains interact and that these interactions are affected by polymorphic rtsidues in both areas, conmbuting to the efficiency of heteroditner expression and, most likely, ia quartcmary conformation. the aim of this project is to identify contact residues of the t cell receptor (tcr) with antigen and/or mhc class i1 molecules. as a model system, a vp17-containing tcr has been chosen since the majority of vb17' t cell hybrids react with ie molecules of the k,s,d, and b haplotype. t cell hybrids have been made which have a dual reactivity: they are vp17+ and recognize ie molecules but also show reactivity towards a known antigen, namely chicken ovalbumin (ova). one such hybrid has been mutagenized with ethyl methane sulfonate (ems). mutants were selected on the basis of their survival after stimulation by either antigen or ie. it was expected that mutations in all different kind of genes involved in t cell recognition and t cell activation would be found. mutants obtained fall into two major groups: 1) loss variants of tcr a or fl chains,t3 or l3t4: 2) mutants with point mutations in one of these genes. we are currently analyzing the mutants biochemically and functionally in order to identify the particular gene affected. point mutations in the a and p genes of tcr mutants will be localized using the polymerase chain reaction in combination with dideoxy sequencing. activation of t lymphocytes requires the intracellular fragmentation of foreign antigens and their presentation by class i or class i1 major histocompatibility complex glycoproteins. the direct binding of peptides to class i1 molecules has been shown in a number of experimental systems and its specificity compared to that of t cell activation. in contrast, direct binding of peptides to class i molecules has been difficult to detect; although peptide sensitization experiments and the crystallographic structure of hla-a2 persuasively argue for its occurence and importance. in this study, we demonstrate specific binding to hla-a2 of an influenza matrix peptide (flu-m1 residues 56-68) that has previously been shown to act as a target for certain hla-a2 restricted influenza-specific cytotoxic t lymphocytes. we estimate that less than 0.3% of the purified hla-a2 molecules were able to bind the added peptide. we and others have shown that allorecognition by cytolytic t lymphocytes (ctl) is analogous to t cell recognition of foreign antigens in that both can occur via presentation of antigenic peptides by products of the major histocompatibility complex. we have used peptides corresponding to the alphal helix of selected hla molecules to analyze t cell recognition of this polymorphic region. the alpha alpha helix of hla-b44 and -b13 are identical, and show a high degree oh homology with those of hla-bw58, -b47, and -b27. peripheral blood lymphocytes from 5 normal donors were stimulated in vitro with targets expressing hla-b44 to derive allospecific ctl lines and clones. in some individuals, the allospecific response was almost totally directed against the alphal helix. the ability of peptides corresponding to the alphal helix of these hla molecules to inhibit and induce lysis as well as to modify other assays of t cell activation will be discussed. diseases and *national institute of child health and human development, d bethesda, md 20892 . classical transplantation antigens are constitutively expressed on cells of all tissues exce t brain. transaiption is regulated by the interaction of nuclear factors with 5' flanking regions tiat include the class i re latory element (cre). previously, the cre has been divided mto 3 re om on the basis of nuclear t%or blndin . several studies have implicated the nuclear protein (ri) wfich binds to the inverted repeat geggattcccca) of re 'on i as necessary for gene transai tion although region i is identicarin all se uencedouse $d and l enes, it is not conservefin qa r y genes. a comparison of the c& from h-2ld with that of 610, a qa region gene expressed o y in the liver and fetal olk sac, shows that there are two changes within the inverted r eat se uence (tgaggactcc$a). these differences disru t the dyad symmetry. another nugotide diierence between h-2l and qlo falls within re 'on ifof the cre. however, qlo can bind to the nuclear factor (rii) that binds to region ii of the fit2ld cre, whereas qlo region i can not bind to the nuclear factor (ri) that binds to the region i inverted re at. to test whether the differences m region i contribute to the restricted tissue e ression of q l r w e have used site-directed in vitro mutagenesis to make the inverted repeat of]cglo region i like that of the classical class i genes. a change at either base enhances transcription as measured in a transient transfection system. either change also allows binding of the nuclear factor that binds to the classical r alterations in the cre regon i contribute to the limited tissue expression of310. the presence of disrupted cre region i in other region genes likely contributes to their tissue restricted expression. on i sequence. thus, molecular analysis of t cell receptor structure/function in sperm whale myoglobin specific t cell clones. jayne s.danska, alexandra m. livingstone, toshi isihara and c. garrison fathman, stanford university medical school, stanford, ca. we have undertaken structural characterization of the t cell receptors (tcr) utilized by a well defined panel of murine dba/2 t cell clones that recognize epitopes within the 110-120 peptide of sperm whale myoglobin (sp wmb) presented by i-ad or i e . only 2 of 14 independent clones show alloreactivity for 10 whc haplotypes. using the polymerase chain reaction (pcr) and dna sequencing of the tcr a and fc chains from matched sets of clones bearing either whc restriction or epitope specificity in common, we are addressing structural relationship between tcr and mhc/antigen for this model system. among 6 i-ed restricted t cell clones reactive with spwmb 110-120, all have highly homologous tcr 6 chains associated with a minimum of three different tcr a chains, some of which are derived from novel v gene families. to further characterized the specificity of these clones we are generating substituted peptides to identify residues within the epitope important for interaction with tcr or restricting mhc molecule. functional verification of the relationship between given tcr primary sequences, and recognition capability will be addressed by transfer of the a and/or 8 chafns cdnas created by pcr amplification into t-cell hybridomas expressing endogenous tcr genes of known sequence and specificity. with mhc fine specificity. the differential impact of substitutions with the n-terminal and c-terminal portions of the apl domain is consistent with models of auap structure in which the n-terminus interacts with peptide while the c-terminus interacts with both peptide and the tcr. or aauapu-resmcted t cell clones. the antigens tested were l-tymsine-p-lmmunogenicity c 218 expression of the q4p gene, patricia m. day, katherine e. lapan and jeffrey a. frelinger, department of microbiology and lmmunolog university of north carolina at chapel hill, chapel hill, nc 27599. generally, the transcription of class i genes tom the q a a region is limited to tissues of hematopoietic origin. previous work in our lab demonstrated widespread transcription of the q4 gene in the 81 0.p mouse, with high levels of mrna found in liver, lung, lymph node, spleen, testes and thymus. less rna was present in muscle and brain tissues. however,,it is not known whch individual cell types within these tissues are responsible for the transcription of the q4 gene. we raised polyclonal antisera against a synthetic peptide, derived from the predicted amino acid sequence of the q4p transmembrane region. we selected this region since it is the most locus specific. this antisera immunoprecipitates a class lsized protein. a monoclonal antibody, directed against the same peptide, has also been produced. sv40-transformed h-2p fibroblasts show an abundance of q4 message. suprisingly, indirect immunoluorescent staining with the monoclonal antibody reveals a cytoplasmic localization of the protein with a perinuclear concentration. different patterns have been observed in examination of the h-2b em onal carcinoma cell lines 402ax and pcc4. qgspecific antibodies allow us to identify the cell ty es which express the24 gene product. the application of in situ hybridization techniques will correlate the cellular site ofmrna synthesis and protein detected by antibodies. understanding the paltern of expressim of the q4 gene is the first step in determining the so far elusive function of these mhc genes. and il2r mrna a f t e r mitogenic stimulation. antibodies against cd45r, but not against c045 common determinants, synergise with suboptimal doses o f mitogen t o induce il2 and il2r mrna expression, suggesting t h a t cd45r molecules are operative i n transmembrane s i g n a l l i n g i n immature thymocytes. there i s also an i n d i c a t i o n from northerns using cd45 probes t h a t cd45p180 mrna i s not induced i n activated cd348-thymocytes as i t i s i n mature t c e l l s . these r e s u l t s support the idea t h a t cd45r+ molecules are essential f o r generating signals required f o r c e l l survival w i t h i n the productive intrathymic lineage. we examined a panel of thl and th2 t cell clones for the ability to induce antibody synthesis in a mishell-dutton culture system under cognate b-t cell conditions: our findings indicate that both thl and th2 t cells are heterogeneous, i.e., some but not all thl and some but not all th2 clones have the capacity to induce antibody under these conditions. we examined the effect of 7-irradiation or rnitomycin-c pretreatment of our thl and th2 clones on their ability induce antibody synthesis. asano et al. (j. immunol 138:667) have reported that th2 clones are exceedingly sensitive to 7-irradiation, with doses as low as 500 rads abrogating the ability of th2 clones to induce antibody synthesis. we found that while the helper activity of th2 clones was very radiation sensitive, helper activity in thl clones was very radiation resistant. thl clones given 2 0 0 0 rads of irradiation were as effective as unirradiated clones in inducing anti-tnp plaque forming cells (pfc). moreover, when used at higher t cell/b cell ratios in culture, irradiated thl clones were more effective than unirradiated clones in inducing antibody synthesis. the effect of 7irradiation on th2 clones was not simply due to inhibition of proliferation, since mitomycin-c pretreatment of the clones had little effect on helper activity. conservation, alexander l. dent, pamela j. fink and ste hen m. hedrick, department of biology, university of california, san diego, 8a 92093. the p chain gene of the murine t cell receptor has been shown previously to have an alternative1 spliced form of message. this message contains a novel exon, termed c& which is inserted between the vdj and constant region exons. we have studi6d expression of the cpo exon at the mrna level by rnase protection. we have found that about 1% or less of of p messages in normal t cell clones contain the cgo exon, whereas p m e s a es. in the thymus contain the exon at 10-20 fold higher levels. to address t i e importance of the c 0 exon in the immune ,system, we have undertaken a phylogenetic approach. \y cloning and sequencin the rat analogue of cpo, we have found that while the rat exon is very simifar to the mouse exon, both donor and acceptor rna splice signals are defective in the rat cpo gene. this implies that rat cpo cannot be spliced into rat p m e s a 8s. furthermore, we have sequenced the analo ous region to mouse cpo in 8 e human p chain locus, and have found no stretct of sequence remotel homolo ous to cpo. because cpo is not conserved evolutionarily, we beieve that ! he cpo gene element does not sewe an important function to the immune system of most vertebrates. 1988) . we found that one arrdno acid substitution at a vdjp juntional region position found to be highly conserved in pigcon cytochrome c-specific tcr's results in a change in antigen fine specificity, while an* change abolishes all detectable responses characteristic of the d6 tcr. we will present the results of mutagenesismansfection analyses of two other pigeon cytochrome c-specific tcr's. the murine ctl response to human class i molecules is 1-2 orders of magnitude lower than the response to murine alloantigens, due to structural differences between human and murine homologs. we investigated whether this discrepancy could be overcome by exposure of developing t cells to human class i molecules in transgenic c57bl/6 mice expressing hla-a2.1. ! c222 zhe bdixujiar basis of . lbve digiustn ard ed p d l u b 2 r , divof s ch mice expressed hla-a2.i in spleen, bone marrow and thymus at levels similar to those of endogenous h-2 molecules. however, the frequency of ctl specific for other human alloantigens remained similar to that of normal mice. the frequency of hla-a2.1 restricted influenza specific ctl was 1-2 orders of magnitude less than the frequency of h-2 restricted ctl. these results indicate that the poor response of murine ctl to human class i antigens is not determined by selection in the thymus, but by species-specific constraints on the interaction of mhc antigens with t-cell recognition structures. while the mice are tolerant to hla-a2.i expressed on murine cells, they still respond to hla-a2.1 expressed on human cells. the epitopes defined by such clones are present on hla-a2.1 positive human cells derived from several different tissues. such epitopej are not dependent upon the species of p2m associated with the class i molecule, nor upon the structure of the attached carbohydrate. the results suggest that one or more highly conserved normal human proteins contribute to the formation of such epitopes, and provide an explanation for the failure of ctl raised against class i molecules on human cells to recognize the same molecules expressed on murine transfectants. this suggests that normal endogenously expressed molecules may also be important in the formation of epitopes on class i antigens recognized by allospecific ctl. we previously demonstrated t h a t several subclones derived from a c03+, cd4-/cd8-t-cel i l i n e have undergone secondary rearrangements a t t h e t-cell receptor (tcr) a locus w h i l e maint a i n i n g i t s o r i g i n a l tcrb and igh d-j rearrangements (marolleau e t . al., i n press). these secondary rearrangements r e s u l t i n t h e j o i n i n g of germline va and j a gene segments which replace the p r e -e x i s t i n g va-jacmplexes of t h e parental t-cell line. i n an e f f o r t t o examine t h e molecular mechanism responsible f o r these va-ja gene replacements, t h e s t r u c t u r e s o f tcra cdnas prepared from both t h e parental and subcloned t-cell l i n e s were determined. i n addition, northern b l o t and southern b l o t analyses were performed on both t h e parental and subcloned t-cell l i n e s using a panel o f va and j a probes. our r e s u l t s i n d i c a t e t h a t : 1) secondary rearrangements r e s u l t i n both productive and non-productive va-ja j o i n s , 2) the mechanism whereby secondary rearrangements occur i s a d e l e t i o n event t h a t involves germline va genes 5 ' t o t h e p r e -e x i s t i n g va-ja complex j o i n i n g t o j a the class ii major histocompatibility complex (mhc) antigens are a family of integral membrane proteins whose expression is tissue-specific and developmentally regulated. a pair of consensus sequences, x and y, separated by an interspace element, is found upstream to all class ii genes. deletion of each of these sequences eliminates expression of class ii genes in vitro or in transgenic mice (1-3). furthermore, the absence of a specific binding protein for the hla dr a x box in patients with severe combined immunodeficiency disease whose cells lack class ii suggests a critical role for these proteins in class ii gene transcription (4). report the cloning of a agtll cdna encoding a dna binding protein (human x-box binding protein, hxbp-1) which, like the proteins in whole nuclear extract, recognizes both the x box and interspace elements of the human dra and murine aa genes. the hxbp-1 cdna hybridizes to two rna species, 2.2 kb and 1.8 kb in human, that are expressed in both class ii positive and class ii negative cells. hxbp-1 does not cross-hybridize to two murine aa x box binding cdnas recently isolated in our laboratory which also recognize the dra and a ax boxes. these observations provide evidence for the existence of multiple x box binding proteins which recognize a common or overlapping motif. chromosome mapping studies demonstrate that hxbp-1 arises from a multi-gene family two of whose members map to human chromosomes 5 and 22. taken together, these data suggest a high degree of complexity in the transcriptional control of the class ii gene family. france . in an attempt to analyze positive or negative in vivo regulation of clonal expansion of cytolytic t lymphocytes (ctl), we immunized blo.br mice with the kb specific ctl clone kbs-cu). and we tested whether t cells obtained from such mice would influence the in vitro development of the ctl clone kbs-c?o. a clone-specific helper effect has k e n observed, which is mediated by cd4+ splenic cells from immunized mice. control immunizations of b1o.br mice with ti negative variants of suggest that this growth regulation involves the recognition of the ti of kbsc20. the precise nature of the antigen recognized on the ctl clone, the possible involvement of ti determinants with or without mhc products u e now under investigation. we have shown that thy-]+ dendritic cells present in the epidermis of mice (dec) express cd3 associated v73 and v61 gene products. we have produced a monoclonal antibody directed against v73 and found that a wave of cells appearing at the earliest stages of fetal thymic development express v73. phenotypic and functional analysis of v73+ cells in the early fetal thymus indicates that they have characteristics in common with the v73+ dec. both populations express high levels of ly-1 and are ly-6c+. neither express cd4 or cd8. interestingly, the v73+ fetal cells express elevated levels of il-2 receptor, indicating that they may have been activated. functional analysis demonstrated that, unlike other fetal thymocytes, the v73+ cells can be stimulated to produce lymphokines and lyse a panel of target cells which are also lysed by the adult thy-l+ dec. these results raise the intriguing possibility that the first receptor-bearing component of the t cell system to appear in ontogeny might give rise to the thy-]+ dec. (3ritical to an understanding of the function of cells bearing the gamma-delta t cell receptor will be an understanding of when and where such cells function. in order to investigate this, we have used a variety of techniques (in situ hybridisation, cdna cloning, and pcr) to examine m a s of tcr gamma delta gene expression. one conspicuous site of expression is the intestinal epithelium, which is by contrast almost devoid of tcr alpha beta expression. interestingly, the v gene segment usage in this location is quite specific and is different to the specifcity that we have found in the spleen and in the thymus, and that others have found in the skin. this specificity suggests in turn that expression of the resmcting elements recognised by gamma delta may also be spatially nxticted. extensive analysis of junctional diversity can pmvide infomation on the diversity of antigen nxogniscd by gamma delta. the basis for selective expnssion of v gene segments may in part lie in different requkments of the v-gannna gene pmoters. to examine this, the wnscriptional capabilities of the various gamma gene promoters in t cells murine tcr gamma genes: distinct spatial restriction of v-gene segment usage, adrian thyday*, susan kyes*, simon carding#, charles a. janevay, being compared by linkage to the chloramphenicol acetyl transferase gene. biochemistry, university of wisconsin-madison, madison, 11 53706. murine strain a sublines a/j and a/wysnj have a genetic polymorphism that regulates serum immunoglobulin responses to several protein antigens. strain a/j secondary igg1 responses to bovinv gamma globulin, oralbumin, hemocyanin and galactosidase l-ere 50-, l o -, i -and 4-fold greater, respectively, than a/wysnj responses. subline a/hej is a low responding strain like .l/wysnj. analysis of h-2 class 1 and class i 1 molecules provided no evidence for a breeding error to account for the genetic polymorphism. instead, an important immune response gene outside h-2 may hare been heterozygous when the sublines diverged, and the polymorphism resulted from sezregation and differential allele fixation. a mutation subsequent to subline divergence is also a possible source of the polymorphism, but is less likely. the high responder phenotype inheritance pattern in (a/wysnj x a/j)fl, f2, and backcross mice was consistent with segregation of a single, recessive gene. we named this locus l a for the strain a sublines that define it; strain a/j represents the k a h allele and strains a/yysnj and a/hej represent the allele. hayes, keith d. hanson, faye nashold, and david j . miller, department of the secondary iggza responses were also affected. several different proteolytic digests of denatured seb have been tested for their ability to stimulate t cell hybrids to produce il-2. a tryptic digest that retains activity has been fractionated by hplc and the stimulatory component is being analyzed. examination of the amino acid sequence of seb and the proteolytic cleavage sites has led us to synthesize several peptides for analysis. these peptides, and their analogues, will be tested for their function in vivo and in vitro. to understand the interactions involved in the famation of peptide-mhc complexes, an assay has been developed to detect dr specific binding of peptide analogues of t e l l determinants to cell surfaces. ebv msformcd b cell lines (bcls) w m incubated with biotinylated peptide followed by fltc conjugated streptavidin, and then anaiysed by flow cytomctg. a panel of bcls homoygous for diffmnt dr types bound analogues of peptide 307-319 from influenza virus haemagglutinin (previously shown to be a helper t cell determinant restricted through dr1) to varying degrees, w h m no binding was observed to the dr-bcl rj225. binding could be specifically inhibited by the natural unbiotinylated t cell determinant or other drl restricted determinants. competition by a range of peptides revealed quantitative diffmnces in their ability to bind drl. the assay is currently being used to generate a detailed model of the complex formed betweenha307-319anddrl. and trp for leul 6. and hla-a2.3 differs from hla-a2.i by the substitutions of thr for ala 4 9 glu fo??a1152 and trp for zeu156. residues 9 and 95 in the 8-sheet of the molecule, and residues 149, 152, and 156 in the a-helix are thought to interact with bound peptide or the tcr. to evaluate the role of these residues on ctl-defined epitopes, two genes were constructed that encoded novel molecules which differ from hla-a2.1 only at residues 9, 43, and 95, or at residue 156. the effect of a-helix substitutions on serologic and ctl-defined epitopes that varied between hla-a2.i and hla-a2.3 were evaluated by constructing genes that encoded the individual differences at residues 149, 152, and 156, as well as additional non-naturally occuring substitutions at these same positions. hla-a2.1 specific ctl were found that were: (1) insensitive to substitutions at either residues 9, 43, and 95, or residue 156, but were lost when all four positions were changed; (2) dependent upon the residues 9, 43, 95, but not residue 156; (3) dependent upon residue 156, but not residues 9. 43, and 95; and (4) dependent upon residues 9, 43, 95, and residue 156. further epitope mapping with the a-helix mutants demonstrated that a substitution at residue 152 often destroys an epitope not affected by substitution at residue 156. even conservative substitutions at position 152 were more disruptive than nonconservative changes at residue 156. residue 149, while important in defining an mab epitope, had no effect on any ctl epitopes. these results indicate that spatially separate residues in the a-helix and 8-sheet of the molecule can contribute to the epitope recognized by a given ctl. furthermore, considerable complexity must exist in the spectrum of t cell receptors utilized to recognize hla-az, as 28 ctl clones exhibited 21 distinct fine specificity patterns. to follow the evolution of these class i types, to discern the chief selective pressures on its members and thus indicate the probable functional properties of the antigens. a cosmid library was screened for class i genes. 91 clones were mapped and could be grouped into 17 clusters of contiguous dna spanning 1,264 kb. by hybridisation studies, 61 class i genes/ gene fragments could be distinguished. transfection analysis revealed that 10 genes could be expressed as cell surface antigens: two genes, in a block of duplicated dna encoded serologically defined rt1.c products, the other 8 genes gave rise to novel class i antigens detected by the xeno-antibody 0x18. using region specific probes, we could detect clear rat homologues of the mouse qa and h-2 genes, however there were only two rat genes with limited homology to the mouse tla genes. the analysis showed extensive remodelling of the class i region in the evolutionary gap between rat and mouse. while the immunological role of t cells bearing the ap t cell receptor (tcr) has been well characterized, much less is known about the function of t cells bearing the $3 tcr. we investigated the role of tcr $cells in the immune response to complete freund's adjuvant (cfa). after immunizing mice with cfa, we observed a greater than 26-fold increase in the number of tcr $3 cells present in lymph nodes draining the sites of immunization, compared to a 3-4-fold increase in the number of tcr ap cells. there were at least three different species of 3tcr's expressed on these cells in the draining lymph nodes, including two protein products derived from the rearrangements of cyl and cp, and one product derived from cy4. 37% of tcr ys cells from immunized lymph nodes expressed the il-2 receptor in vivo. and these cells constituted roughly 50% of the proliferative response of total lymph node t cells to 11-2. tse, et al. (j.lmmun..vol.l25, p.491.1980) have demonstrated that at least three cell types are involved in the t cell proliferative response to antigen, including an antigen specific-t cell, an antigen-presenting cell, and a t cell that is found in unprimed lymph nodes or spleen, which has been termed the recruitable cell. we have utilized their approach of analyzing the slope of log cell number-log response curves to examine whether tcr @ cells can function as "recruitable" cells. we found that tcr ys cells as well as tcr ap cells can function as recruitable cells in this system. these data suggest that tcr $3 cells can participate in the immune response without being specific for the antigen. analysis of the membrane associated phosphoprotein profiles of b cells harvested from cultures of resting cells exposed to il-4 for 18-24 hrs reveals the presence of phosphoprotein with an mr in the range 75-80,000. destroy the autoradiographic signal from this phosphoprotein suggesting that it is phosphorylated upon tyrosine residues. appearance of this molecule, and lps also apparently fails to result in the presence of a 75kd structure in the phosphoprotein profiles. anti-il-4 antibody. 11811, in the cultures prevents the appearance of the 75kd phosphoprotein. the genes for t n f -a and tnf-p are tandemly arranged on mouse chromosome 17, with only 1.1 kb separating the 3' end of the tnf-p mrna from the 5' end of the tnf-a mrna. yet, the two genes are independently regulated. in vitro transcription and nuclear run-on experiments indicate that the two genes are transcribed from independent promoters. in macrophages, which express tnf-a but not tnf-p, only the tnf-a promoter is active. in t lymphocytes, which can synthesize both proteins, both promoters are active. activation of either cell type results in a moderate (up to 10-fold) increase in the level of transcription, while mrna levels increase more than 1wfoid under the same conditions. interestingly, the tnf-p gene is aanscribed 10-fold less than the tnf-a gene in t lymphocytes, although the corresponding mrna is more abundant. these results indicate that the accumulation of both tnf-a and tnf-p mrna after cell activation and their relative steady state levels are controlled mostly at a post-transcriptional step. acanomycin d chase experiments reveal that tnf-a mrna stability in macrophages is not significantly altered after activation by lf's, and therefore that stabilization done cannot account for the observed accumulation of tnf-a mrna. in order to examine more closely which elements are required for the regulation of tnf-a and tnf-p mrna abundance, we constructed hybrid genes combining putative control regions of tnf-a and tnf-p with known constitutive control elements. results obtained from the transfection of these hybrid genes into various cell types indicate that elements located both 5' and 3' of the coding sequence are required for the proper regulation of tnf-a and tnf-p mrna abundance. celiac disease is characterized by small intestinal mucosal injury and malabsorption. disease is activated when a genetically susceptible host ingests wheat gliadin or similar proteins (i.e., prolamins) in rye and barley. d region specif icities -dr3 and -dqw2. class i1 d-region haplotype associated with celiac disease is extended and also includes genes in the hla-dp subregion. chain gene with those encoding dr3 and dqw2 may indicate that the hla haplotype associated with celiac disease exhibits an unusual degree of linkage disequilibrium or, alternatively, that disease susceptibility involves the gene products of more than one hla locus. to characterize possible hla structural variants unique to celiac disease, the polymorphic second exons of the expressed dr, dq and dp genes were amplified from genomic dna of celiac disease patients, and their nucleotide sequences determined. our studies indicate the presence of a unique constellation of d region genes associated with the celiac haplotype, and exclude the presence of a disease specific dr, eq or dp structural gene variant in this disease. disease susceptibility is strongly associated with the hla class i1 we recently determined that the hla this same population of t cells contains a high frequency 0 1 % ) of cells which will respond to a given allogeneic mhc protein, or to differences at two other genetic loci termed mls, in conjunction with mhc. we have transfered the a and b chain genes from a pigeon cytochrome c/el specific, alloreactive. and mis' specific murine t cell clone into an unrelated host t cell. we demonstrate that the genes encoding a single a b receptor chain pair can transfer the recogntion of self mhc molecules c m p l e x e d with fragments of antigen, allogeneic mhc molecules. and an m1sc (hls-2) encoded determinant. in this case the transfer of antigen specificity and alloreactivity requires a specific a8 receptor chain combination, whereas mlsc reactivity can be transfered with the 6 chain alone into a recipient expressing a randomly selected a chain. site directed mutagenesis of the ja region has also been performed in an attempt to identify sites involved in the alloreactivity of this t cell clone. in addition. we demonstrate that a single amino acid change in the v-j junction of the a b receptor can alter mhc restriction a s well a s antigen fine specificity. department of genetics, washington university school of medicine, st. louis, i(0 63110. the s49 tumor sublines are variants isolated from a sing1 parent balb/c tumor which demonstrate locus-specific shut-off of their kd, dd and l8 genes. four phenotypically different sublines were characterized at the dna and rna level. southern blot analysis indicated that no major chromosomal deletions have occurred, and treatment of the sublines with 5-azacytidine had no effect on class i expression. between loci are unlikely. none of the repressed class i antigens could be induced with interferon even though the expressed antigens were fully inducible. northern blot analysis revealed message only for the expressed antigens, showing that the repression mechanism is acting at the transcriptional level. rnase protection analysis confirmed this result and demonstrated that the transcriptional repression is exquisitely specific for the kd, dd and ld genes as other "class i-like'' messages are present in. all the cell lines. expressing class i antigens from both fusion partners, but the negative class i antigens originating from the s49 partner were not expressed. lymphokine gene expression was examined in a panel of 116 short-term murine t lymphocyte clones derived by single-cell micromanipulation from allogeneic mixed leukocyte cultures. about 30% of clonable t cells, including both cd4+cd8-and cd4-cdw cells, could be expanded for assay at an average of 22 days after cloning. following stimulation with concanavalin a or anti-cd3 antibody, all clones secreted detectable granulocyte-macrophage colony stimulating factor (gi(-csf), interleukin-2 (il-2) and il-3, but cd4+ clones on average secreted higher 'levels of each lymphokine than cd8+ clones. clones (85%-96%) expressed detectable gm-csf, interferon-y and il-3 mrna and 11% expressed il-4 mrna. when the frequencies of co-expression of any pair of lymphokine mrnas vere determined, all were found to correspond to the values predicted for random assortment of the individual frequencies. for example, among 13 il-4-positive clones, 11 also transcribed interferon-y, giving the frequency of double-positive clones expected for random association (9.6% 10.8%). expression of the four lymphokine genes therefore segregated independently among the clones and did not allow the division of t cells into subsets vith distinct patterns of lymphokine synthesis. greater than 20-fold in the adult liver cell line, 2 to 3 fold in the macrophage cell line and just slightly in l-cells. we have subcloned the region 5' to the li gene which contains sequences that may be important to regulating expression of the li gene. this region includes a 15-mer (cctagaaacaagtga) which occurs 5' to many ifn?i regulated genes. current research has been directed towards identifying and comparing proteins from nuclear extracts prepared from control and ifn-7 treated cells which bind to this region (-260 to -1 1). this data indicates the li molecule may be expressed in cells not known to be directly involved in the immune response. although there has been considerable interest in the recently identified gamma, delta t cell receptor, relatively little is known as to its function. during our studies of the human immune response to autologous b cell lymphomas, we generated cytotoxic t lymphocytes (ctl) specific for tumor idiotype. these ctl lysed only autologous tumor cells and none of a large panel of other autologous and allogeneic cells. inhibitable by anti-idiotypic and anti-immunoglobulin antibodies but not by a panel of classical anti-mhc antibodies. phenotypic analyses showed that these ctl were cd3+, cd4-, cd8-, and express the delta, and presumably gamma! t cell receptor. such ctl can be used to gain new insights into the function of the gamma, delta t cell receptor and t cell recognition of immunoglobulin, and may prove clinically useful in adoptive immunotherapy. tumor lysis was for ebv-induced antigens. furthermore, lcl variant .221, which does not express any hla -a, -b. or -c determinants. is killed by cultures primed to lcl-.180. antibody blocking experiments suggested that this killing was mediated by t cells, and was not restricted by known class i antigens. depletion of leu 19 positive cells from the effector population did not eliminate cytotoxicity on lcl-.221. cold-target blocking studies further suggested that the class 11-nonexpressing lcl-.180 and the class i-nonexpressing lcl , 2 2 1 share residual deterninant(s) other than hla class i or class i1 that can restrict cytotoxic t cell responses to ebv-induced antigens. national jewish center for immunology and respiratory medicine, denver, co 80206 it is uncertain to what extent lymphokines can be differentially produced by activated primary t cell populations. to determine if il4 and ifnr were differentially regulated in uncloned human t cells from adults (ad) and neonates (nt), these mrnas vere measured by in situ hybridization after maximal stimulation by ionoaycin and pma. il4 mrna was detected in 1.2% of total (tl), 3.5% of cd4', 10% of cd4' cd45r-, and 0.1% of cdb' ad t cells, but in none of the tl, cd4+, or cd8' nt t cell populations (virtually all nt t cells were cd45r'). in contrast, ipnr mrna was found in 39.42% of tl, 34.36% of c d 4 ' , 51% of cd4' cd45r-, and 58% of cd8+ ad t cells, but only 2.3% of tl, 2% of c d 4 ' , and 4% of cd8' nt t cells. these results agreed with other estimates of il4 and ifnr production based on ria of cell culture supernatants, rna blotting, and gene transcription assays. in contrast to il4 and ipnr, il2 was expressed in similar amounts by ad and nt t cell fractions, as well as the ad cd4' cd45r' and cd45r' subsets. thus, the capacity for increased il4 and ifnr production by ad t cells appears attributable, in large part, to the postnatal acquisition of the cd45r' subset (putative memory t cell population). aowever, additional mechanisms exist which act transcriptionally to limit il4 production by both neonatal and adult t cells. such selective expression may be important for restricting the potentially pleiotropic effects of certain lymphokines t o appropriate responder cells. we observed significant inhibition (>70% at 800 ng/ml) of the presentation of wova and of ova 323-339 by the anti-ap 57-78 peptide mab's. exhibited significant inhibition. 61 peptide mab's. after incubation with antigen +/-mab, indicate that the inhibition occurs at the level of antigen presentation. dg11, was also observed for the anti-p chain peptide mab's and to a lesser extent by the anti-a chain peptide mab's. peptide sequences are capable of interfering with antigen presentation, in vitro. supported by nih grant, ai-14764. the ovalbumin (ova) i-ad restricted t cell hybridoma, do1l.10 was used to the anti-i-ad mab, mkd6, also much less inhibition was observed with the anti-% 43-experiments with glutaraldehyde fixation of the b1d.p cells before or inhibition of i-ad allorecognition by the t cell hybridoma. these results indicate that mab's generated against class i1 rijllinghoff, institute for clinical microbiology, university of erlangen-nurnberg, 8520 erlangen, f.r.g. and the *institute for clinical immunology and rheumatology, university of erlangen-niirnberg, 8520 erlangen. f.r.g. recently we have shown that cloned l . major-specific l1/1 t-helper cells of type 2 (th2cells), when stimulated with antigen, are able to induce polyclonal b-cell proliferation (1). we here present evidence demonstrating that this process is dependent on a direct cellcell interaction between t-and b-cells. which in the effector phase, i.e. during stimulation of the b-cells by activated t-cells, can be mediated by a mechanism other than cognate interaction. this conclusion is derived from experiments, in which highly purified resting b-cells were polyclonally stimulated by l1/1 t-cells triggered by an anti-t3 monoclonal antibody, in the absence of antigen. the triggering process was independent of the presence of the fc part of the antibody and occurred in cultures devoid of macrophages. thus, the well established cognate recognition does not appear to be the only way of b-cell induction by t-helper cells of type 2. studies show that a proportion of the peripheral blood cd3' t lymphocytes do not express cd4 or cd8 and are called double negative t cells. they normally have a 1 6 tcr. however, another population of double negative t cells exists that expresses the a@ heterodimer. w e have purified and expanded such a population isolated from the peripheral blood of a healthy individual and studied i t s phenotypical and functional characteristics. the c e l l s are cd3' cd4-cd8-, positive for wt31 and negative for the nk markers. they express a and p mrna b u t lack ymrna. from surface iodinated cells were precipitated w i t h monoclonal pf1 two closely running bands (46 & 48 kd) . functional studies demonstrate that they proliferate to anticd3 and pha, t h i s response was blocked by cyclosporin a. there was no nk lysis b u t anticd3 induced l y s i s of target cells. the cells responded t o il-2 and il-4 as previously shown for other t c e l l s , b u t also t o il-3, a lymphokine thought t o affect mainly stem cells and not previously shown t o stiaulate growth of mature cells. long term growth of these c e l l s was also maintained by these cytokines . roberto biassoni , silvano ferrini , rafck p. sekaly , and eric 0. long , laboratory of immunogenetics, national institute 2f allergy and infectious diseases, nih, beth-md 20892, and istituto nazionale per la ricerca sul cancro , 16132 genova, italy. cd3-cells grown in vim in the presence of il-2 acquire the ability to l~s e a wide variety of tumor cells in an mhc-unrestricted manner. we have previously shown that cd3-16 clones expressed the cd3 epsilon gene but no functional transcript from cd3 gamma, cd3 delta, tcr alpha, tcr beta and tcr gamma genes. this result suggested that these cd3-16' cells represented an early stage in t cell differentiation. to test for expression of the tcr delta gene in these cells, rna from a panel of cd3-16' clones and from three highly enriched populations was hybridized with several dna fragments of the delta locus. abundant transcripts were detected with a c delta probe and a j delta 1 probe in 6 out of 8 clones and in all three populations. at least four different transcripts were present with sizes similar to those found in cd3' tcr gamma-delta' cells. however, the tcr delta transcripts in cd3-16' cells are most likely derived from unrearranged genes because no rearrangement could be detected in dna from an enriched population using a j delta 1 probe, and because these aanscripts hybridized to a dna fragment corresponding to the unrearranged genomic sequence 5'-upstream of j delta 1. expression of unrearranged tcr delta genes in cd3-cells provides further evidence that these cells belong to the t cell lineage. functional capabilities and by differential release of either il2 or il4 upon activation. we have produced a new monoclonal antibody to cd45 which has allowed us to separate normal murine cd4+ cells into two populations based on the density of expression of cd45 epitope. the separated populations seem to be analogous of subsets found in cloned t cell lines. cd4+ t cells with high density of cell surface cd45 after polyclonal activation produce il2 and mrna encoding ifw and il2. it does not produce il4 or il4 mrna. cd45 low density population on the other hand transcribes mrna for il4 and secretes il4 protein. data will be presented to demonstrate that the two subsets of normal cd4+ cells also differ in their proliferative response to mitogenic stimuli and to exogenously added growth factors. the substitution of v to l at 95 was the only change that could be discriminated by 2 of 9 allospecific ctl lines. suggesting that those 2 ctl lines recognize a2.1 plus a peptide whose presentation andlor binding is affected by the v to l substitution in the floor of the peptide binding site. in contrast, the l to w substitution at 156 (but not the other 2 substitutions) abolished the ability of the a2 molecule to present the viral peptide to 24 out of 25 peptide-specific a2.1-restricted ctl lines, suggesting that this substitution alters the presentation of the influenza matrix peptide but does not inhibit the ability of the peptide to bind to the a2 molecule. although y8tcr.s have a great potential for diversity, it remains to be determined whether this potential is realized in terms of expressed y6tcrs. preliminary studies in several laboratories have indicated that y6tcrs expressed in earlg t h r c y t e s and adult epithelial tissues are more restricted in diversity com ared to adult tc expressin thymocytes. we have derived a panel of cloned dendritic epigrmal t cells (jetc, lines and5ybridomas that express at least three types of y6 receptors -c 8, cy26 and c n . immunoprecipitation, northern and southern blot analyses, and sequence anazses of l gt 10 cloned cdna or olymerase chain reaction ( k r ) amplified cdna segments have been used to anal ze in detail &e extent of diversit in the expressed y and 6 chains and whether restricted airin o?y and 6 chains occurs. our resu& indicate that for this panel of cloned cell lines 7 and ! irkg is nonrandom and that variability in certain types of receptors appears to be restricted. %owever, we have observed significant 6 chain diversity in these cells that is obtained by the use of multiple v-regions, and n-region and junctional diversity. we are investigating whether the observed y and 6 chain pairing, and pattern of 6 chain diversity are present in other $tcr bearing cells or whether they are only characteristic of detc. activation of ctl precursors from murine unprimed spleen cells with ril-2 or ril-4 results in distinct lytic spectra, depending on which lymphokine is present. we have used allo-stimulation in limiting dilution analysis with subsequent testing on an allo-specific target (a20) and an mhcdeficient, non-specific target (rle). in the presence of ril-4 exclusively allo-specific ctl are generated, while ril-2 supports a proximately equal numbers of precursors that k~ll a20 and rie targets. dose response analysis of ril-2-supported killing activity indicates that the lytic spectrum is independent of the amount of ril-2 used, and therefore this il-2 effect is intrinsic in its activity on unprimed spleen cells. mixing experiments indicate that ril-4 can partially override the effect of il-2 on the generation of non-specific killer cells. split well analysis and cold target inhibition experiments are in rogress to ascertain the actual proportion of specific killer cells which can be generated with ril-2. be. are also testing the ability of cofactors, such as il-1 and il-6, to optimize the response of il-4 generated ctl. we conclude that il-4, not il-2, must be used when ctl are generated from unprimed spleen cells in mice. t r a n s c r i p t s i n y/6 tcr populations. i n t e r e s t i n g l y , these same v genes, as well as a further+crosshybridizing v gene previously designated va7.2, are expressed by peripheral a& tcr c e l l s as 1.6kb tcra transcripts. these data suggest t h a t b2a2-dn th represent a developmentally unique subset i n which both v6 and vg segments are non-randomly expressed. furthermore they i n d i c a t e t h a t there i s considerable overlap between the v a and v6 gene repertoires . indianapolis, in 46285 in order to detect the small amounts of lymphokines generated in vivo following antigen stimulation, we developed a co-culture system which allows for detection of il-2/4, il-3/csf and tnf from ln cells stimulated in vivo with picryl chloride (pcl). utilizing thb system in combination with facs analysis and receptor binding studies, we examined the production of these lymphokines in primary and secondary immune responses. during a primary immune response, the production of il-2 was not readily detectable on dl, peaked on d3 and was gone by d5. at no time were we able to demonstrate the presence of il-4. alternatively, the presence of il-3/csf and tnf was w i l y detected on dl, but olso peaked on d3. in comparison to primary responses, secondary immunization lead to at least two alteraticns. (i) peak production of all lymphoki es shifted towards dl. (2) although most lymphokines did not demonstrate increasea in the amount produced/lo cells, the amount of lymphokine generated/ln was vastly increased due to an increased number of cells. utilizing single and dual color facs analysis we also examined the ln cells for alterations in t cell subpopulations. during the course of the primary response: (i) the percentage of thy i+ and l3t4+ cells decreased until d3 and then began to recover, (2) the percentage of thy-i+, t4-,t8-cells peaked at the time of greatest lymphokine production (i.e.-d3) and (3) the il-2 receptor was expressed solely on thy-i+ cells, was detected on both t4+ and t8+ subsets and peaked on d3. most of these alterations also occurred during the secondary response, but their timecoune was shifted so that maximal effects occurred earlier (e.g., dl). finally. the maximal binding of radiolabeled il-2 by the ln cells following both primary and secondary sensitization correlated with the expression of the il-zr as detected by facs analysis. in addition, binding of radiolabeled il-4 demonstrated similar patterns except for the detection of significant binding on dl. these results demonstrate that (i) an ordered timecourse of lymphokine production occurs in vivo following exposure to antigen and (2) the secondary immune response to pcl is characterrd by an accelerated tempo of lymphokine production, rather than an increased level of lymphokine production/lo cells. activation as direct g-protein activation by a1f4 pi-hydrolysis using phorbol diester stimulation of pkc restores the inhibi$$ble phenotype and the ability to upregulate c-fos. even more interesting, sig-linked ca responses by vs2.12-c1.2 are equivalent to those observed in the wildtype wehi-231. resul$g suggest that contrary to current thought, sig-generated signals may not be coupled to ca fluxes via inositol phospholipid hydrolysis. thus, vs2.12-c1.2 is a new and powerful tool with which to analyze signalling through sig at the molecular level. unlike the wildtype, crosslinking of sigm on vs2.12-c1.2 did the signaling defect in vs2.12-cl.2-appears to be proximal to phospholipase c triggers pi-hydrolysis and bypassing these latter lmmunogenicity c 302 analysis of t cell receptor 7 chains from adult cd4-,cd8-thymocytes mark w. moore, i. nicholas crispe and michael j. bevan, department of immunology, research institute of scripps clinic, la jolla, ca 92037. the role of tcr 7 genes in t cell development has not been determined. to extend out understanding of the repertoire of tcr 7 expression, we prepared a cdna library from cd4-,cd8-adult balb/c thymocytes and cloned and sequenced 15 tcrq genes from this cdna library. we found that 2 clones were transcripts of the unrearranged c7, gene and that 3 clones terminated in the j7, region. nine of the remaining clones were v71,2-j7 c7 genes and five of these were in frame. only one clone corresponded to c71 and was v7 -jy c7jofned'in frame. sds-page analysis of the 7-chain proteins from the surface of both balb/c anzcdbl)6 adult cd4-,cd8-thymocytes did not detect the 32,000 mw vy c7 protein, but did detect the 35,000 mw v7c7 protein. these results suggest that despite the abundanc$%f pull-length, functionally joined, v7 c7 transchpts in the thymocyte subset, the protein product is not expressed on the cell surface as the prehfcted 32,000 mw 7 protein. finally, our analysis of the v-j jointing of the 7 genes reveals both flexibility at the v-j junction and extensive n-region nucleotide addition that lead to diversity of the predicted protein sequence. il5 in response to the same stimuli. e identification of these two subsets of cd4' helper cells is mostly based on studies performed with long-term cultured t cell lines and it is not clear whether these two subsets exist in vivo and represent distinct lineages of t cells. in particular, the frequency, tissue distribution and ontogeny of cells capable of secreting il4 in vivo is not known. these studies have been hampered by the fact that freshly isolated t cells from unprimed animals failed to secrete detectable amounts of ila and il5 when stimulated in vitro by lectins or alloantigens, whereas iu is readily detectable in these same cultures. data presented here indicate that freshly isolated t cells from unprimed animals can be induced to produce il4 in a receptor-de endent, antigen-independent manner upon stimulation by anti-cd3 antibodies. our results also stow that only cd4' and not cdst cells can be induced to secrete il4 and that cross-linking of the receptor is required for o timal activity. we believe that this approach will be useful in identifying in vivo cells recomittefto the th2 pathway and study their ontogeny, activation requirements and tissue distriiution. hlb, brussels, belgium. we have studied the murine tcr repertoire against the c-terminus of cytochrome c in association with certain alleles of the mhc class i1 molecule, eakepk (iek) and eakepb (ieb). for mice possessing these alleles, the majority of responsive t cells utilize one member of the variable val1 gene family in conjunction with a limited set of vp genes. as an extension of these studies, we have examined ie specific, alloreactive hybridomas derived from ie non-expressing (eab) cytochrome c non-responder mice to determine their usage of va and vp genes. tion assay showed that fourteen utilized the same val1 gene segment used by the majority of cytochrome c specific, ie restricted t cells and eight utilized a closely related val1 gene that also is associated with this antigen response. element most commonly used by cytochrome c-specific t cells was not found among the alloreactive hybridomas tested, @ genes less frequently used in the cytochrome response were expressed by seven of the 22 alloreactive hybridomas whose va segments were defined by rnase protection. determining recognition of ie molecules both in mhc-restricted, antigen specific immune responses and in alloreactive responses. the t-helper cells of seven mouse strains, representing 5 class i1 haplotypes (ias, ia4, iab, iakiek, iadied) were responsive to immunization and restimulation with parent peptide. the ied determinant was shown to be a presenting element by monoclonal antibody blocking and by use of l-cell-transfectants as af'cs to purified t cells and to t cell hybridomas. a series of overlapping synthetic peptides identified two minimal t-cell sites within the parent peptide: mice expressing ia and ie responded to a fragment at the n-terminus of the parent peptide (site 1) while mice expressing only ia responded to a distinct but overlapping fragment at the c-terminus (site 2 ) . these minimal sites identified in vitro could be used to immunize mice in vivo in an mhc-restricted manner. the human 6 tcr locus is strategically located within the atcr complex between the cluster of va/v6 region and the ja segments. which can be spliced to ca in pre t cells, separates 6 from the ja segments. pulse field gel mapping as we11 as molecular cloning link diversity (ds), j g , c,5 and tea within 35 kb. considerable 6 tcr diversity is generated despite the predominant use of one v 6 and j 6 segment. d61 and d62 are 9 and 13 bp long, are frequently recombine as d,1/d62? and reveal exonucleolytic trimning with extensive "n" segment addition. specialized 5' and 3 ' 6 deleting elements, 6 rec and p j a , separate the 6 locus from the a locus. cells with 6 rec/$b ja recombinations comprise most 6 deletion events although 6 rec recombines with 2 other major acceptor sites in fetal and post-neonatal thymic dna. the 5' 6 deleting element ( 6 rec) is evolutionarily conserved in the mouse and functional comparisons are underway. delete the 6 locus may prove to be the pivotal event establishing separate y6 and ae lineages. to study the mechanism of t-cell tolerance, transgenic mice were generated that expressed the mlsa reactive t-cell receptor (tcr) o-chain vb8 1 on -90 % of peripheral t-cells. in transgenic mice bearing mlsd, the numbers of high tcr expressing thymocytes and of thy 1.2+ peripheral t-cells were reduced. the cd4/cd8 ratio of peripheral t-cells was decreased fourfold compared to negative littermates. both mlsa and mlsb tcr &transgenic mice were able to mount a t-cell dependent antibody response against viral antigens whereas the capacity to generate alloreactive and virusspecific cytotoxic t-cells was impaired in tcr &transgenic mlsa, but not in transgenic mlsb mice. rna analysis and immunof luorescence with tcr vb-specific mab further revealed, that the expression of endogenous tcr 0-genes in these mice was suppressed. tolerogen-reactive lymphocytes, as measured in the mlr, in spite of their long-term acceptance of a skin graft bearing the tolerated antigens. lymphokine production by mlr+ tolerant lymphocytes is different from that of syngeneic normal lymphocytes. normal lymphocytes produce only il-2 in primary response to tolerogen, while tolerant lymphocytes produce il-2 and il-4. using limiting dilution analysis, we have to estimated the frequencies of pil-2 and pil-4 (precursor) cells in these cultures. after primary k vitro stimulation, normal responders have a low but measurable frequency of pil-4 cells, while tolerant responders have a much higher pil-4 frequency. however, following subsequent & restimulations, the pil-4 frequency of normal responders rises and begins to approach that of the tolerant responders, such that the two populations are indistinguishable based on pil-4 frequencies following the third round of in vitro stimulation. these data suggest that the high frequency of il-4 producers (presumably t,, cells) among the tolerant lymphocytes resembles unexpectedly a "primed" state, rather than "unprimed"as in nontolerant responders (where th1, dominate the early response). the existence of "primed" t cells in phenotypically tolerant animals raises the possibility that precocious activation of tr1 (by neonatal exposure to tolerogen?) suppresses the later emergence of t,,, which would be expected to contain the cells responsible for graft rejection. a large number of cd4+ t-cell clones, obtained from peripheral blood t lymphocytes by direct limiting dilution, allowed us to address the question whether functional heterogeneity exists within the human cd4+ t-cell subset. six out of 12 cd4+ clones were able to lyse daudi or p815 cells in the presence of anti-cd3 antibodies. the remaining 6 cd4+ tcell clones tested did not acquire this cytotoxic capacity during a culture period of 20 weeks. in the absence of anti-cd3 mab, no lytic activity against daudi. p815 and k562 target cells was observed under normal culture conditions. these two types of cd4+ t cells showed high reactivity with anti-cdw29 (4b4) mab and no reactivity with anti-cd45r (284) mab. the cd4+ clones without anti-cd3 mediated cytotoxic activities (th2) consistently showed a higher expression level of cd28 antigens. th1 cd4+ clones did produce il-2, ifngamma and tnf-alpha.beta. whereas the th2 t-cell clones produced minimal amounts of il-2. ifn-gamma and tnp-alpha. beta in response to anti-cd3 mab and pma. not all cd4+ clones did release il-4, but there was no correlation with cytotoxic activity. moreover, as compared to the th1 cd4+ clones, tr2 cd4+ clones proliferated moderately in response to anti-cd3 mab. however, anti-cd3 mab induced proliferation of only the th2 cd4+ t-cell clones was enhanced by anti-cd28 mab. both cd4+ subsets provided help for polyclonal b-cell activation with anti-cd3 mab. our data suggest that the human cd4+ subset, in analogy to the murine system, comprises two functionally distinct t-cell subpopulations. in the mouse, when la antigens are isolated immunochemically, the predominant species isolated are the isotypic matched pairs, aaap and eaep. however, when la ap dimer expression is studied using an l cell transfection model, it is found that the isotype-mismatched dimer apdea is readily expressed at the cell surface. these results suggest that differences in assembly andl or transport of different la pairs may be most readily visualized in a competitive environment where multiple distinct la chains are available. to investigate this possibility, the relative efficiency of inter-and intra-isotypic dimer formation and expression was evaluated using a sequential l cell transfection system. l cells already expressing an ap dimer on the cell surface (apdea or apdaad) were supertransfected with a third la gene (aad or ea, respectively). synthesis of this second a or p protein led to competition for the unique partner chain. individual clones were scored for cell surface expression of the distinct dimers (e.g., apdea vs epdea or apdaad vs apdea) using facs analysis with chain specific monoclonal antibodies. in addition, each species of mrna was quantitated by northern blot hybridization using bcus specific probes. our results indicate that in the h-2d haplotype. isotype-matched dimers are expressed with 3-4x the efficiency of isotype-mismatched dimers. this result suggests that, regardless of the cell type studied, if each of the four murine la genes is expressed at equivalent levels, intraisotypic dimers will be expressed to the virtual exclusion of the interisotypic dimers. however, if chain synthesis asymmetry occurs, the isotype mismatched pairs may be expressed at immunologically relevant levels. differential we have identified a series of discrete stages among the cd3-double negatives which seem to form a sequence, with tcr gene rearrangement and rna expression gradually progressing, but with potential for expansion and repopulation of irradiated thymuses diminishing along the series. on this pathway cd3 must be expressed late or after the acquisition of cd4 and cd8. cell cycle analysis shows the highest rates of cell division to be among the rsa+ il-2r-pgp-1-population which probably precedes the transition to cd4+cd8+ and tcr expression. thus it seems unlikely that tcr/antigen interactions play a role in cellular events occurring among the double negative cells which lead on to mainstream t-cell development. egr-l is a murine early growth factor inducible gene which encodes a protein with zinc fingers. its expression was investigated in murine b-lymphocytes stimulated through their antigen receptor (sig) with anti-recptor antibodies (anti-ig) . rapid (by 15 minutes) upregulatlon of egr-l mrna expression was observed at doses of anti-ig sufficient to drive the majority of go cells into cell cycle. agonists and inhibitors of protein kinase c (pkc) showed that expression was coupled to the pkc component of receptor immunoglobulin transmembrane signalling. interestingly, signalling through sig on the murine b lymphoma wehi-231 did not upregulate egr-l expression even though similar signalling pathways are associated with this receptor in these cells. southern analysis showed that egr-l is not deleted or translocated in this cell line. importantly, cell growth and proliferation of wehi-231 is inhibited by anti-ig stimulation suggesting a relationship for egr-l expression and differential processing of receptor ig signals. this notion is further supported by the finding that murine b lymphomas whose proliferation is not inhibited by anti-ig showed receptor immunoglobulin coupled egr-l expression. reeulation of exdression of a class 1 wc transeene. dinah s . the expression of the transgene product. the patterns of expression of the transgene parallels that observed in situ, indicating that regulatory elements necessary for normal patterns of expression are contained within the injected 9 kb dna segment, and that trans acting factors involved in its regulation function between species. included among these elements are those specifying preferential expression in b cells relative to t cells. in vivo treatment of transgenic mice with a/@-interferon results in increased expression of the transgene in a number of tissues. the response parallels that observed for the endogenous h-zkb, but differs markedly from qa-2. analysis of the chromatin structure of the transgene reveals a single constitutive dnase i hypersensitive site present in both spleen and thymus, which is not altered by interferon. both a novel negative and positive regulatory elements have been identified in the 5'flanking region of the transgene. the negative regulatory element reduced the activity of both the homologous class i promoter and a heterologous viral promoter. in vivo competition experiments indicated that the functions of the positive and negative elements are mediated by distinct cellular trans-acting factors. the negative regulatory element requires the presence of a positive regulatory element to function. this interaction between elements represents a novel mechanism for regulating gene expression. mcdevitt. department of microbiology and immunology, stanford university school of medicine, stanford, ca 94305. published data show that encephalitogenic h-zu murine t cell clones with specificity for the n-terminal eleven amino acid peptide of myelin basic protein display a restricted fine specificity when tested on substituted analogs of the native peptide. for example, substitution of alanine at certain positions in the peptide totally abolishes the response of each clone (acha-orbea et al.. 1988. cell 54:263) . recent experiments also have shown that the ability of some peptide analogs to bind to h-zu i-a gene products does not always correlate with their ability to stimulate the t cell clones (see accompanying abstract by david c. wraith and hugh 0. mcdevitt). this suggests that h-2u mice may lack a t cell repertoire capable of recognizing these peptides complexed to h-2u i-a gene products. to test this possibility, h-2u mice were immunized with a panel of peptide analogs, as well as the native peptide. the in vitro t cell proliferative response to each of the peptides then was measured. the results show that in vivo immunogenicity of the peptide analogs also does not strictly correlate with their capacity to stimulate the t cell clones. in this way, the polyclonal t cell repertotre of h-zu mice for the myelin basic protein peptide analogs was examined, and could be compared with the i-a binding characteristics of the peptides. terms of antigen and mhc recognition. this response involves a limited repertoire of t cells which crossreact on species variants of the antigen. in addition, t cells specific for the antigen in association with syngeneic mhc can recognize antigen on similar allogeneic mhc molecules. the groupin of clones by functional phenotypes defined by these crossreactivities allowed us to corrcfate tcr gene usage with either antigen or mhc recognition. some of the pigeon cytochrome c-specific clones within one functional phenotype use receptors that differ by as few as two amino acid residues. other clones e y s s very different tcrs but exhibit similarities in antigen/mhc reco nition. the efect of these tcr differences on recognition was assessed using a pane? of anti en analogs with single amino acid substitutions presented on different mhc molecufes. each clone exhibited a unique pattern of res onse to the antigen analog panel, even clones with very similar receptors. also, eace residue in the antigenic region of the peptide was critical for interaction with at least one t cell receptor. therefore, the antigen must either be a linear molecule with each residue available to interact with the tcr or be able to assume several conformations to interact with mhc and the tcr. lmmunogenicity c323 thy-1+ cd3+ ly-5(b220)+ cd4-cd8-tcrx-6' helper cells. anne i. we have found that these cells can be preferentially stimulated to proliferate when cocultured with the b lymphoma, ch12. one to 2% of nylon wool non-adherent, ia-, jlld-, and cd8-lymph node cells from normal unimmunized mice have the phenotype thy-l', cd3', cd4-. and cd8-. these cells proliferate when co-cultured with a syngeneic surface ig' lymphoma, ch12, even in the absence of any added antigen, mitogen, or fetal calf serum. prior to stimulation we find that approximately 30% of thy 1.2' cd3' cd4-cd8-express the marker ly-5(b220), however after culture with ch12 the majority of cells with this phenotype express the marker ly-5(b220). after ch12 dependent proliferation the ly-5(b220)' t cells are able to provide help for secretion of ig by fresh ch12 b cells. surface labelling and precipitation of t cell receptor molecules reveals that most of the thy-1' cd3' ly-5(b220)* cd4-cd8-cells express tcr(r-6). furthermore, cd3 precipitation shows that as many as four different 7-6 heterodimers are utilized within the entire responding population. this suggests that a heterogeneous population of double negative tcri-6 cells are involved in the response to ch12. college of kedicine at east tennessee state university, johnson city, tn 37614 interferon-producing (t 1) and interleukin 4 (il4) producing (t 2) clones were assayed for their ability to diregtly induce cytostatic activity in macro:hages generated from splenic myeloid precursors (m -c). in the presence, but not in the absence, of antigen, t 1 clones activated the m -c to inhibit the growth of p815 tumor cells in vitro. th2 cjlones were not able to activate such effector activity in the i4 -c. effectively present antigen to the t 2 clones as evidenced by the proliferation of t 2 cells cultured with antigen in the pfesence, but not in the absence, of m -c. thereyore, although both t 1 and t 2 were activated by cognate interaction with antigen presenting (ba) or nippostrongylus brasiliensis (nb). spleen cells from these mice were cloned at limiting dilution with alloantigen stimulation, and every two weeks, lk production in response to con a was measured. clones derived from, and stimulated with, cells from unimmunized mice initially tended to secrete low lk levels, with few clearly defined th1 or th2 clones. by 56 days after cloning, some clones had acquired th1 or th2 patterns. cfa, ba and nb-imnunized mice gave rise to clones that were mostly th1 or th2 even at early times. cfa and ba immunizations induced almost exclusively th1 clones, whereas nb induced more th2 clones. these results are consistent with a model in which resting, previously unstimulated t cells produce low amounts of lks, and progress through stage(s) where they secrete both th1 and th2 lks before finally differentiating into th1 and th2 cells. the results with cfa, ba and nb-primed mice suggest that this process occurs in vivo as well as in vitro. strains as carriers of melioidosis antigens to the immune system, deja tanphaichitra, mahidol university, p.o. box 4-217, bangkok 10400, thailand the attenuated gale mutant, salmonella typhi strain, tyzla, served as the recipient in a conjugal dna transfer experiment. conjugal dna transfer was obtained by the mating procedure on an appropriate blood agar medium. were examined serologically. one selected strain was found to have the serological characteristics of the recipient s . typhi, tyfla strain and also expressed the pseudomonas the donor strain was a pseudomonas pseudomallei mu107. the resulting antigen clones were repurified by restreaking on the medium and pseudomallei antigen. the s. typhi transconjugant strain is due to the presence of the pseudomonas pseudomallei plasmid. a group of subjects when received four doses of this bivalent vaccine strain in this study it appears that pseudomonas pseudomallei synthesis in developed antibodies against pseudomonas pseudomallei up to 70%. pseudomallei, an intracellular pathogen, produces a characteristic antigen probably to be plasmid coded, we considered that the gale salmonella typhi tyzla oral vaccine strain, highly effective against typhoid fever, might be modified so as to be protective also against melioidosis due to pseudomonas pseudomallei. terminal deoxynucleotidyl transferase (tdt) is a lymphoid-specific nuclear enzyme present in early lymphocytes. to investigate the regulation of tdt gene expression, pre-b and pre-t cells were treated with phorbol 12-myristate 13-acetate (pma) o r three analogs, and tdt steady-state mrna levels were determined by northern blot analysis. treatment of early lymphocytes with pma results in a rapid and reversible decline in steady-state tdt mrna levels within six hours. this rapid decline can be blocked by pretreatment of the cells with a protein kinase c inhibitor, implicating protein kinase c activation in the decline of tdt mrna. nuclear run-off studies demonstrate that tdt transcription is rapidly down-regulated within 45 minutes after pma treatment, indicating that this regulation occurs mainly at the level of transcription. furthermore, cycloheximide blocks the decline in tdt in rna showing that new protein synthesis is required for transcriptional inactivation. the nucleoprotein gene from the influenza virus a/nt/60/68 was stably cloned into the attenuated aroa-strain of salmonella typhimurium sl3261. nucleoprotein purified from pnp -3261 was tested for the ability to generate virus-specific immunity. immunization with recombinant derived nucleoprotein induged immunity to all type a influenza tested but not against type b viruses. cd4 helper t cells were primed but no evidence was found for priming of class i restricted ctc. mice immunized with recombinant nucleoprotein were protected against a subsequent challenge of influenza virus. the information obtained from the study of the immunity and protection generated by the purified recombinant protein was then used to design experiments to investigate the possibility of using the attenuated salmonella vector to deliver the nucleoprotein molecule to the immune system by the parenteral or enteral routes. we characterized the extrachrom-1 circular i n i s in 19-day-fetal and 4-week-old m u r i n e thpmcytes and 8-week-old m u r i n e splenocytes. f popllation of circular chias was clone3 into the kgtll phase vector. we screened ca. 10 tna cl-by plaque hybridizations with all far kirds of tcr gene probes derived from jal , val 0, db1, db2, jyl , j61 and 562 loci. cut of 10,000 cna cl-from fetal and 4-week-ld thymocytes, 30 hybridized with tcr aprobes and 5 hybridized with tcr &probes. positive cl-with tcr yand 6probes were 3 to 7 in fetal thymocyte4erived library, but few in 4-week-old thymocyte. of 7 fetal tcr 6 clcnes analyzed, 6 cl-had dd or vd reciprocal joints and 1 clcne had vd ar dd d i n g joint. relative frequencies of circular dna clones for four different tcr genes are consistent with the order of the expression of the genes the t cell developnent. of 10,000 tna clsignalling could be studied. llzmambxane signalling was maasured by 9 ability to t?z3nslocate fkc frcrm the cytcplasa to the nw2leus after surface i-a was banrl by a or p dxdn specific monoclcnal antibody. i(pmwing either 6 or 12 amino rids fmn the a chain cvtoplasnic (cy) damin did not affect the ability of tkse i-a r m l d e s to trarslocate pkc to the nucleus. normal splenic b c e l l s were rendered non-responsive t o subsequent challenge w i t h lps, as measured by a decreased a b i l i t y t o generate antibody forming c e l l s (afc), by incubation overnight (18-24 hours) w i t h 10 ug/ml a n t i -i g . both i n t a c t and f(ab)', a n t i -i g , as well as monoclonal anti-igm (bet2 and b-7-6) , were able t o induce 6 c e l l non-responsiveness t o subsequent lps challenge, suggesting t h a t sig/fcr i n t e r a c t i o n s are not necessary i n the induction o f lps non-responsiveness. i n contrast, induction o f nonresponsiveness t o subsequent challenge w i t h fitc-prucella abortus required i n t a c t a n t i -i g . the a b i l i t y o f mitogenic a n t i -i g (rab f(ab)', o r 6-7-6 northern blot analysis and bioassay data were used to analyze 9 separate lymphokines as well as the il-2 receptor (murine tac). northern blot comparison of fresh and primedt4 enriched rna revealed that primed t cells produced 10-fold more lymphokine than the fresh t cells. the only lymphokine that showed equal amounts of mrna for both fresh and primed t cells was il-2. a time course of fresh and primed t4+ cell lymphokine production was also analyzed. the primed cells produced a short burst of lymphokine mrna that peaked between 7.5 and 13 hr after con a stimulation and declined after 18 hr. the fresh t cells produced a longer burst of lymphokine mrna that peaked 18-44 hr after stimulation. the il-2 receptor @-2r) mrna time course from activated primed cells showed different kinetics than lymphokine mrna. this suggested that molecular regulation of the il-2r might be different than lymphokine regulation. to further examine molecular regulation in the primed t cells polysome profiles were evaluated for lymphokines, l 2 r , and other cellular genes. the recently developed method of gene amplification by the polymerase chain reaction (pcr) has proven to be particularly suited for the analysis of t cell receptor (tcr) genes. we adopted existing methods for the preparation of cytoplasmic rna from as little as 1000 cells and used this material as template for first strand c-dna synthesis. pcr amplification of this c-dna, using v-and c-specific oligonucleotide primers yielded enough material to produce single-stranded dna in a second pcr which could then be sequenced without cloning. in case of unknown v-usage, the pcr was employed for screening for v-beta elements by sequential reactions with different v-beta specific primers. we have used this method to reinvestigate the h-2b restricted cytotoxic t cell response to tnp in c57b116 mice. beta chain sequences of 26 ctl clones obtained by direct cloning of immune spleen cells were compared to sequences of 11 clones obtained by cloning of individual short-term in vitro ctl lines. it was found that a) in vitro bulk-stimulations reduced the heterogeneity of the beta-chain responses to tnp, b) similarities between different tcr-beta-chains concentrated on the usage of certain jb-elements ( jb2.6, 2.5, 2.1 ) rather than v-region or nid-region sequences, and c) the majority of jb2.6 containing beta-chains was associated with alpha-chains expressing v-segments of the val 0 family. these expression of genes which encode the t cell antigen receptor is cenval to the generation of the t cell repemire. our labomtory has been investigating genes for both the alpha and beta chains of this receptor in inbred strains of runus norvqicus (the laboratory rat), a species in which several autoimmune disease models have been developed. and which is used extensively in transplantation studies. using genomic southern blots and mouse probes specific for five different v a subfamilies, we have estimated the size of the v a repertoire in ten inbred strains of rat. results show a significant increase in the size of one subfamily and suggest increases in two others in all ten strains. the rat v a l subfamily has about twice as many members as the mouse, while the va2 and vu5 subfamilies, depending upon the enzyme used, show a similiar duplication. the va6 and va9 subfamilies have a comparable number of members in both species. these data are most easily explained by a single duplication event in the rat invoking at least one and perhaps three subfamilies, but not encompassing the entire v a locus. this implies that the val subfamily (perhaps together with va2 and va5 subfamilies) is regionally clustered and not interspersed with either the va6 or va9 subfamily. based on restriction fragment length polymorphisms, we find evidence for six distinct v a haplotypes in the ren strains tested. we have also cloned eight unique germline v a l gene segments. one of these has been sequenced. and has a coding region 87% identical to the most closely related mouse v a l sequence. this degree of relatedness is similiar to ra#nouse vg homologues. which share 8548% nucleotide sequence similarity. we are using these clones to generate angle copy probes from flankiig regions to further map the v a l locus. current approaches to mhc-peptide binding studies require either large quantities of highly purified mhc protein and/or the use of sophisticated detection apparatus. i n order to simplify detection of peptide-mhc interactions we have investigated the use of photosensitive-crosslinkers. two reagents have been successfully tested. a benzophenone derivative of peptide 1-16 from rat myelin basic protein (rmbp) was only effective after the introduction of a glycine spacer residue between peptide and crosslinker. an azido-nitro-benzoyl derivative of peptide 7.4, a heteroclitic analog of rmbp 1-11 (1). had a high affinity and bound specifically to the peptide binding site. the 7.4 photoaffinity probe has been used to test the binding properties of other analogues of rmbp 1-11 and is currently being used to define (a) the kinetics, (b) ph and (c) temperature dependence of the binding event. this particular photoaffinity conjugate retains both the mhc binding and biological properties of the original peptide and is helping us to define the roles of "determinant" versus "t cell repertoire" selection in the mhc linked autoimmune response to mbp the antigen-specific t cell repertoire is diverse in its ability to recognize a wide universe of foreign antigens. this t cell repertoire is composed of a set of clones each of which is specific for a given foreign antigen. therefore the precursor frequency of t cells specific for any give foreign antigen is extremely low. however, two prominent exceptions to this general rule exist, and these are the t cells present at high precursor frequency which are specific for foreign hhc products or for the products of the minor lymphocyte stimulatory (mls) genes in the mouse. the present studies were undertaken in order to examine factors involved in t cell repertoire formation by assessing the relationship between t cell repertoire for conventional foreign antigens and for mls products. studies indicate a striking degree of overlap between the set of t cells specific for pigeon cytochrome c and the set of t cells specific for mlsc gene products. demonstrate that the basis for this overlap lies in the predominant expression of one tcr vp gene, vbs, by those t cells which recognize mlsc. involvement of specific tcr afl dimers in recognition of mlsc and further suggest that t cell reactivity to these gene products may play an important role in establishing the t cell repertoire for foreign antigens. conclude that, rather than destruction of some essential apc structure, ecdi fixation prevents the apc from actively responding during the encounter with the t cell. this results in a failure to express new structures (probably located on the apc plasma membrane) that appear to be essential for stimulating t cell proliferation. these structures are distinct from ia or il1. the induction of these structures during t-apc interaction occurs in six hours, requires protein synthesis, and can be elicited by il1, il4 or lps, but not ifn-gamma. in the absence of these induced structures, the apc stimulates a partial t cell response, il4 release, but the t cells fail to proliferate. these induced structures on the apc may be either adhesion molecules that stabilize the t-apc interaction, or they may provide additional stimuli to the t cell. were not c m n t o the three s t r a i n s o f mice (balb/c, regions 1, 3, 5, 6 and 7; c3h/he, regions 2, 3, 5, 6, 6', 7 and 7'; and c57bl/6, regions 2, 4, 5, 6 and 7). immunisation with type i1 collagen (cii) leads to development of arthritis in mice with certain mhc haplotypes and is associated with an immune response against cii. we have been studying the t-cell response in the arthritis susceptible strain dbm1 (h-2q) . analysing the proliferative response in cultures of lymph node cells from immunised mice a s well as t-cell lines and clones established from such cultures it was found t h a t li the t-cell response after immunisation with heterologous cii was preferentially directed against foreign determinants on the cii molecule with little o r no crossreactivity against autologous cii. 2 ' both the primary response and the reactivity of established lines and clones were directed against the cbll fragment of the cii molecule, using c b l l fragments prepared from chick, bovine or rat cii. 3/ pepsin present in cii preparations after using pepsin digestion for solubilisation of the collagen is strongly immunogenic even in very small amounts and it was therefore necessary to use cii prepared from lathyritic cartilage without pepsin digestion for immunisation. in contrast to the pattern in lymph node cultures from immunised mice we found that when culturing spleen cells from unimmunised mice there was a t-cell response against collagen that was preferentially directed against autologus cii. since we earlier have found that autologus cii may induce an immune response and also arthritis in dbn1 mice we conclude that there exist t-cells capable of reacting with autologus collagen and inducing an immune response as well as arthritis but that these cells are under regulation so that they not readily can be activated into proliferation but may be induced to perform certain effector functions. tested. the characterization of these two cd6 rdsas will be presented. analysis of hla polymorphism using sequence specific oligonucleotide probe hybridization to amplified dna, lee ann baxter-lowe, jay b . hunter, and jack gorski, the blood center of southeastern wisconsin, milwaukee, wisconsin 5 3 2 3 3 . hla polymorphism plays a key role in antigen:mhc interaction. the polymorphism of the first domain encoding exon of the hla-dr p chain has been studied by in vitro dna amplification and use of sequence specific oligonucleotide probe hybridization (ssoph) to detect polymorphic sequences. a 230 bp segment of genomic dna was amplified and hybridized with synthetic oligonucleotide probes (12-19 bases) under conditions that detect single base pair mismatches. identification of these mismatches can be used to predict micropolymorphism in the protein products, including single amino acid changes. haplotype specific patterns of oligonucleotide probe hybridization were defined for a panel of homozygous typing cells. analysis of family data demonstrated the expected inheritance patterns. most known serological specificities are encoded by multiple allelic forms of dr p chains and ssoph can identify these differences. this was exemplified by detection of unique ssoph profiles for subtypes of dr4, drw6 and drw52 alleles. this procedure was also used for analysis of hla-dr polymorphism in large numbers of heterozygous individuals, including an hla-deficient scid patient. the ssoph data were correlated with serological specificities and will be useful for delineation of hla restriction in alloand autoimmunity. different cell membrane receptors have been shown to be involved in human t lymphocyte activation induced by either monoclonal antibodies or mitogenic lectins. these t cell surface molecules can be divided into two categories : a) the t cell antigen receptor (tcr) associated with the non-polymorphic cd3 antigen b) t cell differentiation molecules not linked to cd3/ti such as cd2 (t11) and tp44 (9.3). monoclonal antibodies directed against these t cell surface structures triggered different t lymphocytes functions : mitogenesis, il-2 receptor expression, il-2 secretion. our knowledge about early events involved in t cell membrane activation is not complete, especially involving the transduction mechanism mediated by gtp-binding proteins ; nevertheless, numerous authors have demonstrated that cd3/ti complex triggering induces the activation of phospholipase c, leading to the phosphoinositide cascade associated with an increase of free cytoplasmic calcium ions. in the present report, we show that different activating cell molecules (con a , pha and pma) can trigger oxygen free radical liberation when incubated with the human jurkat tumor t cell line. since membrane oxidative metabolism has been shown to be related to the stimulation of the phospholipase a2, and to be the final consequence of a membrane nadphoxidase : this could represent a previously undescribed pathway of t lymphocyte activation. high affinity monoclonal antibodies (mab), specific for staphylococcal nuclease (nase), were produced and characterized. competitive inhibition assays were conducted resulting in a series of complementation groups that define eight overlapping epitopes. it is estimated that these epitopes account for 70% or more of the accessible surface of nase. mutagenesis of the coding sequences for nase was carried out to produce a series of variant molecules (each differing from wild-type. nase and from each other by a single amino acid) that will enable mapping of nase epitopes, determination of residues involved in antibody binding, and the contribution of various physical and chemical factors to affinity and fine specificity. screening some of these mutants with the panel of mab enabled us to map several nonoverlapping epitopes and further subdivided some of the mab complementation groups. oligonucleotide-directed mismatch mutagenesis has been done on codons encoding the original amino acid residue and other surface residues in its immediate vicinity. determination of enzyme activity and structural analysis by cd spectropolarimetry of several of the mutant proteins suggests that any structural changes that may occur are local and not global. supported by grants ai20745, l32ca09109 and s07rr05431 from the national institutes of health. activation of t cell proliferation is believed to occur via the hydrolysis of inositol phos holipids, which, through the second messengers inositol-1,4,5-tris hosphate and diacylglycerof(dag), promotes the elevation of intracellular calcium levels anjactivation of protein kinase c (pkc), respectively. the role of pkc in t cell activation was investigated by comparing the effects of stimulation by 12-0-tetradecanoyl phorbol acetate (tpa), and the dag, oleoylacetyl glycerol (oag), on a >99% pure population of t cells cultured in rpmi 1640 medium containing 10% autologous serum. treatment with either tpa or oag caused down-regulation of the t cell rece tor, a consequence of its hosphorylation, but only tpa, in syner leuiin 2 receptor (il2-r), expression and, sgsequently, proliferation. immunohistochemical staining with antisera specific for the pkc subspecies a, pi, pii and 7 shows that restin t cells express a, pi and pii pkc subspecies which are diffusely distributed throughout the celt. after 20 minutes treatment with either oag or tpa all three subspecies are redistributed to a focal area within the cell. the redistribution is transient in oag stimulated cells, where the pkc distribution is similar to that in untreated cells after 1 hour of treatment. in tpa stimulated cells, however, the pkc redistribution is prolonged, becoming more marked until mitosis occurs after 48-72 hours of treatment. these results suggest that transient intracellular redistribution ofpkc causes phosphorylation and down-regulation of the t cell receptor, but that prolonged redistribution is required or t cell proliferation. sm is a nucleoprotein complex associated with small rna molecules in eukaryotic cells. the spontaneous generation of anti-sm antibodies is specific for patients with systemic lupus erythematosus (sle) and develops in 2 5 % of mrl mice. the response has been shown to be t-cell dependent in mrl/lpr mice. t-cells specific for sm are found only in mrl (h-2k) mice and mice bearing h-2s and h-2f haplotypes (which do not develop anti-sm antibodies). we are currently working to define the variable regions of the t-cell receptor genes used in the sm response. a series of t cell hybridomas from mrl mice has been generated and are being screened for sm positivity. a technique has been designed to amplify specific alpha and beta chain tcr genes using the polymerase chain reaction allowing for a more rapid sequence analysis. it is also our intention to locate the sm specific epitopes of the t-cell hybridomas. d. bloom, p.l. cohen, and s.h. clarke, department medical institute and experimental immunology branch, nci. nih, bethesda. md 20892. to determine whether prior activation history affects t cell receptor mediated activation of t cell clones, the murine type i helper clone ae7 was maintained in tissue culture by stimulation every ten days with either (1) antigen (cytochrome c), irradiated h-zk spleen cells. and il-2 or (2) il-2 alone. ae7 cells grown with antigen and antigen presenting cells (ae7-ag) proliferated and produced t cell growth factor activity (tcgf) in its culture supernatants following stimulation with immobilized anti-t3 antibody. the tcgf activity was shown by bioassay using indicator cell lines and specific blocking antibodies to be almost entirely due to gm-csf with little or no il-2 activity detectable. detectable il-2 mrna levels. (ae7-ilz) displayed substantially greater anti-t3 induced proliferation than did ae7-ag cells. in contrast to ae7-ag cells, ae7-il2 cells produced large quantities of il-2 in response to anti-t3 stimulation. furthermore. one cycle of stimulation of clone ae7-ag with il-2 in the absence of antigen and irradiated spleen cells was sufficient to cause this clone to produce substantial amounts of il-2 upon subsequent anti-t3 stimulation. these data suggest that t cell receptor mediated stimulation of t cell clones by specific antigen and antigen presenting cells inhibits subsequent anti-t3 induced il-2 production. t cell proliferative responses and sera antibody levels of myasthenic patients to several synthetic peptides representing different epitopes of the human achr were examined. we detected significant differences in the humoral and cellular responses of mg patients compared to healthy controls to peptides of the human achr alpha-subunit with sequences p195-212, p257-269 and ~310-327. proliferative responses of lymphocytes from myasthenic patients to p195-212 and to p257-260 correlated significantly with hla-dr5 and with hla-dr3, respectively. in order t o investigate further the immune responsiveness to selected sequences of the human achr, t cell lines and clones specific for peptides p195-212 and p259-271 were established from lymph nodes of c3h.sw mice. the recognition specificities of these lines were tested by examining crossreactivity to a series of shortened and/or extended peptides of the above sequences. deletions of amino acids in positions 211 and 212 (211=p, 212=l) resulted in a decrease of the peptides' stimulatory activity on the ~195-212 specific t cell line, whereas deletion up to position 200 on the n-terminal end had no effect on the triggering potential of the peptides. similar results were obtained when deleting residues 270 and 271 (270=v, 271=p) in stimulation assays of the p250-271 specific t cell line. help in determining important t cell epitopes on the human achr. the role of guanine nucleotide binding regulatory proteins (g proteins) in the regulation of phosphorylation of the y subunit of the cd3 antigen has been examined. cd3 y chain phosphorylation in isolated t cell microsomes or permeablised t cells was stimulated by the g protein activator, guanosine 5'-0 thiotriphosphate (gtpys), but other nucleotides such as camp or gdpbs were ineffective. dependent. these data are consistent with the involvement of a g protein in the signalling mechanisms that regulate the phosphorylation of the cd3 y chain. the regulatory effects of calcium and gtpys were compared in normal peripheral blood derived t cells and jurkat cells. there were differences regarding g protein regulation of cd3 y chain phosphorylation in normal t cell and jurkat cells and current models explaining these differences will be described. expression of the gamma-delta t cell receptor has been thought to first occur in a population of thymocytes shortly after their precursors populate the thymus between 11 and 13 days of gestation. in the course of our studies investigating the ontogeny of t cell receptor expression in the mouse embryo we have identified an extrathymic site of gammadelta expression in a population of cells present at distinct times of gestation. evidence will be presented demonstrating two periods of activity of the murine gamma locus in the developing embryo. are colonizing the thymus from the liver and the gene segment useage detected is different to that first expressed in cells of the developing thymus. around the time of birth) involves the functional rearrangement and expression of a gamma gene segment corresponding to the initial functional rearrangements detected earlier in gestation in the thymus, which can occur independently of thymic influence. demonstrate a new site of gamma-delta receptor expression in the liver of newborn mice that can occur in the absence of any thymic influence. the primary (in vivo) response of cs7bl/6 animals to the class i antigen qa-1 is a helper (th) dependent event as indicated by the requirement for copriming with a distinct antigen capable of activating helper cells. in contrast, the secondary (in vitro) response to qa-1 demonstrates no need for costimulation with the helper antigen. in attempts to more closely examine the helper requirements for activation of primed ctlp, we have observed that depletion of l3t4 cells from spleens of qa-1 primed mice abrogates the in vitro generation of anti-qa-1 effectors. the response is restored by the addition of concanavalin a induced supernatant (cas) or by the addition of syngeneic but not qa-1 allogeneic l3t4 cells. indeed, even in the presence of cas, l3t4 cells expressing the qa-1 alloantigen specifically suppress the activation of anti-qa-1 ctl in a manner reminiscent of that seen with lyt-2 veto cells. although the mechanism whereby l3t4 cells exert suppression is unclear, we have determined that ctlp are susceptible to veto only within approximately the first 48 hours of culture, after which they resist suppression. results from further studies of the nature of suppression and the l3t4 veto cell will be presented. group i1 proteins induce ige ab responses in -90% of mite allergic patients. murine mab and human igg and ige ab. unrelated. crossreactive epitopes on gpi and gpii allergens from different mite species. in contrast, igg ab in balb/c mice immunized with loug specific" epitopes and <1% was a n t i -u i (a gpi homologue, with -80% amino acid sequence homology to i). four non-over lapping epitopes were defined by mab, with one species specific immunodominant site on each gpi allergen. cross-reactive gpi epitope and this mab could inhibit human ige ab binding by -40%. specificity of the murine anti-gpi response was not h-2 restricted, but could be altered by immunizing balb/c mice with lower ag doses (lug) in alum or 8 . dertussis. using these regimes, up to 52% of the murine igg ab responses was gpi cross-reactive. responses to gpii allergens appear to be strain dependant. unresponsive to gpii. however, balb/b, a/j, cba, c3h 6 c57b16 all produce gpii cross reactive igg ab. anitgenic sites on gpi allergens are conformational, whereas those on gpii may be sequential. known to affect ige expression in mice may also affect the epitope specificity of igg ab. we have compared the b cell epitopes on these allergens using panels of however, ag binding ria on 73 sera showed that human igg and ige ab recognize the gpi and gpii allergens are antigenically i in cfa was directed against "species murine ab balb/c are completely thermal denaturation and reduction and alkylation expts suggest that the results with the gpi allergens suggest that immunization regimes which are c425 this report demonstrates for the the exclusive recovery of 72-84-specific t cell clones c 426 further molecular analysis should identify and characterize achr reactive autoimmune clones and/or suppressor cells. cohplex, mogens h. claesson, p e t e r bkams a n d s t e e n d i s s i n g , l a b . e x p . h e m a t . immunol., d e p t . med. anatomy a, a n d d e p t . g e n e r a l p h y s the ly-6 alloantigens represent a family of phosphatidylinositol anchored proteins that function as accessory molecules in the process of t lymphocyte activation. the expression of these alloantigens is often induced on t and b lymphocytes after activation by mitogens or antigens. previous studies have shown that the induction of ly-6 alloantigens in t cells is at least in part due to the action of ifn-a/b or ifn-7. in the present study, we have demonstrated that ifn-7 also induced ly-6 molecules on b lymphocytes and bone marrow cells. furthermore, we now show that tnf also participates in the induction of at least one of the ly-6 proteins, ly-6a/e. tnf was found to synergize with ifn-7 to induce ly-6a/e expression in thymocytes, t lymphocytes, and bone marrow cells, but not b cells. for t lymphocytes, the synergistic induction of ly-6a/e by tnf was restricted to cells from the ly-6.1 haplotype whereas ifn-7 was sufficient to fully induce ly-6a/e expression in cells from the ly-6.2 haplotype. this result is consistent with the notion that there is more complex regulation of the ly-6afe molecules in t cells obtained from the ly-6.1 haplotype. for t cells from balb/c (ly-6.1) mice, ly-6a/e, but not ly-cc, molecules were induced by ifn-7 and tnf. furthermore, when compared to ly-6a/e, the regulation of mhc class 1 molecules in these t cells by tnf was minimal. the induction of ly-6afe molecules on balbfc t cells resulted in an enhanced capacity to activate these cells through the ly-6 t cell activation pathway. one transformed t cell line, 5.1.2. was also identified whose ly-6a /e molecules were synergistically induced by ifn-7 and tnf. optimal expression of ly-6a/e molecules on 5.1.2 cells required continuous culture of this cell line with these two cytokines and resulted in the detection of optimal levels of cytoplasmic ly-6afe mrna by northern blot analysis. this latter result suggests that ifn-7 and tnf regulate ly-6a /e at the level of transcription and/or mrna stabilization. ut southwestern medical center, dallas, texas 75235. an igm antlcd3 mab (38.1) was found to modulate cell surface cd3 on highly purified human t cells within 5 hours in the absence of a secondary antibody or accessory cells. inhibition could be overcome with accessory cells or il2. the inhibitory effects of 38.1 could be mimicked by briefly pulsing cells with the calcium ionophore, ionomycin. 38.1 or ionomycin pulsed cells were inhibited in their subsequent capacity to resp nd to pha even when exposures were carried out in the presence of egta to prevent increases in [cap*]. from extracellular sources. inhibition was not the result of an inability to respond to pha 'by increasing [ca2+] .. moreover the newly expressed cd3 molecules were capable of generating increases in [ca2*].' after reacting the cells with anti-cd3 + a cross-linking secondary antibody. these studies dem'onstrate that a state of nonresponsiveness in resting t cells can be induced by modylating cd3 with an anti-cd3 mab in the absence of co-stimulatory signals. a brief increase in [ca ' 1. resulting from the mobilization of intracellular calcium stores appears to be sufficient to induce'this state of t cell nonresponsiveness. cd3. laurie s. davis, mary c. wacholtz, and peter e. lipsky, dept. of internal medicine, lmmunogenicity c a central lab.blood transf.service, lab. of exp. and clin.immunology of the univ. of amsterdam, amsterdam. the netherlands monoclonal antibodies (mab) directed against the human cd3 molecular complex induce a strong proliferation of t cells, when immobilized on microtiter wells. this activation system, that was shown to be independent of accessory cells, accessory-cell derived factors or lfa-1 mediated intercellular adhesion (1). allows one to study the requirements for t-cell proliferation and differentiation in a well defined manner. il-2 and ifn-gamma but no il-4 could be detected i n culture supernatants of coated anti-cd3 stimulated t cells. the addition of ril-1 or ril-2 had only a moderate effect on t-cell proliferation, vhereas helper activity for ig production was strongly enhanced in the presence of these factors. in this system differentiation of precursors to cytotoxic t lymphocytes (ctl), as measured in anti-cd3mediated cytotoxicity, could be demonstrated within 2 days after initiation of the activation. allospecificity of the induced effector ctl was demonstrated using a panel of hla class-i p815-transfectants. in this system the regulatory role of the cd28 molecule in tcell activation and differentiation was studied. addition of anti-cdz8 mab to t cells stimulated with coated anti-cd3 mab enhanced il-2 production, proliferation as well as ig production. interestingly, pctl differentiation was also enhanced by anti-cd28 mab. this system seems valuable for the analysis of requirements for differentiation of human t cells subsets. 1. van noesel et al., nature 333, 850-852, 1988 analysis of the requirements for human t-cell differentiation, rolien de jong. vivienne rebel, g i j s van seventer. miranda brouwer, frank miedema, rene' van lier, the newly described t cell receptor (tcr) 6 locus is located inside the tcr a locus between va and ja . despite this unique situation, a highly efficient regulatory mechanism results in the complete independence of these two loci. we have recently described, in humans, a site specific recombination which joins a 5' deleting element (srec) to the send of the ja's (yja) resulting in the deletion of the tcr-6 locus in t lymphocytes expressing the a/b tcr. rearrangements of the tcr as well as immunoglobulin genes are mediated by a unique recombination machinery and therefore, the specificity of these rearrangements is thought to be the result of a differential accessibility of the dna involved in the recombination process. as a consequence (and/or cause) of the opening of a segment of dna, the region involved is fxst transcribed as a sterile transcript prior to the rearrangement. in that regard, we have found that the 2 kb of dna u p s a u~n of yja are actively transcribed ('t early a" transcript, tea) early during fetal development. the presence of the tea transcript presumably reflects the opening of the tea sequence prior to the tcr-6 deletional rearrangement. in order to better understand the mechanisms involved in the dna accessibility model, we started to look for dna-binding proteins which might play a putative role in the opening or blocking of the tea sequence. by the technique of "gel shift assay" we found such a negative regulatory protein in the nuclear extract from a non-lymphoid cell. the binding activity appeared to be specific as it was competed out by an excess of unlabeled autologous dna and not by an excess of irrelevant dna. further studies are now in progress to determine first wether the presence of this binding activity can be correlated with a "closed" configuration of the tea region and second to determine the precise location of the dna binding region. cohen, laboratory of chemical biology, niddk, national institutes of health, bethesda, md 20892. mabs retard lymphoproliferation as well as autoimmunity. interesting, so does the adminisuation of a mab to l3t4 , thus suggesting that the t helper subset, which is not part of the unusual expanding population, is required for initiating the pathology in these animals. as a means of characterizing the expanding population of abnormal cells as well as the phenotypically mature (l3t4+) cells that may be associated with them, i have generated a series of t cell hybridomas from the enlarged lymph nodes and spleen of m p r mice. in parallel, i have derived a series of control (non-lprflpr) hybridomas from mrulpr x balb/c f1 animals (which show no sign of pathology), and a series from mrl, mice (which have a delayed onset of autoimmunity without lymphadenopathy). very few hybridomas (20-30) were obtained in the non-lpr derived fusions. when i con a stimulated the lymphocytes from non-lpr mice prior to fusion however, many more hybridomas were obtained(l20-220). this is in contrast to the fusion efficiency obtained from lprnpr mice which did not require in viuo lymphocyte stimulation to obtain a comparable number of hybrids. this result suggests that the m u p r lymphocytes are activated in situ. in addition, while less than 15% of the lymphoid mass is comprised of t helper (l3t4+) cells , over 50% of the hybrids are l3t4+. the fact that a dispropomonate number of t helper cells are rescued by fusion suggests that the cells activated in situ may be autoreactive t helper cells. currently i am characterizing these t helper cells for their lymphokine production, t cell receptor gene usage and auto-specificity and will compare them to the hybridomas obtained from non-diseased animals. goodnow, s. gilfillan, h-j. garchon, j. erikson and m. davis. stanford university, stanford, ca 94305. we have made transgenic mice bearing gene constructs encoding the t cell receptor a and p chains from a cytochrome c-reactive t cell hybridoma. despite a lack of tissue-specificity in mrna expression, cell surface expression of uansgene-encoded protein was limited to t cells, presumably because both chains require cd3 proteins in order to assemble on the cell surface. in mice carrying only the a chain consuuct, the transgene was expressed in the thymus as early as day 15 of fetal life, 1-2 days before endogenous a chain mrna. the first detectable cell surface expression of a transgene was on 25% of day 15 fetal thymocytes. this vast increase in up-bearing cells in fetal thymus was due to pairing of transgenic a chains with endogenous p chains, of which a substantial number are. normally rearranged by day 15 of fetal liie. the balance between ap-expressing t cell supopulations was grossly disturbed in these mice, the most marked abnormality being an increase in the number of l3tnyt-2-cells both in thymus and in peripheral lymphoid organs. it therefore appears that premature expression of surface ap t cell receptor may disturb t cell differentiation pathways by allowing t cells to leave the thymus without expressing l3t4 or lyt-2. mice carrying the p construct showed no increase in surface expression of t cell receptor in fetal life, since endogenous a chain rearrangement was limiting. in mice carrying either the a or p chain mansgenes, the number and surface phenotype of t cells expressing y& t cell receptors was unaffected in early fetal liie. suggesting that the a p and y5 t cell lineages diverge before thc rearrangement and expression of the appropriate subset of t cell receptor genes. department of microbiology and immunology, institute and the university of pennsylvania, philadelphia, pa. 19104.the thymic stroma plays a major role in initiating the colonization, organization and differentiation of precursor stem cells into functionally mature t cells. a variety of cell types including thymic nurse cells, cortical and medullary epithelial cells, nonepithelial dendritic cells, and macrophages, combine to form the thymic stroma. the differential role of such cells in thymic development is unclear. we have isolated a number of morphologically distinct stromal cell lines from the thymuses of sv40 transgenic mice. several of the cell lines are of epithelial origin, while others have features consistent with non-epithelial "dendritic" cells. we have focused on one of these cell lines, bearing the phenotype of a cortical epithelial cell, for its ability to support the growth and differentiation of stem cells from the fetal liver and fetal thymus, and cloned pre-t cells obtained from adult mice. the cortical epithelial cell line produces factors that induce the dramatic proliferation of fetal liver and thymic stem cells . in addition, fetal liver cells cocultured with this cell line are induced to rearrange and express their t cell receptor (tcr) genes. a cloned pre-t cell line is also induced to rearrange its tcr oenes in resoonse to sianals mediated bv this cell line. gugrin, marie c. b6n6, corinne amiel, nadia coniglio, jacques leclsre, laboratoire d'immunologie and clinique endocrinologique, chu de nancy and facult6 de mgdecine, 54500 vandoeuvre les nancy, france. the lfal molecule, an adhesin of the lfa family involved in cell-cell interactions, is physiologically expressed on all white blood cells. it is absent in some congenital immune deficiencies ((id), and is expressed on a decreased number of peripheral blood lymphocytes (pbl) in aids. we investigated its presence on pbl from 60 patients with auto-immune disorders of the thyroid. a monoclonal antibody (iot16, immunotech) directed to a conformational epitope involving both chains of lfal was used in indirect immmunofluorescence on pbl from blood drawn at a similar time in all patients. a calibrated flow cytometer (epics profile, coultronics) was used to measure the percentage and numbers of positive cells, as well as the mean fluorescence (mf) and shape of the fluorescent peak. data were correlated with clinical information,therapeutic, and other pbl features such as the cd4icdb ratio. the percentage of lfa1+ cells was significantly decreased in patients with graves' disease, hypothyroidism and hyperthyroidism. the mf was lower and the shape of the fluorescent peak seldom displayed the bimodal characteristic noted in controls. these data suggest the participation of the altered expression of lfal in the pathogenesis or evolution of auto-immune diseases. pt=ciilat.pd that excess hla r l a s s tt expression, ciinmonly found i n a i t i v e human nutoinimiine tlisrases maintdin:? the *rctivatinn of dutnreactivr t c e l l s which in turn prnducr mediators which maintain r.la:;s i t expression. this hypothesis has been tested i n many ways i n t h y r o i d i t i s . crj t i c a l l y autoreactive t cell:? are â�¬nilrid i n thyroid autoinnline tissues which a r e rrstimnlatrd hy thyroid f o l l j c u l a r r r l l s . more rrcently we have been exploring the s p e c i f i c i t y of the autoantigen reactive t c e l l s in hashinoto's t h y r o i d i t i s where thyroy-lobulin s p e c i f i c clones have been found, i n contrast t o graves' disease, where thyrocyte recognizing clones do not react wi.th tliyroglnhulin. tn rheumatoid a r t h r i t i s , collagen type i1 clones have been found, persistently in the activated (il-2r') t c r l l pmil over several years i n t.he same p a t i e n t . to verify t h a t antigen present,ation is involved i n rhrumatoid art.hritis ( r a ) a disease i n which, unlike thyroi.dj t i s the nature of the major antigen presenting c e l l (apc) is unknown, thc e f f e c t of ,~nticl.ass i1 dntibodies a t 1-oncentration which block *ari;j vation of t r-el is mi the synthesis n â�¬ rla-dr mrna wa:j waluat.rd. the inhibitory effect supports d i.rifira1 role nf an d s yet iiriknown apc i n maintaining the i:hronj.ci t y o f r a conversely, all the clones were unable to respond to a substitution at 91 (tyr to asp). nase mutant proteins were constructed with the same single amino acid substitution and t cell responses to peptides and mutants were compared. preliminary evidence suggests that the mutant proteins like the peptides, substituted at residue 88 and 91, will not induce t cell clone responsiveness. these data suggest that the overall structure of the protein will not compensate for the lose of a particular amino acid which is necessary for t cell recognition. medicine, baltimore, md 21201. to explore the variables important in t cell priming, an adjuvantfree immunization regimen was developed. bio.a mice were primed subcutaneously with syngeneic spleen cells that had been pulsed with high concentrations (100pm) of the peptide 81-104, a cnbr cleavage fragment of pigeon cytochrome e. the t cell response was assessed using a sensitive limiting dilution assay that measures lymphokine production with the ctl-l cell line. the precursor frequency of antigen-specific cells in the draining lymph nodes of mice primed with antigen-pulsed spleen (aps) was 1 in 4000, indistinguishable from the frequency of 1 in 3400 found in mice primed in the footpads with 10 nmol of 81-104 in complete freund's adjuvant (cfa) (data are given as geometric means, n=5, s.e.m = x/t 1.7 and 1.3, respectively). despite the apparent similarity in the t cell compartment of mice primed using these different regimens, antibody induction was strikingly different. mice primed with 81-104 in cfa developed serum igm and igg responses against the peptide, with antibody detectable in an ellsa assay at a 1 :3000 dilution. mice primed with 81 -1 owaps, however, produced no detectable anti-peptide antibodies. maximal t cell clonal expansion therefore appears to be possible in the absence of antigenspecific b cells. these data argue against the hypothesis that antigen-specific b cells play an obligate role in t cell proliferation in vivo. the reasons for the lack of antibody induction are currently under investigation. cell receptor (tcr) complex of jurkat cells. the coprecipitation of these peptides with tcr requires treatment with monoclonal antibodies (mabs) directed against tcr (c305 or r140) prior to cell lysis and immunoprecipitation. treatment of jurkat cells with mabs directed against cd2 (9-1 or 9.6) or hla (w632) does not not induce the association of these peptides with tcr. the signal-transduction mutant cell lines, j.cam1 and j.cam2, have previously been described (1,z). these cell lines, derived from jurkat, fail to activate the inositol-phopholipid second-messenger pathway in response to anti-tcr mabs. treatment with mab c305 induces the association of the 35 and 39 kd peptides with tcr in j.cam2 cells but not in j.cam1. j.cam1 modulates tcr normally in response to anti-tcr mab treatment (1). hence, these observations suggest that the two peptides are involved in the signal-transduction pathway of the t cell receptor complex rather than receptor internalization. sle is an autoimmune disorder associated with several different hla class i1 antigens. we studied a large sle patient population by sequencing of the pcr amplified first domain of the dqb and dqa chains and by sequence specific oligonucleotide probes to further define these associations. shared dqb sequences at amino acid positions 26=1eu, 30=tyr, and 57fasp may predispose some individuals with hla dr1,2,4, or 6 to develop sle. a novel dqb sequence found in two drw6 dqwl sle patients shares these amino acids in the dqb hypervariable regions. the association of the drz dqwl.azh gene was greatly increased in the sle patients with lupus renal disease. the hla association may be directly due to structural aspects of the hla genes. when parent -+ f1 chimeras are prepared with supralethal irradiation (1300 rad + 900 rad), the donor-derived cd4+ cells differentiating in the chimeras show partial tolerance to host-type h-2 determinants, despite the apparent absence of host-type apc. donor-derived cd4+ cells give only low proliferative responses to host-type apc in primary mixedlymphocyte reactions (mlr); furthermore, in i-e-+ i-e+ combinations, the donor cd4+ cells show molecules. this finding implies that tolerance is induced intrathymically, presumably through contact with a non-marrow-derived component of the thymus, e.g. epithelial cells. in support of this possibility, thymectomized & + ( a x b)f1 chimeras given strain j? marrow cells and a strain thymus graft (irradiated) show no detectable tolerance to host-type strain b determinants: the strain & cd4+ cells differentiating in these chimeras give strong mlr to strain b and do not show deletion of v 11+ cells. = 70% deletion of cd4+ cells expressing i-e-reactive v 11 t cell receptor b measured by these two parameters applies not only to lymph node (ln) cd4+ also to cd4+ cells recovered from the thymus. interphotoreceptor retinoid-binding protein) is a glycoprotein of 1264 residues (bovine) which localizes in the retina and pineal gland and induces inflammatory changes in these organs (eau and eap, respectively) in immunized animals. the experimental disease is considered a model for certain uveitic condiiions in man. we have recently shown that irbpderived synthetic peptides can also induce eau/eap in lewis rats. the present study compared two such peptides, "r4" (residues 1158-1 180) and "r14" (1 169-1 191). peptide r14 was found to be immunodominant, shown by its being recognized by lymph node cells (lnc) or line cells sensitized against whole irbp. in contrast, peptide r4 was not recognized by the whole irbp-specific lymphocytes and is considered nondominant. in addition, lnc sensitized to r14, but not to r4, responded to intact irbp. r14 was superior to r4 in producing eau/eap and cellular immunity (minimal doses: 0.06 vs 67 pg/rat). on the other hand, the two peptides were comparable in their capacity to stimulate presensitized lymphocytes. moreover, lnc sensitized against r4 were similar to those sensitized against r14 in their capacity to adoptively transfer eau/eap to naive recipients. this study thus provides a unique system in which both immunodominant and nondominant peptides produce autoimmune disease and can be compared for their immunological features. the age-related diminution in immune responsiveness has been shown to result from increased regulatory mechanisms and not from a paucity of immunobgical recruitment (aging: immunology and infectious disease 1,47, 1988). we present evidence based on "libraries" of monoclonal antibodies (mabs) omained from young and aged donors that there occurs with aging an increase in autoimmunity which is possibly the result of the accumulation of liielong "original antigenic sins". the resultant increased connectivity of the immune system is represented by mabs obtained from aged donors which are multiply anti-self cross-reactive. furthermore increased connectivii is supported by the evidence that anti-2.4,6-trinitrophenyl mabs are ad8 positive, 2d3 positive as determined by i n h b i i n studies using mabs anti-idiitypic reagents. analysis of the vh and vk region genes utilized by these mabs indicate a nonrandom gene usage. life bng stochastic immunological events lead to a pattern of cross-reactiities and non-random usage of vh genes. these immnological events lead to the emergence of the patterns which are partially elucidated by the data presented. these patterns mimick those seen early in ontogeny, but indicate a possible convergence to an ever-increasing connectance of the idiitypic repertoire expression. in other words, life-long immunological experiences contribute to a down-regulation resulting in both paucity of drimaw immune reswnses and an increase in autoimrmnity which are both the earmarks of immunity in aging. (supported by usphs grants ag-04042 to eag and al 18316 to cab) lmmunogenicity c449 stimulation of these cell lines in suspension with saturating levels of mab okt3 produces total and fractional inositol phosphate accumulation linearly related to receptor number, (r > 0.9 ). this technique also allows an approximation of the minimal number of reccptors which must be engaged for second messenger generation in this system, which we estimate as 6.5~102 receptors per cell. or terminate t cell activation. since this molecule plays an important role in human t cell development we sought to identify the murine homologue of cd28 in order to determine its expression on murine t cell and its role in activation. we have used a human cd28 cdna clone to isolate a full length cdna encoding the murine equivalent of cd28 from an el4 t cell lymphoma library. this clone shows similar domain organization and a high degree of homology to the human cd28 molecule. the murine cdna clone has been used to examine mrna expression of cd28 in normal and activated murine t cells, and in various t cell tumors. peptides generated from the translated sequence will be used to produce antisera to correlate the surface expression of cd28 with mrna expression, and to biochemically and functionally characterize this molecule. pat happ and ed palmer, basic sciences division, dept. of pediatrics, national jewish center for immunology and respiratory medicine, denver, co 80206. we have attempted to determine the frequency of rearrangement and expression of the individual a and g chain v gene segments that make up an unselected, untolerized t cell repertoire. in order to do this we generated over 500 t cell hybridomas from freshly-isolated thymocytes of newborn c57blllo mice and subjected rna from these hybrids to northern dot blot analysis using 11 va, 16 vp. cy and c6 probes. comparison of the expressed repertoire of vp gene segments in this newborn thymocyle population with similar data previously generated from an adult peripheral t cell population reveals two vg genes, vp12 and vpl5, whose expression is decreased in the periphery, possibly due to the effects of tolerance. two additional vp gene segments were expressed more frequently in the peripheral population than in the newborn thymus, vp5 (4.5 times higher in the periphery) and val0 (2 times higher). it is possible that these represent ewo instances of positive selection of t cells which is determined primarily by the receptor's vg gene segment. va gene segments were expressed in only 15% of newborn thymocyte hybridomas (compared to 58% expressing vp) and determination of va rearrangement frequencies was complicated by the unexpectedly large number (67%) of hybrids expressing cs mrna. further examination revealed that several va gene probes were actually detecting rearrangements to cs. the most notable of these was va7, which accounted for approximately 34% of the expressed va repertoire but was rearranged exclusively to cs. barbara bergman, brenda bradley, kevin lafferty and mary portas. barbara davis center for childhood diabetes, u. colo. health sci. ctr., denver, co 80262. we have produced a panel of islet-specific t cell clones by culturing lymphoid cells obtained from non-obese diabetic (nod) mice in the presence of nod islet cell antigen and antigen-presenting cells (apc). these clones were selected to the panel on the basis of (a) their antigen-specific reactivity to islet cells and apc in an in vitro proliferation assay and (b) their ability to mediate islet graft rejection in vivo in a tissue-specific manner. we have further characterized these lines for cell surface phenotype, 11-2 production, and proliferative response to non-nod islet antigen. all of the clones tested to date are of the cd4 phenotype and make il-2 in response to islet antigen and nod apc. nearly all of the clones we have tested also make good proliferative responses to islet cell antigen obtained from mouse strains other than the nod or to a mouse beta cell tumor line. preliminary results indicate that at least one of these clones can lead to islet cell damage in a disease transfer experiment in which the cloned t cells are injected into a non-diabetic nod f1 recipient. we are currently carrying out tests to further characterize lymphokine production by these cloned cell lines, to analyze differences in antigen recognition and mhc restriction requirements among the clones, and to determine their effectiveness in mediating the disease process in nondiabetic animals. in an attempt to identify the epitopes on class i mo ecules recognized by alloreactive cytotoxic t lymphocytes (ctl) we have examined k -specific ctl for tpir recognition of synthetic peptides with sequences derived from the native k molecule. co secutive overlapping peptides molecule were tested for their capacity to inh&bit k -specific ctl clones in their recognition of cells expressing the native k molecule. in these studies inhib9ion by peptide was found to be an extremely rare event, although one peptide (k 111-122) did inhibit recognition by a particular ctl clone (clone 13). in a separate set of experiment8 it was observed that clone 13 could recopize kblll-122 when presented by h-2 class i molecules. as clone 13 was of h-2 origin, this finding led to conclude that inhibition may be due to class i-restricted recognition of the k pegtide on the surface of the ctl clone, peptide and native kb for the t cell receptor. we present evidence in favor of this conclusion. the pepscan method is used for the systematic identification of sequential b cell epitopes i n protein molecules (geysen, meloen, barteling. pnas 81: 3998; 1984) . it was designed for the synthesis and subsequent testing for antibody binding of large numbers of overlapping peptides directly on their solid supports. the mhc dependent presentation required for t cell recognition seemed prohibitive for the use of pepscan to identify t cell epitopes. however we now have shown that by a novel modification the peptides can be recovered from their solid supports and used in t cell assays. holmdahl, department of medical and physiological chemistry, box 575 uppsala university. s-75123 uppsala, sweden. both autoreactive t cells and autoantibodies play an important role in the pathogenesis of type i 1 collagen (cii) induced arthritis in mice. we have earlier reported that only strains with h-2q , h-2w3, h-2w17 and h2-r were responders to autologous mouse cii and only these strains developed arthritis after immunization with autologous or heterologous cii. however, heterologous cii induced a more acute and severe disease and a more pronounced autoantibody response. this findings indicate that 1) the ability to mount an immune response against autologous cii is a prerequisite for the susceptibility to collagen arthritis and 2) that a crossreactive autoantibody response after immunization with heterologous cii may further enhance development of arthritis. we have now studied activation of autoreactive b cells after primary immunization of den1 mice with rat cii. in hybridoma collections, obtained 9-11 days after immunization, 30.80% of the hybridomas produced igg reactive with autologous cii, 10-15% produced multispecific igm and a significant number produced igg rheumatoid factors. the anti-cii antibodies recognized at least 5 different epitopes on the cii molecule and originated from many different vh and v kappa gene families. furthermore, none out of 6 investigated anti-cii hybridoma expressed cd5 rna message. we therefore suggest that the primary anti-cii autoantibody response involves activation of memory b-cells. these memory b cells have most likely been earlier activated by cii autoreactive t cells. in these aspects the origin of the anti-cii autoantibody response is principally different from the origin of "natural" autoantibodies. t cell receptors (tcr) recognize antigen in association with self mhc molecules, usually following processing to smaller peptides. the t cell repertoire to an antigen, therefore, reflects not only the ability of a given mhc molecule to interact with antigen, but also the affects of initial repertoire selection by self mc. we have t#tn analyzing the tcr repertoire specific for beef insulin (61) in balb/c mice (h-2 ), which are high responders to the antigy. these studies revealed that vp.3 is dominantly used in the tcr's specific for bi/a and our preliminary data suggests that the vgb.3 chain may be involved in mhc restriction. we have now obtained several t cell hybridmas specific for bi from (balb/cxa/j) f1, animals. a/j mice (h-2a) are low responders to bi while the f 1 m ce a e high responders. most of the balb/cxa/j hybridmas were restricted to the hin the balb/c hybridmas. interestingly, the analysis of v gene usage demonstrated that vg8.3 was not used in the balb/cxa/j hydridonas. the relevance of these results to the development of the tcr repertoire in different mouse strains will be discussed. this work was supported by the mrc of canada. ctl specific for the q k molecule were generated from normal splenocytes by & vitro culture with a2k bearing stimulators. these ctl have been shown to lyse transfected targets expressing hla-a2 regardless of their murine haplotype, and they specifically kill a2 bearing human target cells. furthermore. the effector function of these ctl can be inhibited with an hla-a2 specific monoclonal antibody. thus, the transgene product functions correctly as a tolerogen and is recognized directly as a class i antigen. although transgenic mice have been shown to be tolerant to a2k expressed by murine cells, transgenic ctl specific for hla-a2 on the surface of human cells have been generated. these the major virulence factor of m.pneumoniae was shown t o be a 168 kda protein which is located in the tip structure membranes of these cells. beside the adhesin function this protein is also involved in first massive humoral and cellular responses of the human host during the acute phase of upper respiratory tract infections and interstitiel pneumonia. intranasal inoculation of guinea pigs with the isolated 168 kda protein led to lympho-histiocyte infiltrations around bronchi and small vessels of the lungs which are characteristic infiltrations after an infection with live m.pneumoniae cells. furthermore one peptide ( 1 7 amino acids long) which was synthesized according to the amino acid sequence of the adhesin, showed a proliferative activity to in vitro cultivated t-cells of bronchial washings, whereas synthetic peptides with th e sequences of the direct neighbourhood showed no in vitro activity. most interestingly this t-cell proliferative activity is located on a surface loop of this protein which is also responsible for the adhesin f uction. christopher a. smith, gwyn t. williams, rosetta kingston and john j.t. owen. department of anatomy, university of birmingham, medical school, vincent drive, birmingham 815 2tj, uk. rearrangement of t-cell receptor a and b chain gene segments during t-cell development results in a diverse array of receptor specificities. to avoid auto-immune responses, cells that have generated self reactive receptors are thought to be eliminated or inactivated, to produce self tolerance. recent studies have provided compelling evidence that clonal deletion of immature receptor bearing cells within the thymus makes an important contribution to this process, although the mechanisms involved are not uderstood. of immature mouse thymocytes with anti-cd3 antibodies added to thymus organ cultures, induces dna degradation and cell death through the endogenous pathway of apoptosis. is in marked contrast to the activation of mature t-cells by the same anti cd3 preparation and is specific to the extent that apoptosis is not induced by either anti-cd-4 or anti-thy-1. to organ cultures suggesting a role for changes in intra-cellular c a w levels in the signalling pathway leading to the induction of apoptosis in immature cells binding. thus activation of the process of apoptosis in immature cells binding self antigens may be the mechanism responsible for the selective deletion of cells that could generate an auto-reactive response if allowed to mature. we have now obtained evidence that engaging the cd3/t-cell receptor complex this in addition, calcium ionophore (ionomycin) also causes apoptosis when added anderson cancer center. houston, tx 77030 immunization of patients with bcg and irradiated tumor cells induces specific delayed-type hypersensitivity (dth) to tumor cells and not to normal colon cells. since igg antibodies may require t-cell help, we wished to characterize the igg-defined tumor-associated autoantigens (taaa) of human crc so as to define a subset of the t-cell repertoire for crc. western blots of detergent extracts of 73 primary and metastatic human colorectal carcinomas and paired normal tissues were probed with autologous igg. nine taaa were recognized by 20% or more of the sera: 74, 72, 58, 52, 45, 41, 38, 29 . and 26 kda. these taaa may be normal colon differentiation antigens, since they were present in extracts of normal colon. autoantibodies are more frequently present to the 41 kda antigen in patients with metastases (79%) than in primary tumors (47%. prl-8 p p l a t i o n . m t s indicate that antigen receptolg on hath inmature and mature -itive t cells tmnsdwe signals via calcium mobilization, h-er the maqnitu3e of fnflux of e&acellular q'+ wfiich follckfi birding of antireceptor a n t q d i f f e r s tetmen these pqulaticns. specifically, imnature cells shcw a m& reduced q influx espcnse carpared to mature cells. we dmw here that dligation of ~~n p has different amepexe w i t h regard to q'+ nnbilization in mature and inmnture cells, no sucfi difference is seen f o l l a d r q ligaticm of the receptnr's transducer, a. ihe zpsults suggest that the signall* cascade leading to the influx of extracellular is intact hen c d~ is ligated, but is inccnplete w i e i i m p , the physiological liw, is ligated. in addition, ligation of cw or cd8 on bmdture t cells i n a~~ influx of extracellular a ' + canparable to that sem i n mature t cells. a clonal population has been isolated frcm inmnture thymocytes whir31 has the characteristic signal tramdmtion pxqerties of the tulk of inmnture thymdcytes. 'ihese f i r d h p suggest that "signal" transfer frcm xpnp to 03 may be inefficient in cd4+8+ cells. struchual analysis of the xpnp/cd3 canplex in hnature and mtum t cells is in progress. flood and alan friedman, dept. of pathology, yale university school of medicine, new haven, ct, 06510. protective immunity to the ultraviolet (w) light-induced sarcoma 1591-re is directed toward a single tumor-specific transplantation antigen expressed by the 1591-re tumor cells. termed the a antigen. a progressive variant line of 1591-re, termed 1591-pro4, lacks only the expression of this a antigen. immunization of mice with 1591-re tumor cells haptenated with trinitrophenyl (tnp-1591-re) leads to the subsequent rejection of tnp-haptenated progressive tumors and to increased delayed-type hypersensitivity and ctl responses to tnp in normal, immunocompetent syngeneic mice. however, little or no humoral immunity to tnp is seen in animals injected with tnp-1591-re tumor cells. pro4 did not exhibit tnp-specific tumor protective or cell-mediated immunity, but rather exhibited tolerance to subsequent immunizations with more immunogenic forms of tnp. biochemical and molecular genetic studies have revealed the a antigen to exist on the cell surface as a complex of 3 class i mhc-like molecules. transfection studies with dna encoding each of these molecules into 1591-pro4 reveals that the expression of one, and only one, of these three molecules mediates this increased immunity. these experiments suggest that an mhc-like antigen expressed on the 1591-re sarcoma acts as a natural adjuvant to increase cellmediated but not humoral immunity to linked antigens. the mechanism of this increased immunity is discussed. efforts to immunize cattle against economically important gastrointestinal nematodes showed that inrmunity is manifested by: 1) a response that reduces the fecundity of established and subsequently acquired worms. and/or 2 ) a reduction in the number of worms developing upon challenge infection. however. the ability of individuals to mount such immunity is highly variable. extending these studies to naturally infected populations indicate that there is a great difference in the number of eggs excreted by individual young calves on pasture. to delineate whether these differences were the result of host genetics and to begin to elucidate the mechanisms of resistance to parasite infection, a genetically defined cattle herd was assessed for parasite levels by determining fecal eggs per gram. three years of sampling of the calves during their first grazing season indicates that: 1) certain individuals in the herd will consistently excrete high or l o w numbers of parasite eggs, 2 ) the high or low phenotype is significantly controlled by the genetic make-up of the calf, and 3 ) the high or low phenotype is highly heritable (heritability -40). susceptibility is currently under investigation. calves have been determined and mhc class i1 typing is currently in progress. information is being used to assess the role of the bovine mhc in controlling immunoresponsiveness to parasite antigens. we have been studying the differential effects of il 1 + il 2 versus il 4 on the growth and differentiation of cd 4-, cd 8-thymocytes. culture of highly purified cd 4-, cd 8-thymocytes with il 1 (4 u/ml) + il 2 (100 u/ml) resulted in marked proliferation and increased cell size without change from the cd4-, cd0-phenotype. culture with il 1 or il 2 alone did not cause proliferation. a substantial contribution to the proliferation was secondary il 4 release: addition of anti-il 4 (11b11) blocking antibody inhibited proliferation induced by culture with il 1 + il 2 . il 4 mrna was demonstrated by northern blot analyses after 4 8 and 7 2 hours of culture with il 1 + il 2 whereas none was detected at culture initiation and very little was present at 24 hours. effects of il 1 + il 2 on il 4 transcription rate will also be reported. despite a marked inhibition of proliferation with anti-il 4 , there was no affect on expansion of cd 3+ cells following culture with il 1 + il 2 (increase from 10% to 60% in 7 2 hours). thus, in this system, il 4 enhances proliferation of progenitor thymocytes but does not contribute to induction of t cell receptor. carplex. lhese cwplexes can be used to inmmize mice in the absence of protein carriers or adjuvants, thus facilitating the study of the inmum to a sml1 ckmically defined antigen. use of this tecfinology has allawed us to identify two t helper cell epitopes in cclllserved regions of hn gp 160 not previcusly identified by computer algorithims, defined by amino acids 485-518 and 585-615. inummization with these peptides in pptide-@nqhlipid cwplexes results in the prpauction i* and i* antibodies, which cioss react with cloned fragmnts of the w l e protein. us& this &logy we have begun to characterize the innume response to individual peptide antigens. ?he reqonse of h2-k mice to amino acids 494-518 of 9p 160 of hiv, has been analyzed. lhe optimal dose of a peptide containing both b and t cell epitopes was found to be 15-30 ug, depending on the route of administration. im d z a t i o n requir& less antigen for opthum antibody resporrsf, than did ip. ment for an ant-response. additional variables, as phosfholipid carpasition and method of cross-linking have been studied anl will be . webelievethattheuseof this peptide-phospholipid canplex tehmlogy will be significant both for studying the innwe response to single epitcpes and for vaccine develolment. based on assays in which t cell proliferation was induced via oxidative mitogenesis and exposure to mhc alloantigens, it has been reported that langerhans cells (lc) isolated from normal mouse skin aquire maximum capacity to activate t cells only after 72 hours of culture. we have studied lc from balb/c mouse skins for their capacity to present ovalbumin (ova) and ia doantigens to unprimed t cells and to antigen-specific t cell hybridomas. the data reveal that both fresh and cultured lc presented ova and alloantigens with equal efficiency to previously primed responders (and with 10 fold greater efficiency than spleen cells or the b cell lymphoma a20.1-11). by contrast g& cultured lc displayed the capacity to present antigen to ynorimed t cells. we propose that the antigen presenting potential of freshly prepared and cultured langerhans cells, respectively, reflect the in vivo functional properties of intraepidermal lc and of lc that have picked-up antigen in the epidermis and migrated via dermis to the regional lymph node. if so, these data suggest that resident epidermal lc are fully prepared to present cutaneous antigens to memory/effector t cells (efferent limb), whereas resident lc must leave the influence of the epidermis in order to develop the capacity to meet the more stringent conditions required for antigen presentation to porimed t cells (afferent limb). we have investigated the structural restrictions placed on residues contained within a minimal t cell determinant, using the balb/c class i1 restricted t cell response to the site 1 determinant of the influenza hemagglutinin molecule as a model system. to delineate which of the residues comprising the site 1 determinant are involved in interaction with the t cell receptor, we have determinaed the response of a large panel of site 1 specific t cell hybridomas to a collection of peptide analogs differing by single conservative or non-conservative substitutions at 9 positions. the fine specificity patterns of the t cell panel is extremely diverse; t cells varied in both the location and number of residues within the antigenic peptide that effected recognition. our results implicate at least 6 out of 9 residues within the antigenic pepetide as being involved in interaction with the t cell receptor. this result suggest that peptides comprising the site 1 determinant do not form alpha helical structures when in association with mhc molecules. rubella-specific isotype and igg subclass responses were evaluated using elisa techniques in 44 rubella ha1 seronegative adult females undergoing rubella immunization (ra 27/3 strain). responses were evaluated prior to immunization and at 1,2,3,4,5,6,12 and 24 wks post-immunization. pre-immunization sera showed detectable levels of rubella-specific antibody in the igg class (17/44); iga class (32144) and in one or more of igg subclasses (22/44). post-immunization, i 1 subjects failed to develop igm class responses by the ha1 (sdg) technique while 43/44 developed igm antibody by elisa techniques. iga responses were detected at low levels in all vaccinees beginning at 3-4 wks and declining by 24 wks post-immunization. antibody in iggl and igg3 subclasses by 2-3 wks post-vaccine with sustained iggl levels but significant decline in igg3 levels noted between 6 and 24 wks post-immunization. no seroconversion was noted in the igg2 subclass although 9 individuals had detectable pre-immunization iggz rubella antibody present. igg4 levels were detected in all vaccinees post-vaccine with a delayed and progressive rise over the study period. subsequent correlation was then performed between rubella-specific antibody responses and the presence or absence of adverse joint reactions occurring in association with rubella vaccine administration. all individuals produced detectable c624 t lymphocyte responses to varicella zoster virus. anthony hayward, abbas vafai, roger giller & eileen villanueba. departments of pediatrics and microbiology, university of colorado school of medicine, denver co 8 0 2 6 2 61 university of iowa school of medicine, iowa city i0 the proliferative response of blood lymphocytes from varicella zoster virus (v2v)-immune donors to live vzv, extracted vzv antigens or purified glycoproteins is predominantly by cd4+, hla-d restricted t cells but little is known of the specificies of the responder cells. we restimulated t cells cloned by limiting dilution from vzv-stimulated cultures with purified vzv glycoproteins gpi, gpii and gpiii and found that t cell clones with specificity for each of these mediated both help for antibody responses and hla-dr restricted vzv-specific cytotoxicity. 5 polypeptides of 10 to 14 amino acids length corresponding to predicted amphipathic sequences in the primary structures of g p i, gp i1 and gp iv were synthesised. proliferative responses were observed to 3 of these peptips (one from each glycoprotein) with responder cell frequencies in the 1:lo blood t cells range. the gp i peptide additionally defined an epitope recognised by serum antibody. an immunomodulatory approach to treating hsv-1 corneal disease, hendricks rl, departments of ophthalmology, and microbiology/immunology, university of illinois school of medicine, chicago, il 60612 herpes simplex virus type i (hsv-1) corneal infections are a leading cause of blindness worldwide. we and others have demonstrated that the cellular immune response to hsv-1 contributes to the elimination of virus from the cornea, but in doing so causes the tissue destruction that is responsible for the blinding complications of the disease. we have demonstrated that specifically suppressing the cytotoxic t lymphocyte (ctl) response to hsv-1 renders mice resistant to corneal disease following topical corneal hsv-1 infection. in agreement with this observation was our recent finding that in vivo depletion of wt4' (t helper/inducer, and most dth effector cells) neither reduced susceptibility to corneal disease, nor increased susceptibility to disseminated disease. the corneal lesions in wt4 depleted mice contained numerous lyt-2 (t suppressor/cytotoxic) cells, and no l3t4 cells. the wt4 depleted mice exhibited normal hsv-specific ctl precursor frequencies. experiments designed to determine the effect of in vivo lyt-2 depletion on susceptibility to corneal disease are in progress. our goal is to identify cellular immune responses to hsv-1 that maximize protection, while minimizing immunopathology in the cornea, and identify hsv-1 epitopes that preferentially activate those responses. supported we found that affinity purified antibodies to bsa, klh and diptheria toxoid all contain a substantial amount of specific anti-idiotypic activity. against bsa react with mouse anti-bsa antibodies, which suggests that we are dealing with internal image antibodies. 9 mrl-lpr/lpr mice develop spontaneous autoimmunity. we found that these mice make anti-anti-(self h-2) antibodies prior to making appreciable amounts of pathological autoantibodies such as anti-dna, anti-rnp.sm, and rheumatoid factor. the anti-anti-self antibodies are detected using an inhibition of antibody mediated cytotoxicity assay, that also detects anti-anti-(self h-2) in ordinary allogeneic anti-sera. the antibodies are not rheumatoid factors, although the animals do make rheumatoid factors later in the development of the disease. anti-self activity is fully developed at 2 months, when the other autoantibodies are typically barely detectable. important role in the etiology of the disease. the anti-we conclude that anti-anti-self antibodies could play an c 627 feedback regulation of 11-1 synthesis in monccytes by t cell products: dual effect of 11-4. mikko hurme, tessa palkama and marja sihvola, department of bacteriology and immunology, university of helsinki, sf-00290, helsinki, finland. il-i production of human monocytehnacrophages is regulated by several cytokines some of which are themselves able to activate the il-1 production (e.g. tnf and il-2) while others (e.g. ifn-y) modulate the production activated by other signals. we have now examined the effect of 11-4 on the 11-1 synthesis. 11-4 alone did not induce any 11-1 bioactivity or il-la or 11-1 0 mrna expression in freshly isolated peripheral blood adherent cells. in contrast, il-4 effectively suppressed the lps induced 11-1 production. this suppression took place without any decrease in the steady-state levels of il-la and il-i 0 mrna, suggesting that this downregulative effects is posttranscriptional. monocytehnacrophages are known to rapidly loose their ability to produce il-i when cultivated in vitro. if ifn-yis present in the culture fluid, the cells remain capable of producing 11-1. as ifn-yand have been reported to have similar "priming" effects on macrophages (e.g. increasing the tumoricidal capacity and mhc class ii antigen expression) we cultivated monocytes for 24 h in the presence of either ifn-y or 11-4, and after washing the cells they were stimulated with lps. il-1 activity could be detected both in the ifnyand il-4 preincubated cultures (but not in the cultures preincubated with medium alone). these data suggest that il-4 can also display a similar upregulatory function in il-i production as ifn-y. gahreston, tx 77550 development of immunity to members of the spotted fever group of rickettsiae is a t-cell dependent response. we have used t-cell hybridomas and cloned t-cell lines from immune animals and convalescent humans to identify the rickettsial antigens that induce antigen-responsive t-cells. in these studies we found that the 155 kda antigen of rickettsia tickettsii. the causative agent of rocky mountain spotted fever, is one of the immunodominant tcell antigens. t-cells from immune animals and humans were responded in culture to a recombinant 155 kda antigen. both sources of t-cells were of the t-helper type (l3t4* and 04' respectively) and produced 1l-2 and interferon. it was found that soluble antigenic material of b. rlckettsii obtained by extraction with hypotonic buffer maximally stimulated the t-cell lines. this material was enriched far the high molecular weight polypeptides of 1s5 kda and 120 kda. also. ethirwwi ' will induce a long-lived immunity against infection with r. rickettsii. infected guinea pigs develop a minimally cross-reactive antibody response to b. nckettsii. in contrast. a strong cross-reactive t-cell proliferative response is produced. studies are in progress to determine the nature of the common protective antigen of r. humans infected with the parasitic nematode ascaris lumbricoides vary considerably in antibody responsiveness to a 14 kda component of the parasite. this molecule is secreted by the parasite, and is also abundant internally. this heterogeneous reactivity has been modelled in laboratory rodents, and the antibody response to it is h-2-and rt1-restricted in mice and rats, respectively. using inbred and congenic animals, only mice of h-2' and rats of rtiu were, so far, found to be responders, and this restriction only operated in the context of infection. the specificity of the ige response in these animals was assayed by passive cutaneous anaphylaxis, and in an ige-specific elisa assay. the data show that the above mhc restriction also applied to the specificity of the reaginic antibody response, although animals of all mhc haplotypes responded to other ascaris allergens. amino acid analysis of the 14 kda equates it to a previously identified "allergen a" of the parasite, and we now have its sequence available. these findings have implications for the genetic control of allergic responses in general, and, in particular, to the hypersensitivity responses which are such a feature of infections with parasitic nematodes. there are also implications for the generation of hypersensitivity responses by recombinant vaccines involving certain parasite antigens. the cns. immunohistochemial analysis of both frozen sections prepared from the brains of animals immunized in this manner and of highly enriched glial cell subpopulation cultures for viral gp70 expression indicated that oligodndrocytes and possibly a subset of astrocytes were the targets of this infection. further, microscopic analysis of frozen sections failed to reveal any overt signs of gross pathologic changes associated with the viral infection. we have been able to demonstrate the presence of virus specific antibody in the serum of these mice as well as virus specific cytolytic t cells in the peripheral lymphoid organs. ments are currently underway to determine whether the lack of pathology associated with wb91 infection in light of the previously shown virus specific immune responses in these mice is due to a failure of antigen presentation within the cns or some other form of immunoregulatory phenomena. the t lymphocyte proliferative response to pigeon cytochrome 5 in bio.a mice is restricted to the egk:e,k ia molecule and specific for the c-terminal determinant comprised of residues 93-104. blo.a(3r) and blo.a(sr) mice are nonresponders to pigeon cytochrome 2 nonetheless, the t cell repertoire of blo.a(3r) or (5r) contains some t cell clones capable of recognizing and proliferating to pigeon cytochrome c w h e n presented by bio.a antigen-presenting cells (aft). therefore, one would expect to stimulate such clones in allogeneic bone marrow chimeras of the type bio.a +blo.a(3r) or (5r) b1o.a apcs and a blo.a(3r) or (5r) t cell reperto4!6~.~espectively. ,en(isea9c22rzave were primed with pigeon cytochrome cytochrome 5, they showed a good antigen specific proliferative response in vitro. surprisingly, however, if pigeon cytochrome 5 was used for priming, no response was detected, even at priming doses as high as 400 nmol per mouse. 81-104 could only be achieved by treating the allochimeras with an anti-cdb monoclonal antibody in vivo during the priming step. clones specific for purified protein derivative (ppd) in the same chimera. thus the regulation which involves cd8 positive cells is antigen specific. transfer of pigeon cytochrome 81-104 primed lymph node cells from the chimera into naive bio.a mice prevented priming of the recipient for a t cell proliferative response to pigeon 81-104, but not priming to the moth synthetic fragment. chimeras of an antigen-specific suppression mechanism involving cd8 positive cells. faculty of medicine, kyoto university, kyoto 606, and department of oncology, nagasaki university school of medicine, nagasaki 852, japan. sera from b6 mice immunized with a syngeneic ctl specific for fbl-3 tumor of b6 origin blocked the cytotoxic activity of only the immunizing ctl clone. therefore, a monoclonal antibody (mab) n9-127 was produced by fusion of the b6 spleen cells immune to a syngeneic fbl-3-specific ctl clone (no. 8). the specificity of the mab n9-127 was confirmed by immunoprecipitation, blocking of cytolytic activity, stimulation of proliferation, and induction of tcr-mediated nonspecific cytolysis of the ctl clone no. 8. in some b6 mice, 3-13% of the anti-fbl-3 mltc cells were positive for this n9-127-defined idiotype, and formed a well demarcated population upon examination by flow cytomehy. even in mice in which no such population was observed some ctl clones established by limiting dilution culture were also positive for this idiotype (10 out of 89 clones from 3 mice). the cytotoxic activities of these ctl clones were blocked by n9-127, which in turn induced the nonspecific cytolysis in redirected assay. however, no positive cells were detected in non-cultured normal or fbg3-immune spleen and lymph node cells. this indicates the presence of cross-reactive (dominant) idiotype in the b6 anti-fbl-3 cytotoxic t cell responses and may provide a potent tool for analyzing the idiotype-mediated regulation of the anti-tumor immune responses. slade andsylvie gillard, max-planck-institut fur immunbiologie, d-7800freiburg, federal republic of germany t cells play a n essential role in t h e protective immune response to malaria and a r e associated with s o m e of t h e pathological consequences of t h e disease. however, t h e n a t u r e of their responses and t h e antigens t o which they respond a r e not well defined. w e have developed a limiting dilution assay system in which specific t cell responses to malaria antigens c a n be monitored a t t h e clonal level. i t is possible to determine t h e nature of t h e responding t cell by t h e growth f a c t o r s they s e c r e t e and by their ability to a c t as helper cells for t h e antibody response to malaria antigens. our d a t a suggest t h a t t h e t cell response changes during t h e primary infection and in hyperimmupe animals. o n e to t w o weeks a f t e r initiation of a blood s t a g e infection t h e major cd4+ t cell which proliferates in response t o parasite antigens s e c r e t e s il-2 and ifn-y but is not a n efficient helper cell for antibody responses. in c o n t r a s t l a t e r in infection and in immune animals t h e r e is an e f f e c t i v e helper cell response and many of t h e s e cells a r e distinct from those secreting ifn-y and il-2. we a r e currently investigating whether these cells retain these phenotypes when grown in long-term in vitro culture and whether defined antigens of t h e erythrocytic parasite elicit different t cell responses. we have localized linear neutralization epitopes on the coronaviruses ibv, mhv, fipv and tgev. the results can be summarized as follows: 1. linear epitopes of the spike proteins (1162-1452 residues) could be mapped to a resolution of a single residue by expression of gene fragments in the prokaryotic pex plasmids and/or pepscan peptide synthesis. 2. the length the epitopes varied from 4 to at least 20 amino acid residues. we present evidence that the larger epitopes, although conformation-independent according to operational criteria, are nevertheless discontinuous. 3 . in ibv, we localized several overlapping but different epitopes within an immunodominant region of 30 residues. this region is recognized by all polyclonal antisera tested. we propose that its immunodominancy is a consequence of its structure and function and does not depend on antigen presentation or idiotypic networks. an immune response against the mouse testis-specific antigen ldh-c4 reduces fertility by 70 percent in female baboons. an immune reaction to human ldh-c4 would be expected to be more effective in primates. since the human testis enzyme is not readily available in large quantities, recombinant dna technologies were uscd to create a source of human ldh-c4. antibodies to mouse ldh-c4 were used to screen a xgtll human testis cdna expression library. a full length human ldh-c clone was identified, sequenced, and the ldh-c cdna was engineered for expression in e.coli. the 5' and 3' untranslated sequences were removed by restriction enzyme digestion, and synthetic linkers were added adjacent to the start and stop codons of translation. the modified cdna was subcloned into the prokaryotic expression vector pkk223-3 and introduced into w3110 l a c iq cells. cells were grown to mid-log phase, and induced with iptg for positive regulation of the strong hybrid tac promoter. induced cells overexpressed the 35 kd subunit which spontaneously formed the enzymatically active 140 kd tetramer. human ldh-c4 was purified 196-fold from liter cultures of cells by two step affinity chromatography to a specific activity of 90 i.u./mg. the 20 n-terminal amino acids sequenced were identical to those predicted from the nucleic acid sequence. antibodies to synthetic peptide epitopes of human ldh-c4 cross-reacted with the enzyme produced in e.coli. two mg human ldh-c4 were expressed per liter of bacterial cells. the purified protein is now available for innunogenicity and fertility studies. it is now generally accepted that the principal effector mechanism in the host's defence against leishrnaniasis is gamma-interferon (ifn-y) which activates infected-macrophage to eliminate intracellular parasites. mice by prior sublethal whole body irradiation or treatment with anti-igm or anti-cd4 antibody. protection can also be induced by repeated intravenous or intraperitoneal immunisation with killed parasites or purified antigens. ly immunised mice produce little or no il-3 or il-4 but substantially elevated levels of ifn-y when stimulated with leishmania1 antigens in vitro. lymphoid cells from balb/c mice with progressive disease can inhibit the maf (macrophage activating factor) and leishmanicidal activities of the culture supernatant of lymphoid cells from mice recovered from l. major infection. maf appears to be ifn-y, whereas the maf inhibiting factors are il-3 and il-4. system can be reproduced with recombinant ifn-y, il-3 and il-4 and the maf inhibiting activity of the suppressive supernatant can be reversed by specific anti-il-3 and anti-il-4 antibodies. the disease by influencing the ability of macrophage to kill the intracellular parasite. the development of efficacious vaccines against malaria requires an understanding of the mechanisms involved in protective immunity. f'revious studies with plasmodium berghei demonstrated that sporozoite immunity is dependent upon antibody responses specific for the repeat region of the circumsporozoite (cs) protein and cell mediated mechanisms involving cd8+ t cells. in this study we analyzed the splenic t cell repertoire directed against epitopes on the cs protein of p. berghei and determined whether sporozoite-immune cd4+ and cd8+ t cells respond to shared or distinct epitopes. sporozoite-immune spleen cells, cd4+ and cd8+ enriched t cell populations of balb/c (h-m), c3h @i-%), and c57bv6 (h-2b) mouse strains were cultured in the presence of irradiated sporozoites or synthetic peptides representing 70% of the complete cs protein. surprisingly, none of the cultures proliferated to any of the peptides tested, although proliferative responses to sporozoites were observed in unfractionated spleens and cd4+ t cell populations. cd8+ t cells did not respond to any of the antigens tested, even in the presence of exogenously added 11-2. titration of cd8+ cells into proliferating cd4+ cell cultures did not suppress the anti-sporozoite response. the lack of anti-peptide reactivity contrasts with uniform responses to sporozoites and may be the result of the context in which cs antigens are presented to t cells. functional analysis of accessory splenic b cells and macrophages revealed that while the anti-sporozoite proliferative responses were not affected by the removal of macrophages, sporozoite-primed b cells were essential for the responses. these data suggest that the cs protein on sporozoites is not processed extensively by macrophages to yield many potential t cell epitopes, but instead is presented by immuncdominant b cells that resmct responses to a limited number of t cell clones. of the primary infection and is also required for optimum protection against reinfection. current studies have demonstrated that relatively few of the viral antigens tested to date ( 7 viral envelope glycoproteins or 2 nonsmctural nuclear proteins) are recognized by hsv-1 immune ctl populations generated in several different strains of mice (h2 haplotypes h2b, h2d. or h2k). this failure of hsv specific ciz to recognize the cloned gene products in in v i m assays was demonstrable at the clonal level and could not be attributed to a peculiarity of the recombinant vaccinia conshucts used because studies with adenovims vectors or tranfected l cell constucts yielded the same results. surprisingly, despite their inability to be recognized by hsv specific ciz in vim, when used to immunize mice several of the vaccinia virus constructs would induce memory ciz populations capable of lysing hsv-1 infected autologous cells. for example, hsv-1 glycoprotein c (gc) was recognized by h2b restricted but not h2k restricted hsv specific ctl. however, immunization of either haplotype of mice with a vaccinia gc recombinant induced ctl populations which upon in v i m restimulation with hsv-1 would lyse histocompatible cells infected with hsv-1. this demonstrates that despite the presence of suitable epitopes (intrinsic factors) the context of the immunogen (extrinsic factors) will also influence it's ability to induce ctl. the results of further studies into the nature of these extrinsic factors will be presented and discussed with relevance to future sub-unit vaccine design. w d ~upponrd by public ~~l t h service g~mu, ai 14981 md ai 24471 fran the ti-^ ~n,litu= md lnrcniour d ,~~~~~~. infection of mice with hsv-1 induces a brisk ciz response which is necessary for the subsequent resolution we have investigated the structural basis for antigen mimicry by anti-idiotypic internal image antibodies. two mouse monoclonal antibodies (mabs) that bear internal images of a well-defined protein epitope, i.e., the rabbit immunoglobulin (ig) a1 allotype, were produced and the variable region sequences were determined by rna primer extension sequencing. the results showed that the mab light chains did not contain any allotype-related residues; however, both heavy chain v regions contained a unique sequence homologous to the nominal antigen but in opposite orientation. this reversed sequence was expressed within cdr2 of both mabs. synthetic peptides corresponding to the putative antigenic regions of rabbit ig and the mab internal images, respectively, were tested for the ability to mimic the al-like determinant. although the homologous residues were presented in opposite orientations, both peptides completely inhibited at similar concentrations the binding of rabbit ig to anti-a1 antibody. a paired thr and clu was necessary for expression of the a1 epitope as revealed by conservative substitutions in the peptide sequence. computer-generated, energy-minimized models of rabbit ig and the mabs revealed that the critical a1 residue side chain placements could be almost superimposable in either context. thus, it appears that an antigenic epitope can be determined solely by md 20892. proliferation of murine type i cd4+ t cell clones quires simultaneous occupancy of the t cell antigen receptor and delivery of an accessory cell-duived costitnulamy signal in contrast, isolated t cell receptor occupancy induces the cell into a state of reduced proliferative responsiveness to antigen. based on the observation that pkc-activating phorbl esters can at times substitute for the p s e n c e of accessory cells in t cell proliferative response. to mitogens or anti-cd3 mnodonal antibodies, we investigated the requkment for accessory cells in the antigen-and con a-induced hydrolysis of p m and activation of pkc. the presence of normal accessory cells was found to be unnecessary for the development of pkc-dependent phosphorylations and the addition of normal accessory cells had no effect on the activity of pkc. cell il-2 synthesis and proliferation presents a paradox. we have studied the effects of ueatment with a calcium ionophore and p h h l ester on t cells and find that increased [ca2+]i and pkc activation are in fact insufficient biochemid second messengers in the induction of proliferation. while pliferation was induced at high t cell density in response. to these stimuli, incubation of t cells at decrrased cell density drmonsuated markedly reduced proliferation, and single t cells failed to divide. this suggested that cellular interactions were. q u i r e d in the response. additions of either il2 or normal accessory cells allowed p l i f d o n at low density, consistent with a requirement for an accessory cell-derived costimulatoq signal in the induction of i l 2 synthesis, even in the plifcrative response to ionomycin and pma. this result underscons the importance of an accessory cell-duived costimulatory signal, acting independently of t cell receptor-mediated increases in [caz+] i and pkc activation, in the induction of t cell proliferation. we describe experiments designed to determine the molecular requirements for recognition by fluorescein-specific ctlps and ctls derived both from n a i v e and from immunized mice. we the production of prostaglandin e, a major immunesuppressor secreted by the macrophages was inhibited by the addition of 0.1 m indomethacin to the cultures of monocytes harvested from patients suffering from pulmonary tuberculosis and those from equal number of normal controls. the il-i activity was estimated i n the supernatants of these cultures by their ability to proliferate mice thymocytes. it was found that the supernatants from cultures with indomethacin showed a greater il-i activity than the ones without it(44% p 0.001). this indicates the possibility of pge offering a negative feedback control over il-i production. the defective cell mediated immunity i n patients with pulmonary tuberculosis may be explained through the inhibition on il-i production by pge whose enhanced production is reported i n our earlier studies. the results and our hypothesis on the autoregulation of il-i production w i l l be presented and discussed. in variant viruses which differ from the parental virus (gv) at specific epitopes recognized by monoclonal antibodies directed against the env gene product, gp70. biological clones isolated from gv express the gv phenotype suggesting that the loss of specific epitopes is the result of selective de novo processes in the immunocompetent host. additionally, inoculation of adult mice with a biological clone expressing the gv phenotype also results in similar variant viruses. however, inoculation of gv into neonatal or nonlethally irradiated mice results in a population of viruses expressing only the gv phenotype suggesting that the emergence of antigenic variants may be influenced by neutralizing antibodies and/or cellular host res sds-page analysis of immunoprecipitates of sg~s~~,elled lysates of fibroblasts infected with clones expressing gv or variant pehnotypes shows a size difference of the gp70 precursor. additionally, the recognition of a neutralizing epitope (e-55) associated with gp70 by mab55 is dependent on the appropriate native conformation of the epitope which appears to require glycosylation for expression. experiments are in progress to further examine the immunogenetic basis for the generation of these variants and to determine the molecular changes in the virus genome responsible for changes in epitope expression. investigated the capacity of murine splenict cells depleted of acceso cells ( ac ) t o proliferate in response t o stimulation by con a, @ cd3 ab and activated t cells. the zepletion procedures consisted of carbonyl iron treatment, 2x "panning " on anti-ig coated flasks, 2x anti-la cytotoxic treatments and percoll gradient purification of small resting t la-cells. the appropiate concentration of con a (10 ng/ml ) and plastic-bound (pb) @cd3 lg or its f (ab)' 2 fra ments induce proliferation, 112 r expression and 112 (but not 114 secretion in t la-cellscultured for 48% at 5x105 cells/well . responsiveness of tlacells t o con a and dcd3 in low density cultures (5x104 cells/well) is restored by the addition of irradiated th2 cloned cells but not thl ,splenic cellsor r l l l + rll2 + r114. likewise, responsiveness t o non activating doses of con a (lnglml) or soluble @cd3 is restored by the addition of irradiatedth2 costimulatory cells . these experiments demonstrate that the ability of t cells t o proliferate in the absence of ac is critically dependent on t-t interactions. t cell subsets prepared by either negative (l3t4-and ly2'cells) or positive selection proliferate in response t o pb @cd3 lg . although the proliferative responses of both l3t4-and ly2-cells are maximal at 48h, the l3t4-cells require l o x more pb @cd3 lg for maximal stimulation and their res onses decline much faster than those of ly2cells. in addition, l3t4-cells are not stimulated by pb &cd3 f(ab)'2 fra ments and their responses t o @cd3 i are inhibitable by anti fcr as well as anti-lfa abs . re onsesof%oth l3t4-and ly2-cells are !nhibita%le by @i12 and @i12 r abs but not by @l3t4, @ly2 or b l l 4 . these experimentsdocument interesting differences in the triggering requirements of l3t4-and ly2 'cells. supported by nih grants po1 ca 19266, t 326m-07183 and gm 07281. the 19k glycoprotein encoded in the e3 region of ad2 and ad5 (gpl9k) binds to class i mhc antigens in the endoplasmic reticulum and prevents their translocation to the cell surface. this has been proposed as a mechanism by which virus infected cells can avoid recognition by the host cytotoxic t lymphocyte (ctl) response. we have shown that gpl9k can inhibit target cell lysis by adenovirus specific ctl, but the effectiveness of this inhibition varies greatly between different mouse strains. this is due in part to differences in the affinity of gpl9k for different mhc class i molecules, but this cannot account for a l l the variation observed. i t has been shown that cd4+8+ immature thymocytes fail to secrete il-2 or express il-2 receptors in response to activation signals. furthermore. they cannot induce il-2 gene transcription. several tumor lines have now been characterized which have a cd4+8+ phenotype and fail to secrete i l -2 or express il-2 receptors in response to stimulation with ionomycin plus pma. these cells also do not express il-2 mrna after stimulation, as determined by northern blotting and rnase protection. to determine the molecular mechanism for this lack of transcriptional activity, nuclear extracts were analysed for the presence of the d n a binding factor nfat-i. this nuclear factor i s present only in ac we have undertaken an mhc analysis using the polymerase chain-reaction (pcr) and dot blot analysis of the amplified lyme arthritis patients dna with allele specific oligonucleotide (aso) probes. genomic dna for the first domain of the dq beta chain and of the dr/pi from 20 patients with lyme arthritis has been amplified and we are analyzing the distribution of dridrr and w a l l e l e s in this population to test the hypothesis that the mhc class i1 genes might be involved in presentation of selected spirochete epitopes whose recognition by t lymphocytes leads to lyme arthritis. most inbred strains of mice do not respond to porc insulin (pins). experiments were conducted to elucidate the mechanism of the non-responsiveness in h-zk mice: 1) purification of cd-4' t c e l l s from pins-immune b1o.mbr mice revealed pins-specific t helper (th) cells, 2) these pins specific th cells could be activated by i-ak and i-ek expressing l929-fibroblasts. therefore, both i-ak and i-ek molecules can present pins in an immunogenic manner and activate pins-specific th cells. by means of different cell-fractionation procedures, it was found that antigen-specific t suppressor (ts) cells regulated the pins immune response. these ts cells were of the fcr-, cd-4-, cd-8'. thy-1' phenotype, and they were present in normal mice. we believe that these experiments indicate that antigen-specific ts cells exist and are important regulators of immune and autoimmune responses. the possibility of functional inactivation of cd4+ clones by ts-cells was investigated. m leprae-responsive cd4+ clones were preincubated with ts cd8+ clones, apc and antigen for 1 ; hours. after which the cd8+ cells were removed from culture. the cd4+ clones were then restimulated with e. leprae and apc. cd4+ clones incubated with cd8+ cells and antigen were unresponsive to restimulation by antigen, although they were not killed and could respond well to il-2. addition of il-2 in the preor post-incubation culture neither prevented the induction of unresponsiveness nor reversed it. earlier models of tolerance have suggested that receptor occupancy in the absence of second signals induces tolerance in b-and t-cells. we would suggest that in the presence of ts-cells. a second signal may be negated leading to th-cell unresponsiveness. university of texas southwestern medical school, dallas, tx 75235 graft versus host disease (gvhd) poses a serious threat to the survival of patients with bone marrow transplants. the state of immunosuppression established in gvhd results in a variety of immunological abnormalities at the humoral and/or cellular level. we have developed a murine model of chronic gvhd across a minor histocompatibility (mh) barrier. in this model, immunosuppression develops. spleen cells from mice undergoing this type of gvhd are unable to respond to the polyclonal activators lipopolysaccharide and concanavalin a . however, the response against the b cell leukemia bcll remains intact. the protective immune response against bcll is directed towards the mh antigen h-40 and is mediated by cytotoxic t lymphocytes. thus, the specific t cell response against a mh antigen can occur in the presence of chronic gvhd despite the absence of a polyclonal b and t cell response lymphocytic choriomeningitis virus (lcmv), a member of the arenavirus family, has a biseqmented rna genome which encodes at least three polypeptides. the smaller rna segment encodes two virus structural proteins, the slycoprotein (gp) and the nucleoprotein (np). upon infection of mice with lcmv a cytotoxic t cell immune response directed against these proteins is measurable in vitro and in vivo. it can be demonstrated that depending on the haplotype of the mice, one or the other protein may play a major part in the immune response. in order to define the immunogenic epitope(s) of the nucleoprotein which are recognized specifically by the t cell receptors of cytotoxic t cells, stepwise 3 ' truncated qene fraaments encodina the nucleoprotein were cloned and expressed in vaccinia virus. with these recombinant vaccinia viruses, protection experiments in mice aqainst lcmv infection were performed in parallel with in vitro studies, namely specific recoonition of target cells expressing truncated fragments of the nucleoprotein by lcmv primed spleen cells. cdna clones encoding the mouse and human t cell il-1 receptors have been isolated and expressed in mammalian cells. the recombinant receptor binds il-1 indistinguishably from the natural il-1 receptor, and is functional in signal transduction. deletion of the cytoplasmic portion of the receptor abolishes its signal transduction abilities. sequence and secondary structure analysis suggest that the cytoplasmic segment of the il-1 receptor binds a nucleotide. experiments designed to test this hypothesis and to examine the mode of signal transduction will be presented. also to be discussed are the mechanism of triggering of the receptor by il-i. and the nature of il-1 receptors expressed in other cell types such as b cells. it became evident that these subsets reflect different stages of helper t cell maturation before and after activation. therefore, these t cell subsets have been designated as naive t cells (cd45r/2h4+, cdw29[4b4]-) and memory t cells (cd45r/2h4-, cdw29[4b4]+). we analysed the expression of these antigens in dermal lymphohistiocytic infiltrates from different benign skin diseases and cutaneous t cell lymphomas (chronic contact dermatitis (n=14), parapsoriasis en plaques (n=5), lymphomatoid papulosis (n=4), mycosis fungoides (n=15), sezary's syndrome (n-2), pleomorphic t cell lymphoma (n=6) and high grade t cell lymphomas (~4)). in almost all cutaneous t cell infiltrates memory t cells were preferentially found whereas in the peripheral blood both subsets are equally distributed. this implicates, that t cells infiltrating the skin already have had contact with their respective antigen. where the switch from naive to memory t cells takes place can not be answerded by our findings, as we have investigated rather longstanding skin diseases. however, these memory t cells, which can be activated more easily, make diseased skin more e f f e c t i v e in the nmdlification of an immune resnonse. organs and after several days of stimulation with antigen or mitogen and lymphokines. we find that fresh th synthesize and secerte -iu,ifng,il3 and gmcsf but very little il4 or il.5 within 24-48 hours. this pattern resembles the pattern of lymphokines secreted by thl cell lines. the th responsible for this secretion are cd4 positive t cells which are long-lived since they disappear very slowly following adult thymectomy. they are also sensitive to the in vivo administration of ats(antithyrn0cyte serum) and they express high levels of pgp-1. the kinetics of lymphokine secretion and the phenotype of the cells suppon the hypothesis that lymphokine secretion from fresh lymphoid cells comes from a population of memory cells. in contrast we fmd that we can also stimulate a separate, ats-resistant population to become lymphokine-secreting cells after four days of in v i m priming.these primed cultures rapidly synthesize an secrete large amounts of i u and il5 in addition to ifng , il3 and gmcsf( a phenotype which could be combination of both thl and th2 helpers), when they are restimulated with ag or mitogen. the cells whic are responsible are cd4 positive and have a shorter liespan since they decline considerably after adult thymectomy. we suggest that the lymphokine secreting cells detected after priming come from a population(s) of helper t cell precufiofi which have differentiated to become effectors. this generation 0: effectors requires lymphokines, especially e-4 andlor ilz and apcs. thus the development of helper th appears to follow a similar pathway as that of cells of the b cell lineage developing into ab-secreting cells and cd8 positive t cells which develop into cytotoxic effectors from precursors. we have studied the secretion of lymphokines by helper t cells freshly obtained from lymphoid interleukin-2 production by t cells has been shown to be required for both humoral as well as cell-mediated imune responses. thus, il-2 production was measured in syphilitic rabbits as a function of their imune response. maximal il-2 production induced by con a at 10-14 days post-infection was only l/2 that observed for uninfected rabbits and this correlated well with a decrease in t cell proliferation ( < 35% that of normal rabbits) upon stimulation with con a . this decrease in il-2 production in infected rabbits was restored upon removal of most of the adherent cells. furthermore, the il-2 production by 10-14 day infected spleens was restored above normal levels upon addition of indomethacin. this decrease in il-2 levels was not due to an increase in the ability of infected spleen cells to adsorb il-2. finally, studies assessing il-2 production at various times postinfection indicated that at 4 days post-infection il-2 levels were higher than normal, however as early as 10-14 days after infection il-2 levels decreased below normal levels and continued to be depressed as late as 30 days post-infection. these results may explain why all organisms are not eliminated during primary infection w i t h ' . pallidum and why secondary and tertiary phases of the disease may develop. has been shown that especially the antigenic presentation of the fusion protein is important for eliciting a functional immune response. to study the immunolo ic properties of the f protein, we expressed the f gene in e.coli as a $galactosidase-f-fusion protein after insertion in a pex vector. we constructed deletion mutants with fragments generated with restriction enzymes and with the polymerase chain reaction method. using a panel of monoclonal antibodies a rough epitope mapping has been performed. two arears were found on the protein, with one area two monoclonal antibodies react and with an other area four monoclonal antibodies react. both area's were found in f1, the c-terminal part of the protein. the pepscan method was used to fine map the epitopes of the monoclonal antibodies reacting with the second area on the primary sequence. in at least one viral system, cd8+ effector cells can be induced in animals lacking cd4+ t cells. since cd8+ effector cells are important in immunity to malaria sporozoites, we wished to know if they,too, could be generated without help from cd4+ cells. we depleted balb/c mice of their cd4+ t cells by injection of an anti-cd4 monoclonal antibody, and then tried to immunize them with irradiated plasmodium yoelii sporozoites. when challenged with infectious sporozoites, these mice were not protected against malaria infection. although they did not make antibodies to sporozoites, passive transfer of hyperimmune serum into these animals still did not protect them against a sporozoite infections. cd8+ t cells from these animals functioned normally in in vitro assays against tnp labelled targets. it appears that, unlike viral systems, the generation of cd8+ effectors in malaria requires cd4+ helper cells. thus both cd4 and cd8 epitopes should be included in any synthetic vaccine against malaria sporozoites. univ. pennsylvania, philadelphia, pa 19104 migrate from fetal liver or bone marrow. rearrange t cell receptor (tcr) genes, express tcr. undergo thymic selection and finally emerge as mature single positive t lymphocytes. most studies of thymic t cell development have been performed by using polyclonal populations of t lymphocytes, which have made the interpretation of the results complicated. cells (0 clone) from nude mice by culturing nylon wool non-adherent cd4-cd8-spleen and lymph node cells in the presence of wehi3 supernatant and con a supernatant. clone was thy-1-cd3-cd4-cd8-il2r(il2 receptor)-and they have been maintained more than 16 months without changing phenotype. when the c9 clone was stimulated with il4. ili/il2. illnl6. gm-csf, the cells were induced lo express thy-i, tcr and il2r proteins. however, culture of the cells with gm-csffll2 did not induce the expression of these molecules. southern blotting of the dna isolakd from gm-csffll2 culture suggested that they have undergone partial db 1 -jp 1 rearrangement. the cultured cells were then recloned twice by limiting dilution. the cloned cells were again shown to induce expression of cd3 complex by the stimulation of il4 enriched medium. therefore. we have established a system in which to induce differentiation of cloned pre t cell line into tcr+ cells in vitro. the human lymphocyte differentiation antigen cd8 is encoded by a single gene which gives rise to a 32 kda glycoprotein expressed on the cell surface as a dimer, and in higher molecular weight forms. we demonstrate that the mrna is alternatively spliced such that an exon encoding a transmembrane domain is deleted. that is secreted and exists primarily as a monomer. messenger rna corresponding to both forms is present in peripheral blood lymphocytes,(pbl), con a activated pbl and three cd8+ t cell lines with the membrane form being the major species. ratio of mrna for membrane cd8 (mcd8) and secreted cd8 (scd8) exist. in addition, the splicing pattern we observe differs from the pattern found for the mouse cd8 gene. this mrna is also alternatively spliced, but an exon encoding a cytoplasmic region is deleted giving rise to a cell surface molecule which differs in its cytoplasmic tail from the protein encoded by the longer mrna. neither protein i s secreted. this is one of the first examples of a different splicing pattern between two homologous mouse and human genes giving rise to very different proteins. this represents one mechanism of generating diversity during speciation. cd4' t cells in the rat can be divided into two non-overlapping subsets by theii reactivity with the monoclonal antibody mrc ox-22 which binds some of the high molecular weight forms of the cd45 antigen. recent work, to be described has shown that the two subsets represent different stages of t cell maturation, with distinct t cell functions. the lymphokine repertoire of the memory t cell pool will be discussed with reference to the antigenic environment fmm which the cells are obtained. pancreatic islet allografts, gill, ronald g. and lafterty, kevin j., barbara davis center for childhood diabetes i univ. colo. health sciences center, 4200 e. 9th ave, box b-140, denver, co. 80262 we studied the cellular interactions requkd for the rejeaion of cultured mhc class i-dispiuate islet allografts. this model was suitable for studying t-t collaboration in that islet allograft immunity is cd4 dependent but rejection of the cultured islet graft is mediated by the cd8 cell. recipient c57by6 (b6) mice were grafted with mhc class idisparate b6.c-h-2bml (bml) islets beneath the mal capsule. islet grafts wen preaated for 7 days in 95% oxygen culture to reduce immunogenicity. thirty days after grafting, recipient mice wen immunized with 1oe6 live spleen cells from the strains indicated below. rejection of the established graft was not trig-by challenge with donortype bml spleen cells, indicating that the mhc class i stimulus was insufficient to initiate all@ immunity. further, immunization with a mixture of 1 m bml and 1oe6 mhc class ii-disparate b6.c-h-2bm12 (bml2) spleen cells failed to trigger host immunity. however, challenge with loe6 (bml x bml2)fl spleen cells t r i g g d acute rejection of the established bml islet grafts. the requirement for l i i presmtatidrecognition of class i and class 11 all* antigens to trigger allograft immunity indicates that the antigen-presenting (apc) plays an essential role for t-t collaboration in vivo. uature hla-dr complexes are purported to spontaneously internalize from and recycle to the plasma membrane of b but not t lymphocytes. using a neuraminidase protection assay, we have radiolabeled surface class i1 antigens on intact cells and cultured these cells under conditions which permit or prevent endocytosis; subsequently, surface glycoproteins on viable cells were desialylated and class i1 molecules were analyzed by iamunoprecipitation and two-dimensional gel electrophoresis. a panel of buman b lymphoblastoid cell lines and activated tonsillar b cell blasts failed to exhibit any internalization of class i1 complexes; control transferrin receptor molecules were endocytosed as ascertained by insensitivity to neuraminidase digestion. class ii+ pba blasts and sezary cells of the t lineage were also deficient in detectable hla-dr internalization. results did not vary regardless of the time allowed for efficient endocytosis (1251 ok 3~saethionine). or the addition of anti-class i1 monoclonal antibody during the chase period for endocytosis. therefore. within the limits of sensitivity of this assay, class 11 complexes do not appear to be internalized, either spontaneously or uben crosslinked by antibody. recycling represent a dynamic pathvay for regulating surface expression of class i1 antigens or a means of associating with and presenting foreign antigenic peptides. supported in part by usphs grants #5 t32 cao9058-14 and #5 eo1 a123081-03. in previous studies of antigen-specific t cell responses in two distinct models of autoimmune tubulointerstitial nephritis (tin), viiia villosa lectin binding (vv+) t cells have been shown to be necessary for effector t cell expression and mediation of tin. in anti-tubular basement membrane disease, antigen-specifi vv+ t cells direct the phenotypic selection of cd8+ nephritogenic t cells in susceptible mouse strains (j. immunol. 141, nov. 1,1988) . this function is mediated by an antigen-binding, i-js+ soluble protein factor. current studies investigate the role of the t cell glycoprotein which binds vv lectin in mediating w+ t cell function. using the previously described effector t cell induction assay, we found that n-acetyl-d-galactosamine (galnac) (at 25 mm but not 2.5 mm) inhibits vv+ t cell function and cd8+ effector t cell selection. when cd8+ effector t cell differentiation occurs in the presence of soluble factors derived from antigen-primed vv+ t cells, galnac is not inhibitory. these studies suggested that soluble gal nac may competitively bind to a soluble protein which stimulates vv+ t cells, in part by binding to the w lectin receptor, to synthesize andlor secrete their biologically active soluble factor. as an additional test of this hypothesis, we prepared detergent solubilized membranes from vv+ t cells and purified vv lectin binding proteins by affinity chromatography. like galnac. these membrane derived lectin binding proteins also inhibit vv+ t cell function and cd8+ effector t cell selection. inhibition by soluble 'lectin receptors' is dose dependent and is demonstrable with lectin binding glycoproteins derived from 15-20 x lo6 cells, in an assay utilizing 10 x106 vv+ cells. we are now further characterizing the lectin receptor and its endogenous ligand. elementary bodies and outer membranes of chlamydia trachomatis produce a high-titered igg response in rabbits and mice as measured by elisa and microscopic immunofluorescence assays. western blot analysis of total elementary body protein identifies a 40kd major outer membrane protein (momp) as the predominant antigen. to identify the cbmical structure of the epitope, purified momp was subjected to chemical and enzymatic fragmentation and the resulting peptides were purified by hplc and assayed for immunoreactivity. an immunoreactive 6kd cyanogen bromide peptide was amino-terminal sequenced and a series of overlapping synthetic peptides were synthesized and assayed for immunoreactivity. sequential single amino acid deletions at both the nhz and cooh termini allowed us to identify the precise epitope as a 12 amino acid peptide spanning residues 291-302 of momp. two amino acid substitutions at positions 293 (phe-gly) and 300 (pro-gly) completely eliminated antibody binding. the 12-amino acid synthetic peptide is a potent immunogen producing high-titered antibody responses that are specific for the momp molecule. analysis of an independently derived mutant harboring the same defect has shorn that this trans-acting gene is not required for transport of class i1 molecules. class i heavy chain is synthesized in this cell line and associates with b2m. transport of the class i appears to be blocked in the er or cis4olgi as the majority of the class i glycoproteins are not processed to the endo b resistant form. the ability of the cell to significantly increase expression of surface class i when the incubation temperature is lowered from 37oc to 22oc suggests that this gene may function to stabilize a particular conformation of the protein. consistent with this is the increased sensitivity of class i molecules in the mutant as compared to the parent to degradation when cell lysates are incubated at elevated temperatures. the inability to immunoprecipitate class i antigens in the mutant is possibly due to the action of endogenous proteases present in these lysates. two complementing approaches are being employed to isolate this gene and further analyze its role in class i biosynthesis. the first involves inactivation of the trans-acting gene by insertion of a retroviral vector and subsequent pcr amplification of regions flanking the vector. in another approach a cdna library will be introduced into the mutant cell line and the cdna will be reisolated from cells reexpressing surface class i. houston. tx. we have induced a panel of highly immunogenic (imm+) vanants of the murine fibrosarcoma mca-f using i-methyl-3niml-niuasoguanidine (mnng). 5-aza-2'-deoxycytidine (5-azacdr). and uv radiation. these tumors grew m immunosuppressed mice. but were complelely rejecled by normal syngeneic hosts. mice thac had rejected large numbers of imm+ also developed a smng, tumor. specific immunity to the parental mor. lmmunizalion with low numbers of lmm+ engendered only variant-specific immunity. the frequency of imm+ variant g e n e d o n was similar for the three induction different protocols (64% to 92%), suggesling lhat generauon of imm+ was more closely relalcd to the cell line used than to the inducing agent however, the swngth of the imm+ phenaypc was related lo ihe agent used, since mnng induced clones had the m g e s t immunogeniciues and uv-b ihe weakest the smng neoantigens expressed by mnng induced imm+ were varunt-sppifc. while uv and s -d d r induced clones displayed significant cross-reactivilies not attributable to the parental t u n a antigen. increased or inappropriate expression of class-l mhc antigens did not correlate with the imm+ phenotype. we investigated the phenotypes of the spleen cells medrating tumor rejccuon using the local adopllve lransfer a s a y (lata). variant-specific immunity w mnng, 5-azacdr and uv induced imm+ were all m d a t c d by thy1.2+. l3t4+. lyc2.1-t cells. afrw immunization with high numbers of imm+ w engender both anti-lmm+ and anu-parental immunity. both cd4+ and cdw effectors rejecled the imm+ in lata, while only ihe c w + t cells could wnsfer resistance w the parent immunity 10 the parenlal tumor anugen engendered by the imm+ suggeslcd associative recognition of the parental and neoantigem wgelher on ihe cell surface. this hypochfsis was supported by failure of lmm+ u) pmlect againu an antigenically disunct tumor (mca-d) admixed with it, either at the lime of immunization or at challenge. fusion of ihe h m * vanant with mca-d yielded a unique, hybrid parental umor antigen that was associatively recognized with rhc original imm+ neoanugen, demomirating the importance of antigen cocxpression. grant rr-5511-23. w e have recently demonstrated and reported that substitution of anionic side chain carboxylic groups with aminoethylamide groups on protein antigens exhibits a pattern of enhanced immunogenicity both in vivo and in vitro. this enhanced immunogenicity was also observed in low responder strains of mice and we investigated the mechanism by which it is achieved. we examined antigen processing and presentation of native (nbsa) and modified bsa (mbsa) to t helper c e h isolated from c57/bl low responder mice. a greatly reduced amount of mbsa than nbsa was required to activate both nbsa and mbsa primed th. proliferation of nbsa and mbsa primed t cells increased in proportion to the amount of time of exposure of the antigen presenting cells (apc) to nbsa, peaking at 8h. conversely, apc required less than 30 min exposure to mbsa to achieve optimal activation, indicating rapid uptake of mbsa. paraformaldehyde fixed apc recognized mbsa without a lag phase processing, indicating that this event also occurred quite rapidly. apc processed nbsa w a s presented to primed t cells more effectively than the soluble antigen m shown by the increased rate of t cell proliferation. in contrast, mbsa was equally well presented to th cells by apc m in soluble unprocessed form. our data demonstrate that the reduced response in low responders is greatly enhanced by a modified antigen which is rapidly taken up and processed by apc. b cells which bear surface innunoglobulin (sig) receptors specific for a particular antigen are abile t o present fragments of that antigen very efficiently t o t cells. this i s due. in part, t o the high affinity of the receptor, which facilitates antigen binding at low concentrations. using tnp-abc and specific antigen, we have demonstrated that the tnp-abc process antigen very effectively. w e have compared specific antigen with i t s polyclonal analog, anti-ig, and demonstrated differences in the kinetics of degradation of anti-ig and tnp-antigens by tnp-aex. both antigen and anti-ig bound by tnp-abc are degraded into small fragments which are released into the supernatant. however, the following differences have been found: 1) the rate of release of small fragments of tnp-antigen parallels the rate at which these cells become able to directly conjugate with t cells (a lneasure of antigen presentation), reaching a plateau between 4 and 6 hours. in contrast, the degradation of anti-ig and release of fragnents continues for 12 hours. 2) analysis of initial kinetics demonstrated that release of fragments of tnp-antigen begins 15 minutes after binding; there i s no significant release of anti-ig fragrnents u n t i l about 30 minutes. 3) in contrast to anti-ig where there i s significant accumulation of degradation intermediates within the cells, there i s very l i t t l e intracellular accumulation of intennediate-size fragments of tnp-antigen. thus, we propose that the processing of antigen bound via specific sig may involve a specific intracellular pathway and that intracellular routing may be determined either by the degree of cross-linking of sig induced by antigen vs anti-ig or the mode of interaction of the various ligands with sig. alt*, departments of biochemistry (*) and medicine (+), college of physicians and surgeons of columbia univerity, new york, new york 10032. we have recently analysed the structure of the 7 / 6 t cell receptor (tcr) expressed by the normal human thymocyte clone cii. cii expresses a c ' 2 constant region that is a polymorphic form lacking a copy of an izternal exon; the sequence of this constant region accounts for the size of the 7 chain and noncovalent linkage of 7 and 6 chains in the cii tcr. in order to elucidate its role, this 7/6 tcr will be reconstituted in immortalized t-cell lines. in addition, the productively rearranged human 7 / 6 receptor will be transgenically introduced into mice in order to assess the effect of the complete receptor on the development of t cells. the humoral immune response to human immunodeficiency virus has been shown to contain antibodies which act to mediate the uptake of virus through fc receptor mediated mechanisms. it is therefore possible that vaccination with the entire envelope polypeptide may present immunologic determinants that enhance infection. one means by which to generate an immune response to hiv that shall possess neutralizing activity in the absence of infection enhancing activity is to generate anti-idiotypic abs that bear the internal image of neutralizing human antibodies directed against hiv. we affinity purified human antibodies from hiv+ patients on a viral lysate column. we have produced 15 monoclonal anti-idiotypic antibodies directed against these abi's. two of these monoclonals were shown to he ag inhibitable by their ability to inhibit the binding of p o l y e l o n a l human antisera to hiv viral lysate on ortho hiv ab t,est, wells. one monoclonal, 0 b 0 , when coupled t.o klh and used to immunize mice, produced an abs that. bound to viral lysate in an elisa assay. an affinity column containing rbs was used to purify an abi that was shown to bind to p24 and p17 hy western blot analysis. these data suggest that 8br may be a potential vaccine candidate. we have recently described a transgenic mouse model which co-expresses the tcr u and fl chains from the 2c cell line (recognized by the 1b2 anti-clonotype). t celh bearing the transgenic clonotype are positively selected by elements of the h-zb mhc for expression on cd8' cells. thus in the periphery of h-zb animals 40-80% of the t cells are 1bz1/cd8*. the same peripheral expression is observed when the transgenes are expressed in f1 animals bearing a "neutral" mhc haplotype (eg. h-zb'*). however, when the transgene hi expressed in f1 animals which also express the h-2ld gene product, negative selection occurs by clonal deletion. however, this deletion is functional rather than structural as the 1b2 clonotype is present on 10-40% of peripheral t cells. these cells are unusual in that they express neither of the characteristic peripheral molecules cd4 or cd8. the absence of cd8 expression on the 1b2* cells appears to allow these potentially self-reactive clones to exist without evidence of autoimmunity. the original clone as well as 1b2+/cd8+ cells from h-2b animals are strongly inhibited by anti-cd8 reagents. in an effort to understand the process of negative selection and self-tolerance we have examined the capacity of these cells to be activated directly by the anti-clonotype rather than antigen (h-2ld). the results demonstrate that the clonotype is fully functional on these double negative cells, indicating a normal maturation in the thymus. further examination of their surface phenotype also supports the conclusion that these are fully mature cells which are phenotypically distinct from double negative cells which exist in the thymus of h-2b animals. of imunohematology. azl, leiden, the netherlands;2praxis biologics, rochester, new york, usa and 'university of southampton, uk. immunity to disease caused by neisseria menineitidis is associated with the presence of bactericidal and opsonic antibodies to the capsular polysaccharide (cps), lipopolysaccharide and to outer membrane proteins (omps). the cps of group a and c meningococci are proven efficacious vaccines, although the immunogenicity in infants is poor and the immunity is of short duration. the combination with t-helper epitopes will certainly improve the immunogenic properties of these t-independent (ti,) antigens. the group b cps is poorly immunogenic in humans probably because of tolerance due to structural similarity to host glycopeptides and/or glycolipids. we have focused our research onto the class 1 omps which show limited heterogeneity amongst meningococci. murine monoclonal antibodies to these proteins are highly bactericidal in vitro and will be used to map b-cell epitopes. t-epitopes have been identified by theoretical prediction of immunodominant sites by analysis of the amino acid sequence of the omp followed by their solid phase synthesis and subsequent testing for polyclonal activation of t-lymphocytes obtained from hl4-typed volunteers immunized with the omp. in addition human t-cell clones are generated with omps and maintained with antigen, ebv-transformed b-cells, fresh feeders and ril2. the clones are tested for antigen specificity, io vitro helper function, mhc restriction element, expression of surface markers and recognition of common meningococcal t-cell epitopes. c 642 demonstration o f p-azobenzene-arsonate-l-tyrosine (aba-tyr) speclfic t cells in low responder h-26 mice by il-1 supported t cell proliferatlon previous studies have shown that h-zb mice immunized with aba-tyr fail to produce aba specific delayed-type hypersensitivity and show little or no t cell proliferation in vitro to aba-tyr. these observations suggest that h-zb mice are deficient in th1 cells that respond to aba-tyr. by contrast, immunization of h-2b mice with tnp conjugates of aba-tyr revealed good cognate help, suggesting that these mice do possess aba-tyr specific th2 cells and that such cells are not revealed in conventional lymphoproliferative assays. because such assays are widely used to evaluate ir gene control and to map t cell epitopes, the databases generated from such studies may seriously under represent the total number of responder phenotypes and t cell epitopes. because of this concern, we established culture conditions that wlii support aba-tyr specific t cell proliferation in h-2b mice. in these studies, c57bu6.l mice were immunized s.c. with aba-tyr and 7 to 14 days later the draining lymph nodes were cultured with varying doses of aba-tyr or with varying doses of aba-tyr and varying doses of recombinant il-1 alpha (rll-la), a known costimulator of th2 cells. culture with aba-tyr alone produced no proliferation. by contrast, culture with aba-tyr and rll-la revealed t cell proliferation that titrated with the dose of aba-tyr and the dose of rll-la specific for conalbumin presented on ryngeneic antigen presenting cells and dependent on il-1 for its proliferation, was used a s an indicator cell for the ability of neonatal murine spleen cells to present antigen and produce il-1 and il-2.the antigen presenting capacity of neonatal spleen cells is low. during antigen presentation there is an augmentation of il-1 and il-2 production by the antigen presenting spleen cell population. however, neonatal spleen cells do not respond as well a s adult cells. the low levels o f il-1 can not be attributed t o a low potential for producing il-1 since neonatal cells produce high levels of il-1 after induction by a crude il-1 inducer factor (il-1-if).the this impairment leads t o a decreased stimulus of the 1-helper cell to produce inducer factors which leads t o low levels of il-1 and il-2 production by the neonatal cells during antigen presentation. no suppressor mechanisms responsible for the l o w interleukin production were detected. human or murine class i genomic dna was transfected into a b-lymphohlastoid x t-lymphoblastoid hybrid cell line. this fusion hybrid has lost both t cell derived copies of chromosome six and contains deletions spanning the class i1 region on both copies of chromosome six derived from the b-cell parent. previous data have described a transacting factor within this region that is responsible for class i antigen expression. hla-bw58 and b7 glycoproteins, although synthesized, were not transported to the plasma membrane in the hybrid. were surface expressed. these data suggest a fundamental difference between human and mouse histocompatibility antigens in their requirements for intracellular transport. the role of glycans in this transport dicotomy is currently under investigation. in addition, hybrid human-murine genes are being used to identify regions of the class i molecules involved in this transport phenomenon. we probed t h e means by which t h e a n t l g e n p r e s e n t l n g c e l l (apc) handles t h e a n t i g e n produce p e p t i d e s t h a t bind t o mhc-molecules. we propose t h e e x i s t a n c e o f a new type o f i n t e r n a l image i n which immunoglobulin v-region peptides. formed by processing, imitate peptides from conventional a n t i g e n s . w e r e f e r t o such denatured i n t e r n a l images as r e s i d u e internal images, since t h e y a r e a s s o c i a t e d w i t h t h e r e s i d u e of p e p t i d e s remaining a f t e r processing. in some cases, r e s i d u e internal images may be actual sequence images, i . e . , the v-region sequence m y be i d e n t i c a l t o the conventional a n t i g e n sequence.to be class i h-2ka-restricted cytolytic t lymphocytes (ctl) are directed against two immunodominant sites on the a/jap/305/57 influenza hemagglutinin (ha) that can be mimicked by synthetic oligopeptides spanning residues 202-221 in the ha1 and 523-545 in the hydrophobic, transmembrane region. analysis of the fine specificity of hal-specific ctl clones demonstrated that these ctl clones can be subdivided into at least two group based on their patterns of recognition of closely related influenza h2n2 field strains and a monoclonal antibody derived variant of a/guiyang/4/57. using a series of nested synthetic peptides spanning the 202-221 region, the minimal amino acid residues necessary for recognition by the two groups of ctl clones were defined and found to consist of two separate but overlapping sites. sequence comparison of the ha of the a/jap/305/57, the influenza field isolates and the monoclonal antibody derived variant has identified two amino acids, asn at position 207 and gly at position 215, that are critical for t cell recognition. thus, animo acid substitutions induced either by antigenic drift or by monoclonal antibody selection can affect class i ctl recognition. pretreatment with a n t m e s reactive with class 11 mhc anti-has previously been reported to be successful in exov~~kj a n t i g e n -w i r q dendritic cells (m) fran rodent tissue grafts. we have extended these exper-to inta? whole organ grafts. ilia pnmxses also demcnstrated a prolonged survival (17 f 2 days) ccapared to controls (11 t 1 days) (p < 0.01) tihen v l a n t e d into streprozatocin treat& da recipients. antigenic variation in the haemagglutinin (ha) of influenza a viruses frequently introduces new oligosacchekide attachment sites ( aan-x-serlthreo) and carbohydrate addition prevents antibody recognition by steric hindrance. acid substitution in mutant viruses of the h3n2 subtype (ha1 63 asp+asn), that introduces an n-glycosylation site (hn6gcys6&thr65), abrogates antibody and cd4+ t recognition. infected with x31 virus recognise a synthetic peptide corresponding to antigenic site e, ha1 56-76, and are sensitive to a single substitution (ha1 63 asp-basn) in mutant viruses. virus infected target cells, thereby confirming that carbohydrate addition prevents cd4' t cell recognition. here ve show that an amino cell i-ad restricted, ha specific t cell clones f r m balblc mice-reviously recognition of mutant viruses is restored however by tunicamycin-treatment of key: cord-015147-h0o0yqv8 authors: nan title: oral communications and posters date: 2014-09-12 journal: inflamm res doi: 10.1007/bf03353884 sha: doc_id: 15147 cord_uid: h0o0yqv8 nan the drosophila host defense is a multifaceted process which involves reprogramming of gene expression, activation of proteolytic cascades in the blood and uptake of microrganismsby professionalphagocytes. most of the recent studies have focused on challenge-induced expression of antimicrobial peptides and have addressed the following questions : (1) which genes are upregulated during various types of bacterial, fungal or viral infections and what are their functions? (2),what is the nature of the intracellular signalling cascades which lead togene transcription during these infections; (3) how does drosophila recognize infections and does it discriminate between various types of aggressors (e.g. fungal versus bacterial or viral) to mount an appropriate response. over the last ten years we have gained significant insights into these various aspects and the presentation will review our current understanding of the drosophila immune response and put it into a phylogenetic perspective, namely by drawing some stringent parallels with the mammalian innate immune response. there is strong evidence that autoimmunity to myelin antigens plays a major role in the development of multiple sclerosis. several myelin-derived autoantigenic targets have been described and include myelin basic protein (mbp), proteolipid protein and myelin oligodendrocyte glycoprotein. there has been a particular focus on mbp for at least two reasons: mbp-specific cd4+ tcell receptors (tcrs) have been found in multiple sclerosis brains, and cells presenting an immunodominant mbp(85-99) peptide in complex with hla-dr2b have been shown to be present in multiple sclerosis lesions. also, humanized mice expressing the hla-dr2b gene and a human t-cell receptor (tcr) that recognises the mbp85-99 peptide in the context of hla-dr2b either spontaneously or after immunization with mbp85-99 develop experimental autoimmune encephalomyelitis, which has several features in common with multiple sclerosis. this talk will focus on, how humanized mice recently has been used to study the interplay between genetic and environmental risk factors in multiple sclerosis. to resolve the pathogenic mechanisms of rheumatoid arthritis (ra) we need to identify the causative genetic and environmental factors. this has however proven to be complex, with many factors and genes interacting. inbred animals are useful for studies of the identification of genes associated with complex traits and diseases such as ra. animal models offer a possibility to better define the traits, and to segregate the genes in a controlled way enabling linkage analysis. there are several arthritis models, which each may reflect various variants of the heterogeneity of ra in humans. examples are collagen induced arthritis (cia) and pristane induced arthritis (pia), which both fulfills the clinical diagnostic criteria for ra. both diseases are genetically complex and the susceptibility is, as ra, dependent on many polymorphic genes operating in concert. so far 2 genes in this concert have been identified; the mhc class ii ab gene in the mouse (1) and the ncf1 gene in the rat (2) and in the mouse (3) . the ncf1 protein is a part of the nadph oxidase complex mediating oxidative burst. the discovery of the ncf1 polymorphism led to a new proposed pathway in which oxygen radicals modify antigen presentation and the resulting activation of autoreactive t cells. mice with the deficient ncf1 allele are more susceptible to cia, and also developed a chronic form of arthritis. interestingly, the immune response to cii was enhanced by the ncf1 deficiency linking the ncf1 pathway to the adaptive immune response. oxidation of t cell membranes seem to be a key event in the pathogenic mechanism as reduction of t cell membranes induces arthritis in rats (4). on the basis of these findings a new type of therapy myasthenia gravis is a prototypic autoimmune disease, caused in most cases by autoantibodies to the muscle acetylcholine receptor (achr) at the neuromuscular junction. the antibodies reduce the number of achr leading to failure of neuromuscular transmission and muscle weakness. the achr antibodies as measured in conventional immunoprecipitation assays are igg, high affinity, polyclonal and specific for human achr. they reduce the numbers of achr by antigenic modulation and by complement-mediated damage to the neuromuscular junction. myasthenia gravis has a very intriguing relationship with the thymus gland. in many younger patients, the thymus is hyperplastic with immune cell infiltrates and germinal centre formation. around the germinal centres, within the medulla, there are rare muscle-like cells called myoid cells that express achrs. there are many b cells and plasma cells and thymic lymphocyte preparations synthesise achr antibodies. the possibility that the thymic achr induces the germinal centre formation and achr antibody synthesis is supported by much evidence. some patients, however, have thymic tumours and in these the role of the thymus is less clear. moreover, older patients with typical myasthenia usually have thymic tissue which is normal for their age. there are up to 20% of myasthenia patients that do not have the typical achr antibodies. some of these have instead antibodies to muscle specific kinase, a receptor tyrosine kinase that is restricted to the neuromuscular junction. the pathogenic mechanisms by which the antibodies cause disease are not yet clearly identified and the evidence will be discussed. finally, among the patients who have neither achr nor musk antibodies by conventional testing, we have evidence for lower affinity antibodies to achr which can now be detected using molecular approaches which will be described. arry-886 (azd6244) is an inhibitor of mek1/2 currently in development for cancer. phase 1 determined the msd (100 mg) and the safety of the compound given continuously. in decreasing frequency, common treatment-related side effects were rash, diarrhea, nausea, peripheral edema, and vomiting. paired pre-and postdose tumor biopsies showed a reduction in perk (-83%) and proliferative index (-46%). the trough plasma concentration (400 ng/ml) corresponded to~40% inhibition of perk. about 45% of pts had stable disease after 2 months. these results demonstrate that arry-886 (azd6244) is well-tolerated, hits its target, and produces a high incidence of long-lasting stable disease. there are several on-going phase 2 studies, in melanoma, colorectal, lung and pancreatic cancer. arry-162 is another potent, selective mek 1/2 inhibitor, currently in development for inflammatory diseases. when human whole blood was stimulated with tpa, arry-162 inhibited tnfa, il-1b and il-6 (ic50s of 23, 21 and 21 nm, respectively). 50% inhibition of perk required 280 nm. arry-162 was highly efficacious in cia and aia rat models, with ed50s of 3 and~10 mg/ kg, respectively. in normal volunteers arry-162 was well-tolerated and there was a dose-proportional increase in drug exposure. in ex vivo blood samples, there was a dramatic time-and concentration-dependent inhibition of tpa-induced tnfa and il1b. an on-going multiple ascending dose clinical study is further exploring the pharmacokinetics, pharmacodynamics and tolerability of arry-162 monotherapy. in addition, we have initiated a clinical trial designed to evaluate arry-162 in combination with methotrexate in patients with rheumatoid arthritis. rho kinases (rock) are involved in many physiological and pathological processes including smooth muscle contraction, cytoskeletal arrangement, cell adhesion, migration and proliferation.rocks prominent role in cytoskeletal architecture suggests that rock inhibitors should have therapeutic impact in oncology and fibrotic diseases which require cytoskeletal rearrangement to progress.we have synthesized small molecule inhibitors of rock which are specific for the rock-2 isoform.these rock-2 inhibitors, typified by slx-2119 and slx-3060, are potent (ic50 < 100 nm), selective for rock-2 (>100 fold selectivity for rock-2 over rock-1) and exhibit good oral bioavailability.this talk will focus on several areas in oncology and fibrotic disease where the ability to demonstrate an in vitro effect on the cytoskeleton translates into activity in the disease model in vivo.slx-2119 inhibits cell proliferation and migration in several tumor cell lines including ht-1080, panc-1 and mda-mb-231. moreover in xenograft studies using nude mice, slx-2119 significantly inhibited tumor growth with these same cell lines. in liver fibrosis, slx-2119 prevents the differentiation of rat primary hepatic stellate cells into myofibroblasts and inhibits the proliferation of myofibroblasts as well as inhibiting hepatic steatosis in an atherosclerosis model.slx-3060 is an effective antifibrotic agent in the kidney unilateral urethral obstruction model and inhibits renal fibroblast differentiation and proliferation.these data suggest that rock-2 selective inhibition of cytoskeletal modification in key cell types (e.g. tumor cells, stellate cells and fibroblasts) by compounds such as slx-2119 and slx-3060 will provide effective treatment for oncology and fibrotic disease. cyclooxygenases (cox) catalyze the first step in the synthesis of prostaglandins (pg) from arachidonic acid.cox-1 is constitutively expressed.the cox-2 gene is an immediate early-response gene that is induced by variety of mitogenic and inflammatory stimuli.levels of cox-2 are increased in both inflamed and malignant tissues.in inflamed tissues, there is both pharmacological and genetic evidence that targeting cox-2 can either improve (e.g., osteoarthritis) or exacerbate symptoms (e.g., inflammatory bowel disease).multiple lines of evidence suggest that cox-2 plays a significant role in carcinogenesis.the most specific data that support a cause-and effect relationship between cox-2 and tumorigenesis come from genetic studies.overexpression of cox-2 has been observed to drive tumor formation whereas cox-2 deficiency protects against several tumor types.selective cox-2 inhibitors protect against the formation and growth of experimental tumors.moreover, selective cox-2 inhibitors are active in preventing colorectal adenomas in humans.increased amounts of cox-2-derived pge2 are found in both inflamed and neoplastic tissues.the fact that pge2 can stimulate cell proliferation, inhibit apoptosis and induce angiogenesis fits with evidence that induction of cox-2 contributes to both wound healing and tumor growth.taken together, it seems likely that cox-2 induction contributes to wound healing in response to injury but reduces the threshold for carcinogenesis. (1), k hagihara(2), t nishikawa(1), j song(1), a matsumura (2) (1) health care center, osaka university, japan (2) osaka university graduate school of medicine, japan it is still less known about the actual pathogenic role of il-6 in the inflammatory status. to know the pathogenic role of il-6 and the efficacy of il-6 blockade in inflammation, a humanized anti-il-6 receptor antibody, tocilizumab, was used for the treatment in chronic inflammatory diseases, such as castlemans disease, rheumatoid arthritis and crohns disease. since il-6 blocking therapy improved the clinical symptoms and the laboratory findings, the il-6 function in inflammation could be analyzed for the induction of inflammatory molecules, such as serum amyloid a (saa). saamrna induction, saa promoter activity and assembling of transcriptional factors on saa promoter were analyzed by the real time rt-pcr, gel shift assay and dna affinity chromatography in hepatocyte stimulated with the proinflammatory cytokines, il-6, il-1 and tnf-alpha. in result, il-6 was an essential cytokine in induction of saamrna through the activation of stat3 which constructed the complex with nf-kappab p65 and a cofactor p300. although there was no stat3 consensus region on saa promoter, stat3 bound at the 3 site of nf-kappab re. the above research proved that il-6 signal is essential on the synergistic induction of saa via newly discovered stat3 transcriptional mechanism, suggesting the presence of this stat3 mechanism in inflammation, and confirming the normalization of serum saa level by il-6 blocking therapy in inflammatory diseases. this research method develops a subsequent therapy for serious aa amyloidosis by inhibition of saa production, and elucidates the cytokine mechanism on immunopathogenesis of chronic inflammatory diseases. takashi wada(1), k matsushima(2), s kaneko (1) (1) kanazawa university, japan (2) university of tokyo, japan accumulating evidence indicates that chemokine/chemokine receptor system plays a key role in the pathogenesis of various renal diseases via leukocyte migration. pathophysiological impacts of chemokines have shed light on molecular mechanisms of leukocyte trafficking and their activation in the inflammatory aspects of progressive renal injury.locally expressed chemokines are proven to be capable of inciting leukocyte migration to the kidney, resulting in initiating and promoting chronic kidney diseases.the possible positive amplification loop from cxc chemokines to cc chemokines may contribute to progressive renal injury, resulting in sclerosis/fibrosis.it is of note that monocyte chemoattractant protein (mcp)-1/ monocyte chemotactic and activating factor (mcaf)/ ccl2, a prototype of cc chemokines, promotes and escalates chronic kidney diseases with any etiologies via the infiltration and activation of monocytes/macrophages, proteinuria and collagen synthesis.interactions between infiltrated inflammatory cells and resident renal cells eventually lead to the progression of fibrosis. new insights into renal fibrosis have been uncovered by the regulation of fibrocytes dependent on chemokine system. in addition, recent studies demonstrate that chemokines have been expanding their universe beyond leukocyte migration to the kidney, including homeostasis, development and repair of the kidney.the selective intervention of chemokines might have the therapeutic potential to alter inflammatory responses, thereby halting the progression of renal injury. we focus on recent progresses on the role of chemokines and their cognate receptors in renal injury in this symposium. (1), p lacamera (1), b shea (1), g campanella (1), b karimi-shah (1) , n kim (1), z zhao(2), v polosukhin (3), y xu(2), t blackwell (3) aberrant wound-healing responses to injury have been implicated in the development of pulmonary fibrosis, but the mediators directing these pathologic responses remain to be fully identified.here we demonstrate that lysophosphatidic acid (lpa) is induced by lung injury in the bleomycin model of pulmonary fibrosis, and that mice deficient for one of its receptors, lpa1, are dramatically protected from pulmonary fibrosis and mortality following bleomycin challenge. the absence of lpa1 markedly reduced fibroblast responses to the chemotactic activity present in the airspaces following bleomycin, and attenuated the subsequent accumulation of fibroblasts in the lung.the increase in vascular permeability caused by lung injury was also markedly reduced in lpa1-deficient mice, whereas bleomycin-induced leukocyte recruitment was preserved.these results demonstrate that lpa1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak, two of the wound-healing responses that are thought to be inappropriately excessive when injury leads to fibrosis rather than repair.lpa1 therefore represents a new target for lung diseases in which aberrant responses to injury contribute to the development of fibrosis, such as idiopathic pulmonary fibrosis and the acute respiratory distress syndrome. we have reported that inflammation is detrimental for survival of new hippocampal neurons early after they have been born. our data now show that microglia activation, as an indicator of inflammation, is not pro-or antineurogenic per se but the net outcome is probably dependent on the balance between secreted molecules with pro-and antiinflammatory action. we have found that a substantial fraction of the new hippocampal neurons formed after status epilepticus survive despite chronic inflammation. we have started to explore the role of tnf-alpha for adult neurogenesis. infusion of an antibody to tnf-alpha was shown to reduce survival of new striatal and hippocampal neurons generated after stroke, probably by interfering with action of the ligand on the tnf-r2 receptor. we have shown that tnf-r1 is a negative regulator of progenitor proliferation in basal and insult-induced hippocampal neurogenesis. we have also used patch-clamp technique to explore whether a pathological environment influences the synaptic properties of new granule cells. rats were exposed to either a physiological stimulus, i.e., running, or a brain insult, i.e., status epilepticus which is associated with inflammation. we found that new granule cells in runners and status epilepticus animals had similar intrinsic membrane properties. in contrast, the new neurons which had developed in the physiological and pathological tissue environments differed with respect to tonic drive and short-term plasticity of both excitatory and inhibitory afferent synapses. the role of inflammation for these differences is currently being explored. proteinase-activated receptor-2 (par-2) is cleaved within its aminoterminal extracellular domain by serine protei-nases such as trypsin, unmasking a new aminoterminus starting with sligkv that binds intramolecularly and activates the receptor. par-2 is implicated in innate defense responses associated with lung inflammation. we showed that par-2 is expressed by human alveolar (a549) and bronchial (16hbe) epithelial cell lines, and is activated by trypsin and by the activating synthetic peptide sligkv-nh2. in cystic fibrosis patients, airspaces are invaded by polymorphonuclear neutrophils that release elastase and cathepsin g, two serine proteinases, and by pseudomonas aeruginosa that secretes an elastolytic metalloproteinase.we demonstrated that these three proteinases do not activate par-2, but rather disarm this receptor, preventing its further activation by trypsin but not by sligkv-nh2. preincubation of a par-2 transfected cell line with either proteinases leads to the disappearance of the cleavage/activation epitope. proteolysis by these three proteinases of synthetic peptides representing the aminoterminal extracellular domain encompassing the cleavage/activation sequence of par-2, generate fragments that would not by themselves act as receptor-activating ligands and that would not yield receptor-activating peptides upon further proteolysis by trypsin. our data indicate that neutrophiland pathogen-derived proteinases can potentially silence the function of par-2 in the respiratory tract, thereby altering the host innate defense mechanisms. caspase-3 -dependent killing of host cells and to disrupt intestinal barrier function, which, at least in the case of giardiasis, ultimately causes lymphocyte-dependent intestinal malfunction, and the production of diarrheal symptoms. ongoing research is investigating whether par agonists and microbial pathogens may cause epithelial apoptosis, increased permeability, and overall epithelial malfunction in the gastrointestinal tract, via common or intersecting pathways. the intestinal epithelium is exposed to a variety of proteases in both health and disease, including digestive proteases such as trypsin.given that protease-activated receptor 2 (par2) responds to trypsin and is expressed on intestinal epithelial cells, we investigated the effect of trypsin on intestinal epithelial barrier function.scbn, caco-ii and t84 epithelial cells were grown to confluence on filter supports and mounted in ussing chambers to study short circuit current (isc) and transepithelial resistance (rte).cell monolayers were incubated with inhibitors of transcellular ion transport in order to isolate the contribution of the paracellular pathway to rte.apical exposure to serine proteases including trypsin, elastase and chymotrypsin caused a rapid and sustained increase in rte and decreased the transepithelial flux of a 3000mw dextran.interestingly, the effect of trypsin could not be replicated by activators of pars 1, 2 and 4, suggesting that the effect on rte was not due to activation of pars.subsequent experiments showed that trypsin activated phosphatidylinositol-dependent phospholipase c.a trypsin-induced increase in intracellular calcium was not involved.inhibition of pkc-zeta, but not of typical pkcs, also blocked the response.our data point to a role for postprandial trypsin that extends beyond that of a digestive enzyme; it is also a participant in cellular pathways that control tight junction permeability. physiologically, the trypsin-induced increase in resistance could augment transcellular transport by reducing passive paracellular back-diffusion of ions. further studies will assess how these pathways might be disrupted in the barrier dysfunction characteristic of intestinal inflammation. clustering of inflammatory bowel disease in large families and the observation of an increased concordance between monozygotic twins suggests heritable components in these disorders. the high concordance in monozygotic twins (>55%), which is not seen in dizygotic twins (<5%) points to strong contribution of genetic susceptibility to the overall risk for disease. ibd represents a "complex disease" and may involve a large number of interacting disease genes. crohns disease has become an example for the successful molecular exploration of a polygenic etiology. crohns disease was not known before 1920. incidence has increased since now leading to a lifetime prevalence of up to 0.5% in western industrialized countries. the current hypotheses propose unknown trigger factors in the life style of western industrialized nations that interact with a polygenic susceptibility. it appears that increased expression and production of tnf and an enhanced state of activation of the nfkb system are main drivers of the mucosal inflammatory reaction. the exploration of inflammatory pathophysiology of crohns disease using full genome, cdna and oligonucleotide based arrays, respectively, has generated large sets of genes that are differentially expressed between inflamed mucosa and normal controls. while this may lead to new targets for a pathophysiology oriented therapy, it appears, however, that the dissection of the inflammatory pathophysiology does not allow to identify the multifactorial etiology of the disease. genome-wide linkage analysis has demonstrated eight confirmed susceptibility regions with the one on chromosome 16 being most consistent between different populations. in 2001 three coding variations in the card 15 gene were identified that are highly associated with development of the disease. all variants affect a part of the gene that codes for the leucin rich part of the protein, that appears to be involved in bacteria induced activation of nfkb in macrophages and epithelial cells. interestingly, the three disease associated snps are never found on the same haplotype. in compound heterozygotes or homozygotes they result in a rr of > 35 to develop crohns disease as an adult. a particular subphenotype with localization of the disease in the ileocecal region is highly associated with the variants in the card 15 gene. variations in the card 15 gene do not fully explain the linkage finding in the pericentromeric region of chromosome 16. after stratification for card 15 variants, the broad linkage peak is reduced to two more defined peaks on 16p and 16q, respectively. while the exploration of these regions has led to several association signals that are subject to further fine mapping a further disease gene progress has been greater in the other linkage regions (i.e. on chromosomes 10 and 5, respectively). dlg-5 is the example of a low-risk susceptibility gene with a modest associated odds ratio (1.2-1.5) . interestingly, the associa-tion signal appears to be confined to young males. slc22a4/5 which encode the kation-transporters octn1 and 2 have been suggested to represent the disease gene in the 200+ kb haplotype block on chromosome 5q31. mdr1 has also been implicated as a disease gene in ibd. although the human association studies have resulted in highly controversial findings a knockout mouse with a colitis phenotype makes mdr1 likely as a low risk susceptibility gene. with the advent of high-density, genome wide association studies enormous progress has been made to discover the remaining disease genes. recently a 330k illumina scan has been published identifying il-23r as a further disease gene. we used a genome wide candidate gene approach (with appr. 20.000 csnps) to identify atg16l1 as a further disease genes. both genes were confirmed and a further regulatory snp involving ptger4 was annotated by a belgian genome wide scan. by the time of presentation three further genome wide snp scans in crohn disease will most likely have entered the public domain. the further exploration of crohns disease (and other inflammatory conditions of barrier organs) will have to annotate the function and pathophysiologies based on genetic risk maps that are completed with amazing speed. the creation of a medical systems biology of disease will lead to new models and eventually new therapies. the chemokine receptor ccr9 plays a pivotal role in mediating the migration of t cells to the gastrointestinal mucosa. the ligand for ccr9, teck, s highly expressed in the gi tract. the pathogenicity of intestinal ccr9+/ cd4+ t cells has been demonstrated in animal models and this cell population is substantially increased in the peripheral circulation of crohns and celiac disease patients. ccx282-b is a highly selective and potent, orally bioavailable, small molecule antagonist of ccr9.the compound proved to be highly efficacious in the tnf-aare and mdr1a-/-murine models of inflammatory bowel disease (ibd). in phase i trials, ccx282-b was well-tolerated, and no drug-related saes were reported.a 28-day placebo-controlled phase ii study was recently completed in patients with moderate to severe crohns disease. ccx282-b was shown to be both safe and to have encouraging clinical results: 56% of patients on ccx282-b (cdai !250, crp >7.5mg/l) exhibited a 70-point drop in cdai compared to 29% on placebo. furthermore, a crp decrease of 11 mg/l was seen in the ccx282-b group compared to placebo. colonic biopsy samples were analyzed for expression of several pro-inflammatory cytokines. a mean decrease from baseline in the concentrations of tnf-alpha, il-12 p70, ifn-gamma, and the chemokine rantes was shown in the ccx282-b group while levels remained stable in the placebo group. ccx282-b is the first chemokine-based inhibitor of leukocyte trafficking to be tested in ibd. the compound shows anti-inflammatory activity and encouraging evidence for clinical benefit in the treatment of crohns disease. the activating receptor nkg2d seems to be implicated in the pathogenesis of several autoimmune diseases in humans and in animal models for type 1 diabetes and multiple sclerosis. the aim of this study was to asses the role of nkg2d in a model of inflammatory bowel disease, where cd4+cd25-t cells from balb/c mice are adoptively transferred to scid mice, and to evaluate the therapeutic effect of an anti-nkg2d antibody therapy. the expression of nkg2d was evaluated by flow cytometry, immunohistochemistry and by pcr. we found a marked up-regulation of nkg2d on the cell surface as well as increased levels of nkg2d mrna in cd4+ t cells from colitic scid mice as compared to normal balb/c mice. we next studied the effect of anti-nkg2d antibody (cx5) treatment initiated either before onset of colitis, when the colitis was mild, or when severe colitis was established. cx5 treatment decreased the cellsurface expression of nkg2d and prophylactic administration of cx5 attenuated the development of colitis significantly. a moderate reduction in the severity of disease was observed after cx5 administration to mildly colitic animals, whereas cx5 did not attenuate severe colitis. thus, nkg2d may be involved in the pathogenesis of colitis in this model, particularly in the early phases, since the expression of nkg2d in cd4+ t cells increased markedly during the development of disease and since administration of cx5 early but not late in the course attenuated the disease severity. proteins are used already for more than a century in the treatment of disease. the first generation were proteins derived from animals such as antisera used to treat infectious diseases as diphtheria and tetanus and later bovine and porcine insulin for the treatment ofdiabetes. the second generation were natural proteins from human source like the plasma derived clotting factors and human growth hormone. the development of the recombinant dna and cell fusion technology in the seventies of the 20th century opened up the possibilities to produce human proteins and monoclonal antibodies in unlimited amount in microbial and mammalian host cells. in 1982 human insulin was introduced as the first recombinant dna derived biopharmaceutical and since than more than 160 have gained approval. the pipeline contains many more potential biopharmaceuticals and at present 1 in 4 new drug applications concerns a biotechnology derived product. a major problem of therapeutic proteins is the induction of antibodies. for foreign proteins such as the murine derived monoclonal antibodies thisimmunogenicity was to be expected. however the humanization of monoclonal antibodies has reduced but not solved the problem of immunogenicity. and also the proteins which are homologues of endogenousfactors such as gm-csf, interferons etc. induce antibodies, sometimes even in the majority of patients. by definition we are immune tolerant to products which are copies of endogenous proteins. the products not necessarily need to be exact copies of the natural proteins to share this immune tolerance. when human therapeutic proteins induce antibodies, they are breaking b cell tolerance, which starts with the activation of autoreactive b-cells. presenting the self-epitopes in an array form is very potent activator of these b-cells. this explains why aggregates of human proteins are the most important factor in induction of antibodies. these aggregates may not be immediately present in the product, but may appear during storage making stability and formulation an important issue in predicting the immunogenicity. there are only a few studies in experimental model systems on the properties of the aggregates which break b-cell tolerance, indicating that only multiple order aggregates (>trimers) are involved. we study the capacity of a protein product to break b-cell tolerance in mice made transgenic for the specific protein. these mice are immune tolerant and there is a good correlation of an immune response in these mice and in patients. although these models have helped to identify the factors important for breaking b-cell tolerance and also have been useful in improving the formulation of products, there is not yet enough experience to use them as absolute predictors of immunogenicity of human proteins. they also allow to study the involvement of tcells in breaking b cell tolerance. all data obtained untilnow indicate this process to be t-cell independent. contact information: dr huub schellekens, central laboratory animal institute, utrecht university, utrecht, the netherlands e-mail: h.schellekens@gdl.uu.nl biomonitor aps, and institute for inflammation research (iir), rigshospitalet, copenhagen, denmark using recombinant technology, one can now produce protein drugs which are almost identical with naturally occurring human proteins, including antibodies (abs). many have assumed that these drugs may be administered with little or no risk of triggering specific t-and/or b-lymphocyte reactivities, because patients according to immunological dogma are tolerant towards their own proteins. unfortunately, this is not the case, and even socalled 100% human biologicals are potentially immunogenic (1) (2) . i shall discuss two examples: 1) recombinant human cytokines (ifn-beta-1a and -1b), and 2) anticytokine ab constructs (anti-tumor necrosis factor (tnf)-alpha). ifn-beta has been used for treatment of patients with multiple sclerosis since the early nineties. though initially neglected as a clinical problem, ifn-beta like many other human proteins is indeed immunogenic, especially those produced by recombinant gene technologies. the reported frequencies and titers of anti-ifn-beta ab vary considerably depending upon ifn-beta preparations and administration, and the types of assays being used (2-4). it took more than 10 years of clinical use before abmediated decrease in bioactivity of ifn-beta, a condition in which the clinical effect of continued injection of rec. ifn-beta is minimized or abrogated, was universally recognized (5, 6). 2) anti-tnf-alpha human ab constructs tnf-alpha is an inflammatory cytokine of central pathogenic importance in many immunoinflammatory conditions, and measures to diminish production and/or effects of tnf-alpha have long been a goal in the treatment of these conditions. currently, there are three approved and two other anti-tnf-alpha biopharmaceuticals in clinical use. unfortunately, response failure is frequently encountered. thus, 30-40% of patients are primary non-or lowresponders to the anti-tnf constructs, and secondary response failure is commonplace, mostly due to induction of anti-abs. several different methods have been used to assess circulating levels of anti-tnf drugs as well as anti-abs. most of these have been based on elisa technology, with their inherent problems of false positivity, susceptibility to nonspecific interference, etc. interferon beta (ifnbeta) has been an important step forward in the treatment of multiple sclerosis(ms), an inflammatory disease of the human central nervous system. however, one of the problems of ifnbeta is its immunogenicity; a substantial percentage of ms patients treated this recombinant protein develop anti-ifnã� antibodies, primarily of the igg class. the level of these antibodies tends to be low in the first month or two and peaks by six to eighteen months after initiation of therapy. most studies of these antibodies have measured their ability to neutralize ifnbetas effect in vitro, using assays in which sera from ms patients inhibit the protective effect of ifnbeta on viral killing of target cells. this antibody population is called neutralizing antibodies (nabs). tests measuring binding of antibodies to ifnã� in vitro are called binding antibody (bab) assay. anti-ifnbeta antibodies detected by bab assays are present in a high percentage of ms patients, and can occur at low levels without any apparent adverse effect on ifnbeta bioactivity. the distinction between babs and nabs is artificial, and all binding antibodies are likely neutralizing, if the neutralizing assay system is adequately sensitive; i.e., the development of babs and nabs is a continuum with the assay systems simply measuring the strength of the antibody response. in many treated patients, the anti-ifnbeta antibody response is strong, despite the resemblance of the injected protein to the human homologue, and high levels of neutralizing antibodies develop. high levels of anti-ifnbeta antibodies with high affinity results in loss of ifnbeta bioactivity, a phenomenon which has been called antibody-mediated decreased bioactivity or adb. adb can be considered the in vivo correlate of the neutralizing effect of the anti-ifnã� antibody population, while the nab assay measures the in vitro neutralization of this population of immunoglobulins in the serum. the three ifnbeta preparations have different incidences of nabs and different patterns of appearance and disappearance over time of nabs. because there is no direct correlation between nab levels and bioactivity at moderate levels of nab, in vivo bioactivity assays for ifnbeta have become increasingly utilized. in a large multicenter study in the us, called the insight study, bioactivity as measured by ifnbeta induced upregulation of the ifn-response genes mxa, viperin, and ifit1, was shown to be highly correlated with nab levels, confirming a single center study (pachner, a.r., pak,e., narayan, k., multiplex analysis of expression of three ifnbeta-inducible genes in antibody-positive ms patients, neurology, 66:444-446, 2006) . multiple studies, including a large multicenter study in denmark and a recent study from our center using high resolution mri of the brain once a month, have demonstrated that nabs abolish the salutary effects of ifnbeta on clinical aspects of ms, especially inflammation. recent guidelines for european neurologists recommend stopping ifnbeta in nab-positive patients. in order to maintain bioactivity of this important medication for ms, some neurologists have attempted to use immunosuppressives either to prevent the development of nabs, or to treat them once they have developed. however, at this point in time, there is no clearly optimal way to treat nabs. major efforts have been underway to decrease the immunogenicity of ifnbeta and a new formulation of one of the higher immunogenicity products has been recently developed and tested. proteinase-activated receptors (pars). endogenous serine proteinases such as thrombin, mast cell tryptase, trypsins, kallikreins, cathepsin g, for example, as well as exogenous proteases released by mites or bacteria are involved in cutaneous inflammation, host defense or tumor cell regulation. thus, the expression of pars on keratinocytes, endothelial cells, nerves, and immune cells suggest important role of pars as a part of the communication system in the skin during inflammation and the immune response. for example, par2 activates nf-kb in keratinocytes and endothelial cells, stimulates the release of chemokines and cytokines, and is involved in proliferation and differentiation. on sensory nerves, this receptor controls neurogenic inflammation by modulating edema and extravasation via release of neuropeptides into the inflammatory site. par1 and par2 also modulate leukocyte-endothelial interactions in the skin, thereby regulating inflammatory responses such as leukocyte trafficking through the vessel wall. they also stimulate signal transduction pathways involved in cutaneous inflammation. in sum, this novel receptor family requires a paradigm shift in thinking about the role of proteases in cutaneous biology and disease. novel compounds regulating protease and par function may be beneficial for the treatment of several skin diseases such as atopic dermatitis, psoriasis or pruritus. serine proteinases are upregulated in arthritic joints where their enzymatic activity participates in the destruction of articular soft tissues. in addition to their degradative functions, serine proteinases can also act as signalling molecules by activating members of the gprotein coupled receptor family called the proteinase activated receptors (pars). these receptors are known to regulate tissue inflammation and pain, although their function in joints is unclear. our study examined the effect of par4 activation in joint inflammation and pain. male c57bl/6 mice received an intra-articular injection of either the par4 activating peptide aypgkf-nh2 or the inactive peptide yapgkf-nh2 (100 mg) into the right knee. knee joint blood flow was then measured in these mice by laser doppler perfusion imaging while joint diameter measurements gave an indication of tissue oedema. mechanical allodynia was also assessed in these animals by application of von frey filaments onto the plantar surface of the ipsilateral hindpaw and a pain score was calculated. intra-articular injection of the par4 activating peptide caused knee joint blood flow to gradually increase by up to 25% over the succeeding 2hrs. knee joint swelling was also observed as well as the development of a mechanical allodynia. all responses could be blocked by pre-treatment with the selective par4 antagonist pepducin p4pal10 (100 mg i.p.). the control peptide yapgkf-nh2 had no discernible effect on joint inflammation or pain. these experiments show that peripheral activation of par4 receptors in mice knees causes joint inflammation and pain. vincent lagente (1), e boichot (2) (1) air liquide, centre de recherche claude-delorme, jouy en josas, france (2) inserm u620, universitã� de rennes 1 matrix metalloproteinases (mmps) are a major group of proteases known to regulate the turn-over of extracellular matrix and so they are suggested to be important in the process of lung disease associated with tissue remodelling. these led to the concept that modulation of airway remodeling including excessive proteolysis damage of the tissue may be of interest for future treatment. among metalloproteinases (mmps) family, macrophage elastase (mmp-12) is able to degrade extracellular matrix components such as elastin and is involved in tissue remodeling processes in chronic obstructive pulmonary disease (copd). pulmonary fibrosis has an aggressive course and is usually fatal for an average of three to six years after the onset of symptoms. pulmonary fibrosis is associated with deposition of extracellular matrix (ecm) components in the lung interstitium. the excessive airway remodeling as a result of an imbalance in the equilibrium of the normal processes of synthesis and degradation of extracellular matrix components could be in favor of anti-protease treatments. indeed, the correlation of the differences in hydroxyproline levels in the lungs of bleomycin-treated mice strongly suggests that a reduced molar pro-mmp-9/timp-1 ratio in broncholaveolar lavage fluid is associated with collagen deposition, beginning as early as the inflammatory events at day 1 after bleomycin administration. finally, these observations emphasize those effective therapies for these disorders must be given early in the natural history of the disease, prior to the development of extensive lung destruction and fibrosis. in addition to their degradative properties, proteases can act as signalling molecules that send specific messages to cells.recent work has demonstrated that proteases are able to signal to peripheral sensory neurons, thereby participating to neurogenic inflammation processes and to the transmission or inhibition of pain messages. serine proteases cleaving specifically at an arginin site are able to activate protease-activated receptors (pars), which then send specific messages to cells. we have demonstrated that 3 members of the par family (par1, par2 and par4) are present on peripheral sensory neurons, where they can be activated by different proteases.the activation of par1 and par2 in isolated sensory neurons provokes calcium mobilization and the release of substance p and cgrp, while the activation of par4 inhibited bradykinin-and capsaicin-induced calcium signal, and neuropeptide release.thrombin and pancreatic trypsin caused inflammation respectively through a par1 and par2-dependent mechanism involving the release of neuropeptide.the extrapancreatic form of trypsin (mesotrypsin or trypsin iv) also caused neurogenic inflammation through a par2 and par1dependent mechanism, and causes inflammatory hyperalgesia and allodynia, through a par2-dependent mechanism.in contrast, activation of par4 on peripheral sensory neurons inhibited inflammatory hyperalgesia and allodynia. taken together, these results provide evidences that proteases can interfere with inflammatory and pain mechanisms through the activation of pars on peripheral sensory neurons.determining the role of each individual proteases and their receptors in sensory neuron signalling and above all inflammatory and pain mechanisms constitutes an important challenge to raise new anti-inflammatory and analgesic drugs. introduction: a scoring system for disseminated intravascular coagulation (dic) in humans has been proposed by the international society on thrombosis and haemostasis (isth). it was the objective of this study to develop and validate a similar scoring system for dic in dogs in order to establish the dog as a spontaneous animal model. methods: for the developmental study, 100 consecutive dogs admitted to the intensive care unit (icu) were enrolled prospectively (group a). blood samples were collected daily and a broad panel of coagulation assays performed. diagnosis of dic was based on the expert opinion of one human physician and two veterinarians. a multiple logistic regression model was developed with the coagulation parameters as explaining variables for the diagnosis of dic. integrity and diagnostic accuracy was subsequently evaluated in a separate prospective study according to the stard criteria. the validation study prospectively enrolled 50 consecutive dogs (group b). results: 37 dogs were excluded from group a where 23/63 dogs (37%) had dic. final multiple logistic regression model was based on aptt, pt, d-dimer and fibrinogen and had a very high diagnostic sensitivity and specificity. diagnostic accuracy of the model was sustained by prospective evaluation in group b. conclusion: based on generally available assays, it was possible to design an objective diagnostic model for canine dic, which has both a high sensitivity and specificity. such a model will provide basis for treatment optimization and make it possible to conduct multicentered therapy studies with a minimum risk of systematic misclassification of patients. in 1997, a coagulation independent change in light transmittance (biphasic waveform [bpw] ) was reported in automated activated partial thromboplastin time assays (aptt) in patients with disseminated intravascular coagulation (dic). a calcium-dependant precipitate of creactive protein and very-low-density-lipoprotein was causing the bpw. our group recently identified this phenomenon in dogs also. initially, bpw was introduced as a complementary tool to assist diagnosing dic. however, recent studies reported that bpw may have a stronger potential as a prognostic marker for survival. the aims of the study were to prospectively investigate (a) the diagnostic significance of bpw regarding dic and (b) the significance of bpw to outcome, in dogs with diseases known to predispose for dic. the study was performed as a prospective, observational study including 50 consecutive dogs with a final diagnosis known to predispose for dic (20% were finally diagnosed with dic). outcome was 28-day survival. bpw was assessed by means of a hirudin-modified aptt assay (kjelgaard-hansen et al., jvim 2006:20; 765-766) . relative risk according to bpw (rr [95% confidence interval]) for (a) a dic diagnosis and (b) 28-day mortality, were assessed. 28-day mortality in the study population was 44%. 28% were bpw positive. bpw was not a significant diagnostic factor for dic (rr=0.64 [0.16; 2.67] ), but strongly so for outcome (rr=2.57 [1.46;4.52] ) with a 79% (11/14) mortality amongst bpw positive dogs. in conclusion, bpw was observed in dogs predisposed to dic, with a strong potential as a risk factor for outcome, a finding in line with recent findings in humans. (1), b hideo (2) (1) department of molecular pathology, kumamoto university, japan (2) department of gastroenterological surgery, kumamoto university, japan aeromonas species are facultative anaerobic gramnegative rods that are ubiquitous, waterborne bacilli, most commonly implicated as causative agents of gastroenteritis. aeromonas infections often develop sepsis and disseminated intravascular coagulation syndrome (dic) is a life-threatening complication of sepsis patients, causing multiple organ failure.however, a mechanism leading to coagulation induction in the bacterial infection has not been known. to study the dic induction by aeromonas species infection, we investigated coagulation activity of a serine protease (asp) from aeromonas sobria, predominantly isolated in patients blood. proteolytically active asp shortened both activated partial thromboplastin time and prothrombin time of human plasma in a dose-dependent manner starting at an enzyme concentration of 30 nm. asp activated human prothrombin, releasing hydrolytic activity for thrombinspecific substrate boc-val-pro-arg-mca, but no enzymatic activity was produced from coagulation factors ix and x. analysis by sds-page revealed that asp released a prothrombin fragment with a molecular weight identical with that of fâ¿-thrombin in an incubation timedependent manner. western blotting using biotinylated phe-pro-arg-chloromethylketone, a thrombin inhibitor, showed that asp produced an enzymatically active fragment whose molecular weight was same as that of fâ¿-thrombin. prothrombin incubated with asp but not the protease itself caused platelet aggregation. these results indicate that asp activates prothrombin, producing fâ¿-thrombin that converts fibrinogen to fibrin clot, and suggest that asp coagulation-inducing activity contributes to dic development in sepsis caused by aeromonas sobria infection. the present study shows a link between inflammation and coagulation mediated by a bacterial protease. hemolytic episodes are often associated to high amounts of free heme in circulation (up to 20 um) and the development of an inflammatory response that may develop to a chronic inflammation. our group has shown that free heme is a prototypical proinflammatory molecule, able to induce neutrophil migration, actin cytoskeleton reorganization and nadph oxidasederived reactive oxygen species (ros) generation, as well as pkc activation and interlukin-8 expression (graã�a-souza et al., 2002) . moreover, free heme inhibits human neutrophil spontaneous apoptosis, a feature that is closely related to the impairment of resolution of inflammation and consequent promotion of chronic inflammatory status. heme protective effect requires nadph oxidase-derived ros and involves the activation of mapk, pi3k and nf-kb signaling cascades as well as heme oxygenase (ho) activity (arruda et al., 2004) . more recently, we have shown that heme antiapoptotic effect is closely related to the maintainance of mitochondrial stability, inhibition of bax insertion into mitochondria and a dramatic increase on bcl-xl/bad protein ratio in a ros-dependent manner, requiring the same signaling pathways that regulate heme anti-apoptotic effect. these findings attest to a prominent role of free heme in the onset of inflammation associated to hemolytic episodes as well as the statement of chronic inflammation related to these disorders. the recent advance on the study of free heme as a proinflammatory molecule brings up hope for the development of new strategies to ameliorate acute and chronic inflammation found during hemolytic episodes.financial support: faperj, cnpq, capes. (1) (1) university of melbourne, victoria, australia (2) monash university, victoria, australia we have previously demonstrated that mice lacking the anti-oxidative enzyme, glutathione peroxidase (gpx1), show significantly larger infarcts after stroke. recent studies have demonstrated that adhesion molecule-mediated leukocyte recruitment is associated with increased tissue damage in stroke, while mice lacking key adhesion molecules conferred neuro-protection. nevertheless, the involvement of oxidative stress in leukocyte recruitment and subsequent regulated cell injury is yet to be elucidated. to explore this, gpx1-/-mice were subjected to transient mid-cerebral artery occlusion (mcao) followed by cerebral intravital microscopy, for assessment of leukocyte-endothelium interactions in intact cerebral microvasculature. after 1hr mcao, leukocyte-endothelium interaction was significantly reduced in gpx1-/-mice compared to wt counterparts during the second hour of reperfusion. laser doppler and direct measurement of blood flow in pial postcapillary venules revealed a reduction of reperfusion in gpx1-/-mice following transient mcao. this suggests that the reduction in nutritive blood flow following stroke in gpx1-/-mice may explain the enhanced injury in these mice as well as the reduced leukocyte-endothelium interaction. furthermore, matrix metalloproteinase-9 (mmp9) which has previously been shown to be implicated in endothelial dysfunction and the pathogenesis of stroke was found to be up-regulated in gpx1-/-mice to a greater extent than in wt mice after mcao, suggesting a role for oxidative stress in cerebral microvascular injury. the data present here suggests oxidative stress may be one of the factors that contribute to reduced post-ischemic perfusion, via the disruption of the endothelial function as indicated by the increased level of mmp9. chris bolton(1), c paul(2), s barker (3), r mongru (3) (1) william harvey research institute, london, uk (2) university west of england, bristol (3) queen mary university of london adrenomedullin (am) acts as a vasodilator in many vascular beds including the cerebral circulation where the peptide is produced in larger amounts than in the periphery.in vitro work has shown that am beneficially regulates blood-brain barrier (bbb) characteristics including transendothelial electrical resistance, permeability and p-glycoprotein pump activation.our preliminary studies in acute experimental autoimmune encephalomyelitis (eae), a model of the human disease multiple sclerosis (ms), have demonstrated significant elevations in am peptide levels corresponding with am mrna changes during late, neurological disease where am production may be linked to the restoration of bbb function. however, am is not exclusively produced as result of am gene upregulation. furthermore, am peptide levels do not always match am mrna changes during other disease phases of eae.the current study has investigated, more closely, the relationship between am gene expression and subsequent levels of associated peptides. am mrna levels were determined, by rt-pcr, in the cerebellum, medulla-pons and spinal cord of normal and eae-inoculated lewis rats at the height of disease. am and proadrenomedullin peptide (pamp) levels were measured in the tissues by radioimmunoassay.all tissues examined showed an increase in am gene mrna compared to control levels.am and pamp changes were observed in the samples and differences between the peptide profiles were recorded.an understanding of alterations in the generation of am and related peptides during neuroinflammation may provide insight into mechanisms affecting bbb permeability and be of relevance to the changes in neurovascular function seen during ms. platelet-activating factor (paf) contributes to the robust inflammatory responses in acute phase and spread of secondary injury. although, paf is believed to be a potent edematous but non-painful mediator in peripheral tissues, we recently demonstrated that paf may be a mediator of noxious signaling in spinal cord in case of neuronal injury. paf-induced tactile allodynia may be mediated by atp, glutamate and the generation of nitric oxide (no). the present study elucidated down-stream signaling pathway for paf-induced tactile allodynia. paf-and glutamate-induced tactile allodynia was blocked by the pretreatment with no scavengers and inhibitors of no synthase, soluble guanylate cyclase or cgmp-dependent protein kinase (pkg). recent evidence attributes the generation of pain to specific disfunctions of inhibitory glycinergic neurotransmission. to explore the target molecule for induction of tactile allodynia, the effect of knockdown of glycine receptors containing the a3 subunit (glyr a3) by sirna spinally transfected with hvj-e vector was examined. in mice spinally transferred with sirna for glyr a3, the reduction of glyr a3 was demonstrated in superficial layer of dorsal horn by immunohistochemical analysis. pcpt-cgmp, paf, glutamate failed to induce tactile allodynia in mice spinally transferred with sirna of glyr a3, while these compounds produced tactile allodynia in mice transferred with mutant sirna of glyr a3 as a control. glycine tranporter inhibitors ameriolated paf-and pcpt-cgmp-induced allodynia. these results suggest that glutamate-no-cgmp-pkg pathway plays a key role for paf-induced tactile allodynia in spinal cord and glyr a3 may be a target molecule for pkg to induce allodynia. (1), r leite(2), ys bakhle (3) (1) federal university of minas gerais, belo horizonte, brazil (2) medical college of georgia, augusta, usa (3) imperial college, london, uk selective cyclooxygenase 2 inhibitors (coxibs) induce a characteristic increase in mechanical nociceptive threshold, referred to as "hypoalgesia", in inflammatory pain induced by carrageenan in rat paws.we have here assessed the role of the cytoskeleton in this hypoalgesia induced by celecoxib (cx). male holtzman rats (150-200g; 3-5 animals/group) were injected in the right hind paw (ipl) with a range of cytoskeletal inhibitors (selective inhibitors of microtubules (taxol, nocodazole, colchicine), of actin microfilaments (latrunculin b, cytochalasin b) or of intermediary filaments (acrylamide) (pico to nanomoles per paw) and 30 min later given cx (12mg/kg, s.c.). after a further 30 min, rats were injected (ipl) with the inflammatory stimulus, carrageenan (250 mg/paw). mechanical pain threshold was hourly measured over the next 4 h, using the randall-sellitto method. the cxinduced hypoalgesia was reversed by low doses of latrunculin b or cytochalasin (latrunculin 100% reversal = 1.26 nanomoles), higher doses of microtubule inhibitors (taxol 100% reversal = 23.4 nanomoles) with no effect of acrylamide (7 up to 141 nanomoles).we conclude that 1) local changes in (paw) cytoskeleton occurred during cxinduced hypoalgesia and 2) actin microfilaments were the cytoskeletal components most critically involved in this hypoalgesia.financial support: cnpq, fapemig and capes there are reports regarding the up-regulation of cyclooxygenase isoenzyme particularly inducible isoform i.e. cox-2 in brain during neurodegenerative or neuropsychiatric disorders.in the present study, we examined the effect of nimesulide (a preferential cox-2 inhibitor) in subchronic immobilization stress. mice were subjected to immobilization stress for 6 hrs daily for a period of seven days. nimesulide (2.5 mg/kg, i.p.) was administered daily for 7 days before challenging them to immobilization stress. behavioral analysis revealed the hyperlocomotor activity and increased anxious response. subchronic stress decreased % retention of memory and also caused hyperalgesic response in mice. biochemical analysis revealed that chronic immobilization stress significantly increased lipid peroxidation and nitrite levels and decreased the reduced glutathione and adrenal ascorbic acid levels. chronic treatment with nimesulide significantly attenuated the immobilization stress-induced behavioral and biochemical alterations. these results suggested that the use of nimesulide could be a useful neuroprotective strategy in the treatment of stress. there is accumulated evidence for ngf role as a peripheral pain mediator. ngf is upregulated in diverse inflammatory conditions and evokes hyperalgesia when injected in humans and rats. ngf increase was also observed in temporomandibular join (tmj) after cfa injection, indicating its possible involvement in local hyperalgesic states. therefore, the objective here was to evaluate if ngf participate in the tmj nociception. to test this hypothesis, the ngf was injected into the tmj alone or after carrageenan (cg) and the spontaneous nociceptive behavior of head flinches was counted for up 30min. further evidence for the ngf nociceptive activity was obtained quantifying the local production of ngf after cg injection, by elisa, and the fos-like immunolabeling in the trigeminal sensory nucleus (including the caudalis, interpolaris and oralis) after ngf injection. injections were performed in 0.25ul. ngf (0.2, 1 and 5ug) injected in the tmj challenged 1h prior by cg (100ug) induces a dose-dependent increase in the number of head flinches. this increase was reduced by k252a (1 and 2ug), indicating a trka receptor-mediated effect. we detected a significant increase in the ngf production 1 and 3h after the tmj cg (300ug) injection. the tmj injection of ngf (5ug) alone did not induce detectable spontaneous nociceptive behavior. however, the ngf (5ug) injection induces a significant increase in the fos like immunolabeling (fli) in the sensory trigeminal nucleus compared to the saline injection. these results indicate that the ngf participates in the nociceptive activity in the tmj, specially in inflammatory conditions. mif was reported as a key cytokine in the pathogenesis of rheumatoid arthritis (ra) several years ago, but it now clear that mif is also involved in the pathogenesis of systemic lupus erythematosus (sle) and atherosclerosis. mif-deficient lupus-prone mrl/lpr mice exhibit prolonged survival and reduced renal and skin disease compared to mif-expressing mice. similarly, mif-deficient atheroma-pone ldlr-deficient or apoe-deficient mice are significantly protected from disease and antimif mab therapy is beneficial. ra and sle are each characterised both by an increased prevalence of atherosclerotic vascular disease and by overexpression of mif. given the effects of mif on atherosclerosis it can be hypothesised that mif overexpression participates in the risk of atherosclerotic vascular disease in ra and sle. recent data have provided insights into mechanisms of action for mif relevant to all these concepts. firstly, the newly described role of mif in the selective recruitment of monocyte-macrophage lineage cells is of particular relevance to ra, sle, and atherosclerosis, with evidence that mif mediates macrophage recruitment in sle and atherosclerosis. secondly, glucocorticoid (gc) therapy is possible risk factor for atherosclerosis in patients with ra and sle, and it is now clear that gc increase the expression and release of mif, potentially implicating mif in gc-related increases in atherosclerosis in ra and sle. specific therapeutic targeting of mif in ra and sle may address not only primary disease pathways but also the increased risk of atherosclerosis in these diseases. to enter inflamed tissues, leukocytes must undergo adhesion molecule-mediated interactions with the endothelial surface of vessels at the site of inflammation.cytokines such as tumour necrosis factor (tnf) are established as important mediators capable of promoting leukocyte-endothelial cell interactions.however, in inflammatory diseases such as atherosclerosis and rheumatoid arthritis, elevated expression of another cytokine, macrophage migration inhibitory factor (mif) occurs, yet the role of this cytokine in leukocyte recruitment is unknown.therefore we explored the ability of mif to regulate leukocyte recruitment.this was achieved using intravital microscopy to examine the intact microvasculature in mice following local mif treatment. these experiments showed that mif induced leukocyte adhesion and transmigration in vivo, resulting in accumulation of predominantly cd68+/f4/80-ve/cd11c-ve monocyte/ macrophage lineage cells.mif did not induce upregulation of adhesion molecules p-selectin and vcam-1, although their constitutive expression contributed to recruitment.in contrast, mif-induced recruitment was blocked by antibodies to the monocyte-specific chemokine, ccl2/mcp-1, and its receptor ccr2, and in response to anti-cxcr2.this was supported by in vitro experiments showing that mif induced ccl2/mcp-1 release from cultured murine endothelial cells.finally, mice lacking cd74, the putative mif binding molecule, did not respond to mif.these data demonstrate a previously unrecognized function of this pleiotropic cytokine: induction of monocyte migration into tissues, and indicate the involvement of a pathway involving a complicated chemokine/chemokine receptor pathway with contribution from cd74.this function may be critical to the ability of mif to promote diseases in which macrophages are key participants. gm-csf and m-csf (csf-1) can enhance macrophage lineage numbers as well as modulate their differentiation and function. of recent potential significance for the therapy of inflammatory/autoimmune diseases, their blockade in relevant animal models leads to a reduction in disease activity. what the critical actions are of these csfs on macrophages during inflammatory reactions are unknown. to address this issue, adherent macrophages (gm-bmm and bmm) were first derived from bone marrow precursors by gm-csf and m-csf, respectively, and stimulated in vitro with lps to measure secreted cytokine production, as well as nf-kb and ap-1 activities. gm-bmm preferentially produced tnfa, il-6, il-12 and il-23 while, conversely, bmm generated more il-10 and ccl2; strikingly the latter population could not produce detectable il-12 and il-23. following lps stimulation, gm-bmm displayed rapid ikba degradation, rela nuclear translocation and nf-kb dna binding relative to bmm, as well as a faster and enhanced ap-1 activation. each macrophage population was also pre-treated with the other csf prior to lps stimulation and found to adopt the phenotype of the other population to some extent as judged by cytokine production and nf-kb activity. thus gm-csf and m-csf demonstrate at the level of macrophage cytokine production different and even competing responses with implications for their respective roles in inflammation including a possible dampening role for m-csf. granulocyte macrophage-colony stimulating factor (gm-csf), initially discovered for its role in the differentiation of haematopoietic cells into granulocytes and macrophages, can also affect mature cell function and may be considered proinflammatory. gm-csf is able to prime macrophages for increased pro-inflammatory responses, including the increased release of tnfa and il-12 following stimulation with, for example, lps. in addition, gm-csf has been shown in vivo, using murine disease models, to play a key role in a number of inflammatory diseases. gm-csf-/-mice have been shown to be resistant to several diseases, including arthritis, and, most notably, blockade of gm-csf with a neutralizing monoclonal antibody was effective at ameliorating arthritis when given either prophylactically or therapeutically. t cells appear to be the major cell type responsible for gm-csf production required for arthritis, and gm-csf appears important in the effector phase of disease, subsequent to t cell activation. blockade of gm-csf results in fewer inflammatory cells, particularly macrophages, and cytokines such as tnfa, at the site of inflammation. these findings suggest that blockade of gm-csf may be an effective treatment in a range of inflammatory diseases. the autoimmune disease type 1 diabetes mellitus (t1dm) is thought to be mediated by autoreactive t cells recognizing islet autoantigens, including gad65, ia-2 and proinsulin. this disease arises on a distinctive genetic background, mapping most notably to the mhc, and is also open to strong environmental influence. to investigate the pathogenesis of the disease, and in particular the prevailing paradigm that islet autoreactive t cells are important, we have developed an approach to epitope identification that is mhc allele and autoantigen specific, and operates for both cd4 and cd8 t cells. utilizing this, we have uncovered populations of islet antigen-specific t cells that have the immunological credentials to be both pathogenic (eg th1, tc1) and protective (treg) in the disease. we have cloned some of these cell types, enabling us to analyse their function and provide an insight that will be important for an understanding of disease mechanisms, as well as guiding novel therapeutic interventions. tcr transgenic targeting b:9-23 cause diabetes 2. knockouts of the insulin 2 gene (expressed in thymus as well as islets) accelerates diabetes while knockout of insulin 1 gene (islet expression) prevents 90% of diabetes 3. dual insulin knockout with transgenic insulin with altered peptide (b16:a) prevents all diabetes 4. islets with native b:9-23 sequence, but not altered sequence when transplanted into knockouts restore anti-insulin autoimmunity and diabetes transfer by t cells 5.anti-b9-23 t cells have conserved valpha and jalpha chain usage but no conservation n region or beta chain 6. alpha chain as transgene sufficient to engender anti-insulin autoantibodies 7. kay and coworkers demonstrate insulin reactivity "upstream" of igrp and igrp reactivity nonessential.future studies in nod directed at deleting specific conserved alpha chains to test diabetes prevention and develop therapeutic.in man we can now identify at birth genetic risk as high as 80% of activating anti-islet autoimmunity with mhc analysis and restricted heterogeneity suggesting dominant target.insulin autoantibodies in prospective studies such as daisy usually appear initially and levels are related to progression to diabetes.analysis of cadaveric donors is underway to elucidate primary targets. (t1d) is an autoimmune disease in which genes and environment contribute to cell-mediated immune destruction of insulin-producing beta cells in the islets of the pancreas. the holy grail of autoimmune disease prevention is negative vaccination against autoantigens to induce disease-specific immune tolerance. this has been achieved in rodents by administering autoantigen via a tolerogenic route (mucosal), cell type (stem cell or resting dendritic cell), mode (with blockade of t-cell co-stimulation molecules) or form (as an altered peptide ligand). compelling evidence demonstrates that proinsulin is the key autoantigen that drives beta-cell destruction in the non-obese diabetic (nod) mouse model of t1d, and possibly in humans. proinsulin/ insulin dna, protein or t-cell epitope peptides administered in a tolerogenic manner to the nod mouse can delay or prevent the development of diabetes, via one or more mechanisms (deletion or anergy of effector t cells, induction of regulatory t cells). administration of autoantigen via the mucosal route, which induces anti-diabetic regulatory t cells in the rodent, is the most immediately translatable approach to humans. initial human trials of vaccination with oral autoantigens lacked evidence of bioeffect, probably due to inadequate dosage in end-stage disease. recently, however, the first evidence for a therapeutic effect of mucosal autoantigen has been seen in trials of oral and nasal insulin in islet autoantibodypositive individuals at risk for t1d. combination autoantigen-specific vaccination also shows promise in combination with non-specific immunotherapy in established t1d. leukocyte extravazation is an integral process both physiologically (immunosurveillance) and pathophysiologically (inflammation). the initial paradigm of a 4-step process comprising tethering/rolling, activation, firm adhesion, and diapedesis, each involving specific adhesion molecules, has repeatedly been modified in the light of more recent findings. additionally, organ-specific differences regarding the role of distinct molecules were established. finally, the skin became a good "model" to study due to its accessability and availability of powerful animal models. in-vitro adhesion assays, flow-chamber systems, intravital microscopy, animal models for delayed-type hypersensitivity, and transplantation approaches have successfully been employed to investigate leukocyte extravazation. numerous molecular interactions such as the cutaneous lymphocyte-associated antigen and sialyl-lewisx, or icam-1 and lfa-1, have been proven sufficiently relevant to make them candidates for potential therapies. with the anti lfa-1 antibody efalizumab, approved for the treatment of psoriasis, the first therapeutic agent specifically targeting leukocyte extravazation is already on the market; other compounds are under development. moreover, novel data suggest that well-established anti-inflamamtory therapies such as fumarates also influence this process, thus contributing to their clinical efficacy. ongoing research aks for adopting a more "dynamic" view on leukocyte extravazation as several molecules obviously perform multiple tasks throughout this process rather than being limited to just one step of this multi-step cascade; this is particularly true for the so-called junctional adhesuã­on molecules which obviously mediate more than just diapedesis. finally, similarities between leukocyte extravazation and hematogenic metastases are emerging. consequently, certain anti-inflammatory compounds may turn out to also exhibit striking anti-metastatic efficacy, and vice versa. department of dermatology, heinrich-heine-university, dã¼sseldorf, germany atopic dermatitis, psoriasis vulagaris and cutaneous lupus erythematosus represent chronic inflammatory skin diseases showing distinct clinical phenotypes but sharing one aspect. the recruitment of pathogenic leukocyte subsets into the skin represents a prerequisite for their initiation and maintenance. during recent years, our knowledge of the immunopathogenesis of chronic inflammatory skin diseases increased significantly. with regard to the recruitment pathways of leukocytes, a superfamily of small cytokine-like proteins so called chemokines has attracted significant attention. here the complex interactions within the chemokine ligand-receptor network are introduced, the involvement of chemokines in memory t and dendritic cell trafficking is outlined and current concepts of their role in the immunopathogenesis of atopic dermatitis, psorasis vulgaris and cutaneous lupus erythematosus are summarized. the skin serves as a unique organ for studying general principles of inflammation because of its easy accessibility for clinical evaluation and tissue sampling. a network of pro-inflammatory cytokines including il-1 and tnf-a is known to play a key role in the pathogenesis of cutaneous inflammatory diseases through activation of specific signalling pathways. recently, progress in understanding the underlying mechanisms regulating inflammatory signalling pathways in the immunopathogenesis in skin carcinomas, psoriasis vulgaris and atopic dermatitis has been made. kinases have been identified to play a crucial role in regulating the expression and activation of inflammatory mediators in these inflammatory skin diseases. mitogen-activated protein kinases (mapks) are a family of serine/threonine protein kinases that mediate a wide variety of cellular behaviours in response to external stress signals. increased activity of mapks, in particular p38 mapk, and their involvement in the regulation of synthesis of inflammatory mediators at the transcriptional and translational level has recently been demonstrated. progress in our understanding of inflammatory signalling pathways has identified new targets for treating inflammatory diseases, but the challenge is to place a value on one target relative to another and to evolve strategies to target them. a careful examination of different signalling pathways in various inflammatory conditions is therefore needed. this presentation gathers recent advances in signal transduction in skin inflammation focusing interleukin-1, tnf-âµ, p38 mapk, msk1/2, mk2, nf-kappab and ap-1. histamine is an important inflammatory mediator in humans, and despite their relatively modest efficacy antihistamines are frequently used to treat allergic conditions, as well as other histamine-mediated reactions such as pruritus. in contrast, antihistamines are of very limited use for controlling other conditions where histamine production is abundant, including asthma. the discovery of the histamine h4 receptor (h4r) prompted us to reinvestigate the role of histamine in pulmonary allergic responses, as well as in pruritus. h4r deficient mice and mice treated with h4r antagonists exhibited decreased allergic lung inflammation in several models, with decreases in infiltrating lung eosinophils and lymphocytes and decreases in th2 responses. ex vivo restimulation of primed t cells showed decreases in th2 cytokine production, and in vitro experiments suggest that decreased cytokine and chemokine production by dendritic cells after blockade of the h4r was responsible for the the t cell effects. the influence of h4r on allergic or histamine-induced pruritus was explored in mice using selective histamine receptor antagonists and h4r deficient mice. the h4r was found to mediate the majority of histamine-mediated and allergic itching, while the contibution by the h1r was minor. surprisingly the h4r effect was independent of mast cells or other hematopoetic cells. this work suggests that the h4r can modulate both allergic responses via its influence on t cell activation, and pruritus through mechanisms that are independent of hematopoetic cells. the studies show that the h4r mediates previously uncharacterized effects of histamine and highlight the therapeutic potential of h4r antagonists. (1), bsp reddy (2) (1) nizams institute of medical sciences, hyderabad; india (2) genix pharma, india rupatidine, carries the majority of the histamine h1receptor -blocking activity and has been introducedfor the treatment of allergic rhinitis and urticaria. objectives: the aim of this study was to compare the effect of two by measure of inhibition of histamine induced wheal and flare response. methodology: 12 male volunteers were enrolled after written informed consent before to ethic committee approved protocol. in this randomised, double-blind, single oral dose, cross overstudy, they were randomized to receive either 10 mg rupatidineformulation after overnight fast. washout was 10 days. wheal and flare were induced on the forearm of the trial subjects, by histamine intradermally injection while the subject was lying comfortably with arm resting on the bed. ten minutes later, wheal and flare were visualized under a bright lamp. histamine induced wheal and flare skin test was performed before and regularly to 24hours after drug administration. results: administration of reference and test formulations of rupatidine, significantly inhibited the histamine induced cutaneous response in all the subjects. the least square mean ratio (%) t vs r for peak activity imax-% (maximum inhibition of histamine induced wheal and flare response); area under the activity time curve (auc0-24 mmsq/hr and auc 0-24 %/hr) both for untransformed and log transformed data were found to be within 80-125% of90% ci limits both formulations well tolerated. conclusions: it can thus be concluded that be concluded that test formulation of rupatidine tablet is bioequivalent to reference rupatidine tablet (1), h yoshimura(1), k ohara (1), y mastui (1), h hara (1), h inoue (1), h kitasato (1), c yokoyama(2), s narumiya (3), m majima (1) (1) kitasato university school of medicine, kanagawa, japan (2) tokyo dental medical colledge, tokyo, japan (3) kyoto university school of medicine, kyoto, japan thromboxane (tx) a2 is a potent stimulator of platelet activation and aggregation and vascular constriction. we have reported the magnitude of cytokine-mediated release of sdf-1 from platelets and the recruitment of nonendothelial cxcr4+ vegfr1+ hematopoietic progenitorsconstitute revascularization. we hypothesized that txa2 induces angiogenic response by stimulating sdf-1 and vegf which derived from platelet aggregainflamm. res., supplement 3 (2007) tion.to evaluate this hypothesis, we dissected the role of the txa2 in angiogenesis response using mouse hind limb model. recovery from acute hind limb ischemia, as assessed by the ratio between the treated ischemic limb and the untreated control right limb was assessed in wild type mice (c57bl/6 wt) , prostaglandin i2 receptor (ip) knock out(ipko) and thromboxane (tx) a2 receptor (tp) knock out(tpko). blood recovery in tp-/-significantly delayed compared to wt and ipko. immunohistochemical studiesrevealed that tp-/-mice were less stained against pecam positive cells compared to wt and ipkoplasma sdf-1 and vegf concentration were significantly reduced in tp-/-mice. we observed during in vivo fluorescence microscopic study that compared to tpko, ipko and wt significantly increased platelet attachment to the microvessels around ligated area. tpko translpanted wt bone marrow cells increased blood recovery compared to tpko transplanted tpko bone marrow cells. in addition, mice injected with txa2 synthase c-dna expressing fibroblast increased blood flow recovery compared to control mice. these results suggested that tp signaling rescues ischemic condition by inducing angiogenesis by secreting sdf-1 and vegf from platelet aggregation. purpose: the s100 calcium-binding proteins, a8, a9 and a12 are constitutively expressed in neutrophils and induced in activated macrophages. high levels are found in sera from patients with infection and several chronic inflammatory diseases. the calgranulin complex, a8/a9 is anti-microbial; a8 has oxidant-scavenging functions. a12 is chemotactic for monocytes, and recruits leukocytes in vivo by activating mast cells (mc). effects of these mediators on mc and monocyte function were compared. methods: human pbmc or murine mc were activated in vitro with s100 and mediator release and cytokine induction (assessed by quantitative rt-pcr/elisa), determined. a cys41 to ala41 a8 mutant was used to determine whether effects on mc are mediated by redox. immunohistochemistry was used to demonstrate s100s in asthmatic lung. the s100s were expressed in asthmatic lung, particularly in eosinophils and alveolar macrophages. strong reactivity occurred with an antibody recognising predominantly the hypochlorite-oxidised from of a8. a8, a9 or the a8/a9 complex had relatively low ability to induce il1, tnf, il6, and chemokines mrna from pbmc compared to a12. only a12 induced significant levels of il13; none induced il4 or gm-csf mrna compared to lps. in contrast to a12 which is activating, a8 significantly inhibited mc degranulation provoked by ige cross-linking; suppression was dependent on cys41. conclusions: the cytokine profile generated by a12 in mc and monocytes strongly supports a role the pathogenesis of asthma. in contrast, results strongly support a role from a8 in oxidant defence, particularly to hypobromite generated by activated eosinophils. (1), d mankuta(2), g gleich (3), f levi-schaffer (1) (1) hebrew university of jerusalem, israel (2) hadassah university hospital, israel (3) university of utah, usa the onset, amplitude and termination of allergic responses is regulated at the mast cell/eosinophil interface. eosinophil major basic protein (mbp), which activates mast cells in the late-chronic phase of allergic inflammation, is a central determinant in this interface. characterized more than two decades ago, the exact nature of this activation has not been clarified as yet. here we demonstrate that mbp exerts its activating effect on human mast cells and basophils through cd29 and hematopoietic cell kinase (hck). a genome-wide analysis showed that hck displays shifts in mrna levels specifically upon mbp-induced mast cell activation. hck also shows a unique priming pattern prior to this activation. cd29 is phosphorylated specifically upon activation with mbp and deploys a signaling complex that critically depends on hck. extracellular neutralization of cd29 interferes with mbp entry into the cell, and this as well as rna silencing of hck results in defective mbp-induced activation. finally, cd29 neutralization abrogates mbp-induced anaphylaxis in-vivo. these findings picture for the first time a chronic-phase specific pathway mediating eosinophil-induced mast cell activation with critical consequences for the therapy of chronic allergic inflammation. alexander robinson (1), d kashanin (2), f odowd(2), v williams(2), g walsh (1) (1) cellix ltd, institute of molecular medicine, dublin, ireland (2) university of aberdeen, scotland, uk leukocyte adhesion to endothelial cell bound proteins, such as icam-1 and vcam-1, is an initial step of the inflammatory response. we have developed an in vitro microfluidic system which mimics conditions found in blood vessels in vivo during an immune response. using this system, we can record leukocyte adhesion levels under physiologically relevant flow conditions (e.g. 0-5 dynes/cm2). the adhesion profiles of resting and pmastimulated peripheral blood lymphocytes (pbls) were recorded, with respect to vcam-1, icam-1, and bsa. images at each shear stress level were captured using a digital camera, and analysed using our in-house ducocell software package. distinct morphological changes in pma-stimulated pbls, compared to non-stimulated cells, can be observed. these include a less rounded appearance of the pma-stimulated pbls, and evidence of "uropod" formation, which anchor the t cell to the endothelium as part of the migration process. levels of adhesion to vcam-1 are high (80-90%, compared to control), but there appears to be little difference between the adhesion profiles of non-stimulated and pma-stimulated pbls.however, there is a distinct difference between the adhesion levels of non-stimulated and pma-stimulated pbls to icam-1, with pma-stimulated cells showing a higher affinity for icam-1 than nonstimulated cells (approx. 70% and 40%, respectively).pbl adhesion to bsa is negligible. we present a novel in vitro microfluidic pump system that can simulate leukocyte adhesion to the endothelium under flow conditions. this platform is a more efficient and economical system compared to those currently available, due to reduced material costs and style of construction. introduction: pulmonary aspiration of gastric contents is a common complication observed in icu patients and a potential trigger of ards. in this study we evaluated the course of lung inflammation induced by intranasal instillation of gastric juice (gj). methods: gj was obtained from donor rats (ph 1.6). male c57bl/6 were instilled with 2 ml/kg of gj. after 2 or 24 h, the animals were sacrificed and lung and balf were collected. control group consisted of non-manipulated mice. 287.3ae18.6, sg24h: 277.8ae63.8; pg/ml). discussion: gj aspiration induced an initial adherence of pmn to lung tissue that is correlated with increased tnf-a/il-10 ratio in balf at the 2nd h. the reduction of mpo activity is correlated with the decrease in tnf-a/il-10 ratio. the late increase of pmn in balf might be a consequence of the early production of tnf-a. the results are suggestive that the treatment of patients exposed to acid aspiration should be focused in the initial period of the insult and in the blockage of tnf-a. objectives: intestinal i/r is implicated as a prime initiating event in the development of acute respiratory distress syndrome (ards) after trauma and hemorrhagic shock. we investigated the effects of lps challenge to mice previously submitted to i-i/r, a two-hit model of acute lung injury. methods: male c57bl/6 mice were subjected to 45 min of intestinal ischemia and challenged with 0.1 mg/kg of intranasal lps at the 4th hour of reperfusion (two-hit). balf and culture of lung explants were performed 20 h after lps challenge. mice subjected to i-i/r or lps alone were used as controls. results: two-hit mice showed marked increase in lung evans blue dye leakage compared to i-i/r (375.5ae53.9 vs 48.8ae3.5, mg/mg). lung mpo was increased (0.30ae0.03 vs 0.15ae0.03; od 450nm) whereas the neutrophil recruitment to balf was inhibited in the two-hit group compared to lps group (11.5ae2.6 vs 28.5ae3.4; x 10e3cells/mouse). the levels of nox-in the two-hit group were significantly increased when compared to i-i/ r controls in balf (10.6ae0.5 vs 6.5ae0.8; mm) and in lung explants (3.1ae0.3 vs 1.3ae0.1; mm/mg of tissue). conclusions: intestinal i/r predisposes the animal to an exacerbated response to a low dose lps insult. the exacerbated production of nitric oxide observed in the two-hit group may cause endothelial damage, thereby explaining the major increase in vascular permeability in the two-hit group. the results are suggestive that patients exposed to systemic inflammatory response might develop ards when in contact with secondary inflammatory stimuli. nitric oxide may play an important role in this process. (1) (1) novartis institutes for biomedical research, horsham, uk (2) university of michigan, usa obligatory for using oxygen in energy transfer pathways was the simultaneous co-evolution of enzymes that detoxify the reactive species formed as by-products. thus, we hypothesized that individuals with low aerobic function will have reduced anti-oxidant capacity and, therefore, be more susceptible to smoking-related lung diseases like copd. to test this hypothesis, we exposed high capacity runner (hcr) and low capacity runner (lcr) rats to 3 months of whole-body smoke exposures.the animals, bred over successive generations on the same background strain for high or low running capacity, differ by over 500% (p<1x10-37) for exercise capacity, measured by running on a treadmill.after 3 months of exposures, inflammatory cells in bronchoalveolar lavage fluid were increased in both the hcr-and lcr-smokeexposed(se) animals compared to air-exposed controls (p<0.001); however there was a 2-3-fold increase in the number of neutrophils and lymphocytes in the lcr-over the hcr-se group (p<0.001).histopathology revealed there was greater inflammation and lung damage present in the lcr-versus hcr-se group (p<0.05). metabonomic (metabolite profiling) analysis revealed that while peroxidation of lung lipids occurred for both se groups, oxidative damage to the lung surfactant layer was significantly more extensive for the lcr-se. systemic oxidative damage was also more apparent in the lcr-se group, with metabolic profiling suggesting a reduced capacity to regenerate muscle glutathione. the metabolic data suggest that repair processes maybe more effective in the hcrs. in summary, these data support the concept that aerobic capacity may be central to ones susceptibility to developing smoking-related lung disease. (1), ap ligeiro-oliveira(1), jm ferreira-jr(4), sr almeida(1), w tavares de lima(1), shp farsky (1) (1) university of sâ¼o paulo, brazil (2) regional integrated university of alto uruguai and missã°es, brazil methods: male wistar rats were exposed to vehicle or hq (50 mg/kg; ip.;daily, 22 days, two-day interval every five days). on day 10, animals were ip sensitized with ovalbumin (oa). assays were performed on day 23. results: hq-exposed rats presented reduced number of leukocytes in the bronchoalveolar fluid and by impaired in vitro oa-induced tracheal contraction. the latter effect suggests reduction on mast cell degranulation, and it was corroborated by in vivo decreased mesenteric mast cell degranulation after topical application of oa. the oa-specificity response was confirmed by normal ability of mast cells to degranulate in both groups of animals after topical application of compound 48/80. in fact, lower levels of circulating oa-anaphylactic ige antibodies were found in hq-exposed rats. this latter effect was not dependent on number or proliferation of lymphocytes, nevertheless reduced expressions of costimulatory molecules cd45 and cd6 on oa-activated lymphocytes indicated the interference of hq exposure on signaling of the humoral response during an allergic inflammation. contact information: ms sandra manoela dias macedo, regional integrated university of alto uruguai and missã°es / university of sâ¼o p, department of clinical and toxicological analyses, sâ¼o paulo, brazil e-mail: smdmacedo@yahoo.com.br (1) (1) radboud university nijmegen, medical centre, nijmegen, the netherlands (2) university hospital, zã¼rich, switzerland toll-like receptors (tlr) are essential in the recognition of invading microorganisms. however, increasing evidence shows involvement of tlr in autoimmunity, such as rheumatoid arthritis (ra), as well. here we investigated whether synovial expression of tlr3 and tlr7 was associated with the expression of ifna, tnfa, il-1b, il-12, il-17, and il-18 and studied in what way these receptors and cytokines were associated in vitro. using immunohistochemistry, we found that tlr3 / tlr7 expression in synovial tissue was associated with the presence of ifna, il-1b and il-18, but not tnfa, il-12 and il-17. to investigate whether ifna, il-1b and il-18 could induce tlr3 / tlr7 upregulation in vitro, we incubated separate lymphocyte populations with these cytokines and subsequently determined tlr3/7 mrna expression. ifna incubation resulted in significant tlr3 /tlr7 upregulation, whereas il-1b and il-18 did not. pre-incubation with ifna and subsequent stimulation of tlr3 /tlr7 significantly enhanced il-6, tnfa and ifna/b production, indicating that the ifn-induced tlr upregulation was functional. low amounts of biologically active il-1b were produced upon stimulation with atp, but not upon tlr3 / tlr7 stimulation, although mrna levels were high. interestingly, ifna-priming significantly increased the atp-induced il-1b production. here, we demonstrated a dual role for ifna in vitro, which could explain the association between tlr and il-1b / il-18 in synovial tissue. first, involvement in tlr3 /tlr7 regulation and second, involvement in atp-induced production of biologically active il-1b. these results suggest involvement of anti-viral immune responses in ra and ifna as a key player in chronic inflammation. the pathogenesis of chronic joint inflammation remains unclear although the involvement of pathogen recognition receptors (ppr) has been suggested recently. here, we described the role of two members of the nacht-lrr (nlr) family, nod1 (nucleotide/ binding oligomerization domain) and nod2 in model of acute joint inflammation induced by intraarticular injection of tlr2 (toll-like receptor) agonist streptococcus pyogenes cell wall fragments. we found that nod2 deficiency resulted in reduced joint inflammation and protection against early cartilage damage. in contrast, nod1 gene deficient mice developed enhanced joint inflammation with concomitant elevated levels of proinflammatory cytokines and cartilage damage. to explore whether the different function of nod1 and nod2 occurs also in humans, we exposed pbmcs carrying either nod1frameshift or nod2frameshift mutation with scw fragments in vitro. both tnfa and il-1b production was clearly impaired in pbmcs carrying the nod2fs compared to pbmcs isolated from healthy controls. in line with the nod1 gene deficient mice, human pbmcs bearing the nod1 mutation produced enhanced levels of proinflammatory cytokines after 24h stimulation with scw fragments. these data indicated that the nlr family members nod1 and nod2 have a different function in controlling tlr2-mediated pathways. we hypothesize that intracellular nod1-nod2 interactions determine the cellular response to tlr2 triggers. whether lack of controlling tlr2-driven pathways by nod1 signalling is involved in the pathogenesis of autoinflammatory or autoimmune disease, such as rheumatoid arthritis (ra), remains to be elucidated. leukocyte immunoglobulin-like receptors (lilrs) are a family of receptors with potential immune-regulatory function. activating and inhibitory receptors play a role in maintaining immunological equilibrium and an imbalance may lead to the onset of autoimmune diseases such as rheumatoid arthritis (ra). ra is a chronic inflammatory disease of joints caused by mediators (i.e. tnf-a) produced by activated leukocytes. we recently demonstrated expression of activating lilra2 in synovial tissue macrophages from ra patients. the aim of this study was to determine expression and function of lilra2 in monocytes and macrophages. peripheral blood mononuclear cells (pbmc) were prepared by standard density gradient separation and in vitro-derived macrophages were generated by differentiating thp-1 cells with vitamin-d3. lilra2 expression was measured by flow cytometry before and after modulation with cytokines. differentiation to macrophages significantly up-regulated lilra2 expression (p=0.0239). treatment of macrophages with lps, tnf-a, il-1b and ifn-g but not il-10 caused significant down-regulation of lilra2 (p<0.01). function of lilra2 was assessed by cross-linking with plate-immobilised lilra2-specific mab. soluble tnf-a was measured by elisa. activation of cells elicited tnf-a production in a dose-dependent manner while time-course analysis shows maximal production at 18h. correlation between lilra2 expression and response to cross-linking indicates that level of expression may relate directly to the degree of activation. decrease expression in response to acute-phase cytokines suggests controlled regulation during inflammation. in ra, abnormal regulation of lilra2 could potentially exacerbate inflammation by inducing uncontrolled production of proinflammatory cytokines. pharmacological blocking of lilra2 could potentially provide therapeutic benefit. (1) (1) university of valencia, spain (2) northwick park institute for medical research, uk co-releasing molecules (co-rms) mimic the biological actions of co derived from heme oxygenase activity. in the present work we studied the effects of a water-soluble co-releasing molecule (corm-3) on an animal model of human rheumatoid arthritis. dba-1/j mice were treated with corm-3 (5, 10 or 20 mg/kg/day, i.p.) from day 22 to 31 after collagen-induced arthritis (cia) and sacrificed on day 32. administration of corm-3 resulted in a significant improvement of the clinical profile of this disease since it markedly reduced joint swelling and redness. histological analysis of the joints in control arthritic mice indicated the presence of granulocytes and mononuclear cells, cartilage erosion, chondrocyte death and proteoglycan depletion. all these parameters were significantly reduced by corm-3 treatment with the most pronounced protective effect observed at 10 mg/kg. the levels of pro-inflammatory mediators (pge2, il-1beta, tnfalpha, il-2 and il-6) in the hind paw homogenates were significantly inhibited by corm-3. in addition, comp levels in serum, a marker of cartilage degradation, was reduced by the co-releasing agent. our studies show that therapeutic administration of corm-3 alleviates the clinical features of murine cia at the late phase of this response. the beneficial action of co liberated from corm-3 appears to be associated with a decrease in inflammatory cytokines and reduction of cell infiltration into the synovial tissues ultimately leading to a protective effect on the cartilage. aim: to setup a bovine model for cytokine-induced articular cartilage collagen degradation, and characterize the model using a variety of compounds targeting different disease mechanisms relevant to arthritis. methods: full thickness bovine articular cartilage punches were cultured with or without 10 ng/ml il-1a, tnf-a and oncostatin m. after three weeks the cartilage and culture medium were analyzed for weight changes, water content, dna content, glycosaminoglycans (gag), hydroxyproline (hyp), damaged collagen molecules, mmp activity, ctx-ii and comp. diclofenac, dexamethasone, pioglitazone, remicade, risedronate, galardin and a77-1726 were tested for their effect on cartilage degradation. results: exposure of articular cartilage to cytokines resulted in a decreased cartilage weight, increased proteoglycans degradation, increased collagen degradation, increased percentage of denatured collagen, increased water content and increased levels of active mmps (all p < 0.01). comp release during the first week of culture showed a trend towards up regulation during the first week of culture for all three donors, this was however not significant due to the small number of donors. most of the described processes were modulated by one or more of the drugs tested, indicating that this model for articular cartilage destruction is sensitive to treatment. discussion: stimulation of bovine articular cartilage explants with a cocktail of il-1a, tnf-a and osm results in clear and consistent changes in the cartilage, highly reminiscent of cartilage destruction during arthritis. further research needs to establish whether the model is also sensitive to anabolic factors that potentially could repair the damage. toll-like receptors (tlrs) may contribute to the progression of rheumatoid arthritis through recognition of hostderived damage-associated ligands that have repeatedly been found in arthritic joints. involvement of tlr2 and tlr4 activation in the expression of arthritis was studied using interleukin-1 receptor antagonist deficient (il-1ra-/-) mice, which spontaneously develop an autoimmune t-cell mediated arthritis. spontaneous onset of arthritis was dependent on tlr activation by microbial flora, as germ-free mice did not develop arthritis. after crossing with tlr knockouts, il-1ra-/-tlr2-/-mice developed more severe arthritis compared to il-ra-/-tlr2+/+ littermates; whereas, tlr4-/-il-1ra-/-mice were protected against arthritis. to clarify the mechanism by which tlr2 and tlr4 differentially regulated the disease expression, we studied the role of these tlrs in il-23 production and th17 development, both important in il-1ra-/-arthritis. wild type bone-marrow-derived dendritic cells (bmdcs) produced similar levels of il-23 upon stimulation with tlr2 and tlr4 ligands; however, il-1ra-/-bmdcs produced less il-23 than wild type dcs upon tlr2 stimulation and more il-23 than wild type dcs upon tlr4 stimulation. furthermore, il-1ra-/-t cells produced lower amounts of il-17 when cultured with tlr2-activated apcs and higher amounts of il-17 when cultured with tlr4-stimulated apcs, both in combination with cd3 stimulation. facs analysis of th17 (cd4+/il-17+) cells from both spleen and draining lymph nodes revealed 70% reduction in il-1ra-/-tlr4-/-mice compared to il-1ra-/-tlr4+/+ littermates. specific cd3/cd28 stimulation of non-adherent splenocytes confirmed lower il-17 production in il-1ra-/-tlr4-/-. these findings suggest important roles for tlr2 and tlr4 in regulation of th17 development and expression of arthritis. prostaglandine2 (pge2) stimulates the transactivational activity of p53 through p38map kinase-dependent ser15 phosphorylation (jbc 2006) .p53 controls cell-cycle progression, in part, by differential regulation of ap-1 proto-oncogenes (jun/fos).currently we studied pge2 control of cyclin d1 promoter activity with particular attention to the role of ap-1 oncogenes.pge2 induced a 7.6 fold increase in junb mrna expression (northern blot), a 2.1-fold increase in junb promoter activity (luciferase assay), and increased ser259junb phosphorylation in human synovial fibroblasts (hsf) (western blot).c-jun was strongly inhibited while jund, c-fos, fra1/ 2, and fosb expression were upregulated by pge2.in cell-cycle experiments, transformation with a constitutively active ha-ras construct (ras g12v) resulted in a 3.9 fold increase in cyclin-d1 promoter activity, cyclin-d1 synthesis, thr202/tyr204 phosphorylation of erk1/2 (6.2 fold) and ap-1 (c-jun)-dependent transactivity (3.1 fold); cyclin d1/cdk4-6 inhibitor p16ink4a synthesis was suppressed. addition of excess rass17n dominant negative mutant construct to the plasmid mix abrogated the aforementioned processes.ectopic expression of c-jun, c-fos and especially jund expression constructs stimulated cyclin d1 promoter activity/protein synthesis, blocked p16ink4a synthesis; the latter effects were reversed by the addition of excess junb.pge2 exerted temporal and bi-phasic dose-dependent control of the cyclin d1 promoter activity, largely through differential ap-1 activation and promoted cell cycle arrest and apoptosis in hsf at high physiological concentrations.the results provide further insight into the biology of the cpla2/ cox/pges biosynthetic axis and highlight the complexity of pge2 action in terms of cell-cycle progression. di-glucopyranosylamine (diga) is an antikeratitic (roberts et al., 1990 , acvo conference, scottsdale) immunomodulatory pyranosyl disaccharide with parenteral anti-rheumatic activity (bolton et al., 2005 , inflammation res. 54(s2) s121) and unknown mechanism of action.interestingly, anti-tnf therapy is anti-keratitic.-diga hydrolyses to monoglucosylamine (mga) and glucose, which is prevented by n-acetylation (nacdi-ga).lider (1995, pnas. 92: 5037-41) showed that sulphated disaccharides are orally active, inhibit tnf synthesis and the dth reaction.we have investigated the anti-tnf and anti-rheumatic activity of the sulphated and free digas.human whole blood (hwb) was stimulated with pha (5mg/ml) to synthesise tnf.antigen induced arthritis (aia) was induced in methylated bovine serum albumin (mbsa) sensitised c57bl/6 mice challenged i.a. into the stifle joint.collagen arthritis (cia) induced in dba mice by sensitisation to bovine collagen, were boosted i.p. with collagen at day 21. hwb tnf synthesis was inhibited by diga, mga and nacdiga(ic50 <0.1mm). diga (10ml, 1mm) i.a. prevented 24 hour aia (-0.32+/-0.06mm).diga at 100mg/kg reduced aia when administered i.v. (-0.40+/-0.13mm, p<0.05) and i.p. (-0.34+/-0.13mm, p<0.05), but is hydrolysed p.o. (0.24+/-0.08mm ns). polysulphated diga (diga8s) was unstable, but stabilised by n-acetylation (nacdi-ga8s).tnf synthesis was potently inhibited by both nacdiga and nacdiga8s (ic50 <0.1mm).nacdiga8s (100mg/kg p.o.) inhibited aia (-0.43+/-0.13mm), and nacdiga8s with lower degrees of sulphation (mw 800 and 1200 kda) inhibited the development of mouse collagen induced arthritis as assessed by clinical score. sulphated diglucosylamines represent a new class of heparinoid which are potent inhibitors of tnf synthesis and possess oral anti-rheumatic activity. excessive no appears to play a key role in the pathogenesis of chronic inflammatory diseases. in this study we aimed to evaluate no synthesis in rheumatoid arthritis (ra) before and after therapy. it was performed on 92 persons, divided into 6 groups: a negative control group of healthy volunteers, a positive control group with ra, a group with ra and physiotherapy (phys), a group with ra and low doses of cimetidine (cim) + doxycycline (dox), a group with ra and combined treatment phys + cim + dox, and a group treated with usual doses of ibuprofen (ibu). serum nitrite/nitrate (griess) was measured in order to evaluate no synthesis. results: compared to the positive control group, in all the treated groups no synthesis decreased significantly. there was no significant difference between phys and cim+dox effect alone. the combined treatment, phys + cim + dox had a much better inhibitory effect on no synthesis. between the phys, cim + dox and phys + cim + dox groups and that treated with ibuprofen, there was no significant difference in reducing no synthesis. conclusions: 1) in ra phys + cim + dox treatment was as efficient as ibuprofen in reducing no synthesis. 2) the low doses of cim and dox may allow a longer treatment due to the lower side effects risk enhanced socs1 expression following exposure of murine macrophages to lps implicated socs1 in the control of lps-mediated signaling. socs1 regulates nfkb signaling in murine macrophages, blocking at the level of mal or ikba phosphorylation. we investigated the role of socs1 in regulating the production tnf by lps and pam3csk4-activated primary human monocytes. blood monocytes were isolated by centrifugal elutriation and either infected with an adenoviral vector expressing socs1 (adv-socs1), control vector (adv-gfp) or left untreated. adv-socs1 monocytes were exposed to tlr4 and tlr2 ligands, lps (500 ng/ml) or pam3csk4 (300 ng/ml). facs analysis demonstrated infection efficiencies of 50ae4% and 67ae4% (n=16, mean ae sem) of monocytes expressing adv-gfp or adv-socs1 at moi 50. adv-socs1 blocked lps and pam3csk4 induced tnf mrna and protein production in a dose-dependent manner. in contrast, il-6 and il-10 production by adv-socs1-infected monocytes was not blocked. adv-socs1 also blocked lps and pam3csk4induced tnf production by macrophages isolated from synovial fluid. infection efficiencies of 67ae1% or 72ae1% were obtained. quantitative western blot analysis revealed that the classically defined nfkb pathway was not altered at the level of ikba or p65 activation. furthermore, the kinetics of lps and pam3csk4induced ikba phosphorylation and degradation in adv-socs1 monocytes remained unaffected (n=5 and 2 donors, respectively). further, analysis of parallel mapk pathways demonstrated no block in p38 or erk mapk pathways. these data suggest that socs1 regulation of lps and pam3csk4-induced tnf production by human monocytes occurs downstream of tlrs, possibly at the level of transcription. recently, beta-nad+ has emerged as a novel extracellular player in the human urinary bladder. beta-nad+ is the natural substrate of cd38 which catalyzes the conversion of beta-nad+ to cadpr. under normal conditions in vivo, there is no or only very small quantities (submicromolar range) of extracellular beta-nad+ compared to intracellular levels (200-1000 mm). during inflammation cell lysis may cause bursts of high local beta-nad+ levels. however, the effect of beta-nad+ on the human detrusor smooth muscle cells (hdsmc) was unknown. the effect of beta-nad+ on cultured (explant technique) hdsmc was determined by: 1) measuring cytosolic free calcium ([ca2+] i) in fura-2 loaded hdsmc using spectrofluorometry and 2) force measurements in 10-20 mg detrusor strips. hdsmc responded to beta-nad+ (40-100 mm) with an immediate and transient increase in [ca2+] i. the ca2+ transient was followed by one or two much slower and transient increases in [ca2+] i, indicative of beta-nad+ enzymatic conversion into cadpr. the ca2+ responses persisted in the absence of extracellular calcium. the ca2+ responses to beta-nad+ were not affected by exposure of hdsmc to atp supporting the notion that the effects of beta-nad+ were not mediated via p2x7 purinoceptors. furthermore, beta-nad+ caused a concentration-dependent detrusor muscle relaxation. this is the first study to report that extracellular beta-nad+ affect intracellular calcium homeostasis and force in hdsmc. these powerful actions of beta-nad+ suggest a role for beta-nad+/cadpr system as a novel extracellular player in the human detrusor during inflammation. aids remains a worldwide threat more than two decades after identification of hiv as the etiological agent. its wide dissemination can be partly attributed to its successful suppression of immunity resulting in disease progression and concomitant opportunistic infections including mycobacterial and cytomegalovirus infections. hiv trans-activator (tat) is one of the regulatory proteins that mediates hiv replication and dysregulates cellular functions such as apoptosis and cytokine expression. for example, tat induces tumor necrosis factor (tnf) and enhances gp120-induced neurotoxicity. we recently showed that tat induces the overexpression of il-10 via cellular kinase pkr and activation of transcription factor ets-1. in this study, we examined whether tat plays a role in perturbing interferon-& (ifn&) signal transduction. we showed that tat impaired ifn&-induced stat1 tyrosine phosphorylation, but had no effects on the serine residue of stat1 and jak kinases in primary human blood monocytes. furthermore, we found that the nuclear translocation of phospho-stat1 was abrogated by tat. the inhibition of phospho-stat1 led to the deformation of stat1 homodimers and subsequent stat-dna complex. to investigate the cellular consequences, we measured the expression of ifn&-stimulated genes including human leukocyte antigen (hla) and 2,5oligoadenylate synthetase (2,5oas), a key enzyme in the activation of latent ribonuclease l. the results showed that tat inhibited transcriptional activation of 2,5oas and hla. taken together, we identified a new role for tat in which it impairs ifn& signal transduction and suppresses inflammation, thus crippling the immune system and contributing to hiv persistence, opportunistic infections and disease progression. caspase-1 belongs to the group of inflammatory caspases and is the activating enzyme for the pro-inflammatory cytokine interleukin-18 (il-18), a cytokine known to play an important role in the pathogenesis of psoriasis. the purpose of this study was to determine the expression of caspase-1 in psoriatic skin and the signaling mechanisms involved in stress induced activation of caspase-1 and il-18. interestingly, increased caspase-1 activity in lesional compared with nonlesional psoriatic skin was seen as determined by western blotting. in vitro experiments in cultured human keratinocytes demonstrated anisomycin induced, p38 mapk dependent increased secretion of procaspase-1 and active caspase-1. furthermore, anisomycin increased the mrna expression of il-18 through a p38 mapk dependent but caspase-1 independent mechanism, reaching a maximum level after 12 hours of stimulation. finally, anisomycin caused a rapid (4 hours) increase in the secretion of proil-18 and active il-18. secretion of active il-18 was mediated through a p38 mapk/caspase-1 dependent mechanism, whereas secretion of proil-18 was mediated by a p38 mapk dependent but capsase-1 independent mechanism. these data demonstrate that the activity of caspase-1 is increased in psoriatic skin and that il-18 secretion is regulated by a p38 mapk/caspase-1 dependent mechanism, making caspase-1 a potential target in the treatment of psoriasis. prostaglandin e2 (pge2) regulates the stability of cyclooxygenase-2 (cox-2) mrna through adenylate/uridylate-rich elements (ares) in the 3untranslated region (3utr) by a positive autocrine/paracrine feed-forward loop. the principal objective of this study was to elucidate the molecular mechanisms involved in the pge2dependent stabilization of cox-2 in human synovial fibroblasts (hsfs). transfection of well-known are binding proteins (aubps) demonstrated that tristetraprolin (ttp) potently destabilized a [luciferase-cox-2 3utr] reporter fusion mrna (71ae5.7% decrease in luciferase activity vs. control). ttp protein levels in hsfs remained constant despite il-1b-induced changes in ttp mrna levels, thus suggesting translational regulation of its expression. pge2 did not affect the transcription or translation of this gene in hsfs. western blot analysis of hsf ttp demonstrated the existence of a specific, covalent~55kda heterocomplex containing ttp (ttphcx). although ttphcxs exact composition and stoichiometry is yet to be defined, pge2 selectively regulated the amount of this heterocomplex in a time-dependent manner. furthermore, protein shuttling studies performed using real-time confocal microscopy revealed that pge2 can induce export of a small nuclear pool of ttp-gfp. finally, transfection of ttp into hsfs also influenced cox-2 gene transcription, thus enabling ttp to regulate cox-2 gene expression at both the transcriptional and post-transcriptional level. in conclusion, we have demonstrated that ttp is an rna binding protein capable of influencing cox-2 mrna stability and transcription and whose localization and interaction with other factors is regulated by pge2. these data can provide important insight into deciphering the role of pge2 in fine-tuning physiological and pathophysiological gene regulation. (1) (1) chinese academy of sciences, shanghai, pr china (2) ohio state university, usa mitogen-activated protein (map) kinases play a critical role in innate immune responses to microbial infection through eliciting the biosynthesis of proinflammatory cytokines. map phosphatases (mkp)-1 is an archetypical member of the dual-specificity phosphatase family that deactivates map kinases. induction of mkp-1 has been implicated in attenuating the lipopolysaccharide (lps) and peptidoglycan (pgn) responses, but how the expression of the mkp-1 is regulated is still not fully understood. here, we show that inhibition of p38 map kinase by specific inhibitor sb 203580 or rna interference (rnai) markedly reduced the expression of mkp-1 in lps or pgn-treated macrophages, which is correlated with prolonged activation of p38 and jnk. depletion of mapkap kinase 2 (mk2), a downstream substrate of p38, by rnai also inhibited the expression of mkp-1. the mrna level of mkp-1 is not affected by inhibition of p38, but the expression of mkp-1 is inhibited by treatment of cycloheximide. thus, p38 mapk plays a critical role in mediating expression of mkp-1 at a posttranscriptional level. furthermore, inhibition of p38 by sb 203580 prevented the expression of mkp-1 in lpstolerized macrophages, restored the activation of map kinases after lps restimulation. these results indicate a critical role of p38-mk2-dependent induction of mkp-1 in innate immune responses. the i-kb kinase (ikk) complex regulates the activation of nf-kb a key transcription factor in inflammation and immunity. whilst ikka activity is necessary for proinflammatory and anti-apoptotic gene expression, ikka has distinct roles in lymphorganogenesis and b cell maturation. here we describe a role for ikka in cell mediated immunity (cmi). paw inflammation in methylated bsa-induced cmi was significantly reduced in transgenic mice expressing a mutant ikka protein that cannot be activated (ikka aa/aa ) compared to wild-type (wt). antigen-induced il-2 and ifng production by ikka aa/aa splenocytes and ikka aa/aa t cell:dc cocultures were also significantly reduced ex vivo. this could be normalised by using wt t cell: ikka aa/aa dendritic cell (dc) but not ikka aa/aa t cell:wt dc combinations. this suggests that reduced cmi in ikka aa/ aa mice is due to a defect in ikka aa/aa t cells not dcs. this is not due to a requirement of ikka in tcrmediated activation of t cells, since anti-cd3/cd28 mediated activation of ikka aa/aa t cells was unaltered. however, lps-induced production of the important th1 cytokine il-12 is impaired in ikka aa/aa dcs. we are currently addressing the hypothesis that ikka activity may be required for the generation and maintenance of antigen-specific t cells in vivo. recently we described a role for ikkâµ in the negative regulation of innate immunity and acute inflammation, which is in contrast to its role shown here in promoting adaptive immunity and antigen-driven inflammation. ikka may represent an alternative target for the treatment of autoimmune disease which would not compromise host defence. as a latent transcription factor, nf-kb translocates from cytoplasm into nucleus upon stimulations and mediates expression of genes important in immunity, inflammation and development. although extensive studies have been done regarding how nf-kb is triggered into nucleus, little is known about how it is regulated inside nucleus. by twohybrid approach, we identify a prefolding-like protein snip that is expressed predominantly and interacts specifically with nf-kb inside nucleus. we show that rnai knockdown of snip leads to impaired nucleus activity of nf-kb and dramatically attenuates expression of nf-kb dependent genes. this interference also sensitizes cells to apoptosis by tnf-a. furthermore, snip forms a dynamic complex with nf-kb and is recruited to the nf-kb enhancesome upon stimulation. interestingly, snip protein level correlates with constitutive nf-kb activity in human prostate cancer cell lines. the presence of nf-kb within nucleus of stimulated or constitutive active cells is significantly diminished without endogenous snip. our results reveal that snip is an integral component of nf-kb enhancesome and essential for its stability in nucleus, which uncovers a new mechanism of nf-kb regulation. bone remodeling is a tightly regulated process that couples resorption of old bone by osteoclasts and the deposition of new bone by osteoblasts. an imbalance between bone formation and bone resorption can result in various metabolic bone diseases, such as rheumatoid arthritis and osteoporosis. osteoclasts are terminally differentiated cells that arise from a haematopoietic stem cell lineage, which also gives rise to monocytes and macrophages. osteoclast differentiation and regulation of this process to maintain bone homeostasis are central to the understanding of the pathogenesis and treatment of bone diseases, such as osteoporosis. in vitro, osteoclast formation from bone marrow macrophages is induced by rankl (receptor activator of nf-kappa b ligand) in the presence of m-csf (macrophage colony stimulating factor). osteoclastogenesis is markedly enhanced in bone marrow macrophages from ifnar1-/-and ifnar2-/-mice and results in increased number of multinucleated cells positive for osteoclast marker, trap (tartrate-resistant acid phosphatase). consequently, the mutant mice develop osteoporotic phenotype, characterised by reduced bone density. these findings suggest that the ifn alpha/beta system is critical for the negative feedback regulation of osteoclastogenesis and that rankl signaling is essential for the induction of osteoclast differentiation. atp acting on p2x7 receptors in macrophage is one of the main physiological signals that lead to the processing and release of the pro-inflammatory cytokine, interleukin-1beta (il-1b), their activation also leads to rapid opening of a membrane pore permeable to dyes such as ethidium. here we identify pannexin-1, a recently described mammalian protein that functions as an hemichannel when ectopically expressed, as this dye-uptake pathway and show that signalling through pannexin-1 is required for processing of caspase-1 and release of mature il-1b induced by p2x7 receptor activation. furthermore, maitotoxin and nigericin, two agents considered to evoke il-1b release via the same mechanism were studied. maitotoxin evoked dye uptake whose kinetics were similar to a slow pannexin-1-independent phase induced by p2x7 receptor activation, and this was unaltered by pannexin-1 inhibition.nigericin did not induce dye uptake.inhibition of pannexin-1 blocked caspase-1 and il-1b processing and release in response to this two stimuli.thus, while pannexin-1 is required for il-1b release in response to maitotoxin, nigericin and atp, a mechanism distinct from pannexin-1 hemichannel activation must underlie the former two processes. introduction: saa is a classic acute-phase protein upregulated during inflammatory response. saa is active on leukocytes and modulates inflammation and immunity through the induction of cytokines, including the chemokine il-8. here we verify the effect of saa on the mrna expression and release of mip-3alpha, a chemokyne involved in the recruitment of dendritic cells. methods: peripheral blood mononuclear cells (pbmc) isolated from peripheral blood by density gradient were cultured in rpmi medium in the presence of saa. mip-3alphaconcentration was determinated in the supernatant of cell cultures by elisa. mrnawas analyzed bythe ribonuclease protection assay (rpa). results: pbmc stimulated with saa (20 ug/ml) induced the expression of mip-3alpha mrna at 2, 4 and 12 hours. mip-3alpha protein was found in the suppernatant of 24 and 42 hours cultures (p<0,05) and the addition of sb 203580 (p38 inhibitor) and pd 98059 (erk 1/2 inhibitor) completely abolished the release of mip-3alpha. conclusions: saa is an inducer of mip-3alpha expression in pbmc and p38 and erk1/2 are important pathway signaling to this effect. saa is one of the factors responsible by the recruitment of dendritic cells. the p38 pathway is activated in numerous inflammatory conditions, including ra, ibd asthma, acute coronary syndrome, and copd, and its activation helps drive the production of inflammatory mediators. inhibitors of p38 decrease mediator production and therefore can produce profound anti-inflammatory effects. arry-797 is a potent inhibitor of p38 enzyme (ic50 < 5nm) with a novel pharmacophore and physiochemical properties distinct from those of other p38 inhibitors, being very water soluble. it is extremely potent in human whole blood, blocking lps-stimulated tnf production with an ic50 < 2nm.in animal models of rheumatoid arthritis (cia and aia) the compound significantly normalized histologic endpoints, such as inflammation, bone resorption and cartilage damage (ed50~3 mg/kg). a phase i single ascending dose clinical study was run in healthy volunteers. after an oral dose of 50, 100, 200, 300 or 400 mg), blood was drawn at various times, stimulated ex vivo with lps, and analyzed for cytokines and inflammatory mediatorsfj arry-797 was well-tolerated and drug exposure was proportional to dose. in ex vivo samples, there was both a time-and concentrationdependent inhibition of il1, pge2 and tnffz with >80% inhibition observed at the 50 mg dose level. the plasma concentrations of drug peaked at~20 ng/ml at the 50 mg dose and cytokine inhibition was sustained for >4 hours, showing that low doses of arry-797 produced profound effects on clinical biomarkers. further evaluation of arry-797 in patients with inflammatory diseases is planned. introduction: we demonstrated that in vivo chronicle blockage of nos (l-name, 20mg/kg; oral route; 14 days) impairs leukocyte-endothelial interactions and neutrophils migration into inflammatory focus. these effects may be depending, at least in part, on decreased expression of l-selectin on leukocytes and pecam-1 on endothelium. aimed to clarify the mechanisms involved on these inhibitory effects, we now investigated the role of l-name treatment on secretion of tnf and il-1b; by circulating leukocytes and migrated peritoneal neutrophils. methods: male wistar rats were treated with l-name (20mg/kg; oral route; 14 days) or sterile saline (control). circulating leukocytes were isolated from blood collected from abdominal aorta and migrated neutrophils were obtained 4 hours after i.p. injection of oyster glycogen (1%;10ml). no (griess reaction) and cytokines (elisa) were quantified in supernatants of 1 x 106 cultured cells before and 18 hours after lps stimulation (5m;g/ml). results: levels of no, tnf and il-1b; were reduced in circulating leukocytes from l-name-treated rats in both basal and lps stimulated conditions. on the other hand, only secretion of il-1b; was impaired by migrated neutrophils. conclusions: results show that in vivo l-name treatment, which partially reduces no production, decreases the secretion of pro-inflammatory cytokines by circulating leukocytes. however, the same pattern of inhibition is not detected if neutrophils are in vivo primed. objectives: to investigate the ability and mechanism of ifn-g to suppress interleukin-1 (il-1)-induced mmp-13 expression in articular chondrocytes. methods: human chondrocytes were treated with ifn-g or il-1beta alone or in combination. mmp-13 mrna was analyzed by rt-pcr. mmp-13 protein, phospho-stat1 and p44/42 mapk levels were measured by western blotting. mmp-13 promoter-luciferase, cmv-cbp/p300 plasmids and stat1 sirna were transfected by calcium phosphate method. ap-1 activity was monitored by elisa. stat1-cbp/p300 interaction was studied by immunoprecipitation. results: ifn-gpotently suppressed il-1-induced expression of mmp-13 and promoter activity. blockade with neutralizing ifn-gr1 antibody revealed that mmp-13 inhibition by ifn-â¼ was mediated by the ifn-â¼ receptor. ifn-beta-stimulated activation of stat1 was directly correlated with mmp-13 suppression. knockdown of stat1 gene by specific sirna or its inhibition with fludarabine partially restored the il-1 induction of mmp-13 expression and promoter activity. ifn-g did not alter activator protein (ap-1) binding ability but promoted physical interaction of stat1 and cbp/p300 co-activator. p300 overexpression reversed ifn-g inhibition of endogenous mmp-13 mrna expression and exogenous mmp-13 promoter activity. conclusions: ifn-g through its receptor activates stat1, which binds with cbp/p300 co-activator, sequesters it from the cell system and thus inhibits transcriptional induction of mmp-13 gene in chondrocytes. ifn-g and its signaling pathways could be targeted therapeutically for (1), p asmawidjaja (1), r hendriks(2), erik lubberts (1) (1) erasmus medical center, department of rheumatology, rotterdam, the netherlands (2) erasmus medical center, department of immunology, rotterdam, the netherlands the objective of this study was to identify the role of il-23 in th17 polarization in the prone autoimmune dba-1 mice with and without collagen-induced arthritis and to evaluate th17 specific cytokine and transcription factor expression. il-23 induced th17 cells in vitro from spleen cells of naã¯ve and collagen-type ii (cii) immunized dba-1 mice. the percentage of th17 cells is markedly higher in cii-immunized versus naã¯ve dba-1 mice. adding il-23 to tgf-beta/il-6 stimulated cd4 + t cells did not significantly increase the percentage of th17 cells. tgfbeta/il-6 in contrast to il-23 induced a relatively high percentage of il-17+/ifn-gamma-cells and low il-17-ifn-gamma+ cells. tgf-beta/il-6 did not increase il-23 receptor expression, which may explain why adding il-23 directly or two days after tgf-beta/il-6 did not result in an increase in the percentage of th17 cells. elevated expression of il-17a and il-17f as well as the th17 specific transcription factor rorgammat was found under il-23 as well as tgfbeta/il-6 conditions. interestingly, il-23 but not tgf-beta/il-6 is critical in the th17 cytokine il-22 expression in t cells from ciiimmunized dba-1 mice. these data show that il-23 was more pronounced in inducing il-17+/ifn-gamma-(th17) cells under cii-immunized conditions. furthermore, il-23 did not markedly increase the percentage of th17 cells induced by tgf-beta/il-6. however, il-23 is critical for the induction of il-22 expression, suggesting a unique role for il-23 in the induction of specific th17 cytokines ebi3 was initially discovered as a transcriptionally activated gene in epstein-barr virus-infected human b lymphocytes, and similar to p40 of il-12. ebi3 protein has been shown to form heterodimers with p28. p28/ebi3 termed il-27, can influence the function of multiple t cell subsets, including naive, effector, regulatory and memory t cells. however, previous studies showed that the overlapped expression of ebi3 and p28 is very limited. these data lead to the hypothesis that ebi3 may play a role independently from its association with p28. thus, to define the function of ebi3, we generated ebi3 transgenic (tg) mice expressing in multiple tissues. ebi3 tg mice exhibited no histologic abnormalities in various organs and normal numbers of naive and memory cd4+, cd8+ t cells, b cells, nk cells and nkt cells. cd4+t cells isolated from spleens of ebi3 tg mice, however, produced less ifn-g than cells from wt (wild type) control mice after in vitro stimulation with anti-cd3 and anti-cd28 antibodies. in vivo studies, delayed-type hypersensitivity (dth) and contact hypersensitivity (chs) responses were significantly reduced in ebi tg compared with wt mice. moreover, the chs responses in ebi3 tg mice were recovered with anti-ebi3 polyclonal antibody. notably, chs reaction in wt mice was increased by anti-ebi3 antibody. in contrast, anti-p28 antibody suppressed chs responses in wt mice. these data suggest that ebi3 acts in different from il-27, and reduces th1 responses. (1), o thaunat(2), x houard (1), o meilhac (1), g caligiuri(2), a nicoletti (2) (1) inserm u698 and university denis diderot-paris 7, chu xavier bichat, paris, france (2) inserm umr s 681, universitã� pierre et marie curie-paris 6, centre de recherche des cordeliers, paris, france arteries are composed of three concentric tissue layers which exhibit different structures and properties. because arterial injury is generally initiated at the interface with circulating blood, most studies performed to unravel the mechanisms involved in injury-induced arterial responses have been focused on the innermost layer (intima). in contrast, the role of the outermost tunica, the adventitia, has attracted relatively little attention and remains elusive. in the present review, we focus on involvement of the adventitia in the response to various types of arterial injury leading to vascular remodeling. several lines of evidence show that the initial insult and the early intimal response lead to the genesis of (neo-) mediators that are centrifugally conveyed by mass transport towards the adventitia. these mediators trigger local adventitial responses including angiogenesis, immuno-inflammation, and fibrosis. we propose that these three processes sequentially interact and that their net balance participates in producing each specific pathological condition. hence, an adventitial adaptive immune response predominates in chronic rejection. inflammatory phagocytic cell recruitment and initiation of a shift from innate to adaptive immunity characterize the adventitial response to proteolysis products in abdominal aortic aneurysm. centripetal adventitial sprouting of neovessels, leading to intraplaque hemorrhages, predominates in atherothrombosis. adventitial fibrosis mediated by low inflammation characterizes the response to mechanical stress and is responsible for constrictive remodeling of arterial segments and initiating interstitial fibrosis in perivascular tissues. these adventitial events thus impact not only on the vessel wall biology but also on the surrounding tissue. atherosclerosis has many of the characteristics of an inflammatory disease, and thus would classically involve endothelial cox-derived prostaglandins such as pge2 and prostacyclin acting on ep and ip receptors, respectively.activation of vascular ip receptors is especially important in limiting the atherogenic properties of thromboxane a2 acting on tp receptors.more recently, expression of ghrelin receptors has been shown to be increased in atherosclerotic plaques, and ghrelin itself has anti-inflammatory properties in addition to its classical role as a hunger hormone.as well as the complex crosstalk between g-protein-coupled receptors (gpcrs), recent evidence indicates that many gpcrs exist constitutively as homodimeric complexes, and that the formation of heterodimers not only influences the classical cell signalling pathways used by these receptors, but also affects their subcellular distribution.we have found that ep3-i, tp and ghrelin receptors readily form homodimers, but that co-transfection of hek293 cells with these receptors results in the formation of heterodimers with unpredictable effects on receptor distribution and cell signalling properties.since inflammatory conditions are thought to change the relative expression levels of gpcrs in the vasculature, and since varying the expression levels of gpcrs will affect their ability to form heterodimers, then one might predict that gpcr heterodimerization would indeed influence the reactivity of vascular tissue during inflammation. [this work was fully supported by grants from the research grants council of the hong kong special administrative region (cuhk4267/02m and 2041151 vascular inflammation leads to formation of leukotrienes through the 5-lipoxygenase pathway of arachidonic acid metabolism. leukotriene forming enzymes are expressed within atherosclerotic lesions and locally produced leukotrienes exert pro-inflammatory actions within the vascular wall by means of cell surface receptors of the blt and cyslt receptor subtypes. recent mechanistic studies have supported the notion of a major role of leukotriene signaling in atherosclerosis. leukotriene b4 (ltb4) is for example one of the most potent chemotactic mediators formed within the atherosclerotic lesion, inducing migration of a number different cell-types of both hematopoietic and non-hematopoietic origin. initially identified on neutrophils, blt receptor activation is involved in monocyte chemotaxis and adhesion as well as in vascular smooth muscle cell migration and proliferation, providing examples of potential mechanisms in ltb4-induced atherogenesis. targeting ltb4-induced activation of vascular smooth muscle cells has beneficial effects in models of intimal hyperplasia and restenosis after vascular injury. furthermore, blt receptor expression has been demonstrated on t-cells, suggesting ltb4 as a potential link between innate and adaptive immunological reactions. taken together, the local formation of leukotrienes within the atherosclerotic lesion and the potent pro-inflammatory effects of leukotriene receptor activation in target cells of atherosclerosis provide a rationale for a role leukotrienes in this disease. further experimental and clinical studies are however needed to develop therapeutic strategies of treatments targeting leukotriene signaling in atherosclerosis. in normal physiological conditions, the prostanoid (prostaglandin (pg) and thromboxane (tx)) synthesis is dependent on the constitutive isoform of cyclooxygenase (cox-1). this synthesis and release happen few minutes after cell or tissue stimulation. in vascular preparations submitted to pro-inflammatory conditions for some hours, the inducible isoform of cyclooxygenase (cox-2) and other prostanoid synthases can be observed. as an illustration of the previous experimental results, there is an increased presence of cox-2 and the inducible enzyme responsible for pge2 synthesis (mpges-1) detected by immunocytochemistry in the carotid atherosclerotic plaque with strong inflammation. in vascular cells in culture, pgi2 is the major biological active prostanoid produced in the normal physiological conditions. however, when cox-2 is induced, pgi2 and pge2 are equally produced. the role of cox-1, cox-2 and mpges-1 activities is also dependent on the expression of the various prostanoid receptors in the considered vessel. there is increasing evidence for the presence and a role of the ep receptor subtypes (ep1, ep2, ep3 or ep4) preferentially stimulated by pge2 in the vascular wall. for these reasons, we have characterized the receptors activated by pge2 in human mammary arteries. in these vessels incubated with a pro-inflammatory cytokine (interleukin-1ã¢) and lipopolysaccharides a reduced contractility to norepinephrine has been observed. this effect is abolished by treatment of the vascular preparations with a selective cox-2 inhibitor, suggesting that prostanoid synthesis and/or prostanoid receptors could be involved. rheumatoid arthritis is a syndrome which probably consists of a number of diseases for which the risk factors differ. two major processes were identified: the generation of the anti-citrullinated antigens immune response (highly sepcific for ra).we show that the different hla class ii alleles contribute to the development of anti-ccp-positive and anti-ccp negative ra.the se alleles do not independently contribute to the progression to ra, but rather contributed to the development of anti-ccp antibodies. next we determined the effect of smoking and observed that smoking only conferred risk to contract ra in the ccp-positive group and not in the anti-ccp negative group. for the risk factor ptpn22 (a gene that regulates treshold of lumphocyte activation) the allele c1858t only contributed to ccp-positive ra. in contrast to hla two other risk factors were found to be associated with both ccp-positive and ccp-negative ra. the risk factor in the fcrl-gene as has been identified in the japanese population was also tested in 931 dutch ra cases and 570 unrelated dutch controls. carrier analysis of the snp (rs7528684) revealed association of cc genotype with higher risk of developing ra as compared to tt & tc carriers (p =0.039 and or =1.31). in a meta-analysis of all studies comparing 9467 individuals, the or for the cc genotype to develop ra was 1.2 and the p-value < 0.001. in conclusion, different steps in pathogenesis of the syndrome ra can be delineated this talk will focus on recent advances in understanding primary genetic factors predisposing to inflammatory bowel disease (crohns disease and ulcerative colitis). proven genes containing genetic variants predisposing to crohns disease include ibd5/5q31, card15/nod2 and il23r. data is suggestive but not yet as convincing for many other genes. a common theme is of genetic variants influencing early innate immune responses to intestinal bacterial components, and subsequent adaptive immune responses, leading to intestinal inflammation. only for card15/nod2 is there (partial) understanding of how genetic variation influences biological function to cause chronic disease. some mouse models (gene targeted) of card15 appear to show opposite effects to other models and human systems. in humans, card15 mutations impair responses to bacterial components (muramyl dipeptide) mainly at low dose sensing. it is likely this receptor system normally maintains intestinal crypt sterility and protection from invasive infection. pathogen-recognition receptors (prrs) are key components of immune systems and are involved in innate effector mechanisms and activation of adaptive immunity. since their discovery in vertebrates, toll-like receptors (tlrs) have become the focus of extensive research that has revealed their significance in the regulation of many facets of our immune system. recently a new family of intracellular prrs, the nod-like receptors (nlrs), which include both nods and nalps have been described. mutations within the nalp3/cryopyrin/ cias1 gene are responsible for three autoinflammatory disorders: muckle-wells syndrome, familial cold autoinflammatory syndrome, and cinca/nomid. the nalp3 protein associates with asc and caspase-1 (thereby forming a molecular machine termed inflammasome that displays high proil-1beta-processing activity. macrophages from muckle-wells patients spontaneously secrete active il-1beta. increased inflammasome activity is therefore likely to be the molecular basis of the symptoms associated with nalp3-dependent autoinflammatory disorders. here we will emphasis on the ability of this protein complex to promote the development of autoinflammatory syndromes. allergic inflammation (ai) is a complex phenomenon initiated by allergen binding to ige sensitized mast cells and consequent mast cell activation. this causes the symptoms of the early phase of ai and the onset of the late phase characterized by the penetration in the inflamed tissue of inflammatory cells, notably the eosinophils. their subsequent activation is believed to cause tissue damage and to be the main responsible for the tissue remodeling, especially when the ai becomes a chronic process. we defined a novel functional unit that we termed the allergic synapse formed by mast celleosinophil couples. in the synapse these two old cellular players of ai have a cross talk via soluble mediators and receptor-ligand interactions. this results in mast celleosinophil functional synergism that consequently amplifies and prolongs the inflammatory response. in addition, mast cells and eosinophils are influenced and influence as in a sort of allergic niche the surrounding structural cells, i.e. fibroblasts and endothelial cells. we propose to view the allergic synapse/niche as a specialized effector unit worthy to be blocked for the treatment/prevention of allergic inflammation. (1) (1) erasmus mc, rotterdam, the netherlands (2) department of immunology weizmann institute of science, rehovot, israel allergic asthma is one of the most common chronic diseases in western society, characterized by reversible airway obstruction, mucus hypersecretion and infiltration of the airway wall with th2 cells, eosinophils, and mast cells. if we are to devise new therapies for this disease, it is important to elucidate how th2 cells are activated and respond to intrinsically harmless allergens. dendritic cells (dcs) are the most important antigen presenting cells in the lung and are mainly recognized for their exceptional potential to generate a primary immune response and sensitization to aeroallergens. we have shown that intratracheal injection of ovalbumin (ova) pulsed dcs induces sensitization leading to eosinophilic airway inflammation upon ova aerosol challenge. we investigated the role of dcs in the secondary immune response in a murine asthma model. ova aerosol challenge in ova-dc sensitized mice, induced an almost 100 fold increase in the number of airway dcs as well as an increase in eosinophils and t cells. to investigate the functional importance of dcs for the induction and maintenance of airway inflammation in response to allergen challenge, we conditionally knocked-out endogenous dcs in sensitised cd11c-diphtheria toxin (dt) receptor (cd11cdtr) transgenic mice by airway administration of dt 24 h before ova aerosol (4x) challenge or during an ongoing inflammation (depletion after 3x ova aerosols continued with 3 additional ova aerosols). numbers of balf eosinophils, th2 cytokine production by mediastinal lymph nodes and peribronchial and perivascular inflammatory infiltrates were dramatically decreased, illustrating an essential role for airway dcs during secondary challenge. karolinska institute, stockholm, sweden nk cells are innate lymphocytes with potent immunoregulatory functions. they are potent producers of several cytokines and chemokines, and also respond to similar molecules in the body and at inflammatory sites. even though traditionally best characterized for their role in anti-viral and anti-tumor immunity, they influence several other types of immune responses. for example, they are involved in, and affect, acute as well as chronic inflammatory responses. in the present talk, a general overview on our current knowledge of nk cell biology will be provided, with a special emphasis on the role of these cells in allergic inflammation. basophils are major effector cells in allergic reactions due to their ability to release substantial quantities of histamine and eicosanoids following activation of high affinity ige receptors (fcri) with allergens. although these attributes are shared with their tissuefixed mast cell compatriots, basophils are unique in their ability to also rapidly elaborate th2-type cytokines (e.g. il-4 and il-13), subsequently supporting ige synthesis and underlying atopy. importantly, these mediators are additionally secreted following primary exposure to certain parasites (e.g. s. mansoni) and immunoglobulin superantigens, suggesting a role for basophils in innate immunity and in assisting developing th2-type adaptive immune responses. while we are beginning to understand the potential physiological functions of these cells regarding host defence, blocking their activity with respect to treating symptoms of allergic disease has remained an enigma. recent advances, however, have shed light upon the major intracellular signal transduction processes involved in fcri activation and may lead to novel therapeutic strategies for inhibiting mediator secretions. an important discovery in this regard is the phosphatase ship, which downregulates pi 3-kinase signalling in both basophils and mast cells. recent data shows that ship expressions in basophils are reduced from donors with active allergic disease but that these levels may be increased, and the activity of basophils subsequently inhibited, by targeting receptors associated with ship recruitment (cd200r, cd300r). identifying the natural ligands for these inhibitory receptors may therefore pave the way for new therapies for the treatment of allergic inflammation. mitogenesis and proliferation of vsmc play an important role in atherogenesis. pro-inflammatory secretory phospholipases a2 (spla 2 ) hydrolyse glycerophospholipids of hdl and ldl and release pro-inflammatory agents, lyso-lipids, oxidized and non-oxidized fatty acids and isoprostanes.spla 2 s lipolysis products localize in vascular wall in vicinity of vsmc.we have tested the impact of spla 2 , hdl and ldl and of their hydrolysis products on mitogenesis and pge2 and ltb4 release from vsmc.mitogenesis was significantly enhanced by native hdl, and ldl, and by group v spla 2 . spla 2 hydrolysis of hdl and ldl enhanced mitogenic activity in order v>x>iia.the release of pge2 from vsmc was enhanced by group x spla 2 s but not iia or v.the greatest effect was seen for hdl hydrolysed by group v and x spla 2 .native ldl and its spla2 hydrolysis products enhanced the release of pge2 in order x>v>iia.the release of ltb4 from vsmc was markedly increased by native ldl and hdl, and hydrolysis products of group v and x, but not iia spla2.migration of vsmc was significantly enhanced by spla 2 iia and inhibited by hdl.this study demonstrates a complex interaction of hdl and ldl with pro-inflammatory spla2s, which affects mitogenesis, eicosanoid release and migration of vsmc.study of biocompatible spla2 blockers in the therapy of atherosclerosis is indicated. contact information: professor waldemar pruzanski, university of toronto, department of medicine, toronto, ontario, canada e-mail: drwpruzanski@bellnet.ca (1) (1) ipmc-cnrs umr6097, valbonne, france (2) university of washington, seattle, usa (3) inserm umrs 525, paris, france (4) university of naples, italy the superfamily of phospholipase a2 comprises at least 9 intracellular enzymes and up to 12 secreted pla2s (spla 2 s). elucidating the biological roles of each pla2 member is currently the most challenging issue in the pla2 field. the different spla 2 s are not isoforms and are likely to function either as enzymes producing key lipid mediators (eicosanoids and lysophospholipids) or as ligands that bind to specific soluble or membrane-bound proteins (like cytokines). increasing evidence suggests that spla 2 s iia, iii, v, and x are involved in inflammatory diseases including atherosclerosis. among spla2s, the human group x (hgx) enzyme has the highest enzymatic activity towards phosphatidylcholine, the major phospholipid of cellular membranes and low density lipoproteins (ldl). on human alveolar macrophages, hgx spla 2 can trigger secretion of tnf alpha, il1 and il6 in a non-enzymatic manner. on colorectal cancer cells, hgx spla 2 stimulates cell proliferation, produces potent eicosanoids including pge2, and activates the transcription of key genes involved in inflammation and cancer. the enzyme can also hydrolyze pc and platelet-activating factor (paf) of ldl particles very efficiently. finally, hgx spla 2 is present in human atherosclerotic lesions and converts ldl into a proinflammatory particle that induces macrophage foam cell formation, as well as map kinase activation, arachidonic acid release, and expression of adhesion molecules in huvec cells. some other key molecular features of spla 2 s including hgx will be presented. we have reported preferential release of polyunsaturated fatty acids during hydrolysis of lipoprotein phosphatidylcholine (ptdcho) by spla 2 s, but the mechanism of this selectivity is not known. since both sphingomyelin (sm) and lysoptdcho inhibit the activity while increasing fatty acid specificity of other pla2s, we have examined fatty acid release by spla2siia, v and x in relation to relative increases in proportion of endogenous sm and lysoptdcho during lipoprotein digestion. the analyses were performed by normal phase liquid chromatography with on-line electrospray mass spectrometry (lc/esi-ms) and lc/collision induced dissociation (cid)/esi-ms using conventional preparations ofldl and hdl. the highest preference for arachidonate release from ldl by group x spla 2 was observed when the residual sm/ pdcho molar ratio had reached 1.2 compared to a starting ratio of 0.4.group v spla 2 showed preferential release of linoleate at residual sm/ptdcho molar ratio 1.5, while at intermediate ratios, both arachidonate and linoleate were released at more comparable ratios. the relative increases in lysoptdcho and sm during the digestion with spla 2 iia were much more limited, and a preferential hydrolysis of polyunsaturated fatty acids was not observed. these results suggest a lipid phase separation as a likely basis for a differential hydrolysis of molecular species of ptdcho. the residual sm/ptdcho ratios reached during group v and x spla 2 digestion are similar to those observed for lesional ldl, which promote release of ceramides by smase leading to ldl aggregation. the above findings support a potential role of sphingomyelins in atherogenesis. although sphingomyelin (sm) is one of the most abundant phospholipids in lipoproteins and cell membranes, its physiological significance is unclear. because of its localization in the outer surface of the cells, and its structural similarity to phosphatidylcholine (pc),we proposed that it competitively inhibits phospholipolysis of cell membranes by external phospholipases (pla). we showed that sm inhibits several lipolytic enzymes including secretory pla2 iia, v, and x, and hepatic and endothelial lipases, all of which hydrolyze pc. treatment of sm in the substrate with smase c not only relieved the inhibition but also activated the pla2 reaction further, suggesting that ceramide, the product of smase c, independently stimulates pla2, possibly by disrupting the bilayer structure. smase d treatment, which produces ceramide phosphate, did not stimulate the spla2. the fatty acid specificity of pla2 is significantly affected by sm. thus spla2x exhibited enhanced specificity for the release of arachidonic acid (20:4) in presence of sm, due to a preferential inhibition of hydrolysis of other pc species. in contrast, sm inhibited the release of 20:4 by spla2v. ceramide selectively stimulated the release of 20:4 by both enzymes. only the long chain ceramides (> 10 carbons) were effective, while ceramide phosphate did not stimulate spla2 activity. sm-deficient cells released more 20:4 in response to spla2-treatment than normal cells, and pretreatment of normal cells with smase c increased their susceptibility to spla2 attack. these studies show that sm and ceramide regulate the activity and specificity of pla, and consequently the inflammatory response. secretory phospholipase a2 (spla2) types iia, v, or x, have been associated with inflammatory diseases and tissue injury including atherosclerosis in humans and mice.given the link between spla2 and atherogenesis, a mouse model of atherosclerosis (apoe-/-) was used to study the effects of a-002, an inhibitor of spla2 enzymes, on atherosclerosis and cholesterol levels over 16 weeks of treatment. mice were fed with a high-fat, high cholesterol diet alone during the study (21% fat; 0.15% cholesterol, 19.5% casein) and were treated with vehicle or a-002 bid at 30 mg/kg or 90 mg/kg by oral gavage. total cholesterol was significantly decreased after one month of treatment and remained lower throughout the study.treatment with a-002 significantly reduced aortic atherosclerotic plaque formation in apoe-/-mice fed a high fat diet when compared to the untreated control by approximately 40 %. in a different model that used angiotensin ii in conjunction with a high fat diet in a background of apoe-/-deficient mice for 4 weeks, oral dosing of a-002 (30 mg/kg bid) significantly reduced aortic atherosclerosis and aneurysm rate when compared to vehicle. these data suggest that a-002 is a potential novel therapeutic agent for the treatment of atherosclerosis. (1), s doty(2), c antonescu (3), c staniloae (1) (1) saint vincents hospital manhattan, new york, usa (2) hospital for special surgery, new york, usa (3) sloan-kettering institute for cancer research, new york, usa tnf-stimulated gene 6 (tsg-6) is induced by tnf-a during inflammation and its secreted product tsg-6 glycoprotein is involved in immune-mediated inflammatory diseases and fertility. it regulates cox-2 and prostaglandin synthesis, and participates in extracellular matrix remodeling. considering the chronic inflammatory nature of atherosclerosis we hypothesized that tsg-6 is expressed in atherosclerotic plaques and investigated tsg-6 protein expression and cellular distribution on 12 superficial femoral artery endarterectomy specimens from 6 diabetic and 6 non-diabetic patients with peripheral vascular disease. six histologically normal radial artery specimens were analyzed as control. paraffin embedded samples were studied by immunohistochemistry using a goat polyclonal anti-human-tsg-6 antibody. tsg-6 expression was consistently present in all atherectomy specimens but not in control specimens. a distinct, strong cytoplasmic staining pattern was uniformly detected in the endothelial lining of the intima, as well as in the neo-vessel proliferation of the plaque. cytoplasmic staining was also identified in the smooth muscle cell proliferation of the neo-intima. patchy tsg-6 expression was noted in the extracellular matrix. within the inflammatory plaques from diabetic patients, tsg-6 stained the foamy macrophages. tsg-6 expression was also confirmed and quantified by qrt-pcr that showed a significant up-regulation of tsg-6 gene (more that 100 fold induction compared to housekeeping genes). our study identifies for the first time the preferential expression of tsg-6 in atherosclerotic lesions and characterizes its distribution within the cellular and matrix components of the plaque. tsg-6 is a novel inflammatory mediator of atherosclerosis and a potentially new marker of endothelial / smooth muscle cell activation. (1), r krohn (1), h lue (1), jl gregory(2), a zernecke (1), rr koenen (1), t kooistra (3), p ghezzi(4), r kleemann (3), r bucala(5), mj hickey (2), c weber (1) (1) university hospital of the rwth aachen, germany (2) centre for inflammatory diseases, monash university, melbourne, australia mediators, which cannot be classified into chemokine subfamilies but share functional patterns, e.g. signaling through chemokine receptors, constitute a group termed chemokine-like function (clf)-chemokines. the pleiotropic cytokine macrophage migration inhibitory factor (mif) plays a critical role in inflammatory diseases and atherogenesis. the underlying molecular mechanisms are poorly understood, but, interestingly, mif displays structural features resembling chemokines. we have identified the chemokine receptor cxcr2 as a functional receptor for mif. mif triggered galphai/integrin-dependent arrest and chemotaxis of monocytes specifically through cxcr2, inducing rapid integrin activation. mif directly bound to cxcr2 with high affinity (kd of 1.4 nm). monocyte arrest mediated by mif in inflamed or atherosclerotic arteries involved cxcr2 as well as cd74, a recently identified membrane receptor moiety for mif. accordingly, cxcr2 and cd74 were found to occur in a receptor complex. in vivo, mif deficiency impaired monocyte adhesion to the aortic/arterial wall in atherosclerosis-prone mice, as evidenced by intravital microscopy. thus, mif displays chemokine-like functions by acting as a non-cognate ligand of cxcr2, serving as a regulator of inflammatory and atherogenic recruitment. these data harbor an intriguing novel therapeutic prospect by targeting mif in atherosclerosis and add a new dimension to mif and chemokine receptor biology. (1), r toes (3), h van bockel(2), paul quax (1,2) (1) tno bioscienses, leiden, the netherlands (2) department of vascular surgery, leiden university medical center, the netherlands (3) department of rheumatoly, leiden university medical center, the netherlands the immune system is thought to play a crucial role in regulating collateral circulation (arteriogenesis), a vital compensatory mechanism in patients with arterial obstructive disease. here, we studied the role of lymphocytes in a murine model for artiogenenesis after acutehind limb ischemia. arteriogenesis was impaired in c57bl/6 mice depleted for natural killer (nk)-cells by anti-nk1.1 antibodies and in nk-cell-deficient transgenic mice. arteriogenesis was, however, unaffected in jâµ281knockout mice that lack nk1.1+ natural killer t (nkt)cells, indicating that nk-cells, rather than nkt-cells are involved in arteriogenesis. furthermore, arteriogenesis was impaired in c57bl/6 mice depleted for cd4+ tlymphocytes by anti-cd4 antibodies, and in major histocompatibility complex (mhc)-class-ii-deficient mice that lack mature peripheral cd4+ t-lymphocytes. this impairment was even more profound in anti-nk1.1treated mhc-class-ii-deficient mice that lack both nkand cd4+ t-lymphocytes. finally, collateral growth was severely reduced in balb/c as compared with c57bl/6 mice, two strains with different bias in immune responsiveness. correspondingly, fewer cd3-positive lymphocytes accumulated around collaterals in balb/c mice. these data show that both nk-cells and cd4+ t-cells play an important role in arteriogenesis. moreover, our data hold promise for the development of novel clinical interventions as promoting lymphocyte activation might represent a powerful method to treat ischemic disease. post-interventional vascular remodeling in venous bypass grafts, seen as intimal hyperplasia (ih) and accelerated atherosclerosis, often causing graft failure. inflammation is an important trigger for these processe. complement is an important part of the immune system and participates in regulating inflammation. although involved in several other inflammatory diseases, the role of the complement cascade in vein graft remodeling is unknown. the involvement of the complement system in vein graft disease was studied here using a model in which caval veins are grafted in carotids arteries of hypercholesterolemic apoe3leiden mice. in these veins ih and accelerated atherosclerotic lesions develop within 28 days, consisting mainly of foamcells and smc. to study the functional role of complement in vein graft remodeling, cobra venom factor (cvf:20u daily) was used to deplete complement starting one day prior to vein graft surgery. cvf-treatment reduced vein graft thickening by 64% (p=0.02), when compared to saline treated controls (n=6).to confirm that the reduction by cvf was due to hampered complement function and not a direct effect of cvf, complement activation was blocked using crry-ig (inhibiting c3 convertases). crry-ig (3mg every other day) led to 50% decrease in vein graft thickening (p=0.03) compared to controls receiving non-relevant control igg. these data prove that complement activation plays a major in intimal hyperplasia and accelerated atherosclerosis in vein grafts. (1), m-c koutsing tine(1), p borgeat(2), h ong (1), sylvie marleau (1) (1) universite de montreal, quebec, canada (2) centre de recherche en rhumatologie et immunologie, canada we have previously shown that ep 80317, a growth hormone-releasing peptide (ghrp) analogue binding selectively to the scavenger receptor cd36, elicits a striking reduction in atherosclerosis development in apolipoprotein-deficient (apoe-/-), a condition associated with increased circulating numbers of primed/activated leukocytes. we investigated the effect of ghrp analogues on i/r-elicited remote lung injury in 18week-old apoe-/-mice fed a high fat high cholesterol (hfhc) diet from 4 weeks of age. at 18 weeks old, mice were treated daily with a s.c. injection of ep 80317 (300 mg/kg) for 14 days and were then subjected to unilateral hindlimb ischemia (by rubber band application) for 30 minutes, followed by 180 minutes reperfusion. our results show that ep 80317 significantly reduced leukocyte accumulation by 56% in the lungs, from 3.6 (ae 0.7) in vehicle-treated mice to 1.6 (ae 0.6) x 107 leukocytes/g lung in ep 80317-treated mice (n = 6-7 per group), as assessed by myeloperoxidase assay. this was associated with a 56% reduction of opsonized zymosan-elicited blood chemiluminescence. in contrast, neither blood chemiluminescence, nor leukocyte accumulation in the lungs were signicantly modulated in apoe-/-/cd36-/-deficient mice, from 1.9 (ae 0.5) in vehicle-treated mice to 1.9 (ae 0.8) x 107 leukocytes/g lung in ep 80317-treated mice. we conclude that ep 80317 protects i/r-elicited circulating leukocyte priming/activation and remote lung injury, possibly through a cd36-mediated pathway. glycogen synthase kinase 3beta (gsk-3beta) is a serine/ threonine protein kinase that has recently emerged as a key regulatory switch in the modulation of the inflammatory response. dysregulation of gsk-3beta has been implicated in the pathogenesis of several diseases including sepsis. here we investigate the effects of two chemically distinct inhibitors of gsk-3beta, tdzd-8 and sb216763, on the circulatory failure and the organ injury and dysfunction associated with hemorrhagic shock. male wistar rats were subjected to hemorrhage (sufficient to lower mean arterial blood pressure to 35 mmhg for 90 min) and subsequently resuscitated with shed blood for 4 h. hemorrhage and resuscitation resulted in an increase in serum levels of (a) creatinine and, hence, renal dysfunction, and (b) alanine aminotransferase and aspartate aminotransferase and, hence, hepatic injury. treatment of rats with either tdzd-8 (1 mg/kg, i.v.) or sb216763 (0.6 mg/kg, i.v.) 5 min before resuscitation abolished the renal dysfunction and liver injury caused by hemorrhagic shock. the protection afforded by these compounds was confirmed by histological observations of lung, kidney and liver samples. in addition, tdzd-8, but not sb216763, attenuated the increase caused by hemorrhage and resuscitation in plasma levels of the proinflammatory cytokine interleukin 6. neither of the gsk-3beta inhibitors however affected the delayed fall in blood pressure caused by hemorrhagic shock. thus, we propose that inhibition of gsk-3beta may represent a novel therapeutic approach in the therapy of hemorrhagic shock. (1), y ito (1), h yoshimura (1), h inoue (1), n kurouzu (1), h hara (1), y mastui (1), h kitasato (1), s narumiya(2), c yokoyama (3), m majima (1) (1) kitasato university school of medicine, japan (2) kyoto university school of medicine, japan (3) tokyo medical and dental university, japan thromboxane (tx) a2 is a potent stimulator of platelet activation and aggregation and vascular constriction. we have reported cytokine-mediated release of sdf-1 from platelets and the recruitment of nonendothelial cxcr4+ vegfr1+ hematopoietic progenitors constitute the major determinant of revascularization. we hypothesized txa2 induces angiogenic response by stimulating sdf-1 and vegf which derived from platelet aggregation. to evaluate this hypothesis, we dissected the role of the txa2 in angiogenesis response using mouse hind limb ischemia. recovery from acute hind limb ischemia, as assessed in wild type mice (c57bl/6 wt) , prostaglandin i2 receptor (ip) knock out mice (ipko) and thromboxane (tx) a2 receptor (tp) knock out mice (tpko) by using lase doppler. blood recovery in tpko significantly delayed compared to wt and ipko. immunohistochemical studies revealed that the number of cd31positive cells in the ischemic quadriceps were less stained in tpko compared to wt and ipko.plasma sdf-1 and vegf concentration were significantly reduced in tpko mice. we observed during in vivo fluorescence microscopic study that compared to tpko, ipko and wt significantly increased platelet attachment to the microvessels around ligated area. tpko translpanted wt bone marrow cells increased blood recovery compared to tpko transplanted tpko bone marrow cells. in addition, mice injected with txa2 synthase c-dna expressing fibroblast increased blood flow recovery compared to control mice. these results suggested that tp signaling rescues ischemic condition by inducing angiogenesis by secreting sdf-1 and vegf from platelet aggregation. administration of selective tp agonist may open new therapeutic strategy in regenerative cardiovascular medicine. during renal ischemia/reperfusion (i/r) injury, apoptosis has been reported as a very important contributor to the final kidney damage. the determinant role of cytoskeleton derangement in the development of apoptosis has been previously reported, but a clear description of the different mechanisms involved in this process has not been yet provided. the aim of the study is to know the role of peroxynitrite as inductor of cytoskeleton derangement and apoptosis during the inflammatory process associated to renal ischemia-reperfusion. based in a rat kidney i/r model, by experiments in which both the actin cytoskeleton and peroxynitrite generation were pharmacologically manipulated, results indicate that the peroxynitrite produced during the i/r derived oxidative stress state, is able to provoke cytoskeleton derangement and apoptosis development. thus, the control in the peroxynitrite generation during the i/r could be an effective tool for the improvement of cytoskeleton damage and reduction apoptosis incidence in the renal i/r injury. metabolomics, the global profiling of metabolites, may inform about the multiple interacting processes involved in inflammatory disease. using nmr spectroscopy we analysed metabolite fingerprints in serum from early arthritis, and at a site of inflammation, in the posterior segment of the eye. serum from 101 patients with synovitis of "t 3 months duration whose outcome was determined at clinical follow-up was used. vitreous samples were from 31 patients undergoing vitrectomy for vitreoretinal disorders. one dimensional 1h nmr spectra were acquired. principal components analysis (pca) of the processed data was conducted along with a supervised classification. with the arthritis serum there was a clear relationship between each samples score in the pca analysis and the level of crp. supervised classification of the initial samples was able to predict outcome, whether rheumatoid arthritis, other chronic arthritis or self-limiting arthritis, with high specificity and sensitivity. a similar approach using the eye fluids was able to give a clear discrimination between two pathologically similar conditions lens-induced and chronic uveitis. in this case differences were not due to a straightforward relationship with inflammatory markers (il-6, ccl2), which did not correlate with pca in these samples. similarly, certain molecules, such as lactate, were associated with ocular disease, but not rheumatoid arthritis. these results suggest that underlying inflammatory processes may differ in these conditions or may reflect predisposing metabolic patterns in individual patients. 1h-nmr-based metabolomics may provide a useful measure of outcome in inflammatory diseases and give novel insights into the pathological processes involved. (1), am artoli(2), a sequeira(2), c saldanha (1) (1) instituto de medicina molecular,faculdade de medicina de lisboa, portugal (2) cemat, instituto superior tã�cnico, universidade de tã�cnica de lisboa, portugal the recruitment of leukocytes from the blood stream and their subsequent adhesion to endothelial walls are essential stages to the immune response system during inflammation. the precise dynamic mechanisms by which molecular mediators facilitate leukocyte arrest are still unknown. in this study combined experimental results and computer simulations are used to investigate localized hydrodynamics of individual and collective behaviour of clusters of leukocytes. leukocyte-endothelial cell interactions in post-capillary venules of wistar rats cremaster muscle were monitorized by intravital microscopy. from these experiments the haemorheologic and haemodynamical measured parameters were used in time dependent three-dimensional computer simulations, using a mesoscopic lattice boltzmann solver for shear thinning fluids. the dynamics of leukocyte clusters under non-newtonian blood flow with shear thinning viscosity was computed and discussed. in this paper we present quantified distributions of velocity and shear stress on the surface of leukocytes and near vessel wall attachment points. we have also observed one region of maximum shear stress and two regions of minimum shear stress on the surface of leukocytes close to the endothelial wall. we verified that the collective hydrodynamic behaviour of the cluster of recruited leukocytes establishes a strong motive for additional leukocyte recruitment. it was found that the lattice boltzmann solver used here is fully adaptive to the measured experimental parameters. this study suggests that the influence of the leukocytes rolling on the increase of the endothelial wall shear stress may support the activation of more signalling mediators during inflammation. macrophages are essential for host defence, but when excessively and persistently activated, these cells contribute to the initiation and progression of inflammatory diseases such as rheumatoid arthritis. investigating the function of inflammatory genes in macrophages may identify novel therapeutic targets for inflammatory diseases. one family of transcripts that are highly expressed in activated macrophages are members of the schlafen (slfn) gene family; a recently identified family whose function is still unknown. this study examined the mrna expression of slfn in activated bone marrowderived macrophages in vitro, and in collagen-induced arthritis (cia) in vivo. real-time pcr expression analyses of bone marrow-derived macrophages stimulated with lipopolysaccharide (lps) over a time course, revealed differential expression of individual slfn family genes. in particular, slfn-1, slfn-2, and slfn-4 were maximally induced after 24 hours. the maximal induction of slfn-8 and slfn-9 was observed after 4 hours of lps treatment. individual members of the slfn family were also differentially expressed in cia, a model of rheumatoid arthritis. mrna levels of slfn-1, slfn-2, slfn-4 and slfn-5 were elevated in joints affected by cia. to investigate the role of slfn-4, we have generated a transgenic mouse line, which over expresses slfn-4 specifically in cells of the mononuclear phagocyte system, by using a novel binary expression based on the c-fms promoter and gal4. further characterisation of the slfn-4 over expressing mouse line will be used to assess the function of slfn-4 in macrophage biology and inflammation, and its potential as a therapeutic target. macrophages play an important role in resolving inflammation. it is known that the resolution of inflammation requires alternative activation of macrophages. but the precise events of phenotype switching in macrophages remain poorly understood. we show that lipocalin 2, lcn-2, is able to provoke a switch in macrophage activation. in an in vitro co-culture model for renal epithelial cells and macrophages, we detected by sirna technique that the presence or absence of lcn-2 determines proliferation processes in damaged renal epithelial cells. the proliferative response was dependent on proinflammatory or anti-inflammatory environment. as lcn-2 is an acute phase protein synthesized during inflammation and unregulated in a number of pathological conditions, it may play an important role in survival and regeneration. we anticipate here that our results could be relevant for further research on the mechanisms of the phenotype switch induced by lcn-2. (1), y cao (1), s adhikari (1), m wallig (2) (1) national university of singapore, department of pharmacology, singapore (2) university of illinois at urbana champaign, usa it has earlier been shown that the extent of apoptotic acinar cell death is inversely related to the severity of acute pancreatitis. our previous works have demonstrated that induction of pancreatic acinar cell apoptosis by crambene protects mice against acute pancreatitis. the current study aims to investigate the role of phagocytic receptors and the anti-inflammatory effect of phagocytosis in protecting mice against acute pancreatitis by crambene. acute pancreatitis was induced in the mouse by administering hourly injections of caerulein (50 mg/kg) for 3, 6 and 10 hours respectively. neutralizing monoclonal anti-il-10 antibody (2.5 mg/kg) was administered either with or without crambene (70 mg/kg) 12 hours before the first caerulein injection. rt-pcr, western blotting and immunostaining were performed to detect cd36 expression. apoptosis in pancreatic sections was visualized by tunel. severity of acute pancreatitis was evaluated by estimation of serum amylase, pancreatic myeloperoxidase (mpo), water content, and morphological examination. pancreatic levels of inflammatory mediators were examined by elisa. the protective effect of crambene is mediated by reducing production of pro-inflammatory cytokines such as mcp-1, tnf-a and il-1㢠and up-regulating anti-inflammatory mediators like il-10. phagocytotic clearance in mouse acute pancreatitis may be essentially through macrophage surface receptor cd36.the anti-inflammatory mediator il-10 plays an important role in crambene-induced protective action against acute pancreatitis. the release of anti-inflammatory mediator il-10 is downstream of phagocytosis. these results show that induction of pancreatic acinar cell apoptosis by crambene treatment protects mice against acute pancreatitis via induction of anti-inflammatory pathways. (1,2) (1) northern ontario school of medicine, thunder bay, ontario, canada (2) lakehead university, canada integrin receptors and their ligands are involved in adhesion and internalization of several human pathogens, including pseudomonas aeruginosa. we have recently established that beta1 integrins in lung epithelial cells (lec) provide co-stimulatory signals regulating inflammatory responses (ulanova et al, am j physiol, 2005, 288: l497-l507). we hypothesized that lec integrins serve as receptors to recognize pathogen-associated molecules and mediate the innate immune response to p. aeruginosa. to determine molecular mechanisms of integrin involvement in innate immunity, we used an in vitro model of p. aeruginosa infection of a549 cells. to investigate interactions of bacteria with lec, p. aeruginosa strain pak was chromosomally labeled with a green fluorescent protein gene using a mini-tn7 delivery system.using several fluorescence-based detection systems, we established that the natural beta1 integrin ligand, fibronectin, mediates bacterial adhesion to lec.p. aeruginosa infection caused rapid transcriptional upregulation of alphav and beta4 integrin expression followed by the increased cell surface protein expression. the surface expression of integrin beta1 increased shortly following bacterial exposure without alterations of mrna expression, suggesting rapid protein redistribution within the cells. the data indicate that p. aeruginosa are capable to modulate integrin gene/protein expression in lec, potentially using fibronectin to alleviate bacterial binding to beta1 integrins. upon their engagement, integrin receptors can initiate intracellular signaling involved in innate immune and inflammatory responses to the pathogen. integrin receptors in lec may represent significant therapeutic targets in pulmonary infection caused by p. aeruginosa. the purine nucleoside adenosine has a major modulatory impact on the inflammatory and immune systems. neutrophils, which are generally the first cells to migrate toward lesions and initiate host defense functions, are particularly responsive to the action of adenosine. through activation of the a2a receptor (a2ar) present on neutrophils, adenosine inhibits phagocytosis, generation of cytotoxic oxygen species, and adhesion. also, recent work showed that adenosine can transform the profile of lipid mediators generated by neutrophils, inhibiting leukotriene b4 formation while potentiating that of prostaglandin e2 through the up-regulation of the cyclooxygenase (cox)-2 pathway. moreover, our laboratory determined that a2ar engagement can dramatically modulate the generation and secretion of neutrophil-derived cytokines/chemokines, including tnf-and mips. in mice lacking the a2ar, migrated neutrophils expressed less cox-2 than their wild type counterpart while displaying higher mrna levels of tnf-and mip-1. mononuclear cells from a2ar knock out mice, which eventually replace neutrophils into the air pouch, also displayed a more pro-inflammatory phenotype than those from wild-type animals. signal transduction experiments, aiming to delineate the intracellular events leading to the modulation of neutrophil functions following a2ar engagement, implicate pivotal metabolic pathways such as intracellular cyclic amp, p38 and pi-3k. together, these results indicate that adenosine may have a profound and multi-pronged influence on the phenotype of neutrophils and present this cell as being pivotal in mediating adenosines anti-inflammatory effects. the newest developments regarding adenosines effects on neutrophil functions will be presented.this work is supported by the canadian institutes of health research (cihr). human skin serves not only as a physical barrier against infection, but also as a "chemical barrier" by constitutively and inducibly producing antimicrobial proteins (amps). to identify human skin amps, we analysed extracts of healthy persons stratum corneum by reversed phase-hplc and purified a novel 9 kda amp that showed sequence similarity to mouse hornerin. suggesting that it originates from the human ortholog, we cloned it. human hornerin encodes a 2850 amino acid protein that contains a s100 domain, an ef-hand calciumbinding domain, a spacer sequence and two types of tandem repeats, suggesting that it represents a novel member of the fused s100 protein family. strongest constitutive hornerin mrna expression was seen in differentiated keratinocyte cultures. to follow the hypothesis, that hornerin fragments represent amps, we recombinantly expressed three hornerin peptides, rhrnr2 (tandem repeat unit b), rhrnr3 (tandem repeat unit a) and rhrnr4 (c-terminus) and subsequently analysed their antimicrobial activity using the microdilution assay system. the rhrnr3 peptide, containing the sequence motif found in the purified natural hornerin fragment isolated from stratum corneum, exhibited antimicrobial activity at low micromolar concentrations against escherichia coli, pseudomonas aeruginosa and candida albicans. the other peptides were found to be not or nearly not antimicrobially active. our results suggest that hornerin may have a yet unknown protective function in healthy human skin as part of the "chemical barrier" with preformed amps, which are generated from parts of the tandem repeats of a hornerin precursor molecule by a yet unknown cleavage mechanism. (1), n lu(1), r jonsson(2), d gullberg (1) (1) department of biomedicine, university of bergen, norway (2) the gade institute, university of bergen, norway a11ã�1 is the latest addition to the integrin family of heterodimeric receptors for the extracellular matrix. previously, it has been shown that this collagen receptor takes part in processes such as cell migration and matrix contraction. in this study we investigated the factors that regulate mouse integrin a11ã�1 expression. specifically, we have analyzed the influence of cell passage, growth factors and the 3-d microenvironment. using sv40 immortalized as well as primary fibroblasts, we show that a11ã�1 integrin is up-regulated when these cells are cultured within stressed collagen type i lattices. however, a11ã�1is downregulated when the collagen gels are made under relaxed conditions, allowing cells contract the lattice diameter. we also show here that a11 is upregulated by tgf-a on planar substrates. these findings suggest that mechanical tension and tgf-a are important factors in the regulation of a11ã�1 that need to be to taken into consideration when evaluating the role of a11ã�1 in wound healing and fibrotic disorders. (1), n vergnolle (1), p andrade-gordon (2) (1) inflammation research network, university of calgary, canada (2) rw johnson pharmaceutical research institute, canada the objective of this study was to investigate the effects of par2 deficiency in various models of colonic inflammation in order to elucidate the role of endogenous par2 in the process of inflammation in the gut.colonic inflammation in c57bl6 wildtype and par2 -/-mice was induced by treatment with 2.5% dss (in drinking water) or tnbs (1mg or 2mg in 100ul of 40% ethanol, single intracolonic injection) or pre-sensitizing mice with 3% oxazolone (in olive oil) applied to the skin of the abdomen, and 7 days later, a single intracolonic injection of 1% oxazolone (dissolved in 50% ethanol).intravital microscopy was performed, 7 days (tnbs/dss) or 4 days (oxazolone) after induction of colitis on the colonic venules to assess changes in leukocyte rolling, adhesion and vessel diameter.lastly, various parameters of inflammation were assessed following the intravital microscopy.par2 -/-mice showed significantly lower leukocyte adherence and vessel dilation compared to the wildtype mice in dss, and tnbs challenge. in all three challenges, mpo activity, macroscopic damage score and bowel thickness were significantly higher in wild-type mice, compared to par2 -/-.our evidences indicate that deficiency in par2 attenuates inflammatory responses in the experimental models of colitis associated with either th1 (tnbs/dss) or th2 (oxazolone) cytokine profile.therefore, par2 deficiency in the gut exerts antiinflammatory properties that are independent of th1 or th2 cytokine profile.the present study further highlights par2 as a potential target for inflammatory bowel diseases. (1), n vergnolle (1), p andrade-gordon (2) (1) inflammation research network, university of calgary, canada (2) rw johnson pharmaceutical research institute, canada in a previous study, inflammatory responses induced by three different models of colitis (tnbs/dss/oxazolone) were significantly attenuated in mice deficient for par2 (par2-/-). among the inflammatory parameters observed, infiltration of granulocytes to the colon was consistently reduced by par2 deficiency. aim of this study was to assess the effects of par2 deficiency (via par2-/-mice) on the recruitment of leukocyte in colonic venules. in anaesthetized animals, leukocyte rolling/ adherence and vasodilation were induced, by topical administration of fmlp (100 mm) or paf (100 nm) or by intraperitoneal injection of tnf-a; (0.5 mg -given 3 hours before the intravital microscopy). using intravital microscopy, we evaluated the ability of various leukocyte stimuli to induce leukocyte trafficking and vasodilation in colonic venules of par2 -/-versus par2+/+ mice. fmlp and paf as well as tnf-a; induced significant vasodilation and an increase in rolling/adhesion of leukocytes in mouse colonic venules. par2 -/-mice showed significantly lower leukocyte rolling compared to the wildtype mice in response to fmlp topical administration. leukocyte adherence induced by fmlp and tnf-a; was significantly lower in par2 -/-mice compared to wild types as well. no difference was observed between par2 -/-and wildtype for leukocyte rolling/adherence-induced by paf. the lack of functional par2 attenuated leukocyte trafficking in response to fmlp and tnf-a; but not to paf. the involvement of par2 activation in mouse colon leukocyte trafficking highlights par2 as an important mediator of inflammatory cell recruitment and thereby a potential target for the treatment of inflammatory bowel diseases. (1), kk hansen(2), k chapman(2), n vergnolle (2), ep diamandis (1), md hollenberg (2) (1) advanced center for detection of cancer, mount sinai hospital, university of toronto, toronto, on, canada (2) proteinases and inflammation network, university of calgary, calgary, ab, canada kallikreins (klks) are secreted serine proteinases identified in many cancers and multiple sclerosis lesions. we have recently shown that klks can activate proteinaseactivated receptors (pars), a family of g-protein coupled receptors associated with inflammation. we hypothesized that like trypsin, kallikreins can trigger inflammation via the pars. we studied the ability of klks 6 and 14 to activate pars 1, 2 and 4 in vitro and to cause oedema in a mouse model of paw inflammation in vivo. we found that klk14 is able to activate both of pars 2 and 4 and to prevent thrombin from activating par1. on the other hand, klk6 was a specific activator of par2. kallikrein administration in vivo resulted in a paw oedema response comparable in magnitude and time to that generated by trypsin. the oedema was accompanied by a decreased threshold of mechanical and thermal nociception. our data demonstrate that by activating pars 2 and 4 and by inactivating par1, kallikreins, like klks 6 and 14, may play a role in regulating the inflammatory response and perception of pain. (1), d park (1), b short(2), n brouard(2), p simmons(2), s graves (1), j hamilton (1) (1) melbourne university, melbourne, victoria, (2) peter maccallum cancer institute. melbourne, australia mouse mesenchymal stem cell enriched populations can be isolated from bone tissue by employing lineage immuno-depletion followed by fluorescence-activated cell sorting based on the cell surface expression of the sca-1 antigen. such isolated cells can subsequently be cultured and differentiate towards the osteogenic, adipogenic or chondrogenic linage in vitro. using this model we investigated the influence of the proinflammatory cyto-kines, tnfa or il-1b, on early osteogenesis in vitro. under osteogenic conditions, il-1b was found to inhibit cell proliferation in a dose dependent manner, whereas tnfa exhibited no effect. histochemical examination revealed the presence of either tnfa or il-1b to dramatically decreased mineralization in a dose dependent manner. q-pcr analysis indicated that in the presence of il-1b, despite increased expression of bone-specific alkaline phosphatase (akp2) mrna, levels of other osteogenesis markers (runx2, col1a and sp7) were decreased. in the presence of tnfa, levels of akp2, runx2 and sp7 were all decreased. our findings indicate that the influence of early mesenchymal progenitor cells on bone remodelling may be substantially altered in the presence of proinflammatory cytokines. using are-driven and nf-kb-targeted reporter genes, transfection of the nf-kb p65 subunit and nrf2 into hepg2 or other cells, as well as sirna technique to knockdown endogenous p65 in cells, we found that nf-kb p65 subunit repressed the anti-inflammatory and anticarcinogenetic nrf2-are pathway at transcriptional level. in p65-overexpressed cells, the are-dependent expression of heme oxygenase-1 was strongly repressed. in the cells where nf-kb and nrf2 were simultaneously activated, p65 unidirectionally antagonized nrf2 transcriptional activity. the p65-mediated are inhibition was independent of the transcriptional and dna-binding activities of p65. co-transfection and rna interference experiments revealed two mechanisms which coordinate the p65-mediated repression of are: (1) p65 selectively deprives creb binding protein (cbp) from nrf2, but not mafk, by competitive interaction with the ch1-kix domain of cbp, resulting in inactivation of nrf2 transactivation domain and concomitant abrogation of the nrf2-stimulated coactivator activity of cbp; (2) p65 promotes recruitment of histone deacetylases 3 (hdac3) to are by enhancing the interaction of hdac3 with either cbp or mafk, leading to inactivation of cbp and deacetylation of mafk. this study may establish a novel pro-inflammatory and pro-carcinogenic model for the transrepression of the are-dependent gene expression by p65 subunit. since various inflammatory and tumor tissues constitutively overexpresses p65 in their nuclei, the finding in this study implies a strong repression of are-dependent gene expression must take place in those tissues. in this regard, the findings in this study may help to explain why oxidative stresses and toxic insults usually occur in those pathological loci. dendritic cells (dc) play a pivotal role in the induction of immune response and tolerance. it is less known that dc accumulate in atherosclerotic arteries, where they might activate t-cells and contribute to the progression of disease. the serine protease thrombin is the main effector protease of the coagulation cascade. thrombin is also generated at sites of vascular injury and during inflammation. hence, thrombin generation is observed within atherosclerotic and other inflammatory lesions including rheumatoid arthitis. thrombin activates various cells via protease-activated receptors (pars). immature dc do not express pars. upon maturation with lps, tnfalpha, or cd40l, only lps-matured dc expressed par1 and par3 on their surface. stimulation of dc with thrombin, par1-or par3-activating peptides elicited actin polymerization and concentration-dependent chemotactic responses in lps-, but not in tnf-alphamatured dc. the thrombin-induced migration was a true chemotaxis as assessed by checkerboard analysis. stimulation of pars with thrombin or respective receptoractivating peptides led to activation of erk1/2 and rho kinase i (rock-i) as well as subsequent phosphorylation of the regulatory myosin light chain 2 (mlc2). the erk1/2-and rock-i-mediated phosphorylation of mlc2 was indispensable for the par-mediated chemotaxis as shown by use of pharmacological inhibitors of rock, erk and mlc kinases. in addition, thrombin significantly increased the ability of mature dc to activate proliferation of naive t-lymphocytes in mixed leukocyte reactions. in conclusion, our work demonstrates expression of functionally active thrombin receptors on lps-matured dc. we identified thrombin as a potent chemoattractant for mature dc, acting via rho/ erk-signaling pathways. data concerning the role of circulating modified low density lipoproteins (modldl) in atherogenesis and other pathologies are scarce. one reason for this is the lack of suitable radiolabeling methods for direct assessment of metabolic pathways of modldl in vivo. we report a novel approach for specific labeling of human native ldl (nldl) and modldl (iron-, hypochloriteand myeloperoxidase-oxidized, nitrated, glycated, and homocysteinylated ldl) with the positron emitter fluorine-18 (18f) by either nh2-reactive n-succinimidyl-4-[18f]fluorobenzoate or sh-reactive n-[6-(4-[18f]fluorobenzylidene)-aminooxyhexyl]maleimide (radiochemical yields, 15-40%; specific radioactivity, 150-400 gbq/ mmol). radiolabeling itself caused neither additional oxidative structural modifications of ldl lipids and proteins nor adverse alterations of their biological activity and functionality in vitro. the approach was evaluated with respect to binding and uptake of 18f-nldl and 18f-modldl in cells overexpressing various lipoproteinrecognizing receptors. the metabolic fate of 18f-nldl and 18f-modldl in vivo was delineated by dynamic small animal pet studies in rats and mice. the in vivo distribution and kinetics of nldl and modldl correlated well with the anatomical localization and functional expression of ldl receptors, scavenger receptors, and receptors for advanced glycation end products. the study shows that ldl modification, depending on type and extent of modification, in part or fully blocks binding to the ldl receptor, and reroutes the modldl to tissuespecific disease associated pathways. in this line, 18flabeling of modldl and the use of small animal pet provide a valuable tool for imaging and functional characterization of these pathways and specific sites of pathologic processes, including inflammatory processes, in animal models in vivo. the p38 mapk signaling pathway, which regulates the activity of different transcriptions factors including nuclear factor-ã�b (nf-ã�b), is activated in lesional psoriatic skin. the purpose of the present study was to investigate the effect of fumaric acid esters on the p38 mapk and the down stream kinases msk1 and 2 in cultured human keratinocytes. cell cultures were incubated with dimethylfumarate (dmf), methylhydrogenfumarate (mhf) or fumaric acid (fa) and then stimulated with il-1b before kinase activation was determined by western blotting. a significant inhibition of both msk1 and 2 activations was seen after pre-incubation with dmf and stimulation with il-1b whereas mhf and fa had no effect. also, dmf decreased phosphorylation of nf-kb / p65 (ser276), which is known to be transactivated by msk1. furthermore, incubation with dmf before stimulation with il-1b resulted in a significant decrease in nf-kb binding to the il-8 kb and the il-20 kb binding sites as well as a subsequent decrease in il-8 and il-20 mrna expression. our results suggest that dmf specifically inhibits msk1 and 2 activations and subsequently inhibits nf-kb induced gene-transcriptions which are believed to be important in the pathogenesis of psoriasis. these effects of dmf explain the anti-psoriatic effect of fumaric acid esters. a humanized model of psoriasis was successfully established by transplanting non-lesional skin biopsies from psoriasis patients onto bg-nu-xid mice lacking b, t and nk cells. in this system, a psoriatic process is triggered by intradermal injection of activated autologous peripheral blood lymphocytes. inflammation is associated with the expression of activation markers and inflammatory medi-ators such as tnf-alpha, hla-dr and cd1a and this results in increased proliferation and differentiation of keratinocytes, demonstrated by increased expression of ki-67 and ck-16. epidermal hyperplasia is a typical readout in this model. in a series of studies, this model was found to be sensitive too a wide range of compounds, including inhibitors of tnf-alpha, antibodies directed against growth factors, mmp-inhibitors, calcipotriol, metothrexate, betamethasone and cyclosporine a.in addition, we showed that inhibition of fatty acid oxidation had an anti-psoriatic effect in this model (caspary et al. brit j dermatol 2005; 153, 937-944) . employing lesional skin it was demonstrated that inhibition can also be performed in a therapeutic setting.due to its humanized nature this model represents a powerful tool for the identification or validation of compounds with potential for the treatment of psoriasis. kristian otkjaer (1), e hasselager(2), j clausen(2), l iversen (1), k kragballe (1) (1) aarhus university hospital, denmark (2) novo nordisk a/s, denmark interleukin-20 (il-20) is assumed to be a key cytokine in the pathogenesis of psoriasis. increased levels of il-20 are present in lesional psoriatic skin compared with nonlesional skin where it is barely detectable. whether il-20 is derived from antigen-presenting cells or keratinocytes remains unsolved. the aim of the present study was, therefore, to characterize il-20 expression in non-lesional psoriatic skin ex vivo. 3 mm punch biopsies from nonlesional psoriatic skin were collected. biopsies were transferred to cacl enriched keratinocyte basal media and cultured with vehicle or il-1beta (10ng/ml) for 0, 1, 2, 4, 6, 12 and 24 hours, respectively. the samples were analyzed by in situ hybridisation, qrt-pcr, immunofluorescent staining and elisa. incubation with il-1beta rapidly induced il-20 mrna expression in the biopsies. the highest level of il-20 mrna was detected after 4 hours and in situ hybridisation revealed that basal as well as suprabasal keratinocytes throughout the epidermis were the only cellular source of il-20 mrna. increased levels of il-20 protein were detected in the supernatant of the il-1beta stimulated biopsies. immunofluorescent staining of the biopsies showed no il-20 protein in the keratinocytes, whereas the il-20 protein was present in epidermal cd1a positive dendritic cells. our data emphasize the keratinocyte as the cellular source of il-20 expression in human skin. interestingly, immunofluorescent staining of our cultured biopsies showed il-20 protein in epidermal dendritic cells whereas no il-20 was detected in the keratinocytes. this indicates that epidermal dendritic cells are the target for keratinocytederived il-20. one response of epidermal keratinocytes to inflammatory stress is the induction of matrix metalloproteinases (mmps) that participate in tissue remodeling. excessive proteolytic activity is associated with chronic wounds and tissue damage during persistent inflammation. calcitriol, the hormonally active form of vitamin d, is known to have beneficial effects during cutaneous inflammation. we hypothesized that one way in which calcitriol exerts its effect on inflamed skin is by attenuation of damages caused by excessive mmp proteolytic activity. our experimental model consists of hacat keratinocytes cultured with tnf to simulate an inflammatory state. pro-mmp-9 was quantified by gelatin zymography and mrna by real-time pcr. the levels and activation of signaling proteins were determined by immunoblotting. the increase in pro-mmp-9 activity and mrna levels induced by tnf was inhibited by~50% following 48h treatment with calcitriol. using specific inhibitors we established that the induction of mmp-9 was dependent upon the erk pathway, while p38-mapk and pkc inhibited, and jun-kinase, pi-3-kinase and src did not affect it. levels of c-fos, a component of ap-1 transcription complex known to mediate mmp-9 induction, were elevated by tnf and further increased by calcitriol. the induction of mmp-9 by tnf was abolished by inhibition of the egfr tyrosine kinase attesting to the requirement for egfr trans-activation. calcitriol also inhibited the induction of mmp-9 by egf. we conclude that calcitriol inhibits the induction of mmp-9 gene expression by tnf in keratinocytes by affecting an event downstream to the convergence of the egfr and the tnf signaling pathways. (1), p verzaal (1), t lagerweij (1), c persoon-deen (1), l havekes (1), a oranje (2) (1) tno pharma, department of inflammatory and degenerative diseases, leiden, the netherlands (2) erasmus medical center, department dermatology and venereology, rotterdam, the netherlands mice with transgenic overexpression of human apolipoprotein c1 in liver and skin display a strongly disturbed lipid metabolism. moreover, these mice show a loss of skin-barrier function evident from increased trans epidermal water loss. these mice develop symptoms of atopic dermatitis, i.e. scaling, lichenification, papules, excoriation and pruritus. both hyperplasia of epidermis and dermis are observed. histological analysis shows increased numbers of cd4+ t cells, eosinophils, mast cells and ige-positive cells in the dermis. serum levels of ige are increased as well. cytokine profiling of draining lymph nodes is in favor of a th2-mediated disease. development of atopic dermatis in this model was found to be sensitive to topical treatment with triamcinoloneacetonide, fluticasone-proprionate and tacrolimus. moreover, oral treatment with dexamethasone successfully inhibits the development of disease in this model. impairment of the skin barrier is most likely the underlying cause of the development of atopic dermatitis in this model.this model is useful for identifying new therapeutic strategies and obtaining new insight into the pathogenesis of atopic dermatitis. topical immunosupppressants such as elidel and protopic are highly efficacious therapeutics for the treatment of atopic dermatitis and other dermatological conditions.-when delivered topically, these calcinuerin inhibitors offer several advantages over topical steroids; however, these marketed drugs have received a controversial "black box warning" because of a potential cancer risk. we speculated that systemic exposure of these drugs over long term use may contribute to the cancer risk.accordingly, we have designed and discovered a series of "soft" cyclosporin a (csa) derivatives as potentially safer alternatives.in general, soft drugs are engineered, via medicinal chemistry, to be effective upon local delivery but upon systemic exposure they are rapidly inactivated by metabolic pathways.in this way, exposure of active drug to distal organs is greatly minimized resulting in a significant enhancement in therapeutic index.the results or our drug discovery efforts around soft csa derivatives will be presented. (1), y sawanobori (2), u bang-olsen (3), c vestergaard(4), c grã¸nhã¸j-larsen (1) background: a strain of japanese fancy-mice, nc/nga, serves as a model for atopic dermatitis. under specific pathogen-free conditions, the mice remain healthy, but when kept under non-sterile conditions, they exhibit pruritic lesions like atopic dermatitis. scratching behaviour of the mice precedes the development of dermatitis, and a correlation between registered scratching counts and expression of il-31 mrna has been shown. also, transgenic mice over-expressing il-31 exhibit increased scratching behaviour and develop severe dermatitis. consequently we decided to explore the therapeutic effect of an anti il-31 antibody on scratching behaviour and dermatitis in nc/nga mice. methods: prior to clinical manifestation of dermatitis, we commenced treatment of nc/nga mice with il-31 ratanti-mouse 10 mg/kg intraperitoneally every fifth day for seven weeks. clinical dermatitis, scratching behaviour and weight gain, was assessed throughout the intervention period. serum analysis for ige and il-13 as well as histopathological and immunohistochemistry analysis on skin biopsies were also performed at end-point. results: taken over the entire intervention period, treatment with anti il-31 antibody in nc/nga mice from age seven weeks did not meet the primary end points, which were scratch, dermatitis and body weight. however, post hoc analysis revealed a significant reduc-tion of scratch by the anti il-31 antibody treatment in the time interval day 22-43. our results suggest an anti pruritic role for il-31 antibody in an atopic dermatitis-like animal model. anti il-31 antibody is therefore a new therapeutic opportunity for the treatment of pruritus in atopic dermatitis and perhaps other pruritic diseases. (1), p ferro (1), hm asnagli (1), v ardissone (1), t ruckle (2), f altruda (3), ch ladel (1) (1) rbm merck serono/university of torino, italy (2) merck serono pharmaceutical research institute, geneva, switzerland (3) university of torino, dipartimento di genetica, biologia, biochimica, italy class-i phosphoinositide 3-kinases (pi3ks) play a critical role in modulating innate and adaptive immune responses, as they are important transducers of external stimuli to cells, such as granulocytes and lymphocytes. since pi3k-g plays a pivotal role in mediating leukocyte chemotaxis and activation, as well as mast cell degranulation, the pharmacological blockade of pi3k-g might offer an innovative rationale-based therapeutic strategy for inflammatory skin disorders. in our study the inhibitory properties of a selective pi3k-g inhibitor as605858 on inflammation was applied to murine models modeling skin diseases like psoriasis and dermatitis. two mouse models were used: the first, irritant contact dermatitis (icd), is an innate inflammatory skin condition arising from the release of pro-inflammatory cytokines in response to haptens, usually chemicals. the second, contact hypersensitivity (chs) is a t-cell dependent model, modeling in part t-cell-mediated skin diseases such as psoriasis. we demonstrated the therapeutic effect of pi3kg inhibition and subsequent inhibition of chemotaxis in models of skin diseases and showed that a selective pi3k-g inhibitor can excert an important therapeutic efficacy (dose-dependent) in models of innate immunity (icd) -effective dose 0,3mg/kg p.o. once -as well as in t-cell mediated skin pathology (chs)effective dose 1mg/kg p.o. bid. we conclude that the mechanism of action related to inhibition of pi3k-g are demonstrable after oral administration of selective inhibitors like as605858 in models of acute and chronic skin inflammation and are mediated by modulation of innate and acquired immunity. introduction: high mobility group box 1(hmgb1) has recently been identified as a late mediator of endotoxin lethality. we newly developed an extra corporeal hmgb1 absorber. the purpose of this study was to test the hypothesis that hmgb1 removal could prevent or reduce endotoxin induced lethality or tissue injury of rats. methods: all experiments were conducted in accordance with the institutional care and use committee.male wistar rats were randomly allocated into three groups; hmgb1 absorber group (group i),hmgb1 nonabsorber group (group ii), and vacant column group (group iii).we applied these columns for each groups at 6 hours after lps injection. the rats were sacrificed 48 hours after lps injection for pulmonary histology. we statistically analyzed survival rate with kaplan-meier and the levels of hmgb1 with anova. results: survival rate was 67% in the group i at 48 hours after lps injection, as compared with 0% in the group ii and 11% in the group iii. the pulmonary histology in both group ii and group iii showed acute inflammatory injuries, whereas group i showed less inflammatory changes.the level of hmgb1 in the group i was significantly lower than those of group ii and iii. discussions:these results demonstratethat specific absorption of endogenous hmgb1 therapeutically reverses lethality of established sepsis indicating that hmgb1 inhibitors and absorber can be treated in a clinically relevant therapeutic window that is significantly wider than for other known cytokines. contact information: dr hideo iwasaka, oita university, anesthesiology and intensive care unit, yufu city, japan e-mail: hiwasaka@med.oita-u.ac.jp (1) (1) department of pharmacology, national university of singapore, singapore (2) dso national laboratories, singapore hydrogen sulfide (h2s) is increasingly recognized as a proinflammatory mediator in various inflammatory conditions. in this study, we have investigated the role of h2s in regulating expression of some endothelial adhesion molecules and migration of leukocytes to inflamed sites in sepsis. male swiss mice were subjected to cecal ligation and puncture (clp) induced sepsis and treated with saline, dl-propargylglycine (pag, 50 mg/kg i.p.), an inhibitor of h2s formation or sodium hydrogen sulfide (nahs) (10mg/kg, i.p.), a h2s donor. pag was administered either 1 hour before or 1 hour after induction of sepsis while nahs was given at the time of clp. using intravital microcopy, we found that in sepsis, prophylactic and therapeutic administration of pag significantly reduced the leukocyte rolling and adherence in mesenteric venules coupled with decreased mrna and protein levels of adhesion molecules (icam-1, p-selectin and e-selectin) in lung and liver. in contrast, injection of nahs significantly upregulated leukocyte rolling and attachment as well as tissue levels of adhesion molecules in sepsis. on the other hand, normal mice were given nahs (10mg/kg i.p.) to induce lung inflammation with or without pretreatment of nf-xã�b inhibitor, bay 11-7082. h2s treatment enhanced the pulmonary level of adhesion molecules and neutrophil infiltration in lung. these alterations were reversed by pretreatment with bay11-7082. moreover, expression of cxcr2 in neutrophils obtained from h2s treated mice was significantly upregulated leading to an obvious elevation in mip-2 directed migration of neutrophils. therefore, h2s act as an important endogenous regulator of leukocyte trafficking during inflammatory response. transient receptor potential vanilloid 1 (trpv1) is primarily found on sensory nerves. we have demonstrated its pro-inflammatory potential in arthritis and now present evidence that it is protective in an endotoxininduced model of sepsis. selective trpv1 antagonists are not available for use in the mouse in vivo, thus established trpv1 knockout (-/-) mice were used. c57bl6 wt and trpv1-/-mice were matched for age and sex and injected intraperitoneally (i.p.) with lipopolysaccharide (lps). the response was monitored for 4h. blood pressure, measured before and at intervals after lps in conscious mice via a tail cuff was reduced in both wt and trpv1-/-mice, with trpv1-/-mice showing an enhanced drop at 4h. in a separate group temperature, a proposed pre-mortality marker was also reduced by 4h, again with a significantly increased drop in trpv1ko. furthermore higher levels of two inflammatory markers tnfa and nitrite (as an indicator of no) were measured in peritoneal lavage and higher levels measured intrpv1-/-as compared with wt samples. finally aspartate aminotransferase (ast) levels also enhanced in trpv1-/-versus wt mice, although markers for kidney and pancreatic damage were similar in both genotypes. we conclude that trpv1 plays a protective role in sepsis. trpv1 is known to be present on nonneuronal (e.g. vascular components) and their relative involvement in sepsis is unknown. (1), da souza-junior(2), l de paula (1), mc jamur (2), c oliver (2), sg ramos (2), cl silva (2), lucia helena faccioli (1) ( h37rv) . infected balb/c mice developed an acute pulmonary inflammation and higher levels of tnf-a, il-1, kc, mcp-1 and mip-2 were detected in the lungs by day 15. in vivo degranulation of mast cells by c48/80 led to a reduction of the inflammatory reaction associated to a marked decline proinflammatory cytokine and chemokine levels in the lungs. the magnitude of cellular immune response was also partially impaired in infected mice and treated with c48/80. histologically, the exacerbated granulomatous inflammation shown in the lung parenchyma of infected mice was attenuated in infected mice and treated with c48/80. of interest, the number of mycobacterial bacilli recovered from the lungs was 1 log higher after treatment of infected mice with c48/80. these findings suggest that mcs participate in host defense against m. tuberculosis infection through of the modulation of cytokines and chemokines, which are important for the recruitment and activation of inflammatory cells. (1), ms chadfield (2), db sã¸rensen (1), h offenberg (1), m bisgaard (1), he jensen (1) (1) department of veterinary pathobiology, faculty of life sciences, university of copenhagen, denmark (2) novo nordisk a/s, cell biology, gentofte, denmark introduction: pasteurella multocida is an important cause of pneumonia in several animal species and may spread systemically. the aim of this study was to evaluate initial inflammatory reactions and the inocula effect due to strains of p. multocida of different origin in an aerogenous murine model. materials and methods: 30 female balb/ c-j mice (app. 20 g, taconic, denmark) were infected intranasally with two clinical isolates of p. multocida of avian (vp161) and porcine (p934) origin, at three different levels of inocula concentration. after euthanasia, specimens of lung and liver tissue were collected for bacteriological and histopathological evaluation. furthermore, lung tissue samples were taken for measurement of expression of metalloproteinase mmp-9 and metalloproteinase inhibitor timp-1. results: all mice infected with the avian strain were euthanized after 24 hours. viable counts recovered from lung and liver tissue were high, and histopathology revealed pronounced acute bronchopneumonia. in the liver, disseminated necrosis with formation of microabscess was also seen. on the contrary, a dose response was observed with the porcine strain with regard to recovery of viable counts and development of lesions was apparent after 24, 48 and 72 h. furthermore, differences were seen in the nature of the lesions caused by the two strains. there was a difference in expression of mmp-9 and timp-1 between infected and noninfected mice. the model proved suitable for the evaluation of pulmonary inflammatory reactions between the two different host-derived strains as demonstrated through viable counts, histopathology and expression of mmp-9 and timp-1. (1), r molinaro (1), a franã�a (1), m bozza (1), f cunha(2), s kunkel (3) (1) universidade do rio de janeiro, brazil (2) universidade de sâ¼o paulo, brazil (3) university of michigan, usa introduction and objectives: studies reveal that regulatory t (treg) cells control immune responses; therefore these responses must be controlled to enable the effective protection against infections and cancer. ccr4 knockout mice (ccr4 -/-) are more resistant to lps shock. so, our aim is to study the mechanisms involved in the resistance of ccr4-/-subjected to severe sepsis by cecal ligation and puncture (clp) and how tregs modulate this effect. results: c57/bl6 mice were subjected to clp model, whereby the cecum was partially ligated and puncture nine times with a 21g needle. sham-operated mice were used as control. mice subjected to clp and sham surgery were treated with antibiotic since 6h after and until 3 days. ccr4 -/-mice subjected to clp presented an increase in survival rate (78%) compared with wildtype mice (17%), and a marked improvement in the innate response concern to neutrophil migration to peritoneum and lung, bacteria load and cytokine levels compared to wild-type mice. besides, tregs from ccr4-/-clp mice did not inhibit proliferation of t effector cells as observed for treg from wild clp mice, at a proportional ratio of teffector:treg. interesting, treg from ccr4-/-clp mice did not inhibit neutrophil migration to bal when co-injected with fungal challenge as secondary infection, while the treg from wild clp mice did, as expected. conclusions: these results suggest that treg cells from ccr4-/-mice did not present suppressive response and it could be an important factor in their survival. inflammation and oxidative stress are known to be one of the important causes that are responsible for many diseases. inflammation has been associated with diseases like cancer, diabetes and many other. proinflammatory cytokine (tnf -âµ and il-1ã¢) and no are considered as pivotal mediators in inflammatory conditions like rheumatoid arthritis, sepsis and cancer etc. thus inhibition of pro-inflammatory cytokines and no production are important targets for treatment of inflammatory disorders. nowadays due to the emerging side effects of cox inhibitors, these targets have been paid more attention for the treatment of these conditions. some medicinal plants such as curcuma longa (1), commiphora mukul (2) in humoral memory, antibodies secreted into serum and other body fluids protect an individual against repeated challenges of previously encountered pathogens. antibody-secreting plasmacells are mostly considered to be shortlived, terminally differentiated b lymphocytes, eliminated after a few days or weeks by apoptosis. however, in secondary lymphoid organs and in the bone marrow, plasma cells can survive for months and years, without dna-synthesis and refractory to signals from antigen or antigen-antibody complexes. the lifetime of these longlived plasmacells depends on an intrinsic competence to survive in the distinct environment of those organs, which defines a specific survival niche. the niche provides survival signals like il-6, cxcl12 and tnf. within a functional niche, the lifetime of a plasma cell is apparently not limited intrinsically. the number of niches in the body has to be limited, in order to maintain physiological concentrations of serum immunoglobulins. thus recruitment of new plasmacells to the pool of old memory plasma cells has to be competetive. this competition is probably controlled by a simple molecular mechanism, namely the dual functionality of chemokines like cxcl12, which attract newly generated plasmablasts to a survival niche and at the same time are a survival signal for the plasma cell. plasmablasts and plasma cells express cxcr4, the receptor for cxcl12. while plasmablasts migrate in response to cxcl12, plasma cells depend on it for survival in the niche, but are no longer migratory. thus once disloged from their niche, they will die. plasmablasts newly generated upon systemic secondary immunization, upon concommittant stimulation with interferon-gamma, can also express cxcr3, the receptor for the interferon-gamma-induced chemokines cxcl9, 10 and 11, which may lure the plasmablasts into inflamed tissue. the switch in the potential to migrate provides also an efficient means to eliminate plasma cells of the peak of an immune response, which as plasmablasts had migrated to the tissue inflamed in that pathogenic challenge. inflamed tissue contains survival niches for plasma cells. in the inflamed tissue, plasma cells provide high local antibody concentrations while the tissue is inflamed. upon resolution of the inflammation the plasma cells will be dislodged and die. longlived plasma cells provide longlasting antibody titers (protective memory) and leave memory b cells a role in reactive memory, generating memoryplasmacells in secondary challenges, and if serum titers are not sufficient to protect. in chronic inflammation, this mechanism can contribute to pathogenesis. thus in the nzb/w model of lupus, longlived autoreactive plasma cells are generated early in pathogenesis, which survive in bone marrow and spleen. later, in established disease, autoreactive plasma cells are shortlived and continuously generated. they do not compete with the longlived plasma cells, and both populations coexist as prominent populations. interestingly, longlived plasmacells are resistant to therapeutic immunosuppression, while the generation of shortlived plasma cells is blocked. this may be the reason for the failure to cure antibodymediated immunopathology, e.g. in autoimmunity and allergy, by conventional immunosuppression, (1), h lee (2) c5a is a potent inflammatory mediator produced during complement activation. unregulated c5a signalling through its receptor (c5ar) on neutrophils and other leukocytes is implicated in the pathogenesis of autoimmune diseases including rheumatoid arthritis and systemic lupus erythematosus. considerable effort has gone into development of c5ar antagonists for human therapy. we took neutrophils from genetically modified human c5ar knock-in mice in which the mouse c5ar coding region was replaced with human c5ar sequences and immunized wild-type mice to generate high affinity antagonist monoclonal antibodies (mabs) to human c5ar. these mabs inhibit c5a-induced neutrophil migration and calcium-flux, and bind to a region of the 2nd extracellular loop of c5ar loop that seems to be critical for receptor activity. this study investigated the effectiveness of these mabs in the k/bxn serum-transfer model of inflammatory arthritis. human c5ar knock-in mice were given 1-10 mg/kg mab intraperitoneally, before or after inflammatory arthritis developed. mice treated with anti-c5ar mab one day before serum transfer did not develop swelling or clinical signs of arthritis in contrast to controls. histopathology of the joints in anti-c5ar mab-treated mice revealed a complete block of the massive influx of leukocytes and cartilage erosion seen in controls. furthermore, and most significantly, a single 1 mg/kg dose of anti-c5ar mab given 5 days after initiation of disease completely reversed inflammation. in the collagen-induced arthritis (cia) model, injection of anti-c5ar mab after development of inflammation also reversed inflammation to baseline. these potent new antibodies to human c5ar are in preclinical development. the cytokine macrophage migration inhibitory factor (mif) participates in fundamental events in innate and adaptive immunity. the profile of activities of mif in vivo and in vitro is strongly suggestive of a role for mif in the pathogenesis of many inflammatory diseases, including rheumatoid arthritis (ra), asthma, and sepsis. mif also has a unique relationship with glucocorticoids, in that despite antagonizing their effects, the expression of mif is in fact induced by glucocorticoids. thus, mif functions as a physiological counter-regulator of the anti-inflammatory effects of glucocorticoids. therapeutic mif antagonist may therefore provide a specific means of steroid sparing. since mif are highly conserved among different species, it is hard to develop high affinity antibodies due to immune tolerance.we developed a proprietary technique to break the immune tolerance and selected high affinity mouse monoclonal antibodies against mif.the antibody can neutralize mif activity in cell based assays, and is very effective in a lps induced mouse sepsis model. using this antibody as a tool, we are studying the function of mif in comparison with the function of lps.we found that lps induced inos expression and no secretion are dependent on the secretion of mif.we also found that although both lps and mif induce g1 arrest in macrophage cell line raw264.7, their functions are independent to each other. structure-based small molecule drug design. an effective agent would be the first orally active cytokine antagonist. methods: collagen-induced arthritis (cia) was induced in dba-1 mice by immunisation with bovine type ii collagen/adjuvant on day 0 and 21. cor100140, synthesized on the basis of computer modeling of mif protein x-ray crystallographic data, was administered by daily oral gavage from day 21. etanercept (8mg/kg ip q2d) was used as a positive control. the mek-erk pathway is activated in numerous inflammatory conditions, including ra, ibd and copd. arry-162 is a potent (ic50 = 12 nm), selective, atp-uncompetitive mek1/2 inhibitor.arry-162 is highly efficacious in cia and aia rat models, with ed50s of 3 and 10 mg/kg, respectively, equal to or better than standard agents. addition of arry-162 to methotrexate, etanercept, ibuprofen or dexamethasone regimens in these models results in improved efficacy that is at least additive, if not synergistic. in tpa-stimulated human whole blood, this compound inhibited tnf, il-1 and il-6 production (ic50s of 23, 21 and 21 nm, respectively). in contrast, inhibition of perk required 280 nm to achieve a 50% reduction, demonstrating that inhibition of pro-inflammatory processes is very sensitive to perk inhibition.in clinical studies, healthy volunteers were administered a single oral dose of 10, 20, 30, 40 or 80 mg); blood was drawn at various times after dosing and stimulated ex vivo with tpa. arry-162 was well-tolerated and drug exposure was dose-proportional. in ex vivo blood samples, there was a dramatic time-and concentration-dependent inhibition of tpainduced il1 and tnffz with >80% inhibition observed at plasma concentrations of 50 and 150 ng/ml, respectively. similar inhibition of perk required 300 ng/ml. a multiple ascending dose clinical study has confirmed the pharmacokinetics and pharmacodynamics of arry-162 and helped define tolerability. clinical evaluation of arry-162 in combination with methotrexate in patients with rheumatoid arthritis is on-going. p38 (a mitogen-activated protein kinase) has been shown to play a key role in the release of cytokines such as tnfand il-1a from monocytes in signaling cascades that are initiated due to extra cellular stress stimuli. inhibition of p38 activity is expected to regulate the levels of tnf-a and il-1b thereby alleviating the effects of inflammation in ra. a new class of p38 inhibitors based on the naphthyridininone scaffold have been discovered. x-ray crystallography and site directed mutagenesis studies were critical tools that aided the evolution of the naphthyridinone lead class starting from a pyrido-pyrimidinone template. this presentation will discuss the derivation of key benchmark pre-clinical candidates in these novel scaffold classes (shown below) as influenced by structural biology studies, mutagenesis data and molecular modelling. efficacy studies in animal models for benchmark compounds will also be presented. (1), h aaes (1), w-h boehncke(2), j pfeffer(2), t skak-nielsen(1), i teige (1), k abell (1), ph kvist (1), e ottosen (1), tk petersen (1), lars svensson (1) (1) discovery, leo pharma, 55 industriparken, ballerup, denmark (2) department of dermatology, johann wolfgang goethe-university, frankfurt am main, germany p38 map kinase plays an important role in mediating an inflammatory response in mammalian cells. as a consequence of activation, several inflammatory mediators are released including il-1b] and tnfa. both cytokines have a central role in the pathogenesis of inflammatory conditions such as psoriasis. approximately 30% of psoriasis patients develop psoriatic arthritis. leo15520 is a member of newly developed class of selective p38 map kinase inhibitors. the compound was tested orally in in vivo models relevant for psoriasis and psoriatic arthritis. the in vivo models selected include the cia arthritis model, the human psoriasis xenograft scid mouse model, the uvb-induced dermatitis model, the lps induced tnfa model and a local gvh model. treatment with leo15520 led to an amelioration of the ongoing inflammation in all investigated in vivo models. in the cia model, a clear dose response effect was observed on the developing arthritis in both rats and mice (65 % reduction in mice and 77 % in rats at 10 mg/kg p.o.). in the humanised psoriasis model, leo15520 at a dose of 20 mg/kg, had an effect on both the hyperplastic epidermis (epidermal thickness reduced by 41%) and on the infiltrating inflammatory cells. the anti-inflammatory effect of leo15520 was even close to the effect of systemically delivered steroids in both models. we believe that the new highly selective class of p38map kinase inhibitors has a strong potential as an orally delivered therapy for systemic inflammation diseases such as psoriasis and arthritis. slx-2119 is a potent, selective, orally bioavailable inhibitor of the rho-kinase rock-2. its ic50 for rock-2 and rock-1 inhibition is 100 nm and >10 mm respectively. the ability of slx-2119 to inhibit septic liver injury was investigated in c57bl/6j mice challenged with lipopolysaccharide (lps) and d-galactosamine (d-gal). mice were given lps (10 mg/mouse) and d-gal (18 mg/ mouse) i.p and 5.5 hours later were sacrificed for analysis of liver injury. mice challenged with lps/d-gal had a >10 fold increase in serum alt and ast levels. this increase was reduced by >90% in mice pretreated with slx-2119 either orally (100 mg/kg, 2 and 20 hrs prechallenge) or i.p. (10-100 mg/kg, 15 min pre-challenge). slx-2119 inhibited the increase in hepatic levels of tnffalpha produced by lps/d-gal by >50%. to assess the kinetics of slx-2119s benefit, slx-2119 (100 mg/kg i.p.) was given 15 min prior to, or 15 or 60 min after the lps/ d-gal. slx-2119 was effective at inhibiting the rise in alt and ast levels at all 3 time points suggesting that inhibiting rock-2 even after the initiation of the lps/d-gal driven cascade protects against septic liver injury. in a survival study, 9 out of 10 mice given lps/d-gal were dead by 8 hrs whereas in mice given slx-2119 (100 mg/kg orally) 1 animal died at 10 hours and the remaining 9 mice were alive 48 hrs later. these results show that specific inhibitors of rock-2 may have therapeutic utility in the treatment of sepsis and subsequent liver injury. theta through three key hydrogen bond mediated interactions.they potently inhibit protein kinase c activity in vitro as demonstrated by inhibition of il-2 secretion in human purified t-cells stimulated with anti-cd3 and anti-cd28 or whole blood seb challenge.the pkc-theta inhibitors are orally bioavailable and demonstrate immunosuppressive activity in a mouse model of human delayed-type hypersensitivity responses. (1), j zhang (1), k henley (1), m white (1), d hilton (1), b kile (1) ( to investigate pathogenesis of rheumatoid arthritis, we used mice transgenic for the uniquely human fcgam-mariia in inducible and passively transferred models of arthritis. transgenic mice developed severe ra-like disease in both model systems, indicating that the transgene played a major role in arthritis pathogenesis. disease could be reduced by the administration of either specific monoclonal antibodies to fcgammariia or small chemical entities (sce) designed to bind to the fcgam-mariia dimer. to investigate the cause of this enhanced sensitivity to auto-immune stimuli, the phagocytic capacity of transgenic mice compared to c57bl/6 control mice was examined using phagocytosis of fluorescent beads coated with ova or ova/anti-ova immune complex or opsonised sheep red blood cells. in both assays macrophages from fcgammariia transgenic mice showed significantly increased phagocytosis comapred with cells from control mice at 4 hours.this difference diminished over time andwas only seen where particles were opsonised. treatment of macrophages with specific fcgammariia blocking monoclonal antibody fragments 8.7 f(ab)2 or iv.3 f(ab) reduced phagocytosis to background levels . macrophages from transgenic mice also showed significantly greater production of inflammatory cytokines tnf-alpha and il-1beta when stimulated in vitro with heat aggregated immunoglobulin (hagg). moreover, this response was also blocked by specific fcgammariia monoclonal antibody fragments or sce. thus, expression of the fcgammariia transgene in these mice leads to increased uptake of and reactivity to immune complexes, resulting in enhancement of inflammatory sequelae in the form of increased th1 cytokine secretion andamplification of the pro-inflammatory response leading to arthritic disease. harald burkhardt (1), u hã¼ffmeier (2), i kã§nig (3), j lacorz (2), a reis (2), k reich (4) (1) johann wolfgang goethe university, frankfurt, germany (2) friedrich-alexander-unisversity of erlangen-nuremberg, germany results: whereas the earlier described strong association of allele tnf*-238a with psoriasis could be confirmed, our study revealed that this association was completely dependent on carrying the psors1 risk allele. for psa, but not psoriasis vulgaris without joint involvement strong association with the allele tnf*-857t was detected (or=1.956, 95% ci 1.33-2.88; pcorr=0.0025) also in patients negative for the psors1 risk allele. our results indicate genetic differences between psoriasis vulgaris patients with and without joint manifestation. while the previously reported association between tnf*-238a and psoriasis seems to primarily reflect ld with psors1, tnf*-857t may represent a risk factor for psa independent of psors1. (1), n modi (1), m stanford (1), e kondeatis (1), r vaughan (1), f fortune (2), w madanat (3), c kanawati(4), p murray (5) methods: dna was obtained from 167 patients with bd, 61 from the uk and 106 from the middle east (me), and 159 controls individuals, 129 from the uk and 30 from me. dna was prepared by proteinase k digestion, and salt extraction and -318 and 49 snp were detected by a pcr-ssp. results: there was no significant difference in expression of -318c/t or 49a/g when all bd patients were compared to all control individuals, (p=0.3 and 0.9, respectively). as we have previously shown differences in snp expression in different patient groups we tested the uk and me patients separately. however, there was no significant difference in either snp in uk bd patients, (p=0.15, p=0.39) or me bd patients (p=0.7, p=0.6) when compared to the appropriate controls. (1), da brown (1), h johnen (1), mr qiu (1), t kuffner (1), pgm curmi (1), l brown (1), m mazzanti (2), sn breit (1) ( introduction: cerebral palsy (cp) is a nonprogressive motor disorder caused by white matter damage in the developing brain. it is often accompanied with neurocognitive and sensory disabilities. the cause and pathogenesis of cp is multifactorial and continues to be poorly understood. chorioamnionitis, clinically silent or manifest, has been reported to be a risk factor for cp both in term and preterm infants. il-16 gene is single copy gene located on chromosome 15q26.1-3 in humans. interleukin-16 is synthesized by a variety of immune (t cells, eosinophils and dendritic cells) and non-immune (fibroblasts, epithelial and neuronal) cells. it is also detected in organ-specific secretions in a number of inflammatory processes. amniotic fluid interleukin-16 concentrations decreased with advancing gestational age. but, women with preterm labor and women with chorioamnionitis have higher interleukin 16 amniotic fluid concentrations than those who delivered at term or those with sterile amniotic fluid. the aim of our study was to estimate allelic frequency for regulatory il16 -295 snp in the children with the cp. methods: dnas obtained from peripheral blood of 46 cp patients and 182 unrelated healthy volunteers were genotyped for the il16 -295 snp pcr-rflp method. results and conclusions: il16 -259 genotype fncc was more common in the population with cerebral palsy in the comparison to healthy volunteers. the significance of the association between il16 fngene polymorphisms and cerebral palsy has to be investigated in the future studies. (1), d delbro (1), e hansson (2) (1) kalmar university, sweden (2) gã§teborg university, sweden background: acetylcholine (ach) is a major signalling molecule, binding partly at nicotinic receptors (nachrs; a family of ions channels with nicotine as a selective ligand). one subtype, the alpha7nachrs, has antiinflammatory effects by way of down-regulation of tnfalpha release from macrophages. the alpha7nachrs have been demonstrated in neuronal as well nonneuronal tissues, e.g. astrocytes and microglia. aim. in rat astrocytes in primary culture, and in astrocytes cocultivated with primary microvessel cultures study: 1. the expression of alpha3nachrs and alpha7nachrs by immunofluorescence and western blot. 2. intracellular ca2+-transients spread within the astroglial networks after stimulation with nicotine. 3. pro-inflammatory cytokines, il-1b, il-6, and tnfalpha, released from microglial cells after stimulation with nicotine. results: alpha7nachrs expression was more evident in astrocytes co-cultivated with endothelial cells, suggesting that endothelial cells release factors, which increase the maturity of astrocytes. the ca2+ transient evoked by nicotine was also more pronounced in the co-cultured astrocytes. these ca2+ responses were blocked by the alpha7nachr antagonist alpha-bungarotoxin. the release of pro-inflammatory cytokines was down-regulated after stimulation by nicotine. conclusion: alpha7nachrs appear to be involved in some of the effects of nicotine administration to rat astrocytes. an anti-inflammatory action of cholinergic nerves on the astrocytes via nachrs seems probable, which may have therapeutic implications. university, department of natural sciences, kalmar, sweden e-mail: ann.pettersson@hik.se gedeon richter plc., budapest, hungary tramadol, an atypical opioid analgesic, is increasingly used for the treatment of osteoarthritis because it does not produce typical side effects of nsaids. review of clinical data show that it produces symptom relief and improves function, but these benefits are small and adverse events often cause participants to stop taking the medication (cohran database 2006). efficacy of tramadol in animal models of inflammatory pain is well established; however complex characterization of the drug regarding analgesic and side effects is missing in rats. our aim was to assess oral efficacy of tramadol at side effect free doses in rats. anti-hyperalgesic effect was determined in complete freunds adjuvant (cfa) induced thermal hyperalgesia test (th) and in model of cfa-induced knee joint arthritis. effect on inflammation was characterized in carrageenan induced paw edema test (et). for the characterization of side effect accelerating rotarod assay (arr) was used. significant impairment in arr was noted at 55 mg/kg dose, and above. in the th test weak 35% effect was seen at side effect free dose (40 mg/kg). in the arthritis model b.i.d. 40 mg/kg dose of tramadol given on days 3-7 after cfa caused a maximum 86% effect on weight bearing incapacitance (day 4). however, its effect seemed to diminish (34% on day 7) upon repeated treatment. in et tramadol had significant anti-inflammatory effect at 100 but not at 30 mg/kg dose. these results show that efficacy of tramadol in rat inflammatory pain models is limited by its side effects, in accordance with clinical data. chronic relapsing experimental allergic encephalomyelitis (cr eae) is a disease that bears striking similarities to the human condition multiple sclerosis (ms). in particular, cr eae and ms have major inflammatory events in the central nervous system (cns) that culminate in demyelination and disruption of axonal function.one group of mediators involved in the progressive cns inflammation are the prostaglandins (pgs).pg generation is regulated in experimental non-immune conditions of the cns by n-methyl-d-aspartate (nmda) receptor activation.nmda receptor-mediated events are also evident in eae and may therefore have the potential to influence pg production.the study was designed to profile pge2 and pgd2 in cns tissues during the development of cr eae and to examine the role of the nmda receptor in pg production through the use of the specific antagonist mk-801.biozzi mice were inoculated for cr eae and cns tissues were sampled during the course of disease.enzyme immunoassay of processed samples revealed pge2 and pgd2 levels within normal limits during the acute and subsequent remission phases of cr eae.in contrast, dramatic changes in pg concentrations were observed with a relapse of symptoms and a remission of disease.mk-801 was therapeutically administered to cr eae-diseased mice at the onset of relapse and changes in cns pg levels were recorded.the relapse phase of cr eae, but not the acute stage of disease, is characterised by an increase in cns pg production that may be influenced by nmda receptor activation. livia l camargo(1), lm yshii (1) (1), sk costa (1) (1) university of sâ¼o paulo, brazil (2) king's college, london, uk (3) butantan institute, sâ¼o paulo, brazil objectives: the neuropeptide substance p (sp) released by capsaicin-sensitive nerves (csn) plays a pivotal role in neurogenic inflammation. despite the prevalence of arthritis, the contribution of sp to the progression of arthritis has not been established. this study investigated the effect of csn ablation and sr140333, a sp antagonist, on knee joint inflammation and pain induced by intraarticular (i.a.) injection of kaolin (10 %, 5 h time course) in female wistar rats. the kaolin-injected knee (ipsilateral -ipsi) of vehicle-treated rats exhibited a significant, timedependent oedema as compared to the contralateral knee. in addition, increased pain score and high levels of myeloperoxidase (mpo, marker of neutrophil accumulation) and both pro-inflammatory (il-1b and il-6, but not tnfa) and anti-inflammatory (il-10) cytokines was detected in the ipsi synovial fluid of these animals. both destruction of knee joint csn fibres by neonatal capsaicin treatment and i.a. injection of rats with sr140333 (1 nmol/cavity) significantly attenuated the kaolin-induced pain score and knee oedema, suggesting that kaolin is acting, at least partially, via a neuronal mechanism. in contrast, the same treatment caused increased mpo activity and cytokine concentrations measured 5 h post kaolin injection. conclusions: peripheral release of sp after kaolin injection acts to increase pain generation, oedema formation and inflammatory cell influx. however, chronic tachykininergic depletion by capsaicin treatment up-regulates the production of pro-inflammatory cytokines that are important in triggering cell influx in the synovial cavity. (1) (1) university of sâ¼o paulo, sâ¼o paulo, brazil (2) butantan institute, sâ¼o paulo, brazil objectives: previously, intra-tracheal (i.tr.) injection of dep or 1,2-naphthoquinone (1,2-nq) evoked plasma extravasation and cell influx in rat airways. we now investigated whether simultaneous injection of these pollutants had a synergistic inflammatory action. we also determined the ability of dep and 1,2-nq-induced airway inflammation to evoke changes in the rat isolated thoracic aorta (rta) and corpus cavernosum (rcc) reactivity using organ bath assays. results: capsaicin-or vehicle-treated male wistar rats received i.tr. injection of dep (1 mg/kg) and 1,2-nq (35 nmol/kg). after 15 min, dep and 1,2-nq produced a potent (additive) plasma extravasation in the trachea and bronchi, but not lung, compared with each compound alone. in capsaicin-treated rats or treated with tachykinin antagonists, the response was inhibited, suggesting an important role for c-fibres, primarily tachykinins. increased mpo and cytokine levels were detected in bronchi of capsaicin-treated rats following 3 h treatment with pollutants. this treatment contributes to augment the ach (10-9-10-4 m)-induced relaxation in the rta but not in the rcc. in capsaicin-treated rats, the rta response to the pollutants was not affected but it was capable of evoking a marked relaxation in rcc in animals challenged with pollutants. conclusions: 1,2-nq exacerbates dep-induced plasma extravasation and mpo activity in the airways, indicating a neurogenic mechanism through tachykinins. the exposure to dep and 1,2-nq affects the endotheliumdependent response in rta without interfering with rcc. neuropeptides are unlikely to affect the pollutantsinduced changes in the rta. acknowledgements: capes, cnpq, fapesp. we thank ma alves for technical assistance. trans-resveratrol (rv) is a naturally occurring polyphenolic compound present in certain foods that has anticancer and anti-inflammatory properties. the purpose of this study was to determine the effect of rv on the production of proinflammatory cytokines and reactive oxygen species stimulated by lipopolysaccharides (lps) in glial cells. rt-pcr showed that rv (5, 25, 50 mm) dose-dependently inhibited 500 ng/ml lps induced tnfa, il-1b, il-6, mcp-1 and inducible nitric oxide synthase mrna expression. rv also inhibited lps-induced production of these cytokines (elisa), nitric oxide and reactive oxygen species in a dose-dependent manner. western blot analyses showed that resveratrol could inhibit lps-stimulated phosphorylation of erk1/2 and jnk but not p38. nf-kb reporter assay showed rv could inhibit nf-kb activation by lps in microglia and astrocytes. these results suggest that rv may inhibit lps-induced microglial and astrocyte activation through erk1/2, jnk and nf-kb signaling pathways. therefore, rv is a natural product with therapeutical potential against disease conditions in cns that involve an overproduction of proinflammatory cytokines and reactive oxygen species. (1), cs patil(2), sv padi (1), vp singh (1) (1) university institute of pharmaceutical sciences, panjab university, chandigarh, india (2) pharmacology r & d, panacea biotec ltd. lalru, punjab, india persistent stimulation of nociceptors and c-fibers by tissue injury causes hyperalgesia and allodynia by sensitization of nociceptors and facilitation of synaptic transmission in the spinal cord. the important participant in the inflammatory response of injured peripheral nerve may be nitric oxide (no). the aim of the present study was to test the sensitivity of pde5 inhibitor sildenafil in chronic constriction injury (cci) model, a rat model of neuropathic pain. sciatic nerve injury is associated with development of hyperalgesia 14 days after the nerve ligation. sildenafil (100 and 200fã� g/rat, i.t.) produced a significant decrease in pain threshold, which in lower dose did not alter the nociceptive threshold. the hyperalgesic effect of sildenafil was blocked by l-name and methylene blue (mb), which on per se treatment showed antinociceptive effect in nerve ligated rats. the results from the present study indicated that the major activation of no cgmp pathway in the chronic constriction injury model of neuropathic pain. the aggravation of hyperalgesic response might be due to the increased cgmp levels resulting in pkg-i activation and its upregulation. glycine transporter (glyt) 1 and glyt2 are expressed in glia and neurons, respectively. glyt1 make clearance of glycine released from glycinergic neuron in synapse and thus terminates the neurotransmission and also regulates over-stimulation by glycine spilled over to nmda receptors, while glyt2 supplies glycine into synaptic vesicles in glycinergic neurons. therefore, glyt inhibitors could modulate inhibitory glycinergic or excitatory glutamatergic neurotransmission. the present study examined the effects of glyt inhibitors on pain in animal models. inhibitors of glyt1 (sarcosine and org25935) and glyt2 (alx1393 and org25543) by intrathecal (i.t.) injection reduced formalin-induced nociceptive behaviors. glyt1 inhibitors reduced allodynia score and reversed the reduction of paw withdrawal threshold in complete freund adjuvant (cfa)-induced inflammation mice but the antiallodynia effects appeared after latent period. on the other hand, glyt2 inhibitors produced antiallodynia effects immediately after the i.t. injection in cfa-treated mice. these inhibitors produced the similar antiallodynia effects in the partial sciatic nerve ligationinjury or streptozotocin-induced diabetic neuropathic pain models, either by i.t. injection or i.v. injection.pretreatment of specific antagonists of glycine site of the nmda receptors disappeared the latent periods of glyt1 inhibitors and potentiated the antiallodynia effect. glycine receptor antagonist, strychnine by i.t. injected reversed the antiallodynia effect of i.v. injected glyt inhibitors. these results suggest that both glyt1 and glyt2 inhibitors by enforcing glycinergic inhibitory neurotransmission in spinal cord produce potent antinociceptive effect and may be novel candidate for medicament of pain control. the tumour microenvironment in particular tumour associated macrophages (tams) play a role in determining tumour outcome. despite strong causative links between inflammation and human gastric cancer progression, little is known of the role of tams in this disease. we have utilized our mouse model of gastric tumourigenesis, the gp130757ff mouse to assess the effect of the gp130757ff mutation on macrophage function and ascertain the role of macrophages in tumor formation. this mouse has a knockin mutation in the il-6 family cytokine receptor gp130 preventing shp2/ras/erk signaling and leading to constitutive stat3 transcriptional activation. tumour development is inflammation dependent, there is a requirement for il-11, and development is inhibited by nsaid treatment or microbial eradication, however an adaptive immune response is s410 inflamm. res., supplement 3 (2007) posters dispensable for tumorigenesis. in gastric antrum the gp130757ff mutation results, decreased erk1/2 activation and constitutive phosphorylation of stat3, abnormal signaling is replicated in macrophages. antral stat3 activation is unaffected by depletion of il-6. however in macrophages an absence of il-6 results in higher stat3 activation demonstrating the anti-stimulatory role of il-6 on macrophages. the gp130757ff mutation results in macrophages with decreased il-6 and increased inos mrna expression reflecting a more basally activated phenotype. manipulations of the gp130757ff mouse that reduce tumor size (eg. antibiotic or nsaid treatment or stat3 hemizygosity) coincidently result in reduced macrophage infiltration of antral mucosa. macrophages of gp130757ff mice display aberrant gp130 signaling potentially resulting in exaggerated response to stimuli. the key difference between mutant gastric mucosa and macrophages are changes in transcription of target genes. (1), y riffo-vasquez(2), s brain(2), s costa (1) (1) university of sâ¼o paulo, brazil (2) king's college london, uk objectives: we have previously shown that simultaneous intra-tracheal injection of diesel exhaust particles (dep) and 1,2-naphthoquinone (1,2-nq) caused a potent inflammation in rat airways partially dependent on neurogenic-mediated mechanism. this study investigates the mechanism of action of thee pollutants using inflammatory assays and histopathological approach in the lung and trachea of wild type (wt) and trpv1 knockout (ko) mice exposed to dep and 1,2-nq. dep (1 mg/kg) and 1,2-nq (35 nmol/kg)-induced airway inflammation was assessed via 125i-labelled albumin 1 h post pollutants injection. mpo assay and histopathology were performed 3 h after treatment. staining of lung and trachea specimens with h&e provided a profile of cell infiltration in both wt and ko animals. results: injection of dep and 1,2-nq evoked a potent plasma extravasation into the trachea and lung of wt, but not trpv1 ko, suggesting these pollutants act via a trpv1-mediated mechanism. in contrast, mpo activity in the airways of trpv1 ko mice was exacerbated compared to wt mice data. likewise, the histopathology revealed high numbers of leukocytes and macrophages infiltrated into the lungs and trachea of trpv1 ko mice compared to wt. conclusions: inhibition of increased microvascular permeability in the airways of trpv1 ko mice treated with pollutants suggests that these receptors are the predominant mechanism involved in the inflammation. however, neutrophils/macrophages accumulate more in trpv1 ko, indicating that the lack of trpv1 receptors up-regulates production of inflammatory cells in response to pollutants, thus supporting a protective role for trpv1 receptors. acknowledgements: capes, cnpq, fapesp. (1), n sato(1,2), y endo (1), s sugawara (1) (1) division of oral immunology, department of oral biology, tohoku university graduate school of dentistry, sendai, japan (2) division of fixed prosthodontics, department of restorative dentistry, tohoku university graduate school of dentistry, sendai, japan biotin is a water-soluble vitamin of the b complex and functions as a cofactor of carboxylases.biotin deficiency causes alopecia and scaly erythematous dermatitis.moreover, serum biotin levels are significantly lower in atopic dermatitis patients than in healthy subjects, indicating that biotin deficiency is involved in inflammatory diseases.however, immunological effects of biotin on allergic inflammation remain unclear.in this study, we investigated the effects of biotin-deficiency on metal allergy using nickel (ni)-allergy model mouse and a murine macrophage cell line j774.1. female balb/c mice (4 weeks old) received a basal diet or a biotin-deficient diet for 8 weeks.ten days after sensitization with intraperitoneal injection of lps and nicl2, the mice were challenged with intradermal injection of nicl2 into the pinnas.allergic inflammation was measured by ear swelling.the ethical board for nonhuman species of the tohoku university graduate school of medicine approved the experimental procedure followed in this study.j774.1 cells were cultured in biotin-sufficient or deficient medium for 4 weeks. ear swelling was significantly higher in biotin-deficient mice than biotin-sufficient mice.il-1 beta productions by splenocytes were significantly higher in biotin-deficient mice than in biotinsufficient mice.moreover, biotin-deficient j774.1 cells produced il-1 beta significantly higher than biotinsufficient j774.1 cells.to investigate the therapeutic effects of biotin-supplementation, biotin-deficient mice received biotin contained-water for 2 weeks.ear swelling was significantly lower in biotin-supplement mice than biotin-deficient mice.these results indicated that biotindeficiency deteriorates allergic inflammation.the augmentation of il-1 beta production is probably involved in those deteriorations. one of the most important targets of cytokine action is the blood vessels, which undergo some structural and functional changes that result in activation of endothelium. applying the elisa technique, levels of il-18, icam-1 and e-selectin were studied in 77 patients with acute pancreatitis. mediators levels were studied in arterial, venous and pancreatic ascites samples. according the atlanta criterion the mild pancreatitis was established in 33 patients and severe -in 44 patients. the highest levels of il-18 were noted in ascites and lowest in arterial samples. the highest concentration of adhesion molecules was in venous samples and lowest in ascites. it was a clear correlation between levels of il-18 and adhesion molecules and severity of pancreatitis. during first week the levels of il-18 gradually increased in patients with severe pancreatitis, while in patients with the edematous pancreatitis its levels decreased starting from the third day. icam-1 levels gradually increased during first three day with the following decrease after this term. the highest levels of e-selectin were noted at the time of admission. the clear correlation between il-18 and adhesion molecules was noted in both groups of patients. besides that, the clear strong correlation was observed between il-18 and quantity of circulating granulocytes and between e-selectin and hematocrite in patients with necrotizing pancreatitis. our study confirms the importance of activation of endothelium as a part of the systemic inflammatory response in patients with acute pancreatitis. subsequently eos infiltrate the tissues, are activated, and release mediators inducing the late phase response. this is characterized by tissue damage and repair, and in chronic reactions, tissue remodeling and fibrosis. mc/eos cross-talk by physical and non-physical contact is an essential feature of late-phase and chronic allergic reactions. we have previously described an mc/eos interaction facilitated by soluble mediators and shown to enhance allergic inflammation. still, pathways that mediate mc/eos cross-talk in allergy are not fully characterized. methods: human cord-blood derived mc were cocultured with peripheral blood eos, and activated with anti-ige. mc/eos couples in co-culture and in human nasal polyp tissue sections were specifically stained and counted using microscopy. expression of surface molecules was analyzed by facs. mc activation was measured by chromogenic assays for ã¢-hexosaminidase. relevant surface molecules were neutralized using antibodies, to assess interference with couple formation and activation. results: mc and eos physically interact, forming welldefined couples in-vitro and in-vivo. in the presence of eos, mc are more releasable under baseline or igeactivating conditions. this effect is partially mediated by cd48 and dnam-1 on mc, and 2b4 and nectin-2 on eos. we describe a novel physical interaction between mc and eos that we name "the allergic synapse". this synapse may upregulate allergic reactions, thus serving as a target for therapeutic intervention in allergic and inflammatory diseases. methods: mc were obtained from cord blood mononuclear cells (6-8 weeks with scf, interleukin-6 and prostaglandin e2, cbmc). cbmc were activated, after their culture for 5 days with myeloma ige (2mg/ml), by rabbit anti-human ige antibodies (5mg/ml), for 1, 3 and 6h at 378c. activation was measured by b-hexosaminidase release, determined by enzymatic-colorimetric assay. the expression of flip, mcl-1, bcl-2, bcl-xl, bak and bax was assessed by immunoblot analysis. results: two anti-apoptotic proteins were found to be upregulated: flip, which is involved in the extrinsic apoptotic pathway and mcl-1 that is mainly implicated in the intrinsic apoptotic pathway. in contrast, the expression of two other anti-apoptotic proteins that we have examined (i.e. bcl-2 and bcl-xl) was not altered. likewise, the expression of pro-apoptotic proteins from the bcl-2 family (i.e. bak and bax) was either undetectable or unchanged. conclusions: our findings reveal that ige-dependent activation of human mc mainly induces the selective increase in the expression of two pro-survival molecules. this may be one of the mechanisms that underlay mc hyperplasia in the chronic allergic inflammation. (1), c armishaw(2), z yang (1), h cai (1), p alewood(2), c geczy (1) (1) university of new south wales, faculty of medicne, sydney, australia (2) university of queensland, institute for molecular biosciences, st lucia, australia purpose: human s100a8, s100a9 and s100a12 are closely related proteins associated with inflammation. s100a12 is expressed in the human genome, but not in the mouse. s100a12 is a potent monocyte chemoattractant and mast cell (mc) activator. mouse (m) s100a8 and human (h) s100a8 share 58% structural identity, but the hinge domains are more divergent. the ms100a8 hinge (ms100a842-55) is a potent chemoattractant for leukocytes whereas this sequence in hs100a8 (hs100a843-56) is inactive. methods: s100a12 hinge domain and its alamine scan mutants were synthesized and their activities were tested by using thp1 cells or murine mc in vitro and mouse footpad injection. results: s100a12 hinge domain (s100a1238-53) was chemotactic for monocytes and mc and provoked mc degranulation in vitro and oedema, and leukocyte recruitment in vivo. in contrast to s100a12, the hinge domain only weakly induced cytokine production (il6, il8) by macrophages. residues essential for oedema were hydrophobic in nature (leu40, isoleu44, isoleu47 and isoleu53). n42 and i44 were essential for responses provoked by 10-12m s100a1238-53 whereas mutation of k38, l40, n46, i47, d49, k50 and i53 significantly reduced migration with 10-9m s100a1238-53. conclusions: s100a12 and ms100a8 may be functional chemattractant equivalents; s100a12 may have arisen by duplication of human s100a8. isoleucine residues in s100a12 hinge domain are essential for its proinflammatory properties. (1), g kiriakopoulou (1), e tsimara(2), a voultsou(2), k zarkadis (1) (1) general hospital of zakynthos, greece (2) medical centre of katastari, zakynthos, greece schistosome is a disease which pests in 74 tropical countries. the endemic areas are south america, far and middle east, and africa. our aim is to present an incident which concerning a parasitic infection, not endemic in greece. patient: man 30 years old who immigrated from pakistan (at the side of the aparkenar river) in greece, a year ago. he turned out with anlage, headache and weight loss. he is a swimmer. he mentioned also a fever before migrating to greece. clinically: largely-scaled paleness, stomach -mild and diffused sensitivity, with also lightly increased enteric sounds and a small degree of hepatomegaly, when palpated deeply. laboratory examination: leucocytes 9.030 eo 24.8%, hb 8.2g/dl, ht 27.2%, mcv 65,6fl, mch 19.1pg, thrombocytes 419.000, blood sedimentation 10mm, fe 10mg/ml, ferritin 2.98ng/ml. normal biochemical examinations. u/s: livers size lightly increased 16.5mm, hepatoportal vein with normal amplitude. parasitology of feces: in the immediate confection with lugol of the second sample, there were observed: big scattering oval ovules (130 -60mm) with a thin wall and quills on the side, as well as three imago worms (>10 mm): schistosoma mansoni. treatment: praziquantel was given. recheck in a months time: blood examinationleucosites 11.230, eo 9.8%, hb 10,2g/dl, ht 33.6%. parasitology of feces is negative. in the diagnosis of anemia combined with fever, to patients who are immigrants, schistosomiasis posters inflamm. res., supplement 3 (2007) should be taken into account, especially when sideropenic anemia is accompanied with intense eosinophile, because the disease is mostly a reaction of retardate supersensitivity. bronchial asthma is a chronic airway inflammatory disease caused by immune cells such as t lymphocytes and eosinophils. recently, high-sensitivity crp (hs-crp) has become available for detecting small changes in crp levels within the normal range, allowing for assessment of subclinical inflammation. this study was undertaken to investigate the relationship between hs-crp and bronchial asthma. we collected blood samples from 109 patients with bronchial asthma with or without attacks and measured serum eosinophil cationic protein (ecp) and pulmonary function as well as serum hs-crp. serum crp levels in patients without attacks (average 0.473 mg/ l; p < 0.001) and with attacks (average 0.908 mg/l; p < 0.001) were significantly higher than those of normal controls (average 0.262 mg/l). serum hs-crp levels were inversely correlated with fev1.0% in asthmatic patients (r = -0.4915, p < 0.01). in conclusion, these results indicate that serum hs-crp as well as ecp may be related to the state of asthma exacerbation and allergic inflammation. objectives: the pshr assay can be used to test the biologic activity of allergens since it mimics the effector phase of a type i hypersensitivity reaction. in this study we tested methods for removing ige-antibodies (stripping) from donor basophils. moreover a method was developed for improving the antigen specificity profile in pshr. proof-of-concept was provided using absorption with complete allergen extracts. methods: buffy coats were screened to exclude reactivity against relevant allergens. subsequently pbmcs were purified and basophils were stripped with either lactate or a phosphate buffer. cells were passively sensitized with patient sera and challenged with allergen extracts in various concentrations. released histamine was measured spectrofluorometrically (hr-test, reflab). cutoff was 10% hr. for absorption experiments patient sera (from a peanut allergic and a codfish allergic patient) were incubated with streptavidin-coated sepharose beads coupled with biotinylated allergens (peanut, and bsa as control). after centrifugation the supernatant was used to passively sensitize stripped basophils. hr was measured as described above. results: stripping experiments using the two buffers only partially removed surface ige but passive sensitization of stripped basophils was equally effective enabling determinations of sub-nanogram quantities of peanut allergen. absorption experiments showed that it was possible to specifically remove peanut specific ige from patient serum. removal of specific ige reactivity to peanut extract was verified by western blotting. conclusions: using peanut extract as a model it was demonstrated that in pshr antigen specificity can be modified. (1), sk bk(1), v sharma(2), rp bhandari (3) (1) nepal medical college teaching hospital, nepal (2) all india institute of medical sciences, new delhi, background: nepal has one of the highest maternalmortality rates in the world. this study was to evaluate the incidence, disease pattern, and risk-factors for thromboembolism in pregnant nepalese women. methods: women with thromboembolic diseases were identified and their case records retrieved and reviewed s414 inflamm. res., supplement 3 (2007) posters from january 1998 to december 2006. demographiccharacteristics were compared between women with and without thromboembolism. the total number of deliveries over the study period was 16,993, giving an incidence of 1.88 per 1000 deliveries. there were two cases of pulmonary-embolism and one resulted in a maternal-death. the others had deep-vein-thrombosis of which over 80% were limited to calf veins only. the ultrasound-examinations requested for suspected deep-venous-thrombosis before and after the event of maternal-death were 1.62 and 10.7 per 1000 deliveries (p <.001);the corresponding cases of deepvenous-thrombosis diagnosed were 0.29 and 2.94 per 1000 deliveries, respectively (p <.001). the majority (75%) of cases were diagnosed in the postpartum period, mainly after cesarean-delivery. women with venous-thromboembolism were older, had higher bmi, and a higherincidence of preeclampsia. there were approximately twice as many postpartum as antepartum events. bloodgroup a, multiple-pregnancy, caesarean-section, cardiacdisease, delivery at gestational-age of <36 weeks, a bmi of25, or more and maternal-age of 35 or over were all found to increase incidence of venous-thromboembolism. the long-standing belief that thromboembolism is rare among nepalese is at least partly because of undiagnosis most of these events are deep-veinthromboses occurring in the postpartum period and it is very essential for primary prevention developing country like nepal. (1), ch ladel (1), t ruckle(2), c rommel(2), r cirillo (1) (1) rbm-merck serono, colleretto giacosa, italy (2) serono pharmacological research institute, geneva, switzerland rheumatoid arthritis (ra) is a severe articular disease. massive leukocyte activation and infiltration into joints result in cartilage and bone destruction. blockade of pi3k signalling pathway has been demonstrated to be curative in a murine model of ra, collagen-induced arthritis (cia). in this study we explored the molecular mechanisms by which pi3k signalling inhibition resulted in clinical amelioration of disease symptoms. as605858, a novel isoform non-selective, yet specific class-i-pi3k inhibitor, administered at 15 mg/kg twice-a-day for 8 days, to mice showing signs of arthritis, paw swelling and inflamed digits, induced a significant amelioration of disease course. at the end of treatment, post-arthritic paws were removed and phosphrylation levels of akt (p-akt), downstream target in pi3k-mediated signal, were determined by semi-quantitative immunohistochemistry, also immunophenotyping of circulating cells by flowcytometry was conducted. akt phosporylation resulted to be significantly enhanced by disease induction and as605858 was able to decrease its levels down to values comparable with naã¯ve animals. controls and as605858treated mice were bled before treatment, after two days of treatment and at treatments end. no changes in cellular composition (morphology and hematology parameters) between experimental groups were observed. t cell number was not affected, however a significant decrease of natural-killer, memory and regulatory t cells was observed after as605858 administration. finally, a non-significant, moderate reduction of bcell number was also observed. these data demonstrate that efficacy of as605858 in arthritis models is mediated by direct modulation of the target resulting in a mixed anti-inflammatory (via pi3kg) and immunosuppressive (via pi3kd/a/b) activity. (1) (1) institute of biomedical science, university of sao paulo, brazil (2) ibilce -sao paulo state university, brazil epidemiologic data suggest that female sex hormones are involved in the pathophysiology of allergic asthma. we investigated in rats the immunomodulatory potential of estradiol and progesterone on the expression of allergic asthma. seven days after being ovariectomized (ovx), groups of rats were sensitized with ovalbumin (oa). fourteen days after sensitization, the animals were oachallenged and used 1 day thereafter. allergic,shamoperated animals were used as controls. some ovx animals were treated with estradiol (280 ã¬g/kg) or progesterone (200 ã¬g/kg) 24 h before being challenged. mast cell degranulation was quantified in samples of isolated, oa-challenged bronchi. the airway reactivity of inner bronchi to methacholine and the functional activity of cells we analysed. ovx caused reduction of the allergic lung inflammation and bronchial hyperresponsiveness with regard to intact female rats. estradiol reverted the reduced cellular recruitment into lungs, whereas progesterone reduced the pulmonary inflammatory response and reverted the bronchial hyperresponsiveness. cultured bal and bone marrow cells from allergic rats increased posters inflamm. res., supplement 3 (2007) s415 the release of il-10 and reduced that of il-1 and tnf. the release of il-4 by bone marrow cells was significantly reduced. these effects were reverted by estradiol, and progesterone reduced il-4 and increased il-10 production in bal and increased that of il-1 and tnf in bone marrow cells. bronchial mast cell degranulation upon direct contact with oa in ovx rats was less than in controls. it is suggested that female sex hormones can modulate the allergic lung inflammation in rats by acting on cellular migration/activity and airway responsiveness. objectives: to study the participation of fsh on modulation of e-and l-selectin, icam-1 and mac-1 expression in ovariectomized (ovx) rats made allergic. methods: female rats were sensitized (oa/alumen) after 1 (ovx-1) or 7 days (ovx-7) of ovx or sham-operated (sh). fourteen days thereafter animals were challenged (oa, 1%; aerosol) and sacrificed 24 h after. bronchoalveolar lavage (bal) was collected and flow citometry analyses oficam-1, mac-1 and l-selectin expression was studied. in parallel, lungs were frozen and sections were analysedfor e-selectin expression by immunohistochemistry. results: at day 1, e-selectin expression increased(ovx-1=1,8ae0,08) and at day 7, decreased (ovx-7=1,3ae0,1) as compared to respective controls (sh-1=1,45ae0,08; sh-7=1,9ae0,08). estrogen treatment reverted this profile in both groups (ovx-1+e=1,37ae0,09; ovx-7+e=1,8ae0,1). mean fluorescence intensity of bal cells showed increase of mac-1 expression (ovx-1=19ae0,5 vs sh-1=15,5ae1,0), icam-1 (ovx-1=18,1ae1,1 vs sh-1=13,3ae0,2) and l-selectin (ovx-1=11,2ae0,8 vs sh-1=9,5ae0,12) at day 1 i.e., ovx-1 group. on the other hand, we observed a decrease in icam-1 (ovx-7=14,2ae0,75 vs sh-7=19ae1,4) and mac-1 expression (ovx-7=20,7ae1,4 vs sh-7=27,5ae1,5) was seen in ovx-7 group. conclusions: oscillation of hormone levels during immunization with oa increased (ovx-1) and decreased (ovx-7) expression of adhesion molecules. estradiol treatment reverted this effect. this results suggest that fsh modulates the ali in rats by acting on cell (1), s lim (1), y lin (1), bp leung (1), c thiemermann (2), wsf wong (1) (1) national university of singapore (2) the william harvey research institute, london, uk glycogen synthase kinase 3b (gsk-3b) is known to regulate various cellular functions including inflammatory responses. we hypothesized that inhibition of gsk-3b may have anti-inflammatory effects in a mouse asthma model. balb/c mice were sensitized with ovalbumin (ova) and challenged with aerosolized ova. tdzd-8, a non-atp competitive gsk-3b inhibitor, was administrated by i.v. injection one hour before ova challenge. tdzd-8 significantly reduced the ova-induced eosinophilia in a dose-dependent manner and inhibited the levels of il-5, il-13 and eotaxin in bronchoalveolar lavage (bal) fluid. tdzd-8 also suppressed the mrna levels of icam-1, vcam-1 and chitinase proteins in the lung. histological studies revealed that tdzd-8 substantially reduced the inflammatory cell infiltration and mucus secretion in the lung tissue. tdzd-8 also decreased ova-specific ige level in the serum. in addition, ova-induced increase in airway resistance and reduction in dynamic compliance were attenuated by tdzd-8. our findings suggest that inhibition of gsk-3b may have therapeutic potential for the treatment of allergic airway inflammation. (1), a yildirim (1), f ercan (2), n gedik (3), m yuksel(4), inci alican (1) ( materials and methods: sprague-dawley rats (200-250 g) were exposed to 90 oc (burn group) or 25 oc water bath (control group) for 10 s under ether anesthesia. adm (100 ng/kg; s.c) was administered 10 min before burn and all rats were decapitated 24 h after the burn insult. trunk blood was collected for the measurement of tnf-alpha level and the lung, ileum and kidney samples were stored for microscopic scoring and for determination of lipid peroxidation (lp), myeloperoxidase (mpo) activity and formation of reactive oxygen metabolites (roms) using chemiluminescence assay. results: burn resulted in severe morphologic damage in tested tissues. lp increased in lung and kidney (p<0.01-0.001) and mpo activity showed a marked increase in all tested tissues (p<0.001) of the burn group. adm reversed these parameters effectively (p<0.05-0.001). luminol chemiluminescence levels showed increases in both ileum and lung (p<0.01-0.001) whereas lucigenin chemiluminescence levels increased in ileum and kidney (p<0.01) of the burn group. adm treatment was also beneficial in reducing chemiluminescence levels near to controls (p<0.01). adm reduced plasma tnf-alpha level (p<0.01) which showed a significant increase in burned animals compared to controls (p<0.001). conclusions: adm is beneficial in remote organ damage following burn insult via decreasing neutrophil infiltration, rom generation, lp, and the release of proinflammatory cytokine tnf-alpha. kalpana panday (1), sd joshi (2), kr reddy (3) ( we determined the crystal structure of human hematopoietic prostaglandin (pg) d synthase (h-pgds) as the quaternary complex with glutathione (gsh), mg2+, and an inhibitor, hql-79, with anti-inflammatory activities in vivo, at 1.45 resolution. hql-79 was found to reside within the catalytic cleft between trp104 and gsh in the quaternary complex. hql-79 inhibited h-pgds competitively against the substrate pgh2 as well as noncompetitively with respect to gsh. surface plasmon resonance analysis revealed that hql-79 bound to h-pgds with an affinity that was 10-fold higher in the presence of gsh and mg2+ than in their absence. hql-79 inhibited selectively pgd2 production by human h-pgds-expressing megakaryocytes but only marginally affected the production of other prostanoids, suggesting the tight functional engagement between h-pgds and cyclooxygenase. orally administered hql-79 inhibited antigen-induced production of pgd2, and airway inflammation in mice without affecting the production of pge2 and pgf2fâ¿. knowledge about this quaternary structure should accelerate the structure-based development of novel anti-inflammatory drugs that inhibit pgd2 production specifically. introduction: it has been proved that high levels of mechanical ventilation produce lung injury as well as local inflammation. this study was designed to evaluate how the generation of inflammatory mediators by an over-stretched lung affects the non-hyperventilated lung. methods: male wistar rats (250-275g) were anesthetized and paralyzed, and the two lungs were independently intubated. differential ventilation was applied for 3h (70 breath/min). one lung was subjected to hyper-ventilation (20ml/kg/lung) and the other was ventilated with a normal volume (5ml/kg/lung). in a control group, both lungs were ventilated with a normal volume. after sacrifice, samples of lung, plasma and liver were collected. the expression of the pro-inflammatory chemokine mip-2 was evaluated by rt-pcr and the edema was assessed by the ratio between the wet and dry weight of the lung. systemic inflammation was estimated in liver by measuring the expression of tnfa by rt-pcr as well as its levels in plasma. the hiper-ventilated lung showed an increase in the ratio between the wet and dry weight and in mip-2 expression compared to the normal ventilated lung. no differences were found in edema, neither expression of mip-2 between the normally ventilated lung and control lungs. no significant changes were observed in liver expression and plasma levels of tnfa as a consequence of unilateral lung hyper-ventilation. the over-straining caused to the hyperventilated lung leaded to a local inflammatory response without systemic effects. the normal ventilated lung is not affected by the inflammatory process triggered on the over-strained lung. (1), j-y gillon(2), v lagente (1), e boichot (1) (1) university of rennes 1, rennes, france (2) serono international s.a., geneva, switzerland macrophage elastase (mmp-12) is a metalloproteinase involved not only in emphysema but also in the inflammatory process associated with copd (chronic obstructive pulmonary disease). the mechanism of action of mmp-12 in the development of pulmonary inflammatory process is still unknown. in the present study, we investigated the effect of recombinant human mmp-12 (rhmmp12) on il-8/cxcl8 release from alveolar epithelial cell line a549 and we explored the underlying mechanisms. a549 cells were stimulated with rhmmp-12 (1.10-3-2.10-1 u/ml) during 6 hours and il-8/cxcl8 level in supernatant was determined by elisa. involvement of map (mitogen activated protein)-kinases was studied by western-blotting and also using chemical inhibitors. nfkb activation was examined with the transam nfkb p65 kit. we observed that mmp-12 elicited il-8/cxcl8 release in a dose-dependent manner. this production could be prevented by a pretreatment for 1hour with a selective mmp-12 inhibitor (as111793 1-30 mm) or with the nonselective inhibitor batimastat (1-30mm) . the il-8/cxcl8 production was also inhibited by actinomycin d (5mg/ml), erk1/2 inhibitors (u0126 5mm and pd98059 10mm) and nfkb inhibitors including bay11-7082 (10mm) and nfkb activation inhibitor (10nm), whereas p38 kinase inhibitor (sb203580) had no effect. stimulation with mmp-12 was rapidly followed by a phosphorylation of erk1/2 (5min) and an nfkb nuclear translocation and activation (1h). the nfkb activation was not inhibited by a treatment with u0126. these data suggest that alveolar epithelium is a target of mmp-12 since it upregulates gene expres-s418 inflamm. res., supplement 3 (2007) posters sion and release of il-8/cxcl8, via erk1/2 and nfkb activation, but these two pathways appears to be distinct. agents which are associated with lung inflammation, such as cigarette smoke and lipopolysaccharide (lps), induce the production of pro-inflammatory chemokines in lung epithelial cells in vitro, and the induction of interleukin (il)-8, in particular, is often used a measure of relative toxicity.in this study we have compared mrna expression and mediator release in nci-h292 human lung epithelial cells exposed to lung toxicants, namely: cigarette smoke total particulate matter (tpm), lps, bleomycin, diesel exhaust particles, residual oil fly ash (rofa), carbon black and vanadyl sulphate.polystyrene, poly(methyl-methacrylate) and the tpm vehicle, dimethyl-sulphoxide were used as negative controls.confluent monolayers of h292 cells were exposed to serial dilutions of test agents in serum-free medium for 24 hours.the conditioned medium was then removed and assayed for a range of pro-inflammatory cytokines and other selected mediators by luminex technology.the levels of gene expression of il-8, matrix-metalloprotease-1 (mmp-1), the gel-forming mucin muc5ac, heparinbinding epidermal growth factor-like growth factor (hb-egf) and the cytochrome p450s cyp1a1 and cyp1b1 were determined by quantitative-polymerase chain reaction.all of the toxicants induced similar responses whereas the negative controls were largely ineffective.-such a panel of biomarkers may enable an in vitro assessment of the potential to cause lung inflammation.-moreover the use of several biomarkers could give a more accurate picture of toxicity than the determination of il-8 alone, particularly in the case of agents such as tpm, where the conventional vehicle is found to have some biological activity. respiratory tract infections are a major public health issue. prevention in high risk populations relies mainly on vaccination. vaccination is highly recommended in decrease absenteeism. immunomodulating drugs are important tools in the treatment of infectious diseases. immunomodulatory agents are probably contributive in decreasing exacerbation rates. the authors present different classes of immunomodulators that are currently in use. the vaccine, created from a bacterial protein, reeducates the immune system to stop inflammation. by preventing infections, vaccines prevent the development of a strong t helper (th1) response. the challenge is now to inform about new possibilities of an optimal prevention respiratory tract infections. deoxypodophyllotoxin (dpt) is a medicinal herbal product that is isolated from anthriscus sylvestri. that inhibits cyclooxygenase-2 (cox-2) and cox-1dependent phases of prostaglandin d2 (pgd2) generation in bone marrow-derived mast cells (bmmc) in a concentration-dependent manner with ic50 values of 1.89mm and 65.3mm, respectively. this compound inhibited cox-1 and 2-dependent conversion of the exogenous arachidonic acid to pgd2 in a dose-dependent manner with an ic50 values of 0.01mm and 12.1mm, respectively. however, dpt did not inhibit cox-2 protein expression up to a concentration of 30mm in the bmmc, indicating that dpt directly inhibits cox-2 activity. furthermore, this compound consistently inhibited the production of leukotriene c4 (ltc4) in a dose dependent manner, with an ic50 value of 0.37mm. these posters inflamm. res., supplement 3 (2007) s419 results clearly demonstrate that dpt has a dual cox-2/5-lox inhibitory activity in vitro. therefore, this compound might provide the basis for novel anti-inflammatory drugs. in order to determine anti-allergic and antiasthmatic activity of dpt in vivo, we used rat pca model which was activated by anti-dinirophenyl ige and ovalbumin/alum induced mouse asthmatic animal model, respectively. as a result, dpt strongly inhibited pca reaction as well as it reduced infiltrated eosinophil numbers in bronchoalveolar lavage fluid. furthermore, dpt decreased the mrna levels of the th2 cytokines in a murine asthmatic model. in addition, northern blot analysis showed that dpt also reduced both the eotaxin and arginase i mrna levels in a dose dependent manner. these results suggest that dpt may be beneficial in regulating various inflammatory diseases. an imbalance of proteases and anti-proteases in the lung has been implicated in the pathogenesis of chronic obstructive pulmonary disease (copd), a smokingrelated disorder associated with accelerated lung function decline.in particular, the activity of matrix metalloproteases (mmps) have been implicated in driving both the inflammation and parenchymal destruction observed in copd patients.here, we tested whether a broad spectrum mmp inhibitor, pkf-242484, could block the inflammation induced by an acute exposure to cigarette smoke in 2 strains of mice, balb/c and c57/bl6.animals were administered the compound (1-10 mg/kg) either per os (p.o.) or intranasally (i.n.) 1 hour before and 5 hours after exposure to smoke on three consecutive days.bronchoalveolar lavage (bal) was performed and lungs were flash frozen for inflammatory marker analysis.pkf-242484 dose-dependently reduced lung neutrophilia in balb/c mice when dosed either p.o. (~45% at 10 mg/kg; p < 0.01)or i.n. (~60% at 10 mg/kg; p < 0.01).however, the compound had no clear effect on bal neutrophil infiltration in c57/bl6 mice by either route of administration.interestingly, in both strains bal macrophages dose-dependently trended towards an increase when the compound was dosed p.o. and decreased when dosed locally (p < 0.05). examination of lung tissue cytokine levels revealed that while smoke-exposure increases il-1beta, kc, and mip-2, pkf-242484 had little effect on these cytokines.these data suggests the ability of broad spectrum mmp inhibitors to inhibit smoke-induced acute neutrophil inflammation is strain-dependent, while its ability to limit macrophage infiltration may be route dependent. to investigate the role of seh in the regulation of the pulmonary inflammatory response, we have used seh deficient mice in a locally administered lps model. male seh deficient mice (ko) and their wildtype (wt) littermates were exposed to inhaled lps.four hours later they were sacrificed and bal was performed. differential counts and cytokine levels in bal were evaluated. results: lps induced a significant increase in total cell number and neutrophil number in bal in the seh deficient mice and in wt mice;no significant differences between the groups were seen (table 1 ) cytokine analysis showed significant increases in tnfalpha, il-6, kc, gm-csf, mcp-1, il-1beta and rantes in the lps-exposed wt mice. no significant differences were seen between lps exposed wt and ko mice except for a significant increase in tnfa in ko mice. our results show that seh has no pivotal role for the regulation of the acute inflammatory response to lung administered lps. fam.liliaceae. based on literature data which signaled the presence of steroidic saponins in the rhyzomes, isolation, identification and quantitative determination of these compounds were done. the antiinflammatory activity was tested in non-immune chronic inflammation model:the cotton-pellets granuloma test in rats, and in an immune chronic inflammation model:arthritis test induced by freunds adjuvant in rats. in the first test, the antiinflammatory effect of steroidic saponins 600 mg/kg is weak, statistically insignificant. in the arthritis test, steroidic saponins 600 mg/kg proved an antiinfalammatory activity, influencing especially the primary response, but also the secondary one, in the last part of the experiment (after 16 days). in both tests, the suprarenal glands weight was modified. objectives: dendritic cells (dcs) are professional antigen presenting cells. many types of dc with subtle difference in phenotype have been reported in several organs. existence of dc was reported in synovial tissue of rheumatoid arthritis (ra), however, the details in ra dc still remains unclear. in this study, we generated a new lineage of dc with gmcsf (+tnfa) and investigated their functions. furthermore the ability of osteoclastgenesis was examined. methods: monocyte-derived dcs or macrophage were generated in (1) tnfa + gm-csf (2) gm-csf (3) il-4 + gm-csf (4) mcsf. the phenotypes of these cells were analyzed by morphological examination and flow cytometry (facs calibur). cell proliferation was examined by wst-8 assay. dc functions were assessed in antigen presenting ability (mlr assay), cytokine production (elisa), and endocytosis (fitc-dextran uptake). concerning osteoclastgenesis, monocyte-derived dcs were incubated with rankl and mcsf. trap stain was performed and the resorption ability was assessed on osteologic cell culture system and dentine slices. results: these cells were dendritic-like and their surface markers were cd1a low cd11b + cd11c + cd14 + cd86 + cd83 low hla-dr + dc-sign low and different from conventional dc or macrophage. they had an antigen presenting ability to induce na*ve cd4+ t cell proliferation, il-12 production and endocytosis. in the presence of rankl and mcsf, they differentiated multinuclear trap-positive cells with bone resorption ability, which was strengthened by tnfa. we generated a new lineage of dc with gm-csf (+ tnfa). the dc seemed to play a pivotal role in inflammatory arthritis under tnf immunity. the clinical effectiveness of rituximab and other b cellattenuating rheumatoid arthritis (ra) therapies has increased interest in understanding the role of b cells in ra pathogenesis.the possible mechanisms underlying the effectiveness of rituximab were investigated by performing biosimulation research in the entelos ra physiolab platform, a mathematical model of the joint of an ra patient.the platform dynamically integrates the contributions of immune cells (t cells, b cells, and macrophages), resident cells (fibroblast-like synoviocytes and chondrocytes) and mediators to the joint inflammation and structural damage observed in ra.the b cell lifecycle is represented in the platform, as well as effector functions such as antigen presentation, mediator and autoantibody production, and immune complex formation.the dynamics of these b cell properties were calibrated to reproduce reported experimental behaviors and clinical outputs from ra patients (e.g., acr score and radiographic progression rates).an assessment of the contribution of individual b cell functions to clinical outcome suggests that plasma cell-derived immune complexes are key modulators of inflammation in ra patients. in contrast, proinflammatory cytokine production by b cells contributes minimally to synovial hyperplasia, but plays a role in the progression of structural damage.immune complex formation leads to monocyte activation, increased mediator production by macrophages and an increase in antigen availability to t cells.biosimulation research in the ra physiolab platform is advancing our understanding of the mechanisms underlying effective b cell-targeting ra therapies, and may guide the development of improved second-generation therapeutic approaches. methods: the hmscs were obtained at the operation.the mononuclear cells were extracted and the colony forming assay were performed after 2weeks. the hmscs were cultured and in passage1,the cell surface antigens of both groups were analyzed by flow cytometory.in passage2, in control group, the cells were cultured with beta glycerophosphate(bgp) and in osteogenic group, the cells were cultured with bgp and ascorbic acid(aa) and dexamethasone(dex).after 2weeks, alp staining and activity were measured in each group.after 3weeks, alizarin red s assays were performed.rna was extracted from the cells cultured with bgp and aa and dex for 2weeks and 3weeks and the gene expressions of bone formation markers were examined by real time pcr. the mann-whitney test was used for the statistical analyses. the colony forming assays showed no significant differences in oa and ra. in flow cytometory, the cell surface antigens in oa and ra were almost same.in alp activity,there were no significant differences in oa and ra.in alizarin red s, there were significant differences.in real time pcr,the gene expressions showed no significant differences in oa and ra. conclusions: the hmscs of ra will be able to use for regenerative therapy. silje vermedal hã¸gh (1), hm lindegaard (2), gl sorensen (1), a hã¸j (3), c bendixen (3), p junker (2), u holmskov (1) ( cytosolic phospholipase a2 (cpla2) plays a crucial role in eicosanoid production, by releasing an arachidonic acid from membrane phospholipids. in addition, cpla2 regulates the phagocyte nadph oxidase-releasing superoxides and that is the only isozyme responsible for the production of eicosanoid in phagocytic cells. collageninduced arthritis (cia) in mice is an experimental model of auto-immune diesease with several clinical and histological features resembling rheumatoid arthritis in humans. previous studies show that cpla2-deficient mice are resistant to cia. thus we aimed to study whether cpla2 is up-regulated during the development of cia and to detect its exact location in the inflamed joints. immunoblot analysis revealed an increase in the level of joint cpla2 protein during the development of the disease which correlates with the severity of the inflammation, as examined by paw thickness. immunohistochemistry with specific anti-cpla2 antibodies revealed low positive cpla2 protein levels in skeletal muscles, sebaceous glands and skin (epidermis, dermis) tissues of healthy paws. in the joints of the cia mice, large amounts of inflammatory infiltrate containing cpla2 were detected. in addition, robust cpla2 protein expression in the skeletal muscles surrounding the joints and strong cpla2 positive staining in sebaceous glands were detected. the high correlation between the severity of inflammation and the elevated cpla2 protein, due to an inflammatory infiltrate and increased cpla2 expression, suggests an important role of cpla2 in the development of arthritis. rheumatoid arthritis (ra) is the complex disease depending on environmental as well as genetic factors. in spite of the large research efforts we know in fact only small number of genes involved in this disease. animal models are useful tools for better understanding of the pathogenic mechanisms and genes leading to the disease process. the aim of the current project is to identify the genes and their functional role importance for arthritis. two loci associated with arthritis were identified using a cross between the b10.q (intermediate susceptible) and nod.q strains (resistant to arthritis). one on chromosome 2 a disease protective locus (cia2) and another on chromosome 1 a disease-promoting locus (cia9). nod.q allele at cia9 promotes arthritis whereas cia2, has a protective effect in contrast to the b10.q allele on chromosome 2. a promising candidate gene in cia2 locus is complement factor 5 (c5) as the nod.q allele produced defective c5 protein. cia9 locus contains several genes of potential importance for disease such as fc riib, fc riii, fc riv ncf2, fh. the results of cia (collagen induced arthritis) and caia (collagen antibody induced arthritis) experiments using the subcongenic mice generated that contains fc r region showed a significant difference in incidence and severity of arthritis. the disease is controlled in a recessive pattern. the fragment devoid of fc r region seems to be protective. the subcongenic for the cia2 locus has been generated recently which will be tested for cia and caia susceptibility. the results from these experiments will be discussed in detail. angela pizzolla, ka gelderman, r holmdahl ncf1 is a component of the nadph oxidase complex, which produces reactive oxygen species (ros) upon activation into phagosomes and extracellularly. polymorphisms in the ncf1 gene that impair the capacity to produce ros, enhance susceptibility of both mice and rats to arthritis. activation of autoreactive t cells drives arthritis development but neither ncf1 expression nor oxidative burst have been detected in t cells. we hypothesize that antigen presenting cells influence t cell activity by producing ros during antigen presentation. we aimed to clarify the role of ros produced by dendritic cells (dc) on t cell activation. dc were grown from bone marrow from ncf1 mutated and wildtype mice. we could show that ncf1 mutated dc proliferated and differentiated better, had higher expression levels of costimulatory molecules and mhc ii upon stimulation as compared to ncf1 wildtype dc. in addition, ncf1 mutated dc induced higher levels of il-2 production by hybridoma t cells. to analyze the role of ncf1 in dc on arthritis, mice were developed expressing functional ncf1 restricted to dc (b10.qdcn). these mice are characterized for burst, ncf1 expression and ability to present antigen. we published that immunization with myelin oligodendrocyte glycoprotein (mog) protein resulted in higher disease severity than immunization with mog peptide in ncf1 deficient mice. this suggests that ncf1 plays a role in the uptake and processing of posters inflamm. res., supplement 3 (2007) s423 antigens, probably by dc. this will be further investigated with the b10.qdcn mice using in vitro assays as well as in vivo models for arthritis and multiple sclerosis. purpose: macrophage migration inhibitory factor (mif) is a pro-inflammatory cytokine involved in both innate and adaptive immune responses. it is expressed in human ra synovial tissue and its suppression inhibits t or b cell dependent animal models of ra. we investigated the role of mif in k/bxn serum transfer arthritis. methods: arthritis was induced by injection of k/bxn serum on days 0 and 2 in littermate wt and mif-/-mice. arthritis was scored clinically, ankle thickness was measured using microcallipers, and joints collected for histology. sections were scored for synovitis, synovial fluid exudate, cartilage degradation and bone damage. results: wt mice exhibited arthritis as early as day 1 and 100% incidence was observed on day 7. mif -/-mice exhibited delayed arthritis, with onset on day 3 and 100% incidence on day 9. mif -/-mice exhibited significantly reduced disease severity as measured by clinical disease score ( methods: osteoarthritis was induced by bilateral transection of the medial meniscus in dunkin-hartley guinea pigs using minimal invasive surgery to avoid cartilage damage due to inflammation and/or intra-articular bleeding. results: the first signs of osteoarthritis development were macroscopically observed four weeks after meniscal transection. twelve weeks after surgery the lesions were still restricted to the medial side of the joint and did not reach into the subchondral bone. cartilage destruction due to meniscal transection was also histologically detected. however, biomarkers for cartilage destruction (ctx-ii, hp/lp ratio, comp) were not increased. treatments aiming at different processes in osteoarthritis, such as bone destruction (risedronate), inflammation (pioglitazone and anakinra), and cartilage destruction (galardin) were not effective in this model. the early degenerative changes in this transection model are probably too mild to be measured in the systemic circulation using classic biomarkers. further research into new biomarkers is needed to detect and monitor the early stages of osteoarthritis. the ineffectiveness of the compounds tested in this model underscores the urgent need for new strategies to treat the disease. the meniscal transection model might prove to be useful tool for identifying new biomarkers and treatments. livia l camargo (1), a denadai-souza (1), lm yshii (1), a schenka (2), ma barreto (1), d boletini-santos (3), c lima (3), v rioli (3), mn muscar (1), e ferro (1), sk costa (1) ( methods: aia was induced via intraarticular (i.a.) injection of methylated bovine serum albumin in immunized male rats. knee oedema and pain score were assessed daily in controls and animals treated with hemopressin (10 or 20 ã¬g/day; i.a.). histopathological changes, cell number and cytokines in the synovial fluid of aia rats were determined at day 4. results: aia rats developed a severe mono-arthritis characterized by a joint oedema and pain. at day 4, there was marked cellular infiltration, hyperplasia, pannus formation and destruction of bone and cartilage, but pro-inflammatory cytokines were undetectable by elisa. both doses of hemopressin significantly reduced the knee oedema, but only 20 mg of hemopressin attenuated the pain score. acute joint inflammation was significantly reduced by hemopressin, but failed to significantly affect chronic histopathological signs (hyperplasia, pannus etc.). conclusions: hemopressin has potential for treating acute signs of aia by reducing synovial plasma protein extravasation, alleviating pain and reducing acute joint histopathological changes, thus providing an alternative strategy for treatment of oedema and pain in arthritis. calcitriol, the hormonal metabolite of vitamin d and it synthetic analogs exert an anti-inflammatory action on psoriatic skin lesions while eliciting mild inflammation on healthy skin. the map kinase erk plays an important role in the induction of chemokines, cytokines and adhesion molecules in keratinocytes that maintain the epidermal inflammatory response.we hypothesized that the dual effect of calcitriol may be partially attributed to differential effects on erk activation in the presence or absence of inflammatory mediators. our experimental model was immortalized non-tumorigenic human hacat keratinocytes cultured in the absence of exogenous growth factors or active mediators. inflammation was mimicked by exposure to tnf. level and activation of signaling molecules were determined by immunoblotting. by using the specific egf receptor (egfr) tyrosine kinase inhibitor, ag1487, we established that tnf activates erk in an egfr-dependent and egfrindependent modes. the egfr-dependent activation resulted in the induction of the transcription factor, c-fos, while the egfr-independent activation was of a shorter duration and did not affect c-fos expression. treatment with calcitriol alone increased erk activation and c-fos induction. pretreatment with calcitriol enhanced egfr-dependent erk activation and tyrosine phosphorylation of the egfr, but completely abolished egfr-independent tnf-induced erk activation. pretreatment with calcitriol increased the rate of de-phosphorylation of activated erk, accounting for the inhibition of egfr-independent erk activation by tnf. it is possible that effects on the erk cascade underlie the dual action of calcitriol and its synthetic analogs on cutaneous inflammation. christina barja-fidalgo (1), r saldanha-gama (1), ja moraes (1), r zingali (2), c marcienkewicz (3) (1) universidade do estado do rio de janeiro, rio de janeiro, brazil (2) universidade federal do rio de janeiro, rio de janeiro, brazil (3) temple university, philadelphia, usa neutrophils adhere on vascular endothelium and directly migrate toward inflamed tissue to exert their primary defense function. integrin are receptors that drive cell adhesion and motility and interfere with cell activation, functions and survival.acting as both anchoring molecules and signaling receptor, transducing signals outsidein and inside-out, integrins are potential targets for therapeutic and diagnostic opportunities. disintegrins are a family of cystein-rich low-molecular weight peptides that usually contain an rgd sequence, a cell attachment site of ecm and cell surface proteins recognized by integrins. they are considered selective and competitive antagonists of integrins, being potent inhibitors of platelet aggregation and cell-cell/cell-ecm interactions. we reported that rgd-disintegrins, selectively interact with integrin amb2, a5b1 and/or avb3) on human neutrophils, interfering with cell functions through the activation of integrin-coupled intracellular signaling pathways. recently showed that, a selective ligand of a9/a4b1 integrins, vlo5, induces neutrophil chemotaxis, cytoskeleton mobilization and potently inhibiting neutrophil spontaneous apoptosis. these effects are mediated vlo5 interaction with a9b1 integrin, activating the focal adhesion cascade. vlo5 effects on the delay of neutrophil is modulated by pi3k, erk-2 mapk and nf-kb pathways that seems to interfere with the balance between anti-and pro-apoptotic bcl-2 family members and with mitochondrial membrane potential. data emphasize mechanistic details of the role of a9b1 integrins interactions on human neutrophils and support the use of disintegrins as prototypes to develop logical combinations of drugs to optimize or minimize the susceptibility of a selected target cell population to apoptosis during therapeutic interventions. (faperj, cnpq, capes, ifs-sweeden) (1), h serezani (2), m peters-golden(2), sonia jancar (1) '(1) university of sâ¼o paulo, brazil (2) university of michigan, usa it is been shown that leukotriene (lt) b4 and cysteinyl lt (ltc4, ltd4 and lte4) enhances fcr-mediated phagocytosis in alveolar macrophages (am), dependent on protein kinase c (pkc). in contrast, ltb4 but not cyslt effects are exclusive on syk activation. in the present study we investigated the role of specific pkc isoforms and its upstream and downstream targets involved in lt-enhanced fcr-mediated phagocytosis. to this purpose, ams were pretreated or not with inhibitors of pkc-d (rottlerin -6 um), pkc-a (ro-32-0432-9 nm), pi3k (ly290042-10 um and wortmannin-10nm), erk 1/ 2 (pd98059 -2 um), cpla2 (aacocf3-10 um), p38mapk (sb20190-10 um) and ca++ (bapta/am-10 um), before stimulation with ltb4 or ltd4 and addition of igg-opsonized red blood cells for 90 min. activation (phosphorylation) of signaling molecules by lts were analyzed by western blot. our results demonstrate that ltb4 -enhanced phagocytosis is dependent on pkc-a, while ltd4 effects are mediated by pkc-d. cell proliferation and differentiation, adhesion, cell activation and apoptosis. while galectin-1 mainly acts as an anti-inflammatory and pro-apoptotic molecule, galectin-3 is known as a strong pro-inflammatory and anti-apoptotic signal. we have recently recognized galectin-3 as a new molecular target of immunomodulatory drugs in monocyte/macrophage-like cells. in this study we investigated the effects of immunomodulatory drugs (aspirin, indomethacin, hydrocortisone and dexamethasone), applied in therapeutic ranges on the expression of galectin-1 at gene and protein level in monocytic thp-1 cells. we have also tested the effects of these drugs on both galectins in the cells activated by lipopolysaccharide from e. coli (lps). the targeted mrna level was evaluated using quantitative rt-pcr technique and the expression of both galectins in cell homogenates was determined by western-immunoblot analysis. the results showed that immunomodulatory drugs affected the expression of galectin-1 on both, gene and protein level, and that the effects were dependent on drug type and applied concentration as well as time of the exposure. the modulatory effects of the applied drugs on galectin-1 and -3 expressions were also observed in the cells activated by lps. these findings represent important step in the understanding of the effects of immunomodulatory drugs on galectin-1 and-3 expressions, as well as the role of these lectins in the physiology of monocytes. introduction: pancreatitis-associated protein (pap) has been recently described as an endogenous mechanism involved in the regulation of inflammation. in the present study, we show some of the molecular mechanisms implicated in the intracellular signaling pathways modulated by pap. the pancreatic human cell line panc1 was incubated with pap (500ng/ml) and/or tnfa (100ng/ml). total rna was obtained and the expression of tnfa was examined by rt-pcr. in addition, the effect of pap on nfkb activation was measured by inmunofluorescence in cells. western blot analysis was used to determine the expression of nfkb mediators: phosphorylated ikk, ikba and p65. results: we observed that pap administration to cells prevented nfkb translocation to the nucleus as well as the tnfa-induced tnfa gene expression. when tnfastimulated cells were treated with cycloheximide in order to block protein synthesis, the induction of tnfa gene expression was completely restored. on the other hand, pap had no effect on ikk phosphorylation or ikba degradation. conclusions:in this study we have provided evidence that pap modulates the inflammatory response by blocking nfkb translocation to the nucleus. this pap-induced nfkb inhibition requires a jak/stat-dependent de novo protein synthesis. objectives: this study investigated the inhibitory mechanism of hyaluronan (ha) on lipopolysaccharide (lps)stimulated production of proinflammatory cytokines in u937 macrophages. methods: ha was added to u937 macrophage cultures in the presence of lps, with or without pretreatment with anti-intercellular adhesion molecule-1 (icam-1) antibody. secreted levels of tumor necrosis factor a (tnfa), interleukin (il)-1b, and il-6 were determined by enzyme-linked immunosorbent assay. the phosphorylation of nuclear factor (nf)-kb, ikba, and mitogenactivated protein kinases (mapks) was analyzed by immunoblotting. results: lps stimulated production of tnfa, il-1b, and il-6. in contrast to 800 kda ha, 2700 kda ha at 1 mg/ ml inhibited lps-induced cytokine production. anti-icam-1 antibody blocked the effects of ha on the lps actions on u937 cells. lps activated nf-kb and mapk pathways, whereas ha down-regulated p65 nf-kb and ikba phosphorylation by lps without affecting mapks. inhibition studies revealed the requirement of nf-kb for lps-stimulated cytokine production. anti-icam-1 antibody reversed the inhibitory effects of ha on phosphorylation of p65 nf-kb and ikba. conclusions: ha of intrinsic molecular weight suppresses lps-stimulated production of proinflammatory cytokines via icam-1 through down-regulation of nf-kb and ikb. exogenous ha into arthritic joints could act as an anti-nf-kb agent by the mechanism demonstrated in the present study. the principal eicosanoid product of endothelial cox-2 is prostacyclin (pgi2), which is a potent vascular patency factor. induction of endothelial cox-2 under hypoxic conditions is well documented. this response, along with associated pgi2 release, is likely an important protective homeostatic response. in order to explore the role of candidate signalling agents in cox-2 expression in response to hypoxia, studies were undertaken using luciferase reporter constructs of the cox-2 promoter region in huvec. cox-2 induction under hypoxic conditions was confirmed with the wild type construct. strategic mutations of transcription factor binding sites showed that sites for hypoxia inducible factors (hifs) were more important for cox-2 expression than those for nfkb. furthermore, expression of cox-2 was increased under normoxic conditions by transfection of huvec with normoxia-stable hif mutants. emsa showed hif binding in nuclear extracts from untransfected hypoxic huvec. under these hypoxic conditions, increased release of pgi2 but not vaso-occlusive thromboxane a2 was seen. thus the putative protective induction of cox-2 in endothelial cells in response to hypoxia involves signalling by hifs. crescentic glomerulonephritis is characterized by crescent formation and rapid progress to renal failure, where the predominance of th1 immune response plays a crucial role. however, the therapeutic efficacy of the regulation of th1-predominant immune responses remains to be investigated. therefore, the effects of a th1 selective inhibitor tak-603 were investigated in a model of crescentic glomerulonephritis in wky rats. methods: tak-603 was administered orally, starting at the time of induction of glomerulonephritis. in group 1, the drug was administered daily for the initial 6 days. tak-603 was administered on day 0 only in group 2, and from day 3 to 5 in group 3. in each group, nephritic rats were killed on days 6 and 56. results: in group 1, glomerular damage, including crescent formation, was improved on day 6, with reductions in the numbers of cd4, cd8 and ed-1 positive cells, as well as in urinary protein excretion. protein and transcript levels of th1 cytokines in the diseased kidneys were markedly decreased by tak-603 treatment. renal pathology, including glomerulosclerosis and interstitial fibrosis, was ameliorated and proteinuria was markedly decreased. elevated levels of serum creatinine showed concomitant improvement. in group 3, in which treatment was initiated shortly after the appearance of glomerular abnormalities, glomerular damage was also diminished, resulting in a decrease in urinary protein excretion. treatment only on the first day in group 2, partially rescued renal dysfunction. conclusions: these results suggest that the initial inhibition of th1 immune response has an appealing therapeutic potential for crescentic glomerulonephritis. parasitic nematodes and their hosts are now known to produce a wide range of galectins. whilst host galectins have been shown to modulate the recruitment and effector function of inflammatory cells including mast cells, neutrophils and eosinophils, the role of secreted parasitic galectins is less well defined. studies at moredun have demonstrated that both the endoparasitic helminth, haemonchus contortus, and the ectoparasitic mite, psoroptes ovis, produce galectin-like factors which, in vitro, directly influence the migration and survival of eosinophils from their natural sheep host. excretory-secretory extracts from both parasites contained potent chemokinetic activity and were also able to promote eosinophil survival in the presence of dexamethasone. separation by affinity chromatography, as well as specific sugar inhibition and mass spectrometric profiling, revealed the active components to be galectins. in the case of h. contortus, there was homolgy with known est sequences, which allowed subsequent cloning and expression studies to be undertaken. a functional in vivo role for these parasitederived galectins awaits confirmation, but the possibility is raised that they could directly influence the host immune response following infection. this may have particular significance in mite infections in which exudates from the associated eosinophilc lesion appear s428 inflamm. res., supplement 3 (2007) posters to provide the primary nutrient source for their survival. moreover, the observation that two very different parasites may have evolved similar mechanisms for manipulating the host inflammatory response to their benefit, raises the further possibility that parasite galectins may provide potentially novel therapeutic targets. the aim of the study was to investigate the time course of cytokine gene expression in liver and lungs of mice with lipopolysaccharide (lps)-induced septic shock and to assess the effect of three different immunomodulatory agents on cytokine mrna levels in these tissues. male cd-1 mice were injected intraperitoneally with 50 mg/kg lps alone or concomitantly with an intravenous dose of pentoxifylline (100 mg/kg), lisofylline (100 mg/kg) or prednisolone (10 mg/kg). the tissues were harvested 0, 1, 4, 6, and 24 h following lps administration and stored at -808c. relative quantification of tumor necrosis factoralpha (tnf-alpha), interleukin-1beta (il-1beta), interleukin-6 (il-6), and interferon-gamma (ifn-gamma) mrna levels was performed by real-time rt-pcr. the highest levels of cytokine mrna were observed at 4 or 6 h after lps administration, whereas the expression of tnf-alpha and il-1beta in lungs and il-6 in liver reached the peak values at 1h and then decreased gradually. in addition, the lps effects on cytokine mrna were more pronounced in liver when compared to lungs. all administered compounds inhibited the lpsinduced tnf-alpha mrna expression (by up to approximately 50%), whereas lisofylline significantly increased ifn-gamma mrna levels in both tissues at most investigated time points. for other cytokines, the observed differences did not reached statistical significance. in conclusion, with the exception of ifn-gamma, the time course of cytokine mrnas differed considerably depending on the type of tissue. in the murine model of lps-induced septic shock, only tnf-alpha gene expression was suppressed by all compounds under investigation. maria sanz(1), m losada (1), c company (1), c lope-gines(1), l piqueras(2), j cortijo (3) the migration of leukocytes into inflamed tissues involves a cascade of molecular events finely regulated by cell adhesion molecules and chemokines. fractalkine/ cx3cl1 (fr) is a membrane-bound chemokine that functions as a mononuclear leukocyte chemoattractant and as an adhesion molecule. clinical studies and animal disease models have shown that fr is also involved in the pathogenesis atherosclerosis. we have demonstrated that angiotensin-ii (aii) has proinflammatory actions inducing the initial attachment of mononuclear cells to the arteriolar endothelium. in the present study we have investigated whether aii can cause the synthesis and expression of fr on human umbilical arterial endothelial cells (huaecs). huaecs were stimulated with ang-ii 1 microm or with tnfalpha (20 ng/ml) for 1, 4 and 24 h. fr was determined in the culture supernatants by conventional sandwich elisa. fr was only detected after 4 h and 24 h stimulation with tnfalphafnwhereas aii was unable to provoke the cleavage of the chemokine. semiquantitative rt-pcr analysis of huaecs showed increased fr mrna expression in aii-stimulated cells for 1 and 4 h. these effects were caused by the interaction of aii with its at1 receptor since they were abolished by losartan (at1 receptor antagonist). tnfalpha also increased fr mrna. immunohistochemical analysis of the cultured endothelial cells showed a clear expression of fr in huaecs stimulated with aii or tnfalpha for 4 and 24 h. these results suggest that fr could be a key chemokine in the selective adhesion of mononuclear leukocytes to the arterial endothelium elicited by aii. the lipophilic yeast malassezia is an exacerbating factor in atopic dermatitis (ad).among organisms of the malassezia species, m. globosa and m. restricta are particularly dominant on the skin of ad patients. our previous study has demonstrated that human keratinocytes responded to the two malassezia species with different th2-type cytokine profiles, i.e. m. globosa induced il-5, il-10, and il-13 secretion from the keratinocytes, whereas m. restricta induced il-4 secretion.these findings suggest that m. globosa and m. restricta play a synergistic role in triggering or exacerbating ad by stimulating the th2 immune response. pattern recognition receptors (prrs) of human keratinocytes play an important role in the induction of inflammatory and innate immune responses. in this study, we assessed the role of prrs for cytokine production by human keratinocytes in response to malassezia species. human keratinocytes were pretreated with various anti-prr monoclonal antibodies (mabs) and stimulated with m. globosa or m. restricta. cytokine secretion from keratinocytes was measured by using fast quant elisa kit. exposure of human keratinocytes to m. globosa and m. restricta resulted in enhanced secretion of il-5 and il-4, respectively. the m. globosainduced increase in il-5 secretion was inhibited by mabs against cd14 and cd91. in case of m. restricta, mabs against toll-like receptor 2 (tlr2) and cd14 suppressed significantly il-4 secretion from keratinocytes. these findings suggest that the distinct prrs interactions with fungal pathogen-associated molecular patterns (pamps) are key factors in differential cytokine secretion from keratinocytes stimulated with malassezia species. atopic dermatitis (ad) is a chronic, relapsing inflammatory skin disease associated with allergy. mdc (macrophage-derived chemokine/ccl22) and tarc (thymus and activation-regulated chemokine/ccl17) are th2type cytokines, and it has been reported that serum mdc and tarc levels are associated with ad disease. in present study, we investigated the effect of prunus yedoensis matsum barks on the inflammatory chemokines (mdc and tarc) and jak-stat pathway in hacat keratinocytes. as a result, etoac fraction and e5 sub-fraction inhibited the mrna expression and protein level of mdc and tarc in a dose-dependent manner. also, e5 sub-fraction showed inhibitory activity on the stat1 protein level. these results suggest that p. yedoensis may have an anti-atopic activity by suppressing the inflammatory chemokines (mdc & tarc). the il-1 family now consists of 11 members, most of which have assigned functions.there are 10 members of the il-1 receptor family (including the decoy receptor type ii il-1r).many of the il-1 family members possess neither a signal peptide nor an apparent prodomain, but nevertheless manage to exit the cell.the il-1 family members il-1f6, f8 and f9 signal through a complex of the il-1r family member rp2 in association with il-1r acp to activate common inflammatory pathways.the specific activity is is low, on the order of 1-10ug/ml ec50.we have found that removal of a few n-terminal amino acids from il-1f5, f6, f8 and f9 can increase their bioactivity approximately 1000-fold. the location of the n-terminus leading to increased specific activity is quite specific; removal of one more or one fewer amino acid eliminates the effect.in addition, n-terminally truncated il-1f5 is capable of antagonizing signaling via il-1rrp2, but full-length f5 is inactive. (1) university of ulsan, japan kyoto university, japan inflammation plays a pathogenic role in the development of obesity-related complications such as type ii diabetes and atherosclerosis. tumor necrosis factor alpha (tnfa) is closely associated with the enhanced inflammatory responses in obesity and the obesity-related pathologies. tr2 (hvem/tnfrsf14), which is a member of the tnf receptor superfamily and the receptor for lymphotoxins-related inducible ligand that competes for glycoprotein d binding to herpesvirus entry mediator on t cells (light/tnfsf14), is a potent mediator of inflammatory responses. the purpose of this study is to examine the hypothesis that obesity-induced inflammatory responses can be attenuated by inhibiting tr2 pathway. c57bl/6 tr2 knockout mice and their wild-type control were fed a high-fat diet for 12 weeks and the obesity phenotypes were determined in the obese tr2 knockout mice and the control. the obese tr2 mice fed a high-fat diet elicited the attenuation of body weight gain and insulin resistance relative to wild-type control mice. expression levels of inflammatory genes significantly decreased in the adipose tissue of the obese tr2 knockout mice compared with those of the control. our results demonstrate that obesity-induced inflammatory responses and insulin resistance can be attenuated in obese tr2 knockout mice fed a high-fat diet. objectives: the present study was undertaken to investigate the role of insulin on allergic airway inflammation. methods: diabetic male wistar rats (alloxan, 42 mg/kg, i.v.) and controls were sensitized with ova (100 ã¬g) and al(oh)3 (8 mg, s.c.) 10 days after alloxan or saline injection. the animals were challenged 14 days later by the intratracheal instillation of ova (1 mg/0.4 ml). the following analyses were performed 6 h thereafter: (a) total and differential cell counts in bronchoalveolar lavage (bal) fluid; (b) quantification of tnf-alpha and il-1 beta in the bal by elisa; and (c) immunohistochemistry for p-and e-selectins on lung vessels. results: compared to the control animals, diabetic rats exhibited reduced number of neutrophils (90%) and mononuclear cells (50%); reduced levels of tnf-alpha (45%) and il-1 beta (30%), and reduced p-selectin expression (30%) in response to ova challenge. these abnormalities were corrected after treatment of diabetic rats with a single dose of nph insulin (4 iu, s.c.), 2 h before ova challenge. although we did not find differences in e-selectin expression between diabetic rats and controls, expression of this molecule was amplified by insulin. conclusions: data presented show that insulin controls neutrophils migration during allergic airway inflammatory possibly by modulation of tnf-alpha and il-1 beta production and selectin expression. supported by fapesp and pronex. hormonally active vitamin d derivatives are beneficial in the treatment of cutaneous inflammatory disorders, particularly in psoriasis. their anti-inflammatory effect is usually attributed to inhibition of the activity of infiltrating immune cells.we examined whether vitamin d also interferes with the pro-inflammatory action of the keratinocytes themselves. human hacat keratinocytes cultured in the absence of exogenous growth factors or active mediators were exposed to tnf to simulate an inflammatory challenge and their response was monitored by assessing mrna levels of the cytokine tnf, the chemokine il-8 and the adhesion molecule icam-1 by real-time pcr. icam1 and il-8 were induced rapidly peaking after 2h, their mrna levels increased again from 8h to reach a plateau between 16h to 24h after exposure to tnf, whereas tnf mrna levels increased steadily between 2h and 24h. 24h pretreatment with calcitriol, the hormonal form of vitamin d, inhibited induction of il-8 but did not affect that of icam-1 or tnf 2h following exposure while calcitriol markedly inhibited the induction of all 3 pro-inflammatory genes 16h after the tnf challenge.calcitriol inhibits the activation of jun kinase (jnk) and p38 by tnf. this action was mimicked by the posters inflamm. res., supplement 3 (2007) s431 jnk inhibitor sp600125 and the p38 inhibitor sb203580.the combination of the two inhibitors fully reproduced the time and gene dependent modulatory effect of calcitriol. we conclude that vitamin d attenuates the active contribution of keratinocytes to cutaneous inflammation and that this modulatory effect is explained by inhibition of the jnk and p38 cascades. (1), cm lotufo (2), p borelli (1), zs ferreira (2), rp markus (2), shp farsky (1) (1) department of clinical and toxicological analyses, school of pharmaceutical sciences, university of sâ¼o paulo, brazil (2) department of physiology, bioscience institute,university of sâ¼o paulo, braziil introduction: we showed that endogenous glucocorticoids (eg) control neutrophil mobilizations from the bone marrow and peripheral compartment by modulating the expression of l-selectin on segmented cells. aims: we evaluated the role of eg on endothelial cells (ec) and the molecular mechanisms responsible for hormonal actions in neutrophils and ec. methods: neutrophils were collected from blood, segmented leukocytes from femoral bone marrow and ec were cultured from testis vessels. cells were obtained from adrenalectomized (adx), ru 38486-treated, shamoperated, vehicle-treated and non-manipulated (nm) wistar rats. results: circulating neutrophils and segmented cells from ru 38486-treated rats presented elevated and decreased expressions of l-selectin vs cells from control animals, respectively. the effects were not dependent on alterations of l-selectin mrna levels. ec from adx animals presented more ability to adhere neutrophils from nm rats and enhanced mrna levels and membrane expressions of icam-1, vcam-1 and pecam-1. participation of the glucocorticoid cytosolic receptor(gcr) on these effects was shown by similar results in cells from ru 38486 treated rats. nfkappab translocation in neutrophils was equivalent in all groups of animals, but it was enhanced in ec from adx or ru 38486-treated rats. conclusions: data show the participation of the gcr on events involved in neutrophil mobilizations, but nfkappab transcription is only involved on ec. (1), y naito(2), t okuda (3), k mizushima (3), t okayama (3), i hirata (3), h tsuboi (3), t suzuki (3), o handa (1) background: despite the inhalation of co at high concentrations had been considered as a toxic gas, the inhalation of co at low concentration has recently been shown the cytoprotective and anti-inflammatory effect against various animal models. however, it is unclear whether the direct exposure of co to the intestinal inflamed mucosa is effective or not. in this study, we investigated the therapeutic efficacy of the rectal co administration for rat colitis model. acute colitis was induced with trinitrobenzene sulfonic acid (tnbs) in male wistar rats. co(200ppm-10ml) was intrarectally administrated twice a day after the induction of colitis. rats were sacrificed at 3 days after the administration of tnbs. the distal colon was removed, and the ulcer lesions were measured. thiobarbituric acid (tba)-reactive substances and tissueassociated myeloperoxidase (mpo) activity were measured in the colonic mucosa as indices of lipid peroxidation and neutrophil infiltration, respectively. moreover, we evaluated the expressions of cinc-1 mrna/protein and p-p38 mapk protein. the intracolonic administration of co ameliorated tnbs-induced colonic ulceration. the increases in tba-reactive substances and mpo activity after tnbs administration were both significantly inhibited by treatment with co. moreover, the rectal administration of co significantly inhibited the increased expression of cinc-1 mrna/protein and p-p38 mapk protein after the induction of tnbs-induced colitis. the rectal administration of co protected from the intestinal inflammation in rats. based on these data, the beneficial effects of co on the intestinal mucosal injury may be attributed to its anti-inflammatory properties. alessandra gambero (1), m marã³stica (1), m saad(2), j pedrazzoli jr (1) (1) sâ¼o francisco university medical school, brazil (2) state university of campinas, brazil recent studies have shown that adipocytes produce and secrete several bioactive molecules like adipocytokines. the adipose tissue can also present short and long-term changes during inflammation and infectious pathologies. in this study, the alterations of mesenteric and perinodal mesenteric adipose tissue during experimental colitis induced by repeated intracolonic tnbs instillations were evaluated. the adipocyte size was measured after collagenase digestion. the basal lipolysis (glycerol release) and adipocytokine production was monitored after short time culture of adipose tissue. the colitis animals showed higher mesenteric fat mass (1.02+-0.06 and 0.78+-0.09 % of body weight for colitis and control, respectively; p<0.05) in despite of the lower body weight. the mesenteric adipocytes from colitis animals presented reduced diameter (31.67+-0.28 and 35.69+-0.37 um for colitis and control, respectively; p<0.01), higher basal lipolysis (41.67+-6.89 and 18.77+-3.66 ug.mg-1 for colitis and control, respectively; p<0.05) and tnf-alpha production (8.64+-0.77 and 5.51+-0.86 ng.mg-1 for colitis and control, respectively; p<0.05). perinodal mesenteric adipocytes presented normal diameters, higher basal lipolysis (72.48+-15.38 and 25.96.77+-3.05 ug.mg-1 for colitis and control, respectively; p<0.05), increased tnfalpha (46.34+-5.82 and 15.71+-2.15 ng.ml-1 for colitis and control, respectively; p<0.01), leptin (400.41+-77.10 and 201.01+-52.01 pg.ml-1 for colitis and control, respectively; p<0.05) and adiponectin production (15029+-2340 and 5918+-498 ng.ml-1 for colitis and control, respectively; p<0.01). the mesenteric adipose tissue was modified during the experimental inflammation, but some alterations were site specific. perinodal adipose tissue retained the ability to produce anti-inflammatory and pro-inflammatory cytokines, while mesenteric adipose tissue only the pro-inflammatory one. this work was financially supported by fapesp. inflammatory bowel disease (ibd) is a group of chronic inflammatory disorders of the intestine. the role of the pro-inflammatory p38 mapk signalling cascade in the pathogenesis of ibd is highly controversial. we therefore aimed to investigate the role of p38 mapk in chronic dextran sodium sulfate (dss) induced colitis, an experimental model of ibd. chronic intestinal inflammation was induced by oral cyclic administration of 3 % dss in sjl mice. clinically, the dss treatment produced episodes of colitis manifested by diarrhoea, gross intestinal bleeding, marked loss of body weight, and shortening of the colon. at the molecular level, this was accompanied by an up-regulation of tnfa, il-1ã¢, il-6, il-17, kc, cox-2, igg heavy chain, and phospho-stat3 in the dss treated mice.the clinical and molecular features described above recapitulate findings reported in human ibd. in order to assess the role of p38 mapk, the activation of the p38 mapk signalling cascade was analysed by western blot analysis. the expression and phosphorylation levels of both p38 mapk and of mk2 and hsp27, two down-stream targets, were not increased in dss treated animals compared to controls. leo 15520, a potent inhibitor of p38 activity in vivo, was dosed as pretreatment and after completion of dss treatment. pretreatment had a deteriorating effect on all measured cytokines, whereas treatment after disease induction had no effect on any measured parameters. collectively, these results strongly suggest that the p38 kinase pathway only plays a minor role, if any, in the dss model. (sp) were gmcsf differentiated, dcs purified through gr1+ cell depletion, and spleen tcells isolated by pan tcell negative selection. spdcs or bmdcs were stimulated +/-100ng/ml lps. for mlr, balb/c tcells were added for 5 days. cells were incubated with sb203580 (4-(4-fluorophenyl)-2-(4-ethylsulfinylphenyl)-5-(4-pyridyl)1h-imidazole, sb) or ml3403 ((rs)-{4-[5-(4-fluorophenyl)-2-methylsulfanyl-3h-imidazol-4-yl]pyridine-2-yl}-(1 -phenylethyl)amine, ml) and washed prior to lps stimulation (bmdcs) or cell mixing (t cells). 3hthymidine incorporation was measured, cell viability by mtt assay, tnfa and il-12 production by elisa. mlr tcell proliferation inspdcs or bmdcs was inhibited by sb (ic50 spdc 0.06mm, bmdc 1.0mm) and ml (ic50 spdc 0.03mm, bmdc 0.03mm). preincubation with dcs had no effect, despite reduced lps stimulated il-12 and tnfa synthesis by sb (ic50 il-12 1.2mm, tnf 0.16mm) and ml (ic50 il-12 0.9mm, tnf 0.11mm). preliminary data shows that preincubation of t cells with sb and ml modifies the mlr response. p38 plays a role in the interaction of dcs and t cells in antigen recognition. however, pre-incubation of drugs with dcs was ineffective. the role of t cell p38 mapk in the mlr is under investigation. p38 inhibitors may possess disease modifying properties because of reduced tcell antigen reactivity to dc antigen presentation. (1), s luik(2), s laufer(2), m seed (3), v holan(4), s fiorucci (5) (1) synovo gmbh, tã¼bingen, germany (2) university of tã¼bingen, germany in vivo anti-inflammatory activity of certain p38 kinase inhibitors is limited by bioavailability. however, it is possible that they may be useful in the therapy of ibd should it be possible to mediate there uptake in and around bowel lesions. we reasoned that activity could be especially increased if drug physical properties were altered to allow preferential partition into macrophages and neutrophils (wbc) associated with lesions. we prepared prodrugs of p38 inhibitors and screened them using whole human blood, murine spleenocytes and peritoneal macrophage. pharmacologically inert macrocycle (azilide) conjugates were assessed for enhanced efficacy in murine collagen induced arthritis either therapeutically (after onset of signs) or prophylactically (2 d post boost) or in a dss or tnbs model of ibd in the mouse. in both types of models, the prodrugs achieved improved suppression of arthritis and inflammatory score in colon sections at tolerated doses with optimal activity at 15mmolkg-1d-1. we propose that the prodrugs increase efficacy via improved pharmacokinetics partly related to biased disposition of the prodrug toward immune cells. despite the potent anti-inflammatory and immunosuppressive properties of glucocorticoids its applying in the management of severe necrotizing pancreatitis is still controversial. the plasma levels of interleukins (il-8, il-18) and adhesion molecules (e-selectin and icam-1) were measured in 36 patients with necrotizing pancreatitis. the measurement was performed immediately after admission, at the 3, 7, and 14 day. all patients were divided on two groups: first group compiled 20 patients, in which dexamethasone (16 mg/day during 7-8 days) was applied in the complex management of acute pancreatitis, and control group -16 patients that did not receive corticosteroids. all patients received the initial therapy. the increased levels of il-6, il-8, il-18, icam-1, and eselectin were noted in both groups of patients at the time of admission. the gradually increase of all proinflammatory mediators plasma levels up to seventh day was noted in patients of the control group. its levels clear correlated with the severity of mods and spreading of necrotic processes confirmed by ct. starting from the third day the gradually decrease of mediators levels were noted in the patients of the first group. the incidence of contamination of necrotic foci had no difference in both groups of patients. the ability of glucocorticoids to inhibit expression of proinflammatory mediators due to the glucocorticoids-mediated repression of nf-kappa b pathway provide the pathogenetic substantiation for the applying of glucocorticoids in the complex management of necrotizing pancreatitis. the objective of this study was to examine whether t cell specific overexpression of the th2 transcription factor gata-3 can inhibit th1/th17 cell mediated experimental mbsa arthritis. mbsa-immunized wild type mice developed joint inflammation which gradually increased in time with a maximum at day 7. at day 1, t cell specific gata-3 tg mice did not show any difference in arthritis score compared to wild type mice. however, at day 7, wild type mice had developed severe joint inflammation having the maximum arthritis score. in contrast, gata-3 tg mice showed only mild joint inflammation, suggesting that t cell specific overexpression of gata-3 protects against development of severe joint inflammation. facs analysis revealed low levels of il-17 +/ifn-gammacells in wild type as well as in gata-3 tg mice at day 1. as expected, il-4 positive cells were higher in gata-3 tg mice compared with wild type mice. interestingly, at day 7, the percentage of il-17 +/ ifn-gamma-cells were markedly increased in wild type mice but not in gata-3 tg mice, suggesting prevention of th17 expansion under gata-3 overexpression in vivo. these data revealed that t cell specific overexpression of the th2 transcription factor gata-3 protects against progression of severe joint inflammation during mbsainduced arthritis. furthermore, il-17 +/ifn-gammacells play a critical role in the progression of joint inflammation in this model and gata-3 overexpression in t cells prevents expansion of the il-17 +/ifn-gamma-t cell subset. pingping jiang (1), pt sangild(2), t thymann (2), hh-y ngai (1), w-h sit (1), k-l chan (3), jm-f wan (1) ( necrotizing enterocolitis (nec) is a severe intestinal inflammatory disease for which the disease etiology and progression remain unclear. preterm delivery and enteral milk formula feeding are factors predisposing to nec. to understand the pathophysiology of nec, two-dimensional gel electrophoresis (2d page) proteomic approach was applied in studying changes in intestinal protein pattern in preterm piglets with spontaneous nec occurring in response to 2 days of parenteral feeding followed by 1 day of enteral formula feeding. the intestinal proteomes of pigs with clinical symptoms of nec (n = 3) were compared with corresponding pigs remained healthy (n = 4). syproruby staining was used and differently expressed proteins were identified by maldi-tof ms or maldi-tof/tof ms. the proteins with significantly different expression between nec and healthy pigs involve in energy metabolism (sorbitol dehydrogenase, mitochondrial aldehyde dehydrogenase 2 and chain a, medium-chain acyl-coa dehydrogenase with 3-thiaoctanoyl-coa etc.), inflammation (peptide-binding protein 74 (pbp74) and snail homolog 3), signal transduction proteins (thyroid hormone binding protein precursor, park7 protein and chain b, structure of the rho family gtp-binding protein cdc42 in complex with the multifunctional regulator rhogdi etc.) and anti-oxidation (manganese-containing superoxide dismutase(sod)). these data underscore the significant impact of intestinal proteomics in unraveling nec pathophysiology and biomarker discovery. blood are used to monitor the progression of inflammation. the aim of our study were to investigate systemic markers of disease in a rat model of lps induced pulmonary inflammation to provide a link between preclinical in vivo research and early clinical research. animals were exposed to bacterial lipopolysacharide (e.coli 026:b6) by inhalation. the lungs were lavaged 6 hours post provocation and the level of cell influx was determined. relevant mediators of acute pulmonary inflammation were analysed with standard elisa technology in bronchoalveolar lavage fluid and in blood. in addition, measurement of changes in body temperature were performed at different time-points post provocation in order to monitor the systemic inflammatory responses to the local pulmonary inflammation manifested as alteration in body-temperature. results showing the effects of lps challenge on local and systemic parameters will be presented and the possible link to lps responses in man discussed. pulmonary inflammation models are widely used in pharmacological research. however, provocations and treatments aimed directly at the lung are often invasive which limits the possibility to perform repeated administrations of test agents and compounds. also, results derived from bronchioalvelar (bal) fluid are subject to variability if the retrieval techniques are non standardized. here we describe a non-invasive standardized method for retrieval of bal fluid to be used in mice. we present the characterisation of these techniques using the inflammatory response to lps and propose that this non invasive method can be used to refine lps and other challenge models. the objectives were to evaluate the dynamic response after a single intra-tracheal administration of of 5mg (50ml/animal) of lps (p.aeruginosa) to c57bl/6j mice. control animals received a single dose of sterile 50ml 0.9% saline/animal. the mice were terminated 4, 24, 48, 72 and 96h after instillation using a non invasive and operator independent lavage technique. results showing the effects of single lps challenge on bal parameters, excised lung gas volume and lung weight will be presented showing reliable dynamic responses. these techniques open the possibility to run repeated treatments and chronic provocations and are not subject to variability from bal fluid retrieval. the human psoriasis xenograft scid mouse model is one of the most accepted and well characterized models for screening of novel anti-psoriatic compounds. the model has primarily been applied for testing novel treatment principles via systemic or intradermal administration routes. in order to evaluate the model for topical treatment, psoriatic keratome biopsies were grafted to immune-deficient scid mice. transplanted mice were treated with daivonex /dovobet (calcipotriol) and bms (betamethasone). the results show a strong antipsoriatic efficacy after treatment with bms (epidermal thickness reduced by 68%). treatment with daivonex / dovobet also showed an anti psoriatic effect with a 31% reduction in epidermal thickness. serum did not contain test compounds, indicating that the observed effect were not due to systemic exposure. the observed effects are in concordance with clinical results of treatment of psoriasis. it is concluded that the model is useful for testing topical treatments. we have demonstrated that adult rats offspring of dams submitted to protein restriction during early lactation, presented impaired acute immune responses probably related to an imbalance in glucocorticoids and insulin secretion (barja-fidalgo; inflamm res 52 (11): 2003) . here, we evaluated the innate immunity mediated by neutrophils and host defense against infection in adult rats offspring of dams fed with either a protein free diet (un-group) or 22% protein diet (c-group) during the first 10 days of lactation. un rats showed lower number of blood pmn, though no difference in bone-marrow neutrophils number was observed. blood neutrophils from un-group presented a significantly reduced phagocytic activity against opsonized zymosan, constitutively expressed inos and spontaneously produced o2-, no and tnf-alpha. in vivo treatment with lps, at non-lethal doses, significantly increases tnf-alpha and superoxide production by neutrophils, compared with controls. lps increased no production by neutrophils from both groups, inducing inos expression in control cells, but no further increase in inos expression in un rats. nucleare nf-kb is constitutively augmented in un rats. un animals presented a higher survival rate in a model of clp-induced severe sepsis. these results indicate that a metabolic programming induced during early lactation affects the innate immune responses in adult rats, which are unable to properly mount an inflammatory response, may predispose to chronic diseases in adult life. transgenic mice over-expressing vascular endothelial growth factor (vegf) in the epidermal basal layer under the human keratin 14 (k14) promoter have previously been reported to develop a psoriasis-like inflammatory condition in the skin. important hallmarks of psoriasis are epidermal hyperplasia in association with infiltration of t-cells in the dermis and epidermis and also increased dermal angiogenesis. the aim of this study was to describe the epidermal hyperplasia and the infiltration of the skin with t-cells in transgenic k14/vegf mice. we induced a cutaneous inflammation in the ear skin by repeated topical treatments with 12-o-tetradecanoylphorbol-13-acetate (tpa), in order to investigate the inflammatory response. the in vivo pharmacological effect of topical treatment with a number of reference compounds, including betamethasone-17-valerate, was also investigated. the ear thickness was significantly increased in transgenic animals compared to wild type animals following tpa-induction. the epidermal thickness measured in histological sections of biopsies from the ear skin was also significantly increased in transgenic animals. furthermore, increased dermal vascularisation was observed in the histological sections of the ear skin. a marked infiltration with cd3-positive cells was observed in both dermis and epidermis, and this was highly correlated with the increase in epidermal thickness. finally, topical treatment with betamethasone-17-valerate significantly reduced the ear swelling and epidermal thickness. we conclude that over-expression of vegf in the epidermal basal layer plays an important role in skin inflammation and for the development of important psoriatic hallmarks. the model may furthermore be used as an in vivo screening tool for novel anti-psoriatic compounds. background and aims: the diabetes-prone bb (bbdp) rat spontaneously develops insulin-dependent diabetes resembling type 1 diabetes (t1d) in man. the bbdp rat is t-cell lymphopenic with a profound lack of regulatory t cells. the recent thymic emigrants in bbdp rapidly undergo apoptosis unless rescued from apoptosis by tcr stimulation. the increase in apoptosis is due to a frameshift mutation in gimap5 which causes a severe truncation of the protein. the mutation is the strongest genetic factor for rat t1d. we aim to detect how gimap5 affects the lifespan of t cells. results: overexpression in c58 cells of both wt gimap5 and gimap5 with the bbdp mutation causes an increase in apoptosis -the latter with a very rapid onset. reduction of human gimap5 by rna-interference in jurkat cells did not affect the number of apoptotic cells. overexpression of human gimap5 causes apoptosis in jurkat cells and primary naã¯ve t cells but not in activated t cells. finally, gimap5-mrna is upregulated in in vitro activated human primary t-cells (detected by rt-pcr). conclusions: based on the phenotype of the bbdp, rat gimap5 was expected to be anti-apoptotic. however, we report here that overexpression of both mutated and wt gimap5 causes rapid death of the cells. this suggests that gimap5 is pro-apoptotic. the results with human wt gimap5 support this conclusion: recently, much focus has been on the cellular cd38/ cadpr signaling system during inflammatory processes. the cd38/cadpr system has been shown to be regulated by interferon, estrogen and the proinflammatory cytokine il-8. to our knowledge, the expression and function of the cd38/cadpr signaling system in the human detrusor muscle have not been described. cd38 protein expression in cultured (explant technique) human detrusor smooth muscle cells (hdsmc) was demonstrated by western blot (wb) and confocal microscopy (cm). cytosolic free ca2+ concentration ([ca2+] i) in hdsmc and isometric force in human detrusor strips were measured by spectrofluorometry and myograph technique, respectively. wb and cm showed that hdsmc expressed cell surface cd38 which could be upregulated by il-8 (20 ng/ml). in hdsmc briefly activated with il-8 (20 ng/ml) cadpr induced a rapid, transient dose-dependent increase in [ca2+]i. cyclic adpr-mediated ca2+ increase was greatly reduced in ca2+ free medium suggesting ca2+ entry as well as ca2+ release. cyclic adpr -elicited ca2+ increase was mimicked by 3-deaza-cadpr, and blocked by 8-bromo-cadpr, a cadpr antagonist, but not by nifedipine or verapamil. in the presence of il-8, cadpr caused concentration-dependent relaxations of detrusor muscle. we report for the first time that 1) hdsmc express cell surface cd38, 2) the expression and function of cd38 are augmented by il-8, 3) externally added cadpr elicited a rapid, il-8 -dependent, and 8-bromo-cadpr-inhibitable ca2+ mobilization, 4) cadpr induces relaxation of human detrusor muscle. the study indicates a role of cd38/cadpr in human urinary bladder inflammation. miao lin is a formulation of sen miao san and lingzhi that consists of cortex phellodendri, atractylodisa rhizoma, radix achyranthis bidentatae, and ganoderma lucidum. these ingredients are reported to have anti-inflammatory and analgesic effects. in this study, we have investigated the anti-arthritic property of miao lin in an animal model of arthritis induced by unilateral injection of freunds complete adjuvant (fca) into rat knees. contents of the miao lin capsules were dissolved in saline and administered to the rats daily by intraperitoneal or oral route for 7 days before induction of arthritis and 7 days after. extension angle, size and blood flow of the rat knee joints were measured to give indexes of algesia, oedema, and hyperaemia, respectively. assessments of the extent of cell infiltration, tissue proliferation, and erosions of cartilage and bone provided additional indexes of the arthritis condition. single unilateral injection of fca into rat knees produced significant oedema, algesia, hyperaemia, immune cell infiltration, synovial tissue proliferation, and erosions of cartilage and bone in the ipsilateral knees compared with the contralateral saline-injected knees. intra-peritoneal injection of miao lin (50 mg/kg/day) suppressed oedema, pain and hyperaemia in the inflamed knees, and oral administration (500 mg/kg/day) suppressed oedema and hyperaemia. histological examination showed that both routes of administrations of miao lin reduced immune cell infiltration and erosions of cartilage and bone, and intraperitoneally administered miao lin also attenuated synovial tissue proliferation. these findings suggest treatment with intra-peritoneal or oral miao lin could provide significant anti-arthritic effects. an extract of the anti-arthritic thermalife cream contains 13 trace elements. diffusion studies were undertaken to assess the permeability of human epidermis to the trace elements. non-penetrating trace elements were discarded from the test formula (t2), and compared with the original formula (t1) for in vitro anti-inflammatory efficacy (tnf-a secretion in lps-challenged human monocytes). methods: human epidermis was mounted in vertical franz type diffusion cells (stratum corneum facing up). t1 cream (n=4) or no cream (n=4) was applied to the donor compartment of diffusion cells, with pbs in the receptor compartment (3.0ml ; stirred continuously at 37 c). 240 min after administration the receptor fluid was analysed for presence of metal ions by icp-ms. a replication study used a different skin donor. subsequently, human monocyte cultures (10% fcs, 5% co2) were either stimulated with 500ng/ml lps (e.coli 0111:b4,) or not in the presence of 10% t1, 10% t2, or no treatment.24 hours after incubation, culture media were collected, centrifuged, and assayed (cytokine elisa). statistical analyses used a treat by lps anova (p < 0.05). results: zinc was the only trace element to penetrate the human epidermis significantly. both formulations strongly suppressed lps-induced tnf-a secretion. t2 with zinc only was more effective than t1 (treat:f2,12 = 57.13, p < 0.0001; lps:f1,12 = 245.47, p < 0.0001; treat by lps:f2,12 = 70.01, p < 0.0001). conclusions: anti-tnf efficacy from thermalife extracts was retained with zinc chloride as the only trace element. (1) (1) osprey pharmaceuticals limited, canada (2) probetex, inc., texas, usa the ccl2/ccr2 chemokine/receptor axis, infiltrating monocytes/macrophages (m/m), th1 cells and mast cells play a pathological role in tissue damage and fibrosis in kidney diseases. the eradication of the supernumerary activated leukocytes should curb the production of inflammatory mediators and modulate chemokine communications, thus ameliorating disease. a recombinant fusion protein comprised of the human ccl2 chemokine fused to a truncated form of the enzymatically active a1 domain of shiga toxin has been developed. the ccl2 portion binds specifically to ccr2-bearing leukocytes and enters the cells, where the sa1 portion inhibits protein synthesis. the compound was tested in a model of anti-thymocyte serum (ats)-induced mesangioproliferative glomerulonephritis. male rats were injected with ats on day 0 and treated intravenously with vehicle, 50 or 100mg/kg of the recombinant protein q2d from day 2 until day 8. urine and blood collections were made prior to ats injection and on days 5 and 9. animals were sacrificed on day 9. no treatment related effects on body weight or signs of clinical toxicity were observed. urine protein levels were decreased in treated animals. histopathological analyses of kidney sections revealed maximum reductions of 40, 36, 38, and 28% for glomerular lesions, m/m count, fibronectin and âµ-smooth muscle actin, respectively. the latter two proteins are markers for extracellular matrix synthesis and mesangial cell activation, respectively. these results indicate a significant renal-protective effect in this model of nephritis. further observations suggest that different chemokine-ligand toxins may be used in the treatment of diseases modulated by other chemokine/receptor axes. inflamm. res., supplement 3 (2007) posters immuno-depletion followed by fluorescence-activated cell sorting based on the cell surface expression of the sca-1 antigen. such isolated cells can subsequently be cultured and differentiate towards the osteogenic, adipogenic or chondrogenic linage in vitro. using this model we investigated the influence of the proinflammatory cytokines, tnfa or il-1b, on early osteogenesis in vitro. under osteogenic conditions, il-1b was found to inhibit cell proliferation in a dose dependent manner, whereas tnfa exhibited no effect. histochemical examination revealed the presence of either tnfa or il-1b to dramatically decreased mineralization in a dose dependent manner. q-pcr analysis indicated that in the presence of il-1b, despite increased expression of bone-specific alkaline phosphatase (akp2) mrna, levels of other osteogenesis markers (runx2, col1a and sp7) were decreased. in the presence of tnfa, levels of akp2, runx2 and sp7 were all decreased. our findings indicate that the influence of early mesenchymal progenitor cells on bone remodelling may be substantially altered in the presence of proinflammatory cytokines. coronary artery disease (cad) is characterized by enrichment of inflammatory cells in the vessel wall. we hypothesized that an altered transmigration and activation of monocytes may contribute to plaque build up. in vivo transmigration was studied by use of a skin blister model. blisters are raised by suction and cells are analysed the following morning (0h blister) and after additional ten hours of incubation with pbs or autologous serum, corresponding to intermediate and intense blister. monocytes were analysed by flow cytometry for the expression of cd11b, before and after in vitro fmlp stimulation. chemokines in serum and blister fluid was analysed in parallel. cd11b expression on resting monocytes harvested from 0h blister was lower in patients as compared to controls (p=0.001). lower expression of cd11b in patients was also observed in the intermediate and intense blisters after stimulation with fmlp (p=0.04 and p= 0.005, respectively). the number of transmigrated cells was similar in both groups and increased with the intensity of inflammation. serum concentration of mip-1âµ was higher among patients (p=0.01) and similar levels were seen in blister fluids. concentration of mcp-1 was similar in both serum and blister fluid. we demonstrate that monocytes from patients with cad have a reduced expression and ability to up-regulate the adhesion molecule cd11b at sites of inflammation. these differences may modulate events related to the transmigration process and indicate a changed activation pattern. to which extent this feature might contribute to monocyte entrapment at the atherosclerotic site needs further studies to be delineated. in inflammation, nitric oxide (no) is produced by inducible nitric oxide synthase (inos) induced by bacterial products and cytokines, and no acts as a regulatory and proinflammatory mediator. one of the anti-inflammatory mechanisms of glucocorticoids is the inhibition of no production. the aim of the present study was to investigate the mechanisms how glucocorticoids inhibit inos expression and no production. dexamethasone and a dissociated glucocorticoid ru24858 inhibited no production, and inos protein and mrna expression in murine j774 macrophages exposed to bacterial lipopolysaccharide (lps). in the presence of a glucocorticoid receptor (gr) antagonist mifepristone, the effects of dexamethasone and ru24858 on no production were reduced. the role of histone deacetylation in the glucocorticoid effect was studied by using three inhibitors of histone deacetylases (hdacs); non-selective trichostatin a and apicidin, and hdac1 selective mc1293. hdac inhibitors reversed the effects of dexamethasone and ru24858 on inos expression or no production. stably transfected a549/8 cells containing human inos promoter were used in promoter-activity studies. cytokine-induced inos promoter activity was inhibited by dexamethasone and the inhibitory effect was reversed by trichostatin a. these results suggest that glucocorticoids inhibit inos expression and no production by a gr-mediated and gre-independent manner possibly through histone deacetylation and transcriptional silencing. we are investigating mechanisms involved in tnfainduced hyperalgesia in the mouse paw. previously, we have seen that tnfa causes a trpv1-dependent bilateral hyperalgesia. here we investigate the role of cox in this process. female cd1 mice (25-30g) were given intraplantar injections (i.pl.) of tnfa (10pmol/50microl) and tyrode (as vehicle, contralateral paw; 50microl). thermal hyperalgesic thresholds were measured using the hargreaves technique before and 1h after injection. indomethacin (20mg/kg) was co-injected with tnfa whilst contralateral paw was injected with tyrode and corresponding amounts of indomethacin vehicle (5% nahco3). another group of mice were injected with tnfa i.pl. plus 5% nahco3 with the contralateral paw injected with tyrode plus indomethacin (20mg/kg). results are expressed as mean ae s.e.m and statistical analysis performed using students t-test. tnfa (10pmol) leads to significantly reduced (p<0.05 compared to baseline values) paw withdrawal latency in both paws 1h after injection i.e bilateral hyperalgesia. however, local injection of indomethacin (20mg/kg) with tnfa prevented this reduction in paw withdrawal latency in both paws suggesting that prostaglandins are important in the development of hyperalgesia. interestingly, indomethacin co-injected with tyrode in the contralateral paw did not prevent the reduction in paw withdrawal latency in both paws. the same results were seen using the selective cox-2 inhibitor, nimesulide. in conclusion, cox-2 derived prostaglandins are important in the development of hyperalgesia. local cox-2 inhibition at the site of tnfa-induced inflammation prevents the bilateral hyperalgesia suggesting that local prostaglandin production is sufficient to cause hyperalgesia in the contralateral paw. hydrogen sulfide (h2s) is synthesized naturally in the body from cysteine by cystathionine g lyase (cse). h2s has been variously reported to exhibit both pro-and antiinflammatory activity. in an attempt to obtain further information about the role of h2s in inflammation we examined the effect of dexamethasone on lipopolysaccharide (lps)-mediated endotoxic shock. male sprague dawley rats (240-280g) were administered dexamathasone (1 mg/kg, i.p.) either 1 h before or 1 h after lps (4 mg/kg, i.p.) injection. animals were killed 3 h after lps administration and plasma and tissues harvested. as expected, lps injection significantly increased plasma tnfa and il-1b as well as liver and lung myeloperoxidase (mpo) activity. lps also increased plasma nitrate/ nitrite (nox), h2s concentration and liver and kidney h2s synthesis from exogenous cysteine indicative of upregulation of cse in these tissues. either pre-or post treatment of animals with dexamethasone reduced signs of inflammation and also reduced the increase in plasma h2s and tissue h2s synthesizing activity. in separate in vitro experiments, exposure of rat peripheral leucocytes to lps (100 ng/ml, 3 h, 37oc) resulted in upregulation of both cse and inos (measured by western blot). dexamethasone (100 nm) significantly (p<0.05) reduced expression of both cse and inos. these data provide further evidence that h2s is synthesised during endotoxic shock and suggest, for the first time, that at least part of the anti-inflammatory effect of dexamethsone may be related to inhibition of h2s production. (1), u jalonen (1), h kankaanranta (1), r tuominen(2), e moilanen (1) (1) the immunopharmacology research group, medical school, university of tampere and tampere university hospital, tampere, finland (2) the division of pharmacology and toxicology, faculty of pharmacy, university of helsinki, helsinki, finland tristetraprolin (ttp), also known as nup475, tis11, g0s24 and zfp36, is a factor that binds to 3utr of mrna of some transiently expressed inflammatory genes and regulates mrna stability. ttp has been implicated in the posttranscriptional regulation of e.g. tumor necrosis factor a and inducible nitric oxide synthase. however, the regulation of the expression of ttp itself is largely unknown. in the present study, we investigated the role of classical protein kinase c (cpkc) isoenzymes in the regulation of ttp expression. in j774 macrophages ttp expression is induced by lipopolysaccharide (lps) and this can be further enhanced by addition of 100 nm phorbol myristate acetate (pma). this additive effect of pma on ttp was abolished by a prolonged preincubation with a higher s442 inflamm. res., supplement 3 (2007) posters concentration of pma for 24 h, which also downregulated the expression of pkca, pkcbi and pkcbii isoenzymes. pkc inhibitors ro318220 (inhibits pkcb, & and e), gã�6976 (inhibits pkca, b and &) and cgp53353 (inhibits pkcbii) reduced lps + pma -induced ttp protein and ttp mrna expression. pkcbii inhibitor cgp53353 did not affect ttp mrna half-life and therefore we measured the effects of cgp53353 on the activation of transcription factors involved in ttp expression. cgp53353 had no effect on the activation of nf-kb, egr1 or sp1. in contrast, cgp53353 reduced the activation of transcription factor ap-2, which may explain its inhibitory action on ttp expression. the results suggest that pkcbii is involved in the regulation of ttp expression in activated macrophages, possibly through the activation of transcription factor ap-2. the most widespread gracilaria verrucosa in the sea of korea is the attached form of red algae growing on a rockly substrate. in this study, we isolated fourteen compounds from g. verrucosa and investigated their inhibitory effect on the production of inflammatory markers (tnf-a il-6, il-1 and no) in raw264.7 cells. among them, 10-oxooctadec-8-enoic acid and 11-oxooctadec-9-enoic acid inhibited the production of tnf-a, il-6, il-1 and no at the concentration of 20 mg. also, these two compounds showed inhibitory activity on the mrna expression and protein level of inflammatory markers (tnf-a il-6, il-1 and inos) in a dose-dependent manner. these results suggest that g. verrucosa may have anti-inflammatory activity through the inhibition of inflammatory cytokines and inos. lene jensen(1), p hjarnaa (1), j fensholdt (1), p-p elena(2), k abell (1), tk petersen (1) (1) discovery, leo pharma, ballerup, denmark (2) iris pharma, la gaude, france angiogenesis is known to play an important role in many inflammatory diseases including arthritis. additionally, inflammation is known to play a role in the angiogenesisdriven disease age-related macular degeneration (amd). we have synthesized a potent angiogenesis inhibitor, leo-a, targeting kinases related to angiogenesis, e.g. vegfr-2. additionally, leo-a has potent effects on a broad panel of other kinases, whose normal functions are related to inflammation and immunity. the compound was tested systemically in inflammatory in vivo models in mice and rats. the in vivo models selected include the cia arthritis model (mice and rats), the local gvh rat model, the lps induced tnfa model (mice and rats), the anti-cd3 induced il-2 response mouse model and the rat argon laser-induced choroidal neovascularisation (chnv) model, a model for amd. the following results were obtained after systemic treatment with doses of up to 30 mg/kg i.p. or 50 mg/kg p.o. once daily: in the local gvh model, leo-a significantly inhibited the growth of the local lymph node by 50 %. in the cia model, leo-a had a significant inhibitory effect on the progress of arthritis both in mice and in rats when dosed early (pretreatment). in the lps induced tnfa model in mice, high doses of leo-a were found to inhibit the tnfa release. in the chnv model, a significant effect was obtained following systemic treatment. in conclusion, leo-a has an interesting profile for the treatment of diseases in which inflammation and angiogenesis are involved. mice lacking pi3kg and d isoforms display severe impairment of thymocyte development, but the outcome of this developmental defect has not been investigated. we show here that mice harbor pi3kg gene depletion and pi3kd kinase-inactive mutation, pik3cgd koi, exhibited thymus atrophy, similar to previously reported pi3kg and d double knockout (p110g/d-/-) mice, and profound peripheral lymphoid depletion, markedly reduced lamda chain production and seemingly lymphopenia-provoked effector/memory t cell activity. in particular, serum igg1/ igg2a ratio and ige level were elevated in pik3cgd koi mice corresponding to a skewed th2 profile in vitro. histological analysis revealed eosionophil-and t celldominated inflammation in stomach and salivary gland as well as occasionally other organs of pik3cgd koi mice, but organ-specific auto-antibody was not detected in circulation. on the contrary, when mature wt t cells were treated with pi3k d or together with pi3k g selective inhibitors, while th1 cytokines were suppressed th2 cytokines were not augmented in vitro. thus, t cell development, but not peripheral t cell proliferation or cytokine production, requires cooperativity of pi3kg and d. genetic inactivation of these two isoforms leads to the development of severe lymphopenia, skewed type 2 ig and t cell response, and increased susceptibility to eosinophilic multiple organ inflammation; whereas pharmacological inhibition at the adult stage would probably not promote th2 reaction but attenuate th1 medicated disorders. platelet activating factor (paf) is an important mediator in several pathophysiological processes. paf receptor activation can causes a series of cellular and tissue modifications and can lead to the production and/or release of diverse molecules, including cytokines, chemokines and receptors, amongst others, which are capable of amplifying the inflammation. paf can up-regulate kinin b1 receptor expression by various mechanisms. our aim was to investigate the role for kinases in paf-induced kinin b1 receptor up-regulation. wistar rats were treated with paf, or left untreated as controls, 6h before i.d. injection of 0.1ml pbs containing des-arg9-bradykinin (dapk, 100nmol right hind paw) and 0.1ml pbs (for control, left paw). various kinase inhibitors were administered to the rats after paf treatment and oedema was measured by the use of a plethysmometer (ugo basile) 10-120 minutes after dapk-injection. oedema was expressed in ml as difference between right and left paws.additionally paw samples were taken for western blot analysis for total and phosphorylated forms of jnk and erk1/2. dabk-induced paw oedema after pafinjection is significantly inhibited by the selective jnk sp600125 and erk1/2 pd98059 inhibitors. western blot analysis shows that phosphorylation of jnk and erk1/2 is important in the up-regulation of b1 receptors. our results clearly show that the phosphorylation of both erk1/2 and jnk mapkinases is an important step for the in vivo up-regulation of b1 receptors by paf. however, the exact mechanisms (transcriptional and post-transcriptional) by which paf can trigger kinase phosphorylation and then up-regulate the b1 receptor require further investigation. continued interest in development of small molecule inhibitors of p38 mitogen-activated protein (map) kinase is based on the central role this enzyme plays in inflammatory cell signaling. activation of p38 leads to increase production of pro-inflammatory cytokines such as tnf-a and il-1b making it an prominent target for antiinflammatory drug discovery. a virtuell screening approach identified 3-(2-chlorophenyl)-6-((4-methoxyphenoxy)methyl)[1, 2, 4] triazolo [3,4-b] [1, 3, 4] thi adiazole as a potential hit. this was confirmed by synthesis and testing. to explore further sar, a first set of derivates was prepared by cyclization of the 5-substituted-4-amino-3-mercapto-4h-1,2,4-triazoles with carboxylic acids in presence of phosphorus oxychloride. the synthetic strategy used allows both variation at position 3 and 6. synthesis and sar will be presented. cytokines like il-1b and tnfa play central roles in inflammatory diseases like rheumatoid arthritis. production of cytokines in monocytes, macrophages and other cells is triggered by factors such as lps, uv-light, osmotic and cellular stress or physical and chemical attraction. in particular il-1b and tnfa are key regulators as they amplify inflammatory stimuli in cells by induction and upregulation of further cytokines. involved in this signal pathway, p38mapk as a pivotal enzyme is considered to be a validated drug target and therefore, p38mapkinhibitors are of therapeutical interest. in this study, we developed and validated an economic in vivo whole blood assay for optimization and characterization of small molecule p38mapk-inhibitors with promising in vitro activity. the assay procedure involves defined blood cell stimulation by lps and isolation of tnfa or il-1b, which are subsequently quantified by tmb-elisa technique via photometric measurement. the validation of the assay conditions involved well characterized p38mapk inhibitor sb203580 and a highly active compound developed in our lab. a data set was generated by determining 18 whole blood samples consisting of in each case three male and female individuals on three different days. statistical methods were used to analyze specificity, baseline-peak correlations, repeatability, robustness as well as gender specific intra-and interindividual differences. p38 mitogen-activated protein (map) kinase is required for the biosynthesis and release of pro-inflammatory cytokines il-1 and tnf a. inhibition of p38 map kinase could reduce the expression of these cytokines and is therefore a promising target for the treatment of many inflammatory disorders, like rheumatoid arthritis and inflammatory bowel disease. trisubstituted pyridinylimidazoles are potent inhibitors of the p38 map kinase. scope of this work was to investigate 2-thio-ether moiety as a position to link the inhibitors to macrocyclic drug carriers. we synthesised 2-alkylsulfanyl, 4-(4-fluorophenyl), 5-(2-aminopyridin-4-yl) substituted imidazoles as p38 map kinase inhibitors. as substitution at this pyridinyl moiety allows both increase the anti-inflammatory activity as well as selectivity. the synthesis and biological testing of effective the 2-aminopyridin-4-yl imidazoles with low inhibitory concentrations are described. biological data demonstrate both the imidazole derviates and the linked imidazoles lead to highly efficient inhibitors.variation at the 2-thio-ether moietywhich interacts in the phosphate binding region of the enzyme -with polar groups shows no loss of activity. studies underscored the importance of hydrogen bonding with the backbone nh group of met109, for inhibitory activity. less clear is the importance of the hydrogen bond between n3 of the imidazole ring and lys53 of p38 map kinase.to investigate the role of lys53 in interacting with the scaffold we prepared two sets of 4,5diaryl-substituted isoxazoles. these data suggest a dynamic interaction of the core heterocycle with lys53, contrary to the observation on the compound vk-19911 and p38 map kinase, that a nitrogen atom bearing a lone pair in position 3 of the imidazole ring could be necessary to avoid a repulsive interaction with the positively charged side chain of lys53 rather than to form an attractive interaction with p38 map kinase. to complete our study, we focused on the interdependency of biological effects exerted by substitution at the pyridine ring for a series of 3-substituted and unsubstituted 4,5-diarylisoxazoles investigating the interaction with the hydrophobic pocket ii of p38. these data indicate that the isoxazole has better scaffold properties compared with imidazoles, suggesting that heterocycles that are stable as regioisomers, such as isoxazole (in contrast to tautomeric imidazoles), are worthy of further investigations. despite of the intensive research effort, sepsis is still the leading cause of death in critically ill patients. it is a consequence of acute inflammatory response to lipopolysaccharide (lps), a major component of the outer membrane of gram-negative bacteria. natural products are known sources of bioactive components exerting antioxidative and anti-inflammatory effects. in this study, we investigated the effect of ferulaldehyde (fa), a natural compound of red wine, on lps-induced endotoxic shock in mice and on lps-stimulated murine macrophage-like raw 264.7 cells. treatment of c57bl/6 mice with fa significantly attenuated the lps-induced inflammatory response in the gastrointestinal tract, and decreased the level of the two major pro-inflammatory cytokines tnf-a and il-1b in the serum. the serum level of the anti-inflammatory cytokine il-10 was higher in mice treated with fa and lps compared to lps treatment alone. lps-induced phosphorylation and thereby activation of akt, and jnk was also strongly inhibited by fa treatment whereas the phosphorylation level of erk1/ 2 and p38 mapks remained unaltered. activation of nuclear factor-kappab (nf-kb) in liver of fa-treated mice were significantly suppressed. although fa had no effect on the production of inflammatory cytokines, or on inhibition of signal transduction pathways in raw 264.7 cells either, it decreased the lps-induced ros and nitrite production in a dose-dependent manner. our results suggest that fa has antioxidative and anti-inflammatory activities by enhancing antioxidative defense systems, which in turn decrease inflammatory cytokine response and suppress nf-kb activity via the down-regulation of akt and jnk. myeloperoxidase (mpo), stored in the azurophilic granules of the neutrophil granulocyte, is a heme enzyme with the unique property of oxidising chloride ion to the powerful reactant hypochlorous acid in the presence of hydrogen peroxide. therefore, it plays an important role at inflammatory loci in killing invading micro-organisms. on the other hand, hypochlorous acid reacts with a variety of biomolecules as amino acids or membrane lipids and causes therefore host tissue damage resulting in widespread diseases like atherosclerosis or rheumatoid arthritis, e.g. the formation of chloramines from taurine or ammonium ions is one possibility to reduce tissue toxicity while maintaining bactericidal properties. membrane charge alterations during apoptosis provide docking sites for the kationic enzyme myeloperoxidase and this close contact to the membrane lipids opens the possibility for lipid alteration pathways even though these reactions will normally not take place because of their slowness. we investigated alterations in phospholipids after reaction with hypochlorous acid or the myeloperoxidase-hydrogen peroxide-chloride system by matrixassisted laser desorption and ionisation time-of-flight mass spectrometry (maldi tof ms). specific reaction products play an important role in the modulation of the immune response. comparative pathobiology of the disease is also discussed within the context of current human and animal reoviral disease models. objectives: to study the safety and efficacy of infliximab plus leflunomide combination therapy in adult rheumatoid arthritis (ra). methods: twenty patients with active ra received leflunomide 100 mg for 3 days followed by 20 mg daily for 32 weeks. at week 2 all patients started infliximab 3 mg/kg, and received a further four infusions at weeks 4, 8, 16 and 24. results: the commonest adverse event was pruritis associated with an eczematous rash. there was no relationship between the serum concentration of a77 1726, the active metabolite of leflunomide, and adverse events. the mean disease activity score (das28) fell from 7.18 at week 0 to 5.18 (p<0.0001) at week 4 and remained between 3.85 and 4.85 up to week 32. in those patients remaining on treatment, more than 80% achieved an acr20 response from week 8 to week 28, and up to 46% achieved an acr70 response. conclusions: infliximab plus leflunomide combination therapy appears to be highly efficacious in the treatment of adult ra. however, widespread use may be limited by adverse events, which were common and in some cases severe. objective: the transcription factor nuclear factor-kb (nfkb) regulates the expression of proinflammatory cytokines such as tnfa and il-1 those play pivotal roles in pathogenesis in rheumatoid arthritis. parthenolide, a sesquiterpene lactone, was reported to inhibit the dna-binding of nfkb. the objective of this study is to investigate the potential of parathenolid to inhibit the pathogenesis of collagen-induced arthritis. methods: mice were injected i.p. with a cocktail of 4 anticollagentype ii mabs on day 0, followed by i.p. injection of lps on day 3 to induce anti-collagen mab-induced arthritis. the mice were orally administrated with parathenolide (50 mg/kg/day) starting on the day of first immunization (day 0) in prophylactic treatment group and after the onset of arthritis (day 4) in the therapeutic treatment group. clinical disease score, radiographic and histological scores were evaluated. mrna expression of il-1b and tnfa in the affected joints were measured by real-time pcr. results: clinical disease scores were significantly reduced both in prophylactic treatment group (7.4ae3.7) and therapeutic treatment group (7.25ae3.1) compared to untreated group (13.6ae2.7, p = 0.0163 and p = 0.0084 respectively). histological scores of joint destruction were significantly reduced in prophylactic treatment group compared to untreated mice (p<0.05). steady state mrna levels of il-1b and tnfa in isolated joints were significantly decreased in prophylactic treatment group compared to untreated mice (p<0.05). the results in this study suggest that nfkb is an important therapeutic molecular target for treatment of inflammatory arthritis. fibrinogen is a soluble plasma glycoprotein, multifunctional, that participates in haemostasis and has adhesive and inflammatory functions through specific interactions with other cells. the concentration of this glycoprotein increase in inflammatory conditions. a fundamental paradigm involved in the acute inflammatory response is neutrophil migration to the affected tissues to mount an initial innate response to the aggression. the objective of this study is to characterize how fibrinogen modulates the pattern of neutrophil activation. neutrophils from healthy donors were isolated from peripheral venous blood and loaded with the fluorescent probe dihydrorhodamine 123 (1ã¬m) to detect oxygen free radical production. the cells (1,0x 106 cell/ml) were then incubated with a range of concentrations of fibrinogen (0-400mg/dl) for 15 minutes. our results show that posters inflamm. res., supplement 3 (2007) s449 fibrinogen leads to an increase in neutrophil activation as measured by free radical production. this effect becomes evident at borderline-high concentrations (300-400mg/ dl), and in some of the individuals it was possible to differentiate two subpopulations of low-responsive and high responsive neutrophils to activation by fibrinogen. we hypothesize that, in this regard, the concentrations of fibrinogen identified as a risk factor might promote the setting of an inflammatory microenvironment in the circulation and facilitate cardiovascular disease progression. cyclooxygenases (cox-1 and cox-2) are isoenzymes involved in the first steps of the biosynthesis of prostanoids. the constitutively expressed isoform cox-1 is mainly involved in homeostatic processes, while the inducible isoform (cox-2) is associated with inflammatory reactions. various in vitro assays have been developed in order to define the selectivity against cox-1 and cox-2 of nonsteroidal anti-inflammatory drugs (nsaids). however, these in vitro assays can give discordant results related to several parameters. the aim of this study was to optimize and standardize two distinct in vitro methodologies to evaluate new nsaid candidates. first, in an enzymatic cox assay, the arachidonic acid concentration (aa; cox substrate), and the species of cox enzymes tested (ovine vs. human), two factors able to conceal the anti-cox activity of nsaids, have been evaluated and optimized. next, we developed an in vitro cell-based assay using human whole blood depleted from plasma and reconstituted in saline solution. this cell-based assay allows concomitant measurement of anti-cox-1 and anti-cox-2 effects by prostaglandin e2 (pge2) measurement after a23187 (calcimycin) and bacterial lipopolysaccharide (lps) stimulations, respectively. both assays have been calibrated and compared by testing 7 reference nsaids, selective or not for cox-1 or cox-2. fifty % inhibitory concentration (ic50) values against cox-1 and cox-2 and cox-2:cox-1 ratios obtained were in accordance with the previously described nsaid specificity and coherent between both assays (r= 0.93). in conclusion, both in vitro assays are optimized to determine the efficiency and the selectivity of new nsaid candidates against human cox-1 and cox-2. for increasing the success of preclinical drug candidate molecules, there is a need for translatable animal models. the human serum skin chamber technique and the rodent carrageenan induced air pouch model are two wellestablished methods for measuring interstitial inflammation in respective species. we aimed to study the translational aspects of these models. material and methods: in humans, epidermal skin chambers were stimulated with autologous serum for 10 hours. in rats, a dorsal subcutaneous air pouch was stimulated with autologous serum on day 6. the inflammatory response was measured after 4, 8 and 24 hours. the cellular distribution of in vivo transmigrated cells, the expression of cytokine receptors, adhesion molecules and inflammatory mediators was investigated. results: at 8/10 hours the cellular distribution was similar in air pouch and skin chambers. the major population constituted of granulocytes, followed by monocytes/macrophages and lymphocytes. both in human and rats the concentrations of mpo and mcp-1 were increased. furthermore, transmigrated cells displayed a different chemokine receptor pattern. in rats transmigrated cells expressed cd11b, were cd45lo, ssclo and rp-1+ (granulocyte marker). in humans, transmigrated granulocytes expressed cd16 and cd11b. these cells had a significantly higher cd11b expression compared to corresponding cells in peripheral circulation. our results indicate that the serum induced human skin chamber technique and rodent air pouch model translate well to each other. these models may be useful for bridgingpreclinical and clinical drug discovery. furthermore, they may work as translatable proof of mechanism (pom) models for drug candidates targeting different inflammatory components. objectives: to analyse if neopterin (a by-product of activated macrophage metabolism) is elevated in patients with systemic inflammatory insult at the time of ischemic stroke. material and methods: we investigated 86 consecutive patients with mean age 67ae7.8 years who were admitted within 24 h after ischemic stroke. a control group of 37 patients with mean age 58ae4.9 years without ischemic stroke was also tested. measurement of serum neopterin levels were performed using enzyme linked immunosorbent assay. results: patients with acute ischemic stroke had significantly higher serum levels (mean value+sd) of neopterin than those without acute ischemic stroke: 9.6ae1.2 and 7ae0.8 nmol/l. correlation analysis revealed p<0.01. discussion: immune mechanisms contribute to cerebral ischemic injury. the finding of higher serum levels of neopterin, which is regarded as a humoral component of the immune-mediated inflammatory response sustains the hypothesis that patients with ischemic stroke may show higher levels of inflammatory markers like neopterin. our results indicate increased macrophage activation after ischemic stroke. in patients with stroke it has been shown that neopterin was determinant of endothelium-dependent vascular dysfunction. however, these preliminary results need be confirmed by controlled studies. produced a marked (p<0.01) reduction in the number and duration of ventricular tachycardia (vt) during both ischemic and reperfusion phases. the total number of ischemic ventricular ectopic beats (vebs) reduced from 667ffae116 in the control to 66ffae22 at the concentration of 50 ffmg/ml (p<0.001). in the ischemic phase, cynodon dactylon (50 ffmg/ml) also decreased the incidence of vt from 100% (control) to 33%. in addition, incidences of reperfusion-induced vt, total vf and reversible vf duration were significantly lowered by the same concentration (p<0.01 for all). the results show that cynodon dactylon has a protective effect against i/r-induced cardiac arrhythmias in isolated rat hearts. regarding the presence of flavonoid glycosides confirmed during phytochemical screening of the extract and their potential role in the scavenging of oxygen free radicals, it seems that the cardioprotective effects of cynodon dactylon probably is due to its anti-inflammatory properties.key words: cynodon dactylon; arrhythmias; anti-inflammatory; isolated heart; rat objectives: intestinal ischemia-reperfusion (iri) is well known to be associated with distant organ dysfunction; but no evidences to date have focused either the brain or skeletal muscle. we thus decided to investigate the effects of iri on nos and cox isoforms, neutrophil infiltration (mpo), lipoperoxidation (tbars) and protein tyrosine nitration (nt) in different brain areas and diaphragm muscle of wistar rats. methods: iri comprised the occlusion of superior mesenteric artery during 45 min followed by 2 h of reperfusion. sham animals were submitted to the surgical procedure with no interference on the blood flow. results: iri resulted in increased expression of mrna for nnos (cortex) and cox-2 (hypothalamus) associated to a marked reduction of ca2+-dependent nos activity in cortex, hypothalamus and hippocampus (but not in cerebellum). tbars contents were also reduced in cortex and hypothalamus. neither mpo activity nor nt was altered by iri in the brain. diaphragms from animals with iri exhibited increased mpo and ca2+-dependent nos activities, as well as tbars content and nt. in contrast, enos protein expression and both gene and protein nnos expression were reduced. no effects were observed on cox isoforms or enos gene expression. conclusions: these findings suggest that, within the first 2 h of reperfusion following intestinal ischemia, an oxidative response is observed in diaphragm, involving both lipid and protein modifications. in the cns, distinctive susceptibility to the iri seems to occur in the different areas, probably as a defensive strategy aimed to counteract the iri-mediated systemic injury. anne-sofie johansson (1), h qui (2), m wang (2), i vedin (1), jz haeggstrã§m (2), j palmblad (1) ( (1), r carnuccio(2), p romagnoli (3), f rossi (1) (1) second university of naples, italy (2) university of naples, italy (3) university of florence, italy we previously found that several inflammatory markers, e.g., nuclear factor-kb (nf-kb), were increased and a neointima was formed in a model of carotid surgical injury (1) . the purpose of the present study was to determine if chronic treatment with rosiglitazone protects rat carotid artery from surgical injury induced by an incision of the vascular wall. to this aim we measured cox-2, nf-kb, platelet aggregation and neointima formation in rats administered rosiglitazone (10 mg/kg/ die, by gavage) for 7 days before carotid injury and 21 days after injury. control rats received physiological solution. 14 days after injury cox-2 expression, evaluated by western blot, was significantly lower in the treated carotid versus controls (p<0.0001). rosiglitazone also caused a significant decrease of nf-kb/dna binding activity, evaluated by electrophoretic mobility shift assay, in nuclear extracts of treated carotids at all time points considered. platelet aggregation was reduced by 30% in treated versus control carotids (p<0.0005). the influx of inflammatory cells in response to injury, monitored by electron microscopy and immunohistochemistry, was lower in treated than in control carotids starting 7 days after rosiglitazone treatment. the results indicate that rosiglitazone inhibits molecular and cellular inflammatory events induced by vascular injury. the aim of the present study was to investigate the relevance of peripheral macrophage activity for the susceptibility to the induction of experimental allergic encephalomyelitis (eae). rats of eae-susceptible dark agouti and eae-resistant albino oxford strain were immunized with guinea pig spinal cord homogenate (dagpsc and aogpsc), while non-immunized rats served as controls (danim, aonim). on day 15 after immunization rat peritoneal macrophages were tested for adherence capacity, zymosan phagocytosis and respiratory burst. macrophages from aonim rats exhibited lower adherence capacity and higher phagocytosis and h2o2 production then macrophages from danim rats. immunization decreased adherence and phagocytosis and increased h2o2 production in macrophages from ao rats, but did not influence these activities in macrophages from da rats. our results suggest that inflammatory activities of macrophages from ao rats could be considered as regulatory mechanisms connected with the resistance to eae induction ( (1), b sehnert (2), h lanig(2), s pã¤ã�ler(2), r holmdahl (3), h burkhardt (1) (1) johann wolfgang goethe university, frankfurt, germany (2) friedrich-alexander university of erlangen-nuremberg, germany (3) lund university, sweden objectives: the aim of the present study was to characterize the interaction sites between the prototypic arthritogenic murine igg mab ciic1that is highly somatically mutated and its epitope on type ii collagen (cii, aa359-369). methods: the establishment of a dynamic simulation modelling of a ciic1 single-chain fragment (scfv) in complex with the triple helical ciic1 epitope permitted structural insights into immune complex formation. the computer-based data were experimentally tested by mutations of predicted critical residues into alanine in the c1scfvs and the respective ciic1 epitope that were produced as recombinant constructs. the binding affinities of the mutated scfvs were determined by elisa and surface plasmon resonance measurements. the mutation experiments confirmed the predicted interaction sites of cii in the cdr2 and cdr3 regions of both heavy andlight chain. surprinsingly also the model prediction, that the conversion of the c1scfv sequence into the respective germline does not affect cii binding affinity (kd 3x 10-8) could be confirmed experimentally by the mutagenesis of 13(!) positions. our data indicate that potentially harmful cartilage specific humoral autoimmunity is germline encoded. the molecular modeling further demonstrate that the rigid collagen triple helix restricts the likelihood of molecular interactions with the corresponding cdrregions of the antibody considerably compared to globular antigens. these sterical constraints might provide an explanation why somatic mutations have no obvious impact on cii recognition by the arthritogenic autoantibody. moreover, the structural insights into cii-autoantibody interaction might be useful in future developments of collagenomimetic ligands for therapeutic and diagnosistic purposes. we observed a significant association between the mbp-elicited cd4+ t-cell proliferation and active brain lesions, on the one hand, and il-4, il-5 and ifn-gamma, on the other. when grown in the presence of standard serum from a healthy donor, pbmc from healthy individuals responded to mbp with a higher il-10 production than pbmc from ms patients. thus, normal pbmc respond to mbp with production of tnf-alpha, ifn-gamma and il-10, but ms is associated with enhanced tnf-alpha-, ifn-gammaand decreased il-10 responses, and disease activity is associated with mbp-induced proliferation of cd4+ t cells. (1), k goula (1), p georgakopoulos (2) (1) renal unit, st. anrdew hospital, patras, greece (2) intensive care unit, st. anrdew hospital, patras, greece background: urethritis is an infection of the urethra. most cases are sexually transmitted. haemodialysedpeople seem more prone to all kinds of urinary tract infectionsthan others. patients with underlying diabetes are also a specific population at risk. urethritis may be caused by some sexually transmitted diseases (chlamydia, gonorrhea, and ureaplasma urealyticum infections) and by the same organisms that cause urinary tract infections (e. coli or klebsiella). viral causes of urethritis include herpes simplex virus and cytomegalovirus. neisseria gonorrhoeae and c trachomatis account for most cases of urethritis in men (70%). the aim of our study was to determine all cases of urethritis of haemodialysed patients at our unit during the last five years. we also determined diabetes as a coexisting factor in the infected patients. we retrospectively reviewed all cases of urethritis of 72 maintenance haemodialysis patients at our center over the past 5 years. the diagnosis was made according to patients symptoms and signs but also using urine specimens for culture.12 patients (16.6%) from the study group were diabetic. results: 4 cases of urethritis were determined. all infected patients were diabetic. isolated microorganisms were e. coli (2 cases), enterobacter aerogenes (1 case objectives: to explore the ability to use paquinimod as a steroid sparing drug in an animal model for sle. methods: mice were initially treated with a high dose of prednisolone (2 mg/kg/day). thereafter the amount of steroid was reduced to 0.5 mg/kg/day and a low dose of paquinimod (0.2 mg/kg/day) was added. the development of glomerulonephritis was measured as hematuria during the experimental period. serum was collected for analysis of anti-dsdna antibodies. kidneys were collected and histopathological observations were performed. organ weight and lymphocyte sub-populations were assessed in the spleen. results: when treatment with high dose prednisolone was replaced by low dose prednisolone andpaquinimod a steroid sparing effect was seen in a number of variables. a significant reduction in the level of hematuria, in spleen enlargement and in the total number of cd4+, cd8+ and on cd4-cd8-t cells was observed in mice treated with paquinimod and low dose of prednisolone compared to mice treated with high dose prednisolone alone. the development of glomerulonephritis was also significantly reduced in these mice. an almost complete inhibition of anti-dsdna in serum was seen in all treated groups. conclusions: when high dose prednisolone was replaced by low dose prednisolone and paquinimod a steroid sparing effect was seen when a number of variables e.g., hematuria, t-cell sub-populations and development of glomerulonephritis were examined. this setting could be of great importance in future treatment of human sle in order to reduce the steroid dose needed in the treatment of this disease. and la(ssb). the purpose of this study was to screen for novel antibodies against cell surface antigens in primary sjs. proteins (mp) were isolated from cell membranes (hela cells), and were tested with sera from sjs patients or healthy blood donors individually in western blot (wb) at 1:100. mp were separated on 2-d gels and tested in wb (1:100) to locate the appropriate spots for mass spectrometry (ms) analysis. paraformaldehyde fixed hela cells were incubated with sera from patients or blood donors and examined by fluorescence microscopy. antigens were isolated at around 35, 50, 75, 100 kda (64 total positive/79 tested patients). the dominant antigen was at 50 kda. large quantities of endogenous proteins were obtained and the membrane fraction was enriched. one of the main obstacles to further study possible surface antigens as m3 muscarinic receptor was overcome. proteins were separated on 2d-gels and tested in wb to locate the relative spots for ms. the correct localization of the patients antibodies on the cell surface was confirmed by fluorescence microscopy. in conclusion, membrane or membrane-associated antigens were recognised by sera from sjs patients. one of them might correspond to m3 muscarinic receptor. this identification might help in developing a diagnostic assay for sjs. osamu handa, s kokura, k mizuahima, s akagiri, t takagi, y naito, n yoshida, t yoshikawa aim: various additives and preservatives are used in cosmetics, foods and medicines in order to prevent deterioration. however the precise mechanism of cytotoxicity of these additives are not known. in this study, we investigated the effects of ultraviolet-b (uvb) exposure on additives-treated human normal skin keratinocytes (hacat). most popularly used additives in cosmetics such as methylparaben (mp), octandiol (od) and phenoxyethanol (pe) were used. hacat keratinocyte was cultured in mp-containing medium for 24 h, exposed to uvb and further cultured for another 24 h. subsequent cellular viability was evaluated by fluorescent microscopy and flow cytometry using double staining method with hoechst 33342 and propidium iodide or annexin-v. same experiments were done using od and pe respectively instead of mp under same condition. in addition, gene chip analysis was performed in each group. results: uvb exposure enhances cytotoxicity of these additives even at low concentration. gene chip analysis showed that the expression of apoptosis-related genes, oxidative stress-related genes and transcription related genes were significantly upregulated in each group. these results indicate that some additives, which have been considered safe preservatives in cosmetics, may have harmful effects on human skin when exposed to sunlight. these kinases in the pathogenesis of psoriasis. recently, increased focal activation of the downstream target mitogen-and stress-activated protein kinase 1 (msk1) was demonstrated in psoriatic epidermis. the purpose of this study was to investigate msk2 and the transcription factor camp-response-element-binding protein (creb) in psoriatic skin and in cultured normal human keratinocytes. keratome and punch biopsies were taken from patients with plaque-type psoriasis. normal human keratinocytes were cultured and stimulated by interleukin-1㢠(il-1ã�) or anisomycin. some of anti-inflammatory plant flavonoids as a form of whole plant extracts have been used topically for skin inflammatory disorders. on human skin inflammation, matrix metalloproteinase-1 (mmp-1) plays a pivotal role on unbalanced turn-over or rapid breakdown of collagen molecules. in the present study, for establishing a therapeutic potential against skin inflammatory disorders, the effects of natural flavonoids on mmp-1 activity and mmp-1 expression were examined. from the results, the flavonols including quercetin and kaempferol were revealed to be strong inhibitors of human recombinant mmp-1 with the ic50s of 39.6 -43.7 ã¬m, while the flavones such as apigenin and wogonin showed weak inhibition. when the effects of flavonoids on mmp-1 induction were studied, it was found that quercetin, kaempferol, apigenin and wogonin (12.5 -25.0 ã¬m) strongly inhibited mmp-1 induction from tpa-treated human dermal fibroblasts, but naringenin (flavanone) did not. by gel shift assay, these flavonoids were also found to inhibit the activation of the transcription factor, ap-1, whereas naringenin did not. among mapks, quercetin inhibited the extracellular signal-regulated protein kinase (erk) and p38 mapk activation, and kaempferol inhibited the p38 mapk and c-jun n-terminal kinase (jnk) activation. on the contrary, the flavones and naringenin did not inhibit the activation of these three mapks. all these results indicate that the capacity of mmp-1 inhibition and mmp-1 down-regulation of flavonoids may block collagen breakdown in certain pathological conditions and certain flavonoids are useful to treat skin inflammation, especially by topical application. (1) (1) university of valencia, spain (2) istituto di chimica biomolecolare cnr, napoli, italy avarol is a marine sesquiterpenoid hydroquinone with several pharmacological properties including antioxidant, anti-inflammatory, and antipsoriatic effects. recently, its derivative avarol-3-thiosalicylate (ta) also demonstrated interesting perspectives as anti-inflammatory drug in vitro and in vivo.it is interesting to note that avarol and ta inhibited nf-ã�b activation in hacat keratinocytes. now, the effect of avarol and ta was investigated in the tpa-induced hyperplasia murine skin model, which presents some similarities with psoriatic lesions. topical treatment with ta (20 mg/ml) produced a 97 % inhibition of oedema and a strong reduction of pge2 (100 %), ltb4 (100 %) and mpo activity (65 %) in skin homogenates. the inhibitory effect of avarol at the same dose was 79 % for oedema, 90 % for pge2, and 50 % for ltb4 and mpo activity. histological study for both compounds showed a decrease in epidermal hyperplasia as well as leukocyte infiltration respect to tpa treatment. besides, the reduction of cutaneous tnf-a by avarol and ta was also detected by immunohistochemical analysis. these compounds were also capable of suppressing nf-ã�b nuclear translocation in mouse skin. in summary, our results suggest that inhibition of proinflammatory metabolites by ta and avarol might be beneficial for the treatment of the inflammatory component of psoriasis. its mechanism of action is related to the inhibition of nf-ã�b activation and can be mediated by the downregulation of intracellular signal-transduction (1), ams silva(2), cmm santos(2), dcga pinto(2), jas cavaleiro(2), jlfc lima (1) (1) requimte, departamento de quã­mica-fã­sica, faculdade de farmâµcia da universidade do porto, porto, portugal (2) departamento de quã­mica, universidade de aveiro, aveiro, portugal 2-styrylchromones are a novel class of chromones, vinylogues of flavones (2-phenylchromones), which have recently been found in nature. several natural and synthetic chromones have demonstrated to possess biological effects of potential therapeutic applications. however, the anti-inflammatory potential of 2-styrylchromones has not been explored so far. thus, the aim of this work was to evaluate the putative anti-inflammatory properties of several synthetic 2-styrylchromones by studding their influence on different systems that are related to the inflammatory process. the putative inhibitory effects of several 2-styrylchromones on the proinflammatory enzymes cyclooxygenase 1 (cox-1), cyclooxygenase 2 (cox-2) and 5-lipoxygenase (5-lox) was evaluated in vitro and compared with structurally related flavonoids. the capacity of the studied 2-styrylchromones to scavenge reactive oxygen (ros) and nitrogen species (rns) was also assessed by different in vitro assays, which allowed to identify the influence of those compounds in each reactive species, separately. from the tested 2-styrylchromones, those having a catecholic bring where shown to be the most effective scavengers of ros and rns, being, in some cases, more active than flavonoids. no considerable correlation was found between the scavenging profile of these compounds and their interactions with pro-inflammatory enzymes. the results obtained from the present study indicate that some of the tested compounds are promising molecules with potential therapeutic value. the usefulness of 2-styrylchromones in the prevention or control of inflammation can only be clarified with additional studies concerning their influence on other relevant mechanisms of this pathology. the importance of tumor-associated inflammatory cells, able to affect different aspects of neoplastic tissue, is a current matter of debate. primarily monocytes are recruited from the circulation into solid tumors and metastases where they differentiate into macrophages with several phenotypes and, e.g., may significantly contribute to uptake of certain radiotracers. we therefore sought to characterize the uptake of various radiotracers used for positron emission tomography (pet) in a well characterized in vitro model of human monocytes/macrophages in comparison with that in various human tumor cells. uptake of radiotracers 18f-fluorodeoxyglucose (fdg), 3-o-methyl-6-18f-fluoro-l-dopa (omfd), and 18f-labeled native/oxidized low density lipoproteins (nldl, oxldl) in single-or cocultivated human myeloid (monocytic) leukemia cell line thp-1 was compared with that by squamous cell carcinoma (fadu), mamma (mcf-7) and colorectal adenocarcinoma (ht29) cell lines (without or in the presence of specific inhibitiors). several thp-1 phenotypes along the monocytic pathway (monocytes, differentiated macrophages, retrodifferentiated cells) were studied before, during and after incubation with phorbol myristate acetate. differentiated thp-1 cells show, when compared with tumor cells, a comparable fdg accumulation, a considerably lower omfd uptake, and a significantly higher oxldl uptake. on the other hand, during differentiation and retrodifferentiation thp-1 cells obviously establish a distinct sequence of biological processes also reflected by considerable alterations in radiotracer uptake. the observed differences in uptake of several radiotracers in vitro in-between thp-1 phenotypes and between thp-1 phenotypes and tumor cells, respectively, stimulate studies on the contribution of macrophage radiotracer uptake to the overall uptake in neoplastic or inflammatory lesions in vivo. genomic and full-length cdna sequences provide opportunities for understanding human gene expression. determination of the mrna start sites would be the first step in identifying the promoter region, which pivotally regulates transcription of the gene. although the mrna start sites of most genes show heterogeneity, this may reflect physiological, developmental, and pathological states of the particular cells or tissues. recently, we have developed a 5-end sage (5sage) that can be used to globally identify the transcriptional start sites and frequency of individual mrnas. a strong association exists between states of chronic inflammation and cancer, and it is believed that mediators of inflammation may be responsible for this phenomenon. another important factor in tumor development seems to be the epigenetic effects on tumor suppressor genes. because of its ability to suppress tumor cell proliferation, angiogenesis, and inflammation, the epigenetic drug such as histone deacetylase (hdac) inhibitor is currently in clinical trials. however, how epigenetic drugs mediate its effects is poorly understood. to assess the effects of epigenetic drugs, the gene expression by 5sage in colon cancer cell lines treated with epigenetically affecting agents, 5-aza-2deoxycytidine, a potent inhibitor of genomic and promoter-specific dna methylation and trichostatin a, a hdac inhibitor was investigated. epigenetic modification induced not only the change of expression of several inflammation-associated genes and the cell cycle progression-associated genes in human colon cancer cells but also the gene expression with aberrant start sites. colon cancer is one of the most frequently diagnosed cancers in western societies. interleukin-6 (il-6) is a potent, pleiotropic, inflammatory cytokine that contributes to a multitude of physiological and pathophysiological processes. il-6 is produced by many different cell types. the main sources in vivo are stimulated monocytes, fibroblasts, and endothelial cells. a variety of studies have demonstrated that over expression of il-6 contributes to the pathogenesis of various inflammatory diseases as well as cancer. it has been reported that human colorectal cancer cells display a wide heterogeneity in their potential to express and produce il-6. serum levels of il-6 are elevated in patients with colorectal cancer, however serum levels of il-6 were found to be independent of il-6 mrna expression in tumor tissue. in this study we analyzed il-6 mrna expression by real-time pcr in 50 sporadic colon cancer tissue as well as corresponding normal mucous tissue. il-6 mrna expression in tumor tissue was lower than in the corresponding normal mucous tissue (p=0,0074). there was no correlation betweenil-6 mrna expression and tumor grade or stage. thus we can conclude that il-6 produced at the tumor site is not involved in sporadic colon cancer progression. (1), t aiamsa-ard (1), v chinswangwatanakul (2), ki techatraisak (3), s chotewuttakorn (1), a thaworn (1) ( material and methods: huvec were cultured as standard techniques and grown to confluence until use. serum was obtained from cholangiocarcinoma patients and normal healthy subjects. huvec were treated with 10% of serum and incubated for 24 hours. cells were analyzed by using [3h] thymidine and immunoblotting assay for cell proliferation and cox-2/nos-2 protein expression, respectively. results: serum of cca patients trend to have more effect on proliferation of endothelial cell than healthy control subjects. on the protein expression, cca serum significantly increased the expression of cox-2 but not nos-2 in hevec. however, the proliferate effect on endothelial cells by cca sera did not correlate with the expression of cox-2. conclusions: this result suggested that some factors in serum of cancer patients could induce cox-2 protein expression in huvec. the increasing of cox-2 might be one of various factors involve in the proliferation process. aim: superoxide is responsible for the neutrophil-mediated tumoricidal activity. the aim of our work was to monitor the changes of superoxide production from neutrophil attributed to tumor development from the early phase to the advanced stage, and to investigate the effects of ok-432@on neutrophil-derived superoxide production and tumor growth. methods: ah109a rat hepatocellular carcinoma cells were implanted into the hind leg of male donryu rats. pmns were harvested from rat peritoneal cavity 6 h after intraperitoneal injection of oyster glycogen. superoxide production were measured by the method of cladependent chemiluminescence, which has high sensitivity and specificity to superoxide. the counts of peripheral leukocytes were significantly increased during tumor progression, and there are significant difference between that of controls and tumor-bearing rats after 18 days of tumor inoculation. both pma and oz-induced superoxide generation derived from neutrophils became significantly reduced in the advanced stage of cancer. the suppression of neutrophil-derived superoxide generation was accompanied with tumor progression and an increased number of neutrophils in the peripheral blood. the subcutaneous administration of ok-432, a biological response modifier, prevented the suppression of neutrophil-derived superoxide generation during tumor progression, which might induce the tendency of tumor growth suppression. our results suggested that the decreased superoxide generation as well as the high leukocytes concentration in the peripheral blood could be considered as indicators of an advanced stage of cancer. furthermore, the effect of ok-432 on neutrophil-derived superoxide production in cancer-bearing rats may provide pharmacological evidence to the therapeutic effects of ok-432. (1), m jokic (2), v zjacic-rotkvic(1), s kapitanovic (2) (1) university hospital sestre milosrdnice, bucharest, romania (2) division of molecular medicine rudjer boskovic institute, bucharest, romania introduction: il-6 is a pleiotropic cytokine mapped to chromosome 7p21-24. its promoter snp -174 g/c is associated with high serum cytokine production, and according to current investigation can play a role in the development and progression of different gastrointestinal malignancies. we tested its genotypes in the gastrointestinal and pancreatic neuroendocrine tumors (gep-nets). patients and methods: dnas from 80 patients diagnosed with gep-net and 162 age and sex-matched volunteers were analyzed for -174 g/c snp of the il-6 gene. to analyze il6 -174 c/g polymorphism we used pcr -nlaiii rflp method. for statistical analysis ã�2 test and fishers exact test were used. the level of significance was 0.05. results: there were no differences observed in the frequencies of the -174 high expression (gc and gg) genotypes between the patients and healthy volunteers (p=0.5518), as well as between patients with gastrointestinal or pancreatic endocrine tumors (p=0.3762). -174 g/c genotype was statistically more frequent among patients with non-functional pancreatic endocrine tumors (pets) than in those with functional pets (p=0.0246). conclusions: high expression genotypes of il-6 -174 snp are more frequent in non-functional pets and may be a marker for the mentioned malignancies. are important in inflammation, are found around and within a variety of human tumors. their number correlates with tumor vascularity and aggressiveness and is a negative indicator for patient survival. how mast cells influence tumor growth is not well understood. the neuroendocrine peptide, neurotensin (nt) is a potent secretagogue of mc that has tumor-promoting effects in animals and promotes the growth of a variety of human cancer cells, acting via its gpcr nt-type 1 receptor (nts1). here we show that hmc-1 human mc express nt-precursor (pront) mrna and protein, and secrete immunoreactive nt when stimulated. rt-pcr on hmc-1 cell rna yielded a band with 99% sequence identity to pront and a band corresponding to the pront processing enzyme, pc5a.immunocytochemistry on hmc-1 cells showed specific staining for pront. stimulation of hmc-1 cells with a23187 + pma, pge2, c48/80 or mastoparan released immunoreactive nt.rt-pcr on hmc-1 cell rna yielded a band with 99% sequence identity to human nts1. western blotting gave bands corresponding to unglycosylated (49 kda) and glycosylated (55 kda) nts1.immunocytotochemistry on hmc-1 cells showed specific staining for nts1. these finding have significance for the role of mast cells in tumor growth. (1), j buddenkotte (1), mp schã§n(2), m steinhoff (1) (1) university hospital mã¼nster, germany (2) university hospital wã¼rzburg, germany the proteinase-activated receptor par-2 has been demonstrated to modulate tumor growth, invasion and metastasis in various tissues. however, the role of par-2 in cutaneous cancerogenesis is still unknown. here we could show a protective role of par-2 in the development of epidermal skin tumors: we established a mouse skin tumor model using chemically induced carcinogenesis. to this end, par-2-deficient and wild-type mice were painted once with dmba (7,12-dimethylbenz[a]anthracene) for sensibilization, followed by topical application of the phorbol ester pma (phorbol myristate acetate (12-o-tetradecanoylphorbol-13-acetate)) twice per week at the same sites. tumors started to appear after eight weeks. after 13 weeks, par-2-deficient mice showed a significantly increased number of skin tumors (14 per animal on the average) in contrast to the wild-type (eight tumors per mouse). analysis of possible signal transduction pathways activated upon par-2 stimulation in hacat keratinocytes showed an involvement of extracellular signal regulated kinase 1/2 (erk1/2) and profound epidermal growth factor receptor (egfr) transactivation, leading to secretion of the tumor-suppressing factor transforming growth factor-beta 1 (tgf-ã¢1). thus, our results provide the first experimental evidence for a tumor-protective role of par-2. (1), ma arbã³s (1), a fraga (1), i de torres(2), j reventã³s (1), j morote (3) ( pathogenesis of benign prostatic hyperplasia (bph) and prostate cancer (pca) is still unresolved, although chronic inflammation may play a significant role in disease progression. prostate stromal fibroblasts may be contributing to the inflammatory process through the expression and secretion of pro-inflammatory mediators, in particular proteoglycan-bound chemokines and other chemoatractants, and the interaction with inflammatory cells such as monocytes. to better understand molecular mechanisms underlying functional differences among prostate fibroblast populations, our primary objective was to characterize proteoglycan and chemokine gene expression in human fibroblasts of different histological/ pathological origin cultured in normal and monocyteconditioned media. we analysed 20 primary human fibroblast cultures from normal transition zone (tz), normal peripheral zone (pz), benign prostatic hyperplasia (bph), and pathologically confirmed prostate cancer (ca). cells of different origin displayed distinct mrna expression profiles for the core proteins of proteoglycans and both sdf1/cxcr4 and mcp1/ccr2 chemokine axis. when incubated with monocyte-conditioned medium all four cell types significantly changed sdf1/cxcr4 and mcp1/ccr2 expression in a fibroblast population dependent manner. monocyte-fibroblast cell adhesion and the chemotactic response of fibroblasts to human peripheral blood monocytes were investigated in a coculture system. monocytes adhered rapidly to fibroblasts and preferentially to bph and pz cells. in addition, chemotaxis was significantly induced in both fibroblast cultures after incubation with monocytes. our results suggest that prostatic fibroblasts have a key inflammatory role associated to a distinctive proteoglycan gene expression and chemokine induction, which is dependent on their histological and pathological source. supported by the spanish urology society (madrid, spain). we have recently shown that paf-receptor is involved in phagocytosis of apoptotic and necrotic but not viable cells, possibly through its interaction with paf-like molecules present on the surface of these cells. removal of altered cells by macrophages could modify the microenvironment at an inflammatory site, and thus influence tumor growth. in the present study we investigated the impact of apoptotic cells or treatment with paf-r antagonist on ehrlich ascitic tumor (eat, ip) and melanoma b16f10 (sc). paf-r antagonist, web2170 (5mg/kg, ip) was given daily for 6 days. we found that eat growth was significantly reduced by pretreatment with web2170, and that inoculation of apoptotic cells (thymocytes) before tumor implantation stimulated tumor growth, an effect reversed by web2170 pretreatment. eat growth was accompanied by increased production of prostaglandin e2, vegf and no which was reduced significantly by web2170 treatment. in b16f10 melanoma, web2170, alone or in association with an apoptosis inducer chemotherapeutic agent, dacarbazin (dcb, 40 ug/kg,ip) significantly reduced tumor mass volume and the number of intratumoral small vessels. in association with dcb, web-2170 reducedactive caspase-3 expression in the tumor andmarkedly increased the survival of tumor-bearing mice. the data obtained here show that during tumor growth, activation of paf-r by molecules present in the surface of apoptotic/necrotic cells, or by paf produced in the milieu, favors tumor growth and suggests that pafantagonists could be useful in tumor treatment, particularly when in association with chemotherapy. financial suport by fapesp and cnpq. (1), mt quiles (1), a figueras(2), r mangues(2), f vinals(2), jr germa(2), g capella (2) (1) institut de recerca vall de hebron, barcelona, spain (2) translational research laboratory, idibell -institut cataladoncologia, spain the malignant potential of tumor cells may be influenced by the molecular nature of k-ras mutations. we have previously shown that codon 12 mutations associate with an increased resistance to apoptosis. we hypothesized that their different malignant potential in vivo could be also related to the generation of a distinct angiogenic and inflammatory profile including vascular structure, macrophage infiltration and expression of angiogenic modulators, proteolytic mediators and the cxcl12(sdf-1)/ cxcr4 chemokine axis. to do so we have combined in vitro and in vivo studies using stable cys12 and asp13 nih3t3 transfectants. cys12 tumors showed a higher microvessel density associated with shorter latency period. prominent vessels with âµ-smooth muscle actin positives cells surrounded by f4/80 macrophages were only observed in asp13 tumors associated with a shorter growth period. asp13 tumors displayed increased vegf expression both at the rna and protein levels, mainly produced by tumor cells. tsp-1 protein levels were similarly diminished in both transfectants. higher mmp9 and mmp7 activities and expression were observed in asp13 tumors probably produced by macrophages or stromal cells. total and active mmp2 levels were higher in cys12 tumors. the expression of sdf-1 and cxcr4 remained unchanged while sdf-1g isoform was selectively induced in cys12 tumors, suggesting sdf-1a or b are induced in asp13 tumors. these results show distinct k-ras mutations induce specific angiogenic phenotypes. the differential stimulation of vegf expression, metalloprotease activities and sdf-1 expression observed is the result of the joint action of tumor cells and the local microenvironment. contact information: dr maria a arbos via, institut de recerca vall de hebron, unitat de recerca biomedica, barcelona, spain e-mail: maarbos@ir.vhebron.net incisional hernias (ihs) represent a common complication of laparotomies, involving remarkable healthcare costs. representative ih animal models are lacking and characterization of human tissue resources is scant. this limited understanding of fundamental mechanisms regulating the destruction of the abdominal wall currently limits the prevention and treatment of ihs. here, we compared tissue specimens (carefully obtained > 5cm of the defect) and primary fibroblasts cultures from fascia and skeletal muscle of subjects with/without ih hernia. the most prominent morphologic characteristics of ih tissue were: alterations of the microstructure of the connective tissue and loss of extracellular matrix (ecm), and a paucity of fibroblasts. in ih muscles, inflammatory infiltrates were observed. other significant changes were: decreased collagen type i/iii ratio; differential proteoglycans mrna expression; enhanced metalloproteinases/ endogenous inhibitors ratio (mmps/timps); and upregulation of apoptosis effectors (caspase-3 and substrates; tnf-alpha; il-6). in vitro, hernia fibroblasts (ihfs) exhibited significantly higher (2-fold) cellular proliferation and migration rates and decreased strength of adhesion as compared to control fibroblasts, even after several passages. moreover, ihfs ultrastructure analysis revealed accumulation of autophagic vacuoles, autophagolysomes-like structures and multilayered lamellar and fingerprint profiles, as well as mitochondrial swelling. based on these descriptive results in human tissues, a novel hypothesis emerges regarding ih formation. specifically we propose that inflammation-related mechanisms triggering proteolytic and apoptotic effectors regulate cell turnover and eventually contribute to atrophy and progressive tissue insuffiency. overall, this may be causally involved in the mechanisms of ecm destruction yielding ih (supported by fis pi_ 030290 and gencat_agaur_ xt_0417). (1), m spinola(2), c pignatiello(2), w cabrera (1), og ribeiro (1), n starobinas(1), t dragani (2) (1) butantan institute, sao paulo, brazil (2) istituto nazionale tumori, milan, italy airmax and airmin mice are phenotypically selected for maximal or minimal subcutaneous acute inflammatory response, respectively, and display high inter-line differences in protein exudates and neutrophil infiltration, as well as in bone marrow granulopoiesis, inflammatory cytokines, and neutrophil apoptosis. in a combined experiment of urethane-induced lung inflammatory response and lung tumorigenesis, airmin mice developed a persistent subacute lung inflammation and a 40fold higher lung tumor multiplicity than airmax mice, which showed a transient lung inflammatory response. we have analyzed gene expression profiles of these outbred lines in comparison to the lung cancer resistant c57bl/6 and lung cancer susceptible a/j mouse strains. gene expression profile analysis of urethane-treated and untreated animals was performed using the applied biosystems mouse genome survey microarray containing 32,000 mouse transcripts. mrna expression of candidate differentially expressed genes was validated by quantitative real-time pcr and the over-represented biological themes were analyzed with the ease software. urethane treatment modulated the gene expression profile in all four lines. among the confirmed genes, vanin3 (vnn3) and major histocompatibility antigen e alpha (h2-ea) resulted common to both mouse models. the most represented gene categories in air model were acute phase response, immunoresponse, electron and lipid transport, complement activation and tissue repair. mhc/antigen process and presentation and immunoresponse were the major themes in the inbred model. moreover, a gene cluster in chromosome 3 (45.0 cm) was observed. the study suggests that the expression of a subset of genes may show a strain-and line-specific modulation pattern during inflammatory response and lung tumorigenesis. inhibition of tumour induced angiogenesis constitutes very attractive anti-cancer therapeutic approach.it is well established that the vegf signal transduction pathway is one of the key drivers of deregulated angiogenesis and selective inhibition can lead to inhibition of tumour growth. however, multiple angiogenic growth factors and pathways are involved, leading to a phenomenon of redundancy and overcoming of an inhibition of vegf signalling only. we have developed a nanomolar inhibitor (compound a) of the receptor tyrosine kinase vegfr-r2 (kdr), which was subsequently shown to be a potent inhibitor of closely related kinases (vegfr-1 and -3, pdgfr, kit, csf-1r) but also unrelated soluble tyrosine kinases (src-familily of kinases and raf). compound a potently inhibits vegf stimulated endothelial cell proliferation but has no effect on non-ec proliferation, which is suggestive of a selective antiangiogenic potential. the unique kinase inhibitory profile of compound a combined with excellent oral bioavailability (87%) has translated into superior in vivo antiinflamm. res., supplement 3 (2007) posters tumour efficacy when compared to the relatively selective kdr inhibitor ptk787. thus, treatment of nude mice implanted with either commercial atcc derived tumour cells (a431 and du-145) or low passage patient derived tumors (cxf 1103; colon cancer, rxf 631; renal cancer) with compound a resulted in inhibition of tumour growth which was significantly better than for ptk787 treated mice. compound a is fairly well tolerated by rodents and extended toxicological studies have been initiated to determine the therapeutic index, which also may allow for exploration of other non-cancer indications. (1), p bobrowski(2), m shukla (3), t haqqi (3) (1) albany medical college, usa (2) rainforest nutritionals, inc, usa (3) case western reserve university school of medicine, usa background: the amazonian medicinal plant sangre de grado (croton palanostigma) has traditional applications for wound healing and inflammation. we sought to characterize an extract (progrado) in terms of safety, proanthocyanidin profile, antioxidant activity and anabolic/catabolic actions in human cartilage explants. methods: acute oral safety and toxicity was tested in rats according under oecd protocol #420. proanthocyanidin oligomers were quantified by hplc and progrados antioxidant activity assessed by the orac, norac and horac assays. human cartilage explants, obtained from surgical specimens, were treated with il-1b (10 ng/ ml) to induce matrix degradation and glycosaminoglycans (gag) release. progrado (2-10 mg/ml) was tested for its ability to maintain optimal igf-1 transcription and translation in cartilage explants and cultured chondrocytes. results: progrado displayed no evidence of toxicity (2000 mg/kg po) leading to gsh safety rating of 5/unclassifiable. oligomeric proanthocyanidin content was high (158 mg/kg) with the majority of oligomers > 10mers.progrado was a remarkably potent antioxidant and in an ex vivo model of inflammation-induced cartilage breakdown, progrado was exceptionally effective in reducing both basal and il-1b induced glycosaminoglycan release from human cartilage explants. progrado prevented il-1b induced suppression of igf-1 production from human cartilage explants as well as stimulating basal igf-1 production (p<0.05). comparable changes in igf-1 gene expression were noted in cultured human chondrocytes. conclusions: progrado has a promising safety profile, significant chondroprotective and antioxidant actions, and promotes the production of the cartilage repair factor, igf-1. this suggests that progrado may offer therapeutic benefits in joint health, wound healing and inflammation. the solvent extracts from korean fermented soybean (chungkukjang) were evaluated for their protective effects against the generation of free radicals and lipid peroxidation. the activities of chungkukjang were compared with several antioxidants and soybean isoflavones including genistein and daidzein. in addition, the protective effects against h 2 o 2 -induced cytotoxicity and oxidative dna damage in the nih/3t3 fibroblasts line were examined. the extracts from chungkukjang and soy isoflavones inhibited the generation of 1,1-diphenyl-2picryl hydrazine (dpph) radicals, and had an inhibitory effect on ldl oxidation. the extracts from chungkukjang and soy isoflavones strongly inhibited h 2 o 2 -induced dna damage in the presence or absence of endonuclease iii and fpg. furthermore, they showed cytoprotective effects against h 2 o 2 , without cytotoxicity except for the hexane extract at high concentrations (> 450 mg/ml). the ethanol and n-butanol extracts appeared to have most potent antioxidant activities. these in vitro results show that the extracts of chungkukjang may be a useful antigenotoxic antioxidant by scavenging free radicals, inhibiting lipid peroxidation and protecting against oxidative dna damage without having cytotoxic effect. moreover, the extracts of chungkukjang inhibited mda formation in the liver, dna damage assessed by comet assay and the microucleated reticulocyte formation of peripheral blood in kbro 3 -treated mice. these in vivo results were similar to those of in vitro experiments. therefore, chungkukjang containing soy isoflavones is a promising functional food that can prevent oxidative stress. (supported by bk21 project from korea research foundation). sirt1 is a histone deacetylase, involved in oxidative stress and aging. because the role of aging and exercise on sirtuins activity in rats is unknown, we investigated the effects of exercise on age-related changes in the sirt1 activity, comparing heart (h) and adipose (a) tissue of sedentary young (n10), sedentary old (n10) and trained old (n10) rats. the trained old rats performed a 8-weeks moderate training on treadmill. on h and a tissue of all rats sirt1 activity was evaluated by assay kit, peroxidative damage measuring malondialdehyde (mda) and protein-aldehyde adducts 4-hydroxynonenal (4-hne), mnsod, catalase and foxo3a by western blot, and gadd45a, cyclin d2 and foxo3a mrna by rt-pcr. aging reduced sirt1 activity in h (p<0.0001) without effects in a, producing an increase of mda (h, p<0.0005; a, p<0.0001) and 4-hne (h, p<0.005; a, p<0.0005), and a decrease of mn-sod (p<0.02) and catalase (p<0.0001) expression in both h and a. aging did not affect foxo3a protein expression in h, and foxo3a mrna in a. exercise produced an increase in h foxo3a protein expression (p<0.02) and in a foxo3a mrna, associated to higher mn-sod (h, p<0.01; a, p<0.005) and catalase (h, p<0.0001; a, p=0.01) levels in both h and a of aged rats. in heart exercise-induced higher sirt1 activity bring on decrease in cyclin d2 and increase in gadd45a mrna expression. in a we found a similar decrease in cyclin d2, without changes in gadd45a mrna expression. these findings suggest that exercise is able to increase sirt1 activity in aged rats. (1), t horiguchi(1), k abe(2), h inoue(2), t noma (1) (1) institute of health biosciences, the university of tokushima graduate school, tokushima, japan (2) minophagen pharmaceutical co. ltd, japan objectives: glycyrrhizin (gl) is a major component of glycyrrhizae radix (licorice) that is generally used for treatment of hepatitis. gl has a regulatory activity on arachidonic metabolism, immunological function, and anti-viral effects. however, the molecular mechanisms of the effects remain unclear. to analyze the molecular basis of gl signaling, we performed the microarray analysis using ccl4-induced mouse hepatitis models. methods: eight-week-old icr male mice were treated intraperitoneally with 100 fã�l/ kg bw of ccl4 w/wo 250 mg/ kg bw of gl. after 24 hours and 72 hours, livers and serum were collected and analyzed. for microarray analysis, the expression patterns of genes between 72 hour-treated-livers (ccl4 or ccl4 and gl) and no treated-livers were compared. results: gl-treatment dramatically decreased the gpt activity in plasma at 24 hours compared to that in ccl4treated plasma. however, the levels of mrna expression of inflammatory genes such as phospholipase a2, hsp47, and procollagen were still very high in gl-treated liver. after 72 hours, the mrna levels of them were significantly reduced in gl-treated mice compared to those of ccl4-treated liver. then, we screened 41,000 genes by microarray and found that 71 genes were up-regulated and 63 genes were down regulated in ccl4+gl compared to ccl4 treatment. interestingly, ros scavenger-related genes were significantly up-regulated in ccl4 + gl. detail analysis is currently ongoing. we found the unique relationship between gl activity and ros regulation. this finding suggests a novel way to treat inflammatory diseases including hepatitis. objectives: experimental autoimmune encephalomyelitis (eae) is a demyelinating autoimmune disease that results from an immunological reaction against different myelin components at the cns. it is widely employed as an animal model of human multiple sclerosis. interestingly, the number of studies relating these diseases with peripheral organs is limited. we thus investigated the consequences of eae on the degree of lipoperoxidation (tbars) and mpo activity in different rat peripheral organs (eg. lung, spleen, liver, stomach, duodenum, colon, ileum, kidney and bladder). university of waikato, hamilton, new zealand mitochondria play a fundamental role in the life and death of all eukaryotic cells. cells with dysfunctional mitochondria are known to have higher levels of a molecular stress protein (cpn60). this protein is increasingly being implicated to play a role in modulating cellular inflammation. we have developed an in vitro model cell system using thp-1 monocyte cells with compromised mitochondrial bioenergetic functions to investigate the relationships between mitochondrial dysfunction, cpn60 expression and modulation of proinflammatory cytokine responses. we have found that the ability of cpn60 to modulate tnf-a expression was strongly correlated with the loss of mitochondrial bioenergetic functions in our thp-1 cells. we also demonstrate that such modulation involves both erk1/2 and p38mapk pathways. the significance of these results in relation to the role of mitochondria as modulators of inflammation will be discussed. (1), b arnold(2), g opdenakker (3) (1) jagiellonian university, department of evolutionary immunobiology, krakow, poland (2) german cancer research center, department of molecular immunology, heidelberg, germany (3) rega institute for medical research, university of leuven, laboratory of immunobiology, leuven, belgium we showed that in mice genetically deprived of metalloproteinase 9 (mmp-9-/-) at least one compensatory mechanism operates as there are elevated levels of pge2 of cox-1 origin expressed by peritoneal macrophages during zymosan peritonitis; and this leads to increased early vascular permeability observed in those animals. also infiltration of peritoneal cavity by inflammatory neutrophils is changed in mmp-9-/-mice as at 6 hrs of inflammation, when otherwise highest numbers of neutrophils are detected in peritoneum, the cell numbers are significantly lower in the mice in comparison to their controls. in contrary, at 24 hrs of peritonitis, when normally resolution of peritonitis takes place, no decrease in neutrophil counts is observed. thus the aim of the present study was to evaluate if impairment of neutrophil apoptosis could account for this latter phenomenon in mmp-9-/-mice. for this numbers of apoptotic (annexin v) and necrotic (7-aad) peritoneal leukocytes were evaluated and levels of active caspases were tested by application of either caspase detecting antibodies or fluorochrome-labelled inhibitors; all analyses were performed by flow cytometry. the results revealed that both, numbers of apoptotic cells and levels of active caspase 3 were significantly lowered in mmp-9-/-mice while levels of caspase 7, 8 and 9 were significantly elevated in comparison to control animals. we conclude that an impairment of apoptosis is observed in mmp-9-/mice during zymosan peritonitis and it is due to the decreased levels of active caspase 3. the increased activity of other examined caspases is most probably independent of apoptosis. (1), h james (1) the selective inhibition of nitric oxide generation by inhibiting the activity of nitric oxide synthase(nos) isoforms represents a novel therapeutic target for the development of anti-inflammatory agents. the aim of this study was to evaluate the activity of nos inhibitors in experimentally induced inflammation, pain and hyperalgesia. the effect on acute inflammation was studied in carrageenan-induced paw edema in rats. the effects on carrageenan-induced hyperalgesia, tail flick response to radiant heat and acetic acid-induced writhing were also studied. nos inhibitor ng-nitro-l-arginine methylester (l-name), 10 and 20 mg/kg produced a dose-dependent inhibition of paw edema (42% and 57% at 2h; 45% and 57% at 4h). a marked reduction in paw edema was observed with ng-monomethyl-l-arginine acetate (l-nmma), 10 mg/kg(79% at 2h; 91% at 4h). selective inducible nos(inos) inhibitor aminoguanidine hemisulfate inhibited the paw edema at a dose of 20 mg/ kg(59% at 2h; 64% at 4h) but not with a dose of 10 mg/kg . the effects were comparable to nonselective cox inhibitor indomethacin 5 mg and 10 mg/kg (40% and 77% at 2h; 29% and 72% at 4h respectively) and selective cox-2 inhibitor rofecoxib, 5 mg/kg (49% and 78% respectively). nos and inos inhibitors significantly increased the pain threshold latency in the tail-flick test. these inhibited the acetic acid-induced writhes, the effect being comparable to indomethacin. however, carrageenan-induced paw hyperalgesia was not inhibited. the results suggest that nitric oxide plays a role in carrageenan-induced acute inflammation and both nosand inos inhibitors have a potential anti-inflammatoryand anti-nociceptive activity. (1), p hart(2), j edwards (1), c quirk (1) (1) molecular pharmacology limited (usa), australian division, perth, western australia (2) telethon institute for child health research, perth, western australia thermalife cream, an anti-arthritic biological product, has been successfully used off-label for sun burn recovery. a novel product, derived from thermalife, was assessed on its therapeutic potential in oxsoralen-uvb burns. as a possible mechanism for the sunburn efficacy, suppression of tnf-a and il-1㢠production by human monocytes was assessed in vitro. methods: sunburn: four sites were marked on the arm of the subject. three sites were exposed to oxsoralen (1%) plus uva/uvb light, one site was exposed to oxsoralen only. cream was applied at 5min, or at 4hrs after injury. a third injury site was not treated. photographs were taken before, 24hrs, and 7weeks after injury. cytokines: human monocyte cultures (10% fcs, 5% co2) were either stimulated with 500ng/ml lps (e.coli 0111:b4) or not in the presence of 0% or 10% active ingredient.24hrs after incubation, culture media was collected, centrifuged, and assayed (cytokine elisa). results: at 24hrs after oxsoralen-uv, the 5min treatment site showed slight erythema, the 4hr treatment site had pronounced erythema and slight blister formation, whereas the untreated site had pronounced erythema and strong blister formation. 7 weeks after injury, the 5min site was normal, the 4hr site was a dark colour, whereas the untreated site had a significant scar. oxsoralen alone had no effect on the skin. the novel product suppressed lps-induced tnf-a and il1㢠secretion by 48.7% and 71.1%, respectively. conclusions: a novel thermalife-derived product reduced total injury after oxsoralen enhanced uva/ uvb burns, which is possibly related to cytokine suppression. (1), p hart(2), j snowden (1), maud eijkenboom (1) (1) molecular pharmacology limited (usa), australian division,perth, western australia (2) telethon institute for child health research, perth, western australia a mixture of bovine plasma protein fractions and zinc chloride (bov-zn) was assessed for its ability to regulate cytokine production by lps-stimulated monocytes. dosereponse curves for tnf-a suppression were generated. further, competition with fcs in the culture medium and the metabolism of monocytes under influence of bov-zn were assessed. in all experiments the culture medium environment was similar. human monocyte cultures (10% fcs, 5% co2) were either stimulated with 500ng/ml lps (e.coli 0111:b4) or not in the presence of 0%, 2.5%, 5%, 7.5%, 10%, 20% or 40% bov-zn (two pooled experiments). 24 hours after incubation, culture media were collected, centrifuged, and assayed (cytokine elisa). a competitive inhibition design for the standard tnf-a assay was set up for 0%, 1%, 5%, 10% fcs against 0%, 2.5%, 5%, 10% bov-zn. the culture media were treated as above. metabolism of non-proliferating monocytes was measured via accumulation of bioreduced formazan (promega celltiter 96) in treated and untreated cell cultures over 0-45 hrs at intervals. the ic50 for tnf-a suppression was reached at 2.5% bov-zn in each of two experiments. fcs did not compete with bov-zn in suppressing tnf-a in lpsstimulated monocytes. at low fcs concentrations bov-zn stimulated tnf-a production in the absence of lps. this tnf-a increase was countered with increasing concentrations of fcs. metabolism of cells was not affected by 10% bov-zn. conclusions: bov-zn could reliably and effectively reduce tnf-a secretion in vitro, without competing with the fcs in the culture medium, and without disturbing the metabolism of monocytes. inflammatory diseases such as rheumatoid arthritis (ra) result from overproduction of cytokines including tnf-â£\ and il-1fã�. these cytokines are known to be regulated by the stress-activated p38fnfnmap kinase pathway. because of this, inhibition of p38 map kinase has been one of the most compelling targets for the treatment of inflammatory disease. over the last 10 years, numerous groups have reported on the development of p38 map kinase inhibitors. x-ray co-crystallization with the enzyme suggests a propensity to accommodate structurally diverse molecules. regions of the binding site are known to be unique to p38 vs other kinases, enabling the development of p38 selective molecules. inflamm. res., supplement 3 (2007) posters anti-inflammatory activities. a series of 11 labdane-type diterpenoids (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) with various patterns of substitution were tested for potential anti-inflammatory activity.of these compounds, 4 and 11 were selected to evaluate their influence in targets relevant to the regulation of the inflammatory response. these derivatives displayed good in vivo anti-inflammatory activity, and maximum inhibitions of 50 and 90 % were noted in the 12-o-tetradecanoyl-phorbol-13-acetate (tpa)-induced ear oedema in mice. in addition, inhibition of myeloperoxidase activity, an index of cellular infiltration, was also observed. the diterpenoids also reduced the production of nitric oxide, prostaglandin e2, and tumour necrosis factor-alpha in bacterial endotoxin-activated raw 264.7 macrophage cells with ic50 in the range 1-10 mm. inhibition of these inflammatory mediators was related to reductions in the expression of inducible nitric oxide synthase, and cyclooxygenase-2, as determined by western-blot analysis and rt-pcr. since nuclear factor-kappab (nf-kb) plays a central role in the transcriptional regulation of these proteins, we investigated the effects of these diterpenoids on this signalling pathway. our results indicate that both compounds interfere with the phosphorilation of ikbalpha and ikbã�, resulting in inhibition of their degradation. in summary, the anti-inflammatory effects of these labdane diterpenoids are related to the inhibition of inflammatory mediators by blocking nf-kb activation and provide potentially therapeutic perspectives in inflammatory conditions. the aim of the study was a research of mechanisms of inflammatory action of a new drug fepolen at a dosage of 100 mg/kg prepared from bee products (bee pollen and phenolic hydrophobic extract of propolis) for prostatitis treatment. to fulfill above mentioned task a model of zimozan induced oedema whose dynamics gives a possibility to estimate influence of a drug on both routs of arachidonic acid metabolism -via cyclooxiginase and lipooxigenase was used. a comparison with diclofenacum at a dosage of 8 mg/kg and substance ffw-755ã� (inhibitor of cyclooxygenase and lipooxygenase and has a high antiinflammatory effect (41%) at a dosage of 16 mg/kg) was made. the results of influence of drugs dynamics of zimozan inflammation show that anti-inflammatory action of fepolen is based on decrease of release of biogenic amines and activity of lipooxigenase and is higher then effect of diclofenacum. fepolen revealed the highest effect during first 30 min and 1 hour of inflammation that was higher then action of diclofenacum. these data proves that fepolen decreases lipooxygenase activity that is in charge for the inflammation during this period. during next hours therapeutic effects of fepolen and diclofenacum were at the same level. fepolen showed the same dynamics of anti-inflammatory action as ffw-755ã� that demonstrates a property to influence both routs of arachidonic acid metabolism. in summary with previous results in conditions of carageninic inflammation we can conclude that anti-inflammatory action of fepolen is based mostly on influence on lipooxygenase then cyclooxygenase. the aim of this study was to establish a method by which probiotic bacteria can be selected for their immuno modulatory properties, especifically the ability of certain strains to suppress an inflammatory response. the gastrointestinal inflammatory condition crohns disease involves a th1-response with increased levels of proinflammatory cytokines like tnfa and il12, and mouse models of crohns disease show that the balance of il10/12 is crucial for disease progression. we have used mouse bone marrow derived dendritic cells (bmdc) to model a proinflammatory crohns disease like condition in vitro with cocktail-induced bmdc secretion of il12, il6 and tnfaf jthe model was validated using anti-inflammatory molecules like dexamethasone and prostaglandin d2, which were able to suppress the cocktail induced il12 secretion. further validation of the model is confirmed by the fact, that probiotic strains which are able to suppress tnbs induced colitis in mice in preventive studies, also show potent anti-inflammatory activity in our model. among clinically relevant as well as novel probiotic strains, we have selected strains with potent anti-inflammatory properties, and are currently investigating the possible mechanism of action of these strains. in summary, our established model is suitable for identification of anti-inflammatory activity of probiotic strains and potentially other immune suppressing components, for rational selection of candidates for further preclinical and clinical evaluation and development. p11-12 inflammation and human incisional hernia pathophysiology maria antonia arbos via(1) eae was induced by immunization of female lewis rats with guinea-pig myelin basic protein (mbp) in complete freunds adjuvant (cfa) and the animals were studied at the stage iii of the disease (characterized by complete paralysis of the hind-limbs) compared to cfa rats, eae resulted in increased mpo activity (u/mg tissue) in kidney (280 ae 75 vs. 121 ae 14 179 ae 35; p<0.001), and higher tbars contents (nmol mda/mg tissue) in liver acknowledgements: capes, cnpq, fapesp. contact information: ms simone teixeira, university of sâ¼o paulo, department of pharmacology, campinas, brazil e-mail: mone@usp.br tolerability, investigator and subject global assessments and rescue medication consumption supported by bk21 project from korea research foundation) contact information: mr young hoon kim here we report on the development of the pge2 mimetic combination therapy (dp-837953) that inhibits basal and lps/tlr4 induced tnf-?, il-1ã�, and mmp-1, 8, 9, 13 in human and murine synovial membranes and peripheral macrophages.in a murine model of chronic synovitis (dorsal skin air pouch), dp837953 dramatically inhibited il-1ã�, tnf-?, mip2, mcp-2 and il-8 expression, delayed the profile of leukocyte/neutrophil extravasation and reduced exudate volume.in a model of inflammatory arthritis (collagen induced arthritis, cia), dp837953 markedly reversed the inflammatory pathology by reducing synovial hyperplasia, cartilage erosion and articular inflammation.in addition, tnf-?, il-1ã�, mmp-8 and to a lesser extent mmp-9 expression/synthesis levels were strongly suppressed as judged by rt-pcr and elisa measurements we have developed two rias, one for functional blood levels of the above mentioned anti-tnf-alpha constructs, and one for anti-abs (all isotypes), and we have used these methods to monitor patients treated with infliximab/remicade and etanercept/enbrel ; i shall present some of these data (7, 8 anatomy-physiology, faculty of medicine, laval university, quebec, canada neutrophils, which are often the first leukocytes to migrate at inflamed sites, can generate ltb4 from the 5-lipoxygenase pathway, pge2 through the inducible cyclooxygenase (cox-2) pathway and cytokines/chemokines as tnf-alpha, il-1beta, il-8, mip-1alpha, mip-1beta, mip-2alpha and mip-3alpha. engagement of the adenosine a2a receptor (a2ar) blocks the in vitro synthesis of ltb4 while it potentiates the cox-2 pathway in fmlp-treated neutrophils. in addition, it selectively prevents the expression and release of tnfalpha, mip-1alpha, mip-1beta, mip-2alpha and mip-3alpha in toll-like receptor-4-stimulated human neutrophils. little effect was observed on il-1beta and il-8. using the murine air pouch model of inflammation with a2ar-knockout mice, we observed that the activation of a2ar positively impacts the expression of cox-2 in vivo, with particular magnitude in inflammatory leukocytes. in mice lacking the a2a receptor, neutrophils that migrated into the air pouch 4h following lps injection expressed higher mrna levels of tnf-alpha, mip-1alpha and mip-1beta than neutrophils from wild type mice. together, these results indicate that neutrophils are important mediators of adenosines protective effects. given the uncontrolled inflammatory phenotype observed in a2ar-knockout mice and in view of the potent inhibitory actions of pge2 on inflammatory cells, an increased cox-2 expression and a prevented release of tnf-alpha, mip-1alpha and mip-1beta caused by a2ar activation, observed particularly in neutrophils, may take part in an early modulatory mechanism promoting anti-inflammatory activities of adenosine. sepsis induced by endotoxins including lipopolysaccharide (lps) is a big problem in clinical medicine. for a better insight into the molecular pathways and to assess markers of endotoxin-induced sepsis, we applied thetwo dimensional gel electrophoresis (2d-page) and maldi-tof to follow the changes of significant proteins in a murine macrophage cell line -raw 264.7 after challenged with lps (escherichia coli 026:b6) for 12, 18 and 24 hours. we identified 21 proteins from approximately 500 detected protein spots with either increased or decreased in relative abundance as a result of lps treatment. the proteins identified with increased expression are the retinoblastoma binding protein 7, capg protein, poly(rc) binding protein 1, isocitrate dehydrogenase 3 (nad+) alpha, lactate dehydrogenase 1, a chain, guanine nucleotide binding protein (g protein), beta polypeptide 2 like 1, triosephosphate isomerase 1 and proteasome alpha 5 subunit); and ones with decreased expression are the acidic ribosomal phosphoprotein p0, malate dehydrogenase, soluble, proliferating cell nuclear antigen, proteasome (prosome, macropain) subunit, alpha type 1 and rho, gdp dissociation inhibitor (gdi) beta). many of these altered proteins have interesting functions in inflammation. with the information obtained with the proteomic approach, it is possible to improve current methods of monitoring endotoxemia and to identify new therapeutic targets. the ubiquitous mitogen-activated protein (map) kinases are important enzymes in signal-tranduction cascades which regulates diverse cellular events such as cell transformation, proliferation, differentation, and apoptosis. they are therefore potential drug targets for therapeutic intervention in the treatment of inflammation, cancer, and other immune diseases. based on a virtual screening approach we identified 6-amino-1-benzyl-4-(4-bromophenyl)3-methyl-1,4-dihydropyrano[2,3c] pyrazole-5-c arbonitrile as a potential novel lead structure as p38 map kinase inhibitors. a set of compounds were prepared starting from different substituted pyrazol-5(4h)-ones via a base-catalyzed condensation with aldehydes and ch acids, such as malononitrile, to provide them for biological tests in a p38 enzyme assay. first structure-activity relationship confirm the value of this novel lead. this study was conducted to determine the physiological c-reactive protein (crp) and alpha 1-acid glycoprotein (aag) levels for two groups of beagle dogs: healthy dogs of various ages and pregnant dogs. serum crp levels were measured by elisa and aag levels were measured in healthy beagles of various ages by tia, and then separately -in pregnant beagles -by srid. serum crp levels ranged from 1.5 to 16.0 ã¬g/ml in male, and from 1.8 to 18.9 ã¬g/ml in female dogs. no significant sex-related differences were observed in the values. further, there were no significant age-related differences either. serum crp levels increased during pregnancy and peaked at 70.2-90.4 ã¬g/ml 30 or 45 days after ovulation, demonstrating two characteristic features of crp levels change in pregnant dogs. serum aag levels ranged from 40 to 960 ã¬g/ml in male, and from 47 to 833 ã¬g/ml in female dogs, without any significant sex-or age-related variation. serum aag levels increased in all pregnant beagles and peaked in the middle of gestation at 250-1,000 ã¬g/ml. despite a high value of 1,210 -1,360 ã¬g/ml being observed for serum aag levels in 3 pregnant beagles inoculated with staphylococcus aureus, its levels in umbilical cord blood were below the detection limit of srid (40 ã¬g/ml). no significant sex-/-age related differences were observed in serum both crp and aag levels and these levels increased during pregnancy. the results of aag levels in umbilical cords were below the detection levels suggest aag is not transported to the placenta. polymorphonuclear neutrophils (pmns) play a key role in the inflammatory response against infectious agents.however, they can elicit significant tissue damage and in this respect, anti-inflammatory drugs are of interest.in this study, we examined the effect of pbi-1393, a low molecular weight immunomodulatory molecule, on pmn activation by lps both in vitro and in vivo. we measured by elisa the production of tnf-a by human lps-activated pmn in the presence or absence of pbi-1393.the ability of pbi 1393 to modulate pmn activation and recruitment in vivo was assessed using a rat air pouch model of inflammation.exudates from different groups of animals (controls and pbi-1393 treated animals, n=6) were used to assess leukocyte infiltration and to measure by elisa tnf-âµ, mcp-1 and pge2 production.in vitro, pbi-1393 is able to significantly decrease by 28.8% ae 0.08% (p<0.05), tnf-a production by human lpsactivated pmn.in vivo, pbi-1393 significantly decreased the production of tnf-a (41.4% ae 7.2%; p<0.005), mcp-1 (16.3% ae 8.4%; p<0.05) and pge2 (29.2% ae 13.5%; p<0.05) induced by lps injection.however, pbi-1393 did not significantly inhibit leukocyte infiltration.these results show that pbi-1393 is able to modulate pmn activation and inflammatory response and suggest potential use as anti-inflammatory agent. (1), lj lowenstine,(2), aj norris(2), t spangler(2), lm woods (2) (1) zoological society of san diego, usa (2) department of pathology, microbiology, and immunology, university of california, davis, usa this study investigated the role of a novel reovirus in a 2004 outbreak of necrotizing typhlocolitis in american crows in california. included is a detailed characterization of the necrotizing and inflammatory characteristics of the disease, as well as a discussion of the implications of these findings upon proposed mechanisms of pathogenesis. complete histopathology including stains for lesion characterization and potential concurrent etiologic agents was performed on all outbreak crows. feces and ceca were submitted for culture, parasitology, and negative contrast electron microscopy. two control groups (n=10 each) were selected for parasitology and em (group 1), and gross and histopathology (group 2). all outbreak cases and group 2 controls tested negative for west nile virus by pcr.all outbreak crows had marked, necrotizing heterophilic typhlocolitis, fibrinonecrotizing splenitis, and variable intestinal lamina proprial necrosis and hemorrhage.two cases had multifocal hepatic necrosis. negative contrast em revealed reovirus particles in 100 % (4/4) of outbreak cases and in 0% (0/ 10) of controls. supplemental tests failed to suggest other concurrent or confounding etiologic agents.overall, the findings suggest association between the reovirus and the outbreak of typhlocolitis, and the absence of reovirus in controls suggests that it is not ubiquitous in the crow population.there was a noteable absence of similar typhlocolitis in 65 archived crows submitted to the vmth from 1994-2004, suggesting an emerging corvid disease in california, which bears further investigation. mitogen-activated protein kinase (mapks) pathways play an important role in the signalling system activated by proinflammatory cytokines. among the most important cascades the activation of erk1/2 by mek1/2 is reported to be responsible for inflammatory responses and degradation of osteoarthritic cartilage. as701820, a selective mek1 inhibitor, demonstrated anti-inflammatory properties in reducing tnf-alpha production induced by lps injection (ic50 2 mg/kg). therefore, primary aim of the present study was to assess the therapeutic strength of the as701820 in a mouse model of collagen-induced rheumatoid arthritis (cia) assessing the effect of the compound on structural changes related to the cartilage. cia is characterized by severe polyarthritis affecting peripheral joints, synovial hyperplasia with persistent inflammation and cartilage erosion. as701820 treatment was initiated when signs of arthritis were clinically visible (in terms of paw swelling and redness) and was continued for 7 days (twice daily), by oral route at the doses of 10, 30 and 100 mg/kg. as701820 at 30 and 100 mg/kg significantly reduced clinical arthritic read-outs such as clinical score and paw swelling. at histology, vehicle-treated animals showed severe inflammation and joint surface erosion. administration of as701820 significantly decreased inflammatory infiltrates and treated cartilage surfaces that presented normal levels of proteoglycan content. in conclusion, the results obtained in this study clearly demonstrate that the selective blockade of mek1 could be considered as an innovative therapeutic approach to treat rheumatoid arthritis. experimental evidences have shown that the toxicity of ni salts may involve inflammatory processes, with a subsequent overproduction of reactive oxygen species (ros) and carcinogenicity. neutrophils are the most abundant leukocytes of blood, and participate actively in the inflammatory innate host defense response. however, relatively little is known about the potential of nickel salts in activating human neutrophils.thus, the aim of the present study was to evaluate the putative stimulation of oxidative burst in isolated human neutrophils by nickel nitrate. the measurement of neutrophil burst was undertaken in vitro, by chemiluminescence, by monitoring the oxidation of luminol by neutrophil-generated ros and reactive nitrogen species (rns). enzymatic inhibitors and specific reactive species scavengers were used to evaluate which species were involved in neutrophils activation by nickel nitrate. the obtained results showed that nickel nitrate stimulates human neutrophils burst in a concentration-dependent manner, within levels that may be attained in vivo. in the present experimental conditions, the reactive species involved in neutrophils activation by nickel nitrate were superoxide radical (o2-.), hydrogen peroxide (h2o2), hydroxyl radical (ho.) and perchloric acic (hocl). the observed activation of isolated human neutrophils burst by nickel nitrate and subsequent tissue damage due to a sustained formation of reactive species may contribute for the deleterious effects attributed to this transition metal, though this assumption needs to be confirmed in vivo. (1), h spalteholz (1), u reibetanz (1), p salavei (1), m fischlechner (1), h-j glander(2), j arnhold (1) (1) university of leipzig, medical faculty, institute for medical physics and biophysics, germany (2) university of leipzig, derpartment of dermatology, andrology training centre of the european academy of andrology, germany unintentional childlessness often caused by common reasons as inflammation affects 15 -20 % of german couples. inflammations of the male genital tract lead to an infiltration of polymorphonuclear granulocytes (pmn), respectively induce a restricted spermatozoa quality associated with early triggered acrosome reaction (ar) and apoptosis as well as changes in the lipid structure and reduced mobility. stimulated pmn release the strongly cationic heme protein myeloperoxidase (mpo), which is able to bind to negatively charged membrane surfaces, e.g. apoptotic cell membranes with externalized phosphatidylserine (ps). a population of freshly prepared spermatozoa shows only a very small amount of cells with mpo binding ability as well as externalization of ps. the number of spermatozoa able to bind mpo raises considerably in samples containing predamaged cells or introducing the ar as could be observed with rhodamine b isothiocyanate (ritc)labelled mpo and antibody techniques by fluorescence microscopy as well as flowcytometry. the activation ofmpo with its substrate hydrogen peroxide (h2o2) in the presence of chloride ions generates the powerful oxidizing and chlorinating species hypochlorous acid (hocl) and enhanced markedly the number of annexin v positive and non-vital cells. components of seminal plasma as well as serum albumin can protect spermatozoa for the deleterious effects of mpo. the coincidence of ps externalization and mpo binding to spermatozoa surfaces indicates an up to now unknown role of this enzyme in recognition and removal of apoptotic cells during inflammation. recent findings suggest a crucial role of proteinaseactivated receptor-2 (par2) in inflammation and innate immunity. par2 is the second member of a novel g protein-coupled receptor subfamily with seven putative trans-membrane domains. this subfamily is characterized by a unique mechanism of receptor activation. accessible serine proteases cleave the receptor to expose a new, previously cryptic, n-terminal sequence ("tethered ligand") which further interacts with the same receptor and activates it. tryptase, trypsin, and bacterial serine proteases are capable of directly activating par2. par2 is expressed by human neutrophils, however its functions on these cells remained unclear. the data of our present study indicate that par2 agonists enhance interferon gamma (ifna)-induced up-regulation of cell surface fca;ri, one of the key receptors involved in neutrophil phagocytic activity. moreover, par2 agonists (serine proteases as well as synthetic activating peptide) and their receptor represent an additional system which controls neutrophil transendothelial migration and apoptosis in vitro. additionally, there is a significant increase of par2 expression on the neutrophil cell surface in the case of septic patients as compared to cells from healthy volunteers. together, our results indicate that par2 may be involved in the pathophysiology of acute bacteria-induced human diseases (sepsis or septic shock, for example) potentially by regulating neutrophil apoptosis, transendothelial migration and fca-receptor expression. aim: to ascertain the role of macrophages as direct inducers of regeneration after renal ischemia/reperfusion, and to establish whether inflammatory conditions contribute to the process. we determined whether adoptive transfer of macrophages at different stages of kidney inflammation after mouse renal i/r could restore reparation and assessed the influence of inflammation in the process.results: i/r provoked the increases in renal regeneration, as evaluated by inmunohistochemistry and pcr mrna of stathmin and pcna. the cytokine profile revealed the influence of the inflammatory environment on kidney repair. regeneration was macrophage-dependent, decreasing when depletion was provoked, and increasing with adoptive transfer of macrophages; however, administration of resting macrophages did not induce repair at the time points in which tissue was inflamed, and was only able to promote regeneration in the absence of inflammation (72 hours). pro-inflammatory cytokines increased at the early stages of reperfusion, coinciding with low regeneration, and anti-inflammatory cytokines increased during the longer periods of reperfusion when regeneration was more evident.conclusions: macrophages directly induce renal regeneration after ischemia/reperfusion in an inflammationdependent manner. (1), k bendtzen (1), f sellebjerg (2), ch nielsen (3) ( antibodies against myelin basic protein (mbp) are present in sera from patients with multiple sclerosis (ms), but the role of these antibodies is controversial. we collected sera from 22 ms patients and 17 healthy individuals and found that both groups contained igm anti-mbp antibodies, while ms sera contained small amounts of igg anti-mbp. however, the two groups of sera did not differ significantly with respect to the content of either antibody subclass. addition of mbp to the various sera and subsequent addition of the mixtures to normal peripheral blood mononuclear cells (pbmc) resulted in a significant deposition of igm on cd14+ monocytes, indicating that formation of mbp/igm complexes had occurred. this deposition was strongly inhibited by addition of 10 mm edta to the sera, indicating that it was complement dependent. the pbmc produced significant amounts of il-10, tnf-alpha and ifn-gamma upon stimulation with mbp, and the extent of the cytokine production did not depend upon whether sera from ms patients or from healthy controls were present. however, disruption of the tertiary structure of mbp by boiling significantly reduced the production of all three cytokines, supporting a role for antibodies in the induction of cytokine responses to mbp. we propose that natural igm autoantibodies may form complexes with mbp, facilitating the uptake of mbp by antigenpresenting cells (apc). since sera from ms patients did not enhance this uptake and the subsequent cytokine production, the mechanism may be part of an appropriate peripheral regulation of self-reactivity. we currently investigate this possibility. loredana postiglione(1), g tarantino(2), a spanã²(2), p ladogana (1), fl perrone(1), s padula(2), a riccio (2) (1) federico ii university medical school of naples, department of molecular and cellular biology and pathology l.califano, naples, italy (2) federico ii university medical school of naples, departmentof clinical and experimental medicine, naples, italybackground: hepatitis c virus (hcv) infection can induce immunological disorders with different clinical expression such asarthritis, sjogren sindrome and various form of vasculitis.aim: to study the prevalence of anti-cyclic citrullinated peptides antibodies (anti-ccp) in a group of patients affected by hcv-related arthritis and the eventual correlations with rheumatoid factor (rf) and/orantinuclear antibodies (ana), and articular involvement. study design: 30 patients with arthritis were selected in a population of 380 subjects affected by hcv infection. each patients was evaluated by clinical examination (23 denoted poliarticular and 7 mono-oligoarticualr involvement), by x-graphic aspects of joint involvement (8 patients presented join erosions), by ana, rf and anti-ccp positiveness.results: 33,3% of patients presented positivenessfor anti-ccp, without significant correlation between suchparameter and ana, rf and articular involvement. anti ccp resulted positive in 4 out of the 8 patients with joint erosions, and only in 6 out of the 22 patients without joint erosions. such frequency analyzed by chi square ended up in no significant differences. our patients presented an interesting prevalence of the positiveness for anti-ccp. these data suggest a consideration about the specificity, commonly attributed to this parameter in the diagnosis of rheumatoid arthritis. expression of nkg2d on cd4+ t cells is generally rare in both mice and humans, but has been reported in a number of inflammatory diseases, including rheumatoid arthritis, crohns disease and an animal model of type 1 diabetes. the monoclonal antibody cx5 recognizes murine nkg2d and has been shown to block ligandbinding and mediate internalization of nkg2d. furthermore, cx5 can inhibit and/or ameliorate disease in animal models of type 1 diabetes and inflammatory bowel disease. thus, it is very likely that nkg2d plays an important role in the development of inflammatory and autoimmune diseases. since little is known about the pharmacokinetics and pharmacodynamics of the cx5 antibody, we decided to study this in both regular balb/ c mice and immunodeficient cb17.scid mice. different doses of cx5 antibody was injected intraperitoneally and pk and pd was measured by elisa (anti-cx5 elisa in serum) and flow cytometry (down-regulation of nkg2d on cd49b+ nk cells) for up to two weeks after administration. we found that cx5 very efficiently down-regulate nkg2d on cd49b+ nk cells and that the effects of the antibody can be seen for more than two weeks after one single injection. finally, we propose a model which may be helpful in predicting the effects of different doses of cx5 antibody in vivo. (1), k mehta(2), n deo(2), j chaudhary(2), p bobrowski (3) (1) albany medical college, usa (2) vedic lifesciences, usa (3) rainforest nutritionals, inc, us background: the efficacy and safety of reparagen, in treating osteoarthritis was compared to glucosamine sulfate in a mumbai-based multi-center, randomized, double-blind study.methods: subjects (n=95) were screened and randomized to receive glucosamine sulfate (n= 41, 1500 mg/day) or reparagen (n=38, 1800 mg/day), a polyherbal consisting of vincaria (uncaria guianensis) and rni 249 (lepidium meyenii) administered orally, twice daily. primary efficacy variables were womac scores, visual analog score (vas) for pain, and response to treatment defined as a 20% improvement in womac pain, with assessments at 1, 2, 4, 6 and 8 weeks. secondary variables were results: subject randomization was effective and both treatments showed significant benefits in primary outcomes within one week (p<0.05), with a similar, progressive improvement over the course of the 8 week treatment protocol (42-49% reduction in total womac or vas scores). the response rate was substantial for both glucosamine (88%) and reparagen (92%), which exceeded placebo responses (55%, p <0.01) and supported by investigator and subject assessments. tolerability was excellent and safety parameters were unchanged. rescue medication use was significantly lower in the reparagen group (p <0.01), and serum igf-1 levels were unaltered.conclusions: both reparagen and glucosamine sulfate produced substantial improvements osteoarthritis symptoms. response rates were high and the safety profile was excellent, with significantly less rescue medication use with reparagen. we speculate that the high response rate to glucosamine sulfate may reflect higher baseline pain levels or synergy with dietary curcumin. inflammation accompanies and aggravates progression of all modern human chronic pathological conditions. growing evidence indicates the beneficial role of proper nutrition in controlling inflammation. we investigated the effects of selected essential nutrients in experimental inflammation and the molecular mechanisms involved. tested nutrient mixture (nm) consisted of green tea catechins, citrus flavonoids hesperidin, naringenin and quercetin, ascorbate, lysine, proline, arginine and cysteine. systemic inflammation in mice challenged with bacterial lipopolysaccharide (lps) was monitored by blood plasma levels of fourteen key inflammatory cytokines. two week supplementation with 250 mg nm/kg body weight prior to lps challenge provided significantly greater protection than did supplementation with ibuprofen. induction of interleukin-6 (il-6) and monocyte chemoattracting protein-1, two cytokines especially responsive to lps challenge, was reduced in nmsupplemented animals by 58% and 86%, respectively. corresponding reduction in ibuprofen group was 34% and 43%. protective mechanisms involved were assessed in human cultured u937 macrophages stimulated with lps.the cytokines most responsive were tumor necrosis factor alpha (71% and 17% reduction by supplementation with nm and ibuprofen, respectively) and il-12 (66% and 15% in corresponding reduction). nm supplementation dramatically reduced prostaglandin e2 secretion by stimulated macrophages along with cyclooxigenase-2 (cox2) cellular protein expression. mrna levels forcox2 and inflammatory cytokines were also dramatically reduced. quercetin was the most effective nutrient when tested individually. however, nm appeared to surplus the combined effect of individual components. we conclude that the tested combination of essential nutrients demonstrates strong beneficial effects in experimental inflammation by targeting responsible gene expression. (1), hp kim (1), kh son (2) (1) college of pharmacy, kangwon national university, south korea (2) department of food and nutrition, andong university, south korea chalcones belong to flavonoid family from plant origin and some of them possess anti-inflammatory activity. recently, several natural and synthetic chalcones were reported to inhibit inducible nitric oxide synthase (inos)-catalyzed no production in cell cultures. in the present study, to find the optimal chemical structures and to elucidate their action mechanisms, 41 synthetic chalcones having the substituent(s) on a-and b-rings were prepared and their effects on inos-catalyzed no production were evaluated using lps-treated raw 264.7 cells. among the tested compounds, 2-methoxy-3,4-dichlorochalcone (ch15), 2-hydroxy-6-methoxychalcone (ch29), 2-hydroxy-3-bromo-6-methoxychalcone (ch31) and 2-hydroxy-4,6-dimethoxychalcone (ch35) potently inhibited no production (ic 50 s, 7.0 -9.9 mm). the favorable chemical structures were found to be a methoxyl substitution in a-ring at adjacent position (2 or 6) to carbonyl moiety with/without 2-(or 6-)hydroxyl group and 3-halogen substitution in b-ring. when the cellular action mechanisms of ch15, ch31 and ch35 were further examined, it was revealed that ch15 and ch31 clearly down-regulated inos expression while ch35 did not. moreover, ch15 and ch31 were proved to suppress the nuclear transcription factor-kb activation. from the results, it is suggested that certain chalcone derivatives potently inhibit inos-catalyzed no production by the different cellular mechanisms, inos down-regulation or inos inhibition, depending on their chemical structures. these chalcone derivatives may be possibly used as lead compounds for developing new anti-inflammatory agents. an oligomeric stilbene alpha-viniferin (avf) was isolated from root of carex humilis (cyperaceae) as an inhibitor of cyclooxygenase (cox)-2 activity by bioassayguided fractionation. the avf was later found to downregulate lipopolysaccharide (lps)-induced cox-2 expression as well as to inhibit nuclear factor (nf)-kb activation, in addition to its inhibitory effect on cox-2 activity. furthermore, the compound exhibited antiarthritic effect in vivo. avf is a trimer of resveratrol and contains benzofuran moieties in its central part. starting from benzofuran and its related chemicals, 2cyclohexylimino-6-methyl-6,7-dihydro-5h-benzo [1, 3] oxathiol-4-one (lyr-64) was discovered to inhibit lpsinduced nf-kb transcriptional activity in macrophages raw 264.7. the lyr-64 reduced lps-induced dna binding activity and nuclear translocation of nf-kb as well as inhibited lps-induced degradation and phosphorylation of inhibitory kb (ikb) protein. these results suggest that lyr-64 could suppress lps signaling molecule, putatively ikb kinase (ikk) complex, upstream ikb degradation in nf-kb activating pathway. lyr-64 inhibited in vitro kinase activity, gst-ikb phosphorylation, of wild type ikkbeta or a constitutively active ikkbeta mutant (c/a, cys-179 to ala) but did not affect that of another constitutively active ikkbeta mutant (ss/ee, ser-177 and 181 to glu). therefore, lyr-64 could inhibit lps-induced nf-kb activating pathway by targeting ser-177 and/or 181 residues on the activation domain of ikkbeta. as pharmacological actions, lyr-64 prevented nf-kb-dependent expression of inducible nitric oxide synthase, cox-2, or inflammatory cytokines at the transcription level in lps-stimulated macrophages raw 264.7. furthermore, lyr-64 protected lpsinduced septic shock in vivo. faculty of medicine, institute of pharmacology, ljubljana, slovenia a part of anti-inflammatory action of antidepressants can arise from their effect on histamine elimination from the side of inflammation. in mammals histamine is mainly degraded by two enzymes: histamine-n-methyltransferase (hnmt) and diamine oxidase (dao). the aim of present investigation is to establish whether antidepressants amitriptyline and sertraline can affect histamine metabolism. their effects on enzyme activity and mrna expression were studied in guinea pig tissues. plasma and tissue homogenates were incubated with saline (control) and different antidepressant concentrations. specific enzymatic activities of dao and hnmt were determined by radiometric assay. in addition, guinea pigs were treated with saline or amitriptyline (4 mg/kg, ip), afterwards dao and hnmt mrnas were detected by pcr in different tissues. results showed thatamitriptyline, 100 nm, 50, 100 and 500 mm, increased guinea pig plasma dao activity by 5, 7, 17 and 11 %, respectively, while sertraline increased it at 30 mm (by 15 %). at higher concentrations (100 and 500 mm) sertraline decreased dao activity. in the guinea pig tissues hnmt activity changes were found only when incubated with amitriptyline; sertraline had no effect. at 10 and 50 nm amitriptyline the activity of hnmt increased by 20 and 9 %, respectively. in animals treated with amitriptyline an induction of dao and hnmt mrna expression was noticed in several tissues. our results suggest that in guinea pigs due to higher histamine metabolism antiinflammatory effects can be expected at lower concentrations of antidepressants. the effect might be the opposite with higher amitriptyline concentrations. steven hefeneider(1,2), c macarthur (1), d trune (1), s mccoy (2) (1) oregon health and science university, portland, oregon, usa (2) targeted gene delivery, inc., portland, oregon, usa engagement of toll-like receptors (tlrs) by bacterial components such as lps and dna initiates inflammation.the current study examines a novel anti-inflammatory peptide, termed p13, for treatment of inflammation induced by either lps or bacteria.peptide p13 was derived from an immunoregulatory protein of vaccinia virus, and interferes with tlr signaling.in this study we examined the efficacy of p13 to limit inflammation in a mouse model of sepsis and a model of middle ear inflammation, termed acute otitis media (aom).we demonstrate in the sepsis model, that in vivo treatment of mice with p13 inhibited lps-induced production of serum inflammatory mediators.moreover, p13 treatment, administered after initiation of inflammation, significantly increased survival of mice injected with lps.in the aom model, peptide p13 significantly reduced in vivo middle ear inflammation and fluid accumulation initiated by h. influenza.assessment of route of administration and delayed treatment studies demonstrated the efficacy of peptide p13.simultaneous injection of bacteria and peptide p13 resulted in a significant reduction in fluid accumulation, infiltrating cells, and tympanic membrane thickness.fluid accumulation within the eustachian tubes was also significantly reduced following p13 treatment.-subcutaneous and oral administrations of p13, but not intravenous administration, were also efficacious in reducing inflammation. administration of p13 after initiation of an ongoing inflammatory response was effective at reducing inflammation and fluid development.taken together, these results demonstrate the therapeutic potential of peptide p13 to limit an inflammatory response and suggest a possible new treatment strategy for bacterial-induced inflammation. (1), c zhou(2), y zhang(2), m sun(2), x wan (1), h yu(2), x yang(2), rd ye (3), j-k shen (1) formyl peptide receptor-like 1 (fprl1) is a structural homologue of fpr, which binds chemotactic peptides of as small as 3 amino acids (e.g., fmet-leu-phe, fmlf) and activates potent bactericidal functions in neutrophils. in comparison, fprl1 ligands include peptides of 6-104 amino acids, such as trp-lys-tyr-met-val-[d]met (wkymvm) and other synthetic peptides. to determine the core peptide sequence required for fprl1 activation, we prepared various analogues based on wkymvm and evaluated their bioactivities in an fprl1-transfected cell line. although substitution of d-met6 resulted in loss of activity, removal of val5 together with d-met6 produced a peptide that retained most of the bioactivities of the parent peptide. the resulting peptide, wkym, represents a core structure for an fprl1 ligand. further substitution of lys2 with nle slightly improved the potency of the tetrapeptide, which becomes a dual agonist for both fprl1 and fpr. based on these structure-activity studies, we propose a model in which the modified tetrapeptide trp-nle-tyr-met (wnleym) binds to fprl1 through aromatic interactions involving the side chains of trp1 and tyr3, hydrophobic interaction of nle2, and the thio-based hydrogen bonding of met4, with the respective residues in fprl1 which have not been identified. the identification of the core sequence of a potent peptide agonist provides a structural basis for future design of peptidomimetics as potential therapeutic agents for fprl1-related disorders.there is a growing awareness of the interaction of food constituents with the immune system. the present study aims to evaluate immunomodulatory effects of two of these nutritional components, i.e. glycine and lactoferrin. mice orally supplemented with glycine, lactoferrin or a combination were injected intradermal (in the ear) with zymosan. ear swelling, as a measure for inflammation, as well as il-1, tnf-a and il-6 levels in the ear and the number of tnf-a producing spleen cells were analyzed.-glycine and lactoferrin were able to decrease the zymosan induced inflammatory response locally (decreased ear swelling and pro-inflammatory cytokine levels) as well as systemically (reduced number of tnf-a producing spleen cells).glycine effects (20, 50 and 100 mg/mouse/day) were concentration dependent whereas for lactoferrin only the lowest doses (0.1 and 1 mg/mouse/ day) inhibited the inflammatory response significantly. surprisingly higher doses of lactoferrin (5 and 25 mg/ mouse/day) failed to influence the inflammatory reaction. a combination of both nutrients (lactoferrin 0.1mg/ mouse/day in combination with glycine 20 or 50 mg/ mouse/day) inhibited the zymosan induced ear swelling synergistically. additionally an additive effect of both components was seen on the number of tnf-a producing spleen cells. the present data show anti-inflammatory activity of glycine and lactoferrin using the zymosan induced inflammation model.moreover a combination of both components demonstrated a synergistic effect on inflammation of the skin and an additive effect on the number of tnf-a producing spleen cells. (1), p sambrook(1), k fukudome(2), m xue (1) (1) university of sydney, st leonards, nsw, australia (2) saga medical school, saga, japan objectives: to investigate the i) expression of endothelial protein c receptor (epcr) in synovial membrane and peripheral blood monocytes from patients with rheumatoid arthritis (ra) and osteoarthritis (oa) and ii) role of epcr and its ligand, activated protein c (apc), on the function of monocytes from ra patients.methods: epcr, cd68 and pc/apc in synovial tissues were detected by immunostaining and in situ pcr. monocytes were isolated from peripheral blood of patients with ra and treated with apc, lipopolysaccharide (lps), and/or epcr blocking antibody, rcr252. cells and supernatants were collected to analyze the expression/activation of epcr, nuclear factor nf-kb and tumour necrosis factor tnf-a.results: epcr was expressed by both oa and ra synovial tissues but was markedly increased in ra synovium. epcr was colocalized with pc/apc mostly on cd68 positive cells in synovium. in ra monocytes, apc upregulated epcr expression reduced monocyte chemoattractant protein-1-induced chemotaxis of monocytes by approximately 50%. apc also completely suppressed lps-stimulated nf-kb activation and attenuated tnf-a protein by more than 40% in ra monocytes. the inhibitory effects of apc were reversed by rcr252, indicating that epcr modulates the inhibitory effects of apc.conclusions: our results demonstrate for the first time that epcr is expressed by synovial tissues, particularly in ra, where it co-localizes with pc/apc on monocytes/ macrophages. in addition, apc inhibits the migration and activation of ra monocytes via epcr. these inhibitory effects on ra monocytes suggest that pc pathway may have a beneficial therapeutic effect in ra. key: cord-004879-pgyzluwp authors: nan title: programmed cell death date: 1994 journal: experientia doi: 10.1007/bf02033112 sha: doc_id: 4879 cord_uid: pgyzluwp nan it is widely held that all developmental cell death is of a single type (apoptosis) and that neuronal death is primarily for adjusting the number of neurons in a population to the size of their target field through competition between equals for target-derived factors. we shall draw on our research and on that of others to criticize these views and replace them by the following. at least three types of neuronal death occur, only one of which resembles apoptosis; a neuron can choose between several self-destruct mechanisms depending on the cause of its death. the purpose of the death is to regulate connectivity, not neuron number. competitors for trophic factors are unequal, and many losers have made axonal targeting errors. a neuron's survival and differentiation depend on multiple anterograde and retrograde signals. activity affects retrograde signals and some but not all anterograde ones. the pattern of activity is more important than the overall amount. in rodents, the period of naturally occuring cell death of motoneurons is followed by a period of supersensitivity to axonal injury. thus, in newborn rodents lesion of the facial nerve leads to a rapid degeneration of the injured motoneurons. we have tested whether overexpression, in rive, of the bcl-2 proto-oncogene was capable of preventing death of axotomized motoneurons. to address this question we used transgenic mice whose motoneurons overexpress the bcl-2 protein. one of the two facial nerves of newborn mice was transected on the 2nd-3rd post-natal day. seven days after the lesion, the morphology of the facial nuclei was analyzed. in control mice, and when compared to the intact nucleus, 70 to 80 % of axotomized motoneurons had disappeared. in contrast, in the transgenic animals, the number of motoneurons on the lesioned side remained unchanged when compared to the eontralateral nucleus. furthermore, their axons remained visible up to the distal lesion site. these experiments show that, in rive, motoneurons overexpressing the bcl-2 protein survive after axotomy, and suggest that, in rive, bcl-2 protect neurons from experimentally induced cell death and could be a target for treatment of motoneurons degenerative diseases. messmer s., mattenberger l., sager y., blatter-garin m-c., pometta d., kate a., james r.w. drpt de mrdeeine, drpt. de pharmacologie, div. de neurophysiologie clinique, facult6 de mrdecine, gen~ve. clusterin is a widely expressed glycoprotein, highly conserved across species. numerous functions have been postulated for this protein. the most important are roles in lipid transport, as elusterin is associated with apolipoprotein ai in hdl, complement regulation and tissue remodelling, in particular during cell death and differentiation. using cultures of rat spinal cord neurones (90% neurons and 5-10% non-neuronal cells), we have studied the expression of clusterin and ape e in glutamate-induced neuronal cell death to examine potential roles in lipid management. up-regulation of the two proteins was observed. clusterin and ape e appear in the conditioned medium respectively 15h and 7.5h after incubation with glutamate. control studies, in the presence of a noncompetitive nmda receptor agonist showed the secretion of clusterin and ape e to be diminished by >60%. no up-regulation of either protein was observed in complementary studies with exclusively non-neuronal cell cultures. the cellular origin of the 2 secreted proteins is presently under investigation. programmed cell death and tissue remodelling are consequences of hormonally induced restructuring of the rat ventral prostate after castration and the rat mammary gland after weaning. we used the "differential display"-method (liang and pardee, 1992, science 257:967) to detect and isolate edna fragments whose corresponding rnas are regulated either coincidentally, or in an organ specific fashion during mammary gland involution and postcastrational prostate regression. partial sequencing of 12 clones revealed high, but not absolute homology of 5 fragments with sequences, previously characterized in different biological contexts. these five encode functions which could be anticipated to be important for cell growth and/or programmed cell death, we are presently investigating the functions of several of these transcripts in cell culture and in rive. antisense oligos are being employed in vivo to determine whether these genes contribute to the phenotype of programmed cell death. b epitopes derived from the envelope gp52 glycoprotein (ep3) or from the viral superantigen of mmtv have been incorporated into inert or live vaccines. the inert vaccine consists of purified chimeric proteins which contain the b epitopes alone or fused to multimeric promiscuous t helper epitopes from tetanus toxin. mice were immunized subcutaneously with these chimeric proteins. the live vaccine consists of an avirulent strain of salmonella typhimurium which expresses the mmtv epitopes in the form of chimeric proteins fused to the nucleocapsid protein of hepatitis b virus. this vaccine is given to mice in one oral dose. the level, duration and isotype of the immune response generated by each vaccine have been measured and compared. the level of protection has been investigated by systemically challenging immunized mice with the relzovims. a reduced binding of oxytocin (ot) occurs with aging in some, but not all, areas of the rat brain (arsenijevic et al., experientia 1993, 49, a75) . the candate putamen showed the most impressive loss of ot receptors. two other regions, the hypothalamic ventromedial nucleus (vmh) and the islands of caueja (icj) had also an important deficit of ot binding sites. on the other hand, these two regions were known to be sensitive to sex steroids. in the present work, we treated from 20 month old rats during one month with testosterone propionate (2 #g/kg s.c., once every 3 days) dissolved in oil. three rats of the same age injected with oil only served as controls. we labelled ot receptors throughout the brain of old rats using a 125i-labelled ligand specific for ot receptors. analysis of autoradiograms by an image analyzer revealed that the testosterone treatment increased ot binding sites in the vmh, in the icj, and, to a lesser extent, in the bed nucleus of the stria terminalis, a region also sensitive to sex steroids, by contrast, in the caudate putamen, the disappearance of ot receptors was not compensated. in conclusion, the decrease of ot receptors occurring in vmh and icj with aging can be reversed by administration of gonadal steroids. in contrast, the loss of ot receptors in the striatum appears to depend on another mecanism. vasopressin (avp) receptors are expressed transiently in the facial nucleus during development (tribollet et el., 1991, dev. brain res., 58, 13-24) . avp may therefore play a role in the maturation of neuromuscular connexions in the neonate rat, and possibly in the restanration of these connexions after nerve lesion in the adult. in order to investigate the latter proposition, we have sectionned the facial nerve in adult rats and used quantitative autoradiography to look at avp binding sites in the facial nucleus at various postoperative times. we observed a massive and transient increase of avp binding sites on the operated side. the number of facial avp binding sites reaches a maximum about one week after nerve section, remains stable during 2-3 weeks, then begin to decrease towards control level. the induction of avp receptors is markedly delayed if the proximal stump of the nerve is ligated. to assess whether other motor nuclei would also react to axotomy by up-regulating the expression of avp receptors, we have sectionned the hypoglossal nerve and the sciatic nerve. in both cases, the binding of avp receptor ligand increases massively in the respective motor nuclei, with a time-course similar to that found in the facial nucleus. altogether, our data suggest that central avp could be involved in the process of nerve regeneration. cytotoxic t-cell mediated apoptosis schaerer,e, karapetian,o.,adrian,m. and tschopp,j. inst.de biochimie, univ.de lausanne, 1066 epalinges. an apoptotic cell death mechanism is used by cytolytic t cells (ctl) to lyse appropriate target cells. ctl harbor cytoplasmic storage compartments, containing the lytic protein perforin and serineproteases (granzymes), whose content is released upon target cell interaction. we show that these granules are multivesieular bodies and that degranulation releases these intragranular vesicles (igv) having granzymes, t-cell receptor and yet undefined proteins associated. isolated igvs and perforin induce dna breakdown in target cells within 20 minutes. microscopic analysis demonstrates that igv specifically interact with target cell via the t-cell receptor and that their contents is taken up by the target cell. already 15 min. after interaction, 3 distinct igv proteins are found in the nucleus of the target cell.one of the molecules has been identified to be granzyme a, previously reported to be involved in apoptosis. we propose that lymphocytes transfer apoptosisinducing proteins to the nucleus of the target cells using vesicles as vehicles for delivery. cytotoxic t cells kill their targets by a mechanism involving membranolysis and dna degradation (apoptosis). recently, two sets of proteins have been proposed as dna breakdown-inducing molecules in t cells: granzyme a, b and tia-i. in this study, we cloned and further characterized the tia-i mouse homologue. aa sequence comparison with the human tia-1 showed an overall identity of 93%. devoid of a signal peptide, tia is yet localized to cytotoxic granules, probably targeted via a gly-tyr-motif. as tia-i, its mouse homolcgue contains three rnabinding domains. expression of tia during development shows a very strong signal in the brain and weaker signals in thymus, heart and other organs. during embryonic development several structures that contribute to organogenesis form transiently and are later eliminated by apoptosis. this pattern of tia expression could indicate its involvement in apoptosis. prostate involution occurs after castration in rats and is associated with the death by apoptosis of a large fraction of the epithelial cells. we have isolated several genes from a prostate involution bacteriophage lambda library using differential screening methods. among these clones, one d~monstrated an especially strong signal when used as a probe against northern blots of prostate mlhna obtained before, and at different times after castration. this gene is down-regulated after castration by 40-fold within 5 days. intramuscular injection of a testosterone depot resulted in complete restoration of expression within 24 hours. upon sequencing it became apparent that this clone has a high degree of homology to a known ndah dehydrogenase encoded in mitochondrial dna. the clone failed to hybridize to any transcripts from rat organs other than prostate. we are now in the process of isolating the htm~n hc~olog to this gene for use as a biomarker in study of benign hyperplasia and developing carcinoma. this gene is a possible indicator for testosterone-independent cell populations or of cells lacking ftl~ctional testosterone receptor. during the first three postnatal weeks the rat lung undergoes the last two developmental stages, the phase of alveolarization and the phase of microvascular maturation. the latter involves a decrease of the connective tissue mass in the alveolar septa and a merging of the two capillary layers to a single one. speculating that programmed cell death may play a role during this remodeling, we searched for the presence of apoptotie cells in rat lungs between days 10 and 24. lung paraffin sections were treated with y-terminal transferase, digoxigenin-dutp, and anti-digoxigeninfluorescein-f(ab)-fragments, and the number of fluorescent nuclei was compared between sections at different days. while the number of apoptotie ceils was low until the end of the second week and at day 24, we observed an about eight fold increase of fluorescent nuclei towards the end of the third week. we conclude that programmed cell death is involved in the structural maturation of the lung. brunner, a., wallrapp, ch., pollack, i, twardzik, t. and schneuwly, s. lehrstuhl genetik, biozentrum universit~t w~rzburg, mutants in the giant lens (g/l) gene show a strong disturbance in ommatidial development. in the absence of any gene product, additional phetoreceptors, cone cells and pigment cells develop. opposite effects can be seen in flies in which the gene product of the giant lens gene can be ectopically expressed by heat shock. a second very typical phenotype is the disturbance of photoreceptor axon guidance. molecular analysis of gil shows that it encodes a secreted protein of 444aa containing three evolutionary conserved cystein-motives very similar to egf-like repeats. we propose that gil functions as a secreted signal, most likely a lateral inhibitor for the development of specific cell fates and that gil, either directly or indirectly, is involved in targeting photoreceptor axons into the brain. the decrease in cellularity during scar establishment is mediated through apoptosis desmouliere, a., redard, m., darby, i., and g. gabbiani department of pathology, cmu, 1 rue michel server, 1211 gen~ve 4 dudng the healing of an open wound, granulation tissue formation is characterized by replication and accumulation of fibroblastic cells, many of which acquire morphological and biochemical features of smooth muscle cells and have been named myofibroblasts (sch0rch et el., histology for pathologists, t992). as the wound evolves into a scar, there is an important decrease in ceuuladty, including disappearance of myofibroblasts. the question adses as to which process is responsible for myofibroblast disappearance. during a previous investigation on the expression of (z-smooth muscle actin in myofibroblasts, we have obsewed that in late phases of wound healing, many of myofibroblasts show signs of apoptosis end suggested that this type of cell death is responsible for the disappearance of myofibroblasts (darby et al., lab. invest. 63:21, 1990) . we have tested this hypothesis by means of electron microscopy and morphometry and by in situ end-labeling of fragmented dna (wijsman et al., j. histochem. cytochem. 41:7, t 993) . our results show that the number of apoptotic cells increases as the wound closes and suggest that this may be the mechanism for the disappearance of myofibroblasts as well as for the evolution of granulation tissue into a scar. (supported by the swiss national science foundation, grant n~ s01-16 r. jaggl, a. marti and b. jehn. universit~t bern, akef, tiefenaustr. 120, 3004 bern at weaning the mammary gland undergoes a reductive remodelling process (involution) which is associated with the cessation of milk protein gene expression and apoptosis of milk-produclng epithelial cells. this process can be reversed by returning the pups to the mother within 1 day. elevated nuclear protein kinase a (pka) activity was observed from one day post-lactation, paralleled by increased c-los, junb, ]und and to a lesser extent c-]un mrna levels. ap-1 dna binding activity was transiently induced and the ap-1 complex was shown to consist principally of cfos/jund. oct-1 dna binding activity and oct-1 protein were gradually lost from the gland over the first four days of involution, whereas oct-1 m_rna levels remained unchanged. comparing nuclear extracts from normal mammary glands with nuclear extracts from glands which had been cleared of all epithelial cells three weeks after birth revealed that pka activation, ap-1 induction and oct-1 inactivation are all dependent on the presence of the epithelial compartment. the increased fos/jtm expression and the inactivation of oct-1 may be consequences of the increased pka activity. when involution is reversed, both, pica activity and ap-1 dna binding activity (and fos andjun mrna levels) are reduced to basal levels. our data suggests a role for pka and ap-1 on progranlmed cell death of manlnmry epithelial ceils. bcl-2~ does not require membrane attachment for its survival activity c. borner*, i. martinout, c. mattmann*, m. irmler*, e. sch&rrer*, j.-c. martinou-j-, and j. tschopp*. * institute of biochemistry, university of lausanne, 1066 epalinges, 1 institute of molecular biology, glaxo inc.,1228 plan los ouates. 8cl-2(z is a mitochondrial or perinuclear-associated oncoprotein that prolongs the life span of a variety of cell types by interfering with programmed cell death. how it exerts this activity is unknown but it is believed that membrane attachment is required. to identify critical regions in bcl-2o~ for subcellular localization and survival activity, we created by site-directed mutagenesis, various mutations in regions which are most conserved between the different bcl-2 species. we show here that membrane attachment is not required for the survival activity of bcl-2o< a truncation mutant of bcl-2(z lacking the last 33 amino acids (t3) including the hydrophobic domain is soluble, yet fully active in blocking apoptosis of sympathetic neurons induced by ngf deprivation or l929 fibroblasts induced by tnfc~ treatment. we further provide evidence for a putative functional region in bcl-2 which lies in the conserved domains 4 and 5 upstream of the hydrophobic cooh terminal tail. the breakdown of nuclear dna is considered to be a hallmark of apoptosis. we previously identified the perinuclear membrane localized dnase i as the endonuclease involved in the formation of oligonucleosomal-sized fragments (dna ladder). it is not clear how the nuclease is activated and has access to the dna. we show that in thymocytes induced to undergo apoptosis, lamin breakdown preceded dna laddering. by transfeeting hela cells with a constitutively active cdc2 mutant, nuclear envelope breakdown and typical apoptotic features (ehromatin condensation) were observed. moreover, co-transfection with cdc2 mutant and dnase i led to dna degradation. we propose that apoptosis can be induced by wrongly timed and hence abortive mitosis leading to uncontrolled nuclear membrane disintegration. s02-01 s02-04 platelet-derived growth factor (pdgf) is thought to play an active role in fibrosing diseases. bronchiolitis obliterans-organizing pneumonia (boop) is a condition characterized by intraluminal proliferation of connective tissue inside distal air spaces. to evaluate pdgf expression in boop we performed immunohistoehemistry on lung biopsies from 20 patients and 10 controls free of fibrosis. sedal sections were stained with an antibody against either pdgf or the monoeyte/macrophage marker cd68, in both groups the pdgf ~9 cells were essentially tissue macrophages. using point counting to measure volume fraction (vv) , pdgf-pesitive cells represented 4.65+1.63% (mean+sd) of the volume occupied by lung tissue in the boop cases, and 2,12+0.65% in the controls (!0<0,001). similarily, 10.73+4.69% of the lung tissue was occupied by cd68 e~ macrophages in the boop cases, compared to 5.37:~3.73% in the controls (p